#version: 0.2
i n
t i
r e
t h
a n
e n
e r
e d</w>
o n
o f</w>
a t
r o
i n</w>
th e</w>
i t
a ti
a r
an d</w>
o n</w>
s i
a l
s t
a l</w>
o r
i c
a s
d i
e c
en t
a c
l o
in g</w>
d e
o r</w>
a s</w>
u r
t o</w>
e r</w>
w it
u l
wit h</w>
s e
o m
a m
o l
u c
e s
re s
o c
l y</w>
in e</w>
l e
en t</w>
p h
p ro
o u
p ati
c on
r i
w as</w>
d uc
ati on</w>
T h
er e</w>
v e</w>
i d
e s</w>
at ed</w>
a d
o s
v e
s .</w>
h e
p er
f f
a t</w>
i s</w>
a n</w>
i c</w>
m e
o t
a g
a p
i l
w ere</w>
ent s</w>
u s
c h
c e
i m
duc ed</w>
ti on</w>
i s
a b
t re
h y
t er
c om
t r
f or</w>
Th e</w>
p a
s u
n e
in e
o x
ec t
b y</w>
u n
pati ents</w>
e x
in duced</w>
b e
p l
re n
v er
e ff
ati on
in c
w e
e n</w>
r at
h i
a r</w>
it y</w>
m ent</w>
t er</w>
s ,</w>
p res
re as
a f
re d</w>
c ar
i f
m in
th at</w>
u t
h a
n o
c e</w>
s y
ti on
o p
g n
l i
t e
0 .
u d
l e</w>
r a
- induced</w>
m a
an t
ti c</w>
af ter</w>
tre at
m o
y .</w>
p re
v i
w h
g /
i st
at e</w>
ro u
p t
e m
th er
p or
con t
ti ve</w>
i z
u m
si on</w>
q u
ic al</w>
c l
) .</w>
e p
si gn
as e</w>
an t</w>
d o
ul ar</w>
c o
r u
m on
p o
th e
d a
b e</w>
e t
h o
u m</w>
on e</w>
g h
ur e</w>
ou s</w>
p ar
in f
d .</w>
os e</w>
re ce
i r
inc reas
no t</w>
if ic
car di
ther ap
s er
m g/
ect s</w>
an ti
treat ment</w>
g rou
res p
si s</w>
an g
sign ific
th er</w>
) ,</w>
or m
y ,</w>
e l
v ed</w>
g en
ent r
in g
i a</w>
b u
s e</w>
ar y</w>
lo w
m ic
d ru
u re
min ist
y l
hy per
ti v
c or
m or
as s
ad minist
e v
oc i
c a
ro m</w>
en ce</w>
I n</w>
t en
lo g
si on
d ur
f rom</w>
s p
o b
al ly</w>
e .</w>
re l
ti c
u ro
ass oci
lo p
u s</w>
S :</w>
pa th
eff ec
di s
th is</w>
t a
st ud
e ar
in d
eff ects</w>
re por
ar e</w>
es e</w>
tr a
b lo
us e</w>
de ve
p ot
tre ated</w>
ha d</w>
i d</w>
oc a
t ed</w>
ox ic
d ose</w>
O N
ve l
a z
t s</w>
d er
s ho
i o
deve lop
e st
ro m
th an</w>
associ ated</w>
e ,</w>
mg/ k
i th
se s</w>
su b
ti m
c ur
ac tiv
dur ing</w>
+ /
0. 0
f ol
f i
ou n
ation s</w>
cont ro
bu t</w>
m y
s c
o l</w>
resp on
ut e</w>
in j
id e</w>
ne uro
or y</w>
c y
o log
un c
l l
pot en
w ith
r an
administ r
rece i
ma y</w>
d ec
us ed</w>
v en
res ul
effec t</w>
pati ent
am ine</w>
i ti
rat s</w>
l l</w>
m ent
ren al</w>
stud y</w>
g h</w>
pati ent</w>
( 1
in ed</w>
p os
W e</w>
b o
o d</w>
ff e
en d
an c
in ter
i a
ati ve</w>
d ,</w>
be en</w>
tr an
v er</w>
+/ -</w>
therap y</w>
da y
t oxic
d y
ar di
grou p
n orm
si ve</w>
ag e</w>
es s</w>
ac t
signific ant
hi b
pres s
r on
c oca
d e</w>
fol low
es t</w>
we e
ha ve</w>
f unc
es .</w>
increas ed</w>
w he
com p
al l</w>
ation .</w>
be t
a il
al u
p i
f l
dec reas
sy n
significant ly</w>
0 0</w>
ot h</w>
ch ang
se iz
- 1
c entr
g g
u b
wh o</w>
cl in
me th
t w
l on
y ear
g i
mic ro
dru g
le vel
ac ute</w>
ic h</w>
en c
an ce</w>
administr ation</w>
n o</w>
wh ich</w>
v as
in tra
in v
at e
rece pt
ec h
su gg
am in
u di
( 2
ri s
in hib
or s</w>
grou p</w>
ag on
he m
ou t</w>
he ar
s t</w>
ffe ren
h as</w>
t ri
ab le</w>
re e</w>
f ail
id ence</w>
sho w
hi gh
di se
g l
signific ant</w>
gh t</w>
ob ser
s o</w>
p e
st udi
ve n</w>
cardi a
th ese</w>
S I
g r
d ro
g ra
dru g</w>
we en</w>
ec tion</w>
blo od</w>
develop ed</w>
bet ween</w>
re qu
ou r</w>
m pt
c ase</w>
oc ardi
an al
ul d</w>
v entr
di fferen
b oth</w>
ec tive</w>
pro te
Th is</w>
activ ity</w>
st r
me di
tran s
pa red</w>
al so</w>
s en
ine -induced</w>
sy st
wee k
de p
ventr ic
ine .</w>
f orm
f or
al l
si b
oc cur
1 .
b r
tion s</w>
i al</w>
re at
tw o</w>
ect ed</w>
rel ated</w>
o ther</w>
ure s</w>
c as
ine ,</w>
it s</w>
rat e</w>
clin ical</w>
i t</w>
m a</w>
ph en
de r</w>
d ic
com pared</w>
s ec
re c
tion .</w>
in u
ti al</w>
iz ed</w>
m an
lon g
m il
5 -
C L
mpt om
e th
es ,</w>
level s</w>
er g
tr ac
f ir
al s</w>
pl ic
n on
cardia c</w>
M E
mor e</w>
ventric ular</w>
cont inu
a st
i de
m g</w>
g e
mg/k g
t o
ol d</w>
v ing</w>
coca ine</w>
ver ,</w>
al o
p ri
SI ON
% )</w>
a in
u sion</w>
te st
lo w</w>
c lo
duc tion</w>
con centr
y p
hyper ten
R E
hear t</w>
ar i
ar ter
per i
S U
pl as
0 0
he pati
mo de
ev alu
c al
er al</w>
ec ti
d om
s ur
c ular</w>
increas e</w>
do ses</w>
si a</w>
resul ts</w>
contro l</w>
ris k</w>
C ON
se s
dep end
ep i
ou s
di d</w>
CL U
CON CLU
ti s</w>
CONCLU SION
sy mptom
m i
e -
si st
ne ph
Th ese</w>
b l
ver se</w>
se v
mon th
th i
A C
n it
re g
ch ol
an im
day s</w>
rat s.</w>
i .
y c
he mo
inc l
ch ron
com b
es the
show ed</w>
m al
recei ved</w>
treat ment
le p
ech an
blo c
do se
L T
a x
inhib it
ti g
toxic ity</w>
l ess</w>
si de</w>
my ocardi
m at
le v
u e</w>
l at
dy s
c i
il e</w>
norm al</w>
I n
su p
da y</w>
m echan
o ph
ation ,</w>
T H
it y.</w>
hy poten
follow ing</w>
path y</w>
press ure</w>
s ti
th rom
5 0</w>
ant agon
obser ved</w>
sev ere</w>
e i
2 .
func tion</w>
respon se</w>
is o
u se
T I
hi st
ac tion</w>
li ver</w>
mg/k g</w>
ven ous</w>
b as
an e
oun d</w>
ul ation</w>
o di
de ter
ar k
hy th
e d.</w>
v al
pa in</w>
incl ud
r hyth
oc y
v ul
we ver,</w>
SU LT
e d
at ing</w>
RE SULT
me as
or al</w>
de f
pl ac
an d
in al</w>
repor ted</w>
t ac
RESULT S:</w>
gra ph
ol y
po st
O D
chang es</w>
1 0</w>
il ity</w>
repor t</w>
tion ,</w>
s uc
chron ic</w>
f e
sib le</w>
recept or</w>
ri b
whe n</w>
se l
il l
us ing</w>
os t</w>
on ly</w>
d op
ind ic
k e</w>
ser um</w>
f act
m us
es tig
ic in</w>
ine -
e red</w>
t ro
comp le
' s</w>
l im
er s</w>
me an</w>
inv estig
m un
per id
myocardi al</w>
in .</w>
ME TH
pres sion</w>
l it
y m
olog ical</w>
ati c</w>
vas cular</w>
pres ent</w>
erg ic</w>
fail ure</w>
neph ro
in ,</w>
ar c
as ses
w e</w>
ous ly</w>
ad verse</w>
con vul
h or
hy dro
b ra
os ph
1 0
s ed</w>
5 %</w>
with out</w>
ce ll
t h</w>
th ree</w>
un der
bloc k
METH OD
decreas ed</w>
therap y.</w>
fi b
per io
- old</w>
y -
pro t
st er
c an</w>
th ou
in -
mechan is
p it
me t
fir st</w>
anal y
inc idence</w>
for e</w>
at ri
2 -
f requ
epi lep
E C
g lo
resp ecti
ex pos
ia .</w>
ph osph
v ari
gi ven</w>
cas es</w>
re duced</w>
w om
ab ol
tim e</w>
( P
i l</w>
a .</w>
inj ection</w>
b i
ver y</w>
d at
sugg est</w>
ad e</w>
u al</w>
sion .</w>
ar rhyth
recei ving</w>
d rom
i r</w>
m ost</w>
tion al</w>
si s.</w>
d ue</w>
u p
c at
3 .
patient s.</w>
administ ered</w>
s tim
al ph
de sc
si mil
hi gh</w>
ect ro
inf l
sen si
n er
t ing</w>
plas ma</w>
com plic
dise ase</w>
p at
in iti
ar g
im mun
comb in
as t</w>
re f
seiz ures</w>
plac e
en z
syn drom
f ound</w>
s y</w>
b le
im pro
ha vi
p r
em ia</w>
T o</w>
fl u
th ose</w>
pre vi
sion s</w>
respecti vel
hy po
ocy t
ac et
sec on
ia ,</w>
( A
an esthe
s )</w>
sho uld</w>
m it
t ot
H o
sp ec
f ind
o re
METHOD S:</w>
m ac
2 0</w>
sugg est
ent ed</w>
thou gh</w>
c ap
m er
s al
ma in
sy ch
( C
ca used</w>
sub j
h alo
year -old</w>
x im
il d
high er</w>
cardi o
we ll</w>
contro l
syst em
d ox
be havi
eff ect
com m
inf usion</w>
enc y</w>
ing s</w>
P A
intra venous</w>
duc e</w>
se qu
depend ent</w>
a ff
ei ther</w>
ent ly</w>
ad ren
per im
ce ll</w>
dise as
occur red</w>
t yp
c anc
sion ,</w>
gen er
mic e</w>
week s</w>
on ary</w>
a y
syndrom e</w>
symptom s</w>
studi es</w>
o gen
it e</w>
m ark
or ub
3 0</w>
ac id</w>
d am
simil ar</w>
the ir</w>
am p
p sych
gr am
de mon
be fore</w>
ve l</w>
re co
ou t
el ectro
ad di
d s</w>
( P</w>
h e</w>
d ra
re ac
group s</w>
pro g
si de
p er</w>
Ho wever,</w>
ran dom
norm al
no w
ce re
develop ment</w>
CONCLUSION S:</w>
bra in</w>
di ag
s om
com par
k g
C A
f t</w>
ve ly</w>
po si
en ti
e m</w>
r h
es s
in -induced</w>
at al</w>
ec t</w>
k now
A l
ne ur
lo s
drug s</w>
ic i
a ,</w>
vi e
V E
a v
k e
m ul
1 9
3 -
pro duced</w>
o ver</w>
k ine
dra w
4 -
cor onary</w>
dis continu
re ver
t ol
k ing</w>
dat a</w>
met abol
d ed</w>
en ce
m s</w>
5 0
ol e</w>
cur ren
ter m</w>
p ine</w>
ex perim
U N
m ia</w>
c hem
treatment .</w>
per form
mor ph
c ul
decreas e</w>
st at
combin ation</w>
ph y
inv ol
tot al</w>
c hemo
ure .</w>
o ver
month s</w>
in to</w>
am ide</w>
ch ild
R O
ox y
n ec
be ta
dis or
with in</w>
it y,</w>
t ox
se ver
m in</w>
ar ac
r ang
c le
low er</w>
ab ility</w>
e d,</w>
b ut
re t
um b
ti s
ro le</w>
dox orub
pre v
b ec
anim als</w>
with draw
ac h</w>
tol er
s ul
hypoten sion</w>
di st
L -
we i
suc h</w>
is t</w>
y o
4 .
i ly</w>
wh ile</w>
cardi a</w>
0.0 0
trans pl
non -
am ph
g reat
por t
r ine</w>
v alu
v al</w>
id ine</w>
ot or</w>
r at</w>
e lev
on e
( 3
u red</w>
mode l</w>
ca use</w>
1 2</w>
lo c
I t</w>
ol ic</w>
l or
ic ac
m is
ox id
mg/ m
e u
me dic
Th ere</w>
% ,</w>
br al</w>
u res
pi lo
s on
ic ally</w>
ho ur
find ings</w>
re gi
ra di
ane ous</w>
effec tive</w>
ex c
I I
v id
ar mac
f our</w>
c le</w>
th ere</w>
) -
A f
et y</w>
i p
le ft</w>
tac hy
z ed</w>
throm bo
h um
i es</w>
o per
M A
u r</w>
az ep
op en
sur g
at es</w>
uc le
t ub
dose -
o id
al e</w>
cy clo
1 -
e re
v ol
do g
t um
olog ic</w>
re as</w>
de s</w>
cat al
se t</w>
con cl
an y</w>
t e</w>
re ve
dy n
al ed</w>
ot oxic
i red</w>
5 .
eff icac
patient s,</w>
ur al</w>
d ing</w>
ent al</w>
pro long
- term</w>
a y</w>
u p</w>
d os
inf arc
re vie
m ents</w>
( S
K G
ant s</w>
halo perid
( 0.
le vel</w>
alph a
T w
concentr ations</w>
anc ed</w>
hepati c</w>
m ic</w>
1 5</w>
s af
ex peri
mode l
arter ial</w>
differen t</w>
is h
- dose</w>
v it
con di
B AC
s ing
a use</w>
RO UN
KG ROUN
BAC KGROUN
2 4</w>
da ily</w>
ap pro
meth yl
co uld</w>
c in
m ol
k in
A n
m ine</w>
prog res
pilo car
inj ur
at ory</w>
li thi
de t
arac ter
e tic</w>
y l</w>
poten tial</w>
s odi
ag ain
great er</w>
pe a
inj ec
micro gram
ing .</w>
p ac
an e</w>
O B
si s,</w>
re duction</w>
J EC
A N
ph eral</w>
d ul
Af ter</w>
im pa
ex am
pro p
bas el
again st</w>
c ol
u l</w>
in ary</w>
g en</w>
ar b
en s
0.0 5
hyperten sion</w>
ch aracter
stim ul
s a
ing ,</w>
l ab
. )</w>
l ine</w>
includ ing</w>
car b
f em
7 .
TI VE
bo d
OB JEC
o id</w>
al ter
l in
di ab
oca ine</w>
amph et
studi ed</w>
g o
OBJEC TIVE
at ten
is chem
glo mer
ad y
neur on
co ur
w ar
1 )</w>
p ul
6 -
hepati tis</w>
lo l</w>
dop amine</w>
ph armac
ur ther</w>
phy si
i ous</w>
2 0
mg/kg )</w>
6 .
( p</w>
ev idence</w>
on g</w>
i tion</w>
on ic</w>
am e</w>
o graph
p p
nit ro
reve aled</w>
pos sible</w>
n umb
BACKGROUN D
str uc
ro p
r ac
on set</w>
e ach</w>
ve ment</w>
year s</w>
prote in</w>
al ,</w>
meas ured</w>
ate ly</w>
am e
os pit
cell s</w>
beta -
prote in
pri m
en h
peri pheral</w>
centr al</w>
infl am
bod y</w>
l id
us ,</w>
N T
mon it
O n
br ady
1 ).</w>
follow ed</w>
dur ation</w>
yc in</w>
th al
iti es</w>
comm on</w>
S E
BACKGROUND :</w>
mal e</w>
th rou
l if
im port
ent an
A d
ac ti
p y
vi r
ch lor
catal ep
it ed</w>
v ac
tic s</w>
P ati
n a
o f
ll ed</w>
on t
perform ed</w>
G rou
ap p
seiz ure</w>
eu tic</w>
n ic
ad en
4 0</w>
antagon ist
A ll</w>
id enti
sodi um</w>
ri c</w>
( n</w>
poten ti
tic al</w>
s m
previ ously</w>
posi tive</w>
ad ul
c um
CONCLUSION :</w>
f low</w>
a in</w>
re ,</w>
po in
whe ther</w>
A D
Al though</w>
f ul
efficac y</w>
ge si
de x
evalu ated</w>
o d
ine ph
concentr ation</w>
chol est
wee k</w>
fl ur
t ly</w>
is m</w>
ta ined</w>
therap eutic</w>
1 ,</w>
N A</w>
y e
ma j
s ol
di vid
mg/kg ,</w>
mus cle</w>
he mor
b il
cere bral</w>
a d</w>
6 0</w>
he pat
re n</w>
l y
p oly
canc er</w>
curren t</w>
str ated</w>
c es</w>
pro po
ur ia</w>
hemor rh
enz ym
desc ri
A B
mic e.</w>
c is
stat us</w>
le u
secon d
n i
know n</w>
cardi om
cal ci
- treated</w>
ar ly</w>
an s</w>
pl e</w>
par tic
ce p
om a</w>
2 5</w>
perio d</w>
expos ure</w>
t .</w>
re duc
re cor
( N
ex pression</w>
an a
tiv ity</w>
st res
throm b
t est</w>
ear ly</w>
i. p
f en
ati n</w>
an ce
som e</w>
h ospit
ish ed</w>
child ren</w>
2 ,</w>
tox ic</w>
path y.</w>
s /
deter mine</w>
9 5%</w>
dyn am
typ e</w>
sing le</w>
r am
syst em</w>
id ne
Pati ents</w>
al .</w>
te m
k ed</w>
c oun
f ac
d ou
anti -
r ati
8 .
s hor
deter min
( D
basel ine</w>
s us
o st
S )</w>
( H
respon ses</w>
a ined</w>
demon strated</w>
az ol
hyper al
N o</w>
er .</w>
diag no
withdraw al</w>
enc ed</w>
los s</w>
con sist
N e
leu k
ac id
f urther</w>
1 00</w>
c ent
in ine</w>
numb er</w>
long -term</w>
whe reas</w>
al y
C h
z ap
oc amp
analy sis</w>
pri or</w>
ab normal
hi pp
en e
u tion</w>
mon ary</w>
l y,</w>
lit er
recept ors</w>
k idne
fi ed</w>
subj ects</w>
b o</w>
disor der
cardio vascular</w>
gl ut
m g
psych o
c ess
asses sed</w>
( 4
a th
si x</w>
i. v
c it
c er
P )</w>
seiz ures
I I</w>
re sist
P ro
pro duc
place bo</w>
hipp ocamp
de l
as si
di rec
chang e</w>
ation s.</w>
transpl ant
fi ve</w>
diseas e.</w>
bec ause</w>
convul s
al ity</w>
A c
system ic</w>
el l
includ ed</w>
A )</w>
ur inary</w>
nic ot
fact ors</w>
ep iso
ence ph
ac tive</w>
st ar
OBJECTIVE :</w>
r ap
oc h
c reat
in trac
i v
s hi
s :</w>
on e.</w>
in ten
( M
re le
mul ti
respectivel y.</w>
medi an</w>
pro b
A T
ad v
or ph
gl yc
exam ined</w>
0 %</w>
differen ces</w>
se en</w>
S T
surg er
sel ective</w>
rib ed</w>
olog y</w>
t ,</w>
stud y.</w>
ro s
he par
sur vi
e de
st ro
am ong</w>
R e
pro st
hour s</w>
hist ory</w>
hum an</w>
st ri
increas es</w>
mechanis m</w>
investig ated</w>
ti es</w>
prote ren
indic ate</w>
A M
tis su
in duc
f er
app ear
sub st
doxorub icin</w>
p ir
inf u
C om
u lo
ang io
ud e</w>
o -
min ut
bl ad
arter y</w>
w or
5 ,</w>
me n</w>
f entan
0 -
ge sia</w>
Grou p</w>
li ke</w>
- 1</w>
sensi tivity</w>
a u
sp inal</w>
cardiom yo
he ad
is ol
a w
oper ative</w>
prolong ed</w>
m m
he al
2 )</w>
resul ted</w>
sp ont
lithi um</w>
hyperten sive</w>
r it
ol -induced</w>
c ir
m en
experim ental</w>
su s</w>
ne w</w>
f ul</w>
atten u
ag e
A I
ren ce</w>
pres ented</w>
if ic</w>
- bl
otoxic ity</w>
chemo therapy</w>
l as
iz ation</w>
e l</w>
dys kine
ma xim
wom en</w>
liter at
medi ated</w>
gl uc
hydro x
f ol</w>
p le
ner v
f ic
8 -
second ary</w>
am ide
pres ent
re s</w>
pro f
contro lled</w>
e ti
E ff
% ),</w>
wei ght</w>
j u
mechanis ms</w>
sc op
ag ent</w>
maj or</w>
de press
ab s
ver sus</w>
cl on
G AB
iti s</w>
ev ents</w>
ag ent
the li
throu gh</w>
import ant</w>
calci um</w>
rat es</w>
spec ific</w>
n ucle
a ut
I C
dou ble
re st
bi op
in duction</w>
ro sis</w>
ate d.</w>
A t</w>
% ).</w>
dro me
cap sa
arrhyth mi
i ed</w>
dis c
ti co
pres su
le s</w>
am eth
frequ ency</w>
car cin
atri c</w>
ra z
syn drome
inhib ition</w>
m otor</w>
lo ro
associ ation</w>
en do
Tw o</w>
iso proteren
group s.</w>
v is
prim ary</w>
en g
dys function</w>
toxic ity.</w>
P re
ox ide</w>
N -
head ac
neuro pathy</w>
D E
s ame</w>
ster oid
p op
hem at
a k
1 4
inflam mat
cy t
pa m</w>
fem ale</w>
di ff
n ot
( E
tachy cardia</w>
ic e</w>
un der</w>
wom an</w>
ar d</w>
elev ated</w>
H B
a si
vac a
n ess</w>
er ,</w>
ati s
ab l
st and
o ro
infl u
m .</w>
alpha -
cyclo phosph
ab ly</w>
arb it
1 4</w>
ti s.</w>
pl us</w>
inflammat ory</w>
lid ocaine</w>
k al
tran si
pi vaca
comple te</w>
fib ri
con trac
con side
t al</w>
con f
res ol
experi enced</w>
ph ase</w>
or s.</w>
g u
P O
sup por
pul monary</w>
pre treatment</w>
differen ce</w>
ain ing</w>
l arg
m l
convuls ant</w>
ti l
impa ir
glo b
b ol
al one</w>
lit ax
i gn
o m</w>
k et
ag ents</w>
on i
neuro log
ta king</w>
s ;</w>
o lol</w>
1 3
u ally</w>
propo fol</w>
fibri ll
e qu
double -bl
ur ine</w>
tri al</w>
re ma
m m</w>
n ing</w>
rat s,</w>
d oc
antagon ist</w>
C on
on e,</w>
oc c
dam age</w>
9 .
repor ts</w>
o sis</w>
gr ade</w>
injur y</w>
random ized</w>
M D
place bo
in duce</w>
( -1
m b
( T
inj ected</w>
ho wever,</w>
u ses</w>
sub sequ
pres ence</w>
e pam</w>
agon ist
stim ulation</w>
S t
blad der</w>
at eral</w>
5- H
f o
u s.</w>
out com
1 2
v s</w>
c ut
x i
ac in</w>
O ur</w>
e ven</w>
diagno sis</w>
show n</w>
stud y,</w>
m ag
de g
administr ation.</w>
+/ -
res h
dynam ic</w>
dog s</w>
an emia</w>
sever al</w>
7 -
se d
ation shi
p ent
gen ic</w>
cour se</w>
amphet amine</w>
re tion</w>
hy p
C I
treatment ,</w>
ex amin
in d</w>
fail ure.</w>
n os
struc t
ot on
t y</w>
stres s</w>
ogen e
enceph alo
con tr
b ac
s in
re pe
p en
b enz
sal ine</w>
s ).</w>
D -
s o
py ri
pre dic
per f
tic ally</w>
secon d</w>
m id
infarc tion</w>
group .</w>
a re
A n</w>
follow -
1 1</w>
ye ar</w>
reac tions</w>
therap y,</w>
initi al</w>
On e</w>
pro l
ag e,</w>
rel ationshi
previ ous</w>
- related</w>
ana esthe
saf ety</w>
op io
su ff
sp ective</w>
fact or</w>
as pir
i g
effect s.</w>
ne g
s it
comb ined</w>
ab out</w>
t op
mo der
str ic
li ke
( 5
t y-
th resh
ro w
os ine</w>
ocyt open
discontinu ation</w>
is on</w>
ay ed</w>
le ast</w>
d ar
in divid
d -
conside red</w>
a ver
per sist
te d.</w>
m an</w>
li p
in tr
glomer ular</w>
cum ul
pos sib
oc ic
ob arbit
inter val</w>
ur ing</w>
func tion.</w>
pre gn
pac litax
mark ed</w>
behavi oral</w>
bas ed</w>
rang e</w>
l ym
c an
1 6</w>
par t
on d
the sis</w>
t en</w>
resul t</w>
al ine</w>
ure ,</w>
ro lim
ineph rine</w>
determin ed</w>
ag e.</w>
expos ed</w>
regi on
oc hem
mil d</w>
my o
c ent</w>
inhibit or</w>
f ree</w>
(2 )</w>
at h</w>
er y
adul t</w>
prot ective</w>
pilocar p
ell ular</w>
al s.</w>
sever ity</w>
p tion</w>
i di
g ast
evalu ate</w>
s co
high -dose</w>
cor rel
con fir
atri al</w>
in o
I V</w>
ner ve</w>
descri be</w>
demon st
v s.</w>
diab etic</w>
) ;</w>
pat ter
ap pea
ang i
activ ation</w>
P A</w>
the y</w>
impro ved</w>
epilep tic
cont rib
diag nos
b le</w>
mor t
AN D</w>
tim es</w>
rati o</w>
phen y
oph yl
haloperid ol</w>
az epam</w>
catalep sy</w>
a sis</w>
the tic</w>
pa ren
e very</w>
anal gesi
suggest s</w>
I S
en d</w>
b io
thromb ocytopen
ch loro
ex er
( L
( -
zap ine</w>
ri pt
or g
inter sti
heal th
b ro
am in</w>
d r
1 7
requ ired</w>
st e
sen s
C a
1 3</w>
revie w</w>
ol ,</w>
re tro
y n
ob tained</w>
con tra
1 5
re action</w>
im en
s h
re x
rat ory</w>
acet yl
disc us
ti zed</w>
me mb
ser oton
sul f
lym ph
ame ter
ic ill
de li
3 ,</w>
reas t</w>
i f</w>
f oc
complic ations</w>
um .</w>
2 00
t u
qu in
microgram s/
inc e</w>
0 ,</w>
ph yl
valu es</w>
lev o
1 8</w>
intersti tial</w>
M e
and /
D i
tre m
my e
m es
and/ or</w>
2 %</w>
y ro
ta k
de ath</w>
H y
obser v
invol ved</w>
ev ent
enzym e</w>
le sions</w>
io dar
rele ase</w>
ol .</w>
ment al</w>
all y,</w>
ate le
th en</w>
b reast</w>
suggest ed</w>
reco very</w>
n al</w>
fe at
1 %</w>
ri am
aly sis</w>
vi v
respon se
I V
monit or
com mon
y oun
tion s.</w>
it ing</w>
a m</w>
al ized</w>
se d.</w>
day s.</w>
al though</w>
t -
s k
e pt
E x
pl atin</w>
glyc er
b ind
ag es</w>
1 8
val pro
like ly</w>
oly tic</w>
hor mon
sign s</w>
l y.</w>
azep ine</w>
y st
l u
P ark
O n</w>
( 6
sy m
ma z
mo di
bu pivaca
nerv ous</w>
mis sion</w>
epilep tic</w>
complic ation</w>
activ ity.</w>
phen yl
mi ght</w>
i or</w>
per it
Ac ute</w>
ve ,</w>
rema ined</w>
ati vely</w>
alph a</w>
st ,</w>
ocic ep
rever sible</w>
go ing</w>
Park in
D O
n or
enh anced</w>
be ing</w>
use .</w>
sm all</w>
ro ph
( B
ri tis</w>
lo x
ic in-induced</w>
P h
A L
k g</w>
C O
wei gh
adv anced</w>
m ou
P -
1 6
tum or</w>
loc al</w>
H g
man if
en ing</w>
P T
C lin
D )</w>
tissu e</w>
p ur
e t</w>
brady cardia</w>
p ec
le .</w>
ex pl
ery th
3 %</w>
B oth</w>
ot ens
an ne
abnormal ities</w>
ve d.</w>
relationshi p</w>
ref le
pro per
pl atele
b ene
kidne y</w>
col l
as s</w>
prop ran
def ici
syst olic</w>
morph ine</w>
R )</w>
pro ce
. ,</w>
ven tion</w>
pilocar pine</w>
con duc
adren ergic</w>
seizures .</w>
hyperal gesia</w>
health y</w>
c op
W he
ser ious</w>
ac hi
ad ju
ex trac
vol um
te red</w>
i ratory</w>
or atory</w>
N S
v es</w>
mye lo
appea red</w>
st atis
par ameter
g row
do es</w>
me mor
creat inine</w>
addi tion,</w>
f -
di g
character is
tro ph
perit one
na use
desc ribed</w>
co ag
ation al</w>
r he
Th e
test ed</w>
ri l</w>
group ,</w>
re .</w>
min im
eth yl
a thi
tem por
re main
memb ran
me d
ca uses</w>
ox if
g ran
cumul ative</w>
ation s,</w>
( 7
A -
pot assi
resp iratory</w>
glut am
transi ent</w>
multi ple</w>
me ta
drug .</w>
ch anne
asses s
si a.</w>
vit amin</w>
o path
O f</w>
tub ular</w>
ri st
reco gn
minut es</w>
st ained</w>
investig ate</w>
week s.</w>
r ing</w>
graph ic</w>
con ver
coca ine-
m uc
de pres
ab dom
theli al</w>
occur rence</w>
hydrox y
um ,</w>
ev o
direc t</w>
19 9
( 8
cut aneous</w>
aff ected</w>
m ed</w>
cont aining</w>
re d.</w>
vari ous</w>
spont aneous</w>
ot yp
ex hib
n al
f r
ay s</w>
ab il
for m</w>
contr ast</w>
S E</w>
or s
par tial</w>
occ ur</w>
injec tions</w>
convul sions</w>
c y</w>
mg/m 2</w>
prev ented</w>
continu ous</w>
anesthe sia</w>
vas cul
rel ative</w>
med ical</w>
ap am
ag ed</w>
re p
manif est
bloc k</w>
0.05 ).</w>
ex ten
impro vement</w>
ri al</w>
pro v
pro duce</w>
de ath
chol in
ar th
a i
D uring</w>
( R
sho w</w>
in s</w>
identi fied</w>
H g</w>
r are</w>
l ,</w>
immun o
angi otens
C B
i.v .</w>
ei ght</w>
Parkin son
prev ent</w>
pres c
poin t
t ent</w>
anim al</w>
am iodar
se ven</w>
M T
( O
s ch
de pression</w>
a c</w>
s mo
re comm
(1 .
xim ately</w>
i tive</w>
ede ma</w>
asses s</w>
a ro
th ir
i ally</w>
( G
frequ ently</w>
dos age</w>
5-H T
ri ght</w>
l ac
survi val</w>
sign ed</w>
moder ate</w>
neuron s</w>
inhibit ed</w>
R NA</w>
4 %</w>
( +
Th ree</w>
ograph y</w>
form ation</w>
reg imen
ochem ical</w>
res t</w>
or ,</w>
meas ure
doc um
gl y
agon ist</w>
compar ison</w>
% .</w>
pot ent</w>
es tive</w>
E R
1 ),</w>
pharmac o
ameth as
ogen ic</w>
mal ign
comple te
appear s</w>
an xi
we ll
cor e</w>
ti me
suff ici
ischem ic</w>
est abl
ud ed</w>
d n
ca ffe
anc es</w>
H C
mit ted</w>
er o
abs ence</w>
2 1</w>
p an
im medi
co gn
ud ine</w>
s .
respectivel y
monitor ing</w>
com it
an d,</w>
lo com
ch est</w>
N a
pro c
im plic
w at
l ast
cle ar
proce d
flur ane</w>
increas ing</w>
halo th
h er</w>
s -
ri g
em ic</w>
ech ocardi
bind ing</w>
ane ously</w>
addi tion</w>
suggest ing</w>
neuro lep
influ ence</w>
diab et
cy sti
em ia.</w>
drug s.</w>
amin o
se x
in test
control s</w>
ot rop
medic ation</w>
k s</w>
w ide
under going</w>
syndrome .</w>
contra st,</w>
sy .</w>
l am
il tr
es s,</w>
nicot ine</w>
episo des</w>
6 %</w>
w ent</w>
s ity</w>
post -
le ad
dop a</w>
och ond
m al</w>
1 ,
of ten</w>
follow- up</w>
biop sy</w>
ti z
cep ti
th ec
protein uria</w>
di l
micro g/
m ar
amin ergic</w>
sin us</w>
hyper troph
adren oc
gener ation</w>
bo di
4 ,</w>
ogene sis</w>
ur ther
f ar
o red</w>
neg ative</w>
c ros
8 %</w>
lip id</w>
l ed</w>
um -
paclitax el</w>
def ic
volum e</w>
vi r</w>
ent am
disor der</w>
arrhythmi as</w>
P G
u sion,</w>
ox ic</w>
or s,</w>
T reat
. 0
consist ent</w>
(1 0</w>
f et
e di
inf ec
cor tico
in ic</w>
in de
func tional</w>
er s.</w>
ch all
ag l
Q T</w>
l un
t s.</w>
sensi tive</w>
appro ximately</w>
sus cepti
model s</w>
mag ne
resul ting</w>
evalu ation</w>
e p</w>
ur ac
ti l</w>
over all</w>
inc rist
hyperten sion.</w>
hospit al</w>
drug -induced</w>
cyclophosph amide</w>
at e,</w>
repe ated</w>
pa thetic</w>
om e</w>
mort ality</w>
literat ure</w>
wh om</w>
ur b
regi men</w>
recei ve</w>
re duce</w>
nephro tic</w>
ep ti
dex amethas
addi tional</w>
month s.</w>
man age
im ag
es pec
b or
anti psycho
al lo
a vir
ran ial</w>
pen icill
( I
impair ment</w>
espec ially</w>
mg/k g/
deg ree</w>
at e.</w>
ret ur
d g
S er
2 .</w>
ul arly</w>
aspir in</w>
S i
2 00</w>
ris perid
h al
av ail
vis ual</w>
subsequ ent</w>
hepar in</w>
coca ine-induced</w>
con sc
carb am
9 %</w>
us ers</w>
transpl ant</w>
press ed</w>
a de
r o</w>
dose- dependent</w>
b ri
C ardi
( 1</w>
under went</w>
potassi um</w>
post operative</w>
es tim
cy cl
ot rex
cardiomyo pathy</w>
achi e
3 )</w>
opio id</w>
m ut
arrhyth mic</w>
larg e</w>
C )</w>
A R
1 7</w>
ru s</w>
rolim us</w>
ic ul
concl ude</w>
antagonist s</w>
al co
Whe n</w>
8 0</w>
ver apam
thresh old</w>
m ,</w>
patient 's</w>
pa in.</w>
control s.</w>
a ke</w>
y cl
v om
c al</w>
alter ations</w>
acti vi
u tive</w>
s he</w>
or .</w>
mit ochond
progres sive</w>
pro phyl
platele t</w>
ore ,</w>
nec rosis</w>
do pa
4 8</w>
sk in</w>
p ected</w>
ocyt e</w>
clin ically</w>
U R
om orph
h ic
t om
stand ard</w>
memor y</w>
inhibit ors</w>
au th
I m
y ing</w>
micro scop
ex ist
attenu ated</w>
6 ,</w>
un d
suppor t</w>
he dul
chall eng
5 )</w>
D e
pl at
T R
ophyl line</w>
7 %</w>
d en
0. 5</w>
thrombo sis</w>
re current</w>
pre dn
ent .</w>
az ine</w>
( V
te en</w>
su stained</w>
he x
surger y</w>
par kin
comp oun
sp ite</w>
o z
flu oro
feat ures</w>
T )</w>
id al</w>
i.p .)</w>
b one</w>
Tw ent
H e
F urther
use ful</w>
the re
Treat ment</w>
st age</w>
sch iz
mol /
st ron
hippocamp al</w>
cy to
test s</w>
qu anti
con comit
9 0</w>
ta in</w>
initi ation</w>
ent ,</w>
d ine</w>
con sec
cogn itive</w>
am ine-induced</w>
aff ect</w>
Th us,</w>
t am
revie w
grow th</w>
an th
sc hedul
o v
er ing</w>
youn g</w>
anesthe tized</w>
p ic
manage ment</w>
g entam
frequ ent</w>
fibrill ation</w>
arc h</w>
adrenoc ept
o ff
lon g</w>
intra peritone
ut ed</w>
parkin son
nec ess
n ed</w>
intest inal</w>
complete ly</w>
R ec
neuro toxicity</w>
mon o
character ized</w>
F )</w>
rap id</w>
ment .</w>
indic ated</w>
S R
oc lon
ai m</w>
ag ic</w>
tak en</w>
path w
ad riam
ab normal</w>
suc cess
exc retion</w>
di ure
cholin ergic</w>
om e
i atric</w>
aden osine</w>
TI ON
L i
vi a</w>
sti t
perf usion</w>
isol ated</w>
anti depress
W ist
N A
ter min
statis tically</w>
pro ble
id ity</w>
hypoten sive</w>
hear ing</w>
az ole</w>
anti convulsant</w>
anal o
a or
s ),</w>
is ed</w>
cholest er
ac tions</w>
ne ut
f atal</w>
evo ked</w>
epileptic us</w>
clon idine</w>
agl and
- associated</w>
ve .</w>
s core</w>
respectivel y,</w>
pea k</w>
lab oratory</w>
h our</w>
are a</w>
SE :</w>
se g
on e-
7 5</w>
v incrist
man y</w>
as .</w>
Parkinson 's</w>
se m
meta st
immun e</w>
not ed</w>
le ,</w>
gra m</w>
N O
thrombocytopen ia</w>
thec al</w>
oxy gen</w>
neuron al</w>
inter val
f y</w>
common ly</w>
C N
ni qu
maxim um</w>
l .</w>
ho l</w>
det ected</w>
cor related</w>
repor ted.</w>
sp ecti
rever sed</w>
mi x
meth otrex
lat er</w>
er gen
p ap
ob j
ine d.</w>
conduc ted</w>
1 9</w>
ref r
n ine</w>
mon th</w>
inter action</w>
g am
consec utive</w>
viv o</w>
recor ded</w>
un til</w>
neuro path
ly ing</w>
em ergen
( 9
toler ated</w>
s li
oc on
gr ad
di ast
cardi otoxicity</w>
Ne uro
u pt
pilocarp ine-induced</w>
iz ed,</w>
i an</w>
electro cardio
el der
al -
refr act
prob ably</w>
capsa icin</w>
bet a</w>
as e,</w>
al le
I N
kg (-1
id om
ac comp
oph ren
develop ing</w>
C P
ve red</w>
resol ved</w>
headac he</w>
ch arg
ro w</w>
isoproteren ol</w>
inf ants</w>
anim als.</w>
s ing</w>
fentan yl</w>
est ro
canc er.</w>
bupivaca ine</w>
ap pe
th yro
pro m
dist urb
fail ed</w>
car e</w>
ar t
per cent</w>
i ve</w>
ect om
dose .</w>
c r
- like</w>
dop aminergic</w>
w o
subj ect
sel f-
parameter s</w>
on ucle
effect .</w>
ed ly</w>
di ed</w>
rit er
ri bu
re m
rat .</w>
mg/ d
double-bl ind</w>
diagnos ed</w>
UR PO
P URPO
-1 .
m l</w>
m RNA</w>
Clin ical</w>
sym pathetic</w>
con g
block ade</w>
aver age</w>
AI D
tion s,</w>
M )</w>
( mean</w>
seroton in</w>
mechan ical</w>
con si
K -
9 -
under lying</w>
prol act
metabol ic</w>
j ection</w>
b ility</w>
at s</w>
S e
vit ro</w>
PURPO SE:</w>
% ;</w>
nit ric</w>
ischem ia</w>
arrhyth mia</w>
schiz ophren
resist ant</w>
prost agland
mo re,</w>
GAB A
D NA</w>
perio d.</w>
individ u
war far
p ren
o lo
ble ed
sco res</w>
intra ven
di pyri
st op
propran olol</w>
dipyri dam
In tra
2 ).</w>
fe w</w>
ect ing</w>
cl u
alter n
( 5</w>
resist ance</w>
las tic</w>
accomp an
C H
level s.</w>
il l</w>
ide ,</w>
hemorrh age</w>
er b
enc es</w>
di azepam</w>
ac h
S ub
(2 .
pregn anc
ne w
li e
en al</w>
ch ed</w>
wo uld</w>
refle x</w>
no rep
tam oxif
se ,</w>
rec i
del ayed</w>
P R
refract ory</w>
le ar
ap omorph
ag g
1 00
surg ical</w>
t ech
se em
or der</w>
lun g</w>
com pl
E E
) -induced</w>
pop ul
confir med</w>
v es
pre val
per cent
conf idence</w>
chlor ide</w>
ap plic
ance .</w>
rel atively</w>
bil i
al tered</w>
L )</w>
C I</w>
lam iv
anti bodi
0.05 )</w>
y s</w>
ster oid</w>
gast ro
u ter
toler ance</w>
ti s,</w>
ref ore,</w>
nal ox
Wist ar</w>
C D
v ag
s por
Eff ects</w>
ocicep tive</w>
mark edly</w>
lo p</w>
deve lop</w>
(1 )</w>
random ly</w>
patter n</w>
effect s,</w>
diseas e,</w>
8 ,</w>
sup ple
mou se</w>
bil ateral</w>
A s</w>
2 8</w>
2 3
ve hic
stri atal</w>
ru b
h is</w>
diast olic</w>
c riter
b ile</w>
n .</w>
locom otor</w>
reg ul
om eth
be g
n g/
continu ed</w>
p raz
auth ors</w>
ac ce
7 ,</w>
2 5
tri als</w>
ol ar</w>
chol ine</w>
ar ge
0.0 00
side -
s le
partic ularly</w>
Th ir
I )</w>
z e</w>
tw ice</w>
os f
no vel</w>
gen eral</w>
correl ation</w>
8 0
vas odi
obser ved.</w>
n or</w>
hyperal gesi
eth an
diabet es</w>
de spite</w>
II I</w>
prot ection</w>
upt ake</w>
eryth ro
ind ometh
foc al</w>
am ine,</w>
C S
te x</w>
re ly</w>
activi ties</w>
2. 5</w>
valu e</w>
oxid ative</w>
behavi or</w>
Further more,</w>
trem or</w>
st ra
sion s.</w>
potenti ally</w>
ex ac
c ri
an ter
ad mitted</w>
( F
el ic
dyskine si
con sequ
am ine.</w>
activ ity,</w>
ac c
R es
P ,</w>
2 50</w>
pr us
mar row</w>
ful ly</w>
transplant ation</w>
st ate</w>
recomm end
ap paren
T E
requ ir
ne on
fol d</w>
analgesi c</w>
G F
D A</w>
inde x</w>
examin ation</w>
child ren
y r
prov ide</w>
intra thecal</w>
concomit ant</w>
us ually</w>
st re
pl ay</w>
high -
exc it
est er
dis charg
da il
t s,</w>
pheny to
otrop ic</w>
inten sity</w>
t le</w>
rap id
pre vention</w>
pre treated</w>
p as
ic ,</w>
at tri
50 %</w>
ster one</w>
glomer ul
cor tical</w>
cong estive</w>
2 4
subst anti
occur ring</w>
en e</w>
demonst rate</w>
de d.</w>
u it
physi ological</w>
ing es
in suffici
impa ired</w>
et ine</w>
benz odi
i um</w>
i es.</w>
wat er</w>
gener alized</w>
appro pri
A S
0 00</w>
su per
reci pi
phen obarbit
n =
hemo dynamic</w>
ffe red</w>
progres sion</w>
ineph r
ex tr
S he</w>
P er
se arch</w>
ne x
docum ented</w>
ap op
cor tex</w>
adren aline</w>
as th
5- F
metabol it
neurolog ical</w>
imag ing</w>
doxorub ic
adju st
S H
psych iatric</w>
ne ed</w>
exhib ited</w>
em ia,</w>
A m
tempor al</w>
outcom e</w>
oni um</w>
channe l</w>
caffe ine</w>
block ing</w>
thal am
mi gra
bas al</w>
st able</w>
neurolog ic</w>
iz e</w>
hypo kal
attri but
amiodar one</w>
Q T
vir al</w>
thir d</w>
su m
al s,</w>
SI G
r al</w>
prot oc
oc or
m as
. 00
p ub
mol ec
lif er
ide .</w>
hypo thesis</w>
E )</w>
o side</w>
m ade</w>
g est
ex cep
elev ation</w>
concl uded</w>
a -
per oxid
main tained</w>
2 2</w>
wide ly</w>
im pl
cas es.</w>
vol un
my oclon
metabol ism</w>
ep inephrine</w>
am ne
C Y
nitro prus
7 0</w>
reg ar
monit ored</w>
methyl -
ha em
a di
O R
In c
pro lifer
o ti
mid azol
wh ite</w>
symptom atic</w>
sti ll</w>
oly sis</w>
da y,</w>
at ro
R enal</w>
tech niqu
ol amine</w>
hem olytic</w>
rat e,</w>
pre -
p ose</w>
ocyt es</w>
nec ro
anti coag
F or</w>
E P
DE SIG
obj ective</w>
concl usion,</w>
Twent y-
urac il</w>
proper ties</w>
pro pi
n at
low -
co hor
am oun
1 .</w>
0.00 1).</w>
on ce</w>
am pl
in si
immun os
encephalo pathy</w>
elder ly</w>
tre at</w>
mat er
l ast</w>
decreas es</w>
car ri
vi rus</w>
stri at
rhe um
mus cular</w>
es s.</w>
disorder s</w>
di et
con duction</w>
cess ation</w>
sens ory</w>
se t
meth ad
hemorrh agic</w>
graph y</w>
an ,</w>
F our</w>
z ol
at tac
anti oxid
E n
ti ally</w>
ribu tion</w>
ne ed
id ate</w>
angiotens in</w>
y :</w>
le ad</w>
ind ,</w>
ate d,</w>
haloperid ol-induced</w>
fib ro
ep id
em bol
car bo
acti n</w>
te tra
stro ke</w>
s ince</w>
rop en
perform ance</w>
ot er
mitochond rial</w>
main ten
anti bio
B ec
5 00</w>
low ing</w>
st on
sensi tiz
s oci
reg ulation</w>
di z
bi ochemical</w>
accompan ied</w>
ab use</w>
y mptom
pharmaco kine
partic ip
in a</w>
cont ent</w>
5 %)</w>
t ure</w>
p epti
metast atic</w>
le y</w>
is h</w>
func tion,</w>
discontinu ed</w>
as es</w>
year s.</w>
ul e</w>
th reat
patient .</w>
p u
do but
H -
om a.</w>
oc ular</w>
epilep sy</w>
bol us</w>
H e</w>
mo dul
ine- treated</w>
defici ency</w>
z in
ket amine</w>
induc es</w>
hypoten sion.</w>
clo zapine</w>
verapam il</w>
se par
gen ous</w>
est radi
( p
rel ap
flu id</w>
fic ial</w>
em br
compar able</w>
E D
D 2</w>
ta ke</w>
repor t.</w>
random ized,</w>
gen e
b ic
6 )</w>
4 )</w>
j unc
high ly</w>
hyper activity</w>
discus sed.</w>
convul sive</w>
v ast
r ho
pr ag
org an
malign ant</w>
ill ary</w>
en al
def ined</w>
tachy cardia
pa in,</w>
maxim al</w>
fail ure,</w>
e y
clear ance</w>
apop to
C R
retur ned</w>
pub l
ou ab
S prag
D aw
3 5</w>
pressu re,</w>
p t</w>
symptom s.</w>
s. c
pro spective</w>
in te
dexamethas one</w>
d o</w>
Bec ause</w>
( 95%</w>
pre par
lim b
agonist s</w>
achie ved</w>
en .</w>
dog s.</w>
cle s</w>
ram idal</w>
prostagland in</w>
m ia.</w>
in dependent</w>
dep le
ca the
aut o
Daw ley</w>
DESIG N
3 0
u e-
toxic ity,</w>
star ting</w>
s ite</w>
persist ent</w>
or -
om en
gr af
coun t</w>
N MD
B P</w>
is tic</w>
hy dr
2 3</w>
) )</w>
prof ile</w>
infu sion.</w>
immunos up
hormon e</w>
di et</w>
contrib ute</w>
c h</w>
se .</w>
rapid ly</w>
preval ence</w>
pre ci
plas tic</w>
os in</w>
der iv
ab o
M R
n if
mo ve
membran e</w>
lim ited</w>
iltr ation</w>
divid ed</w>
Eff ect</w>
An ti
2 6</w>
vas o
syn ap
stre pt
injec tion.</w>
hepat oc
G )</w>
D ru
1. 5</w>
t ur
rib avir
ox i
model .</w>
b ar
ati c
appe ar</w>
tum ors</w>
si mul
remain s</w>
ph al
l ate</w>
in toxic
pharmac ological</w>
le ph
comp on
ax is</w>
w a
risperid one</w>
pro duction</w>
mainten ance</w>
inf used</w>
glutam ate</w>
aor tic</w>
star ted</w>
nitro glycer
inflam m
cis e</w>
ce f
cat ech
b rom
azep am
assess ment</w>
act ing</w>
comple x</w>
as c
DESIGN :</w>
the si
sed ation</w>
mon ke
intraven ously</w>
chang ed</w>
appropri ate</w>
A ,</w>
we ak
or ation</w>
nucle us</w>
o ver,</w>
idom ide</w>
gen e</w>
block ed</w>
M y
st ere
k .</w>
f rac
A T</w>
one -induced</w>
group s,</w>
pit uit
neut ropen
my c
cysti tis</w>
con sum
a un
4 5</w>
4 4</w>
ra m</w>
placebo -
or ally</w>
fem al
dom in
day s,</w>
cor ding</w>
P .</w>
s '</w>
meth amphetamine</w>
inf ection</w>
antagonist ,</w>
w er</w>
om as</w>
g al
di alysis</w>
cyclo spor
consc ious</w>
arc in
uro myc
the ophylline</w>
par t</w>
methotrex ate</w>
in sul
anti arrhythmic</w>
threat ening</w>
pe di
neur al</w>
in st
carcin oma</w>
0.0 1).</w>
surger y.</w>
mic e,</w>
long er</w>
inc id
dose ,</w>
bec ame</w>
F ol
si g
om et
kin ase</w>
if osf
S C
th io
struct ural</w>
p al
m u
inhibit ory</w>
S .</w>
E i
meth o
day )</w>
Hy per
volun te
p s</w>
lox acin</w>
anter ior</w>
reg res
qu ine</w>
pur pose</w>
os in
m ia,</w>
lif e-
g li
condi tions</w>
avail able</w>
Sprag ue-
us ual</w>
supple ment
phen omen
double-bl ind,</w>
cis platin</w>
b re
al one.</w>
M ore
E NT
tamoxif en</w>
rheum at
path ogenesis</w>
ma .</w>
it al</w>
immedi ately</w>
descri be
am ine-
U n
well -
seizures ,</w>
res er
pro por
indic ating</w>
experi ence</w>
cyclophosph amide
bet ter</w>
V )</w>
2 ,
carbam azepine</w>
b ul
antibodi es</w>
W h
PA TI
lo fen
de n</w>
ance ,</w>
Sprague- Dawley</w>
S cal
S -
7 )</w>
ro tox
ran s
point es</w>
B e
week ly</w>
st -
p ut
ol /
log ical</w>
is e</w>
emergen cy</w>
al b
GAB A</w>
3 2</w>
3 00</w>
suscepti bility</w>
otoxic ity.</w>
cor rec
C o
wor sen
saf e</w>
presc ribed</w>
ox in</w>
o ther
long -
lid oca
lat eral</w>
invol vement</w>
gastro intestinal</w>
consi der
compoun ds</w>
M P
2 /
possib ility</w>
amin onucle
PATI ENT
HB V</w>
sup pression</w>
literat ure.</w>
lead ing</w>
l act
haloth ane</w>
gam ma
characteris tics</w>
possib ly</w>
or th
or b
nephro pathy</w>
main ly</w>
li g
el ec
C A</w>
rati o
im b
fr action</w>
depend ently</w>
compar e</w>
as ,</w>
analy zed</w>
adrenocept or</w>
throu gh
stop p
ro x
respon sible</w>
n s</w>
levo dopa</w>
high est</w>
dyskine sia</w>
Ad minist
ic ardi
exac erb
es sen
r ation</w>
min ant</w>
le th
id s</w>
ex tent</w>
c ed</w>
The refore,</w>
test ing</w>
poin t</w>
min ,</w>
ex amine</w>
c he
aun dic
anxi ety</w>
S M
R ats</w>
More over,</w>
L ,</w>
H D
rec ent</w>
r as
prom ot
ph asi
pedi atric</w>
ocor tico
inf orm
hy pe
ere bral</w>
U /
C .</w>
4 00</w>
su d
rat e
p uromyc
lif e</w>
fi el
em b
av oid
appear ance</w>
ant in
a sia</w>
S ince</w>
up on</w>
th us</w>
reco vered</w>
pos ed</w>
norep inephrine</w>
nause a</w>
h ,</w>
fet al</w>
dys function.</w>
applic ation</w>
P las
sm all
le dg
P D
5 ).</w>
v an
ol ar
gener ally</w>
con ven
at or</w>
F ive</w>
(1 00</w>
y )</w>
sh oc
pop ulation</w>
oxy gen
op tic</w>
N G
0. 1</w>
t on
recommend ed</w>
pro vid
pr amine</w>
it ation</w>
vasodi lat
ur ic</w>
mat ure</w>
in ing</w>
en ro
be ll
administr ation,</w>
C -
reduc ing</w>
p ect
injur y.</w>
ic k
e ly</w>
I F
( 2</w>
system .</w>
rec ently</w>
pic rotox
ot en
magne si
ev id
di min
condi tion</w>
stron g
neuro pathy.</w>
e mo
an other</w>
L /
3 6</w>
3 .</w>
3 ,
- dependent</w>
t or
rang e,</w>
prolong ation</w>
neph ritis</w>
le g
f at
equ al</w>
bleed ing</w>
V PA</w>
on s</w>
nif edi
includ e</w>
fic ation</w>
endo genous</w>
amin oph
( n=
si m
sex ual</w>
ograph ic</w>
antagon ized</w>
A mon
0. 6
use ,</w>
spont aneously</w>
pro ca
occur s</w>
know ledg
dopa -induced</w>
condi tion
cl ero
ari ly</w>
anth rac
aminoph en</w>
C ocaine</w>
ser ies</w>
cl assi
P D</w>
transplant ation.</w>
ti le</w>
studi ed.</w>
sec retion</w>
phosph ate</w>
oc ript
lit tle</w>
level s,</w>
ic s</w>
alco hol</w>
2 7</w>
y si
steroid al</w>
seem s</w>
r ad
o ur
iti s.</w>
f ron
f low
er ior</w>
enal ap
thi az
rat e.</w>
pro specti
minim al</w>
intrac ranial</w>
il d</w>
excep t</w>
e jection</w>
apparen t</w>
ad ol
EC G</w>
Amon g</w>
uc in
ot oc
kg -1</w>
fac il
ear li
anti- inflammatory</w>
0 %)</w>
on al</w>
gly co
ence ,</w>
elec tr
contrac ep
cere bro
acet am
3 %)</w>
warfar in</w>
pro xim
ol an
ev ent</w>
cholester ol</w>
T -
NMD A</w>
2 9
v als</w>
rheumat oid</w>
oph ysi
month s,</w>
mo d
low -dose</w>
h all
g a
da y.</w>
ch o
ab ine</w>
0. 5
ven til
endo thelial</w>
cas es,</w>
cal cul
abo ve</w>
I ,</w>
1 /
year s,</w>
typ ical</w>
l ine
gran ulo
glut athi
epid ural</w>
EE G</w>
D es
wh ere</w>
ur g
sc ale</w>
phenyto in</w>
ot oxic</w>
hippocamp us</w>
S N
flu ox
d ent
c u
N O</w>
pu t</w>
oph il
mat ched</w>
ens ity</w>
I -
sc re
predn isol
men ing
medic ations</w>
lim iting</w>
fib rosis</w>
f am
drug s,</w>
deter i
coca ine.</w>
brady cardia
at yp
S im
simul t
sc al
ro ut
review ed</w>
puromyc in</w>
ob struc
min .</w>
l -
inter vals</w>
hyperten sion,</w>
hyper sensitivity</w>
e )</w>
deli ri
as ed</w>
w ill</w>
up per</w>
typ es</w>
s ac
prop yl
on ate</w>
ocardi al</w>
j aundic
ine mia</w>
in take</w>
identi fy</w>
ha ving</w>
g ang
dobut amine</w>
ap y
ad dic
abdom inal</w>
Plas ma</w>
8 )</w>
trans por
through out</w>
syn thesis</w>
ra ther</w>
adriam ycin</w>
ade qu
7 2</w>
tre mor
si d
re mia</w>
r ic
p .
k g/
indometh acin</w>
hypoten sion,</w>
fo ur
cor tis
A g
10 -
un i
s al</w>
r ab
quanti t
predic t
mus car
microgram s</w>
mg/kg ),</w>
mater nal</w>
li ght</w>
k ind
a reas</w>
ures .</w>
ur ia,</w>
sup pressed</w>
neurolep tic</w>
it h</w>
ful minant</w>
establ ished</w>
er s,</w>
to ge
parkinson ian</w>
is m.</w>
cohor t</w>
can n
antipsycho tic</w>
a emia</w>
OBJECTIVE S:</w>
produc es</w>
p lo
myo pathy</w>
meth od</w>
as signed</w>
H i
rat ing</w>
last ing</w>
i.v .)</w>
b asis</w>
as part
ac cording</w>
A .</w>
1 %)</w>
0. 9
rel ax
present ing</w>
om al</w>
drug ,</w>
de signed</w>
cir cul
arter i
anal gesia</w>
W ith</w>
U S
Administ ration</w>
tr ic
path y,</w>
impro ve</w>
ap pl
2 ),</w>
y g
ti vely</w>
retro spective</w>
requ i
individ ual</w>
ence .</w>
con cer
L .</w>
tac rolimus</w>
sit es</w>
re ten
lab el
individu als</w>
chem ical</w>
cell ular</w>
(A B
pituit ary</w>
oter icin</w>
ol der</w>
ne um
h om
as e.</w>
anesthe tic</w>
6 5</w>
to -
ret ino
re lev
o t</w>
life- threatening</w>
exist ing</w>
CA SE</w>
4 .</w>
un treated</w>
thrombo tic</w>
t a</w>
inf ected</w>
hum an
ca us
S ev
prol actin</w>
lamiv udine</w>
glob in</w>
dipyridam ole</w>
de oxy
ar rest</w>
' -
sup pres
nalox one</w>
h r</w>
go od</w>
describe d.</w>
cell s.</w>
pheny leph
percent age</w>
path ophysi
ma in</w>
impl ant
fer ase</w>
do w
chemo therapy.</w>
tic s.</w>
recept ors.</w>
proxim al</w>
on in</w>
gluc ose</w>
gast ric</w>
gamma -
ethan ol</w>
ate -
apy ramidal</w>
ame li
ac qu
AT P
t ex
se ly</w>
gentam icin</w>
es sive</w>
en ,</w>
af ter
ac tic</w>
L I
2 9</w>
0. 7
oc ca
m mol/
lo ad
invol ving</w>
hyper prolact
det ect
al ter</w>
agent s.</w>
Sev ere</w>
PG E
C T
( 3</w>
tri al.</w>
treat ments</w>
se ud
ri tis.</w>
requir ing</w>
necess ary</w>
infarc tion.</w>
in ation</w>
f ore
elic ited</w>
cy cle</w>
acet aminophen</w>
D S)</w>
1 50</w>
war d</w>
vascul itis</w>
respon ding</w>
mm Hg
ment ,</w>
le -
l eng
headac he
experim ents</w>
ce mia</w>
AC T</w>
week s,</w>
subsequ ently</w>
propo fol
posi tion</w>
per for
o .</w>
inges tion</w>
cir rho
atyp ical</w>
abdom y
Ser um</w>
0.00 1)</w>
valpro ic</w>
se ve
s os
re curren
muscar inic</w>
criter ia</w>
conven tional</w>
Me an</w>
region al</w>
preci pit
meas ures</w>
diff er</w>
com a</w>
co -
aw are</w>
anaesthe sia</w>
al op
Inc reas
4 %)</w>
2 4-
( group</w>
uro sem
sa des</w>
penicill amine</w>
ne o
me dul
m s.</w>
id ov
hall ucin
conver ting</w>
un it</w>
til ity</w>
patient ,</w>
midazol am</w>
kg )</w>
e me
abol ished</w>
(P <
y clo
sli gh
reduc es</w>
prev ent
oz otoc
gang li
cere bell
cardiomyo pathy.</w>
brom ocript
as al</w>
X -
3 9
stric tion</w>
s amp
region s</w>
or ity</w>
on .</w>
oc cl
anti body</w>
ti n</w>
there fore</w>
the m</w>
sus pected</w>
ri se</w>
qu es
fac e</w>
exer cise</w>
depress ed</w>
de s
ant s.</w>
7 %)</w>
19 8
0. 8
( 0.0
vaso press
osin ophil
i ved</w>
end -
contrib ut
cholest asis</w>
au g
allo dyn
2 %)</w>
rab b
nephro toxicity</w>
lac k</w>
episo de</w>
ent ly,</w>
re mo
on -
muc h</w>
migra ine</w>
cum ulation</w>
I NT
D op
Ad verse</w>
ti az
or i
mm Hg</w>
k ,</w>
cl ass</w>
children .</w>
art an</w>
ant ly</w>
ST R
On ly</w>
C M
3 ).</w>
0.0 1)</w>
ur ia.</w>
t as
spec ific
sp as
si a,</w>
response .</w>
ors ade</w>
o si
methad one</w>
iz ing</w>
depend ence</w>
deg re
ar m</w>
toxic ities</w>
pit e</w>
leuk emia</w>
hy d
hepatoc ellular</w>
comp ound</w>
anesthe sia.</w>
Des pite</w>
6 %)</w>
- -
sub cutaneous</w>
medul l
lat ency</w>
g ue</w>
H IV
H )</w>
Fol lowing</w>
0. 2</w>
vincrist ine</w>
sle ep</w>
s ar
rel ation</w>
om ycin</w>
ic -
he l
g re
fen flur
end ing</w>
1. 0</w>
( i.
p ron
n er</w>
magnesi um</w>
h und
cap top
b ir
R -
pressu re.</w>
ml /
lat er,</w>
glob ul
enzym es</w>
altern ative</w>
(2 0</w>
( 50</w>
top ical</w>
r in
pul se</w>
physi cal</w>
observ ation</w>
isoproteren ol-induced</w>
ine )</w>
diz zin
direc tly</w>
bu propi
9 9
os mol
m L</w>
fe rence</w>
estim ated</w>
ep inephr
cholest atic</w>
all y.</w>
A r
ma ,</w>
initi ated</w>
f av
dose s.</w>
diure tic</w>
desc rib
cor tex
al k
The y</w>
A s
1 2-
sud den</w>
steroid s</w>
sion s,</w>
mus t</w>
intraperitone al</w>
immun ore
b ur
aspart ate</w>
5- fluoro
vi ous</w>
ribavir in</w>
perio d,</w>
or e</w>
mix ed</w>
hist ological</w>
g ,</w>
dist ribution</w>
diff icul
arg inine</w>
Com par
(3 )</w>
need ed</w>
me tr
know n.</w>
inter fer
cy cles</w>
carbo platin</w>
ag e-
Cardi ac</w>
A P
2 6
tr as
suc cin
pre domin
hypertroph y</w>
doxorub icin-induced</w>
dos ing</w>
dam age.</w>
challeng e</w>
Pre treatment</w>
CY P
CI ,</w>
3 1</w>
( i
w all</w>
vom it
trans f
stro k
rig idity</w>
n oc
f ed</w>
antioxid ant</w>
al ol</w>
adren al
ac t</w>
ab le.</w>
w ay</w>
valpro ate</w>
si l
iso flurane</w>
is ch
investig ation</w>
il .</w>
i.p .
cros s-
cour ses</w>
carri ed</w>
L e
I g
st en
regres sion</w>
reac tive</w>
ot om
och rom
iti es.</w>
defic its</w>
cor d</w>
at a</w>
an o
amph otericin</w>
C ,</w>
trac t</w>
synap tic</w>
pro mis
f urosem
es )</w>
epilep sy.</w>
d ensity</w>
cul t
Si x</w>
2 7
vom iting</w>
ure a</w>
thresh ol
regimen s</w>
me ti
S P
ro n</w>
r y</w>
or ig
observ ations</w>
mg/ day</w>
ke le
inhib it</w>
implic ated</w>
hund red</w>
gen etic</w>
fi t</w>
d )</w>
ac cumulation</w>
U D
Q u
z idov
thi op
subject s.</w>
strept ozotoc
pro maz
physi ci
n a</w>
hyper cal
func tion
fron tal</w>
ent er
consist ed</w>
[ 3
s wit
hepati tis.</w>
find ing</w>
d ors
bene ficial</w>
ampl it
STR ACT</w>
C T</w>
5 7
ron ch
res c
recogn ized</w>
op i
on g
normal .</w>
n one</w>
kg(-1 )</w>
i b
el im
e -induced</w>
an .</w>
W OR
TE D</w>
PA N</w>
E l
D o
(+ )-
thal idomide</w>
strong ly</w>
resol ution</w>
regar ding</w>
prof en</w>
par tially</w>
norm oten
complic ated</w>
bor n</w>
block er</w>
WOR DS)</w>
UN CA
UNCA TED</w>
TR UNCATED</w>
F if
(AB STRACT</w>
un it
syn cop
subst ance</w>
publ ished</w>
ne i
ia sis</w>
glutathi one</w>
di sp
de part
MT X</w>
F -
vas ocon
ron ic</w>
pa rox
od ds</w>
molec ular</w>
gluc ocortico
extr apyramidal</w>
ev er</w>
2 8
sy ,</w>
spec tr
place ment</w>
dyskinesi as</w>
diagnos tic</w>
cl er
ad ine</w>
L V</w>
In ter
2 5-
radi o
ra rely</w>
om ic</w>
em at
di azepam
al bu
tiv en
test .</w>
shor t</w>
remain ing</w>
over dose</w>
nitroprus side</w>
micro g</w>
inform ation</w>
i.p .</w>
gra v
ca ref
W ith
Scal e</w>
H ist
sligh tly</w>
sel ected</w>
placebo- controlled</w>
olog ically</w>
intr am
clon id
aminonucle oside</w>
al g
TION :</w>
pro vi
pre ce
placebo .</w>
on ,</w>
e osinophil
Wh ile</w>
ve loc
tic ent
sp i
pres ents</w>
pregnanc y</w>
pent obarbit
nei ther</w>
min )</w>
infu sions</w>
f all</w>
activ ated</w>
0. 3</w>
( range</w>
v ant</w>
syn th
som n
re fl
metabolit es</w>
atro pine</w>
ar tic
success fully</w>
ici ans</w>
di an</w>
cer tain</w>
a ph
dil tiaz
cl onic</w>
ca using</w>
appl ied</w>
amoun t</w>
O ther</w>
C l
si ze</w>
par acetam
ot rans
neon atal</w>
l ic
il ateral</w>
hist opath
gu an
b ronch
adol es
L D
C or
4 0
4 ).</w>
y ;</w>
se s.</w>
oc arcin
manifest ations</w>
l er
g y
extrac t</w>
ex trem
ex pres
anticoag ul
amne sia</w>
al ong</w>
al most</w>
I T
-1 -
pro fi
potenti ated</w>
pl asia</w>
or rh
move ments</w>
fentan il</w>
estro gen</w>
ch ic
ameli or
MA P</w>
un usual</w>
sensitiz ation</w>
rh abdomy
it ory</w>
in ning</w>
deriv ati
3 3</w>
( 3.
samp les</w>
rever sal</w>
pron oun
par alle
o vari
lox ac
i dis
ch ar
O )</w>
- type</w>
vast atin</w>
um -induced</w>
re lie
prophyl axis</w>
pr acti
nause a,</w>
find ing
fi x
de generation</w>
d on
attribut ed</w>
T H</w>
M eth
B y</w>
ymptom atic</w>
respon ded</w>
protein s</w>
open -
lo cal
im i
G lu
Ch ronic</w>
3 7</w>
1 20</w>
ri f
p neum
n ociceptive</w>
follow- up
comple x
a )</w>
H ep
respectively ).</w>
injec tion,</w>
flu o
c .
bili ary</w>
ad ded</w>
symptom s,</w>
poly morph
mag nit
initi ally</w>
creat ine</w>
ap lastic</w>
S ign
M A</w>
I .</w>
CN S</w>
ul tras
ta il
studi es.</w>
pregn ant</w>
ost e
nifedi pine</w>
g er</w>
anti hypertensive</w>
S ,</w>
vari ety</w>
trans mission</w>
tem per
si vely</w>
inter mit
h .</w>
facil it
estradi ol</w>
essen tial</w>
dors al</w>
death .</w>
tri gg
t onic</w>
st o
phenobarbit al</w>
n ess,</w>
my el
mg )</w>
metabol ite</w>
maj ority</w>
f en</w>
b aro
IS C
A b
9 ,</w>
res on
ob ut
li po
le sion</w>
impro ve
import ance</w>
hydro chloride</w>
di ar
der ived</w>
comple ted</w>
a im
ISC US
I N</w>
F or
D ISCUS
5 5</w>
vie w</w>
vehic le</w>
treat ing</w>
stere otyp
rou s</w>
re verse</w>
pac t</w>
org an</w>
oni az
od -
is oniaz
extrac ellular</w>
exten sive</w>
di pine</w>
depres sive</w>
cathe ter
arac h
aden ocarcin
Y :</w>
1. 0
st rate
regi on</w>
prevent ing</w>
prednisol one</w>
pi ri
phosph at
per son
out put</w>
inhibit or,</w>
i bu
hemat ologic</w>
degre es</w>
cis plat
c -
bl ast
am mon
G -
F urther</w>
DISCUS SION
wh ose</w>
st in
shor t
path ological</w>
os pas
l up
ch rom
bene fit</w>
alb um
agent ,</w>
adju vant</w>
a vir</w>
M MA
ve -
test o
op tim
is ,</w>
equ i
det ection</w>
dent ate</w>
c ou
P ost
3 4</w>
thou ght</w>
reson ance</w>
plas mic</w>
pan ic</w>
op en</w>
on at
mg/kg ).</w>
he ad</w>
epi thelial</w>
drug -
capsa icin-induced</w>
b al
as e-
arrhythmi as.</w>
D is
B )</w>
t in
su ffered</w>
seg ment</w>
p id
open ia</w>
meas ure</w>
li ver
hepat otoxicity</w>
g em
enh ance
enceph al
dy ston
R A</w>
DISCUSSION :</w>
AD R</w>
0. 4
th at
sp ir
proc es
inten sive</w>
insuffici ency</w>
in es</w>
i onic</w>
fiel d</w>
experim ent
evalu able</w>
dist inc
St ud
Res ul
P C
AC E</w>
8 %)</w>
( 50
temper at
pronoun ced</w>
po or</w>
os cop
muc os
mg ,</w>
earli er</w>
a ir
U sing</w>
B lo
) /
tiven ess</w>
re mission</w>
nor adrenaline</w>
n -
mo vement</w>
induc ing</w>
g all
fac ial</w>
cl ar
catech ol
adequ ate</w>
T TI
SE TTI
F K
F .</w>
t y
reac h
o ventricular</w>
mpt om</w>
e ph
def ects</w>
at roph
anim als,</w>
a fferen
v ent
t orsade</w>
revie we
provid ed</w>
pre mature</w>
pi de
pepti de</w>
min or</w>
li th
l an
in tro
] ,</w>
S yst
3- year-old</w>
succin yl
mor b
hemo globin</w>
bar ri
b us
ation -
ab le
Thir ty-
SETTI NG
u ti
quin ol
prim arily</w>
enro lled</w>
electro n</w>
e :</w>
dig oxin</w>
curren tly</w>
consum ption</w>
M ost</w>
year s)</w>
ti d</w>
sol ution</w>
paclitax el
capsa ic
cap ac
apomorph ine</w>
anthrac ycl
ad mis
Sim il
SU RE
SU MMA
SUMMA R
R ,</w>
H ear
20 -
yl -
y pt
wa ve</w>
ru pt
pent yl
p on
log ic</w>
loc ated</w>
lo b
clin ic
cler osis</w>
beg inning</w>
anti epileptic</w>
acce ler
Resul ts</w>
AI M
ve in</w>
tic s,</w>
syndrome ,</w>
provi des</w>
mg .
differen tial</w>
ang ina</w>
alco h
adjust ed</w>
synth ase</w>
ros s</w>
q /
opath ic</w>
magne tic</w>
ex cl
enalap ril</w>
day s)</w>
benzodi azepine</w>
acetyl choline</w>
H ]
D ata</w>
5 .</w>
3 6
( AC
sulf ate</w>
rem if
pres sive</w>
pa inf
p olar</w>
mo ther
measure ments</w>
ifosf amide</w>
embr y
disorder .</w>
dic lofen
ce .</w>
c ulo
b en
amphet amine-induced</w>
adul ts</w>
R S</w>
ME A
Ad di
( range,</w>
toge ther</w>
side- effects</w>
rif amp
recipi ents</w>
re tic
quantit ative</w>
predn is
one ph
ch ild</w>
cann ab
T N
P <
MEA SURE
H .</w>
tub ul
re -
physi ologic</w>
p seud
occl usion</w>
man ner
magnit ude</w>
l )</w>
ic ular</w>
electr ical</w>
echocardi ography</w>
amin otrans
acce pt
3 8</w>
ul monary</w>
tac t</w>
t oc
sur face</w>
sion al</w>
reten tion</w>
mark er</w>
limb ic</w>
in ated</w>
human s.</w>
h and,</w>
es cal
differen ti
di ethyl
complic ations.</w>
atten tion</w>
athi op
angio edema</w>
Blo od</w>
5- year-old</w>
ve si
use d.</w>
relev ant</w>
pren atal</w>
mul ticent
le pt
interval ,</w>
im pact</w>
describ es</w>
ci meti
chloro quine</w>
c. v
be at
atri oventricular</w>
at er
N one</w>
5 4</w>
u nex
oc lop
embol ism</w>
de hydro
cal c
arth ritis</w>
anti gen</w>
an emia.</w>
20 %</w>
( N</w>
toler ability</w>
ter at
sul ph
pl ayed</w>
oti de</w>
kele tal</w>
con st
amin es</w>
-1 ,</w>
( MA
tig mine</w>
lo be</w>
lin ked</w>
ith rom
in tact</w>
gram s</w>
g s</w>
cri tical</w>
all ,</w>
ad mission</w>
a k</w>
SETTING :</w>
S D
9 %)</w>
4 2</w>
s pre
perio ds</w>
levo dopa-induced</w>
leth al</w>
le b
incl u
analy sis.</w>
agonist ,</w>
SUMMAR Y:</w>
P /
D ox
st abil
recor d
radi ation</w>
prob able</w>
ophyl l
o w
indic ates</w>
in tub
hospit al
hist amine</w>
cle ar</w>
bi polar</w>
be lie
ac tion.</w>
Si x
M P</w>
M I</w>
, 000</w>
ye t</w>
y s
tub er
ren in</w>
prog ester
pre disp
pentyl ene
olan zapine</w>
dr in
de gener
arge t</w>
antidepress ant</w>
. (ABSTRACT</w>
sup ra
press or</w>
immedi ate</w>
enc y.</w>
electro ly
di aly
de ,</w>
chang es.</w>
bupropi on</w>
van com
set t
rest ing</w>
reg ular</w>
proc ess</w>
pneum on
persist ed</w>
non steroidal</w>
medi ate</w>
fir st-
f il
et om
a ud
X )</w>
Sign ific
tor sades</w>
t arget</w>
refle x
recurren ce</w>
lear ning</w>
inflamm ation</w>
hist or
g ir
f asc
3 0-
10 %</w>
success ful</w>
m E
larg er</w>
idi opathic</w>
hour s.</w>
ectom y</w>
at ors</w>
ab les</w>
a qu
Intra venous</w>
ATP ase</w>
5 2</w>
withdraw al.</w>
studi es,</w>
per icardi
nitroglycer in</w>
hypokal emia</w>
hypo thesi
dose s,</w>
psycho tic</w>
produc ing</w>
painf ul</w>
op o
modi fied</w>
malign anc
li gi
l arge
cardi otoxicity.</w>
ap ne
C C
4 8
3 7
1 2.
0. 4</w>
w ide</w>
ul f
ther mia</w>
ri m
rhyth m</w>
protoc ol</w>
pentylene tetra
m ass</w>
intermit tent</w>
ine ster
in i
id o
hear ts</w>
fluox etine</w>
dimin ished</w>
co lo
chlor promaz
bili rub
ab stin
a sive</w>
Pre vious</w>
Ph ase</w>
P E
H IV</w>
Dru g</w>
0 )</w>
stimul ated</w>
propran olo
min ute</w>
l ing</w>
infu sion,</w>
electrocardio graphic</w>
deter m
agent .</w>
adriam yc
CS F</w>
= 0.0
wor k</w>
ul ar
ti es.</w>
shor ten
port al</w>
outcom es</w>
neutropen ia</w>
n ar
level .</w>
knowledg e,</w>
in ity</w>
identi fi
fat ty</w>
f el
er ous</w>
deliri um</w>
ane ur
R B
worsen ing</w>
su peri
schedul e</w>
reduc tions</w>
pres um
normoten sive</w>
mas sive</w>
lo fen</w>
il ,</w>
effec tiveness</w>
di hydro
Se ver
9 )</w>
1 1
( 30</w>
show s</w>
sev o
lo we
in- treated</w>
d ram
bromocript ine</w>
A p
4 50</w>
weigh t,</w>
sal t</w>
re sid
p -
normal ized</w>
amino phen
val v
super oxide</w>
ris ks</w>
meth yl</w>
globul in</w>
g ab
exc essive</w>
eti n</w>
estro gen
dist al</w>
d one</w>
biop si
benzodi azep
ac ut
L ong
A ),</w>
3 8
vac u
re stric
re li
orub icin</w>
intram us
i me
ha emo
control .</w>
at ax
ar d
apopto sis</w>
agg res
V T</w>
Ph en
O ver
C s
4- year-old</w>
(2 -
yl ate</w>
shoc k</w>
poin ts</w>
plac ed</w>
op ic</w>
li gh
enhance ment</w>
dis appeared</w>
det om
clo zap
channe l
blo od-
6- year-old</w>
5-F U</w>
time ,</w>
striat um</w>
stit ution</w>
peroxid ation</w>
ost atic</w>
n ,</w>
m um
kidne ys</w>
h r
et ax
catalep tic</w>
M ale</w>
M B
FK 50
u st
sens or
proca in
on omic</w>
o in
nephro sis</w>
mort al
me ans</w>
l ay
intrac erebral</w>
hal f</w>
e rec
dose- related</w>
de ep</w>
de .</w>
chloro thiaz
bri e
as ymptomatic</w>
S even</w>
L- arginine</w>
D H
7- year-old</w>
stand ing</w>
separ ate</w>
response ,</w>
ox idi
oc al</w>
neuropath ic</w>
lead s</w>
l is
hyp onat
heal th</w>
ex pressed</w>
ate -induced</w>
ast ro
ass ay</w>
a ther
E v
6 00</w>
5-H T</w>
- positive</w>
p um
o sis.</w>
me detom
ind in
in sti
ec oxi
disorder s.</w>
catalep sy.</w>
bra in.</w>
an ine</w>
Se iz
I L
G l
Con tro
A /
6 .</w>
ul ated</w>
tw o-
ref er
mono therapy</w>
log y</w>
jaundic e</w>
inter actions</w>
il i
gran ule</w>
form s</w>
electro encephalo
e ment</w>
aug ment
ath yro
3 9</w>
1 1.
tran sc
that ,</w>
thalam ic</w>
tachycardia .</w>
respon si
pro found</w>
ouab ain</w>
ol -
o k</w>
le d,</w>
g )</w>
fib ers</w>
fib er</w>
fi br
ere bro
epi rub
e .,</w>
chol inester
bac ter
PATIENT S</w>
El ectro
A Z
tri glycer
te d,</w>
t ob
stron g</w>
reviewe d.</w>
ren t</w>
reco ver
perfor me
pathw ay</w>
ill ed</w>
de m
cy tot
coll ected</w>
calcul ated</w>
be low</w>
an e-
album in</w>
a y.</w>
D ec
-1 0</w>
th re
subj ective</w>
propor tion</w>
o d.</w>
mg .</w>
mer ic
fl uc
dehydro gen
consc i
con current</w>
analgesi c
P V
P ),</w>
5-fluoro uracil</w>
yl ated</w>
w k</w>
sy mptom</w>
respecti vely</w>
neuro muscular</w>
is on
inv asive</w>
er v
coll ag
cit alop
ce phal
angio graphy</w>
K- 80
10 00</w>
un changed</w>
smo k
per me
ill in</w>
glomerul oneph
f oun
f iltration</w>
emb olic</w>
deple tion</w>
ar y,</w>
Ph armac
I D
A meric
A E
( W
s ot
re search</w>
prophyl actic</w>
mg/kg .</w>
ide -induced</w>
excit atory</w>
ex tra
erg y</w>
enc ing</w>
de si
cal cit
ca ud
ca ro
3 0%</w>
volunte ers</w>
ti mo
superi or</w>
stopp ed</w>
s ou
ol ig
o ,</w>
ha z
control s,</w>
ca ution</w>
block ers</w>
N- methyl-
M ul
Ei ght</w>
Ca 2
8- year-old</w>
4 7</w>
vari ables</w>
tuber culo
rang ed</w>
poten cy</w>
popul ation.</w>
hum ans</w>
hepar in-induced</w>
gen ital</w>
en s</w>
az athiop
T ,</w>
Com pared</w>
AD R
vomit ing,</w>
tic ,</w>
testo sterone</w>
ter ms</w>
ter but
spectr um</w>
ph leb
patter ns</w>
infec tion.</w>
di c</w>
cy te</w>
cur ve</w>
beta- adrenergic</w>
arg et
agg reg
S uc
R is
NS AID
Im mun
B ,</w>
met oclop
fentan yl
expos ure.</w>
abs or
P H
NO S</w>
yg d
spre ad</w>
remif entan
recept ors,</w>
microscop ic</w>
mic rom
maz en
leuk o
i ron</w>
g/ m
effect ,</w>
col chic
characteris tic</w>
analy ses</w>
am ygd
aff inity</w>
MA IN</w>
A V
ther mal</w>
s low</w>
respon sive</w>
mid d
lat ter</w>
kg ,</w>
intoxic ation</w>
hyperalgesi a.</w>
h ero
gen otyp
ful l</w>
event s.</w>
dynam ics</w>
[3 H]
4 3</w>
1 5-
weak ness</w>
tre n
th ym
sur ve
phosph or
insi pid
in h
ho od</w>
fe wer</w>
discontinu ed.</w>
der s</w>
dec line</w>
ant .</w>
al ing</w>
ad y</w>
acqu ired</w>
S O
2- year-old</w>
-1 )</w>
vas ospas
tri meth
se pt
s am
present ation</w>
pharmacokine tic</w>
ouab ain
myoclon us</w>
lim it
diff use</w>
d in
aud itory</w>
ant s,</w>
a e</w>
T en</w>
S T</w>
An im
y sm
ves sel
veloc ity</w>
s on</w>
m Glu
iz ation.</w>
ci prof
amin o</w>
U nit
T .</w>
N or
F o
D R
(1 0
tr ypt
techniqu e</w>
sli ght</w>
presc ri
post erior</w>
kin in</w>
iti s,</w>
is he
inf iltr
f le
dose- response</w>
disturb ances</w>
ant ,</w>
acid ,</w>
a sis.</w>
TION S:</w>
P L
Increas ed</w>
zidov udine</w>
uc ul
to pro
sol u
se em</w>
rever sib
resp ect</w>
re d,</w>
pro posed</w>
model ,</w>
me topro
mac roph
f ever</w>
enc ies</w>
deteri oration</w>
confir m</w>
bene f
b ound</w>
arach no
Li ver</w>
F ,</w>
C oca
3 /
3 ),</w>
2 5%</w>
ve d,</w>
th ,</w>
test ,</w>
t arget
se x</w>
se d,</w>
ques tion
prost ate</w>
po d
mg/m (2)</w>
mE q/
i on
gene sis</w>
func tions</w>
el ective</w>
demonst rates</w>
death s</w>
coca ine,</w>
cell s,</w>
asth en
al kal
ad renal</w>
acet aminophen
P P
IC H</w>
C G
5 5
0. 6</w>
( r</w>
un d</w>
th ick
qu ality</w>
micrograms/ kg</w>
lact ate</w>
h imb
dose- limiting</w>
clo se</w>
bl ind
avoid ance</w>
an tr
am ine
adv ant
administ ere
METHOD :</w>
7. 5</w>
uter ine</w>
ul tra
tro n</w>
ro se</w>
microscop y</w>
lup us</w>
ist ry</w>
hyper kal
ex clu
diar rhe
defici ent</w>
N either</w>
Ex perim
Ad riam
4 1</w>
0.0 5</w>
( e
( 4.
w ise</w>
w ild
t able
su mm
stimul i</w>
ser v
sequ el
rang ing</w>
par athyro
p. o
nephro pathy.</w>
lin es</w>
lat er.</w>
l ind
inte gr
i es,</w>
comp eti
ch ain</w>
ST UD
D F
D 1</w>
4 5
(0. 5</w>
the l
re present</w>
po i
pl ays</w>
leng th</w>
k -
he ter
grad ually</w>
epi lept
compon ent</w>
clo sely</w>
an dro
an -
acet ate</w>
P ain</w>
10 ,</w>
un known.</w>
s qu
progester one</w>
proble m</w>
patient s)</w>
oph thal
oc clu
neuro toxic</w>
iti es,</w>
intraperitone ally</w>
exc re
dose- dependently</w>
dis played</w>
cyclospor ine</w>
coun ts</w>
chron ically</w>
cerebell ar</w>
S ),</w>
HB e
B .</w>
- mediated</w>
z ole</w>
trans amin
tom ography</w>
to ok</w>
tiv ari
supplement ation</w>
short -term</w>
reg urg
phenyleph rine</w>
inhib its</w>
ine ff
expl ain</w>
er mal</w>
doc etax
cysti tis.</w>
concentr ations.</w>
ch ing</w>
behavi ors</w>
bac lofen</w>
angiotens in-
ame ter</w>
agent s,</w>
Unit ed</w>
Stud y</w>
P hy
My ocardial</w>
H R
DO X
Ch ang
A g</w>
ures ,</w>
suscepti ble</w>
side -induced</w>
se tron</w>
schizophren ia</w>
prob ability</w>
pe g
particip ants</w>
p anc
ol ip
immuno hist
f ati
end omet
em phasi
dipyridam ol
deli very</w>
cy ste
al azine</w>
U )</w>
Signific ant</w>
L- N
4 9</w>
ycl ic</w>
signific ance</w>
prolifer ation</w>
ox amine</w>
n ess.</w>
medic ation.</w>
ing ly</w>
evid ent</w>
aminotrans ferase</w>
ag grav
M M
M K-80
1 5.
(1 5</w>
val ent</w>
u me
star t</w>
se -
s w
occur red.</w>
o ural</w>
implic ations</w>
hyp ox
exc ess</w>
ec ain
condition ed</w>
INT ER
I T</w>
F rom</w>
B ased</w>
w ays</w>
tra um
tr am
sig n</w>
recogn ition</w>
quin idine</w>
proced ure</w>
partic ular</w>
ob lastic</w>
interfer on</w>
immunosup pressive</w>
enc y,</w>
do g</w>
depres sion.</w>
d s.</w>
cros s
anxi et
antin ociceptive</w>
aff ecting</w>
Sub j
P ar
ME NT
Hear t</w>
F lu
1- year-old</w>
st aining</w>
re uptake</w>
oxic ity</w>
opio id
ischem ia.</w>
is m,</w>
immuno deficiency</w>
depart ment</w>
captop ril</w>
bu lo
bec ome</w>
amplit ude</w>
amide ,</w>
ag ne
QT c</w>
ven ess</w>
vasopress in</w>
v ar
set ting</w>
sec re
pro min
par alysis</w>
investig ated.</w>
ing u
hyperprolact inemia</w>
hydro chlorothiaz
furosem ide</w>
el ect
cor responding</w>
conver sion</w>
can not</w>
barri er</w>
am id
al anine</w>
T ran
G en
F in
C P</w>
(1 -
unc lear
ul cer
th .</w>
sam ple</w>
ocy cl
ochrom e</w>
n asal</w>
is om
inf ant</w>
fenflur amine</w>
fe ren
el uc
bo y</w>
antagon ism</w>
all ergic</w>
al low
ag ain</w>
ER I
DO X</w>
Compar ison</w>
6 0
2. 0</w>
wild -type</w>
we l
tri ax
time .</w>
su mat
small er</w>
rel b
re placement</w>
phenomen on</w>
mod ulation</w>
it .</w>
intrac ellular</w>
ino relb
inf iltration</w>
id en
i .</w>
fl ut
evalu ated.</w>
determ ined.</w>
def ect
cholinester ase</w>
beg an</w>
bac k</w>
b yp
STUD Y</w>
E arly</w>
sumat ript
smo oth</w>
s.c .)</w>
ru ption</w>
p .</w>
orth ostatic</w>
mac ro
lim b</w>
l umb
in ser
ide s</w>
i ble</w>
fe ver,</w>
eph ed
enh ance</w>
dis ul
diet ary</w>
coun ter
cle arly</w>
carbam azep
ar ab
acid .</w>
L E
H ere
H ,</w>
9- year-old</w>
3 5
1 4.
yl ine</w>
vit ro
subj ected</w>
se p
sal ic
per man
paracetam ol</w>
ograph y.</w>
no w</w>
monke ys</w>
model s.</w>
le sion
hal f-
bic ucul
allodyn ia</w>
al one,</w>
stimul ating</w>
show ing</w>
sevo flurane</w>
respectively )</w>
qu e</w>
pressu res</w>
picrotox in</w>
par a
ous ly.</w>
hist ologic</w>
fact ors.</w>
appro ach</w>
aim ed</w>
T d
S D</w>
Dop pl
1 3.
us t</w>
struct ure</w>
sti l
som e
simil ar
seroton ergic</w>
prot ected</w>
mum ol/
ment s.</w>
m am
haem orrh
h ere</w>
fasc icul
ex pected</w>
embr yo
em plo
d ly</w>
alter ation</w>
a emic</w>
F e
D- penicillamine</w>
8 ).</w>
(N S
system s</w>
s low
ret inal</w>
prot ect</w>
proced ures</w>
present ed.</w>
perf used</w>
off sp
neuro trans
mo l</w>
mal form
infarc tion,</w>
ine ur
experim ent</w>
effec tively</w>
detect able</w>
bir th</w>
auto immune</w>
ar yn
S A
D 3</w>
( IC
under taken</w>
suff ering</w>
rec tal</w>
ratio s</w>
r in</w>
ph ot
oxid ase</w>
out patient</w>
ol ine</w>
lamiv ud
headache ,</w>
d d
d ;</w>
cannab in
attribut able</w>
abil ity.</w>
reach ed</w>
r e</w>
ocicep tion</w>
nicot ine-induced</w>
k ain
hospit alized</w>
gir l</w>
distinc t</w>
d an
consci ous
caro tid</w>
bu s</w>
arter ies</w>
I O
H er</w>
G r
50 ,</w>
ver sion</w>
ter al</w>
pl an
ovari an</w>
op yr
measure ment</w>
inter ven
infec tions</w>
exam ined.</w>
er -
contracep tiv
aut onomic</w>
am bul
Sever al</w>
H U
6 ).</w>
withdraw n</w>
us al</w>
tu be</w>
pro ved</w>
prev ents</w>
predic tive</w>
os ing</w>
ome tr
o vir</w>
manner .</w>
le ar</w>
is su
ig n</w>
ic ity</w>
electro physiological</w>
cycl ic</w>
capac ity</w>
b est</w>
atic ally</w>
ardi ve</w>
arachno id</w>
afferen t</w>
S ome</w>
IS O
E M
D X
( 4</w>
us ers.</w>
tic -induced</w>
retino ic</w>
phen otyp
manifest ed</w>
last ed</w>
in otropic</w>
eth in
ep e
en tial</w>
cardiom y
ax onal</w>
anti gen
R A
PR L</w>
Hy poten
H ospit
wh ole</w>
vancom ycin</w>
th or
stil be
sle ep
over dose.</w>
ma k
m s,</w>
insul in</w>
h )</w>
es oph
epileptic us.</w>
em erg
duc t</w>
cyt ochrome</w>
cross over</w>
const ant</w>
competi tive</w>
apomorph ine-induced</w>
anti tumor</w>
N )</w>
Chang es</w>
C 57
-1 0
-1 ,
+ )</w>
(2 )
ur ation</w>
tic lop
ta ining</w>
t one</w>
stilbe stro
st s</w>
si rolimus</w>
pharmacokine tics</w>
iso flur
hallucin ations</w>
group s:</w>
gem cit
g ain</w>
es :</w>
diltiaz em</w>
cas e-
anticoag ulation</w>
Ne ph
N it
C ase</w>
B M
0.05 ),</w>
( median</w>
yo himb
ti tr
ten ded</w>
t )</w>
substanti al</w>
sub cut
re presents</w>
prospecti vely</w>
pro x
op ril</w>
neuro toxicity.</w>
myocardi um</w>
morb idity</w>
mal ar
ju g
intra -
immunore activity</w>
if ied</w>
i. c.v
he at</w>
fix ed</w>
eti ology</w>
ent s.</w>
control led,</w>
CH F</w>
B P
us cit
thyro idis
thyro id</w>
tachycardia ,</w>
syn erg
sing le-
si x
o pa
nicot inic</w>
i on</w>
es ;</w>
den af
compar ing</w>
cas e,</w>
bradycardia .</w>
at es.</w>
anti cholinergic</w>
anthracycl ine</w>
ant o
ant ine
V PA
ST -
S A</w>
R ating</w>
I P
( Group</w>
vol ume
sym path
s or
rout ine</w>
po ison
os yn
optim al</w>
nephro genic</w>
medi a</w>
mark ers</w>
ine d,</w>
glob al</w>
ecti vely</w>
drin king</w>
def in
chemo therapeutic</w>
biopsi es</w>
attac ks</w>
Me dian</w>
H is</w>
C l</w>
valv ular</w>
rec tom
orph ine</w>
no de</w>
n ational</w>
mo od</w>
los s.</w>
docum ent
consequ ences</w>
cocaine- dependent</w>
cho ice</w>
cerebro spinal</w>
beat s/
ane -induced</w>
am ant
M -
A u
seiz ure
recor ds</w>
pharmac ologic</w>
perme ability</w>
o ve
ne ver</w>
m os
le thal
foun d.</w>
flu mazen
f ur
ex ce
dos ages</w>
defic it</w>
d ri
convul sions.</w>
control ,</w>
consequ ence</w>
c re
and s</w>
S event
O r
I so
Hi gh
AM E</w>
(2 00</w>
wel ve</w>
ventric le</w>
um erous</w>
ri a</w>
recor ded.</w>
pro fen
p ast</w>
ox ane</w>
metho ds</w>
medetom idine</w>
ir rit
in- associated</w>
hyper plasia</w>
headac h
glomerul i</w>
cur onium</w>
cr yst
compl ain
av oid</w>
U C
J ap
Gr ade</w>
Doppl er</w>
C57 B
4 ),</w>
stra in</w>
st em</w>
reac tion.</w>
pre lim
pap illary</w>
pa w</w>
p el
om otor</w>
morph ological</w>
m io
ine :</w>
in )</w>
ex ter
ede ma,</w>
dil ated</w>
chemo therap
amygd al
am il
am but
W e
U r
Phy si
For ty-
D .</w>
0.00 1),</w>
uti li
uni que</w>
spec ies</w>
s keletal</w>
s atis
resid ual</w>
promin ent</w>
predomin antly</w>
pivaca ine</w>
p in
ox yl
o vascular</w>
new ly</w>
n atal</w>
microm ol/
me perid
isoniaz id</w>
ing ly,</w>
hemo dialysis</w>
f ast
condi tions.</w>
behavi oural</w>
am it
al in</w>
T M
M R</w>
Long -term</w>
L o
H )
5 8</w>
5 7</w>
10 (-
( 4-
ure th
ure mic</w>
supra ventricular</w>
rema in</w>
performe d.</w>
o sis,</w>
nex t</w>
mening itis</w>
load ing</w>
l ess
ithrom ycin</w>
inf requ
fl ecain
ent ered</w>
dail y,</w>
caref ul</w>
ab le,</w>
L ith
Di fferen
D B
Com b
5 3</w>
thrombo embolic</w>
system ,</w>
sol ute</w>
prednis one</w>
phy sos
pathophysi ology</w>
olog y.</w>
me lat
le uc
k noc
intra vascular</w>
intr ad
haloperid ol.</w>
g/ d
dig it
at en
am ,</w>
M et
J an
I f</w>
Fin ally,</w>
E ach</w>
E T
2 ;</w>
to ward</w>
te mpt
sil denaf
se e
scre ening</w>
res uscit
ras h</w>
prelim inary</w>
om al
medi al</w>
lowe red</w>
lo ad</w>
l ation</w>
ir reversible</w>
inf or
hero in</w>
ed -
di p
cirrho sis</w>
chang es,</w>
can ine</w>
all -
ac ro
ac count</w>
SI AD
IV )</w>
GF -
. g
(H B
( K
y s.</w>
y ric</w>
x ameth
ver sity</w>
tu bulo
sub arachnoid</w>
stopp ing</w>
st om
sensi tiv
prospecti ve,</w>
proble ms</w>
phosph olip
mg/kg/ day</w>
me ll
man ag
intramus cular</w>
ine- associated</w>
imi pramine</w>
ill ust
femal es</w>
erythro poi
ede ma.</w>
dys function,</w>
develop mental</w>
amit ript
amide -induced</w>
V al
PA )</w>
MA T
Af ric
0. 8</w>
( 5.
valu es.</w>
temperat ure</w>
ri fic
pac ing</w>
ox antr
minut es.</w>
microgram /
mal es</w>
l ing
if ost
i el
end oc
duc t
decreas ing</w>
con sti
c lop
attenu ate</w>
ap ine</w>
antibio tic</w>
an emia,</w>
abnormal ities.</w>
S p
GABA ergic</w>
G ,</w>
( a</w>
( 40</w>
wom en.</w>
ventil ation</w>
vasocon stric
under g
ser ial</w>
sac rific
rhabdomy olysis</w>
res s</w>
requir e</w>
r amide</w>
op ulmonary</w>
olog ic
lithi um-induced</w>
ligi ble</w>
kind led</w>
id azol
h ar
f lo
eryth emat
dyston ia</w>
de v
ac ts</w>
ab use.</w>
O ral</w>
Neph ro
Grou ps</w>
youn ger</w>
vari able</w>
tivari ate</w>
schedul ed</w>
ra ised</w>
pl ast
per ox
mg/m 2/
mell it
low ering</w>
li pos
inc re
in s.</w>
in appropriate</w>
f as
docetax el</w>
diseas es</w>
discontinu ing</w>
dis mut
amide .</w>
alk alo
ac etic</w>
R et
Hep ar
G S
D N
7 ).</w>
50 -
4 6</w>
4 0%</w>
z om
transpor t</w>
ti car
threshol ds</w>
sol id</w>
soci al</w>
responsi veness</w>
respon d</w>
recept or-
pro mpt
plac e</w>
p up
on es</w>
olog y,</w>
midd le</w>
lim it</w>
inorelb ine</w>
hypothesi zed</w>
haem at
fo ot</w>
f inal</w>
discharg e</w>
dec l
cortis ol</w>
cle .</w>
bic arb
angio graph
acid osis</w>
U T
N P
L A</w>
AID S</w>
A D</w>
7 6</w>
ul c
tric yclic</w>
thor ac
shor tly</w>
s ha
prog no
produc t</w>
otom y</w>
opi ate</w>
hypercal cemia</w>
g ol
enc oun
cortico steroid</w>
continu ously</w>
blood- brain</w>
ather os
ap ar
analy sis,</w>
anaesthe tized</w>
ac u
Re ver
O -
MR I</w>
L- DO
Jan u
C ap
AM P</w>
6 7</w>
) :</w>
war r
un ilateral</w>
ty ros
suc c
sign aling</w>
re cur
press ing</w>
placebo ,</w>
it s.</w>
hyp oc
graf t</w>
follow-up .</w>
em ent.</w>
doxorubic in.</w>
creat in
cimeti dine</w>
ch i
VE N
T A
L ab
AT P</w>
0. 7</w>
0 /
(-1 )</w>
y ri
us h
ul ate</w>
tro p
timo lol</w>
th em
stimul ation.</w>
sp ac
se min
s clero
prov o
neut roph
neuropath y,</w>
mo tion</w>
medi um</w>
li gn
injur y,</w>
in hal
hyperalgesi c</w>
hemorrh age.</w>
fel l</w>
fam ily</w>
discus sed</w>
dep olar
def ect</w>
cir c
ation :</w>
R F
D ,</w>
8 7</w>
00 -
(4 )</w>
y iel
x y
st er</w>
simult aneously</w>
se l</w>
relap se</w>
re infor
praz osin</w>
plat in
ot al</w>
my asthen
mat ter</w>
ine /
id az
ia :</w>
i )</w>
hype remia</w>
ey e</w>
chlorpromaz ine</w>
S SR
S R</w>
P os
M ,</w>
INTER VEN
I L-
G .</w>
vul ner
un its</w>
tram ad
thiop ent
tetra hydro
syn thetic</w>
sp e
rest ored</w>
resp ective</w>
regimen .</w>
on azole</w>
numb ers</w>
ma x
investig ations</w>
in os
hel p</w>
establ ish</w>
elev ations</w>
diclofen ac</w>
dehydrogen ase</w>
cyto plasmic</w>
cir cum
cathe ter</w>
ati vel
antidepress ants</w>
an n
Rec ent</w>
Q RS</w>
MAT ERI
D P
CA 1</w>
C E
An g
5 6</w>
1 ;</w>
(0. 1</w>
ysm al</w>
un common</w>
stra ins</w>
shor ter</w>
rig id
rele as
refer red</w>
pre term</w>
potenti ation</w>
perman ent</w>
ocy tic</w>
ng/ ml
min oxidi
main tain</w>
inter vention</w>
inf erior</w>
increas ed.</w>
fibrill ation.</w>
elect rom
det ect</w>
cyste ine</w>
cer v
b ran
atroph y</w>
as h
arth ritis.</w>
ag it
a udi
P a
N-methyl- D-
C lo
C entr
AS A</w>
3. 0</w>
1 8.
theli um</w>
tempor ary</w>
t ardive</w>
subj ect</w>
statis tical</w>
simult aneous</w>
seve rely</w>
retro specti
pum p</w>
pa ir
omet ric</w>
mother s</w>
in somn
g on
fe ed
estim ate</w>
eff ici
d ap
correc ted</w>
consist ing</w>
ch ore
Subj ects</w>
N ine</w>
Janu ary</w>
II ,</w>
H D</w>
Anim als</w>
(O H)
vi sion</w>
un chang
ter s</w>
syn the
re mark
p H</w>
lo dipine</w>
lab et
ing est
ine ;</w>
h il
gluc o
epirub icin</w>
electrocardio gram</w>
depres sion,</w>
del ay</w>
byp ass</w>
brie f</w>
ar rest
U se</w>
S yn
N E</w>
MK-80 1</w>
M ed
L-N AME</w>
In trac
H alo
H R</w>
D el
C y
5 ),</w>
. ),</w>
( EC
yc in.</w>
ventr al</w>
v ec
un known</w>
sion -
self- administration</w>
seem ed</w>
remifentan il</w>
psycho sis</w>
pro ven</w>
pl asi
pas sive</w>
nephro sis.</w>
neg ati
methyl prednisolone</w>
low est</w>
los artan</w>
locom o
ll ing</w>
line ar</w>
indometh ac
frac tional</w>
fr ag
etom idate</w>
electroly te</w>
der ,</w>
cocaine- associated</w>
c ranial</w>
c ra
as yst
an e.</w>
] -
S ide</w>
M an
6 6</w>
5 9
. ).</w>
+/ -1
unclear .</w>
tissu es</w>
thromb in</w>
man ner</w>
lith iasis</w>
ic k</w>
hour s,</w>
fact ors,</w>
equi valent</w>
endomet rial</w>
emplo y
echocardi ographic</w>
cyclophosphamide -induced</w>
cortex ,</w>
comple tion</w>
cef triax
b )</w>
angiotensin- converting</w>
analo gue</w>
Re g
N- acetyl
F 1</w>
6 1</w>
3. 5</w>
(P T
(A D
tra ining</w>
thrombo embolism</w>
terbut aline</w>
suffici ent</w>
ser tr
se s,</w>
ri min
rad ical</w>
pro gram
praz ol
path ology</w>
on se
ol i
myoclon ic</w>
minim um</w>
level ,</w>
gli al</w>
fe a
ex tre
er 's</w>
compon ents</w>
ation )</w>
analo g</w>
al ways</w>
air way</w>
age al</w>
Sub sequ
M in
L V
I ts</w>
G T
G E
CB F</w>
1 6.
vi ron
val ve</w>
vacu ol
syncop e</w>
ser ved</w>
s well
rou gh</w>
ri tis,</w>
ret in
phleb itis</w>
pathw ays</w>
part um</w>
myo pathy.</w>
lumb ar</w>
ibu profen</w>
hydro chlor
gu ine
glomeruloneph ritis</w>
f un
f re
dog s,</w>
depend ence.</w>
de le
dat ab
chrom at
carcin oma.</w>
canc er,</w>
azathiop rine</w>
appro ach
alle vi
ac yclo
Th rom
M ic
Ei gh
( +/-
te trac
succinyl choline</w>
su xameth
sal ine,</w>
profi les</w>
op sy</w>
neo plastic</w>
mortal ity.</w>
mes na</w>
meas uring</w>
man nit
knoc k
is op
hospit al.</w>
ep tic</w>
ectom ized</w>
da un
d :</w>
cyt osine</w>
contrac tion</w>
com mun
at tempt
arrhyth mia.</w>
ap ri
amino glyco
abil ity,</w>
With in</w>
U -
SM -
L ).</w>
Hi gh</w>
He al
FK50 6</w>
Americ an</w>
(E D
vie w
sugg estive</w>
smo king</w>
pr ur
pilo t</w>
p ol
o il</w>
norep inephr
metopro lol</w>
lind ane</w>
iz ation,</w>
first- line</w>
dist ingu
diethyl stilbestro
dex tro
cerebro vascular</w>
ce ,</w>
cap illary</w>
behavi our</w>
an e,</w>
amin ophylline</w>
al located</w>
St udi
HIV -
C arb
(2. 5</w>
wide spread</w>
ut ure</w>
spec imen
sou ght</w>
pi per
panc re
obut yric</w>
n im
me gal
maz e</w>
inh aled</w>
in tak
h ap
fav or
f usion</w>
eth ambut
est er</w>
catech olamine</w>
attenu ation</w>
alg ia</w>
adenocarcin oma</w>
T ri
S ).</w>
He pati
B et
7 3</w>
7 .</w>
0. 0</w>
(2 5</w>
(+ )</w>
we l</w>
ut ing</w>
thrombo sis.</w>
ter ol</w>
subject s,</w>
so ur
shor t-
re activity</w>
prepar ations</w>
po or
physici ans</w>
peritone al</w>
mg/ d</w>
lab el</w>
hear t.</w>
expl ained</w>
correl ate</w>
con junc
circul ating</w>
bradycardia ,</w>
be ats</w>
ati tis</w>
Seiz ures</w>
P B</w>
L VE
viv o.</w>
sul piri
sc an</w>
retur n</w>
response s.</w>
protein uria.</w>
prot ects</w>
propyl thio
proces ses</w>
pres er
om a,</w>
nucle ar</w>
neuron s.</w>
necro sis.</w>
m L/
le sions.</w>
dys rhyth
dizzin ess</w>
di men
deteri or
dail y.</w>
channel s</w>
block .</w>
b is
atri ure
as p
ar ch
aff ective</w>
Pro po
Per i
P rop
Hypoten sion</w>
D ex
6 4</w>
yl )
vag inal</w>
u los
tas k</w>
sus p
relie f</w>
procain amide</w>
post natal</w>
phasi c</w>
ou s,</w>
opo i
nat ure</w>
men opa
mechanis ms.</w>
m im
leuko encephalopathy</w>
le ven</w>
f if
en viron
ect ed.</w>
derivati ves</w>
compl i
compar ative</w>
c m
aneur ys
anaesthe sia.</w>
an ol</w>
acc umb
absor ption</w>
MEASURE MENT
Cs A</w>
C M</w>
ur on
struct ures</w>
re sem
prom pt</w>
post ural</w>
obstruc tive</w>
mucos al</w>
min ocycl
kine tic</w>
in- related</w>
ifost ine</w>
iden tical</w>
hemat oma</w>
glucocortico id</w>
fi ram</w>
enh ances</w>
ecoxi b</w>
e ;</w>
der mal</w>
contracep tive</w>
concentr ation.</w>
con genital</w>
case- control</w>
at or
asi c</w>
amoun ts</w>
am b
Studi es</w>
M .</w>
7 8
4 0-
yl ation</w>
surger y,</w>
schizophren ic</w>
repor ting</w>
reg ard</w>
pos ses
poor ly</w>
paralle l</w>
oc tre
nitro -
neurotrans mit
me ly</w>
indin avir</w>
event s,</w>
ev ol
dou ble</w>
continu ation</w>
condi tions,</w>
chol ec
at tem
anti diuretic</w>
ant ed</w>
an con
al fentanil</w>
Dru g
B r
20 ,</w>
/ -
- to-
(- )-
under sto
tion ally,</w>
so ,</w>
ra ph
qu eti
predic t</w>
pap er</w>
p all
n atriure
multicent er</w>
metoclop ramide</w>
label ed</w>
intrac erebro
h er
gest ation</w>
erythemat os
em is
che mic
cat at
arter io
al do
al de
a uc
SN P</w>
PA N
Over all,</w>
N P</w>
BACKGROUN D</w>
A P</w>
8 5</w>
0. 3
vec ur
vari ed</w>
scop olamine</w>
re ference</w>
qu al
predict ors</w>
ox al
otoxic ity,</w>
om y
ocy to
occa sion
mg/ day)</w>
lithi um-
k illed</w>
iz ed.</w>
identifi ed.</w>
gentam ic
di phen
cyt es</w>
cont ribution</w>
colchic ine</w>
col on
citalop ram</w>
block ade
bilirub in</w>
ben ign</w>
arab ino
an at
Tran si
P B
G i
Dox orubicin</w>
B i
4 ,
( r
vag al</w>
v inorelbine</w>
the ophyll
significant .</w>
restric ted</w>
requi re
reac tions.</w>
of f</w>
modi fy</w>
it sel
in dependently</w>
id ine,</w>
gy rus</w>
gly ce
fol ic</w>
extre mely</w>
di ameter</w>
de mo
condi tion.</w>
comp uted</w>
clin icians</w>
calcit ri
aw a
attenu ates</w>
at el
amin obutyric</w>
alde hy
Twent y</w>
SH R</w>
PATIENT S:</w>
P sych
O 2</w>
METHOD S</w>
L ),</w>
F ancon
C F
10 )</w>
( from</w>
z ed.</w>
ur ticar
subst ances</w>
st ly</w>
s ph
res ,</w>
qu inine</w>
methyl phen
lay er</w>
hydrox y-
granulo mat
di lat
cortico steroid
comp ens
bo wel</w>
anti retro
am is
aggres sive</w>
ac cur
] .</w>
C at
C R</w>
A V</w>
5- hydroxy
0. 9</w>
( c
u sions</w>
tre x
sal ine.</w>
regul ated</w>
precipit ated</w>
prece ded</w>
perid ol</w>
paren teral</w>
myocardi tis</w>
mix ture</w>
melat onin</w>
lis in
li qu
isop ren
io hex
ific ation</w>
finding s,</w>
fas hi
en ergy</w>
embryo s</w>
e ous</w>
e ach
discus s</w>
disc rimin
collag en</w>
ciprof loxacin</w>
am .</w>
acid s</w>
O H-
C ol
7 7</w>
1. 2</w>
(p <
vis c
t ase</w>
sot alol</w>
sign al</w>
relax ation</w>
re produc
re ady</w>
potenti als</w>
ogen ous</w>
nerv es</w>
mos sy</w>
min al</w>
mGlu R
long- lasting</w>
l ide</w>
induc ible</w>
increas ingly</w>
implant ed</w>
il -induced</w>
g ad
four th</w>
excl uded</w>
del ta</w>
coag ulation</w>
cardi otoxic</w>
car nit
bio logical</w>
arrhythmi as,</w>
apne a</w>
an omal
al is</w>
Re por
Pro long
Pos sible</w>
N ar
ME TH</w>
Contro l</w>
C57B L/
6 3</w>
0.000 1).</w>
tyros ine</w>
tri als.</w>
the refore,</w>
strate gi
spas m</w>
rep olar
r al
pyri dox
neuro genic</w>
n es
mit oxantr
lipos omal</w>
it rate</w>
gre l</w>
fr act
form ul
en -
electrom yo
de sign
d s,</w>
ar ing</w>
ang ial</w>
acid -induced</w>
ac ross</w>
U ni
S ur
R .</w>
PA R
N on
E p
7 0
6 2</w>
5 9</w>
3 0,</w>
2 5,</w>
u sion.</w>
tum ors.</w>
test s.</w>
te zom
ta il</w>
substanti a</w>
stit uted</w>
sit u
sequ ence</w>
regurg itation</w>
rabb its</w>
ot otoxicity</w>
organ ic</w>
nephro toxic</w>
na prox
ishe d.</w>
inter pre
influ enced</w>
if y</w>
histopath ological</w>
exacerb ation</w>
eme tic</w>
dis semin
dem enti
de grad
cytot oxic</w>
contribut ing</w>
clo mi
baro reflex</w>
acc id
ab solute</w>
Z )</w>
Transi ent</w>
Ne w</w>
MATERI AL
M S</w>
E valu
3 4
tri al,</w>
t on</w>
t ary</w>
stop pe
sequ ential</w>
s at
ratio ,</w>
rad ic
promis ing</w>
pr inc
os ar
n umerous</w>
lesion ed</w>
hyp om
he av
he al</w>
glomer ulos
finding s.</w>
episo de
elim ination</w>
difficul t</w>
di hydroxy
contribut es</w>
combin ations</w>
but am
basel ine,</w>
ation ;</w>
ap l
ac cumul
Thir ty</w>
T welve</w>
P/ d
I s</w>
Ch in
CO 2</w>
0.0 1),</w>
(i. e.,</w>
y -induced</w>
ves sel</w>
termin ation</w>
tac rolim
streptozotoc in</w>
specific ally</w>
sc i
proper ties.</w>
produc ts</w>
phenyleph r
patient s'</w>
par as
oxygen ase</w>
out put
nit r
m atic</w>
lidoca ine.</w>
knock out</w>
i.p. ),</w>
h and
f in
en ox
en ed</w>
disorder s,</w>
determin ation</w>
d P/d
at rop
amin o-
albu min
ad junc
N ine
Here ,</w>
CO M
C yclo
C al
AIM S:</w>
6 9</w>
(P AN
trans ferase</w>
thorac ic</w>
ro d
retic ul
requi res</w>
outcom e.</w>
odi um</w>
ochem istry</w>
new born</w>
nec k</w>
menopa usal</w>
medull a</w>
inhib i
inc or
g y</w>
flow .</w>
equ ally</w>
ephed rine</w>
deriv ative</w>
consist ently</w>
compl ained</w>
bacter ial</w>
at rac
ast er
asses sed.</w>
P F
M o
In iti
C s</w>
C D</w>
(M T
war ds</w>
vast at
ton ic-
tin nit
st one</w>
sel ectively</w>
sel ec
s or</w>
pentobarbit al</w>
path ologic</w>
ond an
ne t</w>
nat ural</w>
n mol
me l
kine sia</w>
iso prost
inhibit or
ex t
encephalo pathy.</w>
electro physiologic</w>
cult ured</w>
con cent
cerv ical</w>
achie ve</w>
V -
Suc h</w>
N-methyl-D- aspartate</w>
Clin icians</w>
AR F</w>
(C B
y ).</w>
week ,</w>
ur in
ultra structural</w>
ten d
survi v
substanti ally</w>
subcut aneously</w>
su it
soci ation</w>
si ded</w>
record ings</w>
not ed.</w>
ne arly</w>
n mol/
ke y</w>
invol ve</w>
ine -</w>
i.p .,</w>
gluc uron
gemcit abine</w>
fo od</w>
fac t</w>
f ying</w>
f os
exce ed
disturb ance</w>
desc ending</w>
cortex .</w>
child hood</w>
ac idi
a :</w>
SC H</w>
O UT
E 2</w>
DE S</w>
D ep
Cardi ovascular</w>
Adriam ycin</w>
Addi tionally,</w>
5 %,</w>
00 ,</w>
(A )</w>
trans fer
tra z
termin al</w>
syndrom es</w>
survi val
second -
random ised</w>
question na
predic ted</w>
pre feren
per gol
ol s</w>
norm ally</w>
mg/m 2,</w>
ment s,</w>
local ized</w>
ling ual</w>
ine ural</w>
icac y</w>
hy bri
group )</w>
gl auc
emergen ce</w>
dismut ase</w>
der .</w>
dail y)</w>
d ate</w>
cortico steroids</w>
consi der</w>
be f
b .
attem pt</w>
antibio tics</w>
ambul atory</w>
al ready</w>
al az
administere d.</w>
ac hol</w>
Ris k</w>
Res pon
O R</w>
B -
9 6</w>
1. 3</w>
yohimb ine</w>
wh at</w>
ti es,</w>
stimul ant</w>
st a
s par
ren ess</w>
ren e</w>
progres sed</w>
po wer</w>
phosphat ase</w>
not .</w>
neuro protective</w>
neph ritis.</w>
mes angial</w>
medic ations.</w>
lor azepam</w>
inhibit ing</w>
ineff ective</w>
in ner</w>
hydrochlorothiaz ide</w>
hepati tis,</w>
fact ory</w>
exer t</w>
erec tile</w>
dissemin ated</w>
discharg ed</w>
den erv
decl ined</w>
cit rate</w>
caus al</w>
atrac ur
ate g
antipsycho tics</w>
anaesthe tic</w>
am yl
aff ects</w>
Simil ar</w>
IS O</w>
Fif ty-
Ca2 +</w>
B u
As ses
9 5</w>
9 0
6 8</w>
6 0%</w>
5-HT (1
3, 4-
1 5,</w>
( 7.
( 6.
y clin
vessel s</w>
vari ability</w>
ti ve,</w>
side s</w>
rat s:</w>
pre g
poly uria</w>
pati on</w>
path ic</w>
pac e
p <
om ime
measure d.</w>
intrad ermal</w>
inten se</w>
inhibit ors.</w>
ine 's</w>
he re
haloperid ol,</w>
gamma- aminobutyric</w>
foc i</w>
d u
contrib uted</w>
com for
bre ak
ameth ox
ad ver
T n
S af
E -
CYP 2
A ce
3 44</w>
(O R</w>
vasospas m</w>
vasocon striction</w>
trimeth op
transpor ter</w>
tonic- clonic</w>
ten sion</w>
t ment</w>
sumatript an</w>
sol ub
sec tions</w>
ro f
predisp osing</w>
poly mer
oz yg
ox y-
ni gr
mg/m (2
mal e
l af
laf ax
is ms</w>
il lo
haemo dynamic</w>
glyc ine</w>
glutam at
doxorubic in,</w>
dow n
character ize</w>
bre ath
amelior ated</w>
abnormal ity</w>
Ur inary</w>
Peri pheral</w>
P ac
N S</w>
Mic ro
M g
In hib
Centr al</w>
C lon
7 9</w>
4 /
(P R
(D E
we ak</w>
vesi cal</w>
vasodilat or</w>
var ying</w>
simil arly</w>
schizophren ia.</w>
s lic
review .</w>
prop an
pre existing</w>
pos ite</w>
other wise</w>
nephro toxicity.</w>
min -1</w>
mg/m 2.</w>
m ing</w>
in tran
in stitution</w>
in dex
ide -
hyponat remia</w>
flumazen il</w>
flow ,</w>
encoun tered</w>
ec it
disorder ,</w>
dam age,</w>
cy tic</w>
comp ris
co logy</w>
c im
analo gu
an ser
an ore
accept able</w>
V T
M on
M S
G F</w>
= 0.00
8 4</w>
6 ),</w>
5 1</w>
5 ,
1. 4</w>
(2 )-
us -
un related</w>
some times</w>
rec ru
protein uria,</w>
offsp ring</w>
obstruc tion</w>
no d
meth amphet
lymph oma</w>
lymph oblastic</w>
leuk emia.</w>
j ust</w>
insi c</w>
ill ness</w>
ho w</w>
gi ven
exhib it</w>
esoph ageal</w>
do m</w>
dex medetomidine</w>
con n
cholest asis.</w>
cas e.</w>
c ateg
anti convuls
an j
Nar anj
Ho dg
H IT</w>
Be havi
8 .</w>
2 %,</w>
(e .g
vascul itis.</w>
ther ,</w>
te tr
ste ad
ris k.</w>
retrospecti vely</w>
ran iti
r ul
pregnanc y.</w>
para dig
pace mak
ocyt es.</w>
occasion ally</w>
nucle i</w>
mechanis m.</w>
ly sos
liver .</w>
it y:</w>
insipid us</w>
inc ub
id ,</w>
i s.</w>
hippocamp us.</w>
h and</w>
g ro
et al</w>
dy st
di aph
cont in
cardi opulmonary</w>
bl ing</w>
benef its</w>
bar ic</w>
b und
an ese</w>
T ac
PA P</w>
P ri
Naranj o</w>
K et
IO P</w>
I /
Hg ,</w>
E D</w>
CB Z</w>
C e
8 0%</w>
6 %,</w>
x anth
tum our</w>
thiop ental</w>
tail -
sulf amethox
salic yl
respectively ;</w>
ra re.</w>
ot ec
osi tive</w>
os mo
o gen</w>
natriure tic</w>
mg/ day,</w>
l -induced</w>
intro duction</w>
incor por
id -
he mic
exter nal</w>
end oscop
en o
d end
calc ineur
benz o
az osin</w>
arteri os
appe ti
ana emia</w>
al er
V er
Syst emic</w>
R T
O c
NA ME
D D
B ra
An alysis</w>
7 4</w>
7 0%</w>
1 60</w>
vehic le
v in
ur rent</w>
trigg ered</w>
sildenaf il</w>
ren in-
recover y.</w>
re mis
prur it
pro st</w>
parameter s.</w>
on ol
myo si
mit ral</w>
me t</w>
mat ri
k s.</w>
im e</w>
gen es</w>
enter ic</w>
eluc idate</w>
deli ver
death ,</w>
de tail
cortico sterone</w>
con jug
chemo therapy,</w>
ana phyl
ain s</w>
M ore</w>
D L
AN CA
1 2,</w>
( 6</w>
vol t
un affected</w>
th o
suppor ts</w>
releas ing</w>
recomm end</w>
prolifer ative</w>
po w
pilocarp ine.</w>
par aly
p unc
osmol ality</w>
od rine</w>
myasthen ia</w>
man ia</w>
ir e</w>
ip )</w>
in :</w>
i ,</w>
hypercal ce
hydrox yl
hormon al</w>
glutamat ergic</w>
gest ational</w>
ge al</w>
et ing</w>
dizzin ess,</w>
cy st
cont ained</w>
compar is
clop ido
c old</w>
bal ance</w>
augment ed</w>
attac k</w>
am ycin</w>
acut ely</w>
T P
R an
R OD
Med ical</w>
HBe Ag</w>
Eff icacy</w>
9 0%</w>
9 ).</w>
8 2</w>
1. 6</w>
1 :
1 %,</w>
worsen ed</w>
w ash
ven tive</w>
tren d</w>
ti b
suit able</w>
stres s.</w>
st ep
so on</w>
scop ol
saf ely</w>
pi g
peroxid ase</w>
om yc
man ic</w>
li pide
i op
hyp no
hem olysis</w>
guine a</w>
fluox et
flecain ide</w>
fascicul ations</w>
ey es</w>
exer ci
es /
diseas es.</w>
de sign</w>
contrac tile</w>
conf oun
concentr ations,</w>
co de
caref ul
cannabin oid</w>
c och
az oc
ari pi
ar ly,</w>
am -
abstin ence</w>
ROD UC
P 450</w>
INT RODUC
HB s
CO X-
Am iodar
A L</w>
3 %,</w>
1 25</w>
(C H
year .</w>
y ch
su ic
resul ts.</w>
r af
pap aver
onol act
monit or</w>
min /
le t
label ing</w>
j oin
ing -
h n
fluo res
f uture</w>
expl an
ei gh
com pa
bil ater
bas ement</w>
antiretro viral</w>
alkal ine</w>
Saf ety</w>
S ymptom
N S)</w>
H em
F l
E leven</w>
CI :</w>
7 8</w>
5-F U
1. 8</w>
1 7.
0. 9%</w>
0. 5%</w>
um or</w>
tubulo interstitial</w>
swell ing</w>
suppor tive</w>
st ren
sim ple</w>
shorten ing</w>
sex ,</w>
s ca
repe ti
princ ip
prepar ation</w>
pre frontal</w>
patient s).</w>
parox etine</w>
opyr amide</w>
occlu sive</w>
nitr ite</w>
ml )</w>
mil li
log raf
liqu id</w>
levo dopa
in /
hyper ther
gener ated</w>
experi encing</w>
ex encephal
es ul
dyskine tic</w>
contro lling</w>
conscious ness</w>
carcin omas</w>
carb on</w>
beta- adrenoceptor</w>
antagonist s,</w>
anc es,</w>
amant adine</w>
am oxic
Th er
S G
R epe
MATERIAL S</w>
INTRODUC TION:</w>
Fif teen</w>
Dec emb
C erebral</w>
Asses s
AC TH</w>
3 ;</w>
2. 0
1 -1
(- /-
( 3-
u preg
tub ule</w>
tu mo
tri am
ti form</w>
sal butam
ra y</w>
psych ological</w>
practi ce</w>
p ine-induced</w>
om es</w>
mg/m 2)</w>
il ine</w>
id azole</w>
heav y</w>
gam ma</w>
fluo resc
exten ded</w>
erg ot
e asi
cy s
cent er</w>
az one</w>
adul ts.</w>
acet am</w>
Ther ap
Th us</w>
Rever sible</w>
O p
Heal th</w>
Drug -induced</w>
Ca (2
24- hour</w>
100 %</w>
trans -
thrombocytopen ia,</w>
striat um.</w>
sing le
secon ds</w>
sacrific ed</w>
ra re,</w>
ra -
propofol .</w>
pre pared</w>
pa fen
opio ids</w>
on going</w>
olan zap
oid s</w>
ogen icity</w>
ne ar</w>
mo bil
meperid ine</w>
medull ary</w>
lo o
large ly</w>
inf ants.</w>
id ine.</w>
gentam icin-induced</w>
fem oral</w>
exac t</w>
employ ed</w>
emis sion</w>
dis ruption</w>
der mat
cy pro
cur ves</w>
convul sion</w>
carb achol</w>
block s</w>
bicarb onate</w>
b er
at ally</w>
aryn geal</w>
anc ing</w>
al low</w>
al )</w>
adi ly</w>
ad d
Propo fol</w>
Prolong ed</w>
P K
L- NAME
AC h
( in</w>
use d,</w>
ta x
stat es</w>
sp ectro
si z
si c
see king</w>
scop ic</w>
reser ve</w>
point es.</w>
pent am
peg ylated</w>
parkinson ism</w>
knowledg e</w>
intrac or
in s,</w>
in o</w>
impair ment.</w>
i lo
i b</w>
hypo the
haz ard</w>
h ind</w>
exer ts</w>
ex cell
epinephr ine-induced</w>
e le
dram atically</w>
discontinu ed,</w>
diethylstilbestro l</w>
complic ation.</w>
circ ulation</w>
ce ph
catechol amines</w>
catal ase</w>
cardiomyo pathy,</w>
bu pren
bra ins</w>
bor tezom
au tis
at o
anticoagul ant</w>
al lograf
] )</w>
O b
Lab oratory</w>
F our
B /
7 %,</w>
5. 0</w>
year s;</w>
volunte ers.</w>
vascul ar
unchang ed.</w>
ul es</w>
tubul es</w>
tr act
tic .</w>
there by</w>
streptozotoc in-induced</w>
s.c .</w>
s ure</w>
reve al</w>
repor ted,</w>
re plic
rang e.</w>
post synaptic</w>
phosph o
ph er
pa w
p ly</w>
oph osph
oly sis.</w>
o plastic</w>
myelo ma</w>
mul tivariate</w>
los s,</w>
intr insic</w>
inter ac
fam il
ex plo
enti re</w>
enti n</w>
disul firam</w>
cor d
caus ative</w>
avoid ed</w>
anesthe sia,</w>
am ifostine</w>
alpha- methyl
ag ing</w>
ag es.</w>
SE .</w>
M I
M ),</w>
B as
Al so,</w>
A S</w>
1 A</w>
0 .</w>
( 8.
y me
under standing</w>
ud g
u ne
tumo ur
tramad ol</w>
tion )</w>
tig m
ti ve.</w>
seg ments</w>
ret ard
relap sed</w>
pati al</w>
p g/
ous ly,</w>
ogene sis.</w>
ob last
normal ,</w>
is ot
infu sion
i v</w>
form ation.</w>
fet uses</w>
ex ogenous</w>
entr y</w>
em a</w>
dur al</w>
drug -related</w>
carnit ine</w>
car r
canc er
bl un
belie ved</w>
belie ve</w>
b if
arg in
appro ved</w>
anto in</w>
ad ap
R NA
P N</w>
P -induced</w>
Mul ti
Immun o
Hospit al</w>
Evalu ation</w>
Decemb er</w>
Com ple
Chin ese</w>
C ).</w>
AM -
A A</w>
- cell</w>
(1 50</w>
( ></w>
z ing</w>
visc eral</w>
toler ated.</w>
ta st
stren g
strate gy</w>
sten osis</w>
sed ation,</w>
remo val</w>
polymer ase</w>
pentylenetetra z
patient s;</w>
on ly.</w>
nic ardi
ng/ ml</w>
na ive</w>
metr on
m ary</w>
great ly</w>
g er
evalu ating</w>
dro p</w>
deli vered</w>
degener ative</w>
contrac tility</w>
catalep sy,</w>
c rac
b red</w>
arb oxyl
apparen tly</w>
anti inflammatory</w>
adoles c
T or
S u
R el
Phen y
Na +
L- dopa</w>
Fancon i</w>
8 00</w>
0.0 1</w>
y lo
ver b
ven lafax
tra ined</w>
therap ies</w>
t ation</w>
synerg istic</w>
su fentanil</w>
si rolim
sca ven
pre fer
post partum</w>
pentam idine</w>
par ad
ou gh</w>
other s</w>
octre otide</w>
nor adrenergic</w>
neurolep tics</w>
mus cim
mitoxantr one</w>
manifest ation</w>
li um</w>
ist s</w>
impro ves</w>
hypo thermia</w>
hyper thermia</w>
headache .</w>
half- life</w>
ha ir</w>
go al</w>
gen it
epilep tiform</w>
enalap ri
em ul
diazepam ,</w>
di ffered</w>
brady kinin</w>
behavi or.</w>
allow ed</w>
W il
T oxicity</w>
T otal</w>
N ational</w>
N R
He mo
D SM-
Ch ild
AZ T</w>
9 7</w>
8 ),</w>
5-hydroxy trypt
(D O
( 60</w>
wom en,</w>
vitro .</w>
verb al</w>
tuberculo sis</w>
tri pt
st ages</w>
specimen s</w>
sim vastatin</w>
side- effect</w>
sensor ineural</w>
s ampl
r ag
progres sively</w>
proced ure.</w>
presum ably</w>
ph ases</w>
par tly</w>
p ure</w>
osmo tic</w>
oper ativel
monke ys.</w>
ml ,</w>
mannit ol</w>
labet alol</w>
ischem ia,</w>
intra operative</w>
inges tion.</w>
illust rates</w>
id .</w>
i si
hypo thalam
he i
gu ide
form ulation</w>
expres sion.</w>
examin ations</w>
ed ;</w>
deoxy chol
concer ning</w>
com pati
careful ly</w>
b arbit
analgesic s</w>
adriamyc in-induced</w>
acceler ated</w>
T B
Q -
Pro te
P e
Lith ium</w>
I U/
G P
B B
9 2</w>
3 90</w>
19 .
1. 1</w>
1 5%</w>
-1 00</w>
trans genic</w>
swit ched</w>
sub clinical</w>
st ed</w>
spec i
re combin
presc rib
potenti ate</w>
pl ant
par t,</w>
p.o .)</w>
or ing</w>
one- treated</w>
ograph y,</w>
obser ved,</w>
log istic</w>
le d.</w>
ket oro
iz es</w>
ish ing</w>
indic es</w>
id ation</w>
high- risk</w>
hemat uria</w>
group ).</w>
facilit ate</w>
f ind</w>
edi atric</w>
easi ly</w>
e a</w>
dy sp
dis comfor
del ta
colo rectal</w>
clin ic</w>
ce -
amil or
administ ering</w>
ad he
acro megal
ac coun
V as
Simil arly,</w>
O ut
H z</w>
GAB A-
C V
Bas el
AT RA</w>
A C</w>
5 8
3- 4</w>
(N MD
(MA P)</w>
( m
weigh t.</w>
week .</w>
ultras on
u tility</w>
typ ically</w>
transamin ase</w>
terat ogenic</w>
sub unit</w>
strok e.</w>
st ru
specific ity</w>
s l
r y
pro cess
placebo- controlled,</w>
pericardi al</w>
parox ysmal</w>
out .</w>
ouabain -induced</w>
on ia</w>
no dul
nitro s
necess it
mono amine</w>
mg/kg ;</w>
lign ocaine</w>
intra ventricular</w>
incid ences</w>
i.p. ).</w>
hippocamp us,</w>
experim ent,</w>
dialy sis.</w>
day ).</w>
contraceptiv es</w>
cap able</w>
c up
ax is.</w>
atheros clero
anti parkinsonian</w>
amitript yline</w>
aldehy de</w>
T T
S ec
Pati ent</w>
PGE 2</w>
Ig G</w>
ED 50</w>
D AT
A F</w>
3 %),</w>
18 0</w>
+/ -1.
( one</w>
( >
( 5-HT
zin c</w>
week s)</w>
war ran
test s,</w>
ston es</w>
stimul us</w>
sed ative</w>
s pro
r ated</w>
progno sis</w>
pre- existing</w>
per cutaneous</w>
pa re
ot opic</w>
modul ate</w>
microg/ kg</w>
metabol ism.</w>
mes enteric</w>
man .</w>
main taining</w>
locomo tion</w>
is ing</w>
inter view
inten si
id -induced</w>
hypertroph y.</w>
hemat ological</w>
he pt
function ing</w>
fati gu
ect opic</w>
ec tion.</w>
dyskine sia.</w>
don or</w>
develop ment.</w>
contr al
classi fied</w>
arrhyth mo
anti platelet</w>
anesthe tics</w>
aldo sterone</w>
ak athi
aggreg ation</w>
admis sion,</w>
abs ent</w>
S ch
Ret ro
RF -1
R ole</w>
PGE 1</w>
E uro
CY P</w>
Be fore</w>
B U
A spir
5 6
% );</w>
vent ro
ut ri
ultras ound</w>
succinyl chol
str ych
resul ts,</w>
res .</w>
refl ect</w>
opoi etic</w>
ocic ept
nit rous</w>
mut ation</w>
mo de</w>
micro M</w>
li ver,</w>
lev of
kg(-1 ),</w>
in direct</w>
ic ot
hydr amine</w>
hemorrh age,</w>
favor able</w>
fail ure
es tic
dep ri
con striction</w>
compati ble</w>
com e</w>
cl as
bra inst
ardi zed</w>
abnormal ities,</w>
S K
Rec ently,</w>
R R</w>
Pro t
OUT COM
OUTCOM E</w>
M us
H z
H ere</w>
Experim ental</w>
EP O</w>
tur no
there after
survi ved</w>
strategi es</w>
stit ute</w>
solub le</w>
si der
shi ft</w>
saf et
sac char
s one</w>
ro ute</w>
raz ole</w>
ran ulo
r un
put ative</w>
patient s),</w>
pall id
open- label</w>
month -old</w>
mode st</w>
microscop y.</w>
me tri
me flo
m ir
lisin opril</w>
initi ating</w>
ine- related</w>
immunosup pression</w>
ill ing</w>
h ind
h en
great est</w>
gen cy</w>
fun g
ep ide
endoc rine</w>
end- stage</w>
dyst onic</w>
diltiaz em
dig ox
d- release</w>
cor tic
condition ing</w>
complex es</w>
bra in,</w>
blind ed</w>
benzodiazep ines</w>
avail ability</w>
aten olol</w>
arabino side</w>
ar abine</w>
anc er</w>
adjust ment</w>
ab users</w>
[ CI
V entr
Symptom s</w>
St at
Pac litax
Nit ro
Jap anese</w>
F E
5 %),</w>
4 ;</w>
(OH) 2
( odds</w>
( U
wom en
toler ated,</w>
thyroidis m</w>
thal idom
termin ated</w>
su med</w>
stro ph
spir onolact
si s:</w>
sett ing.</w>
sept al</w>
seiz ure.</w>
ru pt</w>
ondan setron</w>
moder ately</w>
mo stly</w>
kg -1,</w>
intub ation</w>
in da
h ome
gly cemia</w>
expl ore</w>
es ).</w>
e ).</w>
dow n</w>
dis opyramide</w>
dis appearance</w>
demonst rating</w>
comp uter
comp ul
com a.</w>
centr ally</w>
ce l
calcineur in</w>
as eptic</w>
antin ociception</w>
anti viral</w>
anat om
al f
T D
ST- segment</w>
S D)</w>
P AC
Me as
M ice</w>
Le ft</w>
II I
HIV- infected</w>
H b</w>
Ev idence</w>
DX R</w>
CA 3</w>
B H
Ace t
3 %).</w>
0. 2
( i.v.)</w>
z il</w>
we ver</w>
vari ation</w>
vari abl
uter o</w>
tic -
significant ly.</w>
sertr aline</w>
proced ures.</w>
physos tigmine</w>
penicill in</w>
patient -
pa ired</w>
non- small</w>
micro angio
methylphen idate</w>
matri x</w>
mal on
ma x</w>
long- acting</w>
lidoca ine,</w>
lac tic</w>
l ac</w>
ful ness</w>
discontinu ation.</w>
diarrhe a</w>
dat a,</w>
consider ably</w>
clo sed</w>
challeng ed</w>
b ase</w>
artic le</w>
aro und</w>
ar ti
ar -
amplit u
acqu isi
Td P</w>
NSAID s</w>
LI D</w>
Hy po
De pression</w>
Assess ment</w>
AN CA</w>
14 ,</w>
1 %),</w>
0. 25</w>
( at</w>
% -
ven ti
understo od.</w>
unc er
treatment s.</w>
to wards</w>
ter .</w>
st radi
som at
sequel ae</w>
re :</w>
radio therapy</w>
prece ding</w>
praz ole</w>
pharmaco dynamic</w>
p tive</w>
ot rig
mmHg ,</w>
minut es,</w>
mam mary</w>
malform ations</w>
lo st</w>
kg ro
intoxic ation.</w>
inos it
implant ation</w>
ia )</w>
hypertroph ic</w>
hyper baric</w>
hemo dynamics</w>
haloth ane-
gon ad
g .</w>
f ar</w>
exclu ded.</w>
ester n</w>
es are
def ovir</w>
dec i
cyclophosphamide ,</w>
cul ture</w>
conf usion</w>
az ot
awa reness</w>
atax ia</w>
aspir in,</w>
ac ted</w>
a ur
M or
M any</w>
Gi ven</w>
GF R</w>
Cor onary</w>
C ent
A z
2. 4</w>
vecur onium</w>
ve di
transplant ed</w>
suppres s</w>
suppor ted</w>
s patial</w>
regimen s.</w>
recept or.</w>
reac tions,</w>
promot ing</w>
proca ine</w>
pr one</w>
p sor
oxid ation</w>
oc hemic
observ ational</w>
o tic</w>
nitro gen</w>
micro M)</w>
mic tur
mg/ day.</w>
man ip
line zol
kind ling</w>
isch aemic</w>
intr act
inter nal</w>
inter mediate</w>
ing s.</w>
imi pr
idi osyn
h loro
form alin</w>
fol low</w>
fib rate</w>
ethambut ol</w>
endo theli
en si
en anti
ecti n</w>
contro ver
contrac tions</w>
co administration</w>
cholester ol
behavi our
asp ects</w>
am ate</w>
addi tive</w>
a /
W estern</w>
Th al
T rans
Hep at
H IT
C 3
Basel ine</w>
9 1</w>
7 1</w>
5 %).</w>
4. 5</w>
2 6.
(C O
vi ro
tremor ,</w>
tion ed</w>
tion :</w>
time -
ticlop idine</w>
ter ,</w>
system atic</w>
syn thesi
si c</w>
s he
repolar ization</w>
remo ved</w>
re adily</w>
ph il
pel v
out patients</w>
otec an</w>
oc occ
normal ization</w>
neon ates</w>
meth oxy
meth amphetamine-induced</w>
man aged</w>
leng th
ibu profen
hyper ammon
hist ology</w>
hepat ocytes</w>
hemat oc
fol ate</w>
fi g
f loxacin</w>
event ually</w>
esare an</w>
erythropoi etin</w>
e /
dram atic</w>
dop amine-
de pos
contral ateral</w>
complic ations,</w>
com promis
colon y-
children ,</w>
cardio protective</w>
calcitri ol</w>
av es</w>
aqu eous</w>
aminonucle o
all ed</w>
adrenal ine-induced</w>
acyclo vir</w>
activ ation.</w>
Val pro
Uni versity</w>
Repe ated</w>
O ver</w>
N K
M agne
M ).</w>
HU S</w>
Bra in</w>
Al ter
A no
A (2
2. 3</w>
(-/- )</w>
z ine</w>
vincrist ine-induced</w>
traum atic</w>
tr ue</w>
tox in</w>
te m</w>
sib ility</w>
se c</w>
s ine</w>
ro pivacaine</w>
repeti tive</w>
recor ding</w>
qu ad
py r
psych omotor</w>
propylthio uracil</w>
prompt ly</w>
pro pafen
pilocarp ine,</w>
phen ic
on uc
omime tic</w>
olig uric</w>
n ocicept
my co
mus cles</w>
meta -
ment ation</w>
m -
lymph ocytic</w>
lo mer
lipo protein</w>
lethal ity</w>
le g</w>
j ac
intract able</w>
insti ll
in contin
fl ush
eryth ema</w>
efficac ious</w>
di phenyl
cys tic</w>
cyclospor in</w>
cou pl
concentr ation,</w>
compul sive</w>
cocaine- related</w>
coag ul
cisplat in,</w>
cis -
circul atory</w>
challeng e.</w>
cap ecit
c Tn
bupivaca ine.</w>
basel ine.</w>
az ol</w>
as alazine</w>
am phenic
am ous</w>
aden os
accumb ens</w>
R ),</w>
N ,</w>
Hodg kin
D ay</w>
Ar g
8 3</w>
1 1-
(N O)</w>
(N O
( the</w>
warran ted.</w>
ur ally</w>
thre e-
ter ious</w>
sulpiri de</w>
st as
seg mental</w>
ro ot</w>
rin one</w>
resc ue</w>
pro -
per cep
olog ous</w>
no v
mor ning</w>
micrograms/ kg/
m urine</w>
lat er
lamivud ine-
k ine</w>
insuffici ency.</w>
inhibit ors,</w>
in uria</w>
ic lo
hyperalgesi a,</w>
hydr ation</w>
gen der</w>
form ed</w>
fibr in
exer ted</w>
et op
enanti om
discharg es</w>
day s).</w>
day -old</w>
combin ation.</w>
com orb
can di
c li
block er,</w>
bicucul line</w>
antine oplastic</w>
anore x
am lodipine</w>
advant age</w>
ac k</w>
a vi
U l
Physi ci
LVE F</w>
K +
Iso proteren
Inc idence</w>
INTERVEN TIONS:</w>
Hg )</w>
H a
GS H</w>
E P</w>
D ).</w>
COX- 2</w>
A dul
ve lop
ul a</w>
tw or
ti r
t un
sup ine</w>
sulf on
slow ly</w>
shi f
s in</w>
repor t,</w>
renin- angiotensin</w>
regul atory</w>
pri de</w>
pre cur
pp m</w>
ph ent
pa ir</w>
or d
onuc lide</w>
on d</w>
ome g
nitroprus side-induced</w>
morph ology</w>
mitochond ria</w>
m M</w>
lig ation</w>
leuk openia</w>
less er</w>
know n,</w>
it s,</w>
it ,</w>
intra ocular</w>
ingest ed</w>
indic ative</w>
increas ed,</w>
ic .</w>
he im
h ab
follow-up ,</w>
fluoresc ence</w>
e ar</w>
dr y</w>
dipyridamol e-induced</w>
degrad ation</w>
de d,</w>
d ang
cult ures</w>
cra ving</w>
complain ts</w>
clonid ine.</w>
bran ch</w>
bo dy
bac kgro
b ru
ay s.</w>
as cit
ap aro
alcoh olic</w>
adoles cent</w>
Ventr icular</w>
T ak
S S</w>
S BP</w>
MD MA</w>
M T</w>
M PT
J un
In te
Grou p.</w>
G V
Fo od</w>
F atal</w>
F ).</w>
E 1</w>
7 ),</w>
5 /
2 3.
- based</w>
vac c
tiz ing</w>
t es</w>
sub -
s pl
s clerosis</w>
recipi ents.</w>
re jection</w>
prescrib ing</w>
pre operative</w>
pos t</w>
per ative</w>
pat ch
p tion.</w>
ove rex
om yo
om as.</w>
mg/d L</w>
ket ocon
iohex ol</w>
ing )</w>
inflamm ation.</w>
impair ments</w>
immunore active</w>
id ine-induced</w>
hospital ization</w>
hormon es</w>
gab ap
g an
fer ri
ex pan
epilept ogenic</w>
enh ancing</w>
dos age.</w>
dog .</w>
depress ant</w>
def ine</w>
conjunc tion</w>
classi cal</w>
cap sul
bri le</w>
b asic</w>
adrenocept ors</w>
adolesc ents</w>
abol ic</w>
W K
Rec o
R s</w>
N D
L ocal</w>
L P
In f
IC U</w>
IC RF-1
Hodgkin 's</w>
H emat
CA )</w>
C ancer</w>
AIM :</w>
6 ;</w>
6 0-
4 %,</w>
20 00</w>
2 4.
0 -1
( 8</w>
we an
vit al</w>
traum a</w>
tra di
tissu e.</w>
thrombocytopen ia.</w>
surviv ors</w>
str al</w>
stimul ation,</w>
stand ardized</w>
st ent</w>
st atic</w>
so ft</w>
side .</w>
sec tional</w>
ri gh
reli able</w>
rele ased</w>
recombin ant</w>
rat e-
rat ,</w>
provo ked</w>
prost atic</w>
prolact in
pect or
ob ses
neo plas
ne os
nar co
mut ations</w>
mor tem</w>
month s)</w>
m isoprost
lymph ocyte</w>
log raph
invol ves</w>
impro ving</w>
i -
hyper activity.</w>
high ligh
ga ve</w>
fl are</w>
exacerb ated</w>
es ),</w>
er )</w>
efficac y,</w>
e ligible</w>
di methyl
develop ed.</w>
decreas ed.</w>
de myel
cri tically</w>
cont ex
con sol
coll ap
clar ify</w>
captop ri
ca v
asth ma</w>
ass ay.</w>
analgesi a.</w>
ST Z
MT X
M orph
Inhib ition</w>
G ra
Ch ol
Al z
A ).</w>
1/ 2</w>
1 %).</w>
-1 7</w>
(i )</w>
treatment -
transf usion</w>
table ts</w>
system s.</w>
spi k
somn ol
rifamp icin</w>
regar d
regard less</w>
reduc tase</w>
ras h,</w>
radi onuclide</w>
propranolo l.</w>
pre clinical</w>
ph ere
p ine.</w>
p ine,</w>
oxy toc
osmol ar</w>
os ed</w>
om ep
o d,</w>
ne twor
n utri
my ocyte</w>
morph ine-induced</w>
ml .</w>
minoxidi l</w>
minocycl ine</w>
meth od
las er</w>
it y-
gall bladder</w>
excell ent</w>
ev ing</w>
etop oside</w>
en co
dyskinesi as.</w>
dele terious</w>
cor b
con stric
capsaic in-
ca u
c m</w>
bronch odi
atracur ium</w>
ap pa
aneurys m</w>
activ ating</w>
a er
Thir teen</w>
S pec
Re search</w>
O H
NS AI
N icot
N I
N .</w>
Hist opath
E pi
D M
CN U</w>
C ont
9 .</w>
2 A</w>
.00 1).</w>
- M
(S T
(S E)</w>
(1 9
(1 2</w>
ym pathetic</w>
vin blast
ve tir
ur able</w>
tremor s</w>
tim ul
thel ess,</w>
sup press
strok e,</w>
slic es</w>
sh am-
selec tivity</w>
rim -
re mic</w>
raz oxane</w>
presum ed</w>
post menopausal</w>
paren t</w>
o ple</w>
non selective</w>
negati ve.</w>
ne a</w>
n om
month s).</w>
meth ion
medi ating</w>
ist er
invol ve
intracerebro ventricular</w>
interval s.</w>
ic s,</w>
gre at</w>
gn os
genotyp e</w>
g ross</w>
extra vas
elim inated</w>
dy stroph
dur ation,</w>
diphen hydramine</w>
diclofen ac
capsaic in.</w>
c ran
b ar</w>
arter y.</w>
apopto tic</w>
anthrac yclin
antagon ize</w>
acetaminophen -induced</w>
S odium</w>
Pri or</w>
Pre vention</w>
Me dic
GABA (A)</w>
B ilateral</w>
An esthe
Alz heim
8 6</w>
5 ;</w>
3. 2</w>
23 390</w>
2 %),</w>
( 5-
zidov ud
weigh ted</w>
vulner ability</w>
un common
ter ti
stres s
ste ad</w>
squ amous</w>
reg ist
reas on
re al</w>
py ramidal</w>
prote in,</w>
process ing</w>
proc ess.</w>
patient s:</w>
p. o.</w>
of -
nigr a</w>
neuro n</w>
monit ore
micro som
m ec
m arg
kg -1.
ketoro lac</w>
is ation</w>
io di
insti tu
in- 1</w>
in verse</w>
ia /
hyperkal emia</w>
hyper cholesterol
home ost
hepat ocyte</w>
g ri
fact or-
experiment s,</w>
enz yme
e duc
diure tics</w>
dis co
depend ent.</w>
de struc
conside red.</w>
carbo plat
b ing
b ,</w>
appeti te</w>
a reas
Throm bo
ST Z</w>
SE ,</w>
M ethyl
K +</w>
I MP
I CA
En gl
Comple te</w>
Aspir in</w>
Ar ter
Ang io
AM I</w>
4. 0</w>
4 %),</w>
1. 9</w>
1. 7</w>
1, 25-
1 8-
0.0 2).</w>
(D A)</w>
(0. 3</w>
ta ined.</w>
suxameth onium</w>
stat e.</w>
sit u</w>
se en.</w>
s- -
s ection</w>
posi tively</w>
pl ate</w>
pl ant</w>
pathw ay.</w>
ozyg ous</w>
onucle ar</w>
ol )</w>
ogen etic</w>
nitro- L-arginine</w>
nim esul
neurotransmit ter</w>
neuro chemical</w>
metho d.</w>
manag ement.</w>
kine tics</w>
kidne y.</w>
kain ic</w>
infec tion,</w>
i m</w>
hepatoc arcin
gnos tic</w>
expos ure,</w>
escal ating</w>
dro w
diazepam .</w>
conver ted</w>
carb onate</w>
bus ulf
bef ore,</w>
aut opsy</w>
antagonist s.</w>
antagonist .</w>
ammon ia</w>
a j
With draw
V ari
SP EC
Physici ans</w>
O x
Hepar in-induced</w>
Fo s</w>
E th
De velop
Coca ine-induced</w>
8 %),</w>
6 9
-1 .</w>
- free</w>
(M D
(C Y
(3 00</w>
(0. 2</w>
y r</w>
vasodi lation</w>
unex pl
ulo x
ulc er</w>
transplant ation,</w>
transc ri
tinnit us</w>
susp ici
spec ial</w>
sour ce</w>
side ,</w>
ser a</w>
salbutam ol</w>
ro stral</w>
retro grade</w>
respon ders</w>
repe at</w>
recur red</w>
raz ol
rabb it</w>
psych os
prop ose</w>
present .</w>
phy loc
phenyl propan
ph e
person s</w>
per in
pe ople</w>
particip ated</w>
parathyro id</w>
ocyt es,</w>
ochrom ocyt
neuron s,</w>
me lan
lob al</w>
it amin</w>
infec tions.</w>
improve ments</w>
ic tal</w>
hypo thalamic</w>
g ain
fung al</w>
flut ter</w>
fibro sis.</w>
fati gue</w>
f osf
es us</w>
ep icardi
em ent,</w>
echocardi ography.</w>
desi pramine</w>
dec om
clinic al,</w>
clar ithromycin</w>
caud al</w>
bund le</w>
ate )</w>
ap ril</w>
acet azol
a sis,</w>
T o
S w
S up
R P
On cology</w>
M it
Jun e</w>
G lobal</w>
G ),</w>
Four teen</w>
E .</w>
DAT A</w>
D PA
Cat al
A M</w>
2 5.
.0 5).</w>
(1 0-
up -
traz od
tob ram
to ol</w>
tend ency</w>
techniqu es</w>
sub type</w>
stit ut
se n</w>
scal e.</w>
ro om</w>
ro les</w>
ro l
ro curonium</w>
reser pine</w>
raniti dine</w>
phosphor ylation</w>
perid one</w>
orig in</w>
onse t,</w>
necro sis,</w>
morph ine,</w>
micrograms/ kg)</w>
mel phal
literat ure,</w>
kg .</w>
k appa
it ary</w>
ir radiation</w>
individu als.</w>
in toler
identi fication</w>
hyperprolact ine
hyper lipide
heter ogene
headach es</w>
gangli a</w>
frequ encies</w>
for ced</w>
ex pect
evid enced</w>
establ ished.</w>
er ro
ei r</w>
dro xy
dilat ation</w>
de vi
dap sone</w>
cyt arabine</w>
cyclophosphamide .</w>
correl ates</w>
continu e</w>
concentr ation
compris ed</w>
colony- stimulating</w>
cep t</w>
bl ue</w>
an oid</w>
alb ino</w>
admis sion.</w>
aden omas</w>
Th eir</w>
NS CL
M echan
I P</w>
Ev ans</w>
E E</w>
Cont inu
C ),</w>
AM P
A Q
9 9</w>
8 %,</w>
5 -1
1 2)</w>
0.000 1)</w>
/ -</w>
- P
vi g
venti lat
v es.</w>
un able</w>
tr in
test ing.</w>
tachy cardi
supplement ed</w>
sub lingual</w>
stud ying</w>
stru al</w>
stat us.</w>
sig ma</w>
seve re,</w>
resuscit ation</w>
put am
predict or</w>
pre ventive</w>
pre treatment.</w>
ox ical</w>
orth otopic</w>
ol -treated</w>
ni gh
n ia</w>
mus cl
morph ologic</w>
micro injection</w>
medic ation,</w>
loc us</w>
lithi um
le f
itsel f</w>
inhibit or.</w>
influ ences</w>
im azole</w>
if or
hemo dynam
hear t,</w>
h am
grad ual</w>
glomerulos clerosis</w>
fe brile</w>
ex p
cyt os
concent rating</w>
coch lear</w>
aor ta</w>
anser in</w>
anc es.</w>
al prazol
Six ty-
Pharmac o
I S</w>
F re
Am ph
Afric an</w>
8 1</w>
3 5%</w>
2. 7</w>
2. 1</w>
.00 0
(AC E)</w>
( NT
xanth ine</w>
us ers,</w>
ul l</w>
ti d
surve y</w>
super ficial</w>
stoppe d.</w>
st ain
sist ent</w>
ri t</w>
pyri dine</w>
pod ocyte</w>
plas ma
pergol ide</w>
pa res
os por
naprox en</w>
interval .</w>
in stead</w>
im ages</w>
hepar in.</w>
g as</w>
four -
fluc tu
examin ation,</w>
ethin yl</w>
er up
endo thel
embry onic</w>
clo sure</w>
cimeti d
chrom os
cholec yst
ca use
bupren orphine</w>
arter ies.</w>
ap ical</w>
ang in
amygdal a</w>
acquisi tion</w>
a y,</w>
a defovir</w>
Six teen</w>
SR L</w>
Retro spective</w>
Parkin son</w>
N H
F em
Carb am
C ar
9 ),</w>
7 5%</w>
2 8.
1 4-
- onset</w>
(e.g .,</w>
(S E
yc in-induced</w>
y /
well- known</w>
we re:</w>
vi ol
triam te
tast e</w>
shorten ed</w>
sensitiv ity.</w>
s lop
rupt ed</w>
risperid one.</w>
rim- sulfamethox
pren atally</w>
post ulated</w>
plast y</w>
parathyro idis
multicent er,</w>
muc osi
morph ine.</w>
malon di
le ak
l ine,</w>
intra hepatic</w>
intak e.</w>
i. e.,</w>
hypertroph y,</w>
hyper calci
hepat otoxicity.</w>
g old</w>
g ated</w>
eth yl</w>
en flurane</w>
dys ph
di ed.</w>
cycl es.</w>
chron otropic</w>
ca in
bl ind</w>
antioxid ants</w>
analy zed.</w>
age- matched</w>
aff ected.</w>
addic tion</w>
V .</w>
Tor sades</w>
Prop ran
P res
I P)</w>
I ).</w>
HC V</w>
AL T</w>
A ut
A t
A U
5 '-
24- h</w>
(E E
y- state</w>
withdraw al,</w>
une vent
underg o</w>
u xim
tri azol
syn chron
sub acute</w>
si ve,</w>
rh esus</w>
reac h</w>
re striction</w>
re se
pro gnostic</w>
pneumon ia</w>
pent azoc
ot umor</w>
oper ated</w>
ome gal
oly sis,</w>
necro tizing</w>
na di
microg/ kg/
meas urable</w>
m RNA
lam otrig
ke phal
hypoc al
hypo ther
haemat ological</w>
etom id
en kephal
efficac y.</w>
e ),</w>
detail ed</w>
der m
dat a.</w>
continu ing</w>
consider able</w>
concomit antly</w>
clozap ine.</w>
cle ,</w>
cholin erg
ceftriax one</w>
carbamazep ine.</w>
cal cin
barbit ur
azol e.</w>
atro b
atel y,</w>
analy sed</w>
ab und
Ser ial</w>
L-DO PA</w>
Hg .</w>
D obut
C H</w>
= .0
7 ;</w>
7 %).</w>
3. 3</w>
2. 6</w>
- specific</w>
( <
year s).</w>
y le
v ox
unex pected</w>
un likely</w>
throm bus</w>
t ting</w>
sub mitted</w>
stereotyp y</w>
spi ke</w>
sci atic</w>
remark able</w>
ran k</w>
queti apine</w>
phyloc occ
ph ase.</w>
pacemak er</w>
or ic
op posite</w>
olo l,</w>
ol e-
ng/ m
mit omycin</w>
mictur ition</w>
loc ation</w>
lif e.</w>
k in</w>
is os
inser tion</w>
ine ).</w>
induc tion.</w>
hist ologically</w>
hap s</w>
gene tically</w>
fif th</w>
fact or.</w>
extrem e</w>
evol ution</w>
escal ation</w>
er ol</w>
eosinophil ia</w>
ent s,</w>
ec stas
diagno sis.</w>
dec arboxyl
correl ations</w>
coll ecting</w>
chlor amphenic
ceph alo
car vedi
c anal
aw ake</w>
assess ing</w>
arrhyth mia,</w>
appea red.</w>
an -induced</w>
ag es,</w>
acc ess</w>
Withdraw al</w>
Sevent y-
MEASUREMENT S</w>
I ),</w>
G R
G MP</w>
F os
F ),</w>
E ,</w>
D T
C K
B AL
Ano ther</w>
AV P</w>
A PAP</w>
5-HT(1 A)</w>
2. 2</w>
(NS AID
(NMD A)</w>
( s)</w>
( by</w>
xi let
w i
vetir acetam</w>
ver theless,</w>
ut roph
ur niqu
un responsive</w>
ular ,</w>
ul e
to urniqu
titr ated</w>
tion -
ten sive</w>
t ap
t al
t /
si ve-
ris k,</w>
relationshi ps</w>
rat ings</w>
promot e</w>
pro convulsant</w>
pre- treatment</w>
poly neuropathy</w>
peri pher
p tion,</w>
oper atively</w>
op tion</w>
oni um.</w>
on ce-
occur .</w>
non- steroidal</w>
ni ght</w>
my algia</w>
mus cle.</w>
modi fication</w>
microgram s.
medic ations,</w>
me xilet
local ization</w>
lidoca ine-induced</w>
k le</w>
it y;</w>
ino gen</w>
inhal ation</w>
ing :</w>
im oz
i. e.</w>
hyper parathyroidis
h erb
grad ed</w>
fact or
examin ation.</w>
epilep sy,</w>
end ot
dos ed</w>
dom eth
discomfor t</w>
creatin ine,</w>
concl usion</w>
concer ns</w>
con struc
compli ance</w>
code ine</w>
categ or
cardiomy ocytes</w>
ca re.</w>
c ost</w>
at ure</w>
as one</w>
arrhythmo genic</w>
aminoglyco side</w>
alter s</w>
Un der</w>
Further ,</w>
E mer
Clon idine</w>
An gi
Adul t</w>
9 %,</w>
7 /
6. 5</w>
3 7.
1 10</w>
0.0 3</w>
(E P
(A R
z o
vi gab
vigab at
un complicated</w>
ulo pathy</w>
ul tim
turno ver</w>
thyro x
thrombo sis,</w>
thrombo embol
test ed.</w>
t wit
sub stitution</w>
sub group</w>
spironolact one</w>
sig ma
sh ar
rit odrine</w>
re tri
prog est
preser ved</w>
prescri ption</w>
par ano
ophthal mo
nit rate</w>
neutroph il</w>
ne ede
n e</w>
lob ular</w>
lat encies</w>
isch aemia</w>
ir radi
inter action.</w>
inte rest</w>
im otor</w>
idiosyn cr
idaz ox
hypox ia</w>
hom ogen
hem is
gem fibro
func tions.</w>
form er</w>
fore arm</w>
erythro cyte</w>
eosinophil ic</w>
effici ent</w>
ed :</w>
document ed.</w>
di l</w>
bus pir
brainst em</w>
be y
associ ations</w>
anc y</w>
amin ophyll
V is
V O
Twenty- four</w>
S C</w>
P artic
NSAI D</w>
N C
L eu
Initi al</w>
In v
In dometh
Di ag
Comb ined</w>
Ca2 +
Ca ffe
Bet ween</w>
Amiodar one</w>
Addi tional</w>
9 4</w>
50 )</w>
3. 8</w>
2 %).</w>
13 5</w>
) ]</w>
(A N
z e
z ation</w>
w all
venlafax ine</w>
v on</w>
tw ic
trans formation</w>
ten of
t an
ser ve</w>
secre tion.</w>
sco red</w>
sc hem
rod ent</w>
recomm en
ral oxif
radic als</w>
pur pur
prote ase</w>
pro myelo
pos it
ple x
platele ts</w>
pic ture</w>
phen azine</w>
papaver ine</w>
over t</w>
orph in</w>
ometr y</w>
oid al</w>
off er</w>
neurolep tic-induced</w>
neuro transmission</w>
modi fic
mo ther</w>
mmHg )</w>
men strual</w>
lysos omal</w>
lomer ular</w>
li k
l ist</w>
immunohist ochemical</w>
ia sis.</w>
histor y,</w>
gl it
form ing</w>
echocardi o
duct us</w>
drow sin
determin ing</w>
depri v
demonst rat
cortis one</w>
compar tment</w>
breath ing</w>
beta- blocker</w>
aut ologous</w>
as corb
app ing</w>
app a</w>
ap preci
antagon istic</w>
angiograph y.</w>
al -induced</w>
acid -
a e.</w>
Sw is
S te
S /
Paclitax el</w>
PT U</w>
P ).</w>
O N</w>
L S</w>
II )</w>
I C</w>
HC l</w>
F S</w>
En do
C i
B D
A 1</w>
19 7
1 6-
, 00
(4 00</w>
ym al</w>
volum es</w>
vig il
tradi tional</w>
tion ;</w>
sha m</w>
rest ingly,</w>
resp ir
repe ate
rectom y</w>
reas on</w>
re inst
quanti fied</w>
pre medication</w>
phosph on
pathophysi ological</w>
over -
non ionic</w>
neuro psychiatric</w>
myelo id</w>
mg. kg-1</w>
metr y</w>
men .</w>
me an
l y-
isos orb
isoflur ane-induced</w>
intracor onary</w>
intra vesical</w>
intra renal</w>
inter f
interf ere</w>
ine ),</w>
indic ation</w>
in nerv
if en
i le
haemorrh age</w>
frac tions</w>
frac tion
fentanyl -induced</w>
feed ing</w>
f ing
f illing</w>
exten sion</w>
explan ation</w>
experiment ally</w>
ep o
enro l
electroencephalo graphic</w>
e x</w>
drom e</w>
diet .</w>
di ameter
develop s</w>
de af
d or
convul sions,</w>
colo r</w>
cis apri
cancer :</w>
c AMP</w>
bey ond</w>
are a.</w>
addic tion.</w>
a emia.</w>
P o
P 2
Meas ure
Hepati c</w>
He ad
B T
B NP</w>
3. 6</w>
20 )</w>
2 9.
2 7.
- opioid</w>
(A L
( two</w>
( a)</w>
z es</w>
ver te
unexpl ained</w>
underg one</w>
tremor .</w>
toge ther,</w>
terti ary</w>
ta uro
sens ation</w>
sc an
sar co
salicyl ic</w>
repor ts,</w>
re challenge</w>
protoc ol.</w>
pro arrhythmic</w>
pres yn
ph thal
or rhe
oc ur
nal trex
medic ated</w>
ly )</w>
loc ally</w>
intro duced</w>
insomn ia</w>
inosit ol</w>
inj ured</w>
infrequ ent</w>
indin avir
incid ent</w>
in ti
in t
impa ir</w>
ill ance</w>
icill in</w>
i.c.v .</w>
hybri diz
hic cup
given .</w>
ester ase</w>
direc ted</w>
detect ed.</w>
con serv
carb ox
blockade .</w>
biop sy.</w>
ar y.</w>
anti hist
anti emetic</w>
amis ul
al ve
aden o
V itamin</w>
R o</w>
PD .</w>
P G</w>
IN R</w>
Hemo dynamic</w>
E SR
Cyclo phosph
Br ady
B o
Ap pro
A ra-
2. 9</w>
(1 00
z one</w>
weigh t)</w>
throm ycin</w>
sub set</w>
stead y-state</w>
sen se</w>
ret te</w>
rem ia.</w>
re l</w>
re gener
propranolo l,</w>
promyelo cytic</w>
prob uc
princip al</w>
pri l</w>
predict able</w>
pre hen
popul ation,</w>
platin um</w>
pi g</w>
phenotyp e</w>
ol ate</w>
ob tain</w>
myosi tis</w>
multi focal</w>
mir ta
mim ic
mg/d l</w>
men ,</w>
membran es</w>
mec amyl
lamivudine- resistant</w>
lab or</w>
k i
invol un
ini b</w>
in ;</w>
id one</w>
hypokal emia.</w>
hil ar</w>
hem i
fast er</w>
f all
excit ability</w>
eff usion</w>
dur ation.</w>
di dan
dementi a</w>
dam aged</w>
d ual</w>
cyto sis</w>
cross- sectional</w>
clonid ine-induced</w>
cef ot
bac lofen
anter o
alk yl
TION AL
T op
T em
T c-
T am
RA TIONAL
Ne vertheless,</w>
Lo w</w>
Gl uc
Dis continuation</w>
DOX -induced</w>
CR F</w>
B 6
B 2</w>
AE s</w>
A min
5-fluoro urac
4 %).</w>
10 (9
- 2</w>
(5 00</w>
( b)</w>
( ME
( 9.
ucle ar</w>
swit ch</w>
sus pect
str um
str ati
stereotyp ed</w>
spro uting</w>
sh un
sec ret
rele ase.</w>
reduc ed.</w>
re perfusion</w>
qual it
per haps</w>
p imoz
osar coma</w>
neos tigmine</w>
n ox
min ).</w>
mg/kg/ day)</w>
lim its</w>
k ne
k appa</w>
instill ation</w>
incl usion</w>
hi p</w>
hemat opoietic</w>
granulomat ous</w>
glucuron ide</w>
gangli on</w>
feat ure</w>
f ast</w>
f .</w>
exam eth
ex change</w>
d ulox
d ot
d ).</w>
criter ia.</w>
controver si
citalop ram
ci ga
beta- D-
baro receptor</w>
b allo
arrest .</w>
amilor ide</w>
aler t</w>
acu ity</w>
V F</w>
TN F-
PO RT
P oly
Na Cl</w>
LI CA
L am
IMP LICA
II I,</w>
F K</w>
Di se
D (2)</w>
Com p
CD 4</w>
8- OH-
1 1,</w>
, 2
(P GE
(P D)</w>
y ),</w>
volume ,</w>
use fulness</w>
triglycer ide</w>
thick ness</w>
stere ot
sensor imotor</w>
sensi tized</w>
rul ed</w>
response s,</w>
reas ons</w>
re pair</w>
re bound</w>
rat es.</w>
provid ing</w>
previ ously.</w>
piper az
pepti des</w>
paras ympathetic</w>
p em
oxytoc in</w>
oxi b</w>
oper ation</w>
ocyto sis</w>
neutroph il
n g</w>
myel inated</w>
mix t
iz ine</w>
iz ations</w>
ist r
isoproteren ol.</w>
iop amid
involun tary</w>
injec tions.</w>
indic ations</w>
inclu des</w>
in adequate</w>
improve ment.</w>
imb al
hyper plasi
hematoc rit</w>
granulo cyte</w>
gabap entin</w>
fatigu e,</w>
facilit ated</w>
es cap
epide mio
elic it</w>
ectom y.</w>
dysrhyth mi
duc ts</w>
dis abl
crac k</w>
conf usion,</w>
concentr ation-
compoun ds.</w>
cell s/
bodi es</w>
bif id
behavi or,</w>
assess able</w>
aripi prazole</w>
anti cancer</w>
ang u
al ization</w>
age en
ab rupt</w>
Ver apam
SIAD H</w>
Qu in
P ath
P 2</w>
O C</w>
N MS</w>
L i</w>
Isoproteren ol</w>
Intra thecal</w>
IF N</w>
I fosf
HBe Ag
GT N</w>
E lev
8 9</w>
8 8</w>
4 8-
2 40</w>
1 3-
/ kg</w>
(1. 5</w>
yiel ded</w>
vi de
ul y</w>
tri als,</w>
tiv ation</w>
tib ular</w>
survi ving</w>
st and</w>
spl en
separ ated</w>
sc inti
s we
s per
ru gad
rigid ity.</w>
rest ra
resist ance.</w>
regimen ,</w>
pseud o
practi ce.</w>
phe ochromocyt
oxygen ation</w>
oro facial</w>
or in</w>
modul ating</w>
modi fi
model s,</w>
milli on</w>
meflo quine</w>
ma ke</w>
lab or
junc tional</w>
join t</w>
in ating</w>
fle xi
f al
exist s</w>
exist ence</w>
erythematos us</w>
electroencephalo gram</w>
dist rib
difficul ty</w>
diarrhe a,</w>
deple ted</w>
demo graphic</w>
cyt openia</w>
cyclo oxygenase</w>
cr amp
contex t</w>
con currently</w>
com a,</w>
chloro qu
cephal ospor
carr ageen
c alled</w>
c )</w>
bronchodi lat
ate ment</w>
anxiet y,</w>
anti thrombotic</w>
ant ly,</w>
andro gen</w>
alpha- adrenergic</w>
ag ranulo
ac tion,</w>
T G</w>
S ing
S hor
S P</w>
P seud
Multi ple</w>
Meth amphetamine</w>
Inter national</w>
F act
EM G</w>
E :</w>
Dep art
DL IN
Cap sa
C a</w>
Arter ial</w>
3 '-
2- adrenoceptor</w>
(1. 0</w>
(+/- )-
( up</w>
( n
( control
yle stradi
wor k
warr anted</w>
w ing</w>
ves '</w>
vehicle -treated</w>
valu es,</w>
utroph il</w>
uc asi
transc ript
therap y:</w>
the se,</w>
t or</w>
summ ary,</w>
ste at
st .</w>
sc ans</w>
res ection</w>
repor ts.</w>
recru ited</w>
recommen ded.</w>
recept or
re plac
pro gram</w>
pp ed</w>
potenti ates</w>
poison ing</w>
picrotox in-induced</w>
pi ratory</w>
physici an</w>
perio dic</w>
nov o</w>
neuro toxicity,</w>
monitor ing.</w>
methyl dopa</w>
meth orph
mellit us</w>
lymph ocytes</w>
lo l.</w>
lo l,</w>
lin k</w>
limb s</w>
lep tic</w>
k er
ir rig
ine ly</w>
in strum
ifor m</w>
id s,</w>
gene ic</w>
flur bi
fluoro quinol
exencephal y</w>
en large
e en</w>
dist ress</w>
differenti ated</w>
diaph rag
depend ing</w>
cyto kine</w>
cy cle.</w>
correc tion</w>
conjug ated</w>
concer n</w>
col itis</w>
chang e.</w>
carcin ogenesis</w>
c ot
assess ments</w>
ass ays</w>
asc ending</w>
angio graphic</w>
an d.</w>
amoxic illin</w>
amiodar one.</w>
alop ec
albumin uria</w>
advant ages</w>
adoles cent
Thal idomide</w>
T ol
T est
RO S</w>
P R</w>
MEASURE S:</w>
L evo
K )</w>
Inte restingly,</w>
In duction</w>
Im pro
IMPLICA TIONS:</w>
I R</w>
High -dose</w>
Gra ves'</w>
G u
C is
9 8</w>
8 6
6 /
2 -1
2 +/-
17 5</w>
100 ,</w>
(L V)</w>
(HB V)</w>
x .</w>
w aves</w>
ur k
ur idine</w>
um- dependent</w>
tur nal</w>
toxic ology</w>
thereafter .</w>
subst rate</w>
striat um,</w>
str al
solu tions</w>
so deoxychol
sion :</w>
ro t
ro dent
resem bling</w>
relev ance</w>
rel im
receptor- mediated</w>
propor tional</w>
propafen one</w>
ph ore
ne u
metri c</w>
meth oxy-
met ab
meas ures.</w>
me m
like li
lig ands</w>
le sions,</w>
l /
j er
j ec
investig ating</w>
in ver
in do
im mu
ill ic
gy nec
glyce mic</w>
g rel
for ce</w>
f at</w>
extrem ity</w>
ex pressing</w>
event .</w>
ept ogenic</w>
ent or
enox apar
diseas e:</w>
depos its</w>
day ),</w>
consider ation</w>
clon azepam</w>
char t</w>
block ,</w>
beats/ min</w>
be aring</w>
as ti
anti cataleptic</w>
analy ze</w>
amelior ate</w>
al gi
RE PORT
P ot
N on-
ME DLIN
MD D</w>
II .</w>
HC T
F 2</w>
Dec reas
D s</w>
Compar ative</w>
Ca(2 +)</w>
B rugad
B ac
Au stral
9 /
2 1-
1 40</w>
0. 15</w>
(C NS)</w>
(50 )</w>
zol pide
yr -old</w>
yl )-
yc in,</w>
viv o,</w>
ul t
tw ent
troph ic</w>
tro pine</w>
thiopent one</w>
th an
sus pen
su sta
ser ocon
rof ecoxib</w>
rit on
rigid ity,</w>
rec all</w>
r ine.</w>
pyridox ine</w>
prote in-
phenylephr ine-induced</w>
path y:</w>
os c
ophthal mic</w>
op ositive</w>
om at
methotrex ate.</w>
macroph age</w>
m on</w>
lithi um.</w>
le x
l s</w>
l aparo
isopren aline</w>
inter ference</w>
immu ne
ic in,</w>
ic es</w>
hypno tic</w>
hydroxyl ase</w>
h ome</w>
gluc os
gi ving</w>
fil am
epti de</w>
end- diastolic</w>
emul sion</w>
emerg ent</w>
eme sis</w>
e al</w>
dis per
coupl ed</w>
compens atory</w>
cholester ol,</w>
augment ation</w>
at ter
asyst ole</w>
ar ds</w>
anesthe si
allograf t</w>
ag itation</w>
Tak en</w>
Syn drome</w>
Subsequ ent</w>
St atis
S al
RATIONAL E:</w>
Prot ective</w>
L ;</w>
ICRF-1 87</w>
I M
H C</w>
GABA A</w>
E ch
C E</w>
C C</w>
Behavi oral</w>
B P)</w>
As sociation</w>
8-OH- DPA
3 8.
2, 3,
(P E
(8 0</w>
( grade</w>
us )</w>
tion ally</w>
thir d-
sy -
suspici on</w>
sub stituted</w>
stat us,</w>
smok ers</w>
sel y,</w>
seiz ure,</w>
scaven g
s lower</w>
rout inely</w>
ro ten
refl ected</w>
reach ing</w>
re placed</w>
rang e:</w>
posi tion.</w>
popul ations</w>
piri form</w>
ph enter
percep tion</w>
pen ile</w>
partic i
pan curonium</w>
on co
oc ci
n ociception</w>
mut ant</w>
mucos a</w>
model ing</w>
mg ),</w>
mal e,</w>
loxac in,</w>
kidne y,</w>
kg ),</w>
j udg
it ud
intra thec
infarc t</w>
indic ator</w>
incid ence,</w>
in patient</w>
ia ;</w>
hyd ram
hepar in,</w>
h ost</w>
grav is</w>
fo s</w>
fibrill ation,</w>
experi ences</w>
evalu ation.</w>
epi thelium</w>
enzym es,</w>
electromyo graphic</w>
e modi
dow n-
domin ant</w>
decarboxyl ase</w>
de position</w>
cr uc
cour se.</w>
complic ating</w>
clomi pramine</w>
chemotherap y-induced</w>
ch ec
bro ad</w>
bl ed</w>
aver aged</w>
asyst ol
ap tic</w>
anomal ies</w>
anc iclo
agonist s.</w>
agit ation,</w>
agg er
accid ental</w>
Vis ual</w>
U p
Swis s</w>
Ran dom
RB V</w>
Propran olol</w>
P ren
Mus cle</w>
L-DO PA
L id
Inv estig
Immuno hist
I r
Hyper tension</w>
HBs Ag</w>
G A
F 344</w>
D a
Con comit
Ch lor
9 ;</w>
7 %),</w>
6- hydroxy
5. 5</w>
3 3%</w>
1 30</w>
(2 50</w>
(- )</w>
( <</w>
' ,
year ,</w>
week -old</w>
vir t
ventil ated</w>
ut aneous</w>
ur ine.</w>
trop onin</w>
tim ing</w>
tic ity</w>
ti dine</w>
th ro
target ed</w>
sur ro
sub types</w>
sal ine-treated</w>
ra ise</w>
prophyl axis.</w>
profi le.</w>
proble m.</w>
present ation.</w>
predomin ant</w>
pre ference</w>
polymorph ism</w>
per t
pea ked</w>
parad oxical</w>
pa ediatric</w>
ox ide,</w>
oscop y</w>
ol ed</w>
ob vious</w>
o- occlusive</w>
nucle otide</w>
noc turnal</w>
metron idazole</w>
metoclop ram
man ,</w>
macroph ages</w>
likeli hood</w>
intran asal</w>
inhibi tion.</w>
inda c</w>
inclu ded.</w>
idiosyncr atic</w>
i az
hex ameth
guide lines</w>
gluco se,</w>
gangli onic</w>
g all</w>
fore brain</w>
fl un
feat ures,</w>
ex ist</w>
epicardi al</w>
enzym atic</w>
ene di
end ocardial</w>
emo tional</w>
dic hloro
demon str
datab ase</w>
cross- over</w>
clopido grel</w>
cirrho sis.</w>
cere br
carb on
ca uti
atri pt
at es,</w>
arg atrob
ar y-
antibodi es.</w>
am -induced</w>
allow s</w>
ag on</w>
activi ties.</w>
ab or
Whe reas</w>
W T</w>
V R
T GF-
St ates.</w>
Sp ont
S we
S ta
S ep
Qu anti
P rim
P ilo
P RE
NA C</w>
M arch</w>
LT )</w>
L Y
L A-
I A</w>
Halo peridol</w>
G B
Develop ment</w>
Clo zapine</w>
C r
9 3</w>
6 %).</w>
5-HT 1A</w>
5 +/-
3 A
3 9.
2 2.
0.00 1</w>
.0 1).</w>
(V PA)</w>
( IV)</w>
x yl
wash out</w>
val id
unit raz
u si
tw o
trigg er</w>
ter fen
survival .</w>
stimul atory</w>
st ay</w>
st av
sp ina</w>
small -cell</w>
sive- compulsive</w>
sion ;</w>
sed ation.</w>
sat uration</w>
ro d</w>
ri tic</w>
reduc ed,</w>
ran dom</w>
r ich</w>
qu ick
py raz
pup s</w>
promot ed</w>
pro thrombin</w>
pro genit
pre dis
pentylenetetraz ol</w>
par anoid</w>
p h</w>
ow ing</w>
one uro
ni gro
neutropen ia,</w>
muscim ol</w>
mitochond ri
mil dly</w>
microgram s)</w>
manif est</w>
malignanc ies</w>
ma king</w>
lymph oma.</w>
lat ent</w>
ip si
investig ation.</w>
gram .</w>
glauc oma</w>
fos car
fl unitraz
excep tion</w>
erythro id</w>
episode s.</w>
ens ory</w>
eff or
diabet es.</w>
defin ite</w>
decreas ed,</w>
dat e,</w>
d ental</w>
coun tri
classi c</w>
ch il
cephalo th
catal eptogenic</w>
c ,</w>
busulf an</w>
bilater ally</w>
as alaz
all- trans-
aden oma</w>
acid osis,</w>
accompan ying</w>
ac he</w>
ac e
Whe ther</w>
WK Y</w>
Th ere
St ates</w>
S tro
S ou
R T</w>
O A
Neuro toxicity</w>
N al
L ow
L M
In tr
H V
G er
Fem ale</w>
F ir
Emer gency</w>
Dop amine</w>
Depart ment</w>
D ys
D exameth
Ca ucasi
B CNU</w>
Alzheim er's</w>
AD V</w>
A N</w>
3. 7</w>
2 b</w>
1 2.5</w>
(S D)</w>
(1 )-
w al
under stand</w>
trac ted</w>
trac heal</w>
thym idine</w>
tempor ally</w>
techniqu e.</w>
sud den
sto p</w>
steroid s.</w>
star ted.</w>
sodi um,</w>
sit es.</w>
ser ies.</w>
rever ses</w>
rem ia,</w>
reinst atement</w>
region s.</w>
questionna i
punc t
produc tion.</w>
prehen sive</w>
pos ure</w>
ple ural</w>
phenyl but
phenyl )
ph ase,</w>
pector is</w>
p ill
output ,</w>
or =
one )</w>
ob es
non- selective</w>
new bor
nalox one.</w>
monitore d.</w>
micro g)</w>
memor y.</w>
male ate</w>
linezol id</w>
levof loxacin</w>
isosorb ide</w>
in ergic</w>
illic it</w>
ho wever</w>
hemo glob
hab it
foc us</w>
femal es.</w>
experiment s.</w>
epinephr ine.</w>
ecti ous</w>
differenti ation</w>
diagno sis,</w>
dev oid</w>
depend ent,</w>
ch ymal</w>
calcit onin</w>
c- fos</w>
b in
aut om
ang inal</w>
ad ic
accoun ted</w>
ab ec
Un like</w>
U .</w>
S tre
S ter
L E</w>
K (+)-
J uly</w>
H E
H A</w>
G- CSF</w>
ET -1</w>
EP S</w>
E Na
Con ver
Ce f
CYP -induced</w>
C ro
Anti -
Angi otens
Ad en
A H
8 /
6- week</w>
13 %</w>
1- adrenoceptor</w>
1- 2</w>
0.05 ,</w>
(7 5</w>
( all</w>
vitro ,</w>
ves tibular</w>
verapam il.</w>
ur i
um p
ul l
trimethop rim-sulfamethox
tourniqu et</w>
toc oph
ti vi
t rough</w>
sub sided</w>
su m</w>
spac e</w>
sot al
single -bl
sin us
s op
reversib le.</w>
rel ated.</w>
reinfor ce
reac tion,</w>
re a</w>
preval ent</w>
pre -</w>
praz os
polymorph isms</w>
persist ence</w>
ox carb
over load</w>
out flow</w>
or adi
one- associated</w>
odi pine</w>
ocur ar
occa sional</w>
nephro calcin
mon onuclear</w>
max )</w>
malondi aldehyde</w>
malar ial</w>
malar ia</w>
m t
m )</w>
leuc ov
l amin
l ),</w>
ketocon azole</w>
issu e</w>
isot retino
io do
indomethac in.</w>
in tolerance</w>
in adver
im mobil
glo bus</w>
fibro blast
facil itation</w>
ethyl ene</w>
estim ates</w>
ent ly.</w>
enlarge ment</w>
e f</w>
design .</w>
defect s.</w>
d- amphetamine</w>
cour se,</w>
corticosteroid s.</w>
consti tu
computer ized</w>
compa red.</w>
chang ing</w>
ca ine</w>
blun ted</w>
analo gs</w>
amiodar one,</w>
am ic</w>
altern ate</w>
alcoh ol
U S</w>
TR PV
T e
Syst olic</w>
Subsequ ently,</w>
Stre pt
Sec ond
Respon se</w>
Pren atal</w>
P ulmonary</w>
N-acetyl cysteine</w>
M B</w>
L os
IN D
Fol low-
F A</w>
E X
DB A/
D NA
BAL B/
B ri
Ab normal</w>
AC TH
6 0,</w>
6 ,
6 %),</w>
50 6</w>
3 50</w>
3 3
2 1%</w>
10 ).</w>
(S N
(L D
( medi
( i.p.)</w>
y s,</w>
well- tolerated</w>
vomit ing.</w>
ven ile</w>
upreg ulation</w>
under li
uncer ta
un like</w>
trin itrate</w>
trans mis
thromb oxane</w>
surve illance</w>
stat es.</w>
slop e</w>
significant ,</w>
sequel ae.</w>
salic ylate</w>
rest oration</w>
relax ant</w>
recipi ent</w>
ra i
r ant</w>
pur po
psor iasis</w>
pro ve</w>
pr ac
physos tigm
ol one</w>
ol e
oclon al</w>
no dos
nicot ine.</w>
n af
myelo suppres
my algi
methion ine</w>
metab otropic</w>
leth arg
ishe d,</w>
inter national</w>
inten s
initi ated.</w>
in sp
in bred</w>
in active</w>
impro ved.</w>
ili ary</w>
i x
he at
group ),</w>
frequ ency,</w>
follow s:</w>
fibro sis,</w>
fea sibility</w>
f f</w>
extravas ation</w>
expl oratory</w>
epileptic us,</w>
electro physi
dos ing.</w>
dis closed</w>
demonstrat ed.</w>
cyto kin
coun ter</w>
consol idation</w>
chore a</w>
bortezom ib</w>
ass ayed</w>
arth ro
ar ms</w>
administere d,</w>
activ ation,</w>
abl ation</w>
ab use,</w>
a emia,</w>
V en
Tam oxif
S )-
P =0.0
MB F</w>
L O
Hist ological</w>
H yp
H T
H 2
Follow- up</w>
Ex posure</w>
Comb ination</w>
CI PA
B 12</w>
Au g
2 5)</w>
17 %</w>
13 ,</w>
12 %</w>
0 ).</w>
(M R
(G SH
(C P
(C M
(A T
( including</w>
wor king</w>
well .</w>
ur sodeoxychol
unit .</w>
thick ening</w>
swit ching</w>
stimul ate</w>
sti ff
sign s,</w>
sev ent
ses sions</w>
sel ection</w>
sco res,</w>
repeate dly</w>
psych otropic</w>
precur sor</w>
por phy
plac ental</w>
phenobarbit al,</w>
perform ance.</w>
p ,</w>
oxid ant</w>
ou ter</w>
ot otoxic</w>
os uxim
organ ization</w>
op ri
od enal</w>
obses sive-compulsive</w>
nox ious</w>
nmol )</w>
nephro lithiasis</w>
neede d.</w>
necro tic</w>
misoprost ol</w>
mil d,</w>
mexilet ine</w>
membran ous</w>
lip ids</w>
lab ell
l angu
ing s,</w>
incontin ence</w>
hypom agne
hyd antoin</w>
g anciclo
fluores ce
fl ic
fav our
f illed</w>
expan sion</w>
ex agger
ethyl -
estic ular</w>
escap e</w>
ep sy</w>
endoscop ic</w>
double -
dopa .</w>
dist ribu
di ent</w>
demo graph
def er
confoun ding</w>
combin ing</w>
cerebell um</w>
cel ecoxib</w>
brady cardi
br achi
bal anced</w>
ati d
anim al
an x
amb uc
allo geneic</w>
aff or
adjunc t</w>
ac y</w>
T yp
Sp inal</w>
Sevent een</w>
R V
Prote inuria</w>
Pro spective</w>
M al
L T</w>
K I</w>
Indometh acin</w>
In flu
In de
IL -1
G lomerular</w>
Fre y</w>
For ty</w>
Del ta
D ue</w>
Cardi otoxicity</w>
C57BL/ 6
AU C</w>
AD )</w>
8. 5</w>
4 5%</w>
2 2%</w>
- 2
(i i)</w>
(C S
( or</w>
( 6-
year s),</w>
ye li
weigh ts</w>
vincrist ine.</w>
vari ations</w>
vari ant</w>
tumour s</w>
til t</w>
thi or
se mi
scal e,</w>
sar coma</w>
ri s</w>
region .</w>
re activation</w>
prostagland ins</w>
poison ing.</w>
phent olamine</w>
phenomen on.</w>
perox is
path ogenetic</w>
par ts</w>
par ti
paclitaxel .</w>
p ene
org ans</w>
op y
olo m
non invasive</w>
my osin</w>
mon oclonal</w>
modific ations</w>
m us</w>
leg s</w>
lamotrig ine</w>
isopren al
interven tions</w>
interpre ted</w>
inter medi
ing 's</w>
in ate</w>
im mature</w>
im idazol
ha emodi
gest ation.</w>
expres sion,</w>
en ough</w>
electro shock</w>
distrib uted</w>
dextro methorph
depress or</w>
de -induced</w>
consider ing</w>
con flic
compromis ed</w>
co- administration</w>
cardi otoxicity,</w>
c esarean</w>
b p
b er</w>
b and</w>
avail able.</w>
av age</w>
atrop ine,</w>
as ked</w>
as e)</w>
an ion</w>
amin ation</w>
alve olar</w>
akathi sia</w>
aim s</w>
ag re
acetyl cholinesterase</w>
ac etin</w>
a ;</w>
W ar
W H
SI S:</w>
S y
Reco very</w>
Rec urrent</w>
R P</w>
R N
Pro g
Pheny to
PO -
P- SM
P =
Or gan
O HD
Nicot ine</w>
High er</w>
Hepati tis</w>
Eigh teen</w>
Ech ocardi
Dobut amine</w>
Differen tial</w>
D- penicill
D ip
Continu ous</w>
Caffe ine</w>
CB 1</w>
B Z
AL F</w>
A 2</w>
7 ,
3. 4</w>
2. 8</w>
16 ,</w>
16 %</w>
(i. c.v
(P =0.0
(L VE
( greater</w>
yl line</w>
ventilat ory</w>
us age</w>
ur red</w>
tub ocurar
tobram ycin</w>
sympath omimetic</w>
suppor ting</w>
stres s,</w>
ste p</w>
sensitiz ation.</w>
sco re.</w>
satis factory</w>
safet y,</w>
respectively ),</w>
regurg it
recommend ations</w>
propofol ,</w>
pre cise</w>
plic ations</w>
phenomen a</w>
phen az
p s
oxygen ase-
ove mb
ovemb er</w>
oni um,</w>
ol ith
n ur
n ing,</w>
modul ates</w>
micro dialysis</w>
mg/kg/ day,</w>
mening itis.</w>
lac king</w>
ki log
kg(-1 ))</w>
impair ment,</w>
im ine</w>
idazox an</w>
hyper activity,</w>
hour s)</w>
highligh ts</w>
hel p
gal act
g ar
foc used</w>
exhib iting</w>
excre tion.</w>
estrogen s</w>
er a</w>
ep t</w>
end ed</w>
electro graphic</w>
electro convulsive</w>
elder ly.</w>
diar rho
di al</w>
de -
cyclo hex
cruc ial</w>
cri sis</w>
cor p
cont ents</w>
condi tion,</w>
bleed ing.</w>
blad der.</w>
bi osyn
attempt ed</w>
aspir in.</w>
as es.</w>
anxi olytic</w>
antidepress ants.</w>
andro gen
an s.</w>
an ic</w>
albu terol</w>
adrenoc or
] ).</w>
V ,</w>
Th ose</w>
S tr
R ap
Prim ary</w>
Pharmac ological</w>
P l
N orm
Meth ad
M es
IN G
Head ache</w>
Euro pe
CP P</w>
C ases</w>
Ad ren
Ac cording</w>
8 %).</w>
6 7
3. 9</w>
20 1</w>
10(9 )/
0.00 5).</w>
(-1 ))</w>
( with</w>
( 5-F
( +/-</w>
wor l
ver .</w>
vasodilat ation</w>
valu able</w>
urticar ia</w>
urk inj
tum ors,</w>
treat ed,</w>
transplant .</w>
transi tional</w>
transfer red</w>
succ ess</w>
stri king</w>
st rat
st atin</w>
sal v
s lowing</w>
ru s.</w>
retri ev
res um
recogn ize</w>
publ ic</w>
protoc ols</w>
pro long</w>
predic ting</w>
precipit ating</w>
pow er
posses s</w>
polymorph ic</w>
phospholip id</w>
phen olate</w>
phen acetin</w>
perio perative</w>
pentylenetetra zol
partic ular,</w>
pal sy</w>
pal pit
p tions</w>
oli go
occur red,</w>
o edema</w>
non specific</w>
nitro fur
neu tr
neph ritis,</w>
n ic</w>
mu g/
minim ize</w>
mi gr
mg/ 100</w>
membran e-
mark eting</w>
m ot
lithium- pilocarpine</w>
l ad
l ).</w>
ine mia,</w>
incub ation</w>
incorpor ation</w>
imag ing.</w>
ic al
i.c.v .)</w>
hydrochlor ide,</w>
human s,</w>
hn 's</w>
graph y.</w>
glycer yl</w>
g/m 2</w>
fle x</w>
fentanyl .</w>
exacerb ate</w>
environ mental</w>
eff e
ect able</w>
e sis</w>
dis soci
dexamethas one-induced</w>
denerv ation</w>
den se</w>
del ay
defic its.</w>
de red</w>
cran i
cent ers</w>
carvedi lol</w>
capecit abine</w>
but yl
bradycardi c</w>
blo t</w>
backgro und</w>
atax ia,</w>
arth r
ant -induced</w>
analogu es</w>
amne sic</w>
amin id
all y-
al lowing</w>
agonist s,</w>
W om
V incrist
TI CIPA
TICIPA NT
T er
Spont aneous</w>
Seiz ure</w>
REPORT :</w>
Pre -
PT Z</w>
PT H</w>
PAR TICIPANT
P N
N B
M ild</w>
M PA</w>
L ip
H S</w>
D ),</w>
Co operative</w>
9. 5</w>
8 ;</w>
6. 7</w>
4. 8</w>
3. 1</w>
3- week</w>
2- chloro
19 -
15 )</w>
0.0 2</w>
(H R)</w>
(1 2.
( both</w>
volt age</w>
vit amin
ventro lateral</w>
ven o-occlusive</w>
vacc ine</w>
us -induced</w>
ultim ately</w>
ulcer ative</w>
ty pe
tri phosphate</w>
trazod one</w>
trans dermal</w>
top otecan</w>
terbut al
t esticular</w>
surro un
struct urally</w>
speci men</w>
si st</w>
sh ap
schedul es</w>
re war
re presented</w>
re generation</w>
rap amycin</w>
raloxif ene</w>
ra sid
questionna ire</w>
proper ty</w>
program med</w>
proble ms.</w>
pro be</w>
present ation,</w>
pod ocytes</w>
plan ned</w>
pl aqu
pharmac ology</w>
pentylenetetra zole</w>
pene tr
pat ch</w>
p mol/
outcom es.</w>
os .</w>
offsp r
off ers</w>
nod ular</w>
new er</w>
myelo suppression</w>
mortal ity,</w>
morph ine-
month ly</w>
mmHg .</w>
min er
min ),</w>
melphal an</w>
manner ,</w>
mam mal
mal es,</w>
m (-
lograph y</w>
lit er</w>
le vetiracetam</w>
langu age</w>
k s,</w>
itud inal</w>
irrit ation</w>
ip rasid
intramus cul
ine d-release</w>
in ium</w>
ic in.</w>
ia -
i setron</w>
hybridiz ation</w>
histopath ologic</w>
h ol
fol inic</w>
flush ing</w>
fl ick</w>
fib ers.</w>
fen o
f ly</w>
explo red</w>
excre tion,</w>
epinephr ine,</w>
dro pped</w>
diagno ses</w>
des ferri
depend s</w>
deliver y.</w>
comorb id</w>
chromat ography</w>
chlor per
che lat
cer vi
cardiomy ocyte</w>
brachi al</w>
ax im
ation -induced</w>
as tic</w>
ari es</w>
arach id
apl asia</w>
amne sia.</w>
ame ly</w>
alter ing</w>
alpha- tocoph
aggrav ated</w>
adjust ing</w>
X ,</w>
Wom en</w>
We e
T a
SE )</w>
Psych iatric</w>
N ovember</w>
N T</w>
N F-
N AD
METH -induced</w>
LD L</w>
L- argin
IND ING
II I-
F INDING
E A</w>
Dise ase</w>
Di ab
D et
D Z
AC )</w>
A trial</w>
9 %).</w>
6. 0</w>
6- month</w>
5- year</w>
4- week</w>
2- 3</w>
2 9%</w>
2 4,</w>
10 .</w>
1 +/-
0. 5,</w>
-1 2</w>
(I F
(C R
(B P)</w>
week s).</w>
weak ness,</w>
vigil ance</w>
vari ants</w>
v oxamine</w>
u z
triglycer ides</w>
triglycer ide
tra u
titr ation</w>
thrombo phlebitis</w>
the -
t ing.</w>
studi ed,</w>
spar ing</w>
s ole</w>
ron eph
ri um</w>
reg ularly</w>
recept or,</w>
re th
rac heal</w>
r ine-induced</w>
pseud otumor</w>
progres s</w>
predisp ose</w>
phenyl )-
per sist</w>
parkinson ism.</w>
ot ri
or ic</w>
olog ies</w>
ochem istr
occa sions</w>
oc il
nephro pathy,</w>
nadi r</w>
n io
n ative</w>
mo ving</w>
mo bility</w>
microg/ kg)</w>
micro gram</w>
methyl- 4-
metabol ism,</w>
meta- analysis</w>
mes sen
mem ant
mechanis ms,</w>
mecamyl amine</w>
m ural</w>
kne e</w>
kg ).</w>
k age</w>
ju venile</w>
isoproteren ol,</w>
isom ers</w>
inf er
incre mental</w>
i.v .).</w>
hype remic</w>
ho t</w>
herb al</w>
g .
flurbi profen</w>
fashi on.</w>
ex tub
es mo
en larg
dulox etine</w>
dox azosin</w>
diff ers</w>
dex razoxane</w>
deterior ated</w>
defici ency.</w>
cyto plas
correc t</w>
cor ne
catheter ization</w>
cardio genic</w>
canal icular</w>
bifid a</w>
ax on
atri zo
ati tis,</w>
antine utrophil</w>
antigen s</w>
antero grade</w>
add ress</w>
ad ding</w>
activ ate</w>
accept ed</w>
a w</w>
X .</w>
War far
W or
Verapam il</w>
U rine</w>
S elective</w>
R h
O X
O F</w>
NP Y</w>
MEDLIN E</w>
MD MA
M aj
L D</w>
ICA L</w>
G M
Europe an</w>
Electro n</w>
Dexameth asone</w>
Del ayed</w>
Cro hn's</w>
C ]
C NS
Appro ximately</w>
4. 6</w>
3 +/-
18 ,</w>
18 %</w>
1, 000</w>
1 0.
1 -</w>
-1 7
(H C
(G F
(0. 25</w>
( total</w>
( t
( relative</w>
( day</w>
( 7</w>
x )</w>
vari ate</w>
us h</w>
urkinj e</w>
ulc ers</w>
tri me
tis :</w>
thromb olytic</w>
ter m,</w>
tas k.</w>
t os
streng th</w>
sin o
se mia</w>
scopol amine-induced</w>
reticul um</w>
retic ulo
reflex es</w>
rec re
overex pression</w>
ovari ectomized</w>
osmol al
nucle oside</w>
nitroglycer in-induced</w>
n amely</w>
myocardi um.</w>
mou se.</w>
molec ules</w>
mo tility</w>
mmol/ L</w>
men tioned</w>
medic ine</w>
m u</w>
li b
jaundic e.</w>
ipsi lateral</w>
ip en
involve ment.</w>
inter leuk
immunosup press
immun ological</w>
hear ts.</w>
gener al
fib res</w>
f a
exceed ed</w>
examin ing</w>
estradi ol
eluc id
effe rent</w>
ed ull
dose )</w>
dis play</w>
dihydroxy phenyl
dihydro -
digit alis</w>
di az
dex fenfluramine</w>
describ ing</w>
def en
cont act</w>
comparis ons</w>
clonid ine,</w>
clear ance,</w>
ch amb
caffe ine.</w>
ca strated</w>
bu ffered</w>
bl ack</w>
ast atin</w>
as sist
ap o
anti malarial</w>
amis ole</w>
aminonucleo side-induced</w>
achi eving</w>
a ine</w>
VT E</w>
V II
Throm b
TNF- alpha</w>
Re duction</w>
Pilo car
PG I
PARTICIPANT S:</w>
P neum
P E</w>
Neuro logical</w>
MEASUREMENT S:</w>
Influ ence</w>
Impro vement</w>
Hem orrh
FINDING S:</w>
F entan
E A
Do se-
Da ily</w>
D P</w>
D A
Conver sely,</w>
Catal epsy</w>
Brugad a</w>
B ar
7. 4</w>
3/ 4</w>
1. 25</w>
1 1%</w>
- negative</w>
) ).</w>
(R R</w>
(P =
(M M
(5-F U)</w>
ventil ation.</w>
ve red.</w>
variabl es.</w>
val s
v o
us p
unc lear</w>
ud ing</w>
u ment</w>
typ e.</w>
tum or.</w>
tot ally</w>
to o</w>
tic -like</w>
syndrom es.</w>
susta ined-release</w>
suppres ses</w>
success ful
si s;</w>
sever ity.</w>
sep tic</w>
sclero der
rifamp in</w>
rever sing</w>
require ments</w>
replic ation</w>
regul ating</w>
rec t</w>
queti ap
ques tion</w>
psychos timul
presyn aptic</w>
plasma phere
pilocarp ine-treated</w>
pi gs</w>
pericardi tis</w>
per oxide</w>
par ameter</w>
op yri
ont ine</w>
ologic ally,</w>
ol g
off ending</w>
oblast oma</w>
nodul es</w>
multi -
mic ro</w>
mer cap
lo be
le t</w>
le a
inter act</w>
inst ances</w>
ic ally,</w>
ic al,</w>
hr .</w>
histor ies</w>
hemorrh ages</w>
haloth ane.</w>
glutam ic</w>
glucocortico ids</w>
gener al,</w>
gen der,</w>
form in</w>
excit ation</w>
eth osuxim
essen tially</w>
erg oline</w>
end ocardi
enc es.</w>
en i
ecti ve.</w>
each .</w>
diseas es,</w>
dis ability</w>
diet ,</w>
diabet es,</w>
di atrizo
depriv ation</w>
concl u
co done</w>
cle ft</w>
cl a
chloramphenic ol</w>
caud ate</w>
carcin ogenic</w>
carbamazep ine,</w>
c ing
bro ad
be ag
b uc
b rou
b .</w>
ax ial</w>
atript an</w>
asth matic</w>
approach es</w>
anti- HB
am i
ac ous
abstin ent</w>
[ 4-
Therap y</w>
T r
T C</w>
Second ary</w>
SPEC T</w>
S el
R o
Post operative</w>
P en
P RO
P I
O .</w>
Nine teen</w>
NT G</w>
N a</w>
Maj or</w>
M M</w>
Lith i
Lam iv
K+ -
HCT Z</w>
F isch
F i
CL IN
C o-
Bi ochemical</w>
An t
AZ T
AN F
7 5
4. 4</w>
4. 2</w>
2 a</w>
2 1,</w>
19 %</w>
1. 4
1- year</w>
1 16</w>
0 ),</w>
/ d
-1 ),</w>
) -</w>
) ),</w>
(A M
(2 4</w>
(0. 1-
( three</w>
( control</w>
( but</w>
( SIAD
( 0-
z iprasid
volun tary</w>
ver tig
uro thelial</w>
trimeth aph
triamte rene</w>
tran s</w>
symptom at
summ ar
sul indac</w>
sham- operated</w>
sensitiv ity,</w>
scre ened</w>
risperid one,</w>
ri z
reduc tion.</w>
pyr ro
putam en</w>
prurit us</w>
proper ties,</w>
profi le,</w>
pro motion</w>
posit ron</w>
por al</w>
plant ar</w>
phosph odi
perf usion.</w>
parameter s,</w>
p ris
operativel y,</w>
open ia,</w>
omegal y</w>
olog ists</w>
ocyt oc
nor tript
non- Hodgkin's</w>
nimesul ide</w>
nigro striatal</w>
nicardi pine</w>
networ k</w>
neoplas ms</w>
narco tic</w>
n ocicep
mono therapy.</w>
mo fe
m ox
m c
loo p</w>
leuk ocyte</w>
kain ate</w>
k ept</w>
ir regular</w>
iopamid ol</w>
intra uterine</w>
integr ity</w>
insuffici ency,</w>
inf ectious</w>
in ess</w>
hyd roneph
hy pot
hallucin ations,</w>
h inal</w>
grow ing</w>
gl and</w>
gl and
gemfibro zil</w>
fraction ated</w>
fen ol
exten sively</w>
exclu sively</w>
exagger ated</w>
end omy
emphasi zes</w>
ecstas y</w>
ec h</w>
diure sis</w>
diseas e-
di pi
di oxide</w>
develop ed,</w>
destruc tion</w>
defect s,</w>
cryst all
cou gh</w>
conduc t
comple ment</w>
clas ses</w>
cerebr i</w>
brou ght</w>
bri dg
break through</w>
bo th.</w>
bleed ing,</w>
be at</w>
b. w
b. i.
ax on</w>
at r
as sum
ant rol
amitript yl
amin es,</w>
alprazol am</w>
alph a,</w>
adjunc tive</w>
adequ ately</w>
adenocarcin omas</w>
acut e,</w>
acetazol amide</w>
Y -
V e
Tamoxif en</w>
Stro ke</w>
Six ty</w>
Re gi
Partic ip
O P
Nephro toxicity</w>
L arg
I B
Di azepam</w>
Co x</w>
Ch loro
CLIN ICAL</w>
CA D</w>
C57BL/ 6</w>
Ara- C</w>
A(2 A)</w>
A R</w>
5. 3</w>
2 8%</w>
0.0 4
0.0 3).</w>
0 %,</w>
(i. e.</w>
(PAN )</w>
(C A
( approximately</w>
( L-NAME
yo to</w>
yl thio
ycl in</w>
vulner able</w>
vincrist ine,</w>
vigabat rin</w>
vari ance</w>
utili zation</w>
ur ide</w>
uc t
triazol am</w>
treat ed.</w>
th y
te l
t ative</w>
syndrome :</w>
sulph asalazine</w>
sub thalamic</w>
strych nine</w>
ste ady</w>
som atic</w>
significant ly,</w>
side- effects.</w>
separ ation</w>
scre en</w>
sch o
sal ine-
rodent s.</w>
rac emic</w>
psycho sis.</w>
protein s.</w>
propofol -induced</w>
pro s
pregn an
power ful</w>
popul ation-
phylococc us</w>
per ce
pe th
patter n
patient- controlled</w>
oter ol</w>
orig inal</w>
ord ination</w>
or y,</w>
onse t.</w>
on ly,</w>
ologic al,</w>
ol d,</w>
ocy s
ob tained.</w>
nod al</w>
nit ren
min (-1)</w>
microsom al</w>
microangio pathy</w>
micro vascular</w>
mg ).</w>
metho hex
le pro
label ,</w>
l enal
kg -1)</w>
ir respective</w>
insi ght</w>
injec tions,</w>
inflamm ation,</w>
in- releasing</w>
in um</w>
in put</w>
in complete</w>
hypothesi ze</w>
hormon e-
gen ce</w>
fluc onazole</w>
f action</w>
es tion</w>
draw n</w>
do ses
distingu ish
daun orubicin</w>
com position</w>
character ization</w>
chang e,</w>
catat onia</w>
carb ach
canc ers</w>
c GMP</w>
bupivaca ine,</w>
bor der
blad ders</w>
bing e</w>
behavi ors.</w>
azepam ,</w>
ation ).</w>
atid yl
ascorb ic</w>
as sumed</w>
as es,</w>
ar ub
ar ity</w>
anti ci
anatom ical</w>
amphet amine,</w>
activ ator</w>
acous tic</w>
acet yl</w>
acc o</w>
ac yclin</w>
V P
UN E
T orsade</w>
SK F</w>
Pe ak</w>
Particip ants</w>
M N
M /
Ket amine</w>
K yoto</w>
H T</w>
G s</w>
Eigh ty-
DE X</w>
D ose</w>
Concomit ant</w>
Cent er</w>
CD 4
C urrent</w>
C hemo
C S</w>
Brady cardia</w>
ADR -induced</w>
A ne
A k
8 5%</w>
2 -</w>
0 %).</w>
-to- treat</w>
(T ax
(EE G)</w>
(2 ))</w>
( RO
z ym
z olom
wor se</w>
withdraw n.</w>
we dg
virt ually</w>
viro logical</w>
verapam il,</w>
valid ated</w>
v es,</w>
uni ver
ul in</w>
thyrox ine</w>
thiaz ide</w>
ther n</w>
the sia</w>
test ing,</w>
tamoxif en.</w>
tachycardi as</w>
t y.</w>
suic ide</w>
succ essive</w>
solu tion.</w>
ses sion</w>
secret ory</w>
ron ate</w>
retard ation</w>
re absorption</w>
rat es,</w>
qu er
pro chlorper
pregnanc y,</w>
precipit ate</w>
potassi um,</w>
po real</w>
pi perid
perin atal</w>
percent )</w>
parox et
pares thesi
pare sis</w>
par i
p ass
ox ide.</w>
other .</w>
ot e</w>
or din
oph an</w>
once- daily</w>
om ing</w>
ocytoc lastic</w>
ocy te
nucle oti
ni acin</w>
necess ary.</w>
mit te
metabolit es.</w>
metabol ized</w>
man u
man ia.</w>
m sec</w>
lop urin
leuk aemia</w>
judg ed</w>
it er
isotretino in</w>
isol dipine</w>
induc tion,</w>
index ,</w>
immunosup pres
im ipen
ic s.</w>
i. t.</w>
i p</w>
hypokal emic</w>
homeost asis</w>
hei ght</w>
haz ards</w>
gluc agon</w>
erythro cytes</w>
end point</w>
emphasi ze</w>
effec tive,</w>
ed ar
ec hol</w>
dos age,</w>
dis sociation</w>
descri ption</w>
deliri um.</w>
defin itive</w>
dat es</w>
d ac
coun t,</w>
comm ence
combin ation,</w>
clu ster</w>
ciga rette</w>
calci um-
calc ification</w>
ca dian</w>
block ers.</w>
biop sy,</w>
bi om
ber ate</w>
benzodiazep in
ax ons</w>
artic les</w>
arteri ol
ap o</w>
anti thyroid</w>
angio edema.</w>
an al</w>
amisul pride</w>
amiodar one-induced</w>
adul tho
acetyl salicylic</w>
ab sc
[ 2-
Y MDD</w>
W B
V N
Ul tra
Ser oton
R V</w>
Pro st
PO )</w>
Nal ox
M axim
Leu k
K ap
Increas ing</w>
HB I
H um
G D</w>
Fact ors</w>
E stro
E R</w>
De li
DSM- IV</w>
Carbam azepine</w>
CYP2 C
BU N</w>
AN P</w>
99 m
6. 1</w>
4. 7</w>
3 2%</w>
2- receptor</w>
2 8-
2 4%</w>
14 )</w>
1 7-
(1 ,
( range:</w>
vac cin
uni versity</w>
un controlled</w>
um )</w>
ul ph
u g
trac he
toxic ity:</w>
toler ate</w>
tob acco</w>
them .</w>
termin als</w>
tenof ovir</w>
t ly,</w>
synthesi zed</w>
sup pressing</w>
sulph ate</w>
strept omycin</w>
stimul i.</w>
stat e,</w>
sp in
sp ent</w>
sion )</w>
scop y</w>
sco re,</w>
salv age</w>
s cor
s );</w>
review s</w>
reinfor c
regar ded</w>
rai ses</w>
radi ological</w>
r s</w>
r ine,</w>
qu ite</w>
qu ar
ps ori
pres erv
predisp osed</w>
possib le.</w>
po oled</w>
plex us</w>
pi rox
phenyto in.</w>
phenobarbit one</w>
pentazoc ine</w>
pent amid
pat ent</w>
pancre atitis</w>
oxygenase- 2</w>
ost atin</w>
orb ital</w>
ont al</w>
non fatal</w>
need s</w>
need le</w>
necessit ating</w>
micro liter
medi ates</w>
leucov orin</w>
l ic</w>
interfer on-
ing ;</w>
inde sine</w>
il st</w>
id ed</w>
i.v .,</w>
i ox
hypoc ap
hiccup s</w>
hemo dialysis.</w>
head -
guan ine</w>
glut amine</w>
gamma- glutam
g ic</w>
fluoresce in</w>
fea sible</w>
failure :</w>
exten d</w>
evalu ations</w>
dose :</w>
disturb ances,</w>
dep end</w>
def ined.</w>
cycl ine</w>
cour ses.</w>
conserv ative</w>
commun ity</w>
commun ic
co incid
cir cu
cTn T</w>
bu ff
bre ast
bra in-
blind ness</w>
ble .</w>
b ab
aw ak
apopto sis.</w>
antibodi es,</w>
amil ton</w>
alkyl ating</w>
addic ts</w>
a red</w>
Valpro ic</w>
T oxic</w>
Sur vi
Sing le</w>
Sim ult
ST N</w>
S urg
S oci
S m
S CH
Re duced</w>
R est
Per sistent</w>
P ent
O lan
Nine ty-
Neuro leptic</w>
Mon it
K(+)- ATPase</w>
IL- 6</w>
IF N-
H ol
H LA-
H AM-
H 2</w>
G astro
F unc
ENa C</w>
E ven</w>
E ry
Caucasi an</w>
Ca ref
CH F.</w>
C K</w>
Aug ust</w>
AT P-
7. 0</w>
7 50</w>
6 7%</w>
5-HT (2
2 3%</w>
2 %.</w>
10 4</w>
1. 5
1 );</w>
, "</w>
(c )</w>
(S H
(C s
zolpide m</w>
z er
w ast
volume .</w>
verte bral</w>
vel y.</w>
vehic le.</w>
vaso active</w>
v ocal</w>
ureth ral</w>
ur ine,</w>
underli e</w>
ultrason ography</w>
u ation</w>
tri ge
treatment ;</w>
treatment -related</w>
trans mural</w>
tob er</w>
to ,</w>
threshol d.</w>
thou gh
tauro chol
tachy arrhythmias</w>
ta m</w>
stra ins.</w>
stav udine</w>
squ are</w>
some what</w>
sever ity,</w>
se leg
respon der
relie ved</w>
relap se.</w>
recre ational</w>
re d-
protein uric</w>
proces ses.</w>
por tion</w>
phospho kinase</w>
pelv ic</w>
par ac
paclitaxel -induced</w>
paclitaxel ,</w>
p ra
oxal i
ow n</w>
out -
omep razole</w>
ol factory</w>
occur ren
naltrex one</w>
my ocytes</w>
my alg
muscl es.</w>
micro sph
meth y
memor y,</w>
ma de.</w>
low ,</w>
lo vastatin</w>
leak age</w>
larg est</w>
jac ent</w>
isom er</w>
inser ted</w>
inj ecting</w>
infrequ ently</w>
ill ness,</w>
i.v .),</w>
i NOS</w>
hypokal emia,</w>
hepat otoxicity,</w>
glyc opyr
form ation,</w>
flu voxamine</w>
fl av
fibr in</w>
fashi on</w>
expos ures</w>
exhib its</w>
endomy ocardial</w>
en su
en cour
echocardi ograph
dys plasia</w>
doc ument</w>
disper sion</w>
dis appeared.</w>
de sensitization</w>
day ;</w>
com prehensive</w>
collap se</w>
co ffe
co er
co ated</w>
cla vul
ciprof loxac
ci es</w>
chil d.</w>
c .</w>
beta- blocking</w>
b ed</w>
ay na
auto antibodies</w>
areas .</w>
an ionic</w>
an em
an abolic</w>
aminotrans fer
amin es.</w>
am ylo
alpha-tocoph erol</w>
alpha ,
acidi c</w>
a ure
a ,
Vari ous</w>
V i
U RE
Tac rolimus</w>
Sta phylococcus</w>
S V
Quanti tative</w>
Pre gn
Or th
O xy
Magne tic</w>
M 2</w>
In jection</w>
Histopath ological</w>
H amilton</w>
H F</w>
GAB A)</w>
Caref ul</w>
Cal ci
CC K-
An a
Alter ations</w>
AD R-
AD HD</w>
A pril</w>
A S)</w>
5. 6</w>
3 6.
3 3.
3 00
2. 5%</w>
2- adrenergic</w>
14 %</w>
0.0 2)</w>
0. 75</w>
0. 2%</w>
.00 1)</w>
- containing</w>
(P C
(O R
(3 )
(2 ),</w>
( serum</w>
( less</w>
yri dam
wh ole-
vis u
valu e.</w>
v ary</w>
un mas
ule us</w>
tr us
top ir
thi azol
testo ster
system ically</w>
similar .</w>
shoc k.</w>
seve re.</w>
se ts</w>
sat ur
sar com
ro pi
rheum atic</w>
rex cit
require ment</w>
refl ecting</w>
prop ensity</w>
progres sion.</w>
proce dural</w>
prepar ations.</w>
pl ain</w>
pin do
phenyto in,</w>
parano ia</w>
p inal</w>
ox etine</w>
ol ateral</w>
oc om
ob ia</w>
nor mo
nephro toxicity,</w>
n ull</w>
n mol</w>
n ess
myel in</w>
myco phenolate</w>
mut ants</w>
month .</w>
mirta zapine</w>
mg/m l</w>
metabolit e,</w>
met allo
messen ger</w>
mechan ically</w>
me an,</w>
m atic
m ast</w>
ly sis</w>
lign oca
is radi
interval s,</w>
insuffici ent</w>
in- based</w>
id s.</w>
hydro cortisone</w>
hepat otoxic</w>
glyc os
foscar net</w>
form al
flunitraz epam</w>
fact or,</w>
epi theli
enti ty</w>
encephalo pathy,</w>
ect ed,</w>
dur ations</w>
dro ps</w>
dro peridol</w>
dop amine,</w>
dobut amine-induced</w>
distingu ish</w>
disor i
disabl ing</w>
dipi vox
diltiazem ,</w>
describe d,</w>
de trus
d re
d ol
d enti
cycl ase</w>
cra v
clin ici
circul ation.</w>
chemotherap y-
characteris tics,</w>
cefot et
catheter s</w>
cat s</w>
cain ide</w>
buspir one</w>
bupivaca ine-induced</w>
block ers,</w>
benz yl
behavi or
be d
b ot
atro genic</w>
ati ve,</w>
atherosclero tic</w>
aster n</w>
ar a-
anxiet y.</w>
anx io
ant ec
ang le</w>
ameli oration</w>
age- related</w>
ad jacent</w>
] ),</w>
[ 95%</w>
Z )-induced</w>
VPA -induced</w>
V 1</w>
Twenty- six</w>
To ge
Therap eutic</w>
T ime</w>
T CD
Suc cess
Ser ious</w>
R ayna
Post -
Over all</w>
Oc tober</w>
O u
O ,</w>
Neuro logic</w>
Ne on
Meth otrex
K idne
IV ,</w>
I GF-
Gen eral</w>
Fisch er</w>
F etal</w>
Experim ent</w>
Dip yridam
Di rect</w>
DF O</w>
D il
Cyclophosph amide</w>
Com plications</w>
Child ren</w>
At ten
8. 0</w>
4. 1</w>
4 '-
20 /
2, 3-
2 %;</w>
18 )</w>
1, 25
(T d
(OH)2 D3</w>
(L V
(E M
(4 5</w>
(1 0%)</w>
( GABA
ycl ine</w>
x ,</w>
vastat in,</w>
vasoconstric tor</w>
v inc
u sional</w>
transf er</w>
the- counter</w>
target s</w>
surroun ding</w>
sup port
strong er</w>
ster ile</w>
ser um,</w>
ser i
satis faction</w>
sal iv
saf e,</w>
rupt ure</w>
rou gh
rest ore</w>
recor d</w>
prim ing</w>
pregnanc ies</w>
preferen tially</w>
pharmac ologically</w>
ph aryngeal</w>
pallid us</w>
open- label,</w>
om yeli
od y</w>
ocys tis</w>
occi pit
o grams</w>
nar row
mus cle,</w>
mou th</w>
monke y</w>
migra ine.</w>
memb ers</w>
mechanis m
mater ial</w>
manu fact
low .</w>
lig and</w>
li ving</w>
lef t-
lan sop
k D
jug ular</w>
invol ved.</w>
intub ation.</w>
intrathec ally</w>
in ability</w>
ill ness.</w>
il -
hypercalci uria</w>
hype rexcit
hil us</w>
hex iline</w>
here in</w>
hei gh
har m
haloth ane,</w>
gram ,</w>
glyco l</w>
fibrill ar</w>
femal es,</w>
f urther
f ish</w>
f ,</w>
examin es</w>
enkephal in</w>
en ium</w>
en flur
disul fir
disori ent
dis h</w>
depend ence,</w>
dam s</w>
d ens
cros s</w>
corne al</w>
con cept</w>
clo t</w>
cisapri de</w>
cing ulate</w>
cholecyst o
chlor ambuc
cap ill
ca th
c ad
bru ary</w>
azol e-induced</w>
aut oradi
aut op
attempt s</w>
attac ks.</w>
ati ve.</w>
arth ritis,</w>
arteri olar</w>
argatrob an</w>
arachid onic</w>
ar ri
ar m.</w>
applic ation.</w>
antibio tics.</w>
anti sense</w>
anti cholinerg
ane ously.</w>
ane ous
all-trans- retinoic</w>
all y)</w>
acid osis.</w>
Twenty- three</w>
Twenty- five</w>
Tol er
Success ful</w>
Sep tem
S L</w>
Regi onal</w>
Re view</w>
P s</w>
P K</w>
NS ).</w>
MT D</w>
MD A</w>
L IS
K O</w>
J o
Ifosf amide</w>
ISO -induced</w>
IF O</w>
H is
Gl ut
F requ
F ran
Differen ces</w>
D ou
CG P</w>
C an
B rom
AR S</w>
A G</w>
7 0-
6 +/-
5. 2</w>
4. 9</w>
30 )</w>
3- hour</w>
2- year</w>
2 25</w>
2 1.
100 -
1 st</w>
1 1)</w>
1 %.</w>
0.0 3
0 %),</w>
(MT X)</w>
(EC G)</w>
(3 ,
( L-
( 9</w>
yst ag
ye lo
wat er.</w>
vol vement</w>
vis its</w>
vascul itis,</w>
valpro ate.</w>
v ic
utili zed</w>
un stable</w>
ub ular</w>
ton gue</w>
th is,</w>
th -
te mo
table t</w>
synthe sis,</w>
sw im</w>
sur fac
succinylchol ine-induced</w>
stom ach</w>
spe ech</w>
sinus oidal</w>
sign als</w>
ser um.</w>
sept um</w>
second- line</w>
schedul e.</w>
s arc
rhyth m.</w>
reversib ility</w>
reten tion.</w>
ret ar
respir ation</w>
reli ably</w>
reac ted</w>
radi ographic</w>
quick ly</w>
quantit atively</w>
pyri d
prov oc
prolong ing</w>
progenit or</w>
pro tracted</w>
prefer red</w>
pre treatment,</w>
pre -treated</w>
performe d,</w>
pathw ays.</w>
pathophysi ologic</w>
ot otoxicity.</w>
ors '</w>
orig in.</w>
opy ram
ol ;</w>
ococc al</w>
obarbit al</w>
non- small-cell</w>
nitros amine</w>
neuro psychological</w>
neuro degenerative</w>
nalox one,</w>
myelo ma.</w>
mucosi tis</w>
mu -opioid</w>
move ments.</w>
mm 3</w>
ml/ min</w>
mil rinone</w>
metast ases</w>
medi ator</w>
manip ul
mammal ian</w>
malignanc y</w>
long itudinal</w>
kal emia</w>
insipid us.</w>
ingest ing</w>
indomethac in,</w>
inc i
immunohist ochemistry</w>
immuno globulin</w>
immune -mediated</w>
i ed.</w>
hydro gen</w>
hor iz
haloth ane-induced</w>
haem olytic</w>
gu n</w>
group ;</w>
g/d l</w>
fo ot
fluoro uracil</w>
flun ar
flu phenazine</w>
flu or
et ,</w>
er ic</w>
epti d
endot racheal</w>
enantiom ers</w>
doxorubic in-treated</w>
diz ocil
distinguish able</w>
diet s</w>
de ep
day s),</w>
dP/d t
d B</w>
cytot oxicity</w>
cou gh
cont ent,</w>
consti pation</w>
cocaine- exposed</w>
clopido grel
cisplat in.</w>
chemic ally</w>
c ure</w>
bur ning</w>
bo th,</w>
bi phasic</w>
beta- blockers</w>
atic ,</w>
as ymptom
aro tid</w>
antici p
anti convulsive</w>
ann ab
aneurys ms</w>
amphet amine-
aggrav ation</w>
af in
adren o
ab er
a b</w>
Y )</w>
Wist ar-
W -
W )</w>
U ,</w>
T ic
Survi val</w>
Stat us</w>
S A)</w>
R em
Prop ylthio
PT Z
P rin
P ositive</w>
Neon atal</w>
N- nitro
Mul tivariate</w>
Measure ments</w>
MM P-
M idazol
M em
Lid ocaine</w>
In volvement</w>
Hum an</w>
Hg ;</w>
H SP
D ays</w>
CYP2 D
C ur
Anim al</w>
Ac tivation</w>
5-hydroxytrypt amine</w>
4 4
3 8%</w>
2 -induced</w>
(p =0.0
(S SR
(O R,</w>
(AD R)</w>
(5 %)</w>
(2 ,
( IS
z on
wh ilst</w>
wh ic
vi si
visi t</w>
vesi cular</w>
uncommon .</w>
ud 's</w>
tri ple</w>
transi ently</w>
time -dependent</w>
til ide</w>
thi obarbit
temo zolom
te tan
te ach
synthe sis.</w>
survival ,</w>
sur al</w>
suc rose</w>
sub units</w>
strok es</w>
stres sed</w>
strati fied</w>
strat um</w>
st ability</w>
sph inc
sp le
sit es,</w>
si lon
si an</w>
sertr al
serocon version</w>
reversib le,</w>
rese arch
requi red.</w>
radio immuno
rabb its.</w>
quanti fy</w>
pyrro lid
pre medicated</w>
post ulate</w>
pol yp
phenyl -1,
perio ds.</w>
per oxy
path ogenic</w>
particip ate</w>
paralle l-
paradig m</w>
p ens
p =
oxcarb azepine</w>
over- the-counter</w>
out ,</w>
ot o
ophosph ate</w>
operativel y.</w>
on it
om as,</w>
oli po
ol ab
ogene sis,</w>
od ine</w>
ochemic ally</w>
neg atively</w>
n R
morph one</w>
miner al
mg/ 24</w>
mer open
medi ators</w>
malignanc ies.</w>
mRNA s</w>
m L
lithi um,</w>
levodopa .</w>
lev amisole</w>
le sion.</w>
kilog ram</w>
it rac
intracerebro ventric
inter ruption</w>
intak e,</w>
inh er
ine- containing</w>
induc ed,</w>
indic ators</w>
in- dependent</w>
in tim
in sen
hypo glycemia</w>
hyperprolact in
hydrochlor ide.</w>
gre en</w>
gran isetron</w>
gener 's</w>
ganciclo vir</w>
fract ure</w>
famil ial</w>
exer cis
ex amp
esoph ag
ery thromycin</w>
epilept ogenesis</w>
entr ant</w>
enrol led.</w>
enoxapar in</w>
eng e</w>
ed -dose</w>
ectom y,</w>
dist res
discontinu e</w>
dimen sional</w>
dig ital</w>
di deoxy
dextromethorph an</w>
devi ation</w>
delta -
decom pens
d antrol
concentration -dependent</w>
con ce
common ,</w>
com mer
co administered</w>
circum st
caus ality</w>
carcin oma,</w>
brie fly</w>
bir th.</w>
bac k
atheros clerosis</w>
aryn g
anti hyperalgesic</w>
anti bod
anthracyclin es</w>
amelior ates</w>
allodyn ia.</w>
al te
add res
acid s,</w>
[CI ],</w>
We gener's</w>
U .
TH E
R I
Out come</w>
OD )</w>
Nalox one</w>
N im
M ay</w>
Le w
Lamiv udine</w>
L H</w>
L AD</w>
J )</w>
In fusion</w>
INTERVEN TION:</w>
HC C</w>
H A
G Y
G T</w>
Fe bruary</w>
F L
F ANF
Ex tr
Ex amination</w>
Electro cardio
Con sider
CA -
C /
A 2A</w>
9 00</w>
9 +/-
7 +/-
19 ,</w>
13 )</w>
10 -1
1. 3
0. 1%</w>
-1 6</w>
(i.c.v .)</w>
(I N
(H D
(6 )</w>
(0. 5-
( "
wom an,</w>
weigh ing</w>
vinblast ine</w>
ventric les</w>
usp id</w>
tubocurar ine</w>
transi tion</w>
toxic ities.</w>
tic ed</w>
thrombocytopen ic</w>
terfen adine</w>
tacrolim us.</w>
sudden ly</w>
sub groups</w>
su be
strych n
stitut es</w>
sten osis.</w>
son 's</w>
sit e.</w>
shar p</w>
scor ing</w>
scal es</w>
sarco plasmic</w>
sal me
ro ta
ris k
reve als</w>
ret e</w>
resul t
resist ance,</w>
reser pine-induced</w>
recover y,</w>
re mor
re ad
prop ag
promot er</w>
practi tion
po ol</w>
plic ation</w>
pl us-
phenylpropan olamine</w>
peroxis ome</w>
peri vascular</w>
pe d
partici pation</w>
part uri
output .</w>
op a</w>
ob lo
nor adrenal
ni gra
neutropen ia.</w>
neuro blast
modi fying</w>
mg/d l,</w>
method s.</w>
meth imazole</w>
ment ed</w>
m 2</w>
lex y</w>
labor ator
l ;</w>
ket amine,</w>
inver sely</w>
inter neurons</w>
incre ment</w>
in- resistant</w>
in -</w>
in ).</w>
hypo thyroidism</w>
hypertroph ied</w>
hyper tonic</w>
hyper thyroidism</w>
hydr alazine</w>
hospital ization.</w>
h is
h abil
h ).</w>
group s;</w>
graf ts</w>
gen e-
gemcit ab
gain ,</w>
g adol
fre ely</w>
f ru
extrac ts</w>
experim ent.</w>
excre ted</w>
es tin</w>
ergot amine</w>
erg ol
er adic
epid ermal</w>
enalapri l.</w>
en tic</w>
el ing</w>
dox y
dil uted</w>
didan osine</w>
dev ice</w>
det ecting</w>
dem and</w>
deci sion</w>
de b
cytokin es</w>
cycl es,</w>
confir ms</w>
conf ined</w>
compoun ds,</w>
collag en
col on</w>
co st-
ch es</w>
catal y
bortezom ib
blockade ,</w>
beag le</w>
azot emia</w>
az ithromycin</w>
az ide</w>
asth ma.</w>
ar ,</w>
am en
all ergy</w>
al /
Typ e</w>
T ).</w>
T ),</w>
Statis tical</w>
Septem ber</w>
SO D</w>
S ex
Rh abdomy
Rap id</w>
R adi
Pneum ocystis</w>
P TH
P IL
M ark
L C
In stitute</w>
Gen er
G o
D (3)</w>
Con sequ
Com mon</w>
Ch aracter
Calci um</w>
B6 C3
Ane mia</w>
AT )</w>
AC E
> /
55 ,2
1. 5%</w>
0.000 1),</w>
- matched</w>
- 3</w>
(P B
(C D
(5 )</w>
(1 1.
(1 -1
(0. 4</w>
( an</w>
( GABA)</w>
we t</w>
w id
volt age-
vessel s.</w>
us :</w>
up- regulation</w>
un known,</w>
un detectable</w>
tuberculo sis.</w>
transcri ption</w>
ton ,</w>
tis m</w>
til ity.</w>
tac tile</w>
t ing
system atically</w>
suspen sion</w>
suspect ed.</w>
sup pl
stimul ates</w>
steroid -induced</w>
somat ostatin</w>
similar ities</w>
si as</w>
short- acting</w>
sep sis</w>
sed ated</w>
retriev al</w>
ret y
rest less
resc entic</w>
recogn ized.</w>
re d
quin pi
pseud olith
prote in.</w>
prost acyclin</w>
promot es</w>
population- based</w>
pharmaco dynamics</w>
persist ing</w>
patter n.</w>
paralle led</w>
par s</w>
over l
op tical</w>
on to</w>
om o
occipit al</w>
obser ve</w>
ob ese</w>
norepinephr ine,</w>
non- specific</w>
neuro physiological</w>
neph rin</w>
move ments,</w>
ml/ min/
mimic king</w>
midazol am,</w>
micro mol</w>
mic ron
memant ine</w>
mak es</w>
mEq/ L</w>
m O
load ed</w>
lif e
l ut
jaundic e,</w>
iodi x
intra- arterial</w>
imb ic</w>
ic ter
i sed,</w>
hyp oxic</w>
hor n</w>
histopath ology</w>
hepar an</w>
haemorrh agic</w>
gran ular</w>
glit azone</w>
g p</w>
g ative</w>
frequ ency.</w>
fluores cent</w>
fluctu ations</w>
femal e,</w>
favour able</w>
f it
exerci se.</w>
exam ic</w>
eu tical</w>
ep silon
en ing.</w>
en e,</w>
ell a</w>
duc tal</w>
droxy progesterone</w>
dox ep
differenti ate</w>
detrus or</w>
dend rit
de tri
cysti tis,</w>
con sumed</w>
con s
commence ment</w>
clear ance.</w>
chol ang
cannab is</w>
atroph y.</w>
atri a</w>
arterio venous</w>
arteri es,</w>
are a,</w>
appear ing</w>
aneur ysm
al lopurin
al is
agranulo cytosis</w>
agonist .</w>
adul ts,</w>
accur ate</w>
ac ne</w>
a ir</w>
U/ L</w>
Twenty- two</w>
TH C</w>
TA M</w>
Sever ity</w>
S ymptomatic</w>
S ]
S 1</w>
Repor ts</w>
Repor t</w>
Rayna ud's</w>
Pro phyl
P C</w>
N-acetyl -
M ater
L- dopa-induced</w>
Ig M</w>
I GF
HD L</w>
H ).</w>
GV HD</w>
Elev ated</w>
E m
Do ses</w>
Coca ine-
C s)</w>
C CR
Bu propi
Bo NT
BACKGROUND /
B6C3 F1</w>
B R
Angio edema</w>
8. 4</w>
55,2 12-
5. 8</w>
4 50
3A 4</w>
2. 5,</w>
10 1</w>
1 0.0</w>
-1 6
(R B
(P< 0.05).</w>
(P D).</w>
(NSAID s)</w>
(D F
( normal</w>
( Q
yl ]
wat er-
w anted</w>
vi sion,</w>
ventric le.</w>
urac il-induced</w>
unc ture</w>
un toward</w>
u ren
twic e-
transf u
transc ranial</w>
tra st
tid al</w>
thromboembol ism.</w>
thiobarbit uric</w>
the mo
thal lium</w>
terat ogen
teach ing</w>
suic idal</w>
su los
stress -induced</w>
sti tu
sion- free</w>
seizure -induced</w>
seizure -
se )</w>
schiz o
s. (ABSTRACT</w>
s ati
rest .</w>
reproduc ible</w>
recogn ised</w>
re ne
rat )</w>
radi al</w>
qu i
prurit us,</w>
prot ect
prog estin</w>
pri ap
pre neoplastic</w>
pot ently</w>
pi l</w>
phosph atidyl
phenobarbit al.</w>
ph ag
perox ides</w>
per m
per form</w>
p olar
out side</w>
otom y.</w>
ot roph
omyo si
omeg alo
oly sacchar
ol e,</w>
o ffered</w>
nephrocalcin osis</w>
neph rectom
n isoldipine</w>
mou se,</w>
modul atory</w>
mineral ocortico
min ;</w>
mim ic</w>
micrograms/ ml</w>
microgram s,</w>
mg/d )</w>
mercap to
m sec
los art
lo st
lo g</w>
liver s</w>
limit ed.</w>
lethal ity.</w>
l aryngeal</w>
l -treated</w>
k an
j aw</w>
it y
inter rupted</w>
infu sions.</w>
inform ed</w>
in activation</w>
in ),</w>
illust rate</w>
il ater
hyperprolactine mia.</w>
horiz ontal</w>
high- grade</w>
high- frequency</w>
hepatocarcin ogenesis</w>
help ful</w>
he avi
gra dient</w>
glucos aminid
glomerulos clero
fin ally</w>
extrem ities</w>
expres sions</w>
ethin ylestradi
et ric</w>
escal ated</w>
entor hinal</w>
elev ated.</w>
electro phore
el at
ed )</w>
dos ing,</w>
differen tially</w>
di ed,</w>
deli berate</w>
de s.</w>
dar k</w>
dan azol</w>
d itary</w>
cyt omegalo
cor d.</w>
consti pati
circum flex</w>
cir cadian</w>
ci par
ci lost
che wing</w>
cephaloth in</w>
cent er.</w>
cause s.</w>
catat on
carri er</w>
c il
bronch ial</w>
brom ide</w>
azol e,</w>
ation ),</w>
astro cytes</w>
ap olipo
antipsycho tics.</w>
anticonvuls ants</w>
and -
anaphyl actic</w>
amphet amine.</w>
alpha- 2</w>
al gesia</w>
al fentan
administr ations</w>
ad ine.</w>
ac r
abs orb
] ;</w>
Y M
Wistar- Kyoto</w>
WH O</w>
V AS</w>
Twenty- one</w>
T rial</w>
T oxic
S ensi
S ed
R S
Pre vi
Physi cal</w>
PA ,</w>
P S</w>
P I</w>
O H</w>
Na (+
NO -
My oclon
Mor ris</w>
Monit oring</w>
Li ght</w>
L at
Kidne y</w>
H ),</w>
Gen etic</w>
Gastro intestinal</w>
G I</w>
Fif ty</w>
F as</w>
F ail
F D
Engl ish</w>
ESR D</w>
E F</w>
DE S
D TI
Co gn
Chol est
CP -induced</w>
Afric an-
Aden osine</w>
8-OH-DPA T</w>
5 4
4 2%</w>
4 00
25 ).</w>
2 6%</w>
100 ,000</w>
1. 6
0.0 1,</w>
- evoked</w>
- a</w>
(P V
(NS CL
(6 %)</w>
(5-HT )</w>
(2 0%)</w>
(1 1</w>
(1 ,</w>
( as</w>
yn uren
ye 's</w>
whic h,</w>
ven a</w>
us -like</w>
ureth ane-
unevent ful</w>
twit ch</w>
trimethoprim-sulfamethox azole</w>
tric uspid</w>
treatment s,</w>
third- generation</w>
therap y;</w>
theophyll ine-induced</w>
them sel
sub cortical</w>
st ers</w>
spectr al</w>
sol v
sol ely</w>
six th</w>
single- agent</w>
sil ent</w>
secre ting</w>
se tr
se di
se ar
se -induced</w>
schizo affective</w>
sc at
ro bus
robus t</w>
ric h
regist ered</w>
re aring</w>
re al-
quad ri
provo ke</w>
prot ecting</w>
probuc ol</w>
point s.</w>
pirox ic
phosphodi esterase</w>
phenylbut azone</w>
peth idine</w>
person ality</w>
p ran
over dose,</w>
open- field</w>
occlu sion.</w>
o vir
neutropen ic</w>
neuro trophic</w>
n ystag
n on</w>
n am
myo pathy,</w>
molec ule</w>
min (-1
metabolit es,</w>
mellit us.</w>
mark et
m o</w>
lym ph</w>
loxac illin</w>
lithium -treated</w>
le de
irrig ation</w>
io d
intrac arotid</w>
intoxic ated</w>
inte resting</w>
insomn ia,</w>
injur ies</w>
indic ated.</w>
incub ated</w>
in patients</w>
impa i
il lede
ifosf amide-induced</w>
if edi
identi fying</w>
i ons</w>
i i)</w>
i an
hyperparathyroidis m</w>
here ditary</w>
glyco protein</w>
function ally</w>
flu x</w>
fal cipar
f ro
excl usion</w>
erup tion</w>
enco ding</w>
en cy
em iz
effec tive.</w>
eff lu
edi c</w>
dysrhythmi as</w>
dyskinesi a,</w>
diphenyl hydantoin</w>
differen c
develop ment,</w>
de tox
d ),</w>
cy clop
cord ance</w>
consequ ent</w>
concentration- time</w>
con sul
clozap ine,</w>
cl imb
chromos ome</w>
candi date</w>
c ally</w>
bur st</w>
blad der,</w>
beta- carb
b asi
aure us</w>
atrop ine.</w>
atri um</w>
assi st</w>
ascit es</w>
ar n
ap or
anti micro
anaesthe sia,</w>
an olic</w>
alle le</w>
al gesi
af il</w>
acyclo vir
acromegal ic</w>
accur acy</w>
a id</w>
[CI ]</w>
TM P-SM
T ou
T im
T UNE
Su stained</w>
Si rolimus</w>
SU B
SUB JEC
ST )</w>
S kin</w>
S W
S .
Respon ses</w>
PP I</w>
PA ),</w>
On ce</w>
Nephro tic</w>
Na use
NSCL C</w>
NSAID s.</w>
N ifedi
Mo der
Mater nal</w>
M otor</w>
M orphine</w>
M D</w>
Levo dopa-induced</w>
In divid
I tal
Halo th
H un
Glu R
Fail ure</w>
E ),</w>
Diag nos
Decreas ed</w>
De x</w>
D ig
Capsa icin</w>
Ca Cl
C d
BB B</w>
B one</w>
B cl
Anti convulsant</w>
Anesthe sia</w>
An xi
Ag )</w>
AN G</w>
A TION:</w>
7- N
50 %,</w>
4 3%</w>
2 8,</w>
199 5</w>
17 beta-
16 )</w>
12 5
0.00 1,</w>
-1 ).</w>
(S D</w>
(HB s
(E D)</w>
(A P
(A I
(1 7.
(1 6.
(1 5.
(0.0 5</w>
( d
( +/
yiel d</w>
wom an.</w>
w an
upt ak
ul atory</w>
uc h
toler able</w>
tol u
theophyll ine.</w>
test ed,</w>
t ).</w>
sw im
stereot y
stabil ized</w>
sk in.</w>
sit ting</w>
sino atrial</w>
signific ance.</w>
si um</w>
si s
shif ted</w>
sclero sis.</w>
scan ning</w>
ropi um</w>
rof ecoxi
rhabdomy olysis.</w>
respon d
regul ate</w>
re vascular
re b
random ised,</w>
r a</w>
progres sing</w>
pro ic</w>
pressu re
preferen tial</w>
posses ses</w>
po ses</w>
plas ticity</w>
picrotox in,</w>
phospholip ids</w>
phen el
per -
pea k
pari etal</w>
par at
or poreal</w>
oph asic</w>
open ing</w>
ol ec
nocicept ors</w>
nicot ine,</w>
neuro ten
ner ve.</w>
myoclon us,</w>
myelo genous</w>
monitor ing,</w>
modul ated</w>
min eral</w>
midd le-
micro g,</w>
mg/d L,</w>
me themo
me pivacaine</w>
maxim ally</w>
mac ular</w>
lor at
loc k
lif e,</w>
li pop
le n</w>
lamivud ine.</w>
labet al
l ate-
l amp
k es</w>
it em
ind ed</w>
inadver tent</w>
improve ment,</w>
im mobility</w>
ide )</w>
id azine</w>
i. m.</w>
hyd rate</w>
hexameth onium</w>
hem e</w>
gra des</w>
gr and</w>
ga it</w>
g/ kg</w>
g ained</w>
frag ments</w>
formul ations</w>
form e</w>
for tun
fluoxet ine.</w>
fentanyl ,</w>
feat ures.</w>
exp and
enzym es.</w>
embry o</w>
el l</w>
ear ly-
e ver
e ating</w>
dyston ia.</w>
dyn orphin</w>
drowsin ess</w>
don epe
do fe
dipivox il</w>
di lu
dexamethas one.</w>
detri mental</w>
derivati ve,</w>
del ine
deaf ness</w>
cypro hept
cryst als</w>
conn ective</w>
conduct ance</w>
coffe e</w>
ce tin</w>
cas es)</w>
bro mo
border line</w>
biop sy-
bicarb on
be gun</w>
b um
b im
az ine,</w>
ay s,</w>
auth ors'</w>
ation /
ati ves</w>
asth matic
asc ribed</w>
ari ju
anti muscarinic</w>
anti body
anaesthe ti
amplitu des</w>
allevi ate</w>
al ce
aggrav ate</w>
adv ised</w>
administ er</w>
adi c</w>
ac illin</w>
ac cent
abund ance</w>
[3 5
[ 1,
U K</w>
Top ical</w>
T MA</w>
St and
SUBJEC T
Rec om
Re ye's</w>
QT -
Pheny leph
P rom
P oin
Op io
Olan zapine</w>
O l
Nor th</w>
Na+ ,
N M
N 2
IC R</w>
Hol ter</w>
Hemorrh agic</w>
HBs Ag
G ).</w>
E astern</w>
Dox orub
Differen t</w>
DP H</w>
Com mitte
CD4 +</w>
Al tered</w>
A F
: 1</w>
9 %),</w>
8 +/-
5- day</w>
5 %
37 8
23 39
2 :</w>
199 8</w>
10 8</w>
10 ),</w>
1. 7
1. 0,</w>
1 15</w>
0.00 5)</w>
0.00 2).</w>
-- a</w>
(9 5</w>
(4 %)</w>
(3 3%)</w>
(1 4
( five</w>
( and</w>
( [
wi se,</w>
week s'</w>
warr ants</w>
w ound</w>
us ti
ur nal</w>
un predictable</w>
un ilater
u ous</w>
tri al
treatment :</w>
tissu es.</w>
ti ve
ti li
thir ds</w>
there after</w>
ter one</w>
ter azosin</w>
tail- flick</w>
t able</w>
system s,</w>
sub unit
sub dural</w>
su fentan
ston es.</w>
somnol ence</w>
sk in,</w>
siz e,</w>
sevo flur
ser ves</w>
sal t-
saf er</w>
s c</w>
ro le.</w>
result ant</w>
res cu
ren al,</w>
remark ably</w>
refer ral</w>
re habil
r ation
pur ified</w>
protoc ol
prolong ation.</w>
progres sion-free</w>
pri mat
pri lo
pr ick</w>
potenti al.</w>
post- operative</w>
post operatively</w>
platin um-
plas ma.</w>
phen e</w>
pap illede
oxy codone</w>
orrhe a</w>
on es.</w>
omyc in,</w>
om edi
olanzap ine,</w>
ol d)</w>
off -
ocytopen ia</w>
oca in
oc ellular</w>
o protective</w>
no ticed</w>
neuro surgical</w>
neuro genesis</w>
neuro degeneration</w>
ne vir
n- propyl
min us</w>
mg/ day).</w>
macro scopic</w>
m(- 2)</w>
m /
leg e</w>
las s</w>
kappa B</w>
it ect
ip p
ip ex
initi s</w>
in directly</w>
ill nes
if er
hyperther mia.</w>
hyper -
hemo dialy
guan idine</w>
gi ve</w>
fol lic
fil gr
fig ures</w>
fail ing</w>
f ist
extrac ted</w>
exercis ed</w>
ethin ylo
et ary</w>
estrogen -induced</w>
episo dic</w>
endothel in-1</w>
em pt
electrocardio grams</w>
ele ments</w>
el y,</w>
ec tion,</w>
ec lamp
dysp nea</w>
dys plastic</w>
dys arth
do pam</w>
dis ru
dimin ish</w>
determin ant</w>
der ang
depolar izing</w>
defic its,</w>
de s,</w>
cy an
complex .</w>
com pression</w>
cohor ts</w>
clo fib
cholest asis,</w>
channel s.</w>
c ne
bl ast</w>
bicucul line,</w>
b rety
b atter
aut oph
atel y.</w>
at ors.</w>
assess ment.</w>
arter itis</w>
arch itect
anti py
anthracycl ine-induced</w>
amoxic ill
alcoh ol,</w>
agre ement</w>
adrenocor tic
aden ylate</w>
act ually</w>
ach loro
acetyl chol
ac y
ab ly,</w>
[35 S]
Z .</w>
Tic lop
Thirty- five</w>
Th ough</w>
THE SIS:</w>
T ax
Simult aneous</w>
Scal e,</w>
SSR I</w>
S H</w>
Ris peridone</w>
R LS</w>
Qu es
Phenyto in</w>
PC R</w>
P rac
P DE
Nor plant</w>
NG -
Methad one</w>
MA P,</w>
M K
I schem
I M</w>
Hist ologic</w>
HB V-
H PL
H O
H 1</w>
Flu oro
Fentan yl</w>
E nal
Dru gs</w>
Deli rium</w>
Cogn itive</w>
Ca(2 +
C57BL/6 J</w>
Amph et
AS T</w>
AMP H</w>
A G
: 00</w>
8. 9</w>
6. 9</w>
5. 1</w>
5- fold</w>
5 alpha-
5 4-year-old</w>
4 8%</w>
3- year</w>
2- week</w>
2 n
2 7%</w>
199 0</w>
10 7</w>
1- methyl-4-
0.0 8</w>
0.0 4</w>
)- positive</w>
(S )-
(H Be
(A DR
(50 %)</w>
(2 5%)</w>
(1 4</w>
(1 3</w>
(1 20</w>
( TI
( QT
( 0,</w>
y sti
w k.</w>
ver tical</w>
vel y,</w>
vasodi l
vals artan</w>
val ence</w>
v ity</w>
urg ent</w>
un less</w>
un altered</w>
u ma
tum ori
trige minal</w>
tre ad
transmis sion.</w>
tr un
toler ance.</w>
tiv es</w>
tissu e,</w>
thre e
th ing</w>
test ).</w>
ten der
tem po
taurochol ate</w>
tas ks</w>
tam sulos
t ar
t :</w>
syncop al</w>
stereoty pi
sten o
stabil izing</w>
spec ies.</w>
sign s.</w>
ro om
relim inary</w>
rele ase,</w>
rel ate</w>
reinforc ing</w>
r ule</w>
ques tions</w>
punc ture</w>
propor tions</w>
prompt ed</w>
pro j
present ,</w>
pre mat
potenti ating</w>
poten cies</w>
port un
pin acidi
phot o
phenyl -
phen yl</w>
perce ived</w>
pelv is</w>
paraly sis.</w>
p ontine</w>
ou s.</w>
otrop in-releasing</w>
oten tial</w>
oper ating</w>
olo l.</w>
offspr ing.</w>
norepinephr ine.</w>
norepinephr ine-induced</w>
no ea</w>
neurotrans mis
neuro peptide</w>
necess arily</w>
nause a/
mod al
mod afin
microgram/ kg/
met formin</w>
medi a.</w>
mechanis m,</w>
me droxyprogesterone</w>
marg inal</w>
man age</w>
lu minal</w>
lith iasis.</w>
lipop olysacchar
ligh t-
life time</w>
leuko encephalopathy.</w>
leg ia</w>
l ing.</w>
kidne ys.</w>
ket o
k ing.</w>
isradi pine</w>
iso propyl
intro duc
inter fe
instrum ented</w>
in stituted</w>
impl ants</w>
impair s</w>
imbal ance</w>
im idaz
ic os
ic e.</w>
ic ally.</w>
i bility</w>
i atrogenic</w>
hyper glyce
hom ozygous</w>
histor ical</w>
gra vi
gentamic in.</w>
g/d L</w>
g insen
fibro tic</w>
extrac tion</w>
ext inc
ex ec
ethan ol.</w>
estradi ol-induced</w>
eosinophil ia,</w>
environ ment</w>
enti ally</w>
endo thelium</w>
electro des</w>
effici ency</w>
ec ho
e NOS</w>
dy e</w>
document ation</w>
distinc tive</w>
discharg e.</w>
dil ution</w>
degener ation.</w>
daun orub
counter acted</w>
cord ingly,</w>
conven i
contraceptiv es.</w>
consum ption,</w>
conduc ted.</w>
common .</w>
coll ection</w>
cne mi
classi fication</w>
chemic als</w>
char co
ch ill
calc ific
bu terol</w>
bronch ospas
ble s</w>
be d.</w>
ax is,</w>
auto regulation</w>
ate :</w>
arub icin</w>
anxio genic</w>
anti globulin</w>
antagonist )</w>
angio plasty</w>
angio genesis</w>
angin a.</w>
an ia</w>
amine -</w>
alkalo id</w>
age -</w>
after depolar
adver sely</w>
abil ities</w>
VII a</w>
T est</w>
S equ
S G</w>
Rel ative</w>
Pl atele
Parkinson ism</w>
Parkinson ian</w>
P reliminary</w>
P otential</w>
P or
P M</w>
O cular</w>
N /
M yo
M yelo
M PO-
Iso flurane</w>
IC H.</w>
HD .</w>
F ind
F R
Ex pression</w>
E G
D VT</w>
D R</w>
D M</w>
Consequ ently,</w>
Con vul
CE :</w>
CB (1)</w>
C reat
B 6</w>
B ).</w>
An g</w>
ACh E</w>
A ll
A -induced</w>
99m Tc-
78 8</w>
7. 1</w>
6- tetrahydro
6 5%</w>
6 -1
5. 4</w>
4 3-year-old</w>
4 +/-
3. 0
2- amino-
2 20</w>
2 10</w>
17 )</w>
15 ).</w>
12 ).</w>
1. 73</w>
0.0 2
.0 5)</w>
- ,</w>
) .(ABSTRACT</w>
(T M
(R A)</w>
(H R</w>
(A Z
(1 99
( to</w>
( s
( TH
( ISO
vehic le,</w>
vasodilat ory</w>
vag otomy</w>
v indesine</w>
typ e,</w>
twent y-
trigg ering</w>
transamin ases</w>
tim es,</w>
therap ies.</w>
the ore
th r
terat ogenicity</w>
techniqu es.</w>
tamoxif en
t ently</w>
synthe tase</w>
synap ses</w>
suscepti bil
stoppe d,</w>
steroid s,</w>
spe ed</w>
spas ms</w>
sodi um.</w>
shoc k,</w>
sho ul
seleg iline</w>
sc ra
roten one</w>
resol ved.</w>
requ est
rel ated,</w>
region ,</w>
rec t
re pair
re entrant</w>
radi ologic</w>
r p
r ,</w>
r )</w>
protoc ol,</w>
prost en
prolact inemia</w>
progno sis.</w>
pressu re-
post- treatment</w>
plast y.</w>
plasi a.</w>
plas min
piperaz in
pimoz ide</w>
picrotox in.</w>
phenyl-1, 2,3,
phenyl-1,2,3, 6-tetrahydro
phen o
phen acet
pharmaco therapy</w>
p.o .,</w>
p yl
p ith
ox ot
ot onic</w>
org est
omorph ic</w>
omeg a-
oly tic-
obstruc tion.</w>
o pathy</w>
nit rit
nim odipine</w>
ng/ml ,</w>
myo glob
min ip
micrograms/ kg,</w>
micrograms. kg-1.
microg/ m
metron idazol
metr y.</w>
me eting</w>
manip ulation</w>
ly sine</w>
lo dip
ligi ble.</w>
lat ano
lab or.</w>
k ynuren
j usti
iv )</w>
ister nal</w>
is m
investig ators</w>
intramuscul arly</w>
interview ed</w>
interven tion.</w>
inten tional</w>
infec tions,</w>
in ulin</w>
ia -induced</w>
hyper glycemia</w>
headach es.</w>
grow th.</w>
graph y,</w>
gra y</w>
gluco se-
ge l</w>
ga p</w>
fing er</w>
fi ve-
fel t</w>
falcipar um</w>
erythematos us.</w>
erg ic,</w>
en rich
el y.</w>
echocardi ography,</w>
dy scra
du odenal</w>
down regulation</w>
discrimin ation</w>
determin ations</w>
desferri oxamine</w>
des methyl
dermat omyosi
derm atitis</w>
demonstr ation</w>
del ays</w>
dec ano
dec ade
death s.</w>
dP/d t</w>
d p
cy nom
corp us</w>
controversi al.</w>
cont ain</w>
charg e</w>
cardio ver
carb oxy
caffe ine,</w>
ca use.</w>
biom ark
b ind</w>
arterios clero
aripi prazol
ap parat
alpha )</w>
allevi ated</w>
all- trans</w>
af en
adv oc
ad d</w>
ab users.</w>
a the
a kine
a ).</w>
Vas cular</w>
Up on</w>
TRPV 1</w>
Sy mptom</w>
STZ -induced</w>
S L
Rhabdomy olysis</w>
Q- T</w>
Pen icill
PG -
PA C</w>
P urkinje</w>
P H</w>
P )-induced</w>
Nit ric</w>
NO S)</w>
Midazol am</w>
M 1</w>
Lithi um-induced</w>
Larg e</w>
L ong</w>
L im
L ev
L F
L C</w>
Jo hn
Intra peritoneal</w>
I sol
I s)</w>
H or
H ence,</w>
G nR
Fe w</w>
Experim ents</w>
Diagnos tic</w>
D S</w>
Ca2+ ]
CO X</w>
C r</w>
C lass</w>
Bupropi on</w>
Brom ocript
As soci
AM PA</w>
8 0-
6-hydroxy dopamine</w>
5 8-year-old</w>
5 5%</w>
4. 3</w>
4. 0
3 6%</w>
3 5-year-old</w>
3 20</w>
2. 5
2 +</w>
199 3</w>
15 -1
12 3</w>
10 5</w>
10 2</w>
1 :</w>
1 -1.
0.0 7</w>
0.0 6</w>
0. 5-
) =
(medi an,</w>
(SIAD H)</w>
(GSH )</w>
(ED 50</w>
(C I)</w>
(A U
(1 4%)</w>
( Z
( CL
z en</w>
weigh t/
ver sus
ver age</w>
vasopress or</w>
vas omotor</w>
vag ina</w>
us cular</w>
ure a,</w>
uncommon ,</w>
ular -
tubul es.</w>
tren ds</w>
trans verse</w>
ti lit
thromb i</w>
thalam us</w>
ter rit
ta z
t .)</w>
supple ments</w>
supple mental</w>
sulfon yl
steat osis</w>
st ent
spik es</w>
somat os
smok ing,</w>
smo ked</w>
sil on</w>
sic kle</w>
si s)</w>
sal ts</w>
rod ents</w>
retar ded</w>
res or
region s,</w>
reco vered.</w>
reason able</w>
re modeling</w>
r able</w>
py rex
prot on</w>
prot ection.</w>
propor tion
prof es
proced ure,</w>
prednis one.</w>
pr amine.</w>
post mortem</w>
poly dip
point es,</w>
pig s.</w>
phenylpropan ol
ph or
path ies</w>
pair s</w>
p et
oxot remor
oste osarcoma</w>
os omal</w>
ore r</w>
op portun
one :</w>
olg us</w>
ogen s</w>
nitroglycer in,</w>
nifedi pine.</w>
new -onset</w>
neur itis</w>
nause a.</w>
myelo peroxidase</w>
multi forme</w>
mon grel</w>
molec ul
mofe til</w>
mit ript
min -1)</w>
mil l</w>
midazol am.</w>
micro glial</w>
metho d,</w>
methamphet amine-
meth icill
mellit us,</w>
mark et</w>
mal es.</w>
lu oro
laparo tom
ix is</w>
isoflur ane.</w>
intraven ously.</w>
infiltr ate</w>
increas e.</w>
in distinguishable</w>
immun ost
immun oblo
id opa</w>
hypothe sis,</w>
hyperammon emia</w>
headach es,</w>
hand ling</w>
graf t-
glut ar
gastro cnemi
fol lowe
fir ing</w>
fenflur amine,</w>
fast ing</w>
extr ap
expos ure
exam ple</w>
eti ologic</w>
ethosuxim ide</w>
et opo
episo de.</w>
endotheli um-dependent</w>
endo plasmic</w>
efflu x</w>
dystroph y</w>
down- regulation</w>
don ors</w>
dom peridone</w>
dis opyram
dipyridamol e-
defer oxamine</w>
dang erous</w>
cytoplas m</w>
cytomegalo virus</w>
cyclop ent
cyclo oxygenase-2</w>
curren ts</w>
criter ia,</w>
cramp s</w>
clo fibrate</w>
cli o
clavul anic</w>
chol e
chlor prop
characteris tics.</w>
cent ri
cardio respiratory</w>
calci um,</w>
c ro
c rescentic</w>
c id
biosyn thesis</w>
ballo on</w>
azepam .</w>
ast emiz
assist ed</w>
arterios us</w>
aro usal</w>
ar ray</w>
ar m,</w>
antibio tics,</w>
anorex ia</w>
anesthe tics.</w>
analo g
amine /
am ine)</w>
alopec ia</w>
alkal i</w>
al i
adap tive</w>
ad ine,</w>
acceler ation</w>
ab normally</w>
ab en
a -induced</w>
a ),</w>
Wh ite</w>
VO D</w>
V an
T- cell</w>
T 2-
T 1</w>
S ud
S qu
R if
Ques tion
P PA</w>
P =0.00
Ob j
O P</w>
Moder ate</w>
Magne sium</w>
MI B
M i
M CT</w>
Low -dose</w>
Long -
L ate</w>
K ,</w>
In vent
I mi
I denti
I U</w>
I R
I .
Hy dro
Hospit al,</w>
Hear ing</w>
H LA</w>
G entam
G O
Find ings</w>
Extr apyramidal</w>
DF P</w>
D ic
CI P</w>
C ir
C K-
Bri ef</w>
Aut opsy</w>
Ac cordingly,</w>
AQ P
ADR s</w>
A )
4 6
200 2</w>
199 9</w>
199 7</w>
17 ,</w>
0. 50</w>
. "</w>
) .
(S BP)</w>
(P G
(N M
(CH F)</w>
(C T)</w>
(7 )</w>
(1 5%)</w>
( no</w>
( max)</w>
( VE
" )</w>
zer o</w>
x en
warfar in.</w>
vi ability</w>
versus -
vasoconstric tion.</w>
v oid
uro thelium</w>
urb an</w>
un necessary</w>
u lop
u ate</w>
two- stage</w>
tw ard</w>
trimethop ri
top ically</w>
ti ter</w>
thyroidis m.</w>
thior idazine</w>
therap y-
tetr ap
t one.</w>
t ocain
suggest ed.</w>
stabil ization</w>
spor adic</w>
sit e,</w>
shun t</w>
sex es</w>
se e</w>
salme terol</w>
restra ined</w>
rem ote</w>
refl ects</w>
real- time</w>
ram i
ra emia</w>
r s
r d</w>
publ ic
pt s</w>
protein s,</w>
propi onic</w>
prolactin oma</w>
pro per</w>
pro lol</w>
prepar ation.</w>
phil ic</w>
pheny leth
peroxid ation,</w>
perform ing</w>
pentobarbit al-
paracetam ol-induced</w>
pap ill
pancre atic</w>
p mol
p e</w>
ot ep
oste o
ophthalmo logic</w>
op tions</w>
ometr y.</w>
ocy ste
occ u
o sides</w>
not able</w>
non- competitive</w>
nio tic</w>
nephro sis,</w>
ne ocor
ne bul
n M)</w>
multi ple
mu st
mod ality</w>
minim ally</w>
microg/ kg,</w>
mg/m2/ day</w>
mg/kg/ d</w>
methamphet amine.</w>
mes ylate</w>
ment ally</w>
maz epam</w>
mater i
m iti
m ariju
m M)</w>
lipo ic</w>
j un
it em</w>
ish es</w>
intr apl
interpre tation</w>
inter ictal</w>
influ enz
infiltr ation.</w>
increas e,</w>
implic ate</w>
immuno fluorescence</w>
immun opositive</w>
im at
if ens
ic ulation</w>
ibuprofen ,</w>
hypo phosphat
hypo album
hypercalce mic</w>
hospit als</w>
hospit al,</w>
heterogene ous</w>
heter ozygous</w>
heavi ly</w>
heal ing</w>
glycopyr ro
gad odi
g avage</w>
fle x
fib ron
fat al
fall s</w>
exceed ing</w>
evo ke</w>
event ,</w>
evalu ation,</w>
eti ologies</w>
eti l</w>
esmo lol</w>
erg ot</w>
enzyme -
eno ic</w>
eno graf
em .</w>
ecti ve,</w>
diphen hydram
differen t.</w>
dex tr
denerv ated</w>
demyel inating</w>
dehydrogen ase,</w>
de form
day s;</w>
cynom olgus</w>
cum in</w>
cu ff</w>
cop i
contr ary,</w>
cont ent.</w>
clinic .</w>
cle ared</w>
circ uit
cholec ysti
cervi x</w>
centri lobular</w>
cav ity</w>
cauti ously</w>
catat onic</w>
cat abol
carri ers</w>
cardi ac
cann ul
c ab
broad -
batter y</w>
b ular</w>
az os
ar te
ar ising</w>
apop lexy</w>
anxiet y-
antidepress ants,</w>
anticoagul ation.</w>
angiotens inogen</w>
analgesic s.</w>
amygdal a,</w>
amne sia,</w>
ammon ium</w>
alter ations.</w>
after ,</w>
affor ded</w>
afferen ts</w>
activ ates</w>
act in
act .</w>
acetyl -
[ 14
Z ),</w>
X ),</w>
Twenty- seven</w>
TI ON</w>
Sed ation</w>
SO UR
R ates</w>
Prost agland
Pregn ant</w>
PT U
P ub
P raz
O F
M CA</w>
L it
L QT
Isol ated</w>
Intrac erebro
Im port
Im medi
IN H</w>
F C</w>
E V
E LIS
DO CA-
Co A</w>
Ci prof
Ca ution</w>
BALB/ c</w>
BACKGROUND/ AIMS:</w>
Anxi ety</w>
An tin
Al so</w>
Al ph
A P-
A ED
9 6
6. 2</w>
5. 7</w>
4 9
4 5-year-old</w>
4 1%</w>
4 0,</w>
4 %;</w>
1. 8
1 4-year-old</w>
- derived</w>
(r =
(Td P)</w>
(T B
(H R
(H IV)</w>
(C V
(C G
(2 00
(2 0-
(1 9%)</w>
(1 /
( age</w>
women )</w>
weak ness.</w>
we en-
var ic
valpro ate,</w>
vacuol ization</w>
v oc
ut ropen
upreg ulated</w>
un desi
un acceptable</w>
u sion-
tr abec
tot al,</w>
tiz an
tion ).</w>
therap eu
tak en.</w>
ta urine</w>
t y,</w>
t welve</w>
t ors</w>
syncop e.</w>
super sensitivity</w>
sulph asalaz
suff er</w>
succin ate</w>
sub tle</w>
stom ach
ste ato
sphinc ter</w>
son iaz
slow ed</w>
sleep ing</w>
sevent h</w>
ser ies,</w>
sear ched</w>
schizophren ia,</w>
scaven ger</w>
s inu
rout es</w>
retin ol</w>
retic ular</w>
ren z
re organization</w>
prof il
prochlorper azine</w>
press in</w>
predic tion</w>
precipit ation</w>
posi tion,</w>
popul ations.</w>
po orer</w>
pneumon ia
pituit ary-
pic t
phosphor ylated</w>
person -
per hexiline</w>
pa per
pa in-
p 53</w>
os ensi
ori s.</w>
on orgest
omyc in-
oca proic</w>
oc cul
ob ic</w>
o gram</w>
no vel
no ti
nitroglycer in.</w>
nitro gen
neurolep tics.</w>
n ing.</w>
myoclon us.</w>
morb id</w>
mon ophasic</w>
migr ation</w>
mg ;</w>
metoclopram ide.</w>
methyl prednisol
methotrex ate-induced</w>
methotrex ate,</w>
metallo protein
melan oma</w>
medi ation</w>
meas ures,</w>
me .</w>
marg in</w>
manifest ations.</w>
man dat
mO sm
m idine</w>
low- density</w>
lop ri
lit ter
lis uride</w>
lenal idomide</w>
lad der</w>
labell ed</w>
k P
j ump
iso forms</w>
iodix anol</w>
intra hippocampal</w>
interac tions.</w>
infusion )</w>
inf ants,</w>
inde d,</w>
inclu de
in- converting</w>
immun ologic</w>
im age</w>
ifosf amide.</w>
hypercalce mia.</w>
hype remia.</w>
hydroxy chloroquine</w>
hydrox yl</w>
hy ste
ger iatric</w>
g ).</w>
fre e
frac tion,</w>
fibrin olytic</w>
feed back</w>
fav or</w>
extrac orporeal</w>
expl oration</w>
eti ological</w>
episode s,</w>
ens ure</w>
end- systolic</w>
em ph
electro de</w>
electro chemical</w>
edull ary</w>
dri ve</w>
doxorubic in-
dis rupted</w>
dil ation</w>
diagno sed.</w>
di verse</w>
di bular</w>
dendrit es</w>
cypro terone</w>
cre am</w>
conn ected</w>
comm encing</w>
com es</w>
clar ithrom
cholecysto kinin</w>
char ts</w>
catechol aminergic</w>
beta-D- glucuronide</w>
be than
be ating</w>
autis m</w>
ate d;</w>
ar y
apopto sis,</w>
antin uclear</w>
ann ual</w>
aneur ysmal</w>
an emic</w>
amygd alo
altern ating</w>
alter ations,</w>
alpha- methyl-
al ip
adrenocept or-
adrenal ectomized</w>
activi ties,</w>
acetaminophen .</w>
ac ral</w>
ac onit
ab using</w>
[3H] -
W IN</w>
Vincrist ine</w>
U ro
TR H</w>
T rem
T D</w>
Seroton in</w>
SD ,</w>
S Y
Pro b
Par tial</w>
PE T</w>
OH DA</w>
Nitro glycer
Ne utropen
N umerous</w>
N F
Mul ticent
MPT P</w>
M il
LD H</w>
L if
K ore
K (+)</w>
John son</w>
Immedi ately</w>
I soniaz
I s
Hepar in</w>
HBI G</w>
H g/
Gluc ocortico
G M-
F ish
Ex c
Ep inephrine</w>
En h
D ap
D 2
Committe e</w>
Col lege</w>
C erebro
Bet a-
B A
B 1</w>
AR T</w>
ADR .</w>
A PA
8- week</w>
7 00</w>
6- OHDA</w>
3 1,</w>
29 ,</w>
2/ 3</w>
15 6</w>
0. 1,</w>
(i ii)</w>
(e g,</w>
(LVE F)</w>
(I O
(B )</w>
(A E
(1. 0
(- )
( mean,</w>
( for</w>
( f
( IV
ziprasid one</w>
with in-
wh o,</w>
well- documented</w>
wedg e</w>
wall .</w>
volunte er</w>
viro logic</w>
v )</w>
ureth ane</w>
unclear ,</w>
ud in</w>
u ated</w>
trypt ophan</w>
trans l
tran examic</w>
toler ant</w>
toler ance,</w>
threshol d,</w>
thi on
th us,</w>
tetrac ycline</w>
target ing</w>
t es,</w>
t amp
tamp on
stat ins</w>
sodi um-
shoc k
sett ings</w>
self- reported</w>
second- generation</w>
schedul e,</w>
safet y.</w>
s oun
ru v
riton avir
ribavir in-induced</w>
rhabdomy olysis,</w>
retino pathy</w>
resol ve</w>
regener ative</w>
ral gi
quar tile</w>
pt h</w>
psycho sis,</w>
prosten ol</w>
prolifer ating</w>
proces sed</w>
prim idone</w>
pre cor
pneumon ia.</w>
ple as
plasmin ogen</w>
plac ent
pl ay
pith ed</w>
person al</w>
peripher ally</w>
per ind
pathw ay,</w>
p s.</w>
os al
orth op
orph anol</w>
ore s</w>
or i</w>
or ally,</w>
opyri dine</w>
olanzap ine.</w>
ol em
ochond rial</w>
oc e
nitren dipine</w>
ng/ml .</w>
ng/ml )</w>
neuro behavioral</w>
nes tic</w>
nephro n</w>
naf c
mt DNA</w>
modul ator</w>
ml .
mil d.</w>
middle- aged</w>
micro injections</w>
mg/ L</w>
methyl enedi
methoxy- 4-
meth amine</w>
membran e.</w>
memb er</w>
manufact ure
mal ai
m apping</w>
lipo proteins</w>
lin ing</w>
li um-
leuk emia,</w>
j e
it y)</w>
it es</w>
issu es</w>
iso form</w>
ir in
intr ap
intensi ties</w>
inf ant.</w>
ineff ective.</w>
immunohist ochemistr
im olar</w>
ide al</w>
id osis</w>
id ity.</w>
i tic</w>
hyperther mia,</w>
hyperammon emic</w>
hy dra
head- up</w>
haloperid ol
glauc oma.</w>
given ,</w>
g yr
frag mentation</w>
for ward</w>
flut amide</w>
fir st
f az
excl uding</w>
exam ined,</w>
eti d
emerg ed</w>
electroly tes</w>
earli est</w>
e .g
dy ses
dur ing,</w>
drug- free</w>
dom ain</w>
disturb ances.</w>
discus sed,</w>
disco vered</w>
disc rete</w>
di urnal</w>
de pth</w>
cryst al</w>
counter act</w>
cor d,</w>
contr act
continu es</w>
consum ption.</w>
complic ation,</w>
coer uleus</w>
co sts</w>
clozap ine-induced</w>
climb ing</w>
clear .</w>
cl am
chromat ography.</w>
chlor ide,</w>
children :</w>
ch y
cephal or
ce ased</w>
cat echol</w>
captopri l,</w>
ca emia</w>
c ame</w>
bilirub in,</w>
bicucul l
benz tropine</w>
bec oming</w>
baclofen .</w>
b ial</w>
b asis.</w>
az ine.</w>
atten ding</w>
atic .</w>
appro xim
apomorph ine.</w>
antec ed
antagon izes</w>
annab in
anesthe tiz
an kle</w>
amin ocaproic</w>
amethas one</w>
alpha-methyl dopa</w>
alkalo sis</w>
agl ate</w>
aer os
admis sions</w>
act ,</w>
accumb en
ac ne
a str
a p</w>
Y oun
VPA .</w>
U. S.</w>
U nex
Soci ety</w>
SE R
Rever sal</w>
Res piratory</w>
R A.</w>
Question na
Q X</w>
Prog res
Pre dic
PAN -induced</w>
PA .</w>
PA -
O ne
NG F</w>
ND I</w>
Morph ological</w>
Min ocycl
M as
Lit tle</w>
L oc
L ine
Intracerebro ventricular</w>
Increas es</w>
In formation</w>
Immunohist ochemical</w>
G ly
G em
Flu mazen
Ex er
E C</w>
Dis ul
D AT</w>
Con tr
Col chic
CD -1</w>
CA SE:</w>
C Y</w>
B W
B O
Amph otericin</w>
African- American</w>
Acet yl
A- I</w>
> or=
7. 8</w>
7- day</w>
6. 3</w>
6 5-year-old</w>
6 3%</w>
6 00
5 6-year-old</w>
5 %.</w>
38 39
3 -1
2 3-
2 1)</w>
2 ',
17 0</w>
14 5</w>
14 17
10 %,</w>
1. 5-
1-methyl-4- phenyl-1,2,3,6-tetrahydro
1 14</w>
0.0 4).</w>
/ A</w>
-1 4
- independent</w>
(e.g .</w>
(2 2</w>
(1 7</w>
(1 4.
ze tim
zetim i
xyl azine</w>
wor th
weak ly</w>
w ild</w>
vi sible</w>
versus- host</w>
ventil ation,</w>
val ves</w>
val idity</w>
ure -
uma b</w>
tur n</w>
trime ster</w>
tri fluoro
tread mill</w>
tran yl
trac er</w>
tom ographic</w>
to sis</w>
tion ing</w>
ti um</w>
thym ic</w>
that :</w>
thal as
temperat ure,</w>
ta per
t rou
t ality</w>
syncop e,</w>
swit ch
suppress ants</w>
succinylchol ine.</w>
struct ures.</w>
stimul ants</w>
six ty-
side )</w>
sed ent
se of
seof ul
sarc olem
sampl ing</w>
s low-
s "</w>
ron edar
righ ting</w>
rhyth m,</w>
rever ted</w>
reten tion,</w>
reproduc tive</w>
repor te
ren ch</w>
remis sions</w>
remis sion.</w>
rem oxi
re presenting</w>
rat :</w>
quer cetin</w>
purpur a</w>
promaz ine</w>
pro meth
precor dial</w>
peroxy nitrite</w>
perf usion,</w>
pect oris.</w>
patter n,</w>
pas e-
par val
par am
p ine
otrop in</w>
or ally.</w>
opioid s.</w>
op re
omep razol
om a:</w>
neg ligible</w>
mo re
mil der</w>
mil d-
migra ineur
methylphen id
methemo glob
methad one.</w>
mes n
mat ous</w>
manag ing</w>
lorat adine</w>
lin king</w>
lev onorgest
lay ers</w>
lamin a</w>
ket amine.</w>
kD a</w>
itrac onazole</w>
it uit
isot onic</w>
intraven ous
intens ity,</w>
inten ded</w>
infarc tions</w>
incre ments</w>
improve d,</w>
immunosuppres sion.</w>
imipr amine,</w>
imag ing,</w>
im ple
if ep
ifep rist
ic o
hypocal ce
hypo phy
hyper sensitivity.</w>
hyper kinesia</w>
hour .</w>
hospital ization,</w>
high .</w>
high ,</w>
hepar in-
harm ful</w>
ha m</w>
gli oblastoma</w>
gen icity</w>
g m</w>
g ating</w>
fro zen</w>
flunar izine</w>
fiel ds</w>
fibroblast s</w>
fibrill ary</w>
fenol dopam</w>
fat al.</w>
fasc iculation</w>
factor- alpha</w>
f oci
experi ence.</w>
ex piratory</w>
etomid ate.</w>
er y</w>
equ ili
end points</w>
en ing,</w>
emerg ing</w>
em pir
ed ing</w>
dyston ia,</w>
dis section</w>
din itrate</w>
dihydro pyridine</w>
diethyl nitrosamine</w>
diclofenac ,</w>
dialy s
di azep
deoxy corticosterone</w>
defen se</w>
dantrol ene</w>
cu los
cor n</w>
copi es/
convuls ing</w>
compris ing</w>
complete ly.</w>
compar t
clinici an</w>
cirrho sis,</w>
cho sen</w>
charco al</w>
challeng es</w>
cardio version</w>
cardi otoxic
carb idopa</w>
car ry</w>
capsaicin- evoked</w>
capecit ab
can des
cTn I</w>
bus ulph
be pri
be .</w>
avail able,</w>
aug ment</w>
at um</w>
asti m</w>
ant ar</w>
ant adine</w>
an is
am niotic</w>
am nestic</w>
age )</w>
adrenocept ors.</w>
adolescent s.</w>
ac tions.</w>
ac ill
abstin ence.</w>
[ Ca2+]
Z ,</w>
Y or
V P</w>
Twenty- nine</w>
The ophylline</w>
T2- weighted</w>
T ai
T X
Sup pression</w>
Sex ual</w>
SSR Is</w>
S ulf
S S)</w>
S OD
S -related</w>
Q D</w>
Prophyl actic</w>
Pro l
PRE TA
PR L-
P< 0.001).</w>
P2 X
Ox id
Ne gative</w>
Na +</w>
Mor tality</w>
K+- ATPase</w>
Inde x</w>
In din
Ig A</w>
INTER PRETA
Hypo kalemia</w>
Hyper sensitivity</w>
Hy droxy
H P</w>
H ER
H E</w>
G SH
G -induced</w>
E r
E N
Dou ble
Dop a</w>
Diag no
Diab etic</w>
DOX .</w>
DN F</w>
D- amphetamine</w>
D uration</w>
Com pan
Child ren
C l-
BM T</w>
B ody</w>
Acet aminophen</w>
A A
8 9
8 8%</w>
7. 3</w>
6 3-year-old</w>
4 9.
3 80</w>
3 1%</w>
2n d</w>
200 1</w>
200 ,</w>
20 .</w>
2 6,</w>
12 2</w>
12 00</w>
12 .</w>
10 9</w>
10 6</w>
1 -induced</w>
0. 3,</w>
- /-</w>
(p =
(ST Z)-induced</w>
(SH R)</w>
(S R
(N a
(MR I)</w>
(DE S)</w>
(9 %)</w>
(10 (-
(1 7%)</w>
( 0</w>
zym e</w>
worl d
whe re
ver s</w>
ven s-
vens- Johnson</w>
vacu olar</w>
ursodeoxychol ic</w>
uncer tain</w>
tw o,</w>
transcript ase</w>
tra it</w>
tolu ene</w>
to remif
tho rough</w>
thalidom ide.</w>
ta in
swim ming</w>
stabil iz
st ret
st ain</w>
specti ve,</w>
spec ulate</w>
somnol ence,</w>
solu tion,</w>
situ ation</w>
serv ice</w>
seg ments.</w>
ro cur
ris ing</w>
ribavir in.</w>
reviewe d,</w>
ret te
ren dered</w>
remain der</w>
relie ve</w>
rel in</w>
reinforce ment</w>
rehabil itation</w>
regul ates</w>
re mitted</w>
rac lopri
r ing
r -
quinol ones</w>
quanti ty</w>
qualit atively</w>
qualit ative</w>
py ruv
pseudolith iasis</w>
propofol -
prim ate</w>
pot ence</w>
posi tive,</w>
plan ch
phot on</w>
phenter mine</w>
phen oxy
ph ine</w>
perio dic
perform ance,</w>
pan cytopenia</w>
pal ate</w>
p g/m
p )</w>
ox o-
opioid -induced</w>
ophthal m
op posed</w>
one- third</w>
one ;</w>
on cology</w>
ol im
obj ect</w>
nortript yline</w>
nor -
nom ifens
nitrofur antoin</w>
nitro sou
neuroten sin</w>
n ous</w>
myo fibrillar</w>
minut es)</w>
mid -
micro gli
mic e:</w>
mg/m 2).</w>
mg/ d.</w>
mg. /
metho do
me fen
mas k</w>
lun gs</w>
lium- 201</w>
lin es.</w>
iso enzyme</w>
ip olar</w>
intra arterial</w>
integr ated</w>
insp ired</w>
innerv ation</w>
ing i
ine- evoked</w>
induc ed.</w>
individu als,</w>
in sensitive</w>
imidazol ine</w>
ifosf amide,</w>
hyperprolactin aemia</w>
hyper locomotion</w>
hydroneph rosis</w>
high- performance</w>
hemat uria.</w>
habit ual</w>
h lor
graft- versus-host</w>
gene- related</w>
g/ day</w>
g ),</w>
furosem ide.</w>
for ty-
fe ver.</w>
fam oti
fam ili
extra hepatic</w>
exten sor</w>
exce ed</w>
et oric
est rous</w>
epsilon -
en ic</w>
em ,</w>
earli er.</w>
dyskinesi as,</w>
dist en
digit alis
diff usion</w>
diarrho ea</w>
dexamethas one,</w>
derivati ves.</w>
dec re
cyt open
culos keletal</w>
cop per</w>
contra indicated</w>
consequ ences.</w>
confir ming</w>
con stitute</w>
compromis e</w>
compoun d,</w>
comparis on,</w>
chem istry</w>
che lation</w>
categor ies</w>
cas es),</w>
carri es</w>
capsul es</w>
capsaic in,</w>
ca re,</w>
bi di
beta 2-
bec omes</w>
b /
av o
ati tis.</w>
arth ralgi
arteriol es</w>
arrest ,</w>
aor ta
anticoagul ants</w>
anorex ia,</w>
analy ses.</w>
an te
alkal in
agon ism</w>
age ment</w>
adhe rence</w>
ab use
a per
a kinetic</w>
[ SD
Z n</w>
Warfar in</w>
Ven ous</w>
U F
Trem or</w>
Thrombo tic</w>
Tac hy
T A</w>
Sud den</w>
Ste vens-Johnson</w>
Stand ard</w>
SH R.</w>
S ul
S tri
Rif amp
Q )</w>
Prac ti
Per io
PT X</w>
PK C
PH T</w>
PA N-
P ediatric</w>
Ne ur
Nause a</w>
N ig
M ar
Li -
Intr alip
In duced</w>
IC P</w>
I- II</w>
Hepat ocellular</w>
Hemat ologic</w>
Halo perid
H S
H D-
G ram
G R</w>
Func tional</w>
E pid
DE S-
DBA/ 2</w>
D an
D S
Contro lled</w>
Consider ing</w>
C utaneous</w>
C um
C s.</w>
C oc
C 3</w>
ANCA -positive</w>
AD M</w>
A ra
9 0-
8. 3</w>
6. 4</w>
6 8-year-old</w>
6 7-year-old</w>
5-H I
5 3-year-old</w>
5 24
5 00
5 -10</w>
4 7-year-old</w>
3 60</w>
3 %.</w>
29 )</w>
20 ).</w>
14 2</w>
13 6</w>
13 3</w>
10 3</w>
10 /
1 12</w>
0.0 2),</w>
0. 12</w>
.0 1)</w>
(p =0.00
(P< 0.05)</w>
(NO S)</w>
(N E)</w>
(MT D)</w>
(M I)</w>
(CS F)</w>
(A OR</w>
(2 5-
(1 :
(1 6</w>
( hazard</w>
( days</w>
( average</w>
( adjusted</w>
( 8-
( 0.00
warr ant</w>
veloc ities</w>
variabl es,</w>
v ect
ust ine</w>
uni variate</w>
uncerta in.</w>
un recognized</w>
un if
un fractionated</w>
transpl ants</w>
transf usions</w>
tivi ties</w>
termin ating</w>
te leph
te -
taper ing</w>
ta ined,</w>
t ing-
sw ol
sur ge
suffici ently</w>
sub stitu
stre am</w>
stiff ness</w>
step wise</w>
step -
spac e.</w>
sp ray</w>
sirolim us.</w>
side- effects,</w>
ser ially</w>
seoful v
se ven
run ning</w>
riz atriptan</w>
rist ol-
ristol- My
ristol-My ers</w>
risperid one-induced</w>
ri vas
resul t,</w>
resem bled</w>
re started</w>
re distribution</w>
re challenged</w>
raniti d
random ization</w>
r hi
quinol one</w>
quin idine,</w>
pyraz in
psych i
prilo caine</w>
present ations</w>
pre eclamp
pr act
potassi um-
pop ular</w>
platele t-
planch nic</w>
pl ate
perind opril</w>
peri ventricular</w>
path ology.</w>
p- chloro
p il
p ass</w>
p =0.0
ox et
over use</w>
ost ri
osc ill
orb it
or =</w>
oph armac
om asti
olytic- uremic</w>
of ur
ococc us</w>
ochemic al,</w>
occl uded</w>
non- invasive</w>
non competitive</w>
nodos um</w>
nigr al</w>
ng/ mL</w>
neutr al</w>
neuropath ological</w>
n um
multi drug</w>
mou th,</w>
month s;</w>
mono therapy,</w>
mon omorphic</w>
modafin il</w>
mmol/ l</w>
mio sis</w>
min d</w>
micro L</w>
me trex
me q/
mb le</w>
manifest ing</w>
lup us-like</w>
los ses</w>
limit ing.</w>
limb s.</w>
leuk emic</w>
lepro sy</w>
le i
lei omy
jec tions</w>
is ox
irradi ation.</w>
intr at
ini i</w>
inhibi tion,</w>
influ x</w>
in struc
in put
in 's</w>
impai red.</w>
hyperlipide mia</w>
hyper nat
hyper bilirub
hy pop
hom ocyste
hist one</w>
glomeruloneph ritis.</w>
gener ate</w>
gall stones</w>
form ,</w>
flow s</w>
fl up
fix ed-dose</w>
filgr astim</w>
fe lodipine</w>
exist ed</w>
ev ening</w>
estradiol -17</w>
erro r</w>
equi potent</w>
equ imolar</w>
epidemio logical</w>
ep silon</w>
enti rely</w>
enox acin</w>
enc ies.</w>
emphasi zed.</w>
el uting</w>
ec gon
e jac
dp /d
doxy cycline</w>
dos ages.</w>
disturb ed</w>
discus sion</w>
diaphrag m</w>
dend ritic</w>
deliri um,</w>
d- tubocurarine</w>
cycl ing</w>
cont ains</w>
construc ted</w>
consist s</w>
concl usions</w>
con fig
col um
clo x
clio quin
clam p</w>
citalopram .</w>
cirrho tic</w>
ce ton,</w>
cath ep
carcin ogenicity</w>
carb oxyl
car inii</w>
calcul ated.</w>
cal bind
bum in</w>
bul bar</w>
brady kinesia</w>
bl urred</w>
bio log
beta- end
beta 1</w>
avo ide
autis m.</w>
attenu ating</w>
attac k.</w>
atracur i
atherosclero sis.</w>
at tained</w>
at or.</w>
ast ric</w>
as certain</w>
arti ficial</w>
anti dot
an a</w>
amygdalo id</w>
amide s</w>
am isol
alpha -</w>
allopurin ol</w>
alf a-
aldo ster
al ive</w>
act ual</w>
ac it
ac cordance</w>
ab str
[ OR
Z e
VPA ,</w>
Ultra structural</w>
Twenty- eight</w>
There fore</w>
T- wave</w>
T c</w>
T BP
Syst em</w>
Swe dish</w>
Sprag ue</w>
SOUR CE
S tim
S le
R i
R ,
Prol actin</w>
Prin ceton,</w>
Phen yl
Phen obarbital</w>
PR A</w>
NMD A-
N o
N J)</w>
Min oxidi
Met oclop
MT )</w>
M g</w>
M O</w>
LV F
LT G</w>
LD 50</w>
L-DOPA -induced</w>
K .</w>
Im pres
Im paired</w>
I/ II</w>
I bu
I D</w>
Hz )</w>
Ho wever</w>
H en
H /
Gl u</w>
GM- CSF</w>
GB M</w>
G L
F rench</w>
F as
F /
E S</w>
Do se
Dipyridam ole</w>
D RE
D G</w>
Cum ul
Compan y,</w>
Ci meti
Cef triax
CT /
CG RP</w>
C l,</w>
B ristol-Myers</w>
B lock
B enz
B F</w>
Az athiop
Anti arrhythmic</w>
An th
Ag e</w>
Ad ju
AT 2</w>
A UC
A P)</w>
A K
A E</w>
9 7
8 -1
7 6%</w>
7 3-year-old</w>
7 -1
6. 8</w>
6 6%</w>
5 9-year-old</w>
5 7%</w>
5 6%</w>
5 50</w>
30- year-old</w>
3 5.
3 2
200 -
2- 4</w>
19 )</w>
16 5</w>
15 ),</w>
13 2</w>
13 ).</w>
1 50
1 13</w>
1 1.5</w>
- controlled</w>
) -1-
(i e,</w>
(SE ).</w>
(OH)2 D
(OH) (2)
(3 0%)</w>
(2) 17
(+/ +)</w>
( Y
( 0
% /
y el
warfar in-associated</w>
vertig o</w>
ure ly</w>
unilater ally</w>
unchang ed,</w>
ulcer ation</w>
ul inum</w>
tuberculo us</w>
trigg ers</w>
treatment- emergent</w>
trans port
trans forming</w>
to genic</w>
tilit y,</w>
theophyll ine,</w>
tamsulos in</w>
ta p</w>
swol len</w>
support .</w>
supplement ation.</w>
sup ras
sup ply</w>
sulf adi
spi ro
somatos ensory</w>
sol ved</w>
sleep .</w>
sl udg
situ ations</w>
single -dose</w>
si s-
scinti graphy</w>
sacchar in</w>
s.c .
s of
row n</w>
riton avir</w>
relationshi p.</w>
recru it
record s.</w>
reat h</w>
re si
rat s;</w>
rat s)</w>
punct ate</w>
pu pil</w>
psori atic</w>
promis e</w>
prolong ation,</w>
profen ,</w>
pressu res,</w>
pren olol</w>
pre cl
post operatively.</w>
polymorph ous</w>
poly myositis</w>
poin t.</w>
plas tin</w>
pheochromocyt oma</w>
pert urb
particip ating</w>
panc reas</w>
pa uc
p al</w>
over activity</w>
ov an
outcom e,</w>
ous -
oste op
osmolal ity,</w>
orb ent</w>
omat ous</w>
om b
olog ic,</w>
ob sc
nucle us.</w>
non- ionic</w>
non oliguric</w>
nifedi pine,</w>
negati ve,</w>
ne l</w>
nar row</w>
myocardi tis.</w>
myo pathic</w>
my dri
mon ophosphate</w>
minut e,</w>
minim izing</w>
microg/ mL</w>
mes en
me ter</w>
man ual</w>
mal formation</w>
load ,</w>
lisin opri
le ak</w>
kin ase,</w>
it ari
intr ag
intoler ant</w>
influ encing</w>
individ ually</w>
in- like</w>
in otrop
in al,</w>
ico plan
ic )</w>
ibuprofen .</w>
ib b</w>
hypo vol
hyperten si
homogen ates</w>
hi r
hex achloro
hepat ocytes.</w>
hemoglob in,</w>
hemat uria,</w>
hem olysis.</w>
h ot
gri seofulv
gr al</w>
glomerul i.</w>
gland ular</w>
gentamic in,</w>
gain .</w>
fol i
flu id.</w>
fibr e</w>
fet us</w>
f usi
f resh
ey es.</w>
exerci se-induced</w>
examp le,</w>
exacerb ates</w>
erec tion</w>
epo prostenol</w>
enc es,</w>
emph asis</w>
electr ically</w>
doxep in</w>
double-bl inded</w>
dopa ,</w>
dizocil pine</w>
discrimin ate</w>
dis c</w>
dip lop
difficul ties</w>
diazepam -induced</w>
di ver
depart ment.</w>
defic it
daun omycin</w>
cyt es.</w>
cy cle,</w>
creatin ine.</w>
conscious ness.</w>
comple ting</w>
com posite</w>
col lateral</w>
cocaine- seeking</w>
cl ind
cimetid ine.</w>
chlorambuc il</w>
cel ecoxi
catheter .</w>
cas pase-
cap s
bur sts</w>
broad- spectrum</w>
beta- receptor</w>
bet ween-
be fore
bas olateral</w>
avoid ing</w>
aur a</w>
ator vastatin</w>
atax ia.</w>
aspir ation</w>
arter y,</w>
appropri ately</w>
apar t</w>
anteced ent</w>
antagon izing</w>
anat omic</w>
an )</w>
amp icillin</w>
ami k
am ox
alpha 2-
algesi c</w>
al end
agonist )</w>
ad ural</w>
acetaminophen ,</w>
ac alce
aber rant</w>
a em
We b
TH P</w>
T W
Stud y.</w>
Scal e.</w>
STZ -
SE M)</w>
S h
S B
R g
Oxid ative</w>
Organ ization</w>
Nifedi pine</w>
NSCL C.</w>
N E
Man agement</w>
M elat
M I.</w>
Li ke
L- Dopa</w>
L ack</w>
Jap an.</w>
Intrac ranial</w>
In dian</w>
I D)</w>
Haloth ane</w>
HV A</w>
H I
H CO
Flu oxetine</w>
Fl uc
F DA</w>
Ery thro
E O
Do gs</w>
DN A-
D oc
Cumul ative</w>
Cap top
CP Z</w>
CI -
C och
BH T</w>
Anth rac
AI N</w>
A qu
A gg
A :</w>
9. 2</w>
9 %;</w>
8. 7</w>
7 4-year-old</w>
6 4%</w>
6 %;</w>
5- az
4 9-year-old</w>
4 7.
4 7%</w>
3 7%</w>
3 5,</w>
3 2.
3 1.
3 %;</w>
2 B</w>
15- 45
12- lead</w>
1 1).</w>
1 %;</w>
0. 8%</w>
0. 13</w>
- in</w>
- exposed</w>
(R R
(EP S)</w>
(E R
(D H
(AR F)</w>
(A LT)</w>
(8 %)</w>
(1 ),</w>
( dd
zidovud ine.</w>
z af
xim e</w>
wor k-
wh en
ver ified</w>
vasospas m.</w>
vasodilat ing</w>
vascular ,</w>
van illo
vacuol es</w>
use s.</w>
ultras oun
two fold</w>
transi ent,</w>
tran sp
tib ial</w>
thrombo plastin</w>
thir ty-
test )</w>
tas k,</w>
tamoxif en,</w>
tac h
t ness</w>
t ent
symptomat ology</w>
sym metr
sulf ox
sulf hydr
sulf asalazine</w>
su perim
stric t</w>
star tle</w>
stain ing.</w>
st age,</w>
spre ad
splen ic</w>
sple en</w>
sp ine</w>
small ,</w>
sit y-
single-bl ind</w>
similar ity</w>
sign al
ser opositive</w>
sep sis.</w>
semi -
s.c .,</w>
s planchnic</w>
s car
ros s
ri es</w>
retard ation,</w>
resum ption</w>
restric tive</w>
replac ement.</w>
ren ovascular</w>
reli eving</w>
regul ation.</w>
reac he
re appeared</w>
ras h
rang es</w>
quinpi role</w>
quanti fication</w>
pup illary</w>
pul sati
provoc ation</w>
prot amine</w>
prolifer ation,</w>
progres sion,</w>
pro arrhythmia</w>
pris ingly,</w>
predis position</w>
prazos in,</w>
pr am
post transplant</w>
posi tive.</w>
plasmaphere sis</w>
perfor ant</w>
percent ,</w>
per c
peak -dose</w>
pal li
p ill</w>
p estic
ox ide-
oste omyeli
ost om
os ,</w>
oper ation.</w>
open- chest</w>
on es,</w>
of loxacin</w>
od ol
octre oti
oci al</w>
o plas
nor floxacin</w>
non hematologic</w>
non cardiac</w>
neuro endocrine</w>
neon ate</w>
nec rop
mumol/ kg</w>
mon ocyte</w>
moder ate-
moder ate,</w>
mg/m(2 ),</w>
mg/ d,</w>
methohex it
mes alazine</w>
membrane- bound</w>
mechanism (s)</w>
measure ments.</w>
mat uration</w>
malignanc y.</w>
malform ations.</w>
mal ine</w>
loxac in-induced</w>
long- standing</w>
lo z
l ution</w>
l li
l aryng
iodi de</w>
intraven ously,</w>
intracerebroventric ularly</w>
ing ),</w>
ine- based</w>
immunosuppress ant</w>
immun ocyt
imipr amine.</w>
im mer
identifi able</w>
ib i</w>
ian -like</w>
i. m
hypothalam us</w>
hypocal cemia</w>
hyperexcit ability</w>
hype remia,</w>
hybri d</w>
hom ovan
high light</w>
hepati tis
hel d</w>
hear t-
guan eth
gr ap
glucocortico id-induced</w>
glit az
gastrocnemi us</w>
gamma-glutam yl
g et
furosem ide,</w>
frac tion.</w>
fluoxet ine,</w>
extrem ities.</w>
expand ed</w>
excl ude</w>
eu than
eth oxy
es citalopram</w>
enlarg ed</w>
enc ap
en ge
em ptive</w>
el ,</w>
e a,</w>
dop amine.</w>
diatrizo ate</w>
di am
demyel ination</w>
de man
dd I</w>
d .)</w>
d -induced</w>
cyt arab
cor responded</w>
consum ing</w>
consci ous,</w>
compoun d.</w>
compl aining</w>
col lo
co ordination</w>
co ordin
chloro procaine</w>
chloro -
child ho
chamb er</w>
chall enge
centr e</w>
candi dates</w>
ca ver
c oc
c ity</w>
but ,</w>
bromocript ine.</w>
blo od.</w>
biopsy- proven</w>
bi v
beta x
ben cl
ballo on
azol ine</w>
at or,</w>
ascit es,</w>
as y</w>
as par
arb azine</w>
ar sen
ar ms.</w>
appreci able</w>
apolipo protein</w>
anticip ated</w>
anti histamine</w>
anti fungal</w>
angiograph y,</w>
ane ously,</w>
analgesi a,</w>
aminotransfer ase,</w>
am ibi</w>
albu min,</w>
aff initi
af loxacin</w>
adriamyc in-treated</w>
adreno receptor</w>
ad duct
accur ately</w>
ac up
ac erb
abnormal ity.</w>
ab rupt
a etiology</w>
[Ca2+] i</w>
Web ster</w>
W eight</w>
W R
VN B</w>
Un til</w>
Un fortun
Thirty- six</w>
Td P.</w>
T ra
T 3</w>
Sur ve
Squ ibb</w>
Sou th</w>
Signific antly</w>
Sequ ential</w>
SOURCE S:</w>
R enograf
R TI
Prostagland in</w>
Previ ously</w>
Pre- treatment</w>
Praz osin</w>
PGI 2</w>
P gp</w>
P 1</w>
Out comes</w>
Ou ab
Obj ective</w>
Nitro prus
Neutropen ia</w>
Na (+)</w>
NT S</w>
N '-
Multicent er</w>
Met abolic</w>
Mes na</w>
Mechan isms</w>
MR P2</w>
MIB G</w>
M od
M ental</w>
M c
Like wise,</w>
Li ke</w>
II I.</w>
Hg ).</w>
Ha emo
HIV -positive</w>
H ipp
H L</w>
GY KI</w>
Flumazen il</w>
F ul
Ex acerb
Epid ural</w>
E AC
Diagno sis</w>
DRE SS</w>
DNA ,</w>
D-penicill amine.</w>
D X</w>
D A-
Con sistent</w>
Cis platin</w>
Ch est</w>
CYP2D 6</w>
CA P</w>
C ho
C arcin
C PA</w>
Bar r</w>
B W</w>
B -induced</w>
Angiotens in</w>
Angiotens in-converting</w>
Ana esthe
Adriam ycin-induced</w>
Ab s
AB T-
A ER
>/ =
9. 4</w>
9. 3</w>
9 -1
80 1</w>
8 3%</w>
7 3%</w>
7 %;</w>
6. 6</w>
50- year-old</w>
5 8%</w>
5 4%</w>
3- PP
3 rd</w>
3 A</w>
2 2,</w>
16 ).</w>
15 00</w>
1. 0%</w>
1 20
0. 6%</w>
0. 16</w>
0. 10</w>
(V T)</w>
(T R
(PR L)</w>
(P D
(P B)</w>
(N =
(H AM-
(G P
(F K
(DO X
(C R)</w>
(A TR
(1 1%)</w>
( which</w>
( cumulative</w>
( SI
( METH
( 7.5</w>
( 7-
' .</w>
% ]</w>
yl ic</w>
year -
y ed</w>
y e</w>
x in</w>
weigh t-
weigh ed</w>
w ri
ver m
ventric le,</w>
ve ins</w>
vastat in.</w>
vascul ature</w>
vag otom
vag in
ur aemic</w>
up .</w>
unex pect
undesi rable</w>
trast uz
transpor ters</w>
tra in
thal lium-201</w>
tetrahydro cannabin
tetrac aine</w>
ter ans</w>
t .
supple ment</w>
sumatript an.</w>
sulf ate.</w>
studi ed:</w>
stro ke
stead ,</w>
stand ard
six -
si s).</w>
sett ing,</w>
sens ations</w>
self- administration.</w>
se st
s cler
rupt ured</w>
respon ds</w>
rel ating</w>
reg ained</w>
ratio .</w>
quin one</w>
question ed</w>
pul ses</w>
pub er
propag ation</w>
pro drug</w>
pri v
prescri ptions</w>
pregnan cy
post treatment</w>
porphy ria</w>
phosph oro
phenter m
per tin
per one</w>
pel le
peg interferon</w>
pe ti
path olog
paren chy
par ap
pap illo
or y.</w>
or aph
or an
opo rosis</w>
oni um-induced</w>
ol ing</w>
ol in</w>
ol ic,</w>
oin tment</w>
occ up
nur sing</w>
nicot ine-
newbor ns</w>
neuropath ies</w>
nerv es.</w>
neon ates.</w>
ne a,</w>
mumol/ L</w>
mul tic
micro l</w>
micro l)</w>
mg/m2/ d</w>
methylenedi oxy
ment ary</w>
me si
mar row
ma y,</w>
ma pro
m as</w>
m ang
ly ;</w>
leuk ocytoclastic</w>
leuk em
latano prost</w>
ker at
ish ment</w>
iox aglate</w>
intra striatal</w>
intoxic ation,</w>
inten tion
insi di
inhibitor -induced</w>
inflam ed</w>
infiltr ates</w>
ine- 3-
ine mia.</w>
implant ation.</w>
immun ocom
im poten
im ply</w>
ill ic</w>
ild en
i 's</w>
hypomagne semia</w>
hypo plasia</w>
hyperplasi a,</w>
hypercalce mia,</w>
hyper kine
hour ly</w>
hist ochemical</w>
high er,</w>
heterogene ity</w>
hepat omegaly</w>
har ve
guine a-
gravi s.</w>
go rous</w>
gi t</w>
gest ation,</w>
genotyp es</w>
gene sis.</w>
g ingi
foun d,</w>
formal in-induced</w>
flexi on</w>
fist ula</w>
fe eling</w>
f und
est ram
es -
enalapri l,</w>
embry os.</w>
embol ism.</w>
elim inate</w>
elev ated,</w>
el ast
ede ma
ect op
ec onomic</w>
e zetimi
e in</w>
dys function
drug 's</w>
dra w</w>
dimen sion</w>
diab e
dexamethas one-treated</w>
determ ined,</w>
design ,</w>
depend ency</w>
degener ation,</w>
def ective</w>
de smo
d 4
cy tidine</w>
criter ion</w>
countri es</w>
corticosteroid s,</w>
confir me
comp et
common est</w>
col onic</w>
coincid ed</w>
coch le
cilost azol</w>
characteris ed</w>
caud ate-
cat arac
cardio protection</w>
carboplat in,</w>
caffe ine-induced</w>
c ation</w>
bri um</w>
brety lium</w>
bir th
bind ing,</w>
barbitur ate</w>
bac te
aug ments</w>
ass ays.</w>
ass ay,</w>
arthr algia</w>
arteriosclero tic</w>
arterio graphy</w>
approach .</w>
app ed</w>
apomorph ine,</w>
ap ular</w>
ap s</w>
analogu e,</w>
anaestheti sed</w>
amp ut
amp icill
all .</w>
agon istic</w>
age ;</w>
age :</w>
aff ili
adhe sion</w>
adenocarcin oma.</w>
acid )</w>
absc ess</w>
a re,</w>
Z -
U L
Toge ther,</w>
Thirty- two</w>
Th iop
TN )</w>
TCD D</w>
T -induced</w>
Surg ical</w>
Str uct
St age</w>
S ilden
S c
S C)</w>
Reco gn
Random ized</w>
PF C</w>
P SA</w>
P O</w>
O V
Nig er
NS ),</w>
NO AR
NF- kappaB</w>
N ec
Mg (2
MPO- ANCA</w>
MA )</w>
M MP
Lip id</w>
J ,</w>
Import antly,</w>
HBeAg -positive</w>
H P
GP i</w>
G TN
G F)</w>
Fos -
F ocal</w>
F ab
Exacerb ation</w>
Ex cept</w>
Enal april</w>
EE G.</w>
Double -bl
Dic lofen
DR G</w>
DO PAC</w>
DESIG N</w>
D BP</w>
Cyclo spor
Con centr
Comp uted</w>
Cardi omyo
Can ad
CA .</w>
B us
Amin o
A(2 A)
A pop
A ff
A )-
9. 7</w>
8. 8</w>
8. 6</w>
7-N I</w>
7 9%</w>
60- year-old</w>
55,212- 2</w>
5. 9</w>
5-F luoro
5 th</w>
5 5-year-old</w>
40- year-old</w>
4 7
4 6-year-old</w>
4 4%</w>
30- min</w>
3- h</w>
3- fold</w>
3 7-year-old</w>
3 6-year-old</w>
24 )</w>
200 4</w>
200 3</w>
2 3-year-old</w>
2 2-year-old</w>
2 2)</w>
1: 1</w>
199 4</w>
19 6
18 ).</w>
15 4</w>
14 .</w>
12 9</w>
1- receptor</w>
1 19</w>
1 11</w>
) ].</w>
(Tax ol;</w>
(S P
(S HR
(P L
(M B
(D X
(Cs A)</w>
(4 0%)</w>
(3) H]
(2 2%)</w>
(2 0
(1 000</w>
( six</w>
( chi
( 5-FU
" .</w>
when ever</w>
well- recognized</w>
wean ing</w>
wat er)</w>
warfar in,</w>
wan n</w>
ventro medial</w>
valpro ate-induced</w>
v oric
v ice</w>
utili zing</w>
ure ter
un wanted</w>
un iform</w>
un affected.</w>
ulo pathy.</w>
twice- daily</w>
twent y</w>
triam cin
trem ulo
trans mit
tract us</w>
tr amine</w>
thr ice</w>
thio guanine</w>
them ,</w>
tend on</w>
temozolom ide</w>
te g
tac rine</w>
t ris
t ing,</w>
synerg is
sulf ate,</w>
subcut aneous
sub endocardial</w>
sp on
sol itari
siz e.</w>
sign al-
sic k
sh are</w>
sed ati
secre tion,</w>
sco res.</w>
scat tered</w>
sar coma.</w>
ronedar one</w>
ron tal</w>
ric ket
ri ses</w>
rewar ding</w>
rese mble</w>
res h</w>
renz ep
remo val
relim b</w>
reflex .</w>
re present
re challenge.</w>
quinol ine</w>
psychos ocial</w>
prolifer ation.</w>
profes sion
pro thrombotic</w>
practition ers</w>
potenti al,</w>
possib il
poly drug</w>
play ing</w>
placebo -treated</w>
pil si
physostigm ine.</w>
phleb itis.</w>
phenyl alanine</w>
phent ol
pharmac eutical</w>
percent ),</w>
pe op
patch es</w>
pa ins</w>
pa in-related</w>
p amid
over come</w>
other s.</w>
ot an</w>
orig in
opi ates</w>
one ).</w>
olig uria</w>
ob taining</w>
o estrogen</w>
neuroblast oma</w>
nal bu
n ose</w>
myelo pathy</w>
myalgi as</w>
muscl es,</w>
mou th
morph ologically</w>
month ,</w>
mo tiv
mmol/ kg</w>
mixt ures</w>
mineralocortico id</w>
micrograms/kg/ min</w>
micro cephal
mg/m(2 ))</w>
mg/d l)</w>
mg/d L.</w>
mg. kg-1.
melat on
mal a
mac ulop
ma st
lun g,</w>
load .</w>
lit ers</w>
levo bupivacaine</w>
lat e,</w>
las go
lasgo w</w>
large -
lac tam</w>
l ar</w>
kind ling.</w>
iter pen
investig ation,</w>
inj ectable</w>
initi ation.</w>
ini um-
ing re
inc o
in- mediated</w>
in in</w>
impl ant</w>
ifosf amide
ic /
hypocap nia</w>
hyperkal aemia</w>
hypercholesterol emia</w>
hyper triglyceride
hydroxy- 3-
hydroxy but
high- density</w>
hemodynam ically</w>
hemo dilution</w>
hear ts,</w>
hap lo
hallucin ations.</w>
gli bencl
gl um
general ised</w>
gen es.</w>
gall stone</w>
fol d)</w>
flu ids</w>
fl an
fibron ectin</w>
extinc tion</w>
examin ations,</w>
ex ci
ever olim
eu phor
eth ane</w>
erro rs</w>
eptid ase</w>
enti ty.</w>
endomet ri
enco ded</w>
en e.</w>
en e-
eme togenic</w>
electr on-
dro ph
dose- effect</w>
donepe zil</w>
docum ents</w>
disturb ance,</w>
dis s
diaz oxide</w>
diaph ore
dex medetom
der s,</w>
depart ments</w>
dementi a.</w>
defect .</w>
de d-release</w>
cytot oxic
cypro mine</w>
cre ated</w>
cop e</w>
confir m
compa res</w>
comm enced</w>
co enzyme</w>
clear ances</w>
cisplat in-induced</w>
cin acalce
catalep sy
cardio selective</w>
carb im
bo th
ble omycin</w>
bio availability</w>
beta ,</w>
backgro un
bab ies</w>
b reath</w>
b am
ax illary</w>
ax etil</w>
avir in</w>
ativel y,</w>
aster ixis</w>
aspir in-
asp ect</w>
as :</w>
areas ,</w>
antin ocicep
antibod y,</w>
anti anginal</w>
angiograph ically</w>
anesthetiz ed,</w>
an odine</w>
an ide</w>
an and
aminophyll ine.</w>
aminophyll ine,</w>
allodyn ic</w>
ain -
ain ,</w>
aggreg ates</w>
ag glut
ag al</w>
affiniti es</w>
af f</w>
accumul ated</w>
acceler ate</w>
ac ar
a e,</w>
[SD ]</w>
Ze al
Wee k</w>
Thirty- three</w>
TN F</w>
TH )</w>
TB ARS</w>
T umor</w>
T ime
T en
T S</w>
T 4</w>
Sch wann</w>
SUBJECT S:</w>
S ot
Ran iti
RB C</w>
R ib
Propo fol
Pot assi
Pa CO2</w>
PP H</w>
PB N</w>
PAN -treated</w>
P 450
O LT
Nitroglycer in</w>
N-nitro sodi
N- methyl
MM F</w>
LE V</w>
L- type</w>
J aundic
In di
IV .</w>
ISO -treated</w>
II -
IGF- I</w>
ID 50</w>
I T)</w>
Hipp ocamp
HC V-
H M
Ex peri
Estro gen</w>
Electro physiological</w>
E PO
E F
E (2)17
Disul firam</w>
Dis or
Dex razoxane</w>
DES- exposed</w>
D ist
D PD</w>
Con current</w>
Co- administration</w>
Car bo
CP K</w>
CB D
C riter
C X
C G</w>
Austral ian</w>
Americ ans</w>
Am ifostine</w>
Am B</w>
99 m</w>
9. 8</w>
9. 0</w>
8. 1</w>
7, 8-
6 8%</w>
6 1-year-old</w>
5 2%</w>
4- fold</w>
4 2.
4 2-year-old</w>
25- year-old</w>
2. 8
2. 5-
1- 3</w>
1 6-year-old</w>
1 5-year-old</w>
1 17</w>
00- mg</w>
0.0 5%</w>
0. 17</w>
(SN P)</w>
(N -
(I L
(H IT
(6 00</w>
(4 4%)</w>
(3 5</w>
(1 3.
(1 2.5</w>
(1 2%)</w>
(0. 5
( v
( aged</w>
ym panic</w>
yl ]-
x -
wor sen</w>
wh y</w>
week )</w>
wean ling</w>
wast ing</w>
war m</w>
void ing</w>
vinblast ine,</w>
vascul at
vacu ous</w>
us age.</w>
ure teral</w>
unif orm
uc h</w>
toxic ities,</w>
ting- enzyme</w>
tim es.</w>
ti t
thi x
thalam us,</w>
ter s.</w>
te icoplan
tap ered</w>
tail- tremor</w>
sympath o
suppres sion.</w>
superim posed</w>
successful .</w>
sub o</w>
sub chronic</w>
stom atitis</w>
stand ar
st aff</w>
spik e-
sp ot
sotal ol,</w>
sor afen
so gest
sirolim us,</w>
si al
short -</w>
shap e</w>
sh rin
sett ings.</w>
sest amibi</w>
sequ in
separ ately</w>
sel enium</w>
sc ot
s me
rp 2</w>
rhi z
rest ,</w>
res tim
remis sion,</w>
regimen s,</w>
recurren ce.</w>
re in
radi olab
r one</w>
pro tr
pro mi
prescri p
pre gab
practi ce,</w>
prac tic
plus- maze</w>
pleas ant</w>
pinacidi l</w>
phosphon o
persist s</w>
persist ently</w>
per phenaz
pentobarbital- anesthetized</w>
parkinson ian-like</w>
paren ts</w>
paren chymal</w>
paras it
parallel- group</w>
p ane
pane l</w>
ox on</w>
ox az
orthop edic</w>
orth o
or bidi
oph il</w>
on 's</w>
ol imbic</w>
nutri tional</w>
nucle us,</w>
not e</w>
nitroprus side.</w>
nic oran
neuro active</w>
necessit ated</w>
ne omycin</w>
ne l
ne ar-
nausea/ vomiting</w>
n g)</w>
n as
myelosuppres sion,</w>
myelo dysplastic</w>
mus culoskeletal</w>
monke ys,</w>
mo id</w>
micro M,</w>
mg/m(2 )/
mg/m(2 ).</w>
mg/ day),</w>
mg/ K
methyl ene</w>
met for
meropen em</w>
meflo qu
measure d,</w>
manag ement,</w>
man ic-
maculop apular</w>
macro lide</w>
m oc
long- term,</w>
lip id-
lik re
letharg y,</w>
larg e,</w>
lact ation</w>
l d</w>
l at</w>
kind s</w>
it alop
isoprenal ine-induced</w>
isoniaz id.</w>
isoniaz id-induced</w>
irradi ated</w>
intrapl antar</w>
intim al</w>
interfe res</w>
intens ity.</w>
inher ited</w>
indinavir .</w>
in yl)
in sec
immunost aining</w>
imat inib</w>
ide n</w>
hypothe ses</w>
hyponat remia.</w>
hyperther mic</w>
hyperglyce mia,</w>
hyper reflex
hydr ation,</w>
hr ,</w>
hormon e.</w>
homovan illic</w>
hepar in
haz ard
h /
gy rus.</w>
graf ting</w>
gonad al</w>
glycopyrro late</w>
glutam ate,</w>
glucosaminid ase</w>
genotyp ed</w>
g um</w>
g el
fiel d,</w>
fib rous</w>
fail s</w>
fac ility</w>
extrap ol
ex pen
etoric oxib</w>
eti ology.</w>
estim ation</w>
essen ti
ere bell
erebell ar</w>
enro ll
enrich ed</w>
end- tidal</w>
en abl
electroly tes,</w>
elect ric</w>
effor t</w>
ed ly,</w>
echocardio gram</w>
e f
dysph ag
drug s:</w>
document ed,</w>
dizzin ess.</w>
disorder :</w>
discontinu ation,</w>
discontinu ance</w>
dis solved</w>
dipyridamol e.</w>
didan os
di one</w>
dextr an</w>
determin ants</w>
den si
defin it
defici ency,</w>
decano ate</w>
de sogest
de bil
dd C</w>
day time</w>
d one.</w>
d /
cy ano
cr ypt
cou mar
conver ting-enzyme</w>
control ;</w>
continu ed.</w>
conscious ness,</w>
com orbidi
colchic ine-induced</w>
cogn ition</w>
clioquin ol</w>
chron ic,</w>
channel s,</w>
categ ory</w>
carr ying</w>
cann ula</w>
canc ers.</w>
but yl-
busulph an</w>
bur n</w>
bronchodilat or</w>
bol uses</w>
blo tting</w>
blo od,</w>
betax olol</w>
behaviour .</w>
be it</w>
b un
b a
azol e-
audi ogenic</w>
ato prost</w>
ation -related</w>
aten olol,</w>
ass ay
arthr alg
antipsycho tics,</w>
anti serum</w>
antagon ised</w>
angin a,</w>
anaphyl axis</w>
an uric</w>
alpha (2)-
albu ter
al beit</w>
adriamyc in.</w>
adrenal ine.</w>
adeno virus</w>
activ ity;</w>
acetyl cysteine</w>
[35S] TBP
[ (3)H]
Yor k</w>
With out</w>
Wil son's</w>
Thirty- eight</w>
T x
T MP
T J
Sub st
St ate</w>
SA H</w>
S S
S F
Rel ationshi
RB Cs</w>
Prom pt</w>
Pre clinical</w>
Ph osph
Per icardi
PTU -induced</w>
PIL O</w>
PG- 9</w>
P lac
P i
One -
O I
Nor thern</w>
N P)</w>
N C</w>
Mit ochondrial</w>
Methotrex ate</w>
Melat onin</w>
Measure ment</w>
M- mode</w>
Los s</w>
Li Cl</w>
L ess</w>
L M</w>
K A</w>
Invent ory</w>
Intrac erebral</w>
Inter action</w>
IS P</w>
II I)</w>
IC V</w>
HBV- DNA</w>
G ranulo
G M</w>
FE V1</w>
F uture</w>
F at
Exer cise</w>
Ex tensive</w>
EX P
EC G,</w>
E po
E B</w>
Do x</w>
Do es</w>
Di ff
D (1)</w>
Contro ls</w>
Clo zap
Cl )</w>
Chloro quine</w>
Carbam azep
Captop ril</w>
CYP 3A4</w>
CH D</w>
C oun
Bromocript ine</w>
Block ade</w>
Bac lofen</w>
B or
B IS</w>
Ak t</w>
AQ P2</w>
AID S-related</w>
A plastic</w>
7. 7</w>
7- nitro
7 2-year-old</w>
6 9%</w>
5 2-year-old</w>
5 1%</w>
4 -1
3839 3</w>
3- day</w>
3 H-
3 9-year-old</w>
3 70</w>
3 4-year-old</w>
3 4%</w>
3 2)</w>
3 -</w>
2, 000</w>
2 2-
14 4</w>
13 9</w>
1,25- dihydroxy
0.0 3)</w>
- interstitial</w>
,00 0/
(W K
(T D
(N S)</w>
(IC H)</w>
(AC h
(2. 0</w>
(2 7.
(2 6</w>
(2 3</w>
(1 8</w>
( non-
( mean
( di
( defined</w>
( d)</w>
( alpha-
zidovud ine,</w>
yr )</w>
youn g,</w>
yn thetic</w>
yl )</w>
wor ds</w>
wor d</w>
wid ening</w>
week s),</w>
wa ve
w rit
w k
vinc a</w>
vi sion.</w>
vi able</w>
vanillo id</w>
van ishing</w>
us er</w>
unit s/
unex posed</w>
unevent ful
un myelinated</w>
un de
umb il
ular ly,</w>
ug inos
u ter</w>
typ es.</w>
tum or-
trimethaph an</w>
triamte rene
tri c</w>
tocain ide</w>
ticlop idine-induced</w>
ti ters</w>
ther l
themsel ves</w>
the ory</w>
thalidom ide-induced</w>
temperat ure.</w>
taz idi
suxameth onium.</w>
susceptibil ity.</w>
suppress ant</w>
suppres sive</w>
suppl ied</w>
sugg estion</w>
sub threshold</w>
stimul i,</w>
stereotyp ic</w>
steno ses</w>
sour ces</w>
si es</w>
shif ts</w>
self- report</w>
seizure -like</w>
sed ating</w>
sec tion.</w>
se mis
semis ynthetic</w>
s.c .),</w>
ro ot
righ t-
review ,</w>
resem bles</w>
re min
re jec
radio therapy.</w>
radio active</w>
r ings</w>
r .</w>
questionnai res</w>
provid ers</w>
priap ism</w>
pre ven
poin t,</w>
po t</w>
piper azine</w>
phyl axis</w>
phenylephr ine.</w>
pheno thiaz
persist ed.</w>
periodic ally</w>
peri portal</w>
pent oxif
particip ants.</w>
pan cur
p es</w>
ox yp
ous ness</w>
otep a</w>
osteop oro
oste oporosis</w>
osal ic
organ ophosph
one ),</w>
om ycin.</w>
of ,</w>
ocy an
obj ec
objec tives</w>
nucle i.</w>
noti ce
non sustained</w>
non significant</w>
no tion</w>
neutrophil s</w>
neurotransmit ters</w>
neuro cognitive</w>
ne sted</w>
ne ostri
mye lography</w>
multic entr
mol ar</w>
modifi es</w>
mmHg ;</w>
ml ).</w>
mit ting</w>
min i
min -1,</w>
mimic ked</w>
mid odrine</w>
micrograms/ ml,</w>
micrograms/ ml)</w>
mg/d l.</w>
mg/ l</w>
metast asis</w>
membran es.</w>
me glum
m er</w>
ly s
lu men</w>
low ers</w>
long est</w>
log -
lipopolysacchar ide</w>
limb s,</w>
lim itation</w>
lik ely.</w>
li ve</w>
lev amisol
laparotom y</w>
kin ase-
kal likre
k- alkali</w>
is ons</w>
intrac isternal</w>
interleuk in-
insti lled</w>
insi gh
insec tic
inhibitor )</w>
infu sions,</w>
infarc ted</w>
individu al
ind ole</w>
in- of-
in oc
ill u
ill ain-
il s</w>
hypother mic</w>
hypothalam ic-
hypomagne sem
hydrochlorothiaz ide,</w>
hr s</w>
his ti
hemodynam ics,</w>
hemis phere
hear t
h u
gynec ologic</w>
gly bur
glomerulosclero sis.</w>
gest od
ger m</w>
g k
g aug
form .</w>
follow ing:</w>
fo relimb</w>
flex or</w>
fl ud
fix ed-
fibr inogen</w>
fib ers,</w>
ferri tin</w>
f resh</w>
extra -
extr adural</w>
exten ded-release</w>
expres s</w>
ethan ol-induced</w>
eth yn
et .</w>
estram ustine</w>
establ ished,</w>
es cent</w>
es c
equi val
epsilon- aminocaproic</w>
epilep sy
ep omedi
ens or
encephal itis</w>
encap sul
emb ran
elder ly,</w>
el ed</w>
dys functions</w>
drug- drug</w>
drowsin ess,</w>
dou b
dofe tilide</w>
digox in.</w>
dextro se</w>
detox ification</w>
depres sion
depolar ization</w>
deple tion.</w>
dele tion</w>
de fl
cytos kele
cur cumin</w>
cu t</w>
conce pt
con stitutes</w>
comp uter</w>
commer ci
com posed</w>
coca ine's</w>
coag ulopathy</w>
cholecysti tis</w>
ch ick
cephalor idine</w>
carb imazole</w>
calcul i</w>
but ylated</w>
bis ulf
bind s</w>
bic al
bical ut
beta-carb ol
basel ine)</w>
azathiop rine.</w>
attac ks,</w>
asystol e.</w>
as ym
arri val</w>
arrhyth m
ardi ac</w>
anti bacterial</w>
analo g,</w>
amylo id</w>
amino )
am lodip
am bi
alte red.</w>
all ing</w>
alf a</w>
ag oraph
afterdepolar izations</w>
affili ated</w>
aer uginos
adultho od.</w>
acro le
achie ved.</w>
abund ant</w>
ab used</w>
a -like</w>
X -induced</w>
VE GF</w>
V /
V ).</w>
Un ilateral</w>
Tri meth
Tri als</w>
Tou rette
Tai w
T P</w>
T :</w>
Sur prisingly,</w>
Spec ific
SH R
S- transferase</w>
S ensory</w>
S CL
S B-
S -induced</w>
Re actions</w>
Random ized,</w>
R -induced</w>
Questionna ire</w>
Poin tes</w>
Pharmaco kinetic</w>
Pati ent
PGE (2)</w>
PA ).</w>
Orth ostatic</w>
On set</w>
Ob serv
O -induced</w>
N-nitrosodi ethyl
N K</w>
My co
Mem ory</w>
Maxim al</w>
MTX ,</w>
MP EP</w>
MENT AL</w>
MA ,</w>
M eni
Lo g
L ang
L Y</w>
L EC
K ing
K D</w>
K Cl</w>
Jaundic e</w>
Investig ation</w>
INTERPRETA TION:</w>
I F</w>
Hun ting
Hem olytic</w>
HIV -1</w>
HD L-
HD ,</w>
HC H</w>
H al
H V</w>
H AL
GnR H</w>
Gem cit
Ful minant</w>
Forty- six</w>
F SG
Epi lep
EXP ERI
EXPERI MENTAL</w>
E MB
Doxorub icin-induced</w>
DSM- III-
DBA/ 2
Cur ren
Cor tical</w>
Clin ically</w>
Cholest atic</w>
Cardiomyo pathy</w>
Ca +
CM V</w>
CM F</w>
C ell</w>
C O</w>
C N</w>
B ladder</w>
B K</w>
Am antadine</w>
Addi tion</w>
ANCA -associated</w>
AM PH
A verage</w>
A tropine</w>
A O
A ;</w>
8. 2</w>
8 4%</w>
70- year-old</w>
7 7
7 6-year-old</w>
6 9-year-old</w>
6 7.
6 2%</w>
50 %.</w>
5-fluorourac il.</w>
5-az acy
5-HT 1
5-FU .</w>
5-FU -induced</w>
5- amin
5, 7-
5 3%</w>
40 )</w>
4 th</w>
4 80</w>
4 5,</w>
4 1-year-old</w>
4 %.</w>
3 :</w>
3 2-year-old</w>
2', 3'-
2 );</w>
199 6</w>
199 2</w>
16 4</w>
13 8</w>
12- week</w>
10(- 5)</w>
1. 9
1. 3%</w>
1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine</w>
1- week</w>
1- hour</w>
1- h</w>
1, 0
1 8-year-old</w>
1 7-year-old</w>
1 24</w>
0. 20</w>
0. 14</w>
- fed</w>
- activated</w>
, 0
(NM S)</w>
(H U
(H R),</w>
(H IV
(GF R)</w>
(F D
(D M
(AZ T)</w>
(AU C)</w>
(A d
(3, 4-
(2 7%)</w>
(2 6.
( seven</w>
( four</w>
w t</w>
w indo
windo w</w>
vari es</w>
valpro ex</w>
v .</w>
uro logical</w>
uptak e.</w>
under took</w>
un usually</w>
un bound</w>
umbil ical</w>
typ es,</w>
tro pon
trimethopri m</w>
tric ho
tri phasic</w>
tri mox
tranyl cypromine</w>
transcript s</w>
toxic osis</w>
toxic ological</w>
thyroidis m,</w>
three fold</w>
thio per
tempor arily</w>
te mazepam</w>
tachy arrhythmia</w>
surg ically</w>
struct ur
steroid -
stereotypi es</w>
stere o
step s</w>
st or
st ing</w>
spectro phot
solv ent</w>
sol e
si zed</w>
sha red</w>
ses sions.</w>
ser ologic</w>
sequ ences</w>
sensitiz ation,</w>
self- administered</w>
selec tiv
sedent ary</w>
second s.</w>
scho ol</w>
sc rat
sc )</w>
rout e.</w>
ro su
rivas tigmine</w>
ris k-
retro bulbar</w>
request ed</w>
repair .</w>
relax ants</w>
rel y,</w>
regres sed</w>
reflex ,</w>
re ple
re ar
ration ale</w>
radi ograph
pu er
prot otyp
propranolo l-induced</w>
propi onate</w>
prolong s</w>
prol ide</w>
profession als</w>
prof oun
procain amide,</w>
pra vastatin</w>
poly uria.</w>
poly neuropathy.</w>
poly amine</w>
pindo lol</w>
pill s</w>
pi renzep
phosph ate.</w>
phen ir
pertin ent</w>
perit on
percent ages</w>
per son</w>
per ic
pentylenetetrazol e-induced</w>
pentobarbit al.</w>
pentobarbit al-induced</w>
pentamid ine.</w>
pe floxacin</w>
pattern s.</w>
path ies.</w>
paraly zed</w>
papillede ma</w>
pall idal</w>
pa in:</w>
p =0.00
p 38</w>
over dosage</w>
or ies</w>
oph ageal</w>
oper able</w>
oneuro pathy</w>
one al</w>
ondan setr
om on
olog ist</w>
olec ular</w>
olar yn
off "</w>
ocon vul
oc ap
observ ation.</w>
o proliferative</w>
nystag mus</w>
nucle i,</w>
no reth
nitroprus side,</w>
nif ied</w>
neuropath y:</w>
neph ron
nat ur
narrow ing</w>
na ec
myocardi um,</w>
mul tivari
morph ometric</w>
month s),</w>
mo re.</w>
minip um
mid line</w>
micromol/ L</w>
microangio pathic</w>
micro M).</w>
micro M),</w>
mic ,</w>
mg/m l)</w>
metopro lol,</w>
metabol izing</w>
mes yl
medi ast
me tic</w>
maz e.</w>
mat ur
mark ers,</w>
manic- depressive</w>
m ifeprist
m e</w>
lumb os
loo ked</w>
li sted</w>
li osis</w>
leuk ocytes</w>
leg al</w>
le ver</w>
late- onset</w>
lansop razole</w>
l ess.</w>
l es.</w>
kg ;</w>
k Hz</w>
junc tion</w>
jer ks</w>
ituit ary</w>
ipex ole</w>
investig ational</w>
interview s</w>
insul t</w>
ino si
inges tion,</w>
ine- like</w>
incorpor ated</w>
in one</w>
im pulse</w>
il /
ic v</w>
ia sis,</w>
hyper insul
hydroxy- 2-
hydroxy urea</w>
histor y.</w>
halothane- anesthetized</w>
h ous
h ard</w>
h ),</w>
glutathi one-
gingi val</w>
gentamic in-treated</w>
gangli a,</w>
gadol inium</w>
g estive</w>
g ar</w>
fusi dic</w>
ful filled</w>
fle st
fea sib
fact ,</w>
facilit ates</w>
expect ed,</w>
et odol
erythropoi esis</w>
er s:</w>
er ase</w>
epilept ogenesis.</w>
epi di
epidi dy
ent ec
emphasi zed</w>
elucid ated.</w>
elev ation,</w>
electrocardio gram.</w>
ecgon ine</w>
ec lo
e g
e droph
dyscra sias</w>
drug- resistant</w>
drin k
dra in
disturb ance.</w>
dist or
dist ance</w>
diltiazem .</w>
digit oxin</w>
diff ering</w>
diclofenac .</w>
dialys ate</w>
de ta
d otal</w>
coun ts,</w>
cortis ol-induced</w>
control s)</w>
cont ribu
cont ext
constipati on,</w>
conn ection</w>
conflic t</w>
conf er</w>
com promi
coll icul
co w
co efficient</w>
circu it</w>
chloroqu ine-induced</w>
chloro ethyl
chlor diazep
challeng e,</w>
ch oro
ch arge
cerebell um.</w>
cef azol
cau tion.</w>
carboplat in.</w>
capsaicin- sensitive</w>
byp as
but orphanol</w>
bupren orph
brady kin
br ush</w>
bo ys</w>
beta-end orphin</w>
bet amethasone</w>
benzodiazepin es,</w>
bef radi
beats/ min.</w>
basi lar</w>
b.i. d.</w>
b os
atten tion-
ation s;</w>
ate d:</w>
aspir in-induced</w>
aro x
antihist amines</w>
antidepress ant
anti le</w>
anore xi
angio grams</w>
angi ect
analog ous</w>
an in</w>
alpha- 2b</w>
alpha (1)-
allodyn ia,</w>
agranulo cyto
agit ation.</w>
aff ected,</w>
adv is
ad al
acu ity,</w>
acti vely</w>
absorb ed</w>
absor ption.</w>
abec arn
a pro
] o</w>
Zeal and</w>
Z idov
Z D
V SD</w>
V CR</w>
Un it</w>
URE S:</w>
U/ L,</w>
Toler ance</w>
Ticlop idine</w>
Thromb ocytopenia</w>
There after,</w>
Th at</w>
Tem poral</w>
Tachy cardia</w>
TM S</w>
T re
T issue</w>
T CA</w>
Subj ective</w>
Sub cutaneous</w>
Ster oid</w>
SY N
SYN THESIS:</w>
S pir
S o
S in
S ,
Prote in</w>
Prot ection</w>
Potassi um</w>
Platele t</w>
Pilocar pine</w>
Phenyleph rine</w>
Par t</w>
PAN .</w>
PAN ,</w>
P ic
P PAR
P CR
Oc tre
Ne therl
NK 1</w>
N er
N CT
Mg SO
ME L</w>
Los artan</w>
Lo wer</w>
Lew is</w>
LE .</w>
L is
L P</w>
L N
L AM</w>
K ing's</w>
Inde ed,</w>
Im pression</w>
I K
Hyper prolactinemia</w>
Here in,</w>
HU S.</w>
HC .</w>
H2 O</w>
Gu illain-
G H</w>
Fir st,</w>
Enh anced</w>
En d-
ER K</w>
E stradi
E GF</w>
Dil tiaz
Det ail
De ath</w>
D SE</w>
D MT
D L-
Cy t
Convul sions</w>
C PT
C -induced</w>
Bu t</w>
Bu pivacaine</w>
Ap plication</w>
Anesthe si
Ab out</w>
AM P-
AID S.</w>
A/ J</w>
A x
A typical</w>
A sian</w>
A AP</w>
8 6%</w>
7-nitro inda
6 4-year-old</w>
5-HT 3</w>
5-Fluoro uracil</w>
5 8.
5 7-year-old</w>
4- amin
4 8,</w>
4 6.
3-PP P</w>
3- 5</w>
3,4- dihydroxyphenyl
26 ).</w>
2. 0%</w>
17 ).</w>
14 9</w>
12 6</w>
1. 5,</w>
1. 4%</w>
0.05 ;</w>
0.00 1;</w>
0.0 9</w>
0. 30</w>
0 ;</w>
.00 1),</w>
-M ei
-1 /
)- associated</w>
) ],</w>
(RO S)</w>
(P< 0.01).</w>
(P F
(M PT
(H IT)</w>
(FK 50
(D SM-
(D R
(CY P)-induced</w>
(AT P)</w>
(8 0%)</w>
(7 %)</w>
(4 1%)</w>
(3 6%)</w>
(3 )/
(3 %)</w>
(2 9%)</w>
(2 4%)</w>
(2 1%)</w>
(2 ).</w>
(2 %)</w>
(1 6%)</w>
(0.0 1-
(0. 7
( about</w>
( X
( 5,</w>
( '
ym ph
yiel ding</w>
y ocardial</w>
with dre
well ,</w>
week ly.</w>
warfar in-related</w>
vol emic</w>
vi rus.</w>
ver ing</w>
vel s</w>
vasodilat ors</w>
urin alysis</w>
urethane- anesthetized</w>
univer sity-
un reported</w>
un diagnosed</w>
ultra structure</w>
ub i
u es</w>
tubulo -interstitial</w>
trou bl
trau ma.</w>
topir amate</w>
tom ography,</w>
to- moderate</w>
to id</w>
tion ),</w>
thi otepa</w>
tenof ovir
teleph one</w>
tel angiect
techniqu e,</w>
tax ol</w>
syndrom es,</w>
swe ating</w>
suspect ed,</w>
sulfox imine</w>
sulfhydr yl</w>
sub scale</w>
sub cellular</w>
streng th
stra in,</w>
st ell
st asis</w>
spectro scopy</w>
side s.</w>
si ve.</w>
short ness</w>
seroton in,</w>
ser ine</w>
sequin an</w>
se ter</w>
scleroder ma</w>
scaveng ing</w>
sampl ed</w>
rest less</w>
respon der</w>
res ectable</w>
represent ative</w>
reduc tion,</w>
reco ver</w>
rec ur</w>
reac t</w>
re tained</w>
rate -induced</w>
rat ropium</w>
rac e,</w>
quin oxal
quin ine-induced</w>
quanti ties</w>
propo sed.</w>
program .</w>
prof ylline</w>
produc tion,</w>
procain amide.</w>
proc ou
proc ess,</w>
pro pri
preserv ation</w>
prednis one,</w>
predis poses</w>
post ure</w>
poly uria,</w>
plas ma,</w>
pituitary- adrenal</w>
pide mic</w>
phylococc al</w>
ph ed
paw -
pauc ity</w>
parturi ents</w>
parkinson ism,</w>
pares thesia</w>
par g
pa in
pa id</w>
oxali platin</w>
oxali plat
other ,</w>
os a</w>
op e</w>
omo dul
ologic ally.</w>
oligo dend
oligodend ro
olaryn g
observ ation,</w>
obes ity</w>
ob vi
o edema,</w>
not ably</w>
not ,</w>
neuro toxic
neuro protection</w>
n M</w>
multicentr e</w>
morph ic</w>
mo i
ml -1</w>
mil l
migraineur s</w>
microscop y,</w>
micrograms/ ml.</w>
microg/ rat)</w>
micro -
mg/m 2),</w>
methy ser
methad one-
megal oblastic</w>
mat ching</w>
market ed</w>
m oun
lysos omes</w>
ly so
lut e
lumbos acral</w>
line arly</w>
limit s.</w>
letharg y</w>
lear ning,</w>
lan -Mei
kin d</w>
kidne ys,</w>
ket o-
ke t</w>
k er</w>
k Hz
jump ing</w>
j o
itsel f.</w>
it ance</w>
isoniaz id,</w>
isoflur ane,</w>
iso -
isch aemia.</w>
irin otecan</w>
ir t
ip ratropium</w>
invol ved,</w>
investig ator</w>
intoler able</w>
inter view</w>
inter acts</w>
inter -
intention -to-treat</w>
int ent
insigh ts</w>
inosi ti
ind ap
inclu sions</w>
in izing</w>
in ess,</w>
immunos orbent</w>
im potence</w>
im ide</w>
ifen pro
if entan
ide s,</w>
id )</w>
ia -like</w>
hypot on
hyperkal emia,</w>
hyper cap
hydro morphone</w>
hum oral</w>
hr )</w>
hot -
hept ano
hemi paresis</w>
hemat oma.</w>
hem olytic-uremic</w>
gyr us,</w>
gynec omasti
grow th,</w>
grap h</w>
granulo cytopenia</w>
gram s.</w>
gl ands</w>
g ross
func tions,</w>
follow s</w>
fol d,</w>
fluoroquinol ones</w>
flu vox
ff -
fet us.</w>
ezetimi be</w>
ey e.</w>
ess ation</w>
ere 's</w>
eradic ation</w>
epo etin</w>
enantiom er</w>
en erg
emplo ying</w>
em ents</w>
elic its</w>
eff usion.</w>
e leven</w>
e icos
dys regulation</w>
drug -dependent</w>
dri ven</w>
dose -</w>
diure tics.</w>
dist ant</w>
dissoci ated</w>
din it
diameter ,</w>
den ied</w>
del usions</w>
debil it
de tach
de hydration</w>
de fibrill
datab ase.</w>
da zole</w>
cy r
coun sel
conver sion.</w>
context ual</w>
con nec
compens ated</w>
compar ison
col later
co vari
clon us</w>
clo tting</w>
cli pp
citalopram ,</w>
circu its</w>
cir cl
ciprofloxac in.</w>
chem oconvul
cent ,</w>
cauti ous</w>
cau tions</w>
catheter ization.</w>
cataton ia.</w>
cat s.</w>
cas es).</w>
captopri l.</w>
calci um.</w>
cal f</w>
ca sts</w>
c- Fos</w>
brady arrhythmia</w>
bio assay</w>
beta- blockade</w>
benzo yl
benef it.</w>
az ine-induced</w>
az ana
ate d-
at azana
associ ation.</w>
ar ise</w>
ar is
ar ial</w>
ar ate</w>
appea red,</w>
app ly</w>
antipsycho tic-induced</w>
antimicro bial</w>
anti- arrhythmic</w>
anti thrombin</w>
angio gram</w>
angio genic</w>
amplitu de,</w>
amphet amines</w>
am rinone</w>
alpha- adrenoceptor</w>
all erg
all enge</w>
al cit
al as
ag in
adjust ments</w>
acti ve,</w>
ac .</w>
abol ish</w>
a x</w>
a rom
[14 C]
Youn g</w>
X ).</w>
W A
Valpro ate</w>
Unfortun ately,</w>
Thirty- one</w>
Test o
Tax ol</w>
TT P-
T F
T 2</w>
Silden afil</w>
SC s</w>
S tra
S ar
S AM
Reg ular</w>
Recogn ition</w>
Pro spective,</w>
Par ad
Par acetam
PD ,</w>
PA /
P< 0.05).</w>
P r
P he
Op tic</w>
O tot
Na +/
NP C</w>
NG- nitro-L-arginine</w>
NCT 00
N ot
Meni ere's</w>
Maxim um</w>
Mark ed</w>
Le vels</w>
L HR
L CT</w>
Ischem ic</w>
Intralip id</w>
Inf ants</w>
In tensive</w>
Immunohist ochemistry</w>
IC )</w>
Hyper tensive</w>
Hyper cal
Hg ),</w>
Hepat otoxicity</w>
HIT .</w>
H u
H ET
H )-
Gl yc
GABA ,</w>
G lasgow</w>
G AD
Frequ ency</w>
Fi bro
Fe wer</w>
Fancon i's</w>
Exc essive</w>
Ep o</w>
ED (50)</w>
EC Gs</w>
E tom
Doc etax
De ep</w>
DZ R</w>
DOCA- salt</w>
DO PA</w>
DO CA</w>
D on
D IC</w>
D I
D C
Cap ecit
C u
C essation</w>
C :</w>
BT X</w>
B asal</w>
Ap omorph
Al co
Abs ence</w>
AP L</w>
AD AM
AC h</w>
AC S</w>
A ge
9 3
86 44</w>
8 7
7 7%</w>
7 5-year-old</w>
6- OHD
6 2-year-old</w>
50 00</w>
5-HT 2</w>
5 HT
4 9%</w>
4 6%</w>
3- month</w>
3 4.
3 3-year-old</w>
3 1-year-old</w>
25 %,</w>
24 h</w>
200 6</w>
2. 9
2. 6
2- fold</w>
2 C</w>
2 7-year-old</w>
2 7,</w>
2 6-
2 3)</w>
17beta- estradiol</w>
15-45 13</w>
1417 16
14 ),</w>
12 8</w>
12 1</w>
10- year</w>
1 A
1 0.5</w>
)- treated</w>
(PAN )-induced</w>
(P< 0.001).</w>
(P P
(HC V)</w>
(EM G)</w>
(CY P)</w>
(C I
(B B
(7 5%)</w>
(2 1</w>
(1 8.
(1 ).</w>
(1 )
(0. 3
(-1 ),</w>
(+ )
z ine,</w>
yl- L-
withdre w</w>
week s;</w>
wal king</w>
w t)</w>
vul gar
vis ed</w>
ve /
ve )</w>
vaccin ation</w>
uter o.</w>
usion- weighted</w>
us sis</w>
us ate</w>
us -associated</w>
uromyc in</w>
ur ic
un successful</w>
un restrained</w>
un anesthetized</w>
u lography</w>
troubl es
triamcin olone</w>
tri ple
tri phosphatase</w>
tri az
tremor s,</w>
treatment )</w>
tre t
tret ino
transi t</w>
transcri p
trans mitted</w>
tract .</w>
trac tion</w>
topir am
tizan idine</w>
tion /
ti p</w>
thereafter ,</w>
therap y-induced</w>
ther .</w>
testoster one,</w>
ter s,</w>
ter med</w>
ter -
ten d</w>
tech ne
te d
tax an
tampon ade</w>
ta ins</w>
t ly.</w>
synap tos
symmetr ical</w>
susp ect</w>
supras pinal</w>
supplement s.</w>
subst rates</w>
subst ance
sub sets</w>
ston es,</w>
stit uting</w>
ster nal</w>
stell ate</w>
spro ut
spec ulated</w>
spec ies,</w>
spe ech
sol itary</w>
smok ers.</w>
sludg e</w>
significant ).</w>
side s,</w>
shap ed</w>
seroton in-
sec )</w>
se arch
sarcom as</w>
s.c .).</w>
s. go
rota rod</w>
ri a,</w>
restra in
reser p
relap sing</w>
regurgit ation.</w>
regul ar
refract or
recur ring</w>
recogn i
recipi ents,</w>
reas ,</w>
re ward</w>
re model
re flux</w>
raph e</w>
rap am
raclopri de</w>
r in,</w>
r ar
quetiap ine.</w>
propi on
progest ogen</w>
princip ally</w>
prescri bed.</w>
pre- test</w>
prazos in.</w>
poly ethylene</w>
pi v
physi ology</w>
phy to
phospho inositi
phosphat ase,</w>
phenotyp es</w>
phenel zine</w>
phen id
phen ad
ph as
pg/ ml</w>
peroxid ation.</w>
pentylenetetraz ol-induced</w>
penetr ation</w>
pem ph
pathw ays,</w>
paroxet ine.</w>
palli ative</w>
oxidi zed</w>
oxal ate</w>
over flow</w>
out patients.</w>
ot subo</w>
ot ox
osalic ylic</w>
os ity</w>
ori es,</w>
organ s.</w>
ophthalm op
op ini
op ac
onco log
on om
on itrate</w>
on -induced</w>
ol e.</w>
of ovir</w>
occur ,</w>
oc ol
o- called</w>
o himb
normal ized.</w>
non- diabetic</w>
non- NMDA</w>
nitrogen ,</w>
ni ff
nephro toxic
nat urally</w>
n ine
myoglob in
my ocytes.</w>
must ine</w>
mu g</w>
mon onitrate</w>
mode stly</w>
mitochondri a.</w>
mit otic</w>
mirta zap
mg/kg/ day.</w>
mg/ day;</w>
meth oxamine</w>
medull a.</w>
medi um-
mc g/
manipul ations</w>
malar ia.</w>
m ad
lute inizing</w>
loxac in.</w>
loxac ill
locomo tion,</w>
litter mat
lic king</w>
lib it
li ves</w>
levodopa ,</w>
leu prolide</w>
length ening</w>
leg ic</w>
lea f</w>
le aves</w>
lac ked</w>
it y).</w>
ir rel</w>
investig ates</w>
intest ine</w>
intent -to-treat</w>
intensi fied</w>
inst ability</w>
injec tion)</w>
initi ate</w>
infu sional</w>
in-of- four</w>
in- hospital</w>
in es.</w>
import ant.</w>
implic ations.</w>
il ity,</w>
ic l
hypother mia,</w>
hyponat raemia</w>
hypom ania</w>
hyperten sion:</w>
hyperlipide mia,</w>
hype re
hydrox y</w>
hydro lysis</w>
hydro cephal
hydr alaz
hyd anto
hy pos
hy al
hind limb</w>
high er.</w>
haemo dynamics</w>
haem olysis</w>
group :</w>
gross ly</w>
gri p</w>
granulomat osis.</w>
grad u
gk 1
gen der
g -
function ing.</w>
fru sem
follic ular</w>
flan k</w>
fin aster
fif ty-
faz od
factor ial</w>
f ai
exec utive</w>
excit otoxic</w>
ex foli
estro genic</w>
ere s</w>
equili brium</w>
enzyme- linked</w>
endothel in</w>
endoc annabin
ence :</w>
encapsul ated</w>
en cainide</w>
elim in
elev ation.</w>
eigh t-
effec tiven
echocardio grams</w>
ech o</w>
e min
e "</w>
drug -associated</w>
dou bled</w>
dose- dependent,</w>
distribu tion,</w>
distingu ished</w>
dismut ase,</w>
discus ses</w>
discharg e,</w>
dis proportion
dis position</w>
differenc es.</w>
di git</w>
des flurane</w>
derivati ves,</w>
der gic</w>
deple tion,</w>
demograph ics,</w>
decreas e.</w>
decompens ated</w>
dec ided</w>
dec ade</w>
de mic</w>
dang er</w>
crani otomy</w>
countri es.</w>
cortico ster
contraceptiv es,</w>
contrac tility.</w>
continu ous-
cont amin
conjunc tiv
conf used</w>
comparis on.</w>
commerci ally</w>
comm is
com ycin</w>
col itis.</w>
cohor t.</w>
coca ine-</w>
co- administered</w>
clo b
clob az
clinic ally.</w>
cl usion</w>
cimetid ine,</w>
chole lithiasis</w>
chlorprop amide</w>
chlor thal
ch i</w>
cere bri
cell -
cefot ax
cef tazidi
carcin ogen
carbox ylate</w>
capill aries</w>
c ations</w>
c at</w>
c am
bupropi on.</w>
bu met
bronch opulmonary</w>
bridg ing</w>
break down</w>
bor der</w>
block er.</w>
biv olol</w>
beta 2</w>
benzodiazepin es.</w>
behavi orally</w>
bacter io
b oun
avoide d.</w>
atroph y,</w>
ate /
at ab
asymptom atic.</w>
asthen ia</w>
assum ption</w>
applic ation,</w>
ap noea</w>
ap ir
anxi oly
anti- epileptic</w>
an op
am ine-treated</w>
allograf ts</w>
all yl
al :</w>
aggrav ates</w>
ag astr
aeros ol</w>
adduct or</w>
ad ducts</w>
ad d-
acet ate.</w>
accumul ation.</w>
accoun ting</w>
acc ru
[35S]TBP S</w>
Z n
Y ohimb
V T,</w>
V T)</w>
V L
Un der
U G
Treat ment
Thirty- four</w>
TUNE L</w>
Strept ozotoc
Stim ulation</w>
Sign s</w>
Sensi tivity</w>
SE NT
R- 27
R it
R ac
R 1</w>
Pot enti
Per fusion</w>
PTH r
PC B</w>
P- 450</w>
P ituitary</w>
P S
P M
P CA</w>
Opio id</w>
NS .</w>
Myoclon us</w>
Minoxidi l</w>
Mas sive</w>
MTX .</w>
M id
M ain
M CA
Log istic</w>
L-NAME ,</w>
L ov
L 2</w>
L );</w>
K ),</w>
Ital ian</w>
Intra -
Initi ally,</w>
Inf arc
Im mediate</w>
III B</w>
Hodg kin</w>
Haloperid ol-induced</w>
H US
G E</w>
G AD</w>
G 2</w>
Forty- eight</w>
Fl ecain
F V
Eigh ty</w>
ED .</w>
EC G.</w>
EAC A</w>
E B
Dex medetomidine</w>
DB S</w>
D atab
D :</w>
Colchic ine</w>
Children 's</w>
Chemo therapy</w>
Ca(2+ )-
CT .</w>
COM T</w>
CN U
CI )</w>
C oma</w>
C hem
C TR
C D)</w>
C 1</w>
Br d
BD 10
B re
B DNF</w>
Associ ated</w>
Antin ociceptive</w>
An aly
Alter n
ATP ase,</w>
AR F.</w>
AL L</w>
AC .</w>
A I</w>
A A)</w>
A -treated</w>
9 8
9 2%</w>
7. 2</w>
7 8%</w>
7 6
7 2%</w>
7 1%</w>
6, 7-
6 8
6 1%</w>
58 26
5. 0
5 9%</w>
5 2
48 6</w>
4 8.
4 30</w>
4 3.
4 3-
3 9%</w>
3 8-year-old</w>
3 5-
200 7</w>
20 %,</w>
2. 7
2 9-year-old</w>
2 70</w>
2 3,</w>
2 2
2 1-year-old</w>
19 ).</w>
16 7</w>
16 .</w>
13. 5</w>
11. 8</w>
10 %.</w>
1. 7%</w>
1. 6%</w>
1,25- (OH)2D3</w>
0.00 3).</w>
0. 19</w>
.000 1).</w>
-1, 3-
-1 3
- J
- 0.
, 8
(p H</w>
(P E)</w>
(P A
(ISO )-induced</w>
(IS O)</w>
(IO P)</w>
(E T
(C a
(C K)</w>
(C F
(B UN
(ATR A)</w>
(A ED
(7 0</w>
(2 3%)</w>
(1 5-
(1 3%)</w>
(0.0 1</w>
(0. 15</w>
( max
( groups</w>
( especially</w>
( LT
zaf ib
yclin es</w>
work- up</w>
wor k,</w>
wi der</w>
well- established</w>
well ing</w>
w /
ven tional</w>
vasospas m,</w>
vas culo
val id</w>
un remark
un pleasant</w>
ultrason ography.</w>
ular- weight</w>
ul tr
ud itory</w>
u sions,</w>
tum or
tubul es,</w>
trun k</w>
troubles ome</w>
tro glitazone</w>
trau ma,</w>
transplant ation:</w>
trabec ular</w>
ton gu
to phore
time ly</w>
ti gh
thior idaz
thiopent al,</w>
theore tical</w>
ter ing</w>
tender ness</w>
te tro
te ,</w>
t ari
t adal
synergis tically</w>
susp ended</w>
struct ured</w>
stri ps</w>
stilbestro l</w>
stereotyp y,</w>
sten osis,</w>
st u
st ores</w>
st ated</w>
squ irrel</w>
sole us</w>
sleep -
simult aneously.</w>
sim ply</w>
seve re
ses ophageal</w>
sensi tivities</w>
seizures ;</w>
seizures :</w>
scal p</w>
s o-called</w>
s a</w>
ry anodine</w>
ro si
ro pivaca
ri l
retro peritoneal</w>
ren sic</w>
remo ph
relax ation.</w>
reache d.</w>
reac tion
re- exposure</w>
re produced</w>
rate- pressure</w>
rate /
rate )</w>
ram ad
rac e</w>
quantit ated</w>
pyri midine</w>
pyrex ia</w>
pyl ori</w>
pros thetic</w>
propylthio urac
prop oxy
proble ms,</w>
pro enkephalin</w>
prepar ations,</w>
pract olol</w>
poly uric</w>
pneumonia e</w>
plaqu e</w>
pic ardi
phosphor us</w>
phosphon ates</w>
phenylpropanol amine.</w>
phenylephr ine,</w>
phenomen on,</w>
phen olic</w>
pharmac y</w>
peroxid ase,</w>
perio ds,</w>
per mitted</w>
patient ),</w>
path ologically</w>
path ogenesis.</w>
pare sis,</w>
pal sy.</w>
pa i
p H,</w>
oxygen .</w>
oxygen ,</w>
over doses</w>
outcom es,</w>
ouabain .</w>
osin ophil</w>
osar com
optim um</w>
oper ations</w>
oper ation,</w>
om e-
olog ist
ocyto sis.</w>
ob st
ob iliary</w>
nor mother
non- treated</w>
non- fatal</w>
non toxic</w>
non pregnant</w>
nigh t
ng/m L.</w>
nevir apine</w>
nalox one-
na ph
n ings</w>
n ar</w>
n ACh
mul tiv
muc ous</w>
mox on
morph ology,</w>
mono aminergic</w>
molec ular-weight</w>
mobil ization</w>
mo tivation</w>
ml/ kg</w>
mir ro
min ority</w>
mild- to-moderate</w>
mil rin
microg/kg/ min</w>
mg/kg );</w>
methamphet amine,</w>
meth icillin</w>
mes olimbic</w>
mes artan</w>
mer its</w>
medi um.</w>
me ,</w>
mas s,</w>
malai se,</w>
los ing</w>
loc i</w>
lobe m
limit ations</w>
li ability</w>
leuk open
lat ency,</w>
lamivud ine,</w>
lac king.</w>
l um
kg(-1 ).</w>
kg -1.</w>
ket anserin</w>
k a
je jun
inv ari
intraperitone ally)</w>
interven tion,</w>
interac tions,</w>
inst ance</w>
insipid us,</w>
infiltr ation,</w>
inf antile</w>
indo l</w>
ind u
in ib
impair ing</w>
im p
if ied.</w>
identifi ed,</w>
id ine
ici ally</w>
hyperkal emia.</w>
hyper thyroidism.</w>
hyper plastic</w>
hyper kinetic</w>
hydro ly
hot- plate</w>
hom ogene
hind paw</w>
hemat opoi
heat -
health y,</w>
he rent</w>
he re.</w>
hazard ous</w>
haemodi alysis</w>
h arm</w>
gy naec
guan osine</w>
group ed</w>
griseofulv in</w>
glucose- 6-
gi ant</w>
gemfibro z
furosem ide-induced</w>
ful l-
frequ ently,</w>
frequ ent,</w>
four ,</w>
form ulated</w>
fluoroquinol one</w>
flav on
fl at</w>
fir st,</w>
feno fibrate</w>
f ex
f ear
f air
exist ent</w>
exencephal ic</w>
evalu ates</w>
et es</w>
establ ishment</w>
ery throm
erv ical</w>
er m
epidemio logic</w>
encoun te
en sis</w>
en il</w>
elic iting</w>
electrophysi ology</w>
electromyo graphy</w>
effor ts</w>
eff ac
ed ed</w>
ec tiveness</w>
e tra
drug- seeking</w>
dro perid
dor sol
disease- free</w>
diseas ed</w>
disc rep
dis par
diazepam -
diameter s</w>
detail s</w>
derm atitis,</w>
dem eclo
deliver y,</w>
death s,</w>
de son
dan azol
d ronedarone</w>
cyprohept adine</w>
cy sts</w>
cros ses</w>
cran io
cr ude</w>
cough ,</w>
cortic otropin-releasing</w>
convul sion.</w>
contribu tions</w>
consol id
consec u
conjunc tivi
concentr ated</w>
compli ance.</w>
complex ity</w>
complex es.</w>
complex ,</w>
complain t</w>
com pres
cocaine- kindled</w>
coca ethylene</w>
coagul ation.</w>
co st
co existing</w>
clopidogrel .</w>
cl amp
circum feren
cinacalce t</w>
chol angi
chlorpromaz ine-induced</w>
chemotherapy- naive</w>
challeng ing</w>
cep tion</w>
celecoxi b,</w>
cause s,</w>
cat ar
carrageen an</w>
carcin ogen</w>
car til
capsul e</w>
cannabin oids</w>
canc ers,</w>
cab ergoline</w>
c ue</w>
c rest</w>
bromocript ine,</w>
bre ak</w>
brady kine
bod y.</w>
bis phosph
bind ing.</w>
bim atoprost</w>
bepri dil</w>
behaviour s</w>
behavior al,</w>
be ,</w>
balloon ing</w>
autis tic</w>
atten tion.</w>
atten tion,</w>
at ing,</w>
asi a.</w>
asc icul
are sis</w>
architect ure</w>
ar s</w>
appro val</w>
applic able</w>
apne a.</w>
aper ta</w>
antioxid ant,</w>
antibio tic,</w>
anti tumour</w>
anti tuberculous</w>
anti eme
anthracyclin es.</w>
analgesic ,</w>
anaesthe tics</w>
an s,</w>
alpha 7</w>
alpha 1-
allevi ating</w>
albumin uria,</w>
akathi sia,</w>
agit ated</w>
adrenoceptor- mediated</w>
administr ation;</w>
adi pose</w>
aden ine</w>
addic tive</w>
acup uncture</w>
acromegal y</w>
accumul ate</w>
accomp any</w>
ac in.</w>
ac counts</w>
abdom en</w>
a kinesia</w>
Z P</w>
Wor ld</w>
Wh it
WB C</w>
W est</w>
V T.</w>
V AN
V ),</w>
URE :</w>
U PD
U L-
Th yro
Th i
T ardive</w>
T S
T AS
Sm all</w>
Sle ep</w>
Sec on
SC r</w>
Repor ted</w>
R T-
Pro found</w>
Post operatively,</w>
PTZ -induced</w>
PRO C
PROC ED
PRE SENT
PAC AP</w>
P D)</w>
OUT CO
OUTCO ME
O phthal
O S</w>
O CD</w>
O ),</w>
Ner ve</w>
NS F</w>
N ).</w>
N (G
N(G )-
Mo vement</w>
Mechan ical</w>
MEASURE :</w>
MA .</w>
M ac
M E</w>
Li -treated</w>
L or
Kap lan-Mei
K d</w>
K 1</w>
IT S</w>
II IN
Heal th
HPL C</w>
H :</w>
H (2)
Ger man</w>
Gentam icin</w>
G ol
Forty- five</w>
Fir st</w>
Fifty- two</w>
F urosem
F r
F ab</w>
Echocardi ography</w>
EP I</w>
ELIS A</w>
Diltiaz em</w>
Di ethyl
Det ection</w>
D yst
D os
Con gestive</w>
Cerebro spinal</w>
Cal c
CP .</w>
CG I-
CCK- 8-
C u</w>
C italop
C erebellar</w>
C D-
C CNU</w>
Behavi oural</w>
B ene
Azathiop rine</w>
Atten uation</w>
AT 1</w>
AL A-
AD .</w>
AC ,</w>
A(2A) R</w>
A uditory</w>
A ri
A part</w>
A b</w>
A F-
9. 1</w>
9 4%</w>
8 8
8 2%</w>
8 0,</w>
7 9
6 -induced</w>
524 66</w>
50 ),</w>
5-HI AA</w>
5 H-
5 6.
5 6,</w>
5 3
5 1-year-old</w>
30 ).</w>
30 ),</w>
3. 3%</w>
28 ).</w>
24 7</w>
23 2</w>
2, 4-
2 8)</w>
2 50
2 +
198 8</w>
13 1</w>
12 5,</w>
12 ),</w>
10- 20</w>
1 1),</w>
0.00 2)</w>
0.0 3),</w>
0. 25,</w>
0 2</w>
-1 00
(i. t.)</w>
(V AS)</w>
(PGE 1)</w>
(N A
(DO X)</w>
(CB F)</w>
(AN CA
(A ra-
(8 6%)</w>
(8 5</w>
(2 2.
(14 )
(1 8%)</w>
(1 7
( non
( maximum</w>
( mGluR
( inter
( after</w>
" ,</w>
yri dox
yohimb ine.</w>
yl ,</w>
wh it
we ster
wester n</w>
water- soluble</w>
war d.</w>
wall s</w>
wa reness</w>
w est</w>
w as,</w>
w ake</w>
volunte ers,</w>
vitamin osis</w>
viol ent</w>
vide o-
vi anolic</w>
ver atro
vast ating</w>
valv ulopathy</w>
us ;</w>
ursodeoxychol ate</w>
uro lithiasis</w>
up- regulated</w>
up ,</w>
unit ,</w>
under taken.</w>
unde restim
unc ular</w>
um /
u odenal</w>
two- dimensional</w>
tri ed</w>
tra in-of-four</w>
toremif ene</w>
top o
toler ability.</w>
tissu es,</w>
timo lol.</w>
timo lo
til mic
tico ag
ther mo
tetrac hlor
t -term</w>
synerg ism</w>
survi ved.</w>
sugg es
stereotyp y.</w>
sten osed</w>
steato hepatitis</w>
stain ing,</w>
sta phylococcal</w>
st able.</w>
small -
simul ated</w>
sider oblastic</w>
si veness</w>
sen sus</w>
secon d,</w>
se en,</w>
samp le.</w>
saf e.</w>
s niff
s ?</w>
rhyth ms</w>
rhyth mic</w>
reve aling</w>
resuscit ated</w>
resum ed</w>
restless ness,</w>
remoxi pride</w>
relationshi p,</w>
recurren ces</w>
re feren
re construc
qu il
qu arter
psor iasis.</w>
protein ur
prophyl ac
prop yl</w>
produc ts.</w>
proble m,</w>
prob able.</w>
previ ously,</w>
pregab alin</w>
predomin ance</w>
pre operatively</w>
pow der</w>
post- transplant</w>
pneumon ia,</w>
placebo )</w>
pilsi cainide</w>
pide mio
pi al</w>
phleb itis,</w>
phenotyp ic</w>
pert ussis</w>
per phenazine</w>
per ia
pentoxif ylline</w>
penicill amine.</w>
pemph ig
partic les</w>
parad oxic
paracetam ol.</w>
para ventricular</w>
pamid ronate</w>
pal mit
pai red-
p eptic</w>
oxantr one</w>
ox ine</w>
oto acoustic</w>
oscop ic</w>
os up
org as
or )</w>
open- angle</w>
one- half</w>
olig onucle
oli pidemic</w>
ol us</w>
off ic
ocyto sis,</w>
occul t</w>
occu pati
occl usion,</w>
obes ity,</w>
o esophageal</w>
o athe
o )</w>
numb ness</w>
nomifens ine</w>
neuro -
ner ve,</w>
nephro lithiasis.</w>
neph rectomy</w>
nafc illin</w>
n ally</w>
myosi tis.</w>
myasthen ic</w>
mus cle
morb idity.</w>
mor ic
mono amine-
mmHg ).</w>
ml/ 100</w>
mitochondri a,</w>
minoxidi l.</w>
midazol am
micrograms/ m
mi anserin</w>
mg/kg )-induced</w>
mg/d L).</w>
metrex ol</w>
methohex ital</w>
methemoglob inemia</w>
met al</w>
mesen chymal</w>
mening eal</w>
medic ally</w>
me pivaca
maxim um-
manifest ations,</w>
mandat ory</w>
magnit u
macroph ages.</w>
lo metrexol</w>
lithium /
lig and
lidoca ine-
li ved</w>
leuk openia,</w>
leu kin
leg .</w>
left- sided</w>
lansop razol
kan amycin</w>
k now</w>
iz otan</w>
itsel f,</w>
item s</w>
intub ation,</w>
interfer ing</w>
insomn ia.</w>
inform ation.</w>
infarc tion:</w>
in version</w>
in completely</w>
import ant,</w>
import ance.</w>
imipen em
il it
il -based</w>
icter ic</w>
ia ).</w>
hypox emia</w>
hypo physi
hyperplasi a.</w>
hyper phosphat
homocyste ine</w>
hist ology.</w>
hist ology,</w>
hepar in-associated</w>
hemat omas</w>
heigh ten
h id
h ence</w>
glut eth
gluco se.</w>
gluc onate</w>
gen otoxic</w>
gadodi amide</w>
ful l
fre e-
fract ures</w>
fol d.</w>
fluc loxacillin</w>
flo sequinan</w>
flecain ide.</w>
first -dose</w>
filam ents</w>
fenflur amine-
fascicul ations.</w>
facilit ating</w>
f rank</w>
f osin
f lox
f issu
ext ent,</w>
expect ancy</w>
estradi ol,</w>
essenti al.</w>
epomedi ol</w>
epide mic</w>
eosinophil s</w>
entec avir</w>
ent an</w>
endotheli um-
endocardi tis</w>
ell s</w>
electroencephalo graphy</w>
educ tal</w>
educ ation</w>
ec tions</w>
e osinophil</w>
e asy</w>
duc ts.</w>
dorsol ateral</w>
diseas e;</w>
discrimin ative</w>
dis playing</w>
diplop ia</w>
dimen sions</w>
digox in,</w>
differen ce.</w>
di l,</w>
det ection.</w>
der ly</w>
depend ed</w>
deoxychol ic</w>
deoxy glucose</w>
densi ties</w>
demograph ic,</w>
delta 9-
deline ate</w>
decreas e,</w>
de vastating</w>
datab ases</w>
dac arbazine</w>
d "</w>
cytos keletal</w>
cur ative</w>
cu e-induced</w>
cortis ol,</w>
convuls ants</w>
contrac tions.</w>
contrac ted</w>
contrac epti
consecu tively</w>
conflic ting</w>
com promising</w>
cohor t,</w>
cocaine- treated</w>
co- trimox
co- infected</w>
co vered</w>
clinic opath
cisplat in-based</w>
chromat ograph
cholester ol.</w>
children 's</w>
chec ked</w>
cess ation.</w>
cef uro
cathep sin</w>
categor ized</w>
catechol amine-induced</w>
catabol ism</w>
cas c
casc ade</w>
carb en
capac ity.</w>
candes artan</w>
c ister
but yn
bu deson
br ation</w>
bl astic</w>
bio logic</w>
beta-carbol ine-3-
beta- 1</w>
beats/ min,</w>
be hind</w>
barri er.</w>
barbitur ates</w>
b y-
b li
b end
aver age,</w>
aten olol.</w>
ate ),</w>
at om
aripiprazol e.</w>
ari s.</w>
ar ms,</w>
appl ying</w>
antipy re
antigen ,</w>
anticoagul ated</w>
angio edema,</w>
anesthe tic.</w>
anesthe tic-induced</w>
anesthe tic,</w>
an ec
an ast
amisul pri
amik acin</w>
am s</w>
alu min
alpha 2</w>
all- cause</w>
all er
alend ronate</w>
alcoh ol.</w>
al an
al .,</w>
agonist -induced</w>
age- dependent</w>
adriamyc in,</w>
adrenal ectomy</w>
administr ated</w>
aden osis</w>
ad op
act oid</w>
acet ate,</w>
accumben s.</w>
ac ri
ac in,</w>
abor tion</w>
ab ated</w>
Y ,</w>
Vas o
V ol
Ul tras
T um
T ramad
T OF</w>
Stri atal</w>
St ar
Specific ally,</w>
Spec ific</w>
Shor t-term</w>
Sevent y</w>
SER CA
S- adenos
S (+)-
Rest ing</w>
Relationshi p</w>
R ing
R I</w>
Qu inine</w>
Progres sive</w>
Plac e
PP E</w>
PN D</w>
PG s</w>
PC P</w>
PA NS
PA F</w>
P uromycin</w>
P -treated</w>
Ouab ain</w>
O LT</w>
O D</w>
O CT</w>
Norm al</w>
NT E</w>
My ocardi
Mod ulation</w>
Minocycl ine</w>
Micro scopic</w>
Mechan ism</w>
Man ia</w>
MR I.</w>
M rp2</w>
M odi
M ex
M en
M N</w>
M IT
M C</w>
M C
Lov astatin</w>
LT ,</w>
LP S</w>
LD L-
L ind
L E)</w>
K 2</w>
J .</w>
Investig ations</w>
Intra operative</w>
Individ ual</w>
In j
In dependent</w>
Identi fication</w>
IV -
IL- 1</w>
I P),</w>
I :</w>
Hypoten sive</w>
Hyp onat
HIV /
HC Q</w>
HA ART</w>
H ex
H R,</w>
H A)</w>
GR 13
GR13 89
GABA- ergic</w>
G GT</w>
Forty- two</w>
F B
Experi ence</w>
Eth anol</w>
Eth ambut
Estro gen
Engl ish
Electro encephalo
EM LA</w>
E pidemio
E ligible</w>
E .
Double-bl ind</w>
Dig oxin</w>
Diab etes</w>
Di etary</w>
DTI C</w>
DNA .</w>
DE N</w>
Cor relation</w>
CON TE
CH F,</w>
CF R</w>
C er
C elec
C are</w>
C B</w>
BP C</w>
B ro
B raz
B ic
B en
Ari pi
An ticoag
Amphet amine</w>
Amiodar one-induced</w>
AM L</w>
A wareness</w>
9. 6</w>
9 3%</w>
7. 9</w>
7 5,</w>
7 4%</w>
6- keto-
6 6-year-old</w>
6 6-
6 4
6 -</w>
5-amin osalicylic</w>
4 8-year-old</w>
4 5-
30 %,</w>
3 00,</w>
200 5</w>
200 4.</w>
200 3,</w>
200 2.</w>
20- year-old</w>
20 ),</w>
2- h</w>
2 1),</w>
198 7</w>
17 2</w>
15 1</w>
15 /
14 ).</w>
13 ),</w>
12- month</w>
12 /
11 %,</w>
10- fold</w>
10(- 9)</w>
10(- 6)</w>
10 ;</w>
1 1/
1 -10</w>
00 0
0. 3%</w>
0. 11</w>
. ;</w>
-to- beat</w>
-1 5</w>
-1 1</w>
(control )</w>
(WK Y)</w>
(S OD)</w>
(P O
(P =</w>
(NSCL C).</w>
(N D
(M C
(L-NAME )</w>
(L DH
(IN R)</w>
(C T
(C )</w>
(A V)</w>
(7 0%)</w>
(6- OHD
(6 0%)</w>
(5 8%)</w>
(3 8.
(2 9</w>
(1 9.
(1 5
(0. 3-
' ,</w>
zol e,</w>
yel low</w>
x am
wri thing</w>
withdraw n,</w>
weigh t).</w>
we re,</w>
war ning</w>
war m
w all,</w>
vulgar is</w>
vul g
viol ence</w>
vincrist ine-treated</w>
vic tim
verm ectin</w>
ver ify</w>
vect or</w>
ve in.</w>
vasoconstric tive</w>
vancom ycin.</w>
val er
vag us</w>
uro th
uro logic</w>
up ward</w>
up or</w>
unexpect edly</w>
understo od,</w>
um :</w>
ultr af
trop ane</w>
tremulo us</w>
transf usion.</w>
trans duction</w>
ti schem
ti line</w>
ti ght</w>
thromboembol ism,</w>
thromb olysis</w>
therap ies,</w>
th in
tetrahydrocannabin ol</w>
tetrac a
terbutal ine.</w>
tacrolim us,</w>
tachy arrhythmias.</w>
t ations</w>
summar ize</w>
summ ation</w>
subcutaneous ly)</w>
sub convulsant</w>
stric tly</w>
strept oz
strategi es.</w>
ster ic</w>
star ted,</w>
standard -dose</w>
st rom
st em
st age.</w>
spin al-
sph ing
spec ified</w>
spas ticity</w>
spas m.</w>
sp ind
somn ambul
sleep ,</w>
sion ).</w>
single-bl ind,</w>
similar ,</w>
si ll
sex -matched</w>
ses sion.</w>
serocon ver
sequ entially</w>
self- limited</w>
sc ol
scol io
sar alas
s ent</w>
ro flu
rifamp icin.</w>
reversib ly</w>
reticul ata</w>
responder s.</w>
resol u
res sion</w>
regurgit ation,</w>
rect us</w>
record ings.</w>
pyruv ate</w>
pyri mid
pul sed</w>
pul se
psychostimul ant</w>
propyl ene</w>
prim ed</w>
premat urely</w>
precur s
pre pulse</w>
post marketing</w>
posi tive
pl au
phosphoinositi de</w>
phosph ate-
phenylbut az
phen cycl
ph ere</w>
perfor ation</w>
per oneal</w>
pepti dergic</w>
pem oline</w>
patient ).</w>
parval bumin</w>
parathyro id
param etric</w>
paraly sis,</w>
palpit ations</w>
pac ing.</w>
p. m.</w>
p ame
ox o
ox ide
ox amine.</w>
oti tis</w>
ot olaryng
orig in,</w>
organ isms</w>
or n
opioid s,</w>
one /
on azole.</w>
om es.</w>
ol l
ol d.</w>
off set</w>
od ular</w>
occur s.</w>
occup ancy</w>
occa sions,</w>
ob ac
o s</w>
num er
not ed,</w>
nit rates</w>
nigra .</w>
nigra ,</w>
neuron es</w>
ner 's</w>
necess ity</w>
ne fazod
nat ure.</w>
naprox en,</w>
n ad
myocardi tis,</w>
myel in
mus ,</w>
mucos a.</w>
monitore d,</w>
modi um</w>
mod al</w>
moc lobem
mm ,</w>
mm )</w>
ml/ min,</w>
micro vesicular</w>
mg/d L)</w>
methyl ation</w>
met am
mer captop
mechan o-
measure ments,</w>
mar k</w>
man n</w>
main tained.</w>
mac aqu
mGlu R</w>
mEq/ L.</w>
m s)</w>
m ist
m Glu</w>
m ;</w>
low- osmolar</w>
low- molecular-weight</w>
low- grade</w>
lor acar
lo op
ll ect
levo thyroxine</w>
lep ir
labell ing</w>
lab our
l a
j ud
iti n</w>
isom erase</w>
irrit ability,</w>
ion ized</w>
involve ment,</w>
intub ated</w>
intran e
intermit tently</w>
interleuk in</w>
ine mic</w>
index .</w>
ind ole
incontin ence.</w>
include d:</w>
in- 2-
in s
in osine</w>
implic ating</w>
immun omodul
ime l
imag es.</w>
ile um</w>
ide a</w>
ide -treated</w>
hyperparathyroidis m.</w>
hyper ton
hyper polar
hyper glycemic</w>
hyper coagul
hormon es.</w>
hi m</w>
hex y
hex idine</w>
hemo static</w>
hand -
ha ir
h in
h and.</w>
h ;</w>
great er.</w>
glutathi one,</w>
glomerul us</w>
gener ation,</w>
gall -
g/m 2/
g az
g ate</w>
fur azol
four .</w>
fo rensic</w>
flu id,</w>
fiel d.</w>
fi ed.</w>
fe ar</w>
favor ably</w>
fav our</w>
far ,</w>
famili ar</w>
famil ies</w>
fair ly</w>
ey es,</w>
exc ret
examin ations.</w>
ex ud
ex pon
ethyl ]-
ethinylo estradiol</w>
ethinylestradi ol</w>
estim ating</w>
ery the
epirub ic
ep tive</w>
ep s</w>
end or
encephal y</w>
en ec
empt ying</w>
electrophore sis</w>
electrocardio graphy</w>
effect s;</w>
effect s:</w>
ec tr
each ).</w>
dyses thesia</w>
dy l</w>
drug ;</w>
dro ple
drain age</w>
doxorubic in/
double-bl inded,</w>
dop amin
dom ains</w>
diure tics,</w>
disorient ation</w>
discharg es.</w>
dis charge
dis cer
differen ce,</w>
di um</w>
detect ed,</w>
des at
dermatomyosi tis</w>
degener ating</w>
defic it.</w>
deep -
dec lining</w>
dec ay</w>
de pot</w>
de ad</w>
dam ental</w>
dam ages</w>
d ine,</w>
d ated</w>
cyclospor ine.</w>
cyclo -
cut ane
cross- reactivity</w>
cros sed</w>
coun ted</w>
cor respond</w>
conveni ent</w>
consider ations</w>
consi st</w>
conjunctiv al</w>
conf usional</w>
conduc t</w>
concer ned</w>
complain ts.</w>
compens ate</w>
commun ity-
combin ations.</w>
com at
clo su
clin ics</w>
cl es.</w>
cis- RA</w>
chlor phenir
chlor ide.</w>
childho od.</w>
chem opre
character ized.</w>
ch ing,</w>
ch ance</w>
cent ro
cent ers.</w>
cef am
cefam and
cataly tic</w>
cardio vascular,</w>
car mo
ca val</w>
c ages</w>
bromocript ine-induced</w>
bo x</w>
ble ph
bl ac
bin ant</w>
bi us</w>
beta- CC
benzo [
bend roflu
beg in</w>
be zafib
be long
be l
bal ance,</w>
autoph ag
auth or</w>
ate ;</w>
atax ic</w>
astemiz ole</w>
ari um</w>
ara- C</w>
ar in</w>
apparat us</w>
ano rec
ane )</w>
analy ses,</w>
an k
alpha-methyl dopa.</w>
allevi ation</w>
al oxif
al c
aggres sion</w>
after load</w>
after discharge</w>
adv ance
addres sed</w>
addic ts.</w>
ad duct</w>
acti ve.</w>
acromegal y.</w>
ac compl
ac cess
abrupt ly</w>
a prot
a PT
[ CI,</w>
Z R</w>
Y .</w>
Wil c
W R-27
V ir
V inorelbine</w>
V CM
U nified</w>
Trimeth op
Toxic ities</w>
Tourette 's</w>
TE )</w>
TD P</w>
Stat es,</w>
St ress</w>
Shor tly</w>
SSR I
SCH 23390</w>
S um
Rem ifentan
Reg ist
Recom binant</w>
Rec ently</w>
R at</w>
R )-
Q R
Q ,</w>
Propylthio uracil</w>
Pro cain
Pre dn
Post mortem</w>
Phenyl propan
Path ological</w>
PRESENT ATION:</w>
PO 2</w>
PE G-
P- glycoprotein</w>
P T</w>
P -1
Ol der</w>
O (2)</w>
Nim esul
Na+, K(+)-ATPase</w>
N is
Min im
MATERI AL</w>
M er
Line zol
LVF X</w>
LM W
L-argin ine,</w>
L DA</w>
Kaplan-Mei er</w>
K CC
Isoniaz id</w>
Indin avir</w>
Increas e</w>
Im pair
IN )</w>
IL-1 beta</w>
IGF -1</w>
Hist ologically,</w>
Hippocamp al</w>
Haemo dynamic</w>
H T)</w>
H 3</w>
GABA (B)</w>
G c-
Flecain ide</w>
FK50 6.</w>
FANF T</w>
Euro pe</w>
En dom
El ectr
EC )</w>
E S
Diclofen ac</w>
Detail ed</w>
Delta 9-
De mo
D- 2</w>
Criter ia</w>
Col l
Coca ine-associated</w>
Coc E</w>
Co omb
Character ization</w>
Cat ech
Carbo platin</w>
Carbamazep ine-induced</w>
CS F)</w>
CONTE X
CN I</w>
CA D.</w>
C ;</w>
B y
B up
B le
B art
Analy ses</w>
An algesic</w>
Ag e,</w>
AZT -treated</w>
AS ).</w>
AR B</w>
AN OV
AL A</w>
AD P</w>
A v
9 2
8 th</w>
8 %;</w>
7 7-year-old</w>
7 3
6- di
6 6
6 5-
59 4</w>
50 %)</w>
5-HT (2)</w>
5- di
5 4.
5 %;</w>
4- 6</w>
4 7,</w>
4 5.
4 4-year-old</w>
3. 3%)</w>
3- mercapto
3 ',
25 6</w>
200 7,</w>
200 6.</w>
200 5.</w>
2- 5</w>
2 8-year-old</w>
2 7-
2 15</w>
19 1</w>
19 0</w>
17 1</w>
15 9</w>
14 th</w>
14 3</w>
13 .</w>
12 7</w>
11 ;</w>
1. 3-
1. 2-
1. 2%</w>
1 50,</w>
1 3-year-old</w>
1 0.0
0.05 );</w>
0.00 1);</w>
0. 45</w>
-1. 5</w>
-1 H-
-1 ;</w>
-1 8</w>
- 2-
(W H
(T T
(T P
(R )-
(PGE 2)</w>
(P< 0.001)</w>
(METH )</w>
(MD A)</w>
(L ID)</w>
(L ID
(IC 50</w>
(I P)</w>
(HU S)</w>
(HBs Ag)</w>
(HBe Ag
(G B
(G -
(D B
(CB Z)</w>
(A V
(50 ,</w>
(5. 0</w>
(5- 20</w>
(4 5%)</w>
(3 6</w>
(2 /
(1 25</w>
(1 0,</w>
(1 %)</w>
(0.0 3</w>
(0. 75</w>
( within</w>
% ])</w>
z ones</w>
ylestradi ol</w>
y rate</w>
weak er</w>
wal k</w>
w ol
w k,</w>
w av
voric onazole</w>
vis it.</w>
vehic le-
ve ;</w>
vasopress in.</w>
vasodilat or,</w>
v ine</w>
us -related</w>
urticar ia/
uro theli
ur ium</w>
uniform ly</w>
un ipolar</w>
ultras onic</w>
uc to
tu be.</w>
tro methamine</w>
tric ycl
tre tin
transi ent.</w>
tran quil
tox ins</w>
tor r</w>
ton 's</w>
to- severe</w>
time- course</w>
tigm ine,</w>
ticlop idine.</w>
ti ag
thio l</w>
the ade
th en,</w>
th emia</w>
ter t-
ter g
ten ance</w>
tel mis
te le
te ar</w>
tax ane</w>
tar tr
tachycardi c</w>
t es
t ;</w>
syst ole</w>
sulf oxide</w>
sugges tions</w>
streptoz oc
step- through</w>
spon dy
spi perone</w>
speech ,</w>
speci al
sp ect
sli t</w>
six teen</w>
situ ation.</w>
sirolim us-
sign alling</w>
sic k</w>
shrin kage</w>
shoul der</w>
shar ply</w>
ser ving</w>
ser ological</w>
sed -
scop y.</w>
sclero sis,</w>
scler osing</w>
sc an.</w>
satur ated</w>
satis fac
s kele
s gk1
rot ational</w>
ris o
ribavir in,</w>
rib onucle
reticulo cyte</w>
rest oring</w>
responsi ven
relie f.</w>
rel ations</w>
reci pit
rec ently,</w>
ras h.</w>
rar a</w>
radiolab eled</w>
radioimmuno assay</w>
rac em
rabb its,</w>
quetiap ine,</w>
quadri ple
pyridox al</w>
py el
pyel oneph
py e
pur inergic</w>
pul mon
pseudo ephedrine</w>
promis ed</w>
prolact in-
prolact in,</w>
produc ts,</w>
proces ses,</w>
proced ures,</w>
priv an</w>
pres ently</w>
prece de</w>
pre therapy</w>
prac tical</w>
pr o</w>
possib le,</w>
poly cy
plate a
piroxic am</w>
pin prick</w>
pic a</w>
perio d
perc enti
per iden</w>
peop le.</w>
pent agastr
pe liosis</w>
paralle l,</w>
par tum
paper ,</w>
paired- pulse</w>
pacemak er.</w>
p.o .).</w>
p 24</w>
oxy butyn
ox azepam</w>
over active</w>
oton ia</w>
osi 's</w>
orrh ag
or phenad
ong st</w>
oneuro tic</w>
omyc in-induced</w>
omon as</w>
obser ve
o sid
o pathy.</w>
nutri tion</w>
numb er,</w>
nucleoti des</w>
nortript yl
non convulsive</w>
nocicept or</w>
nocicep tion.</w>
nmol ),</w>
nitrofur anto
ng/m L,</w>
neurotransmis sion.</w>
neurolep tics,</w>
neuro developmental</w>
nel fin
necess ary,</w>
nec k,</w>
ne y</w>
nalbu phine</w>
n- 3</w>
n ation
myelosuppres sion.</w>
minut e)</w>
mini ature</w>
min i-
mill ilit
mil k</w>
mil k-alkali</w>
midazol am-induced</w>
microgram/ ml</w>
micro injected</w>
micro g.</w>
micro circulation</w>
mi befradi
mg/ min</w>
mg/ m</w>
method s,</w>
methad one,</w>
meth im
mes o
meperid ine,</w>
men orrhag
mediast inal</w>
medi um
me g
me dox
medox om
maximum- tolerated</w>
mariju ana</w>
main stay</w>
mac rom
mGluR 5</w>
mEq/ L)</w>
lymph oid</w>
lu k
lox y
lip id
lin es,</w>
ligh theade
lib id
leuc ocytoclastic</w>
lear ned</w>
le x</w>
le sion,</w>
l ings</w>
l essen
l es,</w>
l and</w>
kg(-1 ).
k ly</w>
iz er</w>
isoproteren ol-treated</w>
isoproteren ol-
ip ),</w>
intraperitone ally,</w>
intrad uodenal</w>
intrac ardiac</w>
interval :</w>
interac tion,</w>
inter ventricular</w>
inter leukin
inte lli
inte llect
insul in,</w>
institu tion.</w>
ing "</w>
infusion ;</w>
in noc
import antly,</w>
implic ated.</w>
implant able</w>
impl ying</w>
impair ment
immobil ization</w>
imipen em</w>
il )</w>
ifen sive</w>
id arubicin</w>
ic ity.</w>
ic a</w>
i. d.</w>
i gral</w>
hyponat remia,</w>
hypercholesterol emia,</w>
hyp olipidemic</w>
hydroneph ro
hour s).</w>
her ni
hemis phere</w>
he re,</w>
ham ster
haemorrh age.</w>
h aled</w>
gu ide</w>
glomeruloneph ritis,</w>
glomerul i,</w>
gli osis</w>
gener ic</w>
gener ating</w>
gen e.</w>
gaug e</w>
gar lic</w>
g odi
g ide</w>
frag ment
for sk
flu phenaz
fl atten
filam ent</w>
fic ation.</w>
fibrin olysis</w>
fenflur amine.</w>
fen bu
fatigu e.</w>
fall ing</w>
f loxacin,</w>
f ine</w>
exten ding</w>
expos ures.</w>
expl ains</w>
experi ence,</w>
exfoli ative</w>
exerci se,</w>
excret ory</w>
exc ised</w>
ex po
everolim us</w>
etomid ate,</w>
eti ology,</w>
ergot amine/
erec tions</w>
enzyme ,</w>
encephal ic</w>
ell ar</w>
eff usion,</w>
ect o
e.g .</w>
e gal
e NO
dyn es/
dro p
dose- dependent.</w>
diss ected</w>
direc tion</w>
differenti ating</w>
diagno sed,</w>
di valproex</w>
di e</w>
desmo pressin</w>
des loratadine</w>
der s.</w>
deple ting</w>
demonstr able</w>
defin ition</w>
de tail</w>
de position.</w>
de m</w>
de )</w>
dat e.</w>
dap tom
d- aspartate</w>
d- amphetamine-induced</w>
d a</w>
cyr rhiz
cu es</w>
crystall uria</w>
crav ing,</w>
coupl ing</w>
control )</w>
contra st-
contr ary</w>
continuous- infusion</w>
cong es
config uration</w>
comb ined,</w>
comat ose</w>
cogn iti
clinic ally,</w>
clind amycin</w>
cisplat in-
cis atracurium</w>
circul ation,</w>
chromos omal</w>
chore oathe
cholin omimetic</w>
cholang itis</w>
chol ine-
chlorothiaz ide</w>
chelat ing</w>
chang ed.</w>
ch on
cephalospor ins</w>
cells/ micro
cell s)</w>
ce fac
ce as
caspase- 3</w>
cardiotoxic ity:</w>
cardiom egal
carcin omas.</w>
ca ve
ca str
c ure
c ial</w>
c all</w>
bupropi on,</w>
buff er</w>
bu min
bot ulinum</w>
block age</w>
biolog ically</w>
beta- lactam</w>
beta 4</w>
benzo ate</w>
before .</w>
b es
az ithrom
az ido
autom atic</w>
atroph ic</w>
astro glial</w>
asthmatic s</w>
as )</w>
arboxyl ic</w>
aqu apor
apri de</w>
approxim ate</w>
applic ations</w>
appl ied.</w>
apar t.</w>
antigen -positive</w>
anticonvuls ants.</w>
analy z
ana emia.</w>
ana emia,</w>
an uria</w>
an hydr
an :</w>
an -treated</w>
aminoglyco sides</w>
amide )</w>
am ongst</w>
al istic</w>
agne tic</w>
agit tal</w>
advoc ated</w>
administr ation:</w>
adap tation</w>
acut e-
acne .</w>
acid :</w>
acetam ,</w>
access ory</w>
accent uated</w>
absor ption,</w>
a i</w>
W ol
Unex pect
Tre ated</w>
Thrombo sis</w>
Thirty- seven</w>
Testo sterone</w>
Test s</w>
Tem por
Td p</w>
TB I</w>
T NS
Seventy- five</w>
Se x</w>
ST S</w>
SN P-induced</w>
SIAD H.</w>
SH R,</w>
SE LEC
S wit
S NA
Reg istry</w>
Recom m
RV LM</w>
R ech
R apam
R aloxif
R U
R AMP
Pseud otumor</w>
Propylthio uracil-induced</w>
Plas modium</w>
Pilocar pine-induced</w>
Pent azoc
PTHr P</w>
PG F2</w>
PE .</w>
P an
P MS
P DA</w>
P B,</w>
P 400</w>
Otot oxicity</w>
Or g</w>
O T
Non steroidal</w>
Nitroprus side</w>
Neuro pathy</w>
Neur onal</w>
Na+ ,</w>
NT 69
NSAID s,</w>
NR H</w>
Myelo suppression</w>
Min or</w>
Micro injection</w>
Metoclop ramide</w>
Medic ines</w>
Man nit
Main tenance</w>
MA MP</w>
M en</w>
Long- Evans</w>
Lif e-
Le vetiracetam</w>
LI D
L- NOAR
L s</w>
L R
Kap osi's</w>
Inter view</w>
Individ u
In stead,</w>
Immun osup
IC 50</w>
Hor mon
High -
Here in</w>
He modi
HIT T</w>
HD ).</w>
Guillain- Barr</w>
Gc- globulin</w>
G d-
G al
Fran ce</w>
Fluoro -J
F orm
F ib
F K-
F F
English -
English- language</w>
Electrocardio graphic</w>
El derly</w>
Echocardi ographic</w>
EC T</w>
EC S</w>
E 2-induced</w>
Dose- response</w>
Disor ders</w>
DOX ,</w>
DMT U</w>
DE NA</w>
D MI</w>
Cy A</w>
Con ventional</w>
Coch ran
Co administration</w>
CONTEX T:</w>
CK- MB</w>
C- fiber</w>
C MR
C Cl
Bup ren
B reast</w>
B F
B ),</w>
Alzheim er</w>
Al most</w>
Al fentanil</w>
AM CA</w>
ADR -treated</w>
AD E</w>
AC E-
AC -
AB R</w>
= .
9. 9</w>
8 7%</w>
7. 6</w>
7. 5,</w>
7. 5%</w>
7-nitroinda zole</w>
7- OH-
7 1-year-old</w>
6- TG</w>
6 J</w>
6 3
5-azacy tidine</w>
40 %,</w>
4- year</w>
4- 5</w>
3 ]</w>
3 2-
29 ).</w>
28- day</w>
21- day</w>
200 7.</w>
200 2,</w>
2 60</w>
2 16</w>
16 8</w>
15 .</w>
15 %,</w>
14- day</w>
14 8</w>
14 1</w>
10 ,000</w>
10 (6)</w>
10 (3)/
1. 0-
1, 3-
0.000 1</w>
0.000 0
0. 24</w>
0. 2,</w>
.0 5),</w>
-1 3</w>
- square</w>
, 11-
(control ),</w>
(TB AR
(T GF-
(PT U)</w>
(P )</w>
(O R)</w>
(NSCL C)</w>
(NS AI
(M K-80
(E SR
(CO X)</w>
(B M
(A DH
(9 0%)</w>
(9 /
(5 3%)</w>
(5 ,
(4 8</w>
(4 /
(3 8%)</w>
(3 5.
(3 5%)</w>
(3 3</w>
(3 1%)</w>
(3 0-
(1. 2</w>
(1 0)</w>
(0.1- 1</w>
( peak</w>
( measured</w>
( h
( J
( 90</w>
zol mitript
z otoc
yr ,</w>
youn g
yn ic</w>
yl)- 2-
y "</w>
women ;</w>
war nings</w>
w iden
voltage- dependent</w>
viv o
veratro l</w>
ver -
vasculat ure.</w>
v il
university- affiliated</w>
un premedicated</w>
un g</w>
ultra -
ulcer ogenic</w>
ul i
u gh
trimeth adi
tr y</w>
tob ac
tinnit us.</w>
thy ron
the less</w>
thalidom ide,</w>
thalas semia</w>
ten ds</w>
teg mental</w>
te li
tail- cuff</w>
surger y:</w>
sulphasalaz ine.</w>
struct ure.</w>
strong est</w>
stri k
strik ingly</w>
st ents</w>
spir al</w>
sorafen ib</w>
sor ption</w>
sl ice</w>
single- photon</w>
sing le,</w>
sensitiz ing</w>
see k</w>
second- degree</w>
schedul es.</w>
sal ine)</w>
s.go v</w>
rul line</w>
rosu vastatin</w>
ro und</w>
ro lip
rolip ram</w>
ril men
rifamp icin-induced</w>
ri bo
revascular ization</w>
ret initis</w>
ret ard</w>
reser ve.</w>
reser pine.</w>
res our
res ected</w>
reproduc ibility</w>
repor t:</w>
removal .</w>
rejec tion,</w>
regul ation,</w>
ref rac
recover ing</w>
recogn izing</w>
rec ent
reat er</w>
reas ses
raz ox
ran spor
rami pri
r t
r d
quin ine.</w>
quin idine.</w>
qu ater
putam en,</w>
pup ils</w>
pt osis</w>
psori atic
procain amide-induced</w>
proble matic</w>
pro line</w>
pro jection</w>
pro grams</w>
preser ve</w>
pres cho
prefer able</w>
predic ts</w>
pr amine-induced</w>
poten c
potassi um.</w>
post ul
polyp eptide</w>
point s,</w>
pod ocytes.</w>
po )</w>
platele ts.</w>
platea u</w>
placebo ;</w>
piv otal</w>
pimoz ide,</w>
picardi al</w>
pi thelial</w>
physici ans.</w>
phosphor yl
phospholip ase</w>
phenomen a.</w>
phen procou
phen idate</w>
pharmacokine tics.</w>
pharmacokine tics,</w>
peria qu
pentobarbit al,</w>
patient s);</w>
paresthesi as</w>
pancre atitis,</w>
paclitaxel -
pa rous</w>
oxy acetic</w>
ox ime</w>
out- patients</w>
oun ds</w>
ouabain -treated</w>
ou pl
ot op
oste ogenic</w>
oscop y.</w>
osar coma.</w>
os ulf
opath ology</w>
one 's</w>
on ov
on )</w>
om er
ol mesartan</w>
od en
ocy anine</w>
ocor tical</w>
occa sions.</w>
oc arb
obstruc tion,</w>
obst etric</w>
observ ations.</w>
ob io
ob enz
o urinary</w>
o therapy</w>
non human</w>
non diabetic</w>
non depolarizing</w>
noc ifensive</w>
no ise</w>
nit rate/
nicardi pine-induced</w>
neuro imaging</w>
ne tilmic
n g.
multivari able</w>
more over,</w>
modul ators</w>
mo ti
mit omycin-
mis sed</w>
mid brain</w>
microsph eres</w>
micrograms/ kg),</w>
microgli a</w>
micro tubule</w>
micro g.
mic rom</w>
mg/kg/ min</w>
mg/d L),</w>
methylenedioxy methamphetamine</w>
methad one-induced</w>
meth oc
meth iodide</w>
meth ach
metabolit e.</w>
mesn a,</w>
men )</w>
membran e,</w>
mefen amic</w>
max ,</w>
mas seter</w>
manifest s</w>
manage able</w>
mal ari
magnesi um,</w>
macroph ages,</w>
m s).</w>
m mol</w>
lymph aden
lun g
loz enge</w>
lor azepam.</w>
liter )</w>
lin kage</w>
lignoca ine.</w>
li p</w>
levonorgest rel</w>
le )</w>
lac ks</w>
l ine.</w>
l ick
ke ep</w>
ke d,</w>
ka olin</w>
ist os
isol ation</w>
is th
is let</w>
intrac aver
insectic ide</w>
injur ious</w>
inf ant
ind ocyanine</w>
in yl</w>
in operable</w>
in herent</w>
implic ation</w>
immun ity</w>
illnes ses</w>
idi l</w>
id ity,</w>
ia c</w>
hyste rectomy</w>
hypothe sis.</w>
hypothalamic- pituitary-adrenal</w>
hypo plastic</w>
hypo kine
hous ed</w>
hour ,</w>
homeost asis.</w>
her pes</w>
hepat obiliary</w>
hem olysis,</w>
hem ip
he rence</w>
harve sted</w>
haemo globin</w>
h app
h ands</w>
gynaec ological</w>
guinea- pig</w>
gu t</w>
granulo cy
glyco gen</w>
gam bling</w>
gall- bladder</w>
gal ant
g ases</w>
further ,</w>
fun damental</w>
fore ign</w>
flumazen il.</w>
fibro blast</w>
fib rom
ff- Parkinson
ff-Parkinson -
ff-Parkinson- White</w>
fet uses.</w>
fenol dop
failure ;</w>
extub ation</w>
exist .</w>
exacerb ations</w>
ex chang
evol ved</w>
ev ul
ethan ol,</w>
estrogen ,</w>
es sively</w>
es '</w>
epitheli um.</w>
episo de,</w>
ep ing</w>
enzyme .</w>
entor ial</w>
ent ering</w>
en graf
en comp
employ ed.</w>
eme sis.</w>
embryo pathy</w>
elev ate</w>
electrocardio gram,</w>
el se
each ,</w>
e- like</w>
e ye
e y</w>
e tretin
e ther</w>
e ligible.</w>
e h
e b
dysrhyth mic</w>
dysp ep
dysarth ria,</w>
dys plasia.</w>
dys lipide
doxorubic in-related</w>
down ward</w>
dom perid
dom inal</w>
disorient ation,</w>
dis col
dis ability.</w>
dimin ishing</w>
differen tly</w>
dideoxy cytidine</w>
detect able.</w>
destruc tive</w>
day s'</w>
dap son
dail y).</w>
cyto static</w>
cyt es,</w>
cutane a</w>
cot ranspor
cortico striatal</w>
correc tly</w>
correc ted
corp uscular</w>
cor on
control le
con vol
commer cial</w>
cogn i
co infected</w>
co incident</w>
clox acillin</w>
chlorpromaz ine,</w>
chlor al
chi ef</w>
chemoconvul s
cerebell um,</w>
cer amide</w>
cent res</w>
cell ular
ceftriax one.</w>
cefazol in</w>
cardiomyo path
carboxyl ic</w>
carbon ate.</w>
carbamazep ine-induced</w>
carb onic</w>
bru ising</w>
bodi es,</w>
block er
bleed s</w>
ble omycin,</w>
bio logy</w>
bicucull ine-induced</w>
bi guan
bi ge
ber g</w>
barri er,</w>
baclofen ,</w>
ba ical
autoph agic</w>
aut osomal</w>
ate -dose</w>
ate -dependent</w>
at ors,</w>
as /
arthralgi as</w>
arthralg ia,</w>
arth ri
arterios us.</w>
ar is</w>
apne a,</w>
antiretro vir
anti- emetic</w>
anti malari
anti arrhyth
antagon ism.</w>
ant op
anne xin</w>
anim al.</w>
androgen s</w>
andro genic</w>
amygdal a-
ampl ified</w>
amelior ating</w>
altern atives</w>
alpha, beta-
alpha 2
aller gi
adv ise</w>
adi pon
aden oma.</w>
acr ynic</w>
acid- base</w>
acid s.</w>
abs ent.</w>
[ n</w>
[ corrected
Wil m
U ),</w>
Toge ther</w>
TT P</w>
TI MI</w>
T MP</w>
Sin us</w>
ST- T</w>
SN C
SD ).</w>
S ide-
S ci
S 9
Ris perid
Rec ur
RE M</w>
RB F</w>
R s)</w>
R ep
R S)</w>
Quin idine</w>
Qu eti
QT- prolonging</w>
Pseud omonas</w>
Pre ventive</w>
Potenti ation</w>
Pic rotox
PT )</w>
PL D</w>
P ap
P W
P P</w>
P IIIN
P CO2</w>
Op tim
Octre otide</w>
O m
Nine ty</w>
Nim odipine</w>
Ne w
Na+ -
Na -
NT -
NS ,</w>
NO S
NM S.</w>
NA G</w>
N2 O</w>
N-acetyl- beta-D-
N Y
N ,
MR S</w>
MA O</w>
MA O-
MA C</w>
M n
M K</w>
M 5</w>
M -1</w>
Lim ited</w>
Lew y</w>
LI D.</w>
L- carnitine</w>
L H-
L 6</w>
L 1</w>
K now
In voluntary</w>
Impair ment</w>
Im pact</w>
Ig E</w>
IT B</w>
I ]
I E
Hypercal cemia</w>
Hyper algesia</w>
Ha emat
HR T</w>
HLA- DR
HET E</w>
HAM- D</w>
H U</w>
H B</w>
H 2-
Gener alized</w>
GABA B</w>
G reater</w>
G re
Fish er</w>
FK50 6-
F olic</w>
Etom idate</w>
E(2)17 G</w>
E K
E (2)</w>
Dose- limiting</w>
Di privan</w>
De si
De f
DSM-III- R</w>
D s)</w>
D Y
D -1</w>
Creat inine</w>
Con version</w>
Con cer
Compar isons</w>
Ch E</w>
CT A</w>
CM .</w>
CI =
CA ,</w>
C57B l/
C ros
C hi
C ana
C CB
Bor tezom
BoNT /A</w>
Bcl -
B io
B ay</w>
B aro
B :</w>
Ar rhyth
Ant agonism</w>
Anesthesi ologists</w>
Am p
Alco hol</w>
Ab dominal</w>
ATP- sensitive</w>
AN F</w>
AB P</w>
A udi
A ten
A TIONS:</w>
A PD
A AF</w>
A (1)</w>
9 5
8 97</w>
6- fold</w>
6 6.
6 5
5 5.
5 5-
48- hour</w>
4 4.
4 20</w>
39 ,</w>
3. 9
3. 8%</w>
3. 0,</w>
3 5)</w>
3 40</w>
3 000</w>
2339 0,</w>
23 %,</w>
200 6,</w>
2. 4
2 7)</w>
2 6)</w>
2 28</w>
2 1.</w>
199 1</w>
18 3</w>
16 2</w>
15-1 788</w>
15 55</w>
14 7</w>
14 6</w>
13 7</w>
13 4</w>
125 I-
12- year-old</w>
10- year-old</w>
10- day</w>
10(9)/ L</w>
1. 1-
1 13
1 1-year-old</w>
1 0.9</w>
1 0.6</w>
1 0.2</w>
0.00 8).</w>
0. 22</w>
0. 18</w>
0. 12
-1. 0</w>
-1, 2-
-1 4</w>
- A</w>
- 4-
- -</w>
(W T)</w>
(V i
(ST Z)</w>
(S M
(S ):</w>
(P N
(M P
(L AD)</w>
(HBs Ag
(H V
(D N
(D D
(CH F).</w>
(C y
(Ad riam
(A RF
(8 5%)</w>
(6 3%)</w>
(5 2.
(3 9%)</w>
(3 7%)</w>
(2 0%</w>
(100 %</w>
(1-1 3)</w>
(1 9</w>
( increased</w>
( incidence</w>
y ol
xam oterol</w>
writ ten</w>
where by</w>
week ly,</w>
wat er,</w>
w in
volume tric</w>
vol ar</w>
vir us-
vesi cles</w>
ver s
vasodil ation.</w>
vac iz
v afloxacin</w>
ush ing's</w>
us ),</w>
uro dynamic</w>
ur gency</w>
unmas ked</w>
uncerta in,</w>
un resectable</w>
un ineph
um ;</w>
ul nar</w>
ul ic</w>
ucin do
u wol
u ve
u pri
tw o.</w>
trin it
tri meta
trastuz umab</w>
transplant ,</w>
trans thoracic</w>
trans itory</w>
tramad ol,</w>
trache a</w>
tol ter
tobac co
tic s:</w>
thym us</w>
thre e,</w>
thre at</w>
though ,</w>
thir st</w>
thioper amide</w>
the ta</w>
tetra zol
territ ory</w>
terbutal ine,</w>
ter m.</w>
tacrolim us-induced</w>
ta zol
t -induced</w>
t 's</w>
symptom atic,</w>
sur pris
suppres sion,</w>
super vision</w>
sulpiri de,</w>
sulfamethox azole</w>
sulfadi azine</w>
sulf asalaz
sul ind
subst ances.</w>
sub mucosal</w>
su t
ster ior</w>
sten otic</w>
st ran
spread ing</w>
spont aneously.</w>
specimen s.</w>
spas tic</w>
spar floxacin</w>
sp ra
sp ong
sotal ol.</w>
soci o
smo ke</w>
small -dose</w>
sion -induced</w>
simul ating</w>
sh am
sep ti
self- administration,</w>
self- administer</w>
seizure -related</w>
sedi ment</w>
scopol amine,</w>
sampl es.</w>
sal vianolic</w>
s one-induced</w>
s l</w>
s av
s agittal</w>
rough ly</w>
rifamp ic
ri lu
retur ning</w>
reth ral</w>
restrain t</w>
resol ved,</w>
requ is
remoph or</w>
relap se,</w>
reinfor ced</w>
regres sion.</w>
rectom y.</w>
recipi ent.</w>
recipi ent
re produce</w>
re entry</w>
re acting</w>
rat s).</w>
ra uwol
ra c</w>
r t-
r in.</w>
r CBF</w>
quad rant</w>
pulsati le</w>
publ ished.</w>
pu st
protocol s.</w>
prophyl axis,</w>
promot ers</w>
prometh azine</w>
prog ab
proc al</w>
pro inflammatory</w>
pri ma
presum ptive</w>
present ed,</w>
pregnan olone</w>
pot ent,</w>
posses sing</w>
por t</w>
poly cystic</w>
pneumon itis</w>
plat form</w>
plant ation</w>
pl an</w>
piri de</w>
pine al
person- years</w>
periaqu eductal</w>
per oxidative</w>
pepti de,</w>
pemphig us</w>
pec uli
paw .</w>
patch y</w>
pass ed</w>
partici pat
paradig m.</w>
p.o .),</w>
p mol</w>
oxotremor ine</w>
oxi b
ox prenolol</w>
over night</w>
out bred</w>
ouabain -
organophosph or
or ally)</w>
opioid ergic</w>
on yl</w>
ometr y,</w>
omal ac
om edull
ol e-induced</w>
off '</w>
of en
oce le</w>
occur s,</w>
oc eptive</w>
ob tained,</w>
normoten sion</w>
non- pregnant</w>
non ischemic</w>
nitrosou rea</w>
ng/m L)</w>
neuropath ies.</w>
neurolog ically</w>
networ ks</w>
nerv es,</w>
nephrectom ized</w>
nalox one-induced</w>
n ical</w>
n ary</w>
myo globin</w>
myalg ia,</w>
mu tism</w>
mu mol</w>
mou se)</w>
moti f</w>
mother s.</w>
month s'</w>
mono amines</w>
moderate- to-severe</w>
mo ro
ml ),</w>
mifeprist one</w>
microgram .
mi as</w>
mg/kg/ day).</w>
mg/ 70</w>
metr y,</w>
metopro lol.</w>
methoc tramine</w>
meth i
meth azol
metast ases.</w>
meta- analysis.</w>
mes angi
mening itis,</w>
me et</w>
me -
maz indol</w>
maz e,</w>
mat ine</w>
macro li
mOsm /
m ur
lymph oma,</w>
lymph adeno
ly ).</w>
losart an.</w>
lo fex
lip ids,</w>
life- threat
li tis</w>
level s;</w>
lea ving</w>
lat ency.</w>
laparo scopic</w>
lact ate,</w>
laborator y,</w>
l- N
l es
l av
kin ase.</w>
ith m</w>
ip ).</w>
ion tophore
iod inated</w>
intra ventric
intermedi ate-
interferon- alpha</w>
inter cellular</w>
integr ation</w>
insul ts</w>
instruc ted</w>
initi ated,</w>
inhal ation.</w>
ing ).</w>
inf ective</w>
ine a</w>
induc er</w>
index es</w>
indap amide</w>
ind welling</w>
inci sion</w>
in significant</w>
immunomodul atory</w>
immunohistochemistr y.</w>
immunocom promised</w>
immunoblo tting</w>
immuno globul
im idazole</w>
il -treated</w>
if ying</w>
ide :</w>
id ine-
ic y</w>
ic ity,</w>
ic h
i as</w>
hypother mia.</w>
hypoten sion:</w>
hypo perfusion</w>
hypo glyce
hypercholesterol emia.</w>
hyperbilirub inemia</w>
hydrochlorothiaz ide.</w>
hydr ation.</w>
hist ochemistry</w>
hepati tis:</w>
hepat ocytes,</w>
hematoc rit
heighten ed</w>
health care</w>
haemorrh age,</w>
h -1</w>
gu ided</w>
granulomat osis</w>
granulo ma</w>
gran ules</w>
graf ting.</w>
gluteth imide</w>
gestod ene</w>
genit ourinary</w>
gen e,</w>
gabap ent
g/ min</w>
g/ kg)</w>
g av
g ;</w>
fund us</w>
fresh ly</w>
frag ment</w>
four- point</w>
four teen</w>
followe d.</w>
foci .</w>
foc using</w>
flut ter.</w>
flur ane-induced</w>
flu -like</w>
fatal ities</w>
fat ality</w>
fat al,</w>
famoti dine</w>
facilit atory</w>
fac e,</w>
f ut
f iltr
exter na</w>
explo red.</w>
explan ations</w>
exceed s</w>
event ual</w>
eu gen
ethan ol
et h</w>
estrogen -
erg onov
ere d.</w>
er obic</w>
epi rac</w>
epi gastric</w>
ephed rine.</w>
enter ocol
ent ally</w>
enrol led,</w>
enc ies,</w>
en sed</w>
en profylline</w>
en demic</w>
em poral</w>
electro -
eigh th</w>
effac ement</w>
ectop y</w>
ecti vely,</w>
e pl
e ase</w>
dysrhyth mia</w>
dy sur
down stream</w>
dog s)</w>
docetax el
dis plays</w>
dis odium</w>
dis cour
direc tional</w>
diphenhydram ine,</w>
dimin ution</w>
digox in-induced</w>
diaphrag matic</w>
diagnos ing</w>
dex fenfluramine,</w>
develop .</w>
deterior ation.</w>
depri ved</w>
depres s</w>
dementi a,</w>
def ined,</w>
de x</w>
day -
d ,
cytoskele ton</w>
cytos olic</w>
crav ing.</w>
cranio facial</w>
coun ting</w>
cost- effective</w>
cortic es</w>
convul sion
contra sted</w>
cons ent</w>
confirm ation</w>
conduc tion,</w>
con stituted</w>
con sensus</w>
compon ents.</w>
compli ance,</w>
complete .</w>
comple ted.</w>
colum n</w>
co- treatment</w>
co ding</w>
co d
cm ;</w>
clomi pramine.</w>
clomi phene</w>
clarithrom ycin.</w>
cis- retinoic</w>
circl ing</w>
chon dro
cho ose</w>
chlorpromaz ine.</w>
chloral ose</w>
cerv ic
cent er,</w>
catechol amines.</w>
catechol amines,</w>
catal ase,</w>
cas t</w>
carcin oid</w>
capac ity,</w>
cad aver
cadaver ic</w>
ca use,</w>
c res
c iclo
c age</w>
bri mon
body -
blun t</w>
bl ind,</w>
bicarbon ate.</w>
bic yclo
beta- hydroxylase</w>
beta- adrenoceptors</w>
ben ser
behavi ors,</w>
beat -to-beat</w>
be vaciz
bal ance.</w>
b asis,</w>
azot emia,</w>
azos in,</w>
avi an</w>
atracuri um.</w>
ation s:</w>
ate -treated</w>
asth ma,</w>
ast at
aro se</w>
argin ine-
arc ot
arachno idi
anxiety- like</w>
antidepress ant,</w>
anti phospholipid</w>
anti migraine</w>
anser in,</w>
anorec tic</w>
angi oneurotic</w>
angi itis</w>
anast om
analy sed.</w>
an y,</w>
aminoglyco side-induced</w>
am ifost
alpha 1</w>
alpha -1</w>
alopec ia,</w>
allo steric</w>
all y-induced</w>
al "</w>
again .</w>
ag ra
aeruginos a</w>
adultho od</w>
adrenal ine,</w>
addic tion,</w>
ad ec
ad ds</w>
achie vement</w>
acetyl transferase</w>
accompl ished</w>
ac ade
able ;</w>
a e)</w>
Zidov udine</w>
Z O
Z ).</w>
Yohimb ine</w>
X- A</w>
Wol ff-Parkinson-White</w>
Wilm s'</w>
W al
Ve terans</w>
Unexpect edly,</w>
U A</w>
Tw o-
Toler ability</w>
Th en</w>
Tempor ary</w>
TN S</w>
T u
T LP
T LE</w>
Syn cope</w>
Strept ococcus</w>
Statis tically</w>
Sot alol</w>
Side- effects</w>
ST AT
SR S</w>
SH Rs</w>
SH ,</w>
SC -
S mo
S ensor
S em
S e</w>
S core</w>
S P)</w>
Rib avirin</w>
Res er
Rech allenge</w>
Rec or
Re duc
Rapam ycin</w>
RA 0
R- R</w>
R y
Pseud o
Predic tors</w>
Phy sos
Pharmaco kinetics</w>
PR S</w>
PF 4</w>
P ul
P ergol
P arox
P ON
OUTCOME :</w>
O Cs</w>
Ne ural</w>
Na(+ )/
N- methyl</w>
N eu
N RA0
Myocardi tis</w>
Myo pathy</w>
Methyl phenidate</w>
MT .</w>
MP O</w>
MENT :</w>
M ZR</w>
M I,</w>
M G</w>
Leuk openia</w>
Lab et
LHR H</w>
L-NAME .</w>
Kore an</w>
Ket ocon
Imi pramine</w>
Im proved</w>
IV ).</w>
II ),</w>
I T-
HI P/
H 2-receptor</w>
Go od</w>
GS K
GABA .</w>
GA P-
G ran
G rad
Furosem ide</w>
Forty- one</w>
Fluc onazole</w>
F s</w>
F O</w>
Ev ent</w>
Epi leptic</w>
Endo thelial</w>
El ect
ER K
EE Gs</w>
ED TA</w>
EC 50</w>
E osinophil
E ar
Docetax el</w>
DP CP
DF P-induced</w>
D yn
D y
Curren tly,</w>
Concentr ations</w>
Cochran e</w>
Clin ically,</w>
Centr e</w>
Calc ineur
CS F.</w>
CO (2)</w>
CF U-
CD 8
CBD CA</w>
CB D</w>
C- reactive</w>
C lop
C .
Ble eding</w>
Bcl -2</w>
BT X-A</w>
B ut
B is
Aut o
Apop tosis</w>
Anti oxidant</w>
Ant ine
Am ne
Am lodipine</w>
Ad v
AZT -induced</w>
AT P,</w>
AR CH</w>
AO AA</w>
AM ,</w>
A symptomatic</w>
A cyclo
A K</w>
A F.</w>
= .00
9 0,</w>
8 1%</w>
7- fold</w>
7 %.</w>
6. 0
50 /
5- methyl
5 9.
4- day</w>
4, 5-
36 ).</w>
30- day</w>
30 %.</w>
3, 5-
3 3)</w>
24 3</w>
200 0.</w>
2. 3
2 1).</w>
2 '-
199 4,</w>
19 80</w>
19 4</w>
10(- 3)</w>
1- 4</w>
1 h</w>
1 20,</w>
1 0.4</w>
0.5 2</w>
0.000 5).</w>
0.000 1,</w>
0.00 4).</w>
0.0 1
0. 28</w>
0. 1-
.0 1),</w>
-10 ,11-
-1 8
- n-propyl
- drug</w>
- 7</w>
- 0.4
, S)-
+/ +</w>
)- related</w>
(p< 0.05).</w>
(S V
(S OD
(S A
(R P
(R ,S)-
(P =0.00
(NSAI D)</w>
(MA )</w>
(I D
(HBe Ag)</w>
(H b)</w>
(FK50 6)</w>
(D P
(C PK
(Adriam yc
(A SA</w>
(A F)</w>
(8 1%)</w>
(7 3%)</w>
(7 /
(50 -
(50 )=
(5 7%)</w>
(5 2%)</w>
(4- fluoro
(3 0
(3 ),</w>
(2 8%)</w>
(2 5
(1- 7)</w>
(1 6
(1 0.
(+/- )</w>
( without</w>
( gamma-
zon is
zon a</w>
zol e.</w>
y t
y 's</w>
xim al</w>
x ia</w>
world wide</w>
wor k.</w>
with ,</w>
wei gh</w>
wa y.</w>
w hi
vis it,</w>
vi gorous</w>
vi d</w>
vessel s,</w>
vecur onium.</w>
vastat in-induced</w>
vasodilat ation.</w>
vasoconstric tion,</w>
vari able.</w>
v inorelb
us ).</w>
ure ter</w>
ur ished</w>
ur ap
ur aemia</w>
under -
um ab
u y
tun nel</w>
tro glitaz
triglyceride s,</w>
tri hexy
trihexy phenid
treatment ).</w>
traz ol</w>
transp eptidase</w>
transmis sion,</w>
trans duc
toxic ity;</w>
toc olytic</w>
to uch</w>
to ols</w>
time ;</w>
ti um-
ti ous</w>
thyron ine</w>
therap y)</w>
ther to</w>
tempo l</w>
t s:</w>
t s)</w>
synchron ous</w>
sy ring
surviv ors.</w>
subst ances,</w>
str ab
stitut ed.</w>
stimul us.</w>
stat in-
st able,</w>
spinal- epidural</w>
spi king</w>
sper mat
spar te
so .</w>
smok ing.</w>
sl urred</w>
sertral ine,</w>
sel dom</w>
scrat ching</w>
scopol amine.</w>
scolio sis</w>
sci enti
scal es.</w>
sar izotan</w>
sar coma,</w>
s.c. )-induced</w>
s ound</w>
s er</w>
ru n</w>
rop ini
room .</w>
rom yo
rofecoxi b.</w>
ro le,</w>
rit od
risk- benefit</w>
rilu zole</w>
rh initis</w>
ret ina</w>
resol ving</w>
resist ance
requis ite</w>
ren oprotective</w>
recommend ation</w>
recent -onset</w>
rec ti
re tin</w>
re perfusion.</w>
rat entorial</w>
rat 's</w>
rami pril</w>
radioimmuno assay.</w>
radio activity</w>
r f
r TMS</w>
questionnai re.</w>
quater nary</w>
qu it
purpo se,</w>
pum p.</w>
pulse less</w>
psycho pathology</w>
psycho active</w>
psych opharmac
pseud o-
prob es</w>
prob enec
pri ate</w>
preser ved.</w>
prescri be</w>
prepar ation,</w>
prefer ring</w>
prednisol one.</w>
pre mixed</w>
pre conditioning</w>
pr amine,</w>
post- training</w>
posi tivity</w>
pos tischem
polymorph onuclear</w>
polycy themia</w>
pol lic
po ison</w>
physostigm ine,</w>
phot oph
phosph ate,</w>
pheochromocyt oma.</w>
phenotyp e.</w>
ph an</w>
pg/ mL</w>
pentobarbit one</w>
pent ol
penicill in-
pea ks</w>
pea king</w>
patient :</w>
path ology,</w>
pare sis.</w>
pac ked</w>
pa the
pa st
p o</w>
p ad
ouabain ,</w>
otroph ic</w>
oti fen</w>
ot e
osteomyeli tis</w>
orn ith
orig inating</w>
orbit of
or tic</w>
opportun ity</w>
ophil ic</w>
oper ant</w>
opath y,</w>
op ent
on ec
on "</w>
omeprazol e.</w>
omedull in</w>
ome ga
omat osis</w>
olo l-induced</w>
ol ution</w>
ograph ically</w>
ocyt uria</w>
och ol
occupati onal</w>
obses sive</w>
obser ver</w>
o glyc
nucle ol
noradrenal ine,</w>
no urished</w>
no otropic</w>
no des</w>
nitro tyrosine</w>
nitren dip
nicoran dil</w>
nevir ap
ne bivolol</w>
natur alistic</w>
nat ure,</w>
naprox en.</w>
n- Whit
n s.</w>
n ia,</w>
my o-
mut ation.</w>
mucosi tis,</w>
moxon idine</w>
morphine- dependent</w>
mon om
mo genic</w>
mmol/ L)</w>
mm /
ml/min/ 100</w>
mit tent</w>
minocycl ine-induced</w>
minipum ps</w>
minim al-
min(-1 ),</w>
mim ics</w>
mil lis
millis ec
migra ine,</w>
microcephal y</w>
mg/m L</w>
methyser gide</w>
methyl dopa.</w>
methicill in-resistant</w>
methamphetamine- dependent</w>
metam iz
melan oma.</w>
medic ine.</w>
medi ated.</w>
materi al.</w>
mat ch</w>
mark ers.</w>
man ia,</w>
man 's</w>
malform ations,</w>
m argin
ly tic</w>
low- risk</w>
low- protein</w>
low er,</w>
long term</w>
log- rank</w>
lo us</w>
lo r</w>
lo bul
limit ed,</w>
lig ation-induced</w>
libid o</w>
li ve
levamisol e.</w>
leuk otri
l ing,</w>
iz ations.</w>
iv ocal</w>
iti s:</w>
is ometric</w>
is ob
is ms.</w>
inv asi
intracor tical</w>
interval )</w>
integr al</w>
insidi ous</w>
inser tion.</w>
injur ies.</w>
injec tion
ingre dient</w>
ing eal</w>
ing -induced</w>
inde ed</w>
inadver tently</w>
in- sensitive</w>
in ase</w>
in appropriately</w>
im pul
il legal</w>
il ing</w>
il ic</w>
ia ),</w>
i ome
hypo glycemic</w>
hypo activity</w>
hyperprolactine mic</w>
hydroxy ure
hormon e,</w>
high -</w>
hi therto</w>
hex a
heter ozyg
he aled</w>
haloth ane
gynecomasti a</w>
guaneth idine</w>
gram s,</w>
go t</w>
gn ath
gir ls</w>
gi ves</w>
ge u
ge fit
gaz e</w>
g/ d</w>
g o</w>
furazol idone</w>
function ing,</w>
frequ ently.</w>
frequ ency
frequ encies.</w>
form oterol</w>
form al</w>
fo od-
fo etal</w>
fluoxet ine-induced</w>
flexi ble</w>
fl uroth
first- time</w>
find ing.</w>
finaster ide</w>
femal e.</w>
fe et</w>
fa il</w>
f ain
ey e,</w>
extrapol ated</w>
expl or
evul inic</w>
evol ving</w>
etopo side,</w>
etodol ac</w>
ethambut ol-induced</w>
eth al</w>
estradi ol.</w>
establ ishing</w>
ept or</w>
epilep tics</w>
epi andro
enzym ic</w>
endot ox
end arte
end ,</w>
en thix
empir ical</w>
emin ence</w>
electro cortico
ed- onset</w>
ec hi
e sis.</w>
e at
dystroph y.</w>
dysarth ria</w>
dynes/ cm
du oden
dose- dense</w>
dos ages,</w>
dog ,</w>
disopyram ide.</w>
dis ulf
dis placement</w>
dipyridamol e,</w>
dimin ishes</w>
digox in-
differenti ation.</w>
diff usion-weighted</w>
diag nose</w>
dextro amphetamine</w>
dex amphetamine</w>
dex am
dexam fet
develop s.</w>
deterior ating</w>
desi re</w>
dermat ologic</w>
deg ran
deficit /
deficit/ hyperactivity</w>
decre ment</w>
dec a
debilit ating</w>
de qu
de acetyl
day (-1)</w>
d ine-induced</w>
cyst oscopy</w>
cyclospor ine,</w>
cyclopent yl
crac k
counter acts</w>
coun ts.</w>
coun t.</w>
cor responds</w>
controversi al</w>
control s;</w>
contrac tility,</w>
constric ted</w>
confirme d.</w>
conduc tion.</w>
con curren
commis sural</w>
coll ected.</w>
co herence</w>
cm /
clozap ine-treated</w>
clon al</w>
clo sed-
clipp ing</w>
clas s.</w>
clas s,</w>
circumst ances</w>
cho w</w>
ch ori
cephal ic</w>
cefotet an</w>
caudate- putamen</w>
catarac t</w>
carbach ol-induced</w>
carbach ol,</w>
ca st
c olic</w>
c .)</w>
but yr
bur den</w>
bupivaca ine-
bul im
bu b
bronchospas m</w>
breast ,</w>
br ush
bo vine</w>
bleph aro
ble ,</w>
bis phosphonates</w>
bir th,</w>
bicalut amide</w>
bi ventricular</w>
bi periden</w>
bi ochemical,</w>
bi as</w>
beta- blockers.</w>
beta- adrenoreceptor</w>
beta- 2</w>
beta ine</w>
beta (2)-
benzoyl ecgonine</w>
benzodiazep ine,</w>
bam buterol</w>
b -
aver sive</w>
audi ometry</w>
audi ograms</w>
atr an</w>
ation s)</w>
ati pame
atherosclero sis,</w>
ather ogenic</w>
at re
assess ment,</w>
aspar tic</w>
ase- positive</w>
ascorb ate</w>
asc icular</w>
as pect
as e
art an,</w>
ari e-
arcot -M
arb ox
arabino side.</w>
ar ia</w>
aquapor in-
ap rine</w>
ap r
antipsycho tic-like</w>
antipsycho tic,</w>
antidepress ant-induced</w>
anticoagul ation,</w>
antibod y.</w>
anti- parkinsonian</w>
anti oxidative</w>
antagonist ),</w>
ant en
ant )</w>
anhydr ase</w>
aneurysm s.</w>
anaphyl actoid</w>
an oids</w>
amitriptyl ine.</w>
amine ;</w>
amine :</w>
amin ol
amant adine.</w>
alpha-methyl- p-
alpha 3</w>
all idal</w>
alg or
alfentan il.</w>
aldehy de,</w>
al t
ag en</w>
advant age
adrenocept ors,</w>
adren erg
adju v
adipon ectin</w>
addi tionally</w>
add- on</w>
adap tations</w>
acade mic</w>
ab users,</w>
a ul
[ 3-
YM 430</w>
X- ray</w>
Wee kly</w>
WR-27 21</w>
VT A</w>
V ig
V F.</w>
V CM</w>
V 2</w>
U I</w>
Trimethop rim-sulfamethox
To oth</w>
Time -
TT P/
TH E</w>
T O
T E</w>
T C
Syst em
Suc cin
Subst ance</w>
Struct ural</w>
Sch iz
ST ),</w>
SE ARCH</w>
SE ).</w>
SAM e</w>
S cre
S cop
S CN
S ;</w>
S 14
Ring er's</w>
Ri ght</w>
Recur rence</w>
Re action</w>
R at
R AL
Prolong ation</w>
Pro ximal</w>
Perio perative</w>
Pa O2</w>
PA -induced</w>
P y
P ir
P al
P ER
Ou t</w>
OA B</w>
Neuro psychiatric</w>
NSAID -induced</w>
NO ,</w>
NB QX</w>
NA S</w>
N-nitrosodiethyl amine</w>
N-methyl- d-aspartate</w>
N ov
N G</w>
N CE:</w>
Met o
MPT P-
MM C</w>
MA O
M olecular</w>
M SA</w>
Lind ane</w>
Li pos
Levo dopa</w>
Lang endor
LT ),</w>
L- dopa.</w>
L ymph
L A
K E
Intra ocular</w>
Inter mittent</w>
Inhib itory</w>
Individu als</w>
In tram
In dic
Impres sions</w>
II I/
I mat
I HD</w>
Hyper baric</w>
Hy dr
Hunting ton's</w>
Hospit al.</w>
HUS ,</w>
HBsAg -positive</w>
HBeAg -negative</w>
H Y
GA G</w>
G ab
Forty- three</w>
Fifty- four</w>
FE AT
F ast
F ascicul
F U</w>
F G</w>
Ex trac
Epi rub
Ep inephr
Endo thel
Elect romyo
EC M</w>
EC G
E rec
E phed
E N</w>
E -17
Dose -related</w>
Don epe
Do pa
DBA/2 J</w>
D2 R</w>
D er
D G
D CE</w>
D 1/
Cs A.</w>
Creat ine</w>
Cor tis
Contr ary</w>
Con di
Clop ido
Clin ical,</w>
Cl assi
Cl ar
Cl -</w>
Ch ec
Ch arcot-M
Celec oxib</w>
Ceftriax one</w>
Ce bus</w>
Cd A</w>
Cana dian</w>
CT ,</w>
CR H</w>
C ushing's</w>
C 57</w>
BoNT -A</w>
Bi opsy</w>
Benz odi
BZ D</w>
B P.</w>
B P,</w>
B MI</w>
B C</w>
B ;</w>
Appro priate</w>
An y</w>
Al b
Ace tazol
Ac tivity</w>
Ac cumulation</w>
AR F,</w>
AL )</w>
AF- DX</w>
AE D</w>
ADR +
AD R,</w>
A dequ
> =</w>
8 9.
8 ,
7 9-year-old</w>
6- thioguanine</w>
6 50</w>
6 0)</w>
50- mg</w>
5- M
5 7.
5 3,</w>
4-amin opyridine</w>
4 5)</w>
39 ).</w>
3. 6
3. 5%</w>
3-mercapto propionic</w>
3,4- D
3 6-
3 00-
3 )
23 4</w>
2- hour</w>
2- adrenoceptors</w>
2 9-
2 2).</w>
2 17
2 1
2 )
199 3,</w>
198 9</w>
198 6</w>
19 8</w>
19 80
19 5</w>
16 ),</w>
141716 A</w>
100 %,</w>
1, 6
1 20-
1 1.0</w>
1 0.3</w>
00 /
0.7 5%</w>
0.0 6
0.0 4)</w>
0.0 %</w>
0 +/-
/ P
-1 20</w>
-- -
- I</w>
) ]
(S R)</w>
(S )</w>
(R R)</w>
(P a
(P R)</w>
(N R
(N P
(N H
(N A)</w>
(MA P),</w>
(H A
(F S)</w>
(E AC
(8 00</w>
(5 6%)</w>
(5 5</w>
(3 2</w>
(3 2%)</w>
(3 /
(3 ,</w>
(2 4%</w>
(2 .0
(1 1)</w>
(0. 7</w>
(0. 5,</w>
(0. 25-
( s.c.)</w>
( patient</w>
( more</w>
( left</w>
( high</w>
( heart</w>
( difference</w>
( 50%</w>
( 0-1
z imel
yridox ine</w>
yr amine</w>
yol k</w>
ym path
year )</w>
yc in-
y aw
y al</w>
worl d</w>
work up</w>
work ers</w>
whole- body</w>
wat er
vis ited</w>
verapam il
ver theless</w>
ventric ulography</w>
ve ter
ve ins.</w>
valu e,</w>
v ular</w>
v im
uter us</w>
use ful
urticar ia,</w>
uro toxicity</w>
urg e</w>
ur ate</w>
upri ght</w>
understo od</w>
unc oupl
un treated,</w>
un predict
ulo pathy,</w>
udi l</w>
ub ital</w>
u )</w>
trypt amine</w>
tretino in</w>
treatment- resistant</w>
transfer ase,</w>
tran su
transu rethral</w>
trac ts</w>
trac tive</w>
tra vel
toler ability,</w>
to gen
tissu e-
tis h</w>
ticlop idine,</w>
ticar c
tic /
tic )</w>
thy smo
throm bi
threshol ds.</w>
th s</w>
th in</w>
th ick</w>
ten sion
ten -
teicoplan in</w>
tauro ursodeoxycholate</w>
tan dem</w>
tachy cardiac</w>
ta u</w>
t one,</w>
t apping</w>
syndrome )</w>
sympath o-
swell ing,</w>
sup rac
summ ary</w>
sumatript an,</w>
sulph on
suc h,</w>
subsequ ently,</w>
sub optimal</w>
stud y;</w>
stra ins,</w>
stra i
sti tial</w>
ster on
st y
st upor</w>
st -induced</w>
spectro metry</w>
spectro metry.</w>
specific ,</w>
sol ut
slic es.</w>
sigma (1)</w>
shock -induced</w>
sex u
sequ encing</w>
sensor y-
seizure- inducing</w>
second arily</w>
se as
scre ens</w>
scot omas</w>
sco re
scaveng er,</w>
scal ene</w>
sc en
satis factor
saline- injected</w>
s -induced</w>
run -in</w>
rt- PA</w>
rit uxim
ricket s</w>
retrospecti vely.</w>
retard ation.</w>
resp ect
resid ents</w>
rescu e.</w>
requi red,</w>
reporte dly</w>
replic ation.</w>
replac ement,</w>
relax ations</w>
reinforce ment.</w>
reg im
refrac tive</w>
recogn ized,</w>
radi ocon
rad icular</w>
quin april</w>
quarter s</w>
pur su
public ations</w>
prote oglyc
prot ective.</w>
propylthio uracil-induced</w>
prophylac tically</w>
prolong ed.</w>
program ,</w>
profoun dly</w>
prob able
pro of</w>
pro l</w>
pro convulsive</w>
preven tion.</w>
precl uded</w>
prece des</w>
pre hospital</w>
pos ing</w>
por tions</w>
poison ing,</w>
ple thysmo
plasi a,</w>
plac ing</w>
phot osensi
perman ently</w>
perm it</w>
pericardi tis.</w>
pericardi tis,</w>
perf usate</w>
pe dic
paradig ms</w>
papaver ine.</w>
pal ate,</w>
pal atal</w>
pac ing,</w>
pa in)</w>
pa di
pa d</w>
p assi
p 75
oxcarb azep
over drive</w>
ov agal</w>
ou se</w>
ot oxin</w>
ost er</w>
osmolal ity.</w>
os pinal</w>
origin ally</w>
ore x</w>
or um</w>
or al,</w>
opportun istic</w>
oplas mo
om edullary</w>
olg i</w>
ol in
occurren ces</w>
oc ent
oc al
obj ectively</w>
o estradiol</w>
o edema.</w>
non- significant</w>
nocicep tion,</w>
ng/ kg/
neurolep tic,</w>
neuro vascular</w>
neuro peptides</w>
neuro biological</w>
nephro lith
neoplas ms.</w>
necessit ate</w>
ne fir
n ac
n NOS</w>
n ;</w>
mydri asis</w>
myalg ia.</w>
multi organ</w>
mucos a,</w>
mono hydrate</w>
moi ety</w>
mode s</w>
modal ities</w>
minocycl ine.</w>
micrograms.kg-1. min-1</w>
mibefradi l</w>
mi um</w>
metoclopram ide,</w>
methylprednisol one.</w>
methylphenid ate.</w>
methyl transferase</w>
methyl glutar
mesi al</w>
mes alaz
mefloqu ine.</w>
medic ine,</w>
medi ated,</w>
mean ing
mas ked</w>
mar mo
mapro tiline</w>
male ate,</w>
mala ise</w>
mRNA .</w>
mL/ min/
mE q</w>
m mol
m ia;</w>
m ass
m Ab</w>
m ),</w>
luk ast</w>
lograph y.</w>
locomo tion.</w>
lobe .</w>
lo t
ligi bility</w>
lig ation.</w>
leth an
length ened</w>
leng th,</w>
lenal idom
le ish
leish man
l en
kallikre in</w>
k ling</w>
iz ers</w>
iterpen e</w>
isol ated,</w>
io -
intrag astric</w>
intest inal,</w>
intersti tium</w>
inter scalene</w>
inter im</w>
inter acting</w>
integr in</w>
insul in-like</w>
institu tions</w>
institu tional</w>
insp iratory</w>
inflammat ory,</w>
infiltr ating</w>
infer i
inf using</w>
inf ra
in ous</w>
in determin
in amide</w>
implic it</w>
imipr amine-induced</w>
imidaz enil</w>
ido pa
ic- tonic</w>
ic hi
i vermectin</w>
hypox ia.</w>
hypox ia,</w>
hypomagnesem ia,</w>
hypocalce mia,</w>
hypo gly
hyper sensitivity,</w>
hydroxy toluene</w>
hy ster
hour s;</w>
hol ding</w>
hexachloro cyclohex
her nia</w>
hepat omegal
hemo therapy</w>
heigh t,</w>
haloperid ol-treated</w>
haemodi lution</w>
haemat oma</w>
habit uation</w>
h os
h old</w>
guan fac
grav ity</w>
granulocy te-
go es</w>
glycos uria</w>
glybur ide</w>
glucose-6- phosphate</w>
gluc agon
gl and.</w>
gangli a.</w>
gadol inium-
g inning</w>
g ent</w>
fron t
flur azepam</w>
flest olol</w>
fl us
first- episode</w>
fibrill atory</w>
fashi on,</w>
far .</w>
fai led.</w>
extub ated</w>
extrem ities,</w>
ext ent.</w>
expect ed.</w>
ex per
evid ence
event s:</w>
eti olog
eth acrynic</w>
est er,</w>
es un
es in</w>
erythro cytes.</w>
epirub icin.</w>
epilep sy-
epididy mal</w>
environ ment.</w>
entr y.</w>
enthix ol</w>
ent ation</w>
ent )</w>
ent 's</w>
encounte red.</w>
encephal on</w>
en op
en able</w>
emis sions</w>
embry onal</w>
electro retino
electr onic</w>
edar av
dysph or
dys functions.</w>
drom ic</w>
dou bling</w>
dose- depend
dobut amine.</w>
distribu tion.</w>
disten sion</w>
disru ptive</w>
dis rupt
dis appeared,</w>
diethylstilbestro l.</w>
diaph or
di ents</w>
dex verapamil</w>
desogest rel</w>
dens ity,</w>
demyel in
del usional</w>
degre e.</w>
def ining</w>
dec lines</w>
deb riso
de :</w>
da z
cyclohex yl
cyclo- oxygenase</w>
cur ve.</w>
cult ures.</w>
cri sis.</w>
cre ate</w>
cr yo
cour ses,</w>
convol uted</w>
controver sy</w>
control s).</w>
control ).</w>
contracep tion</w>
contra st-induced</w>
contra indication</w>
conjug ate</w>
cong estion</w>
conf ocal</w>
condi tional</w>
conclu sive</w>
concent ric</w>
concent rate</w>
con i
con flu
comorbidi ties</w>
comorb idity</w>
communic ation</w>
colon y</w>
colchic ine.</w>
clobaz am</w>
clinicopath ologic</w>
clar ified.</w>
cil astatin</w>
cid ofovir</w>
choro idal</w>
chlordiazep oxide</w>
chlor alo
chill s,</w>
chemotherap y:</w>
cer tain
cell ul
cefuro xime</w>
cav a</w>
catechol amine-
carrageen an-induced</w>
cardiomyo pathic</w>
carbox amide</w>
car mustine</w>
calcium- channel</w>
c ine</w>
bypas s.</w>
but olol</w>
bumet anide</w>
bp m</w>
bos entan</w>
bol us.</w>
biomark ers</w>
bin alt
binalt orph
between- group</w>
bas ed,</w>
bacter ium</w>
b one-
b amate</w>
b abo
azot emic</w>
azathiop rine,</w>
auto antibody</w>
auth or
audi ometric</w>
ati ve-
atazana vir</w>
at ric
at or-
ascit es.</w>
artic ular</w>
arth ritic</w>
art esun
arie- Tooth</w>
ar yl</w>
ar yl
ap se</w>
antr one</w>
antipyre tic</w>
antioxid ants,</w>
anti-HB s</w>
anti tuberculosis</w>
anti fibrinolytic</w>
anten atal</w>
ant -
anem ia:</w>
anatom y</w>
anand amide</w>
ana erobic</w>
an other.</w>
an il
amygdal a.</w>
aminonucleo side.</w>
amino guanidine</w>
amide /
ameth yl
alph a.</w>
aggreg ation.</w>
ag o
ag inal</w>
ag al
adul t.</w>
adenos ine,</w>
addic ted</w>
ad ded.</w>
actin omycin</w>
act u
act s,</w>
aconit ine</w>
acetyl ated</w>
accumul ating</w>
accid ents</w>
ac tions,</w>
ac com
abecarn il</w>
ab ut
ab ri
ab ic
a prost</w>
] :</w>
X- 2)</w>
W IN
V A</w>
UPD RS</w>
Treatment -related</w>
Tramad ol</w>
Thiop ental</w>
Th rough</w>
Tac rolim
Ta q
TUNE L-
TR AC
TRAC TION:</w>
TP M</w>
TMP-SM X</w>
T ur
T l</w>
T T</w>
T M</w>
T /
Syn thesis</w>
Surg ery</w>
Secon d,</w>
SV R</w>
ST ,</w>
SN S</w>
SN HL</w>
SC T</w>
SA H.</w>
S us
S o</w>
S NA</w>
S LE</w>
S A),</w>
S 100
Res olution</w>
Repor ting</w>
Recomm end
Raniti dine</w>
Raloxif ene</w>
RE LE
RELE VAN
R ot
R R
R L
R K
R H</w>
R G
Q 10</w>
Propofol -
Prog ester
Pres ent</w>
Practi tion
Post ural</w>
Penicill amine</w>
Pe g
Path ologic</w>
Parad oxical</w>
Paracetam ol</w>
Pa ren
PT ,</w>
PIIIN P</w>
PG )</w>
PATIENT :</w>
PANS S</w>
P ;</w>
O vari
Not ably,</w>
Nephro genic</w>
Na+, K+-ATPase</w>
NT69 L</w>
NT D</w>
NO .</w>
NMDA- receptor</w>
N icardi
N et
N N
Myoclon ic</w>
MTX -induced</w>
MT X)</w>
MDMA /
M er</w>
M H
M F</w>
M F
Loc omotor</w>
Li /
Li -induced</w>
LI Ds</w>
LE ,</w>
L R</w>
L H
KE Y</w>
K- ATPase</w>
K- 3
Jap an</w>
J NK</w>
Inter stitial</w>
In jections</w>
IP ).</w>
II ).</w>
ICRF-1 8
I mag
I MA
I H
Hyponat remia</w>
His -P
Hal f</w>
HO E</w>
HIV -1-
HIT ,</w>
H all
Glut amate</w>
Ger man
Gab ap
GL EP
GLEP P1</w>
G olgi</w>
G ST-
G SP
G 6
Fos car
Flu oxet
Fascicul ations</w>
FEAT URES:</w>
F ree</w>
F am
Ep iso
Electro physiologic</w>
EX TRACTION:</w>
EMB A
EC o
E stim
E AD
E 2,</w>
E ).</w>
Di ure
Di hydro
DX R-induced</w>
DOX -treated</w>
D-penicill amine-induced</w>
D en
D PO
D I</w>
Cs A-
Cros s-
Con sec
Con genital</w>
Comp uter
Clin ic</w>
Cholest asis</w>
Chem ical</w>
Charcot-M arie-Tooth</w>
Cer tain</w>
Capecit abine</w>
Cal cit
Ca ro
CO PD</w>
CNS ,</w>
CM L</w>
CG S</w>
CG RP
CB F
CA T</w>
CA S</w>
CA ),</w>
C ou
C l.</w>
C ase-
C PAP</w>
C L</w>
C F</w>
Be ginning</w>
BZ D
B rown</w>
B iliary</w>
B ile</w>
B ay
Ap parent</w>
An alo
Amino glyco
Am mon
Altern atively,</w>
Alph a-
Adju vant</w>
AS P
AR I</w>
AP PRO
AM )</w>
AH -10
ADR- 5
AD HD.</w>
A mitript
A KI</w>
A -1</w>
A (2)</w>
> or=</w>
< 0.001).</w>
< /
8 9%</w>
7 8-year-old</w>
6- mercaptop
5-fluorourac il,</w>
5-HT(2 B)</w>
5-HT 2A</w>
5-FU ,</w>
5-1 5</w>
5 00,</w>
4. 3%</w>
4 2)</w>
39 )</w>
37 ).</w>
36 ),</w>
3. 6%</w>
3 7)</w>
3 3-
26 8</w>
25 ),</w>
25 %.</w>
24- year-old</w>
24- (OH)(2)
24 ),</w>
200 4,</w>
20 2</w>
20 1
2, 4
2 6-year-old</w>
2 50,</w>
199 9,</w>
16 %,</w>
15. 5</w>
15 7</w>
14 C-
10- min</w>
10(- 7)</w>
10 th</w>
1. 8%</w>
1. 00
1- selective</w>
1,25-dihydroxy vitamin</w>
1 0.8</w>
00 0/
0.6 9</w>
0. 40</w>
0. 27</w>
0 3</w>
-1 50</w>
-- ></w>
- G
- 0.7
+ ,</w>
(v )
(p -
(V TE)</w>
(V PA).</w>
(TM P-SM
(SP EC
(S p
(P I)</w>
(L M
(HC C)</w>
(E E)</w>
(D L
(CO X-2)</w>
(AL L)</w>
(A m
(8 4%)</w>
(6 7%)</w>
(6 4%)</w>
(5 /
(4 3%)</w>
(4 2%)</w>
(4 00
(2. 5,</w>
(2 7</w>
(2 6%)</w>
(100 %)</w>
(10 %),</w>
(1. 25</w>
(1 -10</w>
(0.0 3-
(0. 8</w>
(0. 8
( un
( two
( systolic</w>
( such</w>
( score</w>
( plasma</w>
( mainly</w>
( acute</w>
' )</w>
zom epirac</w>
zol amide/
yr .</w>
yl yl</w>
year- old,</w>
y- -
y ros
worth y</w>
whole- cell</w>
whe reas,</w>
well- described</w>
wean ed</w>
warm th</w>
warfar in-induced</w>
vulg aris.</w>
volum ic</w>
vol ati
visc osity</w>
vir us,</w>
vi b
verapam il-induced</w>
ven ular</w>
vasopress in,</w>
vascul itic</w>
vacuol ation</w>
vacc ine.</w>
urticar ial</w>
urin aly
unmas king</w>
univer sal</w>
un selected</w>
un intentional</w>
uc hen
uc cin
tur ning</w>
tumori genesis</w>
tum or,</w>
tuberculo sis,</w>
transmit ter</w>
transfu sions,</w>
transamin ase,</w>
tran sesophageal</w>
tract ,</w>
topo isomerase</w>
tis ation</w>
tinnit us,</w>
tim ed</w>
thyro trop
threshol ds,</w>
thi one
thi onate</w>
thi azine</w>
th ous
th enium</w>
tetrahydro -
tetrachlor ide</w>
test ;</w>
termin als.</w>
ter 's</w>
tension -type</w>
te .</w>
t ),</w>
syn ergy</w>
symptom s;</w>
sympath ectomy</w>
sym pathe
supplement ary</w>
sup ratentorial</w>
substanti ate</w>
sube pithelial</w>
strom al</w>
streptozotoc in.</w>
stra in.</w>
stereot ax
stat es,</w>
st ut
sper mine</w>
spec ially</w>
son -
slow- release</w>
sk in-
simul ate</w>
sim vastatin.</w>
sim pl
sildenaf il.</w>
short- lasting</w>
sevoflur ane,</w>
sett ings,</w>
ses ;</w>
sertral ine.</w>
sequ ence.</w>
separ ately,</w>
selectiv ity.</w>
seg reg
secre ted</w>
se man
seman tic</w>
se m</w>
sclero tic</w>
scinti graphic</w>
sarcolem mal</w>
sal ine;</w>
run s</w>
rot ations</w>
rilmen idine</w>
rig id</w>
retri e
retic ular
resul t.</w>
rest en
resp i
respi rat
resol ves</w>
reser pin
research .</w>
res veratrol</w>
reproduc i
remodel ing.</w>
relap se-
regul ator</w>
regener ation.</w>
red ness</w>
recur red.</w>
rectom ized</w>
recor ded,</w>
rec alled</w>
reb oun
re medi
re j
re introduction</w>
re al
re admitted</w>
rauwol sc
rapid ,</w>
rang es.</w>
ra rely,</w>
r ut
qu ired</w>
q .
pyrrolid inyl)
pyri dos
pyr one</w>
py ram
puber tal</w>
psoriatic s</w>
protocol s,</w>
prot ection,</w>
proper ty,</w>
pronoun ce
prolong ed,</w>
progres sive,</w>
progest ins</w>
profil es,</w>
produc t,</w>
princ i
prim id
pri mi
pressure- volume</w>
pre emptive</w>
pre cautions</w>
pran dial</w>
pr ud
post traumatic</w>
posi tions</w>
poly godi
poly arteritis</w>
pollic is</w>
pol icy</w>
pmol )</w>
plast y,</w>
plaqu es</w>
piperid ine</w>
pilocarp ine-
phenyleth yl
phentol amine,</w>
ph obia</w>
ph ases.</w>
perf u
per mitting</w>
per g
penicill amine-induced</w>
pelle ts</w>
peculi ar</w>
pector is,</w>
pat h</w>
participat es</w>
partic le</w>
parti ally,</w>
para esthe
par ame
pair -fed</w>
paclitaxel /
pac ed</w>
p antop
oxybutyn in</w>
oxy morphone</w>
ox amine,</w>
ot ap
osi s:</w>
orphenad rine</w>
ori e</w>
organ el
orbitof rontal</w>
or ide</w>
or chi
opioid -
ophyl line
ophthalmop legia</w>
ophthalmo log
on /
ol der,</w>
ol ).</w>
oin t
od al</w>
ocap nia</w>
oc u
oc tap
observ ations,</w>
ob t
ob liter
o k
o be
numer ical</w>
noreth ind
nor- binaltorph
nitrate/ nitrite</w>
nigh t.</w>
nigh t,</w>
nicardi pine.</w>
nic ergoline</w>
ng/ d
newbor n.</w>
neo plasia</w>
natriure sis</w>
n-Whit ney</w>
n ul
muscim ol,</w>
mum ol
multi factorial</w>
mu -
moric izine</w>
mofe til
mmol/ l)</w>
mmol/ L.</w>
ml ;</w>
mit ogen
mist ak
min (-1))</w>
mictur i
microsph ere</w>
microsom es</w>
microscop e</w>
micrograms/ mL</w>
microgram/kg/ min</w>
microgram/ kg</w>
microgram )</w>
micro liters</w>
micro globulin</w>
micro emulsion</w>
micro bub
mic e)</w>
mg/kg/ h</w>
mg/K g</w>
mg /</w>
mg %</w>
membran es,</w>
medull a,</w>
medi um,</w>
mat ter.</w>
mat ter,</w>
mat ory</w>
margin ally</w>
manage able.</w>
man son
mL/ kg</w>
m id</w>
m A</w>
m 2.</w>
m ).</w>
lymph omas</w>
low- frequency</w>
lor azepam,</w>
lob ar</w>
lipo philic</w>
lig ation,</w>
li er</w>
lev ome
lef tward</w>
le ast
labour .</w>
labetal ol.</w>
lab our</w>
kynuren ine</w>
kynuren ic</w>
knoc k-
kg .
ketoro lac
keto profen</w>
ket amine-
kappa -opioid</w>
kP a</w>
k ing,</w>
it ching</w>
iso volumic</w>
iso quinol
is ation.</w>
irt ine</w>
irrit ability</w>
ir regular
ir on-
ip ,</w>
iome prol</w>
invari ably</w>
introduc ed.</w>
intravenous ly)</w>
intram yocardial</w>
intr al
inte rest.</w>
insul t.</w>
inst ances,</w>
innoc uous</w>
influenz a</w>
infer red</w>
induc ibility</w>
individu alized</w>
indic ations,</w>
indetermin ate</w>
inco ordination</w>
incl ined</w>
in- clavulanic</w>
in- 4-
in g/
in ess.</w>
if i
id ze
ic ro
i.m .,</w>
i se
hypothalam us,</w>
hypos padi
hypop ar
hypopar athyro
hypokal aemia</w>
hypo prote
hypertensi ves</w>
hyperten sive,</w>
hyperten sion
hyperprolactine mia,</w>
hyper active</w>
hydrox ylation</w>
hydrocephal us</w>
hydr ated</w>
hippocamp i</w>
highligh ted</w>
hepat oblast
hepat o
hepat ectomy</w>
he xim
he ating</w>
haplo type</w>
haloperid ol-
half- lives</w>
group s)</w>
gro oming</w>
gra de
glomer ulopathy</w>
ginsen osides</w>
gang rene</w>
galact osid
galact os
gal lium</w>
ga str
g/ kg,</w>
g/ 24</w>
g ap
ful min
frusem ide</w>
frequ ent.</w>
four- hour</w>
foscar ne
for ce
flunitraz ep
fluc loxacill
flox uridine</w>
fl am
fif teen</w>
fibrin ogen
fentan yl-
feno profen</w>
famil y.</w>
f its</w>
extrem ity.</w>
extr asystol
extr act.</w>
expl oring</w>
excit ability.</w>
exci sion</w>
ex plic
evo kes</w>
evalu ated,</w>
euphor ia</w>
etid oca
ethyn ylestradiol</w>
estrogen s.</w>
esc ence</w>
es --
erythro dysesthesia</w>
erythematos us,</w>
erythemat ous</w>
erm ally</w>
erg ometr
epid er
epiandro sterone</w>
ent ac
enroll ment</w>
enox im
endocannabin oid</w>
encour aging</w>
encephalo pathy:</w>
en in</w>
em ed</w>
ell ation</w>
electrophysi ologically</w>
ejac ulatory</w>
edroph onium</w>
ear .</w>
dysrhythmi as,</w>
dysph oric</w>
dy ing</w>
dulox et
duct openia</w>
drug- eluting</w>
dri ving</w>
dose- limiting.</w>
dose ).</w>
dn ess,</w>
distres sing</w>
distres s,</w>
disp ens
disor gan
diseas e)</w>
disabl ed</w>
dis ci
disci pl
direc t-
dimin ished.</w>
dilat ation,</w>
dig estive</w>
diarrho ea,</w>
diaphore sis,</w>
dialy sis,</w>
di pyrone</w>
di isopropyl
dev ic
deta il.</w>
design ated</w>
der ing</w>
deliri ous</w>
definit ely</w>
defici encies</w>
de stro
de emed</w>
datab ase,</w>
dan aparo
d ness</w>
d ine.</w>
d .
cyclo hexim
cult ure,</w>
cul ating</w>
crystall ine</w>
counter part
contrac tion,</w>
continu ously.</w>
constitu ent</w>
const ellation</w>
conside red,</w>
consequ ently</w>
consequ ence,</w>
condition ing.</w>
con fer
complic ate</w>
complain ts,</w>
coca ine:</w>
clu sters</w>
cit rulline</w>
chrom atin</w>
cholecyst ectomy</w>
cholec alc
cho ice.</w>
chloro zotoc
chloramphenic ol.</w>
chlor hexidine</w>
chill s</w>
chem osensi
ch or
ch .</w>
cent .</w>
cefotax ime</w>
cef ox
ce li
carmo fur
cardiover sion.</w>
cardi otonic</w>
car pal</w>
car ing</w>
capill ari
capac itance</w>
canal icul
calcul ate</w>
c es.</w>
bu tion</w>
bu il
br and</w>
br ac
bortezomib -induced</w>
bo ard</w>
block er)</w>
blo od
blast s</w>
bl u
bl in
biopsi es,</w>
bi ochemically</w>
beta- H
benz ofur
ben ign
behaviour ,</w>
be ha
be f</w>
basel ine).</w>
bas e-
b ucindo
b ox
b cl
azido thymidine</w>
axon s.</w>
awak e,</w>
aw ay</w>
autophag y</w>
audi ologic</w>
attention- deficit/hyperactivity</w>
ate d)</w>
ate -associated</w>
ate -</w>
at o</w>
at ase</w>
arc uate</w>
ar ic</w>
apr ind
approach ed</w>
appear ance.</w>
apne ic</w>
aph asia</w>
ap it
ap ath
anxiety- related</w>
antihist amin
antidot e</w>
anticonvuls ant,</w>
antibio tic.</w>
anti- oxidant</w>
anti dysrhythmic</w>
anti dyskinetic</w>
anorexi gen
angi ocardi
analy se</w>
an s
an ol,</w>
an of
an /
an 's</w>
amygdala- kindled</w>
amphet amine-</w>
amitriptyl ine,</w>
aminophyll ine-induced</w>
amant adine,</w>
alu minal</w>
alpha, 5alpha-
albu min.</w>
al ),</w>
aj maline</w>
agoraph obia</w>
agal us</w>
advantage ous</w>
adrenocor tical</w>
adenos ine-
acyclovir .</w>
acrole in</w>
acetylchol ine,</w>
acet one</w>
ac in-induced</w>
ac a</w>
abnormal iti
abnormal .</w>
ab ro
a ren
a .
[OR ]</w>
ZO -1</w>
X- 4</w>
W ell
Ver y</w>
V TE
UL- FS</w>
Thyro id</w>
Thrombo embolic</w>
Te trac
Tak otsubo</w>
TM Z</w>
TM X</w>
TLP R</w>
TGF- beta</w>
TGF- beta
TA C</w>
T ric
T c
T G
Swe den
Succin yl
Su xameth
Sou th
Seventy- two</w>
Sel f-
Schiz ophren
SU N
SUN -13
SUN-13 34
SR L-
SI ,</w>
SD BP</w>
SC 1</w>
SA P</w>
S pas
S il
S TI
S J
Rifamp icin</w>
Renograf in-
Remifentan il</w>
Recommend ations</w>
RA S</w>
R ati
Quin ine-induced</w>
Pul se</w>
Pub M
Pro pafen
Pre valence</w>
Practi ce</w>
Place bo</w>
Pergol ide</w>
Penicill amine-induced</w>
Paclitax el
PV N</w>
PT U.</w>
PR L,</w>
PR ,</w>
PH ,</w>
PE ,</w>
PA G</w>
P U
P PA
P NS</w>
Oxy toc
Out patient</w>
O d
Neuro lep
Na Cl
NH L</w>
N- [4-
N MR</w>
Mo od</w>
MgSO 4</w>
Mal ign
MT X-
MT ,</w>
MMP- 9</w>
MK-80 1,</w>
M isoprost
M CP
Life- threatening</w>
Lid oca
Le sions</w>
Lam otrig
Labet alol</w>
L-NOAR G</w>
L- 1</w>
L ethal</w>
L act
L CT/
L 5</w>
KCC 2</w>
K v
Intram uscular</w>
Intra vesical</w>
Intra ventricular</w>
In ten
In flam
IFN- alpha</w>
IF N/
ID V</w>
IC D</w>
I DA</w>
Histopath ology</w>
Histopath ologic</w>
Hist ology</w>
His-P urkinje</w>
Hepar in-associated</w>
Hemat ological</w>
HIP/ PAP</w>
HC C.</w>
HC ,</w>
H om
H ar
H F)</w>
H 1-
Gener ally,</w>
Gemcit abine</w>
Gabap entin</w>
GV HD.</w>
GS K-3
GR1389 50</w>
GR P)</w>
GM -induced</w>
GF ,</w>
G y</w>
G y
G li
G astric</w>
G all
Fluoro-J ade</w>
Fish er's</w>
Fifty- three</w>
Fact or</w>
FK- 506</w>
FANF T-
F ull</w>
F allo
F H
Ethambut ol</w>
Estradi ol</w>
Epirub icin</w>
Epilep sy</w>
Engl and</w>
Endo genous</w>
En ox
Electr ical</w>
EE -treated</w>
ECo G</w>
E-17 G</w>
E van
E c
E L</w>
E 1-induced</w>
Dop aminergic</w>
DE HP</w>
D uchen
D IC
D D</w>
D 6</w>
Cortis ol</w>
Cor tico
Consec utive</w>
Con tri
Citalop ram</w>
Cimeti dine</w>
Chemo therapy-induced</w>
Ch ar
Ce phal
Car vedi
Capsa icin-induced</w>
CT GF</w>
CR P</w>
CR F
CO X
CM RO
CI S</w>
CA 1,</w>
C3 H/
C ranial</w>
C an</w>
By J</w>
Bic ucul
Be sides</w>
BM D</w>
B D</w>
Atten tion</w>
Aqu eous</w>
An ter
Amne sia</w>
Al lo
Ac ut
AP AC
APAC HE</w>
AE s.</w>
AD H</w>
AD ).</w>
AC I</w>
A str
A ortic</w>
A mil
A II</w>
A H</w>
99 )</w>
80- year-old</w>
8- week,</w>
8- hydroxy-2-
8- fold</w>
8 1)</w>
7 0,</w>
6-keto- PG
6 35</w>
6 2.
6 1-
5826 1</w>
5-hydroxytrypt ophan</w>
5-HT(1 B/
5-HT TLPR</w>
5-HT P</w>
5-HT (3)</w>
5- 6</w>
5 7,</w>
5 -</w>
5 );</w>
4. 2%</w>
4- mg</w>
4- hydroxy
30 .</w>
3. 7
3- methyl
3, 000</w>
3', 5'-
3 :
3 1)</w>
3 1
3 );</w>
3 '
28 ),</w>
28 %,</w>
25 3</w>
24 ,
23 7</w>
200 3.</w>
200 1.</w>
20 4</w>
2-chloro procaine</w>
2 80</w>
2 30</w>
199 6.</w>
198 5</w>
17 4</w>
17 %,</w>
15. 0</w>
15- minute</w>
13 /
13 %,</w>
1.0 5</w>
1. 75</w>
1. 4%)</w>
1,25 (OH)2D3</w>
1 18</w>
1 1,
0.6 2</w>
0.5 6</w>
0. 8,</w>
0. 4%</w>
0. 3-
0. 125</w>
/- )</w>
/ c</w>
-1 45
- plantar</w>
)- based</w>
(r 2</w>
(c Tn
(TGF- beta
(SSR Is)</w>
(SE M)</w>
(S NP
(S ER
(PT Z)</w>
(PT Z),</w>
(PR A)</w>
(P< 0.01)</w>
(P N)</w>
(O P
(LD H)</w>
(L )</w>
(I B
(DOX )-induced</w>
(DO PAC
(D el
(C D)</w>
(B rd
(Ara- C)</w>
(ADH D)</w>
(ACh E)</w>
(A ST)</w>
(A IN)</w>
(8 8%)</w>
(8 3%)</w>
(8 2%)</w>
(8 %),</w>
(7 6%)</w>
(6-OHD A)</w>
(6 2.
(5 5%)</w>
(4 8%)</w>
(4 6.
(4 3.
(3 80</w>
(3 4%)</w>
(2. 3</w>
(2- chloroethyl
(2 8</w>
(2 3.
(2 00-
(10 /
(1 80</w>
(1 60</w>
(1 00-
(1 0.0</w>
(0.0 4</w>
(0.0 2</w>
(-1 ).</w>
( week</w>
( on</w>
( nine</w>
( ip)</w>
( except</w>
( blood</w>
( beta-
( anti-
" off"</w>
xen obio
win dow
wa ve,</w>
w t,</w>
voltage- gated</w>
vide otap
verapam il-
ve -induced</w>
vasospas tic</w>
vasodil ation,</w>
vasoconstric t
vaso depressor</w>
v oid</w>
v ill
v ap
utili z
us u
us er
uro protective</w>
ur o</w>
ur ines</w>
un differentiated</w>
um- deficient</w>
two- thirds</w>
twic e,</w>
tw in</w>
tur n,</w>
tubul in</w>
tro vafloxacin</w>
tro pi
tric hloro
tri iodo
tremor s.</w>
transl ational</w>
transcrip tional</w>
trans- retinoic</w>
tr yp
tr unc
tr on
tr al</w>
toxic ologic</w>
tol azoline</w>
tim es)</w>
tic tal</w>
tic "</w>
ti bi
tibi alis</w>
thym ocyte</w>
thym ia</w>
thrombo ses</w>
thir ty</w>
thiopent al.</w>
thick ness,</w>
thiaz ide-induced</w>
thi ou
therap y).</w>
tetr aben
tetan ic</w>
termin ate</w>
terbutal ine-induced</w>
te am</w>
te a</w>
tadal afil</w>
tachy p
t yramine</w>
t le
t ard
tard a</w>
system ic,</w>
symptomat ology.</w>
symptom -free</w>
suxameth onium-induced</w>
surve y.</w>
subst ance.</w>
subject s)</w>
subject ,</w>
sub- Ten
sub population</w>
sub icul
strychn ine-induced</w>
stre et</w>
strati fication</w>
stimul ator</w>
stav ud
st ay.</w>
st ains</w>
sprout ing.</w>
splen omegaly</w>
spi ren
spectr a</w>
spas m,</w>
som no
so ver,</w>
so a
sleep- wake</w>
sl er</w>
sin o-
signal- regulated</w>
sigma 1</w>
sib lings</w>
sib ling</w>
show n.</w>
she ep</w>
sex ually</w>
sex es.</w>
ses )</w>
seroton inergic</w>
seri ous,</w>
separ ately.</w>
semi quantitative</w>
second s,</w>
sec ,</w>
se mic
scienti f
sc an,</w>
saralas in</w>
saliv ary</w>
s ap
ru p
ru bell
rota -
rofecoxi b,</w>
ro ll
rit anserin</w>
ris ks.</w>
ri se,</w>
ri ol</w>
resuscit ation.</w>
restless ness</w>
response )</w>
repolar ization.</w>
remo ve</w>
relapse- free</w>
rej ection.</w>
reflex es.</w>
reflex es,</w>
recurren t,</w>
recogn iz
rec essive</w>
reason ably</w>
re new
re dox
re d;</w>
rat s'</w>
ras ag
rapid -
radio therapy,</w>
radic als.</w>
ra ising</w>
qu ick</w>
prurit us.</w>
proper ly</w>
program me</w>
proce eded</w>
proce ed</w>
pro collagen</w>
primat es</w>
primat es.</w>
pri min
prevent able</w>
pressure ;</w>
pressu res.</w>
prednisol one,</w>
pre requisite</w>
pre pon
prepon der
pre optic</w>
pre morbid</w>
pre medication.</w>
pre load</w>
pram ipexole</w>
potenti als.</w>
post- SE</w>
post injection</w>
post er
post anesthesia</w>
possibil ities</w>
popul arity</w>
polygodi al</w>
pituit aries</w>
pir arubicin</w>
phospholip ids,</w>
phenyl acetic</w>
ph otoc
peroxis omal</w>
perme ability.</w>
perm its</w>
periton itis</w>
peri -
per is
pent adec
paw ,</w>
pattern s,</w>
patch -
pass age</w>
paroxet ine,</w>
parenchy ma</w>
paren tal</w>
parano ia.</w>
parac ellular</w>
papill a</w>
pan ic
painf ul
pac kage</w>
pa uses</w>
pa use</w>
oxid ation,</w>
ox ac
out weigh</w>
out growth</w>
other s,</w>
otec an,</w>
ost at</w>
os al</w>
orth opa
oro pharyngeal</w>
ornith ine</w>
ore p
optim ize</w>
open ,</w>
on y</w>
ol iv
ol ine-induced</w>
ol d-
ol :</w>
occurren ce.</w>
o val
o ds</w>
novel ,</w>
non- alcoholic</w>
non treated</w>
nit raz
neuro toxicity:</w>
neuro psych
nerv ous
neon atally</w>
neg ligible.</w>
nec k.</w>
ne d.</w>
nam ely,</w>
n ia.</w>
myo pathy:</w>
mus cul
mon o-
mode lling</w>
mmol/ kg)</w>
mmol/ L,</w>
mm 3)</w>
mix ed-
minut e.</w>
minoxidi l-induced</w>
minim ized</w>
min -1),</w>
mil nac
mil i
micrograms/kg/ min)</w>
micrograms/ kg.</w>
micro l,</w>
micro globul
mg/ l,</w>
mg. kg-1)</w>
methylglutar yl</w>
methyl- 6-
methodo logy</w>
methi azole</w>
meth asone</w>
meperid ine.</w>
meglum ine</w>
mar -plantar</w>
man eu
malignanc y,</w>
mal e.</w>
main tains</w>
mac h
ma y
ma -like</w>
mL/ min</w>
m U/
m L.</w>
lyso zyme</w>
ly :</w>
lob es</w>
lit ter</w>
libit um</w>
li st
li ber
levonorgest rel
levof loxacin,</w>
leuk aemia.</w>
left- ventricular</w>
leak y</w>
lay er.</w>
lat ter,</w>
labetal ol,</w>
l s,</w>
l :</w>
kg(-1 )
ke eping</w>
kain ate-induced</w>
kP a)</w>
k y</w>
k ed.</w>
k ary
isoflur ane-
iso propyl</w>
ism :</w>
is sure</w>
ir on,</w>
ip uncture</w>
iohex ol.</w>
iohex ol,</w>
intrat ubular</w>
intrane ural</w>
intram ural</w>
interven tions.</w>
insul in-dependent</w>
input s</w>
innerv ated</w>
inj ected.</w>
initi ation,</w>
ing in</w>
ing ham</w>
ing ent</w>
ine- dependent</w>
indole acetic</w>
indic ation.</w>
ind ing</w>
in organic</w>
in es,</w>
in -1-
impoten ce.</w>
impl ies</w>
immunohistochemistr y,</w>
immunohist ochemically</w>
immun olab
immun o-
im pression</w>
im pac
illnes ses.</w>
ific ation.</w>
ifenpro dil</w>
idiosyn c
idiosync rati
idi lol</w>
identifi es</w>
ide ),</w>
ic v)</w>
ic idal</w>
ic -induced</w>
ia- reperfusion</w>
i pr
i let
hypoparathyro idis
hypom an
hypoalbum inemia,</w>
hypo algesia</w>
hypertriglyceride mia</w>
hyperten sion;</w>
hyperreflex ia</w>
hypernat remia</w>
hyperlipide mia.</w>
hydroxy zine</w>
hormon es,</w>
hom o
hom e.</w>
hist amine,</w>
hiccup s.</w>
hepatocarcin ogenesis.</w>
hepati c,</w>
health ,</w>
he d,</w>
har ms</w>
hand- foot</w>
haemo dynam
haemat uria</w>
h ope</w>
h im
h an
guide lines.</w>
gu id
grad ing</w>
gonad otrop
go als</w>
glycos amino
glycer ol</w>
glucocortico id-
gli omas</w>
gl icl
gl ab
geu sia</w>
gen u
gen omic</w>
ganciclo vir
gamma-glutam yl</w>
gamma- hydroxybut
gall amine</w>
galant amine</w>
gal anin</w>
g/m 2,</w>
g/m 2)</w>
g over
g e</w>
g aro
garo toxin</w>
g -1</w>
further .</w>
fre e,</w>
formul ation.</w>
formul ation,</w>
form ance</w>
fore brain.</w>
follow up</w>
foc uses</w>
flut ter,</w>
fluo rop
fl at
fl are
five- year</w>
fil ter</w>
fibroblast s.</w>
fi er</w>
fen oterol</w>
fa ec
f icially</w>
exclu ded,</w>
exacerb ating</w>
ex change,</w>
ev acu
etid ocaine</w>
ethan olic</w>
ethambut ol.</w>
et uses</w>
est rus</w>
es sel</w>
erro r
ergotamine/ caffeine</w>
epirub icin,</w>
epilepsy- prone</w>
ep it
ent ries</w>
ent eral</w>
enflur ane.</w>
endoscop y</w>
end s</w>
end ings</w>
en s,</w>
en em</w>
en anth
empir ically</w>
embry otoxic</w>
embol ization</w>
elucid ating</w>
electro diagnostic</w>
el ess</w>
effect or</w>
ecti ve
e.g .,</w>
dyst oni
dysp nea,</w>
duc ts,</w>
du e,</w>
drug- specific</w>
dose ;</w>
dose ),</w>
dofe tili
diure tic,</w>
disulfir am-induced</w>
disul fi
disopyram ide,</w>
dis k</w>
diphenyl hydanto
dimen hydr
dihydro- 5H-
diarrhe a.</w>
diabe tics</w>
di propyl
di lev
di acetyl
dex razox
desi pramine.</w>
desferri oxamine.</w>
desat uration</w>
derang ements</w>
depart ment,</w>
denerv ation.</w>
demeclo cycline</w>
del ay,</w>
degener ated</w>
deep- vein</w>
de serves</w>
de hydration,</w>
de afferen
dd i</w>
day s/
dam aging</w>
da idze
d4 T</w>
d ]
cyto protective</w>
cyt openia,</w>
crypt ococcal</w>
cross- tolerance</w>
cros sover,</w>
cow s</w>
counsel ing</w>
coumar in</w>
cot inine</w>
contro ll
contrac tion.</w>
contr adic
constric tion,</w>
constitu ents</w>
confoun ders,</w>
conduc ting</w>
computer -
compon ent.</w>
complex es,</w>
complete ly,</w>
compl ain</w>
collo idal</w>
collagen ase</w>
coca ine/
clon ic-tonic</w>
cle f
cle avage</w>
ciprof loxacin,</w>
cin nar
chore iform</w>
chore a.</w>
chlor dec
child 's</w>
character izes</w>
channe l.</w>
ch ose</w>
cephalospor in</w>
cent )</w>
cells/ mm3</w>
caver nous</w>
caver nos
cau tion,</w>
catheter s.</w>
cardiomyo pathy:</w>
cardio -
cardiac ,</w>
carcin ogenesis.</w>
carbo prost</w>
carb idopa
carb ap
calbind in-
caffe ic</w>
c ine
but yl</w>
bronchodi lation</w>
bran ches</w>
br af
blo t
bisphosph onate</w>
birth weight</w>
biomark er</w>
bio avail
bi otrans
bi le.</w>
beta (1)-
benz trop
be red</w>
basel ine),</w>
b.i. d.)</w>
b it
b h</w>
b are</w>
awa iting</w>
avir ,</w>
autoradi ographic</w>
auto regulatory</w>
aut onom
attempt .</w>
atri um.</w>
ate br
at oxin</w>
astro cytic</w>
astro cyt
ast roph
as sign
arti ficially</w>
arterio graphy.</w>
arrhythmi as
arac ter</w>
ar ization</w>
ar ding</w>
ar )</w>
aprot inin</w>
appropri ate.</w>
ap ram</w>
ap point
ap eptide</w>
aorta .</w>
antimicro bi
anticonvuls ants,</w>
antibody -positive</w>
anti- platelet</w>
anti social</w>
anter i
anomal ies.</w>
an z
an osine</w>
an astro
amplitu de.</w>
amin al</w>
am o
am niqu
alpha 2-adrenergic</w>
alkalin ization</w>
alfa- 2a</w>
agon al</w>
aggres siveness</w>
age ).</w>
ag o,</w>
after war
advis able</w>
adrenocortic otropic</w>
aden omas.</w>
ad sorption</w>
actu arial</w>
activ ity:</w>
activ ations</w>
acti ve-
acr yl
achi ev
accumul ation,</w>
accom mod
accid ent</w>
acc es
abuse :</w>
abo ve-
abl ative</w>
aber r
a rec
[3H] spiperone</w>
[ 11
[ 1-
ZD V</w>
Z ol
Z TP</w>
Wilc oxon</w>
W at
Vincrist ine-induced</w>
Ven lafax
Vas cul
V III</w>
Un usual</w>
Top ir
Th io
Ter at
TTP- HUS</w>
TR (-)</w>
TN F
T- positive</w>
T yr
T i
T Q</w>
Sul piride</w>
South west</w>
Ser vice</w>
Scre ening</w>
SE M</w>
SA C</w>
S P-
Reg arding</w>
Re ye</w>
RELEVAN CE:</w>
RE G
R- (+)-
R emission</w>
R a
R M</w>
R CT
R A,</w>
R ).</w>
Qu ality</w>
Propofol- Lip
Progester one</w>
Prob able</w>
Prin z
Phenylpropan olamine</w>
Per formance</w>
Per cutaneous</w>
PO THESIS:</w>
PL C</w>
PF S</w>
PF 4/
PB -treated</w>
PAR P</w>
PA H</w>
P< 0.001),</w>
P- 2</w>
P u
P entam
P em
P S)</w>
P CI</w>
P B.</w>
P :</w>
Ophthal mo
OX C</w>
O me
O ddi</w>
O at
Non hematologic</w>
Netherl ands</w>
Na(+ ),</w>
NS -
NRA0 160</w>
NC r</w>
N- desmethyl
N ot</w>
N orep
N -induced</w>
N (
Mo de
Mg(2 +)</w>
Mg(2 +
Mex ilet
Methyl dopa</w>
Me perid
Man ual</w>
Malign ant</w>
MT EP</w>
MP H</w>
MMP- 2</w>
MI D</w>
Low -
LQT S</w>
LMW H</w>
LCT/ MCT</w>
L- Dopa
L ear
L d
K ir
K O
Ir reversible</w>
Indi a.</w>
Inc id
Imat inib</w>
IL- 6,</w>
IL -17</w>
III/ IV</w>
IF S</w>
I s-
I ll
I Q</w>
I -induced</w>
I (K
Hz ,</w>
Hor ner's</w>
His panic</w>
Hex abri
Haemat ological</w>
HY POTHESIS:</w>
HR P</w>
HCO 3</w>
H er
H ]</w>
H D)</w>
H +</w>
Grou p-
Gol d
GTN -induced</w>
Further more</w>
Fifty- five</w>
F enflur
F UD
F HF</w>
Erec tile</w>
Elev ation</w>
Ei ther</w>
Eff ectiveness</w>
EP S.</w>
ED ,</w>
E w
E ti
E NT</w>
E H
Dyst onia</w>
Diethyl stilbestrol</w>
Dap sone</w>
DR D2</w>
DH T</w>
DH P</w>
DE )</w>
D aun
D CE
D C</w>
D A,</w>
D (2
Cyclospor in</w>
Coca ine-related</w>
Chec k
Character is
Cardi oprotective</w>
Can di
CaCl (2)-
Ca esarean</w>
CYP2C 19</w>
CS F,</w>
CS .</w>
CONCLUSION S</w>
CNS .</w>
CL O
CD 50</w>
CB F)</w>
C- fibers</w>
C yc
C remophor</w>
C am
C V</w>
Bupren orphine</w>
Behavi or</w>
Be zol
Bac lofen
BO O</w>
BH A</w>
B- cell</w>
B S
B R</w>
B CN
B B</w>
Aripi prazole</w>
Ap nea</w>
Anti bodies</w>
Angio graphy</w>
Anaesthe sia</w>
Amil oride</w>
All -
Ak athi
Adequ ate</w>
Acet aminophen
Ac quired</w>
Ac ce
AED s</w>
ACTH -induced</w>
ACTH -
ACE i</w>
A me
A B</w>
>/ =</w>
9 9%</w>
9 5.
9 4
9 1%</w>
80 )</w>
8 8.
8 7)</w>
7- year</w>
7 H
7 79</w>
7 61</w>
7 6,</w>
7 5)</w>
60 %,</w>
6- h</w>
6 th</w>
6 5.
59 3</w>
55 %,</w>
5. 0,</w>
5-hydroxy indoleacetic</w>
5- min</w>
5- mg</w>
5 ]</w>
5 7)</w>
5 5)</w>
5 48</w>
5 40</w>
48 ).</w>
40 /
4. 6%</w>
4- point</w>
4 2-
4 2,</w>
35 %,</w>
3- hydroxy-
3- hydroxy
3- O-
3 K
3 7,</w>
3 2,</w>
28 .</w>
25 00</w>
24 ).</w>
23 5</w>
200 1,</w>
200 0,</w>
20 9</w>
20 %.</w>
2. 0,</w>
2-amino- 7-
2- mercapto
2- deoxyglucose</w>
2 h</w>
2 C
2 13</w>
2 12</w>
198 4</w>
19- year-old</w>
18 7</w>
18 5</w>
18 0
17 3</w>
16 3</w>
15 ;</w>
15 8</w>
15 2</w>
14. 5</w>
11. 2</w>
10-1 5</w>
1. 1%</w>
1- adrenergic</w>
1- 5</w>
1, 500</w>
1, 4-
1 7.5</w>
0.6 6</w>
0.6 5</w>
0.6 3</w>
0.5 7</w>
0.4 6</w>
0.05 .</w>
0.00 6).</w>
0.00 3)</w>
0.0 25</w>
0.0 25).</w>
0. 7,</w>
0. 4,</w>
0. 36</w>
0. 35</w>
0. 31</w>
0. 29</w>
0. 25%</w>
0. 21</w>
0. 2-
/ SM
-1, 4-
-1 2
-1 000</w>
- 2.
)- ATPase</w>
(p< 0.05)</w>
(W B
(Vi agra
(R V)</w>
(R R,</w>
(R -
(QT c)</w>
(PG I
(P K
(P I
(P A)</w>
(P =.0
(N AC)</w>
(M MP
(LDH ),</w>
(IC U)</w>
(HB I
(H M
(H C)</w>
(DX R)</w>
(D VT)</w>
(CR F)</w>
(CM V)</w>
(C GRP)</w>
(BUN )</w>
(AI DS)</w>
(AE s)</w>
(A Q
(8 /
(6 1%)</w>
(6 /
(5- nitro-
(4 7%)</w>
(4 %),</w>
(3 7.
(3 50</w>
(3 2.
(3 1.
(2. 5-
(2. 4</w>
(2 ,</w>
(19 66-
(1. 9</w>
(1. 8</w>
(1 25
(0. 25,</w>
(0. 2-
(0. 1,</w>
( using</w>
( rh
( protocol</w>
( pre
( phase</w>
( not</w>
( level</w>
( alpha</w>
( R</w>
( A</w>
' off'</w>
" on"</w>
zolamide/ timolol</w>
z ero
y ing,</w>
y -</w>
world wide
withdraw ing</w>
w .</w>
w )</w>
vo ice</w>
vis its.</w>
vis it
vis ,</w>
vide o</w>
vi bration</w>
ves ti
vertig o,</w>
ver a</w>
ve rex
verex pression</w>
ve red,</w>
vasodilat ation,</w>
vancom ycin,</w>
valer ate</w>
val idation</w>
val idate</w>
vagotom ized</w>
vacuol ated</w>
use :</w>
urticaria/ angioedema</w>
ure )</w>
urap idil</w>
urac il,</w>
une qu
under score</w>
un suspected</w>
un described</w>
un aware</w>
u d</w>
u -
twice- weekly</w>
tro pic
trimethoprim-sulfamethox azole.</w>
trimethop rim
trimethadi one</w>
trime ster
tricho sis</w>
treatment -induced</w>
treat ed)</w>
treat able</w>
tre s</w>
tre moro
transl ated</w>
transfer rin</w>
transf used</w>
tramad ol.</w>
trac e</w>
tr ast</w>
toxic o
tox oplasmo
tom ography.</w>
tolter odine</w>
tobram ycin.</w>
thromb ocy
thro at</w>
thir teen</w>
thione in</w>
thio guan
thick ened</w>
thi gh</w>
thi amyl
thalam us.</w>
th yl
tetrazol ium</w>
tetr alin</w>
test ),</w>
temperat ures</w>
telmis artan</w>
tech nical</w>
taxan es</w>
tartr ate</w>
tac rine-induced</w>
syst olic,</w>
synth ase,</w>
synchron ized</w>
synaptos omal</w>
synap se</w>
swe at</w>
sw allowing</w>
surfac e.</w>
supra threshold</w>
suppres sed.</w>
support ,</w>
super nat
sup pressor</w>
sup posed</w>
sulfon amide</w>
successful ly.</w>
sub types,</w>
sub side
sub convulsive</w>
su stain</w>
su nit
strate g
stor age</w>
stimul us,</w>
stent ing</w>
st oc
spike- wave</w>
soun d-induced</w>
solitari us</w>
so y
sleep iness</w>
sk ill
six ,</w>
sis -induced</w>
sim vastatin,</w>
sildenaf il,</w>
signal ing.</w>
short- ter
shor test</w>
she ath</w>
ses sions,</w>
ses sion,</w>
seroton in.</w>
seri ously</w>
ser a
sera dish</w>
sep sis,</w>
sem ati
sel f</w>
sel eni
sel ected.</w>
sel ect</w>
sco red.</w>
scaveng ers</w>
scan s.</w>
scal es,</w>
scal e)</w>
samp le,</w>
saliv ation,</w>
salicyl ates</w>
sac ro
sa c</w>
rubell a</w>
rout es.</w>
rota- rod</w>
ropini role</w>
rol idine</w>
rocur onium.</w>
rocur onium,</w>
ro se
ro cortisone</w>
ris t</w>
rib os
rh in
rever sal
revascular ization.</w>
retro viral</w>
responder s,</w>
respon sib
reserp ine-treated</w>
research ers</w>
renin- angiotensin-
remifentan il-based</w>
regener ating</w>
record s,</w>
record ings,</w>
reci procal</w>
rec umb
reat ment</w>
read ings</w>
re appearance</w>
rapid ly.</w>
rap idity</w>
ran ular</w>
ran ol
rac lon
r ural</w>
quar ter</w>
qual ity-
pyrid ine-
pyri methamine</w>
pyri din
pyrazin amide</w>
purpo ses</w>
prud ent</w>
provoc ative</w>
provi ded.</w>
protein )</w>
prote as
prost one</w>
propofol :</w>
prop eptide</w>
proj ect</w>
progester one.</w>
progenit ors</w>
produc t.</w>
pro cycl
pre menopausal</w>
pre junctional</w>
pre ganglionic</w>
post- mortem</w>
post partum
post operatively,</w>
posses sed</w>
por e</w>
polydip sia,</w>
poin ting</w>
po grel
platinum- based</w>
pl u
pl it
pl ates</w>
piperazin -1-
pill s.</w>
pig ment</w>
pi ed</w>
phosphatidyl serine</w>
phosph oc
phosphoc reat
pher ic</w>
phenyto in-induced</w>
phenoxy benz
phenacet in,</w>
phen ol</w>
ph ob
ph ase-
pestic ides</w>
pergol ide.</w>
percent ).</w>
penicill ins</w>
pen is</w>
peg filgrastim</w>
pea k-
particip ant</w>
parallel- group,</w>
pancre atitis.</w>
pancre ati
palpit ations,</w>
pallid otomy</w>
p un
p end
p en</w>
oxaliplat in,</w>
ox ia</w>
overl apping</w>
overex pressing</w>
over sho
ov ary</w>
out ine</w>
ou ts</w>
oter minal</w>
ot es</w>
osteoporo sis.</w>
oscill ation</w>
organ s,</w>
or der.</w>
op es</w>
one- way</w>
on- off</w>
on gest
omime tics</w>
omega )-
oly mer
oligonucle otide</w>
olig uria.</w>
ol der.</w>
ol amine-induced</w>
oid ,</w>
ograph ical</w>
offspr ing,</w>
odi lat
ocyte -
och lear</w>
occu pied</w>
oc utaneous</w>
obes ity.</w>
obac ter</w>
ob long
o protein</w>
o il.</w>
o .)</w>
notice able</w>
normother mic</w>
normal ised</w>
normal -
norethind rone</w>
noradrenal ine.</w>
nor cocaine</w>
non- Hodgkin</w>
nmol/ kg</w>
nio s</w>
nicot ine's</w>
ng/ml ).</w>
new ,</w>
neurotransmis sion,</w>
neurolep tic
neuro sensory</w>
neuro pharmacological</w>
neur al-
nephrocalcin osis.</w>
neon ate.</w>
neocor tical</w>
neocor tex</w>
nefazod one</w>
ne d,</w>
nar ingin</w>
na il</w>
n ame</w>
n M),</w>
n )</w>
myocardi opathy</w>
myo- inositol</w>
my otonia</w>
my ocytes,</w>
mu tis
mu star
msec .</w>
msec ,</w>
morph ology.</w>
mo tion.</w>
mmHg ),</w>
mixt ure.</w>
mis ul
minim al.</w>
microliter )</w>
micrograms. kg-1</w>
microgram/ ml,</w>
microgram s.</w>
microgram s),</w>
micro l/
micro biological</w>
mi pramine</w>
mi metic</w>
mg/m2/ week</w>
mg/m (2)
mg/kg/ d)</w>
mg./ kg.</w>
mg./ kg
methadone- maintained</w>
meth anolic</w>
metalloprotein ases</w>
medi an,</w>
mechan o
mechan ics</w>
mat che
mas ses</w>
mannit ol-induced</w>
malignanc ies,</w>
macro cytic</w>
mOsm /kg</w>
mL/ min,</w>
mGluR s</w>
m ia-induced</w>
m ated</w>
m aps</w>
m V</w>
m L)</w>
lymph oproliferative</w>
lop in
long standing</w>
local ize</w>
loc ations</w>
loc ation,</w>
lo l-induced</w>
liver -
live do</w>
liter ,</w>
lit re
lisinopri l.</w>
ligh tly</w>
lig ated</w>
leukotri ene</w>
leukopen ia.</w>
leu pro
lethal ity,</w>
leg s.</w>
leg s,</w>
lear ning.</w>
le st
lat ter.</w>
lat est</w>
las er-
lact one</w>
l one</w>
l ity</w>
l ingu
l ess,</w>
l ens</w>
l ase</w>
l ability</w>
kg/ min</w>
kg/ day</w>
ket amine-induced</w>
ker ato
ke ys</w>
iso enzymes</w>
ip ec
investig ated,</w>
inver ted</w>
intr aluminal</w>
intest ine,</w>
interleukin -1
inter cal
inter active</w>
inten tion</w>
insul in.</w>
instrum ental</w>
ino ic</w>
influenz ae</w>
ine x
indinavir -associated</w>
indic ations.</w>
inde s
increas es.</w>
incid ents</w>
incid ental</w>
incid ence.</w>
inc h</w>
in consistent</w>
impoten ce,</w>
implic ates</w>
imp ending</w>
immunocyt ochemistry</w>
immuno prophylaxis</w>
immuno assay</w>
ime tic</w>
imag es,</w>
ifen acin</w>
idine di
id- stimulating</w>
ia sis:</w>
i.v .
i ro
hypoten sion
hypokal em
hypo thyroidism.</w>
hypercalci uria.</w>
hyper vitaminosis</w>
hyper uric
hydro lase</w>
hydro las
hydro cortis
hydram nios</w>
hospit als.</w>
hor seradish</w>
homogene ous</w>
homogen ate</w>
ho c</w>
her al
hemo phil
hemi parkinsonian</w>
hematocrit ,</w>
he d
hallucin ation</w>
half- life,</w>
grow th
graph ically</w>
graph ic,</w>
grade ly</w>
gonad otropin</w>
gn aw
glycosamino glyc
gh relin</w>
genu ine</w>
gener ation.</w>
gene sis,</w>
gen der.</w>
gastro enter
gall stones,</w>
g/d l,</w>
g/ day)</w>
full -term</w>
fre e.</w>
fr ucto
fore arm.</w>
foc ally</w>
fo pam</w>
flush ing,</w>
fluor idate</w>
flumazen il,</w>
fl ash
fl a
find ing,</w>
fe el</w>
fast ed</w>
fal se</w>
fail ures</w>
f um
f ra
f issure</w>
extr as
expan sion,</w>
excit ability,</w>
exchang er</w>
ex -
evidence -based</w>
evid ent.</w>
evalu able.</w>
eu tic
eu glycemic</w>
ethyl- beta-carboline-3-
eth nic
estim ated.</w>
erythro der
ergonov ine</w>
ergol ine,</w>
er t</w>
er ine</w>
er :</w>
er -dose</w>
equ ina</w>
epitheli um,</w>
ep ime</w>
ent ine</w>
ent ;</w>
ent -
enlarg ement,</w>
encour age</w>
enabl ed</w>
en ure
en n
en ly</w>
embry otoxicity</w>
embry ol
embran ous</w>
elev ating</w>
electromyo gram</w>
electroencephalo grams</w>
electro shock-induced</w>
ele mental</w>
ele ment</w>
el in</w>
el astic</w>
eigh teen</w>
eh n</w>
ede matous</w>
ed ronic</w>
ear ly,</w>
e dic
e .
dysphag ia</w>
dys functional</w>
dur ation)</w>
drug -treated</w>
drin k</w>
dre am
down regulated</w>
doses )</w>
dose "</w>
dors i</w>
dor sum</w>
don ors.</w>
do x</w>
distor tion</w>
distinc tly</w>
distinc tion</w>
discharge d.</w>
difficul t.</w>
differen t,</w>
differen ce
diff use
diagno ses.</w>
di phosphate</w>
di methyl</w>
di le
di hydrochloride</w>
desi red</w>
derivati ve.</w>
der -
depres ses</w>
deple tions</w>
dep ren
dep olymer
deoxy uridine</w>
delay ed.</w>
defect ,</w>
def ini
decompens ation</w>
decom pression</w>
deci sion-
deaf ness.</w>
de liver</w>
dang ers</w>
dail y),</w>
da ugh
d l-
cys tic
cyclo hept
cycl es;</w>
cy stin
cup s</w>
counterpart s.</w>
control led.</w>
contribut ory</w>
contribut or</w>
contrast- enhanced</w>
contra indications</w>
consul tation</w>
constitu tive</w>
conf ers</w>
concer n.</w>
con temporary</w>
collater als</w>
col i</w>
cochle a</w>
cocaine- ethanol</w>
coca ine;</w>
co-trimox azole</w>
closu re.</w>
clon azepam,</w>
clear -
clear- cut</w>
clear ,</w>
cl aims</w>
circuit ry</w>
ciga ret
cholest asi
chol ed
chi -square</w>
chec k</w>
ch aracter</w>
cer uleus</w>
cer ti
cer iv
cefac lor</w>
ce iling</w>
cav ity.</w>
cas ca
caro ten
cardiomy ocytes.</w>
carcin oma:</w>
carbim azole.</w>
caps ular</w>
cann ulated</w>
can al</w>
calcin osis</w>
calci uria</w>
cal lo
c ation
c DNA</w>
bun garotoxin</w>
bul lous</w>
brush -evoked</w>
brimon idine</w>
bridg e</w>
br y
both ).</w>
bodi es.</w>
blun ting</w>
biosyn the
biopsi es.</w>
bilater ally.</w>
bige min
bicarbon ate,</w>
bethan idine</w>
bethan echol</w>
beta- oxidation</w>
beta- hydroxy
beg un
bec lo
be sides</w>
be am</w>
baro receptors</w>
avir /
aver sion</w>
autoradi ography</w>
autop sy.</w>
autom atic
aur anof
atten tional</w>
attac h
atri a.</w>
ate ).</w>
at tractive</w>
at ing.</w>
at -
asymptom atic,</w>
associ ation,</w>
as cer
as ak
as -
artic le,</w>
arti caine</w>
aris ch</w>
apy ri
appreci ated</w>
appear ance,</w>
app end
aph ere
ap raclon
aor t
antinocicep tion,</w>
antigen .</w>
anticholinerg ics</w>
antiarrhyth mic
anti- tumor</w>
anti- hyperalgesic</w>
anti diabetic</w>
anti cholinesterase</w>
anti amnesic</w>
anthracyclin es,</w>
ano ic</w>
ang er</w>
androgen -independent</w>
analgesic s,</w>
an y
an uria,</w>
an do
ampl ification</w>
amine- associated</w>
am ostat</w>
alpha (2)</w>
all s</w>
alkalo ids</w>
alfentan il,</w>
alf uz
aler tness</w>
aler ted</w>
alcohol ism</w>
alb en
al ;</w>
akine sia.</w>
air ways</w>
air s</w>
agre ed</w>
agranulocyto sis,</w>
after no
aff in
aff ect
adv ances</w>
adriamyc in-
acit retin</w>
acetyl amino
accompan ies</w>
acceler ates</w>
ac in
ac ,</w>
abol ishing</w>
abo ve.</w>
abnormal ity,</w>
abl ation.</w>
ab ine-induced</w>
a uro
a phosphor
a hr</w>
a dis
[ 4,
Y et,</w>
Y ahr</w>
W M</w>
W I</w>
Vascul itis</w>
Valpro ate-induced</w>
V max</w>
V E</w>
V CR
Uni variate</w>
Unex pected</w>
Treat ments</w>
Trans genic</w>
Tr x
Toxic ology</w>
Tim m</w>
Thirty- nine</w>
Th en,</w>
Th ail
Ter but
TUNEL- positive</w>
TR I</w>
TP O</w>
TP MT</w>
T ubular</w>
T ro
T X</w>
T DH
T CP</w>
Sub stitution</w>
Sub acute</w>
Streptozotoc in</w>
Ster oids</w>
Spir onolact
Sixty- seven</w>
Ser ologic</w>
Sc hedul
SW V</w>
SN Ps</w>
SI )</w>
SH )</w>
SG O
SA L</w>
S9 788</w>
S, 3
S ham
S ha
S aline</w>
S a
S Z</w>
S M</w>
Ret inoic</w>
Repe at</w>
Reg ression</w>
Re active</w>
RO C</w>
RN A-
RN 23
RAL H</w>
R outine</w>
R oc
Queti apine</w>
QT L</w>
Q .</w>
Pro j
Pro gram</w>
Por tal</w>
Phenyleph rine-induced</w>
Ph il
Pericardi tis</w>
Per son
Per man
PROCED URE:</w>
PR 3-
PPAR alpha</w>
PON V</w>
PO D</w>
PK C</w>
PG ,</w>
PF4/ heparin</w>
PD TC</w>
PB O</w>
P< 0.05</w>
P reg
P NP</w>
P IP
P 2-
Ox carb
On dan
Oc ca
OP ID
OLT .</w>
OD E</w>
O verexpression</w>
O AT
O A</w>
Nimesul ide</w>
Niger ian</w>
Na prox
NT G-induced</w>
NO- deficient</w>
NI K-
N-acetyl-beta-D- glucosaminidase</w>
N- terminal</w>
N- acetyl</w>
N rf
N P,</w>
N DE
N ),</w>
More over</w>
Modi fication</w>
Mil rinone</w>
Me tron
Mc N-
Mannit ol</w>
Man n-Whitney</w>
MPTP- lesioned</w>
ME S</w>
MB C</w>
MA PK</w>
MA P.</w>
M ain</w>
M H</w>
M ;</w>
Line ar</w>
Lif e</w>
Lear ning</w>
Lamotrig ine</w>
LE ),</w>
L ung</w>
L F</w>
L AM-
L A)</w>
King dom</w>
KG F</w>
K- 2</w>
K ine
K W-
K RN23
K (ATP)</w>
In tran
In sul
In s
In haled</w>
Immuno fluorescence</w>
Immun e</w>
Ibu profen
II :</w>
I S)</w>
I PR
Ho ehn</w>
Hist amine</w>
Hemodi alysis</w>
Hall ucin
HM G-
HMG- CoA</w>
HC )</w>
HAL -induced</w>
H sp
H AL</w>
Gram -positive</w>
Gluc agon</w>
GF R,</w>
GF .</w>
G ly</w>
G HB</w>
Frequ ent</w>
Fl ut
FK50 6-induced</w>
F O
F G
Erythro poi
ER G</w>
EM B</w>
E ye</w>
E b
Dys kinesia</w>
Dose -dependent</w>
Dex tro
Demo graphic</w>
De termin
De pressive</w>
Datab ase</w>
DX R.</w>
DT PA</w>
DH A</w>
DES CR
DESCR IP
D1/ D2</w>
D ac
Cyclospor ine</w>
Cyclophosph amide-induced</w>
Cy to
Con serv
Cl 2</w>
Cis plat
Ciprof loxacin</w>
Ciprof loxacin-induced</w>
Characteris tics</w>
Carvedi lol</w>
Cardi o
Ca+ +</w>
CYP 1A
CYP -treated</w>
CT P</w>
CS F-
CS F
CS A</w>
CPT -11</w>
CP -treated</w>
CO RT</w>
CO 2,</w>
CMRO 2</w>
CM ),</w>
CI s</w>
CH B</w>
CB Z,</w>
CB F,</w>
CA A</w>
C x
C V-
C P)</w>
Bus ulf
Brd U</w>
Bezol d-
BU P</w>
BB N</w>
B olus</w>
B Q
B ID</w>
B AE
B 3</w>
Austral ia.</w>
Aten olol</w>
Arg atrob
Apomorph ine</w>
Amin ophylline</w>
Ame li
Agg res
Adv anced</w>
Adren al
AV -
ATP ases</w>
ASP 58
AS ,</w>
AN IMA
AH-10 58</w>
ADR-5 29</w>
A- 3
A misul
A defovir</w>
> 0.05).</w>
< 10</w>
9- fold</w>
9 6.
9 5%
8 %.</w>
7. 0
7 6.
7 5.
7 4
6 5,</w>
5-hydroxytrypt amine
5 HT</w>
5 54</w>
5 4,</w>
5 3.
5 3)</w>
5 2)</w>
5 %);</w>
45 %,</w>
4. 7
4. 5%</w>
4 25</w>
4 10</w>
4 00,</w>
4 -1.
3. 8
3,4- methylenedioxymethamphetamine</w>
3 alpha,5alpha-
3 75</w>
3 6)</w>
3 48</w>
3 3).</w>
29 ),</w>
27 70
25 ;</w>
24- week</w>
24, 25-
200 5,</w>
20 3</w>
20 ,000</w>
2- fur
2 ]</w>
2 75</w>
2 24</w>
2 0.8</w>
199 9.</w>
199 8.</w>
199 5.</w>
198 2</w>
19 .</w>
18 6</w>
18 2</w>
18 1</w>
18 %,</w>
17 6</w>
17 ),</w>
16 6</w>
15 S)-
14 %,</w>
12- hour</w>
11. 3</w>
100 ,00
10 38
1,25 (OH)2D
1 ]</w>
0.8 5</w>
0.5 9</w>
0.00 5),</w>
0.0 3%</w>
0.0 2,</w>
0. 90</w>
0. 70</w>
0. 7%</w>
0. 39</w>
0. 33</w>
0. 1
0 %;</w>
.000 1),</w>
.0 4).</w>
-1 23</w>
- 3
, 6
(p< 0.001).</w>
(mean +/-
(inter quartile</w>
(di -n-propyl
(V F)</w>
(T NF-
(T E
(SSR I
(S -
(PT U
(PE T)</w>
(O C)</w>
(NSAID s).</w>
(M R)</w>
(M P)</w>
(M I).</w>
(L i
(I T)</w>
(I T
(H PL
(H CT
(G TN)</w>
(G T
(G D)</w>
(F F
(F EV
(E PO)</w>
(E )-
(D ox
(D A),</w>
(CH F),</w>
(CG I-
(C lin
(C h
(C P)</w>
(C M)</w>
(C AB
(B P),</w>
(ARF ).</w>
(AM I)</w>
(AC TH)</w>
(A UC
(A PA
(A A)</w>
(9 5%
(50 )
(4- chloro
(4 5.
(4 2.
(3. 5</w>
(3. 0</w>
(2 %</w>
(10 %).</w>
(1- 3</w>
(1 0%</w>
(0. 6</w>
(+/- )
( t</w>
( low</w>
( iv)</w>
( eight</w>
( case</w>
( F</w>
( .
zolmitript an</w>
zidovud ine-induced</w>
ze braf
z op
z inc
yohimb ine,</w>
yl)-2- thiazol
year s'</w>
y ou
y ness</w>
y b
x er
with held</w>
with hel
with draw</w>
well- tolerated,</w>
wedg ed</w>
we d.</w>
we ar
volati le</w>
voc al
vitamin s</w>
visu alized</w>
visu al
vis ory</w>
vin yl</w>
vi sed.</w>
vi ru
veter inary</w>
venlafax ine.</w>
vehicle )</w>
vaso relaxation</w>
vas omo
var ices</w>
van idilol</w>
v ation</w>
uy ak
use s,</w>
uro kinase</w>
uro genital</w>
ur y</w>
ur ve
up dated</w>
unremark able.</w>
unmas k</w>
under goes</w>
uncoupl ing</w>
unc t
un saturated</w>
un dibular</w>
un commonly</w>
un altered.</w>
umb ar</w>
um p</w>
um ),</w>
ulo se</w>
ulcer s,</w>
u sions.</w>
twit ches</w>
twic e/
tumour s.</w>
tropi setron</w>
triiodo thyronine</w>
tri ad</w>
tre e</w>
transport .</w>
tradi tionally</w>
trabec ul
tox in,</w>
tor tic
tor ic
toler ated;</w>
tol but
toge ther.</w>
tle bor
tlebor o</w>
tiz ation</w>
tis ing</w>
tic ally,</w>
ti ll</w>
thyro toxicosis</w>
thi ocyan
them a</w>
the lin
tetro dot
tetr alo
tetan us</w>
termin ation.</w>
terat ogen</w>
tender ness,</w>
tempo ro
te t
tak es</w>
tachy phylaxis</w>
table ts.</w>
t- tissue</w>
t es.</w>
t ag
t AMCA</w>
syst ol
surge on</w>
sulpiri de-induced</w>
sulph adi
sulfonyl urea</w>
substanti ated</w>
subst rate,</w>
subject s:</w>
sube picardial</w>
sub divided</w>
struct ures,</w>
struct ure-
strok es.</w>
strok es,</w>
stret ching</w>
streng th,</w>
strai ght</w>
strab is
stomach ,</w>
stiff ness,</w>
steat osis.</w>
steat osis,</w>
ste al</w>
ste adily</w>
stabil ity,</w>
st un
st ac
sph er
sp ic
sotal ol-induced</w>
soa ked</w>
so as</w>
smok ers,</w>
small est</w>
sim ple
signal ing,</w>
sid ual</w>
sial ic</w>
si ed</w>
si bu
si a:</w>
sho we
she ll</w>
she ep
sha res</w>
sevent y-
setr on,</w>
serv ices</w>
sept o
sensitiz e</w>
sensi tive.</w>
sensi tisation</w>
self- limiting</w>
sel ective,</w>
sedi mentation</w>
se mic</w>
se al</w>
schizophren ia:</w>
sacrific e</w>
sa phen
saphen ous</w>
s/ R
s-- a</w>
s orbit
s cl
rupt ure.</w>
rodent s,</w>
ro tation</w>
ro le
right- sided</w>
righ tward</w>
ribo se)</w>
rheumat ological</w>
retro gradely</w>
reticul um,</w>
reticul at
responsiven ess.</w>
responsi vity</w>
respir ation,</w>
reser vo
replic ated</w>
reple te</w>
renin-angiotensin- aldosterone</w>
ren ally</w>
remo ved.</w>
relie f,</w>
reli ability</w>
relax ed</w>
relap ses</w>
regres sion,</w>
regar ds</w>
receptor s)</w>
recei ved,</w>
reason s,</w>
read ing</w>
re perfu
re mit
re dox</w>
re ;</w>
ratio )</w>
rat tleboro</w>
rash es,</w>
ranitid ine.</w>
rang e)</w>
radiocon trast</w>
radi ating</w>
rabb it.</w>
r us
quin id
quad r
put resc
purpur ic</w>
pum ps</w>
prototyp e</w>
protein ;</w>
protein /
protect or</w>
proteas ome</w>
prospecti vely.</w>
propafen one.</w>
prometh azine,</w>
produc ed.</w>
proca ine.</w>
pro- inflammatory</w>
pro- arrhythmic</w>
pro jections</w>
princi ple</w>
prima quine</w>
preval ence,</w>
prepar ative</w>
preeclamp sia</w>
pre medic
pre clu
preclu des</w>
pp m,</w>
potassium- sparing</w>
postul ated.</w>
post- transplantation</w>
post- synaptic</w>
post surgical</w>
posi tioned</w>
pos tictal</w>
por tive</w>
polydip sia</w>
poly clonal</w>
poly amines</w>
pol yc
poin ted</w>
pogrel ate</w>
po or.</w>
po l</w>
po doc
plau sible</w>
plasmaphere sis.</w>
placebo -</w>
piri l
pir one</w>
piper onyl</w>
pine al</w>
pig mented</w>
physostigm ine-induced</w>
physici an.</w>
phosphoro fluoridate</w>
phosph ati
phenyl)- 4-
phenel z
pg/ ml,</w>
person s.</w>
perox isom
perox ides,</w>
perio d;</w>
perio d)</w>
pergol ide,</w>
paw s</w>
pathophysi ology.</w>
pathophysi ology,</w>
path ogens</w>
pat ency</w>
particip ants,</w>
parkin son</w>
parg yline</w>
paresthesi as,</w>
paradoxic ally</w>
par aph
pancur onium.</w>
pa que</w>
p< 0.05).</w>
p-chloro phenylalanine</w>
p s,</w>
p ole</w>
p ase</w>
p able</w>
p H
p ,
oxaz aphosphor
over weight</w>
over all,</w>
ovari an,</w>
ov ulation</w>
ot ub
ot ropium</w>
osteo arthritis</w>
oscill ations</w>
os pec
orthopa edic</w>
ors al</w>
orrhe a.</w>
orrhe a,</w>
orph ine,</w>
or rho
opioid -dependent</w>
oper ations.</w>
opent et
op recipit
op or
op ed
oped uncular</w>
ont g
one- related</w>
one ur
ondansetr on.</w>
on ide</w>
on azole,</w>
ol one,</w>
oid -induced</w>
od orsal</w>
occurren ce,</w>
occlu sions</w>
occa sion</w>
obser ving</w>
obsc ure.</w>
o il,</w>
o hex
now ,</w>
normal isation</w>
nor adrenaline-induced</w>
non sedating</w>
nocicep tin</w>
nitroprus side
nim odi
night ma
neuropath ologic</w>
neuro troph
neuro physiologic</w>
neuro hypophy
nephron s</w>
nephrectom y.</w>
nelfin avir</w>
necro tising</w>
nebul ized</w>
ne vertheless</w>
ne o-
nat ally</w>
nafc ill
naf amostat</w>
n s,</w>
n g,</w>
n anop
n M,</w>
my ocyt
mut ations.</w>
multicent re,</w>
multi system</w>
mucosi tis.</w>
mou th.</w>
mot oric</w>
monke y.</w>
mon onucle
modifi ed.</w>
moclobem ide</w>
mis diagnosed</w>
mirro red</w>
minoxidi l,</w>
minip ump
min/ 100</w>
min -1.
mid od
microsph e
micromol/ kg,</w>
micromol/ kg)</w>
micrograms/ g</w>
microg/ 0.5</w>
micro perfusion</w>
micro liter</w>
micro l),</w>
micro g
micro circulatory</w>
micro bleeds</w>
mi vac
mg/ g</w>
mg/ (
metronidazol e,</w>
methyl- 2-
methach oline</w>
meth om
meth anol</w>
metalloprotein ase</w>
meta zol
mesn a.</w>
mening o
membrane- stabilizing</w>
medic inal</w>
meaning ful</w>
me stran
maz ep
mark s</w>
mapro til
manufacture r</w>
man dibular</w>
mainten ance.</w>
macrom olec
macroli des</w>
mac y
mGluR 1</w>
mEq/ L,</w>
m :</w>
m 2,</w>
lymphadeno pathy</w>
lymphaden opathy,</w>
low er-
losart an,</w>
lofex idine</w>
lob a</w>
lo ok</w>
littermat es</w>
lipid- lowering</w>
limb ,</w>
lidoca ine)</w>
li sts</w>
levof loxacin.</w>
leuc openia</w>
lept omen
length s</w>
leishman iasis</w>
lead s.</w>
lay er,</w>
lat e.</w>
lab ile</w>
l uc
l ined</w>
l a</w>
kilog ram
kappa -
k uyak
junc tion.</w>
j it
iz ine,</w>
iz ar
it us</w>
isoprenal ine.</w>
isol ated-
isch aemia,</w>
ir CR
io dine</w>
investig ations.</w>
intraperitone all
intran igral</w>
intrad ermally</w>
intracaver nous</w>
intra vesi
intoler ance.</w>
interven tional</w>
inter n
intellect ual</w>
insul in-
institu tion,</w>
inst ance,</w>
ins ular</w>
injec tion:</w>
initi ates</w>
inhibitor s:</w>
inf undibular</w>
indic es.</w>
indic ated,</w>
increas es,</w>
inclu ded,</w>
inc rimin
inc ess
incess ant</w>
inc er
in ward</w>
in suff
in side</w>
in ner
in activated</w>
imple mentation</w>
impl ied</w>
immuno allergic</w>
immun ization</w>
immer sion</w>
immedi ate-
im pregn
illu strated</w>
il :</w>
id o-
icter us</w>
ical Tri
ic um</w>
ic ally-
ic -like</w>
ibu tilide</w>
i um,</w>
i led.</w>
i al,</w>
hypoten sion;</w>
hypocalce mia.</w>
hypo thyroidism,</w>
hypo thyroid</w>
hypo gon
hypogon adis
hyper sensitiv
hyper lipid
homeost asis,</w>
histopath ologically</w>
hist ologically.</w>
hir udin</w>
hir su
her b</w>
hemorrh ages.</w>
hemorrh ages,</w>
hemodynam ics.</w>
hemodialy sis,</w>
hemo dilu
hematopoi esis</w>
hap to
ham pe
halothane- associated</w>
hall mark</w>
hab en
h o</w>
h (-1)</w>
gynec ological</w>
guan ylate</w>
group s).</w>
granulo cytes</w>
graf ted</w>
glutathione- S-transferase</w>
gli oma</w>
ger bil
gen er</w>
gen ated</w>
gefit inib</w>
gastro -
gad opentet
g out</w>
fut ure.</w>
fosin opril</w>
forsk ol
formul a</w>
for ,</w>
flup enthixol</w>
flu ids,</w>
flu id-
flow metry</w>
flatten ing</w>
fixed- ratio</w>
fil tered</w>
fel bamate</w>
fas ci
f ram
f ox
ext ingu
exc ited</w>
examp les</w>
ex ha
ex change.</w>
ethyl ]
et rial</w>
et in-
estrogen s,</w>
erythe ma,</w>
ere d,</w>
epilept ogenesis,</w>
ep oxide</w>
enti ties</w>
ent opeduncular</w>
ent ing</w>
ensu ing</w>
ensu ed</w>
enhance d.</w>
endotheli um.</w>
endomet rium</w>
end ocytosis</w>
enabl ing</w>
en dur
eme sis,</w>
embol ism,</w>
el as
ect al</w>
echocardiograph ically</w>
earli er,</w>
ear s</w>
each )</w>
eNO S-
e z
e osin</w>
dysrhythmi as.</w>
du plication</w>
drople ts</w>
dro spiren
dro p-
dp/d t</w>
dose- finding</w>
dopamine- mediated</w>
donepe z
dom ain
disturb ing</w>
discrep ancy</w>
discontinu ations</w>
disco vered.</w>
dinit ro
dimethyl amino
dihydroxyphenyl acetic</w>
dihydro-5H- di
digitalis -</w>
differenc es,</w>
diet )</w>
didanos ine.</w>
diclofenac -induced</w>
dic loxacillin</w>
diabet es
di agonal</w>
dexmedetom idine,</w>
dexamfet amine</w>
dev ices</w>
detach ment</w>
det ection,</w>
derm atitis.</w>
derang ement</w>
defen sive</w>
deci sions</w>
dec ongest
de s-
de aling</w>
daz ox
daptom ycin</w>
dang er
d le</w>
d inal</w>
cytarab ine.</w>
cyclospor in.</w>
cu ff
cor ro
cor por
coni ine</w>
con spic
compon ent,</w>
compar ator</w>
compar able.</w>
comp eting</w>
coll ections</w>
colchic ine,</w>
cogni tion.</w>
code ine.</w>
co oling</w>
co existence</w>
clozap ine-related</w>
clox acill
clopidogrel ,</w>
clonid ine's</w>
clon ed</w>
clon azepam.</w>
cl es,</w>
cit rate,</w>
circumferen tial</w>
chori onic</w>
chemo kine</w>
charg ed</w>
ch ains</w>
ch ain
cerebri .</w>
cere bel
cepti bility</w>
ceph apir
cellular ity</w>
ce bus</w>
cation ic</w>
catheter ized</w>
cas es;</w>
cardiomy ocytes,</w>
carcin om
carben icillin</w>
carbam o
captopri l-treated</w>
calci um-dependent</w>
cad mium</w>
c t</w>
c AMP-
bur st-
bu ter
bu ild
bradykine sia,</w>
bp m.</w>
bol us,</w>
bo y,</w>
bisulf ite</w>
bisulf it
bi weekly</w>
bi perid
bevaciz umab</w>
beta- estradiol</w>
beta 4-
bas e,</w>
bacter ia</w>
baclofen -induced</w>
bac k-
b izar
b ing</w>
b id</w>
b arium</w>
auto receptor</w>
aur a.</w>
attem p
ativel y.</w>
ate -related</w>
at ures</w>
ass ays,</w>
aspart ate,</w>
aspar agin
as pi
as phy
arthro plasty.</w>
artesun ate</w>
arteri al,</w>
arrhythmo genicity</w>
aripiprazol e,</w>
are ly</w>
approach ,</w>
apo A-
ap ex</w>
ap atri
aorta ,</w>
antigen s,</w>
anti- inflammatory,</w>
anti- allodynic</w>
anti thymocyte</w>
anti proliferative</w>
anti n</w>
anomal ous</w>
animal s;</w>
animal s'</w>
animal 's</w>
angio plasty.</w>
ance )</w>
an- 2-
an um</w>
an aplastic</w>
an abol
amitriptyl ine-induced</w>
amino oxyacetic</w>
amino acid
amin oterminal</w>
amilor ide.</w>
amide -
ambi ent</w>
am sac
am odi
am il</w>
alumin um</w>
alprazol am,</w>
alpha- lipoic</w>
alpha- amino-
alpha 2b</w>
alpha (1
alopec ia.</w>
alle les</w>
al ity,</w>
age- adjusted</w>
ag o.</w>
ag ed.</w>
ag atran</w>
after wards</w>
advance d,</w>
adul t,</w>
adolescent s,</w>
ad mixture</w>
ad amant
acu ity.</w>
act omy
act ing,</w>
acetyl ator</w>
acetazol amide,</w>
acet amide</w>
accept ance</w>
abstr acted</w>
abs ent,</w>
abl y.</w>
ab ine,</w>
a ined.</w>
a etiological</w>
[corrected ]</w>
[OR ],</w>
[ HR
[ Ca
[ 125
W S</w>
Vaso pressin</w>
Van comycin</w>
Val s
VR L</w>
V G
V F,</w>
Ur d</w>
Up per</w>
UD CA</w>
U/ kg</w>
Twenty- four-hour</w>
Tran sc
Tou rette</w>
The ophyll
Thal idom
Ta king</w>
TM CD</w>
TIVE :</w>
TI N</w>
TI A</w>
TE E</w>
T ex
T ac</w>
T MA.</w>
T G,</w>
T AM
Sup portive</w>
Sum atriptan</w>
Ste re
Soci al</w>
Si rolim
Sha kuyak
Schizophren ia</w>
SU N</w>
SSR 18
SSR18 150
SSR 1038
SPEC TIVE:</w>
SO CS
SNA P</w>
SN D</w>
SG K1</w>
S om
S keletal</w>
S evo
S co
S PAR
S CO
S AR
S 2</w>
Renograf in</w>
Re sidual</w>
Re flex</w>
Rati o</w>
RE SEARCH</w>
RB Cs.</w>
R he
R elev
R AN
R 2</w>
QT- interval</w>
Psych osis</w>
Pro buc
Prinz met
Previ ously,</w>
Post natal</w>
Po sterior</w>
Picrotox in</w>
Physos tigmine</w>
Phen obarbit
Pharmaco vigilance</w>
Patient s'</w>
PV Cs</w>
PR IS</w>
PMS F</w>
PGE 2-induced</w>
PER SPECTIVE:</w>
PE P</w>
P< 0.05),</w>
P< 0.01)</w>
P< 0.001)</w>
P- glyco
P od
P g
P atter
P R)</w>
P Q</w>
P ICU</w>
P H-
P =.0
Oxytoc in</w>
Oxy gen</w>
Optim al</w>
Od ds</w>
Oc curren
Observ ations</w>
OR G</w>
O pen
O ff
O G</w>
O /
Nitro fur
Neuro protective</w>
NT Ds</w>
NIK- 247</w>
NC 92
NC92 H2</w>
NA ,</w>
N-methyl-D- aspartic</w>
N-acetyl cyste
N-[4- (5-nitro-
N-[4-(5-nitro- 2-fur
N-[4-(5-nitro-2-fur yl)-2-thiazol
N- nitro-L-arginine</w>
N(G)- nitro-L-arginine</w>
N ucle
N early</w>
N MRI</w>
N 6-
Mit oxantrone</w>
Mi pa
Mg 2+</w>
Mg +
Methotrex ate-induced</w>
Medic ations</w>
MPT P-induced</w>
METH .</w>
ME K</w>
MD )</w>
MA -induced</w>
M un
M t
M os
M ontg
M ini
M ec
M V
M S.</w>
M P)</w>
M O
M MA</w>
M CF
M 3</w>
Lor azepam</w>
Lo s</w>
Linezol id</w>
Langendor ff</w>
LAM- resistant</w>
L-N MMA</w>
L S:</w>
L S)</w>
L CBF</w>
L 6-
Ketocon azole</w>
Ket oro
K reb
J arisch</w>
Is- 5-M
Ir b</w>
Inter fer
Ins 1
Infarc tion</w>
In stitutes</w>
In dex
Impro ve
Imag ing</w>
Ig G,</w>
Ibu profen</w>
IV H</w>
IS T</w>
IP P</w>
IL- 3</w>
IF O-induced</w>
IF -1</w>
IC ),</w>
I le
I dazox
I X</w>
I P,</w>
I 2</w>
Hormon al</w>
Hear ts</w>
He ter
Ha em
HLA- DR</w>
HB V.</w>
HAM- D
H W
H I-
H F
H AT
Gy nec
GluR 2</w>
Ger many</w>
GF AP-
GE M</w>
G lomer
G T)</w>
G NC92H2</w>
Foscar net</w>
Fifty- six</w>
Fat ty</w>
FE N</w>
FANFT- ---
F rac
F Z-
F R</w>
F ;</w>
Ex clusion</w>
Ew ing's</w>
Euro p
Episo des</w>
Eosinophil ic</w>
Endom etrial</w>
En ter
En cephalo
Emer gence</w>
Eff ective</w>
Ec stas
Ear lier</w>
ERK 1/2</w>
EG b</w>
E toric
E smo
E s
E O</w>
E 2.</w>
E /A</w>
Duchen ne</w>
Dobut amine-induced</w>
Dis opyramide</w>
Di phenyl
Di phen
Di ar
D ia
D LT
D E</w>
D 4</w>
D -induced</w>
D (1
Cr )</w>
Cou mad
Contri bution</w>
Computer ized</w>
Compar ing</w>
Comp ounds</w>
Cocaine- Induced</w>
Clozap ine-induced</w>
Clopido grel</w>
Cir culating</w>
Chol inergic</w>
Chlor ambuc
Cat at
Cardi opulmonary</w>
Carb on</w>
Carb achol</w>
CYP 3A
CM ,</w>
CK ,</w>
CI N</w>
CI -1
CD .</w>
CA s</w>
C3 H</w>
C max</w>
C S)</w>
C M)</w>
Bicucul line</w>
Bezold- Jarisch</w>
Be sides,</w>
BP H</w>
BB B.</w>
BAE P</w>
BA Y</w>
B ot
B inding</w>
B SA</w>
B PD</w>
B H</w>
B E</w>
B 4</w>
B 1
At tempt
Astr agalus</w>
As berg</w>
Ar g</w>
Anticoag ul
Anthrac yclines</w>
Alb ino</w>
Al do
Akathi sia</w>
Administ r
Ad visory</w>
Ad ding</w>
Ad dic
Ab use</w>
ANIMA LS:</w>
ANCA .</w>
ANCA )</w>
AN )</w>
AC Ei
AC ),</w>
ABT- 594</w>
A mi
A 5</w>
A 10</w>
A -</w>
= 1.
99 ,</w>
9. 5%</w>
9 7.
9 3,</w>
80 %,</w>
7 th</w>
7 142</w>
7 -</w>
6-mercaptop urine</w>
6 25</w>
6 -1.
5-HT1 B</w>
5-HT (4)</w>
5- bromo
5 FU</w>
5 80</w>
5 5,</w>
40 ).</w>
4. 1%</w>
4- hour</w>
4- D
4 3)</w>
4 18</w>
378 49</w>
378 4
34 4/
30 %)</w>
3- hydroxy-3-
3- 6</w>
3 8,</w>
3 8)</w>
3 4).</w>
3 30</w>
3 30
3 24</w>
28 2</w>
27 9</w>
27 8</w>
26 .</w>
24 5</w>
24 25
24 %,</w>
23 ),</w>
2. 8,</w>
2. 4%</w>
2. 1%</w>
2- CdA</w>
2 90</w>
2 72</w>
2 27</w>
2 26</w>
199 8,</w>
19 7</w>
19 75</w>
19 6</w>
19 /
19 ),</w>
19 %,</w>
18- month</w>
18 ;</w>
18 0-
18 .</w>
16. 3</w>
16 %.</w>
15- min</w>
15 3</w>
12. 8</w>
12. 6</w>
12. 3</w>
12. 2</w>
12. 1</w>
12- week,</w>
12 ;</w>
10(- 4)</w>
1.0 4</w>
1. 9%</w>
1. 6-
1- month</w>
1- 6</w>
1, 200</w>
1 0.1</w>
1 +</w>
00 )</w>
0.9 8</w>
0.8 %)</w>
0.7 8</w>
0.6 %)</w>
0.5 5</w>
0.5 3</w>
0.5 1</w>
0.0 3,</w>
0. 48</w>
0. 44</w>
0. 4-
/ day</w>
/ capsaicin</w>
.0 3).</w>
-2 '-
-1- piperazin
- frozen</w>
- 4
, 48
+/- 0.0
+/ -1</w>
)- receptor</w>
)- mediated</w>
(p .
(U PD
(T N
(SR L)</w>
(S P)</w>
(S O
(S D
(PP I)</w>
(PAN ).</w>
(P= 0.
(P TH)</w>
(P <</w>
(P -
(O X
(MB F)</w>
(L i)</w>
(L D)</w>
(L A)</w>
(I g
(I R)</w>
(HV A)</w>
(HA AR
(GB M)</w>
(G I)</w>
(EAC A)</w>
(E F
(E )</w>
(D ex
(D LT)</w>
(D -
(CPK )</w>
(C O)</w>
(C K-
(C E
(C AT)</w>
(C AD)</w>
(Brd U)</w>
(AV P)</w>
(AN CA)</w>
(AD P-
(A l
(A SA)</w>
(A LT),</w>
(A ID
(A F
(8 )</w>
(7 1%)</w>
(6 %),</w>
(5 6.
(4. 0</w>
(4 ),</w>
(3 8</w>
(3 6.
(3 4</w>
(2. 5%)</w>
(2 5.
(2 5,</w>
(2 +)</w>
(10- 20</w>
(10 -100</w>
(1 2%</w>
(1 1/
(1 ))</w>
(0.5- 2</w>
(0.0 5-
(0. 25
(+/-)- PG-9</w>
(+ ),</w>
( twice</w>
( rate</w>
( number</w>
( grades</w>
( given</w>
( dose</w>
( delta</w>
( before</w>
( age,</w>
( T</w>
( RE
( OD
( MAP</w>
( C</w>
zol edronic</w>
z ofen
z atebr
yl ine,</w>
yl -1-
yeli d</w>
ycl ine-induced</w>
y et.</w>
xi mel
x- ray</w>
x ),</w>
worldwide .</w>
wor th</w>
wk )</w>
weigh ts,</w>
week ).</w>
wear ing-
wav es.</w>
warfar in-
war ming</w>
wa y,</w>
voc alization</w>
vis ually</w>
vis cer
virus- infected</w>
virt ue</w>
vir us
vid a</w>
vi vid</w>
veloc ity.</w>
veloc ity,</w>
vas ovagal</w>
vari able,</w>
vari ability,</w>
val eric</w>
vag otomy.</w>
v illo
villo us</w>
use d:</w>
urotheli um.</w>
ure mia</w>
underli es</w>
ultrasoun d,</w>
ultrason ographic</w>
ultim ate</w>
ulo spinal</w>
ulc er.</w>
tumor- bearing</w>
tub ero
tryp sin</w>
triple -
treatment ),</w>
treat .</w>
transplant ations</w>
transfu sions.</w>
train ing.</w>
train ing,</w>
trac king</w>
tra it.</w>
tra ff
toxic .</w>
topiram ate.</w>
top ic</w>
tobacco ,</w>
to- body</w>
tit ude</w>
tis ;</w>
tis -like</w>
til t-
tic ity.</w>
tic ally.</w>
tiag abine</w>
ti redness</w>
ti lled</w>
thyro id-stimulating</w>
thrombocy th
thrombo phlebitis,</w>
three- year</w>
thiopent one,</w>
thio redox
thi ocarb
thi amine</w>
themsel ves.</w>
the red</w>
th en
tetrap legic</w>
tetralo gy</w>
tetraca ine,</w>
tet any</w>
teratogen icity.</w>
ter odi
ter i
ten sion,</w>
ten der</w>
teli thromycin</w>
techniqu es,</w>
techne tium-
tech no
te eth</w>
tas ks.</w>
tas k
tari o</w>
tacrolim us-associated</w>
ta .</w>
ta ,</w>
t ation.</w>
t "</w>
synthesi ze</w>
syndrome ;</w>
symptom -
sym metric</w>
survi ve</w>
supra -
supplement ation,</w>
sup rag
sulfonyl ure
sulfon amides</w>
sulf onate</w>
sulf ad
succ umb
subunit s,</w>
subject s).</w>
sub type
sub total</w>
sub therapeutic</w>
sub stituting</w>
sub groups.</w>
su n
stud y:</w>
strychn ine.</w>
strychn ine,</w>
strept ococcal</w>
stop -
stomach .</w>
stimul ant-induced</w>
stereot actic</w>
statis tics</w>
stat ins.</w>
stac hy
stabil ize</w>
sta y,</w>
st ate-dependent</w>
st ag
spont aneous
sper midine</w>
sp an
som an</w>
sof t-tissue</w>
smok eless</w>
siz es</w>
situ .</w>
sit e-
sist ance</w>
sinu si
sino aortic</w>
shif ting</w>
shi vering</w>
sequel ae,</w>
sequ est
sept um.</w>
self- injection</w>
sedati ve-
sec tion,</w>
se ed</w>
scleroder ma-like</w>
scinti graphy.</w>
scientif ic</w>
sc ar</w>
sav ings</w>
sampl es,</w>
sal ine-</w>
sa ving</w>
sa id</w>
s- like</w>
s nor
s -old</w>
s -1</w>
ru thenium</w>
rou re
rosi glitazone</w>
ro li
ritonavir .</w>
risk :</w>
rifamp icin,</w>
rif abut
rib osomal</w>
rh EPO</w>
review ing</w>
rever sion</w>
retrie ved</w>
respond ing.</w>
resor ption</w>
resolu tion.</w>
resid ues</w>
reserpin ized</w>
reser pine,</w>
res in</w>
res in
resin ifer
replac ing</w>
renew ed</w>
remoxi pri
remo ving</w>
rele ases</w>
reg ime</w>
refractor iness</w>
recti fier</w>
record ing.</w>
rec anal
reason s.</w>
re starting</w>
re organ
re med
re institution</w>
re d:</w>
rauwolsc ine</w>
radi ation.</w>
r arity</w>
qui et</w>
pyrrolid in-2-
pyrrolidin-2- one</w>
pyridox ine.</w>
py uria</w>
putresc ine</w>
punct ure.</w>
pulsati lity</w>
public ation</w>
publ ished,</w>
pt s,</w>
pt osis,</w>
psychostimul ants</w>
psychi atri
protect ant</w>
propylthiourac il.</w>
propyl -
prolact in.</w>
progab ide</w>
proca ine,</w>
pro state.</w>
pro be.</w>
pro arrhythmia.</w>
primi tive</w>
prescrip tions,</w>
pres s</w>
preponder ance</w>
pregn an-
preferen ce.</w>
pre transplant</w>
pre chemotherapy</w>
pran olol</w>
potenc y,</w>
post transplantation</w>
poly somno
poly cyst
pneumon itis,</w>
ple mentation</w>
plan ning</w>
placebo ).</w>
placebo ),</w>
pl en
pirenzep ine</w>
piper acillin</w>
pide m</w>
pict ure.</w>
pi ric</w>
phosphono heptano
phenterm ine.</w>
phenterm ine,</w>
phenomen a,</w>
pheno thiazine</w>
phencycl idine</w>
phen oidal</w>
ph on
ph aryn
ph ac
pg/m L,</w>
perturb ation</w>
person nel</w>
persist ent,</w>
peripher y</w>
perin uclear</w>
perfor med
percent .</w>
perce pt
per s</w>
pentylenetetraz ol,</w>
pentamid ine-induced</w>
ped unc
path ogenesis,</w>
parap aresis</w>
parame dic
paradig m,</w>
par a-
pal mar-plantar</w>
p urine</w>
p ter
oz o
oxy bu
oxif loxacin</w>
ox amniqu
ox acin</w>
overl ap</w>
over looked</w>
otom y,</w>
oto x</w>
ot otoxicity,</w>
ot otoxic
ot ing</w>
ot et
osmol al</w>
osc ine</w>
osc il
ori ens</w>
ore x
ord inary</w>
or y-
or der,</w>
opini on</w>
opi ates.</w>
oph ore</w>
oper oxidase</w>
open h
op anc
opanc reat
on ym
on ly)</w>
omega- nitro-L-arginine</w>
olig uria,</w>
ol ive</w>
ol ine,</w>
ol ),</w>
oid s.</w>
ogen s.</w>
of -dose</w>
ocyan id
obvi ously</w>
obe se,</w>
ob ste
ob ia,</w>
o x</w>
o res
numb er.</w>
novel ty</w>
normoten sive,</w>
normo volemic</w>
normal ities</w>
non- users</w>
non- drug</w>
non small</w>
non linear</w>
nodul es,</w>
no vi
nitros o-
nitroglycer in-
neutrophil ia</w>
neuroblast oma.</w>
neuro toxin</w>
netilmic in</w>
nephro pathy:</w>
neph ri
nefir acetam</w>
nad olol</w>
na phthal
na i
nACh R</w>
myo fibri
my x
my oneuropathy</w>
muscim ol.</w>
mul tin
mou se
mother 's</w>
mot ript
morph ogenesis</w>
mono valent</w>
monke y
mon ophosph
moder n</w>
mo od,</w>
mmol/ l,</w>
mmol/ kg,</w>
mm/ sec</w>
mm ;</w>
mm 3.</w>
mm 3,</w>
mm .</w>
ml -1)</w>
ml (-1)</w>
mix ing</w>
mivac urium</w>
mio sis.</w>
minut es).</w>
min s</w>
min g,</w>
min -1.</w>
min -1).</w>
microbub bles</w>
micro tubules</w>
micro M.</w>
micro L,</w>
mg/kg/ min)</w>
mg/d l;</w>
mg/( kg.
mg/ L,</w>
mg. kg-1,</w>
metronidazol e-induced</w>
metri z
methyl dopa,</w>
meth ox
meta proteren
meso theli
ment ation,</w>
mening i
men ;</w>
medic ines</w>
medi a-induced</w>
me -induced</w>
mas s.</w>
malondi aldehyde,</w>
mal nutrition</w>
mal ine-induced</w>
mal es)</w>
main tained,</w>
ma kal
m IU/
m AMPH</w>
lymph ocytes.</w>
lymph ocytes,</w>
low- osmolality</w>
loracar bef</w>
loc ation.</w>
lo vastatin,</w>
ll ation</w>
lithium- pilocarpine-induced</w>
like wise</w>
lig and,</w>
leucov or
lepir udin</w>
le brand</w>
le af
lamin in</w>
lact ating</w>
lac un
laborator y.</w>
labor ative</w>
lab or,</w>
l .
kg -1),</w>
ketocon azole.</w>
ket one</w>
kal emic</w>
kHz .</w>
k ill
jit ter
jer king</w>
iz ed-
ix ed</w>
ist .</w>
issu e.</w>
isoprost ane</w>
iso- osmolar</w>
ischem ia-reperfusion</w>
ir ta
iox ag
iodo -
inv a
inva sion</w>
intub ating</w>
intrat ympanic</w>
intra- aortic</w>
intermit t
interfe red</w>
inter individual</w>
int act,</w>
inst ability.</w>
injec tion).</w>
inhal ational</w>
infusion ).</w>
infra red</w>
infiltr ate.</w>
infarc ts</w>
inf in
inf ant,</w>
ine al</w>
indinavir ,</w>
increas e)</w>
incorpor ating</w>
inci sional</w>
in- A</w>
in th</w>
in tent</w>
in stituted.</w>
in ol</w>
in n
impair ments.</w>
immune -
immun ologically</w>
immun ized</w>
immedi ately.</w>
imbal ance.</w>
im ped
ile al</w>
il iac</w>
il am
il -associated</w>
ig o</w>
idazox an,</w>
id -associated</w>
icalTri al
ibuprofen -induced</w>
ia -related</w>
i.p. ;</w>
hypovol emia</w>
hypot onic</w>
hypospadi as</w>
hyperton ia</w>
hypere osinophil
hypercoagul able</w>
hypercap nia</w>
hyper ventilation</w>
hyper thyroidism,</w>
hyper intense</w>
hydro peroxides</w>
hydro alcoholic</w>
hydram ni
hydra z
hum or</w>
hor ses</w>
hippocamp al-
high- resolution</w>
high- energy</w>
hepato renal</w>
hepati s</w>
hepar an
hemo stasis</w>
hemis pheric</w>
hemis phe
hemat ology</w>
hem opoietic</w>
help ed</w>
hel ps</w>
hed onic</w>
heart- lung</w>
h ard
gri d</w>
graf ts.</w>
graf t.</w>
glyco gen
glyc ine,</w>
glucuron ide-induced</w>
glomerulosclero sis,</w>
glo s
gli otic</w>
genotyp ic</w>
ge t</w>
gamma- HCH</w>
gam bl
gadopentet ate</w>
ga ine</w>
g/d l)</w>
g in</w>
g ains</w>
g (-1)</w>
fron t-
fresh -frozen</w>
free zing</w>
fr ame
fore stomach</w>
followe d-
followed- up</w>
fo rel
fo od.</w>
fluvox amine.</w>
flus piril
fluoro phosphate</w>
fluo rene</w>
flu idity</w>
flecain ide,</w>
flavon oid</w>
fl acc
fil ter
fibrill ation:</w>
fib rate,</w>
fi ve,</w>
fer ulic</w>
fenflur amine-induced</w>
femal es)</w>
feed ing.</w>
fe ver
fe et,</w>
fe el
fav ored</w>
fast -
famil y,</w>
f u
f ec
ey di
eydi g</w>
extravas ation.</w>
extras timul
extr a</w>
expl anted</w>
exencephal y,</w>
excre tions</w>
exc essively</w>
ex pi
event -free</w>
euthan ized</w>
euthan ati
ethyl hex
estrogen .</w>
estradiol -17
esophag itis</w>
erup tion,</w>
erb al</w>
er ation</w>
equi valence</w>
epti des</w>
epinephr ine-
ep ri
eosinophil ia.</w>
endur ance</w>
endot oxin</w>
endoscop y.</w>
endocardi tis.</w>
endoc rin
endo thelin
end- point</w>
encephalo path
en ol
en es</w>
embryol eth
embol i</w>
electron- dense</w>
electrom agnetic</w>
eigh ty-
effectiven ess.</w>
effect )</w>
eff usions</w>
edarav one</w>
ed ),</w>
echocardiograph y:</w>
ech im
early- onset</w>
e yelid</w>
e w
e ren
e a.</w>
e 's</w>
dyspep sia</w>
dyses thesi
du al-
drug s;</w>
dr yness</w>
dp/d t
dox azosin,</w>
dose- related,</w>
dose- intensity</w>
dos cop
dopamine- related</w>
don or,</w>
docetax el,</w>
divid ing</w>
diure tic-induced</w>
diure sis.</w>
diure sis,</w>
distribu tions</w>
distingu ishing</w>
discontinu ous</w>
discol oration</w>
discipl inary</w>
dis tilled</w>
dis place</w>
dis appear</w>
dis advantages</w>
direct- acting</w>
direc t,</w>
diphenhydram ine.</w>
diltiazem -induced</w>
dihydroxy tryptamine</w>
dig iti
diffuse ly</w>
diff er.</w>
dichloro phenyl)
diast olic,</w>
diast ole</w>
diaphor ase</w>
diameter .</w>
diam orphine</w>
diacetyl morphine</w>
determin es</w>
determin ation.</w>
deterior ation,</w>
descri ptive</w>
des min</w>
depression -like</w>
depolar izations</w>
deoxy nucleoti
deoxy adenosine</w>
demonstrat ed,</w>
delta9- THC</w>
deliver ies</w>
dehydro epiandrosterone</w>
degre e,</w>
deform ity</w>
defl ection</w>
defibrill ator</w>
decreas ed;</w>
decl ine.</w>
de oxy-
daunorub icin-induced</w>
daunorub icin,</w>
dar be
danazol .</w>
danaparo id</w>
daidze in</w>
d, l-
d l
d ark
cytopen ia.</w>
cyt ometry</w>
cyt ologic</w>
cyst ectomy</w>
cyclohept en-
cult ures,</w>
cu ed</w>
criter ia:</w>
cri sis,</w>
cramp s,</w>
counter balanced</w>
cot reatment</w>
cortis ol.</w>
corticosteroid -induced</w>
corb ic</w>
cor onal</w>
conveni ence</w>
contracep tion.</w>
contra st.</w>
continu ous,</w>
contamin ated</w>
cont acts</w>
cont acted</w>
constric tion.</w>
constipati on.</w>
consequ ently,</w>
consequ ences,</w>
conjug ates</w>
confoun ded</w>
conflu ent</w>
confirme d,</w>
config ur
confer red</w>
conf usion.</w>
condition s:</w>
con vinc
con genit
compli ant</w>
compet ent</w>
compart ment.</w>
community- acquired</w>
com ing</w>
collicul us</w>
co valent</w>
co operative</w>
co effici
co ar
clonid ine-evoked</w>
clo c
clinic al
clinical trial
clin ic,</w>
cle a
clavul an
clarithrom ycin,</w>
cl or
ci pro
ci es.</w>
chromos omes</w>
choline- devoid</w>
cholangi opancreat
cholang itis.</w>
chol ere
chlorthal idone</w>
chlorthal id
chloroqu ine.</w>
chloroqu ine,</w>
chic ks</w>
chi sis</w>
chi as
chelat or</w>
chec k-
cell aneous</w>
cell -mediated</w>
cell ,</w>
ceftriax one,</w>
cef oper
cav ity,</w>
catarac ts</w>
cas pase</w>
carri ers.</w>
carrageen in</w>
cardiomyo plasty</w>
cardiomegal y</w>
carboplat in-induced</w>
carbo hydrate</w>
carbach ol.</w>
car dinal</w>
capsaic in-treated</w>
calcific ation,</w>
calc ified</w>
calbind in</w>
caffe ine-
c- fos
c ured</w>
c ue-
c t
c iliary</w>
c a</w>
c ]
c /
buprenorph ine.</w>
bund le-
bul k</w>
broad ly</w>
bod y,</w>
bo ost
bo gaine</w>
blo ody</w>
blind ness.</w>
ble ed</w>
bilater ally,</w>
bicucull ine.</w>
bi phasi
bi ochemistry</w>
bezafib rate</w>
beta-carb oline</w>
beta .</w>
benz yl</w>
benz ene</w>
benz amide</w>
benser azide</w>
bed time</w>
beclo methasone</w>
beats/ min)</w>
be n</w>
be ds</w>
be d,</w>
be an</w>
be agl
bcl -2</w>
base- line</w>
bacte remia</w>
bab y</w>
b all
b F
az ido-
az ed
awak ening</w>
aw asak
aver aging</w>
autop sy,</w>
autom ated</w>
auto immun
aut o-
audi o
atri a,</w>
ation al,</w>
ate d
ate "</w>
asym metric</w>
astroph ic</w>
astro cytes.</w>
assum e</w>
asses sed,</w>
assay )</w>
ascer tained</w>
arthri tis:</w>
arom atic</w>
arg ue</w>
apro z
appro x.</w>
appreci ably</w>
apparat us.</w>
apo A-I</w>
apl asia.</w>
apar t,</w>
ap ella</w>
anx ious</w>
anticonvuls ant.</w>
anti- cancer</w>
anti seizure</w>
anti anxiety</w>
anth ocyanid
ant acid</w>
anomal ies,</w>
angiotensin- converting-enzyme</w>
anec dotal</w>
and- wave</w>
anastro zole</w>
anaphyl axis.</w>
an os
an ions</w>
an i
amput ation</w>
amphet amines.</w>
amphet amines,</w>
amiodar one-associated</w>
aminol evulinic</w>
amin ol</w>
alu es</w>
alpha- fet
alpha- bungarotoxin</w>
alpha 5</w>
alkalo sis,</w>
algor ithm</w>
al- based</w>
al one;</w>
al motript
akathi sia.</w>
aggres sion.</w>
age- specific</w>
affor d</w>
aer obic</w>
adop ted</w>
adequ acy</w>
aden omatous</w>
ad ing</w>
activ ity-
activ ity)</w>
acin ar</w>
acidi fication</w>
acetylchol ine-induced</w>
acetyl ators</w>
acetyl ation</w>
accumben s,</w>
abstin ence,</w>
a reflex
[2- (3,4-
Y- maze</w>
Y 56
X +
Wil lebrand</w>
WA Y</w>
WA Y
W F</w>
Ve hic
Val vular</w>
VR 1</w>
VE P</w>
V indesine</w>
V alues</w>
V LDL</w>
Ultras on
U rin
U K.</w>
Tx B2</w>
Tu bulo
Topir amate</w>
Th re
Th iaz
Th ai</w>
TR I
TI C)</w>
TGF- alpha</w>
TE M
TB M</w>
T in
T an
T RE
TRE AT
T LE.</w>
T GF
T D.</w>
Suxameth onium</w>
Sus ceptibility</w>
Sup ra
Sul indac</w>
Subsequ ently</w>
Sub lingual</w>
Sub arachnoid</w>
Strept omycin</w>
Stra in</w>
Star ting</w>
So on</w>
Sm ad
Sim p
Seroton ergic</w>
Ser tr
Sensor ineural</w>
SUBJECT S</w>
STAT 3</w>
SR ,</w>
SM F</w>
SE X</w>
SA D</w>
S- T</w>
S ulph
S timul
S CI
S ARS</w>
Ris ks</w>
Reser pine</w>
Renografin- 76</w>
Rem ark
Regist er</w>
Recor ds</w>
Re as
RO P</w>
RN F
R s.</w>
R os
R om
R en
R ed</w>
R U</w>
R F</w>
R AST</w>
QT .</w>
Q- wave</w>
Q- Tc</w>
Q S/
Q ),</w>
Propofol-Lip uro</w>
Pro toc
Pro echim
Predn is
Practition ers</w>
Pharmac ologic</w>
Per hexiline</w>
Path ophysi
Parkinson ism.</w>
PU FA</w>
PT CA</w>
PH E</w>
PGE 2.</w>
PD -1
PCR .</w>
PC E</w>
PAC AP
P< 0.05)</w>
P< 0.01).</w>
P2 X</w>
P- gp</w>
P- 4</w>
P ur
P s)</w>
P MN
P L</w>
P IC
P D-
P CT</w>
P +
On tario</w>
O- de
O wing</w>
O G)</w>
O 2,</w>
O 2)</w>
Norm alization</w>
No vel</w>
Nis sl</w>
Nicot ine-induced</w>
Nicardi pine</w>
Neuro muscular</w>
Nec ro
N- [
N( omega)-
N i
N ex
N asal</w>
N P.</w>
N A)</w>
N )-
Myco bacterium</w>
Mit omycin</w>
Misoprost ol</w>
Minim al</w>
Mg 2+
Metoclop ram
Methyl -
Med line</w>
MR I,</w>
MI F</w>
MB C.</w>
M u
M is
M irta
M el
M ass
M all
M acro
M S-
M MP</w>
M K-
M CI-1
Lipos omal</w>
Le vel</w>
Lat ency</w>
Lab or
LI MIT
LI D,</w>
L-argin ine.</w>
L eydig</w>
L H,</w>
L EP
King dom
K awasak
Jap an,</w>
Ischem ia</w>
Inj ury</w>
IT C-
IB D</w>
I di
I STR
I 1</w>
Hyper icum</w>
Hu EPO</w>
Hexabri x</w>
Hemo globin</w>
Hallucin ations</w>
HR V</w>
HR .</w>
HD AC</w>
HC P</w>
HC G</w>
HB s</w>
H N</w>
Go od
Gly cyrrhiz
Glucocortico id-induced</w>
GO T,</w>
GF R.</w>
GE C</w>
GABA- mediated</w>
GABA- A</w>
GABA (B
G ene</w>
G O</w>
G G
G C</w>
Fos- IR</w>
Forty- nine</w>
Fl ur
Fat 1</w>
Fab '</w>
FSG S</w>
FK50 6,</w>
F ac
F T</w>
F 344/
F -induced</w>
Ex cit
Esmo lol</w>
Ery thema</w>
Epinephr ine-induced</w>
Em bry
Electro ly
EMBA SE</w>
EH X
EC E
EC A</w>
E MP</w>
E 217
Dyn amic</w>
Dis ruption</w>
Dex fenfluramine</w>
Decreas es</w>
DS P-4</w>
DPCP X</w>
DOX /
DL T</w>
DH S</w>
DESCRIP TION:</w>
DB A</w>
DA ergic</w>
D- Tr
D ulox
D o</w>
D N</w>
D H</w>
D 3,</w>
Coomb s'</w>
Continu ed</w>
Conserv ative</w>
Con fusion</w>
Comb ining</w>
Com prehensive</w>
Coll ectively,</w>
Co Q10</w>
Clon azepam</w>
Chlor promazine</w>
Chang e</w>
Ch rom
Cerebro vascular</w>
Case- control</w>
Candi da</w>
Cal ifor
CY P.</w>
CY A</w>
CR -
CR ,</w>
CP OB
CP H</w>
CP ,</w>
CM -induced</w>
CL D</w>
CD8 +</w>
CA ).</w>
C y</w>
C olo
C au
C annab
C T)</w>
C -treated</w>
Bri tish</w>
Bortezom ib</w>
BD L</w>
BALB/ c
B ipolar</w>
B er
B epri
B alb
B al
B a
B Z</w>
B W)</w>
B PA
B CH
As corbic</w>
Arg inine</w>
Ara- C.</w>
Ap gar</w>
Anti depress
Ang el
Amitript yline</w>
All ergic</w>
Adren aline</w>
Ac id</w>
Ab solute</w>
Ab normalities</w>
AT RA.</w>
ASP58 54</w>
AMPH -induced</w>
AM B</w>
AL C</w>
AIM S</w>
AB .</w>
A si
A mb
A SEX</w>
A P,</w>
A LT,</w>
< 0.05).</w>
90 7</w>
9 6%</w>
9 00
80 ).</w>
8. 4%</w>
8 9-
8 6.
8 2.0
82.0 7
8 12
8 -10</w>
78 10
60 2</w>
60 .</w>
6- year</w>
6- hour</w>
6,7- di
6 40</w>
6 3.
59 2</w>
5. 0%</w>
5-HT(2 C)</w>
5-HT 4</w>
5-HT 2B</w>
5-F U/
5- ASA</w>
5- 8</w>
5, 10-
5 9,</w>
5 8,</w>
5 6)</w>
5 2,</w>
5 %-
48- 67
48 6
40 %.</w>
4. 6
4 7)</w>
4 4)</w>
4 1).</w>
4 0%)</w>
36 6</w>
36 2</w>
30 th</w>
3- (
3,4-dihydroxyphenyl acetic</w>
3 52</w>
3 25</w>
27 .</w>
27 ).</w>
24 /
20- mg</w>
20 4
2-amino-7- phosphonoheptano
2- month</w>
2- day</w>
2- agonist</w>
2- 6</w>
2, 3,4-
2',3'- dideoxycytidine</w>
2 :1</w>
2 48</w>
2 2.5</w>
2 17</w>
2 16
2 0.0</w>
2 -1.
199 7.</w>
199 4.</w>
199 2.</w>
199 0,</w>
17 1555</w>
17 .</w>
17 ,
16 9</w>
16 1</w>
16 /
15. 8</w>
14. 4</w>
14. 2</w>
14 /
13. 9</w>
12. 7</w>
12 th</w>
100 %.</w>
10(9 )</w>
10 7
1. 35</w>
1- like</w>
1- 1</w>
1,25- (OH)2D
1 alpha-
1 a</w>
1 50-
1 1.</w>
1 (-/-)</w>
0.4 2</w>
0.0 %,</w>
0.0 %)</w>
0. 9-
0. 80</w>
0. 23</w>
0. 2%)</w>
0-1 20</w>
/ ml.</w>
/ HCTZ</w>
.00 4).</w>
.00 1</w>
.0 2)</w>
.0 2).</w>
. 7
-bl ue</w>
- up</w>
- out</w>
- of-
- labeled</w>
- H
- B
- >
- 6
- 0.6
,2 3-
, 9
)- containing</w>
)- -
) +
(n= 6)</w>
(i NOS)</w>
(e NOS)</w>
(c )
(TBAR S)</w>
(T MA)</w>
(T D)</w>
(SOD ),</w>
(SIAD H).</w>
(S E</w>
(S CL
(S C)</w>
(PR A),</w>
(P CA)</w>
(P C)</w>
(NS ).</w>
(ND I)</w>
(N a)</w>
(ME S)</w>
(M PA)</w>
(L-NAME ,</w>
(L O
(L E
(IC P)</w>
(HD L)</w>
(HBI G)</w>
(GABA )
(ED 50
(E R)</w>
(E F)</w>
(DR G)</w>
(CP )-induced</w>
(C CK-
(C CB
(C AP
(BB B)</w>
(B PR
(AP L)</w>
(AC h)</w>
(A n
(A MP
(7 9%)</w>
(6 5</w>
(6 5%)</w>
(6 1</w>
(5 5.
(5 4%)</w>
(400 mg/kg,</w>
(4 2</w>
(4 0-
(4 0%</w>
(4 %</w>
(3) H-
(3 1</w>
(2 8.
(14) C-
(10- 50</w>
(1 75</w>
(1 5,</w>
(1 5%),</w>
(1 1
(0. 9</w>
(0. 4
( stage</w>
( risk</w>
( overall</w>
( first</w>
( either</w>
( doxorubic
( baseline)</w>
( ara-
( ages</w>
( a
% :</w>
zonis amide</w>
yros ine</w>
yl- CoA</w>
yl urea</w>
yl cholinesterase</w>
yl -induced</w>
yc ill
y- based</w>
y- Asberg</w>
y ne
y loxy
y ?</w>
xyl az
worsen s</w>
wor st</w>
women :</w>
women ).</w>
wit nes
well- defined</w>
well- characterized</w>
week ),</w>
we t-
wet- dog</w>
wash ed</w>
wa ke
w w
w rist</w>
w ished</w>
w ays.</w>
vitamin -
viol et</w>
view ed</w>
vide o
victim s</w>
vic inity</w>
ventric les.</w>
ventilat or</w>
ve terans</w>
ve get
vasopress ors</w>
vas t</w>
varic ose</w>
vancom ycin-induced</w>
valu es)</w>
val ve.</w>
vacuol ization,</w>
vaccin ated</w>
v ist</w>
v apor
v a</w>
uter o,</w>
usi ve.</w>
us oidal</w>
urticar ia.</w>
ureter ic</w>
ures :</w>
ure ;</w>
ur ide,</w>
uptak e,</w>
unit s.</w>
uneventful .</w>
underestim ated</w>
un identified</w>
un favorable</w>
un consciousness</w>
un affected,</w>
ulcer s.</w>
ulcer ation,</w>
ul ation.</w>
ub ic</w>
u t</w>
two- fold</w>
twit ching</w>
turno ver,</w>
trypt oph
tropon in-
tript ans</w>
trimethoprim /
trimethaph an-induced</w>
trihexyphenid yl</w>
triglycer ide,</w>
triamterene .</w>
tremoro genic</w>
treat ed;</w>
trastuz umab
transplant s.</w>
transfu sion
trans placental</w>
tran d
tract s.</w>
toxic ,</w>
tox in.</w>
tortic oll
tor r,</w>
top ography</w>
tom ato</w>
tol me
tolme tin</w>
tol az
titr e</w>
tit ution</w>
tion ary</w>
tion al,</w>
time )</w>
til ting</w>
ti ve-
ti tres</w>
ti s)</w>
ti otropium</w>
thyro toxic
thiou rea</w>
thioridaz ine.</w>
thin k</w>
thiazol idinedi
thiaz ides</w>
therapeu tically</w>
theore tically</w>
thalam otomy</w>
th en-
tetr amethyl
test es</w>
tes tis</w>
termin als,</w>
tent h</w>
temozolom ide.</w>
te en
tampon ade
ta urine,</w>
ta ke
t. i.d.</w>
t z
t t
t ness,</w>
t le,</w>
t ab
syndrome "</w>
synchron ization</w>
sympatho adrenal</w>
superi ority</w>
summ ed</w>
sulph ate,</w>
sufentan il.</w>
suc kling</w>
subunit s.</w>
sub-Ten on's</w>
sub- effective</w>
sub normal</w>
sub maximal</w>
sub cl
su gar</w>
stu por
stu po
structur ally,</w>
stroke :</w>
strok e-
stric t
streptozotoc in-
strateg y.</w>
strabis mus</w>
stom y</w>
ster ol</w>
stent ing.</w>
stat ory</w>
st ent.</w>
st en</w>
spike- and-wave</w>
spectrophot ometric</w>
specific ally,</w>
spec ul
som nif
sof tw
sleep iness,</w>
sk y</w>
sk ull</w>
sk illed</w>
situ ations.</w>
sing .</w>
sim us</w>
sim end
sig moid</w>
si vity</w>
si s),</w>
shun ting</w>
shi ver
sham- lesioned</w>
sgk1 (+/+)</w>
sex .</w>
ses :</w>
serv ic
ser um-
sequel a</w>
sequ ence,</w>
sept um,</w>
sens ori
seleg il
sel ecting</w>
seizure -free</w>
sed )</w>
sec tions.</w>
seas onal</w>
se ated</w>
sch er
scher ichi
scherichi a</w>
sc rut
scrut in
sc otom
sc ious</w>
sarco idosis</w>
sar pogrelate</w>
salt- sensitive</w>
salbutam ol,</w>
sal ts.</w>
sac ral</w>
s/R Ds</w>
s way</w>
rough out</w>
ros ace
rop ic</w>
root s</w>
roli pr
ro ent
risperid one-treated</w>
rifamp in.</w>
ri zine</w>
ri pen
ri gorous</w>
rhabdomy osarcoma.</w>
retrospecti ve,</w>
retino pathy,</w>
retin oids</w>
retin oblastoma</w>
resuscit ation,</w>
resten osis</w>
rest ore
resist ances</w>
resinifer atoxin</w>
rescu ed</w>
res ume
res titution</w>
repolar ization,</w>
remifentan il.</w>
relax ing</w>
rel y.</w>
rel ates</w>
reflex -mediated</w>
ref used</w>
reduc t
recruit ment</w>
rec le
reas on,</w>
re perfusion,</w>
re move
re i-
re exposure</w>
re challenge
re absorption,</w>
raz od
ration 's</w>
rati os.</w>
rat ings.</w>
raph ic</w>
ranitid ine,</w>
radi atum</w>
radi ant</w>
ra ,</w>
r ational</w>
quinoxal ine-
quin idine-induced</w>
quadriple g
quadri paresis</w>
py ro
pust ular</w>
purpo ses.</w>
pur ity</w>
puer peri
psycho ses</w>
proteoglyc an</w>
prot ec
propoxy phene</w>
proper ti
prop acetam
prolactin omas</w>
proj ecting</w>
progno sis,</w>
pro- convulsant</w>
pro pa
pro anthocyanid
preserv ative</w>
prefer ably</w>
pre proenkephalin</w>
pre menstrual</w>
pre anesthetic</w>
pr e</w>
potenti als,</w>
post seizure</w>
post pon
post dose</w>
poly unsaturated</w>
poly substance</w>
ple ur
platele ts,</w>
plasmaphere sis,</w>
placent a</w>
plac ement.</w>
pir acetam</w>
pindo lol,</w>
pict ure,</w>
physici an-
physi ologically</w>
photoc ell</w>
phosph ate-induced</w>
phenyl )</w>
phenprocou mon</w>
phenothiaz ines</w>
phen ethyl
pharmac ogenetic</w>
phag ia</w>
pet echi
perphenaz ine-induced</w>
peroxid ase-
perme ability,</w>
peri oral</w>
peri ocular</w>
per ineal</w>
pentol inium</w>
pentazoc ine-induced</w>
pentagastr in</w>
penicillin- G</w>
penicill in.</w>
pel let</w>
peg -
pea k,</w>
patient- reported</w>
past ure
partic ulate</w>
partic ularly,</w>
paren ter
parad oxic</w>
parac ervical</w>
palmit ate</w>
pal pable</w>
pain less</w>
p. p.m.</w>
p ure-
p si
p ing</w>
oxyl in</w>
oxide- deficient</w>
ox azol
over growth</w>
over dose:</w>
out- patient</w>
out- of-
osar coma,</w>
orig inate</w>
ori ented</w>
organophosphor us</w>
organ ophosphate</w>
or ial</w>
or al)</w>
opor phy
opioid .</w>
opi per
op allidal</w>
onec rosis</w>
one- year</w>
one -</w>
ondansetr on,</w>
on ce
omet ro
omer y-Asberg</w>
ome ter</w>
om in
ologist .</w>
olanzap ine-induced</w>
ol ine.</w>
ol es</w>
ogen ously</w>
offic in
of ovir
ocyte .</w>
octreoti de,</w>
ocon stric
ochemistr y,</w>
oc t
oc r
obt und
observe d;</w>
obj ect
ob it
o ily</w>
o encephalopathy</w>
normal izes</w>
nor-binaltorph imine</w>
non- stressed</w>
non- opioid</w>
non- human</w>
non- hematologic</w>
non- dyskinetic</w>
non traumatic</w>
non responders</w>
non compliance</w>
non alcoholic</w>
nodul e</w>
nocicept ors.</w>
no de.</w>
nitros ative</w>
nitroglycer ine</w>
nitrofuranto in.</w>
nitrit e-
nine ty-
nifedi p
ni ble</w>
ni acin.</w>
ng/ml ;</w>
ng/ml ),</w>
neuropath ology</w>
neurolep tic.</w>
neuro epithelium</w>
neuro anatomical</w>
neural- tube</w>
neur aminid
ner ve-
necrop sy</w>
nam ed</w>
nal mefen
n ine-
n M).</w>
myelo toxicity</w>
myelo pathy.</w>
myalgi as/
myalgi as.</w>
myalgi as,</w>
my otub
mut ag
mumol/ l</w>
multiv essel</w>
multi plic
move ment.</w>
move ment
mouth rin
mother s,</w>
mos mol/
month )</w>
mon os
mol ind
mol )</w>
mode oxy
mo ,</w>
ml/ kg/
miti gated</w>
miti gate</w>
mit ogenic</w>
misoprost ol.</w>
misoprost ol,</w>
mis match</w>
mis cellaneous</w>
minimal- change</w>
min g
min ent</w>
min -induced</w>
microgram/ ml.</w>
microgram/ kg)</w>
microg/m L)</w>
microg/ side)</w>
microg/ paw
microg/ ml</w>
micro puncture</w>
micro L)</w>
mi g
mg/m2/ day,</w>
mg/m2/ d.</w>
mg/m(2)/ day</w>
mg/m 2;</w>
mg/kg/ day),</w>
mg/ l.</w>
mg/ L.</w>
mg/ 5</w>
mg I/
methyl- 5-
methyl dopa-induced</w>
methy lethan
methoxy phenyl)
methohexit one</w>
metast asi
mesyl ate.</w>
melphal an-
meg ak
megak ary
medoxom il</w>
medic ation-
meas ure.</w>
me ter
me sis</w>
maxim ize</w>
max illary</w>
max ),</w>
mark ed,</w>
mannit ol.</w>
mandat ory.</w>
malform ation.</w>
macro scop
ma p</w>
ma :</w>
mGluR 8</w>
mGluR 2/3</w>
m om
m L,</w>
m 2)</w>
lymph openia</w>
low- flow</w>
lon af
lonaf ar
lonafar ni
log y,</w>
lob es.</w>
lo pathy</w>
lo ose</w>
lisinopri l,</w>
lipos omes</w>
lip s</w>
linezol id,</w>
lind ane.</w>
lind ane,</w>
limb .</w>
lib ido
li d</w>
level s:</w>
leuc ine</w>
leptomen ingeal</w>
leg ia.</w>
le ural</w>
le tion</w>
later alis</w>
laryng oscopy</w>
l-N AME</w>
l atis
latis simus</w>
l ar
l ady</w>
l -associated</w>
know n;</w>
kidne y-
ket otifen</w>
k n
ju x
j aw
iz ine.</w>
it ch</w>
ischem ia:</w>
isch aem
is obut
irrit ant</w>
ipr an</w>
ip in</w>
ion ophore</w>
intran as
intrac ell
intra vaginal</w>
intra -</w>
interview .</w>
intermedi ate-dose</w>
interleukin- 6</w>
interac ted</w>
inter stimulus</w>
inter lobular</w>
intensi fication</w>
intelli gen
integr ity.</w>
intak es</w>
inst ant
inst ances.</w>
initi ally,</w>
inhibitor ),</w>
ingu inal</w>
infusion :</w>
infusion -related</w>
inferi ority</w>
inester ase</w>
ine ar</w>
induc ed-
indu stri
individual 's</w>
individu al.</w>
ind ol
inco ordin
in qu
in olol</w>
in atal</w>
immunolab eling</w>
ilo st
il ian</w>
il ed</w>
if erol</w>
idi pine</w>
ide -associated</w>
ici ous</w>
ic on
ic ol
i.p. )-induced</w>
i.m .)</w>
i.c.v .),</w>
i. t
i. c.</w>
i ris</w>
i pation</w>
i e,</w>
hypophysi al-
hypophy s
hyponat remic</w>
hypocap nic</w>
hypoc ellular</w>
hypo kinesia</w>
hyperpolar ization</w>
hyperparathyroidis m,</w>
hydroxy vitamin</w>
hydroxy proline</w>
hour )</w>
hom ozyg
ho arsen
hist ories,</w>
hist aminergic</w>
hist amine-induced</w>
hist amine-
high- osmolar</w>
high- affinity</w>
hexameth onium,</w>
hex ac
hexac os
hero in.</w>
hepatomegal y,</w>
heparin- platelet</w>
hemor adi
hemoglob in.</w>
hemo sider
heat /capsaicin</w>
hear ing,</w>
har maline</w>
haplo types</w>
han dic
halothane- epinephrine</w>
hall marks</w>
haemodi aly
h ence,</w>
guanfac ine</w>
guan id
growth -associated</w>
granulocyte- macrophage</w>
glyc ol-
glucocortico ids.</w>
gli omas.</w>
general ized,</w>
gen es,</w>
gastro intestinal,</w>
gastro esophageal</w>
gamma-glutamyl transpeptidase</w>
gam mag
gall stones.</w>
galact orrhea</w>
ga thered</w>
g out.</w>
g an</w>
function ;</w>
ful filling</w>
frag ility</w>
fract alk
four fold</w>
fos sa</w>
formul ations.</w>
forel imb
foot .</w>
fol ds</w>
fluroth yl</w>
fl ap
fix ation</w>
fist ul
fic ation,</w>
ffe re
fenbu fen
femal e)</w>
fe lodip
fatal ities.</w>
facil ities</w>
fac ed</w>
fac e-
f ill
extingu ished</w>
expo sed,</w>
explic it</w>
expen sive</w>
expen se</w>
exceed ingly</w>
exc ess.</w>
ex em
exem pl
evid ences</w>
evid ence,</w>
evacu ation</w>
euthanati zed</w>
etomid ate-induced</w>
ethyl-beta-carboline-3- carboxylate</w>
et s</w>
estradi ol-treated</w>
erythropoi etic</w>
erup tions</w>
ergometr ine</w>
er ron
epileptic us-induced</w>
ephed rine,</w>
ep ir
ep in</w>
entr al</w>
entan o
ent :</w>
enrich ment</w>
enoxim one</w>
endoscop ically</w>
endo vascular</w>
endarte rectomy</w>
end point.</w>
en ucle
en em
em ide</w>
em bed
em b</w>
elic obacter</w>
electrocardio graphy,</w>
electro shock,</w>
electro des.</w>
electr on
elas tin</w>
eigh t.</w>
efficac i
effectiven ess,</w>
eff usions,</w>
educ ation,</w>
ecto dermal</w>
ec ith
early- stage</w>
e vi
dysphor ia</w>
dysp noea</w>
dyslipide mia</w>
dyn orph
dram atic
dr as
dras tically</w>
dox apram</w>
down- regulated</w>
dose- related.</w>
dor sal
domin ated</w>
dog s:</w>
document ing</w>
dobut amine-
dn /P
dizzin ess
distres s.</w>
dist ur
discomfor t,</w>
disco very</w>
disco id</w>
discer nible</w>
dis si
dis rupt</w>
dilev alol</w>
dile m
dihydro ergotamine</w>
diet s.</w>
dic arboxylic</w>
diazepam- withdrawn</w>
diam m
dialy tic</w>
di thiocarb
di ethyl</w>
di d.</w>
di amine</w>
dexmedetom idine.</w>
dex tran
desogest rel
des- Arg
des oxy
depren yl</w>
deliver ing</w>
delay ing</w>
delay ed-onset</w>
degran ulation</w>
degrad ed</w>
def initi
deep ly</w>
decre ments</w>
deca des</w>
de oxyp
dapson e.</w>
dP/d t,</w>
d or</w>
d ino
d Tc</w>
cytotoxic ity.</w>
cyclophosphamide -treated</w>
cyclohexim ide</w>
cy st</w>
cy ge
cut -
cul min
cu es.</w>
cro makal
cre am,</w>
cramp s.</w>
cr y
cotranspor ter</w>
corticosteroid .</w>
corro bor
coordin ation,</w>
conver t</w>
control ),</w>
contract ure</w>
contracepti ve-induced</w>
consum ers</w>
consum e</w>
constric tive</w>
const ants</w>
conspic uous</w>
connec tions</w>
conges tion,</w>
con ve
compa red,</w>
comorb idity.</w>
comfor t</w>
colo ur</w>
coincid ing</w>
code ine,</w>
coar se</w>
coagul ative</w>
coagul ation,</w>
coag ulopathy.</w>
clon us,</w>
clinicaltrial s.gov</w>
clind am
cli p</w>
clamp ing</w>
cis DD
ciprofloxac in-induced</w>
cil ni
cigaret tes</w>
ci benz
chromatograph y-
choled och
cholecysto kin
cho osing</w>
cho ices</w>
chlor methiazole</w>
chlor inated</w>
chi e
chi (2)</w>
chemo reflex</w>
chelat ors</w>
character izing</w>
centr al-
cell s;</w>
cefox itin</w>
cef azed
ceas ed.</w>
ce ti
ce tam
caus ation</w>
caus ally</w>
carvedi lol.</w>
carcin ogens</w>
carbox amide
carboplat in-
carbo platin
caps azepine</w>
calcul us</w>
calcific ations</w>
cal orie</w>
cal ib
cad her
ca esarean</w>
c y.</w>
c rist
c occi
c es,</w>
c RA</w>
but toc
but oxide</w>
bur st
bucindo lol</w>
buc cal</w>
bre vi
bran ch
brainst em.</w>
br uc
bp m)</w>
boost ed</w>
bizar re</w>
bilirub in.</w>
bilater al,</w>
bi loba</w>
beta- glucuronide</w>
beta- galactosid
beta- caroten
beta- blockers,</w>
benzodiazep ine-
benef its.</w>
bendroflu azide</w>
be ver
bas ket</w>
bac k.</w>
b.w .,</w>
b ands</w>
b and
b ),</w>
azot emia.</w>
auranof in</w>
aul t</w>
augment ing</w>
atten d
atre sia</w>
atr icians</w>
ation "</w>
ati dine</w>
ather ,</w>
at rin</w>
assess ments.</w>
aspect s.</w>
asp inal</w>
as u
as h</w>
arte me
aro us
ari ses</w>
ar one</w>
ar io
ar i</w>
appeti te-
apparen t.</w>
aphere sis</w>
apatri lat</w>
antimalari als</w>
antidepress ant.</w>
anti- PF4/heparin</w>
anti epileptogenic</w>
anti dromic</w>
anti angiogenic</w>
anti adrenergic</w>
antec ubital</w>
antagon ism,</w>
anorex ic</w>
ann u
angiocardi ography</w>
angio pathy</w>
anesthe tics,</w>
ane di
and all-
andall- Sel
andall-Sel it
analyz ed,</w>
analy zing</w>
analgesic .</w>
anaesthe tics.</w>
an s'</w>
amylo idosis</w>
amsac rine</w>
amoxicill in/
amino hipp
amine- initiated</w>
amine ).</w>
amine ),</w>
amin ase</w>
amen orrhea</w>
amen able</w>
am yr
am en</w>
altern ation</w>
alpha-methyl dopa-induced</w>
alpha-amino- 3-hydroxy-
alpha- smooth</w>
alpha- adrenoceptors</w>
alpha- 2
alpha 1-adrenoceptor</w>
allo pregnanolone</w>
allevi ates</w>
all er</w>
alkalo idal</w>
alkalin ized</w>
aldoster one,</w>
albuter ol.</w>
alben dazole</w>
al is,</w>
al in
al epl
al dol
air flow</w>
again ,</w>
ag matine</w>
affor ds</w>
afferen ts.</w>
af osf
af ine</w>
adren omedullin</w>
adenos ine.</w>
adenocarcin oma,</w>
ad rib
ad just</w>
activ ators</w>
acqu ire</w>
acit ret
acid -associated</w>
acetylamino fluorene</w>
acet onide</w>
accept ability</w>
accent u
ac cord</w>
above- mentioned</w>
abl ated</w>
ab user</w>
ab duc
ab atrin</w>
a, K
a quine</w>
a der</w>
a del
[Ca ]o</w>
[125 I]
[1, 5-
[ P</w>
[ Na
[ 7
[ 10
YM -16
YM-16 15
X- linked</w>
WR 2425
W e,</w>
W SR</w>
W SP</w>
W G</w>
Vir al</w>
Vig abatrin</w>
Vals artan</w>
VE STI
VESTI GA
V ar
V P-
V I</w>
UD C</w>
U tili
U p</w>
U 378
U378 8
Tum ors</w>
Trimethoprim-sulfamethox azole</w>
Ticlop idine-induced</w>
Th ym
Th roughout</w>
Tem pol</w>
Tc- 99m</w>
TP R</w>
TMP /SM
TDH L</w>
TD R</w>
TD M</w>
T x</w>
T razod
T RO
T CPOB
T -treated</w>
System atic</w>
Swit zer
Surve illance</w>
Su per
Spec ial</w>
Shor t</w>
Shakuyak u-
Ser a</w>
Se leg
SUN-1334 H</w>
SN P.</w>
SM emb</w>
SM V</w>
SIG N
SIGN IF
SIGNIF ICA
SIGNIFICA NCE:</w>
SG C</w>
SELEC TION:</w>
SE RT</w>
SE P</w>
SE -induced</w>
SD .</w>
SC s)</w>
SB- 2770
SA R</w>
S. E.
S-adenos yl-L-
S-adenos yl
S ympathetic</w>
S r
S pi
S he
S W</w>
S VR
S 3</w>
S 3
Ro 15-1788</w>
Rhe um
Reg ulation</w>
Reduc tions</w>
RP E</w>
RESULT S</w>
RCT s</w>
R, 4
R AS
R (-)-
Qu er
QT Ls</w>
QT (F
QR S,</w>
PubM ed</w>
Proechim ys</w>
Prob ability</w>
Pre operative</w>
Pr ur
Post partum</w>
Phosph or
Phenyto in-induced</w>
Pharmaco kine
Pharmac ology</w>
Pharmac eutic
Per inatal</w>
PV /
PO P
POP UL
PE A</w>
PDE 3A</w>
PA T</w>
P- S
P- P</w>
P t
P lat
P anc
P Z</w>
P SC</w>
P EP
P -10
P )-
Occurren ce</w>
ON )</w>
OD C</w>
O S
Non- steroidal</w>
Neuro psychological</w>
Netherl and
Nephro calcinosis</w>
Na (+)-
NT S1</w>
NI C</w>
NH E
NH 4
ND I.</w>
NAD PH-
N at
N E-
N A-
N .
N +
My asthenia</w>
Mus cim
Morph ometric</w>
Montg omery-Asberg</w>
Minocycl ine-induced</w>
Mi gra
Meto prolol</w>
Meperid ine</w>
Medic ation</w>
Meas ures</w>
Mac roph
MS O</w>
ME M</w>
MATERIAL S:</w>
MAO I</w>
MA BP</w>
M s</w>
M ay
M ad
M UG
M SDBP</w>
M MI</w>
M CP</w>
M (2)</w>
Li Cl
Larg er</w>
LM W-
LIMIT ATIONS:</w>
LH- RH</w>
LD H,</w>
L-DOPA .</w>
L imbic</w>
L en
L I</w>
L AS</w>
L A,</w>
L .
K ar
Isoproteren ol-induced</w>
Is-5-M n</w>
Intrac or
Inter actions</w>
In cl
Immunosup pressive</w>
Ig G-
Ifosf amide-induced</w>
IN VESTIGA
II b/
II E
ICA M-1</w>
IC I</w>
IC H,</w>
I sot
I s.</w>
I U
I MID</w>
Hz .</w>
Ho w</w>
Health care</w>
He at</w>
HIV-1- infected</w>
HIV- seropositive</w>
HIV -related</w>
HD- MTX</w>
HD T</w>
H elicobacter</w>
H dac
H SCT</w>
H R-
H A.</w>
H -induced</w>
Gran isetron</w>
Good pasture
Glucocortico ids</w>
GSK 3
GO T</w>
GF AP</w>
G row
G e
G adol
G EC
G 35
Func tion</w>
Frac tional</w>
Forty- four</w>
Flur bi
Flu id</w>
Fifty- seven</w>
Fifty- one</w>
Fe ver,</w>
Fab ry</w>
FO LF
FK BP
F oc
F lun
F inal</w>
F icol
F etuses</w>
F er
F N</w>
F J
F CE</w>
Extrac ellular</w>
Excit atory</w>
Ex ogenous</w>
Etoric oxib</w>
Erythropoi etin</w>
Endo theli
Encephalo pathy</w>
Enal apri
En d
Elev ations</w>
Electroencephalo graphic</w>
ER -
EP SCs</w>
EP 1</w>
ENa C,</w>
EK G</w>
EE G,</w>
EE -induced</w>
E scherichia</w>
E qu
E L
Dulox etine</w>
Dos age</w>
Do w
Do fe
Diff use</w>
Develop mental</w>
Desi pramine</w>
Der mat
Dep end
Decreas e</w>
DY RK
DSM- III</w>
DP SGC</w>
DO PAC
DE N-
DD S</w>
D- 00
D ar
D MB
D 3-
D 28
D 2/
D 2-
Cyt ochrome</w>
Cs A,</w>
Contr ast</w>
Concomit antly,</w>
Con trast
Con scious</w>
Com mun
Clar ithromycin</w>
Cho re
Chlor amphenic
Chi ari</w>
Ch ron
Carcin ogenicity</w>
Ca2+ -activated</w>
CR ),</w>
CM I</w>
CG R
CC D</w>
CA R</w>
C- fibres</w>
C s,</w>
C ox
C openh
C op
C ilost
Bot ulinum</w>
Bi op
Bet a</w>
Bepri dil</w>
Ben ign</w>
Bec k</w>
Bcl- x
Bart ter's</w>
BZD s/RDs</w>
BH A,</w>
BALB/ C</w>
B- HT</w>
B ax</w>
B ax
B PRS</w>
B L
B ID
B 19</w>
Av y/
Au th
Associ ations</w>
Assess ments</w>
Ara C</w>
Anti tumor</w>
Anti psychotic</w>
Anti epileptic</w>
Anti depressant</w>
Ang -
An tim
An d</w>
Amb ulatory</w>
Alph a</w>
Aggres sive</w>
Adriam ycin.</w>
Adriam yc
Administ ration's</w>
Acce ler
AZ T,</w>
AZ A</w>
AV M</w>
ATP ase.</w>
AT G</w>
AR B
APPRO AC
AP C</w>
AM P.</w>
AL Y
AL L.</w>
AE s,</w>
AE G35
ACh R</w>
AC C</w>
AC ).</w>
AB T</w>
AB C-
AB -
A- V</w>
A to</w>
A rab
A X</w>
A SI
> 50</w>
> 2</w>
9 ]</w>
9 8%</w>
9 10</w>
9 0/
80 .</w>
8. 5%</w>
8-hydroxy-2- (di-n-propyl
8 3-year-old</w>
8 %);</w>
7H 6</w>
7- CK
7 -10</w>
6. 25</w>
6-keto-PG F1</w>
6- month-old</w>
6,7-di methoxy-4-
6 36</w>
6 3,</w>
6 -12</w>
500 /
50 s</w>
50 6-
50 4</w>
50 ,48
50 ).</w>
5-fluorourac il-induced</w>
5-HT(1B/ D)</w>
5'- phosphate</w>
5 00-
48- h</w>
4- methyl
4- 7</w>
4- 4
4, 5
4 :
4 1,</w>
4 1)</w>
4 -</w>
39 8</w>
38 4</w>
37 7</w>
30 ;</w>
3. 75</w>
3- -
3 TC</w>
3 9-
3 3%,</w>
3 -induced</w>
29 ;</w>
29 9</w>
29 2</w>
29 %,</w>
25 /
24- 48</w>
24 .</w>
2339 0
23 ;</w>
201 Tl</w>
20 th</w>
20 ;</w>
20 %)</w>
2. 6%,</w>
2. 2%</w>
2- oxo
2- ,</w>
2, 2,
2 E1</w>
2 50-
2 23</w>
2 +/-1
2 *
199 7,</w>
198 8,</w>
19. 5</w>
19 66</w>
18. 9</w>
18 4</w>
18 /
18 ),</w>
17 ;</w>
17 7</w>
17 36
16 ;</w>
15. 3</w>
15. 2</w>
15-1 78
15 5</w>
14 0/
13. 6</w>
13. 2</w>
13 1
12. 0</w>
12- 24</w>
11. 1</w>
11 18</w>
10- point</w>
10(- 8)</w>
10 (-1
1. 86</w>
1. 8-
1. 31</w>
1. 27</w>
1. 26</w>
1. 2,</w>
1-1. 0</w>
1, 8-
1 0.7</w>
0.9 3</w>
0.8 4</w>
0.8 2</w>
0.7 4</w>
0.7 %,</w>
0.6 25</w>
0.6 1</w>
0.5 8</w>
0.5 %,</w>
0.00 5</w>
0.0 75</w>
0. 5).</w>
0. 38</w>
0. 32</w>
0. 26</w>
0- fold</w>
0 9</w>
0 8
.00 1,</w>
-10,11- dihydro-5H-di
- striatal</w>
- pretreated</w>
- 0.5
(p< 0.01)</w>
(n ACh
(max ))</w>
(m t
(V AS).</w>
(T MP
(T G)</w>
(T )</w>
(S t
(S TN)</w>
(S K
(PB ),</w>
(P< 0.01),</w>
(P H
(OR :</w>
(NP Y)</w>
(N a,K
(N E),</w>
(MM C)</w>
(M ac
(M F
(I L-
(H R,</w>
(GF AP)</w>
(G- CSF)</w>
(FD A)</w>
(F K</w>
(F E
(ED ).</w>
(E C</w>
(DE X)</w>
(D RE
(D IC)</w>
(D )</w>
(C o
(C NI
(C AD).</w>
(AN P)</w>
(ADP- ribose)</w>
(AC E
(A ST),</w>
(A OA
(> or=
(9 %),</w>
(8 3</w>
(8 %</w>
(7 2%)</w>
(7 %</w>
(6. 7</w>
(6 8%</w>
(5 9%)</w>
(5 4.
(5 2</w>
(5 ),</w>
(4- methyl
(4 6</w>
(4 4.
(4 3</w>
(4 '-
(3. 9</w>
(3. 3</w>
(3. 2</w>
(3 9</w>
(3 4.
(3 3.
(2) =
(2 40</w>
(10- 30</w>
(1. 5%)</w>
(1. 1</w>
(1- 5</w>
(1 3/
(1 2/
(1 00,</w>
(0. 9
( torsade</w>
( ten</w>
( secondary</w>
( s),</w>
( q
( primary</w>
( period</w>
( paracetam
( k
( i.p.,</w>
( hemoglobin</w>
( experiment</w>
( cocaine</w>
( baseline</w>
( area</w>
( L-N
' s.</w>
% -1
" ).</w>
zimel dine</w>
zebraf ish</w>
z otep
yt osine</w>
yn chron
yl] form
yiel ds</w>
yaw ning</w>
y -old</w>
ximel agatran</w>
xer ostom
xen on</w>
witnes sed</w>
within- session</w>
with out.</w>
whi le,</w>
wh at
well- being</w>
weight/ day)</w>
week -
wal a</w>
wa iting</w>
w ,</w>
vinblast ine.</w>
vigil ant</w>
vigabat rin.</w>
video- EEG</w>
vi z
vi remia</w>
ver t</w>
ven ous,</w>
ven ,</w>
vecur onium,</w>
vari ability.</w>
val acyclovir</w>
vacc ine,</w>
v ity,</w>
v ing,</w>
uve itis</w>
ut um</w>
use ;</w>
us ers:</w>
us ality</w>
uro toxic</w>
uro protection</w>
uro graphy</w>
urethane- anaesthetized</w>
ur na</w>
up per-
unineph rectomized</w>
und 's</w>
un remarkable</w>
un published</w>
un likely.</w>
un detectable.</w>
um m
ultrasoun d.</w>
ular .</w>
ul ina</w>
ul ation,</w>
ubi quinone</w>
u til
u gh</w>
ty ram
two- week</w>
tur ned</w>
tubero infundibular</w>
tub al</w>
tro phy
trimethaph an.</w>
trimeta phan</w>
trige min
triaz olo
tri pel
tripel enn
trem e</w>
transplant s,</w>
transp eptid
transcri pt</w>
trans venous</w>
trand rine</w>
trac ing</w>
tot emporal</w>
tongu e,</w>
ton sill
tol met
to oth</w>
to :</w>
tis /
tion ?</w>
time -related</w>
time -</w>
tigm ine.</w>
tid ine.</w>
tic ity,</w>
ti ated</w>
thyro idi
thrombo sis:</w>
thrombi .</w>
thromb ocytosis</w>
three -</w>
thous and</w>
though t.</w>
third- degree</w>
thioredox in</w>
thi aben
therapy- related</w>
ther mal
thalam ocortical</w>
tetra ethyl
tert- butyl
termin ated.</w>
ter in</w>
ten id
tele metry</w>
techne tium</w>
target s.</w>
tak en,</w>
tail- withdrawal</w>
tail ed</w>
t ted</w>
t s
t ol</w>
t i</w>
t ate</w>
syring e</w>
synchron y</w>
synap ses.</w>
sy novi
suxameth onium,</w>
surve yed</w>
surve ill
surpris ingly</w>
sur ance</w>
supra therapeutic</w>
sup ram
summar ized</w>
sulind ac.</w>
sufentan il/
succumb ed</w>
successful ,</w>
subst rate.</w>
subst ance,</w>
subcl avian</w>
sub types.</w>
sub stitute</w>
sub sternal</w>
sub massive</w>
sub capsular</w>
su perf
su bu
struct ure,</w>
stro king</w>
stric ture</w>
stress ful</w>
stres ses</w>
stres s-
streptozoc in-induced</w>
sto ol</w>
stereotypi es.</w>
stereotax ic</w>
stere ospec
ster ing</w>
standar d-
st olic</w>
st arch</w>
st ages.</w>
sple en,</w>
spironolact one,</w>
spermat ozo
sper m
specific ity,</w>
speci alized</w>
spac e,</w>
sp utum</w>
sp ines</w>
sour ce.</w>
soun d-
sorbit ol</w>
son ography</w>
socio economic</w>
so on
small .</w>
sit es)</w>
sino- aortic</w>
sim ulation</w>
sigma -
si es.</w>
si ella</w>
shorten ing,</w>
short- term,</w>
short- lived</w>
shor t,</w>
sha kes</w>
sha k
sh ed</w>
ses ).</w>
serv ice.</w>
ser one
ser ology</w>
sen ing</w>
sen ile</w>
self- injurious</w>
selectiv ity,</w>
sel en
secret ago
scre en
scleroder ma.</w>
sci ence</w>
scho ol-
sch istos
scen ari
satisfac tion.</w>
saliv ation</w>
sal es</w>
sacrific ed.</w>
sac ca
s q</w>
s phenoidal</w>
s ect
s -blue</w>
rub ber</w>
rox ithromycin</w>
roten one-induced</w>
ron ium</w>
roent gen
rim idine</w>
ri le</w>
rex ate</w>
rever t</w>
reve al
retur ns</w>
retin oid</w>
reticular is</w>
resuscit ative</w>
restric tion.</w>
rest ores</w>
responsi ve,</w>
response ;</w>
respond ents</w>
resid ent</w>
require ment,</w>
reporte d;</w>
remin is
reminis cent</w>
rem n
releas ers</w>
relax ation,</w>
rein state</w>
rein stat
regist ered.</w>
reg istry</w>
refl ection</w>
recruit ed.</w>
reco vered,</w>
receptor /
recept ors
reas .</w>
re traction</w>
re tain</w>
re place</w>
re ad</w>
re activation,</w>
re act
rash es</w>
ranol azine</w>
radi ot
radi olig
radi o-
r ing.</w>
r ine-
qual ified</w>
qu is
qu ine-induced</w>
qu ine,</w>
pyridos tigmine</w>
pyrazin amide.</w>
pyraz olo
pyram id
pyr rolidine</w>
py uria,</w>
purpo se.</w>
psychopharmac ological</w>
psych ogenic</w>
prur itic</w>
prostagland ins.</w>
prostagland ins,</w>
prost anoid</w>
prost adi
prost .</w>
proper ty.</w>
progester one,</w>
probenec id</w>
priap ism.</w>
pri t</w>
pri ori</w>
pri migra
prevent ed.</w>
preser ving</w>
prescho ol</w>
pren alter
premat ur
preeclamp sia.</w>
precl ude</w>
pre- operative</w>
pre- ejection</w>
pre- clinical</w>
pre renal</w>
pre pro
pre core</w>
pram ipex
practic es</w>
pra vastatin,</w>
postpartum .</w>
post- liver</w>
post infarction</w>
post ganglionic</w>
possibil ity.</w>
posi tional</w>
por cine</w>
polycyst um</w>
poly therapy</w>
poly sacchar
poly -
po plit
po etin</w>
platinum- resistant</w>
plate au
plasma -
plac ement,</w>
pi x
pi ret
physi ological,</w>
photosensi tivity</w>
phosphodi ester
phosphatidyl choline</w>
phenyl alan
phentol amine.</w>
phen e.</w>
perio per
pericardi um</w>
perg illo
perc us
per zine</w>
pepti de.</w>
pepti de-
pent e
penetr ating</w>
path ologies</w>
patch- clamp</w>
passi ve-
parti al,</w>
pari et
paraly tic</w>
paracetam ol,</w>
papillo mas</w>
pancreati tis
pal sy,</w>
pa ro
pa in;</w>
p urely</w>
p g</w>
oxi b,</w>
oxazaphosphor ine</w>
ox a
overex pressed</w>
over loo
over load
out i</w>
otroph in</w>
otri me
otrime praz
oten ic</w>
ote pa
ot ed</w>
ospas m</w>
os an</w>
ortho gnath
orthognath ic</w>
oro lingual</w>
orgas mic</w>
organ ogenesis</w>
or ci
orci pren
or al-
or /
op posing</w>
op it
oni um-
onco logic</w>
on ly;</w>
on line</w>
on ic
on go
on ed</w>
on ad
ometr ically</w>
omeprazol e,</w>
om ot
om icro
om echan
olith iasis</w>
olanzap ine-treated</w>
ol s.</w>
ol s,</w>
ogen ,</w>
officin alis</w>
off ice</w>
of loxacin,</w>
of ilam
ocu log
octap eptide</w>
ococc i</w>
ochemic ally,</w>
oc rit</w>
obstruc ted</w>
o ked</w>
o gn
nystag mus,</w>
nutri tion.</w>
nutri ents</w>
nucleoti de-
nucle o
nox -G
nox-G ast
nox-Gast au
nox-Gastau t</w>
not es</w>
nortriptyl ine.</w>
normal ;</w>
norm ocapnia</w>
noreth ister
norethister one</w>
nor thern</w>
nor ZTP</w>
non- oliguric</w>
non- epileptic</w>
non- convulsive</w>
non users</w>
non randomized</w>
non prescription</w>
non malignant</w>
non epileptic</w>
nmol/ min/
nit rate-
nicardi pine,</w>
neutrophil s.</w>
neuropath y;</w>
neurolep t</w>
neuro surgery</w>
neuro excitatory</w>
neuro degeneration.</w>
neuro biology</w>
neur ulation</w>
neur axial</w>
neos tigmine,</w>
neo plasia.</w>
negati vity</w>
ne st
ne fopam</w>
narco tics</w>
naf enop
nadi rs</w>
n-propyl -
myelosuppres sive</w>
mye lography.</w>
myco bacterial</w>
my otoxicity</w>
mut ual</w>
mut ations,</w>
mustar d</w>
mumol/ kg)</w>
multiple ,</w>
multi- organ</w>
multi drug-resistant</w>
muc ocutaneous</w>
mt DNA-
motiv ational</w>
mor ning.</w>
mor ning,</w>
monoamine- depleted</w>
mon oc
molind one</w>
modifi able</w>
moder ate.</w>
mo val</w>
mm ed</w>
mitoxantr one.</w>
mitogen -activated</w>
mirtazap ine.</w>
minim izes</w>
milnac ipran</w>
millisec ond
milli grams</w>
micromol/ l</w>
micromol/ l)</w>
micrograms/kg/ min.</w>
microgram. kg-1.
microg/ ml)</w>
micro g),</w>
micro fil
micro bial</w>
mi me
mg/ h</w>
metronidazol e.</w>
metri zo
methylphenid ate,</w>
methyl )-
methyl )
methom yl</w>
methim azole-induced</w>
meth otrimepraz
meth an
metfor min.</w>
metazol ine</w>
metallo thionein</w>
metabol ic,</w>
met ar
mestran ol</w>
mes enter
mepivaca ine.</w>
melaton in.</w>
medul lo
medium- sized</w>
mecamyl amine,</w>
measure ment.</w>
me tric
me rely</w>
materi als</w>
mast ectomy</w>
mas ked,</w>
marrow .</w>
marrow ,</w>
market .</w>
manufacture r
man ually</w>
malai se.</w>
macro globul
mac ula</w>
ma de,</w>
mL .
mEq/ kg</w>
m s;</w>
m oxifloxacin</w>
m ole</w>
m itis</w>
m afosf
m RNA-
m M).</w>
lung s,</w>
low -</w>
los por
long- chain</w>
long er.</w>
lo recle
lipo protein-
lipo prote
lin ks</w>
limit s,</w>
light- dark</w>
ligh ter</w>
lidoca ine;</w>
lic ensed</w>
li z
lev o-
leukem ia:</w>
leuk ocyturia</w>
leiomy osarcoma</w>
ledg e</w>
leb itis</w>
le an
le ;</w>
le :</w>
lav icular</w>
lat ing</w>
lat encies.</w>
large- scale</w>
lansoprazol e,</w>
lam ellar</w>
l- arginine</w>
l us
l ished</w>
l and
l -1</w>
kine tics.</w>
kin ases</w>
kg(-1 )),</w>
ket otic</w>
ket ogenic</w>
kan am
k il
k h
k en</w>
k 5</w>
justi fy</w>
jaundic ed</w>
j at
ity ?</w>
iter ature</w>
isth oton
isosorb ide-
isoflur ane
iso thiocyan
is chemic
is al</w>
irradi ation,</w>
iontophore sis</w>
iodo benzyl
investig ations,</w>
intraventric ularly</w>
intrap aren
intraparen chymal</w>
intr as
interval s)</w>
interfer on.</w>
inter rupt</w>
inter group</w>
inter course</w>
inte rest
inte g
int act.</w>
inner -
inner- city</w>
injur y;</w>
initi ator</w>
inhibitor -related</w>
inhibit or-
ing -related</w>
inform ation,</w>
infarc tions,</w>
infarc t.</w>
inex pen
ine/ kg</w>
ine- ,</w>
indu str
incrimin ated</w>
incid ent.</w>
in- vivo</w>
in- inhibitor</w>
in pyraz
in ert</w>
in -1
improve ment
implant s.</w>
impai red,</w>
immunosup pressed</w>
immunore activity.</w>
immunoblo t</w>
immuno fluoresc
imipenem -
im id
ido sis.</w>
iden tic
id ol</w>
ici pal</w>
ic lospor
i.c.v .).</w>
i. t.)</w>
hypothe tical</w>
hypothalam us.</w>
hypothalam o-
hypoten sion-
hypophysial- portal</w>
hypophosphat emia</w>
hypoglyce mia.</w>
hypoalbum inemia</w>
hypertriglyceride mia,</w>
hyperkal emic</w>
hypercal caemia</w>
hyper- responsiveness</w>
hyper trophy
hyper osmolality</w>
hydroxy ethyl</w>
hydro philic</w>
hydro morph
hydra zine</w>
hybridiz ation.</w>
hyal in
hu perzine</w>
hospital izations</w>
hoarsen ess</w>
hirsu tism</w>
hind quarters</w>
hil us.</w>
high- intensity</w>
hexacos anol</w>
hexachlorocyclohex ane</w>
hero in,</w>
hepatocarcin ogenicity</w>
hepatoc ell
hepatoblast omas</w>
hemodialy zed</w>
hemisphere .</w>
hemip legia</w>
health .</w>
head ,</w>
hamster s,</w>
ham sters</w>
halo genated</w>
h arb
gu statory</w>
grow th-
gre y</w>
graph ical</w>
granulomat osis,</w>
granulo cytosis</w>
graf ts,</w>
gradu ally.</w>
go od,</w>
glutam ate-
glucuron id
glucosaminid ase,</w>
glucocortico id
glob ally</w>
glo ve</w>
glibencl amide,</w>
gli a</w>
gland s.</w>
gland s,</w>
gl ass</w>
gl and,</w>
ginsen g</w>
gemfibroz il.</w>
gemcitab ine.</w>
gemcitab ine-induced</w>
ge ment</w>
galactos amine</w>
g/m 2.</w>
g m/
g elat
g ed</w>
g d</w>
g ati
g as
frame work</w>
fract ures.</w>
frac tions.</w>
form s.</w>
force d-
for amen</w>
foci ,</w>
foc al,</w>
flurbi profen,</w>
flur ane,</w>
flup irtine</w>
fluoro -
fluo ren
flud rocortisone</w>
flu id
flo uro
flacc id</w>
fl ush</w>
first- degree</w>
fing ers</w>
filter ability</w>
fif ty</w>
fibroblast s,</w>
fib er
fi ve
fi les</w>
fenfluramine- phentermine</w>
feel ings</w>
fe et.</w>
fact ori
f uc
f low-
f er</w>
f ate</w>
f =
extrasystol es</w>
extrac ranial</w>
extra vascular</w>
extra renal</w>
extr am
extr act,</w>
expi red</w>
exha us
exer ting</w>
exclu sive</w>
excit ement</w>
excep tional</w>
exacerb ation.</w>
ex am</w>
evid ence.</w>
evalu ations,</w>
eugen olol</w>
etretin ate</w>
etopo side.</w>
etiolog ies.</w>
eth ical</w>
et y,</w>
et ron</w>
estro l</w>
establ ishes</w>
est ers</w>
est ed</w>
esophag us</w>
es ulf
es orubicin</w>
erythropoi et
erythrom ycin.</w>
erythro cytes,</w>
ero sive</w>
erec t</w>
equ ivocal</w>
episode s),</w>
epidemio logy</w>
epid ur
ent rop
engraf tment</w>
energ e
endothelium- derived</w>
end point,</w>
end orph
encephal omyeli
encephal itis.</w>
enanth ate</w>
en tion</w>
en buterol</w>
em piric</w>
eluc idation</w>
else where</w>
elim inating</w>
electroretino gram</w>
electroly tic</w>
electrocardio graph</w>
ejac ulation</w>
ef avi
ect in,</w>
ect ed
echocardio gram.</w>
e- based</w>
e -</w>
e '</w>
dystroph y,</w>
dur able</w>
drug- naive</w>
droperid ol.</w>
drink ers</w>
dr in</w>
doxorubic in:</w>
doses :</w>
dose- escalation</w>
dopa -
dop pl
domperid one,</w>
dog s;</w>
dithiocarb amate</w>
disulfir am.</w>
disulf ide</w>
dissoci ative</w>
disproportion ately</w>
dispens ing</w>
discomfor t.</w>
direc tly,</w>
dipyridamole- thallium</w>
dimenhydr inate</w>
dimen sion
dil .</w>
digiti zed</w>
difficul ties,</w>
difficul t,</w>
diamm ine
di version</w>
di hydroxy-
di el
di ary</w>
dextro r
desi pramine,</w>
der ma</w>
der i
depriv ation.</w>
depend ence:</w>
del usions,</w>
del ay.</w>
defl ation</w>
defic it,</w>
decision- making</w>
decade .</w>
decade ,</w>
dec apit
de sensitization.</w>
de ma</w>
de ine</w>
de fibrillation</w>
day -1</w>
day (-1))</w>
d umm
d n</w>
d f=
d B)</w>
d -1</w>
cyto genetic</w>
cytarab ine,</w>
cyt ometry.</w>
cyt ology</w>
cyge us</w>
cyclophosphamide /
cycl ine.</w>
cycl es)</w>
cy sto
cult ure.</w>
cul prit</w>
criter ia)</w>
creatin ine;</w>
countri es,</w>
cost- effectiveness</w>
cor tin</w>
convul sed</w>
conver sion,</w>
controlle d-release</w>
control :</w>
contra indicated.</w>
continu um</w>
cont ents,</w>
consul ted</w>
const ant.</w>
conjunctivi tis</w>
conjunctivi tis,</w>
confoun ders.</w>
concomit ant
concentr ation)</w>
compon ents,</w>
comple mentary</w>
compar atively</w>
comp an
comb ined.</w>
collap se.</w>
col on.</w>
coagul ant</w>
coag ulopathy,</w>
co sis</w>
co operation</w>
co ded</w>
co d</w>
cm 2</w>
clor azep
clofib rate,</w>
clinic o-
classi cally</w>
cister na
circumst ances,</w>
circum ference</w>
cibenz oline</w>
ci lex
chromat ographic</w>
chore a,</w>
chole lithiasis.</w>
chloroqu ine-
chlorambuc il.</w>
chloralo se-
chic k</w>
chemopre ventive</w>
chemo -
chem ist
che st-
characteris tically</w>
ch urna</w>
ch ro
cetam olol</w>
cervi x.</w>
certain ly</w>
cerebro protective</w>
cephalospor in,</w>
centro temporal</w>
cefamand ole</w>
cave ol
cau tionary</w>
catheter ization,</w>
catechol -
cat s,</w>
cat enin</w>
cat .</w>
carmofur -induced</w>
cardi olip
carbap enem</w>
capsul es.</w>
capecitab ine.</w>
capac ities</w>
calcul i.</w>
calcitri ol.</w>
cal retin
cal modul
c u</w>
c row
c is</w>
c hemoradi
c alls</w>
c ).</w>
buspir one,</w>
bundle- branch</w>
budeson ide</w>
bromo -
brety li
break through
bre e
brain- derived</w>
br ing</w>
br ad
bp m,</w>
bor ne</w>
bor e</w>
body weight</w>
blot ting.</w>
ble omycin.</w>
bl inde
bir ds</w>
bio genic</w>
bicyclo phosphoro
bic eps</w>
bi g</w>
bi bli
beta- thalassemia</w>
beta /
bes artan</w>
behaviour al,</w>
begun .</w>
bed side</w>
beat s.
beat s,</w>
be st-
bas es</w>
barbit uric</w>
backgroun d.</w>
backgroun d,</w>
bac k,</w>
b.w .</w>
b.w .)</w>
b y,</w>
b rown</w>
b erb
b avirin</w>
b ath
azol ,</w>
axon s,</w>
av y</w>
aur a,</w>
atten ded</w>
attac k
atis m</w>
ation ?</w>
ation .(ABSTRACT</w>
ati gue</w>
ate- evoked</w>
at opic</w>
asystol e,</w>
ast ly,</w>
aspirin- sensitive</w>
asi a,</w>
as ses</w>
as k</w>
as etron</w>
as e;</w>
arthro pathy</w>
arteri tic</w>
arsen ic</w>
arri ved</w>
arrhythm ia:</w>
arom atase</w>
ar ities</w>
apro cl
approach es.</w>
appreci ated.</w>
appeti te,</w>
apolipo proteins</w>
ap sed</w>
ap ra
ap one</w>
ap illary</w>
anxioly tic-like</w>
antinocicep tion.</w>
antigen -
antidot es</w>
anticoagul ants.</w>
antibio tic-induced</w>
anti- tuberculosis</w>
anti- HCV</w>
anti parkinsonian-like</w>
anti apoptotic</w>
aneurysm .</w>
anesthesi a
ane- based</w>
ance ment</w>
anc ies</w>
analy tical</w>
analy sis).</w>
analogu es.</w>
an oxic</w>
amyl amine</w>
amph oter
amoxicill in-clavulanic</w>
amox ycill
amox apine</w>
amisulpri de.</w>
amin orex</w>
amin op
amilor ide,</w>
amifost ine.</w>
amb ulation</w>
am rin
altern ative.</w>
alprazol am.</w>
alpha-methyl-p- tyrosine</w>
alpha-methyl dopa,</w>
alpha-fet oprotein</w>
alpha- blocking</w>
alpha- H</w>
alpha /
alpha -1-
alkalo ids,</w>
alg ia.</w>
alfa- 2b</w>
aldol ase</w>
alcohol ics</w>
alcoh ol-
albuter ol,</w>
al ity.</w>
al in,</w>
al e-
al ).</w>
al 's</w>
agranulocyto sis.</w>
agonist ),</w>
aggres sion,</w>
age ing</w>
age ),</w>
ag outi</w>
ag o</w>
ag ene
aff lic
advoc ate</w>
adul ter
adrenocortic otropin</w>
adi pos
adhe sive</w>
adenos ine-induced</w>
adenocarcin omas.</w>
aden ylyl</w>
aden oma,</w>
adel ph
ad mixed</w>
ad mit
acyclovir -induced</w>
actomy osin</w>
acri lex</w>
acquisi tion,</w>
aconit ine-induced</w>
acne ,</w>
acet ate-
ace butolol</w>
accru ed</w>
acceler ating</w>
ac yl</w>
ac yl
abro gated</w>
abor tion.</w>
abol ished,</w>
abil ities.</w>
abduc ens</w>
ab it
ab and
ab alin</w>
aPT T</w>
a ]
[4- (2-
[2-(3,4- dichlorophenyl)
[ 8
Z -induced</w>
Z )-
Y ale-
Wor sening</w>
With ania</w>
Wil ms</w>
Warfar in-induced</w>
WK Y.</w>
WK Y,</w>
W er
W ash
Venlafax ine</w>
VT s</w>
VPA -associated</w>
VP T</w>
V es
V IP
V H</w>
V -induced</w>
Uro logical</w>
Up jo
Ultra structurally,</w>
U/ L),</w>
U preg
Typ ical</w>
Thre e-
Thiop ent
Ta urine</w>
TMP-SM Z</w>
TI DA</w>
T rop
T riam
T et
T ER
T CR</w>
T A-
Sy d
Succinyl choline</w>
St res
Sou thern</w>
Smo king</w>
Sixty- two</w>
Sixty- three</w>
Sixty- four</w>
Sing le-
Sim vastatin</w>
Shor t-
Sevo flurane</w>
Seventy- eight</w>
Sep arate</w>
Sensi tization</w>
Scop olamine</w>
Sal butam
STZ- diabetic</w>
STUD Y:</w>
ST- elevation</w>
SSR18150 7</w>
SPEC T.</w>
SP N</w>
SOD ,</w>
SNC 80</w>
SE RV
SC T.</w>
SC ).</w>
SC ),</w>
SB-2770 11
SB P,</w>
S-adenosyl-L- methionine</w>
S t.</w>
S or
S low</w>
S ig
S ham</w>
S an</w>
S R)</w>
S HB
S F</w>
S );</w>
Roc he
Ro yal</w>
Ret inal</w>
Rep eti
Remark ably,</w>
Relev ant</w>
Rel atively</w>
Reas ons</w>
Re moval</w>
Re fract
RU 486</w>
RT- PCR</w>
RESULT :</w>
REPORT S:</w>
REG ISTR
R e-
R ather,</w>
R ab
R X</w>
R VO
R N-
R CC</w>
R A)</w>
Qu al
Pub lished</w>
Prur itus</w>
Procain amide</w>
Procain amide-induced</w>
Pro gram
Pro -
Prinzmet al's</w>
Preg abalin</w>
Po oled</w>
Po ison</w>
Physi ological</w>
Phil adelph
Perman ent</w>
Pericardi al</w>
Pentazoc ine</w>
Partic ipation</w>
PT X-induced</w>
PT T</w>
PR IS
POPUL ATION:</w>
PL P</w>
PKC epsilon</w>
PI 3K
PH EN</w>
PH ).</w>
PGI 2,</w>
PGE 1.</w>
PC PA</w>
PB C</w>
PAN- injected</w>
P< 0.00
P ure</w>
P op
P in
P dn/P
P ast</w>
P N.</w>
P L-
P F</w>
P C-
Oxcarb azepine</w>
Orth o</w>
Organ ic</w>
OF F</w>
OD .</w>
OB SERV
OAT -
O s
O PC
O H,</w>
O CS</w>
Nrf 2</w>
Niger i
Neurolep tic-induced</w>
Neuro toxic</w>
Neuro sc
Net work</w>
Nephro lithiasis</w>
Na ,
NT S
NO SIS:</w>
NDE A</w>
NB Q
NAD PH</w>
NA GE
NAGE MENT:</w>
N-acetyl- beta-
N-[4-(5-nitro-2-furyl)-2-thiazol yl]form
N- hexacosanol</w>
N- 2-
N ur
N d
N Z
N N</w>
Mos sy</w>
Mini -M
Mini-M ental</w>
Mexilet ine</w>
Met formin</w>
Mem ant
Mar row</w>
MS- 8
MS M</w>
MR -
MPT P-treated</w>
MM T</w>
MK-80 1.</w>
MK 801</w>
MK 80
ME T</w>
ME LD</w>
MB s</w>
MA NAGEMENT:</w>
M ut
M uc
M ill
M U</w>
M P-
M P,</w>
M 1,</w>
Long itudinal</w>
Lidoca ine-induced</w>
Li gh
Li ,</w>
Leuk emia</w>
Len nox-Gastaut</w>
Le uc
LN C-
LNC- 8
L-argin ine-
L iterature</w>
L enal
L astly,</w>
Know ledge</w>
Ketoro lac</w>
Kawasak i</w>
KW- 39
K m</w>
K (+)
Ir respective</w>
Inv asive</w>
Intracor onary</w>
Intra- arterial</w>
Intra hippocampal</w>
Intr ad
Inter vention</w>
Inhib it
Inf ectious</w>
Indic ations</w>
Im plications</w>
IV ),</w>
IU/ l,</w>
INVESTIGA TIONS:</w>
IM PA
IIb/ III
III- IV</w>
III ).</w>
II -induced</w>
IGF B
IFN- gamma</w>
IF X</w>
ID C</w>
I(K r)</w>
I sop
I den
I H</w>
I A)</w>
Hemorrh age</w>
Hemat uria</w>
Hem olysis</w>
He in
HR -12
HLA- B
HIV .</w>
HER G</w>
HD P</w>
HD MTX</w>
HB O2</w>
HB F</w>
HB )</w>
HAM-D -17</w>
H2 O
H ic
H ess</w>
H PA</w>
Granulo matous</w>
Granulo cyte</w>
Gra des</w>
GnR H-
Gl y-
GSK-3 beta</w>
GR K2</w>
GAP- 43</w>
GAD 65</w>
G- protein</w>
G- Co
G-Co A)</w>
G s)</w>
G ross</w>
G as
G am
G P</w>
G DNF</w>
G /
Fre und's</w>
Fran ce.</w>
Fe atures</w>
Fas udil</w>
FR 1736
FOLF O
FL AP</w>
FE V
FD C</w>
FB M</w>
F- 41</w>
F low</w>
F lest
F ever</w>
F eno
F atigue</w>
F P-
F ITC-
F AC</w>
Ex treme</w>
Ex tra
Evan s-blue</w>
Estrogen s</w>
Epidemio logical</w>
Epi lept
Ep ste
Enox apar
Enh ancement</w>
En dot
En doc
Em erg
Electroly te</w>
Eb ste
ET V</w>
EO G</w>
EG CG</w>
EE -
ED 7</w>
E T</w>
E MT
Dys kine
Dou ble</w>
Dos ages</w>
Donepe zil</w>
Dis order</w>
Diphen hydramine</w>
Dil ated</w>
Dig it
Dia stolic</w>
Di azepam,</w>
Di az
Di alysis</w>
De termination</w>
De pres
De fic
Dap sone-induced</w>
Dan azol</w>
DT P</w>
DN A)</w>
DM CM</w>
DI AG
DIAG NOSIS:</w>
DE S.</w>
DE C</w>
DD E</w>
D x</w>
D u
D ro
D iz
D em
D bh</w>
D WI</w>
D AR
D 3.</w>
D -treated</w>
D (3
D (2)-
Cy sti
Cy pro
Cur cumin</w>
Cross- sectional</w>
Cor rec
Cor dar
Con sci
Com peti
Coch lear</w>
Clo se</w>
Cl (-)</w>
Child -P
Cent er,</w>
Cef otet
Carcin oma</w>
Car nit
Calcineur in</w>
CaCl 2</w>
CaCl (2)</w>
Ca usality</w>
Ca ud
CV D</w>
CT/ LCT</w>
CT C</w>
CR s</w>
CP u</w>
CP T</w>
CP E-
CP ),</w>
CO L
CNS -
CN U)</w>
CM P</w>
CLO Z</w>
CI PN</w>
CH F
CH )</w>
CCK-8- SE</w>
CCB s</w>
CC PA</w>
CB 2</w>
C- 96
C yst
C Z</w>
C C.</w>
C 2</w>
Braz ilian</w>
Br -
BM C</w>
BCH E</w>
B ur
B rattleboro</w>
B otox</w>
B ir
B U</w>
B RS</w>
B M</w>
B L</w>
Auth ors</w>
Austral ia,</w>
Attempt s</w>
At tac
Argatrob an</w>
Antine utrophil</w>
Anti hypertensive</w>
Anti cholinergic</w>
Anthrac ycline</w>
Ang us</w>
Ang ina</w>
Ana phylaxis</w>
An wala</w>
Amisul pride</w>
Am oxic
Am io-
Age -related</w>
Afric a.</w>
Af ter
Adriam ycin,</w>
Adren ergic</w>
Ad C</w>
Acetyl cysteine</w>
Acetazol amide</w>
AV A</w>
AV 3
ATP ase)</w>
AT ),</w>
AS P</w>
AS L-
AS A-
AS -
AP O</w>
ANOV A</w>
AN ALY
AM P)</w>
AL R</w>
AER s</w>
ADAM TS
AD ,</w>
AC Z</w>
AC PT
AC P-10
AC C-96
AB )</w>
A- IV</w>
A tri
A tor
A septic</w>
A s)</w>
A granulocytosis</w>
A PO
A L-
A HR-12
A 2
< or=</w>
< .05).</w>
90 %.</w>
90 %,</w>
9 7%</w>
9 66</w>
9 50</w>
9 20</w>
9 1,</w>
9 ,
8 A</w>
8 8)</w>
8 65</w>
8 5)</w>
8 4-year-old</w>
8 4
8 33</w>
8 20</w>
7-OH- AAF</w>
7 5-
7 5%,</w>
7 40</w>
7 4.
7 );</w>
60- min</w>
6- 8</w>
6 55
6 5)</w>
6 3)</w>
6 000</w>
6 )
6 %.</w>
57 .</w>
524 6
5. 8
5-HT(1 A)-
5-HT 6</w>
5-HT ,</w>
5- 7</w>
5,10- imine</w>
5 6-
5 -1-
48- 72</w>
48 /
4-D AMP</w>
4 67</w>
4 6-
4 000</w>
3alpha,5alpha- THP</w>
39 7</w>
39 %,</w>
38 1</w>
37 %,</w>
35 ),</w>
32 P-
30- mg</w>
30- day-old</w>
30- 60</w>
3. 7%</w>
3. 5%,</w>
3- benz
3- 7</w>
3, 7-
3 8-
3 6,</w>
3 4)</w>
3 0.0</w>
3 %);</w>
29 3</w>
28. 5</w>
28 4</w>
27 ),</w>
25 1</w>
21- day-old</w>
200 8.</w>
20- HETE</w>
2. 3%</w>
2. 25</w>
2. 1-
2-mercapto ethane</w>
2-chloro adenosine</w>
2-amino- 5-
2- antagonist</w>
2 :
2 29</w>
2 2),</w>
2 2%.</w>
2 11</w>
2 1.5</w>
2 1.3</w>
2 +/-1.
199 6,</w>
199 5,</w>
198 3</w>
19. 2</w>
18. 5</w>
18 9</w>
18 8
17. 3</w>
17 8</w>
16 00</w>
16 ,23-
16 ,
15S)- di
15 4,5
14 5
131 I-
13. 1</w>
13- cis-retinoic</w>
13 ;</w>
12. 5,</w>
12. 4</w>
12 79
113 89-
11. 9</w>
11. 4</w>
11 th</w>
100 %)</w>
10 -12</w>
10 %;</w>
1.0 8</w>
1.0 7</w>
1.0 2</w>
1. 6,</w>
1. 4,</w>
1. 17</w>
1. 10</w>
1. 00</w>
1,8- cine
1 ]
1 20/
1 18
1 165</w>
1 12
1 100</w>
00 2</w>
0.8 %,</w>
0.6 8</w>
0.6 4</w>
0.6 %,</w>
0.000 5)</w>
0.00 6)</w>
0.0 25)</w>
0. 4%)</w>
0. 37</w>
0. 34</w>
/ LVE
.00 8).</w>
.00 5).</w>
-1. 7
- B</w>
- 5-
- 0.8
+ ).</w>
(f MR
(dd I)</w>
(control s)</w>
(WH O)</w>
(V OD)</w>
(V N
(TR PV
(T UNE
(T O
(SPEC T)</w>
(SHR ).</w>
(S LE)</w>
(RR =
(R V
(R T)</w>
(P< 0.001),</w>
(N Y
(Mac aca</w>
(MA O
(M S
(M PO
(M M)</w>
(LD 50)</w>
(L QT
(IN H)</w>
(IC RF-1
(I M
(I )</w>
(HM G-CoA)</w>
(HAAR T)</w>
(H PA)</w>
(ED 50)</w>
(E P)</w>
(E Na
(E N
(Del ta
(DSM- IV)</w>
(D AT)</w>
(C K),</w>
(B U
(B T
(B R
(B MT)</w>
(B A
(AR B)</w>
(APA P)</w>
(AL F)</w>
(AED s)</w>
(ADR s)</w>
(AC TH
(AC )</w>
(A D)</w>
(9 1%)</w>
(7 8</w>
(7 4.
(7 2</w>
(7 %),</w>
(6 9%)</w>
(6 8%)</w>
(6 6%)</w>
(6 2%)</w>
(6 )-
(6 ),</w>
(6 %).</w>
(50 %),</w>
(5. 5</w>
(5 4</w>
(5 %).</w>
(4 1</w>
(3 9.
(3 6%),</w>
(3 0%</w>
(3 %).</w>
(2. 7%)</w>
(2. 6%)</w>
(2-chloroethyl )-1-
(10- 40</w>
(1. 3</w>
(1. 3%)</w>
(1 8
(1 3%),</w>
(1 2)</w>
(0. 3,</w>
(0. 125</w>
(0. 1-10</w>
(-1 )
(-/- ))</w>
( standard</w>
( primarily</w>
( paclitaxel</w>
( maximal</w>
( lower</w>
( l-
( i.v.).</w>
( i.p.
( four
( dopamine</w>
( con
( adriamyc
( [3H]
( UD
( QTc</w>
( 8-OH-DPA
( 5%</w>
% ],</w>
% ]).</w>
zofen opril</w>
z oster</w>
z onal</w>
z alcit
yl- 4-
yl line,</w>
year ly</w>
ye icos
y- chain</w>
y rimidine</w>
y rap
y losing</w>
xi s.</w>
xenobio tic</w>
xanth ines</w>
x ic</w>
withdraw al-induced</w>
widen ed</w>
wat ch</w>
war ned</w>
w t/
w t
w er's</w>
w ax
w alk
w -
vol %</w>
vit re
visual ize</w>
visu al-
vis its,</w>
vim entin</w>
vil inear</w>
vesti bulo
venlafax ine,</w>
ven om</w>
vel b
ve "</w>
vasomo tion</w>
vas ogenic</w>
vari ance.</w>
vancom yc
van inolol</w>
val ,</w>
vagotom y,</w>
vag ue</w>
vacu ole</w>
vaca ine</w>
v indes
utili ze</w>
us s</w>
uro genic</w>
urg ical</w>
urg -
urg- Stra
urg-Stra uss</w>
ureth ra</w>
unremark able,</w>
unit s,</w>
unevent fully</w>
under scores</w>
under line</w>
uncerta in
un usu
un treated.</w>
un successful.</w>
un restricted</w>
un n</w>
un medicated</w>
um ).</w>
ular ly.</w>
ul es.</w>
uch s</w>
ubi quit
u min
u an
tz man</w>
tyros ine,</w>
typ ing</w>
twenty- four</w>
turno ver.</w>
tumour .</w>
tumori genic</w>
tum oral</w>
tubul e.</w>
tuber cul
trun k,</w>
tro pan
tro meth
tript yline</w>
triazol am.</w>
triazol am,</w>
tri gu
tremor i
tremori genic</w>
trazod one,</w>
transf usion,</w>
transamin ases,</w>
trans luminal</w>
tran dol
tra ins</w>
tr ab
tox ins,</w>
tos ylate</w>
top ographic</w>
tongu e-
tolbut amide</w>
to uch
to tic</w>
to p</w>
to e</w>
to .</w>
tion s)</w>
tim es/
tilt- table</w>
ticarc illin</w>
tic ulo
ti sed</w>
ti gi
ti ary</w>
thym oxamine</w>
thrombocytopen ia/
thromb oly
three- month</w>
thre e.</w>
thiopent one.</w>
thi otepa
therapy- na</w>
therapeu tic"</w>
the ories</w>
the ophylline
th ol</w>
tetrac yclic</w>
testoster one.</w>
terti ary-
terg uride</w>
terfen adine.</w>
terat ogenesis.</w>
ter bin
tem oc
te olol</w>
te mazep
te j
te ar
tari bavirin</w>
tamoxifen -induced</w>
tachyp nea,</w>
tachy arrhythmias,</w>
table ts,</w>
t s/
t c
synap to
sym metric
sy mb
symb ol</w>
switch ,</w>
swe ating,</w>
susta ined,</w>
surroun ded</w>
surge ons</w>
suprag ranular</w>
super vised</w>
sup posit
sunit inib</w>
summar izes</w>
sulpiri de.</w>
sulfonylure as</w>
sulf ated</w>
sufentan il,</w>
succinylchol ine,</w>
succ ess.</w>
subu ro
substitu tions</w>
subst ra
subj ectively</w>
subcut aneously,</w>
sub type.</w>
sub traction</w>
sub sensitivity</w>
sub lingu
sub dermal</w>
su staining</w>
su ffere
stut tering</w>
stud y)</w>
striat oni
striatoni gral</w>
stres s/
strept o
strat a</w>
stra in
stom atitis,</w>
stimul ants.</w>
stere ological</w>
ster ixis</w>
stem -cell</w>
ste ep
spot s</w>
spong e</w>
spondy lo
spind le</w>
sphing omy
specific .</w>
spas ms.</w>
sparte ine</w>
span ning</w>
spac es</w>
sp illo
sp an</w>
soy bean</w>
soon er</w>
son- Angus</w>
son ographic</w>
somnif era</w>
somnambul ism</w>
som edi
som ato
solub ility</w>
solu tion)</w>
so y</w>
smo o
sme ar</w>
sligh t,</w>
sirolimus- based</w>
sing ly</w>
sing ,</w>
sin ess</w>
simend an</w>
signal- averaged</w>
sign al.</w>
sign .</w>
sign ,</w>
sig mo
sick ness</w>
si lym
silym arin</w>
sheep .</w>
sh ad
sgk1 (-/-)</w>
sex -</w>
sex -
seven ,</w>
sensory- motor</w>
sensitiz es</w>
sens ing</w>
semati lide</w>
self- terminating</w>
self- reports</w>
sel ectin</w>
seiz urogenic</w>
seg ment.</w>
seg ment
sedative- hypnotic</w>
second- order</w>
second s).</w>
secon d.</w>
sec .</w>
se t,</w>
se a</w>
scot oma</w>
scat ter</w>
sc ann
satur ation,</w>
satisfac tion,</w>
satis fied</w>
sarcolem ma</w>
saline- pretreated</w>
salbutam ol.</w>
sal ts,</w>
sal sal
sa i
s. ).</w>
s pati
s in,</w>
ry th
rul ing</w>
ru tin</w>
rom an
roman dibular</w>
ro stro
ro bu
ris tin</w>
ri mmed</w>
ri a.</w>
rewar d.</w>
review ers</w>
rever sed,</w>
retino pathy.</w>
retino in</w>
reticulo cytes</w>
respirat ory,</w>
resp ects</w>
resi due</w>
reproduc ib
reproducib ly</w>
repeate d
ren omedullary</w>
ren in,</w>
ren al-
remifentan il-
relax ant,</w>
reinst ated</w>
regimen )</w>
ref ined</w>
reduc tion)</w>
recur .</w>
record ing,</w>
reconstruc tion</w>
recogni tion,</w>
rece ptive</w>
re- uptake</w>
re vision</w>
re taining</w>
re started.</w>
re produces</w>
re mac
re introduced</w>
re administration</w>
re activation.</w>
re absorption.</w>
rate- limiting</w>
rate- corrected</w>
rate :</w>
rat ed.</w>
rat ).</w>
radic als,</w>
rad icul
rac hi
rab ep
r ite</w>
r ing,</w>
quis qual
quinol inic</w>
qui escent</w>
question able</w>
quanti fied.</w>
quadriple gic</w>
quad ric
qu asi
quasi -
qu ant
qu am
pyri meth
pyrex ia,</w>
py razol
puromyc in.</w>
puromyc in-induced</w>
pup s.</w>
pt osis.</w>
psychi at
psych ic</w>
prur igo</w>
proxim ity</w>
protr usions</w>
protr usion</w>
prost anoids</w>
pros the
propri etary</w>
promaz ine,</w>
prolactin oma.</w>
prolactin aemia</w>
proj ected</w>
progres s.</w>
prog uan
profil es.</w>
profen .</w>
probuc ol-treated</w>
pro stat
pro pos
pro hib
pro gen
pro drugs</w>
pro cysteine</w>
prim ary,</w>
pressure )</w>
preser ves</w>
pren olol,</w>
pregnancy -induced</w>
pregnan- 20-
preci sely</w>
pre medication,</w>
pre contracted</w>
prac tically</w>
pr ic
post- treatment.</w>
post ures</w>
post menstrual</w>
possib ly,</w>
pos th
porphy rin</w>
poplit eal</w>
poly neuropathy,</w>
poly mer</w>
pol acrilex</w>
point es
ple ocytosis</w>
plas matic</w>
piroxic am.</w>
pilocarp ine-</w>
pig mentation</w>
pi perox
photoph obia</w>
phosphocreat ine</w>
phosphatidyl inositol</w>
phosphat ases</w>
phosphat ase.</w>
phosph ot
phosph onic</w>
phil us</w>
phenotyp e,</w>
phenobarbit al-
phenacet in.</w>
phenacet in-
pharmaco therapies</w>
phag ocytosis</w>
ph le
perme able</w>
perm selectivity</w>
perin atally</w>
peri partum</w>
peri orbital</w>
percept ual</w>
percep tion.</w>
per- indomethacin</w>
per oz
per ir
per ,</w>
pent etra
ped uncular</w>
pe tic</w>
patient- years</w>
patient )</w>
patholog ies.</w>
particip ant
parenter ally</w>
parathyroid ectomized</w>
parameter .</w>
papaver ine-induced</w>
pantop razol
pan cytopenia,</w>
palpit ation</w>
pain- free</w>
pac ing-induced</w>
pa ins,</w>
pH i</w>
p< 0.001)</w>
p75 (NT
p, p-
p ing
p ct
p 53,</w>
oxygen ation.</w>
oxy phen
oxy pert
ox opiper
ox ide-induced</w>
ox aproz
ow n.</w>
over view</w>
over dosage.</w>
over .</w>
out line</w>
out let</w>
out flow.</w>
otom imetic</w>
ot ere
ostom y</w>
osteoporo sis,</w>
oste openia</w>
oste omalac
ost asis</w>
os ul
origin ates</w>
orgas m</w>
organel les</w>
organ ell
or on
optim ized</w>
optim ization</w>
optim ally</w>
opioid ,</w>
opi ates,</w>
opi ate-
ophthalmo logical</w>
opac ification</w>
op tions.</w>
op isthoton
op amid
onym ous</w>
onic id</w>
oncolog ists</w>
once- weekly</w>
omet rial</w>
ome- wide</w>
om is
oly l</w>
oligo deoxy
ol- 3-
ol amine-
of ten
ochemistr y.</w>
och ro
oc ulo
oc oc
oc in</w>
oc am
oblast oma.</w>
o v</w>
o propa
o profen</w>
o plast
o ocytes</w>
nucle olar</w>
nucle ic</w>
not e
nos al</w>
normoten sion,</w>
normal ize</w>
normal )</w>
non- use</w>
non- pegylated</w>
non- ischemic</w>
non lymphocytic</w>
non inflammatory</w>
non e,</w>
no tic</w>
no i
no -
nitrosou re
nitros amine.</w>
nitrit e/
nitraz epam</w>
nit us</w>
nigh tly</w>
nicotine- N'-
nicot ine-treated</w>
ng/ ml/
neuropsych ologic</w>
neurolog y</w>
neuro filament</w>
neuro ectodermal</w>
neur ite</w>
neu mo
ness :</w>
ness /
nes ot
nervous ness,</w>
nerv ousness</w>
nerv osa</w>
nephro toxicity:</w>
neostri atum</w>
neostri atal</w>
neocor tex
neo antigens</w>
neo adjuvant</w>
necro ses</w>
nebul ization</w>
nation wide</w>
nalmefen e</w>
n- acetylcysteine</w>
n l)</w>
myoglobin uric</w>
myoglobin uria,</w>
myoglob inuria</w>
myelo dysplasia</w>
myelo blastic</w>
myelo ablative</w>
mye litis</w>
my otoxic</w>
my oc
mut ational</w>
mut ants.</w>
mumol/ L,</w>
mumol e/
multiple -
multi modal</w>
multi factori
mtDNA- encoded</w>
motiv ated</w>
morb idity,</w>
mol/ l)</w>
modeoxy uridine</w>
model s:</w>
mode st,</w>
modal ities.</w>
mmol/ l.</w>
mmol/ L).</w>
mmol/ L
mm Hg/
ml/ kg)</w>
mis use</w>
mirtazap ine,</w>
mirro r</w>
mio sis,</w>
microsphe res.</w>
micromol/ l,</w>
micromol/ L)</w>
microm ,</w>
microliter s)</w>
micrograms/ rat</w>
micrograms.kg-1. min-1)</w>
microg/m L.</w>
microg/ kg),</w>
micro vessels</w>
micro l;</w>
micro dialysis.</w>
mg/m l).</w>
mg/kg/ h)</w>
mg/d L
mg/ L)</w>
mg./kg .,</w>
metriz amide</w>
meti pranolol</w>
methylprednisol one,</w>
methion ine-
metabol izer</w>
metabol ised</w>
metabol ically</w>
met aplasia</w>
mes h
mes encephalic</w>
mes al
menorrhag ia</w>
meningo encephalitis</w>
medi odorsal</w>
medi a,</w>
mechanis tic</w>
measure ment,</w>
me val
me traz
me tered</w>
me ter.</w>
me te
maxim um,</w>
mark er,</w>
mariju an
mannit ol,</w>
man o
man n
mammal s.</w>
mal nourished</w>
mal e)</w>
mainten ance,</w>
magnesi um.</w>
macromolec ules</w>
macaqu e</w>
ma -
mRNA ,</w>
m(- 2).</w>
m ia:</w>
m as.</w>
m M/
m M,</w>
lysos omes.</w>
lymph om
lu min
lox apine</w>
low- level</w>
low er.</w>
loracar bef
long- QT</w>
lon anserin</w>
lograph y,</w>
log ar
loc ations.</w>
lobe line</w>
lo th
lo s</w>
liver -associated</w>
lithium/ pilocarpine</w>
lit er.</w>
lip oxygenase</w>
lin ole
lightheade dness</w>
ligand s,</w>
libido ,</w>
li zation</w>
li a</w>
levome promazine</w>
levodopa -
levo thyrox
lessen ed</w>
lesion -induced</w>
lepir ud
leg ia,</w>
leb siella</w>
lear n</w>
lear n
le in</w>
le 's</w>
last ing,</w>
large -dose</w>
lan d.</w>
lamotrig ine,</w>
lad os
lact at
la g</w>
l end</w>
l ation.</w>
kg(-1 );</w>
kg -1).</w>
ke b
keb ach</w>
ke 's</w>
k ilo
k illing</w>
junc tions</w>
je op
iz ations,</w>
ity- -
ity .(ABSTRACT</w>
it ting</w>
it ch
ist s.</w>
issu e,</w>
isosorbide- 5-
isolated- HIT</w>
isol one</w>
isob aric</w>
iso zyme</w>
irrit ation,</w>
irrit ating</w>
irregular ities</w>
irCR F-41</w>
ir y</w>
ir lukast</w>
ipp ed</w>
iopamid ol,</w>
ion ic,</w>
invasi vely</w>
intraven ous,</w>
intraperitone ally.</w>
intracor poreal</w>
intr aspinal</w>
interview ,</w>
interven tions,</w>
intersti ti
interpre t</w>
intermitt ent,</w>
inter peduncular</w>
inter cros
inten sely</w>
intelli gence</w>
insuffici ency
inst ability,</w>
insp ection</w>
inotrop y</w>
inn ate</w>
injur y:</w>
initi ators</w>
inib .</w>
inher it
inhal ation,</w>
infrequ ent.</w>
infrequ ent,</w>
infl ation</w>
infiltr ates,</w>
infer tility</w>
inf anc
ine ligible</w>
industri al</w>
indomethac in-treated</w>
ind or
incorpor ate</w>
include :</w>
inc ap
in- Barr</w>
in usoidal</w>
in take
in stead,</w>
in opril</w>
in one,</w>
in conclusive</w>
in active.</w>
impro ve.</w>
imple mented</w>
implant ation,</w>
immunocom pet
immuno therapy</w>
immun oprecipit
immediate- release</w>
immedi ately,</w>
imipenem /
im pulses</w>
im perative</w>
im il
ili ac
ig no
ifosfamide /
ifer in</w>
if ies</w>
if erous</w>
if era</w>
idi xic</w>
ide ;</w>
icot inic</w>
icl one</w>
ical "</w>
i um.</w>
i quantitative</w>
i er</w>
i ent</w>
i PTH</w>
i =
hyste rectomy.</w>
hypox ia-induced</w>
hypoten sion)</w>
hypophosphat emic</w>
hyperinsul inemia</w>
hyperglyce mia.</w>
hypercholesterol aemia</w>
hyperammon emia.</w>
hyperalgesi a:</w>
hyper sensitive</w>
hyper secretion</w>
hyper oxal
hyper lipoprote
hyper dynamic</w>
hydrox yeicos
hydro codone</w>
hydralaz ine.</w>
hydralaz ine,</w>
hyd roure
hour s),</w>
hospital ised</w>
hormone- refractory</w>
homogen ates.</w>
hol id
hol ds</w>
ho o
high- salt</w>
high- pressure</w>
high- dose,</w>
heter otop
herb s</w>
heral d</w>
hepat otoxic
heparan ase</w>
hemoglob inuria</w>
hemodynam ic,</w>
hemisphere s</w>
hemic hol
hemi paresis,</w>
hem op
heav y-chain</w>
hear ing.</w>
hampe red</w>
ham ster</w>
half- time</w>
haemodialy sis.</w>
haemodi lu
haben ula</w>
h AI
hAI ]
gro om
gre ml
gr as</w>
gonad otropin-releasing</w>
go ro
go od.</w>
go od-
gnaw ing</w>
glyco side</w>
glyc ation</w>
glucos uria,</w>
glomer ulopathy.</w>
glomer ulo
glicl azide</w>
glibencl amide</w>
gir l.</w>
gir l
get ting</w>
gentamic in-mediated</w>
genotyp e.</w>
gener al.</w>
gangli oside</w>
gabapent in.</w>
gab a
g/m (2)</w>
g/ kg/
g out
g aining</w>
g R
gR [
gR[ hAI]
fron totemporal</w>
fron t</w>
fragment ation.</w>
fract ure.</w>
fore paw</w>
fore arms</w>
for d</w>
foot -
food- maintained</w>
fluvox amine,</w>
fluspiril ene</w>
flush es</w>
fluor inated</w>
fluid- attenuated</w>
flud arabine</w>
fluctu ations.</w>
fluctu ating</w>
fluc ytosine</w>
fluc onazole.</w>
flu vastatin</w>
flecain ide-induced</w>
fl or
fl in
fl ick
fl er
fl are,</w>
fin ished</w>
filam ent
fibrom y
fib ros
fib res.</w>
fib rate-induced</w>
fi gh
fer tility</w>
fenbu fen</w>
fen oter
femal e;</w>
feed ing,</w>
feasib le.</w>
fascicul ations,</w>
factor- beta1</w>
f oxine</w>
f loxac
ey es)</w>
ey e-
extub ation.</w>
exter nally</w>
exten sion.</w>
exposure :</w>
expon entially</w>
explor ation.</w>
exper t</w>
exist s.</w>
exist ,</w>
excit otoxicity</w>
excit ation,</w>
ex tran
ex pose</w>
ev enly</w>
etidoca ine,</w>
eti foxine</w>
ethan ol-
eth opropa
esthe sia</w>
es .
ero sion</w>
eradic ate</w>
er ule
er s'</w>
er ;</w>
er /
er ),</w>
equ ip
epit opes</w>
epirubic in/
epirub icin-induced</w>
epicardi um</w>
epi genetic</w>
epi b
ep oxygenase</w>
eosinophil s.</w>
eosinophil s,</w>
enti az
ent in,</w>
ent h</w>
ent ero
eng aged</w>
enflur ane,</w>
endo gen
end- organ</w>
end points.</w>
encephalomyeli tis</w>
encephalo pathic</w>
enc kebach</w>
en ess</w>
en ables</w>
employ ed,</w>
emerg e</w>
embry os,</w>
elev ates</w>
electrophore tic</w>
el uate</w>
el an
effici ently</w>
ed s</w>
ec um</w>
ear s,</w>
ear ly.</w>
ear ,</w>
e ligibility</w>
e ?</w>
dystroph in</w>
dysrhyth mia.</w>
dysph onia</w>
dysfunction :</w>
dys morphic</w>
dys men
dys geusia</w>
duc t.</w>
drug- taking</w>
drug )</w>
drospiren one</w>
dro x
dro ps.</w>
doxorubicin- containing</w>
double- dumm
doses ;</w>
dor somedi
dopamin erg
dol asetron</w>
do steron
diure tic.</w>
disulfir am-
disulfir am,</w>
disrupt s</w>
disproportion ate</w>
disp osing</w>
diseas e).</w>
discharg es,</w>
dis placed</w>
dis inhibition</w>
dis appears</w>
dimin ished,</w>
dimethyl thiourea</w>
digoxin- specific</w>
digitalis -induced</w>
dideoxy inosine</w>
diatrizo ate.</w>
diatrizo ate,</w>
diabetes -induced</w>
di ri
di plo
di phasic</w>
di isopropyl</w>
di fluoro
di flun
di a</w>
develop ment
dev ice.</w>
deta iled.</w>
design ing</w>
descri ptions</w>
des quam
dermat ological</w>
der m</w>
der ive</w>
depos its.</w>
depos its,</w>
depend ently.</w>
deoxyp yridoxine</w>
deoxynucleoti dyl</w>
deline ated</w>
delay ed,</w>
degre es,</w>
definiti vely</w>
deep er</w>
decade s,</w>
dec ed
deb ate</w>
de vised</w>
de hyd
de bri
daunorub icin.</w>
daun omycin-induced</w>
darbe poetin</w>
dantrol ene.</w>
da m</w>
dP/d tej
d- amphetamine.</w>
d- amphetamine,</w>
d t</w>
d res
d ine-associated</w>
d actinomycin</w>
d F
d (-1))</w>
cytotoxic ity,</w>
cyto sis.</w>
cyto k
cystic er
cyst oscopic</w>
cyst ometro
cyan ide</w>
cure d.</w>
cumul ated</w>
cu stom
cu ne
cryst als.</w>
cri tic
cortic otropin</w>
corpor a</w>
cor ds</w>
copies/ mL</w>
cop ulatory</w>
cop al</w>
convuls ant,</w>
controll able</w>
contract ures</w>
contrac tions,</w>
contra sting</w>
continu ed,</w>
contin gency</w>
cont amination</w>
constric tor</w>
consolid ation.</w>
consider ations.</w>
conn ecting</w>
conges tion.</w>
concurren tly.</w>
concomitant ly.</w>
concl usive.</w>
concentration- response</w>
con su
con form
con dy
con du
con c
compromi se.</w>
compoun d
complete d,</w>
complete ,</w>
compet e</w>
compar ably</w>
com ycin-induced</w>
com man
collo id</w>
collap sed</w>
collag en-
coll ected,</w>
coll ect</w>
col d-
col a</w>
cogniti ve-
cocaine- positive</w>
cocaine- abusing</w>
coca ine)</w>
co- occurring</w>
co vering</w>
co verage</w>
co sis.</w>
co localized</w>
co existed</w>
co bal
cm )</w>
clu es</w>
closed- chest</w>
clofib rate.</w>
clo ser</w>
cl um
cl org
cl adrib
cisapri de,</w>
cinnar izine</w>
choreoathe toid</w>
chor io
cholere tic</w>
choledoch olithiasis</w>
cholecyst ectomy.</w>
cholecalc iferol</w>
cholang itis,</w>
chol ic</w>
chlordec one</w>
chie fly</w>
chick s.</w>
chemoconvuls ants</w>
che st,</w>
channe l-
chamb er.</w>
ch l
ch )</w>
cere bru
cerebru m</w>
cephapir in</w>
cephaloth in.</w>
cephal ex
cent ric</w>
cent ers,</w>
cell .</w>
ceftriax one-associated</w>
cefotet an.</w>
cef tiz
cef onicid</w>
caud a</w>
catheter ,</w>
catechol- O-
catalepsy :</w>
cas opit
cas e).</w>
cartil age</w>
cardiolip in</w>
cardio depressant</w>
cardio active</w>
car inic</w>
car dic
cannul ae</w>
cann ulation</w>
cal i
cal '</w>
cab ergoline,</w>
ca emia,</w>
c us</w>
c os
c in</w>
c c</w>
but azone</w>
but az
bronchospas m,</w>
bronchodilat ing</w>
breath ing,</w>
bradykin in,</w>
brady arrhythmias</w>
both )</w>
bo y.</w>
block ed.</w>
blin k</w>
blepharo spasm</w>
bl ur
bif ur
bi phenylacetic</w>
bi le-
bi ased</w>
bi -
beta-hydroxy steroid</w>
beta- blocker,</w>
beta- HS
beta-HS D2</w>
beta -</w>
beta )</w>
bet ter,</w>
ber aprost</w>
benzodiazep ine-induced</w>
benzo[ a,
benef it,</w>
benef ici
belong ing</w>
beg ins</w>
be ers</w>
barbitur ate-induced</w>
baical ein</w>
b.w .
b.i. d
b ute</w>
b ones</w>
b erg
b ath</w>
b at
b arely</w>
b ]
b ).</w>
azole- associated</w>
ax is
avir .</w>
aur icular</w>
au x
attenu ated.</w>
attac k,</w>
athi one</w>
ather o
ath s</w>
ate- day</w>
at taining</w>
at op
at a.</w>
asyst olic</w>
asthen ia,</w>
assess ments,</w>
ass ing</w>
as pergillo
as ing</w>
arthro plasty</w>
arterios us,</w>
arteriol es.</w>
arteri ole</w>
arter ially</w>
arrest ed</w>
arn s
ar yl-
ar van
ar izine</w>
aquaporin- 2</w>
apyri dine</w>
apra xia</w>
appropri ately.</w>
apopto sis-
apne as</w>
apath y</w>
ap ism</w>
ap ine,</w>
antihist amines.</w>
anticholinerg ics.</w>
anti- neutrophil</w>
anti- muscarinic</w>
anti- hypertensive</w>
anti- cataleptic</w>
anti- androgen</w>
anti trypsin</w>
anti parkinson</w>
anti manic</w>
anti estrogen</w>
anti cocaine</w>
anti bacter
anti androgen</w>
anti allodynic</w>
anti akinetic</w>
anthrac enedi
anth us</w>
antagonist ;</w>
ant "</w>
anser in.</w>
anomal y,</w>
ann ually</w>
ank ylosing</w>
anis ocor
angio edema
anesthesi ologist</w>
anesthesi a-induced</w>
andro lone</w>
ance :</w>
anastom osis</w>
anal icular</w>
anaesthe tic.</w>
an om
an icteric</w>
an eth
an ;</w>
an -</w>
ampicill in.</w>
amoxicill in.</w>
amoun ted</w>
amodi aquine</w>
amne si
aminotransfer ases</w>
aminonucleo side,</w>
aminonucleo side
amino- 8-
amino-8- D-
amino ind
amino )-
amine 's</w>
am ent</w>
alu s.</w>
alte red,</w>
alpha2 ABC-
alpha- naph
alpha- hydroxy-
alpha(2)- adrenoceptor</w>
alpha 7-
almotript an</w>
allyl glycine</w>
allograf t.</w>
allergi es</w>
all-trans- RA</w>
alf op
alend ron
albu min)</w>
al lox
al izing</w>
al ide</w>
al aprocl
akine sia,</w>
agonist -
agglut inin</w>
ag u
ag le</w>
af t</w>
adver tent</w>
adv ice</w>
adv ancing</w>
adhe ren
aden osin
addres sed.</w>
addic tion
adap ted</w>
ad vised.</w>
ad venti
ad ine-induced</w>
acyclovir ,</w>
acut ely,</w>
act s.</w>
acryl amide</w>
acromegal y,</w>
acid ophilic</w>
achiev es</w>
achie ved,</w>
acetazol amide.</w>
ace ae)</w>
accur ac
accid entally</w>
acceler ator</w>
ac -induced</w>
absorb able</w>
absc es
abo ve,</w>
aberr ations</w>
ab solut
ab le-
a us
a ifen
a ids</w>
_ F</w>
[Na ]o</w>
[4, 3-
[3 H]</w>
[ mean</w>
[ 5-
[ 3.
[ 2.
[ 199
[ (2-
Zn (2+)</w>
Z Rs</w>
Z ;</w>
Z -treated</w>
YM-1615 1-1</w>
X R</w>
Wor k
Well -
Wee ks</w>
Wat er</w>
Wash ing
W omen
W enckebach</w>
W all
W /
Vari ations</w>
VN R</w>
VIP (-/-)</w>
VCR -induced</w>
V erbal</w>
V aginal</w>
V R</w>
V IP</w>
V I
V EC
Urin alysis</w>
Upreg ulation</w>
Ultras ound</w>
Ul tim
U/ L.</w>
U/ L);</w>
U K-
U K
U -1
U-1 59
Tric yclic</w>
Tran examic</w>
Tra um
Tin nitus</w>
Thail and.</w>
Th resh
Th or
Test ing</w>
Terbut aline</w>
Ter tiary</w>
Te tra
TW EA
TRI AL</w>
TR s</w>
TP P</w>
TJ -
TI s</w>
TH F</w>
TGF-beta (1)</w>
TGF- beta1</w>
TE T</w>
TE PA</w>
TE P</w>
TCPOB OP</w>
TCD D-induced</w>
TAS K-2</w>
TAM -induced</w>
TA F
T ob
T g</w>
T URE:</w>
T SH</w>
T LC</w>
T L
T AT
T 1-
Sur face</w>
Supra ventricular</w>
Sub group</w>
Sub -
Su peroxide</w>
Ster oid-induced</w>
Star D6</w>
Sta v
Som n
Sixty- one</w>
Simult aneously,</w>
Simp son-Angus</w>
Seventy- seven</w>
Ser ological</w>
Sem iquantitative</w>
Sel ected</w>
Sch istos
Salbutam ol</w>
Sal ic
SVR I</w>
SR 250
SR 141716A</w>
SN R.</w>
SN P,</w>
SELEC TION</w>
SD S</w>
SCN 5
SC T)</w>
SC S</w>
SB-277011 A</w>
SA ).</w>
S. D
S(+)- ketamine</w>
S ympath
S patial</w>
S atis
S ando
S VT</w>
S PA
S N</w>
S K</w>
S B</w>
Risperid one-induced</w>
Rest less</w>
Res cue</w>
Repeti tive</w>
Rel ation</w>
Refract ory</w>
Rec eptor</w>
RNA ,</w>
RAMP 2</w>
R ut
R opi
R are</w>
R PN</w>
R D</w>
R AM
R -treated</w>
Quin idine-induced</w>
QT c
QS/ QT.</w>
Q o
Q O
Q Kd</w>
Q ).</w>
Pub lic</w>
Pt O2</w>
Proj ect</w>
Pri apism</w>
Pres ented</w>
Pres ence</w>
Post marketing</w>
Pharmac eutical</w>
Ph ent
Perio dic</w>
Per me
Pentam idine</w>
Pem oline</w>
Peg ylated</w>
Pdn/P dn</w>
Patter ns</w>
Parox etine</w>
Par alle
Panc re
PT CR</w>
PT ),</w>
PROCED URES:</w>
PR C</w>
PO G</w>
PN U-159
PL G</w>
PL ).</w>
PK A</w>
PIC TURE:</w>
PGI (2)</w>
PGE 2,</w>
PGE 1-induced</w>
PG .</w>
PD-1 28
PD-128 ,
PAN- perfused</w>
PA -treated</w>
P ram
P at
P ED
P C,</w>
P =</w>
P <</w>
P :
P 50</w>
P 4
P 120
Open -
Op en</w>
Ome prazole</w>
Observ ational</w>
Ob ses
OR :</w>
OR ,</w>
OI H</w>
O ther
O ste
O S)</w>
O PN</w>
O EA</w>
O AC</w>
Norep inephrine</w>
Nor adrenergic</w>
Nitroprus side-induced</w>
Ninety- three</w>
Neuro pathic</w>
Neuro genic</w>
Neur ons</w>
Ne os
Na(+ )
Na PB</w>
Na HCO3</w>
Na Cl,</w>
Na /
Na (v)
NT- pro</w>
NSAID ,</w>
NR 2B</w>
NO S,</w>
NG ,</w>
NAD H</w>
NA c</w>
N- butyl-
N- (2-
N(omega)- nitro-L-arginine</w>
N MB
Myco phenolate</w>
Multi focal</w>
Mon keys</w>
Mirta zapine</w>
Min nesot
Migra ine</w>
Methyl prednisolone</w>
Mem orial</w>
Mec amylamine</w>
Me an
May o</w>
Mar yl
MV O2</w>
MUG A</w>
MT ),</w>
MS NA</w>
MR Z</w>
MM .</w>
MDMA/ METH</w>
MD A,</w>
MA PD</w>
MA ),</w>
M- 0
M ouse</w>
M IF-1</w>
M Hb</w>
M CE</w>
M .
M -1
Lymph ocyte</w>
Lis inopril</w>
Ld T</w>
Lang er
LY 37
LY37 9
LY 27
LY27 46
LV .</w>
LT ).</w>
LP O</w>
LP -1</w>
LM W</w>
LE ).</w>
LC V</w>
L- Arginine</w>
L y
L g
L L
L BNP</w>
L -</w>
L )-
Kreb s</w>
KO P-
K+ ,</w>
K it
K I-
K 1
J u
J er
J 2</w>
Isop ren
Intrac isternal</w>
Intrac ellular</w>
Intra hepatic</w>
Inter nal</w>
Insul in</w>
Inflam matory</w>
In stitut
In appropriate</w>
In advertent</w>
Improve ments</w>
Iden tical</w>
Idazox an</w>
IU/ L,</w>
IM /
IL K</w>
IIb/III a</w>
II B</w>
IF N)</w>
IF N
IC G</w>
IC ).</w>
I- converting</w>
I- III</w>
I so</w>
I c</w>
I atrogenic</w>
I -123</w>
Hz ).</w>
Hypoten sion,</w>
Hyper kalemia</w>
Hydro chlorothiazide</w>
Hun t</w>
Hic cups</w>
Hg Cl2</w>
He y
He avy</w>
HIV -associated</w>
HCV- coinfected</w>
HC N</w>
HC H,</w>
HAM- A</w>
HA AR
H(2) O
H R)</w>
H L
H AM
Gre at</w>
Glycyrrhiz a</w>
Gly bur
Gen otyp
Gen der</w>
GY KI-
GV HD,</w>
GT P
GSP E</w>
GR 1279
GP T</w>
GM 1</w>
GABA (A
G- 6-
G unn</w>
G LP-1</w>
G ITS</w>
G HB
G BM
Fos- ir</w>
Fir st-
Fentan yl-induced</w>
Fenflur amine</w>
Fast ing</w>
FF P</w>
F344/ NCr</w>
F uchs</w>
F ore
F lup
F c
F arns
F Z</w>
F X
F VIIa</w>
F M
F IO
F AN</w>
F 2-
Ex amin
Er k</w>
Epste in-Barr</w>
Endothel in</w>
En doscop
Electrocardio gram</w>
Ebste in's</w>
ET (A)</w>
ESR D.</w>
EP S,</w>
EP 3</w>
ED T
E vent
E u
E pac
Drug -related</w>
Dis opyram
Dipyridam ole-induced</w>
Di azepam
Dextro methorph
Des cri
Dep letion</w>
Del ta</w>
De teri
Daun orubicin</w>
Dan ish</w>
DR 3</w>
DPA T</w>
DN F)</w>
DH E</w>
DES -treated</w>
DES -induced</w>
DEN- initiated</w>
DE X
DE S,</w>
DD T</w>
DD P</w>
D-00 4</w>
D- pen</w>
D osing</w>
D am
D DP
D ;</w>
D (2)
Cysti tis</w>
Con trac
Comp ound</w>
Colo r</w>
Classi fication</w>
Cl- BZ
Chol ester
Cho rea</w>
Chloramphenic ol</w>
Chin a.</w>
Child-P ugh</w>
Ch urg-Strauss</w>
Ch -7</w>
Cent ers</w>
Catal ase</w>
Caro lin
Carnit ine</w>
Canad a</w>
Canad a.</w>
Ca+ 2</w>
CT X</w>
CT S</w>
CS s</w>
CS S</w>
CR L
CPE- C</w>
CP Z.</w>
CP U
CP G</w>
CO 2)</w>
CO -
CN QX</w>
CM R</w>
CI .</w>
CH O-
CH ,</w>
CCR 2</w>
CCK-8- NS</w>
CB V</w>
CA S:</w>
CA PE</w>
CA MI</w>
CA F</w>
C ath
C annabin
C ZP</w>
C Q</w>
C PA/
C PA,</w>
C P-
C C)</w>
C >
C -related</w>
C (max)</w>
Bio logical</w>
Benzodi azep
Bene ficial</w>
Be agle</w>
Baro reflex</w>
BR L</w>
BAL B</w>
B ud
B ronch
B im
B S</w>
B N
B LA</w>
B ChE</w>
B AL</w>
Az ot
Auto immune</w>
Aut onomic</w>
Au tism</w>
Asses sing</w>
Arrhyth mias</w>
Arg -
Aqu af
Anticoag ulation</w>
An tic
Amio- Aqueous</w>
Ameli oration</w>
Alter native</w>
Alter ation</w>
Alph a
All- trans-retinoic</w>
Al f
Aff ective</w>
Aff airs</w>
Administ ered</w>
Acyclo vir</w>
Acyclo vir
Acetaminophen -induced</w>
Ac cid
AV P-
AT P.</w>
AT P)</w>
AT N</w>
AS ),</w>
AR ,</w>
AQP 6</w>
AP- 2</w>
AP s</w>
AP L.</w>
AP B</w>
AP -1</w>
ANCA ,</w>
ANALY SIS:</w>
AN T</w>
AN H</w>
AM I.</w>
AHR-12 234</w>
AH ).</w>
AE ,</w>
AD P/
AD P-
ACTH ,</w>
ACC-96 53</w>
AC EA
ABT- 7
AB- 47</w>
A- lesioned</w>
A- (1-1
A y
A sterixis</w>
A sac
A ro
A reas</w>
A c</w>
A OA
A K-
</ =
< 0.01).</w>
< .001)</w>
< .001).</w>
99 m-
95 191</w>
9 cRA</w>
9 27</w>
9 0)</w>
9 '
9 %.</w>
80 ),</w>
8. 7%</w>
8. 3%</w>
8- OHD
8 7.
8 5-year-old</w>
8 2-year-old</w>
7 9)</w>
7 6.</w>
7 11389-
600 2</w>
6. 7%</w>
6. 5%</w>
6. 4
6 ]</w>
6 8.
6 4.
6 00-
55 2
506- treated</w>
50 3</w>
50 .</w>
50 %).</w>
5. 4
5. 2%</w>
5-methyl -10,11-dihydro-5H-di
5-HT -
5- minute</w>
5- flouro
5,7- dihydroxytryptamine</w>
5 ]
5 7-
5 62</w>
5 3-
5 )
48-67 91</w>
48 %,</w>
4- h</w>
4- OH-
4- 8</w>
4, 4'-
4 :</w>
4 91</w>
4 47</w>
4 2%,</w>
4 00-
39 ),</w>
37 8</w>
35 ;</w>
32P- post
30- minute</w>
30 5</w>
30 /
30 %).</w>
3. 4%</w>
3. 2,</w>
3. 0-
3,4-dihydroxyphenyl alanine</w>
3,4-D AP</w>
3 h</w>
3 B</w>
3 7-
3 4-
3 4,</w>
3 33</w>
3 2),</w>
3 12</w>
3 10</w>
3 1).</w>
27 3</w>
27 %,</w>
26 ),</w>
24 6</w>
24 4</w>
24 1</w>
24 00</w>
20- 40</w>
20 ,
2.0 %,</w>
2. 6%</w>
2. 4)</w>
2. 2,</w>
2-amino- 4-
2- wk</w>
2- methyl
2- adrenoceptor-mediated</w>
2- DG</w>
2 19</w>
2 18</w>
2 1/
2 1%)</w>
2 0.1</w>
2 0.0
1: 200
1: 100,000</w>
199 2,</w>
199 0.</w>
198 6,</w>
198 4,</w>
19 74</w>
19 3</w>
19 2</w>
19 28
17- item</w>
16. 6</w>
16. 4</w>
15. 7</w>
15- 30</w>
15 th</w>
15 %)</w>
14. 8</w>
14 ;</w>
13 93
12. 5%</w>
12 8
10- 30</w>
10(9)/ l</w>
10 20</w>
10 %)</w>
1, 8
1 H-
0.9 6</w>
0.9 4</w>
0.9 2</w>
0.8 6</w>
0.8 3</w>
0.7 6</w>
0.7 0,</w>
0.5 %.</w>
0.4 7</w>
0.4 1</w>
0.4 %,</w>
0.3 %,</w>
0.000 )</w>
0.00 7).</w>
0.00 4)</w>
0.0 25%</w>
0. 6,</w>
0 7</w>
0 1</w>
0 -10
.00 2).</w>
.0 5</w>
. s.).</w>
. 4.</w>
-1. 6
-1. 2</w>
-1,3- dipropyl
-1 7.
-1 65</w>
- shaped</w>
- abusing</w>
- S
- DXR</w>
+/-1 2</w>
+/- 4</w>
* 3</w>
)- dependent</w>
(r =</w>
(p= 0.
(p. o.)</w>
(n= 10)</w>
(n NOS)</w>
(medi an:</w>
(mean :</w>
(V PA),</w>
(UPD RS)</w>
(Tax ol)</w>
(T x
(T LE)</w>
(T LE),</w>
(Sp ear
(SSRI s).</w>
(SE ),</w>
(S B
(RB V)</w>
(R AS)</w>
(PT Z)-induced</w>
(PC P)</w>
(P T)</w>
(P S
(P PA)</w>
(P IL
(P HT)</w>
(P DE
(P AR
(Na,K )-ATPase</w>
(NO ),</w>
(NH L)</w>
(N GF)</w>
(M g
(M T)</w>
(M N
(M M).</w>
(M CA)</w>
(M CA
(LD L)</w>
(L F
(L C
(K (i)</w>
(IC V)</w>
(HR :</w>
(HBeAg )-positive</w>
(H O
(G V
(G E
(G 6
(F HF)</w>
(F A)</w>
(ESR D)</w>
(ED (50)</w>
(EC S)</w>
(E X
(E B
(DRE SS)</w>
(DF O)</w>
(D i
(D BP)</w>
(CY P2
(CP P)</w>
(CM L)</w>
(CG I)</w>
(C NS),</w>
(C N
(C IP
(C I</w>
(C I,</w>
(C I),</w>
(C C
(C A)</w>
(C 3
(C ),</w>
(BM I)</w>
(B NP)</w>
(B F
(B D
(Adriamyc in)</w>
(AQ P
(ANCA )-positive</w>
(AB R)</w>
(A ng</w>
(A P)</w>
(9 6%)</w>
(9 4%)</w>
(9 2%)</w>
(9 )</w>
(8 R,
(7 8%)</w>
(7 ),</w>
(6 0%</w>
(6 %</w>
(5-FU ),</w>
(5, 7-
(5 7</w>
(5 5%).</w>
(5 1%)</w>
(5 %),</w>
(4 8.
(4 6%)</w>
(4 ,</w>
(3. 7%)</w>
(3. 3%)</w>
(3 %),</w>
(25 -100</w>
(2 9.
(2 6%</w>
(2 5%</w>
(2 4.
(2 4
(2 2%),</w>
(2 0,</w>
(2 0%).</w>
(2 %).</w>
(12. 5%)</w>
(1. 6</w>
(1. 4</w>
(1 9-
(1 7%</w>
(1 5/
(1 4%</w>
(1 4%),</w>
(1 30</w>
(1 3-
(1 3%).</w>
(1 )-induced</w>
(0.3- 3</w>
(0.3 -10</w>
(0. 9%</w>
(-)- nicotine</w>
(- 4
(- 3
(+)- PD-128,
(+)- CP
( vitamin</w>
( sem</w>
( selective</w>
( s.
( s).</w>
( recombin
( ratio</w>
( positive</w>
( plus</w>
( placebo</w>
( of</w>
( intravenous</w>
( icv)</w>
( e)</w>
( decreased</w>
( creatinine</w>
( between</w>
( beta</w>
( M</w>
( January</w>
( In
( 0)</w>
% ]),</w>
" ),</w>
} -
zolpide m.</w>
zol e-induced</w>
z icon
z alepl
yst emic</w>
yri mid
yme tac
ym pan
ym b
yl- 6-
yl- 2-
year ;</w>
y .(ABSTRACT</w>
xy lo
x ip
with out,</w>
wild -
wide -
where in</w>
whe l
weight/ day</w>
wei g
wean ing,</w>
weak ,</w>
warran ted,</w>
wall s.</w>
w/ w)</w>
w t).</w>
w ks</w>
w as:</w>
w all-
w .
vom ited</w>
volun t
volum es.</w>
viru ses</w>
vill us</w>
view .</w>
ver y-
ven ules</w>
ven ipuncture</w>
ven ess,</w>
ve ins,</w>
vastat in-
vascul arly</w>
vari ants,</w>
vari ably</w>
vals art
val ir
val dec
ut ch</w>
use d;</w>
use -dependent</w>
us ly</w>
us er.</w>
urve dic</w>
ures ;</w>
up ff
upff er</w>
uncertain ty</w>
un responsiveness</w>
un paired</w>
un opposed</w>
un loading</w>
un infected</w>
un d-
un conjugated</w>
un conditioned</w>
un adjusted</w>
um -</w>
ultraf iltration</w>
ultraf iltr
ulcer ation.</w>
uc lid
uc ent</w>
u sion
u f
twice/ day</w>
tun g
tung sten</w>
tumour s,</w>
tumour ,</w>
tumor s:</w>
tubul e,</w>
tu f
trypt ase</w>
troglitaz one-induced</w>
tript an</w>
trimester .</w>
tric h
triamterene ,</w>
tri tiated</w>
tri phenyl
tri flu
triflu oper
treatment- naive</w>
tre on
tranyl cy
tranylcy prom
transport ,</w>
transpl an
transfer ase.</w>
transf er.</w>
transc utaneous</w>
trans location</w>
trans formed</w>
trans form</w>
tract able</w>
tra in</w>
toxoplasmo sis</w>
toxico kinetics</w>
tot al)</w>
tor sa
togen y</w>
toc olysis</w>
to fore</w>
ting ling</w>
time -to-
tigi l</w>
tigh tness</w>
tic- range</w>
tic '</w>
thyrotrop in</w>
thyro id
thyl isothiocyan
through out.</w>
thrombo phlebitis.</w>
thrombo -
thromb ectomy</w>
three- week</w>
three- fold</w>
threat ening.</w>
thix ene</w>
thirty- six</w>
thiopent al-
thiop urine</w>
thio -
thiamyl al</w>
thi s.</w>
therap y),</w>
thalas semic</w>
tetro fos
tetrac ycl
terfen adine,</w>
terbin afine</w>
terat ogenesis</w>
ten sions</w>
ten on</w>
teen ag
technetium- 99m</w>
tast arch</w>
tamoxifen -treated</w>
tak otsubo</w>
tadal af
tacrolim us-related</w>
tacrolim us)</w>
tachy kin
tachy arrhythmia.</w>
table t.</w>
ta ilo
t ympanic</w>
t wel
t inea</w>
t RA</w>
t -</w>
system :</w>
synchron isation</w>
syn geneic</w>
symptom s)</w>
sympath olytic</w>
sw allow
sut ured</w>
suspici ous</w>
surviv ors,</w>
surveill ance.</w>
suprac lavicular</w>
suppress ants.</w>
supernat ant</w>
super sensitivity.</w>
sup ran
sulphasalaz ine-induced</w>
sulphadi azine</w>
sulph ated</w>
sulfad ox
sulf inpyraz
sudden ,</w>
suc ce
subunit ,</w>
substance -induced</w>
subject -
subicul um</w>
sub lethal</w>
su m.</w>
su m,</w>
su ited</w>
stupo rous</w>
structure- activity</w>
stri pe</w>
stress ors</w>
stress -related</w>
stres sor</w>
streptozotoc in-treated</w>
strength ened</w>
sto ols</w>
sti ll
ste ine</w>
stand ing,</w>
stand ardi
stabiliz ers</w>
stabiliz er</w>
stabil ized,</w>
stabil ity.</w>
st ored</w>
st ents.</w>
st asis.</w>
spot ting</w>
spind les</w>
spik es.</w>
sphing osine</w>
specul ative.</w>
special ist</w>
spe ed,</w>
spas ms,</w>
sp ring</w>
sp in</w>
sp ells</w>
sou gh
sorafen ib
son ograms</w>
som uc
solu tion
sol ifenacin</w>
sniff ing</w>
sme ll</w>
slow ing.</w>
slop es</w>
six- month</w>
site- specific</w>
sirolim us-induced</w>
sinu ses</w>
sinu s.</w>
single- drug</w>
single- center</w>
significant )</w>
signific ance,</w>
sigmo id
side- effect.</w>
sick ness
sickness -like</w>
sibu tramine</w>
si vely.</w>
si vely,</w>
si s/
si alo
shor ten</w>
shiver ing,</w>
sham -treated</w>
sh allow</w>
sexu ality</w>
sex es,</w>
sevoflur ane.</w>
severe )</w>
seven -
ses ame</w>
serone gative</w>
seroconver sion,</w>
ser osi
sequest ration</w>
sens or</w>
sens ation.</w>
semin al</w>
semi- synthetic</w>
sel ective
seizures )</w>
seg ments,</w>
sed atives</w>
search es</w>
se ous</w>
se -1,
scre ening.</w>
scre en,</w>
score )</w>
sco res
schem e</w>
scar ce.</w>
scal e:</w>
sap onin</w>
salme ter
sal ine
sai rei-
sacro coc
s plic
s pa
s ):</w>
ru ment</w>
rosi glitaz
room ,</w>
rofecoxi b
ro se,</w>
ro l</w>
rituxim ab</w>
rituxim ab
ripen ing</w>
ric -
ribonucle ic</w>
rheumat ology</w>
rh IL-1
rh G-CSF</w>
rever se-
ret ching,</w>
resume d.</w>
responsib le.</w>
respond ence</w>
respon ded.</w>
respir ation.</w>
respectively );</w>
resor uf
reser ved</w>
reser ve,</w>
res ection.</w>
repor ter</w>
repe ated.</w>
ren dering</w>
ren der</w>
remove d,</w>
remn ant</w>
remin der</w>
remedi es</w>
reli ance</w>
reinfor ces</w>
regul ators</w>
regres sions</w>
regist r
regim ens
regi me.</w>
reflex -
refer r
ref ine</w>
reduc tions.</w>
reduc ed-
recumb ent</w>
recommend s</w>
recipient s:</w>
receptor- blocking</w>
recei ves</w>
reb oxet
rear rang
re treated</w>
re modelling</w>
re challenge,</w>
rati os,</w>
rate- dependent</w>
rat s),</w>
rasag iline</w>
rapid ly,</w>
rapam yc
random ization,</w>
random -
ramipri l.</w>
radiot ele
radiograph s</w>
radi ol
radiol ucent</w>
radi ation-induced</w>
rachi al</w>
r in-
r SO
r ),</w>
question ing</w>
qu inu
quinu pri
pyri form</w>
pyri do
pyeloneph ritis</w>
put aminal</w>
purpur a-
purpura- hemolytic</w>
pure- tone</w>
pur ple</w>
punct ate-evoked</w>
pum p,</w>
pulmon ary,</w>
pul sive</w>
psycho pathological</w>
psych otomimetic</w>
prox ymetac
propranolo l-
promin ently</w>
prolifer ators</w>
progres sed.</w>
produc ed,</w>
probuc ol,</w>
pro lin
pro kinetic</w>
pro coagulant</w>
pro cat
procat erol</w>
pro carb
princip les</w>
prilo ca
prevent ed,</w>
preven tion,</w>
presyn cope</w>
pregnancy :</w>
preferen ce,</w>
precurs or,</w>
pre treating</w>
pre pubertal</w>
pre operatively,</w>
pre malignant</w>
pre determined</w>
pre defined</w>
pr asu
pp m)</w>
pow er.</w>
post- traumatic</w>
post ure.</w>
positive )</w>
popul ations,</w>
polydip sia.</w>
poly myositis.</w>
poly myosi
poly b
polyb rene</w>
pol l
point es)</w>
pod ocytes,</w>
po or-
plu g</w>
pl anne
piroxic am,</w>
piret anide</w>
pirenzep ine,</w>
pilocarp ine-evoked</w>
pig s,</w>
pig mentary</w>
pict ures</w>
physici an,</w>
physi opathology</w>
physi cally</w>
phthal ate</w>
phot ograph
phospho protein</w>
phle bo
phil ia</w>
pheochromocyt omas</w>
phenyleth yn
phenyl glycine</w>
phenyl biguan
phenprocou mon
pharmaco vigilance</w>
pharmac ore
pharmac ists</w>
ph aryng
pg/ ml)</w>
peroxisom es</w>
peroxid ase.</w>
peris inusoidal</w>
perir hinal</w>
perio d).</w>
peri renal</w>
perfor atum</w>
perf usion-
percenti le</w>
per mis
per ist
perist al
per al</w>
pepti de
pentyl ent
pentylent etra
penicill in-induced</w>
pec tral</w>
pe ol</w>
pe metrex
pe er-
paw- pressure</w>
path omechan
path ogn
path ogens.</w>
pass ing</w>
parval bumin
parturi ent</w>
parano ia,</w>
paramedic s</w>
paradig ms.</w>
papaver ine,</w>
pancreatitis -associated</w>
palpit ations.</w>
pal sy
pal mo
pa st,</w>
pa rom
pa qu
p< 0.001).</w>
p- coumar
p x
p ine-treated</w>
p i</w>
p and
pand ed</w>
p H.</w>
oxygen ation,</w>
oxybu procaine</w>
oxid ase-
oxamniqu ine</w>
oversho ot</w>
overloo ked.</w>
overl apped</w>
over load.</w>
over activity.</w>
ou tward</w>
ou red</w>
ou ght</w>
otyp al</w>
otom ies</w>
ot um
ot emporal</w>
oste osarcom
osal ping
os m
os i</w>
os co
osco rea</w>
os a
ortho g
orthog onal</w>
orrh agic</w>
orph an
oro somuc
organ isms.</w>
or ies.</w>
or ice</w>
or der
or all
opi pam</w>
ophthalmolog ists</w>
oph aryngeal</w>
oper icardi
open ed</w>
opa r</w>
oneuro pathy.</w>
one ],</w>
on- off"</w>
on- chronic</w>
on war
on ;</w>
on ).</w>
omis sion</w>
omedi ast
om y</w>
oly sis:</w>
oly m
olom e</w>
olog raphic</w>
oligonucle oti
oligodendro cytes</w>
ol ide</w>
ol id</w>
ol ay
ol amine,</w>
oid s,</w>
ofur in</w>
off ,</w>
ocy n
ocor tic
ocom ial</w>
ochrom es</w>
och lor
ocent esis</w>
oc hor
obste tr
observ able</w>
obsc ure</w>
oblong ata</w>
obit z</w>
obarbit al,</w>
ob entine</w>
o B</w>
nul li
nucleol i</w>
not ochor
nos ocomial</w>
nor th</w>
non- responders</w>
non- painful</w>
non- acetaminophen-induced</w>
non transgenic</w>
non responders.</w>
non protein</w>
non hematological</w>
non cardiovascular</w>
nodul es.</w>
no f
nof sky</w>
nmol ).</w>
nitr one</w>
nit ration</w>
nit rates,</w>
nit rate,</w>
nimesul ide-
nimesulide- beta-
nimesulide-beta- cyclo
nimesulide-beta-cyclo dextr
nigh ts</w>
nifedi pine-induced</w>
nex in</w>
new -
neutrophil s,</w>
neuro surgery.</w>
neuro radiological</w>
neuro adaptations</w>
neur one</w>
neur algia</w>
neostri at
neo plasi
neede d,</w>
necro sis;</w>
ne y,</w>
ne ar
ne a.</w>
naltrex one.</w>
nalbu ph
nadi r,</w>
nACh Rs</w>
n- hex
n- 3
n is
n ail
n NOS
myocardi tis:</w>
myelo ma,</w>
myalgias/ arthralgias</w>
my otonic</w>
my opericardi
mut h</w>
mut ants,</w>
muscim ol-
muscar in
mun icipal</w>
mug/ kg</w>
move ment,</w>
mot or-
morph olin
morph ism</w>
mon olay
mon ni
molecul e.</w>
mol/ L</w>
mofetil ,</w>
model ed</w>
model :</w>
mo tility,</w>
mo .</w>
mmol/ liter</w>
mm ).</w>
ml/ 24</w>
mixt ures.</w>
mixt ure,</w>
mitomycin- C</w>
mit ot
mit ogen</w>
mistak en</w>
mis sing</w>
miner alization</w>
min g.</w>
min aprine</w>
min );</w>
mili e
milie u</w>
midod rine.</w>
microscop ically.</w>
microscop ical</w>
micrograms/kg/ min,</w>
micrograms/kg/ d</w>
micrograms/ kg).</w>
micrograms/ day</w>
micrograms/ d
microgram s).</w>
microg/paw ),</w>
microg/kg/ min,</w>
microg/kg/ day</w>
microg/ kg).</w>
microg. kg(-1).
microangio pathy.</w>
micro phthal
micro infusion</w>
micro dissected</w>
micro L/
mg/m l,</w>
mg/kg/ week</w>
mg/d L;</w>
mg/d ;</w>
mg. kg(-1).
mexilet ine.</w>
mexilet ine,</w>
methyl-6- (
methyl ]-
methodo log
meth cath
metfor min,</w>
metar aminol</w>
metaproteren ol</w>
metamiz ol</w>
metabol izers</w>
meta z
mesh work</w>
mesen ch
meropen em.</w>
men tion</w>
medullo blast
me d.</w>
me d,</w>
mc g</w>
may be</w>
matur ation.</w>
mat ric
mas king</w>
mark edly,</w>
mark ed
manson i</w>
manifest ation.</w>
manag ed.</w>
man ometry</w>
man dates</w>
mam ent
malform ed</w>
male ate.</w>
malar ia,</w>
magnitu des</w>
magnesi um-deficient</w>
macroph age-
mac ron
mRNA- containing</w>
mL (-1)</w>
mGluR s,</w>
mEq/ L).</w>
m- 2</w>
m s:</w>
m osph
m ess
m M
m .)</w>
m (2)</w>
m (2)
lymph atic</w>
lut eal</w>
lus it
lox ic
lorecle zole</w>
lor azepam
lopin avir/
lop ec
long itud
lonafarni b</w>
log ram</w>
local ised</w>
loc illin</w>
load s</w>
load ing.</w>
lo tin
lo t</w>
lli gence</w>
liver :</w>
littermat es.</w>
lithium/ pilocarpine-induced</w>
lithium- associated</w>
lit ters</w>
lis dexamfetamine</w>
lipo id</w>
lip ase</w>
linezol id.</w>
lignoca ine,</w>
ligh t.</w>
ligand s.</w>
lig and.</w>
lig and-
life-threat ening.</w>
life-threat ening,</w>
life- time</w>
lick ing,</w>
li xim
levodopa /
level ;</w>
leukem ia)</w>
leuk ocytosis</w>
les sen</w>
least ,</w>
lear ance</w>
le vetir
le flun
le d;</w>
le an</w>
le /
later ;</w>
lados tigil</w>
lacun os
lact ate.</w>
lac rim
labetal ol-induced</w>
l ich</w>
l ect
l ecith
l aud
l acti
knowledg e.</w>
knock down</w>
kg o</w>
justi fied.</w>
jump ing,</w>
jud ic
join ts,</w>
join t.</w>
jer ks.</w>
jejun um</w>
j our
j el
iz ation-
it ol</w>
it an</w>
ist s,</w>
isoproteren ol
isoprenal ine,</w>
isom er,</w>
isol ate</w>
iso prolol</w>
iso eugenolol</w>
iso electric</w>
ish ,</w>
ischem ia/
is tic-like</w>
irrit ation.</w>
irrig ation.</w>
ir reversible,</w>
ir CRF</w>
ipec ac</w>
ioxag late,</w>
iopamid ol.</w>
ion otropic</w>
invol ution</w>
investig ator
intrag lomerular</w>
intrac ister
intra patient</w>
intoler ance,</w>
intim a</w>
intest ine.</w>
inter rup
inter neurons.</w>
inter neurons,</w>
inter current</w>
inte rest,</w>
int act
institu tion
inst rument</w>
inosit ol
inos uccin
inoc ulation</w>
innerv ating</w>
injec tion;</w>
inj ect
initi s.</w>
inhibit ed.</w>
inhibit ed,</w>
inhibi tions</w>
inher itance</w>
inhal ing</w>
inhal er</w>
ingre dients</w>
ing ing</w>
infec tion:</w>
ineff icacy</w>
ineff ectiveness</w>
ineff ective,</w>
ine- pretreated</w>
ine ]</w>
induc ed)</w>
ind atr
indatr aline</w>
increas ing,</w>
in- secreting</w>
in uria,</w>
in stitute</w>
in kgo</w>
in ism.</w>
in dependent,</w>
in complete.</w>
import antly</w>
import ance,</w>
imped ance</w>
immunosuppres sion,</w>
immuno fluorescent</w>
immobil ized</w>
imipenem- cilastatin</w>
im pressive</w>
im in
im azole-induced</w>
ill ingham</w>
ill in-induced</w>
ile us</w>
il y,</w>
il ity.</w>
ifi ed,</w>
if est
idi oventricular</w>
idi ol</w>
ide ation</w>
id ly</w>
icalTrial s.gov</w>
ic ted</w>
ic king</w>
ib otenic</w>
ia ?</w>
i xis.</w>
i sed.</w>
i i</w>
hypot onia</w>
hypoprote inemia,</w>
hypom anic</w>
hypo plasia.</w>
hypo plasia,</w>
hypo locomotion</w>
hyperreflex ia,</w>
hyperphosphat emia</w>
hypernat raemia</w>
hypercalci uric</w>
hyperal dosteron
hyper intensity</w>
hyper intensities</w>
hyp olip
hydroxybut yl)
hydroxy ethyl
hydrolas es</w>
hydrochlor ide)</w>
hydro ceph
hydroceph alus.</w>
hydro carbon</w>
hydramni os.</w>
hy oscine</w>
hr s.</w>
hospit al-based</w>
hor t</w>
hor n.</w>
hom ologous</w>
ho st
histor ic</w>
histopath ology.</w>
histopath ology,</w>
histi ocytes</w>
hist amine.</w>
his tidine</w>
hipp ocam
high- potency</w>
high- dosage</w>
high er-dose</w>
here tofore</w>
her petic</w>
hepatocarcin ogenic</w>
hepatitis -like</w>
hepati s.</w>
hepat oprotective</w>
hepat opathy</w>
hepat ocytic</w>
heparin ized</w>
hemorrh age:</w>
hemop ty
hemodilu tion,</w>
hemichol inium-
hem in</w>
hem angi
heat ,</w>
he tastarch</w>
he n</w>
he ated</w>
he ade
haz ar
harve st
hard ly</w>
hapto globin</w>
hap ten</w>
hand s.</w>
hand ling.</w>
hallucin ogenic</w>
half- maximal</w>
haemorrh ages</w>
h l</w>
h ens</w>
h ad
h :</w>
guid ance</w>
guan aben
guanaben z</w>
gu es</w>
gu ar
group -
granulo mas</w>
gran ul
gram -negative</w>
gradu ally,</w>
gra dients</w>
gout y</w>
go se
glycos uria,</w>
glycopyr ronium</w>
glycol- conjugated</w>
glyco sides</w>
glycer yl
gly cyrrhiz
globul in,</w>
glab ra</w>
gi um</w>
gentamic in-
gender -matched</w>
gen ome-wide</w>
gemcitab ine,</w>
gel atin</w>
ge me
gastro- intestinal</w>
gastro scopy</w>
gamma R
g/m 2),</w>
g/d L)</w>
g/ kg),</w>
g um.</w>
g p
g ot
g m.</w>
g m
g ing</w>
g ases,</w>
g al</w>
function )</w>
fulmin ans</w>
ful .</w>
front- line</w>
frequ encies,</w>
fract ures,</w>
fra il</w>
fosin opri
fos phenytoin</w>
forskol in,</w>
form s,</w>
form er.</w>
forelimb s</w>
fore arm,</w>
for ce-
fo sel
fo od
fluorop yrimidine</w>
fluoro uracil,</w>
fluor ide</w>
flu ids.</w>
flow metry.</w>
fla res</w>
fl ap</w>
first- pass</w>
filtr ation.</w>
filgr as
filgras tim
figh ting</w>
fi xime</w>
fi er:</w>
fet us,</w>
feasib ility,</w>
fav oured</w>
fav ors</w>
fasc icular</w>
factor- beta</w>
fac ts</w>
f us
f uro
f rom
f ost
f mol/
f loxacin-induced</w>
f ile</w>
f all,</w>
extre mit
extram edullary</w>
extr usion</w>
exten ds</w>
expon ential</w>
experi ences.</w>
expand ing</w>
exerci se
exer tional</w>
excit ation.</w>
excep tionally</w>
ex ogenously</w>
evol u
ev ening.</w>
eti l,</w>
ethyl enedi
ethosuxim ide,</w>
ethinylo estradiol-induced</w>
ethinylestradi ol-induced</w>
ethan olamine</w>
eth nic</w>
et -
es .(ABSTRACT</w>
erythropoi esis.</w>
erythro blast
ergot amine,</w>
erec tions.</w>
ere br
er ing,</w>
er -induced</w>
equ ipped</w>
equ ations</w>
equ ation</w>
epinephr ine-containing</w>
epileptic us:</w>
epilepsy :</w>
environ ment,</w>
enterocol itis</w>
ent ered,</w>
ensu ed,</w>
enkephal ins</w>
enhance d,</w>
endothelium- independent</w>
endometri osis</w>
end ritic</w>
end osulf
end ings.</w>
encour aged</w>
ence ;</w>
ence )</w>
enalapri l-treated</w>
en ig
en apine</w>
en -induced</w>
emergen cies</w>
emergen cies.</w>
embryo pathy.</w>
embol ization.</w>
elic a</w>
elev ations,</w>
el y
el u
effect ;</w>
eff ected</w>
educ ated</w>
ed ge</w>
ecstas y
ec tic</w>
ec opipam</w>
ec lofen
eat ers</w>
e zing</w>
e ther
e sis,</w>
e ochromocyt
e k</w>
duoden um</w>
droperid ol,</w>
drop- out</w>
draw back</w>
dr astic</w>
doxorubic in-based</w>
dow n.</w>
doub t
dose- ranging</w>
dorsomedi al</w>
doppl er</w>
dog s),</w>
dofetili de-induced</w>
do ing</w>
diure tic
disul ph
disru ptions</w>
dispar ity</w>
disp ensed</w>
disor dered</w>
dis appear
dis advantage</w>
diri thromycin</w>
dino prostone</w>
dinit rate.</w>
dimethyl benz
dilu ent</w>
dihydroxyphenyl alanine</w>
difficul ties.</w>
diff usion,</w>
diel drin</w>
di versity</w>
di str
di phosph
di morphic</w>
di methylethan
di mer</w>
di meglum
di a
di (2-
df= 1,</w>
devi ation,</w>
devi ation)</w>
develop mentally</w>
determin ations.</w>
desi re,</w>
dermatomyosi tis-like</w>
depriv ation,</w>
depres sion)</w>
depres sed.</w>
deple te</w>
dens it
deman ds</w>
del toid</w>
dehyd rat
decreas e)</w>
deafferen tation</w>
de signs</w>
de sig
de serve</w>
de position,</w>
de methyl
de aminase</w>
dd C,</w>
day -1)</w>
day );</w>
dap sone-induced</w>
da .</w>
d- -
d it
d ing.</w>
d ge
d UT
d );</w>
d '</w>
cytos ol</w>
cytokin es.</w>
cyt ochromes</w>
cyt ochro
cyt ochemical</w>
cyst s.</w>
cyprohept adine,</w>
cyclospor ine-treated</w>
cyclospor ine-induced</w>
cyclohepten- 5,10-imine</w>
cycl es).</w>
cyan osis</w>
cy cli
cut off</w>
curren ts.</w>
curren t,</w>
cres yl</w>
creatin ine
cre am.</w>
crac k-
cr ush
counter action</w>
coun try</w>
cou ple
cost al</w>
correl ation.</w>
correc ts</w>
correc ting</w>
correc ted.</w>
cord ant</w>
cor respondence</w>
cor n
cop y</w>
cop per-indomethacin</w>
convul se</w>
convinc ing</w>
controversi al,</w>
cont ingent</w>
cont ents.</w>
consum p
consolid ation,</w>
conserv atively</w>
conjug ation</w>
conduc ted,</w>
concer n,</w>
concentration -related</w>
conce iv
computer -controlled</w>
competi tively</w>
competi tion</w>
compar ative,</w>
comp rise</w>
comp act
compact a</w>
comm issu
combin ation:</w>
com pressive</w>
com pressed</w>
com position.</w>
colon oscopy</w>
colo cysto
collag en.</w>
col itis,</w>
cohor ts.</w>
co inc
clonid ine;</w>
clo sing</w>
clo fil
clindam ycin.</w>
cl ump
cl entiaz
cisplat in
circumst ances.</w>
cimetid ine-induced</w>
cil astat
ciclo prolol</w>
chore ic</w>
chol ine-induced</w>
chlorprop amide.</w>
chlorphenir amine</w>
chlorphenir amine,</w>
chlorozotoc in</w>
chemopre vention</w>
chemo prophylaxis</w>
chem ot
channe l,</w>
ch lo
ch in
ceti rizine</w>
ceriv astatin</w>
cephalospor ins,</w>
cent ur
cellul itis</w>
cells/ microL</w>
ceftriax one-induced</w>
cefotax ime
ce mia.</w>
ce ment</w>
cause -
caudate- putamen,</w>
cataton ia,</w>
cat astrophic</w>
cast s.</w>
cas es/
cas e
carvedi lol,</w>
caro ti
cardiover ter-
cardiac -
cardi tis</w>
carcin omas,</w>
carboxy piperaz
carbon yl</w>
carben icill
carb ons</w>
carb aryl</w>
capecitab ine-induced</w>
capecitab ine,</w>
cap re
canalicul i</w>
calib er</w>
calcium- binding</w>
calcitri ol,</w>
calcific ation.</w>
calci um-induced</w>
cal pain</w>
ca zole</w>
ca .</w>
c m,</w>
c GM
butyr ylcholinesterase</w>
butyl bicyclophosphoro
but yro
bur n
bupivaca ine/
bun azosin</w>
bul b
budeson ide.</w>
bronch ogenic</w>
bronch oconstric
bronch i
bro ader</w>
brevi ated</w>
bre ed</w>
br in
br ary</w>
box .</w>
bo ther
bo ar
bl ue-
bl inded,</w>
bisphosph onat
bis muth</w>
bir th-
biotrans formation</w>
bif era</w>
bif ascicular</w>
bi ot
bi oc
bever ages</w>
beta- methyl-
beta- lact
beta 1-
bet amethas
berb erine</w>
benztrop ine,</w>
benzodiazep ine.</w>
benign ,</w>
benef ited</w>
belong s</w>
behaviour s.</w>
be ings</w>
be ar</w>
barbit al</w>
bam buter
bacterio logic</w>
back- diffusion,</w>
babo ons</w>
b p</w>
b ony</w>
b an
b ag
azithrom ycin.</w>
az in
az ide-induced</w>
az ide,</w>
aux iliary</w>
auto receptors</w>
autis m,</w>
attri bute</w>
atri um,</w>
atri o-
atom oxetine</w>
ative- free</w>
ation- ,</w>
ation -associated</w>
ate- 3-O-
atazana vir
at tained.</w>
at onic</w>
at ology</w>
at mosph
at able</w>
at .</w>
at ,</w>
asym metr
astro gliosis</w>
aster ixis.</w>
assist ance</w>
aspart ate.</w>
as sem
as se
as enapine</w>
as e/
arub icin,</w>
arti cles.</w>
arter itis.</w>
arrhythmias ;</w>
are .</w>
ard less</w>
arachnoidi tis</w>
arabino side,</w>
ar ryth
ar mament
apri l,</w>
apraclon idine</w>
ap ine-induced</w>
ap art
antipsycho tic
antibacter i
anti-HB e</w>
anti- seizure</w>
anti- anxiety</w>
anti rheumatic</w>
anti proteinuric</w>
anti myosin</w>
anti genic</w>
anti fibrillatory</w>
anti epileptics</w>
anti dotal</w>
anti dopaminergic</w>
anti depressive</w>
anti al</w>
anthracycl ine-based</w>
anth anum</w>
antero ventral</w>
antagonist -induced</w>
ant olol</w>
anim al,</w>
anil ide</w>
ang rad
aneurysm ,</w>
ane ph
ane :</w>
ana x</w>
ana -dependent</w>
an uria.</w>
an hedonic</w>
amyr in</w>
amp les</w>
amlodip ine,</w>
amisulpri de,</w>
aminoglyco sides.</w>
amino) tetralin</w>
amino glutethimide</w>
amin ,</w>
ambi gu
am peroz
altern ati
altern ate-day</w>
altern ans</w>
alpha1- adrenergic</w>
alpha- mang
alpha- ENaC</w>
alpha,beta- me
alpha ),</w>
allopurin ol,</w>
alle y</w>
alkalo ids.</w>
ali ve,</w>
albumin uria.</w>
al um</w>
al titude</w>
al though,</w>
al so,</w>
al prostadi
al one)</w>
al one
al dose</w>
air .</w>
aim ing</w>
ail able</w>
aifen esin</w>
aggreg ating</w>
agglut ination</w>
agglut in
agent ;</w>
ag ing.</w>
afterwar ds.</w>
after load,</w>
af luoro
adul t-
adreno receptors</w>
adolescent .</w>
administr ation)</w>
adjust ment,</w>
addic ts,</w>
act in,</w>
acitret in.</w>
acidi fied</w>
acetylchol ine.</w>
acetam .</w>
acet oxy-
accumul ations</w>
accoun t,</w>
accept ably</w>
ac tam</w>
ac knowledg
ac k
ac ide
ac he
ac eclofen
absor p
abic yclo
abdom in
ab ac
aPT T
a king</w>
a ided</w>
a ]</w>
[HR ]</w>
[CI ]:</w>
[1, 2,4
[(3)H] -
[ odds</w>
[ RR
[ 1</w>
Z in
Y MRS</w>
X- ra
X O</w>
Women 's</w>
Wer nic
Warfar in-associated</w>
Wall is</w>
WIN 55,212-
W AI
Vi usi
Vari ables</w>
VTE ,</w>
VPA -
V inorelb
V Y)</w>
V OD.</w>
V DS</w>
Uni ver
Under standing</w>
Ultim ately,</w>
UF P-1
U3788 3A</w>
U- exposed</w>
U sed</w>
U p-
U R</w>
U M-
U H</w>
Trx R1</w>
Trans plantation</w>
Trans plant</w>
Top otecan</w>
Thresh old</w>
Thio guanine</w>
Tetra hydro
Td P,</w>
Tan g</w>
Taiw anese</w>
Taiw an.</w>
TW A</w>
TTP/ HUS</w>
TREAT MENT:</w>
TR H,</w>
TNS r</w>
TMP/SM X</w>
TI CH</w>
TI )</w>
TA S</w>
T ren
T arget
T K</w>
T G)</w>
T 2
T -1</w>
Syst em.</w>
Syn erg
Syn drome
Swe den</w>
Surve y</w>
Super ficial</w>
Suc c
Stud y,</w>
Stud ent's</w>
Struct ured</w>
St op
Spironolact one</w>
Sm aller</w>
Sixty- six</w>
Sixty- five</w>
Simil arly</w>
Sertr aline</w>
Seleg iline</w>
Sec ond</w>
Schistos oma</w>
Schedul e</w>
ST .</w>
SSRI s.</w>
SR250 8</w>
SR .</w>
SP s</w>
SN r</w>
SM S</w>
SM P</w>
SM ON</w>
SJ L</w>
SETTING ,</w>
SE ),</w>
SCI D</w>
SCH 000
S14 G-
S14 0
S100 B</w>
S.E. M
S,3 R-
S,3R- AC
S taining</w>
S pe
S lit
S amples</w>
S P,</w>
S 1)</w>
S )-1-
S (+)</w>
Rib avir
Reg ardless</w>
Rec i
Re fer
Re bound</w>
Re N
ReN 18
Rap idly</w>
Rac 1</w>
RVO T-
RP N.</w>
RNF L</w>
RNA .</w>
RL S.</w>
REGISTR ATION:</w>
RE )</w>
RAS SF
RAN K
RA L</w>
R- T
R oles</w>
R k
R ectal</w>
R ate</w>
R andall-Selit
R ami
R S-
R E</w>
R AE
R 56
Questionna i
Prost acyclin</w>
Prophyl axis</w>
Probuc ol</w>
Pro vid
Pro ble
Pres cri
Pregn ancy</w>
Predn isolone</w>
Pre disposing</w>
Pram ipexole</w>
Post- mortem</w>
Por sol
Poly uria</w>
Poin tes.</w>
Platele ts</w>
Ph lebitis</w>
Per it
Partic ular</w>
Pancre atitis</w>
Paclitaxel -induced</w>
Pac ific</w>
PTU -associated</w>
PT s</w>
PT A</w>
PRL- R</w>
PR A,</w>
PP H.</w>
PKC gamma</w>
PH ),</w>
PG S</w>
PG F
PE NK</w>
PD E</w>
PD ).</w>
PD ),</w>
PA/ kainate</w>
P= 0.
P< .001).</w>
P450 sc
P s
P il
P ear
P b</w>
P Y
P P-
P NE</w>
P Is</w>
P C.</w>
P (2
One- year</w>
Ondan setron</w>
Olan zap
Ob served</w>
OT FC</w>
ON .</w>
OLT X</w>
OD N</w>
OBSERV ATIONS:</w>
O v
O ROS</w>
O LO
O (2))</w>
Nor adrenaline</w>
Non invasive</w>
Non convulsive</w>
Ninety- six</w>
Neuro pharmacological</w>
Neuro logy</w>
Neuro imaging</w>
Neuro chemical</w>
Neos tigmine</w>
Ne vir
NaCl -treated</w>
Na, K-ATPase</w>
Na v</w>
NY HA</w>
NSCL C,</w>
NSAI D-
NO x</w>
NO -induced</w>
NO (
NMD A/
NK 3</w>
NAD PH
N-[4-(5-nitro-2-furyl)-2-thiazolyl]form amide</w>
N- ethyl-
N- Acetylcysteine</w>
N, N-
N utri
N one.</w>
N ociceptive</w>
N isoldipine</w>
N el
N a,</w>
N ECA</w>
N 3-
N 0
Mus cular</w>
Mt TW
Mon o
Mode l</w>
Mic hi
Metron idazole</w>
Meth od</w>
Meth amphetamine-induced</w>
Met ab
Met a-
McN- 56
Mark ov</w>
Man ifest
Mall ory</w>
Mad opar</w>
MT 42</w>
MS-8 57</w>
MP I</w>
MP E
METH ,</w>
ME D</w>
MDMA ,</w>
MD S</w>
MD .</w>
MD ,</w>
MCI-1 54</w>
MA P-induced</w>
MA OI
M uch</w>
M ass</w>
M VO
M P.</w>
M I-
M G
MG MT</w>
M CR</w>
M B)</w>
M 3
Lithi um-
Li Cl.</w>
Lg A</w>
Leuk oencephalopathy</w>
Lamiv ud
LY379 268</w>
LY 14
LY14 18
LVE F.</w>
LV M</w>
LO U/
LNC-8 34</w>
LEP s</w>
L6- S1</w>
L- lysine</w>
L- dopa,</w>
L- W</w>
L- AP
L- 70
L-70 1,
L s)</w>
L 6,</w>
L 4</w>
L 4-
Know n</w>
Kap osi</w>
K upffer</w>
K rus
K lebsiella</w>
K i</w>
K R
K CN</w>
Jer se
Isopren aline</w>
Isoniaz id-induced</w>
Is radi
Is ra
Intran asal</w>
Intrac aver
Intra vascular</w>
Inte lligence</w>
Incid ences</w>
In stitu
In patient</w>
In direct</w>
In clusion</w>
Immunosup pression</w>
Immun ological</w>
Im potence</w>
Ill ness</w>
Ig G
Ig E
Identi fier:</w>
Ibuprofen -induced</w>
IV M</w>
ISO .</w>
ISO -
ISO ,</w>
IP SCs</w>
IN Rs</w>
IL- 2</w>
III :</w>
III ),</w>
II A</w>
II /
IGFB P-
IF O,</w>
ICRF-18 7.</w>
IC U.</w>
IC ER</w>
I. V.</w>
I ohex
I mid
I b
I DE
I )
Hypo glycemia</w>
Hyper trophic</w>
Ho e</w>
Hist ory</w>
High ly</w>
Hepat ocyte</w>
Hen och
Hemat opoietic</w>
Hemat oma</w>
Hein z</w>
HW -165</w>
HU S)</w>
HU 210</w>
HU -2
HT ),</w>
HSP 70</w>
HPL C.</w>
HIV +</w>
HIT TS</w>
HI- I</w>
HDL- cholesterol</w>
HCV- infected</w>
HC l.</w>
HC l,</w>
HBI g</w>
HB O</w>
H oxa
H ct</w>
H b,</w>
H b
H NP</w>
H HI-I</w>
H (3
Gram -negative</w>
Glyc er
Glut athione</w>
Glucocortico id</w>
Glomer ul
Gl n</w>
Gem fibro
GSH -P
GP x</w>
GABA(B (1
G6 PD</w>
G- CSF.</w>
G ar
G AP
G 145
G145 R</w>
G (
Four ier</w>
Fos -like</w>
Flurbi profen</w>
Flu t</w>
Flest olol</w>
Fi bri
Fem oral</w>
Fem al
FG IN
FD G</w>
F/ Y56
F ast</w>
F S.</w>
F (2)-
F(2)- isoprostane</w>
Ex panded</w>
Eth in
Estradi ol
Epilept ogenic</w>
Ephed rine</w>
Ephed ra</w>
Endom yocardial</w>
End- stage</w>
En zyme</w>
Emerg ent</w>
Electromyo graphy</w>
Electromyo graphic</w>
Eighty- seven</w>
Echocardi ograms</w>
EV IDE
ESR D,</w>
EPO .</w>
EP R</w>
EP 3
ELIS A.</w>
EL B</w>
EE G-
EC T.</w>
EAD s</w>
EA AC
E mesis</w>
E PO-
E FS</w>
E DA</w>
Dyskine sias</w>
Dys function</w>
Dox -induced</w>
Dise ases</w>
Di oscorea</w>
Di et</w>
Dexameth as
Deteri oration</w>
Depend ence</w>
Dep ending</w>
Delta9- THC</w>
Defic its</w>
De aths</w>
Dam age</w>
Dac arbazine</w>
Da hl</w>
DZ P</w>
DPO AEs</w>
DP I</w>
DO X-
DO C</w>
DO B</w>
DM SA</w>
DH PG</w>
DF MO</w>
DESIGN ,</w>
DCE -
DAT A:</w>
DA P,</w>
D- like</w>
D ual</w>
D ROP</w>
D PD
D P.</w>
Cyclo oxygenase-2</w>
Cor tic
Cor responding</w>
Copenh agen</w>
Cop per</w>
Consider able</w>
Con focal</w>
Comple x</w>
Colchic ine-induced</w>
Col laborative</w>
Co ur
Clon idine-induced</w>
Clo stri
Cir rho
Cir cadian</w>
Cilost azol</w>
Chrom os
Cholester ol</w>
Chlorambuc il</w>
Ch ic
Ch AT</w>
Cephal ospor
Catech olamine-induced</w>
Catat onia</w>
Catal eptic</w>
Cardi omy
Cap gras</w>
Calcit riol</w>
Caffe ine-induced</w>
Ca p</w>
Ca MK
CYP2C 8
CX CR
CX 7
CV R</w>
CV AD</w>
CSF- AK</w>
CS ,</w>
CR .</w>
CP DD</w>
CP 94
CO P</w>
CO C</w>
CNS B
CN I-
CL S</w>
CL )</w>
CK 8</w>
CI- 9
CH .</w>
CG I</w>
CD DP</w>
CC B</w>
CB F.</w>
CB (2)</w>
CA RT</w>
CA I</w>
CA D
CA B
CA 3,</w>
CA -induced</w>
C3H/ He</w>
C ult
C ri
C p</w>
C lear</w>
C ity</w>
C ellular</w>
C ells</w>
C c
C ]</w>
C X-
C 4</w>
Busulf an</w>
Brugad a-
Brd U-
Brady kinin</w>
Br n-3
Bo th,</w>
Bir th</w>
Biop sies</w>
Benzodi azepine</w>
Balb /c</w>
BU d
BU P,</w>
BS O</w>
BP 897</w>
BM IPP</w>
BF U-
BD Z</w>
B ow
B ost
B el
B ab
B SE
B )
B (t
Ax is</w>
Av ailable</w>
Austral ia</w>
Attac k</w>
Arter io
Arab ic</w>
Ar e</w>
Aquaf ol</w>
Apop totic</w>
Anti platelet</w>
Anti bio
Anter ior</w>
Ant agonists</w>
Ang- (1-7)</w>
Ang elica</w>
Anesthe tized</w>
Ana phyl
An algesia</w>
Ammon 's</w>
Am B.</w>
Al prazol
Al pers</w>
Administr ation.</w>
Addic tion</w>
Acyclovir -induced</w>
Accid ental</w>
Ac ross</w>
Ab str
Ab er
AZ T.</w>
AZ T-
AV3 V</w>
AT 3/
AT3/ EAAC
AT ,</w>
AS A,</w>
APPROAC H:</w>
AM PA/kainate</w>
AM L.</w>
AM I,</w>
AM .</w>
ALA- D</w>
AID S,</w>
AI M</w>
AG N</w>
AEG35 156</w>
AD A</w>
AC F</w>
ABT-7 69</w>
AB D</w>
AB C</w>
A ther
A systole</w>
A sc
A pp
A lopec
A ir
A ca
A beta-
A J</w>
A 3</w>
A )-induced</w>
> 50%</w>
> 12</w>
= 65</w>
= 50</w>
= 1</w>
= .000
< 90</w>
99mTc- DMSA</w>
9. 8%</w>
9. 0
9- tetrahydrocannabinol</w>
9 5)</w>
9 0%)</w>
80 8</w>
80 2</w>
8 5/
8 5.
8 4.
8 1-year-old</w>
78 ),</w>
711389- S</w>
70 %,</w>
7 8.
7 2)</w>
7 )
61- 80
60 %.</w>
6- 7</w>
6 ByJ</w>
6 9.
6 0%)</w>
6 '-
55 8</w>
55 562</w>
52 22</w>
50 6-induced</w>
50 %;</w>
5-HT(2 A)</w>
5-HT 7</w>
5-HT 2C</w>
5-HT .</w>
5-1- 6</w>
5- methoxy
5- Az
5, 6,
5, 5-
5 9)</w>
5 8)</w>
5 60</w>
5 6%,</w>
5 4)</w>
5 4),</w>
5 4%,</w>
5 30</w>
5 25</w>
5 2%,</w>
5 00-mg</w>
5 +/-1
48 ;</w>
45 8</w>
45 1</w>
40- 50</w>
40 ;</w>
40 8</w>
4. 6,</w>
4- deoxypyridoxine</w>
4- Cl-BZ
4 ]</w>
4 9).</w>
4 77</w>
4 4,</w>
4 29</w>
4 1%,</w>
38 9</w>
38 ).</w>
35 47
300 164</w>
30- second</w>
30- fold</w>
30- 40</w>
30 6</w>
30 2</w>
3. 5,</w>
3-hydroxy-3- methylglutaryl</w>
3- NT</w>
3- /-</w>
3,4-D CPG</w>
3, 4
3, 3-
3, 0
3'- deoxy
3 T3</w>
3 55</w>
3 3,</w>
3 2%,</w>
3 18</w>
3 1),</w>
29 4</w>
29 .</w>
28 ;</w>
28 9</w>
27 6</w>
26 7</w>
26 4</w>
26 3</w>
25- mg</w>
25 4</w>
25 %)</w>
24,25- (OH)2D3</w>
23 8</w>
23 1</w>
23 ).</w>
200 9,</w>
200 8</w>
200 8,</w>
200 0-
20- minute</w>
20 5</w>
20 24</w>
2. 7-
2. 5)</w>
2. 1;</w>
2- min</w>
2- a]
2- OH
2- -
2,3, 4,5-
2 B
2 =
2 5.0</w>
2 21</w>
2 2.</w>
2 2,
199 3.</w>
198 5.</w>
198 5,</w>
1928 370</w>
19 77</w>
19 73</w>
19 60
19 2024</w>
18. 7</w>
18. 4</w>
17 /
16 +/-
15. 6</w>
15- day</w>
15- 20</w>
140/ 90</w>
14. 3</w>
14. 3%</w>
14. 1</w>
14 29
14 2
13. 7</w>
12. 9</w>
12- h</w>
12 ,000</w>
12 ,
11. 6</w>
100 .</w>
100 ,000/
100 )</w>
10- mg</w>
10(- 2)</w>
10 ,00
1.0 1</w>
1. 55</w>
1. 49</w>
1. 44</w>
1. 4-
1,25- (OH)2
1, 24-(OH)(2)
1, 00
1 mg/kg</w>
1 A2</w>
1 A-
1 14
1 +/-1.
1 +/-1
1 )
0.9 )</w>
0.9 %,</w>
0.8 7</w>
0.8 1</w>
0.7 7</w>
0.7 6,</w>
0.02 2).</w>
0.000 3).</w>
0.000 2).</w>
0.00 7)</w>
0.00 2</w>
0.0 8
0.0 6).</w>
0.0 2%</w>
0.0 18).</w>
0.0 15).</w>
0. 8)</w>
0. 72</w>
0. 17
0. 15%</w>
0. 12,</w>
0. 1).</w>
0 -10</w>
.00 3).</w>
.0 5,</w>
-P C</w>
-1- phosphate</w>
-1, 2,4-
-1 60</w>
-1 6-
-1 0,</w>
- motor</w>
- inducing</w>
- deficient</w>
- R
- ATPase</w>
- 9.
- 3,</w>
, 7
+/ -10
)- infected</w>
)- 2-
(paracetam ol)</w>
(mt DNA)</w>
(mGluR s)</w>
(m )</w>
(d 4
(chi 2</w>
(chi (2)</w>
(WB C)</w>
(Viagra )</w>
(VE GF)</w>
(V CM
(Tax otere
(SV R)</w>
(SE M</w>
(SA H)</w>
(RP P)</w>
(RB Cs)</w>
(P< 0.05),</w>
(P ro
(P h
(P W
(P G)</w>
(OP ID
(OH) 2-
(O V
(O P)</w>
(O LT)</w>
(NT S)</w>
(NT G)</w>
(NT Ds)</w>
(NS C</w>
(NA G)</w>
(N RTI
(N E
(N C
(N Ac
(MT X
(MD D)</w>
(M n
(M UG
(M PO)</w>
(M H
(LV D
(LM W
(LID ).</w>
(L-NAME ;</w>
(L i-
(H ol
(H US
(H D-
(H CF
(H )</w>
(GSH ),</w>
(GP i)</w>
(G lu
(F L
(ED50 =
(ED (50)=
(EC T)</w>
(E LIS
(D Z
(D M)</w>
(CI ):</w>
(CAB G)</w>
(CA S:</w>
(BUN ),</w>
(B Z
(B HT)</w>
(ANCA )-associated</w>
(AE D)</w>
(AD V)</w>
(AD M)</w>
(AD HD).</w>
(A TP
(9 3%)</w>
(8. 0</w>
(8 9.
(8 7%)</w>
(8 %).</w>
(7 7.
(7 7%)</w>
(7 6.
(7 0%</w>
(62. 5%)</w>
(6 6</w>
(6 6.
(6 5%</w>
(6 4</w>
(50 %).</w>
(5 8.
(5 1.
(5 00
(4. 3</w>
(4. 2</w>
(4. 1%)</w>
(4-fluoro phenyl)
(4- hydroxybutyl)
(4 9%)</w>
(4 4</w>
(3- 30</w>
(3 3%).</w>
(3 20</w>
(3 %</w>
(200 0)</w>
(2. 9</w>
(2. 7</w>
(2. 2</w>
(2. 1</w>
(2)- receptor</w>
(2 7%),</w>
(2 50-
(2 5%).</w>
(2 5%),</w>
(2 2-
(2 1/
(2 0%),</w>
(2 +
(19 8
(1. 25-
(1 8%</w>
(1 8%).</w>
(1 7%).</w>
(1 6%),</w>
(1 5%).</w>
(1 4/
(1 4%).</w>
(1 2%).</w>
(1 2%),</w>
(1 10</w>
(1 -100</w>
(1 )/
(1 %</w>
(0.00 1-
(-)- 3-PPP</w>
(+)- amphetamine</w>
(+)- UH</w>
(+)- AJ</w>
( ventricular</w>
( usually</w>
( type</w>
( thre
( therapeutic</w>
( stat
( single</w>
( severe</w>
( saline)</w>
( range)</w>
( pre-
( placebo)</w>
( negative</w>
( mGlu
( induced</w>
( estimated</w>
( each</w>
( diabetic</w>
( determined</w>
( control,</w>
( acetaminophen
( II)</w>
( 9%</w>
( 5-HI
" on-off"</w>
zop iclone</w>
zatebr adine</w>
zaf irlukast</w>
z yme
z ed,</w>
z )</w>
ym ic</w>
ym e</w>
yl] -1-
yl) prop
yl transferase</w>
year- old-
ye ast</w>
ye ast
y- related</w>
y pe
y osin</w>
y no
x perim
xperim ent</w>
x eno
x /
x ).</w>
wom an-
withdraw al:</w>
wid th</w>
what ever</w>
weight/ body</w>
weight- based</w>
weigh t;</w>
wave form</w>
wav es,</w>
wast ing.</w>
wash -out</w>
wa ve.</w>
wa king</w>
w inter
vomit ing)</w>
volunt arily</w>
volume )</w>
vir gin</w>
vinorelb ine.</w>
vim entin,</w>
vib ratory</w>
vesi cles.</w>
ves :</w>
verapamil- sensitive</w>
ver tic
ver atri
ventilat ing</w>
ventil ated.</w>
ventil ated,</w>
ven o
vehicle ;</w>
vehicle -</w>
vasodilat or.</w>
vasculo pathy</w>
vasculat ure,</w>
vas ore
vari ations.</w>
valv es,</w>
valpro ate:</w>
val ently</w>
val .</w>
vagin a.</w>
vag ally</w>
v ices</w>
v ent</w>
v as</w>
user s;</w>
us age,</w>
us '</w>
uro toxicity.</w>
urinaly sis,</w>
ure mia.</w>
ure a.</w>
ure -induced</w>
ure ).</w>
urac il.</w>
ur ine-
ur ic.</w>
ur ge
ur a</w>
ur .</w>
univer s
uni qu
uneventful ly.</w>
uneventful ,</w>
unequ ivocal</w>
under recognized</w>
und s.</w>
un translated</w>
un te
un stressed</w>
un satisfactory</w>
un interrupted</w>
un fortun
un determined</w>
un covered</w>
un buffered</w>
un biased</w>
um -treated</w>
ultrason ography,</w>
ultim ately,</w>
ulop ontine</w>
ulo phine</w>
ule us,</w>
ule g
ul us</w>
ul d,</w>
ud y</w>
uct ose</w>
ucle otide</w>
uch al</w>
u mo
u ed</w>
u ating</w>
u ally,</w>
two- compartment</w>
twit ch
tumori genesis.</w>
tubocurar ine,</w>
tropon ins</w>
tro lean
trolean dom
trinit rate.</w>
trimethoprim/ sulfamethoxazole</w>
trifluoro acetylated</w>
trifluoro acetyl</w>
trial :</w>
tri phosphate-induced</w>
tri oxide</w>
tri mipramine</w>
tri heptano
tri -
tremulo us
treatment- seeking</w>
tre prost
treprost in
treprostin il</w>
travel ed</w>
transplant able</w>
transi ents</w>
transfusion -dependent</w>
transf ected</w>
transduc er</w>
trans ection</w>
tran st
trac er.</w>
trab ected
tra its</w>
tr u
tr iterpen
touch -evoked</w>
tot oxic</w>
torticoll is</w>
tor r.</w>
ton ically</w>
to rod</w>
tizan idine.</w>
tiv es.</w>
tiv ated</w>
tion s;</w>
tion ed.</w>
timolo l-induced</w>
tid ine,</w>
ticlop id
tic/ pharmacodynamic</w>
tic ular</w>
tic oline</w>
tic k</w>
tic ally-
thyrotrop in-releasing</w>
thyro id,</w>
thromb olysis.</w>
thromb ocyte</w>
thre o-
though ts</w>
thorac otomy</w>
thor ax</w>
tho roughly</w>
thir st,</w>
thion amide-induced</w>
thio glucose</w>
th ous</w>
th )</w>
tetrap aresis</w>
tetraben azine</w>
testoster one-
ten- year</w>
ten ing</w>
tem sirolimus</w>
tem pl
teli throm
telangiect asia</w>
telangiect asia.</w>
te trandrine</w>
te lukast</w>
target ,</w>
tain ment</w>
tachycardia :</w>
tachycardi as.</w>
ta u
t- to-
t- day</w>
t s;</w>
t rough
t olyl</w>
t PA</w>
synthesi s/
synth ase.</w>
symptomat ology,</w>
symptom atic.</w>
symptom .</w>
symptom ,</w>
sympathe tically</w>
sympath omimetics</w>
sy phil
swit ches</w>
swell ing.</w>
sw ings</w>
susceptibil ity,</w>
survi ved,</w>
surve ys</w>
surger ies</w>
surfac e,</w>
sur ing</w>
supra optic</w>
suppress ants,</w>
sulph onate</w>
sulfasalaz ine.</w>
sulf ation</w>
suggest ed,</w>
subside d.</w>
subject s'</w>
sube pend
subepend ymal</w>
sub- chronic</w>
sub icular</w>
sub groups,</w>
sub fiel
sub endothelial</w>
su k
su gamma
stun ning</w>
stud ents</w>
struct ure
struc tion</w>
stroke /
stro gen
stric ta</w>
stri dor</w>
stri a</w>
stret ch</w>
stres sed.</w>
streptozotoc in,</w>
stin /d
stin/d alfop
stimul ant,</w>
stereo isomers</w>
ster ols</w>
step- down</w>
sten osi
stavud ine.</w>
stat ins,</w>
stabil ized.</w>
stabil ization,</w>
st yr
st ayed</w>
st atic
st ages,</w>
st aff
squ a
spra y.</w>
spl it</w>
spironolact one.</w>
spir april</w>
spillo ver</w>
spi per
spermatozo a</w>
specimen s,</w>
spas m
sp an.</w>
somnol ent</w>
somn ia</w>
solu tions.</w>
smoo th-
small- vessel</w>
slow ly.</w>
sligh tly.</w>
sligh tly,</w>
slic es,</w>
sleep iness.</w>
sle e
skele ton</w>
six ty</w>
sion s-
single ton</w>
sin s</w>
similar ities,</w>
sildenaf il-induced</w>
sigma 2</w>
sigma (2)</w>
side ),</w>
showe d:</w>
short age</w>
she ath
severe ).</w>
seven .</w>
ses qu
seroton ergic,</w>
seri ous.</w>
ser s</w>
ser a.</w>
ser a,</w>
sensi tive,</w>
sensi tised</w>
sens ation,</w>
sen escent</w>
semic arb
semi- quantitative</w>
self- limiting.</w>
sel ected,</w>
seiz ed</w>
seg ment,</w>
sed :</w>
second )</w>
sec tioned</w>
se t.</w>
se men</w>
se ll</w>
se ll
se al
scre ening,</w>
scl eral</w>
schiz otypal</w>
scenari o</w>
scal e).</w>
sc abic
sc ab
sarcom as,</w>
sarc open
sampl ing.</w>
sam e.</w>
sal t,</w>
sacrococ cygeus</w>
sacrific ed,</w>
sacrific e,</w>
s- Webster</w>
s pared</w>
s orb
s na
s kin
s in-
s hel
s a.</w>
s P120
rout e,</w>
ropivaca ine.</w>
ro torod</w>
ro sis.</w>
ro sis,</w>
ro d,</w>
ris ks,</w>
rin sing</w>
rim antadine</w>
rifamp in,</w>
rif ug
ric e-
ribavir in-related</w>
rib ose</w>
ri sen</w>
ri mal</w>
rhyth ms.</w>
rhin orrhea</w>
rh IGF-1</w>
reveal ed.</w>
retin yl</w>
reticulat a,</w>
reticul um.</w>
restric t</w>
responsiven ess,</w>
respect s.</w>
resolu tion,</w>
resi ding</w>
reservo ir</w>
research ,</w>
require ments.</w>
reproduci ble,</w>
repor ting.</w>
reple tion</w>
ren ic</w>
removal ,</w>
remed y</w>
remac emide</w>
rema ind
relev ant.</w>
relax ant.</w>
relationshi p
rel in,</w>
rel ide</w>
rel ati
rehabil it
regul arity</w>
refle xi
reduct ase,</w>
reconstruc tive</w>
recommend ing</w>
recommend ations.</w>
recogniz able</w>
receptor s;</w>
reboun ded</w>
reasses s
rear ing,</w>
reaction s;</w>
reaction s:</w>
re- entry</w>
re teral</w>
re tains</w>
re member</w>
re mem
re induction</w>
re flu
re cycling</w>
re breathing</w>
re bleeding</w>
rati os
rate- treated</w>
rat es:</w>
rapam ycin,</w>
rang e
ram ycin</w>
radiolig and</w>
radic al-
radi ation,</w>
racem ate</w>
ra rely.</w>
r- HuEPO</w>
r CMR
quinupri stin/dalfop
quinoxaline- 2,3-
quin uclid
quin ine-dependent</w>
quin ine-associated</w>
quick er</w>
questionnai re,</w>
ques tion.</w>
quer ied</w>
quality- adjusted</w>
quadripleg ia</w>
qu arti
pyridox al-
pyri da
pyraz ine</w>
pyl ori
putam en.</w>
purpur a,</w>
pup pi
pum ps.</w>
puerperi um</w>
puer peral</w>
pt s)</w>
psych ometric</w>
provo kes</w>
protein- coupled</w>
prot oporphy
prot amine-
protamine- heparin</w>
prost at</w>
propranolo l)</w>
propor tionally</w>
propofol- fentanyl</w>
propo sed,</w>
pronounce d,</w>
pron ociceptive</w>
prolifer ator-
proliferator- activated</w>
prolactin- secreting</w>
prol apse</w>
proguan il</w>
progres sor</w>
progres sive.</w>
progres ses</w>
program m
profes sional</w>
procycl idine</w>
prochlorper azine.</w>
probable "</w>
pro ven,</w>
pro parg
pro mo
pro dynorphin</w>
pro drug,</w>
pro arrhythmia,</w>
priv ate</w>
primigra vida</w>
primat es,</w>
pri van
pri or
previ ous
prevent ative</w>
prev ail
preserv ative-free</w>
prescrip tions.</w>
prescri ption.</w>
pres sion.</w>
prenalter ol</w>
premat ure
predomin ate</w>
pre- emptive</w>
pre treatments</w>
pre infusion</w>
pre existent</w>
pre em
pre -term</w>
praz osin
prasu grel</w>
potenc y.</w>
postpon ed</w>
postischem ic</w>
post- pacing</w>
post- marketing</w>
post- ingestion</w>
post- infusion</w>
post- CA
post ur
post prandial</w>
post infusion</w>
post exposure</w>
posi tive-
posi tions.</w>
posi tioning</w>
pos itory</w>
pos ac
port os
portos ystemic</w>
poly (ADP-ribose)</w>
poison ed</w>
poin ter</w>
po oling</w>
pneumon itis.</w>
platin um.</w>
platelet- derived</w>
plas macy
plan ar</w>
pl enic</w>
pl ant.</w>
pix antrone</w>
pir acetam,</w>
piper acill
pineal ectomy</w>
pineal ectomized</w>
pindo lol.</w>
pi ent</w>
pi ec
physician- diagnosed</w>
physici ans,</w>
phy se
photo dynamic</w>
phospholip idosis</w>
phospho kinase,</w>
phil icity</w>
pher d</w>
phenylbutaz one.</w>
phenylbutaz one,</w>
phenyl piperaz
pharmac ology,</w>
pharmac ologic
phag ocytic</w>
ph renic</w>
ph a
pha eochromocyt
pg/m L)</w>
pg/ mg</w>
peti t</w>
pestic ide</w>
perit ubular</w>
percep tions</w>
percent ;</w>
per spec
per mit
pepti des,</w>
pentylenetetrazol e.</w>
penicill ins.</w>
penicill in,</w>
pedunc ulopontine</w>
paw )</w>
pati on.</w>
pathw ay
pat as</w>
paresthesi a,</w>
paras ympath
param agnetic</w>
parac rine</w>
par ane
parane oplastic</w>
par amethasone</w>
par aff
papillede ma.</w>
pancur onium,</w>
palmo plantar</w>
palmit o
pallid us.</w>
pal ate.</w>
pac k
pa y</w>
pa c</w>
p< 0.01).</w>
p< 0.001),</w>
p< 0.0001)</w>
p75 NT
p-chloro amphetamine</w>
p- 6-
p,p- DDE</w>
p ush</w>
p up</w>
p ons</w>
p neumo
p ep
p entano
p ed</w>
p allo
pallo r</w>
p ale</w>
oxy meth
oxy metazoline</w>
oxy cod
oxib s</w>
oxi metry,</w>
oxal actam</w>
ox alo
ox adi
ox acillin</w>
ox -
over whel
oval e</w>
ov aginal</w>
out-of- hospital</w>
out lined</w>
out break</w>
ous )</w>
otrop ia</w>
otolaryng ologic</w>
ot ype
osteomyeli tis.</w>
oste osarcoma.</w>
osmol arity</w>
osmol ar
osc illo
os seous</w>
os in.</w>
os in-
os clerosis</w>
ors ing</w>
orosomuc oid</w>
ori es:</w>
organ ism</w>
organ .</w>
orex in-A</w>
ore mentioned</w>
ord inated</w>
orcipren aline</w>
or ative</w>
or able</w>
opy ran
opi ate-induced</w>
ophysi cal</w>
oph obia</w>
opath ogenesis</w>
op pose</w>
one- trial</w>
one- dependent</w>
one theless,</w>
on ych
on togeny</w>
on set
on s.</w>
on ine</w>
on in,</w>
on ia.</w>
on ds</w>
on ate,</w>
on :</w>
omeg a</w>
om ni
om it
om ide</w>
om embranous</w>
olo [
oliv ary</w>
ol/ drospirenone</w>
ol is</w>
off en
odi lation</w>
od or</w>
ocyte -specific</w>
oculog yric</w>
ocardi um</w>
oc ard</w>
obj ects</w>
ob tun
o th
o p</w>
o h
o gastric</w>
o edema
nulli parous</w>
now .</w>
nov o
notice d.</w>
note worthy</w>
normoten sion.</w>
normal izing</w>
norepinephr ine-
non- hematological</w>
non- depolarizing</w>
non- convulsing</w>
non- convulsant</w>
non- cardiac</w>
non- binge</w>
non- ICU</w>
non users,</w>
non smokers</w>
non responsive</w>
non immune</w>
non enzymatic</w>
non arteritic</w>
nodos um.</w>
nodos a</w>
nodos a.</w>
no ea,</w>
nitro arginine</w>
nitrite/ nitrate</w>
nitrendip ine-treated</w>
nitrate- free</w>
nimesul ide.</w>
nimesul ide,</w>
nigro -striatal</w>
nigh t-
nic k-
ng/kg/ min)</w>
neurotroph in</w>
neurolep tic-
neurohypophy sis</w>
neuro plastic</w>
neuro pharmacologic</w>
neuro genesis,</w>
neuraminid ase</w>
networ ks.</w>
nes tin</w>
nephrotoxic .</w>
nephro path
neon ates,</w>
neo vascular
need le.</w>
need le-
necro lysis</w>
ne gl
ne dap
naloxone- precipitated</w>
nal idixic</w>
nal -
na )</w>
n uchal</w>
n s).</w>
n inth</w>
n g),</w>
n arc
n ap
n abil
myotub es</w>
myocardi opathy.</w>
myocardi a</w>
myo pathies</w>
myelo -
myco phenolic</w>
my ometrial</w>
muscar ine</w>
mumol/ l)</w>
multiv itamin</w>
multiplic ity</w>
multiple -dose</w>
multi- center</w>
multi disciplinary</w>
mug/ ml</w>
mu k
more )</w>
month -
monitor .</w>
mon ocytes</w>
mon etary</w>
mom ent</w>
molecul es.</w>
modul ation.</w>
model )</w>
mo ved</w>
mo glyc
mo )</w>
mmol/ l).</w>
mmol .
ml/min/ 1.73</w>
miti gating</w>
mis e</w>
minut e/
minipump s.</w>
minipum p</w>
ming ly</w>
min(-1 ).</w>
millisec onds</w>
millilit er</w>
mild- type</w>
migr ation,</w>
mid face</w>
microsom es,</w>
micron s</w>
micron odular</w>
microm ol
micrograms/m L)</w>
microgram/kg/ min,</w>
microgram/kg/ min)</w>
microgram.kg-1. min-1</w>
microg/m L,</w>
microg/ rat</w>
microg/ mouse,</w>
micro surgical</w>
micro graph
micro M/
micro A</w>
mic e;</w>
mic e).</w>
mg/kg/ min,</w>
mg/kg/ injection)</w>
mg/d l),</w>
mg/d ).</w>
mg/ sq</w>
mg. kg(-1)</w>
meval onate</w>
methyser gi
methyl-6-( phenylethyn
methyl xanthine</w>
methyl atropine</w>
methoxy flurane</w>
methotrimepraz ine</w>
methion ine.</w>
methemo globin</w>
metamiz ole</w>
metalloprotein ase-
met /
mesi late</w>
meropen em
mer bar
ment ing</w>
ment -
mening iti
men :</w>
memant ine.</w>
melaton in,</w>
melan in</w>
medium -term</w>
medium -</w>
medi ators.</w>
medetom idine,</w>
mechan ical,</w>
measure d:</w>
mean )</w>
me z
me tac
me obentine</w>
me loxic
mb ran
materi al,</w>
matche d,</w>
marmo sets</w>
marked ly.</w>
marijuan a,</w>
manufacturer 's</w>
mann 's</w>
mal e-
mal athi
mal adaptive</w>
mafosf amide</w>
macrom olecular</w>
ma ;</w>
mGluR 4</w>
mGlu 5</w>
mE q
m us.</w>
m omet
m ia)</w>
m ation</w>
m apped</w>
m T
m M.</w>
m M),</w>
m L;</w>
m K</w>
m 2).</w>
m (O
lys ophosph
lys ine-
lymph omas.</w>
ly "</w>
lup us,</w>
lu peol</w>
lowe red.</w>
low- dose,</w>
low- affinity</w>
los s)</w>
los al</w>
lopurin ol</w>
loop s</w>
long er-
log (10)</w>
locom ot
local iz
localiz ation-related</w>
load ing,</w>
lo ud</w>
lo ts</w>
lo se</w>
liver -related</w>
liter s)</w>
line age</w>
lind ane-induced</w>
limit ations.</w>
like )</w>
lightheade dness,</w>
light- heade
lif t</w>
lif es
li ability.</w>
level s)</w>
leuko encephalopathy:</w>
leuko encephalopathy,</w>
leuk ocytosis.</w>
leuk ocytes,</w>
leuk ocyt
leuc ine-
let es</w>
lepro matous</w>
length y</w>
length -of-
leg ,</w>
leflun omide</w>
le y,</w>
le ts</w>
le sional</w>
le ).</w>
latano prost
laser- Doppler</w>
laryng ospasm</w>
lansoprazol e.</w>
lam y
lact ated</w>
lac rimal</w>
lac eration</w>
laborator ies</w>
lab ility,</w>
l yc
l in</w>
l avage</w>
l ars</w>
l anthanum</w>
l and,</w>
l agg
l -related</w>
knock- out</w>
kind ling
kin s</w>
kin in
kg(-1 )).</w>
ketocon azole-induced</w>
keto profen,</w>
ker atitis</w>
kal -
kal- Wallis</w>
k wise</w>
k 's</w>
join tly</w>
jitter iness</w>
jer ks,</w>
jel ly</w>
jat am
jatam ans
jatamans i</w>
j iro
jiro vec
iv oc
it osan</w>
it ochondrial</w>
it ed.</w>
isth mus</w>
isox sup
isox azole</w>
isox azol
isosorbide-5- mononitrate</w>
isol dip
iso quinoline</w>
iso enzymes.</w>
ise thionate</w>
ir on.</w>
io prom
investig ators,</w>
introduc tion.</w>
intravesi cally</w>
intraperitoneall y).</w>
intrap ulmonary</w>
intrap leural</w>
intramuscul arly,</w>
intramuscul ar
intra striat
intra hippocamp
intrahippocamp ally</w>
intra dialytic</w>
intra aortic</w>
intoxic ations</w>
interven ing</w>
interpre ting</w>
interleuk in-1</w>
interferon- gamma</w>
intercal ated</w>
inter rupt
inter quartile</w>
inter neuron</w>
inter connected</w>
intensi fy</w>
instant aneous</w>
insidi ously</w>
inqu ire</w>
inositol -1-phosphate</w>
inges tions</w>
infrequ ently.</w>
infor m</w>
influ ence.</w>
inflamm ation-related</w>
infl ated</w>
infiltr ates.</w>
infarc t-
infant s:</w>
inf used.</w>
inf usate</w>
inf ancy</w>
ine- -
ine vit
ine .
indomethac in-induced</w>
ind omet
incoordin ation.</w>
incontin ence,</w>
includ ing:</w>
inc iting</w>
in- stent</w>
in uria.</w>
in di
in ations</w>
in ase-
in aemia</w>
in adequately</w>
impregn ated</w>
impac ted</w>
immunost ain
immunore activities</w>
immunoglobul ins</w>
immunocompet ent</w>
immuno assay.</w>
imipen em,</w>
imidazol e-
imbal ance,</w>
im pres
im posed</w>
im migr
im ino
illust rating</w>
ill ness
il ;</w>
ig a
iga rette</w>
if ol
if f</w>
idiosyncrati c,</w>
idiosyncr asy</w>
ide s.</w>
id ine-associated</w>
id -related</w>
icul ate</w>
ici ency</w>
ical cit
ic lon
ic in-associated</w>
ic ide</w>
i.p. c.</w>
i ri
i qu
i o</w>
i ed,</w>
i bogaine</w>
i as.</w>
hypoton ia,</w>
hypoparathyroidis m</w>
hypop ituit
hypokine sia.</w>
hypogonadis m</w>
hypoglyce mia,</w>
hypo ventilation</w>
hypno tics</w>
hypertensi ves.</w>
hyperplasi as</w>
hyperlipide mic</w>
hyperkine sia.</w>
hyperexcit ability.</w>
hypercalci uria,</w>
hyper vol
hyper ventilation,</w>
hyper ren
hyper reactivity</w>
hyper pyrexia</w>
hyper lactat
hyper hid
hyper gly
hydroxyure a.</w>
hydroxyl ase,</w>
hydroxyl amine</w>
hydroxy quinol
hydroxy fas
hydroxy anis
hydroxyanis ole</w>
hydronephro sis.</w>
hydronephro sis,</w>
hydrocortis one.</w>
hydrochlor ic</w>
hybri ds</w>
hund red-
human .</w>
hu PB
hos tility</w>
hoo ded</w>
homozyg otes</w>
homogen ized</w>
ho uld</w>
histi ocytic</w>
hist ochemically</w>
hist amine
highligh ted.</w>
high er-
hid den</w>
heter otopic</w>
herni ation</w>
here in.</w>
hepat oxicity</w>
hemi anop
hemat otoxicity</w>
hemat ologic
heat- shock</w>
health -
head .</w>
he me-
he don
harb oring</w>
hand s,</w>
hamster s.</w>
halothane- altered</w>
halothane /
haloperidol :</w>
hair y</w>
haemo glob
haem olysis.</w>
ha ve,</w>
h ans</w>
h ERG</w>
guide lines,</w>
guanid inosuccin
gran i
gra vis,</w>
gra de,</w>
goro usly</w>
gonad ectomized</w>
go -
glyco proteins</w>
glucuron idation</w>
gluco sid
globul in.</w>
glauc omatous</w>
glauc oma,</w>
gi es</w>
gest ation)</w>
gerbil s</w>
ger m
genotyp ing</w>
genotyp es.</w>
gener ates</w>
gener ated.</w>
gen ist
gen iculate</w>
gast rectomy</w>
gap ,</w>
gammag lobul
gamma-hydroxybut yrate</w>
galact orrhea.</w>
gal an
g/ mouse,</w>
g/ ml)</w>
g/ cm
g ut
g ell
further more</w>
fum arate</w>
full- field</w>
fructo se-1,
free z
free dom</w>
fractalk ine</w>
fract ure,</w>
fr ame</w>
four- fold</w>
fost ered</w>
forsk olin</w>
form er
former ly</w>
for ces</w>
foot- shock</w>
followe d,</w>
fo x</w>
flut amide.</w>
flut amide,</w>
fluphenaz ine.</w>
fluoren yl
flucloxacill in.</w>
flest olol,</w>
five fold</w>
first- trimester</w>
fing er-
fin ally,</w>
filam ents.</w>
fil m</w>
fibrill ations</w>
fib ric</w>
fet uses,</w>
fenoldop am-induced</w>
fenbufen .</w>
femal es;</w>
feat ure.</w>
feasib le,</w>
fe vers</w>
fe ed</w>
favor ing</w>
fascicul aris
factor s:</w>
fac e.</w>
fa ther</w>
f ri
f light</w>
f ell
exud ative</w>
exter oceptive</w>
expres sive</w>
expos ures,</w>
explo res</w>
expl aining</w>
expan sion.</w>
exp end
expend it
excell ent.</w>
exameth onium</w>
ex it</w>
evi prostat</w>
event -related</w>
euphor ia,</w>
etin- beta</w>
ethosuxim ide.</w>
ethambut ol,</w>
et an
et )</w>
esophag us,</w>
esophag itis.</w>
escal ations</w>
es oxime</w>
es citalopram,</w>
es ac
es ?</w>
es );</w>
erythro mel
erule in</w>
erec tion,</w>
er lotin
er do
epilep sies.</w>
epididy mitis</w>
epider mi
ephed r
ep tion</w>
eosinophil uria</w>
enti ty,</w>
entac apone</w>
ent ra
ent a
eni i</w>
enhance ment,</w>
eng th</w>
ene -induced</w>
ene )</w>
endoscop y,</w>
endocannabin oids</w>
endoc ochlear</w>
end- of-dose</w>
end point
end orsing</w>
encephal on,</w>
enceph aly
en- VPA</w>
emul si
empt ying,</w>
empt y</w>
embryoleth ality</w>
embed ded</w>
elucid ated</w>
else whe
elic itation</w>
electrophore sis.</w>
electron- microscopic</w>
electro shock.</w>
electro cortical</w>
elast ine</w>
eigh t,</w>
effect :</w>
ef arox
educ ation.</w>
ed at
ed -type</w>
ed "</w>
echo graphic</w>
echo genic</w>
ec z
ec ur
ec centric</w>
ec arbox
eNOS- deficient</w>
e- dependent</w>
e- associated</w>
e lo
e lithiasis</w>
e ]
dystoni as</w>
dysphag ia,</w>
dysp nea.</w>
dyscra si
dynes/cm 5</w>
dynam ics,</w>
dur ations.</w>
dur a</w>
duct ular</w>
duc t,</w>
drug ).</w>
drom otropic</w>
drink ing,</w>
dri p</w>
dri ed</w>
doxep in.</w>
dox o-
down regulating</w>
double-dumm y,</w>
double- masked,</w>
doub t</w>
dose-depend ently.</w>
dose /
dop amine/
dop amine
don or
dol lars</w>
doc tors</w>
dn ess.</w>
diver gence</w>
distrib ut
dissi p
disper sed</w>
disorgan ized</w>
discrep ancies</w>
discol or
dis similar</w>
dis section,</w>
dis location</w>
dis ap
dis ability,</w>
diplo id</w>
dip s
din ucleotide</w>
dilem ma</w>
diisopropyl fluorophosphate</w>
dihydro pyrimidine</w>
dihydro pyridine-
diethyl carbam
diethyl -
dichloro diammine
dic hlor
diaz oxide,</w>
dialy zed</w>
diagno ses,</w>
diabet es;</w>
dia thesis</w>
di(2- ethylhex
di ed;</w>
di buc
di benz
dextromethorph an,</w>
dexamethas one-
devic es.</w>
devi ations</w>
determin ations,</w>
detect able,</w>
det ects</w>
destruc tion.</w>
desoxy corticosterone</w>
dermatomyosi tis.</w>
depress ing</w>
depres sion:</w>
deple tes</w>
dep lo
deoxy corticoster
den sely</w>
demograph ics</w>
dem arc
dele ted</w>
dehydrogen ase.</w>
degrad ation.</w>
degrad able</w>
def eren
decano ate.</w>
decade s.</w>
dec id
debriso quine</w>
deb ated.</w>
de st</w>
de hydration.</w>
de fibrillation.</w>
de bul
de als</w>
de al</w>
de ad
day (-1),</w>
daugh ters</w>
dam s.</w>
dUT P</w>
dP/dtej c</w>
dP/d t)</w>
d iterpene</w>
d f</w>
d ase</w>
cytopen ic</w>
cytokin es,</w>
cytochro me-
cyto sis,</w>
cyt ometric</w>
cyprohept adine.</w>
cycl ical</w>
cy tox
cy cle
curren t.</w>
cur vilinear</w>
cur ves.</w>
cur ve,</w>
cur ar
cryst al
crypt ogenic</w>
cross- sensitization</w>
cross- resistance</w>
cros sing</w>
cro moglyc
crist ae</w>
crani os
cr yp
covari ates</w>
covari ates,</w>
counter parts</w>
counter acting</w>
coun ty</w>
coun tr
coun tered</w>
cough ing</w>
cou mad
cortic es.</w>
cortic al,</w>
correl ating</w>
convulsion s;</w>
conver gence</w>
contrac t</w>
continu ance</w>
contin ent</w>
construc tion</w>
const ant,</w>
consist ent.</w>
consider ably.</w>
cons enting</w>
condy lo
conclu sively</w>
concept uses</w>
concept us</w>
concentration s:</w>
concentr ation;</w>
con templ
con gener</w>
con cordance</w>
compres sion.</w>
compart mental</w>
comit ant</w>
comb ine
comb at</w>
com mitted</w>
com mitte
com ato
colony- forming</w>
colo red</w>
colo rect
coll ection.</w>
coer ulospinal</w>
cochle a.</w>
cocaine- using</w>
cocaine- maintained</w>
co- morbidity</w>
co valently</w>
co uld,</w>
co ol
co il</w>
co factors</w>
cm/ s</w>
clozap ine-associated</w>
cloc kwise</w>
clo ts</w>
clo faz
cl im
cl ick</w>
cl aim</w>
cit rate.</w>
cis- platin</w>
circum ci
circuit s.</w>
ciprofloxac in-associated</w>
cimetid ine-associated</w>
cilni dipine</w>
ci l</w>
chromatography- mass</w>
chromatograph y/
choro id</w>
cholestasi s:</w>
cholest atic
cholangiopancreat ography</w>
chol ine,</w>
cho ol</w>
chloro form</w>
chloro fluoro
chlor pro
chil d,</w>
chemosensi tiz
chemic al,</w>
challeng es.</w>
ch eno
ch ain,</w>
cess ation,</w>
cervic ovaginal</w>
certi fic
cephalospor ins.</w>
cell s:</w>
celecoxi b.</w>
cefotet an-induced</w>
cef epime</w>
ce t
ce mbran
ce fosel
catar acts,</w>
catalepsy -associated</w>
catal yst
castr ation</w>
cartil agin
caro ta</w>
carnit ine,</w>
cardiomyo pathies</w>
cardiac -specific</w>
cardi ology</w>
cardi ologic</w>
carboxypiperaz in-4-
carbox am
carboxam ido
carbamazep ine
carbam ate</w>
car teolol</w>
car must
captopri l-induced</w>
capsul e.</w>
capillari es.</w>
cap t
candi di
candes art
cancer -related</w>
can ,</w>
cam era</w>
callo sum</w>
cali br
calcul ations</w>
calc ulation</w>
cal oric</w>
caffe ine-treated</w>
ca red</w>
ca re
ca ecum</w>
ca ,</w>
c. ),</w>
c yl
c up</w>
c k</w>
c iclospor
butylbicyclophosphoro thionate</w>
buspir one.</w>
bupropi on-induced</w>
bumet an
bulim ia</w>
bul bifera</w>
buff ering</w>
buc umo
buc olome</w>
bru x
bronchospas m.</w>
brom ide,</w>
bro basilar</w>
brin zolamide/timolol</w>
breath ,</w>
breast .</w>
bran ched</w>
brain- stem</w>
brady cardiac</w>
brady arrhythmias.</w>
br a</w>
bortezomib .</w>
bortezomib -associated</w>
bol us-
bol us),</w>
bo ys.</w>
blood- retinal</w>
blood- pressure</w>
block s.</w>
blo t.</w>
blind ness,</w>
biosynthe sis,</w>
biop sy
bioavail ability.</w>
bio tin</w>
bigemin y</w>
bi valir
bi us'</w>
beta-caroten e</w>
beta- catenin</w>
beta- agonists</w>
beta ENaC</w>
bet le</w>
benzofur an-
benzo[a, d]
benzo ic</w>
benz il
benef it
beha ves</w>
beha ved</w>
beagl es.</w>
beag les</w>
be er</w>
basel ine:</w>
bas ophilic</w>
bar k</w>
bal ancing</w>
bacte remia,</w>
backgroun ds</w>
b. d.</w>
b ud
b ones.</w>
b one,</w>
b lonanserin</w>
b iting</w>
b )
azos in.</w>
azoc ine</w>
azido- 3'-deoxy
az treon
az o
az ide.</w>
axon opathy</w>
awak en
aver ages</w>
av itary</w>
av id
automatic ity</w>
auto antibodies.</w>
auto antibodies,</w>
augment ation.</w>
audi t</w>
audi ological</w>
audi ogram</w>
aud it
auc us</w>
attenu ation,</w>
attenu ated,</w>
attend ant</w>
attempt ing</w>
attemp ted.</w>
atrio- ventricular</w>
ati cal</w>
ath le
at- risk</w>
asymptom atic
astro cyte</w>
astemiz ole,</w>
associ ative</w>
associ ated.</w>
associ ated,</w>
associ ate</w>
assign ment</w>
asses ses</w>
asphy xia</w>
ase- mediated</w>
as le
as e),</w>
as arone</w>
arthralg ia.</w>
arterios clerosis</w>
arter itis,</w>
arrhythmi as:</w>
arrest s</w>
arg ues</w>
arachnoidi tis.</w>
ar ming</w>
ar ia
ar c</w>
aprind ine,</w>
approach -
approach- avoidance</w>
appetite- suppressant</w>
apop lex
aph thous</w>
anxioly tics</w>
anxi olysis</w>
anto in-induced</w>
antieme tics</w>
antidepressant -associated</w>
anticonvuls ant
anticholinerg ic,</w>
antiarrhythmic s</w>
anti- Parkinson</w>
anti- Gi
anti sera</w>
antagon ise</w>
ant ing</w>
angiograph y:</w>
angio plasty,</w>
anesthesi ologists</w>
anesthe ti
ane /
and os
ance ).</w>
anatom ically</w>
anand amide,</w>
analy tic</w>
analogu es,</w>
analgesic -induced</w>
ana em
an swe
an other,</w>
an es</w>
an ),</w>
amyl ase</w>
ampicill in-
ammon emia</w>
aminonucleoside -treated</w>
amino ]-
amin om
amide ]</w>
amide -related</w>
am y
am pros
am mary</w>
am a</w>
altern ations</w>
alpha2- adrenoceptors</w>
alpha-tocoph er
alpha-naph thylisothiocyan
alpha- asarone</w>
alpha- 2a</w>
alpha ENaC,</w>
alpha 4
alpha (7)</w>
alpha (1)</w>
allerg y.</w>
alle les.</w>
alle ged</w>
alkalo sis.</w>
alkalo id,</w>
alk yl</w>
alfentan il-induced</w>
aldoster on
al curonium</w>
al -treated</w>
al '</w>
aggreg ation,</w>
aggrav ating</w>
ag relide</w>
afterdepolar izations.</w>
after discharges</w>
after -
afen ib</w>
af orementioned</w>
adv ent</w>
adul ts:</w>
adrenocept or
adrenerg ic-
administr ative</w>
adjunc ts</w>
adequ ate.</w>
adenosin ergic</w>
adeno viral</w>
addres ses</w>
addic tion:</w>
addic t</w>
ad judic
acute- on-chronic</w>
acup unct
acknowledg ed</w>
acetyl methad
acetaminophen -
acet aldehyde</w>
ace promazine</w>
acceler ome
ac yl-CoA</w>
ac yclin
ac ic</w>
ac eous</w>
ac en
ac cord
absolut ely</w>
abs ences</w>
abol ition</w>
abnormal ,</w>
abdom en,</w>
ab enz
a- -
a phasi
a .)</w>
a 's</w>
] );</w>
[ S
[ N-
[ 7-
[ 4.
[ 2,
[ 2
[ 15
[ (3
Zidov ud
Z angrad
Youn ger</w>
Y M-0
Y 1</w>
Y ),</w>
X- C</w>
X a</w>
X L</w>
WR2425 11</w>
WR -10
W ech
W a
W EB</w>
Vol um
Vis c
Vi ro
Ven o-occlusive</w>
Ve h</w>
Van ishing</w>
Van comycin-induced</w>
VTE .</w>
VT /
VP U</w>
VP -16</w>
VE Ps</w>
VE GF
VCM s</w>
VCM s.</w>
V oric
V ecur
V ag
V S</w>
V M-
V IT</w>
V II</w>
V D</w>
V B</w>
V AL
VAL /HCTZ</w>
V -related</w>
Utili zing</w>
Ur sodeoxychol
Up- regulation</w>
Un treated</w>
US P
U/ ml</w>
U. S.
U- shaped</w>
U- II</w>
U se
U Q</w>
U ;</w>
U ).</w>
Two- thirds</w>
Tubulo interstitial</w>
Triam te
Tri azol
Tri al.</w>
Trazod one</w>
Tran sesophageal</w>
Tr p</w>
Thrombo phlebitis</w>
Thromb olytic</w>
Thir d</w>
Thiopent one</w>
Thi or
Th r
Th om
Th ermal</w>
Terat ogenic</w>
Tem per
TWEA K</w>
TNF alpha</w>
TN G</w>
TI VE</w>
TI MP
TH P,</w>
TH L</w>
TH C.</w>
TEM PO
TEMPO L</w>
TD P.</w>
TA A</w>
T ub
T radi
T onic</w>
T it
T ech
T R</w>
T PV/
T PA</w>
T OC</w>
T O</w>
T LE,</w>
T KI</w>
T C)</w>
T +
Syd ney,</w>
Sy n</w>
Swit ching</w>
Swis s-Webster</w>
Sweden .</w>
Stop ping</w>
Ster ile</w>
Stav udine</w>
St AR</w>
Spir ulina</w>
Sp ina</w>
Sor afenib</w>
Six -
Seventy- one</w>
Ser vices</w>
Se ve
Se g
Se Cr</w>
Scal es</w>
Sar coma</w>
Salic ylate</w>
Sal mon
STZ- icv</w>
STZ .</w>
ST EP</w>
ST -1</w>
SSR1038 00</w>
SSR 14
SSR14 97
SSR1497 44
SR -14
SR-14 17
SR-1417 16
SPAR C-
SPARC- null</w>
SM- 58
SK _F</w>
SK F
SH P</w>
SGO T</w>
SG As</w>
SERCA 2</w>
SCL C</w>
SCL -
SCH000 13</w>
SC F</w>
SC D</w>
SA E</w>
S usp
S ural</w>
S to
S hould</w>
S est
S PA</w>
S LS</w>
S LE
S I</w>
S CD
S AP
S A.</w>
S -</w>
S (c)
Rit alin</w>
Rg 5/
Rg5/ Rk
Rg 3
Rg 1</w>
Rest oration</w>
Rep ub
Rem oxi
ReN18 69</w>
Radi ation</w>
RV M</w>
RS V</w>
RP P</w>
RO S-
RO M-1
RAM H</w>
RA -induced</w>
R56 865</w>
R- AN
R- 467</w>
R- 3</w>
R ous
R oten
R of
R ho
R b
R SR</w>
R SA</w>
R S.</w>
R Rs</w>
R IS</w>
R IS
R CA</w>
R ATG</w>
R (+)-
Quer cetin</w>
QT ,</w>
QT (
Q- AMI</w>
Q ST</w>
Psych opharmac
Propran olol,</w>
Propafen one</w>
Prom oting</w>
Progres sion</w>
Pro state</w>
Pres sor</w>
Prednis one</w>
Pre -</w>
Porsol t</w>
Pod ocyte</w>
Phosphor ylation</w>
Phenyto in,</w>
Per sist
Parox ysmal</w>
PV -
PT R</w>
PR3- ANCA</w>
PR s</w>
PR M</w>
PPAR beta/
PP ).</w>
PO MC</w>
PMN Ls</w>
PL- DOX</w>
PL A</w>
PIL O-induced</w>
PG ),</w>
PEG- IFN</w>
PDE 3B</w>
PD T</w>
PC R)</w>
PC NA</w>
PC D</w>
PC C</w>
PAN /
PA S</w>
P450sc c</w>
P yridoxine</w>
P recipit
P ost</w>
P it
P epti
P anic</w>
P H.</w>
P -</w>
Over t</w>
Ovari ectomy</w>
Or ally</w>
Ophthal mic</w>
Occa sional</w>
Oat p
OT Z</w>
OPC -145
OP P</w>
OA AS</w>
O smo
O per
O SA</w>
O K
O Cs.</w>
O ATP-
O AB.</w>
O 2/
O 2-
O .
Norm oten
Nitro -
Nex t,</w>
New born</w>
Neurosc i.</w>
Neuro physiological</w>
Neuro peptide</w>
Neuro n</w>
Neu N</w>
Ne omycin</w>
Nause a,</w>
Nal trex
Na- K-
Na S</w>
NY T</w>
NT G.</w>
NT )</w>
NSAID .</w>
NP S</w>
NO S-
NO P</w>
NMDA/ glycine</w>
NK 2</w>
NK (1)</w>
NI H</w>
NI ),</w>
NG .</w>
NF- kappa</w>
NE -induced</w>
ND I,</w>
NB U</w>
NAD H-
N2 O-
N-desmethyl diazepam</w>
N-acetylcyste ine,</w>
N-acetyl-beta- glucosaminidase</w>
N-2- fluorenyl
N onetheless,</w>
N ic
N VP</w>
N SU
N R</w>
N R-AN
N E,</w>
N Ac
N AT2</w>
N AC
N 1</w>
My ocyte</w>
My HC</w>
Morph ologic</w>
Mod afin
Minim um</w>
Micro injections</w>
Mg C
Methad one-induced</w>
Meth imazole-induced</w>
Meta- analysis</w>
Met for
Mer open
Memant ine</w>
McN-56 52</w>
MT D.</w>
MT ).</w>
MS X-
MP C</w>
MN NG</w>
MI- ARI</w>
MI ).</w>
MH PG</w>
MEDLIN E,</w>
ME P</w>
MD R-T
MD D.</w>
MCF P</w>
MB .</w>
MAO- B</w>
MA L</w>
MA F
MAF b
M- TMCD</w>
M at
M ammary</w>
M ag
M a
M _
M Z</w>
M 204
M 16
M -induced</w>
Low ering</w>
Lim it
Li po
Lev ofloxacin</w>
Lev amisole</w>
Le iden</w>
Lat er</w>
Langer hans</w>
LY 29
LY29 3
LY293 558</w>
LT P</w>
LR 132</w>
LH ON</w>
LE V.</w>
L-DOPA ,</w>
L- 5-HTP</w>
L up
L u</w>
L ond
L ate-
L A.</w>
L :</w>
L 9'
L9' A</w>
L 78
Krus kal-Wallis</w>
Kingdom .</w>
Kar nofsky</w>
KW-39 02</w>
KRN23 91</w>
K- 35
K+ -induced</w>
K loth
K i-
K T-
K Cl,</w>
K CN
K 18</w>
K (v)
J ack
Isradi pine</w>
Isot retinoin</w>
Iso flurane-induced</w>
Intrad ermal</w>
Inter leuk
Inter ictal</w>
Inten se</w>
Initi ation</w>
Initi ally</w>
In dap
In -
Impres sions-
Immun ocyt
IgE -mediated</w>
Idi opathic</w>
IV R</w>
IV :</w>
IU/ L</w>
IS E</w>
IR C</w>
IP C</w>
IO P,</w>
IL-1 0,</w>
IL 6</w>
IL -10</w>
IK r</w>
III b</w>
II EF</w>
IGF- IL-3</w>
IFN/ RBV</w>
IF S-induced</w>
IC S</w>
IB O</w>
I- 00
I s,</w>
I UD
I HA</w>
I EN
IEN F</w>
I 1-
Hypo thermia</w>
Hyp ox
Hydroxy chloroquine</w>
Hydro x
Hy pe
Hy d
Hunting ton</w>
Hey mann</w>
Hen le</w>
Hem olytic-uremic</w>
Health y</w>
Haloperid ol,</w>
Haemo philus</w>
HSP 90</w>
HR- 592</w>
HM G</w>
HIV/ AIDS</w>
HIV ,</w>
HER 2</w>
HCV- RNA</w>
HC a</w>
HC Cs</w>
HBeAg -
HBV- HIV</w>
H- reflex</w>
H- F
H examethonium</w>
H T.</w>
H S-
H F.</w>
H A,</w>
Gu inea</w>
Gu ide
Grad ual</w>
Goodpasture 's</w>
Glycer yl</w>
Gluc ose</w>
Gluc ar
Gen ital</w>
Gemcit abine-induced</w>
Gar lic</w>
Gadol inium</w>
GV G</w>
GTP gamma
GTN .</w>
GT D</w>
GST- P</w>
GSK3 34
GSK 20
GSK20 70
GSK2070 40</w>
GSH ,</w>
GR1279 35</w>
GEC s</w>
GBM .</w>
GAP- 43-
G c</w>
G ang
G H,</w>
G D3</w>
G A</w>
G ;</w>
Fran ce
Fol ey</w>
Fluoxet ine-induced</w>
Flu ores
First- line</w>
Fifty- nine</w>
Fibro test</w>
Fibri llation</w>
Fc gammaR
Farns worth
Fam oti
FUD R</w>
FOLFO X-4</w>
FL X</w>
FK506- related</w>
FK 3
F n
F dd
F SL</w>
F SH</w>
F LA-
F I
F AA</w>
F 1-
Europ e,</w>
Ep i</w>
Endoscop ic</w>
Eighty- one</w>
Eighty- eight</w>
Ecstas y</w>
EX PG</w>
ER P</w>
ER .</w>
EP 4</w>
EE )</w>
ED 95</w>
ED -1-
EC 145</w>
E x</w>
E wing</w>
E q/
E max</w>
E ll
E ligibility</w>
E X-4</w>
E 18.
Drug -
Doxorub icin,</w>
Dox azosin</w>
Double-bl ind,</w>
Donepe z
Diz zin
Del ay
De b
DSM- IV-
DR G.</w>
DNA- positive</w>
DLT s</w>
DIC .</w>
DIC ,</w>
DH EA</w>
DF O.</w>
DES -associated</w>
DE X-induced</w>
DE NS
DE NA-
DD AVP</w>
DD ).</w>
D2/ D3</w>
D2 B6
D2B6 F1</w>
D-penicill amine,</w>
D-Tr p-6-
D- 99</w>
D utch</w>
D s.</w>
D om
D aucus</w>
D antrol
D T-
D MSO</w>
D ID</w>
D AB
D 5
D 3-induced</w>
D 2-receptor</w>
D 2-induced</w>
D 1-like</w>
Cyclo oxygenase</w>
Cx 43</w>
Curren tly</w>
Coumad in</w>
Cortico steroids</w>
Cordar one</w>
Concer ns</w>
Con f
Commun ity</w>
Com pl
Co- treatment</w>
Co deine</w>
Clostri dium</w>
Clon ic</w>
Clo mi
Citalop ram
Cis apride</w>
Cirrho sis</w>
Chol elithiasis</w>
Chlor prop
Check li
Character istic</w>
Ch ild</w>
Ch -induced</w>
Cent er.</w>
Cau ses</w>
Caro tid</w>
Carb imazole</w>
Canad a,</w>
Cam bodi
Cal vert</w>
CaCl(2)- treated</w>
Ca2+ .</w>
Ca(2+ )]
Ca the
Ca )</w>
CYP3A 4,</w>
CYP2C 9</w>
CXCR 4</w>
CV -1
CT R</w>
CT -induced</w>
CR F1</w>
CR ).</w>
CPA/ EE</w>
CP94 253</w>
CP K,</w>
CON TRO
CM T</w>
CK DH</w>
CK D</w>
CI P.</w>
CH A</w>
CGRP -</w>
CG S
CF M-
CD- 8
CD C</w>
CCl 4</w>
CC G
CB Z.</w>
CA F
CA D,</w>
C57Bl/ 6J</w>
C yclic</w>
C s).</w>
C ost
C learance</w>
C in
C igarette</w>
C i</w>
C he
C esarean</w>
C ab
C a,</w>
C _
C ]-
C SE</w>
C F)</w>
C CNU
C CA</w>
C C,</w>
Bus pirone</w>
Bromocript ine-induced</w>
Bra ins</w>
Bow man's</w>
Bortezom ib
Benzodiazep ines</w>
Be ing</w>
Bac opa</w>
BW ),</w>
BT S</w>
BT F</w>
BPA A</w>
BFU- E</w>
BD 100
BA U</w>
B u</w>
B max</w>
B mK</w>
B illingham</w>
B T</w>
B RR</w>
B MT.</w>
B L-
B IP
B CKDH</w>
B AC</w>
B 6,</w>
B -type</w>
Azot emia</w>
Az ithromycin</w>
As th
Arrhyth mia</w>
Aripi prazol
Ap peti
Ap o</w>
Anti convulsive</w>
Anter o
Analo g</w>
Ami k
Americ ans.</w>
Americ a</w>
Am sler</w>
Alprazol am</w>
All ergy</w>
Al together,</w>
Al lopurinol</w>
Al buterol</w>
Al bumin
Ag ing</w>
Ag ain,</w>
Adul ts</w>
Adren oc
Adju sted</w>
Ad mission</w>
Acut e,</w>
Acetyl cholinesterase</w>
Ac tivities</w>
Ac tive</w>
Ac tion</w>
AV P,</w>
ATP /
ATP/ ADP</w>
ASL- 8
ASL-8 123</w>
AS A
AS 1928370</w>
AR .</w>
AQP 8</w>
APA P.</w>
APA P-induced</w>
APA P-
AN T1</w>
AN ,</w>
AM LE
AM 12
AL S</w>
AL S.</w>
AL N+
AI N.</w>
AI )</w>
AG E</w>
AF P</w>
AF L</w>
AER S</w>
AED s.</w>
AE .</w>
ADR s.</w>
AD HD,</w>
AD C</w>
AD ),</w>
ACP-10 3</w>
ACE I</w>
AC 927</w>
AB I-00
AA P,</w>
A-(1-1 7)</w>
A- associated</w>
A- 7
A-7 400
A-7400 03</w>
A trac
A rac
A TI
A LT
A AN</w>
A A.</w>
A 2a</w>
A 1
A )/
A (1)
= 50%</w>
< 3</w>
< 0.05)</w>
< .01).</w>
: 1.</w>
90 ).</w>
9. 5,</w>
9- year</w>
9- month</w>
9 th</w>
9 47</w>
9 4)</w>
9 26</w>
9 2)</w>
9 19</w>
812 97</w>
8- hour</w>
8- day</w>
8 H</w>
8 9%,</w>
8 50</w>
8 5-
8 4,</w>
8 38
8 29
8 -12</w>
8 ,000</w>
73 15
70 %.</w>
7/ 7</w>
7. 7
7-N I,</w>
7-CK A</w>
7- 9</w>
7 9.
7 0)</w>
69 593</w>
60- 90</w>
60 6</w>
6-OHD A.</w>
6-OHD A-lesioned</w>
6- thioguan
6- nitro-
6- n-propyl-
6- glucuronide</w>
6- day</w>
6 :</w>
6 80</w>
6 7-
6 7,</w>
6 30</w>
6 2.5%</w>
6 2%,</w>
6 1,</w>
6 +/-1
58 %,</w>
54 18</w>
50 ,000</w>
50 %),</w>
5/ 6</w>
5. 7
5. 5%</w>
5. 1%</w>
5-hydroxytrypt oph
5-F C</w>
5- week</w>
5, 6-
5 70</w>
5 4).</w>
5 3.</w>
5 20
5 ,000</w>
45 ;</w>
40- 7
40 th</w>
40 .</w>
40 ),</w>
4- -
4 9)</w>
4 6,</w>
4 6)</w>
4 4.</w>
4 1.
4 -12</w>
4 -10</w>
4 );</w>
39 2</w>
39 1</w>
37. 5%</w>
36 7</w>
35 /
33. 3%</w>
3. 3,</w>
3. 2%</w>
3. 1;</w>
3. 1%</w>
3. 0)</w>
3- weekly</w>
3- methoxy-4-
3- (3-
3,4- di
3',5'- monophosphate</w>
3 7.5</w>
3 5%)</w>
3 3),</w>
3 27</w>
3 2.5</w>
3 -10</w>
3 +/-1
3 '</w>
29 8</w>
28 6</w>
28 3</w>
27 ;</w>
26. 5</w>
26 ;</w>
26 1</w>
25 9</w>
25 5</w>
25 .</w>
23 9</w>
23 6</w>
200- 400</w>
200 9.</w>
200 -1
20- fold</w>
20 6</w>
2. 8%</w>
2. 7)</w>
2. 6-
2. 5-fold</w>
2. 4,</w>
2. 20</w>
2. 2).</w>
2. 0-
2-chloro proca
2-OH E</w>
2-1 7
2- mediated</w>
2- agonists</w>
2- (
2,3, 7,8-
2, 500</w>
2 ]
2 A/
2 7.5</w>
2 65</w>
2 22</w>
2 18
2 1.9</w>
2 1.2</w>
2 0.3</w>
2 "</w>
198 8.</w>
19. 3</w>
19- 00
19 78</w>
19 4
188 84</w>
18. 8</w>
18- 24</w>
17. 8</w>
17 8
17 5,</w>
16. 8</w>
16. 7%</w>
16. 5</w>
16. 2</w>
16- week</w>
16 377</w>
16 0
15S)-di HETE</w>
154,5 26</w>
15. 4</w>
15 -</w>
15 ,
14. 9</w>
13. 4</w>
13. 3</w>
13- week</w>
13 3
12 50</w>
12 %,</w>
11. 7</w>
11 195</w>
100 635</w>
10- week</w>
10 -100</w>
10 ,
10 (6
1/ 2)</w>
1.0 4-1.
1.0 -1.
1. 9,</w>
1. 83</w>
1. 8,</w>
1. 7%)</w>
1. 65</w>
1. 59</w>
1. 48</w>
1. 34</w>
1. 29</w>
1. 19</w>
1. 18</w>
1-methyl-4-phenyl-1,2,3,6-tetrahydro pyrid
1- treated</w>
1- min</w>
1- des
1- M
1- 7</w>
1- -
1,25 (OH)2
1,25 (OH)(2)
1, 2-
1, 1-
1 =
0.9 ;</w>
0.9 9</w>
0.9 7</w>
0.9 ,</w>
0.9 %)</w>
0.7 5,</w>
0.7 3</w>
0.5 4</w>
0.4 9</w>
0.3 8,</w>
0.12 5%</w>
0.000 3)</w>
0.000 ).</w>
0.00 3</w>
0.00 1
0.0 8,</w>
0.0 7).</w>
0.0 5-
0.0 14-
0.0 12).</w>
0.0 1%</w>
0. 60</w>
0. 50,</w>
0. 1%,</w>
0 6</w>
/ N
/ B
.00 2</w>
.0 1</w>
. mmHg
-1H- 3-benz
-16 ene
-1 9
-1 4.
-1 0-
-1 );</w>
- selective</w>
- only</w>
- assisted</w>
- 6</w>
- 3-
,00 0,</w>
+/-1. 5</w>
)- deficient</w>
) -1
(two ),</w>
(recombin ant)</w>
(r CBF)</w>
(p< 0.01).</w>
(p< 0.0001).</w>
(n= 8)</w>
(n= 12)</w>
(n .s.).</w>
(medi an
(i ox
(cTn T)</w>
(VN B)</w>
(V T).</w>
(V P)</w>
(V L
(TMP-SM X)</w>
(TI A)</w>
(T ac
(St udy</w>
(SSR I)</w>
(S)- 4
(S W
(S S
(S NR
(S G
(RP N)</w>
(R LS)</w>
(R F
(PT X)</w>
(PR ).</w>
(PGI 2)</w>
(P< .001).</w>
(P ar
(P TH
(P M
(OR s)</w>
(OR =
(N- methyl-
(N or
(N I
(N F
(N B
(MUG A)</w>
(MR SA)</w>
(MPT P)-
(MK-80 1),</w>
(MD A),</w>
(MA O)</w>
(M e
(M S)</w>
(M PO-
(M PA),</w>
(M O
(M DR
(L Y
(L S)</w>
(L H
(L C)</w>
(K )</w>
(IV -
(IL )-
(IF O)</w>
(IF N-
(IF N)</w>
(IF N)-
(ICRF-1 87)</w>
(I R
(I Q
(I M)</w>
(I .
(HR V)</w>
(HPL C)</w>
(HIV ).</w>
(HIT T)</w>
(HCT Z)</w>
(H SP
(H F
(H E
(H D)</w>
(H AL)</w>
(G nR
(G ST-
(G D
(F ish
(F V
(F S
(F ANF
(F (1,
(ET -1)</w>
(EC o
(EC OG)</w>
(EC M)</w>
(EC )</w>
(E xperiment</w>
(E S
(E 2),</w>
(DP H)</w>
(DOPAC )</w>
(DF P)</w>
(DE S).</w>
(D I
(D HE
(D A
(CO ),</w>
(CCK- 8-
(CB Z).</w>
(CB Z),</w>
(CB D
(C r)</w>
(C a,
(C TR
(C R),</w>
(C PA)</w>
(C NS).</w>
(C Is)</w>
(C Cl
(C AS</w>
(C AR
(B o
(B SI
(B CNU)</w>
(AM L)</w>
(ADR )-induced</w>
(A S
(A PL).</w>
(A N)</w>
(A G)</w>
(A ER
(A E)</w>
(A DE)</w>
(A ,</w>
(> /
(< or=
(9 6</w>
(8 8.
(8 6.
(8 1</w>
(7 9</w>
(7 6</w>
(6 8.
(6 2</w>
(50 -100</w>
(50 ))</w>
(5-FU ).</w>
(5 F
(5 9</w>
(5 1</w>
(5 -10</w>
(4. 5</w>
(4. 1</w>
(4- 6</w>
(4 8%</w>
(4 7</w>
(4 2%</w>
(4 )
(3. 7</w>
(3. 6</w>
(3. 1</w>
(3 7</w>
(3 6%</w>
(3 3%</w>
(3 0%),</w>
(3 -10</w>
(25- 50</w>
(2. 8</w>
(2. 1%)</w>
(2- 3</w>
(2 A)</w>
(2 6/
(2 4%).</w>
(2 1.
(19 %),</w>
(15- 30</w>
(13. 6%)</w>
(100 %),</w>
(10(- 5)</w>
(1. 8
(1. 7</w>
(1. 7%)</w>
(1. 5-
(1- pyrrolidinyl)
(1, 3-
(1 8%),</w>
(1 50-
(1 40</w>
(1 3%</w>
(1 2-
(1 15</w>
(1 1%).</w>
(1 1%),</w>
(0.5- 5</w>
(0.1- 0.3</w>
(0.03- 0.3</w>
(0. 9%)</w>
(0. 7%)</w>
(0. 56</w>
(0. 5%)</w>
(0. 1-1.0</w>
(0. 1-1
(0. 1%)</w>
(+/-)- SM</w>
(+/-)- 2-
(+)-PD-128, 907</w>
(+)-CP CA</w>
(+)- 5-methyl-10,11-dihydro-5H-di
(+)- 3-PPP</w>
( weeks</w>
( t-
( study</w>
( starting</w>
( reference</w>
( reduction</w>
( pro
( placebo,</w>
( patients</w>
( over</w>
( once</w>
( occurring</w>
( means</w>
( male</w>
( l
( diastolic</w>
( dex
( containing</w>
( confidence</w>
( compared</w>
( cohort</w>
( chronic</w>
( chi</w>
( central</w>
( cardiac</w>
( calcium</w>
( bolus</w>
( baseline),</w>
( based</w>
( 0/
' s)</w>
" high
" crack
" atyp
zolpide m,</w>
ziprasid one.</w>
z os
z o-
yr one</w>
yr in-
yr ).</w>
young er,</w>
yohimb ine-induced</w>
year s-old</w>
yc le</w>
yc in-treated</w>
yb dot
y- proven</w>
y- evoked</w>
y thro
ythro poi
y mo
y ment</w>
y go
ygo tic</w>
y gium</w>
y a</w>
y .
xerostom ia,</w>
x es</w>
women ),</w>
women 's</w>
within- subject,</w>
withhel d.</w>
with holding</w>
whit e-
whe el</w>
wh ole.</w>
well- tolerated.</w>
well- differentiated</w>
weak ened</w>
we l.</w>
water ),</w>
wast ing,</w>
warr anting</w>
war n</w>
war m-
wall s,</w>
wake fulness</w>
w ish</w>
w illing</w>
w ay
vulner ability.</w>
vo uc
vo gli
visu alization</w>
vir al-
vigabat rin,</w>
vib ris
vi sions</w>
vi an</w>
vi ability.</w>
vesi cle</w>
vertig o.</w>
verte brobasilar</w>
veratri dine</w>
ver ine</w>
ver at
ventro -
ventric ulo
ventric les,</w>
ven ography</w>
ve in-
ve in,</w>
vasore activity</w>
vasopress ors.</w>
vascul iti
varic ocele</w>
vari ed,</w>
vari ation.</w>
vari able-
vap t
valv es.</w>
vag olytic</w>
vacuol isation</w>
v orum</w>
v antolol</w>
v ,</w>
utiliz ation.</w>
ust a
useful .</w>
uscit ation</w>
us -treated</w>
us -dependent</w>
uro log
uro lithiasis.</w>
uro cortin</w>
urg ently</w>
ureth ra
urethra .</w>
ures ).</w>
ure ter.</w>
ur s</w>
ur ized</w>
ur gen
ur an
ur ,</w>
upt a
upta ke
upreg ul
unte ers</w>
units/ min</w>
unexpl ained.</w>
und us</w>
un successful,</w>
un sell</w>
un recognised</w>
un protected</w>
un known;</w>
un doub
un determined.</w>
un controllable</w>
un associated</w>
un acceptably</w>
um -related</w>
ulos a</w>
ulo plas
ul eti
uleti de</w>
ul erg
ug ment
ud in,</w>
ucle ar-
u tility.</w>
tyros ine-
type -1</w>
type )</w>
two- year</w>
two- step</w>
two -</w>
twenty- eight</w>
tw ins</w>
tuf ts</w>
tubercul in</w>
tub es</w>
tu be,</w>
trunc al</w>
tropic amide</w>
tro duction</w>
tris omy</w>
trimethopri m.</w>
trichloro ethane</w>
tren d.</w>
treatment- limiting</w>
treatment -associated</w>
treat ,</w>
trazod one.</w>
transpor ters.</w>
transcrip tion-
transcription- polymerase</w>
trans- nicotine-N'-
trans sphenoidal</w>
trans lation</w>
tranquil iz
tran se
tram id</w>
traff icking</w>
tract s,</w>
tract ant</w>
tra vel</w>
tr uly</w>
tourniqu et,</w>
tongue- task</w>
toler able.</w>
togen ari
to sis.</w>
to dd
todd l
to )</w>
tiv ity,</w>
tion -induced</w>
timo lol,</w>
tim ide</w>
til lo
tic- pharmacodynamic</w>
tic ated</w>
tib ia</w>
thyro toxic</w>
thyro parathyroidectomized</w>
thym idine,</w>
through put</w>
thrombo genic</w>
thrombi ,</w>
thromb in-induced</w>
thromb in-
thir d,</w>
thioper amide,</w>
thion ine</w>
thio ph
thiazolidinedi ones</w>
thiazol idine-
thiaben dazole</w>
thi ols</w>
thi epin</w>
thi en
theophyll ine-
the se.</w>
the ast</w>
thalidom ide-
thal ass
th yo
th ia
th an-
tetrodot oxin</w>
tetrodot ox
tetrac hloro
test s:</w>
test s)</w>
test ing;</w>
test inal</w>
tertiary- care</w>
terat ological</w>
ter )</w>
tent ing</w>
tenofovir ,</w>
tenid ap</w>
ten si
ten fold</w>
ten ding</w>
temoc april</w>
temazep am,</w>
teg af
techno logy</w>
techniqu e)</w>
tear fulness</w>
te dly</w>
te d)</w>
tax ol,</w>
target -
tamponade .</w>
tail- tremor.</w>
tachycardia ;</w>
tachycardia /
tachy kinin</w>
ta urine.</w>
ta hydro
ta -
t. i.
t- AMCA</w>
t ympan
t us</w>
t us
t urb
t s),</w>
t led</w>
t andos
synthesi zing</w>
synthesi zed.</w>
syndrome ).</w>
syn ucle
syn onymous</w>
sy ru
suspen sion.</w>
surro gate</w>
surg e</w>
surfac es</w>
sur moun
supran uclear</w>
super precipitation</w>
sup pository</w>
summar ized.</w>
sulfon amide
sulfadox ine-
sulf ate
sulf amo
suk ub
suggest ,</w>
sugamma dex</w>
suburo thelial</w>
subside d,</w>
subject- rated</w>
sub unit.</w>
sub side</w>
sub di
subdi visions</w>
sub anesthetic</w>
sty rene</w>
stut ter
structur al,</w>
stroke ;</w>
striat a</w>
stri opallidal</w>
stri ated</w>
streptozoc in</w>
strepto kinase</w>
strength s</w>
stre am.</w>
strategi es,</w>
stra in-dependent</w>
str ation</w>
stimul ations</w>
sti bo
steroid .</w>
steroid -treated</w>
steroid ,</w>
ster il
stat in-induced</w>
stachy s</w>
st one.</w>
st ered</w>
st ents,</w>
st em.</w>
st aging</w>
splic ing</w>
spiro peridol</w>
spiro metry</w>
spin y</w>
specti vely,</w>
spect ac
specimen .</w>
specific ity.</w>
spec t</w>
spar floxacin,</w>
sp ell
sour ces.</w>
sos omal</w>
son ography,</w>
somnambul istic-like</w>
somatos ensor
som ite</w>
solu tion;</w>
solitari i</w>
sol vent
sol ic
sol ar</w>
sodi um/
socio demographic</w>
snor ing</w>
sniff ing,</w>
small er,</w>
slow- wave</w>
skill s</w>
skele ton
six .</w>
sit e
sis- like</w>
sis ?</w>
sion- inducing</w>
sion s:</w>
sinusi tis.</w>
single-bl inded</w>
single- cell</w>
simple x</w>
sil ver</w>
sign als,</w>
sigma (2)-receptor</w>
sider osis</w>
sic ca</w>
sib ly</w>
si tis</w>
si s--
si res</w>
si lastic</w>
shoc ks</w>
she ll
sha ke</w>
sh run
sevent een</w>
sett led</w>
ses amin</w>
sertral ine-treated</w>
seroton in
ser ythropoi
ser t
ser ous</w>
ser ologically</w>
sequ enti
sequ enced</w>
sequ enc
septi caemia</w>
sensor ium</w>
sensitiz ation;</w>
self- medication</w>
see mingly</w>
see king.</w>
sed ative,</w>
sed ated,</w>
sect ors</w>
secret e</w>
sec tions,</w>
sec tioning</w>
search .</w>
sear ching</w>
se len</w>
se en
se ).</w>
scho ol
scan s,</w>
scab ies</w>
sc rot
scrot um</w>
sc ram
satur ation.</w>
satisfactor ily</w>
sat ran
satran idazole</w>
sar in</w>
salicyl ate,</w>
sal t)</w>
sal ine).</w>
s- old)</w>
s ore</w>
s lowe
s lim
slim ming</w>
s ay</w>
s ]</w>
s ],</w>
s ,
rout es,</w>
room -
room- temperature</w>
ron aut
rom e</w>
rolipr am,</w>
ro yal</w>
ro vorum</w>
ro mo
ritonavir ,</w>
risk "</w>
ring ed</w>
rim cazole</w>
righ t.</w>
ricket s.</w>
ric- oxide</w>
ri d
ri be
rheumat ologic</w>
reversal .</w>
rever ting</w>
rever sed.</w>
retur n.</w>
retro sternal</w>
retin oblastoma.</w>
reticulo endothelial</w>
reticul in</w>
restric tions</w>
restric ted.</w>
restore d.</w>
responsi ve.</w>
response ).</w>
respon ded,</w>
resour ce</w>
resem bl
resembl ance</w>
resc ents</w>
requ est</w>
reproduci bil
replic ate</w>
reperfu sion-induced</w>
rep ut
ren dipine</w>
remifentan il,</w>
remifentan il
remem bered</w>
remaind er,</w>
reli ed</w>
reinforce ment,</w>
reinforc er</w>
reinfor ce</w>
region ally</w>
regimen :</w>
regim es</w>
refractor iness.</w>
ref rontal</w>
red- cell</w>
recurren ces,</w>
recruit ed,</w>
recru iting</w>
recogni tion.</w>
recogni sed.</w>
recipi ent,</w>
receptor- dependent</w>
receptor- alpha</w>
recanal ization</w>
rec ently.</w>
rec all,</w>
rearrang ement</w>
re- entrant</w>
re visit
re uptake.</w>
re treat</w>
re transplantation</w>
re loc
reloc ation/
re ds</w>
re d)</w>
rat s.(ABSTRACT</w>
rat ings,</w>
rat a
rasag il
rapid- sequence</w>
rapam ycin.</w>
rap e</w>
ranitid ine-induced</w>
random ized.</w>
random ization.</w>
ran ked</w>
rai sed.</w>
rag ge
ragge d-
radic ulopathy</w>
racem osa</w>
rac ial</w>
rabep razole</w>
rSO (2)</w>
r- pro
r- hu
r unc
r ump</w>
r alazine</w>
r ade</w>
quinol ones,</w>
quin ine,</w>
qui pa
question ed.</w>
quant al</w>
quality- of-
qual ity,</w>
quadric eps</w>
quadri paresis,</w>
qu ine.</w>
pyrrolidinyl) methyl]-
pyrrolid in
pyrida zin
pyramid ale</w>
pyeloneph ritis,</w>
py ran
purpur a/
pup il
pun ished</w>
pul se,</w>
pul s
puber ty</w>
psychostimul ant-induced</w>
psycho sis:</w>
psycho ses,</w>
psycho geriatric</w>
psychiatri sts</w>
psychiat ry</w>
psychi atr
psych omot
psor iasis,</w>
pseudolith iasis.</w>
pseud omembranous</w>
proxymetac aine</w>
prostagland in-induced</w>
prost acyclin
pros thesis</w>
propylthiourac il,</w>
propyl -1-
propyl )
propos al</w>
propofol -M
propafen one,</w>
pronounce d.</w>
prompt ing</w>
prolifer ate</w>
prolact inemia.</w>
progres sive-
program ming</w>
progester one-induced</w>
progest ag
progen y</w>
profil ing</w>
pro li
pro be,</w>
pri or,</w>
prescri bed,</w>
preferen ces</w>
preeclamp sia,</w>
precipit ous</w>
pre- training</w>
pre treatments.</w>
pre treatment)</w>
pre load,</w>
pre fer</w>
pre dil
predil ection</w>
pre ablation</w>
pramipex ole,</w>
pract olol,</w>
pr in
posth yp
post renal</w>
pos tis
popul nea</w>
polyp s</w>
polymorph isms.</w>
polyc hemotherapy</w>
poly ur
poly trauma</w>
poly ribos
poly herbal</w>
poly graphic</w>
poly acrylamide</w>
pol ice</w>
pointes "</w>
point es:</w>
podoc aly
po sed.</w>
po ols</w>
po ol.</w>
po fung
pofung in</w>
po di
pneum ococcal</w>
pmol ),</w>
plo t</w>
platinum- containing</w>
platin um,</w>
plat in,</w>
plas ticity.</w>
plac e.</w>
pl ying</w>
pl ane</w>
pir one,</w>
piperox an</w>
piperid in-1-
pimoz ide.</w>
pilsi cain
pilo -
pill s,</w>
pig mentation,</w>
phyto sterols</w>
phyto estrogen</w>
physi c
phy ria</w>
phthal ein</w>
photoph obia,</w>
phosph ates</w>
phenylethyl ene</w>
phenyleth an
phenyl) -1-
phenyl piperazine</w>
phenoxybenz amine</w>
phenobarbit al-induced</w>
phenacetin- containing</w>
pharyn x</w>
pharmac y,</w>
pharmac ology.</w>
phac o
phaco emulsi
ph iliac
ph ases,</w>
ph an,</w>
petechi ae</w>
person ne
persist ed,</w>
perphenaz ine.</w>
permis sive</w>
peritone um</w>
period ical</w>
perin uclear-
peri kary
pergol ide-induced</w>
performed :</w>
perform ances</w>
perfor ated</w>
percus sion</w>
per taining</w>
per pet
per il
pepti dom
pepti des.</w>
pentylenetetrazol e-
pentol ini
pente trazol</w>
pentazoc ine,</w>
pentadec apeptide</w>
pentadec anoic</w>
pent osi
pentosi dine</w>
pent ose</w>
penicill amine,</w>
penetr ate</w>
pemetrex ed</w>
pel vis,</w>
peer- reviewed</w>
paw- withdrawal</w>
patient ;</w>
pathogn om
pathognom onic</w>
patch es,</w>
parti tion</w>
part ly,</w>
parenchy ma.</w>
parasit osis</w>
parameter s:</w>
parac entral</w>
par t.</w>
par af
par ab
parab rachial</w>
papillede ma,</w>
papill a.</w>
pap ular</w>
pantop razole</w>
pan ic,</w>
pan -
pamid ron
pallid us,</w>
pal met
pal m
pair s.</w>
painful ,</w>
paclitaxel/ cisplatin</w>
paclitaxel- eluting</w>
pacemak er,</w>
pac king</w>
pa ins.</w>
pa edi
p< 0.0001).</w>
p- di
p-di oxin</w>
p- aminohipp
p wise</w>
p ush
p tively</w>
p inch</w>
p idine</w>
p ic</w>
p enc
p ).</w>
oxypert ine</w>
oxotremor ine-induced</w>
oxide /
oxid ants</w>
oxcarbazep ine.</w>
ox ,</w>
over using</w>
over production</w>
over lying</w>
over doses,</w>
over dosed</w>
ovari es</w>
ov ary,</w>
otyp ic</w>
otrop h</w>
otri p
ototoxic ity:</w>
oton sill
ote tr
ost aining</w>
osm oly
oscop y,</w>
oscil lat
osa hexa
osahexa enoic</w>
os tin</w>
os plen
orub ic
oron asal</w>
organophosphor us-induced</w>
organell es.</w>
organ ochlor
organ ized</w>
orchi ectomy</w>
orb idity</w>
oral- contraceptive</w>
or li
orli stat
or ized</w>
or ch
opini on,</w>
oper ator</w>
opath ological</w>
op tion.</w>
op soas</w>
op positional</w>
op posit
op am,</w>
oni um)</w>
one- week</w>
one- hour</w>
ond amine</w>
onco genic</w>
on ly).</w>
on fer
on azole-induced</w>
on a</w>
omega- oxidation</w>
omediast inum</w>
ome- encapsulated</w>
omat osis.</w>
om apatrilat</w>
om a-
ole ifera</w>
ol l</w>
ol itis</w>
ol der
ol -associated</w>
off- drug</w>
off ering</w>
ocyn in</w>
ocycl ic</w>
octreoti de.</w>
ocr ypt
och lo
occul ta</w>
occ ured</w>
oc togenari
oc alce
observe d:</w>
observ ational,</w>
obser vers</w>
obser ver
obliter ation</w>
oblast s</w>
ob acill
obacill us</w>
o- t
o- p-dioxin</w>
o vul
o uring</w>
o steron
o rough</w>
o des</w>
o -</w>
nutri tion,</w>
nur ses</w>
nur se</w>
numb ers,</w>
nucleotide- binding</w>
nucle osides</w>
normal- appearing</w>
norm oxic</w>
nor meperidine</w>
non- toxic</w>
non- sustained</w>
non- randomized</w>
non- problematic</w>
non- dopaminergic</w>
non users.</w>
non neoplastic</w>
non ketotic</w>
nomifens ine,</w>
no thing</w>
no se,</w>
nmol/ mg</w>
nmol/ g</w>
nmol/ 0.5</w>
nmol .
nmol ,</w>
nitroprus side-
nitrite- nitrate</w>
nitrit e,</w>
nit ro</w>
nit ric-oxide</w>
nit rates.</w>
nit rate.</w>
nine ty</w>
night- time</w>
nicot inamide</w>
nick- end</w>
nic k</w>
ni p</w>
ng. /ml.</w>
newbor ns.</w>
neutrophil ic</w>
neutr alized</w>
neutr alization</w>
neurotransmit ters,</w>
neurotoxic ,</w>
neuro toxins</w>
neuro steroids</w>
neuro steroid</w>
neuro po
neuro pil</w>
neuro humoral</w>
neuro effector</w>
neuro cardiogenic</w>
neur ally</w>
nephrotoxic ,</w>
nephro tic-range</w>
nephro sclerosis</w>
nephro genous</w>
neoplas m</w>
necrop sied</w>
ne sic</w>
nausea/ vomiting,</w>
narco sis</w>
narc ol
nanop articles</w>
naloxone- reversible</w>
nad olol,</w>
n= 8)</w>
n m</w>
n iz
n a.</w>
n M/
myosi tis,</w>
myopericardi tis</w>
myoclon ic,</w>
myelo mening
myelo ma:</w>
myel ination</w>
mydri atic</w>
mydri asis,</w>
myasthen ia-like</w>
my op
my ogenesis</w>
my ofilam
mutis m,</w>
muscimol- stimulated</w>
mun o</w>
mumol/ L)</w>
multi for
multi f
multi agent</w>
mul tis
muk ul</w>
muc inous</w>
mu g)</w>
msec )</w>
mother ,</w>
mot or,</w>
mos enii</w>
morb ill
morbill iform</w>
monoamine- depleting</w>
monkey s:</w>
mon oneuropathy</w>
mon ocytic</w>
mon ocyte
mon ab
momet asone</w>
molecul e,</w>
modul ator,</w>
moder ate-dose</w>
mode ,</w>
modal ities,</w>
moc k</w>
mo od.</w>
mo -
mmol/ kg).</w>
mm (3)</w>
ml/ min)</w>
ml/ g/
ml -1,</w>
mitoxantr one,</w>
mis use.</w>
mis sed.</w>
minocycl ine,</w>
minim al,</w>
min ation</w>
min :</w>
milrin one-induced</w>
milrin one,</w>
milli ons</w>
mili eu
migra ine-like</w>
midazolam /
microscop e.</w>
micromol/ l.</w>
microliter s/
microliter /
micrograms/d l.</w>
microg/ rat,</w>
microg/ g</w>
micro tubul
micro some</w>
micro g).</w>
micro electrode</w>
micro circulation.</w>
mic ar</w>
mic .</w>
mi anserin,</w>
mg/m2/ day.</w>
mg/kg .
mg/d l).</w>
mg/ min)</w>
mg.kg-1. min-1</w>
mg.kg-1. d-1</w>
mg. ml-1</w>
metrizo ate</w>
metopro lo
methyl- 6,7-dimethoxy-4-
methyl cell
methicill in.</w>
methazol amide</w>
methamphet amine-</w>
meth iodi
meth ane</w>
metaz epam</w>
metast ases,</w>
meta- analyses</w>
mesyl ate,</w>
mesangi um</w>
mesalaz ine.</w>
mes ulerg
mer it</w>
mer cur
meningi oma</w>
men thol</w>
men stru
men s</w>
membran oproliferative</w>
melan oma,</w>
medication- free</w>
medic ines,</w>
medi um-induced</w>
mean ing</w>
me qu
me phenytoin</w>
me phed
maz ind
matur ation,</w>
matri x.</w>
mat ings</w>
mat ch
mat a</w>
marrow -
mar ri
maprotil ine.</w>
manufact ured</w>
mano alide</w>
manipul ation.</w>
manip ulated</w>
manifest ation,</w>
mang iferin</w>
mang anese</w>
man e
mam m
mamm als</w>
male /
mala ox
mal tolyl</w>
maj or
mag na</w>
mag n
macroscop ically</w>
macron odular</w>
macro cytosis</w>
mach ine</w>
macaqu es</w>
ma iled</w>
ma i-
mOsm/ kg,</w>
mL/ 100</w>
mL (-1))</w>
mGluR 5,</w>
mGlu 3</w>
mGlu 2</w>
mEq/ L),</w>
m y</w>
m ide</w>
m ere</w>
m ate</w>
m assi
m AChR</w>
m 2;</w>
lymph oplas
lymph o
lusit ropic</w>
lung s.</w>
lun g.</w>
lum en.</w>
loz eng
lox oprofen</w>
low- potency</w>
lot ec
los ses.</w>
los oxantrone</w>
lor metazepam</w>
lopinavir/ ritonavir</w>
loo king</w>
long- interval</w>
logar ithm</w>
log ram
log 10</w>
loc ate</w>
lo vian</w>
lo cy
liver ;</w>
lith otrip
liter ),</w>
lit re</w>
liqu orice</w>
lipos ome-encapsulated</w>
lipopolysacchar ide-induced</w>
lipid- soluble</w>
lip omatosis</w>
lip ids.</w>
lip -DXR</w>
line -</w>
line )</w>
lin k
limit ,</w>
limb -
like '</w>
like "</w>
lik ely,</w>
lig ation-,</w>
life- year</w>
lif est
lifest y
lidocaine- kindling</w>
li go
li able</w>
level )</w>
leuk ocytosis,</w>
leuc ocyte</w>
leuc o
leu ke
lesion s;</w>
les s)</w>
length -dependent</w>
leiomy osarcom
lef t,</w>
leaf let</w>
lead -induced</w>
lea ve</w>
le xi
laud anosine</w>
later ally</w>
last ing.</w>
lan dic</w>
lamy dial</w>
lamivud ine-treated</w>
lact ulose</w>
lact otroph</w>
lacrim ation</w>
lab ele
l- ephedrine</w>
l ends</w>
l ectin</w>
l b</w>
l ay</w>
l aryn
l (-1)</w>
l 's</w>
kinase- MB</w>
kin ins</w>
kidne y
ket amine-treated</w>
kan zo-
kal a-
kala- az
k ra
k r
k e-
k Pa
justi fied</w>
justi fi
junc tive</w>
junc tions.</w>
judg ment</w>
ju n</w>
jejun um,</w>
j et</w>
iz ation;</w>
iz ation).</w>
iv .</w>
iv ,</w>
itrac onazole,</w>
iti s).</w>
item poral</w>
it y),</w>
it ly</w>
it ation,</w>
it amin
isox azole-
isoxazole- 4-
isopropyl -
isop uleg
isom er.</w>
isol ates</w>
isol ated.</w>
iso volumetric</w>
ism ;</w>
ise thion
is ondamine</w>
is er</w>
irin otecan,</w>
ir besartan</w>
iqu ante
iquante l</w>
iop ent
iod ine
investig ator.</w>
investig ated:</w>
invari able</w>
inv ent
introduc ed,</w>
intrathec ally.</w>
intrastriat ally</w>
intram itochondrial</w>
intrag astr
intragastr ically</w>
intracerebroventric ularly,</w>
intracaver nosal</w>
intrac utaneous</w>
intra- hepatic</w>
intra- CA1</w>
intra operatively</w>
interleukin-1 beta</w>
interest ed</w>
inter oceptive</w>
inter contraction</w>
intensi vi
inten tionally</w>
intelligen ce.</w>
instruc tions</w>
institu tions.</w>
instill ations</w>
instill ation.</w>
instill ation,</w>
inst em</w>
input .</w>
inoc ulated</w>
inoc ula</w>
innerv ation.</w>
innerv ate</w>
initi ally.</w>
inhibit ors
ing er</w>
ing -dose</w>
influ x.</w>
infant 's</w>
inf ul</w>
inf ra-
inexpen sive</w>
ine- sensitive</w>
ine ?</w>
indor amin</w>
ind ine</w>
increas ing.</w>
increas e).</w>
incid ence:</w>
inci pient</w>
incer ta</w>
incap acit
inc urred</w>
in- vitro</w>
in- stimulated</w>
in- patients</w>
in- 3</w>
in yl
in trigu
in stituting</w>
in spir
in spi
in ol,</w>
in dependent.</w>
in apparent</w>
in activating</w>
imple ment
impac ts</w>
immunosuppress ants</w>
immunosuppress ant.</w>
immunore activity,</w>
immunohist ochemical,</w>
immunocyt ochemical</w>
immuno electron</w>
immun operoxidase</w>
immun ogenic</w>
immobil ity.</w>
immobil ity,</w>
immer sions,</w>
imipenem/ cilastatin</w>
imen s</w>
imbal ances</w>
imat inib
imag ery</w>
im possible</w>
im pe
im er</w>
ilo prost</w>
ill in,</w>
ill -
ili rub
ili opsoas</w>
ile ut
il umin
igno red</w>
ifenpro dil,</w>
idi um</w>
idi opath
identifi ed;</w>
identifi ed:</w>
iden tically</w>
ide oxy
ide ally</w>
id y</w>
id um</w>
id aemic</w>
id -treated</w>
ich thyo
ic in-
ic al-
ic -</w>
ic ),</w>
ic "</w>
ib er
ia --
i.v .;</w>
i. c.)</w>
i prone</w>
i on-
i g</w>
i es:</w>
hyster osalping
hypox ia-
hypox anth
hypot est
hypotest osteron
hypophysi al</w>
hypophosphat emia,</w>
hyponat ra
hypomagnesem ia.</w>
hypolip idaemic</w>
hypokal aemia.</w>
hypokal aemia,</w>
hypogly caemia</w>
hypoalbum inemia.</w>
hypo insul
hypo aldosteron
hyperten sion)</w>
hyperphosphat emia.</w>
hyperlipoprote inemia</w>
hypere strogen
hyperbilirub inemia,</w>
hyperalgesi a)</w>
hyper trichosis</w>
hyper tricho
hyper susceptibility</w>
hyper phagia</w>
hyper osmolar</w>
hyper metabolism</w>
hyper locomotion,</w>
hyper gammaglobul
hyper filtration</w>
hyper cellularity</w>
hype rem
hyp ochol
hydroxyl ase-
hydroxy phenyl)-
hydroxy chloroquine-
hydroxychloroquine- plus-
hydrochlorothiaz ide-
hydrochlor ide
hydrocephal us,</w>
hydro bromide</w>
hy aline</w>
hr s,</w>
hr lich</w>
hospital ized.</w>
hospit als,</w>
hormone- releasing</w>
hor ses.</w>
home ostatic</w>
ho we
histor ically</w>
hist amin
high- level</w>
high- amplitude</w>
heterotop ia</w>
heter o
her it
hepat oma</w>
hepar ins</w>
hemorrh ag
hemopty sis</w>
hemo stasis.</w>
hemo philiac
hemo di
hemodi af
hemisphe res.</w>
heat .</w>
health- care</w>
hazar dou
hazardou s.</w>
happ ens</w>
handic apped</w>
hand ling
halothane- adrenaline</w>
haloperidol -</w>
hallucin atory</w>
habit uated</w>
h olic</w>
h MBF</w>
guaneth idine,</w>
gu aifenesin</w>
group s),</w>
gra vis
gra di
gover ning</w>
gol d-induced</w>
glycyrrhiz in</w>
glyceryl trinitrate</w>
glycer in</w>
glyc olysis</w>
glutathi one.</w>
glutam ate-induced</w>
glucuron ide.</w>
glucocorticoid- inducible</w>
gluc arate</w>
glo t
gli oma.</w>
gli oblast
gg ed</w>
genotyp es,</w>
genist ein</w>
gener ations</w>
gener alization</w>
gene- targeted</w>
gender -related</w>
gen ipin</w>
gen dered</w>
geme prost</w>
gell an</w>
ge ometric</w>
gastr in</w>
gast ritis,</w>
ganciclovir ,</w>
gan ax
gamma-glutamyl transferase</w>
gamma- vinyl</w>
gamma- ENaC</w>
gamma ,</w>
gamma )</w>
gall ic</w>
gall bladders</w>
gabapent in,</w>
gaba ergic</w>
ga it,</w>
g/d L.</w>
g out,</w>
g m)</w>
g f
gf 8</w>
g ating.</w>
fund us
function al,</w>
function :</w>
fructose-1, 6-di
front al,</w>
from ,</w>
frequency -dependent</w>
foscarne t.</w>
forty- two</w>
formul a.</w>
follic ulo
fol ia</w>
fol ate-induced</w>
fluphenaz ine,</w>
fluoxet ine-treated</w>
fluoxet ine-
fluorop yrimid
flunitrazep am.</w>
flunitrazep am
flunar izine,</w>
flumazen il-treated</w>
fluctu ation</w>
flo or</w>
flexi on,</w>
flav one</w>
flat ul
flare .</w>
fit ting</w>
fissu re.</w>
first- order</w>
finger- tapping</w>
fing ers.</w>
filament ous</w>
fibron ectin,</w>
fibromy algia</w>
fibro sis;</w>
fibro sis:</w>
fibrin oid</w>
fibrill ation;</w>
fib rates</w>
fi ed,</w>
fi ant</w>
fer rit
fenfluramine- associated</w>
fe w.</w>
favor able.</w>
fai led,</w>
factor- kappaB</w>
fac i
f usion.</w>
f ur</w>
f ine-
f ill</w>
f ed
f acti
f )</w>
exud ate</w>
extub ation,</w>
extravas ation,</w>
extrastimul i</w>
extrapol ation</w>
extran e
extra striatal</w>
exposure )</w>
explo ited</w>
expendit ure</w>
exp ands</w>
exp and</w>
exist s,</w>
exec ution</w>
excit ement,</w>
exci pi
excell ent,</w>
ex port</w>
ex pir
ex on</w>
ex encephaly
evo king</w>
evid ent,</w>
everolim us.</w>
ever y-
eugen ol</w>
eu k
etopo side
ethyl ket
ethyl )</w>
ethoxy qu
ethinylestradi ol/drospirenone</w>
eth idium</w>
estrogen -treated</w>
estradi ol-3-
est rone</w>
esmo lol-induced</w>
escal ation.</w>
es citalopram.</w>
erythrom ycin,</w>
erythe ma.</w>
error s.</w>
ergot oxine</w>
ergot -derived</w>
erg oc
erec tion.</w>
er arch
er a.</w>
equival ents</w>
equival ent.</w>
equip ment</w>
equili bration</w>
equ ine</w>
epinephr ine's</w>
epilep sies</w>
epib atidine</w>
ephed rine-induced</w>
ep s,</w>
ep oxy
ep if
entrop y</w>
enterocol itis.</w>
enter ococcal</w>
enter itis</w>
enta enoic</w>
ent er</w>
ent ate</w>
ent ).</w>
ensu ed.</w>
enroll ment.</w>
enrol led;</w>
enop us</w>
enlarg ement.</w>
enh ar</w>
energe tics</w>
energ etic</w>
endotheli al-
endometri oid</w>
endocardi um</w>
end- of-
end- expiratory</w>
end plate</w>
encephalo pathies.</w>
encephal y.</w>
en il,</w>
en ia</w>
en gendered</w>
en during</w>
en ded.</w>
emphasi zing</w>
emergen cy.</w>
embryo pathy:</w>
em physe
ely x</w>
electrophysi ology,</w>
electrocortico graphic</w>
el uted</w>
el ong
el lo
el apsed</w>
el abor
el ab
elab oration</w>
eight- year-old</w>
eigh ty</w>
eicos ap
eicosap entaenoic</w>
eicos anoids</w>
ei ther.</w>
efficac ies</w>
effect s--
educ ational</w>
edat rexate</w>
ed- release</w>
ed- forward</w>
ed ical</w>
ed ).</w>
ectom ized,</w>
ectom ies,</w>
echocardio gram,</w>
echan ical</w>
early- phase</w>
ear ance</w>
e ties</w>
e ased</w>
e an</w>
e IF
e GFR</w>
dysur ia.</w>
dysur ia,</w>
dysrhyth mia,</w>
dyskinesi a:</w>
dysfunction ;</w>
dys plasia,</w>
dys plasi
dynam ics.</w>
dynam ically</w>
dy serythropoi
dur ation;</w>
duoden um,</w>
du plic
drin ks</w>
dri ve.</w>
dri man
doxo- HF</w>
dow n,</w>
doses ).</w>
dose- rel
dor zolamide/timolol</w>
dopamin ergic,</w>
dop examine</w>
donepez il,</w>
domperid one.</w>
dobutamine- atropine</w>
dobut amine,</w>
do stachys</w>
dizziness /
disulph ide</w>
distor ted</w>
diss ecting</w>
disrupt ing</w>
disru ption.</w>
dispar ities</w>
disp ut
disorient ation.</w>
disorder s:</w>
disease- modifying</w>
discrimin ation.</w>
discour age</w>
discontinu ed;</w>
disap pointing</w>
dis solution</w>
dis satisfaction</w>
dis position.</w>
dis ed</w>
dis close</w>
dis appoint
dis abilities</w>
diphenylhydanto in.</w>
diphenylhydanto in,</w>
dimethyl -1-
dilat or</w>
dilat ing</w>
dil ute</w>
dil ate</w>
dihydroxy vitamin</w>
dihydro folate</w>
dihydro benzofuran-
dihydrobenzofuran- 7-
digit orum</w>
digit alis,</w>
diflun isal</w>
diff use,</w>
diethyl nitros
diet -fed</w>
dic h
dibenz o-p-dioxin</w>
diaz oxide.</w>
diarrho ea.</w>
diaphrag m.</w>
di vision</w>
di oxo-
di ffe
dex fenfluramine.</w>
develop ,</w>
detox ifying</w>
deterior ations</w>
destro yed</w>
desmethyl imipramine</w>
desi rable</w>
desat ur
des-Arg 9-
des methyl</w>
dermat ome</w>
dermat ology</w>
depres sions</w>
depos ited</w>
depolymer ization</w>
depolar ization,</w>
deoxychol ate</w>
deoxy guanosine</w>
denti str
dens ity.</w>
dend rite</w>
denaf il</w>
demyelin ation.</w>
demyelin ation,</w>
deman d.</w>
delta ,</w>
dele tions</w>
del en
degener ate</w>
defici ency
deferen s</w>
defer oxamine,</w>
defer iprone</w>
def ovir
def ec
decom position</w>
decl ined.</w>
decarboxyl ase,</w>
dec or
dec entr
dec el
debul king</w>
death )</w>
death ),</w>
de pot
de mented</w>
de fiant</w>
de al
deal t</w>
de activation</w>
daunorub ic
dapson e-
dac arb
dP/dt max</w>
d- to-
d- PG
d rank</w>
d one,</w>
d al
cytoplas m.</w>
cyto protection</w>
cyclospor ine-
cyclopentyl adenosine</w>
cyclopent olate</w>
cyclohexyl adenosine</w>
cycl ine-induced</w>
cycl ase,</w>
cyano sis,</w>
cyan o-
cut- off</w>
cure tt
cup s/
cul ated</w>
crystall uria.</w>
cryp t</w>
crow ded</w>
cross- over,</w>
cross- linking</w>
cross- fo
cromakal im</w>
cro cin</w>
cri ses</w>
cres cent</w>
creat es</w>
crack- cocaine</w>
cr ush</w>
cr )</w>
covari ates.</w>
countr y.</w>
cou reteral</w>
cortic otrop
cortic ospinal</w>
cortic es,</w>
coron ary,</w>
cor tag
copies/ ml)</w>
coordin ation.</w>
convulsion s)</w>
convuls ants.</w>
conver sely,</w>
controlle d-
contribut ors</w>
contral ater
contempl ating</w>
consul t
construc t</w>
constric tions,</w>
constitu tively</w>
constitu tional</w>
const antly</w>
consider ation.</w>
cons ent,</w>
cong ru
confoun ders</w>
conform ational</w>
confirm ation.</w>
conclu de,</w>
concentration- effect</w>
concentr ation:</w>
con val
con tig
con ference</w>
computer- assisted</w>
compromi se,</w>
complic ates</w>
complex ing</w>
complex -mediated</w>
compens ation</w>
compart ments</w>
comp as
compas sion
comorbidi ties,</w>
comorb idity,</w>
community- based</w>
common ly,</w>
comb ine</w>
com prehen
com position,</w>
com edic
colorect al,</w>
collap sing</w>
collagen -</w>
collag en,</w>
cogniti ve,</w>
cod on</w>
cocci di
cocaine- like</w>
coag ulo
co- transporter</w>
co- infection</w>
co ver</w>
co stly</w>
co st.</w>
co re,</w>
co ordinated</w>
co de</w>
clu b</w>
clofib rate-induced</w>
clo sel
clo r</w>
clinico- pathological</w>
clinic s.</w>
clentiaz em</w>
clear ing</w>
clear -cell</w>
clea ved</w>
classi fication,</w>
cl ue</w>
cl enbuterol</w>
cl au
cl aimed</w>
cit rovorum</w>
cit rat
cister na</w>
cisplatin- containing</w>
cis- platinum</w>
cir cular</w>
cipro fibrate</w>
cilex etil</w>
ciga rette
cid ofovir
ciclo vir</w>
ci ticoline</w>
chron ic-
choreoathe tosis</w>
cholinester ases</w>
cholinester ase,</w>
cholinerg ically</w>
cholinerg ic,</w>
cholester yl</w>
cholecysti tis.</w>
cholecalc ifer
chol era</w>
chol angiography</w>
cho ic
cho anal</w>
chloro form
chlordiazep oxide,</w>
chloralose- anesthetized</w>
chlor isondamine</w>
chlor ide-induced</w>
chl oral</w>
chil les</w>
chemotherap y;</w>
chemot actic</w>
chemo at
chemoat tractant</w>
chemist ries</w>
chemic als.</w>
chemic ally-induced</w>
chem ilumin
chelat or,</w>
chec k
characteris e</w>
char ybdot
ch os
ch im
ch asing</w>
cervic ogenic</w>
cervi x,</w>
certi fied</w>
cerebr al,</w>
cer uloplas
centr ally-
centr al)</w>
cent ).</w>
ceftazidi me</w>
cefoper azone</w>
cefazed one</w>
cefac lor
ce- daily</w>
ce mic</w>
catheter s,</w>
catheter isation</w>
cathep sins</w>
categor ies.</w>
categor ical</w>
categ ories:</w>
catal ase.</w>
catal ase)</w>
catabol ism.</w>
cat ap
cat abolic</w>
castr ation.</w>
casopit ant</w>
case- crossover</w>
cardio- respiratory</w>
cardio pathy</w>
cardio graphy</w>
cardio accelerator</w>
cardic ,</w>
cardia ,</w>
carcinogen ,</w>
carcin ogenesis,</w>
carboplatin- paclitaxel</w>
carboplatin /
carbam yl
car ami
capillari es,</w>
capill ar
cap ture</w>
cannab is,</w>
canc erous</w>
cam pt
calci um/
cal ab
cadher in</w>
ca erulein</w>
ca emia.</w>
c ubic</w>
c rescents</w>
c o</w>
c ing</w>
c GVHD</w>
butam ben</w>
bur sting</w>
bulim ic</w>
build ing</w>
buff er,</w>
bu fur
bu d</w>
bronchodilat ors</w>
brom ide.</w>
bro modeoxyuridine</w>
bro mazepam</w>
brie fl
bree der</w>
breath ing.</w>
breast -
bran ded</w>
brainst em,</w>
brad yp
bot ul
bortezomib -
bone- marrow</w>
blun ts</w>
blu e,</w>
block ;</w>
blind ly</w>
blac k,</w>
bl at
blat t</w>
birth- weight</w>
biphasi c,</w>
bio available</w>
bing e.</w>
bing e-
bim odal</w>
bil at.</w>
bifid a.</w>
bicucul line-</w>
bi polar
bi le,</w>
beta-lact am
beta-galactosid ase</w>
beta-end orph
beta-H SD</w>
beta- amyloid</w>
beta- agonist</w>
beta- adrenoceptor-mediated</w>
beta ,
bet agal</w>
benzyl penicillin</w>
benztrop ine.</w>
benz opyran
benz aprine</w>
ben flu
ben azep
belie f</w>
beg an,</w>
beats/ min
beat /
be vantolol</w>
be statin</w>
be lotec
be ds.</w>
barri ers</w>
baro reflex-mediated</w>
barbitur ates.</w>
bar rel</w>
bambuter ol,</w>
baical ensis</w>
bacter icidal</w>
bacter ia.</w>
bacte remia.</w>
back scatter</w>
bF GF</w>
b t
b out
b ob
b ites</w>
b id.</w>
b arb
b all</w>
b ad</w>
azos ulf
azep ine,</w>
azathiop rine-induced</w>
azathiop r
az imil
az elastine</w>
axon opathy.</w>
ax etil,</w>
awak ened</w>
awa ren
avoide d,</w>
avoid ance.</w>
avi d</w>
av lovian</w>
autop sies</w>
autop sied</w>
autonom ous</w>
auto antibody-positive</w>
auth ors.</w>
aut otrans
au gh
attention- deficit</w>
attempt s,</w>
attach ment</w>
attach ed</w>
atro phy
atro gen
atri enoic</w>
atracuri um,</w>
atipame zole</w>
ation ally</w>
ati ve/
ath ymic</w>
aten olo
ate- specific</w>
ate- adjusted</w>
at us</w>
at tain</w>
at ories,</w>
at omic</w>
asthmatic us</w>
asthmatic s.</w>
ast ronaut
ast e</w>
assay ed.</w>
ass ur
ass antin</w>
asparagin ase</w>
as e-induced</w>
as e).</w>
arvan il</w>
arti fact</w>
arthro scopic</w>
arthralgi as,</w>
arteriol es,</w>
arterio graphy,</w>
arteri al-
arteme ther
arous al.</w>
armament arium</w>
arg ued</w>
areflex ia,</w>
are ol</w>
arbit r
ar rang
ar ra
aqu ap
aquap orin</w>
approxim ated</w>
appropri ate,</w>
appl ied,</w>
apparen t,</w>
app ra
apoplex y.</w>
ap no
aort as</w>
aor to-
anxio gen
antiretrovir als</w>
antipy rine</w>
antipy rene</w>
antioxid ants.</w>
antioxid ant.</w>
antigen s.</w>
anticoagul ants,</w>
anticip ated.</w>
antibody -mediated</w>
anti- nuclear</w>
anti- nociceptive</w>
anti- myeloperoxidase</w>
anti- ischemic</w>
anti- eme
anti- diuretic</w>
anti- convulsant</w>
anti- cocaine</w>
anti- apoptotic</w>
anti- amnesic</w>
anti- TNF-alpha</w>
anti- MPO</w>
anti- L
anti- HIV</w>
anti tus
anti hypercalcemic</w>
anti hyperalgesia</w>
anti dystonic</w>
anti catatonic</w>
anti acetylcholine</w>
antagonist s:</w>
antagonist ).</w>
ant acids</w>
ant -like</w>
ans wer</w>
angiotens in
angio pathic</w>
ang les</w>
ang e</w>
anesthe tic
aneph ric</w>
anem ia;</w>
andro st
anatom y.</w>
anaphyl axis,</w>
analy zes</w>
analy sing</w>
analo g.</w>
an us</w>
an oxia</w>
an encephaly</w>
amyl ase,</w>
amphetamine- like</w>
amphetamine- group</w>
amperoz ide</w>
amp ren
amoxicillin/ clavulan
amoun ting</w>
amino- acid</w>
amino )</w>
amin ophylline
amin obut
amik acin.</w>
amide ),</w>
am ple</w>
am ex
am es
alumin ium</w>
altern ately</w>
alter ation,</w>
alpha- synucle
alpha- subunit</w>
alpha- actin
alpha- EMT
alpha- ,</w>
alpha(2)- adrenergic</w>
alpha 4</w>
allodyn ia/
allo wed.</w>
allergi es.</w>
all y;</w>
alin idine</w>
alfuz osin</w>
alfa- 2
aldehy de-
alcohol ism.</w>
al- prone</w>
al ol-induced</w>
al ol,</w>
al arming</w>
al -related</w>
ail -
agonist ;</w>
aggres sively</w>
aggres si
aggreg ated</w>
aggreg ate</w>
agene sis</w>
ag ulation</w>
ag ing,</w>
ag am
after load.</w>
afflic ted</w>
affin ity.</w>
affin ity,</w>
afferen ts,</w>
aff ir
advis able.</w>
adventi tial</w>
adv ance</w>
adultho od,</w>
adrenocortic otrophic</w>
adrenoceptor- blocking</w>
adren omedullary</w>
adren ergic,</w>
administr ation).</w>
adjust ed-dose</w>
adheren ce.</w>
adhe sion,</w>
adequ ate,</w>
aden otonsill
aden omyo
ade n</w>
addres sing</w>
addi tive.</w>
addi tive,</w>
ad y-state</w>
acut e/
acid- reactive</w>
acid A</w>
acid /
acid -treated</w>
acetyl enic</w>
acetyl codeine</w>
acetyl ators.</w>
accumb al</w>
accru al</w>
acc ess.</w>
ac rine</w>
ac hal
ac char
ac ampros
absc ess.</w>
abol ishes</w>
abol ished.</w>
abil ities,</w>
abdom en.</w>
ab ul
ab sten
a/ Tr
a/Tr an</w>
a ving</w>
a o
a ine-
a f</w>
a etiology,</w>
a defovir
a SAH</w>
a -associated</w>
[corrected ].</w>
[3H] flunitrazepam</w>
[2-(3,4-dichlorophenyl) ethyl]-
[11 C]
[ Mg2+
[ 2,3-
[ 1-1
Zol pidem</w>
Zin c</w>
Zangrad o</w>
Y 2</w>
X enopus</w>
Wilc ox
Wh ole-
Wh at</w>
Wech sler</w>
WR-10 65</w>
WIN 55,212-2</w>
WAY -100
W alk
W MH</w>
W ICH</w>
W D</w>
Vol unteers</w>
Vig il
Ver a/Tran</w>
Ventr ic
Vehic le
Vecur onium</w>
Vas odilat
Vari ation</w>
Val ve</w>
VT ).</w>
VR ).</w>
VPA -treated</w>
VL BW</w>
VG B</w>
V- t
V ic
V c
V O</w>
V M</w>
V IE
VIE W
V 1
Use fulness</w>
Uro lithiasis</w>
Ultrason ographic</w>
UL N</w>
UFP-1 12</w>
UF H</w>
UD S</w>
U/ L)</w>
U- 4
U su
U MB
Trop onin</w>
Triamte rene</w>
Tren delen
Trans mission</w>
Trans forming</w>
Tra it</w>
Thym us</w>
Thromb olysis</w>
Thor acic</w>
Thiaz ide</w>
Thalidom ide-induced</w>
Th orough</w>
Tex as</w>
Te li
Taiw an</w>
Tai pe
Tac rine</w>
TX A</w>
TT S</w>
TR K-
TP E</w>
TN P-
TMP-SM X.</w>
TM J</w>
TJ Ms</w>
TI s.</w>
TI MP</w>
TH A</w>
TGF beta1</w>
TF A-
TE O
TD F</w>
TD 50</w>
TC PO2</w>
TB V</w>
TAS K
TASK -1</w>
TA U</w>
T2 *</w>
T1- weighted</w>
T remor
T ras
T ot
T on
T gR[hAI]
T each
T aste</w>
T ail-
T V
T MTX</w>
T MA,</w>
T D,</w>
T AMI</w>
T )-induced</w>
Symptom s,</w>
Sup plementation</w>
Sulf on
Sulf asalaz
Subj ect
Sub clinical</w>
Streptozotoc in-induced</w>
Ste pwise</w>
Ste ady-state</w>
Spec tr
Spec i
Sp O2</w>
Smad 4</w>
Sle ep
Sixty- eight</w>
Simil arities</w>
Sil ent</w>
Si ri
Shakuyaku- kanzo-
Sh am-
Sem i-
Secon d-
Sci ence</w>
Sch u
Sch iff</w>
Scal e-
SUMMAR Y</w>
ST /
ST ).</w>
SSR I.</w>
SR-141716 A</w>
SR S
SR L,</w>
SR I</w>
SR 1417
SP -induced</w>
SN R</w>
SN A)</w>
SM-58 87</w>
SM IT</w>
SM 1</w>
SL M</w>
SI RM</w>
SI B</w>
SHB G</w>
SGO T,</w>
SERCA 2a</w>
SE VO</w>
SE RT
SERT (+)</w>
SE M
SD Z</w>
SD ),</w>
SC ,</w>
S- 3
S- (-)-
S t</w>
S hi
S ear
S cat
S aw</w>
S SS</w>
S LE.</w>
S LE,</w>
S CBF</w>
S -100</w>
Ry R
Rot aro
Ropi vacaine</w>
Rof ecoxib</w>
Ro enig
Ro 15-4513</w>
Rever sibility</w>
Ret t</w>
Res uscitation</w>
Remoxi pride</w>
Rel apse</w>
Reduc ing</w>
Re y
Re view
Re sistance</w>
Re produc
ROS- mediated</w>
RNA s</w>
RG 13
RE VIEW
RB V-induced</w>
RASSF 1A</w>
RA PA</w>
R- wave</w>
R- mediated</w>
R od
R iz
R ig
R h</w>
R W
R T.</w>
R SD</w>
R P,</w>
R M-
R ;</w>
R /
R (-/-)</w>
Quanti fication</w>
Qo L</w>
QT(F ram
QO L</w>
Q- NO
Q L</w>
Q B</w>
Q /
Pu er
Psych otic</w>
Protoc ol</w>
Prostagland ins</w>
Propofol ,</w>
Pro voc
Pro minent</w>
Pro lifer
Pro gest
Pro arrhythmic</w>
Predic tive</w>
Pot entially</w>
Pop ulation</w>
Po is
Place bo
Pilo t</w>
Pi ribe
Phent olamine</w>
Pharmaceutic als,</w>
Ph ot
Perme ability</w>
Per haps</w>
Pen ile</w>
Patient -controlled</w>
Pati ents,</w>
Pathophysi ology</w>
Parkinson ism,</w>
Par ap
Pap aver
Paclitax el,</w>
Pac ker</w>
Pa inful</w>
PV- immunopositive</w>
PT U,</w>
PT FC</w>
PT D</w>
PRL- secreting</w>
PRL- producing</w>
PNU-159 548</w>
PGE (1)</w>
PF T-
PF (11)</w>
PEP /LVE
PEP/LVE T</w>
PDE 4</w>
PDE 3</w>
PD- deficient</w>
PD N</w>
PD A.</w>
PCR ,</w>
PC r</w>
PB S</w>
PAN- nephrotic</w>
P=0.0 2).</w>
P= 0.01).</w>
P2X (7)</w>
P- 450
P(2 y
P v
P t</w>
P ol
P m(O
P i</w>
P c</w>
P avlovian</w>
P ase</w>
P W</w>
P PA.</w>
P OD
P M/
P ISE</w>
P CO
P 25</w>
P .
Ox ali
Out patients</w>
Ouab ain
Osmo tic</w>
Opio id-induced</w>
Ophthalmo logic</w>
On going</w>
On co
On ce-daily</w>
On -
Octre oti
Occa sion
OBJEC TIVE</w>
OAT- ICH</w>
OA c</w>
O- (2-
O ligo
O ZRs</w>
O PG</w>
O H.</w>
O B</w>
Normoten sive</w>
Nor way</w>
Nor plant
Nitrofur antoin</w>
Nit ro</w>
Nit rendipine</w>
Ninety- one</w>
Nigeri ans</w>
Neph rin</w>
Necro tizing</w>
Nec rosis</w>
Nec rop
Ne bivolol</w>
Nat ural</w>
Nar dostachys</w>
Naprox en</w>
Naltrex one</w>
Na+/ H+</w>
Na+- K+-ATPase</w>
Na(+)/ K(+)-ATPase</w>
Na(+)/ K(+)
Na(+)/K(+) ATPase</w>
NS- CAP</w>
NS VT,</w>
NS F.</w>
NR-AN X-C</w>
NO- synthase</w>
NO- cGMP</w>
NO( x)</w>
NO V
NMD A,</w>
NM S,</w>
NG Cp</w>
ND ST-1</w>
NC SE</w>
NC Q
NA SH
NA .</w>
NA ),</w>
N2 O/
N. OAc</w>
N-nitro sou
N-butyl- N-
N- nitroso-
N- ethyl
N- desmethyl</w>
N- S
N umb
N uclear</w>
N or-
N esac
N ac.</w>
N GF,</w>
N E.</w>
N CPH</w>
Muscim ol</w>
Mus carinic</w>
Mul tivari
MtTW 15</w>
Morph ine-induced</w>
Modafin il</w>
Mit o-
Mipa fox</w>
Mipa fox
Minnesot a</w>
Mill er</w>
Mil k-alkali</w>
Mid odrine</w>
Micro dialysis</w>
Meth ion
Metab otropic</w>
Mes angial</w>
Men ing
Medic ine</w>
Mean while,</w>
Me flo
Man ic</w>
Mal a
MTX- N
MT -
MSX- 3</w>
MR I-
MR -18
MP PA</w>
MMP- 9,</w>
MMP s</w>
MM SE</w>
MM F,</w>
MM ,</w>
MK- 9
MIT O</w>
MI ),</w>
METHOD OLO
MDMA/ THC</w>
MD S-
MD B</w>
MCP -1</w>
MB ),</w>
MA P
MA HA</w>
MA -treated</w>
M/ W
M obitz</w>
M ixed</w>
M ei
M az
M al</w>
M SO
M S)</w>
M PA,</w>
M ODE</w>
M LT</w>
Long- lasting</w>
Loc alized</w>
Limit ations</w>
Li -PC</w>
Lact obacillus</w>
Lact ate</w>
LY2746 14</w>
LY 23
LY23 59
LV -
LT E</w>
LOU/ M/W
LO X</w>
LO CM</w>
LN NA</w>
LMW- GAG</w>
LM s</w>
LID O</w>
LI TE</w>
LF P</w>
LEC TION</w>
LDL- C</w>
LC x</w>
L78 10</w>
L/ min</w>
L-NAME -induced</w>
L-AP 4</w>
L-701, 324</w>
L- tryptophan</w>
L- dopa
L- OH
L- NG-
L- Arg</w>
L- 5418</w>
L- 36
L ou
L PBN</w>
L P-S
L HL</w>
L H.</w>
L D)</w>
L CR
L As</w>
L AD.</w>
L 2,</w>
Kv 3.4</w>
Kine tics</w>
Ket amine,</w>
KR H-
KG )</w>
K er
K en
K anz
K ain
K a
K W</w>
K S</w>
K P
K OP
K O)</w>
K MgC
K F
KF 178
K A,</w>
K (i)</w>
Jerse y</w>
J oin
J T</w>
Ital y</w>
Ital y.</w>
Investig ators</w>
Intra ven
Interfer on-
Initi ative</w>
Inf usions</w>
Indometh acin-induced</w>
Indin avir
Inc ub
In troduction</w>
In testinal</w>
In hal
Immun ostaining</w>
Immun oblo
Imi pen
IT P</w>
IS DN</w>
INTERVEN TION</w>
IN R,</w>
IN H
IN ).</w>
IMP ase</w>
IMP PA</w>
IM L</w>
IL- 2,</w>
II a</w>
IFN- alpha2b</w>
ID .</w>
ICRF-18 7,</w>
IC V-
IC SS</w>
IC RF</w>
IC Ds</w>
I t
I sl
I ron</w>
I on
I lo
I c
I a</w>
I MI</w>
I HC</w>
Hyper tension,</w>
Hyper calciuria</w>
Hyper activity</w>
Hyp om
Hydroxy urea</w>
Hydr alaz
Hoxa 2</w>
Hormon e</w>
Hom er</w>
Histopath ologically,</w>
Hi sian</w>
Hep G2</w>
Hemodi lution</w>
Head -up</w>
He ad</w>
Ha emodi
HV PG</w>
HSP 47</w>
HLA-DR 3</w>
HIV/ HCV-coinfected</w>
HIT T
HE 6
HE6 E
HE6E 7
HD L2</w>
HC V,</w>
HC M</w>
HB V,</w>
HB .</w>
HAT T</w>
H-F ABP</w>
H- graft</w>
H- P</w>
H(3 )-receptor</w>
H(2) O(2)</w>
H s</w>
H TN
H MR-18
H A),</w>
H 76,</w>
H 3-
H 1-receptor</w>
H (3)</w>
H (2)-
Guide lines</w>
Grow th</w>
Grou p,</w>
Gold enhar</w>
Gold blatt</w>
Gol gi
Glybur ide</w>
Glut amic</w>
Glut am
German y,</w>
Gentam icin-induced</w>
Gener ally</w>
Gang li
Gall stones</w>
Gal -1</w>
GYKI- 23</w>
GY /
GTPgamma S</w>
GSK334 429</w>
GS SG</w>
GG T-positive</w>
GFAP- IL6</w>
GF P</w>
GF ),</w>
GA L-
G insen
G inkgo</w>
G est
G entac
G d</w>
G as</w>
G W
G S</w>
G C-
G AM
G )-
Fos -positive</w>
Fore arm</w>
Fluoxet ine,</w>
Fl ud
Fir st
Fin aster
Fibro scan</w>
Fi br
Femal es</w>
Fe der
Fas L</w>
Fas -
Farnsworth -M
Farnsworth-M unsell</w>
FSG HS</w>
FIO 2</w>
FH F,</w>
FE SS</w>
FD A-
FB AL</w>
F- actin</w>
F ur
F rontal</w>
F ri
F ram
F il
F gf8</w>
F el
F av
F OS</w>
F CR</w>
F BF</w>
F =
F 1,6
Exc ess</w>
Ex encephaly</w>
Evalu ations</w>
Eth osuxim
Estim ates</w>
Estim ated</w>
Erythro cyte</w>
Epo R-
Endotheli um-dependent</w>
Endot racheal</w>
Endoc rine</w>
En profylline</w>
Electrocardio graphy</w>
Electro physiology</w>
Eighty- six</w>
Eighty- five</w>
EVIDE NCE:</w>
ER ,</w>
EPO CH</w>
EPO ,</w>
EP s)</w>
EP C</w>
EP (4)</w>
EO s</w>
EMB -induced</w>
EM s</w>
EHX A</w>
EE .</w>
ED (50)
ECE -1</w>
EA E</w>
EA AT3/EAAC
EAAT3/EAAC 1</w>
E217 G</w>
E specially</w>
E sc
E s</w>
E picardial</w>
E jection</w>
E hrlich</w>
E ho</w>
E a
E PA</w>
E M</w>
E I
E BF</w>
E 2-17
Dox il</w>
Dofe tili
Disul fir
Dis soci
Dis semin
Dip yrone</w>
Diff usion-weighted</w>
Diff icul
Diar rho
Diar rhe
Di hydroxy
Dex -induced</w>
Determin ants</w>
Depres sion,</w>
Dep o-
Delta9- TH
Deli berate</w>
Delay ed-onset</w>
Def ects</w>
De pressed</w>
De fin
Datab ase.</w>
Dap tom
DYRK 3</w>
DX R-treated</w>
DTI C.</w>
DP -induced</w>
DO TAT
DO I</w>
DN QX</w>
DM N.OAc</w>
DM CM-induced</w>
DL B</w>
DG Cs</w>
DF X</w>
DF O-
DEX -treated</w>
DE K</w>
DE H
DB U</w>
DB H</w>
DAR PP-
D(2 )/
D ideoxy
D ental</w>
D SE,</w>
D PH,</w>
D M-
D K-35
D GF</w>
D G2</w>
D AIDS</w>
D A)</w>
D 2)</w>
D (1)-
D(1)- like</w>
Cr Cl</w>
Coun ty</w>
Coun cil</w>
Cortic otropin-releasing</w>
Correc tion</w>
Cor ti</w>
Cor ne
Contro l,</w>
Contrast -induced</w>
Concer n</w>
Con tramid</w>
Compar able</w>
Comb inations</w>
Com pulsive</w>
Com mon
Cocaine- exposed</w>
Coca ine,</w>
Co .,</w>
Cl ind
Cis -
Chin a,</w>
Chic ago,</w>
Ch allenge</w>
Centr ally</w>
Ceftriax one-associated</w>
Cef epime</w>
Cd k5</w>
Catech olamine</w>
Cardio respiratory</w>
Cardi oxane</w>
Cannab is</w>
Calcit onin</w>
Ca elyx</w>
Ca CO
Ca /
CYP2D 6.</w>
CYP2D 6
CX7 17</w>
CV PP</w>
CV P</w>
CV ,</w>
CV ),</w>
CS SA</w>
CS F).</w>
CS C</w>
CR F.</w>
CPU 228</w>
CP P,</w>
CP DG2</w>
CP -10
CP-10 1,
COX- 2-
COX -1</w>
COL LECTION</w>
CO RM-
CO ER</w>
CN A)</w>
CM F
CL Z</w>
CL L</w>
CL E</w>
CL 2</w>
CFM- 2</w>
CF SL</w>
CF R.</w>
CE F</w>
CD ZP</w>
CD P-induced</w>
CD 44</w>
CD 1</w>
CC K
CC 1</w>
CA s)</w>
CA T,</w>
CA ST</w>
CA PD</w>
CA B-induced</w>
CA 1.</w>
C57BL/6 J,</w>
C3 H
C- units</w>
C- terminal</w>
C tr
C s/
C rescentic</w>
C re
C old</w>
C il
C ervical</w>
C as
C anc
C T-
C R)</w>
C PA.</w>
C G)</w>
C CL2</w>
C 3.</w>
C 2,</w>
C 1
Bre wer's</w>
BrdU- labeled</w>
Braz il.</w>
Bra instem</w>
BoNT /
Bo wel</w>
Bet ter</w>
Bene fits</w>
Bay K-
Bart ter</w>
Bar re</w>
Bal ti
Baclofen ,</w>
Bac ter
BP H.</w>
BD100 8</w>
BD10 47</w>
BD K</w>
BCN U-exposed</w>
B ul
B rit
B onfer
B ilirub
B X
B UN
B SI
B E-
B E
B CVPP</w>
B CNU
B AM
BAM -1
B 8</w>
B -treated</w>
Azathiop rine-induced</w>
Az U
Atrac urium</w>
Ather osclerosis</w>
Asac ol</w>
App earance</w>
Antin uclear</w>
Anti thrombotic</w>
Antero grade</w>
Ano rex
Angio vist</w>
Anesthe tic</w>
An n
An algesi
Amphet amine-
Amiodar one-associated</w>
Aminoglyco side</w>
Amin o</w>
Alopec ia</w>
Aldo sterone</w>
Al though,</w>
Al a
Air way</w>
Agg ression</w>
Agg ra
Ag on
Ag matine</w>
Afric a,</w>
Adren omedullin</w>
Aden ocard</w>
Addi tive</w>
Ad junctive</w>
Aber rant</w>
Ab bot
ATP- dependent</w>
AT D-treated</w>
AT (1)</w>
AS A)</w>
AS /
AR C</w>
AQP 4</w>
AP I
AP H,</w>
AP 5</w>
AP ),</w>
AOA A.</w>
ANOV A,</w>
AN .</w>
AL F,</w>
AK AP
AID A</w>
AI T</w>
AH F</w>
ADR AC</w>
ADAMTS 13</w>
AD M.</w>
AD M-induced</w>
AD 00
ACTH -</w>
ACEi .</w>
AC (-
AB ,</w>
A/ Org</w>
A- H</w>
A(1) R</w>
A z</w>
A trop
A stro
A muno</w>
A micar</w>
A l</w>
A chilles</w>
A ST
A PD</w>
A O-
A H)</w>
A F,</w>
A AV
A A,</w>
A 5
A 2,</w>
A .
A -related</w>
> 10</w>
= 4</w>
= 3</w>
= 2</w>
</ =</w>
< 70</w>
< 0.0
99 9
93 129</w>
90- min</w>
90 107
90107 A/Org</w>
90 .</w>
9- month-old</w>
9 9.
9 8)</w>
9 7%,</w>
9 5,</w>
9 4.
9 2,</w>
9 +/-1
82.07 15</w>
80 %)</w>
8. 5,</w>
8-hydroxy-2-(di-n-propyl amino)tetralin</w>
8-OHD PAT</w>
8- wk</w>
8- phenyl
8- hydroxy-
8- cyclopentyl
8- amino
8- OH
8 8,</w>
8 77</w>
8 72</w>
8 7-year-old</w>
8 40</w>
8 );</w>
7810 94</w>
78 .</w>
78 %,</w>
75 %.</w>
70 5</w>
7. 8
7. 5-
7- oxo-
7- chloro
7 9%,</w>
7 8)</w>
7 62</w>
7 6)</w>
7 5).</w>
7 4)</w>
7 4%,</w>
7 27
7 26
7 2-
7 1)</w>
66. 7%</w>
61-80 48</w>
60 ;</w>
60 ).</w>
60 ),</w>
6. 4%</w>
6. 1%</w>
6- oxo-
6- /-</w>
6 9,</w>
6 8,</w>
6 8)</w>
6 8%)</w>
6 7),</w>
6 7%,</w>
6 6)</w>
6 44</w>
6 4-
6 3-
6 1,
5alpha- pregnan-20-
5HT 1A</w>
59 +/-
57 9</w>
57 ).</w>
56 999
55 9
55 1</w>
50,48 8H</w>
50 6)</w>
50 5</w>
50 +/-
5. 6%</w>
5-flouro uracil</w>
5-HT1 B/
5,7- DHT</w>
5 75</w>
5 1).</w>
5 0.0</w>
5 -1.
48- week</w>
48 ),</w>
45 ),</w>
40 116</w>
4. 8
4. 5;</w>
4-OH- CB
4- wk</w>
4- month</w>
4- hydroxy-
4- (3-
4, 5,
4 H
4 9,</w>
4 7-
4 7%,</w>
4 5%)</w>
4 40</w>
4 4).</w>
4 39</w>
4 36
4 34</w>
4 31</w>
4 3%,</w>
4 14</w>
4 1),</w>
4 -induced</w>
39. 5</w>
39. 3</w>
36 9</w>
36 %.</w>
36 %,</w>
35 7</w>
35 %.</w>
34 %,</w>
32P-post labeling</w>
30 min</w>
30 366</w>
3. 9%</w>
3. 8).</w>
3. 5)</w>
3. 5%)</w>
3. 4;</w>
3-methoxy-4- hydroxy
3- phenyl
3- nitrotyrosine</w>
3- month-old</w>
3 CR
3 500</w>
3 5.5</w>
3 41</w>
3 4),</w>
3 38</w>
3 34</w>
3 31</w>
3 3.3</w>
3 3%)</w>
3 26</w>
3 23</w>
3 22</w>
3 20/
3 2.6</w>
3 2.3</w>
3 15
3 1.</w>
3 1%.</w>
29 7</w>
29 6</w>
29 5</w>
29 1</w>
29 +/-
28. 7</w>
28. 6</w>
28. 4</w>
28 +/-
26. 6%</w>
26 9</w>
26 2</w>
26 %,</w>
25. 6</w>
25. 1</w>
25 +/-
25 (OH)
24 2</w>
2339 0.</w>
23. 7</w>
23 3</w>
21- item</w>
200 2-
20- 30</w>
20 mg</w>
2.0 5</w>
2. 8;</w>
2. 7;</w>
2. 7).</w>
2. 7%</w>
2. 58</w>
2. 4;</w>
2. 48</w>
2. 32</w>
2. 30</w>
2. 13</w>
2. 1,</w>
2-oxo thiazolidine-
2-chloro deoxyadenosine</w>
2-amino-7-phosphonoheptano ic</w>
2-amino-5- phosphono
2- month-old</w>
2- methyl-6-(phenylethyn
2- hydroxy
2- EE</w>
2- AAF</w>
2,3,4- tetrahydro
2, 6-di
2, 6
2 ],</w>
2 D</w>
2 D6</w>
2 C)</w>
2 2/
2 1st</w>
2 1.7</w>
2 1%,</w>
199 7-
198 9,</w>
198 7.</w>
19. 9</w>
19-00 5</w>
19 ;</w>
19 79</w>
19 70</w>
19 70
17. 7</w>
17 9</w>
17 53
16. 7</w>
16 %).</w>
15 55
15 +/-
15 %),</w>
14. 0</w>
14 C</w>
14 0
1393 17</w>
13. 8</w>
13. 0</w>
13- fold</w>
13- cis-RA</w>
13 5,</w>
12 9/
12 9)</w>
12 5-
12 -1
11. 4%</w>
11- dehydro
10. 3%</w>
10 mg/kg</w>
10 :1</w>
10 9/
10 1)</w>
10 (7)</w>
1/ 2-
1.0 9</w>
1.0 6</w>
1.0 3,</w>
1.0 1-1.
1. 9)</w>
1. 8%,</w>
1. 7-
1. 7,</w>
1. 67</w>
1. 4;</w>
1. 43</w>
1. 3;</w>
1. 23</w>
1. 20</w>
1. 15</w>
1. 14
1. 1.
1- wk</w>
1- day</w>
1- [2-
1- 8</w>
1- (2-
1,8-cine ole</w>
1,25-dihydroxy cholecalciferol</w>
1,25- (OH)(2)
1, 9
1, 600</w>
1 alpha</w>
1 S,3R-AC
1 R</w>
1 A.</w>
1 A)</w>
1 17)</w>
1 (
1 %);</w>
00 1).</w>
0.9 5</w>
0.9 1</w>
0.8 8</w>
0.8 %;</w>
0.8 %.</w>
0.7 ;</w>
0.7 0
0.6 0,</w>
0.4 3</w>
0.2 5)</w>
0.02 );</w>
0.0000 1).</w>
0.00 9).</w>
0.00 3),</w>
0.00 2),</w>
0.0 9
0.0 4),</w>
0.0 27).</w>
0.0 1;</w>
0.0 11</w>
0.0 1-
0. 4).</w>
0. 37
0. 18
0. 12).</w>
0. 10).</w>
0. 1)</w>
0-10 .</w>
0- 2</w>
0 5</w>
/ macrophage</w>
/ benefit</w>
.00 5)</w>
.0 7).</w>
.0 2),</w>
. 8
. 5.</w>
-16 ene-
-10 /
-1 9-
-1 6.
-- an</w>
- D</w>
,000/ cu</w>
, N-
+/-1. 3</w>
+/ -10</w>
+ ),</w>
)- 3-
)- 2</w>
)- 1</w>
(p< 0.001)</w>
(p >
(nACh Rs)</w>
(n= 7)</w>
(n= 15)</w>
(n= 10
(n= 1).</w>
(m ca
(i.c.v .),</w>
(i. c.)</w>
(i NO
(fMR I)</w>
(ara- C)</w>
(acetaminophen )</w>
(Y 56
(V R
(V )</w>
(U K
(TRPV 1)</w>
(TO F)</w>
(TD P)</w>
(T X
(T NF
(T G),</w>
(T F
(T CA)</w>
(T C)</w>
(SPEC T).</w>
(SCL C).</w>
(S NH
(S L
(S CO
(S CH</w>
(S CH
(S AM
(R- R</w>
(R T-
(R S)</w>
(R R),</w>
(R P)</w>
(Par lo
(PV N)</w>
(PR ),</w>
(PG s)</w>
(PE F
(PC R)</w>
(PAN SS)</w>
(PAN S
(P< 0.05</w>
(P< 0.0001)</w>
(P K)</w>
(P CP
(P CO
(P CNA)</w>
(P CI
(P AC)</w>
(P AC
(O CT
(O CD)</w>
(NY HA)</w>
(N e
(N S),</w>
(N P)</w>
(N N
(N K
(N C)</w>
(N AS
(N ,N-
(MT X).</w>
(MT D),</w>
(MM P-
(MM G)</w>
(METH )-induced</w>
(MD MA
(MA P).</w>
(MA DR
(M I),</w>
(M D)</w>
(LMW H)</w>
(LD L-
(L-NAME ),</w>
(L- NOAR
(IT B)</w>
(IQ R</w>
(IC H).</w>
(I (K
(HUS ).</w>
(HIV )-infected</w>
(HIT T
(HIT ),</w>
(HAM- D),</w>
(H b</w>
(H F)</w>
(H CC
(H 2
(GSH -P
(GF R),</w>
(GABA) A</w>
(GABA )-
(GABA (A
(G rade</w>
(G TN
(G GT
(G AD)</w>
(F SG
(ENa C)</w>
(EE G).</w>
(EE G),</w>
(ECo G)</w>
(EC G),</w>
(E m
(E ho</w>
(E T)</w>
(E G
(E 2)</w>
(DM CM),</w>
(DE S)-
(DE NA)</w>
(DE N)</w>
(D ose</w>
(D SE)</w>
(D P)</w>
(D MP
(D G)</w>
(Cy A)</w>
(CY )</w>
(CP Z)</w>
(CK- MB)</w>
(CF R)</w>
(CB F
(C3 H</w>
(C r
(C l
(C a)</w>
(C X
(C DD
(B u
(B W
(B P
(B DNF)</w>
(B CNU
(Am B)</w>
(AT P),</w>
(AT 1)</w>
(AL L).</w>
(A ugment
(A r
(A RB
(A NOV
(A K
(A IM
(A H
(9 9
(9 7.
(9 5)</w>
(9 1</w>
(8. 6</w>
(8 9%)</w>
(7. 6%)</w>
(7 9.
(7 5,</w>
(7 4%)</w>
(7 3</w>
(6 9.
(6 8</w>
(6 7</w>
(6 5.
(6 3%</w>
(6 3%),</w>
(6 0%).</w>
(5F U)</w>
(5-HT ),</w>
(5-HI AA)</w>
(5,7- DH
(5 9.
(5 8</w>
(5 7%</w>
(5 6</w>
(5 1%</w>
(4. 7%)</w>
(4. 0-
(4- amino
(4- D
(4- (2-
(4 9</w>
(4 7.
(4 5%),</w>
(4 4%</w>
(4 1%</w>
(4 %).</w>
(3. 1%)</w>
(3- chloro
(3 9%</w>
(3 4%),</w>
(3 3%),</w>
(3 1%).</w>
(3 1%),</w>
(200- 250</w>
(2. 0-
(2- 8</w>
(2 H)-
(2 A)
(2 8%),</w>
(2 7%).</w>
(2 5/
(2 4-
(2 3/
(2 1.4%)</w>
(2 1%</w>
(2 1%).</w>
(2 0/
(199 5)</w>
(14) C]
(125 )
(10- 300</w>
(1. 4%)</w>
(1. 2%)</w>
(1. 0-
(1- 4</w>
(1 H)-
(1 8/
(1 3
(1 28</w>
(1 23</w>
(1 2
(1 1.3</w>
(1 1%</w>
(0.1- 3</w>
(0.00 3-
(0.0 75</w>
(0. 2
(-1) );</w>
(- -
(- ))</w>
(+)- S</w>
( vehicle)</w>
( urinary</w>
( transient</w>
( tacrolimus)</w>
( superoxide</w>
( saline</w>
( respiratory</w>
( previously</w>
( percentage</w>
( particularly</w>
( nausea,</w>
( most</w>
( modified</w>
( moderate</w>
( lidocaine)</w>
( late</w>
( i.v.),</w>
( early</w>
( drug</w>
( d</w>
( class</w>
( both,</w>
( although</w>
( alpha
( absolute</w>
( above</w>
( L</w>
( F)</w>
( 0.05,</w>
( 0%)</w>
( %</w>
( %
' s,</w>
"high "</w>
"crack "</w>
"atyp ical"</w>
" 2</w>
{ 3-
zop iclon
zonis amide.</w>
zom epir
ziprasid one,</w>
zidovud ine-treated</w>
zicon otide</w>
zero .</w>
zero ,</w>
zalepl on</w>
zalcit abine</w>
z el</w>
ys ms</w>
yrin- G</w>
yr s</w>
yp e</w>
you ths</w>
ym ph</w>
yl-6- AzU
yl-6-AzU d</w>
yl- coenzyme</w>
yl ate.</w>
year s);</w>
yc in-associated</w>
y- like</w>
y rate,</w>
y po
y er</w>
xylaz ine-
x ia,</w>
ww w.
wri th
worth while</w>
work ers.</w>
wor ks</w>
wo od</w>
withdraw als</w>
withdraw al;</w>
wide ,</w>
wh or
wh ol
weight/ day,</w>
weig hed,</w>
week s:</w>
wean lings</w>
weak ening</w>
weak .</w>
we d,</w>
we aring</w>
we an</w>
wave forms</w>
wash es</w>
war tzman</w>
war med</w>
war d,</w>
wall- motion</w>
wal k.</w>
w rist
w ounds</w>
w ire</w>
w ing,</w>
w if
vouc her</w>
voric onazole.</w>
volum es,</w>
viv o-
vitre ous</w>
vit real</w>
viscer a</w>
visc ous</w>
vill i</w>
vigabat r
videotap ed</w>
victim ization</w>
vi sed,</w>
vi al</w>
vi ability,</w>
vesi coureteral</w>
verte bra
ventric ular,</w>
ventric ul
ventric u
ven tions</w>
veloc ity-
veloc ities,</w>
vehicle- controlled,</w>
vehicle /
vehic les</w>
ve- mask</w>
ve dac
ve -like</w>
vasodilat ors.</w>
vasodilat ors,</w>
vasoconstrict or.</w>
vasoconstric tors</w>
vaso relaxant</w>
vasculo genic</w>
variabl es:</w>
vari ance,</w>
valu es),</w>
valpro ate)</w>
valdec oxib</w>
val ve-mask</w>
vagin a,</w>
vacuol es.</w>
v l
v ing.</w>
v asive</w>
v a
v WF</w>
uter i</w>
ut ory</w>
ust at</w>
useful ,</w>
uro logy</w>
urk it
ure mia,</w>
ur onal</w>
ur idine.</w>
ur ide.</w>
ur gence</w>
ur aemia.</w>
ur aemia,</w>
up stream</w>
unusu al.</w>
unpredict ably</w>
univers ally</w>
unit s-
unit ary</w>
unit -
unilater al,</w>
unex plo
under scoring</w>
un treated;</w>
un suitable</w>
un stead
un selective</w>
un resolved</w>
un ds</w>
un diluted</w>
un conscious</w>
un competitive</w>
un coated</w>
un blinded</w>
umab .</w>
um s</w>
ultra- short-acting</w>
ul ty</w>
ul in
uct ured</w>
ub in
ubin ac</w>
u al
u LI
uLI F</w>
tyram ine,</w>
type -
two- way</w>
two- side
two-side d.</w>
two ;</w>
twenty- two</w>
tur t
tur ning,</w>
tun ately,</w>
tumori genicity</w>
tumor- promoting</w>
tubulo pathy</w>
tubulo pathy.</w>
tub es.</w>
tu ate</w>
trypt oline</w>
trough -
trough- concentrations</w>
trop ical</w>
troleandom ycin-induced</w>
troglitaz one.</w>
tris odium</w>
tris mus</w>
tris mus,</w>
tript yl
triple- binge</w>
trifluoper azine</w>
tricycl ics</w>
tricycl ic-induced</w>
tricho tillo
trich rome</w>
tric hom
tric arboxylic</w>
triazolo [1,5-
tri maz
trex ed</w>
trem end
tremend ous</w>
treatment s:</w>
treat s</w>
trazod one-induced</w>
traz ol-induced</w>
transpor ter
transpor ted</w>
transplant ation),</w>
transfer ase-mediated</w>
trans gene</w>
trans for
transfor aminal</w>
trandol april</w>
tramad ol/
trache ostom
trabecul ectomy</w>
trabected in</w>
tra enoic</w>
tr ying</w>
tr ade</w>
tox in-induced</w>
tor r)</w>
top otecan,</w>
top oside</w>
tom e
tome tr
tom a.</w>
tolu ene.</w>
tol azol
to x</w>
to o.</w>
to es</w>
to es.</w>
tive ;</w>
tissue- type</w>
tissu e)</w>
tion "</w>
time- of-
time- intensity</w>
tim ulation</w>
tim plantation</w>
tim es),</w>
til t.</w>
til t-induced</w>
tico -
tic les</w>
tic -associated</w>
ti vely.</w>
ti tu
ti tis</w>
ti tious</w>
ti prenolol</w>
thyrotoxic osis.</w>
thym id
thy mo
thrombocytopenia/ thrombosis</w>
thrombocytopen ia:</w>
thrombocytopen ia)</w>
thromb openia</w>
though ts,</w>
tho se,</w>
thirty- nine</w>
thioph ate</w>
thiop urines</w>
thion amide</w>
thio semicarb
thick ness.</w>
thick ening,</w>
thiazol -4-
thi osulf
thi omal
thi gh
thi am
thermo regulatory</w>
therapy- -a</w>
ther mic</w>
them orrhagic</w>
thalidom ide
thalass aemia</w>
thalam otomies</w>
thalam ic,</w>
th rice-
th ly</w>
th inning</w>
tetrofos min</w>
tetrap are
tetrahydro pyran
tetrahydropyran yl
tetraethyl ammon
tetan y.</w>
tetan us,</w>
test s).</w>
test :</w>
test -positive</w>
test -negative</w>
tert- butyl-
territ ories.</w>
termin ation,</w>
termin ates</w>
terg oline</w>
teratogen ic.</w>
ter pen
terpen oid</w>
tensi le</w>
tenofovir .</w>
tempor ary,</w>
tempo romandibular</w>
tem plate</w>
tem afloxacin</w>
telithrom ycin.</w>
teicoplan in.</w>
te zos
te l-
tel- Ha
te eth
te enth</w>
te a,</w>
taxan es.</w>
tast e,</w>
task ;</w>
target -controlled</w>
tap er</w>
tan g</w>
tailo red</w>
tail ,</w>
tachy phyl
ta il.</w>
t- [35S]
t ude</w>
t s).</w>
t ory</w>
t old</w>
t ann
t all</w>
t al,</w>
system ;</w>
system )</w>
syphil is</w>
synth ase-
syndrome ?</w>
syndrom es:</w>
syncop es</w>
syncop e:</w>
syn echi
symptom atically</w>
sympatho- inhibitory</w>
sympath omime
sympath ectomized</w>
swe et
swallow ing.</w>
sw ine.</w>
suspen sions</w>
suscepti ble.</w>
sur fact
supram axim
supramaxim al</w>
supra physiological</w>
supposit ories</w>
super saturated</w>
sup ine,</w>
sun burn</w>
sumatript an-induced</w>
sulind ac,</w>
sulfox im
sulfinpyraz one</w>
sulfate -17</w>
sulfasalaz ine-induced</w>
sulfasalaz ine,</w>
sulfadoxine- pyrimethamine</w>
sulf oxide,</w>
sulf one</w>
sul prostone</w>
suit ability</w>
suic ide.</w>
suffere rs</w>
suff ers</w>
sufentan il-
succ es
suc tion</w>
substra ins</w>
substitu ents</w>
substanti al,</w>
subst rates.</w>
subst rates,</w>
subject s;</w>
subject s),</w>
subject .</w>
subfiel ds.</w>
subcut aneously.</w>
sub thalamotomy</w>
sub tenon</w>
sub stitutes</w>
sub sides</w>
sub si
sub scales</w>
sub populations</w>
sub conjunctival</w>
su gar
sty rene
stud y).</w>
stud ent</w>
strict ures</w>
stri ps.</w>
streptozotocin- diabetic</w>
strength ens</w>
streng then</w>
streng th.</w>
str ative</w>
str and</w>
stomach s</w>
stoc k</w>
stimul i
stimul ation-
stimulation- evoked</w>
stimul ants,</w>
stiff ness.</w>
stereotax ically</w>
stereospec ific
stent ing,</w>
stent -assisted</w>
stem s</w>
stat in,</w>
star ch
standar d.</w>
stain .</w>
stachy a</w>
st ation
st al
stal k</w>
st age-specific</w>
st age-
sprout ing,</w>
spread ,</w>
spor ts</w>
spondy litis</w>
splen ectomy</w>
spiro cer
spik es,</w>
sphingomy el
sphinc ter
spher oids</w>
spectrophot ometry.</w>
speci es-
speci es
spec tra
spe ed.</w>
spas ticity.</w>
spas ticity,</w>
spas modi
spasmodi c</w>
spar se.</w>
sp ur
sp lot
sough t.</w>
son ogram</w>
somatosensor y-evoked</w>
som e,</w>
solub il
sol id-
sol di
sodium- depleted</w>
sniff ing.</w>
smooth- muscle</w>
smok ing-related</w>
sme ars</w>
slow s</w>
slow ing,</w>
sleep walking</w>
slee ve</w>
skill s,</w>
six fold</w>
sist er</w>
sis "</w>
sirolimus- eluting</w>
sirolim us-treated</w>
single- vessel</w>
single- fiber</w>
sin us,</w>
simple ,</w>
similar ly,</w>
sign als.</w>
sigma- receptors</w>
side- effect,</w>
sib ling
si es,</w>
si a/
shun ting.</w>
shrin k
showe d,</w>
shoul der-
shoulder- hand</w>
shorten s</w>
shorten ing.</w>
short-ter m/
shi p</w>
shi har
shak es,</w>
shad ow
sevent y</w>
ses sion)</w>
seroton erg
ser osal</w>
sequel a.</w>
septi cemia</w>
septi cemia.</w>
separ ating</w>
sep sis-induced</w>
sensori -motor</w>
sensor y,</w>
sensi tive
sens ations.</w>
sem ide</w>
self- report.</w>
self- rating</w>
self- limited,</w>
seleni um-deficient</w>
seizures ).</w>
seiz ing</w>
see king,</w>
see k
sedati ve/
sed ;</w>
sed /
sed/ refractory</w>
secretago gues</w>
second -</w>
se ts.</w>
scre w</w>
scrat ching,</w>
scopol amine),</w>
sclero therapy</w>
sclero sis:</w>
scl areol</w>
scar ring</w>
scann ing.</w>
scan ned</w>
scal e;</w>
scal e),</w>
sc ro
sc he
sc ,</w>
sati va</w>
sati v
sarcom as.</w>
sarcolem ma,</w>
salt- independent</w>
salsal ate</w>
sal ine),</w>
sa ve</w>
sa u
sP120 T</w>
s/ BW</w>
s- rubella</w>
s st
s pot</w>
s in.</w>
s apir
s ant</w>
s ad
s ]),</w>
s G145R</w>
rub idaz
rub bing</w>
rs 6
rs 16
rs16 947</w>
rs 112
rs112 73
rs11273 54</w>
rox ithrom
rot ation.</w>
ross over</w>
rose us</w>
rosace iform</w>
ros ophil
rosophil a</w>
ropivaca ine-induced</w>
ropivaca ine,</w>
romo phthalein</w>
ro se.</w>
riz ona</w>
riz atript
ritonavir -
ritod rine.</w>
ritod rine-induced</w>
risk ),</w>
ript ans</w>
rin ast</w>
rifug ation</w>
rifampic in-associated</w>
rifabut in-induced</w>
ribonucle ase</w>
ri monab
ri es,</w>
ri b</w>
rhabdomy osarcoma,</w>
rh uLIF</w>
rh H
reversib ility.</w>
retur ned.</w>
retro spect
ret ards</w>
resuscit ated.</w>
resul ted.</w>
restric ts</w>
restric tion,</w>
response :</w>
respon dent
respon d.</w>
respectively ].</w>
resp ired</w>
resour ces</w>
resor p
resistance ;</w>
resi sti
reservo ir
rescu e"</w>
res urgence</w>
res thesia</w>
repeti tion</w>
repeated ly.</w>
repair ,</w>
rep titious</w>
reorgan ization.</w>
ren z</w>
ren perone</w>
ren o
remoxipri de,</w>
remodel ing,</w>
remo ves</w>
remifentan il-induced</w>
rema ined.</w>
releas er</w>
relap sed/refractory</w>
relap sed,</w>
rel ent
reinstat ement.</w>
regul ated,</w>
regist ration</w>
region -specific</w>
reflexi ve</w>
refer ring</w>
reduced- function</w>
reduc tion;</w>
reduc tion/
reduc tas
reduc ed-dose</w>
red -dose</w>
recurren ce,</w>
recti fying</w>
recover .</w>
recor de
recor d.</w>
recommend ations,</w>
recommen ded,</w>
recogn ise</w>
receptor- positive</w>
receptor- binding</w>
receptor s:</w>
receptor -like</w>
receptor )</w>
recei ved.</w>
recei pt</w>
rec ted</w>
rec oll
rec apit
rec alcit
recalcit rant</w>
reassess ment</w>
reache d,</w>
re- treatment</w>
re vised</w>
re otide</w>
re mitting</w>
re instituted</w>
re initiated</w>
re infection</w>
re infarction</w>
re formulated</w>
re evaluated</w>
re considered.</w>
re appear</w>
re alized</w>
re activity.</w>
re )</w>
re 's</w>
ratio =
ratio :</w>
rate ;</w>
rata eg
rataeg us</w>
rapid- cycling</w>
rapid -onset</w>
rap idil</w>
raloxif ene,</w>
radio frequency</w>
radical- scavenging</w>
radi us</w>
radi opharmac
raclopri de,</w>
rabb it,</w>
ra ys</w>
ra re
ra j</w>
r-hu EPO</w>
r icul
r as</w>
r amp
r IFN
r FVIIa</w>
r =
quinupristin/dalfop ristin</w>
quinuclid inyl</w>
quinpi role,</w>
quinoxaline-2,3- dione</w>
quin one
quick ly.</w>
questionnai res.</w>
question able.</w>
quarti les</w>
quantit ate</w>
quanti fying</w>
quality-of- life</w>
qual ities</w>
qu oti
qu ili
quili brium</w>
qu at</w>
q d</w>
pyruv ate,</w>
pyram ids</w>
pyr amine</w>
pyeloneph ritis.</w>
py re
py k
pyk notic</w>
pursu it</w>
pur ification</w>
pur ch
punc tuate</w>
pul se-
pul p</w>
pter ygium</w>
psycho therapy</w>
psycho sexual</w>
psycho pathy</w>
psych otri
pseudo ephedrine.</w>
pseud ochol
pseudochol inesterase</w>
prur i
proxim al,</w>
prox il</w>
provo king</w>
provi sion</w>
prototyp ical</w>
proteinur ia:</w>
protein- bound</w>
protein- I</w>
protein ase</w>
prote olytic</w>
prote in-1</w>
prote ases</w>
prot on-
prot ective,</w>
prost ate-specific</w>
prost ,</w>
propyl ]-
propofol-M CT/LCT</w>
propofol- lidocaine</w>
propofol /
propag ation.</w>
propag ated</w>
pron eness</w>
promis ing.</w>
proli gest
progressive- ratio</w>
profoun d,</w>
process ing.</w>
probuc ol.</w>
prob es)</w>
pro- cataleptic</w>
pro viral</w>
pro ves</w>
pro lol,</w>
pro jec
primin g.</w>
primid one.</w>
press urized</w>
present ations,</w>
present ;</w>
prescho ol-
pres ses</w>
pres pec
prespec ified</w>
pregnanc ies.</w>
prednisol one-induced</w>
precurs ors</w>
pre- synaptic</w>
pre- natally</w>
pre- existent</w>
pre pa
pre loaded</w>
pre injection</w>
pre exposure</w>
pre drug</w>
pre dose</w>
pre cautionary</w>
pre admission</w>
praz iquantel</w>
pra vastatin.</w>
pow er,</w>
pow dered</w>
potenti ation.</w>
poster i
post- partum</w>
post- operatively.</w>
post- natal</w>
post- drug</w>
post- SE,</w>
post transfusion</w>
post pacing</w>
post nat
post induction</w>
post dosing</w>
post anesthetic</w>
post -</w>
possib le
posac onazole</w>
pos themorrhagic</w>
porphy r
population- based,</w>
popul ation:</w>
pon s,</w>
polyp epti
polymorph ism,</w>
poly po
poly pharmacy</w>
poly microbial</w>
poly angiitis</w>
poi kilo
podoc in</w>
pneumonia e.</w>
pmol/ mg</w>
pmol/ l</w>
pmol/ l)</w>
pmol/ 100</w>
pmol ,</w>
plo ts</w>
plex us,</w>
plethysmo graphy</w>
ple uro
ple kh
plekh h
plau sib
platelet- rich</w>
platelet- activating</w>
plaqu es.</w>
planne d.</w>
place b
pl ant,</w>
pituit ary.</w>
pit ting</w>
pit falls</w>
pinacidi l-induced</w>
pic ro
physici ans'</w>
physici an's</w>
physi cal
physical ,</w>
photo refractive</w>
photo damaged</w>
phosphor us,</w>
phosphon o-
phospho kinase.</w>
phosphati dyl</w>
phosph o-
phenylethan olamine-
phenylalan ine,</w>
phenyl- N-
phenyl)-4- methyl-
phenyl)- piperazin-1-
phenyl ]-
phenyl ]
phen e-induced</w>
phen e,</w>
phen di
phendi metraz
phen ,</w>
phase- II</w>
pharyng itis</w>
pharmacore sistance</w>
pharmac y.</w>
pharmac ist</w>
ph onic</w>
ph ase)</w>
pg/m L).</w>
pg/ g,</w>
person s,</w>
perphenaz ine,</w>
peris one</w>
peripher al,</w>
perioper atively</w>
perim es
perimes encephalic</w>
pericardi um.</w>
peri adolescent</w>
perg ill
pergill us</w>
perfor ation.</w>
perf usions</w>
perf us
per vasive</w>
per sever
per oral</w>
per ma</w>
peptide- (25-
pentylentetra zole</w>
pentylenetetrazol e,</w>
pentazoc ine.</w>
pentamid ine,</w>
pent enoic</w>
pent a
pem oline-induced</w>
pel let
peg- IFN</w>
peg yl
pedic el</w>
pedic el
pedi atricians</w>
pea k.</w>
pe tr
paw s.</w>
patholog ies,</w>
path ogene
path ogen</w>
patch es.</w>
patch .</w>
patch ,</w>
passive- active</w>
pas ses</w>
parturi ents.</w>
partic ular.</w>
paroxet ine-treated</w>
parkinson i
pariet o-
parieto- occipital</w>
parenchy ma,</w>
parathyroid ectomy</w>
paras ite</w>
parameter ,</w>
paralle ls</w>
paraesthe sia</w>
para dis
paradis cal'</w>
par kin</w>
par asi
parasi tic</w>
par an
par agu
paragu ari
paraguari ensis</w>
papillo ma</w>
papill ae</w>
paper s</w>
paper .</w>
panic ked</w>
panc reas
pan nic
pan ic.</w>
pan ames
pallid um</w>
pall or,</w>
pad .</w>
paclitaxel -associated</w>
paclitaxel -</w>
pa kine</w>
p< 0.05</w>
p< 0.01)</w>
p-coumar ate</w>
p- tyrosine</w>
p- p38</w>
p soas</w>
p s-rubella</w>
p l</w>
p kr
p 35</w>
p 11.
p /
oxygenase- 1</w>
oxy morph
oxy l</w>
oxy ]-
oxotremor ine.</w>
oxotremor ine,</w>
oxopiper azin
oxide- oxygen</w>
oxid ation.</w>
oxid ant
oxalo acetic</w>
oxac tam</w>
ox orubicin</w>
ox it
ow a</w>
overl ap
over load,</w>
over doses.</w>
ov orin</w>
output s</w>
our niqu
oun t</w>
oun is</w>
ou se
ou ma
oter idol</w>
ot rol
ot ax
osteo arthritis.</w>
oste olytic</w>
oste oc
osmolal ities</w>
osi s-like</w>
oscillo metric</w>
oscillat ory</w>
os timul
os m</w>
os in-induced</w>
os in,</w>
os cy
orrho ea,</w>
orph anol,</w>
orig inated</w>
organ ogenesis.</w>
orall y),</w>
or idine</w>
or gement</w>
opyri dine.</w>
optim izing</w>
opre valence</w>
opoi esis</w>
opo sterior</w>
opi om
opiom elan
ophthalmop legia.</w>
oper ate</w>
open ia.</w>
open er</w>
opamid ol</w>
opac ities</w>
op amine</w>
onych omy
ont 's</w>
ongo ing.</w>
oneur ial</w>
one- like</w>
onco logical</w>
onco gene</w>
once- per-
once- daily,</w>
on- line</w>
on ectomy</w>
on ce.</w>
omyeli a</w>
omycin- C</w>
olytic- uraemic</w>
ologist s.</w>
olog y:</w>
olip id</w>
olin -1
oligodeoxy nucleotide</w>
oligo hydramnios</w>
ole- board</w>
ole anolic</w>
ol- mediated</w>
ol ized</w>
ol itan</w>
ol dest</w>
ol d).</w>
ol d),</w>
ol amines</w>
oint ment.</w>
ograph ies</w>
ogen .</w>
ofur anos
offic e-based</w>
of :</w>
ocyto tic</w>
ocur onium</w>
oculo motor</w>
ocom pati
oclon ic</w>
ocil in</w>
ochromocyt oma</w>
ochond ria</w>
ochlo remic</w>
oce les</w>
occur red;</w>
occasion ally,</w>
ocal oric</w>
ocal ci
oc tahydro
oc rom
oc orm
oc ob
oc lo
oc lav
oc er
ob tain
ob romophthalein</w>
ob ia.</w>
ob er
o rous</w>
o proxil</w>
o plasmic</w>
numb er-
number- neede
number-neede d-to-
num eric</w>
novo "</w>
nortriptyl ine,</w>
normother mia</w>
normo kalemic</w>
normal ized,</w>
normal ization.</w>
norm als</w>
noradrenal ine-
nor floxacin,</w>
non- significantly</w>
non- protein</w>
non- nephrotoxic</w>
non- leprosy</w>
non- inferiority</w>
non- inducible</w>
non- enzymic</w>
non- dependent</w>
non- comparative</w>
non- cocaine</w>
non- Q-wave</w>
non surgical</w>
non smoking</w>
non responder</w>
non randomized,</w>
non peptide</w>
non parametric</w>
non irradiated</w>
non aspirin</w>
nom ogram</w>
nodul aris</w>
nocicept ors,</w>
noc ist
no se-
no de,</w>
nmol/min/ gm</w>
nmol/ l</w>
nitros obut
nitroglycer ine.</w>
nitrofuranto in,</w>
nitro- N-nitro
nitro-N-nitro so
nitrit e.</w>
nitraz ep
nimodi pine,</w>
nimesulide-beta-cyclodextr in</w>
nimesul ide-induced</w>
nicot in
nicoran dil,</w>
ng/m L;</w>
ng/m L).</w>
ng/m L),</w>
ng/ mg</w>
ng/ kg</w>
ng/ L;</w>
ng/ 5</w>
new- born</w>
nevirap ine-containing</w>
neutr alizing</w>
neurotransmit ter,</w>
neuron s;</w>
neuron s)</w>
neuro trop
neuro lept
neuro kinin</w>
neuro degeneration,</w>
neur itis.</w>
neur itis,</w>
neur alg
networ k.</w>
nest cage</w>
nes s)</w>
ner stone</w>
ner amex
nephron .</w>
nephrolith iasis:</w>
nephrolith iasis,</w>
neph ritic</w>
neph rin,</w>
neoplas m.</w>
neon ate,</w>
neocortex .</w>
nei gh
nedap l
nedapl atin</w>
necrop sy,</w>
necessit ates</w>
nebul ised</w>
near- normal</w>
ne t
ne doc
nedoc rom
ne ,</w>
narco sis.</w>
nar inone</w>
naph th
naltrex one,</w>
nalox on
nalbuph ine.</w>
nai ve,</w>
nafenop in</w>
n= 8),</w>
n- c
n-c b
n- 6</w>
n ude</w>
n s)</w>
n isoldip
n ine,</w>
n es</w>
n anom
nanom olar</w>
n androlone</w>
n amic</w>
n M.</w>
myoc ells</w>
myo fibroblasts,</w>
myelin olysis.</w>
mye los
myalg ia/
my onec
my ogenic</w>
mutis m.</w>
mut ation,</w>
muscle )</w>
mumol/ mg</w>
mumol/ L.</w>
mum ps-rubella</w>
multivari ate-adjusted</w>
multif ari
multifari ous</w>
multi plex
muc us</w>
moun t</w>
mother -
mosmol/ kg)</w>
mort alized</w>
morphine- 6-glucuronide</w>
morph ometry.</w>
mor ph</w>
month s:</w>
monos perma</w>
mononucle osis</w>
monom ethyl-
monolay er</w>
monocyte /macrophage</w>
mono- infected</w>
mono therapies</w>
monni era</w>
mon telukast</w>
mon ey</w>
molecul are</w>
mol es/
mol ar
mofetil .</w>
modific ations.</w>
mobil ization.</w>
mo tility.</w>
mo st,</w>
mo od-
mmol/ L;</w>
mm 3).</w>
mm 2)</w>
mm ),</w>
mm (3
ml/ min.</w>
ml/ min).</w>
ml. min-1</w>
mix ed,</w>
mitochondri al-
mis sense</w>
mis s</w>
mis leading</w>
mini- pump</w>
min(-1 )).</w>
min or
min -associated</w>
milrin one.</w>
mil itary</w>
mil d;</w>
migraineur s.</w>
migra inous</w>
middle- ear</w>
microscop ically</w>
micromol/ kg</w>
micromol/ L.</w>
micromol/ L,</w>
micrograms/m L.</w>
micrograms/ side)</w>
micrograms/ mouse)</w>
micrograms/ ml).</w>
micrograms/ min</w>
micrograms/ kg;</w>
microgram/ ml)</w>
microg/kg/ day)</w>
microg/ kg.</w>
microg/ 5</w>
microangio pathy,</w>
micro vasculature.</w>
micro stachya</w>
micro gnath
micro V)</w>
micro Eq/
mic onazole</w>
mg/m(2) ).</w>
mg/m l.</w>
mg/kg/ hr</w>
mg/kg )+
mg/d L);</w>
mg/(kg. d)</w>
mg/ week</w>
mg/ l)</w>
mg/ L).</w>
mg. kg/day</w>
mez locillin</w>
methylprednisol one-treated</w>
methylenedi oxy-
methyl atropine,</w>
methy lox
methohexit one.</w>
methodo logical</w>
methemoglob inemia,</w>
methcath inone</w>
methazol amide.</w>
methad one-treated</w>
methad one's</w>
meth iaz
metfor min-induced</w>
mete red-dose</w>
metabol ism:</w>
meta iodobenzyl
met all
metall ic</w>
met -
messen g
mesotheli oma</w>
mesal amine</w>
mes or</w>
merbar one,</w>
ment :</w>
men tions</w>
men tioned.</w>
melphal an.</w>
melaton in-
medic ations;</w>
medic ally.</w>
medetom idine.</w>
mechano- insensitive</w>
mechano- allodynia</w>
mec onium</w>
measure ment
meas l
measl es-
measles- mumps-rubella</w>
me x
me th</w>
me ters</w>
me ter,</w>
me pyramine</w>
me f
mef antr
mefantr ine</w>
me al</w>
matur ity</w>
matric es</w>
mater nally</w>
mas quer
mariju ana-dependent</w>
manson i.</w>
mane b</w>
man ic-like</w>
malathi on</w>
mala oxon</w>
mal function</w>
mal e;</w>
magnitu de.</w>
magnitu de,</w>
macroglobul inemia</w>
mach ines</w>
mac ul
mac hin
mac /
ma )</w>
mL/min/ 1.73</w>
mL/ minute/
mGlu 7</w>
mEq/ liter</w>
mEq/ l</w>
mEq/ l,</w>
mEq/ kg)</w>
m- chloro
m rp2</w>
m oxalactam</w>
m it</w>
m ap
m To
mTo R</w>
m L).</w>
m CPP</w>
m .,</w>
m 's</w>
lyso zym
lymphoplas macy
lymphadeno pathy.</w>
ly sin
ly ),</w>
lu mefantrine</w>
low- birth-weight</w>
low n</w>
loracarbef -treated</w>
lop ent
lop amil</w>
longitud inal,</w>
longer- lasting</w>
long- ter
long us</w>
long er
longer -term</w>
log ists</w>
log ically</w>
log ic,</w>
locy tic'</w>
locomot or-
local ,</w>
loc us.</w>
loc king</w>
loc ations,</w>
lob es,</w>
lo must
lo co
lixim ab</w>
liver s.</w>
liver -cell</w>
lithium 's</w>
lith iasis,</w>
liter ).</w>
lis uride,</w>
linezol id-induced</w>
line arity</w>
lind ers</w>
lin comycin</w>
limit ing,</w>
limb ic,</w>
lim on
ligi ble,</w>
ligh ts</w>
ligh t,</w>
lifesty le</w>
life- saving</w>
lie f</w>
lidoca ine/
libit um.</w>
li tis,</w>
li gam
levonorgestrel .</w>
levodopa/ carbidopa</w>
levodopa -treated</w>
levo simendan</w>
levo bupivacaine.</w>
level and</w>
leupro relin</w>
leuk ostasis</w>
leuk ocytopenia</w>
leuk ocytes.</w>
leuk aemia,</w>
leucovor in,</w>
letharg ic</w>
lethal .</w>
less -
lesion ed,</w>
ler can
lercan idipine</w>
length-of- stay</w>
leng th.</w>
lead -in</w>
latanoprost -
latanoprost- timolol</w>
lat ency
las er-induced</w>
laparo scopy.</w>
lan reotide</w>
lamotrig ine.</w>
lamivud ine-induced</w>
lamin ae</w>
lam b
lagg ed</w>
lad ders</w>
lact ation.</w>
label ing,</w>
l-N NA</w>
l in,</w>
l ax
l aur
l aden</w>
l -</w>
kra in</w>
knock- in</w>
kne es</w>
kn ech
kine tics,</w>
kind ling,</w>
kinase- MM</w>
kilogram ,</w>
kil led.</w>
kidney- transplant</w>
ki ren</w>
kg/ min)</w>
ketorolac .</w>
ketorolac ,</w>
ketocon azole,</w>
ket amine/
kerato pathy</w>
ker t</w>
ke y
ke ph
kallikre in-
kain ate,</w>
kHz ,</w>
kD a,</w>
kD a)</w>
k D,</w>
junc tion,</w>
jun -B</w>
ju ice</w>
jer ky</w>
jeop ardized</w>
jaw -
ization- activated</w>
ix is,</w>
ivoc al.</w>
ity- related</w>
iti s)</w>
it u
it ro
istr y,</w>
istr uctured</w>
ist ing</w>
issu es,</w>
issu ed</w>
isoxsup rine</w>
isob olographic</w>
is ocaloric</w>
is oc
is m)</w>
is ke</w>
is axon
is )</w>
irrit ability.</w>
ir reversible.</w>
ir regularity</w>
ir ing</w>
ir ac
ip sapir
ip ran
iox il
ion s.</w>
investig ators.</w>
invent ory</w>
inv ited</w>
inv alu
invalu able</w>
intub ated,</w>
intro duce</w>
intrapl ant
intraperitone al)</w>
intrac avitary</w>
intra- articular</w>
intra- accumbens</w>
intra- abdominal</w>
intra vitreal</w>
intra renally</w>
intra individual</w>
intoxic ation:</w>
intim ately</w>
interview ing</w>
interval ;</w>
interval -
interval ),</w>
interstiti um.</w>
intermedi olateral</w>
interfer on/
interfer on-induced</w>
intercros s.</w>
inter- individual</w>
inter vie
inter vertebral</w>
inter ru
inter patient</w>
inter nal
inter face</w>
inter cross</w>
intensivi sts</w>
inten sit
integr in-
inte restingly,</w>
insul a,</w>
insuff lation</w>
institution alized</w>
inser ts</w>
input s.</w>
inosit ol,</w>
injur y-induced</w>
injec tion-
inj ure</w>
initi s,</w>
inh abit
ing ,"</w>
infu sion-
influenz a-like</w>
infl icted</w>
infin ity).</w>
infec tion
infarc tion)</w>
infarc tion
infanc y,</w>
inf ran
inf inity</w>
ine- 2-
ine th
ine mia-induced</w>
ine d:</w>
ine ],</w>
ine -1-
induc i
indo bu
indic es,</w>
inclu sions.</w>
inci sion,</w>
in- utero</w>
in- patients.</w>
in- derived</w>
in stitut
in significant.</w>
in sensitivity</w>
in s)</w>
in patients.</w>
in patients,</w>
in ofuranos
in ocyte</w>
in i</w>
in es
in consistently</w>
in conclusive.</w>
in ception</w>
in avian</w>
in attention</w>
in )-induced</w>
in (1-13)</w>
impl an
immunosuppress ant,</w>
immunoprecipit ation</w>
immuno histological</w>
immune- complex</w>
immigr ants</w>
immer sed</w>
imin odi
imidazole- 4-
imid april</w>
ime tics</w>
im purity</w>
im mortalized</w>
illu strative</w>
ili itis</w>
ile um.</w>
il itation</w>
il ),</w>
ifol ia</w>
ific ation,</w>
ifeprist one</w>
ido sis,</w>
idiopath ic,</w>
idine dione</w>
ide- sensitive</w>
id ose</w>
id ine-treated</w>
id anosine</w>
id -</w>
ich -
icalcit ol</w>
ic o</w>
ic aine</w>
ic -related</w>
ic '</w>
iber i
ia -associated</w>
i.t .).</w>
i.p. );</w>
i otrol
i es;</w>
hypox emia.</w>
hypox emia,</w>
hypoton y</w>
hypoten sive,</w>
hypoten sion).</w>
hypopituit ar
hypophys ectomized</w>
hypophy seal</w>
hypop nea</w>
hypoman ia/
hypom ag
hypomag nes
hypocal ci
hypocal caemia</w>
hypo kinetic</w>
hypo function</w>
hypo algesic</w>
hypno sis,</w>
hyperpolar ization-activated</w>
hyperkine sia,</w>
hypercholesterol emic</w>
hypercap nia,</w>
hyperammon aemia</w>
hyper somnolence</w>
hyper responsiveness</w>
hyper responsive</w>
hyper magne
hyper hydration</w>
hyper glyc
hyper acute</w>
hyper activation</w>
hydroxyure a-associated</w>
hydroxyfas udil</w>
hydroxyeicos ate
hydroxyeicosate traenoic</w>
hydroly zed</w>
hydraz ide</w>
hydra ulic</w>
hyd ant
hydant oin
hybridiz ation,</w>
hyalin osis</w>
hyal uron
hr -1</w>
hr ).</w>
howe ver.</w>
hous ing</w>
hospital ized,</w>
hormone- binding</w>
hor se</w>
hor n,</w>
homo sexual</w>
hom olog
hom ogenous</w>
ho locytic'</w>
ho dg
hodg kin
histor ies.</w>
hist ological,</w>
hist olog
hist ochemistry.</w>
hist o
his tid
hippocam pi
hind paw.</w>
hind limbs</w>
hil us,</w>
highligh ting</w>
hid onic</w>
hexa hydro
hex o
heterozyg ote</w>
heterozyg osity</w>
heter ogenous</w>
hepatocell ular-
hepatitis ;</w>
hepat otox
hepat osplen
heparin- coated</w>
hepar in-dependent</w>
hemisphe res,</w>
hemianop ia</w>
hematopoi esis.</w>
hemat oxylin</w>
hemat omas,</w>
hem i-
hel per</w>
heart- to-body</w>
heart- rate</w>
heart beat</w>
heal ing.</w>
headache :</w>
headache )</w>
har maline-induced</w>
hand ling,</w>
halothane/ epinephrine</w>
haloperidol +
half- life.</w>
half- li
haemat uria.</w>
haemat ocrit</w>
ha sten
h op
h ole-board</w>
h CG</w>
h BNP</w>
h .
h -1)</w>
h -
guinea- pigs</w>
guide d,</w>
guan ylyl</w>
guan idine,</w>
group s.(ABSTRACT</w>
group );</w>
gro und</w>
greml in</w>
great er,</w>
gre w</w>
gravis :</w>
grap e</w>
granulo mas.</w>
granulo ma.</w>
grani setron,</w>
gran ulosa</w>
gram -positive</w>
gradu al,</w>
gra ve</w>
gose relin</w>
gonad otroph
gol d-
go it
glycosaminoglyc ans</w>
glyc yl
glyc ol,</w>
glutar ate</w>
glutam yl</w>
glucuron ide,</w>
glucos uria</w>
glucagon .</w>
glomerul us,</w>
glomerul ar,</w>
gli osis,</w>
gl y,</w>
gl ustat</w>
gl ue</w>
gl u
gl c</w>
gir l,</w>
ginsen o
ginsen g,</w>
genotyp e,</w>
gene tics</w>
ge ometry</w>
gati floxacin</w>
gangli osides</w>
gang ren
gamma-glutamyl transpeptid
gamma-glutam yl-
gamma- aminobut
gamma- HCH,</w>
gamma ENaC</w>
gambl ing.</w>
gambl ing,</w>
gall bladder,</w>
galact orrhea,</w>
gadodi amide.</w>
gad oteridol</w>
ga it.</w>
g/d L,</w>
g/d L).</w>
g/ liter</w>
g p)</w>
g ates</w>
g allo
g -1).</w>
fut ure,</w>
fur a-
function ed</w>
full -dose</w>
fu gu
fraction ation</w>
frac tions,</w>
frac tion)</w>
fr uctose</w>
four- month</w>
four th-
fosf amide</w>
foscarne t,</w>
formal in-
form ations</w>
forced- swim</w>
for ti
for ce.</w>
for ce,</w>
follow s.</w>
fol ded</w>
fol d).</w>
fo am</w>
fo am
foam y</w>
flup irt
fluoro meth
fluc onazole,</w>
flu -
flow s,</w>
flow ers</w>
flow )</w>
flick er</w>
flex ure</w>
flash es</w>
fl ash</w>
fl aps</w>
fit ted</w>
first- generation</w>
first -</w>
fir m
fing er
filtr ation,</w>
fill ing.</w>
fig uring</w>
fig ure</w>
fiel ds,</w>
fic ations</w>
fibros ing</w>
fibro blastic</w>
fib rate.</w>
fet u
ferri oxamine</w>
fer oxamine</w>
fenoldop am,</w>
fen amic</w>
fen -
felodip ine.</w>
fel ine</w>
fec al</w>
fe w,</w>
famoti dine.</w>
fal lop
fail ures.</w>
f used</w>
f ]
f VIII</w>
ez ing,</w>
extremit y,</w>
extrap ulmonary</w>
extra- adrenal</w>
extra ocular</w>
exten s
expos ing</w>
explan ation.</w>
exercis ing</w>
exencephal y.</w>
exempl ified</w>
excit otoxicity.</w>
exc rete</w>
exc ess,</w>
exam s</w>
ex o</w>
ex ic</w>
ex haled</w>
ex changes</w>
ex anth
ex act
exact ly</w>
ex .</w>
evid ently</w>
ever y
evalu ations.</w>
evalu ated:</w>
evalu able,</w>
eu volemic</w>
eu ph
etomid ate-
etiolog ies,</w>
ethyl- 5-
ethyl ene,</w>
ethyl )
ethopropa zine,</w>
ethanol -</w>
eth mo
etan idazole</w>
et c.</w>
et c.
et 's</w>
estrogen -dependent</w>
estim ations</w>
est r
est er.</w>
est .</w>
ess ness</w>
esmo lol,</w>
es tic</w>
es otropia</w>
es erine</w>
es citalopram
erythroder ma,</w>
erythro cytic</w>
erythro blasts</w>
erup tions,</w>
erron eous</w>
erron e
errone ously</w>
ergot amine.</w>
erdo steine</w>
eradic ated</w>
er- 344</w>
er tap
er s)</w>
er ian</w>
er a,</w>
equ ation.</w>
ept ors</w>
epoxy eicos
epoxyeicos atrienoic</w>
epinephr ine-treated</w>
epinephr ine)</w>
epileptic ,</w>
epilepsy -related</w>
epidermi di
epider moid</w>
epid urally</w>
epi -
ep och
ep ist
enure sis.</w>
enucle ated</w>
entra in
entr y,</w>
ent ers</w>
ent ail
ent "</w>
eng orgement</w>
ene -1-
endothelin -1,</w>
endothel in-converting</w>
endosulf an</w>
endogen ously</w>
endocrin ological</w>
end otoxic</w>
end oneurial</w>
end olym
end ar</w>
encounte red,</w>
encomp asses</w>
encomp ass</w>
ence -
enantiom ers.</w>
en- 3-
en yl</w>
en velop
en th
en sis,</w>
en qu
en -associated</w>
en )</w>
emo zolom
emerg ed.</w>
embryo .</w>
em ic,</w>
em -
ell ing</w>
ell ed</w>
elimin ated.</w>
electrophysi ological,</w>
electrophore sis,</w>
electromyo graphy.</w>
electrom echanical</w>
electrocortico gram</w>
electrocardio graphy.</w>
electro retin
electro grams</w>
electro des,</w>
electro clinical</w>
ele ments.</w>
el .</w>
el -
eg g</w>
efficaci ous,</w>
effect ing</w>
effect ).</w>
efavi renz
ed- in</w>
ed ?</w>
ect in.</w>
echocardiograph ic,</w>
echocardio grams.</w>
eb selen</w>
ear -
each ;</w>
eIF 2
e- N
e- 1</w>
e uc
e li
dysrhyth mogenic</w>
dysph asia</w>
dysp noea,</w>
dyskine tic,</w>
dysfunction )</w>
dys chromat
dyschromat op
dynorph in(1-13)</w>
dynes/cm 5,</w>
duloxet ine,</w>
drowsin ess.</w>
drow sy</w>
drop s,</w>
drin king.</w>
driman ial</w>
dres sing</w>
dre ams</w>
draw ing</w>
draw bac
dr icaine</w>
dp/dt max</w>
doxorubic in;</w>
doxorubic in-associated</w>
doses ),</w>
dose- escalating</w>
dos age-
dorsal is</w>
dopamine- dependent</w>
dopamine- beta-hydroxylase</w>
dop amine-induced</w>
donepez il.</w>
don ors,</w>
don or.</w>
don or)</w>
dog s).</w>
dofetili de,</w>
do -
dl- propranolol</w>
diver gent</w>
dit e
disten tion</w>
dist ances</w>
disru p
dispar ate</w>
disorgan ization</w>
disorder s;</w>
disease- related</w>
diseas e
dise quilibrium</w>
discus sion.</w>
discrimin ating</w>
discour aged</w>
disc retion</w>
dis section.</w>
dis placing</w>
dis plac
dis oproxil</w>
dis odi
dis figuring</w>
dis appearing</w>
dis advant
dipyridamole- echocardiography</w>
dipyridamol e/
diplop ia,</w>
diphenyl acetoxy-
diphen yl</w>
dimen sions,</w>
dil uting</w>
dil ation.</w>
diisopropyl phosphorofluoridate</w>
dihydro tachy
digitalis -
digit ox
dig estion</w>
difluoro methyl
difficul t-to-
difference ).</w>
diethylcarbam azine</w>
diet s,</w>
dideoxy inos
dichlorodiammine platinum</w>
dichloro diphenyl
dichloro -
dic arbox
dic arb
diast ol
diaphrag m,</w>
diaphore sis</w>
diameter s/BW</w>
di valent</w>
di v
di tion</w>
di thio
di quat</w>
di propionate</w>
di oxide.</w>
di olol</w>
di morphism</w>
di meth
di enes</w>
di encephalon</w>
di acetate</w>
di -
dextror phan</w>
dexamethas one)</w>
develop ed;</w>
dev oted</w>
determin ants.</w>
deterior ate</w>
detail ing</w>
destro ys</w>
desc ent</w>
des pair</w>
des flurane-induced</w>
des butyl
derang ed</w>
depression -related</w>
depress ants</w>
depres si
deple ted,</w>
depend ent)</w>
deoxycorticoster one-
deoxy ribonucleic</w>
dens a</w>
denerv ation,</w>
den ud
den omin
demeclo cycline.</w>
deman d,</w>
delta- aminolevulinic</w>
delta- ALA-D</w>
delta -opioid</w>
deli an</w>
del usions.</w>
defini tion.</w>
def ascicul
decongest ant</w>
decom pression.</w>
decid ing</w>
deci sive</w>
decentr alized</w>
dec line
dec ide</w>
deaf ness,</w>
de st
de sensitized</w>
de l</w>
de ionized</w>
dd Y</w>
dd I.</w>
dd I)</w>
days/ week</w>
daptom ycin.</w>
danger ous.</w>
dam ,</w>
dail y;</w>
da ,</w>
dP/dt max,</w>
dP/dt (max)</w>
dP/dt (max))</w>
dP/d T</w>
dF Urd</w>
d4 T-
d- positive</w>
d- chain</w>
d ronedar
d b</w>
d G</w>
d B.</w>
d .(ABSTRACT</w>
cytox an</w>
cytoplas m,</w>
cytopen ias</w>
cyto static
cyt ometry,</w>
cystometro grams</w>
cystin uria.</w>
cyclo oxygen
cyclo benzaprine</w>
cycl ing.</w>
cycl ic-
cycl ase-
cyan ocob
cur cu
culmin ating</w>
cue- elicited</w>
crystal lization</w>
cryst als,</w>
cryst allo
cry os
criter i
creat ing</w>
cre ation</w>
cre a)</w>
cranios chisis</w>
crani ospinal</w>
cramp ing</w>
cour ses)</w>
couple ts</w>
cough .</w>
cot ton</w>
cost s,</w>
cortis one,</w>
cortis ol
corticoster one,</w>
cortico -
cortex )</w>
correl ates.</w>
correl ated.</w>
cor nerstone</w>
copies/ ml</w>
cop ing</w>
convul sion,</w>
conver ts</w>
controversi es</w>
control s),</w>
contracepti ve,</w>
contra -
contig uous</w>
cont ention</w>
cont act.</w>
constric tions</w>
configur ations</w>
conf ron
condu it</w>
conclu sions.</w>
conclu des</w>
conclu ded,</w>
concept ual</w>
concentration s;</w>
conce pts</w>
con formed</w>
con e</w>
con ception</w>
con cep
compromi sed.</w>
complic ations;</w>
complic ation
comple ment.</w>
compens ates</w>
comparison s,</w>
compar able,</w>
compa red:</w>
comp ut
communic ation.</w>
communic ation,</w>
commun ity.</w>
commun ities</w>
colo ured</w>
collap se,</w>
collag ens</w>
coll ectively</w>
col or
col ic,</w>
col d,</w>
cocaine/ crack</w>
cocaine- primed</w>
co-trimox azole.</w>
co- ordination</w>
co- morbid</w>
co ved</w>
co localization</w>
co b
co al
cm 2)</w>
cm -
clum siness</w>
clu stered</w>
clu ster
closu re,</w>
clorg yline</w>
clon es</w>
clofib rate-treated</w>
clo trimaz
clo sed.</w>
clio quinol
clinicopath ological</w>
clef ts,</w>
clear ances,</w>
cle are
classi fication.</w>
clas ses,</w>
clar ification</w>
clar ification.</w>
clamp ed</w>
cl ub
cl aud
claud ic
cit ric</w>
cisplat inum</w>
cisplat in-</w>
cirrho tics</w>
circuit .</w>
cir cle</w>
cilost azol,</w>
chromat ography,</w>
chro ma
chondro itin</w>
cholinester ase.</w>
cholin omime
cholester ol/
chlorthalid one,</w>
chlorozotoc in.</w>
chlorofluoro carbons</w>
chloro procaine.</w>
chloro procaine,</w>
children )</w>
child bearing</w>
chick en
chemotherapy- related</w>
chemoradi ation</w>
chemic als,</w>
che mon
che d-chain</w>
chang es;</w>
chang es:</w>
chang e:</w>
chamb ers</w>
chamb er,</w>
challenge d.</w>
ch itosan</w>
ch atter
ceruloplas min</w>
ceriv astat
cerebel lo
cephaloth in,</w>
cephalex in</w>
centr al,</w>
cent res.</w>
cellul itis.</w>
cell /
celi ac</w>
cefuro xi
ceftriax one-treated</w>
ceftriax one-dependent</w>
ceftazidi me,</w>
cefotet an,</w>
cefoper az
ceas ed,</w>
ce in</w>
catechol-O- methyltransferase</w>
catap lexy</w>
case- patients</w>
casca de.</w>
cas pofungin</w>
cas ein</w>
cas eating</w>
cartilagin ous</w>
carrageen in-induced</w>
carmo fur</w>
careful ly.</w>
cardiover sion,</w>
cardiomyopath y;</w>
cardiomyo plasty.</w>
cardiomegal y,</w>
cardio selectivity,</w>
carboxyl ate)</w>
carboxamido adenosine</w>
carbox yp
carbim azole,</w>
carbamazepine -10,11-
carb oxy-
carb ocrom
car pi</w>
capt ured</w>
capsaic in-</w>
cap ability</w>
cannul as</w>
cannab idiol</w>
cancer )</w>
calmodul in</w>
calcul ating</w>
calcitri ol-induced</w>
calcific ations.</w>
calab ura</w>
cal losal</w>
cal endar</w>
caffe ine's</w>
ca regi
ca emic</w>
cGM P-
c y,</w>
c ubital</w>
c p
c ),</w>
butyl ]-
but orphanol,</w>
but ano
busulf an,</w>
burn t</w>
bur ns</w>
bur gh</w>
bur g</w>
bur den
buprenorph ine,</w>
bund les</w>
bul l
bul bos
bulbos pinal</w>
buff er.</w>
bucumo lol</w>
bu tr
bu s.</w>
bruc ello
bronchodilat ation</w>
bronch oscopy</w>
bronch o-
brom peridol</w>
bro aden
brie f,</w>
bretyli um,</w>
breath .</w>
breast fed</w>
break fast</w>
brain- barrier</w>
bradykine sia.</w>
bradykin in.</w>
bradycardia ;</w>
brady arrhythmias,</w>
bra ins.</w>
bra in)</w>
boun d
bother some</w>
bone- labeling</w>
bol us)</w>
bol ab
bolab rin</w>
body weight,</w>
bo wel.</w>
bo ur
bo o
blur ring</w>
blood- nerve</w>
blood- flow</w>
blood- brain-barrier</w>
blocker -induced</w>
blockade -induced</w>
block )</w>
bli sters</w>
ble b
blad ders.</w>
blad der
blac k
bl ica</w>
bl an
bivalir udin</w>
bis -
bis (2-chloroethyl)-1-
biperid en.</w>
biperid en,</w>
biosynthe sis.</w>
biosyn thetic</w>
biopsi ed</w>
bioavail ability,</w>
bio active</w>
bin ucle
bili ary,</w>
biguan ides</w>
bige minal</w>
bifid a,</w>
bic ycle</w>
bi as.</w>
beta-H SD
beta-D- glucuronide-induced</w>
beta- glucuronide-induced</w>
beta- blocker.</w>
beta- blockade,</w>
beta- AR</w>
beta- ,</w>
beta(1)- adrenergic</w>
beta ine,</w>
beta 2-receptor</w>
beta 2-adrenoceptor</w>
beta 2
beta 1-adrenoceptor</w>
beta 1,</w>
benzoyl ecgon
benzofur an</w>
benz ene
benign .</w>
benefici al.</w>
ben dazole</w>
belotec an</w>
bed time.</w>
bec lin</w>
bec arn
beat s.</w>
be fun
be ad
bas e/
bas e.</w>
bal ance
bag -
bag- valve-mask</w>
bacterio logical</w>
bacter ia,</w>
back cross</w>
bac illary</w>
bac ill
b.w t.</w>
b w</w>
b out</w>
b on
b lown</w>
b itemporal</w>
b isoprolol</w>
b er's</w>
b ari
aztreon am</w>
azol -induced</w>
azithrom ycin,</w>
ax it
avoid s</w>
autoradi ograph
autoimmun ity.</w>
auto regulation.</w>
autis tic-like</w>
author ities</w>
auth ors,</w>
aus cult
auro thioglucose</w>
atten d</w>
atrogen ically</w>
atri al,</w>
ator vastatin,</w>
ator vastat
atmosph eric</w>
atic a</w>
ati sm
athero thrombotic</w>
athe tosis</w>
ath letes</w>
ate :
at ure.</w>
at tracted</w>
at tainment</w>
aster ixis,</w>
astemiz ole.</w>
associ ations.</w>
asse mb
ass ure</w>
ass ed</w>
ass a
aspir in)</w>
aspir ated</w>
aspi ro
as comycin</w>
arthro gr
arth ria</w>
arterio grams</w>
arterio gram</w>
arteri al
arrest s.</w>
ark in
aria e</w>
ari es,</w>
argatrob an-treated</w>
are :</w>
architect ure.</w>
arabino side
arab inofuranos
ara- C.</w>
ar y;</w>
ar ranged</w>
ar r
ar anthus</w>
aprot in
aprind ine</w>
apri l.</w>
approach ing</w>
approach es,</w>
appro val,</w>
applic ability</w>
appear ances</w>
apparat us,</w>
apomorph ine)</w>
apo E</w>
apne a-
aph rag
ap terin</w>
ap ine.</w>
ao ren
anz aoren
anxiet y/
anxiet y-</w>
antipsycho tic.</w>
antine oplast
antihistamin ics</w>
antihist amines,</w>
antieme tic,</w>
antidepressant -like</w>
anticip ate</w>
anticholinerg ics,</w>
antibacteri als</w>
antiarrhyth mic,</w>
anti-HB c</w>
anti- tumour</w>
anti- nicotinic</w>
anti- neoplastic</w>
anti- human</w>
anti- glomerular</w>
anti- anginal</w>
anti- TCA</w>
anti- Go
anti tumoral</w>
anti myoclonic</w>
anti cardiolipin</w>
anth rene</w>
antero septal</w>
ante mortem</w>
ante grade</w>
antagonist /
answe red</w>
anorex ia.</w>
anomal y</w>
annu ally.</w>
anisocor ia</w>
animal s),</w>
anim al)</w>
angio gram.</w>
angi itis.</w>
anesthesi ologist.</w>
anec dot
ane- treated</w>
and inavian</w>
ance ),</w>
anc y.</w>
anc es)</w>
analy sis:</w>
analgesi c-
anaestheti st</w>
anabol izing</w>
an- 3-
an ia.</w>
an ia,</w>
an hedon
an encephaly.</w>
an amycin</w>
an -associated</w>
an -1,
amrin one,</w>
amplitu des,</w>
amphetamine- evoked</w>
amlodip ine/
amlodip ine.</w>
amiodar one:</w>
amiodar one-treated</w>
aminoind an-1,
aminoglyco side-
aminoacid uria,</w>
amino ]
amin oc
amil ial</w>
amide -associated</w>
am obarbital</w>
am ni
am er
alve us</w>
alve ol
alternati ves.</w>
altern atively</w>
altern ated</w>
alprostadi l</w>
alpha2- isoform</w>
alpha-mang ostin</w>
alpha-amino-3-hydroxy- 5-methyl
alpha-amino-3-hydroxy-5-methyl isoxazole-4-
alpha-amino-3-hydroxy- 5-
alpha-EMT BL</w>
alpha- receptor</w>
alpha- r
alpha- hydroxylase</w>
alpha- chloralose</w>
alpha,beta- amyrin</w>
alpha(1)- adrenergic</w>
alpha (3)</w>
allox an</w>
allodyn ia)</w>
allerg y,</w>
alle lic</w>
all ergen
alk ylated</w>
ali ve.</w>
algor ith
alg ia-like</w>
aler tness,</w>
alendron ate.</w>
alcohol ism,</w>
alcohol -related</w>
alcoh ol-induced</w>
al- body</w>
al so.</w>
al one).</w>
al e,</w>
ak er</w>
aj maline-induced</w>
ai ve</w>
agre es</w>
ago gic</w>
aggres sive,</w>
aggreg ability</w>
agent s;</w>
agent -induced</w>
ag ricul
ag reli
ag mat
ag li
ag eu
af ness</w>
af e
adreno receptors.</w>
adrenal ine-
adrenal ectomy,</w>
adren olytic</w>
adolesc ence</w>
adol ine</w>
admis sions,</w>
administr ations.</w>
adjudic ated</w>
adipos ity</w>
adi one</w>
addi tion.</w>
ad ed</w>
activ ator.</w>
act s;</w>
act in-
acr ylate</w>
acide mia</w>
acid- sensitive</w>
acid otic</w>
achiev able</w>
ache ,</w>
achal ol</w>
acetylmethad ol</w>
acetyl- L-carnitine</w>
acetazol amide-induced</w>
acetate- salt</w>
aceclofen ac</w>
accommod ation</w>
accommod ation.</w>
accid ents.</w>
accent uation</w>
acceler ation.</w>
ac yclic</w>
ac ial</w>
ac her</w>
ac ea</w>
ac cep
abstr acts</w>
abstr act</w>
abrupt ly.</w>
abl act
aband oned</w>
ab u
ab ruption</w>
ab breviated</w>
a- mediated</w>
a- day</w>
a- actin
a use
a ined,</w>
a ic</w>
a emo
a V
a -related</w>
a )
a '</w>
a "</w>
[RR ]</w>
[3H] dopamine</w>
[(2- methyl
[ P
[ NS
[ N
[ K+
[ 9
[ (-)-
Z PI</w>
Yale- New</w>
YM 872</w>
Y- 23
Y-23 ,0
Y et</w>
Y NA</w>
Y AG</w>
X E
Wil li
Wh ole</w>
We gener</w>
Wat ch</w>
Wal den
WH I</w>
WB H</w>
W P</w>
W I)</w>
W AR
W .</w>
Voric onazole</w>
Viusi d</w>
Visc eral</w>
Vigil ance</w>
Vi ol
Vi gi
Ve ter
Vas odilation</w>
Val idation</w>
VT ;</w>
VT ),</w>
VPA -exposed</w>
VPA )</w>
VN B,</w>
VE L</w>
V s</w>
V ital</w>
V inc
V e</w>
V al</w>
V agal</w>
V acu
V P)</w>
V MAT
VMAT 2</w>
V HD</w>
V HD
V FT</w>
V D
V AN</w>
V AL</w>
V AD</w>
V AC
V 2-receptor</w>
Ur ticar
Upjo hn
Uni vers
Unfortun ately</w>
Under lying</w>
Ultrason ography</w>
USP IO
US A</w>
UM- 272</w>
UL- morphine-induced</w>
UL DA</w>
UK- 61,
UD P-
U/ m2</w>
U/ kg)</w>
U- B</w>
U- 900
U- 69593</w>
U- 50,488H</w>
U sers</w>
U reth
U rapidil</w>
U max</w>
U krain</w>
U T</w>
U P</w>
U B</w>
Tur ner's</w>
Tur ke
Tum our</w>
Tro glitazone</w>
Trendelen burg</w>
Trans plant
Tradi tional</w>
Tourette -like</w>
Tor onto</w>
Tob ramycin</w>
Tn T</w>
Time- course</w>
Tim olol</w>
Thom son
Theophyll ine-induced</w>
Tetrac yclines</w>
Tetrac ycline-induced</w>
Test .</w>
Tech ne
Teach ing</w>
Tc- TBI</w>
Taq IA</w>
Ta il</w>
TX A2</w>
TX 14
TX14 (A)</w>
TTP- HUS.</w>
TT X</w>
TRPV 5</w>
TRPV 1
TRK- 820</w>
TR -</w>
TO R)</w>
TO F-
TNF- alpha,</w>
TM T</w>
TJ- 80
TJ s</w>
TH IS</w>
TE s</w>
TE R</w>
TE M</w>
TE M-
TEM- untreated</w>
TD I</w>
TB Z</w>
TAF I</w>
T+ A</w>
T yrosine</w>
T yro
T ween</w>
T sukub
T s</w>
T riptans</w>
T rac
T ourniqu
T et</w>
T emozolom
T el
T UR
T PTD</w>
T OR
T L</w>
T C,</w>
T A)</w>
T ;</w>
T 10</w>
Syn thetic</w>
Sweden ,</w>
Swe et's</w>
Susp ici
Sulf adi
Su anzaoren
Str ong</w>
Str ati
Stere ological</w>
St om
Sr l</w>
Spont aneously</w>
Spectr um</w>
So -1
Slit 2</w>
Sixty- nine</w>
Sing ap
Sil astic</w>
She pherd</w>
Sham- operated</w>
Sh wartzman</w>
Sex ,</w>
Seve rely</w>
Sep ar
Sensor imotor</w>
Sel ection</w>
Seg mental</w>
Schu knech
Sc andinavian</w>
Satis factory</w>
Salmon ella</w>
STZ -treated</w>
ST AT</w>
ST A</w>
SSRI -induced</w>
SSR149744 C</w>
SSR1038 00,</w>
SSR I,</w>
SR BT</w>
SPAR C</w>
SPA D</w>
SP- IR</w>
SP S</w>
SP ),</w>
SO (4)</w>
SN Z
SN FP-
SNFP- VS</w>
SM emb
SL F</w>
SK P</w>
SK -1</w>
SIAD H,</w>
SI S</w>
SI P</w>
SHR SP</w>
SG PT</w>
SE Ps</w>
SE M;</w>
SE M,</w>
SE M).</w>
SCO P-induced</w>
SCN 8A</w>
SCL- 90-
SC- 36
SC T).</w>
SB- 26
SB-26 99
SA H,</w>
S14G- HN</w>
S140 80</w>
S/ HYPOTHESIS:</w>
S tren
S pan
S on
S mac/
S m</w>
S ites</w>
S ine
S hen
S et
S en
S cot
S clero
S chool</w>
S ]</w>
S S-
S ASP</w>
S ACS</w>
S -1</w>
S -145
S (+
Rut land</w>
Roten one</w>
Rotaro d</w>
Roenig k</w>
Ro 436
Ro436 8
Ro4368 554</w>
Risperid one,</w>
Ribavir in-induced</w>
Rest ric
Respon ding</w>
Relationshi ps</w>
Refer ral</w>
Rec re
Rec over
Rec ord
Rec ei
Re ticulo
Re lief</w>
Rat s,</w>
Raniti dine-induced</w>
Rami pril</w>
Rab b
Ra rely,</w>
RVOT- VT</w>
RTI -1
RS NA</w>
RS I</w>
RS B</w>
RO L</w>
RO 15-4513</w>
RN- x</w>
RN A)</w>
RI HA</w>
RI A.</w>
RF S</w>
RB C.</w>
RB C)</w>
RATIONAL E</w>
RAMP 3</w>
RAMP 1,</w>
RA M</w>
RA D</w>
R s,</w>
R ocuronium</w>
R es.</w>
R as</w>
R as
R S,</w>
R RSB</w>
R PL
R PD</w>
R O</w>
R IA</w>
R (-)</w>
Qual it
QT d</w>
QT c-
QT c,</w>
QR :</w>
Q-NO H</w>
Q S
Q N
Q -treated</w>
Pu pil</w>
Psych omotor</w>
Psych i
Pseud o-
Provoc ation</w>
Propran olol-induced</w>
Pro vera</w>
Pro motion</w>
Pro gnostic</w>
Pro convulsant</w>
Pro chlorper
Pro ce
Pri mid
Pri ma
Pres um
Pre medication</w>
Pre emptive</w>
Por t
Poly morphic</w>
Poly morph
Pois son</w>
Pneum on
Platele t-
Picrotox in-induced</w>
Physi ology</w>
Phen procou
Phe ochromocytoma</w>
Pg I2</w>
Person ality</w>
Persist ence</w>
Per ox
Per ception</w>
Per ce
Pent obarbital</w>
Pe liosis</w>
Path ogenesis</w>
Paren teral</w>
Paralle l</w>
Parad oxic
Paracetam ol-induced</w>
Par as
Par ameter
Pa rent</w>
Pa ired</w>
Pa O2/
PV A</w>
PTZ ,</w>
PTH /
PTH/ PTHrP</w>
PT P
PT A-
PRIS .</w>
PR L:</w>
PR L.</w>
PR .</w>
PO M</w>
PO B</w>
PL A/
PIP IDA</w>
PI3K gamma</w>
PI SE.</w>
PH T.</w>
PGE (1)-induced</w>
PG- 9.</w>
PG P
PFT- alpha</w>
PF ),</w>
PE FR</w>
PE ).</w>
PD s</w>
PD GF-
PD G,</w>
PC- SOD</w>
PC ).</w>
PB -
PATI ENT</w>
PA- injected</w>
PA O</w>
PA M</w>
PA )-induced</w>
P=0.0 4).</w>
P< 0.001;</w>
P< .001),</w>
P2X 7</w>
P2X 3</w>
P2- component</w>
P- selectin</w>
P- like</w>
P up
P ro</w>
P reser
P ra
P p
P lo
P imoz
P anax</w>
P amid
P VT</w>
P SV
P S.</w>
P N,</w>
P CP.</w>
P '</w>
Over -
Ovari an</w>
Ov x</w>
Other wise,</w>
Orth otopic</w>
Opio ids</w>
Op tical</w>
Ome prazol
Off spring</w>
Occasion ally,</w>
Obj ect</w>
Ob ser
OR X
OR .</w>
OPID N</w>
OH- H
OH- D(2)</w>
OD N
OD ,</w>
OA E</w>
O- acetyl</w>
O T</w>
O LDA</w>
O 2-</w>
O ).</w>
Nutri tion</w>
Nov a</w>
Norm alized</w>
Norep inephr
Nor inyl</w>
Non- invasive</w>
Non- hematologic</w>
Nit rous</w>
Ninety- two</w>
Ninety- nine</w>
Ninety- eight</w>
Nimesul ide-induced</w>
Nim odi
Nicot inic</w>
Ni acin</w>
Netherland s.</w>
Nephro toxic</w>
Nephro pathy</w>
Neph rosis</w>
Necrop sy</w>
Ne ed
Nd 1-
Na+/ K+</w>
Na+/ K+-ATPase</w>
Na(+) ,
NT D.</w>
NT -3</w>
NS Cs</w>
NR T</w>
NP Y-
NP Y
NO LA</w>
NO C
NMB As</w>
NK H
NK 1,</w>
NK )</w>
NI MO</w>
NI ;</w>
NHE 3</w>
NHE 3,</w>
NF s</w>
NE- ARF</w>
ND PD</w>
NC r
NB IA</w>
NADH- oxidase</w>
NA SH</w>
NA F</w>
N-methyl- N'-
N-methyl-N'- nitro-N-nitroso
N-butyl-N- (4-hydroxybutyl)
N-acetylcyste ine.</w>
N-acetyl procainamide</w>
N-[ (1-
N- type</w>
N- Methyl-
N-Methyl- D-
N- 76
N(G)- nitro-
N ag
N ac</w>
N X</w>
N M</w>
N J
N IC
N HB
N D</w>
N CA
N -</w>
N -13</w>
N (6)-
Myo glob
My algia</w>
Mut ations</w>
Mus culoskeletal</w>
Multivari able</w>
Multi -
Morph ine-
Mor ic
Mon th</w>
Mon ophasic</w>
Mo (t
Mit omycin-C</w>
Midazol am-induced</w>
Micro scop
Micro angiopathic</w>
Mi befradi
MgSO (4)</w>
Mg(2+ )-ATPase</w>
Mg Al</w>
Mg ATPase</w>
Metron idazol
Methion ine</w>
Meth ods</w>
Met -
Mes enteric</w>
Mening itis</w>
Men strual</w>
Medic ation-induced</w>
Me fenamic</w>
Mas seter</w>
Mannit ol-induced</w>
Manifest ations</w>
Man tel-Ha
Mal e,</w>
MTX /
MS SBP</w>
MS A.</w>
MR- 33</w>
MR SA</w>
MR ,</w>
MPT P.</w>
MPO- ANCA,</w>
MN U</w>
MMP- 2,</w>
MMA ,</w>
MIB I</w>
METHOD S/
METH -
ME G</w>
ME .</w>
MDMA -induced</w>
MD P</w>
MD ),</w>
MCP -1
MC L</w>
MAFb x</w>
MA Q-NOH</w>
MA P)</w>
MA 40-
MA /
M. S.</w>
M- 6-
M ifepristone</w>
M e-
M ang
M X
M LM
M J</w>
M I)</w>
M HT</w>
M HC</w>
M FS</w>
M CNS</w>
M 40
M 30</w>
M 2,</w>
M 1-selective</w>
M 1-
Long- acting</w>
LiCl /
Li/ D
Li kert</w>
Li Cl,</w>
Lenal idom
Le u</w>
Le ber's</w>
Lat encies</w>
Lat ano
Labor atories,</w>
Labor ator
LY1418 65</w>
LY 3547
LY 1753
LVE F,</w>
LV O</w>
LT CPP</w>
LT B4</w>
LID s.</w>
LID /
LI TA</w>
LI S</w>
LH- Z
LE VEL</w>
LDL- c</w>
LD .</w>
LA AM</w>
L4- L5</w>
L-NG- nitroarginine</w>
L-Dopa .</w>
L-Dopa -induced</w>
L- thyroxine</w>
L- glutamic</w>
L- dihydroxyphenylalanine</w>
L- ascorbate</w>
L ys
L u
L t
L of
L ign
L as
L RTI
L O</w>
L Na</w>
L Na+
L I-
LI- PILO</w>
L G
L En
L Ca</w>
L AR</w>
L 3-
L 180
L 13
L13 08
L1308 F</w>
L (-1)</w>
Kloth o</w>
Kine tic</w>
Ket anserin</w>
KP 14
KOP- R</w>
KOP r
KF178 37</w>
K1 C-
K- dependent</w>
K ounis</w>
K anamycin</w>
K YNA</w>
K T</w>
K IT
K CD-
K 8/
K8/ K18</w>
K /
K (Na)</w>
Ju venile</w>
Join t</w>
Janu ary,</w>
J cl
Iso v
Iohex ol</w>
Intraven ously</w>
Intracaver nous</w>
Intra thec
Intr insic</w>
Interfer on</w>
Inter ruption</w>
Inter group</w>
Ins1 P</w>
Inhibit ors</w>
Inhal ation</w>
Inflam mation</w>
Inf ection</w>
Indometh acin,</w>
Indin avir,</w>
Indi a</w>
Indap amide</w>
Incub ation</w>
Incl uded</w>
Inc .,</w>
In tub
In os
In do
In bred</w>
Impres sion-
Import ant</w>
Immunocyt ochemistry</w>
Immunoblo tting</w>
Immun operoxidase</w>
Imid az
Ilo prost</w>
Ig M,</w>
Ig A-
Ig A,</w>
Ifosf amide,</w>
IV A</w>
IU/ L.</w>
IU D</w>
IT PA</w>
IS V</w>
IS MN</w>
IS F-induced</w>
IS -
INTERPRETA TION</w>
IN H.</w>
IL -10/
II/ III</w>
II- IV</w>
II b</w>
IGF BP
IE G</w>
ID V
ICV- STZ</w>
IC H)</w>
IC A</w>
I. v.</w>
I- ex
I to</w>
I sch
I rel
I ran
I ox
I lex</w>
I R)</w>
I M,</w>
I E</w>
I B</w>
I AD</w>
I ;</w>
I (f
Hypo the
Hypo kal
Hyper trichosis</w>
Hyper lipide
Hyp oxia</w>
Hyp ocapnia</w>
Hydro cortisone</w>
Hydralaz ine-induced</w>
Hydr alazine</w>
Hg );</w>
Heter ozygous</w>
Hepar in,</w>
Hen le's</w>
Hemo dynamics</w>
Heal th,</w>
Hdac 3</w>
Har ris</w>
Haloth ane-induced</w>
Ha ven</w>
HSP 72</w>
HS- PG</w>
HS V-t
HR CB
HM PAO</w>
HLA-DR 4</w>
HE6E7 T-1</w>
HE S</w>
HE C</w>
HDL- c</w>
HD Cy</w>
HD C.</w>
HD ),</w>
HC T</w>
HC N1</w>
HC A</w>
HC 1</w>
HC ).</w>
HBsAg (+)</w>
HBeAg ,</w>
HB e</w>
HB ).</w>
HA I</w>
H2- blocker</w>
H2 O,</w>
H os
H ong</w>
H ero
H az
H and</w>
H an
H T,</w>
H S.</w>
H PS</w>
H PD</w>
H HE6E7T-1</w>
H A-
H 3
H3 R</w>
H 2,</w>
H (1)</w>
Gynec ologic</w>
Guillain- Barre</w>
Gran ule</w>
Gram ont's</w>
Grad ed</w>
Glyc ine</w>
Glut amine</w>
GluR 2+</w>
Glomerul i</w>
German y)</w>
Gentac oll</w>
Genotyp ing</w>
Gas 6</w>
GW 29
GTN ,</w>
GT P</w>
GSP E
GSH-P x</w>
GS ).</w>
GP I</w>
GHB A</w>
GF R)</w>
GB S</w>
GAP-43- IR</w>
GAD 67</w>
GABA A/
G-6- PD</w>
G- protein-coupled</w>
G s-
G onad
G all</w>
G _
G PT
G Cs</w>
G CV</w>
G CS</w>
G B)</w>
G 1</w>
Fram ingham</w>
Fos- immunoreactive</w>
Form ation</w>
For tunately,</w>
Fol ate</w>
Fn 14</w>
Flut amide</w>
Flup irtine</w>
Fluores cein</w>
Flun arizine</w>
Fisch er-344</w>
Finaster ide</w>
Fifty- eight</w>
Fib rosis</w>
Fi ve-
Fdd A</w>
Fav orable</w>
Fam ily</w>
Fallo t</w>
Fac ilitation</w>
FV B/
FR1736 57</w>
FL U
FL I</w>
FK506- associated</w>
FH F.</w>
FGIN -1-
FGIN-1- 27</w>
FEV 1,</w>
F1,6 BP</w>
F/Y56 7
F undus</w>
F ru
F lo
F linders</w>
F ish</w>
F en-
F e</w>
F c</w>
F amilial</w>
F al
F ZP</w>
F Z,</w>
F VII
F SRS</w>
F SH,</w>
F S
F PZ</w>
F MF</w>
F M</w>
F HR</w>
F DP</w>
F CH
F -1</w>
Exer ci
Ex tended</w>
Ex cl
Evalu ating</w>
Ev oked</w>
Europ e.</w>
Euro s</w>
Etom id
Eti ology</w>
Eti ologic</w>
Ethosuxim ide</w>
Estrogen -induced</w>
Estradiol -17</w>
Er b
Equ al</w>
Epidemio logic</w>
Enter ococcus</w>
Enoxapar in</w>
Endothel in-1</w>
End- systolic</w>
En viron
Em pir
Electroencephalo graphy</w>
Eighty- two</w>
Eighty- four</w>
Echocardi ogram</w>
EV L</w>
ET (B
ESR S</w>
ES O</w>
ES M</w>
EP SC</w>
EP M</w>
EP .</w>
EM E</w>
EM ,</w>
EE ,</w>
ED L</w>
ED 50s</w>
ECG s.</w>
ECG s,</w>
EC TS</w>
EC S.</w>
EC S-induced</w>
EC OG</w>
EC D</w>
EB +
E2-17 G</w>
E18. 5.</w>
E- /-</w>
E vol
E very</w>
E toposide</w>
E topo
E to</w>
E qui
E pac</w>
E dition</w>
E dema</w>
E X</w>
E S:</w>
E S)</w>
E PO)</w>
E LITE</w>
E AA</w>
E ;</w>
E 40
E (GABA)</w>
Dyst onic</w>
Dys k</w>
Drug -associated</w>
Doppl er-
Diure tic</w>
Dissemin ated</w>
Disopyram ide-induced</w>
Dis cri
Dis charge</w>
Dipyridam ole-
Diphenyl hydantoin</w>
Diphenyl hydanto
Digit alis</w>
Dig ox
Differen ti
Diaz emul
Diarrho ea</w>
Di valproex</w>
Di urnal</w>
Di rected</w>
Dex verapamil</w>
Dex -
Determin ing</w>
Des ferrioxamine</w>
De le
De anol</w>
De afness</w>
Dar k</w>
Daptom ycin</w>
Dantrol ene</w>
DZ R,</w>
DY N</w>
DX NP</w>
DT PA-
DT I</w>
DT C</w>
DS M</w>
DP ).</w>
DOX Y</w>
DOPAC ,</w>
DO TA</w>
DO PS</w>
DN G</w>
DN .</w>
DM 235</w>
DL PFC</w>
DH A-
DENS PM</w>
DC X-
DARPP- 32</w>
DA- 8
DA B</w>
DA -1</w>
D2- like</w>
D-Trp-6- LHRH</w>
D- glutam
D- MED</w>
D- AMPH</w>
D(2)- like</w>
D x
D ur
D up
D uct
D ry</w>
D rosophila</w>
D im
D idanosine</w>
D ams</w>
D SE.</w>
D S,</w>
D L</w>
D KA</w>
D IA</w>
D CA</w>
D BP
D -1
D (3)
D (2),</w>
Cyclophosph amide,</w>
Cyc les</w>
Cy A/
Cy A.</w>
Cult ured</w>
Cs A-</w>
Convul sive</w>
Consci ousness</w>
Conf idence</w>
Concer ning</w>
Con clu
Competi tion</w>
Col umb
Cocaine- dependent</w>
Coca ine's</w>
Coc k
Co hort</w>
Co agulation</w>
Co A-
Clo mipramine</w>
Clo fibrate-induced</w>
Clind amycin</w>
Clin ic,</w>
Citalopram -induced</w>
Ciprof loxac
Cimeti dine-induced</w>
Chol inesterase</w>
Chlorprop amide-induced</w>
Chloro quine-induced</w>
Chlor promaz
Chlor hexidine</w>
Check list</w>
Ch ina</w>
Ch .</w>
Cephal oridine</w>
Cent res</w>
Cefotet an-induced</w>
Caucasi ans</w>
Cath aranthus</w>
Carb oxyp
Car mo
Capsa icin,</w>
Califor nia</w>
Calcineur in-inhibitor</w>
Ca2+ -
Ca(2+)- dependent</w>
Ca(2+)- ATPase</w>
CYP2D6 *
CYP2C 9
CYP1A 2*
CYP1A2* 1
CYP 3A</w>
CYP 1A2</w>
CY P-
CY P,</w>
CX- 397</w>
CTR -treated</w>
CSF Q</w>
CS D</w>
CRL R,</w>
CRF (1)</w>
CP EC</w>
CO PD.</w>
CO 2.</w>
CO ,</w>
CNSB 002</w>
CN )</w>
CM V-
CL P</w>
CL 218
CI- AKI</w>
CI- 779</w>
CI MD</w>
CI :
CI (95)</w>
CHF 3
CH P</w>
CH C</w>
CGS 216
CGI- SF</w>
CGI- S</w>
CFU- GM</w>
CF M-1</w>
CF B</w>
CE S-
CE Q</w>
CE ,</w>
CD8 32</w>
CD-8 32</w>
CD 34
CD 154</w>
CD 11
CD ,</w>
CD ).</w>
CD ),</w>
CCR 9</w>
CCR 3</w>
CCK- 8</w>
CC O</w>
CC K</w>
CB A</w>
CB (1)
CAD O</w>
CA VB</w>
CA RV</w>
CA P+
CA N</w>
CA 1-3</w>
CA )-
C57BL/ 10
C3H/ He
C ys</w>
C rossover</w>
C rac
C ra
C oxibs</w>
C ost</w>
C n</w>
C leveland</w>
C inc
C Z
C RE
C PA-induced</w>
C MT
C IC
C E)</w>
C CN
C CI</w>
C CI-779</w>
C 3,</w>
Bu pivaca
Bu erg
Bre ak
Bost on</w>
Bonfer ron
Bis phosphonates</w>
Beta- blockers</w>
Benz tropine</w>
Be h</w>
Bcl-x (L)</w>
Bax ter</w>
Bar nes</w>
Baclofen -induced</w>
BZD /
BZD/ RD</w>
BW ,</w>
BUd R</w>
BR L
BP N</w>
BP ).</w>
BM Cs</w>
BL- 3
BL-3 45
BID ,</w>
B- 6</w>
B v
B ran
B os
B lu
B lack</w>
B end
B atter
B asi
B NP)</w>
B N</w>
B K
B HR</w>
B ER</w>
B EP</w>
B Ch
B CAA</w>
B 2)</w>
B 2
B -related</w>
B (2)</w>
Avy/ A</w>
Audi ometric</w>
Ator vastatin</w>
Aspir in-induced</w>
As pergillus</w>
As p</w>
Aro clor</w>
Arg entine</w>
Arac hidonic</w>
Ara U</w>
Ara G</w>
Ar ticles</w>
Appeti te</w>
Apomorph ine,</w>
Ap paren
Antim al
Antidepress ants</w>
Anti emetic</w>
Ann ual</w>
Angi osarcoma</w>
Angel man</w>
Anaesthe ti
An der
Amphet amine-induced</w>
Amph oB</w>
Ammon ia</w>
Americ a,</w>
Am rinone</w>
Am B,</w>
Alpha- lipoic</w>
Allo pregnanolone</w>
Allo P</w>
Albumin uria</w>
Al er
Al anine</w>
Ak t,</w>
Aggra vation</w>
Age -matched</w>
Ag itation,</w>
Ag ents</w>
African- Americans</w>
Adrenoc eptor</w>
Adrenal ectomy</w>
Administ ering</w>
Ad ol
Ad .
Acetazol amide-induced</w>
Acceler ation</w>
Aca demic</w>
Ac tu
Ac tivated</w>
Ac cur
Ab s</w>
Ab )</w>
AV P)</w>
AUC -1/
AT T-
AS 2-
AS2- 1</w>
AS +
AR N-
AQ P-2</w>
API SE,</w>
ANCA ).</w>
AN P.</w>
AN A</w>
AMPH /
AMP H-
AMLE t</w>
AM PA-
AM P,</w>
AM /
ALN+ D28
AL F.</w>
AKAP 150</w>
AI S</w>
AI R</w>
AED s,</w>
AE s)</w>
AD OR
ACTH .</w>
ACEA -10
ACE Is</w>
ABI-00 7</w>
A-3 17
A-317 491</w>
A- 8
A- ->
A wake</w>
A tax
A st
A sp
A sia.</w>
A rizona</w>
A pr
A po
A my
A long</w>
A j
A becarn
A TION</w>
A O</w>
A G)</w>
A ECM</w>
A E)</w>
> 300</w>
> 1</w>
= 60</w>
= 20</w>
= 10</w>
= "
< or=
< 50%</w>
< 40</w>
< 2</w>
< 0.001)</w>
< .05)</w>
: YAG</w>
: ICR</w>
: 1)</w>
: 00,</w>
99mTc- glucarate</w>
99mTc- PIPIDA</w>
99m Tc</w>
99 ;</w>
95% CI</w>
90 ,
9 33</w>
9 11</w>
9 -1.
86 44.</w>
838 36
83836 E</w>
829 58</w>
80 /
80 %.</w>
8. 5+/-
8. 4
8. 25</w>
8. 0%</w>
8-cyclopentyl -1,3-dipropyl
8-OH-DPA T,</w>
8- year</w>
8- week-old</w>
8- 243</w>
8 9,</w>
8 8%,</w>
8 6.7</w>
8 6%,</w>
8 5%,</w>
8 4),</w>
8 3%,</w>
8 2,</w>
8 1%,</w>
8 %-
7315 a</w>
70 ),</w>
7. 7%</w>
7. 6%</w>
7- hydroxy-
7 F/Y567
7 7.
7 44</w>
7 3.
7 14</w>
7 14
7 1.4%</w>
7 0/
7 0%)</w>
67 %.</w>
6. 6,</w>
6. 2%</w>
6-keto- prostaglandin</w>
6- wk</w>
6- dimethyl
6 9).</w>
6 8).</w>
6 7;</w>
6 7)</w>
6 64</w>
6 5%,</w>
6 2)</w>
6 1)</w>
6 0.5</w>
6 %);</w>
5HT 3</w>
5826 1,</w>
57 ;</w>
57 %,</w>
56 %).</w>
55 ,9
50 6,</w>
50 48
50 1</w>
5. 6,</w>
5. 6%,</w>
5. 5%,</w>
5. 4%</w>
5-bromo uracil</w>
5-bromo -2'-
5-HT(2 A/
5-F U-
5- point</w>
5- microm</w>
5- lipoxygenase</w>
5- ISMN</w>
5- CHO-
5- 9
5- 25</w>
5- 20</w>
5'- dFUrd</w>
5 mg</w>
5 Y</w>
5 :
5 4-
5 1,</w>
5 1
486 92</w>
48 1</w>
45 -1
400 %</w>
40- minute</w>
40 4</w>
40 30
4030 W
40 %).</w>
4. 9
4. 4%</w>
4. 4%)</w>
4. 0-
4-OH-CB 107</w>
4-Cl-BZ T</w>
4-4 602</w>
4- dichloro
4, 6-
4'- iodo-
4 9.</w>
4 8)</w>
4 7.5</w>
4 60</w>
4 5.9</w>
4 4-
4 4),</w>
4 4%,</w>
4 3,</w>
4 3),</w>
4 2.</w>
4 2.7</w>
4 2.5</w>
4 2).</w>
4 2
4 1%.</w>
4 1%).</w>
4 0.3</w>
4 0.0%</w>
4 +</w>
39. 2</w>
39 9</w>
3839 3,</w>
38. 9</w>
38. 8</w>
38. 5</w>
38. 5%</w>
38 8</w>
38 %,</w>
38 %).</w>
3784 9.</w>
36. 4%</w>
36 00</w>
35 9</w>
35 +/-
34 4)</w>
31 P</w>
300 ,000</w>
30 8</w>
30 36
30 1</w>
30 ,000</w>
3. 5-
3. 4-
3. 4
3. 36</w>
3. 32</w>
3. 25</w>
3. 0).</w>
3. 0%</w>
3- methoxy-
3- hydroxylase</w>
3- OH
3,4- dihydro
3, 7
3',5'- T2</w>
3' U
3 x
3 alpha-
3 MA</w>
3 H]
3 65</w>
3 5).</w>
3 43</w>
3 4.6</w>
3 3%),</w>
3 29</w>
3 1;</w>
3 11</w>
3 1.6</w>
3 00-mg</w>
3 0.6</w>
3 -1.
29. 6</w>
29 6
29 %);</w>
28 th</w>
28 8</w>
27 80</w>
27 7</w>
27 %),</w>
26. 8</w>
26 %.</w>
25- hydroxyvitamin</w>
25- 75</w>
25 7</w>
24. 3</w>
24 ;</w>
24 9</w>
24 0-
23390 -induced</w>
23. 6</w>
23. 4</w>
23. 3</w>
23 3
23 2
23 /
23 ,8
23,8 84</w>
23 ,
21. 4%</w>
200-1 10</w>
200 7)</w>
20- year</w>
20 :1</w>
20 8</w>
20 8-243</w>
20 7</w>
20 -</w>
20 +</w>
20 +/-
2.0 2</w>
2. 96</w>
2. 94</w>
2. 75</w>
2. 7,</w>
2. 6;</w>
2. 5;</w>
2. 52</w>
2. 5).</w>
2. 4%)</w>
2. 35</w>
2. 3%,</w>
2. 15</w>
2. 00</w>
2-oxothiazolidine- 4-
2-chloroproca ine-
2-chloro -
2-amino-4- phosphon
2- selective</w>
2- minute</w>
2- mg/kg</w>
2- en-VPA</w>
2- acetylaminofluorene</w>
2- [
2- CADO</w>
2,3, 4,
2,2, 2-
2, 5-di
2',3'- dideoxyinosine</w>
2 B)</w>
2 6-week</w>
2 25-
2 20
2 2.7</w>
2 2.0</w>
2 2%).</w>
2 14</w>
2 1.6</w>
2 1-</w>
2 0.7</w>
2 '
2 %);</w>
1alpha- OH-D(2)</w>
1S,3R-AC PD</w>
199 9-
199 1,</w>
199 0
198 9.</w>
198 7,</w>
198 3,</w>
198 0,</w>
196 6-
19. 8</w>
19 9</w>
19 76</w>
19 71</w>
19 68</w>
19 *
19 %.</w>
19 %),</w>
18. 3</w>
18. 0</w>
18- month-old</w>
18 8</w>
17. 2</w>
16. 9</w>
16. 6%</w>
16. 0</w>
16 0)</w>
150 ;</w>
15. 4%</w>
15. 2%</w>
15 d-PG
142 801</w>
14- fold</w>
14 :00</w>
13 th</w>
13 640</w>
13 00</w>
13 0/
13 ,
13 %.</w>
13 %)</w>
125I- labeled</w>
120- min</w>
12 h</w>
12 S</w>
12 54</w>
12 -</w>
12 %.</w>
12 %),</w>
11. 8%</w>
11. 1%</w>
11 %),</w>
100- mm</w>
100- fold</w>
100,00 0).</w>
100 ),</w>
10-1 4</w>
10- month</w>
10(9)/ L,</w>
10 5
10 (3)</w>
1/ 3</w>
1/ 35</w>
1/ 2-year-old</w>
1/ 2,</w>
1.5- 3</w>
1.3 2,</w>
1.0 ;</w>
1. 9-
1. 9%,</w>
1. 77</w>
1. 72</w>
1. 70</w>
1. 7%,</w>
1. 61</w>
1. 5-1
1. 5%,</w>
1. 5%)</w>
1. 45</w>
1. 41</w>
1. 38</w>
1. 36</w>
1. 25-
1. 24</w>
1. 14</w>
1. 11</w>
1. 1,</w>
1-des amino-8-D-
1-1 4</w>
1- month-old</w>
1- 4,</w>
1- ,</w>
1, 5
1, 4
1, 000/
1 h.</w>
1 a
1 B
000 ,000</w>
0.9 2).</w>
0.9 1,</w>
0.9 0
0.9 ).</w>
0.8 ;</w>
0.8 9</w>
0.8 +/-
0.7 9</w>
0.7 3,</w>
0.6 5,</w>
0.6 1,</w>
0.6 -1.
0.5 ;</w>
0.5 ),</w>
0.4 8,</w>
0.4 5,</w>
0.2 1).</w>
0.01 ).(ABSTRACT</w>
0.000 1;</w>
0.00 9),</w>
0.00 7</w>
0.00 5,</w>
0.00 5%</w>
0.00 2,</w>
0.00 ).</w>
0.0 9).</w>
0.0 8).</w>
0.0 4,</w>
0.0 2;</w>
0.0 11).</w>
0.0 1.</w>
0.0 0</w>
0.0 ,</w>
0. 7-
0. 6-
0. 6)</w>
0. 39
0. 25-
0. 24
0. 2)</w>
0. 19,</w>
0. 17,</w>
0. 12)</w>
0. 10
0- 4</w>
0 :
0 ,
0 %.</w>
/ low</w>
/ cm2</w>
/ O
/ METHODS:</w>
/ HC
/ 24</w>
.000 1)</w>
.00 00
.0 4)</w>
.0 25)</w>
. 9
. 5</w>
. 3.</w>
-1-piperazin yl]
-1- phenyl-
-1 9</w>
-1 99
-1 7-
-1 500</w>
-1 5.
-1 25
-1 200</w>
-- in</w>
-- case</w>
- log</w>
- F
- C</w>
- 50</w>
- 0.4</w>
,8 72</w>
+/-1. 9</w>
+/-1. 7</w>
+/-1 4</w>
+ BZ</w>
). m(2)
)- resistant</w>
)- ,</w>
(v /
(p Hi
(n= 2),</w>
(n =</w>
(max ).</w>
(m -
(gamma- hexachlorocyclohex
(dd C)</w>
(chi 2=
(Z D
(Y56 7F/Y567
(Y MR
(X 2</w>
(WH O</w>
(W or
(W R
(W I)
(W A
(V P-1
(V P
(V F).</w>
(UD CA)</w>
(Taxotere )</w>
(TR I)</w>
(TNF- alpha)</w>
(TMP-SM Z)</w>
(TI N)</w>
(T ype</w>
(T W
(T SH)</w>
(T NS
(T J
(T AS
(T -
(SSR I),</w>
(SNP s)</w>
(SNP )-induced</w>
(SHR ),</w>
(SB P),</w>
(S)-4 C3H
(S TR
(S NA
(S LE).</w>
(S D:</w>
(S BP</w>
(S AP)</w>
(S AL
(S .</w>
(RO S),</w>
(RB F)</w>
(R I)</w>
(Q o
(Parlo del
(Pa CO2</w>
(PTU )-induced</w>
(PR C)</w>
(PGE (2))</w>
(PF C)</w>
(PE P)</w>
(PAR P)</w>
(PAN ),</w>
(P= 0.4
(P= .00
(P< 0.001</w>
(P< 0.0001).</w>
(P v
(P f
(P S)</w>
(P ON
(P MS
(P H)</w>
(P D),</w>
(P >0.05).</w>
(OPID N)</w>
(O TC)</w>
(O S)</w>
(O Cs)</w>
(NT -
(NT )</w>
(NSAID s),</w>
(NR H)</w>
(NO x)</w>
(NO S),</w>
(NO ).</w>
(NMD A),</w>
(N .</w>
(MPTP)- lesioned</w>
(MPT P)</w>
(MM I)</w>
(MK-80 1,</w>
(ME S),</w>
(MD MA,</w>
(MD MA)</w>
(MB C)</w>
(MA BP</w>
(MA BP)</w>
(M VO
(M PE
(M M),</w>
(M I
(M DD).</w>
(M CA),</w>
(LVE F),</w>
(LID s)</w>
(LID ),</w>
(L- dopa
(L- AP
(L PS)</w>
(L HR
(L H)</w>
(L 1-
(K i=
(K O)</w>
(K D)</w>
(IL -1
(IFN- alpha)</w>
(IC H),</w>
(IC )</w>
(I GF
(HD MTX)</w>
(HC Q)</w>
(HBsAg )-positive</w>
(H T)</w>
(H T
(H S)</w>
(H P
(H E)</w>
(H C).</w>
(H AT
(H AL
(GSH-P x)</w>
(GP x)</w>
(GABA A)</w>
(G CS)</w>
(G BM
(G AD
(Fish er's</w>
(FANF T)</w>
(F R
(F G
(F =
(ER P)</w>
(ED (50)
(EC T).</w>
(E n
(E RP
(E O
(E M)</w>
(Dox )</w>
(Del ta</w>
(DX R
(DSM- III-
(DO CA)-
(DM I)</w>
(DL B)</w>
(DF P).</w>
(DB S)</w>
(D TIC)</w>
(D PO
(D MT
(D M</w>
(Clin or
(Clin icalTrials.gov</w>
(CY P).</w>
(CR s)</w>
(CO 2)</w>
(CF U-
(CD 50)</w>
(CB 1)</w>
(C al
(C R</w>
(C PT)</w>
(C IP)</w>
(C HC).</w>
(C CK
(C AM
(C 57
(BPR S)</w>
(B ZD
(B P</w>
(B O
(B K)</w>
(B Ch
(AMP H)</w>
(AD C)</w>
(AD ).</w>
(ACTH )-induced</w>
(A ra
(A c
(A b
(A R)</w>
(A PT
(A PO
(A AP
(A -
(A (2A)
(99 m
(9 7%)</w>
(9 3.3%)</w>
(9 -
(9 ),</w>
(9 %).</w>
(8. 2</w>
(8 9</w>
(8 7.
(8 4%</w>
(8 0%</w>
(8 ),</w>
(7 9%</w>
(7 50</w>
(7 5-
(7 4</w>
(7 4%</w>
(7 3%</w>
(7 1%),</w>
(7 0-
(6. 5%</w>
(6. 0</w>
(6 9%),</w>
(6 7.
(6 7%</w>
(6 4%</w>
(6 4%),</w>
(5. 0%)</w>
(5-HT )
(5 8%</w>
(5 8%),</w>
(5 6%).</w>
(5 5%),</w>
(5 3</w>
(5 3.
(5 0.0</w>
(4. 6</w>
(4. 4</w>
(4 9.
(4 7%</w>
(4 5%</w>
(4 3%</w>
(4 3%).</w>
(4 3%),</w>
(4 1.
(4 ))</w>
(3. 8</w>
(3- 4</w>
(3 7%</w>
(3 6%).</w>
(3 5%</w>
(3 5%),</w>
(3 3.3%)</w>
(3 2%</w>
(3 2%),</w>
(3 0-1
(3 '-
(2. 6</w>
(2. 4%)</w>
(2- Cd
(2- 4</w>
(2 9/
(2 80</w>
(2 8
(2 60</w>
(2 6%).</w>
(2 6%),</w>
(2 6
(2 3%</w>
(2 2%).</w>
(2 1)</w>
(2 1%),</w>
(2 00,</w>
(2 0.8%)</w>
(2 -10</w>
(2 );</w>
(2 )/
(1: 1)</w>
(16. 7%)</w>
(125) I]
(10 mg/kg,</w>
(1/ 2)</w>
(1. 25
(1. 00
(1. 0,</w>
(1- 30</w>
(1- 2</w>
(1 6/
(1 45</w>
(1 35</w>
(1 29</w>
(1 22</w>
(1 1.5</w>
(1 %).</w>
(0.001- 0.1</w>
(0.0 8</w>
(0.0 6</w>
(0. 63</w>
(0. 48</w>
(0. 12</w>
(0. 125,</w>
(0-1 0)</w>
(0 ;</w>
(-1 );</w>
(-1 )).</w>
(-- )-
(-)- sulpiride</w>
(+/- SD)</w>
(+)- propranolol</w>
(+ 5
(' M
( weight</w>
( versus</w>
( vehicle
( time</w>
( t)</w>
( spontaneous</w>
( sham
( s.c.</w>
( renal</w>
( reduced</w>
( myocardial</w>
( mostly</w>
( mono
( minimum</w>
( log-rank</w>
( isoproterenol</w>
( initiated</w>
( initial</w>
( infusion</w>
( increase</w>
( if</w>
( i.p.),</w>
( hot</w>
( formerly</w>
( expressed</w>
( elevated</w>
( during</w>
( doxorubicin</w>
( dox
( d-
( cyclophosphamide,</w>
( complex</w>
( cisplatin,</w>
( beta-CC
( apo
( ap
( anti-HB
( also</w>
( according</w>
( UN
( R)</w>
( LT)</w>
( L-DOPA
( CON
( =</w>
( 0.001</w>
( 0%</w>
( 0%),</w>
( *
' paradiscal'</w>
' holocytic'</w>
% .mmHg
" white</w>
" therapeutic"</w>
" rescue"</w>
" in</w>
" ecstasy
zotep ine</w>
zolmitript an.</w>
zimel idine</w>
ze ma,</w>
z ileut
ystag mo
yst olic</w>
ysi al</w>
yri an</w>
yr s)</w>
young est</w>
yo derma</w>
yne -
ynchron ization</w>
ymb ol</w>
yle ster</w>
yl] pyridine</w>
yl) phthalate</w>
yl) ethyn
yl)ethyn yl]pyridine</w>
yl y
yl cytosine</w>
yl ase</w>
yl ]</w>
yeast -induced</w>
year ).</w>
year 's</w>
yc lopent
y/ learning</w>
y- o</w>
y tos
y to
yto plasmic</w>
y ser
y raz
y n</w>
y '</w>
xyl in</w>
xip amide</w>
xanth one</w>
wrist .</w>
worsen ing.</w>
worsen ed,</w>
worl d.</w>
work up,</w>
wor se.</w>
wor ked</w>
wor ds,</w>
wo ke</w>
within- subjects</w>
withhel d,</w>
withdraw al-
with standing</w>
with :</w>
window .</w>
widen ing,</w>
wide spread,</w>
wide ly.</w>
whole- brain</w>
whol ly</w>
white- matter</w>
whit e,</w>
whe ezing</w>
wh ole,</w>
weight- to-body</w>
weight- adjusted</w>
weigh t
week ly)</w>
wearing- off</w>
we aving</w>
we ar</w>
war ds,</w>
wan ed</w>
w/ v)</w>
w- nitro-L-arginine</w>
w ron
w rin
w ra
wra p</w>
w is
w ed</w>
vulg are</w>
vomit ing;</w>
vol tam
vo uch
vo s</w>
viz .</w>
vivo :</w>
vivo "</w>
visual- spatial</w>
virus -positive</w>
vir us-related</w>
vinorelb ine,</w>
vindes ine.</w>
vincrist ine-associated</w>
vin yl-
vil li
view ,</w>
videotap e</w>
vic on</w>
vi tis</w>
vi st-
vessel .</w>
vertic il
verticil lat
vers a.</w>
verm is</w>
verat rine</w>
ver tex</w>
ver sion.</w>
ver s,</w>
ver olim
ver ifying</w>
ver 's</w>
ventric ular-
ven .</w>
veloc ities.</w>
veget ative</w>
vecur onium-induced</w>
vect ors</w>
ve d:</w>
ve 's</w>
vastat in-associated</w>
vasopress in-resistant</w>
vasoconstric ting</w>
vasculo pathy.</w>
vas op
vapor ized</w>
valv ulopathy,</w>
valu es;</w>
valu e)</w>
valpro mide</w>
valer ate,</w>
val ium</w>
vacuol ation,</w>
vaccin ation.</w>
vacc ine-
v ity.</w>
v is</w>
v icious</w>
v ic</w>
v alo
valo yl</w>
v ae</w>
utroph ilic</w>
utili zed.</w>
util isation</w>
ut tering</w>
ut om
utom erase</w>
usi dic</w>
use -
us er,</w>
us ?</w>
us +
urotheli um,</w>
uro pathy</w>
urinaly sis.</w>
urin es,</w>
urin aria</w>
ureter itis,</w>
ur s
ur onic</w>
ur ia)</w>
ur i</w>
up set,</w>
uniqu ely</w>
unineph rectomy</w>
unexplo red.</w>
unequ al</w>
undoub tedly</w>
underestim ate</w>
under nourished</w>
under lines</w>
un washed</w>
un steady</w>
un pro
un necessary.</w>
un modified</w>
un intended</w>
un injured</w>
un favourable</w>
un familiar</w>
un detected</w>
un blocked</w>
un anticipated</w>
un anesthetized,</w>
un anaesthetized</w>
uma rol</w>
um ents</w>
um 's</w>
ultra- short</w>
ultra structur
ultrastructur ally.</w>
ulo se,</w>
ull ary</w>
ulcer ations</w>
ulcer ,</w>
ul in,</w>
ul ation-
ul ate,</w>
ul a,</w>
ug e</w>
ucle ated</w>
uccin ic</w>
ucasi an</w>
uc osal</w>
uc i
u tr
u a</w>
ty ph
two- vessel</w>
two- choice</w>
twenty- one</w>
tur ns</w>
tur ke
tun ing</w>
tumor- free</w>
tumor s;</w>
tubul in,</w>
tuber cular</w>
tu ft</w>
tt p
ttp :
ttp: /
ttp:/ /
trun k.</w>
troph oblastic</w>
trop olitan</w>
trometh amine.</w>
triple -drug</w>
triphenyl tetrazolium</w>
trinit ro
trimethoprim-sulfamethox azole,</w>
trimethopri m,</w>
trimethop rim-
trimethaph an,</w>
triheptano in</w>
triglyceride s.</w>
triglycer id
trifluoro methyl
trichom on
triazolo[1,5- c]
trial s:</w>
trial ;</w>
tri methyl
tri azine</w>
tri ad
tri acyl
trex ol</w>
tren e</w>
tren ded</w>
tren d);</w>
tren d).</w>
treatment s;</w>
treat ed),</w>
tre e,</w>
travel l
trastuzumab ,</w>
tranylcyprom ine,</w>
transplant ation;</w>
transplan ted,</w>
transmit ters</w>
transmit ters.</w>
transi tioning</w>
transi tion
transition al-
transitional- cell</w>
transf ers</w>
transduc ers</w>
transamin ases.</w>
trans mucosal</w>
trans membrane</w>
trans lo
trans lating</w>
trans lat
trans jugular</w>
trans formation.</w>
trans femoral</w>
trans duced</w>
trans -1,2-
tranquil izers</w>
tramad ol-induced</w>
tram adol
trache a,</w>
trac ings</w>
trac ed</w>
trabecul ae</w>
tra y</w>
tra it,</w>
tr iterpene</w>
tr apping</w>
toxic ity).</w>
tot aling</w>
tos ylate.</w>
tos uccinic</w>
toremif ene,</w>
tonsill ectomy.</w>
tonic- clon
tometr ine</w>
tom eg
tomeg alo
tomegalo virus</w>
tolter od
tolaz amide.</w>
tocain ide.</w>
toc otri
tocotri en
toc olysis.</w>
to- female</w>
to- G</w>
to day</w>
to -treated</w>
tizan idine,</w>
tiv ity.</w>
titr ating</w>
tissu e;</w>
tis -
tion al.</w>
time- activity</w>
til t,</w>
tigm ine-
tig en</w>
tig ated</w>
tic- dynamic</w>
tic a</w>
tiaz ofurin</w>
tiag abine,</w>
ti trexed</w>
ti ters.</w>
ti ter.</w>
ti o
ti ming,</w>
ti es;</w>
ti en
tien ilic</w>
ti apride</w>
ti apri
thyrox ine.</w>
thymo quinone</w>
thym oma</w>
thym idine.</w>
thrombocyth emia.</w>
thrombo- embolic</w>
thrombo sis;</w>
thrombo sis)</w>
thrombo philia</w>
thromb us,</w>
thromb ot
thromb osed</w>
throm bus.</w>
thro at,</w>
three- year-old</w>
three- vessel</w>
thous ands</w>
though t,</w>
thorac ic,</w>
tho rough
thir d.</w>
thiotepa ,</w>
thiosulf ate</w>
thiosemicarb azide</w>
thioridaz ine,</w>
thiopent one-
thiomal ate</w>
thio thixene</w>
thio diphosph
thiazol-4- yl)ethynyl]pyridine</w>
thi ocol
thiocol chic
thi obut
thi apine</w>
thermal g
therapy- resistant</w>
ther modi
theore tic</w>
then- pct
then- cisDD
the ta
the pt
thept ene</w>
the modi
themodi alysis</w>
th- west</w>
th inner</w>
th in-
th ana
tetrahydro isoquinol
tetrahydro folate</w>
tetrahydro -1H-3-benz
tetrachloro dibenzo-p-dioxin</w>
tetraca ine.</w>
tetrac yclines</w>
tetra enoic</w>
tetr ameth
territ ories</w>
terodi line</w>
terodi line,</w>
termin ally</w>
teratogen s.</w>
teratogen icity,</w>
ter oneph
ter n
tern atin</w>
ter ine</w>
ter ic</w>
ter azosin,</w>
ter /
ten u
ten sor</w>
ten sion.</w>
ten sion-
ten atal</w>
temporo ammon
temporoammon ic</w>
temper ament</w>
tem .</w>
telmis artan,</w>
tele metric</w>
teenag ers</w>
tech nic
te lo
te en-
te bo
tebo ro
teboro xime</w>
te aring</w>
tc p</w>
taz ana
taurochol ic</w>
tap e</w>
tann in</w>
tamoxifen :</w>
tal c</w>
tail s</w>
tachyp nea</w>
table t,</w>
tab ul
ta- lateral</w>
ta utomerase</w>
t. d.
t-[35S] butylbicyclophosphorothionate</w>
t- test).</w>
t- positive</w>
t- G
t ural</w>
t or,</w>
t ocic
t ness.</w>
t fold</w>
t ectal</w>
t ec
t al-
t PA,</w>
t )-
systol ic-
system ically.</w>
system ically,</w>
system atic
syst ole,</w>
syru p</w>
synthesis/ release</w>
syndrome ),</w>
synaptos omes</w>
synap ses,</w>
syn tometrine</w>
syn cy
syncy tial</w>
symptom- limited</w>
symptom s:</w>
sympatho inhibitory</w>
sympathe tically-
symmetric al,</w>
switch ers</w>
swell ings</w>
survi vals</w>
surve y,</w>
surve y
surpris ing</w>
surmoun table</w>
surg e.</w>
surfact ant</w>
surfac es.</w>
surfac e)</w>
sur reptitious</w>
sur passed</w>
supplement s,</w>
suppl y.</w>
supernat ants</w>
super ven
super spinal</w>
super sensitive</w>
super oxide.</w>
sulph ate.</w>
sulph ate-associated</w>
sulfon yl</w>
sulfamo yl-
sulfamethox azole-
sulfadi azine.</w>
sulf hyd
sul b
sulb act
sufentanil- propofol</w>
succinylchol ine;</w>
succin ate,</w>
succe eded</w>
succ essively</w>
succ ess,</w>
subtype -selective</w>
substance -abusing</w>
subsi ding</w>
subsequ ently.</w>
subj ective,</w>
sub- )</w>
sub type,</w>
sub tracted</w>
sub tended</w>
sub regions</w>
sub protective</w>
sub plantar</w>
sub lines</w>
sub group,</w>
sub granular</w>
sub fraction</w>
sub field</w>
sub family</w>
su profen</w>
su perfused</w>
stupor .</w>
studi ed;</w>
stud y--
stud y
stru m</w>
stroke- prone</w>
stri ped</w>
stres s)</w>
strept omycin.</w>
strept omycin-induced</w>
strept omycin,</w>
strength ening</w>
strab ism
strabism us.</w>
stor age.</w>
stimul us-induced</w>
stimul ator.</w>
stimul ator,</w>
stimul ation:</w>
stimul ation-induced</w>
stimul ated,</w>
stimul ant
stil bo
stibo gluconate</w>
steroid- sensitive</w>
steroid -free</w>
steroid -dependent</w>
stereotyp ical</w>
stereotyp es</w>
stereotyp e</w>
stereospec ific</w>
stereo selective</w>
stereo isomer</w>
ster ,</w>
step .</w>
steno ses.</w>
sten osis:</w>
steep er</w>
steato hepatitis.</w>
steato hepatitis,</w>
ste ep</w>
ste al.</w>
ste al-prone</w>
star v
standar d)</w>
stand still</w>
stand -
stabiliz er.</w>
stabil ization.</w>
st s,</w>
st inging</w>
st em,</w>
st ays</w>
st ay
st ation</w>
st ant</w>
sst (1)</w>
squa res</w>
spra ys</w>
spor t</w>
spor ad
spont aneously,</w>
spont ane
spirocer cosis</w>
sper mid
sper m</w>
spectro scopic</w>
spectro metric</w>
spectro meter</w>
spectr um,</w>
specti ve.</w>
species -specific</w>
spe eds</w>
spe ak
spati ally</w>
spar se</w>
spac es.</w>
spac es,</w>
spac ed</w>
spa red.</w>
soun ds</w>
sos orb
sorb ate</w>
sor al
somat otop
som it
solv ents</w>
solv ent.</w>
solitari us,</w>
sol ve</w>
softw are</w>
softw are.</w>
sodi um)</w>
smok er</w>
sm ural</w>
slow ,</w>
sleep- inducing</w>
sle epl
skeleton s</w>
siz es,</w>
sixty- two</w>
sixty- nine</w>
sixty- five</w>
six- week</w>
situ ation,</w>
sit afloxacin</w>
sist ant</w>
sis -related</w>
sion s;</w>
sion s)</w>
sinus oids</w>
single- pass</w>
single- nucleotide</w>
single- center,</w>
simult aneously,</w>
simult aneous
similar :</w>
sim vastatin-induced</w>
sil ver-
significant ),</w>
sigma -1</w>
sibu tr
sibling s.</w>
sial ylation</w>
si tis.</w>
si gh
si e
si dom
shun t.</w>
shun t,</w>
shrink age.</w>
short-term/ working</w>
short- sleep</w>
short- course</w>
short- axis</w>
short- acting,</w>
shor ter-
shor t.</w>
shif t.</w>
she n</w>
she ar</w>
sha king</w>
sh aft</w>
sex /
sex -specific</w>
sex -related</w>
sex -,</w>
sevoflur ane-based</w>
sevoflur ane-
sett ing:</w>
sesqu iterpene</w>
servic es.</w>
serv o-
servo- controlled</w>
sert indole</w>
serotonin- selective</w>
serotonin- reuptake</w>
serosi tis</w>
seri ous
ser o-
ser o
ser ine,</w>
septo plasty.</w>
sen cephal
semin iferous</w>
semati li
self- stimulation</w>
self- selection</w>
self- rated</w>
self- administering</w>
selegil ine.</w>
selegil ine,</w>
selec tion.</w>
selec tion,</w>
seizure- prone</w>
seizure -associated</w>
segreg ation</w>
segreg ated</w>
seen :</w>
seem s,</w>
sedati ves,</w>
sed ation;</w>
secre tions</w>
search ,</w>
seal ants</w>
se- pretreated</w>
se ;</w>
se :</w>
scrutin y.</w>
scopol amine-</w>
scop e</w>
sco p</w>
schistos om
schedul es,</w>
sc .</w>
sc ),</w>
satur ations</w>
sarcopen ic</w>
sarco plas
sarco idosis,</w>
sap orin</w>
salv a</w>
salt- loaded</w>
salmeter ol,</w>
saline- exposed</w>
salicyl azosulf
salicyl ate-induced</w>
sal ure
sal ient</w>
sairei- to</w>
saf ely.</w>
saf ely,</w>
sacrific e.</w>
sacchar in,</w>
sacca dic</w>
sa w</w>
sa quin
sa k
s.go v,</w>
s.c. ;</w>
s- of-
s port
s ne
s n
s l-
s i</w>
s hipp
s d</w>
s atel
satel lit
s aff
saff lower</w>
s .)</w>
s (-1)</w>
runc ulin</w>
run ning,</w>
run down</w>
rul es</w>
ru bral</w>
rt PA</w>
rox yl
roten one.</w>
rostro caudal</w>
rose um</w>
ros acea</w>
root s,</w>
ron e,</w>
ron cho
rofecoxib :</w>
ro megal
ro lling</w>
ro landic</w>
rivas tigmine,</w>
rituximab .</w>
ritonavir- boosted</w>
risk /benefit</w>
rimonab ant</w>
rim ox
rifampic in-dependent</w>
ricket s,</w>
ric etin</w>
ribos ylation</w>
ribonucle otide</w>
ri se.</w>
ri de</w>
rhabdomy oly
rhIL-1 R
rhIL-1R a</w>
rhH GF</w>
rh inos
rhinos inu
reverse- transcriptase</w>
retrospect ,</w>
retriev al.</w>
ret est</w>
resuscit ate</w>
restore d,</w>
respectively :</w>
respect ,</w>
resour ce-
resoruf in-
resorufin- O-de
resor ption.</w>
resol ve,</w>
resistance -associated</w>
resist ant.</w>
resid ence</w>
resid ence.</w>
reserp ine-
rese ar
res ynchronization</w>
res sin</w>
res ;</w>
res )</w>
require ments,</w>
require ment.</w>
request s</w>
request ed.</w>
repolar isation</w>
replac em
repeti tively</w>
repeate d-
repe ated,</w>
repair ing</w>
rep uted</w>
rene .</w>
remoxipri de.</w>
remis sions.</w>
remin ds</w>
remifentanil- propofol</w>
remif ent
remifent nail</w>
remed y.</w>
rema in.</w>
relocation/ separation</w>
relev ance.</w>
relax ants.</w>
relationshi ps.</w>
relap ses,</w>
rel uct
rel ation.</w>
regular ly.</w>
regul ations</w>
regres sed.</w>
regimens :</w>
reg ain</w>
refract ory,</w>
refr action</w>
reflu x.</w>
reflex ogenic</w>
referr als</w>
referen ces</w>
referen ce,</w>
ref ers</w>
ref er</w>
reduction/ discontinuation</w>
red und
red "</w>
recumb ency</w>
recru desc
recrudesc ence</w>
recover ies</w>
recommend ation).</w>
recoll ection</w>
recipient :</w>
reb oxetine</w>
reasses s</w>
reason s:</w>
real ized.</w>
real ize</w>
reach es</w>
re- in-
re- exposed</w>
re- examined</w>
re- evaluated</w>
re- administration</w>
re visited</w>
re trac
re sides</w>
re presentation</w>
re per
reper to
re operation</w>
re myelination</w>
re mind</w>
re ma</w>
re location</w>
re introduced.</w>
re emergence</w>
re elin</w>
re con
re ared</w>
re ally</w>
raz oline</w>
raz epam</w>
rate ),</w>
rat s--
rat ing,</w>
rat er</w>
rat ed,</w>
rat ),</w>
random- effects</w>
ran ean</w>
ramipri l,</w>
raloxif ene
rai sed,</w>
ragged- red</w>
radio graph</w>
radi ography</w>
radi alis</w>
rac e/
race/ ethnic
ra rest</w>
ra re;</w>
ra emic</w>
r-pro UK</w>
r yn
r y,</w>
r r
r ha
rha ph
r an</w>
r HuEPO</w>
r HV
r CBV</w>
quinol one,</w>
quin azoline</w>
quin acrine</w>
ques tion,</w>
quasi- morphine</w>
quantit ation</w>
q ,</w>
pyrro lo
pyro phosphate</w>
pyrimeth amine-
pyridox ine,</w>
pyridin ium</w>
pyrid ine,</w>
pursu ed</w>
pursu e</w>
purpura/ hemolytic</w>
puppi es</w>
pup s,</w>
punct ure,</w>
pum ps,</w>
pum p
pulmon ary-
pul ses.</w>
pul se.</w>
pul l</w>
puer arin</w>
pter idine</w>
pt l
pt ed</w>
psychostimul ant.</w>
psychopharmac ologic</w>
psychi atric
pseud oc
provid er.</w>
prototyp ic</w>
protoc ol-
protein ).</w>
protein ),</w>
prot ective
prostat ectomy</w>
prostagland in-
prost an
propyl-1- phosphonic</w>
propyl }-
propranolo l),</w>
proportion ate</w>
propofol- remifentanil</w>
propofol -related</w>
propion ate.</w>
propi on</w>
prophyl axis
proparg yl
propacetam ol</w>
prop ane</w>
prompt ly.</w>
promot ers.</w>
promin ent.</w>
promaz ine.</w>
prolifer ator</w>
prolactin omas.</w>
prolactin omas,</w>
progres sively.</w>
program s.</w>
progest in-
progab ide,</w>
prof ylline,</w>
prof use</w>
procycl idine,</w>
prochlorper azine,</w>
process ing,</w>
proce eding</w>
proce dur
procarb azine,</w>
proble matic
prob ing</w>
prob es.</w>
prob able,</w>
prob abilities</w>
proanthocyanid in</w>
pro- thrombotic</w>
pro ving</w>
pro trac
pro state,</w>
pro position</w>
pro platin</w>
pro kine
pro estrus</w>
pro drome</w>
pro drom
prodrom al</w>
pro conflict</w>
primid one,</w>
priap ism,</w>
prevent able.</w>
preval ent.</w>
preval ences</w>
presyn copal</w>
pressu re:</w>
pres urgical</w>
prepar e</w>
pren at
premature ly.</w>
prematur ity,</w>
pregnancy -related</w>
pregnan olone,</w>
pregab alin,</w>
preem ptively</w>
predomin ately</w>
predomin ance,</w>
prednis one-treated</w>
predict ably</w>
predic tions</w>
precurs ors.</w>
precl uding</w>
precipit ates</w>
pre- treatment.</w>
pre- transplant</w>
pre- chemotherapy</w>
pre weaning</w>
pre training</w>
pre trained</w>
pre test</w>
pre piriform</w>
pre operatively.</w>
pre loading</w>
pre ischemic</w>
pre exist
pre conditioning.</w>
pre administration</w>
prazos in-
pram ine-treated</w>
practition er</w>
prac ticed</w>
pr ick
pr ice</w>
pp m.</w>
pp ing</w>
potenti ated.</w>
pot ent.</w>
postur ing,</w>
postischem ia</w>
posthyp oxic</w>
poster olateral</w>
post- succinylcholine</w>
post- ischemic</w>
post- infusion.</w>
post- glomerular</w>
post- exposure</w>
post- acute</w>
post- LT
post- BMT</w>
post treatment.</w>
post synap
post stenotic</w>
post rema</w>
post junctional</w>
post ero
post dose.</w>
positive- pressure</w>
pos timplantation</w>
pos themodialysis</w>
port able</w>
porphy rin
porphy ria.</w>
por ted</w>
por adic</w>
popul ation).</w>
popul ar
poor- risk</w>
polysomno graphic</w>
polyribos omes</w>
polymer ization</w>
poly sorbate</w>
poly radicul
poly hydramnios</w>
poly hydramnios.</w>
poly ene</w>
poly arthritis,</w>
poll ici
pollici s.</w>
polar ization</w>
polar ity</w>
point es).</w>
poin t-
pod ocyte
pod ate</w>
po ver
po sed
po or,</w>
po ),</w>
pneumonia e,</w>
pneum omediastinum</w>
pmol/ l,</w>
plo tted</w>
plo idy</w>
plateau ed</w>
plat form
plasma ;</w>
plan ime
placent as</w>
placent a-mediated</w>
placebo :</w>
placeb os.</w>
plac es</w>
plac e,</w>
pl ied</w>
pl ase</w>
pl anted</w>
pituit ary,</w>
piroxic am
pirox antrone</w>
piri be
piperid ine-
piperid in
pimoz ide-induced</w>
pilsicain ide,</w>
pilocarpine- PVA</w>
pilocarp ine:</w>
pill .</w>
pid ase</w>
picrotox in-</w>
picrotox in-
pic loz
pi ate</w>
pi )</w>
physi otherapy</w>
physi ologic,</w>
phyloc occi
phy tate</w>
phosphot yrosine</w>
phosphoryl ation.</w>
phosphoro thio
phosphor amide</w>
phosphor amid
phospholip ids.</w>
phosphodiester ase,</w>
phere sis</w>
pheochromocyt oma,</w>
phenylpropanol amine,</w>
phenyl-1, 3-
phenyl)-piperazin-1- yl]-
phenyl)-4-methyl- 7,8-
phenyl)- 2-
phenyl methyl
phenyl isopropyl
phenyl amino
phenprocoumon -induced</w>
phenotyp ing</w>
phenotyp ed</w>
phenobarbit one,</w>
phenelz ine.</w>
phenel zine,</w>
phen ol-induced</w>
phas ed-
phas e;</w>
pharyn x,</w>
pharmaco therapeutic</w>
phag ia,</w>
phaeochromocyt oma.</w>
ph otic</w>
ph obic</w>
pg/m L;</w>
pg/ ml;</w>
pg/ ml.</w>
peth idine.</w>
petechi al</w>
pestic ide,</w>
perturb ations</w>
perspec tives.</w>
personne l.</w>
person- years)</w>
permit ted.</w>
perman ent,</w>
peripher y.</w>
peripher al-
period ontal</w>
peril ymph</w>
peric on
peri- operative</w>
performed ;</w>
percep tion,</w>
per spective.</w>
per petr
per operative</w>
per one,</w>
per if
per amide</w>
peptide-(25- 35
peptide-(25-35 )-induced</w>
pepti dic</w>
peop le,</w>
pentylenetetrazol e-</w>
pentobarbit al-treated</w>
pent oxy
pen ic
penic illo
pem pidine</w>
pedi atric
pe d,</w>
paw s,</w>
pauc i-
patient s?</w>
patient /
pathomechan ism</w>
path .</w>
pat .</w>
past e</w>
passive- avoidance</w>
passi vely</w>
parval bu
parvalbu min,</w>
participant s'</w>
particip ated.</w>
parti al)</w>
part ner</w>
part ner
part ate</w>
parom omycin</w>
paro tid</w>
paresthesi as.</w>
pares the
parasympath omimetic</w>
paraph il
parap legia,</w>
paralle ling</w>
paraesthe si
paradig ms,</w>
para- tyrosine</w>
para hippocampal</w>
par ity,</w>
par ative</w>
par amount</w>
par amen
paramen ingeal</w>
par a</w>
pantoprazol e.</w>
pannic ul
panc reas.</w>
pan uveitis</w>
pan ick
palmet to</w>
pal pation</w>
pal pation.</w>
pal ms</w>
painful ness</w>
paclitaxel/ carboplatin</w>
paclitaxel :</w>
paclitaxel -treated</w>
paclitaxel -evoked</w>
paclitaxel -based</w>
pacemak ers</w>
pa st.</w>
pa rec
pa fox
pa enia</w>
p< 0.01</w>
p75(NT R)-
p.o .;</w>
p yoderma</w>
p tive,</w>
p ine-,</w>
p ine)</w>
p in</w>
p O2</w>
p ERK1/2</w>
p 65</w>
p 300</w>
p .)</w>
p '-
oz one-
oxyphen butazone</w>
oxyl in-
oxylin- eosin</w>
oxygen -
oxycod one,</w>
oxy tocic
oxy benz
oxopiperazin yl-1-
oxif ylline</w>
oxid ore
oxidore duct
oxid ative/
oxid ase,</w>
oxic -
oxi gen
oxazol id
oxaproz in</w>
oxac alcit
oxacalcit riol</w>
ox y</w>
ox acill
overwhel ming</w>
over- expression</w>
over- all</w>
over all.</w>
ove al</w>
out lines</w>
ouse hold</w>
our ce</w>
oun d
ouabain- hypertensive</w>
ouabain -dependent</w>
ou ret
ou gh
otyp e</w>
otolaryng ologists</w>
oti fen
ot ological</w>
ot ologic</w>
ot ere</w>
osyn cr
osyn aptic</w>
osteomalac ia</w>
osteo arthritic</w>
osmolar ity,</w>
osi s-
oscop ically</w>
os timulation</w>
os per
os om
os ensory</w>
os clero
ors fall</w>
orrho ea</w>
oro xylin</w>
oro -
orig ins</w>
orig ins.</w>
ori metric</w>
ori entation</w>
organel le</w>
ore active</w>
ordin arily</w>
order :</w>
orchi ectomy.</w>
orb it,</w>
oradi ometric</w>
or ders</w>
opri l,</w>
opri de</w>
opre dn
opposit e.</w>
opiomelan ocor
opiomelanocor tin</w>
opioid -like</w>
opi ate.</w>
ophthalmo pathy</w>
ophthalmo logy</w>
oper ative,</w>
op tico-
op odium</w>
op eptides</w>
op eptide</w>
onwar ds.</w>
ongo ing,</w>
ong er</w>
one- fifth</w>
one- -
ond apar
ondapar inu
onco statin-
once- a-day</w>
on- treatment</w>
on- going</w>
on- demand</w>
on to
on tin</w>
on thly</w>
on s,</w>
on lein</w>
on is
onis amide</w>
on in-
on if
onif lor
on es:</w>
on ce,</w>
on azole-associated</w>
on ate.</w>
omyo graphy</w>
omyc in/
omorph ological</w>
ometr y)</w>
omegal y,</w>
ome trexol</w>
ome theptene</w>
omasti a</w>
om iting</w>
om ers</w>
om a)</w>
om ,</w>
olog y-
olo[ 3,
olo[3, 2-a]
olo mic</w>
olo -
oliv oc
olin-1 alpha</w>
oligonucleoti des</w>
ole gal</w>
ol- exposed</w>
ol- 20-
ok ad
okad aic</w>
oint ments</w>
oid /
ogene ity</w>
often .</w>
often ,</w>
off- pump</w>
off- period</w>
off- line</w>
ofen adine</w>
of r
odi azepine</w>
od endritic</w>
ocytopen ia,</w>
ocys tic</w>
octreoti de)</w>
octap eptides</w>
ocon striction</w>
ocon centr
oclav ine</w>
ochrom ic</w>
ochol ate-3-O-
ochemic ally.</w>
och olic</w>
occur ;</w>
occlu ded.</w>
occl ud
occasion s:</w>
ocarcin oma</w>
ocarb oxaz
oc o
oc et</w>
oc ad
obvi ated</w>
obtund ation</w>
obtund ation,</w>
obtain able</w>
obstetr ical</w>
obser ver.</w>
obsc ure,</w>
ober man</w>
obenz o
obac tam</w>
ob ul
ob lig
ob ladder</w>
o thec
o il
o ides</w>
o fibrate</w>
o estrous</w>
o Cy
oCy te</w>
nystag mus.</w>
numb ness,</w>
nucle i)</w>
notochor d</w>
normoten sion;</w>
norm ocalce
norepinephr ine)</w>
nor- B
nor pethidine</w>
non- traumatic</w>
non- surgical</w>
non- randomised</w>
non- pigmented</w>
non- neoplastic</w>
non- insulin-dependent</w>
non- injured</w>
non- injected</w>
non- imidazole</w>
non- haematological</w>
non- enzymatic</w>
non- cirrhotic</w>
non- case</w>
non- arteriosclerotic</w>
non- anesthetized</w>
non- Q</w>
non transmural</w>
non susceptible</w>
non survival</w>
non squamous</w>
non spatial</w>
non significantly</w>
non progressive</w>
non operative</w>
non narcotic</w>
non kindled</w>
non ionic,</w>
non invasively</w>
non inferiority</w>
non genotoxic</w>
non exposed</w>
non e
non convulsing</w>
non compliant</w>
non cirrhotic</w>
non castrated</w>
non cardiogenic</w>
non calcified</w>
non anticoagulated</w>
nocist atin</w>
no se.</w>
no otrop
no des,</w>
nmol/ L</w>
nitroglycerin- ,</w>
nitrogen .</w>
nitrendip ine.</w>
nitrendip ine,</w>
nitr ative</w>
nis can
nimodi pine.</w>
nightma res.</w>
night time</w>
nif e
nife kal
nicot ine)</w>
ni ger</w>
nex t-day</w>
newbor ns,</w>
newbor n,</w>
neut ered</w>
neurotransmit ters.</w>
neurolog ist</w>
neurolog ic,</w>
neuro- ophthalmologic</w>
neuro radi
neuro pore</w>
neuro modulator</w>
neuro genesis.</w>
neuro chemical,</w>
netilmic in-treated</w>
nerve- conduction</w>
nerv os
neramex ane</w>
nephron ,</w>
nephrocalcin osis,</w>
nephro pathies.</w>
nephrectom ized-
neph rin.</w>
neostriat um,</w>
neos tigmine.</w>
neoplas ms,</w>
neo- Timm</w>
neigh bor
necrop sy.</w>
nec ros
nec dotal</w>
near- complete</w>
ne vertheless,</w>
nation al,</w>
nas opharyngeal</w>
nas ogastric</w>
narrow ed</w>
narcol epsy</w>
naltrex one-
nal orphine</w>
nafcill in.</w>
na vig
na prolol</w>
nNOS (-/-)</w>
n- regulation</w>
n t
n ir
nir uri</w>
n id
n ically</w>
n g).</w>
n ers</w>
n agogic</w>
myx edema</w>
myofibri ls,</w>
myocyt olysis</w>
myoclon ia</w>
myo path
myo fibers</w>
myelo toxicity,</w>
myelo proliferative</w>
myelo peroxidase-
myelo pathy,</w>
myelo monocytic</w>
myco logic</w>
myalgia/ arthralgia</w>
my ricetin</w>
my ri
my otoxicity.</w>
my onecrosis</w>
my ocilin</w>
mutag enic</w>
mut ated</w>
mut ant,</w>
muscarin ic,</w>
mur mur
mumol/ liter)</w>
mumol/ kg/
mumol/ L).</w>
mum ole</w>
mum ol)</w>
multiple x</w>
multin ucleated</w>
multifactori al.</w>
multicent ric</w>
multi- centre</w>
multi stage</w>
multi parous</w>
multi form</w>
mul tigated</w>
mul ler
muller ian</w>
mu- opiate</w>
msec ).</w>
mox is
moxis yly
mouse :</w>
mother- infant</w>
mother .</w>
morphine- tolerant</w>
morph ometr
morph ol
morph o
morph ine-treated</w>
morph in
month ly.</w>
month 's</w>
monomethyl- L-arginine</w>
monom eric</w>
mono amines.</w>
mon oxide</w>
mon osynaptic</w>
mon onit
mon oneur
mon ocyte-
mon ic</w>
mol/ l</w>
mol/ l),</w>
mol sidom
moi ety,</w>
modul ators,</w>
modifi ers</w>
modifi er</w>
modifi ed,</w>
model ing.</w>
mode ll
modal ity.</w>
modafin il,</w>
mo ve</w>
mo st.</w>
mo st-
mo pathy</w>
mo genicity</w>
mmol/L ]</w>
mm 2</w>
ml/ kg,</w>
ml/ g</w>
ml -1.</w>
ml -1),</w>
ml );</w>
mixed- breed</w>
mix ed-type</w>
mit r
mit o
mistak enly</w>
mis ,</w>
minut es;</w>
minut es),</w>
minoxidi l-treated</w>
minim ization</w>
minim ised</w>
minim ise</w>
min ing</w>
min -1;</w>
mime tics</w>
milnac ipran
millilit ers</w>
milli on,</w>
milieu .</w>
mil d
migra ine:</w>
mig ratory</w>
mifeprist one.</w>
midod rine,</w>
midazolam/ meperidine</w>
mid facial</w>
mid brain,</w>
micturi tions</w>
microtubul e-
microsom es.</w>
microscop ically,</w>
micromol/ l).</w>
micromol/ g</w>
micrograph s</w>
micrograms/m L).</w>
micrograms/ l</w>
micrograms/ 0.5</w>
micrograms/ 0.2</w>
microgram/ kg,</w>
microg/kg/ min)</w>
microg/ ml;</w>
microg/ mL
microg/ hour</w>
microg/ g,</w>
microg/ day</w>
microg/ L</w>
microg.kg(-1). h(-1)</w>
microfil are
micro- dystrophin</w>
micro vasculature</w>
micro tubules.</w>
micro tubular</w>
micro structural</w>
micro regional</w>
micro prolactinoma</w>
micro phonic</w>
micro n</w>
micro dialysate</w>
micro cystic</w>
micro circulation,</w>
micro biologic</w>
micro V/
mic ally</w>
mi x</w>
mi glustat</w>
mgI/ ml)</w>
mg/m(2)/ week</w>
mg/m l/
mg/m L,</w>
mg/m L)</w>
mg/kg/ infusion)</w>
mg/kg/ day;</w>
mg/ 100
mg. ml-1)</w>
mg :</w>
mex ic
mexic anum</w>
metr y)</w>
metoclopram ide-treated</w>
metoclopram ide-induced</w>
methylenedioxy amphetamine</w>
methyl-6,7-dimethoxy-4- ethyl-beta-carboline-3-carboxylate</w>
methyl- 8-
methyl xanthines</w>
methyl ergonovine</w>
methy leth
methoxy flurane,</w>
methoxy )
methotrex ate-treated</w>
methohexit al.</w>
methohexit al,</w>
method ).</w>
methion ine,</w>
methim azole.</w>
methicill in-sensitive</w>
methicill in-induced</w>
methad one-associated</w>
meth oxyp
meth aemo
metastasi zing</w>
metast asis.</w>
metaiodobenzyl guanidine</w>
metabol ism
met/ dex</w>
met yrap
mesyl ate-induced</w>
messeng ers</w>
mesench yme</w>
mesalaz ine,</w>
mes ocortic
mes encephalon</w>
mercap to-
mer s.</w>
mer ic</w>
mequ iv
mequiv /
meq/ kg)</w>
mepivaca ine,</w>
menorrhag ia,</w>
mening itis:</w>
men ol</w>
men ),</w>
memor y/learning</w>
memor y-
melphal an,</w>
meloxic am</w>
melan chol
mel amine</w>
medoxom il-based</w>
medium- chain</w>
medic olegal</w>
medic al,</w>
mechanis tically</w>
mec li
meas ures:</w>
meas ur
me tropolitan</w>
me trazol</w>
me tra
me tergoline</w>
me los</w>
mcg/ kg/min</w>
mc g/kg</w>
maxim izing</w>
max illo
maxillo facial</w>
matri x,</w>
mat ing</w>
mass age</w>
mas cul
marri ed</w>
marmo set</w>
mar melos</w>
mar ital</w>
manufacture r.</w>
manner ;</w>
maneu ver</w>
man ometric</w>
man ic.</w>
man di
malon ate/
malonate/ MDMA</w>
malform ation,</w>
male- to-female</w>
male ),</w>
mal es;</w>
mal ate</w>
maj or.</w>
mai- y
magnesi um-
macro prolactinoma</w>
mac ulopathy.</w>
ma them
mRNA s.</w>
mL/ s</w>
mL/ min.</w>
mL. min-1</w>
mEq/ liter,</w>
mEq/ L;</w>
m- H
m-H orsfall</w>
m(- 2),</w>
m s),</w>
m erg
m dr
m ca
m /kg</w>
m .
lysos om
lysophosph atidyl
lys ine.</w>
lymph osarcoma</w>
lymph omas,</w>
lymph oceles</w>
ly sis.</w>
ly ser
lut ea</w>
lup us.</w>
lum irac
luc idum</w>
loxacill in-induced</w>
low- molecular</w>
low er-dose</w>
los s;</w>
long- acting,</w>
lon ium</w>
lograph ic</w>
log y.</w>
log dose</w>
locomotor- activating</w>
local ization.</w>
lobul e.</w>
lobe ,</w>
lo x</w>
lo st,</w>
lo sed</w>
lo reth
lo id</w>
lo der
lo ci
ll erian</w>
liver -/-</w>
liver )</w>
litter mate</w>
litre -1</w>
lithium- neuroleptic</w>
lithium- methomyl</w>
lith otomy</w>
lith ogenic</w>
lith ocholate-3-O-
literat ure;</w>
lit tle,</w>
lit az
lis uride.</w>
liqu id-
lipo proteins,</w>
lipo fus
lip s,</w>
lip id,</w>
linole ic</w>
ling er-
linger- Ell
linger-Ell ison</w>
limit s)</w>
lik e,</w>
lignoca ine/
lignoca ine-induced</w>
light-heade dness,</w>
lidoca ine-</w>
lid onine</w>
lick ing.</w>
lic k</w>
li tis.</w>
levothyrox ine,</w>
levonorgestrel ,</w>
levo bupivacaine,</w>
levetir acetam.</w>
level s),</w>
levamisol e-induced</w>
lev osul
lev orphanol</w>
leupro li
leuke moid</w>
leuk omalac
leuco agglutinin</w>
lessen s</w>
less ons</w>
lesion s:</w>
lesion ing</w>
lept om
lenalidom ide.</w>
lenalidom ide-
lenalidom ide,</w>
leiomy oma</w>
lect ins</w>
lecith in</w>
leak age.</w>
lead s,</w>
le ver-
le gged</w>
le ag
leag ues</w>
lay ers.</w>
lay ers,</w>
later alized</w>
later al/
lateral/ basolateral</w>
lat runculin</w>
last s</w>
last -
larg er,</w>
lar vae</w>
lan diolol</w>
lamivudine- untreated</w>
lamivudine- na</w>
lam oxactam</w>
lam ell
lacunos um-
lacti tol</w>
lact otroph
lact ate:
lactate: pyruvate</w>
labor ating</w>
labor :</w>
label s</w>
lab oring</w>
l/ min,</w>
l/ m</w>
l- -
l idine</w>
l ation,</w>
l ate
kne e.</w>
kindling ).</w>
kin ins,</w>
kin es</w>
kg/ m2</w>
kg/ m
key words</w>
ket otifen
ket ol
ket anserin,</w>
kerato plasty</w>
ker atin</w>
kain ate.</w>
k y
k ot
k o
k ingly,</w>
k )</w>
jux tam
jud gement</w>
jour n
join t,</w>
jirovec i</w>
j ect
iz ot
iz ole</w>
iz ed;</w>
iz ation:</w>
iz an
izan idine</w>
iv ),</w>
iti dine</w>
ithrom ycin-induced</w>
iter ranean</w>
item ,</w>
itamin s</w>
it y/
it in.</w>
it e,</w>
ist ,</w>
isradi pine,</w>
isot ope</w>
ison icotinic</w>
isom yosin</w>
isom ers.</w>
isom ers,</w>
isol ectin</w>
isoflurane- anesthetized</w>
iso zym
iso volemic</w>
ish .</w>
isethion ate.</w>
ischemic ,</w>
ischemia/ reperfusion</w>
ischem ia;</w>
ischem ia-induced</w>
isaxon ine</w>
is ometheptene</w>
is al.</w>
is :</w>
irrit able</w>
irrig ations</w>
irrig ation,</w>
ir reversibly</w>
ir )</w>
ipsi later
ip .</w>
iohex ol)</w>
iodix an
io ther
io glos
ioglos sus</w>
investigator -bl
invasi ve,</w>
intub ations</w>
intub ated.</w>
intro n</w>
intrigu ing</w>
intrathec ally,</w>
intran i
intrani gr
intral e
intrale sional</w>
intracister nally</w>
intracerebroventric ularly.</w>
intracell ularly</w>
intrac ytoplasmic</w>
intrac erebr
intra- operative</w>
intra vital</w>
intr a</w>
intoxic ations.</w>
interview s.</w>
interval- prolonging</w>
interrupt ing</w>
intermediate- caudal</w>
interleukin- 6,</w>
interleukin- 2</w>
interfer on,</w>
inter subject</w>
inter related</w>
inter play</w>
inter peak</w>
inter nuclear</w>
inter feren
intellect ually</w>
integ rate</w>
intact -
int ent.</w>
insufficiency :</w>
inspir ation</w>
insipid us:</w>
insipid us-like</w>
inser ted.</w>
inotrop ism</w>
inotrop ic,</w>
injur ies,</w>
injection- site</w>
injec tion),</w>
initi ation-
inhibitor- based</w>
inhibitor -associated</w>
inhibi tion-induced</w>
inherit ance.</w>
inhal er.</w>
inges tion;</w>
ing- treatment</w>
ing ly.</w>
infusion ),</w>
infrequ ently,</w>
infran odal</w>
influ ence,</w>
inflamm ation)</w>
infiltr ations</w>
infiltr ated</w>
infiltr ate,</w>
infer tility.</w>
infarc tion;</w>
infarc t,</w>
inevit able</w>
ine- rich</w>
ine ligible.</w>
ine ered</w>
ine );</w>
ine )-induced</w>
ine "</w>
induc ted</w>
induc ers</w>
indomethac in-
indobu fen</w>
individu ally,</w>
individu al,</w>
indinavir -treated</w>
indinavir -induced</w>
indic ators.</w>
index ed</w>
index ).</w>
inde ed,</w>
inda zole</w>
ind ole,</w>
incub ation,</w>
incre mentally</w>
incor rect</w>
incor rec
inclu sion.</w>
incid entally</w>
incer ta-lateral</w>
incapacit ating</w>
inc ed</w>
in- positive</w>
in- patient</w>
in- labeled</w>
in- immunoreactive</w>
in- 3-
in to:</w>
in k
in ess
in duration</w>
in dispens
indispens able</w>
in discriminate</w>
in dione</w>
in definitely</w>
in definit
in consistent.</w>
in compatible</w>
in come</w>
in born</w>
in ally</w>
in aemic</w>
impul sivity</w>
improvement )</w>
impro ve,</w>
impro per</w>
implic ated,</w>
implant .</w>
impairment /
immunofluoresc ence,</w>
immunoblo t
immuno prophylaxis.</w>
immun oradiometric</w>
immobil ization.</w>
immobil ization,</w>
iminodi acetic</w>
imi metic</w>
im y
im .</w>
illnes ses,</w>
ill .</w>
ill ,</w>
ili as</w>
il les</w>
ig atran</w>
ifosfamide/ mesna</w>
ifer ine</w>
if oli
if l
iel d</w>
idi pine,</w>
idi c</w>
identic al,</w>
identi ty</w>
ide spread</w>
id in</w>
id ene
id arubicin,</w>
id -like</w>
ick 's</w>
ich- Wistar</w>
ic- coated</w>
ic- androgenic</w>
ic us</w>
ic s;</w>
ic ks</w>
ic ile</w>
ic e-
ic an</w>
ic ;</w>
ic ).</w>
iaz emul
ia '</w>
i.v. )-induced</w>
i.p )</w>
i.c.v .,</w>
i. pl
i. a.</w>
i ses</w>
i proplatin</w>
i as,</w>
i K
i ).</w>
hypoxanth ine</w>
hypox aemia</w>
hypovol emic</w>
hypovol emia,</w>
hypotestosteron emia</w>
hypoprote inemia</w>
hyponatra emia.</w>
hypomagnes aemia</w>
hypokine sia,</w>
hypoaldosteron ism</w>
hypo prolactinemia</w>
hypo perfused</w>
hypo esthe
hypo density</w>
hypo active</w>
hypno tic,</w>
hypertrophy :</w>
hyperten sin
hypersensitiv ity-
hyperreflex ia.</w>
hyperprolactin aemia,</w>
hyperphosphat emia,</w>
hyperoxal uria</w>
hyperlipid aemia.</w>
hyperkine sis.</w>
hyperkal aemia.</w>
hyperalgesi a).</w>
hyperaldosteron ism</w>
hyperal bum
hyperalbum inemia-induced</w>
hyper triglycerid
hyper thyrox
hyper thymia</w>
hyper sexuality</w>
hyper sensi
hyper permeability</w>
hyper motility</w>
hyper cortisol
hyper coagulation</w>
hyper activ
hyp ochloremic</w>
hyp esthesia</w>
hydroxy zine,</w>
hydrox ide</w>
hydroure teroneph
hydronephro tic</w>
hydromorph one.</w>
hydroly sis,</w>
hydrocortis one,</w>
hydro ps</w>
hydro alcohol</w>
hyd rate.</w>
hy stere
hy gi
hund reds</w>
human s:</w>
huPB L-
hr ),</w>
hour s);</w>
hospital isation</w>
hormone- dependent</w>
hormon e-induced</w>
homogen ate.</w>
homocyste ine,</w>
homo iother
ho b
hippocampal- striatal</w>
hind brain</w>
high- throughput</w>
high- flow</w>
high- degree</w>
hi g
hig he
hi erarch
hexameth yl
hexachloro phene</w>
hex os
heterogene ous,</w>
heterogene ity,</w>
hero in-dependent</w>
hero in-
here in,</w>
herb s,</w>
heral ded</w>
hept adine</w>
hepatomegal y.</w>
hepat oproliferative</w>
hepat omas</w>
hepat ocyt
heparin- protamine</w>
hemor he
hemophiliac s</w>
hemophil iac</w>
hemophil ia</w>
hemodiaf iltration</w>
hemo perfusion,</w>
hemisphere ,</w>
hemip legic</w>
hemicholinium- 3</w>
hemi- parkinsonian</w>
hemi paresis.</w>
hemat omas.</w>
hemat ologically</w>
hemat ological,</w>
hemat ologic,</w>
hemangi omatosis</w>
hem otoxicity</w>
hem if
hel pl
hear t/
health y.</w>
headache ;</w>
head -to-
haz ya</w>
har m.</w>
hapto glob
handling -induced</w>
hand grip</w>
ham art
hamart oma</w>
ham ar
haloperidol- elicited</w>
haloperidol -associated</w>
haloperid ol;</w>
haloperid ol)</w>
hal ving</w>
hal f
haemoglob in,</w>
haemodynam ics,</w>
haemodilu tion,</w>
haemo static</w>
haemo phagocytic</w>
haemat opoietic</w>
haem olytic-uraemic</w>
had ,</w>
ha im</w>
h/ rat</w>
h. p.
h ur
h uge</w>
h ue</w>
h ouse</w>
h ole</w>
h mt
h as,</w>
h PF4</w>
h (-1))</w>
gynecomasti a.</w>
gy non-
guide line</w>
guid ing</w>
guanidinosuccin ate</w>
guan idine.</w>
guan abenz
gu y
growth- promoting</w>
group- housed</w>
gro unds</w>
grel ,</w>
granul es,</w>
gran in-derived</w>
gran di
gra vida</w>
gra vid
gra de.</w>
gover n
good- risk</w>
gonadotrop h</w>
glycosaminoglyc an</w>
glycopyrro late.</w>
glycopyrro late,</w>
glybur ide,</w>
glutathione- S-
glutar yl-coenzyme</w>
glutar aldehyde</w>
glutam ine,</w>
glutam ate.</w>
glucosid ase,</w>
glucos amine</w>
glucocortico steroids.</w>
gluco se
glucagon ,</w>
gluc onate,</w>
glomeruloneph ri
gli osis.</w>
glauc ine</w>
girl s)</w>
gh t,</w>
gh t
get s</w>
ger an
gentamic in)</w>
gener ative</w>
gener ational</w>
gener ally,</w>
gene tic,</w>
gen ome</w>
gen icity,</w>
gen ic,</w>
gen ers</w>
gemfibroz il-induced</w>
gemfibroz il,</w>
ge ographical</w>
gav age.</w>
gaug e,</w>
gastro scopy.</w>
gast ritis</w>
gast rectomy.</w>
gang rene.</w>
ganciclovir .</w>
ganax olone</w>
gamma-glutamyl cysteine</w>
gamma- deficient</w>
gamma- D-glutam
gall ate</w>
gal as
galas ap
gadolinium- DTPA</w>
g/m2/ day</w>
g/m (2))</w>
g/d l).</w>
g/ ml</w>
g/ l,</w>
g/ day.</w>
g/ L)</w>
g um,</w>
g row</w>
g ren
g odipine</w>
g au
g ation</w>
g -1.</w>
g -1.
g -1)</w>
furo ate</w>
fur an</w>
fur an-2-
full- blown</w>
ful fill</w>
ful fil
fugu e-like</w>
fructose-1,6-di phosphate</w>
fru it</w>
fron top
fron to-
fro g</w>
freez e-
fram e,</w>
fragment ation,</w>
frag mented</w>
four- year-old</w>
four ;</w>
four -</w>
foun d:</w>
fosinopri l-induced</w>
fosf ob
fos sa.</w>
forty- one</w>
forty- five</w>
formal in,</w>
fore -</w>
for ty</w>
for t
foot ball</w>
foot ,</w>
folliculo stellate</w>
fol d;</w>
fol ates</w>
foc us.</w>
fo ti
fluoroquinol ones.</w>
fluoropyrimid ine-based</w>
fluorometh olone</w>
fluoro scopic</w>
fluoro phenyl)
flunar izine.</w>
fluid ;</w>
fluc ytos
flu ency</w>
flexi ble
fler oxacin</w>
flavon oid,</w>
flap s.</w>
fixed- effect</w>
fix ed,</w>
fissu res</w>
firm ly</w>
fil ters</w>
fig ures.</w>
fifty- one</w>
fifty- five</w>
fibro genic</w>
fibro genesis</w>
fibrinogen ,</w>
fibrill ation)</w>
fibrill ated</w>
fibr in-
fib res,</w>
fib ati
ff in</w>
fet al,</w>
feren ces</w>
fer ubinac</w>
fer tili
fer rous</w>
fentanyl -treated</w>
fenoter ol.</w>
feno fibrate,</w>
fenflur amines</w>
fen ob
feed back,</w>
fec es</w>
feat uring</w>
fe moro
favour ably</w>
fat ,</w>
fast- acting</w>
fast ing,</w>
fascicularis )</w>
fascicul ation.</w>
fallop ian</w>
fall .</w>
fain t</w>
factor- I</w>
facti tious</w>
face- rubbing</w>
fac ial,</w>
f u</w>
f ondaparinu
f loxacin.</w>
f lowing</w>
f i</w>
f ade</w>
f MRI</w>
f EP
ey el
extrem es</w>
extravas ated</w>
extrac tion.</w>
extrac ardiac</w>
extra- pyramidal</w>
extr insic</w>
extinc tion,</w>
exposure ;</w>
explor ation,</w>
expl ants</w>
expl ant</w>
expl ain,</w>
expir ation</w>
experi ences,</w>
exp 2</w>
exerci se-
exer tion</w>
excit ation-
exce ede
examin er</w>
ex- vivo</w>
ex pul
ex pedi
ex ped
ex pector
ex ons</w>
ex il
ew ish</w>
every day</w>
event ually,</w>
event s;</w>
evalu ated;</w>
evalu ate,</w>
euk ario
eukario tic</w>
eu thymic</w>
eu thymia</w>
eu s.</w>
eti ologically</w>
ethyl- 2-
ethyl ene
ethyl adenine</w>
ethyl )-
ethoxy )
eth oxy-
eth idine</w>
etc. ).</w>
et y.</w>
et te</w>
et in.</w>
et exil
esulf onate</w>
estradiol-3- sulfate-17</w>
estr us,</w>
est -
esmo lol.</w>
escal ation,</w>
escal at
escalat ing-dose</w>
es olid</w>
erythropoiet in.</w>
erythro dysesthesi
erythro cy
erythematos us:</w>
erup tion.</w>
ero tic</w>
ero sions</w>
ergot rile</w>
ergol ine.</w>
ergoc rist
er s;</w>
er ations</w>
er );</w>
er ).</w>
equi hypotensive</w>
equi effective</w>
equi analgesic</w>
equ ivocal.</w>
eptid ase-
eptidase- G2</w>
ept al</w>
epo etin-beta</w>
episode s)</w>
epinephr ine/
epileptic s.</w>
epidur al,</w>
epidermidi s</w>
epid oxorubicin</w>
epi- doxorubicin</w>
epi si
epi phy
ep s.</w>
ep ic
enzym atically</w>
environ ments.</w>
envelop e</w>
enure sis</w>
entrain ment</w>
enth usi
entero hepatic</w>
enter opath
enter ic-coated</w>
entan ,</w>
ent e</w>
ent ary</w>
ens zel</w>
enroll ment,</w>
enqu iry</w>
enoxapar in.</w>
enoxapar in,</w>
enkephal inergic</w>
enkephal in.</w>
eni platin</w>
enh ancer</w>
enh anc
engraf t
eng org
eng mai-y
eng ineered</w>
endotheli um,</w>
endometri osis.</w>
endo phthal
end s.</w>
end om
end ocytic</w>
encoun tering</w>
encoun ter</w>
encomp assed</w>
enco des</w>
enco de</w>
ence ).</w>
ence ),</w>
enantiom er.</w>
enalapri lat</w>
enalapri l-induced</w>
en- 2-
en icillin</w>
en gender</w>
en d.</w>
en ;</w>
emo tion
emo den
emergen cy
emerg es</w>
embran e</w>
embol us</w>
emat ous</w>
elsewhe re,</w>
ell ular
elimin ates</w>
eli ac</w>
elev ations.</w>
electrophysi ologic,</w>
electromyo gram.</w>
electroencephalo gram.</w>
electroencephalo gram,</w>
electrocardio grams,</w>
electrocardio gram
elder ly:</w>
el godipine</w>
el ectively</w>
el ected</w>
el berg
eigh tfold</w>
eicos anoid</w>
eg le</w>
effect s)</w>
efavi renz</w>
edic ,</w>
edema ;</w>
ectop y.</w>
ecto derm</w>
ect asia</w>
ecstas y)</w>
echo thiophate</w>
ech loreth
ec zema,</w>
ec utive</w>
earli er)</w>
each ):</w>
each ),</w>
eNOS- Tg</w>
eNO S,</w>
e-N e</w>
e- mediated</w>
e sian</w>
e sia</w>
e oniflor
e at</w>
e ae)</w>
e able</w>
e +
dysur ia</w>
dysphag ia.</w>
dysmen orrhea</w>
dysfunction ).</w>
dysesthesi as</w>
dys r
dy e,</w>
dur ing-treatment</w>
dur ation:</w>
duloxet ine-treated</w>
drug- related.</w>
drug- coated</w>
drug :</w>
drox y-
dro p,</w>
dri ve,</w>
dream s,</w>
dramatic ally.</w>
dramatic ally,</w>
dra ined</w>
dra in</w>
doxy cycline.</w>
doxorubicin/ docetaxel</w>
doubt ful</w>
double- stained</w>
dou bl
dose- intensive</w>
dose =
dopamine- receptor</w>
don or-
don ation.</w>
domin ance</w>
domain s.</w>
dom estic</w>
dog :</w>
dog 's</w>
docetaxel /
docetaxel .</w>
doc osahexaenoic</w>
do dec
dizocil pine,</w>
diver tic
disulfiram- ethanol</w>
distur bed.</w>
distur b</w>
dist ended</w>
dist ance.</w>
dist ance,</w>
dissoci ation.</w>
dissoci ate</w>
dissip ated</w>
disorder ing</w>
discus sing</w>
discrimin ation,</w>
discolor ation,</w>
disco ver</w>
discer n</w>
disappear .</w>
disabl ing.</w>
dis on's</w>
dis integration</w>
dis array</w>
dis appea
dipi valoyl</w>
diphenylacetoxy- N-methyl
din ir</w>
dimethyl-1- propargyl
dimension ally</w>
dimenhydr in
dilu tions</w>
dilu ent.</w>
diltiazem -treated</w>
dilat es</w>
dilat ation.</w>
dihydrotachy sterol</w>
dihydro ergocrist
digit ally</w>
digit alized</w>
dig oxigen
difficul ty.</w>
diff icile</w>
diethylstilbestro l-
diethylnitros amine-initiated</w>
diethyl propion</w>
diet ;</w>
diet ),</w>
dichlorodiphenyl trichloroethane</w>
dichlor vos</w>
dicarbox ylate</w>
dic yclo
dibuc aine</w>
diazepam -treated</w>
diaz abicyclo
diast ere
diaphore sis.</w>
diagno sis;</w>
diabet es-
diabe tics.</w>
di py
di pren
di ph
di ol</w>
di methoxy
di mesylate</w>
di meglumine</w>
di d,</w>
di butyr
di aldehyde</w>
dextror phan,</w>
dextran .</w>
dextran ,</w>
dexrazox ane.</w>
devic e,</w>
development ;</w>
develop s,</w>
determ ine:</w>
deterior ated,</w>
desmo press
desig ned,</w>
des Arg
dermat osis</w>
derivati ves:</w>
depres sed,</w>
depolar ization.</w>
deplo yment</w>
depend ency.</w>
depart ments.</w>
depart ments,</w>
dep ic
denud ation</w>
den uded</w>
den sed</w>
demyel inated</w>
demograph ically</w>
demarc ated</w>
deman ding</w>
delta- amino
deline ated.</w>
del usion</w>
dehydrogen ase-
dehydrat ase</w>
deform ities</w>
deform ability</w>
definit e,</w>
defini tions</w>
deficit -
deficit- hyperactivity</w>
defici encies.</w>
defer oxamine.</w>
defect s:</w>
defect ),</w>
defascicul ation.</w>
deep- brain</w>
decreas es.</w>
decor ticated</w>
decongest ants,</w>
decom pressed</w>
decl ar
dec ur
dec tin</w>
dec ont
dec eased</w>
debilit ated</w>
death ;</w>
death :</w>
deaf ened</w>
deacetyl ase</w>
de sensitize</w>
de re
de met
de af</w>
de ;</w>
de /
dd C-induced</w>
day s
datab ases,</w>
danazol -induced</w>
danazol ,</w>
dam pen
dam aged.</w>
dam age;</w>
dail y-
da zole.</w>
dP/dt max),</w>
dP/dt (max).</w>
d4 T
d- modality</w>
d- methadone</w>
d- certified</w>
d- alpha-tocopherol</w>
d- Chiari</w>
d,l- propranolol</w>
d ures</w>
d t/
d t
d s)</w>
d act
d ab
d PAG</w>
d (CH
d(CH 2)
d(CH2) 5
d (-1)</w>
cytoskele ton
cyt olytic</w>
cystin uria</w>
cystic a</w>
cysti tic</w>
cyste ine.</w>
cyl ind
cyclospor ine-based</w>
cyclospor in,</w>
cyclohex anedi
cyclo- oxygenase-2</w>
cyanocob al
cyano tic</w>
cy tidine.</w>
custom ary</w>
curren tly,</w>
curren t-
curett age</w>
cur arization</w>
cumul ative.</w>
cu tis</w>
cu es,</w>
cu .
crystallo id</w>
crystall uria,</w>
crypt ococ
crush ing</w>
cruc i
cross-fo stering</w>
cross- legged</w>
cros ses,</w>
cromoglyc ate</w>
cri minal</w>
cran ium</w>
crack /
crack/ cocaine</w>
cow 's</w>
counter part</w>
coun ting,</w>
coun sel</w>
coumad in</w>
cost- utility</w>
cos metic</w>
corticosteroid ,</w>
corticoster one.</w>
cortag ine</w>
corrobor ate</w>
correl ative</w>
correc ted,</w>
coron ary-
cor tically</w>
cor nea</w>
cop ies</w>
convuls ant-induced</w>
conve yed</w>
controver sy.</w>
contradic tory</w>
contract ures,</w>
contract ure.</w>
contraceptiv es:</w>
contra sts</w>
contr acting</w>
continu ity</w>
continu al</w>
contex t.</w>
contex t,</w>
consul tation.</w>
construc ts</w>
consist ency</w>
conserv ation</w>
consequ ence.</w>
cons ented</w>
congru ent</w>
confoun ding.</w>
confir matory</w>
conf u
conf id
conduct ances</w>
condition ed-
concer ns.</w>
concer ned,</w>
concent rates</w>
conceiv able</w>
con geners</w>
con found</w>
con formation</w>
con densed</w>
con dens
con cordant</w>
computer ised</w>
compres sions</w>
compon ent
complic ations:</w>
complex ed</w>
comple tion.</w>
comple mented</w>
compet ence</w>
comparison s.</w>
comparison s).</w>
comp ute</w>
comp elling</w>
comp act</w>
comp ac
common er</w>
combin es</w>
combin ation-
comato se.</w>
colocysto plasty</w>
collicul us.</w>
collagen ase-induced</w>
collagen ase,</w>
coll ection,</w>
colchic ines</w>
col lege</w>
col leagues</w>
col d-induced</w>
coinc ides</w>
cognitive- enhancing</w>
cogn ate</w>
cochle a,</w>
cocaine- use</w>
cocaine- reinforced</w>
cocaine- free</w>
cocaine- exposed,</w>
cocaine- evoked</w>
cocaine- addicted</w>
coca ine
coca ethylene,</w>
co- morbidity,</w>
co- localized</w>
co st,</w>
co oled</w>
co ol</w>
co factor</w>
co des</w>
co axial</w>
co arsen
co arc
coarc tation</w>
co -treated</w>
cm ),</w>
clump ing</w>
clozap ine's</w>
closel y.</w>
clorazep ate</w>
clonid ine-
clon azepam
clomi pramine-treated</w>
clomi pramine-induced</w>
clobaz am.</w>
clo ti
clipp ing.</w>
clioquin ol.</w>
clinici ans,</w>
climb ing,</w>
classi fy</w>
clas ses.</w>
cladrib ine</w>
cladrib ine.</w>
cla f</w>
cl one</w>
cl it
cl ing</w>
cl icks</w>
cl aw
cl ass
citrat us</w>
citalopram -induced</w>
cisplatin um,</w>
cisplat in/
cisapri de.</w>
cisapri de-induced</w>
cisDD P-
cisDDP- then-pct
cis- RA)</w>
circumst antial</w>
circul ations.</w>
circ us</w>
cing ulate,</w>
cigarette ,</w>
ci razoline</w>
ci es,</w>
chron ologic</w>
chroma ffin</w>
chos en.</w>
cholinester ase-positive</w>
cholinerg ics</w>
choline- supplemented</w>
cholin oc
cholecystokin in.</w>
cholecyst ectomy,</w>
cholecalcifer ol.</w>
chol ate</w>
chol angiography,</w>
chol angio
cho w
chlorprop amide,</w>
chlorothiaz ide.</w>
chlordec one-induced</w>
chlorambuc il-induced</w>
chloralo se.</w>
chlor imipramine</w>
chlor ide)</w>
childho od,</w>
child :</w>
chias mal</w>
chias m</w>
chi p</w>
chest- pain-related</w>
cheno deoxycholic</w>
chemotherapy- na</w>
chemotherap ies</w>
chemotherap eu
chemosensitiz ers</w>
chemosensi tive</w>
chemoradi otherapy</w>
chemo- na</w>
check- up.</w>
chec ks</w>
che wing,</w>
characteris tics:</w>
character ized,</w>
character ization.</w>
channel- blocking</w>
chang ed,</w>
chain s,</w>
chain .</w>
ch ylo
ch ocer
ch lamydial</w>
ch ances</w>
ch -
cerebri ,</w>
cer ulospinal</w>
cer uletide</w>
cer ta
cephaloth in-
cephalospor in-induced</w>
cephal ad</w>
centr ally.</w>
cent re.</w>
cent age</w>
cembran oids</w>
cell ulose</w>
cell s),</w>
celi prolol</w>
ceftiz oxime</w>
ceftiz oxi
cefotet an-
cefosel is</w>
cefazol in,</w>
cef dinir</w>
ce fixime</w>
ce ;</w>
cavernos al</w>
caveol in-1</w>
cav a.</w>
cause- and-
cause-and- effect</w>
caus ality.</w>
cau tioned</w>
catheter izations</w>
catech in</w>
cataly zes</w>
cataly ze</w>
castr ation,</w>
cas es);</w>
cas e)</w>
cartil age,</w>
caroti d,</w>
carnit ine.</w>
cardioverter- defibrill
cardiom otor</w>
cardio thoracic</w>
cardio embolic</w>
cardiac- valve</w>
carcin omatosis</w>
carbon yl
carbon ate-induced</w>
carbon ate,</w>
carbocrom ene</w>
carbo hyd
carami phen,</w>
car min
car bet
capsul e,</w>
capsaicin- stimulated</w>
cannul a.</w>
cannul a,</w>
candidi asis</w>
candes artan,</w>
can cell
calretin in</w>
calibr ated</w>
calcul ated:</w>
calcitri ol-treated</w>
calcineur in.</w>
calcineur in-inhibitor</w>
calbindin- D(2
calbindin-D(2 8
calbind in,</w>
cal di
cal cemic</w>
caffeine- free</w>
caffe inism.</w>
caffe inated</w>
ca vit
ca ulophine</w>
ca ucasian</w>
ca proic</w>
c-fos ,</w>
c- jun</w>
c us
c oxib
c ox
c ited</w>
c id</w>
c d
c c/
c ar</w>
c AUC-1/
cAUC-1/ 2</w>
byp assing</w>
by- pass</w>
butyro phen
butyl bromide</w>
but yric</w>
busulf an.</w>
buspir one-treated</w>
burst- suppression</w>
burst- forming</w>
bur row
bupivacaine- fentanyl</w>
bufur alol</w>
bud ralazine</w>
bu thionine</w>
bronchodilat or,</w>
bronchoconstric tion,</w>
bronch itis</w>
bronch itis.</w>
bro ther</w>
bro ken</w>
brimon idine.</w>
bridg ed</w>
bridg e,</w>
bretyli um.</w>
breakthrough s</w>
break s</w>
break down.</w>
branch ial</w>
bran ch.</w>
bradycardia )</w>
brady cardic,</w>
brac ket</w>
br ings</w>
bout ons</w>
botul ism</w>
bot tle</w>
bor der,</w>
body- surface</w>
bodi ly</w>
boar d-certified</w>
bo y
block ers:</w>
blind ing</w>
ble ed,</w>
blast oma</w>
blast ocy
blac ks.</w>
bit ter</w>
bisulfit e.</w>
bisphosphonat es.</w>
bis(2-chloroethyl)-1- nitrosourea</w>
bis an
bisan trene</w>
bis (3,
bis (1-
biot in
biopsy- confirmed</w>
biomark ers,</w>
biolog ical,</w>
bioc hemotherapy</w>
bio physical</w>
bio distribution</w>
bio assays</w>
bio assay,</w>
bing ing</w>
bing e'</w>
bim onthly</w>
bilater al.</w>
bigemin y,</w>
bicalut amide-
bibli ographies</w>
bi directional</w>
bezafib rate,</w>
bevaciz umab.</w>
bethan ech
beta-galactosid ase,</w>
beta-CC t</w>
beta-CC E</w>
beta- receptors</w>
beta- blocker
beta- blockade.</w>
beta- antagonist</w>
beta- E</w>
beta- (4-
beta(1)- adrenoceptor</w>
beta =
bet agam
best- known</w>
bepri dil
benzodiazep ine/
benzo[a,d] cyclohepten-5,10-imine</w>
benef icially</w>
bendroflu azide.</w>
benazep ril</w>
ben ch
belie ved.</w>
behavior :</w>
beats/ min),</w>
beats. min-1,</w>
be me
be have</w>
be ef</w>
bat an
basi chondro
baro reflexes</w>
baro receptor-
baro denervated</w>
barbitur ates,</w>
bar .</w>
ball s,</w>
bacterio static</w>
bac osides</w>
b w)</w>
b uni
b rate</w>
b outs</w>
b ly</w>
b id)</w>
b ending</w>
b ark
azol .</w>
azimil ide,</w>
az april</w>
ay urvedic</w>
axon al,</w>
ax ill
awa it</w>
aver t</w>
aver m
av ocad
autop sy
automatic ity,</w>
autom atis
automatis ms</w>
autom atically</w>
autoimmun ity,</w>
audi ometry.</w>
atyp ia</w>
atr ici
atom oxet
ato sib
atipame zole.</w>
ation --
ati z
athle tic</w>
ather omatous</w>
ather ogenesis</w>
ath esin</w>
atele t</w>
ate gies</w>
ate d"</w>
ate 's</w>
at ran
at on</w>
at on
at ing-
at es),</w>
at ergic</w>
asymptomatic ;</w>
asymmetr ical</w>
astronaut s</w>
astrocyt oma</w>
astro cytosis.</w>
astro cytes,</w>
asth ma;</w>
assum ptions</w>
assum ing</w>
assum es</w>
assemb ly</w>
assem bled</w>
aspir in/
aspart ate-
asparagin ase.</w>
asle ep
asi atica</w>
as su
as on</w>
arti cles,</w>
arthralgi as/
arteriosclero tic,</w>
arteriosclero sis.</w>
arterio pathy</w>
arterial ized-
arteri es:</w>
artemether /
artemether/ lumefantrine</w>
arte mis
arrhythmi as)</w>
arrhythm ia;</w>
arrest )</w>
aro used</w>
armac ia</w>
arkin son's</w>
ari se.</w>
ari an</w>
arginine- vasopressin</w>
argatrob an,</w>
arg ument</w>
arec oline,</w>
areas :</w>
arch ,</w>
arbitr ary</w>
arb azepine</w>
ar ily,</w>
ar /
apri lat</w>
applic ations.</w>
appeti te.</w>
append ic
apoptosis- associated</w>
apoA- I,</w>
apno e
apnea- hypopnea</w>
apne ic,</w>
apath y,</w>
ap posed</w>
ap er</w>
any where</w>
anxioly tic,</w>
anxiet y)</w>
antitus sive</w>
antiretrovir als,</w>
antin icotinic</w>
antimicrobi als</w>
antihistamin ic</w>
antihist amine.</w>
antigen- presenting</w>
antieme tics,</w>
anticoagul ation-related</w>
anticoagul ant.</w>
anticholinerg icity</w>
antiarrhythmic s,</w>
anti- cholinergic</w>
anti serum.</w>
anti myeloperoxidase</w>
anti mitotic</w>
anti heparin-platelet</w>
anti glutamatergic</w>
anti estrogens</w>
anti estrogenic</w>
anti biom
anti amphetamine</w>
anti -</w>
anthracycl ine-
anthracenedi ones</w>
anthrac ene</w>
anth ra
anteri or,</w>
antagon ization</w>
ant i</w>
ant azoline</w>
ant ),</w>
anorexigen -associated</w>
anomal y.</w>
ano dermal</w>
ank yrin-G</w>
ani on,</w>
angiotensin- receptor</w>
angiograph ic,</w>
angio pathy.</w>
angio -
aneurysm s,</w>
anesthetiz e</w>
anesthesia -related</w>
anesthesi a;</w>
anesthesi a:</w>
anem ias</w>
anem ia)</w>
ane/ nitrous</w>
ane- associated</w>
ane ).</w>
ane ),</w>
androgen ,</w>
and y</w>
ance ;</w>
ance -
anc rod</w>
anc illary</w>
anatom y,</w>
anastom osis.</w>
analy sis;</w>
analog s.</w>
analo gy</w>
anal eptic</w>
anal bum
anaesthe tics,</w>
anaesthe tic-induced</w>
anaesthe tic,</w>
anaesthe sia:</w>
anaesthe si
an- niacin</w>
an- G
an-G an
an-Gan z</w>
an- American</w>
an hepatic</w>
an as
an agrelide</w>
an ).</w>
amylo idosis.</w>
amy otrophic</w>
ampren avir</w>
amplitu des.</w>
ampl ifi
ampicillin- cefotaxime</w>
ampicill in,</w>
amphetamine- dependent</w>
amphetamine- class</w>
amph o</w>
amoxicillin/ clavulanic</w>
amoxicill in,</w>
aminotransfer ase.</w>
aminop eptidase</w>
aminoindan-1, 5-
aminoindan-1,5- dicarboxylic</w>
amino propyl
amino acids</w>
amine- containing</w>
amine- atropine</w>
amelior ated.</w>
ambul ate</w>
ambul ance</w>
am id</w>
am end
am ),</w>
aly :</w>
alter ation.</w>
alte plase</w>
alpha-r ANP</w>
alpha-methyl histamine</w>
alpha-amino-3-hydroxy-5- methyl-4-
alpha- keto
alpha- blockers</w>
alpha- blocker</w>
alpha- adrenoceptors.</w>
alpha- TC</w>
alpha- Methyl-
alpha-Methyl- p-tyrosine</w>
alpha- HCH</w>
alpha,beta-me ATP</w>
alpha(1)- adrenoceptor</w>
alpha 2a</w>
alpha 2-</w>
alpha -induced</w>
allyl cysteine</w>
allograf ts.</w>
all yl-
alkyl ase</w>
aldoster one-
alcohol ics,</w>
alcoh ol)</w>
albumin /
albumin -
album inemic</w>
alaprocl ate</w>
al- specific</w>
al w
al th</w>
al prenolol</w>
al prenolol,</w>
al pidem</w>
al is.</w>
al ine-induced</w>
al ine,</w>
al imbic</w>
al ign
al bolabrin</w>
al /kg</w>
aj mal
agricul tural</w>
agoraph obia,</w>
agonist s:</w>
agonist /
agonist -like</w>
agmat ine.</w>
agl ate)</w>
agit ated,</w>
aggressi veness,</w>
ageu sia</w>
agent s),</w>
agent )</w>
age- ,</w>
ag ranular</w>
ag litaz
ag ency</w>
ag en
ag ed-
ag arose</w>
afterno on</w>
afterno on.</w>
after .</w>
af un
af ascicular</w>
aeruginos a.</w>
aeros olized</w>
ady namic</w>
advoc ated.</w>
adulter ated</w>
adul ts;</w>
adrenocept or.</w>
adrenerg ically</w>
adren al-
adolesc ence.</w>
admis sions.</w>
administere d;</w>
adi p
adhe sions</w>
adhe rent</w>
aden osis.</w>
addi tives</w>
addi tionally,</w>
adap t</w>
ad sor
ad nex
ad ded,</w>
acy tidine</w>
acute- phase</w>
acute- onset</w>
acupunct ural</w>
acu point</w>
acu min
active- controlled,</w>
activ ated,</w>
act in.</w>
acromegal ics</w>
acro meg
acquisi tion.</w>
acid- rich</w>
acid -related</w>
acid +
acid ),</w>
ach es</w>
acetyl- L-
acetaminophen -related</w>
acet olol</w>
acet amide-induced</w>
ace promazine,</w>
ace but
ace a
accurac y,</w>
accord ingly.</w>
accid ent.</w>
acces sed</w>
accept ance.</w>
accept able.</w>
accep ted.</w>
accentu ates</w>
accent uate</w>
ac ul
ac itidine</w>
ac ept</w>
ac epif
abuse /
absten tion</w>
absorb ance</w>
absces ses</w>
absc ess,</w>
abor tions,</w>
abnormaliti es;</w>
abnormaliti es:</w>
abl o</w>
abdom inal,</w>
ab user.</w>
ab ine.</w>
ab ine-associated</w>
ab duction</w>
a. m.</w>
a. m.,</w>
a- Pacific</w>
a vascular</w>
a kin
a id.</w>
a etiology.</w>
a VF,</w>
a F
a ?</w>
] =
[K+ ]</w>
[8 ]</w>
[5- amino-
[3H] thymidine</w>
[2, 1-
[14 C]-
[10 ]</w>
[1-1 1
[1-11 C]
[1- (14)C]
[(2-methyl -1,3-
[(2-methyl-1,3- thiazol-4-yl)ethynyl]pyridine</w>
[ median</w>
[ bis
[ T
[ Li
[Li (+
[Li(+ )]</w>
[ G
[ Ca(2+)]
[Ca(2+)] (i)</w>
[ AUC
[ A
[ 7.
[ 19
[ 18
[ 13
[ 0.6
[ (125)I]
[ (+/-)-
Zol linger-Ellison</w>
Zn SO(4)</w>
Zidovud ine-induced</w>
Z yb
Z onisamide</w>
Z T
Z Rs.</w>
Z P)</w>
Yor k,</w>
Yale- Brown</w>
Y KP14
XE LOX</w>
X LH</w>
X I
X ;</w>
X 2</w>
X /
Willi ams</w>
Wil son</w>
Wh ilst</w>
Wernic ke's</w>
Washing ton</w>
Washing ton,</w>
Walk er</w>
WR 27
WR27 21</w>
W/ F
W/F u</w>
W- ICH.</w>
W is
W idespread</w>
W eigh
W ard</w>
W T
W PW</w>
W LP-S
WLP-S -10</w>
W I
W F-
W A</w>
W A-3
WA-3 35</w>
W ,</w>
Volum e</w>
Vol ume
Vincrist ine,</w>
Ves tibular</w>
Verapam il-induced</w>
Verapam il,</w>
Vehicle +
Vehicle+ Isoflurane</w>
Ve si
Val salva</w>
Vag otomy</w>
VM- 26</w>
VE R</w>
V on</w>
V m</w>
V indes
V PD</w>
V MR
V II.</w>
V I,</w>
V CD</w>
V AS-
V AS,</w>
V :</w>
V 3</w>
V 232
V 1-
V (1)</w>
Ursodeoxychol ic</w>
Ur gent</w>
Upjo h
Univers ity,</w>
Un controlled</w>
Ultra structure</w>
UT R</w>
US PI
US A.</w>
UMB 24</w>
UK-61, 26
UF T</w>
UF A)</w>
UD R)</w>
U/ ml,</w>
U.S. A.</w>
U-900 42</w>
U terine</w>
U claf</w>
U V</w>
U TIs.</w>
U RO
U N</w>
U MD
U K,</w>
U I.</w>
U GI</w>
Trimethoprim-sulfamethox azole-induced</w>
Tri phasi
Traum atic</w>
Tras ina</w>
Transc ranial</w>
Trans placental</w>
Trans dermal</w>
Tran smural</w>
Tran sit
Tourniqu et</w>
Tor r</w>
Tor on
Tn I</w>
Time -dependent</w>
Tim entin</w>
Ti e
Thrombo embolism</w>
Thir d,</w>
Thior idazine</w>
Theophyll ine-associated</w>
The ore
Th is,</w>
Th 1</w>
Tetrahydro cortisol</w>
Testo ster
Test ,</w>
Ten ofovir
Teli thromycin</w>
Techne tium-
Td R</w>
Tc ES</w>
Tax ol,</w>
Target ed</w>
Tamoxif en-induced</w>
Tam m-Horsfall</w>
Tacrolim us,</w>
TX B2</w>
TT X-
TT P.</w>
TP ).</w>
TMP y
TMP -induced</w>
TM S)</w>
TIMP -1</w>
TI -
THE O</w>
TGF-beta II
TGF-betaII R</w>
TG B</w>
TF MP
TCD D,</w>
TB OB</w>
T izanidine</w>
T ig
T iaz
T c)</w>
T UDC</w>
T SH,</w>
T SC
T LS</w>
T I</w>
T GR</w>
T GR
TGR (A
TGR(A 1-
TGR(A1- 7)
TGR(A1-7) 3
T FA</w>
T CC</w>
T CAs</w>
T C.</w>
T 9-
T 5</w>
T 4)</w>
T 1
Synerg istic</w>
Syndrome .</w>
Syn aptic</w>
Sw an-Ganz</w>
Sur viv
Sup port</w>
Sup ine</w>
Sulph asalazine</w>
Sulf asalazine</w>
Succinyl choline-induced</w>
Succ essive</w>
Subst anti
Suanzaoren tang</w>
Stri kingly,</w>
Strati fication</w>
Str ategies</w>
Stat ins</w>
Stand ardized</w>
St uttering</w>
St upor</w>
St ate-
St an
Squ amous</w>
Spironolact one-induced</w>
Spi ro
Specific ity</w>
Speci al
Spec tral</w>
Spe ech</w>
Sou theast</w>
Son ographic</w>
Somn ol
Somn ambul
So ft</w>
Smad 3</w>
Smac/ Di
Smac/Di ablo</w>
Sirolim us-induced</w>
Siri raj</w>
Single- agent</w>
Silden af
Signific antly,</w>
Shen fu</w>
Shakuyaku-kanzo- to</w>
Shakuyaku- Kanz
Shakuyaku-Kanz o-
Seventy- nine</w>
Sev en-
Sel enium</w>
Seiz ures,</w>
Sco res</w>
Schuknech t</w>
Sch war
Sch onlein</w>
Sar izotan</w>
Sal v
Sal ine,</w>
SY 5Y</w>
SUMMAR IE
SUMMARIE S:</w>
SULT 1
SU F</w>
STR AT
STRAT EG
STRATEG Y:</w>
ST- depression</w>
ST P1</w>
ST N.</w>
ST N-
SRL- based</w>
SR1417 16</w>
SR T</w>
SP- PI</w>
SOD 1</w>
SO N</w>
SN H
SM Vs</w>
SL P</w>
SL 327</w>
SK EO</w>
SI LE
SILE NT</w>
SI CH</w>
SI ).</w>
SHR SR</w>
SH x</w>
SH AM</w>
SG PT,</w>
SG ).</w>
SF O</w>
SERCA 2b</w>
SE M),</w>
SE Fs</w>
SD s</w>
SD S-
SD RR</w>
SD H</w>
SD :</w>
SCN5 A</w>
SCL S</w>
SCH 23390,</w>
SCH -
SC O</w>
SC .</w>
SB- 2
SB P.</w>
SB 33
SB33 48
SB3348 67</w>
SAR s</w>
SA A</w>
S.E.M .)</w>
S-3 12-
S- methyl
S- allylcysteine</w>
S- 3,4-DCPG</w>
S- 2-
S yrian</w>
S v
S tric
S ti
S poradic</w>
S p</w>
S ol
S light</w>
S can</w>
S can
S S.</w>
S S,</w>
S Q
S LV
S HC.</w>
S AD)</w>
S -treated</w>
S -associated</w>
S -18
S-18 1
Ry anodine</w>
Ros u
Riz atriptan</w>
Rit on
Rifamp in</w>
Rifamp icin-induced</w>
Rheum atology</w>
Rh esus</w>
Rg5/Rk 1</w>
Rg3 (S)</w>
Retro spectively,</w>
Retro spective,</w>
Retro grade</w>
Ret inol</w>
Ret ention</w>
Respon ders</w>
Repub lic</w>
Rel ax
Reg 2</w>
Recre ational</w>
Record ings</w>
Reci procal</w>
Rec on
Re liable</w>
Re al-
Rb +</w>
Rayna ud</w>
Random ised</w>
Randall-Selit to</w>
Ran kin</w>
Ran dom</w>
Radi otherapy</w>
Radi ological</w>
Radi al</w>
Rac emic</w>
RTI -3
RTI-3 36</w>
RT- PCR.</w>
RT X</w>
RT ).</w>
RPL S</w>
RP ).</w>
RN ase</w>
RL S,</w>
RG13 9
RG139 65</w>
RE M)</w>
RAE B-
RA C</w>
RA -treated</w>
R,4 R-
R, 3
R(+)- BAC</w>
R u
R osi
R hazya</w>
R ev
R ash
R as-
R PTP
RPTP beta</w>
R NS</w>
R HA</w>
R CM</w>
R :
R .
R -1
R (-
Quin pi
QT(F ri
QN B</w>
Q- A</w>
Q OD</w>
Q -induced</w>
Py raz
Psychopharmac ological</w>
Psych ophysical</w>
Pseudo ephedrine</w>
Prom pted</w>
Prolifer ating</w>
Proj ect
Proce dures</w>
Proble matic</w>
Prob ands</w>
Pro ver
Pro ducts</w>
Preser vation</w>
Prescri ption</w>
Pres sure</w>
Pres ently,</w>
Predic ting</w>
Precipit ation</w>
Pre- existing</w>
Pre mature</w>
Pre incubation</w>
Pre existing</w>
Por phyria</w>
Poly myositis</w>
Poly amines</w>
Po wer</w>
Po or</w>
Pm(O (2))</w>
Plat inum</w>
Pl us</w>
Pl aqu
Pit ts
Pir arubicin</w>
Pin sch
Pin acidi
Pimoz ide</w>
Pilocar pine-treated</w>
Pilocar pine,</w>
Pil o</w>
Physos tigmine,</w>
Phosph odi
Phosph atidyl
Philadelph ia</w>
Phenyl butazone</w>
Phenobarbit al-induced</w>
Pharmaco dynamic</w>
Person s</w>
Perox is
Perit oneal</w>
Peri -
Per centage</w>
Pentazoc ine-induced</w>
Pent oxifylline</w>
Pent obarbit
Park ,</w>
Parameter s</w>
Paradoxic ally,</w>
Par a
Pamid ronate</w>
Pal li
Pa w</w>
Pa CO</w>
Pa CO2,</w>
PW V</w>
PV R</w>
PV M</w>
PV L</w>
PV G
PVG /c</w>
PURPO SE</w>
PTH ,</w>
PT X.</w>
PT SD</w>
PT CA.</w>
PR O</w>
PR IN
PR I</w>
PR BC</w>
PR -
PPA DS</w>
PP Is</w>
PP I.</w>
PO SURE
PO RP</w>
PO 2,</w>
PIL O,</w>
PH AR
PGI 2.</w>
PG I-
PF C.</w>
PED F</w>
PE T.</w>
PE T,</w>
PE S</w>
PE MA</w>
PE AK</w>
PDGF- B</w>
PD C</w>
PC x</w>
PB SC</w>
PACAP +/-</w>
PAC PP</w>
PA LA</w>
PA K</w>
PA H.</w>
PA H,</w>
PA G)</w>
PA ;</w>
P< 0.0001).</w>
P4 50,</w>
P2 1,</w>
P/ 3/4</w>
P-glyco protein,</w>
P- positive</w>
P- immunoreactive</w>
P- BM
P- 3.0</w>
P yridox
P yr
P si
P s.</w>
P edi
P as
P arg
P ab
P S,</w>
P PVL</w>
P PCx</w>
P MM</w>
P M,</w>
P J
P I/
P I,</w>
P >0.05).</w>
P -1</w>
P );</w>
Oxy morphone</w>
Over dose</w>
Ouabain -induced</w>
Organ ophosph
Open- label</w>
One- hundred-
One ,</w>
Om ni
Om apatrilat</w>
Olanzap ine-treated</w>
Observ ation</w>
Ob struction</w>
OX R1</w>
OX O
OS U</w>
OR TC</w>
OR R</w>
OR L-1</w>
OR E</w>
OR /O
OR/O S-
OPC-145 97</w>
ON O-
OH D2</w>
O-(2- thiodiphosph
O t
O piate</w>
O perative</w>
O ]
O X</w>
O PD</w>
O P-induced</w>
O MD</w>
O M</w>
O CS.</w>
O C,</w>
O AD</w>
O A.</w>
O 2.</w>
O 2),</w>
O (2).</w>
Norepinephr ine-induced</w>
Nor triptyline</w>
Nor dic</w>
Non cardiac</w>
Nitrofur antoin-induced</w>
Nitro- L-arginine</w>
Nitro bid</w>
Nis sl-
Ninety- four</w>
Ninety- five</w>
Nic ergoline</w>
New ly</w>
Neurolep tics</w>
Neuro behavioral</w>
Nel son's</w>
Nec k</w>
Na- K-ATPase</w>
Na(v) 1.8</w>
Na(+)- K(+)-ATPase</w>
Na(+), K(+)-ATPase</w>
Na HCO
Na BB</w>
NZ W</w>
NT R)</w>
NT P</w>
NT G-
NT F</w>
NT /
NS- 398</w>
NS S</w>
NS E</w>
NS -3</w>
NP ).</w>
NO T</w>
NM U</w>
NH4 Ac</w>
NE T</w>
NE O</w>
NADPH- diaphorase</w>
NAD (P
NAD(P )
NAC -treated</w>
NA SH,</w>
NA PA</w>
NA F
NA -treated</w>
NA ).</w>
N6- cyclohexyladenosine</w>
N0 82</w>
N-nitrosodiethyl amine-initiated</w>
N-methyl-N'-nitro-N-nitroso guanidine</w>
N-methyl-D- aspartate,</w>
N-methyl- 2-
N-Methyl-D- aspartate</w>
N-76 A</w>
N- nitrosobut
N- n-propyl
N- methylox
N- lesioned</w>
N- ammonia</w>
N- [2-
N- (1-
N- (
N x</w>
N w-nitro-L-arginine</w>
N tcp</w>
N omega-nitro-L-arginine</w>
N odular</w>
N oc
N albu
N af
N W</w>
N PRS</w>
N L</w>
N IN
N ID
N E)</w>
N C.</w>
N 36
N36 3
N 1-
N (2)
Myo -
Myelo toxicity</w>
My otonia</w>
My ocet</w>
My algi
Muscim ol,</w>
Mun ich-Wistar</w>
Mu MT
Morph ologically,</w>
Mono amine</w>
Monit or
Mo(t )/
Mo dul
Mn PO</w>
Mito- Q</w>
Minoxidi l,</w>
Min i</w>
Mil der</w>
Micro gynon-
Michi gan</w>
Mg+ +</w>
Meto /HCTZ</w>
Methyl phenid
Methyl ene</w>
Metfor min-induced</w>
Met yrap
Met am
Mes alazine</w>
Meropen em</w>
Mer ck</w>
Medic ine,</w>
Med ullary</w>
Med Watch</w>
Mechan istic</w>
Meas ured</w>
Meas ure</w>
Me t</w>
Me droxyprogesterone</w>
Me dro
Me di
Mantel-Ha enszel</w>
Mala oxon</w>
Macroph ages</w>
Macro scopic</w>
Mac aca</w>
Ma haim</w>
MVO 2,</w>
MS SA</w>
MR C</w>
MR 1</w>
MR .</w>
MPE P,</w>
MP P
MP E</w>
MP ),</w>
MN PA</w>
MM F.</w>
MK-80 1-induced</w>
MK-80 1)</w>
MF S.</w>
MEDLIN E.</w>
ME NT</w>
ME ,</w>
MDR-T B</w>
MDMA (+)</w>
MD S/
MD K</w>
MD D)</w>
MCA v</w>
MCA O</w>
MCA -induced</w>
MATERIAL /METHODS:</w>
MAO- A</w>
MA G
MA D
MAD RS</w>
MA -exposed</w>
MA -abusing</w>
M3 G</w>
M- PGF2</w>
M orbidity</w>
M atri
M as</w>
M PA.</w>
M ORE</w>
M OR</w>
M OP</w>
M NPC</w>
M Hz</w>
M G.</w>
M CT/LCT</w>
M CL
M CA.</w>
M BP</w>
M AC)</w>
Lup us</w>
Lor acar
Lof ex
Loc alization</w>
Lis uride</w>
Lis dexamfetamine</w>
Lipo ic</w>
Lign ocaine</w>
Lidoca ine,</w>
LiCl -treated</w>
Li vers</w>
Li ver
Lev amisol
Leuc ovorin</w>
Leu -
Lenal idomide</w>
Le sion</w>
Late- onset</w>
Lat er,</w>
Las er</w>
LY1753 26</w>
LV S</w>
LV H</w>
LRTI s</w>
LP S-induced</w>
LP C</w>
LO S</w>
LHR H,</w>
LH-Z I</w>
LE C</w>
LDL- cholesterol</w>
LD F</w>
LD (50)</w>
LCR /HC
LCR/HC R</w>
LC 6
L-arginine- nitric</w>
L-N MMA,</w>
L-N I
L-DO PA)</w>
L-36 5,
L-365, 260</w>
L- lysin
L- glutamate</w>
L- NO
L- 655
L-655 ,
L-655, 70
L- 3,4-dihydroxyphenylalanine</w>
L umbar</w>
L ox
L ometrexol</w>
L in
L ength</w>
L e</w>
L amb
L actic</w>
L ])</w>
L W</w>
L V)</w>
L SD</w>
L R)</w>
L P)</w>
L OC</w>
L N)</w>
L CB
L CA
L AC,</w>
L 1-
L 1,</w>
Kore a.</w>
Kir 6.2</w>
Kir 2.3</w>
Kingdom ,</w>
Kidne ys</w>
Ken y
Kain ic</w>
KT- 362</w>
KRH- 594</w>
KOPr -1</w>
KMgC it</w>
KCD- 232</w>
K+- channel</w>
K ey</w>
K et</w>
K appa
K RAS</w>
K IT</w>
K Cl
K A.</w>
K 8</w>
K (m)</w>
K (i
J ust</w>
J udg
J o-
J NK
J ).</w>
Isoproteren ol-treated</w>
Ir -
Ir- CP
Ion tophore
Investig ators.</w>
Invent ory,</w>
Intrathec ally</w>
Intrac arotid</w>
Intra striatal</w>
Intra renal</w>
Intr apl
Inter ventions</w>
Inter active</w>
Inten si
Inte gr
Institut e,</w>
Inj ectable</w>
Inhibit or</w>
Index .</w>
Incl uding</w>
In ulin</w>
In tractable</w>
In toxic
In stead</w>
In somnia</w>
In otropic</w>
In ner</w>
In g
In duc
Impressions- Severity</w>
Immuno fluorescent</w>
Immuno electron</w>
Immuno deficiency</w>
Immun ologic</w>
Imipen em</w>
Ig G.</w>
Ifosf amide
Idi osyncr
Ib g</w>
IV th</w>
IV U</w>
IV I
IVI G</w>
IV B</w>
IU/ kg</w>
IU/ L;</w>
IT S)</w>
IT Pase</w>
IT ERI
ITERI A:</w>
ISO P</w>
IS /
IS ).</w>
IP SC</w>
IP R</w>
IP H</w>
IO CM</w>
INTERVEN TION
IMPA 1</w>
IM/ P/3/4</w>
IL-1 beta,</w>
IL- 6-/-</w>
III A</w>
II B
IIB 7
II -</w>
IGF- I,</w>
IFN- alpha-2b</w>
IF S-</w>
IC P.</w>
IC (50)</w>
I- IV</w>
I- II)</w>
I sosorb
I shihar
I ra
I owa</w>
I le</w>
I bogaine</w>
I b/
I X,</w>
I R,</w>
I MT</w>
I M.</w>
I M)</w>
I HD,</w>
I GE</w>
I B-
IB- ME
I AN</w>
I (Na
I (2)</w>
Hyper prolactinaemia</w>
Hyper ammonemia</w>
Hydroxy zine</w>
Hydr ation</w>
Hy paque</w>
Hsp 27</w>
Hospit als</w>
Hist ochemical</w>
His -
Hg/ min</w>
Hg ]</w>
Hero in</w>
Hepat ocytes</w>
Hepar an</w>
Henoch -
Henoch- Schonlein</w>
Hemat ocrit</w>
Head ache,</w>
Haemodi lution</w>
HV A/
HV A,</w>
HU-2 10</w>
HU TT</w>
HU ,</w>
HT N-
HSP G</w>
HSP 73</w>
HS P-
HRCB P</w>
HPL C-
HP +
HO CM</w>
HO -1</w>
HMR-18 26</w>
HL 60</w>
HIV- negative</w>
HI T-positive</w>
HET 00
HET00 16</w>
HD- CTX</w>
HD AR
HCT Z.</w>
HC B</w>
HBsAg ,</w>
HBeAg .</w>
HB c
HB MP</w>
HB D
HB ,</w>
HAT T.</w>
HAM D</w>
HAL ,</w>
HAAR T.</w>
HA- 966</w>
H2 O2</w>
H2 O.</w>
H/ M</w>
H- benz
H- PILO</w>
H u</w>
H ir
H ence</w>
H el
H e-Ne</w>
H cy</w>
H abit
H S)</w>
H N,</w>
H MM</w>
H LR</w>
H H</w>
H FS</w>
H E)</w>
H Ch
H CBD</w>
H AT</w>
H AS</w>
H 9
Gu an
Gs- coupled</w>
Grou pe</w>
Gre en
Gram -
Golgi -
Glu R-3</w>
Gl a</w>
Gi ant</w>
Gemfibro z
Ge fit
Gam ma-
Gall amine</w>
Gal lium</w>
GV IA</w>
GT S</w>
GT CSs</w>
GST- P-positive</w>
GSH P
GR1389 50,</w>
GP i,</w>
GP IIb/IIIa</w>
GL UT
GF R-
GF -induced</w>
GE N</w>
GB R</w>
GAP 43-
GAP43- ir</w>
GABA- peptides</w>
GABA- B</w>
GABA(A )-
GA ER
G( o)</w>
G y,</w>
G ri
G px
G illes</w>
G ene
G al</w>
G U</w>
G STP1</w>
G P)</w>
G L-
G CF</w>
G AE
GAE E</w>
Fre e
Fran cis
Four -
Fos B</w>
Forty- seven</w>
Form alin</w>
Fluoro-J ade
Fluoro J
Flun it
Fluc loxacillin</w>
Flu voxamine</w>
Flu o
Fin ally</w>
Fibro Scan</w>
Fentan yl,</w>
Feder al</w>
Fe brile</w>
FcgammaR II
Fallo t.</w>
Fallo t,</w>
FZ- enanthate</w>
FZ- decanoate</w>
FVB/ n</w>
FV B</w>
FSG S.</w>
FL AIR</w>
FK3 17</w>
FJ +</w>
FI GO</w>
FE F
FCH L</w>
FANFT---- 5%</w>
FANF T-induced</w>
F- PAN</w>
F z</w>
F usidic</w>
F ixed</w>
F ent</w>
F enol
F emoden
F UR</w>
F T)</w>
F S,</w>
F N,</w>
F LA</w>
F IVB</w>
F F</w>
F Cs</w>
F AD</w>
F AB</w>
F (
Extrac orporeal</w>
Extr adural</w>
Experi ences</w>
Exerci se-induced</w>
Ex agger
Ethin ylestradiol</w>
Eth inyl</w>
Esc italop
Es sen
Er got</w>
Epo etin</w>
Epilep tiform</w>
Eosinophil ia</w>
Environ mental</w>
Endo MT</w>
En zym
En tec
En flurane</w>
En d</w>
Empir ical</w>
Embry onic</w>
Electrocardio grams</w>
Eigh t-
Eff icac
Eff ect
EX POSURE
ET -1,</w>
ET (A
EPO- resistant</w>
EP3 (-/-)</w>
EP I-ex
EP ),</w>
EM ).</w>
EK C,</w>
EG C</w>
EF AD</w>
ED-1- positive</w>
ECE -1
EC ,</w>
EB RT</w>
E- 9,
E verolim
E st
E le
E duc
E ast</w>
E ar</w>
E V</w>
E SAE</w>
E Q</w>
E ORTC</w>
E OP
E HDP</w>
E GT
E GFP</w>
E GF-
E 17</w>
Dys arthria</w>
Dyn orphin</w>
Dy sp
Dro p</w>
Dox .</w>
Dow n-regulation</w>
Dom peridone</w>
Dofe tilide</w>
Docetax el,</w>
Dobut amine-atropine</w>
Do b</w>
Dizzin ess</w>
Disulfir am-induced</w>
Dist inc
Dis continuance</w>
Dil antin</w>
Diethyl stilbestro
Diclofen ac-induced</w>
Diarrhe a</w>
Di privan
Di git</w>
Di aly
Dextromethorph an</w>
Dexamethas one-induced</w>
Dex medetomidine,</w>
Dex -treated</w>
Dex )</w>
Detail s</w>
Des c
Dermat omyosi
Dep oCyte</w>
Den /
Demo graphic,</w>
Def ective</w>
Decemb er,</w>
Dec .</w>
De sign,</w>
Dan azol-induced</w>
DX ,</w>
DTI C,</w>
DT- diaphorase</w>
DT G</w>
DT FC</w>
DR R</w>
DPO AE</w>
DPD PE</w>
DOTAT OC</w>
DN P</w>
DN P-
DMB A-induced</w>
DM O</w>
DM H</w>
DL B.</w>
DK-35 C</w>
DF P.</w>
DE ,</w>
DD T-induced</w>
DCX- labeled</w>
DC G-
DB P,</w>
DA-8 159</w>
D-Tr p
D- rich</w>
D- glucose</w>
D- arginine</w>
D- amphetamine.</w>
D- amphetamine-induced</w>
D- Phe
D(1 A)</w>
D ronedarone</w>
D r
D oberman</w>
D en</w>
D e</w>
D andy</w>
D VT,</w>
D P)</w>
D MP</w>
D MP
D MI
D M,</w>
D IP</w>
D II
D HC
D GF.</w>
D G.</w>
D G)</w>
D CP</w>
D CM</w>
D CK
D A.</w>
D 1,</w>
D (4)</w>
D (3),</w>
Cypro terone</w>
Cypro heptadine</w>
Cyc le</w>
Cy totoxic</w>
Cy tomegalovirus</w>
CsA- based</w>
Cs/ HP
Cs A-treated</w>
Cro ton</w>
Cra ving</w>
Cr yst
Cr ypt
Cour ses</w>
Corne al</w>
Cor relates</w>
Contrast ing</w>
Contrac eption</w>
Continu ation</w>
Consci ous,</w>
Condi tioned</w>
Concentr ation</w>
Concentr ation-
Con tra
Con ner
Con duction</w>
Competi tive</w>
Common ly</w>
Com posite</w>
Com plic
Coca ethylene</w>
Co ffe
Clozap ine-associated</w>
Clo fibrate</w>
Clin opodium</w>
Classi cal</w>
Cisplat in-induced</w>
Cis apri
Cimeti dine,</w>
Cimeti d
Chromos omes</w>
Chloro procaine</w>
Chlorambuc il-induced</w>
Child hood</w>
Child 's</w>
Char ts</w>
Ch ,</w>
Cent re,</w>
Cd kn
Caud a</w>
Catal ep
Carmo fur
Cardiomy ocyte</w>
Cardi otoxic</w>
Cardi ogenic</w>
Carbo platin,</w>
Carb onic</w>
Carb enicillin</w>
Capecit abine-induced</w>
Cambodi an</w>
Cab ergoline</w>
CaMK II
Ca/ Cr</w>
Ca(2+ )
Ca M</w>
Ca Cl</w>
Ca -
Ca (V
Ca(V )
Ca(V) 3.2</w>
CYP2C8 *3</w>
CYP2C 8</w>
CYP2 B1</w>
CYP1A2*1 F</w>
CYP- injected</w>
CYP s</w>
CY -induced</w>
CX 3CR
CX3CR 1</w>
CV- L</w>
CV O</w>
CTR -
CT Z</w>
CT L</w>
CT D</w>
CS P</w>
CS -
CR T</w>
CR T.</w>
CR ITERIA:</w>
CR F,</w>
CPT -P
CPT -1
CP X</w>
CP P)</w>
CP F
CP B</w>
COX- inhibitors</w>
CONCLUSION S/
CO N</w>
CO .</w>
CNI- free</w>
CN Is</w>
CN Is.</w>
CN I-induced</w>
CMR g</w>
CM G</w>
CL218 ,872</w>
CL O</w>
CL ,</w>
CK D.</w>
CI M</w>
CI C</w>
CHF3 381</w>
CH D,</w>
CH AR
CHAR GE</w>
CGRP 8-
CGRP8- 37</w>
CGRP (8-
CGI- I</w>
CG A,</w>
CG ,</w>
CD A</w>
CD 7
CD 40</w>
CD 40-
CD 36</w>
CD 34</w>
CCl 4-induced</w>
CCR 7,</w>
CCR 10</w>
CCK- B</w>
CCK- A</w>
CC U</w>
CB IR</w>
CB D-rich</w>
CAF F-PAN</w>
CAB G</w>
CA P.</w>
CA M
CA 2</w>
C57Bl/ 6</w>
C57B L</w>
C1 q</w>
C/ 2</w>
C. I.</w>
C- type</w>
C- nociceptor</w>
C- fibre</w>
C- dams</w>
C ot
C lu
C eph
C ell
C HB.</w>
C F1</w>
C EEG</w>
C CO
C 4,</w>
C +
But orphanol</w>
Busulf an-induced</w>
Buerg er</w>
Bud d-Chiari</w>
Brugada- type</w>
Brugad a-like</w>
Bre vicon</w>
Braz il,</w>
Brady kinesia</w>
Brady cardia,</w>
Bonferron i</w>
Bo ard</w>
Bis pectral</w>
Bim oclo
Bim atoprost</w>
Bilirub in</w>
Bi phasic</w>
Bi ochemically,</w>
Beta- blocker</w>
Beta- adrenergic</w>
Bel gi
Behavi oral,</w>
Basel ,</w>
Baro receptor</w>
Bac kgro
BUN ,</w>
BQ 123</w>
BP O</w>
BO LD</w>
BM S-181
BH ),</w>
BH (4)</w>
BD10 63</w>
BB PRI</w>
BAM-1 120</w>
B6 NCr
B- precursor</w>
B- 24
B urkit
B t
B locking</w>
B ladders</w>
B in
B c
B arbit
B ang
B allo
B ack</w>
B V</w>
B SP</w>
B S-
B RAC</w>
B IIB7
B IH</w>
B EAC
B CA
B B-
B A</w>
B .
B -associated</w>
B (t)</w>
Ax onal</w>
Avy/ a</w>
Auto antibodies</w>
Aut oradi
Aug ment
Atten tional</w>
Atri um</w>
Atax ia</w>
Ast emiz
Aspir in,</w>
Asi a-Pacific</w>
As say</w>
As partate</w>
Arg 296
Arg296 Cys</w>
Ar ti
Ar th
Ar te
Ar rest</w>
Ar n
Apomorph ine-induced</w>
Antin ociception</w>
Anti- inflammatory</w>
Anti viral</w>
Anti thyroid</w>
Anti sense</w>
Anti psycho
Angio vist-
Angio graphic</w>
Ang (1-7)</w>
Ander son</w>
Anaphyl actic</w>
Analgesi c
Anaestheti sts</w>
An x
An tigen</w>
An tenatal</w>
An atom
An aemia</w>
Amp icill
Amp B</w>
Aminoglyco side-induced</w>
Amino oxyacetic</w>
Amin ophyll
Amin o-
Americ an,</w>
Am p</w>
Altern ating</w>
Al end
Al bumin</w>
Al a-
Ak t/
Age -dependent</w>
Adriam ycin-
Adju st
Ad. N
Ad dison's</w>
Ad -
Acceler ated</w>
Ac -
Abecarn il</w>
Ab stin
Ab rupt</w>
Ab n-cb
AVP- stimulated</w>
AV NRT</w>
AUC s</w>
AU C.</w>
AU C,</w>
ATT- ALF</w>
ATI N.</w>
AT T</w>
AT RA-induced</w>
AT .</w>
AT ).</w>
ASA- dipyridamole</w>
AS L</w>
AS H</w>
AS A.</w>
AS 18
AS18 92
AS .</w>
ARN- x</w>
ARB s</w>
AR T.</w>
AR A-
APPRO Ve</w>
APD C</w>
AO- 8</w>
AN R</w>
AN ES</w>
AM N082</w>
ALA- synthetase</w>
AL ,</w>
AK- FLU
AK T1</w>
AI d</w>
AI c</w>
AI U</w>
AI N-76A</w>
AI N,</w>
AI ),</w>
AER D</w>
ADR- E
ADP- ribosylation</w>
AD X-
AD T</w>
AD NF
AD HD-
ACTH -independent</w>
ACE- inhibitor</w>
AC(- O
AC S)</w>
AC R</w>
AC E,</w>
AC A</w>
AB CD</w>
AB CB1</w>
AA F)</w>
A/ LPS</w>
A/ B</w>
A- to-G</w>
A- mediated</w>
A- delta</w>
A- I,</w>
A voiding</w>
A tazana
A o</w>
A necdotal</w>
A m</w>
A im</w>
A egle</w>
A delta-
A cit
A ci
A beta</w>
A X
A TIN</w>
A ST,</w>
A R)</w>
A Q-A</w>
A HR</w>
A GE
A G,</w>
A ALF</w>
A 2)</w>
A 1,</w>
> 500</w>
> 5.0</w>
> 40</w>
> 25%</w>
> 15</w>
= 250</w>
= 12</w>
< 60</w>
< 50</w>
< 300</w>
< 0.01)</w>
< 0.0001),</w>
< .01),</w>
< .001),</w>
< .0
: 00
99 8</w>
99 4</w>
99 ),</w>
90- day</w>
90 9</w>
9. 1%</w>
9- week</w>
9- ethyladenine</w>
9- cis-retinoic</w>
9 :00</w>
9 90</w>
9 8%,</w>
9 7)</w>
9 62</w>
9 6-hour</w>
9 6,</w>
9 6)</w>
9 54</w>
9 5),</w>
9 45</w>
9 4),</w>
9 3%,</w>
9 1-
9 1%,</w>
9 1
85/ 340</w>
80 00</w>
80 +/-
8/ 10</w>
8. 8%</w>
8. 6%</w>
8. 5%)</w>
8. 2%</w>
8-phenyl theophylline</w>
8-amino quinoline</w>
8- MOP</w>
8 ].</w>
8 ]
8 9-year-old</w>
8 7).</w>
8 6)</w>
8 6%)</w>
8 5).</w>
8 1.
8 -</w>
77 434</w>
75 th</w>
726 64</w>
7/ 10</w>
7. 4%;</w>
7. 3%</w>
7. 2%</w>
7. 1%</w>
7. 1%)</w>
7-oxo- PgI2</w>
7- week</w>
7- F
7 9,</w>
7 7)</w>
7 6-
7 6),</w>
7 53</w>
7 3-
7 3)</w>
7 3).</w>
7 2%.</w>
7 2
7 1,</w>
7 1%,</w>
7 0.5%</w>
7 0.0</w>
67 -1
65- 65
65-65 70</w>
64 139</w>
600 1</w>
60- 80</w>
60 1</w>
60 -120</w>
6. 3,</w>
6. 1,</w>
6-oxo- prostaglandin</w>
6-keto-PG F
6-hydroxy melatonin</w>
6-hydroxy dopamine.</w>
6-hydroxy dopamine-
6-OHD A/LPS</w>
6- week,</w>
6- tetramethyl
6- methoxy-
6 9)</w>
6 9%)</w>
6 8-
6 8%,</w>
6 7).</w>
6 5.</w>
6 5.3</w>
6 5%)</w>
6 48</w>
6 43</w>
6 2,</w>
6 17</w>
6 162</w>
6 13</w>
6 1%,</w>
6 );</w>
5alpha- reductase</w>
5HT 2</w>
59 2,</w>
59 ),</w>
58 6</w>
56999 A</w>
56 ;</w>
56 %.</w>
559 40</w>
552 12-
55,9 40</w>
55 ;</w>
55 9</w>
55 %.</w>
500 -1000</w>
50- 60</w>
50 ;</w>
50 8</w>
50 6.</w>
5. 7%</w>
5. 3,</w>
5. 3)</w>
5-hydroxytryptamine (1
5-hydroxytryptamine(1 A)</w>
5-hydroxytrypt amine,</w>
5-di methyl-
5-bromo-2'- deoxyuridine</w>
5-HT1B/ D</w>
5-HT(1B/ 1
5-HT(1B/1 D)</w>
5-HT(1A)- receptor</w>
5-HT(1 B)</w>
5-HT 1-like</w>
5-HT -1
5-FU/ LCV</w>
5-FU -related</w>
5-F (2
5-F(2 t)-
5-1 50</w>
5- ethyl-5-
5'- triphosphate</w>
5'- O-(2-thiodiphosph
5'- N-ethyl
5 99
5 9-
5 82</w>
5 8-
5 8).</w>
5 6).</w>
5 43</w>
5 37</w>
5 3.9</w>
5 3.7</w>
5 13</w>
5 1)</w>
48/ 80</w>
48 9</w>
48 5</w>
48 0-
45 Ca2+</w>
45 3</w>
45 +/-
44. 4%</w>
44 408</w>
40- min</w>
40- 59
40 s</w>
40 3</w>
40 ,000</w>
4/ 10</w>
4. 9%</w>
4. 8%</w>
4. 7%</w>
4. 3,</w>
4. 2,</w>
4. 1)</w>
4. 0,</w>
4- week-old</w>
4- month-old</w>
4- iPTH</w>
4- HC</w>
4, 0
4'- epi-doxorubicin</w>
4 ],</w>
4 H-
4 90</w>
4 9+/-
4 8.5</w>
4 8.4</w>
4 79</w>
4 7.</w>
4 7).</w>
4 62</w>
4 50,</w>
4 5).</w>
4 4;</w>
4 36</w>
4 3).</w>
4 3%.</w>
4 28</w>
4 23</w>
4 1-
4 0.8</w>
4 0.1</w>
4 0.0</w>
4 ,000</w>
4 +
4 %
3H- TBOB</w>
3: 1)</w>
39. 9</w>
39 4</w>
39 3</w>
38 ;</w>
38 9
38 5</w>
38 227</w>
38 +</w>
3784 9,</w>
37. 6</w>
37 ;</w>
37 6</w>
37 4</w>
37 ),</w>
36. 3</w>
36 ;</w>
35 S-
34 ;</w>
33 %.</w>
320/ 25</w>
30- year</w>
30- month-old</w>
30- 35</w>
30 9</w>
30 -</w>
30 ,
30 );</w>
3/ 8</w>
3.0 ;</w>
3. 95</w>
3. 7,</w>
3. 7)</w>
3. 63</w>
3. 52</w>
3. 4-fold</w>
3. 4,</w>
3. 2;</w>
3. 1-
3. 1,</w>
3. 0.</w>
3-methyl chol
3-1 99
3-(3- hydroxyphenyl)-
3- minute</w>
3- mg/kg</w>
3- methyl-5-
3- methoxy
3- fold)</w>
3- OH-H
3- 8</w>
3- 4)</w>
3,7- disulf
3,4- DC
3,4- DAP,</w>
3'- azido-3'-deoxy
3' UTR</w>
3 =
3 5.6</w>
3 5.4</w>
3 42</w>
3 4.5</w>
3 37</w>
3 36</w>
3 32</w>
3 2).</w>
3 2%).</w>
3 14</w>
3 1/
3 1.1</w>
3 1-
3 1%,</w>
3 0.8</w>
3 0.8%</w>
3 +</w>
3 )-
3 (2H)-
2A/ 2C</w>
29. 4</w>
29. 4%</w>
28 5</w>
28 00</w>
27. 8</w>
27. 7</w>
27. 6</w>
27. 6%</w>
27. 4</w>
26. 7</w>
26. 3</w>
26 /
25. 9</w>
25. 5</w>
25- OHD2</w>
25 8</w>
25 %;</w>
24. 9</w>
24. 5%</w>
24. 1</w>
24- month-old</w>
24 th</w>
24 -</w>
24 %)</w>
23. 1</w>
23 762</w>
23 0
23 .</w>
23 +/-
22. 9%</w>
22- oxacalcitriol</w>
200- 300</w>
200 5).</w>
200 2),</w>
200 1).</w>
200 0).</w>
200 0),</w>
200 0
20- min</w>
20- day-old</w>
20- 24</w>
20 655
20 1-
201- 99
20 );</w>
2/ day</w>
2.0 ;</w>
2.0 6</w>
2. 9-
2. 9,</w>
2. 8-
2. 8).</w>
2. 8%,</w>
2. 6,</w>
2. 54</w>
2. 46</w>
2. 45</w>
2. 3,</w>
2. 21</w>
2. 2-
2. 10</w>
2-1 99
2-1 2</w>
2-1 .0
2- propion
2- methoxy-4-
2- methoxy
2- ethylhex
2- dimensional</w>
2- deoxy-
2- adrenoreceptor</w>
2- adrenoceptors.</w>
2- 8</w>
2- 2</w>
2,3- dihydroxy
2,3- dihydrobenzofuran-7-
2,3,7,8- tetrachlorodibenzo-p-dioxin</w>
2,3,4- tetrahydro-
2, 8
2 beta-
2 R)</w>
2 D
2 2.6</w>
2 2.3</w>
2 2%,</w>
2 2%)</w>
2 1;</w>
2 14
2 13)</w>
2 10
2 1.8</w>
2 0.2</w>
2 +)</w>
2 ))</w>
1H- NMR</w>
1A 2,</w>
1:200 ,000</w>
199 3-199
199 1-1
198 1).</w>
197 6,</w>
197 55</w>
197 1,</w>
1960 s,</w>
19. 6</w>
19. 4</w>
19 72</w>
19 67</w>
19 65</w>
19 64</w>
18. 6%</w>
18. 2</w>
18- hydroxy
18 00</w>
18 0,</w>
18 %)</w>
17. 3%</w>
17 %.</w>
16,23- D(3)</w>
16 th</w>
16 0-
16 -1
16 %;</w>
15d-PG J2</w>
15. 9</w>
15-178 8.</w>
15-178 8,</w>
15- 21-day-old</w>
15 A10</w>
15 00-mg</w>
14C- IMPPA</w>
14. 8%</w>
14. 2%</w>
14 00</w>
14 ,
14 %.</w>
13. 5%</w>
13 9.</w>
13 5)</w>
13 0
12. 3+/-
12- wk</w>
12- dimethylbenz
12 5)</w>
12 10</w>
12 -18</w>
12 -14</w>
12 %).</w>
11/ 15</w>
11. 5%</w>
11 beta-hydroxysteroid</w>
100- 200</w>
100 ).</w>
100 %).</w>
10/ 11</w>
10.0 ,</w>
10- unit</w>
10- mg/kg</w>
10- day-old</w>
10- cm</w>
10(9)/ l,</w>
10(9)/ L)</w>
10(6 )/
10(3)/ microliter
10 7.
10 172</w>
10 -</w>
1.5 8-
1.0 3</w>
1. 95</w>
1. 85</w>
1. 84</w>
1. 56</w>
1. 54</w>
1. 50</w>
1. 5-fold</w>
1. 5)</w>
1. 5%),</w>
1. 47</w>
1. 42</w>
1. 28</w>
1. 27,</w>
1. 22</w>
1. 21</w>
1. 2-1
1. 2).</w>
1. 13</w>
1. 12</w>
1. 11,</w>
1. 10-
1. 1-1.
1. 1-1
1. 1).</w>
1. 00-
1-1 2</w>
1-1 00</w>
1- {3-
1- null</w>
1- methyl
1- infected</w>
1- antitrypsin</w>
1- adrenoceptors.</w>
1- 5)</w>
1- 4)</w>
1,8 4-iPTH</w>
1,4- dihydropyridine</w>
1,3- bis(2-chloroethyl)-1-nitrosourea</w>
1,25-(OH)2D 3.</w>
1,25-(OH)2 D2</w>
1,25- (OH)2-
1,25(OH)2D 3.</w>
1, 700</w>
1, 57
1, 5-
1 st,</w>
1 ]).</w>
1 0.6
1 -10
0/ Eho</w>
0.9 7,</w>
0.9 6).</w>
0.8 5,</w>
0.8 1;</w>
0.8 -1.
0.7 8,</w>
0.7 2).</w>
0.7 %)</w>
0.6 7,</w>
0.6 4,</w>
0.6 3,</w>
0.6 2,</w>
0.5 9,</w>
0.5 1,</w>
0.5 -1.0</w>
0.4 9,</w>
0.4 %;</w>
0.4 %).</w>
0.3 ;</w>
0.3 7,</w>
0.2 2,</w>
0.2 %.</w>
0.04 5).</w>
0.04 2).</w>
0.04 );</w>
0.03 1).</w>
0.02 6)</w>
0.000 4).</w>
0.00 8</w>
0.00 6</w>
0.00 6),</w>
0.00 3-
0.00 1.</w>
0.0 8%</w>
0.0 7)</w>
0.0 6,</w>
0.0 34</w>
0.0 32</w>
0.0 3-
0.0 29).</w>
0.0 25,</w>
0.0 17).</w>
0.0 16).</w>
0.0 15</w>
0.0 13).</w>
0.0 12)</w>
0.0 12
0.0 1);</w>
0.0 ).</w>
0.0 %),</w>
0. 8-
0. 7)</w>
0. 5%)</w>
0. 28
0. 25).</w>
0. 2).</w>
0. 16).</w>
0. 16
0. 15,</w>
0. 11,</w>
0. 10,</w>
0. 1%)</w>
0-1 99
0- 3.</w>
0 8</w>
0 ,000</w>
0 );</w>
/ year.</w>
/ 8
.g -1.
.000 1</w>
.00 5</w>
.00 3)</w>
.0 3)</w>
. 14).</w>
. /
. -
-16ene- 23
-14 C]
-100 %</w>
-10 (-
-1. 25</w>
-1,2- bis(3,
-1, 2,3,4-tetrahydro
-1 8.
-1 5-
-1 4,
-1 25</w>
-- the</w>
- the</w>
- squ
- pull</w>
- active</w>
- a-
- We
- 5
- 4</w>
- 48</w>
- 3.
- /-)</w>
,00 0
+/-1. 6</w>
+/-1. 2</w>
+/-1. 0</w>
+/-1 7</w>
+/-1 6</w>
+/- 5</w>
+/- 2</w>
+ MR-
+ +</w>
)- selective</w>
)- like</w>
) dt/
) and</w>
) >
) (-/-)</w>
) %</w>
(v/ v)</w>
(thre e),</w>
(stat ins)</w>
(s d</w>
(s d)</w>
(r= 0.9
(r TMS)</w>
(pHi )</w>
(p< 0.001),</w>
(p seud
(n= 8),</w>
(n= 6),</w>
(n= 50),</w>
(n= 5);</w>
(n= 3)</w>
(n= 20)</w>
(n= 19)</w>
(n= 16)</w>
(n= 14
(n= 10</w>
(mGluR 5)</w>
(m RNA)</w>
(i.p. ))</w>
(four ),</w>
(e NO
(dd C),</w>
(control s).</w>
(cTn I)</w>
([ Ca2+]
(YMR S),</w>
(Wor ld</w>
(W MD</w>
(V T),</w>
(V SD)</w>
(V OD
(V M
(V D
(V AS</w>
(Td P).</w>
(TT P/
(TR H)</w>
(TP R)</w>
(TM P)</w>
(TH )</w>
(TD F)</w>
(TD 50)</w>
(T or
(T T)</w>
(T S)</w>
(T S
(T NS)</w>
(T GF
(T CD
(T C),</w>
(T AM)</w>
(Spear man's</w>
(SR S)</w>
(SA P,</w>
(S)- 4-
(S er
(S e
(S S)</w>
(S R</w>
(S NS)</w>
(S GO
(S F
(S D,</w>
(S D),</w>
(S Cr)</w>
(S AP
(S A)</w>
(RT- PCR)</w>
(RR s)</w>
(RB C)</w>
(R,S)- AM12
(R W
(R VL
(R T
(R NS)</w>
(R CT
(R A).</w>
(R A),</w>
(R =
(R )
(QT Ls)</w>
(Q O
(Ph armacia</w>
(PV C)</w>
(PT U),</w>
(PT ),</w>
(PR L)-
(PIL O)</w>
(PGI 2),</w>
(PE G-
(PCI ).</w>
(PC T)</w>
(PANS S),</w>
(P< 0.001);</w>
(P< .05).</w>
(P< .01).</w>
(P SA)</w>
(P R</w>
(P NP)</w>
(P DT
(P CI)</w>
(P ),</w>
(P '</w>
(O r
(Na Cl)</w>
(NSAID ).</w>
(NO )-
(N SC-
(N SC
(N EC
(N DE
(N BQ
(N AD
(N A),</w>
(N /
(MP H)</w>
(MMP s)</w>
(MM P)</w>
(MM F)</w>
(MK-80 1)</w>
(MI F)</w>
(MH PG)</w>
(ME )</w>
(MD S).</w>
(MB C).</w>
(MAO Is)</w>
(M rp
(M g)</w>
(M RP
(M C)</w>
(M BP)</w>
(M AC)</w>
(LT P)</w>
(L I
(L E)</w>
(L CBF)</w>
(L A</w>
(Ig G)</w>
(IN R</w>
(IL- 6)</w>
(IC (50)</w>
(IB D).</w>
(I(K r
(I S)</w>
(I P
(I NH
(I K
(I F)</w>
(I A)</w>
(I /
(I -
(HD- MTX)</w>
(HBsAg ),</w>
(HBeAg ),</w>
(HB V).</w>
(HAT T)</w>
(H SCT)</w>
(H P)</w>
(H A)</w>
(Glu R
(GST- P)</w>
(GP x),</w>
(GGT ),</w>
(GE M)</w>
(G ST)</w>
(G R)</w>
(G P)</w>
(G M-
(G GT)</w>
(G )</w>
(FEV 1,</w>
(FEV 1)</w>
(FE SS)</w>
(FD P)</w>
(F os
(F lu
(F M
(F 344)</w>
(F -
(EP S),</w>
(EP M)</w>
(ELIS A)</w>
(EC E
(E str
(E KG)</w>
(E AD
(E AA)</w>
(E ),</w>
(DXR )-induced</w>
(DSM-III- R)</w>
(DSM- IV</w>
(DOCA)- salt</w>
(DO X),</w>
(DH P)</w>
(DES)- exposed</w>
(DE X
(DD AVP)</w>
(D iazemul
(D bh</w>
(D ay</w>
(D WI)</w>
(D TI
(D T
(D R)</w>
(D P</w>
(D IC).</w>
(D I)</w>
(D G
(Cy tox
(Ca, L)</w>
(Ca (2+
(CYP2 C
(CY P
(CS P)</w>
(CS F),</w>
(CS A)</w>
(CR P)</w>
(CR ).</w>
(CP M)</w>
(CO X
(CN I)</w>
(CM R)</w>
(CM F)</w>
(CH D)</w>
(CDD P)</w>
(CCB s)</w>
(CA R)</w>
(C57 B
(C ap
(C SE)</w>
(C RF
(C Q)</w>
(C PP).</w>
(C OR
(C K
(C HB)</w>
(C HB).</w>
(C C)</w>
(C AT),</w>
(C AT
(C .
(C -
(C ,</w>
(Bo NT/
(BU P)</w>
(B IC),</w>
(B E)</w>
(B D)</w>
(B BB
(B 6)</w>
(AZ A)</w>
(AU C</w>
(AR C)</w>
(AN F)</w>
(AM PA)</w>
(AL A)</w>
(AER S)</w>
(AED s).</w>
(AED s),</w>
(ADR ),</w>
(AD R-
(AD H)</w>
(AC Ei
(AC C)</w>
(A SE
(A O
(A LT,</w>
(A HF)</w>
(A EC
(A AL
(A A),</w>
(> 15</w>
(< 10</w>
(95% CI:</w>
(9. 8</w>
(9. 2%)</w>
(9 9</w>
(9 5%)</w>
(9 2</w>
(9 0
(87. 5%)</w>
(8. 7</w>
(8. 3</w>
(8-OH-DPA T)</w>
(8 S,
(8 9%</w>
(8 7%</w>
(8 2%</w>
(8 1%),</w>
(8 0-120</w>
(8 0%).</w>
(8 0
(7. 7</w>
(7. 1%)</w>
(7- OH-
(7 8%</w>
(7 7</w>
(7 7%</w>
(7 3.
(7 0/
(7 0%),</w>
(6. 7%)</w>
(6. 2</w>
(6- TG)</w>
(6 3</w>
(6 0-120</w>
(6 0-1
(6 0-
(6 %;</w>
(50- 200</w>
(5. 8</w>
(5. 7%)</w>
(5. 6</w>
(5. 2%)</w>
(5. 1</w>
(5-HT 3)</w>
(5- ASA)</w>
(5,7-DH T)</w>
(5 3%</w>
(45. 5%)</w>
(4. 9%)</w>
(4. 8</w>
(4. 5%)</w>
(4. 3%)</w>
(4. 2%)</w>
(4-chloro phenyl)-
(4-amino phenyl)-4-methyl-7,8-
(4- hydroxy
(4 9%</w>
(4 7%).</w>
(4 7%),</w>
(4 ,
(31. 3%)</w>
(30- 300</w>
(3. 75</w>
(3. 6%)</w>
(3. 5-
(3. 4%)</w>
(3 alpha-hydroxy-
(3 9%).</w>
(3 75</w>
(3 70</w>
(3 7
(3 000</w>
(3 0.0</w>
(3 0,</w>
(3 0%).</w>
(26. 7%)</w>
(22. 2%)</w>
(2/ 3)</w>
(2. 5
(2. 3%)</w>
(2. 2%)</w>
(2- mercapto
(2, 6-di
(2) ),</w>
(2 9%).</w>
(2 8/
(2 75</w>
(2 7-
(2 4/
(2 3%).</w>
(2 25</w>
(2 2%</w>
(2 1-
(2 000</w>
(2 0.0%)</w>
(2 0),</w>
(2 %;</w>
(2 %),</w>
(19 66</w>
(19 %).</w>
(15- 20</w>
(11. 1%)</w>
(100- 200</w>
(10. 1%)</w>
(10(- 6)</w>
(10(- 6)
(10 4</w>
(10 -15</w>
(10 ),</w>
(1. 75</w>
(1. 6%)</w>
(1. 1%)</w>
(1 90</w>
(1 8-
(1 77</w>
(1 7/
(1 7-
(1 7%,</w>
(1 7%),</w>
(1 67</w>
(1 6-
(1 6%).</w>
(1 4),</w>
(1 39</w>
(1 37</w>
(1 3)</w>
(1 3)
(1 2.4</w>
(1 1),</w>
(1 0.5</w>
(1 ,000</w>
(0.5- 1</w>
(0.25- 0.5</w>
(0.01- 0.1</w>
(0.0 25</w>
(0.0 ,</w>
(0. 83</w>
(0. 8%)</w>
(0. 6%).</w>
(0. 55</w>
(0. 45</w>
(0. 32</w>
(0. 3%</w>
(0. 16</w>
(0. 10</w>
(0- 30</w>
(-1 0
(-1 .
(-)- adrenaline</w>
(-)- OSU</w>
(+/-)-2- carboxypiperazin-4-
(+)- cis</w>
(+)- PH
( when</w>
( values</w>
( ultrasonic</w>
( u
( treatment</w>
( toxic</w>
( torsades</w>
( through</w>
( those</w>
( tested</w>
( systemic</w>
( sub-)</w>
( sodium</w>
( short</w>
( sensitivity</w>
( see</w>
( schedule</w>
( saline-
( saline,</w>
( response</w>
( responder
( regimen</w>
( prostaglandin</w>
( prostacyclin
( principally</w>
( platelet</w>
( per</w>
( part</w>
( pain,</w>
( other</w>
( oral</w>
( one).</w>
( nor-B
( nausea</w>
( mixed</w>
( midazolam
( micro
( mice)</w>
( mes
( maximum,</w>
( last</w>
( laser</w>
( ischemia</w>
( injected</w>
( i.v.</w>
( i.p.</w>
( i.p.).</w>
( hyperglycemic</w>
( human</w>
( hippocampus,</w>
( haloperidol</w>
( glomerular</w>
( gestational</w>
( genotype</w>
( final</w>
( excluding</w>
( every</w>
( equivalent</w>
( electromagnetic</w>
( diphenyl
( didanos
( diazepam</w>
( decrease</w>
( corrected</w>
( coronary</w>
( complete</w>
( central)</w>
( c-
( baseline,</w>
( basal</w>
( average,</w>
( around</w>
( allodynia)</w>
( albumin,</w>
( X</w>
( QT</w>
( QRS</w>
( L-DOPA)</w>
( IV</w>
( IIE
( GABA(A)</w>
( B</w>
( 0.05
( 0%).</w>
( %)</w>
' binge'</w>
' ;</w>
% ):</w>
"ecstasy ")</w>
" torsade</w>
" sub
" spontaneous
" sinus
" probable"</w>
" normal
" non
" de</w>
" clozapine</w>
zon ula</w>
zon es.</w>
zomepir ac.</w>
zol amide</w>
zileut on</w>
zetimi be</w>
zap rinast</w>
z z
z one.</w>
z ol</w>
z ine.</w>
z in</w>
z ia</w>
z ,</w>
ys ine</w>
yp ne
ypne a-
ypnea- ortho
ypnea-ortho de
ypnea-orthode ox
yo e
yoe it
ymph atic</w>
ymb opo
ymbopo g
ymbopog on</w>
ym ents</w>
yl-L- carnitine</w>
yl-2- phenoxy
yl- 3-
yl)- pyridine</w>
yl)- N-
yl)- 5-
yl) urea</w>
yl) butyl]-
yl) amino]
yl methyl
yl idene
yl carbamo
yl ate,</w>
yl amine</w>
yl -</w>
yel low
yel inic</w>
yclopent ane
y/ radiotherapy</w>
y lox
ylox y-
y ing.</w>
y et,</w>
y );</w>
xylazine- ketamine</w>
xi par
xerostom ia</w>
xeno graft</w>
xanth ine,</w>
x/ day;</w>
x- then-cisDD
x ine</w>
x enograf
x ene,</w>
x edema</w>
x L</w>
wt .,</w>
wron g</w>
writ ing</w>
writ ing,</w>
wrin kling</w>
worsen ing,</w>
worsen ed.</w>
work load</w>
work er</w>
work day</w>
wor ds.</w>
wom an)</w>
wk ).</w>
within- subject</w>
withdraw al)</w>
wit z</w>
winter ian
winter i</w>
wif e</w>
wide- complex</w>
whole- blood</w>
where upon</w>
whe el
whe al</w>
whe al,</w>
wh ites</w>
well- controlled</w>
well- be
weigh t),</w>
weigh s</w>
week- old)</w>
week s-old</w>
week ly).</w>
week ends</w>
wee t</w>
wearing- off,</w>
weak ness:</w>
we ed</w>
we av
wax /
wax/ polymer</w>
water- replete</w>
water- maze</w>
wash out,</w>
wash ing</w>
warm th,</w>
warfarin- drug</w>
war ning.</w>
war dly</w>
walk ing,</w>
wake ful
wa ve-
wa it</w>
w t),</w>
w orm
vul us</w>
vom it</w>
volunte ers:</w>
volume -
voltage- sensitive</w>
voltage- clamp</w>
volt age.</w>
vol vulus</w>
vogli bo
voglibo se.</w>
vocal izations</w>
vivo- in</w>
vitamin- D2</w>
vitamin s.</w>
vitamin s,</w>
vis iting</w>
virus -mediated</w>
viol ence,</w>
viol aceous</w>
vinorelb ine/
vindes ine,</w>
vincrist ine-evoked</w>
vincrist ine-
vie 's</w>
vic ti
victi m</w>
vi t</w>
vi s.</w>
vi ri
vi gorously</w>
vi br
vestibulo -
vessel ,</w>
vesi co
vesi cles,</w>
ves )</w>
verticillat us</w>
vers ol</w>
verapamil ]o</w>
verapam il/
ver sy</w>
ver sa</w>
ver ified.</w>
ventric le-
ventric le)</w>
ventil ation).</w>
vent ing</w>
veno venous</w>
veno occlusive</w>
ven tion.</w>
ven om
ven odilat
ven -
velocity- encoded</w>
velb ine</w>
vein- stenosed</w>
vehicle- pretreated</w>
vehicle- injected</w>
vehicle- infused</w>
vehicle ).</w>
vedac lidine</w>
vecur oni
ve g
ve ).</w>
vasospas ms</w>
vasopress ors,</w>
vasoconstrict ors,</w>
vascular ity</w>
vascul itis:</w>
vas ation</w>
varic osi
varicosi ties</w>
varic ella</w>
varic eal</w>
vari ant.</w>
vari ant
var denafil</w>
vapt an</w>
vapor iz
vanillo id
vancomyc in-resistant</w>
valv ulopathy.</w>
valv ulo
valvulo pathies</w>
valu e:</w>
vals artan,</w>
valpro ate-treated</w>
val ganciclovir</w>
val g</w>
vagin ally</w>
vag i.</w>
vacuol ization.</w>
vaccine- escape</w>
vaccin ation,</w>
va 2]
v s-
v i</w>
v ).</w>
uy tren
uytren 's</w>
utiliz ation,</w>
uter us.</w>
uter us,</w>
uter otonic</w>
uter o
use t
uset ts</w>
use /
use )</w>
us pid
us hed,</w>
us h,</w>
us artan</w>
us --
urticaria/ angioedema.</w>
urs olic</w>
uroth yl</w>
uro xene,</w>
uro toxicity,</w>
uro spor
uro protect
uro porphyr
uroporphyr inogen</w>
uro kinase,</w>
uro graphy.</w>
urin iferous</w>
uric holic</w>
uri tic</w>
urge -We
urge-We ber</w>
urethane- anaesthetised</w>
ureth ra,</w>
ureth ane.</w>
ures --
ures )</w>
ure ters</w>
ure less</w>
ure d.</w>
urap idi
urapidi l,</w>
uran yl</w>
ur n</w>
ur ine"</w>
ur ination</w>
ur idine-induced</w>
ur idine-
ur icos
ur ic,</w>
upreg ulate</w>
upper- extremity</w>
up swings</w>
up s</w>
up lo
up lex</w>
unusu al,</w>
unstead iness</w>
unpredict able,</w>
university- based</w>
unit ro
unit ;</w>
uniform ity</w>
uni directional</w>
uni -</w>
unfortun ate</w>
undesi rab
under- reported</w>
under- recognized</w>
under way.</w>
under taken,</w>
un successfully</w>
un stained</w>
un relieved</w>
un reliable</w>
un recognized.</w>
un purified</w>
un ning</w>
un net
un necessary,</w>
un matched</w>
un loaded</w>
un important</w>
un impaired</w>
un impaired.</w>
un healthy</w>
un encapsulated</w>
un ding</w>
un defined</w>
un corrected</w>
un burnt</w>
un available.</w>
um- exposed</w>
ultrasoun d-
ultraf ast</w>
ultra- low</w>
ultra structure.</w>
ulos clerosis</w>
ulo se.</w>
ulin astatin</w>
ul y,</w>
ul ent</w>
ul ations</w>
ul ating</w>
uci ating</w>
uc iferine</w>
ubiquit ously</w>
ubi qu
ubiqu itin</w>
u sid
u reas.</w>
u per
u ge
u g.
u er</w>
u ates</w>
u al,</w>
u ),</w>
tyrosine- methionine-
tyrosine-methionine- aspartate-
type :</w>
type ).</w>
typ ed</w>
two- year-old</w>
two- week-old</w>
two- sided</w>
two- kidney</w>
two- drug</w>
twice/ day,</w>
twenty- five</w>
twel ve-
tw isting</w>
tw in,</w>
turt les</w>
turke ys.</w>
tur keys</w>
tumor :</w>
tum ,</w>
tubocurar ine.</w>
tuber osa</w>
tuber cle.</w>
tu bu
tubu log
tubulog lomerular</w>
tryptoph an-niacin</w>
tryptoph an,</w>
trypt amine,</w>
trunc ated</w>
trou bling</w>
troponin- T</w>
tropic amide.</w>
trop yl</w>
trometh amine,</w>
tro x
tro r
tror rh
trorrh ag
triterpen oid</w>
tript ans,</w>
tripelenn amine</w>
tripelenn amine,</w>
trinit rate,</w>
trimeta ph
trime sters</w>
trihexyphenid yl,</w>
trifluoro ethane</w>
trichloro ethan
tric uspid
triazolo[1,5-c] pyrimid
triacyl glycer
tri phenylethylene</w>
tri phenyl</w>
tri ed,</w>
tren d,</w>
tremor genic</w>
tremor )</w>
treatment- refractory</w>
treatment 's</w>
tre e.</w>
trau b</w>
transt ympanic</w>
transporter -1</w>
transpor ter,</w>
transplant -free</w>
translat es</w>
transl uc
transi tioned</w>
transi tion,</w>
transi ently,</w>
transfer rin,</w>
transfer ases</w>
transe pid
transepid ermal</w>
transcript ase-
transamin itis,</w>
trans-1,2- cyclohexanedi
trans vaginal</w>
trans rectal</w>
trans position</w>
trans parent</w>
trans mitral</w>
trans late</w>
trans ketol
trans formation,</w>
trans activators</w>
tranquiliz er,</w>
tramadol/ APAP</w>
tract -
trache otomy</w>
trache a.</w>
trac ers</w>
trac ers.</w>
tra ined,</w>
toxoplasmo sis.</w>
toxic osis.</w>
toxic ology.</w>
toxic ity?</w>
toxic ity--
toxic -
toxic )</w>
tox oplasmic</w>
tox ins.</w>
tox in-sensitive</w>
tourniqu et
tot al-body</w>
torticoll is,</w>
tor af
topiram ate-induced</w>
topiram ate-
topiram ate,</w>
tongu e.</w>
ton ic/
tonic/ clonic</w>
tom y.</w>
tom ograph
tolmet in.</w>
tolmet in,</w>
toler ating</w>
tolaz amide</w>
tol cap
tolcap one</w>
tol aryng
tocoph erol</w>
to- systemic</w>
to- side</w>
to- right</w>
to- left</w>
to uc
to dol
todol ac</w>
to day,</w>
titr ation.</w>
titr ation,</w>
titr ate</w>
tis/ dermatomyositis</w>
tion- event</w>
tion al
tional -dose</w>
tion -associated</w>
timolo l-
times/ week</w>
time :</w>
time ).</w>
tili de-induced</w>
tigm ine-induced</w>
tigh tly</w>
tic- rigid</w>
tic ryn
tiag abine.</w>
ti pran
ti pped</w>
ti or
tior rhiz
ti o</w>
ti le,</w>
ti flu
tiflu ad
ti d)</w>
ti a</w>
ti .</w>
thyrox ine,</w>
thyrotoxic osis,</w>
thyroidi tis</w>
thromboly tics.</w>
thrombocyth aemia</w>
thrombo genesis</w>
thromb ocytosis,</w>
thromb ocyto
thromb ectomy.</w>
thrice- weekly</w>
three- quarters</w>
three- dimensional</w>
threat ened</w>
thre e;</w>
thorac otomy.</w>
thorac ol
thoracol umbar</w>
thirty- three</w>
thirty- four</w>
third- line</w>
thiou re
thioridaz ine-induced</w>
thion amides</w>
thiocolchic o
thiobut yro
thio- TEPA</w>
thio acetamide-induced</w>
thio TEPA</w>
thick nes
thick en
thiaz ide-sensitive</w>
thiaz ide
thiamyl al-
thia di
thi xen
thi ethyl
thiethyl per
thi er</w>
thermo graphy</w>
there of</w>
therap eutical</w>
ther mist
ther g
ther :</w>
then uria</w>
themsel ves,</w>
thana sia.</w>
thalas sem
thalassem ia.</w>
thalam o-
th umb
th in,</w>
th esin</w>
tex t
tetrap legia</w>
tetrameth yl-
tetrahydrocannabin ol-
tetrahydro- 7,8-
tetrahydro deoxycorticosterone</w>
tetrahydro cortisol</w>
tetraethyl ammonium</w>
tetracycl ine.</w>
tetracycl ine-
tetraben azine-induced</w>
tetra acetic</w>
tetr amine</w>
tetr alin,</w>
tetr afluoro
tetr ab
tetan us.</w>
testoster one-treated</w>
test s;</w>
test ing:</w>
test ed;</w>
territ ory.</w>
terg uride,</w>
teratogen s</w>
ter odine</w>
ter azosin.</w>
ter :</w>
tent ative</w>
tenofovir -induced</w>
tenid ap
ten s</w>
tempor al-
temperat ure)</w>
temper am
telangiect asia,</w>
tegaf ur</w>
tech nically</w>
te lomer
telomer ase</w>
te d;</w>
te bral</w>
taxan es,</w>
tax otere</w>
tax ol.</w>
taurochol ate,</w>
tast e.</w>
task -related</w>
tartr ate,</w>
target s,</w>
target .</w>
tar io
tario ,</w>
tar g</w>
tar da.</w>
tap ered.</w>
tandos pirone</w>
tamsulos in,</w>
tamponade ,</w>
tamoxifen )</w>
tamoxifen 's</w>
tal ipex
tal ine-induced</w>
tag lu
tadalaf il.</w>
tacrolim us:</w>
tacrolim us-
tachyphyl axis.</w>
tachycardia )</w>
tac rine-
tac rine,</w>
tac alcit
tabul ated.</w>
ta ur
ta BO
taBO M</w>
t.d. s.</w>
t-G ault</w>
t- type</w>
t- test.</w>
t- PA)</w>
t- MDS/
t- E
t-E aton</w>
t- A-
t-A- C
t-A-C ath</w>
t ouret
touret tism</w>
t ors
tors ad
torsad ogenic</w>
t or.</w>
t ness/
tness/ Sedation</w>
t max</w>
t ing)</w>
t ases</w>
t ance</w>
t amide</w>
t alk
t 1/2</w>
t .,</w>
t -related</w>
systolic- diastolic</w>
systol ic/
synthesi sed</w>
synovi tis,</w>
synovi al</w>
syndrome --a</w>
syndrome '</w>
syndrome ",</w>
synchron ously</w>
synchron ized,</w>
synaptos omes.</w>
synapto genesis</w>
sympatho- adrenal</w>
sympath ovagal</w>
sympath ectomy.</w>
symmetr ic,</w>
sy- proven</w>
switch ing-
swe ating.</w>
sw ine</w>
sut ureless</w>
susta ined.</w>
susceptibil ities</w>
survey ed.</w>
surger y)</w>
surge on.</w>
surg ical,</w>
surfac e-
sur prisingly,</w>
sur ate</w>
supras pin
supram am
supra physiologic</w>
supra orbital</w>
supra hy
suprahy oid</w>
suppress ant.</w>
suppres sibility</w>
supplement ,</w>
supple ment.</w>
suppl ying</w>
super vision.</w>
super vision,</w>
super sensitivity,</w>
super infections</w>
super -
sup posed
supposed ly</w>
sup ination</w>
summ er</w>
summ aries</w>
summ ari
sulpiri de
sulphon amide</w>
sulphasalaz ine,</w>
sulph oxidation</w>
sulfonyl urea,</w>
sulfonyl naphthal
sulfonylnaphthal ene-1-
sulfonylnaphthalene-1- sulfon
sulfonylnaphthalene-1-sulfon amide,</w>
sulfadi azine-induced</w>
sulfad oxine</w>
sulf oxide.</w>
sulf obromophthalein</w>
sulf apyridine</w>
sulf am
sul fo
sufentanil/ midazolam</w>
sudden -onset</w>
succ imer</w>
suc ral
sucral f
subst ances)</w>
sublingu ally.</w>
subject 's</w>
sube picardi
sube p
sub-Ten on</w>
sub- groups</w>
sub toxic</w>
sub serving</w>
sub scales,</w>
sub o-
sub ling
subling ually</w>
sub diaphragmatic</w>
sub continent</w>
sub average</w>
sub analysis</w>
sub acute,</w>
su ture</w>
su b</w>
stutter ing.</w>
stupor ,</w>
studi es)</w>
studi es).</w>
stru gg
strom 's</w>
strok ing,</w>
strok e-like</w>
stric ,</w>
striat al-
stri ps,</w>
stri p</w>
stret ched</w>
stret ch
stress ors.</w>
stress or,</w>
stren uous</w>
stre am,</w>
strati fied,</w>
stran ded</w>
stra p</w>
stra in).</w>
str ang
stor hin
stom at
stoc king</w>
sto res,</w>
sto ols.</w>
stimul i)</w>
stimul ators.</w>
stimul ations,</w>
stimul ation)</w>
sti p
stip pl
sti ff</w>
steroid- sparing</w>
steroid- only</w>
steroid -based</w>
steril ization</w>
stereotypi es,</w>
stereotyp y;</w>
ster one,</w>
ster i
step p
step ,</w>
steno ses,</w>
steat ogenic</w>
stead .</w>
ste al"</w>
station ary</w>
statin- gemfibrozil</w>
statin- fibrate</w>
stat ure.</w>
stat in.</w>
stat ,</w>
star ing</w>
star ing,</w>
standard- risk</w>
standar dised</w>
standar d,</w>
stand ards</w>
stain able</w>
stag ge
stabiliz ers.</w>
sta urospor
sta sis,</w>
sta phylococci
st orm
st oring</w>
st one-like</w>
st ob
st ening</w>
st ear
st ating</w>
st at</w>
st ;</w>
squ am
squam ous
squamous -cell</w>
squ al
squal ene</w>
spro uted</w>
spot s,</w>
spontane ous,</w>
spong io
spong iform</w>
spondy litis.</w>
spon so
sponso red</w>
splot ch</w>
sple en.</w>
spl itting</w>
spl in
spiro metric</w>
spir adoline</w>
spin ally</w>
spin al-induced</w>
spin al,</w>
sphingomy elin</w>
sphing os
spermat ogenesis</w>
sper sed</w>
spell s,</w>
speech .</w>
spectrophot ometrically</w>
spectra .</w>
spectr um.</w>
specimen ,</w>
specific ities</w>
species- typical</w>
spec ify</w>
spe ed
speed ball
spati otemporal</w>
spasm olytic</w>
spas mogenic</w>
sparte ine,</w>
spar floxacin-induced</w>
spac er</w>
spac ef
sp aper</w>
sp an,</w>
sou thern</w>
sou th</w>
soral en</w>
sorafenib ,</w>
son- Re
son-Re es</w>
son omicro
somnol ence.</w>
somato statin-
somat odendritic</w>
som ites</w>
som ata</w>
solv ent,</w>
solub ility,</w>
solid- organ</w>
solic ited</w>
soldi ers</w>
sof tening</w>
sodium- potassium</w>
sodium- independent</w>
sodi um-induced</w>
sodi um-dependent</w>
soci o-
snor ting</w>
smok ed.</w>
smok e,</w>
sme ar
small- molecule</w>
small -</w>
sludg e,</w>
slop e,</w>
sli des</w>
sleep -dependent</w>
skin- test</w>
siz es.</w>
siz able</w>
sixty- one</w>
situ ,</w>
site (s)</w>
sis- associated</w>
sirolim us)</w>
sion ed</w>
sion ),</w>
sinusi tis</w>
sino- atrial</w>
single- nephron</w>
single- dose,</w>
single- centre</w>
sin ap
sinap ic</w>
simul ations</w>
simpl ified</w>
simpl er</w>
similar ly.</w>
sim vastatin-
sim vastat
sim plic
sill ar</w>
sil ence</w>
sign ifying</w>
sign alled</w>
side- to-side</w>
side- effects:</w>
side- chain</w>
side -related</w>
sick ness.</w>
sick ness,</w>
sic um</w>
sibutr amine.</w>
sib le,</w>
si ve/
si res.</w>
shrun ken</w>
show n,</w>
shorter- acting</w>
short-ter m
short- duration</w>
shock ;</w>
shipp ed</w>
shell ,</w>
shel f</w>
sheep ,</w>
she d
shed ding</w>
shar p-
shar p
sharp ness</w>
sh ut
sh aring</w>
sevoflur ane-induced</w>
sever al-
several- fold</w>
ses '</w>
seroconver sion.</w>
sero status</w>
seri ousness</w>
ser ia</w>
sequenc ing.</w>
sequ ell
septo plasty</w>
sensitiv ity:</w>
semin oma</w>
sem istructured</w>
sell ar</w>
self- perceived</w>
self- limited.</w>
self- described</w>
self- controlled</w>
selen ite</w>
selective ')</w>
sel f
sel ecti
seizures =
seizures .(ABSTRACT</w>
seizure- prolonging</w>
seizure- free,</w>
seg mented</w>
see ing</w>
sedent ary;</w>
sedati ves.</w>
sed ation/
sect or</w>
second s),</w>
sec ured</w>
sec ure</w>
sec tion
sec (-1
sec(-1 ).m(2)
sec(-1).m(2) .
sec(-1).m(2). cm
se st</w>
se pi
se eds</w>
se "</w>
scrutin y</w>
scro tal</w>
scre ens,</w>
scram bling</w>
scotom as,</w>
scor ing.</w>
sco re:</w>
scleroder moid</w>
scinti graphy,</w>
school- age</w>
school children</w>
scho ol.</w>
schizophren ia-like</w>
schedul ing</w>
schedul es:</w>
schedul e:</w>
schedul e-dependent</w>
sch ist
scen ario
scar city</w>
scar ce</w>
scann ing,</w>
sc ribed</w>
sc rape</w>
sc oline</w>
sc ene</w>
sc ant</w>
sc ant
sc ).</w>
sc )-induced</w>
satisfactor y.</w>
satisfactor y,</w>
sarco glyc
sarc openia</w>
saralas in-treated</w>
sar izot
saquin avir</w>
salt- depleted</w>
salt- dependent</w>
salmeter ol.</w>
saliv a</w>
salicyl ate.</w>
sal t
sal ine:</w>
saf er,</w>
sacro iliitis</w>
sacca des</w>
s/ min,</w>
s. e.
s. "</w>
s-of- function</w>
s- S
s-S ay
s-Say re</w>
s ulation</w>
s tig
s s
s orbent</w>
s old</w>
s ke
s ings</w>
s ine
s h</w>
s angu
s and
s ].</w>
s -related</w>
s ")</w>
ry ocy
ryocy storhin
rupt ure,</w>
run -
run- in,</w>
rubidaz one</w>
ru m</w>
ru g
ru di
rt L180
rr ALR</w>
roxithrom ycin.</w>
rox indole</w>
row siness</w>
roten one-treated</w>
roten one,</w>
rot ation,</w>
rosiglitaz one.</w>
roph ag
rop yri
rop ometric</w>
ron oun
ronoun ced</w>
rom is
roll ment</w>
role um</w>
role -induced</w>
rof t-Gault</w>
roentgen ogram</w>
ro taline-induced</w>
ro ta</w>
ro lingual</w>
ro lid
ro l)</w>
ro ci
roci verine</w>
rizatript an,</w>
ritonavir -treated</w>
rit anserin,</w>
risperid one-
risk ;</w>
rin one,</w>
rin )</w>
rim ifentan
rimifentan il</w>
right- to-left</w>
ribo flav
ribavir in-associated</w>
rib s</w>
ri mental</w>
ri m</w>
ri gorously</w>
ri fication</w>
ri es.</w>
ri er</w>
rhyth mias</w>
rho ids</w>
rho dam
rhodam ine
rho d
rhod amine</w>
rhinosinu sitis.</w>
rhi zom
rheum atism</w>
rhe ological</w>
rhaph y.</w>
rhabdomy osarcoma</w>
rhIL-1 1</w>
rh initis.</w>
rf onad
rewar d)</w>
revisit ed.</w>
reversal ,</w>
rever se,</w>
rever s
rety lium</w>
retro vir</w>
retro placental</w>
retriev al,</w>
retin ol-
retinol- binding</w>
reticulo cytes,</w>
reticulat a.</w>
ret initis.</w>
ret ching</w>
restless ness.</w>
resten osis.</w>
rest orative</w>
rest ing,</w>
rest ;</w>
responsib le,</w>
response ),</w>
responder s"</w>
respond ing,</w>
respon sibility</w>
respon ses;</w>
respon ses)</w>
respir ations</w>
respect .</w>
resource- limited</w>
resoruf in</w>
resorp tions,</w>
resor ption,</w>
resisti n</w>
resistance )</w>
reserp ine-</w>
research er</w>
resc ence</w>
res ect
reput ation</w>
reproducibil ity,</w>
reporte d:</w>
replic ative</w>
replic ating</w>
repeti tions</w>
reorgan ization,</w>
renin- -
renin-- angiotensin</w>
ren al/
remit ters</w>
rema ster</w>
rema ined,</w>
reluct ant</w>
reli able,</w>
relax ants,</w>
relationshi ps,</w>
relap se
rel ational</w>
rel ation,</w>
reinstat ement,</w>
regurgit ations</w>
regul ated.</w>
regul ar,</w>
regres s</w>
registr y.</w>
regist ers</w>
regist ered,</w>
regist er</w>
region s:</w>
regimen ).</w>
regar d.</w>
reg aining</w>
reflex )</w>
referen ce.</w>
refer red.</w>
ref ine
recurren ces.</w>
recur red,</w>
recur arization</w>
rectom y,</w>
recover s</w>
rechallenge d.</w>
receptor- stimulating</w>
receptor- selective</w>
receptor- medi
receptor- independent</w>
receptor :</w>
receptor -related</w>
rec uper
rec all.</w>
reboxet ine.</w>
reboun d.</w>
reasses sed</w>
reas suring</w>
reas signed</w>
reas on.</w>
read iness</w>
reac ts</w>
reac tive.</w>
reac tion;</w>
re-in- an
re- uptake.</w>
re- evaluation</w>
re- emergence</w>
re uptake,</w>
re treats</w>
re tested</w>
re positioning</w>
re parative</w>
re paralysis</w>
re oxygenation</w>
re infusion</w>
re hospitalization</w>
re exposed</w>
re evaluation</w>
re entry.</w>
re duplication</w>
re consider</w>
re ated</w>
re agents</w>
re agents.</w>
re activity,</w>
re activated</w>
rate- blood</w>
rate ).</w>
rat ers</w>
rat ax
rat ;</w>
rans plant</w>
rang e;</w>
ran ks</w>
ran k
ramp ant</w>
ramipri lat</w>
ram p</w>
ram o
ramo setron</w>
raloxif ene.</w>
raloxif ene-
ral titrexed</w>
radiolab elled</w>
radioimmuno assays.</w>
radio- labeled</w>
radio receptor</w>
radic ulography</w>
radi osensi
radi ological,</w>
radi o</w>
rad ine</w>
rad )</w>
rac he
rac h
rac e;</w>
rac e-
ra d</w>
ra Ver
rHV -1</w>
rCMR Glu</w>
r y.</w>
r uciating</w>
r ings.</w>
r ine:</w>
r ine-related</w>
r Hu</w>
r BLA</w>
r 1</w>
r 1(
r1( neo-
r1(neo- /-)</w>
r ).</w>
quoti ent</w>
quisqual ic</w>
quisqual ate</w>
quinpi role.</w>
quinoxaline- 7-
quinoxal ine
quinoxal in-1-
quinone imine</w>
quinid ine-like</w>
quin april,</w>
quick ly,</w>
question ed,</w>
qual ity.</w>
quadri paresis.</w>
quadr ants</w>
qu ineth
q. i.d.</w>
q 12
pyruv ic</w>
pyrrolid one</w>
pyrimid inyl)
pyrimid in
pyrimidin yl-2-phenoxy
pyridoxal- phosphate</w>
pyridox ine-
pyridos tigmine.</w>
pyrido [1,
pyrid ines</w>
pyri lam
pyrazolo [4,3-
pyrazol e-
pyrazole- 3-
pyrazole-3- carboxamide
pyl oric</w>
pyl or
pye lography</w>
pye litis,</w>
py lo
push -pull</w>
puromyc in-
puromycin- aminonucleoside</w>
purch ase</w>
pur ities</w>
pupil s,</w>
pun ding</w>
pulmon ic</w>
public ations.</w>
puber ty.</w>
pub ic</w>
pu zz
pt s.</w>
pt s),</w>
psychostimul ants.</w>
psychostimul ants,</w>
psycho ses.</w>
psycho pathology.</w>
psychiatric -like</w>
psych ot
psychot ogenic</w>
pseudolith iasis,</w>
pseudo- obstruction</w>
pseudo- Bartter's</w>
pseudo aneurysms</w>
pseudo aneurysm</w>
pseudo acromegaly</w>
pseud otum
pseud op
ps apir
pruri ens</w>
proxim ate</w>
prox if
provi der</w>
provi ded,</w>
prov ince</w>
proteinur ia;</w>
protein- mixed</w>
protein- binding</w>
protein ase-
protein aceous</w>
protec tion)</w>
prosthe ses.</w>
pros tigmine-
propylthio -</w>
propyl pentano
propylpentano yl)urea</w>
propyl -2
propyl )-
propranolo l:</w>
propranolo l-treated</w>
propofol- LCT/MCT</w>
propofol +
propofol )</w>
propo ses</w>
prophylaxis ;</w>
properti es:</w>
proper .</w>
propan olol</w>
propacetam ol,</w>
prop olis</w>
prop en
prop anoic</w>
prompt ly,</w>
promis ing,</w>
prom oter
prom nesic</w>
prolong ed-release</w>
prolin ic</w>
proligest one</w>
prol ine,</w>
prokine tic
proj ect
prohib ited</w>
progres sions</w>
progestin- only</w>
proced ure).</w>
procain amide
problematic .</w>
pro- drug</w>
pro- ANP</w>
pro to-
pro to
pro sencephal
pro parac
pro motion.</w>
pro hypertensive</w>
pro be
pro apoptotic</w>
pro -</w>
priloca ine,</w>
prick ,</w>
pric ks</w>
pri or.</w>
pri mor
previous ly-
preval ent,</w>
presyn ap
pressure- lowering</w>
pressure- diameter</w>
press ors</w>
preserv ative.</w>
preser ved,</w>
prescrip tion-event</w>
prescrib ing.</w>
prescho ol
preschool ers</w>
pren olol.</w>
premedic ant.</w>
prelim in
pregnancy ;</w>
pregnanc ies,</w>
pregn ant,</w>
preexist ing,</w>
predomin ance.</w>
predis position.</w>
predict ability</w>
predic ted,</w>
precur arization</w>
precipit ant</w>
prece d
pre- induction</w>
pre- drug</w>
pre treated,</w>
pre test)</w>
pre tectal</w>
pre mise</w>
pre marketing</w>
pre injury</w>
pre induction</w>
pre index</w>
pre hypotension</w>
pre excitation</w>
pre constricted</w>
pre cancerous</w>
pre c
prec oci
precoci ous</w>
pre adolescent</w>
prazosin )</w>
praz ocin</w>
practition ers,</w>
practic ing</w>
pr un
pr ices</w>
pr amine)</w>
pr al
pral id
pp sal
pp (N
pp(N H)
potenti ation,</w>
potenti ated,</w>
poten cy
poten cies.</w>
postul ated,</w>
postis o
postiso proteren
post-CA B,</w>
post- translational</w>
post- therapy</w>
post- receptor</w>
post- prandial</w>
post- nat
post- herpetic</w>
post- arvanil</w>
post- acquisition</w>
post- MI</w>
post- LT</w>
post ures.</w>
post treatment,</w>
post switch</w>
post natally</w>
post myocardial</w>
post index</w>
post drug</w>
post baseline</w>
post ablation</w>
positive /
posi tion
pos ited</w>
porphy ria,</w>
por ter</w>
popul ation)</w>
polysacchar ides</w>
polysacchar ide</w>
poly vinyl</w>
poly synaptic</w>
poly neuropathies</w>
poly my
polymy xin</w>
poly modal</w>
poly estradiol</w>
poly anion</w>
poly amines,</w>
poll ak
point s:</w>
point s),</w>
point es;</w>
point )</w>
podocaly x
pod ocytic</w>
po res</w>
po isons</w>
pneum ococci</w>
pneum atic</w>
plu gs</w>
plekhh 2</w>
ple uritic</w>
ple ocytosis.</w>
ple i
plausib le.</w>
plat ypnea-orthodeox
plast y:</w>
plas mid</w>
plas m
plant aris</w>
planime tric</w>
plan i
plan es</w>
placent ally</w>
placent a,</w>
pl ug
pl es.</w>
pl es,</w>
pl ate,</w>
pl ants</w>
pl akin
pkr 1-null</w>
piv ampicillin</w>
pituitary- adrenocortical</w>
pirox antr
piri de-induced</w>
pirenzep ine.</w>
pir profen</w>
pir menol</w>
piperid in-4-
piper ine</w>
pilo t,</w>
pilo erection</w>
pill ,</w>
pig ment
pig .</w>
piec eme
pieceme al</w>
picrotox inin</w>
picloz otan</w>
pic a.</w>
physic ochemical</w>
physi opath
phy tom
photosensi tive</w>
photograph s</w>
photo aging</w>
phosphorothio ic</w>
phosphono- 3-
phosphon op
phosphonop entano
phosphonopentano ic</w>
phosphon acetyl-L-
phospholip id-
phosphocreat ine,</w>
phosphati dy
phosphatidy lethan
phosphate- depleted</w>
phosphate- dehydrogenase</w>
phosphate- buffered</w>
phosphat uria</w>
phosphat ase)</w>
phosph ofr
phosphofr ucto
phosph ite</w>
phosph ate/
phosphate/ creatine</w>
phor bol
phon ophobia</w>
phob ics,</w>
phob ia.</w>
pher om
pheochromocyt omas.</w>
phenyto in-
phenylpropanol amine-containing</w>
phenylbutaz one-associated</w>
phenyl- 2-
phenyl)- 8-
phenyl propyl)
phenyl hydantoin</w>
phenyl glycol</w>
phenyl acetate</w>
phenter amine</w>
phenoxybenz amine.</w>
phenoxybenz amine,</w>
phenotyp es.</w>
phenotyp es,</w>
phenothiaz ine-induced</w>
phenomen ology</w>
phenobarbit one-
phenobarbit al:</w>
phenobarbit al)</w>
phenir amine</w>
phenaz opyridine</w>
phenad rine</w>
phen formin</w>
phen ethyl</w>
pharmacokine tic/pharmacodynamic</w>
pharmacokine tic-pharmacodynamic</w>
pharmaco therapy.</w>
pharmaco therapy,</w>
phacoemulsi fication</w>
phac lofen
ph ores
phores ed</w>
pg/ ml).</w>
pg/ 10</w>
peti form
peth idine,</w>
pet roleum</w>
person- year)</w>
person al
persist s.</w>
persist .</w>
persist ,</w>
perox ide.</w>
perox ide,</w>
peritone ally</w>
periton itis.</w>
peristal tic</w>
peripher ally,</w>
perinuclear- staining</w>
perif ascicular</w>
perid ol,</w>
pericardi ocentesis</w>
peric analicular</w>
peri venular</w>
peri metry</w>
pergol ide-treated</w>
perfusion- fixed</w>
perform s</w>
perfor ation,</w>
perf ect
perfect ly</w>
per spective</w>
per spective,</w>
per sec
per s,</w>
per orally</w>
per nio
per min
per ineural</w>
per ineur
per hap
perhap s,</w>
peptidom imetics</w>
pepti dase</w>
pentylenetetrazol -
pentylenetetraz ol.</w>
pentolini um,</w>
pentobarbit one,</w>
pentetra zole-induced</w>
pentamid ine-associated</w>
pentam eric</w>
pentagastr in.</w>
pent oth
penicill amine-associated</w>
penicill amine)</w>
pen e</w>
pen butolol</w>
pem pid
pem oline.</w>
pem iro
pelle ts.</w>
pelle t,</w>
pel vis.</w>
pegyl ated-
peg- IFN-alpha2b</w>
peg IFN</w>
peg IFN)</w>
ped al</w>
peak )</w>
pe floxac
paw :</w>
pauci- immune</w>
patient- specific</w>
patient s--
pati onal</w>
pati on,</w>
pat ency.</w>
pass ant</w>
pass ages</w>
parvalbumin -containing</w>
partum ,</w>
parti cles.</w>
parti cles,</w>
part ners</w>
parox ysms</w>
parg yline,</w>
paresthesi ae</w>
paren ts,</w>
pare un
parathyroid ectomy,</w>
parasit es.</w>
parasit aemia</w>
paraph ilias</w>
parap legia</w>
paramedic s.</w>
parame dic</w>
paraly zing</w>
paraly sed</w>
paraff in-
paradoxic ally,</w>
paradoxic al,</w>
par icalcitol</w>
paqu e.</w>
papillo macular</w>
papill a,</w>
pap ules</w>
panic ogenic</w>
pan cytopenia.</w>
pan cerebellar</w>
palsy :</w>
palpit ation,</w>
palmito yl</w>
palm ar</w>
pallid otomy.</w>
palli ation</w>
pal sies</w>
pal m</w>
pair wise</w>
pad s</w>
pad ,</w>
paclitaxel- resistant</w>
pack aging</w>
pacemak ers.</w>
pa in/
pa in-induced</w>
pa in).</w>
pa in),</w>
pa eoniflor
p= 0.5
p= 0.
p< 0.01,</w>
p< 0.01),</w>
p< 0.001</w>
p75NT R-
p75(NTR)- IR</w>
p75(NT R)</w>
p-chloro phenylalanine,</w>
p- value</w>
p- benzo
p, p'-
p ud
p ine-
p in-
p ice</w>
p ess
p ending</w>
p T
p >
p 50</w>
p ),</w>
oz ygotic</w>
oz ol
ozol inone</w>
oz antrone</w>
oxytocic s</w>
oxytoc in,</w>
oxymorph one,</w>
oxybenz amine</w>
oxy tetracycline</w>
oxy methamphetamine</w>
oxy hemoglobin</w>
oxy co
oxyco done.</w>
oxopiperazinyl-1- yl)prop
oxopiper azine</w>
oxo- 5-
oxidi zing</w>
oxide -mediated</w>
oxide -dependent</w>
oxidative/ nitrosative</w>
oxic- ischemic</w>
oxic am</w>
oxi metry</w>
oxi b.</w>
oxcarbazep ine,</w>
oxaliplat in.</w>
oxaliplat in-induced</w>
oxadi az
ox ol
oxol inic</w>
ox ides</w>
ox azine</w>
ox androlone</w>
ox andro
oxandro lon
ovul atory</w>
oversho ot
overload -induced</w>
overl aps</w>
over stimulation</w>
over dose
ove restim
ovari ectomy</w>
oval bumin</w>
ov ine</w>
ov es
ov ary.</w>
ov aqu
out weighs</w>
out weighed</w>
out flow,</w>
ous ness,</w>
ous ?</w>
our s</w>
our s,</w>
ou rea</w>
ou mar
otrop y</w>
otrans ferase</w>
otoxic ,</w>
otox ins</w>
otox in,</w>
otolaryng ologist</w>
oto protectant</w>
oti lonium</w>
other "</w>
othec in</w>
otetr alin</w>
ot strap</w>
ostom y.</w>
osteosarcom as</w>
osteomyeli tis,</w>
osteo dystrophy</w>
oste otomy</w>
oste onecrosis</w>
oste oblastic</w>
osmoly tes</w>
osmo receptor</w>
oscy amine</w>
oscil lop
os uria</w>
os ome</w>
os ine-
os )</w>
orth ost
orphan '</w>
orph ine.</w>
orph anin</w>
orph an</w>
ori ent
ori b
orib ine</w>
organophosph orous</w>
organochlor ine</w>
ore t
ord on</w>
ord an</w>
orb ed</w>
or ts</w>
or tion</w>
or tin</w>
or sak
or s).</w>
or rhaphy.</w>
or is</w>
or ally-
or -induced</w>
opyri dine,</w>
opyri d
opy rine</w>
opri m</w>
opportun ities</w>
opoi etin</w>
opo etic</w>
opioid -treated</w>
opioid -related</w>
ophthal mia</w>
ophosph amide</w>
oper ations,</w>
open- arm</w>
open s</w>
op osi
op olysacchar
op neum
op indo
op ex
op e
op amil</w>
onto genetic</w>
oni onic</w>
oni an</w>
oni -
oni- Deb
oni-Deb r</w>
ong -B
ong-B aker</w>
one- vessel</w>
one- sided</w>
one- quarter</w>
one- methyl</w>
one ]</w>
oncolog y,</w>
onco tic</w>
once-per- cycle</w>
on- time</w>
on- only</w>
on idine</w>
on ad</w>
on -associated</w>
on ),</w>
on '</w>
omyc es</w>
omit ted</w>
omicro scopy</w>
omeprazol e-induced</w>
omegal y.</w>
omega- 3</w>
omedi ol</w>
ome prol
om yelo
om ifens
om eric</w>
om ata</w>
olog y;</w>
olog ies,</w>
olo l:</w>
olivoc ochlear</w>
oligodeoxy nucleotides</w>
oligodendro cyte</w>
oligo hydramnios.</w>
oligo -
olig uric.</w>
olamine- pretreated</w>
ol-20- one</w>
ol ong</w>
ol esoxime</w>
ol az
ol -</w>
ol 's</w>
oint ment,</w>
oid .</w>
oid -
offen ders</w>
off .</w>
of loxacin.</w>
of loxacin-induced</w>
of er
of .</w>
odol pas
odi amide</w>
ocyte- integr
ocyte-integr ins
ocyte ,</w>
ocyt es)</w>
ocurar ine</w>
octreoti de:</w>
octogenari ans.</w>
ocrypt ine</w>
ocorm ia</w>
ocompati bility</w>
ocom o
ocomo tion</w>
ochem ist
ocent ric</w>
oce le.</w>
occup ying</w>
occup ancy.</w>
occul ta,</w>
occlud ens
occludens -1</w>
occlu der</w>
oc ket</w>
oc ine</w>
oc in
oc erebellar</w>
obvi ate</w>
obste tric
obst ac
obses sional</w>
observer s.</w>
observ ation-
observation- carri
observation-carri ed-forward</w>
obsc ured</w>
oblong ata.</w>
object s,</w>
object -
obio logy</w>
obenz odiazepine</w>
obenz amide</w>
ob last</w>
ob ic
o-t subo</w>
o- urinary</w>
o- lateral</w>
o yl-
o tility</w>
o sterol</w>
o romandibular</w>
o phen
o il/
o estradiol,</w>
o est
o X
nutri ent</w>
nur ser
nur se,</w>
numer ically</w>
numb ness.</w>
num bered</w>
nul l)</w>
nucleotide- gated</w>
nucleoti dase</w>
nucleol on
nucleo sides.</w>
nucle ation</w>
nov o.</w>
noti ce</w>
not es.</w>
normal s.</w>
normal s,</w>
normal ity</w>
normal ised.</w>
normal cy</w>
normal ),</w>
norm s</w>
norm ocap
nor-binaltorph im
nor veg
nor meperidine,</w>
nor ketamine</w>
nor fenfluramine</w>
nor fenfluramine,</w>
nor cocaine,</w>
non- voiding</w>
non- steroid</w>
non- sedating</w>
non- schizophrenic</w>
non- reactive</w>
non- pharmacological</w>
non- obstructive</w>
non- noxious</w>
non- lithium</w>
non- insulin</w>
non- inferior</w>
non- infectious</w>
non- hormonal</w>
non- failing</w>
non- ergot</w>
non- cocaine-exposed</w>
non- clear-cell</w>
non- castrated</w>
non- cancer</w>
non- TDM</w>
non- Q-AMI</w>
non- FA</w>
non- B</w>
non valvular</w>
non survivors</w>
non suffering</w>
non smokers.</w>
non significant,</w>
non responding</w>
non relapse</w>
non psychiatric</w>
non prednisone</w>
non perfused</w>
non painful</w>
non myocyte</w>
non melanoma</w>
non matching</w>
non lymphoblastic</w>
non lactating</w>
non injected</w>
non inferior</w>
non haematological</w>
non glomerular</w>
non glandular</w>
non existent</w>
non dyskinetic</w>
non drug</w>
non diagnostic</w>
non arteriosclerotic</w>
non adrenergic</w>
non acetylated</w>
noi se.</w>
nod ulo
nocicept in
nociceptin (1-1
nociceptin(1-1 3)
nociceptin(1-13) NH
noc tamide</w>
no stri
no on</w>
no des.</w>
no .</w>
nmol/ h</w>
nmol/ 5</w>
nmol ;</w>
niz atidine</w>
nitroglycerin- stimulated</w>
nitroglycer in-</w>
nitro- L-arginine,</w>
nitro sam
nitro blue</w>
nitrit es</w>
ninety- seven</w>
nine teen</w>
nightma res</w>
nightma res,</w>
nifekal ant</w>
nicotine- exposed</w>
nicardi pine-,</w>
ni ac
ng/ml/ hr.</w>
ng/ml/ 16</w>
ng/d L</w>
ng/ mouse)</w>
new spaper</w>
new est</w>
nevirap ine-based</w>
neurotrop ic</w>
neurotransmit ter
neurotoxic ity;</w>
neurotoxic .</w>
neuropsych ometric</w>
neuropath y)</w>
neuropath y).</w>
neuropath ies,</w>
neuron s:</w>
neurolog ists</w>
neurolep tic-like</w>
neuroblast oma,</w>
neuro tic</w>
neuro stimulation</w>
neuro secretory</w>
neuro psychiatric-like</w>
neuro protection.</w>
neuro protect
neuro plasticity</w>
neuro phy
neuro peptide,</w>
neuro inflammatory</w>
neuro hormonal</w>
neuro filamentous</w>
neuro fibrom
neuro chemistry</w>
neur ulation,</w>
neur algia.</w>
nest in,</w>
nephropath y;</w>
nephro sis:</w>
nephro logy</w>
nephro angiography</w>
nephri tis;</w>
nephrectom y,</w>
neostriat um.</w>
neocortex ,</w>
nelfin avir,</w>
negati ve)</w>
needle- free</w>
need s.</w>
need les</w>
need l
need ing</w>
necro sis:</w>
necro genic</w>
nec tic
near- fatal</w>
near -term</w>
ne omycin.</w>
ne omycin,</w>
ne obladder</w>
ne f
nef opam,</w>
ne )</w>
ne 's</w>
navig ation</w>
nause a)</w>
nation ally</w>
nat i</w>
nas al,</w>
narrow ing.</w>
narrow ing,</w>
narrow er</w>
nar atriptan</w>
naph tho
nanop article</w>
naloxon azine</w>
nalox one],</w>
nal- fetal</w>
nal orphine,</w>
nail s.</w>
nabil one,</w>
n- rump</w>
n- SOD</w>
n t-
n s-Sayre</w>
n mole</w>
n lein</w>
n ipec
n ing-
n al,</w>
n .)</w>
myri ad</w>
myonec rosis.</w>
myoglobin uria.</w>
myocyt olysis,</w>
myo pathies.</w>
myo fibroblasts</w>
myo fibre</w>
myelos chisis</w>
myelomening ocele</w>
myelo- optic</w>
myelo peroxidase,</w>
myelo encephalopathy</w>
myelo dysplasia.</w>
myelin olysis</w>
myelin oid</w>
mye logram
myco ses.</w>
myasthen ia.</w>
myasthen ia,</w>
myalg ic</w>
my oton
my ocyte.</w>
my oblasts</w>
my enteric</w>
my dricaine</w>
mutag en
muscul ature.</w>
muscle -
mumol/ liter</w>
mumol/ kg),</w>
multiplex ,</w>
multiple -drug</w>
multin ational</w>
multifor me.</w>
multifactori al,</w>
multi- institutional</w>
multi lamellar</w>
mug/ kg)</w>
muc in</w>
mu M)</w>
mt DNA.</w>
mt DNA,</w>
moxon idine,</w>
movement -related</w>
mouth washes</w>
mouse ),</w>
moun ted</w>
mos m/kg</w>
mos apride</w>
morpho functional</w>
morph ometrically</w>
morph ological,</w>
morph ogenetic</w>
morph ine;</w>
morph ine)</w>
more over</w>
mor tem.</w>
mor bidi
month s-old)</w>
month s);</w>
month ;</w>
monos odium</w>
mononucle osis-like</w>
mononit rate,</w>
mononeur itis</w>
monoc rotaline-induced</w>
mono oxygen
mono arthritic</w>
mon ozygotic</w>
mon oxide.</w>
mon oter
mon ocular</w>
mon idine</w>
mon -induced</w>
molecul es,</w>
molecul e-1</w>
molec ule
molar s.</w>
mol/ l).</w>
mol ars</w>
modific ations,</w>
modific ation.</w>
moderate- severe</w>
moder ate;</w>
modell ing.</w>
moclobem ide,</w>
mobil ization,</w>
mobil isation</w>
mo- epidermal</w>
mo tion,</w>
mo s</w>
mo bile</w>
mmol/ kg),</w>
mmol ,</w>
mm(3 ))</w>
mm ug.
ml/min/ kg</w>
ml/min/ kg,</w>
ml/min/ g)</w>
ml/g/ min,</w>
ml/ min),</w>
ml/ kg).</w>
ml. min-1.
ml. 100</w>
mixt ure-induced</w>
mixed- action</w>
mitot ane</w>
mit ozantrone</w>
mis lead
mislead ing.</w>
mis interpreted</w>
mis diagnosis</w>
mis carri
minut e
minimal- type</w>
min(-1 )),</w>
min or.</w>
min or,</w>
min idose</w>
min d.</w>
min ]</w>
min .,</w>
min -1
min -
milnacipran -treated</w>
millisecond s,</w>
milli on.</w>
milli gram</w>
mil tiorrhiz
mil k,</w>
migraineur s,</w>
migra ines</w>
migra ine-
mig rating</w>
midazolam ;</w>
midazolam 's</w>
midazol am-
mid zonal</w>
mid agli
mid -</w>
micturi tion,</w>
micron s)</w>
micron e
micromol/ min/100</w>
micromol/ L/
micromol/L/ mg</w>
micromol es;</w>
microm olar</w>
microm .</w>
microliter ),</w>
microl/ side)</w>
micrograms/m L,</w>
micrograms/ ml),</w>
micrograms/ g)</w>
micrograms/ g
micrograms.kg-1. min-1).</w>
micrograms. kg-1)</w>
microgram/kg/ min.</w>
microgram/ liter</w>
microgli a/
microgli a-
microg/mL );</w>
microg/m L),</w>
microg/kg/ minute</w>
microg/kg/ min.</w>
microg/ ml.</w>
microg/ l</w>
microg/ kg;</w>
microg/ hour.</w>
microg/ day,</w>
microg/ day)</w>
microg/ d</w>
microg. /
microg x
microcephal y.</w>
microcephal y,</w>
micro villi</w>
micro villi
micro surgery.</w>
micro prolactinoma.</w>
micro l.</w>
micro l--
micro l).</w>
micro hematuria</w>
micro crystals</w>
micro array</w>
micro V,</w>
micro -opioid</w>
mic e),</w>
mic e
mic afun
mic -
mi pafox
mi gran
mi ght,</w>
mi as.</w>
mi anser
mgI/ ml</w>
mg/m2/ wk</w>
mg/m2/ week.</w>
mg/m(2) ),</w>
mg/m(2 );</w>
mg/m mol</w>
mg/kg/ in
mg/kg/in j</w>
mg/kg/ dose)</w>
mg/kg/ d,</w>
mg/kg/ d).</w>
mg/kg/ d),</w>
mg/kg -
mg/kg )/
mg/K g)</w>
mg/100 g</w>
mg/ twice</w>
mg/ liter)</w>
mg/ l),</w>
mg/ g
mg/g m),</w>
mg/ 8</w>
mg/ 0.5</w>
mg. kg-1.</w>
mg. h-1</w>
mg. %</w>
mg I</w>
mg -
mg );</w>
metri f
methysergi de,</w>
methylphenid ate-induced</w>
methyleth yl)
methylenedioxy- 5H-
methyl- glutaryl-coenzyme</w>
methyl scopolamine</w>
methyl lyc
methyllyc aconitine</w>
methyl ene
methyl ation,</w>
methoxyp soralen</w>
methoxy-4- iodo
methoxy- idazoxan</w>
methoxy flur
methox y</w>
methox amine-induced</w>
method )</w>
method ),</w>
methiaz ide</w>
methazol amide,</w>
methamphetamine- related</w>
methamphet amine-treated</w>
methadone- related</w>
methadone- exposed</w>
meth ylester</w>
meter gol
metalloproteinase- 2</w>
metabol izes</w>
metabol ize</w>
metabol ising</w>
met ocur
met keph
met at
metat ar
metatar sal</w>
mesulerg ine</w>
mess ages</w>
mess age</w>
mesotheli oma.</w>
mesocortic olimbic</w>
mesenter y</w>
mesenter ic,</w>
mes ocortical</w>
mes na
meropenem -treated</w>
merg ing</w>
mercur ic</w>
mercap tosuccinic</w>
mer ,</w>
meq/ kg</w>
mephed rone</w>
meperid ine-associated</w>
menorrhag ia.</w>
mening ococcal</w>
mening itic</w>
mening ism</w>
mening es</w>
mening es.</w>
men tioning</w>
men ian</w>
men ).</w>
memor y:</w>
memor ies</w>
memb ers,</w>
memant ine,</w>
melphalan- prednisone</w>
meglum ine/
meglumine/ sodium</w>
megakary ocyte</w>
mefloqu ine,</w>
medulloblast oma</w>
medication- overuse</w>
medic ations)</w>
mediast inum</w>
medi ate,</w>
mechano- hyperalgesia</w>
mechano receptor</w>
mechanism s:</w>
mechanism :</w>
mechanism (s).</w>
mechanis m)</w>
mechan ics.</w>
measur able,</w>
mean +/-
me trorrhag
me re-
me quit
me prob
me et
me droxy-
me als</w>
me ag
mc a</w>
mc M</w>
may a</w>
max .</w>
matri x-
matche d-
mast ocytosis</w>
massi ve,</w>
masquer ading</w>
mascul ine</w>
mas tic
mas ker</w>
mas k.</w>
mas ,</w>
mark ers:</w>
map s,</w>
manufacture r,</w>
manipul ations.</w>
maneu vers</w>
man ia:</w>
man assantin</w>
man :</w>
malon ate-induced</w>
malign ant-like</w>
male/ female</w>
male ate-induced</w>
male ate)</w>
malar ia:</w>
mal nutrition,</w>
mal function.</w>
mal absorption</w>
mak ing,</w>
magnesi um-dependent</w>
magne t</w>
mag noc
macrophage- derived</w>
macroph ag
macro -
machin ery</w>
mac ulopathy</w>
ma il</w>
ma de:</w>
ma d</w>
mT OR</w>
mOsm/ kg)</w>
mL/min/ kg,</w>
mL/ s,</w>
mL/ kg/
mL/ kg,</w>
mL .g-1.
mIU/ ml</w>
mEq .</w>
mE q.
mE C</w>
m- PW
m- 2;</w>
m- 2,</w>
m- 2)</w>
m uricholic</w>
m s/
m s
m oxi
m ith
m entin</w>
m bil
m atical</w>
m app
m ant
m U/L</w>
m TLE</w>
m PFC</w>
m IPSC</w>
m AMPH
m 2/day</w>
m .),</w>
lys ine,</w>
lymphaden opath
lymph openia,</w>
lymph edema</w>
lymph -
ly sis,</w>
lumin a</w>
luk ast
lu x
lower- extremity</w>
low- output</w>
low- income</w>
low er)</w>
low )</w>
low "</w>
losart an-treated</w>
losart an),</w>
los s:</w>
los s-of-function</w>
los oxantr
lorat adine.</w>
lop ontine</w>
loop ,</w>
long-ter m
long- sleep</w>
long- lasting,</w>
long- infusion</w>
long- access</w>
long er,</w>
long -</w>
log- linear</w>
log is
log ies</w>
loco regional</w>
lock ed-in</w>
local izes</w>
local izations</w>
local ization,</w>
lob ule</w>
lob az
lo targ</w>
lo st.</w>
lo mustine</w>
lo in</w>
lo caine</w>
liver- spleen</w>
litter s.</w>
lithotrip sy</w>
lithium- containing</w>
lith ocholic</w>
lith iasis:</w>
lit res
lis dexamfet
lipos ome</w>
lipoprotein- cholesterol</w>
lipoprotein- X</w>
lipo philicity</w>
lipo peroxidative</w>
lipid- containing</w>
lip oxygenation</w>
lingu al-
linezol id-associated</w>
line ).</w>
lin iske</w>
limon exic</w>
limit ation.</w>
lim bic
lik el
lignoca ine)</w>
lightheade dness.</w>
ligh t/
ligand- binding</w>
lig ent</w>
lig ations</w>
lig ation/
ligation/ reperfusion</w>
life- long</w>
lidoca ine:</w>
lic hen</w>
liber ation</w>
liber ated</w>
li sting</w>
li o
li es</w>
li brary</w>
levof loxac
levodopa -associated</w>
levetir acetam,</w>
level :</w>
lev acetylmethadol</w>
leukotri enes</w>
leukopen ic</w>
leuk aem
leucine- enkephalin</w>
leucine- enkephal
leuc ocytes</w>
lethal ities</w>
leth al,</w>
lessen ing</w>
less ;</w>
lepro sum</w>
lepirud in.</w>
lep tin</w>
length s.</w>
lenalidomide- based</w>
len ticular</w>
len s.</w>
leiomyosarcom as.</w>
leiomy osarcoma,</w>
leg ally</w>
left- to-right</w>
lef t.</w>
lef rine</w>
leak age,</w>
le- closure</w>
le tro
le ster
le mon</w>
le dge
later odorsal</w>
late- gestation</w>
late x</w>
last- observation-carried-forward</w>
laser- evoked</w>
laryng oscopy.</w>
large- scale,</w>
laparotom y.</w>
laparotom y,</w>
laparo scopy</w>
lamivudine- refractory</w>
lamb da</w>
lam p</w>
lact o
lac king,</w>
lac idipine</w>
lac hr
lachr ym
labour ,</w>
laborator y-based</w>
label ing.</w>
label -
label- restricted</w>
lab yr
lab ouring</w>
lab oration</w>
lab ial</w>
la uric</w>
l- carnitine</w>
l- bucindolol</w>
l t,</w>
l o</w>
l m
l ine-induced</w>
l ine-
l ergotrile</w>
l er</w>
l c
l aw
l ate"</w>
l as</w>
l ands</w>
l ab</w>
l Co
l (-1))</w>
know ledge
kinase- 3
kin in-1</w>
kin d.</w>
kin ase)</w>
kilogram )</w>
kilo dal
kil led,</w>
kidne y:</w>
kidne y/
ki ren
kg/ h</w>
kg -1;</w>
ketamine/ xylazine</w>
ket olide</w>
ket amine)</w>
kerat ocon
kerat ectomy</w>
ker atitis,</w>
ke- K
ke-K orsak
kappa- receptor</w>
kanam ycin-
kallikrein- kinin</w>
kala-az ar</w>
kal i
ka ol
kHz ).</w>
k ward</w>
k ur
k out</w>
k o-
k leptom
k la
k i</w>
k he
k en,</w>
k d</w>
k b</w>
k Hz)</w>
k B</w>
juxtam edullary</w>
justifi es</w>
justi fication</w>
jun -D</w>
jud icious</w>
jud ici
judici ously</w>
join ts</w>
join t:</w>
jejun um.</w>
jaw- stretch</w>
jaw ,</w>
jaundic ed,</w>
j as
jas plakin
j a</w>
j a
ja 1
j )</w>
iz oribine</w>
iz ation)</w>
iz ation),</w>
iz ant</w>
iv .)</w>
iv ).</w>
ity "</w>
iti es;</w>
item s.</w>
it rulline</w>
it rat
it inase</w>
it in,</w>
it ful</w>
it ed,</w>
it )</w>
it 's</w>
istr y.</w>
ister ia</w>
isradi pine.</w>
isotretino in.</w>
isot op
isoquinol inium</w>
isopuleg ol</w>
isoproterenol- mediated</w>
isoproterenol -</w>
isoproteren ol;</w>
isoprost anes</w>
isoprenal ine-
isoniaz id
ison dam
isoc itrate</w>
iso pro
iso forms,</w>
ischaem ia-induced</w>
is seria</w>
is ophosphamide</w>
is ocarboxaz
is ms,</w>
is -
irt ually</w>
irrit ative</w>
irin otec
ir on/
ipen em</w>
ip unct
ioxag late.</w>
ioprom ide</w>
iopent ol,</w>
iodo phenyl</w>
iodo antipyrine</w>
iodix anol,</w>
iodine -1
io versol</w>
io thalam
io l</w>
involve d-
investigator 's</w>
investig ator-
inv oked</w>
inv ading</w>
introduc tion,</w>
introduc ing</w>
intraventric ularly,</w>
intras ub
intrapl atelet</w>
intraperitoneall y),</w>
intrap allidal</w>
intrane uronal</w>
intram yelinic</w>
intram ucosal</w>
intram edullary</w>
intral umbar</w>
intracerebr ally</w>
intrac ol
intra- striatal</w>
intra- atrial</w>
intra- arterially</w>
intra- VTA</w>
intra oral</w>
intra operatively.</w>
intra operatively,</w>
intra epidermal</w>
intra arterially</w>
intr insi
intrinsi cally</w>
intr apor
intr aly
intraly sosomal</w>
intest in
interval s;</w>
interval s:</w>
interval s).</w>
interval ).</w>
interstiti um,</w>
interrup ted,</w>
intern us</w>
intermediate- risk</w>
intermedi ates</w>
intermedi ary</w>
interferon/ ribavirin</w>
interferon- alpha-2b</w>
interferen ce.</w>
intercal ating</w>
interac tion?</w>
inter spike</w>
inter spersed</w>
inter relationship</w>
inter posed</w>
inter national,</w>
inter digit
inter dependence</w>
inter course,</w>
inter costal</w>
inter atrial</w>
inter -</w>
intention -to-
intensi ties.</w>
intelligen ce,</w>
integrin- linked</w>
integr ins,</w>
integr in,</w>
integr ative</w>
intake ;</w>
int romis
insul ts.</w>
insul ts,</w>
insul in-induced</w>
insuff lation.</w>
instrum ents</w>
instrum entation</w>
instrum ent
insti lling</w>
insomn ia)</w>
inser ting</w>
inser t</w>
inotrop e</w>
inosit ol.</w>
inosit ol-
ino sis,</w>
injur y)</w>
inj in
inj ected,</w>
inib -induced</w>
ini um.</w>
inhibitor ;</w>
inhibitor ).</w>
inhibi tion:</w>
inhabit ants</w>
inh ale</w>
ingest ed.</w>
ing s;</w>
ing er-
ing e</w>
ing -</w>
inform al</w>
influ ences.</w>
influ ences,</w>
influ ence
inflamm ation:</w>
infarc tions.</w>
infarc tion),</w>
infarc t-related</w>
infanc y.</w>
inf used,</w>
inf low</w>
inf eren
inf er</w>
inf ecting</w>
ines capable</w>
ine- controlled</w>
ine- 2,4-
ine mia;</w>
ine d;</w>
ine +
industr y</w>
induc tion:</w>
indole amine</w>
indol ent</w>
indo profen</w>
individual s:</w>
indinavir -related</w>
indic a</w>
index :</w>
index )</w>
indefinit ely.</w>
inde red</w>
indap amide,</w>
ind oline</w>
ind ole-
incub ating</w>
increas es)</w>
increas ed;</w>
increas e;</w>
incorrec tly</w>
inclu sive.</w>
incid ent,</w>
incid ent
incid ence)</w>
inc urable</w>
inc ture</w>
inc arc
in- diabetic</w>
in- depth</w>
in- clavulan
in- IR</w>
in- 6-
in wardly</w>
in verte
in stead.</w>
in soluble</w>
in sk
in significantly</w>
in qui
in nov
in nati</w>
in ization</w>
in homogeneous</w>
in homogene
in es:</w>
in directly,</w>
in direct,</w>
in comitant</w>
in as
inas much</w>
in apar
in activation,</w>
in activate</w>
in a.</w>
in :
impul sive</w>
impul si
improvement ;</w>
implic ations,</w>
implement ed.</w>
imple ment</w>
implant s,</w>
implan ted.</w>
impairment :</w>
impair ments,</w>
immunosuppres si
immunoglobul ins.</w>
immuno gold</w>
immuno assay,</w>
immuno adsorption</w>
immune ,</w>
immun ization,</w>
immun ity.</w>
immun ity,</w>
imidazole-4- carboxamide</w>
imidaz opyridine</w>
imidaz obenzodiazepine</w>
imid aprilat</w>
ime x</w>
im pressed</w>
im possible.</w>
im minent</w>
im aged</w>
im age.</w>
illness ;</w>
ill- defined</w>
ill s</w>
il/ folinic</w>
il- sparing</w>
il y.</w>
il vie's</w>
il ly</w>
il -related</w>
il ).</w>
ifosfamide -related</w>
ific ations</w>
ido thymidine</w>
idiosyncr as
identic al.</w>
ide ation.</w>
ide /
ide -</w>
ide ).</w>
idazox an.</w>
id otomy</w>
id ofovir</w>
id er
id ase</w>
id ).</w>
icter us,</w>
iclo vir</w>
ick y</w>
ick man</w>
icill in-resistant</w>
ici ent</w>
icalTrial s.gov,</w>
ic- mediated</w>
ic in-treated</w>
ic ho
ic ana</w>
ib all
ia --a</w>
i. th
i. d.)</w>
i. c.),</w>
i. a.)</w>
i podate</w>
i es)</w>
i e</w>
i bo
ibo g
ibog a</w>
i ance</w>
i 3</w>
i ),</w>
hyth mic</w>
hyste rectomized</w>
hypox emic</w>
hypoton ous</w>
hypothesi sed</w>
hypother mic,</w>
hypothe ses.</w>
hypothalam us-
hypophosphat emia.</w>
hypophosphat aemic</w>
hypoparathyroidis m.</w>
hypoparathyroidis m,</w>
hypoman ia,</w>
hypom otility</w>
hypom ethyl
hypoinsul inemia,</w>
hypogly caemia.</w>
hypogly caemia,</w>
hypochol ester
hypocholester ol
hypocap nia.</w>
hypocap n
hypocalci uric</w>
hypo uric
hypo thyroidis
hypo ren
hypo perfusion.</w>
hypo perfusion,</w>
hypo fibrinogen
hypo algesi
hypo albumin
hypo activity.</w>
hypo -</w>
hypo -
hypno tic.</w>
hypno sis</w>
hypervol aemic</w>
hyperuric emia</w>
hypertricho sis.</w>
hypertension -related</w>
hypertensi ve.</w>
hypersensi vity</w>
hyperren inemia</w>
hyperprolactin aemic</w>
hyperpolar izing</w>
hypernat remia,</w>
hypermagne semia</w>
hyperlactat aemia</w>
hyperkine sias</w>
hyperinsul inism.</w>
hyperhid rosis</w>
hypergly caemia</w>
hyperexcit ability,</w>
hypereosinophil ia</w>
hypereosinophil ia.</w>
hypercap nia.</w>
hyperammon emia,</w>
hyperalgesi a;</w>
hyper ventilation.</w>
hyper somn
hyper secretory</w>
hyper pyrexia,</w>
hyper pyrex
hyper prostaglandin</w>
hyper osmolality,</w>
hyper magnesi
hyper locomotor</w>
hyper lip
hyper homocyste
hyper amyl
hyperamyl as
hyper adrenocortic
hyper -</w>
hyp nagogic</w>
hydroxyquinol ines</w>
hydroxyl ysine</w>
hydroxy-2- acetylaminofluorene</w>
hydroxy methylglutaryl</w>
hydroxy chloroquine-induced</w>
hydrox yn
hydrox ylated</w>
hydrox yc
hydrox amic</w>
hydrox am
hydroure ter</w>
hydrochlor ide-induced</w>
hydro pic</w>
hydro philicity</w>
hydro peroxide</w>
hydro pen
hydro ce
hydroce les</w>
hydralaz ine-induced</w>
hy 926</w>
human -
hum an,</w>
huPBL- SCID</w>
hr ;</w>
hr /
hour /
host )</w>
hos pice</w>
hormone- resistant</w>
hormon ally</w>
horiz ont
homogen ates,</w>
homo e
homoe opathic</w>
hom icidal</w>
ho st-
hmt 2</w>
histid ine-rich</w>
histamine 2</w>
hir udin,</w>
hippocampal- entorhinal</w>
hippocamp us:</w>
hind paws</w>
hind paws.</w>
hind -
hin olaryng
him achalol</w>
hil us
high- voltage</w>
high- power</w>
high- flux</w>
high- efficacy</w>
high- altitude</w>
hiccup s,</w>
hic cup</w>
hi sian</w>
hi p.</w>
hexy loxy
hexameth onium.</w>
hexachloro phene.</w>
hex obarbital</w>
hex obarbital,</w>
hex obarbit
hex apeptide</w>
hex ane-
hex afluoro
herni orrhaphy.</w>
herit able</w>
her petiform
her p
hept a
hepatosplen omegaly,</w>
hepatocellular- cholestatic</w>
hepati s,</w>
hepat otoxin</w>
hepat omas,</w>
hepat oblastoma</w>
hepat ectomy.</w>
heparin oid</w>
hemorrh aging</w>
hemorrh age;</w>
hemorrh age)</w>
hemorhe ological</w>
hemor rhoids</w>
hemodialy sis;</w>
hemo therapy.</w>
hemo therapy,</w>
hemo philic</w>
hemo perfusion</w>
hemo gram</w>
heme- L-lysin
hematocrit .</w>
hemat ology,</w>
hem olysis:</w>
hem iball
hem angio
hemangio endotheli
hel ical</w>
heighten s</w>
heigh t.</w>
heavi er</w>
heat -induced</w>
heart/ body</w>
heart burn</w>
heart beats</w>
hear t)</w>
heal ing,</w>
headache -free</w>
head-to- head</w>
he ver</w>
he ta
he loder
he li
harvest ed.</w>
harvest ed,</w>
harm ful
har ml
har ,</w>
happ ened</w>
hamar toma.</w>
ham mock</w>
haloperidol ).</w>
haloperidol 's</w>
hallucin osis</w>
hallucin ations;</w>
hallucin ation.</w>
hal ved</w>
hal ted</w>
hal f.</w>
hair ,</w>
haemorrh ages.</w>
haemodynam ically</w>
haemodynam ic,</w>
haemat uria,</w>
haemat ologic</w>
haem olysis,</w>
had :</w>
habil itation</w>
hab its,</w>
hab it</w>
ha ron</w>
ha em</w>
h/ day</w>
h y</w>
h t
h p
h indered</w>
h at</w>
h ass
h -1.</w>
guar ante
guanfac ine.</w>
guanabenz .</w>
guan osine-
guan ine-
group s--
group --
group ):</w>
group 's</w>
gro unds.</w>
gro o
gren 's</w>
great ly,</w>
gravi d</w>
graph y;</w>
granulocyte- monocyte</w>
granulo cytopenic</w>
gran /
gra y.</w>
gra ded,</w>
gr as
gr ac
gp ),</w>
govern ment</w>
gonad otrophin</w>
go- go
go-go -related</w>
go od
go at
go al.</w>
go al-
go al,</w>
glycogen osis</w>
glycer ophosph
glycer ides</w>
glycer aldehyde-
glyc olytic</w>
glyc ine.</w>
gly cyr
gluteth im
glutathione- dependent</w>
glutamate- mediated</w>
glucuronid ase,</w>
glucose-6- phosphate-dehydrogenase</w>
glucose- free</w>
glucocorticoid -mediated</w>
glucocortico ids,</w>
gluc ar
glot tis</w>
glomeruloneph ro
glomerulo pathies</w>
glomerulo pathies.</w>
glitaz one-induced</w>
glibencl amide.</w>
gir ls,</w>
gir dle</w>
gingi vitis</w>
gestod ene,</w>
germ line</w>
germ -cell</w>
gentamicin- cephalothin</w>
gentamic in-resistant</w>
general ize</w>
general ization.</w>
gene (s)</w>
gen otype
gen ioglossus</w>
gen icity.</w>
gen ation</w>
gemcitab ine/
gemcitab ine-associated</w>
gel ser</w>
ge ot
gav aged</w>
gau ze</w>
gastroenter itis.</w>
gastroenter itis,</w>
gastro stomy</w>
gastro intestin
gangren os
gangli on-
gangli on,</w>
gangli on
gammag lut
gamma-hydroxybut yric</w>
gamma-D-glutam yl
gamma- globulin</w>
gamma- butyro
gamma- acetylenic</w>
gamma- G
gam mopathy</w>
gall amine,</w>
gal lopamil</w>
gadolinium- based</w>
gadodi amide-related</w>
gab acul
ga stric,</w>
g/m L,</w>
g/m 2).</w>
g/m (2)/
g/d l;</w>
g/d l.</w>
g/ min.</w>
g/ min)</w>
g/ l)</w>
g/ kg/min</w>
g/ kg).</w>
g/ day,</w>
g/ d.</w>
g/ L</w>
g/ 100</w>
g. kg(-1).
g wheel</w>
g st</w>
g in
g ilvie's</w>
g g</w>
g epir
gepir one</w>
g c
gc d-
g aps</w>
g and
further more,</w>
furosem ide:</w>
furazol id
fur an
fundus cop
function s:</w>
fum ar
fulmin ating</w>
fuc ose</w>
frusem ide,</w>
frusem ide)</w>
fructo se-pretreated</w>
fru st
fru its</w>
fru itful</w>
frontop ari
frontopari etal</w>
front- loading</w>
front ally</w>
fri end</w>
frequency )</w>
freeze- fracture</w>
free- field</w>
free base</w>
fram e.</w>
frag ments.</w>
frag ments,</w>
fraction s;</w>
four- week</w>
four- gland</w>
four )</w>
fos phenytoin.</w>
forty- six</w>
forty- seven</w>
forty- eight</w>
fortun ately</w>
forti fied</w>
fort nightly</w>
formul a,</w>
formul a)</w>
formal in.</w>
formal in-</w>
form yl</w>
form aldehyde</w>
form )</w>
fore paws</w>
fore head.</w>
for ward.</w>
for ni
for maz
for got
foot shock</w>
food- reinforced</w>
fondaparinu x</w>
follow-up ;</w>
follow-up :</w>
follic le</w>
fol ds,</w>
fol ding</w>
fol d),</w>
fol ate.</w>
foc us
fo ods</w>
fo od,</w>
fo etuses</w>
fmol/ micromol</w>
flut amide-induced</w>
flush ing.</w>
flush ed</w>
flupirt ine.</w>
fluphenaz ine-
fluoroquinol ones:</w>
fluoroquinol one,</w>
fluoro- beta-
fluoro metric</w>
fluoresce in.</w>
fluoresc ence,</w>
fluores cent
fluorescent -labeled</w>
fluor ine</w>
flud ro
flud arab
flu tre
flu ocin
flu indi
flu id)</w>
flow s.</w>
flin ching</w>
flexi bility</w>
flatten ed</w>
flash es,</w>
fl y,</w>
fl uroxene,</w>
fixed- interval</w>
fix ation,</w>
five- day</w>
fistul as</w>
fistul a.</w>
fir st.</w>
fir m</w>
fing er.</w>
fine- motor</w>
finaster ide.</w>
filgrastim ,</w>
fil ter.</w>
fil ms</w>
fifty- six</w>
fiel d-
fibros ar
fibro proliferative</w>
fibro elast
fibrin opeptides</w>
fib re
fi ve.</w>
ffe inated</w>
ff ective</w>
fex ofenadine</w>
fer tile</w>
fer ric</w>
fentanyl :</w>
fentanyl /
fenob am</w>
feno profen,</w>
feno fibrate.</w>
fenflur amine;</w>
fen pro
fen est
fen adine</w>
femoro femoral</w>
femal es).</w>
fem ur</w>
fem ur.</w>
felodip ine,</w>
fell .</w>
fel low</w>
feed back.</w>
feat ure,</w>
fear s</w>
fear -associated</w>
fea red</w>
fe barb
faz ad
favour able.</w>
fast ,</w>
fasci otomy</w>
fasci otomy.</w>
fasc ia</w>
famoti dine,</w>
famili es,</w>
famili arity</w>
famil y-based</w>
fam ciclovir</w>
fall s.</w>
fain tness</w>
failure ?</w>
failure )</w>
failure ).</w>
failure ),</w>
fail ures,</w>
faec alis</w>
factor- beta
factor- alpha,</w>
factor s;</w>
fact .</w>
facilit ation.</w>
facil ity.</w>
fa ulty</w>
f usional</w>
f uch
f ratax
f oster</w>
f onad</w>
f man</w>
f ather
f ang
fang chin
fangchin oline</w>
f alle
falle n</w>
f .
eye drops</w>
eye blink</w>
eye balls,</w>
extrac erebral</w>
extra uterine</w>
extinc tion.</w>
exten sive,</w>
exten sion,</w>
expres sions.</w>
expres ses</w>
exposure ).</w>
exposure ),</w>
explor ations</w>
explo sive</w>
explo red,</w>
explan ations,</w>
explan ation,</w>
expl ained.</w>
experiment ally-induced</w>
experim enter
expect ation</w>
exp 1</w>
exempl ifies</w>
excre tion;</w>
exclu sively,</w>
excipi ents.</w>
excep tions,</w>
exceede d.</w>
exc ruciating</w>
exc iting</w>
examin ers</w>
evolu tion.</w>
evolu tion,</w>
evi prostat
ev es</w>
ev ening,</w>
euthan ized,</w>
euphor ia.</w>
euc alce
eu thanasia.</w>
etretin ate.</w>
etoric oxib,</w>
etopo side)</w>
etop yraz
etomid ate:</w>
etodol ac.</w>
etidoca ine.</w>
eti lefrine</w>
ethylenedi amine</w>
ethyl]- 4-(3-
ethyl]-4-(3- phenylpropyl)
ethyl] -1,4-
ethyl]-1,4- diazabicyclo
ethyl]-1,4-diazabicyclo [4.
ethyl]-1,4-diazabicyclo[4. 3.0
ethyl]-1,4-diazabicyclo[4.3.0 ]
ethyl]-1,4-diazabicyclo[4.3.0] non
ethyl phosphorothioic</w>
ethopropa zine</w>
ethnic ity,</w>
ethmo zin</w>
ethinylo estradiol.</w>
ethinylestradi ol.</w>
ethanol 's</w>
eth es
eth chlor
ethchlor v
et ri
et orphine,</w>
et am
et a</w>
estrogen- progestogen</w>
estrogen- progestin</w>
estrogen -related</w>
estradiol-17 beta-glucuronide</w>
estradi ol)</w>
estim ates.</w>
ester -
esophag itis,</w>
escap ed</w>
es omeprazole</w>
erythropoiet in,</w>
erythropoi e
erythromel algia-like</w>
erythrom yc
erythrodysesthesi a,</w>
erythroder ma</w>
erythro n</w>
erythro cytosis</w>
erythro blast</w>
ery thermalg
erup tions.</w>
ertap enem</w>
erlotin ib</w>
erlotin ib
ergotamine/ caffeine.</w>
ergot amine-induced</w>
erg ocryptine</w>
erg ic)</w>
erb in
er- equipped</w>
er t-Eaton</w>
er ine,</w>
er culo
er ated</w>
equival ently</w>
equival ent
epti fibati
epti de,</w>
epo prosten
epo i
epo etin.</w>
epitheli oid</w>
epitheli a</w>
epit ope</w>
epirubic in-treated</w>
epinephr ine:</w>
epinephr ine-</w>
epilept oid</w>
epilept ogene
epilept ogen
epilepsy ;</w>
epid erm
epicardi um.</w>
epic anth
epi me-induced</w>
ephed ra,</w>
ep run
ep im
ep end
enzyme- inducing</w>
enzyme -1</w>
enzym uria</w>
enzym es;</w>
entr ap
enti rely.</w>
enti al,</w>
enterocol itis,</w>
entero pathy</w>
enter ococci</w>
entail s</w>
ent of
ent ered.</w>
ent '</w>
ens it
enro ll</w>
enox acin,</w>
enol ase</w>
enlarge d,</w>
enkephal in
engraft ment.</w>
energe tics.</w>
enem as</w>
enedi one</w>
enedi amine</w>
ene- 23-
endotox in-induced</w>
endothel in-3</w>
endomy ocardium</w>
endometri um.</w>
endom ysial</w>
endolym ph</w>
endocardi tis,</w>
endo don
endodon tic</w>
endo -
endarte rectomy.</w>
end- points</w>
end rin</w>
end ing,</w>
encour aging.</w>
encour ages</w>
encomp assing</w>
enco ding.</w>
encephalo pathies</w>
encephalo graphic</w>
encephal ocele</w>
encephal itis,</w>
ence /
encap sulation</w>
enc losed</w>
en yl)
en suring</w>
en surate</w>
en ough
en ess.</w>
emul sion.</w>
empt ying.</w>
employ ed:</w>
emplo y</w>
emphyse ma</w>
emphasi ses</w>
emphasi sed.</w>
emphasi se</w>
emph ig
emo tionally</w>
emo tion</w>
emergen ce,</w>
emerg ed,</w>
embryoleth ality,</w>
embry otoxicity.</w>
embry os
embran es</w>
embol i.</w>
embol i,</w>
emb usartan</w>
em ide,</w>
em ia:</w>
em an
elucid ated,</w>
elong ation</w>
elo da
ell enic</w>
ell a-
elimin ation.</w>
elic ited.</w>
elev enth</w>
electroretin ography</w>
electrophysi ologically,</w>
electron ystagmo
electron ically</w>
electromyo graphy,</w>
electromyo graphical</w>
electroly tes.</w>
electrocardio graphically</w>
electrocardio graphic,</w>
electro- ocu
electro- diagnostic</w>
electr oneuro
electr ical-
elberg er</w>
elast olytic</w>
elan dopam</w>
el ym
el ution</w>
eighty- one</w>
effor ts,</w>
efflu x.</w>
effici ent.</w>
efficaci ous.</w>
effec tively.</w>
effec tive;</w>
eff usions.</w>
eff u
efarox an,</w>
ef oni
edroph onium-
edema :</w>
ede mat
ed rine</w>
ed .(ABSTRACT</w>
ectom ies</w>
ect o-
ecstas y/
eclamp sia</w>
echo genicity</w>
echo -
ecarbox amide)</w>
ec ortin</w>
ec onom
ec chy
ecchy mo
eat ers.</w>
easi er</w>
earli er);</w>
ear ns-Sayre</w>
ear ly
eIF2 alpha
e/ non-case</w>
e ther,</w>
e rence</w>
e perisone</w>
e in,</w>
e gu
e go
e gg
e astern</w>
e as
e ,"</w>
dystroph ic</w>
dystoni as.</w>
dystoni as,</w>
dysrhyth mogenicity</w>
dysphor ia,</w>
dysph onia.</w>
dyspep sia.</w>
dyspep sia,</w>
dyslipide mia.</w>
dyslipide mia,</w>
dyskinesi a).</w>
dyscrasi as.</w>
dys regulation.</w>
dys regulated</w>
dys pareun
dys morph
dys albuminemic</w>
dynam ite</w>
dur ability</w>
duplic ate</w>
duct ules</w>
duct or</w>
duc ted</w>
drug- using</w>
drug- refractory</w>
drug- induced.</w>
drug- adsorption</w>
drug s--
drug ?</w>
drug --
drople ts,</w>
drop out
dro oling</w>
dro mically</w>
dream ing</w>
drawbac ks</w>
draw n.</w>
dp p</w>
doxorubic in)</w>
dox il</w>
dox ifl
double- stranded</w>
double- masked</w>
double- labelled</w>
double -dose</w>
dose- titration</w>
dose- severity</w>
dose- range</w>
dos ing;</w>
dors ally</w>
dopamine- sensitive</w>
dopamine- blocking</w>
dopamine- beta-
dop ing</w>
domain .</w>
dom opredn
dom ain,</w>
dol icho
docetaxel/ carboplatin</w>
do thiepin</w>
do or</w>
do es.</w>
dn -
dn- sec(-1).m(2).cm
dizocil pine.</w>
dizocil pine-induced</w>
divertic ul
div or
dite kiren</w>
disulfir am
disulfi de,</w>
disturb s</w>
disturb anc
distribut ed.</w>
dist ally</w>
dist al,</w>
dissoci ation,</w>
disrup ted.</w>
displac ements</w>
disopyram ide-induced</w>
dismut ase.</w>
disease- -
discrimin ated</w>
disco vered,</w>
disco ver
disc ri
disc re
disappoint ing.</w>
disadvant ages.</w>
dis regarded</w>
dis placement,</w>
dis cordant</w>
dis car
direc tly.</w>
direc tions</w>
direc tion.</w>
dipyridamole- thallium-201</w>
dipy ron
diplop ia.</w>
dipivox il/
diphenylacetoxy-N-methyl piperidine</w>
diphenyl pyrrolidin-2-one</w>
dimethylethan olamine</w>
dimethylethan olamine-pretreated</w>
dimethyl hept
dimen sion,</w>
dilem ma.</w>
dihydroxy- 6-nitro-
dihydroxy-6-nitro- 7-
dihydroergocrist ine</w>
dihydro- 6
dihydro- 2-
dihydro quinidine</w>
dihydro lisuride</w>
dihydro chloride,</w>
digox in)</w>
digitox in.</w>
difluoromethyl ornithine</w>
difficult-to- treat</w>
differenti ation,</w>
differenti ated,</w>
diffe red.</w>
diethylstilbestrol- exposed</w>
diethylstilbestro l-induced</w>
diethylstilbestro l,</w>
diethyl carbamo
diethyl amino
dicyclo mine</w>
diclofenac /
dichloro methane</w>
dicarb oxy
dic umarol</w>
dic ho
dic arboxyl
diazepam )</w>
diaz emul
diatrizo ate)</w>
diastere omers</w>
diarrho e
dialy sis;</w>
diabetes- insipidus-like</w>
diabe tic,</w>
di potassium</w>
di oxopiperazine</w>
di op
di one)</w>
di methyl-4-
di methoxyphenyl)
di methoxy-
di mercaptosuccinic</w>
di ligent</w>
di hydralazine</w>
di folia</w>
di estrus</w>
di encephalon,</w>
di en
di aries</w>
di amin
di -n-propyl
dextromethorph an.</w>
dextro se.</w>
dextro amphetamine,</w>
dextro -
dexamethas one:</w>
dex ter
dex fenfluramine-induced</w>
dex ,</w>
devi sed.</w>
devi ation.</w>
detrus or.</w>
detom idine</w>
deterior ate,</w>
detail ,</w>
detach ments</w>
detach ment.</w>
desquam ation</w>
desogestrel -containing</w>
desmo id</w>
desig ned.</w>
desi pramine-induced</w>
desferri oxamine,</w>
descri pt
desc ended</w>
desbutyl bupivacaine</w>
desatur ation.</w>
desArg 9
desArg9 Leu
desArg9Leu 8-
des pair
des min,</w>
des flurane,</w>
des acetyl
dermat o
deri ving</w>
depolar iz
depolar isation</w>
deple tor</w>
depic ting</w>
depend ence;</w>
deoxy doxorubicin</w>
deoxy cortisol</w>
denti sts</w>
denomin ator</w>
dendrit es.</w>
dend rin</w>
den oted</w>
den ial</w>
demethyl ase</w>
demet on-
delta9- TH
delta-amino valeric</w>
delta- aminol
delta 9
delta .</w>
delta -</w>
deliver s</w>
deli vered.</w>
delay s,</w>
delay ed-
del a
dehydrogen ase)</w>
degre es.</w>
degran ulation.</w>
degrad ing</w>
degrad ation,</w>
degener ation)</w>
deform ity,</w>
deform ities.</w>
deform ations</w>
deficiency :</w>
defici encies,</w>
defer red</w>
defec ation</w>
def ines</w>
def ensi
decreas e).</w>
decreas e),</w>
decompens ation.</w>
declar ative</w>
decl ared</w>
deci sions.</w>
decel erations</w>
deced ent's</w>
decapit ated</w>
deca ffeinated</w>
dec hall
dec ayed</w>
debriso quine.</w>
deb ate.</w>
death ).</w>
deacetyl thymoxamine</w>
de- novo</w>
de synchronization</w>
de sensitization,</w>
de se
de phosphorylation</w>
de medull
de formed</w>
de duced</w>
de d)</w>
de anol</w>
de amino-
dd l,</w>
dd C-treated</w>
day- case</w>
day -1);</w>
day 's</w>
daugh ters.</w>
dat rexate</w>
dat as
dapsone- exposed</w>
dam ages,</w>
dac ryocystorhin
dab igatran</w>
dP/d t.</w>
d4T- based</w>
d- tubocurarine,</w>
d- propranolol</w>
d- penicillamine</w>
d- carnitine</w>
d- amphetamine-
d- PPH</w>
d welling</w>
d war
d ut
d uplex</w>
d ually</w>
d or.</w>
d k
d ing,</w>
d ence</w>
d Tc-
d L</w>
d B,</w>
d .,</w>
d -</w>
d -1)</w>
d 's</w>
cytostatic s.</w>
cytoskele ton,</w>
cytopen ias.</w>
cytomegalo virus,</w>
cytok ine-
cytok ine,</w>
cytochrome- c</w>
cyto protective.</w>
cyto keratin</w>
cyto architect
cytarab ine-induced</w>
cyt ologically</w>
cysticer cus</w>
cyste ine)</w>
cyste amine</w>
cyst s,</w>
cyst ometry</w>
cyst oid</w>
cyclophosphamide :</w>
cyclophosphamide -associated</w>
cyclophosphamide )</w>
cyclopent enyl</w>
cyclop legic</w>
cyclohex anec
cyclase- activating</w>
cycl ed</w>
cyano sis.</w>
cyano acrylate</w>
cy clin
cyclin -dependent</w>
cut- points</w>
cut off
cut aneously</w>
cur tailed</w>
cups/ day,</w>
cumul ative,</w>
cumul ating</w>
cum st
cul tur
cul pr
cul atory</w>
cu st
cu prolinic</w>
cu pational</w>
cryo globul
crush ed</w>
crow n-rump</w>
cross- tolerant</w>
cross- reaction</w>
cross- reacting</w>
cross- reacted</w>
cros s.</w>
cromakal im
cro uch
cro cin
creatin ine:</w>
creatin ine)</w>
cre dence</w>
cre ati
creati vity,</w>
crav ings</w>
cranio facial,</w>
crac k,</w>
cr ying</w>
cr ushed,</w>
cr assi
crassi pes</w>
cow s.</w>
cour ses;</w>
counter puls
counter -
counsel ed</w>
coun ts)</w>
cough ing,</w>
cou ple</w>
cot rimox
cot reated</w>
cost s.</w>
cortis one.</w>
corticotrop in-secreting</w>
cortico -striatal</w>
cortex ;</w>
corrobor ated</w>
correl ations.</w>
correl ated,</w>
correc tion.</w>
correc tion,</w>
cor ds,</w>
cor difolia</w>
cop per,</w>
convuls ants,</w>
convuls ant
convinc ingly</w>
conver s
conval escent</w>
contribut ory.</w>
contract ure,</w>
contracepti ve.</w>
continu es.</w>
continu ally</w>
consump tion;</w>
consu mers.</w>
const ant-
consist ent,</w>
conserv atively.</w>
conserv atively,</w>
consec uti
cons ent.</w>
connec tion.</w>
configur ation.</w>
confer ring</w>
conf used,</w>
conduc tive</w>
condu its</w>
condition s;</w>
condition ing,</w>
condition ;</w>
condition )</w>
condens ation</w>
concurren tly,</w>
concl usion.</w>
concentration s)</w>
concentration /
conc ur</w>
con us</w>
con tempor
con stituting</w>
con serving</w>
con served</w>
con genic</w>
computer- generated</w>
compres sion,</w>
compassion ate</w>
compac ta.</w>
comp rises</w>
communic ations</w>
communic ation:</w>
communic ating</w>
communic ate</w>
commun ity,</w>
common :</w>
commissu re,</w>
commence d.</w>
comm ensurate</w>
comfor table</w>
comedic ation</w>
combine d-modality</w>
com mentary</w>
colum ns</w>
colum nar</w>
colon oscopy.</w>
colon ization</w>
colon ies</w>
collicul us,</w>
collater al-
collagen /
cold- pressor</w>
col pos
col on,</w>
col li
col laborative</w>
col icky</w>
col i,</w>
coincid ental</w>
coincid ent
coinc ide</w>
cohor t)</w>
cognitive- behavioral</w>
cogniti vely</w>
cogni tion-
cogn izant</w>
coffe e,</w>
coer uleus,</w>
coeffici ents</w>
coeffici ent.</w>
coeffici ent,</w>
code ine-induced</w>
coccidi oidal</w>
cocci .</w>
cocaine/ heroin</w>
cocaine- stimulated</w>
cocaine- paired</w>
cocaine- only</w>
cocaine- alcohol</w>
coc atropine</w>
cobal amin</w>
cob ble
cobble stone-like</w>
coarsen ing</w>
coal es
co- morbidi
co- medication</w>
co- ingestion</w>
co- ingested</w>
co vit
co variate</w>
co it
co incidence</w>
co eliac</w>
co at</w>
cm 3)</w>
cm ).</w>
cm (3)</w>
clu sive</w>
clozap ine/
cloxacill in.</w>
cloxacill in-induced</w>
clorg yline,</w>
clorazep ate,</w>
clon ogenic</w>
clon es.</w>
clomi pramine,</w>
clomi phene.</w>
clofil ium</w>
clofil ium,</w>
clofaz im
clo thing</w>
clo thiapine</w>
clioquinol -treated</w>
clinic oradi
clinic al/
cli pped</w>
cli ent</w>
clef ts</w>
clef t,</w>
cleare d.</w>
clear ance)</w>
claudic ation.</w>
classi fying</w>
classi cal
classical "</w>
clarithrom ycin-induced</w>
cl av
cl aim
cisterna e</w>
cisterna e,</w>
cisplat in:</w>
cis- platinum.</w>
cis- dichlorodiammineplatinum</w>
circumferen ces</w>
circumci sion.</w>
circum vent</w>
circul ations</w>
circuit ry.</w>
cir in,</w>
ciprofloxac in:</w>
cinnar izine.</w>
cinacalce t.</w>
cin oxacin</w>
cilost azol.</w>
cilost amide</w>
cilni dip
cilastat in.</w>
cilastat in,</w>
cidofovir .</w>
ciclospor in</w>
chylo us</w>
chron otrop
chron icity</w>
chromatography/ mass</w>
chorio retinal</w>
choreoathe tosis.</w>
chor nea</w>
cholester ol-
cholestatic -
cholestatic- hepatocellular</w>
cholecystokin in,</w>
cholecysti tis,</w>
cholangiopancreat ography,</w>
chol angiographic</w>
choic e,</w>
cho w.</w>
chlorthalid one.</w>
chlorpro thixene</w>
chlorpro thixen
chlorphenir amine.</w>
chlorothiaz ide,</w>
chloroform -induced</w>
chloro but
chloramphenic ol-induced</w>
chlor tal
chlor isondam
chlor imipramine,</w>
chlor ide-
childho od
chick en</w>
chi 2</w>
chemotherapy- evoked</w>
chemotherapeu tics</w>
chemo receptor</w>
chemilumin escence</w>
chem istry,</w>
check- up</w>
chec king</w>
che lidonine</w>
che lation.</w>
che late</w>
che ek</w>
charybdot oxin</w>
charco al/kg</w>
chang es'</w>
ch ond
ch o</w>
ch ard</w>
ch aper
ch ap
ch am
cham bered</w>
ch alaz
cervi x
cerv ical,</w>
certific ates</w>
cerebro cortical</w>
cerebel lopontine</w>
cerebel lopathy</w>
cer uleus,</w>
cepti ble</w>
cephalothin- gentamicin</w>
cephalor idine-induced</w>
cephal y</w>
ceph radine</w>
centur y.</w>
centro phen
centro lobular</w>
central- acting</w>
cent s,</w>
cent re,</w>
cent ),</w>
cellular ity,</w>
cells/micro L,</w>
cells/micro L)</w>
cells/ l.</w>
cell s).</w>
cell -specific</w>
cefuroxi me.</w>
ceftazidi me.</w>
ceftazidi me-induced</w>
ceftazidi me
cefox itin.</w>
cefotetan- coated</w>
cefotaxime ,</w>
cefamand ole.</w>
cefaclor ,</w>
ceas ing</w>
ce mia,</w>
ce :</w>
cd k5</w>
cc/ 100</w>
cavernos um</w>
cave olin-1alpha</w>
cause- effect</w>
caus ative.</w>
caus ation.</w>
caudate- putamen.</w>
caud ate,</w>
caud ally</w>
categor y.</w>
categ ories,</w>
catecholamine- facilitated</w>
catechol amine-</w>
catalyst s</w>
cataly zed</w>
catabol izing</w>
cat en
cat apl
cat ,</w>
cast rate</w>
case- controlled</w>
casca de,</w>
cas es:</w>
cas e/non-case</w>
carri ers,</w>
carrageen an-</w>
carnit ine-treated</w>
carmust ine,</w>
caregi vers</w>
cardioverter- defibrillator</w>
cardiover ter/
cardiomyopath y-induced</w>
cardiomyo pathies.</w>
cardio vascularly</w>
cardio vascular
cardio selectivity</w>
cardio protection.</w>
cardi ological</w>
cardi o</w>
carcinom a)</w>
carcinogen s,</w>
carboxyp eptidase</w>
carboxy methylcell
carboxy lester
carboxy cyclo
carbon yl)
carbidopa ,</w>
carbenicill in.</w>
carbamazep ine-treated</w>
carbamazep ine-associated</w>
carbach ol-
carb amide</w>
car ies</w>
car ies.</w>
car cas
capsaic in)</w>
cap abilities.</w>
cannabin ol</w>
candi de
candi dat
cancer ;</w>
canalicul i.</w>
calretin in,</w>
callo sum,</w>
calcium/ creatinine</w>
calcitri ol)</w>
calcineur in-
calbindin-D(28 K)</w>
calbindin- immunoreactive</w>
calbindin- D28
cal ori
cad a
cada ver</w>
ca ine.</w>
cAMP- mediated</w>
cAMP- dependent</w>
c.v .</w>
c- AMP</w>
c ures</w>
c n</w>
c m.</w>
c ec
c c
c ation.</w>
c ally.</w>
c ally,</w>
c age.</w>
c RNA</w>
c PKCgamma</w>
c PKC</w>
c BLA</w>
c AV
cAV B</w>
bypas ses</w>
bypas s,</w>
by- time</w>
by- product</w>
buttoc ks</w>
butano yl
but yrate</w>
busulf an-induced</w>
burst- spiking</w>
burst /
burrow ing,</w>
bur ning,</w>
bupropi on-only</w>
buprenorph ine's</w>
bupivacaine- sufentanil</w>
bupivacaine- morphine</w>
buni onectomy</w>
bund le.</w>
bund le,</w>
bumetan ide,</w>
bulb ectomy</w>
bul ls</w>
bul la</w>
bul ky</w>
bul b</w>
build up</w>
buil ders</w>
buil der</w>
buil der.</w>
budeson ide,</w>
brux ism,</w>
brush ing</w>
bruc ellar</w>
bronchodilat or.</w>
bronchodilat ation.</w>
bronchoconstric tion.</w>
bronch opneum
bronch i</w>
bromo phenyl)
bro ther
briefl y.</w>
brie f.</w>
breast feeding</w>
breakthrough .</w>
bre aking</w>
bran ds</w>
bran ched-chain</w>
brain- damaged</w>
bradycardia :</w>
brady arrhythmic</w>
brad y-
brac ket
bra ins,</w>
bra in;</w>
bra in:</w>
br ary,</w>
bound aries</w>
boun d,</w>
boun cing</w>
bot tled</w>
bortezomib ,</w>
border zone</w>
bor naprolol</w>
boo ks</w>
bolus- injected</w>
bol us;</w>
body weights</w>
bob b
bobb ing,</w>
bo ys,</w>
bo wing</w>
bo wel
bo otstrap</w>
blot ting,</w>
blood stream.</w>
blood less</w>
block s,</w>
block ing)</w>
block age,</w>
block :</w>
blo t,</w>
blin king</w>
bleed ings.</w>
bleed ing:</w>
blast ogenesis</w>
blad ders,</w>
blac k-
bl ade</w>
bisulfit e,</w>
bis pectral</w>
bis dioxopiperazine</w>
birth s</w>
birth s,</w>
biotrans formed</w>
biopsy- proved</w>
biopsi es),</w>
biop terin</w>
biom embranes</w>
bio prosthetic</w>
bio phase</w>
bio genesis</w>
bio degradable</w>
bio activation</w>
bing e"</w>
bind ing)</w>
bim od
bili protein</w>
bile- duct</w>
bil li
bifur cation</w>
bif eprun
bicyclo l</w>
bibli ographic</w>
bi refr
bi ochemistry,</w>
bi dimensionally</w>
bi ases</w>
bi as,</w>
bethanech ol.</w>
betamethas one.</w>
betamethas one-induced</w>
beta2- microglobulin</w>
beta-lactam ase-
beta-endorph in,</w>
beta-caroten e,</w>
beta-blocker /
beta-D- arabinofuranos
beta- thalassemic</w>
beta- mimetic</w>
beta- methyl
beta- glucosidase,</w>
beta- ENaC</w>
beta(2)- adrenoceptor</w>
beta(2)- adrenergic</w>
beta 1-selective</w>
beta -induced</w>
beta (3)</w>
beta (2)</w>
bet ter.</w>
bet am
bet acy
berg ,</w>
bepri dil.</w>
benzyl penicillo
benzyl isoquinolinium</w>
benzyl iden
benzoylecgon ine,</w>
benzo[ f]
benzo thiazol
benzo (
benzo( a,
benzo(a, d
benzil ate,</w>
benz amides</w>
benser az
benflu orex</w>
bel ly</w>
behaviour s,</w>
beg in
beg an.</w>
befun olol</w>
before )</w>
beats/min .)</w>
beats/ minute</w>
beats/ min;</w>
beats/ min).</w>
beat ing,</w>
beat ,</w>
beagl es,</w>
be side</w>
be low-
be long</w>
be line</w>
be e</w>
be dd
be ad</w>
batan opride</w>
bas ophil</w>
bas al,</w>
bas al)</w>
baroreceptor- denervated</w>
baro reflex-
baro receptors.</w>
bar ,</w>
band s,</w>
ban ned</w>
bacterio logically</w>
backgro unds.</w>
back ward</w>
back crosses</w>
back bone</w>
back "</w>
bacill i</w>
ba g</w>
b/ ribavirin</w>
b.w t.,</w>
b.i.d .),</w>
b w
b urg
b unitro
b um</w>
b roncho
b right</w>
b ond</w>
b is</w>
b id,</w>
b d</w>
b ati
b ant</w>
b and.</w>
b an</w>
b ]</w>
b -exposed</w>
b ,
azole- dependent</w>
azol e)</w>
az osin
az obenz
az ine)</w>
az et
axit inib</w>
ax .</w>
awaren ess,</w>
aw ai
avoid ance,</w>
avoid able</w>
avid in-
aver age.</w>
autoradi ography.</w>
autoradi ography,</w>
autoradi ographically</w>
autopsy ;</w>
auto immunity</w>
auro thiomalate</w>
aure us,</w>
augment ation,</w>
audit ory,</w>
audio visual</w>
audi ometry,</w>
atrop ine-like</w>
atre sia,</w>
atrac heal</w>
atosib an</w>
atorvastat in-related</w>
ator y,</w>
ator ial</w>
atom s</w>
atipame zole,</w>
ation s--
ation s).</w>
ation --a</w>
ation '</w>
atid ine,</w>
atic s</w>
ati bant</w>
athyro id</w>
atheros permin
ateg or
ate-3-O- glucuronide</w>
ate d).</w>
ate d),</w>
atazanavir .</w>
atazanavir -associated</w>
at ubular</w>
at ovaqu
at ors'</w>
at om</w>
at oid</w>
at es;</w>
at al
at a,</w>
at /
at -to-beat</w>
at )</w>
asym metry</w>
ast atic</w>
associ ates</w>
assist ance.</w>
assign ment,</w>
aspiro dec
aspirin- use</w>
aspir ation.</w>
aspir ation,</w>
asphy xia,</w>
aspergillo sis</w>
aspergillo sis.</w>
aspect s,</w>
ase olus</w>
as ynchron
as sum</w>
as ole</w>
as emia,</w>
as ed-
artic le.</w>
arthrogr ypo
arthro scopy</w>
arthro pathy.</w>
arterio lopathy</w>
arterialized- venous</w>
arter y)</w>
artemis in
arteme ther</w>
art an-induced</w>
arri val.</w>
arri val,</w>
arrhythmo genesis</w>
arrhythm ia
arrhyth mic
arginine- aspartate</w>
argin ine,</w>
argatrob an.</w>
arg uments</w>
arg assum</w>
arec oline</w>
arec oline-induced</w>
are a)</w>
architect ure,</w>
arch es</w>
arch es,</w>
arch .</w>
arbox amide</w>
arb onate</w>
arb er</w>
arachid onate</w>
arabinoside :</w>
ara- C,</w>
ar ylation</w>
ar y)</w>
ar resting</w>
ar m).</w>
ar m
ar ),</w>
aqu eductal</w>
apraclon idine.</w>
approxim ating</w>
appreci ate</w>
appra isal.</w>
applic ability.</w>
appl ies</w>
appear ,</w>
appe d.</w>
apparen t;</w>
apopto sis:</w>
apomorph ine-</w>
apomorph ine-
apne as.</w>
apl asia,</w>
aphasi a,</w>
apart )</w>
aparo id</w>
ap ocynin</w>
ap ipuncture</w>
ap ing</w>
ap ex.</w>
ap amin</w>
aorto- femoral</w>
aor to
any one</w>
antr um</w>
antipyre tics</w>
antipy retic
antioxid ant
antimicrobi al,</w>
antihist one</w>
antihist amine-induced</w>
antigen emia</w>
anticoagul ation-associated</w>
anticoagul ant
antici pation</w>
antibody -associated</w>
antibody -
anti-L SP</w>
anti-HB e.</w>
anti- viral</w>
anti- tremor</w>
anti- thyroid</w>
anti- smooth</w>
anti- retroviral</w>
anti- hepatitis</w>
anti- dyskinetic</w>
anti- cefamandole</w>
anti- MR
anti-MR BC</w>
anti- LH-RH</w>
anti- IgG</w>
anti- Fas</w>
anti- DNP</w>
anti- B19</w>
anti thromb
anti smooth</w>
anti sen
anti platelets</w>
anti mycobacterial</w>
anti hypertensives</w>
anti fibrotic</w>
anti dromically</w>
anti asthmatic</w>
anti arryth
anthracycl ine,</w>
anthracenedi one</w>
anthra quin
anteri or.</w>
anteri or-
ante partum</w>
antagonist s;</w>
antagonist s)</w>
ant /
anorexigen s</w>
anorexigen -exposed</w>
anorexi ant</w>
ano rectal</w>
ann ulus</w>
anis otropy</w>
anis otropic</w>
anhedon ia</w>
angiotensin- (1-7)</w>
angioedema :</w>
angiocardi ography.</w>
angio genesis.</w>
angio genesis,</w>
angin a-like</w>
angin a)</w>
ang ular</w>
ang le-closure</w>
anecdot ally</w>
ane- anesthetized</w>
ane uplo
and ;</w>
anciclo vir</w>
ance /
anc ou
anastom otic</w>
anaphyl axis
analy sis
analogu e.</w>
analog s,</w>
analgesi a:</w>
analbum inemic</w>
anal ge
anaesthe sized</w>
anabol ic-androgenic</w>
ana emic</w>
an-3- yl)
an the
an sw
an oti
an od
an ococ
an o-
an isol
an ir
an hydro
an amnestic</w>
an amne
amylo id-
amput ations</w>
amput ations,</w>
amput ation,</w>
amphet amin
amp shi
amoxycill in-clavulanic</w>
amoxycill in-clavulan
amoxicill in-induced</w>
amox apine.</w>
amoun ts.</w>
amoun t.</w>
amodi aqu
amne sias</w>
amne sia:</w>
amlodipine/ benazepril</w>
aminophen ol</w>
aminom ethyl
aminoind an</w>
aminoglyco sides,</w>
aminoc yclopentane
aminoacid uria</w>
aminoacid uria.</w>
amino- terminal</w>
amino- 5-bromouracil</w>
amino -1-
aminid ase</w>
amin opyrine</w>
amifost ine,</w>
amide -type</w>
amer icana</w>
amend ment</w>
amen orrhea.</w>
amen orrhe
ame zin
ambul ation,</w>
amant ad
am ed</w>
am ate.</w>
aly )</w>
altern atively,</w>
altern ative,</w>
alte plas
alpha2ABC- knockout</w>
alpha2ABC- /-</w>
alpha1- subunit</w>
alpha-synucle in</w>
alpha-naphthylisothiocyan ate</w>
alpha-methyl-p- tyrosine,</w>
alpha-methyl-p- tyros
alpha-methyl- 5-HT</w>
alpha-methyl dopa
alpha- tropyl</w>
alpha- smooth-muscle</w>
alpha- reductase</w>
alpha- lipoprotein</w>
alpha- hydroxyvitamin</w>
alpha- fluoro-beta-
alpha- ethinylestradiol</w>
alpha- antagonist</w>
alpha- antagonism</w>
alpha- actin</w>
alpha- OH-
alpha- MD</w>
alpha- (
alpha, alpha
alpha,alpha '-
alpha(1 D
alpha 4-
alpha 2A</w>
alpha 2-adrenoceptor</w>
alpha 1-</w>
alpha (q
alpha (4)
alph ax
alph as)</w>
alone .(ABSTRACT</w>
alo id</w>
allopurin ol.</w>
allodynia/ hyperalgesia.</w>
allodyn ia;</w>
allo thionein</w>
allo genic</w>
allergi es,</w>
all- or-
all yl</w>
all idotomy</w>
alkyl xanthines</w>
alkalo id.</w>
alk ylation</w>
alk yl-
ali ke</w>
aler t,</w>
alcohol -dependent</w>
albuter ol-induced</w>
alaz ine-associated</w>
alas in</w>
al- to-
al titu
al one),</w>
al mo
al location</w>
al ised</w>
al im
al ia</w>
al bic
al am
al -associated</w>
al )-induced</w>
akine tic-rigid</w>
ajmal ine.</w>
ain st</w>
ain .</w>
agonist/ antagonist</w>
agonist- antagonist</w>
agonist s)</w>
agl es.</w>
aggreg ates.</w>
aggrav ation.</w>
agent s:</w>
aged- matched</w>
age- dependent.</w>
age al,</w>
ag ree</w>
ag ing:</w>
afterwar ds,</w>
afterdepolar izations,</w>
affect ,</w>
aeruginos a,</w>
aer t
advance ment</w>
adult- onset</w>
adrenal ectomy.</w>
adolescent -onset</w>
adnex al,</w>
admit ted.</w>
admit ted,</w>
adjuv ants</w>
adjuv ant.</w>
adenotonsill ectomy.</w>
adeno pathy</w>
adeno fibrom
aden yl
aden omas,</w>
aden om
aden oid
aden itis</w>
addiction -related</w>
addiction -like</w>
addi tively</w>
ad versity</w>
ad ur
ad option</w>
ad odiamide</w>
ad ducts.</w>
ad .</w>
acyclo uridine</w>
acut ely.</w>
acut e"</w>
acumin ata.</w>
activity- increasing</w>
active- controlled</w>
activ ity.(ABSTRACT</w>
activ ator,</w>
activ ation/
activ ation-
activ ated.</w>
actin omycin-
acti ve
acti tol</w>
act olol</w>
act )</w>
acrole in,</w>
acro dermatitis</w>
acri dine</w>
acr ylic</w>
acqu i
acid ity</w>
acid -</w>
ach usetts</w>
ach lor
acetyl- carnitine</w>
acet oxy
acet one,</w>
acet ate:</w>
acet amides</w>
acet abul
acetabul um</w>
acen oc
acen aph
ace us</w>
accumul ates</w>
accoun t.</w>
acces sibility</w>
accept ability,</w>
acceler omyography</w>
acceler ometer</w>
acceler atory</w>
acc red
acampros ate</w>
ac tion)</w>
ac teric</w>
ac lam
ac iclovir</w>
ac emide</w>
ac cumulative</w>
ac clim
ac cept</w>
ac al
ac -treated</w>
ac -
abstin ent,</w>
absorp ti
absor b</w>
absces ses.</w>
abs ences,</w>
abol ism</w>
able :</w>
able )</w>
ablact ation.</w>
abl ation,</w>
abil ity/
abil is</w>
abdomin is</w>
abac avir</w>
ab sen
ab ductor</w>
aF GF</w>
a-actin in</w>
a- inducing</w>
a- -a</w>
a, 5,6,
a side</w>
a phasic</w>
a pati
a evulinic</w>
a D</w>
a 5
a5 GABAA</w>
a );</w>
[Mg2+ ]</w>
[HR ],</w>
[4-(2- methoxyphenyl)
[3H]- taurocholate</w>
[3H] nicotine</w>
[3H] muscimol</w>
[3H] HCh
[3H]HCh -3</w>
[3H] GABA</w>
[3 1]
[2-(3,4-dichlorophenyl) ethyl]-1,4-diazabicyclo[4.3.0]non
[15 O]
[15O] H2O</w>
[14C] sucrose</w>
[11C] raclopride</w>
[1-11C] acetate</w>
[1,2,4 ]
[ verapamil]o</w>
[ p</w>
[ interquartile</w>
[ c]
[ V
[ MAP
[ Leu
[ LVE
[ IV
[ ID
[ID (50)=
[ ASA
[ 4
[ 3</w>
[ 2</w>
[ 22
[ 10</w>
[ 1,</w>
[ 1
[ 0.
[ (R,S)-
[ (+)-
[ (+)
[ (
ZT P.</w>
Z uc
Z op
Z iprasid
Z af
Z S
ZS F1</w>
Yohimb ine,</w>
YM-0 9
YM-09 15
YM-0915 1-2</w>
YM-0 80
YKP14 47</w>
Y-23,0 28</w>
Y- 79</w>
Y- 40
Y JT</w>
Y 12
Y12 28</w>
Y -14,
Y -14
Y-14 802</w>
Y ).</w>
X-ra y,</w>
X+ Isoflurane</w>
X+ CH
X+CH R
X imel
X I</w>
X AC</w>
Work place</w>
Wor king</w>
Withdraw als</w>
With holding</w>
Wh ich</w>
Wh ere</w>
Wernic ke-Korsak
Well butr
Weigh ts</w>
We an
We ak
Walden strom's</w>
Wal sh</w>
Wal es</w>
Wa iting</w>
WR2425 11,</w>
WR 330
WR330 63</w>
WIN55,212- 2,</w>
WI N-
WH AT</w>
WF- CP</w>
WB Cs/HP
WAI CH</w>
W- 7</w>
W y
W ong-Baker</w>
W ild
W arm</w>
W all</w>
W Y-14,
W O</w>
W DR</w>
W .
Volume tric</w>
Viro logical</w>
Viro logic</w>
Vinc a</w>
Vic tor
Vi sion</w>
Vi rus</w>
Vaso active</w>
Var ic
Val ette</w>
Val acyclovir</w>
Vacu ol
VT VF</w>
VP- sensitive</w>
VP -16-
VN B.</w>
VMR T</w>
VI G
VIG OR</w>
VEGF /
VE N</w>
VE D</w>
V232 I
V232I +
V232I+ L1308F</w>
V1 I,</w>
V/ LAM</w>
V omiting</w>
V ocal</w>
V mca</w>
V irtually</w>
V enti
V ancou
V ]</w>
V X2</w>
V WF-CP</w>
V RS</w>
V R-
V PDs</w>
V PC
VPC s</w>
V KA</w>
V II,</w>
V I.</w>
V HD.</w>
V GLUT
V FC</w>
V DR</w>
V DB
V C,</w>
V BL</w>
V 2
V2 I,</w>
V (max)</w>
Utili zation</w>
Usu ally,</w>
Urticar ia</w>
Ureth ane-anesthetized</w>
Upjohn )</w>
Univer sity-
Un intentional</w>
Un ineph
USPI O</w>
US A)</w>
UR B
URB 59
UL AR
ULAR IT
UG S</w>
UF T.</w>
U/ mL</w>
U/ kg,</w>
U/ h)</w>
U/ L;</w>
U/ L).</w>
U-4 30
U- E)</w>
U- 99
U-99 194
U-99194 A</w>
U ri
U ppsal
U niqu
U mbil
U gand
U d
U ST
U I/
U A,</w>
U 83836E</w>
U 69
U 5048
U 50,48
Tyr -M
Tyr-M IF-1</w>
Tyr -
Turke y.</w>
Tub ocurarine</w>
Tsukub a,</w>
Trx R</w>
Tro vafloxacin</w>
Tri phasic</w>
Tri gg
Tri angle</w>
Treatment -
Treatment- emergent</w>
Treat ing</w>
Tre mens</w>
Traum a</w>
Transit ory</w>
Trans fusion</w>
Trans amin
Tramad ol,</w>
Tr ypt
Tr p-
Top ically</w>
Tol u
Tol terodine</w>
Tit ration</w>
Tim ed</w>
Tie 2-
Tie2- Cre
Tie2-Cre ;
Tic arc
Tiaz ofurin</w>
Thyro xine</w>
Thromb in</w>
Thomson ide</w>
Thi 5,
There after</w>
Theore tical</w>
Thalidom ide,</w>
Thal lium-201</w>
Th r</w>
Tet /
Terat ology</w>
Ten ofovir</w>
Temper ament</w>
Temozolom ide</w>
Te mazepam</w>
Te icoplan
Td p.</w>
Target ing</w>
Tan dem</w>
Tam sulos
Taipe i</w>
Tacrolim us-associated</w>
Ta uro
TV 3
TTP/ HUS.</w>
TTP/ HUS,</w>
TSC M</w>
TS ST</w>
TRO 196
TREAT MENT</w>
TPV/ r</w>
TP T</w>
TMP Z</w>
TM P,</w>
TL CA-induced</w>
TJ-80 14</w>
TI- 201</w>
TI N)</w>
TI MP-
TI A,</w>
TI ),</w>
TH P)</w>
TH IP</w>
TGR(A1-7)3 292</w>
TFMP P</w>
TF (max)</w>
TEO AEs</w>
TE P)</w>
TE OAE</w>
TD s</w>
TD ).</w>
TC -treated</w>
TB I.</w>
TB AR
TAS ,</w>
TAF I,</w>
TA- 606</w>
T9- T
T- type</w>
T- lymphocyte</w>
T- containing</w>
T- amplitude</w>
T- UDCA</w>
T wel
T s)</w>
T oni-Debr</w>
T ocain
T h</w>
T erbin
T ask</w>
T ar
T UR</w>
T S.</w>
T S-
T NG.</w>
T N-
TN- R</w>
T MT.</w>
T J</w>
T G.</w>
T CA
T 4/
T 1)</w>
T )-
T (2)-
T(2)- weighted</w>
Syst olic,</w>
Synerg ism</w>
Syn copal</w>
Switzer land.</w>
Sus pected</w>
Surviv ors</w>
Surve y.</w>
Sulph asalaz
Sulfon amides</w>
Sulfasalaz ine-induced</w>
Sul ind
Succ ess</w>
Subst antial</w>
Subject s'</w>
Sub- chronic</w>
Sub tle</w>
Sub groups</w>
Sub chronic</w>
Su icide</w>
Su gg
Stud y).</w>
Stud ent</w>
Stro op</w>
Stro k
Stric t</w>
Stri dor</w>
Stres s-induced</w>
Stres s
Strept omyces</w>
Str ych
Str onger</w>
Stom atitis</w>
Stimul ants</w>
Stim Veh</w>
Stim Cap</w>
Sti ll
Ster oid
Ster n
Ste ady</w>
State- Trait</w>
Stat 5</w>
Stan ford</w>
St urge-Weber</w>
St atin</w>
St able</w>
Sprague- Daw
Spi elberger</w>
Spec imens</w>
Spas ms</w>
Spas m</w>
Span ish</w>
Sot alol-induced</w>
Smo k
Sleep iness</w>
Singap ore
Sim vastatin-induced</w>
Si ve
Sham Veh</w>
Sham Cap</w>
Seventy- three</w>
Seventy- six</w>
Seventy- four</w>
Separ ation</w>
Self- reported</w>
Sel f</w>
Seiz ure-induced</w>
Seiz ure
Second- line</w>
Second -</w>
Sec retion</w>
Sci atic</w>
Scat chard</w>
Scal e)</w>
Sc S
ScS n</w>
Satis faction</w>
Salv age</w>
Sal vianolic</w>
Sal via</w>
Sal ine-treated</w>
Saf e</w>
SW R</w>
SV R.</w>
SUN-1334 H,</w>
SULT1 A1</w>
SULT 1</w>
SU R1</w>
ST I</w>
SSRI s,</w>
SRL- CsA-
SR S,</w>
SR L.</w>
SR 141716
SQ 29
SQ29 548</w>
SPEC T,</w>
SP V</w>
SP PI</w>
SP N,</w>
SP K,</w>
SP IR
SPIR O</w>
SP +
SOUR CE:</w>
SOD 2-
SOCS -3,</w>
SO S</w>
SO ;</w>
SO ),</w>
SNH L.</w>
SN GFR</w>
SMemb -positive</w>
SM A</w>
SM 3</w>
SM 2</w>
SLV 3
SLE -like</w>
SK F-
SI .</w>
SI -
SI ),</w>
SHR s.</w>
SHR ;</w>
SH RS
SHRS P,</w>
SH R-
SHR- STZ</w>
SH C</w>
SH AM-
SER T-
SE R</w>
SE NSU
SE D</w>
SE ;</w>
SDS- PA
SD ]</w>
SD N</w>
SD I</w>
SD I-
SCL-90- R</w>
SCL C,</w>
SCH Z</w>
SC-36 602</w>
SC h</w>
SC P</w>
SB-2699 70</w>
SA S</w>
SA M</w>
SA H-
S100 A
S100A 6</w>
S.D .,</w>
S. D.</w>
S-adenosyl methionine</w>
S-2- (3-
S- allyl</w>
S)-1- aminoindan-1,5-dicarboxylic</w>
S(c) O(2)</w>
S(c) O(2).</w>
S(+)- norketamine</w>
S(+ )-</w>
S usta
S traub</w>
S ten
S s</w>
S plenic</w>
S pin
S pain.</w>
S olid</w>
S odi
S mad</w>
S lc
S k
S j</w>
S ite</w>
S ick</w>
S har
S ens
S e-
S at
S argassum</w>
S arc
S ap
S an-
S V</w>
S SPPI</w>
S SI
S SH
S O</w>
S LA</w>
S L.</w>
S K-
S G)</w>
S F-
S D-
S AEs</w>
S A/
SA/ -</w>
S 24
S24 8
S )
Ry R2</w>
Ru thenium</w>
Rous sel</w>
Rot ter
Rosu vastatin</w>
Rom an</w>
Roche ,</w>
Riton avir</w>
Risperid one-associated</w>
Ring er</w>
Rig idity</w>
Ri vas
Ri j</w>
Rheum atoid</w>
Rg b</w>
Rey e-like</w>
Reticulo cyte</w>
Ret urn</w>
Ret in
Restric tive</w>
Respon siveness</w>
Res veratrol</w>
Relax ation</w>
Recor ding</w>
Recomm ended</w>
Real- time</w>
Re y</w>
Re verse</w>
Re ferences</w>
Re b
Re administration</w>
Re ad
Re activation</w>
Rat ings</w>
Rash es</w>
Radi ologic</w>
Radi ographic</w>
Rabb it</w>
Rab ep
Ra f</w>
RV M.</w>
RU 38
RTI-1 77</w>
RT- PCR,</w>
RT I</w>
RS 86</w>
RP C)</w>
RO P,</w>
RO CK</w>
RO -induced</w>
RO )</w>
RI As</w>
RI A,</w>
RG N</w>
REVIEW ER
REVIEWER '
REVIEWER' S</w>
RESULT (S):</w>
REG ULARIT
RE S</w>
RB Cs,</w>
RANK L/
RANKL/ OPG</w>
R-1 29
R-129 09</w>
R- AAP</w>
R- 2</w>
R,4 R)-
R(-)- fluoxetine</w>
R us
R s).</w>
R im
R il
R enin</w>
R arely</w>
R af
R WM</w>
R U-430
R S),</w>
R R,</w>
R IST</w>
R CM-induced</w>
R AR
R AD00
R 599
R599 49</w>
R 3</w>
R 1)</w>
R -</w>
Quin ine-associated</w>
Quin ine,</w>
Quer cet
Qualit ative</w>
Qu e
QTc- interval</w>
QT(Fri d),</w>
QT(Fram )</w>
QT( u)</w>
QT vi</w>
QT /
Q X.</w>
Q U
Q T)</w>
Pyraz inamide</w>
Pyr rolidine</w>
Pur pur
Pur ple</w>
PubM ed,</w>
Psych osis-
Provid ers</w>
Prot amine</w>
Propafen one-induced</w>
Progest ogens</w>
Proble ms</w>
Pro tracted</w>
Pro ton</w>
Pro pri
Pro lact
Pro gram.</w>
Pro g</w>
Pro duction</w>
Pro M
ProM ACE-
ProMACE- Cy
ProMACE-Cy taBOM</w>
Prim ing</w>
Pri locaine</w>
Pres yn
Preg S</w>
Pre vent</w>
Pre treatments</w>
Pre menopausal</w>
Practition ers'</w>
Prac tical</w>
Pr actolol</w>
Pp IX</w>
Post- treatment</w>
Post- training</w>
Post operatively</w>
Post infarction</w>
Pos tischem
Por t-A-Cath</w>
Pop ulation-
Polymorph ous</w>
Poly neuropathy</w>
Po isons</w>
Pneumon itis,</w>
Plo ugh
Plas ma
Plaqu enil</w>
Placebo -controlled</w>
Pl a</w>
Pitts burgh</w>
Piribe dil</w>
Pir acetam</w>
Pir acetam,</w>
Pinacidi l</w>
Pil si
Pi renperone</w>
Physi ologic</w>
Phosphor ylated</w>
Phosphodi esterase</w>
Phenylpropan ol
Phenprocou mon-induced</w>
Phen oxybenzamine</w>
Phen o
Phe n</w>
Pharmacokine tic/pharmacodynamic</w>
Pharmac ogenetic</w>
Pharmac ists</w>
Ph aseolus</w>
Ph aryngeal</w>
Ph B</w>
Person al</w>
Perman ente</w>
Peri partum</w>
Perce ived</w>
Per sea</w>
Per flutre
Pentam idine-induced</w>
Pent agastr
Pem oline-induced</w>
Peg interferon</w>
Pear son's</w>
Pe floxacin</w>
Patter n</w>
Patient -
Patient- reported</w>
Pas sive</w>
Paren ts</w>
Parap legia</w>
Par is,</w>
Par athyroid</w>
Par ano
Papaver ine</w>
Pap io</w>
Pan curonium</w>
PaO2/ FIO2</w>
Pa rom
Pa O</w>
PW L</w>
PV C</w>
PV C
PV ),</w>
PTZ .</w>
PTHr P,</w>
PTA- AM</w>
PT E</w>
PT A,</w>
PS VT</w>
PS A-
PRL- R,</w>
PRL- AB</w>
PRIN CIPA
PRINCIPA L</w>
PR A.</w>
PR 2</w>
PR ),</w>
PPA R-
PP Is,</w>
PORT AN
PON V.</w>
PO- PL
PO R
PO M.</w>
PO ,</w>
PO ),</w>
PN 21</w>
PM/ DM</w>
PM s</w>
PLA/ DZR</w>
PK R1</w>
PK )</w>
PJ 34</w>
PIP C</w>
PI3K gamma-deficient</w>
PH T-induced</w>
PH T,</w>
PH A</w>
PH -treated</w>
PH -induced</w>
PGF (2
PGE 1,</w>
PG P</w>
PG E</w>
PF C)</w>
PEG- IFN/RBV</w>
PEG- IFN-
PE S
PE H</w>
PE F
PD A,</w>
PCR -
PCO S</w>
PC s)</w>
PC NS
PC 1</w>
PB SCT</w>
PB SCT.</w>
PATIENT (S):</w>
PAR P.</w>
PAN/ procysteine</w>
PAC U</w>
PA- nephrotic</w>
PA I
PA ED</w>
P= 0.01)</w>
P= 0.001)</w>
P= 0.000
P< 0.01),</w>
P: <
P:< 0.001;</w>
P450 s</w>
P450 -mediated</w>
P2X 2/3</w>
P2- deficient</w>
P/ Q
P/ MAP</w>
P/ J</w>
P/ D</w>
P-S V</w>
P-BM 5</w>
P- containing</w>
P tio
P ronounced</w>
P retest</w>
P mO
P leural</w>
P is
P indo
P ick's</w>
P en</w>
P emphig
P b-exposed</w>
P antop
P allidotomy</w>
P SS</w>
P SP
P SG</w>
P PO
P PE.</w>
P PE,</w>
P PA,</w>
P M.</w>
P M)</w>
P I.</w>
P CT-induced</w>
P CI.</w>
P CB
P 8</w>
P 75</w>
P 7,</w>
P 4</w>
P 21</w>
P 200</w>
P 14</w>
P 12</w>
P 10</w>
P -1.5</w>
P (+)</w>
Oxali platin</w>
Ox ford</w>
Over drive</w>
Otot oxic</w>
Or phenadrine</w>
Or gan</w>
Oper ation</w>
Open ,</w>
One-hundred- and-
One- third</w>
Ondan setron,</w>
On tario,</w>
On '</w>
Om maya</w>
Oligo hydramnios</w>
Ol mesartan</w>
Ol factory</w>
Ol esoxime</w>
Octreoti de,</w>
Oc cupational</w>
Obses sive</w>
Obses sive-compulsive</w>
Obser ver's</w>
Oatp 2</w>
OXO -16ene
OX C.</w>
OX C,</w>
OX 4
OX4 2+</w>
ORX T</w>
OR -
ONO- 87
OLT ,</w>
OK T3</w>
OI H.</w>
OF F-
ODN s</w>
OB M</w>
OB )</w>
OATP- C</w>
OA A/
OAA/ S</w>
O- Bu</w>
O- 2</w>
O tolaryng
O sc
O rolingual</w>
O rac
O lig
O esophageal</w>
O UA</w>
O T-
O L
O HR</w>
O H)</w>
O G
O E
O CD.</w>
O CD-
OCD- like</w>
O AL
OAL I</w>
O (6)-
Numb er</w>
Nucle us</w>
Nucle oside</w>
Nov .</w>
Nor plant.</w>
Non- convulsive</w>
Non alcoholic</w>
No w</w>
No v</w>
No otropic</w>
No DCE-
Nitroglycer in-induced</w>
Niger ia</w>
Nifedi pine-induced</w>
Nifedi pine,</w>
Nicot ine,</w>
New -onset</w>
Nevir apine-induced</w>
Neutropen ic</w>
Neuro physiologic</w>
Neuro pathologic</w>
Neuro inflammation</w>
Neuro cognitive</w>
Neuro active</w>
Net work.</w>
Nesac aine-
Necro tic</w>
Ne vertheless</w>
Ne oral</w>
Ne o-
Ne isseria</w>
Ne fopam</w>
Ne fir
Nd1- L</w>
Nd :YAG</w>
Nar co
Nag ase</w>
Naf c
Na/ H</w>
Na- Cl</w>
Na+- binding</w>
Na+ K+</w>
Na Cl)</w>
Na B
Na ),</w>
NTS 1(-/-)</w>
NT- pro-ANP</w>
NT S.</w>
NT S,</w>
NT PP</w>
NT G,</w>
NT Ds.</w>
NT A</w>
NSU D</w>
NR V
NR TIs</w>
NR P</w>
NR M,</w>
NR H.</w>
NR 2
NR 1</w>
NR /N
NR/N p</w>
NPY- LI</w>
NP O</w>
NP FT</w>
NOS 3-/-</w>
NOC -18</w>
NO -mediated</w>
NN G)</w>
NK CC1</w>
NK -1</w>
NHB D</w>
NH ANES</w>
NG- monomethyl-L-arginine</w>
NF kappaB</w>
NF kB</w>
ND I1</w>
ND E</w>
NCA M</w>
NC V</w>
NC V)</w>
NBQ X.</w>
NBQ X,</w>
NASH .</w>
NADPH d</w>
NADPH d-positive</w>
NAD +</w>
N6- cyclopentyladenosine</w>
N363 S</w>
N0 M
N-nitrosou rea</w>
N-nitroso- N-methyl
N-nitro som
N-methylox azepam</w>
N-methyl- D:</w>
N-ethyl- N-
N-ethyl-N- hydroxyethyl
N-butyl-N-(4-hydroxybutyl) nitrosamine</w>
N-acetyl glucosaminidase,</w>
N-2-fluorenyl acetamide</w>
N-(2- propylpentanoyl)urea</w>
N- sulfated</w>
N- pyrimidinyl-2-phenoxy
N- propyl
N- phosphonacetyl-L-
N- ethyl</w>
N- de
N, N'-
N r1(neo-/-)</w>
N onionic</w>
N omifens
N ocicept
N o.</w>
N inth</w>
N igral</w>
N ested</w>
N em
N ad
N SI,</w>
N LA</w>
N I</w>
N FLX</w>
N F</w>
N ER
N EF</w>
N EA</w>
N CI</w>
N CI-
NCI- CTC</w>
N C,</w>
N AI
N AC.</w>
N AC,</w>
N ;</w>
N :</w>
N 1
N -10
N (M
Myoglob inuria</w>
Myo pathy,</w>
Myco plasma</w>
My xedema</w>
My lotarg</w>
Mul tiv
Morph ine,</w>
Mon onuclear</w>
Modi fications</w>
Mode lling</w>
Mo(t)/ B(t)</w>
Mo del
Mn SOD</w>
Mit ochondria</w>
Mit o
Mis sour
Mil d,</w>
Mil an,</w>
Mid dle</w>
Micro scopy</w>
Mibefradi l</w>
Mg+ 2</w>
Mg+ +,</w>
Mg(2+ )/
Mg(2+)/ Ca(2+)</w>
Mg(2+ )-
Mg Cl
Metoclopram ide-induced</w>
Metoclopram ide,</w>
Methotrex ate-related</w>
Methad one,</w>
Meth yser
Meth oxamine</w>
Meth icillin-resistant</w>
Meth azol
Met allothionein</w>
Mes na.</w>
Mes alazine-associated</w>
Men delian</w>
Melat onin,</w>
Mel phal
Mel bour
Mei ge</w>
Meflo quine</w>
Medic are</w>
Medi ation</w>
Med iterranean</w>
Me trazol</w>
Me detomidine</w>
McN- A-3
McN-A-3 43</w>
Mc Nem
Mc G
McG ill</w>
Maz indol</w>
Matri x</w>
Mat ched</w>
Mass achusetts</w>
Maryl and,</w>
Mar ital</w>
Mal on
Mal es</w>
Mal ay
M_ M.</w>
MTX-N tox</w>
MTX -related</w>
MT S</w>
MT /
MSO -induced</w>
MRI- 8
MRI-8 27
MRI-827 3-
MR P2-deficient</w>
MR N-lesioned</w>
MR Is</w>
MPT )</w>
MP S</w>
MP R</w>
MP ;</w>
MP 15</w>
MP ).</w>
MN CV,</w>
MMP -1</w>
MM C-induced</w>
MLM -160</w>
MK80 1.</w>
MK-9 12</w>
MK -1
MK-1 42</w>
METHODOLO G
METHODOLOG Y:</w>
MEASURE (S):</w>
ME T-induced</w>
ME SNA</w>
ME Q</w>
ME Ps</w>
ME D
ME )</w>
MDS- CAs</w>
MDMA )</w>
MDMA (-)</w>
MD R</w>
MD ).</w>
MCI-1 54,</w>
MC T)</w>
MB F)</w>
MB As)</w>
MB -
MB ,</w>
MAOI s.</w>
MA PK
MA NEA</w>
MA EA</w>
MA -dependent</w>
MA -
M16 28
M16 209</w>
M s)</w>
M ove
M others</w>
M ot
M ix
M g,</w>
M epi
M d</w>
M ature</w>
M ariju
M apro
M apping</w>
M an</w>
M PA-
M PA
M OPP</w>
M O-induced</w>
M Is</w>
M IP
MIP -1
M IC
M HS</w>
M HD</w>
M HC
MHC -I</w>
M CT-induced</w>
M CS</w>
M CR
MCR C</w>
M CD</w>
M C-
M ACE</w>
M AC,</w>
M 65</w>
M 552
M 2-
M 2)</w>
M 2).</w>
M )-induced</w>
Lys (15
Lys(15 )]
Lou is,</w>
Loracar bef</w>
Lor azepam,</w>
Long er</w>
Lond on.</w>
Lofex idine</w>
Lo beline</w>
Lis sau
Lip id-
Linezol id-associated</w>
Lim iting</w>
Lim b</w>
Ligh t-
Li/D VP</w>
Li/ Li</w>
Li/ C</w>
Li- uraemic</w>
Li- pilocarpine</w>
Li- PC
Li brary</w>
Levo simendan</w>
Le ak
Ld T.</w>
Latano prost</w>
Lamivud ine,</w>
Lamb ert-Eaton</w>
Lab or</w>
LY3547 40</w>
LY 34
LY34 14
LY -17
LVE Fr
LV DP</w>
LV ,</w>
LT D4</w>
LQT 1</w>
LP SPs</w>
LOU/M/W sl</w>
LO S
LO ,</w>
LNa+ HCa</w>
LN D-
LND- 6
LL L</w>
LID/ MET</w>
LI PFC</w>
LI M</w>
LG B</w>
LD -induced</w>
LD ,</w>
LD +BZ</w>
LD (con
LCB F/
LCBF/ delta</w>
L. min-1.
L. min(-1
L-argin ine:</w>
L-argin ine/
L-OH P</w>
L-NO Arg</w>
L-NI L</w>
L- isomer</w>
L- cysteine</w>
L- T</w>
L- 6
L- 2-oxothiazolidine-4-
L ocomotion</w>
L ob
L isteria</w>
L ist
L illy</w>
L ig
L aryngeal</w>
L an
L RS</w>
L O)</w>
L N</w>
L N,</w>
L L)</w>
L K
L I)</w>
L D-
L C-
L BUP,</w>
L BBB</w>
L AD
L 6/
L 4,</w>
L 3</w>
L 2)</w>
L .,</w>
L (L
Kreb s-
Kore a,</w>
Kit (Y567F/Y567
Ki- 67</w>
Ket otifen</w>
Ker at
Ka iser</w>
KRN23 9
KOP- r</w>
KO s</w>
K/ liver-/-</w>
K- variant</w>
K- MB</w>
K+- evoked</w>
K+ ATP</w>
K+ .</w>
K(v) 7</w>
K(i )=
K ynuren
K yn
K v</w>
K ind
K i=
K earns-Sayre</w>
K appa</w>
K amp
K RT
K IT-
K CH</w>
K B-24
K 3</w>
K (+
K(+ )-induced</w>
Jo h
Jcl :ICR</w>
J uly,</w>
J ud
J our
J ordan</w>
J an</w>
J AK-
J AK
J -
Ital ian
Isra el.</w>
Isosorb ide</w>
Iso .</w>
Iso -induced</w>
Isl and</w>
Ishihar a</w>
Is ob
Irel and</w>
Iran .</w>
Ir-CP I</w>
Ir besartan</w>
Ir b
Invent ory.</w>
Intrapl antar</w>
Intran igral</w>
Intra uterine</w>
Inter view.</w>
Inter -
Inte rest</w>
Inos itol</w>
Ing estion</w>
Influ ences</w>
Infarc t</w>
Indinavir -associated</w>
Incid ence,</w>
Inc re
Inc ,</w>
In surance</w>
In complete</w>
Immun oreactive</w>
Imi pramine-induced</w>
Imag es</w>
Im pulse</w>
Im pul
Im plementation</w>
Im plan
Ile 105
Ile105 Val</w>
Ile /
IgG- saporin</w>
IgG IR</w>
Idiosyncr atic</w>
Idazox an,</w>
Ic tal</w>
Ib/ IX</w>
IV U,</w>
IV H.</w>
IT A</w>
ISO s</w>
IS G</w>
IS ),</w>
IR REGULARIT
IR AEs</w>
IPR -induced</w>
IP SS</w>
IP RO-induced</w>
IO Ps</w>
INTERVENTION (S):</w>
INH -related</w>
IN H-induced</w>
IMPA 1-
IMPA1- /-</w>
IM/ oral</w>
IM PORTAN
IM N</w>
IL- 8</w>
IL- 6/
IL- 4,</w>
IL P</w>
IL K/liver-/-</w>
IL -1,</w>
III- V</w>
IIE 0
II- A</w>
IH 636</w>
IF OS</w>
IF O.</w>
IF O
IF -
ID Z</w>
ID PN</w>
ID ,</w>
IC U,</w>
IC U)</w>
IC P/MAP</w>
IC P,</w>
IC :</w>
IC ,</w>
IB-ME CA</w>
IB S</w>
IB 4-
IB 4
I/ mg</w>
I. P
I- II,</w>
I- Bu</w>
I- 3
I vermectin</w>
I trac
I rin
I psapir
I opamidol</w>
I fenpro
I de
I d
I b</w>
I U,</w>
I U)</w>
I R-AAP</w>
I QR:</w>
I P-
I B,</w>
I A.</w>
I -associated</w>
I );</w>
I (Na)</w>
Hypox emia</w>
Hypo thyroidism</w>
Hypo kalemic</w>
Hyperlipide mia</w>
Hyper vitaminosis</w>
Hyper triglyceride
Hyper thermia</w>
Hype remic</w>
Hy pot
Hy oscine</w>
Hy bri
Hun g
Hu EPO-
Hos tility</w>
Hol tzman</w>
Ho ff
His panic,</w>
Hippocamp us</w>
High- risk</w>
High- frequency</w>
Hg/ min]</w>
Hg .
Hex achloro
Heter ogeneity</w>
Hepat otoxicity,</w>
Hepat obiliary</w>
Henoch -S
Henoch-S ch</w>
Hem i
Haz ards</w>
Haloth ane-
Hal o</w>
HTN ,</w>
HT X</w>
HT N</w>
HR P)</w>
HR C</w>
HLA-B 8</w>
HLA-B *
HLA-B* 57
HIV/ HCV</w>
HIV-1- positive</w>
HIV -1.</w>
HITT S,</w>
HIT ;</w>
HIT /
HIT -related</w>
HER 2-
HE M</w>
HDL- mediated</w>
HD M
HD L1</w>
HD I</w>
HD C</w>
HCO -3</w>
HC l-induced</w>
HC FCs</w>
HBsAg -
HBeAg- seropositive</w>
HBI G.</w>
HBI G,</w>
HB V-related</w>
HB -7</w>
HAM- D,</w>
HAM D(1
HAMD(1 7)</w>
HA L-
H3- receptor</w>
H2- receptors</w>
H(2)O (2)-
H(2)- histamine</w>
H ickman</w>
H ellenic</w>
H awai
H as
H ap
H ampshi
H am
H _
H VOD</w>
H SI,</w>
H SC</w>
H PV
H PD
H O</w>
H O)</w>
H MS</w>
H L-
H K-2</w>
H FO</w>
H AC-
H 1-</w>
H .
H -</w>
H ,
Guan fac
Gu aneth
Grou ps.</w>
Granulo cytopenia</w>
Gr aft</w>
GnRH- antagonist</w>
Glutam atergic</w>
Glucar pidase</w>
GluR 2-
GluR2- immunoreactive</w>
GluR -1</w>
Glomer ulosclerosis</w>
Gi -
Gest ational</w>
Gemfibro zil</w>
Gefit inib</w>
Gd- containing</w>
Gd- DTPA-
Gas 6-
Gadol inium-
GY/ TR-</w>
GW29 74</w>
GT P-
GSPE +
GSK-3 b</w>
GSH /
GSH/ GSSG</w>
GPT L4</w>
GP E</w>
GM 1-treated</w>
GL- PS</w>
GL AST</w>
GHB -induced</w>
GG T,</w>
GF- 2</w>
GF P-
GE N-induced</w>
GC- MS</w>
GB T</w>
GB R-12909</w>
GAM S,</w>
GABA(B (1))</w>
GABA mimetic</w>
GABA ergic,</w>
GABA -</w>
G-6- PD-deficient</w>
G- proteins</w>
G( alphas)</w>
G y).</w>
G ray</w>
G ordon</w>
G om
G o</w>
G ly.</w>
G le
G ingi
G gg</w>
G aert
G adodiamide</w>
G ST</w>
G PT,</w>
G N</w>
G MBF</w>
G J
G H
G G</w>
G E)</w>
G DE
G D1</w>
G D,</w>
G D
G 4:</w>
G 3:</w>
G 2:</w>
G -treated</w>
G (i
Fur azol
Func tioning</w>
Free dom</w>
Francis co</w>
Fran ce,</w>
Four th</w>
Foscar ne
Fos B/
FosB/ Delta
For t</w>
For ce</w>
Foc ally</w>
Flup enthixol</w>
Fluoro quinolone</w>
Flunit razepam</w>
Flud rocortisone</w>
Flu phenazine</w>
Flu -like</w>
Fl urothyl</w>
Fl are</w>
First -dose</w>
Fin n
Ficol l</w>
Fibr in</w>
Fib rous</w>
Fi brom
Fer tility</w>
Fen- Phen</w>
Femoden e</w>
Fel bamate</w>
Fas- L</w>
Famoti dine-associated</w>
Fac es</w>
FX II</w>
FV R,</w>
FV C</w>
FR1736 57.</w>
FR L</w>
FR 1</w>
FP- CI
FLA- 63</w>
FITC- albumin</w>
FG S</w>
FF R</w>
FD G-
FD G)</w>
F- kappa
F- 9
F-9 70
F-970 13-
F- 344</w>
F ur</w>
F un
F ro
F rag
F ound
F ine</w>
F ddI</w>
F d-PPH</w>
F ]</w>
F U/
F U.</w>
F TI
F Rs</w>
F Q/
F J</w>
F GF-2</w>
F G-
F A/
F 2,</w>
F 0</w>
F )]</w>
Extra vasation</w>
Extra hepatic</w>
Ex pl
Everolim us</w>
Ev ents</w>
Eth ics</w>
Escitalop ram</w>
Ery th
Er got
Epo prostenol</w>
Epo -treated</w>
Epi thelial</w>
Epac 2</w>
Epac 1</w>
Ep silon</w>
Ep omediol</w>
Entec avir</w>
Enalapri lat</w>
En rollment</w>
Embry otoxicity</w>
Electroencephalo gram</w>
Electro graphic</w>
Electro convulsive</w>
Eight- week-old</w>
Efficac y,</w>
Eff orts</w>
Ech o</w>
Ear ly-
Ea hy926</w>
EXPOSURE :</w>
EV -treated</w>
ET A</w>
ET (B)</w>
ER- alpha</w>
EPI-ex t</w>
EP s</w>
EP H</w>
EP 1(-/-)</w>
EP /LVE
EP/LVE T)</w>
EP (3)</w>
EN U</w>
EN L</w>
EM Ggg</w>
EM G,</w>
EM D</w>
EI TRs</w>
EF F
EE /
EDT A.</w>
ED(50) s</w>
ED s</w>
ED V</w>
ED 50)</w>
ED (50)=
ECG ;</w>
EC G-
EC AM
EB+ P</w>
EB GM</w>
EA B</w>
E. G.</w>
E. E.G.</w>
E- enriched</w>
E- containing</w>
E- 40
E y
E vid
E todolac</w>
E scal
E datrexate</w>
E d
E R)</w>
E ON</w>
E ME
E L.</w>
E HE
E A.</w>
E 6</w>
E 15</w>
E 13</w>
E 13.
E 1,</w>
E -</w>
E (1)-induced</w>
E 's</w>
Dys ph
Dy sport</w>
Dup uytren's</w>
Drug- Induced</w>
Dox epin</w>
Dox apram</w>
Dox -treated</w>
Dox ,</w>
Dow n
Dose- finding</w>
Dop amine,</w>
Donepez il.</w>
Doc um
Do g</w>
Diure tic-induced</w>
Diure sis</w>
Dist ribution</w>
Dist al</w>
Dissoci ated</w>
Disor ders,</w>
Discri minant</w>
Dis continuing</w>
Dis ability</w>
Diprivan .</w>
Diphenylhydanto in-induced</w>
Dil at
Dihydro pyrimidine</w>
Dihydro ergotoxine</w>
Dig ital</w>
Difficul ty</w>
Dic hloro
Diazepam -induced</w>
Diazepam -,</w>
Diaz oxide</w>
Di lev
Dex ,</w>
Develop ing</w>
Det rimental</w>
Descri ptive</w>
Descri ption</w>
Desc ribed</w>
Des -
Des- Arg
Des-Arg 9-
Dermat ologists</w>
Depo- Provera</w>
Depart ment,</w>
Den mark
Den +
Delta Hb</w>
Delta APD</w>
Delta (9
Delta(9 )-
Dele terious</w>
Del usional</w>
Defin itive</w>
Deb riso
De oxy
De generation</w>
De generating</w>
De feroxamine</w>
Dap son
Dan aparoid</w>
Dac arb
DZ P)</w>
DYRK 3-/-</w>
DTI s</w>
DT Z</w>
DR Rs</w>
DR R)</w>
DPCP X+Isoflurane</w>
DPA -induced</w>
DP H.</w>
DP )-induced</w>
DOCA- saline</w>
DOCA- hypertensive</w>
DO CA,</w>
DO C,</w>
DO )</w>
DNA- polymerase</w>
DN L</w>
DN ,</w>
DMB A-
DM- 9
DM CM,</w>
DM -induced</w>
DL B
DII HA</w>
DHA- paclitaxel</w>
DH T,</w>
DH EC
DH B</w>
DG C</w>
DF U</w>
DF P-treated</w>
DF P-
DENA- initiated</w>
DEH P.</w>
DE X.</w>
DDP M</w>
DD T,</w>
DD D</w>
DD Abs</w>
DCE ,</w>
DC F</w>
DBA/2 J,</w>
DB N.</w>
DAB A</w>
DA SI
DA -related</w>
D5 W</w>
D3- treated</w>
D2 F1</w>
D-penicill amine-treated</w>
D-Trp 6-
D- dimer</w>
D- amphetamine-evoked</w>
D- Penicillamine</w>
D- Glucar
D- Arg-
D(3 )-treated</w>
D(2)/ 5-HT(1A)</w>
D(2) (-/-)</w>
D(2 -like</w>
D(1 -like</w>
D up</w>
D rowsiness</w>
D rd
D oxy
D ev
D ent's</w>
D endritic</w>
D ang
D ak
D VT/
D VT.</w>
D SG</w>
D SE-induced</w>
D S.</w>
D R-
D R)</w>
D P,</w>
D ID.</w>
D CMP</w>
D As</w>
D AVA</w>
D AC</w>
D 3)</w>
D 2,</w>
D 1-receptor</w>
D .,</w>
D .
D -</w>
D +
D (2-
D(2- like)</w>
Cyt osine</w>
Cy tos
Cu /
Cu ,</w>
Cu ,
Cs A-induced</w>
Cs A),</w>
Criter ia,</w>
Cri tical</w>
Cr ry</w>
Cr ry,</w>
Cox 's</w>
Cour se</w>
Coun ty,</w>
Coumad in-induced</w>
Cou mar
Cortico steroid</w>
Correc ted</w>
Cor relations</w>
Cor d</w>
Convul sant</w>
Contro versy</w>
Contro l-
Contra st-
Consequ ences</w>
Conner s'</w>
Condi tions</w>
Con stric
Con sti
Con stant</w>
Con sensus</w>
Con nectic
Con currently,</w>
Con ce
Compl iance</w>
Compl ain
Com pon
Col onic</w>
Col on
Coca ine-</w>
Co- trimox
Co oling</w>
Clozap ine-related</w>
Clozap ine,</w>
Clon idine,</w>
Clomi pramine-induced</w>
Clin icalTrials.gov,</w>
Cl- Kyn
Cl enbuterol</w>
Cl ).</w>
Cisplat in-based</w>
Cir cumst
Ciprofloxac in-associated</w>
Cinc innati</w>
Cin nam
Chromos ome</w>
Chol angiograms</w>
Cho ice</w>
Chlorpromaz ine-induced</w>
Chloro quine,</w>
Chlor methiazole</w>
Checkli st.</w>
Checkli st-
Cephalospor ins</w>
Cefotet an</w>
Ce fixime</w>
Cd A.</w>
Cc r</w>
Cc O</w>
Caud al</w>
Caucasi ans.</w>
Cau tious</w>
Catech olamines</w>
Catalep sy,</w>
Catal eptogenic</w>
Cat astrophic</w>
Carmofur -induced</w>
Cardio selective</w>
Carcin ogenesis</w>
Carbamazep ine,</w>
Car mustine</w>
Capsa ic
Cap sicum</w>
Cap illary</w>
Califor nia,</w>
Cal culated</w>
CaMKII alpha</w>
CaMK II</w>
CaCl(2)- untreated</w>
CaCl(2)- treated,</w>
CaCO 3</w>
Ca val
Ca stration</w>
Ca S</w>
Ca EDTA</w>
CZ P.</w>
CYP3A 4.</w>
CYP2D 6,</w>
CYP2C9 *
CYP2C8 *
CYP2C 19,</w>
CYP2 B
CYP 450</w>
CYP 4
CV- IBS</w>
CV VHD
CTR L</w>
CTR ;</w>
CT/ LC
CT LD</w>
CT -treated</w>
CT -1</w>
CSF- flow</w>
CSF P</w>
CS s)</w>
CS S
CS A,</w>
CS -treated</w>
CS ).</w>
CS ),</w>
CRE -mediated</w>
CR- VPA</w>
CR F2</w>
CR D</w>
CP-101, 60
CP- injected</w>
CP R</w>
CP M</w>
CP L</w>
CP K-MB</w>
CP K),</w>
CP /
COX- 2,</w>
CORM- 3</w>
CONTRO L</w>
CONTRO L-
CONCLUSION (S):</w>
CO PA</w>
CO 2-
CN I.</w>
CN ,</w>
CM N,</w>
CM L.</w>
CL IP</w>
CL C-
CLC- 2</w>
CK- ISOs</w>
CK .</w>
CK )</w>
CI-9 24</w>
CI-9 21</w>
CI ],</w>
CI S
CI H,</w>
CI ;</w>
CI -free</w>
CES- D,</w>
CE Z</w>
CE L)</w>
CD4 (+)</w>
CD34 +</w>
CD- 25</w>
CD P-
CD H</w>
CCNU -treated</w>
CCN U,</w>
CC r</w>
CC ).</w>
CBF hypercapnia</w>
CB(1) KO</w>
CB Z-
CB Z
CB C</w>
CB )</w>
CAP+ HS</w>
CA T.</w>
CA RT-
CA LGB</w>
CA E</w>
CA DASI
CA C</w>
CA B</w>
CA .
CA. OC</w>
CA -treated</w>
CA (F)</w>
C> T,</w>
C57Bl/ 10</w>
C57BL/6 N</w>
C57BL/10 ScSn</w>
C57B 1/
C3 d</w>
C/ I.</w>
C- sires</w>
C- MM</w>
C+ E</w>
C ymbopogon</w>
C res
C rataegus</w>
C p
C lobaz
C ity,</w>
C itrate</w>
C idofovir</w>
C hemic
C h</w>
C eti
C etam
C el</w>
C e</w>
C ats</w>
C ategor
C ann
C af
C W</w>
C U
C Q-treated</w>
C PA-
C NTF</w>
C MT.</w>
C ER
C Ch-induced</w>
C CSs</w>
C CAC</w>
C CA.</w>
C 57,</w>
C 4
C 2-
C -associated</w>
C -</w>
C '
But ea</w>
But ,</w>
Bus pirone,</w>
Bupren orphine,</w>
Bu ffered</w>
Bt x</w>
Brugada- ECG</w>
Bro mo
Brn-3 a</w>
Brit ain</w>
Bri monidine</w>
Bortezomib -induced</w>
Blo od-
Bimoclo mol</w>
Bic arbonate</w>
Bet ween-
Ber lin,</w>
Ben dectin</w>
Belgi um.</w>
Be at-to-beat</w>
Be agles.</w>
Bcl- 2.</w>
Bcl xL</w>
Batter y</w>
Barbit urate</w>
Balti more,</w>
Ballo on</w>
BX D</w>
BW W</w>
BW 37
BW37 3
BW373 U
BW ).</w>
BU O</w>
BT Z</w>
BT MPS</w>
BR M</w>
BR E</w>
BR -16
BR-16 A</w>
BP ]</w>
BP C.</w>
BMS-181 174</w>
BM Y-40
BM Y-14802</w>
BM PR2</w>
BM IP
BM I.</w>
BM C-treated</w>
BM +
BL-345 9,</w>
BL -10
BIP N.</w>
BH T-treated</w>
BF V</w>
BEAC OPP</w>
BD10 18,</w>
BD L.</w>
BD I</w>
BCNU -induced</w>
BCN U.</w>
BB- 94</w>
BALB/c J</w>
BACKGROUND/ PURPOSE:</w>
B6 D2F1</w>
B1 R</w>
B retylium</w>
B hmt2</w>
B ethes
B est</w>
B e</w>
B cr
B azet
B asic</w>
B am
B U-
B REM</w>
B PO
B MT,</w>
B E.</w>
B D.</w>
B CPT-P
B 12-
B 1-
Az idothymidine</w>
Az a</w>
Ay urvedic</w>
Ay urve
Aut ologous</w>
Aug mentin</w>
Au -induced</w>
Asc ending</w>
Arterio graphy</w>
Arter itis</w>
Arn old-
Aripiprazol e-induced</w>
Arg 10</w>
Arg -16</w>
Ara- C,</w>
Ara C.</w>
Ar menian</w>
Ar c</w>
Aqu e
Apr indine</w>
Apparen tly,</w>
Antine oplastic</w>
Anticoagul ants</w>
Anticoagul ant</w>
Antic ancer</w>
Anti tuberculosis</w>
Anti retroviral</w>
Anti parkinsonian</w>
Anti diuretic</w>
Anti cholinergics</w>
Anti E</w>
Anthrac ycline-induced</w>
Anthrac ycl
Anorex ia,</w>
Anesthesi ology,</w>
Anaphyl actoid</w>
Analo gue</w>
An nexin</w>
An imex</w>
An dro
An agreli
Amy g
Amphet amine,</w>
Amoxic illin</w>
Amoxic illin-induced</w>
Amon gst</w>
Amitript yl
Amisul pri
Amiodar one,</w>
Amino guanidine</w>
Amin opyridine</w>
Amik acin</w>
Americ a.</w>
Ameli orative</w>
Am ox
Am ount</w>
Alf uz
Aler tness/Sedation</w>
Alend ron
Al together</w>
Al le
Al fentan
Al chornea</w>
Al bendazole</w>
Aj maline</w>
Ag itation</w>
Ag es</w>
Ag ainst</w>
Afric a</w>
Aff inity</w>
Adul t,</w>
Adren ocortic
Adjust ment</w>
Adju sting</w>
Aden osis</w>
Ad renal</w>
Actu arial</w>
Acit retin</w>
Acet ate</w>
Acce pt
Ac tions</w>
Ac tin
Ac romegal
Ac ral</w>
Ac compan
Ac b</w>
Ac )</w>
Abstr act
Abstin ence</w>
Abeta- afferents</w>
AZT- exposed</w>
AZT ;</w>
AZ T)</w>
AZ M</w>
AV- nodal</w>
AV M.</w>
AUC (0-
AU C)</w>
ATP- ase</w>
ATP ase-
AT R</w>
AT 877</w>
ASI Cs</w>
ASA- sensitive</w>
ASA +MR-
ASA+MR- DP</w>
AS1892 802</w>
AS/ KS</w>
AS S</w>
ARB s.</w>
ARA- C</w>
AR s)</w>
AR B.</w>
AQP 1</w>
APO E</w>
APA P)</w>
AP- 5</w>
AP 7</w>
AP 3</w>
AN P)</w>
AN GPTL4</w>
AN -1
AMPH/ CDP-induced</w>
AM P),</w>
AM L,</w>
AM D
AM ),</w>
ALN+D28 00</w>
AL- IF</w>
AK-FLU OR</w>
AK BR</w>
AIM S/HYPOTHESIS:</w>
AI R)</w>
AI HA.</w>
AI EMs</w>
AI B</w>
AI AI</w>
AH S</w>
AH ),</w>
AGE s</w>
AF- TOC</w>
AF L.</w>
AF B1-
AER s,</w>
AED ,</w>
ADR-E NA</w>
ADR- injected</w>
ADR- CM</w>
ADR+ LOS
ADR s,</w>
ADP/ O</w>
ADP/ ATP</w>
ADOR A2A</w>
ADAM -17</w>
ADAM -10</w>
AD V/LAM</w>
AD V.</w>
AD P-induced</w>
AD L</w>
AD H-
ACTH- Z</w>
ACPT -I</w>
ACPT -1</w>
AC(-O Ho
AC TI
AC S.</w>
AC R-induced</w>
AC M</w>
ABT- 431</w>
AB LC</w>
AB A</w>
AA PD
AA F,</w>
A/ a</w>
A-8 69
A- selective</w>
A(2 a)</w>
A void
A tom
A side</w>
A sia,</w>
A s.</w>
A rom
A rea</w>
A pri
A neur
A kinetic</w>
A dams</w>
A dam
A Y-23,028</w>
A X.</w>
A X-
A VT</w>
A II-A</w>
A ECA</w>
A A/
A 2780</w>
A 1-receptor</w>
A 1-
>or= 2</w>
> 90</w>
> 60</w>
> 20</w>
> 200</w>
> 2.5</w>
> 100</w>
=.0 2),</w>
= 70</w>
= 5</w>
= 4.
= 1.4</w>
= .001).</w>
< 80</w>
< 200</w>
< 1</w>
< 12</w>
< 1%</w>
< 0.001,</w>
< 0.0001).</w>
< .0001),</w>
: P</w>
99mTc- MAG
99m Tc
99 9/
99 %).</w>
95% CI:</w>
90- day-old</w>
90 Y-
90 ;</w>
90 ),</w>
90 %).</w>
9. 8)</w>
9. 7)</w>
9. 7%</w>
9. 38</w>
9. 3%</w>
9-1 3</w>
9- wk</w>
9- di
9- cis-RA</w>
9- TH
9- 3.
9 8).</w>
9 7;</w>
9 7.</w>
9 7,</w>
9 5th</w>
9 5-
9 5+/-
9 5%,</w>
9 4.</w>
9 4,</w>
9 4).</w>
9 3-
9 3)</w>
9 2;</w>
9 20,</w>
9 18</w>
9 1).</w>
9 1),</w>
9 )
88 4,</w>
86 %),</w>
80 6</w>
80 -induced</w>
8. 7)</w>
8. 1%</w>
8. 0;</w>
8-cyclopentyl-1,3-dipropyl xanthine</w>
8-OH-DPA T.</w>
8-OH dG</w>
8-1 4</w>
8-1 2)</w>
8- month</w>
8- day-old</w>
8- 9</w>
8- 35</w>
8- ,</w>
8, 9-
8, 5
8 ]</w>
8 :00</w>
8 80</w>
8 8%),</w>
8 7,</w>
8 6-year-old</w>
8 5,</w>
8 5),</w>
8 5%.</w>
8 3).</w>
8 25</w>
8 2.4%</w>
8 2)</w>
8 2
8 1,</w>
8 00/
8 -1.
8 +</w>
8 +/-1
78 ;</w>
714 2.</w>
70- 80%</w>
70 1</w>
70 .</w>
70 ).</w>
70 %).</w>
7/ 8</w>
7/ 7/7</w>
7.5- 75</w>
7. 9%</w>
7. 6,</w>
7. 6),</w>
7. 5)</w>
7. 4%</w>
7. 2+/-
7-chloro kynurenic</w>
7-OH- MTX</w>
7-F 6-
7- hydroxy-2-acetylaminofluorene</w>
7- hydroxy
7- chloro-
7- Cl-Kyn
7- 2
7- (4-
7, 12-dimethylbenz
7 ].</w>
7 99</w>
7 92</w>
7 9).</w>
7 8,</w>
7 8).</w>
7 70</w>
7 7-
7 7%,</w>
7 5.</w>
7 5%)</w>
7 48</w>
7 46</w>
7 4-
7 4).</w>
7 30</w>
7 3.5%</w>
7 3,</w>
7 3%,</w>
7 2h</w>
7 28</w>
7 20</w>
7 2-hour</w>
7 2-h</w>
7 2,</w>
7 19
7 1.4</w>
7 1+/-
7 1%.</w>
7 0.1</w>
69 ]</w>
69 76</w>
69 %,</w>
69 %).</w>
67. 3%</w>
67 +/-
63 5.</w>
61- yr-old</w>
60- 75</w>
60- 70</w>
60- 0
60 9</w>
60 -</w>
60 -100</w>
6. 9)</w>
6. 8
6. 7
6. 4)</w>
6-keto-PGF (1
6-keto-PGF(1 alpha)</w>
6-hydroxydopamine- lesioned</w>
6-hydroxy dopamine,</w>
6-OHD A,</w>
6- months</w>
6- mg</w>
6- hr</w>
6- [
6- Thioguanine</w>
6- TG
6- (N-
6, 6-tetramethyl
6 9.8</w>
6 9-
6 75</w>
6 6,</w>
6 59</w>
6 47</w>
6 4.5</w>
6 4,</w>
6 4)</w>
6 3),</w>
6 26</w>
6 25,</w>
6 22</w>
6 19</w>
6 15</w>
6 14
6 12</w>
6 10</w>
6 1).</w>
6 -10</w>
6 ,000</w>
6 )-induced</w>
6 %-
59 1</w>
59 ).</w>
58 9</w>
58 8</w>
57 +/-
57 ),</w>
57 %;</w>
56 C</w>
56 /
55212- 2</w>
55- 65</w>
55,212- 2,</w>
55 %),</w>
54 %.</w>
5246 6.</w>
5246 6,</w>
51 Cr
500- 600</w>
50- 55</w>
50- 400</w>
50 :</w>
50 -</w>
50 -100</w>
50 -1000</w>
50 's.</w>
5. 9%</w>
5. 8).</w>
5. 7%,</w>
5. 3%</w>
5. 3
5-methoxy tryptoline</w>
5-hydroxytryptoph an-induced</w>
5-hydroxytrypt aminergic</w>
5-hydroxy indole</w>
5-fluorourac il-based</w>
5-azacy tidine.</w>
5-az acitidine</w>
5-HT-1 A</w>
5-HT(1A)- receptors</w>
5-HT(1 B)
5-HT T</w>
5-HT )</w>
5-H PQ</w>
5-H P
5-FU/ FA</w>
5-FU- based</w>
5-F(2t)- Iso
5-CHO- THF</w>
5-Az acytidine</w>
5-Az C</w>
5- mg/kg</w>
5- dimethyl
5- 5.
5- 2.
5- (3-
5,6, 7,8-
5) S]
5'-O-(2-thiodiphosph ate),</w>
5'- dideoxy
5 c</w>
5 SCD</w>
5 FU.</w>
5 :</w>
5 8.3</w>
5 72</w>
5 7.7</w>
5 67</w>
5 55</w>
5 5).</w>
5 4;</w>
5 4.5</w>
5 38
5 36</w>
5 3.2</w>
5 3).</w>
5 3),</w>
5 28</w>
5 23</w>
5 20</w>
5 2.</w>
5 2%.</w>
5 2%)</w>
5 10</w>
5 1.
5 1%,</w>
5 0.0%</w>
5 -100</w>
5 '</w>
49 -induced</w>
48 A</w>
48 .</w>
48 %).</w>
47. 3%</w>
47 %.</w>
46 5)</w>
46 %.</w>
45 6</w>
45 %.</w>
45 %).</w>
44 +/-
43- kd</w>
42. 8%</w>
400- 500</w>
400 /
40- micrograms/kg</w>
40- 50%</w>
40- 380</w>
40 7</w>
40 5</w>
40 2</w>
40 %;</w>
40 %),</w>
4.0 5</w>
4. 8,</w>
4. 6;</w>
4. 6+/-
4. 5,</w>
4. 5%,</w>
4. 4.</w>
4. 4%.</w>
4. 2;</w>
4. 2+/-
4. 14</w>
4. 1).</w>
4-hydroxy glutethimide</w>
4-4 60
4-1 99
4- hydroxy</w>
4- diphenylacetoxy-N-methylpiperidine</w>
4- Aminopyridine</w>
4- 4.
4,5, 6,7-
4, 7
4, 4
4'-iodo- 4'-
4'- epidoxorubicin</w>
4'- deoxy-
4'- 0-
4'-0- tetrahydropyranyl
4 h</w>
4 ];</w>
4 C]
4 ;
4 95</w>
4 9%,</w>
4 8.3</w>
4 75</w>
4 74</w>
4 7.4</w>
4 7+/-
4 6;</w>
4 69</w>
4 63</w>
4 6.5</w>
4 54</w>
4 500</w>
4 5.2</w>
4 49</w>
4 45</w>
4 41</w>
4 33</w>
4 3.3</w>
4 3.2</w>
4 3.1</w>
4 20,</w>
4 15</w>
4 13</w>
4 12</w>
4 12
4 1.7</w>
4 1.7%</w>
4 1.5</w>
4 1.4</w>
4 00-mg</w>
4 0.5</w>
4 %-
39. 2%</w>
39 ;</w>
39 5</w>
39 %;</w>
39 %).</w>
38. 2%</w>
38 8,</w>
38 ),</w>
38 %;</w>
378 49-induced</w>
37. 8</w>
37. 7</w>
37. 4</w>
37. 4%</w>
37. 3</w>
37. 1</w>
37 1</w>
37 0.</w>
37 0
37 %),</w>
36. 9</w>
36. 6</w>
36- yr-old</w>
36 4</w>
36 1</w>
36 /
36 .</w>
35 6</w>
35 1</w>
34 34
34 3-
315 40</w>
3036 6,</w>
300 0,</w>
300 /
30- 45</w>
30 s</w>
30 :</w>
30 4</w>
3/ 6</w>
3. 92</w>
3. 9-
3. 9).</w>
3. 8-
3. 8,</w>
3. 8%;</w>
3. 78</w>
3. 67</w>
3. 6-
3. 6)</w>
3. 5;</w>
3. 21</w>
3. 13,</w>
3. 1)</w>
3-methylchol anthrene</w>
3-methyl xanthine</w>
3- wk</w>
3- way</w>
3- monthly</w>
3- min</w>
3- kinase</w>
3- hr</w>
3- [(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine</w>
3- NP</w>
3- NP
3- ,</w>
3- (4-
3- (2-
3,7-disulf ate</w>
3,4- dicarboxy
3,3- diphenylpyrrolidin-2-one</w>
3, 20-
3, 000/
3, 00
3'- deamino-
3'- (2-
3 r
3 alpha-hydroxy-
3 alpha,</w>
3 ].</w>
3 OMD</w>
3 6.5</w>
3 54</w>
3 5-year</w>
3 49</w>
3 47</w>
3 46</w>
3 40-380</w>
3 4%)</w>
3 3;</w>
3 39</w>
3 3/
3 3.</w>
3 3.0</w>
3 21</w>
3 2.</w>
3 2.1</w>
3 2%;</w>
3 2%.</w>
3 19</w>
3 16</w>
3 15</w>
3 1.2</w>
3 0.4</w>
3 0.4%</w>
3 -16</w>
3 -100</w>
3 -10
2n d,</w>
2D 6.</w>
29 th</w>
29 ,
28. 8</w>
28. 3</w>
28 1</w>
27. 5%</w>
27. 0</w>
27 4</w>
27 3,</w>
27 1</w>
27 ,
26. 5%</w>
26. 4</w>
26. 2%</w>
26. 1</w>
26 6</w>
26 30
26 ,2
26,2 7-F6-
26 %;</w>
26 %),</w>
25. 4</w>
25. 2</w>
25- year</w>
25- 35</w>
25 ,000</w>
25 );</w>
25 %).</w>
24/ 76</w>
24. 4</w>
24. 3%</w>
24- month</w>
24- dihydroxyvitamin</w>
24,25- (OH)2D
24 h,</w>
24 OXO-16ene
24 %;</w>
23. 8</w>
23. 5%</w>
23. 3%</w>
23- month-old</w>
23 2,</w>
23 ,000</w>
23 %.</w>
23 %).</w>
22. 2%</w>
214 20</w>
21. 7%</w>
21. 6%</w>
21 days</w>
201-99 5</w>
200- mg</w>
200 5);</w>
200 4;
200 4)</w>
200 ,000</w>
20/ 20</w>
20/ 200</w>
20- hydroxyeicosatetraenoic</w>
20- gauge</w>
20- 40%</w>
20 7
20 %).</w>
2/ 57
2/ 1</w>
2.8 %;</w>
2.5- 20</w>
2.5 %;</w>
2.0 9</w>
2.0 8</w>
2.0 4</w>
2.0 .</w>
2. 90</w>
2. 9)</w>
2. 9%</w>
2. 85</w>
2. 8-fold</w>
2. 64</w>
2. 61</w>
2. 5%,</w>
2. 5%)</w>
2. 4-fold</w>
2. 4-
2. 3;</w>
2. 39</w>
2. 29</w>
2. 2),</w>
2. 11</w>
2. 0)</w>
2-methyl-6-(phenylethyn yl)-pyridine</w>
2-chloroprocaine- CE</w>
2-amino-7-phosphonoheptano ate</w>
2-amino-5-phosphono valeric</w>
2-amino-5- phosphonopentanoic</w>
2-1 6</w>
2- yr</w>
2- yr-old</w>
2- receptors</w>
2- phenylamino
2- microglobulin</w>
2- mg</w>
2- hydroxy-
2- bromo
2- [4-
2- CP</w>
2- Br-
2- APH,</w>
2- AAF,</w>
2- 2.5</w>
2- (p-
2-(p- bromophenyl)
2- (2-
2,3- quinoxaline
2,3- benzodiazepine</w>
2,3- benzodiazep
2,3,4,5- tetrahydro-1H-3-benz
2,3, 5-
2,2,2- trifluoroethane</w>
2,2, 6,6-tetramethyl
2, 6-
2, 2-
2, 0
2+ ,</w>
2) IgG-saporin</w>
2', 5'-dideoxy
2 S</w>
2 R</w>
2 R,4R-
2 PAM</w>
2 K1C-
2 DG</w>
2 :00</w>
2 80
2 3.5</w>
2 2nd</w>
2 2;</w>
2 25,</w>
2 20,</w>
2 2.9</w>
2 1:
2 1.0</w>
2 1%),</w>
2 0.6%,</w>
2 -10</w>
2 %]</w>
2 %-
1A- adrenoceptor</w>
1: 1000</w>
1: 100,00
1991-1 99
199 1.</w>
199 0-199
1980 s</w>
1980 s.</w>
1980 .</w>
198 2.</w>
198 1</w>
198 1.</w>
198 1,</w>
197 7.</w>
19. 7</w>
19. 2%</w>
19- NTPP</w>
19 60</w>
19 6)</w>
19 -</w>
180- minute</w>
18. 8%</w>
18. 6</w>
18- yr-old</w>
18- h</w>
18 th</w>
18 F-
18 :
18 81</w>
18 25
18 0/
18 ,
17beta- estradiol,</w>
17beta- Estradiol</w>
17. 9</w>
17. 4</w>
17. 2%</w>
17. 1%</w>
17 p11.
17 %)</w>
16. 1</w>
16. 1%</w>
16- fold</w>
16- 2
16 0/
16 0,</w>
1555 A</w>
150 /
15/ 44</w>
15. 8%</w>
15. 5,</w>
15. 3%</w>
15. 2%,</w>
15. 1</w>
15-45 13,</w>
15- month</w>
15- fold</w>
15- ,</w>
15 7,</w>
15 56C</w>
15 4
15 13</w>
15 00/
15 %.</w>
1429 48A</w>
14. 7</w>
14. 0
14- 21</w>
14 5,</w>
14 45
14 00
14 0.</w>
14 0)</w>
14 +/-
14 %).</w>
14 %),</w>
133 X
13. 3%</w>
13- cis</w>
13- cis-
13 92</w>
13 2.6</w>
13 %;</w>
13 %).</w>
125 48
120- mg</w>
120 4</w>
12. 9%</w>
12. 2%</w>
12. 0%</w>
12- week-old</w>
12- month-old</w>
12- day</w>
12 909</w>
12 6,</w>
12 3)</w>
12 );</w>
12 %;</w>
12 %)</w>
11. 9%</w>
11. 5,</w>
11. 3%</w>
11. 2%</w>
11-dehydro -
11- fold</w>
11- deoxycortisol</w>
11 beta-HSD</w>
11 -13</w>
11 -1
11 +/-1
11 %).</w>
107 18</w>
100 6
100 0/
100 0-1
100 0-
100 /
100 -150</w>
100 -1
100 %;</w>
10.0 %</w>
10. 6%</w>
10-1 9</w>
10- second</w>
10- month-old</w>
10- 50</w>
10- 40</w>
10- ,</w>
10(9)/ L).</w>
10(3)/ mm3</w>
10(3)/ mm3.</w>
10(3)/ microL</w>
10(-1 0)</w>
10 :
10 7,</w>
10 50</w>
10 4)</w>
10 139</w>
10 1,</w>
10 1),</w>
10 0.0</w>
10 +/-
10 (8)</w>
10 (4)</w>
10 (10)</w>
10 %),</w>
1/ epsilon</w>
1/ 2/
1.7 3%</w>
1.5 %;</w>
1.4 +/-
1.3- 5.
1.1- 8.
1.1- 5.
1.1- 3.
1.0- 5.
1.0 9-1.
1.0 6-1.
1.0 2-
1.0 2,</w>
1.0 .</w>
1.0 )</w>
1.0 ).</w>
1.0 %,</w>
1. 9;</w>
1. 99</w>
1. 98</w>
1. 93</w>
1. 90</w>
1. 9%;</w>
1. 8;</w>
1. 76</w>
1. 66</w>
1. 63</w>
1. 60</w>
1. 6).</w>
1. 46</w>
1. 40</w>
1. 37</w>
1. 33</w>
1. 32</w>
1. 3+/-
1. 26,</w>
1. 2%;</w>
1. 2%,</w>
1. 16-
1. 11-
1. 1%,</w>
1. 1%)</w>
1-{3- [4-(2-
1-methyl-4-phenyl-1,2,3,6-tetrahydropyrid ine-treated</w>
1-methyl-4- phenyl
1-methyl uric</w>
1-1 4,</w>
1- immunopositive</w>
1- amino-5-bromouracil</w>
1- adrenoceptors</w>
1- 8
1- 4
1- 30</w>
1- 2%</w>
1,3- DM
1,25-(OH)2- 24OXO-16ene
1,25-(OH)2 -16ene
1,25(OH)2D 3-induced</w>
1,25(OH)2 D</w>
1,25(OH)2 -16ene-23
1,25(OH)(2) D(3)</w>
1,24-(OH)(2) D(3)</w>
1,2- dimethyl
1,0 22</w>
1, 350</w>
1, 24-dihydroxyvitamin</w>
1, 2,3,4,
1, 000,000</w>
1 x</w>
1 b/
1 a,</w>
1 C</w>
1 A,</w>
1 ;
1 50%</w>
1 18)</w>
1 17
1 14)</w>
1 10,</w>
1 1%)</w>
1 )-induced</w>
1 (I)</w>
1 %]</w>
1 %/
1 %-
00 ;</w>
00 0)</w>
00 0).</w>
00 ),</w>
0.9 9).</w>
0.9 8)</w>
0.9 7).</w>
0.9 3;</w>
0.9 3)</w>
0.9 2,</w>
0.9 0.</w>
0.9 0,</w>
0.9 .</w>
0.8 7)</w>
0.8 2+/-
0.8 2).</w>
0.8 0,</w>
0.8 ).</w>
0.7 5%.</w>
0.7 5%,</w>
0.7 1</w>
0.6 8,</w>
0.6 7</w>
0.6 5;</w>
0.6 50</w>
0.6 4)</w>
0.6 ).</w>
0.5- 2.0</w>
0.5- 1</w>
0.5 8;</w>
0.5 7,</w>
0.5 6-1.
0.5 6,</w>
0.5 3,</w>
0.5 2,</w>
0.5 %).</w>
0.5 %),</w>
0.4 7,</w>
0.4 5)</w>
0.4 5%</w>
0.4 1)</w>
0.4 1).</w>
0.4 %),</w>
0.3- 3</w>
0.3 4)</w>
0.2 7,</w>
0.2 6,</w>
0.2 3,</w>
0.2 2).</w>
0.06 25</w>
0.05 ]</w>
0.04 9)</w>
0.03 5).</w>
0.03 4).</w>
0.03 1)</w>
0.014- unit</w>
0.01 ].</w>
0.000 7)</w>
0.000 5,</w>
0.000 2),</w>
0.000 1);</w>
0.00 7),</w>
0.00 5;</w>
0.00 25).</w>
0.00 2);</w>
0.00 12).</w>
0.0 9-
0.0 9,</w>
0.0 9)</w>
0.0 8-
0.0 8),</w>
0.0 7,</w>
0.0 6%</w>
0.0 4;</w>
0.0 3;</w>
0.0 39).</w>
0.0 36).</w>
0.0 31</w>
0.0 30</w>
0.0 3%,</w>
0.0 29,</w>
0.0 27</w>
0.0 19</w>
0.0 16)</w>
0.0 15),</w>
0. 80
0. 5)</w>
0. 4)</w>
0. 300</w>
0. 2;</w>
0. 29
0. 25;</w>
0. 25
0. 2%,</w>
0. 1;</w>
0. 15
0. 14).</w>
0. 125,</w>
0. 11).</w>
0- 7</w>
0- 5.
0 :</w>
0 2,</w>
0 19</w>
0 %-
/d tmax</w>
/d t</w>
/d l.</w>
/ kg)</w>
/ g</w>
/ day)</w>
/ AT</w>
/ +</w>
.00 5),</w>
.00 4),</w>
.00 1);</w>
.0 28).</w>
.0 1;</w>
. A</w>
. 7</w>
. 6.</w>
-2 4%</w>
-1H- pyrazole-3-carboxamide
-19- nor-
-16- ene-23-
-10 ,000</w>
-1. 9</w>
-1. 1</w>
-1- nitrosourea</w>
-1- mediated</w>
-1- [2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]non
-1,2-bis(3, 5-di
-1, 3,4-
-1 K-
-1 98
-1 8-
-1 3)</w>
-1 16</w>
-1 13
-1 1-
-1 .0
-- with</w>
-- are</w>
- ph
- made</w>
- domain</w>
- dP/dt</w>
- aspartate</w>
- administered</w>
- Fanconi</w>
- DX
- 9</w>
- 5.
- 40</w>
- 4.
- 30</w>
- 25.
- 0.9</w>
,000/ micro
,00 0-
,00 0).</w>
, 593</w>
+/- 3</w>
+/ T</w>
+/ +)</w>
+ LD</w>
+ H
+ B
* NO</w>
)dt/ B(t
)/ kg</w>
)-- and</w>
)- stimulated</w>
)- immunopositive</w>
)- amisulpride</w>
) R</w>
) 2</w>
) -1,</w>
(vehicle ),</w>
(t PA),</w>
(t 1/2)</w>
(s gk1
(rh o</w>
(r t-PA)</w>
(r -
(r )</w>
(p=0.0 4)</w>
(p=0.0 4
(p< or=
(p< 0.001</w>
(p ut
(p H
(p GT</w>
(p ANCA)</w>
(p A2</w>
(nACh R)</w>
(n= 6,</w>
(n= 24
(n= 22)</w>
(n= 16
(n= 13
(median =
(mca )</w>
(mGlu R)</w>
(m TOR)</w>
(m Ab)</w>
(m ACh
(iox aglate</w>
(iNO S),</w>
(i.c.v .).</w>
(i. d.)</w>
(i ))</w>
(gamma- GT)</w>
(f )</w>
(doxorubic in)</w>
(didanos ine;</w>
(dd C).</w>
(d Tc)</w>
(control );</w>
(control ).</w>
(c) O(2))</w>
(c ure</w>
(adriamyc in)</w>
([Ca2+] i)</w>
(ZD V)</w>
(Y MDD)</w>
(X eloda
(X O),</w>
(WK Y),</w>
(WH I)</w>
(W e
(W M)</w>
(W -
(VOD ).</w>
(VL BW)</w>
(VE )</w>
(V TA)</w>
(V PA</w>
(V LD
(V IP)</w>
(V DS)</w>
(V CR)</w>
(V A)</w>
(U LN)</w>
(U F
(Tx B2)</w>
(TUNE L</w>
(TUNE L)</w>
(TTP/ HUS)</w>
(TT P-
(TNF- alpha),</w>
(TN F)</w>
(TMP /SM
(TM S)</w>
(TI DA)</w>
(TH C)</w>
(TGF-beta 1)</w>
(TGF-beta )</w>
(TE M)</w>
(TD R)</w>
(TCD D)</w>
(TBAR S),</w>
(TB I)</w>
(TB I).</w>
(T ri
(T ren
(T r
(T n
(T alw
(T able</w>
(T UR
(T TP).</w>
(T P)</w>
(T G
(T EE)</w>
(T D).</w>
(T BP
(T AC)</w>
(T 3
(T +
(T ),</w>
(Spear man</w>
(ST Z)-
(ST A)</w>
(SN R)</w>
(SN P,</w>
(SN P),</w>
(SK F</w>
(SIAD H),</w>
(SHR s)</w>
(S)- 2-
(S yn
(S ig
(S h
(S el
(S ando
(S Z)</w>
(S W)</w>
(S VR
(S OD</w>
(S G)</w>
(S CI
(S AH).</w>
(S .
(S (c)O(2))</w>
(R,S)-AM12 41</w>
(R,S)- 3,4-DCPG</w>
(R)- alpha-methylhistamine</w>
(R oc
(R o</w>
(R o
(R S)-1-aminoindan-1,5-dicarboxylic</w>
(R S)-
(R IA)</w>
(R I
(R G
(R CA)</w>
(R AMP
(Qo L)</w>
(PV R)</w>
(PV Cs)</w>
(PV ),</w>
(PTH ),</w>
(PT X).</w>
(PT X),</w>
(PT SD)</w>
(PP H)</w>
(PP E)</w>
(PO G)</w>
(PN D</w>
(PN D)</w>
(PL D)</w>
(PK C)</w>
(PI SE).</w>
(PH A-
(PF S),</w>
(PEF R)</w>
(PE G)-
(PE ).</w>
(PD A)</w>
(PCP ).</w>
(PC PA)</w>
(PC NA).</w>
(PC E)</w>
(PB N)</w>
(PAN ,</w>
(PA H)</w>
(PA F)</w>
(P=0.0 2).</w>
(P=0.0 2),</w>
(P= .
(P< 0.01,</w>
(P< 0.0
(P< .001)</w>
(P- gp)</w>
(P osm</w>
(P l
(P ir
(P arkinson's</w>
(P UFA)</w>
(P SA),</w>
(P RO
(P PI
(P PAR
(P PA
(P M)</w>
(P M),</w>
(P L)</w>
(P IP
(P IIIN
(P I</w>
(P HT),</w>
(P G),</w>
(P EP/LVET)</w>
(P CT
(P CP),</w>
(P BM
(P AN</w>
(P AI
(P >
(P 400
(P ).</w>
(OX C)</w>
(OV X+CHR
(OCT ),</w>
(O m
(O S),</w>
(O R),</w>
(O LT).</w>
(O H)</w>
(O E
(O AB)</w>
(O A)</w>
(O -
(Na velb
(NT G
(NT E)</w>
(NT D)</w>
(NSAID ),</w>
(NMD A</w>
(NMD A,</w>
(NM S),</w>
(ND I).</w>
(NA PA)</w>
(N O</w>
(N MBAs)</w>
(N IC)</w>
(N F-kappa
(N AS)</w>
(N AC),</w>
(N 2
(N ).</w>
(Mg SO
(MVO 2)</w>
(MTX )-induced</w>
(MT X),</w>
(MR I),</w>
(MPO- ANCA)</w>
(MPO ).</w>
(MMP- 9)</w>
(MD MA</w>
(MCA O)</w>
(MC T)</w>
(MC E)</w>
(MAO I)</w>
(MADR S),</w>
(MA O-
(M SA)</w>
(M S).</w>
(M PA</w>
(M NNG)</w>
(M K
(M IB
(M G)</w>
(M CT
(M B)</w>
(M -
(M )</w>
(Li Cl)</w>
(LY 16
(LVE F).</w>
(LV F
(LV ),</w>
(LHR H)</w>
(LE V)</w>
(LDL- C)</w>
(L-N MMA
(L V</w>
(L SE
(L PO)</w>
(L P),</w>
(L Na+
(L EV
(L AM)</w>
(L AM
(L AB
(L 6-
(L /
(K i</w>
(K Cl)</w>
(K A)</w>
(K +)</w>
(K (ATP
(K(ATP ))</w>
(IV- rhHGF</w>
(ISO ).</w>
(ISO ),</w>
(IR :</w>
(IO P),</w>
(IL )-1
(IF X)</w>
(IC P).</w>
(IC I)</w>
(IB D)</w>
(I. P)</w>
(I so
(I OP
(I NR
(I HA)</w>
(I GF-
(I E
(I CAM
(HR T)</w>
(HR )=
(HO E</w>
(HIV -1)</w>
(HIT ).</w>
(HD L-
(HCF C</w>
(HCC s)</w>
(HAM- D)</w>
(H y
(H e
(H PS)</w>
(H Cl)</w>
(H CV
(GnR H)</w>
(GV HD)</w>
(GV HD).</w>
(GSH P
(GABA) (A)</w>
(GABA(A ))</w>
(GABA ).</w>
(GABA ),</w>
(G6 PD</w>
(G- CSF).</w>
(G lasgow</w>
(G d-
(G Y
(G R
(G O
(G M)</w>
(G HB)</w>
(G F)</w>
(G C-
(G AM
(Fos -
(FS GS).</w>
(FL AIR)</w>
(FK50 6).</w>
(FF A)</w>
(F ig
(F e
(F UDR)</w>
(F SH)</w>
(F S),</w>
(F R)</w>
(F HR)</w>
(Estr acy
(Em blica</w>
(EX CEL)</w>
(EX :</w>
(ESR D),</w>
(ERP s)</w>
(ER K)</w>
(EP R)</w>
(EP I)</w>
(EE )-induced</w>
(ED(50) =</w>
(E po)</w>
(E po
(E pi)</w>
(E S)</w>
(E R</w>
(E O)</w>
(E A)</w>
(E (2)17
(Diazemul s)</w>
(Dex )-induced</w>
(Delta 9-TH
(DOPAC ),</w>
(DO CA)</w>
(DH A)</w>
(DF P),</w>
(DE SAD)</w>
(DE S),</w>
(DA 1)</w>
(D ec
(D X)</w>
(D PD)</w>
(D N)</w>
(D MB
(D IC),</w>
(D EC)</w>
(D CM)</w>
(D AT
(D 2)</w>
(Cs A)-
(Cs A),</w>
(Co omb
(Ch AT)</w>
(Ca Cl
(CYP2 D
(CV R)</w>
(CR ;</w>
(CP u)</w>
(CO MT)</w>
(CNI )-based</w>
(CL O
(CL L)</w>
(CK- MB),</w>
(CH EOP
(CG P</w>
(CE I)</w>
(CBD CA)</w>
(CB F).</w>
(CB 1
(CB ),</w>
(CA P)</w>
(C57B L/
(C or
(C on
(C max)</w>
(C V)</w>
(C PD
(C PA),</w>
(C P),</w>
(C N)</w>
(C IN)</w>
(C H)</w>
(C G)</w>
(C CO-
(C CNU
(C CA)</w>
(C AL
(C /
(BoNT/ A)</w>
(BZ D)</w>
(BT X)</w>
(BPR S),</w>
(BF U-E)</w>
(BBB ).</w>
(BA EPs)</w>
(B rom
(B otox
(B W)</w>
(B S
(B RS)</w>
(B PH).</w>
(B PA
(B MI),</w>
(B M)</w>
(B IS)</w>
(B I
(B A)</w>
(An g
(Al lium</w>
(AZ T)-induced</w>
(AUC ),</w>
(AQP 2)</w>
(APA P),</w>
(AOA A),</w>
(ANOV A)</w>
(AN G</w>
(AM L).</w>
(AL LH
(AL L),</w>
(AK I)</w>
(AID S).</w>
(AI r</w>
(AE s).</w>
(ADR ).</w>
(AD L)</w>
(AC T)</w>
(A- V)</w>
(A rfonad
(A TIN)</w>
(A SP
(A P),</w>
(A M)</w>
(A IN).</w>
(A II)</w>
(A H)</w>
(A GE
(A FB
(A AP)</w>
(A /
(>/ =</w>
(> or=</w>
(> 3</w>
(> 1</w>
(< 12</w>
(99m Tc-
(97. 3%),</w>
(95% CI</w>
(9. 0</w>
(9 9.
(9 8</w>
(9 8%)</w>
(9 7</w>
(9 6.
(9 6%</w>
(9 3</w>
(9 3.
(9 00</w>
(9 0%).</w>
(9 -1
(8S, 15S)-diHETE</w>
(8R, 15S)-diHETE</w>
(8. 1%)</w>
(8. 0%</w>
(8- S
(8 8%).</w>
(8 8%),</w>
(8 7</w>
(8 6</w>
(8 6%</w>
(8 5.
(8 5%</w>
(8 5%).</w>
(8 5%),</w>
(8 2</w>
(8 25</w>
(8 2%).</w>
(8 1%).</w>
(8 00
(7. 8</w>
(7. 8%)</w>
(7. 5%)</w>
(7. 4</w>
(7. 4%),</w>
(7. 2%)</w>
(7- NI;</w>
(7 8%),</w>
(7 5.9</w>
(7 5%).</w>
(7 5%),</w>
(7 1%).</w>
(7 ,</w>
(7 %).</w>
(66. 7%)</w>
(6. 9</w>
(6. 9%)</w>
(6. 5</w>
(6. 4</w>
(6 9</w>
(6 8%).</w>
(6 7%).</w>
(6 6%),</w>
(6 3.
(6 2%</w>
(6 1%).</w>
(6 ,</w>
(50 00</w>
(5. 9</w>
(5. 8%</w>
(5. 8%)</w>
(5. 5%)</w>
(5. 3%)</w>
(5. 2</w>
(5 mg/kg,</w>
(5 9%</w>
(5 9%).</w>
(5 7%),</w>
(5 6%</w>
(5 5%</w>
(5 4%).</w>
(5 3-
(5 2%</w>
(5 2%).</w>
(5 '-
(46. 4%)</w>
(40- 60</w>
(4.0- 8.0</w>
(4. 9</w>
(4-chloro phenyl)-1-
(4-aminophenyl)-4-methyl-7,8- methylenedioxy-5H-
(4- 5</w>
(4'- fluorophenyl)
(4 8%),</w>
(4 6%</w>
(4 50</w>
(4 5-
(4 4%),</w>
(4 0%).</w>
(4 0%),</w>
(4 ).</w>
(35. 7%)</w>
(30- 90</w>
(30 -100</w>
(3. 4</w>
(3. 45</w>
(3-chloro styr
(3- M
(3- 5</w>
(3, 5-
(3)H- MK-801</w>
(3 H)-
(3 8%),</w>
(3 7%).</w>
(3 4%</w>
(3 3.3</w>
(3 1%</w>
(3 00-
(3 00
(3 0)</w>
(27. 5%)</w>
(25- 200</w>
(200- 400</w>
(200 2)</w>
(20- 80</w>
(2. 9%)</w>
(2. 85</w>
(2. 8%)</w>
(2. 5-10</w>
(2. 4%</w>
(2-mercapto ethane</w>
(2-chloroethyl)-1- nitrosoure
(2-Cd A)</w>
(2- hydroxy-3-
(2- fold</w>
(2- 6</w>
(2, 4-dichloro
(2, 4,6-
(2 mg/kg,</w>
(2 R,4R)-
(2 9%</w>
(2 9%),</w>
(2 8%</w>
(2 6%;</w>
(2 50,</w>
(2 )-induced</w>
(2 '-
(1966- January</w>
(19 80</w>
(19 80-
(19 2)IgG-saporin</w>
(18. 6%)</w>
(17. 5%)</w>
(16. 4</w>
(16. 1%),</w>
(150- 200</w>
(14. 1%),</w>
(12. 5-25</w>
(12. 5,</w>
(11. 7%)</w>
(100- 400</w>
(100 mg/kg,</w>
(100 0-1
(100 -150</w>
(100 %,</w>
(10. 5%)</w>
(10(- 8)</w>
(10(- 4)</w>
(10(- 3)</w>
(10 mg/kg)</w>
(10 9</w>
(10 5</w>
(10 -1
(10 %,</w>
(1. 8%)</w>
(1. 5%</w>
(1. 4
(1. 17
(1. 15</w>
(1. 1)</w>
(1. 1%).</w>
(1- 8</w>
(1- 7
(1- 6</w>
(1- 50</w>
(1, 25
(1, 200</w>
(1, 2-
(1) H-
(1 S,3
(1 92</w>
(1 9%</w>
(1 78</w>
(1 74</w>
(1 65</w>
(1 6.7</w>
(1 6-1
(1 6%</w>
(1 56</w>
(1 5.5</w>
(1 5%</w>
(1 5%,</w>
(1 33</w>
(1 27</w>
(1 26</w>
(1 21</w>
(1 200</w>
(1 2.1</w>
(1 19</w>
(1 11</w>
(1 1.8</w>
(1 1.6</w>
(1 1-
(1 0.8%)</w>
(1 0.7</w>
(1 0.4</w>
(1 0.0
(1 %,</w>
(0.5- 3</w>
(0.3- 30</w>
(0.1- 5</w>
(0.05- 1</w>
(0.01- 0.3</w>
(0.01- 0.03</w>
(0.00 5</w>
(0.0 3,</w>
(0.0 25-
(0. 84</w>
(0. 8-
(0. 65</w>
(0. 6%)</w>
(0. 5%),</w>
(0. 44</w>
(0. 41</w>
(0. 40</w>
(0. 4-
(0. 4%)</w>
(0. 3%)</w>
(0. 28</w>
(0. 2%)</w>
(0. 1%</w>
(0. 1
(0-1 2
(0- 2</w>
(-1 5</w>
(-1 )),</w>
(-)- spect
(-)- nicotine,</w>
(-)- cibenzoline</w>
(-) PTT</w>
(- 32</w>
(+/-)- propranolol</w>
(+/ +
(+)-5-methyl-10,11-dihydro-5H-di benzo(a,d
(+)- MDMA</w>
(+ 4
(+ ))</w>
( y
( withdrawal</w>
( white</w>
( vs</w>
( vs.</w>
( urine</w>
( tubular</w>
( tri
( treated</w>
( theophylline
( that</w>
( summary</w>
( sub
( stratum</w>
( significantly</w>
( sigma
( sevoflurane</w>
( sc)</w>
( sc
( safety</w>
( resulting</w>
( referred</w>
( received</w>
( pulmonary</w>
( pts)</w>
( propranolol)</w>
( probably</w>
( prevalence</w>
( predominantly</w>
( pos
( phenytoin</w>
( perhaps</w>
( penicillamine)</w>
( pegIFN)</w>
( partial</w>
( onset</w>
( one),</w>
( olanzapine,</w>
( octreotide)</w>
( normal,</w>
( nor
( nicotinic</w>
( new</w>
( n-
( motor</w>
( ml/min/g)</w>
( min)</w>
( men</w>
( mechanical</w>
( low-
( losartan),</w>
( log</w>
( lind
( leukocyte</w>
( indomethacin</w>
( incidence:</w>
( ic
( i.p)</w>
( hypertension,</w>
( host)</w>
( highest</w>
( higher</w>
( headache,</w>
( head</w>
( haloperidol)</w>
( glutathione</w>
( glutamate,</w>
( gamma</w>
( frusemide)</w>
( free</w>
( exp
( exencephaly
( encoding</w>
( encainide</w>
( ejection</w>
( effective</w>
( dosage</w>
( donor)</w>
( diazepam,</w>
( diameter</w>
( dexrazox
( derived</w>
( daily</w>
( dP/dt</w>
( dP/dt
( cycle</w>
( continuous</w>
( combined</w>
( clinical</w>
( characterized</w>
( cerebral</w>
( carboplatin</w>
( calculated</w>
( bupropion</w>
( bupivacaine,</w>
( bpm)</w>
( body</w>
( bicuculline,</w>
( below</w>
( baseline).</w>
( bF
( aver
( anti
( anterior</w>
( anesthetized</w>
( alone</w>
( all,</w>
( age:</w>
( ad
( acetylsalicylic</w>
( aPTT
( [35S]TBP
( The</w>
( SU
( S</w>
( ON
( Ins1
( II
( H</w>
( Group-
( D</w>
( ACE</w>
( 7-N
( +</w>
( (+/-)-
', 3'-
' t</w>
' on'</w>
' minimal</w>
' a'</w>
' On'</w>
' ).</w>
% ];</w>
% ).(ABSTRACT</w>
"sub therapeutic"</w>
"sinus "</w>
" sil
" saf
" other"</w>
" meth</w>
" low-
" low"</w>
" late"</w>
" good</w>
" cow's</w>
" coronary</w>
" classical"</w>
" binge"</w>
" acute"</w>
" :</w>
zyme -
zotoc in</w>
zotep ine,</w>
zopiclon e.</w>
zol e).</w>
zinc .</w>
zinc -induced</w>
zinc ,</w>
zin ophthal
zinophthal az
zinophthalaz ine-treated</w>
zidovud ine-
zicon oti
ze al
zeal ous</w>
zatebr adine.</w>
zalepl on.</w>
z otan</w>
z ocine</w>
z i
z ep
z eniplatin</w>
z elandopam</w>
z el
zel and
zeland opam,</w>
z =</w>
z -
yst onia</w>
yros ine-
yro philic</w>
yri dine</w>
yr ylcholinesterase</w>
yr s,</w>
yr -
yp tin</w>
young er.</w>
young -onset</w>
youn ger
youn g-
you th</w>
yo s</w>
yo -
yno l</w>
yno diol</w>
yne- vitamin</w>
yne -19-nor-
yne-19-nor- 26,27-F6-
ym is</w>
yloxy )
ylo estradiol</w>
ylestradi ol,</w>
yl]-1- isopropyl
yl]-1-isopropyl pyridine-
yl]-1-isopropylpyridine- 2
yl]-1-isopropylpyridine-2 (1H)-
yl]-1-isopropylpyridine-2(1H)- one</w>
yl]- form
yl]- L-
yl] benzene
yl-L- proline</w>
yl-L- leuc
yl-4- pyrimidinyl)
yl- lysozyme</w>
yl- 2'-
yl)- propyl-1-phosphonic</w>
yl)- piperaz
yl) pyridine</w>
yl) oxy]-
yl) -1,2-
yl us</w>
yl sucrose</w>
yl methion
yl ene</w>
yl ene
yl cypromine</w>
yl carbonyl)
yl ates</w>
yl .</w>
yellow ish</w>
yeast .</w>
year-old- female</w>
year s:</w>
year s-old)</w>
yclo [3.
yaw ning,</w>
y- specific</w>
y- moving</w>
y- -a</w>
y rate)</w>
y over</w>
y et-
y ed,</w>
y R
y ="
y ,"</w>
y ")</w>
xylo caine</w>
xyl yl-6-AzUd</w>
xyl azine.</w>
xyl azine-induced</w>
xy quinoline</w>
xipar ine</w>
xen on-
xen on
xenon -1
xenon-1 33</w>
xanth ine)</w>
xam oter
xamoter ol,</w>
x odes</w>
x ide</w>
x heim
xheim er</w>
x anol</w>
x D2</w>
x 4</w>
x 10(9)/l</w>
wri st,</w>
worth whi
worthwhi le.</w>
worsen ,</w>
worl d,</w>
work place</w>
wor se,</w>
wor ris
wor m</w>
wor d
woman- years</w>
wom an's</w>
wk -old</w>
within- patient</w>
within- group</w>
withdrawal- emergent</w>
withdraw n;</w>
with standing,</w>
with out
with /
with/ without</w>
wit ch</w>
wis dom</w>
window s</w>
win ter</w>
wild- type,</w>
wild- type)</w>
wid th.</w>
wi se.</w>
wi res</w>
whic hever</w>
whe y</w>
whe at
wh om,</w>
well-be ing,</w>
well- recognised</w>
well- nourished</w>
well- matched</w>
well- functioning</w>
well- demarcated</w>
well ;</w>
weight- lif
weight-lif ter</w>
weigh ts.</w>
weig he
weighe d.</w>
week- long</w>
week s-
week ends.</w>
week end</w>
week ;</w>
weak ens</w>
weak en</w>
we re;</w>
we b
way s:</w>
wave )</w>
water- immersion</w>
water ;</w>
water ).</w>
wat ched</w>
wat ch
wast age.</w>
wash out.</w>
wash -
warfar in:</w>
warfar in-treated</w>
warfar in's</w>
war med,</w>
war d-
wan ing</w>
wa vel
wavel ength</w>
wa ist
wa b</w>
w/ v</w>
w t.</w>
w s</w>
w oun
w ishes</w>
w ing
wing ed</w>
w in</w>
w ill
will in
willin gn
willingn ess</w>
w b
wb c</w>
w ays,</w>
w ash</w>
w ann
wann oma</w>
w ak
wak e-
vulgar is,</w>
vouch ers</w>
voltam metry</w>
volt age-</w>
volt age,</w>
vol u
vol i
vol %,</w>
vogli b
voglib ose</w>
vl PAG</w>
vl PAG)</w>
viz .,</w>
viz ,</w>
vitro ;</w>
vitre oret
vitreoret inal</w>
vit rectomy</w>
visual- evoked</w>
visu al,</w>
viru ses.</w>
viro logic,</w>
viral- hepatitis-like</w>
vir us:</w>
vir g
vir al-induced</w>
vir al,</w>
vir -associated</w>
viol et
viol ent,</w>
viol ence.</w>
vinyl- GABA</w>
vinc ulin,</w>
vil le,</w>
vigil ance.</w>
vigil ance,</w>
vigabatr in-induced</w>
video- recorded</w>
video /
video/ EEG</w>
vid one</w>
vibris sa.</w>
vi ties</w>
vi sed)</w>
vi ously,</w>
vi lox
vi ation</w>
vi als</w>
veter an</w>
vestibulo- ocular</w>
vestibulo toxicity</w>
vesti bu
ves narinone</w>
vertebra e,</w>
verte br
vers a,</w>
verapamil/ beta-blocker</w>
ver sive</w>
ver sion,</w>
ver sing</w>
ventro- medial</w>
ventric ularly</w>
ventric le).</w>
ventr ally</w>
ventr al-
ventilat or.</w>
venlafax ine-
ven ules.</w>
ven ue</w>
ven o-
veget ables</w>
vec tion-
vection- enhanced</w>
ve st
ve in
vasospas m:</w>
vasopress in-mediated</w>
vasopress in-
vasopress in)</w>
vasoconstrict ors.</w>
vaso relaxing</w>
vaso depressive</w>
vascular ization</w>
vascular is</w>
vas o-
vas a</w>
varic ella-
varicella- zoster</w>
vari eties</w>
vari ed;</w>
vari ates</w>
vari ants.</w>
vari ant,</w>
vaporiz er-equipped</w>
vap tan
vaptan -treated</w>
van ish
van ill
valu es).</w>
valu es
values ):</w>
valu e).</w>
valsart an;</w>
valid ity.</w>
valid ity,</w>
val vul
val ve,</w>
val noctamide</w>
val ine</w>
val bumin</w>
val acyclovir
vagotom ies</w>
vag otonic</w>
vag al-
vag al)</w>
vaccin es</w>
vaca ine,</w>
va2] TRH</w>
v oids</w>
v ism</w>
v icular</w>
v ented</w>
v ault</w>
v ary,</w>
v ar</w>
v af
v O2</w>
v ),</w>
v (mean
uz umab</w>
uve itis.</w>
uve itis,</w>
utroph ils</w>
utili zes</w>
util ising</w>
uti tion</w>
uti ta</w>
utero placental</w>
uter o-
utero- placental</w>
ut ley,</w>
ut es</w>
ut ectic</w>
ust om
useful ness.</w>
use -related</w>
use ).</w>
us+ taste</w>
us tion</w>
us tin</w>
us sus
ussus ception</w>
us cri
uscri pt</w>
us carinic</w>
us al,</w>
us al
urticar ia-
urticar ia
ursodeoxychol ate-3-O-glucuronide</w>
urolog ist</w>
uro xi
uro protection.</w>
uro flow</w>
uro fen</w>
uro [2,3-
uro[2,3- e]
uro[2,3-e] pyrido[1,
uro[2,3-e]pyrido[1, 2-a]
uro[2,3-e]pyrido[1,2-a] [1,
uro[2,3-e]pyrido[1,2-a][1, 3
uro[2,3-e]pyrido[1,2-a][1,3 ]
uro[2,3-e]pyrido[1,2-a][1,3] diazep
uro[2,3-e]pyrido[1,2-a][1,3]diazep in-1
uro[2,3-e]pyrido[1,2-a][1,3]diazepin-1 2-
uro[2,3-e]pyrido[1,2-a][1,3]diazepin-12- ium</w>
urk ish</w>
urin ol</w>
uri x</w>
uri ents</w>
urgen cy,</w>
urg ed</w>
ureter s,</w>
ureter itis</w>
ures ),</w>
ure- effect</w>
ure- activity</w>
ure than</w>
ure ter,</w>
ure d,</w>
ur ring</w>
ur idine,</w>
ur ia:</w>
ur -
uptake ),</w>
uptak es</w>
upregul ates</w>
upper- quadrant</w>
up wards</w>
up titration</w>
up slope</w>
up on.</w>
up dates</w>
up date</w>
up dat
unpredict able.</w>
unpredict ability</w>
univer sal
units/ L</w>
unit- erythroid</w>
unit ),</w>
unilater al.</w>
unif ocal</w>
uni variable</w>
unexpl ained,</w>
unexpect ed.</w>
unexpect ed,</w>
une valuable</w>
under studied.</w>
under perfusion</w>
under nutrition.</w>
under ly</w>
und- glass</w>
und- Wistar</w>
un well</w>
un targeted</w>
un stimulated</w>
un specific</w>
un safe</w>
un responsive,</w>
un resect
un rel
un record
unrecord able</w>
un ra
un pleas
un obstructed</w>
un likely,</w>
un labeled</w>
un iti
un involved</w>
un influenced</w>
un identified.</w>
un happ
unhapp iness,</w>
un folded</w>
un due</w>
un documented</w>
un diminished</w>
un defined.</w>
un damaged</w>
un controlled,</w>
un classified</w>
un blinde
un available</w>
un ambigu
umb er
umb ent</w>
um- replete</w>
um- based</w>
um on
um er
um "</w>
ultrason ographically</w>
ultrafiltr ation.</w>
ultra- low-dose</w>
ultra violet</w>
ultra structurally</w>
ulph ate</w>
ulo us</w>
ulcer ations.</w>
ulcer ations,</w>
ulcer ated</w>
ul trac
ultrac ent
ultracent rifugation</w>
ul nar
ul l,</w>
ul ine)</w>
ul eus.</w>
uge e</w>
ucindo lol</w>
uc ky</w>
uc ella</w>
ub 's</w>
u zole</w>
u vular</w>
u ous,</w>
u n</w>
u minal</w>
u log
u g</w>
u .</w>
u ,</w>
tyrosine-methionine-aspartate- aspartate</w>
tyros ine.</w>
typh oid</w>
type 2</w>
type -I</w>
typ ical"</w>
typ es;</w>
typ es:</w>
ty -</w>
twor m</w>
two- phase</w>
two- period,</w>
two- kidney,</w>
two- day</w>
twitch ing.</w>
twel f
twelf th</w>
tw ist</w>
tw ins.</w>
turb in
tur ition</w>
tun ed</w>
tumo rous</w>
tubul o</w>
tubul es)</w>
tubocurar ine-induced</w>
tuber cles</w>
tu it
tu be
ttp:// www.
trou ble</w>
troponin- T,</w>
tropon in.</w>
tropon in,</w>
tropan yl</w>
troglitaz one,</w>
tro lox</w>
tro fosfamide</w>
tro ch
troch anter
trochanter ic</w>
tro car</w>
tris mus.</w>
tript ans.</w>
tript an
triple- vessel</w>
trinit rate-induced</w>
trimethoprim- sulfadiazine</w>
trimethadi one,</w>
trimetaph an-induced</w>
trimeta z
trigu ingly,</w>
triglycer ide-
trigemin o-
trifluoromethyl phenylpiperazine</w>
tricycl ics,</w>
trichotillo mania</w>
trichloroethan e.</w>
trichloro acetic</w>
trich ro
tric eps</w>
tric eps,</w>
triaz in-
triaz eno
triamterene -
triamcin ol
trial s;</w>
trial s)</w>
tri- hom
tri-hom o-
tri-homo- 22,
tri-homo-22, 24-
tri-homo-22,24- di
tri phosphate.</w>
tri phosphatase.</w>
tri peptide</w>
tri mi
tri hydroxy
tri dec
tri anis
trianis ene</w>
tri al)</w>
tren ds.</w>
tremulous ness</w>
tremulous ness.</w>
tremoro lytic</w>
tremor ;</w>
tremor :</w>
tremor -
treatment- seeking,</w>
treat ed-
tre phine</w>
tre mens</w>
tre mely</w>
tre es</w>
trazod one:</w>
traz ol,</w>
travell ers</w>
trast -induced</w>
tranylcyprom ine.</w>
transt ubular</w>
transport ation</w>
transport -
transport- competent</w>
transplant ),</w>
transplan ted.</w>
transketol ase</w>
transi tion.</w>
transi s
transis th
transisth mic</w>
transfer ,</w>
transf ection</w>
transe pithelial</w>
transcriptase- polymerase</w>
transcri ption.</w>
transamin asemia,</w>
transamin ase.</w>
trans-1,2-cyclohexanedi ol</w>
trans- 3,4-
trans ves
trans ver
trans sectional</w>
trans placentally</w>
trans it.</w>
trans it,</w>
trans it
trans glut
transglut amin
trans ection.</w>
trans ection,</w>
tranquil ization</w>
trandol apri
train ing)</w>
traff ic</w>
tract- involved</w>
trache otomy.</w>
trache oesophageal</w>
trac k</w>
trac hom
trachom ati
trachomati s</w>
tra versing</w>
tra ject
tra its,</w>
tr ics</w>
tr ading</w>
tr aben
traben azine</w>
toxic- metabolic</w>
toxic ology,</w>
toxic in-induced</w>
toxic "</w>
tox .</w>
tot aled</w>
tot al).</w>
torsa de.</w>
toremif ene-induced</w>
top otec
top ographically</w>
top ographical</w>
top ical,</w>
tonsill ectomy</w>
tonic-clon ic,</w>
ton us</w>
ton sil
ton ometry.</w>
ton ic
ton -H
ton-H all</w>
ton -
tolterod ine.</w>
tolbut amide.</w>
tolazol ine-induced</w>
tol vaptan-treated</w>
tocotrien ol</w>
toc olysis,</w>
tobram ycin-induced</w>
tobacco .</w>
tobacco -related</w>
to- face</w>
to- apex</w>
to phoresed</w>
to ols,</w>
to ol.</w>
to ol,</w>
to m</w>
to day.</w>
to -1</w>
to -1
to-1 2-hour</w>
tiz ed,</w>
tivi ties,</w>
tiven ess,</w>
tive /
titr atable</w>
tissue- specific</w>
tis m,</w>
tir pation</w>
tion/ reinstatement</w>
tion- potential</w>
tion s/
tion -</w>
tinnit us+taste</w>
ting- up.</w>
ting ling,</w>
tin ent</w>
tin -</w>
timolo l-treated</w>
timolo l-related</w>
time-of- flight</w>
time-of- day</w>
time- release</w>
time- points</w>
time- point</w>
time- effect</w>
time- dependently</w>
time- courses</w>
time "</w>
tim es:</w>
tim es-
tim ate</w>
tilmic in</w>
til ts</w>
til ting-up.</w>
tigh tness.</w>
tigh tness,</w>
tig o</w>
tid ine-induced</w>
tid al)</w>
ticryn af
ticarc illin-induced</w>
ticarc illin,</w>
tic us</w>
tic s)</w>
tic es</w>
tic ).</w>
tib ia.</w>
tiapri de.</w>
ti ps</w>
ti ps.</w>
ti ously</w>
ti form
ti d.</w>
ti com
ti bol
ti ar
ti april</w>
ti a
tia profen
tiaprofen ic</w>
thyroidi tis,</w>
thyro troph
thyro idal</w>
thymid ine;</w>
thymid ine)</w>
thym ol
thymol eptic</w>
thym idine-induced</w>
thyl enyl)
thy mic,</w>
thumb s</w>
thrombot est</w>
thromboly sis-related</w>
thromboembol ism:</w>
thrombocytopen ia-
thrombocyto paenia</w>
thrombo- embolism</w>
thrombin- antithrombin</w>
thromb olysis,</w>
threshol d)</w>
threshol d).</w>
three- way</w>
three- drug</w>
three- dose</w>
three- day</w>
threat ening,</w>
thorac otomy,</w>
thorac o-
thor ax.</w>
third- order</w>
thir st
thioure a.</w>
thiotepa .</w>
thiopent one/
thiopentone/ propofol</w>
thiopent al/
thiocolchico side.</w>
thiobutyro lactone</w>
thio phene</w>
thio TE
thin- layer</w>
thin king</w>
thien opyridine</w>
thick ness/
thick er</w>
thick ening.</w>
thiazol e-
thiaz ides,</w>
thiaz ide.</w>
thiaben dazole.</w>
thi os
thios ulphate</w>
thi oc
thioc itrulline</w>
thi ep
thi amphenic
theta (
thesi as</w>
thermodi lution</w>
thermo regulation,</w>
thermal -
thereafter ;</w>
therap y.(ABSTRACT</w>
ther mon
ther mia,</w>
ther m
theophylline- ephedrine</w>
theophyll ine-related</w>
theophyll ine-associated</w>
the ory,</w>
the at
the astern</w>
than- expected</w>
thalidomide- dexamethasone</w>
thalidom ide-treated</w>
thalas semic
thalamo- striatal-
thalam otomy.</w>
th s.</w>
th is
th ine</w>
th enal
th ;</w>
tezos entan</w>
tezos entan,</w>
tex t</w>
tetrofos min,</w>
tetrodotox in-resistant</w>
tetrap eptide</w>
tetramethyl cyclo
tetramethylcyclo propyl</w>
tetrahydro-7,8- dihydroxy
tetrahydro-7,8-dihydroxy -1-
tetrahydro-7,8-dihydroxy-1- phenyl
tetrahydro- 3-methyl-5-
tetrahydro-3-methyl-5- phenyl
tetrahydro corticosterone</w>
tetraethylammon ium,</w>
tetrachlor ide-induced</w>
tetrac ycline-induced</w>
tetra k
testoster one-induced</w>
test ed:</w>
test );</w>
test "</w>
tes tis,</w>
tert-butyl nitrone</w>
tert-butyl amino-
tert- butyl</w>
terodi line).</w>
termin us</w>
termin ations</w>
teratogen ically</w>
teratogen .</w>
teratogen -exposed</w>
ter tile</w>
tenu ifoli
tenuifoli side</w>
tent atively</w>
tent -to-treat</w>
tension- time</w>
tenofovir -containing</w>
tender ness.</w>
tend ino
tend ency,</w>
ten- year-old</w>
ten tion</w>
ten ess</w>
ten ed</w>
ten ,</w>
temporo parietal</w>
tempor al,</w>
temperat ures.</w>
temperat ure;</w>
temperat ure-effect</w>
temozolom ide,</w>
telo mere-
teleph one,</w>
tel encephalon</w>
teicoplan in-induced</w>
teg ment
teeth .</w>
teenag er</w>
teen age</w>
techniqu e).</w>
techniqu e),</w>
te ms</w>
te d).</w>
te am.</w>
tc PCO2</w>
tax ane-
tauro deoxycholic</w>
tau ght</w>
tast atin</w>
target ing,</w>
tap s</w>
tandos pirone,</w>
tamsulos in)</w>
tamoxifen -related</w>
tal ipexole</w>
tak ing,</w>
tak en;</w>
tail- pinch</w>
taglu timide</w>
tacrine- loaded</w>
tachykin in-A</w>
tachycardia/ fibrillation</w>
tachy systole,</w>
tachy arrhythmic</w>
tachy arrhythmias:</w>
tachy arrhythmia,</w>
tac rine.</w>
table ts).</w>
table ts),</w>
ta i
ta e</w>
t. ;</w>
t-MDS/ AML</w>
t- test</w>
t- ox</w>
t- dependent</w>
t- butylbicyclophosphorothionate</w>
t- butyl</w>
t z</w>
t ulo
t ual</w>
t resp
t or-
t one-
t ly-
t ing:</w>
t es)</w>
t ation,</w>
t ang
t ane</w>
t ally</w>
t abuse
t Cr</w>
t 1,</w>
t 0,</w>
t -1,2-
t (3
t(3 ;
systolic/ diastolic</w>
systematic ally.</w>
system atic,</w>
syring e.</w>
synthe t
synthe ses</w>
synovi tis.</w>
synergis tic,</w>
synerg izes</w>
syndrome -like</w>
syndrome '.</w>
syncop e;</w>
syncop al)</w>
synchron ization.</w>
synapto phy
synapto genesis.</w>
syn ergic</w>
syn carcinogenic</w>
symptom- free.</w>
symptom s"</w>
symptom atic
sympathomime tics,</w>
sympatho excitation</w>
sympath one
sympathone ural</w>
sympath ectomy,</w>
symmetr ically</w>
sy s
sy l
switch over</w>
switch ing.</w>
switch .</w>
swell ings,</w>
sweet ened</w>
sweet en
swe at
sw ings.</w>
sw allow</w>
suxameth oni
suspici on.</w>
suspen sions.</w>
suspen sion,</w>
susp ending</w>
survival ;</w>
survival /
surpris ing,</w>
surger y;</w>
surger y).</w>
surge ons.</w>
surfac ed</w>
suprac lin
supraclin oid</w>
supra- ventricular</w>
supra- therapeutic</w>
suppres sible</w>
suppor ted.</w>
supplement ing</w>
supplement ed,</w>
superven ed.</w>
superf icially</w>
superf amil
superfamil y.</w>
superf am
superfam ily</w>
sup rap
suprap ubic</w>
sup radi
supradi aphrag
supradiaphrag matic</w>
sup position</w>
sup pose</w>
sunit inib.</w>
sun bur
sulphon ylurea</w>
sulphon yl
sulphadi azine-induced</w>
sulph oxide</w>
sulph amethox
sulfoxim ine,</w>
sulfonyl ureas.</w>
sulfonamide -containing</w>
sulfinpyraz one.</w>
sulfamethox azole.</w>
sulfamethox azole,</w>
sulfamethox azol
sulfam etopyraz
sulfadi azine,</w>
sulf ur</w>
sulf otransferase</w>
sulf ate-
sulf apyri
sul c
sul bac
sulbac tam</w>
suic ides</w>
suic ide,</w>
suic id
suggest s,</w>
sugar ,</w>
suffici ent.</w>
suffere r
sudden ly,</w>
sucralf ate.</w>
succe eding</w>
suc rose,</w>
suc ro
sucro se-
suc cum
suburo thelium</w>
subunit -containing</w>
subtype -specific</w>
subtype )</w>
substra in</w>
substitu tions,</w>
substanti ally,</w>
substance -dependent</w>
substance (s)</w>
subst rat
subsequ ent,</w>
subo- like</w>
sublingu ally)</w>
subj ecti
subicul um;</w>
subep imy
subepimy ocardium</w>
sub- regions</w>
sub- additive</w>
sub tests</w>
sub stituted.</w>
sub stitut
sub sid
sub seizure</w>
sub score</w>
sub scale,</w>
sub sarcolemmal</w>
sub sample</w>
sub regions.</w>
sub paralyzing</w>
sub nucleus</w>
sub mucous</w>
sub mitochondrial</w>
sub lux
sub intimal</w>
sub hypnotic</w>
sub groups:</w>
sub group.</w>
sub group--
sub fulminant</w>
sub fractions</w>
sub for
subfor nical</w>
sub fields</w>
sub endomyocardium</w>
sub endocardium</w>
sub endocardi
sub chronically</w>
sub arachno
sub aortic</w>
su profen,</w>
su perfusion</w>
su e</w>
styr yl-
stupor '</w>
stud y),</w>
stud y's</w>
structure- function</w>
structur ally-
struc tive</w>
stroph anth
stron gly,</w>
stroke/ TIA</w>
stroke- associated</w>
strok es)</w>
stro me
strict ure.</w>
striat opallidal</w>
stri ational</w>
stret ch.</w>
stress/ rest</w>
stres s:</w>
streptozoc in-diabetic</w>
strepto kinase.</w>
strept avidin-
stre et-
stre ak
strati fy</w>
strati fication.</w>
strate gic</w>
stra in-
stra Z
straZ enec
straZenec a,</w>
str ingent</w>
stor m</w>
stoppe d;</w>
stop- exposure</w>
stomat ocytosis</w>
stom atitis.</w>
sto res.</w>
sto ols,</w>
sto ichi
stimuli --the</w>
stimulant -dependent</w>
stimul us-
stimul ations.</w>
stimul ant.</w>
stilbo estrol</w>
stig mata</w>
stiff -
stiff- person</w>
sti pul
steroid s:</w>
steroid -related</w>
stereospecific ity</w>
stere ology</w>
ster ified</w>
ster ically</w>
stenosi s)</w>
steep ness</w>
steato hepatitis
stear ic</w>
ste el</w>
stay ing</w>
statis tics.</w>
statis tically,</w>
stat ure,</w>
stat es:</w>
starv ation,</w>
starch ,</w>
star tle,</w>
staphylococci .</w>
standardi zed.</w>
stand- alone</w>
stand s</w>
stand point</w>
stand ing.</w>
stain s.</w>
stain s,</w>
stain ings</w>
stain ing)</w>
stabiliz ers,</w>
stabil izations</w>
stabil ised</w>
stabil is
sta phylococcus</w>
st- cell</w>
st uzumab</w>
st s'</w>
st rib
strib uted</w>
st r</w>
st on</w>
st ine</w>
st eth
steth oscop
st ented</w>
st ate)</w>
st ate
st an
st air
stair case</w>
st aged</w>
st ably</w>
st ab
spur t</w>
spread s</w>
sporad ically</w>
spondylo tic</w>
splen omegaly.</w>
splen ium</w>
splen ectomy.</w>
spir ulina</w>
spin es,</w>
sphingomyel in,</w>
sphincter otomy</w>
sphincter otomy.</w>
sphinc ter,</w>
spher ical</w>
spermid ine,</w>
sperm ine,</w>
sperm ine)</w>
speedball ing.</w>
spectro scopy.</w>
spectro metry,</w>
spectac le</w>
specific ation</w>
special ists</w>
special ists.</w>
spec kle</w>
spec ified,</w>
spe eded</w>
spas mo
sparte ine.</w>
spacef light</w>
spac ing</w>
sp ine.</w>
sp icy</w>
sp ects</w>
sour ce,</w>
sound- source</w>
sou th-west</w>
sorafenib .</w>
sor iasis</w>
sor hythmic</w>
son ic
sonic ated</w>
son .</w>
son ,</w>
somno graphic</w>
somnambul ism,</w>
some what
some time</w>
somatotop y</w>
somato stat
som eth
someth ing</w>
som atiz
somatiz ation,</w>
solvent s,</w>
solv able</w>
solution -treated</w>
solut es</w>
solitari us.</w>
sol es</w>
sol es.</w>
sol ecith
sodi um:</w>
soci ally</w>
soci al,</w>
soci ability</w>
so reness</w>
so gelser</w>
sne ezing,</w>
smok ing-
smok er,</w>
small er.</w>
sm R
slowe d.</w>
slowe d,</w>
slow- twitch</w>
slow ly,</w>
slow est</w>
slow .</w>
slic e.</w>
sleepl essness</w>
skin- structure</w>
skin- nerve</w>
skele tally</w>
sk ill</w>
siz ed,</w>
siz e;</w>
siz e-
sixty- six</w>
sixty- seven</w>
six- year</w>
sive/ defensive</w>
situ ational</w>
situ ated</w>
sit ting,</w>
sit osterol</w>
sit e)</w>
sist ers</w>
sis/ HCC</w>
sis tive</w>
sirolimus- tacrolimus</w>
sirolim us-associated</w>
sion --
sinus oid
sinu ses.</w>
sinu ses,</w>
single-bl inded,</w>
single- subject</w>
single- strand</w>
single- day</w>
single- bolus</w>
single -</w>
sing -
sine sis</w>
sin ensis,</w>
similar ;</w>
silver- stained</w>
sil ica</w>
sil encing</w>
significant ;</w>
significant :</w>
signific ative</w>
signal- to-
sign s;</w>
sign ify</w>
sign all
sign al,</w>
sigmoid oscopy</w>
sigmoid oscopy.</w>
sider oblasts</w>
sider oblast
sic .</w>
sib ly,</w>
sial omet
sialomet aplasia</w>
si ve"</w>
si um.</w>
si tis,</w>
si s.(ABSTRACT</w>
si rol
sirol mus</w>
si lo
si li
si ght</w>
si eh
si di
si al</w>
si a;</w>
si a-
si a)</w>
shut tle</w>
shun ts.</w>
shrun ken,</w>
shoul ders,</w>
shoul der,</w>
shoul d,</w>
shorten ed.</w>
short-ter m)</w>
short- li
shor ter,</w>
shock :</w>
shock -like</w>
shoc ks.</w>
shoc ks,</w>
shoc k-
shi k
shi el
shel ves</w>
sheath s.</w>
she ets</w>
she ds</w>
sham- oper
sham- betagal</w>
shad owing</w>
sh engmai-y
sh af
sexu ally-
sex ;</w>
severe );</w>
severe ),</w>
sever ities</w>
seventy- five</w>
seven- year-old</w>
seven- day</w>
set tle</w>
set )</w>
sesqu iterpen
sesquiterpen es</w>
ses sions;</w>
ses am
sesam ol</w>
ses ),</w>
servic es,</w>
servic e,</w>
serotonin 1A</w>
seroton in-induced</w>
seroconver sions</w>
sero- negative</w>
serious "</w>
ser um)</w>
ser um),</w>
ser oprevalence</w>
ser ine/
ser ine-
sequest r
sequenti ally,</w>
sequ ences.</w>
sequ ences,</w>
sequ ence
sequ el</w>
septo hippocampal</w>
sept al/
sepi apterin</w>
separ ation,</w>
separ atel
separ ate,</w>
sep sis;</w>
sensori um,</w>
sensitiz er,</w>
sensitiz ation).</w>
sensitive )</w>
sensi tis
sens ors</w>
sen sibility</w>
sen se,</w>
semi- quantitatively</w>
semi quantitatively</w>
semi purified</w>
sematili de,</w>
sem ia,</w>
self- sustaining</w>
self- ratings</w>
self- poisoning</w>
self -</w>
seleni um-replete</w>
selecti ve)</w>
seizures ),</w>
seizure- resistant</w>
seizure ;</w>
seiz uring</w>
seiz ured</w>
seiz e</w>
segreg ate</w>
segment al,</w>
seg mentation</w>
seg mentally</w>
seek ers.</w>
see ks</w>
sedi ment.</w>
sedi ment
sedent ary-
sedative/ hypnotic</w>
sed ations</w>
sed ation:</w>
sed ated.</w>
section ed,</w>
secretago gue</w>
secre tions.</w>
secre tion)</w>
second s)</w>
second ary,</w>
sec t</w>
sec ;</w>
sec 1/2</w>
sec /
sec -
seas on.</w>
se ts,</w>
se tiform
se ret
se p</w>
se lia</w>
se ed
se dat
se bum</w>
se am</w>
se a-
sea- level</w>
se -treated</w>
screen ings</w>
scre en.</w>
scotom as.</w>
scotom a,</w>
scores :</w>
score ),</w>
scopol amine:</w>
scop y,</w>
scolio sis.</w>
scleroder ma,</w>
sclero therapy.</w>
sclero sis-like</w>
scler osed</w>
scinti llation</w>
scientif ically</w>
scienti sts</w>
scho ols</w>
schizophren ics.</w>
schistosom iasis</w>
schistos ome</w>
sch wannoma</w>
scenario s</w>
scaveng es</w>
scat ter.</w>
scar ce,</w>
scar ce
scarce ly</w>
scan ner</w>
scal p.</w>
scal p,</w>
scal e-
scal a</w>
sca -1
sca-1 (pos
sca-1(pos )</w>
sc ri
sc /
sav ing.</w>
satur ating</w>
satur ate</w>
sativ um</w>
satis fying</w>
satellit e</w>
sarcom eric</w>
sarcom eres</w>
sarco idosis.</w>
sand w
sampl ing,</w>
salt- losing</w>
saliv ation.</w>
saline- infused</w>
saline +
salicylazosulf apyridine</w>
salbutam ol-induced</w>
sal t.</w>
sal t-</w>
sal sol
sal mon</w>
sal ine/
sal e</w>
sairei- to-treated</w>
sad ness,</w>
sacchar in-
sac lofen</w>
sac he
s/ s</w>
s/ mm3)</w>
s/ min/
s/ g</w>
s/ cm-
s/ THE</w>
s/ Q
s.c. -</w>
s.c m-
s- per
s-per ill
s-perill yl</w>
s- based</w>
s- associated</w>
s- Sto
s-Sto kes</w>
s, tot
s weet</w>
s ular</w>
s tick</w>
s po
s opharyngeal</w>
s oph
soph is
s ob
s mell
smell ing</w>
s lu
slu gg
slugg ish
s lit
s chol
schol astic</w>
s carr
scarr ing.</w>
s arrhythmia</w>
s age</w>
s add
s ICAM-1</w>
s EPSCs</w>
s EPO</w>
s E-
s 47</w>
s /</w>
s .,</w>
s ))</w>
s )
s ')</w>
s '
s %,</w>
s ".</w>
ry anod
rut in.</w>
rus /
rup tio</w>
run way</w>
rul e-
rug inea</w>
rudi mentary</w>
rub omycin</w>
rtL180 M/
rt M204
rs 727
rs727 0
rs 29
roxyl in</w>
row n-
rough s</w>
rota rod,</w>
rosi ri
rosiri us</w>
rosace a.</w>
rosace a-like</w>
ros covit
ros a</w>
ropi setron</w>
rophag ocytosis</w>
rop uncture</w>
room s</w>
ron ell
ron ate)</w>
ron al</w>
ron .</w>
ron -
ron- emission</w>
rom y
rom met
rom ine</w>
roll man</w>
rolipr am.</w>
rolim us)</w>
roentgen ographic</w>
rod mann</w>
rocur onium-induced</w>
rocur oni
robu st.</w>
ro unding</w>
ro str
ro r
ro l,</w>
ro g
ro di
ro bi
ro ,</w>
riz onal</w>
riz ine-induced</w>
rituximab ,</w>
risperid one;</w>
risperid one:</w>
risperid one-associated</w>
risk y</w>
ris h</w>
ris b
ring ton</w>
rin sing.</w>
rim ant
rim -induced</w>
rilmen idine,</w>
rig ors</w>
rig ors.</w>
rifampic in:</w>
rifampic in-
rifabut in-related</w>
rifabut in-associated</w>
ric t</w>
ric in
ric h,</w>
ric et
ricet ulus</w>
riboflav in</w>
ri x</w>
ri form</w>
ri dg
rhyth m;</w>
rhodamine 123</w>
rhizom es</w>
rhin orrhoea,</w>
rhe tic</w>
rh o</w>
rh am
rh achi
rhachi a</w>
rewar ming</w>
rewar ming,</w>
rewar ded</w>
revisit ed:</w>
reversib le
reverse- phase</w>
revers als</w>
revascular ization,</w>
retur ned,</w>
retro virus</w>
retro spect</w>
retrie ved.</w>
retin ol,</w>
retin oids.</w>
retin oid,</w>
retin ide</w>
retin amide</w>
retin a.</w>
retin a,</w>
reticulo cytosis</w>
reticulo cytosis.</w>
reticulo -
retar d,</w>
ret initis,</w>
resume d,</w>
resum ing</w>
resum e</w>
restric ted,</w>
restrain t.</w>
restra int
restra ined,</w>
restless ness
response --
respond ent</w>
respon ds,</w>
resp .</w>
resorufin-O-de ethyl
resorufin-O-deethyl ase</w>
resol ve;</w>
resist ances,</w>
resid u
resi dent
resi den
residen tial</w>
reservoir s</w>
reserpine- enhanced</w>
reser ves</w>
research es</w>
resear ched</w>
rescu e,</w>
res veratro
res thesias</w>
res orbed</w>
res in.</w>
res ections</w>
res ection,</w>
res ec
reproduc tive,</w>
repor ts/
replic ates</w>
replacem ent
replac ements</w>
reperto ire</w>
reperfu sion:</w>
repeated- measures</w>
repe ats</w>
repe ating</w>
repe at
renal/ adrenal</w>
ren tiapril</w>
ren in.</w>
remis sions,</w>
rema zocine</w>
rem ia/
relie f
reli eves</w>
reli es</w>
relev ance,</w>
relent less</w>
releas ed,</w>
releas e)</w>
releas able</w>
relationship :</w>
relap sing-
relap ses.</w>
rel ay</w>
rel atives</w>
rel ations.</w>
rel ations,</w>
rel ated;</w>
rel ,</w>
rejec tions,</w>
reinforce ment
reinforce d.</w>
rein stituted.</w>
rehabilit ation.</w>
regurgit ation:</w>
regurgit ation)</w>
regurgit ant</w>
regres sive</w>
regres sions.</w>
registr ations</w>
regist ries</w>
regimens ;</w>
regimen ;</w>
regimen -related</w>
regi me,</w>
regi me
regener ate</w>
regar d,</w>
reg ate</w>
refractor iness,</w>
reflex ia</w>
refl ect
reflect ance</w>
referen ced</w>
ref ugee</w>
ref illing</w>
ref action</w>
ref .</w>
reduct ase.</w>
reduced- intensity</w>
reduc tive</w>
reduc tions,</w>
reduc tion).</w>
reduc es,</w>
reduc ed;</w>
reduc e,</w>
red- stained</w>
recur s</w>
recur ,</w>
rect ally</w>
recre ation
recover y)</w>
recover able</w>
recorde d:</w>
recon stitution</w>
recomm enced</w>
reco ve
receptor/ G-protein</w>
receptor- knockout</w>
receptor- deficient</w>
receptor -induced</w>
receptor -associated</w>
recei ver</w>
rece ded</w>
recapit ulate</w>
recanal ization.</w>
rec utita</w>
rec ir
rec idi
recidi vism</w>
rec alle
reboxet ine,</w>
reasses sed.</w>
reas surance</w>
reas e</w>
real- life</w>
read mill</w>
read ers</w>
react ors</w>
reac tion-
re-in-an o</w>
re- evaluate</w>
re- challenged</w>
re- challenge</w>
re y</w>
re xi
re treatment</w>
re transplantation.</w>
re tig
re t</w>
re studied</w>
re sistive</w>
re set</w>
re r
rer gic</w>
re production</w>
re producing</w>
re pressor</w>
re pres
re plen
re pl
re ph
reph inephrine</w>
re paired</w>
re operation.</w>
re opening</w>
re mediation</w>
re jections</w>
re iter
re initiation</w>
re initiated.</w>
re infarction,</w>
re hydration</w>
re hydration,</w>
re hospitalized</w>
re hemorrhage,</w>
re generated</w>
re examination</w>
re dness,</w>
re distributed</w>
re conc
re challenging</w>
re appeared.</w>
re agent</w>
re affir
re ader</w>
re activity;</w>
re activity:</w>
re absorbable</w>
re a,</w>
re /
re ),</w>
raz ine</w>
ration ale,</w>
rati a</w>
rate -</w>
rat ing.</w>
rat es;</w>
rat es
rat a.</w>
rat /
rash es.</w>
rasagil ine.</w>
ras u
rare r</w>
raph e,</w>
rapamyc in)</w>
rap h</w>
ranol azine.</w>
random ized;</w>
random ized-
random isation.</w>
random ,</w>
ran k-
ran cid</w>
ram one</w>
ram ,</w>
raloxifene- associated</w>
radiotele metered</w>
radiolab el</w>
radioimmuno assay,</w>
radiograph s,</w>
radiograph ically</w>
radiograph ic,</w>
radiograph .</w>
radiograph ,</w>
radiocon trast-induced</w>
radio iodinated</w>
radio allerg
radioallerg os
radioallergos orbent</w>
radic al.</w>
radi ologically</w>
radi ologically,</w>
radi ography,</w>
raclopri de.</w>
race/ethnic ity</w>
rabep razol
rabb it
ra y,</w>
ra w</w>
ra sion</w>
ra refaction</w>
rIFN alpha2b</w>
rIFN alpha2
rCMR glc</w>
r- 34</w>
r yst
r ying</w>
r y-
r ush</w>
r n
r ino
r VIIa</w>
r -based</w>
quinpi role-induced</w>
quinoxalin-1- one</w>
quinoxal ines</w>
quinol ones.</w>
quinol one-induced</w>
quinol in
quinid ine-associated</w>
quin tile</w>
quin ox
quin ol</w>
quin april.</w>
questionnai res,</w>
question s:</w>
quer cit
quercit rin</w>
quasi- experimental</w>
quantit atively.</w>
quanti fi
qual ification</w>
quadripleg ia.</w>
quadr ant.</w>
quadr ant,</w>
quad azocine</w>
qu ine/
quine/ sparteine</w>
q 4
q 3
q .</w>
pyrrolidinyl)methyl]- 2-
pyrrolid ino
pyro phosphatase</w>
pyrimethamine- sulfadoxine</w>
pyrimeth amine.</w>
pyridox amine</w>
pyrido [2,1-
pyrido[2,1- b]
pyridazin one</w>
pyridazin on-
pyrid yl)
pyrid yl
pyre tic</w>
pyrazolo [1,5-
pyrazolo -
pyrazin obut
pyrazin amide,</w>
pyraz in-2-
pyrazin-2- yl]-1-isopropylpyridine-2(1H)-one</w>
pyr rol
pylo romy
pye lography,</w>
pye logram</w>
pust ulo
purpo ses,</w>
purpo se
puromyc in,</w>
pur ported</w>
pur ified,</w>
puppi es.</w>
pup il.</w>
pup il-sparing</w>
pump ;</w>
pum p)</w>
pulmonary- renal</w>
pul sus</w>
pul p,</w>
pud end
pudend al</w>
puber ty,</w>
pu ff
puff s</w>
pt az
pt ake</w>
pt ain
psychotri dine</w>
psychomot or-
psychomotor- stimulating</w>
psycho therapeutic</w>
psycho pathic</w>
psychiatri sts,</w>
psychiatr ically</w>
psychiatr ic,</w>
psychiat rist</w>
psych ophysical</w>
psych ophysi
psych ologic</w>
psor iasis:</w>
psi lateral</w>
psi ,</w>
pseudoc ocaine</w>
pseudo- Bartter</w>
pseudo ephedr
pseudo allergic</w>
pseudo agouti</w>
pseud olym
pseudolym ph
pseud ocystic</w>
pseud obul
pseudobul bar</w>
prox y</w>
provid ers.</w>
protrac ted.</w>
protr uding</w>
protoporphy rin</w>
proton- pump</w>
protocol- defined</w>
proto- oncogene</w>
proteinase- 3</w>
protein/ mg</w>
protein/ h</w>
protein- unbound</w>
protein- mediated</w>
protein- III</w>
protein- 2</w>
protein urea</w>
protein s)</w>
protein :
protein: creatinine</w>
protec tion"</w>
prote ome</w>
prote ic</w>
prot ,</w>
prosthe sis.</w>
prostan oids.</w>
prostagland in-mediated</w>
prosencephal on</w>
propyl}- pyrrolidin-2-one</w>
propyl )-2-
propri onic</w>
propoxy phene.</w>
proportion ality</w>
proportion al-
proportional- hazards</w>
propor tions.</w>
propor tion.</w>
propofol- remifentanil-based</w>
propofol ;</w>
propofol -evoked</w>
properti es;</w>
proparg yl-1-
propag ation,</w>
prop entof
prop an-2-
pron eth
pron e,</w>
pron ation-
pronation- supination</w>
promoter s,</w>
promot er.</w>
promo tional</w>
promin ent,</w>
promin ence</w>
prometh azine.</w>
prolin tane</w>
prolifer ators.</w>
prolifer ative,</w>
prolactin oma,</w>
prol yl</w>
prol ap
prolap se.</w>
prohib itive</w>
progres sion;</w>
programm es</w>
progest ogens</w>
progest ogen,</w>
progest ogen
progest ins.</w>
progest in,</w>
progest agen</w>
profoun d.</w>
profen -treated</w>
profen -induced</w>
produc tion;</w>
prochlorper azine-induced</w>
proced ure)</w>
proced ure
procarb azine</w>
proca ine-induced</w>
probuc ol-induced</w>
probuc ol)</w>
probenec id-treated</w>
prob es,</w>
proanthocyanid ins</w>
pro- oxidant</w>
pro- conflict</w>
pro- arrhythmia.</w>
pro triptyline</w>
pro survival</w>
pro ptosis,</w>
pro posing</w>
pro oxidant</w>
pro n</w>
pro ischemic</w>
pro hormone</w>
pro hemorrhagic</w>
pro drugs,</w>
pro convulsant,</w>
pro cer
procer a</w>
prior ity.</w>
prin ts</w>
primin g,</w>
primin g
prima quine.</w>
prim e</w>
previous ly).</w>
prevail ing</w>
prev ent,</w>
presynap tically</w>
presyn cop
presum e</w>
pressure- rate</w>
pressure /
pressure .(ABSTRACT</w>
pressure -dependent</w>
pressure ),</w>
pressu res;</w>
present ation;</w>
prescrip tion
prescrib ers</w>
prescri ption,</w>
preschool- sevoflurane</w>
pres ymptomatic</w>
pres ence,</w>
prepro tachykinin-A</w>
prepro somatostatin</w>
prepro TRH</w>
pren yl
prematur ity.</w>
prefer red.</w>
predomin ates</w>
predomin ated</w>
predict ors,</w>
predict able.</w>
predict able,</w>
precurs ors,</w>
precipit ations</w>
pre- specified</w>
pre- procedure</w>
pre- operatively</w>
pre- nephrotic</w>
pre- morbid</w>
pre- methotrexate</w>
pre- exposed</w>
pre- administration</w>
pre- ADR</w>
pre- ,</w>
pre weanling</w>
pre therapy,</w>
pre term,</w>
pre septal</w>
pre packed</w>
pre load.</w>
pre incubation</w>
pre frontal,</w>
pre formed</w>
pre discharge</w>
pre d
pre conditioned</w>
pre coc
pre clinically</w>
pre chronic</w>
pre caution</w>
pre cau
precau tions,</w>
pre bypass</w>
prazosin- controlled</w>
pran oprofen</w>
pran olol-induced</w>
pran ol</w>
pramipex ole.</w>
practition ers.</w>
practic es.</w>
practic es,</w>
practic al.</w>
practic able</w>
pract olol.</w>
pp m),</w>
pow der.</w>
pow der,</w>
pover ished</w>
poten cies,</w>
potassi um;</w>
potassi um-dependent</w>
pot ting</w>
pot ropic</w>
postpartum ,</w>
postisoproteren ol,</w>
postischem ia.</w>
postis ch
postisch aemic</w>
postero ventral</w>
poster o-lateral</w>
post-nat ally.</w>
post-LT .</w>
post- transplantation.</w>
post- transfusion</w>
post- therapy,</w>
post- suxamethonium</w>
post- stress</w>
post- natally</w>
post- methotrexate</w>
post- menopausal</w>
post- ischemia.</w>
post- ischemia,</w>
post- injection,</w>
post- ingestion.</w>
post- ictal</w>
post- hoc</w>
post- dose.</w>
post- chemotherapy</w>
post- challenge</w>
post- bilateral</w>
post- baseline</w>
post- admission</w>
post- SE)</w>
post- PCB</w>
post- MTX</w>
post- HDT</w>
post- ECT</w>
post- EA</w>
post- ADR</w>
post uring</w>
post ures,</w>
post ure,</w>
post translational</w>
post therapy</w>
post systolic</w>
post rest</w>
post rema
post rans
post randomization</w>
post necrotic</w>
post injection.</w>
post inhibitory</w>
post dose)</w>
post delivery</w>
post anaesthetic</w>
post al</w>
possibil ity,</w>
posit ron-emission</w>
posi tions,</w>
posi s,</w>
por to-systemic</w>
por tion.</w>
popul ation),</w>
popul ar,</w>
pon tis</w>
pon tis,</w>
polyur ia-
polyuria- polydipsia.</w>
polysomno graphy</w>
polyradicul oneuropathy</w>
polypo sis</w>
polypepti de
polyp s.</w>
polyp s,</w>
polyp eptides</w>
polymyosi tis/dermatomyositis</w>
polymorph ism.</w>
polymer ized</w>
poly- L-
poly vidone</w>
poly sulphated</w>
poly spike</w>
poly serositis</w>
poly phenolic</w>
poly neuropathy:</w>
poly m
poly galasap
poly dy
polydy p
poly arthritis</w>
poly arthralgia,</w>
pollak i
pol e.</w>
pol e-
poison ings</w>
poison ing:</w>
point s]),</w>
point s;</w>
point s)</w>
point s).</w>
poin te</w>
poikilo ther
poi esis</w>
podocyte -associated</w>
podocalyx in,</w>
podocaly xin</w>
pod ocyturia</w>
pod ocyte.</w>
po x</w>
po rous</w>
po ol,</w>
po ol
po dox
podox ime</w>
po do
po dium</w>
po 2</w>
po -
po- entorhinal</w>
pneumon iti
pneum ocystis</w>
pmol/ g</w>
pmol es</w>
plus- maze.</w>
plus- maze,</w>
plex uses</w>
plex us.</w>
pleuro pericarditis</w>
pleur itis</w>
pleur a,</w>
plethysmo graphy.</w>
plethysmo graphic</w>
plei otropic</w>
ple omorphic</w>
ple omorph
ple dg
ple d
pled get</w>
play er</w>
platinum- sensitive</w>
platinum- refractory</w>
platinum- free</w>
platin um-induced</w>
platform -
platelet- associated</w>
plat form.</w>
plas ties</w>
plas ticity,</w>
plas mas</w>
plas mal
plasmal em
plasmalem ma</w>
plaqu e.</w>
plant )</w>
planne d,</w>
plan e,</w>
placent ae.</w>
placebo /
placebo );</w>
plac em
pl ate.</w>
pl ans</w>
pl agu
piroxicam -treated</w>
piribe dil,</w>
piri form,</w>
pir arubicin,</w>
pir acetam
piperox an,</w>
piperid ino
piperazin yl</w>
piperaz ines</w>
piperacill in,</w>
piper ate</w>
pineal ectomy,</w>
pindo lol-induced</w>
pinacidi l,</w>
pin pricks</w>
pin prick,</w>
pin na</w>
pilocarp ine)</w>
pilo- GVG</w>
pilo erection,</w>
pigment osa</w>
piec e</w>
pict ures.</w>
picrotoxin- threshold</w>
picrotox in-treated</w>
picrotox in
picro toxicin-induced</w>
pic rosirius</w>
pi pe</w>
pi ents</w>
pi e
pie bal
piebal d</w>
pi dic</w>
phytom en
physostigm ine-
physi ology.</w>
physi ologically,</w>
phyl l
phy sis</w>
photo thrombotic</w>
photo beam</w>
phot otoxic</w>
phot ographic</w>
phot odi
phosphot yrosine-
phosphoryl ase</w>
phosphoramid on</w>
phosphor ic</w>
phospholip id,</w>
phosphofructo kinase</w>
phosphodiester ase-
phosphodiesterase- 5</w>
phosphatidyl inositol-
phosphatidylinositol- specific</w>
phosphatidyl choline,</w>
phosphat es.</w>
phosphat es,</w>
phosphat emia</w>
phosphat ases.</w>
phosphat ases,</w>
phosph omon
phosph ol
phosphol amb
phospholamb an</w>
phosph o</w>
phosph atid
phorbol -1
phon ocardi
phon ation.</w>
phil ia.</w>
pheochromocyt oma:</w>
phenyto in
phenylpropanol amine:</w>
phenylisopropyl adenosine</w>
phenylethyl amine</w>
phenylethanolamine- N-methyl</w>
phenylethanolamine- N-methyl
phenylephr ine-</w>
phenylbiguan ide</w>
phenylbiguan ide-induced</w>
phenyl- 3-
phenyl)-piperazin-1-yl]- propyl}-pyrrolidin-2-one</w>
phenyl)-2- amino
phenyl hydrazine</w>
phenyl di
phenyl benzo
phenyl -2
phenterm ine-
phenoxy )
phenothiaz ines.</w>
phenomen on)</w>
phenobarbit one.</w>
phenobarbit al-treated</w>
phendimetraz ine.</w>
phencycl idine-induced</w>
phencycl idine,</w>
phencycl id
phenacet in/
phenacetin/ aspirin</w>
phen otype
phen indione</w>
phased- array</w>
phase- I</w>
phas es:</w>
phas es)</w>
phas e),</w>
pharmacologic ally-induced</w>
pharmaco epidemiologic</w>
pharmaco dynamics.</w>
pharmac ists,</w>
phal ic</w>
phag ocytes</w>
phaclofen ,</w>
ph rag
ph o
ph lor
ph iltr
philtr um,</w>
ph en</w>
ph atic</w>
ph ,</w>
ph )</w>
pg/ ml),</w>
pg/ g</w>
perturb ed</w>
perturb ations.</w>
person ,</w>
persist ence,</w>
persever ative</w>
persever ation</w>
perphenaz ine-</w>
perpetr ation</w>
peroxy nitrite-
perox ide
perman ently,</w>
peritone al,</w>
periton sillar</w>
periton itis,</w>
perit ransplant</w>
peripher y,</w>
peripher ally.</w>
perioper atively.</w>
periodic ally.</w>
perio d:</w>
perio d/
period/ left</w>
perio d),</w>
perim en
perikary a</w>
pericon ception</w>
pericardi ocent
peric entral</w>
peric ellular</w>
peri- infarct</w>
peri venous</w>
peri or</w>
peri meter</w>
peri arterial</w>
perfusion- cultured</w>
perfus ate.</w>
perf used.</w>
perf used,</w>
perf ect</w>
percenti le)</w>
per- visit</w>
per- protocol</w>
per version</w>
per su
per one
perone al,</w>
per ineph
perineph ric</w>
per hex
perhex il
per ceptible</w>
per .</w>
peptidom imetic</w>
peptide -1</w>
peptide (1-
pep pers,</w>
pentylenetetrazole- kindled</w>
pentylenetetrazol- kindled</w>
pentylene trazol</w>
pentoxif ylline,</w>
pentoth al</w>
pentobarbital- anesthetized,</w>
pentobarbital- anaesthetized</w>
pentobarbit one.</w>
pentobarbit one-induced</w>
pentobarbit one-
pente trazol-induced</w>
pentano yl</w>
pentagastr in,</w>
penta acetic</w>
pent acyclic</w>
pent achloro
penicill inase-
penicill in-resistant</w>
penetr ation.</w>
penetr ated</w>
pene tran
pend ular</w>
penc il</w>
penc il-
pencil- point</w>
pen um
pen is.</w>
pemiro last</w>
pelle ts,</w>
pelle t.</w>
pegylated- interferon</w>
pedicel s</w>
pedic le</w>
pediatric s.</w>
peculi arities</w>
pector is:</w>
peak /
pe floxacin.</w>
pe bral</w>
pct x-then-cisDD
paw- lick
paw-lick /
pattern ).</w>
patter ning</w>
patter ned</w>
patient- years.</w>
patient s],</w>
patient s.(ABSTRACT</w>
patient );</w>
pathway s)</w>
pathophysi ologically</w>
patholog ist</w>
pathogene ses</w>
path y?</w>
path omorphological</w>
path ologically.</w>
patch- clamping</w>
partum .</w>
participat e.</w>
partici pation.</w>
parti tioning</w>
parti alis</w>
part s,</w>
part ment</w>
paroxet ine-controlled</w>
parkinsoni ans.</w>
parkinson ism:</w>
pariet al-
paren ts.</w>
parasympath olytic</w>
parasit es,</w>
parasit emia</w>
paras omni
parasomni as,</w>
paras ites</w>
paraphil ia</w>
parap legic</w>
parameter s;</w>
paraly sis:</w>
parallel- design</w>
paraffin- embedded</w>
paraf oveal</w>
paraf orm
paraesthesi ae</w>
paraesthe sia.</w>
para- aminohipp
par ting</w>
par ity</w>
par aver
par ath
parath or
parathor mon
par alimbic</w>
paqu e-
papillo pathy</w>
paper s.</w>
pap io
pantoprazol e,</w>
pannicul itis</w>
panic king</w>
pancur onium-
pancur onium)</w>
pancreas -
pancreas- kidney</w>
panames ine,</w>
pan lobular</w>
pan ic-
panic- inducing</w>
pan hypopituitar
pan el,</w>
pan cytopenic</w>
pamidron ate-associated</w>
palmito yl
palm -like</w>
pallid um,</w>
pair s,</w>
pair -matched</w>
pair )</w>
paeoniflor in</w>
paedi atrici
paclitaxel -containing</w>
paclitaxel )</w>
pac hy
pachy meningitis</w>
pa ying</w>
pa vine</w>
pa uses,</w>
pa emic</w>
p=0.00 6,</w>
p=0.00 5).</w>
p= 0.7
p= 0.001)</w>
p< 0.0001),</w>
p75NT R</w>
p. p.
p-benzo quinoneimine</w>
p-aminohipp urate</w>
p- nitro
p- EGFP</w>
p- ANCA</w>
p- 3</w>
p,p'- DDT</w>
p us</w>
p under
p tion/
p ont
p ond
p om
p iz
piz otifen</w>
p io
p ins</w>
p g)</w>
p elic
pelic ans</w>
p ear
p d</w>
p ating</w>
p anto
p an</w>
p NR1</w>
p Ki</w>
p H-
p CR</w>
p CO2</w>
p A2</w>
p A(2)</w>
p 75</w>
p 53-
p 450</w>
p 38+</w>
p 19
p19 q</w>
oyl- dopamine</w>
oxytoc in.</w>
oxytoc in-
oxytoc ic</w>
oxyphen butaz
oxypert ine.</w>
oxyp urines,</w>
oxyl ic</w>
oxygen )</w>
oxy n
oxyn ol-
oxy me
oxy hemoglobin,</w>
oxy flurane</w>
oxy demeton-
oxydemeton- methyl</w>
oxy )
oxo plasma</w>
oxit ropium</w>
oxidoreduct ase</w>
oxide- releasing</w>
oxide- blocked</w>
oxidase- deficient</w>
oxic ,</w>
oxib -induced</w>
oxi metry.</w>
oxi me
oxazol idinedione</w>
oxaz olo[3,2-a]
oxaproz in-induced</w>
oxamniqu ine.</w>
oxal dine</w>
oxal ate-
oxal acetic</w>
oxadi azol
ox prenolol.</w>
ox prenolol,</w>
ox ide)</w>
ox azepam,</w>
ox acin,</w>
ox abenz
ox .</w>
ox )</w>
ow ner</w>
ow n,</w>
oves tibular</w>
overshoot .</w>
overlap .</w>
over- activation</w>
over zealous</w>
over weight,</w>
over used</w>
over ri
over medication</w>
over ly</w>
over loading</w>
over flow.</w>
over dosing</w>
over dose)</w>
over dosage,</w>
over coming</w>
over all
overall ),</w>
over activity,</w>
ovari ectomized,</w>
ov um</w>
outcom e:</w>
outcom e).</w>
out standing</w>
out patients,</w>
out l
outl ined.</w>
out break
ouma rol</w>
ouabain- infused</w>
ouabain- displacing</w>
ouabain -like</w>
ou ve
ou mad
ou los</w>
ou l</w>
ou ber
ouber t</w>
otum ori
otrop is</w>
ototoxic ,</w>
otop oulos</w>
otom ous</w>
otom ies,</w>
otolaryng ology</w>
oto protective</w>
oti lit
otilit y,</w>
other ).</w>
other 's</w>
ot ria</w>
ot a
ostri ec
ostri atal</w>
osteosarcom a:</w>
osteoporo tic</w>
osteop ontin</w>
osteo arthritis,</w>
ost oma</w>
ost en
osper mia</w>
osmo tically</w>
osin or</w>
osi tis</w>
osi s;</w>
oscill ations,</w>
osalic ylates</w>
os us</w>
os odium</w>
os mium</w>
os mia</w>
os ity.</w>
os ine-induced</w>
os ant</w>
ory- Den
ory-Den k</w>
orubic in)</w>
orthop edic,</w>
ortho dromic</w>
orth ostasis</w>
orth obenzo
orth o-
orrh age</w>
orphan ol.</w>
oro- pharyngeal</w>
oro pharynx,</w>
orm ous</w>
orm al</w>
orm ad
oric e,</w>
ori pavine</w>
organell es,</w>
organ otypic</w>
organ o
organ izing</w>
organ ization.</w>
organ ization,</w>
organ ism.</w>
ore xin</w>
ore x.</w>
ore x,</w>
ore m
orch io
orchio ides</w>
or s:</w>
or n</w>
or me
or list
orlist at</w>
or dering</w>
or ange</w>
or al.</w>
or adic
or ).</w>
opyr rolid
optim al.</w>
oporphy rin</w>
opolysacchar ide</w>
opoi et
opisthoton us</w>
opioid- na</w>
opioid s:</w>
opini role</w>
opi riform</w>
opi perid
opi ate-dependent</w>
ophthalmop legia,</w>
ophthalmolog ist</w>
ophthalm oscopic</w>
ophil ized</w>
oph y
opex in</w>
oper ational</w>
oper able,</w>
open- ended</w>
open ly</w>
open er,</w>
open ed,</w>
opath y:</w>
opac ity</w>
opa usal</w>
op pon
op le's</w>
op kins</w>
op ip
op epti
op apillary</w>
onychomy cosis.</w>
onucle ase-
onit ri
ong -
oneph ritis</w>
one/ joint</w>
one- kidney</w>
one- fourth</w>
one- day</w>
one- containing</w>
one- compartment</w>
oncostatin- M</w>
oncolog y.</w>
once )</w>
onat remia</w>
on- off'</w>
on- drug</w>
on ward</w>
on nai
on ly-
only- treated</w>
on ing</w>
on in.</w>
on es)</w>
on chocer
onchocer c
on c
on azol
on acc
onacc i</w>
on ab
on -</w>
omycin/ vinblastine</w>
omycin- detectable</w>
omy oclonic</w>
omo tion</w>
omo ses</w>
omit ted.</w>
ometh yl</w>
ometh oxy-
omega- con
omega-con otoxin</w>
ome ter.</w>
ome )</w>
omat oid</w>
oma- bearing</w>
om y,</w>
om epirac</w>
om e,</w>
om as:</w>
om a;</w>
oly sis)</w>
ology- Head</w>
ologist ,</w>
ologic al.</w>
olog y/
olo g</w>
olo cal
olocal ization</w>
olipo protein</w>
oligodendro gliomas</w>
oligodendro glial</w>
oligo- anuric</w>
oligo anuric</w>
ole- coated</w>
ole oyl-dopamine</w>
ole amide,</w>
older -onset</w>
olanzap ine:</w>
olanzap ine/
ol uminal</w>
ol ta
ol mes
olmes art
ol li
ol enic</w>
ol e:</w>
ol ate,</w>
ol amine-</w>
ol amide</w>
ol .,</w>
ol -related</w>
ol "</w>
oil s,</w>
oid omy
ograph s</w>
ogen icity,</w>
ogen ic,</w>
offic ial</w>
off- therapy</w>
off ici
offici als</w>
off )</w>
of uro[2,3-e]pyrido[1,2-a][1,3]diazepin-12-ium</w>
of loxac
oest rus.</w>
odi xanol</w>
odi phenyl
odi gestive</w>
odi encephalic</w>
od rine,</w>
od d
od ar
od )</w>
ocytopen ia.</w>
ocyt es/
ocy tin</w>
ocy stine</w>
octreoti de-induced</w>
octahydro -5-
ocr yptin</w>
ocon ut</w>
oco elo
ocoelo mic</w>
ocicep tin</w>
oci verine</w>
och ronal</w>
oce phalic</w>
oce le,</w>
occur ring.</w>
occul t-positive</w>
occlu sion-induced</w>
occl uding</w>
occa sion.</w>
occ i</w>
ocarcin omas</w>
ocap illary</w>
ocalci uria</w>
ocal cemia</w>
oc urine</w>
oc tion</w>
oc occi
oc ia</w>
oc ho
ocho duodenal</w>
oc erebral</w>
oc el
obtun ded.</w>
obtun ded,</w>
obt und</w>
obstruc ting</w>
observer -bl
obliter ation.</w>
oblig atory</w>
oblast osis.</w>
object- recognition</w>
obic yclo[3.
obe se.</w>
ob tur
ob ronch
ob asal</w>
ob act
o-t subo-like</w>
o- vascular</w>
o- physiologic</w>
o- associated</w>
o- Nov
o-Nov um</w>
o- Dur
o val</w>
o sides,</w>
o olong</w>
o ils</w>
o ileal</w>
o il)</w>
o gram.</w>
o gram,</w>
o gest
o estrogen-induced</w>
o estrogen
o es</w>
o dul
o do
o ate</w>
o /
o -1
o )
nurser y</w>
nur se.</w>
number-needed-to- treat</w>
number-needed-to- harm</w>
nul lif
nullif ied</w>
nucleo side-induced</w>
nucle us)</w>
nucle osomal</w>
nucle olus</w>
nucle ated</w>
nucle ar-
now ad
nowad ays</w>
nov ar</w>
notochor d
notice d,</w>
noti fied</w>
not ed;</w>
not e,</w>
not ;</w>
not -
nose- throat</w>
norveg ic
nortriptyl ine-treated</w>
normoten sive.</w>
normoten si
normocalce mic</w>
normo vol
normo kal
normo glycemic</w>
normal- salt</w>
normal iz
normal ises</w>
norm s.</w>
norm ochromic</w>
norm ally,</w>
norepinephrine- selective</w>
nor pethidine.</w>
nor mon
normon at
normonat remic</w>
nor apomorphine</w>
none theless</w>
non- users.</w>
non- users,</w>
non- sustained,</w>
non- surviving</w>
non- substance</w>
non- smoking</w>
non- severe</w>
non- seizure</w>
non- responding</w>
non- responders.</w>
non- responder</w>
non- resectable</w>
non- psychiatric</w>
non- pretreated</w>
non- parkinsonian</w>
non- nociceptive</w>
non- nephrotic</w>
non- malignant</w>
non- lymphocytic</w>
non- lithium-treated</w>
non- linear</w>
non- kindled</w>
non- innervated</w>
non- injecting</w>
non- immune</w>
non- hypertensive</w>
non- hereditary</w>
non- genotoxic</w>
non- ergot-derived</w>
non- dose-related</w>
non- diagnostic</w>
non- cardioembolic</w>
non- abusers</w>
non- ST</w>
non- ST-segment</w>
non- NSAID</w>
non- AT</w>
non- APAP</w>
non- A,</w>
non white</w>
non verbal</w>
non use</w>
non treatment</w>
non synonymous</w>
non serious</w>
non selective,</w>
non renal</w>
non reabsorbable</w>
non randomly</w>
non psychotic</w>
non prophylactic</w>
non preferring</w>
non platinum-based</w>
non oxynol-
non obstructive</w>
non nucleoside</w>
non naproxen</w>
non lesioned</w>
non injurious</w>
non infectious</w>
non inbred</w>
non immobil
non hypotensive</w>
non hypertensive</w>
non hepatic</w>
non functional</w>
non fatal.</w>
non e.</w>
non contrast</w>
non compliance.</w>
non comparative</w>
non clipped</w>
non cholinergic</w>
non caseating</w>
non cardioselective</w>
non blind</w>
non azotemic</w>
non anemic</w>
non ambulatory</w>
non addictive</w>
nom inal</w>
noi se,</w>
noc tur
no sid
no rephinephrine</w>
no do
nodo ventricular</w>
no de
no ,</w>
nmol/ kg)</w>
nmol/ kg),</w>
nmol/ L)</w>
nmol e/
nmol .</w>
nitroso- vasodilators</w>
nitros amino)
nitroprusside :</w>
nitroprusside ).</w>
nitroglycer in;</w>
nitrofur an</w>
nitro- arginine</w>
nitro phenyl</w>
nitro flurbiprofen</w>
nitrazep am.</w>
nitrazep am,</w>
nit rergic</w>
nit rate-induced</w>
nisoldip ine;</w>
nis can</w>
nipec otic</w>
ninety- three</w>
ninety- nine</w>
nine- year-old</w>
nimesulide-beta-cyclodextr in,</w>
nigro -
nifedip ine/
nifedipine/ beta-blocker</w>
nid us</w>
nicotin amide.</w>
nicot ine-related</w>
nicoran dil.</w>
nic ergoline.</w>
nic arb
ni dipine</w>
ni acin-induced</w>
ni acin,</w>
ng/d l</w>
ng/d l.</w>
ng/ side)</w>
ng/ mouse,</w>
ng/ l</w>
ng. ml-1</w>
ng. kg-1.
newbor n
nevirap ine,</w>
neutrophil s/mm3)</w>
neutropen ic.</w>
neutropen ia;</w>
neutropen ia)</w>
neutr al
neut ro
neurotoxic ity)</w>
neuroten sin,</w>
neuropo re,</w>
neuropath y?</w>
neuropath y),</w>
neuron s).</w>
neuron es.</w>
neuroleptic -</w>
neurohypophy seal</w>
neuro- ophthalmology</w>
neuro- ophthalmic</w>
neuro toxicities</w>
neuro stimulation.</w>
neuro retinitis</w>
neuro protective,</w>
neuro protection,</w>
neuro physiology</w>
neuro peptides,</w>
neuro myopathy.</w>
neuro modulatory</w>
neuro modulators</w>
neuro lysis</w>
neuro kinin-1</w>
neuro imaging.</w>
neuro hypophysial</w>
neuro hormon
neuro filaments</w>
neuro filam
neuro fibrillary</w>
neuro epithelium.</w>
neuro development</w>
neuro cortical</w>
neuralg ia,</w>
neur al,</w>
nervos a.</w>
nerv ous,</w>
ner ve)</w>
nephrotoxic ity;</w>
nephrolith otomy</w>
nephro toxins</w>
nephro tics</w>
nephro sclerosis.</w>
nephro pathies</w>
nephro logical</w>
nephro gram</w>
nephro angiography.</w>
nephri tis:</w>
neph roure
neovascular ization</w>
neoplasi as</w>
neoplasi as.</w>
neo form
neo adjuv
nelfin avir.</w>
nel len</w>
negl ected.</w>
negl ect</w>
negati ve;</w>
negati ve/
neg ligible,</w>
neg ated</w>
nefir acetam,</w>
nefazod one-treated</w>
nefazod one,</w>
needl estic
needlestic k</w>
need les,</w>
nedocrom il.</w>
necros ectomy</w>
necro tic.</w>
necro sis),</w>
necro -
necess ary
near- syncope.</w>
near- maximal</w>
near by</w>
ne ys</w>
ne ver-
ne pic
ne op
ne me
neme str
ne mat
ne biv
ne ap
nausea/ vomiting.</w>
nause ated</w>
natur ally-
naturally- occurring</w>
nation wide,</w>
nas ally</w>
narco tics,</w>
narco tic-
naphthal en-2-
naphthal en
nam ing</w>
nam ese</w>
naltrexone- precipitated</w>
naloxone- sensitive.</w>
nalox onium</w>
nalbuph ine,</w>
nal tr
nal )</w>
nai ;
nai; ve</w>
nafcill in-induced</w>
nafcill in-associated</w>
nafcill in,</w>
nabil one</w>
nM/ 0.5</w>
n= 5),</w>
n= 15)</w>
n-hex ane</w>
n- superoxide</w>
n- methyl
n- butyl-
n- butyl
n y</w>
n us
n orgest
n org
n m.</w>
n m),</w>
n l</w>
n ith
nith ine</w>
n ine.</w>
n i</w>
n d</w>
n able</w>
n SM
n NOS,</w>
myotub es,</w>
myoton ia.</w>
myosi tis:</w>
myop ia,</w>
myoglob in,</w>
myofibri ls</w>
myocardi um;</w>
myocardi um:</w>
myocardi al-
myocardial- infarcted</w>
myocardi a.</w>
myo relaxant</w>
myo pathology</w>
myo fibers.</w>
myeloperoxidase- antineutrophil</w>
myelogram .</w>
myelo- optico-
myelin ation.</w>
myel oradic
myel in.</w>
mye lography,</w>
mye logram</w>
myco tic</w>
myc in</w>
my oneuropathy.</w>
my omas</w>
my ographic</w>
my oblast</w>
my c</w>
mut ed</w>
muscul ature</w>
muscle -specific</w>
muscle -related</w>
mus h
mus culo
murmur s</w>
mur m
murm ur</w>
mur aglitaz
mumol/ mouse)</w>
mumol/ l.</w>
mumol/ l,</w>
mumol/ kg).</w>
mumol/ g</w>
mumol ),</w>
mum ol,</w>
multis ite,</w>
multifor me,</w>
multi tude</w>
multi systemic</w>
multi spike</w>
multi plying</w>
multi focal,</w>
multi drug-
multi discipl
multi day</w>
multi channel</w>
mul tim
mul ti</w>
mug/ ml,</w>
mug/ min)</w>
mug/ kg/min)</w>
mug/ kg,</w>
mug/ g</w>
mu sic.</w>
mu /kg)</w>
mu -</w>
mt BER</w>
msec ;</w>
moxisyly te</w>
moxi role</w>
mouthrin ses</w>
moun ting</w>
moun tain</w>
mou se-
motiv ational,</w>
motiv ating</w>
mother -to-
mot orized</w>
mot or)</w>
mosmol/ kg
mortal ity:</w>
mortal ity
morphometr ical</w>
morpholin o-
morphol ino</w>
morphine- sensitized</w>
morphine- neostigmine</w>
morphine- chloralose</w>
morphin an</w>
morph ine/
morph ine-</w>
morph ic
moric izine.</w>
mor ib
morib und</w>
mood- stabilizing</w>
monoter pene</w>
monom ers</w>
monolay ers</w>
mono- ADP-ribosylation</w>
mono therapy-induced</w>
mono oxygenase</w>
mono hydrated</w>
mono amines,</w>
mono -</w>
monni era,</w>
monke y,</w>
monitor ing)</w>
monitor ,</w>
mon ofilam
mon ocyto
mon ocytes/
mon oblastic</w>
mon ,</w>
molsidom ine</w>
molec ular,</w>
mol/ L.</w>
mol/ L,</w>
mol/ L)</w>
mol/ L),</w>
mol et
mol .</w>
modul es</w>
modul ators.</w>
modul ation,</w>
modific ation,</w>
model s;</w>
mode )</w>
moclobem ide.</w>
mo pathy,</w>
mo ).</w>
mmug. /ml.</w>
mmol/L ];</w>
mmol/ kg/
mmol/ kg.</w>
mmol/ day</w>
mmol/ L),</w>
mmHg ]</w>
mm 2,</w>
mm (3),</w>
mm (2)</w>
ml/ minute,</w>
ml/ h).</w>
ml/ 10</w>
ml.min-1. 100</w>
ml U/ml,</w>
ml (-1).</w>
ml (-1))</w>
mitr al,</w>
mitoxantr one-induced</w>
mitomycin- c</w>
mitomycin- C.</w>
mitochondri a-
miti gates</w>
mit rine</w>
mit osis</w>
mit ogens</w>
mit ogenesis</w>
mis sing.</w>
mis adv
misadv ent
mio tic</w>
mio sis;</w>
mio -
mio- Aque
mio-Aque ous)</w>
minut e).</w>
minim um-
minim ising</w>
mini- pumps</w>
mini- dose"</w>
mini -dose</w>
mineralocortico ids.</w>
miner als,</w>
min/ m2,</w>
min/ g</w>
min(-1 );</w>
min ido
min ating</w>
milrin one-associated</w>
millisecond s;</w>
millilit er.</w>
mill ary</w>
mil k
mil der.</w>
migra ines,</w>
migra ine
midagli zole</w>
mid- papillary</w>
mid pontine</w>
mid brain.</w>
mid -to-
mid-to- apical</w>
mid ,</w>
micturi tion;</w>
microtubule- stabilizing</w>
microscop y)</w>
microscop e,</w>
micron s.</w>
micron s,</w>
micron g)</w>
micromol/ l),</w>
micromol/ kg),</w>
micromol/ L
microm )</w>
microliters/ min/100</w>
micrograms/kg/ min),</w>
micrograms/kg/ hr</w>
micrograms/kg/ day,</w>
micrograms/kg/ day)</w>
micrograms/ rat).</w>
micrograms/ min,</w>
micrograms/ min)</w>
micrograms/ kg
micrograms/ h</w>
micrograms/ day.</w>
micrograms/ day,</w>
micrograms/ day)</w>
micrograms/ day),</w>
micrograms/ L</w>
micrograms/ 50</w>
micrograms/ 100</w>
micrograms.kg-1. min-1,</w>
micrograms.kg-1. min-1),</w>
micrograms. ml-1</w>
micrograms. kg
micrograms.kg -1/
micrograms.kg-1/ day,</w>
microgram/ liter)</w>
microgram. /ml.</w>
microgram ,</w>
microgram ).</w>
microgram ),</w>
microglobul inuria,</w>
microglobul in,</w>
microglobul in)</w>
microglia- conditioned</w>
microgli a.</w>
microg/paw )</w>
microg/m L).</w>
microg/kg/ hour.</w>
microg/ week</w>
microg/ paw,</w>
microg/ ml);</w>
microg/ min</w>
microg/ kg
microg/ d
microg/ 24</w>
microg /</w>
microfilare mia</w>
microfil ariae</w>
microcephal ic</w>
microbub ble</w>
micro villous</w>
micro tubules,</w>
micro transplanted</w>
micro stom
micro particles</w>
micro organisms</w>
micro micron
micro filaments</w>
micro environment</w>
micro encapsulated</w>
micro dialysis,</w>
micro cytic</w>
micro cysts</w>
micro bi
micro arra
micro M
microM )-
micro Ci</w>
micro -</w>
micafun gin</w>
mianser ine</w>
mi le
mi anserin.</w>
mg/ml/ hr</w>
mg/m2/ wk.</w>
mg/m2/ week,</w>
mg/m2/ week)</w>
mg/m2/ d,</w>
mg/m(2)/ day.</w>
mg/m l),</w>
mg/m /
mg/kg/ min.</w>
mg/kg/ injection</w>
mg/kg/ i.p.,</w>
mg/kg/ i.p.)</w>
mg/kg/ hr)</w>
mg/kg/ h,</w>
mg/kg/ day
mg/kg/ 4</w>
mg/kg ]</w>
mg/kg :</w>
mg/kg /</w>
mg/kg ):</w>
mg/d ),</w>
mg/K g,</w>
mg/(kg. d).</w>
mg/ rat</w>
mg/ min,</w>
mg/ min),</w>
mg/ mg</w>
mg/ infusion)</w>
mg/ hour.</w>
mg/ h/rat</w>
mg/ eye
mg/ day
mg/ M2</w>
mg/ 24
mg/ 150</w>
mg.kg-1. min-1)</w>
mg./kg .;</w>
mg. l-1</w>
mg. kg</w>
mg. kg-1),</w>
mg. kg(-1).</w>
mg. ).</w>
mg s%,</w>
mg %,</w>
metyrap one</w>
metrizo ate,</w>
metra zole-induced</w>
methylprednisol one-induced</w>
methylenedioxy methamphet
methylene tetrahydrofolate</w>
methyl-6- oxo-
methyl-5- phosphono-3-
methyl sulphon
methyl nitrosourea</w>
methyl nitrosamino)
methyl histamine,</w>
methyl ergonov
methyl ergometrine</w>
methyl ergometr
methyl ]
methyl -1-phenyl-
methoxy-4-iodo phenyl)-2-amino
methoxy naphthalen-2-
methoxy ch
methoxych lor</w>
methoxy ]
methotrex ate:</w>
methotrex ate-related</w>
methodolog ies</w>
methodolog ically</w>
methodo logic</w>
method s:</w>
methiodi de-induced</w>
methemoglob inemia.</w>
methan esulfonate</w>
methamphetamine- exposed</w>
methaemo globin</w>
methad one:</w>
metergol ine,</w>
metaproteren ol,</w>
metam orph
metabolit e)</w>
metabolit e
metab onom
metab olomic</w>
meta- iodobenzyl
met/ dex
met- enkephalin</w>
met ocurine</w>
met ine</w>
met in-induced</w>
met aplastic</w>
met a</w>
mesotheli oma,</w>
meso dermal</w>
meso accumbens</w>
mesi late,</w>
mesench yme
mesangi olysis.</w>
mesangi ocapillary</w>
mes ostriatal</w>
mes op
mes odiencephalic</w>
mes ine</w>
mes encephalon,</w>
meropen em,</w>
mercaptop urine.</w>
mequit azine</w>
meq/ lt,</w>
meq/ kg,</w>
meq/ day</w>
mepivaca ine-treated</w>
mephed ron
meperid ine-related</w>
meperid ine)</w>
meperid ine's</w>
ment )</w>
menstru ating</w>
menopa use</w>
menopa use.</w>
menopa use,</w>
meningo encephalitis.</w>
meningiti s-like</w>
membrane- permeable</w>
membran es;</w>
mem antine
melphalan- platinum</w>
meloxic am,</w>
mellit us;</w>
melatonin- injected</w>
melanchol ia,</w>
melan oma:</w>
melan ocor
mel perone</w>
mel a
mela en
meg estrol</w>
mefloqu ine:</w>
medulloblast oma.</w>
medull a),</w>
medroxy- acetate</w>
medoxom il-induced</w>
medium -dose</w>
medic ines.</w>
medic ine-
medic ation;</w>
medic ation)</w>
medi ator,</w>
medi ated)</w>
medi al,</w>
mecli zine</w>
mechano- responsive</w>
mechano receptive</w>
mechano -</w>
mechan omyo
mecamyl amine.</w>
mec lofen
measurement s)</w>
measure ),</w>
me therg
me test
me tach
me q</w>
me phenteramine</w>
me lit
melit tin</w>
me ga
me anti
meanti me,</w>
me an-
me al.</w>
me al,</w>
me al
mdr 1
mc g,</w>
may onnai
maxim um)</w>
maxim ized</w>
maxim al,</w>
maxim a</w>
max ;</w>
max ).</w>
matur ity.</w>
matrix- assisted</w>
matic s</w>
mathem atical</w>
mater nal-fetal</w>
mater nal,</w>
match -to-
mat uring</w>
mat es</w>
mat er</w>
mast at</w>
mass age.</w>
mas ses,</w>
marrow -derived</w>
market ing.</w>
market ing,</w>
mark et,</w>
mark er.</w>
mark er)</w>
marg in,</w>
mar a</w>
maprotil ine,</w>
mapp ing,</w>
manufact uring</w>
manufact ures</w>
manipul ative</w>
manipul ation,</w>
manipul ating</w>
manifest .</w>
mang ane
mangane se,</w>
maneu vers,</w>
mandat ory,</w>
manage able,</w>
man uscript</w>
man si</w>
man nose</w>
man date</w>
malondi aldehy
malign ant,</w>
malform ations:</w>
male :
male: female</w>
malar ia-
mal onate</w>
mal es),</w>
mal distribution</w>
mal ate,</w>
mal absorption.</w>
mal -
maj or,</w>
magnoc ellular</w>
magne to
macroscop ic,</w>
macroli de-
macrolide- resistant</w>
macroglobul inemia.</w>
macro structural</w>
macro prolactinoma.</w>
mach ines.</w>
ma st-cell</w>
ma ine</w>
mM/ L)</w>
mL/ minute</w>
mL/ min)</w>
mL/ h</w>
mL/ g/min</w>
mL/ d</w>
mL. min-1.
mL (-1),</w>
mGluR 1-
mGluR 1,</w>
mGlu 2/3</w>
mGlu 1a</w>
mEq/ kg/day</w>
mEq/ kg/
mEq/ kg,</w>
mEq/ d</w>
mEq. L-1</w>
m/ mg</w>
m/ day</w>
m. w.
m- CP
m- 2.</w>
m ul</w>
m t</w>
m nesic</w>
m itis.</w>
m itis,</w>
m i</w>
m es</w>
m echloreth
m d
m arc
m V,</w>
m V)</w>
m V).</w>
m U</w>
m RCC</w>
m N</w>
m L-1</w>
m CD</w>
m CAT</w>
m A,</w>
m A)</w>
m -induced</w>
m --a</w>
lysophosphatidyl choline</w>
lysine- vasopressin</w>
lymphoplasmacy tic</w>
lymphom a;</w>
lymph- node</w>
lymph oma:</w>
lymph ocytosis,</w>
lymph ocytopenia</w>
lymph ocele</w>
ly- tail</w>
ly ophilized</w>
lun ted</w>
lumirac oxib</w>
lum ens</w>
lum en,</w>
luc ifer
lozeng e.</w>
lox apine,</w>
low- signal</w>
low- normal</w>
low- intensity</w>
low- fat</w>
low- doses</w>
low- back</w>
low- K(+)-induced</w>
low :</w>
los s/
los s),</w>
lorat adine,</w>
loracarbef ,</w>
lor id
lopin avir</w>
loop s,</w>
loop .</w>
loo ks</w>
loo k-
look- ali
look-ali ke
look-alike "</w>
longitud inally</w>
long- observation</w>
long- latency</w>
long- lasting.</w>
long ,</w>
lon gl
longl ast
longlast ing</w>
lon a,</w>
lograf t</w>
logar ith
log rank</w>
lofex idine.</w>
lofex idine,</w>
loci .</w>
local ized,</w>
local isation</w>
lob ectomy</w>
load ing)</w>
lo vastatin.</w>
lo tion</w>
lo tion.</w>
lo peramide</w>
lo l-
lo l)</w>
lo del</w>
lm Categor
lmCategor y="
lixim ab
liver s,</w>
liver /
littermat es,</w>
litter s,</w>
litres /
litre -1)</w>
lithium- pilocarpine.</w>
lithium :</w>
lithium -related</w>
lith rix</w>
liter ;</w>
lit ter,</w>
lit res</w>
list ening</w>
list ed,</w>
lipopolysacchar ide,</w>
lipofus cin
lipo protein,</w>
lipo peroxides,</w>
lipo peroxidation</w>
lip iz
lip idosis</w>
lip ase,</w>
lingual- faci
lingual-faci al-
lingual-facial- buccal</w>
line :</w>
lind ane-treated</w>
lin olenic</w>
lin k.</w>
limit ation,</w>
limit .</w>
lim ination</w>
lim aprost</w>
lignocaine/ ketamine</w>
ligi ble
light-heade dness</w>
light- microscopic</w>
light- chain</w>
ligand- gated</w>
ligand -</w>
ligam ent</w>
lig ature</w>
life- table</w>
life- support</w>
lif ting</w>
lif e;</w>
lie u</w>
lid ine,</w>
lic ular</w>
lic l
lic kin
lickin g/
lic ation</w>
lic arbazepine</w>
li ving,</w>
li ves.</w>
li v
li sten
li st.</w>
li potropic</w>
li pidic</w>
li ability,</w>
levonorgestrel -containing</w>
levome promazine.</w>
levof loxacin-induced</w>
levodopa :</w>
levo- isomer</w>
lever- pressing</w>
level s).</w>
level ed</w>
level ).</w>
level ),</w>
levamisol e,</w>
lev it
leupro relin,</w>
leukocyt uria,</w>
leuko encephalopath
leukem ias</w>
leukem ias,</w>
leuk ocyte-integrins
leuk aemic</w>
leucovor in.</w>
leucine-enkephal in,</w>
leuc oencephalopathy</w>
letharg y.</w>
lest at</w>
less on</w>
less ness</w>
less ly</w>
lesion ing.</w>
lept in,</w>
lepro sum.</w>
lepro sum,</w>
length ;</w>
leng then</w>
leiomy omas</w>
lect ins.</w>
leb bec
least -
least- squares</w>
learn ing:</w>
leaf lets</w>
le y's</w>
le ver.</w>
le rene</w>
le mon
le ine-
leine- Lev
leine-Lev in</w>
le gi
le av
le ase</w>
le aping</w>
lay er-
layer- specific</w>
later ality</w>
later )</w>
later ).</w>
late- phase</w>
lat encies,</w>
lat .</w>
las tic,</w>
laryn x,</w>
large- tumor</w>
large- conductance</w>
large- artery</w>
large ment</w>
large -cell</w>
larg e.</w>
langu age-
land ing</w>
lan der</w>
lamotrig ine-associated</w>
lamin ar</w>
lam el
lamel lipo
lacunosum- moleculare</w>
lacunos um</w>
lacun ar</w>
lact ulose,</w>
lact ofer
lac -induced</w>
labyr in
labyrin thine</w>
lab d
labd ane</w>
l. min-1,</w>
l. m.w.
l- propranolol</w>
l- propranolol,</w>
l- methyl
l- isoproterenol</w>
l- dopa</w>
l- bun
l-bun olol</w>
l- baclofen</w>
l- DO
l- CMRg</w>
l- B
l- 201</w>
l s.</w>
l d
l b,</w>
l ass
l apsed</w>
l ant
l ag
l :
l -like</w>
l -1,</w>
l '
kynuren ate</w>
know .</w>
know ,</w>
knock- down</w>
knock out
kinin ogen
kine matical</w>
kind le
kinase- 1</w>
kin inogen</w>
kilogram s</w>
kilodal ton</w>
kill ing.</w>
kidney/ pancreas</w>
kidney- pancreas</w>
kidney s)</w>
kidne y;</w>
khe ll
kg/m (2))</w>
kg(-1) day(-1),</w>
kg .,</w>
keto profen.</w>
keto acidosis</w>
ketamine- alfentanil</w>
ket ones</w>
ket anserin.</w>
ket amine:</w>
ket amine),</w>
kerat ouve
kerat inocyte</w>
kerat in,</w>
kary otyp
kaol in-induced</w>
kanam ycin-induced</w>
kali ure
kPa -1,</w>
kP a.</w>
kP a,</w>
kD a-
k- up</w>
k tail</w>
k it
k en
k ed:</w>
k dynes/cm
k dyn
k a-
k J</w>
k 2</w>
k /
jux tac
justi fying</w>
junc tivi
jun ,</w>
jump ing.</w>
jug ated</w>
judg ments</w>
judg e</w>
join ts.</w>
jo ules</w>
jo ining</w>
jirovec ii</w>
jer k</w>
jejun oileal</w>
je al
jaundic ed.</w>
jat mansi</w>
jasplakin olide</w>
jac ulatory</w>
jac ch
j ump</w>
j ect</w>
iz er,</w>
iz able</w>
ity ,"</w>
ity '</w>
itrat uria</w>
itrac onazole.</w>
itrac in</w>
ithrom ycin,</w>
ith ful</w>
iter ative</w>
it tin</w>
it rile</w>
it ori
it ol-
it ching,</w>
it ch.</w>
it ;</w>
it /
it/ explicit</w>
ist ostatin</w>
isozym es</w>
isoxazol -5-
isotretino in,</w>
isoproterenol- stimulated</w>
isoproterenol- sensitive</w>
isoproterenol- pretreated</w>
isoproteren ol/
isoprenal ine-treated</w>
isom eric</w>
isol ect
isolect in-
isol ates),</w>
isol ate),</w>
isoflurane -</w>
isobut yl
isob olog
iso- PGF(2
iso thermal</w>
iso form
iso flav
ischemia/ reperfusion-induced</w>
ischem ia)</w>
ischaem ia-reperfusion</w>
isch -
isch- Her
isch-Her xheimer</w>
is s</w>
is ole</w>
is ochrom
is lets</w>
is le
is lands</w>
is ),</w>
irrit ation),</w>
irrig ated</w>
iron/ HCB</w>
iron- mediated</w>
irCR F)</w>
ir regularly</w>
ir rational</w>
ir on
ir i</w>
ir bes
ir algia</w>
ir al</w>
ipsilater al,</w>
ipsi -</w>
ipsapir one</w>
ipsapir one,</w>
ip pin
ioxil an,</w>
iotrol an</w>
iotrol an,</w>
iothalam ate</w>
ioprom ide,</w>
iontophore tic</w>
ion tophoresed</w>
ion s,</w>
ion ization</w>
iodine-1 25-
iod ine/
io sis</w>
io din
investigator-bl inded,</w>
investig ators'</w>
investig ate,</w>
inverte d-
inverted- screen</w>
intub ation-induced</w>
intravesi cal
intravesical ),</w>
intraventric ularly.</w>
intravenous ly).</w>
intravenous ly),</w>
intravenous )</w>
intrasub ject</w>
intraplant arly</w>
intranigr ally</w>
intranas ally</w>
intranas al,</w>
intramuscular ly.</w>
intramuscular ly)</w>
intramuscul ar,</w>
intram y
intram embranous</w>
intral ymphatic</w>
intral amin
intralamin ar</w>
intracol licular</w>
intracerebroventric ular
intrac aud
intracaud ate</w>
intra- raphe</w>
intra- group</w>
intra- amniotic</w>
intra- CP</w>
intra vesicular</w>
intra urethral</w>
intra thoracic</w>
intra jugular</w>
intra abdominal</w>
intr ic
intr atracheal</w>
intr alip
intr afascicular</w>
intoxic ated.</w>
intim ate</w>
intest ines</w>
intervie wed.</w>
intervie wed,</w>
interrup ted.</w>
interru ption.</w>
interpre tation.</w>
interpre table</w>
internal ization</w>
intermitt ently.</w>
intermediate- duration</w>
intermediate- acting</w>
intermedi ate.</w>
intermedi ate,</w>
interleukin-1 beta,</w>
interferon- gamma,</w>
interferon- alpha2a</w>
interferon- alpha.</w>
interferon- alpha-2
intercros s,</w>
interac tion)</w>
interac tion
inter rog
inter pol
inter personal</w>
inter nucleosomal</w>
inter menstrual</w>
inter body</w>
intensi fication.</w>
intensi fi
integr ins</w>
intact )</w>
int y.</w>
int ussusception</w>
insul t,</w>
insul in/
insul a</w>
insufficiency ;</w>
insuffici ently</w>
insuffici ent.</w>
instrum ent,</w>
institution 's</w>
institut e.</w>
institu tions,</w>
inst atement</w>
inst anc
inst all
inspi red)</w>
insidi ous,</w>
inser tions</w>
inser tion,</w>
insectic ides</w>
insectic ide,</w>
inqu iry</w>
inotrop y.</w>
inotrop ism.</w>
ino ]
innov ative</w>
innoc ent</w>
injection s;</w>
injection s:</w>
injection s).</w>
injection -associated</w>
inject ed;</w>
inj ures</w>
initi atives</w>
inhibitor s)</w>
inhibitor :</w>
inhib in</w>
ingre di
ing- Bre
ing-Bre uer</w>
ing ual</w>
ing row
ing iv
ing es</w>
ing a</w>
ing ?</w>
ing ."</w>
infusion s;</w>
infusion s)</w>
infra- Hisian</w>
infra- His</w>
inform ative</w>
inflamm ation-induced</w>
infl ation.</w>
infl ation,</w>
inferi or,</w>
infer oposterior</w>
infec tion;</w>
infarct- like</w>
infarc tion?</w>
infarc tion).</w>
inf liximab</w>
inf lexi
inf est
inf erence</w>
inf ected,</w>
inf ected
infected ).</w>
inf -DXR</w>
inexpen sive,</w>
ine- trimethoprim</w>
ine- pancuronium</w>
ine- dinucleotide</w>
ine- N-
ine- -a</w>
ine mic,</w>
ine /</w>
ine '</w>
industr y.</w>
induc tively</w>
induc tion;</w>
induc ed;</w>
induc ed:</w>
indor amin
indoramin .</w>
indomethac in:</w>
indomethac in
indomet acin</w>
individual s)</w>
individual ize</w>
individu ally.</w>
indinavir /
indinavir -containing</w>
indic ator.</w>
index -
index ),</w>
ind opril</w>
incub ations</w>
incub ation.</w>
increas ed:</w>
increas ed
increas e),</w>
incre ments,</w>
incre menting</w>
incre ment
incorpor ates</w>
incoordin ation,</w>
include s:</w>
includ ing,</w>
incid ences.</w>
inci sion.</w>
inc urring</w>
inc ised</w>
inc en
incen tive</w>
inapar sin</w>
inadver t
in/ platelet</w>
in/ plasma</w>
in/ clavulanic</w>
in-3- ol</w>
in- house</w>
in- fibrate</w>
in- conjugated</w>
in- aden
in-aden ine-dinucleotide</w>
in- 4</w>
in- 2</w>
in surance</w>
in sur
in operable,</w>
in ism</w>
in ine,</w>
in hospital</w>
in distinguish
in direct-acting</w>
in dig
indig es
in dependently.</w>
in depend
in conveni
in comprehen
incomprehen sible</w>
in bre
in appropriate,</w>
in apo
inapo ylsucrose</w>
in aemia,</w>
in adequate.</w>
in activates</w>
in accuracy</w>
in (1-
in(1- 31)</w>
impul ses.</w>
improve d"</w>
impregn ation</w>
implic it/explicit</w>
impe ded</w>
imp act,</w>
immunost ained</w>
immunore active.</w>
immunofluoresc ence.</w>
immunocyt ochemistry,</w>
immunoblot ting,</w>
immunoblo ts</w>
immuno- electrophoresis</w>
immuno- allergic</w>
immuno therapy,</w>
immuno expression</w>
immuno deficient</w>
immune -related</w>
immun opathogenesis</w>
immun opath
immun ologic,</w>
immun ochemically</w>
imipr amine-
imipr amine)</w>
imidazol e,</w>
imidaz o</w>
imidaz o-
imidaz o
imidaz enil,</w>
imatinib ,</w>
imat inib.</w>
imag ing)</w>
imag e-
im yelo
im purities</w>
im poverished</w>
im potent</w>
im post
im pose</w>
im perfor
im m</w>
im ido
ilo prost.</w>
illu mination</w>
illo pharmacological</w>
illic itly</w>
ile ostoma</w>
ilater al,</w>
il- sensitive</w>
il ine-induced</w>
il ic
igno red.</w>
ig mesine</w>
ifosfamide -containing</w>
ifenpro dil.</w>
idiosyncrati c.</w>
idi tis</w>
idi aphrag
idiaphrag m</w>
ider oblastic</w>
identi f
ide ation,</w>
id- rifampin</w>
id ystonia</w>
id ine)</w>
id ine's</w>
id ergic</w>
id ectomy</w>
id din
id ;</w>
id ),</w>
icul us</w>
icter us.</w>
iclo zotan</w>
ichthyo sis</w>
ichi 's</w>
ic- type</w>
ic- clonic</w>
ic- acid-induced</w>
ic v.</w>
ic one</w>
ic le</w>
ic idin</w>
ic ide,</w>
ic ene</w>
ic eb
iceb erg
iceberg ?</w>
ic ation</w>
ic atibant</w>
ic aria</w>
ic als,</w>
ic a.</w>
ibuprofen -treated</w>
ibuprofen -related</w>
ibuprofen -associated</w>
ibu tilide-induced</w>
iberi otoxin</w>
ia- hypercalciuria</w>
ia .(ABSTRACT</w>
iK r</w>
i.v )</w>
i.th .)</w>
i.t .,</w>
i.t .),</w>
i.pl .</w>
i.p. )-
i.p ,</w>
i.p ).</w>
i.m .),</w>
i.c.v .;</w>
i.c.v .-
i. t.
i. d
i. c.
i verm
i u</w>
i tion,</w>
i po
i otopoulos</w>
i os
i ii)</w>
i ence</w>
i atrogenically</w>
i NOS,</w>
i NO</w>
i CCD</w>
i AVP</w>
i -like</w>
hysterosalping ography</w>
hyster oscopy</w>
hypoxia- responsive</w>
hypox ia-related</w>
hypox aemia,</w>
hypovol emic,</w>
hypovol aemia</w>
hypoton y,</w>
hypother mia;</w>
hypother m
hypothe ses,</w>
hypothalamo- pituitary</w>
hypotension- sensitive</w>
hypotension- evoked</w>
hypos ensi
hyposensi tivity</w>
hyporen inaemic</w>
hypopituitar ism.</w>
hypophysi otropic</w>
hypophys ectomy</w>
hypomethyl ation</w>
hypomania/ mania</w>
hypoman ia.</w>
hypomagnesem ia-hypercalciuria</w>
hypomagne semic</w>
hypom otility,</w>
hypokalem ia;</w>
hypokalem ia:</w>
hypokal aemic</w>
hypogonadis m,</w>
hypocholesterol emic</w>
hypocalce mic</w>
hypoc itraturia</w>
hypoc arb
hypocarb ia</w>
hypoalbum inemic</w>
hypo vitaminosis</w>
hypo ventilation,</w>
hypo gastric</w>
hypo fractionated</w>
hypo estrogen
hypo der
hypoder mic</w>
hypo activity,</w>
hypo activations</w>
hypno tics,</w>
hypno s</w>
hyperuric emia.</w>
hyperuric emia,</w>
hyperuric aemia</w>
hypertrophy ;</w>
hypertricho sis,</w>
hyperton us</w>
hyperton ia,</w>
hyperthyrox inemia</w>
hyperther mia-induced</w>
hypertension ,"</w>
hypertensin ogenic</w>
hypertensi ves,</w>
hyperten sion-induced</w>
hyperten sion).</w>
hypersensitiv ity)</w>
hyperprolactine mia:</w>
hyperprolactin aemia.</w>
hyperplasi a:</w>
hyperoxal uria.</w>
hypernat raemic</w>
hypermagnesi uria</w>
hyperlipid aemic</w>
hyperlipid aemia</w>
hyperlipid aemia,</w>
hyperlip emia,</w>
hyperkine sis</w>
hyperkine sis,</w>
hyperkal aemia,</w>
hyperkal aem
hyperinsul inemic</w>
hyperinsul inemia,</w>
hyperhid rosis,</w>
hyperglyc inemia</w>
hyperestrogen emia</w>
hypereosinophil ia,</w>
hypercoagul ability,</w>
hypercholesterol aemia.</w>
hypercalce mia;</w>
hypercalce mia:</w>
hyperal im
hyper- responsive</w>
hyper- reactivity</w>
hyper- prolactinemia</w>
hyper volemic</w>
hyper thyroid</w>
hyper thymic</w>
hyper salivation,</w>
hyper production</w>
hyper pigmentation</w>
hyper pigmentation,</w>
hyper physiological</w>
hyper phosphorylated</w>
hyper phagia,</w>
hyper p
hyper motility,</w>
hyper fractionated</w>
hyper filtration,</w>
hyper androgen
hyper aemia</w>
hyper adrenergic</w>
hyper activity:</w>
hype resthesia</w>
hyp sarrhythmia</w>
hyp oxic,</w>
hydroxyl ation.</w>
hydroxyeicos a-
hydroxychloroquine-plus- piroxicam-treated</w>
hydroxychloroquine-plus- piroxicam,</w>
hydroxybut yrate</w>
hydroxy-3- [4-
hydroxy- ethoxy)
hydroxy-ethoxy) tropane</w>
hydroxy- DA-
hydroxy urea,</w>
hydroxy proline,</w>
hydroxy apati
hydroxy anisol
hydroxyanisol e,</w>
hydroxam ates</w>
hydrox yl-
hydroureteroneph rosis</w>
hydropen ia</w>
hydromorph one,</w>
hydroly zes</w>
hydrochlorothiazide- triamterene</w>
hydrochlorothiaz ide-induced</w>
hydrochlor ide;</w>
hydrochlor ide),</w>
hydro peroxy
hydro peroxide
hydro ethanol</w>
hydro cod
hydro carbons</w>
hydro bromide,</w>
hydramni os,</w>
hydra zone</w>
hydra zinophthalazine-treated</w>
hydr o</w>
hydr ation)</w>
hydantoin )</w>
hybri dis
hyaluron idase</w>
hyalin ization</w>
hy oscyamine</w>
hy osc
hum oral,</w>
huPB L</w>
hr -1)</w>
hot plate</w>
hospital izations.</w>
hospital isation.</w>
hospital is
hospit al-
hormone- treated</w>
hormone- secreting</w>
hormone- related</w>
hormone- producing</w>
hormone- independent</w>
homozyg ot
homolog ue</w>
homoiother ms.</w>
hom ota
hom e-
hom e,</w>
holid ays</w>
hol low</w>
hodgkin s
ho st.</w>
histolog y)</w>
histi ocytosis</w>
histi ocytosis.</w>
histi ocytes.</w>
histamine- 1</w>
histamin erg
hist oplasmo
hist omorph
hist ologically,</w>
hist ologic,</w>
hist ocompatibility</w>
hist ochemistry,</w>
hist ochemically.</w>
hist ochemical,</w>
hist ine,</w>
hippocampi .</w>
hippocamp us-dependent</w>
hippocamp us)</w>
hippocamp us
hippocam po-entorhinal</w>
hind quarter</w>
hind quarter
hin der</w>
him self</w>
hilus =
high- risk,</w>
high- quality</w>
high- normal</w>
high- level,</w>
high- fat</w>
high )</w>
hierarch ical</w>
hexos amine,</w>
hexobarbit al-induced</w>
hexo se,</w>
hexamethyl melamine</w>
hexafluoro cyclo
hexafluorocyclo but
hexa relin</w>
hex atri
hexatri ene</w>
hex achlor
heterozyg otes</w>
heterotop ically</w>
heterogene ous.</w>
heterogene ity.</w>
heter ocyclic</w>
heta starch
herp es
herni as</w>
her nia.</w>
her nia,</w>
heptano ate</w>
hept aminol</w>
hepatocyt es;</w>
hepatocell ular.</w>
hepatoc arc
hepatocarc inogen</w>
hepatoblast oma,</w>
hepatitis ).</w>
hepati tic</w>
hepati cally</w>
hepat otrophic</w>
hepat oma,</w>
hepat ectomy,</w>
heparin ization</w>
heparin isation</w>
heparin :
heparin: PF4</w>
hepar ins.</w>
hepar in:</w>
hepar in-related</w>
hepar in)</w>
hemosider osis</w>
hemorrhag ic,</w>
hemorrh age
hemorrhage -induced</w>
hemoglob inuria.</w>
hemoglob inuria,</w>
hemoglob inemia</w>
hemodialy sis)</w>
hemo stasis,</w>
hemis uccin
hemif acial</w>
hemicholinium- 3,</w>
hemiball ism</w>
hemi parkinsonism</w>
heme-L-lysin ate</w>
hematopoi esis,</w>
hemat oxylin-eosin</w>
hemat ospermia</w>
hemat opoetic</w>
hemat omyelia</w>
hemat oma:</w>
hemat oma,</w>
hemangioendotheli oma</w>
hem oconcentr
hem idystonia</w>
hem idiaphragm</w>
helpl ess
heat- stable</w>
heat- pain</w>
heat- inactivated</w>
heat stroke</w>
heart- valve</w>
heart s:</w>
hear t:</w>
headache /
headache "</w>
head- weaving</w>
he v
hazard ous?</w>
hasten s</w>
hasten ed</w>
harm less</w>
harm ful.</w>
hard wood</w>
har monic</w>
har mal
haptoglob in.</w>
hap ten
hand- eye</w>
hand led</w>
hand ful</w>
hand )</w>
hampe red.</w>
halothane- treated</w>
halothane- exposed</w>
halothane- MIF</w>
halothane- -
halothane-- epinephrine</w>
halothane -</w>
haloth ane)</w>
haloperidol- increased</w>
haloperidol- enhanced</w>
haloperidol ),</w>
halo alk
hallucin ator
hallucin ation,</w>
hallucin ating</w>
hall uc
half-li ves,</w>
hal ting</w>
hal ide</w>
hair s</w>
haemodynam ics.</w>
haemodilu tion.</w>
haemo filtration</w>
haemo filtration.</w>
haemat oxylin</w>
haemat ological,</w>
haemat ob
haem opexin</w>
habit ually</w>
hab its</w>
hab its.</w>
ha v</w>
ha sten</w>
ha ,</w>
h/ day)</w>
h.p. f.</w>
h us
h un
h s</w>
h ou
h opes</w>
h mi</w>
h inal,</w>
h es
h MT</w>
h G
h CGRP8-37</w>
h -1,</w>
h ))</w>
h )
h 's</w>
gyr us;</w>
gyr us)</w>
gy pt
guy ann
guyann ensis</w>
gut ,</w>
guinea- pigs.</w>
guarante e</w>
guaneth idine.</w>
guaneth idine-induced</w>
guan oxabenz
gu vac
grow s,</w>
grow n</w>
group s
group 1</w>
group -1</w>
group "</w>
groom ing,</w>
groom ing),</w>
groo ve</w>
gro und-glass</w>
griseofulv in.</w>
gri mac
greml in,</w>
gre pa
gravid as</w>
grav ity,</w>
graph y:</w>
graph y)</w>
graph ically.</w>
graph .</w>
granulomat osis:</w>
granulo cytopenia.</w>
granulo cytopenia,</w>
granulo cytic</w>
gran/ dex</w>
gram icidin</w>
gram -
graf ting,</w>
graf ine</w>
grad uate</w>
grad ing.</w>
gra y-
gr ati
gr anted</w>
gr /
gose relin,</w>
good- quality</w>
gonadotrop ins</w>
gonad ectomy</w>
gonad ally</w>
gonad al,</w>
gol den</w>
gol d.</w>
gol d
goat s.</w>
goal- directed</w>
gnaw ing,</w>
gm/ m2</w>
glycos ylation</w>
glycos uria.</w>
glycopyr rol
glyco sides.</w>
glyco side,</w>
glyco fer
glycofer ol-
glyceraldehyde- 3-
glyceraldehyde-3- phosphate</w>
glycer ol-induced</w>
glyc ol.</w>
glyc ol
glyc ine-induced</w>
glyc ine-
glyc inamide</w>
glyc in
glybur ide.</w>
gly caemic</w>
glutethim ide.</w>
glutamat ergic,</w>
glutam ine.</w>
glutam ate)</w>
glucuronid ation,</w>
glucuronid ase</w>
glucuron yl</w>
glucosid ase</w>
glucose- mannose</w>
glucose- insulin</w>
glucocorticoid- regulated</w>
glucocorticoid -like</w>
glucocortico steroid</w>
glucocortico id,</w>
gluco se)</w>
gluc oside</w>
gluc oron
gluc opri
gluc onate.</w>
glos sopharyngeal</w>
glos sal</w>
glomerulosclero tic</w>
glomerul us.</w>
glob ular</w>
glioblast omas</w>
glicl azide-induced</w>
glibencl amide),</w>
gli stening</w>
gli oma,</w>
gli oblastoma.</w>
gli o-vascular</w>
gli a-
glab rous</w>
gl utition</w>
given ;</w>
girl s:</w>
ginseno sides.</w>
gi ardi
gh t-
gh rel
gest ations</w>
gerbil s.</w>
gerbil s,</w>
geran yl
ger minal</w>
ger min
genit o-urinary</w>
general izes</w>
gener ations.</w>
gene sis:</w>
gen u</w>
gen s</w>
gen omes</w>
gen om
gen ic.</w>
gen ase</w>
gemcitab ine-containing</w>
gemcitab ine-
gelat inase</w>
gelat in
gel .</w>
ge ographic</w>
ge les</w>
ge dly</w>
gcd- null</w>
gaz e-
gaze- evoked</w>
gati floxacin,</w>
gastroenter itis</w>
gastrocnemi us)</w>
gastro protective</w>
gar lic
gap .</w>
gangli a-
ganglia- thalamocortical</w>
gan da.</w>
gan )</w>
gammaglut amyl
gammaglutamyl transferase</w>
gamma-glutamyltranspeptid ase-positive</w>
gamma-glutamyl transferase,</w>
gamma-butyro lactone</w>
gamma-aminobut yrate</w>
gamma-G T-positive</w>
gamma- thiobutyrolactone</w>
gamma- HC
gamma- GT</w>
gam et
gallo tannin</w>
gallo catechin</w>
gall amine.</w>
galant amine,</w>
galan in-IR</w>
galact ose</w>
gal oblastic</w>
gadolinium- enhanced</w>
gadol inium.</w>
gadodi amide,</w>
gabapent in-induced</w>
ga x</w>
ga ren
ga ined.</w>
g/m2/ d</w>
g/m 2;</w>
g/kg/ day,</w>
g/ sq</w>
g/ ml),</w>
g/ minute</w>
g/ l</w>
g/ day),</w>
g/ d)</w>
g/ body</w>
g/ L),</w>
g. kg-1</w>
g-1. min-1</w>
g un
g um),</w>
g th</w>
g s.</w>
g rommet
g ous</w>
g one</w>
g lipiz
g ingiv
g iddin
g est</w>
g d)</w>
g b)</w>
g at
g al,</w>
g );</w>
g (-1).</w>
g (-1),</w>
fusi form</w>
furosem ide-treated</w>
fur yl)-
fung icidal</w>
funduscop ic</w>
fundus copy</w>
function /
fun dic</w>
fun al
funal trex
fulfil led.</w>
ful ly.</w>
ful ly-
ful lerene</w>
ful fi
fulfi l</w>
fuch sin</w>
fuc osid
fuc oid
fu gax</w>
frust e</w>
fructo se-induced</w>
fronto- parietal</w>
front line</w>
frequ enc
free- water</w>
free- radical</w>
free- moving</w>
free- flow</w>
fre el
freel y-moving</w>
fre e)</w>
fragment ed.</w>
fourth- order</w>
four- week-old</w>
four teenth</w>
foti amine</w>
fosinopri l.</w>
fosfob ion</w>
foscarne t-induced</w>
forty- four</w>
forskol in-stimulated</w>
formul ary</w>
formul ae</w>
form ular
form s:</w>
form ers</w>
form ation:</w>
form ation)</w>
form ally</w>
fore brain,</w>
fore arms.</w>
fore arms,</w>
fore ar
forced- swimming</w>
force- interval</w>
force ment</w>
for med.</w>
foot pad</w>
food- taking</w>
food )</w>
follow-up )</w>
follic les</w>
foli aceus</w>
focus sed</w>
fo ve
fo et
fluspiril ene,</w>
flur idine</w>
flur azepam.</w>
flur azepam,</w>
flup enti
flupenti x
fluoxet ine:</w>
fluoroquinol ones,</w>
fluoro uracil.</w>
fluocin olone</w>
flunitrazep am,</w>
flumazen il-induced</w>
flucytos ine,</w>
fluctu ations,</w>
fluctu ated</w>
flucloxacill in-induced</w>
flu- like"</w>
flu xes</w>
flu x.</w>
flu x,</w>
flu vastatin,</w>
flu parox
flu oxyme
flu ency,</w>
flox uridine.</w>
flow- limiting</w>
flow metry,</w>
flow meter,</w>
flow ed</w>
flow ;</w>
flow :</w>
flor id</w>
flor a,</w>
flo s</w>
flo ating</w>
flin ch
flexible -
flexi bly</w>
flavon oids</w>
flatul ence</w>
flatul ence,</w>
flat ter</w>
flat ,</w>
flare -up</w>
fl u</w>
fl orum</w>
fl ame</w>
fl accid
fix ation.</w>
five- mutation</w>
five- fold</w>
fistul ae</w>
fissu re,</w>
first- cycle</w>
first- choice</w>
first ;</w>
first )</w>
fir ing.</w>
finding s;</w>
find s</w>
fin anc
financ ial</w>
filgrastim .</w>
fil tering</w>
fil ter,</w>
fil es,</w>
fifty- eight</w>
fiel d;</w>
fibrosar coma</w>
fibromy algia.</w>
fibroelast osis</w>
fibroblast -like</w>
fibro tic,</w>
fibro sis-associated</w>
fibro sis).</w>
fibro adenomas</w>
fibrinogen ating</w>
fibrin- rich</w>
fibrin olysis,</w>
fibrin oly
fibrill ation),</w>
fibrill ating</w>
fibri ls</w>
fibri ls,</w>
fiber optic</w>
fib rate-
fib er-
fib er,</w>
fib er)</w>
fi ve)</w>
fi del
fidel ity</w>
fet otoxic</w>
fertili z
ferrit inemia,</w>
ferrit in,</w>
feren tial</w>
fer tility.</w>
fer tility,</w>
fer ruginea</w>
fer ro
fentanyl/ bupivacaine</w>
fentanyl- supplemented</w>
fentanyl ;</w>
fentanyl -associated</w>
fentanyl )</w>
fenoter ol,</w>
fenoldop am.</w>
fenoldop am
feno profen.</w>
fenfluramine- related</w>
fenflur amines,</w>
fenflur amine)</w>
fenflur amine
fenest rated</w>
fenbufen ,</w>
fen retinide</w>
fen ac</w>
femal e's</w>
fell ,</w>
fel bam
fed rine</w>
feat ures:</w>
fear -related</w>
fear -
fear ,</w>
fe ed-forward</w>
fe bri
fazad inium</w>
favour able,</w>
fav ouring</w>
fatal ity.</w>
fat al)</w>
fat .</w>
fat -free</w>
fast ing.</w>
fashi on;</w>
fashi on:</w>
fascicularis ).</w>
fascicul us</w>
fascicul ating</w>
fascicul aris</w>
fasc ic
far nes
far -
famoti dine-induced</w>
famili al,</w>
famil ies.</w>
fall s,</w>
falcipar um.</w>
fal x</w>
fal sely</w>
failure -free</w>
fail s.</w>
faec alis.</w>
factor- alpha.</w>
factor )</w>
face- to-face</w>
fac ing</w>
fac et</w>
fa romine</w>
fa ithful</w>
fEP SPs</w>
f. =
f usion,</w>
f ran
f ostriec
f ore,</w>
f mol</w>
f mol
f mann</w>
f loc
f it,</w>
f ish,</w>
f ep
fep ramone</w>
f ed.</w>
f are</w>
f ade
f PD</w>
ez ing.</w>
ey ond</w>
exud ates</w>
extub ate</w>
extrasystol es,</w>
extrastimul i.</w>
extrane uron
extrac tion,</w>
extra- pontine</w>
extr asystole</w>
extr an</w>
extr acts,</w>
extinc tion/reinstatement</w>
exter nal-
exter na.</w>
exter i
exten sively.</w>
ext ents</w>
expul sion</w>
expres sion:</w>
expres sed,</w>
exposure -
expo sed.</w>
expo sed)</w>
expo sed
explo it</w>
explic itly</w>
explan ations.</w>
expl ained,</w>
experimenter -administered</w>
experiment al,</w>
experi ence
experi enc
exper ts</w>
expedi tious</w>
expect ed)</w>
expect ations</w>
expan sive</w>
exist ence,</w>
exhaus tive</w>
exhaus tion</w>
exhaus tion.</w>
exha ust
exercise -related</w>
exercise -</w>
exerci ses</w>
exer tion.</w>
exec uted</w>
exec ute</w>
exclu des</w>
excitation- contraction</w>
excit otoxin</w>
excit ator
excit ations</w>
exci sed,</w>
excep tional.</w>
excep tion,</w>
exc ite</w>
exc es
exanth ema</w>
examin ation)</w>
exam s,</w>
exam isole</w>
exam ine
exam ,</w>
exagger ation</w>
exagger ates</w>
exacerb ations,</w>
exacerb ation,</w>
ex tirpation</w>
ex stroph
ex sangu
ex ovascular</w>
ex ocoelomic</w>
ex anthe
exanthe ma,</w>
ex ,</w>
evol ves</w>
evol ve</w>
evo ked,</w>
evid encing</w>
every- 3-week</w>
event s).</w>
ev inced</w>
ev en
euph oric</w>
euph ori
eucalce mic</w>
eu thyroid</w>
etretin ate,</w>
etodol ac,</w>
eti din
ethylket azoc
ethylenedi amine
ethylene imine</w>
ethyl]-4-(3-phenylpropyl) piperazine</w>
ethyl]- 2-
ethyl sulfonylnaphthalene-1-sulfonamide,</w>
ethyl ]</w>
ethyl ,</w>
ethoxyqu in</w>
ethoxyqu in,</w>
ethoxy resorufin-O-deethylase</w>
ethinylo estradiol-treated</w>
ethinylo estradiol,</w>
ethchlorv ynol</w>
ethan ol/
eth ological</w>
etexil ate</w>
et orphine</w>
et ofibrate</w>
et namese</w>
et c.)</w>
et c
etc .,</w>
esul erg
esulerg ine</w>
estrogen -like</w>
estrogen -containing</w>
estram ust
estradiol-17 beta</w>
estradiol :</w>
estim ated,</w>
ester ified</w>
ester ase,</w>
ester -type</w>
est rus/
est ers.</w>
est ,</w>
essenti al,</w>
esophag ogastric</w>
esoph ageal,</w>
esc ence.</w>
es. s.cm-
es s)</w>
es orub
es ol
es na</w>
es licarbazepine</w>
es er
es cul
escul ent
es ch
es ,
erythroder mic</w>
erythro leukemia</w>
eryth rophagocytosis</w>
ery ptosis.</w>
ery ptosis,</w>
erro r,</w>
ero sion,</w>
ero ben</w>
ergot s</w>
ergol ine-induced</w>
erg ometer</w>
erec tions,</w>
ere brate</w>
erculo sis</w>
er/ density</w>
er- based</w>
er istostatin</w>
er ing.</w>
er ing-
er al
er a-
equival ent,</w>
equi setiform
equi sedative</w>
equ imyelo
equ als</w>
equ ally.</w>
eptid ase,</w>
epti n</w>
epsilon- amino</w>
epsilon ,</w>
epomedi ol.</w>
epoi etin-beta</w>
episode s;</w>
episi otomy</w>
epirubicin/ paclitaxel</w>
epirubic in-based</w>
epinephr ine/kg</w>
epinephr ine).</w>
epinephr ine),</w>
epileptic us;</w>
epileptic us)</w>
epileptic us).</w>
epilepsy -induced</w>
epilepsy ).</w>
epilep sia</w>
epidemio logy,</w>
epi gallocatechin</w>
epi apterin</w>
ephed rine-
ep pra
ep oxy-
ep o-
ep i</w>
ep ensis</w>
ep al
ep -
eosinophil uria.</w>
enzyme- altered</w>
enzyme ),</w>
enzym uria,</w>
enzym es:</w>
enzym es'</w>
enti ties.</w>
enti rely,</w>
enti a</w>
enthusi astic</w>
enteropath ica</w>
enter otoxins</w>
enter ococcus</w>
entec avir.</w>
ent ucky</w>
ensit ometry</w>
ensi tive</w>
enrol ment</w>
enro lling</w>
enoxapar in-treated</w>
enox acin-induced</w>
eno tic</w>
eno gest</w>
enlarge d.</w>
enlarg ing</w>
enkephal in-
enhance ments</w>
enhanc er.</w>
engraf ted</w>
engorg ement.</w>
eng e,</w>
eng aging</w>
eng age</w>
enflur ane/nitrous</w>
energ y-
enedi oxymethamphetamine</w>
ene- 3,20-
endpoint ;</w>
endpoint )</w>
endotox in-treated</w>
endotox in-
endothelium- intact</w>
endothelin -1.</w>
endothel in-
endosulf an.</w>
endorph inergic</w>
endorph in,</w>
endor sed</w>
endocrin ologic</w>
endoc rino
endoc rine,</w>
endo /
endo/ epi</w>
end-of- treatment</w>
end- products</w>
end- inspiratory</w>
end tidal</w>
end orphin</w>
end opiriform</w>
end onuclease-
end oluminal</w>
end ang
encour aged.</w>
encephalo graphy</w>
ence -based</w>
enantiom ers,</w>
enanti o
enalapri lic</w>
en-3- one,</w>
en- VPA
en se</w>
en profylline,</w>
en ormous</w>
en etri
en em,</w>
en ed.</w>
en di
en de
en chymal</w>
en ching</w>
en a
emul sive</w>
emul sions</w>
emo tional,</w>
emis sion.</w>
emin gly,</w>
emergency -
emergen cy,</w>
emerg ently</w>
eme sis;</w>
embryo ,</w>
embran oids</w>
embol us,</w>
embol ism
em pye
em it
em ic.</w>
em ia)</w>
em ia),</w>
em ents.</w>
em ent-
elym oclavine</w>
elsewhe re.</w>
ell ular-
ell aria</w>
electron- microscope</w>
electron ically.</w>
electromyo grams</w>
electroly te,</w>
electroencephalo graph</w>
electroencephalo gic</w>
electrocortico graphy</w>
electrocardio graphical</w>
electrocardio grams.</w>
electro graphic,</w>
electro gram</w>
electro convulsions</w>
electro convulsions.</w>
electr ical,</w>
ele ments,</w>
elast olysis.</w>
elast ase,</w>
elabor ated</w>
el vic</w>
el lip
el li
el fare</w>
el ="
el )</w>
el 's</w>
ejac ulation.</w>
ejac ulation,</w>
eighty- six</w>
eight- week</w>
eigh ner</w>
ei ther:</w>
ei j
ego ,</w>
eg ocentric</w>
effor ts.</w>
effor t.</w>
efficac y;</w>
effect s),</w>
effect s"</w>
effect -
effect (s)</w>
effe ren
effac ement,</w>
eff er</w>
efarox an.</w>
edroph onium,</w>
edi tion</w>
edi tion)</w>
ede mas</w>
edarav one.</w>
ed d
edd 4-
ed /
ed .
ed --
ecz ematous</w>
ecz ema</w>
ectro pi
ectom ised</w>
ecto- ATPase</w>
ect s,</w>
ect or</w>
ecstasy/ cocaine-induced</w>
eclo cycline</w>
eclamp sia.</w>
echocardiograph y;</w>
echocardiograph ically.</w>
echo genicity,</w>
ech in
ec yst
ec tiveness,</w>
ec opip
ec ol</w>
ec ity</w>
ec ham</w>
ec c
ecc rine</w>
ec ,</w>
eat ers,</w>
early- gene</w>
ear- nose-throat</w>
ear s.</w>
ear ned</w>
e. c.
e- type</w>
e- seropositive</w>
e- restricted</w>
e- related</w>
e- free</w>
e- antigen</w>
e- -
e+ APAP)</w>
e version</w>
e ved</w>
e timide</w>
e ther.</w>
e osin-
e metine</w>
e k
e g,</w>
e fly,</w>
e bo
ebo witz</w>
e -1
dystroph in-
dyston ia;</w>
dyston ia-
dyst ocia</w>
dysr rhythmias</w>
dysplasi as</w>
dyspareun ia</w>
dyskinesi a)</w>
dyskine tic)</w>
dyskine sis</w>
dyserythropoi etic</w>
dyscrasi as,</w>
dyscra sia</w>
dyscra sia.</w>
dyschromatop sia,</w>
dys thymic</w>
dys thymia</w>
dys synerg
dys raphic</w>
dys raph
dys phasi
dys morphogenesis</w>
dys metabolic</w>
dys germin
dys genesis</w>
dys functioning</w>
dynes/ s/cm-
dynam ic,</w>
dyn ia</w>
dyn es.s.cm-
dy stro
dwar f
dut y</w>
dul l</w>
duct us-dependent</w>
duct openia.</w>
duc t-
dual- pathway</w>
drug- independent</w>
drug ),</w>
drug (s)</w>
drox idopa</w>
drop outs</w>
drop out</w>
dronedar one.</w>
dronedar one,</w>
dro ptain
dro pping</w>
drink ers.</w>
dri ving,</w>
dres sings</w>
dre am</w>
dram atic,</w>
dr af
draf t)</w>
dp/d t:</w>
dp/d t,</w>
doxy cycl
doxorubicin/ paclitaxel</w>
doxorubicin/ kg.</w>
doxorubicin/ kg,</w>
doxorubicin- treated-
doxorubicin- pretreated</w>
doxorubic in).</w>
doxep in,</w>
dox azosin.</w>
down- regulation.</w>
down- regulates</w>
down regulates</w>
doubt ful.</w>
double- labelling</w>
double- labeling</w>
double -</w>
doubl ecortin</w>
doub ts</w>
dose-rel ated
dose-related ly.</w>
dose-depend ently,</w>
dose- reduction</w>
dose- normalized</w>
dose- limiting,</w>
dose- independent</w>
dose- dependence</w>
dose '</w>
dos ing-
dos ing).</w>
dos age;</w>
dos age:</w>
dor zolamide</w>
dor sum.</w>
dopaminerg ic-
dopamine/ norepinephrine</w>
dopamine/ norepinephrine-selective</w>
dopamine- replacement</w>
dopamine- like</w>
dopamin omimetics</w>
dopamin omimetic</w>
donor- strain</w>
domperid one-induced</w>
domin ate</w>
domin ant,</w>
domain s,</w>
dol ase
dolase tr
dog s.
dodec yl</w>
document ation.</w>
docetaxel -
doc tor.</w>
do t</w>
do familial</w>
dn-sec(-1).m(2).cm (5
dn-sec(-1).m(2).cm(5 ))</w>
dl -</w>
dizocil pine)</w>
diz ygotic</w>
divor ce
divorce d/
diuretic -treated</w>
dithio thre
disulfi des,</w>
distribu tive</w>
distr acted</w>
distinc t,</w>
dissoci ating</w>
dissoci able</w>
dissi pation</w>
dissemin ation</w>
disru ption,</w>
disper sion.</w>
disorder s"</w>
disorder ;</w>
disodi um-induced</w>
dismut ase)</w>
disease- like</w>
diseas es:</w>
diseas e?</w>
diseas e/
discus sed:</w>
discrimin ation-
discrimination- reversal</w>
discrimin ates</w>
discri minant</w>
discover ies</w>
discour aged.</w>
discontinu ation)</w>
discharge -
discer nable</w>
disc s</w>
disc .</w>
disc ,</w>
dis solution,</w>
dis sections</w>
dis sect</w>
dis missed</w>
dis integrin</w>
dis inhibited</w>
dis inapoylsucrose</w>
dis agreement</w>
dis abilities.</w>
dis abil
direc tions.</w>
direc tions,</w>
dips tick</w>
dips ogenic</w>
dipivoxil/ lamivudine</w>
diphosph onate</w>
diphen idol</w>
diph ther
dioxo- benzo[f]
dioxo-benzo[f] quinoxaline-7-
dinitro quinoxaline-2,3-dione</w>
dimethylamino )</w>
dimethyl uric</w>
dimethyl nitrosamine</w>
dimeth adione</w>
dimension al,</w>
dimen sions.</w>
dimeglum ine;</w>
dimeglum ine.</w>
dimeglum ine,</w>
dile mm
dil ation,</w>
dil ated.</w>
dil ated,</w>
dihydroxy-6-nitro-7- sulfamoyl-
dihydropyridine- class</w>
dihydro-6 H-benz
dihydro-6H-benz ofuro[2,3-e]pyrido[1,2-a][1,3]diazepin-12-ium</w>
dihydro-2- acenaph
dihydro-2-acenaph thylenyl)
dihydro- beta-
dihydro-beta- erythro
dihydro- 5-azacytidine</w>
dihydro- 5-
dihydro- 2,3-quinoxaline
dihydro testosterone</w>
dihydro pyridines</w>
dihydro ergotoxine</w>
dihydro alprenolol</w>
digoxigen in-labeled</w>
digitalis- toxic</w>
digitalis- provoked</w>
digitalis -like</w>
digit al
dig its</w>
difficul ty,</w>
differenti ates</w>
difference =
difference :</w>
diffe red,</w>
diethyl nor
diethyl nitrosamine.</w>
diethyl nitrosam
diethyl enetri
diethyl ene</w>
diet -induced</w>
diet -dependent</w>
diet -
diet ).</w>
dideoxyinos ine.</w>
dideoxy cytidine.</w>
didanos ine/
didanos ine,</w>
dicho tic</w>
dichloro platinum</w>
dichloro kynurenic</w>
dichloro hexafluorocyclobut
dic ated</w>
dibutyr yl</w>
diazepam- ketamine</w>
diazepam ;</w>
diazepam -dependent</w>
diazep oxide</w>
diast ole,</w>
diast emat
diarrhoe a)</w>
diarrhe a)</w>
diaphrag ms</w>
diaphor ase,</w>
diammine dichloroplatinum</w>
diamin odiphenyl
diameter -
dialy sis-
diagnos tics</w>
diagno sis:</w>
diagno sis)</w>
diabet ogenic</w>
di(2-ethylhex yl)phthalate</w>
di se</w>
di ps</w>
di ol)</w>
di o
di mesylate.</w>
di mesylate,</w>
di i</w>
di ed:</w>
di butyl
di benzo[
di athe
di as
dias chisis</w>
di aries,</w>
di ant
di acetolol</w>
dextro mor
dex -treated</w>
detox ified</w>
detox ification.</w>
determin ant.</w>
determin ant"</w>
determ ined:</w>
determ ine,</w>
deterior ate.</w>
detect or</w>
detect ,</w>
destro ying</w>
dest ination</w>
desquam ation.</w>
despair "</w>
desmopress in.</w>
desmethyl astemizole</w>
desi pramine)</w>
describe d;</w>
describe ,</w>
descri ptive,</w>
desc ending,</w>
desArg9Leu8- BK</w>
des-Arg9- BK</w>
des per
des or
dermat opathology</w>
dermat omes</w>
derivati zation</w>
derivati ves)</w>
deriv es</w>
deriv ates</w>
deri ved,</w>
dere pression</w>
derang ements.</w>
der mo-epidermal</w>
der line</w>
der ic
depression /
depression/ anxiety</w>
depress ants,</w>
depren yl,</w>
depolymer izing</w>
depolariz ation-induced</w>
depolar ising</w>
deple tor,</w>
depend s,</w>
depend ent:</w>
depend ency,</w>
depart ment:</w>
depart ment
dep th.</w>
dep th,</w>
dep icted</w>
deoxycorticosterone- NaCl-treated</w>
dentistr y.</w>
densit ometry</w>
densi ties.</w>
densi ties,</w>
den opamine</w>
den op
demethyl ated</w>
dementi a:</w>
demeclo cycline-induced</w>
dem y</w>
delta9- tetrahydrocannabinol</w>
delta9- THC.</w>
delta-aminol aevulinic</w>
delta- AV
deliver y:</w>
deliver ies.</w>
deliri ous.</w>
dele tions.</w>
dele ting</w>
delay ed-type</w>
del usion,</w>
del ays.</w>
del T
delT 96
delT96 1
dehydrogenase- deficient</w>
dehydro emetine</w>
dehydro cholate</w>
degran ulation,</w>
degener ation-
deform ities,</w>
defici ent,</w>
defen ses</w>
defen se.</w>
defect s;</w>
def ence</w>
deep ,</w>
decur sin</w>
decreas es,</w>
decont amination</w>
decompens ation,</w>
decom pressive</w>
decline d,</w>
decl ine,</w>
decision- making,</w>
deci sion.</w>
deci bel
deci be
decibe ls</w>
decapit ation.</w>
dec erebrate</w>
debriso quine/sparteine</w>
debriso quine,</w>
debri s,</w>
debri de
deb ated</w>
deb at
death s:</w>
dead ly</w>
deacetyl ation</w>
de/ RR</w>
de- de-
de ter</w>
de tention</w>
de synchronized</w>
de stabilizing</w>
de personal
de methoxy-
de menting</w>
de hydrated</w>
de grades</w>
de fibrinogenating</w>
de dicated</w>
de d-
de buffered</w>
de activated</w>
de -associated</w>
de ),</w>
de 's</w>
dd I,</w>
dd C.</w>
day (-1).</w>
day (-1));</w>
daun omycin,</w>
datab ases.</w>
dat a-
dark -
dar ub
dar inaparsin</w>
dar ifenacin</w>
dapsone- related</w>
danger ous,</w>
dampen s</w>
dam s,</w>
dam age:</w>
dam age)</w>
dam age),</w>
daily- half</w>
dact yl
dacryocystorhin ostomy</w>
dacarb azine.</w>
dTc- lidocaine</w>
d. f.=
d. f.</w>
d- sotalol</w>
d- pregnant</w>
d- degree</w>
d- chlorpheniramine</w>
d- B
d- AMPH-induced</w>
d(CH2)5 D
d s).</w>
d pp
d orm
d ine)</w>
d i</w>
d ating</w>
d ane)</w>
d Tc
dTc -induced</w>
d PI/
d P</w>
d B;</w>
d B).</w>
d A</w>
d ?</w>
d (-1));</w>
cytotoxic /
cytotoxic/ suppressor</w>
cytot oxin</w>
cytoskeleton -associated</w>
cytoplas mic-
cytochrome- P450</w>
cyto reductive</w>
cyt oly
cyt .
cystin uria,</w>
cysticer cosis</w>
cysticer cosis.</w>
cysti tis:</w>
cyste inyl
cyste ine,</w>
cyst ostomy</w>
cyst oscopy.</w>
cyst oscopy,</w>
cyst ometric</w>
cyclospor ine-</w>
cyclophosphamide -related</w>
cyclophosphamide -based</w>
cyclophosphamide -</w>
cyclohexanec arboxamide</w>
cyclohex yl]benzene
cyclohex yl)
cyclohex en
cyclo cytidine</w>
cyclic- GMP</w>
cyclic- AMP</w>
cycle -
cycl es),</w>
cycl ase;</w>
cycl ase.</w>
cycl amate</w>
cyanocobal amin</w>
cyano acryl
cyanoacryl ate)</w>
cyan opindo
cy geal</w>
cut ellaria</w>
current- clamp</w>
curren ts,</w>
curcu min.</w>
curcu min,</w>
curar ized</w>
cur ves,</w>
cur ly-tail</w>
cup -to-
cup-to- disc</w>
cune ate</w>
culpr it.</w>
culmin ated</w>
cul igo</w>
cuff )</w>
cu. mm</w>
cu .</w>
cryo therapy</w>
cryo therapy.</w>
cryo stat</w>
cross- tal
cross- sensitivity</w>
cross- react</w>
cross- links</w>
cross- linked</w>
cross- fostered</w>
cross- correlation</w>
cross reactivity</w>
cross over.</w>
cross ings</w>
cros ses.</w>
crocin s</w>
criteri on.</w>
criteri on,</w>
criter ia).</w>
cri mes</w>
cri be</w>
cres cents,</w>
creatinine >5.0</w>
creatin ine),</w>
creat ine-
creat ine,</w>
cre ws</w>
cre vicular</w>
cre ative</w>
cre am
crani otomy.</w>
crani otomy,</w>
crani ocerebral</w>
crani ectomy.</w>
crani ectomy,</w>
cra w
cr ying,</w>
coxib s.</w>
coupl ing.</w>
counterpuls ation</w>
counter ing</w>
counter clockwise</w>
counter ,</w>
counsel ing.</w>
coun ting.</w>
coumar in-induced</w>
cotranspor ter,</w>
cotranspor t</w>
cos ol
corticosteroid -treated</w>
corticosteroid -</w>
cortico id</w>
cortic al-
cortex -to-
cortex-to- serum</w>
cortex -
corrobor ates</w>
correl ation,</w>
correl ates,</w>
correc tive</w>
corne a,</w>
corn u</w>
cor ticom
cor rhachia</w>
cor ii</w>
copies/ mL,</w>
copi pam</w>
coordin ation)</w>
coordin ates</w>
cool ing.</w>
cool ing,</w>
convuls ant.</w>
convul sion-inducing</w>
convol u
conver tases</w>
conven tional-dose</w>
conval escence</w>
controlled- onset,</w>
control s:</w>
control --
control-- --
control "</w>
contribut e,</w>
contrast- enhancing</w>
contradic tor
contradic ted</w>
contracep tion,</w>
contrac tilit
contra versive</w>
contra indicate</w>
contra indic
continuous- wave</w>
contex tu
contamin ant</w>
cont acts;</w>
cont acts,</w>
cont act,</w>
consum ptive</w>
consum er</w>
consult ation,</w>
consul t</w>
consu med.</w>
constric ting</w>
constitu ent,</w>
constipati on;</w>
constant- rate</w>
consider s</w>
consider ations,</w>
consider ation,</w>
consequ ential</w>
consecuti vely.</w>
conn ects</w>
conjunctivi tis.</w>
conjunctiv a</w>
congenit ally</w>
congenit al,</w>
cong ested</w>
confron ted</w>
conflu ence</w>
conflic t"</w>
confirm ation,</w>
confid ently</w>
conf usion
condylo mata</w>
conduct ance,</w>
conduc tivity</w>
conduc ive</w>
conditioned- hyperactivity</w>
condition s).</w>
concomit antly,</w>
conclu sive,</w>
concer ted</w>
concer t</w>
concer ns,</w>
concer ned.</w>
concentration- dependently</w>
concentration ).</w>
conce aled</w>
con specific</w>
con nexin</w>
con nex
con cise</w>
con 1</w>
con -
computer .</w>
computer -based</w>
comput ational</w>
compromi sed,</w>
compres sions,</w>
compres sion-
complic ated.</w>
complex :</w>
comple tion,</w>
comple ment,</w>
complain s</w>
compati bility</w>
compassion ate-
compassionate- use</w>
compart ments.</w>
compart ments,</w>
comparison ).</w>
comparison ),</w>
compan ies</w>
comp iled</w>
comp iled.</w>
comp anion</w>
comorbidi ties.</w>
communic ated</w>
common ;</w>
committe e</w>
committe e.</w>
commis sure</w>
comman ds</w>
comman ds.</w>
comm and</w>
comfor t.</w>
comedic ation.</w>
combination- therapy</w>
combin ation)</w>
comb ating</w>
comato se,</w>
com ment</w>
com a:</w>
collo id)</w>
collater als.</w>
collagen/ epinephrine-induced</w>
collagen- epinephrine</w>
collagen ase-
collagenase- like</w>
collagen -induced</w>
coll a</w>
cold- water</w>
col orimetric</w>
col oni
col itis:</w>
col iti
col ic.</w>
col d.</w>
cohor ts,</w>
code ine-containing</w>
cochle ae</w>
coccidi oidomy
cocaine- taking</w>
cocaine- negative</w>
cocaine- injected</w>
coc ult
coc ktail</w>
cobal t</w>
coales ced</w>
coagulo pathic</w>
coagulo path
coagul ability</w>
co-trimox azole,</w>
co- pretreatment</w>
co- ordin
co- incubation</w>
co- factors</w>
co- existing</w>
co- administer</w>
co vers</w>
co varied</w>
co protein</w>
co oper
co ital</w>
co injection</w>
co infused</w>
co gwheel</w>
co factor,</w>
co existent</w>
co ast
co al</w>
co administration.</w>
cm/ s)</w>
cm 3</w>
cm 2/
club s</w>
clu stering</w>
clozapine/ olanzapine</w>
clozap ine),</w>
clotrimaz ole</w>
cloti azepam</w>
closed- question</w>
clopidogrel :</w>
clopidogrel -treated</w>
clon ing</w>
clon ed.</w>
clofib ric</w>
clofaz imine</w>
cloc k</w>
clo tted</w>
clo sest</w>
clo sed,</w>
clo se,</w>
clo but
clinicoradi ologic</w>
clinici ans.</w>
clinic s,</w>
clinic al-
clim acteric</w>
clear ance),</w>
clea ving</w>
cle mast
cle av
clau strum</w>
classi fied.</w>
classi fi
classi cal'</w>
cl ick
cl asses
cit ronell
cit rate-
cisterna e.</w>
cister ns</w>
cisplatin- etoposide</w>
cisplat in;</w>
cis- platinum,</w>
cis- diamminedichloroplatinum</w>
cis atracurium.</w>
cis -</w>
cirrho sis/HCC</w>
circumst anti
circumstanti al,</w>
circumci sion</w>
circum vention</w>
circum scribed</w>
circul ating,</w>
circuit s,</w>
circl ing,</w>
cipro fibrate,</w>
cine angiography,</w>
cin ti
cin ation</w>
cid ol</w>
ciclospor in-induced</w>
ci razol
ci proxif
chron ology</w>
chron ic)</w>
chromos om
chrom ati
chromati d</w>
chro tron</w>
chorio retinopathy</w>
chore omyoclonic</w>
chore atic</w>
chore a;</w>
chore a:</w>
chondro sarcoma</w>
chond rification</w>
cholinoc eptors</w>
cholinester ase-
cholinerg ically-
cholinerg ic-induced</w>
cholinerg ic-
cholin olytic</w>
cholest -4-
cholest-4- en-3-one,</w>
choled ochoduodenal</w>
chole lithiasis,</w>
cholangi olitis</w>
chol ing
cho ic</w>
chlortal idone</w>
chlorprothixen e.</w>
chlorpromaz ine)</w>
chloroquine- resistant</w>
chloroqu ine:</w>
chloroethyl clonidine</w>
chloroethyl clonidine,</w>
chloro- 7-
chloro trianisene</w>
chloro phenylalanine</w>
chlor phenylpiperaz
chlor phentermine,</w>
chlor ide),</w>
chin chill
children ;</w>
children ),</w>
chic k.</w>
chi (2),</w>
chest- pain</w>
cheno deoxychol
chemotherapy- naive,</w>
chemotherap y).</w>
chemotherap ies,</w>
chemosensitiz er</w>
chemosensi tivity</w>
chemon aive</w>
chemoconvuls ants.</w>
chemoconvuls ants,</w>
chemoconvul sions</w>
chemo prophylaxis.</w>
chemo kines</w>
chemo hormonal</w>
chemo -</w>
chemist ries,</w>
chem otoxic</w>
chem osensory</w>
check- up,</w>
che st.</w>
che l
chatter ing</w>
chatter ing,</w>
charybdot ox
charge -
charg es</w>
characteris tic.</w>
characteris tic,</w>
character ised.</w>
character .</w>
chap ters</w>
chang e;</w>
chamb ers,</w>
challenge d,</w>
challenge )</w>
challeng ing.</w>
ch y</w>
ch oring</w>
ch iral</w>
ch ause
chause n</w>
ch al
chal epensis</w>
cervic itis.</w>
certain ty</w>
cerebro ventricular</w>
cerebro ventricle-
cerebro vasomotor</w>
cerebro -
cerebri )</w>
cerebr um,</w>
cerebell um)</w>
cephalospor in.</w>
cephalor idine.</w>
cephalex in.</w>
centrophen oxine</w>
centrally- acting</w>
cent rizonal</w>
cent rifugation</w>
cent ered</w>
cent er's</w>
cells/micro liters</w>
cells/micro L).</w>
cells/ mm3,</w>
cells/ mm3)</w>
cell -to-
cell-to- granule</w>
cell -derived</w>
ceftriax one:</w>
ceftizoxi me.</w>
cefotaxime -treated</w>
cefamand ole-coated</w>
cefamand ole,</w>
cef podoxime</w>
ce lona,</w>
ce ).</w>
cavernos um.</w>
cave ats</w>
caud ate/
caudate/ putamen</w>
caud at
catheter isation.</w>
cathep sin-
catecholamine- sensitive</w>
catecholamine- depleted</w>
catechol-O- methyl</w>
catechol amine.</w>
cataton ia:</w>
catar acts.</w>
catar act,</w>
catar act
catapl ectic</w>
catalep tic,</w>
catalep sy-
catabol ism,</w>
cat nip</w>
cat astroph
caspase- 3,</w>
cases/ 100</w>
case- series</w>
case in;</w>
cas ual</w>
cas e;</w>
cas e),</w>
carrageen an/
carr yover</w>
carmofur .</w>
carmin omycin</w>
careful ly,</w>
cardioverter/ defibrill
cardiover ter</w>
cardiomy ocyt
cardiomegal y.</w>
cardio selectivity.</w>
cardio protective.</w>
cardio hemodynamic</w>
cardio graphic</w>
cardio angiography</w>
cardiac -related</w>
cardia .</w>
cardi tis,</w>
cardi otomy</w>
cardi ostimul
cardi ologists</w>
cardi ologist</w>
carcinom as
carcinogen s.</w>
carcinogen .</w>
carcin osarcom
carboxy- 3-hydroxy
carboxy l</w>
carbox amide,</w>
carboplatin/ taxane</w>
carboplatin/ paclitaxel</w>
carboplatin :</w>
carboplat in-treated</w>
carboplat in-based</w>
carbon s.</w>
carbohyd rates,</w>
carbim azole-induced</w>
carbidopa .</w>
carbet ocin</w>
carbenicill in,</w>
carbamazepine-10,11- epoxide</w>
carbamazep ine's</w>
carb ocyste
carb ac
carbac eph
car umon
captopri l-
capsul es,</w>
capsul ar,</w>
capsaicin- pretreated</w>
caps azepine,</w>
caps azep
capre omycin</w>
capre omycin,</w>
capillar itis</w>
capillar itis.</w>
capecitab ine:</w>
cap ut</w>
cap itis.</w>
cap abilities</w>
cannul ation.</w>
cannul ation,</w>
cannul ated.</w>
cannabin oids.</w>
candidi asis.</w>
candide mia</w>
cancer s;</w>
cancer s:</w>
cancer ).</w>
cancell ation</w>
campt othecin</w>
cam pa
cam era-
calori e-restricted</w>
caldi amide,</w>
calcul i,</w>
calcul ated,</w>
calcium- free</w>
calcium- containing</w>
calcit onin,</w>
calci um:</w>
calc imimetic</w>
cal ves</w>
cal ves.</w>
cal ories</w>
cal f.</w>
caffeine- exposed</w>
caffe ine;</w>
caffe ine-</w>
caffe ine)</w>
ca used,</w>
ca re;</w>
ca p</w>
cTn T,</w>
cGM P,</w>
c-fos .</w>
c- jun,</w>
c umber
c s
c rown</w>
c roft-Gault</w>
c rest
c remophor</w>
c oxib</w>
c or</w>
c on</w>
c oconut</w>
c occi</w>
c k's</w>
c ic
c ence</w>
c ations.</w>
c ations,</w>
c ation-
cation- selective</w>
c ass
c ant</w>
c ages.</w>
c ac
c ]</w>
c TB
cTB S</w>
c AM
cAM P-induced</w>
byp ass
butyrophen ones</w>
butyr yl
butyl ]
buttoc ks,</w>
buter ol-induced</w>
butanoyl morphine</w>
but yrate,</w>
but en
but aclam
busulph an.</w>
busulf an/
burst s/min,</w>
burg ,</w>
burden ,</w>
bupropi on's</w>
bupivaca ine;</w>
bupivaca ine)</w>
bunitro lol</w>
bund les.</w>
bumetan ide.</w>
bull ae</w>
bulb s</w>
bul b,</w>
buil t</w>
bu ying,</w>
bt b</w>
brux ism</w>
brucello sis</w>
bronchopneum onia.</w>
bronchodilat ory</w>
bronchodilat ors,</w>
bronchodi lation,</w>
bronch oscopy.</w>
bronch oconstriction</w>
bromocript ine-related</w>
brom o</w>
brom ide)</w>
broaden s</w>
bro xyquinoline</w>
bro faromine</w>
bro benz
brobenz oxaldine</w>
brie fer</w>
bridg ing.</w>
bridg es</w>
bri dge
brevi ation</w>
breath -
breast- feeding.</w>
break points</w>
bre wer's</w>
branch es,</w>
bran ching</w>
brainst em-
brain- microvascular</w>
brain- injured</w>
bradyp nea</w>
bradykin in-induced</w>
bradycardia -
brady kinetic</w>
brady dysrhythmias</w>
brady asystolic</w>
brachi ocephalic</w>
brac ing</w>
brac hy
bra in/plasma</w>
br yos</w>
bp m;</w>
bp m).</w>
boy s)</w>
box ,</w>
bowel s</w>
boun ded</w>
boun d)</w>
bother som
bot tom</w>
border ing</w>
bor ders</w>
bol i</w>
body- weight</w>
body- builder</w>
body building</w>
bodi es:</w>
bob bing</w>
boar d,</w>
bo oster</w>
bo ok</w>
blur ry</w>
blue- yellow</w>
blu e.</w>
blood- perfused</w>
blood- filled</w>
blood- borne</w>
blood stream</w>
blocker s)</w>
blockade ;</w>
block ing,</w>
blind ness:</w>
blin d.</w>
bli stering</w>
blepharo spasm.</w>
blepharo spasm,</w>
bleb s</w>
ble omycin-detectable</w>
ble ed.</w>
ble b</w>
blastocy st</w>
blan ching</w>
blad der-
black ),</w>
bl y,</w>
bl ation</w>
bl and</w>
biv udine</w>
bisphosphonat es,</w>
bis(1- methylethyl)
bis mu
birefr ingent</w>
bir thing</w>
biotrans formation.</w>
biotin ylated</w>
biopsi ed.</w>
biolog y,</w>
bio impedance</w>
bio equivalence</w>
bio energetics</w>
bio energetic</w>
bio artificial</w>
binucle ation</w>
bing e
bin uclear</w>
billi on/
bilirub inemia</w>
bil ity.</w>
biguan ide</w>
bifur cation.</w>
bifeprun ox</w>
bicarbon ate;</w>
bicarb onat
bic yt
bi variate</w>
bi phenyl</w>
bi ocytin</w>
bi ochemist
bi g-
between- treatment</w>
between- subjects</w>
bethan idine.</w>
betagam ma</w>
beta4- subunit</w>
beta4- /-</w>
beta2- leukocyte-integrins
beta2- /-</w>
beta2 (-/-)</w>
beta-methyl- iodophenyl</w>
beta-methyl- 5alpha-pregnan-20-
beta-lactamase- positive
beta-carboline-3- carboxylic</w>
beta-carboline-3- carboxylate</w>
beta-D- glucuronide,</w>
beta-CC M</w>
beta- thalassaemia</w>
beta- sympathomimetic</w>
beta- pregnan-20-
beta- oxidation,</w>
beta- modified</w>
beta- glucuronide.</w>
beta- glucuronidase</w>
beta- funaltrex
beta- antagonists</w>
beta- amyrin</w>
beta- amino</w>
beta- adrenoceptors.</w>
beta- PCT</w>
beta- OH
beta- HCH</w>
beta- Adrenergic</w>
beta ine.</w>
beta M</w>
beta 2-adrenergic</w>
beta 2,</w>
beta 1-adrenergic</w>
beta 1-</w>
beta ).</w>
beta ),</w>
bet we
bet anin</w>
bet ame
bet ab
betab lock
best- corrected</w>
bes ylate,</w>
bepridil )</w>
bepri dil,</w>
benzyl acyclouridine</w>
benzopyran o
benzofur an
benzodiazep ine-like</w>
benzodiazep ine-3-
benzodi ox
benzo flavone</w>
benzo ate)</w>
benzo (f
benzo(f )
benzil ate</w>
benz ylthio
benz yloxy
benz en
benz ar
benz amil</w>
benseraz ide)</w>
benser azide,</w>
benefit /
benefici al,</w>
bene ath</w>
beme gri
belong ed</w>
behaviour ally</w>
behavior s:</w>
behavior s)</w>
behavior ally.</w>
behavior ;</w>
behavior ).</w>
begin ning,</w>
bedd ing.</w>
beats/ mm</w>
beat .</w>
bead s</w>
be st.</w>
be st
be low.</w>
be li
be ings.</w>
be ings,</w>
be having</w>
be et
be er.</w>
be d-
be d)</w>
be ars</w>
be -induced</w>
bath ing</w>
basichondro cranium</w>
basi cally</w>
basel ine);</w>
base- to-apex</w>
bas es.</w>
barri ers,</w>
barri er;</w>
barri er)</w>
baro receptor-mediated</w>
bark s</w>
bari um-exposed</w>
barbitur ate-
barbitur ate,</w>
bar r
band s.</w>
ball istic</w>
balance d,</w>
bal dness.</w>
bacte remia/
baclofen 's</w>
back cros
back ache</w>
bac ulo
bac ter</w>
bac itracin</w>
babo on</w>
bab ies.</w>
bab ies,</w>
b/ Fe
b/Fe J</w>
b.w. t.)</w>
b.w. /
b.w .).</w>
b.i.d .,</w>
b.i.d .).</w>
b. p.m.</w>
b) beta(3)</w>
b) )(-/-)</w>
b y:</w>
b y
b udg
b ts</w>
b risk</w>
b remazocine</w>
b ought</w>
b one/joint</w>
b one.</w>
b inary</w>
b illing</w>
b ic</w>
b er,</w>
b c
b ax
b alb
balb /c</w>
azosin )</w>
azobenz ene</w>
azo semide</w>
azo o,</w>
azithrom ycin-induced</w>
azido thymidine-induced</w>
az oxymeth
az one,</w>
az etidin
az etid
az aspirodec
az alide</w>
az ad
az abicyclo
ay iotopoulos</w>
ay asu
ayasu 's</w>
ax oplas
ax o-
ax ial,</w>
ax i
awaren ess.</w>
awaken ings</w>
awak ening.</w>
awak en</w>
awa ke
aw a</w>
averm ectin</w>
aver ted</w>
avail ability.</w>
av al</w>
autotrans planted</w>
autoradiograph ically.</w>
autom atism</w>
autom atism
auto- receptor</w>
auto- immune</w>
auto fluorescence</w>
auto antibody,</w>
author ization</w>
aut os
aut ac
auro sis</w>
aur a)</w>
augh an</w>
audit ory-
audio grams.</w>
audio grams,</w>
audi ometr
aud ited</w>
attribut ed,</w>
attri tion</w>
atten tive</w>
attemp ted,</w>
attack -like</w>
atroph ic,</w>
atrop ine-induced</w>
atrop ine-</w>
atriure sis</w>
atri al-
atri a-
atran ,</w>
atracuri um-induced</w>
atracuri um-
atr ics</w>
atovaqu one/
ator vastatin.</w>
ator vastatin-induced</w>
ator va</w>
atop y</w>
atop ics</w>
aton ic,</w>
ativel y-
atipame zol
ation- mediated</w>
ation- matched</w>
ation- approved</w>
ation s/
ation s),</w>
atic -
ati zation</w>
ati veness</w>
ati veness,</w>
ati form</w>
ati dyl</w>
atherospermin ine</w>
ather ogenesis.</w>
athe toid</w>
ater -
atebr adine</w>
ate- type</w>
ate- exposed</w>
ate- Lip
ate -like</w>
atax ia:</w>
atal eptic</w>
at ympanic</w>
at trac
at titude</w>
at ry</w>
at ony</w>
at las</w>
at in,</w>
at i</w>
at es)</w>
at :</w>
at ),</w>
asystol e)</w>
asynchron y</w>
astro cytosis</w>
astr agalus</w>
asthmatic us.</w>
asthmatic s,</w>
asthen ic</w>
asthen ia/
asthen ia.</w>
astemiz ole-induced</w>
ast ressin</w>
ast er</w>
associ ating</w>
assign ment.</w>
assess able.</w>
assem bly,</w>
asse mble</w>
assay ).</w>
assa h</w>
ass ault</w>
aspirin/ NSAID</w>
aspir in:</w>
aspir in-treated</w>
aspir in's</w>
aspi rates</w>
aspi rate</w>
aspart ate-dependent</w>
aspart ate)</w>
asle ep</w>
asi a:</w>
ased- fiber</w>
ase -</w>
ascorb ate,</w>
asc rib
asc iculation</w>
as tigm
as one,</w>
as king</w>
as cribe</w>
aryl piperazines</w>
aryl pempid
ary- prevention</w>
arub icin.</w>
arti caine.</w>
arthro scopy.</w>
arthri tis)</w>
arthralgias/ myalgias</w>
arterio pathic</w>
arterio grams.</w>
arterio -
arteri es;</w>
artemisin in-based</w>
art urients</w>
arrest ).</w>
arrang ement.</w>
arous al,</w>
ark e
ari l</w>
ari b
ari als</w>
arginine- methyl</w>
arg yrophilic</w>
arec oline.</w>
are a;</w>
are a/
ard y</w>
ard ing,</w>
ard 's</w>
architect ural</w>
arc hed,</w>
arb our</w>
arb or
arachnoidi tis,</w>
arachid on
arac his</w>
ar ms:</w>
ar mit
ar isch-Herxheimer</w>
ar is,</w>
ar caine</w>
ar ap
aprotin in.</w>
aprind ine.</w>
appro val.</w>
appra isal</w>
appoint ments</w>
append ectomy.</w>
appe aling</w>
apoptosis- inducing</w>
apomorph ine).</w>
apolipo proteins.</w>
apo C-
apnoe ic</w>
apne as,</w>
aphasi a.</w>
apart ),</w>
aparo scopic</w>
ap prehen
ap position,</w>
ap eptide,</w>
ap amin,</w>
aort as.</w>
aor titis</w>
anxiogen ic.</w>
anxiet y:</w>
antiretrovir al-induced</w>
antineoplast ons</w>
antineoplast on</w>
antine utrophilic</w>
antine oplas
antin ause
antimicrobi al-induced</w>
antimalari als,</w>
antihist amine,</w>
antigen -specific</w>
antieme tics.</w>
antidot e.</w>
antidepressant /
antidepressant/ anxiolytic</w>
anticoagul ant-induced</w>
anticoagul ant,</w>
anticip ated,</w>
antibiom an
antibioman ia
antibio tic
antibacteri als,</w>
antiarryth mic</w>
anti-eme tics</w>
anti-L K
anti-HB e-seropositive</w>
anti-HB c,</w>
anti- tuberculous</w>
anti- substance</w>
anti- stress</w>
anti- proliferative</w>
anti- oxid
anti- mouse</w>
anti- malarial</w>
anti- infective</w>
anti- hypoxic</w>
anti- fibrotic</w>
anti- factor</w>
anti- e</w>
anti- depressant</w>
anti- catatonic</w>
anti- atrophic</w>
anti- allergic</w>
anti- aggreg
anti- acetylcholine</w>
anti- S
anti-S SG</w>
anti- Parkinsonian</w>
anti- HBs
anti- GBM</w>
anti- DNA</w>
anti- CD
anti- C3d</w>
anti tubercular</w>
anti thrombosis</w>
anti tachycardiac</w>
anti striational</w>
anti serotonergic</w>
anti rifampicin</w>
anti pyr
anti porter</w>
anti obsessive</w>
anti mon
anti mitochondrial</w>
anti metabolite</w>
anti leukemic</w>
anti leukemia</w>
anti hypertensive,</w>
anti hepatitis</w>
anti glomerular</w>
anti estrogens,</w>
anti epileptics.</w>
anti diuresis</w>
anti de</w>
anti cholinesterases</w>
anti blastic</w>
anthracycl ine-pretreated</w>
anthracycl ene</w>
anth ropometric</w>
anth ran
anteced ents</w>
ante dated</w>
antagonist :</w>
antagon ized,</w>
antagon ising</w>
antagon is
ant adine-induced</w>
ant -associated</w>
anoti a</w>
anos mia</w>
anorexi genic</w>
anorec tics,</w>
anop thal
anococ cygeus</w>
ano- Ward</w>
ano [
ann ulo
ann ular</w>
anis omycin</w>
anis omet
animal s:</w>
animal s.(ABSTRACT</w>
animal s)</w>
anim ation</w>
ani on.</w>
angu ard</w>
angiotensin- II</w>
angiotens in.</w>
angioedema )</w>
angio- oedema</w>
angio pathy,</w>
angio grams.</w>
angi oten
angi opo
ang itis</w>
aneth ole</w>
aneth ole,</w>
anestheti st</w>
anesthesia ?</w>
anesthe tic-
anem ic.</w>
anem ia-related</w>
ane ]</w>
ane ;</w>
ane :
ane -1-
androst enedione</w>
androgen s.</w>
androgen -
andall-Selit to</w>
and amide</w>
ance str
anc rod,</w>
anc ient</w>
anatom ic,</w>
anat abine,</w>
anast omoses</w>
anamne sis</w>
analyz er</w>
analyz er,</w>
analy sis)</w>
analy ses;</w>
analy ser
analy sed,</w>
analogu e),</w>
analgesic- antipyretic</w>
analgesic /
analgesi a;</w>
analgesi a
analge tic</w>
anaestheti st.</w>
ana deine</w>
ana -F
ana-F arber</w>
an- subcontinent</w>
an- cyclophosphamide</w>
an- Wistar</w>
an us.</w>
an uric,</w>
an tion</w>
an onym
an one</w>
an ome
an ner</w>
an ions.</w>
an iline</w>
an i</w>
an ex
an cy
an ap
amyr in,</w>
amylo id-associated</w>
amrin one.</w>
amput ation.</w>
amplitu de/RR</w>
ampl ify</w>
amphoter icin-induced</w>
amphetamine- type</w>
amphetamine- associated</w>
amphet amine;</w>
amph oB</w>
amoxicillin/clavulan ate</w>
amoxicillin/clavulan ate.</w>
amo eb
ammon is</w>
ammon ia.</w>
ammon ia,</w>
ammon i
amlodip ine;</w>
amiodar one-related</w>
amiodar one-
aminotransfer ases.</w>
aminotransfer ases,</w>
aminophylline -</w>
aminop ter
aminonucleo side-
aminoglyco side,</w>
aminocyclopentane -1,3-
amino-8-D- arginine</w>
amino- n-
amino guanidine,</w>
amino adamant
amino acridine</w>
amine ]</w>
amin otetralin</w>
amin opyridine</w>
amin obicyclo[3.
amin ergic,</w>
amide s.</w>
amide s,</w>
amide ;</w>
amen orrhoea</w>
amen orrhea,</w>
amelior ative</w>
amelior ated,</w>
ambul ated</w>
ambul ant</w>
ambi valence</w>
amant adine-induced</w>
am yl</w>
am ustin</w>
am po
am orph
am obarbital,</w>
am aurosis</w>
am ate,</w>
am a
am B</w>
alveol i</w>
altern ans.</w>
alprostadi l,</w>
alprazol am
alpha2- adrenoceptors,</w>
alpha2 A-
alpha1- preferring</w>
alpha-tocopher ol.</w>
alpha-tocopher ol)</w>
alpha-methyl- para-tyrosine</w>
alpha-methyl norepinephrine</w>
alpha-mang ost
alpha-keto glutarate</w>
alpha-fluoro-beta- alanine</w>
alpha-amino-3-hydroxy-5-methylisoxazole-4- propionic</w>
alpha-amino-3-hydroxy-5-methyl-4- isoxazole</w>
alpha-actin in</w>
alpha-2 b)</w>
alpha- tropan
alpha- phenyl-N-
alpha- methyl</w>
alpha- mediated</w>
alpha- glucosidase</w>
alpha- ethyl-
alpha- blockade</w>
alpha- adrenoreceptors</w>
alpha- adrenoreceptor</w>
alpha- adrenolytic</w>
alpha- Methyl
alpha- M
alpha- HCH,</w>
alpha- D-
alpha- A
alpha- 7</w>
alpha,beta-me ATP)</w>
alpha,beta- methylene</w>
alpha, betame
alpha, 25-
alpha(4) beta(2)</w>
alpha(2)- adrenoceptors</w>
alpha(1D )-
alpha(1 B
alpha(1 A)-
alpha(1A)- adrenoceptor</w>
alpha(1 )-</w>
alpha 5-</w>
alpha 5-
alpha (II
alpha(II b)beta(3)</w>
alph acal
alphacal cidol</w>
alph ab
alone );</w>
almo kal
allo we
allo tted</w>
allo sterically</w>
allo cortical</w>
allevi ated.</w>
aller ian</w>
alle le.</w>
alle le,</w>
alle gedly</w>
all- trans
all y-</w>
all y),</w>
all mann's</w>
all ine</w>
all 's</w>
alkyl /
alkyl/ aryl-
alkal isation</w>
alis )</w>
alim entary</w>
align ed</w>
ali um)</w>
alg ia,</w>
alfuz osin,</w>
alfa-2 a,</w>
alf athesin</w>
alf a
alepl on</w>
aldoster one-treated</w>
aldehy de.</w>
alcohol- free</w>
alcohol ic.</w>
alcohol ic,</w>
albumin- bound</w>
alaprocl ate,</w>
alam azoo,</w>
al-to- apical</w>
al- variant</w>
al- anesthetized</w>
al together</w>
al ston
al s),</w>
al ol.</w>
al o</w>
al mitrine</w>
al location.</w>
al ization.</w>
al ga
al d
al ar</w>
akine sia/
akathi sia:</w>
air way.</w>
air e</w>
air -
aim iri</w>
ai robi
ai ko-
agoraph obia.</w>
agoraph ob
agonist ).</w>
agonist "</w>
agon ism.</w>
aggreg ations</w>
aggreg ate,</w>
agglutin ins,</w>
agent s--
agent s)</w>
agent 's</w>
age- dependent,</w>
age ing-induced</w>
age ?</w>
age /
ag ra</w>
ag ing"</w>
ag iline</w>
ag encies</w>
ag ed,</w>
ag atran,</w>
ag )</w>
affili ated,</w>
aff ectively</w>
afe brile</w>
afe bri
aeros ols</w>
aeros ol,</w>
aer odigestive</w>
aem ia:</w>
advis ability</w>
adver se-
adur abol
adult- generated</w>
adul ts)</w>
adriamycin- cardiomyopathy.</w>
adrenocortic otrophin</w>
adrenocor tico
adrenoceptor- selective</w>
adrenal in</w>
adrenal ectomized,</w>
adren ic</w>
adren als</w>
adren al,</w>
adolescent s:</w>
adolesc ence:</w>
admis sion;</w>
admis sion).</w>
administere d)</w>
adjust ment.</w>
adjust ed.</w>
adipos ity,</w>
adheren ce,</w>
adenyl ate-
adenos ine)</w>
adenomyo sis</w>
adenofibrom as</w>
adenocarcin omas,</w>
adeno virus-mediated</w>
adeno hypophy
aden yl</w>
aden osis,</w>
adefovir -
adefovir- resistant</w>
adefovir ,</w>
ade l</w>
addi tives.</w>
addi tions</w>
add- on.</w>
adap tative</w>
adal afil</w>
ad vised,</w>
ad sorbent</w>
ad ol,</w>
ad o</w>
ad mixture.</w>
ad mixture,</w>
ad mit</w>
ad joining</w>
ad j</w>
ad ducted</w>
ad assah</w>
activity- regulated</w>
activi ti
active- treatment</w>
activ ity).</w>
act ing)</w>
acrole in.</w>
acro phase</w>
acri din
acqu iring</w>
aconit yl-lysozyme</w>
aconit ase</w>
acne form</w>
acide mia,</w>
acid/ l</w>
acid- sensing</w>
acid- Schiff</w>
acid- ,</w>
acid ].</w>
acid ;</w>
acid -mediated</w>
acid --
acid (A)</w>
ach es,</w>
acetyl- CoA</w>
acetyl transferase,</w>
acetyl salicylate</w>
acetyl morphine</w>
acetyl cysteine.</w>
acetaminophen- protein</w>
acetaminophen ;</w>
acetaminophen :</w>
acetaminophen -treated</w>
acetaminophen -containing</w>
acet y
acet ophen
acet ate;</w>
acet ate-induced</w>
acet amide.</w>
acepif ylline</w>
acea e),</w>
ace promaz
accur ate,</w>
accred ited</w>
accord ingly</w>
accommod ative</w>
accid ents,</w>
acchar ide</w>
acces sioned</w>
acces sible</w>
accept or</w>
accept ance,</w>
accentu ating</w>
accelerome ters</w>
accelerome ter.</w>
acc ine</w>
acc ess,</w>
ac tion-potential</w>
ac ted,</w>
ac re</w>
ac )</w>
abuse/ dependence</w>
abuse ;</w>
abund ance,</w>
abu tin</w>
abu met
abs ent;</w>
abor tive</w>
abor tion,</w>
abor ti
abor ted</w>
abor t</w>
abnormaliti es)</w>
able "</w>
abl ing</w>
abil ity;</w>
abil ity:</w>
abecarn il.</w>
abecarn il,</w>
ab users:</w>
ab used,</w>
ab stained</w>
ab ruptio</w>
ab rasion</w>
ab breviation</w>
ab ated.</w>
ab '
ab' )2</w>
a- tri-homo-22,24-di
a- determinant"</w>
a,5,6, 7,
a,5,6,7, 8
a,5,6,7,8 ,8
a,5,6,7,8,8 a,
a,5,6,7,8,8a, 9-
a, 27
a,27 a-tri-homo-22,24-di
a, 26
a,26 a,27a-tri-homo-22,24-di
a use,</w>
a stral</w>
a relin</w>
a phen
a is</w>
a ine,</w>
a ids.</w>
a etiologies</w>
a esthesia</w>
a effer</w>
a e).</w>
a ]-
a [1,
a T</w>
a MIBI</w>
a L</w>
a H
aH sd</w>
a GVHD</w>
a 5</w>
a 2</w>
a -treated</w>
a ")</w>
]- FDG-
] -induced</w>
] -</w>
[bis (4-fluorophenyl)
[bis(4-fluorophenyl) methoxy]
[SD ],</w>
[N va2]TRH</w>
[Mg2+ ]
[A OR
[AOR ]</w>
[5-amino- 3-
[4-(2-methoxyphenyl) -1-piperazinyl]
[4-(2-methoxyphenyl)-1-piperazinyl] ethyl]-
[3H]- thymidine</w>
[3H]- QNB</w>
[3H]- GABA</w>
[3H] ryanodine</w>
[3H] quinuclidinyl</w>
[3H] choline</w>
[3H] TRH</w>
[3H] PRL</w>
[3H] MK-801</w>
[35S] GTPgammaS</w>
[31] )
[31]) P</w>
[3- (4-
[2-(3,4-dichlorophenyl)ethyl]- N-methyl-2-
[2- [4-
[2- (6-
[199 8
[19 69]</w>
[18 ]-FDG-
[14C] succinate</w>
[14C] iodoantipyrine</w>
[14C] 5-HT</w>
[14 C]</w>
[11 C]-
[11C]- car
[1,2,4 ]-
[1, 4
[1,4 ]
[(3)H] albumin</w>
[(3 5)S]
[ range</w>
[ range,</w>
[ d.f.=
[ beta-
[ alanine</w>
[ adjusted</w>
[ [2-
[ [
[ X
[ Sar
[ SI
[ SD</w>
[ RRs</w>
[ Na+
[Na+ ],</w>
[ Met
[Met 5]
[Met5] enkephalin</w>
[ M
[ Hyp
[ H]</w>
[ H
[ GSH
[GSH ]</w>
[ F
[ DBP
[ D-
[ CMF
[ B
[ Arg
[Arg (14),</w>
[ ></w>
[ 9]</w>
[ 95.
[ 5
[ 4,5-
[ 27
[ 12
[ 11.
[ 1.5</w>
[ 1,25(OH)2D
[ 0.7
[ 0.2
[ -1
[ +/-</w>
[ +
[ (p
[(p F
[(pF )
[(pF) Phe
[ (3-
[ "
Zyb an,</w>
Zuc ker</w>
ZO -1,</w>
Z)- tetraenoic</w>
Z ung</w>
Z omepirac</w>
Z n,</w>
Z atebradine</w>
Z aleplon</w>
Z I-
Z -dependent</w>
Z -2
YM-080 50</w>
YM 4
YM4 30,</w>
Y- containing</w>
Y el
Y ang
Y U</w>
Y PE</w>
Y OH,</w>
Y MSM</w>
Y MR
YMR S,</w>
Y L</w>
Y 1204</w>
Y -like</w>
Ximel agatran</w>
XI AP</w>
X- irradiation</w>
X- A)</w>
X R)</w>
Work up</w>
Wor k-up</w>
Wist ar/
Wis con
Wild -type</w>
Wilcox on's</w>
Whole- cell</w>
Whit acre</w>
Whe reas,</w>
Wernicke-Korsak off</w>
Wellbutr in</w>
Well- designed</w>
Well come</w>
Wean ling</w>
Weak ness</w>
We b</w>
Wal es.</w>
Wal es,</w>
WY-14, 643</w>
WR 300
WR300 90</w>
WIN55,212- 3,</w>
WB M</w>
WB H.</w>
WB 4
WAY-100 635</w>
WAY-100 135</w>
WAY 100635</w>
WAR s</w>
W. H.
W.H. O.</w>
W- ICH</w>
W- 30</w>
W- 24</w>
W it
W ide</w>
W i
W est
W elfare</w>
W ater-
W allerian</w>
W U
WU BR</w>
W T.</w>
W T)</w>
W R</w>
W O
WO MAC</w>
W MA
WMA s</w>
W M
W K</w>
W IT
WIT H</w>
W IL
W G.</w>
W ),</w>
Volum es</w>
Vol t
Vir gin
Vir acept</w>
Viol ent</w>
Vindes ine,</w>
Vigi base,</w>
Vic tim
Vi etnamese</w>
Vi agra</w>
Veter inary</w>
Veter ans'</w>
Ves narinone</w>
Verapam il-sensitive</w>
Ver sion</w>
Ver a</w>
Venti lation</w>
Ven ipuncture</w>
Ve loc
Vc f.</w>
Vasodilat ation</w>
Vas urix</w>
Vas ospas
Vas omotion</w>
Vari ant</w>
Vari able</w>
Vari ability</w>
Var ying</w>
Var denafil</w>
Vancou ver</w>
VR CZ</w>
VR 1-
VR (1)</w>
VP- HNP</w>
VP F</w>
VP 16</w>
VP -1
VO 2
VII a)</w>
VII I.</w>
VG B.</w>
VEGF/ VPF</w>
VEC P</w>
VEC -
VE LO
VELO CI
VELOCI T
VE H</w>
VE BEP</w>
VAS- Sedation</w>
VAN .</w>
VAN -induced</w>
VAC TER
VACTER L</w>
V/ Delta
V o
V itamins</w>
V it</w>
V in
V ide
V ed
V anguard</w>
V alg
V al,</w>
V accine</w>
V ac
V SM
V R,</w>
V P.</w>
V P).</w>
V M,</w>
V M
V K</w>
V III,</w>
V F)</w>
V BD
V AC</w>
V 1,</w>
V .
V )-
V (mca)</w>
V (EN
V(EN DO)</w>
Usu ally</w>
Uro thelial</w>
Uro logists</w>
Uro logic</w>
Uro cortin</w>
Uri dine</w>
Ur d)</w>
Ur ban</w>
Uppsal a</w>
Upjoh n,</w>
Univer sal</w>
Unit ,</w>
Uniqu e</w>
Uni on</w>
Under sogelser</w>
Un less</w>
Un fractionated</w>
Un changed</w>
Umbil icaria</w>
Ul cer
Ugand an</w>
Ud valg</w>
US ,</w>
URB59 7</w>
UR R</w>
UPD RS-
UMD M)</w>
UM- 27
UM-27 2.</w>
UL N,</w>
UK-61,26 0,</w>
UK U</w>
UDP- glucuron
U69 ,593</w>
U5048 8
U50488 h</w>
U/ l</w>
U/ l.</w>
U/ l,</w>
U/ kg/h</w>
U-4 3,4
U-43,4 65</w>
U- wave</w>
U tility</w>
U sage</w>
U ric</w>
U re
U pr
U ne
U ganda.</w>
U cn</w>
U S.</w>
U S-
U MB</w>
U L</w>
U K)</w>
U F</w>
U C</w>
Typ ically,</w>
Tx nip</w>
Two- hundred</w>
Two- dimensional</w>
Twel ve-
Tw ice</w>
Tw ice-
Tubulo -interstitial</w>
Trp- P-2</w>
Trop onin-
Tro glitazone-induced</w>
Triphasi l</w>
Trimethop rim-induced</w>
Trimeth aph
Triazol am</w>
Triazol am-induced</w>
Triam cin
Tremor ,</w>
Treatment -induced</w>
Treat ment,</w>
Transi tional</w>
Transc ri
Trans thoracic</w>
Trans national</w>
Trans f
Tran ylcypromine</w>
Trac t</w>
Tra stuzumab</w>
Tra ining</w>
Tou hy</w>
Tot al,</w>
Tor sa
Topir am
Ton ic-clonic</w>
Tolu ene</w>
Tol metin-induced</w>
Tol azoline</w>
Tol az
To ichi's</w>
Time- averaged</w>
Tim ing</w>
Tim es</w>
Tig ason</w>
Tie2-Cre; Lox
Tie2-Cre;Lox p-EGFP</w>
Ticarc illin</w>
Ti apride</w>
Ti ag
Thromb opoietin</w>
Three- month</w>
Thior idaz
Thiop urine</w>
Thiaz ide-induced</w>
The o-Dur
Thal amic</w>
Thal am
Thail and,</w>
Th y</w>
Th r-34</w>
TgR[hAI] high</w>
Tex t</w>
Tetrahydro cannabinol</w>
Tetrac ycline</w>
Tet/ Dox</w>
Tet any</w>
Terbut aline,</w>
Terbin afine</w>
Ter son's</w>
Ter fenadine</w>
Tenofovir -related</w>
Temper ature</w>
Tem oc
Tel bivudine</w>
Teicoplan in</w>
Te trandrine</w>
Te trabenazine</w>
Te acher</w>
Td P-
Tc- IDA</w>
Tc- 99m-
Tax Ch.</w>
Taq IB,</w>
Tamsulos in</w>
Tak ayasu's</w>
Taiw an,</w>
Tail- tremor</w>
Tacrolim us-related</w>
Tacrolim us-induced</w>
Tachy phylaxis</w>
Tac rine,</w>
Ta us
Ta ur</w>
TX A
TX ).</w>
TW LI</w>
TV3 279</w>
TTX- resistant</w>
TT C</w>
TT ),</w>
TS- MO
TS-MO ST</w>
TRPV1 b</w>
TRPV 1-
TRPV (1)</w>
TRO196 22</w>
TR PM
TR P</w>
TR I.</w>
TR H-
TP P,</w>
TP N,</w>
TOR ),</w>
TOF- ratio</w>
TNS s.</w>
TNP- ATP</w>
TMPy P</w>
TMP-SM Z.</w>
TM O</w>
TLP R)</w>
TJ M
TI T</w>
TI D)</w>
TI C</w>
TI A.</w>
TH I</w>
TH F)</w>
TH F
THF s/THE</w>
TH C,</w>
TH ,</w>
TGF- beta-modified</w>
TGF- beta,</w>
TG M.</w>
TF C)</w>
TER T</w>
TEM -treated</w>
TE N</w>
TE C</w>
TD (50)</w>
TCD D
TB I,</w>
TAM -related</w>
TA G</w>
TA A-
TAA- rats</w>
TA ).</w>
T4/ T1</w>
T1 W</w>
T/ T</w>
T- amplitude/RR</w>
T- A</w>
T- 82</w>
T- 2</w>
T w</w>
T urkish</w>
T rough</w>
T ropisetron</w>
T ris
T rin
T readmill</w>
T racheal</w>
T oxoplasma</w>
T oxin</w>
T orem
T oc
T l-201</w>
T issues</w>
T g)</w>
T esticular</w>
T es
T en-
T ear</w>
T arget</w>
T anz
T adalafil</w>
T YPE</w>
T T-containing</w>
T T,</w>
T SH
T S:</w>
T S)</w>
T R)</w>
T PE,</w>
T OR</w>
T NS.</w>
T MTX/
T MB-
T DF
T CV-1
T CI</w>
T BM
T AM-
TAM- containing</w>
T AM,</w>
T AC
T A),</w>
T 30</w>
T 10.</w>
T 1/2</w>
T 1,</w>
T 0</w>
T -</w>
T (>
T(> 0.05)</w>
T (1)</w>
T (
T 's</w>
System ically</w>
Syst em,</w>
Syn ap
Symptom s.</w>
Switzer land</w>
Switzer land
Suxameth onium-induced</w>
Susta ined-release</w>
Suspici ousness</w>
Suspici on</w>
Surve ys</w>
Surg er
Sup pressive</w>
Sup ple
Sum atript
Sulind ac-induced</w>
Sulfadi azine-induced</w>
Sulfadi az
Sulf hemoglobinemia</w>
Substanti a</w>
Subj ect</w>
Sub optimal</w>
Sub cortical</w>
Su perior</w>
Struct ure-activity</w>
Stress ful</w>
Streptozotoc in-
Stren uous</w>
Stren gth</w>
Stra ub's</w>
Str uc
Still 's</w>
Stern berg</w>
Ste p</w>
Statis tically,</w>
Stat in-induced</w>
Stat in-fibrate</w>
Stat es)</w>
Sta phylococcal</w>
St esolid</w>
St aging</w>
St ability</w>
Sprague-Daw ley,</w>
Spe ed</w>
Spas ticity</w>
Sp /+</w>
Somnol ence,</w>
Som atic</w>
Sodi um-
So-1 100</w>
Smok eless</w>
Smo oth</w>
Sm ith
Sle eping</w>
Six- week-old</w>
Six- month</w>
Six -</w>
Sive lestat</w>
Sirolim us-associated</w>
Sirolim us,</w>
Sing le
Sine met</w>
Sine met
Sin ce,</w>
Simp son</w>
Simil ar,</w>
Sim vastatin,</w>
Sildenaf il-associated</w>
Signific ance</w>
Sign al</w>
Sig ma</w>
Sig ma
Sh A)</w>
Sevo flurane-induced</w>
Sest amibi</w>
Sest aMIBI</w>
Sertr aline-induced</w>
Ser vic
Ser ratia</w>
Sequ encing</w>
Septem ber,</w>
Semi- structured</w>
Semi- Structured</w>
Self- reports</w>
Seizure -P
Seizure-P rone</w>
Sed ative</w>
Second ly,</w>
Sear ch</w>
Se emingly,</w>
Scot tish</w>
Scop olamine,</w>
Sclero der
Sci ences</w>
Schwar tz</w>
Schedul ed</w>
Sch le
Sch aeffer</w>
Scat tered</w>
Scan ning</w>
Scal p</w>
Sarc openia</w>
Sar alasin</w>
Sando z)</w>
Sando statin</w>
Sal t</w>
Sal iv
Saf ety,</w>
Sa O
SaO 2
SW V.</w>
SW OG</w>
SV P</w>
SV I</w>
SV I/
SVI/ blindness</w>
SU ES:</w>
SU D</w>
STZ- injected</w>
STZ- SHRs</w>
STZ ,</w>
STN- DBS</w>
ST S,</w>
ST R</w>
ST OR
STOR Y:</w>
ST M</w>
ST 36</w>
SSR18150 7,</w>
SSR T</w>
SSH L</w>
SS TIs</w>
SS SI
SS G)</w>
SRS s.</w>
SR s</w>
SR C</w>
SR ;</w>
SR :</w>
SR 142801</w>
SR ),</w>
SP SS</w>
SP L.</w>
SP K</w>
SP H</w>
SP 4</w>
SOD2- OX</w>
SOD -like</w>
SO L</w>
SO FA</w>
SNZ c</w>
SNC V</w>
SN F</w>
SM T</w>
SM ON.</w>
SLE ;</w>
SKF 38393</w>
SK- N-
SJ L/
SJL/ J</w>
SIAD H-induced</w>
SI S3</w>
SI ON</w>
SI B
SHR s,</w>
SHB G,</w>
SH E</w>
SH (-)</w>
SH (+)</w>
SF P</w>
SETTI NG</w>
SER M</w>
SENSU S</w>
SEM :</w>
SE D+
SDS-PA GE</w>
SD s,</w>
SD F</w>
SD ):</w>
SCO P</w>
SCO P-treated</w>
SCL C.</w>
SCH- 23390</w>
SC- 560</w>
SC s,</w>
SC r.</w>
SC )-induced</w>
SB 36
SB36 67
SB 20655
SAP S</w>
SAP S-
SAH- hydrolase</w>
S9 78
S3 (30)</w>
S3 (0)</w>
S248 F</w>
S14G- HN,</w>
S/ QT)</w>
S/ Ibg</w>
S.D .
S. E
S-methyl iso
S-2-(3- aminopropyl
S-145 2-
S-1452- treated</w>
S-145 2,</w>
S- phase</w>
S- nitroso-
S- myosin</w>
S- mephenytoin</w>
S- lesioned</w>
S- dams</w>
S- Li</w>
S- I</w>
S- A</w>
S- 508</w>
S- 204
S-204 352</w>
S- 20
S-20 68
S- (+)-
S ymbol</w>
S s)</w>
S pre
S potting</w>
S pati
S par
S omat
S lowing</w>
S lightly</w>
S kin
S itu
S ideroblastic</w>
S h</w>
S gcd-null</w>
S er</w>
S eptal</w>
S epiapterin</w>
S ene
S cutellaria</w>
S cler
S c</w>
S ample</w>
S SL</w>
S SE
S S).</w>
S OR
SOR BA</w>
S OD)</w>
S NS
SNS -induced</w>
S N-
S LC6
S CIS</w>
S CI</w>
S CBF,</w>
S ABP</w>
S A,</w>
S 2)</w>
S 1.</w>
S 1
S .)</w>
S -14
S-14 52</w>
S ,2
S ):</w>
S )-induced</w>
S (-)</w>
S (-)-
Rut a</w>
Rus selia</w>
Rosi glitazone</w>
Rom ano-Ward</w>
Rod ents</w>
Rod ent</w>
Roche ster</w>
Roc he</w>
Rivas tigmine</w>
Rit odrine</w>
Rit anserin</w>
Ril uzole</w>
Rifamp icin-associated</w>
Rifamp ic
Rif abut
Ribavir in,</w>
Rhabdomy osarcoma</w>
Rh o</w>
Rg3 (R
Rg l</w>
Rev ised</w>
Retro peritoneal</w>
Resul ts.</w>
Reser pine-induced</w>
Res ource</w>
Reproduc ible</w>
Reproduc ibility</w>
Ren in-
Ren in,</w>
Remifentan il-induced</w>
Rem ote</w>
Relev ance</w>
Rel ton-Hall</w>
Rel ated</w>
Regist ration</w>
Reg ulatory</w>
Reg imens</w>
Reg 2-
Reg2- /-</w>
Recon sider
Reci pients</w>
Recei ver</w>
Rec all</w>
Reb oxetine</w>
Re- exposure</w>
Re sistant</w>
Re plic
Re instatement</w>
Re habilitation</w>
Re ference</w>
Ras ay
Ras agiline</w>
Raniti dine,</w>
Randall-Selit to.</w>
Ran ol
Ran cho</w>
Rami pri
Radi onuclide</w>
Radi ographs</w>
Radi o
Rac lopri
Rac ine's</w>
Rac em
Rabep razole</w>
RVOT- VT.</w>
RV R</w>
RV L
RVL M.</w>
RU38 486</w>
RU-430 44</w>
RTI -
RT V</w>
RT ),</w>
RP M</w>
RP F</w>
RP :</w>
ROM-1 26</w>
RO Is</w>
RO 4-4602</w>
RO 2)</w>
RO .</w>
RN- lesioned</w>
RN V</w>
RN Es</w>
RK P</w>
RIS -induced</w>
RG H-
RGH- 2
RGH-2 202</w>
RG 76</w>
RF s</w>
RF s.</w>
RF +
REVIEW :</w>
RE AD
RCT N
RB V.</w>
RB V
RB Fs</w>
RB F.</w>
RAR S,</w>
RAL D</w>
RAE B,</w>
RAD00 1</w>
R-(+)- 8-OHDPAT</w>
R- tropanyl</w>
R- C</w>
R- 3)</w>
R- 24
R-24 03</w>
R,4 S)-1-
R upt
R ub
R ox
R opinirole</w>
R ol
R ociverine</w>
R e</w>
R d,</w>
R ash</w>
R YU</w>
R Y</w>
R VT</w>
R SI.</w>
R SDS</w>
R SD
R P.</w>
R J
RJ R-2403</w>
R CA.</w>
R A),</w>
R :</w>
R 76,</w>
R 4</w>
R (-/-))</w>
Queti apine,</w>
Questionnai res</w>
Questionnai re.</w>
Questionnai re,</w>
Ques tions</w>
Quercet in,</w>
Quanti tation</w>
Qu a
QTc d</w>
QT/ QTc</w>
QT- RR</w>
QT(Fram ),</w>
QT c.</w>
QT btb</w>
QT P</w>
QT L
QT -3</w>
QT (B
QT(B ),</w>
QS 2
Q max</w>
Q _
Q X,</w>
Q M
Q D.</w>
Q A</w>
Q A-treated</w>
Q ;</w>
Q 10,</w>
Py ramidal</w>
Purpur a</w>
Puer ariae</w>
Ptio 2</w>
Psychi atry</w>
Psych otropic</w>
Psych otria</w>
Psych opathy</w>
Psych opathology</w>
Psych ometric</w>
Pseudo- allergic</w>
Pseudo ephedrine-induced</w>
Ps A</w>
Provid ed</w>
Prote us</w>
Propylthio urac
Propri ospinal</w>
Propofol-Lip uro
Propofol -induced</w>
Propafen one,</w>
Prop ylene</w>
Prolong ing</w>
Progres sion-free</w>
Program me</w>
Program me.</w>
Prog ress</w>
Prochlorper azine</w>
Pro ven</w>
Pro tium</w>
Pro thrombin</w>
Pro static</w>
Pro s
Pro por
Pro file</w>
Pro duct</w>
Pro ,</w>
Prinzmet al-variant</w>
Prima quine</w>
Prima quine-induced</w>
Presyn aptic</w>
Pres enting</w>
Pren atally</w>
Prednis one,</w>
Predic tion</w>
Pre- natal</w>
Pre ven
Pre term</w>
Pre morbid</w>
Pre dominant</w>
Praz osin-induced</w>
Prac tices</w>
Pr ince</w>
Potenti als</w>
Pot ent</w>
Post- operative</w>
Post- marketing</w>
Post ulated</w>
Post synaptic</w>
Post menopausal</w>
Pos sibly</w>
Pos sibly,</w>
Pos ms</w>
Poly therapy</w>
Poly somnographic</w>
Poly radicul
Poly godi
Poly cystic</w>
Poin tes,</w>
Po stres
Po C</w>
Po (2)</w>
PmO (2)</w>
Plough )</w>
Plat es</w>
Plasma pheresis</w>
Plac ental</w>
Pis a</w>
Pinsch ers</w>
Pi rox
Pi renzep
Phy ll
Phot ophobia</w>
Phil ippin
Phenyl butaz
Pheny leth
Phenobarbit one</w>
Phenobarbit al,</w>
Phe -
Pharmacokine tic-pharmacodynamic</w>
Pharmaco Vigilance</w>
Pharmac ologically</w>
Pharmac ol.</w>
Ph arm.</w>
Ph ar
Peroxis ome</w>
Perit ubular</w>
Perio d</w>
Peri- operative</w>
Peri pher
Perflutre n</w>
Per tinent</w>
Per t
Per iod
Per indopril</w>
Pepti care</w>
Pentobarbit one</w>
Pentagastr in</w>
Penicill amine-associated</w>
Pemphig us</w>
Peg filgrastim</w>
Pedi atricians</w>
Pear l</w>
Pe ople</w>
Pe ople's</w>
Pe king</w>
Pe g-
Pe ak
Patient 's</w>
Pathophysi ologic</w>
Path ology,</w>
Path ogens</w>
Pat ent</w>
Parom omycin</w>
Parkinson ian-like</w>
Paras ympathetic</w>
Parano ia</w>
Parad oxic</w>
Par lodel</w>
Pap ua</w>
Pap illary</w>
Pantop razole</w>
Pan ayiotopoulos</w>
Pan am
Palli ation</w>
Pal atal</w>
Paclitaxel /
Pab 2-
Pa yments</w>
Pa resthesia</w>
Pa ediatric</w>
Pa CO
PY 343</w>
PW P,</w>
PVC 's</w>
PV Ts</w>
PV N,</w>
PV ,</w>
PTZ -</w>
PTZ -,</w>
PTZ -
PTH .</w>
PT SD.</w>
PT Rs</w>
PT P</w>
PT CA,</w>
PT C</w>
PT B</w>
PT /
PT -1
PSV T.</w>
PSV T,</w>
PR3- ANCA-positive</w>
PR s).</w>
PR OD
PROD ACT</w>
PR ACTI
PPO H</w>
PPARbeta/ delta</w>
PPARbeta/ delta.</w>
PPAR- y</w>
PPAR alpha-
PP Is.</w>
PP F</w>
POR C</w>
PO EE</w>
PO CD</w>
PO AG</w>
PNU-159 54
PNU-15954 8,</w>
PN P.</w>
PN L</w>
PN ),</w>
PMS F,</w>
PM VT</w>
PM P,</w>
PM ;</w>
PL P.</w>
PL MS</w>
PL K</w>
PL D-
PLD- docetaxel</w>
PL A(2)</w>
PL 37</w>
PL 37,</w>
PKC epsilon,</w>
PKC beta2,</w>
PKC beta1,</w>
PK Rs</w>
PHAR M
PH Z</w>
PH T-treated</w>
PH H</w>
PH EN
PH A-
PH )-induced</w>
PGP 9.
PGP9. 5-
PGP9.5- positive</w>
PGI- M</w>
PGF 2
PGF2 alpha</w>
PGE (2).</w>
PG s,</w>
PG S.</w>
PG N)</w>
PG D</w>
PF C,</w>
PES B.</w>
PEP .</w>
PEF R,</w>
PE I</w>
PE GS
PE C</w>
PDE -
PDE- inhibitor</w>
PD-1 233
PD- like</w>
PD IE</w>
PD H</w>
PD :</w>
PD 9
PD 56,</w>
PC Z</w>
PC W
PC V</w>
PC V.</w>
PC V,</w>
PC NA
PCNA +</w>
PC 12</w>
PC ),</w>
PB- inducible</w>
PANS S,</w>
PAN/ temocapril</w>
PAN- FSGS</w>
PAN K2</w>
PAN ).</w>
PACAP (-/-)</w>
PAC P
PAC HE)</w>
PAC (1)</w>
PA/ caffeine</w>
PA s</w>
PA ]</w>
PA P)</w>
PA M)</w>
PA F,</w>
P=0.00 8),</w>
P=0.00 3),</w>
P=0.0 3)</w>
P=0.0 1),</w>
P= 0.001).</w>
P<0.00 1
P< 0.05;</w>
P< 0.01</w>
P< 0.001);</w>
P< 0.0001)</w>
P< .01).</w>
P2X (4)</w>
P2 R-
P2 1.</w>
P/Q -type</w>
P-glyco protein.</w>
P-glyco protein-mediated</w>
P-450 -mediated</w>
P-450 (11)</w>
P-1 302</w>
P- wave</w>
P- pretreated</w>
P- lowering</w>
P- associated</w>
P- R</w>
P- NS</w>
P- NMR</w>
P(2y 2)</w>
P uro
P soriasis</w>
P s,</w>
P s).</w>
P resc
P refrontal</w>
P red</w>
P rec
P rasu
P ow
P lication</w>
P ill</w>
P ig
P iclozotan</w>
P hob
P g</w>
P f
P eroben</w>
P ene</w>
P co
P arturients</w>
P allidal</w>
P air
P ain,</w>
P ad
P V</w>
P UF
P SAD</w>
P S/
P S),</w>
P PA/caffeine</w>
P P)</w>
P NPO</w>
P MS</w>
P M),</w>
P LT
P K-
P III</w>
P ChE</w>
P Ca
P CP/
PCP/ sigma</w>
P CP-induced</w>
P CP,</w>
P CN
PCN A-
P CI,</w>
P C)</w>
P B)</w>
P 9,</w>
P 8,</w>
P 600</w>
P 50,</w>
P 400
P 3</w>
P 3,</w>
P 17</w>
P 12,</w>
P 1-
P 1)</w>
Oxy genation</w>
Ox prenolol</w>
Ox azepam</w>
Ox aproz
Ox amniqu
Ox acillin</w>
Ox -ph
Over- expression</w>
Otolaryng ology-Head</w>
Oste oporosis</w>
Os m</w>
Orth o-Novum</w>
Organ ophosphate</w>
Organ izations</w>
Orac on</w>
Or nithine</w>
Or gas
Ophthalmo logy</w>
Ophthalmo logical</w>
Open- label,</w>
Op posite</w>
One -,</w>
Omni paque.</w>
Omeprazol e-induced</w>
Om niscan</w>
Olig uria</w>
Ol aHsd</w>
Off '</w>
Od di
Octreoti de-induced</w>
Ob viously,</w>
Ob structive</w>
Oat ps</w>
OX 8+</w>
OX 39
OX39 +</w>
OV X</w>
OUTCOME S:</w>
OS CS-
OSCS- contaminated</w>
OS A.</w>
OR X</w>
OR AC(-OHo
ORAC(-OHo )</w>
OR ).</w>
OPID N.</w>
OP P,</w>
ONO-87 11</w>
ON RYU</w>
ON -
ON- state</w>
ON ,</w>
ON +
OFF- period</w>
OF R</w>
OF Q/
OD T</w>
OD Q</w>
OD Q,</w>
OBJECTIVE S</w>
OBJEC TS:</w>
OBJEC T:</w>
OB E</w>
OAT- ICH.</w>
O. S.</w>
O-de alkylase</w>
O- Methyldopa</w>
O vid</w>
O roxylin</w>
O rig
O reg
O raVer
O mitting</w>
O mission</w>
O le
O kla
O ic
O ]</w>
O TC</w>
O S.</w>
O S,</w>
O P-
O P,</w>
O HC
O EF
O Cs,</w>
O CT-treated</w>
O AC.</w>
O 2).</w>
O )-induced</w>
O 's</w>
O '
Nutri tional</w>
Nur sing</w>
Nur ses</w>
Numb ers</w>
Nrf 2
Not able</w>
Norplant -2</w>
Norm alised</w>
Nor- Prog
Nor way
Nor triptyl
Nor m</w>
Non- haematological</w>
Non sustained</w>
Non selective</w>
Non randomized</w>
Non hematological</w>
Non fatal</w>
Non cirrhotic</w>
Non arteritic</w>
Nomifens ine</w>
Noc turnal</w>
Nitroglycer in,</w>
Nissl- stained</w>
Nigeri ans.</w>
Nicardi pine-induced</w>
Nex t-day</w>
Nevir apine</w>
Neuro ten
Neuro pathological</w>
Neuro path
Neuro l</w>
Neuro l.</w>
Neuro genesis</w>
Neuro degeneration</w>
Neuro anatomical</w>
Neu tr
Neu /
Neu/ Erb
Netherland s,</w>
Nesac aine</w>
Nephro logy</w>
Nel fin
Nefir acetam</w>
Need le</w>
Need le-
Ne utrophils</w>
Ne utrophil</w>
Ne u</w>
Ne tilmicin</w>
Ne t</w>
Ne oplastic</w>
Ne odolpas
Ne fazod
Naprox en-induced</w>
Naprox en-associated</w>
Nalox one,</w>
Nalbu phine</w>
Nal orphine</w>
Nafc illin</w>
NaHCO 3,</w>
Na-K- ATPase,</w>
Na+/ K+-
Na+- K+</w>
Na+, K+-
Na Cl-
NT- A)</w>
NT S-lesioned</w>
NT D
NTD s,</w>
NT 79</w>
NT ),</w>
NSAID- sensitive</w>
NSAID- related</w>
NS VT</w>
NS F
NSF -like</w>
NS AI</w>
NRV L</w>
NR M</w>
NPY -induced</w>
NP Y.</w>
NP H</w>
NOS 3-
NO 3</w>
NO /
NN NS</w>
NMD OH</w>
NMD LA</w>
NMD A
NM U-
NKH 477</w>
NKH 47
NKH47 7,</w>
NK 3-
NJ ),</w>
NID DM</w>
NIC .</w>
NI H-
NI F</w>
NI AI
NIAI D</w>
NH X</w>
NH L,</w>
NH 2-
NH2- terminal</w>
NH (4
NH(4 +
NH(4+ )-treated</w>
NG C</w>
NCQ 436</w>
NC SE.</w>
NC S</w>
NC G</w>
NC E</w>
NC C</w>
NC ;</w>
NB I
NB F</w>
NB ),</w>
NAc ,</w>
NASH -like</w>
NAI ON</w>
NADPH- d</w>
NAD(P) H</w>
NA SCIS</w>
NA R</w>
NA P</w>
NA L</w>
N2O/ 30%</w>
N2O- O2</w>
N2O- O2-
N2 O.</w>
N2 O,</w>
N/ P-3.0</w>
N/ OF
N-propyl nor
N-nitrosodiethyl amine.</w>
N-nitro so</w>
N-methyl-D- aspartate.</w>
N-methyl-D- aspartate-dependent</w>
N-desmethyl tamoxifen</w>
N-acetyl-beta-D- glucosaminidase,</w>
N-acetyl-beta-D- glucosaminid
N-acetyl- p-benzoquinoneimine</w>
N-acetyl transferase</w>
N-acetyl glucosaminidase</w>
N-[4-(5-nitro-2-furyl)-2-thiazol yl]-form
N-[(1- ethyl-2-
N-S SEP</w>
N-2-fluorenyl acetamide.</w>
N-10 55</w>
N-(2- pyridin
N- tert-butyl-
N- propargyl-1-
N- oleoyl-dopamine</w>
N- Me-
N- (2,
N, N,
N,N, N
N,N,N ',
N,N,N', N'-
N(M HC)</w>
N(6)- cyclopentyladenosine</w>
N(2) O</w>
N utley,</w>
N urofen</w>
N or</w>
N ociceptin</w>
N mt</w>
N lmCategory="
N injin
N erv
N edd4-
N cAMP</w>
N ative</w>
N ation
N as
N airobi
N RTI</w>
N PH
N PDG,</w>
N NA</w>
N MRI-
N IN</w>
N GF.</w>
N EC</w>
N CA</w>
N AC-
N 20/
Myo- inositol</w>
Myo sitis</w>
Myelo pathy</w>
Myalgi as</w>
My elin</w>
Mun chausen</w>
Multiv essel</w>
Multicent ric</w>
Multicent er,</w>
Multi plic
Multi phasic</w>
Muc ositis</w>
Muc osal</w>
MuMT V</w>
Mt 3-
Mt3- null</w>
Move ments</w>
Morph ometry</w>
Moric izine</w>
Mor inga</w>
Mon te
Mon otherapy</w>
Mon osodium</w>
Mon ocyte</w>
Mon grel</w>
Mon astral</w>
Modul atory</w>
Modi fying</w>
Model s</w>
Mode st</w>
Mo de</w>
Misoprost ol,</w>
Mirta zap
Mipafox ,</w>
Mini -
Min neap
Min aprine</w>
Mill ar</w>
Microscop ically,</w>
Micro vascular</w>
Micro tubule</w>
Micro perfusion</w>
Micro glial</w>
Micro cephaly</w>
Michi gan)</w>
Mic turition</w>
Mic ros
Mic ropuncture</w>
Mi anserin</w>
Mg(2+)- free</w>
Mex ico</w>
Mex ican</w>
Metoclopram ide-treated</w>
Methyser gide</w>
Methylphenid ate-induced</w>
Methyl enedioxymethamphetamine</w>
Methyl dopa-induced</w>
Methotrex ate,</w>
Methazol amide</w>
Methad one-associated</w>
Methad one-
Meth yl</w>
Meth oxyflurane</w>
Meth ohex
Meth imazole</w>
Metfor min-associated</w>
Metam izole</w>
Met riz
Mes enchymal</w>
Meropen em
Mepi vacaine</w>
Men thol</w>
Melphal an</w>
Mel ittin</w>
Medic us</w>
Medic ines.</w>
Medic am
Medic aid</w>
Med line,</w>
Me sial</w>
Me galoblastic</w>
Me dium</w>
Me CCNU</w>
McNem ar
Mass on</w>
Mass on's</w>
Maryl and</w>
Mark et
Mark ers</w>
Mark edly</w>
Mariju ana-dependent</w>
Mar mara</w>
Mapro tiline</w>
Manifest ation</w>
Mang iferin</w>
Man u
Man ip
Man assantin</w>
Malon dialdehyde</w>
Mall ory-Denk</w>
Mal ay</w>
Magne vist</w>
Magne si
Mag nus
Macroph age</w>
Macroph age-
Macro cytosis</w>
M_ M</w>
MVO (2)</w>
MTX-N tox.</w>
MTX- LV</w>
MTX -treated</w>
MT s</w>
MT Ds</w>
MT -/-</w>
MT +/+</w>
MSO -treated</w>
MS NA,</w>
MS G</w>
MR SA.</w>
MR I/
MRI/ MR
MR A-
MRA- MT</w>
MPP +</w>
MP- CDZP</w>
MP T</w>
MP H.</w>
MP FC</w>
MO AT</w>
MN U-
MN G</w>
MN ),</w>
MMP- 3</w>
MMP 1</w>
MMP /
MMP/ TIMP</w>
MMP -13</w>
MMP -1,</w>
MM R</w>
MM NC</w>
MM I,</w>
MM C.</w>
MM C-related</w>
MK80 1-induced</w>
MK80 1,</w>
MK-9 12,</w>
MK -14
MI P</w>
MI D)</w>
MH PG,</w>
MH N</w>
MF S,</w>
METHODS/ RESULTS:</w>
METHODS/ MATERIALS:</w>
METHODOLO GY/
METHODOLOGY/ PRINCIPAL</w>
ME MA
ME LAS</w>
ME L,</w>
ME K
ME D,</w>
ME Cs</w>
MDMA .</w>
MDMA +</w>
MD P,</w>
MD L
MD I,</w>
MD D,</w>
MCP-1 (-/-)</w>
MCP-1 (+/+)</w>
MCL ),</w>
MCA v(mean
MCA O.</w>
MCA ,</w>
MC- 26</w>
MC U</w>
MB H</w>
MB Fs</w>
MAO Is</w>
MA40- 4</w>
MA40- 2</w>
MA PD
MA P;</w>
MA O,</w>
MA MP-CDZP</w>
MA MP
MA HA.</w>
MA H)</w>
MA DR
MADR S,</w>
MA ;</w>
MA -</w>
MA ).</w>
M3 G-induced</w>
M. D.</w>
M-6- G</w>
M-6- G/
M-6-G/ MOR</w>
M ur
M rp
M izoribine</w>
M iosis</w>
M eti
M ethan
M esulergine</w>
M embranous</w>
M embrane</w>
M ed</w>
M atric
M arg
M ann
M W</w>
M U/
M PA-induced</w>
M O,</w>
M O)</w>
M NCV</w>
M N-SSEP</w>
M MR
M MECs</w>
M LA,</w>
M IF
MIF 's</w>
M Hz).</w>
M H-
M CC</w>
M AC.</w>
M AC-
M 1/
M .,</w>
M -treated</w>
M (3)</w>
M (1)</w>
Lymph ocytes</w>
Ly sosomal</w>
Lu ke's</w>
Los oxantrone</w>
Los artan-induced</w>
Loc ation</w>
Lob und-Wistar</w>
Lo op</w>
Lo g</w>
Lo est
Lithium- associated</w>
Lithi um,</w>
List er</w>
Lipos ome</w>
Lipid- Lowering</w>
Lip opolysaccharide</w>
Lim itation</w>
Lig ation</w>
Lid dle</w>
LiCl/ pilocarpine</w>
Li-PC -treated</w>
Li- treatment</w>
Li- l</w>
Li ebowitz</w>
Li brary,</w>
Li Cl-
Lev osul
Lev ofloxacin,</w>
Leuk otri
Leuk openia,</w>
Leuk ocytes</w>
Lenalidom ide,</w>
Leak age</w>
Le o)</w>
Le g</w>
Lat in-
Langendor ff-
Labet alol-induced</w>
Lab el="
LY3414 95</w>
LY2359 59</w>
LVF X-induced</w>
LVF X,</w>
LVEFr n</w>
LVE Fs</w>
LV dP/dt</w>
LV P,</w>
LV H,</w>
LV F</w>
LV AD</w>
LT X)</w>
LR D</w>
LR 172</w>
LQT S.</w>
LQT S-related</w>
LQT 2</w>
LP S-
LOU/M/W SL</w>
LO FG</w>
LO C.</w>
LND-6 23</w>
LMW H.</w>
LMW H,</w>
LM V</w>
LL LT</w>
LI L
LI .</w>
LF P,</w>
LF /
LF/ HF</w>
LE G/
LE F</w>
LE F-
LE A</w>
LE A.</w>
LD(con v)</w>
LD X</w>
LD U</w>
LD MF</w>
LD L,</w>
LD H-
LD H
LD 50's.</w>
LC- PUFA</w>
LC x.</w>
LC X</w>
LC 3</w>
LA AM.</w>
L1- L2</w>
L/ min).</w>
L/ h,</w>
L/ S</w>
L/ N-type</w>
L.min-1. %
L.min-1.% SaO2
L-arginine- NO</w>
L-argin ate</w>
L-NOAR G.</w>
L-N NA</w>
L-DOPA -treated</w>
L-DOPA -
L- dopa-
L- disopyramide</w>
L- asparaginase</w>
L- alpha-
L- 44408</w>
L(L act)</w>
L yme</w>
L ess
L atin</w>
L are
L aparoscopic</w>
L ac
L a</w>
L ZRs</w>
L ZRs.</w>
L UT
L SP</w>
L SM
L SI,</w>
L PDG,</w>
L P/J</w>
L P-BM5</w>
L L</w>
L H)</w>
L GE</w>
L F)</w>
L ENT
L DOPA</w>
L Cs</w>
L CH</w>
L C.</w>
L AR.</w>
L AR,</w>
L ABA</w>
L A-induced</w>
L A),</w>
L 5-
L 250
L250 T</w>
L 20/
L20/ F
L 1825
L1825 P</w>
L -induced</w>
L -1.</w>
L (+)-
Kynuren ic</w>
Kv 1.5</w>
Krebs- Ringer</w>
Kit(Y567F/Y567 F)</w>
Ketoro lac-induced</w>
Ketocon azole-induced</w>
Kerat inocyte</w>
Keny a.</w>
Kappa -
Kamp o</w>
KW-39 02,</w>
KW- 6002</w>
KRN23 91,</w>
KCC 2.</w>
K- 49
K+ -2
K(v) 7.
K ras</w>
K noc
K liniske</w>
K line</w>
K leine-Levin</w>
K ing</w>
K i
K g</w>
K entucky</w>
K au
K allmann's</w>
K alamazoo,</w>
K Y</w>
K T.</w>
K T-induced</w>
K Cl.</w>
K B</w>
K A-induced</w>
K A)</w>
K 293</w>
K .,</w>
K ).</w>
Jud kins</w>
Jour nal</w>
Jo- 1</w>
Jack son</w>
Jack son-Rees</w>
JAK- STAT</w>
JAK /
JAK/ STAT3</w>
J oubert</w>
J ewish</w>
J e
J arisch-Herxheimer</w>
J ama
J P-1302</w>
J .,</w>
J .
Italian o</w>
It aly)</w>
Isra el</w>
Isov ue</w>
Isov ue-
Isoniaz id-related</w>
Isob olographic</w>
Isch aemic</w>
Irin otecan</w>
Ir rit
Ir radiation</w>
Ipsapir one</w>
Iontophore sis</w>
Intub ation</w>
Intub ating</w>
Intrad ermally</w>
Intracaver nosal</w>
Intra- amniotic</w>
Intra vital</w>
Intra vertebral</w>
Intr atympanic</w>
Intoxic ation</w>
Interleuk in-1</w>
Interleuk in-
Inter view
Inter ventional</w>
Inter strain</w>
Intensi fication</w>
Integr ated</w>
Insul in-like</w>
Institut e.</w>
Institu tional</w>
Institu t</w>
Ins1 P-
Inj ected</w>
Inf ections</w>
Inf antile</w>
Inf ant</w>
Indometh ac
Indinavir -induced</w>
Indic ation</w>
Indi an-subcontinent</w>
Incre mental</w>
In ver
In triguingly,</w>
In tras
In tolerance</w>
In tent-to-treat</w>
In take</w>
In tact</w>
In strum
In novar</w>
In her
In formed</w>
In adequate</w>
Impul sivity</w>
Improve ment,</w>
Impression- Improvement</w>
Immunohist ochemically,</w>
Immun olocalization</w>
Imidaz enil,</w>
Imi pramine.</w>
Imi .</w>
Im mature</w>
Im i</w>
Ill ino
Ile/ Ile</w>
Ifosfamide -M
Ifosfamide-M esna</w>
Ifenpro dil</w>
Identi fying</w>
Identi fied</w>
Ibuprofen -associated</w>
Ibu profen,</w>
IV- L</w>
IV U.</w>
IV S</w>
IV RA</w>
IV PMP,</w>
IV C</w>
IV ;</w>
IU/ mL</w>
IU/ kg)</w>
IU/ day</w>
IU/ d)</w>
IU/ L),</w>
IU GR</w>
IT- MTX</w>
IT- BUP</w>
IT ,</w>
ISO M,</w>
ISO -</w>
IS/ TIA</w>
IS- 5-M
IS SUES:</w>
IS S</w>
IS RCTN
IS M
IS H</w>
IS B</w>
IS .</w>
IS -5-
IS-5- MN</w>
IR F</w>
IPR O</w>
IPR .</w>
IPR -treated</w>
IP- 3</w>
IP SCs)</w>
IP K</w>
IP )-induced</w>
IO T</w>
IO R</w>
IO P.</w>
IND O</w>
IN PEA</w>
IN ),</w>
IMA RY</w>
IM L,</w>
IM -induced</w>
IL-10/ TGF-beta</w>
IL-10/ TGF-beta-modified</w>
IL-1 b</w>
IL-1 2,</w>
IL- 6.</w>
IL- 4</w>
IL P.</w>
IL ).</w>
IK r,</w>
III ;</w>
IIE0 24
II- inactive</w>
II- III</w>
II B-
II ;</w>
II --
IH SA</w>
IH G-
IH A.</w>
IGFBP- 3</w>
IGF -1.</w>
IFO -mediated</w>
IFN/ ribavirin</w>
IF S.</w>
IF N.</w>
IF N-induced</w>
IF N,</w>
IF G</w>
IF F</w>
IF ,</w>
IDV -treated</w>
IDV -associated</w>
ID XR</w>
ID C,</w>
ID A-related</w>
ICRF-1 61</w>
ICA -
ICA- 27
IC a</w>
IC V,</w>
IC V)</w>
IC R:
IC I
IC E</w>
IC D.</w>
IC D
I/ ml)</w>
I/ R</w>
I/ R-induced</w>
I/ O</w>
I/ III</w>
I/ II,</w>
I/ GI</w>
I/ ARB</w>
I. c.v.</w>
I. P.</w>
I- III,</w>
I- III)</w>
I(Na L)</w>
I xodes</w>
I tems</w>
I tem</w>
I t's</w>
I stan
I sorhythmic</w>
I som
I rish</w>
I odixanol</w>
I o
I f,</w>
I deal</w>
I darub
I atrogenically</w>
I U.</w>
I RR</w>
I R.</w>
I Q.</w>
I Q,</w>
I Q
I PRL</w>
I PH-treated</w>
I PD</w>
I P.</w>
I ON
I MS</w>
I L)</w>
I HD.</w>
I H).</w>
I GT</w>
I G
I E-containing</w>
I E)</w>
I BM
I A,</w>
I 2,</w>
I 1-receptor</w>
I (k
I(k r)</w>
Hz ),</w>
Hypox aemia</w>
Hypot ony</w>
Hypom agne
Hypo thalamic</w>
Hyper tonic</w>
Hyper thyroidism</w>
Hyper thermia,</w>
Hyper parathyroidis
Hyper kalemic</w>
Hyper kal
Hyper insul
Hydroxy ure
Hydroxy chloroquine-induced</w>
Hydrox yl</w>
Hydro codone</w>
Hyd roneph
Hyd antoin</w>
Hy paque-
Hum ph
Hu EPO)</w>
Hsp 70</w>
Hom ozygous</w>
Hom ozyg
Hol land</w>
Hoff mann</w>
Ho ward</w>
Ho ign</w>
Ho e-1
Hist ological,</w>
Hist amine-
Hippocamp i</w>
High- performance</w>
Hg/ sec</w>
Hg/ s</w>
Hg/ min;</w>
Hg :</w>
Hex arelin</w>
Her ing-Breuer</w>
Hep ato
Hen ry</w>
Hemorrh ages</w>
Hemo pericardium</w>
Hem occult-positive</w>
Head aches</w>
He b/FeJ</w>
Hb O2</w>
Hb A1
Has haron</w>
Har rington</w>
Halo -treated</w>
Haem orrhagic</w>
Haem olytic</w>
Haem acce
Habit ual</w>
Ha ving</w>
H_ E</w>
HVA/ DA</w>
HV A.</w>
HV ,</w>
HTN- ESRD</w>
HTN :</w>
HT LV-
HSV-t k</w>
HSP- 27</w>
HS +
HR- 592,</w>
HR s</w>
HR T,</w>
HR G</w>
HPV -16</w>
HPD G</w>
HP T</w>
HP S.</w>
HO ),</w>
HLA-B*57 01</w>
HLA- identical</w>
HL- 60</w>
HL GD</w>
HIV- uninfected</w>
HIV- RNA</w>
HIV- HCV-coinfected</w>
HIT T.</w>
HIP/ PA
HI STORY:</w>
HF M</w>
HER 2.</w>
HE TE
HE N)</w>
HE K293</w>
HE 3),</w>
HDAR AC</w>
HD- fed</w>
HD S</w>
HD C-
HDC- 9
HCT -116</w>
HCO 3-</w>
HC l)</w>
HC V.</w>
HC Q,</w>
HC M,</w>
HC L</w>
HC H),</w>
HC FU</w>
HBsAg .</w>
HBeAg (-)</w>
HBc Ab
HBD T</w>
HB V
HB E</w>
HAL O</w>
HAC- 911</w>
H9 C2</w>
H2O ;</w>
H2 O)</w>
H1- antihistamines</w>
H1- antihistamine-induced</w>
H1- antagonists</w>
H/ PF4</w>
H/ C</w>
H(2)O(2)- (.
H(2)O(2)-(. )
H(2)O(2)-(.) OH</w>
H(2) O</w>
H(2) O.</w>
H ousehold</w>
H omer
H ind
H ill</w>
H erbal</w>
H an-Wistar</w>
H adassah</w>
H Y</w>
H W</w>
H TG</w>
H SOS</w>
H SG</w>
H SCT.</w>
H OR
H NR</w>
H NP.</w>
H M</w>
H EP</w>
H E.</w>
H CBD
HCBD -induced</w>
H CB
H AS/
HAS/ LAS</w>
H ;</w>
H 3,</w>
H 1,</w>
H (1)-
Gynec omastia</w>
Gy naec
Guanfac ine</w>
Guaneth idine</w>
Grow ing</w>
Gre ec
Grad ually</w>
Gr af
Gpx 1
Gpx1 +/+</w>
Golgi- Cox</w>
GnRH- a</w>
Glycyrrhiz in</w>
Glyc opyr
Glybur ide-induced</w>
Gluc osuria</w>
GluR 5</w>
GluR 2/
GluR 1-immunopositive</w>
Glu R</w>
Glomerul onephritis</w>
Gli oblastoma</w>
Gli al</w>
Gli adel</w>
Gli 3</w>
Gl auc
Ginsen g</w>
Gingi val</w>
Gi HUS</w>
Gi /
German y.</w>
Gentam icin-treated</w>
Gentam icin-associated</w>
Gen ipin</w>
Gemfibroz il-induced</w>
Gemcit abine-associated</w>
Gd- based</w>
Gd- DTPA</w>
Gas6- Rs</w>
Gangli onic</w>
Gangli on</w>
Gam ma</w>
Gal act
Gadolinium- based</w>
G_ C_
G_C_ G_
GYKI- 41</w>
GV HD).</w>
GTP- gamma-
GST- Pi</w>
GSK3 beta</w>
GSHP x</w>
GSH .</w>
GS P</w>
GR 113
GP x,</w>
GP s</w>
GP p</w>
GP i.</w>
GP a</w>
GP V</w>
GO S</w>
GO G</w>
GM- CSF,</w>
GM P.</w>
GM P)</w>
GM -mediated</w>
GM +
GL Y</w>
GL OBE</w>
GFP- BMC</w>
GFAP- positive</w>
GF P)</w>
GF P(+)</w>
GE ,</w>
GB CA</w>
GAP 43</w>
GAL- WT</w>
GAL- KO</w>
GABAA/ alpha1-preferring</w>
GABA- modulatory</w>
GABA- mimetic</w>
GABA- dependent</w>
GABA- T</w>
GABA(B(1 b))(-/-)</w>
GABA(A)- Rs</w>
GABA erg
GABA a</w>
GABA /
G6 60</w>
G- mediated</w>
G- CSF)</w>
G- B</w>
G(i /
G(i/ o)</w>
G y/
G y)</w>
G usta
G rollman</w>
G ro
G rape</w>
G old</w>
G licl
G i</w>
G eme
G betagamma</w>
G ati
G XR</w>
G V</w>
G UST
G SI
G SAD</w>
G S,</w>
G PR
G LA</w>
G ICAL</w>
G D3,</w>
G CSF</w>
G CS.</w>
G CH
GCH 1</w>
G CB</w>
G CB
G AT
GAT A-
G ALF</w>
G AL
G 4</w>
G 4
G4 34
G 3</w>
G 20
G20 210
G20210 A</w>
G 2)</w>
Furosem ide-induced</w>
Furazol idone</w>
Fur th</w>
Func tionally,</w>
Fru semide</w>
Fro zen</w>
Fri deric
Frequ ently</w>
Frequ ency
France :</w>
France )</w>
Fr ucto
Fr act
Fr 1</w>
Four- week-old</w>
Four ty-
Found ation</w>
Foscarne t-induced</w>
FosB/Delta FosB</w>
Fos ,</w>
Form al
For m</w>
For ce.</w>
Fol inic</w>
Foc al,</w>
Fo ot</w>
Fo etal</w>
Flut amide-induced</w>
Flut ,</w>
FluoroJ ade
Fluoro-Jade .</w>
Fluoro uracil</w>
Fluoro quinolones</w>
Flu v</w>
Flo sequinan</w>
Flecain ide-induced</w>
Fl u</w>
Fl k
First ly,</w>
Finn ish</w>
Ficol l-
Fibro blasts</w>
Fibr inogen</w>
Fib rate</w>
Fib onacci</w>
Fi ve,</w>
Fer ol.</w>
Fenol dopam</w>
Feno fibrate</w>
Feno fibrate,</w>
Fe lodipine</w>
Fe eding</w>
Fe ar</w>
Fe TMPyP</w>
Fe Na
FcgammaRII A/
FcgammaRIIA/ hPF4</w>
FcgammaR IIA</w>
Fast -
Famoti dine</w>
Fam ciclovir</w>
FX II-
FVII a.</w>
FUD EC
FU/ LV</w>
FS G.</w>
FR 139317</w>
FP-CI T</w>
FM LP</w>
FM L</w>
FLA- 63,</w>
FL A
FKBP 51</w>
FKBP 12/
FKBP12/ 12.6</w>
FK506- based</w>
FK S-508</w>
FK 97
FK 9
FK9 73</w>
FK 664</w>
FGIN -1</w>
FG- 7142</w>
FEV (1)</w>
FEF 25-
FE NA</w>
FD I</w>
F2- alpha</w>
F1- dams</w>
F/Y56 9
F/ P</w>
F/ CO</w>
F-97013- GD</w>
F- N</w>
F u
F s)</w>
F lox
F lorid
F inger</w>
F eighner</w>
F d</w>
F as,</w>
F Z.</w>
F Z-2
F V</w>
F S)</w>
F NG</w>
F N
F IM</w>
F GH</w>
F E</w>
F DE
F CZ</w>
F C
F AS</w>
F AMP</w>
F AM
F AA.</w>
F A.</w>
F A-treated</w>
F :</w>
F 100
F 1,</w>
F -treated</w>
F -</w>
F (2)</w>
Expl oratory</w>
Excl uding</w>
Excl uded</w>
Exc retion</w>
Exagger ated</w>
Ex tremely</w>
Ex ten
Ex pressed</w>
Ex posed</w>
Ex per
Ex ecutive</w>
Ex act</w>
Evol ving</w>
Evol ution</w>
Evid ence-based</w>
Event ually,</w>
Event -free</w>
Evalu able</w>
Eu phor
Eu hypnos</w>
Etomid ate,</w>
Eth yl
Eth anol,</w>
Eth acrynic</w>
Estradiol -17
Estradiol-17 beta-D-glucuronide</w>
Estim ation</w>
Est abl
Es ophageal</w>
Erythropoi etic</w>
Erythro mel
Erythro cytes</w>
Erb a,</w>
Equi valent</w>
Equ imolar</w>
Episo dic</w>
Epinephr ine-
Epidemio logy</w>
Enter obacter</w>
Enox acin</w>
Engl and.</w>
Endo grafine</w>
End- diastolic</w>
End- Stage</w>
End MT</w>
Enalapri l-induced</w>
Enalapri l-associated</w>
En largement</w>
Em base,</w>
Electrocardio gram,</w>
Ele ments</w>
El i</w>
Eighty- three</w>
Eighty- nine</w>
Eff iciency</w>
Eff ectiveness,</w>
Educ ation</w>
ET ).</w>
ER- beta</w>
ER Ps</w>
ER PF</w>
ER G.</w>
ER G)</w>
ER CP</w>
ER CC1</w>
ER 22/
ER22/ 23
ER22/23 E
EP3 (+/+)</w>
EP SCs)</w>
EP S-related</w>
EP ;</w>
EP 3.</w>
EP 2</w>
EP (1)</w>
EO AEs)</w>
ENT AN
ENTAN YL</w>
EN M</w>
EME RALD</w>
EMBA SE,</w>
EMB 's</w>
EM PO
EM G-
EM F</w>
ELIS A,</w>
EK C</w>
EHX A-treated</w>
EHE N</w>
EGT A</w>
EGF- R</w>
EG Cs</w>
EFF ECTS</w>
EF V</w>
EF S.</w>
EF <
EF< 45%</w>
EE/ DNG</w>
EE LV</w>
EE H</w>
EE G),</w>
EDT A,</w>
ED P</w>
ED Ds</w>
ED (9
ECE-1 (+/-)</w>
EC HO</w>
EC G)</w>
EC 30</w>
EC .</w>
EC (50)</w>
EB F.</w>
EAD s.</w>
EA As</w>
EA -10
E-9, 11,
E-9,11, 13
E- I</w>
E- Ferol.</w>
E- 20
E(2)17 G-mediated</w>
E(2)17 G-induced</w>
E tude</w>
E t
E s)</w>
E pidemic</w>
E motion</w>
E limination</w>
E droph
E din
E copipam</w>
E ating</w>
E U</w>
E TH
E SR</w>
E S,</w>
E N,</w>
E H</w>
E GFR</w>
E GF,</w>
E G</w>
E AE,</w>
E AC</w>
E 60
E60 9
E 23
E23 G</w>
E 15,</w>
E 12</w>
E 1.</w>
E 1)</w>
E -induced</w>
E (2),</w>
E (1)</w>
Dys regulation</w>
Dx MD</w>
Duct openia</w>
Duchen ne's</w>
Dro peridol</w>
Dr ymis</w>
Dox il)</w>
Down regulation</w>
Dow n</w>
Double -
Dou bts</w>
Doppler- derived</w>
Doppl er.</w>
Doppl er)</w>
Don or</w>
Dofetili de)</w>
Do thiepin</w>
Dizzin ess,</w>
Distinc t</w>
Dist urb
Dist rict</w>
Dist ortion</w>
Dise ases,</w>
Dis sociation</w>
Dis cus
Diphen hydram
Dim er-
Dilat ation</w>
Dil ant
Digox in,</w>
Digit oxin</w>
Difficul ties</w>
Differenti ation</w>
Diff usion</w>
Diethylstilbestro l,</w>
Dideoxy inosine</w>
Diclofen ac
Dialy s
Diagnos tics,</w>
Diagno ses</w>
Dia phrag
Di vision</w>
Di ego,</w>
Dextromethorph an,</w>
Dex- hypertension</w>
Dex a-induced</w>
Dex CE</w>
Desi pramine-induced</w>
Des ensi
Dermatomyosi tis-like</w>
Der ived</w>
Dep ot</w>
Den/ morph</w>
Dem entia</w>
Dem eclocycline</w>
Delta9-TH C-induced</w>
Delta9- tetrahydrocannabinol</w>
Delta(9)- tetrahydrocannabinol</w>
Delta N(MHC)</w>
Delta MM</w>
Delta -
Deli ri
Del usions</w>
Del ay</w>
Decreas ing</w>
Dec om
Dec aD</w>
Debriso quine</w>
De sign</w>
De pakine</w>
De hydro
De generative</w>
De ep-
De c</w>
De Ba
DeBa key</w>
Datab ase,</w>
Dan azol,</w>
Dak ot
DZ R.</w>
DY T1</w>
DX M</w>
DX -treated</w>
DVT/ PE</w>
DTI C-induced</w>
DT PA)</w>
DSM-IV- defined</w>
DSM-III- R.</w>
DSM-III- R,</w>
DSM- IV,</w>
DS I</w>
DR- 33
DR D3</w>
DR /
DP max</w>
DP V</w>
DP ;</w>
DP -related</w>
DOX/ SED</w>
DOX/ GW2974</w>
DOX Y
DOX ;</w>
DOPAC /
DO X)</w>
DO I-induced</w>
DO D</w>
DNP- SG</w>
DNA ),</w>
DN X</w>
DN B</w>
DMT U
DMI -induced</w>
DMB A</w>
DM-9 384</w>
DM SO
DM D</w>
DM -1K-
DLT s.</w>
DI AN</w>
DHC -1</w>
DH E,</w>
DH C</w>
DH AD</w>
DH A.</w>
DH ),</w>
DF P/
DF P,</w>
DF P);</w>
DES- lineage</w>
DENA- only-treated</w>
DE R</w>
DE NA-treated</w>
DE .</w>
DDP +
DCG- IV</w>
DBA/2 NCr</w>
DB V</w>
DB S.</w>
DB P.</w>
DB A-
DAR s</w>
DA- terminal</w>
D-Glucar ates</w>
D- pen
D- isomer</w>
D- Tic
D- Penicillamine-induced</w>
D- AP5</w>
D- 32</w>
D- 2,</w>
D(2) (+/-)</w>
D ub
D re
D ra
D orme
D omin
D imen
D extran</w>
D examisole</w>
D ermal</w>
D entate</w>
D ensitometry</w>
D ay
D ana-Farber</w>
D U
D SP4</w>
D SIP</w>
D S-
D Q
D P),</w>
D ONRYU</w>
D OB
D MD.</w>
D M.</w>
D IL
D I.</w>
D G,</w>
D D.</w>
D CM.</w>
D CA-
D C.</w>
D AV
D A1</w>
D 3:</w>
D 1-</w>
D 0</w>
D -15</w>
D -1/
D-1/ D-2</w>
D ,
D (3)/
D(3)/ D(2)</w>
D (1-
D(1- like)</w>
D (-)-
D (-)
D(-) AP5</w>
Cyto genetic</w>
Cyt ochemical</w>
Cyst oscopy</w>
Cyclophosph amide
Cy tot
Cy t-ox</w>
Cy anide</w>
Cx LP</w>
Cur culigo</w>
Cult ures</w>
Cu/ Zn</w>
Cu -
Ctr l</w>
CsA- Pred</w>
Crypt ococcus</w>
Cross- reactivity</w>
Cres yl</w>
Crac k</w>
Cr l:
Cr .</w>
Cr ,</w>
Cox -2</w>
Coun ter
Cost -
Cost- effectiveness</w>
Cor ti.</w>
Cor relative</w>
Cor por
Copenh ag
Coomb s</w>
Coomb 's</w>
Conver ting</w>
Continu ous-
Continu ing</w>
Consider ation</w>
Condi tioning</w>
Condi tional</w>
Concomit antly</w>
Concentration- response</w>
Con temporary</w>
Con sul
Con fir
Compon ents</w>
Complic ated</w>
Comple xes</w>
Comple ment</w>
Complain ts</w>
Committe e,</w>
Com partment</w>
Colon oscopy</w>
Coll agen</w>
Colchic ine,</w>
Col on</w>
Col laborating</w>
Cock croft-Gault</w>
Cocaine- using</w>
Coc E's</w>
CoA- SH,</w>
Co-trimox azole</w>
Co- perfusion</w>
Co uld</w>
Co Q10,</w>
Co ,</w>
Clu ster</w>
Clopido grel,</w>
Clon idine's</w>
Clobaz am</w>
Clin icalTrials.gov</w>
Clar ithromycin-induced</w>
Cl- APB</w>
Cl- /
Cl-/ HCO-3</w>
Cl ure</w>
Cl Br
Cl ),</w>
Cl (-)-
Cisplat in,</w>
Cisapri de-induced</w>
Cis atracurium</w>
Circumst ances</w>
Cir culatory</w>
Ciprof loxacin,</w>
Cin acalce
Cil nidipine</w>
Cil azapril</w>
Chron ically</w>
Chore iform</w>
Chore ic</w>
Children ,</w>
Chi -square</w>
Chemo therapy-na</w>
Char t</w>
Char les</w>
Chang ing</w>
Ch oline</w>
Ch T</w>
Ch E-
Ch E)</w>
Ceti rizine</w>
Cephalospor in</w>
Centr al-
Cent re.</w>
Celec oxib-induced</w>
Ceftriax one-related</w>
Ceftriax one,</w>
Cef tazidi
Ce A</w>
Cd Cl2</w>
Caucasi an,</w>
Cathe ters</w>
Cathe ter
Catat onic</w>
Cas pase-
Carolin a</w>
Carolin a.</w>
Carolin a,</w>
Cardi Pro</w>
Carboxyp eptidase</w>
Carboxyp eptidase-G2</w>
Carb aryl</w>
Car lo</w>
Captop ri
Capsa icin-
Cannabin oids</w>
Cannabin oid</w>
Cannab idiol</w>
Canc er.</w>
Cam pt
Calcineur in-
Calci um-
Cal otropis</w>
Caffe ic</w>
Caf ergot</w>
CaCl 2,</w>
Ca2+ -free</w>
Ca2+ ,</w>
Ca2 +/
Ca+ +
Ca++ --
Ca++-- binding</w>
Ca(2+)] (i))</w>
Ca(2+)- independent</w>
Ca(2+) (i)</w>
Ca ulophine</w>
Ca strated</w>
CYP2D6* 10</w>
CYP2C9* 3/
CYP2C9*3/ *3</w>
CYP2C 19*
CYP2 B</w>
CYP1A 1,</w>
CYP 3
CX CL
CV-1 808</w>
CV- C</w>
CV P,</w>
CV B3</w>
CTR- 05</w>
CTR .</w>
CT/LC T)</w>
CT/ MCT)</w>
CT C)</w>
CS T</w>
CS P-associated</w>
CS CR</w>
CS A.</w>
CS -mediated</w>
CRL :
CRL: (WI)
CRL:(WI) WUBR</w>
CRF (2)</w>
CR T,</w>
CPU 2
CPT-1 1/
CPF X</w>
CP-101,60 6,</w>
CP-101, 606</w>
CP Z,</w>
CP Pene</w>
CP NN</w>
CP NE</w>
CP 55,940</w>
COX-2- specific</w>
CONCLUSIONS/ SIGNIFICANCE:</w>
CON T</w>
CON SENSUS</w>
CO2- response</w>
CO L</w>
CO C-related</w>
CO (2)
CNSB 00
CNS- active</w>
CN S)</w>
CN 5</w>
CN .</w>
CN ).</w>
CMV- T</w>
CM MG</w>
CM M
CM Hs</w>
CM F.</w>
CM A</w>
CM -
CM ).</w>
CM (i)</w>
CLO CK</w>
CL T</w>
CL IN</w>
CL CN5</w>
CI- CTC)</w>
CI P,</w>
CI Na</w>
CI NC
CI N.</w>
CI H</w>
CHF :</w>
CH X</w>
CH X+
CH T</w>
CH OP</w>
CH O
CH E)</w>
CH -C</w>
CH ),</w>
CF R,</w>
CF -1</w>
CF ),</w>
CER -induced</w>
CE A</w>
CE .</w>
CD40- CD154</w>
CD4 +
CD R3</w>
CD I</w>
CD DP.</w>
CD 45
CD 3</w>
CD 25</w>
CD 25
CD /AT</w>
CCl 4.</w>
CCR 8,</w>
CCR 7-10</w>
CCNU -induced</w>
CCK- 5-8</w>
CCK- 2-
CCK-2- 8-
CCK-2-8- SE</w>
CCB s.</w>
CCB F/CO</w>
CC W</w>
CC S</w>
CC F</w>
CC ),</w>
CBF rest
CBF hypotension</w>
CB C.</w>
CB A/
CB 1R</w>
CB 1-receptor</w>
CB 1-
CB -2</w>
CB -1</w>
CA s).</w>
CA S.</w>
CA RE
CA RB
CA R,</w>
CA R
CA PD.</w>
CA L</w>
CA As</w>
CA 5</w>
CA 4
CA4 P</w>
CA 3=
CA 3.</w>
CA 3-
CA 10</w>
CA 1-
C57Bl/ 10
C57BL/6 NCr</w>
C57BL/6 J
C57BL/ Tw</w>
C57BL/ 10</w>
C57B1/ 6</w>
C57 /B
C57 .</w>
C3H/He N</w>
C3 Heb/FeJ</w>
C/ s</w>
C/ GFR</w>
C- urea</w>
C- terminus</w>
C- fibers.</w>
C- cells</w>
C- cells,</w>
C- LEPs</w>
C- APB</w>
C- 3</w>
C- ->
C' 3</w>
C ys
C ycl
C ul
C ub
C s;</w>
C ross</w>
C res</w>
C remoph
C re</w>
C ph</w>
C oupl
C ough</w>
C ore</w>
C ol,</w>
C ob
C o</w>
C max,</w>
C loxacillin-induced</w>
C lio
C hel
C embranoids</w>
C ause</w>
C ard</w>
C anine</w>
C Z)</w>
C TE
C PG
C ODE</w>
C Na
C NA</w>
C MAP</w>
C F,</w>
C CT</w>
C CNU)</w>
C CMA</w>
C CD.</w>
C 600</w>
C 6,</w>
C 4/
C 2)</w>
C 118
C118 T</w>
C 10</w>
C 1,</w>
C .,</w>
C )-induced</w>
C (s
C (P)</w>
By J,</w>
By J)</w>
Bv 8</w>
But yrylcholinesterase</w>
Burkit t's</w>
Bur st</w>
Bupropi on-induced</w>
Bupivaca ine-induced</w>
Bupivaca ine,</w>
Bu ff
Bromocript ine,</w>
Bromo -treated</w>
Brom o</w>
Bro modeoxyuridine</w>
Bro ca</w>
Bri efly,</w>
Break points</w>
Bra hmi</w>
Br ucella</w>
Br of</w>
Bost on,</w>
Bos entan</w>
Bor g</w>
Bor derline</w>
BoNT/ A-induced</w>
Bo dy
Blood- brain</w>
Block ers</w>
Bi periden</w>
Bi ochem
Bi har,</w>
Between- group</w>
Beta- adrenoceptor</w>
Ber aprost</w>
Bene fit</w>
Bend amustin</w>
Ben flu
Be side</w>
Be h
Bc l</w>
Bazet t's</w>
BayK- 8644</w>
BayK- 8644.</w>
Bay ley</w>
Bay esian</w>
Bax ,</w>
Bart ter
Bar rier</w>
Bar celona,</w>
Bang ko
Bam buterol</w>
Balti more</w>
Bacter oides</w>
Backgro und</w>
Bac osides</w>
Bab insk
Bab esia</w>
Ba Cl
Ba 2+</w>
BZ Ds</w>
BZ 1</w>
BZ .</w>
BX L
BW373U 86</w>
BW G</w>
BT 4
BSI F</w>
BSE R</w>
BSE Q</w>
BS- CB</w>
BS I</w>
BRL 35
BR S,</w>
BR L-44408</w>
BP s</w>
BP R</w>
BO S</w>
BN I</w>
BN I.</w>
BN 520
BM+ PBSC</w>
BM S-204352</w>
BM Is</w>
BL-10 20</w>
BL A.</w>
BK -induced</w>
BIP N</w>
BH T.</w>
BH T-induced</w>
BH T,</w>
BH R,</w>
BH (4),</w>
BF ;</w>
BE- TOC</w>
BCh E-/-</w>
BCPT-P -1</w>
BCN U,</w>
BCA A.</w>
BB s</w>
BB N,</w>
BB B,</w>
BB B)</w>
BALB/c ByJ</w>
BAL .</w>
BAL )</w>
BACKGROUND/ AIM:</w>
BA B</w>
B6NCr l</w>
B6 xD2</w>
B2 KO</w>
B- chronic</w>
B sep</w>
B rown-
B risb
B reath</w>
B pd</w>
B omb
B lunted</w>
B isoprolol</w>
B ifen
B eyond</w>
B ev
B ethan
B eij
B ech
B SC
B S.</w>
B PH,</w>
B P/
B NP,</w>
B N.</w>
B MMNC</w>
B MA
B L)</w>
B K.</w>
B K-
B ID)</w>
B HR.</w>
B H-
B F)</w>
B ECTS</w>
B CPNN</w>
B CP</w>
B C.</w>
B AP
BAP N</w>
B 2,</w>
B "</w>
Az imil
Avoid ance</w>
Autoradi ographic</w>
Aut om
Augment in-induced</w>
Aug mentation</w>
Audi ologic</w>
Audi ogenic</w>
Au stri
Atten tion-
Atrop ine,</w>
Atri oventricular</w>
Ator vastatin-induced</w>
Astro glial</w>
Asth matics</w>
Asth ma</w>
Astemiz ole</w>
Aspir ation</w>
Asc ites</w>
Asac ol.</w>
Arti caine</w>
Arte par
Arom atase</w>
Arg ;</w>
Ar g,</w>
Ar fonad</w>
Ar den</w>
Ar -125
Ar-125 4-
Ar-1254- promoted</w>
Aqu apor
Ap plying</w>
Ap plied</w>
Ap olipoprotein</w>
Ap ocynin</w>
Ap noea</w>
Anx io
Antine oplast
Antimal arials</w>
Antimal arial</w>
Antim uscarinic</w>
Antidepress ant-associated</w>
Anticoagul ant-induced</w>
Antic ataleptic</w>
Antibio tic</w>
Antibio tic-associated</w>
Anti- oxidant</w>
Anti- infective</w>
Anti- epileptic</w>
Anti- convulsant</w>
Anti- arrhythmic</w>
Anti thrombin</w>
Anti proteinuric</w>
Anti cholinesterase</w>
Ant agon
Anorex ia</w>
Ano rexi
Angiovist- 370</w>
Angel es.</w>
Angel es,</w>
Ang ptl
Aneur ysmal</w>
Anesthe tics,</w>
Anatom ical</w>
Analo gous</w>
Analgesic -induced</w>
Anaesthe tized</w>
Anaesthe tic</w>
Anaesthe si
An geles</w>
An c
An agrelide</w>
Amyg dal
Amphet amines</w>
Amoxic ill
Amne sic</w>
Aminophyll ine,</w>
Aminoglyco sides</w>
Am rinone,</w>
Am plit
Am antadine-induced</w>
Alpha- 2</w>
Alpha 2
All- trans</w>
All yl
Alfuz osin</w>
Alfentan il-induced</w>
Aldo -
Alco holic</w>
Alco hol
Ala- Gly-
Al thesin</w>
Al lograft</w>
Al buterol-induced</w>
Agon ists</w>
Agon ist</w>
Age ing</w>
Ag ed</w>
Ag SD</w>
Ag -
Afric ans.</w>
Aff ected</w>
Adriamycin- ---
Adriamycin---- CMF</w>
Adriamyc in-treated</w>
Adriamyc in-mediated</w>
Adrenal ine-induced</w>
Adol escent</w>
Administr ation-approved</w>
Aden osine-induced</w>
Aden ocarcinoma</w>
Addi tionally</w>
Adam s-Stokes</w>
Ad.N ull</w>
Ad ria</w>
Ad mixture</w>
Ad ap
Acut ely</w>
Acut ely,</w>
Acut e-
Acromegal y</w>
Aci dic</w>
Acetyl salicylic</w>
Acetyl choline</w>
Acetyl choline-induced</w>
Acetyl ator</w>
Acet yl</w>
Accur ate</w>
Accur acy</w>
Aca demy</w>
Ac- CCK-2-8-SE</w>
Ac tual</w>
Ac ta</w>
Ac t-
Ac id-
Ac cumulating</w>
Ac Neu</w>
Abstract Text</w>
Abs ent</w>
Ab sorption</w>
Ab normally</w>
Ab breviated</w>
AZT +
AZ A.</w>
AV- block</w>
AV B)</w>
AUC 0-
AUC0- infinity</w>
AUC (0-12
AUC(0-12 h)
ATP -</w>
AT RA,</w>
AT R
AT E</w>
AT D</w>
AT 2.</w>
AT 1a</w>
AT 1a
AT1a R(-/-)</w>
AT 1-receptor</w>
AST -120</w>
ASL- 812
AS+ A
AS+A Q</w>
AS Y
AS D</w>
AS CT</w>
AS A/
AR S),</w>
AR G,</w>
AR DS</w>
AR Cs</w>
AR CCS</w>
AR -3</w>
AR -
AR- R</w>
AR ).</w>
AQ E</w>
AQ +
AQ+ SP</w>
APPROAC H</w>
APO .</w>
AP- 43)</w>
AP V</w>
AP T</w>
AP S</w>
AP L,</w>
AP HC1</w>
AP H</w>
AO M</w>
AO D</w>
ANOV A).</w>
ANCA -
ANCA ),</w>
AN-1 32</w>
AN P,</w>
AN LL</w>
AMPH- sensitized</w>
AMPA- KA</w>
AMP- system</w>
AMP H)</w>
AMP ;</w>
AMP ).</w>
AM12 41,</w>
AM/ CL</w>
AM NS</w>
AM L/
AM I/GI</w>
AM H)</w>
AM CA)</w>
AM 17
AL- 369</w>
AL P</w>
AL LO</w>
AL L-
AL F-induced</w>
AL E</w>
AL B</w>
AL A,</w>
AK T</w>
AK I.</w>
AIM S.</w>
AI P.</w>
AI HA</w>
AI C</w>
AI C
AI A,</w>
AI ,</w>
AH-10 58,</w>
AH SCT.</w>
AH N-1055</w>
AH I</w>
AH /
AH/ PO</w>
AF F</w>
AEG35 15
AEG3515 6.</w>
AED .</w>
AE R</w>
ADR- pretreated</w>
ADR- nephropathy</w>
ADR+ MR1</w>
ADR+ IgG</w>
ADR+ G-CSF</w>
ADR /
ADAMTS -13</w>
AD s</w>
AD R)</w>
AD P,</w>
AD M,</w>
AD D
AD 50</w>
ACh Rs</w>
ACh E-/-</w>
ACP-10 3,</w>
ACEA-10 21,</w>
ACEA -13
ACE- inhibitors.</w>
AC s</w>
AC h,</w>
AC T.</w>
AC S/
AC S,</w>
AC Rs</w>
AC EA</w>
ABT- 59
AB VD</w>
AB RS</w>
AB P,</w>
AB C/2</w>
AAV 2-
AAPD s.</w>
A5 MB.</w>
A-869 29</w>
A- sensitive</w>
A- receptor</w>
A- based</w>
A- II</w>
A- CHF</w>
A- 77
A(2A) R-mediated</w>
A(2A) R(-/-)</w>
A sh
A s,</w>
A round</w>
A modi
A men
A i
A gency</w>
A etiological</w>
A blation</w>
A beta-induced</w>
A and</w>
A ])</w>
A ]).</w>
A VPA</w>
A RE
A PTT</w>
A PA</w>
A G-
A As</w>
A AL
A :
A 23
A 1555
A1555 G</w>
A 1/
A .,</w>
A )-</w>
? )</w>
>or= 4</w>
>/= grade</w>
>/= 60</w>
> 90%</w>
> 8</w>
> 5</w>
> 30</w>
> 30%</w>
> 150</w>
> 120</w>
=.0 2).</w>
= grade</w>
= 6</w>
= 300</w>
= 30%</w>
= 24</w>
= 22</w>
= 0.9
= -
</= 0.7</w>
< AbstractText</w>
< 5</w>
< 40%</w>
< 15</w>
< 0.006)</w>
< 0.005).</w>
< 0.001),</w>
< 0.0001)</w>
< .01)</w>
< .001,</w>
< .000
< .00
: 30</w>
: 12
999/ mm3)</w>
99 6</w>
99 ).</w>
97 -induced</w>
96. 6%</w>
95% :</w>
90/ 60</w>
90 8</w>
9/ 8
9/ 32
9. 9%</w>
9. 9
9. 8%,</w>
9. 7%,</w>
9. 4%</w>
9. 1/
9. 0,</w>
9. 0)</w>
9-di en-3-
9-1 0-
9- week-old</w>
9- to-12-hour</w>
9- 5
9- 4.
9- 2.
9 ].</w>
9 F/Y569
9 :</w>
9 9.0</w>
9 82</w>
9 8.
9 8+/-
9 8),</w>
9 8%),</w>
9 77</w>
9 75</w>
9 70</w>
9 61</w>
9 60</w>
9 6.9</w>
9 6).</w>
9 6%),</w>
9 59</w>
9 58</w>
9 5.</w>
9 5-1
9 5).</w>
9 4.0</w>
9 4%.</w>
9 4%,</w>
9 4%),</w>
9 38
9 3.3%</w>
9 3.
9 3),</w>
9 3%.</w>
9 25</w>
9 20
9 1.3</w>
9 -</w>
9 -10</w>
9 -1.6
9 );</w>
9 %/
89. 5%</w>
88. 9%</w>
87 2,</w>
86. 6%</w>
86 5)</w>
86 44
86 %.</w>
85/ 85</w>
82.07 15,</w>
80- 200</w>
80 ;</w>
80 9</w>
80 8)</w>
80 1,</w>
80 1)</w>
80 %;</w>
8. 8),</w>
8. 7).</w>
8. 6;</w>
8. 6,</w>
8. 6%,</w>
8. 6%).</w>
8. 5)</w>
8. 3,</w>
8. 0)</w>
8-hydroxy-2-(di-n-propyl amino)</w>
8-hydroxy-2- di-n-propyl
8-OHD PA
8-OH Gu
8- mg</w>
8- hydroxy
8- PT,</w>
8- (p-
8- (
8 c</w>
8 a</w>
8 :</w>
8 98</w>
8 9)</w>
8 9),</w>
8 8.1</w>
8 8-year-old</w>
8 8-
8 8).</w>
8 75</w>
8 68</w>
8 63</w>
8 6,</w>
8 5%).</w>
8 48</w>
8 4.1%</w>
8 4+/-
8 4)</w>
8 4).</w>
8 3
8 245</w>
8 23
8 2).</w>
8 18
8 13</w>
8 1.8%</w>
8 1.5</w>
8 1%.</w>
8 1%)</w>
8 00-
8 00,</w>
8 0.0</w>
8 0.0%,</w>
8 -16</w>
8 )).</w>
78 1</w>
78 %;</w>
78 %),</w>
77 %.</w>
76 1,</w>
76 ,000</w>
75 %;</w>
72- 96</w>
70 9</w>
70 7</w>
70 );</w>
70 %;</w>
7.0 5</w>
7. 8,</w>
7. 8),</w>
7. 7,</w>
7. 67</w>
7. 5.</w>
7. 5%,</w>
7. 4)</w>
7. 4).</w>
7. 4),</w>
7. 3%)</w>
7. 2;</w>
7. 2,</w>
7. 1;</w>
7. 1%,</w>
7-nitroinda zole,</w>
7-OH- DPAT</w>
7-Cl-Kyn A,</w>
7-1 3</w>
7- week,</w>
7- nitro</w>
7- ethoxyresorufin-O-deethylase</w>
7- 2.
7- (2-
7,8- benzoflavone</w>
7, 13-
7,13- dihydro-6H-benzofuro[2,3-e]pyrido[1,2-a][1,3]diazepin-12-ium</w>
7 th-
7 alpha-hydroxylase</w>
7 alpha-
7 ]</w>
7 LiCl</w>
7 H-
7 :</w>
7 97
7 80</w>
7 7%;</w>
7 7%)</w>
7 68</w>
7 6.5</w>
7 6%,</w>
7 56</w>
7 500</w>
7 50,</w>
7 5-mg</w>
7 41</w>
7 4,</w>
7 4%;</w>
7 38</w>
7 36</w>
7 34</w>
7 3.</w>
7 3.6</w>
7 3,
73, 806</w>
7 3),</w>
7 20
7 2.2%</w>
7 2).</w>
7 2%,</w>
7 2%).</w>
7 12</w>
7 11</w>
7 1.3</w>
7 -1.
7 +/-1
7 %);</w>
69 8</w>
69 ),</w>
68. 6%,</w>
68 %.</w>
67 580</w>
66 %.</w>
65- 85</w>
65 Zn</w>
64 139.</w>
63- yr-old</w>
63 );</w>
62. 2%</w>
62. 1%</w>
600 /
60-0 175</w>
60- s</w>
60- minute</w>
60- mg</w>
60 8</w>
60 6
60 4</w>
60 /
60 %;</w>
6.0 4</w>
6. 9;</w>
6. 8%</w>
6. 7;</w>
6. 7%;</w>
6. 6;</w>
6. 6%</w>
6. 6%,</w>
6. 6
6. 2-
6. 2%;</w>
6. 0,</w>
6. 0)</w>
6-thioguan ine.</w>
6-n-propyl- TDHL</w>
6-hydroxy dopamine-induced</w>
6-hydroxy dopa</w>
6-hydroxy dop
6- week-old</w>
6- phenyl
6- min</w>
6- hydroxy-DA-
6- chloro-
6- az
6- OH</w>
6- 9</w>
6- 7).</w>
6- ,</w>
6- (2-
6,7-dimethoxy-4- ethyl-
6,7- dinitroquinoxaline-2,3-dione</w>
6+/- 2</w>
6) Cl(-)</w>
6'- disinapoylsucrose</w>
6 h</w>
6 ],</w>
6 LiCl</w>
6 LiCl,</w>
6 J)</w>
6 B
6 ;
6 91</w>
6 90</w>
6 9.7</w>
6 9.0</w>
6 87</w>
6 83</w>
6 81</w>
6 8.4</w>
6 8),</w>
6 79</w>
6 7/
6 7%).</w>
6 60</w>
6 6.6</w>
6 6.0</w>
6 6).</w>
6 6%,</w>
6 52</w>
6 5/
6 5.2</w>
6 42</w>
6 4.8</w>
6 4).</w>
6 4%,</w>
6 31</w>
6 3.7</w>
6 3.6%</w>
6 3.3</w>
6 3+/-
6 24</w>
6 20</w>
6 20
6 2.5</w>
6 2%;</w>
6 2%.</w>
6 2
6 15
6 11</w>
6 1.8</w>
6 1+/-
6 1%)</w>
6 00-mg</w>
6 0.9</w>
6 -17</w>
5alpha- pregnan-
5] dec
59. 9%</w>
59 Fe</w>
59 ;</w>
59 -1
59 %).</w>
58. 6%</w>
58 54),</w>
58 3</w>
57- yr-old</w>
57 8</w>
57 4</w>
56. 9%</w>
56 %;</w>
55 7</w>
55 3</w>
55 ),</w>
55 %).</w>
54. 5%</w>
54. 2%</w>
54 %;</w>
53. 7%</w>
52 256</w>
52 %-
500/ mm3</w>
50/ ED50)</w>
50- fold</w>
50- day-old</w>
50- 80</w>
50- 65</w>
50- 450</w>
50 mg/kg,</w>
50 9</w>
50 7</w>
50 6-</w>
50 -150</w>
50 's</w>
5/ 90</w>
5/ 80</w>
5. 81</w>
5. 8%;</w>
5. 6+/-1
5. 5-
5. 5).</w>
5. 4,</w>
5. 3%)</w>
5. 25</w>
5. 0%,</w>
5-hydroxytrypt amine-
5-fluorourac il/folinic</w>
5-fluorourac il-associated</w>
5-fluoro deoxyuridine</w>
5-fluoro cytosine</w>
5-di methoxy-4-iodophenyl)-2-amino
5-HT1 A/
5-HT(2A/ 2C)</w>
5-HT(2 B)
5-HT 1</w>
5-HT -</w>
5-HT -2</w>
5-H z</w>
5-H y
5-Fluoro uracil-induced</w>
5-FU/ FA/
5-F u
5-1 4</w>
5-1 3</w>
5-1 0%</w>
5- month-old</w>
5- micrograms/kg</w>
5- d</w>
5- amino</w>
5- [5-amino-3-
5- LO</w>
5- 75</w>
5- 32</w>
5- 30</w>
5- /-</w>
5- -
5,7- dichlorokynurenic</w>
5,7- DHT,</w>
5,7- DCK
5, 6
5+/- 9</w>
5+/- 0.8</w>
5'- diphosphate</w>
5 x</w>
5 x
5 n</w>
5 mg)</w>
5 j</w>
5 g</w>
5 beta-pregnan-20-
5 b,</w>
5 a</w>
5 V</w>
5 A</w>
5 :1</w>
5 9.7</w>
5 9%)</w>
5 87</w>
5 85</w>
5 68</w>
5 6.</w>
5 6.7</w>
5 52</w>
5 47</w>
5 46</w>
5 41</w>
5 4.</w>
5 4.7</w>
5 4%).</w>
5 35</w>
5 32</w>
5 31</w>
5 3%,</w>
5 3%).</w>
5 2.5</w>
5 2.4</w>
5 2.3</w>
5 2).</w>
5 18
5 16</w>
5 15
5 1.8</w>
5 1.6%</w>
5 1.3</w>
5 1),</w>
5 0.9</w>
5 0.8%</w>
5 0.6</w>
5 ).(ABSTRACT</w>
5 ))</w>
49. 7</w>
49. 6</w>
49 465)</w>
49 );</w>
49 %.</w>
48/ 80,</w>
48-67 91,</w>
48 h</w>
48 8</w>
48 3</w>
48 ,6
48 %.</w>
47. 5%</w>
47. 4%</w>
450 ,000</w>
45. 5%</w>
45. 1%</w>
45- 60</w>
45 Ca</w>
45 9</w>
45 7</w>
45 %;</w>
42. 2%</w>
42- day-old</w>
412 348</w>
4030W 92</w>
4030W 92,</w>
400 mg</w>
400 mg/kg,</w>
400 ,000</w>
40/ 340</w>
40-7 592</w>
40-59 67</w>
40 6</w>
40 11</w>
40 ,
4/ 94</w>
4.6+/- 0.3</w>
4.0 ;</w>
4.0 9</w>
4.0 7</w>
4.0 6</w>
4.0 2</w>
4. 9;</w>
4. 93</w>
4. 9,</w>
4. 9).</w>
4. 8%,</w>
4. 5)</w>
4. 5).</w>
4. 4;</w>
4. 4%;</w>
4. 4
4. 3%)</w>
4. 3
4. 2+/-1.
4. 18)</w>
4. 12</w>
4. 10</w>
4. 1+/-
4. 0)</w>
4. 0%</w>
4-amin opyridine.</w>
4-amin opyridine,</w>
4-Cl-BZ T.</w>
4- quinoline</w>
4- phosphate</w>
4- methyl-
4- hydroperoxy
4- ethylsulfonylnaphthalene-1-sulfonamide,</w>
4- MC</w>
4- AAF</w>
4- 8
4- 67
4- 6)</w>
4- 3.
4- (2-
4- (
4,5,6,7- tetrahydro
4,4 a,5,6,7,8,8a,9-
4, 9-dien-3-
4+/- 4</w>
4'-iodo-4'- deoxydoxorubicin</w>
4 :00</w>
4 9;</w>
4 97</w>
4 8.8</w>
4 8.2</w>
4 8%)</w>
4 70</w>
4 7),</w>
4 7%)</w>
4 7%).</w>
4 61</w>
4 6.8</w>
4 6,
4 6+/-
4 6).</w>
4 6%,</w>
4 50-
4 5.</w>
4 5.8</w>
4 5.4</w>
4 48</w>
4 44</w>
4 43</w>
4 4.6</w>
4 4.5</w>
4 4.2</w>
4 4.1</w>
4 38</w>
4 37</w>
4 3.</w>
4 3.8</w>
4 3.5</w>
4 3.0</w>
4 3%)</w>
4 3
4 26</w>
4 22</w>
4 20-
420- 600</w>
4 2.4</w>
4 2.3</w>
4 2.2</w>
4 2),</w>
4 2%.</w>
4 17</w>
4 16</w>
4 1.8</w>
4 1+/-
4 0.8%</w>
4 0.2</w>
4 -16</w>
4 -10
4 +/-1.
4 +/-1
4 )-
3H- thymidine</w>
3H- digoxin</w>
39. 8</w>
39. 6</w>
39. 1</w>
39. 1%</w>
39 6</w>
39 166</w>
39 0)</w>
39 .</w>
39 +/-
39 %)</w>
38. 7</w>
38. 7%</w>
38. 6</w>
38. 3</w>
38. 1</w>
38. 0</w>
38 92)</w>
38 2</w>
38 /
38 +/-
37. 9</w>
37. 7%</w>
37. 0</w>
37 5
37 3</w>
37 ,
37 +/-
37 %.</w>
37 %).</w>
36 ]</w>
36 Cl-</w>
36 3</w>
36 0,</w>
36 +/-
36 %;</w>
35S- sulfate</w>
35. 7%</w>
35. 6%</w>
35- 40</w>
35 8</w>
35 3</w>
35 %;</w>
343- Stat5</w>
34. 8%</w>
34. 4%</w>
34 ]-
34 1
34 +/-
34 %.</w>
33. 0,</w>
33- month-old</w>
33 +/-
32. 4%</w>
32 +
32+ 33</w>
31. 8%</w>
31. 7%,</w>
31. 4%</w>
31. 2%,</w>
31 P-NMR</w>
300- 400</w>
300- 350</w>
30- s</w>
30- 40%</w>
30 761</w>
30 276</w>
30 %),</w>
3/ 7</w>
3/ 16</w>
3.5- 4.0</w>
3.0 9</w>
3.0 3</w>
3.0 2</w>
3.0 +/-
3. 94</w>
3. 93</w>
3. 91</w>
3. 87</w>
3. 7;</w>
3. 77</w>
3. 73</w>
3. 7-
3. 7).</w>
3. 62</w>
3. 6%,</w>
3. 51</w>
3. 5-fold</w>
3. 42</w>
3. 4)</w>
3. 4%;</w>
3. 4%,</w>
3. 35</w>
3. 3-fold</w>
3. 3).</w>
3. 27</w>
3. 2-
3. 2+/-
3. 2).</w>
3. 16</w>
3. 10;</w>
3. 1+/-
3. 1).</w>
3-phenyl tropane</w>
3-PP P,</w>
3-OH-H Q</w>
3-OH KY</w>
3-O- methyldopa</w>
3-1 4</w>
3-- 4</w>
3-( methylnitrosamino)
3-( (+/-)-2-carboxypiperazin-4-
3- week-old</w>
3- phosphono
3- mg</w>
3- isobut
3- desacetyl
3- day-old</w>
3- but
3- bromo-
3- antineutrophil</w>
3- M
3- 60</w>
3- 4),</w>
3- 30</w>
3- 21</w>
3- /
3,5- DHPG</w>
3,4-dicarboxy phenylglycine</w>
3,4-di aminopyridine</w>
3,4-DC PG
3,4- methylenedioxyamphetamine</w>
3,4- dihydro-
3, Thi5,
3, 8
3, 6-dimethyl
3, 6'-disinapoylsucrose</w>
3, 500</w>
3, 3'-
3+/- 3</w>
3+/- 0.
3) %</w>
3(2H)- pyridazinon-
3'U TRs</w>
3'U TR
3'-deamino- 3'-(2-
3'-azido-3'-deoxy thymidine</w>
3 beta-methyl-5alpha-pregnan-20-
3 beta-(4-
3 a-
3 D</w>
3 80
3 7-day</w>
3 7%)</w>
3 6.0</w>
3 6%)</w>
3 50)</w>
3 50%</w>
3 5.</w>
3 40/340</w>
3 4.8</w>
3 4.3</w>
3 4.1</w>
3 4.0</w>
3 389</w>
3 35</w>
3 35
3 3.8</w>
3 3.5</w>
3 3-year</w>
3 3%).</w>
3 200</w>
3 20
3 2.2</w>
3 1st</w>
3 17</w>
3 12
3 1.8</w>
3 1.7</w>
3 1.25</w>
3 1,
3 0.5</w>
3 0.3</w>
3 0.2</w>
3 0.0
3 +)</w>
3 ',</w>
2K1C- betagal</w>
2B 1/
29. 9</w>
29. 8</w>
29. 7</w>
29. 3%</w>
29. 2</w>
29. 1</w>
29. 0</w>
29- yr-old</w>
29 2)</w>
29 00</w>
29 %.</w>
29 %)</w>
29 %).</w>
28. 9</w>
28. 8%</w>
28. 6%</w>
28. 4%</w>
28. 2</w>
28. 0</w>
28- week</w>
28 7)</w>
28 2)</w>
28 1)</w>
28 0-
28 %)</w>
28 %).</w>
27. 9</w>
27. 7%</w>
27. 3</w>
27. 1</w>
27 /
27 -1
27 %;</w>
27 %.</w>
26. 9</w>
26. 7+/-
26. 0</w>
26 th</w>
26 5)</w>
26 4,</w>
26 0-
26 %).</w>
25/ 100</w>
25. 7</w>
25- mg/m2</w>
25- 50</w>
25(OH) D
25 th</w>
25 2</w>
25 00-
25 00,</w>
25 -100</w>
25 ,
25 %),</w>
240- 300</w>
24. 7</w>
24. 6</w>
24. 6%</w>
24. 4%</w>
24. 3%,</w>
24. 1%</w>
24- hydroxylase</w>
24- hr</w>
24- 72</w>
24 a,26a,27a-tri-homo-22,24-di
24 3
24 213</w>
24 20
2420 84</w>
24 13
24 0,</w>
24 %.</w>
24 %).</w>
24 %),</w>
23390 -</w>
23. 8%</w>
23. 5),</w>
23. 2</w>
23. 00</w>
23 6
23 3-
23 %;</w>
23 %)</w>
23 %),</w>
22. 8</w>
22. 6%</w>
22. 6%,</w>
22. 5%</w>
21- d</w>
21 C-->
21 +/-1
207 12
200- mg/m(2)</w>
200- 500</w>
200 mg</w>
200 mg/kg</w>
200 9)</w>
200 4).</w>
200 3-
200 2)</w>
200 1)</w>
200 1),</w>
200 ,00
200 ).</w>
20- tetrak
20- month</w>
20- mg/day</w>
20- 80</w>
20- 60</w>
20- 30%</w>
20- 25</w>
20 mg/kg.</w>
20 :1.</w>
20 :
20 5,</w>
20 10)</w>
2/ CM
2/ 8</w>
2.8 %.</w>
2.5 %.</w>
2.0 8,</w>
2.0 3</w>
2. 9-fold</w>
2. 9%,</w>
2. 9%).</w>
2. 88</w>
2. 87</w>
2. 8+/-
2. 8)</w>
2. 7),</w>
2. 7%;</w>
2. 7%,</w>
2. 67</w>
2. 62</w>
2. 6-1
2. 6).</w>
2. 53</w>
2. 50</w>
2. 44</w>
2. 41</w>
2. 4+/-
2. 4%,</w>
2. 33</w>
2. 31</w>
2. 30,</w>
2. 3-fold</w>
2. 3-
2. 3)</w>
2. 27</w>
2. 26,</w>
2. 23</w>
2. 2%,</w>
2. 2%)</w>
2. 19</w>
2. 18</w>
2. 17</w>
2. 14</w>
2. 11;</w>
2. 1%)</w>
2. 0%)</w>
2-methyl-6-(phenylethyn yl)pyridine</w>
2-mercapto ethan
2-hydroxy estradiol</w>
2-chloro deoxy
2-chloro adenosine,</w>
2-amino-4-phosphon obutyric</w>
2-amino-4-phosphon obut
2-amino-4- methyl-5-phosphono-3-
2-amino- 3-phosphono
2-Br- LIS</w>
2-1 4</w>
2-1 26</w>
2- week,</w>
2- stage</w>
2- day-old</w>
2- antagonists</w>
2- aminobicyclo[3.
2- adrenoreceptors.</w>
2- adrenoceptors,</w>
2- ME,</w>
2- Chloro
2- B
2- 9</w>
2- 7</w>
2- 3)</w>
2- 3
2- 2.6
2- 0
2- )</w>
2,4 18</w>
2,3-dihydroxy benzoic</w>
2,3-dihydrobenzofuran-7- carboxamide
2,3,5- triphenyltetrazolium</w>
2,3,4-tetrahydro- 6-nitro-
2,3,4,5- tetrahydro-7,8-dihydroxy-1-phenyl
2, 800</w>
2, 228</w>
2'- deoxyguanosine</w>
2',5'-dideoxy adenosine</w>
2 microg/rat)</w>
2 ])</w>
2 C-
2 C,</w>
2 B2</w>
2 7%)</w>
2 6%)</w>
2 4.5</w>
2 26
2 2%),</w>
2 16)</w>
2 1.4</w>
2 1.1</w>
2 0.9</w>
2 0.8%</w>
2 0.5</w>
2 0.4</w>
2 0.4%,</w>
2 0.2%</w>
2 ):</w>
2 ).(ABSTRACT</w>
2 )-
2 (+/-)</w>
1alpha- immunoreactive</w>
1A 1/
1:200 ,000,</w>
1: 400,000</w>
1997- 2001</w>
199 3).</w>
199 2-
1980 -199
198 6.</w>
198 5
198 4.</w>
198 2,</w>
197 8,</w>
197 7,</w>
197 5,</w>
197 3,</w>
197 2-1
197 1).</w>
197 0,</w>
196 6,</w>
19. 9%</w>
19. 5%</w>
19. 1</w>
19- nor-
19- fold</w>
19 th</w>
19 :
19 78.</w>
19 69</w>
19 53</w>
19 50</w>
19 5)</w>
19 43</w>
19 40</w>
19 0/
19 -1.
19 ,
19 %;</w>
19 %)</w>
18F- FDG</w>
180- 220</w>
18. 9%</w>
18. 4%</w>
18. 1%</w>
18-hydroxy deoxycorticosterone</w>
18- day-old</w>
18- 70</w>
18- 65</w>
18 93</w>
18 884,</w>
18 0)</w>
18 0).</w>
18 -</w>
18 +/-
18 %;</w>
18 %.</w>
17p11. 2-12</w>
17. 7%</w>
17. 6</w>
17- year</w>
17- month-old</w>
17 th</w>
17 779</w>
17 7)</w>
17 00</w>
17 0
16/ 20</w>
16. 00</w>
16- week-old</w>
16,23- D3-treated</w>
16 :
16 37
16 3)</w>
16 0.</w>
16 %)</w>
1500/ 30</w>
150- day-old</w>
15- week</w>
15- s</w>
15- day-old</w>
15- 21</w>
15 O-
15 :
15 55,</w>
15 5)</w>
15 00
1500 IU</w>
15 );</w>
1429 7,</w>
141716 A,</w>
1417 16)</w>
14. 9%</w>
14. 5,</w>
14. 5%</w>
14. 4%,</w>
14. 1%</w>
14. 0%</w>
14. 0%,</w>
14- day-old</w>
14 C]
14 9),</w>
14 7)</w>
14 4/
14 0-1
14 0,</w>
14 -18</w>
14 %;</w>
14 %)</w>
133X e</w>
131I- ferritin</w>
131I- MIBG</w>
13-cis- isomers</w>
13 90</w>
13 4)</w>
13 0%</w>
129/ OlaHsd</w>
128 130</w>
125 IHSA</w>
120- hour</w>
120 -1
120 ),</w>
12. 7%</w>
12. 6%</w>
12. 5+/-
12. 2+/-
12. 0,</w>
12- year</w>
12- mm</w>
12- ,</w>
12 h,</w>
12 99</w>
12 9%</w>
12 9
12 4).</w>
12 -16</w>
12 +/-
11- year-old,</w>
11- month-old</w>
11- A</w>
11 2,</w>
109/ l),</w>
100- mg</w>
100- 500</w>
100- 400</w>
100 635.</w>
100 00</w>
100 0,</w>
100 0)</w>
10/ group)</w>
10/ 16</w>
10.0 %,</w>
10. 8)</w>
10. 7%</w>
10. 4%</w>
10. 1,</w>
10. 1%</w>
10-1 1.</w>
10- week,</w>
10- minute</w>
10- fold)</w>
10- 3</w>
10- 20%</w>
10,00 0)</w>
10,00 0),</w>
10(9)/ l)</w>
10(9)/ l).</w>
10(3)/microliter s,</w>
10(- 3)
10 h</w>
10 b-
10 D2/
10 9)</w>
10 83</w>
10 8
10 71</w>
10 65</w>
10 47</w>
10 4.</w>
10 3)</w>
10 17</w>
10 ,0
10 );</w>
10 (5)</w>
10 %).</w>
1/ 75</w>
1/ 3
1/ 2.</w>
1.7 3
1.6 3;</w>
1.6 2;</w>
1.5 8,</w>
1.5 3;</w>
1.5 %.</w>
1.4 2-
1.4 %;</w>
1.3 6,</w>
1.3 %.</w>
1.25- 5</w>
1.00 ),</w>
1.0 ]</w>
1.0 8;</w>
1.0 8,</w>
1.0 7-
1.0 7,</w>
1.0 4-4.
1.0 4,</w>
1.0 2-1.
1.0 1-
1.0 ),</w>
1.0 %.</w>
1. 99,</w>
1. 94</w>
1. 91</w>
1. 9%).</w>
1. 82</w>
1. 81</w>
1. 8-fold</w>
1. 8%)</w>
1. 79</w>
1. 74</w>
1. 71</w>
1. 7-fold</w>
1. 6-fold</w>
1. 6)</w>
1. 6%,</w>
1. 5;</w>
1. 58</w>
1. 57</w>
1. 56
1. 55
1. 51</w>
1. 5+/-
1. 4%,</w>
1. 39</w>
1. 36
1. 3)</w>
1. 3%)</w>
1. 29;</w>
1. 25,</w>
1. 21,</w>
1. 2)</w>
1. 2),</w>
1. 2%).</w>
1. 19-1.
1. 18
1. 16</w>
1. 14-
1. 11
1. 1
1-methyl-4-phenyl-1,2,3,6-tetrahydropyrid ine.</w>
1-1 5</w>
1- year,</w>
1- mm</w>
1- minute</w>
1- fold</w>
1- and</w>
1- agonist</w>
1- [3-(4-
1- 8)</w>
1- 5,</w>
1- 2;</w>
1- 2
1- -3</w>
1- (2-chloroethyl
1,4- benzodiazepines</w>
1,3-DM UA</w>
1,3- dimethyluric</w>
1,25-(OH)2D 3,</w>
1,25-(OH)2-24OXO-16ene D3,</w>
1,25(OH)2-16ene-23 yne-19-nor-26,27-F6-
1,25(OH)(2) D(3)-treated</w>
1,24-(OH)(2) D(2)</w>
1,2-dimethyl hydrazine</w>
1, 800</w>
1, 750</w>
1, 378</w>
1, 300</w>
1, 2,
1, 100</w>
1+/-1. 2</w>
1+/- 5</w>
1) Cr
1 p19q</w>
1 mg/kg/day</w>
1 ])</w>
1 ]),</w>
1 D</w>
1 5-F(2t)-Iso
1 20)</w>
1 187</w>
1 16,</w>
1 10-1
1 10)</w>
1 10).</w>
1 10
1 0.9
1 0.7%,</w>
1 0.3
1 +
1 )-
000/ microL</w>
00- 2000</w>
00 88-
00 ).</w>
0.90 -1.
0.9 9;</w>
0.9 9,</w>
0.9 5-
0.9 4)</w>
0.9 3-1.
0.9 1-1.
0.9 %;</w>
0.8 9),</w>
0.8 8),</w>
0.8 7,</w>
0.8 6;</w>
0.8 5;</w>
0.8 4;</w>
0.8 4.</w>
0.8 2-1.
0.8 1),</w>
0.8 ),</w>
0.8 %),</w>
0.7 9)</w>
0.7 8).</w>
0.7 7;</w>
0.7 5-
0.7 4,</w>
0.7 3).</w>
0.7 2;</w>
0.7 -1.
0.7 ).</w>
0.7 %).</w>
0.6 8)</w>
0.6 8).</w>
0.6 6,</w>
0.6 5).</w>
0.6 4;</w>
0.6 2).</w>
0.6 0.</w>
0.6 0
0.6 %.</w>
0.6 %).</w>
0.6 %),</w>
0.5- 4.0</w>
0.5- 4.
0.5 8)</w>
0.5 6-
0.5 6+/-
0.5 5-
0.5 4).</w>
0.5 35%</w>
0.5 3).</w>
0.5 1).</w>
0.5 .</w>
0.4 7-
0.4 4),</w>
0.4 3)</w>
0.4 2-
0.3 8)</w>
0.3 4,</w>
0.3 3).</w>
0.3 0,</w>
0.3 -1.
0.3 -1
0.2- 0.3</w>
0.2 6)</w>
0.2 4%</w>
0.2 1,</w>
0.2 %),</w>
0.12 5-
0.05 )).</w>
0.04 6).</w>
0.04 3)</w>
0.03 6)</w>
0.03 5,</w>
0.03 3).</w>
0.02 1)</w>
0.02 1).</w>
0.001 ):</w>
0.0000 1</w>
0.0000 1)</w>
0.000 7).</w>
0.000 6)</w>
0.000 6).</w>
0.000 5</w>
0.000 5),</w>
0.000 4,</w>
0.000 2)</w>
0.000 ),</w>
0.00 9</w>
0.00 9,</w>
0.00 9)</w>
0.00 8,</w>
0.00 8)</w>
0.00 4</w>
0.00 45)</w>
0.00 3,</w>
0.00 2;</w>
0.00 17).</w>
0.00 11).</w>
0.0 9+/-
0.0 82</w>
0.0 75%</w>
0.0 50</w>
0.0 49</w>
0.0 48</w>
0.0 48).</w>
0.0 47</w>
0.0 38).</w>
0.0 37).</w>
0.0 36),</w>
0.0 35),</w>
0.0 34
0.0 26).</w>
0.0 24</w>
0.0 21</w>
0.0 19).</w>
0.0 19
0.0 18</w>
0.0 16</w>
0.0 16),</w>
0.0 15-
0.0 14
0.0 13)</w>
0. 80).</w>
0. 50)</w>
0. 50%</w>
0. 50
0. 30).</w>
0. 3).</w>
0. 3%)</w>
0. 29;</w>
0. 27
0. 25),</w>
0. 20).</w>
0. 19).</w>
0. 18-
0. 175</w>
0. 16,</w>
0. 150</w>
0. 15-
0. 14,</w>
0. 14),</w>
0. 12-
0. 12%</w>
0. 11)</w>
0. 11%</w>
0. 10%</w>
0. 1-1.0</w>
0. 1-1
0. 1%.</w>
0-1 60</w>
0-1 40</w>
0- ppm</w>
0- fold,</w>
0- U</w>
0- 6</w>
0- 6.
0- 5</w>
0- 20:
0- 2.</w>
0- 2)</w>
0 8.
0 7
0 4</w>
0 4-67
0 2:00</w>
0 20</w>
0 -</w>
0 ,0
0 +/-1
/N =
/ year</w>
/ ml)</w>
/ min</w>
/ day,</w>
/ d)</w>
/ T)</w>
/ E</w>
/ ARB</w>
.000 6).</w>
.000 5),</w>
.00 8),</w>
.00 7).</w>
.00 6).</w>
.00 3,</w>
.00 2),</w>
.00 1;</w>
.0 8).</w>
.0 5;</w>
.0 5.</w>
.0 4),</w>
.0 3,</w>
.0 26).</w>
.0 25).</w>
.0 12).</w>
. We</w>
. 7.</w>
. 4</w>
. 2</w>
. 2.</w>
. 125</w>
-2- deoxyuridine</w>
-17 G),</w>
-16-ene-23- yne-vitamin</w>
-15- labeled</w>
-1. 8</w>
-1. 210</w>
-1-piperazin yl)
-1- pyrrolidin
-1,3- di
-1,3,4- tricarboxylic</w>
-1,2-bis(3,5-di oxopiperazinyl-1-yl)prop
-1,2- diphenyl</w>
-1, 2</w>
-1, 200</w>
-1, 1-
-1 :
-1 9.
-1 808)</w>
-1 8.9</w>
-1 8.4</w>
-1 6.0</w>
-1 254</w>
-1 2,</w>
-1 -</w>
-1 ,000</w>
-0. 50
-- IP</w>
- tail</w>
- sensitive</w>
- r
- kinase</w>
- j
- independent,</w>
- dP/dt(max).</w>
- c
- arterial</w>
- aminocaproic</w>
- Re
- LD</w>
- K+</w>
- K
- IV
- ATPase,</w>
- ALA-D</w>
- ALA-
- 7-
- 65</w>
- 5</w>
- 520
- 5)</w>
- 33</w>
- 3.7</w>
- 20</w>
- 0.9
- )
+/-1. 8</w>
+/-1 8</w>
+/-1 5.
+/- 6</w>
+/- 0.04</w>
+/- )</w>
+ dP/dt(max)</w>
+ HS+
+ HF</w>
+ 28</w>
* 0
* )</w>
)- responsive</w>
)- negative</w>
)- atropine</w>
) n</w>
) agonists</w>
) M</w>
) F1</w>
) C-
) >/=
) ,
(y es/
(two -</w>
(two )</w>
(two ).</w>
(thre e)</w>
(stat in)</w>
(sham )</w>
(sc Met
(s. p.)</w>
(s. e.
(responder s)</w>
(r= 0.4
(r t
(r SO
(r CB
(r (2)</w>
(pseud otumor</w>
(pro )
(pre infusion:</w>
(paracetam ol
(p=0.00 5).</w>
(p=0.0 3)</w>
(p= 0.8
(p= 0.01)</w>
(p< 0.05),</w>
(p< 0.02),</w>
(p< 0.005).</w>
(p- value</w>
(p- chloro
(p ERK
(p <</w>
(p .)</w>
(nor-B NI),</w>
(n= 9)</w>
(n= 9).</w>
(n= 8).</w>
(n= 5)</w>
(n= 5).</w>
(n= 5),</w>
(n= 4).</w>
(n= 4),</w>
(n= 36),</w>
(n= 29)</w>
(n= 20),</w>
(n= 17)</w>
(n= 15).</w>
(n= 14)</w>
(n= 13)</w>
(n= 12).</w>
(n= 1),</w>
(n /N=
(mes na)</w>
(median= 0)</w>
(median =0.0
(medi an)</w>
(mean+/- SEM:</w>
(max ),</w>
(mGlu )</w>
(m ifeprist
(m TOR),</w>
(m RS</w>
(m CPP)</w>
(low- dose)</w>
(lind ane)</w>
(l- NAME
(iox aglate)</w>
(i. pl
(i. m.)</w>
(i opamid
(i omeprol
(gamma- HCH),</w>
(fMR I),</w>
(f ))</w>
(doxorubic in;</w>
(doxorubic in),</w>
(diphenyl methoxy)
(dexrazox ane).</w>
(d4 T)</w>
(d4 T
(d p
(d B)</w>
(control ;</w>
(chi (2)=
(c GMP)</w>
(bF GF)</w>
(ara- C).</w>
(apo )</w>
(anti- LK
(alpha- T
(aPTT s)</w>
(a )
([35S]TBP S)</w>
([ Ca(2+)](i))</w>
(Z n)</w>
(Z O
(We ek</w>
(WA Y</w>
(WA Y
(W SR)</w>
(W SP)</w>
(W R-27
(W MD)</w>
(W G)</w>
(W G),</w>
(W DR)</w>
(W BC</w>
(Viagra ).</w>
(VE Ps)</w>
(VE H),</w>
(VE GF
(V olta
(V mca
(V is
(V er
(V alium)</w>
(V al
(V T/
(V RS)</w>
(V PCs)</w>
(V NTR)</w>
(V M)</w>
(V FT)</w>
(V CR).</w>
(V AS,</w>
(V AS),</w>
(V AN)</w>
(V AC
(V (MCA
(V(MCA ))</w>
(UPD RS),</w>
(UF H)</w>
(U K-
(U DS)</w>
(U C)</w>
(Tr x
(Td p)</w>
(Tax ol).</w>
(Talw in)</w>
(Tac rolimus)</w>
(TUR P)</w>
(TTP- HUS)</w>
(TT P)</w>
(TT C)</w>
(TRPV 1).</w>
(TP P)</w>
(TP MT)</w>
(TNF )-
(TM Z)</w>
(TM X)</w>
(TI MP
(TH P)</w>
(TH ),</w>
(TGF )-
(TD 50</w>
(TB Z)</w>
(TAS S)</w>
(T imm</w>
(T gR[hAI]
(T e
(T anner</w>
(T V
(T PV/
(T NS).</w>
(T L)</w>
(T EOAEs)</w>
(T EMPO
(T E)</w>
(T CP)</w>
(T CD)</w>
(T CAs)</w>
(T BM
(T AC
(T 4/
(T 4)</w>
(T 30:</w>
(T 2-
(Ser ies</w>
(Sel dane)</w>
(Sando statin</w>
(SV R),</w>
(STZ)- diabetic</w>
(STR ),</w>
(ST Z).</w>
(ST S)</w>
(SSRI s),</w>
(SO 3
(SNP ).</w>
(SNH L)</w>
(SNH L),</w>
(SN A)</w>
(SM ON
(SI )</w>
(SGO T),</w>
(SER T)</w>
(SCO P)-induced</w>
(SAM e+APAP)</w>
(SAM e)</w>
(S)-2- (6-
(S)-2-(6- methoxynaphthalen-2-
(S)- (-)-
(S te
(S o-1
(S ch)</w>
(S VT)</w>
(S V),</w>
(S T)</w>
(S NP</w>
(S N)</w>
(S LE),</w>
(S J
(S H)</w>
(S DRR)</w>
(S D).</w>
(S Ch
(S CD)</w>
(S C-
(S C
(S BP
(S AS
(S AL)</w>
(S ,</w>
(Roc he</w>
(RW M)</w>
(RVL M)</w>
(RV M)</w>
(RR :</w>
(RO CK)</w>
(RO C)</w>
(RCT s)</w>
(R- (+)-
(R) aminoindan</w>
(R yR
(R ox
(R is
(R enograf
(R andall-Selitto</w>
(R U
(R S
(R PL
(R NF
(R L
(R IS)</w>
(R CC)</w>
(R AS
(R AMH)</w>
(R AD00
(R A
(R :</w>
(R ))</w>
(R (2)=
(QT c),</w>
(QT c
(QO L)</w>
(Q S/QT)</w>
(Pa CO2)</w>
(Pa (O
(PW V)</w>
(PTU ).</w>
(PTU )-associated</w>
(PT R)</w>
(PT A),</w>
(PR s)</w>
(PR M),</w>
(PR L-
(PR L),</w>
(PPAR alpha)</w>
(PON V).</w>
(PO M)</w>
(PK C
(PK A)</w>
(PIIIN P)</w>
(PGE 2
(PGE 1)-induced</w>
(PG AD
(PF S)</w>
(PE NK)</w>
(PE G)</w>
(PE ),</w>
(PDT C)</w>
(PD T)</w>
(PD E</w>
(PC W
(PC PA),</w>
(PC C)</w>
(PB SCT)</w>
(PB SC)</w>
(PB ;</w>
(PB ).</w>
(PAC AP)</w>
(PA R)</w>
(PA L-
(PA )-induced</w>
(P=0.00 9).</w>
(P=0.0 11),</w>
(P=0.0 1),</w>
(P= 0.0001).</w>
(P< 0.02)</w>
(P< 0.005)</w>
(P< 0.005).</w>
(P< 0.0005)</w>
(P< .01)</w>
(P< .001</w>
(P t
(P r
(P pa
(P SV
(P SE)</w>
(P SA).</w>
(P RE
(P R,</w>
(P PE).</w>
(P PA),</w>
(P O)</w>
(P N</w>
(P GF
(P F)</w>
(P ET).</w>
(P ED
(P DE)</w>
(P CR),</w>
(P CNS
(P CE
(P AS)</w>
(P AL
(P AE,</w>
(P :</w>
(P /
(P '
(Om niscan
(OVX+CHR ON+
(OR adj</w>
(OD C)</w>
(O gilvie's</w>
(O T)</w>
(O PC
(O LTX)</w>
(O L
(O IH).</w>
(O G
(O CT)</w>
(O CS)</w>
(O 2-)</w>
(O 2)</w>
(Ne w</w>
(NTG )-induced</w>
(NT S).</w>
(NSC -1
(NRTI s),</w>
(NO )-deficient</w>
(NO (
(NMD A)-
(NM S).</w>
(NF )-
(NC SE)</w>
(NB U)</w>
(NAS H).</w>
(NA G),</w>
(N2 O)</w>
(N-methyl- D-
(N- acetyl-
(N o
(N Z
(N VP)</w>
(N S-
(N REM)</w>
(N R)</w>
(N IC
(N HE3),</w>
(N G)</w>
(N G),</w>
(N G
(N CI-CTC)</w>
(N ADH</w>
(N AC
(N ),</w>
(MTX )-related</w>
(MT Ds)</w>
(MS SA)</w>
(MR S)</w>
(MPT P).</w>
(MPT P)-induced</w>
(MPT P
(MPO )-
(MPE P,</w>
(MP EP),</w>
(MN U)</w>
(MN CV),</w>
(MM SE)</w>
(MM S)</w>
(MIB G)</w>
(MF S)</w>
(ME T)</w>
(ME SNA)</w>
(ME M)</w>
(ME LD)</w>
(ME D,</w>
(MDMA ).</w>
(MC R)</w>
(MAO- B)</w>
(MADR S)</w>
(MA Ps)</w>
(MA PK)</w>
(MA MP)</w>
(MA ),</w>
(M it
(M in
(M et
(M an
(M TEP)</w>
(M SNA)</w>
(M P),</w>
(M O)</w>
(M NCV)</w>
(M H)</w>
(M CT/LCT)</w>
(M CF
(M :
(M 1)</w>
(Li )-induced</w>
(LY16 3892)</w>
(LY 3547
(LVE DP)</w>
(LVE DP).</w>
(LV dP/dt
(LV P),</w>
(LV ).</w>
(LT G,</w>
(LQT S)</w>
(LQT S).</w>
(LQT S),</w>
(LH ON)</w>
(LF P)</w>
(LEV ),</w>
(LDH ,</w>
(LDH ).</w>
(LC x)</w>
(LC V)</w>
(LAM )-resistant</w>
(L6- S1)</w>
(L1- L2)</w>
(L-dopa )</w>
(L-NOAR G),</w>
(L-NMMA ),</w>
(L-NAME ).</w>
(L-DOPA ),</w>
(L- NO
(L- Dopa
(L ami
(L VP
(L P)</w>
(L CT/MCT)</w>
(L AS)</w>
(K i)</w>
(K eppra
(K Y
(K T)</w>
(K A).</w>
(J M40
(IV R)</w>
(IOP )-
(INR ),</w>
(IL)- 6</w>
(IL)- 6,</w>
(IL K)</w>
(IIE F),</w>
(IFN)- gamma,</w>
(IF S).</w>
(IF N</w>
(ID V)</w>
(ID 50</w>
(IC R)</w>
(IC 50)</w>
(IC ).</w>
(IB IS-
(I/ R)</w>
(I mg/kg)</w>
(I ST)</w>
(I SI)</w>
(I PR
(I PD)</w>
(I OR/OS-
(I MID)</w>
(I HD)</w>
(I HC)</w>
(I C</w>
(Hol ter)</w>
(Hol lander</w>
(HV A),</w>
(HR =
(HPL C).</w>
(HIV )-associated</w>
(HIV ),</w>
(HD C)</w>
(HD AC)</w>
(HC M)</w>
(HBsAg ).</w>
(HBeAg ).</w>
(HBeAg )-negative</w>
(HBI G).</w>
(HB Ig
(HAM- D</w>
(HAM- D-1
(HAM- D).</w>
(HAM- A)</w>
(H sp
(H i
(H em
(H c
(H b),</w>
(H V)</w>
(H S
(H RPC)</w>
(H N)</w>
(H L
(H IC)</w>
(H CN)</w>
(H AT)</w>
(H AI)</w>
(H -
(Glu )</w>
(GY KI</w>
(GT S)</w>
(GT )n</w>
(GSHP x)</w>
(GM- CSF)</w>
(GF R).</w>
(GF P)</w>
(GF AP
(GBM ).</w>
(GBM ),</w>
(GABA)- ergic</w>
(GABA )-mediated</w>
(G px
(G la
(G d
(G ST
(G S)</w>
(G PR
(G OS)</w>
(G M)-induced</w>
(G ITS)</w>
(G EC)</w>
(G DNF)</w>
(G D</w>
(G Cs)</w>
(G C
(G AP-43)</w>
(G A
(G :</w>
(G 1:</w>
(G ),</w>
(FSG S)</w>
(FF P)</w>
(FEV 1),</w>
(FE N)</w>
(FD A).</w>
(F(1, 8)</w>
(F(1, 10)</w>
(F isch
(F i
(F ast
(F P
(F N)</w>
(F J
(F C)</w>
(F BAL)</w>
(F B
(F AA)</w>
(F A
(F ),</w>
(Estracy t)</w>
(ET )-1</w>
(ESR D).</w>
(ER G)</w>
(EP SCs)</w>
(EP S).</w>
(EP I</w>
(EP I).</w>
(EP (1)</w>
(EM G).</w>
(EM G),</w>
(EM B)</w>
(ELIS A).</w>
(EF S)</w>
(EE Gs)</w>
(ED s)</w>
(ED L)</w>
(ED 50,</w>
(ED 50),</w>
(ED (min)</w>
(ED (50))</w>
(EC OG</w>
(EC HO)</w>
(EC Gs)</w>
(EB GM</w>
(EB F)</w>
(EAD s)</w>
(E)- 2-amino-4-methyl-5-phosphono-3-
(E)- 2-
(E thy
(E V
(E SW
(E R-
(E P</w>
(E OG)</w>
(E H
(E GF)</w>
(E A),</w>
(E A
(E -
(E (2))</w>
(Dox il)</w>
(DP CP
(DOX /
(DOX ).</w>
(DO PA)</w>
(DO CA-
(DO C)</w>
(DN Q
(DN L)</w>
(DN ),</w>
(DMT U),</w>
(DMP X),</w>
(DMB A)</w>
(DM P-
(DL ST)</w>
(DH T)</w>
(DH E)</w>
(DG Cs)</w>
(DF X)</w>
(DF O),</w>
(DE X),</w>
(DE S,</w>
(DE NA
(DE N).</w>
(DE H
(DD T)</w>
(DD P)</w>
(DB H)</w>
(DB A/
(D- pen
(D epo-
(D aun
(D Y
(D S)</w>
(D M),</w>
(D LT
(D E)</w>
(D DP
(D CE)</w>
(D C)</w>
(D C
(D AV
(D AD
(D AB
(D 2R)</w>
(D 2</w>
(D (2))</w>
(Cytox an)</w>
(Cs A</w>
(Cs A).</w>
(Cs A)-induced</w>
(Cr Cl)</w>
(Con tro
(Co Q
(Ch E)</w>
(Cal lithrix</w>
(Ca(2+ )
(Ca 2+
(CYP2D 6)</w>
(CV P)</w>
(CV D)</w>
(CV -1808)</w>
(CTR L,</w>
(CT B)</w>
(CS F
(CR H),</w>
(CP R)</w>
(COX )-2</w>
(COR T)</w>
(CO PD)</w>
(CO P)</w>
(CM P)</w>
(CM I)</w>
(CL Z)</w>
(CL E)</w>
(CL D)</w>
(CK D)</w>
(CIP N)</w>
(CH L)</w>
(CGI- S),</w>
(CGI- I)</w>
(CG RP).</w>
(CE Q)</w>
(CD C)</w>
(CD 4,</w>
(CCl 4</w>
(CCl 4)</w>
(CCK-8- SE)</w>
(CCK-8- NS)</w>
(CCK- 8)</w>
(CB F),</w>
(CAP +HS+
(CAP ).</w>
(CAM I)</w>
(CA A)</w>
(CA 10)</w>
(C57BL/ 6J)</w>
(C x
(C oumad
(C hr.</w>
(C cr)</w>
(C Z
(C Y</w>
(C V</w>
(C T).</w>
(C S</w>
(C S)</w>
(C S).</w>
(C PT-1
(C PR
(C PP
(C PA)-induced</w>
(C MT)</w>
(C MAP)</w>
(C ID
(C HD).</w>
(C F)</w>
(C DZP)</w>
(C CI)</w>
(C C),</w>
(C AVB)</w>
(C ;</w>
(C :</w>
(C (s
(Brom age</w>
(Bo NT-A)</w>
(BZ 1)</w>
(BU N</w>
(BT X-A)</w>
(BS O)</w>
(BR S),</w>
(BI H)</w>
(BD L)</w>
(BB N)</w>
(BB N).</w>
(B rattleboro</w>
(B r
(B max)</w>
(B as
(B TS</w>
(B SE
(B SC
(B P).</w>
(B MT).</w>
(B MD)</w>
(B HA)</w>
(B F)</w>
(B CHE)</w>
(B CA
(B 1
(B (t
(Ara- C).</w>
(Ara- C),</w>
(An tabuse
(Al f
(Adriamyc in).</w>
(Ad C)</w>
(AUC (0-
(AU C,</w>
(AT P</w>
(AT (1))</w>
(ASP 5854),</w>
(ARF ),</w>
(ARB s)</w>
(AR V)</w>
(AR T)</w>
(APT T),</w>
(APO )-induced</w>
(AP s)</w>
(AP S)</w>
(AP D)</w>
(AOA A,</w>
(AOA A)</w>
(AN R</w>
(AN LL)</w>
(AMP ),</w>
(AM L),</w>
(AL F).</w>
(AIM S),</w>
(AID S)-
(AID A),</w>
(AI HA)</w>
(AGE s)</w>
(AE s),</w>
(ADR- 5
(ADR s).</w>
(ADR AC).</w>
(ADH D-
(AD M).</w>
(AD ),</w>
(ACh R)</w>
(ACE Is)</w>
(ACE I)</w>
(ACE I
(AC Z)</w>
(AC S)</w>
(AC S
(AC I)</w>
(AC EA-10
(AC E),</w>
(AB P)</w>
(AB D)</w>
(AB C)</w>
(AAP )-induced</w>
(A(2A) R)</w>
(A ra</w>
(A ng)</w>
(A mio-Aqueous)</w>
(A d-
(A b)</w>
(A T)</w>
(A ST
(A SI
(A SA),</w>
(A S)</w>
(A PO)</w>
(A PI
(A PD
(A PACHE)</w>
(A P-
(A NT)</w>
(A MI).</w>
(A L)</w>
(A H</w>
(A G
(A F),</w>
(A A).</w>
(A :</w>
(> 50%</w>
(> 25%</w>
(> 100</w>
(< 500</w>
(< 1</w>
(< 150</w>
(95% CI)</w>
(9. 8%)</w>
(9. 6%)</w>
(9. 5%</w>
(9. 5%)</w>
(9. 4%)</w>
(9. 2</w>
(9 9%)</w>
(9 7%</w>
(9 6%),</w>
(9 5.
(9 4.
(9 4%</w>
(9 2%),</w>
(9 1.7%)</w>
(9 00
(9 0.2%)</w>
(9 0%</w>
(8R, 15S)-di
(8R, 15S)-
(89. 2%)</w>
(88. 6%)</w>
(8. 7%)</w>
(8. 5</w>
(8. 4</w>
(8. 1%),</w>
(8-S PT)</w>
(8-OH-DPA T),</w>
(8- OH
(8 8</w>
(8 7%),</w>
(8 6%).</w>
(8 50</w>
(8 4</w>
(8 4.4%)</w>
(8 4%).</w>
(8 0%),</w>
(8 ,</w>
(8 ).</w>
(8 %;</w>
(75- 250</w>
(7. 9%)</w>
(7. 7%)</w>
(7. 6</w>
(7. 5-15</w>
(7. 4%).</w>
(7. 3%)</w>
(7. 2</w>
(7-OH- AAF)</w>
(7-N I)</w>
(7- methyl
(7- NI),</w>
(7 7.1</w>
(7 7%).</w>
(7 7%),</w>
(7 6%),</w>
(7 40</w>
(7 4%).</w>
(7 3%),</w>
(7 2%),</w>
(7 1</w>
(7 0%).</w>
(6. 7%</w>
(6. 6%</w>
(6. 5%),</w>
(6. 4%)</w>
(6. 3%)</w>
(6. 1%</w>
(6-OHD A).</w>
(6-OHD A)-
(6- MP)</w>
(6 8%),</w>
(6 7%),</w>
(6 6%).</w>
(6 6
(6 5%),</w>
(6 4.
(6 25</w>
(6 1.6</w>
(6 1.4</w>
(6 1.4%)</w>
(6 1%</w>
(6 00-
(6 00,</w>
(54. 4%</w>
(52. 6%)</w>
(50- 400</w>
(5. 9%)</w>
(5. 7</w>
(5. 7
(5. 4</w>
(5-HT) 2A</w>
(5-HT TLPR)</w>
(5-HT T)</w>
(5-HT (2
(5-FU )-based</w>
(5- methyl
(5- 50</w>
(5- 25</w>
(5 HT
(5 E-9,11,13
(5 7.1%)</w>
(5 7%).</w>
(5 4%</w>
(5 1/
(5 1)Cr
(5 00/
(5 00,</w>
(5 -</w>
(5 -15</w>
(5 -1
(45. 8%)</w>
(41. 2%)</w>
(4. 9%</w>
(4. 8%)</w>
(4. 7</w>
(4. 3%</w>
(4. 3%).</w>
(4. 2%</w>
(4. 1%),</w>
(4-fluoro phenyl)</w>
(4-fluoro phenyl
(4-D AMP)</w>
(4-(2- methoxyphenyl)
(4- iodo
(4- OH-
(4- 8</w>
(4- 7</w>
(4 9%).</w>
(4 9%),</w>
(4 80</w>
(4 62</w>
(4 6/
(4 6%),</w>
(4 5.1</w>
(4 4%).</w>
(4 3/
(4 20</w>
(4 2%),</w>
(4 1.8</w>
(4 1.4%)</w>
(4 0,</w>
(4 0%,</w>
(4 -1
(39. 8%)</w>
(37. 5%)</w>
(35. 3%)</w>
(34. 6%)</w>
(32. 1%)</w>
(3. 82</w>
(3. 8%)</w>
(3. 8%).</w>
(3. 7%).</w>
(3. 7%),</w>
(3. 4)</w>
(3. 2%),</w>
(3. 2
(3. 0-
(3-M PA)</w>
(3,4- dimethoxyphenyl)
(3'- azido-3'-deoxy
(3 rd</w>
(3 beta-
(3 H)
(3 9-
(3 8%</w>
(3 7.5,</w>
(3 6)Cl(-)</w>
(3 5.0</w>
(3 40</w>
(3 3.3%</w>
(3 2-
(3 00,</w>
(3 0.9</w>
(3 0.4%)</w>
(3 0),</w>
(3 -18</w>
(3 -100</w>
(3 );</w>
(28. 9%)</w>
(26. 6%)</w>
(25- 75</w>
(25- 40</w>
(24 h)</w>
(23. 1%)</w>
(22. 5%)</w>
(21. 4%).</w>
(200- 300</w>
(20- 60</w>
(20- 30</w>
(20 mg/kg,</w>
(2.5- 20</w>
(2.0 %)</w>
(2. 8%</w>
(2. 8
(2. 74</w>
(2. 6%</w>
(2. 5%</w>
(2. 3%),</w>
(2- DG)</w>
(2- 20</w>
(2, 5-dimethoxy-4-iodophenyl)-2-amino
(2, 400</w>
(2, 3-
(2) ).</w>
(2) ))</w>
(2 b).</w>
(2 S,
(2 D)</w>
(2 :
(2 8%).</w>
(2 7/
(2 7%</w>
(2 6%,</w>
(2 5th</w>
(2 57</w>
(2 56</w>
(2 4%),</w>
(2 3.3%)</w>
(2 20</w>
(2 2.6</w>
(2 10</w>
(2 0.2%)</w>
(2 -1
(2 ,000</w>
(1S,3 R,4S)-1-
(1H)- quinol
(1: 200,00
(1: 1,</w>
(199 0)</w>
(1966- February</w>
(19. 2%)</w>
(18. 8%)</w>
(17. 6%)</w>
(17. 4%)</w>
(17 beta-estradiol</w>
(16. 6%)</w>
(15. 8%).</w>
(15. 7%)</w>
(15. 6%)</w>
(15. 5%)</w>
(15. 0%)</w>
(15 )
(14. 5%),</w>
(14. 3%).</w>
(13- cis-retinoic</w>
(13) N-ammonia</w>
(12. 8%)</w>
(11. 7%).</w>
(11. 6%)</w>
(11. 2%)</w>
(11 )C-
(1000-1 200</w>
(10- 80</w>
(10- 60</w>
(10- -100</w>
(10(-6) M</w>
(10 8</w>
(10 7</w>
(10 3</w>
(10 1</w>
(10 (-10
(1/ 2))</w>
(1/ 10)</w>
(1.0 8</w>
(1.0 7</w>
(1.0 3</w>
(1. 9%)</w>
(1. 9%).</w>
(1. 82</w>
(1. 8%</w>
(1. 7)</w>
(1. 61</w>
(1. 51</w>
(1. 5,</w>
(1. 4-
(1. 4%</w>
(1. 4%),</w>
(1. 35%)</w>
(1. 3-
(1. 22</w>
(1. 2-
(1. 2%).</w>
(1. 13</w>
(1. 11</w>
(1. 0%)</w>
(1-1 3),</w>
(1,2- dihydro-2-acenaphthylenyl)
(1, 500</w>
(1, 5-
(1, 3,3-
(1)/ A(2A)</w>
(1 mg/kg</w>
(1 mg/kg)</w>
(1 R,3
(1 H-
(1 96</w>
(1 87</w>
(1 83</w>
(1 8.7</w>
(1 8%,</w>
(1 70</w>
(1 7.5</w>
(1 7,</w>
(1 7),</w>
(1 6.5</w>
(1 6),</w>
(1 500</w>
(1 50
(1 5)</w>
(1 48</w>
(1 47</w>
(1 44</w>
(1 42</w>
(1 4)</w>
(1 38</w>
(1 34</w>
(1 31
(1 3,</w>
(1 25,</w>
(1 12</w>
(1 1.7</w>
(1 0.9%)</w>
(1 0.1</w>
(1 0.0%)</w>
(1 )-</w>
(0.7 -1.
(0.5- 4</w>
(0.5 -1.25</w>
(0.4 2+/-
(0.3- 3.0</w>
(0.25- 0.75</w>
(0.25 -1.0</w>
(0.25 %)</w>
(0.2- 0.5</w>
(0.1- 3.0</w>
(0.1- 0.2</w>
(0.03- 1</w>
(0.01- 2.5</w>
(0.003- 0.1</w>
(0.0 8)</w>
(0.0 6-
(0.0 35</w>
(0.0 25%)</w>
(0.0 2-
(0.0 1,</w>
(0.0 1%</w>
(0. 95</w>
(0. 93</w>
(0. 9%).</w>
(0. 87</w>
(0. 79</w>
(0. 74</w>
(0. 70</w>
(0. 6-
(0. 50</w>
(0. 49</w>
(0. 46</w>
(0. 4,</w>
(0. 4%</w>
(0. 38</w>
(0. 37</w>
(0. 35</w>
(0. 33</w>
(0. 31</w>
(0. 24</w>
(0. 22</w>
(0. 21</w>
(0. 20</w>
(0. 19</w>
(0. 18</w>
(0. 15,</w>
(0. 14</w>
(0. 13</w>
(0. 11</w>
(0. 1-1.
(0. 1%,</w>
(0. 1%),</w>
(0 mg,</w>
(-4 9%)</w>
(-1 2.2</w>
(-/- )).</w>
(--)- 3-PPP</w>
(-)-spect aline</w>
(-)- enantiomer</w>
(-)- Sulpiride</w>
(-) isoproterenol-induced</w>
(-) isoproterenol,</w>
(- 6
(- 50</w>
(- 30%)</w>
(- 21</w>
(- )-</w>
(- ),</w>
(+/-) 8-OH-DPAT</w>
(+/- )-1-
(+/ +),</w>
(+)-5-methyl-10,11-dihydro-5H-di benzo[a,d]cyclohepten-5,10-imine</w>
(+)- tubocurarine</w>
(+)- cibenzoline</w>
(+)- MK-801</w>
(+)- 2-aminobicyclo[3.
(+) ]
(+ dP/dt(max))</w>
(+ 3
(+ )/
(* )
( zero</w>
( y</w>
( women,</w>
( wherein</w>
( where</w>
( w/v)</w>
( visual</w>
( ven
( vehicle</w>
( tumour</w>
( tumor</w>
( trifluoro
( total,</w>
( timolol</w>
( thiobarbituric</w>
( thermal</w>
( theophylline</w>
( thalidomide</w>
( th)</w>
( tetracaine</w>
( test</w>
( target</w>
( systolic,</w>
( symptomatic</w>
( sustained</w>
( surgical</w>
( stroke,</w>
( still</w>
( started</w>
( some</w>
( sitting</w>
( sit
( since</w>
( similar</w>
( signal</w>
( short-term)</w>
( severe)</w>
( seven
( sensory</w>
( saline),</w>
( saline
( s.c.
( round</w>
( representing</w>
( reported</w>
( related</w>
( reflecting</w>
( rats).</w>
( rat</w>
( rapid</w>
( ranging</w>
( radial</w>
( proved</w>
( protein</w>
( proportion</w>
( prior</w>
( previous</w>
( prevention</w>
( presumed</w>
( premature</w>
( potency</w>
( post
( possibly</w>
( poor</w>
( plug</w>
( pl
( perfusion</w>
( performed</w>
( paw-pressure</w>
( paroxysmal</w>
( pain</w>
( orthostatic</w>
( or)</w>
( one-way</w>
( omega</w>
( normal)</w>
( non-selective</w>
( nimesulide-beta-cyclodextrin,</w>
( ng/ml)</w>
( neutrophil</w>
( neurogenic</w>
( nephrectomized-
( nearly</w>
( ne
( myofibroblasts,</w>
( muscarinic</w>
( mossy</w>
( morphine</w>
( morning</w>
( moderate-
( ml/min/100</w>
( min</w>
( mild</w>
( mg/kg)</w>
( meperidine)</w>
( men:</w>
( memory</w>
( maternal</w>
( malondialdehyde</w>
( malondialdehy
( lowest</w>
( low-dose</w>
( long</w>
( locomotor</w>
( lithium</w>
( linezolid,</w>
( lignocaine)</w>
( lidocaine,</w>
( levels</w>
( lepirud
( lef
( ketamine)</w>
( isolated</w>
( isoflurane</w>
( ischemic</w>
( irCRF)</w>
( iohexol)</w>
( intraperitoneally</w>
( intact-
( inf
( indicating</w>
( increasing</w>
( incidence,</w>
( immediately</w>
( hypersensitivity)</w>
( hyperalgesia)</w>
( hydroxylation</w>
( hours</w>
( high-dose</w>
( guinea</w>
( good</w>
( generalized</w>
( gd)</w>
( frequency</w>
( fourth</w>
( following</w>
( folic</w>
( fluoxetine</w>
( fluoro-
( fixed-effect</w>
( female</w>
( fatal</w>
( external</w>
( exposed</w>
( experiment
( esmolol</w>
( es
( erythema</w>
( end</w>
( duration</w>
( duration,</w>
( due</w>
( draft)</w>
( dizocilpine)</w>
( differences</w>
( diazepam
( delayed</w>
( cyclic</w>
( creatine</w>
( colloid)</w>
( cocaine-induced</w>
( clozapine</w>
( caudate</w>
( carbidopa
( captopril,</w>
( bupivacaine</w>
( beta
( because</w>
( basi
( baseline:</w>
( basal)</w>
( autoregulatory</w>
( atropine,</w>
( assessed</w>
( aspirin</w>
( aspartate</w>
( arterial</w>
( approximate</w>
( approx.</w>
( apomorphine)</w>
( apo</w>
( antiepileptogenic</w>
( anticonvulsant</w>
( another</w>
( annual</w>
( analgesi
( amlodipine</w>
( alpha,beta-meATP)</w>
( all-trans-
( adrenal
( adjuv
( adenosine</w>
( abdominal</w>
( [31])P</w>
( Y-
( U-
( Theo-Dur
( SUN</w>
( Re
( Q-
( OD)</w>
( OB
( International</w>
( III)</w>
( 5-hydroxytrypt
( /
( (R)-
( (+)-
' very</w>
' s-like</w>
' s).</w>
' probable
' on-off'</w>
' low-
' dyston
' classical'</w>
' acute</w>
' Off'</w>
' C
' '
%/ year.</w>
%/ y</w>
%.mmHg -1,</w>
% ]);</w>
% FS</w>
% +/-1
# 1</w>
"spontaneous "</w>
"sil ent"</w>
"normal "</w>
" very</w>
" st
" specific</w>
" sof
" serious"</w>
" sensitiz
" retinoic</w>
" pre
" over
" on</w>
" non-
" neuro
" mini-dose"</w>
" look-alike"</w>
" high</w>
" g
" flu-like"</w>
" drug-
" clinical</w>
" at</w>
" agonist"</w>
" acute</w>
" a-determinant"</w>
" Torsade</w>
" >
}- 2,2-
}-2,2- dimethyl
}-2,2-dimethyl propyl)-2-
}-2,2-dimethylpropyl)-2- (3,4-dimethoxyphenyl)
}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl) acet
{ [(
{[( cyano
{[(cyano imino
{[(cyanoimino )
{[(cyanoimino) (5-
{[(cyanoimino)(5- quinol
{[(cyanoimino)(5-quinol inyl
{[(cyanoimino)(5-quinolinyl amino)</w>
zyme- linked</w>
zym osan</w>
zym os
zotep ine.</w>
zopiclon e,</w>
zon ation</w>
zomepir ac,</w>
zolpide m
zolmitript an,</w>
zolamide/ timolol.</w>
zol ine</w>
zol i</w>
zol e:</w>
zol e-
zol amide,</w>
zol )</w>
zofen opril,</w>
zo ster,</w>
ziprasid one-</w>
ziprasid one)</w>
zinc -pretreated</w>
zimel dine,</w>
zidovudine- experienced</w>
zidovud ine-related</w>
zidovud ine)</w>
zi one</w>
zebraf ish,</w>
ze hn
zehn t
zehnt ner
zehntner i</w>
zalcit ab
z- body</w>
z ymo
z y</w>
z oxazol
zoxazol amine</w>
z one,</w>
z omal</w>
z ine:</w>
z ine)</w>
z ime
z i,</w>
z et
z er</w>
z ech</w>
z am
zam be
zambe sic
z able</w>
z .</w>
z -type</w>
z --
z-- K</w>
z ).</w>
ysti tis</w>
ysm s.</w>
yros ine,</w>
yrimid ines,</w>
yr s;</w>
yr s),</w>
younger ;</w>
young sters</w>
youn g.</w>
you th.</w>
yohimb ine's</w>
yoeit o</w>
yo u</w>
yo tic</w>
yo pathic</w>
yo him
yohim be</w>
yo ff</w>
yno sto
ynosto sis,</w>
yne tic</w>
ynchron ous</w>
yn yl)
ynyl) est
ynyl)est ra-
ynyl)estra- 4,9-dien-3-
ynyl)estra-4,9-dien-3- one],</w>
ymo blastoma</w>
ym pathe
ym ous</w>
ym me
ymme tre
ym arin</w>
ylthio uracil</w>
yloxy- 4-
yloxy-4- methoxy
yloxy-4-methoxy methyl-
yloxy) phenylmethyl
yloxy)phenylmethyl )</w>
yloxy )-
ylo caine</w>
ylidene )-1-
ylene tetra
yle st
ylest radio
ylestradio 1/75</w>
ylcarbonyl) piperidine</w>
ylcarbamo yl-
ylcarbamoyl- 5-fluorouracil</w>
ylcarbamo yl)-1,2-
ylcarbamoyl)-1,2- meth
ylcarbamoyl)-1,2-meth ano[
ylcarbamoyl)-1,2-methano[ 60
ylcarbamoyl)-1,2-methano[60 ]
ylcarbamoyl)-1,2-methano[60] fullerene</w>
yl]-L- alan
yl]- N'-
yl]-N'- methyl
yl]-N'-methyl urea</w>
yl]- 4-
yl]- 3-phenyl
yl]-3-phenyl propan-2-
yl]-3-phenylpropan-2- ol</w>
yl] tropane</w>
yl] ethyl]
yl-L-leuc yl-L-proline</w>
yl-6- non
yl-6-non en
yl-4- chloro-
yl-4-chloro- N-methyl-
yl-4-chloro-N-methyl- N</w>
yl-3- pyrrolidin
yl-3-pyrrolidin yl)-5-
yl-3-pyrrolidinyl)-5- chloro-
yl-3-pyrrolidinyl)-5-chloro- 2-methoxy-4-
yl-3-pyrrolidinyl)-5-chloro-2-methoxy-4- methyl
yl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methyl amin
yl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylamin obenzamide</w>
yl-2'- hydroxy-ethoxy)tropane</w>
yl-1- methylxanthine</w>
yl- poly-
yl-poly- L-lysine</w>
yl- glycinamide</w>
yl- carnitine</w>
yl- 5-fluorourac
yl- 4-hydroxy
yl-4-hydroxy butyl
yl)prop en
yl)butyl]- 2-
yl)butyl]-2- naphth
yl)butyl]-2-naphth amide]</w>
yl)amino] phenyl]
yl)amino]phenyl] amino
yl)amino]phenyl]amino ]</w>
yl)amino] -</w>
yl)-piperaz ine],</w>
yl)-N- substituted</w>
yl)-2- (2-
yl)-2-(2- furyl)-
yl)-2-(2-furyl)- pyrazolo[4,3-
yl)-2-(2-furyl)-pyrazolo[4,3- epsilon
yl)-2-(2-furyl)-pyrazolo[4,3-epsilon ]
yl)-2-(2-furyl)-pyrazolo[4,3-epsilon] -1,2,4-
yl)- phthalate</w>
yl)- doxorubicin</w>
yl)- N'-
yl)-N'- (4-(2-
yl)-N'-(4-(2- methyl
yl)-N'-(4-(2-methyl prop
yl)-N'-(4-(2-methylprop yloxy)phenylmethyl)</w>
yl)- 6
yl)-6 H-
yl) thiaz
yl)thiaz olo[
yl)thiazolo[ 5,
yl)thiazolo[5, 4-
yl)thiazolo[5,4- e]
yl)thiazolo[5,4-e] [1,2,4]
yl)thiazolo[5,4-e][1,2,4] triazolo[1,5-c]pyrimid
yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimid ine-
yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine- 2
yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2 (3H)-
yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)- thi
yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thi ones</w>
yl) piperidino
yl)piperidino ]-
yl)piperidino]- p-
yl)piperidino]-p- xyl
yl)piperidino]-p-xyl ene</w>
yl) -1H-pyrazole-3-carboxamide
yl)-1H-pyrazole-3-carboxamide ],</w>
yl sulfon
ylsulfon yl)
yl methyl)-
yl methyl)
yl methoxy
ylmethoxy )-2-
ylmethoxy)-2- chlo
ylmethoxy)-2-chlo ropyri
ylmethoxy)-2-chloropyri dine)</w>
yl line.</w>
yl line)</w>
yl hydraz
ylhydraz yl</w>
yl guanidine</w>
yl glycerol</w>
yl en
yl benzamides</w>
yl ation,</w>
yl acetyl
yet- unidentified</w>
yel ination</w>
year-old- man</w>
year- old.</w>
year s
ye w</w>
ye w,</w>
ycl o</w>
ycin- induced,</w>
ycin- impregnated</w>
yc le.</w>
yc in-related</w>
yc anth
ycanth a),</w>
yb an)</w>
yaw ns</w>
yaw ning.</w>
y/ short</w>
y/ radio
y/radio therapy)</w>
y/ motor</w>
y/ jitter
y/ efficacy</w>
y/ ar
y/ar hin
y/arhin encephaly</w>
y. Post-mortem</w>
y- to-
y- responsive</w>
y- interposed</w>
y- guided</w>
y- bound</w>
y- associated</w>
y- aminobutyric</w>
y- Sch
y-Sch mid
y-Schmid t</w>
y- Glycyrrhiza</w>
y- -19</w>
y van
y tol
y rone,</w>
y rate),</w>
y pre
ypre x
y posis,</w>
y our</w>
y otonia</w>
y op
yop ia.</w>
y ner
y lethan
ylethan olamide</w>
y ing),</w>
y do
ydo akathisia</w>
y codon</w>
y chol
y benz
y ant</w>
y ance</w>
y amo
y algia</w>
y 1</w>
y ',</w>
y ').</w>
y ".</w>
xylo metazoline</w>
xylo choline</w>
xylaz ine/
xylazine/ ketamine-treated</w>
xylaz ine-treated</w>
xyl azine,</w>
xip amide,</w>
ximel agatran,</w>
xer osis</w>
xenograf ts.</w>
xenobio tics.</w>
xeno grafts</w>
xen ogene
xenogene ic</w>
xanth ine-
xanth ine),</w>
x/ minute,</w>
x- maze,</w>
x oten
x iv
x ing</w>
x illic</w>
x ia.</w>
x 9</w>
x 2</w>
x 15</w>
x 10(9)/L,</w>
x 10
x ))</w>
x (L)</w>
x "</w>
wt/ wt)</w>
wt/ day,</w>
wt/ day),</w>
wt -1</w>
writh ing,</w>
worsen ing).</w>
worsen .</w>
worris ome,</w>
worm s,</w>
worldwide ,</w>
work- up.</w>
work- up,</w>
work load,</w>
work ing,</w>
wor rying</w>
wor n</w>
wor ks.</w>
women /year</w>
woman- months</w>
wo A</w>
wk :</w>
wk ),</w>
without )</w>
within- subjects,</w>
withdraw als,</w>
withdraw al-related</w>
withdraw al
with -
winterian us</w>
window ,</w>
window "</w>
wild type</w>
wif e,</w>
widen ing)</w>
wide- range</w>
wide st</w>
wide ly-
wide -based</w>
wid th,</w>
wid ens</w>
wi se:</w>
wi re,</w>
whor led</w>
whole- kidney</w>
whole- embryo</w>
whole- animal</w>
whit es,</w>
whit es)</w>
whit e.</w>
whit e)</w>
whi tish</w>
wheel ch
wheelch air</w>
whe ther,</w>
whe ezing.</w>
whe ezing,</w>
wh en,</w>
wh ate
well- validated</w>
well- tolerated;</w>
well- standardized</w>
well- reported</w>
well- established.</w>
well- established,</w>
well- documented.</w>
well- developed</w>
well- compensated</w>
well known</w>
well being</w>
well be
well )</w>
well 's</w>
weight- matched,</w>
weight- loss</w>
weight );</w>
weigh ted,</w>
weigh t:</w>
week s);</w>
week ly-
week :</w>
week 's</w>
wedg e,</w>
weav ing.</w>
weav ing,</w>
wearing- off.</w>
wean ing.</w>
weak ness
weakness ;</w>
weak nes
weaknes ses</w>
we zi,</w>
we t/
wet/ dry</w>
we e</w>
we ap
we ane
weane d.</w>
we alth</w>
wax y</w>
wax ing</w>
wave- to-
wave-to- R-wave</w>
wave- break</w>
wave let</w>
wave front</w>
wave fron
wave form,</w>
water- deprived</w>
watch ful</w>
wat ery</w>
wast e</w>
wast age</w>
wash- out
wash ing.</w>
wash -in</w>
warr ants,</w>
warm- water</w>
warfar in;</w>
warfar in)</w>
war n
war ming.</w>
war ming,</w>
war dam
wardam ang
wardamang ia,</w>
war /
war/ tropical</w>
war .</w>
wan da.</w>
wall- to-
wall ;</w>
walk ing.</w>
walk er.</w>
wal k,</w>
wakeful ness
wakefulness -
wakefulness- sleep</w>
waist /
waist/ hip</w>
wa y-
w/ w</w>
w- a-
w-a- Man</w>
w thor
wthor n</w>
w t.)</w>
w r
wr apped</w>
w l</w>
w ist
wist ar</w>
w iring</w>
w ip
wip ing</w>
w ine.</w>
w ind
w in-
win- shift</w>
w il
wil for
wilfor dii</w>
w as
w ant</w>
w ag
wag and
wagand h
wagandh a</w>
w a</w>
w 4</w>
w 's</w>
w '</w>
vulner ability,</w>
vul sant</w>
vul on</w>
vs- host</w>
vox el</w>
vouch er.</w>
voric onazole-associated</w>
vomit ing:</w>
vomit ing
vomit .</w>
volunte ering</w>
volunte ered</w>
volume /
volume -related</w>
volume -</w>
volume ).</w>
volume ),</w>
volu tion
volution ized</w>
voltam metry,</w>
voli tional</w>
volati les</w>
vol %.</w>
void s,</w>
void ing.</w>
void ed</w>
vocal izing</w>
vocal ization.</w>
vocal ization,</w>
vocal ization).</w>
vivo- antigen
vivo-antigen -dependent</w>
vivo ;</w>
vivo 1H-NMR</w>
vivo /
vivo '</w>
vitro :</w>
vitro )</w>
vitro ),</w>
vitamin- D</w>
vitamin- D2-induced</w>
vitamin .</w>
vit el
vitel line</w>
vit ality</w>
visual izing</w>
visu ally,</w>
visit s)</w>
visit ).</w>
viscer on
visceron ociceptive</w>
visc osity.</w>
vis -a-
vis-a- vis</w>
virus- free</w>
virus /
virt ual</w>
viro logy</w>
viro log
virolog ical,</w>
viri on
virion s/
virg in,</w>
viral- like</w>
vir us)</w>
violet -</w>
viol ence;</w>
viol ation.</w>
viol ated</w>
vinyl- GABA,</w>
vinorelbine/ trastuzumab</w>
vincristine- induced)</w>
vincrist ine-</w>
vinc ulin</w>
vinc ristin</w>
vinblast ine-
vinblastine- bleomycin</w>
vin ce,</w>
vin (GF)</w>
vilox azine,</w>
vigabatr in-treated</w>
vig net
view point</w>
view ing</w>
videotap es</w>
video intensity</w>
video fluoroscopic</w>
vide oradi
videoradi ography</w>
vid one-
vidone- iodine</w>
vid a,</w>
vid ,</w>
victim s.</w>
vibris sa</w>
vibris sa
vibr ation-induced</w>
vib rat
vibrat ome</w>
vi vid,</w>
vi st
vi sion-
vision- threatening</w>
vi sibility</w>
vi remic</w>
vi remia.</w>
vi era</w>
vi duct,</w>
vi agra
vi a,</w>
vi ,</w>
vestibulo toxicity.</w>
vestibu loc
vestibuloc ochlear</w>
vesti bul
vessel s'</w>
vesico stomy</w>
vesico prostatic</w>
vesi culated</w>
vesi co-
vesi cl
vesicl es)</w>
vesi cant</w>
very- low-density</w>
very- low-birth-weight</w>
very- high-dose</w>
vertic is</w>
vertebra e</w>
vertebr al,</w>
verte brate</w>
verte b
versus- time</w>
vers ine),</w>
verat rum</w>
verapamil- sensitive,</w>
verapamil- ,</w>
verapamil ;</w>
verapamil :</w>
verapamil -related</w>
verapamil -</w>
ver- operating</w>
ver- function</w>
ver s.</w>
ver mis,</w>
ver ification</w>
ver bal
ver a,</w>
ver -treated</w>
ventro- rostral</w>
ventro basal</w>
ventriculo stomy</w>
ventricular- wall</w>
ventricu lography.</w>
ventric le:</w>
ventral- lateral</w>
ventr alis</w>
ventil ation-
ventilation- perfusion</w>
ventil ation)</w>
venti ve"</w>
vent .)</w>
venodilat or</w>
venodilat ation</w>
veno- venous</w>
venlafax ine-induced</w>
ven ule</w>
ven ul
ven ogram</w>
ven oconstric
ven occlusive</w>
ven ly</w>
ven ipunct
ven ep
ven dor.</w>
velb ine)</w>
vel y:</w>
vehicle/ METH</w>
vehicle :</w>
vedac lidine,</w>
vecuroni um's</w>
vecur onium)</w>
vect or-
vect or,</w>
vect or
ve- care</w>
ve t
vet ta</w>
ve ret
ve loci
ve in).</w>
ve d;</w>
ve d-
ve d)</w>
ve :</w>
ve .)</w>
ve -associated</w>
ve -</w>
ve ),</w>
ve (inf
ve(inf )</w>
vastatin- gemfibrozil</w>
vastat in-treated</w>
vasopress or-
vasopressor- SNP</w>
vasopress in-like</w>
vasopress in-induced</w>
vasop legia</w>
vasop ar
vasomo tion.</w>
vasodilat atory</w>
vasodil ative</w>
vasodil ation)</w>
vasoconstrict or,</w>
vasoconstric tions</w>
vasoconstric t</w>
vaso- active</w>
vaso pressive</w>
vaso depression</w>
vasculo toxicity</w>
vascular ized</w>
vascular ity,</w>
vascular -
vascul aris.</w>
vas omot
varic ocele.</w>
variable- pa
variable-pa yoff</w>
variable- cost-
variable-cost- variable-payoff</w>
vari ously</w>
vari es.</w>
vari ation,</w>
var us.</w>
var denaf
var .</w>
vapt an,</w>
vapor izer</w>
vap our</w>
vap ors</w>
vanish ing.</w>
vanilloid -type</w>
vanill yl-6-nonen
vancomyc in-related</w>
vancomyc in-associated</w>
van ished</w>
van illin,</w>
valvul itis</w>
valv ar</w>
valu es:</w>
valu ed</w>
valu able,</w>
valsart an.</w>
valsart an)</w>
vals pod
valspod ar</w>
valpro ate-related</w>
valpro ate-associated</w>
valid ation.</w>
valid ated.</w>
valid ated,</w>
valer ate-induced</w>
valacyclovir -related</w>
val ves:</w>
val ley</w>
val ine
valine 2-
val in</w>
val id.</w>
val id,</w>
val acyclovir,</w>
val ;</w>
vagin ally.</w>
vagin ally,</w>
vagin alis</w>
vagin al-
vagal- mediated</w>
vag us,</w>
vag i</w>
vacuol ization;</w>
vacuol es,</w>
vacuol ations</w>
vacuol ation.</w>
vaccin ated.</w>
va h's</w>
v x)</w>
v s.
v p
v one</w>
v ing;</w>
v aul
vaul t,</w>
v O2),</w>
v AV3V</w>
v 2.0</w>
v /
v .)</w>
uz zy</w>
uz est
uzest an
uzestan ica</w>
uz en-
uzen- tai
uzen-tai ho
uzen-taiho -
utiliz ed:</w>
util ised</w>
uti ve)</w>
uti loba</w>
uter ine-
ut most</w>
ut me
ut ing-
uting- bead</w>
ut esc
ut e
ut ative</w>
usu ally,</w>
usu al.</w>
ustom ed</w>
usion s;</w>
usion -related</w>
usion ),</w>
usid ),</w>
ush ing</w>
ush ing
ushing oid</w>
user s)</w>
user s).</w>
use/ non-use</w>
use/ abuse</w>
use- dependent,</w>
use d--
use d-
use ),</w>
uscit ation,</w>
us- soleus</w>
us sis-
ussis- tetanus</w>
us s.</w>
us nit
usnit z--K</w>
us ness</w>
us ch
us an
us al.</w>
us aid</w>
us acral</w>
us "</w>
urticaria/ angioedema,</w>
uroxi me-induced</w>
urotheli um:</w>
urotheli um-
urothelium- denuded</w>
uroprotect or.</w>
uro protectant</w>
uro prophylaxis</w>
uro pathy,</w>
uro lithiasis:</w>
uro epithelial</w>
uro cor
urocor tin-</w>
uro -
urkinj e's</w>
urine- concentrating</w>
urine- analysis</w>
urin es.</w>
urin ate.</w>
uridine- positive</w>
uricos uric</w>
uri e</w>
urgen cy.</w>
urge d.</w>
urg es</w>
urg ery</w>
urethane- anesthetized,</w>
ureth ro
ureth ritis</w>
ureth ritis,</w>
ureter oscopic</w>
ureter o
uretero vesical</w>
ure t
ure sis</w>
ure mic
ure ment</w>
ure ja</w>
ure as</w>
ure :</w>
ure -treated</w>
ure ),</w>
uran ium</w>
urac eae)</w>
ur tic
urtic ation,</w>
ur sodi
ur so
ur onate</w>
ur ine)</w>
ur ine),</w>
ur idine)</w>
ur ide)</w>
ur ia;</w>
ur g</w>
ur ate-
ur al,</w>
ur a's</w>
ur )</w>
uptake )</w>
upregul ating</w>
upper- tract</w>
up- regulating</w>
up- regulated,</w>
up- regulate</w>
up uncture</w>
up to</w>
up surge</w>
up set</w>
up s.</w>
up ron
upron )</w>
up ont
up date.</w>
up an
upan ine-2-
upanine-2- pyrrol
upanine-2-pyrrol carbonic</w>
unresect able,</w>
unra vel</w>
unpro ven.</w>
unpro ved,</w>
unpredict able;</w>
unpleas ant
unnet t,</w>
unnet t's</w>
unmas ks</w>
university- affiliated,</w>
universal .</w>
units/ mL</w>
units/ kg/day</w>
units/ day</w>
units- erythroid</w>
units- erythro
units-erythro id,</w>
unit z-type</w>
unit s)</w>
unit s).</w>
unit :</w>
uniqu e,</w>
unineph rectom
uninephrectom ised</w>
uniform .</w>
uni variates</w>
unfortun ately</w>
unfortun ately,</w>
unex posed.</w>
unex po
unexpo sed)</w>
une venly</w>
une sterified</w>
une ,</w>
undoub ted</w>
undesirab le.</w>
undesirab le,</w>
undesi red</w>
underestim ating</w>
underestim ated.</w>
under- estimation</w>
under way</w>
under taking</w>
under take</w>
under stand
under sho
undersho ot</w>
under reported</w>
under recognized,</w>
under pin
underpin nings</w>
under ne
underne ath</w>
under min
under lined</w>
under lich</w>
under diagnosed</w>
under developed</w>
unde rem
underem phasi
underemphasi zed</w>
unde d-
unded- back</w>
und- the-
und-the- clock</w>
und um</w>
und s,</w>
und a</w>
uncoupl ed</w>
uncommon ;</w>
unchang ed;</w>
unchang ed.(ABSTRACT</w>
unchang ed)</w>
unc tional</w>
unc h</w>
unc an</w>
unblinde d'</w>
unambigu ously</w>
un well,</w>
un warranted</w>
un ve
un vaccinated</w>
un treated),</w>
un surpassed</w>
un supervised</w>
un stenosed</w>
un solved</w>
un separated</w>
un scar
unscar red</w>
un satisfactory,</w>
un reveal
un restrained,</w>
un rest</w>
un responsiveness.</w>
un responsive.</w>
un responsi
un resolved.</w>
un resected</w>
un reporte
un remitting</w>
un relent
unrelent ing,</w>
un related.</w>
un reasonable</w>
un punished</w>
un proven</w>
un preced
unpreced ented</w>
un perturbed</w>
un pac
un necessarily</w>
un k</w>
un impres
un ilam
unilam ellar</w>
un ified</w>
un g-
ung- Con
ung-Con de</w>
un filtered</w>
un favorably</w>
un enhanced</w>
un dul
undul ating</w>
un disturbed</w>
un differenti
un diagnosed.</w>
un determined,</w>
un detect
un descended</w>
un covering</w>
un coordinated</w>
un conditional</w>
un comfortable</w>
un classifi
unclassifi able.</w>
un charged</w>
un born</w>
un blinding</w>
un availability</w>
un answered</w>
un altered,</w>
un acc
unacc ustomed</w>
un a</w>
un -
umer ically,</w>
um/ urine</w>
um/ gri
um/gri d'</w>
um- supplemented</w>
um- na
um-na velbine</w>
um- intracell
um-intracell ul
um- fed</w>
um- derived</w>
um ption</w>
um oral</w>
um mon
ummon d,</w>
um ?</w>
um (II)</w>
ultrasound- mediated</w>
ultrasoun d)</w>
ultrason ograms</w>
ultras m
ultrasm all</w>
ultras hort</w>
ultrafiltr ates</w>
ultrafiltr ate</w>
ultrafiltr able</w>
ultra- performance</w>
ultra distal</w>
ultr arap
ultrarap id</w>
ult ative</w>
ulog en</w>
ulo usness</w>
ulo -
ulo ,</w>
ulnar ,</w>
ull ar</w>
ulcer s)</w>
ulcer ous</w>
ular is</w>
ular -</w>
ul ts</w>
ul tram
ultram icro
ul l)</w>
ul et</w>
ul es/
ul ,</w>
udi l,</w>
ud otox</w>
ucin ous</w>
ubiquit ous</w>
ubi quinone
ubiquinone -10</w>
ub le</w>
ub itus</w>
ual a</w>
u tion,</w>
u sive</w>
u sis.</w>
u rease</w>
u reas,</w>
u porous</w>
u ph
u oden
u kot
ukot su
ukotsu -
ukotsu- bo
ukotsu-bo rei-
u hyp
uhyp nos
uhypnos )</w>
u g/
u dex
udex )</w>
u L
uL IF,</w>
u IPSCs</w>
u /
u .
u. v.</w>
u ))</w>
tyram ine-
tyramine- restricted</w>
type- III</w>
type- II</w>
type ;</w>
type -2</w>
type --
type '</w>
typ ical,</w>
ty- acid</w>
ty po
typo logies</w>
ty ?</w>
ty -induced</w>
two- trial</w>
two- tailed</w>
two- ta
two-ta ile
two- part</w>
two- month</w>
two- month-old</w>
two- minute</w>
two- fold.</w>
two- centre</w>
twitch es,</w>
twit ching,</w>
twic e)</w>
twenty- three</w>
twenty- six</w>
twelve- week</w>
tw in-
tw ig
twig -M
twig-M agen
twig-Magen die</w>
turbin ates</w>
turb idom
turbidom etric</w>
tur ns.</w>
tur ns,</w>
tur key</w>
tur c
turc ica</w>
tur b</w>
tur ally</w>
tun ica</w>
tumour s:</w>
tumour i
tumour -
tumour- bearing</w>
tumor- protective</w>
tumor ;</w>
tum oric
tumoric idal</w>
tum escence</w>
tum .</w>
tulo buterol</w>
tuf ts.</w>
tubulo reticular</w>
tubulo pathy,</w>
tubulo interstitium</w>
tubulo capillary</w>
tubul itis</w>
tubul in.</w>
tubul i</w>
tubul ar-
tubular- interstitial</w>
tubul ar,</w>
tuberculo static</w>
tuberculo id</w>
tubercul in-
tuberculin- syringe</w>
tuber cles.</w>
tube )</w>
tub er</w>
tu bo
tu ations</w>
ttp:// clinicaltrials.gov</w>
ts/ mm3</w>
tryptoph an.</w>
trypt ase,</w>
trypt aminergic</w>
trypt amine-induced</w>
tru xillic</w>
tru e.</w>
trox idone</w>
trox id
troponin- I</w>
troponin- I.</w>
tropic s.</w>
tropi setron,</w>
troph y</w>
troph ozo
trophozo ites</w>
troph in</w>
tropan e-
trop olone</w>
troleandom ycin</w>
tro vaf
tro pin
tro glo
troglo dy
troglody tes)</w>
tro fosf
triterpen es</w>
tris phosphate</w>
triptyl ine.</w>
tript yline,</w>
tript an.</w>
triple d.</w>
trinitro glycerin</w>
trinitro glycer
trinitroglycer in.</w>
trin or</w>
trimi pramine.</w>
trimethoprim- sulphamethox
trimethadi one)</w>
trimeth oxy
trimeth obenzamide</w>
trimetaz idine</w>
trimeta phan,</w>
trimester ,</w>
trimester ).</w>
trime trex
trime pranol</w>
triiodo thyron
trihexyphenid yl.</w>
triglyceride- lowering</w>
triglycer ide.</w>
trigemino- parasympathetic</w>
trigemin ovascular</w>
trifluoro acetyl-
trifluoroacetyl- altered</w>
trifluoper azine,</w>
tridec apeptide</w>
tricycl ics.</w>
tricycl ic-
tricuspid :</w>
tricuspid ,</w>
trichro me
trichotillo mania.</w>
trichomon iasis.</w>
tric olo
tricolo r</w>
tric hlor
trichlor methiazide</w>
tric eps.</w>
tric apr
tricapr yl
tric ally.</w>
triazolo benzodiazepine</w>
triazolo (1,5-
triazol o</w>
triazol ep
triazolep yridine</w>
triazol am-induced</w>
triazin- 3,5-
triazin-3,5- dione</w>
triazeno )
triazeno) imidazole-4-carboxamide</w>
triaz o
triazo lop
triaz en
triax ial</w>
triamterene- hydrochlorothiazide.</w>
triamcin olone,</w>
trial s),</w>
trial ),</w>
triad in</w>
triacylglycer ols</w>
tri- o-
tri-o- cresyl</w>
tri vial</w>
tri um
tri synaptic</w>
tri s</w>
tri phosphate-
tri phosphate,</w>
tri phosphatase,</w>
tri mid
trimid ox</w>
tri methyl-2-
trimethyl-2- ox
tri methyl-
tri logy</w>
tri foli
trifoli atus</w>
tri exponential</w>
tri eth
tri ent
tri ed.</w>
tri amine
triamine pentaacetic</w>
tri al-
tri age</w>
tri aL</w>
tretino in.</w>
tresp ass</w>
tren d)</w>
tremulous ness,</w>
tremor- dominant</w>
tremor ing</w>
treatment- termin
treatment s).</w>
treatment ?</w>
treatment (EPI</w>
treat able,</w>
tread ing</w>
tread ing,</w>
tre zol</w>
tre es.</w>
tre de
trede kin</w>
tre ach</w>
travell ers.</w>
trau ma:</w>
trau ma
trauma -induced</w>
trastuzumab ;</w>
trastuzumab .</w>
transver sal</w>
transport -deficient</w>
transpor ting</w>
transpor ters,</w>
transpor ter.</w>
transplant ations.</w>
transplant -related</w>
transpeptid ase-positive</w>
transmit ting</w>
transluc ency</w>
translo case</w>
translo case,</w>
transit ory,</w>
transi ently.</w>
transglutamin ase,</w>
transfu sion-
transfusion- chelation</w>
transfer s,</w>
transf usional</w>
transduc er,</w>
transcript ,</w>
transcri ption,</w>
transamin itis</w>
trans-nicotine-N'- oxide</w>
trans-nicotine-N'- oxide,</w>
trans-nicotine-N'- oxide
trans-nicotine-N'-oxide s.</w>
trans-3,4- dichloro-
trans- resveratrol</w>
trans- 4-methyl
trans-4-methyl cyclohexyl)
trans-4-methylcyclohexyl) -1-nitrosourea</w>
trans- 3,4
trans-3,4 a,
trans-3,4a, 10b-
trans-3,4a,10b- tetrahydro
trans-3,4a,10b-tetrahydro -4-
trans-3,4a,10b-tetrahydro-4- propyl-2
trans-3,4a,10b-tetrahydro-4-propyl-2 H,
trans-3,4a,10b-tetrahydro-4-propyl-2H, 5H-
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H- [
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[ 1]
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1] benzopyrano
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3- b]
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b] -1,4-
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4- oxaz
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxaz in-
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin- 9-
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9- ol
trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol )]</w>
trans sexual</w>
trans sarcolemmal</w>
trans mur
trans mit</w>
trans methylation</w>
trans membran
transmembran eous</w>
trans glomerular</w>
trans genesis.</w>
trans forms</w>
trans ections</w>
trans ected</w>
trans dihydrolisuride</w>
trans cellular</w>
trans catheter</w>
tranquiliz ers.</w>
tranquil izing</w>
tranquil izer</w>
tran dr
tramadol/ acetaminophen</w>
tramadol )</w>
traject ory</w>
traff ick
tract )</w>
tracheostom y.</w>
tracheostom y,</w>
trache otomy,</w>
trache obronch
tracheobronch ial</w>
trache al,</w>
trac ker</w>
trac es</w>
trac es.</w>
trac e-
trac e,</w>
trab amate</w>
tra y.</w>
tra its.</w>
tra ine
traine e</w>
tra il</w>
tr itan</w>
tr it
tr ine.</w>
tr ap
tr amine,</w>
tr agic</w>
tr af
tr acting</w>
toxoplasmo sis,</w>
toxico kinetic</w>
toxico dynamic</w>
toxic ologically</w>
toxic ity.(ABSTRACT</w>
toxic ity-related</w>
toxic ity)</w>
toxic ity
toxic iti
toxic ant</w>
tox in
tourniquet -induced</w>
tourniqu ets</w>
tourniqu et.</w>
touc h.</w>
tot ally.</w>
tot alling</w>
tot al:</w>
tos omal</w>
tortic olli
torticolli s.</w>
torsa des.</w>
torsa de
toremif ene.</w>
toremif ene-
toremifene- treated</w>
toraf ur</w>
tor- containing</w>
tor tu
tor so</w>
tor so.</w>
tor sion</w>
tor sin
tor hinolaryng
tor hinal</w>
top y</w>
top ped</w>
top ography,</w>
top ically.</w>
top ic.</w>
top ic
tonsil litis</w>
tonic oclonic</w>
ton- pump</w>
ton sur
tonsur ans</w>
ton otopic</w>
ton ometry</w>
ton es</w>
tomograph y)</w>
tom ograms</w>
tom at
tolu ene,</w>
tolmet in-dependent</w>
toler ances</w>
toler ance;</w>
toler ance:</w>
toler able,</w>
tolaz amide-induced</w>
tol ylguanidine</w>
tol vaptan</w>
tol i</w>
tol am
toge ther
toddl ers</w>
toddl er</w>
tocoph er
tocopher ols</w>
tocain ide/
tocainide/ lidocaine</w>
tocain ide,</w>
toc oly
tobram ycin-treated</w>
tobram ycin,</w>
tob i
tobi prof
tobiprof unda</w>
to- mild</w>
to- mesenchymal</w>
to- high-dose</w>
to- end</w>
to- GU</w>
to y</w>
to ols.</w>
to o,</w>
to graph
to genicity</w>
to day;</w>
to day's</w>
to ad</w>
tive/ disruptive</w>
tiv es,</w>
tiv al</w>
tit res,</w>
tit ating</w>
tissu es:</w>
tissu e/
tis sular</w>
tis ocial</w>
tis m.</w>
tis ine,</w>
tis -induced</w>
tis --
tipran avir</w>
tipran avir/
tion- progression</w>
tion- limiting</w>
tion- Event</w>
tion s:</w>
tion ine</w>
tion >=</w>
tion .(ABSTRACT</w>
tion --an</w>
tion '</w>
ting ia</w>
ting en</w>
tin idazole</w>
timul atory</w>
timolol- latanoprost</w>
timolol- hydrochlorothiazide</w>
times/ week)</w>
times- daily</w>
time-to- peak</w>
time-to- onset</w>
time-to- event</w>
time- weighted</w>
time- velocity</w>
time- varying</w>
time- sequence</w>
time- on-
time-on- task</w>
time- limited</w>
time- domain</w>
time- dependence</w>
time- density</w>
time points</w>
time d-pregnant</w>
time ),</w>
tim ulated</w>
tim ide,</w>
tim es;</w>
tim es).</w>
tilit y;</w>
tilit y:</w>
til t).</w>
til es.</w>
til be
til agin
tilagin ous</w>
til ,</w>
tigh tened</w>
tigh t-
tig er</w>
tig ation</w>
tifluad om</w>
tifluad om,</w>
tid ine's</w>
ticulo us</w>
ticrynaf en</w>
ticlopid ine;</w>
ticlopid ine:</w>
ticlopid ine-related</w>
ticlop ride</w>
ticarc ill
tic- zone</w>
tic- resistant</w>
tic- regression</w>
tic- drug-induced</w>
tic- acid-induced</w>
tic ularis</w>
tic s;</w>
tic osus</w>
tic ine</w>
tic entr
ticentr e</w>
tic ation</w>
tic :</w>
tic -type</w>
tic ),</w>
tic (s)</w>
tibol one</w>
ti vely,</w>
ti tre
ti ters,</w>
ti ter,</w>
ti ses</w>
ti pame
tipame zole</w>
ti ming.</w>
ti ming
timing "</w>
ti le-
ti dyl</w>
ti di
ti des.</w>
ti de</w>
ti d,</w>
ti ca,</w>
ti bio
ti ation</w>
ti a,</w>
thyrotroph ic-
thyrotrophic- releasing</w>
thyrotoxic osis:</w>
thyroidi tis.</w>
thyroid ectomized</w>
thyro parathyroid</w>
thyro id.</w>
thyro ary
thyroary ten
thyroaryten oid</w>
thym us.</w>
thym ulin</w>
thym ia.</w>
thym ia,</w>
thy mus,</w>
through out
throughout ),</w>
through -
through- and-
through-and- through</w>
thrombot est.</w>
thromboly zed</w>
thromboembol ism;</w>
thrombocytopenia- thrombosis</w>
thrombocytopen ia).</w>
thrombocytopen ia
thrombocyth aemia,</w>
thrombocy themia</w>
thrombo tics</w>
thrombo tic,</w>
thrombo ses.</w>
thrombo prophylaxis</w>
thrombo plast
thromboplast in-induced</w>
thrombo phleb
thrombo philic</w>
thrombo philia.</w>
thrombo hemorrhagic</w>
thrombin- activ
thrombin-activ atable</w>
thromb open
thrombopen ia)</w>
thromb omodul
thrombomodul in</w>
thromb ocytosis.</w>
thromb in,</w>
throm ycin-induced</w>
thro id,</w>
thro b
throb bing</w>
thrice- daily</w>
threshol d:</w>
threo- 3-hydroxy
threo-3-hydroxy aspartic</w>
threo- 3,4-dihydroxyphenyl
threo-3,4-dihydroxyphenyl serine</w>
three- step</w>
three- hour</w>
three- combined</w>
three- ,</w>
threat ens</w>
thre onine</w>
thre e)</w>
thr ust</w>
thr ush</w>
thr in,</w>
though t
thorough ly.</w>
thorough ly,</w>
thoraco- abdominal</w>
thor ity.</w>
tho propa
thopropa zine</w>
thix ene,</w>
this .
this. Aminoglycoside</w>
thirty- two</w>
thirty- one</w>
thirty- five</w>
thirty- eight</w>
thirst y</w>
third- generation,</w>
thir teenth</w>
thir st.</w>
thioridaz ine)</w>
thioredox in,</w>
thiopentone- vecuronium</w>
thiopentone- suxamethonium</w>
thiopental- halothane</w>
thiopental- anesthetized</w>
thion ine-
thioguan ine.</w>
thioguan ine-related</w>
thiocyan ate</w>
thio thixene,</w>
thio phosphoric</w>
thio glucose.</w>
thio glucose
thio fen
thiofen -2-
thio ate</w>
thio acetamide</w>
thio ]
thin- 3-O-
thin-3-O- gallate</w>
thigh s,</w>
thigh .</w>
thiethylper azine</w>
thiep in-1
thiepin-1 0-
thiepin-10- yl)oxy]-
thickness/ LV
thicknes ses</w>
thiazolidinedi ones,</w>
thiazole- 2-
thiazole-2- carboxamide,</w>
thiazol idinedione</w>
thiazol -2-
thiazol-2- amine</w>
thiazide -like</w>
thiaz olo[3,2-a]
thiamylal- enflurane</w>
thiam azole</w>
thiam azole-induced</w>
thiadi azol
thiadi azepine</w>
thia -1-
thia-1- azabicyclo
thi omorph
thi ols.</w>
thi ol,</w>
thi ol
thiol -1
thiol-1 1-des
thiol-11-des oxy</w>
thi ocy
thi amin,</w>
theta( albumin)</w>
theta 1</w>
thesi a,</w>
thermon ociceptive</w>
thermodi lu
thermo regulation</w>
thermo graphic</w>
thermist or-
thermistor- tipped</w>
thermal- pain</w>
therm ally</w>
thereafter )</w>
there of.</w>
there in</w>
there by,</w>
there -
therapeu tics</w>
therapeu tically.</w>
therapeu tic.</w>
therapeu tic-
therapeu tic,</w>
therap y?</w>
therap y.Post-mortem</w>
therap y's</w>
therap ists</w>
ther mode</w>
ther ization</w>
ther ing</w>
theophylline- intoxicated</w>
theophylline /kg</w>
theophylline -</w>
theophyll ine-containing</w>
thenal idine</w>
then uria,</w>
then ia</w>
then ate</w>
themo glob
them y
thec olamine-induced</w>
the- tiger</w>
the ta,</w>
the sis,</w>
the sia.</w>
the ses</w>
the ory.</w>
the orized</w>
the ob
theob rom
theobrom ine,</w>
the dium</w>
thalidomide- affected</w>
thalidomide -related</w>
thalassemic s</w>
thalamo-striatal- cortical,</w>
thalam us)</w>
thalam i</w>
thal li
th- 5th</w>
th yl</w>
th ump</w>
th row</w>
th ol.</w>
th es
th enic</w>
th ation
thation e</w>
th -associated</w>
th -10
th-10 th</w>
text books</w>
tex t.</w>
tex -
tetrodotox in-sensitive</w>
tetrodotox in,</w>
tetro xide</w>
tetrazol ium.</w>
tetrapare sis,</w>
tetrap legia.</w>
tetramethyl- p-
tetramethyl- 2
tetramethyl-2 H
tetramethyl-2H -1-
tetramethyl-2H-1- benzopyran
tetramethyl-2H-1-benzopyran -
tetramethyl-2H-1-benzopyran- 6-
tetramethyl-2H-1-benzopyran-6- ol,</w>
tetramethyl pyrazine</w>
tetrahydropyranyl adriamyc
tetrahydropyranyladriamyc inol</w>
tetrahydroisoquinol ine,</w>
tetrahydrocannabinol- dimethylhept
tetrahydrocannabinol-dimethylhept yl</w>
tetrahydrocannabin ol.</w>
tetrahydro-3-methyl-5-phenyl -1H-3-benz
tetrahydro progesterone</w>
tetrahydro pal
tetrahydro isoquinoline</w>
tetrahydro folic</w>
tetrahydro cortisone</w>
tetrahydro cortisol,</w>
tetrahydro aminoacridine</w>
tetrafluoro ethane</w>
tetraethylammon ium.</w>
tetracycline- class</w>
tetrachloro bi
tetrachlorobi phenyl)</w>
tetraca ine),</w>
tetraben azine.</w>
tetrab amate</w>
tetrab am
tetra si
tetrasi lox
tetrasilox ane</w>
tetra d</w>
tetr adec
tetr abut
tetrabut yl
testosterone- replacement</w>
testosterone- 6</w>
test s),</w>
test ings</w>
test es.</w>
test ed)</w>
test ed
test --
test -
tes un
tes ol
tert-butylamino- 2-hydroxy
tert-butylamino-2-hydroxy )
tert-butylamino-2-hydroxy) prop
tert-butylamino-2-hydroxy)prop oxy-
tert-butylamino-2-hydroxy)propoxy- 3,4-dihydro
tert-butylamino-2-hydroxy)propoxy-3,4-dihydro carbo
tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbo sty
tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbosty ril</w>
tert-butyl amino)
tert-butylamino) propoxy
territ ory,</w>
territ ories,</w>
termin ated,</w>
termin als),</w>
termin alis</w>
termin al-
terfen adine-induced</w>
terbutal ine)</w>
teratogen -induced</w>
terat ology</w>
terat oid/
teratoid/ rh
teratoid/rh ab
teratoid/rhab do
teratoid/rhabdo id</w>
terat ogenesis,</w>
ter- fibrillation</w>
ter s)</w>
ter nal</w>
ter ms:</w>
ter ms.</w>
ter ms,</w>
ter m)</w>
ter in,</w>
ter azos
terazos in-treated</w>
ter ;</w>
ter -type</w>
tenu ifolia</w>
tension- velocity</w>
tenofovir -related</w>
tenofovir -associated</w>
tenidap -treated</w>
tend ency.</w>
tend encies</w>
ten- week</w>
ten- month</w>
ten us</w>
ten ths</w>
ten sions.</w>
ten se</w>
ten oxicam</w>
ten ipo
tenipo side</w>
ten don
tendon itis</w>
ten der,</w>
ten asc
tenasc in-
tenascin- R</w>
ten able</w>
tempt ed</w>
temporo -
tempor ar
tempor alis</w>
temperam ent,</w>
temozolom ide-induced</w>
temoc apri
tem af
telomere- stabilizing</w>
telo mere</w>
telmis art
telmisart an-treated</w>
teleph oned</w>
teleph one-
tele metered</w>
telangiect ases,</w>
tel encephalic</w>
teicoplan in,</w>
tegaf ur,</w>
techno logy.</w>
techno logies</w>
technic al-
technical- grade</w>
technetium- 99m-
techne tate</w>
te- macrophage</w>
te ur
te trezol</w>
te thering</w>
te red,</w>
te rectomy</w>
te re
tere ff
te olol,</w>
te ment</w>
te lor
te en.</w>
te en,</w>
te d-
ted- diet,</w>
te ased-fiber</w>
te ams</w>
te acher</w>
te a.</w>
te )</w>
taz obactam</w>
taz obact
tax ane/
taxane/ trastuzumab</w>
tax ane-induced</w>
tax ane-based</w>
taurochol ate.</w>
tauro ursodeoxychol
tauro lithocholic</w>
taur ine-treated</w>
tast es</w>
tas ks,</w>
tartr ate.</w>
tari qu
tariqu id
tariquid ar</w>
target- vessel</w>
target- concentration</w>
target -free</w>
tar traz
tap .</w>
tan nic
tannic -
tannic- acid</w>
tamsulos in.</w>
tamoxifen :
tamoxifen ),</w>
tamoxif en-
talipex ole.</w>
tal- like</w>
tal ip
talip es</w>
tal in,</w>
tal ),</w>
tak o-tsubo</w>
tak ing.</w>
tak ers</w>
tak ers.</w>
tak er
taker s'
takers' '</w>
tailo r</w>
tail- vein</w>
tail- tremors</w>
tail ;</w>
tag lomerular</w>
tadalaf il-induced</w>
tadalaf il,</w>
tacrolimus- based</w>
tachykin in-mediated</w>
tachykin ergic</w>
tachycardia/ ventricular</w>
tachycardia -induced</w>
tachycardia -
tachycardia ).</w>
tachy dysrhythmia.</w>
tachy cardic,</w>
tacalcit ol</w>
tac y</w>
table ts:</w>
table ts)</w>
table )</w>
tab un</w>
tab ulated</w>
tab ular</w>
ta u)</w>
ta h</w>
ta g</w>
ta )</w>
t/ anxiety</w>
t.i. d.,</w>
t.i. d.)</w>
t-1,2- CHD</w>
t- tubular</w>
t- tests).</w>
t- of-dose</w>
t- butyl-
t-butyl- bicyclophosphoro
t- butyl
t-butyl amino-
t-butylamino- propoxy
t-butylamino-propoxy )</w>
t- be
t- avid</w>
t- 5
t-5 36
t-536 93</w>
t- 2-
t-2- ene-
t-2-ene- 2-
t y)</w>
t x)</w>
t ures</w>
t tingen</w>
t s--
t ous</w>
t ochemical</w>
t mann
t m</w>
t ly;</w>
t ly:</w>
t les</w>
t le.</w>
t ins</w>
t inic</w>
t incture</w>
t estic
t es:</w>
t ect
tect a</w>
t ds</w>
t ated</w>
t at
t apped</w>
t angles</w>
t angi
tangi ble</w>
t ance.</w>
t ally.</w>
t ally,</w>
t aller</w>
t al)</w>
t able.</w>
t able,</w>
t RNA.</w>
t NSAID.</w>
t AM
tAM CA.</w>
t 5</w>
t 30,</w>
t 3,</w>
t 2</w>
t +
t (L)</w>
t (2)=
t (1/2)</w>
t (1/
systol ic)</w>
systematic ally,</w>
system s)</w>
system ic-
system );</w>
system ).</w>
system 's</w>
syst ole-
systole- specific</w>
sys kinetic</w>
syring omyelia</w>
syring e,</w>
syphil is,</w>
synthet ase,</w>
synthesis/ secretion</w>
synthesi zed,</w>
synthe tized</w>
synthe tas
synthase- dependent</w>
synth ases</w>
synth ase/
synergis tic.</w>
synerg ized</w>
synechi a</w>
syndrome ?)</w>
syndrome -
syndrome ,"</w>
syndrome (s).</w>
syndrome ")</w>
syndrom ic</w>
syncop e)</w>
synchron ize</w>
synchron ised</w>
synaptos ome</w>
synaptophy sin.</w>
synap tically</w>
synap se.</w>
syn trophin</w>
syn chrotron</w>
symptom- free,</w>
symptom s/
symptom ology</w>
sympatho- inhibitors</w>
sympatho- excitatory</w>
sympatho inhibition</w>
sympatho excitatory</w>
sympatho excitation,</w>
sympatho adrenomedullary</w>
sympathetically- mediated</w>
sympathetically- maintained</w>
sympath ic
symmetric ally.</w>
symmetric .</w>
sym tom
sym podi
sympodi alis</w>
syl ated</w>
sych iatric</w>
sy ph
syph ili
syphili s.</w>
sy m</w>
switching- off</w>
switch ing,</w>
switch es.</w>
switch ers.</w>
swim ming.</w>
swim ming,</w>
swim .</w>
swe et,</w>
swallow ing,</w>
sw anger</w>
sw ab
sut uring</w>
sut ures.</w>
suspici ousness,</w>
suspici on,</w>
suspen sion)</w>
suspen ded.</w>
suspen ded,</w>
suspect .</w>
suscepti ble,</w>
sus )</w>
survival/ repair</w>
surviv or</w>
survi ved)</w>
surveill ance,</w>
surger y/radiotherapy</w>
surger y/radiotherapy)</w>
surger y),</w>
surger y').</w>
surge ons,</w>
surg ically,</w>
surface- area</w>
surfac es,</w>
sur passes</w>
sur mise</w>
supraspin ally</w>
supras ystolic</w>
supran ormal</w>
supramam millary</w>
suprag lot
supraglot tic</w>
suprac on
supracon vulsant</w>
suprac hi
suprachi as
suprachias matic</w>
supra- additive</w>
supra op
supraop tic,</w>
suppress or,</w>
suppress ant
suppres sion;</w>
suppres sion:</w>
suppres sed,</w>
supposit ories.</w>
supposit ori
support ;</w>
suppor tive.</w>
suppl y,</w>
suppl ies</w>
superven ed,</w>
superim pos
superimpos able</w>
superi or,</w>
superi or
super paramagnetic</w>
super hydroxide</w>
super antigen
superantigen -related</w>
sup ral
supral im
supralim inal</w>
sup pur
suppur ative</w>
sunit inib
sunbur n.</w>
sun light.</w>
summari sed.</w>
summari es:</w>
summar iz
summar ised</w>
summ ated</w>
sumatript an-treated</w>
sumatript an-associated</w>
sum -
sum- score</w>
sulpiride ).</w>
sulphon yl)</w>
sulphasalaz ine-related</w>
sulph oxidi
sulphoxidi sers</w>
sulph ate/
sulind ac
sulfoxim ine.</w>
sulfonylure a-induced</w>
sulfonamide s.</w>
sulfon ate)</w>
sulfon amide-induced</w>
sulfon amide)</w>
sulfo phenyl)
sulfhydr ylic</w>
sulfhydr yl-
sulfhydr yl)</w>
sulfhyd ril
sulfhydril s,</w>
sulfhyd ri
sulfhydri ls</w>
sulfamethoxazole- trimethoprim</w>
sulfamethoxazol e;</w>
sulfadox ine.</w>
sulfadi az
sulf ur-
sulf onic</w>
sulf ate-treated</w>
sulf ate)</w>
sulf atase</w>
sulf anil
sulc i</w>
sulbact am-
sul cus</w>
sul cular</w>
suicid ality</w>
suic ides,</w>
suggest ed;</w>
suggest :</w>
sufferer s,</w>
sufentanil/ propofol</w>
sufentanil/ midazolam.</w>
sufentan il:</w>
sud ative</w>
sud ation</w>
succumb ing</w>
succum b</w>
succin ate.</w>
succes sion</w>
suc rose.</w>
subunit )</w>
subtype (s)</w>
substrat um</w>
substitu tion.</w>
substitu tion,</w>
substitu tion)</w>
substitu ent</w>
substanti ates</w>
substanti al.</w>
subsid ence</w>
sublux ation</w>
sublingu al)</w>
subjecti vely.</w>
subfiel ds,</w>
subepicardi um</w>
sube ffective</w>
subcutaneous ly).</w>
subcutaneous ly),</w>
subcutaneous ).</w>
sub- region</w>
sub- items.</w>
sub- group</w>
sub- epithelial</w>
sub- divided</w>
sub- convulsant</w>
sub- clinical</w>
sub- cataleptic</w>
sub- analysis</w>
sub- Sa
sub-Sa har
sub-Sahar an</w>
sub urban</w>
sub tractive</w>
sub tracting</w>
sub tle,</w>
sub thalamus.</w>
sub test</w>
sub tend</w>
sub sets.</w>
sub set,</w>
sub scale.</w>
sub retinal</w>
sub region</w>
sub populations.</w>
sub population.</w>
sub plant
sub ototoxic</w>
sub occipital</w>
sub myoclonic</w>
sub merging</w>
sub membranous</w>
sub medi
submedi us</w>
sub maximally</w>
sub fove
subfove al</w>
sub family,</w>
sub cutis</w>
sub critical</w>
sub cortex</w>
sub corneal</w>
sub classes,</w>
sub car
subcar inal</w>
sub acutely</w>
sub -</w>
su tism</w>
su tility</w>
su stains</w>
su profen.</w>
su nif
sunif ir
su n</w>
su es</w>
styrene -exposed</w>
stupo ro
stuporo us,</w>
stun ted</w>
stun ning,</w>
study ]</w>
study ):</w>
studi es;</w>
studi es:</w>
studi es
stud y/short</w>
stud ents.</w>
strychn ine-sensitive</w>
strugg le</w>
structure d,</w>
structure -specific</w>
structurally- related</w>
strong -
strome lys
stromelys in-1</w>
stroke/ transient</w>
stroke/ systemic</w>
stroke- resistant</w>
stroke- related</w>
stroke )</w>
striat um:</w>
stri king.</w>
stri kes</w>
stri dor.</w>
stretch ing-
stretching- yawning</w>
stret ches</w>
stress- velocity</w>
stress- responsive</w>
stress- regulatory</w>
stress ogenic</w>
stress "</w>
stres sed,</w>
streptozotocin- induced)</w>
streptozotoc in)</w>
strept omycin-
strept ococcus</w>
street- ketamine</w>
streak s</w>
stre et
strategi es:</w>
strateg y,</w>
strate gy
strain- gauge</w>
strain s;</w>
strain s:</w>
strain s)</w>
strain s).</w>
strai ght-
strai ght
strabis mus,</w>
stra ined</w>
stra in)</w>
str um,</w>
str ings</w>
str ation,</w>
str ange</w>
storm .</w>
stopp age</w>
stop- watch</w>
stop- signals</w>
stop- signal</w>
stop- flow</w>
ston es).</w>
stomach aches,</w>
stomach :</w>
stom ati
stoichi ometry</w>
stoc k.</w>
stoc k
stob adine</w>
sto ol,</w>
sto od</w>
stitut ed,</w>
stipul ated</w>
stippl ed</w>
stimuli ;</w>
stimul us).</w>
stimul ators</w>
stimul ation;</w>
stimul ated.</w>
still born</w>
still birth</w>
still ,</w>
stilbo estro
stilboestro l,</w>
stil bene
stiff ening</w>
stiff ening.</w>
sti llation</w>
steroid- responsive</w>
steroid- responsive,</w>
steroid s;</w>
steroid ogenic</w>
steroid ogenesis</w>
steroid ogenesis.</w>
steroid al,</w>
steroid -</w>
steri le,</w>
stereotyp y-like</w>
stereoty ped,</w>
stereot ac
stereospecific ally</w>
stereo selectivity</w>
stereo selectivity.</w>
stereo selectively</w>
stereo selective,</w>
stere oscopic</w>
stere olog
ster osalping
sterosalping ography</w>
ster not
sternot omy,</w>
ster n
stern um.</w>
ster dam,</w>
ster .</w>
step- wise</w>
step s.</w>
stenosi s-
stenosis- occlusion</w>
steno ses:</w>
stem ming</w>
stem -evoked</w>
steep ly</w>
steatohepatitis -inducing</w>
ste trics</w>
ste in</w>
ste ers</w>
ste al
steal ."</w>
ste adi
stavud ine:</w>
staurospor ine,</w>
static )</w>
stat .</w>
star vation</w>
star ts</w>
star ts.</w>
star ch.</w>
standardi ze</w>
standard- induction</w>
standard -</w>
stand ing),</w>
stain less</w>
stain ings,</w>
stagge red</w>
stage- 3</w>
stag n
stag horn</w>
stag es:</w>
staff .</w>
staff 's</w>
stabiliz er,</w>
stabilis ers.</w>
stabil izes</w>
sta ined,</w>
sta b</w>
st- time</w>
st ump</w>
st rep
st razine</w>
st rating</w>
st ore</w>
st one,</w>
st omal</w>
st ner</w>
st mann</w>
st ly.</w>
st esolid</w>
st esol
stesol id.</w>
st atic,</w>
st atement</w>
st ated.</w>
st and.</w>
st all</w>
st agg
stagg ering</w>
st age;</w>
st able;</w>
squa res
squares -
squares- discriminant</w>
squ e
squ are,</w>
squ are
spur ious</w>
sprout ing;</w>
spread she
spreadshe et</w>
spra yed</w>
spra y,</w>
spot ty</w>
sporad ic.</w>
spontaneous -like</w>
spondylo myelopathy</w>
spondylo arthro
spondyloarthro pathy,</w>
spon gi
spongi ous</w>
spo ro
sporo trichosis</w>
splin t</w>
splic e</w>
splen ectomy,</w>
sple ens</w>
spl it
spiro peridol,</w>
spiper one-induced</w>
spiper one-
spiper one,</w>
spinal- block
spinal-block -induced</w>
spin ous</w>
spin ocerebellar</w>
spin al.</w>
spillo ver.</w>
spik ing,</w>
spik es/
spik e.</w>
spik e,</w>
spi ke
sphingos ine-1-
sphingosine-1- phosphate.</w>
sphingomyel inase</w>
spher oid</w>
spermatozo a,</w>
sperm ine-induced</w>
sper matic</w>
spell .</w>
spectrophot ometry</w>
spectrophot ometer</w>
spectra ,</w>
spectr atyp
specti vely</w>
spectac ular</w>
spect abilis</w>
specific ity:</w>
speci es)</w>
spec ulation</w>
spec tion.</w>
spec ified.</w>
spec ifi
specifi ed)</w>
speak ing.</w>
speak ing,</w>
spe ed;</w>
spe aking</w>
spe ak</w>
spasm -induced</w>
spas tic,</w>
spas m;</w>
sparte ine/
sparteine/ debrisoquine</w>
spar ing,</w>
spac es;</w>
spac e)</w>
spa yed</w>
spa red,</w>
sp urred</w>
sp rin
sprin k
sprink les</w>
sp p.</w>
sp in-
sp id
sp antide</w>
sp a</w>
soy ab
soyab ean</w>
soy a</w>
sour ce;</w>
sour ,</w>
sound- silence</w>
sound- pressure</w>
sound- evoked</w>
soun ds.</w>
soun d.</w>
sough t,</w>
sou theast</w>
sos omes</w>
sorb ed</w>
sorafenib -
sorafenib- refractory</w>
sor tium</w>
sor )</w>
sophis ticated</w>
sop razole</w>
sop oro
sonomicro meter</w>
son ville,</w>
son s</w>
son or
sonor nicotine</w>
son ography.</w>
son ographically</w>
son ographical</w>
son o
sono grams.</w>
somnambul ism.</w>
somit es)</w>
somewhat )</w>
somatostat in/
somato statin,</w>
somat omotor</w>
som itic</w>
som an.</w>
som an,</w>
som al</w>
solvent s.</w>
solution s:</w>
solution ]</w>
solut es.</w>
solut e-free</w>
solubil ized</w>
solu tions,</w>
solu tion:</w>
solu tion).</w>
solid- phase</w>
solecith in</w>
sole us,</w>
sol e-
sole- plate</w>
sodium/ potassium</w>
sodium/ myo-inositol</w>
sodium- rich</w>
sodium- pump</w>
sodium- myo-inositol</w>
sodium- dosed</w>
sodi um-</w>
socio- economic</w>
soci ety</w>
soci ety.</w>
sob ri
soa king</w>
so ventral</w>
so therapy</w>
so guvac
sna ke</w>
sna k
sn out</w>
smooth- surfaced</w>
smoo th
smok ing)</w>
smok er.</w>
smear s.</w>
small- fiber</w>
small- caliber</w>
small- bore</w>
sluggish "</w>
sludg ing,</w>
slow- onset,</w>
slow- acetylator</w>
slow '</w>
slop ing</w>
slop e.</w>
slop e
slope =
slope= -0.
slit -
sligh t.</w>
sligh t-
sli pide
slipide mia</w>
sleep ;</w>
sleep /
sleep -related</w>
sl er,</w>
skin- twitch</w>
skin /
ske w</w>
sk y-
size- dependent,</w>
siz eable</w>
sixty- three</w>
sixty- four</w>
sixty- eight</w>
sixty- eigh
sixty-eigh t)</w>
six- year-old</w>
six- months</w>
six- fold</w>
six )</w>
sive- stage</w>
sive- compul
sive-compul si
sive-compulsi ve-like</w>
sive- Compulsive</w>
site- directed</w>
site (s),</w>
sit e?</w>
sit e;</w>
sis/ meningitis</w>
sis- stimulating</w>
sirolim us-related</w>
sion- converting</w>
sion s).</w>
sion ate</w>
sion ary</w>
sion /
sion -related</w>
sion -</w>
sion );</w>
sion "</w>
sinusi tis,</w>
sinus ;</w>
sinu atrial</w>
single- stage</w>
single- lung</w>
single- labeling</w>
single- institution</w>
single- injection</w>
single- ingredient</w>
single- case</w>
single- arm</w>
single- agent,</w>
sing ult
sin- Tang</w>
sin- II</w>
sin us-
sin om
sinom )</w>
sin ki</w>
sin ia</w>
sin ergic</w>
sin ensis</w>
sin ce.</w>
sin ce,</w>
sin apo
sinapo yl</w>
simvastatin- ezetimi
simultaneous ly;</w>
simult ane
simplic ity,</w>
simpl ify</w>
simpl ification</w>
simpl est</w>
similar ity,</w>
similar ities.</w>
silon -aminocaproic</w>
silo sis</w>
sildenaf il)</w>
sildenaf il
sildenafil 's</w>
sil k</w>
sil icone</w>
sil ico</w>
sil ent-
significant ly;</w>
significant ly:</w>
significant ly)</w>
signall ing,</w>
signal-to- noise</w>
signal ing)</w>
sign ified</w>
sign fic
signfic antly</w>
sigma- oscillations</w>
sigma- augmentation</w>
sigma ST</w>
sigh ts</w>
sig ne
signe d-
sig -B
sig-B ing</w>
sieh -H
sieh-H sin-Tang</w>
sie ve</w>
sie h,</w>
sidi ous</w>
sideroblast s.</w>
sider osis.</w>
sider osis,</w>
side- in</w>
side- F
side red</w>
side effects</w>
side /
side -</w>
side ).</w>
sick ling</w>
sib il
sialo protein</w>
sialo gangliosides</w>
sial orrhea</w>
sial orrhea,</w>
si ties</w>
si rag
sirag u
si osis</w>
si genic</w>
si form</w>
si dine</w>
si dar
sidar ).</w>
si cal</w>
si ae,</w>
si ac</w>
si a),</w>
si RNA</w>
shun ts</w>
shun ted</w>
show ,</w>
shoul ders</w>
shoul der.</w>
short-term '</w>
short-ter m-
short-li ved,</w>
short- lasting,</w>
short- infusion</w>
short- ch
short-ch ain-
short-chain- fatty</w>
shock -treated</w>
shock -</w>
shock )</w>
sho t</w>
shiver ing.</w>
shik aw
shiel d</w>
shengmai-y in</w>
shell .</w>
she pherd</w>
sharp- wave</w>
shap es</w>
shap e.</w>
shap e,</w>
sham-oper ated,</w>
sham- eNOS</w>
sham- RN-x</w>
sham- ECS.</w>
sham ;</w>
shak y/jitter
shadow s</w>
sha ved</w>
sha king,</w>
sha k</w>
sh outs</w>
sh op
sh in
sh am,</w>
sexually- dimorphic</w>
sexu alized</w>
sex/ group)</w>
sex- adjusted</w>
sex ecutive</w>
sex -dependent</w>
sevoflurane- sparing</w>
sevoflur ane/nitrous</w>
sever ity;</w>
seventy- six</w>
seventy- seven</w>
seventy- four</w>
seve rest</w>
seve rely,</w>
sett led.</w>
sett ings;</w>
sett ing;</w>
setr on.</w>
setr on-induced</w>
sest ami
sestami bi
ses sions:</w>
ses /
serum- ratio</w>
serum- free</w>
serotonin- release</w>
serotonin- norepinephrine</w>
serotonin- dopamine</w>
serotonin- depleted</w>
serotonin- 2</w>
serotonin erg
serotonerg ic/
seroton in-1</w>
seroton in-1
seroton in)</w>
serosi tis.</w>
serosi tis,</w>
serone gati
seronegati vity,</w>
seroconver ters</w>
seroconver sion;</w>
serine/ phosphatidylcholine</w>
seret sky</w>
ser um;</w>
ser um-</w>
ser tion</w>
ser ot
serot inergic</w>
ser oposi
ser ologies,</w>
ser ological,</w>
ser ologic,</w>
sequin an,</w>
sequenti al,</w>
sequence -dependent</w>
sequell ae</w>
sequ ence-
septal/ diagonal</w>
sept o-
septo- hippocampal</w>
sept ation</w>
separ ation.</w>
sep sis/meningitis</w>
seoful vin(GF)</w>
sensory- evoked</w>
sensory- discriminative</w>
sensory- conduction</w>
sensori um.</w>
sensor y/motor</w>
sensor ial</w>
sensitiz er</w>
sensitiz ed-
sensitized- state</w>
sensitiz ation:</w>
sensitiz ation)</w>
sensitiz ation
sensitiv ity).</w>
sensi tively</w>
sensi tises</w>
sens ations,</w>
sens ation
sen ticosus</w>
sen su
sen se-
sen ior</w>
semic ir
semicir cular</w>
semi- purified</w>
semi quinone</w>
sematili de.</w>
sem ustine</w>
sem ide,</w>
sell a</w>
self- tuning</w>
self- perpet
self- perception</w>
self- limiting,</w>
self- injury.</w>
self- injur
self- injection,</w>
self- identified</w>
self- harm</w>
self- dosing</w>
self- control</w>
self- control.</w>
seleni um)</w>
selen -treated</w>
selective ),</w>
selective '
selective' ),</w>
sel y-bound</w>
sel s</w>
sel ectively,</w>
sel ective.</w>
seizures /
seizures --
seizure- producing</w>
segreg ates</w>
segment s)</w>
seg res
seen ;</w>
seem ing</w>
seed s,</w>
sediment able</w>
sedi ments</w>
sedi ments,</w>
sedi mentation,</w>
sedentary- isoproteren
sedentary-isoproteren ols</w>
sedent ary.</w>
sedative- antianxiety</w>
sed ative.</w>
sed .(ABSTRACT</w>
secretago gu
secret ing,</w>
secre tion:</w>
secre t</w>
second- messenger</w>
second- look</w>
second s;</w>
second ly</w>
second ary-prevention</w>
second arily,</w>
sec uring</w>
sec undum</w>
sec tions)</w>
sec tioned.</w>
sec tion:</w>
sec tion)</w>
sec s</w>
sec -1</w>
sec ).</w>
seas on</w>
seal ant</w>
se- exposed</w>
se- control</w>
se- Ell
se-Ell s
se-Ells worth</w>
se ydoakathisia</w>
se viera</w>
se vered</w>
se ver</w>
se lol</w>
se lling</w>
se e-
see- sa
see-sa w'</w>
se bos
sebos up
se arched,</w>
se aled</w>
se ),</w>
se )
se '</w>
scrutin ized</w>
scro tum,</w>
screen ing/
screening/ weaning</w>
screen ed,</w>
scrat ch
scratch ing.</w>
scram bled</w>
scot oma.</w>
score rs</w>
score ).</w>
scor pi
scopol amine;</w>
scopol amine-
scopol amine)</w>
scopol amine
scop ical</w>
scop -treated</w>
scop -induced</w>
scler osant</w>
scler itis,</w>
scinti graphy;</w>
sci ure
sci atic-
sciatic- tibial</w>
school- halothane</w>
schizophren ic-like</w>
schizophren i-
schizophreni- form</w>
schiz o-
schizo- affective</w>
schistos omes</w>
schist ocytes</w>
schem es</w>
schem es.</w>
schem a</w>
schedul e;</w>
sche me.</w>
sche me,</w>
scenari os,</w>
scaveng ers.</w>
scaveng er.</w>
scaveng ed</w>
scat tered,</w>
scant y</w>
scant y.</w>
scal p-
scalp- recorded</w>
scal ing</w>
scal es;</w>
scal es:</w>
scal ar</w>
scabic ides</w>
scabic ide</w>
scabic ide.</w>
sca ff
sc roll
sc hemic
sc atter
scatter ),</w>
sc apular</w>
sc ap
sau .</w>
sativ us</w>
satisfactor ily,</w>
satis fi
sat urable</w>
sarizot an,</w>
sarcoplas m.</w>
sarcom e
sarcom as:</w>
sarcolem ma.</w>
sarcoglyc an-
sarcoglycan- deficient</w>
saralas in.</w>
sampl es;</w>
sam pe
sampe los</w>
sam e-
salure tic</w>
salt- depleted,</w>
salsol inol</w>
salsal ate,</w>
saliv atory</w>
saline- perfused</w>
saline- ,</w>
salicylazosulf apyri
sal utory</w>
sal t-induced</w>
sal ience</w>
sal en</w>
sal azosulf
salazosulf apyridine</w>
sal azide</w>
safet y/efficacy</w>
saf egu
sadd le</w>
sacrific es</w>
sache ts/
sacchar in.</w>
sacca des.</w>
sac s</w>
sac cular</w>
sac -derived</w>
sa ved</w>
sa u</w>
sa si
sa id,</w>
sa ;</w>
sP120 T,</w>
sE- Sel
sE-Sel ectin</w>
s/min/ 1.73
s/min/1.73 m2</w>
s/R Ds)</w>
s/ year)</w>
s/ neuromodulators</w>
s/ h)</w>
s/ gender
s/ day,</w>
s/ MB
s/MB Cs</w>
s/ 10(8)</w>
s.e. m.),</w>
s.c )</w>
s. p.</w>
s. n.</w>
s. n.)</w>
s. e.</w>
s. e
s. d.</w>
s. d.)</w>
s. The</w>
s. 5.</w>
s-- were</w>
s-- also</w>
s- transferase,</w>
s- positive</w>
s- limon
s-limon ene</w>
s- infected</w>
s- in-
s- generating</w>
s- a</w>
s- O
s-O seretsky</w>
s,tot )</w>
s tic</w>
s sue</w>
s quin
s paper,</w>
s ocket</w>
s mol
smol dering</w>
s m</w>
s lo
s lack</w>
s in-induced</w>
s field</w>
s ent
s cur
s as</w>
s apor
s an</w>
s an,</w>
s alu
salu bri
salubri ous</w>
s ])</w>
s ICH.</w>
s G
s EPO,</w>
s Cr</w>
s Cr,</w>
s AD</w>
s AD.</w>
s ?
s 42</w>
s -1.</w>
s -1).</w>
s )],</w>
s )-
s '-
s'- positive</w>
s ":</w>
ryst alline</w>
ry- aggressive</w>
ry ukotsu-borei-
ry u</w>
ry sotherapy</w>
ry os
ryos urgical</w>
ruv ate</w>
rut in,</w>
rupt ures</w>
rupt ured.</w>
runc al</w>
run k</w>
rul es.</w>
rul e.</w>
rubidaz one,</w>
rub b
rubb ing-
rubbing- scratching</w>
ru re
rure tic</w>
ru pp
rupp o</w>
ru in
ruin ink
ruinink s-Oseretsky</w>
ru ed</w>
ru bra</w>
ru b</w>
rtM204 V)</w>
rtL180M/ rtM204V)</w>
rt N
rtN 236
rt 204
rs7270 101</w>
rs6 277</w>
rs6 275</w>
rs29 75
rs 46
rs 44
rs44 36
rs4436 57
rs443657 8-
rs 113
rs113 58
rs11358 40</w>
roxyl on</w>
rox -
rout ine
rout e).</w>
rou sed.</w>
roten one-
roten e</w>
rota virus</w>
rota rod
rot teur
rot atory</w>
rot ating</w>
rot ated</w>
rot aline</w>
rosu vastatin.</w>
rosu vastatin-associated</w>
rosu vastat
rostro ventral</w>
rostr ally</w>
rosiglitaz one-associated</w>
rose um,</w>
roscovit ine</w>
ros al</w>
ror rhiz
rorrhiz a</w>
ropyri dy
ropyridy loxy
ropyridyloxy )]
ropyridyloxy)] benzene</w>
ropivaca ine-treated</w>
ropivaca ine)</w>
ropini role.</w>
ropi um,</w>
ropi on</w>
roph im
rophim osis,</w>
rop yrimidines,</w>
rop ia</w>
root s.</w>
root .</w>
root -
root- mean-
root-mean- square</w>
room s.</w>
ron tal,</w>
ron ous</w>
ron ini</w>
ron in</w>
ron iaz
roniaz id-induced</w>
ron -induced</w>
ron ,</w>
rom b
romb encephalon</w>
rolipr am-induced</w>
role ;</w>
rofecoxib ;</w>
rodi siac</w>
rod on</w>
robu stly</w>
robu st,</w>
robu st
ro unded-back</w>
ro t-be
ro strum</w>
ro striatal</w>
ro of</w>
ro of.</w>
ro log
rolog ie</w>
ro line</w>
ro l.</w>
ro it</w>
ro fil
rofil aria</w>
ro ds</w>
ro d.</w>
ro d-
ro c
roc ket</w>
ro ad</w>
ro a</w>
rn r-
rnr- r1</w>
rizatript an.</w>
rivas tigmine.</w>
ritonavir -induced</w>
ritonavir -containing</w>
ritonavir )</w>
ritod rine-
ritod rin-
ritodrin- HCl</w>
rit on</w>
rit anserin.</w>
rist in.</w>
rist ate-
ristate- stimulated</w>
risperidone- compared</w>
risperid one).</w>
risperid one's</w>
risk- set</w>
risk :
risk: benefit</w>
risk )</w>
ris tic,</w>
ris -
ris- Bene
ris-Bene dic
ris-Benedic t</w>
ripen ing,</w>
ring ).</w>
rin- alpha</w>
rin- IX</w>
rin sing,</w>
rin sed</w>
rin king</w>
rin i
rini ol)</w>
rimant adine.</w>
rim ary</w>
rim )</w>
rigid ity?</w>
rigid ity-
rigid ity)</w>
rigid ,</w>
right- heart</w>
right- hand
right-hand ed</w>
righ ting,</w>
righ t)</w>
rig ors,</w>
rig or</w>
rif abutin</w>
ridg es</w>
rid ol,</w>
rid den</w>
ricin us,</w>
ric- reducing</w>
ric hed,</w>
ric h.</w>
ribos ome-
ribonucle oprotein</w>
ribo se)
ribavir in/
rib es</w>
rib ers</w>
rib bl
ri pen</w>
ri l)</w>
ri goro
ri din
rhyth ms,</w>
rhyth mic
rhyth m:</w>
rhyth m-
rhythm- qualified</w>
rho -kinase</w>
rheumat ology:</w>
rheumat ologists</w>
rheumat ological,</w>
rham nos
rhamnos yl</w>
rhabdomyoly sis-induced</w>
rhabdomy osarcom
rhabdomy olysis:</w>
rh initis,</w>
rh SOD</w>
rh G-CSF.</w>
rh -
rewar d,</w>
reviewe d:</w>
review s.</w>
review s,</w>
review er</w>
review :</w>
reversible ?</w>
reversib le;</w>
reversib le)</w>
rever sions.</w>
rever ses,</w>
reve i
revascular ised</w>
revascular isation</w>
retrospecti vely,</w>
retro peritoneal,</w>
retro gnath
retro coll
retrocoll is,</w>
retro -
retro- orbital</w>
retriev als</w>
retri ever</w>
retrac tion,</w>
retrac tement</w>
retin oid-induced</w>
retin amides</w>
retin amide,</w>
retin aldehyde</w>
retig abine</w>
reticulo- thalamic</w>
reticulo cytosis,</w>
reticular is:</w>
reticular is,</w>
reticular is
reticularis -like</w>
reticul um)</w>
reticul aris.</w>
retard ation:</w>
retard ation),</w>
retar ding</w>
retar ded.</w>
retar d.</w>
ret s.</w>
ret a</w>
resveratro l,</w>
resuscit ations</w>
resul ted,</w>
restric ting</w>
restric ted-diet,</w>
rest ed</w>
rest at</w>
response -
response- contingent</w>
responder s),</w>
respondent s,</w>
respond ingly,</w>
respon ses:</w>
respon ses).</w>
respon ses
respon der.</w>
respon ded)</w>
respirat ory-
respiratory- chain</w>
respir ations,</w>
respectively ]</w>
respectively .(ABSTRACT</w>
resp ected</w>
resorufin-O-de alkylase</w>
resorp tion;</w>
resor ptions</w>
reson ance.</w>
reson ance,</w>
resol ved;</w>
resol ve.</w>
resisti ble</w>
resist s</w>
resist ant,</w>
resist ant)</w>
resist ant"</w>
resist ances.</w>
resident s,</w>
resi li
resh ly</w>
reservoir .</w>
reserpine- increased</w>
reserpin ised</w>
reser ve;</w>
resec tion>=</w>
research ers,</w>
resear ching</w>
rescu es</w>
rescu e)</w>
resc ine,</w>
res in,</w>
res ected.</w>
res al)</w>
res ).</w>
request ing</w>
reput edly</w>
reproducibil ity.</w>
reproduci ble.</w>
represent ativeness</w>
repres sive/defensive</w>
repor ts:</w>
repor ting,</w>
repor ters</w>
repor t;</w>
repor t).</w>
repolar izing</w>
replic ation,</w>
reple tion.</w>
reple ted</w>
replacement -induced</w>
repl ies</w>
repeti tive,</w>
reperto i
reperfu sion;</w>
reperfu sion)</w>
repeat ers</w>
repe atable</w>
repair s.</w>
rep ancies</w>
reorgan ized</w>
reno protection</w>
renin- aldosterone</w>
renew al</w>
rene ,</w>
renal- sparing</w>
renal- cell</w>
ren yl</w>
ren perone,</w>
ren ders</w>
ren de
rende red.</w>
ren al.</w>
remoph or,</w>
remodel ed</w>
remo vals</w>
remit ters)</w>
remit ted,</w>
remis sions;</w>
remis sion:</w>
remin ded</w>
remifentanil- isoflurane-
remifentanil-isoflurane- based</w>
remifentanil -</w>
remifentanil );</w>
remedi es.</w>
remedi es,</w>
remedi able</w>
remain s,</w>
remac emide,</w>
rem ot
rem it</w>
rem ia:</w>
relocation/ observation</w>
relie ved.</w>
relie ved,</w>
reli ably,</w>
releas er,</w>
rele ase-
release- inhibiting</w>
relationship ?</w>
relati ves.</w>
relati ves,</w>
relapsing- remitting</w>
relap sing,</w>
relap sed.</w>
rel ying</w>
rel l</w>
rel ess</w>
rel ax</w>
rel atively-
relatively- safe</w>
rejec tion;</w>
rejec tion)</w>
reinforcement ).</w>
reinforc ing,</w>
reinfor cer
rein stituted,</w>
rehabilit ative</w>
regular .</w>
regul ar-
regres sion)</w>
regres ses</w>
regres sed,</w>
region s;</w>
region ally-
regionally- specific</w>
region )</w>
region ).</w>
regener atory</w>
regener ation,</w>
reg ut</w>
reg ma</w>
reg ained.</w>
refractor y/
refrac tion,</w>
reflu x,</w>
reflex- linked</w>
reflex- enhancing</w>
reflex ly</w>
reflex ia.</w>
reflex -induced</w>
reflex ).</w>
refl ective</w>
refine ment</w>
referr al.</w>
referr al-based</w>
referen ces.</w>
refer able</w>
ref using</w>
ref ining</w>
ref ill</w>
ref ed</w>
redund ant</w>
reductas e-
reduc tion),</w>
reduc ed)</w>
redox -active</w>
red- green</w>
red- dose,</w>
red dish</w>
recur s.</w>
recuper ate</w>
rect angular</w>
rect ally.</w>
recru its</w>
recru it</w>
recreation al"</w>
recover y;</w>
recove red;</w>
recorde d;</w>
recor dial</w>
recor der</w>
recor d-
reconstruc tion.</w>
reconstruc ting</w>
reconc ili
reconcili ation</w>
recon cil
reconcil ed</w>
recommend ation.</w>
recommend ,</w>
recogniz ed:</w>
recogn izes</w>
recogn ising</w>
recogn ised,</w>
recir culating</w>
recipient --case</w>
reci proc
reci eved</w>
rechallenge ;</w>
rechallenge )</w>
receptors .
receptors ),</w>
receptor-medi ated
receptor-mediated );</w>
receptor- regulated</w>
receptor- phosphotyrosine-
receptor-phosphotyrosine- 343-Stat5</w>
receptor- negative</w>
receptor- linked</w>
receptor- ionophore</w>
receptor- Cl</w>
receptor s).</w>
receptor ial</w>
receptor -1</w>
recei ver-operating</w>
recei ve,</w>
rece ption</w>
recanal ization,</w>
recalle d,</w>
rec ta</w>
rec es
rec alls</w>
rec ace
recace ae</w>
reboxet ine-treated</w>
reboun d,</w>
reassess ment.</w>
rear s)</w>
rear ings</w>
real ization,</w>
real isation</w>
reaffir ms</w>
read ings,</w>
read ing,</w>
reaction s)</w>
reaction .A</w>
react ants</w>
reac tivities</w>
re/ core</w>
re- started</w>
re- operation</w>
re- occurred</w>
re- observed</w>
re- introduction</w>
re- infarction,</w>
re- examined.</w>
re- examine</w>
re- established</w>
re- emphasizes</w>
re- elevate</w>
re- biopsy</w>
re x</w>
re wards</w>
re volutionized</w>
re vised.</w>
re vi
re uptake),</w>
re uni
re ti
re testing</w>
re tastatin</w>
re side</w>
re sedation</w>
re randomized</w>
re r</w>
re pressive</w>
re presentations</w>
re population,</w>
re perfused</w>
re percussion</w>
re percus
re occur.</w>
re myelination.</w>
re modelling.</w>
re model</w>
re ment</w>
re mediated</w>
re location,</w>
re intubation.</w>
re introduced,</w>
re initiated,</w>
re infection.</w>
re infection,</w>
re infected</w>
re ich
reich 's</w>
re hemorrhage</w>
re heating</w>
re hear
rehear sal</w>
re fe
refe rent</w>
re exploration</w>
re evaluation.</w>
re evaluated.</w>
re established</w>
re ement</w>
re distribution,</w>
re developed</w>
re d).</w>
re cycled</w>
re conversion</w>
re constructed</w>
re constituted</w>
re consideration</w>
re clin
reclin ing</w>
re challenges</w>
re challenges.</w>
re bleeding.</w>
re bleeding,</w>
re at</w>
re appraisal.</w>
re analysis</w>
re alization</w>
re alistic</w>
re al.</w>
re agents,</w>
re admission</w>
re admission,</w>
re administration.</w>
re administered</w>
re adi
re activator</w>
re activation/
re absorp
re absorb</w>
re -induced</w>
re "</w>
razol e-induced</w>
raz ep
rauwolsc ine.</w>
rauwolsc ine,</w>
rauwol f
rauwolf ia</w>
rats-- DFU</w>
ratios )</w>
ratios ).</w>
ratio >
ratio ;</w>
rati o-
rates =
rate- related</w>
rate ]</w>
rate .(ABSTRACT</w>
rat s?</w>
rat s-
rat or</w>
rat es)</w>
rat ?</w>
rash ),</w>
rasagil ine,</w>
rasagil ine)</w>
ras mus</w>
rare r.</w>
rar ae</w>
rapid- eye-
rapid-eye- movement</w>
raph ites</w>
rap tor-containing</w>
rank- sum</w>
rank ).</w>
range ]</w>
range )]</w>
rang ing,</w>
rang es,</w>
rang es)</w>
rang e).</w>
random- assignment,</w>
random ly,</w>
ran io
ranio facial</w>
ran d's</w>
ramipri l;</w>
ram ifications</w>
ram ide,</w>
ram id
ram er</w>
ram atic</w>
raloxifene :</w>
ral "</w>
radiotele metry</w>
radiotele metric</w>
radiot rac
radiosensi tizing</w>
radiopharmac y</w>
radiopharmac eutical</w>
radiopharmac eutic
radiopharmaceutic als</w>
radioimmuno assay)</w>
radiograph s.</w>
radio- raclopride</w>
radio protective</w>
radio paque</w>
radio immun
radio activities</w>
radic al-induced</w>
radi x</w>
radi us.</w>
radi onuc
radionuc li
radionucli de-
radi ology</w>
radi ography.</w>
radi ocalci
radiocalci um</w>
radi oc
radioc hemotherapy</w>
radi i</w>
radi ation-related</w>
radi ant-
radiant- heat-induced</w>
radi al,</w>
rad s)</w>
rad or</w>
rad ically</w>
rad ecol</w>
rache ally</w>
rach ta</w>
racem ic,</w>
race- matched</w>
race- ,</w>
rac lavicular</w>
rac ing</w>
rac es</w>
rac e.</w>
rabeprazol e,</w>
rabbit s:</w>
ra xia,</w>
ra ther,</w>
ra red</w>
ra re:</w>
ra phy
ra def
radef ylline)</w>
rSO 2.</w>
rIFNalpha2 b
rIFNalpha2b -based</w>
r= 0.7
r-pro UK
r-proUK -treated</w>
r- processing</w>
r ypt
r yp
r ylhydrazyl</w>
r ush
r uria</w>
r l)</w>
r k-
rk- Shi
rk-Shi ley</w>
r ing-
r b),</w>
r atic</w>
r ]</w>
r TPA</w>
r TM
rTM S,</w>
r P)</w>
r HuEPO-
rHuEPO- beta</w>
r FVIIa.</w>
r ATG</w>
r ACC</w>
r 2</w>
r /
r/ ATP</w>
r (21)</w>
quit ting</w>
quit oes</w>
quipa zine</w>
quipa zine,</w>
quinupristin/dalfop ristin.</w>
quinoxaline-2,3- dione)</w>
quinoxal in
quinox aline</w>
quinol one-associated</w>
quinol one-
quinol in-6-
quinid ine-treated</w>
quinid ine-related</w>
quineth olate</w>
quineth olate,</w>
quin tile,</w>
quin ti
quin one-induced</w>
quin one,</w>
quin ine-containing</w>
quin ine-
quin ine)</w>
quin azol
quinazol in
quinazolin ones</w>
qui et,</w>
quetiap ine:</w>
quetiap ine-induced</w>
quetiap ine)</w>
questionnai re;</w>
ques tions,</w>
quer cet
quercet in.</w>
quater nar
quaternar y-
quarter ly</w>
quar tiles.</w>
quantit ating</w>
quanti fication.</w>
quant um</w>
qualit ative/
qualitative/ quantitative</w>
qual ify</w>
quadric eps,</w>
quadr atic</w>
quadr ants.</w>
quad rap
quad azoc
qu it</w>
qu isi
quisi tion</w>
qu ifoli
quifoli aceae)</w>
qu enching</w>
qu amous</w>
q3 wks</w>
q12 h.</w>
q/ min</w>
q/ m2).</w>
q. d.</w>
q. d.
q od</w>
q i</w>
pyrrolo [
pyrrolo -
pyrrolidinyl) isoxazole</w>
pyrrolidino indoline</w>
pyrrolid ine-2,4-
pyrrolidine-2,4- dicarboxylic</w>
pyrro liz
pyrroliz idine
pyrrolizidine acetamide</w>
pyrimid ine,</w>
pyrimid in-4-
pyrimethamine- sulfadoxine.</w>
pyrilam ine,</w>
pyridyl) porphyrin
pyridyl)porphyrin ato</w>
pyridoxine- responsive</w>
pyridox ine-treated</w>
pyridox ine-dependent</w>
pyrido[2,1-b] oxazine</w>
pyridine- class</w>
pyrid yl)-
pyrid ine-induced</w>
pyrid in-3-ol</w>
pyri l
pyril amine</w>
pyri daz
pyrex ia.</w>
pyre throid,</w>
pyrazolo[4,3- e]
pyrazolo[4,3-e] -1,2,4-
pyrazolo[1,5- d]
pyrazol o</w>
pyrazinobut azone</w>
pyramid ale,</w>
pyloromy otomy</w>
pylori -positive</w>
pylori -negative</w>
pylori ,</w>
pye lography.</w>
py uria.</w>
py ema</w>
puzz ling</w>
puzz le</w>
putam en)</w>
put atively</w>
pust ules.</w>
purpura/ haemolytic</w>
purpur a;</w>
purpur a.</w>
purpo se-
pure- line</w>
pur ulent</w>
pur inoc
purinoc eptor</w>
pur ine-
pur ify</w>
pur ged</w>
pupil s.</w>
pup illopharmacological</w>
punc h</w>
pum p-
pump- perfused</w>
pulse- spray</w>
pulmon ale</w>
pul sel
puerperi um.</w>
puerperi um,</w>
puer ile</w>
publ icity</w>
pu ter</w>
ption/ ionization</w>
ptaz inol</w>
pt ual</w>
pt ing</w>
pt )</w>
pt ).</w>
psychotri dine.</w>
psychostimul ant,</w>
psychomot or
psycho therapy.</w>
psycho sis-
psycho sis)</w>
psycho pathology,</w>
psycho -active</w>
psycho -
psychiatri sts'</w>
psych omimetic</w>
psych ological,</w>
psi .</w>
pseudotum or,</w>
pseudo- randomized</w>
pseudo- allergy</w>
pseudo prolactinoma</w>
pseudo glandular</w>
pseudo ginseno
pseudoginseno side-F
pseudo ephedrine-induced</w>
pseudo ain
pseudoain h
pseudoainh um</w>
pseud ox
pseudox anth
pseud otonic</w>
pseud ocy
ps s)</w>
prun ing</w>
prun e</w>
proxymetac aine,</w>
proxim ally</w>
prox y.</w>
prox etil</w>
provo ked:</w>
provo ked.</w>
provid er-
provider- rated</w>
provi de,</w>
prov in
protr usions,</w>
protoporphy rin-IX</w>
protoporphy ria.</w>
protoc ol;</w>
protoc ol)</w>
proto oncogene</w>
proteoglyc ans</w>
proteinur ic.</w>
proteinur ia/
proteinuria/ day.</w>
proteinur ia-associated</w>
proteinur ia)</w>
proteinur ia).</w>
proteinur ia),</w>
protein/ creatinine</w>
protein- stabilized,</w>
protein- restricted</w>
protein- overload</w>
protein- based</w>
protein- 27</w>
protein s;</w>
protein s:</w>
protein ase,</w>
protein -1.</w>
protein -1,</w>
protein -1)</w>
protective '</w>
protective "</w>
protect ors</w>
protect or.</w>
protect ants</w>
prote us</w>
prote omic</w>
prote inemia,</w>
prote ase-
prote ase,</w>
prote an</w>
prot ected.</w>
prot amine,</w>
prostigmine- morphine</w>
prostigmine- morphine-induced</w>
prosthe ses</w>
prostan oids,</w>
prostagland in-treated</w>
prostagland in
prostadi l</w>
prost rate</w>
prost one,</w>
prost atitis.</w>
prost atic
prost ate:</w>
prost a
prospecti vely,</w>
pros ap
prosap osin-
prosaposin- derived</w>
propyl}- 3,3-diphenylpyrrolidin-2-one</w>
propylthiourac il-associated</w>
propyl- di
propyl-di ethoxy-
propyl-diethoxy- methyl-
propyl-diethoxy-methyl- phosph
propyl-diethoxy-methyl-phosph inic</w>
propyl) glycine</w>
propyl ene
propri ospinal</w>
propri onate</w>
propri oceptive</w>
propri oc
proprioc eption</w>
propranolol- pretreated</w>
propranolol- premedicated</w>
propranolol- insulin</w>
propranolol- ,</w>
propranolo l;</w>
propranolo l).</w>
propoxy phene,</w>
propos al.</w>
proportion ately</w>
proportion ality,</w>
propor tion,</w>
propofol/ mixtures</w>
propofol- suxamethonium</w>
propofol -associated</w>
propofol ).</w>
propion yl</w>
propion yl-CoA</w>
propion yl)
propion ate),</w>
propion aldehyde</w>
prophylac tics</w>
propentof ylline</w>
propen yl)-piperazine],</w>
proparac aine</w>
propan amide</w>
propafen one-induced</w>
propacetam ol:</w>
prop ul
prop ens
propens ity.</w>
prop ane-
prop -2-
prop -1-
proneth alol,</w>
pron or
pronor mo
pron ociception</w>
pron eness.</w>
promyelo cytes</w>
prompt s</w>
prompt ,</w>
promot er,</w>
promo tion-progression</w>
promo tion,</w>
promi se.</w>
promaz ine-
promazine- fluvoxamine</w>
prolong ations</w>
prolong ation:</w>
proligest one.</w>
prolifer ator
proliferator -induced</w>
prolifer ated</w>
prolactin- raising</w>
prolactin- producing</w>
prolactin- positive</w>
prolactin- lowering</w>
prolactin- elevating</w>
prolactin aemia,</w>
prolactin 's</w>
prolact inemic</w>
prolact in-induced</w>
prokinetic in</w>
project .</w>
project ,</w>
projec tions.</w>
proj ects</w>
progres sing,</w>
progres ses,</w>
progres sed,</w>
programm es.</w>
programm able</w>
program s,</w>
program ming.</w>
program me.</w>
progestogen -only</w>
progester one-
progester one)</w>
progester one's</w>
progestag ens,</w>
progestag en
progestagen s.</w>
progest ogens.</w>
progest ational</w>
progenit ors,</w>
progen y.</w>
progab ide.</w>
profil es:</w>
profession als.</w>
profen ),</w>
produc ts)</w>
produc tive</w>
produc ed:</w>
produc e.</w>
process or.</w>
proces ses:</w>
procedure -related</w>
procedur ally.</w>
procedur al,</w>
proced ures;</w>
proce ed
proc urement</w>
proc umbent</w>
proble ms:</w>
proble m;</w>
probenec id.</w>
probenec id-like</w>
probe -</w>
probable ],</w>
probable )</w>
prob it</w>
prob ing,</w>
prob ands</w>
prob and</w>
prob ability.</w>
prob ability,</w>
prob ab
probab ly"</w>
proanthocyanid ins,</w>
pro- opiomelanocortin</w>
pro- drug,</w>
pro- convulsive</w>
pro- brain</w>
pro- atherogenic</w>
pro- apoptotic</w>
pro- absence</w>
pro ved,</w>
pro states</w>
pro spects</w>
pro ptosis</w>
pro of-
proof- of-
proof-of- concept</w>
pro mul
pro gnos
prognos tic
pro glum
pro dysrhythmic</w>
pro collagen.</w>
pro cognitive</w>
pro arrhythmic
pro active</w>
pro acceler
proacceler in</w>
pro BNP</w>
pro BNP)</w>
pro )</w>
privan )</w>
priv an,</w>
pris ingly</w>
prior ;</w>
princip le
principle (s)</w>
prin t</w>
primin g)</w>
primigra vida,</w>
primi par
primat es:</w>
prima quine,</w>
prim ary.</w>
prim aries</w>
priloca ine.</w>
pric es,</w>
pric ed</w>
pri or/
prior/ sequential</w>
pri mer
primer s,</w>
pri me-induced</w>
pri ma</w>
prevent ed?</w>
prevent atively</w>
preven tion)</w>
preval ence.</w>
prevail s</w>
prevail .</w>
presyncop e.</w>
presum ptively</w>
presum able</w>
pressure- work</w>
pressure- pain</w>
pressure- natriuresis</w>
press ors.</w>
press ing,</w>
press in-resistant</w>
preserv atives</w>
present ed:</w>
present ative</w>
present ations.</w>
present ).</w>
prescription s).</w>
prescrip tions)</w>
prescrib ing,</w>
prescrib er</w>
preschool- halothane</w>
pres ystolic</w>
pres witch</w>
pres sions</w>
pres ence.</w>
pres age</w>
preponder ant</w>
prepar tum.</w>
prepa red.</w>
prepa re,</w>
prenyl amine.</w>
prenat ally.</w>
prenat ally,</w>
prenalter ol,</w>
premedic ated,</w>
premedic ants</w>
premedic ant</w>
premature ly;</w>
prematur ity</w>
prelimin arily</w>
pregnancy ).</w>
pregnanc ies)</w>
pregn enol
pregnenol one
pregnenolone -16</w>
pregn ane-
pregn an</w>
pregn a
preferen ces,</w>
preeclamp tic</w>
predomin ently</w>
predomin ated.</w>
predomin ant.</w>
prednisol one-treated</w>
prednisol one)</w>
prednis one;</w>
prednis one)</w>
prednis one),</w>
predis position,</w>
predis posed.</w>
predict ors.</w>
predic tive.</w>
predic ted.</w>
predic ted).</w>
pred nicarb
precur sor)</w>
precur ar
precurar ization.</w>
precoc ity.</w>
precipit ously</w>
precipit ant.</w>
preci sion</w>
preci sely,</w>
preci se,</w>
preced ent</w>
prece des,</w>
pre- treatment,</w>
pre- translational</w>
pre- training,</w>
pre- therapeutic</w>
pre- papaverine</w>
pre- neoplastic</w>
pre- infusion</w>
pre- incubation</w>
pre- hypotensive</w>
pre- haemodilution</w>
pre- exposure</w>
pre- established</w>
pre- defined</w>
pre- OLT</w>
pre- IVU</w>
pre- I</w>
pre- HDT</w>
pre- BMT</w>
pre- AMB</w>
pre trial</w>
pre treatment(EPI</w>
pre treated.</w>
pre transplantation</w>
pre study,</w>
pre set</w>
pre retinal</w>
pre randomization</w>
pre proteinuric</w>
pre pro</w>
pre planned</w>
pre partum</w>
pre pare
prepare dness</w>
pre pacing</w>
pre operativel
pre occlusion</w>
pre motor</w>
pre monit
premonit ory</w>
pre molar</w>
pre leukemic</w>
pre kallikre
prekallikre in,</w>
pre incubated</w>
pre incision</w>
pre hydration</w>
pre h
preh end</w>
pre expanded</w>
pre excited</w>
pre excitation.</w>
pre excitation,</w>
pre drug)</w>
pre dialysis</w>
pre dec
predec ess
pre dat
pre contrast</w>
pre communicating</w>
pre co
preco re/core</w>
pre central</w>
pre angiographic</w>
prazosin ;</w>
prazosin 's</w>
prazos in-treated</w>
pran olol.</w>
pralid oxime</w>
pralid oxime
pralidoxime -2-
pralidoxime-2- chloride</w>
practition ers;</w>
practition ers'</w>
practition er.</w>
practic al,</w>
practi ce:</w>
practi ce-
practice- based</w>
pra vastatin-induced</w>
pr amine-
pp(NH) p</w>
pp m
ppm PB</w>
power fully</w>
power ful
powerful ,</w>
pow ers</w>
pow er)</w>
potenti ation)</w>
potency :</w>
potassium- stimulated</w>
potassium- losing</w>
potassium- depleted</w>
potassium- conserving</w>
potassi um)</w>
pot entate</w>
postur al,</w>
postul ates</w>
postsynap tically.</w>
postrema .</w>
postrans plant)</w>
postpon ing</w>
postnat ally.</w>
postnat al.</w>
postischem ia,</w>
posthyp notic</w>
posteri or,</w>
poster obasal</w>
post-LT x</w>
post-CA B</w>
post-CA B).</w>
post- viral</w>
post- ventilatory</w>
post- treatment,</w>
post- transplant.</w>
post- status</w>
post- spinal</w>
post- renal</w>
post- paracetamol</w>
post- occlusive</w>
post- mortem.</w>
post- lidocaine</w>
post- ischaemic</w>
post- insult</w>
post- injury</w>
post- injection</w>
post- injection.</w>
post- infusion,</w>
post- implantation</w>
post- hepatectomy</w>
post- first</w>
post- exposure,</w>
post- exercise</w>
post- error</w>
post- dosing.</w>
post- discharge</w>
post- consolidation</w>
post- conceptual</w>
post- cocaine</w>
post- bone</w>
post- STEP</w>
post- SNP</w>
post- SE.</w>
post- SC</w>
post- OLT.</w>
post- IVU</w>
post- I</w>
post- HBIG</w>
post- DEC</w>
post urography</w>
post treatments</w>
post trauma.</w>
post transplantation.</w>
post transplant.</w>
post training</w>
post therapy.</w>
post test.</w>
post surgery</w>
post stress</w>
post steroid</w>
post resuscitation</w>
post remission</w>
post recumbency</w>
post pump</w>
post pubertal</w>
post procedure</w>
post procedural</w>
post phlebo
postphlebo graphic</w>
post operative,</w>
post occlusion</w>
post morphine</w>
post lesion</w>
post learning</w>
post intervention</w>
post injury</w>
post inflation,</w>
post industrial</w>
post fertiliz
postfertiliz ation)</w>
post exercise</w>
post epileptic</w>
post en
posten uria,</w>
post embed
postembed ding</w>
post ed</w>
post dural</w>
post dosing.</w>
post dobutamine</w>
post dialysis</w>
post conversion</w>
post coit
post cocaine</w>
post closure</w>
post cholecystectomy</w>
post chemotherapy</w>
post cardiotomy</w>
post capillary</w>
post bunionectomy</w>
post angiography</w>
post anaesthesia</w>
post alcoholic</w>
post /
post -treated</w>
possible '</w>
possible "</w>
possib le;</w>
positive/ disorganized</w>
positive ;</w>
position ing.</w>
posi tively.</w>
posi tion)</w>
posi t</w>
pos tic
pos thy
pos ses</w>
portun istic</w>
port .</w>
porphyrin ogenicity</w>
porphyr ins</w>
por ts</w>
por tray</w>
por tions.</w>
population- attributable</w>
popular ity.</w>
pop ularly</w>
poor- prognosis</w>
poor- metabolizer</w>
pool ed,</w>
pont ine-
pontine- cerebellar</w>
pon tis.</w>
pon s-
pon cirin,</w>
pom pic</w>
polysomno graphy.</w>
polysomno graphically</w>
polyribos ome</w>
polypo sis.</w>
polypeptide -</w>
polyp lo
polyp ectomy</w>
polymyosi tis:</w>
polymyosi tis,</w>
polymorph isms,</w>
polymorph ism)</w>
polymer ic</w>
polymer ases</w>
polym ers</w>
polygalasap onin</w>
polydyp sia,</w>
polyc hemotherapy,</w>
polyc ation</w>
poly-L- lacti
poly-L-lacti d</w>
poly- ADP-
poly-ADP- ribose</w>
poly- (ADP-ribose)</w>
poly valent</w>
poly urethane</w>
poly therapy.</w>
poly therapy,</w>
poly styrene</w>
poly specific</w>
poly serositis.</w>
poly phen
poly phasic</w>
poly pharmacy.</w>
poly pharmacy,</w>
poly p</w>
poly neuropathic</w>
poly neuritis</w>
poly graphically</w>
poly ethyleneimine</w>
poly disper
polydisper se</w>
poly dactyl
polydactyl y/arhinencephaly</w>
poly chlorinated</w>
poly bre
polybre ne
polybrene .</w>
poly -drug</w>
poly (ADP-
poly(ADP- ribose)
poly (
poly( butyl</w>
pollic is,</w>
pollaki uria,</w>
polar izing</w>
pol y</w>
pol ici
polici es</w>
pol ic
polic y.</w>
pol aro
poison s.</w>
poison ings.</w>
point s"</w>
point es'</w>
point ).</w>
poin te.</w>
poikilo thermic</w>
poi etin-
podocyte )</w>
podo phyl
podophyl lo
podophyllo toxin</w>
podi um/grid'</w>
podi atric</w>
pod ocyt
po we
po vidone-iodine</w>
po o
poo rest</w>
po .</w>
pneumoniti s;</w>
pneumon itis).</w>
pneumon ia;</w>
pneumon ectomy</w>
pneumon ectomised</w>
pneumo thorax</w>
pneumo peritoneum</w>
pneum ot
pneumot ac
pneumotac ho
pneumotacho graph.</w>
pneum ococci
pneum ocardi
pmol/ rat)</w>
pmol/ ml</w>
pmol/ L,</w>
pmol/ L
pmol/L -1;</w>
pmol/ 0.5</w>
pmol .
pmol. mm
pmol.mm -1.
pmol.mm-1. min-1,</w>
plus- lorazepam</w>
plug s.</w>
plug s,</w>
plic or</w>
plic it</w>
plex opathy</w>
plex itis.</w>
plex iform</w>
pleur is
pleur a.</w>
plethysmo graphy,</w>
plethysmo graph</w>
plekhh 2,</w>
pledg ets</w>
ple ocytosis,</w>
ple ased</w>
play ers</w>
plausib ility,</w>
plau sibility</w>
platypnea-orthodeox ia-like</w>
platypnea-orthodeox ia,</w>
platin um(II)</w>
platin ating</w>
platform- size</w>
platelet- reactive</w>
platele ts/mm3</w>
platele ts)</w>
platele t/
platele t,</w>
plateau ing</w>
plateau .</w>
plate -like</w>
plat in-related</w>
plat form,</w>
plat es.</w>
plasmacy tosis</w>
plasmacy tosis.</w>
plasmacy toma.</w>
plasma- level</w>
plasma perfusion</w>
plasma :</w>
plasma -derived</w>
plasma -cell</w>
plasm alo
plasi c</w>
plas ties.</w>
plas tic,</w>
plaqu es,</w>
plaqu e-like</w>
plaqu e,</w>
plant 's</w>
plani metry</w>
placent a.</w>
placebo- baseline</w>
plac ed.</w>
pl uri
pl ants,</w>
pkr 1</w>
pituitary- testicular</w>
pituitary- ovarian</w>
pituitary- gonadal</w>
pituit aries,</w>
pituit ari
pituitari es.</w>
pith ing</w>
pith ing.</w>
pit fall</w>
pit ch</w>
pit ation</w>
pit al</w>
piroxicam )</w>
piroxantr one,</w>
piribe dil</w>
piri de.</w>
piri de,</w>
piret an
piracetam 's</w>
pir acetam.</w>
piperidine- 3alpha-
piperidin-4- yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)</w>
piperidin-1- yl-
piperidin-1- yl)</w>
piperid inyl)
piperidinyl) hexyloxy
piperidinyl)hexyloxy ]-
piperidinyl)hexyloxy]- 3-methyl
piperidinyl)hexyloxy]-3-methyl flavone</w>
piperid ine-based</w>
piperid ine-1-
piperidine-1- oxyl</w>
piperazin-1- yl)-2-
piperazin-1- yl)
piperazin yl]-3-phenylpropan-2-ol</w>
piperazin yl)butyl]-2-naphthamide]</w>
piperaz ino]
piperazino] butyl]-
piperazino]butyl]- 4-methyl-
piperazino]butyl]-4-methyl- 2
piperazino]butyl]-4-methyl-2 H,
piperazino]butyl]-4-methyl-2H, 4H
piperazino]butyl]-4-methyl-2H,4H -1,2,4-
piperazino]butyl]-4-methyl-2H,4H-1,2,4- triazin-3,5-dione</w>
piperaz ine),</w>
piperaz ine
piperazine dione</w>
piperacill in/
piperacill in-
piper oxane</w>
pinacidi l's</w>
pin- prick</w>
pin ching</w>
pin ch
pimoz ide-treated</w>
pilocarpine- stimulated</w>
pilocarpine- epileptic</w>
pilocarp ine;</w>
pilocarp ine/
pilocarpine/ timolol</w>
pilocarp ine),</w>
pilo- saline</w>
pilo ts.</w>
pilo t-
pill -related</w>
pide m,</w>
picrotoxin in,</w>
picrotox in)</w>
pic tro
pic rylhydrazyl</w>
pic om
pic obenz
picobenz ide</w>
pic ked</w>
pic a,</w>
pi val
pi rosis</w>
pi renperone</w>
pi r</w>
pi pet
pipet te</w>
pi pem
pipem idic</w>
pi p</w>
pi on
pi g,</w>
pi -
phytomen adi
phyto therapeutic</w>
phyto hem
phyto haem
phytohaem agglutinin</w>
phyto estrogens</w>
phyto estrogens,</w>
physiopath ologic</w>
physician- reported</w>
physic ally-
physically- limited</w>
physi opathological</w>
physi ologically.</w>
physi ol.</w>
phyll um</w>
phy ton</w>
phy g
phyg mo-
phthal mitis</w>
phthal imido
phthalimido )
phthalimido) butyl]
phthalimido)butyl] piperazine</w>
photosensi tivity,</w>
photograph s,</w>
photograph ed</w>
photodi stributed</w>
photoc o
phot otoxicity</w>
phot otoxicity,</w>
phot ostimulation</w>
phot ore
phot ometry.</w>
phot ometric</w>
phot ography</w>
phot o-
phosphoryl choline</w>
phosphoryl ation,</w>
phosphoryl ated
phosphorylated :
phosphorylated: total</w>
phosphoramid on,</w>
phosphono- heptanoate</w>
phosphono valeric</w>
phosphono phenylglycine</w>
phosphon ate,</w>
phosphomon o
phospholipid- laden</w>
phospholip idosis.</w>
phosphoinositi de-
phosphoinositide- coupled</w>
phospho- Thr-34</w>
phospho- ERK1/2</w>
phospho kinase-MB</w>
phospho hydrolase</w>
phospho ERK</w>
phosphatidylethan olamine</w>
phosphatidyl serine/phosphatidylcholine</w>
phosphatid yl-
phosphati dic</w>
phosphate- supplemented</w>
phosphat uria,</w>
phosph oline</w>
phosph in
phosph ate)</w>
phorbol-1 2,
phorbol-12, 13-
phorbol-12,13- di
phor a</w>
phon oph
phlor acetophen
phloracetophen one</w>
phlebo graphy</w>
phleb otomy</w>
phleb it
phlebit ogenic</w>
pherom one</w>
pheochromocyt omas,</w>
phenytoin "</w>
phenyto in;</w>
phenyto in:</w>
phenylpropanol amine)</w>
phenylpiperaz ine.</w>
phenylmethyl sulfonyl</w>
phenylethyl malon
phenylethylmalon amide</w>
phenylethanolamine-N-methyl transferase</w>
phenyleth yl-6-AzUd</w>
phenyleth yl)-2-(2-furyl)-pyrazolo[4,3-epsilon]-1,2,4-
phenyleph edrine</w>
phenyldi guan
phenylbiguan ide-</w>
phenylbenzo quinone-induced</w>
phenylalan ine-
phenyl-3- piperidin
phenyl-2- propenyl)-piperazine],</w>
phenyl-2 (5
phenyl-2(5 H)-
phenyl-2(5H)- furan
phenyl-2(5H)-furan on)</w>
phenyl-1,3- dise
phenyl-1,3-dise len
phenyl-1,3-diselen ole</w>
phenyl-1,2,3,6-tetrahydro pyridine</w>
phenyl-1, 3,
phenyl-1,3, 8-
phenyl-1,3,8- triaz
phenyl- 4-
phenyl- 4,</w>
phenyl- 3,
phenyl-3, 3a-
phenyl-3,3a- dihydro-
phenyl-3,3a-dihydro- 4-
phenyl-3,3a-dihydro-4- oxo-5-
phenyl)-piperazin-1-yl]- 2-hydroxy-
phenyl)-piperazin-1-yl]-2-hydroxy- propyl}-3,3-diphenylpyrrolidin-2-one</w>
phenyl)-8- pyrrolizidineacetamide</w>
phenyl)-4- methyl
phenyl)-4-methyl -1H-pyrazole-3-carboxamide
phenyl)-4- [4-(2-
phenyl)-4-[4-(2- phthalimido)butyl]piperazine</w>
phenyl)-4- (4-methyl
phenyl)-4-(4-methyl sulphonyl)</w>
phenyl)- 8,9-
phenyl)-8,9- dihydro-
phenyl)-8,9-dihydro- 8-
phenyl)-8,9-dihydro-8- methyl-
phenyl)-8,9-dihydro-8-methyl- 7H
phenyl)-8,9-dihydro-8-methyl-7H -1,3-di
phenyl)- 3-
phenyl)- 3,5-
phenyl)- 3(2H)-pyridazinon-
phenyl)-3(2H)-pyridazinon- 2-propion
phenyl)-3(2H)-pyridazinon-2-propion amide</w>
phenyl nitrone</w>
phenyl ind
phenyl enediamine</w>
phenyl acetyl
phenyl -2'-
phenyl-2'- cyclopent
phenyl-2'-cyclopent yl-2'-hydroxy-ethoxy)tropane</w>
phentermine- fenfluramine</w>
phenterm ine).</w>
phent o
phenoxy) butyrate</w>
phenoxy methyl</w>
phenoxy isobut
phenoxy )-
phenotyp ing.</w>
phenotyp ically</w>
phenothiaz ine-associated</w>
phenomen on;</w>
phenomen ological</w>
phenobarbital- like</w>
phenobarbital- containing</w>
phenobarbit one-</w>
phenethyl ene
phenethylene glycol</w>
phenethyl biguanide</w>
phenethyl amine</w>
phenelz ine-induced</w>
phenelz ine-associated</w>
phenelz ine-
phencyclid ine/
phencyclidine/ NMDA</w>
phenaz opyridine.</w>
phenacetin- fed</w>
phenacet in-induced</w>
phen ol,</w>
phen ol
phen oid</w>
phen for
phen erg
phen azone</w>
phen anthrene</w>
phen anth
phenanth ridin
phe lebitis</w>
phasi cally</w>
phasi c,</w>
phased- tracking</w>
phase- contrast</w>
phas e
pharyng itis.</w>
pharmacore sistant</w>
pharmacologic al-induced</w>
pharmacologic al)</w>
pharmacokine tically</w>
pharmacokine tic/
pharmacokine tic-dynamic</w>
pharmaco economic</w>
pharmac omechan
pharmacomechan ical</w>
pharmac ologically.</w>
pharmac ologically,</w>
pharmac ologic,</w>
pharmac ist.</w>
pharmac ies</w>
pharmac eutic</w>
phag ocytosis.</w>
phag ia.</w>
phaeochromocyt oma,</w>
phacoemulsi fication.</w>
ph ox</w>
ph ox,</w>
ph oton
ph osis</w>
ph orb
phorb ol</w>
ph ocamp
phocamp ylus</w>
ph ine,</w>
ph ased</w>
ph ar
ph al</w>
ph 1(-/-)</w>
pg/m L.</w>
pg/m L);</w>
pg/ ml/
peth id
pet rosal</w>
pess ary</w>
perturb s</w>
perturb ations,</w>
perturb ation.</w>
pertin )</w>
pert ussis-tetanus</w>
perspec tives</w>
personne l,</w>
person- years;</w>
person- years).</w>
person ally</w>
person ality,</w>
person 's</w>
persist ant</w>
persec utory</w>
peroxy nitrite.</w>
peroxy nitrite,</w>
peroxy l</w>
peroxisom es.</w>
peroxisom es,</w>
peroxidase- anti
peroxidase-anti peroxidase</w>
peroxidase- 1</w>
peroxid ative,</w>
peroxid ation/
peroxidation/ oxidant</w>
peroxid ase)</w>
pernio sis,</w>
permit s.</w>
perme ant</w>
perme ability/
permeability/ injury,</w>
perman ently.</w>
perman ent.</w>
perman ence</w>
peritone um.</w>
peristal sis</w>
peristal sis,</w>
peripheral- vascular</w>
peripher al)</w>
periodic ,</w>
period s:</w>
period s).</w>
period .(ABSTRACT</w>
perinuclear- ANCA</w>
perineur ial</w>
perind opril,</w>
perin ates</w>
perimen opausal</w>
peril ymph
perikary al</w>
perid ol.</w>
pericon cep
periconcep tional</w>
pericardiocent esis.</w>
pericardi tis;</w>
peric y
peric ranial</w>
peric aval</w>
peric ard
peria ortic</w>
peri- sinusoidal</w>
peri ventricular,</w>
peri vascular
peri par
peripar tal</w>
peri oc
perioc ularly</w>
peri metric</w>
peri hemat
perihemat omal</w>
peri bronchial</w>
peri apical</w>
peri anal</w>
perhexil ine,</w>
perform ances,</w>
perform ance
perfor ations</w>
perfor ant-
perf using</w>
perf used-
percept ual,</w>
percenti le;</w>
percenti le:</w>
percenti le
percent ual</w>
percent age,</w>
per- kilogram</w>
per- and-
per-and- pencil</w>
per turb</w>
per technetate</w>
per pend
perpend icular</w>
per ical
perical losal</w>
per col
percol ated</w>
per ative.</w>
per amide,</w>
peptide- Y</w>
peptide(1- 42
peptide(1-42 )-
peptide(1-42)- infused</w>
peptide -like</w>
pepti de-induced</w>
pepti d
peop le:</w>
penum bra</w>
pentylenetetrazole- ,</w>
pentylene tetrezol</w>
pentoxy resorufin-O-dealkylase</w>
pentoxy if
pentoxyif ylline</w>
pentobarbitone- anaesthetized</w>
pentobarbital- ,</w>
pentobarbit alized</w>
pentetra zole</w>
pentetra zole,</w>
pentazoc ine-treated</w>
pentamid ine-
pentamidine- associated.</w>
pentamid ine's</w>
pentagastr in-stimulated</w>
pentadec apeptide,</w>
pentachloro biphenyl</w>
penta valent</w>
pent o
pent ane
pentane -1,3,4-tricarboxylic</w>
penicillinase- resistant</w>
penicillin- allergic</w>
penicillin- G,</w>
penicill ins,</w>
penetran ce</w>
penetr ation,</w>
penetr ation)</w>
penetr ant</w>
pen is,</w>
pen but
pen al
pen -shaped</w>
pemph i
pemphi gu
pemphigu s.</w>
pem oline,</w>
pelv oc
pelvoc aly
pelvocaly ce
pelvocalyce al</w>
pellet s)</w>
pellet /
pellet/ supernatant</w>
peg ylation</w>
peg interferon.</w>
peg IFN-alpha</w>
peer- review.</w>
pedunc les</w>
pedic led</w>
pedi s</w>
pedi atrics</w>
pedi atrici
ped ance</w>
pec ac</w>
peak- to-
peak- plasma</w>
peak- forming</w>
peak- diastolic</w>
peak- T
peak-T end</w>
pea ks.</w>
pe sia</w>
pe floxacin,</w>
pe eled</w>
pe el-
peel- away</w>
pe dig
pe d.</w>
pctx-then-cisDD P,</w>
paw-lick/ lift</w>
paw- pad.</w>
pattern s:</w>
pattern ;</w>
pattern :</w>
patter n-
patient- year)</w>
patient- months</w>
patient s]</w>
patient s--a</w>
patient s"</w>
pati c</w>
patholog y;</w>
patholog y-proven</w>
patholog ist.</w>
pathogn omon
pathognomon ic,</w>
pathogene tical</w>
path ies,</w>
path ia.</w>
pat z</w>
pat ory</w>
pat er
pater nal</w>
past ),</w>
pass age.</w>
pas sionate</w>
pas sed.</w>
pas es</w>
parvalbumin -</w>
parvalbumin -
parturi tion,</w>
parturi ents,</w>
parturi ent.</w>
participant s;</w>
partic ular
parti ally.</w>
parti al.</w>
part ne
partne red</w>
part ly.</w>
part )</w>
paroxet ine;</w>
parox ysms.</w>
parox ys
parom omycin.</w>
parom omycin,</w>
paro us,</w>
parietal- occipital</w>
pariet al,</w>
paresthesi as)</w>
paresthesi ae.</w>
paresthe sia.</w>
paren the
paren t-
parec oxib</w>
parec oxib,</w>
paraver tebral</w>
parathyroid ectomy.</w>
parathyro ids</w>
parat yrosine,</w>
parasit emia.</w>
paras ympathe
paras om
parasom nia</w>
paras agittal</w>
paraphil ia.</w>
paraph ilic</w>
paraph er
parapher nal
paraphernal ia</w>
parap silosis</w>
parap legia.</w>
parap are
parano ia:</w>
paran oidal</w>
paran asal</w>
parameter s)</w>
parameter ),</w>
param yotonia</w>
param edical</w>
paralle lled</w>
paralle l.</w>
paraff in</w>
paraesthesi as,</w>
paraesthe sias</w>
paradig ms:</w>
paradig matic</w>
paradig m;</w>
paradig m),</w>
parad ox</w>
paracetam ol/
paracetamol/ day.</w>
paracetam ol)</w>
parac rystalline</w>
para-aminohipp uric</w>
para- chlorophenylalanine</w>
para ventricular,</w>
para ox
para aminohipp
par v
par ty</w>
par rot-be
par onych
par ity.</w>
par gly
par axial</w>
par ations</w>
par ati
par aspinal</w>
par aqu
par amethas
paramethas one.</w>
par aldehyde.</w>
papio .</w>
papillo toxic</w>
papillo edema</w>
papill ae,</w>
pap io</w>
pap a
papa veret
pantoprazol e-induced</w>
panto thenate</w>
pannicul itis)</w>
panick ers,</w>
panhypopituitar ism</w>
pancuronium- narcotic</w>
pancreatitis ).</w>
pancreati co
pancreatico biliary,</w>
pancre atic,</w>
pancre atic
panc reat
panc reas,</w>
panames ine</w>
pan- gastrointestinal</w>
pan- caspase</w>
pan ze
pan or
pan ipenem</w>
pan el.</w>
pan .</w>
pan ,</w>
pamidron ate.</w>
pamidron ate,</w>
pame zole.</w>
palsy ;</w>
palmit ate.</w>
pallid otomy,</w>
pall or.</w>
pall ido
pallido thalamic</w>
pal sies,</w>
pal pebral</w>
pal pation,</w>
pal mi
palmi tic</w>
pal at
paired- click</w>
pair ings</w>
painful .</w>
pain/ haematuria</w>
pain- signaling</w>
pain- relieving</w>
pain- producing</w>
pain- on-
pain-on- injection</w>
pain- modulating</w>
pain- inten
pain-inten sity-
pain- inducing</w>
pain t</w>
pain s)</w>
pain kill
pain ?</w>
paedi atricians</w>
pad s.</w>
pad )</w>
paclitaxel/ cisplatin.</w>
paclitaxel- cisplatin-etoposide</w>
paclitaxel );</w>
paclitaxel ).</w>
paclitaxel 's</w>
pacemak er;</w>
pace ).</w>
pac ket</w>
pac ing;</w>
pac e</w>
pac e,</w>
pa z</w>
pa yment</w>
pa yer</w>
pa ve</w>
pa uses.</w>
pa use.</w>
pa statin</w>
pa ron</w>
pa r</w>
pa per-and-pencil</w>
pa kot
pa k
pa 1-
pH- dependent</w>
p=0.00 8)</w>
p=0.00 7).</w>
p=0.00 2).</w>
p=0.0 7).</w>
p= ns).</w>
p= 0</w>
p= 0.9
p= 0.05
p= 0.01).</w>
p= 0.001).</w>
p= 0.001),</w>
p= 0.000
p< 0.05,</w>
p< 0.05),</w>
p< 0.02).</w>
p< 0.005).</w>
p< 0.002).</w>
p< 0.0001,</w>
p75NTR- containing</w>
p53- mediated</w>
p/ L
p.p. m.)</w>
p.o .
p. S9
p-coumar ate,</w>
p-chloro phenoxyisobut
p-chloro amphetamine,</w>
p-aminohipp uric</w>
p-aminohipp ur
p- sulfo
p- isopropyl-
p-isopropyl- iminodiacetic</w>
p- iodo
p- hydroxy
p- gp</w>
p- glycoprotein</w>
p- enhancing</w>
p- dimethylamino
p-dimethylamino azobenzene</w>
p- cre
p-cre sidine</w>
p- cho
p-cho loro
p-choloro aniline</w>
p- aminophenol</w>
p- F-
p-F- H
p-F-H H
p-F-HH Si
p- AP</w>
p- (2-
p-(2- carboxy
p-(2-carboxy ethyl)</w>
p,p- D
p,p-D DE,</w>
p y</w>
p ure
p tional</w>
p tion-Event</w>
p son</w>
p seydoakathisia</w>
p ox,</w>
p our</w>
p oun
poun ds,</w>
p oli
p ocket</w>
p mole</w>
p ing,</w>
p ine:</w>
p cid
p add
p ]</w>
p Rh</w>
p M</w>
p KB</w>
p K(i)=
p F)</w>
p En
p Cl
pCl Phe
p CPA-
pCPA- pretreated</w>
p ANCA</w>
p ANCA-positive</w>
p A</w>
p A2
pA2 gat
pA2gat a
pA2gata 1-
pA2gata1- DYRK3</w>
p 53.</w>
p 11.2</w>
p .,</w>
ozone- sparing</w>
ozone- depleting</w>
oxytocin- ergometrine</w>
oxytoc in-induced</w>
oxyphenbutaz one.</w>
oxyphen is
oxyp urinol</w>
oxymorph one-induced</w>
oxymeth olone,</w>
oxygen- 88%</w>
oxygen ated</w>
oxygen -15-labeled</w>
oxygen ).</w>
oxygen ),</w>
oxybu procaine.</w>
oxybu procaine,</w>
oxy]- tropane</w>
oxy resorufin</w>
oxy metazol
oxo-5- thia-1-azabicyclo
oxo glutarate</w>
oxide/ cyclic-GMP</w>
oxide- redox</w>
oxidase- negative</w>
oxidase- B</w>
oxidant /
oxidant/ anti-oxidant</w>
oxidant -mediated</w>
oxid ative-
oxidative- nitrosative</w>
oxid ase).</w>
oxid ability</w>
oxic ity,</w>
oxic am.</w>
oxic -induced</w>
oxib :</w>
oxi dised</w>
oxcarbazep ine-treated</w>
oxcarbazep ine-induced</w>
oxazolid inone</w>
oxazolid inone,</w>
oxazol idinedi
oxazolidinedi one,</w>
oxaproz in,</w>
oxantr one,</w>
oxandrolon e.</w>
oxandrolon e,</w>
oxalo acetate</w>
oxaliplat in-based</w>
oxalate- rich</w>
oxal ate.</w>
oxal act
oxalact am,</w>
oxadiaz olo-
oxadiaz olo
oxacill in.</w>
oxacill in-associated</w>
oxac in-treated</w>
ox- CBZ</w>
ox ycantha),</w>
ox orubic
ox onidine</w>
ox on-induced</w>
ox od
ox ip
ox ious</w>
ox genase</w>
ox azole</w>
ox azepam.</w>
ox amide.</w>
ox acin.</w>
ow ic
owic z,</w>
ow ,</w>
ovul ation.</w>
overwhel med</w>
oversho oting</w>
overri des</w>
overload ing.</w>
overload ing,</w>
overload )</w>
overlap )</w>
overex pressing,</w>
overex presses</w>
overex press</w>
overex posure</w>
overestim ation</w>
overestim ate</w>
overdose -induced</w>
over- the-
over weight.</w>
over tly</w>
over stimulation.</w>
over sion</w>
over sensitivity</w>
over production.</w>
over night,</w>
over medication.</w>
over loaded</w>
over flowing</w>
over dose;</w>
over contraction</w>
over came</w>
over activity:</w>
ovari ectom
ovari an/
ovarian/ peritoneal</w>
oval bumin
ovalbumin -induced</w>
ov x</w>
ov ic</w>
output s.</w>
output ;</w>
output )</w>
outcom es;</w>
outcom e)</w>
outbreak .</w>
out- patients.</w>
out- patients)</w>
out stretched</w>
out side-in</w>
out performs</w>
out patients:</w>
out numbered</w>
out lining</w>
out lier</w>
out door</w>
ous- system</w>
ous ;</w>
ous /
ous/ depressive</w>
our ,</w>
oun sfield</w>
ouma rol,</w>
ouabain- intoxicated</w>
ouabain :</w>
ouabain /kg</w>
ouab ag
ouabag enin</w>
ou treach</w>
ou sy.</w>
otroph in-induced</w>
otroph in-1</w>
otrop e</w>
otri meric</w>
otri dine</w>
otrans plantation</w>
otoxic ity-
otox ity</w>
ototoxic .</w>
otop ical</w>
oton ic,</w>
otom ized</w>
otom ies.</w>
otolaryng ological</w>
oto protection</w>
oto -</w>
other wise,</w>
other s)</w>
other ;</w>
other -
oth on
othon us,</w>
otet anus</w>
otax ime
otax ic</w>
ot ubular</w>
ot s</w>
ot runcal</w>
ot rin)</w>
ot rache
ot otopical</w>
ot or
otor hinolaryng
ot opi
ot ele
otele metric</w>
ot axis</w>
ot as
otas semia</w>
ot arizine</w>
ot age
ot -
osyn thesis</w>
osup pression</w>
osteosarcom as.</w>
osteop ont
osteopont in,</w>
osteomalac ic</w>
osteomalac ia.</w>
osteoc ar
osteocar tilaginous</w>
osteoc alc
osteocalc in</w>
osteo arthritis:</w>
osten sibly</w>
oste otomy.</w>
oste otomies.</w>
oste osarcoma,</w>
oste openia.</w>
oste openia,</w>
oste oid</w>
ost atics</w>
osper mia,</w>
ospec ific</w>
osom es,</w>
osom al-
osomal- dominant</w>
osmoly te</w>
osmolar ity.</w>
osmol ar)</w>
osmol )</w>
osi tioning</w>
osi tion</w>
osi s)</w>
osi s),</w>
osi er</w>
osclero derma</w>
oscillop sia.</w>
oscillop sia,</w>
oscill ation,</w>
oscil logram
oscillogram s</w>
osarcom as</w>
osarcom as,</w>
osa e),</w>
os ympathetic</w>
os ub
os pirosis</w>
os mio
osmio philic</w>
os ity,</w>
os ine,</w>
os ha
osha -j
osha-j ink
osha-jink i-
osha-jinki- gan</w>
os able</w>
os M</w>
os (t
os(t )
os(t) ide</w>
orthost asis,</w>
orthopa edic,</w>
orthop nea,</w>
orthop e
orthope dist
orthobenzo ate)</w>
orth otropic</w>
orth optic</w>
orth olog
ors --
ors "</w>
orrho e
orphenad rine.</w>
orph ine
oro tracheal</w>
oro t
oro stral</w>
oro pharynx</w>
oro logic</w>
ornith ine.</w>
ormad inone</w>
orm ic
ormic um)</w>
orlistat .</w>
orlistat -assisted</w>
origin ,"</w>
orig in;</w>
ori enting</w>
ori entate</w>
ori ens,</w>
ori -motor</w>
orgas mia,</w>
organophosph ates</w>
organophosph ate.</w>
organochlor inated</w>
organo platinum</w>
organ om
organ izations</w>
organ isms,</w>
organ -specific</w>
org an,</w>
ordin ately</w>
ord inal</w>
ord able</w>
orcipren al
orciprenal ine.</w>
orchi ectomy,</w>
orchi ectomized</w>
orch itis</w>
orb it.</w>
orb id</w>
oran dil</w>
orally- treated</w>
orally- administered</w>
or/ and</w>
or- promoting</w>
or- free,</w>
or yl
or y's</w>
or y"</w>
or s)</w>
or ly</w>
or g/
or derly</w>
or dered</w>
or den
orden -S
orden-S patz</w>
or ax
or ating</w>
or ;</w>
opyrrolid ine-2,4-
opyrrolidine-2,4- dicarboxylate</w>
opyri mid
opyri da
opyrida zine</w>
opyr one</w>
opyr in,</w>
optim ise</w>
optim al,</w>
opri de,</w>
oprecipit ate,</w>
opre vention</w>
oposi tivity</w>
opor tal</w>
opoiet in-like</w>
opisthoton us,</w>
opisthoton os,</w>
opiperid ine-2-
opiperidine-2- carbon
opiperidine-2-carbon yl-L-leucyl-L-proline</w>
opiper az
opiperaz inyl)
opiperazinyl) benz
opiperazinyl)benz imidazole</w>
opioid- tolerant</w>
opioid- receptor</w>
opioid- naive</w>
opioid- agonists,</w>
opioid /
opioid -mediated</w>
opioid -</w>
opiate- receptor</w>
opiate- naive</w>
opiate- exposed</w>
opi ate-like</w>
ophthalmolog y.</w>
ophthalmo pathy.</w>
ophthalmo pathy,</w>
ophthalm oscopy</w>
ophthalm oscopy.</w>
ophthalm itis,</w>
ophosph or
ophil ia</w>
oph ore
oph erol</w>
oph aryng
oph agic</w>
oph agen</w>
oper fused</w>
oper culo
operculo insular</w>
open- labele
open-labele d.</w>
open- chamber</w>
open ing.</w>
open ing,</w>
open ic</w>
open ers</w>
open ers,</w>
open er.</w>
open er)</w>
opath y"</w>
opath ies</w>
opac ities.</w>
opac ification.</w>
op ur
op ulation</w>
op tions,</w>
op tion,</w>
op tically</w>
op tica</w>
op t</w>
op sychiatric</w>
op poses</w>
op ontin</w>
op ont
opont ocerebellar</w>
op ium</w>
op ist
opist othonus,</w>
op ia</w>
op anax</w>
op 's</w>
onychomy co
onucle osis</w>
onset ;</w>
onset )</w>
onse ts</w>
onse t-to-
onse t-of-dose</w>
onorgest rel</w>
oni on
oni ine,</w>
ong- Tang</w>
ong .</w>
oneur ons</w>
oneph ro
one/ acetaminophen</w>
one- to-
one- supplemented</w>
one- sensitive</w>
one- on-
one-on- one</w>
one- forming</w>
one- ethinyl</w>
one- cyclophosphamide</w>
one- -a</w>
one utr
one urium</w>
one +
one )-treated</w>
oncolog y;</w>
oncolog ist</w>
oncolog ist.</w>
once-per- day</w>
once ;</w>
once /day</w>
once ),</w>
onc ocytic</w>
onab ant)</w>
on- specific</w>
on- period</w>
on- intron</w>
on y-Glycyrrhiza</w>
on wards</w>
on ous</w>
on our</w>
on ly:</w>
on lay</w>
on lay
on l
onl ays</w>
on ins</w>
on idazole</w>
on ic)</w>
on g,</w>
on en</w>
on d.</w>
on cirin,</w>
on be
onbe l)</w>
on ally</w>
on ally,</w>
on -related</w>
omyelo pathy</w>
omyelo ce
omyeloce le</w>
omyc in-associated</w>
omodul ator</w>
omni phagia.</w>
omni paque</w>
omin eral</w>
omicro scope</w>
omethoxy- 3
omet rium</w>
omet abolism</w>
omer s)</w>
omer ca
omerca zole).</w>
omeprazol e:</w>
omen orrhea</w>
omen cl
omega- oxidative</w>
omega- ag
omega-ag atoxin</w>
omega- Con
omega-Con otoxin</w>
omega -</w>
omega -1</w>
omediast in
ome trically.</w>
ome ter,</w>
ome promazine</w>
ome dic
omat osis:</w>
omasti a,</w>
omalac ia</w>
omal ies</w>
oma- -a</w>
om yst
om udex)</w>
om pa
om ized</w>
om inous</w>
om ial</w>
om ery</w>
om edical</w>
om agne
ology/ American</w>
ologist s;</w>
ologist 's</w>
ologic .</w>
olog us</w>
olog ously</w>
olo l)</w>
olmesart an)</w>
oll is</w>
oliv opontocerebellar</w>
olith iasis,</w>
olip ids</w>
oligonucleoti des,</w>
oligodendro glioma</w>
oligodendro glioma.</w>
olig ur
olig omenorrhea</w>
ole- treated</w>
ole ic</w>
ole board,</w>
olar ization</w>
olar -arterial</w>
olanzapine/ risperidone</w>
olab eling</w>
ol- unexposed</w>
ol- defined</w>
ol- containing</w>
ol- compared</w>
ol- 5-
ol s/
ol onic</w>
ol ones</w>
ol one-induced</w>
ol itis.</w>
ol itis,</w>
ol ite</w>
ol is,</w>
ol ine-</w>
ol ine-3-
oline-3- carboxylate</w>
ol id
ol icus</w>
ol i</w>
ol factor
olfactor y-
ol evulinic</w>
ol e)</w>
ol ds</w>
ol d;</w>
ol d
ol azone</w>
ol ac
olac oides</w>
oint ments.</w>
oid/ Susp
oid/Susp icious</w>
oid- lipofuscin
oid -mediated</w>
oh y</w>
oh onen</w>
oh land</w>
ograph ic,</w>
ogest rel</w>
ogen icity.</w>
ogen es,</w>
ogen -activated</w>
ogen )</w>
offic es.</w>
off- line.</w>
off- lic
off- label</w>
off- cells</w>
off ices</w>
off -cell</w>
of- the-tiger</w>
of- care</w>
of (B(t
of(B(t )dt/B(t
oestrogen ized</w>
oedema ;</w>
odul es.</w>
odo rous</w>
odilat or</w>
odi pir</w>
odd ball</w>
od s.</w>
od or,</w>
od on
od -dependent</w>
ocytopen ic</w>
ocyte- restricted</w>
ocyte -derived</w>
ocyte )</w>
ocycl azocine</w>
ocy tic.</w>
ocy clo
ocyclo -
ocyclo- pentane-1,3,4-tricarboxylic</w>
ocur rence</w>
oculog ram</w>
octahydro benzo(f)
octahydrobenzo(f) quinoline</w>
oct yl]-L-alan
oct ano
ocr atic</w>
ocorm ia,</w>
ocor onary</w>
ocon trac
ocom promised</w>
ococc us.</w>
oco e
ocil pine</w>
och ran
och le
ocel es,</w>
occurren ces.</w>
occurren ce
occurrence ?</w>
occupati onally</w>
occupati on.</w>
occlu sions.</w>
occlu sion;</w>
occlu sion-
occlu sion)</w>
occlu ded,</w>
occl udin</w>
occipit al,</w>
occasion ed</w>
occasion ally.</w>
occa sion,</w>
occ id
occid ent
occident alis)</w>
ocap ill
ocapill aris</w>
ocal orie</w>
oca val</w>
oca ine-induced</w>
oc ular-
oc t-2-ene-2-
oc rit
oc lobem
oclobem ide</w>
oc k</w>
oc ity</w>
oc iliary</w>
oc ellular-
oc E)</w>
obvi ating</w>
obvi ates</w>
obul lous</w>
obtur ators</w>
obtun ding</w>
obt use</w>
obstruc ted.</w>
obstetr ics</w>
obstac les</w>
obstac le</w>
obses sive-compulsive-like</w>
obses sions</w>
obses sion</w>
observer-bl inded</w>
observ able-
observable- effect</w>
obser ver-
obser ver,</w>
obliter ative</w>
obliter ation,</w>
obliter ated</w>
oblast omas</w>
oblast -
oblast- transplanted</w>
object s.</w>
obj ectively,</w>
obj ective,</w>
obit ridol,</w>
obes ity;</w>
obac ter
ob ta
ob scur
ob ligated</w>
ob li
obli que</w>
ob ic/
obic/ anaerobic</w>
ob ia)</w>
ob ex.</w>
ob ar</w>
oathe toid</w>
oX ome</w>
oX ome)</w>
o- tolylguanidine</w>
o- sulphate,</w>
o- proliferative</w>
o- dihydroxyphenyl
o-dihydroxyphenyl serine</w>
o- carboxy
o-carboxy ethyl-
o-carboxyethyl- phosphoramide</w>
o- based</w>
o- athetosis</w>
o- acet
o-acet ate/
o-acetate/ 3-
o-acetate/3- hydroxybut
o-acetate/3-hydroxybut yrate)</w>
o- M-
o-M- 60</w>
o- EEG</w>
o- AP</w>
o- ,</w>
o viduct,</w>
o sides.</w>
o selectivity</w>
o protein,</w>
o plasic</w>
o ocytes,</w>
o ocyte</w>
o kinetic</w>
o ke</w>
o is</w>
o il-induced</w>
o il-
o grams,</w>
o g
o fl
ofl azine</w>
o fibrate,</w>
o ffe
o estrogens</w>
o estrogenic</w>
o esophagitis</w>
o esophag
o embryonic</w>
o edemat
o dynamics</w>
o deoxycholic</w>
o de
o bu
o at</w>
o adjuvant</w>
o .),</w>
o .
o ),</w>
o '</w>
nystag mus
nutri tive</w>
nutri tionally</w>
nutri ents,</w>
numb ers.</w>
numb er:</w>
numb er
nucleoti des,</w>
nucleoti de
nucleolon ema</w>
nucleolon em
nucleolonem al</w>
nucleol us,</w>
nucleol i.</w>
nucleo side-
nuclear- encoded</w>
nucle us:</w>
nucle os(t)ide</w>
nucle i).</w>
nt -14
nt -1
novel ty-induced</w>
novel ty-
novel .</w>
nov a</w>
notochord al-
notochordal- basichondro
notochordal-basichondro cranial</w>
notice ably</w>
noti fy</w>
note worth
not withstanding</w>
not ed:</w>
not ching</w>
not ch</w>
not ations</w>
not ably,</w>
not )</w>
nostri ls,</w>
nostri l</w>
nosid ase</w>
norvegic us)</w>
normother mia.</w>
normokal emic.</w>
normocap nic</w>
normocalce mia.</w>
normo thymic</w>
normo phosphat
normo kalemia</w>
normo glyce
normo glycaemic</w>
normo -</w>
normaliz e.</w>
normal- salt,</w>
normal :</w>
normal -to-
norm s,</w>
norm oxia</w>
norm omagne
norm ocytic</w>
norm ocytic.</w>
norm ocellular</w>
norm ocalorie</w>
norm ocalciuria</w>
norm ally.</w>
norm .</w>
norgest rel</w>
norg estim
norepinephrine- driven</w>
norepinephr ine-</w>
noradrenaline- precontracted</w>
noradrenal in,</w>
nor-binaltorphim ine.</w>
nor-binaltorphim ine,</w>
nor- dexverapamil</w>
nor testosterone</w>
nor nicotine,</w>
nor met
normet aneph
normetaneph rine</w>
nor fluoxetine</w>
nor floxac
nor diazepam</w>
nor adrenergic-
nor adrenergic,</w>
nootrop ics</w>
nootrop ic
nootropic -treated</w>
nonoxynol- 9</w>
nonimmobil izer</w>
none theless,</w>
non- white</w>
non- warfarin</w>
non- vasculogenic</w>
non- vascular</w>
non- valvular</w>
non- uraemic</w>
non- tumor-bearing</w>
non- transgenic</w>
non- toxic.</w>
non- synonymous</w>
non- survivors</w>
non- substance-abusing</w>
non- stimulant</w>
non- smokers</w>
non- smoker</w>
non- sinus</w>
non- serious</w>
non- seizuring</w>
non- sedative</w>
non- reversible</w>
non- response</w>
non- response.</w>
non- responders,</w>
non- renal</w>
non- related</w>
non- rapid</w>
non- protective,</w>
non- prostanoid</w>
non- peptidic</w>
non- peptide</w>
non- parametric</w>
non- paracetamol</w>
non- opiate</w>
non- nucleoside</w>
non- neurological</w>
non- neurogenic</w>
non- myopathic</w>
non- myeloid</w>
non- meningitic</w>
non- married</w>
non- localized</w>
non- irradiated</w>
non- interventional</w>
non- infused</w>
non- inflammatory</w>
non- inflamed</w>
non- hypercalciuric</w>
non- hyperalgesic</w>
non- homogeneous</w>
non- heme</w>
non- generic</w>
non- fulminant</w>
non- fluorinated</w>
non- existent</w>
non- endothelial</w>
non- elevated</w>
non- drug-using</w>
non- dominant</w>
non- diabetics</w>
non- delayed</w>
non- dapsone-exposed</w>
non- cytotoxic</w>
non- cross-
non-cross- resistant</w>
non- compliance</w>
non- compli
non- coagulopathic</w>
non- clinical</w>
non- cases</w>
non- caseating</w>
non- block</w>
non- bacterial</w>
non- atopic</w>
non- aspirin</w>
non- arteriosclerotic,</w>
non- array</w>
non- anticoagulated</w>
non- antibiotics</w>
non- anaesthetic</w>
non- akathisia</w>
non- adherence</w>
non- abuser</w>
non- UI</w>
non- TAS,</w>
non- SH</w>
non- PD</w>
non- PB</w>
non- OAT-ICH</w>
non- NRTIs</w>
non- MI</w>
non- L-dopa-
non-L-dopa- responsive</w>
non- Hodgkin
non- Hispanic</w>
non- HIT</w>
non- H-P</w>
non- Cocaine-Induced</w>
non- CaCl(2)-treated</w>
non- CIP</w>
non viral</w>
non vasodilating</w>
non upregulated</w>
non trophoblastic</w>
non transplant</w>
non trained</w>
non thrombocytopenic</w>
non tender</w>
non synaptic</w>
non sustained,</w>
non survivors.</w>
non steroid</w>
non stenotic</w>
non steady-state</w>
non specific.</w>
non specific,</w>
non significant.</w>
non septic</w>
non sense</w>
non seized</w>
non sarcopenic</w>
non ruptured</w>
non reversible</w>
non responders,</w>
non regulated</w>
non regenerative</w>
non rapid</w>
non proteinuric</w>
non progressive,</w>
non premedicated</w>
non pitting</w>
non physiologic</w>
non phosphorylated</w>
non pharmacologic</w>
non perfusion</w>
non peptide,</w>
non paranoid</w>
non overdose</w>
non ototoxic</w>
non organic</w>
non opiate</w>
non nicotine</w>
non neural</w>
non myelosuppressive</w>
non myeloablative</w>
non mutant</w>
non metastatic</w>
non linearity</w>
non iodinated</w>
non invasive,</w>
non invasi
non intravenous</w>
non initiated</w>
non infused</w>
non inducible</w>
non induci
non immunologic</w>
non immune-mediated</w>
non hypotonous</w>
non hemorrhagic</w>
non filtr
nonfiltr ating</w>
non exposed)</w>
non exercise</w>
non episode</w>
non enzymic</w>
non enal</w>
non effective</w>
non e;</w>
non dividing</w>
non digitalized</w>
non diagnos
nondiagnos tic.</w>
non diabetics.</w>
non diabetic,</w>
non detectable</w>
non declarative</w>
non cumulative</w>
non crossover</w>
non convulsant</w>
non contingent</w>
non confusional</w>
non compressive</w>
non clear</w>
non cholestatic</w>
non carriers</w>
non carriers.</w>
non captopril</w>
non bullous</w>
non bipolar</w>
non benzodiazepine</w>
non antithrombotic</w>
non antimuscarinic</w>
non anesthetized</w>
non -</w>
nomifens ine),</w>
nom ograms</w>
noi se-exposed</w>
nodulo sis,</w>
nodulo cystic</w>
nodul aris.</w>
nodos um,</w>
nodos a-like</w>
nod al-
nodal- field</w>
nociceptin(1-13)NH (2),</w>
nocicept in/
nociceptin/ orphanin</w>
nocicept in-induced</w>
nocicep tive-
no- treatment</w>
no ver</w>
no tics,</w>
no th
no sis</w>
no se
no p
no j
noj iri
nojiri mycin</w>
no ise
no iditis</w>
no ea.</w>
no dd
no ble</w>
nmole/ liter</w>
nmol/min/ mg</w>
nmol/min/ g</w>
nmol/ paw)</w>
nmol/ mouse,</w>
nmol/ ml</w>
nmol/ min/100</w>
nmol/ l;</w>
nmol/ l,</w>
nmol/ l
nmol/ kg,</w>
nmol/ g),</w>
nmol/ 2.5</w>
nmol/ 0.2</w>
nmol. 100</w>
nmol. /
nmol./ l.</w>
nmol es</w>
nmol es)</w>
nmol )-induced</w>
niz atidine,</w>
nitrosoure a-induced</w>
nitrosoure a,</w>
nitrosou reas</w>
nitrosou reas.</w>
nitrosou reas,</w>
nitros amines,</w>
nitroprusside- evoked</w>
nitroprusside ;</w>
nitroprusside -treated</w>
nitroprusside -</w>
nitroprusside 's</w>
nitrogen -containing</w>
nitrofuranto ins</w>
nitrofur antion</w>
nitro- l-arginine</w>
nitro- L-arginine:</w>
nitro tyrosine,</w>
nitro sy
nitro soguvac
nitro propionic</w>
nitro phenyl-3-piperidin
nitro guanidine</w>
nitro gran
nitrogran ulogen</w>
nitro flurbiprofen,</w>
nitro flurbi
nitrite- treated</w>
nitrate/ nitrite,</w>
nitrate- stimulated</w>
nitr ation,</w>
nit rates:</w>
nit os
nisoldip ine,</w>
ning- dosed</w>
nine fold</w>
nimesul ide:</w>
nigro- neostriatal</w>
nigra -
night 's</w>
nigh ts.</w>
nifedip ine-treated</w>
nif e</w>
nicotine-N'- oxides</w>
nicotine- patch</w>
nicotine- like</w>
nicotine- deprived</w>
nicotine- dependent</w>
nicot ine;</w>
nicot ine:</w>
nicot ine-containing</w>
nicoran dil
nic titating</w>
niac inamide</w>
niac in's</w>
ni g-
nig- Hoffmann</w>
ng/ml/ hr</w>
ng/ml )+
ng/kg/ min</w>
ng/kg/ min;</w>
ng/kg/ min.</w>
ng/d L.</w>
ng/ min</w>
ng/ mg,</w>
ng/ kg)</w>
ng/ hr,</w>
ng/ h</w>
ng/ g</w>
ng/ day</w>
ng/ L)</w>
ng/ L).</w>
ng/ GP)</w>
ng/ 0.5</w>
ng.kg-1. min-1</w>
ng. ml-1,</w>
ng. h/
ng.h/ ml</w>
nex t,</w>
nex ate</w>
nex ,</w>
new spaper,</w>
new s"</w>
new er,</w>
nevirap ine-related</w>
nevirap ine-induced</w>
neutroph il,</w>
neutral izes</w>
neutr al,</w>
neurotroph ins</w>
neurotroph in-3</w>
neurotrop in</w>
neurotransmis sions</w>
neurotoxic ity--
neuroten sinergic</w>
neuroten sin.</w>
neuroten sin-induced</w>
neuroradi ologists.</w>
neuroprotect ant,</w>
neuropo res.</w>
neuropath ology.</w>
neuropath ic,</w>
neuron es,</w>
neuron ally</w>
neuron al-specific</w>
neuron .</w>
neuron -specific</w>
neuron -
neurolog ically,</w>
neuroleptic- naive</w>
neuroleptic- catalepsy</w>
neuroleptic s;</w>
neuroleptic -mediated</w>
neurolept analgesia</w>
neurolept anaesthesia.</w>
neurolep tics:</w>
neurohypophy s
neurohormon al,</w>
neurofilam ent-
neurofibrom at
neurofibromat osis</w>
neurofibrom a</w>
neuro- protective</w>
neuro toxins,</w>
neuro toxin.</w>
neuro toxicology</w>
neuro sis,</w>
neuro sensorial</w>
neuro retinopathy</w>
neuro radiologic</w>
neuro radiographic</w>
neuro psychotic</w>
neuro psychiatric,</w>
neuro protectant</w>
neuro physiological,</w>
neuro peptidergic</w>
neuro ophthalmologic</w>
neuro myopathy:</w>
neuro motor</w>
neuro mediated</w>
neuro matrix</w>
neuro intensive</w>
neuro immune</w>
neuro hormones</w>
neuro ethological</w>
neuro epithelium,</w>
neuro epithelial</w>
neuro carcinogenic</w>
neuro behavioural</w>
neuro behavioral,</w>
neuro anatomy</w>
neuro adaptive</w>
neuro adaptative</w>
neuro adaptation</w>
neuro -</w>
neuraminid ase,</w>
neuralg ic</w>
neur ulation.</w>
neur it
neur axis</w>
neur amin
neuramin ic</w>
neumo -
neumo- Can
neumo-Can c</w>
networ k,</w>
netilmic in,</w>
ness ).</w>
ness ),</w>
nes -J
nes-J ewish</w>
nervous ness/
nervous ness.</w>
nerve- mediated</w>
nerve- evoked</w>
nerv ous-system</w>
nerv es;</w>
ner ve;</w>
ner .</w>
nepic astat
nephroure terectomy</w>
nephrotoxic ant.</w>
nephron s,</w>
nephrolith ia
nephro tubular</w>
nephro toxins,</w>
nephro stom
nephro sis;</w>
nephro sis--
nephro protective</w>
nephro pathic</w>
nephro log
nephro blast
nephri tis)</w>
nephri tis
nephrectom y;</w>
neph rine</w>
neovascular ization.</w>
neovascular ization,</w>
neos tigm
neop oncirin,</w>
neon ate's</w>
neon at
neoform ans.</w>
neo vascular</w>
neo dy
nemat odes</w>
nel arabine</w>
nel arab
nelarab ine,</w>
neighbor ing</w>
neighbor hood</w>
negl ected</w>
negati vity.</w>
negati vity,</w>
negati ve-
neg ligi
negligi bly</w>
neg ate</w>
nefir acetam.</w>
needle- stick</w>
nedocrom il</w>
nedap lat
necrop sies</w>
necro- inflammation</w>
necro sis?</w>
necro sis).</w>
necro ses,</w>
necro genic,</w>
necess ity.</w>
necess ary)</w>
nebul isation</w>
near- syncopal</w>
near- infrared</w>
near- daily</w>
ne ver-treated</w>
ne stren
ne q/min</w>
ne pin</w>
ne monic</w>
ne mon
nemon apride</w>
ne ffective</w>
ne d;</w>
nausea/ dizziness</w>
nause a--
nause a),</w>
natur al-
natural- product</w>
natriure sis,</w>
nas ociliary</w>
nas endoscopy.</w>
narrow .</w>
narrow ,</w>
narco tics.</w>
narco tic-induced</w>
narco sis,</w>
nar ro
nar do</w>
nar atript
naprox en-associated</w>
naphth a[1,
naphtha[1, 2-
naphtha[1,2- d]
naphtha[1,2-d] thiazol-2-amine</w>
naph t
naph azoline</w>
nap e</w>
nanop articles.</w>
nam es</w>
naltrex ol</w>
naltr indole,</w>
naloxone- sensitive</w>
naloxon azine.</w>
nalox one;</w>
nalox one)</w>
nalmefen e,</w>
nail s</w>
nafenop in.</w>
nafenop in,</w>
nadi r.</w>
nadi r
nad olol.</w>
na velbine)</w>
na ked</w>
nNOS (-/-
nNOS (+/-)</w>
nM/ s.n.)</w>
n= 8).</w>
n= 7
n= 6;</w>
n= 4)</w>
n= 30)</w>
n= 26</w>
n= 18)</w>
n= 160)</w>
n= 12).</w>
n= 11,</w>
n= 10</w>
n= 10)</w>
n= 10).</w>
n-propyl amino)
n-propyl -4-
n-propyl-4- pentenoic</w>
n-propyl -2
n-propyl-2 H-
n-methyl serotonin</w>
n-hex yl-
n-hex ane:
n-hexane: ethyl</w>
n-butyl- (4-hydroxybutyl)
n-butyl -</w>
n- methyl-
n- injured</w>
n- butyl</w>
n- acetyl
n- D
n-D PA</w>
n y
n uciferine</w>
n ub
n s),</w>
n omencl
n omedic
n m,</w>
n m)</w>
n ide</w>
n ative-
native- valve</w>
n ations,</w>
n ation-
nation- wide</w>
n ally.</w>
n abumet
n VH</w>
n ST</w>
n NO
n M;</w>
n E</w>
n :</w>
n .s.).</w>
n .),</w>
n ),</w>
myx oid</w>
myop ia</w>
myonec rosis,</w>
myoglob in.</w>
myofilam ents</w>
myofilam ents,</w>
myofibri ls.</w>
myofibri l</w>
myoclon us)</w>
myocardi tis/
myocardi opathy,</w>
myocardi a,</w>
myoc ar
myocar idal</w>
myo- inositol,</w>
myo plasmic</w>
myo intimal</w>
myo globul
myoglobul inuria.</w>
myo fibroblast</w>
myo fibrillary</w>
myo fibers,</w>
myelosuppres sion;</w>
myelos chi
myeloradic ulography</w>
myelomening ocoe
myelo toxicity.</w>
myelo toxic</w>
myelo tom
myelo peroxid
myelo pathic</w>
myelo id,</w>
myelo fibrosis</w>
myelo fibrosis.</w>
myelo dysplasia,</w>
myelo cytic</w>
myelin olysis,</w>
myel oneuropathy</w>
myel oneuropathy.</w>
myel inating</w>
myel in,</w>
mye lographic</w>
mye lia</w>
mydri asis.</w>
myco sis</w>
myco bacterium</w>
myco bacterio
myalgias/ arthralgias,</w>
myalg ia)</w>
my ths</w>
my ristic,</w>
my ristate-stimulated</w>
my ot
my osm
my osin.</w>
my os
my ometrium</w>
my olysis,</w>
my ography.</w>
my ocyte-specific</w>
my ocellular</w>
my oblast-transplanted</w>
my es
myes thenia</w>
mutagen icity</w>
mut ually</w>
mut ation-
mustar d,</w>
mush rooms</w>
musculo ligam
musculoligam ental</w>
muscul e</w>
muscul ar,</w>
muscle -type</w>
muscimol- containing</w>
muscim ol-induced</w>
muscar ine-induced</w>
murmur .</w>
mumole/ kg)</w>
mumole/ kg),</w>
mumole/ L)</w>
mumol/kg/ min,</w>
mumol/kg/ hr)</w>
mumol/ min</w>
mumol/ min/100</w>
mumol/ min),</w>
mumol/ kg,</w>
mumol/ g.</w>
mumol/ L/
mumol/L/ h)</w>
mumol/ L),</w>
mumol s/g</w>
multiv itamins</w>
multiv al
multival vular</w>
multis l
multisl ice</w>
multis ite</w>
multiplic ities,</w>
multiple- gated</w>
multiple s</w>
multin odular</w>
multin ational,</w>
multim ers</w>
multidrug- resistance</w>
multidiscipl in
multidisciplin ary,</w>
multicentr ic,</w>
multi- vessel</w>
multi- transfused</w>
multi- system</w>
multi- level</w>
multi- generational</w>
multi- drug</w>
multi- disciplinary</w>
multi unit</w>
multi parametric</w>
multi modality</w>
multi dose</w>
multi directional</w>
multi deficient</w>
multi bacillary</w>
mul ite</w>
mul at
mug/ ml.</w>
mug/ ml)</w>
mug/ mL</w>
mug/ kg/min</w>
mucos al,</w>
muc olytic</w>
muc h
muc ate,</w>
mu- receptor</w>
mu- kappa</w>
mu- agonists</w>
mu sical</w>
mu g/m
mu g).</w>
mu M</w>
mu M,</w>
mu Ci</w>
mu /24</w>
mu ,</w>
mu ).</w>
msec ),</w>
ms/ mmHg,</w>
ms 1/2</w>
mouthrin ses.</w>
mouthrin ses,</w>
mouthrin se</w>
mouth wash
mouth s</w>
mouse- killing</w>
moun ts</w>
motor- training</w>
motor- sensory</w>
motiv ation/
motivation/ energy</w>
mother-to- infant</w>
mother s:</w>
mot tled</w>
mot t
mot or
mot oneurons</w>
mot axis</w>
most- frequent</w>
most- common</w>
mosmol/ kg</w>
mos mol</w>
mos ,</w>
mortal ity;</w>
morphometr ic,</w>
morpholin yl)-doxorubicin</w>
morphol inyl)
morphine/ bupivacaine</w>
morphine- sensitization,</w>
morphine- like</w>
morphine- ,</w>
morphic eptin</w>
morph ologies</w>
morph ologically.</w>
morph ogenesis,</w>
morph o-physiologic</w>
morph ine:</w>
morph ine-related</w>
morph ine).</w>
morph ea.</w>
morph :</w>
morph ,</w>
moric izine,</w>
moric iz
mor nings</w>
mor al</w>
month- long</w>
month s.
month s--
month s):</w>
month ly)</w>
month ).</w>
monophosph o
monophosph ate.</w>
monophosph ate-
monophosphate- activated</w>
monophosph at
monooxygen ases</w>
monom er</w>
monom el
monomel ic</w>
monofilam ents.</w>
monocyto genes,</w>
monocyte- macrophages</w>
monocyte- macrophage</w>
monoc rotaline</w>
monoc hemotherapy</w>
mono- methyl</w>
mono therapy;</w>
mono iodo
mono hydrochloride)</w>
mono acidic</w>
mono acetyl
monoacetyl morphine.</w>
monkey s;</w>
monkey s/gender
monke y:</w>
monke y)</w>
monit ors</w>
mon t</w>
mon oxide-releasing</w>
mon ospecific</w>
mon oneuropathy.</w>
mon omorph
mon ocytes.</w>
mon ocytes,</w>
mon ocyclic</w>
mon obactam</w>
mon gh
mongh olicus</w>
mon ey
mon et
mon e
molsidom ine.</w>
moles/ glomerulus</w>
moles/ glomerulus,</w>
molecule -1,</w>
mol/ L/
mol/L/ 12
mol/L/12 F;</w>
mol lus
mollus c
mollusc um</w>
mol ality</w>
moi eties</w>
modifi ed-release</w>
modifi ed-
modified- Krebs</w>
moderate- sized</w>
moder ators</w>
moder ation</w>
moder ating</w>
moder ates</w>
moder ately,</w>
moder ate:</w>
moder ate/
model ing,</w>
model ),</w>
mode x</w>
mode stly.</w>
mode st.</w>
mode lled</w>
mode .</w>
modal ity,</w>
modafin il.</w>
mod ular</w>
moclobem ide-
mobil ity.</w>
mobil ity,</w>
mobil ised</w>
mo ving,</w>
mo urs</w>
mo tional</w>
mo tion-</w>
mo pressin</w>
mo ods</w>
mo od
mo genesis</w>
mo dates</w>
mo at)</w>
mo -old</w>
mmol/kg/ SC
mmol/kg/SC /
mmol/kg/SC/ twice</w>
mmol/ liter)</w>
mmol/ l),</w>
mmol/ g</w>
mmol/ d);</w>
mmol. l-1</w>
mmol. L-1</w>
mmol e/
mmol .)</w>
mmHg/ s,</w>
mmHg/ s)</w>
mm/ year;</w>
mm(3 ).</w>
mm H
mm 3),</w>
mm 2).</w>
mm 2).(ABSTRACT</w>
mm /kg</w>
mm .
mm (-
mm 's</w>
ml/min/ year)</w>
ml/min/ kg;</w>
ml/kg/ min.</w>
ml/kg/ min).</w>
ml/kg/ hour</w>
ml/kg/ day)</w>
ml/g/ min).</w>
ml/ thiopentone</w>
ml/ s</w>
ml/ s)</w>
ml/ ng)</w>
ml/ m
ml/ kg),</w>
ml/ hr,</w>
ml/ h</w>
ml/ h.</w>
ml/ day).</w>
ml/ 100
ml/100 g/min.</w>
ml. min-1,</w>
ml. min-1)</w>
ml. kg-1.
ml.kg-1. hr-1</w>
ml. kg-1)</w>
ml. hr-1)</w>
ml. h-1</w>
ml. /24</w>
ml s/min/1.73m2</w>
ml U/ml</w>
ml /</w>
ml -1;</w>
ml -1).</w>
ml (-1),</w>
mixt ures,</w>
mixt ure-treated</w>
mixt ure)</w>
mixed- model</w>
mixed- function</w>
mix ed.</w>
mitte 's</w>
mitript an</w>
mitr al-
mitral- valve</w>
mitot ane,</w>
mitomycin- C-induced</w>
mitomycin- C,</w>
mitomycin- C)</w>
mitogen -induced</w>
mitochondrial- mediated</w>
mitochondrial- dependent</w>
mitochondri opathy</w>
mitochondri ally</w>
mito ses,</w>
miti s-infected</w>
miti gation</w>
mith ramycin</w>
mit ter</w>
mit omycin/vinblastine</w>
mit omycin-induced</w>
mit ogenesis.</w>
mistak e,</w>
mist ake</w>
misoprost ol-unexposed</w>
misoprost ol-treated</w>
misoprost ol-exposed</w>
miscarri age.</w>
mis onidazole</w>
mis matched</w>
mis judgment</w>
mis interpretation</w>
mis information</w>
mis h
mis directed</w>
mis const
misconst rued</w>
mis classification,</w>
mirtazap ine-associated</w>
mir abilis</w>
mipafox -treated</w>
mio tics</w>
minute/ m2</w>
minute (-1)</w>
minut es'</w>
minut e;</w>
minut e),</w>
minoxidi l
minoxidil +
minor ity,</w>
minocycl ine-related</w>
minipump s)</w>
minimum- type</w>
minimal- chang
minimal-chang e"</w>
minim um.</w>
minim um)</w>
minim ized,</w>
minim i</w>
minim ally.</w>
mini- pumps.</w>
mini- pump.</w>
mini osmotic</w>
mineralocortico ids</w>
mineralocortico ids,</w>
mineralocortico id-related</w>
mineralocortico id-induced</w>
mineralocortico id-</w>
min/ mmHg,</w>
min- minus</w>
min s.</w>
min s,</w>
min s)</w>
min osae),</w>
min gl
mingl ed</w>
min d,</w>
min ated</w>
min /</w>
min -treated</w>
min -1/
min-1/ 100</w>
min )]</w>
min )-atropine</w>
mimic ry</w>
mime tics.</w>
mime tics,</w>
mime tic,</w>
mim ick
miltiorrhiz a</w>
miltiorrhiz a)</w>
milrin one-
millisecond s.</w>
millilit er-
milliliter- per-kilogram</w>
millilit er,</w>
millilit er)</w>
milli on)</w>
milli metric</w>
milli meter</w>
milli me
millime tres</w>
milk -induced</w>
milieu ,</w>
mile stones</w>
mild- moderate</w>
mil k.</w>
mil it
mil dest</w>
mil d/
migran s</w>
migraine- inducing</w>
migra inos
migra ines.</w>
migra ine-associated</w>
migr ation.</w>
migr ated</w>
mig rate</w>
mifeprist one,</w>
midd le,</w>
midazol ine</w>
mid- thigh</w>
mid- shaft</w>
mid- segment</w>
mid- latency</w>
mid ventricular</w>
mid night</w>
mid night.</w>
mid line.</w>
mid line,</w>
mid course</w>
mid brain)</w>
micturi tion.</w>
microvilli .</w>
microvilli ,</w>
microtubule- disrupting</w>
microsphe res,</w>
microsphe res)</w>
microsph er
microsom ia</w>
microscop ic,</w>
microphthal mos</w>
microphthal mos,</w>
microphthal mia</w>
microphthal mia,</w>
microne uro
micron utri
micron ized</w>
micron g/ml</w>
micron .</w>
micron )</w>
micromol/L ]</w>
micromol/ site</w>
micromol/ site,</w>
micromol/ paw,</w>
micromol/ kg.</w>
micromol/ L),</w>
micromol/ 10</w>
micromol es/
micromol es),</w>
micromicron ./
microm ol)</w>
microm ol),</w>
microm anome
microliters/ min).</w>
microliter ,</w>
microl/ min/g</w>
microl/ min)</w>
microl/ min).</w>
microl-- IS)</w>
microl-- IS),</w>
microgx kg(-1)</w>
microgx kg(-1)
microgxkg(-1) x
micrograph s,</w>
micrograms/kg/ min).</w>
micrograms/kg/ h</w>
micrograms/kg/ d)</w>
micrograms/kg ]</w>
micrograms/ side),</w>
micrograms/ rat,</w>
micrograms/ rat)</w>
micrograms/ mouse</w>
micrograms/ mouse),</w>
micrograms/ ml/24</w>
micrograms/ l,</w>
micrograms/ l)</w>
micrograms/ l).</w>
micrograms/ g;</w>
micrograms/ day;</w>
micrograms/ L,</w>
micrograms/ 24</w>
micrograms/ 10</w>
micrograms/ (min</w>
micrograms. ml-1,</w>
micrograms. ml-1),</w>
microgram/kg/ day)</w>
microgram/ min)</w>
microgram/ h</w>
microgram/ day</w>
microgram/ cc</w>
microgram. ml-1)</w>
microgram. kg-1</w>
microgram s;</w>
microgram .</w>
micrognath ia</w>
micrognath ia,</w>
microglobul inuria</w>
microglobul inuria.</w>
microglia/ macrophages.</w>
microg/m (2)</w>
microg/kg/ min).</w>
microg/kg/ min)-atropine</w>
microg/kg/ hour,</w>
microg/kg/ day,</w>
microg/kg/ d,</w>
microg/kg --IP</w>
microg/ side</w>
microg/ side),</w>
microg/ ml,</w>
microg/ min)</w>
microg/ m2</w>
microg/ h)</w>
microg/ g)</w>
microg/ L;</w>
microg/ L,</w>
microg/ L).</w>
microg/ 100</w>
microg.kg(-1). min(-1)</w>
microg./ l.</w>
microg. kg-1</w>
microg. kg(-1)</w>
microfil arial</w>
microangio pathy:</w>
microangio pathies</w>
microV/ ms)</w>
microV/ ms).</w>
microM/ paw)</w>
microM/ L</w>
microM/ 0.5</w>
microM)- evoked</w>
microL/ min/100</w>
microL/ m2</w>
microL/ h)</w>
microEq/ min</w>
microEq/ 100</w>
micro- spectroscopy</w>
micro- injection</w>
micro- CT</w>
micro wave</w>
micro vessel</w>
micro vesicles.</w>
micro stimulation</w>
micro seizures</w>
micro peroxidase.</w>
micro particles,</w>
micro me
microme ters,</w>
micro hemorrhages.</w>
micro hematuria.</w>
micro gravity</w>
micro g;</w>
micro encephaly</w>
micro electrodes</w>
micro electrodes.</w>
micro electro
micro dissection</w>
micro deposits,</w>
micro crystal</w>
micro calcification,</w>
micro bridges</w>
micro bore</w>
micro bleed
micro biologically</w>
micro albuminuria</w>
micro albuminuria.</w>
micro adenoma.</w>
micro V]</w>
micro U/ml</w>
micro U/
micro L;</w>
micro L).</w>
micro L),</w>
micro L
micro A,</w>
mice .(ABSTRACT</w>
mic s</w>
mic onazole.</w>
mic el
micel le-
micelle- forming</w>
mic e/
mic e.
mibefradi l.</w>
mi rex</w>
mi on).</w>
mi as,</w>
mi an</w>
mi ),</w>
mgI/ ml).</w>
mg/m2/ h</w>
mg/m2/ dose</w>
mg/m2/ day)</w>
mg/m2/ d)</w>
mg/m2/ course</w>
mg/m2/ 24</w>
mg/m(2)/ day,</w>
mg/m(2)/ day)</w>
mg/m(2) over</w>
mg/m L.</w>
mg/m L),</w>
mg/m 2B
mg/m2B SA)</w>
mg/m 2);</w>
mg/m 2
mg/m2 BSA</w>
mg/kg/day ]</w>
mg/kg/ minute</w>
mg/kg/ minute.</w>
mg/kg/ min),</w>
mg/kg/ injection.</w>
mg/kg/ injection).</w>
mg/kg/ i.p.</w>
mg/kg/ h).</w>
mg/kg/ dose</w>
mg/kg/ d.</w>
mg/kg/ d
mg/kg/ 24</w>
mg/kg. h</w>
mg/kg- day</w>
mg/kg)/ min</w>
mg/kg ],</w>
mg/kg .(ABSTRACT</w>
mg/kg ,
mg/kg ).(ABSTRACT</w>
mg/eye /d)</w>
mg/dL ]</w>
mg/dL ],</w>
mg/dL ])</w>
mg/d l
mg/dl );</w>
mg/K g/day</w>
mg/K g/
mg/24 h).</w>
mg/ week).</w>
mg/ min).</w>
mg/ liter.</w>
mg/ liter,</w>
mg/ l
mg/ g).</w>
mg/ day);</w>
mg/ daily)</w>
mg/ caffeine</w>
mg/ L),</w>
mg/ 650</w>
mg/ 50</w>
mg/ 1</w>
mg/ 160</w>
mg/ 15
mg/15 5+/-1
mg/155+/-1 5</w>
mg/ 0.05</w>
mg.kg-1. min-1),</w>
mg.kg-1. hr-1</w>
mg.kg-1. h-1</w>
mg.kg-1. day
mg.kg-1.day -1),</w>
mg.kg-1. d-1)</w>
mg.kg(-1). min(-1)),</w>
mg./ m2</w>
mg. ml-1),</w>
mg. kg-1).</w>
mg. kg(-1),</w>
mg. kg(-1))</w>
mg s</w>
mg kg(-1)
mgkg(-1) day(-1));</w>
mg )-containing</w>
mg (-1),</w>
mg %),</w>
mez loc
mezloc illin,</w>
meval onic</w>
metyrap one.</w>
metrorrhag ia,</w>
metronidazol e-
metriz amide.</w>
metrif onate</w>
metri a,</w>
metrex ate</w>
metraz ol.</w>
metoprolo l/
metoprolo l)</w>
metoprolo l's</w>
metopro lol-induced</w>
metocur ine-pancuronium</w>
metoclopram ide:</w>
metoclopram ide),</w>
metkeph amid</w>
metkeph amid
metkephamid ,</w>
meti amide</w>
methysergi de.</w>
methylsulphon yl)amino]phenyl]amino]</w>
methylphenid ate-</w>
methylergonov ine,</w>
methylenedioxymethamphet amine;</w>
methylenedioxy methamphetamine,</w>
methylcell ulose</w>
methyl-8- (2-hydroxy-3-
methyl-8-(2-hydroxy-3- t-butylamino-propoxy)</w>
methyl-6-oxo- 7,13-dihydro-6H-benzofuro[2,3-e]pyrido[1,2-a][1,3]diazepin-12-ium</w>
methyl-6,7-dimethoxy-4- ethyl-beta-carboline-3-
methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3- carboxylate)</w>
methyl-4- phenyl-
methyl-2- styryl-
methyl-2- pyrrolidinyl)isoxazole</w>
methyl- atropine</w>
methyl- atropine.</w>
methyl- atropine,</w>
methyl- N,N-
methyl-N,N- dimethyl-4-
methyl-N,N-dimethyl-4- amino
methyl- L-arginine</w>
methyl- 4
methyl- 3,7-
methyl-3,7- dihydro
methyl-3,7-dihydro -1H-
methyl-3,7-dihydro-1H- purine-
methyl- ,</w>
methyl)- N-(1-
methyl)-N-(1- methyl
methyl)-N-(1-methyl piperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)</w>
methyl)- 8-
methyl)- 4-(3-
methyl)-4-(3- phenyl-2-propenyl)-piperazine],</w>
methyl) -1H-
methyl testosterone,</w>
methyl scopolamine),</w>
methyl quinoline</w>
methyl prednisone</w>
methyl piperidine-3alpha-
methyl nitrate</w>
methyl nitrate,</w>
methyl naloxonium</w>
methyl mal
methylmal onic</w>
methyl guanine-
methylguanine- DNA</w>
methyl dopa
methyl clo
methylclo fen
methylclofen ap
methyl chloroform</w>
methyl benz
methylbenz [c]
methyl atropine.</w>
methyl ated</w>
methyl amino-
methyl ]</w>
methyl ,</w>
methyl (
methyl( acetoxy
methyl(acetoxy methyl)
methy leph
methoxyflur ane.</w>
methoxy-4- morpholinyl)-doxorubicin</w>
methoxy-4- methylquinoline</w>
methoxy-4- [(
methoxy-4-[( methylsulphonyl)amino]phenyl]amino]</w>
methoxy- idazoxan,</w>
methoxy- 9
methoxy-9 H-
methoxy) ethyl</w>
methoxy tropane</w>
methoxy phenyl</w>
methoxy phenyl)-4-[4-(2-phthalimido)butyl]piperazine</w>
methoxy phenethylamine</w>
methoxy daunorubicin</w>
methoxy chlor
methoxychlor ,</w>
methoxy ben
methoxyben z</w>
methox salen</w>
methotrex ate-associated</w>
methodolog y.</w>
methodo logy,</w>
method :</w>
metho iodide</w>
methiodi de.</w>
methim azole,</w>
methim azol
methcath in
methazol amide-induced</w>
methan one</w>
methan amine</w>
methamphetamine- using</w>
methamphetamine- elicited</w>
methamphetamine- associated</w>
methaemo glob
methaemoglob inaemia</w>
methadone- stabilized</w>
methach oline.</w>
methach oline-</w>
methach oline,</w>
meth oxamine,</w>
meth iod
methiod al</w>
meth anandamide</w>
meth acrylate</w>
metfor min-associated</w>
metest rus</w>
meter s)</w>
meter -controlled</w>
mete red-dose,</w>
metastasi zed</w>
metast atic,</w>
metast as
metar amin
metamorph osis,</w>
metalloproteinase- 3</w>
metallo thione
metach ronous</w>
metac lop
metac ar
metacar pal</w>
metabonom ics</w>
metabolit es;</w>
metabolit es)</w>
metabolit e/
metabolite/ dopamine</w>
metabolit e"</w>
metabolism ).</w>
metabol iz
metabol ities</w>
metabol ic/
metabol ic-
metabol ic)</w>
meta- analysis,</w>
meta phan</w>
met oxy]-tropane</w>
met olazone</w>
met olaz
met aplasia.</w>
met amphetamine</w>
met al-
mesulerg ine.</w>
messen ger
mesop refrontal</w>
meso derm</w>
mesna -treated</w>
mesna +
mesi late.</w>
mesenter y.</w>
mesenchyme -like</w>
mesangi um.</w>
mesangi olysis</w>
mesalaz ine:</w>
mesalaz ine-induced</w>
mesal amine.</w>
mesal amine,</w>
meric an</w>
mercaptop urine</w>
mercapto- ethane</w>
mercapto propionyl</w>
mer itori
meritori ous,</w>
mer idi
meridi onal</w>
mer ch
merch an
merchan dise</w>
mer ase</w>
mer .</w>
mequiv/ 1.</w>
mequ iv</w>
meq/ liter,</w>
meq/ l.</w>
meprob amate</w>
meprob amate,</w>
mepivaca ine)</w>
meperid ine;</w>
ment- fix
ment-fix ing</w>
ment ary.</w>
ment al.</w>
ment al-
mental- status</w>
ment -dependent</w>
menstru ation</w>
menstru ation,</w>
menorrhag ia--
menopa usal,</w>
meningiti di
meningi omas</w>
meningi oma.</w>
mening omyelocele</w>
mening ococci</w>
mening is
men thol.</w>
men ses</w>
men n</w>
men delian</w>
men );</w>
men 's</w>
memory- enhancing</w>
memor y;</w>
memor y)</w>
membrane- spanning</w>
membrane- disordering</w>
membrane- cytoskeleton</w>
membrane- bounded</w>
membran o-proliferative</w>
memb er.</w>
melphalan- prednisone.</w>
melphalan- prednis
melphal an:</w>
melphal an/
melphalan/ prednisone</w>
melatonin- treated,</w>
melaton in-induced</w>
melaton in's</w>
melanocor tins</w>
melanchol ia</w>
melaen a</w>
mel perone,</w>
mel ic</w>
mel ano
megal y</w>
megal oblastosis.</w>
megakary ocytes</w>
megakary ocytes,</w>
mefloqu ine-related</w>
mefloqu ine-induced</w>
meet ings</w>
medull ectomy</w>
medull ary,</w>
medull aris</w>
medull a-
medium- to-high-dose</w>
medium- size</w>
medium -treated</w>
medicine- free</w>
medic ation-related</w>
medic ation-induced</w>
medic ation).</w>
medic ation),</w>
medic al/
medical/ surgical</w>
medic al-
medi um)</w>
medi ators,</w>
medi ate-dose</w>
medi an.</w>
medi a;</w>
medi a:</w>
medi a-
medetom idine-induced</w>
meclofen amate</w>
mecli zine,</w>
mechloreth amine</w>
mechano receptors</w>
mechanism ;</w>
mechanism ).</w>
mechan ically-
mechan ic
mecamyl amine-
meas ures;</w>
meas ures).</w>
meas ure,</w>
meas les</w>
meaning fulness</w>
meaning ful.</w>
mean+/- SD</w>
mean while</w>
mean s.</w>
meal s:</w>
meag er</w>
me x</w>
me tionine</w>
me til
me ticulous</w>
me tic,</w>
me the
me terol</w>
me ptazinol</w>
me lam
melam ine,</w>
me ets</w>
me droxy
medroxy progesterone.</w>
me at,</w>
me -related</w>
me 's</w>
mdr1 b</w>
mdr 1a</w>
md x</w>
mcg/ mL</w>
mcg/ kg)</w>
mcg/ kg(-1)</w>
mcg/ L</w>
mc g/mL,</w>
mc g.</w>
mazind ol:</w>
mazind ol.</w>
mazep am.</w>
mayonnai se,</w>
maxim um.</w>
maxim izes</w>
maxim al-
maximal- tolerated</w>
max ill
max /
matur ational</w>
matri x"</w>
materi als,</w>
mater ially</w>
matched- pair</w>
match-to- sample</w>
match ing
matching -to-
mat ured</w>
mat ure,</w>
mat ing,</w>
mat ine,</w>
mat h</w>
mat ches</w>
mastic atory</w>
mast ocytosis,</w>
mast algia</w>
massi vely</w>
mass ed</w>
mass age,</w>
mass -
mas ks</w>
mas k
mas )</w>
marrow- derived,</w>
marrow- ablative</w>
marmo sets.</w>
market s</w>
mark ed.</w>
marijuan a.</w>
mariju ana
margin al.</w>
marg ins</w>
marg ins.</w>
marg in.</w>
marc gravi
marcgravi i</w>
mar red</w>
mar anthus</w>
maprotil ine:</w>
maprotil ine)</w>
manufacture rs</w>
mant le</w>
mano eu
manoeu v
manipul ated,</w>
manip ulate</w>
manifest ations:</w>
manifest ,</w>
mang ifer
mangifer in,</w>
mang af
mangaf odipir</w>
maneu vers.</w>
maneu ver,</w>
mandi ble.</w>
man ometry,</w>
man idipine</w>
man idipine,</w>
man ic,</w>
man ia-like</w>
man dating</w>
man age.</w>
man ?</w>
man )</w>
mam mar
mam mal</w>
malon ate.</w>
malignanc ies:</w>
malform ations;</w>
male/ 15</w>
male ic</w>
male ).</w>
malaria- infected</w>
malaox on.</w>
malaox on-induced</w>
malaox on,</w>
mal to
mal oprim</w>
mal nutrition.</w>
mal nutri
mal functions</w>
mal es).</w>
mal e:</w>
mal ar</w>
mal ac
mal "</w>
major ity.</w>
major ity,</w>
major :</w>
maj us</w>
maj or)</w>
mainten ance:</w>
mainten ance)</w>
mainten ance).</w>
main ta
main ly,</w>
mai- san</w>
magnitu de:</w>
magneto encephalographic</w>
magnesium- containing</w>
magnesi um-treated</w>
magnesi um-induced</w>
magnesi um),</w>
magn ification.</w>
mag nified</w>
mag nif
mafosf amide.</w>
macul atum</w>
macul ae</w>
macul a.</w>
macroscop ically,</w>
macrophage- mediated</w>
macrophage- conditioned</w>
macroph age,</w>
macron odules.</w>
macromolec ules.</w>
macroli de.</w>
macro- papular</w>
macro prolactinomas.</w>
macro glos
macroglos sia</w>
macro electrodes</w>
macro adenoma</w>
macro adenoma,</w>
machin es)</w>
macaqu es.</w>
macaqu e.</w>
mac ro</w>
mac aw</w>
ma- subunits.</w>
ma- media</w>
ma sto
ma ph
ma .(ABSTRACT</w>
ma ),</w>
ma "</w>
mU/ mg</w>
mU/ mL,</w>
mU/ l</w>
mU/ kg</w>
mRNA s,</w>
mOsm/ kg;</w>
mOsm/ kg.</w>
mOsm/ kg),</w>
mOsm )</w>
mO sm</w>
mM/ kg)</w>
mM hr</w>
mM =
mM /kg</w>
mL/minute/ g,</w>
mL/minute/ 1.73</w>
mL/min/ kg</w>
mL/min/ g,</w>
mL/kg/ h
mL/ s.</w>
mL/ s)</w>
mL/ s).</w>
mL/ kg/min</w>
mL/ kg.</w>
mL/ day.</w>
mL/ cm</w>
mL/ beat/
mL/ 24</w>
mL.min-1. g-1</w>
mL.g-1. min-1,</w>
mL. -1.
mL.-1. g-1</w>
mL g
mLg (-1)
mL -1.
mL-1. min-1.
mIU/ L.</w>
mGluR1- EGFP</w>
mGluR s.</w>
mEq/kg/ day,</w>
mEq/ liter.</w>
mEq/ liter).</w>
mEq/ l),</w>
mAMPH -treated</w>
mAMPH ,</w>
m/ speech</w>
m/ s,</w>
m/ min</w>
m-chloro phenylpiperazine</w>
m-chloro phenyl
m-PW TT</w>
m-PW T
m-PWT T)</w>
m-CP B
m- nitrophenyl-3-piperidin
m- chlorphenylpiperaz
m- Nitro</w>
m- FOLFOX-4</w>
m- AIMS.</w>
m(2) ),</w>
m(- 2))</w>
m um</w>
m s.
m oxif
m osmol)</w>
m olytic</w>
m old</w>
m nemonic</w>
m mg</w>
m inced</w>
m ia-related</w>
m ative</w>
m arb
marb le</w>
m V/
m V.</w>
m T,</w>
m IU</w>
m CR</w>
m Abs</w>
m AMPH-induced</w>
m A),</w>
m 2),</w>
m .).</w>
m -like</w>
lysozym uria.</w>
lysozym uria,</w>
lysosom otropic</w>
lysosom es,</w>
lysophosph atidyl</w>
lyso zomal</w>
lyser gol
lyser gic</w>
lymphoplasmacy tosis</w>
lymphom a).</w>
lympho aden
lymphadenopath ies,</w>
lymphaden itis,</w>
lymph omatous</w>
lymph oid,</w>
lymph ocytosis.</w>
lymph ocytes)</w>
lymph oblast
lymph .</w>
lym oclavine</w>
lyc open
lyc ine</w>
ly solecithin</w>
ly nestren
ly T1)</w>
lut ination</w>
lusit rop
lung :</w>
lumin escence</w>
lumb usacral</w>
lumb ago.</w>
lum p</w>
lum ens,</w>
lukast -associated</w>
lucifer ase</w>
luc i
luci gen
lucigen in-
lucigenin- enhanced</w>
luc encies</w>
lu or
lu id</w>
lozeng es</w>
lozeng e,</w>
loxy dine</w>
lox ilic</w>
lower- limb</w>
lowe st;</w>
lowe st.</w>
low- to-
low- threshold</w>
low- temperature</w>
low- sodium</w>
low- set</w>
low- salt</w>
low- priced</w>
low- pressure</w>
low- incidence</w>
low- frequency,</w>
low- dosage</w>
low- avoidance</w>
low- K(+)-
low- ,</w>
low s</w>
low ly</w>
low ering,</w>
low er/
low ;</w>
low /
lot arg
losoxantr one/
losart an
losartan +
los ure</w>
los s).</w>
los er</w>
loro phenylalanine</w>
lorazepam -induced</w>
lorazepam -dependent</w>
lorazepam -
lor do
lopin avir
lopinavir -
lop es</w>
loop -tail</w>
loo sely-bound</w>
loo kout</w>
loo k.</w>
long-term '</w>
long-ter m)</w>
long- time</w>
long- term.</w>
long- medium</w>
long- duration</w>
long- bone</w>
long ev
long et
longet s)</w>
long .</w>
lonafarni b.</w>
lomust ine,</w>
lol- ANH</w>
logis tic-regression</w>
logarith mic</w>
log- unit</w>
log- transformed</w>
log s</w>
log it</w>
locomot or,</w>
locomo tive</w>
locomo tion)</w>
loco regionally</w>
lock ),</w>
loc us)</w>
loc ked</w>
loc ating</w>
loc ated.</w>
loc ate
locate thin-3-O-gallate</w>
loc ally-
loc ally,</w>
lobul ar,</w>
lob oma</w>
lob ectomy.</w>
lob ectomies,</w>
load s.</w>
load ;</w>
load -independent</w>
load -dependent</w>
lo vastatin-induced</w>
lo vastatin-gemfibrozil</w>
lo t,</w>
lo ropyridyloxy)]benzene</w>
lo od.</w>
lo l:</w>
lo l),</w>
lo in-
loin- pain/haematuria</w>
lo idal</w>
lo iasis</w>
lo d</w>
lo an-
loan- Ket
loan-Ket tering</w>
lo a</w>
lo ,</w>
liz ation.</w>
liz ab
lizab eth</w>
liximab .</w>
liver/ kidney</w>
liver- kidney</w>
liver- function</w>
liver s;</w>
liver .(ABSTRACT</w>
liver -derived</w>
liver -1;</w>
liver 's</w>
live stock.</w>
liv ing-related</w>
litres/ minute/m2</w>
litre (-1)</w>
lithotrip sy.</w>
lithocholate-3-O- glucuronide,</w>
lithium- uraemic</w>
lithium- quetiapine</w>
lithium- pretreated</w>
lithium- polyuric</w>
lithium- polyuria</w>
lithium- polyuria.</w>
lithium- olanzapine</w>
lithium- free</w>
lithium- effect
lithium-effect uated</w>
lithium- chlorpromazine</w>
lithium- carbamazepine</w>
lithium- antidepressant</w>
lithium ;</w>
lithium -</w>
lithium )</w>
lith otomy.</w>
literat ures.</w>
liter s).</w>
liter ary</w>
liter /day)</w>
lit re.</w>
listen ers</w>
list s,</w>
lisdexamfet amine.</w>
liquid- liquid</w>
liquid- filled</w>
liqu orice,</w>
liqu ids</w>
lipos omes.</w>
lipopolysacchar ide-
lipopolysaccharide- stimulated</w>
lipo proteins.</w>
lipo phil
lipide mia,</w>
lipid :
lipid: aqueous</w>
lip omatosis:</w>
lip omatosis.</w>
lip -DX
lip ,</w>
linole ate</w>
linole ate,</w>
link er.</w>
ling ering</w>
line ar,</w>
line ar
line ages.</w>
line age.</w>
lind ane:</w>
lind ane-
lin ker</w>
lin ked.</w>
lin k,</w>
lin ing.</w>
lin ing,</w>
lin ical</w>
lin es'</w>
lin astatin</w>
limit ed-
limbic -
limb- threatening</w>
limb- lead</w>
limb ing</w>
lim a
likeli ho
likel y)</w>
like wise.</w>
like ),</w>
lik e.</w>
lignocaine/ placebo</w>
lignoca ine-
lignoca ine),</w>
ligible ;</w>
light/ dark</w>
light- density</w>
ligh ten
ligh t-induced</w>
ligh t-</w>
ligh t+
ligh t"</w>
lig ation;</w>
lifes pan</w>
lifes aving</w>
life- saving.</w>
life -</w>
lif t,</w>
lif el
lifel ong</w>
lif e:</w>
lidocaine- propofol</w>
lidocaine- prilocaine</w>
lidocaine- induced,</w>
lidoca ine-treated</w>
lidoca ine-like</w>
lid onium</w>
lid oflazine</w>
licking/ lif
lic orice</w>
lic oric
lic it</w>
lic es</w>
lic ense</w>
lic .</w>
libit um-fed</w>
libit um,</w>
libid o.</w>
liber ica</w>
li ving.</w>
li tigation</w>
li st,</w>
li paemic</w>
li osis-like</w>
li gu
ligu strazine</w>
li e</w>
li berate</w>
li b</w>
li abilities.</w>
li a
lia ison</w>
li )</w>
lexi gl
lexigl as</w>
levothyrox ine.</w>
levothyrox ine-induced</w>
levosul piride</w>
levonorgestrel )</w>
levome promazine-fluvoxamine</w>
levome promazine,</w>
levofloxac in:</w>
levodopa- primed</w>
levodopa- carbidopa</w>
levodopa -related</w>
levodopa -derived</w>
levodopa )</w>
levodopa ),</w>
levo- naloxone</w>
levo- isomers</w>
levo- alpha-
levo fol
levofol inate</w>
levo bupivacaine-induced</w>
levit ated</w>
level s--
level s'</w>
level led</w>
level -dependent</w>
level -I</w>
lev oc
lev ator</w>
leuproli de.</w>
leukomalac ia</w>
leukomalac ia,</w>
leukocyt uria.</w>
leukocyt es/
leukocytes/ 100</w>
leuko encephalopathies.</w>
leukem ias.</w>
leuk ocytopenic</w>
leuk ocytoc
leuk ocyte)</w>
leuk apheresis</w>
leucovor in)</w>
leuc openia,</w>
leuc omalac
leuc ocyturia</w>
leuc ocytosis</w>
leuc ocytosis,</w>
leuc ocytopenia</w>
leuc ocytes.</w>
leuc emia</w>
letro zole</w>
lethal )</w>
lessen ed,</w>
less- than-
lesion s/
lesion s).</w>
lesion :</w>
lesion -only</w>
lesion -
ler 's</w>
leptomen inges</w>
lept ospirosis</w>
lept ophyll
lepro sy.</w>
lepro sy,</w>
leph one</w>
length s,</w>
length ening.</w>
length ened.</w>
leng thier</w>
len ticularis</w>
len s,</w>
lemon .</w>
leishman iasis,</w>
leg is
left- ventricular-wall</w>
left- side</w>
left- axis</w>
lebbec k,</w>
leb rex
leb rand's</w>
least -square</w>
learn ing),</w>
lear ner
leaf ,</w>
lead -treated</w>
lead -exposed</w>
lead -
lead ,</w>
le/ perfusate</w>
le/ drugs</w>
le- stimulating</w>
le- specific</w>
le- cell</w>
le t.</w>
le ming</w>
le ev
le d-release</w>
le bre
lebre x</w>
le -related</w>
le "</w>
lay er)</w>
lax ati
laxati ves,</w>
law ,</w>
lav age,</w>
laur yl</w>
laur ic,</w>
laur ate</w>
laud anos
laudanos ine,</w>
later oposterior</w>
later alization</w>
later :</w>
latency )</w>
late- stage</w>
latanoprost -treated</w>
latano prost.</w>
lat oxin</w>
lat ,</w>
last .</w>
lass itu
lassitu de,</w>
las co
lasco w</w>
laryng otrache
laryng ospas
laryn x</w>
laryn x.</w>
larg er.</w>
lar val</w>
lar s.</w>
laparotom ized</w>
lant a,</w>
lansoprazol e:</w>
lansoprazol e-induced</w>
language- delayed</w>
land mark</w>
lamivudine- resistance</w>
lamivudine- containing</w>
lamivud ine/
lamivud in</w>
lamin in,</w>
lamin ectomy</w>
lamin ectomies,</w>
lamellipo di
lamellipodi a/
lamellipodia/ cellular</w>
lamell ae</w>
lamb da
lam b</w>
lacunosum- molecul
lactat emia</w>
lact one.</w>
lact ational</w>
lact ation,</w>
lact ate/
lactate/ pyruvate</w>
lact acid
lachrym ation</w>
lac k,</w>
lac cid</w>
laborator y-proven</w>
labor ious</w>
labetal ol;</w>
labell ing,</w>
lab .</w>
lab ,</w>
lCo BF</w>
l/ min</w>
l/ min/
l/ m2,</w>
l/ hour/
l/hour/ m2.</w>
l. h)</w>
l-methyl but
l-methylbut yl)amino]-</w>
l-N NA-treated</w>
l-B ucindolol</w>
l- verapamil</w>
l- naloxone</w>
l- histidine</w>
l- based</w>
l- arginine-methyl</w>
l- Per
l-Per longets)</w>
l- NAME
l- Ephedrine</w>
l- DOPA</w>
l- 20
l-20 1)</w>
l' Etude</w>
l ump
l son</w>
l ic,</w>
l i</w>
l es)</w>
l az
laz aro
l aw</w>
l aun
laun ched</w>
l augh
l apse</w>
l anc
lanc inating</w>
l amino
lamino plasty</w>
l aid</w>
l a.</w>
l PBN</w>
l PB
l .(ABSTRACT</w>
l -1)</w>
l -1),</w>
kynuren ine/
kynurenine/ tryptophan</w>
kynuren ine,</w>
ky phosis</w>
kur roa</w>
knock out,</w>
kleptom ania.</w>
kit tens</w>
kiren -induced</w>
kinin ogen,</w>
kine tic-dynamic</w>
kine sis</w>
kine sis.</w>
kine sigenic</w>
kine sia,</w>
kindle d-
kindled- seizures</w>
kind reds</w>
kinase-3 beta</w>
kinase-3 b</w>
kinase- MB,</w>
kin ky</w>
kin inase</w>
kin es,</w>
kin ase;</w>
kin ase/
kill s</w>
kill er</w>
kidney- transplanted</w>
kidney s;</w>
ki hydrochloride</w>
khell in</w>
kh uzestanica</w>
kg/ min.</w>
kg/ min,</w>
kg/ m(2)</w>
kg/ day)</w>
kg/ d</w>
kg(-1) day(-1)</w>
kg ]).</w>
kg );</w>
ketotifen .</w>
ketotifen ,</w>
ketorolac -associated</w>
ketocon azole-associated</w>
keto acidosis,</w>
ketamine- related</w>
ketamine- propofol</w>
ket opiperidine-2-carbonyl-L-leucyl-L-proline</w>
ket ones,</w>
ket one:</w>
ket amine-</w>
keratouve itis.</w>
keratocon us</w>
keratocon junctivi
kerat osis</w>
kerat osis,</w>
kerat ectomy.</w>
keph amid</w>
ken az
kenaz ic</w>
kele tal,</w>
ke to</w>
ke 0)</w>
kdynes/cm 2)</w>
kdyn /cm2</w>
karyotyp es,</w>
kary otype</w>
kary omegaly</w>
kappa- opiate</w>
kappa- beta.</w>
kappa 1</w>
kanamycin- col
kanamycin-col is
kanamycin-colis tin</w>
kanam ycin.</w>
kan sasi
kan sas</w>
kaliure sis,</w>
kala-az ar)</w>
kain ate/
kain ate-type</w>
ka- ryukotsu-borei-
kPa ).</w>
kHz ;</w>
k- correlated</w>
k- He
k-He imer</w>
k- 8644</w>
k ynetic</w>
k r</w>
k owicz,</w>
k o,</w>
k nife</w>
k new</w>
k its.</w>
k it</w>
k ist
kist rodon</w>
k ine,</w>
k ill</w>
k es-
kes- Adams</w>
k es
kes ha,</w>
k er's</w>
k ep
k el's</w>
k ed-
k cal
k at/
k alo
k al</w>
k a</w>
k a,</w>
k Id
kId r</w>
k D</w>
k A
k :</w>
k 2,</w>
k 2),</w>
k /benefit</w>
k (mono
k(mono )</w>
juxtac analicular</w>
jux tap
jux taglomerular</w>
justifi ed?</w>
junc tival</w>
ju ic
journ als</w>
journ als.</w>
jour neys</w>
jo b</w>
jitter iness,</w>
jer king,</w>
jer k-correlated</w>
jeop ardy</w>
jeop ardi
jejun al</w>
jec tion-associated</w>
jeal ousy.</w>
jaw- thrust</w>
jaundic e;</w>
jacch us).</w>
jac k
ja1 (+/
ja1(+/ flox
j ))</w>
iz zia</w>
iz ine-induced</w>
iz ability.</w>
iverm ectin.</w>
iv c)</w>
iv astatin</w>
ity- based</w>
ity 's</w>
itsel f
itro bacter</w>
itol- 4-phosphate</w>
iti zing</w>
iti ve,</w>
iti l-Perlongets)</w>
ith rin-alpha</w>
iterpen oids</w>
item s)</w>
itch iness,</w>
itari an</w>
it s'</w>
it ron</w>
it ript
it ri
it ine</w>
it er's</w>
it ation-
it ate</w>
it able</w>
it abine</w>
it :</w>
it -drug</w>
it ).</w>
isth mal</w>
ister one-ethinyl</w>
ist radefylline)</w>
ist 's</w>
issu es:</w>
issu es.</w>
isoxsup rine.</w>
isoxazol-5- yl]tropane</w>
isoxazol e
isoxazole propionic</w>
isox az
isotretino in-induced</w>
isothiocyan ate</w>
isosorbide-5- mononitrate,</w>
isos thenuria</w>
isoquinol ines</w>
isopuleg ol,</w>
isoproterenol/ tilt-table</w>
isoproterenol- intoxicated</w>
isoproterenol- infused</w>
isoproterenol +
isoproterenol )-induced</w>
isoprost an
isoprostan es,</w>
isopropyl quinazolinones</w>
isopropyl -,</w>
isoniazid /kg</w>
isoniaz id-rifampin</w>
isoniaz id)</w>
ison itrile</w>
ison ar
isom er),</w>
isolectin- B
isolated- HIT;</w>
isolated- HIT.</w>
isol ation.</w>
isol ation,</w>
isol ating</w>
isoflurane- treated</w>
isoflurane- nitrous</w>
isoflurane ;</w>
isoflurane /
isoflurane ).</w>
isoflur ane)</w>
isoflur ance</w>
isoflav ones,</w>
isochrom atic</w>
isocarboxaz id</w>
isobutyl -1,2-diphenyl</w>
isobolog raph
iso-PGF(2 alpha)</w>
iso- osmolal</w>
iso- 6-
iso-6- cass
iso-6-cass ine</w>
iso zyme
iso thiocy
iso indole</w>
iso eth
isoeth ar
iso enzymes,</w>
iso enzyme.</w>
iso enzyme,</w>
iso electr
isoelectr ic.</w>
iso dium</w>
ism anal
isle ts.</w>
ishe d;</w>
ishe d:</w>
ish es,</w>
ischemic -
ischemic- reperfusion</w>
ischem ia-related</w>
is ur
is s,</w>
is otyp
is osmolar</w>
is or
is obutyric</w>
is m-
is land</w>
is ing,</w>
is ation.(ABSTRACT</w>
is ation,</w>
is ation)</w>
is al,</w>
is ;</w>
is -induced</w>
is ).</w>
is (N-methyl-
is(N-methyl- 4'-
is(N-methyl-4'- pyridyl)porphyrinato</w>
irrit ation)</w>
irrit ant.</w>
irrit ant,</w>
irrig ating</w>
irregular ity.</w>
irregular ity,</w>
irradi ation),</w>
irradi ated.</w>
iron- sulfur</w>
iron- deficiency</w>
iron- chelating</w>
iron -dependent</w>
iro ,</w>
irinotec an:</w>
irinotec an.</w>
irbes artan,</w>
ir reversibility</w>
ir reversib
ir resistible</w>
ir relevant</w>
ir regular,</w>
ir mer</w>
ir lukast
ir cling</w>
ipunct ure)</w>
ipsi laterally</w>
ipr indole</w>
ipec ac-treated</w>
ip sa
ip roniazid-induced</w>
ip onatremia</w>
ip ])</w>
ip ;</w>
ip -
ip- His-
ip-His- Leu</w>
ip )-induced</w>
ioxil an.</w>
iox agl
iopent ol</w>
iop ronin</w>
iontophore sis.</w>
iontophore sis,</w>
ion- channel</w>
ion izing</w>
ion it</w>
ion )</w>
iohex al</w>
iodo- 8-
iodo-8- hydroxyquinol
iodo-8-hydroxyquinol ine)</w>
iodo l</w>
iodo deoxyuridine</w>
iodixan ol.</w>
iodixan ol)</w>
iodine-125- labeled</w>
iodine -123</w>
iodi de.</w>
iodi de-
iodide- osmium</w>
iod ine/kg</w>
iod ine.</w>
io- alveolar</w>
io s</w>
io resal)</w>
io logic</w>
involved- nodal-field</w>
involved- field</w>
involve ments,</w>
involve ment
involve d:</w>
involun t
invol ve,</w>
invol v
investigator-bl inded</w>
investig ative</w>
investig ation
inver sions</w>
inver sion,</w>
inver se"</w>
inv entor
inv agin
inv aded</w>
intub ation;</w>
intub ated),</w>
intromis sive</w>
intric ate</w>
intravenous ly;</w>
intravenous ly-
intrathec ally-
intrathec al,</w>
intrat ympan
intrat umoral</w>
intras plenic</w>
intras eptal</w>
intraperitoneall y/
intraperitone al)-induced</w>
intraperitone al),</w>
intrap refrontal</w>
intranigr al,</w>
intrane urally</w>
intranas ally;</w>
intranas ally.</w>
intranas ally,</w>
intramy ometrial</w>
intralip id</w>
intral obar</w>
intrad uoden
intracor tically</w>
intracor tically.</w>
intracor poral</w>
intracister nally.</w>
intracister nal)</w>
intracerebroventric ular,</w>
intracell ularly,</w>
intrac ut
intrac rine</w>
intrac lass</w>
intra- peritoneally</w>
intra- peritoneal</w>
intra- patient</w>
intra- oral</w>
intra- ocular</w>
intra- day,</w>
intra- cranial</w>
intra- cellular</w>
intra- arteri
intra-arteri ally,</w>
intra- alveolar</w>
intra- LC</w>
intra- Hisian</w>
intra vertebral</w>
intra vascularly</w>
intra vaginally.</w>
intra ureteral</w>
intra thalamic</w>
intra ren
intra perit
intra orbital</w>
intra joint</w>
intra articular</w>
intra alveolar</w>
intr usive</w>
intr usions</w>
intr abil
intrabil i
intrabili ary</w>
intoxic ation;</w>
intoxic ating</w>
intoler ant/
intolerant/ allergic</w>
intoler able.</w>
intim al-
inti ma-media</w>
intest ine:</w>
interview s,</w>
interven e</w>
interrupt s</w>
interru ptions</w>
interpre ted,</w>
interpre tations</w>
interpre t
interpol ation</w>
internal ization,</w>
intern ists,</w>
intern a,</w>
intermediate- grade</w>
intermediate- ,</w>
intermedi ates.</w>
intermedi ates,</w>
interleukin-1 beta.</w>
interleukin- 6.</w>
interleukin- 3</w>
interferon/ ribavirin.</w>
interferon- ribavirin</w>
interferon- alpha-
interferon-alpha- 2B</w>
interfer ons</w>
interfer on-associated</w>
interest s.</w>
interdigit ations</w>
interaction s--also</w>
interac tions;</w>
interac e
interace ae).</w>
inter- systolic</w>
inter- person</w>
inter- peak</w>
inter- hospital</w>
inter trochanteric</w>
inter trial</w>
inter study</w>
inter space</w>
inter space.</w>
inter scapular</w>
inter rater</w>
inter pulse</w>
inter pedicel</w>
inter osseous</w>
inter neurons;</w>
inter neuron
inter net</w>
inter nally</w>
inter na</w>
inter na)</w>
inter myocyte</w>
inter molecular</w>
inter mingled</w>
inter lobar</w>
inter correlations</w>
inter connections</w>
inter chang
inter cept</w>
inter -dose</w>
intention-to- treat.</w>
intention-to- treat,</w>
intensit y/
intensit y).</w>
intensifi es</w>
intensi ve-care</w>
intensi ties,</w>
inten sively</w>
inten se.</w>
intellect .</w>
integr ity,</w>
integr ins.</w>
integr in.</w>
integr ation.</w>
integr ation,</w>
integ rating</w>
intake :</w>
intake ).</w>
intake ),</w>
insulin/ glucose</w>
insulin- syringe</w>
insulin- sensitizing</w>
insulin- group</w>
insul in:
insulin: glucose</w>
insul in-treated</w>
insul a.</w>
insuffici ent,</w>
insuff lating</w>
instrument ation.</w>
instrum ents,</w>
instruc tions.</w>
instruc tion</w>
instruc ting</w>
institut ed,</w>
instant aneously</w>
instanc es;</w>
install ation</w>
inst ant</w>
inst ance.</w>
inspir ation,</w>
inspi red
insp ected</w>
insomn iac</w>
insomn ia;</w>
inser tion;</w>
ins >
ins> del
ins>del ,</w>
inqui ries</w>
inpyraz one</w>
input s,</w>
input ,</w>
inoc ul
ino varus.</w>
ino therapy.</w>
ino pathy,</w>
ino ides</w>
ino atrial</w>
ino a</w>
innerv ates</w>
innerv ated)</w>
inner most</w>
inn ati
innati /
innati/ Northern</w>
injur y-</w>
injur y).</w>
injur ies;</w>
injur ied</w>
inject ors</w>
inj ured,</w>
inj ect</w>
initiation- promotion</w>
initiation- promotion-progression</w>
initi ative</w>
initi al,</w>
ini um,</w>
ini .</w>
inhomogene ity</w>
inhibitors -induced</w>
inhibitor s).</w>
inhibitor -1</w>
inhibit ,</w>
inhibi tion).</w>
inhibi tion),</w>
inherit ance,</w>
inhal ers.</w>
inhal ed,</w>
inhal ations</w>
inhabit ants.</w>
ingu ishing</w>
ingredi ents.</w>
ingest ed,</w>
ingest ants</w>
inges tion:</w>
inger- West
inger-West phal</w>
ing/ pruritus</w>
ing/ licking</w>
ing/ Dre
ing/Dre w</w>
ing- water</w>
ing- frequency</w>
ing- down</w>
ing- dosed</w>
ing- current</w>
ing s.(ABSTRACT</w>
ing s).</w>
ing est</w>
ing '</w>
infusion- produced</w>
infusion- dosed</w>
infusion .(ABSTRACT</w>
infrequ ent:</w>
infrequ ency</w>
infra hisian</w>
influence d.</w>
influence d,</w>
influ x,</w>
inflexi bility</w>
inflammat ory.</w>
infin ity)</w>
infin ity
inferen ce,</w>
infer tile</w>
infection s:</w>
infection -related</w>
infec tion)</w>
infarct- like"</w>
infarct- avid</w>
infarc ts,</w>
inf ratentorial</w>
inf raclavicular</w>
inf lating</w>
inf ero
inf ecti
infecti ous,</w>
inf anti
inf ancy
infancy -only</w>
inf -
inf- DXR.</w>
inex orable</w>
inevit ably</w>
ineth olate</w>
inester as
inesteras emia</w>
iness "</w>
ines s)</w>
ineff icient</w>
ineff ective
ine/ tripelennamine</w>
ine/ propofol/mixtures</w>
ine/ hydroxychloroquine</w>
ine. HCl</w>
ine-3- carboxylic</w>
ine-- an</w>
ine- tricyclic</w>
ine- to-
ine- soaked</w>
ine- mediated</w>
ine- injected</w>
ine- exposed</w>
ine- exacerbated</w>
ine- elicited</w>
ine- docetaxel</w>
ine- dihydrochloride</w>
ine- derived</w>
ine- depleted</w>
ine- converting</w>
ine- conjugated</w>
ine- aspartate</w>
ine- and</w>
ine- MK801</w>
ine- 6-
ine valuable</w>
ine t</w>
ine ous</w>
ine mia)</w>
ine like</w>
ine R</w>
ine )-mediated</w>
industr y-
induci ble
induc tive</w>
induc tion)</w>
induc ers.</w>
induc ers,</w>
induc er,</w>
indu ed</w>
indomethacin- exposed</w>
indomethac in).</w>
indomethac in),</w>
indomet acin-induced</w>
indomet acin,</w>
indole acetamides</w>
indol e)</w>
individual s;</w>
individual izing</w>
individual ized.</w>
indistinguish able,</w>
indinavir/ ritonavir-containing</w>
indinavir )</w>
indiges tion,</w>
indic ence</w>
indic ed</w>
indic ator-
indicator- dilution</w>
indic ator,</w>
indic ation).</w>
index- AI
independ ently,</w>
indap amide-induced</w>
ind us</w>
ind oxyl</w>
ind ole.</w>
ind ol-3-
ind an
indan amine,</w>
ind )</w>
increased ",</w>
increas ing;</w>
increas e
increase >500</w>
incre ments.</w>
incre ment.</w>
incorpor ation,</w>
incorpor ation),</w>
inconveni ence,</w>
incontin ence:</w>
inco herent</w>
include d;</w>
inclu sive</w>
incident ally,</w>
incid ents.</w>
incid ences,</w>
incid ence),</w>
incer ta.</w>
incarc erated</w>
incap able</w>
inc reta</w>
inase- like</w>
in/ eb
in/eb selen-treated</w>
in/ G
in/G HS-
in/GHS- R</w>
in-of- Four</w>
in-2- yl)
in-2- ones</w>
in-1- yl)
in-1 4-
in-14- valerate</w>
in- specific</w>
in- person</w>
in- losing</w>
in- hospital,</w>
in- gemfibrozil</w>
in- fed</w>
in- d
in-d alfop
in-dalfop ristin</w>
in- coated</w>
in- class</w>
in- Po
in-Po ong</w>
in- 7-
in- -
in visible</w>
in vest
in uria)</w>
in um-based</w>
in ulin,</w>
in ul
in to,</w>
in ter</w>
in sudative</w>
in su
in spection.</w>
in sensitivity,</w>
in sensitive.</w>
in patient,</w>
in ordinately</w>
in omas</w>
in oma</w>
in ol.</w>
in o-
in nom
in line</w>
in ized</w>
in ism,</w>
in ins</w>
in ine-aspartate</w>
in gency</w>
in enucle
inenucle otide</w>
in dur
indur ated</w>
in digestion</w>
in der</w>
in dependent)</w>
in dependence</w>
in convenience</w>
in conspicuous</w>
in consol
inconsol able</w>
in congru
in complete,</w>
in competent</w>
in coming</w>
in appropriate.</w>
in app
inapp et
in adequate,</w>
in activity</w>
in activation.</w>
in a,</w>
in .(ABSTRACT</w>
in -1,</w>
in +
imy osarcoma</w>
impulsi vity.</w>
impul se-control</w>
improvement /
improve ments.</w>
improve ments,</w>
improve d)</w>
improve d'</w>
impres sively</w>
impres sions</w>
impregn ation,</w>
implement ed,</w>
implant s)</w>
implant ation:</w>
implant -
implan ted,</w>
imperfor ate</w>
imped ance-
impedance- cardiography</w>
impairment/ amnesia</w>
impairment ;</w>
impairment )</w>
imp acts.</w>
imp act.</w>
immunosuppress ants.</w>
immunosuppress ants,</w>
immunosuppres sion;</w>
immunostain ing.</w>
immunostain ing,</w>
immunostain ing)</w>
immunostain ing),</w>
immunos u
immunolab eled</w>
immunoglobul in.</w>
immunoglobul in,</w>
immunocyt oma-bearing</w>
immunocyt ochemistry.</w>
immunoblot ting.</w>
immuno- suppressive</w>
immuno therapy:</w>
immuno hematologic</w>
immuno fluoro
immuno electrophoresis,</w>
immuno assays.</w>
immuno analysis</w>
immuno active</w>
immune- hematopoietic</w>
immun oprevalence</w>
immun opositivity</w>
immun ophil
immun opathology</w>
immun opathological</w>
immun oneutr
immun obullous</w>
immun o</w>
immun ization.</w>
immobil izing</w>
immobil isation</w>
immobil isation.</w>
immer sions</w>
immer sion,</w>
immediate- early</w>
immedi ate,</w>
imipr amine;</w>
imipr amine-treated</w>
imipr amine-</w>
imipenem/ cilastatin.</w>
imipenem- cilastatin,</w>
imipenem -induced</w>
imipen em.</w>
imino ]
imidazol e.</w>
imidazol e-based</w>
imbal ances,</w>
imatinib -induced</w>
im ura's</w>
im s</w>
im put
im potency</w>
im posed.</w>
im ported</w>
im port</w>
im perative.</w>
im part</w>
im par
im onabant)</w>
im mitis-infected</w>
im min
im ia,</w>
im azole-dependent</w>
im age,</w>
im achalol</w>
im )</w>
iltr ation.</w>
ilo prost,</w>
illu min
illo metric</w>
illness -induced</w>
illic it-drug</w>
illede ma</w>
ill s,</w>
ill ance,</w>
ilic ifolia</w>
iliac us</w>
ile us,</w>
ile um,</w>
ile t</w>
ile ostomy</w>
ile ostomy.</w>
il- resistant</w>
il- lovastatin</w>
il lip</w>
il legally</w>
il le,</w>
il iter
il in</w>
il ib
il er</w>
il c
ilc oxon</w>
il an</w>
il aire</w>
ig al
igal i,</w>
ifosfamide/ mesna.</w>
ifosfamide -associated</w>
ifosfamide -</w>
ifosfamide -
if ron
if lun
if ithrin-alpha</w>
if id
if ene-induced</w>
if e</w>
idopa .</w>
idiosyncrati cally</w>
idiosyncrati c)</w>
idiosyncras y,</w>
idine- di
idine-di gluconate</w>
idine- 6-(N-
idi zed</w>
idi otypic</w>
identifi er:</w>
identif y.</w>
identic al-
identical- appearing</w>
identi ties</w>
identi fication.</w>
iden tically.</w>
ide/ triamterene</w>
ide- hydrochlorothiazide</w>
ide- ethanol</w>
ide mia</w>
ide -related</w>
ide 's</w>
idazol e,</w>
id- pretreated</w>
id- osmotic</w>
id- inducible</w>
id ines</w>
id ene)</w>
id die</w>
id arubicin.</w>
id aceae)</w>
id able</w>
id a's</w>
icul um</w>
icul i</w>
icter ic"</w>
icro scopy.</w>
icos a
icosa (5E-9,11,13
icosa(5E-9,11,13 Z
icosa(5E-9,11,13Z )
icosa(5E-9,11,13Z) tetraenoic</w>
iclospor in</w>
ici encies</w>
ichthyo siform</w>
ically- defined</w>
icalcit ol-treated</w>
ical ein</w>
ical ."</w>
ical '</w>
ic/ thromboembolic</w>
ic/ systolic</w>
ic- inotropic</w>
ic- histologic</w>
ic- dopaminergic</w>
ic- astatic</w>
ic- acid</w>
ic tus</w>
ic to
ic tal-like</w>
ic s)</w>
ic ourea</w>
ic lid
ic it</w>
ic in)</w>
ic h,</w>
ic e,</w>
ic e,"</w>
ic ally),</w>
ic al.</w>
ic -dependent</w>
ic -associated</w>
iberi otox
ib wezi,</w>
ib oten
ib li
ia/ reperfusion</w>
ia/ hypotension,</w>
ia/ New</w>
ia- pertussis-tetanus</w>
ia- myalgia</w>
ia- inducing</w>
ia- Carlo</w>
ia 's</w>
ia '.</w>
ia '
ia' -like</w>
ia "</w>
i.v ,</w>
i.t. ]</w>
i.pl .)</w>
i.p. )-</w>
i.p ),</w>
i.c.v.- ouabain-treated</w>
i. v</w>
i. s.,</w>
i. p</w>
i. h
i.h -1/
i.h-1/ mg</w>
i. g.</w>
i- loaded</w>
i- butyl
i us,</w>
i um
i obitridol,</w>
i leu
i es
i ers</w>
i ans</w>
i ang
i als</w>
i ally,</w>
i U
iU P)</w>
i NOS)</w>
i ;</w>
i 1</w>
hyth mias</w>
hysterosalping ography.</w>
hystere sis).</w>
hyster ical</w>
hyste rectomy,</w>
hyste rectom
hypoxia- reoxygenation</w>
hypoxanth ine.</w>
hypox ia
hypovol aemic</w>
hypovol aem
hypouric emia,</w>
hypoton icity</w>
hypoton ia.</w>
hypothesi zed,</w>
hypothesi se</w>
hypothesi s:</w>
hypothesi s-generating</w>
hypothe tically</w>
hypothe tic.</w>
hypothalamus- zona</w>
hypothalamo- pituitary-adrenocortical</w>
hypothalamo- pituitary-adrenal</w>
hypothalamic- pituitary</w>
hypothalamic- pituitary-adrenocortical</w>
hypothalam ic,</w>
hypothalam i</w>
hypotension- prone</w>
hypotension- bradycardia</w>
hypotension /
hypotension .(ABSTRACT</w>
hypotension -related</w>
hypotension -mediated</w>
hypotension ),</w>
hypoten sion-induced</w>
hypospadi as,</w>
hypos thenuria</w>
hypoprote inemia.</w>
hypophysi tis</w>
hypophosphat aemia,</w>
hypop otassemia</w>
hyponat remia:</w>
hypomania/ mania.</w>
hypokine tic,</w>
hypokine sis,</w>
hypokalem ic.</w>
hypokalem ic,</w>
hypokalem ia)</w>
hypoinsul inemia</w>
hypogonadis m.</w>
hypogly corrhachia</w>
hypofibrinogen emia</w>
hypofibrinogen emia,</w>
hypoesthe sia.</w>
hypochol inesterasemia</w>
hypocapn ia/hypotension,</w>
hypocap nia,</w>
hypocal orie</w>
hypoc ellular
hypocellular ity</w>
hypoalgesi a,</w>
hypoalbumin aemia</w>
hypoalbumin aemia,</w>
hypoalbum inemia;</w>
hypo responsiveness</w>
hypo reflexia</w>
hypo pharynx,</w>
hypo phagia</w>
hypo osmolality,</w>
hypo locomotion.</w>
hypo intensity</w>
hypo gonadal</w>
hypo glossal</w>
hypo geusia</w>
hypo esthesia</w>
hypo dense</w>
hypo baric</w>
hypo activation</w>
hypno tics:</w>
hypno tics.</w>
hypno sis.</w>
hypno pompic</w>
hypno l</w>
hypervol emia</w>
hyperuric aemia,</w>
hypertrophy ).</w>
hypertroph ic,</w>
hypertriglyceride mic</w>
hypertriglyceride mia.</w>
hypertriglycerid aemia,</w>
hyperton icity</w>
hypertension ?</w>
hypertension +
hyperten tion</w>
hyperten sion-
hypersomn ia.</w>
hypersensitivity- type</w>
hypersensitivity- mediated</w>
hypersensitiv ity:</w>
hypersensitiv ity
hyperpyrex ial</w>
hyperplasi as,</w>
hyperplasi a/
hyperplasia/ dysplasia</w>
hyperplasi a)</w>
hyperplasi a),</w>
hyperphosphat aemia</w>
hyperparathyroidis m:</w>
hyperp nea,</w>
hyperlipoprote inemia,</w>
hyperlipide mia;</w>
hyperlipide mia)</w>
hyperlactat emia,</w>
hyperkal emia:</w>
hyperkal aemic</w>
hyperinsul inism</w>
hyperinsul inemic,</w>
hyperinsul inemia.</w>
hyperhomocyste inemia,</w>
hyperglyce mia-induced</w>
hypergly caemia,</w>
hypergammaglobul inaemia</w>
hypergammaglobul inaemia,</w>
hyperexcit able,</w>
hyperestrogen ism</w>
hyperestrogen emia.</w>
hyperem ia;</w>
hyperem ia:</w>
hyperem ia)</w>
hypere choic</w>
hypere ch
hypercortisol ism</w>
hypercortisol ism,</w>
hypercoagul ability</w>
hypercoagul ability.</w>
hypercoagul abil
hypercoagulabil ity"</w>
hypercap n
hypercalce mias</w>
hypercal caemia,</w>
hyperbilirub inemia.</w>
hyperandrogen ism,</w>
hyperalim entation</w>
hyperalgesi a),</w>
hyperalgesi a")</w>
hyperaldosteron ism.</w>
hyperal gic</w>
hyperal esia</w>
hyperadrenocortic ism</w>
hyperadrenocortic ism.</w>
hyper- vitaminosis</w>
hyper- CVAD</w>
hyper ventilated</w>
hyper thyroidis
hyper telor
hyper stimulation</w>
hyper splen
hyper somnolent</w>
hyper somnia</w>
hyper secretion.</w>
hyper salivation</w>
hyper salivation.</w>
hyper responsiveness.</w>
hyper pathia.</w>
hyper parathyroid</w>
hyper osmolality.</w>
hyper nociception</w>
hyper mineralocorticoid</w>
hyper methylation</w>
hyper intensity.</w>
hyper immune</w>
hyper gastr
hypergastr inemia</w>
hyper dense</w>
hyper contractility</w>
hyper coagulopathy.</w>
hyper chrom
hyper cholinergic</w>
hyper chlo
hyperchlo remic</w>
hyper cellularity,</w>
hyper cellular</w>
hyper carb
hyper aggression</w>
hyper aggression,</w>
hyper aemia.</w>
hyper activity;</w>
hyp oxic-ischemic</w>
hyp ometabolism</w>
hyp ocontrac
hyp ochromic</w>
hyp ochond
hyp o</w>
hyosc ine.</w>
hygi ene</w>
hygi ene,</w>
hydroxyure a-induced</w>
hydroxyquinol ines:</w>
hydroxyn or
hydroxyn al
hydroxynal idixic</w>
hydroxylase- like</w>
hydroxyl upanine-2-pyrrolcarbonic</w>
hydroxyl ase-positive</w>
hydroxyl amino-
hydroxylamino- 5-ethyl-5-
hydroxyl amino
hydroxyl amine-induced</w>
hydroxyl )</w>
hydroxyethyl starch</w>
hydroxyeicosa- (5,
hydroxyc oumar
hydroxyapati te</w>
hydroxy-3- methyl-1-phenyl-
hydroxy-3- allyl
hydroxy-3-allyl -1-phenyl-
hydroxy-3-allyl-1-phenyl- 2,3,4,5-tetrahydro-1H-3-benz
hydroxy- methyl-glutaryl-coenzyme</w>
hydroxy toluene.</w>
hydroxy steroid</w>
hydroxy saclofen</w>
hydroxy naphtho
hydroxy metoprolol</w>
hydroxy chloroquine.</w>
hydroxy chloroquine,</w>
hydroxy carbamide</w>
hydroxy -1,1-
hydroxy-1,1- diphosphonate</w>
hydroly zable</w>
hydroly tic</w>
hydroly sis.</w>
hydroly sing</w>
hydrolas e,</w>
hydrocod one/acetaminophen</w>
hydrochlorothiaz ide/triamterene</w>
hydrochlorothiaz ide)</w>
hydro thorax</w>
hydro static</w>
hydro soluble</w>
hydro quinone</w>
hydro phobic</w>
hydro phil
hydro peroxides,</w>
hydro osmotic</w>
hydro gen
hydro chlorofluorocarbons</w>
hydralaz ine-treated</w>
hydra zine,</w>
hydr ation-
hyd ride</w>
hyd rate,</w>
hybridis ation</w>
hybri ds.</w>
hybri ds,</w>
hyaluron an</w>
hyalin ized</w>
hyal uronic</w>
hyal uronate</w>
hyal inosis,</w>
hy postenuria,</w>
hy ph
hy odeoxycholic</w>
hy alin</w>
hus band</w>
hur ts</w>
hur t</w>
hun gr
human- equivalent</w>
human- cit
human-cit rated</w>
human s;</w>
human ized</w>
human itarian</w>
hum idity</w>
hum idity,</w>
ht 7</w>
ht 7
ht7 ?
ht7? ),</w>
hr s)</w>
hr s).</w>
hr inger</w>
hr an</w>
hr .
hr );</w>
hr (-1);</w>
hp f</w>
hp f.</w>
hour/ patient</w>
hour s:</w>
hour s'</w>
hour ;</w>
hour -old</w>
hour -
hour ),</w>
hour 's</w>
hot- plate,</w>
hot pl
host s.</w>
host s,</w>
hospitalis ations</w>
hospital izations,</w>
hospital ization;</w>
hospital ization).</w>
hospital ;</w>
hospital :</w>
hos tility,</w>
hormon otherapy</w>
hormon e:</w>
horizont ally</w>
hor ts</w>
hor ses,</w>
hor se.</w>
hor se,</w>
hor ns</w>
hor ns.</w>
hop ed</w>
homozygot es,</w>
homovan ilic</w>
homota urine</w>
homolog u
homoiother ms</w>
homogene ity).</w>
homogen ates)</w>
homogen ate,</w>
home- use</w>
home opathic</w>
home ;</w>
hom opiperazinyl)benzimidazole</w>
hom onymous</w>
hom ology</w>
hom olog</w>
hom olateral</w>
hom ocystine</w>
hom ic
hom e-like</w>
hom e-based</w>
hom atropine</w>
holid ay</w>
holid ay.</w>
holid ay
hol ter</w>
hodgkin sine</w>
hob nail</w>
ho vah's</w>
ho rea</w>
ho phyton</w>
ho arding,</w>
hn RNA</w>
hloro dibenzo-p-dioxin</w>
histor ical,</w>
histopath ologically.</w>
histo autoradi
histoautoradi ographical</w>
histamine- receptor</w>
histamine- mediated</w>
hist oly
hist ographic</w>
hist amines</w>
hist amine)</w>
his tidine,</w>
hirsu tism,</w>
hippocampi ,</w>
hippocampal- dependent</w>
hippocampal- dentate</w>
hippocamp us;</w>
hindquarter s,</w>
hind- limb</w>
hind ers</w>
hin ia</w>
him bac
himbac ine</w>
him ,</w>
hil um</w>
higher- than-expected</w>
higher- order</w>
higher- level</w>
highe st.</w>
highe st,</w>
high- tone</w>
high- sensitivity</w>
high- magnesium</w>
high- loading</w>
high- frequency,</w>
high- efficiency</w>
high- doses</w>
high- cholesterol</w>
high- amplitude,</w>
high- activity</w>
high ly.</w>
high ;</w>
high :</w>
hierarch y</w>
hiccup s;</w>
hiccup s:</w>
hi p,</w>
hi k
hexyloxy )-
hexyloxy)- 6-
hexyloxy)-6- methoxy-4-methylquinoline</w>
hexos amine</w>
hexane- 2,6-
hexamethyl melamine,</w>
hexameth onium)</w>
hexachloro phene-induced</w>
hexachloro phene,</w>
hexachloro -1:
hexachloro-1: 3-but
hexachloro-1:3-but adi
hexachloro-1:3-butadi ene</w>
hexachlor ide)</w>
hex ylcarbamoyl-5-fluorouracil</w>
hex yl
hex ose</w>
hex idine-digluconate</w>
hex estrol</w>
hex af
hexaf luor
hev in</w>
heterozyg osity,</w>
heterogene ously</w>
hetero sexual</w>
hetero receptors</w>
heter otrimeric</w>
heter otopi
heter osis</w>
heter ologously</w>
heter ologous</w>
heter ogenously</w>
heter odi
heter ochrom
herpetiform is</w>
herpes virus</w>
heroin- addicted</w>
hero ine</w>
hero in-related</w>
hero in-associated</w>
herni ation.</w>
herni ation,</w>
here by</w>
here after</w>
herb omineral</w>
herb als,</w>
herb ,</w>
her mitte's</w>
heptano in</w>
hepatotoxic ity;</w>
hepatotoxic ity:</w>
hepatotoxic ,</w>
hepatotox in.</w>
hepatotox in)</w>
hepatoc analicular</w>
hepato -</w>
hepatitis -B</w>
hepat otumori
hepat otropic</w>
hepat opulmonary</w>
hepat opathy.</w>
hepat onephro
hepat omas.</w>
hepat ology</w>
hepat olith
hepat ocyte.</w>
hepat o-
hepat ectomized</w>
hepat ectom
heparin- reactive</w>
heparin- mediated</w>
heparin- independent</w>
heparin- dihydro-
heparin-dihydro- ergotamine</w>
heparin oid,</w>
heparin ]</w>
heparan ase,</w>
hepar itinase</w>
hepar inotherapy.</w>
hepar in;</w>
hepar in/platelet</w>
hepar in-based</w>
hen oid</w>
hemosider in-positive</w>
hemorrhag ic/thromboembolic</w>
hemorrhag ic.</w>
hemophiliac s.</w>
hemophil ia.</w>
hemophil ia,</w>
hemoglob inuria)</w>
hemodynam ically.</w>
hemodilu tion.</w>
hemodilu tion-
hemodialy sis:</w>
hemodialy sis-induced</w>
hemodialy sed</w>
hemodiaf iltration.</w>
hemoconcentr ation</w>
hemo phagocytic</w>
hemo peritoneum</w>
hemo grams</w>
hemo filtration</w>
hemo diluted</w>
hemisphere )</w>
hemis ensory</w>
hemip leg
hemic horea</w>
hemi hydrate</w>
hemi arthroplasty</w>
heme- L-arginate</w>
hematologic al:</w>
hematologic ;</w>
hematologic .</w>
hematologic )</w>
hematoc he
hematoche zia</w>
hemat oporphyrin</w>
hemat opathology</w>
hemat oma)</w>
hemat om
hemangi osarcoma</w>
hemangi omatosis.</w>
hem otoxic</w>
hem opoiesis</w>
hem oly
hem lock),</w>
hem ime
hem il
helpl essness</w>
heli otrope</w>
hel d.</w>
heigh ten</w>
heigh t)</w>
heavi est</w>
heav iness</w>
heat- labile</w>
heat ing,</w>
heat ;</w>
heart ;</w>
hear tworm</w>
hear d</w>
health food</w>
health -related</w>
heal ed.</w>
heal ed,</w>
head- turning</w>
head- injured</w>
head ings</w>
head ")</w>
he ster</w>
he ren
he pcid
he min.</w>
he m</w>
he el
he als</w>
he -
he (1)
he(1) ]
haz y</w>
hass les,</w>
harml ess.</w>
harmful ,</w>
harmal ine-</w>
harb inger</w>
har ms.</w>
har ms,</w>
har mon
har m,</w>
haptoglob in,</w>
happ iness</w>
handling -related</w>
handic apped.</w>
handic ap</w>
hand writing</w>
hand le</w>
hand held</w>
hand gri
han g</w>
hamster .</w>
ham mer</w>
halothane- related</w>
halothane- epinephrine-induced</w>
halothane- based</w>
halothane- anesthetized,</w>
halothane ;</w>
haloperidol+ vehicle</w>
haloperidol+ idazoxan</w>
haloalk ane</w>
halo gen</w>
hallucin ations)</w>
halluc inosis,</w>
half-li ves.</w>
half- yr-old</w>
half- maximum</w>
half- hour</w>
half- disappearance</w>
half -dose</w>
half ).</w>
hal t</w>
hal er)</w>
hair s.</w>
hair .</w>
haemorrh ag
haemoglob inuria</w>
haemo siderosis</w>
haemo philus</w>
haemo philia</w>
haematob ium</w>
haemat omas</w>
haemat omas.</w>
haem opoiesis</w>
haem oconcentr
haem ate
haemate mesis</w>
haem angi
haemangi omas,</w>
habit uating</w>
haben ula,</w>
ha ze</w>
ha wthorn</w>
hG RE
hGRE .
hGRE. MMP1</w>
h/ mg</w>
h.p. f
h ttp://clinicaltrials.gov</w>
h s).</w>
h s
h ousehold</w>
h oleboard,</w>
h noiditis</w>
h its.</w>
h inge</w>
h en.</w>
h ash
h ang
h all</w>
h V
hV DR/
hVDR/ h
hVDR/h R
hVDR/hR XR</w>
h PF4/heparin</w>
h PA
h GH</w>
h ER
hER G-
h CG,</w>
h B
h -1;</w>
h (-1),</w>
gyr us:</w>
gynecomasti a,</w>
gynec ologist's</w>
gynaec omastia</w>
gy rata.</w>
guy an
guyan ensis</w>
gut tae</w>
gut .</w>
gun -treated</w>
guide wire</w>
guid ance.</w>
guar ana</w>
guanoxabenz -induced</w>
guanosine- 5'-
guanfac ine,</w>
growth- inhibitory</w>
growth- inhibited</w>
growth ).</w>
grow ,</w>
group 2</w>
group --a</w>
group ',</w>
groom ing)</w>
grommet ,</w>
gro unds,</w>
griseofulv in-induced</w>
griseofulv in,</w>
gri d.</w>
gri d)</w>
grepa floxacin,</w>
gray- scale</w>
gravi metry)</w>
gravi metric</w>
grati fying</w>
graph s</w>
graph ics,</w>
graph ,</w>
granulocyte- colony</w>
granulocy te
granulo poiesis</w>
granulo mas,</w>
granul e-
granule- cell-specific</w>
granul ated,</w>
grani setron.</w>
grandi ose</w>
grandi florum</w>
gran zyme
gran d-
grand- mal</w>
gram ;</w>
graft- vs-host</w>
graf t,</w>
graf t)</w>
gradi ents.</w>
gradi ent,</w>
grad ing,</w>
grad ation</w>
grac ile</w>
gra y,</w>
gra in</w>
gra ded.</w>
gr astim</w>
gr /dl.</w>
gp 130</w>
gover ned</w>
gover n</w>
good ;</w>
good '</w>
gonadotroph ins</w>
gonadotrop ins.</w>
gonadotrop in.</w>
gold- standard</w>
gold- salt</w>
gold thioglucose.</w>
gol d,</w>
goit er</w>
goit er.</w>
godi pine-induced</w>
go- go</w>
go ides</w>
go ats</w>
go at</w>
go als.</w>
go /
gnaw ing.</w>
gm/ M2</w>
gm /kg</w>
gm /d
glycyr rhetic</w>
glycyl glycine</w>
glycyl glycin
glycylglycin anilide</w>
glycosaminoglyc an-
glycosaminoglycan- degrading</w>
glycopyr ron
glycogen olysis.</w>
glycogen .</w>
glycoferol- water</w>
glyco side-
glyco protein.</w>
glycer ol.</w>
glycer ol-treated</w>
glycer ol,</w>
glycer ide</w>
glyce mia,</w>
glyc opeptide</w>
glyc opepti
glyc olate</w>
glyc inergic</w>
glyc ated</w>
glyc an,</w>
gly caemia</w>
glutathione-S- transferases</w>
glutathione-S- transferase,</w>
glutathione- s-transferase,</w>
glutathione- reduced</w>
glutathi one)</w>
glutathi on</w>
glutar imide</w>
glutar im
glutamat erg
glutamaterg ic-</w>
glutam yltransferase</w>
glutam ate-</w>
glutam ate
glutamate -1-
glucose-6- phosphatase</w>
glucosaminid ase)</w>
glucopri vic</w>
glucocorticoid -treated</w>
glucocortico steroids</w>
glucagon -like</w>
gluc uronic</w>
gluc ogen,</w>
gluc aric</w>
glu thatione</w>
glot tic</w>
glomerulonephro pathy</w>
glomerulonephro pathy.</w>
glomerulonephri tis:</w>
glomerul us).</w>
glomerul es</w>
glomer ulopathy,</w>
globul in:</w>
globul es</w>
glo be</w>
glioblast omas.</w>
glicl azide,</w>
gli me
gli a.</w>
glauc oma:</w>
glab ra,</w>
gl c)</w>
gl ati
glati ramer</w>
gl ans</w>
gl afen
glafen in</w>
given --
ginsen oside</w>
giddin ess.</w>
giardi asis</w>
gi gas</w>
gi g
gig ant
ghrel in/GHS-R</w>
gh t.</w>
gh ,</w>
geu sia,</w>
get fulness</w>
get ari
getari ans</w>
gestod ene.</w>
gestod ene)</w>
gest ation).</w>
geranyl geran
geranylgeran iol</w>
ger opsychiatric</w>
geot axis,</w>
gentamic in).</w>
gentamic in),</w>
gentamic in
genotype -
genotyp ically</w>
genit or</w>
genit alia</w>
general ized.</w>
general izability.</w>
gener ic,</w>
gener ator</w>
gener ated:</w>
gene- environment</w>
gene tically-
gene tic
gender -,</w>
gender -
gen ol</w>
gen ip
gen in</w>
gen ,</w>
geme prost.</w>
gemcitabine/ vinorelbine</w>
gemcitabine/ docetaxel</w>
gemcitabine- vinorelbine</w>
gelatin olytic</w>
gelat ine</w>
gelat inase-like</w>
gel s</w>
gel :</w>
gel -
gel- filtration</w>
gefit inib.</w>
gefit inib-induced</w>
ge usi
ge ometry,</w>
ge al,</w>
ge 's</w>
gav age-
gavage- fed</w>
gav age)</w>
gav age).</w>
gastrointestin al.</w>
gastroenter ological</w>
gastrocnemi us-soleus</w>
gastro- intestinal,</w>
gastro paresis.</w>
gastro paresis,</w>
gastro duoden
gastr in-stimulated</w>
gast ritis.</w>
gas es;</w>
gas eous</w>
gas 6)</w>
garen oxacin</w>
gap "</w>
gangrenos um,</w>
gangren ous</w>
ganglion- blocked</w>
ganglion ectomy.</w>
gangli osides.</w>
gangli onectomy</w>
gangli on.</w>
gangli a;</w>
ganax olone,</w>
gamma-hydroxybut yrate,</w>
gamma-glutamyltranspeptid ase.</w>
gamma-glutamyl- transpeptidase</w>
gamma-glutamyl- transferase</w>
gamma-aminobut y
gamma-HC H.</w>
gamma-D-glutamyl aminomethyl
gamma-D-glutamylaminomethyl sulphonate</w>
gamma- vinyl-GABA</w>
gamma- linolenic</w>
gamma- hexachlorocyclohexane</w>
gamma- epithelial</w>
gamma- carboxyl
gamma- amino-
gamma-amino- butyr
gamma-amino-butyr ic-acid</w>
gamma- Amin
gamma-Amin obutyric</w>
gall bladder.</w>
galant amine.</w>
galan in,</w>
galactosid ase,</w>
galactos yl</w>
galactos yl-
gal locatethin-3-O-gallate</w>
gal enic</w>
gal ect
gal actitol</w>
gal a</w>
gal ).</w>
gain /
gain/ edema</w>
gain -of-
gain-of- function</w>
gadolinium- containing</w>
gabacul ine</w>
gabacul ine,</w>
gaba ergic,</w>
gab ergic</w>
ga ther</w>
g/m2/ week</w>
g/m2/ h</w>
g/m2/ day;</w>
g/m2/ day)</w>
g/m(2)/ day</w>
g/m (2)).</w>
g/d l),</w>
g/d L),</w>
g/d ),</w>
g/cm (2))</w>
g/ ml).</w>
g/ min,</w>
g/ liter.</w>
g/ kg.</w>
g/ hr,</w>
g/ h/rat</w>
g/ g</w>
g/ day);</w>
g/ day
g/ L.</w>
g/ L,</w>
g/ L).</w>
g-1. min-1)</w>
g- Tang</w>
g- Jun
g-Jun g-Tang</w>
g ym
g ums</w>
g ree</w>
g rating</w>
g r</w>
g ol</w>
g m).</w>
g l</w>
g inkgo</w>
g in-1</w>
g estrol</w>
g ent
g el,</w>
g ay</w>
g ating,</w>
g ases.</w>
g as-
gas- liquid</w>
g as,</w>
g agg
g ag
gag /
gag/ pol
g TX</w>
g A)</w>
g -onset</w>
g -1,</w>
g (2),</w>
g (1)</w>
fusi motor</w>
fus aric</w>
further s</w>
furosem ide)</w>
furosem ide),</w>
furo ate.</w>
furazolid one-induced</w>
furan-2- ylsulfonyl)
furan-2- yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thiones</w>
fura- 2</w>
fura- 2/
fura- 2.</w>
fur in,</w>
fung emia</w>
fund us,</w>
fund i</w>
function ally,</w>
function al-
function .(ABSTRACT</w>
function --
function ),</w>
function ",</w>
fun iculus</w>
fun goides</w>
fun gi
fun doscop
fulmin ant,</w>
full- scale</w>
full- length</w>
ful ly,</w>
ful l,</w>
ful );</w>
fucosid ase,</w>
fucoid an</w>
fru strated</w>
front ocortical</w>
front al-
from :</w>
frequency :</w>
frequency -related</w>
frequency -domain</w>
frequ ent;</w>
free- bas
free ze</w>
free dom
freedom ,</w>
free bas
fratax in.</w>
fratax in,</w>
fran kly</w>
frag il
fraction s/
fraction s)</w>
fraction ator</w>
fraction ation.</w>
fractalk ine-
fractalk ine,</w>
fract ured</w>
frac tioned</w>
fra xiparine</w>
fra k's</w>
fr utesc
fr ic
fourth- line</w>
four- year</w>
four- way,</w>
four- vessel</w>
four- grade</w>
four- drug</w>
four th.</w>
four th,</w>
foun d.(ABSTRACT</w>
fostriec in</w>
fos phenytoin,</w>
fos amprenavir</w>
forti fication</w>
forskol in.</w>
forni x.</w>
formular y.</w>
formul ations,</w>
formul ation)</w>
formul ated.</w>
formalin- inactivated</w>
formalin- ,</w>
form idable</w>
form er,</w>
form ationally</w>
form at</w>
form aldehyde-
formaldehyde- fixed</w>
form ;</w>
form ),</w>
form (s)</w>
forgot ten</w>
forgot ten
forelimb .</w>
fore stomach.</w>
fore stomach,</w>
fore stall</w>
fore ign
fore head</w>
fore brain-
force ful</w>
for war
for tuit
for th
for te,</w>
for med
for getfulness</w>
for cing</w>
for cep
foot shock-induced</w>
foot shock
food s,</w>
food -</w>
follow-up .(ABSTRACT</w>
follow- on</w>
follow- back</w>
follow up,</w>
follow s;</w>
follow ing,</w>
follow -</w>
follic le-stimulating</w>
foli ac
foliac eus.</w>
fol d:</w>
fol d
fol ate,</w>
foet uses.</w>
foci /cm2</w>
foci )</w>
foc us,</w>
foc ally-
focally- evoked</w>
fo regut</w>
fo il.</w>
fmol/ 100</w>
fluvox amine-induced</w>
flut ter:</w>
flut ter-fibrillation</w>
flus h.</w>
flus h,</w>
fluroth yl-induced</w>
fluroth yl,</w>
flupirt ine,</w>
flupentix ol</w>
fluparox an</w>
fluoxyme sterone</w>
fluoxetine- risperidone</w>
fluoxetine- intolerant</w>
fluoxet ine-associated</w>
fluoxet ine)</w>
fluoroquinol one-induced</w>
fluoroquinol one-associated</w>
fluoro scopy.</w>
fluoro scop
fluoro ribose</w>
fluoro phenyl)-4-(4-methylsulphonyl)</w>
fluoro deoxyglucose</w>
fluoro citrate,</w>
fluoro benzyl
fluorobenzyl idene)</w>
fluoro acetyl-
fluoroacetyl- adducted</w>
fluoro acetic</w>
fluoro acetate</w>
fluoro -2
fluoro-2 ',3'-
fluoresce in-labeled</w>
fluoresce in,</w>
fluoresc ence),</w>
fluor quinolones</w>
fluor o</w>
fluor ination</w>
flunitrazepam -</w>
flunitrazepam ).</w>
fluindi one.</w>
fluid :</w>
fluid :
fluid: plasma</w>
fludro cortisone.</w>
fludarab ine,</w>
flucytos ine.</w>
fluctu ate</w>
flucloxacill in-associated</w>
flucloxacill in,</w>
fluc onazole-associated</w>
fluc onazol
flu- like'</w>
flu orimetric</w>
flu ori
flu ore
flu idized</w>
flu idity.</w>
flu ent</w>
flu ency.</w>
floxac in:</w>
flow- dependent</w>
flow metry)</w>
flow meter</w>
flow /
flow .(ABSTRACT</w>
flor a</w>
flor a.</w>
floc cul
floccul ent</w>
flick -related</w>
flexible -dose</w>
flest olol-induced</w>
fler oxacin-treated</w>
fler oxacin,</w>
flecain ide:</w>
flavon oids,</w>
flav ox
flav oprotein</w>
flav ine</w>
flav in-adenine-dinucleotide</w>
flav anone</w>
flash bac
flashbac ks.</w>
flash "</w>
flare -
flap s,</w>
flap .</w>
flap ,</w>
flan king</w>
flaccid ,</w>
flacc idity</w>
fla res,</w>
fla il</w>
fl ec
flec a</w>
fl ared</w>
fixed- dose,</w>
fixed- cycle</w>
fix ed.</w>
fix atives</w>
fix ative</w>
five- year-old</w>
five- month</w>
five- minute</w>
five- item</w>
five- frequency</w>
five- drug</w>
five ).</w>
fit s/h)</w>
fissu res.</w>
fissu re-in-ano</w>
fissu re
fir ing-frequency</w>
finger nails.</w>
fing er,</w>
fine- mapping</w>
finding s:</w>
finaster ide,</w>
fin ite</w>
filtr ate</w>
fill ing,</w>
filam ents,</w>
filam ent)</w>
fil ment</w>
fil ipin</w>
fil er
fil arial</w>
fil aria
fifty- two</w>
fifty- three</w>
fif th.</w>
fif teen.</w>
field- stimulated</w>
fiel d"</w>
fibro vascular</w>
fibro sis/
fibro plasia</w>
fibro ids.</w>
fibro calcification.</w>
fibrinogen -
fibrinogen- fibrin</w>
fibrin- degradation</w>
fibrin ous</w>
fibrill ation/
fibre optic</w>
fibrate- associated</w>
fibr in,</w>
fib res).</w>
fib rate-treated</w>
fib er's</w>
fi ve;</w>
fi lo
fi al
fferen t</w>
fever s.</w>
fever s,</w>
fever /
fever ),</w>
fetu ses;</w>
fetu ses).</w>
fet us?</w>
fet al/
fertili zation</w>
ferro cyanide</w>
fer tility:</w>
fer ric-reducing</w>
fer rets.</w>
fer ret</w>
fer oxamine,</w>
fer mentation</w>
fentanyl- nitrous</w>
fentanyl- etomidate-
fentanyl- dexamethasone,</w>
fentanyl +
fenoter ol-
fenoldopam -mediated</w>
fenfluramine .
fenflur amine:</w>
fenflur amine/
fen- phen</w>
fen- phen
fen nel</w>
fen bendazole</w>
femal e-
fem ur,</w>
fem or
felbam ate,</w>
fel y
fel d</w>
feed forward</w>
fed /low</w>
febarb amate</w>
febarb amate.</w>
feat ures;</w>
feat ured</w>
fear -like</w>
fe min
fe ed-
feed- back</w>
favour s</w>
favour able;</w>
fatigu e/
fatal ities,</w>
fatal ).</w>
fat ty-acid</w>
fast- track</w>
fast ing-induced</w>
fast ing)</w>
fast ed.</w>
fast ed-
fasted- refed</w>
fast -</w>
fascicul ations:</w>
fascicul ation,</w>
fascicul ata</w>
fasci otomies</w>
farnes yltransferase</w>
far mer</w>
far abine</w>
famil y),</w>
fam and
famand ole</w>
fain tness,</w>
fain ting</w>
failure [
failure[ 1]</w>
failure --
fail .</w>
faec ium</w>
faec al</w>
factor-beta 1/2</w>
factor- kappa</w>
factor- beta2</w>
factor s)</w>
factor ?</w>
factor :</w>
factor .(ABSTRACT</w>
factor -induced</w>
factor -1</w>
factor ),</w>
factor (s)</w>
fact ure
fact ors--
fact ored</w>
facilit ation,</w>
facil ity,</w>
facil ities.</w>
face- learning</w>
fac ultative</w>
fac ies,</w>
fac ient</w>
fa ir</w>
fa (c
fa(c p)</w>
f] thiepin-10-yl)oxy]-
f ts</w>
f s,</w>
f rotteur
f p).</w>
f omep
f lop
f light.</w>
f its.</w>
f ish
f inely</w>
f iciency</w>
f ic</w>
f avi
favi renz
f ancon
fancon i</w>
f an</w>
f aded</w>
f Ar
ezetimi be,</w>
eyel ids</w>
eyel ids,</w>
eye- of-the-tiger</w>
eye- head</w>
eye bro
eyebro w</w>
ey es).</w>
ey es),</w>
exud ate.</w>
extremit y:</w>
extrem ities;</w>
extrem is</w>
extrasystol es.</w>
extrastimul us</w>
extrapol ating</w>
extrap ontine</w>
extrap olate</w>
extrane uronal</w>
extrane ural</w>
extran eous</w>
extrac tions</w>
extrac tions.</w>
extrac ted.</w>
extra- stimulus</w>
extra- renal</w>
extra- oral</w>
extra- hippocampal</w>
extra thyroidal</w>
extra dimensional</w>
extra articular</w>
extra aortic</w>
extr uded</w>
extr apy
extrapy ramid
extr alimbic</w>
extr acts.</w>
external- beam</w>
extens ors</w>
extens ors.</w>
exten uates</w>
exten sively,</w>
exten sive.</w>
exten sive-stage</w>
exten sions,</w>
exsangu ination</w>
expres sional</w>
expres sion),</w>
expres sed.</w>
exposure- toxicity</w>
exposure -induced</w>
exposure );</w>
exposed ).</w>
expos ures).</w>
expon ent</w>
explo si
expl ant
expl ain
experiment s;</w>
experiment ally,</w>
experiment ;</w>
experience d.</w>
experienc es;</w>
exper ts,</w>
exper ti
expen sive.</w>
exped ited</w>
exped ite</w>
expector ant,</w>
expect ations,</w>
expect ation,</w>
expect ancy.</w>
expand ing.</w>
expan ded-
expanded- access</w>
exp elled</w>
exp ect</w>
exp 1,</w>
exist ed.</w>
exhib ited,</w>
exhib ite</w>
exhaust ing.</w>
exhaus tion,</w>
exfoli ation</w>
exercise- controls.</w>
exer tion,</w>
exencephaly ;</w>
exec utive)</w>
excre tion:</w>
excre ted.</w>
exclu sionary</w>
exclu sion.</w>
exclu de
excitator y/
excitation- inhibition</w>
excit otoxin,</w>
excit oneuro
excit ed.</w>
excit able</w>
excit abilities</w>
excipi ents</w>
exci sion.</w>
exchang er.</w>
exchang eable</w>
exces sive,</w>
excep tions.</w>
excep tional,</w>
excell ent:</w>
exanth ematous</w>
examin er's</w>
examin ations)</w>
examin able</w>
exam ples.</w>
exam ples,</w>
exam ined:</w>
exagger ate</w>
exacerb ated,</w>
ex- vivo-antigen-dependent</w>
ex- MDMA+</w>
ex position</w>
ex otropia</w>
ex ophthal
ex on-intron</w>
ex ocytosis</w>
ex ocytosis.</w>
ex o
ex itil-Perlongets)</w>
ex cur
ex changes.</w>
ex changed</w>
ex abri
ew es</w>
ew es.</w>
evul inate</w>
evo ked-
eviprostat -</w>
evidence d.</w>
evid ences.</w>
event uate</w>
event s/
even ing-dosed</w>
evalu ation;</w>
ev an
evan escent</w>
ev a</w>
euthan ization</w>
euk ar
eukar yotic</w>
eu thyroid.</w>
etra zole</w>
etoric oxib.</w>
etoposide -related</w>
etomidate- propylene</w>
etomid ate;</w>
etomid ate)</w>
etin- responsive</w>
etin- 2</w>
eti zed</w>
eti opathogenesis</w>
eti ologically,</w>
eti me.</w>
eti l.</w>
ethyn ylestradiol,</w>
ethyn yl-
ethylketazoc ine,</w>
ethylket ocyclazocine</w>
ethylket azocine</w>
ethylenediamine tetraacetic</w>
ethylenedi amine)</w>
ethyl] piperazinyl]-3-phenylpropan-2-ol</w>
ethyl- 3-methyl
ethyl-3-methyl pentanoyl</w>
ethyl- ,</w>
ethyl nitrosourea</w>
ethyl methionine</w>
ethyl line</w>
ethyl amine</w>
ethyl amine)</w>
ethyl )-2-
ethyl)-2- (4-methyl
ethyl)-2-(4-methyl -1-
ethyl)-2-(4-methyl-1- homopiperazinyl)benzimidazole</w>
ethoxy ethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole</w>
ethoxy estradiol</w>
ethoxy ]-
ethoxy )-
ethoxy)- 5-
ethoxy)-5- benzofuran
ethoxy)-5-benzofuran yl]-N'-methylurea</w>
ethnic ity.</w>
ethnic ities</w>
ethinylestradi ol-treated</w>
ethin ylestradio1/75</w>
ethin yl-
ether s,</w>
ether -a-
ether-a- go-go-related</w>
ether -</w>
ethanol- withdrawn</w>
ethanol- clonidine</w>
ethanol amine-
ethanolamine- o-sulphate,</w>
ethanol amide</w>
ethan ol-treated</w>
ethan ol)</w>
ethan e,</w>
ethambut ol:</w>
eth ynodiol</w>
eth nomedic
eth no
eth imide</w>
eth idine-associated</w>
eth ics</w>
eth ane-1-
ethane-1- hydroxy-1,1-diphosphonate</w>
eth ality,</w>
etexil ate,</w>
et ybenz
et t</w>
et kowicz,</w>
et amine</w>
esulf onic</w>
esulf on
estrus/ estrus</w>
estrogen- testosterone</w>
estrogen- receptor</w>
estrogen /
estrogen/ progesterone-induced</w>
estramust ine,</w>
estradiol-17 beta-glucuronide-induced</w>
estradiol-17 beta-D-glucuronide-induced</w>
estradiol -dependent</w>
estradiol -</w>
estradiol ).</w>
estim ates,</w>
estim at
estimat es).</w>
esthe tic</w>
esthe siae,</w>
ester- linked</w>
ester s,</w>
ester s)</w>
ester ases</w>
ester :</w>
est- corrected</w>
est riol</w>
est e
este em,</w>
est ants,</w>
est )</w>
est ).</w>
ess /
espec ially,</w>
esmo lol-ANH</w>
eser ine.</w>
escitalopram ;</w>
escitalopram :</w>
esch ar</w>
escap e,</w>
escal ate</w>
esc ing</w>
esc ents</w>
esc ence,</w>
es/ number</w>
es. 2.</w>
es tions</w>
es pesia</w>
es ne</w>
es fer
es capable</w>
es burg,</w>
es arian</w>
es ,"</w>
es "</w>
es ").</w>
erythropoie sis-stimulating</w>
erythropoi etin-responsive</w>
erythropoi esis,</w>
erythromyc ins</w>
erythromyc ins,</w>
erythromel algia</w>
erythrom ycin-treated</w>
erythrocy te.</w>
erythrocy te
erythroblast s,</w>
erythroblast ocytopenia</w>
erythroblast ocytopenia.</w>
erythro dys
erythrodys aesthesia</w>
erythermalg ia</w>
erythermalg ia.</w>
erythematos us-like</w>
erythemat ous,</w>
erythe ma
erv orden-Spatz</w>
erv ic
erule in,</w>
error s,</w>
error =
erro r.</w>
ero sions,</w>
ero onian</w>
ero ding</w>
erm B</w>
erlotinib -related</w>
erlotinib -induced</w>
ergotamine/ caffeine,</w>
ergometr ine-induced</w>
ergol ine-associated</w>
ergoc alc
ergocalc iferol</w>
erg uride</w>
erdo ste
erarch ical</w>
eral ocortico
eradic ation.</w>
eradic ation,</w>
er- tip</w>
er- than-
er- chromatid</w>
er sinia</w>
er s).</w>
er re</w>
er rati
er os
er field,</w>
er ation,</w>
er L
er '</w>
equisetiform is</w>
equip ment.</w>
equimyelo toxic</w>
equili bri
equili br
equi volume</w>
equi potent.</w>
equi potency</w>
equi hypotension</w>
equi effective,</w>
equ inovarus.</w>
equ ine-conjugated</w>
equ ilib
equ esne</w>
equ atorial</w>
equ ations.</w>
equ ation,</w>
equ al.</w>
eptifibati de</w>
eptifibati de-induced</w>
epti vely</w>
ept h</w>
ept )</w>
epsilon R
epsilonR AC
epsilonRAC K,</w>
epsilon )-
epsilon)- (
epsilon)-( carboxy
epsilon)-(carboxy methyl)
epsilon ),</w>
epoxy- car
epoxy-car vone</w>
epoprosten ol,</w>
epoch s,</w>
epl ase</w>
epitheli a.</w>
epist axis.</w>
epist axis,</w>
episode s).</w>
episi otom
epirubicin/ paclitaxel-containing</w>
epiphy ses</w>
epiphy seal</w>
epinephrine/ kg.</w>
epinephrine- secreting</w>
epinephrine- exacerbated</w>
epinephrine- augmented</w>
epinephr ine;</w>
epim ers</w>
epileptogene sis:</w>
epileptogene sis)</w>
epileptogen ecity</w>
epileptic us-associated</w>
epilept ogenicity</w>
epilepsy -associated</w>
epilep sies,</w>
epif lu
epidermi s.</w>
epiderm is</w>
epide mic,</w>
epicardi ally</w>
epicardi al,</w>
epicanth us,</w>
epicanth al</w>
epib atidine,</w>
epiandro sterone,</w>
epi membranous</w>
epi medium</w>
epi glottis</w>
ephedr ine/propofol/mixtures</w>
ephed ra</w>
epend ymal</w>
epal restat</w>
ep sin</w>
ep s)</w>
ep oxide,</w>
ep onate</w>
ep ineur
ep ine</w>
ep eta</w>
ep em
epem pidine</w>
eosinophil s).</w>
eosinophil ia-myalgia</w>
eosin- stained</w>
enzyme- inhibiting</w>
enzyme- dig
enzyme-dig ested</w>
enzym uria.</w>
enz berg,</w>
environ ments</w>
environ mentally</w>
enure tic</w>
enure sis,</w>
enucle ation</w>
entrop y.</w>
entrap ment</w>
entrap ment,</w>
entr apped</w>
entr ance</w>
entor hinal,</w>
enti ty?</w>
enti ties,</w>
enteropath ica.</w>
enter tained.</w>
enter ocytes</w>
enter ocutaneous</w>
entac ap
entacap one,</w>
ent- echo</w>
ent ropion</w>
ent ous</w>
ent ly;</w>
ent ly-
ent in.</w>
ent a</w>
ent -related</w>
ent ),</w>
ensu es</w>
ensu e</w>
ensu e.</w>
ensor ship</w>
ens ored</w>
enoxim one,</w>
enoxapar ine</w>
enoxapar in:</w>
enoxapar in-related</w>
enough ?</w>
enough ,</w>
enn ial</w>
enkephalin- catabolizing</w>
enkephalin ergic,</w>
enkephal ins,</w>
enhance ment.</w>
enh ance,</w>
engorg ed</w>
eng ulf
eng th
eng ine,</w>
eng agement</w>
eng ag
eng -
eng- mai-san</w>
enflur ane:</w>
enflur ane-based</w>
energ y,</w>
energ y"</w>
enem s</w>
enem as.</w>
ene-3,20- dione</w>
ene-1- alpha,25-
ene-1-alpha,25- (OH)2-
ene-1-alpha,25-(OH)2- D3</w>
ene- di
ene- VPA</w>
ene 's</w>
endotox in,</w>
endothelin -1
endothelial- to-mesenchymal</w>
endothel in.</w>
endothel in,</w>
endoscop ically.</w>
endoscop e</w>
endophthal mitis,</w>
endonuclease- dependent</w>
endometri um,</w>
endogen ous,</w>
endocrino pathies</w>
endocardi um,</w>
endoc apillary</w>
endo- diol)</w>
endo wed</w>
endi x</w>
ende av
endarte rectom
endang ering</w>
end- to-end</w>
end- tid
end- proximal</w>
end- point.</w>
end- plate</w>
end- labeling</w>
end ymoblastoma</w>
end tidal)</w>
end systolic</w>
end stage</w>
end points,</w>
end os
end oneurium</w>
end omicroscopy</w>
end ings,</w>
end feet</w>
end :</w>
encour aging:</w>
enco ding,</w>
encephalopath y;</w>
encephalopath y--19</w>
encephalopath y)</w>
encephalo gram</w>
encephalo gram,</w>
encephal y,</w>
encephal on.</w>
encephal itic</w>
ence/ abuse</w>
ence -related</w>
enc ircling</w>
enc es:</w>
enc as
encas ement</w>
enantiom er)</w>
enantiom er
enanth ate.</w>
enalapri lat.</w>
enalapri l:</w>
en-VPA ),</w>
en- Yang
en-Yang -R
en-Yang-R ong-Tang</w>
en- VPA)</w>
en- Sh
en-Sh en-Yang-Rong-Tang</w>
en- San-
en-San- Y
en-San-Y aun
en-San-Yaun g-Jung-Tang</w>
en sus</w>
en riched,</w>
en ote</w>
en jo
en ings</w>
en il.</w>
en iculum</w>
en ia,</w>
en forcement</w>
en ever</w>
en ess,</w>
en er</w>
en der</w>
en ded,</w>
en cain
encain ide,</w>
en c</w>
en bre
enbre l</w>
en adoline</w>
en adol
en :</w>
emul sions.</w>
emul sion"</w>
empye ma"</w>
emplo ys</w>
empir ically,</w>
emphasi zed,</w>
emphasi sed</w>
emotion ality</w>
emo tions</w>
emo dar
emit ted</w>
emis sions,</w>
emin ence.</w>
emin ence,</w>
emergency- department</w>
emergen cies,</w>
emerg ent).</w>
emerg e.</w>
ement- time</w>
eme togenicity</w>
embryos /
embryos/ fetuses</w>
embryol ethal</w>
embryo pathy,</w>
embry otoxic,</w>
embry ogenesis</w>
embran e-
embolism ),</w>
embol us.</w>
embol ization,</w>
embol ism;</w>
embol isation</w>
embol i)</w>
embol ectomy</w>
embed ment</w>
emb ark
emb )</w>
eman ate</w>
em s,</w>
em pyema</w>
em opamil</w>
em itting</w>
em it</w>
em ia/
em filer
em er
em ent)</w>
em barr
ely x)</w>
elu sive</w>
elu sive,</w>
elu ates</w>
elu ate.</w>
else where
elong ated</w>
ellular is</w>
ellip ticine</w>
elli si
ell ent</w>
ell ar
ell agic</w>
ell a.</w>
ell 's</w>
elimin ation,</w>
elimin ated,</w>
elimin ate,</w>
elic ited,</w>
elic anus</w>
elev ation)</w>
electroretino grams</w>
electroretino gram.</w>
electrophysi ologist</w>
electroneuro myographic</w>
electron- transport</w>
electroencephalo graphy.</w>
electroencephalo graphy,</w>
electroencephalo graphically</w>
electrocortico graphy.</w>
electrocardiogram )</w>
electro-ocu lography,</w>
electro- oscillograms</w>
electro pharmacological</w>
electro microscopic</w>
electro cerebral</w>
electro acupuncture</w>
electro -</w>
electrical- field-stimulated</w>
electrical- ,</w>
elec tivity</w>
ele mentary</w>
ele ment.</w>
elast ography</w>
elast ase</w>
elabor ate</w>
el zine</w>
el uting-bead</w>
el usive.</w>
el son</w>
el semi
el godipine-induced</w>
el der</w>
el bo
elbo w</w>
el ap
elap sed.</w>
el ).</w>
eighty- four</w>
eight- month</w>
eight- hour</w>
eight- fold</w>
eight- fold,</w>
eight- and-
eight-and- a-
eight-and-a- half-yr-old</w>
eicos an
ei ther,</w>
ei ro,</w>
ei omy
egu minosae),</w>
egg s</w>
efoni dipine</w>
efoni dip
effu sion)</w>
effor t,</w>
effor t
effici ency,</w>
effects-- such</w>
effect- site</w>
effect uating</w>
effect s?</w>
effect s.(ABSTRACT</w>
effect s).</w>
effect ?</w>
effect ,"</w>
effect ),</w>
effect "</w>
effec tive
effac ement.</w>
eff lo
efavirenz ,</w>
educ ation-matched</w>
educ ation-,</w>
edrophonium- provoked</w>
edroph onium.</w>
edroph onium-induced</w>
edi onbel)</w>
edema )</w>
ede tic</w>
ede mic</w>
ed side</w>
ed reich's</w>
ed al</w>
ed '</w>
ecz ko,</w>
ecyst ectomy</w>
ectom y-
ectom y)</w>
ectom ies.</w>
ecto domain</w>
ecti ve/
ect us</w>
ect ors</w>
ect asis</w>
ect asia.</w>
ecstasy )-related</w>
ecstas y.</w>
ecstas y-specific</w>
ecstas y-related</w>
ecopip am,</w>
eclamp sia,</w>
echocardiograph y-induced</w>
echocardiograph y-
echocardiograph ical</w>
echo- dobutamine</w>
echo ;</w>
echo ,</w>
ec otropic</w>
ec ation</w>
ec arin</w>
ec apone</w>
ec al</w>
eb ast
eb all</w>
eat en</w>
easi ly,</w>
eas y,</w>
early- systolic</w>
early -</w>
ear s)</w>
ear s),</w>
ear ly)</w>
ear lobes.</w>
ear lobe.</w>
ear ing</w>
eNO S.</w>
eIF2alpha (P)</w>
e.c. g.</w>
e- induced,</w>
e- containing</w>
e- 4-
e-4- phenyl-1,3-diselenole</w>
e thedium</w>
e siosis</w>
e se-Ellsworth</w>
e ligible,</w>
e j
e in.</w>
e hringer</w>
e det
e bro
e ating,</w>
e );</w>
dystrophin- deficient</w>
dystroph in.</w>
dystro glycan,</w>
dyston ia:</w>
dysphor ia.</w>
dysphasi a.</w>
dysphag ia:</w>
dysp noea.</w>
dysmorph ogen</w>
dysmen orrhea.</w>
dysmen orrhe
dyskinesi as
dyskinesi a;</w>
dyskinesi a-
dyskinesi a),</w>
dyskinesi a
dysgermin oma</w>
dysesthesi as,</w>
dyserythropoi esis</w>
dyserythropoi esis,</w>
dysarth ria.</w>
dys synergy</w>
dys morphism</w>
dys metric</w>
dys metria,</w>
dys maturation</w>
dys geusia,</w>
dys geusi
dys genesis,</w>
dys functions,</w>
dys fluency</w>
dys autonom
dysautonom ia</w>
dynorph in-related</w>
dynorph in,</w>
dynes/s/cm- 5),</w>
dynes/cm 5)</w>
dynes.s.cm- 5,</w>
dynam ically,</w>
dynam ic)</w>
dyn es</w>
dy ne
dy n</w>
dy ing-
dy es</w>
dy e-induced</w>
dy e-
dy azide</w>
dwarf ism.</w>
dur ation).</w>
dur ability,</w>
duplic ation.</w>
duloxet ine.</w>
duloxet ine-</w>
duct openia,</w>
duc t-positive</w>
dual- specificity</w>
dual- energy</w>
du ality</w>
du al,</w>
dt (s
dt(s z)</w>
drugs-- in</w>
drug- primed</w>
drug- paired</w>
drug- metabolizing</w>
drug- mediated</w>
drug- induced,</w>
drug- facilitated</w>
drug- exposed</w>
drug- environment</w>
drug- containing</w>
drug- attributable</w>
drug- adverse</w>
drug s-induced</w>
drug s--a</w>
drug s)</w>
drug s).</w>
drug s"</w>
drug .(ABSTRACT</w>
drug -</w>
drug '.</w>
dru s</w>
dru m</w>
drox idopa.</w>
drowsin ess/
drow sy.</w>
drow sy,</w>
drospiren one,</w>
dropout s,</w>
drople ts.</w>
drople t</w>
droperid ol:</w>
droperid ol-induced</w>
drop- outs</w>
drop- out.</w>
drop s:</w>
dro op
drink ing-water</w>
drin ks.</w>
drin ks,</w>
drin k.</w>
drin k,</w>
dri ven.</w>
dri ft</w>
dri d
drid den</w>
dream ing.</w>
draw s</w>
drain age.</w>
dra ining</w>
dr unk</w>
dr agon
dp/dt (max)</w>
doxy fluridine</w>
doxy cycline-induced</w>
doxorubicin/ dexamethas
doxorubicin/dexamethas one],</w>
doxorubicin-treated- catheterized</w>
doxorubicin- only</w>
doxorubicin- mediated</w>
doxorubicin- aconityl-lysozyme</w>
doxorubic inol</w>
doxifl uridine</w>
doxep in-induced</w>
dox azosin)</w>
down- titration</w>
down- regulating</w>
down- regulated.</w>
down ward,</w>
down regulation.</w>
down regulation,</w>
double-dumm y</w>
double- lumen</w>
double- immunolabeling</w>
double- ar
double-ar med</w>
double- J</w>
double d.</w>
doubl ings</w>
dot arizine</w>
dosing- time</w>
doses /day</w>
dose/ response</w>
dose-rel ated;</w>
dose-rel ate
dose-relate dly</w>
dose-depend ently;</w>
dose-depend ant</w>
dose- volume</w>
dose- responsive</w>
dose- ranging,</w>
dose- level</w>
dose- intensity,</w>
dose- escalated</w>
dose- dependency</w>
dose- comparison</w>
dose- and</w>
dose- additive</w>
dose- -a</w>
dose ]</w>
dose );</w>
dose ")</w>
dosage- limiting</w>
dos ings</w>
dos age-dependent</w>
dos age).</w>
dorsal -
dors orostral</w>
dorm ant</w>
dor zolamide/timolol.</w>
dor soventral</w>
dopaminerg ic-related</w>
dopamine-beta- oxidase</w>
dopamine- treated,</w>
dopamine- rich</w>
dopamine- replacing</w>
dopamine- innervated</w>
dopamine- containing</w>
dopamine- antagonistic</w>
dopamine- agonist</w>
dopamine- 2</w>
dopamine- 1</w>
dopamine 1</w>
dopa- mine</w>
dopa- estrogen</w>
dopa- decarboxylase</w>
dop maine</w>
dop am,</w>
donor- derived</w>
donor :</w>
donor ),</w>
don ation</w>
domopredn ate</w>
domopredn ate,</w>
domin ated.</w>
domin ant
dominant -negative</w>
dom et</w>
dom e</w>
dolicho ectasia</w>
dolasetr on.</w>
dol lars.</w>
dog s);</w>
dog '</w>
document s,</w>
docetaxel :</w>
docetaxel ).</w>
docetax al</w>
doc trine.</w>
doc tor</w>
doc tor
do- DHP</w>
do om</w>
do bry
dobry um</w>
do ,</w>
do )</w>
dn a</w>
dn 't</w>
dl- sotalol,</w>
dl- fenfluramine,</w>
dl (-1)</w>
dl (-1),</w>
dk 4</w>
dizziness/ syncope</w>
dizziness/ lightheadedness</w>
dizziness/ lightheadedness.</w>
dizziness +
dizzin ess)</w>
diz ation</w>
divorced/ separated</w>
diver ticular</w>
diver ted</w>
diver sion.</w>
diver sion,</w>
diver ging</w>
div ide</w>
diuretic s;</w>
dithiothre itol</w>
dithio uric</w>
dite kiren
dit sia</w>
disulfiram -like</w>
disulfi des</w>
disulfi de.</w>
disulfi de-
disulfi de)</w>
disulf onic</w>
disturbanc es;</w>
distribut ed,</w>
distribu tional</w>
distrib ute</w>
distres sed</w>
distr action</w>
distr action.</w>
distor tion.</w>
distor tion,</w>
distinguish es</w>
disten tion.</w>
disten sion.</w>
disten sion-induced</w>
disten sion,</w>
disten sibility</w>
dist ances.</w>
dist ally.</w>
dissemin ated,</w>
diss ector</w>
disput ed.</w>
disproportion ality</w>
displac ement-time</w>
disper sion,</w>
disp ute</w>
disp osable</w>
disp en
disorder s)</w>
disorder )</w>
disorder ),</w>
disopyram ide-associated</w>
disodi um.</w>
disease- specific</w>
disease- directed</w>
disease- -a</w>
diseas e),</w>
discrimin ations.</w>
discrep ant</w>
discre tion,</w>
discontinu ous,</w>
discontinu ities</w>
discontinu ance.</w>
discolor ation.</w>
disco vering</w>
discharge- ready</w>
discharge ;</w>
discharg es;</w>
discer ned</w>
discar ding</w>
discar ded</w>
disc -shaped</w>
disappoint ing,</w>
disappear ances</w>
disappea red;</w>
disappea red)</w>
disabl ing,</w>
dis solvable</w>
dis sol
dis satisfied</w>
dis proportionally</w>
dis position,</w>
dis posi
dis missed.</w>
dis mal</w>
dis location,</w>
dis integrins,</w>
dis integrating</w>
dis inhibitory</w>
dis inhibition.</w>
dis h,</w>
dis counting</w>
dis counted</w>
dis closing</w>
dis closed.</w>
dis clo
disclo ses</w>
dis ast
disast rous</w>
dis aggregation</w>
dis abilities,</w>
direct- current</w>
direc ts</w>
direc t"</w>
dipyridamole/ aspirin</w>
dipyridamole- associated</w>
dipyridamole- RNV</w>
dipyridamole- 201Tl</w>
dipyridamol e;</w>
dipyridamol e)</w>
dipren orphine</w>
diplo myelia</w>
dipivox il.</w>
diphther ia-pertussis-tetanus</w>
diphenyl methoxytropane</w>
diphenyl hydantoin
diphenyl -2-
diphenyl-2- picrylhydrazyl</w>
diphenyl -1,
diphenyl-1, 3,5-
diphenyl-1,3,5- hexatriene</w>
diphenyl -
diphenyl- imidazol
diphenhydram ine-induced</w>
diph antoin</w>
dip sia</w>
dip per</w>
dip per
dioxo- 5,5-
dioxo-5,5- diphenyl-imidazol
diop ters</w>
dinitro phenyl</w>
dinitro benzene</w>
dinit rate-</w>
dinit rate,</w>
din ol</w>
dimin ishes,</w>
dimethylbenz imidazol
dimethylamino phenyl)
dimethylamino adamant
dimethyl-4- phenylpiperaz
dimethyl-1-propargyl xanthine</w>
dimethyl-1-propargyl xanthine)</w>
dimethyl sulfoxide</w>
dimethyl sulfoxide,</w>
dimethyl propranolol),</w>
dimethyl barbituric</w>
dimethoxy- 6-(2-
dimeth isterone-ethinyl</w>
dimenhydrin ate.</w>
dimenhydrin ate,</w>
dimen sion.</w>
dilu tional</w>
dilu ents</w>
dilu ents.</w>
diltiazem 's</w>
dilev alol.</w>
dilev alol,</w>
dilemm as</w>
dilat ations</w>
dilat ations.</w>
dil ut
dil antin</w>
dil ant
diisopropyl fluoro
dihydroxy- alpha-
dihydroxy-alpha- truxillic</w>
dihydroxy icosa(5E-9,11,13Z)tetraenoic</w>
dihydroxy but
dihydroxybut anedi
dihydroxybutanedi oate</w>
dihydroxy benzoate</w>
dihydropyridine- type</w>
dihydrobenzofuran-7- carboxamide</w>
dihydro-beta-erythro idine</w>
dihydro-2,3-quinoxaline dione)</w>
dihydro- 7,8-
dihydro- 6-
dihydro uracil</w>
dihydro streptomycin</w>
dihydro rhodamine123</w>
dihydro quinidine,</w>
dihydro progesterone</w>
dihydro ergotamine.</w>
dihydro ergot
dihydro epiandrosterone</w>
dihydro codeine</w>
dihydro chloride.</w>
dihydro benz
dihydro -10-
dihydro -1-
digoxigen in</w>
digox ine</w>
digox in/
digox in-treated</w>
digox in-related</w>
digiti zing</w>
digitalis -,</w>
digit i</w>
digit alization</w>
difluoro methyl</w>
diflun isal,</w>
differenti als</w>
difference= 0.01).</w>
difference );</w>
differenc es?</w>
differen t).</w>
diff usion.</w>
diff using</w>
diff ici
diff er,</w>
diethylnor spermine</w>
diethylenetri amine</w>
diethylcarbamo yl)piperidino]-p-xylene</w>
diethylcarbam azine.</w>
diethylamino ethyl)</w>
diethylamino ethoxy
diethyl- ether.</w>
diethyl- 4,4'-
diethyl-4,4'- stilbene
diethyl dithiocarbamate</w>
diethyl amino)
diethylamino) ethyl</w>
diet :</w>
diet .(ABSTRACT</w>
diet -controlled</w>
diet -</w>
diet +/-
diet+/- AZT,</w>
dien es,</w>
diel drin
dideoxyinos ine,</w>
dideoxy nucleoside-induced</w>
didanos ine:</w>
didanos ine-related</w>
diclofenac/ misoprostol</w>
diclofenac/ misoprostol-treated</w>
diclofenac -treated</w>
diclofenac -dependent</w>
diclofenac )</w>
dichlorophenyl) -1-piperazinyl]
dichlorophenyl)-1-piperazinyl] but
dichlorophenyl)-1-piperazinyl]but yloxy)-
dichlorohexafluorocyclobut ane,</w>
dichlorodiammine platinum(II)</w>
dichloro- 2,2,2-trifluoroethane</w>
dichloro phenazine</w>
dichloro meth
dichloro acetic</w>
dichloro -1,</w>
dichlor v
dich otomy</w>
dich otomous</w>
dich loropyridyloxy)]benzene</w>
dicarboxyl ate,</w>
dic tated</w>
dic tate</w>
dic loxacill
dic ,</w>
dibutyr yl-
dibutyl nitrosamine</w>
dibuc aine-
dibucaine- resistant</w>
dibenzo[ b,
dibenzo[b, f]thiepin-10-yl)oxy]-
diazepam -like</w>
diazepam -evoked</w>
diazepam --
diazep inium</w>
diazemul s</w>
diazemul s,</w>
diathe sis,</w>
diastol ic/systolic</w>
diastol ic.</w>
diastemat omyeli
diarrhe a).</w>
diarrhe a),</w>
diar y-based</w>
diar y,</w>
diaphrag m-like</w>
diaphore tic,</w>
diant um</w>
diameter- diastole,</w>
diameter /
diameter )</w>
diam orphine.</w>
diam mine</w>
diam idine</w>
dialys ates</w>
dialys ate.</w>
dialys ate-
dialysate- side</w>
dialy sis:</w>
diagnos tically</w>
diagnos tic,</w>
diagno sed;</w>
diagno se.</w>
diagno se,</w>
diag ram</w>
diacetyl morphine,</w>
diabet ogenicity</w>
diabet es:</w>
diabe tic.</w>
diabe tic-
di- o-tolylguanidine</w>
di(2-ethylhex yl)</w>
di(2-ethylhex yl)-phthalate</w>
di zed</w>
di vision.</w>
di valproate</w>
di tioned</w>
di sialogangliosides</w>
di re</w>
di r</w>
di propionate.</w>
di polar</w>
di pepti
di palmitoyl</w>
di ocyte</w>
di meric</w>
di hydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benz
di fication</w>
di febarbamate.</w>
di estrous</w>
di enogest</w>
di ene</w>
di ed)</w>
di dn't</w>
di de
di butanoylmorphine</w>
di anhydro
dianhydro galactitol</w>
di an-American</w>
di aminopter
diaminopter idine-6-(N-
di aling</w>
di al-
dial- urethane</w>
di al
dial ing.</w>
di (n-
di(n- but
di(n-but yl)phthalate</w>
df= 3;</w>
dextromor amide</w>
dextro- isomer</w>
dextro se-
dextro rotatory</w>
dextro amphetamine-induced</w>
dexter ity.</w>
dexrazox ane,</w>
dexmedetom idine-associated</w>
dexamethasone- suppressible</w>
dexamethasone- free</w>
dexamethas one;</w>
dexamethas one/
dexamethas one
dex trans</w>
dex fenfluramine)</w>
dex etimide</w>
dex chlorpheniramine,</w>
dex ar
dexar az
dex amp
dexamp etamine</w>
dex amisole</w>
dex a-treated</w>
dex .</w>
dex -H
dex-H T.</w>
devic es,</w>
devi ations.</w>
develop ed:</w>
develop ed),</w>
detri mental.</w>
detox ification,</w>
determin ation,</w>
deterior ates</w>
deterior ates.</w>
deterior ated.</w>
deter rent</w>
deter gent</w>
deter g
detect ed;</w>
detect .</w>
detail s,</w>
detach ed</w>
detach able</w>
det orubicin</w>
destruc tive/disruptive</w>
destruc tion,</w>
dest ine</w>
desquam ative</w>
desper ately</w>
desor ption/ionization</w>
desogestrel .</w>
desogestrel ,</w>
desogestrel )</w>
desmopress in,</w>
desmethyl imipramine,</w>
desmethyl diazepam</w>
desmethyl clomipramine</w>
desmethyl astemizole.</w>
desmethyl astemizole,</w>
design s,</w>
design er</w>
desi red.</w>
desi rab
dese thyl
descript ors</w>
descri ption,</w>
descri p
des-Arg 10
des-Arg10 HOE</w>
des-Arg (10
des-Arg(10 )-
des-Arg(10)- HOE</w>
des loratadine,</w>
des feroxamine</w>
des artan</w>
des acetyl</w>
dermatomyosi tis,</w>
dermato ses</w>
dermat omal</w>
dermat ological,</w>
dermat ologic.</w>
dermat ologic,</w>
derm ally</w>
derivati zed</w>
deriv ate</w>
deri ved:</w>
deri ved.</w>
derang ement.</w>
der ma.</w>
der m-Nitro</w>
der )</w>
depriv ation;</w>
depressi ve-like</w>
depress or,</w>
depress ant-like</w>
depress ant,</w>
depres sive.</w>
depres sions.</w>
depres sion-
depres sed)</w>
depot -type</w>
depot -
depolymer ized</w>
depolymer ization.</w>
depolar ized</w>
depolar izations.</w>
depolar izations,</w>
deple tion;</w>
deple tion/
deple tion)</w>
deple ter</w>
depersonal ization,</w>
depend ents</w>
depend ences</w>
depend ences,</w>
depend ence/abuse</w>
depend ence
depend ,</w>
depart mental</w>
dep ths</w>
dep opulation</w>
deoxynucleoti d
deoxycorticosterone- NaCl</w>
deoxychol ate.</w>
deoxy- Delta
deoxy-Delta 12,
deoxy-Delta12, 14-
deoxy uridine.</w>
deoxy thymidine;</w>
deoxy nojirimycin</w>
deoxy cor
dentistr y</w>
dentistr y,</w>
densit ometry)</w>
dens ity-
dens a.</w>
denop amine,</w>
dendrit e.</w>
dend rin,</w>
den ying</w>
den oting</w>
den ied.</w>
den ham</w>
den at
denat ured</w>
demyelin ative</w>
demonstr ations</w>
demonstr able,</w>
demedull ated</w>
demarc ated,</w>
deman ds,</w>
deman ded</w>
delta- sleep-inducing</w>
delta- delta</w>
delta- amino-n-
delta-amino-n- valeric</w>
delta- HCH</w>
delta- AVA</w>
delta- ALA-
delta FosB</w>
delta (1)-</w>
deliri um)</w>
deline ation</w>
deline ates</w>
deli ber
deli a</w>
dele tion.</w>
dele teri
dele ted.</w>
dele ted,</w>
delay ;</w>
dela y-interposed</w>
delT961 Cn</w>
del ic</w>
del a</w>
dehydrat ed,</w>
dehydrat ase,</w>
defl ection,</w>
deficit s)</w>
deficit )</w>
deficit ),</w>
defibrill ated</w>
defer ox
defensi veness</w>
defect s),</w>
defect ).</w>
defec ate,</w>
def end</w>
deep- tendon</w>
deep ening</w>
decreas ing,</w>
decre mental</w>
decre ment.</w>
decont amin
decontamin ation,</w>
decongest ants</w>
decline d;</w>
decid u
decibel s)</w>
deci sively</w>
deci sions,</w>
dechall enge</w>
dechall enge,</w>
decel eration</w>
deced ents</w>
deced ent</w>
decarboxyl ase.</w>
decapit ate</w>
decade ;</w>
deca hydro
dec ubitus</w>
dec o
dec lines.</w>
dec ilit
dec erebr
dec eptively</w>
dec ay.</w>
dec ameth
debri s</w>
debri s.</w>
debil itation</w>
debat able.</w>
deb ate,</w>
death s)</w>
death s),</w>
death -
deafferen tiation</w>
deafferen tation.</w>
deaf ening.</w>
deaf ening,</w>
deacetyl ases</w>
de-de- pointes</w>
de- escalated</w>
de toxic
de synchronized,</w>
de stin
de sensitisation</w>
de regulation</w>
de potentiation</w>
de posit</w>
de phenylhydantoin</w>
de parting</w>
de odar
de mise</w>
de iodin
de grade</w>
de glutition</w>
de differentiated</w>
de amino-8-D-arginine</w>
de amination</w>
de amin
de activation,</w>
de activ
deactiv ations,</w>
de ).</w>
dd l</w>
dd I
dd C-
ddC- neuropathy</w>
days/ week)</w>
days/ week),</w>
days )].</w>
day- time</w>
day- old)</w>
day- night</w>
day time,</w>
day s.
day s-
day -to-
day-to- day</w>
day -1.</w>
daunorubic in/ebselen-treated</w>
daunorubic in-treated</w>
daun omycin.</w>
daun omyc
daugh ters,</w>
datas et,</w>
datab as
datab an
dat a;</w>
dark- light</w>
dark ness</w>
dark ened</w>
darbe poietin-
dar one</w>
dar ifen
dapson e,</w>
dantrol ene,</w>
danger ousness</w>
danaparo id,</w>
dan sylated</w>
dampen ing</w>
dam ping</w>
dam pen</w>
dam ages.</w>
dam .</w>
daidze in,</w>
dact y
dacarb azine-induced</w>
da zole-induced</w>
da zole,</w>
da iry</w>
da d</w>
dPI/ dt</w>
dP/dtej c)</w>
dP/dt ]</w>
dP/dt ),</w>
d4 T.</w>
d/ wk</w>
d/ mo</w>
d/ mo)</w>
d/ metastatic</w>
d-amphetamine- disrupted</w>
d-B inet</w>
d- week</w>
d- tubocurarine.</w>
d- tubocurarine-induced</w>
d- stage</w>
d- ribose</w>
d- propranolol,</w>
d- jugular</w>
d- isomer</w>
d- glucuronidase,</w>
d- galactosamine</w>
d- dimer</w>
d- carnit
d- bucindolol</w>
d- amphetamine-</w>
d- amphet
d- Tc</w>
d- N-acetylglucosaminidase,</w>
d- AMPH
d-AMPH -treated</w>
d,l- sotal
d, 6
d,6 h),</w>
d(CH2)5D AVP,</w>
d(CH2)5 Tyr
d(CH2)5Tyr (Me
d(CH2)5Tyr(Me )
d(CH2)5Tyr(Me) AVP</w>
d y</w>
d s'</w>
d s
d nig-Hoffmann</w>
d l</w>
d iterpenoids</w>
d ing-
d ine:</w>
d ine-related</w>
d ine's</w>
d ate).</w>
d ance</w>
d actin
d V
d TXB2</w>
d T
dT c,</w>
d SP)</w>
d SP
d Ro
dRo R</w>
d R</w>
d R)</w>
d R
dR /dtmax</w>
d G)</w>
d :
d 8)</w>
d .).</w>
d -related</w>
d (LVP
d(LVP )/
d ';</w>
cytotoxic ,</w>
cytostatic s,</w>
cytos ol.</w>
cytos ine.</w>
cytos ine)</w>
cytoplas ms</w>
cytoplas matic</w>
cytopen ic,</w>
cytoly tic)</w>
cytokine- inducible</w>
cytoarchitect onic</w>
cyto segres
cyto reduction</w>
cyto protectant</w>
cyto proliferative</w>
cyto pathy?</w>
cyto pathic</w>
cyto genetics</w>
cyto differentiating</w>
cyto architecture</w>
cytarab ine:</w>
cyt. c</w>
cyt ology,</w>
cyt ological</w>
cyt ochemistry</w>
cyt ochemistry,</w>
cystometro graphy</w>
cystometro gram</w>
cysti tis-induced</w>
cysti tis)</w>
cysteinyl dopa</w>
cyste inyl</w>
cyste amine.</w>
cyste amine,</w>
cyst ou
cyst oscop
cyst ography</w>
cyst ectomy.</w>
cyst atin</w>
cyst adenomas</w>
cyprohept adine-induced</w>
cynom ologus</w>
cyl inder</w>
cyclosporine- prednisone</w>
cyclosporine- prednisone-treated</w>
cyclospor ine-related</w>
cyclophosphamide/ m2</w>
cyclophosphamide/ etoposide
cyclophosphamide -pretreated</w>
cyclophosphamide -containing</w>
cyclopentyl adenosine,</w>
cyclopent yl</w>
cyclopent amethyl
cyclooxygen ase.</w>
cyclooxygen ase,</w>
cyclohexyl amine</w>
cyclohexyl amine).</w>
cyclohexyl -1-nitrosourea</w>
cyclohexim ide-induced</w>
cyclohexen onic</w>
cyclohex ane</w>
cyclohepten- 5-
cyclohepten-5- ylidene)-1-
cyclohept an-
cycloheptan- 5,10-imine</w>
cyclo thymic</w>
cyclo thymia</w>
cyclo tetrasiloxane</w>
cyclo serine,</w>
cyclo propyl
cyclo oxygenation</w>
cyclo oxygenase-1</w>
cyclo oxygenase-
cyclo oxgenase</w>
cyclo hydrolase</w>
cycli zine.</w>
cycli zine,</w>
cyclase- cyclic</w>
cycl in</w>
cycl idine</w>
cycl ically</w>
cycl es);</w>
cycl an
cyanopindo lol</w>
cyano- 7-nitro
cyan amide</w>
cy tisine,</w>
cy tidine,</w>
cy tidine's</w>
cy te-macrophage</w>
cy st,</w>
cutoff s</w>
cut s</w>
custom ized</w>
custom -made</w>
cus hi
current- voltage</w>
curett age.</w>
cure d,</w>
cur ve(inf)</w>
cur v
cur se,</w>
cur red</w>
cur ious</w>
cur are</w>
cur able</w>
cune atum</w>
cune ate,</w>
cumul atively</w>
cumber some</w>
cultur ist</w>
cult uring</w>
culmin ate</w>
cuff ing</w>
cuff ed</w>
cue- reactivity</w>
cue- exposure</w>
cu. mm.</w>
cu e.</w>
cu bo
cs f</w>
crystall in</w>
cryst al-induced</w>
cryptococ cemia.</w>
cryos urgical</w>
cryos ections</w>
cryoglobul ins</w>
cryo therapy,</w>
cryo preserved</w>
cry oprecipitate,</w>
cry ogenic</w>
cruci ate</w>
cruci al.</w>
cruc ially</w>
crouch ing</w>
cross-tal k</w>
cross-fo ster
cross- titration</w>
cross- sex</w>
cross- sec
cross- reactivity,</w>
cross- reactivities</w>
cross- reactive</w>
cross- reactions</w>
cross- perfused</w>
cross- link</w>
cromoglyc ate,</w>
cromakalim ,</w>
cro ft</w>
critic ized</w>
critic al.</w>
criter ia;</w>
crist ae,</w>
cri spa</w>
cri sis:</w>
cri ed</w>
crest -derived</w>
creatinine "</w>
creatin ines</w>
creatin ine).</w>
creatin in-
cream s.</w>
cre pit
cre eping</w>
cre atin</w>
cre ams</w>
crav ings.</w>
crav ing-related</w>
cranios ynostosis,</w>
crani otom
crani al,</w>
crack -associated</w>
crack ")</w>
cp m/mg</w>
coxib s,</w>
cox a</w>
cox -2</w>
cow s;</w>
covari ance.</w>
cour se:</w>
cour se).</w>
cour aging</w>
coupl ing,</w>
counterpart s,</w>
counter shock</w>
counter s</w>
counsel ing,</w>
coun selling</w>
coumar an-3-yl)
cough s</w>
cough )</w>
cotrimox azole-induced</w>
cot inine,</w>
cost- savings</w>
cost- saving</w>
cost- offset</w>
cost- effective,</w>
cost );</w>
cosol vent
cortis ol-exposed</w>
cortis ol-compared</w>
corticosteroid s:</w>
corticosteroid -
corticoster one-supplemented</w>
corticoster one-induced</w>
corticom edullary</w>
cortico- pontine-cerebellar</w>
cortico id.</w>
cortico id-pretreated</w>
cortical- basal</w>
cortic otropic</w>
cortic opapillary</w>
cortex /
corro sive</w>
correl ational</w>
correl ate.</w>
correc tly.</w>
correc tions</w>
correc tion).</w>
correc table</w>
correc t,</w>
corpor ation</w>
corpor a,</w>
coron aries</w>
coron a
corona virus</w>
corne ally</w>
corne a.</w>
corn u.</w>
corn ification</w>
cord ing.</w>
cord ectomy</w>
cord antly</w>
cor t
cor responds,</w>
cor ded</w>
cor d-
copies/ ml.</w>
copies/ ml,</w>
copies/ mL.</w>
copies/ mL)</w>
cop rimary</w>
cop ious</w>
coordin ative</w>
coordin ate</w>
cooper ative.</w>
convulsion s:</w>
convuls ant-
convul sive,</w>
conver sion;</w>
conver sely</w>
conver ging</w>
conver gent</w>
conver ge</w>
conveni ent,</w>
conven tional,</w>
conve ys</w>
conve ying</w>
controll able.</w>
controll ability</w>
control s.
control .(ABSTRACT</w>
control );</w>
contribut e.</w>
contribu tion.</w>
contralater ally</w>
contralater al)</w>
contradictor y.</w>
contradic tion</w>
contradic t</w>
contract ures.</w>
contrac tion:</w>
contrac tion-associated</w>
contrac tion)</w>
contra indications.</w>
contra indicated,</w>
continu um.</w>
continu ously,</w>
continu ous
continu ations</w>
contin ous</w>
contin ental</w>
contex ts</w>
contex ts,</w>
contempor aneously,</w>
contempor aneous</w>
contamin ating</w>
contamin ants</w>
cont our</w>
cont ain
cont ag
contag ios
cont acts.</w>
cont acting</w>
cont '
consump tion)</w>
consul tations</w>
construc ting</w>
constric tions.</w>
constric t</w>
constitu ents.</w>
constipati on"</w>
consti pating</w>
const ants,</w>
const ant
constant ;</w>
consol idate</w>
consist ently,</w>
consider ably,</w>
consider able.</w>
conside red;</w>
connex in-
connec tivity</w>
connec tivity.</w>
connec tions.</w>
connec tion,</w>
conjug ates.</w>
coni ine-treated</w>
coni ine-induced</w>
congenit a</w>
congenit a.</w>
cong estants,</w>
confusion /
confu sion;</w>
confu sion)</w>
confron t</w>
conflic ting.</w>
conflic ted</w>
conflic t/anxiety</w>
configur ation,</w>
conf used.</w>
condylo ma</w>
conduct ances.</w>
conditioned- cued</w>
condition -
condition- by-time</w>
condition ).</w>
concurren t,</w>
concomit ants</w>
conclu sions:</w>
concer ning.</w>
concept uses.</w>
concept al</w>
concep tion.</w>
concep tion).</w>
concentration/ time</w>
concentration- side</w>
concentration- controlled</w>
concentration- blood</w>
concentration s).</w>
concentration -</w>
conceiv ably</w>
conce al
conceal ment</w>
conc ana
concana valin</w>
con verse</w>
con vection-enhanced</w>
con strain
con son
con sensu
con ing.</w>
con forms</w>
con formation.</w>
con formation,</w>
con form</w>
con e-mediated</w>
con cordantly</w>
con coc
con 2</w>
con 2,</w>
computer- aided</w>
compromi ses</w>
comprehen sively</w>
compound -related</w>
compound 's</w>
compoun ded</w>
compoun d-induced</w>
compoun d-
component s;</w>
complication s--
complication s).</w>
complic ation?</w>
complic ated,</w>
complex es),</w>
complex ;</w>
complex -
complex- partial</w>
complex )</w>
complex ).</w>
comple ters</w>
comple ments</w>
comple ment-fixing</w>
comple ment-dependent</w>
complain ant</w>
competi tive,</w>
compart ment,</w>
comparison s:</w>
compar ator-
comparator- controlled</w>
compan y.</w>
compan y's</w>
compa re,</w>
comp ly</w>
comp any</w>
comorbidi ties;</w>
community- dwelling</w>
common place</w>
common ly.</w>
commissu re-
commis sion</w>
commence ment.</w>
comm ence</w>
combin atorial</w>
combin ations:</w>
combin ations,</w>
comb ustion</w>
comb retastatin</w>
comb at
combat -induced</w>
com ycin.</w>
com pressing</w>
com prehend</w>
com positions</w>
com mitting</w>
com as</w>
com a
coma ',</w>
colum n,</w>
colpos copy</w>
color ata</w>
coloni es.</w>
colocysto plasty,</w>
collo id-osmotic</w>
collicul i</w>
collicul i.</w>
colli sion</w>
collateral- dependent</w>
collateral- CA1</w>
collater als,</w>
collater alized</w>
collap sibility</w>
collap sed.</w>
collagen s.</w>
coll ec
colchic ines.</w>
col laboration</w>
col laborating</w>
col ingual</w>
coincident al.</w>
coincident al,</w>
coincid entally</w>
cognition- improving</w>
cognition- enhancing</w>
cogni tion,</w>
coffe e.</w>
coer uleus.</w>
cod ons</w>
cocult ured</w>
coccidioidomy cosis.</w>
cocaine/ atropine</w>
cocaine/ alcohol</w>
cocaine- withdrawn</w>
cocaine- unrelated</w>
cocaine- seeking.</w>
cocaine- panic</w>
cocaine- mediated</w>
cocaine- kindling</w>
cocaine- experienced</w>
cocaine- diazepam</w>
cocaine- dependent,</w>
cocaine- cue</w>
cocaine- conditioned</w>
cocaine- abuse</w>
coca ine?</w>
coca ine).</w>
coc cygeal</w>
coc a</w>
cobal tous</w>
coal escing</w>
coagul ation:</w>
coagul ation-
coagulation- fibrinolysis</w>
coagul ating</w>
coagul ase</w>
coagul ase-
coagulase- negative</w>
co-ordin ation,</w>
co-morbidi ties</w>
co- treatment.</w>
co- suppression</w>
co- primary</w>
co- prescription</w>
co- operative</w>
co- operation</w>
co- occurrence</w>
co- morbidity.</w>
co- localization</w>
co- injection</w>
co- injected</w>
co- infection:</w>
co- deleted</w>
co- agonist</w>
co- Dobut
co-Dobut amin
co very</w>
co vert</w>
co variance</w>
co res</w>
co receptors.</w>
co re.</w>
co re)</w>
co propor
co localizes</w>
co loboma</w>
co ingestion.</w>
co ingestants</w>
co infusion</w>
co infection</w>
co infection.</w>
co factors,</w>
co exists</w>
co exist</w>
co enzymes</w>
co bra</w>
co at-
coat- core</w>
co assemble</w>
cnemi us</w>
cm2/ min</w>
cm/ sec</w>
cm/ sec,</w>
cm H2O,</w>
cm 2,</w>
cm .
cm (-1))</w>
cm (-
cluster s.</w>
cluster ing,</w>
clump ing,</w>
clum sy</w>
clozap ine:</w>
clozap ine)</w>
cloxacill in:</w>
cloti azepam,</w>
closed- port</w>
closed- loop</w>
clonid ine:</w>
clonid ine-like</w>
clonid ine)-mediated</w>
clonid ine),</w>
clon us.</w>
clon us)</w>
clon ed,</w>
clomi pr
clomi phene-induced</w>
clomi phene,</w>
clofib rate-dependent</w>
clofib rate)</w>
clofazim ine.</w>
clobut inol,</w>
clo voxamine</w>
clo ud
clo ts.</w>
clo ts,</w>
clo th
clo t-
clo t
clo sely,</w>
clo metac
clo bet
clobet asole</w>
clit oris.</w>
clit oral</w>
clinico- therapeutic</w>
clinici an.</w>
clinici an,</w>
clinical/ ethical</w>
clinical- pathologic</w>
clinic ally-
clinic al.</w>
clinic :</w>
clindam ycin-associated</w>
clin ofibrate</w>
clin ofibrate,</w>
climb ing.</w>
clentiaz em,</w>
clemast ine</w>
cleav age-
cleavage- enhancing</w>
clear ly.</w>
cle b
claw ing</w>
clav icle</w>
claudic ation,</w>
clau strum,</w>
clau stroph
classi fications</w>
classi fic
classi c,</w>
classes :</w>
class -specific</w>
clar ified</w>
clamp ,</w>
claim .</w>
cl one.</w>
cl inging</w>
cl en
cl ay</w>
cl an
clan destine</w>
citronell al</w>
citalopram :</w>
cit rate:</w>
cit ing</w>
cisplatin- paclitaxel</w>
cisplatin- ,</w>
cisplatin um-navelbine</w>
cisplat in-treated</w>
cisplat in-resistant</w>
cisplat in-related</w>
cisplat in),</w>
cisapri de-associated</w>
cisapri de-
cisapri de)</w>
cisDDP-then-pct x).</w>
cis- dichlorodiammineplatinum(II)</w>
cis- N-
cis-N- [2-(3,4-dichlorophenyl)ethyl]-
cis-N-[2-(3,4-dichlorophenyl)ethyl]- 2-
cis-N-[2-(3,4-dichlorophenyl)ethyl]-2- (1-pyrrolidinyl)
cis-N-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl) cyclohexylamine).</w>
cis- (+)-
cis-(+)- 5-methoxy
cis-(+)-5-methoxy -1-
cis-(+)-5-methoxy-1- methyl-2-
cis atracurium-induced</w>
cis atracurium,</w>
cirrho sis;</w>
cirrho sis:</w>
cirrho sis).</w>
circumst ance</w>
circumferen ce.</w>
circumferen ce,</w>
circumferen ce
circum ventricular</w>
circum vented</w>
circum oral</w>
circuit ,</w>
circl es,</w>
ciproxif an</w>
cinnar izine,</w>
cing ulated</w>
cinacalce t,</w>
cin chon
cin anserin</w>
cin anserin.</w>
cimetid ine:</w>
cimetid ine-related</w>
cimetid ine)</w>
cim er</w>
cilnidip ine,</w>
cilex etil,</w>
cilex eti
cil 's</w>
cigaret tes,</w>
cidofovir ,</w>
ciclo prolol,</w>
cic atric
cicatric ial</w>
ci tic</w>
ci sional</w>
ci gu
chronotrop ic,</w>
chronic- phase</w>
chronic- onset</w>
chron ological</w>
chron o-</w>
chron ically.</w>
chron ic.</w>
chron ic).</w>
chron ic),</w>
chromos omes.</w>
chromos ome-
chromatography/ time-of-flight</w>
chromatography/ electrochemical</w>
chromatography- tandem</w>
chromat ograms</w>
chrom olytic</w>
chos en,</w>
chori ocarcin
chori ocapillaris</w>
chondro itinase</w>
cholinomime tics,</w>
choling eric</w>
cholinergically- mediated</w>
cholinerg ics)</w>
choline- deficient</w>
cholin oceptive</w>
cholin ';</w>
cholesterol/ HDL</w>
cholesterol ;</w>
cholesterol -like</w>
cholesterol )</w>
cholester ogenesis</w>
cholester ogenesis.</w>
cholestasi s;</w>
cholest atic.</w>
cholecystokin in
cholangi ocellular</w>
cholang iti
chol yl
chol ine-containing</w>
chol angiography.</w>
chol angiogram</w>
chocer ca</w>
chlorpromaz ine-associated</w>
chlorpromaz ine).</w>
chlorothiaz ide-induced</w>
chloroqu ine/hydroxychloroquine</w>
chloroqu ine-</w>
chloroform -
chlorofluoro carbons.</w>
chloroethyl nitrosourea</w>
chlorobut anol</w>
chlorobut anol,</w>
chloro-7- iodo-8-hydroxyquinoline)</w>
chloro- phenyl)-piperazin-1-yl]-propyl}-pyrrolidin-2-one</w>
chloro- APB</w>
chloro- 2,2,2-trifluoroethane</w>
chloro dibenzo[b,f]thiepin-10-yl)oxy]-
chloro benztropine</w>
chloro benzoic</w>
chloro acetaldehyde</w>
chloro -1,
chloro-1, 2,2,2-
chloro-1,2,2,2- tetrafluoroethane</w>
chlorisondam ine,</w>
chlordiazep oxide.</w>
chloramphenic ol,</w>
chlor phentermine</w>
chlor phentermine.</w>
chlor methi
chlor ine</w>
chlor imipramine)</w>
chlor ide;</w>
chlor hydrate</w>
chlor hexidine-digluconate</w>
chlo as
chloas ma.</w>
chim panze
chim ney</w>
chim eric</w>
childhood :</w>
child birth.</w>
child -
child- completed</w>
chicken s.</w>
chicken pox</w>
chicken pox,</w>
chick s,</w>
chias m.</w>
chi ro
chi -squ
chemotherapy- treated</w>
chemotherapy- responsive</w>
chemotherapy- -a</w>
chemotherap y/radiotherapy</w>
chemotherap y)</w>
chemotherap ies.</w>
chemot axis</w>
chemoconvuls ant</w>
chemoconvuls ant-induced</w>
chemo sis,</w>
chemo reflex-induced</w>
chemo prophylaxis,</w>
chemo kine,</w>
chemo genic</w>
chemo embolization</w>
chemo embolization.</w>
chemilumin escence.</w>
chemic al.</w>
chemic al
chem o</w>
chem istry.</w>
chem e</w>
chelat ors.</w>
chelat ors,</w>
chelat es</w>
chel eryth
check list</w>
chec ked.</w>
che ese</w>
che ap
charybdotox in,</w>
charge- density</w>
charge -dependent</w>
characteris ing</w>
character s</w>
character ,</w>
char ts.</w>
char fman</w>
chaper one</w>
channel- blockers</w>
channel s)</w>
channe lopathy</w>
chang es)</w>
chang es),</w>
challenge -
challeng es,</w>
chalaz ion</w>
chain s.</w>
ch rysotherapy</w>
ch op
ch ment</w>
ch ,</w>
ceti rizine-induced</w>
cess ation:</w>
cess (R)</w>
cervix ;</w>
cervix :</w>
cervic al-
certain ly,</w>
certa inty.</w>
cerivastat in-gemfibrozil</w>
cerivastat in,</w>
cerebri ;</w>
cerebello thalamocortical</w>
cerebello medullary</w>
cerebell i</w>
cer oid-lipofuscin
cer amide,</w>
cephapir in,</w>
cephaloth in-induced</w>
cephal y,</w>
ceph azol
centur ies</w>
centur ies,</w>
centro acinar</w>
centrally- injected</w>
centr al/
central/ spinal</w>
cent rifug
cent er-
cent but
cent ;</w>
cembran oid</w>
cellular ity.</w>
cells/micro l;</w>
cells/micro L.</w>
cells/ mm3.</w>
cells/ mm3).</w>
cells/ L</w>
cells/ 3</w>
cell/ mm(3),</w>
cell- rich</w>
cell- reduced</w>
cell- line</w>
cell- deficient</w>
cell- death</w>
cell- cycle</w>
cell ular,</w>
cell s-1</w>
cell ing</w>
cell -like</w>
cell -induced</w>
cell -cell</w>
cell )</w>
cel and</w>
cefuroxi me,</w>
ceftazidime -treated</w>
cefotet an-treated</w>
cefotet an
cefotaxime .</w>
cefosel is-induced</w>
cefoperaz one.</w>
cefoperaz one-induced</w>
cefazed one.</w>
cefazed one)-treated</w>
cef epime-induced</w>
cef epi
cef al
cefal ospor
cef ad
cefad rox
ce t's</w>
ce sium</w>
ce sium.</w>
ce ful</w>
ce ase</w>
ce an</w>
ce -like</w>
ce )</w>
cavit y;</w>
cavernos a</w>
caveol ins</w>
caveol in-
cave olar</w>
cav a,</w>
cauti ously.</w>
cause -specific</w>
cause ".</w>
caus al.</w>
caudat us-
caud ate.</w>
caud alis</w>
caud al-
caud al,</w>
cau ses:</w>
catheter izations,</w>
catheter ization).</w>
catheter ism.</w>
catheter ;</w>
catheter -related</w>
catheter -based</w>
catheter )</w>
cath inone</w>
cath inone,</w>
categor y,</w>
categor ised</w>
catecholamine- halothane-induced</w>
catecholamine- containing</w>
catechol s</w>
catechol aminergic,</w>
catech ol,</w>
cataton ia/
catastroph e</w>
cataract ogenic</w>
catar rh
catar ia)</w>
catar acts;</w>
catar act.</w>
catalyst s.</w>
cataly zing</w>
cataly tic)</w>
cataly tic'</w>
cataly st</w>
catalepsy- enhancing</w>
catalepsy ;</w>
catalepsy )</w>
catalepsy ).</w>
catalepsy ),</w>
catalepsy '</w>
catabol ized</w>
cat chment</w>
castr ation-
castration- resistant</w>
cast rates.</w>
cast or</w>
caspase- 9</w>
caspase- 1</w>
casopit ant,</w>
cases/ person-years</w>
cases/ 1000</w>
case- reports</w>
case- note</w>
case- -
case in)</w>
case i</w>
casca des</w>
cas ual
cas pases</w>
cas h</w>
cas es--
cas enote</w>
carumon am</w>
cartilagin ous.</w>
carri er.</w>
carri age</w>
carrageenan/ kaolin</w>
carrageen an.</w>
carrageen an,</w>
caroti d-jugular</w>
caroten oid</w>
carnit ine;</w>
carnit ine-depleted</w>
carmust ine-
carmofur ,</w>
caregi ver</w>
care r</w>
care -associated</w>
cardioverter/defibrill ator.</w>
cardioverter-defibrill ators</w>
cardioverter-defibrill ator.</w>
cardiover ted</w>
cardiotoxic ity;</w>
cardiotoxic .</w>
cardiotoxic ,</w>
cardiomyopath y--
cardiomyocyt es:</w>
cardiomyo plasty,</w>
cardiomy ocyte-specific</w>
cardio- toxicity</w>
cardio- pulmonary</w>
cardio regulatory</w>
cardio protector</w>
cardio protectant</w>
cardio protect
cardio pathy.</w>
cardio pathy,</w>
cardio inhibition</w>
cardio graphy.</w>
cardio graphy,</w>
cardio acceleration</w>
cardic .</w>
cardi otrophin-1</w>
cardi otoc
cardi ology.</w>
cardi ologists;</w>
cardi c</w>
carcinom as)</w>
carcinom a).</w>
carcin ostatics</w>
carcin omatosis.</w>
carcin oembryonic</w>
carcas s</w>
carcas s.</w>
carboxypiperazin-4- yl)-propyl-1-phosphonic</w>
carboxyp eptidase-G2</w>
carboxymethylcell ulose.</w>
carboxylester ase</w>
carboxylester ase.</w>
carboxyl ate,</w>
carboxycyclo propyl)glycine</w>
carboxy-3-hydroxy phenylglycine</w>
carboxy- ly
carboxy octyl]-L-alan
carboxy methyl</w>
carbox amide)</w>
carboplatin- containing</w>
carboplatin ),</w>
carboplat in)</w>
carbonyl s</w>
carbon )</w>
carbim ide-ethanol</w>
carbim azole-dependent</w>
carbidopa -
carbidopa- levodopa</w>
carbap enem,</w>
carbamyl choline</w>
carbamyl cholin';</w>
carbamo yloxy
carbamazepine -10,</w>
carbamazep ine;</w>
carbamazep ine:</w>
carbaceph em</w>
carb oline-3-carboxylate</w>
car vac
car tograph
car sinom)</w>
car is.</w>
car ious</w>
car ds.</w>
car bodi
carbodi imide</w>
car acemide</w>
captopri l),</w>
capsul e)</w>
capsaicin- untreated,</w>
capsaicin- mediated</w>
capsaicin- injected</w>
capsaicin- containing</w>
capsaicin- based</w>
capsaicin- ,</w>
capsaic inoides</w>
capsaic in:</w>
capsaic in/
capsaic in),</w>
capre omycin.</w>
capecitab ine-docetaxel</w>
capac ities,</w>
cap no
cap itis</w>
cannab imi
candidat es.</w>
candidat es,</w>
candesart an.</w>
candesart an-induced</w>
candesart an)</w>
cancer -associated</w>
cancer --
cancell ed</w>
canalicul us</w>
canalicul i,</w>
canal s</w>
canal .</w>
canal ,</w>
can ned</w>
can .</w>
campt ocormia</w>
campa ign</w>
camera- derived</w>
cam sy
cam era.</w>
calmodul in-dependent</w>
callo sum.</w>
calibr e</w>
caldi amide</w>
calcul ations,</w>
calcul able
calculable ).</w>
calcium/ calmodulin</w>
calcium- sensing</w>
calcium- phosphorus</w>
calcium- entry</w>
calcium- antagonist</w>
calcium- and</w>
calcium- alkali</w>
calcitri ol-mediated</w>
calcit onin.</w>
calcit onin-
calcin osis.</w>
calcific ations,</w>
calci uria,</w>
calci um-</w>
calci um)</w>
calci um's</w>
calbindin- D
calbindin-D 9
calbindin-D9 k</w>
cal pastatin</w>
cal m</w>
cain ide-induced</w>
caffeine- administration</w>
caffe ine-containing</w>
cadher in,</w>
cac hex
cab ergoline.</w>
cab ergoline-induced</w>
ca zole,</w>
ca vities</w>
ca therization</w>
ca thecolamine-induced</w>
ca strat
ca sting</w>
ca siragu
ca re-
ca ine)</w>
ca esarian</w>
ca ecal</w>
ca diocyte</w>
cTn I.</w>
cGMP- dependent</w>
cAMP- regulated</w>
cAMP- PDIE</w>
c/ s;</w>
c/ LDL-c</w>
c-fos -positive</w>
c-fos -
c- positive</w>
c- myc</w>
c- family</w>
c- fa(cp)</w>
c- a</w>
c- Fos-like</w>
c ure.</w>
c ure,</w>
c repancies</w>
c remophor,</w>
c remaster</w>
c ramp</w>
c r</w>
c oxibs</w>
c otrans
c ochemical</w>
c ity.</w>
c f)</w>
c ess</w>
c esare
c er</w>
c ensus</w>
c ensorship</w>
c ecum</w>
c c,</w>
c ane</w>
c ance
c all.</w>
c ages,</w>
c ]-
c RA,</w>
c NOS</w>
c Min
c GVHD.</w>
c GVHD,</w>
c G
c FSGS</w>
c FSGS.</w>
c DNA.</w>
c Clure</w>
c AR
c AMP.</w>
c AMP,</w>
c AMP)</w>
c 2,</w>
c "</w>
bypass :</w>
bypas ses.</w>
bw ).</w>
bw ),</w>
butyryl cholinesterases</w>
butyl- isonitrile</w>
butyl sparteine</w>
buttoc ks.</w>
buttoc k.</w>
butr amine-induced</w>
butaz ones</w>
butaclam ol</w>
but ter</w>
but oxide,</w>
but orphanol.</w>
but aprost</w>
but anol</w>
busulfan/ cyclophosphamide</w>
buspir one:</w>
bus y</w>
burst/ 100</w>
burst s.</w>
burn ing/pruritus</w>
bur ying),</w>
bur n-injured</w>
bur gh,</w>
bupropi on:</w>
bupropi on-associated</w>
buprenorph ine-induced</w>
bupivacaine/ epinephrine/
bupivacaine- ,</w>
bupivaca ine-treated</w>
bund les,</w>
bumin aemic</w>
bulo meter.</w>
bull ae,</w>
bulim ic.</w>
bulb ectomized</w>
bul lo
bul ized</w>
bul ging</w>
bul b.</w>
bul ,</w>
build -up</w>
buff ers</w>
buff ering,</w>
buff er-tip</w>
buff er)</w>
bud ral
bucindo lol.</w>
bucindo lol,</w>
buc kling</w>
buc colingual</w>
buc co-
buc cal
bub ble</w>
bu tramine</w>
bu thionine-
bu se
bu propri
bu procaine</w>
bu pranolol</w>
bu ild</w>
bt O(2)</w>
brucello sis,</w>
bru ising,</w>
bru ise</w>
brother s</w>
bronchospas m)</w>
broncho- pulmonary</w>
broncho- dilating</w>
broncho- alveolar</w>
bronchi olitis</w>
bronchi ectasis</w>
bronch orrhoea,</w>
bronch itis,</w>
bronch io-alveolar</w>
bromocript ine:</w>
bromocript ine)</w>
bromo- 2,5-di
bromo-2,5-di methoxyphenethylamine</w>
bromo fosfamide</w>
bromo -1-
bromo-1- chloro-2,2,2-trifluoroethane</w>
brom peridol.</w>
brom osul
brom ocyclic</w>
brom oc
broaden ing</w>
broad- complex</w>
broad band</w>
broad ,</w>
bro minated</w>
bro iler</w>
briefl y,</w>
bridge -to-
breath- holding</w>
breath s</w>
breath s.</w>
breath lessness</w>
breath ed</w>
breast- conservation</w>
breast feeding.</w>
breast /
breakthrough ,</w>
break s),</w>
break down,</w>
break age</w>
bre vis</w>
bre taz
bre eding</w>
bre ed,</w>
branch es.</w>
bran ded,</w>
brainstem- cerebellum</w>
brainst em
brain- dissociated</w>
brain- death</w>
brain- blood</w>
brain- behavior</w>
braf ish</w>
bradykine tic.</w>
bradykin in-mediated</w>
bradycardia- tachycardia</w>
bradycardia /
bradycardia -induced</w>
bradycardia ).</w>
brady- arrhythmia</w>
brady arrhythmias;</w>
brady arrhythmia.</w>
brady arrhythmia,</w>
bracket ed</w>
bra sili
bra h
bra e</w>
br ush,</w>
br o</w>
br inging</w>
bp m),</w>
box es</w>
boun ds</w>
botul ism.</w>
both ;</w>
both ),</w>
bot tles</w>
bot t</w>
bortezomib- dexamethasone</w>
bortezomib -treated</w>
border line,</w>
bor ns</w>
bor ate</w>
boo ster
bon ding</w>
bolus- dosed</w>
bol uses.</w>
bol us+
bol ster</w>
bol ene</w>
body- building</w>
body builders</w>
bodi es).</w>
bo y)</w>
bo ost</w>
bo ok
blun ted.</w>
blue- albumin</w>
blu e).</w>
blood- pressure.</w>
blood- perilymph</w>
blood- forming</w>
blood- based</w>
blood- aqueous</w>
blood- CNS</w>
blocker s).</w>
blockade :</w>
block s;</w>
block s)</w>
block ing.</w>
block ed,</w>
block age.</w>
block a
blocka des</w>
blo ts</w>
blo ts,</w>
blinde d.</w>
blinde d)</w>
bli ster</w>
bleph ar
blephar itis,</w>
bleph a
blepha rophimosis,</w>
bleed ings</w>
bleed ing;</w>
bleed ing)</w>
bleb s,</w>
ble omycin-induced</w>
ble d,</w>
blast s.</w>
blast ine</w>
blan k</w>
bladder- pelvic</w>
bladder :</w>
bladder -derived</w>
black enings</w>
bl yopia.</w>
bl amed</w>
bizar re,</w>
bismu th,</w>
bis- (2-chloroethyl)-1-nitrosoure
bis-(2-chloroethyl)-1-nitrosoure a),</w>
bis(1-methylethyl) phosphorofluoridate</w>
bis(1- adamant
bis(1-adamant ylcarbamoyl)-1,2-methano[60]fullerene</w>
bis piperazinedione</w>
bis phosphate</w>
bis cus</w>
bis benzyl
bisbenzyl isoquinoline</w>
bis [3-
bis[3- (N,N-
bis[3-(N,N- diethylcarbamoyl)piperidino]-p-xylene</w>
bis [2-
bis[2- (3,5-
bis[2-(3,5- dichloropyridyloxy)]benzene</w>
bis (4'-fluorophenyl)
bis(4'-fluorophenyl) amine</w>
birth weight.</w>
birth s.</w>
bir ds'</w>
bipolar ity,</w>
bipolar ,</w>
biphasi c
biotin ylation</w>
biot in-conjugated</w>
biosyn thesi
biopsy- proven,</w>
biopsy ;</w>
biopsy )</w>
biopsy ).</w>
biopsi es:</w>
biopsi es)</w>
biopsi es).</w>
biopsi es").</w>
biomark ers.</w>
biom icroscopy.</w>
biolog ic,</w>
biochemist ries</w>
bioavail abilities</w>
bio flavonoid,</w>
bio feedback,</w>
bio electrical</w>
bio activation.</w>
binge- eating</w>
binge- abstinence</w>
binge ing</w>
bing es</w>
bind ers</w>
bind ers.</w>
bin omial</w>
bin o-
bin der</w>
bimod ally</w>
bim ato
bim an
biman ual</w>
billion/ mL</w>
bilirub in
bili ver
bile- drained</w>
bilater al),</w>
bil inear</w>
bil ay
bigemin y.</w>
big- ET-1</w>
bifur cations</w>
bifid a:</w>
bif unctional</w>
bif id</w>
bicyclo [2.
bicyclo[2. 2.
bicyclo -
bicyclo- orthobenzoate)</w>
bicucull ine-
bicucul ine</w>
bicarbon ate-treated</w>
bicarbon ate-
bicarbon ate)</w>
bicalutamide- tamoxifen</w>
bicalutamide- anastrozole</w>
bicalut amide.</w>
bicalut amide,</w>
bic eps.</w>
bic eps,</w>
bi- directional</w>
bi- SPEC
bi-SPEC T/
bi-SPECT/ dobutamine</w>
bi sexual</w>
bi pyridine</w>
bi phenyl-4-
bi os
bi le/perfusate</w>
bi le
bi gg
bi ennial</w>
bi dimensional</w>
bi an</w>
bezafib rate.</w>
bezafib rate-induced</w>
bey ond.</w>
bever ages.</w>
between- status</w>
between- product</w>
betwe en
betax olol,</w>
betam imetics</w>
betagam ma-subunits.</w>
betacy totoxic</w>
betacy tot
betablock er.</w>
beta= -
beta4- subunits</w>
beta4- containing</w>
beta2-leukocyte-integrins +</w>
beta2- agonists</w>
beta2- adrenoceptors</w>
beta2- adrenoceptors,</w>
beta1- ,</w>
beta-methyl choline</w>
beta-hydroxy -17</w>
beta-hydroxy -17-
beta-funaltrex amine</w>
beta-carboline-3- carboxamide</w>
beta-carbol ine-induced</w>
beta-OH SD,</w>
beta-HSD 2)</w>
beta-H SD)</w>
beta-D-arabinofuranos ylcytosine</w>
beta-CC E.</w>
beta-(4- dimethylaminophenyl)
beta- stimulatory</w>
beta- rhamnosyl</w>
beta- receptor-blocking</w>
beta- ratio</w>
beta- pregnan</w>
beta- phenylethylamine</w>
beta- oxidation.</w>
beta- ol</w>
beta- naltrexol</w>
beta- muricholic</w>
beta- mimetics</w>
beta- mimetics.</w>
beta- methasone</w>
beta- mediated</w>
beta- hydroxylase-like</w>
beta- cyclopentamethyl
beta- blockage</w>
beta- antagonists.</w>
beta- amyrin,</w>
beta- agonist,</w>
beta- adrenolytic</w>
beta- adrenoceptor-blocking</w>
beta- adrenoceptor-
beta- adren
beta- SR.</w>
beta- GALF</w>
beta- Estradiol</w>
beta- End
beta- Blockade</w>
beta- 2'
beta- (4-chlorophenyl)-1-
beta-(4-chlorophenyl)-1- methylpiperidine-3alpha-
beta- (2'-
beta-(2'- phenyl-2'-cyclopentyl-2'-hydroxy-ethoxy)tropane</w>
beta(2)- agonists</w>
beta(2)- adrenoceptor-mediated</w>
beta(2)- AR</w>
beta(1)- adrenoceptor-selective</w>
beta ]-
beta H</w>
beta H)</w>
beta 3-
beta -1,</w>
beta )-
bet an
bet al
best- assessed</w>
bes ylate</w>
bes udotox</w>
berb erine,</w>
ber ries</w>
benzylthio uracil.</w>
benzylpenicillo yl-poly-L-lysine</w>
benzylpenicillo ate,</w>
benzyloxy resorufin</w>
benzyliden epempidine</w>
benzyliden e-4-phenyl-1,3-diselenole</w>
benzyl pempidine</w>
benzyl glutarim
benzoylecgon ine.</w>
benzodiazepine/ GABAA</w>
benzodiazepine-3- carboxylate)</w>
benzodiazepine- receptor</w>
benzodiazepine- GABAA</w>
benzodiazepine- GABA-
benzodiazepine-GABA- chloride</w>
benzodiazep ine;</w>
benzodi oxane</w>
benzo[ b]
benzo[b] furan-2-ylsulfonyl)
benzo yl-4-chloro-N-methyl-N</w>
benzo yl-
benzo yl)-
benzo ate,</w>
benzo (F
benzene /
benzene/ adrenaline</w>
benz yloxy-4-methoxymethyl-
benz ylate</w>
benz yl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylaminobenzamide</w>
benz yl)
benz oxaz
benz opyrone</w>
benz ol
benz ocaine</w>
benz iso
benz hex
benz ene-
benz arone</w>
benz aldehyde,</w>
benflu orex.</w>
benefit/ risk</w>
benefit ?</w>
benef its,</w>
bendroflu methiazide</w>
bendroflu methiaz
bench side</w>
bench -to-
bench-to- bedside</w>
benazep ri
ben fotiamine</w>
ben dazole,</w>
bemegri de</w>
below- knee</w>
below- average</w>
bell ifer
bell -shaped</w>
belie ve,</w>
behavior )</w>
begun ;</w>
begun ,</w>
before hand)</w>
before ;</w>
bed- ridden</w>
bed ding</w>
beclo meth
bec ause,</w>
beats/ minute.</w>
beats/ minute,</w>
beats/ hour/patient</w>
beats. min-1</w>
beats. min(-1).</w>
beat .
beat ),</w>
bead ing"</w>
be x</w>
be verage</w>
be st,</w>
be low)</w>
be lia</w>
be lat
be er,</w>
be dridden</w>
be d;</w>
be c</w>
be am
bcl -
bax /
bati mastat</w>
bati ma
bath ,</w>
basel ines</w>
basel ine;</w>
base/ kg,</w>
bas ed.</w>
bas eball</w>
bas ally</w>
bas alis</w>
bas al-to-apical</w>
barri er/density</w>
baroreflex- sympathoneural</w>
baro reflex.</w>
baro reflex,</w>
baro receptors,</w>
bari um-treated</w>
barbit al,</w>
bar /
bar/ podium/grid'</w>
band ed</w>
ban ning</w>
ban k</w>
bambuter ol.</w>
balloon s'</w>
ballo on.</w>
bal salazide</w>
bal ances</w>
baical ein,</w>
bag ,</w>
baculo viral</w>
bacteremia/ sepsis/meningitis</w>
backcros sing,</w>
back- efflux</w>
back wards,</w>
back leak</w>
back crosses,</w>
babo ons.</w>
babo on.</w>
bab esiosis</w>
bF GF,</w>
b.w. /day</w>
b. p.
b- hexahydro
b w/
b w,</w>
b row
b ones,</w>
b l</w>
b ital</w>
b isopro
b id;</w>
b ay
bay esian</w>
b ],</w>
b S)-
b J</w>
b :</w>
b /kg</w>
b )-
b ))</w>
aztreon am.</w>
azithrom ycin-induced,</w>
azimil ide</w>
azido- 2',3'-
azido-2',3'- deoxythymidine;</w>
azetidin ylmethoxy)-2-chloropyridine)</w>
azetid in-2-ones</w>
azepam -induced</w>
azepam )</w>
azep ine]</w>
azep in</w>
azep ex
azathiopr ine:</w>
azathiopr ine-treated</w>
azathiopr ine-related</w>
azaspirodec ane
azaspirodecane dione</w>
az locillin</w>
az ine-
az e</w>
az e)</w>
az ard</w>
az acyclo
azacyclo alk
azacycloalk an-2-
azacycloalkan-2- one</w>
az a-
ay ama</w>
ay ag
ayag ida's</w>
axoplas m</w>
axon opathy"</w>
axo- ax
axo-ax onic</w>
ax oplasmic</w>
ax on.</w>
ax ella</w>
ax )</w>
awaken ed.</w>
awak ening,</w>
awak e.</w>
awa y,</w>
awa king</w>
awa ited.</w>
aw oke</w>
aw kward</w>
aw ian</w>
aw ful);</w>
avoid ,</w>
avocad os</w>
avir/ fosamprenavir</w>
avir -induced</w>
avid in</w>
avi um</w>
avi um-intracellul
avi er</w>
aver ting</w>
aver ted.</w>
aver sions.</w>
aver sion.</w>
aver age)</w>
avail able;</w>
avail ability,</w>
av itript
av a</w>
autotrans plantation</w>
autotrans plant
autos omic</w>
autophag osome</w>
autop sy-proven</w>
autop sies.</w>
autonom ically</w>
autom atic,</w>
autoimmun ity),</w>
auto regulation,</w>
auto receptors.</w>
auto receptors,</w>
auto immune,</w>
auto antigen</w>
auto antibody
autis m:</w>
author ized</w>
author 's</w>
aut um
aut osomal-dominant</w>
aut operfused</w>
aut ogenic</w>
auscult ation</w>
aus sian</w>
aure us.</w>
auranof in.</w>
aur idines</w>
aun ois</w>
aun a)</w>
aul ts</w>
aul inoa</w>
augment in)</w>
augment ed.</w>
audio gram.</w>
audi ovestibular</w>
aud anosine</w>
auc her</w>
au x</w>
au to</w>
au kesha,</w>
au hinia</w>
au d</w>
atyp icals,</w>
atyp ical,</w>
atyp ia,</w>
attribut ing</w>
attribut e,</w>
attri tion,</w>
attri bution</w>
attri bu
attention- demanding</w>
attend ance</w>
atten tiveness</w>
atten tion/
atten ded.</w>
atten ded,</w>
attempt s/
attack s/year)</w>
attac h</w>
atroph ied</w>
atrop ine-treated</w>
atrop ine-
atro gin-1</w>
atrizo ate</w>
atria- His</w>
atri sts</w>
atri o
atri m</w>
atri a;</w>
atri a:</w>
atre sia.</w>
atran orin</w>
atracurium- associated</w>
atracuri um-related</w>
atovaquone/ proguanil</w>
atorvastat in-treated</w>
atomoxet ine,</w>
atmosph eres</w>
atism ,</w>
atipamezol e)</w>
ation/ Western</w>
ation- competent</w>
ation ]</w>
ation .
ation -dose</w>
ation 's</w>
ating- therapy</w>
atid ine.</w>
ati ve)</w>
ati ve"</w>
athle te.</w>
athi on</w>
athero thrombosis</w>
athero thrombosis.</w>
ather o-
athe rectomy</w>
atenolo l-verapamil</w>
atenolo l)</w>
aten olol-induced</w>
aten ess</w>
ate-Lip uro</w>
ate- pretreatment</w>
ate- mefloquine</w>
ate- 3,7-disulfate</w>
ate urs</w>
ate ]</w>
ate ?</w>
at- risk"</w>
at- Core</w>
at tus</w>
at tested</w>
at tent
at tained,</w>
at tain
at resi
at ox
at m,</w>
at ever</w>
at RA.</w>
asystol es</w>
asystol e;</w>
asystol e:</w>
asymptomatic )</w>
asymptom atically</w>
asymmetr ically</w>
asymmetr ic,</w>
asym metry.</w>
astronaut s.</w>
astrocyt omas</w>
astrocyt omas,</w>
astrocyt oma.</w>
astrocyt oma,</w>
astro gliosis.</w>
astro gliosis,</w>
astro glia-
astr in</w>
astigm atism,</w>
asthenia/ fatigue</w>
asth ma:</w>
astat in,</w>
ast ute</w>
ast at</w>
ast ,</w>
assur ingly,</w>
assur ance</w>
assum ption.</w>
assu med.</w>
associ ational</w>
assi g
asses sed:</w>
assay ing</w>
assay ed,</w>
assa y-guided</w>
ass aults</w>
aspirin/ nonsteroidal</w>
aspirin- intolerant</w>
aspirin- containing</w>
aspirin- -a</w>
aspir in-related</w>
aspir ations</w>
aspergillo sis:</w>
aspect ,</w>
asparagin ase,</w>
asleep "</w>
asi ati
asi as</w>
ash wagandha</w>
ase- line</w>
ase (s)</w>
ascrib able</w>
asc itis,</w>
asc end
asak i</w>
as/ arthralgias</w>
as- yet-unidentified</w>
as yn
as tig
as ini</w>
as i</w>
as citic</w>
as can</w>
as :
as: MR
as:MR C
as:MRC (WI)
as:MRC(WI) BR</w>
aryng oscopy</w>
aryl- piperazine</w>
aryl- 7-
aryl-7- isopropylquinazolinones</w>
aryl sulfatase</w>
aryl piperazin-1-yl)-2-
aryl pempidine</w>
ary 's</w>
arvan il,</w>
arub icin)</w>
artic ulation</w>
arti facts</w>
arti fact.</w>
arthrogrypo sis</w>
arthrogrypo sis.</w>
arthrogr yposis,</w>
arthro plasties</w>
arthralgi as.</w>
arth rosis</w>
artesun ate,</w>
arteriol e.</w>
arterio- venous</w>
arterio pathy.</w>
arterio graphy:</w>
arterial- jugular</w>
arterial- coronary</w>
arteri es)</w>
arter y;</w>
arter y.
arte ren
art a</w>
arryth mogenic</w>
arryth mias</w>
arri ving</w>
arrhythmo genicity.</w>
arrhythmias ).</w>
arrhythmia .4.</w>
arrhythm ia-
arrhythm ia)</w>
arrhythm ia),</w>
arrest s,</w>
arrest :</w>
arrest -specific</w>
arrang ements</w>
arrang ement</w>
arra yed</w>
arr hy
armit al
armital ia-Carlo</w>
armament ari
armamentari um.</w>
arm rest</w>
arke med
ark -type</w>
aripiprazol e)</w>
arib bean</w>
ari wise,</w>
ari ses,</w>
ari se,</w>
arginine- NO-cGMP</w>
argin ine.</w>
argin ine
arge -
argatrob an)</w>
arg o,</w>
aren a</w>
aren a.</w>
areflex ic</w>
areflex ia</w>
are al</w>
are a-
area- under-
are )</w>
ardi ox
ard wood</w>
architect on
arch es.</w>
arc a</w>
arc .</w>
arbitr arily</w>
arb ors</w>
arachid onyl</w>
arach lorophenylalanine</w>
arac ervical</w>
arabinofuranos ylcytosine</w>
arabino side-induced</w>
arab ine-induced</w>
ara- c</w>
ara- CTP</w>
ar ylated</w>
ar um,</w>
ar ting</w>
ar th</w>
ar sen</w>
ar ms)</w>
ar m-
ar icus</w>
ar d,</w>
ar chi
ar ched</w>
ar ca,</w>
ar auna)</w>
ar arauna)</w>
ar a</w>
ar -treated</w>
ar ).</w>
aquaporin- 8</w>
aquaporin- 2,</w>
aqu ine-induced</w>
aprotin in,</w>
apraclon idine-treated</w>
approxim al</w>
appropri ateness</w>
appropri ately,</w>
appro ve</w>
apprehen sion</w>
appreci ation</w>
appreci ated,</w>
appoint ment</w>
appoint ment,</w>
applic able.</w>
applic able,</w>
appetite- suppressants</w>
append icular</w>
append ectomy</w>
append age</w>
appear ances.</w>
appear ances,</w>
appear .</w>
app raised</w>
app raise</w>
app iness</w>
app endix</w>
apopto sis-related</w>
apomorph ine:</w>
apoC- III</w>
apoA- II</w>
apoA- I.</w>
apo B,</w>
apnoe ic-tonic</w>
apne a:</w>
apl erotic</w>
apl asia:</w>
apl an</w>
aphere sis.</w>
aph rodisiac</w>
aph ak
aper ta.</w>
aper ta,</w>
ap ulmonary</w>
ap t</w>
ap sing</w>
ap rinast</w>
ap ram,</w>
ap prehensive</w>
ap position</w>
ap onidine</w>
ap lan-Mei
ap lac
ap ine-associated</w>
ap gar</w>
ap e</w>
aorto- caval</w>
aorto femoral</w>
aorta e</w>
aorta /
aorta/ serum-ratio</w>
aort ocoronary</w>
aort ocaval</w>
aor tobiprofunda</w>
aor tic-
aor tic,</w>
any time</w>
any thing</w>
anxiety/ somatization,</w>
anxiet y).</w>
anxiet y"</w>
anxi ous/depressive</w>
anxi ous.</w>
anxi ous,</w>
antr one,</w>
antr al</w>
anto ins</w>
anto in,</w>
antitus sive,</w>
antisen se-treated</w>
antiretrovir als.</w>
antiretrovir al-
antiretroviral- naive</w>
antipyretic ,</w>
antipyr ine,</w>
antipsychotic -treated</w>
antipsychotic -associated</w>
antipsycho tics:</w>
antipsycho tic-drug-induced</w>
antinocicep tive,</w>
antineoplas tic,</w>
antine oplasic</w>
antinause a</w>
antimicrobi als.</w>
antimicro tubule</w>
antimalari al.</w>
antihistamin ics,</w>
antigen- seropositive</w>
antigen emia.</w>
antigen -negative</w>
antigen -125</w>
antigen ),</w>
antieme tic.</w>
antidot e,</w>
antidepressant "</w>
anticonvulsant s),</w>
anticonvulsant -exposed</w>
anticonvuls ant-induced</w>
anticoagul ated.</w>
anticoagul ate</w>
anticholinerg ic.</w>
antibody :</w>
antibody -</w>
antibody )</w>
antibio tics:</w>
antibio tic-resistant</w>
antibio tic-associated</w>
anti-eme tic,</w>
anti-aggreg atory</w>
anti-LK M</w>
anti-HB s-
anti-HB s,</w>
anti-HB c-positive</w>
anti-Go alpha
anti-Gi alpha
anti- thrombotic</w>
anti- somatostatin</w>
anti- slit</w>
anti- sense</w>
anti- rhinitis</w>
anti- rheumatic</w>
anti- rat</w>
anti- psychotic</w>
anti- psycho
anti- proteinase</w>
anti- penicillin</w>
anti- oxidative</w>
anti- liver-kidney</w>
anti- leukocyte</w>
anti- idiotypic</w>
anti- hyperlipidemic</w>
anti- hyperalgesia</w>
anti- histone</w>
anti- glaucoma</w>
anti- estrogenic</w>
anti- epileptics</w>
anti- double-stranded</w>
anti- convulsive</w>
anti- cardiolipin</w>
anti- bacterial</w>
anti- arthralgia</w>
anti- angiogenic</w>
anti- angio
anti-angio genic,</w>
anti- anemic</w>
anti- amnestic</w>
anti- alpha-adrenergic</w>
anti- allodynia</w>
anti- aldolase</w>
anti- adrenergic</w>
anti- T</w>
anti- PD</w>
anti- Jo-1</w>
anti- IL-1</w>
anti- IL-17</w>
anti- Helicobacter</w>
anti- HIV-1</w>
anti- H/PF4</w>
anti- CocE</w>
anti- CN</w>
anti- CMV</w>
anti tumorigenic</w>
anti tremor</w>
anti thyroid
anti thrombotics</w>
anti sympathetic</w>
anti stress</w>
anti staphylococcal</w>
anti spasmodic</w>
anti sialo
anti serotonin</w>
anti serotonergic,</w>
anti sera.</w>
anti schizophrenic</w>
anti rifampin</w>
anti peroxidative</w>
anti peroxidative,</w>
anti parkinsonism</w>
anti parasitic</w>
anti pamezole.</w>
anti organelle</w>
anti oestrogen</w>
anti obsessional</w>
anti obesity</w>
anti myeloma</w>
anti myco
anti muscarine-induced</w>
anti metabolite,</w>
anti metabolic</w>
anti manic-like</w>
anti liver/kidney</w>
anti ischemic</w>
anti inflammatory,</w>
anti hyperlipidaemic</w>
anti human</w>
anti glucocorticoid</w>
anti glaucoma</w>
anti gest
anti folate</w>
anti epileptogen
anti cytoplasmic</w>
anti conflict</w>
anti cholestatic</w>
anti cataplectic</w>
anti arthritic</w>
anti androgenic</w>
anti allodynia</w>
anti allergic</w>
anti HB
antiHB c</w>
anthraquin ones.</w>
anthran ilic</w>
anthracycline- resistant</w>
anthracycl ine/
anthracycl ine.</w>
anthracycl ine-related</w>
anthracycl ine-containing</w>
anthrac yl
anth osis,</w>
anth opanax</w>
anth amine</w>
anterior- posterior</w>
anteri or/
anter olateral</w>
antec ollis</w>
ante -</w>
antagonist/ inverse</w>
antagonist "</w>
ant- injected</w>
ant ine</w>
ant e</w>
ant azol
ant ages</w>
ant acids,</w>
answe red.</w>
answ ers</w>
anser in:</w>
anorexi gen</w>
anorex ia:</w>
anopthal mia,</w>
anomal oscop
anom aly:</w>
ano yl
ano derma</w>
annulo plasty</w>
annu um</w>
annu um,</w>
annabin oids</w>
ann esburg,</w>
anisomet ropia</w>
anisocor ia.</w>
anir acetam</w>
anir acetam,</w>
animal s).</w>
animal ).</w>
animal )-induced</w>
anil ine,</w>
anhydr ase,</w>
anhedon ia,</w>
angu ineous</w>
angiotensin- releasing</w>
angiotensin ogen.</w>
angiotensin ogen,</w>
angiotens ine-converting</w>
angiotens in-induced</w>
angiotens in,</w>
angioten sion-converting</w>
angiopo etin-2</w>
angiograph y)</w>
angio plast
angio grams,</w>
angio dema</w>
angio degeneration</w>
angin a;</w>
angin a:</w>
angi oscopy</w>
angi oscopically</w>
angi omatoid</w>
ang ulation</w>
ang ry-aggressive</w>
ang er,</w>
ang -H
ang-H sieh-Hsin-Tang</w>
ang )</w>
aneur ymal</w>
anesthetic- kindled</w>
anesthetic s-induced</w>
anesthetic s)</w>
anestheti sts</w>
anestheti st.</w>
anesthesia -associated</w>
anesthesi ology</w>
anesthesi as</w>
anesthesi a--a</w>
anesthesi a)</w>
anesthesi a).</w>
anesthesi a),</w>
anesthe tics:</w>
aneous '</w>
anem ones</w>
anem one</w>
anem ic,</w>
anem ia?</w>
anedi ones</w>
ane -</w>
androgen s,</w>
androgen -related</w>
and- Resistant</w>
and ler</w>
and atory</w>
and --
ancestr y.</w>
anc hester</w>
anatom ical,</w>
anastro zole,</w>
anas arca</w>
anas arca,</w>
anaphyl ac
anap olis,</w>
analyz ed:</w>
analysis ,"</w>
analyser .</w>
analogu e).</w>
analgesic- antipyretic
analgesic -associated</w>
analgesic )</w>
anal go
anal buminaemic</w>
anal ,</w>
anaestheti sts</w>
anaestheti sts,</w>
anaesthesi a-induced</w>
anaesthe tized,</w>
an-3-yl) -1,3-dipropyl
an-3-yl)-1,3-dipropyl xanthine),</w>
an- 6,7-
an-6,7- endo
an- 4-
an- 3</w>
an yl)</w>
an y.</w>
an y)</w>
an us,</w>
an uric.</w>
an sidar).</w>
an seviera</w>
an sa</w>
an s)</w>
an oxic-ischemic</w>
an ox
an osis</w>
an orgasmia,</w>
an ophthalmia</w>
an ol)</w>
an ol
an oid/Suspicious</w>
an ionic,</w>
an ing</w>
an ian</w>
an hydride</w>
an g</w>
an erg
an el
an choring</w>
an bian</w>
an ation</w>
an ase</w>
an aplerotic</w>
an agreli
an a.</w>
an a,</w>
amyloid- beta</w>
amygdalo allocortical</w>
amygdal ar</w>
amygdal a)</w>
amput ations.</w>
ampren avir/fosamprenavir</w>
amplifi ers</w>
amplifi er</w>
ampl ifies</w>
ampicillin- chloramphenicol</w>
ampicill in-sensitive</w>
ampicill in-resistant</w>
ampicill in-associated</w>
amphoter icin.</w>
amphoter icin,</w>
amphetamine- related</w>
amphetamine- regulated</w>
amphet amine:</w>
amphet amine)</w>
amphet amine's</w>
amph o
amp s</w>
amoxycillin-clavulan ate</w>
amoxycillin-clavulan ate.</w>
amox apine,</w>
amox ).</w>
amoun t,</w>
amorph ous</w>
amoeb ic</w>
amo setron</w>
amni on
amni ocentesis</w>
amnesi a?</w>
amnesi a).</w>
amnesi a),</w>
ammon ium,</w>
ammon emic</w>
amlodip ine-treated</w>
amitriptyl ine/
amitriptyl ine-
amitript yt
amisulpri de-induced</w>
aminophylline /kg</w>
aminophyll ine-treated</w>
aminophen azone,</w>
aminop eptidase,</w>
aminonucleoside- nephrotic</w>
aminoglycoside- iron</w>
aminoglyco side-related</w>
aminocyclopentane-1,3- dicarboxylate</w>
amino]- 5'-N-ethyl
amino- peptidase</w>
amino- oxyacetic</w>
amino- nucleoside</w>
amino- l-methylbutyl)amino]-</w>
amino- caproic</w>
amino- 5-
amino-5- chlorobenzoic</w>
amino- 2-(2-
amino)- tetralin</w>
amino)- ethylphosphorothioic</w>
amino)- 4-
amino) ethylphosphorothioic</w>
amino }-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acet
amino steroid</w>
amino steroid-based</w>
amino propyl-diethoxy-methyl-phosphinic</w>
amino guanidine.</w>
amino glutethimide.</w>
amine- like</w>
amin ot
amin opyridazine</w>
amin omethyl</w>
amin ocyclo-pentane-1,3,4-tricarboxylic</w>
amin obenzo
amin 1A</w>
amilor ide-induced</w>
amilor ide-hydrochlorothiazide</w>
amik acin,</w>
amifost ine)</w>
amide- sensitive</w>
amid o-
amid ine,</w>
ami bi-SPECT/dobutamine</w>
amezin ium</w>
amethyl cyclotetrasiloxane</w>
amenorrhe a/
ame work.</w>
ame f
ame bic</w>
ambul ate,</w>
ambigu us</w>
am ics</w>
am fepramone</w>
am et
am ended</w>
am bulometer.</w>
am blyopia.</w>
am azole</w>
am )</w>
am ):</w>
aly ),</w>
alveol itis.</w>
alve olar-arterial</w>
altitu de.</w>
alternati ves,</w>
altern ating-therapy</w>
altern ans,</w>
alteplas e-associated</w>
alprazolam ).</w>
alprazol am-induced</w>
alphax alone</w>
alpha7- subunit</w>
alpha7- containing</w>
alpha4- containing</w>
alpha4 beta2</w>
alpha2ABC- /-
alpha2ABC-/- ).</w>
alpha2- agonists</w>
alpha2- agonists.</w>
alpha2- /
alpha2-/ I1-receptor</w>
alpha2 delta</w>
alpha1- receptors</w>
alpha/ gamma</w>
alpha/ beta</w>
alpha/ beta-ratio</w>
alpha-tropan yl-2-
alpha-synucle in.</w>
alpha-phenyl-N- tert-butyl</w>
alpha-naphthylisothiocyan ate,</w>
alpha-naph tho
alpha-methyldopa -type</w>
alpha-methyl- gamma-thiobutyrolactone</w>
alpha-methyl- 5-hydroxytryptamine</w>
alpha-methyl tyrosine</w>
alpha-methyl paratyrosine,</w>
alpha-methyl methionine</w>
alpha-methyl dopa-estrogen</w>
alpha-mangost in,</w>
alpha-keto acid</w>
alpha-fet oprotein,</w>
alpha-ethyl- alpha-methyl-gamma-thiobutyrolactone</w>
alpha-amino-3-hydroxy-5-methylisoxazole-4- proprionic</w>
alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic</w>
alpha-OH- DHP</w>
alpha-Methyl histamine</w>
alpha-M p
alpha-A man
alpha-1- anti
alpha-1- acid</w>
alpha-( prop-1-
alpha- receptors.</w>
alpha- positive</w>
alpha- phenylnitrone</w>
alpha- p-chlorophenoxyisobut
alpha- oxoglutarate</w>
alpha- ol-20-one</w>
alpha- myosin</w>
alpha- mercaptopropionyl</w>
alpha- melan
alpha- mediated,</w>
alpha- man
alpha- interferon</w>
alpha- hydroxymetoprolol</w>
alpha- hydroxybutyrate</w>
alpha- hydroxy</w>
alpha- glycylglycinanilide</w>
alpha- ethylmethionine</w>
alpha- ethyl</w>
alpha- ethinyl</w>
alpha- erg
alpha- chloralose.</w>
alpha- carbon
alpha- atrial</w>
alpha- amino
alpha- alkyl</w>
alpha- agonist,</w>
alpha- adrenoreceptors.</w>
alpha- adrenoceptor-mediated</w>
alpha- adrenoceptor-blocking</w>
alpha- adrenoceptor
alpha-adrenoceptor s)</w>
alpha- activity</w>
alpha- [bis
alpha-[bis (4'-fluorophenyl)
alpha-[bis(4'-fluorophenyl) metoxy]-tropane</w>
alpha- Toc
alpha-Toc opherol</w>
alpha- TA
alpha-TA c</w>
alpha- T</w>
alpha- Pregn
alpha-Pregn an-3</w>
alpha- Methyldopa</w>
alpha- MT</w>
alpha- MT,</w>
alpha- GST</w>
alpha- ENaC,</w>
alpha- EH
alpha,beta- epoxy-carvone</w>
alpha,alpha'- diethyl-4,4'-stilbene
alpha,alpha'- bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene</w>
alpha,5alpha- THP)</w>
alpha, 3</w>
alpha(q )</w>
alpha(q )-deficient</w>
alpha(2)- agonist</w>
alpha(2)- adrenoceptors,</w>
alpha(1)- subunit</w>
alpha(1)- adrenoreceptors</w>
alpha(1)- adrenoceptors.</w>
alpha(1)- adrenoceptors,</w>
alpha(1)- Adrenoceptor</w>
alpha MT</w>
alpha ENaC</w>
alpha C-
alphaC- Glu
alphaC-Glu -out</w>
alpha ;</w>
alpha 3,</w>
alpha 2C</w>
alpha 2-receptor</w>
alpha -1
alpha (5)</w>
alpha (5
alpha(5 )-containing</w>
almotript an.</w>
allyl glycine.</w>
allyl glycine-induced</w>
allyl glycine,</w>
ally- intact</w>
allox an-induced</w>
allowe d;</w>
allodynia/ hyperalgesia</w>
allodyn ia-like</w>
allodyn ia),</w>
allo tannin</w>
allevi ated,</w>
allergen s</w>
allergen s.</w>
allerg ic-type</w>
alle olar</w>
alle les,</w>
alle ja</w>
all-trans -</w>
all-or- none</w>
all y:</w>
all istic</w>
all eng
all as</w>
all antoin,</w>
all -</w>
all ).</w>
all "</w>
alkyl/aryl- 8-(
alkyl/aryl-8-( furan-2-yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thiones</w>
alkyl pyrazine</w>
alkalo tic</w>
alkalo id-induced</w>
alkalin ize</w>
alkalin ization.</w>
alkal i-loaded</w>
alkal i,</w>
alk oxyresorufin</w>
alin idine.</w>
alin idine,</w>
ali qu
ali phatic</w>
algorith ms</w>
algorith m.</w>
algi as,</w>
alga )</w>
alg ometry</w>
alg ogenic</w>
alg ia:</w>
alfuz osin.</w>
alfuz osin-induced</w>
alfentan il-
alfa 2b</w>
alf a.</w>
alf a,</w>
aler t)</w>
alendron ate,</w>
alendron ate)</w>
aldosterone- sensitive</w>
aldoster one.</w>
aldoster one-induced</w>
alcohol- na</w>
alcohol ics.</w>
albuter ol)</w>
albumin/ globulin</w>
albumin/ creatinine</w>
albumin ;</w>
albumin -deficient</w>
albumin ).</w>
albic ans</w>
albic ans.</w>
alben dazole.</w>
alb ifron
alaprocl ate.</w>
alan ine.</w>
alan ine,</w>
al- dependent</w>
al- constriction,</w>
al- He
al y</w>
al um.</w>
al s)</w>
al prosta
al pidem,</w>
al ong
al li
al ized,</w>
al iz
al in)</w>
al e.</w>
al d</w>
al cur
al ateral</w>
al amine</w>
al adenitis</w>
al a,</w>
akinesia/ catalepsy</w>
akine tic.</w>
akine sis,</w>
akathi si
ak ist
ak in</w>
ak arta</w>
aj dela</w>
air y</w>
air ways.</w>
air way,</w>
air ,</w>
ain )</w>
ail y,</w>
ail ments</w>
ail ments,</w>
aiko- ka-ryukotsu-borei-
ai er</w>
agra ,</w>
agonist- stimulated</w>
agonist s;</w>
agonist :</w>
agonist -evoked</w>
agonist )-induced</w>
agon -like</w>
agit ation;</w>
agit ation/
aggres sions</w>
aggres sion;</w>
aggres ome</w>
aggreg ation-
aggrav ated,</w>
agglut inated</w>
agent :</w>
agent -
agent ).</w>
agent "</w>
agene sis.</w>
age/ gender-matched</w>
age- related,</w>
age- matched,</w>
age- incidence</w>
age- groups</w>
age- dependency</w>
age ing.</w>
age =
age "</w>
agam et
ag rin</w>
ag rin,</w>
ag os</w>
ag lu
ag late,</w>
ag ination</w>
ag ett</w>
ag encies,</w>
ag ed)</w>
ag awa</w>
ag ascan</w>
ag ar</w>
afterwar d,</w>
afterno on,</w>
after- effects.</w>
after- discharges</w>
after- depolarizations</w>
after ward</w>
after ward.</w>
after math</w>
after discharge.</w>
after )</w>
after "</w>
affir m</w>
affect ed;</w>
affect ed:</w>
affect ed"</w>
affect .</w>
aff lu
aff in</w>
aff er</w>
afebri le,</w>
af tereff
af latoxin</w>
af ine-induced</w>
af a
afa elson</w>
aer obic/anaerobic</w>
aer ial</w>
aem acce
aemacce l)</w>
adverse- effect</w>
adver se.</w>
adventi tia</w>
advantage ous.</w>
advant ages.</w>
advant ages,</w>
advant age.</w>
advance d/metastatic</w>
advance d-stage</w>
adv ice.</w>
adv ance.</w>
adulter ants</w>
adulter ant.</w>
adul t:</w>
adsor ption,</w>
adrib ine</w>
adriamycin- hypertensive</w>
adriamyc inone,</w>
adriamyc in;</w>
adriamyc in:</w>
adriamyc in-14-valerate</w>
adrenocortic otrophin-induced</w>
adrenoceptor s:</w>
adrenoceptor ;</w>
adreno receptors,</w>
adrenergic- neurone</w>
adrenerg ic-induced</w>
adrenaline- secreting</w>
adrenaline- hypertension</w>
adrenal ine.
adrenal ine-evoked</w>
adrenal ine-</w>
adrenal ine-,</w>
adrenal in-induced</w>
adrenal in,</w>
adop ting</w>
adop ted.</w>
adop t</w>
adolescent :</w>
adolescent ,</w>
adolesc ence,</w>
admit tance.</w>
admis sions)</w>
admis sion),</w>
administr ation.(ABSTRACT</w>
administ rating</w>
administ rated.</w>
administ er,</w>
adjuv ant-induced</w>
adjust ments,</w>
adjust ment)</w>
adjust ed-
adjudic ation</w>
adip ocytes</w>
adi rachta</w>
adi al</w>
adhe sions.</w>
adequ ately.</w>
adenosine- receptor</w>
adenosine- hyperemia</w>
adenosine- 5'-triphosphate</w>
adenosine- 3'
adenosine-3' 5'-
adenosine-3'5'- monophospho
adenos ylmethion
adenos quamous</w>
adenos ine-</w>
adenos ine),</w>
adenos ine
adenomyo sis.</w>
adenom as/
adenoid ectomy.</w>
adenohypophy sis.</w>
adenocarcin oma:</w>
adenocarcin oid</w>
adeno hypophyseal</w>
adeno -</w>
aden oid</w>
aden o-associated</w>
adec apeptide</w>
ade x</w>
ade metionine</w>
adduct s/10(8)</w>
adduct ors</w>
adduct ors.</w>
addres sed,</w>
addic ts:</w>
addic tion;</w>
addi tivity</w>
addi tives,</w>
adap tor</w>
adap togenic</w>
adap tive.</w>
adap tation.</w>
adamant yl)
adamant an-3-yl)-1,3-dipropylxanthine),</w>
ad sorbed</w>
ad ri
ad n</w>
ad m.)</w>
ad in</w>
ad here</w>
ad ducts,</w>
ad a</w>
acu points</w>
acu points,</w>
acu ities</w>
actomy osin.</w>
activity- dependent</w>
activi ties;</w>
active- comparator</w>
activation/ deactivation</w>
activ ity),</w>
activ ity
activ es</w>
activ ator
activ ation;</w>
activ ation)</w>
activ ation"</w>
actinomycin- D</w>
acti ve;</w>
acti le</w>
act one</w>
act inic</w>
act ing),</w>
act in)</w>
acromeg aly:</w>
acromeg aloid</w>
acrole in-induced</w>
acrole in-
acro melic</w>
acro iliitis</w>
acridin ecarboxamide)</w>
acri flavine</w>
acqu ain
acitret in-induced</w>
acidi fication.</w>
acidi fication,</w>
acid- transmitted</w>
acid- loaded</w>
acid+ ascorbic</w>
acid uria</w>
acid s)</w>
acid osis;</w>
acid ]</w>
acid B</w>
acid -dependent</w>
acid ).</w>
achloro phenol</w>
achie ved:</w>
ache .</w>
ach ing,</w>
acetylmethad ol,</w>
acetylchol ine-
acetyl- beta-methylcholine</w>
acetyl- Co
acetyl-Co A/
acetyl-CoA/ CoA-SH,</w>
acetyl salicylate,</w>
acetyl promazine</w>
acetyl cysteine,</w>
acetyl cholinesterases</w>
acetyl cholinergic</w>
acetyl ator
acety choline</w>
acetazol amide-associated</w>
acetaminophen -mediated</w>
acet one.</w>
acet on
acet ohex
acet o-acetate/3-hydroxybutyrate)</w>
acet ate)</w>
acet anilide</w>
acet anil
acet amide]</w>
acepromaz ine-treated</w>
acenoc oumarol</w>
aceclofen ac-treated</w>
acebut olol.</w>
acebut olol-induced</w>
acea e).</w>
ace tic-acid-induced</w>
accurac y.</w>
accurac y).</w>
accumb ens
accru ed.</w>
accru ed,</w>
accru al,</w>
accompl ish</w>
accom modates</w>
acclim atization</w>
acclim ated</w>
accid ent,</w>
accept ing</w>
accept able,</w>
accept ability.</w>
accentu ated.</w>
accentu ante</w>
accelerome ters,</w>
acceler ometry</w>
acceler ometric</w>
acceler ated,</w>
acampros ate.</w>
ac yl-
ac utiloba</w>
ac uit
ac tis</w>
ac tion:</w>
ac then</w>
ac ity</w>
ac in)</w>
ac i
ac eponate</w>
ac emide,</w>
ac ellular</w>
ac e</w>
ac cordingly,</w>
ac anthosis,</w>
ac -specific</w>
abuse/ dependence,</w>
abuse -related</w>
abuse -associated</w>
abund ant.</w>
abund ant,</w>
abund ances</w>
abund ance.</w>
abstr acted,</w>
absten tion,</w>
absorpti ometry</w>
absorp tion-limiting</w>
absorb ent</w>
absorb ance.</w>
absor ptive</w>
absor ptions</w>
absen ce-like</w>
abrupt ness</w>
abro gation</w>
abro ad</w>
above- knee</w>
aborti facient</w>
abor ted.</w>
abol ish,</w>
abol ,</w>
abo ve)</w>
abo ve).</w>
abnormal ity;</w>
abnormal /
abnormal/ normal</w>
able .(ABSTRACT</w>
abl es.</w>
abl ations</w>
abil ization</w>
aberr ations.</w>
aberr ations,</w>
aben dazole</w>
abecarn il
abdomin al-constriction,</w>
aband on</w>
aband on
abac avir.</w>
ab user,</w>
ab used.</w>
ab s.</w>
ab ru
ab ating</w>
ab atement</w>
ab ate</w>
ab a
ab )</w>
aV L</w>
aV L,</w>
aPTT s</w>
aPTT s.</w>
a/ vomiting</w>
a/ nicotine</w>
a/ a</w>
a/ UC
a/UC r</w>
a/ IL-1b</w>
a. m.)</w>
a-actin in,</w>
a- syntrophin</w>
a- rod</w>
a- e)</w>
a- alkaloid-induced</w>
a- adrenoceptor</w>
a) quinoxalin-1-one</w>
a) )(-/-)</w>
a weed</w>
a vul
a ural</w>
a uraceae)</w>
a sibility</w>
a roused.</w>
a periodic</w>
a it</w>
a il</w>
a histine,</w>
a head</w>
a had</w>
a etiologic</w>
a SAH.</w>
a R,
a HUS</w>
a 3</w>
a ))</w>
_ E).</w>
_ C_
] oct-2-ene-2-
] o,</w>
] o)</w>
] ammonia</w>
] ANG</w>
] )-
[bis(4-fluorophenyl)methoxy] ethyl]-4-(3-phenylpropyl)piperazine</w>
[[2- methoxy-4-[(methylsulphonyl)amino]phenyl]amino]</w>
[[ (5-
[Sar 1,</w>
[SI OP</w>
[SD ])</w>
[S etkowicz,</w>
[S charfman</w>
[S BP
[RR ],</w>
[P ],</w>
[OR ]:</w>
[Na ]o,</w>
[NS ]).</w>
[Mg2+] i</w>
[MAP ]</w>
[M SD
[Leu 31,
[Leu31, Pro
[Leu31,Pro 34]-
[Leu31,Pro34]- NPY</w>
[LVE F]</w>
[IV A]).</w>
[Hyp 3,Thi5,
[Hyp3,Thi5, D-Tic
[Hyp3,Thi5,D-Tic 7,
[Hyp3,Thi5,D-Tic7, Oic
[Hyp3,Thi5,D-Tic7,Oic 8]</w>
[H (+)]
[DBP ],</w>
[D- Ala
[Ca2+] i.</w>
[Ca ]o)</w>
[CMF ]</w>
[AUC ],</w>
[ASA ]</w>
[A ley</w>
[8 5%
[7- acetyl-
[7- (2-
[7 ]</w>
[5-amino- 7-(2-
[5-amino-7-(2- phenylethyl)-2-(2-furyl)-pyrazolo[4,3-epsilon]-1,2,4-
[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]- N-(2-pyridin
[4- [2-
[4- (7-
[4- (4-fluorophenyl)
[4- (4-
[4- (2,6-di
[4- (2,3-
[4-(2,3- dichlorophenyl)-1-piperazinyl]butyloxy)-
[4,3- a]</w>
[4, 7-
[4,7- dimethoxy-6-(2-
[4, 5]dec
[4 %])</w>
[3H]- glucosamine</w>
[3H]- flumazenil</w>
[3H]- MK-801</w>
[3H]- L-arginine</w>
[3H] spiroperidol</w>
[3H] raclopride</w>
[3H] nimodipine</w>
[3H] inulin</w>
[3H] hemicholinium-3</w>
[3H] flumazenil</w>
[3H] dihydroalprenolol</w>
[3H] acetylcholine</w>
[3H] [3-
[3H][3- Me-
[3H][3-Me- His
[3H][3-Me-His 2]
[3H] SCH</w>
[3H] QNB</w>
[3H] Nimodipine</w>
[3H] M
[3H]M us</w>
[3H] Flu</w>
[3H] E217
[3H]E217 G.</w>
[3H] 4-
[3H]4- benzylpempidine</w>
[3- (di
[3 H
[3H 1]
[3 6
[3 3
[27 %]).</w>
[22 21</w>
[2-(3,4-dichlorophenyl)ethyl]- 4-methyl
[2-(3,4-dichlorophenyl)ethyl]-4-methyl piperazine),</w>
[2- phenyl-4,</w>
[2- (1-
[1998 b]</w>
[199 9]</w>
[199 6]</w>
[199 3]</w>
[18]-FDG- PET</w>
[14C]- leucine</w>
[14C] deoxyglucose</w>
[14C] 2-deoxyglucose</w>
[13 N
[13N ]ammonia</w>
[125I] omega-conotoxin</w>
[125I] alpha-bungarotoxin</w>
[125I] C
[125I]C gTX</w>
[125 I
[11C]-car fentanil</w>
[11 %]),</w>
[10 %]),</w>
[1-1 4C]
[1,25(OH)2D 3]</w>
[1,2,4 ]</w>
[1, 24-(OH)(2)
[0.2 8-
[(pF)Phe (4
[(pF)Phe(4 )]
[(R,S)- 3,4-DCPG
[(35)S] GTPgammaS</w>
[(3)H] norepinephrine</w>
[(-)- naloxone],</w>
[(-)- 2-
[(+/-)- PG-
[(+/-)-PG- 9]</w>
[(+)- naloxone],</w>
[ total</w>
[ thiobarbituric</w>
[ test</w>
[ standard</w>
[ racemate</w>
[ pure</w>
[ peak</w>
[ pantothenate</w>
[ optical</w>
[ mmol/L]</w>
[ leuprolide</w>
[ ip])</w>
[ i
[ hazard</w>
[ group</w>
[ from</w>
[ dexamethasone/
[ deterioration</w>
[ defined</w>
[ control</w>
[ both,</w>
[ beta]-
[ approximately</w>
[ about</w>
[ a]</w>
[ a</w>
[ WH
[WH O]</w>
[ W
[ U
[U -14C]
[ Td
[Td P
[TdP ])</w>
[ Sh
[ Se
[ SSR
[SSR Is
[SSRIs ]),</w>
[ SS
[SS ]</w>
[ SRL</w>
[ SEM
[ S3
[ S-2-(3-aminopropyl
[S-2-(3-aminopropyl amino)ethylphosphorothioic</w>
[ R
[ PT
[ PR
[ P2
[P2 ]</w>
[ Neuro
[ NP
[NP he(1)]
[ N-[4-
[N-[4- (4-(2-methoxyphenyl)
[N-[4-(4-(2-methoxyphenyl) piperazinyl)butyl]-2-naphthamide]</w>
[ MTX</w>
[ ME
[ MD
[ Ile
[Ile 7
[Ile7 ]ANG</w>
[ IP
[ IF</w>
[ I
[I QR
[ Gly
[ GM
[ F</w>
[ E
[ DMSO
[DMSO ])</w>
[ C]</w>
[ CR
[ CI</w>
[ CH
[ CFU-
[ CAD
[ C
[ BP]</w>
[ Amp
[ AZT
[ ATP
[ATP ]</w>
[ AM
[ AC
[ A</w>
[ >or=
[>or= ]</w>
[ 9</w>
[ 80</w>
[ 8/
[8/ 33
[8/33 ]);</w>
[ 8.6</w>
[ 8.
[ 73
[ 6]</w>
[ 6</w>
[ 69
[ 6.0
[ 6
[ 5]</w>
[ 5.8
[5.8 5]</w>
[ 5.3
[ 5-hydroxytryptamine</w>
[ 4]</w>
[ 4'-
[4'- (2-hydroxy-3-
[ 30</w>
[ 2]</w>
[ 26</w>
[ 26-
[ 20</w>
[ 2-</w>
[ 197
[197 3]</w>
[ 17.
[ 14.
[ 11</w>
[ 1.5-
[ 1.3
[ 1.11</w>
[ 1,25-(OH)(2)
[1,25-(OH)(2) D(3
[1,25-(OH)(2)D(3 )]</w>
[ 0.8
[ 0.70
[0.70 ]</w>
[ 0-
[ -
[ (R-(+)-
[(R-(+)- trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol)]</w>
[ (E)-
[ (E
[(E )-1-
[ (DENA)</w>
[ (</w>
[ (4-
[(4- amino-l-methylbutyl)amino]-</w>
[ (15)
[ (14)C]
Zyb an</w>
Zop iclone</w>
Zop iclon
Zol mitriptan</w>
Zol edronic</w>
Zn /g</w>
Zn (2
Zn(2 +).</w>
Ziprasid one,</w>
Zin ec
Zidovud ine-related</w>
Zeal and.</w>
Ze brafish</w>
Zaf irlukast</w>
Zaf irlukast
ZI- LH</w>
ZD V.</w>
Z- RAD</w>
Z- 0
Z ung-Conde</w>
Z omep
Z n.</w>
Z n-superoxide</w>
Z n-SOD</w>
Z icon
Z er
Z eniplatin</w>
Z aprinast</w>
Z ajdela</w>
Z TP
ZTP ;</w>
Z R.</w>
Z I)</w>
Z .,</w>
Z -</w>
Z )-</w>
Youn g-onset</w>
Yohimb ine-induced</w>
Yel low</w>
YM SM
YM 872,</w>
YM 264,</w>
Y56 9F/Y569
Y569F/Y569 F)</w>
Y56 7-
Y- MRS</w>
Y- 0
Y ersinia</w>
Y anbian</w>
Y Z-0
Y RW
YRW R-
YRWR- NH
Y OH</w>
Y OH
Y 719
Y (3-
Y(3- Cl
Y(3-Cl )
Y(3-Cl) YRWR-NH
X/ X-
X-ra ys</w>
X-ra ys,</w>
X- mediated</w>
X- irradiated</w>
X- evoked</w>
X- Y</w>
X- 4.</w>
X- 4)</w>
X+ HP</w>
X yl
X Y</w>
X X
X TT</w>
X O.</w>
X L;</w>
X II.</w>
X II,</w>
X II
X D-
X AC.</w>
X -</w>
X -100</w>
X -100
X )-induced</w>
Wor tmann
Wor ld
With in-
Wit ness</w>
Wistar/ Furth</w>
Wist ars</w>
Wist ar,</w>
Wiscon sin</w>
Wilcox on).</w>
Wil lebrand's</w>
Wi der</w>
Whole- body</w>
Wh y</w>
Wh enever</w>
Wh en,</w>
Wh atever</w>
Wer dnig-Hoffmann</w>
Well- documented</w>
Well- Being</w>
Wee k
We aker</w>
Water- soluble</w>
Warfar in,</w>
War ren</w>
Walk er's</w>
Walden str</w>
WT s.</w>
WR-27 21,</w>
WM H,</w>
WK Y-
WK Y).</w>
WIN55,212- 2.</w>
WIN- 35
WIN-35 ,0
WIN-35,0 65-
WIL L</w>
WBCs/HP F</w>
WBCs/HP F,</w>
WB4 101</w>
WB RT</w>
WB C/
WAY 100635.</w>
WAR s,</w>
WAI CH.</w>
W/ Lac
W/Lac J</w>
W underlich</w>
W sl</w>
W s</w>
W right-
W o
W ills</w>
W ill
W et</w>
W ell</w>
W aukesha,</w>
W ak
W ag
W TM</w>
W TM
W T-
W S-
WS- 96</w>
W S).</w>
W O.</w>
W IP
WIP TI
W G),</w>
W F)</w>
W EB
WEB 20
W AR</w>
W AG
WAG /
WAG/ Rij</w>
W 3/
W3/ 25
W3/25 +</w>
W .)</w>
Volt age</w>
Viusi d,</w>
Virgin ia,</w>
Viol ence</w>
Vinorelb ine-related</w>
Vinorelb ine-induced</w>
Vinorelb ine-associated</w>
Vinorelb ine,</w>
Vinc a-alkaloid-induced</w>
Vin blastine</w>
Vigi base</w>
Vide o-EEG</w>
Victim s</w>
Vi usid
Vi agra,</w>
Ves sels</w>
Verapam il:</w>
Ver tigo</w>
Ver tical</w>
Ver tex-
Ver sion,</w>
Ventric u
Ventric le</w>
Venlafax ine,</w>
Veloc ity</w>
Vehicle -treated</w>
Vehic le</w>
Vehic le/drugs</w>
Vehic le,</w>
Ve getarians</w>
Vc f
Vasospas m-induced</w>
Vasodilat ors</w>
Vaso pressors</w>
Vaso pressor</w>
Vaso pressin-resistant</w>
Vas oconstriction</w>
Varic eal</w>
Vari ants</w>
Van inolol</w>
Van idilol</w>
Van idi
Van com
Valpro ate-associated</w>
Valg anciclovir</w>
Val ium</w>
Val acyclovir-induced</w>
Val 15
Val15 8
Vacuol ation</w>
Vac cination</w>
VT/ VF.</w>
VT A,</w>
VSM Cs.</w>
VR1- expressing</w>
VR- curve.</w>
VR T)</w>
VR C
VRC Z.</w>
VR 1,</w>
VPA- therapy</w>
VPA- Na
VPA-Na /kg</w>
VPA /day</w>
VPA /
VPA -related</w>
VPA ).</w>
VP-16- LV-
VP-16- 213</w>
VP-1 6,</w>
VP- stimulated</w>
VP 16-
VP16- 213</w>
VO2 peak</w>
VO 2,</w>
VO ,</w>
VO ),</w>
VO (2)</w>
VN C</w>
VM- containing</w>
VM L.</w>
VL S,</w>
VL M.</w>
VL M,</w>
VL BW
VLBW I</w>
VII I)</w>
VI STA</w>
VHD F).</w>
VGLUT 3</w>
VG SCs</w>
VELOCIT Y</w>
VEGF 165</w>
VEC- MRI</w>
VE RP</w>
VE RE
VERE D</w>
VE GF.</w>
VE C</w>
VE ,</w>
VE )</w>
VDB T</w>
VD /
VD/ VT</w>
VCR .</w>
VCR ,</w>
VBD S,</w>
V1- V
V/Delta F)</w>
V/ T
V/ HIV</w>
V/ Fn
V- resistant</w>
V- containing</w>
V- T</w>
V- T)</w>
V yvan
V p
V mean
V ia</w>
V glut
V d</w>
V aughan</w>
V a</w>
V SD.</w>
V SD,</w>
V R.</w>
V Q</w>
V P/
VP/ CP
VP/CP M.</w>
V NT
VNT R</w>
V NS</w>
V MP</w>
V MA
VMA T-2</w>
V M.</w>
V LS</w>
V LM</w>
V LDL,</w>
V K
VK OR
VKOR C1</w>
V IT
VIT Y</w>
V III
V I)</w>
V HD-
VHD- CDDP</w>
V HD,</w>
V F
V CO2,</w>
V CA
VCA M-1</w>
V AP-
VAP- CeA</w>
V AC,</w>
V A).</w>
V 6</w>
V 5</w>
V 4.</w>
V 2-
V2- vasopressin</w>
V 2,</w>
V 17
V17 3
V --
V ):</w>
V )-induced</w>
V (s
V (T)</w>
V (MCA)</w>
V (2)</w>
Urticar ial</w>
Ursodeoxychol ate</w>
Uro graf
Urin aly
Ur d,</w>
Upr ,</w>
Upjoh n</w>
Up dated</w>
University- affiliated</w>
Unit s/
Unit .</w>
Unineph rectomized</w>
Uni variable</w>
Unexpect edly</w>
Under nutrition</w>
Un wanted</w>
Un scheduled</w>
Un satisfactory</w>
Un recognized</w>
Un published</w>
Un premedicated</w>
Un known</w>
Un fused</w>
Un common</w>
Un anesthetized</w>
Un adjusted</w>
Un acceptable</w>
Ultra -
Ulcer ative</w>
UT T)</w>
UT S)</w>
UT I</w>
USPIO -
USPIO- enhanced</w>
USPIO ,</w>
USP ST
US A,</w>
US A).</w>
URO .
URO. S</w>
URO -D</w>
UPD RS.</w>
UPD RS,</w>
UN a</w>
UN a/UCr</w>
UMB ER
UMBER :</w>
UL- morphine</w>
UK- based</w>
UK- 38
UK-38 ,48
UK -1
UK-1 14,
UK-114, 54
UK-114,54 2-
UK-114,542- 27</w>
UI/ L</w>
UDP-glucuron yltransferase</w>
UDP- GA</w>
UD PG
UDPG T</w>
UD 95</w>
UD 95.</w>
U50,48 8</w>
U3788 3A
U/ mL,</w>
U/ m2.</w>
U/ h</w>
U/ d</w>
U/ S</w>
U- test).</w>
U- shape</w>
U- 83836E</w>
U- 74
U-74 389
U-74389 G</w>
U tah</w>
U rethral</w>
U remic</w>
U raemia</w>
U ptake</w>
U m2;</w>
U linastatin</w>
U VB</w>
U V-
U SE</w>
U Q
U PL
U PI
UPI TER</w>
U K),</w>
U I)</w>
U I),</w>
U G</w>
U CL
U CH
UCH H</w>
U CD
U Aldo
UAldo V</w>
U A-
U A)</w>
U A),</w>
U 69593</w>
U 46
Tyro de's</w>
Tyr- D-
Tyr 14
Tyr14 72</w>
Typ ically</w>
Tx A</w>
Tx A2</w>
Tx -treated</w>
Tx -exposed</w>
Two- year</w>
Twice- daily</w>
Twelve- lead</w>
Turke y,</w>
Tur ner</w>
Tur key</w>
Tum or-promoting</w>
Tub erculosis</w>
Tu ohy</w>
Tu mours</w>
Tsukub a</w>
Trypt ase</w>
Troponin- T</w>
Tris omy</w>
Triphasi l.</w>
Trin iol</w>
Trimethaph an</w>
Trimeth oprim</w>
Trigg ers</w>
Tric uspid</w>
Tric hophyton</w>
Triazol am,</w>
Triamcin olone-induced</w>
Tri pterygium</w>
Tri ple</w>
Tri molet
Tri metrexate</w>
Tri metaphan</w>
Tri heptanoin</w>
Tri fluoroacetyl-adducted</w>
Tri ethylene</w>
Tri er</w>
Tri en</w>
Tren ds</w>
Tremor s</w>
Trem ulousness</w>
Tre at</w>
Trazod one-induced</w>
Tras ina,</w>
Transplant ation.</w>
Transi derm-Nitro</w>
Transcri ptional</w>
Transc utaneous</w>
Transc ript
Transc ervical</w>
Transamin itis</w>
Trans formation</w>
Trans dihydrolisuride</w>
Trans aminase</w>
Tran s</w>
Tra in-of-four</w>
Tra in-of-Four</w>
Tr p
Tr kA
Toxic ol.</w>
Toxic ity,</w>
Tot als</w>
Tot al-body</w>
Torsa de-de-pointes</w>
Toron to,</w>
Torem ifene-induced</w>
Tor r,</w>
Tor r)</w>
Top otecan,</w>
Top con</w>
Toler ation</w>
Tolaz amide</w>
Tol vaptan</w>
Tocain ide</w>
Tob acco</w>
To R)</w>
Tit rated</w>
Time- of-
Time- mated</w>
Time d-
Tim p-3</w>
Tim m's</w>
Tim entin.</w>
Ticlop idine,</w>
Tiag abine,</w>
Ti otropium</w>
Thyro id-stimulating</w>
Thym idine</w>
Thromb oxane</w>
Thromb ocytopenia,</w>
Three- hour</w>
Thre o-dihydroxyphenylserine</w>
Thomson ide)</w>
Thom pson</w>
Thir teen,</w>
Thir d-degree</w>
Thio peramide</w>
Thio TE
Thiaz ides</w>
Thi otepa</w>
Thi azol
Thi amazole</w>
Thi abendazole</w>
Therap ies</w>
Therap eu
Theophyll ine,</w>
Thalam otomy</w>
Thal lium</w>
Thail and</w>
Th rice-
Th io-
Th espesia</w>
TgR[hAI] non</w>
TgR[hAI] low</w>
Tex as.</w>
Tetrac hlorodibenzo-p-dioxin</w>
Testoster one-dependent</w>
Test )</w>
Tes la.</w>
Terat ological</w>
Terat ogenicity</w>
Ter mination</w>
Ter minal</w>
Ter azosin</w>
Tenofovir -associated</w>
Temoc april</w>
Tem sirolimus</w>
Tem afloxacin</w>
Technetium- 99m</w>
Te z
Te trabamate</w>
Te lephone</w>
Te g
Te am</w>
TdP- liability.</w>
Td p,</w>
Tc 99m-
Tc99m- Sestamibi</w>
Tc ),</w>
Tax us</w>
Tax ol.</w>
Taus sig-Bing</w>
Tauro cholic</w>
Taq Man</w>
Taq ID,</w>
Taq IA)</w>
Tamoxif en,</w>
Tak o-tsubo</w>
Tak o-tsubo-like</w>
Taipe i,</w>
Tail- flick</w>
Tail- cuff</w>
Tacrolim us.</w>
Tachy cardia,</w>
Tac -induced</w>
Tac -based</w>
TX B(2)</w>
TX B
TX A(2)</w>
TW IK
TWIK -related</w>
TUR P</w>
TUR P.</w>
TUR ,</w>
TUNEL- labeled</w>
TTX- sensitive</w>
TTP/ HUS
TTP- HUS,</w>
TT S,</w>
TT I</w>
TT C.</w>
TSH (max)</w>
TS PA.</w>
TRPV 6,</w>
TRPV 5,</w>
TRPM 6</w>
TRI M.</w>
TRH- binding</w>
TR s)</w>
TR IS</w>
TR H)</w>
TR D</w>
TR B,</w>
TPV/ r-based</w>
TPV/ r,</w>
TP S</w>
TP P.</w>
TP MT
TPMT *
TP M,</w>
TO CP</w>
TO AS</w>
TNS c</w>
TNS ",</w>
TNF- alpha/
TNF- alpha.</w>
TNF- a</w>
TNF- a/IL-1b</w>
TNF- a.</w>
TNF alpha-antagonism</w>
TNF alpha,</w>
TN F,</w>
TN C</w>
TN ).</w>
TN ),</w>
TMTX/ 5-FU/LCV</w>
TMPy P)</w>
TMP-SM Z-</w>
TMP-SM X-induced</w>
TMB- 8</w>
TM Z)</w>
TM X.</w>
TM S.</w>
TM N-induced</w>
TM D</w>
TM ).</w>
TJM s,</w>
TJ-80 14,</w>
TJ- 48</w>
TJ- 48
TJ-48 -treated</w>
TJ M</w>
TJ -associated</w>
TION S</w>
TION /
TIMP- 4,</w>
TIMP- 3</w>
TIMP -1,</w>
TI VA</w>
TI Q</w>
TI N.</w>
TI D</w>
TI As,</w>
TI A)</w>
TI /
TI/ TTI</w>
TI .</w>
TH PO</w>
TH P.</w>
TH P-induced</w>
TH P-1</w>
TH IP,</w>
TH IN</w>
TH F.</w>
TH CCO
TH AL</w>
TGF-beta 1/
TGF-beta1/ Smad4</w>
TGF- beta2</w>
TGF- alpha.</w>
TGF s</w>
TGF beta1-
TFA- albumin</w>
TF V</w>
TF Cl</w>
TER T
TERT (-/-)</w>
TEO AEs.</w>
TEM I)</w>
TE M.</w>
TE ;</w>
TE 8,</w>
TE .</w>
TE -
TDH L)</w>
TDF S</w>
TD s,</w>
TD P,</w>
TD 50/ED50)</w>
TD (50
TD(50 )/
TCV-1 16</w>
TCDD /kg</w>
TCD D.</w>
TCA s.</w>
TC C.</w>
TBP S-induced</w>
TBM .</w>
TBAR S.</w>
TB X
TB Ar
TBAr s</w>
TAS .</w>
TAC -induced</w>
TA- T1</w>
TA- CD</w>
TA R)</w>
TA P</w>
TA K
TAK E</w>
TA G.</w>
TA A-treated</w>
T9-T 10)</w>
T2 ];</w>
T/ C</w>
T- treatment</w>
T- mediated</w>
T- maze</w>
T- lymphocytic</w>
T- lymphocytes</w>
T- current</w>
T- channels,</w>
T- based</w>
T- N
T-N tx)</w>
T- MI</w>
T- ->
T( U)</w>
T x.</w>
T s).</w>
T runk</w>
T riton</w>
T retinoin</w>
T race</w>
T r</w>
T ph1(-/-)</w>
T peak-Tend</w>
T omat
T iopronin</w>
T ins</w>
T incture</w>
T ics</w>
T ic</w>
T erguride</w>
T aur
T all</w>
T actile</w>
T X)</w>
T UD
T U</w>
T U/
T TP
T T.</w>
T S,</w>
T Q-treated</w>
T PR.</w>
T PP
TPP -induced</w>
T PA)</w>
T L,</w>
T Gs</w>
T GF</w>
T EE-
T DR
TDR .</w>
T D)</w>
T ChE</w>
T CR,</w>
T CM</w>
T CI.</w>
T CE</w>
T CB
TCB :</w>
T CA,</w>
T C/
TC/ HDL-c</w>
T AT</w>
T ACE</w>
T AB,</w>
T >
T :P</w>
T 9</w>
T 9,</w>
T 8</w>
T 7</w>
T 58
T 5.</w>
T 4:
T4: T1</w>
T 4,</w>
T 3/
T3/ steroid-free</w>
T 3.</w>
T 3
T 2*
T 2)</w>
T 2).</w>
T /kg</w>
System s)</w>
Syndrome ,</w>
Syndrome )</w>
Synap tosomal</w>
Syn thesis,</w>
Symptom atology</w>
Sympath omimetics</w>
Sympath omimetic</w>
Sympath o
Sympath ectomy</w>
Syd ney</w>
Switzerland )</w>
Switzer land,</w>
Swit ches</w>
Sweden )</w>
Swe dish,</w>
Sv /
Survi ving</w>
Surve illance,</w>
Sur prisingly</w>
Supple mental</w>
Sup pressed</w>
Sumatript an-associated</w>
Sum mary</w>
Sulphasalaz ine-induced</w>
Sulfon ylurea</w>
Sulfasalaz ine,</w>
Sulfadiaz ine-associated</w>
Sulf inpyrazone</w>
Sulf amethox
Sul piride-induced</w>
Sugg estions</w>
Sugg ested</w>
Sud an.</w>
Succin ate</w>
Suc cimer</w>
Sub tenon</w>
Sub sensitivity</w>
Sub scale</w>
Sub lethal</w>
Sub cutaneously</w>
Su fentanil</w>
Studi ed</w>
Stud y:</w>
Strych nine</w>
Struc turally</w>
Strok e,</w>
Stro op's</w>
Stri king</w>
Stres sed</w>
Strept ococc
Sto kes-Adams</w>
Stimul ant</w>
Steroid -free</w>
Stere otyp
Stere oselectivity</w>
Sten osis</w>
Ste ps</w>
Ste al-prone</w>
Stav ud
Stat pac</w>
Stat es;</w>
Stat es:</w>
Stat en</w>
Stand ing</w>
St y
St uporous</w>
St ents</w>
St ent</w>
St ate,</w>
Sr l-based</w>
Sr l,</w>
Sr c-family</w>
Spre ad</w>
Spont aneous'</w>
Spir april</w>
Spir adol
Spin al,</w>
Spi ke-
Special ist</w>
Speci alized</w>
Spec ulations</w>
Spec ulation</w>
Spec ies</w>
Spati otemporal</w>
Spas molytic</w>
Spas mogenic</w>
Spar floxacin</w>
Sp ear
Sp 1</w>
Sou theastern</w>
Sou th-west</w>
Sot radecol</w>
Sot azide,</w>
Sot al
Sor bolene</w>
Somnol ence</w>
Somnambul istic-like</w>
Somnambul ism</w>
So-1 129</w>
Sm all,</w>
Slit 2-
Slit2- positive</w>
Slc :ICR</w>
Skin ner</w>
Situ ations</w>
Single- center,</w>
Single -dose</w>
Singapore an</w>
Singapore .</w>
Singap ore</w>
Sin usoidal</w>
Sin ai</w>
Sim vastatin-
Sim ulation</w>
Sim ple</w>
Sildenaf il,</w>
Sil ymarin</w>
Signific ant,</w>
Sign als</w>
Sigma ST,</w>
Sig moid</w>
Sig -1
Sig-1 R</w>
Si phocampylus</w>
Si butramine</w>
Si butramine-induced</w>
Si aladenitis</w>
Si -
Short- latency</w>
Short- acting</w>
Shor e</w>
Shi vering</w>
She eh
Shar ing</w>
Shakuyaku-kanzo- to,</w>
Shakuyaku-Kanzo- to</w>
Shakuyak u</w>
Sh in-Poong</w>
Sh engmai-y
Sh A</w>
Sex ually</w>
Sex -</w>
Seven- week-old</w>
Seven- day</w>
Seve re,</w>
Set ting.</w>
Sest amibi-SPECT/dobutamine</w>
Servic e.</w>
Seroton in
Ser um-</w>
Ser um,</w>
Ser toli</w>
Ser ology</w>
Ser ine</w>
Ser 49
Ser49 Gly</w>
Ser 486
Ser486 Thr</w>
Ser 3
Ser3 11
Ser -
Sequ entially</w>
Sequ ential,</w>
Separ ately,</w>
Sensi tivity,</w>
Sensi tive</w>
Sensi tisation</w>
Sens ori-motor</w>
Sene gal,</w>
Sen na</w>
Sen da
Sem istructured</w>
Self- Dec
Seleg iline-induced</w>
Second ly</w>
Sec tions</w>
Sear ches</w>
Se- deficient</w>
Se ph
Se oul</w>
Se SBP</w>
Se DBP</w>
Se )</w>
Scot land.</w>
Scop olamine-induced</w>
Scop olamine-</w>
Scleroder ma-like</w>
Sclero derma</w>
Scler osing</w>
Sci enti
Sci enc
Schle mm's</w>
Schizophren ic</w>
Sch wab</w>
Sch irmer</w>
Sch ering</w>
Sch ering-
Sch ering,</w>
Sch affer</w>
Scale- IV</w>
Scal e),</w>
Sc r</w>
Sat ureja</w>
Sar pogrelate</w>
Sar comas</w>
Sap indus</w>
Sando z</w>
San- Hu
San-Hu ang-Hsieh-Hsin-Tang</w>
Salmon ella.</w>
Salic yl
Sal meterol</w>
Sal meter
Sal ine-pretreated</w>
Sal ine+
Saf e,</w>
Sa T</w>
Sa O2</w>
SY S-
SYS- MTX</w>
SY MP
SYMP H
SYMPH ON
SYMPHON Y</w>
SW R/
SW N</w>
SVR I,</w>
SV I,</w>
SU I</w>
STZ- diabetes</w>
STZ- Ad.Null</w>
STZ ;</w>
STR ,</w>
STI CAL</w>
STAT 5</w>
ST/ bJ</w>
ST/ T</w>
ST- segment.</w>
ST- 91,</w>
ST Z)</w>
ST OP</w>
ST EM
STEM I).</w>
ST ATI
STATI STICAL</w>
ST AR
SSRI -related</w>
SSR T.</w>
SSI -1</w>
SSE H</w>
SS- immunopositive</w>
SS Z</w>
SS I</w>
SS BP)</w>
SS AT</w>
SRS s</w>
SRS s,</w>
SRL-CsA- ST</w>
SRL- treated</w>
SRL- ST</w>
SR141716 A.</w>
SR1417 16,</w>
SR s)</w>
SR T.</w>
SR S.</w>
SR IF
SR A
SRA 880</w>
SR 48692</w>
SR 1445
SR -
SR ).</w>
SPEC T:</w>
SPA D.</w>
SP+ AS+
SP+AS+ PQ</w>
SP ergic</w>
SP VR</w>
SP T</w>
SP P2</w>
SP P-2</w>
SP M</w>
SP L</w>
SP I</w>
SP E)</w>
SP C.</w>
SP -treated</w>
SP ).</w>
SOURCE S</w>
SOD ;</w>
SOD 2(+/-)</w>
SOD 1)</w>
SOD .</w>
SOD ).</w>
SOD )-
SOCS -3</w>
SOCS -1</w>
SOCS -1/
SOCS-1/ SSI-1</w>
SOCS -
SOCS- 3/
SOCS-3/ SSI
SO PH
SO MCT</w>
SO L.</w>
SO L,</w>
SO -treated</w>
SNZ c,</w>
SNC 80.</w>
SNC 80-induced</w>
SNC 80,</w>
SNA P,</w>
SNA ,</w>
SN S)</w>
SN R,</w>
SN P-treated</w>
SN P
SN L,</w>
SN GFR,</w>
SN CV,</w>
SN .</w>
SMemb .</w>
SM P,</w>
SM ON,</w>
SM IL
SM C)</w>
SM 1,</w>
SLV3 13</w>
SLV3 13,</w>
SLC6 A3</w>
SL I</w>
SL G,</w>
SL CO
SL -induced</w>
SKF- 82958</w>
SKF- 38
SKF-38 ,
SKF-38, 393</w>
SK-N- SH</w>
SJ S</w>
SJ L,</w>
SIB 18
SIB18 93,</w>
SIAD H:</w>
SI- Preven
SI-Preven zione</w>
SI TS-MOST</w>
SI S,</w>
SI RS</w>
SI P)</w>
SI L</w>
SI I,</w>
SI CI</w>
SI B,</w>
SI 3-
SI3- TE8,</w>
SHAM- MA-</w>
SH PGE2,</w>
SH P.</w>
SH LA</w>
SH LA.</w>
SH HF</w>
SH H
SHH F/
SHHF/ Mc
SHHF/Mc c-fa(cp)</w>
SH AR
SHAR P</w>
SH -
SH- SY5Y</w>
SH ),</w>
SG Z</w>
SG K3</w>
SG K2</w>
SG As.</w>
SG /
SG/ GSH</w>
SG ),</w>
SF- 36</w>
SF ;</w>
SERT- /-</w>
SERT- /
SERT-/ --
SERT-/-- specific</w>
SERCA 2
SER Ms</w>
SED+ SAL</w>
SE S</w>
SE D),</w>
SE C</w>
SE =0.0
SDI- refractory</w>
SD s)</w>
SD ])</w>
SD Z-RAD</w>
SD N,</w>
SD H-
SDH- fp).</w>
SD F-1</w>
SD F)</w>
SD ;</w>
SD /
SD )].</w>
SCN5 A.</w>
SCN5 A,</w>
SCN 1A</w>
SCH- 23,
SCH-23, 390</w>
SCH 58261</w>
SCH 23390-induced</w>
SCD /
SCD -treated</w>
SCD ,</w>
SC-36 60
SC- transplanted</w>
SC- 58
SC-58 125</w>
SC- 48
SC-48 334</w>
SC T),</w>
SC F
SCF As</w>
SC CH
SC 19
SC 1/
SC1/ hevin</w>
SC -treated</w>
SB3667 91</w>
SB20655 3</w>
SB-2699 70,</w>
SB-2 28
SB-2 24
SB- PS
SB-PS +
SB- 33
SB-33 486
SB-33486 7-
SAR s.</w>
SAR s,</w>
SAR S,</w>
SAPS- CIP</w>
SAM PL
SAMPL E:</w>
SA N</w>
SA GE
SAGE :</w>
SA G)</w>
SA FI
SAFI RE
SA 2-
SA2- L2</w>
S978 8,</w>
S3 A-
S140 80,</w>
S100 B.</w>
S100 B,</w>
S/ kg</w>
S/ METHODS:</w>
S/ KS</w>
S/ E</w>
S/ +)</w>
S.E.M .;</w>
S.E.M .).</w>
S.E. =0.0
S.E .)</w>
S.D .)</w>
S-nitroso- N-acetyl-
S-methyliso thiourea.</w>
S-adenosyl methionine.</w>
S-adenosyl methionine,</w>
S-adenosyl homocysteine</w>
S-312- d</w>
S-(-)- ET
S-(-)-ET -1
S-(-)-ET-1 26.</w>
S-(-)- 3-(3-hydroxyphenyl)-
S-(-)-3-(3-hydroxyphenyl)- N-n-propyl
S-(-)-3-(3-hydroxyphenyl)-N-n-propyl piperidine</w>
S-(+)- cis-N-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamine).</w>
S- sires.</w>
S- methyl-
S- glutathione</w>
S- enantiomer</w>
S- cysteinyldopa</w>
S- PTH</w>
S- PILO</w>
S- Mg,</w>
S- Li,</w>
S- Ca,</w>
S- CI
S- AC
S- 34
S- (-)-</w>
S- (-)
S,3R-AC PD),</w>
S,2 '
S,2' S)-
S,2'S)- 2-(
S)- mediated</w>
S)- immunopositive</w>
S)- deficient</w>
S(+)- ketoprofen</w>
S(+)- ibuprofen,</w>
S(+)- fluoxetine</w>
S(+)- ,</w>
S(+ ):</w>
S ym
S un
S tras
S till</w>
S tilbe
S po2</w>
S planchnic</w>
S phygmo-
S pect
S pain,</w>
S ource</w>
S oun
S ome
S olar</w>
S of
S nellen</w>
S mit
S lowly</w>
S loan-Kettering</w>
S lices</w>
S jo
S itting</w>
S inoatrial</w>
S ic
S gk
S electivity</w>
S e,</w>
S clerosis</w>
S cho
S cheme</w>
S che
S ch</w>
S b/kg</w>
S as:MRC(WI)BR</w>
S anseviera</w>
S aimiri</w>
S aiko-ka-ryukotsu-borei-
S acroiliitis</w>
S ac
S aba
S ]-
S ])</w>
S Z.</w>
S Z-induced</w>
S Z-
S Z,</w>
S X,</w>
S V,</w>
S SNS</w>
S SAGE:</w>
S RE
SRE s</w>
S NS.</w>
S MT),</w>
S MT
S MA)</w>
S LT
S LI
S L,</w>
S EC,</w>
S Ch-induced</w>
S AS
S AL,</w>
S AL
S AB-
S 727
S 3-
S 3,</w>
S 2/
S 2-
S2- serotonergic</w>
S 1).</w>
S .,</w>
S -1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]non
S-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]non ane),</w>
S (h
S(h )
S(h) UV</w>
S (+),</w>
S ">
RyR 2
RyR2 (R
RyR2(R 24
RyR2(R24 74
RyR2(R2474 S/+)</w>
Ry Rs</w>
Rupt ured</w>
Rub ral"</w>
Rotter dam</w>
Rotter dam,</w>
Rot ational</w>
Rot a-rod</w>
Ros en
Ros ai</w>
Ropi vacaine,</w>
Rol p</w>
Roche ster,</w>
Ro well's</w>
Ro hypnol</w>
Ro 15-45
Ro 15-1788.</w>
Rit uxim
Rit od
Ris ks,</w>
Ris k/benefit</w>
Rim cazole</w>
Rifamp icin,</w>
Rifabut in-associated</w>
Ri o</w>
Rho dobryum</w>
Rho de</w>
Rheum atism</w>
Rhabdomy oly
Rg3(R ),</w>
Review s</w>
Review ing</w>
Retin oids</w>
Ret ri
Ret initis</w>
Ret ard
Resul ting</w>
Resul t
Restric tion</w>
Rest enotic</w>
Rest arting</w>
Res umption</w>
Res pond
Repub lic.</w>
Replic ation-competent</w>
Renin- angiotensin</w>
Ren o-M-60</w>
Ren in-secreting</w>
Remifentan il,</w>
Remark able</w>
Rem yelination</w>
Rem acemide</w>
Regist ro</w>
Regist er,</w>
Regi onally,</w>
Regi on-specific</w>
Reg ular-</w>
Reg istry.</w>
Reg istry,</w>
Reg 2/
Refer red</w>
Recur arization</w>
Recover ing</w>
Recover ies</w>
Recover able</w>
Recor d</w>
Reconsider ation</w>
Recon struction</w>
Recogn ition,</w>
Reas oning</w>
Re- evaluation</w>
Re vision</w>
Re vised,</w>
Re treatment</w>
Re t</w>
Re presentative</w>
Re placing</w>
Re placement</w>
Re modeling</w>
Re lease</w>
Re kindling</w>
Re iter's</w>
Re iske</w>
Re introduction</w>
Re infection</w>
Re exposure</w>
Re emergence</w>
Re assuringly,</w>
Re adily</w>
Rb 2,</w>
Rat tus</w>
Rat s.</w>
Rat s'</w>
Rat ers</w>
Ras- association</w>
Ras- Erk</w>
Rap id-
Rap -1</w>
Ranol azine</w>
Raniti dine-related</w>
Raniti dine-associated</w>
Random ly</w>
Random isation</w>
Ramipri l-associated</w>
Raloxif ene,</w>
Raf /
Raf/ ME
Raf/ME K/
Raf/MEK/ ERK</w>
Radio frequency</w>
Radi otelemetric</w>
Raclopri de</w>
Racem ate</w>
Rabb its</w>
Ra ised</w>
RW IS
RWIS -induced</w>
RVO T</w>
RV s</w>
RV R.</w>
RV A</w>
RV :</w>
RU TH,</w>
RU 486
RU486 :</w>
RTI- 55</w>
RT OG</w>
RT 10
RT10 57)</w>
RT );</w>
RSD S.</w>
RS- determined</w>
RR C</w>
RP P,</w>
ROM-1 31</w>
ROM-1 31,</w>
RO SC</w>
RO O
RO C-3</w>
RO C
ROC -1.5</w>
RO 196
RO ),</w>
RNF LT</w>
RNA- positive</w>
RN- x.</w>
RL P-
RIS A</w>
RIS /
RI s,</w>
RI S)</w>
RI HA.</w>
RI E</w>
RI AH</w>
RI A
RG13 96
RG1396 5,</w>
RF+ 0.6%</w>
RF P</w>
RF LP</w>
RF LP)</w>
RELEVAN CE</w>
REGISTR ATION</w>
READ ER</w>
RE C</w>
RE .</w>
RE ,</w>
RB F,</w>
RB Cs/
RB 1
RAS S</w>
RANK L</w>
RANK L,</w>
RAN TE
RAN GE</w>
RAM H.</w>
RAEB- T,</w>
RAEB- T)</w>
RA G</w>
RA ).</w>
R: DOX</w>
R-(+)- isomers</w>
R-(+)- 8-OHDPA
R-(+)- 7-chloro-
R-(+)-7-chloro- 8-
R-(+)-7-chloro-8- hydroxy-3-methyl-1-phenyl-
R- wave-to-R-wave</w>
R- specific</w>
R- positive</w>
R- documented</w>
R- containing</w>
R- citalopram</w>
R- Ex</w>
R- 6</w>
R- 33)</w>
R- (alpha
R-(alpha )-
R-(alpha)- methylhistamine,</w>
R- (-)-
R,3 R)-
R,3R)- dihydroxybutanedioate</w>
R, 7
R,7 R)-
R(-)- ibuprofen</w>
R(- ):</w>
R(- )-</w>
R wanda.</w>
R unning</w>
R un
R p</w>
R ob
R n</w>
R ib</w>
R hn
R hi
R h)</w>
R est</w>
R en-Shen-Yang-Rong-Tang</w>
R emissions</w>
R ed
R c</w>
R b</w>
R aulinoa</w>
R aster</w>
R ap</w>
R amosetron</w>
R am
R ]</w>
R T,</w>
R T)</w>
R PG
RPG N</w>
R PD.</w>
R P-
R N</w>
R MS
RMS V</w>
R MBF</w>
R LA</w>
R Is</w>
R I.</w>
R I-
RI- QTL</w>
R HA,</w>
R H,</w>
R G</w>
R G)</w>
R F.</w>
R DC.</w>
R D)</w>
R CT</w>
R CD</w>
R 6</w>
R 6
R6 37
R637 X</w>
R 5</w>
R 341
R341 H</w>
R 3
R3 230
R3230 Ac</w>
R 1:</w>
R 0
R .,</w>
R -1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]non
R-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]non ane)</w>
R ,2
R,2 S-(+)-cis-N-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamine).</w>
R (2)=
Quinpi role</w>
Quinpi role,</w>
Quin olones</w>
Quin ine-dihydrochloride</w>
Quin ine-dependent</w>
Quin idine,</w>
Quin acrine</w>
Queti apine-induced</w>
Question ing</w>
Que bec</w>
Que bec
Quanti fying</w>
Qualit atively</w>
Qual ity's</w>
Qua DS-
QuaDS- Q
Qu inetholate</w>
Qu in-2</w>
Qu een</w>
Qo L,</w>
QTc F</w>
QTc B</w>
QTL s.</w>
QT- prolongation</w>
QT( u),</w>
QT vi,</w>
QT d.</w>
QT (c)</w>
QT (U
QT(U ),</w>
QT (B)</w>
QS2 c</w>
QS/ QT,</w>
QM CM</w>
Q- CPZ</w>
Q- AMI,</w>
Q- AM
Q s/Q
Q aT</w>
Q ID</w>
Q A-lesioned</w>
Q A-induced</w>
Q A
QA 33</w>
Pyridox ine-treated</w>
Py uria</w>
Py ruvate</w>
Py k2</w>
Pur ina</w>
Pup illary</w>
Puer arin</w>
Pt O2,</w>
Psychi atr
Psych otridine</w>
Psych ostimul
Psych ologists</w>
Psi epsilonRACK,</w>
Psi dium</w>
Pseudo isochromatic</w>
Pseudo ductules</w>
Pseudo acromegaly</w>
Pseudo acromegaly,</w>
Pseud o</w>
Ps i</w>
Ps A.</w>
Provid ing</w>
Prover a,</w>
Prover a)</w>
Protoc ols</w>
Protoc ol-defined</w>
Prote inuria,</w>
Prote inase</w>
Prote in-losing</w>
Prost anoids</w>
Prost anoid</w>
Pros thetic</w>
Propylthiourac il-associated</w>
Propylthio -
Propor tional</w>
Propofol-Lipuro .</w>
Propofol -associated</w>
Prop olis</w>
Prom ising</w>
Prolifer ation</w>
Project .</w>
Progres sively</w>
Prog nosis</w>
Prochlorper azine-induced</w>
Probuc ol-induced</w>
Probuc ol,</w>
Prob abilities</w>
Pro- inflammatory</w>
Pro- convulsant</w>
Pro- Pro-
Pro vince,</w>
Pro ton-pump</w>
Pro thrombotic</w>
Pro spectively</w>
Pro spectively,</w>
Pro posed</w>
Pro portions</w>
Pro pion
Pro per</w>
Pro opiomelanocortin</w>
Pro methe
Pro genitor</w>
Pro ficiency</w>
Pro caine</w>
Pro arrhythmia</w>
Prinz metal</w>
Primid one</w>
Primid one,</w>
Prim ate</w>
Pri mi
Pri mar
Presum ed</w>
Presum ably</w>
Presum ably,</w>
Prescri ption-Event</w>
Presc ribers</w>
Pres entation</w>
Pres chool</w>
Prednis one-induced</w>
Predic ted</w>
Prec ise</w>
Pre- transplant</w>
Pre- morbid</w>
Pre- irradiation</w>
Pre- emptive</w>
Pre- co-treatment</w>
Pre venting</w>
Pre valent</w>
Pre val
Pre training</w>
Pre therapy</w>
Pre parations</w>
Pre operatively,</w>
Pre mixture</w>
Pre incubating</w>
Pre ferential</w>
Pre eclampsia</w>
Pre cautions</w>
Pre cautionary</w>
Praz osin,</w>
Pra vastatin</w>
Pra usnitz--K</w>
Pow der</w>
Pot ter-type</w>
Pot ter's</w>
Postres uscitation,</w>
Postischem ic</w>
Postischem ia,</w>
Post- ischaemic</w>
Post transplant</w>
Post renal</w>
Post infusion</w>
Post exposure</w>
Post anesthesia</w>
Post -</w>
Pos tictal</w>
Pos m</w>
Pos itron</w>
Port land</w>
Port land,</w>
Population- based</w>
Population- based,</w>
Polyradicul itis</w>
Polymorph isms</w>
Polygodi al,</w>
Poly merase</w>
Poly graphic</w>
Poly galasap
Poly amine</w>
Poly (ADP-ribose)</w>
Pol ish</w>
Pod ocyturia</w>
Pod ocytic</w>
Po 2,</w>
Pneumon itis</w>
Pneum onia</w>
Pneum omediastinum</w>
Plat ycodon</w>
Plat inum-based</w>
Plac ement</w>
Pl antar</w>
Pit ressin</w>
Pirox ic
Piribe dil,</w>
Pirenzep ine</w>
Pir profen</w>
Pinsch er</w>
Pindo lol</w>
Pilsi cainide</w>
Pilsi cainide-induced</w>
Pilo ,</w>
Pic rorrhiza</w>
Pic loxydine</w>
Pi per</w>
Pi per
Pi erre</w>
Pi MZ</w>
Physici an</w>
Physici an's</w>
Physi cochemical</w>
Phyll anthus</w>
Phy tate</w>
Phosphatidyl serine</w>
Phosph olipid</w>
Phob ia</w>
Philippin es.</w>
Philadelph ia.</w>
Phenylpropanol amine-associated</w>
Phenylpropan olamine,</w>
Phenylbutaz one-induced</w>
Phent olamine,</w>
Phenprocou mon</w>
Pheno thiazine</w>
Pheno thiaz
Phen yl</w>
Phen otypic</w>
Phen elzine</w>
Phen acetin</w>
Phe 4,</w>
Pharmacokine tics,</w>
Pharmaco therapy</w>
Pharmaco dynamics</w>
Pharmaceutic als</w>
Pharmac ol.,</w>
Pharmac .</w>
Ph leb
Ph enter
Ph ase.</w>
Ph ase-
Ph QA33</w>
Ph -positive</w>
Pg p.</w>
Pg p-enhancing</w>
Pg P</w>
Pert ussis</w>
Peroxis omal</w>
Perme ability,</w>
Peripher ally</w>
Period ontal</w>
Peri ventricular</w>
Peri oral</w>
Perce ptual</w>
Per sian</w>
Per ineural</w>
Pepti dergic</w>
Pepti care,</w>
Pentazoc ine.</w>
Pentazoc ine-
Pent ylenetetra
Pent obarbital,</w>
Pent etrazole</w>
Pent adecapeptide</w>
Pent achlorophenol</w>
Pen icillin</w>
Pen e,</w>
Peg- IFN</w>
Pear son</w>
Peak -dose</w>
Pe to</w>
Pe ony-Glycyrrhiza</w>
Pco (2),</w>
Pathophysi ological</w>
Path ology</w>
Path ologically,</w>
Path ogenetic</w>
Pat ency</w>
Pat chy</w>
Partic ularly</w>
Partic ularly,</w>
Parg yline</w>
Parg yline,</w>
Paren ter
Paras ites</w>
Parap aresis</w>
Paracetam ol-associated</w>
Para esthesiae,</w>
Par valbumin</w>
Par ti
Par k</w>
Par icalcitol</w>
Par anoid/Suspicious</w>
Par alysis</w>
Papaver ine-induced</w>
Pap illo
Pap illedema</w>
Panc reas</w>
Panam a.</w>
Pan ipenem</w>
Pan cytopenia</w>
Pan ama</w>
Pal pitation</w>
Pal pable</w>
Pal mar-plantar</w>
Pal icourea</w>
Pair wise</w>
Pad ua</w>
Paclitaxel/ cisplatin</w>
Paclitaxel .</w>
Paclitaxel -</w>
Pab2- HRP</w>
Pab 1-
Pab1- HRP</w>
PaO2/ FIO
PaO2/FIO 2,</w>
Pa vulon</w>
Pa vetta</w>
Pa ulo,</w>
Pa resthesias</w>
Pa O2,</w>
Pa CO(2)</w>
PY 567</w>
PV U,</w>
PV T
PV Rs</w>
PV RI</w>
PV I</w>
PV B
PV AB
PV -related</w>
PUF A,</w>
PTZ- convulsed</w>
PTZ -treated</w>
PTZ -evoked</w>
PTH -related</w>
PT/ CLZ</w>
PT T,</w>
PT OX</w>
PT L</w>
PT L4,</w>
PT D)</w>
PT CR.</w>
PT C.</w>
PT .</w>
PSP MT</w>
PSA- Promethe
PS/ PC</w>
PS V</w>
PS S),</w>
PS )-induced</w>
PS )
PS) 3</w>
PRO SORBA</w>
PRO L-
PROL- treated</w>
PRL- positive</w>
PRL- AB.</w>
PRIS -related</w>
PRIS ,</w>
PRESENT ATION</w>
PRE N-
PREN- trial:</w>
PRE -
PRE- atropine,</w>
PRACTI CE:</w>
PR3- ANCA.</w>
PR s.</w>
PR s)</w>
PR P</w>
PR L)</w>
PR IMARY</w>
PPARbeta/ delta,</w>
PPA R</w>
PP- 32)</w>
PP S,</w>
PP I,</w>
PP C</w>
PP BC</w>
POD s</w>
PO-PL L</w>
PO-PL L),</w>
PO x</w>
PO ST-
PO R</w>
PO MC
POMC -treated</w>
PO CA</w>
PO A</w>
PO 4</w>
PO 4
PO ).</w>
PN MT</w>
PN F</w>
PN E.</w>
PN ).</w>
PMS F/
PMN s</w>
PM OH</w>
PLT s.</w>
PL- DOX-treated</w>
PL PG
PLPG H</w>
PL M</w>
PL LV</w>
PL L</w>
PL K
PL 3
PK- C,</w>
PK G</w>
PK D.</w>
PK A,</w>
PK /
PK/ PD</w>
PK .</w>
PIP N</w>
PIL O.</w>
PIL O-
PIIIN P,</w>
PI/ dSP)</w>
PI s,</w>
PI PC
PIPC -induced</w>
PI L</w>
PI D</w>
PI A)</w>
PI 3
PHEN -induced</w>
PHARM AC
PHARMAC OLO
PHARMACOLO GICAL</w>
PHAR MO</w>
PHA- L-
PH- d)</w>
PH NO</w>
PH N</w>
PH H.</w>
PGP 9.5</w>
PGE ,</w>
PGE (2)-induced</w>
PG s.</w>
PG SR</w>
PG S,</w>
PG I</w>
PG F1</w>
PG D2</w>
PG A2</w>
PG /
PG ).</w>
PF I</w>
PF 4,</w>
PF 4)</w>
PER 1</w>
PEGS OD,</w>
PEG- interferon</w>
PED s.</w>
PED F,</w>
PE T)</w>
PE S.</w>
PE MA
PEMA :</w>
PE G660</w>
PE G
PE F</w>
PE AR
PE -treated</w>
PE -like</w>
PE ),</w>
PDE III</w>
PDE 5</w>
PD9 80
PD-1233 19,</w>
PD- inducing</w>
PD yn</w>
PD TC-treated</w>
PD TC,</w>
PD RG)</w>
PD Q-
PD P</w>
PD N.</w>
PD MP</w>
PD IE)</w>
PD I</w>
PD H
PDH a</w>
PD D</w>
PD 80,</w>
PD 150,</w>
PD 1
PD1 17,
PD (50)</w>
PCa g</w>
PCW P.</w>
PCR- amplified</w>
PCR- RFLP</w>
PCR -based</w>
PCNS L</w>
PCNS L.</w>
PCNA- labeled</w>
PCB s</w>
PC- T</w>
PC- 3</w>
PC r/ATP</w>
PC a</w>
PC V
PC O</w>
PC EA</w>
PC 5</w>
PC 1,</w>
PC 02</w>
PC .(ABSTRACT</w>
PB O,</w>
PB -related</w>
PB -induced</w>
PB -free</w>
PB ).</w>
PB ),</w>
PATIENT S/METHODS:</w>
PATIENT S,</w>
PARTICIPANT S,</w>
PAR P-1
PARP-1 +/+</w>
PAR P
PARP -1-
PARP-1- /-</w>
PANS S.</w>
PAN- MCNS</w>
PAI -1</w>
PAI -1.</w>
PACP P.</w>
PACAP 38</w>
PAC U.</w>
PAC U,</w>
PAC E
PAC AP-
PAC .</w>
PAC -induced</w>
PAC -containing</w>
PAC (1)
PA/ EE)</w>
PA l
PA X-
PA T,</w>
PA SI)</w>
PA S
PA R</w>
PA Ps</w>
PA P,</w>
PA G,</w>
PA F.</w>
PA 1</w>
P=0.000 8),</w>
P=0.00 6).</w>
P=0.00 4).</w>
P=0.00 3,</w>
P=0.00 3)</w>
P=0.00 2)</w>
P=0.00 2).</w>
P=0.00 2),</w>
P=0.00 1,</w>
P=0.0 8)</w>
P=0.0 4)</w>
P=0.0 2)</w>
P=0.0 2),</w>
P=0.0 15).</w>
P=.0 1),</w>
P= not</w>
P= NS).</w>
P= 1.00
P= 0.05).</w>
P= 0.05),</w>
P= 0.001),</w>
P= .
P<0.001 ],</w>
P<0.00 91),</w>
P<0.00 1.</w>
P< 0.05,</w>
P< 0.05);</w>
P< 0.01].</w>
P< 0.0001,</w>
P< .001)</w>
P< .000
P: <0.001).</w>
P450 III
P450III A-selective</w>
P450 I
P450I A-selective</w>
P450 -dependent</w>
P400 -induced</w>
P4 50)</w>
P2X (3)</w>
P2X (2)</w>
P2X (2),</w>
P2R- extrasystoles</w>
P2 8)</w>
P120 T</w>
P/ S,</w>
P/ D.</w>
P/ CD</w>
P/ ATP</w>
P. I.
P. D.,</w>
P- transgenic</w>
P- group</w>
P- g
P- based</w>
P- V</w>
P- Cl.</w>
P- 3,</w>
P- 2-
P-2- negative</w>
P- 2),</w>
P+ vehicle;</w>
P+ CTR;</w>
P(2y 4)</w>
P(2 y)</w>
P yro
P yri
P utative</w>
P urkinje's</w>
P urea</w>
P s),</w>
P run
P recordial</w>
P receded</w>
P ositioning</w>
P neumo-Canc</w>
P lexiglas</w>
P lan
P l</w>
P i.h-1/mg</w>
P i-
P ha
P ethidine</w>
P ethidine-associated</w>
P et
P estic
P enzberg,</w>
P eme
P elvic</w>
P dk4</w>
P csf</w>
P c.</w>
P btO(2)</w>
P arachlorophenylalanine</w>
P aracervical</w>
P anadeine</w>
P akist
P airs</w>
P ain
P Y567-
P UI</w>
P Q-induced</w>
P PTs</w>
P PH,</w>
P PA-induced</w>
P NS,</w>
P NA</w>
P NA,</w>
P N)</w>
P MDD</w>
P MA</w>
P LD.</w>
P L,</w>
P IV</w>
P IT</w>
P IC</w>
P IA</w>
P I).</w>
P ECAM
P CI
PCI A</w>
P CA-induced</w>
P CA
P 96
P96 45</w>
P 7.</w>
P 7-9</w>
P 6
P 58</w>
P 58,</w>
P 5.</w>
P 388,</w>
P 30</w>
P 300</w>
P 20</w>
P 20712
P 100.</w>
P 02</w>
P (CsA</w>
P (CR)</w>
P 's</w>
Oxy hemoglobin</w>
Oxy fedrine</w>
Oxy codone</w>
Oxy buprocaine</w>
Oxid ants</w>
Oxcarb azepine,</w>
Oxcarb azep
Oxaproz in-induced</w>
Oxamniqu ine</w>
Ox-ph os</w>
Ox and
Ox acill
Over- the-counter</w>
Over represented</w>
Over dosage</w>
Ovari ens</w>
Ovari ectomized</w>
Ov ral</w>
Out -of-
Out-of- hospital</w>
Ouab ain,</w>
Other wise</w>
Other s</w>
Oste opontin</w>
Oste ogenic</w>
Os molality</w>
Os lo,</w>
Os ]</w>
Orth opa
Orgas m</w>
Organophosph orous</w>
Organophosph ate-induced</w>
Organ on,</w>
Oreg on</w>
OraVer se</w>
Or g
Or bital</w>
Or al-
Optim um</w>
Optim ization</w>
Opio idergic</w>
Opio id-
Ophthalmo logists</w>
Oper ating</w>
Op portunistic</w>
One- way</w>
One- hundred</w>
Ondan setron-induced</w>
Onco paz</w>
Onco logy,</w>
On- Off
On dine's</w>
On chocerca</w>
Omni paque</w>
Om niscan
Ole ylethanolamide</w>
Ol d</w>
Okla h
Off ice</w>
Oddi .</w>
Occurren ces</w>
Oc t
Oc clusive</w>
Obses sive-Compulsive</w>
Obser ver</w>
Ob taining</w>
Ob stetrics</w>
Oat 1</w>
OX Y-
OX O</w>
OX O-
OV CA
OUTCOME S</w>
OT- HNP</w>
OT- HNP.</w>
ORX E</w>
OR- 486</w>
OR al</w>
OR R,</w>
OR (ad
OR(ad j)</w>
OPID P.</w>
OPID N,</w>
OPC -10
OPC-10 85</w>
OP s</w>
OP SE</w>
OP N-
ON ME
ON D</w>
ON :</w>
OK T3/steroid-free</w>
OI M.</w>
OHC s</w>
OH- delta</w>
OH- DOC,</w>
OH R,</w>
OH P)</w>
OH ).</w>
OG N,</w>
OF P,</w>
OF G)</w>
OF F
OF A)</w>
OEF (
OEF( hyperemia)</w>
OE P,</w>
OD s)</w>
OD E,</w>
OBJECTIVE S/HYPOTHESIS:</w>
OATP- C.</w>
OATP- C
OATP-C *
OATP-C* 15</w>
OA G)</w>
O. V.
O. D.</w>
O-de methyl</w>
O-(2- methoxy)ethyl</w>
O- methylation</w>
O- diisopropyl</w>
O(6)- methylguanine-DNA</w>
O' Bri
O torhinolaryng
O ster
O ri
O pan
O hi
O h
O floxacin</w>
O floxacin-induced</w>
O ff</w>
O ff-
O estradiol</w>
O cean</w>
O ZRs.</w>
O UA,</w>
O SCS</w>
O PA1</w>
O P)</w>
O MD.</w>
O MBF</w>
O LS</w>
O HD</w>
O GC</w>
O CP,</w>
O CD,</w>
O C.</w>
O C),</w>
O AC-
OAC- ICH</w>
O A,</w>
O ;</w>
O :
O 330
O330 4</w>
O 2;</w>
O 2:</w>
O .)</w>
O -1
O ,
O, O-diisopropyl</w>
O ))</w>
Nur ses'</w>
Nur se</w>
Nucle ic</w>
Nrf2 (-/-)</w>
Nov ar
Not withstanding</w>
Not ably</w>
Nortriptyl ine-induced</w>
Norplant -associated</w>
Norm ally,</w>
Norm ,</w>
Nor valine2-
Nor pr
Nor plant,</w>
Nor floxacin</w>
Nor cocaine</w>
Nor 2</w>
Non- spatial</w>
Non- selective</w>
Non- heart</w>
Non- diabetic</w>
Non traumatic</w>
Non toxic</w>
Non surgical</w>
Non specific</w>
Non remitters</w>
Non randomized,</w>
Non proteinuria</w>
Non pharmacologic</w>
Non narcotic</w>
Non linear</w>
Non ketotic</w>
Non glomerular</w>
Nocicept in,</w>
NoDCE- R</w>
NoDCE- C</w>
No thing</w>
Nitrofur antoins</w>
Nitro- D
Nitro-D ur</w>
Nitro tyrosine</w>
Nit rate</w>
Nit ra
Nissl- staining</w>
Nis oris</w>
Ninjin yoeito</w>
Nimodi pine.</w>
Nimodi pine,</w>
Nimesul ide,</w>
Niger ia.</w>
Nig rostriatal</w>
Nig ella</w>
Nifedi p
Nic orandil</w>
Ni ght
Nex t</w>
New borns</w>
Neutropen ia,</w>
Neutr alization</w>
Neurosc i</w>
Neuropath ol.</w>
Neuro vascular</w>
Neuro toxicity,</w>
Neuro tic</w>
Neuro steroids</w>
Neuro science</w>
Neuro psychologic</w>
Neuro protection</w>
Neuro protectants</w>
Neuro plasticity</w>
Neuro peptide-Y</w>
Neuro log
Neuro kinin</w>
Neuro hypophysial</w>
Neuro filament)</w>
Neuro blastoma</w>
Neuro behavior</w>
Neuro -
Neur aminidase</w>
Neu/Erb B2</w>
Neu N,</w>
Neu )</w>
Netherland s)</w>
Net work,</w>
Nesacaine- CE</w>
Nerv ous</w>
Nephro toxicity,</w>
Neon ates</w>
Neodolpas se,</w>
Neo- Timm</w>
Nelfin avir,</w>
Nefazod one</w>
Needle- Free</w>
Nedd4- 2</w>
Ne wer</w>
Ne oral.</w>
Ne oadjuvant</w>
Ne bulized</w>
Nause a/vomiting</w>
Nation aux</w>
Nat l.</w>
Narco tics</w>
Narco tic</w>
Naprox en,</w>
Nalbu phine,</w>
Nal mefen
Nairobi ,</w>
Nag asaki</w>
Nad olol</w>
NaCl ;</w>
NaCl ).</w>
NaCl ),</w>
NaB B.</w>
NaB B,</w>
Na/ K</w>
Na-K- ATPase.</w>
Na-K- 2
Na-K-2 Cl</w>
Na, K-
Na+- extrusion</w>
Na+- K+-2
Na+-K+-2 Cl-</w>
Na+ K(+)-ATPase</w>
Na+ /</w>
Na+ -free</w>
Na(v) 1.8-
Na(v) 1.8
Na(+)/ K(+)-
Na(+)- dependent</w>
Na(+)- binding</w>
Na(+) K(+)</w>
Na velbine</w>
Na p</w>
Na dir</w>
Na ]o</w>
Na S;</w>
Na S.</w>
Na PB.</w>
Na OH</w>
Na Cl.</w>
NZ W/LacJ</w>
NZ B</w>
NTS 2.</w>
NTS 2,</w>
NTG- plus-lorazepam</w>
NT69 L.</w>
NT69 L,</w>
NT- proBNP</w>
NT PP)</w>
NT G;</w>
NT G
NT E.</w>
NT D-
NTD- affected</w>
NT D,</w>
NT Cs</w>
NT :</w>
NT 79,</w>
NT 7
NT7 9.</w>
NSAID- intolerant</w>
NS- NSAIDs</w>
NS- NSAIDs.</w>
NS Z.</w>
NS R</w>
NS )].</w>
NRA0 160,</w>
NRA0 160
NRA0160 :</w>
NR TI
NR K</w>
NR K-49
NRK-49 F</w>
NR H,</w>
NR 2b</w>
NR )-containing</w>
NPH S</w>
NP s</w>
NP SH</w>
NP E</w>
NOS3- TG</w>
NOS- IR</w>
NOS 3</w>
NOC -1
NO/ cGMP</w>
NO- synthesis</w>
NO- metabolite</w>
NO- independent</w>
NO- cyclic</w>
NO- cGMP-
NO x.</w>
NO PHARMACOLOGICAL</w>
NO 3-/
NO3-/ mg</w>
NO -related</w>
NN R</w>
NN C-
NNC- 711</w>
NMRI- mice.</w>
NMDA- mediated</w>
NMDA- dependent</w>
NMDA- ,</w>
NMDA receptor</w>
NMD AR</w>
NMD A-related</w>
NMD A-</w>
NMB As.</w>
NMB A</w>
NM N</w>
NK3- Rs</w>
NK H</w>
NK H.</w>
NK CC
NKCC 2,</w>
NK 1-receptor</w>
NIN CD
NINCD S).</w>
NIN ,</w>
NID A-
NI RS-determined</w>
NI MO,</w>
NI M</w>
NI AD</w>
NH4 Ac
NH4Ac .</w>
NH4 +</w>
NH s</w>
NH S
NH 2)</w>
NG- nitro-L-arginine:</w>
NG- nitro-L-arginine,</w>
NG PTL4,</w>
NG C.</w>
NF- kappa
NF- M</w>
NF- H,</w>
NF 160</w>
NER s</w>
NE- infusion</w>
NE /kg</w>
ND WG</w>
ND I).</w>
NCT00 23
NCT00 14
NCT00 0
NCQ 344</w>
NBI A-associated</w>
NB L</w>
NAc c)</w>
NADPH- diaphorase,</w>
NAC- C.</w>
NAC +
NA- turnover</w>
NA T</w>
NA S,</w>
NA PAP</w>
NA G,</w>
NA A</w>
NA A/
N6- cyclopentyladenosine,</w>
N6- (2-
N6-(2- phenylisopropyl
N3- substituted</w>
N20/ P25</w>
N1 N
N1N 11</w>
N1 M
N1M 0
N1M0 )]</w>
N0M 0)</w>
N/OF Q</w>
N/ S:</w>
N/ P-1.5</w>
N/ Bi
N/Bi Rij</w>
N/ 100</w>
N. S.</w>
N-tert-butyl- alpha-phenylnitrone</w>
N-pyrimidinyl-2-phenoxy acetamides</w>
N-pyrimidinyl-2-phenoxy acetamide</w>
N-propylnor ap
N-propargyl-1- (R)aminoindan</w>
N-phosphonacetyl-L- aspartic</w>
N-nitrosou re
N-nitrosom orph
N-nitrosom ethyl
N-nitrosobut ylurea</w>
N-nitrosobut yl-4-hydroxybutyl
N-nitroso-N-methyl urea</w>
N-nitroso-N-methyl nitroguanidine</w>
N-nitroso- n-butyl-(4-hydroxybutyl)
N-n-propyl norapomorphine</w>
N-methyl- tetramethylcyclopropyl</w>
N-methyl- N-nitrosourea</w>
N-methyl- N-[2-
N-methyl-N-[2- (1-pyrrolidinyl)
N-methyl-N-[2-(1-pyrrolidinyl) cyclohexyl]benzene
N-methyl- N-
N-methyl- N
N-methyl- DL-
N-methyl scopolamine</w>
N-methyl bromide.</w>
N-methyl -</w>
N-ethyl-N-hydroxyethyl nitrosamine</w>
N-ethyl-N-hydroxyethyl nitrosamine.</w>
N-ethyl- 2-bromo
N-ethyl-2-bromo benzyl
N-desmethyl diazepam.</w>
N-butyl-N-(4-hydroxybutyl) nitrosamine.</w>
N-butyl- deoxynojirimycin</w>
N-acetyl-beta-D-glucosaminid ase.</w>
N-acetyl- glucosaminidase,</w>
N-acetyl- L-cysteine</w>
N-acetyl penicillamine</w>
N-acetyl neuraminic</w>
N-[4-(5-nitro-2-furyl)-2-thiazolyl]-form amide-induced</w>
N-[(1-ethyl-2- pyrrolidinyl)methyl]-2-
N-[ 8-amino
N-[8-amino -1
N-[8-amino-1 (S)-
N-[8-amino-1(S)- carboxyoctyl]-L-alan
N-S CBC.</w>
N-Me- D-
N-Me-D- Asp</w>
N-2- hydroxyethyl</w>
N-(2, 6-dimethyl
N-(2,6-dimethyl phenyl)-8-pyrrolizidineacetamide</w>
N-(1- benzyl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylaminobenzamide</w>
N- vanillyl-6-nonen
N- tert-butylnitrone</w>
N- isobutyl-1,2-diphenyl</w>
N- form
N- demethylase</w>
N- cadherin,</w>
N- [4,7-dimethoxy-6-(2-
N- Acetyl</w>
N- 4-hydroxy
N-4-hydroxy phenyl</w>
N- (2-chloroethyl
N-(2-chloroethyl )-
N- (2,</w>
N,N- dibutylnitrosamine</w>
N,N,N',N'- tetramethyl-p-
N, 5-dimethyl
N,5-dimethyl -</w>
N(G)-nitro- l-arginine</w>
N(6)- cyclopentyl</w>
N(2) O/
N( epsilon)-(carboxymethyl)
N v</w>
N umerically,</w>
N uciferine</w>
N s)</w>
N oxious</w>
N ow,</w>
N ose</w>
N on</w>
N ociception</w>
N isoldip
N ear-
N di
N ck</w>
N b</w>
N ayagida's</w>
N av
N ature</w>
N atriuresis</w>
N aive</w>
N X+HP</w>
N V</w>
N UMBER:</w>
N REM</w>
N NT</w>
N NR/Np</w>
N MS
NMS -like</w>
N MR
NMR -based</w>
N LF</w>
N ICU</w>
N H</w>
N GF-
N GF),</w>
N FL
NFL X.</w>
N CS
N CP
NCP H.</w>
N CL
N CIC</w>
N C),</w>
N BU
N AT
N AR,</w>
N =
N 4</w>
N 40
N 20</w>
N 100</w>
N 100,</w>
N 1/
N -1-
N (2)-
Myocardi um</w>
Myo sitis,</w>
Myelo suppression,</w>
Myelo peroxidase</w>
Myelo peroxidase-
Myelo ma</w>
Myelo dysplastic</w>
Myelo -
Myco phenolic</w>
Myalgi as/arthralgias</w>
My otoxicity</w>
My osin</w>
My ogenic</w>
My lotarg
My dricaine</w>
My asthenic</w>
Mut ants</w>
Mut ant</w>
Mur aglitaz
Mun tingia</w>
Mun icipal</w>
Multiplic ities</w>
Multi organ</w>
Multi modal</w>
Multi factorial</w>
Multi drug</w>
Multi disciplinary</w>
Muc una</w>
Muc ocutaneous</w>
MuMT V.</w>
Mu 2</w>
MtTW 15,</w>
Mrp 2.</w>
Morphine- 6-glucuronide</w>
Morph ology</w>
Morph ogenesis</w>
Moric izine,</w>
Mor ton's</w>
Mor ning</w>
Mor axella</w>
Montg omery</w>
Monte lukast-associated</w>
Monit or</w>
Mon tre
Mon telukast</w>
Mon oneuropathy</w>
Mon omorphic</w>
Mon mouth</w>
Modi fied</w>
Moder n</w>
Mo y</w>
Mo tiv
Mn POx</w>
Mn DPD
Mn 2+</w>
Mn 2+,</w>
Mn )</w>
Mix tures</w>
Mit ral</w>
Mit oxantrone,</w>
Mit otic</w>
Mit ogen-activated</w>
Missour i,</w>
Mis use</w>
Mipafox -induced</w>
Minnesot a,</w>
Minneap olis</w>
Mini- International</w>
Min utes</w>
Min istry</w>
Min eralocortico
Migra inelike</w>
Midazol am,</w>
Mid west</w>
Mid odrine,</w>
Mid agli
Microscop ical</w>
Microgynon- 30</w>
Microgynon- 30.</w>
Micro somal</w>
Micro hematuria</w>
Micro haematuria</w>
Micro glia</w>
Micro filarial</w>
Micro encephaly</w>
Micro array</w>
Mic onazole</w>
MgSO 4,</w>
Mg -activated</w>
Mexilet ine,</w>
Mex ase</w>
Metyrap one-induced</w>
Metronidazol e.</w>
Metronidazol e,</w>
Metriz amide</w>
Meti pranolol-induced</w>
Methylphenid ate,</w>
Methyl prednisolone-induced</w>
Methyl nitrosourea</w>
Methyl ene-di
Methohex ital</w>
Methan andamide</w>
Methadone- maintained</w>
Meth ods.</w>
Meth amphetamine-dependent</w>
Meth amphetamine,</w>
Metab olomic</w>
Met kephamid</w>
Met abolism</w>
Met abol
Mer rell</w>
Mer c
Meperid ine-induced</w>
Meni ere</w>
Memant ine,</w>
Melbour ne</w>
Melbour ne,</w>
Mei ge's</w>
Medro l</w>
Medic inal</w>
Medic ally</w>
Mec kel's</w>
Me yer</w>
Me trazol-induced</w>
Me themoglob
Me phentermine</w>
Me gestrol</w>
Me g</w>
Me Ch-induced</w>
McNemar 's</w>
McN- A-
McN-A- 34
Mc Le
Mc Ar
McAr dle</w>
Maz e</w>
May tenus</w>
Matric aria</w>
Mat uration</w>
Mass on-
Maryl and.</w>
Market ed</w>
Marg inal</w>
Mar sh
Manu facture
Manip ulating</w>
Mang ifera</w>
Man idipine,</w>
Man aging</w>
Man 's</w>
Malay sia.</w>
Mala oxon-induced</w>
Mal ta.</w>
Mal m</w>
Mal formations</w>
Mal es,</w>
Mal awian</w>
Mal aria</w>
Maj ority</w>
Main ly</w>
Magnus on</w>
Magnesi um-
Mag ical</w>
Mad agascan</w>
Macrophage- migration</w>
Mac Le
MacLe an's</w>
Ma TU/
MX C-
MX -1,</w>
MUG A-
MU/ m2,</w>
MTX/ Ara-C</w>
MTX ;</w>
MTX :</w>
MTX -associated</w>
MTX ).</w>
MTX ),</w>
MT/ Ho
MT/Ho kIdr</w>
MT T</w>
MT LE</w>
MT D,</w>
MS SA.</w>
MS O)</w>
MS L</w>
MS C</w>
MS 3
MS3 25.</w>
MS /
MRI/MR As</w>
MRI-8273- 59</w>
MRI-8273- 30-
MRI-8273-30- 1</w>
MR glc</w>
MR N</w>
MR I).</w>
MR A</w>
MR 16-
MR16- 1</w>
MPTP- intoxicated</w>
MPT P,</w>
MPP (+)-
MPP(+)- lesioned</w>
MPO- ANCA.</w>
MPE +BZ</w>
MPA- I</w>
MPA- D</w>
MPA -</w>
MP s</w>
MP I.</w>
MP EP.</w>
MP 15.</w>
MP 15-
MP15- treated</w>
MO RE,</w>
MNU- inoculated</w>
MN U.</w>
MN U,</w>
MMP- TIMP</w>
MMP I</w>
MMP I,</w>
MM SE.</w>
MM P)</w>
MM MTs</w>
MM G</w>
MM F-
MM C-treated</w>
MM C-
MM C,</w>
MLM -1
MK-80 1).</w>
MK-14 2,</w>
MK- 486</w>
MK- 212</w>
MK E</w>
MIT O-2</w>
MIP-1 beta</w>
MIC s/MBCs</w>
MI P-2</w>
MI L</w>
MI A</w>
MI ;</w>
MI )-induced</w>
MF L</w>
MF F</w>
MF D,</w>
METH- administration.</w>
METH OD</w>
METH -</w>
MEMA N</w>
MEASUREMENT :</w>
MEASURE S</w>
ME SSAGE:</w>
ME S-induced</w>
ME S,</w>
ME P)</w>
ME L)</w>
ME G
MEG X</w>
ME C.</w>
ME -
ME ).</w>
MDR-T B.</w>
MDMA -treated</w>
MDMA -related</w>
MD X</w>
MD R
MD M,</w>
MD A;</w>
MD A.</w>
MD A)</w>
MD 2
MCP -1-mediated</w>
MCP -1,</w>
MCF P.</w>
MCF -10
MCF-10 F</w>
MCAv(mean )</w>
MC P-3,</w>
MC )-
MB s.</w>
MB s,</w>
MB q/m2).</w>
MB C,</w>
MB 's</w>
MAT 2)</w>
MAPD (9
MAPD(9 0)</w>
MAO- inhibitor</w>
MAO- inhibited</w>
MAO- A-I</w>
MAO -type</w>
MAMP -treated</w>
MAC- Awake</w>
MA/ MA.</w>
MA RS</w>
MA Q</w>
MA P/
MA P).</w>
MA MP,</w>
MA L.</w>
MA 3
MA -related</w>
M552 V</w>
M552 I</w>
M40 403</w>
M204 V</w>
M204 I</w>
M2- M5</w>
M1628 7</w>
M1/ M
M/ l)</w>
M/ H
M/H ouse</w>
M-0 80
M- containing</w>
M- OH</w>
M- NC</w>
M- 938
M woA</w>
M w
M ural</w>
M ucinous</w>
M s.</w>
M oz
M oxonidine</w>
M oxifloxacin</w>
M oxalactam</w>
M ount</w>
M olec
M ol.</w>
M oclobemide</w>
M n</w>
M n-SOD</w>
M m
M iti
M ill</w>
M ethanol</w>
M erb
M embrane-
M b.</w>
M ast</w>
M ary's</w>
M arch,</w>
M aps</w>
M ane
M andatory</w>
M anchester</w>
M adop
M ZR.</w>
M X</w>
M W
M VL
M U/m2</w>
M U-
M SD</w>
M SCs</w>
M SC-treated</w>
M S,</w>
M S).</w>
M Q</w>
M PG,</w>
M PAP</w>
M PA-treated</w>
M PA).</w>
M OPP,</w>
M OH</w>
M O.</w>
M O),</w>
M MT,</w>
M M)</w>
M L</w>
M IN
M IL
M G,</w>
M G)</w>
M FC</w>
M FA</w>
M F1</w>
M CT.</w>
M CT,</w>
M CT
M CNS.</w>
M CNS,</w>
M CN,</w>
M CD
MCD E</w>
M C.</w>
M C)</w>
M C),</w>
M =
M 50
M 5-/-</w>
M 4</w>
M 4/
M4/ M1</w>
M 4),</w>
M 3)</w>
M 25</w>
M 2413
M 1)</w>
M 0</w>
M );</w>
M (5
M(5 )-
M(5)- selective'),</w>
M (3)/
M(3)/ M(5)-selective'),</w>
M (3
M(3 )-
M (2)-
M(2)- muscarinic</w>
M (-1)</w>
Lys(15)] nociceptin</w>
Lt d.)</w>
Lox apine</w>
Low- risk</w>
Low- protein</w>
Low- molecular-weight</w>
Low- level</w>
Low- flow</w>
Low ,</w>
Lou /
Lou/ M</w>
Los artan,</w>
Long- term,</w>
Lond on</w>
Lond on,</w>
Loest rin</w>
Loc k
Lo ad</w>
Lo a</w>
Lithium- Effect
Lithium-Effect uated</w>
Lissau er's</w>
Lis uride,</w>
Lipos omes</w>
Lipo dystrophy</w>
Lip iodol</w>
Lip ids</w>
Linezol id-induced</w>
Linezol id,</w>
Lind ane-induced</w>
Lind ane,</w>
Lin n.</w>
Light- microscopic</w>
Ligh ter</w>
Ligh t-</w>
Ligh t,</w>
Life- table</w>
LiCl/ pilocarpine-induced</w>
Li/D VP)</w>
Li- uraemia.</w>
Li- rats,</w>
Li- pretreated</w>
Li- pilocarpine-induced</w>
Li- fed</w>
Li ver-function</w>
Li ons</w>
Li :</w>
Li .</w>
Li +</w>
Levosul piride</w>
Levo bupivacaine</w>
Levamisol e-induced</w>
Lev onorgestrel</w>
Lev omepromazine</w>
Lev ofloxacin-induced</w>
Lev ine</w>
Leukotri ene</w>
Leuc openia,</w>
Leu- Gly-
Leu-Gly- NH2)</w>
Leu prolide</w>
Leu -19-
Leu-19- positive</w>
Le imyosarcoma</w>
Le frak's</w>
Le f
Le ad</w>
Latin- American</w>
Larg e,</w>
Lare b</w>
Langer han
Langendorff- perfused</w>
Lan soprazole</w>
Lamotrig ine-associated</w>
Lamivud ine-induced</w>
Lamivud ine-
Laborator ios</w>
Laborator ies</w>
Lab rador</w>
Lab eling</w>
LY3547 40,</w>
LY2746 14,</w>
LY2359 59,</w>
LY2359 59
LY235959 -treated</w>
LY1418 65,</w>
LY-17 1555</w>
LY 36
LY36 7
LVF X.</w>
LVF X)</w>
LVE T</w>
LV dP/dt)</w>
LV dP/dt),</w>
LV X</w>
LV SF</w>
LV S.</w>
LV P</w>
LV H.</w>
LV D</w>
LV D.</w>
LV D
LV As</w>
LV ).</w>
LV ),</w>
LUT S</w>
LT X</w>
LT P.</w>
LT BM
LT .</w>
LSM LN</w>
LR 176</w>
LR ).</w>
LQT 2,</w>
LQT 1,</w>
LPS- challenge</w>
LP-S -1
LP-S-1 0)</w>
LP S-treated</w>
LP :</w>
LOU/ M</w>
LO D</w>
LO CM.</w>
LO CF</w>
LNa+ LCa</w>
LNC-8 34,</w>
LN a.</w>
LN a,</w>
LMW- heparin</w>
LMW- heparin.</w>
LM /B
LM/B c</w>
LL C-
LLC- PK
LIS ,</w>
LIL ACS</w>
LID/ saline</w>
LID s,</w>
LI P</w>
LI LE</w>
LI ).</w>
LI ),</w>
LH- RH,</w>
LH ON.</w>
LF T</w>
LF Ps</w>
LF B,</w>
LF 3</w>
LEn t</w>
LEn t.</w>
LEn t,</w>
LEP P1)</w>
LENT ).</w>
LEG/ ml</w>
LEF- limb,</w>
LE t)</w>
LE W</w>
LE V,</w>
LE ;</w>
LDH- isoenzyme</w>
LD R</w>
LD L2</w>
LD H.</w>
LD A)</w>
LD :</w>
LD 95</w>
LD 50,</w>
LD 100</w>
LD ).</w>
LCA DE)</w>
LCA +,</w>
LC6 A
LC a,</w>
LC MRglc</w>
LC L</w>
LC 3-
LAD CA</w>
LAD /
LAD/ LCx</w>
LA- supplemented</w>
L6/ S1</w>
L6/ J</w>
L6- S2</w>
L6- S1)</w>
L5- L6</w>
L4- 3
L3- L4</w>
L3- L4,</w>
L20/F 25</w>
L1- S1</w>
L/ min/
L/ min)</w>
L/ kg</w>
L/ kg,</w>
L/ day.</w>
L/ 24</w>
L.min-1.%SaO2 (-1
L.min(-1 ).m(2)
L.min(-1).m(2) ).</w>
L.min(-1 ).
L.min(-1). m(2)</w>
L-dopa /
L-dopa/ carbidopa</w>
L-dopa -treated</w>
L-arginine/ nitric</w>
L-arginine/ NO/cGMP</w>
L-arginine- methyl</w>
L-argin ine-treated</w>
L-OH P,</w>
L-Dopa ,</w>
L-701, 3
L-655,70 8</w>
L-655,70 8,</w>
L-6 59
L-659 ,0
L-6 57
L-36 4,7
L-364,7 18</w>
L-2-oxothiazolidine-4- carboxylic</w>
L-2-oxothiazolidine-4- carboxylate</w>
L- phenylisopropyladenosine</w>
L- phenylalanine</w>
L- penicillamine</w>
L- nitroarginine</w>
L- methionine</w>
L- methionine-
L- citrulline</w>
L- carnitine-treated</w>
L- asparaginase.</w>
L- NA</w>
L- MED</w>
L- His
L- HO
L- Carnitine</w>
L- CC
L-CC GI</w>
L- Arg,</w>
L- ASA</w>
L- 6-
L-6- ketopiperidine-2-carbonyl-L-leucyl-L-proline</w>
L- 5-HT
L urie</w>
L s,</w>
L p
L ove
L one</w>
L ine</w>
L hermitte's</w>
L ever</w>
L et
L equesne</w>
L eiomy
L aus
L audanosine</w>
L ateral</w>
L ate,</w>
L aryngoscopy</w>
L arsen</w>
L and
L am.</w>
L agos</w>
L actitol</w>
L acidi
L ab</w>
L a
L ZP</w>
L X
L SEPs</w>
L SE
L SA2-L2</w>
L S.</w>
L RS
L RR</w>
L P.</w>
L ORR</w>
L ORR,</w>
L OD.</w>
L N.</w>
L MA</w>
L IND
LIND I</w>
L Ca)</w>
L Ca
LCa .(ABSTRACT</w>
L CCG
L CBF,</w>
L C,</w>
L C)</w>
L BBB.</w>
L B-
LB- 46</w>
L AP
LAP 4</w>
L AM.</w>
L AEs</w>
L A).</w>
L 5/
L5/ L6</w>
L 4-5</w>
L 2.</w>
L 1210</w>
L 12
L 1.</w>
L -1)</w>
L ))</w>
L (-)-
L(-)- threo-3-hydroxyaspartic</w>
Kv LQT1</w>
Kv 1.5,</w>
Kore an-
Kore a)</w>
Knoc kout</w>
Kit agawa</w>
Kir 6.2-
Kind led</w>
Ki- 67
Ki-67 -</w>
Ket y-Schmidt</w>
Ket ogenic</w>
Ket amine-associated</w>
Ket alar</w>
Kau fman</w>
Kar nov
Kappa -opioid</w>
KT- 36
KT-36 2,</w>
KRT 8</w>
KRT 18</w>
KRN239 1.</w>
KRN239 1-</w>
KRH- 59
KRH-59 4,</w>
KMgC it,</w>
KIT- PY567-
KIT (Y567F/Y567
KIT (Y
KIT(Y 719
KG s</w>
KG ).</w>
KCN H2</w>
KCN E2</w>
KB-24 13</w>
KB-24 13.</w>
K1C- eNOS</w>
K1 C</w>
K- ras</w>
K- phosphate</w>
K- M</w>
K+- channels</w>
K unitz-type</w>
K uala</w>
K s</w>
K rox-
K os
K ong</w>
K ong.</w>
K ong,</w>
K ohonen</w>
K max,</w>
K inins</w>
K ings</w>
K ing/Drew</w>
K inase</w>
K inase-
K imura's</w>
K illip</w>
K igali,</w>
K iddie</w>
K ibwezi,</w>
K he
K f</w>
K ent</w>
K ell
K V
K T58
K T,</w>
K PS</w>
K O,</w>
K Cl)</w>
K CA
K C</w>
K 8644</w>
K 8644
K8644 -induced</w>
K 801</w>
K 15</w>
K 1/
K -induced</w>
K -</w>
K );</w>
K (d)</w>
Jun ior</w>
Judg ing</w>
Judg ed</w>
Ju n</w>
Ju an</w>
John son,</w>
Joh annesburg,</w>
Jo ules/
Jo hn's</w>
Je hovah's</w>
Jaundic e,</w>
Jap ane
Jan k
Jan eiro,</w>
Jan eczko,</w>
Jama ic
Jack sonville,</w>
JNK ,</w>
J uzen-taiho-
J uss.</w>
J une,</w>
J o</w>
J ia
J en-San-Yaung-Jung-Tang</w>
J akarta</w>
J UPITER</w>
J Ol
J IA</w>
J BR
JBR .
JBR. 10</w>
J AB</w>
J 865)</w>
J 2*
J /cm2</w>
J /
J -113
Itrac onazole</w>
Itrac onazole-induced</w>
Ital y,</w>
Istan bul,</w>
Isovue- 370</w>
Isot retino
Isot onic</w>
Isoproteren ol.</w>
Isoproteren ol,</w>
Isoniaz id-associated</w>
Isom ers</w>
Iso flurane,</w>
Iso eugenolol</w>
Ischem ia-
Isch aemia</w>
Is-5-M n,</w>
Is sues</w>
Is ochronal</w>
Irel and,</w>
Irb -,</w>
Iran ian</w>
Ira qi</w>
Ir win</w>
Ir regular</w>
Ir b,</w>
Ir b),</w>
Iox ilan</w>
Iox aglate</w>
Iontophore tic</w>
Ion ized</w>
Io do-DHP</w>
Investig ating</w>
Investig ateurs</w>
Investig ate</w>
Invent ory-
Intras pinal</w>
Intralip id-treated</w>
Intralip id-</w>
Intralip id,</w>
Intrac olonic</w>
Intrac avitary</w>
Intra- raphe</w>
Intra- periaqueductal</w>
Intra- accumbens</w>
Intra peritoneally</w>
Intra operatively,</w>
Intra arterial</w>
Intr aluminal</w>
Intr al
Intr afascicular</w>
Intoxic ations</w>
Interview s</w>
Interleukin- 6</w>
Interleuk in</w>
Interferon- ribavirin</w>
Interferon- alpha</w>
Inter- observer</w>
Inter val
Inter pre
Inter mediate-dose</w>
Inter im</w>
Inter ference</w>
Inten sity</w>
Inte gral</w>
Institut e's</w>
Institu tions</w>
Ins1P- levels</w>
Inos itol-4-phosphate</w>
Inher ited</w>
Infarc ts</w>
Infarc tion,</w>
Infarc t-type</w>
Infarc t-avid</w>
Inf usion-related</w>
Inf usaid</w>
Inf rared</w>
Inf ection.</w>
Induc ible</w>
Indomethac in-associated</w>
Indo profen,</w>
Indo Pro
Individu alized</w>
Indic es</w>
Indi anapolis,</w>
Indi a,</w>
Index ,</w>
Index )</w>
Increas ingly,</w>
Incid ental</w>
In- vivo</w>
In- hospital</w>
In ula</w>
In timate</w>
In t</w>
In sufficient</w>
In stillation</w>
In sp
In sights</w>
In sidious</w>
In side</w>
In patients</w>
In jection-associated</w>
In filtration</w>
In dependently</w>
In d</w>
In correct</w>
In corporation</w>
In cisional</w>
In activation</w>
In actin</w>
In accurate</w>
Impressions- Improvement</w>
Impression- Sexual</w>
Import ance</w>
Implan on</w>
Impair ments</w>
Immunohist ochemical,</w>
Immunocyt ochemical</w>
Immuno globul
Immun oprecipit
Immun olabeling</w>
Immun o-
Immun ization</w>
Imidaz enil</w>
Imid azole</w>
Imi pramine-
Imat inib.</w>
Im pulsive</w>
Im pedance</w>
Im mobilization</w>
Im age</w>
Illino is</w>
Ill icit</w>
Ile 8]
Ile8] ANG</w>
IgA- N</w>
IgA- N.</w>
Ig M.</w>
Ig M-
Ig G-induced</w>
Ig E.</w>
Ig E,</w>
Ig AN</w>
Ide ation</w>
Ide ally,</w>
Idarub icin,</w>
Ibuprofen -
Ibu tilide</w>
Ib otenic</w>
IV- TR
IV- C</w>
IV R-6</w>
IV R-3</w>
IV MP</w>
IV MP,</w>
IV H,</w>
IV /
IV/ oral</w>
IV --
IV );</w>
IUD R</w>
IUD .</w>
IU/ ml</w>
IU/ l.</w>
IU/ kg/
IU/ kg,</w>
IU/ kg),</w>
IU/ hr</w>
IU/ L)</w>
IU/ L).</w>
IU C</w>
ITC- albumin)</w>
IT- TSPA.</w>
IT- NEO</w>
IT- MTX,</w>
IT T</w>
IT C</w>
ISO- treatment.</w>
ISO M</w>
ISO -pretreated</w>
ISO -evoked</w>
ISO -1</w>
ISO ),</w>
IS-5-M N.</w>
IS SI-Prevenzione</w>
IS PH-induced</w>
IS P-induced</w>
IS P,</w>
IS O)</w>
IS I</w>
IS H)</w>
IS -I</w>
IS ,</w>
IRREGULARIT Y</w>
IR S)</w>
IR HC,</w>
IR AEs.</w>
IR ).</w>
IQ s</w>
IP SPs</w>
IP S</w>
IP S)</w>
IP H.</w>
IP E</w>
IP -induced</w>
ION S</w>
IO P-lowering</w>
IO L</w>
IO CM.</w>
INTRODUC TION</w>
INTERPRETA TION/
INH -associated</w>
ING :</w>
IN S</w>
IN R.</w>
IN R
IN H,</w>
IN F-
INF- MI</w>
IN CM
INCM NSZ.</w>
IMPORTAN CE</w>
IMPORTAN CE:</w>
IMPLICA TION:</w>
IM ID.</w>
IM ID
IM GB
IM D</w>
IM C).</w>
IM -like</w>
IL-6/ GP
IL-6/GP 130</w>
IL-1 alpha</w>
IL-1 2</w>
IL-1 -like</w>
IL- 8,</w>
IL- 5,</w>
IL- 3.</w>
IL R-documented</w>
IL ES)</w>
IL ;</w>
IL -1.</w>
IL -1-
IK 1,</w>
IK )-related</w>
III/ III</w>
III- V.</w>
III- IV)</w>
III- B</w>
III- -
III a,</w>
III R
III B-
IIIB- IV</w>
IIE024 6)</w>
IIE F.</w>
II/ III-V</w>
II- IV,</w>
II- IV).</w>
II B)</w>
II -specific</w>
II -mediated</w>
IHG- 2</w>
IH A).</w>
IGFBP- 5</w>
IGFBP- 3.</w>
IGFBP- 3,</w>
IGFBP s</w>
IGFBP -1</w>
IGFB P-2</w>
IGF- binding</w>
IGF- IL-3.</w>
IGF- I-
IGF BP</w>
IGF -1,</w>
IFN/ Rib</w>
IFN- alpha,</w>
IFN- alpha
IFN )/
IFN)/ ribavirin</w>
IF- IF</w>
IF X.</w>
IF X,</w>
IF ACs</w>
IE LD:</w>
ID V-related</w>
ID V,</w>
ID R</w>
ID O</w>
ID C.</w>
ID 50s</w>
ID /
ID ),</w>
ICRF-1 59</w>
ICD -10
ICA-27 243</w>
ICA M
ICA .</w>
IC s</w>
IC U).</w>
IC S,</w>
IC R,</w>
IC M</w>
IC I,</w>
IC Ds.</w>
IC D-
ICD- 9</w>
IC .</w>
IB4- sapor
IB4 (+)</w>
IB W</w>
IB U</w>
IB O3304</w>
IB IS-I</w>
IB C</w>
I1- receptors.</w>
I1- receptor-mediated</w>
I1- imidazoline</w>
I/ ml</w>
I/ kg</w>
I/ IV</w>
I.P .),</w>
I. t.</w>
I. U.</w>
I. U.
I. D.</w>
I-3 11),</w>
I- exposed</w>
I- V</w>
I- Type</w>
I- III;</w>
I- 2)</w>
I- 2
I- -
I(f )</w>
I(f )-
I(f)- generating</w>
I(f ),</w>
I(Na L),</w>
I(K )</w>
I psilateral</w>
I pecac</w>
I opent
I neffective</w>
I midazoline</w>
I kr</w>
I celand</w>
I c-
I asi</w>
I a,</w>
I Z
I SIS</w>
I RA
I R),</w>
I PV-related</w>
I PRL,</w>
I OR/OS-
I O)</w>
I NA</w>
I M),</w>
I HS</w>
I H.</w>
I GF</w>
I GABA</w>
I G)</w>
I BP
I B)</w>
I 1-</w>
I -treated</w>
I (Ca,L)</w>
I (Ca,
I(Ca, L),</w>
I 's</w>
Hz ;</w>
Hypothe tically,</w>
Hypothe tical</w>
Hypothe ses</w>
Hyponat raemia</w>
Hypomagne semia,</w>
Hypom anic</w>
Hypom ania</w>
Hypokal aemia</w>
Hypo glycemic</w>
Hypo geusia</w>
Hypo album
Hypertriglyceride mia</w>
Hypertriglyceride mia,</w>
Hyperparathyroidis m</w>
Hyperkal emia,</w>
Hyperinsul inemia</w>
Hypercal cemia,</w>
Hypercal ce
Hyper uric
Hyper sexuality</w>
Hyper pigmentation,</w>
Hyper locomotion</w>
Hyper lactatemia</w>
Hyper glycemic</w>
Hyper glycemia</w>
Hyper glycemia,</w>
Hyper cholesterol
Hyper bilirubinemia</w>
Hyper ammonemic</w>
Hyper algesic</w>
Hyper -</w>
Hype remia</w>
Hyp ocalcemia</w>
Hyp notics,</w>
Hyp notic</w>
Hydroxyure a-induced</w>
Hydroxy methylglutaryl</w>
Hydroxy chloroquine-</w>
Hydrox y-
Hydrox amic</w>
Hydroneph rosis</w>
Hydro ethidine</w>
Hydro cortis
Hydro chlorothiazide-induced</w>
Hydro chlorofluorocarbons</w>
Hyd antoin-induced</w>
Hybri dization</w>
Hybri d</w>
Hy sterosalpingography</w>
Hy oscy
Hung ary,</w>
Hung arian</w>
Humph rey</w>
HuEPO- beta).</w>
Hsp 72</w>
Hospit alized</w>
Hos pal</w>
Hor n</w>
Homozyg ote</w>
Homer 1b/
Hoe-1 40</w>
Ho t</w>
Ho osier</w>
Ho fmann</w>
Hist ory,</w>
Hist ologically</w>
His- ventricle</w>
His pan
Hir udin</w>
Hir sutism</w>
Hipp ocratic</w>
Hind limb</w>
High- grade</w>
High est</w>
Hi p</w>
Hi erarchical</w>
Hi biscus</w>
Hg/ sec;</w>
Hg/ s,</w>
Hg. mL-1.min-1.
Hg b</w>
Hg Cl
HgCl 2-induced</w>
Hg -1,</w>
Hg -
Hg- minus</w>
Hey mann's</w>
Hexachloro cyclohexane</w>
Hexabri x,</w>
Heter actis</w>
Here dofamilial</w>
Her pes</w>
Hepati c,</w>
Hepat omegaly</w>
Hepat ocellular-
Hepat oblastomas</w>
Hepat oblastoma</w>
Hepar anase</w>
Hen nepin</w>
Hen le.</w>
Hen le,</w>
Hemo dynamics,</w>
Hemat otoxicity</w>
Hem e</w>
Hel sinki</w>
Hel ical</w>
Hein z-body</w>
Hear t-
Hear t,</w>
Health y,</w>
Heal th.</w>
He me-
He avier</w>
He ating</w>
Hdac 3-
Hawai ians</w>
Har ris-Benedict</w>
Hap lo
Han over</w>
Han nover</w>
Hampshi re's</w>
Ham ster</w>
Halothane- specific</w>
Hall ervorden-Spatz</w>
Hal f-
Haemodi alysis</w>
Haemacce l</w>
Haem orrhage</w>
Habit uation</w>
Ha ven,</w>
Ha ir</w>
Ha em</w>
HY PREN-trial:</w>
HW /
HW ,</w>
HVA/ dopamine</w>
HV A:
HVA: DA)</w>
HUS ).</w>
HU VEC
HU P</w>
HU 2
HTLV- I-associated</w>
HT x</w>
HT LW</w>
HT ).</w>
HSP N,</w>
HSP 47,</w>
HS P,</w>
HS G,</w>
HS -induced</w>
HR T.</w>
HR R</w>
HR PC.</w>
HR C,</w>
HR /
HR ).</w>
HPLC- mass</w>
HPL C,</w>
HP+ NX</w>
HP V</w>
HP L</w>
HP F.</w>
HP +</w>
HOR IZ
HO smR
HO ME</w>
HO L</w>
HMR-18 26,</w>
HM W</w>
HLA-DR 3,</w>
HLA-DR 1</w>
HLA-DR 1,</w>
HLA- matched</w>
HIV/ hepatitis</w>
HIV/ AIDS.</w>
HIV- infected,</w>
HIV- exposed</w>
HIV MPT</w>
HIV MPT
HIV -induced</w>
HIT/ T</w>
HIT T)</w>
HIP/PA P-transgenic</w>
HI- E
HI-E +
HI-E+ HI-
HI PA</w>
HI AA</w>
HF E</w>
HER2- overexpressing,</w>
HER S</w>
HER G-
HERG- transfected</w>
HER G,</w>
HER 2,</w>
HE s</w>
HE TE)</w>
HE T.</w>
HE ),</w>
HDM 220</w>
HDL- c/LDL-c</w>
HDL- C</w>
HDC-9 12</w>
HDAR AC.</w>
HD- MTX.</w>
HD- IFX</w>
HD- CT
HD P,</w>
HD P)</w>
HD MTX:</w>
HD MP</w>
HD M.</w>
HD L.</w>
HD L,</w>
HD L
HD ;</w>
HD :</w>
HCT Z-treated</w>
HCT Z,</w>
HCO 3.</w>
HC s)</w>
HC s).</w>
HC l
HC a.</w>
HC V/HIV</w>
HC V
HC Q.</w>
HC Q-induced</w>
HC P.</w>
HC N4</w>
HC M.</w>
HC I</w>
HC G,</w>
HC C,</w>
HC -
HBsAg -negative</w>
HBsAg (+),</w>
HBeAg- negative.</w>
HBcAb -positive</w>
HBV- DNA-positive</w>
HBV- DNA-
HB s,</w>
HB -2</w>
HAM-D 21</w>
HAM- D-
HAM-D- 21</w>
HAM- D)</w>
HAM- A,</w>
HAL- associated</w>
HAL O,</w>
HAL .</w>
H2O /kg</w>
H2O ).</w>
H2- histamine</w>
H2- antagonists</w>
H2 O/
H2 O),</w>
H1- antagonist</w>
H/ P-3.0</w>
H/ P-1.5</w>
H- bridged</w>
H- V</w>
H- PILO,</w>
H- I</w>
H- A)</w>
H- 3-benz
H-3-benz azep
H- 2</w>
H- 07</w>
H) 7-
H)7- Ac-CCK-2-8-SE</w>
H(3 )-
H(3)- receptors.</w>
H(2)O (2),</w>
H(2) O),</w>
H(1)- antihistamine</w>
H sieh,</w>
H s,</w>
H ounsfield</w>
H opkins</w>
H ope
H ome</w>
H iponatremia</w>
H ind</w>
H imachalol</w>
H ilaire</w>
H b.</w>
H ass
H ardwood</w>
H appiness</w>
H al</w>
H airy</w>
H ag
H Z</w>
H SP</w>
H SA</w>
H S,</w>
H S).</w>
H Q</w>
H PR</w>
H PG</w>
H P.</w>
H OP
H O-2</w>
H MDP</w>
H IC</w>
H H:</w>
H GF.</w>
H G
H EM
HEM -induced</w>
H EDP</w>
H Ca
HCa ).</w>
H AR
HAR MS</w>
H A).</w>
H 76</w>
H 56/
H56/ 28,</w>
H 3K
H 3.</w>
H .,</w>
Gynec omastia,</w>
Gusta ve</w>
Gu il
Gu id
Gu ard</w>
Gu aifenesin</w>
Grow th-associated</w>
Group- III,</w>
Group- II,</w>
Grou p)</w>
Green landic</w>
Green field</w>
Greec e.</w>
Granulo mas</w>
Gram- positive,</w>
Gram- negative,</w>
Grad y</w>
Gra y's</w>
Gra ve's</w>
Gra ham</w>
Gpx 1</w>
Goodpasture -like</w>
Goodpasture 's-like</w>
Gonad al</w>
Gom ori
Golgi /
Gold mann</w>
Go og
Glycopyr ronium</w>
Gly coprotein</w>
Gly T1</w>
Gly -16</w>
Glutam ate-
Glut ethimide</w>
Glucocortico id-inducible</w>
Glucocortico id
Gluc o
Gluc agon-like</w>
GluR2/ 3-
GluR2/3- immunopositive</w>
GluR 2/3</w>
GluR 1</w>
GluR 1,</w>
Glu R-
Glu 27
Glu27 Gln</w>
Glu /
Glu/ tCr</w>
Glicl azide-induced</w>
Gli bencl
Gli 3,</w>
Gle ditsia</w>
Gle ason</w>
Gl n-
Gl ax
Ginsen osides</w>
Gi/ o</w>
Gi- protein</w>
Gi ving</w>
Gi HUS,</w>
Gi 3,</w>
Gi 1,</w>
Gest ation</w>
German y).</w>
Ger stmann</w>
Ger man,</w>
Ger iatric</w>
Genotyp e</w>
Gene tics,</w>
Gen it
Gen der,</w>
Ge org
Gd-DTPA- administration</w>
Gd- EDTA,</w>
Gd- DOTA</w>
Gastro cnemius</w>
Gamma- hexachlorocyclohexane</w>
Gamma- aminobutyric</w>
Gam bro</w>
Gall bladder</w>
Gal lopamil</w>
Gal anthamine</w>
G_C_G_ G</w>
GW29 7
GW297 4.</w>
GV HD)</w>
GUST O-
GTP-gamma- S,</w>
GT S.</w>
GT N-
GT G</w>
GT G
GTG +HF</w>
GT CS</w>
GT 1
GST- P,</w>
GSPE+ drug</w>
GSPE+ drug.</w>
GSPE 's</w>
GSP E.</w>
GSI F</w>
GSHP x,</w>
GSH-P x,</w>
GSH )</w>
GSH ).</w>
GS SG/GSH</w>
GS SG)</w>
GS C)</w>
GR1389 50.</w>
GR1279 35,</w>
GR113 80
GR11380 8A</w>
GR 20
GR20 5
GR 12548
GR12548 7
GR125487 D</w>
GPT .</w>
GPR (5
GP IX</w>
GP I
GP 4
GP4 21
GP421 12
GO AL</w>
GO AL
GM P-
GM 1-
GL U</w>
GJ K</w>
GH SR</w>
GF s)</w>
GEC s,</w>
GE PRs</w>
GE PR-
GE E</w>
GE ).</w>
GDE E.</w>
GC- HT</w>
GB T,</w>
GB M)</w>
GB CAs</w>
GATA- 4</w>
GAER TN
GAER S</w>
GAD .</w>
GAD -65</w>
GAD ,</w>
GABAerg ic.</w>
GABAA/ alpha1</w>
GABA- stimulated</w>
GABA- ionophore</w>
GABA- benzodiazepine,</w>
GABA- alpha-oxoglutarate</w>
GABA(B(1 b))</w>
GABA(B(1 a))</w>
GABA(B(1 a))(-/-)</w>
GABA(A)- current</w>
GABA(A )-receptor</w>
GABA b</w>
GABA A-receptor</w>
GABA A
GABAA ergic</w>
GABA -induced</w>
GAB An
GA PDH</w>
GA G.</w>
G6 Pase</w>
G6 PD-deficient</w>
G434 S</w>
G/ VP/CPM.</w>
G- supplemented</w>
G- pretreated</w>
G- monitored</w>
G- CSF,</w>
G- CSF).</w>
G- CSF
G- 6
G- 5
G y;</w>
G y:</w>
G wardamangia,</w>
G s--
G s,</w>
G ruppo</w>
G raphites</w>
G pp(NH)p</w>
G osha-jinki-gan</w>
G m.</w>
G lascow</w>
G elsemi
G ei
G d
G aucher</w>
G astrin</w>
G anoderma</w>
G allotannin</w>
G ait</w>
G T,</w>
G ST,</w>
G S.</w>
G PT)</w>
G PN</w>
G PD</w>
G PD,</w>
G OF</w>
G O.</w>
G M)</w>
G K</w>
G IV</w>
G ISSI-Prevenzione</w>
G II</w>
G IF-
G I)</w>
G G-supplemented</w>
G EM,</w>
G Ds</w>
G Cs.</w>
G CT
G C/
G C.</w>
G C-induced</w>
G C,</w>
G BP</w>
G AT)</w>
G AI
GAI N:</w>
G A.</w>
G A,</w>
G A)</w>
G >
G 2,</w>
G .,</w>
Fun damental</w>
Ful filment</w>
Frideric ia</w>
Fri edreich's</w>
Frequency -domain</w>
Frequ ency,</w>
Fre e-
Frag ments</w>
Fract ure</w>
Fr uctose</w>
Fr an</w>
Fr amework.</w>
Fourty- four</w>
Fos phenytoin</w>
Fos )</w>
Formal in-induced</w>
Form oterol</w>
Form al</w>
For sk
For ced</w>
Fol low</w>
Fol ates</w>
Foc using</w>
Foc i</w>
Fo rensic</w>
Fo relimb</w>
Fo ot-
Fo od-dependent</w>
Fo eniculum</w>
Flut .</w>
Fluoxet ine.</w>
FluoroJ ade</w>
Fluoro gold</w>
Fluores cent</w>
Fluo ropyrimidines,</w>
Fluo rescence</w>
Flumazen il.</w>
Flud arabine</w>
Fluc tuations</w>
Fluc loxacillin-induced</w>
Flu or
Flu indione</w>
Florid a</w>
Fl ushing</w>
Fl a,</w>
Five- year</w>
Five- week-old</w>
Find ing</w>
Fin land.</w>
Fin k-Heimer</w>
Fil icene</w>
Fil grastim</w>
Fif teen-
Ficoll- Hypaque</w>
Ficol l.</w>
Ficol l,</w>
Fibrom yalgia</w>
Fibrom uscular</w>
Fibro tic</w>
Fenol dopam,</w>
Feno profen</w>
Feno fibrate-induced</w>
Fenflur amine,</w>
Fen- Phen
Feder ation</w>
FeNa %,</w>
Fe asibility</w>
Fe LV.</w>
Fe 2+</w>
Fe (II)</w>
Fc gamma</w>
Fat ality</w>
Fast- Onset</w>
Fast er</w>
Fast ed</w>
Fas -mediated</w>
Fas -induced</w>
Fas -dependent</w>
Farns worth</w>
Fancon i-like</w>
Fal se</w>
Fac ial</w>
Fab re</w>
Fab '
Fab' /
Fab'/ DMI</w>
FZ-2 HCl,</w>
FXII- deficient</w>
FVII a)</w>
FV S</w>
FV C,</w>
FUDEC O</w>
FUD R-induced</w>
FSG S,</w>
FSG S)</w>
FR s,</w>
FR s)</w>
FR G),</w>
FR 5)</w>
FR 1393
FR1393 17.</w>
FQ/ nociceptin</w>
FN 's</w>
FL E)</w>
FL ASH</w>
FKBP 12</w>
FKBP 12.
FKBP12. 6-/-</w>
FK97 3,</w>
FK506- treated</w>
FK506- nephropathy</w>
FK50 6:</w>
FK- 506.</w>
FK- 506,</w>
FK 66
FK66 4,</w>
FJ C-
FJC- positive</w>
FJ +/
FJ+/ PV
FITC- labeled</w>
FINDING S</w>
FH 77</w>
FF P.</w>
FF I</w>
FF A,</w>
FEF25- 75.</w>
FEF 25-75</w>
FE UN</w>
FE SS.</w>
FE N,</w>
FE F</w>
FE C</w>
FDE IA.</w>
FDA- recommended</w>
FDA- grade</w>
FDA- approved</w>
FD A,</w>
FC x</w>
FANFT---- 5.2%</w>
FANFT---- 4.
FANFT- --
FANFT--- -1.
FANF T.</w>
FANF T,</w>
FAM P/
F344/ N</w>
F2- isoprostanes</w>
F2- isoprostane</w>
F2- alpha,</w>
F100 :</w>
F1- sires.</w>
F- to-GU</w>
F- dependent.</w>
F- activated</w>
F- actin-
F- S,</w>
F- J</w>
F- I</w>
F( ab')2</w>
F reshly</w>
F rank</w>
F ra</w>
F ra
F pA</w>
F osin
F osf
F lows</w>
F low-
F lin
F laccid</w>
F issu
F inger-
F ig
F ield</w>
F ick</w>
F e,</w>
F azad
F asciculation</w>
F armitalia-Carlo</w>
F argo,</w>
F alls</w>
F ahad</w>
F ag
F ]
F TD</w>
F SI</w>
F SG</w>
F Q</w>
F PL</w>
F P</w>
F P
F O,</w>
F MRI</w>
F MD</w>
F IELD:</w>
F HPL</w>
F FA</w>
F ENTANYL</w>
F DA
FDA 's</w>
F C)</w>
F BM
FBM /
F BAL.</w>
F AK</w>
F AC
F AB.</w>
F AB
F AA
FAA H</w>
F A,</w>
F A)</w>
F A
F :
F: Y569F/Y569F)</w>
F 50</w>
F 32.
F 2C)</w>
F 200</w>
F 200
F200 :</w>
F 100</w>
F .
F. U.</w>
Extr apulmonary</w>
Extr a</w>
Exten ded-release</w>
Experim entally</w>
Experi enced</w>
Exper ts</w>
Exc essively</w>
Examin ing</w>
Examin ations</w>
Examin ations,</w>
Examin ation,</w>
Exagger ation</w>
Ex ternal</w>
Ex tending</w>
Ex t
Ex pressions</w>
Ex pos
Ex plo
Ex plicit</w>
Ex pected</w>
Ex clusive</w>
Ex change</w>
Ex cell
Ex ce
Ex am</w>
Ex ,</w>
Evan 's</w>
Evalu ations.</w>
Evalu ation,</w>
Euphor ia</w>
Eu genol</w>
Etopo side-related</w>
Etopo side,</w>
Etomid ate-Lipuro</w>
Ethin yloestradiol</w>
Ethambut ol.</w>
Ethambut ol-induced</w>
Ethambut ol,</w>
Eth nic</w>
Et OH</w>
Estrogen s,</w>
Estrogen -
Essen tial</w>
Essen ,</w>
Escal ation</w>
Escal ating</w>
Es oph
Erythromel algia-like</w>
Erythro id</w>
Erythro cebus</w>
Eryth roxylon</w>
Ery thromycin</w>
Erec tion</w>
Er g
Equi valence</w>
Eq/ ml</w>
EpoR- HM</w>
EpoR- H</w>
Epo R</w>
Epo .</w>
Epo )</w>
Epinephrine- augmented</w>
Epinephr ine-containing</w>
Epilept ogenesis</w>
Epilep tic
Epilep sia</w>
Epidemio logy,</w>
Epidemio logic,</w>
Epi gastric</w>
Epi Pen</w>
Epi -P
Epi-P en</w>
Ep worth</w>
Ep silon-aminocaproic</w>
Ep endymoblastoma</w>
Enzym uria</w>
Enzym atic</w>
Enter ococcal</w>
Enoxapar in-associated</w>
Enox im
English .</w>
Endotheli al-dependent</w>
Endot ox
Endoscop y</w>
Endoc rin
Endoc annabinoids</w>
Endo phthalmitis</w>
Endo bronchial</w>
End- tidal</w>
End- of-dose</w>
End ocardial</w>
En zyme-linked</w>
En uresis</w>
En try</w>
En torhinal</w>
En t)</w>
En profylline,</w>
En gl</w>
En flurane-induced</w>
En ergy</w>
En drin</w>
En do</w>
En couraging</w>
En cephal
Emerg ing</w>
Em opamil</w>
Em bryos</w>
Em blica</w>
Em belia</w>
Electroly tes</w>
Electrocardio graphy,</w>
Electro phore
Electro diagnostic</w>
Electr on
Ele ven-
El ective</w>
Edin burgh</w>
Ecstas y")</w>
Echocardi ographically</w>
Ech o-
Eb c</w>
Early- morning</w>
Ea Hy
EX ;</w>
EX +
EX+ DOX</w>
EVIDE NCE</w>
ETH NOPHARMACOLOGICAL</w>
ET(B ))</w>
ET(A )R</w>
ET CO2</w>
ET AR</w>
ET =
ET /
ESR F</w>
ESR .</w>
ER22/23E K</w>
ER- DP</w>
ER s</w>
ER s).</w>
ER n</w>
ER Gs</w>
ER G).</w>
ER CP.</w>
ER A</w>
ER ),</w>
EP SP</w>
EP SP)</w>
EP SP
EP SCs,</w>
EP I,</w>
EP (2)</w>
EO s'</w>
EO T</w>
EO -induced</w>
EO ),</w>
EN U.</w>
EN L.</w>
EN L)</w>
EN F)</w>
EN ).</w>
EMT BL
EMBA SE.</w>
EM QMCM</w>
EM G)</w>
ELIS A;</w>
EL BW</w>
EGF- R.</w>
EF S-induced</w>
EF S,</w>
EEG- power</w>
EEG- changes</w>
EE- cholestasis</w>
EE H.</w>
EE 2</w>
EE -</w>
EE -17
EDT A)</w>
ED-1- positive,</w>
ED(9 5))</w>
ED(50) of</w>
ED s.</w>
ED L,</w>
ED ITS</w>
ED ;</w>
ED 50,</w>
ED 25</w>
ED 1</w>
ED 15</w>
ED 100</w>
ED 1+</w>
ED -1</w>
ED -1,</w>
ED (50))</w>
ECG- enhanced</w>
ECE-1 (+/+)</w>
EC s</w>
EC s)</w>
EC S,</w>
EC F</w>
EC A,</w>
EC 145
EC145 -induced</w>
EC -
EB FF</w>
EAD s,</w>
EAD -like</w>
EAD -dependent</w>
EA -induced</w>
E609 X</w>
E40 31</w>
E40 31.</w>
E40 31,</w>
E217 G-induced</w>
E217 G,</w>
E18. 5,</w>
E13. 5.</w>
E13. 5,</w>
E-40 31</w>
E- series</w>
E- selectin</w>
E- fortified</w>
E- derived</w>
E- deficient</w>
E- cadherin</w>
E- LFB,</w>
E- KO</w>
E- I)</w>
E(2)17 G.</w>
E(2)17 G,</w>
E ver</w>
E ur.</w>
E ticlopride</w>
E thopropazine</w>
E sters</w>
E s).</w>
E ronini</w>
E rasmus</w>
E pit
E perisone</w>
E lymoclavine</w>
E lizabeth</w>
E jaculatory</w>
E gypt
E favirenz
E co-Dobutamin
E ]</w>
E X-4.</w>
E W
E V-T</w>
E U,</w>
E U)</w>
E T-A</w>
E SS</w>
E SPVR</w>
E SPS</w>
E RNA</w>
E PRs</w>
E P,</w>
E ON.</w>
E O2</w>
E ME.</w>
E KGs</w>
E G)</w>
E F.</w>
E F).</w>
E ABR</w>
E :
E 9.5</w>
E 7</w>
E 6/
E6/ E7</w>
E 2/
E 19.</w>
E 18.5</w>
E 15.5,</w>
E 13.5</w>
E 10-
E 1-</w>
E 1
E /
E .,</w>
E -type</w>
E -treated</w>
E +</w>
E +/+</w>
E );</w>
E (max)</w>
E (m
E(m )/
E(m)/ A
E(m)/A (m)</w>
E (2).</w>
E (1),</w>
Dyst on
Dysph oric</w>
Dysp nea</w>
Dys phagia</w>
Dys morphogenesis</w>
Dys kinetic</w>
Dys geusia</w>
Dyn amics</w>
Dy stroph
Dy slipidemia</w>
Dy azide</w>
Duct us</w>
Dub lin,</w>
Du ke</w>
Du ane</w>
Du al-
Drug- eluting</w>
Dro spiren
Drd 2,</w>
Dra w-a-Man</w>
Doxy cycline-induced</w>
Doxorub icin.</w>
Doxorub icin-associated</w>
Doxorub icin-
Doxorub ic
Dox apram,</w>
Dox CM.</w>
Dox ),</w>
Double -labeled</w>
Dose- ranging</w>
Dose- effect</w>
Dose- dense</w>
Don ryu</w>
Dom perid
Dofetili de,</w>
Docum ented</w>
Docum entation</w>
Doc osahexaenoic</w>
Do gs.</w>
Diz ocilpine</w>
Diure tics</w>
Distinc tive</w>
Dist ress</w>
Dist inguishing</w>
Dissoci able</w>
Disopyram ide,</w>
Dise ase.</w>
Dis se.</w>
Dis crepancies</w>
Dis covery</w>
Dis continuations</w>
Dis comfort</w>
Dis appearance</w>
Dis abling</w>
Dipyridamole- thallium</w>
Dipyridamole- thallium-201</w>
Dipyridam ole,</w>
Diphenylhydanto in,</w>
Diphenhydram ine-induced</w>
Dip yrone,</w>
Dip lop
Dimer- X</w>
Dimen sions</w>
Diltiaz em,</w>
Dilev alol</w>
Dilev alol,</w>
Dilant in-induced</w>
Dihydroxy phenylalanine</w>
Dihydro pyridine-class</w>
Dihydro ergocryptine</w>
Dihydro -
Digit -S
Digit-S ymbol</w>
Differenti ating</w>
Dichloro diammine</w>
Diazemul s</w>
Diazemul s,</w>
Diarrhe a,</w>
Diaphrag matic</w>
Dialys ate</w>
Di verse</w>
Di ver
Di rofilaria</w>
Di methylethan
Di methyl</w>
Di atrizoate</w>
Di acetylmorphine</w>
Di acetolol</w>
Dextro -
Dextro- naloxone</w>
Dexamethas one-cyclophosphamide</w>
Dex- hypertension.</w>
Dex tran
Dex razox
Dex medetom
Dex atrim</w>
Dex a</w>
Dex Fent</w>
Develop ment,</w>
Develop ed</w>
Dev ices</w>
Dev ic
Determin ations</w>
Det roit</w>
Desi re</w>
Desensi tization</w>
Descri ptive,</w>
Des-Arg9- BK.</w>
Des mopressin</w>
Des methyl
Des butyl
Dermatomyosi tis</w>
Der iv
Depres sion-related</w>
Depo- Medrol</w>
Depend ent</w>
Depart ment.</w>
Dep renyl</w>
Dep osition</w>
Denmark )</w>
Den+ morph</w>
Demo graphics,</w>
Dem on
Delta9-TH CA-
Delta TSH(max)</w>
Delta MAP</w>
Deliri um,</w>
Deli very</w>
Dehydro epiandrosterone</w>
Defin ite</w>
Defic it</w>
Def iciency</w>
Def iciencies</w>
Deep- tendon</w>
Decom pression</w>
Dec ur
Dec oction</w>
Dec lining</w>
Dec lines</w>
Dec lar
De pressor</w>
De modex</w>
De letion</w>
De hydration</w>
De gree</w>
De gradation</w>
De fen
De erfield,</w>
Day time</w>
Daun omycin-induced</w>
Daun oXome</w>
Dar ifenacin</w>
Dapson e-associated</w>
Dantrol ene,</w>
Dang ers</w>
Dang erous</w>
Dan shen</w>
Dakot a.</w>
Dacarb azine-induced</w>
Dacarb azine,</w>
Dac ron</w>
DZ R:DOX</w>
DZ R-treated</w>
DZ P,</w>
DX R,</w>
DX R)</w>
DX 384</w>
DX .</w>
DT Z.</w>
DT R</w>
DT PA.</w>
DSM-IV- diagnosed</w>
DSM-IV- TR</w>
DS Q</w>
DS -associated</w>
DS (2)</w>
DS (1)</w>
DRE SS.</w>
DR-33 54</w>
DR UG</w>
DR Rs.</w>
DR P</w>
DR N</w>
DR G,</w>
DR C</w>
DR 4</w>
DR 1</w>
DPO AEs.</w>
DPD P)</w>
DPCP X,</w>
DPA T.</w>
DP s)</w>
DP en
DP TI/TTI</w>
DP P</w>
DP O</w>
DP H-
DP H)</w>
DP D)</w>
DOXY -treated</w>
DOX/ EX</w>
DOX- rats</w>
DOX- mediated</w>
DOX Y,</w>
DOX :</w>
DOX 3</w>
DOX 2</w>
DOX 1,</w>
DOX +
DOX+ EPO</w>
DOPAC/ DA</w>
DOCA- Sham</w>
DOCA- Nicotine</w>
DO R</w>
DO PS.</w>
DO CA-treated</w>
DO C)</w>
DO ).</w>
DNA- positive.</w>
DNA- dependent</w>
DN ase</w>
DN R-containing</w>
DN R,</w>
DN QX.</w>
DN L.</w>
DN L,</w>
DN IC</w>
DN FLE)</w>
DN F,</w>
DN B.</w>
DMTU -treated</w>
DMP X</w>
DMI -treated</w>
DMBA- prolactin-
DMBA- initiated</w>
DM-1K- SHR.</w>
DM P-Cl.</w>
DM NA</w>
DM CM
DLT s,</w>
DLIN E)</w>
DLB CL</w>
DLB CL,</w>
DL- tryptophan</w>
DL- tetrahydropal
DL- propranolol</w>
DL- propranolol,</w>
DL- methionine</w>
DL- lysine</w>
DL- buthionine</w>
DL- Threo-dihydroxyphenylserine</w>
DL F</w>
DL )-
DL)- cholesterol</w>
DISCUSSION S:</w>
DISCUSSION /
DISCUS SION</w>
DIL I</w>
DI HA</w>
DI AM
DIAM OND</w>
DHEC P</w>
DHEC P,</w>
DHC -1,</w>
DHA- enriched</w>
DH T.</w>
DH SM
DH PG,</w>
DH O</w>
DH ET</w>
DH EA.</w>
DH AS</w>
DH AC</w>
DH ,</w>
DG Cs.</w>
DFP/ GF</w>
DFP- atropine</w>
DFP- atropine,</w>
DFO- P.</w>
DF U.</w>
DF U-exposed</w>
DF U,</w>
DF S);</w>
DF P)</w>
DF O,</w>
DF O's</w>
DF CI-
DFCI- ALL</w>
DF C,</w>
DEX :</w>
DESCRIP TIONS:</w>
DES -related</w>
DEH P,</w>
DE s),</w>
DE X-
DE X,</w>
DE X)</w>
DE T,</w>
DE NA.</w>
DE N/
DE N-induced</w>
DE N,</w>
DE B</w>
DE A-
DEA- NO</w>
DE :</w>
DDP+ P-based</w>
DDP -induced</w>
DD SK</w>
DD S,</w>
DD DR</w>
DD AVP,</w>
DCG- IV,</w>
DCE- NT</w>
DCE .</w>
DCA- saline</w>
DC QX</w>
DC QX,</w>
DBA/2 Ibg</w>
DBA- 2</w>
DB S,</w>
DB P),</w>
DB N,</w>
DB D</w>
DB B</w>
DB A)</w>
DAV P),</w>
DAT (-/-)).</w>
DA- sensitive</w>
DA- mediated</w>
DA- innervated</w>
DA- depleted</w>
DA- containing</w>
DA- ,</w>
DA P)</w>
DA H</w>
DA ;</w>
D3- protein</w>
D2 L</w>
D1/ 5</w>
D-Trp6- LHRH</w>
D-Arg- [Hyp3,Thi5,D-Tic7,Oic8]</w>
D-Arg- (H
D-Arg-(H yp
D-00 4,</w>
D- sotalol</w>
D- receptor</w>
D- glucose,</w>
D- glucosaminidase</w>
D- glucar
D- gluc
D- deficient</w>
D- binding</w>
D- based</w>
D- arginine.</w>
D- arginine,</w>
D- arabinofuranosylcytosine</w>
D- amphetamine-</w>
D- amphetamine,</w>
D- Pen</w>
D- MED,</w>
D- Leu
D- CMP</w>
D- Arg
D- AP
D- AMPH-induced</w>
D- 21),</w>
D- (-)-
D-(-)- 2-amino-5-phosphonovaleric</w>
D(3) ],</w>
D(3 )-
D(3 ))</w>
D(2)/ D(3)</w>
D(2) ],</w>
D(-)- 2-amino-5-phosphonopentanoic</w>
D uret
D ural</w>
D uodenal</w>
D unnett's</w>
D uncan</w>
D s),</w>
D rinking</w>
D ramatic</w>
D otarizine</w>
D osed</w>
D ol
D isodium</w>
D in
D imin
D iflun
D ic</w>
D epth</w>
D betaH</w>
D av
D allas</w>
D aily,</w>
D ade</w>
D Z</w>
D W</w>
D VP
D VD</w>
D VA</w>
D TR
D SR</w>
D SH</w>
D S).</w>
D S),</w>
D RO
D RB1
D P-containing</w>
D NG,</w>
D MAC</w>
D M)</w>
D KO</w>
D K</w>
D IP-induced</w>
D ING:</w>
D ID,</w>
D H)</w>
D F</w>
D F.</w>
D Cs</w>
D CM,</w>
D C-
D AC.</w>
D AC,</w>
D A/
DA/ ACh</w>
D A),</w>
D 8</w>
D 60</w>
D 56
D 4.</w>
D 4.7</w>
D 4.4</w>
D 4.2</w>
D 4.2,</w>
D 4,</w>
D 2.</w>
D 2.5</w>
D 2-3</w>
D 1R</w>
D 1).</w>
D -1,</w>
D (2/3)</w>
D (2))</w>
Cytot oxicity</w>
Cyto plasmic</w>
Cyto kine</w>
Cyto architecton
Cyt ology</w>
Cyt arabine</w>
Cyt arabine-induced</w>
Cyst ometro
Cyst ectomy</w>
Cyclophosph amide-associated</w>
Cyclo -
Cyclo- oxygenase</w>
CyA/ MTX</w>
CyA/ MP</w>
Cy tox
Cy t</w>
Cy steine</w>
Cy s,</w>
Cy bex</w>
Cy anosis</w>
Cy A-induced</w>
Cx AD.</w>
Cur vilinear</w>
Cur ve</w>
Cub an</w>
Cu, Zn</w>
Cu -deficient</w>
Ctr l
CsA- PK</w>
Cs s</w>
Cs Cl</w>
Cs A/
Cs A)</w>
Cs A).</w>
Cryst al</w>
Cross- sensitization</w>
Cros sed</w>
Cro cus</w>
Crl: CD
Criter ia).</w>
Cri tically</w>
Cremoph or-free,</w>
Cre /
Crac k-
Cr n</w>
Cr amps</w>
Cr P/ATP</w>
Cr ),</w>
Cp (24h)</w>
Cox -2
Cox-2 i</w>
Cox -
Coupl ed</w>
Coun ts</w>
Coun cil's</w>
Coumar ins</w>
Coumar in</w>
Cot reatment</w>
Cost s</w>
Cortico steroid-induced</w>
Corne ll</w>
Cordar one.</w>
Cor respondingly,</w>
Cor relating</w>
Cor onal</w>
Coomb s-positive</w>
Coomb s'-positive</w>
Convul sions,</w>
Convul sion</w>
Conver sely</w>
Conver ging</w>
Contro ls,</w>
Contro l
Contri but
Contrast- enhanced</w>
Contrac eptive</w>
Contr ariwise,</w>
Contr alateral</w>
Continuous- wave</w>
Cont ingency</w>
Cont ents</w>
Constric tive</w>
Consti pation</w>
Consti pation,</w>
Consider ations</w>
Conserv ation</w>
Consequ ently</w>
Connectic ut</w>
Connectic ut
Confir matory</w>
Conf usion,</w>
Condi tion</w>
Conclu sion.</w>
Concentration- effect</w>
Concentr ated</w>
Con ven
Con sist
Con sidered</w>
Con nexin</w>
Con junctival</w>
Con jugated</w>
Con formationally</w>
Con ference</w>
Con currently</w>
Con clusion</w>
Computer -controlled</w>
Comple teness</w>
Commun ity-based</w>
Committe e.</w>
Com puter</w>
Com pressive</w>
Com pression</w>
Com position</w>
Com passionate</w>
Com p</w>
Com orbidity</w>
Com orbid</w>
Com mission</w>
Columb ia</w>
Columb ia,</w>
Coll ecting</w>
Coll apsing</w>
Col loidal</w>
Col laboration</w>
Cogn itive,</w>
Coffe e</w>
Cock croft</w>
Cocaine- positive</w>
Cocaine- increased</w>
Cocaine- dependence</w>
Cocaine- Associated</w>
Coca ine:</w>
Coca ine/
Coc E.</w>
Cob b</w>
CoA- SH</w>
Co- localization</w>
Co variance</w>
Co injection</w>
Co horts</w>
Co existence</w>
Co enzyme</w>
Co de
Co c</w>
Co 2</w>
Co ),</w>
Clu sters</w>
Clozap ine.</w>
Clopido grel
Clomi phene</w>
Clo ti
Clo t</w>
Clo fibrate-treated</w>
Clio quinol</w>
Clin ici
ClBr .</w>
Cl- ]
Cl- ,</w>
Cl in</w>
Cl agett</w>
Cl adribine</w>
Cl ;</w>
Cisapri de,</w>
Cis- dichlorodiammineplatinum</w>
Cis- Dichlorodiammine</w>
Cis sampelos</w>
Cis platin
Cir cling</w>
Cinnam on</w>
Cinnam aldehyde</w>
Cinc innati/Northern</w>
Cinacalce t</w>
Cimetid ine-related</w>
Cimeti dine-associated</w>
Cilost amide</w>
Chron opharmac
Chron ological</w>
Chron o</w>
Chrom osomal</w>
Chore oathetoid</w>
Chore atiform</w>
Chol ecystectomy</w>
Chol angitis</w>
Cho anal</w>
Chloro zotocin</w>
Chloro acetaldehyde</w>
Chlor diazepoxide</w>
Chin chill
Chin a:</w>
Children .</w>
Chic ago</w>
Chemo therapy-
Chemo therapeutic</w>
Chem otaxis</w>
Chem oprevention</w>
Chel ation</w>
Checklist- 90-
Chec k</w>
Che lidonium</w>
Che iralgia</w>
Character isation</w>
Char lson</w>
Char coal</w>
ChE- Is</w>
Ch lamydial</w>
Ch itosan</w>
Ch ills</w>
Ch Cl</w>
Ch ;</w>
Cetam olol</w>
Cer uletide</w>
Cer ivastatin</w>
Cephalospor in-induced</w>
Cephal ex
Ceph alo
Central- nervous</w>
Cent ella</w>
Celec oxib,</w>
Ceftriax one-induced</w>
Cef uroxime-induced</w>
Cef epime-induced</w>
Ce lebrex</w>
Ce famandole</w>
Ce drus</w>
Cdkn 2
Cdkn 1
Caval hei
Caud ate,</w>
Caucasi ans,</w>
Catheter ization</w>
Cathe ter</w>
Cath epsin</w>
Catat on
Catal ase,</w>
Cat echol</w>
Cat ania,</w>
Caspase- 3</w>
Case- patients</w>
Cas sia</w>
Cardiomy ocytes</w>
Cardio protection</w>
Cardi oversion</w>
Cardi otonic</w>
Cardi omegaly</w>
Cardi ology/American</w>
Cardi ac-specific</w>
Cardi Pro,</w>
Carcin ogenesis,</w>
Carb oxyhemoglobin</w>
Carb imazole-dependent</w>
Car teolol</w>
Car moxirole</w>
Captopri l-treated</w>
Capsaicin- evoked</w>
Capsaic in-sensitive</w>
Capecit abine-associated</w>
Cap Cel</w>
Cannabin oid-induced</w>
Cannab is,</w>
Cann ulation</w>
Canc ers</w>
Canc erL
Canad a's</w>
Cana dian-American</w>
Can desartan</w>
Campt ocormia</w>
Cambodi a.</w>
Cam eroonian</w>
Califor nia.</w>
Calcineurin- inhibitor-induced</w>
Calc ulation</w>
Calc imimetic</w>
Cal f</w>
Cal bind
Caffe ine-treated</w>
Caffe ine,</w>
CaCl 2-induced</w>
CaCO 3;</w>
Ca2+ ;</w>
Ca2+ -induced</w>
Ca ve
Ca rotene</w>
Ca iro,</w>
Ca dia</w>
Ca S;</w>
Ca O2</w>
C_ C</w>
C] ;</w>
CYP4 A3</w>
CYP3A 5</w>
CYP2D6* 4.</w>
CYP2C9 *3</w>
CYP2C8* 4,</w>
CYP2C19* 2</w>
CYP2C 19.</w>
CYP2B 1/2</w>
CYP2B -mediated</w>
CYP2 J2</w>
CYP2 J2*
CYP1A 2,</w>
CYP 24</w>
CYP 1A</w>
CYP -</w>
CY SLT
CY .</w>
CY ,</w>
CX- exposed</w>
CVVHD F</w>
CVVHD F,</w>
CV-1 80
CV-180 8,</w>
CV LT</w>
CV D.</w>
CV B</w>
CV ).</w>
CU D</w>
CTR- 0
CTR KOs</w>
CTE PH.</w>
CT- producing</w>
CT X-evoked</w>
CT X,</w>
CT S.</w>
CT P,</w>
CT B</w>
CT AP</w>
CT A.</w>
CT ).</w>
CSS 18</w>
CSS 10</w>
CS Fs</w>
CS F),</w>
CS BF</w>
CS A:</w>
CS -1</w>
CRF 9-
CRF -related</w>
CR- immunopositive</w>
CR- RFLP)</w>
CR V</w>
CR PC</w>
CR D.</w>
CR ;</w>
CPU2 28,</w>
CPT-11/ oxaliplatin</w>
CPT-1 1.</w>
CPT ,</w>
CPA/ EE.</w>
CPA- dosed</w>
CP Z-treated</w>
CP Z-induced</w>
CP Z
CP U</w>
CP U.</w>
CP R.</w>
CP Pene,</w>
CP P),</w>
CP H)</w>
CP EC.</w>
CP E.</w>
CP B.</w>
COX-2- IR</w>
COX- 3</w>
COX -1.</w>
CONTROL- CAP</w>
CONTROL- CA
CONCLUSIONS/ INTERPRETATION:</w>
CONCLUSION /
CONCLUSION/ INTERPRETATION:</w>
CON +
CO- I,</w>
CO VERED</w>
CO SS-
CO RE</w>
CO PD,</w>
CO PA,</w>
CO L-
CO Hb</w>
CO HOL</w>
CO G).</w>
CO Cs</w>
CO Cs.</w>
CO 2R</w>
CO ),</w>
CNSB00 2,</w>
CNS- directed</w>
CNI- sirolimus</w>
CN V.</w>
CN V,</w>
CN T</w>
CN QX.</w>
CN P</w>
CN G,</w>
CN E</w>
CMV- infected</w>
CMT 1A.</w>
CMRO 2,</w>
CMR glc)</w>
CMR g)</w>
CMR .</w>
CMM L,</w>
CMF :</w>
CMF -treated</w>
CM- perfused</w>
CM Z,</w>
CM Y.</w>
CM P.</w>
CM L-
CM L,</w>
CM I.</w>
CM I's</w>
CM F/
CM ;</w>
CM )-induced</w>
CL Z.</w>
CL T.</w>
CL O,</w>
CL E.</w>
CL E,</w>
CL D.</w>
CL D,</w>
CL Cr</w>
CL /
CL/ F</w>
CL -IV
CL-IV R,</w>
CL )-induced</w>
CL ),</w>
CIS 3/
CIS3/ SOCS-3/SSI
CINC -1,</w>
CIC s</w>
CIC F.</w>
CI= 22.
CI= 1.
CI: 0.7-
CI:0.7- 2.4)</w>
CI: 0.3-1.
CI:0.3-1. 2)</w>
CI- 77
CI-77 9)</w>
CI s.</w>
CI ]</w>
CI S3</w>
CI S.</w>
CI S,</w>
CI PS.</w>
CI PN.</w>
CI P-
CI O
CI MD,</w>
CI MD
CI E,</w>
CI +
CI+ IGF</w>
CHX+ Pilo</w>
CHO- K1/
CH F)</w>
CH D;</w>
CH 3-
CH 1)</w>
CGS216 80-induced</w>
CGRP(8- 37)</w>
CGRP(8- 37).</w>
CGR P.</w>
CGR P-immunoreactive</w>
CGR P,</w>
CGI- Improvement</w>
CG VHD</w>
CG P20712
CG 4
CG 2
CG2 H</w>
CG .</w>
CG ),</w>
CFU- S,</w>
CFU- Meg</w>
CFU- E</w>
CFU- E;</w>
CFU- E-derived</w>
CF SL-induced</w>
CF Rs</w>
CF HB</w>
CF C</w>
CF A-induced</w>
CF A-
CF );</w>
CF ).</w>
CF #1</w>
CES- D</w>
CE Z-induced</w>
CE Q.</w>
CE I</w>
CE A,</w>
CE -
CDP- alone.</w>
CD7 1+</w>
CD7 1(
CD71( high)</w>
CD4+ CD25
CD4 4,</w>
CD11 b
CD11 a
CD- 68,</w>
CD P</w>
CD P-treated</w>
CD H,</w>
CD F1</w>
CD F-I</w>
CD DP,</w>
CD ;</w>
CD :</w>
CD 97</w>
CD 4,</w>
CD 31</w>
CD 20</w>
CD 20+</w>
CD 18</w>
CD 15
CD -treated</w>
CD (50)</w>
CCR 8</w>
CCR 5</w>
CCR 2-
CCO -I</w>
CCK-8- SE.</w>
CCK ergic</w>
CCK -like</w>
CCG -19
CCG-19 52</w>
CC reat</w>
CC l</w>
CC S)</w>
CC Q</w>
CC C</w>
CC AC.</w>
CC 2)</w>
CC 1)</w>
CBZ- E</w>
CBZ -10,11-
CBFrest )/
CBF .(ABSTRACT</w>
CBD CA,</w>
CBD :</w>
CBA/ Ca</w>
CB(1) WT</w>
CB Z-treated</w>
CB Z-induced</w>
CB F-to-GU</w>
CB C)</w>
CB -1
CB-1 54</w>
CB ).</w>
CB (1)-
CART- immunoreactive.</w>
CARE T</w>
CARB O</w>
CAR DIA</w>
CAP+ HS.</w>
CAF F</w>
CADASI L.</w>
CAB G.</w>
CAB G,</w>
CA3- C</w>
CA s),</w>
CA V
CA TRs</w>
CA S,</w>
CA R.</w>
CA PE.</w>
CA P-treated</w>
CA MI.</w>
CA H-
CA F,</w>
CA A,</w>
CA 4</w>
CA 2),</w>
CA 1=
CA 1)</w>
CA -1</w>
CA -125</w>
CA +
CA+ SZ</w>
CA (3
CA (1)</w>
C> G,</w>
C57Bl/10 J</w>
C57BL/6 ByJ</w>
C57BL/ 6,</w>
C57B L6/J</w>
C57B L,</w>
C57/B L6</w>
C4 B</w>
C3H/He J</w>
C3 d,</w>
C3 H,</w>
C1 q,</w>
C/ TOF-
C/ I</w>
C/ C</w>
C/ 3</w>
C. N.S.</w>
C. K.</w>
C. I.
C. I
C. A.</w>
C- transplanted</w>
C- nociceptors</w>
C- cell</w>
C- Fos</w>
C- 53</w>
C- 4
C-4 80
C-480 T</w>
C- 312
C(s s,tot)</w>
C zech</w>
C y.</w>
C y)</w>
C vO2</w>
C ure</w>
C s),</w>
C ryosurgical</w>
C remaster</w>
C raniofacial</w>
C onium</w>
C oniine,</w>
C loxacillin</w>
C limbing</w>
C itrobacter</w>
C ins>del,</w>
C ervic
C cr)</w>
C az
C aribbean</w>
C are
C alleja</w>
C a.</w>
C WS-96</w>
C UP</w>
C ST.</w>
C ST,</w>
C SRT</w>
C Q.</w>
C PA),</w>
C N-
C HC.</w>
C HB,</w>
C CO-I,</w>
C CM),</w>
C CBF</w>
C CAs</w>
C 67
C67 7
C677 T</w>
C 57)</w>
C 50</w>
C 4.</w>
C 29</w>
C 20</w>
C 2
C2 19,</w>
C 17</w>
C 1)</w>
C .)</w>
C );</w>
C )-dependent</w>
But ylated</w>
Bur roughs</w>
Bur m</w>
Bupropi on,</w>
Bupren orph
Bul lous</w>
Bul l.</w>
Buff alo</w>
Bud ralazine</w>
Bud d</w>
Bronch ospasm</w>
Bronch oscopy</w>
Bronch ial</w>
Brom fenac</w>
Brom age</w>
Bro ck's</w>
Bro ca,</w>
Bro ad</w>
Brn-3 a/nicotine</w>
Brn-3 a,</w>
Brit ain.</w>
Bri delia</w>
Break through</w>
Bre ath
Bran ched-chain</w>
Bran ch</w>
Bran ch,</w>
Br- 7-NI</w>
Br- 7-
Br yant</w>
Br Ca</w>
Bot ul
Bortezomib ,</w>
Bomb ay.</w>
Body weight</w>
Bo ehringer</w>
Block er</w>
Blo t.</w>
Ble omycin</w>
Bis sau</w>
Bis sau.</w>
Biop sy-proven</w>
Biochem .</w>
Bio logic</w>
Bin swanger</w>
Bin ocular</w>
Bifen thrin,</w>
Bicucul line,</w>
Bic hat</w>
Bi variate</w>
Bi perid
Bi ol.</w>
Bi ochemically</w>
Bi ochemical,</w>
Bi directional</w>
Bi Load</w>
Bev antolol</w>
Bethes da</w>
Bethes da,</w>
Bethan idine</w>
Beta- lactam</w>
Beta- estradiol</w>
Beta- endorph
Beta- blockers,</w>
Beta- Blocker</w>
Bet amethasone</w>
Bet ahistine,</w>
Ber nardo</w>
Benz ylthiouracil</w>
Benz yl
Benz er
Benflu orex</w>
Bene fit
Ben th.</w>
Bel gium</w>
Beij ing</w>
Behavi orally,</w>
Beh cet's</w>
Bech -R
Bech-R afaelson</w>
Bec ker</w>
Bec ker's</w>
Be zafib
Be ren
Be hav</w>
Be fore,</w>
Be echam</w>
Bcr p</w>
Bcl-x L</w>
Bcl-x L.</w>
Bcl- 2,</w>
Bay es</w>
Batter 's</w>
Basi liximab</w>
Basi cally,</w>
Bas ket</w>
Bartter -like</w>
Bar nes-Jewish</w>
Bangko k,</w>
Bang k
Balb /
Bal anced</w>
Bacter iologic</w>
Bacter ial</w>
Baclofen .</w>
Bac kward</w>
Babinsk i</w>
BaCl 2,</w>
Ba icalein</w>
Ba Cl2</w>
BZ T</w>
BXL 746</w>
BW .</w>
BU- thiotepa</w>
BU- TTP</w>
BU P.</w>
BU P-
BU ),</w>
BT4 An</w>
BSI F,</w>
BSE P-
BSC -1,</w>
BS- GSIF</w>
BRL35 135</w>
BRL 44408</w>
BR T)</w>
BR S.</w>
BR AC-
BQ 78
BPO ;</w>
BPO .</w>
BPA A,</w>
BPA A)</w>
BP I</w>
BP ;</w>
BP 180</w>
BO F-
BN520 21</w>
BMY-40 481</w>
BMY-40 48
BMIP P)</w>
BMA T</w>
BM SCs</w>
BM SC-transplanted</w>
BM O</w>
BM I,</w>
BM C-transplanted</w>
BL-345 9</w>
BL- MaTU/
BK Ca</w>
BIIB7 23</w>
BID ;</w>
BID ),</w>
BH- AC</w>
BH T/kg</w>
BH T/
BH T-
BH C</w>
BH 4)-
BH4)- HEDP</w>
BF CN</w>
BE- Injected</w>
BE- Induced</w>
BE -induced</w>
BD10 63,</w>
BD10 47,</w>
BD10 31</w>
BD10 18</w>
BD L,</w>
BCh E+/+</w>
BCNU -treated</w>
BCH E,</w>
BCA A-
BCAA- enriched</w>
BB S</w>
BB +
BAM-1 120,</w>
BALB/c ByJ,</w>
BALB/c By</w>
BALB/ C,</w>
BA PTA-AM</w>
BA ERs</w>
B6 NH
B6 );</w>
B1 KO</w>
B1 B1</w>
B1 *0
B/ 2C)</w>
B. W.</w>
B- therapy</w>
B- regimen)</w>
B- receptor</w>
B- crystallin</w>
B- carboline-3-carboxylate</w>
B- CLL</w>
B(t )dt/B(t
B uc
B ruininks-Oseretsky</w>
B rachial</w>
B ovine</w>
B lonanserin</w>
B lind
B l
B k</w>
B j</w>
B ilateral,</w>
B ifid
B ibli
B est-corrected</w>
B ep</w>
B ell's</w>
B edside</w>
B auhinia</w>
B ase-line</w>
B ark
B arb
B an
B ain</w>
B ad
B Y</w>
B VR</w>
B VR,</w>
B SS</w>
B SO-treated</w>
B SDF</w>
B R-
B R,</w>
B PT/CLZ</w>
B PR
B PO-PLL</w>
B P),</w>
B N/BiRij</w>
B MT).</w>
B LA-
B LA)</w>
B K,</w>
B IVS</w>
B IO
B IBO3304</w>
B FC</w>
B F-dependent.</w>
B EP.</w>
B DNF,</w>
B D,</w>
B CM</w>
B CG</w>
B CC,</w>
B C,</w>
B AN</w>
B A.</w>
B 6.</w>
B 56
B 4-
B4- positive</w>
B 2.</w>
B 12.</w>
B 12,</w>
B 12)</w>
B 10D2/
B -12</w>
B ,
B (max)</w>
B (12)</w>
B (1)</w>
Azathiop rine-related</w>
Az rin</w>
Az ithromycin-induced</w>
Az ithromycin,</w>
Az adirachta</w>
Az .</w>
Az ,</w>
Ayurve da</w>
Ayurve da,</w>
Ax sym</w>
Ax 1</w>
Autom ated</w>
Auto regulation</w>
Aut ophagic</w>
Austral ia/New</w>
Audi ometry</w>
Audi ograms</w>
Au thority.</w>
Atten uated</w>
Attempt ed</w>
Attac ks</w>
Atrop ine-induced</w>
Atrop ine-MK801</w>
Atri um,</w>
Ator va</w>
Atom oxetine</w>
Atom oxet
Aten olol-induced</w>
Aten olol,</w>
Atazana vir</w>
Atazana vir-associated</w>
Astro gliosis</w>
Asth ma,</w>
Assess ment,</w>
Asp -
Asi ans</w>
Asi an.</w>
Asi an,</w>
Ash kenazic</w>
Asc er
As caris.</w>
Arti ficial</w>
Arth rot
Arth ralgi
Arter io-
Artepar on,</w>
Arte paron</w>
Arrhyth mogenic</w>
Aro clor
Arnold- Chiari</w>
Arnold- -
Arnold-- Chiari</w>
Aripiprazol e.</w>
Argatrob an-
Arg- vasopressin</w>
Arg inine-aspartate</w>
Arac hnoiditis</w>
Ara- C)</w>
Ara G/VP/CPM.</w>
Ara CTP</w>
Ara C,</w>
Ar tesun
Ar m</w>
Ar kansas</w>
Ar g)</w>
Ar -1254</w>
Aquapor in-1</w>
Apri l,</w>
Appeti te-
Apparen tly</w>
Apop lexy</w>
Apo A-I</w>
Ap ical</w>
Ap cMin
Ap amin</w>
Ap amin,</w>
Anxio genic</w>
Anxi ety,</w>
Anxi et
Anx a2</w>
Antipsycho tics</w>
Antipsycho tic-like</w>
Antine utrophilic</w>
Antim yosin</w>
Antidepress ants,</w>
Antidepress ant-induced</w>
Antibio tics</w>
Anti- thyroid</w>
Anti- seizure</w>
Anti- myeloperoxidase</w>
Anti- hyperalgesic</w>
Anti- endothelial</w>
Anti- Xa</w>
Anti- IL-17</w>
Anti- HCV</w>
Anti- HBs</w>
Anti thymocyte</w>
Anti serum</w>
Anti retro
Anti pyretic</w>
Anti proliferative</w>
Anti phospholipid</w>
Anti microbi
Anti histamines</w>
Anti histamin
Anti dromic</w>
Anti dopaminergic</w>
Anti convulsant-induced</w>
Anti body</w>
Anti bacterial</w>
Anti amnesic</w>
Anthracycl ine-based</w>
Antagon ization</w>
Anorexi gen
Ano ther,</w>
Ano dermal</w>
Angptl 4</w>
Angiovist- 370.</w>
Angio genesis</w>
Angio edema,</w>
Angio -
Angi oscopically</w>
Angi opoietin-like</w>
Angi oneurotic</w>
Ang- (1-7
Ang inal</w>
Anesthesi a-related</w>
Ane pol</w>
Andro gen</w>
Anc rod</w>
Analo gues</w>
Anaesthesi ologists</w>
An tisocial</w>
An san,</w>
An osmia</w>
An omalies</w>
An k
An icteric</w>
An ger</w>
An encephaly</w>
An cro
An atomic</w>
An abolic</w>
Amygdal a-
Amplit u
Amphetamine- like</w>
Amphetamine- group</w>
Amp 4-8</w>
Amp 1-4</w>
Amoxicill in-clavulanic</w>
Amodi aquine-induced</w>
Ammon ium</w>
Amitriptyl ine-related</w>
Amitriptyl ine-induced</w>
Amisulpri de-induced</w>
Amisulpri de,</w>
Aminophyll ine-induced</w>
Amino- 5-bromouracil</w>
Amik acin,</w>
Ami ens</w>
Amen orrhea</w>
Am ylase</w>
Am sterdam,</w>
Am plicor</w>
Am niotic</w>
Am man,</w>
Am ifost
Am B-treated</w>
Am B-induced</w>
Alz et</w>
Altern atives</w>
Alpha2 ABC-
Alpha2ABC- /-</w>
Alpha- tocopherol</w>
Alpha- methyldopa</w>
Alpha -1</w>
Alopec ia,</w>
Allo pregnanolone,</w>
Allo dynia</w>
Alle viation</w>
Alf athesin</w>
Aler tness</w>
Alendron ate,</w>
Alcohol ism</w>
Albumin uria,</w>
Alb izzia</w>
Al prostadil</w>
Al kalo
Al kal
Al is
Al domet</w>
Al bino-
Al ber
Akt/ protein</w>
Akathi sia,</w>
Agg regate</w>
Agg lutination</w>
Ag reement</w>
Ag oraph
Ag matine,</w>
Ag kistrodon</w>
Ag aricus</w>
After wards,</w>
After ward,</w>
After noon</w>
After load</w>
African- American,</w>
Afric ans</w>
Afric an.</w>
Afric an-</w>
Aff air
Adv antages</w>
Adv ances</w>
Adriamyc inol,</w>
Adrenocortic otropic</w>
Adrenocortic otrophin</w>
Adrenoc eptors</w>
Adrenal ine,</w>
Adrenal ina</w>
Adren erg
Adol escents</w>
Administr ation,</w>
Adequ acy</w>
Aden ocarcinomas</w>
Adelta- units</w>
Adap tive</w>
Ad- POMC-treated</w>
Ad vice</w>
Ad o</w>
Ad herence</w>
Ad hGRE.MMP1</w>
Ad duct-positive</w>
Ad ded</w>
Actu ally,</w>
Actin omycin</w>
Act- D</w>
Acid- base</w>
Aci dification</w>
Acetyl codeine</w>
Acetaminophen -
Acetaminophen- protein</w>
Acetaminophen ,</w>
Acet yl-L-carnitine</w>
Acet anilide</w>
Ace tone</w>
Ace butolol</w>
Accompan ying</w>
Accompan ied</w>
Accept ance</w>
Ac upuncture</w>
Ac tom
Ac tiv
Ac role
Ac ous
Ac ne</w>
Ac idosis</w>
Ac counting</w>
Ac cess(R)</w>
Ac anthopanax</w>
Ac -R
Ac-R Y(3-Cl)YRWR-NH
Abstr acts,</w>
Abstr act</w>
Abs ences</w>
Abn-cb d</w>
Abn-cb d-induced</w>
Abeta- hyperalgesia.</w>
Aber ration</w>
Abbot t</w>
Abbot t-53693</w>
Abbot t,</w>
Ab users</w>
Ab s)</w>
Ab cc
Ab ana</w>
Ab -
Ab ).</w>
AZT- based</w>
AZT+ ddC</w>
AZT /kg</w>
AZT -related</w>
AX- allergic</w>
AX- PLL</w>
AX -related</w>
AVP- dependent</w>
AV- blocked</w>
AV RT</w>
AV P.</w>
AUC(0-12h) S</w>
AUC(0- infinity).</w>
AUC ;</w>
AUC ).</w>
AU ),</w>
ATR A-->
ATP- infused</w>
ATP- binding</w>
ATP- ases</w>
ATP ases,</w>
ATP ase-mediated</w>
ATP ase).</w>
ATP '
AT3/EAAC 1)</w>
AT RA
AT L</w>
AT G)</w>
AT ED</w>
AT C</w>
AT 1A</w>
AT /
AT -1</w>
AT -
ASY S</w>
AST :
ASP58 54,</w>
ASL-812 3,</w>
ASI A</w>
ASI -
ASA/ NSAIDs</w>
AS- co
AS PS</w>
AS I</w>
AS CT.</w>
AS CT,</w>
AS AK</w>
ARE AS</w>
AR PP-32)</w>
AR N</w>
AR F;</w>
AR F)</w>
AR DS.</w>
AR C)</w>
AR +
AR+ CR</w>
AQP 3,</w>
AQP 2,</w>
AQP 1(-/-)</w>
AQ Ps</w>
AQ P-2-negative</w>
APD s</w>
APD H)</w>
APA P,</w>
APA P).</w>
APA P's</w>
AP s.</w>
AP s).</w>
AP V,</w>
AP S.</w>
AP C_C</w>
AP 5),</w>
AP -induced</w>
AOA A,</w>
AO- 8,</w>
AO X</w>
ANOV A),</w>
ANCA /
ANCA )-positive</w>
AN Y</w>
AN T-MI</w>
AN RS</w>
AN C</w>
AMPH/ CDP</w>
AMPA- selective</w>
AMP- dependent</w>
AMP- PDIE)</w>
AMP -related</w>
AML/ MD
AMD 3
AMD (17
AMD(17 ))</w>
AM17 14</w>
AM s</w>
AM T</w>
AM LR</w>
AM L)</w>
AM Is</w>
AM I:</w>
AM I-induced</w>
AM HS</w>
AM G-monitored</w>
AM B-induced</w>
AM 4
AM 22-
AM22- 52</w>
AM ).</w>
AM (22-
AM(22- 52)</w>
ALT :
ALT .</w>
ALN+D28 00
ALA- PDT</w>
AL- AL</w>
AL P,</w>
AL LO,</w>
AL LH
AL L)</w>
AL H)</w>
AL D</w>
AL COHOL</w>
AL B/
AL AT</w>
AL A;</w>
AL A.</w>
AK T,</w>
AK I,</w>
AID S-associated</w>
AID S)</w>
AI r</w>
AI U.</w>
AI ON)</w>
AI F</w>
AI A</w>
AI A.</w>
AH y</w>
AH F,</w>
AH 6
AH 23
AH23 848</w>
AG- II</w>
AG S</w>
AG P</w>
AG C</w>
AF- DX384</w>
AF R</w>
AF L)</w>
AF I),</w>
AF B</w>
AF B1</w>
AED -induced</w>
AE s),</w>
AE A</w>
AE A,</w>
AE ;</w>
AE -
ADX- MA-treated</w>
ADR/ m2</w>
ADR- mediated</w>
ADR- CSA:</w>
ADR- CON</w>
ADR+LOS (6)</w>
ADR+LOS (12)</w>
ADR AC.</w>
ADR :</w>
ADP- stimulated</w>
ADOR A1</w>
ADNF LE</w>
ADNF LE.</w>
ADHD- PI,</w>
ADHD- CT,</w>
ADD A).</w>
ADAM 17</w>
ADAM 17,</w>
ADAM 10</w>
ADAM 10,</w>
AD X</w>
AD P-</w>
AD N</w>
AD H.</w>
AD H-induced</w>
AD H,</w>
AD AM</w>
AD /
ACh Rs.</w>
ACh Rs,</w>
ACh Is</w>
ACh Es</w>
ACh E,</w>
ACTH- (7
ACTH-(7 -1
ACTH-(7-1 6),</w>
ACTH- (4
ACTH-(4 -10
ACTH- (1-1
ACTH- (1-
ACTH 1-
ACTH -treated</w>
ACPT -
ACPT- I,</w>
ACEi /ARB</w>
ACEi ,</w>
ACEA-13 28,</w>
ACEA-10 31,</w>
ACE- I,</w>
ACE Is,</w>
ACE I/ARB</w>
ACE I-induced</w>
ACE I,</w>
AC(- ROO
AC TION</w>
AC T-Ntx)</w>
AC T)</w>
AC SF</w>
AC S).</w>
AC PC</w>
AC MSD</w>
AC M,</w>
AC C.</w>
AC -PC</w>
ABT-59 4
ABT-594 's</w>
AB STRACT</w>
AB PM</w>
AB O-
AB MT.</w>
AB C/3</w>
AB C.</w>
AA/ DHA</w>
AA P.</w>
AA I</w>
AA F.</w>
A5 MB</w>
A23 187</w>
A2 G
A1/ A2A</w>
A1 M</w>
A/ J,</w>
A-8 17
A-817 54,</w>
A-77 636</w>
A- variants.</w>
A- injected</w>
A- fiber</w>
A- exposed</w>
A- containing</w>
A- adrenoceptors</w>
A- CHF.</w>
A- 779</w>
A- 24
A-24 1
A-241 G</w>
A- )</w>
A)/ kg</w>
A)/ A(1)</w>
A(2 A)/A(1)</w>
A(2 ))</w>
A ven
A ur
A topy</w>
A to-treated</w>
A tipamezole</w>
A th
A symmetric</w>
A o.)</w>
A o
A nexate</w>
A maz
A maranthus</w>
A lex
A kinesia</w>
A ir</w>
A ims</w>
A h
A gen
A eros
A erobic</w>
A diantum</w>
A delta,</w>
A d</w>
A bu
A beta,</w>
A ]</w>
A X,</w>
A WI</w>
A VE)</w>
A STS</w>
A SE</w>
A P.</w>
A II.</w>
A II-induced</w>
A G.</w>
A AV</w>
A APH,</w>
A A-
A >
A 5.</w>
A 5,</w>
A 4</w>
A 3,</w>
A 3
A3 243
A3243 G</w>
A 2-agonist</w>
A 2).</w>
A 1.</w>
A 1)</w>
A .)</w>
A -1/
A-1/ apo</w>
A );</w>
A (1-13)</w>
A (1)-
A(1)- adenosine</w>
A '</w>
>or= 2.5</w>
>or= 18</w>
>/= 95</w>
>/= 8</w>
>/= 3</w>
>/= 30</w>
>/= 2</w>
>/= 1</w>
> AF-DX</w>
> 90%,</w>
> 70</w>
> 65</w>
> 4</w>
> 48</w>
> 3</w>
> 3000</w>
> 3.5</w>
> 3.0</w>
> 25</w>
> 19</w>
> 18</w>
> 1.5</w>
> 1.27</w>
> 0.4</w>
=0.0 2</w>
=0.0 2).</w>
=.000 6)</w>
=.000 1,</w>
=.00 9).</w>
=.00 7)</w>
=.00 6).</w>
=.00 5).</w>
=.0 66)</w>
=.0 5</w>
=.0 5)</w>
=.0 4),</w>
=.0 33).</w>
=.0 3)</w>
=.0 3).</w>
=.0 13).</w>
=.0 1).</w>
= 8</w>
= 7</w>
= 5),</w>
= 5%</w>
= 4),</w>
= 30</w>
= 25</w>
= 20%</w>
= 2.4</w>
= 2.0</w>
= 2)</w>
= 2),</w>
= 15</w>
= 100</w>
= 10(4)</w>
= 1),</w>
= 0.05)</w>
= 0.01)</w>
= .001),</w>
<0.0 25),</w>
<.00 6),</w>
< 50%.</w>
< 50%)</w>
< 450</w>
< 400</w>
< 30%</w>
< 25</w>
< 250</w>
< 24</w>
< 20</w>
< 2.5</w>
< 120</w>
< 110</w>
< 100</w>
< 10
< 1.2,</w>
< 0.005)</w>
< .05</w>
< .05),</w>
< .02).</w>
< .001</w>
:12 58
:1258 -1
:1258-1 26
: tamoxifen)</w>
: LPC</w>
: DA</w>
: A>
: =0.0
: 25
:25 9-
:259- 26
: 1;</w>
: 180
:180 SE)</w>
: 18
: 1).</w>
: 00)</w>
99mTc-MAG 3</w>
99mTc- DTPA</w>
99mTc- Annexin</w>
99mTc (Na
99mTc(Na BH4)-HEDP</w>
99 994</w>
99 7</w>
99 %,</w>
98+/- 7</w>
98 7,</w>
98 5,</w>
98 1.</w>
97. 0+/-
96. 9%</w>
96. 0%</w>
96 8)</w>
96 ,000/cu</w>
96 %.</w>
95. 8%,</w>
95. 3%.</w>
95. 2%</w>
95 19
9519 1,</w>
94. 7%</w>
94 2),</w>
93- 0
920 -induced</w>
90Y- DOTATOC</w>
90Y- DOTAT
90/ NO
90- kilodalton</w>
90- 99</w>
90, 23
90, 109</w>
90 th</w>
90 7,</w>
90 5,</w>
90 3</w>
90 3/
90 2</w>
90 -1
90 ,000</w>
90 +/-
90 %;</w>
9/32 3)</w>
9/ 213)</w>
9/ 11</w>
9/ 10</w>
9.1/ 0,</w>
9. ].</w>
9. 9,</w>
9. 9%;</w>
9. 88)</w>
9. 84</w>
9. 8
9. 7
9. 6%</w>
9. 5;</w>
9. 5)</w>
9. 5%).</w>
9. 45</w>
9. 44)</w>
9. 4%,</w>
9. 29</w>
9. 2%.</w>
9. 2%)</w>
9. 1),</w>
9. 1%,</w>
9. 1%),</w>
9. 0%</w>
9-10- weeks-old</w>
9-1 1</w>
9-1 .0
9- tetrahydrocannabinol.</w>
9- phenanthrene</w>
9- months</w>
9- [[2-methoxy-4-[(methylsulphonyl)amino]phenyl]amino]</w>
9- 95,</w>
9- 7.
9+/- 9</w>
9+/- 6.8</w>
9+/- 2.3</w>
9+/- 2.0</w>
9+/- 2.
9+/- 0.6</w>
9%/ mmHg</w>
9 p
9 a</w>
9 ])</w>
9 9.7</w>
9 9.5%</w>
9 8;</w>
9 84</w>
9 8.4</w>
9 8.0</w>
9 8,</w>
9 8%).</w>
9 71</w>
9 7.8</w>
9 7.5%</w>
9 7.4</w>
9 7.1</w>
9 7).</w>
9 7),</w>
9 6;</w>
9 68</w>
9 6.7</w>
9 6.5</w>
9 6.0</w>
9 6-h</w>
9 6%,</w>
9 5.3</w>
9 5.2</w>
9 5.0</w>
9 5%)</w>
9 4.5%</w>
9 4.1</w>
9 35
935 9)</w>
9 31</w>
9 3.5</w>
9 3.2</w>
9 3).</w>
9 3%)</w>
9 28</w>
9 23</w>
9 21</w>
9 201</w>
9 2/
9 2.9</w>
9 2.5</w>
9 2.3</w>
9 2.1</w>
9 2-year-old</w>
9 2).</w>
9 2%.</w>
9 2%,</w>
9 2%)</w>
9 15</w>
9 13</w>
9 1.</w>
9 1.5</w>
9 1.3%</w>
9 1.2</w>
9 1.2%</w>
9 1.
91. 3%).</w>
9 1-year-old</w>
9 1%.</w>
9 00-
9 0.9%)</w>
9 0.6</w>
9 0.2</w>
9 0.0
9 /-
9 +</w>
9 )).</w>
9 %-
9 %);</w>
89. 7%</w>
89. 5,</w>
89 7,</w>
89 %.</w>
88. 3%</w>
88 ]</w>
88 8,</w>
88 00
87. 5%,</w>
87. 1%),</w>
87 %.</w>
86 +/-
86 +)</w>
86 %).</w>
85. 4%).</w>
84 ])</w>
84 60
8460 3-
84603- 55-
84603-55- 4)</w>
829 58,</w>
823 34</w>
82.07 15.</w>
82 16,</w>
818 8).</w>
812 97-induced</w>
81. 8%).</w>
800- 35
800-35 00),</w>
80/ 40</w>
80- yr-old</w>
80- 90</w>
80+/- 58
80+/-58 7)</w>
80 ]</w>
80 7</w>
80 3</w>
80 3),</w>
80 -100%</w>
80 %])</w>
80 %).</w>
80 %),</w>
8/ 98</w>
8/ 89</w>
8/ 18;</w>
8. 96</w>
8. 95%</w>
8. 9,</w>
8. 9%,</w>
8. 9%)</w>
8. 9%).</w>
8. 9%),</w>
8. 8%)</w>
8. 76</w>
8. 7,</w>
8. 7+/-
8. 6
8. 5%,</w>
8. 5
8. 45</w>
8. 3)</w>
8. 2)</w>
8. 0/
8. 0+/-
8. 0).</w>
8. 0
8-hydroxy-2- (di
8-hydroxy- 2'-deoxyguanosine</w>
8-OHGu a</w>
8-OH-DPA T-induced</w>
8-OH- dG</w>
8-OH- DOC)</w>
8-1 1</w>
8-1 1;</w>
8-1 0%</w>
8-(p- sulfophenyl)
8- tetrahydrocannabinol-dimethylheptyl</w>
8- substituted</w>
8- s</w>
8- oxo-
8- oxo
8- month-old</w>
8- methoxypsoralen</w>
8- methoxsalen</w>
8- iso-PGF(2alpha)</w>
8- inch</w>
8- hydroxylamino
8- hourly</w>
8- h</w>
8- fold,</w>
8- fold)</w>
8- bromocyclic</w>
8- bromo
8- arm</w>
8- [(4-amino-l-methylbutyl)amino]-</w>
8- SPT</w>
8- November</w>
8- Hydroxy-
8- 9.
8- 9,</w>
8- 8.3</w>
8- 4
8- 25.
8- 23</w>
8- 20</w>
8- -
8- (3-chlorostyr
8,9- ,</w>
8,5 17</w>
8+/- 6</w>
8+/- 2</w>
8+/- 0.14</w>
8 th-10th</w>
8 d,
8 ]-
8 91</w>
8 9%)</w>
8 84</w>
8 83</w>
8 8.8</w>
8 8.5</w>
8 8),</w>
8 8%)</w>
8 78</w>
8 709</w>
8 7.4</w>
8 7-
8 7+/-
87+/- 33</w>
8 7%,</w>
8 62</w>
8 6-
8 6).</w>
8 5;</w>
8 59</w>
8 57</w>
8 56</w>
8 50-1000</w>
8 5.8</w>
8 5.0%</w>
8 5-1
8 5%;</w>
8 5%)</w>
8 46</w>
8 4.9</w>
8 4.5</w>
8 4.2%</w>
8 4%,</w>
8 4%),</w>
8 30</w>
8 3.3</w>
8 3.3%</w>
8 3.0</w>
8 3.
8 3-
8 3,</w>
8 3)</w>
8 3%;</w>
8 3%).</w>
8 2;</w>
8 29</w>
8 27</w>
8 21</w>
8 2.5%</w>
8 2.5%;</w>
8 2.1%</w>
8 2-
8 2);</w>
8 2),</w>
8 2%,</w>
8 14</w>
8 11</w>
8 1.</w>
8 1.7</w>
8 1.6</w>
8 1.5%</w>
8 1.3%</w>
8 1.1</w>
8 1%).</w>
8 1%),</w>
8 0.8</w>
8 0.7</w>
8 0.7%,</w>
8 0.5%</w>
8 -17
8 +/-1.5</w>
8 %])</w>
7th- day</w>
7alpha- hydroxylation</w>
7H 6,</w>
797 (-)</w>
79. 2%</w>
79 %-
79%- 7.
79%-7. 68%)</w>
7810 94.</w>
7810 94,</w>
78 -198
78 +/-
78 );</w>
78 %).</w>
77- y-old</w>
77 -treated</w>
77 );</w>
77 %-
76 1)</w>
76 );</w>
76 %.</w>
75. 9%</w>
75- mg/kg</w>
75 mg</w>
75 NTR)</w>
74. 9%</w>
74. 4%.</w>
74- yr-old</w>
7315 a,</w>
73- kDa</w>
73 :259-26
720 63)</w>
72- hour-old</w>
72 h,</w>
70- year</w>
70- unit,</w>
70- 90</w>
70 ;</w>
70 6</w>
70 3</w>
70 -</w>
7/ 30</w>
7/ 27
7/ 23</w>
7/ 100</w>
7.0 8</w>
7.0 6</w>
7. 8)</w>
7. 8).</w>
7. 8%;</w>
7. 8%),</w>
7. 7)</w>
7. 66</w>
7. 65</w>
7. 64</w>
7. 6-
7.6- fold.</w>
7. 6%,</w>
7. 6%)</w>
7. 51</w>
7. 5-mg</w>
7. 5-fold</w>
7. 5-15</w>
7. 5-1
7. 5).</w>
7. 5%.</w>
7. 4;</w>
7. 48</w>
7. 44</w>
7. 44,</w>
7. 4,</w>
7. 4
7. 3-
7. 3,</w>
7. 3%),</w>
7. 26.</w>
7. 25;</w>
7. 2),</w>
7. 17)</w>
7. 16</w>
7. 11).</w>
7. 1+/-
7. 1)</w>
7. 1%;</w>
7. 0;</w>
7. 00</w>
7. 0,</w>
7. 0).</w>
7-nitroinda zole:</w>
7-hydroxy- fluphenazine</w>
7-chloro kynurenate</w>
7-OH- AAF.</w>
7-1 9</w>
7-1 1</w>
7-1 12
7-112 ].</w>
7-1 0,</w>
7-(4- [4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-
7- wk</w>
7- week-old</w>
7- pentoxyresorufin-O-dealkylase</w>
7- month-old</w>
7- methyl-3,7-dihydro-1H-purine-
7- dimethyl-1-propargylxanthine)</w>
7- day-old</w>
7- Nitro</w>
7- 8</w>
7- 85.4%).</w>
7- 8,</w>
7- 8
7- 75.
7- 70
7- 5.
7- 4.5</w>
7- 37
7- 30
7- 3.
7- 28</w>
7- 25</w>
7- 2.5
7- ,</w>
7,8- dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benz
7,12-dimethylbenz (a)</w>
7, 705</w>
7, 7-
7, 10,
7,10, 17,
7,10,17, 27,
7,10,17,27, 41</w>
7+/- 4.8</w>
7+/- 2</w>
7+/- 0.4</w>
7) %</w>
7 th,</w>
7 d,</w>
7 ],</w>
7 U/kg)</w>
7 LiCl.</w>
7 :
7 9/
7 9.6</w>
7 9.5%</w>
7 9%;</w>
7 87</w>
7 8.1</w>
7 8-
7 77</w>
7 705</w>
7 7.7</w>
7 7.6</w>
7 7.5</w>
7 7.1</w>
7 7-year</w>
7 7).</w>
7 7),</w>
7 7%).</w>
7 7%),</w>
7 63</w>
7 60</w>
7 6.7</w>
7 6.2</w>
7 6.1</w>
7 6).</w>
7 6%;</w>
7 6%)</w>
7 5;</w>
7 54</w>
7 52</w>
7 50
7 5/
7 5.8</w>
7 5+/-
7 5%).</w>
7 5%),</w>
7 4;</w>
7 47</w>
7 43</w>
7 42</w>
7 4.8</w>
7 4.5</w>
7 4.5%</w>
7 4.3</w>
7 4%)</w>
7 4%).</w>
7 3;</w>
7 32</w>
7 3.8%</w>
7 3.3%</w>
7 3.3%)</w>
7 3-year</w>
7 3%).</w>
7 2;</w>
7 24</w>
7 23</w>
7 22</w>
7 2/
7 2.9</w>
7 2.4</w>
7 2.4%</w>
7 2.0</w>
7 2+/-
7 2),</w>
7 19</w>
7 16</w>
7 15</w>
7 13</w>
7 10</w>
7 1.8</w>
7 1.7%</w>
7 1.2</w>
7 1),</w>
7 1%)</w>
7 000</w>
7 00/
7 00-
7 0.8</w>
7 0.7</w>
7 0.6</w>
7 0.6%</w>
7 0.4</w>
7 -16</w>
7 -1.7
7 ,000</w>
7 +</w>
7 ):</w>
7 )-
7 '-
7'- dichloro
69. 2%</w>
69 4</w>
69 3</w>
69 1)</w>
68 ,
67. 9</w>
67. 1%</w>
67-1 5.0
67-15.0 8)</w>
67 th</w>
66. 3%</w>
66- year-old-
65. 9%</w>
65. 5%.</w>
65- 75</w>
65 ,000</w>
65 +/-1
64. 9%</w>
64. 1,</w>
64- g</w>
64 3.</w>
64 ,000</w>
63. 9%</w>
63 7-
63 -1.210</w>
620 26
62. 3%</w>
62. 0)</w>
615 8].</w>
614 4-
6144- 6158].</w>
61- bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene</w>
600 2,</w>
600 1.</w>
600 .</w>
600 )</w>
60- 70%</w>
60- 65</w>
60- 4.18)</w>
60- -
60 th</w>
60 5</w>
60 51</w>
60 3</w>
60 ,000</w>
60 +/-
60 +
60+ C600</w>
60 %),</w>
6/ 6</w>
6/ 31</w>
6/ 20</w>
6/ 10</w>
6.4 4%)</w>
6.0 8</w>
6.0 3</w>
6. 9%</w>
6. 9%)</w>
6. 82</w>
6. 8+/-
6. 8)</w>
6. 7,</w>
6. 7%.</w>
6. 7%,</w>
6. 69,</w>
6. 6+/-
6. 6).</w>
6. 6%;</w>
6. 5;</w>
6. 56</w>
6. 5,</w>
6. 5)</w>
6. 5%;</w>
6. 5%,</w>
6. 4;</w>
6. 3;</w>
6. 3),</w>
6. 3%</w>
6. 3%,</w>
6. 25,</w>
6. 1;</w>
6. 16</w>
6. 13</w>
6. 1.</w>
6. 1)</w>
6. 1),</w>
6. 1%,</w>
6. 0.</w>
6. 0),</w>
6-thioguan inenucleotide</w>
6-phenyl /
6-phenyl/ (4-methyl
6-phenyl/(4-methyl phenyl)-3(2H)-pyridazinon-2-propionamide</w>
6-n-propyl- LIS</w>
6-methoxy- 8-hydroxylamino
6-mercaptop urine,</w>
6-hydroxy-DA- lesioned</w>
6-az auridines</w>
6-[ 6-
6-[6- (4-hydroxy
6-[6-(4-hydroxy piperidinyl)hexyloxy]-3-methylflavone</w>
6-TG -treated</w>
6-TG -related</w>
6-1 8</w>
6-1 5</w>
6-1 .0
6- year,</w>
6- thio
6- related</w>
6- phosphate</w>
6- nitro
6- minute</w>
6- methyl-2-styryl-
6- diphenyl-1,3,5-hexatriene</w>
6- dimethylbenzimidazol
6- bisphosphate</w>
6- beta-naltrexol</w>
6- aryl-7-isopropylquinazolinones</w>
6- acetyl</w>
6- TG.</w>
6- MP.</w>
6- MAQ</w>
6- Di
6- 87.1%),</w>
6- 5.
6- 35</w>
6- 30</w>
6- 3.
6- 27</w>
6- 27
6- 24</w>
6- 213)</w>
6- 0.8
6- -
6- (3-
6,7-dimethoxy-4-ethyl- B-carboline-3-carboxylate</w>
6,7-dimethoxy-4- ethyl-beta-carboline-3-carboxylate</w>
6, 7,
6, 680</w>
6, 130</w>
6, 0
6+/- 4.
6+/- 3</w>
6+/- 2.3</w>
6'- iodo-
6'- Iodo-DHP</w>
6 x</w>
6 x/day;</w>
6 h.</w>
6 ]).</w>
6 Li</w>
6 J,</w>
6 97</w>
6 95</w>
6 9.9</w>
6 9.5%</w>
6 86</w>
6 85</w>
6 84</w>
6 8/
6 8.9</w>
6 8.5%</w>
6 8.0</w>
6 70</w>
6 7.</w>
6 7.5</w>
6 7.4</w>
6 7.3</w>
6 7.1</w>
6 7-year</w>
6 7%)</w>
6 69</w>
6 68</w>
6 61</w>
6 6.8</w>
6 6.7</w>
6 6.3</w>
6 6.1</w>
6 6,680</w>
6 57</w>
6 54</w>
6 5.1</w>
6 5+/-
6 5),</w>
6 5%.</w>
6 49
6 480-
6480- 649
6 48
648 5
6485 39)</w>
6 4.9</w>
6 4.6</w>
6 4.6%</w>
6 4.3%</w>
6 4.2</w>
6 4,
6 4%)</w>
6 4%).</w>
6 4%),</w>
6 3.</w>
6 3.8</w>
6 3.8%</w>
6 3.5</w>
6 3).</w>
6 3%.</w>
6 3%,</w>
6 250</w>
6 2/
6 2.9
6 2.5,</w>
6 2.5%.</w>
6 2.1</w>
6 2-yr-old</w>
6 2+/-
6 2).</w>
6 2),</w>
6 2%)</w>
6 2%).</w>
6 2%),</w>
6 1.9%</w>
6 1.8%</w>
6 1.5</w>
6 1.5%</w>
6 1.4</w>
6 1%.</w>
6 00,</w>
6 0.8</w>
6 0.8%</w>
6 ,2
6 +/-1.
6 )),</w>
6 %
5beta-pregnan-20- one)</w>
5alpha-pregnan-20- one),</w>
5alpha-pregnan- 3alpha-
5alpha-pregnan-3alpha- ol-20-one</w>
5alpha- androst
5alpha- THP</w>
5alpha- THP,</w>
5HT 4</w>
5HT 1D</w>
5HT (2A)</w>
5: 1,</w>
59. 3%</w>
59. 2).</w>
59 9</w>
59 5</w>
59 3,</w>
59 +/-1.
59 %;</w>
58. 6%,</w>
58. 6%)</w>
58. 3%</w>
58 ].</w>
58 2)</w>
58 %.</w>
57. 9,</w>
57 518
57 43</w>
57 3</w>
57 2-
572- 370
57 1</w>
57 %.</w>
56. 8%</w>
56. 5%</w>
56. 2%</w>
56- yr-old</w>
56- 5
56-5 3-1
56-53-1 ;</w>
56 69</w>
56 3,</w>
56 3)</w>
56 1,</w>
56 %),</w>
55. 6-87.1%),</w>
55. 3%</w>
55- 75%</w>
55- 60</w>
55,212- 3</w>
55 6</w>
55 1-
55 1)</w>
55 -18-
55-18- 5]</w>
54. 8%</w>
54. 7%</w>
54. 6%</w>
54- yr-old</w>
54- 67</w>
54 45</w>
54 0,</w>
54 +/-1.
54 %-
538 57</w>
53. 1%</w>
53 -1)</w>
53 ))</w>
52 6)</w>
51Cr -
51Cr- EDTA</w>
506- based</w>
500/ microL</w>
500 microg</w>
500 ).</w>
50/ 225</w>
50- unit</w>
50- microm</w>
50- 60%</w>
50- 200</w>
50- 200
50- 0
50-0 6-
50+/- 561,</w>
50 s)</w>
50 9)</w>
50 6)-induced</w>
50 2</w>
50 1-
50 -160</w>
50 ,000/micro
5/ 70</w>
5/ 16-
5/16- inch</w>
5/ 15</w>
5/ 11</w>
5/ 10.</w>
5.6+/-1 6.7</w>
5.0 8</w>
5.0 6,</w>
5.0 4).</w>
5. 99</w>
5. 93</w>
5. 9%,</w>
5. 9%),</w>
5. 85</w>
5. 8,</w>
5. 8%</w>
5. 8%,</w>
5. 7;</w>
5. 7%;</w>
5. 68</w>
5. 6%).</w>
5. 5;</w>
5. 5,</w>
5. 5)</w>
5. 4.</w>
5. 4)</w>
5. 3;</w>
5. 35</w>
5. 3+/-
5. 3%,</w>
5. 3%),</w>
5. 28</w>
5. 24</w>
5. 23</w>
5. 2,</w>
5. 2+/-
5. 1-
5. 1),</w>
5. 00</w>
5. 00,</w>
5. 0.</w>
5-hydroxytryptoph an.</w>
5-hydroxytryptoph an,</w>
5-hydroxytryptamine- 3</w>
5-hydroxytryptamine 4</w>
5-hydroxytryptamine 3</w>
5-hydroxytryptamine (2A)</w>
5-hydroxytrypt oline</w>
5-hydroxytrypt amin1A</w>
5-hydroxy indo
5-fluorourac il:</w>
5-fluorourac il-treated</w>
5-fluorourac il-resistant</w>
5-flouro uracil.</w>
5-ethyl-5- phenylhydantoin</w>
5-dimethyl- 3-(3-
5-dimethyl-3-(3- fluorophenyl)-4-(4-methylsulphonyl)</w>
5-bromo -2-deoxyuridine</w>
5-azacy tidine-induced</w>
5-amin osalicylates</w>
5-amin olevulinic</w>
5-Hy droxy
5-HT1A/ 1
5-HT1A/1 B</w>
5-HT1 D</w>
5-HT1 C/2</w>
5-HT- releasing</w>
5-HT- ergic</w>
5-HT(2B) R-positive</w>
5-HT(2A/ 2B)</w>
5-HT(1B) Rs</w>
5-HT(1 a)</w>
5-HT(1 A/
5-HT P,</w>
5-HT 2A/
5-HT2A/ C</w>
5-HT 2/
5-HT 2
5-HT /
5-HT/ tryptophan</w>
5-HT -induced</w>
5-HT (7)</w>
5-HT (6)</w>
5-H t
5-FU dR</w>
5-FU -associated</w>
5-F u</w>
5-F U)</w>
5-9 6),</w>
5-1 99
5-1 8</w>
5-1 6</w>
5-1 6.0</w>
5-1 2</w>
5-1 1)</w>
5-(3- tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril</w>
5- year,</w>
5- wk</w>
5- wk-old</w>
5- week-old</w>
5- s</w>
5- phosphonovaleric</w>
5- pentachlorobiphenyl</w>
5- ol
5- nitro-
5- month</w>
5- ml</w>
5- mg,</w>
5- methyl-8-(2-hydroxy-3-t-butylamino-propoxy)</w>
5- methoxypsoralen</w>
5- methoxy-
5- iododeoxyuridine</w>
5- ht7</w>
5- h</w>
5- fold,</w>
5- dihydro-
5- bed</w>
5- alpha-reductase</w>
5- S-cysteinyldopa</w>
5- Mn)</w>
5- LO)</w>
5- ASA.</w>
5- 9</w>
5- 8%</w>
5- 6.0</w>
5- 6)</w>
5- 50</w>
5- 48
5-48 64</w>
5- 45</w>
5- 4
5- 300</w>
5- 3.
5-3. 58].</w>
5- 24</w>
5- 20%</w>
5- ,</w>
5- (l-
5-(l- hexyloxy)-6-methoxy-4-methylquinoline</w>
5- (3,
5-(3, 3-
5-(3,3- dimethyl-1-
5- (2-
5-(2- azetidinylmethoxy)-2-chloropyridine)</w>
5- (
5,6- dihydroxytryptamine</w>
5,6,7,8- tetrahydro
5,6 29</w>
5,5- dimethylbarbituric</w>
5,5- diethyl
5, 9
5, 8
5, 7,10,17,27,41</w>
5, 5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)</w>
5, 5-di
5, 000/microL</w>
5+/-1 6</w>
5'- regulatory</w>
5'- phosph
5'- monophosphate</w>
5'- bromo
5'- O-
5% ]</w>
5% :</w>
5 q
5 mg/kg)</w>
5 h</w>
5 days</w>
5 ],</w>
5 HIAA</w>
5 H
5 ;
5 9.4</w>
5 9.1</w>
5 84</w>
5 8.9</w>
5 8.6</w>
5 8.5</w>
5 8.4</w>
5 7.9</w>
5 7.3</w>
5 7-year</w>
5 6.9</w>
5 6.5</w>
5 6.2</w>
5 57
5 50-
5 50,</w>
5 5.</w>
5 5.9</w>
5 5%)</w>
5 45</w>
5 408</w>
5 40-
540- 840</w>
5 4/94</w>
5 4.8</w>
5 4.6</w>
5 4.4</w>
5 4.2</w>
5 4.1</w>
5 4.0</w>
5 4%),</w>
5 3;</w>
5 39</w>
5 33</w>
5 3.8</w>
5 3.8%</w>
5 3.0</w>
5 3-year</w>
5 3+/-
5 3%.</w>
5 3%)</w>
5 2:</w>
5 27
527 +/-
527+/- 509</w>
5 26</w>
5 25-
5 25
5 2.6</w>
5 2.3%</w>
5 2-week</w>
5 2%;</w>
5 161</w>
5 15</w>
5 14</w>
5 1.8%</w>
5 1.8
5 1.7</w>
5 1.7%</w>
5 1.6</w>
5 1.5</w>
5 1.5
5 1.2%</w>
5 1.0</w>
5 1-1
51-1 6.0)</w>
5 1-
5 1%;</w>
5 1%.</w>
5 1%).</w>
5 0.9%</w>
5 0.5</w>
5 0.1</w>
5 0.0
5 )]</w>
4H- 2,3-benzodiazep
4H NE</w>
4: 64</w>
4: 1,</w>
4: 1)</w>
49. 5%</w>
49. 2%</w>
49. 2%;</w>
49. 1</w>
49. 0</w>
49 41).</w>
49 %-
480- mg</w>
48. 8%</w>
48. 7%</w>
48. 6%</w>
48. 3%</w>
48. 1%</w>
48 968</w>
48 7</w>
48 6,</w>
48 6)</w>
48 33
4833 4)</w>
48 3),</w>
48 2</w>
48 00</w>
48 -</w>
48 +/-
47. 7%</w>
47. 6</w>
47. 2</w>
47 4),</w>
46. 9%</w>
46. 5%</w>
46. 2%</w>
46- yr-old</w>
46, XY</w>
46 7)</w>
450 3</w>
45. 4%</w>
45. 0,</w>
45-1 26,</w>
45-1 26).</w>
45- min</w>
45 th</w>
45 4-
45 /
45 +).</w>
44. 7%</w>
44. 6%</w>
44. 1%</w>
44 ]</w>
44 0,</w>
44 %.</w>
43. 8%</w>
43. 7%</w>
43. 2%</w>
42. 6%</w>
42- yr-old</w>
42- day</w>
42- 72</w>
41. 7%,</w>
400 0
4000 Hz</w>
400 %)</w>
40/ 5</w>
40/ 2.5</w>
40/ 10</w>
40-7 592,</w>
40- yr-old</w>
40- week</w>
40- mg</w>
40- hour</w>
40- bp</w>
40- 80</w>
40- 60.</w>
40- 6
40- 45</w>
40, 60</w>
40 ]</w>
40 9</w>
40 1</w>
40 1
40 -1
40 +</w>
40 +/-14</w>
40 %-
4/ mm3</w>
4/ 7</w>
4/ 5</w>
4/ 45)</w>
4/ 40</w>
4/ 3</w>
4/ 26)</w>
4/ 15</w>
4/ 11</w>
4/ 100</w>
4.6 7,</w>
4.6 2,</w>
4.2+/-1. 5</w>
4.2+/- 5.6</w>
4.1+/- 0.1,</w>
4.0 8,</w>
4.0 4</w>
4.0 3</w>
4.0 3,</w>
4.0 2,</w>
4.0 %;</w>
4. 91</w>
4. 90</w>
4. 9%,</w>
4. 83</w>
4. 8%),</w>
4. 7;</w>
4. 78
4. 75</w>
4. 75,</w>
4. 7)</w>
4. 61</w>
4. 6)</w>
4. 6).</w>
4. 6%;</w>
4. 55</w>
4. 52</w>
4. 50</w>
4. 5-fold</w>
4. 5+/-
4. 5%;</w>
4. 40</w>
4. 4-fold</w>
4. 4,</w>
4. 38</w>
4. 32)</w>
4. 3)</w>
4. 3%),</w>
4. 25</w>
4. 25,</w>
4. 22</w>
4. 2%,</w>
4. 1;</w>
4. 17</w>
4. 15,</w>
4. 11</w>
4. 10;</w>
4. 1.1.
4. 1,</w>
4. 1%)</w>
4. 00</w>
4. 0).</w>
4. 0),</w>
4-methyl methcathinone</w>
4-hydroxy- 2,2,6,6-tetramethyl
4-amin opyrrolidine-2,4-dicarboxylate</w>
4-OH- CP</w>
4-D MD
4-460 2.</w>
4-460 2,</w>
4-1 98
4-1 5</w>
4-1 1</w>
4-1 0%</w>
4-- 5</w>
4- week,</w>
4- to</w>
4- selective</w>
4- mg/m2</w>
4- hydroxycoumar
4- hourly</w>
4- heparin</w>
4- en-VPA</w>
4- dinitro
4- deleted</w>
4- day-old</w>
4- chlorobenztropine</w>
4- bromo-2,5-dimethoxyphenethylamine</w>
4- bp</w>
4- biphenylacetic</w>
4- acridinecarboxamide)</w>
4- acetylaminofluorene</w>
4- AMP</w>
4- 9</w>
4- 7.
4- 6.</w>
4- 36</w>
4- 22).</w>
4,5- trimethoxy
4,4a,5,6,7,8,8a,9- octahydro-5-
4,4'- dihydroxy-alpha-truxillic</w>
4,4'- diethylaminoethoxy
4,4'- diaminodiphenyl
4, 589</w>
4, 227</w>
4, 2',
4,2', 4'-
4, 000/
4, 000,000</w>
4, *</w>
4+/- 9</w>
4+/- 0.1</w>
4+ .</w>
4'-deoxy- 4'-iodo-
4'-0-tetrahydropyranyl adriamycin</w>
4'-0-tetrahydropyranyl adriamycin.</w>
4 th-5th</w>
4 kHz).</w>
4 h,</w>
4 beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-
4 b</w>
4 a
4 T</w>
4 P)</w>
4 MA,</w>
4 Cy
4 A</w>
4 A1</w>
4 99)</w>
4 99
4 98</w>
4 92</w>
4 9.5</w>
4 9),</w>
4 8.9</w>
4 7;</w>
4 78
4 76</w>
4 73</w>
4 71</w>
4 7.8</w>
4 7.1</w>
4 7.0</w>
4 7%),</w>
4 68</w>
4 65</w>
4 64</w>
4 6),</w>
4 6%).</w>
4 55</w>
4 52</w>
4 50)</w>
4 5.6</w>
4 5.5</w>
4 5.0</w>
4 5-year</w>
4 48
4 46</w>
4 42</w>
4 4/
4 4.9</w>
4 4.0</w>
4 4%)</w>
4 4%).</w>
4 4%),</w>
4 3;</w>
4 394</w>
4 35</w>
4 32</w>
4 3+/-
4 3%;</w>
4 2;</w>
4 29.
4 27.
4 24</w>
4 21</w>
4 20)</w>
4 2/
4 2.5%</w>
4 2%)</w>
4 11</w>
4 1.</w>
4 1.9%</w>
4 1.8%</w>
4 1.6%</w>
4 1.3</w>
4 1.2</w>
4 1.2%</w>
4 1.1</w>
4 1.0</w>
4 1%)</w>
4 0.9
4 0.7</w>
4 0.6</w>
4 +)</w>
4 )].</w>
4 )/
4)/ heparin</w>
4 ).(ABSTRACT</w>
4 ',
4', 5-pentachlorobiphenyl</w>
4 '
4 %);</w>
3r d,</w>
3beta-methyl-5alpha-pregnan-20- one)</w>
3alpha-hydroxy- 3beta-methyl-5alpha-pregnan-20-one)</w>
3alpha,5alpha- THP,</w>
3H- ouabain</w>
3H- noradrenaline</w>
3A 4,</w>
3: 1.</w>
39. 9%</w>
39. 4</w>
39. 0,</w>
39 8.</w>
39 46</w>
39 2.8</w>
39 16
3916 6),</w>
39 1)</w>
39 0%</w>
39 -1.
39 %),</w>
38- year</w>
38- 54</w>
38 8)</w>
38 7</w>
38 6</w>
38 5)</w>
38 00</w>
38 ,0
37. 9,</w>
37. 8%</w>
37. 8%.</w>
37. 6%,</w>
37. 2%</w>
37- yr-old</w>
37 74</w>
37 5-
37 4)</w>
37 3)</w>
37 0,</w>
37 0)</w>
37 .</w>
37 );</w>
37 %;</w>
37 %-
36. 8</w>
36. 5%</w>
36. 4</w>
36. 2%</w>
36. 0,</w>
36- 48</w>
36- 40</w>
36 73</w>
36 7-37
36 6
36 50</w>
36 5).</w>
36 3)</w>
36 0).</w>
36 0
360 th</w>
36 ,
35. 9</w>
35. 8%</w>
35. 7)</w>
35. 32</w>
35. 00</w>
35- 70</w>
35- -40</w>
35 th</w>
35 9).</w>
35 4;</w>
35 4,</w>
35 00-
35 -1.
35 ,
35, 428</w>
35 %),</w>
3434 99;</w>
3434 99)</w>
34. 9%</w>
34. 5%</w>
34 %;</w>
34 %).</w>
34 %),</w>
330 84</w>
33. 67%</w>
33. 5%</w>
33. 3%,</w>
33. 3%).</w>
33. 1%</w>
33. 1%,</w>
33- 45</w>
33 rd</w>
33 :1258-126
33 6,</w>
33 6)</w>
33 );</w>
33 %;</w>
32. 7%</w>
32. 3%</w>
32- month</w>
32- gauge</w>
32- 65</w>
32 ]</w>
315 40.</w>
31. 7%</w>
31. 3%</w>
300 16
30016 4,</w>
300 0/
3000/ mm3</w>
300 -</w>
300 -1500</w>
300 %</w>
300 %)</w>
30.0 mg/kg</w>
30- y-old</w>
30- week</w>
30- month</w>
30- microgram</w>
30- microg</w>
30- mg/kg</w>
30- gauge,</w>
30- 50%</w>
30- 33%</w>
30, 23
30,23 4.</w>
30 th,</w>
30 mg/kg</w>
30 94</w>
30 7</w>
30 762</w>
30 41</w>
30 29)</w>
30 +/-1.
30 +/-
3/ M5</w>
3/ M2).</w>
3/ 91</w>
3/ 8-inch</w>
3/ 5</w>
3/ 47</w>
3/ 4,</w>
3/ 2</w>
3/ 23</w>
3/ 22</w>
3/ 20</w>
3/ 14</w>
3/ 100</w>
3/ 100,000</w>
3.8 3;</w>
3.7 8,</w>
3.7 4,</w>
3.6 6;</w>
3.6 4)</w>
3.4- Methylene-di
3.1- fold</w>
3.0- mM</w>
3.0 5</w>
3.0 1</w>
3. 9;</w>
3. 99)</w>
3. 96</w>
3. 9,</w>
3. 9%,</w>
3. 9%),</w>
3. 89</w>
3. 82</w>
3. 80</w>
3. 80,</w>
3. 8+/-
3. 8)</w>
3. 79</w>
3. 7-fold</w>
3. 7+/-
3. 7),</w>
3. 7%.</w>
3. 7%,</w>
3. 7%)</w>
3. 7%).</w>
3. 6;</w>
3. 67-15.08)</w>
3. 6-</w>
3. 6-1
3. 6+/-
3. 58</w>
3. 58)</w>
3. 5-1
3. 5+/-
3. 5),</w>
3. 5%.</w>
3. 5
3. 49</w>
3. 48;</w>
3. 45;</w>
3. 44</w>
3. 41</w>
3. 3;</w>
3. 39</w>
3. 39,</w>
3. 38</w>
3. 33</w>
3. 32%</w>
3. 3-1
3. 3),</w>
3. 3%).</w>
3. 3%),</w>
3. 3
3. 26)</w>
3. 22</w>
3. 20</w>
3. 20;</w>
3. 2.</w>
3. 2)</w>
3. 2%.</w>
3. 2%,</w>
3. 19</w>
3. 15</w>
3. 13</w>
3. 125</w>
3. 1%)</w>
3. 00</w>
3-methyl-5- (1-
3-methyl-5-(1- methyl-2-pyrrolidinyl)isoxazole</w>
3-methyl adenine</w>
3-methoxy-4-hydroxy phenylglycol</w>
3-methoxy-4-hydroxy phenylethylene</w>
3-methoxy- 4</w>
3-methoxy acetaminophen</w>
3-mercapto propionate.</w>
3-isobut yl-1-methylxanthine</w>
3-hydroxy-3- methyl-glutaryl-coenzyme</w>
3-hydroxy quinidine</w>
3-hydroxy propionic</w>
3-hydroxy acetaminophen</w>
3-OH AA,</w>
3-NP -treated</w>
3-NP -induced</w>
3-M X,</w>
3-1 9</w>
3-1 5</w>
3-(methylnitrosamino) propionaldehyde</w>
3-(3-hydroxyphenyl)- 3-hydroxypropionic</w>
3-( trans-4-methylcyclohexyl)-1-nitrosourea</w>
3- yr</w>
3- week,</w>
3- nitropropionic</w>
3- months</w>
3- indoxyl</w>
3- hydroxylase,</w>
3- hydroxy</w>
3- dioxo-benzo[f]quinoxaline-7-
3- dimensional</w>
3- dihydrobenzofuran-7-carboxamide</w>
3- dihydro-5H-
3- dependent</w>
3- carbamo
3- bis</w>
3- aminopropyl-diethoxy-methyl-phosphinic</w>
3- alkyl/aryl-8-(furan-2-yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thiones</w>
3- adrenoceptor</w>
3- [4-
3- [2-
3- Br-7-NI</w>
3- ANCA)</w>
3- 9</w>
3- 5.3</w>
3- 5%</w>
3- 4-fold</w>
3- 4%</w>
3- 3.
3- 20</w>
3- 2.9
3- 2.
3- (2H)-
3,7 74</w>
3,7 15</w>
3,6-dimethyl pyrazine</w>
3,5- dimethyl
3,5- dihydroxyphenyl
3,4-dihydroxyphenyl alan
3,4-dihydro -2</w>
3,4-DC PG)</w>
3,3- dimethyl
3,000/ mm3</w>
3,0 85</w>
3, 900</w>
3, 6-di
3, 5]
3, 5,7,10,17,27,41</w>
3, 2-
3+/- 8.
3+/- 3.6</w>
3+/- 26</w>
3'-azido-3'-deoxy thymidine.</w>
3'- methoxy
3'- dideoxyinosine</w>
3'- dideoxycytidine</w>
3', 4'-
3', 4',5-pentachlorobiphenyl</w>
3 s</w>
3 p
3 microM</w>
3 mg/kg</w>
3 h.</w>
3 h,</w>
3 cm</w>
3 b</w>
3 TC.</w>
3 M/House</w>
3 H</w>
3 C
3 :1</w>
3 80+/-587)</w>
3 8%)</w>
3 72</w>
3 7-year</w>
3 6.1</w>
3 6-month</w>
3 504</w>
3 5.2</w>
3 5.1</w>
3 5-day</w>
3 45</w>
3 4.9</w>
3 4-year</w>
3 300</w>
3 3.7</w>
3 3.4</w>
3 3.2</w>
3 3.1</w>
3 28</w>
3 20,000</w>
3 2/
3 2.8</w>
3 2.7</w>
3 2,
3 2+/-
3 15;</w>
3 13</w>
3 10,</w>
3 1.6
3 1.3</w>
3 1%).</w>
3 0.9</w>
3 0.6%</w>
3 0.5%</w>
3 0.5%.</w>
3 0.4%;</w>
3 0.3%</w>
3 0.1</w>
3 0.1%,</w>
3 0.0,</w>
3 /</w>
3 -12</w>
3 ):</w>
3 )).</w>
2n d-week</w>
2beta- [3-
2R,4R- APDC</w>
2C- B,</w>
2C 9</w>
2C 9,</w>
2C 8</w>
2C 19</w>
2C 12</w>
2B1/ 2B2</w>
2: 2:1</w>
2: 12)</w>
29. 8%</w>
29. 5</w>
29. 5%</w>
29. 3</w>
29. 2,</w>
29- week</w>
29- 45</w>
29+/- 6</w>
29 7)</w>
29 3)</w>
29 %;</w>
29 %),</w>
28. 1%</w>
28. 0%</w>
28- item</w>
28- day,</w>
28- 60</w>
28- 35</w>
28+/- 3</w>
28 7</w>
28 21</w>
28 1),</w>
28 /
28 );</w>
28 %-
2770 11-A</w>
27. 9%</w>
27. 3%</w>
27. 1%</w>
27- yr-old</w>
27- year</w>
27- gauge</w>
27- -
27 1%)</w>
27 0,</w>
27 0
2630 3,</w>
26. 8%</w>
26. 7%</w>
26. 7%,</w>
26. 3%</w>
26. 2)</w>
26. 0%</w>
26- gauge</w>
26- gauge,</w>
26- day-old</w>
26 88</w>
26 6)</w>
26 00</w>
26 0.</w>
26 ,000</w>
26 )=
2500- ppm</w>
250- mg/kg</w>
250 ;</w>
25. 91</w>
25. 9%</w>
25. 8</w>
25. 8%</w>
25. 6;</w>
25. 5,</w>
25. 5%</w>
25. 4%</w>
25. 3%</w>
25. 2%</w>
25. 0%.</w>
25- mg/kg</w>
25- hydroxy</w>
25- gauge</w>
25- fold</w>
25- day</w>
25- day-old</w>
25- OHD</w>
25- OHD
25- 30</w>
25- 30%</w>
25- 250</w>
25- (OH)(2)
25(OH)D -1-
25(OH)D-1- hydroxylase</w>
25 :
25 92
25 8)</w>
25 5.0,</w>
25 10</w>
25 1.</w>
25 0.00</w>
25 -</w>
25 -1
24a,26a,27a-tri-homo-22,24-di ene-1-alpha,25-(OH)2-D3</w>
2425 11).</w>
24. 8</w>
24. 8%,</w>
24. 7%,</w>
24. 5%,</w>
24. 4%,</w>
24. 2</w>
24. 0%</w>
24-(OH)(2) D(2)</w>
24- mg/kg</w>
24- day</w>
24- 30</w>
24- 28</w>
24- -48</w>
24,25-(OH)2D 3,</w>
24,25- dihydroxyvitamin</w>
24 h)</w>
24 74</w>
24 5]</w>
24 55
24 3,</w>
24 1).</w>
24 0%</w>
24 0%)</w>
24 0
24 +/-
23390 -treated</w>
2339 0),</w>
233 39
23. 9</w>
23. 9)</w>
23. 7%</w>
23. 5,</w>
23. 4%</w>
23. 1%</w>
23- yr-old</w>
23 ]</w>
23 76
23 4-bp</w>
23 4,</w>
23 00</w>
23 0-
230- bp</w>
23 0%,</w>
23 );</w>
220 23</w>
22. 8%</w>
22. 7+/-
22. 7%</w>
22- fold).</w>
22- 24</w>
22, 713</w>
22 Na+</w>
22 :
22 72</w>
21C--> T</w>
216 80</w>
216 80.</w>
21. 6%,</w>
21- year</w>
21- amino
21- ,</w>
201 -10
2003- -a</w>
2002- 2006</w>
2000 IU</w>
2000 ;
200 th</w>
200 9</w>
200 8-November</w>
200 7).</w>
200 6;
200 5;
200 5-
200 4),</w>
200 0)</w>
200 /
200 %.</w>
20/ 50</w>
20/ 15</w>
20.0 mg/kg</w>
20-tetrak is(N-methyl-4'-pyridyl)porphyrinato</w>
20- week</w>
20- g</w>
20- G</w>
20- 75</w>
20- 70</w>
20- 50</w>
20- 50%</w>
20- 44</w>
20- 25%</w>
20, 536</w>
20, 40,60</w>
20 mg/kg</w>
20 mg/kg/day</w>
20 mg/kg,</w>
20 mg,</w>
20 R</w>
20 8)</w>
20 70</w>
20 7).</w>
20 66</w>
20 65</w>
20 57</w>
20 5-9
20 5)</w>
20 21</w>
20 1.</w>
20 -100</w>
20 ,000
20,000 fold</w>
20 ):</w>
20 %;</w>
20 %-
20 %);</w>
20 %),</w>
2/ 9.1/0,</w>
2/ 7</w>
2/ 6</w>
2/ 6)</w>
2/ 55</w>
2/ 25-OHD2</w>
2/ 15</w>
2/ 13</w>
2/ 113</w>
2/ 102</w>
2.9 %.</w>
2.8 8;</w>
2.8 7%</w>
2.8 5,</w>
2.8 +/-1
2.8+/-1 .0
2.8+/-1.0 9)</w>
2.7- 23.5),</w>
2.6 +/-1
2.6 %.</w>
2.5- mg/kg</w>
2.5- 5</w>
2.5 1,</w>
2.5 -10</w>
2.4+/- 0.7)</w>
2.4 7;</w>
2.3 6)</w>
2.3 1;</w>
2.3 );</w>
2.1- fold</w>
2.1- 53)</w>
2.0- 2.5</w>
2.0 8-
2.0 8).</w>
2.0 4,</w>
2.0 1</w>
2.0 ).</w>
2.0 %;</w>
2. 9;</w>
2. 97</w>
2. 93</w>
2. 92</w>
2. 9.</w>
2. 9).</w>
2. 9),</w>
2. 89</w>
2. 83</w>
2. 80</w>
2. 74</w>
2. 72</w>
2. 71</w>
2. 7-1
2. 7+/-
2. 68</w>
2. 60</w>
2. 6-fold</w>
2. 6)</w>
2. 6),</w>
2. 6%)</w>
2. 59</w>
2. 57</w>
2. 51</w>
2. 50;</w>
2. 5.</w>
2. 5),</w>
2. 5%),</w>
2. 48;</w>
2. 47</w>
2. 43</w>
2. 42</w>
2. 4).</w>
2. 39,</w>
2. 38
2. 37</w>
2. 34</w>
2. 30)</w>
2. 3%)</w>
2. 3%).</w>
2. 3%),</w>
2. 2;</w>
2. 28</w>
2. 25+/-
2. 24;</w>
2. 24-
2. 22</w>
2. 21;</w>
2. 2+/-
2. 2)</w>
2. 2%),</w>
2. 16,</w>
2. 15).</w>
2. 13
2. 11)</w>
2. 10,</w>
2. 1+/-1.
2. 1)</w>
2. 1%,</w>
2-propion amid
2-phenylamino adenosine</w>
2-oxothiazolidine-4- carboxylate</w>
2-oxo -1-
2-oxo-1- pyrrolidine</w>
2-methoxy-4- amino-5-chlorobenzoic</w>
2-methoxy idazoxan</w>
2-ethylhex anol</w>
2-ethylhex anoic</w>
2-deoxy- D-glucose</w>
2-chloroprocaine- CE,</w>
2-chloroproca ine:</w>
2-chloro procaine,</w>
2-chloro -2'-
2-chloro-2'- deoxyadenosine</w>
2-amino-7-phosphonoheptano ate,</w>
2-amino-7- phosphono-heptanoate</w>
2-amino-5-phosphono valerate</w>
2-amino-4-phosphonobut yrate</w>
2-amino-3-phosphono propionic</w>
2-[4- [4-(7-
2-[ (8-
2-[(8- chlorodibenzo[b,f]thiepin-10-yl)oxy]-
2-Chloro deoxyadenosine</w>
2-B EA</w>
2-199 4)</w>
2-1 5</w>
2-1 1</w>
2-1 0)</w>
2-1 0%</w>
2-(p-bromophenyl) propionate</w>
2-(p-bromophenyl) propionate),</w>
2-(2- hydroxyethyl
2-( diethylamino)ethyl</w>
2- week-old</w>
2- vessel</w>
2- tailed</w>
2- stimulation</w>
2- sided</w>
2- series</w>
2- propyl
2- phenyl-3,3a-dihydro-4-oxo-5-
2- o-
2- n-propyl-4-pentenoic</w>
2- mum</w>
2- mm</w>
2- ml</w>
2- microglobulin)</w>
2- methyl-N,N-dimethyl-4-amino
2- mercapto-ethane</w>
2- mediated.</w>
2- kg</w>
2- hr</w>
2- fluororibose</w>
2- ethoxyestradiol</w>
2- drug</w>
2- compartment</w>
2- cer
2- benzylglutarim
2- adrenoreceptors</w>
2- adrenoceptor.</w>
2- Mg</w>
2- ME</w>
2- ME.</w>
2- Hz</w>
2- CdA.</w>
2- Cd
2- Adrenergic</w>
2- AR</w>
2- AG</w>
2- 80
2- 62.0)</w>
2- 6.</w>
2- 6).</w>
2- 5)</w>
2- 49</w>
2- 3),</w>
2- 29).</w>
2- 22</w>
2- 20).</w>
2- (4-
2- (1-
2,4- oxazolidinedione,</w>
2,4- dioxo-5,5-diphenyl-imidazol
2,4- dinitro
2,4 68</w>
2,3-dihydrobenzofuran-7-carboxamide s.</w>
2,3- dihydroxy-6-nitro-7-sulfamoyl-
2,3- dihydro-
2,3- de
2,3,7,8- Tetrachlorodibenzo-p-dioxin</w>
2,3,4-tetrahydro-6-nitro- 2,</w>
2,3,4-tetrahydro isoquinoline</w>
2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl -1H-
2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H- 3</w>
2,3, 3',4',5-pentachlorobiphenyl</w>
2,2,6,6-tetramethyl piperidine-1-oxyl</w>
2, z)</w>
2, 820</w>
2, 6,
2, 5-dimethyl
2, 5
2, 450</w>
2, 3</w>
2, 2'-
2, 2
2, 000/
2,000/ microL,</w>
2, 00
2+/-1. 2</w>
2+/-1 5</w>
2+/-1 3</w>
2+/- 5</w>
2+/- 3</w>
2+/- 0.0
2) %</w>
2'- deoxyuridine</w>
2'- deoxyadenosine</w>
2'- O-(2-methoxy)ethyl</w>
2'- 3'-dideoxyinosine</w>
2',3'- dideoxycytidine.</w>
2',3'- Dideoxyinosine</w>
2', 7'-dichloro
2' 3'-dideoxycytidine</w>
2 x</w>
2 cAMP-induced</w>
2 beta-carb
2 b).</w>
2 a-
2 ];</w>
2 ].</w>
2 UD95</w>
2 O</w>
2 K1C</w>
2 E1)</w>
2 B1</w>
2 A-adrenoceptors</w>
2 A)</w>
2 A).</w>
2 =</w>
2 50-mg</w>
2 50%</w>
2 29).</w>
2 29
2 26,</w>
2 24),</w>
2 24
2 20;</w>
2 2%;</w>
2 19)</w>
2 170</w>
2 16-2
2 16).</w>
2 15)</w>
2 13,</w>
2 107</w>
2 10/
2 1-1.
2 1-1
2 1%).</w>
2 0.8%,</w>
2 0.7%</w>
2 0.6</w>
2 0.5;</w>
2 0.3%</w>
2 0.
2 /</w>
2 )).</w>
2 )),</w>
1alpha- hydroxylase</w>
1H- (1,
1H-(1, 2,4
1B 1,</w>
1A1/ 1A2,</w>
1A- adrenoceptors</w>
1A (-)
1A(-) (/
1A(-)(/ )
1= plug</w>
1:100,00 0.</w>
1: 3</w>
1: 300,000</w>
1: 30,000</w>
1: 1:
1: 10</w>
1: 100</w>
1: 1.</w>
1: 1,</w>
1: 00</w>
1: 0.
19: 367-37
1999- 2003</w>
1999- 2002.</w>
1993-199 7.</w>
1993-199 6,</w>
1991-199 4,</w>
1990-199 2.</w>
1990 s,</w>
199 ;</w>
199 9)</w>
199 8-
199 8).</w>
199 7;</w>
199 7).</w>
199 6-1
199 6)</w>
199 6).</w>
199 4-199
199 3),</w>
199 2-199
199 1-
199 1)</w>
1985 a,</w>
1980 -198
198 8).</w>
198 6-
198 4),</w>
198 3.</w>
198 3).</w>
198 1-1
198 1),</w>
198 ),</w>
1972-1 981.</w>
197 9)</w>
197 8-
197 6.</w>
197 6
197 4-
197 3-
197 2.</w>
197 2-
1960 s</w>
1960 s.</w>
196 9-95,</w>
196 8.</w>
196 7,</w>
196 6.</w>
196 5,</w>
19/ 20</w>
19. 9,</w>
19. 8%</w>
19. 7%</w>
19. 6%</w>
19. 3%</w>
19. 2%;</w>
19. 0</w>
19-nor- progesterone</w>
19- year</w>
19- Nor-Prog
19, 141</w>
19 ]</w>
19 :00</w>
19 78-198
19 63</w>
19 55</w>
19 47,</w>
19 40s</w>
19 3.9</w>
19 3,</w>
19 2)</w>
19 .0
19 ,6
19 ,0
18: 6480-649
188 1,</w>
18/ 48</w>
18. 8+/-
18. 55</w>
18. 5%</w>
18. 4%,</w>
18. 3;</w>
18. 3%</w>
18. 2;</w>
18. 2+/-
18. 2%)</w>
18- gauge</w>
18- OH-DOC,</w>
18- 55</w>
18 FDG</w>
18 7,</w>
18 7).</w>
18 63</w>
18 6)</w>
18 50</w>
18 4)</w>
18 3,</w>
18 3)</w>
18 3%</w>
18 2,
18 1,
181, 67
18 0.</w>
18 0%</w>
18 ,000</w>
18 +/-4</w>
18 );</w>
17beta- oestradiol</w>
17beta- estradiol.</w>
17. 9;</w>
17. 9,</w>
17. 8,</w>
17. 8%</w>
17. 6-fold</w>
17. 6%</w>
17. 6%,</w>
17. 6%)</w>
17. 5%</w>
17. 3,</w>
17. 2)</w>
17. 0</w>
17- phenyl</w>
17- day-old</w>
17- HAM-D</w>
17, 803),</w>
17, 2</w>
17 p11.2</w>
17 beta-D-glucuronide</w>
17 beta-D-glucuronide-induced</w>
17 alpha-ethinylestradiol</w>
17 9,</w>
17 4.</w>
17 2,</w>
17 1555,</w>
17 1)</w>
17 0/
17 0)</w>
17 0%</w>
17 -1
16: 0-20:
16:0-20: 4</w>
1637 7),</w>
160 8</w>
16. 7%;</w>
16. 7%,</w>
16. 5%,</w>
16. 2%</w>
16. 1%;</w>
16. 0%</w>
16-1 7,</w>
16- yr-old</w>
16- week,</w>
16- month</w>
16- mg/kg</w>
16- 63</w>
16- 48</w>
16- 24</w>
16, 942),</w>
16, 45
16+/- 6</w>
16 95</w>
16 9/
16 7-4.5</w>
16 65</w>
16 59</w>
16 57</w>
16 55</w>
16 50</w>
16 5,</w>
16 4)</w>
16 1)</w>
16 0%</w>
16 -18</w>
16 );</w>
154,5 26,</w>
150- 250</w>
150 .</w>
150 ,000</w>
150 ).</w>
15. 9%</w>
15. 8%)</w>
15. 6%</w>
15. 5%;</w>
15. 5%,</w>
15. 0%</w>
15. 0
15-F(2t)-Iso P,</w>
15- yr-old</w>
15- year</w>
15- second</w>
15- month-old</w>
15- mm</w>
15- minute,</w>
15- lipoxygenation</w>
15- labeled</w>
15- deoxy-Delta12,14-
15- 70</w>
15- 46</w>
15- 45</w>
15- 41%).</w>
15- 25</w>
15- 24</w>
15- 23</w>
15 min</w>
15 :00</w>
15 98</w>
15 85</w>
15 79</w>
15 70</w>
15 67</w>
15 66</w>
15 65</w>
15 6.
15 6)</w>
15 6).</w>
15 52</w>
15 505</w>
15 4:64</w>
15 48</w>
15 4.5</w>
15 4.2+/-5.6</w>
15 4)</w>
15 33</w>
15 20</w>
15 2.
15 2+/-15</w>
15 2)</w>
15 2).</w>
15 1)</w>
15 00,</w>
15 ,000</w>
15 )]</w>
15 %).</w>
14C- amino</w>
1400 .</w>
140-1 59</w>
14/ 15</w>
14. 71</w>
14. 7%</w>
14. 7%,</w>
14. 6</w>
14. 6%</w>
14. 2%,</w>
14- yr</w>
14- week</w>
14- week-old</w>
14- month-old</w>
14- ,</w>
14, 15-
14 CO2</w>
14 9)</w>
14 7/
14 60</w>
14 6)</w>
14 5)</w>
14 5%</w>
14 40</w>
14 4)</w>
14 2.1</w>
14 2)</w>
14 1)</w>
14 0;</w>
14 0%</w>
14 -16</w>
14 -1.
14 ,7
14,7 72</w>
14 );</w>
133 xenon</w>
131I- HSA</w>
130/ 70</w>
13. 9%</w>
13. 8%</w>
13. 6,</w>
13. 6+/-
13. 5g</w>
13. 5+/-
13. 5),</w>
13. 0%</w>
13- wk</w>
13- hydroxylupanine-2-pyrrolcarbonic</w>
13- day</w>
13- cRA</w>
13- 60%</w>
13- 0.4
13 N-ammonia</w>
13 C-urea</w>
13 9+/-
13 9)</w>
13 80</w>
13 8.</w>
13 8.
13 8%</w>
13 78</w>
13 7+/-
13 7)</w>
13 7
13 6;</w>
13 6
13 5-1
13 5).</w>
13 4).</w>
13 37</w>
13 35</w>
13 3).</w>
13 26</w>
13 18</w>
13 1),</w>
13 0-140</w>
13 0-
13 0+/-
13 0)</w>
13 0),</w>
13 -19</w>
13 -14</w>
13 ,000</w>
13 ):</w>
125I- gentamicin</w>
125I- albumin</w>
125 I</w>
120/ Norm</w>
120/ 80</w>
120/ 67</w>
120- day-old</w>
120 7</w>
12/ 30</w>
12/ 27</w>
12. 7%,</w>
12. 5%,</w>
12. 3%</w>
12. 2%,</w>
12. 1%</w>
12- yr-old</w>
12- months</w>
12- month,</w>
12- mg</w>
12- fold</w>
12- day-old</w>
12- 20</w>
12, 500</w>
12 weeks,</w>
12 th,</w>
12 h
12 :00</w>
12 9),</w>
12 8)</w>
12 7.
12 7)</w>
12 7).</w>
12 7%</w>
12 68),</w>
12 6.
12 6)</w>
12 5.8</w>
12 5.0</w>
12 5-150</w>
12 5%</w>
12 4)</w>
12 30</w>
12 2)</w>
12 19
12 17
12 00,</w>
12 0.7</w>
12 -13</w>
12 -1.
118 ,
11/ 16</w>
11. 7%</w>
11. 7%;</w>
11. 6%</w>
11. 5.</w>
11. 0%</w>
11-dehydro- thromboxane</w>
11-dehydro corticosterone</w>
11- year</w>
11- week</w>
11- thiol-11-desoxy</w>
11- point</w>
11- item</w>
11- epoxide</w>
11- dTXB2</w>
11- EPO
11- 30</w>
11, 959</w>
11, 215</w>
11+/-1 95</w>
11 beta-H
11 b
11 C</w>
11 6.
11 4.7</w>
11 4.6</w>
11 25</w>
11 19
11 1-
11 0.8</w>
11 -17</w>
11 -14</w>
11 -12</w>
11 +</w>
11 %;</w>
10: 1,</w>
1006 35;</w>
1000/ mm3</w>
1000- mg</w>
100/ 65</w>
100- micrograms</w>
100- microg</w>
100- day-old</w>
100- 800</w>
100- 582)</w>
100- 380</w>
100,000/ mm3,</w>
100,000/ microL,</w>
100,00 0)</w>
100 mg</w>
100 mg/kg</w>
100 mg/kg,</w>
100 ;</w>
100 :1</w>
100 907</w>
100 330
100 0-fold</w>
100 ,
100 +
100+ N:</w>
10/ 14</w>
10.0 -25.
10.0-25. 0-
10.0-25.0- Hz</w>
10. 8%</w>
10. 5)</w>
10. 38</w>
10-1 5%</w>
10-1 3%</w>
10-1 2h</w>
10- week-old</w>
10- week-long</w>
10- s</w>
10- mm</w>
10- micrograms/kg</w>
10- microg</w>
10- hydroxynor
10- day,</w>
10- 61</w>
10- 4</w>
10- 37</w>
10- 300</w>
10- 3).</w>
10- 26</w>
10- 24</w>
10- -20</w>
10(9)/ l.</w>
10(9)/ L.</w>
10(6)/ L)</w>
10(3)/microliter s.</w>
10(3)/ mm3,</w>
10(-1 1)</w>
10(-1 0
10(- 6),</w>
10(- 5),</w>
10 mg/kg/day</w>
10 mg/kg)</w>
10 97</w>
10 90</w>
10 9,</w>
10 9),</w>
10 9
10 8;</w>
10 87</w>
10 80</w>
10 8.9</w>
10 8-1
10 8)</w>
10 7.4</w>
10 7-112].</w>
10 7)</w>
10 7%</w>
10 6;</w>
10 6)</w>
10 53</w>
10 50,</w>
10 5,</w>
10 47,</w>
10 40)</w>
10 4%</w>
10 4
10 33</w>
10 26</w>
10 24</w>
10 22,</w>
10 20).</w>
10 2.4</w>
10 2+/-13</w>
10 2)</w>
10 2).</w>
10 11+/-195</w>
10 10</w>
10 1+/-
10 0.7</w>
10 0.2</w>
10 -induced</w>
10 -1.
10 ,6
10 ,000/
10 +/-1
10 (2)</w>
10 (11)</w>
10 ')</w>
10 %-
10 %
1/2/ 0,</w>
1/2- dependent)</w>
1/ s,</w>
1/ day</w>
1/ alpha</w>
1/ 8</w>
1/ 84</w>
1/ 40</w>
1/ 30
1/ 1</w>
1/ 10</w>
1/ 100,000</w>
1/ 1,000</w>
1.9- 9.1),</w>
1.9 3;</w>
1.9 %.</w>
1.8 8).</w>
1.8 7.</w>
1.8 2)</w>
1.7 9;</w>
1.7 8,</w>
1.7 7;</w>
1.7 5-
1.7 5,</w>
1.7 2-
1.6- 9.
1.6- ,</w>
1.6 6)</w>
1.6 6).</w>
1.6 5)</w>
1.6 4)</w>
1.6 1,</w>
1.5- 4</w>
1.5+/- 0.1</w>
1.5 mg/kg)</w>
1.5 6-
1.5 6,</w>
1.5 4;</w>
1.5 2,</w>
1.5 2),</w>
1.5 1;</w>
1.5 1).</w>
1.5 %/
1.4 9;</w>
1.4 4,</w>
1.4 2),</w>
1.4 -1
1.4 %.</w>
1.3-5. 6),</w>
1.3- 8.8),</w>
1.3- 7.6),</w>
1.3+/- 0.1,</w>
1.3 8-
1.3 8,</w>
1.3 7-
1.3 5-3.58].</w>
1.3 5,</w>
1.3 3,</w>
1.3 3)</w>
1.3 2;</w>
1.3 -1
1.2- 3.9).</w>
1.2- 3.8).</w>
1.14 -1.
1.11- 2.
1.10- 3.
1.1-8. 8)</w>
1.1-5. 4).</w>
1.1-3. 4),</w>
1.1-1 2.2),</w>
1.1- 8.5,</w>
1.01-1. 53))</w>
1.00- 5.
1.00 ).</w>
1.0-5. 9),</w>
1.0- mM</w>
1.0 9-
1.0 9,</w>
1.0 9
1.0 7;</w>
1.0 6,</w>
1.0 5-5.
1.0 5-2.
1.0 5-1.
1.0 3-1.
1.0 2;</w>
1.0 1-1
1.0 +/-
1.0 %;</w>
1. 97</w>
1. 96</w>
1. 92</w>
1. 9.</w>
1. 89</w>
1. 88</w>
1. 8+/-
1. 8)</w>
1. 8),</w>
1. 7;</w>
1. 78</w>
1. 7),</w>
1. 69</w>
1. 69
1. 68</w>
1. 64</w>
1. 60;</w>
1. 60-4.18)</w>
1. 59;</w>
1. 55;</w>
1. 52</w>
1. 50,</w>
1. 5.</w>
1. 5).</w>
1. 48;</w>
1. 48-
1. 45
1. 40;</w>
1. 40-
1. 4)</w>
1. 4).</w>
1. 4%).</w>
1. 30;</w>
1. 3-fold</w>
1. 3,</w>
1. 3).</w>
1. 2;</w>
1. 29,</w>
1. 28
1. 25
1. 23%</w>
1. 22-
1. 22).</w>
1. 21-1.
1. 21-
1. 20,</w>
1. 2-fold</w>
1. 2);</w>
1. 2%)</w>
1. 1;</w>
1. 18)</w>
1. 17;</w>
1. 17,</w>
1. 17
1. 16,</w>
1. 15-
1. 13;</w>
1. 12-1.
1. 12-
1. 12,</w>
1. 11;</w>
1. 1+/-
1. 1%).</w>
1. 00,</w>
1-{3-[4-(2- ethoxy-
1-methyl-4-phenyl pyridinium</w>
1-desamino-8-D- arginine-vasopressin</w>
1-desamino-8-D- arginine-
1-[3-(4- arylpiperazin-1-yl)-2-
1-[2- [bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine</w>
1-[2- (diphenylmethoxy)
1-M X</w>
1-M UA</w>
1-M 5)</w>
1-4 )),</w>
1-1. 5</w>
1-1 8</w>
1-1 8.
1-1 50</w>
1-1 3)</w>
1-1 2).</w>
1-1 0-
1-1 0)</w>
1-- 9</w>
1-(2-chloroethyl )-3-
1-(2-chloroethyl)-3- cyclohexyl-1-nitrosourea</w>
1-(2- methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine</w>
1-(2- ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole</w>
1- yr</w>
1- s</w>
1- propranolol</w>
1- n-hexyl-
1- microglobulin</w>
1- mg</w>
1- mg/kg</w>
1- mediated</w>
1- hexylcarbamoyl-5-fluorouracil</w>
1- ethyl</w>
1- di
1- dependent</w>
1- deamino-8-D-arginine</w>
1- chloro-1,2,2,2-tetrafluoroethane</w>
1- bromo-1-chloro-2,2,2-trifluoroethane</w>
1- beta-D-arabinofuranosylcytosine</w>
1- antagonists,</w>
1- antagonist</w>
1- adrenoceptor-mediated</w>
1- adrenoceptor-blocking</w>
1- adrenoceptor
1- Hz</w>
1- ED
1- CMRg</w>
1- Amino-5-bromouracil</w>
1- 7,</w>
1- 6).</w>
1- 515
1- 5.</w>
1- 5),</w>
1- 5%</w>
1- 3;</w>
1- 36</w>
1- 31).</w>
1- 3.
1- 28</w>
1- 2).</w>
1- /-)</w>
1- (4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-
1- (1,2-dihydro-2-acenaphthylenyl)
1-(1,2-dihydro-2-acenaphthylenyl) piperazine</w>
1- (
1,8-cine ole-induced</w>
1,8-cine ole,</w>
1,8 00/
1,800/ microL</w>
1,5- benzodiazepine</w>
1,4- bis[2-(3,5-dichloropyridyloxy)]benzene</w>
1,4- benzodiazepine</w>
1,3- dinitrobenzene</w>
1,3- diazepinium</w>
1,3- CHD,</w>
1,25-dihydroxy -16-ene-23-yne-vitamin</w>
1,25-(OH)2D 2.</w>
1,25-(OH)2-16ene D3</w>
1,25-(OH)(2) D(3)</w>
1,25- Di
1,25(OH)2D 3,</w>
1,25(OH)2-16ene-23yne-19-nor-26,27-F6- D3</w>
1,25 (OH)2-
1,2- dichlorohexafluorocyclobutane,</w>
1,2,3,4, tetrahydroisoquinoline</w>
1,2,3,4, tetrahydroisoquinoline,</w>
1,2, 3,</w>
1,1- trichloroethane.</w>
1,1- diphenyl-2-picrylhydrazyl</w>
1,1- dichloro-2,2,2-trifluoroethane</w>
1,0 89</w>
1,0 80</w>
1,0 70</w>
1, 950</w>
1, 7
1, 6-diphenyl-1,3,5-hexatriene</w>
1, 45;</w>
1, 340</w>
1, 3,4-
1, 25</w>
1, 250</w>
1, 2,4-
1, 2,3,4-tetrahydroisoquinoline</w>
1, 2,3,4-tetrahydro-6-nitro-2,</w>
1, 172</w>
1, 170</w>
1, 1,1-trichloroethane.</w>
1+/-1 9.
1+/- 7.1</w>
1+/- 4</w>
1+/- 22</w>
1+ 2</w>
1 st-time</w>
1 s</w>
1 min</w>
1 microg/g,</w>
1 kHz;</w>
1 b.</w>
1 alpha,</w>
1 ].</w>
1 M)</w>
1 D-
1 Cins>del,</w>
1 B-
1 50)</w>
1 192</w>
1 19
1 18,</w>
1 177</w>
1 16
1 1566</w>
1 15+/-
1 15)</w>
1 15).</w>
1 14/
1 12.</w>
1 10;</w>
1 103</w>
1 10/
1 0.9%</w>
1 0.8
1 0.7;</w>
1 0.4
1 )],</w>
1 '-
1 '
1' S,2'S)-2-(
08 :00</w>
04-67 90</w>
0088- S),</w>
000 1)</w>
00- 800</w>
00- 6
00- 0
00 s,</w>
00 :
00 1,</w>
00 0.</w>
00 );</w>
00 %).</w>
0/ 5,</w>
0/ 20</w>
0.9- 2.0%</w>
0.9 8,</w>
0.9 6;</w>
0.9 6)</w>
0.9 5;</w>
0.9 5-1.
0.9 5)</w>
0.9 4;</w>
0.9 4-1.
0.9 3,</w>
0.9 2;</w>
0.9 2-
0.9 2)</w>
0.9 -1.
0.9 ),</w>
0.9 %.</w>
0.8-1. 1),</w>
0.8 9)</w>
0.8 9).</w>
0.8 8,</w>
0.8 8).</w>
0.8 7;</w>
0.8 7).</w>
0.8 6)</w>
0.8 5-1.
0.8 5).</w>
0.8 3,</w>
0.8 0-
0.8 %);</w>
0.8 %).</w>
0.70 45;</w>
0.7-1. 3),</w>
0.7 9;</w>
0.7 9,</w>
0.7 7)</w>
0.7 6)</w>
0.7 5;</w>
0.7 5.</w>
0.7 5)</w>
0.7 4;</w>
0.7 4-1.
0.7 3;</w>
0.7 2,</w>
0.7 2)</w>
0.7 10,</w>
0.7 1,</w>
0.7 1+/-
0.7 1%</w>
0.7 0;</w>
0.7 0)</w>
0.7 0).</w>
0.7 .</w>
0.7 );</w>
0.7 %;</w>
0.6-1. 3</w>
0.6 ;</w>
0.6 9;</w>
0.6 9).</w>
0.6 8;</w>
0.6 75</w>
0.6 7).</w>
0.6 6;</w>
0.6 6),</w>
0.6 4-
0.6 3)</w>
0.6 2)</w>
0.6 1;</w>
0.6 1).</w>
0.6 0).</w>
0.6 +/-
0.6 %;</w>
0.56- 2.4</w>
0.5-4. 1),</w>
0.5- ml</w>
0.5- mg</w>
0.5- 5</w>
0.5- 2.0)</w>
0.5 mg/kg</w>
0.5 mg/kg,</w>
0.5 M</w>
0.5 8-
0.5 8,</w>
0.5 8).</w>
0.5 7/
0.5 7
0.5 6).</w>
0.5 5).</w>
0.5 4-1.
0.5 4,</w>
0.5 4)</w>
0.5 -15</w>
0.5 -1.5</w>
0.5 -1.
0.5 -1
0.5 %;</w>
0.4- 5.1),</w>
0.4 ;</w>
0.4 8;</w>
0.4 8).</w>
0.4 7;</w>
0.4 7+/-
0.4 7)</w>
0.4 6,</w>
0.4 6)</w>
0.4 5-
0.4 45</w>
0.4 3,</w>
0.4 3).</w>
0.4 1;</w>
0.4 10).</w>
0.4 1+/-
0.4 /
0.4 +/-
0.3- 3.0</w>
0.3- 2.7).</w>
0.3 mg</w>
0.3 mg/kg)</w>
0.3 75</w>
0.3 7)</w>
0.3 6)</w>
0.3 50-unit</w>
0.3 5.</w>
0.3 5,</w>
0.3 5%</w>
0.3 4).</w>
0.3 4%</w>
0.3 33).</w>
0.3 31</w>
0.3 3,</w>
0.3 2).</w>
0.3 2%);</w>
0.3 1,</w>
0.3 1).</w>
0.3 +/-1.
0.3 %;</w>
0.3 %.</w>
0.3 %),</w>
0.28 2).</w>
0.27 8,</w>
0.24 :1</w>
0.2- mg/kg</w>
0.2 8,</w>
0.2 7)</w>
0.2 4,</w>
0.2 3)</w>
0.2 2;</w>
0.2 25</w>
0.2 2-mum</w>
0.2 2),</w>
0.2 1),</w>
0.2 %).</w>
0.16 4,</w>
0.12 5).</w>
0.12 %,</w>
0.10 2%</w>
0.1- 1</w>
0.1- 0.5</w>
0.1 mg/kg</w>
0.1 fold</w>
0.1 13)</w>
0.09 3;</w>
0.06 3),</w>
0.05- 0.25</w>
0.05 ].</w>
0.05 9)</w>
0.05 6</w>
0.05 5)</w>
0.05 5).</w>
0.05 4)</w>
0.05 4).</w>
0.05 ).(ABSTRACT</w>
0.04 9).</w>
0.04 9),</w>
0.04 7)</w>
0.04 7).</w>
0.04 2),</w>
0.04 1).</w>
0.034 3)</w>
0.03 7,</w>
0.03 7)</w>
0.03 3)</w>
0.03 2).</w>
0.03 2),</w>
0.03 );</w>
0.02 8)</w>
0.02 28)</w>
0.02 2,</w>
0.02 2)</w>
0.02 2),</w>
0.014- unit,</w>
0.012 6).</w>
0.01- 0.001).</w>
0.01 ]</w>
0.003- 0.1
0.001 ].</w>
0.001 ).(ABSTRACT</w>
0.0000 5).</w>
0.0000 1),</w>
0.000 9)</w>
0.000 8)</w>
0.000 6,</w>
0.000 6),</w>
0.000 4;</w>
0.000 4),</w>
0.000 3),</w>
0.000 2);</w>
0.000 1]</w>
0.000 1.</w>
0.00 95).</w>
0.00 8);</w>
0.00 8
0.00 7,</w>
0.00 6,</w>
0.00 4;</w>
0.00 4,</w>
0.00 4),</w>
0.00 3;</w>
0.00 31.</w>
0.00 27).</w>
0.00 25)</w>
0.00 25%</w>
0.00 24).</w>
0.00 22).</w>
0.00 21).</w>
0.00 2%</w>
0.00 15).</w>
0.00 13)</w>
0.00 13).</w>
0.00 10,</w>
0.00 1%</w>
0.00 .</w>
0.0 9;</w>
0.0 95)</w>
0.0 8)</w>
0.0 75%,</w>
0.0 75
0.0 70-unit,</w>
0.0 7.</w>
0.0 7);</w>
0.0 7%</w>
0.0 60</w>
0.0 6),</w>
0.0 50,</w>
0.0 40)</w>
0.0 4%</w>
0.0 39</w>
0.0 39,</w>
0.0 38</w>
0.0 36</w>
0.0 35</w>
0.0 30,</w>
0.0 29)</w>
0.0 28</w>
0.0 26</w>
0.0 26
0.0 24)</w>
0.0 24).</w>
0.0 24),</w>
0.0 22</w>
0.0 20</w>
0.0 20)</w>
0.0 2-
0.0 19)</w>
0.0 18)</w>
0.0 18),</w>
0.0 17)</w>
0.0 15%,</w>
0.0 14)</w>
0.0 14).</w>
0.0 14),</w>
0.0 11)</w>
0.0 10).</w>
0.0 10
0. 50-
0. 40)</w>
0. 4-fold</w>
0. 391</w>
0. 39),</w>
0. 37).</w>
0. 36).</w>
0. 35),</w>
0. 35
0. 30%</w>
0. 30
0. 29,</w>
0. 29)</w>
0. 28).</w>
0. 262</w>
0. 26).</w>
0. 23
0. 19;</w>
0. 198</w>
0. 19)</w>
0. 19%</w>
0. 19
0. 18,</w>
0. 18)</w>
0. 17-
0. 17),</w>
0. 167</w>
0. 165</w>
0. 15%,</w>
0. 142</w>
0. 133</w>
0. 11;</w>
0. 112</w>
0. 11
0. 103</w>
0. 100,</w>
0. 10-
0. 10)</w>
0. 1),</w>
0. 1%).</w>
0-5. 7)</w>
0-1 8.7</w>
0-1 6</w>
0-1 1</w>
0-1 0)</w>
0- diisopropyl</w>
0- 7)</w>
0- 7).</w>
0- 3</w>
0- 3),</w>
0- 200
0 ]</w>
0 99</w>
0 90</w>
0 800</w>
0 501</w>
0 50+/-561,</w>
0 5).</w>
0 5
0 2:
0 2)</w>
0 -100</w>
/B CP),</w>
/ ml
/ medium-chain</w>
/ kg.</w>
/ kg.,</w>
/ ethinyl</w>
/ creatinine</w>
/ brain</w>
/ bone</w>
/ VT)</w>
/ O</w>
/ C)</w>
/ 5-FU</w>
/ 2</w>
/ 2)</w>
/ +
.7 7,</w>
.7 1).</w>
.000 4)</w>
.000 2).</w>
.000 1,</w>
.00 7</w>
.00 7)</w>
.00 3),</w>
.00 2)</w>
.00 1]).</w>
.00 1]),</w>
.0 8)</w>
.0 6),</w>
.0 4</w>
.0 49).</w>
.0 48).</w>
.0 43).</w>
.0 40).</w>
.0 3</w>
.0 3),</w>
.0 2;</w>
.0 25),</w>
.0 15)</w>
.0 1,</w>
. ml
. This</w>
. The</w>
. S.)</w>
. O.V.
. It</w>
. 9%</w>
. 8</w>
. 54).</w>
. 50</w>
. 5-
. 44;</w>
. 4
. 37).</w>
. 35</w>
. 31).</w>
. 28).</w>
. 25</w>
. 18)</w>
. 16).</w>
. 15).</w>
. 14,</w>
. 12).</w>
. 10).</w>
. .</w>
. ):</w>
-to- body</w>
-bl ind</w>
-bl ind,</w>
-P res
-P l
-P he-
-M e-
-M K801</w>
-H .,</w>
-B u</w>
-B il</w>
-9. 0;</w>
-6 5).</w>
-520 G</w>
-17 00</w>
-16ene- vitamin</w>
-11- OH-delta</w>
-100 0).</w>
-10(- 3)</w>
-10 mg/kg,</w>
-10 ;</w>
-10 97
-10 5</w>
-10 21C-->T</w>
-10 ,0
-1/ K
-1.7 6;</w>
-1. h-1)</w>
-1. 7</w>
-1. 6</w>
-1. 3</w>
-1-pyrrolidin yl-4-pyrimidinyl)
-1-piperazin yl]-
-1- amine]</w>
-1,4- dihydro-2,3-quinoxalinedione)</w>
-1,3- diethyl-
-1,2-bis(3,5-dioxopiperazinyl-1-yl)prop ane</w>
-1,2,4- triazolo(1,5-
-1,2,3,4-tetrahydro -2-
-1, 2,3,4-tetrahydro-
-1, 2,3,4,
-1, 020</w>
-1 a</w>
-1 R)</w>
-1 97
-1 95
-1 75</w>
-1 5.2</w>
-1 5+/-
-1 4)</w>
-1 3.0</w>
-1 3).</w>
-1 20)</w>
-1 2.8</w>
-1 1.3</w>
-1 1
-0.7 8</w>
-0.7 0,</w>
-0.6 2;</w>
-0.4 5;</w>
-- were</w>
-- was</w>
-- report</w>
-- particularly</w>
-- not</w>
-- may</w>
-- is</w>
-- comparison</w>
-- brain</w>
-- at</w>
-- and</w>
-) -1,2-bis(3,5-dioxopiperazinyl-1-yl)propane</w>
- untreated</w>
- stimulated</w>
- stained</w>
- sensitized</w>
- output</w>
- on</w>
- negative)</w>
- manifested</w>
- limited</w>
- is</w>
- in-
- h
- dp/dtmax</w>
- and</w>
- aminolevulinic</w>
- Tacrolimus</w>
- Protein</w>
- N,5-dimethyl-</w>
- Mantel-Haenszel</w>
- L-
- HT).</w>
- Cl-</w>
- C)</w>
- B,</w>
- 90</w>
- 90-
- 9-
- 9%</w>
- 8</w>
- 60</w>
- 6.1</w>
- 54</w>
- 5.6</w>
- 5.5</w>
- 5.0</w>
- 4.6%</w>
- 4,</w>
- 4%</w>
- 35</w>
- 3.8</w>
- 3.3</w>
- 3.2</w>
- 3.1</w>
- 27</w>
- 26</w>
- 26.
- 240</w>
- 23.
- 2.3</w>
- 2,</w>
- 0.6</w>
- 0.5</w>
- 0.5-4.1),</w>
- 0.5,</w>
- ).</w>
- (4-fluorophenyl)</w>
,2 '-
,000/ mm3.</w>
,00 0-fold</w>
, we</w>
, vs</w>
+H S),</w>
+B IC,</w>
+B IC),</w>
+/-10 2</w>
+/-10 1</w>
+/-1. 5%</w>
+/-1. 4</w>
+/-1. 35</w>
+/-1 9</w>
+/-1 9.
+/-1 0.52</w>
+/-0.0 8;</w>
+/-0.0 6)</w>
+/- 3.5</w>
+/- 0.22</w>
+/- 0.07</w>
+/ +,</w>
+ dP/dtmax,</w>
+ dP/dt</w>
+ L-NAME.</w>
+ BZ.</w>
+ ;</w>
+ 70%</w>
+ 62</w>
+ 50</w>
+ 4.1</w>
+ 390%</w>
+ 23
+ 1</w>
+ 18
+ 0.15</w>
+ -
+ +
+ )-amisulpride</w>
* 3
* ,</w>
* ),</w>
)] enkephalin</w>
)> himbacine</w>
)/ II</w>
)/ 100,000</w>
)-1- [4-[2-
)- releasing</w>
)- receptors</w>
)- elicited</w>
)- cyclohepten-5,10-imine</w>
)- bearing</w>
)- ATPase.</w>
)- 9-
)- 4-
)- 3'-methoxy
)- -induced</w>
)- -in</w>
)+ 0.6%</w>
) fulminant</w>
) cycloheptan-5,10-imine</w>
) Tc-
) I-
) CD71(high)</w>
) A</w>
) ></w>
) 1</w>
) -1.</w>
) *
) );</w>
) %;</w>
(yes/ no
(v WF)</w>
(un treated)</w>
(un bound)</w>
(u P/
(theophylline )</w>
(theophylline ).</w>
(t- test,</w>
(t- butyl</w>
(t AMCA)</w>
(sub )fulminant</w>
(sit ting)</w>
(sigma )</w>
(sham :</w>
(sgk1 (-/-))</w>
(sgk1 (+/+
(sgk1(+/+ )).</w>
(scMet )</w>
(saline- treated)</w>
(saline );</w>
(s.e. m.</w>
(s. d.</w>
(s IL-
(rt M204I</w>
(rh uLIF,</w>
(rh IL-1
(responder s),</w>
(rSO (2))</w>
(rCB F),</w>
(r= 0.81</w>
(r= 0.5
(r= .
(r= -0.8
(r= -0.5
(r= -0.4
(r s</w>
(r ated</w>
(r IL-
(r HuEPO-beta).</w>
(r HuEPO)</w>
(r FVIIa)</w>
(r (s)</w>
(put rescine,</w>
(pseud otum
(prostacyclin )</w>
(prostacyclin ).</w>
(pro) convulsive</w>
(pre- test),</w>
(pre pro
(pre leukemia)</w>
(pl )</w>
(paracetamol )-induced</w>
(pERK 1/2-dependent)</w>
(p> 0.05),</w>
(p> 0.008).</w>
(p=0.04 34)</w>
(p=0.00 9).</w>
(p=0.00 8</w>
(p=0.00 8).</w>
(p=0.00 6,</w>
(p=0.00 6)</w>
(p=0.00 5</w>
(p=0.00 3</w>
(p=0.00 3)</w>
(p=0.00 3).</w>
(p=0.00 2).</w>
(p=0.0 8)</w>
(p=0.0 6)</w>
(p=0.0 44).</w>
(p=0.0 4).</w>
(p=0.0 3).</w>
(p=0.0 25).</w>
(p=0.0 2).</w>
(p=0.0 2),</w>
(p=0. 17).</w>
(p= 0.0002),</w>
(p<or= 0.01)</w>
(p<or= 0.001)</w>
(p< 10-3).</w>
(p< 0.05,</w>
(p< 0.021)</w>
(p< 0.001,</w>
(p< 0.0005).</w>
(p< 0.0001</w>
(p< 0.0001)</w>
(p. o.),</w>
(p uromycin</w>
(p urine</w>
(p g/ml)</w>
(p g/ml),</w>
(p ct
(p al
(p Rh)</w>
(p Ki</w>
(p K(i)=
(p IC(50)</w>
(p CPA),</w>
(p >0.05).</w>
(p 75NTR)</w>
(p ,</w>
(nor adamantan-3-yl)-1,3-dipropylxanthine),</w>
(non- significantly)</w>
(non- NMDA</w>
(non significant,</w>
(non innervated)</w>
(non episode</w>
(non e,</w>
(non e)</w>
(ne ar)</w>
(n=24 2)</w>
(n=10 3).</w>
(n= 9;</w>
(n= 9),</w>
(n= 81)</w>
(n= 60)</w>
(n= 6).</w>
(n= 5;</w>
(n= 56)</w>
(n= 46).</w>
(n= 45
(n= 42,</w>
(n= 42)</w>
(n= 40)</w>
(n= 4)</w>
(n= 32)</w>
(n= 30)</w>
(n= 3),</w>
(n= 28)</w>
(n= 25)</w>
(n= 23)</w>
(n= 21)</w>
(n= 21),</w>
(n= 200</w>
(n= 2.8+/-1.09)</w>
(n= 2.4+/-0.7)</w>
(n= 2)</w>
(n= 2).</w>
(n= 18)</w>
(n= 17),</w>
(n= 16),</w>
(n= 13).</w>
(n= 12,</w>
(n= 12),</w>
(n= 11)</w>
(n= 11),</w>
(n= 10;</w>
(n= 100)</w>
(n= 10).</w>
(n= 10),</w>
(n= 1,57
(n= 1)</w>
(n u)</w>
(n u))</w>
(n t
(n amely</w>
(n ST</w>
(n B
(n .
(moderate- dose,</w>
(mifeprist one)</w>
(midazolam )</w>
(midazolam ).</w>
(micro meter-controlled</w>
(mes or)</w>
(medi ast
(medi an;</w>
(mean+/- SEM)</w>
(mean+/- SD,</w>
(mean+/- SD)</w>
(mean+/- S.D.</w>
(mca ))</w>
(max .</w>
(malondialdehy de)</w>
(mGluR 8)</w>
(mGluR 5),</w>
(mACh R)</w>
(m- AM
(m ural</w>
(m ec
(m dr
(m ToR)</w>
(m IPSCs)</w>
(m EPSCs)</w>
(m AMPH)</w>
(m (2)
(l- CMRg)</w>
(l Co
(iopamid ol).</w>
(iomeprol ,</w>
(inter contraction</w>
(inter class</w>
(intact- gentamicin)</w>
(iNO S).</w>
(i.pl .)</w>
(i.p. );</w>
(i. t.;</w>
(i. c.</w>
(i. c.),</w>
(i. a.)</w>
(i opamidol</w>
(i onic)</w>
(i m</w>
(i e</w>
(i PTH
(i .</w>
(h ttp://www.
(h PA
(h ERG)</w>
(gamma-hexachlorocyclohex ane)</w>
(gamma-hexachlorocyclohex ane
(gamma- GT
(four )</w>
(four );</w>
(four ).</w>
(experiment al)</w>
(exp 2).</w>
(exencephaly )</w>
(es p,</w>
(eNO S)-deficient</w>
(eNO S),</w>
(e zetimibe</w>
(e x</w>
(e utectic</w>
(e NOS</w>
(e GFR)</w>
(e GFP)</w>
(dp m/
(doxorubic in).</w>
(dex -HT).</w>
(dex ),</w>
(dd l)</w>
(d t)</w>
(d l
(d PI/dSP)</w>
(d DAVP),</w>
(con 1)</w>
(chi -square</w>
(chi (2)
(carbidopa ).</w>
(c- Fos)</w>
(c oxib
(c old</w>
(c ic
(c NOS)</w>
(c G
(c AMP-PDIE)</w>
(c AMP)</w>
(beta-CC E)</w>
(beta- CCM),</w>
(beta- AR)</w>
(aver age).</w>
(ara- C),</w>
(anti- Thy</w>
(analgesi a)</w>
(alpha-T Ac)</w>
(alpha- T)</w>
(adriamyc in;</w>
(adriamyc in)-induced</w>
(adjuv ant-injected</w>
(ad j))</w>
([ Na]o</w>
([ 14C]
(ZO -1)</w>
(Z yban)</w>
(Z IO)</w>
(Z I-
(Z =-
(Y S</w>
(Y MRS</w>
(Y M-080
(Xeloda )</w>
(WR-27 21)</w>
(WR 330
(WR 300
(WR 242511).</w>
(WK Y</w>
(WB Cs)</w>
(WAY -100
(W- ICH)</w>
(W interaceae).</w>
(W ilcoxon</w>
(W ald</w>
(W T
(W S)</w>
(W LP-S-10)</w>
(W I)</w>
(W HO),</w>
(W /
(W )</w>
(Volta rol)</w>
(Vmca )</w>
(Vis ual</w>
(Vi usid),</w>
(Val ium</w>
(VT/ VF)</w>
(VR L)</w>
(VR CZ)</w>
(VP-1 6-213)</w>
(VP-1 6)</w>
(VP U)</w>
(VN R)</w>
(VLD L)</w>
(VL BW
(VE LCADE)</w>
(VE GFR-
(VE EG)</w>
(VD /VT)</w>
(VCM s)</w>
(VCM s).</w>
(V ohland</w>
(V max)</w>
(V itamin</w>
(V it</w>
(V isi
(V d)</w>
(V cf)</w>
(V R)</w>
(V PT)</w>
(V PA)-induced</w>
(V PA
(V P</w>
(V NB),</w>
(V MAT2)</w>
(V LDL-
(V IT</w>
(V I)</w>
(V I
(V HD)</w>
(V H)</w>
(V GSC)</w>
(V GB)</w>
(V GAT)</w>
(V CR),</w>
(V BL)</w>
(V AT)</w>
(V AL)</w>
(V -
(V ),</w>
(UN a
(UN OS)</w>
(UK PDRG)</w>
(U osm</w>
(U nified</w>
(U max)</w>
(U l
(U TI)</w>
(U S</w>
(U RO
(U LDA)</w>
(U L)</w>
(U I)</w>
(U A)</w>
(Tx A2)</w>
(Tren tal)</w>
(Tren tal),</w>
(Tor adol,</w>
(Tor adol
(Tn I),</w>
(Theo-Dur )</w>
(Td p),</w>
(Taxotere ),</w>
(Tax ol
(Tac )</w>
(TX B2)</w>
(TX A2)</w>
(TX A)</w>
(TW IK)-related</w>
(TUNE L
(TT S)</w>
(TT P),</w>
(TR I),</w>
(TR (-))</w>
(TP M)</w>
(TP M).</w>
(TP E)</w>
(TNS r</w>
(TNF- alpha,</w>
(TNF)- alpha</w>
(TNF alpha),</w>
(TN G)</w>
(TN F</w>
(TMP-SM X).</w>
(TMP G</w>
(TM S).</w>
(TJ s),</w>
(TJ Ms)</w>
(TIMP s)</w>
(TI MI)</w>
(TI As)</w>
(TI )</w>
(TH R)</w>
(TH C),</w>
(TGF-beta II
(TGF- alpha)</w>
(TGF)- beta</w>
(TGF beta
(TF A-
(TF A)</w>
(TEMPO L),</w>
(TE T)</w>
(TE N)</w>
(TD s)</w>
(TD I)</w>
(TBP S)</w>
(TBM ),</w>
(TBAR S).</w>
(TB M)</w>
(TAS K
(T3 N1M0)]</w>
(T3 N0M0)</w>
(T2- T4)</w>
(T+ A</w>
(T yr-
(T x)</w>
(T rp
(T riniol)</w>
(T pT
(T omudex)</w>
(T l-201)</w>
(T iclid
(T en
(T emodar
(T c-
(T X)</w>
(T UD
(T SC)</w>
(T RO196
(T Q),</w>
(T PO)</w>
(T PE).</w>
(T P).</w>
(T MTX)</w>
(T MD)</w>
(T MA),</w>
(T M)</w>
(T LS)</w>
(T LE).</w>
(T LC</w>
(T K)</w>
(T GB)</w>
(T EM).</w>
(T DFS);</w>
(T D),</w>
(T CR),</w>
(T CI)</w>
(T CAs).</w>
(T AM),</w>
(T AFI),</w>
(T AA)</w>
(T AA
(T A-
(T A)</w>
(T 60),</w>
(T 30),</w>
(T 3)</w>
(T 3).</w>
(T 180).</w>
(T 120),</w>
(T 1-
(T 1)</w>
(T 0)</w>
(T -Bil</w>
(T 's</w>
(Syn drome</w>
(Sp O2</w>
(Sp F:</w>
(Sig ma)</w>
(Ser mion).</w>
(SW OG)</w>
(STR ).</w>
(ST Z</w>
(ST Z-
(ST Z),</w>
(ST R)</w>
(ST M)</w>
(SSR T)</w>
(SSR I).</w>
(SS ADDA).</w>
(SR I)</w>
(SR 1445
(SR 141716)</w>
(SP N)</w>
(SP C)</w>
(SOD ,</w>
(SO3 H)7-Ac-CCK-2-8-SE</w>
(SO LV
(SO CS-1</w>
(SNR ),</w>
(SNA P)</w>
(SN r)</w>
(SN r),</w>
(SN GFR)</w>
(SN D)</w>
(SN ),</w>
(SM emb)</w>
(SM I-311),</w>
(SL M)</w>
(SL A),</w>
(SK _F</w>
(SK F
(SJ S)</w>
(SI R</w>
(SI LENT).</w>
(SI L</w>
(SI B)</w>
(SI ).</w>
(SHR s),</w>
(SHR SP)</w>
(SH AR
(SG Z)</w>
(SER M)</w>
(SER CA2),</w>
(SE S),</w>
(SE P)</w>
(SE MA3
(SE )-induced</w>
(SD N)</w>
(SD H)</w>
(SCL C)</w>
(SCL -90-
(SCI D)</w>
(SC- 48334)</w>
(SAS P)</w>
(SAP S-CI
(SAP S),</w>
(SAL /
(SAL ),</w>
(SA E)</w>
(S- adenosylmethion
(S- 3,4-DCPG)</w>
(S- )-amisulpride</w>
(S)-4C3H PG</w>
(S)-4C3H PG,</w>
(S)-2-(6-methoxynaphthalen-2- yl)-N-substituted</w>
(S)- warfarin,</w>
(S)- emopamil</w>
(S)- Emopamil</w>
(S)- 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole</w>
(S)- (+
(S)-(+ )-1-[4-[2-
(S yn</w>
(S ymmetre
(S til
(S tesol
(S rl)</w>
(S p)</w>
(S low)</w>
(S edionbel)</w>
(S e),</w>
(S ch
(S a
(S Z)-induced</w>
(S Y)</w>
(S VR).</w>
(S V)</w>
(S TI)</w>
(S TI),</w>
(S TEMI)</w>
(S TE
(S T-
(S SS)</w>
(S S)-immunopositive</w>
(S RS
(S R),</w>
(S PV),</w>
(S PA)</w>
(S PA
(S P),</w>
(S ON)</w>
(S OFA)</w>
(S O)</w>
(S MR</w>
(S MA)</w>
(S M-
(S LC6A
(S L</w>
(S HB
(S EM
(S Ds)</w>
(S DS)</w>
(S CG)</w>
(S BP,</w>
(S BP).</w>
(S AS),</w>
(S ARS),</w>
(S AP),</w>
(S AN
(S AH),</w>
(S ACS)</w>
(S AC)</w>
(S AA)</w>
(S A,</w>
(S 3)</w>
(Renograf in-
(Re ese-Ellsworth</w>
(RV R)</w>
(RV CF),</w>
(RU CA
(RT- PCR
(RT X)</w>
(RS)- alpha-
(RS DS)</w>
(RR T)</w>
(RPL S).</w>
(RP E)</w>
(RO S).</w>
(RO S)-mediated</w>
(RNF L)</w>
(RL S).</w>
(RF S)</w>
(RE M)</w>
(RE -
(RB F,</w>
(RB F),</w>
(RAS SF
(RAD00 1)</w>
(R,S)- 3,4-dicarboxyphenylglycine</w>
(R)- alpha-Methylhistamine</w>
(R)- HA-966</w>
(R(2)= 0.79)</w>
(R imonabant)</w>
(R iUP)</w>
(R c)</w>
(R attus</w>
(R X</w>
(R VR).</w>
(R VO
(R SV
(R SI)</w>
(R SI).</w>
(R SA)</w>
(R Q)</w>
(R PGN)</w>
(R P),</w>
(R O</w>
(R N)</w>
(R N
(R M
(R D)</w>
(R D
(R CR)</w>
(R CA).</w>
(R AV
(R AS).</w>
(R AM)</w>
(R ALH)</w>
(R AD)</w>
(R 2</w>
(R +)-amisulpride</w>
(R );</w>
(R )-1-
(QT c).</w>
(QT b</w>
(QT (F
(QO L),</w>
(Q ST).</w>
(Q S
(Q Kd</w>
(Q D</w>
(Q A)</w>
(Q 4)</w>
(Pv ,
(Pt pro)</w>
(Pro H
(Pir arubicin)</w>
(Pir ),</w>
(Ph B)</w>
(Pf izer</w>
(Pf S)</w>
(Parlodel )</w>
(Pa(O (2))</w>
(Pa vul
(Pa O2</w>
(Pa O2)</w>
(PW TT,</w>
(PV T)</w>
(PV F)</w>
(PV B
(PV )-immunopositive</w>
(PV )-</w>
(PTH rP)</w>
(PT s)</w>
(PT Z;</w>
(PT Z).</w>
(PT Z)-</w>
(PT Z)-
(PT T)</w>
(PT CR).</w>
(PT CA).</w>
(PT C)</w>
(PT ).</w>
(PSV T)</w>
(PRL- R)</w>
(PRL)- secreting</w>
(PRL)- producing</w>
(PRE S)</w>
(PR P).</w>
(PR L</w>
(PR IS)</w>
(PR 3-ANCA)</w>
(PR 3)</w>
(PR 3)-
(PPI s)</w>
(PON V)</w>
(PO MC)</w>
(PO CA)</w>
(PO A)</w>
(PO 2)</w>
(PN F).</w>
(PN A)</w>
(PMS F)</w>
(PL P)</w>
(PL P),</w>
(PL M)</w>
(PL C)</w>
(PL A)</w>
(PKC epsilon),</w>
(PIP C)</w>
(PIL O)-induced</w>
(PI s),</w>
(PI SE)</w>
(PI L)</w>
(PHA- L)</w>
(PH E)</w>
(PH A),</w>
(PGF 2</w>
(PGE2 )-induced</w>
(PGE 2;</w>
(PGE 2,</w>
(PGE 2),</w>
(PGE 1).</w>
(PGE (2)),</w>
(PGAD S;</w>
(PG S)</w>
(PG P)</w>
(PG I-
(PF S).</w>
(PF 4)</w>
(PF 4)/heparin</w>
(PEG- IFN)</w>
(PEG- IFN)/ribavirin</w>
(PE S)</w>
(PE I)</w>
(PE F)</w>
(PE A)</w>
(PDE 5)</w>
(PDE -5)</w>
(PD N)</w>
(PD A).</w>
(PCW P),</w>
(PCT )-induced</w>
(PCP )-induced</w>
(PCO S).</w>
(PCO )</w>
(PCNS L)</w>
(PCE A).</w>
(PC PA,</w>
(PC /BCP),</w>
(PBM C)</w>
(PB SCT).</w>
(PB O)</w>
(PB N),</w>
(PANS S).</w>
(PAN ;</w>
(PAN -
(PAN )-treated</w>
(PAI -1)</w>
(PA H</w>
(P> 0.05),</w>
(P=0.4 7).</w>
(P=0.00 8)</w>
(P=0.00 4)</w>
(P=0.00 2)</w>
(P=0.0 48).</w>
(P=0.0 4)</w>
(P=0.0 4).</w>
(P=0.0 3).</w>
(P=0.0 3),</w>
(P=0.0 2)</w>
(P=0.0 19)</w>
(P=.0 5-
(P=.0 2).</w>
(P=.0 1).</w>
(P= 0.73).</w>
(P= 0.05
(P= 0.01)</w>
(P= 0.01).</w>
(P= .008).</w>
(P< 0.</w>
(P< 0.05,</w>
(P< 0.01</w>
(P< 0.009).</w>
(P< 0.004).</w>
(P< 0.001):</w>
(P< 0.0001),</w>
(P< 0.00
(P< .001),</w>
(P400 )).</w>
(P/ CD)</w>
(P sych
(P o
(P mO
(P gp)</w>
(P gp),</w>
(P g
(P elicanus</w>
(P eg
(P d</w>
(P arkemed
(P an</w>
(P Z)</w>
(P V)</w>
(P TE)</w>
(P SS)</w>
(P SC</w>
(P S-34
(P S).</w>
(P S),</w>
(P RBC)</w>
(P RB
(P PH).</w>
(P PH),</w>
(P PH
(P PE,</w>
(P P)</w>
(P OR
(P OD)</w>
(P OAG)</w>
(P NS)</w>
(P NS).</w>
(P MN
(P M/
(P LT),</w>
(P L),</w>
(P KG)</w>
(P IH
(P ICU)</w>
(P I).</w>
(P I),</w>
(P HEN)</w>
(P H</w>
(P ECAM
(P DPH)</w>
(P Cr)</w>
(P CR-RFLP)</w>
(P CB)</w>
(P CA),</w>
(P BP
(P B</w>
(P AS
(P AP)</w>
(P AP),</w>
(P AH).</w>
(P AC-
(P AC),</w>
(P A/
(P A).</w>
(P A),</w>
(P ></w>
(P :=0.0
(P 58).</w>
(P 450</w>
(P 2</w>
(P 29),</w>
(P 21),</w>
(P 20)</w>
(P 0,</w>
(P "</w>
(Or ch
(OX R1)</w>
(OX O)</w>
(OX C).</w>
(OVX+CHRON+ E
(OV X)</w>
(OR R),</w>
(OR L-1)</w>
(OR AC)</w>
(OR =1.
(OR (adj))</w>
(OPID N).</w>
(OPC -145
(OH)2D 3)</w>
(OD Ns)</w>
(OCT AVE)</w>
(O- LM</w>
(O- A)</w>
(O x
(O vx)</w>
(O TFC)</w>
(O T
(O SA)</w>
(O S).</w>
(O S
(O N</w>
(O LT),</w>
(O FQ/
(O F
(O CD).</w>
(O AC)</w>
(O A).</w>
(O A),</w>
(O A
(O 2),</w>
(O /E</w>
(O (2)</w>
(Nor pace).</w>
(No DCE-
(Ne uro
(Navelb ine;</w>
(Na,K )-ATPase.</w>
(Na PB)</w>
(Na Cl).</w>
(Na (+)/
(Na(+)/ K(+)</w>
(NY HA</w>
(NT- proBNP)</w>
(NT S),</w>
(NT P)</w>
(NT G),</w>
(NT Ds),</w>
(NSC- 45
(NSAID S),</w>
(NSAID )-induced</w>
(NS F).</w>
(NS F),</w>
(NRTI )</w>
(NRTI ).</w>
(NR H).</w>
(NP Y
(NP SH)</w>
(NO)- metabolite</w>
(NO( x))</w>
(NO S3-
(NO S)-
(NO P)</w>
(NO )-dependent</w>
(NN R)</w>
(NM U)</w>
(NK 1)</w>
(NI H-07</w>
(NI AID
(NH SD
(NH 2)</w>
(NF-kappa B)</w>
(NF-kappa B),</w>
(NEC A).</w>
(NEC A),</w>
(NE ;</w>
(NE )-induced</w>
(NDE A)/kg</w>
(NDE A).</w>
(ND I),</w>
(NC V)</w>
(NC SE).</w>
(NBQ X)</w>
(NB T)</w>
(NAc )</w>
(NAc ).</w>
(NAD PH-d)</w>
(NAC +
(NA R)</w>
(N= 55
(N= 12)</w>
(N-methyl- d-aspartate</w>
(N- [2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-
(N,N- dipropyl
(N,N- dimethylpropranolol),</w>
(N ovember</w>
(N ov
(N itro
(N eu
(N epeta</w>
(N ational</w>
(N ac)</w>
(N a</w>
(N X)</w>
(N STEMI).</w>
(N RS</w>
(N PC</w>
(N PA)</w>
(N O-
(N M)</w>
(N LA).</w>
(N L4-3
(N L)</w>
(N KCC
(N K1</w>
(N IRS)</w>
(N ID
(N GF
(N G-
(N F)</w>
(N EC)</w>
(N E).</w>
(N DPD)</w>
(N D)</w>
(N CPH)</w>
(N CA)</w>
(N C),</w>
(N AL
(N AION)</w>
(N )</w>
(N (
(N( omega)-
(Mrp 2)</w>
(Mn DPDP)</w>
(Min er</w>
(MgSO 4</w>
(Mg (2+)</w>
(Mg (2+
(Mg(2+ ))</w>
(Met avir</w>
(Me CCNU)</w>
(Man n-Whitney</w>
(MT X-
(MS M)</w>
(MS L)</w>
(MRP 2)</w>
(MR SA),</w>
(MR I).</w>
(MPTP )-treated</w>
(MPT ),</w>
(MPO- ANCA).</w>
(MPO- ANCA)-positive</w>
(MPO)- ANCA</w>
(MPO ),</w>
(MPE P)</w>
(MP R)</w>
(MP EP;</w>
(MP C)</w>
(MO RE)</w>
(MMP I-2)</w>
(MMP I)</w>
(MMP -13)</w>
(MMP )-2</w>
(MM SE).</w>
(MM F).</w>
(MM C)-induced</w>
(MH b)</w>
(MH PG),</w>
(MF S),</w>
(METH ),</w>
(ME S).</w>
(ME P)</w>
(ME L)</w>
(ME L),</w>
(ME L
(ME K)</w>
(ME G)</w>
(ME F2C)</w>
(ME DLINE)</w>
(ME D</w>
(ME D
(MDR ).</w>
(MDR ),</w>
(MD I</w>
(MD I)</w>
(MD B)</w>
(MD A).</w>
(MCT D)</w>
(MCF P).</w>
(MC V)</w>
(MC P)</w>
(MC C)</w>
(MB C),</w>
(MB ),</w>
(MA PD)</w>
(MA PD).</w>
(MA HA)</w>
(MA HA),</w>
(MA BP),</w>
(MA )-induced</w>
(M: F=
(M y
(M ul
(M r</w>
(M otrin)</w>
(M obitz</w>
(M o
(M exitil-Perlongets)</w>
(M etra
(M ellar
(M ed
(M cClure</w>
(M ar
(M adop
(M a
(M Z
(M V
(M U)</w>
(M U
(M SSBP)</w>
(M SO),</w>
(M SA).</w>
(M S),</w>
(M RBC)</w>
(M R-33)</w>
(M PA-
(M PA).</w>
(M NP
(M N)</w>
(M N),</w>
(M MI).</w>
(M L
(M IT
(M IM
(M ILES)</w>
(M IC</w>
(M I,</w>
(M H),</w>
(M G).</w>
(M G),</w>
(M F)</w>
(M DS)</w>
(M CV),</w>
(M CR
(M CP
(M CNS)</w>
(M CD)</w>
(M CA).</w>
(M B,</w>
(M ACE
(M 3/M2).</w>
(M 25)</w>
(M 1-M5)</w>
(M 1).</w>
(M .S.)</w>
(M .</w>
(M ,</w>
(Li Cl),</w>
(Lami aceae)</w>
(LY3547 40),</w>
(LVE F</w>
(LVD P)</w>
(LVD P),</w>
(LV S:</w>
(LV D)</w>
(LT G)</w>
(LT BM
(LT B
(LT ),</w>
(LO CF)</w>
(LO C)</w>
(LNa+ LCa)</w>
(LNa+ HCa).</w>
(LM WH
(LM W-
(LM W)</w>
(LHR H-A)</w>
(LF T)</w>
(LE SS)</w>
(LD A)</w>
(L1- L2</w>
(L-NOAR G)</w>
(L-NO Arg;</w>
(L-N NA)</w>
(L-N IL;</w>
(L-DOPA ;</w>
(L- W)</w>
(L- OHP)</w>
(L- Arg)</w>
(L ys
(L upron)</w>
(L p)</w>
(L ong</w>
(L ioresal)</w>
(L in
(L gA)</w>
(L eguminosae),</w>
(L e
(L auraceae)</w>
(L aunois</w>
(L am
(L ZP)</w>
(L UTS)</w>
(L SP)</w>
(L S),</w>
(L RD)</w>
(L PS)-induced</w>
(L PS),</w>
(L PO),</w>
(L OD,</w>
(L Na),</w>
(L H-
(L F)</w>
(L Ent)</w>
(L EPs)</w>
(L CT)</w>
(L CL)</w>
(L C),</w>
(L BU
(L BNP)</w>
(L BBB)</w>
(L AD),</w>
(L A).</w>
(L 9'
(L 4-
(L 1,</w>
(L ,</w>
(L ),</w>
(L ))</w>
(Ki= 39</w>
(Ki= 237</w>
(Ki= 180</w>
(Keppra )</w>
(KY NA),</w>
(K v)</w>
(K i-
(K et)</w>
(K aplan-Mei
(K OP-
(K F</w>
(K CN
(K CH)</w>
(K A),</w>
(K (+)</w>
(J NK)</w>
(J ME)</w>
(Ins1 P)</w>
(Ins1 P),</w>
(In versine),</w>
(In tron</w>
(Ig )A</w>
(IV P)</w>
(IV ),</w>
(IT T)</w>
(IT S)</w>
(ISO ,</w>
(IS P)</w>
(IS P)-induced</w>
(IS A).</w>
(IP IMC).</w>
(IOR/OS- 3)</w>
(IOP)- lowering</w>
(IO P).</w>
(IO L)</w>
(INH ),</w>
(IN CI:</w>
(IN A)</w>
(IM L)</w>
(IM L),</w>
(IL- 3)</w>
(IL- 2)</w>
(IL -1)</w>
(IK r)</w>
(IK r).</w>
(IIE F)</w>
(IGF BP
(IF X).</w>
(IF X),</w>
(IF S)</w>
(IF N/
(ID M)</w>
(ID C).</w>
(IC V).</w>
(IC S)</w>
(IC I</w>
(IC Ds)</w>
(IC D)</w>
(IC 30)</w>
(IBIS- I)</w>
(I/ D)</w>
(I. D.</w>
(I- II)</w>
(I(Kr ))</w>
(I(Kr )),</w>
(I xoten
(I ssue</w>
(I s-
(I rb),</w>
(I m
(I g)</w>
(I T-
(I QR:</w>
(I Q),</w>
(I PSS),</w>
(I PR)</w>
(I PC),</w>
(I P</w>
(I OP</w>
(I MT)</w>
(I MMP)</w>
(I L-1</w>
(I HS</w>
(I HA).</w>
(I H)</w>
(I GF</w>
(I GE)</w>
(I ENF)</w>
(I E)</w>
(I DX
(I DR</w>
(I D)</w>
(I CA)</w>
(I CA).</w>
(I BM
(I )/II</w>
(I ).</w>
(I (f))</w>
(I (A
(Hol ter</w>
(Hc t)</w>
(HUS ),</w>
(HU VEC
(HSP 73)</w>
(HS PG)</w>
(HR s)</w>
(HR P)</w>
(HR ).</w>
(HPL C-
(HP F)</w>
(HP C)</w>
(HO CM)</w>
(HO -1)</w>
(HITT S)</w>
(HITT S).</w>
(HITT S),</w>
(HIT /T)</w>
(HF A),</w>
(HE P)</w>
(HDL- C)</w>
(HD T)</w>
(HD P)</w>
(HD M)</w>
(HD L),</w>
(HD I)</w>
(HD AC
(HCV )-infected</w>
(HCT Z).</w>
(HCF U),</w>
(HCF Cs)</w>
(HCC ).</w>
(HC P)</w>
(HBsAg -negative)</w>
(HBsAg -</w>
(HBsAg )-
(HBIg )</w>
(HB s</w>
(HB s)</w>
(HB c
(HB V</w>
(HB V),</w>
(HB SAG)</w>
(HB O2)</w>
(HB O)</w>
(HB F)</w>
(HAM-D-1 7)</w>
(HAM- D2
(HAM- D-21),</w>
(HAM- D
(HAM- A),</w>
(HAL )-induced</w>
(H2 O))</w>
(H2 )-receptor</w>
(H ypo
(H onour</w>
(H ismanal
(H ip-His-Leu</w>
(H gb)</w>
(H exabri
(H azard</w>
(H aemaccel)</w>
(H _E).</w>
(H Y
(H W)</w>
(H V</w>
(H UTT)</w>
(H T),</w>
(H S).</w>
(H PR)</w>
(H PH
(H PD)</w>
(H LA-
(H K-
(H IT</w>
(H I)</w>
(H I
(H F).</w>
(H EM,</w>
(H E-LFB,</w>
(H E),</w>
(H DM
(H DL)-cholesterol</w>
(H D</w>
(H D).</w>
(H D),</w>
(H CH)</w>
(H C),</w>
(H AS)</w>
(H AMD(17))</w>
(H A),</w>
(H 3K
(H 2</w>
(H 2)</w>
(H 1</w>
(H 1,</w>
(H 1)</w>
(H 1
(H /
(H +
(H )-
(Group- I,</w>
(GnR H</w>
(Gla uline)</w>
(Gd- DTPA)</w>
(Gd )-based</w>
(GTN ,</w>
(GTN )-induced</w>
(GT CSs)</w>
(GT C)</w>
(GST )]</w>
(GSH /
(GPR D).</w>
(GP s)</w>
(GO T),</w>
(GE PR-
(GD 1=plug</w>
(GC- MS)</w>
(GC- HT)</w>
(GC V)</w>
(GB S)</w>
(GB S).</w>
(GAM S)</w>
(GAM S),</w>
(GAD -65).</w>
(GABA) ergic</w>
(GABA(A )
(GABA ,</w>
(G6 PD)</w>
(G- 6-
(G ra
(G lycine</w>
(G lyT1)</w>
(G leev
(G i
(G er
(G T)</w>
(G SSG)</w>
(G SPE)</w>
(G SK
(G RIA
(G R),</w>
(G O)</w>
(G N)</w>
(G M</w>
(G LP
(G LI
(G LEPP1)</w>
(G H)</w>
(G H
(G ECs)</w>
(G DN
(G CH1)</w>
(G CF)</w>
(G C)</w>
(G APDH)</w>
(G AL-
(G AG)</w>
(G AD),</w>
(G A</w>
(G A)</w>
(Flu o
(Fig .</w>
(Fi bro
(Fe TMPyP)</w>
(FV S)</w>
(FV R)</w>
(FSG HS)</w>
(FS L)</w>
(FR L)</w>
(FM LP)</w>
(FK50 6)-induced</w>
(FK 506</w>
(FG S)</w>
(FG IN
(FD C</w>
(FD C)</w>
(F- J)</w>
(F(1, 26)=
(F rench</w>
(F in
(F c
(F as,</w>
(F ansidar).</w>
(F Z)</w>
(F Z),</w>
(F XII
(F S).</w>
(F PSA-Promethe
(F OS)</w>
(F M</w>
(F K-
(F ITC-albumin)</w>
(F H
(F G)</w>
(F EN).</w>
(F DPs)</w>
(F DA
(F CR),</w>
(F C
(F AS).</w>
(F AN)</w>
(F AD)</w>
(F ACT-Ntx)</w>
(F AC).</w>
(F AB)</w>
(F AB
(F 50:</w>
(F 100+N:</w>
(Epo R-
(Epo ).</w>
(En do
(ET V)</w>
(ET T)</w>
(ET -1),</w>
(ET (A
(ESW S)</w>
(ESR S)</w>
(ESR S).</w>
(ES M)</w>
(ERP F)</w>
(ER PF),</w>
(ER P),</w>
(ER N)</w>
(EP SE
(EO G),</w>
(ENa C).</w>
(ENa C)-dependent</w>
(EM S)</w>
(EM LA)</w>
(EM D</w>
(EH X
(EG Cs)</w>
(EG CG)</w>
(EF V)</w>
(EF S),</w>
(EF P)</w>
(EF :</w>
(EE ),</w>
(ED50= 0.3
(ED(50) =0.0
(ED TA),</w>
(ED SS)</w>
(ED ITS)</w>
(ED A),</w>
(ECE -1),</w>
(ECE -1
(EC R)</w>
(EC G).</w>
(EC F)</w>
(EC ASS</w>
(EC 50)</w>
(EC (50)</w>
(EAC )-bearing</w>
(EA AT3/EAAC1)</w>
(E)-2- benzylidene-4-phenyl-1,3-diselenole</w>
(E)- 6-methyl-2-styryl-
(E(2)17 G)</w>
(E(2)17 G),</w>
(E v
(E uhypnos)</w>
(E max)</w>
(E l
(E b
(E X)</w>
(E V)</w>
(E SP
(E RR</w>
(E PO
(E PA)</w>
(E ON)</w>
(E ME).</w>
(E L</w>
(E L)</w>
(E I
(E HDP)</w>
(E F),</w>
(E CL
(E B,</w>
(E B)</w>
(E AE)</w>
(E 8188).</w>
(E 13.5),</w>
(E /A</w>
(E /
(E -17G),</w>
(Dox orubicin)</w>
(Di amox).</w>
(Dex )</w>
(Dex ),</w>
(Depo- Medro
(Delta9-TH C)</w>
(Delta9-TH C),</w>
(Delta P)</w>
(Dec adurabol
(Daun oXome)</w>
(DZ R)</w>
(DZ R),</w>
(DZ P)</w>
(DZ P).</w>
(DX R</w>
(DTI s)</w>
(DSM- III)</w>
(DR G;</w>
(DR G).</w>
(DR D2)</w>
(DPO AEs)</w>
(DPCP X)</w>
(DP I),</w>
(DOPAC :DA</w>
(DOPAC ).</w>
(DO CA</w>
(DNQ X)</w>
(DN P-
(DN G)</w>
(DM SO),</w>
(DM CM)</w>
(DM )-induced</w>
(DLT s)</w>
(DL B).</w>
(DI AM)</w>
(DHE T)</w>
(DHE A)</w>
(DH S)</w>
(DH S),</w>
(DH PG)</w>
(DH AD)</w>
(DF U;</w>
(DF P)-induced</w>
(DF O-
(DF O).</w>
(DES)- related</w>
(DENA )-
(DEH P)</w>
(DE NA</w>
(DC X)</w>
(DBA/ 2</w>
(DB P),</w>
(DB B)</w>
(DAT (-/-))</w>
(D-pen )</w>
(D- AMPH
(D y
(D x)</w>
(D ur
(D unnett,</w>
(D ormicum)</w>
(D opamine</w>
(D esfer
(D epo
(D ef
(D e
(D betaH)</w>
(D a
(D W)</w>
(D TI)</w>
(D TG)</w>
(D T)</w>
(D S),</w>
(D S
(D PP
(D PI
(D PH).</w>
(D PH),</w>
(D P),</w>
(D NR)-containing</w>
(D NP)</w>
(D NA</w>
(D NA
(D MSO)</w>
(D MD)</w>
(D M-938
(D M).</w>
(D LT).</w>
(D L-
(D L)</w>
(D K
(D IPS)</w>
(D ID)</w>
(D HB)</w>
(D H),</w>
(D ER
(D D)</w>
(D Cs)</w>
(D CM
(D CE-
(D CA)</w>
(D ARPP-32)</w>
(D A</w>
(D A).</w>
(D :</w>
(D 5
(D 3)</w>
(D 1</w>
(D -P
(Cy A/
(Cy A),</w>
(CsA)- based</w>
(Cs A:</w>
(Coumad in).</w>
(Cor darone</w>
(Coomb 's</w>
(CoQ 10)</w>
(Clinor il)</w>
(Clinor il).</w>
(Clinor il),</w>
(Clin ical</w>
(Cl T)</w>
(Ch ild</w>
(CaCl (2)
(CaCl(2) )-induced</w>
(Ca(2+) ATPase)</w>
(Ca elyx)</w>
(Ca 2+)</w>
(Ca (2+)</w>
(CZ P),</w>
(CYP )
(CY P),</w>
(CX 3CR
(CV VHDF).</w>
(CV P),</w>
(CV AD)</w>
(CV A)</w>
(CV ),</w>
(CTR L)</w>
(CT A)</w>
(CT A),</w>
(CS SA),</w>
(CS S),</w>
(CRF ).</w>
(CR p)</w>
(CR T)</w>
(CR LR)</w>
(CR H)</w>
(CR F-
(CPK ,</w>
(CPK )],</w>
(CPD G2)</w>
(CP Z)-induced</w>
(CP P,</w>
(CP L)</w>
(CP K</w>
(CP EC)</w>
(CO Cs).</w>
(CO C)</w>
(CO 2),</w>
(CN Q
(CM RO2)</w>
(CM Gs)</w>
(CM F)]</w>
(CM F).</w>
(CM )-induced</w>
(CLO Z)</w>
(CL P)</w>
(CL O)</w>
(CL D).</w>
(CL )</w>
(CK- MB</w>
(CIP S)</w>
(CIP S):</w>
(CIP N).</w>
(CI s),</w>
(CI P),</w>
(CI MD),</w>
(CI :</w>
(CI )=
(CHEOP S).</w>
(CH F</w>
(CH F)]</w>
(CH A)</w>
(CH A),</w>
(CH 2O</w>
(CGI- SF;</w>
(CGI- S)</w>
(CGI- I),</w>
(CFU- GM)</w>
(CF Cs).</w>
(CF C)</w>
(CF A),</w>
(CD H)</w>
(CD C</w>
(CD 86+)</w>
(CD 50</w>
(CD 50),</w>
(CD 45
(CD 18
(CCl 4).</w>
(CCO- IV</w>
(CCO- I)</w>
(CCNU ),</w>
(CCB )</w>
(CCB ).</w>
(CCB ),</w>
(CC Q).</w>
(CBD CA),</w>
(CB Z
(CB V)</w>
(CB IR).</w>
(CB F,</w>
(CB D),</w>
(CB -1
(CB )-,</w>
(CB (1))</w>
(CAT S)</w>
(CAR DI
(CAR ),</w>
(CAP ),</w>
(CAL GB)</w>
(CAB )-induced</w>
(CA S)</w>
(CA RE
(CA F).</w>
(CA E)</w>
(CA ACS)</w>
(CA 4),</w>
(CA 1)</w>
(C u)</w>
(C u
(C tr
(C ricetulus</w>
(C rataegus</w>
(C r</w>
(C pss)</w>
(C p
(C ox
(C ore</w>
(C ompa
(C ol
(C ochran
(C ocE)</w>
(C max),</w>
(C i
(C hr.
(C hr)</w>
(C h),</w>
(C er
(C e)</w>
(C e
(C ardiox
(C a</w>
(C a-
(C ZP)</w>
(C V-
(C U
(C TN)</w>
(C TD).</w>
(C T),</w>
(C SPS</w>
(C SE,</w>
(C SA</w>
(C S),</w>
(C RP
(C RE
(C R-
(C R,</w>
(C PT),</w>
(C PB).</w>
(C PAP)</w>
(C PA/EE)</w>
(C P</w>
(C P,</w>
(C P).</w>
(C NP)</w>
(C M).</w>
(C M),</w>
(C IC
(C I-
(C I).</w>
(C GP42112
(C E)</w>
(C E),</w>
(C DP)-induced</w>
(C CT)</w>
(C CR
(C CO),</w>
(C CI-779)</w>
(C CI
(C CD)</w>
(C C).</w>
(C B)</w>
(C AN)</w>
(C AI),</w>
(C AD
(C 57)</w>
(C 2-cer
(C 1)</w>
(C (max))</w>
(Bu )
(Botox ).</w>
(Bas d</w>
(BZD s/RDs)</w>
(BZD s)</w>
(BZD s).</w>
(BW W)</w>
(BSI F)</w>
(BSI ),</w>
(BSC -1),</w>
(BR R)</w>
(BR L</w>
(BP H)</w>
(BM PR
(BM Cs)</w>
(BM C),</w>
(BF V)</w>
(BD Z)</w>
(BD I)</w>
(BCh Es).</w>
(BCh E)</w>
(BCh E),</w>
(BCNU )]</w>
(BCNU ),</w>
(BCA A)</w>
(BB R</w>
(BA PTA-AM</w>
(B rugad
(B rown</w>
(B rof
(B rodmann</w>
(B max</w>
(B lood.</w>
(B i
(B e
(B cl
(B act
(B Z)</w>
(B W</w>
(B V)</w>
(B U)</w>
(B TX).</w>
(B T)</w>
(B SO;</w>
(B SA)</w>
(B S</w>
(B S-
(B RLP-
(B RE)</w>
(B R</w>
(B R)</w>
(B PS)3</w>
(B PRS</w>
(B PO-PLL),</w>
(B PD)</w>
(B N)</w>
(B N
(B LA)</w>
(B IS,</w>
(B IA</w>
(B HT),</w>
(B HR)</w>
(B HA),</w>
(B H)</w>
(B ES)</w>
(B E),</w>
(B E
(B CP)</w>
(B CL)-induced</w>
(B CC),</w>
(B ALB/
(B AL)</w>
(B AER
(B A</w>
(B 6
(B (max)</w>
(Augment in)</w>
(Augment in).</w>
(Augment in)-induced</w>
(Arfonad )</w>
(Ara G)</w>
(Ara C)</w>
(Antabuse )</w>
(Ang ptl
(Am p
(Adriamyc in),</w>
(Adriamyc in
(Ad 2/CM
(Ab bott</w>
(Ab 3).</w>
(AZ T),</w>
(AV P).</w>
(AU C-
(ATR A).</w>
(ATR A),</w>
(ATP ase)</w>
(AT C,</w>
(AT 2)</w>
(AT ),</w>
(AST -120)</w>
(ASE X)</w>
(ASE X),</w>
(AS A-
(AS A,</w>
(ARF ;</w>
(AR I).</w>
(AR DS).</w>
(AR CCS)</w>
(AR A-
(AR ;</w>
(AR ).</w>
(APT T)</w>
(API SE),</w>
(AP H)</w>
(AP C)</w>
(AP 7)</w>
(AP 3)</w>
(AO R)</w>
(ANOV A,</w>
(ANCA ).</w>
(AN P),</w>
(AN H)</w>
(AN A)</w>
(AN ).</w>
(AN ),</w>
(AM PA
(AM LEt)</w>
(AM HS).</w>
(AM G).</w>
(ALLH AT)</w>
(AL S)</w>
(AL P)</w>
(AL P),</w>
(AL N+
(AL F),</w>
(AL C)</w>
(AL A),</w>
(AK BR,</w>
(AIM s),</w>
(AIM S).</w>
(AIDS)- related</w>
(AID S),</w>
(AI d)</w>
(AI MS</w>
(AI MAH)</w>
(AH SCT).</w>
(AFB 1,</w>
(AF P)</w>
(AF M)</w>
(AF L)</w>
(AED ).</w>
(AED ),</w>
(AEC M)</w>
(AEC A)</w>
(AE A),</w>
(ADR AC)</w>
(ADR +
(AD X)</w>
(AD R</w>
(AD HD),</w>
(AD AM),</w>
(ACh Is)</w>
(ACh Es)</w>
(ACS :180SE)</w>
(ACEi ;</w>
(ACEi )</w>
(AC T),</w>
(AC S</w>
(AC PT
(AC E-I)</w>
(AC C).</w>
(AC A)</w>
(AC -
(AC ),</w>
(AB V)</w>
(AB T</w>
(AB Rs)</w>
(AB PM)</w>
(AB LC
(AAP :</w>
(A trium
(A to)</w>
(A straZeneca,</w>
(A spir
(A quifoliaceae)</w>
(A o)</w>
(A merican</w>
(A m</w>
(A ley</w>
(A g)</w>
(A dri
(A ch)</w>
(A Y-23,0
(A X)</w>
(A VRT)</w>
(A TN)</w>
(A SP)</w>
(A SI).</w>
(A SA
(A S/KS</w>
(A S),</w>
(A RT).</w>
(A R),</w>
(A PH),</w>
(A PC).</w>
(A PA),</w>
(A O)</w>
(A NGPTL4,</w>
(A MPT)</w>
(A MI)-induced</w>
(A ME)</w>
(A MB
(A M),</w>
(A L</w>
(A L).</w>
(A IP)</w>
(A II
(A I)</w>
(A G),</w>
(A F).</w>
(A E),</w>
(A DNFLE)</w>
(A D</w>
(A C</w>
(A A
(A 10</w>
(A ),</w>
(A (1)/A(2A)</w>
(> 90%)</w>
(> 75%</w>
(> 65</w>
(> 60%)</w>
(> 4</w>
(> 40</w>
(> 20</w>
(> 200</w>
(> 2.4</w>
(> 1.0</w>
(< or=</w>
(< 90</w>
(< 90%)</w>
(< 65</w>
(< 60</w>
(< 50%</w>
(< 10%</w>
(< /
(99m )Tc-
(95% CI,</w>
(9/ 30)</w>
(9/ 12,</w>
(9. 9</w>
(9. 9%)</w>
(9. 7</w>
(9. 7%</w>
(9. 7%),</w>
(9. 6</w>
(9. 3%;</w>
(9. 3%)</w>
(9. 1%)</w>
(9. 1%),</w>
(9. 0%</w>
(9 8%</w>
(9 7%).</w>
(9 5%).</w>
(9 5%),</w>
(9 4.4%)</w>
(9 4%),</w>
(9 3.3</w>
(9 3%).</w>
(9 2.0</w>
(9 2%</w>
(9 0.6%)</w>
(9 0-
(9 0%),</w>
(9 ,</w>
(9 ,
(8R,15S)-di hydroxyeicosa-(5,
(8R,15S)- dihydroxyicosa(5E-9,11,13Z)tetraenoic</w>
(89. 1%)</w>
(89. 1%),</w>
(86. 7%)</w>
(86. 2%).</w>
(85. 7%)</w>
(8/ 9)</w>
(8/ 8)</w>
(8/ 8),</w>
(8. 9</w>
(8. 8</w>
(8. 8%)</w>
(8. 7%</w>
(8. 6%)</w>
(8. 51-16.0)</w>
(8. 4%)</w>
(8. 3%</w>
(8. 3%)</w>
(8. 3%),</w>
(8. 2%)</w>
(8-OH-DPA T).</w>
(8- cyclopentyl
(8- PT)</w>
(8- 25)</w>
(8- (noradamantan-3-yl)-1,3-dipropylxanthine),</w>
(8 9,</w>
(8 9%),</w>
(8 8.5</w>
(8 8.3</w>
(8 8)</w>
(8 8%</w>
(8 70</w>
(8 7.4</w>
(8 6%);</w>
(8 40</w>
(8 3.3%)</w>
(8 3%</w>
(8 20</w>
(8 2%),</w>
(8 1.3%</w>
(8 0.0%)</w>
(8 0-160</w>
(8 0-
(8 0)</w>
(8 -1
(79. 4%</w>
(76. 6%;</w>
(75- 300</w>
(7/ 21)</w>
(7/ 14,</w>
(7. 9</w>
(7. 9%</w>
(7. 8%</w>
(7. 8%),</w>
(7. 8
(7. 7%</w>
(7. 7%).</w>
(7. 5,</w>
(7. 5%).</w>
(7. 4%</w>
(7. 3</w>
(7. 3%</w>
(7. 3%),</w>
(7. 1%</w>
(7. 1%),</w>
(7. 0%)</w>
(7-methyl coumaran-3-yl)
(7- day)</w>
(7- 49</w>
(7 days)</w>
(7 9.5%</w>
(7 9.4</w>
(7 9%,</w>
(7 9%).</w>
(7 8.
(7 6%</w>
(7 6%).</w>
(7 5/
(7 5.
(7 5%</w>
(7 5%,</w>
(7 3.3%)</w>
(7 3%,</w>
(7 3%).</w>
(7 2%;</w>
(7 1%</w>
(7 00</w>
(7 0%;</w>
(7 0
(7 ).</w>
(7 %);</w>
(69. 8%)</w>
(68. 8%)</w>
(67. 7%)</w>
(65. 5%)</w>
(65. 4%),</w>
(60-1 000</w>
(6/ 8),</w>
(6. 8</w>
(6. 6%)</w>
(6. 5%)</w>
(6. 5%).</w>
(6. 3</w>
(6. 3%</w>
(6. 25</w>
(6. 25,</w>
(6. 1</w>
(6. 1%),</w>
(6. 0
(6-OHDA)- lesioned</w>
(6- week-old</w>
(6- n-propyl-
(6- month-
(6- 8</w>
(6 R,7R)-
(6 J)</w>
(6 ByJ)</w>
(6 9.9</w>
(6 8/
(6 8%,</w>
(6 6.7</w>
(6 6%</w>
(6 5.0%</w>
(6 5-
(6 5%).</w>
(6 48</w>
(6 4.3%</w>
(6 4%).</w>
(6 32.8</w>
(6 3.6%</w>
(6 3%);</w>
(6 2,</w>
(6 2%),</w>
(6 17</w>
(6 1)</w>
(6 1%),</w>
(6 0/
(6 0%),</w>
(6 ).</w>
(6 %,</w>
(59. 4%)</w>
(56. 5%)</w>
(56. 3+/-
(55. 7%)</w>
(55. 6%)</w>
(55. 5%)</w>
(55. 2%)</w>
(54. 8%)</w>
(53. 8%)</w>
(53- 3029)</w>
(52. 9%</w>
(52. 7%).</w>
(52. 5%)</w>
(52. 5%).</w>
(51. 6%)</w>
(51. 2%),</w>
(51)Cr -labeled</w>
(500/ 125</w>
(500 microg,</w>
(50- 3
(50 2</w>
(50 /
(50 -150</w>
(50 ),</w>
(5/ 8)</w>
(5/ 7)</w>
(5. 9%</w>
(5. 7+/-
(5. 6%)</w>
(5. 6%).</w>
(5. 6%),</w>
(5. 5%</w>
(5. 41</w>
(5. 4%</w>
(5. 3</w>
(5. 2%),</w>
(5. 1%)</w>
(5. 0%</w>
(5-nitro- 6,7-
(5-hydroxytrypt amine;</w>
(5-HT P)</w>
(5-HT 4</w>
(5-HT 3</w>
(5-HT 2C</w>
(5-HT 2</w>
(5-HT 1A)</w>
(5-HT ,</w>
(5-HT )]</w>
(5-HT (6
(5-HT (3
(5-HT(3 ))</w>
(5-FU ,</w>
(5-FU )-related</w>
(5-F C)</w>
(5- ht7?),</w>
(5- chloro-7-iodo-8-hydroxyquinoline)</w>
(5- LO)</w>
(5- ASA</w>
(5- 8</w>
(5- 40</w>
(5,7-DH T),</w>
(5,7- DCK
(5, 659</w>
(5'- dF
(5 mg/kg</w>
(5 mg/kg)</w>
(5 mg/kg),</w>
(5 ;</w>
(5 9.0</w>
(5 9-
(5 88</w>
(5 76</w>
(5 7/
(5 7
(5 6%),</w>
(5 50</w>
(5 5-
(5 5%-
(5 4.7</w>
(5 4%),</w>
(5 3%,</w>
(5 3%),</w>
(5 26</w>
(5 2.5</w>
(5 0.0%),</w>
(5 )]enkephalin</w>
(5 ).</w>
(5 %,</w>
(49. 1%)</w>
(48. 8%),</w>
(48. 7)</w>
(47. 4%)</w>
(45- 0088-S),</w>
(44. 4%)</w>
(44. 1%)</w>
(42. 9%)</w>
(42. 6%).</w>
(42. 5%)</w>
(42. 2%)</w>
(40- 50</w>
(4/ 8),</w>
(4/ 5)</w>
(4. 8%);</w>
(4. 7)</w>
(4. 7)%</w>
(4. 6%</w>
(4. 4%)</w>
(4. 3)</w>
(4. 24</w>
(4. 0
(4-fluorophenyl methyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)</w>
(4-chlorophenyl)-1- (2,4-dichloro
(4-chlorophenyl)- 2beta-[3-
(4-chloro phenyl
(4-amino phenyl)-8,9-dihydro-8-methyl-7H-1,3-di
(4-OH- CB
(4-D AMP;</w>
(4-1 6)</w>
(4- week-old</w>
(4- week-old)</w>
(4- morpholin
(4- hydroxy</w>
(4- en-VPA),</w>
(4, 3-
(4'- methyl
(4'- deoxy
(4'- chloro
(4 th</w>
(4 mg/kg)</w>
(4 H)-
(4 92</w>
(4 8%).</w>
(4 5,</w>
(4 5%).</w>
(4 4-
(4 4+/-
(4 4%,</w>
(4 28</w>
(4 2%).</w>
(4 1.7%)</w>
(4 1.5</w>
(4 1%,</w>
(4 1%).</w>
(4 03</w>
(4 0.6%)</w>
(4 0.4%)</w>
(4 0.2%)</w>
(4 0-120</w>
(4 -12</w>
(4 +)</w>
(4 );</w>
(4 %;</w>
(3beta- (4-chlorophenyl)-2beta-[3-
(3alpha-hydroxy- 5beta-pregnan-20-one)</w>
(3alpha-hydroxy- 5alpha-pregnan-20-one),</w>
(39. 7%).</w>
(38. 6%,</w>
(38. 6%)</w>
(38. 5%)</w>
(38. 5%),</w>
(38. 2%)</w>
(37. 8%)</w>
(36. 5%)</w>
(34. 3%).</w>
(33. 67</w>
(33. 1%</w>
(32. 2-62.0)</w>
(31. 9%)</w>
(31. 5%).</w>
(31. 2%),</w>
(30-1 000</w>
(30- 60</w>
(30- 60),</w>
(30- 50</w>
(3/ 8)</w>
(3/ 5)</w>
(3/ 4),</w>
(3.5- 5.4</w>
(3.5- 350</w>
(3.2 -100</w>
(3. 9%</w>
(3. 9%)</w>
(3. 84</w>
(3. 8%</w>
(3. 75-
(3. 75,</w>
(3. 67</w>
(3. 51</w>
(3. 5%)</w>
(3. 46</w>
(3. 40</w>
(3. 4+/-
(3. 3%</w>
(3. 3%).</w>
(3. 2%)</w>
(3. 1,</w>
(3. 1%</w>
(3. 1%).</w>
(3- h</w>
(3- fold)</w>
(3- OH
(3- NT),</w>
(3- NP)</w>
(3- Br-7-
(3- 8)</w>
(3- 6</w>
(3- -100</w>
(3,4- dimethoxy
(3,4- dichloro
(3,4- DAP)</w>
(3, 7-dimethyl-1-propargylxanthine)</w>
(3, 4</w>
(3)H- haloperidol</w>
(3'- azido-2',3'-deoxythymidine;</w>
(3 x15</w>
(3 alpha-tropyl</w>
(3 alpha,5alpha-THP)</w>
(3 S-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane),</w>
(3 R-1-[2-(3,4-dichlorophenyl)ethyl]-1,4-diazabicyclo[4.3.0]nonane)</w>
(3 MA),</w>
(3 90</w>
(3 9.4</w>
(3 9.2</w>
(3 9%),</w>
(3 88</w>
(3 8%;</w>
(3 7.4</w>
(3 7)</w>
(3 7%),</w>
(3 6.1</w>
(3 6%;</w>
(3 56</w>
(3 52</w>
(3 50-450</w>
(3 5,</w>
(3 5%);</w>
(3 5
(3 4/45)</w>
(3 4%,</w>
(3 36</w>
(3 30</w>
(3 3/
(3 3.8</w>
(3 3%;</w>
(3 28</w>
(3 2%;</w>
(3 2%,</w>
(3 2%).</w>
(3 18</w>
(3 13</w>
(3 1.6%</w>
(3 1.5</w>
(3 1.3</w>
(3 1)</w>
(3 0/
(3 0.8%),</w>
(3 0.5%)</w>
(3 0.4%),</w>
(3 0.0%),</w>
(3 -11</w>
(3 -1
(3 ,000</w>
(3 ).</w>
(2S, 1'S,2'S)-2-(
(2R,4R)- APDC</w>
(29. 2%)</w>
(28 9/323)</w>
(27. 9</w>
(27. 9%)</w>
(27. 8%)</w>
(27. 8%),</w>
(27. 6</w>
(27- 81</w>
(26. 8%),</w>
(26. 7%),</w>
(26. 1%)</w>
(26 5.2</w>
(250- 500</w>
(250- 300</w>
(25/ 200</w>
(25. 9%</w>
(25. 4%)</w>
(25. 0%)</w>
(25- 30</w>
(25 mg/kg,</w>
(25 %-
(24- months-old)</w>
(23. 9%)</w>
(23. 7%)</w>
(23. 5%)</w>
(23. 4%)</w>
(22. 7%)</w>
(22. 0%)</w>
(21. 3%)</w>
(21- day-old)</w>
(200 mg/kg,</w>
(200 mg/kg)</w>
(200 2-
(200 0-200
(200 -1200</w>
(20/ 4
(20- 40</w>
(20- 30%)</w>
(20- 22</w>
(20- -50</w>
(20 mgkg(-1)day(-1));</w>
(20 2-
(2/ 8),</w>
(2/ 33)</w>
(2.5- 5</w>
(2.0- 4.0</w>
(2.0 6</w>
(2.0 )</w>
(2. 9)</w>
(2. 9%</w>
(2. 9%;</w>
(2. 9%),</w>
(2. 8-8.3</w>
(2. 8%),</w>
(2. 76</w>
(2. 75</w>
(2. 6)</w>
(2. 58</w>
(2. 54</w>
(2. 5%);</w>
(2. 5%).</w>
(2. 4%).</w>
(2. 37</w>
(2. 35</w>
(2. 3-
(2. 3,</w>
(2. 3%</w>
(2. 25</w>
(2. 2-22</w>
(2. 2%),</w>
(2. 16</w>
(2. 15</w>
(2. 1%).</w>
(2- year-old</w>
(2- wk.</w>
(2- hydroxylamino-5-ethyl-5-
(2- DG
(2- CP)</w>
(2- AG)</w>
(2- 32</w>
(2- 3-fold)</w>
(2- 24</w>
(2,5-dimethoxy-4-iodophenyl)-2-amino propane</w>
(2, 44)</w>
(2, 4,2',4'-
(2, 3
(2, 250</w>
(2)- selective')</w>
(2'- fluoro-2',3'-
(2 ml/kg)</w>
(2 mg/kg)</w>
(2 b-
(2 S,3
(2 R,3R)-dihydroxybutanedioate</w>
(2 PAM)</w>
(2 K1C-eNOS</w>
(2 D
(2 :1</w>
(2 98+/-7</w>
(2 95</w>
(2 9-
(2 9),</w>
(2 83</w>
(2 80-
(2 8-
(2 8%,</w>
(2 8%);</w>
(2 76</w>
(2 7/10</w>
(2 7.3</w>
(2 7)</w>
(2 7%;</w>
(2 7%,</w>
(2 60,</w>
(2 6.4</w>
(2 54</w>
(2 53</w>
(2 5.3</w>
(2 5%,</w>
(2 5%
(2 47</w>
(2 40-
(2 40%</w>
(2 4.8</w>
(2 4.2%</w>
(2 4-h</w>
(2 36</w>
(2 31</w>
(2 30</w>
(2 300</w>
(2 3.3%</w>
(2 3)</w>
(2 3),</w>
(2 2/
(2 2.5</w>
(2 2.5-
(2 2
(2 13</w>
(2 12</w>
(2 1.7</w>
(2 1.6</w>
(2 1.0</w>
(2 0.9%)</w>
(2 0.8%);</w>
(2 0.7%)</w>
(2 0.5%)</w>
(2 0.4%).</w>
(2 0-1
(2 0%,</w>
(2 -</w>
(2 ,000-
(2 ',3'-
(1S,3R,4S)-1- aminocyclo-pentane-1,3,4-tricarboxylic</w>
(1R,3 S-AC
(1H)-quinol inone</w>
(1:200,00 0),</w>
(1: 3,</w>
(1: 3)</w>
(1: 3).</w>
(1: 20),</w>
(1: 100,000).</w>
(199 6)</w>
(199 5-96),</w>
(199 4-199
(199 3-
(199 3)</w>
(199 2-1994)</w>
(199 2)</w>
(199 1)</w>
(199 0-
(1980- January</w>
(1966- July</w>
(1966- 2001),</w>
(19. 5%).</w>
(19. 3%).</w>
(19- NTPP)</w>
(19 8</w>
(19 87)</w>
(19 4</w>
(19 3.8</w>
(19 2%)</w>
(19 %,</w>
(18. 7%)</w>
(18. 4%).</w>
(18 )
(17. 7%</w>
(17. 5%</w>
(17. 3%)</w>
(17. 3%),</w>
(17. 2%</w>
(17. 1%</w>
(17 5-
(16. 8</w>
(16. 8%)</w>
(16. 7%</w>
(16. 6</w>
(16. 3</w>
(16 ,23-
(15. 9%).</w>
(15. 8%)</w>
(15. 7%</w>
(15. 6%),</w>
(15. 4</w>
(15. 2%)</w>
(15- min</w>
(15- 60</w>
(15 mg/kg/day,</w>
(15 %);</w>
(14. 8%</w>
(14. 7)</w>
(14. 7%)</w>
(14. 6%)</w>
(14. 5%).</w>
(14. 3%)</w>
(14. 2%)</w>
(14. 0%)</w>
(14)C- urea</w>
(14)C- acetate</w>
(14)C- 2DG</w>
(14) CO(2)</w>
(14 %;</w>
(13. 8%)</w>
(13. 8%),</w>
(13. 4%)</w>
(13. 1%).</w>
(13- cis-RA)</w>
(125 I-
(125 -150</w>
(12/ 25)</w>
(12/ 14)</w>
(12. 9%</w>
(12. 9%)</w>
(12. 9%).</w>
(12. 8-
(12. 5%),</w>
(12. 4%),</w>
(12. 3%)</w>
(12. 3%),</w>
(12- 24</w>
(12- 20</w>
(11. 7)</w>
(11. 3%).</w>
(11. 1%</w>
(11)C- CNS</w>
(11 %-1
(100- 500</w>
(100- 300</w>
(100 -120</w>
(100 -1000</w>
(10/ 29)</w>
(10. 7%</w>
(10. 4%)</w>
(10. 3%)</w>
(10. 2)</w>
(10- week-old</w>
(10- s</w>
(10- day)</w>
(10- 25</w>
(10- 200</w>
(10(-6) -10(-3)</w>
(10(-10 )-
(10(- 9)</w>
(10(- 7)</w>
(10 mg/kg).</w>
(10 60</w>
(10 4)</w>
(10 2</w>
(10 -16</w>
(10 -14</w>
(10 )
(10 %;</w>
(1/ 2,z)</w>
(1.8 3,</w>
(1.8 )%</w>
(1.4 6%)</w>
(1.25- 20.0</w>
(1.25 -10</w>
(1.2- 2.4</w>
(1.17 %-
(1.17%- 6.44%)</w>
(1.0 63-1.210</w>
(1.0 4</w>
(1.0 -1.5</w>
(1. 98</w>
(1. 91</w>
(1. 88</w>
(1. 87</w>
(1. 83</w>
(1. 8%),</w>
(1. 79%-7.68%)</w>
(1. 76</w>
(1. 7%;</w>
(1. 7%).</w>
(1. 7%),</w>
(1. 67+/-
(1. 6%</w>
(1. 6%).</w>
(1. 55</w>
(1. 5%).</w>
(1. 45+/-
(1. 4%;</w>
(1. 30-
(1. 3,</w>
(1. 3%</w>
(1. 3%),</w>
(1. 28</w>
(1. 25,</w>
(1. 25%</w>
(1. 24</w>
(1. 2),</w>
(1. 19-
(1. 18</w>
(1. 16</w>
(1. 10</w>
(1. 00</w>
(1-7 ))</w>
(1-1 3).</w>
(1-1 000</w>
(1- {[(cyanoimino)(5-quinolinylamino)</w>
(1- methyl-4-
(1- imino
(1- h)</w>
(1- [2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine),</w>
(1- M
(1- 60</w>
(1- 3)</w>
(1- 20</w>
(1,3- di
(1,3- bis-(2-chloroethyl)-1-nitrosourea),</w>
(1,3,3- trimethyl-2-ox
(1, 800</w>
(1)/ M(3)/M(5)-selective'),</w>
(1)- selective')</w>
(1)- H</w>
(1 x</w>
(1 st</w>
(1 mg/kg/day,</w>
(1 mg/kg,</w>
(1 S,3R-ACPD),</w>
(1 R,2S-(+)-cis-N-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamine).</w>
(1 R,
(1 91</w>
(1 9.5</w>
(1 9.0</w>
(1 85</w>
(1 800</w>
(1 80-200</w>
(1 8.9</w>
(1 8-OH-DOC)</w>
(1 76</w>
(1 72</w>
(1 700</w>
(1 7.4</w>
(1 7.0</w>
(1 7)</w>
(1 64</w>
(1 62</w>
(1 600</w>
(1 6.1</w>
(1 6,</w>
(1 6)</w>
(1 572-370
(1 55</w>
(1 52</w>
(1 50,</w>
(1 5.8</w>
(1 5.6</w>
(1 5-1
(1 5,
(1 5).</w>
(1 43</w>
(1 41</w>
(1 4.9</w>
(1 4.7</w>
(1 4.2</w>
(1 4-
(1 32</w>
(1 31</w>
(1 300</w>
(1 3.5</w>
(1 3.3</w>
(1 3.2</w>
(1 3-1
(1 3),</w>
(1 3%;</w>
(1 2;</w>
(1 2:12)</w>
(1 24</w>
(1 24,</w>
(1 23
(1 22)</w>
(1 21)</w>
(1 2.7</w>
(1 2.2</w>
(1 2-16</w>
(1 2,</w>
(1 2),</w>
(1 18</w>
(1 16</w>
(1 14</w>
(1 12.5</w>
(1 1.4</w>
(1 1.2</w>
(1 1-1
(1 0.8</w>
(1 -</w>
(1 --
(1 ,000
(1 )=
(1 );</w>
(1 %),</w>
(0.8 8-
(0.8 7,</w>
(0.8 3,</w>
(0.7 5-6</w>
(0.7 5-6.0</w>
(0.7 5,</w>
(0.7 5%)</w>
(0.5- 50</w>
(0.5- 47.5</w>
(0.5- 2.0</w>
(0.5- 0.7</w>
(0.5 microg/rat)</w>
(0.5 -1.0</w>
(0.3- 1</w>
(0.3 75</w>
(0.3 -1.2</w>
(0.3 -1.0</w>
(0.25- 1</w>
(0.25 -1.5</w>
(0.2- 0.9)</w>
(0.2- 0.3</w>
(0.2 -1.0</w>
(0.1-1 00</w>
(0.1- 3.2</w>
(0.1- 0.5</w>
(0.1 mg/kg),</w>
(0.06- 2</w>
(0.05- 0.2</w>
(0.05- 0.25</w>
(0.05 -1.0</w>
(0.03- 0.1</w>
(0.01- 30</w>
(0.01- 1</w>
(0.01- 0.02</w>
(0.00 32-
(0.0 625</w>
(0.0 5%</w>
(0.0 18</w>
(0.0 15</w>
(0.0 1-10</w>
(0.0 1-100</w>
(0.0 1-1
(0. 97</w>
(0. 96</w>
(0. 94</w>
(0. 92</w>
(0. 9,</w>
(0. 86</w>
(0. 86+/-
(0. 81</w>
(0. 8%</w>
(0. 8%,</w>
(0. 8%).</w>
(0. 8%),</w>
(0. 78</w>
(0. 75
(0. 7-
(0. 7%</w>
(0. 7%),</w>
(0. 675</w>
(0. 66%</w>
(0. 62</w>
(0. 625</w>
(0. 60</w>
(0. 6-1.
(0. 54</w>
(0. 51</w>
(0. 5-15</w>
(0. 5%</w>
(0. 5%,</w>
(0. 5%).</w>
(0. 48
(0. 47</w>
(0. 47,</w>
(0. 42</w>
(0. 36</w>
(0. 34%),</w>
(0. 32
(0. 30</w>
(0. 30-
(0. 3%).</w>
(0. 3%),</w>
(0. 29</w>
(0. 27</w>
(0. 25%</w>
(0. 23</w>
(0. 21-
(0. 2%</w>
(0. 2%),</w>
(0. 19,</w>
(0. 18-
(0. 18
(0. 167-4.5</w>
(0. 16-
(0. 15-
(0. 15%)</w>
(0. 14-1.
(0. 135</w>
(0. 125-
(0. 12-
(0. 10+/-
(0. 1%).</w>
(0-1 00)</w>
(0- 9.88)</w>
(0- 5</w>
(0- 30);</w>
(0- 270</w>
(0- 220</w>
(0- 200</w>
(0- 2.0</w>
(0- 0.3</w>
(0 =
(0 -</w>
(0 -10</w>
(0 -1.5</w>
(0 %;</w>
(0 %-
(. 4</w>
(-4 3%),</w>
(-3 2%)</w>
(-1 6%</w>
(-1 4</w>
(-1 0</w>
(-1 0)</w>
(-1 ).
(-)- propranolol</w>
(-)- propranolol.</w>
(-)- enantiomer
(-)- deprenyl</w>
(-)- baclofen</w>
(-)- adrenaline.</w>
(-)- (S)-
(-) isoproterenol</w>
(-) epigallocatechin</w>
(-) -11-OH-delta</w>
(-) (1)</w>
(- dp/dt
(- dP/dt(max))</w>
(- 56%,</w>
(- 48</w>
(- 46.
(- 40%)</w>
(- 4.4</w>
(- 30</w>
(- 3.4</w>
(- 20</w>
(- 2.9</w>
(- 0.5</w>
(- 0.0
(+5 5%)</w>
(+/-)-1- (2,5-dimethoxy-4-iodophenyl)-2-aminopropane</w>
(+/-)- tramadol,</w>
(+/-)- m-nitrophenyl-3-piperidin
(+/-)- baclofen's</w>
(+/-)- Baclofen</w>
(+/-)- 2-amino-7-phosphonoheptanoate,</w>
(+/-) CPP</w>
(+/-) 3,4-methylenedioxyamphetamine</w>
(+/- SE)</w>
(+/- 7.
(+/- 3.
(+/- ))</w>
(+)-PH NO</w>
(+)-PH NO.</w>
(+)-PD-128, 907,</w>
(+)-5-methyl-10,11-dihydro-5H-dibenzo(a,d )cycloheptan-5,10-imine</w>
(+)-5-methyl-10,11-dihydro-5H-dibenzo(a,d )-cyclohepten-5,10-imine</w>
(+)-2-aminobicyclo[3. 1.0
(+)- methyl</w>
(+)- epibatidine</w>
(+)- enantiomer</w>
(+)- MK-801,</w>
(+ dP/dtmax),</w>
(+ LVdP/dt),</w>
(+ 6.6</w>
(+ 5+/-
(+ 32</w>
(+ 31%</w>
(+ 27</w>
(+ 21%)</w>
(+ 1</w>
(+ 18
(+ 17
(+ 112
(+ 10</w>
(+ -MK801</w>
(+ -)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane</w>
(+ )),</w>
((R)- 5-(2-azetidinylmethoxy)-2-chloropyridine)</w>
('M (2)-selective')</w>
('M (1)/M(3)/M(5)-selective'),</w>
('M (1)-selective')</w>
(' orphan'</w>
(' C
(% FS)</w>
(" protocol</w>
(" levodopa</w>
(" empty</w>
(" crack")</w>
(" CD
(" 2</w>
( younger</w>
( young</w>
( women</w>
( wk</w>
( wild-type)</w>
( who</w>
( while</w>
( whether</w>
( weight,</w>
( weakly</w>
( water)</w>
( w/w)</w>
( vomiting</w>
( vomiting,</w>
( vincristine-induced)</w>
( via</w>
( vestibular</w>
( verbal</w>
( vagal)</w>
( used</w>
( upper</w>
( up
( univariate</w>
( unchanged)</w>
( types</w>
( trunk</w>
( tricuspid:</w>
( tretino
( trend</w>
( tremor,</w>
( trans-3,4-dichloro-
( toxic)</w>
( total)</w>
( to
( titrated</w>
( ti
( thyroarytenoid</w>
( this</w>
( thirteen</w>
( thioridazine)</w>
( thermodilu
( tests</w>
( termed</w>
( terfenadine,</w>
( terbutaline)</w>
( ter
( temazep
( tax
( tau)</w>
( targeted</w>
( tardive</w>
( taken</w>
( tacrolim
( table
( syncopal)</w>
( symptoms</w>
( supplied</w>
( supine</w>
( sunifir
( subcutaneous</w>
( stroke</w>
( streptozotocin-induced)</w>
( stratified</w>
( strain</w>
( stimulus</w>
( stimulation</w>
( status</w>
( statistically</w>
( static)</w>
( standing),</w>
( standardized</w>
( stages</w>
( stable</w>
( specificity</w>
( social</w>
( slope=-0.
( skin</w>
( sixty-eight)</w>
( sirolimus)</w>
( sil
( signs</w>
( significant</w>
( short-
( sham-operated</w>
( set</w>
( serving</w>
( serotonin</w>
( serotonin,</w>
( sequence</w>
( separation</w>
( sensitization).</w>
( self-
( seizure</w>
( seen</w>
( second</w>
( se
( scores</w>
( scopolamine)</w>
( scop
( schizophrenia,</w>
( scale</w>
( same</w>
( saline:</w>
( salbutam
( rotarod,</w>
( right</w>
( reversal</w>
( reversal
( retention</w>
( respectively</w>
( respectively)</w>
( resistance)</w>
( requiring</w>
( reporting</w>
( remifentanil</w>
( relap
( regimens</w>
( ref.</w>
( reduced)</w>
( recorded</w>
( recalls</w>
( razox
( rats)</w>
( rasagiline)</w>
( radioallergosorbent</w>
( rac
( rabbit</w>
( quinidine,</w>
( pyruvate</w>
( pulsed</w>
( pulse</w>
( published</w>
( pt
( pruritus,</w>
( proven</w>
( prothrombin</w>
( propranolol</w>
( propranolol,</w>
( propofol</w>
( propofol,</w>
( prolonged</w>
( probable</w>
( prevention)</w>
( pretreatment</w>
( presence</w>
( prazosin)</w>
( potential</w>
( potassium</w>
( postoperative</w>
( possible</w>
( polymorphonuclear</w>
( polymorphic</w>
( polyethylene</w>
( poly
( poison</w>
( podocyte)</w>
( po)</w>
( placebo),</w>
( piroxicam)</w>
( pilocarpine</w>
( pilocarpine-induced</w>
( phenobarbital</w>
( pharmacological</w>
( personal</w>
( perseveration</w>
( peripheral)</w>
( percent</w>
( peak,</w>
( peak
( passive</w>
( paroxetine</w>
( paresthesias)</w>
( panniculitis)</w>
( pan-
( paclitaxel)</w>
( overdose)</w>
( overall,</w>
( ov
( out</w>
( or,</w>
( open</w>
( only</w>
( one)</w>
( olmesartan)</w>
( olanzap
( often</w>
( observed</w>
( objective</w>
( number-needed-to-harm</w>
( normalized</w>
( normal:</w>
( nonfatal</w>
( non-competitive</w>
( nmol/h</w>
( nitrite-treated</w>
( nitric</w>
( nifedipine</w>
( ng/ml),</w>
( ng/mL)</w>
( neutropenia,</w>
( neuronal</w>
( near</w>
( navelbine)</w>
( naive</w>
( myeloid</w>
( muscle</w>
( multifocal</w>
( morphine,</w>
( monoamine</w>
( molecular</w>
( molar</w>
( mix
( mitral</w>
( mitochondria-
( minus</w>
( min),</w>
( midazolam</w>
( mid-thigh</w>
( microspheres)</w>
( mg/kg;</w>
( mg/dL)</w>
( mg/dL),</w>
( mg/
( mg)</w>
( metoprolol</w>
( methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate)</w>
( methadone</w>
( mephedron
( mefloquine</w>
( medial</w>
( measure</w>
( maximally</w>
( max</w>
( man
( mammary</w>
( male/female</w>
( male,</w>
( major</w>
( maintenance</w>
( main</w>
( magnitude:</w>
( magnetic</w>
( macrophag
( lysine-
( loss</w>
( losoxantrone/
( loose</w>
( long-term)</w>
( long-
( logistic</w>
( loading</w>
( lisinopri
( likely</w>
( likely)</w>
( like</w>
( light</w>
( life</w>
( licking</w>
( learned</w>
( laterodorsal</w>
( lateral</w>
( latency</w>
( late-phase</w>
( lasting</w>
( laryngeal</w>
( large</w>
( large-dose</w>
( lamina</w>
( known</w>
( kg</w>
( ketamine,</w>
( kala-azar)</w>
( ivc)</w>
( isoproterenol-induced</w>
( isoproterenol,</w>
( isoproterenol)-induced</w>
( isocitrate</w>
( iso-
( ir)</w>
( ipsilater
( ip
( intraperitoneally,</w>
( intraperitoneally)</w>
( intralaminar</w>
( intraclass</w>
( into</w>
( intact</w>
( instead</w>
( initially</w>
( inhibitory</w>
( inhibitor</w>
( inhibit
( infusion)</w>
( induction)</w>
( indicative</w>
( index</w>
( inactivated</w>
( in-</w>
( improvement</w>
( impairment</w>
( i.v.
( hypotensive</w>
( hypotension)</w>
( hypomanic</w>
( hypo
( hyper
( hydroxyproline</w>
( heroin</w>
( hematologic</w>
( hematocrit</w>
( height,</w>
( healthy</w>
( headache</w>
( he
( halothane</w>
( halothane,</w>
( halothane)</w>
( haloperidol+vehicle</w>
( half-life</w>
( h)</w>
( growth</w>
( grand</w>
( gestation</w>
( generic,</w>
( generally</w>
( gas6)</w>
( gamma-aminobutyric</w>
( fusion</w>
( full</w>
( forward</w>
( formalin</w>
( flunitrazepam).</w>
( fluid</w>
( fluid-attenuated</w>
( flow</w>
( flecainide</w>
( fl
( fixed-ratio</w>
( fewer</w>
( fever,</w>
( fentanyl,</w>
( fasting</w>
( extr
( experimental</w>
( exon</w>
( exercise</w>
( excellent</w>
( exc
( evident</w>
( even</w>
( evaluation</w>
( evaluated</w>
( evaluable</w>
( ethyl</w>
( ethyl-
( ethopropazine,</w>
( estradiol</w>
( estradiol-</w>
( ergotamine,</w>
( erec
( epoetin</w>
( episode</w>
( epinephrine</w>
( epinephrine,</w>
( epinephrine)</w>
( epinephrine),</w>
( enlarged</w>
( endotoxin-
( endogenous</w>
( end-tidal</w>
( electroconvulsive</w>
( effect</w>
( ecstasy)</w>
( ecstasy)-related</w>
( early-phase</w>
( dyskinesia</w>
( dynamic)</w>
( duloxetine</w>
( dry</w>
( doxorubicin/
( doxorubicin,</w>
( double</w>
( double-bl
( dorsal</w>
( dopamine,</w>
( donor:</w>
( docetaxel,</w>
( dizocilpine</w>
( distilled</w>
( direct</w>
( dipyridamole-
( diphenhydramine</w>
( dimethylamino)</w>
( diltiazem,</w>
( difference,</w>
( dexamethasone</w>
( dexamethasone,</w>
( dexamethasone)</w>
( designated</w>
( described</w>
( dependent</w>
( denoted</w>
( delta9-TH
( delta-ALA-
( delirium,</w>
( delirium)</w>
( definite</w>
( deep</w>
( decreases</w>
( de</w>
( darbepoetin</w>
( dP/dtejc)</w>
( cytochrome</w>
( cyclophosphamide</w>
( cutaneous</w>
( crude</w>
( creatinine,</w>
( cough,</w>
( cortex</w>
( cortex,</w>
( corresponding</w>
( controls,</w>
( contextual</w>
( cont'
( congestive</w>
( conditioned</w>
( concentration</w>
( comprising</w>
( compound</w>
( completely,</w>
( combination</w>
( colony-forming</w>
( cocaine,</w>
( cm/s)</w>
( clonidine)-mediated</w>
( clofibrate)</w>
( clobaz
( cisplatin</w>
( cis-RA)</w>
( cholesterol</w>
( cholestatic</w>
( chlorthalid
( chlorpropamide,</w>
( change</w>
( cervical</w>
( cerebroventricle-
( ceftriaxone,</w>
( cathepsin</w>
( catalytic)</w>
( cases)</w>
( carmustine,</w>
( cardiomyopathy</w>
( carboxypeptidase</w>
( capsaicin)</w>
( candesartan)</w>
( calcitriol</w>
( calcitriol)</w>
( caffeine</w>
( ca.</w>
( brief</w>
( bridging</w>
( breakthrough</w>
( bradycardia</w>
( blinded)</w>
( bleeding</w>
( bladder</w>
( black</w>
( bipolar</w>
( bilirubin</w>
( bilateral),</w>
( bicuculline</w>
( biceps,</w>
( beta4</w>
( behavioral</w>
( beginning</w>
( before,</w>
( b</w>
( azido
( awake</w>
( available</w>
( auto
( augmentin)</w>
( atropine</w>
( atrial</w>
( atracurium</w>
( atenolol,</w>
( asystole)</w>
( asymptomatic,</w>
( aspirin)</w>
( ascorbic</w>
( as-
( arm</w>
( applied</w>
( apoptosis</w>
( apoptosis,</w>
( apnea-hypopnea</w>
( anxiety)</w>
( antinocicep
( anticonvulsant
( anterograde</w>
( anorexia:</w>
( annexin</w>
( angiodegeneration</w>
( angina,</w>
( ang)</w>
( anemia,</w>
( and/or</w>
( amphetamine</w>
( amifostine)</w>
( amantadine,</w>
( alpha2ABC-/-).</w>
( alpha,</w>
( alpha)</w>
( alpha(1A)-adrenoceptor</w>
( alkylating</w>
( alkaline</w>
( alfuzosin,</w>
( alendronate</w>
( alendronate)</w>
( albuterol)</w>
( alanine</w>
( agitation,</w>
( age-adjusted</w>
( administered</w>
( ad</w>
( actu
( across</w>
( aconitine</w>
( aPT
( [3H]-
( V</w>
( Urd)</w>
( US
( UR
( Thomsonide)</w>
( Third</w>
( Th
( Reye's</w>
( Registro</w>
( KG
( K-
( June</w>
( July</w>
( Index</w>
( ISO</w>
( III).</w>
( Hoehn</w>
( GABA-
( G</w>
( E</w>
( 7-NI,</w>
( 0.0001</w>
( 0.000
( .0
( +/-1
( (S)-4-
( (E)-
( (3)H-
( (2
( (1/2))</w>
( (-)-
( (+/-)
( (+)-5-methyl-10,11-dihydro-5H-dibenzo(a,d)cycloheptan-5,10-imine</w>
'probable '-
'low- dose'</w>
'dyston ic'</w>
' yoeit
' wet</w>
' unblinded'</w>
' torsade</w>
' stress</w>
' standard
' spike-wave</w>
' slow'</w>
' short-term'</w>
' see-saw'</w>
' ra
' possible'</w>
' pop
' osmotic</w>
' orphan'</w>
' non-nephrotoxic</w>
' low
' long-term'</w>
' in</w>
' high
' good</w>
' flu-like'</w>
' electrographic</w>
' disorder</w>
' catalytic'</w>
' cardiotoxic
' carbamylcholin';</w>
' carbamazepine</w>
' bar/podium/grid'</w>
' balloons'</w>
' autoantibody
' alpha</w>
' adverse</w>
' Spontaneous'</w>
' Reye</w>
' A'</w>
' ?</w>
%/ y)</w>
%/ s</w>
%/ min</w>
%/ min,</w>
%.mmHg -1)</w>
%- 6.
%- 5.
% ].</w>
% -1.
% +/-
% )].</w>
% )-,</w>
"spontaneous ly"</w>
"sof t"</w>
"saf e"</w>
"normal ity,"</w>
"neuro matrix"</w>
"low- risk"</w>
"low- dose"</w>
"g ate"</w>
"drug- rel
" well-
" valproate</w>
" unknown</w>
" typical"</w>
" twisting</w>
" transient</w>
" tr
" toxic"</w>
" torsades</w>
" timing"</w>
" time</w>
" stress"</w>
" sluggish"</w>
" responders"</w>
" regener
" red</w>
" recreational"</w>
" re
" ragged-
" quinine-associated</w>
" pseudo
" protective"</w>
" probably"</w>
" possible"</w>
" phenytoin"</w>
" peak</w>
" over-the-
" opposite</w>
" open</w>
" on
" natural</w>
" multifocal</w>
" moder
" minimal-change"</w>
" marginal</w>
" m
" low</w>
" lipid</w>
" light"</w>
" inverse"</w>
" infarct-like"</w>
" inactive</w>
" ice,"</w>
" hypercoagulability"</w>
" highly</w>
" halothane</w>
" flash"</w>
" empyema"</w>
" dynamite</w>
" drug</w>
" direct"</w>
" definit
" creeping</w>
" control"</w>
" constipation"</w>
" chasing</w>
" ch
" calcium</w>
" blind
" behavioral</w>
" at-risk"</w>
" approach-avoidance</w>
" antidot
" antidepressant"</w>
" antagonist"</w>
" aging"</w>
" activation"</w>
" Type</w>
" TNS",</w>
" T's</w>
" Rubral"</w>
" On-Off
" OC</w>
" K+-
" Cocaine-Induced</w>
" 3-week</w>
" --may</w>
" -
~ 77</w>
~ 6</w>
~ 15</w>
~ 100-fold</w>
~ -
~- 50%)</w>
}- sarcoglycan-deficient</w>
}- 2,3-
}-2,3- di
}-2,3-di hy</w>
} carbonyl)
}carbonyl) hexahydro
}carbonyl)hexahydro -1
}carbonyl)hexahydro-1 H
}carbonyl)hexahydro-1H -1,4-
}carbonyl)hexahydro-1H-1,4- diazep
}carbonyl)hexahydro-1H-1,4-diazep ine)</w>
} .</w>
{3- ethyl
{3-ethyl -1-
{3-ethyl-1- [2-
{3-ethyl-1-[2- hydroxy-3-
{3-ethyl-1-[2-hydroxy-3- (4-
{3-ethyl-1-[2-hydroxy-3-(4- phenyl-
{3-ethyl-1-[2-hydroxy-3-(4-phenyl- piperazin-1-
{3-ethyl-1-[2-hydroxy-3-(4-phenyl-piperazin-1- yl)-
{3-ethyl-1-[2-hydroxy-3-(4-phenyl-piperazin-1-yl)- propyl]-
{3-ethyl-1-[2-hydroxy-3-(4-phenyl-piperazin-1-yl)-propyl]- 2,4-dioxo-5,5-diphenyl-imidazol
{3-ethyl-1-[2-hydroxy-3-(4-phenyl-piperazin-1-yl)-propyl]-2,4-dioxo-5,5-diphenyl-imidazol idine
{3-ethyl-1-[2-hydroxy-3-(4-phenyl-piperazin-1-yl)-propyl]-2,4-dioxo-5,5-diphenyl-imidazolidine }</w>
{ p</w>
{ delta
{delta }-sarcoglycan-deficient</w>
{ average</w>
{ 2-[4-
{2-[4- (1,2-dihydro-2-acenaphthylenyl)
{2-[4-(1,2-dihydro-2-acenaphthylenyl) piperazin
{2-[4-(1,2-dihydro-2-acenaphthylenyl)piperazin yl]
{2-[4-(1,2-dihydro-2-acenaphthylenyl)piperazinyl] ethyl
{2-[4-(1,2-dihydro-2-acenaphthylenyl)piperazinyl]ethyl }-2,3-dihy</w>
{ 1-[3-(4-
{1-[3-(4- (3-
{1-[3-(4-(3- chloro-
{1-[3-(4-(3-chloro- phenyl)-piperazin-1-
{1-[3-(4-(3-chloro-phenyl)-piperazin-1- yl)
{1-[3-(4-(3-chloro-phenyl)-piperazin-1-yl) -</w>
{ 1-
{1- [
{1-[ 6-
{1-[6- (trifluoro
{1-[6-(trifluoro methyl)-
{1-[6-(trifluoromethyl)- 3-
{1-[6-(trifluoromethyl)-3- pyridin
{1-[6-(trifluoromethyl)-3-pyridin yl]-4-
{1-[6-(trifluoromethyl)-3-pyridinyl]-4- piperid
{1-[6-(trifluoromethyl)-3-pyridinyl]-4-piperid inyl
{1-[6-(trifluoromethyl)-3-pyridinyl]-4-piperidinyl }carbonyl)hexahydro-1H-1,4-diazepine)</w>
zymos an-induced</w>
zymos an-
zymosan- activated</w>
zymo graphy.</w>
zymo graphic</w>
zyme- conjugated</w>
zyme .</w>
zotoc in:</w>
zotep ine)</w>
zos in,</w>
zopiclon e-induced</w>
zonis amide,</w>
zon es-
zones- proximal,</w>
zon amp
zonamp anel
zonampanel ),</w>
zom es.</w>
zolpidem -treated</w>
zolpidem -</w>
zolpide m's</w>
zole- kindled</w>
zole- ,</w>
zol e),</w>
zol anti
zolanti dine</w>
zol )-
zol)- induced,</w>
zofen opri
zofenopri l-treated</w>
zo steric</w>
zo ster.</w>
zo ium</w>
zo g,</w>
zo ate),</w>
zo ar</w>
zo al</w>
zo );</w>
zo ).</w>
ziprasid one/
ziprasidone/ risperidone</w>
ziprasid one-treated</w>
ziprasid one-induced</w>
zinc aemia</w>
zinc -mediated</w>
zinc -
zinc- superoxide</w>
zin es</w>
zin )</w>
zime lidine,</w>
zime lid
zimelid ine.</w>
zileut on,</w>
zidovudine- naive</w>
zidovud ine;</w>
zidovud ine:</w>
zidovud ine-containing</w>
zidovud ine).</w>
ziconoti de;</w>
ziconoti de.</w>
ziconoti de,</w>
zi pine</w>
zetimi be-induced</w>
zet to,</w>
zet a-
zeta- potential</w>
zero -</w>
zero )</w>
zero ).</w>
zer o-
zero- order</w>
zer ;</w>
zep ine</w>
zep ine,</w>
zep am,</w>
zebraf ish.</w>
ze it
zeit ge
zeitge b
zeitgeb ers,</w>
ze bra</w>
zatebr adine,</w>
zatebr ad
zatebrad ine-treated</w>
zambesic us</w>
zambesic us.</w>
zalcitab ine/
zalcitabine/ ZDV.</w>
zalcitab ine)</w>
zalcit abine-induced</w>
zalcit abine,</w>
z- scores</w>
z ygium</w>
z yg
zyg oma</w>
z yed</w>
z y.</w>
z y"</w>
z ur</w>
z ul
zul in)</w>
z osin</w>
z one;</w>
z on</w>
z oma</w>
z ki
zki ew
zkiew ic
zkiewic z</w>
z ip
zip per
zipper -like</w>
z ineR</w>
z ine-induced</w>
z ine's</w>
z if
zif /
zif/ 268</w>
z ide</w>
z ias</w>
z feld</w>
z eta</w>
z et</w>
z er)</w>
z eni
zeni platin,</w>
z eman
zeman n</w>
z ec
zec in</w>
z e.</w>
z e,</w>
z c
zc zecin</w>
z ation;</w>
z ation.</w>
z ation,</w>
z ation"</w>
z aril</w>
z anc
zanc k's</w>
z ac)</w>
z able,</w>
z a)</w>
z ]),</w>
z R</w>
z =
z= 0.62,</w>
z ;</w>
z -fed</w>
z )/kg</w>
ytol ic</w>
ytol es</w>
yt tri
yttri um-
yttrium- 90,</w>
yt ine-
ytine- C</w>
yt amine</w>
ysti tis:</w>
ystagmo graphy</w>
yst one</w>
yst one
ystone a</w>
yst g
ystg mus</w>
yst ems,</w>
yst ear
ystear ate</w>
yst an
ystan der
ystander "</w>
ysm en
ysmen orrhoea</w>
yser gol</w>
ys w
ysw y
yswy h,</w>
ys tic</w>
ys th
ysth oton
ysthoton us,</w>
ys port
ysport )</w>
ys A).</w>
yro scop
yroscop es,</w>
yro lact
yrolact one;</w>
yro idi
yroidi ,</w>
yro genic</w>
yrin- G
yrin-G +</w>
yridox ne,</w>
yri din
yridin oline</w>
yri da
yrida zine,</w>
yri asis</w>
yraz ine,</w>
yr- old,</w>
yr yl-glycinamide</w>
yr tac
yrtac eae)</w>
yr s]</w>
yr in</w>
yr ic-
yric- acidA</w>
yr ic
yric etin</w>
yr ase</w>
yr ;</w>
yr /kg)</w>
yr ),</w>
ypt osis</w>
yprex a,</w>
yprex a)</w>
yp yridine</w>
yp sin</w>
yp s</w>
yp 1a
yp1a 2-
yp1a2- null</w>
younger )</w>
young- isolated</w>
young- group</w>
young- adult</w>
young :</w>
youn g)</w>
you ths.</w>
you th;</w>
you th,</w>
yol k-
yolk- sac-derived</w>
yol a</w>
yohimb ine;</w>
yohimb ine-treated</w>
yohimb an
yohimban -16-
yohimban-16- carboxylic</w>
yo- yo
yo-yo "</w>
yo- s
yo-s hy
yo-shy ok
yo-shyok yo-
yo-shyokyo- ka-
yo-shyokyo-ka- ou
yo-shyokyo-ka-ou ren
yo-shyokyo-ka-ouren -
yo-shyokyo-ka-ouren- bu
yo-shyokyo-ka-ouren-bu kur
yo-shyokyo-ka-ouren-bukur you</w>
yo ver,</w>
yo sitis</w>
yo ked</w>
yo iditis</w>
yo dopa-induced</w>
yo -S
yo-S aiko-
yo-Saiko- To</w>
yo ,</w>
yner t</w>
yner a).</w>
yne- D3</w>
yne- 26,27-F6-
yne-26,27-F6- D3)</w>
yne bacterium</w>
yne -S
yne-S to
yne-Sto kes</w>
yn ylestradi
ynylestradi ol-induced</w>
yn yl)-
ynyl)- est
ynyl)-est ra
ynyl)-estra -</w>
yn ur
ynur inic</w>
yn ti
ynti graphy</w>
yn om
ynom olgus</w>
yn ol,</w>
yn e</w>
yn drome</w>
yn an
ynan the</w>
yn amic</w>
yn a</w>
yn -3-
yn-3- ol</w>
yn -2-
yn-2- ol</w>
yn -1-
yn-1- ol</w>
yn ,</w>
yn )</w>
ymph ocytic</w>
ymph o
ympho globul
ymphoglobul ine;</w>
ymo quinone</w>
ymo pathy.</w>
ymo blast
ymoblast omas,</w>
yme tri
ymetri x</w>
ym uc
ymuc on
ymucon ate-
ymuconate- epsilon-
ymuconate-epsilon- semi
ymuconate-epsilon-semi aldehyde</w>
ym ot
ymot ryp
ymotryp sin,</w>
ym oma</w>
ym oma,</w>
ym id
ymid odrine,</w>
ym bifera</w>
ylthio propan
ylthiopropan olamine</w>
yloxy- ethyl)</w>
yloxy- carbon
yloxy-carbon yloxy-ethyl)</w>
yloxy) carbon
yloxy)carbon yloxy
yloxy)carbonyloxy methyl-5-
yloxy)carbonyloxymethyl-5- acetyl-
yloxy)carbonyloxymethyl-5-acetyl- 2-
yloxy)carbonyloxymethyl-5-acetyl-2- n-propyl-
yloxy)carbonyloxymethyl-5-acetyl-2-n-propyl- 3-
yloxy)carbonyloxymethyl-5-acetyl-2-n-propyl-3- [2
yloxy)carbonyloxymethyl-5-acetyl-2-n-propyl-3-[2 '
yloxy)carbonyloxymethyl-5-acetyl-2-n-propyl-3-[2' (1
yloxy)carbonyloxymethyl-5-acetyl-2-n-propyl-3-[2'(1 H</w>
yloxy )-3-
yloxy)-3- isopropyl
yloxy)-3-isopropyl aminobut
yloxy)-3-isopropylaminobut an-2-
yloxy)-3-isopropylaminobutan-2- ol</w>
ylo sis.</w>
ylo caine)</w>
ylo bacter</w>
ylo aminotetralin</w>
ylmethyl)- amino]-
ylmethyl)-amino]- methyl]-
ylmethyl)-amino]-methyl]- piperidin-1-yl-
ylmethyl)-amino]-methyl]-piperidin-1-yl- methanone</w>
ylmethyl)- 2,
ylmethyl)-2, 5-
ylmethyl)-2,5- bis
ylmethyl)-2,5-bis (2,
ylmethyl)-2,5-bis(2, 2,2-
ylmethyl)-2,5-bis(2,2,2- trifluoro
ylmethyl)-2,5-bis(2,2,2-trifluoro ethoxy)
ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy) benz
ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benz am</w>
ylmethyl) pyrrolo
ylmethyl)pyrrolo [1,
ylmethyl)pyrrolo[1, 2,3-de
ylmethyl)pyrrolo[1,2,3-de ]
ylmethyl)pyrrolo[1,2,3-de] -1,4-
ylmethyl)pyrrolo[1,2,3-de]-1,4- benzoxaz
ylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxaz in-6-
ylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6- yl]-1-
ylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1- naphthalen
ylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalen yl
ylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenyl methan
ylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethan one),</w>
ylmethyl) benz
ylmethyl)benz amide)</w>
ylmethyl pyrazolo</w>
ylmethyl aminom
ylmethylaminom ethyl]-
ylmethylaminomethyl]- chrom
ylmethylaminomethyl]-chrom ane</w>
ylmethyl ]</w>
ylmethyl )-1-
ylmethyl)-1- (1-
ylmethyl)-1-(1- naphthalen
ylmethyl)-1-(1-naphthalen yl-
ylmethyl)-1-(1-naphthalenyl- carbon
ylmethyl)-1-(1-naphthalenyl-carbon yl)-6H-
ylmethyl)-1-(1-naphthalenyl-carbonyl)-6H- pyrrolo[
ylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[ 3,
ylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3, 2,
ylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2, 1-
ylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1- i
ylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i ,
ylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i, j
ylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j ]
ylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j] quinolin-6-
ylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6- one</w>
ylmethion yl
ylmethionyl leuc
ylmethionylleuc yl-
ylmethionylleucyl- phenylalanine</w>
ylidene )-9-
ylidene)-9- anth
ylidene)-9-anth rol
ylidene)-9-anthrol ),</w>
ylidene )
ylidene) hydraz
ylidene)hydraz ino]
ylidene)hydrazino] phthal
ylidene)hydrazino]phthal azine</w>
ylestradi ol/drospirenone</w>
ylestradi ol-treated</w>
ylene imine</w>
ylen ol</w>
ylen ol)</w>
yle ster,</w>
yle in
ylein amine</w>
yle ),</w>
ylcarbonyl) pyrrolid
ylcarbonyl)pyrrolid in-3-
ylcarbonyl)pyrrolidin-3- thio
ylcarbonyl)pyrrolidin-3-thio ]-
ylcarbonyl)pyrrolidin-3-thio]- l-methyl
ylcarbonyl)pyrrolidin-3-thio]-l-methyl carbap
ylcarbonyl)pyrrolidin-3-thio]-l-methylcarbap en-2-
ylcarbonyl)pyrrolidin-3-thio]-l-methylcarbapen-2- em-
ylcarbonyl)pyrrolidin-3-thio]-l-methylcarbapen-2-em- 3-</w>
ylacetyl glycerol</w>
ylacetyl )</w>
yl]ethyl] argin
yl]ethyl]argin inamide</w>
yl]ethyl] -1H-
yl]ethyl]-1H- indole</w>
yl]-L- histid
yl]-L-histid yl-
yl]-L-histidyl- L-</w>
yl]-4- quinolin
yl]-4-quinolin ecarboxamide)</w>
yl]-1- phenyl-1,3,8-triaz
yl]-1-phenyl-1,3,8-triaz aspiro
yl]-1-phenyl-1,3,8-triazaspiro [4,5]dec
yl]-1-phenyl-1,3,8-triazaspiro[4,5]dec ane-
yl]-1-phenyl-1,3,8-triazaspiro[4,5]decane- 4-
yl]-1-phenyl-1,3,8-triazaspiro[4,5]decane-4- one]</w>
yl]-1- phenyl-
yl]-1-phenyl- ethyl</w>
yl]-1- benzofuran-
yl]-1-benzofuran- 5-
yl]-1-benzofuran-5- carboxylate</w>
yl]-1- aminom
yl]-1-aminom ethyl-
yl]-1-aminomethyl- 3,4-dihydro-
yl]-1-aminomethyl-3,4-dihydro- 5,6-
yl]-1-aminomethyl-3,4-dihydro-5,6- dihydroxy
yl]-1-aminomethyl-3,4-dihydro-5,6-dihydroxy -1H-
yl]-1-aminomethyl-3,4-dihydro-5,6-dihydroxy-1H- 2-
yl]-1-aminomethyl-3,4-dihydro-5,6-dihydroxy-1H-2- benz
yl]-1-aminomethyl-3,4-dihydro-5,6-dihydroxy-1H-2-benz o</w>
yl]- propyl-1-
yl]-propyl-1- phosph
yl]-propyl-1-phosph onate</w>
yl]- phenoxy
yl]-phenoxy ]
yl]-phenoxy] propyl]-
yl]-phenoxy]propyl]- amino]
yl]-phenoxy]propyl]-amino] ethoxy]-
yl]-phenoxy]propyl]-amino]ethoxy]- benzamide</w>
yl]- methan
yl]-methan one]</w>
yl]- acetic</w>
yl]- acetam
yl]-acetam ido
yl]-acetamido )-3-
yl]-acetamido)-3- ([
yl]-acetamido)-3-([ (5-methyl
yl]-acetamido)-3-([(5-methyl -1,3,4-
yl]-acetamido)-3-([(5-methyl-1,3,4- thiadiazol
yl]-acetamido)-3-([(5-methyl-1,3,4-thiadiazol -2-
yl]-acetamido)-3-([(5-methyl-1,3,4-thiadiazol-2- yl)-
yl]-acetamido)-3-([(5-methyl-1,3,4-thiadiazol-2-yl)- thio]
yl]-acetamido)-3-([(5-methyl-1,3,4-thiadiazol-2-yl)-thio] methyl)-8-
yl]-acetamido)-3-([(5-methyl-1,3,4-thiadiazol-2-yl)-thio]methyl)-8- oxo-5-thia-1-azabicyclo
yl]-acetamido)-3-([(5-methyl-1,3,4-thiadiazol-2-yl)-thio]methyl)-8-oxo-5-thia-1-azabicyclo [4,
yl]-acetamido)-3-([(5-methyl-1,3,4-thiadiazol-2-yl)-thio]methyl)-8-oxo-5-thia-1-azabicyclo[4, 2,0
yl]-acetamido)-3-([(5-methyl-1,3,4-thiadiazol-2-yl)-thio]methyl)-8-oxo-5-thia-1-azabicyclo[4,2,0 ]oct-2-ene-2-
yl]-acetamido)-3-([(5-methyl-1,3,4-thiadiazol-2-yl)-thio]methyl)-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2- carboxylic</w>
yl]- N
yl]-N 4-
yl]-N4- alkyl/aryl-
yl]-N4-alkyl/aryl- thiosemicarb
yl]-N4-alkyl/aryl-thiosemicarb az
yl]-N4-alkyl/aryl-thiosemicarbaz ides</w>
yl]- 5
yl]-5 Z-
yl]-5Z- hex
yl]-5Z-hex enoic</w>
yl]- 3-(
yl]-3-( fur
yl]-3-(fur an-3-
yl]-3-(furan-3- yl)-
yl]-3-(furan-3-yl)- N-methyl
yl]-3-(furan-3-yl)-N-methyl prop-2-
yl]-3-(furan-3-yl)-N-methylprop-2- en
yl]-3-(furan-3-yl)-N-methylprop-2-en amide</w>
yl]- 3-
yl]-3- ethyl
yl]-3-ethyl amino
yl]-3-ethylamino azetid
yl]-3-ethylaminoazetid ine-3-carboxylic</w>
yl]- 2-
yl]-2- (S
yl]-2-(S )-</w>
yl]- (9
yl]-(9 CI
yl]-(9CI )]</w>
yl] pyridaz
yl]pyridaz in-
yl]pyridazin- 3(2H)-
yl]pyridazin-3(2H)- one</w>
yl] propyl
yl]propyl ]
yl]propyl] pyrrolidin-2-one</w>
yl] methyl]-
yl]methyl]- 7-
yl]methyl]-7- [
yl]methyl]-7-[ (Z
yl]methyl]-7-[(Z )-2-
yl]methyl]-7-[(Z)-2- (2-
yl]methyl]-7-[(Z)-2-(2- amino
yl]methyl]-7-[(Z)-2-(2-amino thiazol-4-
yl]methyl]-7-[(Z)-2-(2-aminothiazol-4- yl)-2-
yl]methyl]-7-[(Z)-2-(2-aminothiazol-4-yl)-2- methoxy
yl]methyl]-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxy imino
yl]methyl]-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino acetylamino
yl]methyl]-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetylamino ]-
yl]methyl]-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetylamino]- 8-
yl]methyl]-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetylamino]-8- oxo-5-thia-1-azabicyclo
yl]methyl]-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetylamino]-8-oxo-5-thia-1-azabicyclo [4.
yl]methyl]-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetylamino]-8-oxo-5-thia-1-azabicyclo[4. 2.0
yl]methyl]-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetylamino]-8-oxo-5-thia-1-azabicyclo[4.2.0 ]oct-2-ene-2-
yl]methyl]-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetylamino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylate</w>
yl] methyl]
yl]methyl] -1-
yl]methyl]-1- piperidin
yl]methyl]-1-piperidin yl]ethyl]-1H-indole</w>
yl] methyl-
yl]methyl- 4,5,6,7-
yl]methyl-4,5,6,7- tetra
yl]methyl-4,5,6,7-tetra hydro</w>
yl] benzo
yl]benzo yl]-1-benzofuran-5-carboxylate</w>
yl] amine</w>
yl] acetyl
yl]acetyl ]-
yl]acetyl]- N-[2-
yl]acetyl]-N-[2- [1,
yl]acetyl]-N-[2-[1, 2-
yl]acetyl]-N-[2-[1,2- dihydro-
yl]acetyl]-N-[2-[1,2-dihydro- 3,
yl]acetyl]-N-[2-[1,2-dihydro-3, 5
yl]acetyl]-N-[2-[1,2-dihydro-3,5 (4H)-
yl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)- di
yl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-di oxo
yl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo -1,2-
yl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2- diphenyl
yl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl -3
yl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3 H
yl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H -1,2,4-
yl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4- triazol
yl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol -4-
yl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4- yl]ethyl]argininamide</w>
yl] -1-piperazinyl]-
yl]-1-piperazinyl]- 2-oxo
yl]-1-piperazinyl]-2-oxo ethyl]
yl]-1-piperazinyl]-2-oxoethyl] cyclopent
yl]-1-piperazinyl]-2-oxoethyl]cyclopent yl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl]ethyl]argininamide</w>
yl-L-leuc yl-glycinamide</w>
yl-L- prolin
yl-L-prolin amide,</w>
yl-L- prol
yl-L-prol ine.</w>
yl-L- histid
yl-L-histid yl-L-prolinamide,</w>
yl-L- glutamine</w>
yl-6- (2-
yl-6-(2- pro
yl-6-(2-pro pargly
yl-6-(2-propargly oxy
yl-6-(2-proparglyoxy phenyl)
yl-6-(2-proparglyoxyphenyl) hex
yl-6-(2-proparglyoxyphenyl)hex anoic</w>
yl-5-fluorourac il).</w>
yl-5-fluorourac il),</w>
yl-4-pyrimidinyl) -1-piperazinyl]
yl-4-pyrimidinyl)-1-piperazinyl] meth
yl-4-pyrimidinyl)-1-piperazinyl]meth y</w>
yl-4- piperidin
yl-4-piperidin yl)</w>
yl-4- phenyl-1,2,3,6-tetrahydropyridine</w>
yl-4- methyl-4-
yl-4-methyl-4- az
yl-4-methyl-4-az a,
yl-4-methyl-4-aza, 5alpha-androst
yl-4-methyl-4-aza,5alpha-androst an-3-
yl-4-methyl-4-aza,5alpha-androstan-3- one,</w>
yl-4- methyl-
yl-4-methyl- Thr
yl-4-methyl-Thr 1)-
yl-4-methyl-Thr1)- (Val
yl-4-methyl-Thr1)-(Val 2)-
yl-4-methyl-Thr1)-(Val2)- cyclospor
yl-4-methyl-Thr1)-(Val2)-cyclospor in
yl-4-methyl-Thr1)-(Val2)-cyclosporin ]</w>
yl-4- ethyl-beta-carboline-3-carboxylate</w>
yl-3- methoxyp
yl-3-methoxyp yrazine,</w>
yl-3- indoleacetamides</w>
yl-2- pyrrolidinyl)methyl]-
yl-2-pyrrolidinyl)methyl]- 5-</w>
yl-2- amino
yl-2-amino propane</w>
yl-2- acyl-
yl-2-acyl- GPE</w>
yl-2'- thien
yl-2'-thien yl)
yl-2'-thienyl) thi
yl-2'-thienyl)thi azole</w>
yl-1- phosphonic</w>
yl-1- phenyl-1,3,8-triaz
yl-1-phenyl-1,3,8-triaz a-
yl-1-phenyl-1,3,8-triaza- spiro
yl-1-phenyl-1,3,8-triaza-spiro [4,5]dec
yl-1-phenyl-1,3,8-triaza-spiro[4,5]dec an-4-
yl-1-phenyl-1,3,8-triaza-spiro[4,5]decan-4- one),</w>
yl-1- beta-D-arabinofuranos
yl-1-beta-D-arabinofuranos yl</w>
yl- xanthine</w>
yl- transferase-mediated</w>
yl- terminal</w>
yl- substitution</w>
yl- pyridine,</w>
yl- propylene
yl-propylene amine</w>
yl- phosphorylcholine</w>
yl- penicillins</w>
yl- only</w>
yl- o-
yl-o- Met-
yl-o-Met- Tyr-
yl-o-Met-Tyr- Arg-vasopressin</w>
yl- ly
yl-ly syl
yl-lysyl fluorescein</w>
yl- l-
yl-l- yl)prop
yl-l-yl)prop ane]</w>
yl- isoquinol
yl-isoquinol ino</w>
yl- ison
yl-ison itri
yl-isonitri le)</w>
yl- galactosyl-
yl-galactosyl- hydroxylysine</w>
yl- esters</w>
yl- e
yl-e osin.</w>
yl- derivatives</w>
yl- daunorubic
yl-daunorubic in),</w>
yl- cyclohexanecarboxamide</w>
yl- co
yl-co enzyme-
yl-coenzyme- A</w>
yl- arginine-
yl-arginine- 7-
yl-arginine-7- amido-
yl-arginine-7-amido- 4-methyl
yl-arginine-7-amido-4-methyl coumarin</w>
yl- aminomethyl</w>
yl- amino)-
yl-amino)- 2,
yl-amino)-2, 1,3-
yl-amino)-2,1,3- benzothiazol
yl-amino)-2,1,3-benzothiazol e,</w>
yl- amino
yl-amino ethyl)
yl-aminoethyl) phenol</w>
yl- alpha-p-chlorophenoxyisobut
yl-alpha-p-chlorophenoxyisobut yrate),</w>
yl- ]
yl-] ethyl</w>
yl- [4-(4-fluorophenyl)
yl-[4-(4-fluorophenyl) piperazin
yl-[4-(4-fluorophenyl)piperazin yl]</w>
yl- V
yl-V al-
yl-Val- Ala-
yl-Val-Ala- DL-
yl-Val-Ala-DL- Asp</w>
yl- UD
yl-UD P.</w>
yl- N,N-
yl-N,N- dimethyl
yl-N,N-dimethyl tropin
yl-N,N-dimethyltropin ium</w>
yl- N
yl-N '
yl-N' -</w>
yl- Met-
yl-Met- Leu
yl-Met-Leu -P
yl-Met-Leu-P he</w>
yl- GABA</w>
yl- Co-
yl-Co- methyl
yl-Co-methyl cob
yl-Co-methylcob amide,</w>
yl- 9-ethyladenine</w>
yl- 7-(4-
yl-7-(4- methyl-
yl-7-(4-methyl- piperazin-1-yl)
yl-7-(4-methyl-piperazin-1-yl) 1H-
yl-7-(4-methyl-piperazin-1-yl)1H- indole)</w>
yl- 4H
yl-4H -1,
yl-4H-1, 3,2-
yl-4H-1,3,2- benzodiox
yl-4H-1,3,2-benzodiox aphosphor
yl-4H-1,3,2-benzodioxaphosphor in</w>
yl- 4'-
yl-4'- methylsulphon
yl-4'-methylsulphon yl-daunorubicin),</w>
yl- 3beta-(4-
yl-3beta-(4- tol
yl-3beta-(4-tol yl)-
yl-3beta-(4-tolyl)- tropane</w>
yl- 3(2H)-pyridazinon-
yl-3(2H)-pyridazinon- 2-
yl-3(2H)-pyridazinon-2- yl-[4-(4-fluorophenyl)piperazinyl]</w>
yl- 2,2,
yl-2,2, 5,5-
yl-2,2,5,5- tetramethyl
yl-2,2,5,5-tetramethyl pyrrolidine</w>
yl- 2,
yl-2, 4,6-
yl-2,4,6- tri
yl-2,4,6-tri ox
yl-2,4,6-triox oper
yl-2,4,6-trioxoper hydro
yl-2,4,6-trioxoperhydro pyrimid
yl-2,4,6-trioxoperhydropyrimid ine),</w>
yl- 2
yl-2 (p
yl-2(p Cl-
yl-2(pCl- phenoxy)butyrate</w>
yl- ,</w>
yl)propen yl-1-phosphonic</w>
yl)propen yl
yl)propenyl -1-</w>
yl)prop anol</w>
yl)oxy]- N-methyl-2-
yl)oxy]-N-methyl-2- pyrazin
yl)oxy]-N-methyl-2-pyrazin ecarboxamide)</w>
yl)butyl]- 3-(2H)-
yl)butyl]-3-(2H)- pyridazin
yl)butyl]-3-(2H)-pyridazin one),</w>
yl)butyl]- 2,4-
yl)butyl]-2,4- imidazol
yl)butyl]-2,4-imidazol id
yl)butyl]-2,4-imidazolid i</w>
yl)-piperaz ine)</w>
yl)-N- (3-
yl)-N-(3- oxo-
yl)-N-(3-oxo- 3-
yl)-N-(3-oxo-3- phenyl-
yl)-N-(3-oxo-3-phenyl- 2-methyl
yl)-N-(3-oxo-3-phenyl-2-methyl propyl)-
yl)-N-(3-oxo-3-phenyl-2-methylpropyl)- piperazine</w>
yl)-N- (1,3,3-
yl)-N-(1,3,3- trimethyl
yl)-N-(1,3,3-trimethyl bicyclo[2.2.
yl)-N-(1,3,3-trimethylbicyclo[2.2. 1]
yl)-N-(1,3,3-trimethylbicyclo[2.2.1] hept
yl)-N-(1,3,3-trimethylbicyclo[2.2.1]hept an-2-
yl)-N-(1,3,3-trimethylbicyclo[2.2.1]heptan-2- yl)-1H-pyrazole-3-carboxamide],</w>
yl)-6H- benzo[
yl)-6H-benzo[ c]
yl)-6H-benzo[c] chrom
yl)-6H-benzo[c]chrom ene-
yl)-6H-benzo[c]chromene- 6-
yl)-6H-benzo[c]chromene-6- one),</w>
yl)-5- amino-2-(2-
yl)-5-amino-2-(2- furyl)-
yl)-5-amino-2-(2-furyl)- pyrazolo-
yl)-5-amino-2-(2-furyl)-pyrazolo- (4,3-
yl)-5-amino-2-(2-furyl)-pyrazolo-(4,3- e
yl)-5-amino-2-(2-furyl)-pyrazolo-(4,3-e )
yl)-5-amino-2-(2-furyl)-pyrazolo-(4,3-e) -1,2,4-triazolo(1,5-
yl)-5-amino-2-(2-furyl)-pyrazolo-(4,3-e)-1,2,4-triazolo(1,5- c)</w>
yl)-5- (4-iodo
yl)-5-(4-iodo phenyl)-1-
yl)-5-(4-iodophenyl)-1- (2,4-dichloro
yl)-5-(4-iodophenyl)-1-(2,4-dichloro phenyl)-4-methyl-1H-pyrazole-3-carboxamide
yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide ];</w>
yl)-2- phenylpropan
yl)-2-phenylpropan amide</w>
yl)-2- [(2-methyl
yl)-2-[(2-methyl pyrrolid
yl)-2-[(2-methylpyrrolid in-1-yl)
yl)-2-[(2-methylpyrrolidin-1-yl) methyl]
yl)-2-[(2-methylpyrrolidin-1-yl)methyl] biphenyl-4-
yl)-2-[(2-methylpyrrolidin-1-yl)methyl]biphenyl-4- carboxamide</w>
yl)-1,2- benziso
yl)-1,2-benziso thiazol
yl)-1,2-benzisothiazol -
yl)-1,2-benzisothiazol- 3-</w>
yl)- pyridine,</w>
yl)- piperid
yl)-piperid ine),</w>
yl)- methanone</w>
yl)- caffeine</w>
yl)- butyl]
yl)-butyl] (4-
yl)-butyl](4- phenyl)
yl)-butyl](4-phenyl) benz
yl)-butyl](4-phenyl)benz amide]</w>
yl)- alpha-D-
yl)-alpha-D- N-acetylneuraminic</w>
yl)- N(2)-
yl)-N(2)- (2,
yl)-N(2)-(2, 3,4-
yl)-N(2)-(2,3,4- trihydroxy
yl)-N(2)-(2,3,4-trihydroxy benzyl
yl)-N(2)-(2,3,4-trihydroxybenzyl )</w>
yl)- 7-oxo-
yl)-7-oxo- 7H-
yl)-7-oxo-7H- pyrido[1,
yl)-7-oxo-7H-pyrido[1, 2,3-de
yl)-7-oxo-7H-pyrido[1,2,3-de ]</w>
yl)- 7-hydroxy-
yl)-7-hydroxy- 6-methoxy-
yl)-7-hydroxy-6-methoxy- 2-methyl
yl)-7-hydroxy-6-methoxy-2-methyl -</w>
yl)- 6-nitro
yl)-6-nitro -1,2,3,4-tetrahydro
yl)-6-nitro-1,2,3,4-tetrahydro -1-
yl)-6-nitro-1,2,3,4-tetrahydro-1- quinoxalin
yl)-6-nitro-1,2,3,4-tetrahydro-1-quinoxalin yl]-acetic</w>
yl)- 4-(
yl)-4-( {1-[6-(trifluoromethyl)-3-pyridinyl]-4-piperidinyl}carbonyl)hexahydro-1H-1,4-diazepine)</w>
yl)- 3-methoxy
yl)-3-methoxy benzyl
yl)-3-methoxybenzyl ]-
yl)-3-methoxybenzyl]- N,N-
yl)-3-methoxybenzyl]-N,N- diethyl-
yl)-3-methoxybenzyl]-N,N-diethyl- benzamide</w>
yl)- 3-(
yl)-3-( xanth
yl)-3-(xanth -9-
yl)-3-(xanth-9- yl)</w>
yl)- (4-
yl)-(4- methoxy-
yl)-(4-methoxy- cyclohex
yl)-(4-methoxy-cyclohex yl)-methanone</w>
yl) xanthine</w>
yl) tropane</w>
yl) pyrazine</w>
yl) propyl-1-phosphonic</w>
yl) propyl-
yl)propyl- l-
yl)propyl-l- phosphonic</w>
yl) piperazino]butyl]-4-methyl-2H,4H-1,2,4-triazin-3,5-dione</w>
yl) phthal
yl)phthal ate.</w>
yl) phenyl]-
yl)phenyl]- trans-
yl)phenyl]-trans- 4-(3-
yl)phenyl]-trans-4-(3- hydroxy
yl)phenyl]-trans-4-(3-hydroxy propyl)-
yl)phenyl]-trans-4-(3-hydroxypropyl)- cyclohex
yl)phenyl]-trans-4-(3-hydroxypropyl)-cyclohex anol)</w>
yl) oxy
yl)oxy ]
yl)oxy] yohimban-16-carboxylic</w>
yl) imidazole-4-
yl)imidazole-4- ca
yl)imidazole-4-ca rox
yl)imidazole-4-carox amide,</w>
yl) guanidine</w>
yl) ethyl]-
yl)ethyl]- 2,3-dihydro-
yl)ethyl]-2,3-dihydro- 9-
yl)ethyl]-2,3-dihydro-9- methoxy
yl)ethyl]-2,3-dihydro-9-methoxy -1H-
yl)ethyl]-2,3-dihydro-9-methoxy-1H- pyrrolo[
yl)ethyl]-2,3-dihydro-9-methoxy-1H-pyrrolo[ 3,4-
yl)ethyl]-2,3-dihydro-9-methoxy-1H-pyrrolo[3,4- b]
yl)ethyl]-2,3-dihydro-9-methoxy-1H-pyrrolo[3,4-b] quinol
yl)ethyl]-2,3-dihydro-9-methoxy-1H-pyrrolo[3,4-b]quinol in-1-
yl)ethyl]-2,3-dihydro-9-methoxy-1H-pyrrolo[3,4-b]quinolin-1- one</w>
yl) cyclohexanecarboxamide</w>
yl) cyclo
yl)cyclo h</w>
yl) caffeine</w>
yl) but
yl)but oxy]-
yl)butoxy]- 3,4-dihydro-2</w>
yl) biphenyl-4-
yl)biphenyl-4- yl]methyl-4,5,6,7-tetrahydro</w>
yl) ]-
yl)]- 3-(4-
yl)]-3-(4- piperid
yl)]-3-(4-piperid yl)propanol</w>
yl) ]
yl)] propane</w>
yl) -1,3-dipropyl
yl)-1,3-dipropyl -7-
yl)-1,3-dipropyl-7- methyl
yl)-1,3-dipropyl-7-methyl xanth
yl)-1,3-dipropyl-7-methylxanth ine]</w>
yl yl,</w>
yl yc
ylyc ine.</w>
yl y-
yly- Co-
yly-Co- cyanocob
yly-Co-cyanocob amide,</w>
yl urea.</w>
yl trinitrate</w>
yl trimethyl
yltrimethyl ammoni
yltrimethylammoni um),</w>
yl trifluoro
yltrifluoro acetamide</w>
yl transferases</w>
yl transferase-mediated</w>
yl sulfate-
ylsulfate- polyacrylamide</w>
yl stearic</w>
yl sparteine</w>
yl propan
ylpropan ol
ylpropanol amine)</w>
yl piperazin-1-
ylpiperazin-1- yl)butyl]-3-(2H)-pyridazinone),</w>
yl phosphono
ylphosphono fluoridate</w>
yl phosphate.</w>
yl oric</w>
yl or.</w>
yl on
ylon est)</w>
yl line-induced</w>
yl lin</w>
yl lactic</w>
yl ine.</w>
yl ine-induced</w>
yl in,</w>
yl ifolia</w>
yl hydrazone</w>
yl histamine</w>
yl glycine,</w>
yl es,</w>
yl ecgonine</w>
yl deacetyl
yldeacetyl thym
yldeacetylthym oxamine.</w>
yl cytosine)</w>
yl cysteine</w>
yl cl
ylcl idine</w>
yl cine</w>
yl ceramide</w>
yl bis
ylbis (
ylbis( oxy)
ylbis(oxy) (2,
ylbis(oxy)(2, 2-
ylbis(oxy)(2,2- dimethyl
ylbis(oxy)(2,2-dimethyl pentano
ylbis(oxy)(2,2-dimethylpentano ic</w>
yl benzo(F
ylbenzo(F )-
ylbenzo(F)- quinoxaline</w>
yl benz
ylbenz ene)</w>
yl arthropathy</w>
yl anilide</w>
yl aminomethyl</w>
yl amino-peptidase</w>
yl amino)</w>
yl amino
ylamino antipyr
ylaminoantipyr ine).</w>
yl amine-induced</w>
yl amine),</w>
yl actoid</w>
yl acti
ylacti de-
ylactide- co-
ylactide-co- glyc
ylactide-co-glyc olide</w>
yl [1,2,4]-
yl[1,2,4]- triazolo
yl[1,2,4]-triazolo [2,3-
yl[1,2,4]-triazolo[2,3- a[1,
yl[1,2,4]-triazolo[2,3-a[1, 3,5]
yl[1,2,4]-triazolo[2,3-a[1,3,5] triazin-
yl[1,2,4]-triazolo[2,3-a[1,3,5]triazin- 5-
yl[1,2,4]-triazolo[2,3-a[1,3,5]triazin-5- yl-aminoethyl)phenol</w>
yl :</w>
yl -associated</w>
yl ),</w>
yl (1)-
yl(1)- O-
yl(1)-O- Me-
yl(1)-O-Me- Tyr
yl(1)-O-Me-Tyr 2,
yl(1)-O-Me-Tyr2, Arg
yl(1)-O-Me-Tyr2,Arg 8]-
yl(1)-O-Me-Tyr2,Arg8]- vasopressin.</w>
yiel ded,</w>
yiel d.</w>
yg ous</w>
yg motaxis</w>
yet- unknown</w>
yelo id</w>
yellow -blue</w>
yel inating</w>
years ];</w>
years =0.9
years=0.9 5)</w>
year-old- woman</w>
year- period.</w>
year- period,</w>
year- on-
year-on- year</w>
year- old)</w>
year- 2003</w>
year s]</w>
year s/
years/ patient.</w>
ye ph
yeph rine</w>
ye lography</w>
ye logram</w>
ye ga
yega ard</w>
ye es</w>
yclopent -1-</w>
yclo ar
ycloar ten
ycloarten ol</w>
yclo (2,
yclo(2, 2,
yclo(2,2, 1)
yclo(2,2,1) hept
yclo(2,2,1)hept ane-
yclo(2,2,1)heptane- 2-
yclo(2,2,1)heptane-2- endo
yclo(2,2,1)heptane-2-endo -3-
yclo(2,2,1)heptane-2-endo-3- endo-
yclo(2,2,1)heptane-2-endo-3-endo- dicarbox
yclo(2,2,1)heptane-2-endo-3-endo-dicarbox imido
yclo(2,2,1)heptane-2-endo-3-endo-dicarboximido ]-
yclo(2,2,1)heptane-2-endo-3-endo-dicarboximido]- glutarimide</w>
yclin es.</w>
yclin -based</w>
ycl ing</w>
ycl ic-
yclic- antidepressant-induced</w>
ycl an)</w>
ycin- pimozide</w>
ycin- intermediate</w>
ycin- cefazolin</w>
ycin- carbamazepine</w>
ycin- D,</w>
ycill in/clavulanic</w>
ychol y
ycholy sis,</w>
ychol ate-3,7-disulfate</w>
ych iatric</w>
yc ylhistamine</w>
yc usis.</w>
yc tur
yctur ia,</w>
yc tic,</w>
yc open
ycopen e,</w>
yc oly
ycoly sis
ycolysis "),</w>
yc ol)</w>
yc log
yclog yl,</w>
yc ine,</w>
yc in:</w>
yc in).</w>
yc in),</w>
yc in's</w>
yc illin</w>
yamo ya</w>
yamo y
yamoy a-like</w>
y/ white</w>
y/ prick
y/prick ly</w>
y/ neurosurgery</w>
y/ laser-Doppler</w>
y/ interscalene</w>
y/ failure.</w>
y/ coccidioidomy
y/coccidioidomy co
y/coccidioidomyco sis,</w>
y/ biochemical</w>
y/ appearance</w>
y/ anticancer</w>
y/ analgesic</w>
y/ amo
y/amo tiv
y/amotiv ation'</w>
y/ 14</w>
y. o.</w>
y. 8.</w>
y. 2.</w>
y-to- consumption</w>
y-to- administer</w>
y-- two</w>
y-- specifically,</w>
y-- not</w>
y-- involving</w>
y-- influence</w>
y-- clinical</w>
y-- case</w>
y-- as</w>
y-- after</w>
y-- MR</w>
y- uterine</w>
y- taking</w>
y- sympathetic</w>
y- state
y-state ')</w>
y- severe</w>
y- resulting</w>
y- red</w>
y- promoting</w>
y- powder</w>
y- over</w>
y- oriented</w>
y- na</w>
y- measured</w>
y- low-birth-weight</w>
y- level</w>
y- inducing</w>
y- improving</w>
y- imperfor
y-imperfor ate-
y-imperforate- an
y-imperforate-an us-
y-imperforate-anus- spina</w>
y- high-dose</w>
y- handling</w>
y- glutar
y-glutar yl</w>
y- friend</w>
y- followed</w>
y- flocculent</w>
y- echocardiographic</w>
y- dr
y-dr ying,</w>
y- dependent</w>
y- demand</w>
y- cycl
y-cycl ine,</w>
y- control</w>
y- confirmed</w>
y- case</w>
y- blood</w>
y- bean</w>
y- Ze
y-Ze iss,</w>
y- VE
y-VE P
y-VEP s-
y-VEPs- color</w>
y- V
y-V ella</w>
y- Oster
y-Oster ri
y-Osterri eth</w>
y- Lis
y-Lis s,</w>
y- 1</w>
y tri
ytri l;</w>
y tor
ytor in-
ytorin- Merc
ytorin-Merc k/
ytorin-Merck/ Schering-
ytorin-Merck/Schering- Plough)</w>
y ton's</w>
y thesis</w>
y spondy
yspondy ly</w>
y smo
ysmo graphy</w>
y scale</w>
y razole</w>
y rate.</w>
y quil
yquil ;</w>
y phenylglycol</w>
y phene</w>
y ot
yot o-
yoto- Wistar</w>
y on</w>
y omic</w>
y ol)</w>
y ocardi
yocardi tis,</w>
y novi
ynovi tis.</w>
y nephrine</w>
y na
yna ud's</w>
y mpt
ympt ot
ymptot es)</w>
y ment.</w>
y man's</w>
y m</w>
y leth
yleth ane
ylethane -1,2-
ylethane-1,2- diamine</w>
y leph
yleph ed
ylephed rine,</w>
y ki</w>
y k2),</w>
y ingly</w>
y ing
ying rheumatoid</w>
y hyperreflexia,</w>
y h
yh dro
yhdro genase</w>
y grams</w>
y glycine,</w>
y ester
yester day,</w>
y er.</w>
y en
yen );</w>
y ell</w>
y di
ydi mitis.</w>
y des</w>
y den</w>
y d</w>
y d
yd alis
ydalis ),</w>
y cycl
ycycl ics</w>
y choline-induced</w>
y ce
yce tin-</w>
y azine</w>
y anodine</w>
y am
yam i</w>
y algia,</w>
y ad
yad h,</w>
y a
ya hoo
yahoo .
yahoo. it).</w>
y ]</w>
y >
y> motor,</w>
y =
y= uranium</w>
y :
y: demand.</w>
y 2</w>
y .)</w>
y ."</w>
y -1.2</w>
y )]</w>
y '.</w>
y ')</w>
y ").</w>
y "),</w>
xylo metazol
xylometazol ine.</w>
xylo ca
xyloca ineR</w>
xylazine- sedated</w>
xylazine- ketamine-induced</w>
xylaz ine/kg</w>
xylaz ine's</w>
xyl yl-derivatives</w>
xyl yl-</w>
xyl ator</w>
xy razine</w>
xy oli
xyoli tic</w>
xy metac
xymetac aine</w>
xy li
xyli di
xylidi de</w>
xy ethyl
xyethyl )-3-
xyethyl)-3- pyridin
xyethyl)-3-pyridin ecarbox
xyethyl)-3-pyridinecarbox imid
xyethyl)-3-pyridinecarboximid amide</w>
xiv an</w>
xiv an)</w>
xipar in</w>
xip amide.</w>
xip amid
xipamid .</w>
xi es.</w>
xi dized</w>
xi ated</w>
xi al,</w>
xi -aminocaproic</w>
xer ophthalmia</w>
xenon- contrasted</w>
xenon- computerized</w>
xenon- CT</w>
xenograf ts,</w>
xenograf t,</w>
xenobio tics</w>
xenobio tic-
xenobiotic- metabolizing</w>
xenobio tic,</w>
xenobio tic(s)</w>
xeno estrogens</w>
xeno estrogen
xenoestrogen s)</w>
xen otransplantation</w>
xanthine- metabolising</w>
xanthine- derivative</w>
xanth osine,</w>
xanth omata</w>
xanth omas</w>
xanth omas.</w>
xanth ines.</w>
xanth ine/
xanthine/ xanthine</w>
xanth ine.</w>
xanth ane</w>
x10 3/
x103/ mul</w>
x10 (12
x10(12 )/
x10(12)/ L,</w>
x/ wk</w>
x/ minute</w>
x-then-cisDD P)</w>
x- rays</w>
x- ra
x-ra y.</w>
x- ph
x-ph os)</w>
x- linked</w>
x- irradiation</w>
x- hypothalamus-
x-hypothalamus- hypophy
x-hypothalamus-hypophy sis</w>
x- axis</w>
x ton</w>
x ley's</w>
x ity</w>
x ity.</w>
x isting</w>
x is</w>
x is,</w>
x ir</w>
x ingly</w>
x ing,</w>
x in.</w>
x in-
xin- V</w>
x ili
xili um)</w>
x il</w>
x idergic</w>
x ial</w>
x antine</w>
x anthe
xanthe las
xanthelas mata</w>
x ant</w>
x a
xa 2)</w>
x ]</w>
x Pyruvate</w>
x Phenyl
xPhenyl alanine</w>
x P,</w>
x P)</w>
x MD).</w>
x LP/J</w>
x DBA/2J</w>
x C57B1/6</w>
x 400</w>
x 3cm</w>
x 3).</w>
x 24
x24 ,000,</w>
x 2.5-
x2.5- driven</w>
x 1A</w>
x 1.5</w>
x 1.5+/-0.1</w>
x 1.1+/-
x1.1+/- 0.1</w>
x 0.9</w>
x -related</w>
x -induced</w>
x -</w>
x -1,</w>
x ):</w>
www. psych
www.psych onom
www.psychonom ic
www.psychonomic .
www.psychonomic. org/
www.psychonomic.org/ archi
www.psychonomic.org/archi ve.</w>
www. clinicaltrial
www.clinicaltrial s.gov,</w>
www. act
www.act ab
www.actab iome
www.actabiome dic
www.actabiomedic a.
www.actabiomedica. it)</w>
wt/ wt),</w>
wt/ day)</w>
wt/ day).</w>
wt/ 100</w>
wt -1.h-1)</w>
wt ):</w>
wt )/
wt)/ rat</w>
wt (-1).
wt(-1). day(-1)</w>
wron g
wrong ly</w>
writh ings</w>
writh ings.</w>
writh ings,</w>
writh es</w>
writ ings</w>
wrist watch</w>
wrin k
wrink ling,</w>
woun ds.</w>
woun ds,</w>
woun d.</w>
worth while,</w>
worsen ing)</w>
worris ome</w>
worm s</w>
worm s.</w>
world 's</w>
world '</w>
worl d-
world- wide</w>
work- ups</w>
work- ups.</w>
work- performing</w>
work- load</w>
work up.</w>
work up
workup ;</w>
work shop
workshop .</w>
work place.</w>
work load.</w>
work days.</w>
work ;</w>
work ,"</w>
work )</w>
word s;</w>
word s:</w>
word s);</w>
wor th-
worth- while</w>
wor th,</w>
wor t</w>
wor t,</w>
wor st-
worst- case</w>
wor se-
worse- than-expected</w>
wor se)</w>
wor ry</w>
wor n,</w>
wor e</w>
wor ds)</w>
wor ded</w>
women =
women= 2.5%</w>
women /year.</w>
women .(ABSTRACT</w>
women --
women-- adverse</w>
women ,vs</w>
woman- years=0.95)</w>
woman- years.</w>
woman- years,</w>
wom an;</w>
wom an:</w>
wom an).</w>
wom an
woman ?</w>
wol sc
wolsc ine</w>
wol ff-Parkinson-White</w>
wo ven</w>
wo ol</w>
wo od
wood en-
wooden- hard
wooden-hard "</w>
wo o
woo den</w>
wo A)</w>
wk s)</w>
wk s).</w>
wk ;</w>
wk .)</w>
wk (-1)</w>
witnes sed,</w>
without ;</w>
within- population</w>
within- participant</w>
within- day,</w>
withhel d;</w>
withhel d/
withheld/ dose</w>
withdre w.</w>
withdrawal- suggest</w>
withdrawal- like</w>
withdrawal s/
withdrawals/ drop-outs</w>
withdrawal .(ABSTRACT</w>
withdraw als.</w>
withdraw al/
withdrawal/ chronic</w>
withdraw al),</w>
withdraw al"</w>
withdraw ,</w>
with- valproate</w>
with- drawn.</w>
with stand</w>
with out-
without- valproate</w>
with in:</w>
with hold</w>
with anol
withanol ides</w>
wit ting</w>
wit th</w>
wit t</w>
wit ness</w>
wis s,</w>
wis ps</w>
winterian us.</w>
winterian us,</w>
window s.</w>
window ;</w>
window :</w>
window '</w>
wind k
windk essel</w>
wind -
wind- up
wind-up '</w>
win k-
wink- S
wink-S ak
wink-Sak ur
wink-Sakur ada</w>
wild- types</w>
wild- type
wild-type -like</w>
wild- running</w>
widen ing;</w>
widen ing.</w>
widen ing),</w>
widen ed,</w>
widely- used</w>
widely- different</w>
wide- spread</w>
wide- spectrum</w>
wide- nec
wide-nec ked</w>
wide ly:</w>
wide .</w>
wide -type</w>
wid ths</w>
wid th)</w>
wid th
width /
width/ external</w>
wid ec
widec om
widecom ple
widecomple x</w>
wi se-
wise- increasing</w>
wi res.</w>
wi res,</w>
wi reless</w>
wi re)</w>
whor ls</w>
whor ling</w>
whor led,</w>
whor l</w>
whole- organ</w>
whole- mount</w>
whole- field</w>
whol e).</w>
white- mat
white-mat ter-
white-matter- damaging</w>
white- cell,</w>
whit es.</w>
whit e;</w>
whit e/
white/ other</w>
whit e).</w>
whic h
which --in</w>
whi tis
whitis h.</w>
whi ps</w>
whi le;</w>
where after</w>
when ?</w>
when :</w>
whel ming</w>
wheel s</w>
wheel ing.</w>
wheat ger
wheatger m-
wheatgerm- agglutinin</w>
wheat -dependent</w>
wheat '</w>
whe ther:</w>
whe re,</w>
whe e
whee zes</w>
whe at.</w>
whe als</w>
whe als,</w>
whate ver,</w>
whate ver
whatever .(ABSTRACT</w>
wh is
whis k
whisk y.</w>
wh er
wher as</w>
wellbe ing:</w>
wellbe ing.</w>
well-be ing.</w>
well- vascularized</w>
well- tried</w>
well- trained</w>
well- suited</w>
well- substantiated</w>
well- served</w>
well- selected</w>
well- recognized.</w>
well- recognized,</w>
well- preserved</w>
well- planned</w>
well- managed</w>
well- maintained</w>
well- known;</w>
well- known.</w>
well- gran
well-gran ulated</w>
well- documented,</w>
well- document
well-document ed;</w>
well- developed,</w>
well- designed</w>
well- designed,</w>
well- demarcated,</w>
well- defined.</w>
well- defined,</w>
well- characterized,</w>
well- characterised</w>
well- balanced</w>
well- appreciated</w>
well- appear
well-appear ing,</w>
well s</w>
well known,</w>
well ])</w>
well -</w>
well )-induced</w>
wel led,</w>
weight/ tibia</w>
weight/ heart</w>
weight/ day.</w>
weight/ day),</w>
weight/ d.</w>
weight/ d)</w>
weight/ bodyweight</w>
weight- to-
weight-to- tail</w>
weight- relative</w>
weight- reduction</w>
weight- gain.</w>
weight- drop</w>
weight- control</w>
weight- bearing</w>
weight -related</w>
weight -1</w>
weight -1)</w>
weigh ty</w>
ween- 20,</w>
weeks- delayed</w>
weeks- 72</w>
weeks- 5</w>
weekly- times-
weekly-times- four</w>
weekly- given</w>
week- old,</w>
week- interval</w>
week- gestation</w>
week- 8</w>
week s],</w>
week s.(ABSTRACT</w>
week s.
weeks. At</w>
week s-1</w>
week s'
weeks' gestation.</w>
week ly;</w>
week end.</w>
week days</w>
week day</w>
week 1</w>
week -P
week-P anax</w>
week -</w>
week -2</w>
week -1</w>
week -1,</w>
week );</w>
week (-1),</w>
week (-1))</w>
wedg ing</w>
wedg es</w>
web sites</w>
web site</w>
web -based</w>
wearing- off)</w>
wearing- off'</w>
wear .</w>
weap ons</w>
weap on</w>
wean ling
weanling s.</w>
weak ness)</w>
weak est).</w>
weak er.</w>
weak er,</w>
weak er)</w>
we ver
wever :</w>
we ther</w>
we st,</w>
we lled</w>
we il
weil ers</w>
we gi
wegi an</w>
we ep
weep ing.</w>
we dge
wedge -like</w>
we b</w>
we are
weare r
wearer s.</w>
we ar,</w>
we als.</w>
we al-
weal- and-
weal-and- flare</w>
we a
wea ther</w>
way- K
way-K ath
way-Kath oli
way-Katholi ek</w>
way- ANOVA,</w>
way :</w>
wax ed</w>
wax ).</w>
wavefron ts</w>
wavefron t.</w>
wave lets</w>
wave -related</w>
wave ),</w>
wave "</w>
wav es)</w>
water- solub
water-solub le,</w>
water- reple
water-reple te,</w>
water- prefer
water-prefer ring,</w>
water- maze,</w>
water- load</w>
water- finding</w>
water- drinking</w>
water- deprivation</w>
water- depri
water-depri ved,</w>
water- based</w>
water y-flocculent</w>
water shed</w>
water proof</w>
water -treated</w>
water -induced</w>
watch ),</w>
wat ts</w>
wat ers</w>
wat ching</w>
wat a</w>
wast ing;</w>
wast e'</w>
wash-out '</w>
wash-out "</w>
wash- out,</w>
wash out
washout ).</w>
wash ings,</w>
wash ing).</w>
wash ing),</w>
wash in</w>
was n
wasn 't</w>
was h,</w>
warn ings.</w>
warn ing"</w>
warm- water-immersion</w>
warm- water,</w>
warm- reactive</w>
warm- reacting</w>
warm- cool</w>
warm th.</w>
warm ).</w>
warfarin- using</w>
warfarin- use</w>
warfarin- type</w>
warfarin- metronidazole</w>
warfarin- clopidogrel,</w>
warfarin- aspirin-
warfarin-aspirin- clopidogrel.</w>
warfarin- aspirin,</w>
warfarin- amoxicillin/clavulanate</w>
warfarin- AM/CL</w>
warfar in/
warfarin/ fluconazole</w>
warfar in-like</w>
warfar in).</w>
ward- mas
ward-mas king,</w>
ward- Se
ward-Se e
ward-See king</w>
ward- -associated</w>
war t</w>
war ren
warren ted.</w>
war ns</w>
war ds.</w>
wan no
wanno pathy</w>
wan dering</w>
wan der
wander ings</w>
wan 's</w>
wall-to- lumen</w>
wall-to- chamber</w>
wall- produced</w>
wall erian</w>
wall :</w>
walk -in</w>
walk !</w>
wal ks</w>
wal d</w>
wakeful ness:</w>
wakeful ness.</w>
wake- up</w>
wake- sleep-wake</w>
wake- promoting</w>
wake ful</w>
waist -
waist- hip</w>
wa ving</w>
wa ited</w>
wa it
wait listed</w>
wa ist</w>
wa ist,</w>
wa i</w>
w/ w
w/w ),</w>
w/ v,</w>
w/ v),</w>
w/ o</w>
w- th</w>
w- fluoro
w-fluoro propyl-2
w-fluoropropyl-2 [beta]-
w-fluoropropyl-2[beta]- carb
w-fluoropropyl-2[beta]-carb omethoxy-3
w-fluoropropyl-2[beta]-carbomethoxy-3 [beta]-
w-fluoropropyl-2[beta]-carbomethoxy-3[beta]- (4-iodo
w-fluoropropyl-2[beta]-carbomethoxy-3[beta]-(4-iodo phenyl)
w-fluoropropyl-2[beta]-carbomethoxy-3[beta]-(4-iodophenyl) nor
w-fluoropropyl-2[beta]-carbomethoxy-3[beta]-(4-iodophenyl)nor tropane</w>
w- coloured</w>
w yer</w>
w ven</w>
w ti
wti h</w>
w t.;</w>
w t.
wt. );</w>
w riter
writer 's</w>
w on
won dered</w>
w ob
wob bl
wobbl er</w>
w n</w>
w n
wn ship</w>
w ley</w>
w ks.</w>
w it</w>
w ish.</w>
w ing.</w>
w ing's</w>
w illed</w>
w ill,</w>
w hir
whir l-like</w>
w h</w>
w ent,</w>
w d.</w>
w as.</w>
w as-
was- observed</w>
w ar</w>
w anting</w>
w an</w>
w alled</w>
w ai
wai ver</w>
w af
waf ers</w>
w A)</w>
w 4,</w>
w 3</w>
w 35</w>
w /</w>
w )-
w)- nitro-L-arginine,</w>
vulner able.</w>
vulg ed</w>
vul var</w>
vul ation.</w>
vs. 4</w>
vs. -2.
vs.-2. 8;</w>
vs- 50
vs-50 30</w>
vs- 0.
vs-0. 237</w>
vp O2,</w>
vp O2).</w>
vox il</w>
vox el-
voxel- by-
voxel-by- voxel</w>
vox amine-induced</w>
vouc her
voucher s)</w>
voric on
voricon izole</w>
vomiting .(ABSTRACT</w>
vomiting -like</w>
vomit us</w>
vomit us,</w>
vomit ting</w>
vomit ting,</w>
vomit ing/
vomiting/ retching</w>
volunte er.</w>
volunt ary,</w>
volun tar
voluntar ily.</w>
volume/ hypotension,</w>
volume/ ICH</w>
volume- pressure</w>
volume- overloaded</w>
volume- loaded</w>
volume- expanded</w>
volume ;</w>
volume /g</w>
volume -induced</w>
volume -evoked</w>
volume -dependent</w>
volum es;</w>
volum es/
volumes/ s,</w>
volum es)</w>
volu metry</w>
voltage- operated</w>
voltage- dependence</w>
voltage- activated</w>
volt s;</w>
volt ages</w>
voli tional.</w>
volati lization</w>
vol ution</w>
vol t</w>
vol le
volle ys</w>
vol aemic</w>
vol aemia</w>
vol -
vol- %</w>
vol )</w>
vol %)</w>
vocal izations.</w>
vocal ization;</w>
voc ational</w>
voc alized</w>
voc ad
vocad o)</w>
voc abul
vocabul ary</w>
voc able</w>
vo virus</w>
vo virus.</w>
vo king</w>
vo ices</w>
vo ice-
voice- response</w>
vo ).</w>
vivo/ vitro</w>
vivo/ in</w>
vivo .We</w>
vivo ).</w>
vivo ),</w>
viv ax</w>
viv ax.</w>
vitro --a</w>
vitro ).</w>
vitro "</w>
vitre ous,</w>
vitamin- deficient</w>
vitamin- binding</w>
vitamin- K-dependent</w>
vitamin- D2-
vitamin-D2- treated</w>
vitamin s)</w>
vitamin )</w>
vit y-dependent</w>
vit s'</w>
vit ritis.</w>
vit e,</w>
vit am
vitam er</w>
vit al.</w>
vit al,</w>
visual- motor</w>
visual- field</w>
visual ization.</w>
visual ised</w>
visu os
visuos patial</w>
visu o-
visuo- vestibular</w>
visu ally.</w>
vist a</w>
vist ).</w>
visit s;</w>
visit s-a</w>
visit s),</w>
visit ;</w>
viscer osensory</w>
viscer o-
viscero- somatic</w>
viscer ally.</w>
viscer al-
visceral- acetic</w>
viscer a.</w>
visc osa</w>
vis ing</w>
vis e</w>
vis co
visco elastic</w>
vis aged.</w>
vis -</w>
virus/ hepatitis</w>
virus/ acquired</w>
virus- producing</w>
virus- negative</w>
virus- coinfected</w>
virus- RNA.</w>
virus- (HBV)</w>
virus -</w>
virus )-
virus)- induced.</w>
viru static</w>
viru ses,</w>
virions/ day</w>
virions/ day).</w>
viri lization</w>
viri lit
virilit y;</w>
virg in)</w>
viral- resistant</w>
viral- hepatitis
viral-hepatitis -
viral-hepatitis- like.</w>
vir us-associated</w>
vir amidine,</w>
vir al-associated</w>
vir al'</w>
vir :</w>
vir .</w>
vir ,</w>
violet -related</w>
viol ent)</w>
viol ations</w>
viol ations,</w>
viol ation</w>
viol acea</w>
vinorelbine/ cisplatin</w>
vinorelbine/ cisplatin,</w>
vinorelb ine-associated</w>
vinorelb ine-</w>
vindes ine-
vindesine- cisplatin</w>
vincristine- induced,</w>
vincristine- -associated</w>
vincrist ine:</w>
vincrist ine/
vincristine/ doxorubicin/dexamethasone],</w>
vincrist ine-related</w>
vincrist ine)</w>
vincrist ine).</w>
vinc ris
vincris it
vincrisit ine-evoked</w>
vinc amycin</w>
vinc a-
vinca- alkaloid</w>
vinblast ine-induced</w>
vinblast ine).</w>
vin yllactic</w>
vin orum</w>
vin ka</w>
vin ifera</w>
vin ar</w>
vin ).</w>
vilox azine</w>
villi .</w>
vill ar</w>
vil le</w>
vil ine
viline ar,</w>
vil ian</w>
vignet tes</w>
vignet te</w>
vigil ant
vigilant !</w>
vigil ance:</w>
vigil anc
vigilanc ec
vigilancec enters</w>
vigabatr in-associated</w>
vigabat rin)</w>
vigabat rin
vigabatrin 's</w>
vig or</w>
view s,</w>
view point.</w>
view --not</w>
videotap ing,</w>
videotap ed,</w>
videotap e.</w>
video- urodynamic</w>
video- typed</w>
video- polygraphic</w>
video- ocu
video-ocu lography.</w>
video- monitoring</w>
video- monitored</w>
video- electromyographic</w>
video- electroencephalography</w>
video- electroencephalography.</w>
video- electroencephalographic</w>
video sequenc
videosequenc es
videosequences ].</w>
video intensity.</w>
video intensities</w>
video fluoroscopy.</w>
video ),</w>
vide ore
videore corded</w>
vide op
videop up
videopup il
videopupil logram</w>
vide omicroscopy</w>
vide om
videom an
videoman ometry</w>
vide od
videod ensit
videodensit ometric</w>
vide o.</w>
vide d
vided -dose</w>
vid ing</w>
vid inated</w>
vid )</w>
victim s,</w>
victim ization,</w>
victim iz
victimiz ation/
victimization/ perpetration</w>
vic rist
vicrist ine-induced</w>
vic orn
vicorn um</w>
vic in
vicin ity.</w>
vic ellular</w>
vibrissa e</w>
vibrissa e,</w>
vibr ations</w>
vibr ation,</w>
viagra .</w>
viagra ):</w>
vi xil</w>
vi x</w>
vi ties.</w>
vi sion;</w>
vi sion--
vision-- that</w>
vi sion).</w>
vi sibly</w>
vi rod
virod h
virodh amine</w>
vi remia,</w>
vi re
vire mic.</w>
vi rac
virac ept</w>
vi per,</w>
vi osulf
viosulf on)</w>
vi omycin</w>
vi leg
vileg es</w>
vi l</w>
vi go
vigo ur,</w>
vi gi
vigi base.</w>
vi es.</w>
vi er</w>
vi ed</w>
vi bacterium</w>
vi able,</w>
vi able"</w>
vi )</w>
vetir acetam
vetiracetam :</w>
veter ans.</w>
vestibulo- oculomotor</w>
vestibulo pathy.</w>
vestibul i</w>
vestibul ar)</w>
vestibu lop
vestibulop at
vestibulopat y.</w>
vest .
vest. 6
vest.6 2:</w>
vessel s;</w>
vessel -
vessel- irritating</w>
vessel )</w>
vesico- ureteric</w>
vesico- ureteral</w>
vesi cul
vesicul ar)</w>
vesi cle.</w>
vesi cle
vesicle )</w>
ves tib
vestib ule</w>
ves nar
vesnar inone,</w>
ves cial</w>
ves /
ves/ analgesics</w>
ves .(ABSTRACT</w>
ves --
ves-- four</w>
ves ).</w>
ves '.</w>
very- low</w>
very- low-
very-low- birthweight</w>
very- high-efficacy</w>
vertig o/
vertigo/ somnolence</w>
vertig inous</w>
verticillat us.</w>
vertic al,</w>
vertebra .</w>
vertebr al-
vertebral- basilar</w>
verteb rates.</w>
verteb rates,</w>
verte d"</w>
verte bra</w>
versus- host-
versus-host- disease</w>
versus ;</w>
verm ectin,</w>
verbal ization,</w>
verbal ization)</w>
verb ally,</w>
veratri d
veratrid ine-evoked</w>
verapamil/ EPOCH</w>
verapamil- responsive</w>
verapamil- pretreated</w>
verapamil- intoxicated</w>
verapamil- asystolic</w>
verapamil .(ABSTRACT</w>
verapamil --report</w>
verapamil +
verapamil+ pace,</w>
verapamil ).</w>
verapamil ),</w>
verapamil 's</w>
verapam il-treated</w>
ver- pressing</w>
ver- operator</w>
ver ve
verve t</w>
ver um</w>
ver tically</w>
ver ted</w>
ver sol
versol )</w>
ver sions</w>
ver sion:</w>
ver sion).</w>
ver sati
versati le</w>
ver sar
versar y,</w>
ver sa;</w>
ver million</w>
ver mian</w>
ver mal</w>
ver ing,</w>
ver ine,</w>
ver ification.</w>
ver ifi
verifi ed;</w>
ver age.</w>
ver a;</w>
ver a:</w>
ver a.</w>
ver )</w>
ver ).</w>
venul es,</w>
venul ae,</w>
ventro- oral</w>
ventro- lateral</w>
ventro rostral</w>
ventro posterolateral</w>
ventro medial,</w>
ventro medi
ventromedi ally</w>
ventro lateralis</w>
ventriculo plasty.</w>
ventriculo plasty,</w>
ventriculo peritoneal</w>
ventriculo megaly</w>
ventriculo atrial</w>
ventricular- streptozotocin</w>
ventricular- nodal</w>
ventricular- intraventricular</w>
ventricul r</w>
ventricul itis</w>
ventricul itis:</w>
ventricul itis,</w>
ventricul ectomy</w>
ventricul ectom
ventriculectom y?</w>
ventricu lography,</w>
ventricu lograph
ventriculograph ies</w>
ventricu logram</w>
ventricu log
ventriculog raphy
ventriculography )</w>
ventricle- to-body</w>
ventric ularly.</w>
ventric ular
ventricular /
ventricular/ body</w>
ventric les)</w>
ventric les
ventricles .3.</w>
ventric le
ventricle ),</w>
ventric lar</w>
ventral- medial,</w>
ventr uc
ventruc ular</w>
ventr almost</w>
ventr al,</w>
ventilat ors</w>
ventilat or
ventilator :</w>
ventil ation.(ABSTRACT</w>
ventil ation),</w>
ventil ated;</w>
ventil ate</w>
venti tial</w>
venti r
ventir cular</w>
vent yl</w>
vent ative</w>
vent ),</w>
venom s</w>
venom ation</w>
venom .</w>
venom )</w>
venoconstric tive</w>
venoconstric tion,</w>
veno- arteriolar</w>
venlafaxine- tranylcypromine</w>
venlafaxine- MAOI</w>
venlafaxine- -in</w>
venlafax ine-treated</w>
venipunct ures,</w>
venipunct ure.</w>
venep uncture</w>
venep unct
venepunct ure,</w>
ven- month</w>
ven- astrocyte</w>
ven ular.</w>
ven ues</w>
ven tion,</w>
ven ous.</w>
ven otomy</w>
ven otomized</w>
ven opathy</w>
ven omotor</w>
ven ography.</w>
ven ography,</w>
ven ographically</w>
ven ographic</w>
ven odi
venodi lation.</w>
ven ez
venez u
venezu el
venezuel ae,</w>
ven ess.</w>
ven d
vend ors</w>
ven ac
venac av
venacav ogram</w>
velocity- time</w>
velocity- DPOAEs</w>
veloci metry</w>
veloci metry.</w>
veloc ity:</w>
veloc ity)</w>
vel y--after</w>
vel ty-</w>
vel on</w>
vel ing</w>
vel ess</w>
vel er's</w>
vel ed</w>
vein- wall</w>
vein- femoral</w>
vein- atrial</w>
vein s;</w>
vein s:</w>
vein s'</w>
vehicle/ vehicle</w>
vehicle/ scopolamine</w>
vehicle/ saline,</w>
vehicle/ prostaglandin</w>
vehicle- only</w>
vehicle- line
vehicle-line age"</w>
vehicle- controlled</w>
vehicle- appropriate</w>
vehic les)</w>
veget ations</w>
veget ation</w>
veget arian</w>
veget able</w>
ved- type</w>
ved- cell</w>
vecuroni um:</w>
vecuroni um).</w>
vector- mediated</w>
vector- expressing</w>
vector cardiography</w>
vector cardio
vectorcardio gram
vectorcardiogram :</w>
vect or)</w>
vec uron
vecuron i</w>
vec ;</w>
ve/ repressive</w>
ve/ emotional</w>
ve/ anxiety</w>
ve/ adjuvant</w>
ve- function",</w>
ve- effect</w>
ve- conduction</w>
ve- climbing</w>
ve- break</w>
ve- born</w>
ve- bilateral</w>
ve- Rous
ve-Rous sy</w>
ve xingly</w>
ve olitis,</w>
ve ment.</w>
ve let</w>
ve gan</w>
ve d"</w>
ve d
ved berg</w>
ve ar</w>
ve aled</w>
ve .,</w>
ve .).</w>
ve .(ABSTRACT</w>
ve ."</w>
ve --
ve-- active</w>
ve +
ve+ diabetes</w>
ve '.</w>
vastatin- ezetimibe</w>
vastat ine
vastatine zetimibe</w>
vastat in)</w>
vast us</w>
vast ine,</w>
vasospas m-induced</w>
vasospas m--a</w>
vasore active</w>
vasopressin- supported</w>
vasopressin- regulated</w>
vasopressin- deficient</w>
vasopress or-induced</w>
vasopress inergic</w>
vasopress in:</w>
vasopress in-sensitive</w>
vasopress in).</w>
vasopress in
vasopressin ergic)</w>
vasopar alysis</w>
vasopar aly
vasoparaly tic</w>
vasop legia.</w>
vasomot ric
vasomotric ity</w>
vasomot or,</w>
vasomo tion,</w>
vasomo tion),</w>
vasodilat ory.</w>
vasodilat or;</w>
vasodilat or/
vasodilator/ beta-adrenergic</w>
vasodilat or-induced</w>
vasodilat or-
vasodilator- stimulated</w>
vasodilat ations.</w>
vasodilat ation.
vasodilatation. In</w>
vasodilat ation-induced</w>
vasodil ations)</w>
vasodil ation/
vasodilation/ hemorrhage</w>
vasodil ation),</w>
vasoconstrict ory</w>
vasoconstric tion;</w>
vasoconstric tion).</w>
vasocon struction</w>
vaso- constriction</w>
vaso regulatory</w>
vaso occlusive</w>
vaso depressor,</w>
vasculo pathology.</w>
vasculo pathies</w>
vasculo pathies.</w>
vasculo pathic</w>
vasculiti s?</w>
vasculiti s--a</w>
vasculiti s--
vasculitis-- cross-reactivity</w>
vasculiti di
vasculitidi es,</w>
vasculiti des</w>
vasculiti des.</w>
vasculiti des,</w>
vasculat ure)</w>
vascular- directed</w>
vascular- E
vascular-E B-
vascular-EB- albumin</w>
vascular ization.</w>
vascular is,</w>
vascular .</w>
vascular -selective</w>
vascular -related</w>
vascular -mediated</w>
vascular "</w>
vascul at</w>
vas pressor</w>
vas otonic</w>
vas om
vasom us
vasomus cul
vasomuscul ar,</w>
vas olid
vasolid atory</w>
vas ocil
vasocil ators</w>
vas ocentric</w>
vas occlusive</w>
vas ectomy,</w>
vas cu
vascu al
vascual r</w>
varic oceles,</w>
varic es.</w>
varic es,</w>
variant s."</w>
variant -related</w>
variant -associated</w>
variant -1,</w>
variable- ratio</w>
variable- rate</w>
variable- capacitance</w>
variabl es;</w>
variabl es--
variables-- the</w>
variabl es)</w>
variabl es),</w>
vari es,</w>
vari ations,</w>
vari ation)</w>
vari ately</w>
vari ate,</w>
vari ance-
variance- significantly</w>
vari ance).</w>
vari an</w>
vari able;</w>
vari able
variable -dose</w>
vari ability:</w>
vardenaf il.</w>
vardenaf il,</w>
var y.</w>
var im
varim ax</w>
var ice</w>
var a.</w>
var ,</w>
vapt an.</w>
vaporiz ers.</w>
vapor izers</w>
vap our,</w>
vap or</w>
vanish ingly</w>
vanilloid /capsaicin</w>
vanilloid -1</w>
vanill in.</w>
vancomyc in;</w>
vancomyc in:</w>
vancom ycin-intermediate</w>
van s)</w>
van s'</w>
van ished.</w>
van ished,</w>
van .</w>
valvul itis,</w>
valv otomy,</w>
valu es.(ABSTRACT</w>
valu es--
values-- because</w>
valu e?</w>
valu e);</w>
valu e),</w>
valu ation</w>
valu ated.</w>
valsart an/
valsartan/ hydrochlorothiazide</w>
valsart an-induced</w>
vals ant</w>
valpro ic-acid-induced</w>
valpro ex,</w>
valpro ate-exposed</w>
valir udin,</w>
valid ates</w>
valid ;</w>
valer ate.</w>
valdec oxib.</w>
valdec oxib,</w>
valdec oxi
valdecoxi b)</w>
valacyclovir 's</w>
val ves--four</w>
val ine.</w>
val ine,</w>
val ine)</w>
val ganciclovir,</w>
val g
valg a,</w>
val ero
valero ylurea</w>
val bumin
valbumin -sensitized</w>
val acyclovir.</w>
val acyclovir-induced</w>
val a</w>
vagotom y.2.</w>
vagotom y.(ABSTRACT</w>
vagotom ized,</w>
vagotom ised.</w>
vaginal- urethral</w>
vaginal- only</w>
vagin oscopy</w>
vagin am</w>
vagin am,</w>
vagin al/
vaginal/ peri
vaginal/peri rectal</w>
vagin al.</w>
vagin a:</w>
vagal- related.</w>
vag us.</w>
vag oton
vagoton ia,</w>
vag osympathetic</w>
vag omimetic</w>
vag oly
vagoly tic.</w>
vag initis.</w>
vag inal,</w>
vag i,</w>
vag ally-induced</w>
vag al-related</w>
vaf loxacin-induced</w>
vacuol isation.</w>
vacuol isation.(ABSTRACT</w>
vacuol es;</w>
vacuol es)</w>
vacuol e-containing</w>
vacuol ation]</w>
vacuol ated)</w>
vacu um</w>
vacu olar
vacuolar ,</w>
vaccine- response</w>
vaccin es.</w>
vaccin ations</w>
vaccin ate.</w>
vacc ine;</w>
vacc ine:</w>
vaca ine-induced</w>
vac ulo
vaculo lization.</w>
vac ous</w>
vac or</w>
vac eae)</w>
va2] TRH)</w>
v/ v</w>
v/ med
v/med watch),</w>
v us</w>
v s
vs +
vs+ 0.7</w>
v ot</w>
v ory</w>
v or</w>
v on-
von- Z
von-Z umb
von-Zumb us
von-Zumbus ch</w>
v ol</w>
v mca
vmca -
vmca- PaCO2</w>
v los
vlos ulf
vlosulf on).</w>
v ite</w>
v inv
vinv last
vinvlast ine</w>
v ings</w>
v ing,"</w>
v ili
vili an,</w>
v ifol
vifol ia,</w>
v ents</w>
v ection</w>
v atriptan</w>
v ative-free</w>
v ations</w>
v ated</w>
v ard</w>
v an</w>
v all</w>
v aden
vaden e</w>
v able</w>
v a)</w>
v WF-
vWF- cleaving</w>
v PAG</w>
v O2).</w>
v HD</w>
v HD)</w>
v AV3
vAV3 V.</w>
v ;</w>
v 7
v7 a/
v7a/ T
v7a/T y</w>
v 3,
v3, 28
v3,28 6/
v3,286/ microL;</w>
v 2).</w>
v 1.5</w>
v 1-null</w>
v .
v. 3)</w>
v -treated</w>
v -
v- Ey
v-Ey k,</w>
v ))</w>
uz er</w>
uy ama</w>
uve os
uveos cl
uveoscl eral</w>
uve itic</w>
uve a</w>
utroph il-
utrophil- cytoplasmic</w>
utri ent.</w>
utr iculus</w>
utr i</w>
utr e</w>
utme g</w>
utme g)</w>
utiliz ed,</w>
utiliz e:</w>
utiliz able</w>
util isation.</w>
uti vely,</w>
uti le,</w>
utero :</w>
uterine- gland</w>
uterine- cramp</w>
uter y</w>
uter us;</w>
uter us:</w>
uter us--
uterus-- comparison</w>
uter us)</w>
uter oporphyrin</w>
uter ine,</w>
uter in</w>
uter i.</w>
uter aldehyde</w>
ute otrophic</w>
ute inizing</w>
ut ting</w>
ut ter
utter ly</w>
ut ten
utten lo
uttenlo ch
uttenloch er</w>
ut te</w>
ut ta,</w>
ut op
utop ar,</w>
ut onom
utonom ia</w>
ut ler's</w>
ut in
utin um.</w>
ut h</w>
ut en
uten sil
utensil s</w>
ut e.</w>
ut crac
utcrac ker</w>
ut an</w>
ut amine</w>
ut amen</w>
ut ,</w>
usu al,</w>
usu age</w>
ustom ary</w>
usti x</w>
usti ce,</w>
ust ulo
ustulo derma.</w>
ust in.</w>
usp inal</w>
usp ended</w>
usion- requiring</w>
usion- multilamellar</w>
usion- dosed</w>
usion- appeared</w>
usi vity</w>
usi s),</w>
usi cal</w>
ush -pull</w>
user s],</w>
user s--
users-- entered</w>
user s),</w>
user :</w>
useful ly,</w>
useful ;</w>
used-- with</w>
used-- separately</w>
use- dependence</w>
use- dependence.</w>
use- depend
use-depend ency
use-dependency );</w>
use lessness</w>
use fully</w>
use d.
used. 3</w>
use d)</w>
use d),</w>
use ?</w>
use -induced</w>
use --
use-- became</w>
use );</w>
use ).(ABSTRACT</w>
usch ka,</w>
usch er</w>
usan li</w>
usan li)</w>
usal s)</w>
usal em</w>
usal em,</w>
us-- were</w>
us-- micro
us--micro cytosis,</w>
us-- 3;</w>
us- tacrolimus</w>
us- red</w>
us- projecting</w>
us- lik
us-lik es
us-likes yndrome</w>
us- ligated</w>
us- hemorrhagic</w>
us- females</w>
us- epilepticus</w>
us- encoded</w>
us tion-
ustion- derived</w>
us sive</w>
us piril
uspiril ene</w>
us pen
uspen sion,</w>
us pan
uspan ).</w>
us ly.</w>
us like</w>
us ky</w>
us ing,</w>
us in</w>
us h.</w>
us h)</w>
us females.</w>
us er-
user- fri
user-fri end
user-friend ly</w>
us er's</w>
us eness</w>
us ci
usci ated.</w>
us ates</w>
us arium</w>
us /</w>
us /
us/ 3-h</w>
us ."</w>
us -to-
us-to- H</w>
us -mediated</w>
us -</w>
urve illance</w>
urticaria/ angioedema)</w>
urticaria- free.</w>
urticaria- angioedema.</w>
urticaria- angio
urticaria-angio de
urticaria-angiode ma.</w>
urticaria /</w>
urticaria -type</w>
urticaria -free</w>
urticar ial,</w>
urticar ia)</w>
urticar ia),</w>
ursodi ol</w>
ursodi ol,</w>
ursodeoxychol ate-3,7-disulfate</w>
urso do
ursodo ex
ursodoex ycholate-3,7-disulfate</w>
urso desoxy
ursodesoxy cholic</w>
urs son</w>
uroxi me.</w>
uroprotect ors</w>
uroprotect or,</w>
uron s.</w>
uron ide</w>
uron ectus</w>
uron ally</w>
urolog ists</w>
urolog ists.</w>
urolog ist.</w>
urolog ic,</w>
uro- oncologist.</w>
uro- conjugated</w>
uro xime</w>
uro tic'</w>
uro thi
urothi um,</w>
uro ten
uroten sin-II</w>
uro sepsis</w>
uro sepsis.</w>
uro protector</w>
uro protection,</w>
uro protection)</w>
uro propionic</w>
uro porphyrin</w>
uro pericardial</w>
uro pe
urope an</w>
uro pathy.</w>
uro monab
uromonab -
uromonab- CD3</w>
uro m
urom -1</w>
uro lithiasis,</w>
uro lith
urolith s.</w>
uro kinase)</w>
uro graphy,</w>
uro graphic</w>
uro gram</w>
uro genit
urogenit al,</w>
uro epithelium</w>
uro dynamics</w>
uro dynamically</w>
uro cid
urocid in</w>
uro ;</w>
uro /
uro/ Cap</w>
uro )</w>
urkit t</w>
urkinj e)</w>
urk inge</w>
urk at),</w>
urine- supplemented</w>
urine- stained</w>
urine- soluble</w>
urine- negative</w>
urinaly sis).</w>
urinaly ses</w>
urinaly ses;</w>
urinaly ses,</w>
urin ol.</w>
urin es)</w>
urin ation.</w>
urin ation,</w>
urin ating.</w>
urin ate</w>
urin ate)</w>
urin ary-
urinary- tract</w>
urin ary,</w>
urin ary)</w>
urin ar
urinar ia,</w>
uridine- labeling</w>
uridine- (BrdU)</w>
uricos uria.</w>
uricos uria,</w>
uric acid</w>
uri um.</w>
uri um,</w>
uri um),</w>
uri ously</w>
uri e-
urie- Sal
urie-Sal mon</w>
urgen cy
urgency /
urgency/ frequency</w>
urgen cies</w>
urge d;</w>
urge )</w>
urg it
urgit ant</w>
urg er</w>
urg ent,</w>
urg ent"</w>
urg .</w>
urethro tomy.</w>
urethro grams</w>
urethane- chloralose</w>
urethane- anaesthesized</w>
ureth ritis.</w>
ureth r
urethr ally</w>
ureth ane,</w>
ureter s.</w>
ureter oscopy,</w>
ureter oscop
ureteroscop ically.</w>
ureter opy
ureteropy elect
ureteropyelect asia.</w>
ures-- would</w>
ures-- harmless</w>
ures-- comprising</w>
ures-- before</w>
ures cence</w>
ures .
ures. Mild</w>
ures "</w>
uren -L-
uren-L- glutamine</w>
uremic s,</w>
uremic like</w>
ure- proven</w>
ure- hypnotic</w>
ure- disease</w>
ure- Resistant</w>
ure- 8</w>
ure tic</w>
ure ogenesis,</w>
ure id
ureid o</w>
ure d:</w>
ure au
ureau .</w>
ure a:</w>
ure a)</w>
ure a).</w>
ure :
ure: slight</w>
ure -negative</w>
ure -dependent</w>
ure 's</w>
urb ation)</w>
urate- mediated</w>
urate- halothane</w>
uran est)</w>
urac il/folinic</w>
urac ent
uracent esis</w>
ur- uracil</w>
ur y,</w>
ur us</w>
ur ub
urub icin</w>
ur ti
urti acar
urtiacar ia</w>
ur st</w>
ur se
urse ment</w>
ur ry</w>
ur roughs</w>
ur ray</w>
ur ned</w>
ur ly</w>
ur ling
urling ham</w>
ur l
url erg
urlerg ine,</w>
ur ity</w>
ur ition</w>
ur it
urit car
uritcar ia</w>
ur ised</w>
ur is
uris tically,</w>
ur ine;</w>
ur idine-associated</w>
ur ich</w>
ur ic-
uric- acid-reactive</w>
ur ia.(ABSTRACT</w>
ur ia-
uria- dysuria.</w>
ur ia
uria .
uria. Norm
uria.Norm ocalce
uria.Normocalce mic</w>
ur i,</w>
ur genic</w>
ur cum
urcum a</w>
ur ching</w>
ur ation.</w>
ur ating</w>
ur ates</w>
ur ated
urated -15</w>
ur as
uras hik
urashik i,</w>
ur ane,</w>
ur an</w>
ur am</w>
ur alistic</w>
ur able
urable ',</w>
ur ab
urab ay
urabay as
urabayas hi
urabayashi ,</w>
ur a),</w>
ur -0.4</w>
uptake ;</w>
uptake .(ABSTRACT</w>
uptak en</w>
uptak e-
uptake- inhibitors
uptake-inhibitors -
uptake-inhibitors- metoclopramide</w>
upt urned</w>
upri ght.</w>
upri ght,</w>
upregul ated.</w>
upregul ated,</w>
upreg ulation.</w>
upper- respiratory</w>
upper- airway</w>
upont in
upontin us</w>
upont -M
upont-M er
upont-Mer ke
upont-Merke )</w>
uph ol
uphol ster
upholster y,</w>
uph el
uphel d</w>
updat ing,</w>
updat ing)</w>
updat ing),</w>
up- titration</w>
up- titrating</w>
up- titrated</w>
up- titrate</w>
up- regulatory</w>
up- regulations</w>
up- regulation.</w>
up- regulation,</w>
up- regulates</w>
up- regulated.</w>
up- modulated</w>
up- beating,</w>
up tial</w>
up stroke</w>
up stream,</w>
up silon</w>
up sets</w>
up sets,</w>
up ral</w>
up ply</w>
up per,</w>
up on,</w>
up illary</w>
up eptin</w>
up al
upal mer
upalmer in</w>
up -to-
up-to- date</w>
up )</w>
unve iling</w>
unve il</w>
unte er</w>
unstead iness.</w>
unstead iness,</w>
unreveal ing.</w>
unreveal ing,</w>
unresponsi ve;</w>
unresponsi ve"</w>
unresect ability</w>
unreporte d--
unreported-- papilledema</w>
unreporte d)</w>
unremark able;</w>
unrel enting</w>
unrel ated)</w>
unrel ated"</w>
unra veling</w>
unpro ved.</w>
unpleasant ness</w>
unpleasant ness,</w>
unpleas ant.</w>
unpac ed.</w>
unpac ed,</w>
universal ity</w>
univers ity.</w>
univers ity,</w>
univer si
universi ties,</w>
units/ week).</w>
units/ min)</w>
units/ mL,</w>
units/ m2</w>
units/ m2.</w>
units/ kg</w>
units/ kg/min)</w>
units/ kg/
units/kg/ day).</w>
units/ kg,</w>
units/ hr</w>
units/ d)</w>
units/ L,</w>
units/ 24</w>
units- granulocyte-macrophage</w>
units- granulocyte
units-granulocyte /
units-granulocyte/ macrophage,</w>
uniti zed.</w>
uniti zation</w>
uniti zation.</w>
unit- spleen</w>
unit- megakaryocyte</w>
unit- granulocyte
unit-granulocyte /macrophage</w>
unit s:</w>
unit s.
units. 100</w>
unit s),</w>
unit /ml)</w>
unit -containing</w>
uniqu e.</w>
unineph rectomy.</w>
unineph rectomy,</w>
unimpres sive.</w>
unimpres sive,</w>
unilater aly</w>
uniform ;</w>
uniform ,</w>
unif ying</w>
unif i
unifi ed-
unified- PD-
unified-PD- rating</w>
uni variately</w>
uni sitis,</w>
uni sian</w>
uni ors</w>
uni -
uni- nephrectomy</w>
unexplo red</w>
unexpl ain
unexplain able</w>
unexpect edly,</w>
unexpect ed"</w>
unexpect ed
unexpected ly.</w>
unex tracted</w>
unex pressed</w>
unex posed
unexposed ).</w>
uneventful ly,</w>
unevent ul</w>
unequ ivocal.</w>
unequ ivoc
unequivoc ally</w>
une st
unest abl
unestabl ished</w>
une m
unem plo
unemplo yed,</w>
une ase</w>
une )</w>
undifferenti ated.</w>
undifferenti ated).</w>
undetect able)</w>
undetect ability</w>
undesi r
undesir ably</w>
understand able</w>
understand able"</w>
undermin es</w>
undermin ed</w>
underg round</w>
underestim ation</w>
underestim ates</w>
underestim ated,</w>
under- utilisation</w>
under- treated.</w>
under- represented</w>
under- immunosuppression</w>
under- diagnosed</w>
under- diagnosed,</w>
under- action.</w>
under went,</w>
under utilized</w>
under utilised</w>
under used</w>
under use</w>
under treating</w>
under treated</w>
under treat</w>
under sub
undersub scri
undersubscri bed.</w>
under scored</w>
under s</w>
under represented</w>
under reporting,</w>
under reported.</w>
under recognised</w>
under perfused</w>
under nutrition</w>
under nutrition,</w>
under ly
underly ing,</w>
under fill
underfill ,"</w>
under dosing;</w>
under dosage</w>
under diagnosis</w>
under diagnosed.</w>
under development</w>
under appreciated</w>
under activity</w>
under :</w>
under /
under/ over</w>
unde re
undere valuated.</w>
und- subtracted</w>
und ity,</w>
und ing.</w>
und ing"</w>
und ing
unding '?</w>
und bec
undbec k</w>
und ation,</w>
und ant</w>
und ac
undac ion</w>
unct ate</w>
uncoupl ing.</w>
uncoupl ing,</w>
unclear ;</w>
unchang ing</w>
unchang ed),</w>
uncertain ties,</w>
uncerta inty.</w>
uncerta in:</w>
unc ri
uncri tical</w>
unc ou
uncou ple
uncouple s</w>
unc losed</w>
unc li
uncli pping</w>
unc le</w>
unc le.</w>
unc al</w>
unc aging</w>
unblinde d';</w>
unambigu ous</w>
un- satisfied</w>
un- restrained</w>
un witting</w>
un witnessed,</w>
un willing</w>
un warranted.</w>
un typical</w>
un treatable</w>
un translating</w>
un trained</w>
un touc
untouc hed,</w>
un tional</w>
un til,</w>
un ti
unti ed</w>
un tary</w>
un t</w>
un sustained</w>
un suspected.</w>
un suspected,</w>
un sure</w>
un suppressed</w>
un sulfated</w>
un suitability</w>
un substituted</w>
un substantiated</w>
un studied.</w>
un structured</w>
un stressed,</w>
un sterile</w>
un stained,</w>
un stable.</w>
un stable,</w>
un specified</w>
un specified,</w>
un specifically</w>
un solicited</w>
un sh
unsh it
unshit o,</w>
un settled</w>
un settled.</w>
un selected,</w>
un sedated</w>
un satisfactory.</w>
un s
uns cathe
unscathe d.</w>
un ruptured</w>
un restric
unrestric tedly</w>
un rest.</w>
un rest,</w>
un responsiveness,</w>
un resolving</w>
un resolved,</w>
un resol
unresol ved:</w>
un reported,</w>
un remit
unremit ting.</w>
un reliability</w>
un related,</w>
un refined</w>
un reduced</w>
un recognized,</w>
un recogniz
unrecogniz abl
unrecognizabl eness</w>
un reactive</w>
un re
unre ality</w>
un psychotic</w>
un provo
unprovo ked,</w>
un proven,</w>
un proportional</w>
un pretreated</w>
un prepared</w>
un premedicated,</w>
un predicted</w>
un planned</w>
un physiologic</w>
un palat
unpalat able.</w>
un olol</w>
un occupied</w>
un obstructed.</w>
un o
uno histochemical</w>
un noticed</w>
un net</w>
un monitored</w>
un metabolized</w>
un measured</w>
un marri
unmarri ed,</w>
un marked</w>
un manipulated,</w>
un loc
unloc k</w>
un loading.</w>
un load</w>
un linked</w>
un limited</w>
un lesioned</w>
un lesion
unlesion ed)</w>
un labelled</w>
un ks</w>
un know
unknow n)</w>
un justified</w>
un ity</w>
un ity.</w>
un ited</w>
un interrupted.</w>
un interrup
uninterrup tedly</w>
un intention
unintention al.</w>
un improved</w>
un important.</w>
un impeded</w>
un im
unim odal</w>
un idi
unidi men
unidimen sional</w>
un identified,</w>
un identifiable</w>
un ic
unic ent
unicent ric</w>
un helpful</w>
un heated</w>
un handled</w>
un ge</w>
un garotoxin</w>
un g
ung stic</w>
un fore
unfore seen</w>
un feasible</w>
un favourably</w>
un endur
unendur able.</w>
un e</w>
un dr
undr um.</w>
un disturbed.</w>
un distinguishable</w>
un distinguish
undistinguish able,</w>
un disput
undisput able</w>
un dilut
undilut ed--
undiluted-- by</w>
un dii</w>
un differentiated,</w>
un diagnosed,</w>
un determ
undeterm ined;</w>
un detected.</w>
un detected,</w>
un detectable,</w>
un ded</w>
un dec
undec ene.</w>
un d.</w>
un cur
uncur ling,</w>
un cover</w>
un correlated</w>
un corrected,</w>
un cooper
uncooper ativeness,</w>
un controlle
uncontrolle d--
uncontrolled-- collectively</w>
un controllable.</w>
un contaminated</w>
un consciousness.</w>
un consciousness,</w>
un conscious,</w>
un consci
unconsci ous.</w>
un confirmed</w>
un con
uncon strained</w>
un compromised</w>
un competitive,</w>
un characteristic.</w>
un characterised.</w>
un bu
unbu ffere
unbuffere d).</w>
un bound)</w>
un boosted</w>
un blinded,</w>
un balanced</w>
un balance</w>
un avoidable</w>
un avoid
unavoid able,</w>
un attended</w>
un attain
unattain able.</w>
un arous
unarous able</w>
un approved</w>
un answered.</w>
un aided</w>
un aged</w>
un affect
unaffect ed)</w>
un accounted</w>
un accompanied</w>
un accentuated</w>
un able;</w>
un M
unM ing</w>
un E)</w>
un -in</w>
un ,</w>
ump ur</w>
ump s,</w>
ump ing,</w>
ump ,</w>
umin ium</w>
umin escence</w>
umin es</w>
umer ate</w>
ume x</w>
ume ll
umell a</w>
ume d.</w>
umbil ico
umbilico placental</w>
umb us,</w>
umb o</w>
umab ,</w>
uma rol)</w>
um/ pilocarpine-induced</w>
um/ molecular</w>
um/ high</w>
um/ etoposide</w>
um/ confusion,</w>
um/ 400</w>
um- magnesium</w>
um- lined</w>
um- like</w>
um- independent</w>
um- hydrox
um-hydrox ide-
um-hydroxide- si
um-hydroxide-si meth
um-hydroxide-simeth icone</w>
um- fibrin</w>
um- CA1</w>
um- 82</w>
um- ,</w>
um s,</w>
um s
ums +</w>
um pur
umpur ,</w>
um ps</w>
um nar</w>
um il</w>
um ig
umig an)</w>
um ented</w>
um entary</w>
um e</w>
um bling</w>
um bellifer
umbellifer yl)-alpha-D-N-acetylneuraminic</w>
um atic</w>
um arate</w>
um an
uman n</w>
um acher</w>
um >
um> SN
um>SN r.</w>
um :YAG</w>
um 777</w>
um .
um. ..</w>
um -1
um-1 11-
um-111- antimyosin</w>
um )]</w>
um (defined</w>
um '</w>
um '.</w>
ultrasound- guided</w>
ultrasound- detected</w>
ultrasoun ds</w>
ultrasoun ds,</w>
ultrasoun d),</w>
ultrason ologists</w>
ultrason ograph
ultrasonograph y;</w>
ultrason o
ultrasono gr
ultrasonogr ph
ultrasonogrph y.</w>
ultrason ic,</w>
ultras ensitive</w>
ultramicro scopical</w>
ultramicro scopic</w>
ultraf luid</w>
ultra- small</w>
ultra wide</w>
ultra violet-related</w>
ultra structures</w>
ultra structure,</w>
ultra structurally,</w>
ultra structural,</w>
ultra high</w>
ultra dian</w>
ult mann</w>
ult an</w>
ulph apyridine</w>
ulph an</w>
ulop sis</w>
ulog raphy
ulography :</w>
ulo- peritoneal</w>
ulo- interpeduncular</w>
ulo usly</w>
ulo se-
ulose- based</w>
ulo se).</w>
ulo plasmin
uloplasmin aemia.</w>
ulo phyllum</w>
ulo path
ulopath y;</w>
ulo genesis</w>
ulo cytosis,</w>
ulnar is</w>
ull ).</w>
ulin astatin,</w>
ulin a,</w>
uli ke</w>
ulf ite</w>
ulf id
ulfid line,</w>
ulf ate,</w>
ulf an</w>
uleg ol</w>
ule us:</w>
ulcer s;</w>
ulcer osa</w>
ulcer ogenicity</w>
ulcer ated,</w>
ulcer ;</w>
ulcer )</w>
ulcer );</w>
ulation- most</w>
ular y,</w>
ular ly)</w>
ular ity</w>
ular :</w>
ular -type</w>
ul vinar</w>
ul us,</w>
ul upontinus</w>
ul ture</w>
ul ter</w>
ul tation</w>
ul ster
ulster ones</w>
ul sion,</w>
ul s</w>
ul pating</w>
ul ner
ulner ability</w>
ul ly</w>
ul l-
ull- typed</w>
ul ized</w>
ul itis,</w>
ul is,</w>
ul ine).</w>
ul id).</w>
ul icide</w>
ul i</w>
ul etine</w>
ul es:</w>
ul es,</w>
ul epine</w>
ul ence,</w>
ul enc</w>
ul bar</w>
ul ations.</w>
ul ates</w>
ul ary</w>
ul ari
ulari op
ulariop sis</w>
ul ange</w>
ul along
ulalong k
ulalongk orn</w>
ul ae</w>
ul actin,</w>
ul aceae)</w>
ul ability.</w>
ul a.</w>
ul a).</w>
uit s.</w>
ugh ing</w>
ugh -
ugh- Tur
ugh-Tur cot
ugh-Turcot te</w>
uge d,</w>
ug/ week</w>
ug/ kg.
ug/kg. hr)</w>
ug i</w>
ug al</w>
ue- secured</w>
ue- long</w>
ue- labele
ue-labele d)</w>
ue- contingent</w>
udi s</w>
udi l-</w>
udi bular</w>
ud ulent</w>
ud ring).</w>
ud ral</w>
ud ness</w>
ud n
udn cy</w>
ud ine,</w>
ud inal</w>
ud in;</w>
ud in.</w>
ud dy</w>
ud d-
udd- Chi
udd-Chi ari
udd-Chiari ).</w>
ud ative</w>
ud an</w>
ud al</w>
ud a</w>
ud a
uda g</w>
uclid inyl</w>
ucle us</w>
uci genin</w>
uch rom
uchrom at
uchromat in;</w>
uch es</w>
uch es,</w>
uch erv
ucherv ille,</w>
uc tan
uctan )</w>
uc omyst
ucomyst )</w>
uc oid
ucoid an-treated</w>
uc lin
uclin yl</w>
uc l
ucl tidyl</w>
uc k-
uck- on"</w>
uc k
uck les
uckles .
uckles. (ii)</w>
uc ion</w>
uc in</w>
uc idum</w>
uc idation</w>
uc b</w>
ubiquit ously,</w>
ubiquit in.</w>
ubiquit in-positive</w>
ubiquit in-
ubiquitin- proteasome</w>
ub ulized</w>
ub ular.</w>
ub ric
ubric ating</w>
ub lim
ublim aze)</w>
ub ious</w>
ub es</w>
ub er
uber ant</w>
ub arb
ubarb ).</w>
ub ain)</w>
ual tion</w>
ual it</w>
u/ kg).</w>
u/ L,</w>
u- immunoreactive</w>
u- Tang</w>
u- O
u-O sler</w>
u y,</w>
u wai</w>
u vers</w>
u v).</w>
u us</w>
u tions</w>
u tic</w>
u sible</w>
u ses).</w>
u pron</w>
u pre
upre l</w>
u por
upor ,</w>
u point</w>
u ousness</w>
u ously</w>
u orn
uorn ide</w>
u lography.</w>
u iring</w>
u ing</w>
u il
uil de.</w>
u gl
ugl er</w>
u g/kg/
ug/kg/ week</w>
u g/kg)</w>
u g)</w>
u ene,</w>
u de
ude my
udemy s</w>
u be</w>
u ation,</w>
u ating.</w>
u ate;</w>
u ate-
uate- periventricular</w>
u ate)</w>
u as</w>
u als</w>
u alization</w>
u alis
ualis tic)</w>
u al.</w>
u al-
ual- motor</w>
u a;</w>
u a).</w>
u P</w>
u /kg</w>
u ).</w>
u )-induced</w>
tz ,</w>
tz )</w>
tyrosine-methionine-aspartate- aspartate)</w>
tyrosine- regulated</w>
tyrosine- positive</w>
tyrosine- catalepsy</w>
tyros ine
tyrosine 8-
tyrosine8- bradykinin</w>
tyram ine.</w>
tyram ine-induced</w>
tyram ine-</w>
typh i</w>
typh i.</w>
type-- sinoatrial</w>
type-- forward</w>
type- identical</w>
type- 4</w>
type ?</w>
type -specific</w>
type -selective</w>
type -based</w>
type -3</w>
type "</w>
typ ing.</w>
typ ify</w>
typ ifies</w>
typ icals,</w>
typ ic</w>
typ es.(ABSTRACT</w>
tympan oplast
tympanoplast y).</w>
tympan ometry</w>
tympan ometry,</w>
tympan ogram,</w>
tympan ocentesis</w>
tympan o
tympano plasty</w>
tympan i</w>
ty tes</w>
ty chop
tychop et
tychopet alum</w>
ty ).</w>
ty 's</w>
two-taile d).</w>
two-taile d
two-tailed ].</w>
two- year-period,</w>
two- year-old.</w>
two- year-old,</w>
two- year,</w>
two- thir
two-thir ds.</w>
two- tail
two-tail ]</w>
two- state</w>
two- rod</w>
two- photon</w>
two- period</w>
two- parallel-group</w>
two- ke
two-ke y,</w>
two- hour-
two-hour- i.v.</w>
two- group</w>
two- fold:</w>
two- fold)</w>
two- factor</w>
two- electron</w>
two- dimensional,</w>
two- compartmental</w>
two- colour</w>
two- color
two-color "</w>
two- channel</w>
two- chain</w>
two- carbon</w>
two- by-
two-by- two</w>
two- bottle</w>
two- ,</w>
two fold;</w>
two fold.</w>
two fold,</w>
two -dose</w>
two )</w>
two ),</w>
twitch ings,</w>
twitch es.</w>
twitch ,</w>
twit ch.</w>
twin- to-
twin-to- twin</w>
twin- pair)</w>
twice/ day.</w>
twice- a-day</w>
twic e:</w>
twic e.</w>
twic e-</w>
twenty- seventh</w>
twenty- seven</w>
twenty- second</w>
twenty- nine</w>
twenty- fourth</w>
twenty- first</w>
twelve- hourly</w>
twelve- fold</w>
twel ve-</w>
twel ve)</w>
tw orm
tworm s</w>
tw ist.</w>
tw ist
twist ed</w>
tw ins,</w>
tw inning</w>
tw in)</w>
tw ig</w>
tw i</w>
tw enti
twenti eth</w>
tw are</w>
tw ard,</w>
turt le)</w>
turt l
turtl es:</w>
turno vers</w>
turke ys,</w>
turbin ates.</w>
turb idity</w>
turb id</w>
tur tle</w>
tur tle,</w>
tur ns)</w>
tur ning-
turning- over</w>
tur na
turna round</w>
tur n-
turn- over.</w>
tur n
turn s/s</w>
tur meric</w>
tur ic</w>
tur g
turg or,</w>
tur bo</w>
tun es</w>
tumouri genesis</w>
tumouri genesis.</w>
tumour -related</w>
tumori genicity.</w>
tumori genic.</w>
tumor- reducing</w>
tumor- free.</w>
tumor- derived</w>
tumor s/
tumors/ 16</w>
tumor -induced</w>
tumor )</w>
tumor ).</w>
tumor ),</w>
tumo ural</w>
tum ors"</w>
tum id</w>
tum escent</w>
tum escence,</w>
tulo buter
tulobuter ol.</w>
tuit ously,</w>
tubulo toxic</w>
tubulo pathies.</w>
tubulo -
tubulo- glomerular</w>
tubul us)</w>
tubul orrhe
tubulorrhe xis.</w>
tubul in/
tubulin/ lysosomal</w>
tubul in-immunoreactive</w>
tubul es:</w>
tubul es),</w>
tubul e)</w>
tubul e's</w>
tubul ar),</w>
tubo endometrial</w>
tubo -
tubo- curar
tubo-curar ine</w>
tubero sities</w>
tubero inf
tuberoinf udibular</w>
tuberculo sis?</w>
tuberculo sis)</w>
tuberculo mas,</w>
tubercul um</w>
tube ).</w>
tub ing</w>
tub ers</w>
tub eral</w>
tub ations</w>
tub ation</w>
tub ation,</w>
tub al,</w>
tu gal</w>
ttp://www. clinicaltrials.gov</w>
ts/ min,</w>
ts/ day</w>
ts/ 30</w>
ts-- even</w>
ts-- bupivacaine</w>
ts ville,</w>
ts A-
tsA- 201</w>
ts ,"</w>
ts )
ts) <0.006)</w>
ts ",</w>
ts "),</w>
tryptoph ane</w>
tryptoph an-induced</w>
trypt oline.</w>
trypt oline,</w>
trypt ase)</w>
trypt amine.</w>
tryp sin.</w>
tryp s
tryps in-treated</w>
tryp an</w>
trunc us</w>
trunc us.</w>
trunc i</w>
trunc ation</w>
trunc ating</w>
trun ks</w>
trun ks.</w>
trun k)</w>
tru ths.</w>
tru sive</w>
tru e,</w>
tru e"</w>
troxid one.</w>
troxid on</w>
trovaf loxacin,</w>
trovaf loxac
trovafloxac in-treated</w>
trough ,</w>
trough "</w>
troubles ome-
troublesome- -
troublesome-- hemorrhagic</w>
troubl es.</w>
trou bles</w>
trou bled</w>
trou bled,</w>
troponin- I,</w>
tropon ins,</w>
tropon in:</w>
tropin in</w>
tropic amide,</w>
tropic alis</w>
troph ore
trophore sis</w>
troph ogenicity,</w>
tropane- ring</w>
tropane- 2beta-carb
tropane-2beta-carb oxylic</w>
tropan es</w>
tropan e.</w>
trop omy
tropomy osin-
tropomyosin- troponin</w>
trop in-releasing</w>
trop ic</w>
trop ia,</w>
trop ane
tropane methanamine</w>
tron s.</w>
trometh amine-induced</w>
troglitaz one:</w>
trofosf amide.</w>
trofosf amide,</w>
tro version</w>
tro metam
trometam ol</w>
tro ly
troly te</w>
tro lox
trolox ,</w>
tro le
trole and
troleand rom
troleandrom ycine,</w>
tro l</w>
tro cyt
trocyt omas</w>
tro ,</w>
tro ),</w>
triterpen es.</w>
triterpen e,</w>
trit anop
tritanop y</w>
trit an
tritan -type</w>
tris omic</w>
triptyl in</w>
triptan s;</w>
triptan s)</w>
triptan es.</w>
tript an,</w>
tript amine,</w>
triple- therapy</w>
triple- labelling</w>
triple- injected</w>
triple- column</w>
triple ts</w>
triple t,</w>
triple s</w>
triple d,</w>
triple -blind,</w>
triple ,</w>
triphosphate- sensitive</w>
triphosphate- biotin</w>
triphenyl tetrazolium.</w>
triphenyl tetra
triphenyltetra zoium</w>
triphenyl phosph
triphenylphosph onium-
triphenylphosphonium- conjugated</w>
triphenyl hept
triphenylhept yl-UDP.</w>
tripelenn amine.</w>
tripelenn amine-</w>
tripelenn amine).</w>
trinitro phenyl)
trinitrophenyl) adenosine</w>
trimi pramine,</w>
trimetrex ate</w>
trimetrex ate,</w>
trimethyl- 3,5-
trimethyl-3,5- sulf
trimethyl-3,5-sulf onat
trimethyl-3,5-sulfonat o
trimethyl-3,5-sulfonato phenyl)</w>
trimethyl- 2,4-oxazolidinedione,</w>
trimethyl sil
trimethylsil yltrifluoroacetamide</w>
trimethyl phenyl)-
trimethylphenyl)- 7H-
trimethylphenyl)-7H- pyrrol
trimethylphenyl)-7H-pyrrol o</w>
trimethyl amine,</w>
trimethoprim/ sulfonamides</w>
trimethoprim/ sulfamethoxazole.</w>
trimethoprim/ sulfamethoxazole-
trimethoprim/sulfamethoxazole- resistant</w>
trimethoprim/ sulfamethox
trimethoprim/sulfamethox azole-induced</w>
trimethoprim-sulphamethox azole</w>
trimethoprim-sulphamethox azole)</w>
trimethoprim-sulfamethox azole-
trimethoprim-sulfamethoxazole- related</w>
trimethoprim-sulfamethox asole</w>
trimethoprim sulfamethoxazole</w>
trimethoprim -induced</w>
trimethoprim -</w>
trimethaph an-treated</w>
trimethadi one.</w>
trimetaz id
trimetazid in)</w>
trimetaph an.</w>
trimester s.</w>
trimester s),</w>
triiodothyron ine-elicited</w>
triiodothyron ine,</w>
trihydroxy acetophen
trihydroxyacetophen one;</w>
trihydroxy -16
trihydroxy-16 alpha-methyl
trihydroxy-16alpha-methyl pregna
trihydroxy-16alpha-methylpregna -1,4-
trihydroxy-16alpha-methylpregna-1,4- di
trihydroxy-16alpha-methylpregna-1,4-di ene-3,20-
trihydroxy-16alpha-methylpregna-1,4-diene-3,20- di
trihydroxy-16alpha-methylpregna-1,4-diene-3,20-di one),</w>
trihexyphenid yl:</w>
triheptano in.</w>
triheptano in,</w>
triheptano in's</w>
triglyceride- rich</w>
triglyceride s;</w>
triglyceride /
triglyceride/ phospholipid</w>
triglycer ol,</w>
triglycer ine)</w>
trigg ers.</w>
trigg ers,</w>
trigg ering,</w>
trigg ere
triggere d--
triggered-- the</w>
trigg er
trigger (s)</w>
trigemino- cortico-
trigemino-cortico- trigeminal</w>
trigemin y,</w>
trigemin o/
trigemino/ reticular</w>
trigemin i,</w>
trigemin al/
trigeminal/ cervical</w>
trigemin al-related</w>
trigemin al,</w>
trifluoromethyl phenyl)</w>
trifluoromethyl -1,2,3,4-tetrahydro
trifluoromethyl-1,2,3,4-tetrahydro quinoxaline-2,3-dione</w>
trifluoro per
trifluoroper azine,</w>
trifluoro ethan
trifluoroethan e.</w>
trifluoro acetyl
trifluoroacetyl ated-
trifluoroacetylated- 58</w>
trifluoro acetate</w>
trifluoro -
trifluoro- eth
trifluoro-eth ane)</w>
trifluoper azine.</w>
trieth iodide</w>
trieth iodide.</w>
trient ene</w>
trient ene.</w>
tridec apeptide,</w>
tricyclic- antidepressant-induced</w>
tricyclic- MAOI</w>
tricycl ic-associated</w>
tricycl ic,</w>
tricycl ic),</w>
trichrome )</w>
trichrome ),</w>
trichro me.</w>
trichotillo mania,</w>
trichomon iasis</w>
trichomon iasis,</w>
trichomon as</w>
trichom onal</w>
trichloroethan e,</w>
trichloro ethylene</w>
trichloro ethylene
trichloroethylene ),</w>
tricapryl in</w>
tricapryl in.</w>
tric s).</w>
tric osis,</w>
tric ol
tricol or,</w>
tric itabine</w>
tric ial</w>
tric hi
trichi tillo
trichitillo mania.</w>
tric eps)</w>
tric ate</w>
tric aine</w>
triazolop yrimidine</w>
triazolop yridazine,</w>
triazolo[1,5-c]pyrimid ines.</w>
triazolo[1,5-c]pyrimid ine;</w>
triazolo[1,5-c] pyrimidine</w>
triazolo[1,5- c]-
triazolo[1,5-c]- pyrimidine</w>
triazol es</w>
triazol am)</w>
triazeno )-
triazeno)- imidazole-4-
triazeno)-imidazole-4- carboxamide,</w>
triazen o</w>
triazen -1-
triazen-1- yl)imidazole-4-caroxamide,</w>
triaz ines</w>
triaz in-4-
triazin-4- yl]-3-ethylaminoazetidine-3-carboxylic</w>
triaz enes</w>
triax ene,</w>
triamterene- hydrochlorothiazide</w>
triamterene -related</w>
triamterene -induced</w>
triamterene -derived</w>
triamterene -containing</w>
triamterene --not</w>
triamcinol one.</w>
triamcinol one-treated</w>
triamcinol one-induced</w>
trial- by-
trial-by- trial</w>
trial- -the</w>
trial s.
trials. com
trials.com ).</w>
trial ed.</w>
trial 's</w>
triad s</w>
triad in,</w>
triad .</w>
triacylglycer ols,</w>
triacylglycer ol),</w>
triacyl glycerol</w>
tri- ortho-
tri-ortho- cresyl</w>
tri- iodo-
tri-iodo- thyronine</w>
tri- differentiation</w>
tri weekly</w>
tri valent</w>
tri val</w>
tri une</w>
tri tium-
tritium- labelled</w>
tri tic</w>
tri substituted</w>
tri segment
trisegment ectomies,</w>
tri pl
tripl ed</w>
tri phosphatases</w>
tri phosphatases,</w>
tri phosph
triphosph ate-dependent</w>
tri phal
triphal a</w>
tri p</w>
tri oxide.</w>
tri oxide,</w>
tri octano
trioctano in.</w>
tri o
trio se
triose phosphate</w>
tri mmed</w>
tri methyl-8-
trimethyl-8- (3-chlorostyr
trimethyl-8-(3-chlorostyr yl)xanthine</w>
tri mer</w>
tri linole
trilinole in</w>
tri lept
trilept al</w>
tri iod
triiod thyronine</w>
tri hydrochloride</w>
tri hydrate</w>
tri hydrate.</w>
tri hydrate,</w>
tri hexyl
trihexyl phenid
trihexylphenid yl,</w>
tri gro
trigro id</w>
tri go</w>
tri glyco
triglyco side
triglycoside s),</w>
tri glycine</w>
tri g
trig ine</w>
tri fuc
trifuc ation</w>
tri flus
triflus al-
triflusal- -
triflusal-- have</w>
tri fascicular</w>
tri ethylene</w>
tri ethylene
triethylene tetramine</w>
tri ethyl
triethyl tin</w>
tri es</w>
tri ene-3,20-dione</w>
tri bute</w>
tri ben</w>
tri atri
triatri at
triatriat um)</w>
tri angulation</w>
tri angular</w>
tri amino-
triamino- 6-phenyl
triamino-6-phenyl pter
triamino-6-phenylpter idine)</w>
tri amine</w>
tri allelic</w>
tri aled</w>
tri aged</w>
tri ade
triade s,</w>
trex ed
trexed -associated</w>
tretino in-treated</w>
tretino in-induced</w>
tretino in)</w>
tretino in),</w>
tretin ate</w>
tresp as
trespas s.</w>
treon am</w>
tren ds,</w>
tren d-
trend- level</w>
tren d),</w>
tren d
trend =0.02).</w>
tremor- producing</w>
tremor s).</w>
tremor ine</w>
tremor ine-
tremorine- (TM
tremorine-(TM N)</w>
tremor ine,</w>
tremor gen
tremorgen s.</w>
tremor -inducing</w>
tremor ).</w>
trem bled</w>
treatment-termin ation/
treatment-termination/ castration.</w>
treatment-termin ation-induced</w>
treatment- years)</w>
treatment- time</w>
treatment- sensitive</w>
treatment- seek
treatment-seek ers</w>
treatment- related.</w>
treatment- outcome</w>
treatment- outcome.</w>
treatment- na</w>
treatment- match
treatment-match ing.</w>
treatment- free</w>
treatment s?</w>
treatment s.(ABSTRACT</w>
treatment s)</w>
treatment s),</w>
treatment .(ABSTRACT</w>
treatment -dependent</w>
treatment ).(ABSTRACT</w>
treatment '</w>
treatment "</w>
treat ement</w>
treat ed:</w>
treat able.</w>
treat ;</w>
treat )</w>
treat "</w>
tread mil
treadmil l.</w>
tread ing)</w>
tre x</w>
tre tment</w>
tre sia,</w>
tre mer
tremer ogram</w>
tre men
tremen s.</w>
tre mat
tremat o
tremato de,</w>
tre e
tree .(ABSTRACT</w>
tre bled</w>
tre ach
treach er
treacher ous,</w>
trazod one-treated</w>
trazod one-related</w>
traz ine,</w>
travel ling</w>
travel led</w>
travel ing</w>
travel .</w>
travel -related</w>
traum at
traumat ologic</w>
trau ma;</w>
trastuzumab -treated</w>
trastuzumab -induced</w>
trastuzumab -based</w>
tras timul
trastimul us</w>
tras odium</w>
tras h</w>
trap per,</w>
trap ez
trapez oid</w>
tranylcyprom ine).</w>
transves tism</w>
transves tism,</w>
transves tic</w>
transver se-
transverse- tubules</w>
transt entorial</w>
transporter -3</w>
transporter -2</w>
transport ation.</w>
transport :</w>
transport -dependent</w>
transplant s:</w>
transplant ations,</w>
transplant ation?</w>
transplant ation-associated</w>
transplant ation--a</w>
transplant ation)</w>
transplant ation).</w>
transplant able.</w>
transplant :</w>
transplant )</w>
transplant );</w>
transplant ).</w>
transplant (s)</w>
transplan tion</w>
transpl ante
transplante d:</w>
transpeptid ase;</w>
transpeptid ase.</w>
transpeptid ase,</w>
transp upillary</w>
transp ulmonary</w>
transp apillary</w>
transmur ality</w>
transmur al,</w>
transmit ter.</w>
transmit ter
transmitter s/neuromodulators</w>
transmis sions</w>
transmis sion:</w>
transmis sion/
transmission/ disequilibrium</w>
transmis sion-
transmission- electron</w>
transmis sible</w>
transluc ent,</w>
transluc ency,</w>
translo cat
translocat es</w>
translat able</w>
transl ationally</w>
transl ation.</w>
transl ation,</w>
transketol ase,</w>
transit ory.</w>
transi tions</w>
transi tions.</w>
transi tional,</w>
transi tion-
transition- state</w>
transi ents.</w>
transi ent
transient -evoked</w>
transglutamin ases</w>
transfusion -</w>
transfusion ),</w>
transfusion (s)</w>
transfusion (s),</w>
transfu sion-induced</w>
transfu sion)</w>
transfu sion).</w>
transfer s.</w>
transfer rin.</w>
transfer ase-positive</w>
transfer ase-
transferase- alpha</w>
transfer ase)</w>
transfer ase),</w>
transfer able</w>
transf used,</w>
transf ection.</w>
transf ect
transfect ants</w>
transduc tion,</w>
transduc es</w>
transduc ers.</w>
transduc ers,</w>
transcriptase- PCR.</w>
transcript s.</w>
transcript s,</w>
transcript ome</w>
transcript ase.</w>
transcript ase,</w>
transcrip tionally</w>
transcrip tional,</w>
transcrip tion
transcription -P
transcription-P CR,</w>
transcri bed-
transcribed- polymerase</w>
transc ervical</w>
transc apillary</w>
transamin its.</w>
transamin itis.</w>
transamin ation</w>
transamin ase/
transaminase/ glutamic</w>
transamin ase)</w>
transamin ase),</w>
trans-nicotine-N'- oxides</w>
trans-3,4- Dichloro
trans-3,4-Dichloro -
trans-3,4-Dichloro- N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzene
trans-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzene acetamide</w>
trans-1,2-cyclohexanedi ol,</w>
trans-1,2- Cyclo
trans-1,2-Cyclo hex
trans-1,2-Cyclohex anedi
trans-1,2-Cyclohexanedi ol,</w>
trans- pyrrolidine-2,4-dicarboxylic</w>
trans- octahydrobenzo(f)quinoline</w>
trans- jugular</w>
trans- diol</w>
trans- RA</w>
trans- N-[4-
trans-N-[4- [2-(6-
trans-N-[4-[2-(6- cyano
trans-N-[4-[2-(6-cyano -1,2,3,4-tetrahydro
trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydro isoquinol
trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinol in-2-yl)
trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl) ethyl]
trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl] cyclohex
trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohex yl]-4-quinolinecarboxamide)</w>
trans- 6,7,
trans-6,7, 7
trans-6,7,7 a,
trans-6,7,7a, 8,</w>
trans- 4-
trans-4- [2-(6-
trans-4-[2-(6- cyano-
trans-4-[2-(6-cyano- 3,4-dihydro
trans-4-[2-(6-cyano-3,4-dihydro -2
trans-4-[2-(6-cyano-3,4-dihydro-2 (1H)-
trans-4-[2-(6-cyano-3,4-dihydro-2(1H)- isoquinol
trans-4-[2-(6-cyano-3,4-dihydro-2(1H)-isoquinol inyl)
trans-4-[2-(6-cyano-3,4-dihydro-2(1H)-isoquinolinyl) ethyl]-
trans-4-[2-(6-cyano-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]- cyclohex
trans-4-[2-(6-cyano-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]-cyclohex yl]-(9CI)]</w>
trans- 3-hydroxy
trans-3-hydroxy -1,2,3,4-tetrahydro-2-
trans-3-hydroxy-1,2,3,4-tetrahydro-2- naphth
trans-3-hydroxy-1,2,3,4-tetrahydro-2-naphth yl)-N-(3-oxo-3-phenyl-2-methylpropyl)-piperazine</w>
trans- 3-
trans-3- (3,4-dichloro
trans-3-(3,4-dichloro phenyl)-
trans-3-(3,4-dichlorophenyl)- N-methyl-
trans-3-(3,4-dichlorophenyl)-N-methyl- l-
trans-3-(3,4-dichlorophenyl)-N-methyl-l- indanamine,</w>
trans- 3'-
trans-3'- hydroxyc
trans-3'-hydroxyc ot
trans-3'-hydroxycot inine</w>
trans- 2-amino-
trans-2-amino- 3-hydroxy
trans-2-amino-3-hydroxy -1,</w>
trans- (-)-
trans-(-)- 3,4-
trans-(-)-3,4- dichloro-
trans-(-)-3,4-dichloro- N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzene
trans-(-)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzene acetam
trans-(-)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetam ine],</w>
trans- (+)-
trans-(+)- 4,4a,5,6,7,8,8a,9-octahydro-5-
trans-(+)-4,4a,5,6,7,8,8a,9-octahydro-5- propyl-2
trans-(+)-4,4a,5,6,7,8,8a,9-octahydro-5-propyl-2 H-
trans-(+)-4,4a,5,6,7,8,8a,9-octahydro-5-propyl-2H- pyrazolo-
trans-(+)-4,4a,5,6,7,8,8a,9-octahydro-5-propyl-2H-pyrazolo- (3,4-
trans-(+)-4,4a,5,6,7,8,8a,9-octahydro-5-propyl-2H-pyrazolo-(3,4- g
trans-(+)-4,4a,5,6,7,8,8a,9-octahydro-5-propyl-2H-pyrazolo-(3,4-g )
trans-(+)-4,4a,5,6,7,8,8a,9-octahydro-5-propyl-2H-pyrazolo-(3,4-g) quinol</w>
trans thro
transthro acic</w>
trans sexu
transsexu al.</w>
trans sections)</w>
trans section
transsection s),</w>
trans scleral</w>
trans phosphatid
transphosphatid ylated</w>
trans phenoidal</w>
trans pharyngeal</w>
trans orbital</w>
trans oesophageal</w>
trans min
transmin ase</w>
trans membrane-spanning</w>
trans mammary</w>
trans m
transm urally</w>
trans location.</w>
trans location,</w>
trans located</w>
trans lesional</w>
trans hepatic</w>
trans genic,</w>
trans generational</w>
trans gen
transgen ics.</w>
trans g
transg ression</w>
trans formations</w>
trans form,</w>
trans ferential</w>
trans ecting</w>
trans differentiation</w>
trans differentiated</w>
trans di-
transdi- hydro
transdi-hydro lisuride</w>
trans derm
transderm ally,</w>
trans cortical</w>
trans cardi
transcardi ally</w>
trans carbamyl
transcarbamyl ase</w>
trans buccal</w>
trans axillary</w>
trans axi
transaxi al)</w>
trans ax
transax ially</w>
trans auricular</w>
trans arterial</w>
trans am
transam inemia</w>
trans activator</w>
trans activation.</w>
trans ]-
trans]- 4,4a,5,6,7,8,8a,9-
trans]-4,4a,5,6,7,8,8a,9- o-
trans]-4,4a,5,6,7,8,8a,9-o- dihydro-
trans]-4,4a,5,6,7,8,8a,9-o-dihydro- 5
trans]-4,4a,5,6,7,8,8a,9-o-dihydro-5 n-propyl-2H-
trans]-4,4a,5,6,7,8,8a,9-o-dihydro-5n-propyl-2H- pyraz
trans]-4,4a,5,6,7,8,8a,9-o-dihydro-5n-propyl-2H-pyraz o</w>
tranquiliz ation:</w>
tranquil liz
tranquilliz ers.</w>
tranquil isation</w>
tranquil is
tranquilis ers</w>
trandr ine,</w>
trandr a</w>
trandolapri l-induced</w>
trandolapri l).</w>
trandolapri l),</w>
trandol april.</w>
trand s
trands dermal</w>
tran sudation</w>
tran sep
transep tid
transeptid ase</w>
tran qu
tranqu ill
tranquill is
tranquillis ers,</w>
tran hex
tranhex amic</w>
tran eous</w>
tran dop
trandop ril</w>
tramadol -related</w>
tramadol -associated</w>
tramadol -
tramadol- hydrochloride</w>
tram edullary</w>
tram azoline</w>
tram azol
tramazol ine-induced</w>
tram )</w>
traject ories</w>
train s;</w>
train ers.</w>
train er</w>
traffick ing.</w>
traffick ing,</w>
traff ic.</w>
traf il
trafil tered</w>
traf icking</w>
tradi tion
tradition al"</w>
tract- ventricular</w>
tracheostom ized</w>
tracheostom ized,</w>
trache otomies,</w>
trache ostomy</w>
trache as</w>
trache ally</w>
trace- to-mild</w>
trace- conditioned</w>
trac tion.</w>
trac king.</w>
trac ked</w>
trac k.</w>
trac ings.</w>
trac ing)</w>
trac ed,</w>
trac e.</w>
trac e
trace ble</w>
trabecul ectomy.</w>
trabecul ectomies.</w>
trabecul ae.</w>
trabected in.</w>
trabected in),</w>
tra zole.</w>
tra zole).</w>
tra vist</w>
tra verse</w>
tra st,</w>
tra p</w>
tra ins.</w>
tra ined;</w>
tra in.</w>
tra in-of-
train-of- three</w>
tra in-induced</w>
tra ils</w>
tra il
trail s.</w>
tra de-
trade- off</w>
tra de
trade off
tradeoff s</w>
tr ytamine</w>
tr ycyclics</w>
tr uth</w>
tr ust</w>
tr p
trp v1-null</w>
tr oneph
troneph rosis.</w>
tr on,</w>
tr n
trn sport</w>
tr ick
trick le</w>
tr ically</w>
tr i</w>
tr e</w>
tr ated</w>
tr ate</w>
tr alin</w>
tr al
tral ente</w>
tr age
trage di
tragedi es</w>
tr a</w>
tr 2
tr2 a)</w>
tr 1b.</w>
toxin s;</w>
toxin ergometrine</w>
toxico dynamics</w>
toxico der
toxicoder ma,</w>
toxicity-- predominantly</w>
toxicity-- i.e.,</w>
toxicity-- case</w>
toxicity-- an</w>
toxicity ],</w>
toxicity ',</w>
toxiciti es:</w>
toxiciti es)</w>
toxic- therapeutic</w>
toxic ologies,</w>
toxic ity/
toxicity/ carcinogenicity</w>
toxic ity-
toxicity- free</w>
toxic ity),</w>
toxic ity"</w>
toxic ated</w>
toxic ants</w>
toxic ants,</w>
toxic ant.</w>
toxic ant,</w>
toxic /
toxic/ therapeutic</w>
tox ocity</w>
tox o
toxo plasma</w>
tox ity</w>
tox iti
toxiti y</w>
tox in-associated</w>
tox in--
toxin-- which</w>
tox in)</w>
tox iferine</w>
tox ider
toxider mia</w>
tox id
toxid rom
toxidrom es</w>
tox ical</w>
tox emia</w>
tox cation</w>
tox )</w>
tourniquet s.</w>
tourniquet s,</w>
tourniqu et)</w>
touch ing</w>
touch ing,</w>
touc h).</w>
tot ally,</w>
tot alled</w>
tot al.</w>
tot al-
total- cholesterol,</w>
tot al),</w>
tos ylate,</w>
tos how</w>
tos ensitive</w>
tortu ous</w>
tortu osity</w>
torsin A</w>
torsin A.</w>
torsade s:</w>
torsade genic</w>
torsa de:</w>
torsa de-de-
torsade-de- pointes.</w>
toraf ur,</w>
toraf ur)</w>
tor- open
tor-open '</w>
tor so,</w>
tor semide,</w>
tor s)</w>
tor s).</w>
tor r).</w>
tor neys</w>
tor ial</w>
tor cul
torcul a)</w>
topotec an:</w>
topotec an.</w>
topotec an-induced</w>
topo side).</w>
topiramate- valproate</w>
topiramate- valproate-induced</w>
topiramate- fluvoxamine</w>
topiramate- -
topiramate-- side</w>
topiram ate:</w>
topic s:</w>
topic al)</w>
top ril)</w>
top or
topor phyria</w>
top ography.</w>
top ographies</w>
top ographic,</w>
top od
topod in,</w>
top o</w>
top ics,</w>
top ically,</w>
top ic,</w>
top ia</w>
top ar
topar R)</w>
top -up</w>
tonsill ectomies.</w>
tonsill ar</w>
tonsill ar,</w>
tonsil litis,</w>
tonic-clon ic)</w>
tonic-clon ic),</w>
tonic ".</w>
tongue- protrusion</w>
tongue- depressor</w>
tongue- and-
tongue-and- groove</w>
tone- pi
tone-pi p-
tone-pip- evoked</w>
tone- conditioned</w>
tone- burst</w>
ton- tipped</w>
ton us/</w>
ton us,</w>
ton us)</w>
ton si
tonsi l</w>
ton s</w>
ton s,</w>
ton ometer</w>
ton ometer.</w>
ton ography</w>
ton ofilam
tonofilam ents</w>
ton ic,</w>
ton ic)</w>
ton ia/
tonia/ rigidity</w>
ton es)</w>
ton .</w>
ton -like</w>
tomograph y:</w>
tomograph y-measured</w>
tometr ine)</w>
tomat o-based</w>
tomat o,</w>
tom oraph
tomoraph y,</w>
tom ole</w>
tom ographically</w>
tom ogram</w>
tom o
tomo graph</w>
tom id
tomid ate-Lip
tomidate-Lip uro)</w>
tom etric</w>
tom ethyl-
tomethyl- 3-
tomethyl-3- guanid
tomethyl-3-guanid ino-
tomethyl-3-guanidino- ethyl
tomethyl-3-guanidino-ethyl thio
tomethyl-3-guanidino-ethylthio propanoic</w>
tom a)</w>
tolu ene's</w>
tolterod ine,</w>
tolterod ine)</w>
tolmet in).</w>
toler ogenic</w>
toler ated:</w>
toler ated-
tolerated- -the</w>
toler ate,</w>
toler ant.</w>
toler ance/
tolerance/ dependence</w>
toler ance)</w>
toler ance).</w>
toler ance),</w>
toler ance
tolerance '.</w>
toler able;</w>
toler able.(ABSTRACT</w>
toler able-
tolerable- infusion-related</w>
toler ability:</w>
toler abil
tolerabil ity),</w>
tolbut amide-
tolbutamide- coated</w>
tolazol ine:</w>
tolazol ine.</w>
tolazol ine,</w>
tolaz amide,</w>
tolam olol,</w>
tolam olo
tolamolo l),</w>
tol yl)guanidine</w>
tol vaptan.</w>
tol vaptan,</w>
tol l</w>
tol eth
toleth al,</w>
tol .</w>
tol )-induced</w>
together ;</w>
together --with</w>
togen y.</w>
togen ic.</w>
toddl ers.</w>
toddl ers,</w>
toddl er.</w>
tocotrien ol.</w>
tocotrien ol,</w>
tocoly tics</w>
tocoly tic,</w>
tocain ide:</w>
tocain ide-
tocainide- lidocaine</w>
toc oral</w>
toc ol</w>
toc ochle
tocochle ograms</w>
toc in
tocin on</w>
tobram ycin-related</w>
tobram ycin-impregnated</w>
tobram ycin-cefazolin</w>
tobram ycin's</w>
tobacco ;</w>
tobac co-
tobacco- induced-
tobacco-induced- and</w>
tob er,</w>
to- warfarin</w>
to- subepicardial</w>
to- slight</w>
to- signal</w>
to- severe)</w>
to- rat</w>
to- profound</w>
to- portal</w>
to- plasma</w>
to- perfusate</w>
to- nose</w>
to- norfloxacin</w>
to- minimal</w>
to- lung</w>
to- lumen</w>
to- k
to-k yo-shyokyo-ka-ouren-bukuryou</w>
to- goal,</w>
to- glucose</w>
to- furosemide</w>
to- four</w>
to- excellent</w>
to- effect</w>
to- date</w>
to- dark</w>
to- brain</w>
to- benefit</w>
to- beat</w>
to- Thr</w>
to- Sun
to-Sun ny
to-Sunny bro
to-Sunnybro ok</w>
to- Nose</w>
to- DNA</w>
to- Arg
to-Arg 145</w>
to- ATP</w>
to- 8-month</w>
to ys</w>
to wnship</w>
to ward.</w>
to striatal</w>
to sis,</w>
to ses</w>
to ro
toro grade</w>
to quinone</w>
to oth
tooth ache.</w>
to o-
too- frequent</w>
to ken</w>
to ken,</w>
to ilet</w>
to ids</w>
to globin</w>
to fore,</w>
to ethane</w>
to es'</w>
to e
toe y,</w>
to -</w>
to ).</w>
tly- controlled</w>
tly- anesthetized</w>
tly- acting</w>
tle box</w>
tle /
tle/ prepulse</w>
tiz ox
tizox ).</w>
tiz er.</w>
tiz ation.</w>
tiz ,</w>
tivi zation"</w>
tivi ties.</w>
tive/ stereotyp
tive/stereotyp ic-like</w>
tive- age</w>
tive- K(+)</w>
tive x,</w>
tive -like</w>
tive ),</w>
tive "--may</w>
tiv omiting</w>
tiv ity;</w>
tiv ity-
tivity- specificity</w>
tiv es:</w>
titu tions</w>
titu des</w>
titre d</w>
titre ,</w>
titr ations</w>
titr ation-
titration- to-effect</w>
titr ate-
titrate- to-goal,</w>
tit udinal</w>
tissue/ h)</w>
tissue/ 2h</w>
tissue- to-plasma</w>
tissue- time</w>
tissue- injury</w>
tissue- differentiated</w>
tissue- derived</w>
tissue- binding</w>
tissue- based</w>
tissue- abnormalities</w>
tissue- ,</w>
tissu es).</w>
tissu e:</w>
tissu e).</w>
tis/ stomatitis</w>
tis/ septic</w>
tis/ mucositis</w>
tis/ dermatomyositis.</w>
tis/ Cervic
tis/Cervic itis</w>
tis-- short-</w>
tis-- elevated</w>
tis- myocarditis</w>
tis- dermatomyositis.</w>
tis- Phar
tis-Phar ma),</w>
tis- -induced</w>
tis- -1).</w>
tis tic</w>
tis on.</w>
tis ol
tisol aemia</w>
tis mus</w>
tis m/speech</w>
tis m)</w>
tis h
tish ism</w>
tis /</w>
tis ."</w>
tis -related</w>
tis ,"</w>
tis ),</w>
tis '</w>
tir radi
tirradi ational</w>
tipranavir/ ritonavir</w>
tipranavir/ ritonavir
tipranavir/ritonavir :</w>
tions/ outcomes</w>
tions/ 30</w>
tions/ 24</w>
tion/ reperfusion</w>
tion/ release</w>
tion/ re
tion/re training</w>
tion/ necrosis,</w>
tion/ inten
tion/inten tion-
tion/intention- tremor</w>
tion/ inhibition</w>
tion/ inhalation</w>
tion/ epigastric</w>
tion/ drug</w>
tion/ ablation</w>
tion- were</w>
tion- product</w>
tion- phase</w>
tion- limited</w>
tion- intensified</w>
tion- excitation</w>
tion- evoked,</w>
tion- defective</w>
tion- consolidation</w>
tion- causing</w>
tion- associated,</w>
tion- appearance</w>
tion s),</w>
tion less,</w>
tion ist</w>
tion ated</w>
tion ate</w>
tion ary.</w>
tion arily</w>
tion ally.</w>
tion alized</w>
tion ality</w>
tion al;</w>
tion .)</w>
tion -type</w>
tion -to-treat</w>
tion -related</w>
tion -like</w>
tion --are</w>
tion --
tion-- oral</w>
tion );</w>
tion )/
tion)/ OR
tion)/OR (respiratory</w>
tion ',</w>
tio 2]</w>
tinnit us-like</w>
ting- time</w>
ting- point</w>
ting [2]</w>
ting -type</w>
ting ),</w>
tin y</w>
tin ted</w>
tin s,</w>
tin olol</w>
tin ational</w>
tin ),</w>
timolo l;</w>
timolo l:</w>
timolo l/
timolol/ dorzolamide</w>
timolo l-associated</w>
timolo l)</w>
timolo l
timolol /</w>
timo l</w>
times/ day</w>
times/ day.</w>
times/ day,</w>
times/ day)</w>
time-to- treatment</w>
time-to- progression</w>
time-to- first</w>
time- window</w>
time- scales.</w>
time- scale.</w>
time- sampling</w>
time- sampled</w>
time- points.</w>
time- points,</w>
time- mated</w>
time- locked</w>
time- line</w>
time- killing</w>
time- interval</w>
time- frame</w>
time- frame,</w>
time- efficacy</w>
time- duration</w>
time- dependently.</w>
time- dependent:</w>
time- dependent.</w>
time- depend
time-depend ently,</w>
time- curve</w>
time- course,</w>
time- consu
time-consu ming,</w>
time- concentration</w>
time- action</w>
time- ,</w>
time trics).</w>
time ter)</w>
time points.</w>
time points,</w>
time out</w>
time out.</w>
time frame,</w>
time d,</w>
time /
time/ international</w>
time .(ABSTRACT</w>
time '.</w>
tim er.</w>
tim ental</w>
tim ec
timec our
timecour se</w>
tim al</w>
tim acy</w>
tilt- trials,</w>
tilt- negative</w>
tilt- evoked</w>
tile- suspiciousness,</w>
tile- evoked</w>
til ts.</w>
til ting.</w>
til ting-type</w>
til ting,</w>
til ine,</w>
til es:</w>
til ben
tilben e-
tilbene- 2,2
tilbene-2,2 '</w>
til b
tilb ene</w>
til ase</w>
til ).</w>
tigmine- morphine</w>
tigi al</w>
tight- seal</w>
tight- binding</w>
tigh tly-controlled</w>
tigh tening</w>
tig ma</w>
tig il,</w>
tig e,</w>
tidi tis</w>
tidi s</w>
tid oca
tidoca ine,</w>
tid ine)-induced</w>
tid artery</w>
tid ally</w>
tid ),</w>
ticulo stri
ticulostri ate</w>
ticulo sis,</w>
ticrynaf en,</w>
ticryn afen
ticrynafen )-induced</w>
tico- pulmonary</w>
tico vestibular</w>
tico id-treated</w>
ticlopid ine-based</w>
ticlopid ine),</w>
ticlop idine-
ticlopidine- aspirin</w>
ticarcill in.</w>
ticarcill in)</w>
tically- evoked</w>
tic/ toxic</w>
tic/ sedative</w>
tic/ saline</w>
tic/ megakary
tic/megakary ocyt
tic/megakaryocyt opoietic</w>
tic/ lymphocytic</w>
tic/ dysplastic</w>
tic/ dyskine
tic/dyskine tic).</w>
tic/ developmental</w>
tic- stimulating</w>
tic- nerve</w>
tic- flow</w>
tic- epilepsy</w>
tic- beta-adrenoceptor</w>
tic- antagonistic</w>
tic us),</w>
tic um.</w>
tic s--
tics-- locomotor</w>
tic s).</w>
tic s),</w>
tic ks.</w>
tic ity:</w>
tic ism</w>
tic ide</w>
tic idal</w>
tic dopamine</w>
tic as
ticas one
ticasone -17
ticasone-17 -</w>
tic an)</w>
tic ally-induced</w>
tic al.</w>
tic ?</w>
tic ;</w>
tic :
tic: toxic</w>
tic -to-
tic-to- normal</w>
tic -related</w>
tic -mediated</w>
tibol one).</w>
tibio peroneal</w>
tibio -
tibio- tar
tibio-tar sal</w>
tib ia,</w>
tiaz ofur
tiazofur in.</w>
tiar amide</w>
tiar amide.</w>
tiar amide,</w>
tiapri l-treated</w>
tiapri de-induced</w>
ti um.</w>
ti tis,</w>
ti tered</w>
ti ter
titer s
titers <10
titers<10 mIU/ml</w>
ti se
tise ments</w>
ti schemic
tischemic ,</w>
ti ric</w>
ti redness,</w>
ti red</w>
ti prenolol,</w>
ti p.</w>
ti p)</w>
ti ot
tiot ropium,</w>
ti min
timin gs</w>
ti lonium</w>
ti lling</w>
ti lating</w>
ti ion</w>
ti i.</w>
ti geal</w>
ti fying</w>
ti fication</w>
ti fibati
tifibati de-induced</w>
ti er-
tier- controlled</w>
ti e</w>
ti e-type</w>
ti dinol</w>
ti des</w>
ti des,</w>
ti ca.</w>
ti but
tibut able</w>
ti bulo
tibulo toxicity</w>
ti ble</w>
ti ble.</w>
ti ation,</w>
ti an</w>
ti al,</w>
ti a/
tia/ anotia</w>
ti a.</w>
ti E)</w>
ti -
ti- Trac
ti-Trac k,</w>
ti ,</w>
thyrox ine-treated</w>
thyrox ine-induced</w>
thyrox in,</w>
thyrotroph in-releasing</w>
thyroidi tis)</w>
thyroidi c</w>
thyroid ectomy</w>
thyroid ectomy.</w>
thyroid ectomy,</w>
thyroid -related</w>
thyroid -</w>
thyro tomy.</w>
thyro suppressant</w>
thyro ideal</w>
thyro id-
thyroid- binding</w>
thyro id)</w>
thyro glossal</w>
thyro globulin</w>
thymo globul
thymoglobul in),</w>
thym uses</w>
thym oxamine,</w>
thym omas</w>
thym oma,</w>
thym ol;</w>
thym ectomy</w>
thylisothiocyan ate,</w>
thyl -1,3-dipropyl
thyl-1,3-dipropyl xanthine</w>
thy re
thyre omime
thyreomime tics.</w>
thy om
thyom ethyl
thyomethyl phenyl)
thyomethylphenyl) cyan
thyomethylphenyl)cyan amide]</w>
thumb s,</w>
through out,</w>
through ly</w>
through :</w>
through ,</w>
thrombophleb itis:</w>
thrombophleb itis)</w>
thromboly tics,</w>
thromboembol us</w>
thromboembol ization.</w>
thromboembol isms.</w>
thromboembol ism)</w>
thromboembol ism
thromboembolism .
thromboembolism. Adv
thromboembolism.Adv ancing</w>
thromboembol i.</w>
thromboembol ectomy.</w>
thromboembol ectomies</w>
thrombocytopenia/ thrombosis.</w>
thrombocytopenia/ leukopenia</w>
thrombocytopenia/ grade</w>
thrombocytopenia/ eme
thrombocytopenia/eme sis/
thrombocytopenia/emesis/ rash</w>
thrombocytopenia- by</w>
thrombocytopenia /</w>
thrombocytopenia -positive</w>
thrombocytopen ic.</w>
thrombocytopen ic,</w>
thrombocytopen ia--a</w>
thrombocyto sis).</w>
thrombocyth opo
thrombocythopo enia</w>
thrombocyth aemia.</w>
thrombo- embolism.</w>
thrombo sis.(ABSTRACT</w>
thrombo sis).</w>
thrombo sis"</w>
thrombo ses:</w>
thrombo ses,</w>
thrombo ses)</w>
thrombo prophylaxis;</w>
thrombo prophylaxis.</w>
thrombo prophylaxis,</w>
thrombo phle
thrombophle bi
thrombophlebi tic</w>
thrombo path
thrombopath ia</w>
thrombo kinase</w>
thrombo i
thromboi sis</w>
thrombo haemorrhagic</w>
thrombo genicity</w>
thrombo genicity.</w>
thrombo genicity,</w>
thrombo genesis.</w>
thrombo arteritis</w>
thrombo -</w>
thrombin- specific</w>
thrombin- III</w>
thromb us."</w>
thromb us)</w>
thromb os
thrombos pond
thrombospond in,</w>
thromb opoietin</w>
thromb opoi
thrombopoi etin.</w>
thromb openia,</w>
thromb ol
thrombol ectomies,</w>
thromb ocytes</w>
thromb ocytes,</w>
thromb o</w>
thromb in),</w>
thromb ectomy,</w>
thromb ectomies</w>
throm ycin-treated</w>
throm ycin,</w>
throm po
thrompo phlebitis</w>
thro scopy</w>
thro mo
thromo plastin</w>
thro idectomy</w>
thro cytic</w>
thro cebus</w>
threshol ds).</w>
threshol d"</w>
threshol d
threshold s;</w>
thresh hold</w>
threo- ifenprodil</w>
threo- ifenprodil,</w>
threo- DOPS.</w>
threo- 8-
threo-8- [1-
threo-8-[1- (4-hydroxy
threo-8-[1-(4-hydroxy phenyl)-1-
threo-8-[1-(4-hydroxyphenyl)-1- hydroxy-
threo-8-[1-(4-hydroxyphenyl)-1-hydroxy- propan-2-
threo-8-[1-(4-hydroxyphenyl)-1-hydroxy-propan-2- yl]-1-phenyl-1,3,8-triazaspiro[4,5]decane-4-one]</w>
three- weekly</w>
three- week-old</w>
three- visit</w>
three- to-four</w>
three- times-daily</w>
three- step
three-step ped</w>
three- period</w>
three- period,</w>
three- patient</w>
three- parallel</w>
three- months</w>
three- minute</w>
three- hour)</w>
three- fold)</w>
three- drop</w>
three- compartment</w>
three- class</w>
three- choice</w>
three- channel</w>
three- arm</w>
three fold;</w>
three fold.</w>
three fold,</w>
three fold)</w>
threat .</w>
threat -induced</w>
thre on
threon ine,</w>
thre e).</w>
thr ypsin</w>
thr yoiditis</w>
thr ush.</w>
thr ush,</w>
thr algia:</w>
thous and.</w>
thought lessly</w>
thought ful</w>
though ts;</w>
though .</w>
thorough .</w>
thoraco- mediast
thoraco-mediast inic</w>
thorac o
thoraco abdominal</w>
thorac ic
thoracic >
thoracic> cervical</w>
thorac es,</w>
thor inal</w>
thor act
thoract omized</w>
thor a</w>
tho dromic</w>
tho c</w>
tho ++</w>
this ?</w>
thirty- seven</w>
thirty- one.</w>
thirst /
thirst/ polyur
thirst/polyur ia;</w>
third- week-gestation</w>
third- trimester</w>
third- time</w>
third- person</w>
third- party</w>
third- fourth</w>
thir sted</w>
thir d:</w>
thioure a,</w>
thiotepa /
thiotepa/ carboplatin.</w>
thiotepa -induced</w>
thiosulf ate.</w>
thioridaz ine-tricyclic</w>
thioridaz ine).</w>
thioph ate.</w>
thioper amide-
thioperamide- cimetidine,</w>
thiopentone- atracurium-
thiopentone-atracurium- morphine</w>
thiopental/ fentanyl</w>
thiopental/ fentanyl.</w>
thiopental/ fentanyl,</w>
thiopental- halothane.</w>
thiopental- halothane)</w>
thiopental- anesthetized,</w>
thiopental- Na</w>
thiopental- N2O-
thiopental-N2O- fentanyl</w>
thiopent one;</w>
thiopent al:</w>
thiopent al-induced</w>
thiop ron
thiopron ine)</w>
thiop ia</w>
thion in)</w>
thion ate:</w>
thion amides.</w>
thion amide.</w>
thiomorph olin</w>
thiomorph olin
thiomorpholin yl]</w>
thiomal ate.</w>
thioguan ine-
thioguanine- alkaline</w>
thioguan ine,</w>
thioguan ine)</w>
thioglucose -</w>
thioglucose +HF</w>
thiofen-2- il)</w>
thiofen-2- il
thiofen-2-il )-2-
thiofen-2-il)-2- metil
thiofen-2-il)-2-metil but
thiofen-2-il)-2-metilbut -3-
thiofen-2-il)-2-metilbut-3- yn-2-ol</w>
thiocyan ate,</w>
thiocolchico side,</w>
thiocolchic oside</w>
thiocarb am
thiocarbam ates,</w>
thiobutyro lactone.</w>
thiobut ab
thiobutab arbit
thiobutabarbit one-
thiobutabarbitone- anaesthetized</w>
thiobarbit uricacid</w>
thiobarbit uric-acid-reactive</w>
thiobarbit urate-halothane</w>
thio] triphosphate</w>
thioTE PA.</w>
thioTE PA-treated</w>
thioTE PA,</w>
thio- tetra
thio-tetra zole</w>
thio- barbituric</w>
thio- TE
thio-TE PA.</w>
thio- D-glucose</w>
thio- 2,</w>
thio uracil</w>
thio propyl-
thiopropyl- substituted</w>
thio hydantoin</w>
thio flav
thioflav in</w>
thio ate,</w>
thio ]</w>
thio )
thio) triphosphate</w>
thin ning.</w>
thin ning,</w>
thin ness</w>
thin ner.</w>
thin ned</w>
thin n
thinn ing;</w>
thin king.</w>
thin k
think ing)</w>
thigh s</w>
thigh ,</w>
thiethylper azine.</w>
thiethylper azine,</w>
thiep in.</w>
thien opyrid
thienopyrid ine-derived</w>
thien opyri
thienopyri din
thienopyridin es,</w>
thien odiazepine</w>
thickness/LV Ds</w>
thickness/LV Ds.</w>
thickness/ posterior</w>
thicknes ses.</w>
thicknes ses,</w>
thicken s.</w>
thicken ing)</w>
thicken ing"</w>
thicken ed,</w>
thick ness)</w>
thick ness
thickness -to-
thickness-to- lumen</w>
thick er,</w>
thiazolo[3,2-a] pyridines</w>
thiazolo[3,2-a] pyridine</w>
thiazolidinedi ones.</w>
thiazolidinedi one-induced</w>
thiazolidinedi one,</w>
thiazole- dihydro
thiazole-dihydro chloride),</w>
thiazol ylthiopropanolamine</w>
thiazol ine,</w>
thiazide s)</w>
thiazide -related</w>
thiaz olo
thiazolo triazolopyrimidine</w>
thiaz ides.</w>
thiaz ide:</w>
thiaz ide-treated</w>
thiaz ide-
thiazide- enalapril</w>
thiaz ide,</w>
thiamylal- halothane-anesthetized</w>
thiamylal- enflurane,</w>
thiamyl al.</w>
thiamyl al,</w>
thiamphenic ol</w>
thiamphenic ol;</w>
thiamphenic ol-induced</w>
thiam azole.</w>
thiam azole,</w>
thiadiazol es</w>
thiaben dazole-induced</w>
thia diaz
thiadiaz ide</w>
thi uram</w>
thi otri
thiotri phosphate)</w>
thi ot
thiot re
thiotre itol-
thiotreitol- sensitive</w>
thi orphan</w>
thi open
thiopen th
thiopenth al</w>
thi omethyl</w>
thi g
thig motaxis</w>
thi azepine</w>
thi apine,</w>
thi amine.</w>
thi amine-
thiamine- dependent</w>
thi acy
thiacy tidine)-induced</w>
thi acet
thiacet azone,</w>
theta( albumin
theta(albumin ))</w>
thesi zing</w>
thesi as.</w>
thesi as,</w>
thes opathy</w>
thes in.</w>
thermon ocicept
thermonocicept ors.</w>
thermo therapy,</w>
thermo regulation.</w>
thermo graphy.</w>
thermo graph
thermograph y/laser-Doppler</w>
thermo genic</w>
thermo genesis</w>
thermo dynamically</w>
thermist or</w>
thermist er</w>
thermalg ia</w>
thermal- hot</w>
thermal -specific</w>
thermal -induced</w>
thermal ,</w>
therm ometry)</w>
therl ands</w>
therg oline</w>
thereafter ),</w>
there- by</w>
there- after</w>
there of,</w>
there in.</w>
there in,</w>
there b
thereb y.</w>
therapy- naive</w>
therapy- na
therapy-na i</w>
therapy- medroxyprogesterone</w>
therapy- limiting</w>
therapy- associated</w>
therapy- -is</w>
therapeutic- toxic</w>
therapeutic- agent</w>
therapeu tics;</w>
therapeu tics.</w>
therapeu tics,</w>
therapeu tically,</w>
therapeu tic:toxic</w>
therapeu tic/toxic</w>
therapeu tic-range</w>
therap y,"</w>
therap y);</w>
therap y'.</w>
therap y"</w>
therap utic</w>
therap ists.</w>
therap ist</w>
therap i
therapi es?</w>
ther s
thers burg,</w>
ther petic</w>
ther n-
thern- blot</w>
ther mot
thermot est,</w>
ther more,</w>
ther mol
thermol ab
thermolab ile</w>
ther mia-induced</w>
ther gy</w>
ther gol
thergol ine,</w>
ther adial</w>
ther -a-
ther-a- go-go</w>
theophylline- produced</w>
theophylline- 2-
theophylline-2- ethylenediamine
theophylline-2-ethylenediamine ]-induced</w>
theophylline )</w>
theophylline ).</w>
theophyll ine-treated</w>
theophyll ine-like</w>
thenal idine,</w>
then-cisDD P,</w>
then- paclitaxel</w>
then- cisplatin</w>
then uria.</w>
then ia,</w>
then -1-
then-1- yl-1-phenyl-1,3,8-triaza-spiro[4,5]decan-4-one),</w>
themy oclonic</w>
themy algias,</w>
them ia:</w>
them ;</w>
them .5.</w>
thelin s</w>
theli a</w>
thel min
thelmin tic</w>
thel ine,</w>
thec a</w>
theat re</w>
theat re.</w>
theat er</w>
the- street
the-street ;</w>
the- curve</w>
the- Coun
the-Coun ter</w>
the y,</w>
the ta-
theta- rhythm,</w>
the rectomy</w>
the re.</w>
the re,</w>
the prolonged</w>
the line</w>
the l</w>
the ft</w>
the ba
theba ine,</w>
the ater
theater ;</w>
the al</w>
the L-Dopa</w>
the ,</w>
that :
that: (i)</w>
that .</w>
that .
that. Moreover,</w>
that --
that-- unlike</w>
that 's</w>
thana sias</w>
than ks</w>
thalli um.</w>
thalli um)</w>
thalidomide- na</w>
thalidomide- based</w>
thalidomide ?</w>
thalidomide /
thalidomide/ cisplatin/
thalidomide/cisplatin/ doxorubicin/
thalidomide/cisplatin/doxorubicin/ cyclophosphamide/etoposide
thalidomide/cisplatin/doxorubicin/cyclophosphamide/etoposide ]</w>
thalidomide ).</w>
thalidomide 's</w>
thalidom ide:</w>
thalidom ide-associated</w>
thalidom ide)</w>
thalassemic .</w>
thalass aemic</w>
thalamo-striatal- cortical</w>
thalamo- pituitary</w>
thalam us?</w>
thalam us;</w>
thalam us:</w>
thalam us).</w>
thalam opallidal</w>
thalam oc
thalamoc ing
thalamocing ulate</w>
thalam ic/
thalamic/ occipital</w>
thalam ic-induced</w>
thalam i,</w>
thal mic-
thalmic- pituitary-adrenal</w>
thal lium-
thallium- 201.</w>
thal ide
thalide mide</w>
thal .</w>
thal 's</w>
th- twelfth</w>
th- line</w>
th- generation</w>
th- electrode</w>
th- eaten</w>
th- care</w>
th yl-2-aminopropane</w>
th ygmotaxis</w>
th y</w>
th y,</w>
th ump,</w>
th ru
thru st.</w>
th rin</w>
th rash
thrash ing</w>
th onous</w>
th omb
thomb ocytopenia</w>
th olysis</w>
th off
thoff 's</w>
th mia</w>
th metic,</w>
th iz
thiz onate</w>
th ings,</w>
th ing,</w>
th in-induced</w>
th ic</w>
th ia-
thia- 5-
thia-5- +</w>
th ex
thex ate</w>
th estic</w>
th epin</w>
th en.</w>
th emia,</w>
th aw
thaw ing</w>
th ate</w>
th ap
thap sig
thapsig arg
thapsigarg in</w>
th an,</w>
th amic</w>
th aemia</w>
th a</w>
th a
tha ired</w>
th :</w>
th -containing</w>
th %</w>
text ure.</w>
text book</w>
tex ture</w>
tex t)</w>
tex )</w>
tetrazol i
tetrazoli um-based</w>
tetrazol e-
tetrazole- 5-
tetrazole-5- yl)biphenyl-4-yl]methyl-4,5,6,7-tetrahydro</w>
tetrazol -5-
tetrazol-5- yl)butoxy]-3,4-dihydro-2</w>
tetrapare tic</w>
tetrapare sis.</w>
tetrapare sis"</w>
tetrapare ses</w>
tetrap loid</w>
tetrap lo
tetraplo id,</w>
tetrap leg
tetrapleg ics.</w>
tetrap eptide,</w>
tetramethyl rhodamine</w>
tetrameth yl-4-piperidinyl)</w>
tetralo gies</w>
tetrahydroisoquinol ines</w>
tetrahydroisoquinol ines.</w>
tetrahydroisoquinol ine),</w>
tetrahydrocannabinol- standardized</w>
tetrahydrocannabinol- 9-
tetrahydrocannabinol-9- carboxylic</w>
tetrahydrocannabin ol-induced</w>
tetrahydrocannabin ol,</w>
tetrahydrocannabin ol's</w>
tetrahydro-7,8- dimethoxy-
tetrahydro-7,8-dimethoxy- 3-
tetrahydro-7,8-dimethoxy-3- [3-
tetrahydro-7,8-dimethoxy-3-[3- ]
tetrahydro-7,8-dimethoxy-3-[3-] [2-(3,4-
tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4- dimethoxyphenyl)
tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl) ethyl]</w>
tetrahydro-3-methyl-5-phenyl-1H-3-benz azepine</w>
tetrahydro-3-methyl-5-phenyl-1H-3-benz azepin</w>
tetrahydro-3-methyl-5-phenyl -1-
tetrahydro-3-methyl-5-phenyl-1- H-3-benzazep
tetrahydro-3-methyl-5-phenyl-1-H-3-benzazep ine;</w>
tetrahydro-1H-3-benz azepine</w>
tetrahydro- 9-
tetrahydro-9- oxo-
tetrahydro-9-oxo- 9
tetrahydro-9-oxo-9 H-</w>
tetrahydro- 6-nitro-
tetrahydro-6-nitro- 2,3-
tetrahydro-6-nitro-2,3- dioxo-
tetrahydro-6-nitro-2,3-dioxo- benzo(f)
tetrahydro-6-nitro-2,3-dioxo-benzo(f) quinoxaline-7-
tetrahydro-6-nitro-2,3-dioxo-benzo(f)quinoxaline-7- sulphonamide</w>
tetrahydro- 6-
tetrahydro-6- propyl-
tetrahydro-6-propyl- amino-
tetrahydro-6-propyl-amino- benz
tetrahydro-6-propyl-amino-benz thiazole-dihydrochloride),</w>
tetrahydro- 3H-
tetrahydro-3H- benzopyrano
tetrahydro-3H-benzopyrano [
tetrahydro-3H-benzopyrano[ 3,4-
tetrahydro-3H-benzopyrano[3,4- c]
tetrahydro-3H-benzopyrano[3,4-c] pyrro
tetrahydro-3H-benzopyrano[3,4-c]pyrro le-
tetrahydro-3H-benzopyrano[3,4-c]pyrrole- 2-
tetrahydro-3H-benzopyrano[3,4-c]pyrrole-2- yl)-butyl](4-phenyl)benzamide]</w>
tetrahydro- 3(2H)-
tetrahydro-3(2H)- isoquinol
tetrahydro-3(2H)-isoquinol inone</w>
tetrahydro pyrido
tetrahydropyrido -4-
tetrahydropyrido-4- yl]pyridazin-3(2H)-one</w>
tetrahydro progester
tetrahydroprogester one),</w>
tetrahydro cortisone,</w>
tetrahydro cortisol.</w>
tetrahydro biopterin</w>
tetrahydro biop
tetrahydrobiop terin,</w>
tetrahydro ana
tetrahydroana phthal
tetrahydroanaphthal ene.</w>
tetrahydro -1H-
tetrahydro-1H- 3-</w>
tetrafluoro ethylene</w>
tetrafluoro ethyl</w>
tetraethylammon ium
tetraethylammonium ,
tetraethylammonium, 4-aminopyridine,</w>
tetraethyl thiuram</w>
tetradec yl</w>
tetradec anoyl
tetradecanoyl phorbol-1
tetradecanoylphorbol-1 3-
tetradecanoylphorbol-13- acetate</w>
tetracycline- rifampicin</w>
tetracycline- injected</w>
tetracycl ic)</w>
tetrachlor ide.</w>
tetrachlor ide-
tetrachloride- ,</w>
tetrachlor ide,</w>
tetrachlor ide
tetrachloride -mediated</w>
tetraca ine;</w>
tetraca ine--a</w>
tetraca ine)</w>
tetrac yclines.</w>
tetrabutyl ammonium</w>
tetrabutyl ammonium,</w>
tetraben azine,</w>
tetraben azine)</w>
tetrabam ate-related</w>
tetrabam ate-associated</w>
tetra zole,</w>
tetra zol</w>
tetra isopropyl</w>
tetra hydrate</w>
tetr alin)</w>
tetr agl
tetragl ycylhistamine</w>
tetr a</w>
tetan y:</w>
tetan y,</w>
tetan us:</w>
tetan i</w>
tet anoid</w>
testosterone- stimulated</w>
testosterone- replacement-induced</w>
testosterone- injected</w>
testosterone- (T)</w>
testoster one-</w>
testoster one)</w>
testic ular,</w>
testic le</w>
tested the</w>
tested .3.</w>
test-- as</w>
test-- appeared</w>
test- re
test-re tests</w>
test- MEP)</w>
test s);</w>
test s):</w>
test op
testop an</w>
test ing).</w>
test ing),</w>
test es,</w>
test er,</w>
test ed?</w>
test ed).</w>
test able</w>
test ].</w>
test .It</w>
test .5.</w>
test .4</w>
test '</w>
test '.</w>
test ".</w>
test ")</w>
test "),</w>
tes tis;</w>
tes tis.</w>
tes tifying</w>
tertiary- referral</w>
tertiary- care,</w>
tertiary- butyl-isonitrile</w>
terti les</w>
terti le.</w>
terti le,</w>
tert-butylamino- 2'-
tert-butylamino-2'- hydroxy
tert-butylamino-2'-hydroxy propylthio
tert-butylamino-2'-hydroxypropylthio )-4-
tert-butylamino-2'-hydroxypropylthio)-4- (5'-
tert-butylamino-2'-hydroxypropylthio)-4-(5'- carbamo
tert-butylamino-2'-hydroxypropylthio)-4-(5'-carbamo yl-2'-thienyl)thiazole</w>
tert-butylamino)propoxy ]
tert-butylamino)propoxy] 2,3-
tert-butylamino)propoxy]2,3- naphthal
tert-butylamino)propoxy]2,3-naphthal enedi
tert-butylamino)propoxy]2,3-naphthalenedi ol</w>
tert-butylamino)propoxy )-3'-methoxy
tert-butylamino)propoxy)-3'-methoxy phenyl
tert-butylamino)propoxy)-3'-methoxyphenyl ]</w>
tert-butyl- nit
tert-butyl-nit ron
tert-butyl-nitron e;</w>
tert-butyl- amino
tert-butyl-amino propoxy
tert-butyl-aminopropoxy )-3'-methoxy
tert-butyl-aminopropoxy)-3'-methoxy phenyl]
tert-butyl-aminopropoxy)-3'-methoxyphenyl] -</w>
tert-butyl- (S)-
tert-butyl-(S)- 8-bromo
tert-butyl-(S)-8-bromo -1
tert-butyl-(S)-8-bromo-1 1,
tert-butyl-(S)-8-bromo-11, 12,
tert-butyl-(S)-8-bromo-11,12, 13,
tert-butyl-(S)-8-bromo-11,12,13, 13
tert-butyl-(S)-8-bromo-11,12,13,13 a-
tert-butyl-(S)-8-bromo-11,12,13,13a- tetrahydro-9-oxo-9H-</w>
tert-butyl nit
tert-butylnit rone,</w>
tert-butyl hydroperoxide</w>
tert-butyl ,</w>
tert- butanol</w>
tert- Leu
tert-Leu ,</w>
territ orial</w>
territ or
territor y).</w>
terminal- deoxynucleotid
terminal-deoxynucleotid yl-transferase-mediated</w>
terminal- deoxy
terminal-deoxy n
terminal-deoxyn ucltidyl</w>
termin ology</w>
termin ology,</w>
termin ed</w>
termin ation;</w>
termin ate.</w>
termin at
terminat ing"</w>
termin ally.</w>
termin al.</w>
teri parati
teriparati de.</w>
terg uride.</w>
terg uride)</w>
terbutal ine-treated</w>
terbin afine-induced</w>
teratogen ic,</w>
teratogen :</w>
teratogen ,</w>
terat oma</w>
terat oma,</w>
terat ologies</w>
terat ocarcinoma</w>
terat a,</w>
ter/ simpler</w>
ter- topped</w>
ter- tipped</w>
ter- third</w>
ter- syndrome-like</w>
ter- selective</w>
ter- relaxing</w>
ter- ligated</w>
ter- butyl-
ter-butyl- quinol
ter-butyl-quinol yl)]-3-(4-piperidyl)propanol</w>
ter- Serratia</w>
ter us,</w>
ter tralin</w>
ter tat
tertat olol</w>
ter tahydro
tertahydro pyridine</w>
ter s).</w>
ter ror
terror /
terror/ sleepwalking</w>
ter ro
terro r</w>
ter rib
terrib le</w>
ter onol
teronol -treated</w>
ter one.</w>
ter om
terom ia</w>
ter o
tero yl-L-glutamine</w>
ter nat
ternat in.</w>
ter mon
termon id),</w>
ter m/
term/ recent</w>
ter m-
term- infant</w>
ter m
term s--
terms-- is</w>
ter lun
terlun d,</w>
ter itis</w>
ter ian</w>
ter fly</w>
ter ant</w>
ter active</w>
ter ach
terach ,</w>
ter ability</w>
ter -1</w>
ter ).</w>
ter ),</w>
ter '
ter' sh
ter'sh ouse</w>
tent ative.</w>
tent );</w>
tension -related</w>
tensi ves</w>
tenofovir ;</w>
tenofovir :</w>
tenofovir /
tenofovir/ nevirapine</w>
tenidap .</w>
tenidap 's</w>
tendino pathy</w>
tendino pathy.</w>
tendino pathies.</w>
tender ness),</w>
tend encies,</w>
ten- taught</w>
ten- day</w>
ten- bed</w>
ten uria,</w>
ten uous</w>
ten th-twelfth</w>
ten sions,</w>
ten sional</w>
ten sion;</w>
ten sion:</w>
ten sion)</w>
ten sin</w>
ten si</w>
ten se,</w>
ten oxicam.</w>
ten os
tenos ynovitis.</w>
ten ni
tenni s.</w>
ten ing.</w>
ten ic</w>
ten ia</w>
ten et</w>
ten ess.</w>
ten er
tener ol.</w>
ten ect
tenect eplase</w>
ten cy</w>
ten cephal
tencephal on.</w>
ten berg</w>
ten al
tenal idine</w>
ten able.</w>
ten .</w>
ten ),</w>
tempt ing</w>
tempt ation</w>
temporo- parieto-occipital</w>
temporo- parietal</w>
temporo par
temporopar ital</w>
temporo occipital</w>
temporo mesial</w>
temporo frontal</w>
temporar ily.</w>
temporar il
temporaril y;</w>
temporal- parietal-occipital</w>
temporal- lobe</w>
temporal- integration</w>
temporal- integration,</w>
tempor ary.</w>
tempor ally.</w>
tempo ros
temporos patial</w>
tempo rop
temporop olar</w>
tempo )</w>
tempo ),</w>
temperat ure-dependent</w>
temperat ure).</w>
temperat ure),</w>
temperam ents,</w>
temperam ent.</w>
temper s,</w>
temozolom ide:</w>
temozolom ide-
temozolomide- refractory</w>
temocapri l)</w>
temocapri l),</w>
temoc april,</w>
temo zolamide,</w>
temazep am.</w>
temaf loxacin.</w>
temaf loxacin,</w>
tem sirolimus,</w>
tem pol
tempol )</w>
tem pe
tempe red</w>
tem ide)</w>
tem ber</w>
tem bac
tembac h's</w>
tem ,</w>
telomere- regulating</w>
telithrom ycin:</w>
telithrom ycin-induced</w>
telephone- directed</w>
telephone- administered</w>
teleph one).</w>
tele vision</w>
tele thermography.</w>
tele metry.</w>
tele matic</w>
telangiect atic</w>
telangiect asis.</w>
telangiect asias</w>
telangiect ases</w>
telangiect ases.</w>
tel enz
telenz epine</w>
tel encephalon,</w>
tel biv
telbiv udine,</w>
teicoplan in;</w>
tegment um</w>
tegment um.</w>
tegment i</w>
tegaf ur-0.4</w>
teeth ing</w>
teeth ing.</w>
teeth -
teeth- chattering,</w>
teenag ers.</w>
teen- weeks</w>
teen- day</w>
teen- cis</w>
ted ly.</w>
ted ly,</w>
ted .(ABSTRACT</w>
ted );</w>
ted "</w>
techno logy,</w>
techno logical</w>
techniqu es:</w>
techniqu e:</w>
techniqu e.
technique. Arterial</w>
techniqu e
technique ):</w>
technic s.</w>
technic .</w>
technic ,</w>
technetium-99m- pertechnetate</w>
technetium-99m- HMPAO</w>
technetium- tertiary</w>
technetium- tertiary-butyl-isonitrile</w>
tech nic</w>
tear s.</w>
tear s":</w>
tear ing,</w>
teach ers</w>
teach ers.</w>
teach ers'</w>
te- forming</w>
te trasodium</w>
te trandra</w>
te qu
tequ in,</w>
te pred
tepred no
tepredno l</w>
te pine</w>
te ll
tell .</w>
te le-
tele- chest</w>
te l</w>
te k</w>
te h</w>
te grade</w>
te fl
tefl on</w>
te fenadine</w>
te et
teet ot
teetot aller</w>
te dness,</w>
te d),</w>
te brobasilar</w>
te bor
tebor g</w>
te ased</w>
te ase</w>
te ars</w>
te am,</w>
te am
team s.</w>
te a-like</w>
te a)</w>
te ;</w>
te :</w>
te "</w>
tc p)</w>
tc p),</w>
tazol ine</w>
tazobact am.</w>
tazobact am,</w>
taz zoli</w>
taxane- resistant</w>
taxane- refractory</w>
taxane- containing</w>
taxan es
taxanes -containing</w>
tax ol-induced</w>
tax ol
taxol --in</w>
tax oid</w>
tax i</w>
tax el</w>
tax ane.</w>
tax ane-associated</w>
tax ane,</w>
tax an</w>
tauroursodeoxychol ate:</w>
tauroursodeoxychol ate.</w>
tauro ursodeoxycholic</w>
taur us</w>
taur ine)</w>
tau opathy.</w>
tau .</w>
tau ,</w>
tau +</w>
tau ).</w>
tat too</w>
tast ing</w>
tast e-
taste- recognition</w>
task :</w>
task -induced</w>
task ).</w>
tas ;</w>
tartraz ine</w>
tartraz ine.</w>
tartr ate:</w>
target- profiling</w>
target- detection</w>
target- derived,</w>
target '</w>
tar sor
tarsor rhaph
tarsorrhaph y</w>
tar ry</w>
tar da,</w>
tar but
tarbut aline</w>
tar ax)</w>
taper ing,</w>
taper ,</w>
tap res</w>
tap es,</w>
tap ered,</w>
tap enem</w>
tap ed.</w>
tap e.</w>
tap e,</w>
tap e)</w>
tap e),</w>
tann ins,</w>
tang entially</w>
tang ential,</w>
tang ,</w>
tan yl,</w>
tan ance</w>
tamponade ;</w>
tamoxifen: N-desmethyl</w>
tamoxifen: 4-hydroxy</w>
tamoxifen- receiving</w>
tamoxifen- promoted</w>
tamoxifen /day</w>
tamoxifen .)</w>
tamoxifen -associated</w>
tam o
tamo eb
tamoeb a</w>
tam itochondrial</w>
talk ing,</w>
talk ativeness,</w>
talk ative,</w>
talk activity,</w>
talipex ole-induced</w>
talipex ole,</w>
tal- striatal</w>
tal- dysraphic</w>
tal- anesthetized</w>
tal supram
talsupram ,</w>
tal mo
talmo logical</w>
tal king</w>
tal ion</w>
tal e.</w>
tal c,</w>
tal 1,</w>
tal -related</w>
tal "</w>
take over</w>
take ?</w>
tak o-tsubo-like</w>
tak ing
taking <40</w>
tak ers,</w>
tak er</w>
tak en:</w>
tak e.</w>
tain ted</w>
tain ly,</w>
tailo red"</w>
tail- tremor,</w>
tail- tremor)</w>
tail- skin</w>
tail- cut
tail-cut ting</w>
tail s,</w>
tail ing</w>
tail ing-
tailing- albumin
tailing-albumin ').</w>
tail )</w>
tai led,</w>
taglu timide,</w>
tag ine,</w>
tadalaf il-treated</w>
tacrolimus- induced.</w>
tacrolimus- binding</w>
tacrolim us;</w>
tacrolim us-mediated</w>
tacrine- lithium</w>
tachyphyl axis,</w>
tachyphyl actic</w>
tachyp ne
tachypne ic.</w>
tachykin ins</w>
tachykin in-
tachykinin- NK1-receptor</w>
tachycardia/ palpitations</w>
tachycardia/ fibrillation.</w>
tachycardia- ventricular</w>
tachycardia- flutter</w>
tachycardia .(ABSTRACT</w>
tachycardia -inducing</w>
tachycardia ),</w>
tachycardia "--may</w>
tachycardi as,</w>
tachycardi as)</w>
tachycardi al</w>
tachy systole</w>
tachy dysrhythmias</w>
tachy dysrhythmias.</w>
tachy cardic.</w>
tachy arrythmias</w>
tachy arr
tachyarr thymia</w>
tachy -</w>
tach y</w>
tach ment</w>
tach cardia</w>
tacalcit ol.</w>
tacalcit ol)</w>
tac tile-evoked</w>
tac tile,</w>
tac r
tacr ine),</w>
tac kle</w>
tac king</w>
tac itly</w>
tac in,</w>
tac hem</w>
tac erebral</w>
tac aval</w>
tac apone</w>
tabul ated,</w>
table ts/day</w>
table t/
tablet/ day)</w>
table t-
tablet- taking</w>
table t)</w>
table ],</w>
table ):</w>
tab ash
tabash i</w>
ta- per
ta-per ch
ta-perch a)</w>
ta ves</w>
ta urine-supplemented</w>
ta u-immunoreactive</w>
ta ions</w>
ta in,</w>
ta enia</w>
ta b</w>
ta ).</w>
ta 's</w>
t/ type</w>
t/ sex.</w>
t/ no</w>
t/ literature</w>
t/ left</w>
t/ efferent</w>
t/ /2)</w>
t.i. d</w>
t.i. d.).</w>
t.i. d,</w>
t.d. s.)</w>
t. ))</w>
t-butyl-bicyclophosphoro thionate</w>
t-butyl-bicyclophosphoro thioate</w>
t-[35S] butylbicyclophosphoro
t-[35S]butylbicyclophosphoro thionate:</w>
t-MDS/ AML,</w>
t-G anciclovir</w>
t-1,2- CHD,</w>
t- versus-time</w>
t- versus-host</w>
t- ventricular</w>
t- tests</w>
t- tests.</w>
t- test),</w>
t- sensitive</w>
t- pretreated</w>
t- ox)</w>
t- moment</w>
t- like</w>
t- free</w>
t- controlled</w>
t- changes</w>
t- brush</w>
t- blot</w>
t- based</w>
t- [3H]
t-[3H] butyl
t-[3H]butyl bicyclo
t-[3H]butylbicyclo orthobenzo
t-[3H]butylbicycloorthobenzo ate</w>
t- Teacher</w>
t- R
t-R ingu
t-Ringu et</w>
t- Hess</w>
t- D)</w>
t- Al
t-Al dr
t-Aldr ich</w>
t- AM
t-AM CA,</w>
t- A</w>
t- 60</w>
t- .</w>
t- -
t-- tentatively</w>
t(3; 19),</w>
t(3; 19
t(3;19 )],</w>
t(3; 16)</w>
t(2)= 6.
t(2)=6. 9
t(2)=6.9 56,</w>
t(2)= 4.
t(2)=4. 66
t(2)=4.66 6,</w>
t(1/ 2),</w>
t(1/ 2)
t(1/2) ke
t(1/2)ke 0.</w>
t yroidi,</w>
t y;</w>
t weilers</w>
t valg</w>
t ured</w>
t undation,</w>
t ty</w>
t tic</w>
t sukub
tsukub a
tsukuba ensis,</w>
t s.
ts. Evaluation</w>
t s'</w>
t ress</w>
t pom
tpom s</w>
t p</w>
t ors.</w>
t ors,</w>
t one).</w>
t ome</w>
t ocon
tocon stitu
toconstitu ents</w>
t mias,</w>
t ly)</w>
t ly"</w>
t ler</w>
t le-
tle- studied</w>
t le)</w>
t lanta,</w>
t land</w>
t land,</w>
t k</w>
t ings.</w>
t ese</w>
t es),</w>
t entorial</w>
t entor
tentor ium</w>
t ence</w>
t chy</w>
t c</w>
t b/
tb/ day
tb/day )).</w>
t ative,</w>
t ation-
tation- liaison</w>
t ated,</w>
t art
tart aric</w>
t arn
tarn ished</w>
t ar</w>
t ale</w>
t al.</w>
t agg
tagg ing</w>
t afen
tafen ine</w>
t ables</w>
t ables.</w>
t ability.</w>
t ]</w>
t [
t[ s
t[s z]),</w>
t RNA</w>
t RA.</w>
t RA)</w>
t PDC</w>
t PA-
tPA- agents,</w>
t Hcy</w>
t Cycl
tCycl er-based</w>
t Cr.</w>
t CO2)</w>
t 9-
t9- THC.</w>
t 50</w>
t 4,</w>
t 3/
t3/ Mt
t3/Mt 3</w>
t 2.</w>
t 11</w>
t 1/2.</w>
t 1/2,</w>
t 1/
t1/ 2S</w>
t .),</w>
t ."</w>
t -1,
t-1, 2-</w>
t -1)</w>
t (s)</w>
t (max)</w>
t (max),</w>
t (1)=
t(1)= 7.
t(1)=7. 593,</w>
t %.</w>
t ")</w>
systolic/ diastol
systolic/diastol ic)</w>
systolic- time-interval</w>
systol ic;</w>
systol ic.</w>
systol ic).</w>
systemic- onset</w>
systemic- level</w>
system s;</w>
system s--
systems-- the</w>
system ically),</w>
system ic)</w>
system ic),</w>
system ?</w>
system .6.</w>
system ),</w>
system (s)</w>
system '</w>
syst olo-
systolo- diastolic</w>
syst ole.</w>
syst enic</w>
sys ms</w>
syru ps</w>
syru p,</w>
syring ing</w>
synthetas e-1</w>
synthetas e-
synthetase- I,</w>
synthet ase.</w>
synthesis/ turnover</w>
synthesi sed.</w>
synthesi sed,</w>
synthesi s:</w>
synthesi s-
synthesis- enhancing</w>
synthesi s)</w>
synthe tically</w>
synthe tic,</w>
synthe tic"</w>
synthe tases</w>
synthase/ nitric</w>
synthase/ NADPH-diaphorase</w>
synthase- nitric</w>
synthase- derived</w>
synthase- deficient</w>
synthase- containing</w>
synergis tic-antagonistic</w>
synerg y,</w>
synerg ize</w>
synerg ist.</w>
synerg ism.</w>
synechi as.</w>
synechi as,</w>
synechi ae</w>
synechi a,</w>
syndrome- thrombotic</w>
syndrome- its</w>
syndrome ."</w>
syndrome .
syndrome. Triptans</w>
syndrome -related</w>
syndrome --report</w>
syndrome '?</w>
syndrome ":</w>
syndrome ").</w>
syndrom al</w>
syncop es:</w>
syncop e,"</w>
syncop e'</w>
syncop e"</w>
syncop e
syncope '.</w>
synchron y.</w>
synchron y,</w>
synchron ous;</w>
synchron isation.</w>
synchron ication</w>
synaptophy sin</w>
synap ticdopamine</w>
synap ses).</w>
synap ses),</w>
synap se-
synapse- rich</w>
synap se,</w>
syn m
synm path
synmpath omimetic</w>
syn ,</w>
symtom s</w>
symtom atology</w>
symptoms/ sign
symptoms/sign s/
symptoms/signs/ findings</w>
symptoms/ side-effects</w>
symptomatic ally.</w>
symptomatic )</w>
symptomatic '</w>
symptomat olog
symptomatolog y).</w>
symptom- reducing</w>
symptom- oriented</w>
symptom- endorsing</w>
symptom s-induced</w>
symptom s--a</w>
symptom s--
symptoms-- namely</w>
symptom s-
symptoms- menstrual</w>
symptom less</w>
symptom ato
symptomato Log
symptomatoLog y.</w>
symptom ;</w>
symptom -related</w>
sympathomime tic-like</w>
sympathomime tic,</w>
sympathomime tic),</w>
sympatho- inhibitor,</w>
sympatho- inhibition</w>
sympatho- adrenomedullary</w>
sympatho- -
sympatho-- adrenal</w>
sympatho inhibitor
sympathoinhibitor y-related</w>
sympatho adrenal,</w>
sympathic otomy</w>
sympathic omimetics</w>
sympathetically- independent</w>
sympathe ttic</w>
sympathe tic-mediated</w>
sympathe tic,</w>
sympathe tic)</w>
sympath otonic</w>
sympath ome
sympathome metic</w>
sympath ectomised</w>
sympath ectom
sympathectom y;</w>
symmetric al.</w>
sym tpoms</w>
sym port</w>
sym physis</w>
sym metry</w>
sym bol
symbol ),</w>
sym al</w>
sych osis:</w>
sych ism</w>
sych ic</w>
sy- proved</w>
sy- confirmed</w>
sy tryptamine.</w>
sy s</w>
sy rup
syrup y</w>
sy o-
syo- sai
syo-sai ko-
syo-saiko- to-kyo-shyokyo-ka-ouren-bukuryou</w>
sy nop
synop sis</w>
sy mpt
sympt ons</w>
sy mo
symo graphic</w>
sy kinesia</w>
sy che
syche delic</w>
sy c
syc LI
sycLI T</w>
sy :</w>
sy ."</w>
sy --a</w>
swol l
swoll en,</w>
switching- to</w>
switching- on</w>
switch -on</w>
switch ).</w>
switch "</w>
swit che
switche d,</w>
swim min
swimmin g)</w>
swim ,</w>
swim )</w>
sweeten ers</w>
sweeten ers,</w>
sweeten er</w>
sweat s,</w>
sweat ing/
sweating/ clam
sweating/clam min
sweating/clammin ess</w>
sweat ing)</w>
swe ar
swear ing;</w>
swallow s,</w>
swab bed</w>
swab ,</w>
sw um</w>
sw iss</w>
sw ings;</w>
sw ings).</w>
sw ine,</w>
sw if
swif tly</w>
sw er:</w>
sw ay
sway ing;</w>
sw am</w>
sw allows</w>
sw allowed</w>
suxamethoni um;</w>
suxamethoni um:</w>
suxamethoni um).</w>
suxameth onium-
suxamethonium- -manifested</w>
sut ures</w>
sut ure.</w>
sut ure,</w>
suspici ousness</w>
suspici ous,</w>
suspici ons</w>
suspect ?</w>
susp ects</w>
susp ecting</w>
susceptibil ity-
susceptibility- sensitive</w>
suscepti ble
susceptible ."</w>
suscepti bl
susceptibl ity</w>
survival/ non
survival/non survival.</w>
survival s,</w>
survival :</w>
survival -related</w>
survival )</w>
survival ).</w>
surviv ors)</w>
surviv ors
survivors .(ABSTRACT</w>
surviv or).</w>
surviv ing:</w>
surviv able</w>
surviv ability</w>
survi ves</w>
survi ve.</w>
survey ed,</w>
surve ying</w>
surro unding'?</w>
surro und</w>
surpris ing.</w>
surmoun table.</w>
surmoun t</w>
surger y.(ABSTRACT</w>
surger y--case</w>
surger y);</w>
surger ies.</w>
surge on,</w>
surge on's</w>
surg ically.</w>
surg ically-
surgically- implanted</w>
surg ically),</w>
surg es</w>
surfact ant.</w>
surface- activated</w>
surface- EMG</w>
surfac ing:</w>
surfac es)</w>
sur pri
surpri se</w>
sur passed.</w>
sur ized</w>
sur g</w>
sur ance,</w>
sur alis,</w>
sur al,</w>
supraspin ally-
supraspinally- mediated</w>
supraspin al.</w>
supras ellar</w>
supras cap
suprascap ular</w>
supramam mil
supramammil ary,</w>
supramam illary</w>
suprag ran
supragran ullar</w>
suprac la
supracla vear</w>
suprac ardiac</w>
supra- threshold</w>
supra- pressure</w>
supra- physiological</w>
supra- pain</w>
supra- additively</w>
supra ventriclar</w>
supra renal</w>
supra hisian</w>
supra aortic</w>
supra Hisian</w>
suppressant s:</w>
suppressant s),</w>
suppress or.</w>
suppress ant-induced</w>
suppress ant,</w>
suppres sions</w>
suppres sible,</w>
suppres s,</w>
suppres f
suppresf s
suppresfs sed</w>
suppositori es?</w>
suppositori es;</w>
support )</w>
suppor tive;</w>
suppor ted)</w>
supplement s;</w>
supplement s)</w>
supplement ed.</w>
supplement ations,</w>
supplement ation--
supplementation-- insights</w>
supplement al,</w>
supplement -related</w>
supple -</w>
suppl y:demand.</w>
suppl y-to-consumption</w>
suppl y-demand</w>
suppl iers</w>
suppl anted</w>
suppl .)</w>
supernat ants.</w>
superior ity,</w>
superior is,</w>
superim posed.</w>
superi or.</w>
superf usates</w>
superf ici
superfici al.</w>
super- urgent"</w>
super- sensitivity).</w>
super- repressor</w>
super- imposed</w>
super vising</w>
super vised,</w>
super urgent</w>
super sensitivity:</w>
super selective</w>
super posed</w>
super oxides</w>
super oxide-mediated</w>
super oxide,</w>
super otemporal</w>
super infection</w>
super infected</w>
super flu
superflu ous.</w>
super cooled</w>
super ce
superce ded</w>
super antigens</w>
super antigens,</w>
super antigen</w>
super additive</w>
sup rab
suprab ulbar</w>
sup poses</w>
sup ine'</w>
sunitinib -treated</w>
sunitinib ,</w>
sunbur ned.</w>
sun gen,</w>
sun burn
sunburn -induced</w>
summariz e:</w>
summariz e,</w>
summar izing</w>
summar ized,</w>
summar ise</w>
summ ative</w>
summ ation.</w>
summ ation,</w>
summ aries,</w>
sumatript an;</w>
sumatript an:</w>
sumatript an/
sumatriptan/ vehicle</w>
sumatript an
sumatriptan -like</w>
sumat ory</w>
sum med.</w>
sum ing</w>
sum er</w>
sum )</w>
sulpiride .(ABSTRACT</w>
sulpiride -free</w>
sulpiri de)</w>
sulphonyl ureas</w>
sulphonyl ureas.</w>
sulphonyl ureas,</w>
sulphon ate).</w>
sulphon ate),</w>
sulphon amides</w>
sulphate/ mg</w>
sulphate/ 4-hydroxy
sulphate/4-hydroxy proline</w>
sulphasalaz ine?</w>
sulphasalaz ine-treated</w>
sulphasalaz ine-
sulphasalazine- intolerant</w>
sulphamethox azole.</w>
sulphadi mid
sulphadimid ine,</w>
sulphadi azine.</w>
sulph oxide.</w>
sulph oxide)</w>
sulph onyl</w>
sulph onic</w>
sulph obromophthalein</w>
sulph in
sulphin yl]methyl]-1-piperidinyl]ethyl]-1H-indole</w>
sulph ate;</w>
sulph ate:</w>
sulph ate-pretreatment</w>
sulph ate)</w>
sulph amides,</w>
sulph am
sulpham etopyraz
sulphametopyraz ine-trimethoprim</w>
sulph ad
sulphad ox
sulphadox ine-
sulphadoxine- pyrimethamine</w>
sulindac ).</w>
sulindac ),</w>
sulind ac-induced</w>
sulfur- derivatives.</w>
sulfur- derivative</w>
sulfoxim ine-induced</w>
sulfonylure a.</w>
sulfonyl ureas,</w>
sulfonyl aminom
sulfonylaminom ethyl)-
sulfonylaminomethyl)- bicyclo[2.2.
sulfonylaminomethyl)-bicyclo[2.2. 2]
sulfonylaminomethyl)-bicyclo[2.2.2] oct
sulfonylaminomethyl)-bicyclo[2.2.2]oct an-2-
sulfonylaminomethyl)-bicyclo[2.2.2]octan-2- yl]-5Z-hexenoic</w>
sulfonyl aminobenzo
sulfonylaminobenzo yl)-piperidine),</w>
sulfonamide s,</w>
sulfonamide -like</w>
sulfon yl-6-(2-proparglyoxyphenyl)hexanoic</w>
sulfon ate:</w>
sulfon ate).</w>
sulfon anilide</w>
sulfon amide.</w>
sulfhydryl- disulfide</w>
sulfhydryl- containing</w>
sulfhyd ril</w>
sulfate- rich</w>
sulfate- proteoglycan</w>
sulfate /kg</w>
sulfapyri dine.</w>
sulfapyri dine,</w>
sulfapyri d
sulfapyrid ine),</w>
sulfanil amide</w>
sulfanil amide,</w>
sulfamoyl- hexahydro
sulfamoyl-hexahydro azepine</w>
sulfamoyl- 2,</w>
sulfamo ylbenzo(F)-quinoxaline</w>
sulfamo ylbenzamides</w>
sulfametopyraz ine</w>
sulfametopyraz ine.</w>
sulfametopyraz ine-trimethoprim</w>
sulfamethoxazole- trimethoprim.</w>
sulfamethoxazole- containing</w>
sulfamethoxazol e/
sulfamethoxazole/ trimethoprim</w>
sulfamethox azole-associated</w>
sulfamethox azol</w>
sulfam ate-
sulfamate- substituted</w>
sulfadoxine- pyrimethamine.</w>
sulfadiaz ine/
sulfadiazine/ pyrimethamine</w>
sulfadiaz ine-containing</w>
sulf one,</w>
sulf on-
sulfon- m-
sulfon-m- an
sulfon-m-an isi
sulfon-m-anisi dine</w>
sulf ites</w>
sulf ite</w>
sulf isoxazole</w>
sulf isoxazol
sulfisoxazol e)</w>
sulf isox
sulfisox azole.</w>
sulf ate:</w>
sulf ate-related</w>
sulf ate-induced</w>
sulf aphen
sulfaphen azole</w>
sulf ao
sulfao ylbenzamides</w>
sulf an
sulfan yl</w>
sulf amides</w>
sulf a</w>
sulc us.</w>
sulbactam- coated</w>
sulbactam- cefoperazone</w>
sulbact am.</w>
sulbact am,</w>
sulbact am
sulbactam /
sulbactam/ cefoperaz
sulbactam/cefoperaz one).</w>
sul maz
sulmaz ole</w>
sul fentanil</w>
sul es</w>
sul cal</w>
suk a</w>
suit e.</w>
suit e,</w>
suit ably.</w>
suit able.</w>
suit ,</w>
suicid ality.</w>
suggest .</w>
sugges tive.</w>
sugges tible</w>
sugar s</w>
sugar /
sugar/ fat</w>
sugar ).</w>
sugamma dex,</w>
suffici ently.</w>
suffici ent,</w>
sufferer s.</w>
suffere r</w>
suff usion</w>
suff ice</w>
suff ice.</w>
suff ice,</w>
suff ering.</w>
suff ering,</w>
sufentanil/ clonidine</w>
sufentanil/ bupivacaine</w>
sufentanil/ N2O/
sufentanil/N2O/ vecuronium</w>
sufentanil- bupivacaine</w>
sufentan il;</w>
sufentan il-treated</w>
sufentan il
sufentanil ?</w>
sudden ness</w>
sudden ly:</w>
sudden ly.</w>
sudden .</w>
sucrose- reinforced</w>
sucrose- fed</w>
sucrose- ethanol</w>
sucralf ate),</w>
succum bed.</w>
succinylchol ine:</w>
succinylchol ine-</w>
succinylchol ine-
succinylcholine- assisted</w>
succinylchol ine)</w>
succinyl norcocaine</w>
succinyl mon
succinylmon och
succinylmonoch oline</w>
succin ycholine-induced</w>
successful ly,</w>
successful ly
successfully .(ABSTRACT</w>
successful ;</w>
success /
success/ complications</w>
success ).</w>
succes sive,</w>
succes sion.</w>
succes ses,</w>
succes fully</w>
succe ed</w>
succ im
succim er,</w>
suc tion)</w>
suc king</w>
suc k
suck ling
suckling -</w>
suc h.</w>
subunit -dependent</w>
subunit -deficient</w>
subunit -F
subunit-F ITC</w>
subunit -
subunit- nonselective</w>
subunit (s),</w>
subu reteral</w>
substrat es/
substrates/ modulators</w>
substra ins.</w>
substitut es,</w>
substitut ed-
substituted- benzamides</w>
substitut ed
substituted phenyl)
substitutedphenyl) quinazoline</w>
substitu tions.</w>
substitu tional</w>
substitu tion;</w>
substitu tion:</w>
substitu tion-type</w>
substitu tion).</w>
substitu tion'</w>
substitu ent)</w>
substanti ally.</w>
substanti al;</w>
substance :</w>
substance -specific</w>
substance -related</w>
substance -
substance- use</w>
substance (s).</w>
substance 's</w>
subst rate-
substrate- specific</w>
subst rate
substrate .
substrate. min-1</w>
subst anc
substanc es
substances '
substances' neurodegenerative</w>
subst an
substan tive</w>
subsid ing.</w>
subsi diary</w>
subplant arly</w>
subplant ar,</w>
subo- shaped</w>
sublux ation.</w>
sublingu al,</w>
subjecti ve-effect</w>
subject- completed</w>
subject- as-
subject-as- ow
subject-as-ow n-
subject-as-own- control</w>
subject s/
subjects/ patients</w>
subject s.
subjects. For</w>
subject ing</w>
subject -drug</w>
subject ).</w>
subj ac
subjac ent</w>
subicul um.</w>
subicul um-CA1</w>
subicul um,</w>
subicul ar-
subicular- hippocampal</w>
subgroup-- 5
subgroup--5 33.
subgroup--533. 1+/-1
subgroup--533.1+/-1 3.6</w>
subgroup-- 38
subgroup--38 8+/-1
subgroup--388+/-1 5.3</w>
subgroup-- 23
subgroup--23 2.2+/-
subgroup--232.2+/- 5.8</w>
subepicardi um.</w>
subepicardi al/
subepicardial/ subendocardial</w>
subep ineural</w>
subendocardi um.</w>
subendocardi al/
subendocardial/ subepicardial</w>
subendocardi al-
subendocardial- subepicardial</w>
subcutaneous ly
subcutaneously .)</w>
subcutaneous )</w>
subcut ane
subcutane us</w>
subcl avi
subclavi a,</w>
subarachno idal</w>
subarachno id.</w>
subarachno id,</w>
sub- type-selective</w>
sub- threshold</w>
sub- tenon</w>
sub- scale,</w>
sub- sample</w>
sub- route</w>
sub- route).</w>
sub- pools</w>
sub- optimal,</w>
sub- models.</w>
sub- micromolar</w>
sub- maximal</w>
sub- lingual</w>
sub- lethal</w>
sub- item
sub-item s,</w>
sub- groups,</w>
sub- endothelial</w>
sub- dermal</w>
sub- cutaneously</w>
sub- cutaneous</w>
sub- criteria</w>
sub- convulsive</w>
sub- classes</w>
sub- class</w>
sub- chronically</w>
sub- acute</w>
sub ventricular</w>
sub types;</w>
sub types:</w>
sub traction.</w>
sub totally</w>
sub tly</w>
sub tle.</w>
sub tle)</w>
sub thalamotomy.</w>
sub thalamopallidal</w>
sub temporal</w>
sub telencephalic</w>
sub syndromal</w>
sub study</w>
sub sides.</w>
sub side.</w>
sub sets,</w>
sub set.</w>
sub serves</w>
sub served</w>
sub serve</w>
sub serosal</w>
sub sensitive</w>
sub seizure-producing</w>
sub segmental</w>
sub sectors</w>
sub se</w>
sub scores</w>
sub scores.</w>
sub score.</w>
sub scales:</w>
sub scales.</w>
sub scale)</w>
sub scale).</w>
sub regions,</w>
sub region.</w>
sub region,</w>
sub region
subregion :</w>
sub receptors</w>
sub radiographic</w>
sub rach
subrach no
subrachno idal</w>
sub pressor</w>
sub plate</w>
sub pial</w>
sub paralytic</w>
sub optimal,</w>
sub obstruction</w>
sub nuclei</w>
sub normal,</w>
sub nephrotic</w>
sub mucosa</w>
sub mucosa.</w>
sub modality</w>
sub mitting</w>
sub mitte
submitte d).</w>
sub mit</w>
sub microscopic</w>
sub merg
submerg ed</w>
sub maximal,</w>
sub mandibular</w>
sub m
subm its</w>
sub lumbar</w>
sub lines.</w>
sub lines,</w>
sub line</w>
sub insular</w>
sub hy
subhy aloid</w>
sub groups;</w>
sub group:</w>
sub group).</w>
sub field.</w>
sub fal
subfal cine</w>
sub ero
subero ylanilide</w>
sub endotheli
subendotheli al,</w>
sub dur
subdur ally</w>
sub doses</w>
sub dermally</w>
sub d
subd udral</w>
sub cortically</w>
sub cortical,</w>
sub cortex.</w>
sub convulsant,</w>
sub convulsant
subconvulsant ).</w>
sub continuous,</w>
sub confluent</w>
sub clinically</w>
sub clinically.</w>
sub clinical,</w>
sub classified</w>
sub classified.</w>
sub classification</w>
sub classes</w>
sub class</w>
sub class,</w>
sub chronic,</w>
sub cataleptic,</w>
sub carcinogenic</w>
sub atrial</w>
sub atmospheric</w>
sub analyses</w>
sub anaesthetic</w>
su to,</w>
su sten
susten ance</w>
su stainable</w>
su stain
sustain ly</w>
su st
sust anti
sustanti a</w>
su rea</w>
su re-
sure- volume</w>
su profen
suprofen -dependent</w>
su ms</w>
su its</w>
su it</w>
su it.</w>
su ger
suger y.</w>
su f
suf hydr
sufhydr y</w>
su ed
sued on
suedon orm
suedonorm alization.</w>
su dom
sudom otor</w>
su ant</w>
su ade</w>
styryl- 7-methyl-3,7-dihydro-1H-purine-
styryl-7-methyl-3,7-dihydro-1H-purine- 2,6-di
styryl-7-methyl-3,7-dihydro-1H-purine-2,6-di one]</w>
styrene -treated</w>
styrene -induced</w>
styrene -
styrene- ADR</w>
styrene ,</w>
styr yl)-1,3-dipropyl-7-methylxanthine]</w>
sty n</w>
sty les</w>
sty le</w>
stutter ing."</w>
stutter ing,</w>
stutter ing"</w>
stupo rou
stuporou s.</w>
stun ning.</w>
stun ned</w>
study-- utility</w>
study-- There</w>
study-- Retrospective</w>
study-- Junior</w>
study-- Cocaine</w>
study ,we</w>
studies --a</w>
studies ".</w>
studi es/
studies/ case</w>
studi es),</w>
studi es'</w>
studi ed).</w>
stud ent,</w>
stud ent's</w>
stu ff
stuff iness,</w>
strychn ine;</w>
strychn ine-dependent</w>
strychn ine-
strychnine- insensitive</w>
strychn ine)</w>
strychn ine).</w>
strych inine</w>
strugg le.</w>
strugg le,</w>
structure- teratogenicity</w>
structure- promoting</w>
structure :</w>
structure /
structure/ liver</w>
structure -related</w>
structure -dependent</w>
structurally- unrelated</w>
structur al),</w>
struct uring</w>
struct ures;</w>
struct ures:</w>
struct or</w>
stru vite</w>
stru vite,</w>
stru t</w>
stru ment</w>
strophanth in.</w>
strophanth idin</w>
strophanth id
strophanthid in-induced</w>
stroph antine</w>
strong- opioid-tolerant</w>
strong- opioid-na</w>
strong .</w>
strong ,</w>
stron gl
strongl y.</w>
stron e-induced,</w>
stron aut
stronaut s</w>
strome ly
stromely sin</w>
strom a</w>
strom ,</w>
stroke/ TIA.</w>
stroke ?</w>
stroke ."</w>
stroke ).</w>
strok ing)</w>
strok es?</w>
strok es,
strokes, and</w>
strogen ,</w>
stro ve</w>
stro us-females</w>
stro sternal</w>
stro ma.</w>
stro l</w>
stro both
stroboth nia,</w>
stro b
strob oscopic</w>
strict ures;</w>
strict ures.</w>
strict ures,</w>
stric ts</w>
stric test</w>
stric ter</w>
stric t,</w>
stric kly</w>
striatal- resident</w>
striat um>SNr.</w>
striat um;</w>
striat um).</w>
striat o
striato thalamocortical</w>
striat al,</w>
striat al
striatal pallidothalamic</w>
stri pped</w>
stri pp
stripp ing.</w>
stri der</w>
stri de</w>
stri d
strid or,</w>
stri bution</w>
stri ations</w>
stri ations,</w>
stri al</w>
stretch -out</w>
stretch -induced</w>
stret ching,</w>
stress/ non-cocaine</w>
stress/ fractional</w>
stress/ depression</w>
stress/ depression.</w>
stress/ depression
stress/depression -induced</w>
stress/ cocaine-dependent</w>
stress/ anti-
stress/anti- fatigue</w>
stress- triggered</w>
stress- mediated</w>
stress- inducing</w>
stress- induced,</w>
stress- induced)</w>
stress ors,</w>
stress or.</w>
stress like</w>
stress -dose</w>
stress -</w>
stres sing</w>
stres s--were</w>
stres s),</w>
streptozotocin- injections,</w>
streptozotocin- injected</w>
streptozotocin- effects,</w>
streptozotocin- dosage,</w>
streptozotoc ine</w>
streptozotoc in:</w>
streptozotoc in-related</w>
streptozoc in)</w>
streptoz ot
streptozot oz
streptozotoz in</w>
streptomycin- specific</w>
streptomycin- coated</w>
streptavidin- gold</w>
streptavidin- biotin</w>
streptavidin- biot
streptavidin-biot in-
streptavidin-biotin- peroxidase</w>
strept omyc
streptomyc in)</w>
strept ococci</w>
strept .</w>
strep tidine</w>
strep tidine,</w>
street- ketamine,</w>
street -drug</w>
streak s.</w>
stre am
stream ;</w>
stre ak</w>
strati fying</w>
strati fier</w>
strategy ).</w>
strategy ),</w>
strateg ically</w>
strat um.</w>
strang uria</w>
strang uria.</w>
strang uria,</w>
strang er.</w>
stran ds</w>
stran ding,</w>
strain- specific</w>
straight- chain</w>
straight- arm</w>
straight forward</w>
straight forward.</w>
stra w-coloured</w>
stra in;</w>
stra in-related</w>
stra in-associated</w>
str y</w>
str us,</w>
str o</w>
str ings,</w>
str ase</w>
str anger</w>
str am
stram ustine</w>
str a</w>
storm y</w>
storm :</w>
stor age,</w>
stoppe d:</w>
stoppe d.(ABSTRACT</w>
stoppe d-
stopped- flow</w>
stop- flow-
stop-flow- estimated</w>
stop- E
stop-E Y
stop-EY FP</w>
stop watch</w>
stop s</w>
ston es:</w>
ston ,</w>
stomati tis/mucositis</w>
stomati tis/</w>
stomat ocyto
stomatocyto genic</w>
stomach s.</w>
stomach ache</w>
stom y,</w>
stom ia</w>
stom e.</w>
stoichi ometric</w>
stock /N
stock/N orth
stock/North port</w>
stock "</w>
stoc k,</w>
stob adine.</w>
stob adine,</w>
sto sis.</w>
sto res;</w>
sto plasty.</w>
sto ols/
stools/ diarrhoea)</w>
sto gram</w>
stitut e,</w>
stitu to</w>
stitu tive</w>
stipul ations.</w>
stippl ing</w>
stippl ing.</w>
stin uria</w>
stin amycin</w>
stimulus- response</w>
stimulus- evoked</w>
stimulus- contingent</w>
stimuli :</w>
stimulant -associated</w>
stimulant ).</w>
stimul us;</w>
stimul us-to-H</w>
stimul ators,</w>
stimul ations)</w>
stimul ation?</w>
stimul ation--
stimulation-- whether</w>
stimul ation).</w>
stimul ation),</w>
stimul ation"</w>
stimul ation
stimulation -</w>
stimul ating-
stimulating- factor</w>
stimul ated
stimulated ,"</w>
stimul ant-like</w>
stimul ant-
stimulant- using</w>
stimul able</w>
still births,</w>
still birth.</w>
still .</w>
stilbe sterol</w>
stig ma</w>
stiff er.</w>
stiff ening,</w>
stiff .</w>
stiff ,</w>
stibo gluconate.</w>
stibo gluconate,</w>
sti x.</w>
sti ri
stiri pent
stiripent ol,</w>
sti es,</w>
stethoscop e</w>
stethoscop e.</w>
stethoscop e,</w>
steron ism.</w>
steroid- treated)</w>
steroid- resistant</w>
steroid- resistant.</w>
steroid- replaced</w>
steroid- related.</w>
steroid- pretreated</w>
steroid- maintained</w>
steroid- injected</w>
steroid- glaucoma</w>
steroid- free,</w>
steroid- aggravated</w>
steroid s--a</w>
steroid ogenesis,</w>
steroid :</w>
steroid /
steroid/ salt-</w>
steroid -type</w>
steroid -dose</w>
steril ized</w>
steril ize</w>
steril ization.</w>
steri or-
sterior- anterior</w>
steri le.</w>
stereotyp yd</w>
stereotyp y-inducing</w>
stereotyp y)</w>
stereotyp y).</w>
stereotyp ing</w>
stereotyp ics</w>
stereotyp ical-
stereotypical- repetitive</w>
stereotyp ic,</w>
stereotyp es.</w>
stereotac tically</w>
stereotac tic,</w>
stereospecific .</w>
stereolog y),</w>
stereolog y"</w>
stereo isomers.</w>
stereo isomer,</w>
stere omicroscope</w>
stere ology.</w>
stere oids</w>
stere ochemically</w>
stere o-
stereo- isomer</w>
stere d,</w>
ster y.</w>
ster tor</w>
ster tor.</w>
ster otyp
sterotyp e.</w>
ster otaxic</w>
ster ols.</w>
ster ol.</w>
ster noc
sternoc le
sternocle idom
sternocleidom ast
sternocleidomast oid</w>
ster ne
sterne brae</w>
ster ility</w>
ster ic,</w>
ster ;</w>
ster 's</w>
stepp ing-down</w>
stepp ing)</w>
stepp age</w>
stepp age,</w>
step- through,</w>
step- seconds</w>
step- down
step-down )</w>
step wise-increasing</w>
step s:</w>
step s,</w>
step -3</w>
step -2</w>
step )</w>
step ).</w>
stent s:</w>
stent ing:</w>
stenosi s;</w>
stenosi s/
stenosis/ insufficiency</w>
stenosi s),</w>
steno tic-zone</w>
steno tic-to-normal</w>
steno sed.(ABSTRACT</w>
sten o-occlusive</w>
stem med</w>
stem -like</w>
stem )</w>
stell ectomy.</w>
steatohepatitis ",</w>
steato tic</w>
steato hepatitis:</w>
steat osis:</w>
steat osi
steatosi s/
steatosis/ steatohepatitis</w>
stear ate</w>
steadi ly;</w>
steadi ly,</w>
stead y-state')</w>
stead iness.</w>
stead iness"</w>
stead -Re
stead-Re itan</w>
ste ine)</w>
ste epl
steepl y,</w>
ste ator
steator rhe
steatorrhe a,</w>
ste al,</w>
ste al)</w>
ste al'</w>
ste "</w>
stay :</w>
stay ),</w>
stavud ine/
stavudine/ HU</w>
stavud ine-induced</w>
stavud ine-containing</w>
stavud ine-based</w>
stavud ine-
stavudine- didanosine</w>
stavud ine,</w>
staurospor ine</w>
staurospor ine).</w>
statis tics,</w>
statis tically.</w>
statis tic</w>
statis tic.</w>
station ery</w>
station ed</w>
statin- specific</w>
statin- provoked</w>
state ?</w>
state );</w>
stat utory</w>
stat uses.</w>
stat us:</w>
stat us-epilepticus</w>
stat us)</w>
stat us),</w>
stat ure</w>
stat ure:</w>
stat ory-
statory- affective</w>
stat ine,</w>
stat in-associated</w>
stat in
statin -14</w>
stat es;</w>
stat es)</w>
stat ements</w>
stat em
statem ent;</w>
stat -1</w>
starv ation.</w>
starv ation-
starvation- stressed</w>
star ving.</w>
star ving,</w>
star ved,</w>
star ts,</w>
star tle/prepulse</w>
star ting-point</w>
star ted;</w>
star ted.(ABSTRACT</w>
star ted)</w>
star t.</w>
star t,</w>
star d</w>
star ch)</w>
star -shaped</w>
staphylococci ,</w>
standardi zed,</w>
standardi zation</w>
standardi zation;</w>
standardi sed.</w>
standard- protocol</w>
standard- positive</w>
standard- of-care</w>
standard- deviation</w>
standard- combination</w>
standard s.</w>
standard s)</w>
standard s"</w>
standard /
standard/ high-risk,</w>
standard "</w>
stand- still</w>
stand- by</w>
stand still.</w>
stand still,</w>
stand ably</w>
stain ings.</w>
stain ing).</w>
stain ing),</w>
stain ers</w>
stagn ation</w>
stagn ated</w>
stagge red-
staggered- interval</w>
stagge red,</w>
stage- five</w>
stage- dependence</w>
stage- III</w>
stage- ,</w>
stag ing,</w>
stag es;</w>
stag es--
stages-- initial,</w>
staff s</w>
staff ed</w>
staff -
staff- model</w>
staff ,</w>
stac k
stack ed"</w>
stabiliz ers)</w>
stabiliz ers'</w>
stabiliz er/
stabilizer/ ri
stabilizer/ri gi
stabilizer/rigi di
stabilizer/rigidi fier</w>
stabiliz er)</w>
stabilis ers,</w>
stabil ity;</w>
stabil ising</w>
stabil iser</w>
stabil ise</w>
stabil isation</w>
stab li
stabli zing</w>
stab ilo
stabilo metric</w>
stab bed</w>
sta phylococc
staphylococc i</w>
st- year</w>
st- stained</w>
st- specific</w>
st- seeking</w>
st- rated</w>
st- observable-effect</w>
st- anemia</w>
st- 4-
st-4- ene
st-4-ene -17</w>
st ympanic</w>
st yles,</w>
st yle),</w>
st rates</w>
st one-forming</w>
st oma</w>
st ings,</w>
st in-dalfopristin</w>
st ev
stev ens</w>
st enedione</w>
st el
stel late,</w>
st ays,</w>
st ations</w>
st atically</w>
st ate;</w>
st ate).</w>
st asi
stasi s-induced</w>
st arter
starter s</w>
st arb
starb urst</w>
st ap
stap edi
stapedi al</w>
st ant
stant aneous</w>
st and,</w>
st ance</w>
st al</w>
st airs</w>
st agger
stagger ing)</w>
st age:</w>
st age)</w>
st age).</w>
st age
stage '</w>
st ad
stad t,</w>
st able:</w>
st -related</w>
st -dose</w>
sst (2)</w>
ss sic</w>
ss le</w>
ss T)</w>
ss (50)</w>
squin ting,</w>
squin t</w>
sque ezing</w>
sque al
squeal ing,</w>
square d/
squared/ HR</w>
square d)</w>
squa res,</w>
squ ibb</w>
squ at
squat ting</w>
squ ared</w>
spur t,</w>
sprout s.</w>
sprout ,</w>
spread ing.</w>
spread .</w>
spra ys,</w>
spra y:</w>
spra y-drying,</w>
spot ting,</w>
spot ting)</w>
spot s"</w>
spot .</w>
spot ".</w>
sport s-related</w>
sport s,</w>
sport s
sports men</w>
sport :</w>
sport -related</w>
spontaneous ly;</w>
spontaneous ly)</w>
spontaneous ly
spontaneously )].</w>
spontaneous ?</w>
spontaneous -</w>
spontaneous -
spontaneous- seizure</w>
spontane ous.</w>
spongio tic</w>
spongio sis</w>
spongio sis,</w>
spongio sis"</w>
spong y</w>
spong y,</w>
spondylo myelopathy.</w>
spondylo arthropathy</w>
spondylo arthropathy.</w>
spondy litis,</w>
spon sor</w>
spon s
spons ore
sponsore d,</w>
spon ge
sponge :</w>
spo iled</w>
splot ch.</w>
splot ch)</w>
split -dose</w>
split -
split- skin</w>
splin ting</w>
splin ter</w>
splen ocytes</w>
splen ocytes,</w>
splen ium.</w>
splen ium,</w>
splen ic,</w>
splen ial</w>
splen ectomy-
splenectomy- refractory</w>
splen ectomized</w>
spl it.</w>
spl ine</w>
spl ay
splay ing</w>
spironolact one-sensitive</w>
spironolact one-induced</w>
spironolact one)</w>
spirocer cosis.</w>
spiro period
spiroperiod ol,</w>
spiro perid
spiroperid ol-induced</w>
spiro metry,</w>
spiro grams</w>
spiro gram,</w>
spiro che
spiroche tal</w>
spiro [2,
spiro[2, 5]
spiro[2,5] oct
spiro[2,5]oct ane-1-
spiro[2,5]octane-1- carboxamide
spiro[2,5]octane-1-carboxamide ].</w>
spir onol
spironol ac
spironolac at
spironolacat one</w>
spir o</w>
spir april.</w>
spir april,</w>
spir anol
spiranol act
spiranolact one,</w>
spir al,</w>
spir al"</w>
spir adol
spiradol ine,</w>
spiperone- labelled</w>
spiperone- catalepsy.</w>
spiper one.</w>
spiper on,</w>
spind ling.</w>
spind les.</w>
spind le.</w>
spind le-
spindle- shaped</w>
spinal- nerve</w>
spinal- fluid</w>
spin- trap</w>
spin- echo</w>
spin es.</w>
spin als.</w>
spin alized</w>
spin alized,</w>
spikes/ s,</w>
spikes/ s).</w>
spike- provoking</w>
spike- like</w>
spike- conditioned</w>
spike waves</w>
spike (s)</w>
spik ing;</w>
spid ers</w>
spid ers,</w>
spi er
spier one</w>
spi der</w>
sphingos ine,</w>
sphingos ine
sphingosine -1-phosphate</w>
sphingomyel in
sphingomyelin ase.</w>
sphinc ter.</w>
sphinc ter-relaxing</w>
spher oids,</w>
spher ocytosis</w>
spher icity</w>
spermid ine/
spermidine/ spermine</w>
spermid ine.</w>
spermatozo al</w>
spermat ogenesis.</w>
spermat ogenesis,</w>
spermat ocytes)</w>
spermat o
spermato gon
spermatogon ia</w>
sperm ine/
spermine/ spermidine</w>
sperm ine.</w>
sperm ine-like</w>
spell ing</w>
speedball ")</w>
specul atively</w>
specul ative,</w>
specul ated.</w>
spectrophot ometry,</w>
spectrophot ometer.</w>
spectro scopy,</w>
spectro scop
spectroscop y)</w>
spectro meter.</w>
spectro meter
spectrometer ;</w>
spectratyp ing</w>
spectratyp ing,"</w>
spectr ums</w>
spectr um'</w>
spectr in</w>
spectr in,</w>
spectr ally</w>
spectr al,</w>
spectac les</w>
spectac les.</w>
spect or
spector ate</w>
spect ator</w>
spect .</w>
specific s</w>
specific ity;</w>
specific ity)</w>
specific ities,</w>
specific ations</w>
specific ation,</w>
specific ally.</w>
specific :</w>
specific )</w>
species- comparative</w>
species- MAPK</w>
species -induced</w>
special ty</w>
special izing</w>
special ists,</w>
special ist.</w>
special ising</w>
special ised</w>
special isation</w>
speci ally,</w>
spec k
speck led</w>
spec ifying</w>
spec ifies</w>
spec cit
speccit roph
speccitroph ot
speccitrophot ometric</w>
speak s</w>
spe x</w>
spe eding</w>
spe ed-
speed- up</w>
spati o-
spatio- temporal</w>
spasmo gens</w>
spasmo dic,</w>
spasmo analgetic</w>
spasm s-
spasms- namely</w>
spasm "</w>
spas ms;</w>
spas m)</w>
spar sely</w>
spar se,</w>
spar k</w>
spar ing"</w>
spar floxacin.</w>
spar e</w>
span ;</w>
span )/
span)/ 12</w>
span ).</w>
spacef light.</w>
spac ing,</w>
spac ers.</w>
spac ers,</w>
spac er.</w>
spac er-induced</w>
spac er,</w>
spac e-
space- occupying</w>
spac e),</w>
sp ychiatric</w>
sp uriously</w>
sp ou
spou ses</w>
sp osph
sposph amide</w>
sp ond
spond ylarthropathy</w>
sp itting</w>
sp inu
spinu los
spinulos us,</w>
sp ills,</w>
sp ica</w>
sp end</w>
sp ed</w>
sp ate</w>
sp .</w>
sp ).</w>
soy be
soybe an.</w>
sound- sensitive</w>
sound- attenuated</w>
soun ds,</w>
soun d,</w>
soun d
sound -treated</w>
sough t:</w>
sou theastern</w>
sou th.</w>
sou th)</w>
sotal ol;</w>
sotal ol"</w>
sos mia</w>
sorbit ol.</w>
sorbit ol,</w>
sorbit ol)</w>
sorb ent
sorbent -based</w>
soral ea</w>
sor ts</w>
sor ting</w>
sor ted</w>
sor s).</w>
soporo gen
soporogen ic)</w>
soporo fic</w>
sophis tication</w>
sop or,</w>
soon er.</w>
sonomicro metry.</w>
sonomicro meters</w>
son- years</w>
son- syndrome</w>
son- Gl
son-Gl az
son-Glaz er</w>
son ized</w>
son ic</w>
son ian</w>
somnol ent.</w>
somnol ent,</w>
somnol ence/
somnolence/ depressed</w>
somnif era.</w>
somnif era,</w>
somnambul istic</w>
somn ia,</w>
somit es.</w>
somit es,</w>
somit e-
somite- stage</w>
somewhat ,</w>
some times,</w>
some one</w>
some how</w>
somatotop y.</w>
somatotop ically</w>
somatostatin/ parvalbumin</w>
somatostatin/ calbindin</w>
somatostatin- immunoreactive</w>
somatostatin- containing</w>
somatostatin- LI.</w>
somatostatin- ,</w>
somatostat in-</w>
somatosensor y-</w>
somato statin.</w>
somat otopic</w>
somat ometric</w>
somat a.</w>
som ine</w>
som es</w>
som e.</w>
som e-
some- how</w>
som atization</w>
som atic-
somatic- dysphoric</w>
som an-induced</w>
som a</w>
solvent -treated</w>
solvent -pretreated</w>
solv ing,</w>
solution s).</w>
solution );</w>
solut es,</w>
solubil izing</w>
solubil izer,</w>
solubil ity)</w>
solubil ised</w>
solub ility.</w>
solu tion),</w>
solu me
solume dro
solumedro l.</w>
solitari us-projecting</w>
solic iting</w>
solic itation</w>
solic itation-
solicitation- that</w>
solecith in-treated</w>
sole us;</w>
soldi er</w>
soldi er.</w>
sol itu
solitu de.</w>
sol it
solit ary,</w>
sol ifen
solifen acin,</w>
sol ids.</w>
sol ids,</w>
sol idi
solidi fied</w>
sol idation</w>
sol id,</w>
sol id
solid -dose</w>
sol et
solet e</w>
sol es,</w>
sol d),</w>
sol .</w>
sol .,</w>
softw are,</w>
softw are)</w>
sof t,</w>
sof ar</w>
sodium/ proton</w>
sodium/ fish</w>
sodium/ day.</w>
sodium- valproate-induced</w>
sodium- to-furosemide</w>
sodium- taurocholate</w>
sodium- replete</w>
sodium- potassium-
sodium-potassium- adenosine</w>
sodium- nitroprusside</w>
sodium- nitroprusside-induced</w>
sodium- meglumine</w>
sodium- losing</w>
sodium- enriched</w>
sodium- depletion.</w>
sodium- channel</w>
sodium- associated</w>
sodium- anesthetized</w>
sodium- anaesthetized</w>
sodium- 2-mercaptoethan
sodium-2-mercaptoethan sulfonate)</w>
sodi um-treated</w>
sodi um),</w>
socio- familial</w>
socio- demographic</w>
socio econom
socioeconom ically</w>
socio demographic,</w>
soci ety,</w>
soci eties</w>
soci eti
societi es,</w>
soci ality</w>
soci alis
socialis ation,</w>
soci al-
social- demographic</w>
sobri ety</w>
sobri ety.</w>
sob er</w>
so y-bean</w>
so sitis.</w>
so ren
soren ess.</w>
so pro
sopro zole</w>
so il</w>
so dyl</w>
so des.</w>
so da,</w>
so d.</w>
so A),</w>
so ).</w>
snor ted"</w>
snor ing.</w>
sniff s,</w>
sniff ed</w>
sne ezing</w>
sne ezing.</w>
snak es.</w>
snak es,</w>
sna res)</w>
sna red</w>
sna re)</w>
sna p</w>
sn ythesis</w>
sn ou
snou ting</w>
sn ag
snag el,</w>
smooth ness</w>
smooth ly.</w>
smoking- cessation,</w>
smoking- adjusted</w>
smoking- ,</w>
smok ing;</w>
smok ing:</w>
smok ing-induced</w>
smok ing,"</w>
smok es</w>
smok er
smoker s),</w>
smo other</w>
smo ked,</w>
smo ke
smoke able</w>
smear s,</w>
smear .</w>
sme ar,</w>
small- gauge</w>
small- diameter</w>
small- conductance</w>
small- cel
small-cel led,</w>
small- bowel</w>
small- animal</w>
small er-
smaller- an</w>
small er
smaller .This</w>
small ;</w>
smR x).</w>
sm osomes,</w>
sm art
smart ing.</w>
sm an</w>
sm ,</w>
sm )</w>
sm ),</w>
sluggish ly</w>
sludg ing.</w>
sludg e.</w>
slowe d.(ABSTRACT</w>
slow- rising</w>
slow- onset</w>
slow- growing</w>
slow- flow</w>
slow- eroding</w>
slow- channel</w>
slow ness.</w>
slow ness,</w>
slow er.</w>
slow er,</w>
slow down</w>
slow down.</w>
slop e),</w>
slo ughing</w>
slo t-blot</w>
slit- lamp</w>
slit- diaphragm</w>
slit s.</w>
slight- to-severe</w>
slight- to-moderate</w>
sligh tness</w>
sligh tly;</w>
sligh ter</w>
sligh t;</w>
sligh t/no</w>
slic es).</w>
slic ed</w>
slic e,</w>
slic arbazepine</w>
sli pped</w>
sli des.</w>
sli des,</w>
sli de-
slide- confirmed</w>
sleepl ess</w>
sleepl ess
sleepless ness,</w>
sleep/ wakefulness</w>
sleep/ wake</w>
sleep- wave</w>
sleep- waking</w>
sleep- time"</w>
sleep- arousal</w>
sleep y.</w>
sleep y"</w>
sleep y".</w>
sleep walking.</w>
sleep walking,</w>
sleep ing.</w>
sleep iness)</w>
sleep iness
sleepiness ',</w>
sleep -like</w>
sleep -associated</w>
slee ve).</w>
slee pers,</w>
sle t</w>
sle sional</w>
sl urry</w>
sl o</w>
sl ender</w>
sl c
slc 12</w>
sl augh
slaugh tered</w>
sl ate-
slate- gray</w>
sl apping</w>
sl ant</w>
sl and</w>
sl 's</w>
sky- stained</w>
sky- Ro
sky-Ro ots</w>
skin/ soft</w>
skin/ Human</w>
skin- twitch,</w>
skin- tumor</w>
skin- test-negative</w>
skin- incision</w>
skin- fold</w>
skin ny</w>
skin ned</w>
skin ;</w>
skin :</w>
skin ).</w>
skin "</w>
skill s.</w>
skill .</w>
skeleton s,</w>
skeleton .</w>
skele ton,</w>
skele tal-related</w>
skele tal-dysraphic</w>
skele tal,</w>
ske wed</w>
ske wed,</w>
sk y's</w>
sk ull,</w>
sk ipped</w>
sk ip
skip '</w>
sk i-
ski- We
ski-We iz
ski-Weiz man</w>
sk ep
skep tical</w>
sk 3b</w>
sk ,</w>
sk )</w>
size- lipid</w>
siz ing</w>
siz e-dependent</w>
siz e).</w>
siz e"</w>
sixty- year-old</w>
sixty- three-year-old</w>
sixty- one-
sixty-one- year-old</w>
sixty- eight-year-old</w>
six- trial</w>
six- session,</w>
six- point</w>
six- month-old</w>
six- implant</w>
six- graded</w>
six- drug</w>
six- day</w>
six- beat</w>
six th-line</w>
six -</w>
six --
six-- markedly</w>
six ),</w>
sive/ bradycardic</w>
sive- integrated</w>
situ ations,</w>
situ ated,</w>
situ ).</w>
situ ),</w>
situ "</w>
site- specifically</w>
site- 1</w>
site (s).</w>
sit y).</w>
sit us</w>
sit ter'shouse</w>
sit es;</w>
sit es:</w>
sit es.(ABSTRACT</w>
sit es).</w>
sit es),</w>
sit e/
site/ location</w>
sit e).</w>
sit e),</w>
sit af
sitaf loxacin,</w>
sist or</w>
sist ers.</w>
sist er-chromatid</w>
sist ence</w>
sist ance.</w>
sist ance,</w>
sis/ bilateral</w>
sis-- which</w>
sis-- were</w>
sis-- successful</w>
sis-- VIII.</w>
sis-- Implications</w>
sis- requiring</w>
sis- like)</w>
sis- inducing</w>
sis- a</w>
sis si
sissi pp
sissipp i</w>
sis like</w>
sis (esp,</w>
sis '.</w>
sirolimus- tacrolimus.</w>
sirolimus- cyclosporine</w>
sirolimus- cyclosporine-prednisone</w>
sirolim us-</w>
sion/ plasmaperfusion</w>
sion-- increased</w>
sion-- i.e.,</w>
sion- sensitive</w>
sion- recovery)</w>
sion- based</w>
sion- analytic</w>
sion s--
sions-- although</w>
sion s),</w>
sion ing</w>
sion .(ABSTRACT</w>
sion .
sion. 9.</w>
sion -associated</w>
sion ,
sion, which</w>
sinusoid s),</w>
sinusoid s'</w>
sinusoid al)</w>
sinus- node</w>
sinus- driven</w>
sinus oid</w>
sinus ectomy</w>
sino- auricular</w>
sino auricular</w>
sino aortic-
sinoaortic- denervated</w>
singult us.</w>
singult us)</w>
single-bl ind)</w>
single-bl in
single-blin d.</w>
single- trial</w>
single- tremor</w>
single- time-point</w>
single- shot</w>
single- placebo-controlled</w>
single- peak</w>
single- particle</w>
single- masked,</w>
single- mark
single-mark er-based</w>
single- intraperitoneal</w>
single- intervention</w>
single- gene</w>
single- entity</w>
single- chain</w>
single- bind</w>
single- antibiotic</w>
single- agents</w>
single- access</w>
single ton.</w>
single ton,</w>
single t</w>
single )</w>
sing ularly</w>
sing s.</w>
sing b
singb org
singborg ,</w>
sing ).</w>
sine qu
sinequ an
sinequan on</w>
sin- tang</w>
sin usal</w>
sin us)</w>
sin s:</w>
sin ophilia</w>
sin on
sinon asal</w>
sin ol</w>
sin k
sink ."</w>
sin ess,</w>
sin ).</w>
sin 's</w>
simvastatin-ezetimi be.</w>
simvastatin-ezetimi be-induced</w>
simvastatin- gemfibrozil</w>
simvastatin- ezetimibe</w>
simvastat ine
simvastatine zetimibe-induced</w>
simvastat ina</w>
simvastat in;</w>
simvastat in-treated</w>
simultaneous ly)</w>
simultaneous -
simultaneous- masked</w>
simultaneous "</w>
simultane ous.</w>
simultane ous,</w>
simul ator,</w>
simul ates</w>
simul ated.</w>
simul ated,</w>
simplic ity</w>
simplic ifolia</w>
simple .</w>
simpl ifies</w>
simpl ified.</w>
simpl ified,</w>
similar ity.</w>
similar ).</w>
simil i
simili ar</w>
simil er</w>
simil ating</w>
simend an.</w>
simend an,</w>
sim plex
simplex .</w>
sim mun
simmun e</w>
silver- reticulin</w>
silver- impregnated</w>
silo dos
silodos in</w>
sill ectomy</w>
sili ence</w>
silent- second</w>
silent- second.</w>
sildenaf il;</w>
sildenaf il-treated</w>
sildenaf il-associated</w>
sil vadene</w>
sil hou
silhou ette</w>
sil ently</w>
sil ent.</w>
sil ence.</w>
sil a-
sila- di
sila-di fen
sila-difen idol</w>
sil a
sila eral</w>
sil -1</w>
significant ]).</w>
signific nat
significnat ly</w>
signific i
significi antly</w>
signific ance).</w>
signed- ranks</w>
signed- rank</w>
signall ing.</w>
signal-to- baseline</w>
signal- intensity</w>
signal- inhibitor</w>
signal izing</w>
signal ing),</w>
sign s).</w>
sign ment</w>
sign ing</w>
sign if
signif im
signifim antly</w>
sign i</w>
sign ature</w>
sign ated</w>
sign at
signat ures"</w>
sign al)</w>
sign ).</w>
sigmoid oscopy,</w>
sigmoid oscopic</w>
sigmoid al-
sigmoidal- E(max)</w>
sigmo idal</w>
sigma- receptors;</w>
sigma 2-
sigma2- preferring</w>
sigma 1/
sigma1/ sigma2</w>
sigma /
sigma/ haloperidol</w>
sigma (2)-
sigma(2)- mediated</w>
sigh ts",</w>
sigh tedness,</w>
sigh ing)</w>
sig yna</w>
sig net</w>
sieh -h
sieh-h sin-tang</w>
sie ved</w>
sidi oblastosis.</w>
sideroblast s,</w>
side/ outside</w>
side/ nucleotide</w>
side- impregnated</w>
side- hypotension:</w>
side- effects;</w>
side- effects.(ABSTRACT</w>
side- effect)</w>
side- by-
side-by- side</w>
side ways</w>
side s)</w>
side light,</w>
side d,</w>
side -associated</w>
sid ren
sidren )</w>
sid ent</w>
sid ases,</w>
sid ar</w>
sick le-cell</w>
sick a,</w>
sic ke</w>
sic k.</w>
sic ca.</w>
sic ca,</w>
sic ca
sicca -like</w>
sic ,</w>
sibutr amine-containing</w>
sibling s:</w>
sibil ization,</w>
sibil ant</w>
sib ling.</w>
sib le.</w>
sib ility,</w>
sialo glycoproteins</w>
sialo glycoprotein</w>
sialo ad
siaload hes
sialoadhes in)</w>
sial ylation,</w>
sial agogic</w>
sial adenitis</w>
sial aden
sialaden itis.</w>
sia/ rigidity</w>
sia/ polyuria,</w>
sia/ akinesia</w>
sia- rigidity</w>
sia- avoidance</w>
sia- an</w>
si ves.</w>
si ung</w>
si um-induced</w>
si ties.</w>
si s--a</w>
si s'</w>
si res,</w>
si re</w>
si re.</w>
si psilateral</w>
si our
siour i</w>
si olysis</w>
si ogenic</w>
si odes</w>
si ms</w>
si mian</w>
si meter</w>
si m</w>
si le</w>
si gam
sigam one,</w>
si g</w>
si eving</w>
si er</w>
si ella-
siella- Enter
siella-Enter obac
siella-Enterobac ter-Serratia</w>
si dia</w>
si dad</w>
si d</w>
si cles</w>
si a-induced</w>
shut tlebox</w>
shun ting:</w>
shun ted.</w>
shun t-dependent</w>
shrink age,</w>
shrin king</w>
shrin k</w>
shoul d--
should-- just</w>
shorter- duration</w>
shorten ing;</w>
shorten ing)</w>
shorten ing).</w>
shorten ed,</w>
short-term/ spatial</w>
short-term- group</w>
short-term- exposed</w>
short-term -treated</w>
short-term ')</w>
short-li ved.</w>
short- time</w>
short- term.</w>
short- onset,</w>
short- observation</w>
short- latency,</w>
short- last
short-last ing;</w>
short- form</w>
short- follow-up</w>
short- distance</w>
short- axial</w>
short- access</w>
short- ,</w>
short lasting</w>
short com
shortcom ings</w>
short :</w>
short ),</w>
shor ter/simpler</w>
shor ter.</w>
shop ping,</w>
shock- like,</w>
shock- elicited</w>
shock- ,</w>
shock wave</w>
shock --
shock-- without</w>
shoc ked,</w>
sho p</w>
sho oting</w>
shiver ing:</w>
shipp ing</w>
shin y</w>
shin ing,"</w>
shikaw a,</w>
shikaw a)</w>
shik u</w>
shihar a)</w>
shif ts.</w>
shif ts,</w>
shif ting,</w>
shif ting),</w>
shif ted,</w>
shif t,</w>
shiel ded</w>
shi vered</w>
shi re</w>
shengmai-y in,</w>
shell )</w>
shel f-
shelf- life,</w>
sheath s,</w>
sheath ing,</w>
sheath ;</w>
sheath :</w>
sheath ,</w>
she et)</w>
she et
sheet s/
sheets/ clothing</w>
she aths</w>
sharp- waves</w>
sharp- slow</w>
shar pl
sharpl y,</w>
shar per</w>
shar p.</w>
shar p,</w>
sham-oper ated"</w>
sham- surgery</w>
sham- stimulated</w>
sham- release</w>
sham- operation</w>
sham- operation.</w>
sham- irradiated</w>
sham- injured</w>
sham- injected</w>
sham- eNOS.</w>
sham- control</w>
sham- adrenalectomized</w>
sham- ECS</w>
sham po
shampo os</w>
sham :</w>
sham "</w>
shaky/jitter y</w>
shaky/jitter y,</w>
shak ing)</w>
shak es.</w>
shak es,"</w>
shaf ts.</w>
shaf ted</w>
shaf t.</w>
shadow s,</w>
shadow ing.</w>
shadow ing,</w>
shadow ed</w>
shad o
shado w</w>
sha kin
shakin ess,</w>
sh y</w>
sh rub</w>
sh in</w>
sh immer
shimmer ing</w>
sh il
shil aj
shilaj it</w>
sh eng-mai-san</w>
sh en
shen feld</w>
sh am.</w>
sh allowing</w>
sh .</w>
sexually- naive</w>
sexu ality.</w>
sexu al/
sexual/ reproductive</w>
sexu al-
sexual- aggressive</w>
sex/ species.</w>
sex/ group),</w>
sex/ dose</w>
sex- standardized</w>
sex- reas
sex-reas signment</w>
sex- offending</w>
sex- matched,</w>
sex- linked</w>
sex- dependent.</w>
sex- dependency</w>
sex- comparable</w>
sex --particularly</w>
sex ).</w>
sex ),</w>
sevoflurane- nitrous</w>
sevoflurane- low</w>
sevoflurane- anaesthetized</w>
sevoflur ane:</w>
sevoflur ane-</w>
severe r</w>
severe /
severe/ grade</w>
sever ly</w>
sever ing</w>
sever ily</w>
sever al,</w>
sever al
several fold</w>
seventy- two</w>
seventy- one</w>
seventy- nine</w>
seventy- eight</w>
seventy- eight-year-old</w>
seven- year</w>
seven- year-old,</w>
seven- month</w>
seven fold</w>
seven fold.</w>
seven -,</w>
seven ).</w>
seven ),</w>
seve red.</w>
seve re:</w>
sev ol
sevol urane,</w>
sett les</w>
sett ings.(ABSTRACT</w>
sett es</w>
set up.</w>
set up,</w>
set te-forming</w>
set te,</w>
set back</w>
set amide</w>
set ).</w>
sestamibi .</w>
sestamibi )</w>
ses/ patient/
ses/patient/ year,</w>
ses/ litter,</w>
ses sions)</w>
ses sion:</w>
ses sion).</w>
ses sile</w>
ses amin,</w>
ses ]</w>
ses ],</w>
servic ing</w>
serv on
servon ull</w>
serv o</w>
serum- supplemented</w>
serum- sickness-like</w>
serum- reversible</w>
serum- proteins</w>
serum- protein</w>
serum- marker</w>
serum- lithium</w>
serum- albumin</w>
sertral ni
sertralni e</w>
sertral ine;</w>
sertral ine:</w>
sertral ine/
sertraline/ quetiapine-induced</w>
sertral ine-induced</w>
sertral ine-</w>
sertral ine-
sertraline- oxycodone</w>
sert indole)</w>
sert ind
sertind ole-induced</w>
serotoninerg ically</w>
serotoninerg ic-dopaminergic</w>
serotonin-1 B/
serotonin-1B/ D-receptor</w>
serotonin-1 A</w>
serotonin- xylocaineR</w>
serotonin- receptor</w>
serotonin- potentiating</w>
serotonin- potentiated</w>
serotonin- noradrenaline</w>
serotonin- enhancing</w>
serotonin ergic,</w>
serotonin )-1
serotonin)-1 A</w>
serotonergic/ dopaminergic</w>
serotonergic/ DA</w>
serotonerg ically</w>
serotonerg ic-induced</w>
serotonerg ic-</w>
serotonerg ic)</w>
seroton in;</w>
seroton in/platelet</w>
seroton in/
serotonin/ dopamine</w>
seroton in-releasing</w>
seroton in-mediated</w>
seroposi tivity.</w>
seroposi tive,</w>
seroconver ters.</w>
seroconver ted</w>
seroconver sion)</w>
sero- positive</w>
sero- negative,</w>
sero status.</w>
serious ness,</w>
serious ;</w>
serine/ threonine</w>
serine- exposing</w>
serine- contained</w>
serine- O-
serine-O- phosphate</w>
seri ous-
serious- CMV</w>
seri ally.</w>
seri ally,</w>
seri al,</w>
seret onin</w>
ser yl)-N(2)-(2,3,4-trihydroxybenzyl)</w>
ser ve.</w>
ser ums</w>
ser um/urine</w>
ser um-induced</w>
ser um).</w>
ser pig
serpig inos
serpiginos a,</w>
ser p
serp in,</w>
ser otomimetic</w>
ser os
seros anguineous</w>
ser ore
serore version</w>
ser ology,</w>
ser ologies</w>
ser oc
seroc learance</w>
ser man</w>
ser ine.</w>
ser aton
seraton ergic</w>
ser -
ser- risk</w>
ser ).</w>
sequin an),</w>
sequestr ation.</w>
sequestr ation,</w>
sequestr ants,</w>
sequest ering</w>
sequenti ally.</w>
sequenti al.</w>
sequence- specific.</w>
sequence- finding</w>
sequence 's</w>
sequenc es;</w>
sequenc es:</w>
sequell ae.</w>
sequell ae,</w>
sequel s</w>
sequel s.</w>
sequel a,</w>
sequ ently</w>
sequ ence:</w>
sequ ence)</w>
sequ ella</w>
sequ e
seque L
sequeL ae</w>
septo plasty:</w>
septo apical</w>
septi caemia.</w>
septal/ portal</w>
sept um:</w>
sept um).</w>
sept um),</w>
sept otemporal</w>
sept ine</w>
sept i</w>
sept ation,</w>
sept al-
septal- lateral</w>
sept al,</w>
sepi ap
sepiap terin,</w>
separatel y;</w>
separatel y).</w>
separatel y),</w>
separ ations</w>
separ ated;</w>
separ ated.</w>
separ ated)</w>
separ able.</w>
sep tic.</w>
sep sis:</w>
sep sis)</w>
sep ,</w>
seofulv in</w>
sent enced</w>
sent ence</w>
sensory- sympathetic</w>
sensory- perceptual</w>
sensori omotor</w>
sensor y>motor,</w>
sensor y:</w>
sensor y-induced</w>
sensor y-</w>
sensor ic</w>
sensitization '.</w>
sensitization ")</w>
sensitiz ing,</w>
sensitiz ing)</w>
sensitiz ers</w>
sensitiz ers.</w>
sensitiz ed.</w>
sensitiz ation),</w>
sensitive ty.</w>
sensitive to</w>
sensitive ),</w>
sensitiv ity;</w>
sensitiv ity.(ABSTRACT</w>
sensitiv ity-
sensitivity- pupil</w>
sensitiv ity)</w>
sensitis er</w>
sensitis ation.</w>
sensitis ation'</w>
sensi tivities.</w>
sensi tiveness</w>
sensi tive-K(+)</w>
sense- infused</w>
sense- CF
sense-CF F-
sense-CFF- visual</w>
sensation al
sensational ism</w>
sensation ,"</w>
sens us,</w>
sens ors,</w>
sens ation:</w>
sens ation-
sensation- perception</w>
sens ation)</w>
sencephal y</w>
sen sus)</w>
sen sible</w>
sen sibilization,</w>
sen sibility,</w>
sen ses</w>
sen se.</w>
sen se-treated</w>
sen mide</w>
sen ic</w>
sen i
seni ors</w>
sen ess</w>
sen escence</w>
sen escence.</w>
sen escence,</w>
sen apine</w>
sen -G
sen-G ill
sen-Gill 's</w>
sen ,</w>
sen 's</w>
semicarb azide</w>
semicarb azide.</w>
semic omat
semicomat ose</w>
semic oma</w>
semic -related</w>
semi- urgent</w>
semi- standardized</w>
semi- sitting</w>
semi- routine</w>
semi- naturalistic</w>
semi- monthly</w>
semi- invasive</w>
semi- double-blind</w>
semi- dose-dependently</w>
semi- continuous</w>
semi- auto
semi-auto analyzer</w>
semi quinone,</w>
semi quantitatively.</w>
semi quant
semiquant ative</w>
semi permeability</w>
semi parametric</w>
sem io
semio logy.</w>
sem ide-induced</w>
sem ia)</w>
sem anti
semanti cally</w>
sem ;</w>
sell ing,</w>
sell a.</w>
self-perpet uating</w>
self-perpet uating.</w>
self-injur ing,</w>
self-injur i
self-injuri ous,</w>
self- tolerance</w>
self- titrated</w>
self- sustained,</w>
self- supporting</w>
self- sufficient</w>
self- resumed</w>
self- reports.</w>
self- reported,</w>
self- repor
self-repor t)</w>
self- regulation,</w>
self- regulated</w>
self- protective</w>
self- prescribed</w>
self- poisoning.</w>
self- poisoning,</w>
self- organizing</w>
self- medicated</w>
self- medical</w>
self- medic
self-medic ating</w>
self- matched</w>
self- limit
self-limit ing)</w>
self- inquiries</w>
self- injury</w>
self- injury,</w>
self- injury)</w>
self- injectors</w>
self- inj
self-inj ure.</w>
self- grooming</w>
self- generated</w>
self- exposure</w>
self- exposure.</w>
self- evaluation</w>
self- esteem,</w>
self- enhancement</w>
self- elicited</w>
self- discontinuation</w>
self- directed</w>
self- control;</w>
self- control,</w>
self- confidence</w>
self- catheterization</w>
self- assessment</w>
self- assessed</w>
self- administration;</w>
self- -is</w>
self -induced</w>
seleni um.</w>
seleni um-dependent</w>
seleni um,</w>
seleni um).</w>
selen o-
seleno- organic</w>
selen ite,</w>
selen it
selenit e).</w>
selen inic</w>
selen azol
selenazol -3
selenazol-3 [2
selenazol-3[2 H]
selenazol-3[2H] -
selenazol-3[2H]- one)</w>
selegil ine:</w>
selegil ine-induced</w>
selective "</w>
selecti vities</w>
selec tion)</w>
sel ing</w>
sel f,</w>
sel ectin.</w>
sel ectin,</w>
sel dom
seldom ly</w>
sel -
sel- Uclaf</w>
seizures= 6.1</w>
seizures= 5.4</w>
seizures= 27</w>
seizures= 18</w>
seizures/ mo)</w>
seizures/ mo
seizures/mo ),</w>
seizures-- that</w>
seizures-- behavioral</w>
seizures ?</w>
seizures .5.</w>
seizures .
seizures. Isoniazid</w>
seizures '</w>
seizure- worsening</w>
seizure- susceptibility</w>
seizure- suppressing</w>
seizure- suppressant</w>
seizure- silent</w>
seizure- induction</w>
seizure- induced,</w>
seizure- free.</w>
seizure- enhancing</w>
seizure- brain</w>
seizure- activating</w>
seizure d.</w>
seizure ],</w>
seizure :</w>
seizure /brain</w>
seizure .(ABSTRACT</w>
seizure -type</w>
seizure -mediated</w>
seizure --brain</w>
seizure )</w>
seizure ).</w>
seizure ),</w>
seizure (s),</w>
seizure '</w>
seiz urgenic</w>
seiz ed.</w>
seiz e.</w>
segreg ated,</w>
segreg ants</w>
segment /
segment/ 4</w>
segment -specific</w>
segment )</w>
segment );</w>
seg mentation,</w>
seek ing:</w>
seek ing."</w>
seed s;</w>
sediment s;</w>
sedentary- isoproterenol</w>
sedative/ hypnotics</w>
sedative/ ataxic</w>
sedative/ anticonvulsant,</w>
sedative- hypnotics,</w>
sedation/ unconsciousness</w>
sedation/ ataxia.</w>
sedation/ analgesia</w>
sedation/ analgesia,</w>
sedati ves/analgesics</w>
sedati ve-like</w>
sedati ve-induced</w>
sedat ory</w>
sedat ing.</w>
sedat ing,</w>
sed- wave</w>
sed- phase</w>
sed- over</w>
sed ations.</w>
sed ation?</w>
sed ation-related</w>
sed ation--
sedation-- were</w>
sed ation)</w>
sed ated;</w>
sed ate</w>
sed .This</w>
sed -controlled</w>
sed ),</w>
sed '</w>
sed "</w>
secretagogu es.</w>
secretagogu e,</w>
secret ory"</w>
secret in,</w>
secre tions,</w>
secre tion;</w>
secre tin</w>
secre ted,</w>
second- spot</w>
second- order,</w>
second- messenger
second-messenger -mediated</w>
second- look.</w>
second- intervals</w>
second- intention</w>
second- generation,</w>
second s/
seconds/ 1</w>
second ly.</w>
second ly,</w>
second ary.</w>
second ary)</w>
second ).</w>
second ),</w>
second ((1/2))</w>
second ")</w>
sec/ mmHg</w>
sec/ frame
sec/frame )</w>
sec/ cm
sec/cm 5.
sec/cm5. m2).</w>
sec- butyl</w>
sec- butyl-
sec-butyl- ,</w>
sec- butyl
sec-butyl thiazoline,</w>
sec utory</w>
sec urity</w>
sec ular</w>
sec tion;</w>
sec tion"</w>
sec obarbit
secobarbit al.</w>
sec ]</w>
sec 1/2.</w>
sec .
sec. cm-
sec.cm- 5</w>
sec -1,</w>
sec ),</w>
sebosup pression</w>
sebosup pres
sebosuppres sive.</w>
seas ;</w>
search ing;</w>
search es.</w>
search es
searches :
searches: reference</w>
search :</w>
search '</w>
seal ant)</w>
se-1, 6-bisphosphate</w>
se- urethan</w>
se- stress</w>
se- positive
se-positive "</w>
se- photosensitivity</w>
se- observers</w>
se- muscle</w>
se- language</w>
se- ended</w>
se- Ge
se-Ge is
se-Geis ser</w>
se- Canadian</w>
se- 6-phosphate</w>
se y</w>
se wing</w>
se us).</w>
se udemys</w>
se t-based</w>
se per
seper ated</w>
se monophosphate</w>
se mit
semit end
semitend inos
semitendinos us</w>
se mid,</w>
se mid
semid omin
semidomin ant</w>
se mic,</w>
se men.</w>
se mble</w>
se maph
semaph orin</w>
se m,</w>
se le
sele it</w>
se k</w>
se in</w>
se eding</w>
se bac
sebac ate</w>
se aweed</w>
se ated,</w>
se am.</w>
se /
se/ lassitude,</w>
se -positive</w>
se -like</w>
se --a</w>
se --
se-- for</w>
se 's</w>
scrutin y,</w>
scroll s</w>
scroll s,</w>
scri ption</w>
scri be</w>
screen s.</w>
screen ed.</w>
screen ed
screened );</w>
screen -positive</w>
scre ens
screens ;</w>
scre e
scree ening</w>
scre amed</w>
scre am
scream ing</w>
scrat ch</w>
scram bl
scrambl ing,</w>
scotom at
scotomat ous</w>
scotom a;</w>
scorpi ons,</w>
scorpi on</w>
scores ]</w>
scores ;</w>
scores --
scores-- independently</w>
scores )</w>
scores ).</w>
scores '</w>
score ;</w>
score '.</w>
scopolamine- injected</w>
scopolamine- ,</w>
scopolamine .(ABSTRACT</w>
scopolamine )--and</w>
scop y--influence</w>
scop ically,</w>
scop es</w>
scop e,</w>
scop -
scop- saline</w>
scolio tic</w>
sco ve</w>
sco re-
score- clinical</w>
sco ius,</w>
scleroder ma:</w>
sclero sis),</w>
scler itis</w>
scler as</w>
scler a</w>
sciure us</w>
sciure us)</w>
scinti ll
scintill ation)</w>
scinti graph
scintigraph ic)</w>
scinti grams</w>
sci urea</w>
sci urea.</w>
sci ence,</w>
sci ence
science ".</w>
sci ,</w>
school- sevoflurane</w>
school- sevoflurane,</w>
school- halothane,</w>
school- attending</w>
school- aged</w>
school ing,</w>
school girl</w>
school children,</w>
scho ols,</w>
scho oling</w>
scho ol,</w>
scho ol).</w>
schizophren iform</w>
schizophren ics</w>
schizophren ics,</w>
schizophren ic.</w>
schizophren ic
schizophrenic s:</w>
schizophren ia-associated</w>
schizophren ia--
schizophrenia-- working</w>
schizophren ia'</w>
schizo idi
schizoidi a</w>
schiz oid</w>
schiz oid/
schizoid/ schizotypal</w>
schiz encephaly</w>
schiz encephaly.</w>
schistosom icide</w>
schistosom icidal</w>
schistos omes.</w>
schist osomal</w>
schist ocytosis</w>
schemic :
schemic: normal</w>
schedul es;</w>
schedul ed,</w>
schedul e)</w>
schedul e),</w>
sche me
scheme ).</w>
sche ma.</w>
sch wannopathy</w>
sch ow
schow sky-stained</w>
sch o-
scho- stimulants</w>
sch ner</w>
sch i,</w>
sch berg,</w>
sch an
schan off</w>
sch ),</w>
scenario .</w>
scenari os.</w>
scen es</w>
scen es.</w>
scen es)</w>
scaveng ing,</w>
scaveng ers,</w>
scaveng e</w>
scaven ger
scavenger s:</w>
scar s</w>
scar red;</w>
scap ula,</w>
scap ego
scapego at</w>
scan s;</w>
scan ner.</w>
scan </=
scan</= 7.1</w>
scan ).</w>
scale- up</w>
scale- memory</w>
scale- Bipolar</w>
scal y,</w>
scal ing)</w>
scal es)</w>
scal en
scalen us</w>
scal able,</w>
scaff old</w>
scaff old,</w>
scabic ide,</w>
scabic idal</w>
scab s,</w>
sca re"</w>
sca ph
scaph oid</w>
sc/ wk</w>
sc/ week),</w>
sc/ 8</w>
sc yntigraphy</w>
sc rup
scrup ulously</w>
sc ript
script a.</w>
sc lep
sclep idaceae)</w>
sc ene.</w>
sc c)</w>
sc ant,</w>
sc aled</w>
sc ]),</w>
sc Met</w>
sc Met-
scMet- ED(50)of</w>
sc 70</w>
sav ings,</w>
sav ings).</w>
sav ing,</w>
sav ing"</w>
satur ation).</w>
satur ation),</w>
satur ated,</w>
sativ um)</w>
satisfi es</w>
satisfi ed).</w>
satisfactor ily.</w>
satisfac tion)</w>
satis fy</w>
satis fied,</w>
sati lity</w>
satellit osis.</w>
satellit es</w>
sat ing.</w>
sat -15</w>
sat -1
sat-1 5),</w>
sat ,</w>
sarizot an/
sarizotan/ L-Dopa</w>
sarizot an-</w>
sarcoplas m</w>
sarcoplas m:</w>
sarcoplas m,</w>
sarcopen ic,</w>
sarcopen ia:</w>
sarcopen ia)</w>
sarcome res.</w>
sarcome res,</w>
sarcom ere
sarcomere ,</w>
sarcom a;</w>
sarcom a:</w>
sarcolem mal-
sarcolemmal- dihydropyridine-
sarcolemmal-dihydropyridine- sensitive</w>
sarcolem ma.(ABSTRACT</w>
sarcoglyc an,</w>
sarcoglyc an
sarcoglycan opath
sarcoglycanopath ies.</w>
sarco id
sarcoid osis:</w>
sarco (
sarco( endo
sarco(endo )
sarco(endo) plasmic</w>
sarc otubular</w>
sarc osine,</w>
saralas in,</w>
sar one</w>
sar i</w>
sar dine</w>
saquin avir,</w>
sap on
sapon ins,</w>
sap )</w>
sangu is</w>
sandw ich</w>
sandw ich-
sandwich- ELISA.</w>
sandw ich
sandwich ed</w>
sand fly</w>
sampl es)</w>
samp led.</w>
samp le;</w>
samp le:</w>
samp le)</w>
samp le).</w>
same- day</w>
same- age</w>
sam e,</w>
salv oes</w>
salv age.</w>
salv age"</w>
salure tics</w>
salure tics.</w>
salure tics,</w>
salt- water</w>
salt- split-skin</w>
salt- sensitive.</w>
salt- restricted</w>
salt- mediated</w>
salt- inducible</w>
salt- chlorpromazine</w>
salt- -
salt-- phospholip
salt--phospholip id
salt--phospholipid --
salt--phospholipid-- cholesterol</w>
salt s-induced</w>
salt :
salt: cholesterol</w>
salt -treated</w>
salt )],</w>
salsol inol,</w>
salsal ate.</w>
salsal ate-induced</w>
saliv a.</w>
saline/ sedentary</w>
saline/ exercise</w>
saline/ day</w>
saline- treated,</w>
saline- treat</w>
saline- saline</w>
saline- loaded</w>
saline- glucose</w>
saline- expanded</w>
saline- embedded</w>
saline- drinking</w>
saline- controlled,</w>
saline- control,</w>
saline- Diprivan</w>
saline- -
saline-- heparin</w>
saline+ saline,</w>
saline+ morphine</w>
saline+ doxorubicin</w>
saline ],</w>
saline )
saline) over</w>
saline (3%)</w>
salicylazosulfapyri dine.</w>
salicylazosulfapyri d
salicylazosulfapyrid ine;</w>
salicyl ates.</w>
salicyl ates,</w>
salicyl ate;</w>
salicyl ate-</w>
salicyl ate-
salicylate- based</w>
salicyl ate)</w>
salicyl ate),</w>
salicyl amide</w>
sal ty</w>
sal ty,</w>
sal ts:</w>
sal t;</w>
sal ping
salping o-
salpingo- o
salpingo-o oph
salpingo-ooph o
salpingo-oopho rectomy</w>
sal mon
salmon ella</w>
sal is
salis ylate</w>
sal ine/kg</w>
sal ine-associated</w>
sal es.</w>
sal e.</w>
sal co
salco fen</w>
sal azos
salazos ulphapyridine</w>
sal azine</w>
sal azide-induced</w>
sal az
salaz opyrin,</w>
sal ate</w>
sal ,</w>
sak a</w>
sairei- to.</w>
safet y).</w>
safet y',</w>
safegu ards</w>
safegu ard
safeguard s,</w>
saf est</w>
saf e;</w>
saf e'</w>
sadd le-
saddle- nose</w>
sad ness</w>
sad ness/
sadness/ unhappiness,</w>
sad ness.</w>
sacrococ cygeal</w>
sacro plasmic</w>
sacro ili
sacroili itis.</w>
sacrific ing</w>
sacrific es.</w>
sachets/ d;</w>
sachets/ d).</w>
sache ts</w>
saccharin- promoted</w>
saccharin- ondansetron</w>
saccharin- -a</w>
sacchar in/
saccharin/ nicotine</w>
sacchar in)</w>
sacchar ide</w>
sacchar ic</w>
sac rine</w>
sac ral
sacral /
sacral/ coccygeal</w>
sac ol)</w>
sac ki
sacki e
sackie virus</w>
sac cul
saccul es.</w>
sac car
saccar ide</w>
sac .</w>
sac ,</w>
sa utonomia</w>
sa pro
sapro phy
saprophy ticus</w>
sa p</w>
sa e,</w>
sa 's</w>
sG aw</w>
sG aw
sGaw ,</w>
sE- S
sE-S elect
sE-Select in.</w>
s? --case</w>
s? --a</w>
s/min/ m2)</w>
s/Q t)</w>
s/ volumes;</w>
s/ valve</w>
s/ unstable</w>
s/ sclerosis</w>
s/ regenerating</w>
s/ patient/
s/patient/ month</w>
s/ patient),</w>
s/ myalgias</w>
s/ min</w>
s/ min)</w>
s/ min).</w>
s/ mg</w>
s/ mental</w>
s/ ligands</w>
s/ inverse</w>
s/ infest
s/infest ations</w>
s/ habit
s/habit uation,</w>
s/ gynec
s/gynec ology</w>
s/ group).</w>
s/ fib
s/fib rat
s/fibrat es).</w>
s/ dose/
s/dose/ sex/species.</w>
s/ dose),</w>
s/ day</w>
s/ day.</w>
s/ d</w>
s/ c</w>
s/ behaviour</w>
s/ angiotensin-receptor</w>
s/ activities</w>
s/ absc
s/absc ess
s/abscess ;</w>
s/ Tins</w>
s/ L)-
s/L)- (4</w>
s/ L
s/L )+
s/L)+ (50
s/L)+(50 xPhenylalanine</w>
s/ D
s/D el</w>
s/ BM
s/BM IM
s/BMIM CG)</w>
s/ 5</w>
s/ 1,000</w>
s.e. mean
s.e.mean :</w>
s.e. m)</w>
s.e .)</w>
s.e .),</w>
s.c. .</w>
s.c. ).(ABSTRACT</w>
s.c. )-</w>
s.c. )-
s.c.)- but</w>
s.c ).</w>
s.c ),</w>
s. p.,</w>
s. p.)</w>
s. p.
s.p. ),</w>
s. min(-1).</w>
s. f.</w>
s. d.,</w>
s. These</w>
s. Lymphocyte</w>
s. Le</w>
s. Considering</w>
s. A</w>
s. 3</w>
s. 3.</w>
s. 1</w>
s. (iii)</w>
s. '</w>
s-of- learning</w>
s-in- quiet</w>
s-in- quiet,</w>
s-- who</w>
s-- which</w>
s-- randomized</w>
s-- racemate</w>
s-- or</w>
s-- no,</w>
s-- moclobemide</w>
s-- in</w>
s-- high</w>
s-- headache/
s--headache/ migraine,</w>
s-- fever,</w>
s-- contribute</w>
s-- chiefly</w>
s-- at</w>
s-- aminoglycoside,</w>
s-- all</w>
s-- after</w>
s-- acute</w>
s-- INR,</w>
s- the</w>
s- stupor</w>
s- resistant</w>
s- namely,</w>
s- kynurenic</w>
s- intolerance.</w>
s- hr/
s-hr/ mL,</w>
s- free</w>
s- eye</w>
s- cell</w>
s- blocker</w>
s- beta-carotene,</w>
s- assisted</w>
s- amifostine</w>
s- all</w>
s- adrenergic</w>
s- Tyr-
s-Tyr- D:</w>
s- Sinai</w>
s- RPE</w>
s- Pro-
s-Pro- Ala-
s-Pro-Ala- Asp-
s-Pro-Ala-Asp- Asp-
s-Pro-Ala-Asp-Asp- Ala-Gly-
s-Pro-Ala-Asp-Asp-Ala-Gly- Leu-
s-Pro-Ala-Asp-Asp-Ala-Gly-Leu- Val,</w>
s- Medicare</w>
s- Gri
s-Gri ff
s-Griff ith
s-Griffith s</w>
s- Dur
s-Dur ke
s-Durke e</w>
s- Bl
s-Bl ue</w>
s- 6</w>
s- 5-1
s-5-1 4%,</w>
s- 2</w>
s- -1</w>
s,tot ))</w>
s, with</w>
s, but</w>
s, U-74389G</w>
s, 15.4</w>
s)- seizures,</w>
s)- after</w>
s) <0.0
s)<0.0 28,</w>
s) (max)</w>
s) (max
s)(max );</w>
s word</w>
s welled,</w>
s well</w>
s way.</w>
s way,</w>
s wab</w>
s us,</w>
s son</w>
s serman</w>
s s-adrenergic</w>
s ratio</w>
s planch
splanch nicot
splanchnicot omized</w>
s phenoid</w>
s our</w>
s ory</w>
s ors</w>
s ores</w>
s one-</w>
s oid</w>
s ogenic</w>
s od
sod a</w>
s ock</w>
s now</w>
s no
sno red</w>
s ni
sni ffe
sniffe d,</w>
s nar
snar ling
snarling ),</w>
s nap
snap -frozen</w>
s nail
snail s,</w>
s mil
smil ing,</w>
s man's</w>
s lot</w>
s lot
slot ted</w>
s lips</w>
s ling</w>
s ling
sling -
sling- trained,</w>
s lide</w>
s ity,</w>
s ented</w>
s ectomy,</w>
s d,</w>
s d)</w>
s child
schild )</w>
s bruc
sbruc k</w>
s ays</w>
s axit
saxit oxin</w>
s ated</w>
s arthr
sarthr an</w>
s art
sart ans</w>
s ants</w>
s ance</w>
s anc
sanc tum,</w>
s an-
san- hu
san-hu ang
san-huang -h
san-huang-h sieh-hsin-tang</w>
s ]).</w>
s [4]</w>
s T</w>
s Q
sQ L.</w>
s PD</w>
s PD
sPD A)</w>
s MTX,</w>
s Air</w>
s Ag</w>
s ABC</w>
s ></w>
s 6,</w>
s 57518
s57518 76)</w>
s 2
s2 O
s2O 3)</w>
s -treated</w>
s -12</w>
s -10
s-10 4</w>
s -1)</w>
s -1
s-1 ]</w>
s ,"</w>
s )].</w>
s )/
s)/ tetrahydrocortisone</w>
s )-induced</w>
s )--
s)-- selected</w>
s )).</w>
s (P<0.01).</w>
s (EDs)</w>
s (-1);</w>
s (-1).</w>
s (-1).
s(-1). mmHg
s(-1).mmHg (-1),</w>
s (-1))</w>
s (-1)).</w>
s (
s( (1/
s((1/ 2)).</w>
s ",</w>
ryth ms</w>
ryst al</w>
rypt yline</w>
rypt ine,</w>
ryp tiline</w>
ryn ,</w>
ryanod ine.</w>
ryanod ine-sensitive</w>
ryanod ine-
ryanodine- binding</w>
ry- Ste
ry-Ste phen
ry-Stephen s</w>
ry tiline</w>
ry throcebus</w>
ry hythmias</w>
ry ),</w>
rush ,"</w>
rush ',</w>
rus opt</w>
rus h,</w>
rupt ures,</w>
rupt ure:</w>
rupt ure)</w>
rupt ure).</w>
rupt ly</w>
rupt ing</w>
rup ted)</w>
rup ole</w>
run off</w>
run ning-
running- bouncing</w>
run n
runn ing/
running/ bouncing</w>
run down
rundown "</w>
rule- out</w>
rule- out
rule-out "</w>
rule- in</w>
rul y</w>
rul line,</w>
rul ed-
ruled- out</w>
rul e,</w>
rul e)</w>
rug Log
rugLog ic,</w>
rudi mentary.</w>
rubell a,</w>
rub y)]</w>
rub rum</w>
rub or</w>
rub icin.</w>
ru sts</w>
ru sted</w>
ru ses</w>
ru pro
rupro side-induced</w>
ru ple</w>
ru minating</w>
ru min
rumin ants.</w>
ru loid</w>
ru lo
rulo plas
ruloplas min,</w>
ru k
ruk er,</w>
ru it
ruit ment</w>
ru in</w>
ru floxacin</w>
ru e</w>
ru br
rubr al"</w>
ru bidi
rubidi um-82</w>
rtN236 T</w>
rtN236 T,</w>
rtM204 V</w>
rtL180M/ M204V</w>
rtL180 M</w>
rt204 V</w>
rt204 I</w>
rt- PA.</w>
rt- PA,</w>
rt V173
rtV173 L/
rtV173L/ L180
rtV173L/L180 M/
rtV173L/L180M/ M204V</w>
rt PCR</w>
rt PCR)</w>
rt I
rtI 233
rtI233 V</w>
rt A
rtA 18
rtA18 1
rtA181 V/
rtA181V/ T</w>
rs7270 101,</w>
rs6 27
rs627 5,</w>
rs6 26
rs626 9
rs6269 :A>
rs6269:A> G;</w>
rs46 80
rs4680 :A>
rs4680:A> G)</w>
rs46 33
rs4633 C>
rs4633C> T;</w>
rs4436578- C</w>
rs4436578- C-
rs4436578-C- alle
rs4436578-C-alle le-related</w>
rs2975 226</w>
rs2975 226,</w>
rs29 63
rs2963 238</w>
rs 938
rs938 75
rs93875 22</w>
rs 57518
rs57518 76</w>
rs 48
rs48 18:
rs4818: C>
rs4818:C> G;</w>
rs 380
rs380 3300</w>
rs 37
rs37 614
rs37614 22,</w>
rs 270
rs270 72</w>
rs 26
rs26 525
rs26525 11</w>
rs 25
rs25 531</w>
rs 23
rs23 9
rs239 50
rs23950 29
rs2395029 [G
rs2395029[G ],</w>
rs 109
rs109 37
rs10937 275</w>
rr AL
rrAL R.</w>
rp 3,</w>
rp 2-
rp2- deficient</w>
roxithrom ycin-induced</w>
roxithrom ycin,</w>
rox yphenylglycol</w>
rox indole.</w>
rox in</w>
rox idone</w>
row th</w>
row ning,</w>
row ne</w>
routine ly.</w>
routine ly,</w>
rout ing</w>
rout ines</w>
rout ine,</w>
rout es)</w>
rout e;</w>
rough ness,</w>
rough -
rough- one</w>
rough ,</w>
rough )</w>
rou p)</w>
rotenone- mediated</w>
rotenone- loaded</w>
roten sin-II</w>
roten one+
rotenone+ saline</w>
rotarod /
rotarod/ ED50</w>
rotarod ),</w>
rota- rod,</w>
rot undus</w>
rot os
rotos col
rotoscol io
rotoscolio sis,</w>
rot ations.</w>
rot ation)</w>
rot ate</w>
rot 's</w>
rosuvastat in;</w>
rosuvastat in:</w>
rosu vastatin,</w>
rostro ventromedial</w>
rostro laterally</w>
rostro -
rostro- caudal</w>
rostr al,</w>
rosiglitaz one,</w>
rosiglitaz one)</w>
rosiglitaz one).</w>
rose ospor
roseospor us</w>
rose ;</w>
roscovit ine,</w>
ros plen
rosplen ial</w>
ros ourea</w>
ros orb
rosorb a</w>
ros mia</w>
ros lopes</w>
ros ing</w>
ros chi
roschi sis,</w>
ros amine-
rosamine- -a</w>
ropivaca ine-
ropivacaine- infused</w>
ropini role;</w>
ropini ro
ropiniro le)</w>
ropi um.</w>
rophag ocytic</w>
roph s.</w>
roph ic</w>
ropen y</w>
rop s</w>
rop olitan</w>
rop ess,</w>
rop ent,</w>
root lets</w>
root le
rootle ts,</w>
root ing</w>
root ed</w>
root )</w>
root ),</w>
room s,</w>
room mate</w>
room ing,</w>
roncho alveolar</w>
ron ym</w>
ron totemporal</w>
ron tal-striatal</w>
ron olol</w>
ron odular</w>
ron ing
roning en</w>
ron i
roni e's</w>
ron g
rong ylus</w>
ron est
ronest yl)</w>
ron ectin</w>
ron e.</w>
ron e-induced,</w>
ron e).</w>
ron ate-induced</w>
ron -</w>
ron ),</w>
romo ),</w>
romegal y,</w>
rom ustine</w>
rom so</w>
rom oly
romoly n</w>
rom it
romit ex
romitex an)</w>
rom id-
romid- S
romid-S ')</w>
rom atic</w>
rom as</w>
rom a</w>
roll s</w>
roll s.</w>
roll o</w>
roll ing.</w>
roll ing,</w>
roll er</w>
roll aries</w>
rolid inyl)
rolidinyl) ethyl]
rolidinyl)ethyl] acet
rolidinyl)ethyl]acet amide,</w>
roli pram
rolipram .(ABSTRACT</w>
role ?</w>
role ),</w>
rol es:</w>
rofecoxib -associated</w>
rofecoxib +
rofecoxib+ tramadol</w>
rofecoxi b),</w>
rof ton</w>
rof osf
rofosf amide</w>
rof ex
rofex oci
rofexoci b</w>
rof ,</w>
roentgen ologic</w>
roentgen ography</w>
roentgen ograms,</w>
roentgen ogram,</w>
roent en
roenten ographic,</w>
rodi tism.</w>
rodent s;</w>
rodent s'</w>
rodent )</w>
rod- like</w>
rod- like),</w>
rod otoxin</w>
rod ent.</w>
rod ent,</w>
rocuroni um?</w>
rocuroni um:</w>
rocuroni um-related</w>
robust um</w>
robust ness</w>
robu st;</w>
ro y</w>
ro unds</w>
ro th</w>
ro stal</w>
ro sion</w>
ro settes</w>
ro sette-forming</w>
ro r-processing</w>
ro pine</w>
ro phy
rophy )</w>
ro pe
rope y</w>
ro par
ropar in</w>
ro me-
rome- c</w>
ro max),</w>
ro lytic</w>
ro lled</w>
ro ll</w>
ro le-
role- mediated</w>
ro late,</w>
ro lat
rolat um).</w>
ro ic</w>
ro genic</w>
ro gative</w>
ro g/kg.</w>
ro fenac</w>
ro es.</w>
ro epiandrosterone,</w>
ro dermatitis</w>
ro cortisone,</w>
ro clor</w>
ro chond
rochond rial</w>
ro ch
roch lear
rochlear is</w>
ro cec
rocec al</w>
ro ca
roca 's</w>
ro ben
roben )</w>
ro b
rob ber
robber y.</w>
ro at</w>
ro ar</w>
ro angiography</w>
ro ad
road way</w>
ro )</w>
ro 's</w>
rn stein</w>
riz ine.</w>
riz ine,</w>
rituximab -mediated</w>
ritonavir- didanosine.</w>
ritonavir -mediated</w>
riton -100</w>
ritodrine- or</w>
ritodrine- glycopyrrolate</w>
ritod rine:</w>
ritod rine,</w>
ritod r
ritodr ine).</w>
rit ualistic)</w>
rit ual</w>
rit oxin</w>
rit on-
riton- X-100
riton-X-100 )-
riton-X-100)- skinned</w>
rit e,</w>
rit anserin:</w>
rist ostatin</w>
rist oc
ristoc et
ristocet in-induced</w>
rist in-dalfopristin</w>
risperidone- ritonavir</w>
risperidone- exposed</w>
risperid one-</w>
risperid one)</w>
risperid one),</w>
risk- to-benefit</w>
risk- stratifier</w>
risk- reducing</w>
risk- ratio</w>
risk- prediction</w>
risk- factors</w>
risk- eligible</w>
risk y;</w>
risk y,</w>
risk s?</w>
risk s)</w>
risk =1.
risk=1. 26</w>
risk .(ABSTRACT</w>
risk ",</w>
ris tica</w>
ris peri-
risperi- done</w>
ris ome,</w>
ris odium</w>
ris m</w>
ris king</w>
ris ing.</w>
ris ing)</w>
ris )</w>
ripen ing.</w>
ring- opened</w>
ring- catalepsy,</w>
ring otom
ringotom y)</w>
ring ement.</w>
ring -type</w>
ring -like</w>
ring -14C]
ring-14C] APAP.</w>
rine- releasing</w>
rine- prednisone</w>
rin- positive</w>
rin- interacting</w>
rin- -a</w>
rin se</w>
rin se.</w>
rin ker</w>
rin aline</w>
rin :</w>
rimox azole,</w>
rimonab ant.</w>
rimant adine,</w>
rim- enhancing</w>
rim- Sulf
rim-Sulf ometh
rim-Sulfometh oxazole</w>
rim per
rimper an),</w>
rim mer,</w>
rim cazole,</w>
rim ).</w>
rilu zole.</w>
rilmen idine.</w>
ril ene.</w>
ril -related</w>
rigoro usly.</w>
rigoro us,</w>
rigidity- an</w>
rigidity- -a</w>
rigid ly</w>
rigid ity;</w>
right- ventricle</w>
right- upper-quadrant</w>
right- sided,</w>
right- side</w>
right- lower-
right-lower- lobe</w>
righ ton</w>
righ tening.</w>
righ t/left</w>
righ t,</w>
righ t's</w>
rig or
rigor )--and</w>
rig ham</w>
rig er
riger ator</w>
rig 's</w>
rific e</w>
rifampicin- free</w>
rifampicin- containing</w>
rifampicin- antibody</w>
rifampic in-related</w>
rifampic in-</w>
rifampic in),</w>
rifamp in:</w>
rifamp in-induced</w>
rifamp in-associated</w>
rifabut in.</w>
rif uged,</w>
rif ting</w>
ridg e,</w>
rid al.</w>
rid al).</w>
rid )),</w>
ricket s:</w>
ricin us</w>
rich rome</w>
rich ly</w>
rich ed</w>
rich -
rich- plasma</w>
ric oxide/
ricoxide/ guanylate</w>
ric ing</w>
ric h)</w>
ric ept)</w>
ric eps</w>
ric anyl)</w>
ric .</w>
ribu tions</w>
ribosome- free</w>
ribosome- containing</w>
ribos omes.</w>
riboflav in.</w>
ribo se.</w>
ribbl ing,</w>
ribbl ing)</w>
ribavirin/ interferon</w>
ribavirin/ d</w>
ribavir ind
ribavirind ose</w>
ribavir in;</w>
ribavir in:</w>
ribavir in-treated</w>
ribavir in)</w>
ribavir in).</w>
rib s,</w>
rib iform</w>
rib enz
ribenz amine</w>
rib ,</w>
ri zoate),</w>
ri xivan)</w>
ri van</w>
ri tis/Cervicitis</w>
ri tis'</w>
ri tin</w>
ri thing</w>
ri ses,</w>
ri se"</w>
ri raj</w>
ri pe
ripe ),</w>
ri on</w>
ri ol-mediated</w>
ri od</w>
ri mex
rimex olone</w>
ri m.</w>
ri lization</w>
ri k
rik sen</w>
ri fied</w>
ri es)</w>
ri ef</w>
ri d)</w>
ri an)</w>
ri a:</w>
ri ,</w>
rhythmic ity</w>
rhythmic ity,</w>
rhyth ms)</w>
rhyth mogenic</w>
rhyth mogenesis</w>
rhyth mically</w>
rhyth mias,</w>
rhyth mia</w>
rhyth m)</w>
rhyth m
rhythm ical</w>
rhodamine -123</w>
rhizom a,</w>
rhiz otomy</w>
rhiz oma</w>
rhinosinu sitis</w>
rhin orrhoea</w>
rhin orrhea,</w>
rhin opharyngeal</w>
rhin encephalon</w>
rhi zin)</w>
rheumat ology,</w>
rheumat ologists.</w>
rheum atism
rheumatism .</w>
rheum atica</w>
rhe xis</w>
rhe tinic</w>
rhe ology</w>
rham nose</w>
rhabdomyosarcom as.</w>
rhabdomyosarcom a)</w>
rhabdomyoly sis;</w>
rhabdomyoly sis-a</w>
rhabdomyoly sis)</w>
rhabdomy oli
rhabdomyoli sis</w>
rhabdomy aly
rhabdomyaly sis.</w>
rhH GF)</w>
rh- T</w>
rh- T,</w>
rh thmia</w>
rh on
rhon chi</w>
rh omb
rhomb encephalon.</w>
rh initi
rhiniti s?</w>
rh inal</w>
rh SOD.</w>
rh SOD,</w>
rh EPO.</w>
rh EPO-resistant</w>
rexcit ability</w>
rex olone,</w>
rex in</w>
rex ia,</w>
rex ate,</w>
rewar ds.</w>
rewar ds).</w>
rewar ding,</w>
rewar d/
reward/ stimulus</w>
rewar d-induced</w>
rewar d-
reward- seeking</w>
reviewe d;</w>
review ers.</w>
review ers,</w>
review ;</w>
revi ve</w>
revi sed:</w>
reversible "</w>
reversib ly,</w>
reverse- transcription</w>
reversal s)</w>
reversal :</w>
revers able</w>
rever ts</w>
rever sions</w>
rever sions,</w>
rever sely</w>
rever sed-phase</w>
rever sed'</w>
rever ber
reverber ating</w>
revei wed.</w>
revei w</w>
reveal ed;</w>
reve ious</w>
reve e
revee sible,</w>
revascular ized,</w>
revascular ization),</w>
reuni ons</w>
reuni ens</w>
retur ns,</w>
retur ns)</w>
retur ned;</w>
retur n-
return- curves</w>
retrospecti ve.</w>
retrospect .</w>
retrognath ia.</w>
retrognath ia,</w>
retro splenial</w>
retro rubral</w>
retro pul
retropul sion</w>
retro peritoneum</w>
retro metabolism</w>
retro hepatic</w>
retro colli
retrocolli s.</w>
retro active</w>
retriev al:</w>
retriev al-
retrieval- det
retrieval-det our</w>
retriev al)</w>
retriev able</w>
retrie ve</w>
retri ed</w>
retrac tion),</w>
retino pathy:</w>
retin oscopy</w>
retin oscopy.</w>
retin ol.</w>
retin ol)</w>
retin oids,</w>
retin ography</w>
retin oblast
retinoblast oma,</w>
retin in</w>
retin as,</w>
retin amide]</w>
retin amide.</w>
retin al,</w>
retin ae.</w>
retin ).</w>
retig abine,</w>
reticulo- endothelial</w>
reticulo sis.</w>
reticulo endotheli
reticuloendotheli osis,</w>
reticulo cytopenic</w>
reticulo cytopenic,</w>
reticulo cytopenia</w>
reticulo cyt
reticulocyt es.(ABSTRACT</w>
reticulat a)</w>
reticulat a).</w>
reticul um;</w>
reticul in.</w>
reticul in,</w>
reticul in)</w>
reti ring</w>
reti rement</w>
reth rectomy</w>
reth ine)</w>
reten tion:</w>
reten tion/retraining</w>
reten tion--an</w>
reten tion),</w>
retard ation)</w>
retard ation).</w>
retard ).</w>
retar ded,</w>
ret y,</w>
ret uring</w>
ret to,</w>
ret t's</w>
ret ol</w>
ret ment-
retment- emergence</w>
ret in-associated</w>
ret ardive</w>
resveratro l;</w>
resuscit ation;</w>
resuscit ation"</w>
resuscit ated,</w>
resuscit ated)</w>
resuscit ate"</w>
result s;</w>
result s:</w>
result s).</w>
result s),</w>
result antly,</w>
restric tive.</w>
restric tions.</w>
restric tion;</w>
restraint s),</w>
restraint :</w>
restraint -induced</w>
restrain t,</w>
restrain ers</w>
restrain er.</w>
restra ins</w>
restra ining</w>
restra ined.</w>
restra in</w>
restlessness -
restlessness- pain</w>
restlessness ,"</w>
restlessness ).</w>
restless -
restless- leg</w>
restim ulation</w>
restim ulated</w>
resten osis,</w>
rest us</w>
rest s</w>
rest ore,</w>
rest or
restor ation,</w>
rest enotic</w>
rest aging</w>
rest /
rest/ (99m)Tc-
rest/(99m)Tc- sestamibi</w>
rest -
rest- activity</w>
rest )</w>
rest )-
rest)- by-time</w>
rest ),</w>
responsib le;</w>
responsib ility.</w>
responsi vity.</w>
responsi vity,</w>
responsi vely.</w>
responses .5.</w>
responses .(ABSTRACT</w>
response-- of</w>
response-- as</w>
response-- 47.8</w>
response -related</w>
response ,"</w>
response +
response+ partial</w>
response ).(ABSTRACT</w>
response '</w>
response ")</w>
responder s;</w>
responder s:</w>
responder ).</w>
responder '</w>
responder "</w>
respondent s.</w>
respondent s)</w>
respondent s).</w>
respondent 's</w>
respond ing;</w>
respond ing:</w>
respond ing)</w>
respon sively</w>
respon ses),</w>
respon ses'</w>
respon ed</w>
respon din
respondin g/
responding/ stable</w>
respon d,</w>
respirat ory.</w>
respirat or</w>
respirat or.</w>
respirat or-
respirator- dependent</w>
respirat ed.</w>
respir ations.</w>
respectively ],</w>
respectively ]).</w>
respectively ):</w>
respectively ).(ABSTRACT</w>
respectivel y-resulting</w>
respect .3.</w>
resp one</w>
resp ecting</w>
resp ected.</w>
resp ec
respec ified</w>
resource- poor</w>
resour ces.</w>
resour ceful</w>
resour ce,</w>
resor ting</w>
resor t</w>
reson ance:</w>
resolu tions</w>
resolu tion;</w>
resol ving;</w>
resol vable</w>
resistance ?</w>
resistance :</w>
resistance -
resistance- reversal</w>
resistance (P</w>
resist ent</w>
resist ed.</w>
resinifer atox
resiniferatox in-
resiniferatoxin- binding</w>
resili ent</w>
resili ence</w>
residu es,</w>
residu e.</w>
residu al),</w>
resident :</w>
resid ue-long</w>
resid ual,</w>
resid ine,</w>
resid ent,</w>
resid ency</w>
resh aping</w>
resh ape</w>
resh ad
reshad ow
reshadow s</w>
reservoir s.</w>
reserpin ized,</w>
reserpin ization</w>
reserp ine-evoked</w>
reserp ine--
reserpine-- at</w>
reser ves.</w>
reser ve-function",</w>
reser vations</w>
reser pine
reserpine +
reserpine+ alpha-methyl-p-tyros
reserpine+alpha-methyl-p-tyros ine-</w>
resem bled,</w>
resect able,</w>
resec tions.</w>
research ;</w>
rescu ing</w>
resc end
rescend o</w>
resc ences</w>
resc ences.</w>
resc ence-
rescence- quenching</w>
res uspended</w>
res usciated.</w>
res upply</w>
res titutions</w>
res thesia.</w>
res sive</w>
res sing</w>
res sin,</w>
res sed</w>
res s.</w>
res oun
resoun ding</w>
res ins</w>
res ine.</w>
res in-coated</w>
res hor
reshor tened</w>
res ensi
resensi tization.</w>
res ecting</w>
res ces</w>
res can
rescan ned.</w>
res cal
rescal ed</w>
res absorption</w>
requis ites</w>
require d?</w>
requir ing,</w>
requi res,</w>
request s)</w>
request .</w>
reput e.</w>
reproducibil ity)</w>
reproduc tive-age</w>
reproduc tion,</w>
reproduc tion)</w>
reproduc ed,</w>
represent ative.</w>
represent ations.</w>
repres sion,</w>
reports/ series</w>
reports/ series,</w>
reports/ million</w>
reporte d/
reported/ year</w>
reporte d)</w>
repor ts--even</w>
repor ts)</w>
repor ts),</w>
repor tability.</w>
repor t/literature</w>
repor t-.</w>
repor t),</w>
repolar ization-
repolarization- prolonging</w>
repolar isation)</w>
replic ative.</w>
replic ation;</w>
replic ation-
replication- incompetent</w>
replic ated,</w>
replen ishment</w>
replen ishing</w>
replen ish</w>
reple tion,</w>
replacement s:</w>
replacem ents,</w>
replacem ent:</w>
replac es</w>
replac ed.</w>
replac ed)</w>
repl ied.</w>
repeti tive/stereotypic-like</w>
repeti tions,</w>
repertoi res</w>
repertoi re,</w>
repercus sions</w>
repercus sions.</w>
repeated- treatment</w>
repeated- dose,</w>
repeated ly,</w>
repeated ly)</w>
repeated -dose</w>
repeated -</w>
repeat able,</w>
repair s,</w>
rep tilase</w>
rep on
repon se</w>
rep ens
repens ),</w>
rep ellent</w>
reorgan izations</w>
reno vascular,</w>
reno protection.</w>
reno protection,</w>
reno ate</w>
renin-angiotensin- mediated</w>
renin- secreting</w>
renin- dependent</w>
renin- depend
renin-depend ent'</w>
renin- angiotens
renin-angiotens in-</w>
renew al.</w>
rene wed.</w>
rene line-induced</w>
rene ;</w>
rene -induced</w>
rene -
rene- 9-10-
rene-9-10- di
rene-9-10-di ol),</w>
renal/ genitourinary</w>
renal- transplanted</w>
renal- transplant</w>
renal- hypertensive</w>
renal- compromised</w>
renal- adrenal</w>
renal- ,</w>
ren tiapril-treated</w>
ren ox</w>
ren otubular</w>
ren olide</w>
ren ography</w>
ren ography.</w>
ren ograms</w>
ren n
renn ial</w>
ren k
renk ov</w>
ren inemic</w>
ren inemia</w>
ren in)</w>
ren do
rendo thelial</w>
ren di
rendi pit
rendipit ous</w>
ren d</w>
ren che
renche d.</w>
ren ch-
rench- Americ
rench-Americ an-
rench-American- British</w>
ren cephal
rencephal ic
rencephalic ')</w>
ren ce.</w>
ren alis</w>
ren al).</w>
ren ),</w>
remoxipri de-induced</w>
remoxipri de)</w>
remove d)</w>
remove d).</w>
remove d),</w>
removal s.</w>
removal s,</w>
remot ely</w>
remot e,</w>
remor ine-induced</w>
remodel ing;</w>
remo rolytic</w>
remn ants</w>
remn ants.</w>
remit ting,</w>
remit ters.</w>
remit ters,</w>
remit ted.</w>
remit tance</w>
remis sions:</w>
remis sions)</w>
remis sions).</w>
remis sion;</w>
remis sion-inducing</w>
remis sion)</w>
remis sion).</w>
remin ders</w>
remin der.</w>
remifentanil- ket
remifentanil-ket amine).</w>
remifentanil- isoflurane</w>
remifentanil- TIVA</w>
remifentanil -related</w>
remifentanil -mediated</w>
remifentanil +
remifentanil+ lidocaine</w>
remifentan il:</w>
remem be
remembe red.</w>
remedi ations</w>
remedi ation.</w>
remark ably.</w>
remark able.</w>
remark able,</w>
remaind er.</w>
remain ing.</w>
remain ing,</w>
rema steric,</w>
rem ia-induced</w>
rem erg
remerg ed</w>
rem apped</w>
rem apped.</w>
reluct ance</w>
relief ;</w>
relief :</w>
relief ).</w>
relie f)</w>
reli ably.</w>
reli able.</w>
reli ability.</w>
relev ant,</w>
relent lessly</w>
releas ors,</w>
releas ing-
releasing- hormone</w>
releas er.</w>
releas ed.</w>
releas e?</w>
releas e;</w>
releas e:</w>
releas e/
release/ turnover</w>
releas e
release ")</w>
rele i
relei eved</w>
rele gate</w>
relax ed,</w>
relax ations.</w>
relax ation-
relaxation- enhanced</w>
relax ation).</w>
relax ant),</w>
relax ant
relaxant s:</w>
relationship s)</w>
relationship s).</w>
relationship ;</w>
relationshi p)</w>
relati ves.(ABSTRACT</w>
relati ve;</w>
relati ve)</w>
relati ve's</w>
relapsing- remitting,</w>
relapse- free,</w>
relapse /
relapse/ delivery</w>
relapse -related</w>
relapse -like</w>
relapse ),</w>
relap sing.</w>
relap ses/patient/year,</w>
relap ser</w>
relap se).</w>
relap aro
relaparo tomy.</w>
rel in.</w>
rel in-
relin- depot</w>
rel g
relg estro
relgestro min,</w>
rel ength
relength ening,</w>
rel ectro
relectro de</w>
rel ative-
relative- risk</w>
rel ations:</w>
rel ated:</w>
rel ated-
related- apoptosis</w>
rel ated)</w>
rel ate,</w>
rejec tions)</w>
rej ecting</w>
reiter ates</w>
reiter ated</w>
reiter ated.</w>
reinstat ement)</w>
reinst ated.</w>
reinst ated,</w>
reinforcer s.</w>
reinforcer s,</w>
reinforcement -based</w>
reinforce d,</w>
reinforc ing.</w>
reinforc ers</w>
reinforc er.</w>
rein stituting</w>
rein stitute</w>
rein states</w>
rei- to</w>
rehabilit ation,</w>
rehabilit ating</w>
rehabilit ated</w>
regurgit ation;</w>
regurgit ation).</w>
regular- strength</w>
regular- spiking</w>
regular ity,</w>
regular -</w>
regul ations.</w>
regul ation:</w>
regul ation
regulation ,
regulation, fenoldopam-induced</w>
regul ary</w>
regul arly,</w>
regres sive-integrated</w>
regres sions)</w>
regres sion:</w>
regres sion-based</w>
regres sion).</w>
regres sing</w>
registr y,</w>
registr ation.</w>
regist ries.</w>
regist ries,</w>
regist rar
registrar s</w>
regist ers.</w>
regist er.</w>
regist er,</w>
region al/
regional/ local</w>
region ;</w>
region -selective</w>
region -of-
region-of- interest</w>
region -
region- specifically</w>
regimens .(ABSTRACT</w>
regimen s)</w>
regimen -dependent</w>
regime ;</w>
regime :</w>
regime ).</w>
regim es.</w>
regim ent</w>
regar ded.</w>
reg uiring</w>
reg rowth</w>
reg ret</w>
reg inal</w>
reg ia)</w>
reg ated</w>
reg S)</w>
refractory/ relapsed</w>
refractory/ recurrent</w>
refractor y'</w>
refrac ted</w>
reflu x-related</w>
reflexi ve.</w>
reflexi ve,</w>
reflex- sympathoneural</w>
reflex ological</w>
reflex ia,</w>
reflex es.
reflexes. 6.</w>
reflex .(ABSTRACT</w>
reflex --an</w>
reflex --
reflex-- involvement</w>
reflex (
reflex( es)</w>
refl ec
reflec tivity</w>
refine ments</w>
refine ments.</w>
referen tial</w>
referen ces,</w>
referen ce)</w>
referen ce).</w>
referen c
referenc es;</w>
refer rable</w>
ref uting</w>
ref utes</w>
ref uted</w>
ref uses</w>
ref used.</w>
ref usals)</w>
ref usal</w>
ref usal.</w>
ref usal,</w>
ref rigerator</w>
ref o
refo ot</w>
ref ly</w>
ref low</w>
ref illed</w>
redund ant.</w>
redund ancy</w>
redund ance</w>
reduction/ discontinuation.</w>
reductase- inhibitor</w>
reductase- inhibitor-related</w>
reductas e;</w>
reductas e-like</w>
reductas e)</w>
reductas e).</w>
reduct ases</w>
reduc tions:</w>
reduc tion:</w>
reduc ible</w>
reduc es/
reduces/ prevents</w>
reduc er</w>
redox -
redox- active,</w>
red- sensitive</w>
red- rimmed</w>
red- pulse</w>
red- light-
red-light- elicited</w>
red- immune-
red-immune- deficiency
red-immune-deficiency -
red-immune-deficiency- syndrome</w>
red- colored</w>
red- O</w>
red ution</w>
red th</w>
red iting</w>
red dis
reddis h-
reddish- colored</w>
red ale</w>
red '</w>
red "
red" -like</w>
recurren t.</w>
recurren ce-
recurrence- free</w>
recur sive</w>
recur ring.</w>
recur ring,</w>
recuper ation</w>
recuper ated</w>
recumb ency.</w>
rectom y)</w>
rectom ized,</w>
rect us.</w>
rect us,</w>
rect um</w>
rect angles</w>
recruit ment.</w>
recruit ment,</w>
recruit ment
recruitment -type</w>
recruit able</w>
recru it,</w>
recreation ally,</w>
recre ationally</w>
recre ated</w>
recre ate</w>
recover y2</w>
recover y1</w>
recover y"</w>
recover s,</w>
recover ing.</w>
recover ing,</w>
recover ies,</w>
recove red:</w>
recorde d).</w>
record- linkage</w>
record- confirmed</w>
record ;</w>
recor der.</w>
recor der,</w>
recor d,</w>
reconstruc tion:</w>
reconstruc tion,</w>
reconc ile</w>
recommend ation,</w>
recommen de
recommende d;</w>
recombin ing</w>
recombin ation.</w>
recombin ated</w>
recombin ant/
recombinant/ purified</w>
recoll ecting</w>
recogniz ed;</w>
recogniz ed.(ABSTRACT</w>
recogniz ed--
recognized-- only</w>
recogniz ed)</w>
recogniz able.</w>
recogni tion)</w>
recogni sed:</w>
recogn is
recognis able</w>
recle zole</w>
recir c
recirc ulation</w>
reciproc ity</w>
reciproc ally,</w>
recipient s;</w>
recipient s.(ABSTRACT</w>
recipient --a</w>
recipient 's</w>
reci ved</w>
reci sion</w>
rechallenge :</w>
rechallenge /
rechallenge/ continuation</w>
rechallenge ).</w>
rechallenge "</w>
reces sive,</w>
reces sed</w>
receptors. Here,</w>
receptors. Finally,</w>
receptors ]</w>
receptors ].</w>
receptors ?</w>
receptors .(ABSTRACT</w>
receptors -1</w>
receptors "</w>
receptors ",</w>
receptor/ thirst</w>
receptor/ retinoic</w>
receptor/ glycer
receptor/glycer aldehyde</w>
receptor/ effector</w>
receptor/ dopamine</w>
receptor/ channel</w>
receptor/ cAMP-dependent</w>
receptor/ Ca(2+)</w>
receptor-medi ated)</w>
receptor-medi ated).</w>
receptor- mutant</w>
receptor- mediated.</w>
receptor- inactive</w>
receptor- heart</w>
receptor- expressing</w>
receptor- directed</w>
receptor- chloride</w>
receptor- channel</w>
receptor- blockade</w>
receptor- beta</w>
receptor- bearing</w>
receptor- antagonists</w>
receptor- antagonist,</w>
receptor- alpha,</w>
receptor- activity-
receptor-activity- modifying</w>
receptor- active</w>
receptor- G</w>
receptor s/ligands</w>
receptor ?</w>
receptor );</w>
receptor (mGluR
receptor(mGluR )
receptor(mGluR) 5</w>
recept ors'</w>
recent ly;</w>
recent --in</w>
recei ving,</w>
recei vers</w>
recei vers,</w>
recei ved"</w>
rece vied</w>
rece dex
recedex ),</w>
rece ded.</w>
recapit ulating</w>
recapit ulates</w>
recapit ulated</w>
recanal ized.</w>
recalle d.</w>
rec ution</w>
rec tum,</w>
rec topia</w>
rec tical</w>
rec tic</w>
rec ta.</w>
rec ta,</w>
rec oxib</w>
rec oline</w>
rec ent.</w>
rec ent,</w>
rec ap
recap tured</w>
rec alling</w>
rec all"</w>
rec al
recal culated</w>
reboun ding</w>
reboun d;</w>
reboun d'</w>
reat tempted</w>
reat ment,</w>
reasses sing</w>
reason s"</w>
reason ing,</w>
reason able.</w>
reason able,</w>
reas surance,</w>
reas iness</w>
reas es.</w>
reas e-
rease- gap"</w>
rearrang ements</w>
rearrang em
rearrangem ents,</w>
rear s</w>
rear ranged</w>
rear ings,</w>
rear ing;</w>
rear ing.</w>
rear ing).</w>
rear ing),</w>
real- world</w>
real- world'</w>
real- time.</w>
real time</w>
real ized,</w>
real ise</w>
reaffir med</w>
readi ly.</w>
readi ly,</w>
read y.</w>
read s'</w>
read ing;</w>
read ing.</w>
read er's</w>
read )</w>
reactivation/ hepatitis</w>
reactivation/ hepatitis.</w>
reaction- time</w>
reaction- restriction</w>
reaction- cough
reaction-cough -
reaction-cough- just</w>
reaction s),</w>
reaction ?</w>
reaction '</w>
reaction ',</w>
reaction ".</w>
react ors.</w>
react ors,</w>
react ors
reactors )--
reactors)-- the</w>
react ants,</w>
react ant</w>
react ant
reactant s"</w>
reache d;</w>
reache d)</w>
reac tive,</w>
reac tive),</w>
reac tion/drug</w>
reac tion)</w>
reac tion).</w>
reac tion),</w>
reac quisition</w>
reac quired</w>
reac cumulation</w>
reabsorp tion;</w>
reabsorp tion:</w>
re/ explo
re/explo sion,</w>
re-in-an o.</w>
re-in- after</w>
re- warming,</w>
re- use</w>
re- treatment,</w>
re- treating</w>
re- transplantation</w>
re- tilt</w>
re- tested</w>
re- tested.</w>
re- stratified</w>
re- started,</w>
re- specific)</w>
re- resection</w>
re- randomization</w>
re- presentation</w>
re- oxygenation,</w>
re- oper
re-oper ation:</w>
re- opening</w>
re- occurrence</w>
re- occur.</w>
re- measured</w>
re- learn</w>
re- investigate</w>
re- intubated.</w>
re- institution</w>
re- instituted</w>
re- instituted.</w>
re- initiating</w>
re- hospitalization</w>
re- hospitalised</w>
re- growth</w>
re- gradual</w>
re- forming</w>
re- exposures,</w>
re- exposure.</w>
re- exposure,</w>
re- exploration.</w>
re- experienced</w>
re- expansion.</w>
re- excretion</w>
re- excitation</w>
re- examination</w>
re- evaluated.</w>
re- evalu
re-evalu tion.</w>
re- establishment</w>
re- established.</w>
re- establish</w>
re- equilibr
re-equilibr ation,</w>
re- epitheli
re-epitheli alization</w>
re- entry.</w>
re- enhanced</w>
re- emphasized.</w>
re- emerging</w>
re- emergent</w>
re- emerged</w>
re- emerge</w>
re- elevation</w>
re- elevation,</w>
re- described</w>
re- considered.</w>
re- commenced</w>
re- comm
re-comm ended</w>
re- challenged.</w>
re- challenged,</w>
re- challenge.</w>
re- categorized</w>
re- bleed</w>
re- applied,</w>
re- application</w>
re- appearance</w>
re- analyzing</w>
re- aligned</w>
re- admitted</w>
re- administered,</w>
re- activate</w>
re- AMI</w>
re zepine,</w>
re y-Zeiss,</w>
re wiring</w>
re vocable</w>
re visits</w>
re vised)</w>
re ver</w>
re use</w>
re uptake.(ABSTRACT</w>
re uptake-inhibitors-metoclopramide</w>
re ts</w>
re trial</w>
re treatments</w>
re treatment.</w>
re transplanted</w>
re transplantations</w>
re transplant</w>
re training,</w>
re tracted</w>
re torograde</w>
re tion.</w>
re throscopy</w>
re thrombosis,</w>
re tested.</w>
re ted</w>
re tail</w>
re study</w>
re studied:</w>
re structuring</w>
re strosternal</w>
re stat,</w>
re started,</w>
re start</w>
re sist</w>
re sided</w>
re setting</w>
re release</w>
re recruited,</w>
re prot
reprot oxic</w>
re programming</w>
re pression</w>
re presses</w>
re press</w>
re presented.</w>
re present,</w>
re pository</w>
re position
reposition ing,</w>
re population</w>
re population.</w>
re popul
repopul ate</w>
re plied</w>
re pit
repit ant</w>
re pi
repi dil,</w>
re perfused.</w>
re perf
reperf use.</w>
re paralysis.</w>
re ous</w>
re or
reor ine-induced</w>
re omycin,</w>
re occurrence</w>
re occurred</w>
re occurred.</w>
re occur</w>
re occlusions</w>
re occlusion</w>
re occlusion.</w>
re myelinating</w>
re myelinated</w>
re mun
remun er
remuner ation.</w>
re modell
remodell ing,</w>
re mias.</w>
re methylation</w>
re ments</w>
re member.</w>
re measured</w>
re measured,</w>
re localisation</w>
re loading</w>
re ligi
religi ous</w>
re kindled</w>
re k
rek ic</w>
re issued</w>
re investigated</w>
re intubation</w>
re intubation,</w>
re intubated</w>
re introduction.</w>
re interven
reinterven tions),</w>
re innervation</w>
re injection,</w>
re initiation.</w>
re ingestion</w>
re infused</w>
re infarction.</w>
re infarc
reinfarc tions)</w>
re induce</w>
re implantation</w>
re imb
reimb ursement</w>
re illustrates</w>
re ial</w>
re hydration.</w>
re hospitalization.</w>
re hemorrhages,</w>
re feeding,</w>
re exposure.</w>
re exploration.</w>
re exploration,</w>
re experiencing</w>
re experienced</w>
re excite</w>
re excision</w>
re examination.</w>
re established,</w>
re es.</w>
re equilib
reequilib rate</w>
re entry,</w>
re entr
reentr ant),</w>
re entered</w>
re ening</w>
re emphasized.</w>
re emphasised.</w>
re emerged</w>
re dness.</w>
re distribution.</w>
re distribut
redistribut es</w>
re distrib
redistrib uting</w>
re distension</w>
re direction</w>
re differentiation</w>
re differentiate</w>
re development</w>
re developing</w>
re defines</w>
re defined</w>
re define</w>
re cycle.</w>
re converted</w>
re conver
reconver ted,</w>
re convalescence</w>
re considered</w>
re confirms</w>
re confirm</w>
re configuration.</w>
re compens
recompens ation.</w>
re combination</w>
re choic</w>
re checked</w>
re check</w>
re chall
rechall ange</w>
re ch
rech ne
rechne tium</w>
re ca
reca -specific</w>
re bu
rebu j
rebuj o,</w>
re breathing.</w>
re breathing,</w>
re bleed
rebleed ing?</w>
re biopsy.</w>
re biopsied.</w>
re be
rebe l</w>
re awakened</w>
re ations</w>
re ar</w>
re appraisal</w>
re applied</w>
re appears</w>
re appearing</w>
re appeared,</w>
re appearance.</w>
re anesthetized</w>
re anesthetized,</w>
re analyzed</w>
re alis
realis tically</w>
re al:</w>
re agent.</w>
re agent
reagent s.Lymphocyte</w>
re ag
reag ibility</w>
re admission.</w>
re administering</w>
re administered,</w>
re adjust
readjust ed,</w>
re addressed.</w>
re address</w>
re activity)</w>
re activity
reactivity -</w>
re absorptions</w>
re a
rea ve's</w>
re Lev
reLev ant</w>
re .(ABSTRACT</w>
re -treated</w>
razox ane,</w>
razol on
razolon es-
razolones- intolerant</w>
razol e.</w>
razep am.</w>
razep am-induced</w>
rauwol fi
rauwolfi a),</w>
rats-- the</w>
rats-- electrocardiographic</w>
rats-- by</w>
rats- levels</w>
rats- -1
rats--1 45</w>
ratios =
ratios= 2.54</w>
ratios .(ABSTRACT</w>
ratios +/-
ratios+/- s.e.mean:</w>
ratios ),</w>
ration ally</w>
ratio> 4.38</w>
ratio> 3.25</w>
ratio= 4.0).</w>
ratio= 3.36</w>
ratio= 3.
ratio=3. 60;</w>
ratio= 2.
ratio=2. 38</w>
ratio= 1.6
ratio=1.6 1;</w>
ratio= 1.07;</w>
ratio- 1</w>
ratio- -the</w>
ratio ]</w>
ratio =1.
ratio=1. 25;</w>
ratio ).</w>
ratio ),</w>
ratio (--
ratio(-- cyclic</w>
rati fied</w>
rati cally</w>
rati al</w>
rates= 0.39</w>
rates= 0.22</w>
rates +
rates+ nitrites</w>
rate/ mean</w>
rate/ etofibrate</w>
rate/ day)</w>
rate/ clofibrate</w>
rate- systolic</w>
rate- pressure-
rate-pressure- product</w>
rate- modulated</w>
rate- mediated</w>
rate- limited</w>
rate- independent</w>
rate- fed</w>
rate- control</w>
rate- administration</w>
rate- -
rate-- for</w>
rate >50</w>
rate =
rate= 0.86)</w>
rate (HR)</w>
rata eva</w>
rat/ day).</w>
rat/ d</w>
rat/ d).</w>
rat ta</w>
rat t</w>
rat t,</w>
rat s].</w>
rat s?--case</w>
rat s/group).</w>
rat s);</w>
rat ori
ratori us)</w>
rat ings;</w>
rat ing"</w>
rat es.(ABSTRACT</w>
rat es--
rates-- myco
rates--myco logic,</w>
rat er,</w>
rat ei
ratei on</w>
rat ed:</w>
rat a</w>
rat .
rat. day</w>
rat --
rat-- evaluation</w>
rat -
rat- strain</w>
rat )-induced</w>
rat '</w>
rash :</w>
rash /
rash/ desquamation</w>
ras h).</w>
ras ferase</w>
ras e-
rase- 5A</w>
rare ?</w>
rar ity,</w>
rapid- bolus</w>
rapid ly;</w>
rapid ;</w>
rapid .</w>
rapid -</w>
rapid )</w>
rapamyc in;</w>
rapamyc in-associated</w>
rapamyc in-</w>
rapamyc in),</w>
rapamyc in's</w>
rapamyc in
rapamycin )-based</w>
rapam icin</w>
rapam icin.</w>
rap yrazole</w>
rap e.</w>
rap ar
rapar inu
raparinu x,</w>
rap ap
rapap mycin</w>
rap )</w>
rans worth</w>
rans ected</w>
ranol azine,</w>
rank- ordering</w>
rank =
rank= 2.4,</w>
rank ),</w>
ranitid ine:</w>
ranitid ine-mediated</w>
range ]:</w>
range =
range= 19-
range=19- 60).</w>
range .(ABSTRACT</w>
range );</w>
rang io
rangio pathy,</w>
rang ed,</w>
rang ,</w>
randomized- order</w>
randomized- crossover</w>
randomized- controlled</w>
random- effect</w>
random- digit</w>
random ness</w>
random ly:</w>
random izing</w>
random ization:</w>
random ised.</w>
random isation</w>
random isation,</w>
random i
randomi sed-controlled</w>
random .</w>
random -</w>
ran xilium)</w>
ran tic</w>
ran s</w>
ran on.</w>
ran olol</w>
ran king</w>
ran k,</w>
ran itine</w>
ran ios
ranios chi
ranioschi sis)</w>
ran io</w>
ran ic</w>
ran ially</w>
ran fer
ranfer ases</w>
ran ce</w>
ran )</w>
ramp ing</w>
ramp ing-
ramping- up</w>
ramipri lat.</w>
ramad ol</w>
ram ycin.</w>
ram ycin-impregnated</w>
ram us</w>
ram ified</w>
ram ification</w>
ram i</w>
ram es</w>
ram adol
ramadol -associated</w>
ram .</w>
ram )</w>
ram ).</w>
ram ))</w>
raloxifene- treatment,</w>
raloxifene :tamoxifen)</w>
raloxifene ),</w>
raloxifene 's</w>
raloxif ene)</w>
ral i
rali aceae),</w>
ral es</w>
ral es,</w>
rag min,</w>
raf ts.</w>
radiotrac ers</w>
radiotrac er,</w>
radiotele metry.</w>
radiotele metry,</w>
radiosensi tization</w>
radiosensi tive</w>
radionuclide- labelled</w>
radionuclide- determined</w>
radiolig and.</w>
radiolig and,</w>
radiolig and
radioligand s.</w>
radiolab ele
radiolabele d.</w>
radioimmun ometric</w>
radioimmun odi
radioimmunodi ff
radioimmunodiff usion</w>
radiograph ically.</w>
radiograph ic-histologic</w>
radiocon trast,</w>
radio- translucent,</w>
radio- telemetry</w>
radio- immuno
radio-immuno assay).</w>
radio- contrast</w>
radio- chemotherapy</w>
radio therapy).</w>
radio therapists</w>
radio isotope</w>
radio isotop
radioisotop ically</w>
radio iodine</w>
radio immunos
radioimmunos cinti
radioimmunoscinti graphy</w>
radio immunological</w>
radio gram,</w>
radio gas
radiogas chromatography</w>
radio enzymatic</w>
radio aut
radioaut ography</w>
radio assay</w>
radio assay.</w>
radio actively</w>
radio ablation</w>
radicul aris</w>
radicul ar-
radicular- medullary</w>
radical- trapping</w>
radical- mediated</w>
radic ulography:</w>
radic ation</w>
radic al/
radical/ vitamin</w>
radic al,</w>
radi os
radios otopic</w>
radi ore
radiore sistance,</w>
radi onucle
radionucle id</w>
radi onecrosis</w>
radi on
radion cul
radioncul ide</w>
radi ometric</w>
radi ologists</w>
radi ologists.</w>
radi ologist</w>
radi ologist.</w>
radi ologist,</w>
radi ologically.</w>
radi ogenic</w>
radi ent-echo</w>
radi ation:</w>
radi ation-dose</w>
radi ation-
radiation- sensitizing</w>
radi ated</w>
rad s</w>
rad ine-induced</w>
rad ed</w>
rad /day)</w>
rad ).</w>
raclopri de-induced</w>
rachi tic</w>
rach ed</w>
racem ised</w>
racem ic-</w>
racem ic-
racemic- amisulpride</w>
racem ic)</w>
racem er</w>
race/ethnic ity;</w>
race/ethnic ity,</w>
rac on)</w>
rac k</w>
rac es.</w>
rac e
race horses.</w>
rabeprazol e)</w>
rabbit ?</w>
raVer se).</w>
ra- zole</w>
ra- ge
ra-ge en
ra-geen an-induced</w>
ra- containing</w>
ra z</w>
ra ynaud's</w>
ra y)</w>
ra xin.</w>
ra ves</w>
ra un,</w>
ra umatic</w>
ra ster</w>
ra emia.</w>
ra em
raem ia-induced</w>
ra ea</w>
ra e</w>
rIFNalpha2 b,</w>
rHV -1,</w>
rCMR gl
rCMRgl c,</w>
r=0.7 6;</w>
r=0.7 1;</w>
r= 0.60
r=0.60 6,</w>
r= 0.6
r=0.6 2;</w>
r= -0.6
r=-0.6 3;</w>
r= -0.
r=-0. 36;</w>
r-hu EPO,</w>
r- recommended</w>
r- provided</w>
r- hirudin</w>
r- blocking</w>
r- Hu
r-Hu EPO,</w>
r- CP
r-CP I),</w>
r- 5,6-
r-5,6- AD
r-5,6-AD T
r-5,6-ADT N</w>
r uria.</w>
r uria,</w>
r ural,</w>
r ummond,</w>
r te</w>
r t</w>
r t,</w>
r st</w>
r lid
rlid in
rlidin yl-4-pyrimidinyl)-1-piperazinyl]methy</w>
r its</w>
r ine/
rine/ aut
rine/aut oc
rine/autoc rine</w>
r ine-</w>
r indole,</w>
r inal</w>
r ical</w>
r ic,</w>
r hy
rhy no
rhyno pharynx</w>
r g/g</w>
r ce
rce ase,</w>
r bul
rbul izations.</w>
r benzoyl-4-chloro-N-methyl-N</w>
r b)</w>
r b
rb c/
rbc/ hpf.</w>
r algia</w>
r al-based</w>
r al,</w>
r ageen
rageen an</w>
r age</w>
r age,</w>
r action</w>
r ability</w>
r VII
rVII a,</w>
r MS
rMS SD,</w>
r IL-2,</w>
r IFN</w>
r CBF,</w>
r CBF)</w>
r CBF
rCBF (mca)</w>
r CB
rCB F/
rCBF/ rCMRglc</w>
r An
rAn dom
rAndom ized</w>
r AT
rAT G-induced</w>
r ANP)</w>
r AL
rAL R)</w>
r 1)</w>
r )-based</w>
r (S
r(S )=
r(S)= 0.92,</w>
quoti ents</w>
quoti ent,</w>
quit o</w>
quisqual ate.</w>
quisqual ate,</w>
quis it
quisit ely</w>
quipa zine:</w>
quipa zine.</w>
quipa zine)</w>
quinupri stin-dalfopristin</w>
quinuclid ine-3-carboxylic</w>
quinuclid ine),</w>
quinti les</w>
quinti le.</w>
quinpi role-mediated</w>
quinpi role),</w>
quinoxalin-1- one)</w>
quinoxalin ec
quinoxalinec arboxylic</w>
quinoxal ine),</w>
quinoxal in-6-
quinoxalin-6- ylcarbonyl)piperidine</w>
quinox alline</w>
quinolone- theophylline</w>
quinolone- derivative,</w>
quinolin-6- yl)-(4-methoxy-cyclohexyl)-methanone</w>
quinolin yl)</w>
quinolin ecarbox
quinolinecarbox amide
quinolinecarboxamide ,
quinolinecarboxamide, N-[
quinolinecarboxamide,N-[ trans-4-[2-(6-cyano-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]-cyclohexyl]-(9CI)]</w>
quinol yl)-2-[(2-methylpyrrolidin-1-yl)methyl]biphenyl-4-carboxamide</w>
quinol ones:</w>
quinol one-treated</w>
quinol one).</w>
quinol ine.</w>
quinol ine-2-
quinoline-2- (H)-
quinoline-2-(H)- one],</w>
quinol ine,</w>
quinol -treated</w>
quinine- TMA</w>
quinine- T
quinine-T MA)</w>
quinid ine:</w>
quinid ine).</w>
quinid ine),</w>
quin uclinyl</w>
quin op
quinop ristin-dalfopristin</w>
quin one.</w>
quin one-
quinone- imine</w>
quin ine/kg</w>
quin ine--an</w>
quin idine
quinidine like</w>
quin apri
quinapri l-treated</w>
quin ac
quinac rine.</w>
quin a,</w>
quil izers</w>
quick ,</w>
qui vering,</w>
qui rer</w>
qui rement</w>
qui escence</w>
qui es
quies cent.</w>
quetiap ine-treated</w>
quetiap ine-associated</w>
quetiap ine-</w>
quetiap ine),</w>
quetiap ine's</w>
questionnai re)</w>
questionnai re),</w>
question s;</w>
question ing.</w>
question ing,</w>
question ing),</w>
question aire</w>
ques )</w>
quaternary- chlorpromazine</w>
quaternary- chlorpromazine.</w>
quasi- regular</w>
quasi- randomized</w>
quarti le.</w>
quarti le
quartile -dependent</w>
quarter nary</w>
quantit y,</w>
quantit ative.</w>
quantit ative,</w>
quantit ation.</w>
quantit ates</w>
quantit ated.</w>
quantifi ers</w>
quantifi able</w>
quantifi able.</w>
quanti tively</w>
quanti fied,</w>
quanti f
quantif y.</w>
quality-of- life-
quality-of-life- adjusted</w>
qualit atively.</w>
qualit atively,</w>
qualit ative.</w>
qualit ative,</w>
qual izing</w>
qual ities,</w>
qual inium</w>
qual ifying</w>
qual ification.</w>
qual ific
qualific ations,</w>
qual ene</w>
quadripleg ia,</w>
quadric eps.</w>
quadri polar</w>
quadrap legic</w>
quadrap are
quadrapare sis,</w>
quadazoc ine;</w>
quadazoc ine,</w>
quad rupole</w>
quad ruple</w>
quad rantic</w>
qu oted</w>
qu ities</w>
qu it.</w>
qu ine-treated</w>
qu ine-
quine- artesunate</w>
qu ine
quine lor
quinelor ane</w>
qu indine</w>
qu im
quim od</w>
qu id</w>
qu ents</w>
qu ent</w>
qu ard's</w>
qu al</w>
qu ab
quab ain
quabain -induced</w>
q4 wks</w>
q4 wks).</w>
q4 w</w>
q3 w</w>
q12 h).</w>
q12 )].</w>
q/ mL</w>
q/ lt,</w>
q.d. s.</w>
q.d. s.,</w>
q. w.</w>
q. i.d
q.i.d .;</w>
q. d.)</w>
q. d
q.d .;</w>
q. 6h.</w>
q uric</w>
q udncy</w>
q ter.</w>
q ter,</w>
q rtPCR</w>
q rs</w>
q od.</w>
q id.</w>
q id,</w>
q 8
q8 h.</w>
q 24h)</w>
q 21
q21 )).</w>
q 12h</w>
q 11.
q11. 2).</w>
q +),</w>
q ),</w>
pyruv ate.</w>
pyruv ate-
pyruvate- malate,</w>
pyruv ate)</w>
pyrrolo- isoquinolines</w>
pyrrolo- [2,1-
pyrrolo-[2,1- c]
pyrrolo-[2,1-c] [1,4]
pyrrolo-[2,1-c][1,4] benzodiazep
pyrrolo-[2,1-c][1,4]benzodiazep ine-1-
pyrrolo-[2,1-c][1,4]benzodiazepine-1- carboxylate)</w>
pyrrolidinyl)methyl]-2- methyl-5-
pyrrolidinyl)methyl]-2-methyl-5- sulfamoyl-2,</w>
pyrrolidinyl)methyl]- 5-
pyrrolidinyl)methyl]-5- sulfamoylbenzamides</w>
pyrrolidinyl)methyl]- 2,6-di
pyrrolidinyl)methyl]-2,6-di methoxybenz</w>
pyrrolidinyl)methyl]- 2,3-dihydrobenzofuran-7-
pyrrolidinyl)methyl]-2,3-dihydrobenzofuran-7- carboxamide</w>
pyrrolidino ethoxy)-5-benzofuranyl]-N'-methylurea</w>
pyrrolidin yl)</w>
pyrrolidin one)</w>
pyrrolid ino</w>
pyrrolid ine-to-
pyrrolidine-to- metabolite</w>
pyro sis.</w>
pyro phosphoramide</w>
pyro glutam
pyroglutam yl-L-histidyl-L-prolinamide,</w>
pyro gens</w>
pyrimidinyl) -1-piperazinyl)
pyrimidinyl)-1-piperazinyl) but
pyrimidinyl)-1-piperazinyl)but yl)-1,2-benzisothiazol-3-</w>
pyrimidin-4- yl]amine</w>
pyrimidin-4- yl)</w>
pyrimid o
pyrimido [1,
pyrimido[1, 2-a]
pyrimido[1,2-a] benz
pyrimido[1,2-a]benz imidazol
pyrimido[1,2-a]benzimidazol e;</w>
pyrimid ines</w>
pyrimid ine]</w>
pyrimid ine-
pyrimidine- deoxy
pyrimidine-deoxy ribose</w>
pyrimid inase-
pyrimidinase- related</w>
pyrimid in-7-
pyrimidin-7- one</w>
pyrimeth amine-induced</w>
pyrimeth amine,</w>
pyrilam ine.</w>
pyrilam ine)</w>
pyridyl)- N-[
pyridyl)-N-[ N-(2,</w>
pyridyl)- 5,6,7,8-
pyridyl)-5,6,7,8- tetrahydro-3(2H)-isoquinolinone</w>
pyridyl) ethyl]-
pyridyl)ethyl]- 4-methyl
pyridyl)ethyl]-4-methyl sulfonylaminobenzoyl)-piperidine),</w>
pyridyl cyano
pyridylcyano guanidine</w>
pyridyl amino)
pyridylamino) phenyl]-
pyridylamino)phenyl]- 4,</w>
pyridyl (1)
pyridyl(1) )-
pyridyl(1))- butyl
pyridyl(1))-butyl (1)
pyridyl(1))-butyl(1) ]-
pyridyl(1))-butyl(1)]- indole</w>
pyridoxine- responsive,</w>
pyridoxine- 5'-phosphate</w>
pyridoxal- phosphate-
pyridoxal-phosphate- 6-
pyridoxal-phosphate-6- azo
pyridoxal-phosphate-6-azo phenyl-2
pyridoxal-phosphate-6-azophenyl-2 ',</w>
pyridoxal- phosphate,</w>
pyridoxal- 5'-phosphate</w>
pyridoxal- 5'-phosph
pyridoxal-5'-phosph ate:</w>
pyridox ine;</w>
pyridox ine/kg</w>
pyridox ine/
pyridoxine/ kg,</w>
pyridox ine-induced</w>
pyridox ine)</w>
pyridox amine-
pyridoxamine- 5'-phosphate</w>
pyridos tigmine-induced</w>
pyridos tigmine,</w>
pyrido[2,1-b] oxaz
pyrido[2,1-b]oxaz ines</w>
pyrido -
pyrido- (3,4-
pyrido-(3,4- b)-
pyrido-(3,4-b)- indol-3-
pyrido-(3,4-b)-indol-3- carboxylate)</w>
pyridine- lesioned</w>
pyridine- 4-
pyridine-4- carboxylate</w>
pyridin yl-cyclohexanecarboxamide</w>
pyridin oline</w>
pyridin oline,</w>
pyridin ol
pyridinol ine),</w>
pyridin es,</w>
pyridaz ine],</w>
pyrida zine</w>
pyrid ylmethylaminomethyl]-chromane</w>
pyrid yl]-acetamido)-3-([(5-methyl-1,3,4-thiadiazol-2-yl)-thio]methyl)-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic</w>
pyrid yl)-piperazine)</w>
pyrid ine),</w>
pyrid ine
pyridine dicarboxylate,</w>
pyrid in-4-
pyridin-4- ylmethyl)benzamide)</w>
pyrid in-2-
pyridin-2- ylmethyl)-amino]-methyl]-piperidin-1-yl-methanone</w>
pyre tics</w>
pyrazolo[4,3-e]-1,2,4- triazolo[1,5-c]pyrimidines.</w>
pyrazolo[4,3-e]-1,2,4- triazolo[1,5-c]pyrimidine</w>
pyrazolo[1,5-d] [1,2,4]</w>
pyrazolo[1,5-d] [1,2,4]-
pyrazolo[1,5-d][1,2,4]- triazine</w>
pyrazolo[1,5- a]-
pyrazolo[1,5-a]- [1,
pyrazolo[1,5-a]-[1, 3,5]
pyrazolo[1,5-a]-[1,3,5] triazin-4-yl]-3-ethylaminoazetidine-3-carboxylic</w>
pyrazolo- 3,4-
pyrazolo-3,4- g-
pyrazolo-3,4-g- quinoline</w>
pyrazolo triazine</w>
pyrazol ones</w>
pyrazol ones,</w>
pyrazol one</w>
pyrazol -1-
pyrazol-1- ium
pyrazol-1-ium -1-
pyrazol-1-ium-1- yl]methyl]-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetylamino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate</w>
pyrazinobut az
pyrazinobutaz one.</w>
pyrazin amide-induced</w>
pyrazin amide-associated</w>
pyraz ine-2-
pyrazine-2- thiol</w>
pyran oc
pyranoc arboxylic</w>
pyramid al-
pyramidal- shaped</w>
pyramid al)</w>
pyr rlidinyl-4-pyrimidinyl)-1-piperazinyl]methy</w>
pyr an</w>
pyloromy otomy.</w>
pylori :</w>
pylori )</w>
pylor us</w>
pylor us-ligated</w>
pylor us,</w>
pylor ic,</w>
pylo car
pylocar pine</w>
pyl axis.</w>
pye lographic</w>
pye logram
pyelogram .</w>
pye litis</w>
py rosis</w>
py ribenzamine</w>
py rene</w>
py ogenes,</w>
py ocin</w>
py ere
pyere xia</w>
px Period</w>
putresc ine,</w>
put ting</w>
put ative,</w>
put amin
putamin opallidal</w>
put -output</w>
pustulo sis</w>
pustulo sis.</w>
pustulo derma.</w>
pust ules</w>
pust ules,</w>
pust ulating</w>
push ing</w>
push ing,</w>
push ),</w>
pursu ing</w>
pursu ed.</w>
purpur as</w>
purpur a:</w>
purpur a-like</w>
purpose- built</w>
purpose- bred</w>
purpose less</w>
purpose fully</w>
purpose ful</w>
purpo sely</w>
purpo se:</w>
puromyc in-treated</w>
pure- bred</w>
pure '</w>
pure "</w>
purch ased</w>
purch ase.</w>
pur suit,</w>
pur pl
purpl ish</w>
pur ities,</w>
pur ious</w>
pur ines</w>
pur ine,</w>
pur ine),</w>
pur ina</w>
pur ification,</w>
pur ic</w>
pur gative</w>
pur ate</w>
pupil ."</w>
pup /d)</w>
pup /
pup/ mother</w>
pup .</w>
punder s.</w>
punder s"</w>
punder s".</w>
punct ures</w>
punct ures.</w>
punct ures,</w>
punct ured</w>
punct ated</w>
punct ate,</w>
punct at
punctat a).</w>
punct al-
punctal- canalicular</w>
punc tae</w>
punc ta</w>
pun ishment</w>
pun ish
punish able</w>
pun gent</w>
pun ched</w>
pump s).</w>
pump "
pump" ;</w>
pum ping</w>
pum p.
pump. "</w>
pum p).</w>
pulsel ess.</w>
pulsel ess,</w>
pulse- wave</w>
pulse- train</w>
pulse- rate</w>
pulse- mesor</w>
pulse :</w>
pulse --
pulse-- cost-effective</w>
pulse ),</w>
pulse ',</w>
puls ations.</w>
puls ation.</w>
puls ating</w>
pulmonary- to-systemic</w>
pulmonary- related</w>
pulmon ary
pulmonary -</w>
pulmon al</w>
pul sy</w>
pul ses;</w>
pul ses,</w>
pul sed-wave</w>
pul sating.</w>
pul ps</w>
pul ps.</w>
pul p.</w>
pul led</w>
puer ar
puerar in.</w>
pud ental</w>
public ized.</w>
public ised</w>
public ise</w>
public ations,</w>
public ation.</w>
publ ish</w>
publ ic.</w>
publ ic,</w>
puber tally.</w>
pub is</w>
pub is,</w>
ption/ event</w>
pter s.'</w>
ptaz ane)</w>
pt uses</w>
pt oxin</w>
pt othecin</w>
pt osi
ptosi s--after</w>
pt or</w>
pt o-
pto- Vari
pto-Vari mex</w>
pt azin
ptazin ol.</w>
pt ;</w>
pt .</w>
pt ,</w>
pt ),</w>
psychotri dine-induced</w>
psychostimul ant-
psychostimulant- KT</w>
psychosis- relevant</w>
psychosis- positive</w>
psychos om
psychosom atic</w>
psychophysi ologic</w>
psychophysi cally</w>
psychophysi cally.</w>
psychopharmac ology.</w>
psychopharmac ologically</w>
psychopharmac ologic
psychopharmacologic -induced</w>
psychomotor ically</w>
psychomotor "</w>
psychomot oric</w>
psychomot or,</w>
psycho- social</w>
psycho- organic</w>
psycho tic-induced</w>
psycho therapeutic-agent</w>
psycho sis?</w>
psycho sis-like</w>
psycho sis--Implications</w>
psycho ses).</w>
psycho pathologies</w>
psycho patholog
psychopatholog y--as</w>
psycho dynamic</w>
psychiatric ally,</w>
psychiatri st-rated</w>
psychiatr y.</w>
psych tic</w>
psych otrop
psychotrop ic-related</w>
psych oneuro
psychoneuro sis</w>
psych ometry</w>
psych ometry.</w>
psych ology</w>
psych ologist</w>
psych ologically</w>
psych ogen
psychogen ic.</w>
psych obiology</w>
psoriatic s:</w>
psoriatic s.</w>
psoriatic s-a</w>
psoriatic s,</w>
psor al
psoral en.</w>
psi locy
psilocy b
psilocyb in,</w>
psi -
psi- aminobutyric</w>
psi )</w>
psi ).</w>
pseudoxanth omatous</w>
pseudoxanth omatosis.</w>
pseudotum our</w>
pseudotum or
pseudotumor -like</w>
pseudop sychosis:</w>
pseudop odi
pseudopodi a,</w>
pseudop arkinson's</w>
pseudop arkin
pseudoparkin son</w>
pseudolymph oma</w>
pseudolymph oma;</w>
pseudolymph oma.</w>
pseudolith iasis:</w>
pseudoginsenoside-F 11</w>
pseudoginsenoside-F (11)</w>
pseudoephedr ine/
pseudoephedrine/ dextromethorphan</w>
pseudoephedr ine-related</w>
pseudoephedr ine-containing</w>
pseudocy st.</w>
pseudocy st,</w>
pseudoc ocaine-induced</w>
pseudoc atal
pseudocatal ep
pseudocatalep sy."</w>
pseudo- vitamin</w>
pseudo- splinter</w>
pseudo- parkinsonism:</w>
pseudo- ECG</w>
pseudo vitamin</w>
pseudo vasculitis</w>
pseudo stratified</w>
pseudo seizure</w>
pseudo seizure.</w>
pseudo hypoparathyroidism,</w>
pseudo hyponatraemia.</w>
pseudo her
pseudoher maph
pseudohermaph roditism.</w>
pseudo hallucinations</w>
pseudo ephedrine-
pseudoephedrine- -containing</w>
pseudo ephedrine,</w>
pseudo ductules</w>
pseudo dementia</w>
pseudo atrophy</w>
pseudo aneurysms.</w>
pseud otub
pseudotub erculosis</w>
pseud otetr
pseudotetr apeptide</w>
pseud otetanus</w>
pseud oscleroderma</w>
pseud opre
pseudopre gn
pseudopregn ant</w>
pseud oph
pseudoph ak
pseudophak ia</w>
pseud omy
pseudomy el
pseudomyel inic</w>
pseud ocon
pseudocon ditioned</w>
ps s</w>
ps hy
pshy co
pshyco tic</w>
ps 2</w>
prurit us:</w>
prurit us)</w>
pruri tic,</w>
pruri ens,</w>
prur ig
prurig inous</w>
prud ently</w>
prud ent.</w>
proxim ally.</w>
proxim ally,</w>
proxim al/
proximal/ somatic</w>
proxim al.</w>
proxim al-
proximal- tubular</w>
proxif an,</w>
prox yphene</w>
prox etil.</w>
provoc atus</w>
provoc ations</w>
provoc ation.</w>
provo ke
provoke /
provoke/ facilitate</w>
provin ce:</w>
provin ce
province wide</w>
provid er,</w>
provi sional</w>
provi rus.</w>
provi des,</w>
prov inc
provinc es.</w>
protrac tedly.</w>
protrac ted,</w>
protr usions.</w>
protr usion.</w>
protr usion,</w>
protr usion),</w>
protr uded</w>
prototyp ically</w>
prototyp ic"</w>
prototyp e,</w>
protoporphy ria</w>
proton- mediated</w>
proton- density</w>
proton- density-
proton-density- weighted</w>
protocol- driven</w>
protocol- directed</w>
protocol s;</w>
protocol s:</w>
protocol ised</w>
protocol :</w>
protocol ,"</w>
protocol ).</w>
protocol ),</w>
protoc o
protoco L</w>
proto- onco
proto-onco gene.</w>
proto zoal</w>
proto onco
protoonco genes.</w>
proteoglyc ans.</w>
proteoglyc ans)</w>
proteoglyc an,</w>
proteoglyc an)</w>
proteinur ia-induced</w>
proteinur a</w>
proteinase- 3-antineutrophil</w>
protein/ nmol</w>
protein/ ml.</w>
protein/ kanamycin</w>
protein/ day).</w>
protein/ HDL</w>
protein/ 24</w>
protein- synthetic</w>
protein- sugar</w>
protein- protein</w>
protein- labeled</w>
protein- glutathione</w>
protein- corrected</w>
protein- chimeric</w>
protein- bound,</w>
protein- 72</w>
protein- 43</w>
protein- 2,</w>
protein- (MO
protein-(MO P)</w>
protein s/regenerating</w>
protein s).</w>
protein ization</w>
protein ases</w>
protein ases,</w>
protein ].</w>
protein 's</w>
protective :</w>
protect ors.</w>
protect or,</w>
protect ed"</w>
protect ective</w>
protec tion?</w>
protec tion;</w>
protec tion:</w>
protec tion-defective</w>
protec tion--oral</w>
protease- inhibitor</w>
protease- 3</w>
proteas omal</w>
prote osynthesis</w>
prote osome</w>
prote olysis.</w>
prote inemia</w>
prote ine</w>
prote ase.</w>
prot otype
prototype ).</w>
prot ons.</w>
prot onic</w>
prot on/
proton/ phosphorus</w>
prot on-induced</w>
prot ectively</w>
prot ective/
protective/ behavioral</w>
prot an</w>
prot amine.</w>
prot amine).</w>
prot amin</w>
prot /min</w>
prot /
prot/ min.</w>
prosthe ses)</w>
prostatic us.</w>
prostatic -specific</w>
prostat ectomy.</w>
prostaglandin- independent</w>
prostaglandin- E2</w>
prostaglandin- E1)</w>
prostaglandin- E(2)</w>
prostaglandin- (PGE1)</w>
prostaglandin s;</w>
prostaglandin 1</w>
prostagland ines</w>
prostagland ine</w>
prostagland in.</w>
prostagland in-sensitive</w>
prostagland in,</w>
prostacyclin -like</w>
prostacyclin -
prostacyclin- mimetic</w>
prost one.</w>
prost atitis</w>
prost ate?</w>
prost ate;</w>
prost ate)</w>
prost ate).</w>
prost amides,</w>
prost agl
prostagl adin</w>
prost ;</w>
prost -related</w>
prost ).</w>
prospecti vely:</w>
prospecti ve.</w>
prosencephal on,</w>
pros tigmine</w>
propylthiourac il:</w>
propylthiourac il)</w>
propylthiourac il
propylthiouracil induced</w>
propylene glycol-
propyleneglycol- phenyl
propyleneglycol-phenyl carb
propyleneglycol-phenylcarb in
propyleneglycol-phenylcarbin ol-
propyleneglycol-phenylcarbinol- ethanol</w>
propyl]- pyrrolidin-2-one</w>
propyl]- N-
propyl]-N- phenyl-2-
propyl]-N-phenyl-2- indanamine,</w>
propyl]- 3,3-diphenylpyrrolidin-2-one</w>
propyl]- 2
propyl]-2 H-3-benzazep
propyl]-2H-3-benzazep in-2-
propyl]-2H-3-benzazepin-2- on</w>
propyl-1- yl)-3-(xanth-9-yl)</w>
propyl- xanthine)</w>
propyl- piperazin
propyl-piperazin o-
propyl-piperazino- l-
propyl-piperazino-l- yl-isoquinolino</w>
propyl- N-nitrosoure
propyl-N-nitrosoure a.</w>
propyl- N'-
propyl-N'- (3,4-dichloro
propyl-N'-(3,4-dichloro phenethyl
propyl-N'-(3,4-dichlorophenethyl )
propyl-N'-(3,4-dichlorophenethyl) piperaz
propyl-N'-(3,4-dichlorophenethyl)piperaz ine]</w>
propyl- 9-
propyl-9- hydroxy
propyl-9-hydroxy naphth
propyl-9-hydroxynaphth oxaz
propyl-9-hydroxynaphthoxaz ine)</w>
propyl- 7H-
propyl-7H- pyrazolo</w>
propyl- 5-
propyl-5- phosphono-3-
propyl-5-phosphono-3- pentenoic</w>
propyl- 3-
propyl-3- thia-5-+</w>
propyl)-2- thiobarbituric</w>
propyl)- glycine</w>
propyl)- carboxamidoadenosine</w>
propyl) amino)
propyl)amino) butyl</w>
propyl xanthine,</w>
propyl idene
propylidene -1,1-
propylidene-1,1- bisphosphonate</w>
propyl barbituric</w>
propyl azacycloalkan-2-one</w>
propyl aminotetralin</w>
propyl amino)tetralin</w>
propyl amino)-ethylphosphorothioic</w>
propyl amino)
propylamino) ethyl]-2-
propylamino)ethyl]-2- indol
propylamino)ethyl]-2-indol inone</w>
propyl ]</w>
propyl ]-</w>
propyl )</w>
propyl )-3-
propyl)-3- piperidine</w>
propul xanthine</w>
propul sion</w>
propri onitri
proprionitri le).</w>
propri eties</w>
propri a</w>
propri a,</w>
propranolol- poisoned</w>
propranolo l-related</w>
propran oyl-
propranoyl- l-
propranoyl-l- prol
propranoyl-l-prol ine)</w>
propran olamine</w>
propran ol.</w>
propoxy carbon
propoxycarbon yl)</w>
propoxy ]
propoxy] -1,3-
propoxy]-1,3- dihydro
propoxy]-1,3-dihydro -2
propoxy]-1,3-dihydro-2 H-benz
propoxy]-1,3-dihydro-2H-benz imidazole-
propoxy]-1,3-dihydro-2H-benzimidazole- 2-
propoxy]-1,3-dihydro-2H-benzimidazole-2- one</w>
propoxy )
propoxy) methyl
propoxy)methyl guan
propoxy)methylguan ine,</w>
propos als</w>
propor tions,</w>
propor tionally,</w>
propofol/ thiopentone.</w>
propofol/ opioid</w>
propofol/ lignocaine</w>
propofol/ fentanyl</w>
propofol-M CT/LC
propofol-MCT/LC T-
propofol-MCT/LCT- lidocaine</w>
propofol- sufentanil</w>
propofol- sedated</w>
propofol- remifentanil.</w>
propofol- remifentanil-TIVA</w>
propofol- lip
propofol-lip uro</w>
propofol- higher</w>
propofol- group</w>
propofol- LCT</w>
propofol+ saline,</w>
propofol+ remifentanil</w>
propofol+ remifentanil+lidocaine</w>
propofol+ lidocaine</w>
propofol induced</w>
propofol :
propofol: local</w>
propofol -treated</w>
propofol -mediated</w>
propofol -based</w>
propofol ,
propofol, (1)</w>
propofol 's</w>
propo sed;</w>
propionyl) forskolin</w>
propionyl) ]-</w>
propion yl]-N4-alkyl/aryl-thiosemicarbazides</w>
propion yl-o-Met-Tyr-Arg-vasopressin</w>
propion yl-carnitine</w>
propion yl-L-carnitine</w>
propion yl(1)-O-Me-Tyr2,Arg8]-vasopressin.</w>
propion ate-induced</w>
propi onitri
propionitri le:</w>
propi onit
propionit rile</w>
propi dium</w>
prophylaxis )</w>
prophylac tically.</w>
prophylac tic.</w>
prophylac tic,</w>
prophylac tic"</w>
prophyl ax
prophylax es:</w>
properti es.
properties. 7.</w>
properti es--
properties-- verapamil</w>
properti es)</w>
properti es).</w>
properti es),</w>
proper ty;</w>
proper ty)</w>
proper s</w>
proper s.</w>
proper d
properd in</w>
proper ,</w>
propentof ylline,</w>
propen ylbenzene)</w>
propen yl)</w>
proparac aine,</w>
proparac a
proparaca ine-treated</w>
propane- epinephrine-induced</w>
propane- diol</w>
propan theline</w>
propan theline,</w>
propan olol.</w>
propan ol,</w>
propan amides</w>
propag ates</w>
propag ates.</w>
propafen one;</w>
propafen one)</w>
propafen one's</w>
propacetam ol)</w>
prop-2- yn-1-ol</w>
prop ynyl)estra-4,9-dien-3-one],</w>
prop yloaminotetralin</w>
prop ia</w>
prop enyl</w>
prop ano
propano yl-3beta-(4-tolyl)-tropane</w>
prop anedi
propanedi ol</w>
prop ane)</w>
prop an-
propan- filled</w>
pronounce dly</w>
pronounce d.(ABSTRACT</w>
pronormo blasts</w>
pronormo blasts.</w>
proneth alol</w>
pron ocicept
pronocicept in,</w>
pron ocicep
pronocicep tion.</w>
pron iaz
proniaz id,</w>
pron e"</w>
pron ation</w>
promyelo cy
promyelocy tic).</w>
promul gates</w>
promul gate</w>
prompt ing)</w>
prompt .</w>
promoter -independent</w>
promot or.</w>
promot ed,</w>
promo tive</w>
promis cu
promiscu ous</w>
promin ent;</w>
promin ent:</w>
prom ized</w>
prom ide</w>
prolong ued</w>
prolong ed-
prolonged- duration</w>
prolong ed
prolonged .4.</w>
prolong ation;</w>
prolong ation)</w>
prolong ation),</w>
prolin amide</w>
prolifer ators,</w>
prolifer ator.</w>
prolifer ator,</w>
prolifer ations</w>
prolifer ation/
proliferation/ apoptosis</w>
prolifer ation)</w>
prolifer ating,</w>
proli de-
prolide- alone</w>
prolactin- sparing</w>
prolactin- normalizing</w>
prolactin omas:</w>
prolactin oma--a</w>
prolactin oma)</w>
prolactin ergic</w>
prolactin aemic</w>
prolactin aemia:</w>
prolactin ;</w>
prolact ogenic</w>
prolact inemia,</w>
prolact inemia)</w>
prolact in:</w>
prolact in-releasing</w>
prolact in-related</w>
prol ymphocytic</w>
prol yl-L-leucyl-glycinamide</w>
prol ine-rich</w>
prol apsed</w>
prol acti
prolacti me
prolactime mia</w>
prol .</w>
prol ,</w>
prokinetic in-1</w>
prokinetic in-
prokineticin- 2,</w>
prokine tic,</w>
projec tivity,</w>
projec tions,</w>
projec tion:</w>
projec tion,</w>
prohib its</w>
prohib it</w>
prohib it
prohibit in)</w>
proguan il.</w>
proguan il,</w>
progressive- diabetic</w>
progres siveness</w>
progres sion--increased</w>
progres sion).</w>
progres sed;</w>
progres s,</w>
programm es,</w>
program s).</w>
program mes
programmes '</w>
program med,</w>
program me
programme )</w>
program matic</w>
prognostic ator</w>
prognostic ating</w>
progno ses</w>
progno ses.</w>
proglum ide</w>
proglum ide.</w>
progestogen -dose</w>
progestin- implant</w>
progesterone- positive</w>
progesterone- derived</w>
progester ones</w>
progester one-treated</w>
progester one-like</w>
progestag ens</w>
progestag enic</w>
progestag en-
progestagen- only</w>
progest ogen.</w>
progest ins,</w>
progest in.</w>
progest in-treated</w>
progest in-induced</w>
progest ative</w>
progenit ors.</w>
progenit or/
progenitor/ mature</w>
progen y,</w>
prog essively</w>
profoun d
profound ly,</w>
profil es/
profiles/ sections)</w>
profil es)</w>
profil er</w>
profi le;</w>
profi le:</w>
profi le"</w>
profession als,</w>
profes sion</w>
profes sion,</w>
profen :</w>
profen -related</w>
profen -associated</w>
prof ylline.</w>
prof use,</w>
prof itable</w>
produc ts:</w>
produc ts).</w>
produc ts),</w>
produc tions</w>
produc tion:</w>
produc tion),</w>
produc tin</w>
produc t-moment</w>
produc t)</w>
produc t(s)</w>
produc t's</w>
produc es.</w>
produc es,</w>
produc ed;</w>
produc ed-
produced- identical</w>
produc e--
produce-- apart</w>
procycl indine</w>
procycl idine.</w>
prochlorper az
prochlorperaz ine:</w>
process ing)</w>
process ;</w>
process -specific</w>
proces ses)</w>
proces sed,</w>
proceed ings</w>
proceed ings,</w>
procedure .(ABSTRACT</w>
procedur al-
procedural- learning</w>
proced ures:</w>
proced ures--before</w>
proced ures).</w>
proced ures),</w>
proced ure;</w>
proce ed.</w>
procarb azine.</w>
procainamide ;</w>
procainamide :</w>
procainamide -treated</w>
procainamide -,</w>
procain amide-
procainamide- induced,</w>
proca ine.
procaine. 2.</w>
proca ine-
procaine- induced,</w>
proca ine).</w>
probuc ol-associated</w>
probuc ol-
probucol- fed</w>
problematic "</w>
proble ms;</w>
proble m:</w>
proble m/
problem/ pathological</w>
proble m
problem .(ABSTRACT</w>
probenec id,</w>
probe -derived</w>
probe ).</w>
probable ])</w>
probable ;
probable; "</w>
probable ),</w>
prob it
probit -log</w>
prob io
probio tic</w>
prob and,</w>
prob and
proband s,</w>
prob ably,</w>
prob able;</w>
prob abil
probabil istic</w>
proarrhythmic ity</w>
proarrhythmic ity.</w>
proanthocyanid in.</w>
proanthocyanid in-
proanthocyanidin- rich</w>
pro- urokinase</w>
pro- thyrotropin</w>
pro- rhythmogenic</w>
pro- regenerative</w>
pro- p
pro-p yl]benzoyl]-1-benzofuran-5-carboxylate</w>
pro- opiomelan
pro-opiomelan cortin</w>
pro- lact
pro-lact inemic</w>
pro- irritating</w>
pro- fibrotic</w>
pro- erythroblast</w>
pro- epileptic</w>
pro- dysrhyth
pro-dysrhyth mic,</w>
pro- coagulant</w>
pro- calcemic</w>
pro- atrial</w>
pro- angiogenesis</w>
pro- ANP)</w>
pro zosin</w>
pro xies.</w>
pro ven.</w>
pro ved.</w>
pro ve.</w>
pro uting</w>
pro triptyline.</w>
pro triptyline,</w>
pro triptylin</w>
pro tractive</w>
pro time,</w>
pro tic</w>
pro thesis</w>
pro tenuria,</w>
pro syn,</w>
pro stration</w>
pro stration,</w>
pro states,</w>
pro spect</w>
pro spect.</w>
pro sexual</w>
pro serotonergic</w>
pro scribed</w>
pro scribe</w>
pro renin</w>
pro renin,</w>
pro relin</w>
pro position.</w>
pro posit
proposit us</w>
pro p</w>
pro opiomelanocortin</w>
pro of
proof ed</w>
pro my
promy le
promyle lo
promylelo cytic</w>
pro motor</w>
pro motility</w>
pro meta
prometa zine</w>
pro lol.</w>
pro logical</w>
pro lo
prolo l;</w>
pro lithogenic</w>
pro kynetic</w>
pro inflammat
proinflammat ory"</w>
pro id</w>
pro ic-acid-induced</w>
pro hypotensive</w>
pro hypertrophic</w>
pro h
proh pylaxis.</w>
pro for
profor ma.</w>
pro fit</w>
pro fibrogenic</w>
pro estrus/estrus</w>
pro estrous</w>
pro est
proest rus.</w>
pro epileptogenic</w>
pro enzyme.</w>
pro drugs:</w>
pro drug.</w>
pro drug).</w>
pro dine</w>
pro constrictor</w>
pro con
procon valsant</w>
pro collagens</w>
pro coagul
procoagul ant,</w>
pro caspase-3</w>
pro atherogenic</w>
pro arrhythmia:</w>
pro arrhythm
proarrhythm ia?</w>
pro ar
proar rhthmia</w>
pro angiogenic</w>
pro algesic</w>
pro UK)</w>
pro L
proL actin
proLactin aemia</w>
privan ;</w>
pris on.</w>
pris on
prison ment.</w>
pris ms),</w>
prior itizing</w>
prior ities.</w>
prior ),</w>
princip le,</w>
princip ally,</w>
princip al-
principal- component</w>
princi ples.</w>
princi ples,</w>
princi pl
principl es:</w>
prin ted</w>
prin t.</w>
primor dium</w>
primor dial</w>
primor dia</w>
primor di
primordi um.</w>
primipar as</w>
primipar as,</w>
priming :</w>
priming -induced</w>
priming "</w>
primin g/
priming/ challenge</w>
primin g).</w>
primigra vid</w>
primid one:</w>
primid one/
primidone/ phenobarbital</w>
primid one-related</w>
primid one)</w>
primid one),</w>
primid olol</w>
primi parous</w>
primi para</w>
primat e.</w>
primat e,</w>
prima quine-induced</w>
prim rose</w>
prim es</w>
prim es.</w>
prim ary-prevention</w>
prim ary-
primary- care</w>
prim ary
primary '</w>
prim arily,</w>
prim ).</w>
priloca ine;</w>
priloca ine+
prilocaine+ lidocaine</w>
priloca ine)</w>
pric king</w>
pric e'</w>
priap ism:</w>
priap ism-
priapism- induc
priapism-induc ing/
priapism-inducing/ predisposing</w>
pri vileges</w>
pri stinamycin</w>
pri ority</w>
pri ori
priori ,</w>
pri mers.</w>
pri med,</w>
pri me.</w>
pri fus
prifus or</w>
pri de,</w>
previously- used</w>
previously- untreated</w>
previously- unpublished</w>
previously- healthy</w>
previous ly)</w>
previ ation</w>
prevent ed;</w>
prevent ability</w>
prevent ability.</w>
preval ence:</w>
preval ence)</w>
prevail ed</w>
prev ail</w>
presyncop al,</w>
presynap tically,</w>
presum ption</w>
presum ably,</w>
presum ab
presumab ly)</w>
pressure/ volume</w>
pressure/ tightness</w>
pressure/ flow</w>
pressure- overload</w>
pressure- mediated.</w>
pressure- length</w>
pressure- flow</w>
pressure- dimension</w>
pressure- dependent.</w>
pressure- catheter.</w>
pressure ])</w>
pressure <25</w>
pressure -like</w>
pressure -induced</w>
pressure --
pressure-- only</w>
pressure )/
pressure)/ dt</w>
pressure ).</w>
pressu red</w>
press urised</w>
press or-induced</w>
press or,</w>
press or
pressor '</w>
press ing.</w>
press in.</w>
press ants</w>
press ant</w>
press ant.</w>
press ;</w>
preserv ative,</w>
preserv ability,</w>
present ed;</w>
present ations:</w>
present ation--a</w>
present ation
presentation .A</w>
present )</w>
present );</w>
present ),</w>
prescription ]</w>
prescrib ers.</w>
prescrib er.</w>
prescri bed;</w>
preschool- halothane,</w>
presc reening</w>
presc hedul
preschedul ed</w>
pres ystemic</w>
pres urgery</w>
pres umed.</w>
pres timulatory</w>
pres tige,</w>
pres sive/defensive</w>
pres sion-</w>
pres sion,</w>
pres sibility</w>
pres ses,</w>
pres ensi
presensi tized</w>
pres ence/
presence/ type</w>
pres cut
prescut ation</w>
pres b
presb ycusis.</w>
pres acral</w>
prepro parathyroid</w>
prepro endothelin-1</w>
preponder ance,</w>
prepar ing</w>
prepar atory</w>
prepar ations;</w>
prepar ations)</w>
prepar ations).</w>
prepar ations),</w>
prepar ation;</w>
prepar ation:</w>
prepar ation),</w>
prepa res</w>
prepa red,</w>
preoperativel y;</w>
preoperativel y)</w>
prenyl amine:</w>
prenat ally:</w>
prenalter ol.</w>
pren ylation</w>
pren ylated</w>
pren ylamine</w>
pren uptial</w>
pren olo
prenolo l;</w>
premedic ation;</w>
premedic ation:</w>
premedic ants.</w>
premedic ant
premedicant :</w>
premature ly,</w>
prematur ity-related</w>
premat ure.</w>
prelimin ary;</w>
prelimin ary,</w>
pregnane- 21-
pregnane-21- di
pregnane-21-di ol-20-
pregnane-21-diol-20- ones)</w>
pregnane- 20-
pregnane-20- ones)</w>
pregnancy /
pregnancy/ surgery</w>
pregnancy -specific</w>
pregnanc ies;</w>
pregna -1,
pregna-1, 4,
pregna-1,4, 9</w>
pregn en
pregnen olone</w>
pregn ant"</w>
pregn ane</w>
pregn alone.</w>
pregn acy</w>
pregn ac
pregnac y.</w>
pregn -4-
pregn-4- ene-3,20-dione</w>
pregab al
pregabal in:</w>
preferen ce;</w>
preferen ce).</w>
preferen ce
preference ),</w>
prefer red,</w>
prefer red"</w>
prefer able.</w>
prefer able,</w>
prefer able)</w>
preexist ing)</w>
preem pt</w>
preem p
preemp tively,</w>
preem ies</w>
preeclamp sia-induced</w>
predomin ating</w>
predomin ated,</w>
predomin ate,</w>
predomin antly,</w>
predomin ant)</w>
predomin ance;</w>
prednisol one;</w>
prednisol one-
prednisolone- administered</w>
prednis one:</w>
prednis one).</w>
prednicarb ate</w>
prednicarb ate.</w>
predisp osin
predisposin g/
predisposing/ precipitating</w>
predis positions</w>
predis po
predispo sed,</w>
predict or.</w>
predict ably,</w>
predict ability,</w>
predic tiveness</w>
predic tive;</w>
predic tions.</w>
predic tion,</w>
predic ted)</w>
predic ted),</w>
predic t.</w>
predic ated</w>
predecess or</w>
predecess or.</w>
predat ory</w>
predat or</w>
precur sive</w>
precor dium</w>
precoc ity</w>
precipit ous,</w>
precipit ations,</w>
precipit ation.</w>
precipit ation,</w>
precipit ates,</w>
precipit ately.</w>
precipit ated.</w>
precipit ate,</w>
precipit ants</w>
preci sions</w>
prece eded</w>
prece ded,</w>
pre- verapamil</w>
pre- value.</w>
pre- treatment;</w>
pre- treating</w>
pre- treated)</w>
pre- travel</w>
pre- transplant.</w>
pre- transfusion</w>
pre- test.</w>
pre- tectal</w>
pre- surgery</w>
pre- supplementary</w>
pre- study</w>
pre- stress</w>
pre- set</w>
pre- seizure</w>
pre- school</w>
pre- randomization</w>
pre- pulse</w>
pre- pulse.</w>
pre- psychotic</w>
pre- procedural</w>
pre- post</w>
pre- planned</w>
pre- pain</w>
pre- optic</w>
pre- operatively.</w>
pre- natal</w>
pre- nat
pre-nat ally.</w>
pre- methamphetamine</w>
pre- medication.</w>
pre- mRNAs</w>
pre- lithium</w>
pre- junctional</w>
pre- ischemic</w>
pre- ischemia</w>
pre- ischaemic</w>
pre- intubation</w>
pre- injection</w>
pre- indomethacin</w>
pre- hypotension</w>
pre- hospital</w>
pre- formed</w>
pre- failure</w>
pre- exist
pre-exist ing,</w>
pre- enrollment</w>
pre- endopiriform</w>
pre- enalapril</w>
pre- eclampsia</w>
pre- eclampsia,</w>
pre- dated</w>
pre- curarization</w>
pre- curar
pre-curar izing</w>
pre- cue</w>
pre- convulsive</w>
pre- cocaine</w>
pre- clonidine</w>
pre- clamp</w>
pre- cigarette</w>
pre- cell</w>
pre- castrated</w>
pre- capsaicin</w>
pre- baseline</w>
pre- atropine</w>
pre- arranged</w>
pre- anthracycline</w>
pre- anesthetic</w>
pre- an
pre-an es
pre-anes thestic</w>
pre- SE</w>
pre- PTCA</w>
pre- PCB</w>
pre- LT</w>
pre- LT
pre-LT x</w>
pre- IVU.</w>
pre- IS</w>
pre- I).</w>
pre- HBIG</w>
pre- FK506</w>
pre- ECT</w>
pre- B-cell</w>
pre- B
pre-B MT-
pre-BMT- LVEF</w>
pre- ADR,</w>
pre ventive"</w>
pre tty</w>
pre tretment</w>
pre treatment:</w>
pre treatment).</w>
pre treat</w>
pre transplant,</w>
pre tibial</w>
pre thrombolytic</w>
pre therapeutic</w>
pre tested</w>
pre test,</w>
pre terminal</w>
pre term-infant</w>
pre study</w>
pre strous-females</w>
pre stroke</w>
pre stressor,</w>
pre session</w>
pre selected</w>
pre rogative</w>
pre requisites</w>
pre pyriform</w>
pre pyloric,</w>
pre pump</w>
pre pulsed</w>
pre pubertally.</w>
pre pronociceptin,</w>
pre programmed,</w>
pre procedure</w>
pre procedural</w>
pre pro-thyrotropin</w>
pre pregnant</w>
pre potent</w>
pre piriform,</w>
pre physostigmine</w>
pre period.</w>
pre oxygenation</w>
pre oxidase</w>
pre nephrotic</w>
pre neoplasms</w>
pre neoplasia.</w>
pre ne
prene ;</w>
pre mortem</w>
pre morphine</w>
pre mixture</w>
pre mixing</w>
pre mi
premi ses.</w>
pre menopausal,</w>
pre medications</w>
pre medications.</w>
pre medications,</w>
pre maxillary</w>
pre malignant,</w>
pre loads</w>
pre limbic</w>
pre leukemia.</w>
pre lesion</w>
pre junc
prejunc tionally,</w>
pre insertion</w>
pre injected</w>
pre infusion,</w>
pre inflation,</w>
pre infiltration</w>
pre infarction,</w>
pre incubation,</w>
pre incub
preincub ate</w>
pre implantation</w>
pre hypotensive</w>
pre hospitalization</w>
pre hepatic</w>
pre hemodialysis</w>
pre gangrenous</w>
pre ganglion
preganglion ic,</w>
pre fronto-
prefronto- striatal</w>
pre frontal-
prefrontal- orbitofrontal</w>
pre fil
prefil led,</w>
pre exposed</w>
pre existence</w>
pre existed</w>
pre ex
preex is
preexis iting</w>
pre established</w>
pre empt
preempt ing</w>
pre dosing</w>
pre don
predon isolone</w>
pre dobutamine</w>
pre dialytic</w>
pre di
predi posed</w>
pre determine</w>
pre designed</w>
pre delivery</w>
pre dates</w>
pre date</w>
pre cranial,</w>
pre cortisol</w>
pre convulsive</w>
pre conversion</w>
pre contractions</w>
pre contraction,</w>
pre contracting</w>
pre contraceptive</w>
pre condition</w>
pre conception</w>
pre conce
preconce ived</w>
pre coma</w>
pre clozapine</w>
pre clonidine</w>
pre clip</w>
pre clinically,</w>
pre clinical,</w>
pre cis
precis ly.</w>
pre chemotherapy.</w>
pre chemotherapy,</w>
pre cent</w>
pre axial</w>
pre auricular</w>
pre ared</w>
pre anesthesia</w>
pre anaesthetic</w>
pre al
preal ence</w>
pre adolescence.</w>
pre -induced</w>
pre -dose</w>
prazosin- pretreated</w>
prazosin- -
prazosin-- effects</w>
prazos in-related</w>
prazos in-induced</w>
praz ep
prazep am,</w>
prasu grel,</w>
pran olol,</w>
pramipex ole:</w>
prag ue</w>
prag matic</w>
practic ality</w>
practi sed.</w>
practi se.</w>
practi ce;</w>
practi ce
practice -dependent</w>
pra vastatin-treated</w>
pra vastatin-associated</w>
pra vastatin)</w>
pra ost
praost agland
praostagland in</w>
pr y</w>
pr ulactin,</w>
pr int
print out</w>
pr in</w>
pr amine;</w>
pr amine-associated</w>
pr am,</w>
pr actic</w>
pr V)</w>
pr CO2</w>
pr BCM</w>
pp(NH) p]</w>
pp(NH) p)</w>
pp m).</w>
pp ing,</w>
power ).</w>
power ),</w>
powe red</w>
powe red,</w>
pow ers,</w>
pow ders,</w>
pow der-
powder- in-
powder-in- liquid</w>
pow der)</w>
pover ty</w>
pover ty.</w>
potenti zed</w>
potenti ator</w>
potenti ative</w>
potenti ation?</w>
potenti ation).</w>
potenti ated;</w>
potenti ally,</w>
potenti ality</w>
potenti al:</w>
potenti al-
potential- dependent,</w>
potenti al).</w>
potenti al"</w>
potenti al
potential s")</w>
potency /
potency/ neurotoxicity</w>
potency .4.</w>
poten tion</w>
poten sion.</w>
potassium- wasting</w>
potassium- supplemented</w>
potassium- sparing"</w>
potassium- magnesium</w>
potassium- lowering</w>
potassium- disopyramide</w>
potassium- depleting</w>
potassium- deficient</w>
potassium- controlled</w>
potassium- channel</w>
potassium- activated</w>
potassium- ,</w>
potassi um:</w>
potassi um-related</w>
potassi um-induced</w>
potassi um).</w>
pot ent
potent /
potent/ bi
potent/bi potent</w>
postur ing)</w>
postul ating</w>
postsynap tical</w>
postsynap tic)</w>
postsynap tic"</w>
postrema ,</w>
postrans plant.</w>
postpon es,</w>
postpon ed.</w>
postpartum ;</w>
postnat ally;</w>
postnat ally,</w>
postisoproteren ol.</w>
postischem ia).</w>
postic tally,</w>
postic hem
postichem ia,</w>
posthy potension.</w>
posthy dr
posthydr ation</w>
posth ospit
posthospit al</w>
posth ep
posthep at
posthepat ectomy</w>
posth aem
posthaem orrhage</w>
postero septal</w>
postero inferior</w>
posteri or-
posterior- wall</w>
posteri or).</w>
posteri or
posterior ly.</w>
posteri olateral</w>
postcoit um</w>
postcoit um).</w>
post/ pre</w>
post/ perimenopausal</w>
post-nat ally,</w>
post- withdrawal.</w>
post- weaning.</w>
post- void</w>
post- vaccination</w>
post- tranylcypromine</w>
post- transplant,</w>
post- transfusion.</w>
post- transcriptional</w>
post- training.</w>
post- tissue-injury</w>
post- timolol.</w>
post- thoracotomy</w>
post- test</w>
post- sympathectomy</w>
post- surgery.</w>
post- study</w>
post- stimulant</w>
post- spike</w>
post- signal</w>
post- self-report</w>
post- seizure</w>
post- seizure,</w>
post- rifampicin</w>
post- resuscitative</w>
post- resuscitation</w>
post- response</w>
post- receptorial</w>
post- radical</w>
post- pubertal</w>
post- procedure</w>
post- placebo</w>
post- placebo,</w>
post- partum.</w>
post- paracervical</w>
post- pallidotomy</w>
post- paclitaxel</w>
post- organ</w>
post- operatively</w>
post- operatively,</w>
post- operative,</w>
post- obstruction</w>
post- myocardial</w>
post- microsomal</w>
post- methamphetamine</w>
post- mAMPH,</w>
post- lesional</w>
post- labeling</w>
post- ketamine</w>
post- junctional</w>
post- isoproterenol.</w>
post- ischemia</w>
post- intubation</w>
post- injury,</w>
post- injection).</w>
post- initiation</w>
post- initiation,</w>
post- inhalation.</w>
post- induction</w>
post- induction.</w>
post- index</w>
post- incident,</w>
post- immunization</w>
post- hysterectomy</w>
post- hypotensive</w>
post- hypotension</w>
post- hepatectomy.</w>
post- heart</w>
post- grafting.</w>
post- gentamicin</w>
post- frontal</w>
post- follow-up)</w>
post- fertiliz
post-fertiliz ation;</w>
post- fenoldop
post-fenoldop am-
post-fenoldopam- infusion</w>
post- exposure.</w>
post- exposure)</w>
post- exams</w>
post- ethacrynic</w>
post- epirubicin</w>
post- epileptic</w>
post- embedment</w>
post- drug.</w>
post- dose,</w>
post- dipyridamole</w>
post- dialysis</w>
post- diabetes</w>
post- diabetes.</w>
post- detoxification,</w>
post- delivery.</w>
post- debulking</w>
post- dated</w>
post- coronary</w>
post- column</w>
post- colo
post-colo stomy</w>
post- cigarette</w>
post- cigarette,</w>
post- cigarette
post-cigarette ;</w>
post- challenge.</w>
post- cesarean</w>
post- central</w>
post- cell</w>
post- catheterization,</w>
post- castration,</w>
post- cardiopulmonary</w>
post- capsaicin</w>
post- calcium</w>
post- arrival</w>
post- arrival.</w>
post- anesthesia</w>
post- anaesthetic</w>
post- anaesthesia</w>
post- adolescent</w>
post- administration</w>
post- TURP</w>
post- TPV/r</w>
post- ST
post-ST EP.</w>
post- SMT</w>
post- SE
post-SE ]</w>
post- SCr</w>
post- RCM</w>
post- PZ</w>
post- PTCA</w>
post- PCI</w>
post- PCC</w>
post- PAN</w>
post- OLTX</w>
post- OLT</w>
post- NTG.</w>
post- MTX.</w>
post- MI)</w>
post- LT).</w>
post- IVRA</w>
post- ICU</w>
post- ICH</w>
post- I;</w>
post- HDP</w>
post- ED</w>
post- DROP</w>
post- DFP</w>
post- CPE-C</w>
post- CMF/
post-CMF/ Adriamycin</w>
post- BMT.</w>
post- Adriamycin----CMF</w>
post- AZT</w>
post- AZT;</w>
post zosteric</w>
post void</w>
post vigabatrin,</w>
post verapamil</w>
post urography.</w>
post ures),</w>
post ure),</w>
post trocar</w>
post treatment),</w>
post treated</w>
post transplant,</w>
post transplant),</w>
post transcriptional</w>
post thoracotomy</w>
post tetanic</w>
post tachycardiac</w>
post surgically,</w>
post surgery.</w>
post stress.</w>
post streptococcal</w>
post stimulatory</w>
post stimulation</w>
post spinal</w>
post sensitization.</w>
post rongylus</w>
post riluzole</w>
post receptor</w>
post reaction</w>
post ransplant</w>
post propranolol</w>
post pneumonectomy</w>
post pituitary</w>
post pilocarpine.</w>
post pilocarpine,</w>
post par
postpar tem.</w>
post overdose.</w>
post overdose,</w>
post operativel
postoperativel y)</w>
post obstructive</w>
post mortem.</w>
post morphine.</w>
post micturition</w>
post menopause.</w>
post menopa
postmenopa usal.</w>
post marketing,</w>
post macula</w>
post lesion.</w>
post lesion,</w>
post laparoscopic</w>
post laminectomy</w>
post ketamine.</w>
post junc
postjunc tionally</w>
post intubation</w>
post intubation,</w>
post inspiration,</w>
post insertion</w>
post injection,</w>
post injection).</w>
post ingestion</w>
post inges
postinges tion),</w>
post infusion.</w>
post infusion,</w>
post infarction.</w>
post infarction,</w>
post infarcted</w>
post infarct</w>
post induction.</w>
post induction,</w>
post graduate</w>
post gadolinium</w>
post flight</w>
post fentanyl</w>
post extubation.</w>
post experiment</w>
post er</w>
post epidural</w>
post enhancement,</w>
post endovascular</w>
post drug.</w>
post drug,</w>
post dosing,</w>
post dose,</w>
post discharge.</w>
post deflation</w>
post debulking</w>
post deafening,</w>
post craniotomy</w>
post conversion.</w>
post contrast</w>
post contrast,</w>
post condition)</w>
post conceptual</w>
post concep
postconcep tional</w>
post column</w>
post climacteric</w>
post cardiac</w>
post capsaicin.</w>
post bypass</w>
post axial</w>
post assi
postassi um</w>
post arrest</w>
post arrest.</w>
post angiographic</w>
post amiodarone</w>
post allogeneic</w>
post admission</w>
post admission,</w>
post administration</w>
post acute</w>
post absorptive</w>
post abortion</w>
post -dose</w>
post ,</w>
post ),</w>
possible .
possible. Genetic</w>
possible ),</w>
possibil ities,</w>
possib ly
possibly /
possibly/ probably</w>
possib lity</w>
possib le:</w>
possib le/
possible/ clinical.</w>
possib le-
possible- decrease</w>
possib le)</w>
possib l
possibl ility</w>
posses sions),</w>
posses sion</w>
positive/ negative</w>
positive/ HBe</w>
positive- negative</w>
positive- feedback</w>
positive- controlled</w>
positive .(ABSTRACT</w>
positive --
positive-- negative</w>
positive ).</w>
positive ),</w>
position -dependent</w>
posit es</w>
posit ely</w>
posit e,</w>
posi tivization"</w>
posi tivity;</w>
posi tivity.</w>
posi tives</w>
posi tions;</w>
posi tion:</w>
posac onazole.</w>
posac onazole,</w>
pos tischemic,</w>
pos tirradiational</w>
pos thoc</w>
pos therpetic</w>
pos padi
pospadi as,</w>
pos ologies</w>
pos ologies,</w>
pos olog
posolog ies.</w>
pos ity</w>
pos al</w>
pos Ter
posTer 119
posTer119 po
posTer119po s</w>
port asyst
portasyst emic</w>
port al/
portal/ midzonal</w>
port al-
portal- central</w>
port -deficient</w>
porphyrin ogenic</w>
porphy rogenic</w>
porphy rin,</w>
porphy ric</w>
porphy ria:</w>
por us</w>
por um</w>
por to-portal</w>
por tions)</w>
por tion,</w>
por tio</w>
por tending</w>
por tend</w>
por tacaval</w>
por phob
porphob il
porphobil inogen</w>
por ph
porph in
porphin ato</w>
por o</w>
por minent</w>
por c
porc ine)</w>
population- level</w>
popular ized</w>
popular ity,</w>
popular .</w>
popul ations;</w>
popul ations).</w>
popul ation;</w>
popul ation--
population-- frequency</w>
popul ation"</w>
popul ated</w>
popul at</w>
poplit e
poplite al,</w>
pop ulous</w>
pop per</w>
pop per,</w>
pop edal</w>
pop T
popT ag
popTag ,</w>
poor ly;</w>
poor ly-
poorly- differentiated</w>
poor )</w>
poor '</w>
pool ed.</w>
pont ine/
pontine/ medullary</w>
pons- medulla</w>
pons- medulla,</w>
pon se</w>
pon s.</w>
polyur ic,</w>
polyur ia:</w>
polyur ia).</w>
polysomno graphy,</w>
polysacchar ides,</w>
polysacchar ide,</w>
polysacchar ide)</w>
polyradicul oneuropathy.</w>
polyradicul itis.</w>
polypo id</w>
polyplo idi
polyploidi zing</w>
polyplo id
polyploid y;</w>
polyphen ols.</w>
polyphen ols,</w>
polypeptide s)</w>
polypepti de:</w>
polypepti de.</w>
polypepti de-
polypeptide- 4-
polypeptide-4- influencing</w>
polyp loid</w>
polyp ectomy.</w>
polyp -like</w>
polymyosi tis/dermatomyositis.</w>
polymyosi tis-dermatomyositis.</w>
polymorph onucle
polymorphonucle ar
polymorphonuclear -cell</w>
polymorph ism
polymorphism s:</w>
polymer izable</w>
polymer ation</w>
polymer ase,</w>
polym xin</w>
polygodi al.</w>
polygalasap onins</w>
polydyp sia</w>
polydip sia;</w>
polydip sia/polyuria,</w>
polydip sia-avoidance</w>
polycyst um.</w>
polycyst um)</w>
polycy themia:</w>
polycy themia,</w>
polycy stosis.</w>
polyc hemotherapy.</w>
polyc ation
polycation ic</w>
polyc apillary</w>
poly-L- lysine.</w>
poly- ubiquitin</w>
poly- therapeutic</w>
poly(ADP-ribose) synthase</w>
poly(ADP-ribose) polymerase</w>
poly uric.</w>
poly ubiquitin-positive</w>
poly tic</w>
poly thiazide</w>
poly tetrafluoroethylene</w>
poly sulfate,</w>
poly spiking</w>
poly spikes</w>
poly spikes,</w>
poly somes</w>
poly sialylation</w>
poly sialylation,</w>
poly sialic</w>
poly radiculopathy</w>
poly posis,</w>
poly phenol</w>
poly phagia,</w>
poly ol</w>
poly nuclear</w>
poly nom
polynom ial</w>
poly neuropathy)</w>
poly neuropathy).</w>
poly neuropathies.</w>
poly neuro
polyneuro ap
polyneuroap thy</w>
poly myx
polymyx in-
polymyxin- containing</w>
poly myoclonus</w>
poly myalgia</w>
poly morph</w>
poly microbi
polymicrobi al,</w>
poly hydramnios,</w>
poly hydramni
polyhydramni os
polyhydramnios ),</w>
poly graph</w>
poly graph,</w>
poly glutamat
polyglutamat es)</w>
poly glutam
polyglutam ation,</w>
poly et
polyet yleneimine</w>
poly enes</w>
poly drug-dependent</w>
poly drug,</w>
poly disp
polydisp sia.</w>
poly cyclic</w>
poly chroma
polychroma sia,</w>
poly ch
polych otomous</w>
poly cardiographic</w>
poly cardio
polycardio graphic,</w>
poly carbonate</w>
poly articular</w>
poly arthritis:</w>
poly arthritis.</w>
poly arthri
polyarthri tis."</w>
poly arthralgias</w>
poly arthralgias,</w>
poly arthralgia.</w>
poly arteritis,</w>
poly arter
polyarter itis).</w>
poly anion.</w>
poly ani
polyani on-
polyanion- polycation</w>
poly angiitis.</w>
poly amines.</w>
poly amine-
polyamine- binding</w>
poly -</w>
pollaki uria</w>
pollak isur
pollakisur ia).</w>
poli uric</w>
poli amine</w>
pole- test</w>
pole- descending</w>
pole- climbing</w>
polaro graphy</w>
polaro graphic</w>
polar ized</w>
polar ization,</w>
polar izable</w>
polar ity,</w>
polar ising</w>
pol ylactide-co-glycolide</w>
pol lu
pollu tion.</w>
pol es</w>
pol es,</w>
pol :</w>
poison ous</w>
poison ing;</w>
pointes -type</w>
pointes ".</w>
pointes "-
pointes"- type.</w>
point- specific</w>
point- resolved</w>
point- prevalence</w>
point- of-care</w>
point- counting</w>
point s]).</w>
point ment</w>
point "</w>
point ",</w>
poin te"</w>
poikilother ms</w>
poikilother mia.</w>
poikilother mia)</w>
poikilo thermia</w>
poi esis.</w>
pogrel ate-
pogrelate- Aspirin</w>
podocyt uria.</w>
podocyt es).</w>
podocalyx in.</w>
podoc in,</w>
podo plan
podoplan in.</w>
podi um,</w>
pod s.</w>
pod ocyte-specific</w>
pod ocyte-
podocyte- protective</w>
po vixil</w>
po ved</w>
po uring</w>
po ults</w>
po uches,</w>
po uch</w>
po se.</w>
po res.</w>
po res,</w>
po ren),</w>
po re.</w>
po re-forming</w>
po re),</w>
po physis</w>
po ols.</w>
po ol)</w>
po ke
poke weed</w>
po id
poid '</w>
po fol
pofol :</w>
po et
poet in,</w>
po enia,</w>
po dia</w>
po acu
poacu sia.</w>
po ).</w>
pneumoniti s"</w>
pneumonia e)</w>
pneumonia e),</w>
pneumonia ).</w>
pneumon itis)</w>
pneumon ia:</w>
pneumon ia/
pneumonia/ pneumonitis,</w>
pneumon ectomy.</w>
pneumococci ,</w>
pneumococci ).</w>
pneumocardi ograms,</w>
pneumocardi ogram.</w>
pneumo thorax.</w>
pneumo thoraces,</w>
pneumo phil
pneumophil a.</w>
pneumo peritone
pneumoperitone um,</w>
pneum oton
pneumoton ometry.</w>
pneum omediastin
pneumomediastin ography</w>
pneum ocytes</w>
pneum ococcus</w>
pneum ococcus.</w>
pneum ectomy,</w>
pneum aton
pneumaton ograph
pneumatonograph .</w>
pmol/ site),</w>
pmol/ side)</w>
pmol/ paw)</w>
pmol/ paw
pmol/paw ),</w>
pmol/ mouse,</w>
pmol/ mouse)</w>
pmol/ micromol</w>
pmol/ mg;</w>
pmol/ mg)</w>
pmol/ l;</w>
pmol/ l.</w>
pmol/ l).</w>
pmol/ atropine</w>
pmol/ L</w>
pmol/ L;</w>
pmol/ L).</w>
pmol/ 50</w>
pmol/ 15</w>
pmol/ 10</w>
pmol/ 10
pmol/10 (8).</w>
pmol /</w>
pmol -7</w>
pmol -1</w>
pmol -
pmol- 7.8</w>
pmol ).</w>
plus- tobacco</w>
plus- progestin</w>
plus- placebo</w>
plus- WAR</w>
pluri potent</w>
pluri potent/bipotent</w>
plu gged</w>
plu gg
plugg ing,</w>
plo ying</w>
plo t.</w>
plo id)</w>
plit -
plit- brain</w>
plex opathy.</w>
plex ogenic</w>
pleuro pulmonary</w>
pleuro pericardial</w>
pleuro -
pleuro- pericarditis.</w>
pleuris y</w>
pleuris y,</w>
pleur itis,</w>
pleur al,</w>
plethysmo graphy)</w>
plethysmo graph
plethysmograph y),</w>
pleomorph ous</w>
pleomorph ism</w>
pleomorph ism,</w>
plen ishment</w>
plen ic,</w>
plei omorphic</w>
pledg et
pledget s.</w>
pleas ure</w>
pleas ure,</w>
pleas urable</w>
pleas urable',</w>
pleas ant
pleasant ness</w>
ple uronectus</w>
ple uracentesis</w>
ple thora</w>
ple sia</w>
ple menting</w>
ple g
pleg ia,</w>
ple a</w>
ple -drug</w>
ple -blind</w>
ple -
ple- binge</w>
play ers,</w>
play ed.</w>
plau sibly</w>
platinum- taxane</w>
platinum- paclitaxel</w>
platin um/etoposide</w>
platin um-related</w>
platform- removed</w>
platform ;</w>
platform )</w>
platelet/ vascular</w>
platelet/ plasma</w>
platelet- specific</w>
platelet- sparing</w>
platelet- poor</w>
platelet- lowering</w>
platelet- fibrin</w>
platelet- dominant</w>
platelet- directed</w>
platelet- dependent</w>
platelet- binding</w>
platelet- aggregating</w>
platele ts;</w>
platele t.</w>
platele t-induced</w>
platele t)</w>
plateau ed,</w>
plateau -
plateau- phase</w>
platea us,</w>
plat yspondyly</w>
plat in-induced</w>
plast ers</w>
plast er</w>
plasmin ogen.</w>
plasmin ogen,</w>
plasmin ogen)</w>
plasmalo gen</w>
plasmalo gen,</w>
plasmacy tosis,</w>
plasmacy te</w>
plasma- volume</w>
plasma- renin</w>
plasma- prolactin</w>
plasma- membrane</w>
plasma- lipid</w>
plasma- ionized</w>
plasma- effect</w>
plasma- concentrations</w>
plasma- Intralipid</w>
plasma ph
plasmaph aresis</w>
plasma perfusion.</w>
plasma /
plasma/ kidney</w>
plasma -to-
plasma-to- urine</w>
plasma ),</w>
plasm ocytes</w>
plasm ocyte</w>
plasi a).</w>
plas tics</w>
plas ticity:</w>
plas tic/dysplastic</w>
plas mon</w>
plas modium</w>
plas min</w>
plas min.</w>
plas mic
plasmic /
plasmic/ sarcoplasmic</w>
plas mas.</w>
plas e.</w>
plaqu ing</w>
plaqu enil,</w>
plaqu e;</w>
plaqu e-type</w>
plaqu e-
plaque- produced</w>
plant aris.</w>
plant aris
plantaris ).</w>
plant ar-
plantar- palmar</w>
plant ar,</w>
plant able</w>
plant -derived</w>
planime tered</w>
plani metry.</w>
plani metry)</w>
plan us</w>
plan us,</w>
plan us)</w>
plan s,</w>
plan op
planop il
planopil aris,</w>
plan ning.</w>
plan ning,</w>
plan in,</w>
plan es.</w>
plan e.</w>
plan a</w>
plagu ing</w>
plagu es.</w>
plagu ed</w>
placent as,</w>
placent al,</w>
placent ae</w>
placem ent;</w>
placem ent:</w>
placem ent).</w>
placebo/ sumatriptan</w>
placebo/ amphetamine,</w>
placebo/ alcohol.</w>
placebo- subtracted</w>
placebo- receiving</w>
placebo- d-amphetamine</w>
placebo- corrected</w>
placebo- contro
placebo-contro led,</w>
placebo- an</w>
placebo- administered</w>
placebo- adjusted</w>
placebo- MPTP-treated</w>
placebo- -
placebo-- separated</w>
placebo .(ABSTRACT</w>
placebo -like</w>
placebo )--
placebo)-- hazard</w>
placebo ").</w>
placeb os,</w>
place d,</w>
place bos
placebos ;</w>
place :</w>
plac e-
place- preference</w>
pl unge</w>
pl iss</w>
pl ified</w>
pl ated</w>
pl ants.</w>
pl an.</w>
pl ained</w>
pl ain.</w>
pl .</w>
pix el</w>
pix el
pixel wise</w>
pix antrone,</w>
pival ic</w>
pival ate</w>
piv alo
pivalo ylurea</w>
pituitary- transplanted</w>
pituitary- thyroid</w>
pituit ar
pituitar y).</w>
pit yriasis</w>
pit falls.</w>
pit ching</w>
pit ched</w>
pit ations</w>
pit ,</w>
piroxantr one.</w>
piroxantr one--
piroxantrone-- have</w>
piri d
pirid in-3-ol</w>
piretan ide.</w>
piretan ide,</w>
pirenzep ine-induced</w>
pirenzep ine)</w>
piracetam -like</w>
pir profen.</w>
pir profen-treated</w>
pir profen,</w>
pir one-treated</w>
pir it
pirit ramide,</w>
pir ation</w>
pir arubicin.</w>
piperidino ethoxy)-5-benzofuranyl]-N'-methylurea</w>
piperidine- methiodi
piperidine-methiodi de)</w>
piperidine- based,</w>
piperidine- 1</w>
piperidin-4- yl</w>
piperidin-4- yl)ethyl]-2,3-dihydro-9-methoxy-1H-pyrrolo[3,4-b]quinolin-1-one</w>
piperidin-1-yl- 5-
piperidin-1-yl-5- (4-chlorophenyl)-1-(2,4-dichloro
piperidin-1-yl-5-(4-chlorophenyl)-1-(2,4-dichloro phenyl)-4-methyl-1H-pyrazole-3-carboxamide
piperidin-1-yl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochloride</w>
piperidin-1- yl]-1-phenyl-ethyl</w>
piperidin-1- yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide];</w>
piperidin-1- yl)-1H-pyrazole-3-carboxamide],</w>
piperidin opyrimid
piperidinopyrimid ine)</w>
piperid ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzam</w>
piperid ylidene)-9-anthrol),</w>
piperid ino</w>
piperid ine]</w>
piperid ine)</w>
piperid in-2-yl)
piperidin-2-yl) methyl)-1H-
piperidin-2-yl)methyl)-1H- indol-3-
piperidin-2-yl)methyl)-1H-indol-3- yl]-methanone]</w>
piperazin-1-yl) -1,
piperazin-1-yl)-1, 4:</w>
piperazin-1- yl]propyl]pyrrolidin-2-one</w>
piperazin-1- yl]</w>
piperazin-1- yl)</w>
piperazin ylmethylpyrazolo</w>
piperazin yl)pyrazine</w>
piperazin yl)-7-oxo-7H-pyrido[1,2,3-de]</w>
piperaz inium</w>
piperaz ine.</w>
piperaz ine-1-
piperazine-1- yl)-2-phenylpropanamide</w>
piperaz ine,</w>
piperaz ine)</w>
piperacillin/ tazobactam</w>
piperacillin/ tazobactam.</w>
piperacillin- tazobactam</w>
piperacillin- tazobactam,</w>
piperacill in;</w>
pio glitazone</w>
pio .</w>
pio ).</w>
pineal ectomy-
pinealectomy- stimulated</w>
pine- refractory</w>
pine- reduction</w>
pine- group,</w>
pine- -a</w>
pine al.</w>
pine .(ABSTRACT</w>
pindo lol)</w>
pindo lo
pindolo l).</w>
pinch ing).</w>
pinch -induced</w>
pinacidi l.</w>
pinacidi l-
pinacidil- opened</w>
pin- prick,</w>
pin- pic
pin-pic k</w>
pin point</w>
pin ocytotic</w>
pin ocytosis</w>
pin ocytosis.</w>
pin na
pinna e)</w>
pin k
pink ish.</w>
pin es,</w>
pin ch-
pinch- pain</w>
pin ch)</w>
pin ally,</w>
pimoz ide;</w>
pilsicain ide.</w>
pilsicain ide-induced</w>
pilot- study,</w>
pilot- phase;</w>
pilocarpine- susceptible</w>
pilocarpine- seizure</w>
pilocarpine- inducted</w>
pilocarpine- elicited</w>
pilocarpine- effects</w>
pilocarpine- effects.</w>
pilocarpine- catalepsy</w>
pilocarpine- ,</w>
pilocarp ine-related</w>
pilocarp ine)-induced</w>
pilocar ine</w>
pilo- saline)</w>
pilo- erection</w>
pilo ts</w>
pilo ting</w>
pill s:</w>
pill s)</w>
pill s"</w>
pill induced</w>
pill ar</w>
pill :</w>
pill -induced</w>
pill -free</w>
pil low</w>
pil ing-
piling- up,</w>
pil in-1</w>
pil aris</w>
pigment ed.</w>
pig s.5.</w>
pig s)</w>
pig s).</w>
pig ments</w>
pig ments,</w>
pig ment.</w>
pig :</w>
piec es</w>
pid x)</w>
pid ase,</w>
pictro toxin</w>
pictro toxin,</w>
pict ure;</w>
pict ure:slight</w>
picrotoxin- seizure</w>
picrotoxin- ,</w>
picrotoxin in.</w>
picrotox in:</w>
picrotox in-sensitive</w>
picro roxin</w>
picro ptoxin</w>
picro -M
picro-M all
picro-Mall ory</w>
picom ole</w>
picom ol
picomol es/
picomoles/ 8</w>
picloz ot
piclozot an,</w>
pic torial</w>
pic ritoxin</w>
pic ot
picot es
picotes la</w>
pic e.</w>
pic a"</w>
pi- sulfonate</w>
pi- X)</w>
pi voxil</w>
pi t</w>
pi rosis,</w>
pi renperone,</w>
pi razole</w>
pi onate</w>
pi le.</w>
pi g)</w>
pi elberg
pielberg er-
pielberger- K
pielberger-K h
pielberger-Kh anin</w>
pi -G
pi-G ST,</w>
phytomenadi one-induced</w>
phytomenadi one)</w>
phytomen adione</w>
phytom it
phytomit ogen</w>
phytohem agglutinin</w>
phytohem agglutin
phytohemagglutin in.</w>
phyto therapy-associated</w>
phyto estrogen,</w>
physostigmine- tremor.</w>
physostigmine- glycopyrrolate</w>
physostigmine- catalepsy.</w>
physiopath ology;</w>
physiopath ogenic</w>
physician- staffed</w>
physician- administered</w>
physici ans)</w>
physic ally,</w>
physi tis</w>
physi os
physios tigmine-induced</w>
physi opathogenesis</w>
physi ology,</w>
physi ological.</w>
physi ochemical</w>
physi o
physio therapy,</w>
physi co-
physico- chemical</w>
physi atrists</w>
physe ma</w>
phylococci .</w>
phyloc coc
phyloccoc us</w>
phyll um,</w>
phyl um</w>
phyl line</w>
phyl a</w>
phy tochemical</w>
phy sis.</w>
phy sectomy,</w>
phy s.</w>
phy rin</w>
phy rin-positive</w>
phy lo
phylo genetic</w>
phy ).</w>
phthal azine-
phthalazine- 5
phthalazine-5 (14
phthalazine-5(14 H)
phthalazine-5(14H) ,
phthalazine-5(14H), 12
phthalazine-5(14H),12 (7
phthalazine-5(14H),12(7 h
phthalazine-5(14H),12(7h )-
phthalazine-5(14H),12(7h)- dione</w>
phthal azin
phthalazin o-
phthalazino- 2,
phthalazino-2, 3
phthalazino-2,3 b-
phthalazino-2,3b- phthalazine-5(14H),12(7h)-dione</w>
phthal ate,</w>
phthal ane</w>
phthal aldehyde</w>
photosensi tizer.</w>
photore sistor</w>
photore lease</w>
photoph obia.</w>
photoph ob
photophob ic.</w>
photon s</w>
photon absorpti
photonabsorpti ometry)</w>
photograph ing</w>
photodi stribution</w>
photoco agulation</w>
photoco ag
photocoag ulation.</w>
photoc ycle.</w>
photoc hemotherapy.</w>
photo- uncaging</w>
photo- cell</w>
photo s</w>
photo receptors.</w>
photo receptor</w>
photo periodic</w>
photo period</w>
photo paroxysmal</w>
photo graph</w>
photo electric</w>
photo dermatitis</w>
photo beam
photobeam s;</w>
photo aging,</w>
photo aged</w>
photo -</w>
phot otoxicity-
phototoxicity- inducing</w>
phot os
photos timulated</w>
phot opic</w>
phot op
photop leth
photopleth ysmography</w>
phot ometer</w>
phot olysis</w>
phot ography.</w>
phot ography,</w>
phot ographically</w>
phosphotyrosine- null</w>
phosphot emia,</w>
phosphot ase)</w>
phosphoryl creatine</w>
phosphoryl ations</w>
phosphoryl ations,</w>
phosphoryl ation/
phosphorylation/ dephosphorylation</w>
phosphoryl ation
phosphorylation -dependent</w>
phosphoryl ated:</w>
phosphoryl ated,</w>
phosphorothio ated</w>
phosphoro dithio
phosphorodithio ate</w>
phosphoro diam
phosphorodiam ido
phosphorodiamido fluor
phosphorodiamidofluor id
phosphorodiamidofluorid ate),</w>
phosphor ylate</w>
phosphor us.</w>
phosphor diam
phosphordiam idic</w>
phosphono phenyl
phosphonophenyl glycine.</w>
phosphono form
phosphonoform ate)</w>
phosphon om
phosphonom ethyl]
phosphonomethyl] deca
phosphonomethyl]deca hyd
phosphonomethyl]decahyd r</w>
phosphon obutyric</w>
phosphon ate-related</w>
phosphon ate-exposed</w>
phosphomono esters</w>
phosphomono esters,</w>
phosphomon oest
phosphomonoest ers.</w>
phospholipid- binding</w>
phospholipid- ,</w>
phospholip ase.</w>
phosphoinositi des,</w>
phosphofructo kinase.</w>
phosphodiester ases.</w>
phosphodiester ase.</w>
phosphodiester ase-induced</w>
phosphodi est
phosphodiest rase-5A</w>
phosphocreat ine)</w>
phospho- signal</w>
phospho- PKCepsilon</w>
phospho rous</w>
phospho rescence-quenching</w>
phospho protein,</w>
phospho kinase;</w>
phospho kinase)</w>
phospho [
phospho[ Thr
phospho[Thr 34]-
phospho[Thr34]- DARPP-
phospho[Thr34]-DARPP- 32,</w>
phosphin yl]-2-(S)-</w>
phosphin ates,</w>
phosphatidylethan olamine,</w>
phosphatidylethan ol
phosphatidylethanol amine).</w>
phosphatidyl- serine</w>
phosphatidyl- choline,</w>
phosphatidyl inositol,</w>
phosphatidyl glycerol</w>
phosphatidyl cholin
phosphatidylcholin es.</w>
phosphati des</w>
phosphati date</w>
phosphate- supplemented,</w>
phosphate- replete</w>
phosphate- gamma-glutamyl</w>
phosphate- diaphorase</w>
phosphate- binding</w>
phosphate- 6-az
phosphate-6-az o</w>
phosphat uria.</w>
phosphat es:</w>
phosphat ase-positive</w>
phosphat aemic</w>
phosph os
phosphos lipase</w>
phosph or-
phosphor- Akt,</w>
phosph openic</w>
phosph oline.</w>
phosph oline,</w>
phosph oin
phosphoin os
phosphoinos itol</w>
phosph ate-</w>
phosph ate),</w>
phosph anil
phosphanil ate</w>
phosph amide,</w>
phorbol-12,13-di butyrate</w>
phorbol-12,13-di butyrate,</w>
phorbol -
phorbol- ester
phorbol-ester -induced</w>
phor ia,</w>
phonoph obia,</w>
phonoph obia)</w>
phonocardi ography,</w>
phonocardi ographic</w>
phonocardi ograms</w>
phon ations.</w>
phob ic)</w>
phob ias</w>
phob ia:</w>
phob ia,</w>
phob ia)</w>
phob es</w>
pho tically-induced</w>
pho proliferate</w>
pho B)</w>
phlor iz
phloriz in</w>
phlebo thrombosis:</w>
phlebo thrombosis.</w>
phlebo thrombosis,</w>
phlebo graphy.</w>
phlebo graph
phlebograph ies,</w>
phleb itis)</w>
phleb itis).</w>
phil us),</w>
phil is</w>
phil es.</w>
pherom ones.</w>
pherom one).</w>
phere sis,</w>
phere -
phere- determined</w>
pher ical</w>
phenytoin- without-valproate</w>
phenytoin- with-valproate</w>
phenytoin- equivalent</w>
phenytoin- equivalent.</w>
phenytoin );</w>
phenyto in/
phenytoin/ phenobarbital</w>
phenyto in)</w>
phenyto in),</w>
phenyto in's</w>
phenylpropanol amine-treated</w>
phenylpropanol amine-associated</w>
phenylpiperaz inium.</w>
phenylmethyl sulphonyl</w>
phenylind ane</w>
phenylind an</w>
phenylethyn yl-pyridine,</w>
phenylethyl amino</w>
phenylethyl amine.</w>
phenylethyl amine-induced</w>
phenylethyl amine,</w>
phenylethyl amine)</w>
phenylethanolamine-N-methyl transferase)</w>
phenylethan olamine</w>
phenyleth yl-substitution</w>
phenyleth yl)-5-amino-2-(2-furyl)-pyrazolo-(4,3-e)-1,2,4-triazolo(1,5-c)</w>
phenyleth oxy)
phenylethoxy) phenyl]-
phenylethoxy)phenyl]- ethylamine</w>
phenylephr ine;</w>
phenylephr ine:</w>
phenylephr ine-soaked</w>
phenylephr ine)</w>
phenylephr ine),</w>
phenyldiguan ide</w>
phenyldiguan ide.</w>
phenyldi amine-
phenyldiamine- ascorbate,</w>
phenylbutaz one-related</w>
phenylbutaz one-induced</w>
phenylbutaz one)</w>
phenylbiguan ide.</w>
phenylbenzo quinone</w>
phenylamino ketone</w>
phenylalanine- methyl-
phenylalanine-methyl- ester</w>
phenylalanine- 5-HT</w>
phenylalan ine;</w>
phenylalan ine)</w>
phenylalan ine),</w>
phenylacetyl glutamine</w>
phenylacetyl -Phe-
phenylacetyl-Phe- Ser-
phenylacetyl-Phe-Ser- Arg-
phenylacetyl-Phe-Ser-Arg- N-(2,</w>
phenyl]- N-methyl
phenyl]-N-methyl amin
phenyl]-N-methylamin ocarb
phenyl]-N-methylaminocarb on
phenyl]-N-methylaminocarbon ylmethyl]</w>
phenyl]- 4-
phenyl]-4- carboxamide</w>
phenyl]- 2'-
phenyl]-2'- methyl-
phenyl]-2'-methyl- 4'-
phenyl]-2'-methyl-4'- (5-methyl
phenyl]-2'-methyl-4'-(5-methyl -1,2</w>
phenyl] ethyl
phenyl]ethyl amino]-5'-N-ethyl
phenyl]ethylamino]-5'-N-ethyl carboxamido
phenyl]ethylamino]-5'-N-ethylcarboxamido adenos
phenyl]ethylamino]-5'-N-ethylcarboxamidoadenos ine;</w>
phenyl] -17
phenyl]-17 beta-hydroxy-17-
phenyl]-17beta-hydroxy-17- (1-
phenyl]-17beta-hydroxy-17-(1- propynyl)estra-4,9-dien-3-one],</w>
phenyl] -1,
phenyl]-1, 6-
phenyl]-1,6- dihydro-1-
phenyl]-1,6-dihydro-1- methyl-
phenyl]-1,6-dihydro-1-methyl- 3-
phenyl]-1,6-dihydro-1-methyl-3- propyl-7H-pyrazolo</w>
phenyl-N- tert-butylnitrone</w>
phenyl-N- tert-butyl-nitrone;</w>
phenyl-N- t-butyl</w>
phenyl-3- yl</w>
phenyl-2- p</w>
phenyl-1,3- propanediol</w>
phenyl-1,3- propane-diol</w>
phenyl-1,3- dipropyl
phenyl-1,3-dipropyl xant</w>
phenyl-1,2,3,6-tetrahydro pyridyl(1))-butyl(1)]-indole</w>
phenyl-1,2,3,6-tetrahydro pyridine),</w>
phenyl-1, 2-
phenyl-1,2- benziso
phenyl-1,2-benziso selenazol-3[2H]-one)</w>
phenyl- xanthine</w>
phenyl- substituted</w>
phenyl- pyridazine],</w>
phenyl- pyridazine</w>
phenyl- pentadecanoic</w>
phenyl- glycine</w>
phenyl- ethyl)-
phenyl-ethyl)- pyrimidine</w>
phenyl- cyclohexanec
phenyl-cyclohexanec arboxylic</w>
phenyl- beta-
phenyl-beta- methyl</w>
phenyl- S-glutathione</w>
phenyl- N-methyl-
phenyl-N-methyl- ethanolamine</w>
phenyl- 2,</w>
phenyl- (4-fluoro
phenyl-(4-fluoro -4-
phenyl-(4-fluoro-4- [[(5-
phenyl-(4-fluoro-4-[[(5- methyl-6-
phenyl-(4-fluoro-4-[[(5-methyl-6- methylamino-
phenyl-(4-fluoro-4-[[(5-methyl-6-methylamino- pyridin-2-ylmethyl)-amino]-methyl]-piperidin-1-yl-methanone</w>
phenyl)-8- fluoro
phenyl)-8-fluoro -4
phenyl)-8-fluoro-4 H-
phenyl)-8-fluoro-4H- imidazo-
phenyl)-8-fluoro-4H-imidazo- [1,5-
phenyl)-8-fluoro-4H-imidazo-[1,5- a]</w>
phenyl)-8- (4-chlorophenyl)-
phenyl)-8-(4-chlorophenyl)- 2-methyl
phenyl)-8-(4-chlorophenyl)-2-methyl pyrazolo[1,5-a]-[1,3,5]triazin-4-yl]-3-ethylaminoazetidine-3-carboxylic</w>
phenyl)-4-methyl- N-(
phenyl)-4-methyl-N-( piperidin-1-yl)-1H-pyrazole-3-carboxamide],</w>
phenyl)-4- ox
phenyl)-4-ox obut
phenyl)-4-oxobut yl)</w>
phenyl)-4- morpholino-
phenyl)-4-morpholino- imidazol
phenyl)-4-morpholino-imidazol in-2-
phenyl)-4-morpholino-imidazolin-2- one]</w>
phenyl)-3- pyridylmethylaminomethyl]-chromane</w>
phenyl)-3- (R,S)-
phenyl)-3-(R,S)- methyl
phenyl)-3-(R,S)-methyl pentadecanoic</w>
phenyl)-3,5- pyridinedicarboxylate,</w>
phenyl)-3,5- dihydro-7,8-
phenyl)-3,5-dihydro-7,8- dimethoxy-
phenyl)-3,5-dihydro-7,8-dimethoxy- 4H-2,3-benzodiazep
phenyl)-3,5-dihydro-7,8-dimethoxy-4H-2,3-benzodiazep in</w>
phenyl)-2- (2-
phenyl)-2-(2- oxo
phenyl)-2-(2-oxo -1-pyrrolidin
phenyl)-2-(2-oxo-1-pyrrolidin yl)</w>
phenyl)-2- (1-</w>
phenyl)-1- (4-methyl
phenyl)-1-(4-methyl benz
phenyl)-1-(4-methylbenz yl)-N-(1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl)-1H-pyrazole-3-carboxamide],</w>
phenyl)- salicylic</w>
phenyl)- propionyl]-N4-alkyl/aryl-thiosemicarbazides</w>
phenyl)- n-methyl-
phenyl)-n-methyl- n-
phenyl)-n-methyl-n- [
phenyl)-n-methyl-n-[ (1
phenyl)-n-methyl-n-[(1 S)-1-
phenyl)-n-methyl-n-[(1S)-1- (3-
phenyl)-n-methyl-n-[(1S)-1-(3- isothiocy
phenyl)-n-methyl-n-[(1S)-1-(3-isothiocy nat
phenyl)-n-methyl-n-[(1S)-1-(3-isothiocynat o
phenyl)-n-methyl-n-[(1S)-1-(3-isothiocynato phenyl)-2-(1-</w>
phenyl)- isoxazol-5-
phenyl)-isoxazol-5- yl)tropane</w>
phenyl)- ethylenediamine</w>
phenyl)- [1-
phenyl)-[1- (
phenyl)-[1-( (1-
phenyl)-[1-((1- methyl-
phenyl)-[1-((1-methyl- piperidin-2-yl)methyl)-1H-indol-3-yl]-methanone]</w>
phenyl)- 2beta-
phenyl)-2beta- (3-
phenyl)-2beta-(3- (4'-methyl
phenyl)-2beta-(3-(4'-methyl phenyl)-isoxazol-5-yl)tropane</w>
phenyl)- 2,</w>
phenyl)- 2,5-di
phenyl)-2,5-di ylbis(oxy)(2,2-dimethylpentanoic</w>
phenyl)- 2,
phenyl)-2, 5-dihydro-
phenyl)-2,5-dihydro- 3H-
phenyl)-2,5-dihydro-3H- imidazo</w>
phenyl) tropane-2beta-carboxylic</w>
phenyl) piperazine</w>
phenyl) piperazin-1-yl]propyl]pyrrolidin-2-one</w>
phenyl) isoxazol-5-yl]tropane</w>
phenyl) glutathione</w>
phenyl) ethynyl-
phenyl)ethynyl- 3
phenyl)ethynyl-3 alpha
phenyl)ethynyl-3alpha ,2
phenyl)ethynyl-3alpha,2 1-
phenyl)ethynyl-3alpha,21- dihydroxy-
phenyl)ethynyl-3alpha,21-dihydroxy- 5
phenyl)ethynyl-3alpha,21-dihydroxy-5 beta
phenyl)ethynyl-3alpha,21-dihydroxy-5beta ++</w>
phenyl) ethyl]-
phenyl)ethyl]- N-methyl-2-
phenyl)ethyl]-N-methyl-2- (1-pyrrolidinyl)
phenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl) ethyl
phenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethyl am</w>
phenyl) ethyl]
phenyl)ethyl] -</w>
phenyl) )
phenyl)) -1,4-
phenyl))-1,4- dihydropyridine-
phenyl))-1,4-dihydropyridine- 3,5-
phenyl))-1,4-dihydropyridine-3,5- dicarboxyl
phenyl))-1,4-dihydropyridine-3,5-dicarboxyl a</w>
phenyl tropane</w>
phenyl tropane.</w>
phenyl thiopropyl-substituted</w>
phenyl theophylline</w>
phenyl sulphinyl]methyl]-1-piperidinyl]ethyl]-1H-indole</w>
phenyl sulfonylaminomethyl)-bicyclo[2.2.2]octan-2-yl]-5Z-hexenoic</w>
phenyl s</w>
phenyl quinone</w>
phenyl quinone.</w>
phenyl quinoline-2-(H)-one],</w>
phenyl propyl</w>
phenyl propyl-N'-(3,4-dichlorophenethyl)piperazine]</w>
phenyl proprionic</w>
phenyl proprionate</w>
phenyl propranolamine</w>
phenyl propionyl)]-</w>
phenyl propionate</w>
phenyl piperazin-1-yl)</w>
phenyl nephrine</w>
phenyl methan
phenylmethan esulf
phenylmethanesulf onyl</w>
phenyl isoxazol-5-yl]tropane</w>
phenyl hydrazine,</w>
phenyl hydraz
phenylhydraz ine-induced</w>
phenyl hydantoin)</w>
phenyl hydanto
phenylhydanto in.</w>
phenyl hyd
phenylhyd or
phenylhydor azine</w>
phenyl glycol,</w>
phenyl glyc
phenylglyc ines</w>
phenyl cyclopent
phenylcyclopent yl-N,N-dimethyltropinium</w>
phenyl barbituric</w>
phenyl amino)
phenylamino) adenosine</w>
phenyl alkyl
phenylalkyl amine</w>
phenyl alamine</w>
phenyl ;</w>
pheny lo
phenylo proprionate</w>
phentol amine-induced</w>
phentol amine)</w>
phentol amine
phentolamine .2</w>
phento in</w>
phento alamine</w>
phentermine- fenfluramine.</w>
phenterm ine)</w>
phenprocoumon -treated</w>
phenprocoumon -related</w>
phenprocoumon -associated</w>
phenprocoumon ,</w>
phenoxy)- ethyl]-2-
phenoxy)-ethyl]-2- imidazoline</w>
phenoxy)- 3
phenoxy)-3 [2-
phenoxy)-3[2- 3,4-di
phenoxy)-3[2-3,4-di methoxyphenyl)
phenoxy)-3[2-3,4-dimethoxyphenyl) ethanol
phenoxy)-3[2-3,4-dimethoxyphenyl)ethanol amino]-
phenoxy)-3[2-3,4-dimethoxyphenyl)ethanolamino]- prop</w>
phenoxy) but
phenoxy)but yrate)</w>
phenoxy propyl)amino)butyl</w>
phenoxy methyl
phenoxymethyl penicillin.</w>
phenoxy isobutyric</w>
phenoxy ethyl)</w>
phenoxy acetic</w>
phenoxy )]
phenoxy)] ethyl]
phenoxy)]ethyl] -1,2,4-triazolo(1,5-
phenoxy)]ethyl]-1,2,4-triazolo(1,5- alpha
phenoxy)]ethyl]-1,2,4-triazolo(1,5-alpha )
phenoxy)]ethyl]-1,2,4-triazolo(1,5-alpha) pyrimidine,</w>
phenoxy )</w>
phenotype ?</w>
phenotype ;</w>
phenotype -
phenotype- genotype</w>
phenotyp ically-
phenotypically- altered</w>
phenotyp ically,</w>
phenotyp es:</w>
phenothiaz ines:</w>
phenothiaz ines,</w>
phenothiaz ine.</w>
phenothiaz ine-related</w>
phenothiaz ine-like</w>
phenothiaz ine-containing</w>
phenothiaz ine,</w>
phenothiaz in
phenothiazin es).</w>
phenomen ons,</w>
phenomen on:</w>
phenomen on).</w>
phenomen on),</w>
phenomen on
phenomenon ?</w>
phenomen ologically</w>
phenomen a;</w>
phenomen a)</w>
phenomen a"</w>
phenomen a
phenomena .(ABSTRACT</w>
phenol es,</w>
phenol ate.</w>
phenobarbitone- sleeping</w>
phenobarbitone- primed</w>
phenobarbitone- exposed</w>
phenobarbitone- anesthetized</w>
phenobarbital- type</w>
phenobarbital- sevoflurane</w>
phenobarbital- resistant</w>
phenobarbital- promoted</w>
phenobarbital- pretreatment</w>
phenobarbital- pretreated</w>
phenobarbit one-treated</w>
phenobarbit one-induced</w>
phenobarbit ol</w>
phenobarbit al;</w>
phenobarbit al/kg</w>
phenobarbit al)-induced</w>
phenobarbit al
phenobarbital .(ABSTRACT</w>
phenir amine,</w>
phenid ol</w>
phenfor min.</w>
phenfor min-associated</w>
phenethyl piperidine</w>
phenethyl amino]-5'-N-ethyl
phenethylamino]-5'-N-ethyl carboxamidoadenosine</w>
phenethyl amino</w>
phenethyl amine-induced</w>
phenethyl )-
phenethyl)- 4-(2-
phenethyl)-4-(2- pyridyl)-piperazine)</w>
phenerg an</w>
phenerg an,</w>
phenelzine- venlafaxine</w>
phenelzine- tryptophan</w>
phenelz ine;</w>
phenelz ine:</w>
phenelz ine)</w>
phendimetraz ine</w>
phendimetraz ine,</w>
phendimetraz ine)</w>
phencyclid ine-like</w>
phencycl idine-treated</w>
phenaz opyridine,</w>
phenaz opyrid
phenazopyrid ine;</w>
phenaz opyri
phenazopyri dine-associated</w>
phenaz one,</w>
phenaz one)</w>
phenaz ine-induced</w>
phenanthridin one</w>
phenanthridin one-
phenanthridinone- based</w>
phenacetin- or</w>
phenacet in-</w>
phenacet in).</w>
phen yephrine</w>
phen oxyl
phenoxyl benz
phenoxylbenz amine,</w>
phen oxy-
phenoxy- isobut
phenoxy-isobut yryl-glycinamide</w>
phen one</w>
phen one),</w>
phen ome
phenome logy</w>
phen ols,</w>
phen ol-
phenol- uncoupled</w>
phen ol)</w>
phen ol).</w>
phen metraz
phenmetraz ine</w>
phen ethylene</w>
phen ath
phenath rene-9-10-diol),</w>
phen amic</w>
phen acetic</w>
phen acemide,</w>
phen -
phen- fen
phen-fen ")</w>
phen ),</w>
phed rone</w>
phasi zes</w>
phasi l,</w>
phasi c"</w>
phase- specific,</w>
phase- by-time</w>
phase- II,</w>
phase- 5</w>
phase olus</w>
phase .(ABSTRACT</w>
phas es.
phases. Furthermore,</w>
phas es--
phases-- running,</w>
phas ely</w>
phas e).</w>
phas e"</w>
pharyng olaryn
pharyngolaryn geal</w>
pharyn geal,</w>
pharmacore sistance.</w>
pharmacologic ally-
pharmacologically- active</w>
pharmacokinetic/ in
pharmacokinetic/in direct-
pharmacokinetic/indirect- effects</w>
pharmacokinetic/ biochemical</w>
pharmacokine tics:</w>
pharmacokine tically.</w>
pharmacokine tic,</w>
pharmaco vigilance:</w>
pharmaco vigilance,</w>
pharmaco therapies.</w>
pharmaco therapies,</w>
pharmaco therapeutics</w>
pharmaco kynetic</w>
pharmaco epidemiological</w>
pharmaco dependence</w>
pharmac y-based</w>
pharmac otoxicity</w>
pharmac os
pharmacos urveillance</w>
pharmac ophore</w>
pharmac ophore
pharmacophore /
pharmacophore/ receptor</w>
pharmac ope
pharmacope o
pharmacopeo ia
pharmacopeoia e,</w>
pharmac on</w>
pharmac on
pharmacon kinetics</w>
pharmac ology;</w>
pharmac ologists</w>
pharmac ologies</w>
pharmac ogenic</w>
pharmac ogene
pharmacogene tics)</w>
pharmac ogen
pharmacogen omic</w>
pharmac o</w>
pharmac o-
pharmaco- therapy</w>
pharmac ists.</w>
pharmac ies.</w>
pharmac eutic
pharmaceutic al,</w>
phar mak
pharmak okinetic</w>
phar ma
pharma kinetics</w>
phal oce
phaloce le-
phalocele- exstroph
phalocele-exstroph y-imperforate-anus-spina</w>
phal ein.</w>
phal ang
phalang eal</w>
phag oly
phagoly sosomes</w>
phag ocytotic</w>
phag ocytosis,</w>
phag ocyte</w>
phag a</w>
phaeochromocyt oma</w>
phacoemulsi fication,</w>
phaclofen ),</w>
phac lofen</w>
phac el</w>
ph yctic,</w>
ph roangiography</w>
ph ox)</w>
ph ostin</w>
ph ost
phost rol)</w>
ph os
phos ph</w>
ph oph
phoph oryl
phophoryl creatine</w>
ph one</w>
ph oc
phoc ome
phocome lia</w>
ph loc
phloc occ
phlococc us</w>
ph leg
phleg mon,</w>
ph isi
phisi op
phisiop atology</w>
ph inc
phinc ter</w>
ph ile</w>
ph ian</w>
ph i</w>
ph i,</w>
ph ery
phery ;</w>
ph er</w>
ph enc
phenc ylclidine</w>
ph azoline</w>
ph ath
phath y:</w>
ph asis</w>
ph ant
phant om</w>
ph anin</w>
ph ania</w>
ph allo
phallo idin</w>
ph ages</w>
ph a,</w>
pg/ml/ hr</w>
pg/ml/ hr)</w>
pg/ mouse)</w>
pg/ mouse),</w>
pg/ ml/24</w>
pg/ kg</w>
pg/ fetus,</w>
pg/ 24</w>
petr ation</w>
peti des,</w>
pethid ine:</w>
pethid ine/
pethidine/ norpethidine</w>
pet us</w>
pet s.</w>
pet rous</w>
pet rolatum).</w>
pestic ides.</w>
pestic ides,</w>
pestic ide.</w>
pestic ide-
pesticide- synergist.</w>
pestic ide)</w>
pess ary.</w>
pess ar
pessar y:</w>
perturb ation;</w>
perturb ation,</w>
perturb ation
perturbation s[4]</w>
perturb ated</w>
pertin ent.</w>
pertin ence</w>
pert ures</w>
persu asi
persuasi ve.</w>
persu aded</w>
persu ade</w>
perspec tives:</w>
personal ity-related</w>
person- years.</w>
person- years,</w>
person- time</w>
person- months</w>
person- months,</w>
person- months):</w>
person s;</w>
person ality.</w>
person al,</w>
person .</w>
persist s,</w>
persist ing,</w>
persist ent.</w>
persist ence.</w>
persec ution</w>
persec ution,</w>
perphenaz ine-treated</w>
perphenaz ine-injected</w>
perpetr ation)</w>
perpetr ation).</w>
perpet uation</w>
perpet uating</w>
perpet uates</w>
perpet uated</w>
perpet uate</w>
peroz ide</w>
peroxynitrite- sensitive</w>
peroxynitrite- related</w>
peroxynitrite- mediated</w>
peroxy nitrit
peroxynitrit e)</w>
peroxisom e-
peroxisome- proliferative</w>
peroxidase- like</w>
peroxid ation;</w>
peroxid ation-mediated</w>
peroxid ases</w>
peroxid ability</w>
perox intr
peroxintr ite</w>
perox in
peroxin it
peroxinit rite</w>
perox ides.</w>
perox ide),</w>
perox an,</w>
pernio sis.</w>
pernio sis)</w>
permit s:</w>
permis sion.</w>
permis sible</w>
perme able.</w>
perme abil
permeabil ized</w>
perm selectivity.</w>
perm selective</w>
perm idine</w>
perivascular ly.</w>
perivascular )</w>
peritone ums</w>
peritone ums+</w>
peritone ally.</w>
periton itis:</w>
periton ial</w>
perit umor</w>
peristal sis.</w>
peris one,</w>
perir hinal,</w>
peripheral- type'</w>
peripheral- blood</w>
peripheral- acting</w>
peripher ies,</w>
peripher ial</w>
peripher ally-</w>
peripher ally-
peripherally- acting</w>
peripher al),</w>
perioper atively,</w>
perioper ative,</w>
periodic ity</w>
periodic ities.</w>
period s)</w>
period ont
periodont ally</w>
period '</w>
perio id
perioid ate-
perioidate- lysine-
perioidate-lysine- 2</w>
perio don
periodon titis</w>
perio do
periodo l</w>
perio d--
period-- was</w>
perio d"</w>
perinuclear- pattern</w>
perineur onal</w>
perineur ally</w>
perind opri
perindopri l.</w>
perin odal</w>
perin ate.</w>
perin at
perinat ally,</w>
perimen strual</w>
perim ysial</w>
perim yocarditis,</w>
perim yocardial</w>
perim posed</w>
perim alleolar</w>
perilymph /
perilymph/ kanamycin</w>
perilymph ,</w>
perikary on.</w>
perikary a,</w>
perif oveal</w>
perid ural</w>
pericy tes,</w>
pericy azine,</w>
pericardiocent esis,</w>
pericardi um;</w>
pericardi um,</w>
pericardi tis:</w>
pericardi tis-myocarditis</w>
pericardi tis)</w>
pericardi otomy</w>
pericardi omyo
pericardiomyo pathy.</w>
pericardi o-</w>
pericardi ectomy</w>
pericardi ally</w>
pericard ectomy</w>
pericard ectomy,</w>
peric ystitis</w>
peric ystitis:</w>
peric um</w>
peric hol
perichol angitis</w>
peric athe
pericathe ter</w>
periaqu a
periaqua ductal</w>
peria xial</w>
peri- tricuspid</w>
peri- oral</w>
peri- natal</w>
peri- mitral</w>
peri- event</w>
peri vesicular</w>
peri vesical</w>
peri ventricular-intraventricular</w>
peri vasculitis</w>
peri vascularly</w>
peri procedure</w>
peri procedurally.</w>
peri procedural</w>
peri procedural,</w>
peri portal/midzonal</w>
peri phery;</w>
peri one</w>
peri metry.</w>
peri metry,</w>
peri metr
perimetr y;</w>
peri infarct</w>
peri incisional</w>
peri hematoma</w>
peri glomerular</w>
peri gen
perigen ual</w>
peri enced</w>
peri ductal</w>
peri ater
periater itis</w>
peri arteritis</w>
peri anesthesia</w>
peri ambi
periambi g
periambig us</w>
peri adventitial</w>
peri -</w>
perhexil ine.</w>
pergol ide:</w>
pergol ide-associated</w>
pergol ide).</w>
pergillo sis</w>
perfusion- fixed,</w>
perfusion- fixation.</w>
perfused- fluoresce
perfused-fluoresce inated</w>
perfused- 250-
perfused-250- kDa</w>
perfus ates</w>
perfus ates.</w>
perfus ate,</w>
perfu sion;</w>
perfu sion/plasmaperfusion</w>
perfu sion)</w>
performed )</w>
performance .(ABSTRACT</w>
performance -based</w>
perform s,</w>
perform ance:</w>
perform ance)</w>
perform ,</w>
perforant- pathway</w>
perforant- path</w>
perfor ma.</w>
perfor ator</w>
perfor ator.</w>
perfor ations.</w>
perfor ation
perforation (s)</w>
perfor at
perforat um).</w>
perfor ans</w>
perf ected</w>
percus sive</w>
percus sion.</w>
percept ual-motor</w>
percep trons.</w>
percep tive</w>
percep tions,</w>
percep tion;</w>
percentile ],</w>
percentile ),</w>
percenti les,</w>
percenti le.</w>
percenti le,</w>
percenti l
percentil es),</w>
percent ages.</w>
percent age.</w>
percent age)</w>
perce i
percei ved.</w>
per- patient</w>
per- orally</w>
per- orally)</w>
per- inducer</w>
per- indomethacin),</w>
per- hypocap
per-hypocap no-
per-hypocapno- anemic</w>
per- formed.</w>
per- attempt</w>
per us</w>
per tubations</w>
per tly</w>
per tain</w>
per spex</w>
per sented</w>
per s'</w>
per orally.</w>
per niotic</w>
per nic
pernic osa</w>
per n
pern icious</w>
per muted</w>
per mutations</w>
per meth
permeth rin</w>
per mature</w>
per mac
permac eae)</w>
per kinesia</w>
per isom
perisom atic</w>
per ide</w>
per durable</w>
per down,</w>
per cutaneously</w>
per cut
percut aneously.</w>
per chlor
perchlor ic</w>
per ching</w>
per ceptibility</w>
per azine</w>
per atively,</w>
per acute</w>
per /
per/ zinc-superoxide</w>
peptide-(25- 35)</w>
peptide- produced</w>
peptide- cGMP</w>
peptide- Y,</w>
peptide(1- 42),</w>
peptide (s)</w>
peptid ases,</w>
peptid al</w>
pep statine,</w>
pep statin</w>
pep pers</w>
pep per</w>
pep per.</w>
peop les</w>
peop le"</w>
penum bra
penumbra ,</w>
pentylentetra zole.</w>
pentylentetra zole-kindled</w>
pentylentetra zole,</w>
pentylenetetrazole- treated</w>
pentylenetetrazole- convulsive</w>
pentylenetetrazol- stimulated</w>
pentylenetetrazol e:</w>
pentylenetetrazol ;</w>
pentylenetetrazol :</w>
pentylenetetrazol -</w>
pentylenetetrazol -,</w>
pentylene trazole.</w>
pentylene trazol-induced</w>
pentyl sparteine</w>
pentyl sparteine.</w>
pentyl ene</w>
pentyl barbituric</w>
pentoxy verine,</w>
pentoxif ylline.</w>
pentoxif yllin</w>
pentoth al,</w>
pentolini um.</w>
pentolini um-treated</w>
pentolini um)</w>
pentobarbitone- anesthetized</w>
pentobarbital- stimulated</w>
pentobarbital- chloralose.</w>
pentobarbit al;</w>
pento thal.</w>
pento ic</w>
pentetra zole.</w>
pentetra zole-,</w>
pente trazol,</w>
pentazoc ine:</w>
pentazoc ine/tripelennamine</w>
pentazoc ine-
pentazocine- block</w>
pentazoc ine)</w>
pentagastr in-induced</w>
pentachloro phenol</w>
penta hydrate,</w>
pent yloxy)carbonyloxymethyl-5-acetyl-2-n-propyl-3-[2'(1H</w>
pent yl</w>
pent raxin.</w>
pent ostatin</w>
pent osid
pentosid ine,</w>
pent osan</w>
pent orb
pentorb arbit
pentorbarbit al</w>
pent ob
pentob arti
pentobarti tal-anesthetized</w>
pent eno
penteno ate</w>
pent as
pentas accharide</w>
pent amethyl
pentamethyl ene
pentamethylene tetrazole,</w>
pent ameth
pentameth onium,</w>
pent af
pentaf l
pentafl uropropionic</w>
pent acetic</w>
pent -1
pent-1 yn-3-ol</w>
penicillo yl</w>
penicillinase- producing</w>
penicillin- type"</w>
penicillin- coated</w>
penicillin- G),</w>
penicill ins)</w>
penicill inase</w>
penicill in:</w>
penicill in-treated</w>
penicill in-like</w>
penicill amine-treated</w>
penicill amine-
penicillamine- immune</w>
penetran ce.</w>
penetr ative</w>
penetr ation-
penetration- test</w>
penetr ates</w>
penetr at
penetrat ing),</w>
penetr ant,</w>
penetr ability.</w>
pend ulous</w>
pend ing.</w>
penc illin-induced</w>
penbut olol:</w>
penbut olol.</w>
penal ty</w>
penal ties</w>
pen ultimate</w>
pen is;</w>
pen ile
penile /
penile/ clitoral</w>
pen ic</w>
pen ed</w>
pen ectomy</w>
pempid ine,</w>
pemphig us:</w>
pemphig us,</w>
pemphig oid</w>
pemphig oid
pemphigoid :</w>
pemiro last.</w>
pemetrex ed.</w>
pemetrex ed,</w>
pem ol
pemol ine;</w>
pelv ic)</w>
pelv i</w>
pellet s;</w>
pellet ;</w>
pelle ted</w>
pel mit
pelmit yl</w>
pegylated- IFN-alpha-2b</w>
pegyl ated:</w>
pegyl ated
pegylated -</w>
peg- interferon</w>
peg- IF
peg-IF N)-
peg-IFN)- alpha2b</w>
peg interferon/ribavirin</w>
peg interferon-
peginterferon- alpha-2a</w>
peg filgrastim,</w>
peg filgrastim
pegfilgrastim :</w>
peg IFN-
pegIFN- 2a</w>
pefloxac in:</w>
pefloxac in-
pefloxacin- to-norfloxacin</w>
pefloxac in)</w>
pefloxac in's</w>
pedunc ulupontinus</w>
pedunc ulated</w>
pedunc le.</w>
pedig rees.</w>
pedig ree</w>
pedicel s.</w>
pedicel s,</w>
pedicel 's</w>
pedic ulicide</w>
pediatrici ans,</w>
pediatrici an</w>
pediatric /
pediatric/ paedi
pediatric/paedi atr
pediatric/paediatr ic,</w>
pediatric )</w>
pedi s.</w>
pedi ment</w>
ped s)<0.028,</w>
ped s)</w>
pector is;</w>
pector alis</w>
pect ancy</w>
pec king</w>
pec ific</w>
pear l</w>
pear l
pearl ,"</w>
pear -shaped</w>
peak/ resting</w>
peak/ baseline</w>
peak/ QT</w>
peak-to- trough</w>
peak-to- peak</w>
peak- trough</w>
peak- negative</w>
peak- end
peak-end )</w>
peak- dose"</w>
peak- cardiac</w>
peak ;</w>
peak :</w>
peak "</w>
pea ks,</w>
pe rennial</w>
pe red,</w>
pe ol,</w>
pe o
peo ples.</w>
pe liosis-like</w>
pe hn
pehn acet
pehnacet in,</w>
pe g</w>
pe floxacin-induced</w>
pe ers.</w>
pe eling</w>
pe el</w>
pe el
peel ing,</w>
pe de
pede mic,</w>
pe brae</w>
pe an
pean ut</w>
pe a</w>
pctx-then-cisDD P</w>
pct x</w>
pct x-</w>
paw-lick/ muscle</w>
paw- thickness</w>
paw- tapping</w>
paw- pressure,</w>
paw- on-
paw-on- do
paw-on-do wel</w>
paw- lift</w>
paw- incised</w>
paw s:</w>
paw ;</w>
pauci- immune,</w>
pauc ity.</w>
pauc ity,</w>
pattern- reversal</w>
pattern- ANCA.</w>
pattern s;</w>
pattern less
patternless "</w>
pattern )</w>
pattern ),</w>
patients-- showed</w>
patients-- interindividual</w>
patients-- hypotension,</w>
patients-- 9</w>
patient/ parent</w>
patient/ outpatient</w>
patient/ operator</w>
patient- years,</w>
patient- years)</w>
patient- years).</w>
patient- year</w>
patient- year).</w>
patient- weeks.</w>
patient- week),</w>
patient- treatment-years)</w>
patient- specific,</w>
patient- rated</w>
patient- controlled-
patient-controlled- analgesia</w>
patient- completed</w>
patient- -12,</w>
patient- ,</w>
patient s></w>
patient s":</w>
patient ],</w>
patient ]).</w>
patient :
patient: ALT:
patient:ALT: 294</w>
patient -related</w>
patient --with</w>
patient --a</w>
patient (s),</w>
pathway s'</w>
pathway .(ABSTRACT</w>
pathway ).</w>
pathway (s)</w>
pathway "</w>
pathophysi opathological</w>
pathophysi ology:</w>
pathophysi ologies</w>
pathophysi ologic,</w>
pathomechan isms</w>
pathomechan isms.</w>
pathomechan ism.</w>
pathomechan ism,</w>
patholog y:</w>
patholog ists.</w>
patholog ists,</w>
patholog ist,</w>
patholog ist
pathologist s'</w>
patholog ies;</w>
pathogene tically</w>
path y)</w>
path s</w>
path ologists</w>
path ologically,</w>
path ological.</w>
path ological,</w>
path ogenic,</w>
path obiology</w>
path obio
pathobio logic</w>
path o)
patho) physiology,</w>
path ies:</w>
path -evoked</w>
path -
path- dentate</w>
path ,</w>
patch- use</w>
patch- clamped</w>
patch ily</w>
patch es)</w>
patch :</w>
patch ).</w>
patch ),</w>
pat ine
patine ts</w>
pat in
patin ts</w>
pat es.</w>
pat ent.</w>
pat ellar</w>
pat e,</w>
pat as)</w>
pat .)</w>
passi ve.</w>
passi ve"</w>
pass aged</w>
pas sed,</w>
parvalbumin- staining</w>
parvalbumin- immunopositive</w>
parvalbumin -positive</w>
parv ocellular</w>
parv o-
parvo- cellular</w>
parturi tions,</w>
partner ship</w>
partner s,</w>
partner s),</w>
partner ,</w>
partner )</w>
particular ity,</w>
particular )</w>
participant s)</w>
participant s).</w>
participant 's</w>
particip ated;</w>
particip ant.</w>
particip ant,</w>
parti tions</w>
parti cl
particl es/
particles/ kg</w>
parti alled</w>
parti al;</w>
parti al-
partial- onset</w>
parti al),</w>
parti al
partial ising</w>
part y.</w>
part urition</w>
part s.</w>
part s--acute</w>
part s).</w>
part s),</w>
part ly-
partly- -mediated</w>
part ly)</w>
part -
part- randomised</w>
parrot-be ak
parrot-beak ed'</w>
parrot-be a
parrot-bea ked</w>
paroxys mic</w>
paroxys m</w>
paroxet ine-related</w>
paroxet ine-induced</w>
paroxet ine-,</w>
parox symal</w>
paronych ia</w>
paronych ia,</w>
paro varian</w>
paro tiditis</w>
paro sysms</w>
paro dox
parodox ic</w>
parkinsoni ans</w>
parkinsoni an.</w>
parkinsoni an,</w>
parkinson ism)</w>
parkinson 's</w>
parietal- lobe</w>
pargly ine</w>
parg yline.</w>
paresthe tica</w>
paresthe tica.</w>
paresthe tica,</w>
parenthe ses],</w>
parenthe ses).</w>
parenter ally.</w>
parenter ally,</w>
parent- rated</w>
parent- completed</w>
parenchy matous</w>
parenchy mal
parenchymal ,</w>
parenchy ma.(ABSTRACT</w>
paren t,</w>
parec oxib:</w>
pare thesias,</w>
pare sis:</w>
paraver mal</w>
parati de</w>
parathyroid /bone</w>
parathyro id,</w>
parathormon emia</w>
parathormon e</w>
parathormon e,</w>
parat yrosine</w>
parasympathe tically</w>
parasympathe tic,</w>
parasit osis.</w>
parasit osis)</w>
parasit ologically</w>
parasit ological</w>
parasit ologic</w>
parasit emia,</w>
parasit e's</w>
paras thesias.</w>
paras thesia,</w>
paraqu at</w>
paraqu at.</w>
paraph aryngeal</w>
parapare sis.</w>
parapare sis,</w>
parap leg
parapleg ics</w>
paraox on.</w>
paraox on,</w>
parano ia?</w>
parano ia/
paranoia/ psychosis</w>
parano ia'</w>
paran oid-
paranoid- hallucinatory</w>
paran odal</w>
parameter s.(ABSTRACT</w>
parameter s).</w>
parameter /
parameter/ did</w>
parameter ).</w>
param es
parames angial</w>
param ac
paramac ular</w>
paraly zed.</w>
paraly zed,</w>
paraly sis;</w>
paraly sis)</w>
paraly sis).</w>
paraly ses</w>
parallel- groups</w>
parallel- arm,</w>
paralle lis
parallelis m)</w>
paralle l
parallel ism</w>
paraform aldehyde</w>
paraform aldehyde-
paraformaldehyde- glutaraldehyde</w>
paraform aldehyde,</w>
paraffin- sections</w>
paraff ine
paraffine m
paraffinem bed
paraffinembed ded</w>
paraff in.</w>
paraf ascicular</w>
paraesthe sia,</w>
paradoxic ally.</w>
paradoxic al"</w>
paradig m-
paradigm- antipsychotic</w>
paradig m).</w>
parad ox.</w>
parad ox,</w>
parad ox
paradox :</w>
paracetam ole</w>
paracetam ol-associated</w>
paracetam ol-</w>
paracetam ol-
paracetamol- even</w>
parac rine/autocrine</w>
parac linical</w>
parac erv
paracerv ically.</w>
parac ent
paracent esis,</w>
parac aine</w>
paraaminohipp uric</w>
paraaminohipp urate</w>
para-aminohipp urate</w>
para- hydroxyphenyl)-
para-hydroxyphenyl)- 5-
para-hydroxyphenyl)-5- phenylhydantoin)</w>
para- benzo
para-benzo quinone-imine</w>
para- aminophenol</w>
para proteins</w>
para proteinemia,</w>
para protein</w>
para oxon</w>
para oxidized</w>
para oxidation</w>
para aminoph
paraaminoph ip
paraaminophip purate</w>
par vovirus.</w>
par vicellular</w>
par take</w>
par rot's</w>
par k</w>
par k
park in.</w>
par is</w>
par inu
parinu x</w>
par ing</w>
par ine</w>
par icalcitol-treated</w>
par cel
parcel s</w>
par axon</w>
par athion</w>
par aster
paraster nal</w>
par as.</w>
par apl
parapl atin</w>
par ane-
parane- oplastic</w>
par amount.</w>
par amount,</w>
par aldehyde</w>
par aldehyde,</w>
par ag
parag ig
paragig ant
paragigant ocellular</w>
par achloro
parachloro phenylalanine</w>
paqu e)</w>
paqu e),</w>
papio )</w>
papillo mas,</w>
papillo mas)</w>
papillo ma
papilloma virus</w>
papillo -
papillo- macular</w>
papillede ma)</w>
papill ectomy,</w>
papill ary,</w>
papill ae.</w>
papill a--
papilla-- 74%).</w>
papill a)</w>
paper s,</w>
paper )</w>
papaveret um</w>
papaveret um/400</w>
papaver ine:</w>
pap ile
papile dema</w>
pap il
papil litis</w>
panto thenic</w>
panor amic</w>
panor ama</w>
pannic ulus</w>
panick y</w>
panick ers.</w>
panick ed.</w>
panic s)</w>
panic :</w>
panic -like</w>
panhypopituitar ism,</w>
pancuronium- associated</w>
pancur oni
pancuroni um;</w>
pancreatic /
pancreatic/ biliary</w>
pancreatic -associated</w>
pancreati tis;</w>
pancreati co-
pancreatico- biliary</w>
pancreat ectomy</w>
pancreat ectomy.</w>
pancreas /
pancreas/ pancreatic-associated</w>
pancreas -,</w>
pancreas ).</w>
panc olitis.</w>
panames ine.</w>
pan- based,</w>
pan ventricular</w>
pan sion</w>
pan ophthalmitis,</w>
pan endoscopic</w>
pan el-
panel- reactive</w>
pan el).</w>
pan el's</w>
pan de
pande mic.</w>
pan cytoprotectant</w>
pan cytopen
pancytopen ic.</w>
pan arteritis.</w>
pan agglutin
panagglutin ability.</w>
pan acinar</w>
palsy /
palsy/ paresis</w>
palsy )</w>
palsy ).</w>
palpit ation;</w>
palpit ation.</w>
palmo -plantar</w>
palmitoyl transferase.</w>
palmitoyl phosphatidyl</w>
palmitoyl carnitine,</w>
palmito yl-CoA</w>
palmit ylacetylglycerol</w>
palmit ate,</w>
palmet to.</w>
palmet to,</w>
pallid us)</w>
pallid um:</w>
pallid um.</w>
pallid um)</w>
pallid um),</w>
pallid otomies,</w>
pallid otom
pallidotom y-induced</w>
pallid osub
pallidosub thalamic</w>
pallid of
pallidof ugal</w>
palli ative,</w>
palli ation.</w>
palli ate</w>
palat ine</w>
pal sies.</w>
pal pebrae</w>
pal p
palp ated</w>
pal m-
palm- sized,</w>
pal ities</w>
pal eness,</w>
pal e.</w>
pal e,</w>
pal ates.</w>
pal ates,</w>
pal ate:</w>
pal ate)</w>
pal atable</w>
pal anos
palanos tigma</w>
pal R).</w>
pakot e,</w>
pakot e).</w>
pak ene,</w>
pak ene)</w>
pair s-104</w>
pair s--who</w>
pair s)</w>
pair s);</w>
pair ings.(ABSTRACT</w>
pair ing</w>
pair ing,</w>
pair e</w>
pair -
pair- fed.</w>
painkill ers</w>
painkill er.</w>
painful ly</w>
painful "</w>
pain/ pressure</w>
pain/ anxiety</w>
pain-intensity- related</w>
pain-intensity- encoding</w>
pain- threshold</w>
pain- relief</w>
pain- reducing</w>
pain- rare</w>
pain- like</w>
pain- inhibitory</w>
pain- induction</w>
pain- generating</w>
pain- free.</w>
pain- facilit
pain-facilit ator</w>
pain- evoking</w>
pain- evoked</w>
pain- control</w>
pain- -a</w>
pain- -
pain-- clinical</w>
pain ting</w>
pain ter</w>
pain t-brush</w>
pain ])</w>
pain /</w>
pain ,
pain, 1</w>
pain ",</w>
pai red.</w>
pafox ,</w>
paeoniflor in,</w>
paediatrici ans.</w>
paediatrici an</w>
paediatrici an,</w>
paedi atric
paediatric )</w>
padd ling,</w>
padd le</w>
pad :</w>
paclitaxel/ epirubicin</w>
paclitaxel/ docetaxel</w>
paclitaxel/ carboplatin.</w>
paclitaxel- treated,</w>
paclitaxel- trabectedin</w>
paclitaxel- then-cisplatin</w>
paclitaxel- injected</w>
paclitaxel- gemcitabine-
paclitaxel-gemcitabine- trastuzumab</w>
paclitaxel- disabling</w>
paclitaxel- carboplatin</w>
paclitaxel- Cremophor</w>
paclitaxel ;</w>
paclitaxel -related</w>
paclitaxel --a</w>
paclitaxel -,</w>
pack ers.</w>
pack er.</w>
pack er,</w>
pack aged</w>
pace down</w>
pace down.</w>
pac ks</w>
pac ks.</w>
pac king,</w>
pac ket
packet s.</w>
pac ker</w>
pac ker
packer s")</w>
pac k</w>
pac k-
pack- years,</w>
pac ing:</w>
pac ing-</w>
pac ing
pacing --a</w>
pac ification</w>
pac er-induced</w>
pac ed;</w>
pac e)</w>
pac curonium</w>
pa1- knockout</w>
pa1- 6)</w>
pa yments</w>
pa yer.</w>
pa vor</w>
pa used</w>
pa use,</w>
pa use).(ABSTRACT</w>
pa thergy</w>
pa st-year</w>
pa rosmia</w>
pa inter
painter .</w>
pa int
paint ing.</w>
pa in-</w>
pa hr
pahr mac
pahrmac ology</w>
pa fox</w>
pa 1</w>
pa -P
pa-P la</w>
pT e/
pTe/ QTc,</w>
pT 3
pT3 a</w>
pK(i)= 7.
pK(i)=7. 28.</w>
pK(i)= 6.6
pK(i)=6.6 8.</w>
pH- adjusted</w>
pH s</w>
pH a</w>
pH PT.</w>
pH G
pHG AP</w>
pEn ,</w>
pEn ),</w>
pClPhe 2,</w>
pClPhe 1,</w>
p> 0.58)</w>
p> 0.16).</w>
p> 0.12).</w>
p> 0.05</w>
p=0.9 9),</w>
p=0.9 2),</w>
p=0.7 78).</w>
p=0.7 57)</w>
p=0.7 18;</w>
p=0.5 81.</w>
p=0.5 36).</w>
p=0.5 35).</w>
p=0.5 1).</w>
p=0.05 8)</w>
p=0.05 4);</w>
p=0.000 3</w>
p=0.000 00
p=0.00000 1]</w>
p=0.00 92).</w>
p=0.00 9).</w>
p=0.00 85;</w>
p=0.00 7);</w>
p=0.00 7),</w>
p=0.00 6),</w>
p=0.00 47,</w>
p=0.00 40
p=0.0040 4;</w>
p=0.00 4),</w>
p=0.00 39),</w>
p=0.00 3)</w>
p=0.00 3).</w>
p=0.00 3),</w>
p=0.00 23);</w>
p=0.00 2,</w>
p=0.00 1,</w>
p=0.0 98;</w>
p=0.0 9)</w>
p=0.0 8).</w>
p=0.0 6).</w>
p=0.0 41).</w>
p=0.0 4).</w>
p=0.0 37;</w>
p=0.0 37)</w>
p=0.0 34)</w>
p=0.0 34).</w>
p=0.0 3)</w>
p=0.0 28).</w>
p=0.0 27).</w>
p=0.0 26).</w>
p=0.0 24).</w>
p=0.0 24),</w>
p=0.0 23).</w>
p=0.0 22).</w>
p=0.0 2)</w>
p=0.0 2).</w>
p=0.0 19),</w>
p=0.0 18).</w>
p=0.0 174.</w>
p=0.0 17).</w>
p=0.0 16)</w>
p=0.0 16).</w>
p=0.0 15);</w>
p=0.0 15
p=0.015 1.</w>
p=0.0 14,</w>
p=0.0 14);</w>
p=0.0 14).</w>
p=0.0 13).</w>
p=0.0 10),</w>
p=0. 50
p=0.50 8).</w>
p=0. 29).</w>
p=0. 20
p=0.20 17,</w>
p=0. 14
p=0.14 0).</w>
p= ns,</w>
p= 1.00),</w>
p= 0.</w>
p= 0.99).</w>
p= 0.88),</w>
p= 0.68)</w>
p= 0.6
p=0.6 57;</w>
p= 0.41)</w>
p= 0.3
p=0.3 1),</w>
p= 0.2)</w>
p= 0.16</w>
p= 0.10).</w>
p= 0.05).</w>
p= 0.0007)</w>
p= 0.0005).</w>
p= 0.0004).</w>
p= 0.0003).</w>
p= 0.0000
p=0.0000 36]</w>
p= 0.000)</w>
p= .12).</w>
p< or
p<or =0.00
p<or=0.00 1
p<or=0.001 )).</w>
p< 0.05.</w>
p< 0.05)</w>
p< 0.027</w>
p< 0.006),</w>
p< 0.005</w>
p< 0.005;</w>
p< 0.003</w>
p< 0.001;</w>
p< 0.001,</w>
p< 0.0001;</w>
p< 0.0001);</w>
p< 0.00001).</w>
p< .08)</w>
p< .05.</w>
p< .05,</w>
p< .05)</w>
p< .04).</w>
p< .007).</w>
p< .004).</w>
p< .0001).</w>
p75NTR- immunoreactive</w>
p75NTR- expressing</w>
p75NT R.</w>
p75(NTR)- immunoreactive</w>
p75(NT R),</w>
p53- dependent</w>
p11. 2.</w>
p11. 1-
p11.1- 21,</w>
p/L p</w>
p/L p)</w>
p/ cr)</w>
p/ Scandinavian</w>
p/ +</w>
p/ +;</w>
p.p. m.).</w>
p.o. ]),</w>
p.o. )-induced</w>
p.o s</w>
p.o ./
p.o./ d)</w>
p.o ).
p.o). a
p.o).a Ana
p.o).aAna AV3V</w>
p.S9 G</w>
p.S9 G,</w>
p. s.p.)</w>
p. r.</w>
p. m.,</w>
p. i.</w>
p-sulfo phenyltheophylline</w>
p-sulfo phenyl-xanthine</w>
p-nitro phenol</w>
p-nitro anisol
p-nitroanisol e-
p-nitroanisole- O-de
p-nitroanisole-O-de methyl
p-nitroanisole-O-demethyl ase</w>
p-nitro -blue</w>
p-iodo phenyl-beta-methyl</w>
p-iodo amphetamine</w>
p-hydroxy levamisole</w>
p-hydroxy atorvastatin</w>
p-coumar ic</w>
p-chloro phenylalanine-5-HT</w>
p-chloro phenylalamine</w>
p-chloro phenoxy-isobutyryl-glycinamide</w>
p-chloro amphetamine-</w>
p-chloro -
p-chloro- phenylalanine-methyl-ester</w>
p-benzo quinone</w>
p-aminohippur ate.</w>
p-aminohippur ate,</w>
p-F-HHSi D</w>
p-F-HHSi D,</w>
p- xylyl-6-AzUd</w>
p- wise</w>
p- vasodilator-stimulated</w>
p- stick</w>
p- p
p-p 38
p-p38 MAPK
p-p38MAPK ,</w>
p- like.</w>
p- lift</w>
p- fluoro</w>
p- deletion</w>
p- co
p-co fil
p-cofil in
p-cofilin ].</w>
p- c
p-c residine,</w>
p- antineutrophil</w>
p- aminophen
p-aminophen ol,</w>
p- amin
p-amin osalicylic</w>
p- OH</w>
p- MAPK
p-MAPK AP
p-MAPKAP K-
p-MAPKAPK- 2,</w>
p- Cl-
p-Cl- Phe
p-Cl-Phe 1,
p-Cl-Phe1, 2,</w>
p- Chloro
p-Chloro phenylalanine</w>
p- Akt,</w>
p- ANCA/
p-ANCA/ MPO-ANCA</w>
p- 2</w>
p- (dimethylamino)</w>
p,p'- dichlorodiphenyltrichloroethane</w>
p'- DD
p'-DD T)</w>
p y,</w>
p x</w>
p ush,</w>
p unding.</w>
p ulation</w>
p tions,</w>
p tion)</w>
p sychedelic</w>
p sy.</w>
p suedonormalization.</w>
p stra</w>
p s)</w>
p ruretic</w>
p raise</w>
p ra-zole</w>
p r</w>
p ox.</w>
p ox
pox virus.</w>
p ound</w>
p onatremia</w>
p ol,</w>
p oc
poc ket
pocket .</w>
p m</w>
p m.</w>
p iti
piti ost
pitiost ane</w>
p ist
pist on</w>
p inter
pinter ia,</w>
p inh
pinh ole</w>
p ing.</w>
p ine-</w>
p ine),</w>
p in-like</w>
p im
pim ec
pimec rolimus</w>
p il,</w>
p ifithrin-alpha</w>
p ia</w>
p g/dL,</w>
p g.</w>
p g).</w>
p f</w>
p et,</w>
p entan
pentan one</w>
p ell
pell ucidum</w>
p ective</w>
p d.</w>
p d)</w>
p ce.</w>
p c</w>
p c)</w>
p b
pb n</w>
p anadeine</w>
p age</w>
p Y1228</w>
p Y1204</w>
p T)-induced</w>
p R
pR h.</w>
p O2,</w>
p O
pO (2),</w>
p N</w>
p N
pN 0</w>
p M,</w>
p M
pM -100</w>
p K(i)</w>
p I
pI X)</w>
p Hi
pHi ,</w>
p EPSP</w>
p EC50</w>
p E
pE n</w>
p D2</w>
p CO2.</w>
p CO2)</w>
p CO(2)
pCO(2) (r
pCO(2)(r :</w>
p CMV</w>
p CCK-8</w>
p C
pC PA;</w>
p ANP</w>
p ANCA,</w>
p A)</w>
p >0.05).</w>
p =</w>
p 70</w>
p 70
p70 S
p70S 6
p70S6 K,</w>
p 67
p67 phox,</w>
p 54</w>
p 53
p53 -induced</w>
p 47
p47 phox,</w>
p 35,</w>
p 300,</w>
p 27
p27 (k
p27(k ip
p27(kip 1)</w>
p 24-
p24- antigenemia</w>
p 16</w>
p 16.</w>
p 15.
p15. 3-16</w>
p 13</w>
p 13.
p13. 3)</w>
p /day</w>
p -1</w>
p (a)
p(a) CO(2)
p(a)CO(2) induced</w>
p '</w>
ozyg otes</w>
ozyg osity.</w>
ozone- based</w>
oz ing</w>
oz di
ozdi azepine</w>
oz a
oza ar
ozaar ;</w>
oxytocin- dopamine</w>
oxytocic s,</w>
oxytoc ine</w>
oxytoc in:</w>
oxytoc in),</w>
oxyphenis atin</w>
oxyphenis atin,</w>
oxyphenbutaz one).</w>
oxyp urines</w>
oxymeth olone</w>
oxymeth ol
oxymethol one.</w>
oxymeth ane-induced</w>
oxymetazol ine-induced</w>
oxymetazol ine,</w>
oxyl in-</w>
oxyl ation</w>
oxyl ate.</w>
oxyl ate)</w>
oxygenase- mediated</w>
oxygen- sparing</w>
oxygen- extraction</w>
oxygen- air</w>
oxygen ator</w>
oxygen ator.</w>
oxygen ating</w>
oxygen ate</w>
oxygen ase,</w>
oxygen ase(s)</w>
oxygen ;</w>
oxygen /
oxygen/ nitrogen</w>
oxygen -induced</w>
oxygen -free</w>
oxycod one/
oxycodone/ acetaminophen,</w>
oxycod one-induced</w>
oxycod one).</w>
oxybutyn in:</w>
oxybutyn in.</w>
oxybutyn in-induced</w>
oxybutyn in,</w>
oxybutyn in)</w>
oxybenz en
oxybenzen o-
oxybenzeno- seleninic</w>
oxy- uridine-positive</w>
oxy- hemoglobin</w>
oxy- alk
oxy-alk anes</w>
oxy- D-glucose</w>
oxy- 5H-
oxy-5H- 2,
oxy-5H-2, 3-</w>
oxy- 2-propionamid
oxy-2-propionamid otetralin</w>
oxy) ethan
oxy)ethan e-
oxy)ethane- N,N,N',N'-
oxy)ethane-N,N,N',N'- tetraacetic</w>
oxy toxinergometrine</w>
oxy tetracycline.</w>
oxy radicals</w>
oxy radical</w>
oxy nitrite</w>
oxy methyl]</w>
oxy methamphetamine.</w>
oxy met
oxymet al
oxymetal zoline</w>
oxy fedrine</w>
oxy fed
oxyfed rine,</w>
oxy ethylene</w>
oxy ethoxy)
oxyethoxy) ethoxy]-
oxyethoxy)ethoxy]- 4,5-
oxyethoxy)ethoxy]-4,5- methylenedioxy-
oxyethoxy)ethoxy]-4,5-methylenedioxy- 2-propyl
oxyethoxy)ethoxy]-4,5-methylenedioxy-2-propyl tol</w>
oxy estradiol</w>
oxy d
oxyd ative</w>
oxy cytidine</w>
oxy amine.</w>
oxy acet
oxyacet e</w>
oxotremor ine-</w>
oxotremor ine-
oxotremorine- (O
oxotremorine-(O TM
oxotremorine-(OTM N)</w>
oxot reorine-induced</w>
oxorubic in;</w>
oxorubic in-related</w>
oxopiperazinyl-1-yl)prop ane]</w>
oxopiperazinyl-1- yl)]propane</w>
oxopiperazin yl-l-yl)propane]</w>
oxod G</w>
oxod G)</w>
oxo- thiomorpholinyl]</w>
oxo- pyrrolidine</w>
oxo- 4-
oxo-4- buten
oxo-4-buten yl-4-methyl-Thr1)-(Val2)-cyclosporin]</w>
oxo- 3-(
oxo-3-( substitutedphenyl)quinazoline</w>
oxo -1,2,3,4-tetrahydro-
oxo-1,2,3,4-tetrahydro- 7-
oxo-1,2,3,4-tetrahydro-7- quinolyl)-2-[(2-methylpyrrolidin-1-yl)methyl]biphenyl-4-carboxamide</w>
oxo -1
oxo-1 (4H)-
oxo-1(4H)- pyridyl]-acetamido)-3-([(5-methyl-1,3,4-thiadiazol-2-yl)-thio]methyl)-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic</w>
oxit ropium.</w>
oxit ropium,</w>
oxit in-associated</w>
oxip urinol</w>
oxip urinol.</w>
oxime ):</w>
oxif loxacin-induced</w>
oxif l
oxifl uridine</w>
oxidoreduct ase.</w>
oxidoreduct ase,</w>
oxidi zer</w>
oxide/ oxygen</w>
oxide/ oxygen.</w>
oxide/ oxygen,</w>
oxide/ cGMP</w>
oxide- synthase</w>
oxide- oxygen.</w>
oxide- oxygen,</w>
oxide- oxygen).</w>
oxide- cyclic</w>
oxide- compromised</w>
oxide- blockade</w>
oxide hydrochloride),</w>
oxide ;</w>
oxide :</w>
oxide -related</w>
oxide -</w>
oxide ).</w>
oxidative/ nitrative</w>
oxidase- mediated</w>
oxidase- A</w>
oxidant s;</w>
oxidant -associated</w>
oxid atively</w>
oxid ases</w>
oxid ases.</w>
oxid ase-induced</w>
oxid ase)</w>
oxic- icv</w>
oxic ity.</w>
oxic ities</w>
oxi parine</w>
oxi metric</w>
oxi metri
oximetri es</w>
oxi metr
oximetr y:</w>
oxi meters</w>
oxi meter</w>
oxi met
oximet asone,</w>
oxi ben</w>
oxet ine-treated</w>
oxcarbazep ine:</w>
oxcarbazep ine-related</w>
oxcarbazep ine-associated</w>
oxazolo[3,2-a] pyridines,</w>
oxazolo[3,2-a] pyridine</w>
oxazolo[3,2-a] pyridine,</w>
oxazolid in
oxazolidin ones,</w>
oxazaphosphor ines</w>
oxazaphosphor ines,</w>
oxazaphosphor ine-induced</w>
oxaz oph
oxazoph os
oxazophos hor
oxazophoshor ine</w>
oxaz olo[
oxazolo[ 4,5-
oxazolo[4,5- h
oxazolo[4,5-h ]
oxazolo[4,5-h] [2,
oxazolo[4,5-h][2, 3
oxazolo[4,5-h][2,3 ]-
oxazolo[4,5-h][2,3]- benzodiazep
oxazolo[4,5-h][2,3]-benzodiazep ine],</w>
oxamniqu ine;</w>
oxaliplat in-related</w>
oxaliplat in)</w>
oxalate- containing</w>
oxal in-1-
oxalin-1- One</w>
oxal ate-induced</w>
oxal ate,</w>
oxal ate)</w>
oxal ate),</w>
oxadiazolo- [4,3-a]</w>
oxadiazolo- :
oxadiazolo-: [4,3-a]</w>
oxadiazolo [4,3-
oxadiazolo[4,3- a]
oxadiazolo[4,3-a] quinoxalin-1-one)</w>
oxadiazolo (4,
oxadiazolo(4, 2-
oxadiazolo(4,2- a)quinoxalin-1-one</w>
oxadiazol es</w>
oxadiazol e
oxadiazole (4,3-
oxadiazole(4,3- a)quinoxalin-1-one</w>
oxadiazol -3-
oxadiazol-3- yl)</w>
oxadi azole</w>
oxacill in-related</w>
oxac or
oxacor ),</w>
oxac in-</w>
oxac arbazepine</w>
oxa 2</w>
oxa -1,
oxa-1, 25-
oxa-1,25- (OH)2D3</w>
ox- metal</w>
ox- LDL</w>
ox- CBZ.</w>
ox- CBZ,</w>
ox- 2)</w>
ox- 2),</w>
ox ylate</w>
ox opent
oxopent phylline</w>
ox ome
oxome ;</w>
ox olo
oxolo (4,</w>
ox odi
oxodi benz
oxodibenz [
oxodibenz[ b,
oxodibenz[b, e]
oxodibenz[b,e] azep
oxodibenz[b,e]azep in-1
oxodibenz[b,e]azepin-1 1-
oxodibenz[b,e]azepin-11- yl]-1-piperazinyl]-2-oxoethyl]cyclopentyl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl]ethyl]argininamide</w>
ox meti
oxmeti dine,</w>
ox itin</w>
ox ins.</w>
ox ine.</w>
ox il
oxil orphan</w>
ox ification</w>
ox idine</w>
ox ia,</w>
ox h
oxh ound</w>
ox azine,</w>
ox athi
oxathi olan
oxathiolan e-
oxathiolane- 5,
oxathiolane-5, 3'
oxathiolane-5,3' )-
oxathiolane-5,3')- quinuclidine),</w>
ox aspiro
oxaspiro [4.
oxaspiro[4. 5]dec
oxaspiro[4.5]dec -
oxaspiro[4.5]dec- 8-
oxaspiro[4.5]dec-8- yl]</w>
ox ane-treated</w>
ox amide</w>
ox amide,</w>
ox aglate)</w>
ox adol,</w>
ox a-
oxa- 4-amin
oxa-4-amin obic
oxa-4-aminobic yclo</w>
ox -J
ox-J en
ox-Jen kins</w>
ow ner's</w>
ow ned</w>
ow n;</w>
ow -Protein</w>
ow )</w>
ovul ation,</w>
oves "</w>
overwhel m</w>
overshoot s</w>
overri ding</w>
overloo king</w>
overloo ked,</w>
overload ;</w>
overlap ,</w>
overl ay</w>
overex pression.</w>
overex pression,</w>
overex er
overexer tion;</w>
overdose d.</w>
overdose d,</w>
over- use</w>
over- time.</w>
over- the</w>
over- representation</w>
over- reliance</w>
over- immunosuppression</w>
over- h
over-h asti
over-hasti ly</w>
over- expressing</w>
over- express</w>
over- enthusiastic</w>
over- development</w>
over- compensates</w>
over- coagulation</w>
over- anticoagulation</w>
over- additive</w>
over- activity.</w>
over view.</w>
over use:</w>
over use.</w>
over use-induced</w>
over treatment</w>
over tebral</w>
over talkactivity,</w>
over t,</w>
over sulfated</w>
over stretching</w>
over stimulation,</w>
over stimulates</w>
over sol.</w>
over socialisation,</w>
over simplified.</w>
over shadowed</w>
over setamide</w>
over secretion</w>
over seas;</w>
over ruled</w>
over ride</w>
over representation</w>
over produced</w>
over perfused</w>
over night.</w>
over night-
overnight- improvements</w>
over medicated</w>
over look</w>
over inhibition</w>
over ingestion</w>
over infusion.</w>
over immunosuppression</w>
over i
overi ectomized</w>
over hydrated</w>
over growth.</w>
over flow,</w>
over driving,</w>
over drinking</w>
over dosing.</w>
over dose-related</w>
over dose-
overdose- associated</w>
over dose),</w>
over dosages.</w>
over consumed</w>
over compliance</w>
over compensatory</w>
over comes</w>
over all-
overall- response</w>
over activity;</w>
over activation</w>
over activ
overactiv it
overactivit y-induced</w>
over )</w>
ovariectom y).</w>
ovariectom ized.</w>
ovari um</w>
ovari es.</w>
ovari es,</w>
ovari ectomy.</w>
ovari ectomy,</w>
ovan ad
ovanad ate.</w>
oval eric</w>
oval e.</w>
ov ular</w>
ov sky</w>
ov or
ovor in.</w>
ov o,</w>
ov ic,</w>
ov ary;</w>
ov ario
ovario hysterectomized</w>
ov aer
ovaer ts</w>
output s,</w>
output :</w>
output -</w>
output ),</w>
output "</w>
outcom es:</w>
outcom es).</w>
outcom e),</w>
outbreak ,</w>
out-of- treatment</w>
out-of- protocol</w>
out-of- plan</w>
out-of- control</w>
out- put</w>
out- patients:</w>
out- patients,</w>
out- numbered</w>
out weight</w>
out spread</w>
out side,</w>
out set</w>
out set)</w>
out pouring</w>
out patient.</w>
out patient,</w>
out look</w>
out line
outline d;</w>
out li
outli er)</w>
out let.</w>
out lasting</w>
out lasted</w>
out last</w>
out growing</w>
out flows</w>
out crosses.</w>
out crosses,</w>
out bursts</w>
out bre
outbre ad</w>
out :</w>
out '.</w>
ouse wife</w>
ous- ouabain-displacing</w>
ous- depressed</w>
ous y</w>
ous sel</w>
ous a.</w>
ous :</w>
ous -onset</w>
ous )]</w>
ous ),</w>
ous "</w>
ouret tism)</w>
our th</w>
our al,</w>
our able</w>
our .</w>
ound aries</w>
oun ts</w>
oun ds.</w>
oun d"</w>
oun cil</w>
oun ce
ounce ments.</w>
oumar in</w>
oumar )-induced</w>
ouma rol.</w>
ough ly</w>
ouabain- treatment</w>
ouabain- sensitive</w>
ouabain- resistant</w>
ouabain- insensitive</w>
ouabain- but</w>
ouabain- arrhythmias</w>
ouabain- arrhythmia</w>
ouabain /O
ouabain/O LS</w>
ouabain .3.</w>
ouabain )</w>
ouabain ),</w>
ouabain "</w>
ouab agen
ouabagen in,</w>
ou tis.</w>
ou th</w>
ou ter-third</w>
ou ter,</w>
ou ston</w>
ou ston,</w>
ou se-Geisser</w>
ou rette</w>
ou rea,</w>
ou mal
oumal one,</w>
ou die</w>
ou d,</w>
ou d's</w>
ou b
oub icin</w>
ou )</w>
otyp ically</w>
otumori genicity</w>
otub es,</w>
otroph omonas</w>
otroph in-releasing</w>
otrop ins</w>
otrop in,</w>
otrop il),</w>
otrop ic,</w>
otrop ia,</w>
otri osid
otriosid ase</w>
otri de</w>
otri azole.</w>
otri azole,</w>
otri as
otrias ylceramide</w>
otrex ate</w>
otrans duction</w>
otrans aminase</w>
otoxicity- associated</w>
otoxic ologic</w>
otoxic ity:</w>
otoxic ities</w>
otoxic .</w>
otoxic -induced</w>
otox ocity</w>
otox ins.</w>
otox ins,</w>
otox -treated</w>
ototoxic ;</w>
otorhinolaryng ologist</w>
otorhinolaryng ological</w>
otop ia</w>
oton ically</w>
otom y).</w>
otom es</w>
otolaryng ologist.</w>
oto protection,</w>
oto beam</w>
oti n</w>
oti ent</w>
oti de:</w>
oti d
otid ase,</w>
other- day</w>
other- convulsant-induced</w>
other wise.</w>
other s;</w>
other s:</w>
other s'</w>
other is
otheris k</w>
other ?)</w>
other :</w>
othec in,</w>
oth schild)</w>
otetr aline</w>
otetr alin,</w>
otere )</w>
oter mination</w>
otepa -associated</w>
oten sion</w>
ote plase.</w>
otaxime -induced</w>
otaxime -associated</w>
otax ime</w>
otax ically</w>
otap es</w>
otage '</w>
otage ').</w>
ot zias</w>
ot ungstic</w>
ot t's</w>
ot suto,</w>
ot subo-shaped</w>
ot rophy)</w>
ot remorine-induced</w>
ot raumatic</w>
ot oxylin</w>
ot otraumatic</w>
ot otoxins</w>
ot otoxins,</w>
ot oscop
otoscop ic,</w>
ot osclero
otosclero sis).</w>
ot or)</w>
ot o,</w>
ot line</w>
ot etra
otetra zines</w>
ot est.</w>
ot es.</w>
ot ation</w>
ot astat</w>
ot ane</w>
ot amides.</w>
ot alam
otalam ato</w>
ot age,</w>
ot actin</w>
ot actic</w>
ot ,</w>
osulf ur</w>
osulf ophthal
osulfophthal ein,</w>
osulf ate</w>
osulf ate:</w>
osulf an</w>
osub stituted</w>
ostom y,</w>
ostom atitis.</w>
ostimul ating</w>
osteoporo sis:</w>
osteomyeli tis/septic</w>
osteomyeli tis)</w>
osteomalac ia,</w>
osteoc lasts</w>
osteoc lastic</w>
osteo dystrophy,</w>
osteo dystrophic</w>
osteo dynia</w>
osteo arthrosis</w>
osteo arthropathy.</w>
osteo -</w>
osten uria</w>
oste ophy
osteophy te</w>
oste open
osteopen ic"</w>
oste oblast</w>
oste itis.</w>
oste en</w>
ost overtebral</w>
ost osis</w>
ost osis,</w>
ost oc
ostoc k,</w>
ost ly,</w>
ost asis,</w>
ost asi
ostasi s)</w>
ost ana</w>
osplen omegaly</w>
osph on
osphon ovaleric</w>
osph ing
osphing olipids</w>
ospec tra</w>
osom atic</w>
osmoly tes,</w>
osmolar ),</w>
osmolal ity:</w>
osmolal ity)</w>
osmol arities</w>
osmol ar,</w>
osmol al,</w>
osmo regulated</w>
osmo receptors</w>
osmo receptors.</w>
osmo receptor/thirst</w>
osmo protective</w>
osmo -
osmo- regulating</w>
osis- associated</w>
osin- positive</w>
osin- -made</w>
osin es</w>
osin :</w>
osi s).</w>
osi do-
osido- sorbitol)</w>
osi d</w>
osi al
osial ic</w>
oscop y:</w>
oscop y)</w>
oscop y).</w>
oscop ically,</w>
osclero sis,</w>
osclero dermat
osclerodermat ous</w>
oscillo scopic</w>
oscillo metry</w>
oscillat or
oscillator "</w>
oscill ations)</w>
osc ine).</w>
os zkiewicz</w>
os ystems,</w>
os yltransferases</w>
os yltransferase</w>
os tium.</w>
os tilbene-2,2'</w>
os sicles</w>
os plenic</w>
os paring</w>
os opt</w>
os omes</w>
os mos
osmos ensitive</w>
os mol/
osmol/ kg,</w>
os malar
osmalar ity</w>
os m-
osm- Posm</w>
os in-related</w>
os hib
oshib a,</w>
os er
oser ilin</w>
os ens,</w>
os ening</w>
os clea
osclea rosis</w>
os can</w>
os an,</w>
os amine</w>
os amin
osamin ated</w>
os amides.</w>
os ae)</w>
os acchar
osacchar ides,</w>
os M)</w>
os /day</w>
os -induced</w>
os -exposed</w>
oryl choline</w>
ory- strengthening</w>
ory- associated</w>
orubic inol,</w>
orubic in;</w>
orthost atism</w>
orthost asis.</w>
orthopedist s</w>
orthopedist .</w>
orthop edic
orthopedic /
orthopedic/ physical</w>
ortholog ue</w>
ortholog s</w>
ortho- chlorinated</w>
ortho- ,</w>
ortho steric</w>
ortho ses.</w>
ortho grade</w>
orth yl-</w>
orth ryn,</w>
orth ovanadate.</w>
orth osis.</w>
orth olog</w>
orth odon
orthodon tic</w>
ors -mediated</w>
ors -
ors- multiple</w>
ors );</w>
ors ',</w>
ors '
ors' first</w>
orrhoe ic</w>
orrhoe ae</w>
orrho ea.</w>
orrhe xis,</w>
orrh ages</w>
orphine >
orphine> nal
orphine>nal orphine
orphine>nalorphine =
orphine>nalorphine= naloxonazine.</w>
orphenad rine:</w>
orphenad rine-induced</w>
orphenad rine,</w>
orphan ol;</w>
orphan age</w>
orph ines.</w>
orph in(1-31)</w>
orot atory</w>
orot ate,</w>
orosomuc oid.</w>
oro- nasal</w>
oro- lingual</w>
oro uracil</w>
oro tic</w>
oro megaly</w>
oro genital</w>
oro gastric</w>
oro facil
orofacil al</w>
oro d</w>
oro bulbar</w>
ornith ine,</w>
orn il</w>
orn idazole,</w>
ormad inone,</w>
orm ity</w>
orm icum</w>
orm an,</w>
orm al-
ormal- Protein</w>
orlistat -treated</w>
orlistat -induced</w>
orlistat ,</w>
origin ?</w>
orig in).</w>
orient ing,</w>
orient ed,</w>
orient ation.</w>
orient ated</w>
oric e)</w>
oric ally,</w>
oric "</w>
ori metry.</w>
ori genicity</w>
ori ety</w>
ori es;</w>
ori es)</w>
ori ental</w>
ori bund
oribund i</w>
ori atic</w>
orgas m.</w>
organophosphor ylation</w>
organophosph ate,</w>
organom ent
organoment al'</w>
organom ang
organomang anese</w>
organochlor ide</w>
organo selenium</w>
organel le/
organelle/ unit</w>
organel le.</w>
organ s:</w>
organ osulfur</w>
organ ize</w>
organ izations.</w>
organ iz
organiz ational</w>
organ ised</w>
organ isation.(ABSTRACT</w>
organ ?</w>
organ ;</w>
organ -
organ- failure</w>
org/ mL</w>
org et
orget own</w>
org es'</w>
org astic</w>
org ar
orgar d)</w>
orex inergic</w>
orex in-1</w>
orex in-
orexin- A-induced</w>
orex ate</w>
orex :</w>
oret te</w>
ores cent</w>
ore ticular</w>
ore station</w>
ore activity</w>
ore a,</w>
ore -
ore- T
ore-T ex</w>
ore 's</w>
ordin arily,</w>
order ly,</w>
order ;</w>
order ):</w>
order ),</w>
ord s:</w>
ord al</w>
orcipren aline,</w>
orchi ectom
orchiectom y).</w>
orch idectomy</w>
orch id
orchid opex
orchidopex y</w>
orbitof rontal-striatal</w>
orbitof rontal,</w>
orbit antly</w>
orbit al,</w>
orb its,</w>
orb icul
orbicul aris</w>
orb a,</w>
orax aze)</w>
orax ),</w>
orall y;</w>
orall y:</w>
orall y).</w>
oral- verapamil-induced</w>
oral- popliteal</w>
oral- buccal</w>
oral- buccal
oral-buccal )</w>
or= 170</w>
or/ serious</w>
or/ recipient</w>
or/ imidazoline</w>
or- sphincter</w>
or- section</w>
or- pi-sulfonate</w>
or- motor</w>
or- evoked</w>
or- equal</w>
or- coded</w>
or- basal</w>
or- Heart</w>
or- BN
or-BN I,</w>
or- 6-keto-PGF(1alpha)</w>
or- -tail</w>
or y/analgesic</w>
or y-</w>
or us-induced</w>
or tral</w>
or tment</w>
or tions</w>
or ticoid-treated</w>
or ta</w>
or sal,</w>
or s;</w>
or rubicin.</w>
or rage,</w>
or p,</w>
or ity,</w>
or itizing</w>
or ism,</w>
or ised</w>
or iness</w>
or in-
orin- loaded</w>
or ific
orific e</w>
or ide,</w>
or idaz
oridaz ine,</w>
or ical</w>
or ia</w>
or ia.</w>
or he
orhe ological</w>
or gi
orgi .,</w>
or ders.</w>
or def
ordef rin</w>
or che
orche strating</w>
or ang
orang e-
orange- colo
orange-colo red,</w>
or alis</w>
or al).</w>
or al),</w>
or ach
orach isch
orachisch i
orachischi sis,</w>
or =.05)</w>
or -blind</w>
opyrrolid ine-
opyrrolidine- 2R,4R-
opyrrolidine-2R,4R- dicarboxylate,</w>
opyrimid ines</w>
opyrid ines</w>
opyrid ine),</w>
opyri dine-induced</w>
opyran o
opyrano se)</w>
opyr ine-N-
opyrine-N- demethylase</w>
opyr ine,</w>
opy rimidine</w>
opur ulent</w>
opur puric</w>
optim izes</w>
optim ized,</w>
optim ization,</w>
optim istic</w>
optim ising</w>
optim ised</w>
optim al"</w>
optico- neuropathy</w>
optico- myelopathy</w>
opri van.</w>
opri l-induced</w>
opredn ate</w>
opposit ely</w>
opposit a</w>
oppon ent</w>
oppon ent.</w>
oppon ens</w>
oporphy rin.</w>
opolysacchar ides.</w>
opoiet in-1</w>
opoi e
opoie tic,</w>
opo enia,</w>
oplas ms</w>
oplas m.</w>
opit ant</w>
opisthoton ous,</w>
opisthoton os</w>
opisthoton os.</w>
opiperid inyl)
opiperidinyl) eth</w>
opioid/ hypnotic</w>
opioid/ hypno
opioid/hypno tic/sedative</w>
opioid- typical</w>
opioid- experienced</w>
opioid- dependency</w>
opioid- catalepsy</w>
opioid- antagonist</w>
opioid- anesthesia</w>
opioid s).</w>
opioid ergic,</w>
opioid :</w>
opioid -type</w>
opioid ).</w>
opio dergic</w>
opini ons</w>
opini on.</w>
opini on).</w>
opindo lol.</w>
opiate- dependent,</w>
opiate- dependence</w>
opiate- agonist</w>
opiate- activated</w>
opi um,</w>
opi ates;</w>
opi atergic</w>
opi ate/
opiate/ drug</w>
opi ate-related</w>
opi ate,</w>
opi ate)</w>
opi at
opiat es/
opiates/ opioids</w>
ophysi ological</w>
ophyl lin
ophyllin )</w>
ophy tic</w>
ophy ce
ophyce ae)</w>
ophthalmolog y,</w>
ophthalmolog ist,</w>
ophthalmolog ic,</w>
ophthalmo s</w>
ophthalmo paresis.</w>
ophthalm oscopy,</w>
ophren )</w>
ophosphor ylation</w>
ophosphor ylase</w>
ophore -</w>
ophil ic.</w>
ophil ia,</w>
ophen anth
ophenanth roline</w>
opharyng itis</w>
opharyng itis,</w>
oph thamic</w>
oph talmological</w>
oph oria.</w>
oph ine</w>
oph ed</w>
oph asi
ophasi c,</w>
oph aryn
opharyn geal,</w>
oph an-niacin</w>
oph ag
ophag ocytosis</w>
oper oxidase,</w>
oper one,</w>
oper ineal</w>
oper ich
operich ond
operichond rial</w>
oper azone</w>
oper ator,</w>
oper ative)</w>
oper ation;</w>
oper ation)</w>
oper ation).</w>
oper ation),</w>
oper ation
operation alized</w>
oper ates</w>
oper ated)</w>
oper ate.</w>
oper amide</w>
opepti de-induced</w>
opent yl-esters</w>
opent o
opento acetic</w>
openh ag
openhag en,</w>
open- trial</w>
open- labeled</w>
open- heart</w>
open- field;</w>
open- field.</w>
open- design,</w>
open- chest,</w>
open- che
open-che sted</w>
open label</w>
open ings.</w>
open ings,</w>
open icill
openicill ins</w>
open ias</w>
open ia).</w>
open ed.</w>
open .</w>
open -</w>
ope z</w>
opath y)</w>
opath ologically,</w>
opath ogenetic</w>
opamid ol,</w>
opac ity,</w>
opac ities;</w>
opac ified</w>
opa use</w>
opa .</w>
op ysthotonus,</w>
op y</w>
op utamen</w>
op ulsion,</w>
op tometric</w>
op tional</w>
op tional.</w>
op tion:</w>
op tic-nerve</w>
op sonized</w>
op sia),</w>
op raxia,</w>
op pression</w>
op position</w>
op omorph
opomorph ine</w>
op oli
opoli etic</w>
op olar</w>
op noea</w>
op legia</w>
op kalemia</w>
op ituitary</w>
op ig
opig ment</w>
op etal</w>
op es.</w>
op er</w>
op eptid
opeptid ase/
opeptidase/ endothelin-converting</w>
op edic</w>
op c
opc -10
opc-10 85)</w>
op ath</w>
op ami
opami ro)</w>
onychomyco sis:</w>
onychomyco sis)</w>
onychomy cosis</w>
onwar ds,</w>
onwar ds)</w>
onwar ds).</w>
onwar d,</w>
onucle otide</w>
onto genesis.</w>
ont inu
ontinu ous</w>
ont anel
ontanel le</w>
onset-to- treatment</w>
onset-to- treatment-time</w>
onset ?</w>
onset :</w>
onset ).</w>
onset "</w>
onse ts,</w>
onov um777</w>
onom icro
onomicro metry</w>
onol s,</w>
onlay s/valve</w>
onlay s,</w>
onium- stained</w>
onium- hyoscine</w>
onitri le/
onitrile/ the</w>
onit rosourea</w>
onit en
oniten ),</w>
onion skin"</w>
onion oid</w>
onic ;</w>
oni um-treated</w>
oni um),</w>
oni on-
onion- rich</w>
oni as,</w>
oni ally</w>
oni ach</w>
ongest ants</w>
ong- Evans</w>
ong iform</w>
ong es
onges tion.</w>
oneuro pathies</w>
oneuro n</w>
oneuro myographic</w>
oneuro endocrine</w>
oneur onal</w>
oneph romegaly,</w>
onec rosis.</w>
one/ sodium</w>
one/ phenobarbital-induced</w>
one/ mg</w>
one/ glutathione</w>
one/ amphetamine</w>
one-to- two</w>
one-to- several</w>
one-- should</w>
one-- hence</w>
one-- for</w>
one-- avoid</w>
one- twentieth</w>
one- trial,</w>
one- treated,</w>
one- third,</w>
one- thalidomide</w>
one- tenth</w>
one- tailed</w>
one- stage</w>
one- seventh</w>
one- precipitated</w>
one- patient,</w>
one- page</w>
one- month</w>
one- month's</w>
one- minute</w>
one- mediated</w>
one- lung</w>
one- injected</w>
one- indued</w>
one- hydrochloride)</w>
one- half.</w>
one- filled</w>
one- day-old</w>
one- clip</w>
one- carbon)</w>
one- arm,</w>
one- activated</w>
one- S-transferase</w>
one- Po
one-Po ulenc</w>
one- 3-
one-3- glucoron
one-3-glucoron ide,</w>
one- 21-
one-21- hemisuccin
one-21-hemisuccin ate),</w>
one- ,</w>
one+ ligh
one+ligh t).</w>
one y</w>
one urons.</w>
one treated</w>
one ma.</w>
one induced</w>
one dialdehyde</w>
one ></w>
one =
one= naltrex
one=naltrex one></w>
one .(ABSTRACT</w>
one ."</w>
one -1,</w>
one +</w>
one );</w>
ondansetr on-induced</w>
ondansetr on).</w>
ond parinux</w>
ond .),</w>
oncostatin- M.</w>
oncostatin- M,</w>
oncolog y-related</w>
oncolog ists.</w>
oncolog ic,</w>
onco therapeutics;</w>
onco proteins</w>
onco genicity</w>
onco genesis</w>
onco genes</w>
onchocerc iasis</w>
onchocerc iasis:</w>
onchocerc iasis.</w>
once- monthly</w>
once /day,</w>
once /
once/ week.</w>
once ).</w>
onc khe
onckhe ere
onckheere -
onckheere- Ter
onckheere-Ter pstra</w>
onazol e-</w>
onat ally</w>
onad on
onadon na</w>
onab ant</w>
on/ lamotrig
on/lamotrig ine-induced</w>
on/ early</w>
on/ ADV</w>
on- washin</w>
on- therapy</w>
on- therapeutic</w>
on- the-street;</w>
on- study</w>
on- pump</w>
on- phase</w>
on- off
on-off ").</w>
on- medication</w>
on- line,</w>
on- expand
on-expand able</w>
on- coated</w>
on- cells</w>
on- cells,</w>
on- cell</w>
on- based</w>
on- Mann-Whitney</w>
on- Lamb
on-Lamb ert</w>
on- 26</w>
on- -
on-- extension</w>
on- ,</w>
on- (MO
on-(MO )-induced</w>
on ycholysis,</w>
on ward.</w>
on volution</w>
on ville</w>
on utrient.</w>
on us</w>
on uria</w>
on togeny.</w>
on t</w>
on sillar</w>
on ordefrin</w>
on opathy.</w>
on ogestrel</w>
on odal</w>
on ocicept
onocicept ors</w>
on o
ono ylglycerol</w>
on ly),</w>
on ly"</w>
on line-
online- dialysis.</w>
on ists</w>
on ine.</w>
on ically</w>
on ial</w>
on i</w>
on exic</w>
on es).</w>
on es),</w>
on erous</w>
on emia</w>
on ema</w>
on ella</w>
on ectomy.</w>
on dro
ondro toxicity</w>
on der
onder go</w>
on day-
onday- Fri
onday-Fri day)</w>
on d-B
ond-B lac
ond-Blac k
ond-Black fan</w>
on col
oncol .</w>
on co-
onco- haematological</w>
on azole-
onazole- increased</w>
on ate)</w>
on ate
onate ],</w>
on ase</w>
on as</w>
on ance,</w>
on an,</w>
on al'</w>
on Hal</w>
on -treated</w>
on -like</w>
omyst ).</w>
omyo graphy.</w>
omyo fibrillar</w>
omycin/ vincristine</w>
omycin/ vinblastine.</w>
omycin- toxic</w>
omycin- deafened</w>
omycin- D</w>
omyc in),</w>
omyc es
omyces -like</w>
omy ce
omyce te.</w>
omot or,</w>
omot or)</w>
omorph an</w>
omon ymous</w>
omo to</w>
omni pause</w>
omit ing,</w>
omis sions</w>
omime tic-related</w>
omicro scopy.</w>
ometr ine</w>
omethoxy-3 beta-
omethoxy-3beta- phenyltropane.</w>
omethoxy- 3-
omethoxy-3- beta-
omethoxy-3-beta- (4-fluorophenyl)
omethoxy-3-beta-(4-fluorophenyl) tropane</w>
ometh oxime</w>
ometh an
omethan esulf
omethanesulf onate,</w>
omet al
ometal lography</w>
omer on</w>
omer ic,</w>
omeprol )</w>
omeprazol e-associated</w>
omen ingeal</w>
omen a</w>
omegal ic</w>
omega- position</w>
omega- Nitro-L-arginine</w>
omega- L-arginine</w>
omega- Ag
omega-Ag atoxin</w>
omega- 6</w>
omega- 5</w>
omega- 3/
omega-3/ omega-6</w>
omega- 3-
omega-3- fatty</w>
omega- 2</w>
omeg estrol</w>
omedull in,</w>
omediastin um:</w>
omedi ated</w>
omedi ally.</w>
ome- mediated</w>
ome- length</w>
ome- associated</w>
ome wide</w>
ome ters,</w>
ome prol</w>
ome ostatic</w>
omb s'</w>
omb erg
omberg 's</w>
omat uline)</w>
omat osis,</w>
omasti a.</w>
omalac ia)</w>
omal ities,</w>
omal ia</w>
omal /
omal/ lysosomal</w>
oma- intest
oma-intest ine-
oma-intestine- pancreas/pancreatic-associated</w>
oma- derived</w>
om ustine</w>
om ous</w>
om ophine</w>
om od
omod ulation</w>
om itting</w>
om ileu
omileu sis</w>
om icin</w>
om iasis</w>
om ia.</w>
om es)</w>
om ers.</w>
om er</w>
om b</w>
om azole</w>
om ax)</w>
om app
omapp ing.</w>
om apatri
omapatri lat
omapatrilat -treated</w>
om al-
omal- encapsulated</w>
om ag
omag n
omagn oli</w>
om acro
omacro dex</w>
om a).</w>
om a),</w>
om a's</w>
om -G
om-G ill</w>
om "</w>
olytic- uremiclike</w>
oly tics,</w>
oly tic-like</w>
oly sis),</w>
oly sis"</w>
oly sing</w>
oly saccaride</w>
oly gala</w>
ols/ liter</w>
ology/ clinical</w>
ology- oncology</w>
ology- Self</w>
ologic o,</w>
ologic al;</w>
olog y)</w>
olog ous),</w>
olog ne,</w>
olog ic-
ologic- neurophysiologic</w>
olo- [4,5-
olo-[4,5- c]-
olo-[4,5-c]- pyridin-3-ol</w>
olo- (5,
olo-(5, 4-
olo-(5,4- c)</w>
olo us</w>
olo mon</w>
olo me.</w>
olo me,</w>
olo l/
olol/ pilocarpine</w>
olo l-treated</w>
olo l-associated</w>
olo l-
olol- exacerbated</w>
olo l's</w>
olo ff</w>
olo f
olof t),</w>
olo ch
oloch ic</w>
olo b
olob oma,</w>
olmesart an).</w>
olli ent</w>
oll ars</w>
oll and</w>
oll 's</w>
olivoc erebellar</w>
oliv es,</w>
olith otomy</w>
olip ram</w>
olip id,</w>
olip emic</w>
olin-1 alpha-positive</w>
olin Dis
olinDis k
olinDisk haler)</w>
olin -1,</w>
oligur ic)</w>
oligur ia/
oliguria/ anuria,</w>
oligonucleoti des.</w>
oligonucleoti de
oligonucleotide -mediated</w>
oligodendro gliomas.</w>
oligodendro glia</w>
oligodendro cytes.</w>
oligodendro cyt
oligodendrocyt es),</w>
oligo- priming</w>
oligo s</w>
oligo kinesia,</w>
oligo ethylene</w>
oligo deoxynucleoti
oligodeoxynucleoti des.</w>
oligo dactyl
oligodactyl y.</w>
oligo dacty
oligodacty ly</w>
oligo astrocyt
oligoastrocyt oma)</w>
oligo arthritis</w>
oligo anuria</w>
olig uric,</w>
olig ura</w>
olig ospermia,</w>
olig osaccharides,</w>
olig opeptide</w>
olig omycin,</w>
olig omers.</w>
olig omeric</w>
olig oclonal</w>
olig no
oligno id</w>
olig emic</w>
olig emia</w>
olig emia/
oligemia/ ischemia</w>
olig emia),</w>
olig and</w>
olig -
olig- anuria</w>
olid otin</w>
oli ve.</w>
oli ve-climbing</w>
oli tion-like</w>
oli tics</w>
oli pram,</w>
oli paemic</w>
olfactory- bulbectomized</w>
olfactory- bul
olfactory-bul bo
olfactory-bulbo ectomized</w>
olem mal</w>
olec ranon.</w>
ole- dependent</w>
ole- constricting</w>
ole sion</w>
ole in)</w>
ole ifer
oleifer a-
oleifera- ISP</w>
ole ate</w>
ole amine</w>
ole amide</w>
older ;</w>
older )</w>
older ).</w>
older ),</w>
old- rats.</w>
old- isolated</w>
old- infant</w>
old- group</w>
old stein</w>
old ings</w>
olaz one-induced</w>
olaz apine</w>
olar izing</w>
olanzapine/ risperidone;</w>
olanzap ine-associated</w>
olanzap ine-and</w>
olanzap ine).</w>
olanzap ine'</w>
olan dic</w>
olab ial</w>
olab eled</w>
ol/ kg</w>
ol/ dienogest</w>
ol/ cortisone</w>
ol/ cocaine</w>
ol/ ascorbic</w>
ol/ APAP</w>
ol-5- ylcarbonyl)piperidine</w>
ol-5- ol).</w>
ol-3- sulfate-17</w>
ol- supplemented</w>
ol- refractory</w>
ol- pentazocine</w>
ol- norethindrone</w>
ol- nephrosis.</w>
ol- head
ol-head up</w>
ol- fast</w>
ol- evoked</w>
ol- deficient</w>
ol- O-
ol-O- methyl</w>
ol- Digox
ol-Digox in-
ol-Digoxin- Quinidine</w>
ol- Binding</w>
ol- Age</w>
ol- 2-
ol-2- one,</w>
ol- ,</w>
ol unteer</w>
ol uminescence</w>
ol uble</w>
ol t</w>
ol salazine</w>
ol p),</w>
ol on).</w>
ol lis
ollis ).</w>
ol l.</w>
ol ization</w>
ol is-
olis- St.</w>
ol is
olis uride</w>
ol inium</w>
ol ing,</w>
ol ine-associated</w>
ol in,</w>
ol ide.</w>
ol gamma)</w>
ol ff</w>
ol factori
olfactori um;</w>
ol faction</w>
ol fac
olfac tion.</w>
ol f</w>
ol ey
oley 's</w>
ol ethality,</w>
ol en
olen ticular</w>
ol ectomy.</w>
ol ds)</w>
ol d);</w>
ol b
olb iter
olbiter ans</w>
ol ater
olater al-to-apical</w>
ol ate.</w>
ol ast
olast ine</w>
ol an,</w>
ol aminergic</w>
ol al
olal ia,</w>
ol acri
olacri mal</w>
ol a,</w>
ol ]</w>
ol >
ol> anti-
ol>anti- GBM
ol>anti-GBM =
ol>anti-GBM= gentamicin
ol>anti-GBM=gentamicin >
ol>anti-GBM=gentamicin> nephrectom
ol>anti-GBM=gentamicin>nephrectom y=uranium</w>
ol -like</w>
ol -17-
ol-17- one-hydrochloride)</w>
ol --
ol-- i.e.,</w>
ol +
ol+ electrolytes</w>
ol ):</w>
ok ryptine,</w>
ok ou)</w>
ok ka,</w>
ok ine-
okine- 1</w>
ok ine,</w>
ok ed.</w>
ok ed-
oked- food
oked-food -related</w>
ok aine</w>
ok )</w>
oil/ normal</w>
oil/ lin
oil/lin seed</w>
oil/ kg/d</w>
oil/ 0.50</w>
oil- red</w>
oil- red-O</w>
oil s.</w>
oil /kg</w>
oid- like,</w>
oid s;</w>
oid ed</w>
oid -independent</w>
oid )</w>
oid );</w>
oid ).</w>
oh siung</w>
oh rus</w>
ograph y:</w>
ograph y)</w>
ograph s.</w>
ograph ies.</w>
ogn ition</w>
ogn ine,</w>
oglyc ans</w>
ogest rel,</w>
ogene tically</w>
ogene sis;</w>
ogene sis:</w>
ogene sis--VIII.</w>
ogen tin</w>
ogen s,</w>
ogen ous,</w>
ogen ic'</w>
ogen ia</w>
ogen es</w>
ogen -
ogen- characteristic</w>
ofur in,</w>
ofur an</w>
ofr in-mediated</w>
ofloxac in;</w>
ofloxac in-treated</w>
ofloxac in),</w>
offspr ings.</w>
offspr ing).</w>
offspr ing's</w>
offspr ing
offspring s'</w>
officin alis,</w>
offic es,</w>
offen ders.</w>
offen ders,</w>
offen der</w>
offen der.</w>
offe red.</w>
offe red,</w>
off-lic ence</w>
off-lic ence)</w>
off- treatment</w>
off- target</w>
off- protocol),</w>
off- phase.</w>
off- period,</w>
off- medication</w>
off- kinetics</w>
off- dystonia</w>
off- cells,</w>
off- L-dopa,</w>
off- ,</w>
off sodes.</w>
off set)</w>
off icially</w>
off ice.</w>
off end</w>
off ences,</w>
off -like</w>
off -</w>
off ).</w>
off "),</w>
ofer ritin</w>
ofen opril</w>
ofen ad
ofenad ine?</w>
of- study</w>
of- life</w>
of- know
of-know ing</w>
of- exposure-
of-exposure- related.</w>
of(B(t)dt/B(t ))</w>
of(B(t)dt/B(t )),</w>
of zolpidem</w>
of ten-taught</w>
of rin,</w>
of neuroleptic-induced</w>
of lo
oflo urescence</w>
of lexi
oflexi on</w>
of ischemia.</w>
of id</w>
of colchicine</w>
of cisplatin</w>
of asc
ofasc ial</w>
of ar
ofar ma)</w>
of acial</w>
of Parkinsonism</w>
of GABAA</w>
of Alzheim
ofAlzheim er
ofAlzheimer 's,</w>
of .9%</w>
of --in</w>
of (+/-)8-OH-DPAT</w>
oestrogen /
oestrogen/ progestin-induced</w>
oesophag us.</w>
oesophag oscopy</w>
oedemat ous,</w>
oedemat ogenic</w>
oedema :</w>
oedema -related</w>
oedema -
oedema- promoting</w>
oedema )</w>
oedema ).</w>
oedema '.</w>
odul atory</w>
odon toid</w>
odolpas se)</w>
odol ac</w>
odo logical</w>
odilat or,</w>
odilat ation</w>
odi stributed</w>
odi ly</w>
odi er</w>
odi azepine,</w>
odi al</w>
ode ship</w>
ode anol,</w>
odd sratio</w>
odar one.</w>
od- stabilizing</w>
od- onset</w>
od- maintained</w>
od ylate</w>
od y,</w>
od rine:</w>
od rin</w>
od orsal,</w>
od ors</w>
od ors:</w>
od on,</w>
od get
odget t,</w>
od ene,</w>
od ene
odene 's,</w>
od ds,</w>
od d</w>
od caine</w>
od arone</w>
od al)</w>
od :</w>
ocyto sis:</w>
ocyto phaga</w>
ocyto id</w>
ocyte-integrins (+)</w>
ocyte- toxicity</w>
ocyte- endothelial</w>
ocyte- activating</w>
ocyte -associated</w>
ocyt otoxic</w>
ocyt osed</w>
ocyt ometric</w>
ocyt oma,</w>
ocyt olysis,</w>
ocyste ine</w>
ocyste ine,</w>
ocyn in+
ocynin+ Dex,</w>
ocyn in)</w>
ocycl ic,</w>
ocyan opindolol.</w>
ocyan in</w>
ocy tic/lymphocytic</w>
ocy thaemia</w>
ocy sts</w>
ocy stoplasty.</w>
ocy stinuria</w>
oculog ram)</w>
oculo vestibular</w>
oculo motor)</w>
oculo cephalic</w>
oculo cardiac</w>
ocular- pressure</w>
ocular- hypertensive</w>
ocu lographic</w>
octreoti de;</w>
octreoti de
octreotide -treated</w>
octogenari ans</w>
octogenari an</w>
octogenari an
octogenarian s:</w>
octap epti
octapepti des,</w>
octano ate</w>
octahydro-5- oxo-3-(substitutedphenyl)quinazoline</w>
octahydro quinazoline</w>
oct ylphosphonofluoridate</w>
oct anoic</w>
oct ane-
octane- 3-
octane-3- methanamine</w>
oct an-6,7-endo
octan-6,7-endo ,
octan-6,7-endo, endo-diol)</w>
oct amethylcyclotetrasiloxane</w>
oct afluoro
octafluoro propan-filled</w>
ocrypt ine.</w>
ocrypt in.</w>
ocrypt in),</w>
ocrit .</w>
ocrit ,</w>
ocortico steroid,</w>
ocor tisolaemia</w>
ocor ia</w>
oconvul sants</w>
oconstric tions</w>
ocon version.</w>
ocon trast</w>
ocon jugated</w>
ocompati ble</w>
ocompati bil
ocompatibil ity?</w>
ocol itis</w>
ococci .</w>
ococ cemia,</w>
oclo promide</w>
oclav ine.</w>
ocil )</w>
ocicep tive,</w>
ocicep tive"--may</w>
ocicep tion)</w>
oci s.</w>
oci -in-
oci-in- foci)</w>
ochrom at
ochromat osis-associated</w>
ochro mic,</w>
ochol ine).</w>
ochlor ine</w>
ochlor idemia</w>
ochlo remia,</w>
ochle ae</w>
ochemistr y)</w>
ochemist ry),</w>
ochemic al-specific</w>
ochem ist</w>
ochem is
ochemis tical</w>
och thonous</w>
och im.</w>
och alasin</w>
ocer vix</w>
ocent esis.</w>
ocent er</w>
ocel es.</w>
oce ic
oceic ep
oceicep tion,</w>
occurren ces,</w>
occurren ce:</w>
occur s-the</w>
occur ring,</w>
occur res</w>
occur red:</w>
occur red).</w>
occur rance</w>
occur .(ABSTRACT</w>
occur )</w>
occur "</w>
occupati on,</w>
occup y</w>
occul ta.</w>
occu rence</w>
occlusion- stenosis</w>
occlusion- reperfusion</w>
occlud er.</w>
occlu sively,</w>
occl usal</w>
occl udin,</w>
occl ude</w>
occl ucion</w>
occipit al-
occipital- nuchal</w>
occipit al).</w>
occasion s;</w>
occasion s)</w>
occasion al,</w>
occ curred</w>
ocardi tis</w>
ocardi ally</w>
ocardi a</w>
ocarcin ogenic</w>
ocarcin ogenic,</w>
ocarcin ogenesis</w>
ocarboxaz id</w>
ocarb oxybenzeno-seleninic</w>
ocarb ia</w>
ocap nic</w>
ocap nia,</w>
ocam tide</w>
ocalci uric</w>
ocalce mia,</w>
ocal trol</w>
oca udal</w>
oca proic-acid-induced</w>
oca ine.</w>
oca ine)</w>
oc ylcine</w>
oc ulopathy</w>
oc ulography</w>
oc uli</w>
oc ular,</w>
oc tramine,</w>
oc tocoral</w>
oc taves</w>
oc rome-c</w>
oc ranio</w>
oc ostovertebral</w>
oc omycin</w>
oc olate</w>
oc ol</w>
oc ocaine</w>
oc lean
oclean se</w>
oc k.</w>
oc k
ock hol
ockhol m</w>
oc ir
ocir culatory</w>
oc in.</w>
oc ili
ocili pine</w>
oc idal</w>
oc hemotherapy.</w>
oc hem</w>
oc et)</w>
oc erebro
ocerebro sides.</w>
oc entral</w>
oc ellularis</w>
oc ec
ocec ocystoplasty.</w>
oc ate</w>
oc at
ocat an-6,7-endo
ocatan-6,7-endo ,</w>
oc arm
ocarm ate)</w>
oc ard
ocard lography</w>
oc ane</w>
oc ame</w>
oc alization</w>
obvi ous.</w>
obu trex</w>
obu f
obuf ag
obufag in</w>
obtur ator,</w>
obtund ation;</w>
obtund ation.</w>
obtain able.</w>
obta ined;</w>
obta ined:</w>
obstruc tive,</w>
obstruc tions.</w>
obstruc tion:</w>
obstruc tion.(ABSTRACT</w>
obstruc tion).</w>
obstetric s/gynecology</w>
obstetric s.</w>
obstetric s,</w>
obstetric al,</w>
obstetr icians</w>
obstetr ici
obstetrici an</w>
obses sogenic</w>
observer-bl inded,</w>
observer- rated</w>
observer- rated,</w>
observe d:
observed: expected</w>
observe d/
observed/ predicted</w>
observe d-to-
observed-to- expected</w>
observ ations;</w>
observ ations--
observations-- that</w>
obscur ations.</w>
obscur ations,</w>
obsc ures</w>
obsc en
obscen ities</w>
obronch itis</w>
oblong ata,</w>
oblong at
oblongat a;</w>
oblo t</w>
obliter ans</w>
oblig ed</w>
oblig ate</w>
oblast osis</w>
object- discrimination</w>
object s;</w>
object .</w>
obj ection</w>
obj ecti
objecti vely:</w>
obit z,</w>
obes ity-related</w>
ober ts,</w>
obenz ofuran</w>
obenz amide,</w>
obe y</w>
obarbit uric</w>
obarbit ol.</w>
obacter icidal</w>
obacter ia,</w>
obact ams</w>
ob trusive</w>
ob tains</w>
ob son,</w>
ob solete</w>
ob s</w>
ob olt</w>
ob nub
obnub il
obnubil ation.</w>
ob normal</w>
ob locking</w>
ob let</w>
ob le</w>
ob lastic,</w>
ob lad
oblad der.</w>
ob is-
obis- (3-
obis-(3- ethyl-
obis-(3-ethyl- benzothiazol
obis-(3-ethyl-benzothiazol ine-6-
obis-(3-ethyl-benzothiazoline-6- sulfonic</w>
ob ion</w>
ob ility</w>
ob ility,</w>
ob il
obil ia</w>
ob es.</w>
ob ent
obent ine:</w>
ob an</w>
ob allistic</w>
ob )</w>
o/ HCT
o/HCT Z
o/HCTZ )).</w>
o. i.d.</w>
o. d.</w>
o- xylyl-6-AzUd</w>
o- were</w>
o- trigine</w>
o- tricuspid</w>
o- shaft</w>
o- respiratory</w>
o- psoas</w>
o- posterior</w>
o- phthalaldehyde</w>
o- phosphatidylcholine</w>
o- pen</w>
o- osmolar</w>
o- ordination</w>
o- oral</w>
o- myopathy</w>
o- myoclonic</w>
o- morphometric</w>
o- methyl-
o-methyl- transferase</w>
o- methyl
o-methyl arginine</w>
o- medial</w>
o- masticatory</w>
o- limbic</w>
o- l-</w>
o- inhibition.</w>
o- inflated</w>
o- immune</w>
o- genesis</w>
o- epileptics</w>
o- clinical</w>
o- cellular
o-cellular is</w>
o- bronchitis</w>
o- biochemical</w>
o- athetoid</w>
o- allodynia</w>
o- Thr-34</w>
o- Q),</w>
o- PCs)</w>
o- Mental</w>
o- L
o-L opez</w>
o- A-I,</w>
o- A-
o-A- I)</w>
o- 4H-
o-4H- imidazo</w>
o- 4-
o-4- piperidinopyrimidine)</w>
o- 3</w>
o- 2</w>
o- -a</w>
o- (F
o-(F )
o-(F) quinoxalline</w>
o) phosphate,</w>
o) F
o)F (1)</w>
o ylecgonine</w>
o vits'</w>
o ved</w>
o ul,</w>
o tism.</w>
o tic.</w>
o tic-zone</w>
o thrombosis</w>
o thiophate</w>
o thiazine</w>
o therapy).</w>
o stat.</w>
o septal</w>
o rescence</w>
o rectical</w>
o prol,</w>
o placental</w>
o ozing</w>
o on</w>
o ocular,</w>
o king</w>
o kinase</w>
o kes</w>
o isoquinol
oisoquinol ine-
oisoquinoline- 3-</w>
o ir</w>
o inositi
oinositi de</w>
o imidazole-4-carboxamide</w>
o il:</w>
o il-treated</w>
o ic</w>
o hepatolith
ohepatolith ia
ohepatolithia sis)</w>
o har,</w>
o granular</w>
o ginseng</w>
o fold</w>
o fib
ofib rate/clofibrate</w>
o fi
ofi vermectin</w>
o estrus</w>
o estrus,</w>
o estrogen.</w>
o estrogen-progestogen</w>
o estrogen-dependent</w>
o estradiol
oestradiol :
oestradiol: progesterone</w>
o esophagus</w>
o esophagitis,</w>
o esophageal,</w>
o esoph
oesoph agic</w>
o epidemiologic</w>
o encephalographic</w>
o edematous</w>
o ec
oec ia</w>
o e</w>
o dy
ody no
odyno phagia</w>
o des.</w>
o des,</w>
o der
oder ation</w>
o da
oda k</w>
o analysis</w>
o anaesthesia</w>
o aminidase</w>
o ag
oag ulability.</w>
o a</w>
o a,</w>
o ]</w>
o Smith
oSmith K
oSmithK line,</w>
o P)</w>
o P),</w>
o M</w>
o M),</w>
o FESS</w>
o A-I,</w>
o 2,</w>
o ,
o, p'</w>
o )]</w>
o (R))</w>
o 's</w>
o ",</w>
nystagmus ;</w>
nystagmus )</w>
ny der-
nyder- Kell
nyder-Kell er</w>
nutri tionist</w>
nutri ent
nutrient s-beta-carotene,</w>
nurser y.</w>
nur vala</w>
nur sing.</w>
nur ses.</w>
nur ses'</w>
nur sed</w>
nur se-observers</w>
nur se's</w>
numer ous;</w>
numer ous,</w>
number .(ABSTRACT</w>
number -dependent</w>
numb ers)</w>
numb er/density</w>
numb er/
number/ total</w>
numb er)</w>
numb er).</w>
numb ,</w>
num b</w>
num ;</w>
nulli parous,</w>
nul l,</w>
nucleotide s;</w>
nucleotide s)</w>
nucleoti de,</w>
nucleoti d
nucleotid ases</w>
nucleoside- naive</w>
nucleoside- based</w>
nucleol us.</w>
nucleol onema.</w>
nucleo side/nucleotide</w>
nucleo side,</w>
nuclear- located</w>
nucle uses,</w>
nucle us-encoded</w>
nucle us).</w>
nucle us),</w>
nucle osid</w>
nucle onema</w>
nucle i),</w>
nucle i
nuclei );</w>
nucle ase</w>
nucle ar/
nuclear/ cytoplasmic</w>
nucle ar,</w>
nucle ar
nuclear :
nuclear: cytoplasmic</w>
nub like</w>
nt-14 48
nt-1448 4,</w>
nt-14 459</w>
nt-1 525
nt-1525 7,</w>
nt-1 37
nt-137 30,</w>
nt- signaling,</w>
nt- 94
nt-94 38,</w>
nt- 9
nt-9 80
nt-980 4,</w>
nt- 34
nt-34 60,</w>
nt 3)-
nt3)- null</w>
nox is,</w>
novo ),</w>
novo '</w>
novi tis</w>
novelty- seeking."</w>
novelty- ,</w>
novel ty.</w>
novel ty-</w>
novel ty,</w>
novel -
novel- object</w>
nov ice</w>
notochord al</w>
notochor d.</w>
notice able.</w>
noti fication</w>
noth ing?</w>
noth ing'</w>
noteworth y.</w>
noteworth y,</w>
not- resuscitate</w>
not- in-
not-in- treatment</w>
not- as</w>
not withstanding,</w>
not oriety</w>
not oginseng</w>
not ing</w>
not ed.(ABSTRACT</w>
not ed.
noted. Long-term</w>
not ation</w>
not able;</w>
not able.</w>
not ?</w>
not ),</w>
nosid ase,</w>
nose- septum</w>
nose- only</w>
nose- glucose)</w>
nose bleed</w>
nose bleed
nosebleed s,</w>
nos tic</w>
nos cap
noscap ine</w>
norvegic us.</w>
norveg icus</w>
nortriptyl ine-induced</w>
nortriptyl ine)</w>
normovol emic,</w>
normovol emia</w>
normovol emia,</w>
normother mic.</w>
normother mia;</w>
normotensi ves</w>
normotensi ves,</w>
normotensi ve+diabetes</w>
normoten sion)</w>
normophosphat asia</w>
normophosphat aemia</w>
normomagne semic</w>
normomagne semia)</w>
normokal emia,</w>
normoglyce mia;</w>
normoglyce mia.</w>
normocap nia.</w>
normocap nia,</w>
normo ventilation.</w>
normo ventilated</w>
normo proteinuric</w>
normo protein</w>
normo proteic</w>
normo prolactinaemic</w>
normo physiological</w>
normo frequent</w>
normo blast
normoblast emia,</w>
normo baric</w>
normo albuminuria</w>
normo albuminemic</w>
normo -
normo- hyperkinetic</w>
normaliz e,</w>
normal-to- mild
normal-to-mild ly-
normal-to-mildly- elevated</w>
normal-to- increased.</w>
normal- sized</w>
normal- renin</w>
normal- hearing</w>
normal ization,</w>
normal ity;</w>
normal ity.</w>
normal i
normali sed.(ABSTRACT</w>
normal cy.</w>
normal .(ABSTRACT</w>
normal ).</w>
norm oxia,</w>
norm otonic</w>
norm olipidemic</w>
norm olipemic</w>
norm olipaemic</w>
norm ochromic,</w>
norm ocarbia</w>
norm ocalciuric</w>
norm ocalcemia</w>
norm ative</w>
norm acu
normacu sis.</w>
norgestim ate,</w>
norgestim ate's</w>
norgest rel,</w>
norg estimate</w>
norfloxac in-related</w>
norfloxac in-
norfloxacin- inducted</w>
norethind rone,</w>
norethind rone).</w>
norepinephrine- stimulated</w>
norepinephrine- depleted</w>
norepinephrine- blood</w>
norepinephr ine;</w>
norepinephr ine-evoked</w>
norep ineph
norepineph erine,</w>
noradrenergic- serotonergic</w>
noradrenergic- facilitating</w>
noradrenaline- unresponsive</w>
noradrenaline- rich</w>
noradrenaline- infused</w>
noradrenaline- depleted</w>
noradrenal ine/
noradrenaline/ serotonin</w>
noradrenal ine.
noradrenaline. 5</w>
noradrenal ine-containing</w>
noradrenal ine-</w>
noradrenal ine)</w>
noradrenal ine).</w>
noradrenal in.</w>
nor-binaltorph amine</w>
nor- toxiferine</w>
nor- seizure</w>
nor- dex
nor-dex verapamil,</w>
nor- Delta9-
nor-Delta9- tetrahydrocannabinol-9-carboxylic</w>
nor- BNI.</w>
nor verapamil</w>
nor pseudoephedrine</w>
nor pseudoephedrine.</w>
nor nicotine</w>
nor metaz
normetaz ocine</w>
nor meperidine.</w>
nor meperidine's</w>
nor meperid
normeperid ine/
normeperidine/ meperidine</w>
nor m</w>
nor ibogaine</w>
nor fluoxetine,</w>
nor floxacin.</w>
nor floxacin-induced</w>
nor fenfluramine;</w>
nor fenfluramine.</w>
nor cocaine.</w>
nor coca
norcoca ine),</w>
nor binaltorph
norbinaltorph imine</w>
nor adrenerg
noradrenerg ic-dependent</w>
nor ZTP;</w>
nor -</w>
nor )</w>
nop posed</w>
nootrop ics.</w>
nonoxynol- 9.</w>
noninvasi ve.</w>
noninvasi e</w>
noninduci ble.</w>
noninduci ble,</w>
nonimmobil izer,</w>
non-compli ant.</w>
non-compli ant,</w>
non-Hodgkin 's,</w>
non-Hodgkin 's)</w>
non- warfarin-related</w>
non- violent</w>
non- viable</w>
non- verbal</w>
non- venous</w>
non- use,</w>
non- uroepithelial</w>
non- uniform</w>
non- ulcerous</w>
non- ulcerogenic</w>
non- ulcer</w>
non- tumour</w>
non- tumorous</w>
non- trigeminal</w>
non- tricyclic</w>
non- treatment</w>
non- treatment-seeking</w>
non- trained</w>
non- toxic,</w>
non- tolerant</w>
non- thermal</w>
non- taxane</w>
non- tPA-agents,</w>
non- systemic</w>
non- syndrome</w>
non- synaptic</w>
non- symptomatic</w>
non- sympathectomized</w>
non- suppurative</w>
non- suppressible,</w>
non- sulphated</w>
non- sulfhydryl</w>
non- suitability</w>
non- subtype-specific</w>
non- subtype-selective</w>
non- striatal</w>
non- stress</w>
non- stimulated</w>
non- stereotypical</w>
non- steady</w>
non- steady-state</w>
non- stationary</w>
non- squamous</w>
non- specifically</w>
non- specifically.</w>
non- specific,</w>
non- spatial</w>
non- solid</w>
non- social</w>
non- smokers.</w>
non- smokers,</w>
non- significantly.</w>
non- significantly,</w>
non- significant,</w>
non- significant)</w>
non- shadowing,</w>
non- seroconverters.</w>
non- serious.</w>
non- sensitized</w>
non- selectivity</w>
non- seizure-inducing</w>
non- sedated</w>
non- scheduled</w>
non- ruptured</w>
non- rewarding</w>
non- restrictive</w>
non- restrained</w>
non- responsive</w>
non- responding)</w>
non- replicative.</w>
non- relational</w>
non- relapse</w>
non- reinforcement</w>
non- regenerative</w>
non- receptor</w>
non- reassuring</w>
non- rAndomized</w>
non- pulmonary</w>
non- psychotic</w>
non- pruritic</w>
non- proteolytic</w>
non- protein-bound</w>
non- proteic</w>
non- protective</w>
non- protected</w>
non- prolonging</w>
non- progressive,</w>
non- progression</w>
non- probabilistic</w>
non- pretreatment</w>
non- prescribed</w>
non- pregnant,</w>
non- prednisone</w>
non- predictable</w>
non- prazosin</w>
non- polyuric</w>
non- polyploidizing</w>
non- platinum</w>
non- placebo</w>
non- phenacetin</w>
non- peripheral</w>
non- peculiar</w>
non- participating</w>
non- parenteral</w>
non- panicking</w>
non- panickers.</w>
non- panickers,</w>
non- pair-matched</w>
non- painful,</w>
non- overlapping</w>
non- optimal</w>
non- opioids</w>
non- opioid-treated</w>
non- obstetric</w>
non- observed</w>
non- obese.</w>
non- obese,</w>
non- nutritive</w>
non- nootropic</w>
non- noise-exposed</w>
non- nitroglycerin-
non-nitroglycerin- provoked</w>
non- nicotine</w>
non- neurosurgical</w>
non- neuropathic</w>
non- neuronal</w>
non- neurologic</w>
non- ner
non-ner onal</w>
non- necrotizing</w>
non- necrotic</w>
non- necrogenic,</w>
non- narcotic</w>
non- naproxen</w>
non- naive</w>
non- myocyt
non-myocyt es/number</w>
non- myeloablative</w>
non- myelinated</w>
non- mutagen
non-mutagen ic,</w>
non- muscle</w>
non- muscle-type</w>
non- motor</w>
non- monoaminergic</w>
non- modifiable</w>
non- mod
non-mod fi
non-modfi i
non-modfii able</w>
non- migrainous</w>
non- migraineurs</w>
non- migraine</w>
non- metastatic</w>
non- metastasizing</w>
non- mercap
non-mercap to</w>
non- melanoma</w>
non- megal
non-megal in-
non-megalin- associated,</w>
non- medicated</w>
non- medical</w>
non- match-to-sample</w>
non- lymphoid</w>
non- ligated</w>
non- lethal</w>
non- lesioned</w>
non- kindling</w>
non- ketotic</w>
non- kappa1</w>
non- ischemia</w>
non- ionic,</w>
non- ion
non-ion ic.</w>
non- iodinated</w>
non- involvement</w>
non- invasively</w>
non- invasi
non-invasi vely.</w>
non- intravenous</w>
non- intraocular</w>
non- intensive</w>
non- institutionalized</w>
non- inpatients</w>
non- innerv
non-innerv ated.</w>
non- injection</w>
non- inferior,</w>
non- infected</w>
non- inducibility</w>
non- immunological</w>
non- immunocompromised</w>
non- immunized</w>
non- immune,</w>
non- imidazoline</w>
non- imidazole,</w>
non- ictal</w>
non- hysterectomized</w>
non- hypotensive</w>
non- hydrolyzable</w>
non- homoeopathic</w>
non- hodgkin
non-hodgkin 's</w>
non- heroin</w>
non- hepatic</w>
non- heparin-protamine</w>
non- hemorrhagic</w>
non- hemophiliacs.</w>
non- hemodynamic</w>
non- hemiplegic</w>
non- heart</w>
non- healing</w>
non- headache</w>
non- haloperidol</w>
non- haloperidol-
non-haloperidol- sensitised</w>
non- hallucinating</w>
non- haemorrhag
non-haemorrhag ic'</w>
non- glandular</w>
non- genom
non-genom ic,</w>
non- generalized</w>
non- functional</w>
non- function</w>
non- function.</w>
non- fluoroquinolone</w>
non- fluorescent</w>
non- flowing</w>
non- fibrillating</w>
non- febrile</w>
non- fatal.</w>
non- fatal)</w>
non- fatal).</w>
non- exposure,</w>
non- exposed</w>
non- exencephalic</w>
non- estrogenic</w>
non- estrogen-related</w>
non- esterified</w>
non- erythropoietic</w>
non- ergoline</w>
non- enlarged</w>
non- endotoxic</w>
non- endothelial-
non-endothelial- derived</w>
non- endocrine</w>
non- elderly</w>
non- ectodermal</w>
non- ecstasy</w>
non- dystonic</w>
non- dysplastic</w>
non- dyskinetic,</w>
non- dyskinetic)</w>
non- dyskine
non-dyskine tic;</w>
non- drug-induced</w>
non- drug)</w>
non- dru
non-dru gged</w>
non- dream
non-dream ers.</w>
non- dose-limiting</w>
non- discrimin
non-discrimin atory</w>
non- dilated</w>
non- dihydropyridine</w>
non- diabetic,</w>
non- detectable</w>
non- depressing</w>
non- depressed</w>
non- denuded</w>
non- declarative</w>
non- crystall
non-crystall ine,</w>
non- cross</w>
non- cooled</w>
non- conver
non-conver tors</w>
non- contributory</w>
non- consecutive</w>
non- concentration-dependent</w>
non- concentration-
non-concentration- dependent,</w>
non- compressive</w>
non- compliant</w>
non- compliance.</w>
non- compliance,</w>
non- completers</w>
non- compartmental</w>
non- collagen</w>
non- cocaine-using</w>
non- cocaine-related</w>
non- cocaine-induced</w>
non- cocaine-exposed,</w>
non- cocaine-
non-cocaine- exposed)</w>
non- clozapine</w>
non- closed</w>
non- clea
non-clea ved-cell</w>
non- cisplatin-containing</w>
non- chronically</w>
non- chronic</w>
non- cholinergic</w>
non- chiral</w>
non- chest</w>
non- cerebral</w>
non- central</w>
non- cellular</w>
non- catheterized</w>
non- cataleptic</w>
non- cardiovascular</w>
non- cardiogenic</w>
non- carbon</w>
non- cannabinoid</w>
non- bridging</w>
non- breast-
non-breast- cancer</w>
non- breakthrough</w>
non- break</w>
non- brain</w>
non- blinded</w>
non- bleeding</w>
non- binucle
non-binucle ating,</w>
non- benzodiazepine</w>
non- barbiturate</w>
non- atopics</w>
non- atherosclerotic</w>
non- associative</w>
non- aspirin-sensitive</w>
non- aromatic</w>
non- arom
non-arom atiz
non-aromatiz able</w>
non- anthracycline</w>
non- aneurysmal</w>
non- anesthetic</w>
non- anaesthetized</w>
non- anaesthesized</w>
non- aminergic</w>
non- amine</w>
non- alpha-adrenergic</w>
non- alcoholic.</w>
non- alcohol</w>
non- alcohol-related</w>
non- albino</w>
non- aggressive</w>
non- age-related</w>
non- affected</w>
non- adherence.</w>
non- addicted</w>
non- active</w>
non- activating</w>
non- acetaminophen</w>
non- abusing</w>
non- abusers.</w>
non- VOD</w>
non- US</w>
non- TNS</w>
non- TFA-
non-TFA- modified</w>
non- TD
non-TD M)</w>
non- TAS</w>
non- ST-elevation</w>
non- SRS</w>
non- SIADH-induced</w>
non- SE-induced</w>
non- SCLC,</w>
non- REM</w>
non- Q-AMI,</w>
non- PTX</w>
non- PH</w>
non- OAT-ICH.</w>
non- OAT-
non-OAT- ICH,</w>
non- NDI</w>
non- N-methyl-d-aspartate</w>
non- N-methyl-D-aspartate</w>
non- MTX</w>
non- MA-
non-MA- using</w>
non- LA</w>
non- IgE</w>
non- Ig
non-Ig -associated</w>
non- HIV</w>
non- GABAergic</w>
non- G-protein</w>
non- G-6
non-G-6 PD-deficient</w>
non- Fen-Phen
non-Fen-Phen -induced</w>
non- Fanconi's</w>
non- European</w>
non- English</w>
non- English-language</w>
non- ED</w>
non- E-induced</w>
non- DHP</w>
non- DES-exposed</w>
non- DES-associated</w>
non- DENA-initiated</w>
non- DEN-initiated</w>
non- D2</w>
non- COPD</w>
non- CNS</w>
non- Asian</w>
non- African</w>
non- AMI</w>
non- ACS</w>
non- ACS)</w>
non- AAs</w>
non- A</w>
non- /low</w>
non ymous</w>
non warfarin</w>
non vomiting</w>
non visceral</w>
non verapamil</w>
non venous</w>
non users;</w>
non users--entered</w>
non users)</w>
non urticarial,</w>
non urologic</w>
non uniformity</w>
non uniform</w>
non tumorous</w>
non tumor</w>
non tuberculous</w>
non tricyclic</w>
non treatment-seeking</w>
non transmissible</w>
non transgenic,</w>
non trained,</w>
non toxic,</w>
non tolerant</w>
non thromboembolic</w>
non teratogenic</w>
non teratogenic.</w>
non takers''</w>
non sympathomimetic,</w>
non sympathectomized</w>
non survivors,</w>
non surviving</w>
non surgical,</w>
non sulphated</w>
non successful</w>
non stressed</w>
non stimulated</w>
non stimulated,</w>
non steroidal,</w>
non stationary</w>
non spontaneous</w>
non splenectomized</w>
non specificity</w>
non specifically</w>
non solid</w>
non smoking,</w>
non smokers,</w>
non smoker</w>
non significantly.</w>
non severe</w>
non serotonergic</w>
non serious,</w>
non sedimentable</w>
non sedentary</w>
non sedative</w>
non sedating,</w>
non sedated</w>
non secretory</w>
non saturating</w>
non reversible.</w>
non retinal</w>
non retarded</w>
non responsive,</w>
non response</w>
non response,</w>
non responders),</w>
non remitters</w>
non regurgitant</w>
non reentrant</w>
non redundant</w>
non recovered</w>
non receptor</w>
non reassuring</w>
non reactive</w>
non reactive.</w>
non randomization</w>
non random</w>
non pyramidal</w>
non purpose-bred</w>
non pulsatile</w>
non psychoactive</w>
non pruritic,</w>
non progesterone-treated</w>
non profit</w>
non probing</w>
non prenylated</w>
non premedicated,</w>
non preferred</w>
non predictable</w>
non polyuric</w>
non platinum</w>
non platinum-containing</w>
non photic</w>
non pharmacological</w>
non perseverative</w>
non perfusion.</w>
non perfused,</w>
non peptidal</w>
non pegylated</w>
non patient</w>
non partner)</w>
non paroxysmal</w>
non parenteral</w>
non parathyroid</w>
non paced</w>
non oxygenated</w>
non overlapping</w>
non osseous</w>
non osmotic</w>
non opiatergic</w>
non operated</w>
non oliguric,</w>
non oliguric)</w>
non obese,</w>
non nutritive</w>
non neurosurgical</w>
non neuropathic</w>
non neuronal</w>
non neurologic</w>
non nephrotoxic</w>
non neonatal</w>
non necrotizing</w>
non necrotic</w>
non myoclon
nonmyoclon ic)</w>
non myocardial</w>
non myoc
nonmyoc te</w>
non myalg
nonmyalg ic)</w>
non mutagenic</w>
non monoaminergic</w>
non migraine</w>
non micelle-forming</w>
non methicillin</w>
non metabolic</w>
non medication</w>
non medicated</w>
non medical</w>
non measurable</w>
non match-to-
nonmatch-to- sample)</w>
non marrow</w>
non malarial</w>
non major</w>
non liposomal</w>
non linear
nonlinear ity,</w>
non limbic</w>
non li
nonli quric</w>
non lethal</w>
non irritating</w>
non ionized</w>
non intubated</w>
non interventional</w>
non injured</w>
non inflammatory.</w>
non infected</w>
non infarcted</w>
non infarct-related</w>
non induced</w>
non individualized</w>
non inactivating</w>
non implanted</w>
non immunosuppressive</w>
non immunological</w>
non immunity</w>
non immun
nonimmun ological.</w>
non imidazoline</w>
non imaging</w>
non hysterectomized</w>
non hypoxemic</w>
non hypothalamic</w>
non hypo
nonhypo thyroidic</w>
non hypertensive,</w>
non hormonal</w>
non homogenous</w>
non hepatocytic</w>
non hemophiliacs</w>
non hemolytic</w>
non hemodialysed</w>
non hematologic)</w>
non hemat
nonhemat uric</w>
non healing</w>
non halothane</w>
non habituating</w>
non habituated</w>
non govern
nongovern mental</w>
non glycoside</w>
non glycated</w>
non geriatric</w>
non genetically</w>
non functioning.</w>
non function</w>
non forced</w>
non fluorinated</w>
non fluorescent</w>
non fluent</w>
non filling</w>
non fenestrated</w>
non expressed</w>
non exploratory</w>
non estrous</w>
non ergot</w>
non ergoline</w>
non epileptic,</w>
non enz
nonenz yomic</w>
non enhancing</w>
non elective</w>
non e:</w>
non e-
none- to-minimal</w>
non dystonic</w>
non dyskinetic,</w>
non duodenal</w>
non drinkers</w>
non drinkers.</w>
non dopaminergic</w>
non dopamine</w>
non dominant,</w>
non disseminated</w>
non dip
nondip pers</w>
non differential</w>
non dialy
nondialy zable,</w>
non diabetics</w>
non deprived</w>
non depressed</w>
non depolar
nondepolar izers</w>
non dependent</w>
non delusional</w>
non definite</w>
non declar
nondeclar ative.</w>
non debilitating</w>
non cytotoxic</w>
non contraceptive</w>
non contact</w>
non confounding</w>
non confluent</w>
non conduction</w>
non compliance,</w>
non competitively</w>
non compartmental</w>
non comparative,</w>
non cocaine-exposed</w>
non cocaine-
noncocaine- exposed).</w>
non chronotropic</w>
non choroidal</w>
non cholinergic,</w>
non charged</w>
non cervical</w>
non catalytic</w>
non cases</w>
non carriers,</w>
non cardioembolic</w>
non cardiac,</w>
non carcinogenic</w>
non cancerous</w>
non blinded</w>
non blinded.</w>
non blinded,</w>
non barbiturate</w>
non bacterial</w>
non az
nonaz ylated</w>
non audiologic</w>
non atopic</w>
non atherosclerotic</w>
non atherogenic</w>
non asthmatic</w>
non asphy
nonasphy xiated</w>
non arteriosclerotic,</w>
non anticholinergic</w>
non antiarrhythmic</w>
non anti
nonanti arr
nonantiarr thymic</w>
non anterior</w>
non anesthetic</w>
non analgesic</w>
non alternating</w>
non allergic</w>
non alkalinized</w>
non aging</w>
non adrenoceptor</w>
non adherence</w>
non adherence.</w>
non additivity</w>
non additive</w>
non addicts,</w>
non acidotic</w>
non abusers</w>
non absorbable</w>
non Hodgkin's</w>
non -17-
non-17- alpha</w>
non ,</w>
non ).</w>
nomifens ine.</w>
nomifens ine-induced</w>
nomifens ine)</w>
nomencl atures</w>
nomencl ature</w>
nom inally</w>
nom edical</w>
noise less</w>
noise ;</w>
noi se-induced</w>
nodul es;</w>
nodul es/
nodules/ cm3</w>
nodul es)</w>
nodul es).</w>
nodul e,</w>
nodul ates</w>
nodul aris,</w>
nodul aris
nodularis ;</w>
nodos um;</w>
nodos um-like</w>
nodos a-
nodosa- type</w>
nodos a,</w>
node s;</w>
node ll</w>
node -positive</w>
nodd ing,</w>
nodd ing)</w>
nod ding</w>
noctur n
nocturn us),</w>
noctur ia.</w>
noctur ia,</w>
nocist atin,</w>
nociceptive- responsive</w>
nociceptive- and</w>
nociceptin(1-13)NH (2)</w>
nociceptin(1-13)NH (2).</w>
nocicept ors;</w>
nocicept ors:</w>
nocicept ors).</w>
nocicept or.</w>
nocicept in.</w>
nocicept in-</w>
nocicept in,</w>
nocicep tive-like</w>
nocicep tion-induced</w>
noc uous</w>
no- steroid</w>
no- observable-effect</w>
no- longer</w>
no- go</w>
no- fetal</w>
no- effect</w>
no- VER</w>
no yed,</w>
no yance</w>
no x</w>
no vid</w>
no ve,</w>
no var,</w>
no side</w>
no relgestromin,</w>
no pened</w>
no on,</w>
no on)</w>
no logy,</w>
no h
noh an</w>
no go</w>
no ff</w>
no de:</w>
no de-
node- negative</w>
no -</w>
nmole/ l.</w>
nmol/min/ mg,</w>
nmol/l -10</w>
nmol/l -100</w>
nmol/ site</w>
nmol/ site,</w>
nmol/ side,</w>
nmol/ rat)</w>
nmol/ min
nmol/min .
nmol/min. mg</w>
nmol/ microl)</w>
nmol/ mg;</w>
nmol/ mg,</w>
nmol/ mL</w>
nmol/ mL;</w>
nmol/ mL.</w>
nmol/ liter)</w>
nmol/ liter).</w>
nmol/ liter),</w>
nmol/ l.</w>
nmol/ l-
nmol/l- 30</w>
nmol/ l)</w>
nmol/ l),</w>
nmol/ kg.</w>
nmol/ kg).</w>
nmol/ hr/
nmol/hr/ rat</w>
nmol/ head.</w>
nmol/ head,</w>
nmol/ g/min.</w>
nmol/ g).</w>
nmol/ day,</w>
nmol/ L])</w>
nmol/ L.</w>
nmol/ L,</w>
nmol/ L).</w>
nmol/ 4</w>
nmol/ 3</w>
nmol/ 20</w>
nmol/ 200</w>
nmol/ 10</w>
nmol. min-1.
nmol.min-1. g</w>
nmol. min-1
nmol.min-1 g</w>
nmol. kg-1.
nmol.kg-1. min-1)</w>
nmol es,</w>
nmol es),</w>
nmol e.</w>
nmol e,</w>
nmol -2</w>
nmol ))</w>
niz atidine.</w>
nitrosy lation</w>
nitrosy l-
nitrosyl- urea</w>
nitrosoure ido
nitrosoureido ]-
nitrosoureido]- D-gluc
nitrosoureido]-D-gluc opyranose)</w>
nitrosoure a]</w>
nitrosoguvac oline</w>
nitrosoguvac ine</w>
nitrosobut ylurea</w>
nitrosam ine).</w>
nitros ocysteine,</w>
nitros ation</w>
nitros amines.</w>
nitros amine-initiated</w>
nitros amine,</w>
nitroprusside- produced</w>
nitroprusside- infused</w>
nitroprusside- hypotension</w>
nitroprusside- elicited</w>
nitroprusside- captopril,</w>
nitroprus side)</w>
nitroglycerin- infusion</w>
nitroglycerin- (TNG)</w>
nitroglycerin- (NTG)-induced</w>
nitroglycer ine,</w>
nitroglycer in-related</w>
nitroglycer in-based</w>
nitroglycer in)</w>
nitrogen :</w>
nitrogen /creatinine</w>
nitrogen .2.</w>
nitrogen -13</w>
nitrogen )</w>
nitrogen ).</w>
nitrofuranto in-induced</w>
nitrofuranto in-associated</w>
nitroflurbi profen-treated</w>
nitroflurbi profen),</w>
nitro- quinoxaline-2,3-dione</w>
nitro- l-arginine-methyl</w>
nitro- glycerin</w>
nitro- L-arginine-methyl</w>
nitro xyethyl)-3-pyridinecarboximidamide</w>
nitro xidergic</w>
nitro xide</w>
nitro tyrosine.</w>
nitro tyrosine-positive</w>
nitro surea</w>
nitro sonornicotine</w>
nitro phenyl)-[1-((1-methyl-piperidin-2-yl)methyl)-1H-indol-3-yl]-methanone]</w>
nitro phenyl)-3,5-pyridinedicarboxylate,</w>
nitro phenyl))-1,4-dihydropyridine-3,5-dicarboxyla</w>
nitro imidazole.</w>
nitro im
nitroim ad
nitroimad azole</w>
nitro far
nitrofar antoin-induced</w>
nitro compounds</w>
nitro blu
nitroblu e
nitroblue tetrazolium.</w>
nitro benzo
nitrobenzo phenone),</w>
nitro )
nitro) phenyl-2-p</w>
nitrite/ nitrate.</w>
nitrite/ nitrate,</w>
nitrit e-induced</w>
nitrit e+
nitrite+ nit
nitrite+nit rate)</w>
nitrendip ine-induced</w>
nitrate/ nitrite.</w>
nitrate/ beta-blocker/
nitrate/beta-blocker/ nifedipine</w>
nitrate- nitrite</w>
nitos ourea</w>
nitos ourea,</w>
nit ude</w>
nit ruproside-induced</w>
nit rile</w>
nit ricoxide/guanylate</w>
nit rates+nitrites</w>
nit rate]</w>
nit rate-</w>
nit ine,</w>
nit ecapone</w>
nisoldip ine.</w>
nis c
nisc us,</w>
nipec otamides.</w>
nio tically</w>
nio sis</w>
ninety- five</w>
ninety- day-old</w>
nine- year</w>
nine- week</w>
nine- tenths</w>
nine- months'</w>
nine- month</w>
nine- month-
nine-month- old.</w>
nine- insensitive</w>
nine- fold</w>
nine- bed</w>
nine teenth</w>
nimodi pine:</w>
nimodi pine-refractory</w>
nimodi pine-induced</w>
nimesul ide-associated</w>
nim ustine</w>
nim es
nimes uilde.</w>
nigro- hippocampal</w>
nigro est
nigroest ratial</w>
nigra- reticulata</w>
nigra- lesioned</w>
nigra ).</w>
nightma re:</w>
night mar
nightmar ish</w>
night clubs</w>
night club</w>
night club
nightclub s,</w>
nigh ts,</w>
niff ing</w>
niff ing,</w>
nifekal ant,</w>
nifedip ine;</w>
nifedip ine:</w>
nifedip ine-related</w>
nifedip ine-associated</w>
nifedip ine-
nifedipine- pentoxifylline</w>
nifedip ine).</w>
nifedip in</w>
nifedi pine.(ABSTRACT</w>
nif uroxime.</w>
nif ormity</w>
nif lum
niflum ic</w>
nif i
nifi dep
nifidep ine</w>
nid us.</w>
nid us,</w>
nicotine-N'- oxide</w>
nicotine- specific</w>
nicotine- sensitized</w>
nicotine- sensitive</w>
nicotine- nontolerant</w>
nicotine- labeled</w>
nicotine- kindling</w>
nicotine- kindled</w>
nicotine- induced-
nicotine-induced- erectile</w>
nicotine- convulsions,</w>
nicotine- binding</w>
nicotin ic-
nicotinic- muscarinic</w>
nicotin ic,</w>
nicotin amide-induced</w>
nicot ine/
nicotine/ cotinine</w>
nicot ine-evoked</w>
nicot ine-associated</w>
nicot ine-</w>
nicot ine).</w>
nicot ine
nicotine exposed</w>
nicot inate</w>
nicorandil -induced</w>
nicorandil ),</w>
nick- end-
nick-end- labeled</w>
nicardi pine-treated</w>
nicardi pine-group,</w>
nicarb ate</w>
nic ulitis,</w>
nic oumalone,</w>
nic es</w>
nic ergoline-associated</w>
nic ergoline,</w>
nic ain
nicain oprol,</w>
nic .</w>
ni versary,</w>
ni paque),</w>
ni on</w>
ni mex</w>
ni k</w>
ni k's</w>
ni ias</w>
ni hil
nihil ism,</w>
ni er's</w>
ni an</w>
ni ally</w>
ni al
nial amide,</w>
ng/ml)+ anti-
ng/ml)+anti- RANKL</w>
ng/ml)+ OPG</w>
ng/kg/ minute)</w>
ng/kg/ min,</w>
ng/kg/ d</w>
ng/kg/ d,</w>
ng/d l).</w>
ng/d L,</w>
ng/d L)</w>
ng/d L);</w>
ng/d L),</w>
ng/ paw)</w>
ng/ mouse</w>
ng/ mouse.</w>
ng/ mouse),</w>
ng/ min/
ng/min/ kg</w>
ng/ min)</w>
ng/ microliter
ng/microliter ;</w>
ng/ microl,</w>
ng/ mg;</w>
ng/ mg)</w>
ng/ kg,</w>
ng/ day)</w>
ng/ d)</w>
ng/ d).</w>
ng/ animal)</w>
ng/ animal)-induced</w>
ng/ 3</w>
ng/ 2</w>
ng/ 24</w>
ng/ 10</w>
ng/ 0.2</w>
ng.kg-1. min-1)</w>
ng. ml-1.</w>
ng. ml-1)</w>
ng. kg</w>
ng. /ml
ng./ml .).</w>
newborn s?</w>
newborn s'</w>
newborn :</w>
new- water</w>
new- onset,</w>
new- generation</w>
new ness</w>
new ly-
newly- synthesized</w>
new "</w>
nevirap ine.</w>
nevirap ine).</w>
never- users.</w>
never- smokers.</w>
never- medicated</w>
neutrophil s),</w>
neutrophil ia.</w>
neutrophil -specific</w>
neutrophil -independent</w>
neutrophil 's</w>
neutropen ic,</w>
neutropen ia-associated</w>
neutropen ia).</w>
neutropen ia),</w>
neutro poenia,</w>
neutro paenia</w>
neutro -</w>
neutral ize</w>
neutr ality</w>
neutr al.</w>
neutr al)</w>
neut ron</w>
neurotroph ins,</w>
neurotroph in,</w>
neurotransmitter s/neuromodulators</w>
neurotransmitter s'</w>
neurotransmitter ;</w>
neurotransmitter -related</w>
neurotransmit ter.</w>
neurotransmit ter-selective</w>
neurotransmis sions,</w>
neurotransmis sion;</w>
neurotransmis sion:</w>
neurotransmis sion.(ABSTRACT</w>
neurotoxicity-- side-effects</w>
neurotoxicity-- inability</w>
neurotoxic ologically.</w>
neurotoxic ity?</w>
neurotoxic ity).</w>
neurotoxic ity
neurotoxicity ],</w>
neurotoxic esterase,</w>
neurotoxic ants</w>
neurotoxic -
neurotoxic- convulsant</w>
neuroradi ologists</w>
neuroradi ologist</w>
neuroradi ologic,</w>
neuropsych ology</w>
neuropsych ologically</w>
neuroprotect ants</w>
neuroprotect ants.</w>
neuropo re.</w>
neuropo re.(ABSTRACT</w>
neurophy sins</w>
neurophy sins:</w>
neurophy sin.</w>
neurophy pophysis</w>
neuropath y.(ABSTRACT</w>
neuropath y-improving</w>
neuropath y--clinical</w>
neuropath ologist</w>
neuropath ologies</w>
neuropath ologic-neurophysiologic</w>
neuropath ies:</w>
neuron- dependent.</w>
neuron- blocking</w>
neuron s?</w>
neuron s",</w>
neuron opathy.</w>
neuron anatomical</w>
neuron al-
neuronal- glial</w>
neuron al,</w>
neuron al
neuronal apoptosis</w>
neuron -dependent</w>
neuron ,</w>
neurolog y/neurosurgery</w>
neurolog ists.</w>
neurolog ist.</w>
neurolog ist,</w>
neurolog ist's</w>
neurolog ically-
neurologically- impaired</w>
neurolog ical.</w>
neurolog ical,</w>
neurolog ic.</w>
neuroleptic- responsive</w>
neuroleptic- resistant</w>
neuroleptic- induced:</w>
neuroleptic- induced.</w>
neuroleptic s?</w>
neuroleptic s-induced</w>
neuroleptic s-associated</w>
neuroleptic -type</w>
neuroleptic -treated</w>
neuroleptic -related</w>
neuroleptic -associated</w>
neuroleptic '</w>
neurolept oanaesthesia</w>
neurolept analgesia,</w>
neurolep ics</w>
neurohypophys ectomy</w>
neurohypophys ectomized</w>
neurohypophy sis,</w>
neurohormon es)</w>
neurofilament- microtubule</w>
neurofilament- 200</w>
neurofilam ents,</w>
neuroblast oma)</w>
neuro- stimulatory</w>
neuro- regulatory</w>
neuro- psychiatric</w>
neuro- pathological</w>
neuro- otological</w>
neuro- otologic</w>
neuro- ophthalmologists</w>
neuro- oncology</w>
neuro- inflammatory</w>
neuro- ectoderm</w>
neuro- developmental</w>
neuro virology</w>
neuro vascularly</w>
neuro tubules.</w>
neuro tubule</w>
neuro tubular</w>
neuro trauma</w>
neuro trauma:</w>
neuro trauma.</w>
neuro toxity</w>
neuro toxins.</w>
neuro toxin,</w>
neuro toxicosis</w>
neuro teratological</w>
neuro teratogenicity.</w>
neuro syphilis</w>
neuro synaptosome</w>
neuro surgical,</w>
neuro surgeons</w>
neuro surgeon</w>
neuro suppressant</w>
neuro steroids,</w>
neuro steroid-based</w>
neuro sensitivity</w>
neuro sensitive</w>
neuro sensation</w>
neuro scientists</w>
neuro safety</w>
neuro rehabilitation</w>
neuro regulatory</w>
neuro psychosis</w>
neuro psychopharmacologic</w>
neuro psychiatry</w>
neuro protector</w>
neuro protective.</w>
neuro protection-defective</w>
neuro porus</w>
neuro plasticity.</w>
neuro pilin-1</w>
neuro pile.</w>
neuro pil,</w>
neuro physiopathology</w>
neuro physiologically</w>
neuro physiologically.</w>
neuro phathy:</w>
neuro pharmacotoxicity</w>
neuro pharmacology.</w>
neuro petides,</w>
neuro peptide.</w>
neuro peptide-Y,</w>
neuro pediatrician</w>
neuro patic</w>
neuro pathways</w>
neuro otologic</w>
neuro myotoxicity.</w>
neuro myopathy</w>
neuro myelitis</w>
neuro my
neuromy otoxin</w>
neuro modulator,</w>
neuro modulation,</w>
neuro meter</w>
neuro mental</w>
neuro melanin</w>
neuro mediators</w>
neuro mediators.</w>
neuro mediator</w>
neuro ma</w>
neuro lysis.</w>
neuro kinin
neurokinin 3</w>
neuro ischemia,</w>
neuro inflammation</w>
neuro imaging,</w>
neuro humoral,</w>
neuro graphy</w>
neuro graphic</w>
neuro grams</w>
neuro grams.</w>
neuro glial</w>
neuro gen
neurogen ic-mediated</w>
neuro functional</w>
neuro filaments.</w>
neuro ferrit
neuroferrit inopathy,</w>
neuro excitation</w>
neuro excitation.</w>
neuro excitability</w>
neuro epitheli
neuroepitheli oma,</w>
neuro endocrinological</w>
neuro endocrine,</w>
neuro endoc
neuroendoc rine-releasing</w>
neuro ectoderm</w>
neuro development.</w>
neuro degeneration-
neurodegeneration- marker</w>
neuro degener
neurodegener ation),</w>
neuro cysticercosis.</w>
neuro critical</w>
neuro circulatory</w>
neuro blockade,</w>
neuro biologic</w>
neuro biolog
neurobiolog y.</w>
neuro behavioural,</w>
neuro behaviorally</w>
neuro axonal</w>
neuro arthropathy</w>
neuro arthropathy.</w>
neuro apoptosis</w>
neuro apoptosis.</w>
neuro antigen</w>
neuro anatom
neuroanatom ical
neuroanatomical /
neuroanatomical/ neurochemical,</w>
neuro anaesthesia</w>
neuro amines,</w>
neuro adrenergic</w>
neurit es.</w>
neurit e-
neurite- outgrowth</w>
neuraminid ase.</w>
neuraminid ase)</w>
neuralg ia:</w>
neural- transmission,</w>
neural- plate-like</w>
neural- crest</w>
neur oneuronal</w>
neur ites</w>
neur axis.</w>
neur axis,</w>
neur asthenic</w>
neur algias,</w>
neu )</w>
networ ks,</w>
netilmic in.</w>
nest ed,</w>
ness ?</w>
ness .
ness. Fenoprofen</w>
ness --are</w>
ness '</w>
nes uria,</w>
nes see</w>
nes sed</w>
nervousness/ restlessness,</w>
nervousness/ anxiety</w>
nervous ness)</w>
nervous '.</w>
nervos a-like</w>
nervos a,</w>
nerve- twig</w>
nerve- hemidiaphragm</w>
nerve- diaphragm</w>
nerv es.(ABSTRACT</w>
nerv es
nerves ).(ABSTRACT</w>
neramex ane,</w>
ner ve:</w>
ner ve-induced</w>
ner ve's</w>
ner ic</w>
ner ian</w>
ner -c
ner-c ity,</w>
nepicastat .</w>
nepicastat ,</w>
nepic astat</w>
nephroure teromia</w>
nephrotoxic ity.(ABSTRACT</w>
nephrotoxic ity--
nephrotoxicity-- the</w>
nephrotoxic ity)</w>
nephrotoxic ?</w>
nephrotoxic ;</w>
nephrotoxic );</w>
nephrostom y.</w>
nephrostom y),</w>
nephrosis-- in</w>
nephrosis-- (a)</w>
nephropath y."</w>
nephropath y).</w>
nephropath ies,</w>
nephropath ia</w>
nephron s.</w>
nephrolog ists,</w>
nephrolog ist,</w>
nephrolithia sis;</w>
nephrolithia sis)</w>
nephrolith otomy.</w>
nephrocalcin osis),</w>
nephroblast omas</w>
nephroblast oma's</w>
nephro toxitiy</w>
nephro toxin</w>
nephro toxin.</w>
nephro toxicosis</w>
nephro toxicities.</w>
nephro toxicities,</w>
nephro totoxic</w>
nephro tomography,</w>
nephro tic:</w>
nephro tic,</w>
nephro stogram</w>
nephro sis.(ABSTRACT</w>
nephro sis-induced</w>
nephro sis)</w>
nephro sis'</w>
nephro sis'.</w>
nephro sis"</w>
nephro protective'</w>
nephro patic</w>
nephro logy.</w>
nephro lit
nephrolit omy,</w>
nephro grams</w>
nephro -</w>
nephro -
nephro- urinary,</w>
nephritis .(ABSTRACT</w>
nephritis -associated</w>
nephri tis--induced</w>
nephri tides.</w>
nephrectomized- gentamicin</w>
nephrectomized- control</w>
nephrectom ies</w>
neph ronic</w>
neph romas</w>
neph rin:</w>
neph rin-interacting</w>
neph elo
nephelo metry.</w>
neovascular ity</w>
neostigm ine;</w>
neostigm ine's</w>
neoplasi as,</w>
neoplasi a:</w>
neoplasi a--
neoplasia-- have</w>
neoplas mas</w>
neoplas m,</w>
neop terin</w>
neonat ally.</w>
neonat al,</w>
neon ate-
neonate- -a</w>
neoform ans</w>
neody mium</w>
neody mi
neodymi um:YAG</w>
neoadjuv ant-
neoadjuvant- adjuvant</w>
neoadjuv ant,</w>
neoadjuv ant)</w>
neo- myocardium</w>
neo- antigens</w>
neo- adjuvant</w>
neo- Tr
neo-Tr p,</w>
neo- Tim
neo-Tim m.</w>
neo plasia,</w>
neo intimal</w>
neo intima</w>
neo inti
neointi ma,</w>
neo antigens,</w>
neo antigen</w>
nemestr ina</w>
nemestr ina.</w>
nemestr in
nemestrin a)</w>
nemat odes,</w>
nelfin avir
nelfinavir )</w>
nel -like</w>
neighbor ho
neighborho od.</w>
neigh bour
neighbour hood</w>
nei ther.</w>
negative/ antiHBc</w>
negative/ anti-HBc</w>
negative/ HBe</w>
negative- feedback</w>
negative- dominant</w>
negati ve),</w>
neg roes.</w>
neg atively.</w>
neg atively-
negatively- linked</w>
neg atively,</w>
neg ating</w>
neg an.</w>
neg )CD71(high)</w>
neg ).</w>
nefazod one.</w>
nefazod one-induced</w>
needle- shaped</w>
needle- insertion</w>
needl es)</w>
neede d)</w>
neede d"</w>
need less</w>
need les.</w>
need -based</w>
nedocrom il,</w>
nedaplat in.</w>
nedaplat in)</w>
necros ectomy.</w>
necros ectomies</w>
necrop sies,</w>
necro- inflammatory</w>
necro tic,</w>
necro tic).</w>
necro sis.(ABSTRACT</w>
necro sis-like</w>
necro sis)</w>
necro sis(esp,</w>
necro scopy</w>
necro lysis.</w>
necro lysis,</w>
necro ly
necroly sis).</w>
necessary ?</w>
necessary .(ABSTRACT</w>
necessary ,
necessary, and</w>
necess ar
necessar y),</w>
nec e</w>
nebul izers</w>
nebul izer</w>
nebul izations</w>
nebul izations.</w>
nebul ization.</w>
nebul iz
nebuliz ers,</w>
nebul iser</w>
nebul is
nebulis ation:</w>
nebiv olol.</w>
nebiv olol-treated</w>
nebiv olol,</w>
near- total</w>
near- critical</w>
near- 24-hour</w>
near .</w>
near -</w>
ne y.</w>
ne y).</w>
ne y"</w>
ne vus</w>
ne ubulized</w>
ne u</w>
ne ts</w>
ne sts</w>
ne st-seeking</w>
ne sidioblastosis.</w>
ne protic</w>
ne pol:</w>
ne p</w>
ne oral</w>
ne ophobia</w>
ne opentyl-esters</w>
ne omycin-deafened</w>
ne olignoid</w>
ne ol</w>
ne obladder.</w>
ne ll</w>
ne ic</w>
ne fro
nefro toxicity,</w>
ne form</w>
ne ezing,</w>
ne ed,</w>
ne e</w>
ne dione</w>
ne d:</w>
ne d).</w>
ne ae.</w>
ne a
nea rest</w>
navig ation,</w>
nausea/ dizziness.</w>
nausea-- were</w>
nausea-- occurred</w>
nause ous</w>
nause ated,</w>
nause a?</w>
nause a;</w>
nause a-
nausea- vomiting,</w>
natur al,</w>
natur al)</w>
natur al"</w>
natur al
natural ist</w>
natriure sis.</w>
nat rindole,</w>
nat remia</w>
nat raemia</w>
nat om</w>
nat ing"</w>
nat in,</w>
nas opharyngitis</w>
nas oocular,</w>
nas olacrimal</w>
nas olabial</w>
nas o</w>
nas o-oral</w>
nas o-</w>
nas cent</w>
nas al-
nasal- type</w>
narrow ly</w>
narrow ing)</w>
narrow -
narrow- angle</w>
narro wed.</w>
narro wed,</w>
narcotic- supplemented</w>
narcotic- nitrous</w>
narcotic- containing</w>
narcol eptic</w>
narcol ep
narcolep sy.</w>
narco tized</w>
narco tic,</w>
narc osed</w>
naratript an-induced</w>
naratript an,</w>
naprox yn,</w>
naprox en;</w>
naprox en:</w>
naprox en-
naproxen- but</w>
naprox en)</w>
naphtho flavone</w>
naphtho (2,3
naphtho(2,3 b)
naphtho(2,3b) dihydro
naphtho(2,3b)dihydro ,
naphtho(2,3b)dihydro, 2,3-
naphtho(2,3b)dihydro,2,3- furan
naphtho(2,3b)dihydro,2,3-furan el
naphtho(2,3b)dihydro,2,3-furanel ]
naphtho(2,3b)dihydro,2,3-furanel] ]</w>
naphthalen esulfon
naphthalenesulfon amide</w>
naphthal ene</w>
naphthal ene
naphthalene disulf
naphthalenedisulf onate],</w>
napht ylpiperazin-1-yl)butyl]-3-(2H)-pyridazinone),</w>
napht yl)</w>
naph toquinone</w>
nap thylisothiocyanate,</w>
nap thyl</w>
nap thyl-2-aminopropane</w>
nap tho++</w>
nap en</w>
nanop artic
nanopartic le-
nanoparticle- bound</w>
nam ing,</w>
nam ing,"</w>
nam es:</w>
nam el
namel y:</w>
nam e.</w>
nam e,</w>
naltrexone- insensitive</w>
naltrexone- insensitive.</w>
naltrex one:</w>
naltrex one/amphetamine</w>
naltrex one's</w>
naltr indole</w>
naloxone- reversible.</w>
naloxone- reversible,</w>
naloxone- methiodide</w>
naloxone- insensitive</w>
naloxone- evoked</w>
nalox one=naltrexone></w>
nalox one:</w>
nalox one-treated</w>
nalox one).</w>
nal- neonatal</w>
nal s,</w>
nal orphine.</w>
nal iculi</w>
nail s--a</w>
nail biting</w>
nai ve.</w>
nafenop in-treated</w>
naf oxidine</w>
naf ate</w>
naf ate.</w>
naf ad
nafad otride</w>
nadir ;</w>
nadir :</w>
nadi r)</w>
nad roparin</w>
nac ipran</w>
nac ardi
nacardi aceae),</w>
nabumet one</w>
nabumet one,</w>
nabil one.</w>
na uzer</w>
na sium.</w>
na res</w>
na prosyn,</w>
na prolol,</w>
na ),</w>
na (+)</w>
nSM ase</w>
nSM ase-
nSMase- dependent</w>
nSM ase,</w>
nNOS(-/- )]</w>
nNOS(-/- ),</w>
nNO S/
nNOS/ guanylate</w>
nNO S.</w>
nM/ mg</w>
nM/ L.</w>
nACh Rs.</w>
nACh Rs,</w>
nACh R.</w>
n=7 48;</w>
n=7 4),</w>
n= 9,</w>
n= 9)</w>
n= 9).</w>
n= 8</w>
n= 88</w>
n= 7</w>
n= 76)</w>
n= 7,</w>
n= 7)</w>
n= 6</w>
n= 68).</w>
n= 67;</w>
n= 66
n=66 1.</w>
n= 6-1
n=6-1 3)</w>
n= 6)</w>
n= 5</w>
n= 59)</w>
n= 57;</w>
n= 50)</w>
n= 50).</w>
n= 50),</w>
n= 5)</w>
n= 5).</w>
n= 4</w>
n= 45.</w>
n= 40)</w>
n= 40).</w>
n= 4).</w>
n= 4),</w>
n= 4
n=4 1;</w>
n= 36).</w>
n= 34).</w>
n= 33,</w>
n= 33
n=33 35).</w>
n= 30,</w>
n= 30),</w>
n= 3
n=3 37
n=337 1)</w>
n= 29,</w>
n= 29).</w>
n= 29
n=29 7,</w>
n= 28).</w>
n= 28),</w>
n= 27;</w>
n= 270</w>
n= 27),</w>
n= 26).</w>
n= 25).</w>
n= 24</w>
n= 24)</w>
n= 23)</w>
n= 22).</w>
n= 21</w>
n= 205</w>
n= 20)</w>
n= 20),</w>
n= 2
n=2 24,</w>
n= 19,</w>
n= 19
n=19 0)</w>
n= 177)</w>
n= 17).</w>
n= 16).</w>
n= 15</w>
n= 151</w>
n= 15).</w>
n= 15),</w>
n= 15
n=15 5),</w>
n= 14)</w>
n= 13),</w>
n= 12,</w>
n= 12),</w>
n= 11)</w>
n= 108)</w>
n= 10),</w>
n-propylamino) tetralin,</w>
n-propylamino) tertralin</w>
n-propyl-2H- pyrazolo-3,4-g-quinoline</w>
n-propyl norapomorphine</w>
n-propyl -,</w>
n-methyl- beta-carboline-3-carboxamide</w>
n-methyl serotonin,</w>
n-hex yl</w>
n-hex ane,</w>
n-cb d)</w>
n-butyl- n-
n-butyl-n- (4-hydroxybutyl)
n-butyl-n-(4-hydroxybutyl) nitrosamine.</w>
n-butyl -1-
n-butyl-1- cyclohex
n-butyl-1-cyclohex yl-2,4,6-trioxoperhydropyrimidine),</w>
n-acetyl procainamide</w>
n-acetyl procainamide.</w>
n-Whit ney,</w>
n-Whit ney).</w>
n- type'</w>
n- tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine</w>
n- nitrosobutylurea</w>
n- decano
n-decano ate)</w>
n- acetyl</w>
n- acetyl-
n-acetyl- l-
n-acetyl-l- cysteine</w>
n- Williams</w>
n- U-
n-U- With
n-U-With ney</w>
n- SOD,</w>
n- P
n-P ick</w>
n- CA1,</w>
n- )</w>
n ystgmus</w>
n ycturia,</w>
n wd.</w>
n ventions</w>
n uus</w>
n utmeg</w>
n utcracker</w>
n um</w>
n u</w>
n to</w>
n t</w>
n sbruck</w>
n rbulizations.</w>
n otoxicity</w>
n omegestrol</w>
n omalities,</w>
n oma</w>
n oma,</w>
n oll</w>
n oll's</w>
n ocytophaga</w>
n l/min,</w>
n iti
niti al</w>
n ished</w>
n ip,</w>
n ip).</w>
n ip
nip ples,</w>
n ing).</w>
n ine-dependent</w>
n in),</w>
n il</w>
n il),</w>
n ich</w>
n g;</w>
n g.</w>
n g-
ng- regimen,</w>
n g);</w>
n g
ng ],</w>
n dela
ndela g</w>
n d)</w>
n c
nc 4)</w>
n atives</w>
n ative,</w>
n ations</w>
n ations.</w>
n ate
nate gl
nategl in
nateglin ide</w>
n ast
nast y</w>
n anome
nanome ters</w>
n and
nand o</w>
n an</w>
n ame
name :</w>
n alo
nalo zone,</w>
n al.</w>
n ab
nab -
nab- paclitaxel</w>
n V
nV H-induced</w>
n Tg</w>
n M);</w>
n LiCl</w>
n LiCl
nLiCl '</w>
n HL</w>
n E.</w>
n Ci
nCi /min</w>
n CR</w>
n CR,</w>
n BR</w>
n BNI</w>
n BNI.</w>
n AC
nAC HR).</w>
n ></w>
n =</w>
n 2</w>
n 1-
n1- 2'-
n1-2'- furan
n1-2'-furan id
n1-2'-furanid yl-5-fluorouracil).</w>
n .):</w>
n ,
n, 5-
n,5- dihydroxy
n,5-dihydroxy diclofenac,</w>
n )-
n)- Py
n)-Py P,</w>
n "</w>
myx opapillary</w>
myx omatous</w>
myx oma</w>
myx oid,</w>
myx edemic</w>
myri ad
myriad s</w>
myotub es.</w>
myoton ia,</w>
myot ube</w>
myot atic</w>
myosm ine,</w>
myosm ine).</w>
myosi tis/dermatomyositis</w>
myos mine</w>
myos keletal</w>
myopericardi tis:</w>
myopericardi tis.</w>
myopath y;</w>
myopath y--a</w>
myopath y)</w>
myopath y).</w>
myopath ies,</w>
myop ic,</w>
myop ia
myopia ")</w>
myoglobin uria.(ABSTRACT</w>
myoglobin uria)</w>
myoglob inemia</w>
myofilam ents.</w>
myofilam entous</w>
myofilam ent</w>
myofibri lar</w>
myocyt olytic</w>
myocyt olysis)</w>
myocyt olysis"</w>
myocyt es'</w>
myoclon us:</w>
myoclon ic.</w>
myoclon ic-type</w>
myoclon ic-astatic</w>
myoclon ias.</w>
myoclon ia.</w>
myoclon ia,</w>
myoclon i</w>
myocarditis/ polyserositis</w>
myocarditis/ cardiomyopathy</w>
myocardi um?</w>
myocardi um)</w>
myocardi tis;</w>
myocardi tis--elevated</w>
myocardi tis,"</w>
myocardi otoxicity</w>
myocardi opathy:</w>
myocardi opathies</w>
myocardi al/
myocardial/ plasma</w>
myocardi al,</w>
myoc ite</w>
myo- inositol.</w>
myo- inositol-1-phosphate</w>
myo pathology.</w>
myo pathological</w>
myo k
myok omia.</w>
myo inositol</w>
myo inositol.</w>
myo graph</w>
myo fibroblasts.</w>
myo fibroblastic</w>
myo fibroblast-like</w>
myo fiber</w>
myo electric</w>
myo el
myoel onus</w>
myo dystrophy</w>
myo degeneration</w>
myelotom y</w>
myelotom y,</w>
myelosuppres sive,</w>
myelosuppres sion:</w>
myeloschi sis,</w>
myeloschi sis)</w>
myeloradic ulography.</w>
myeloperoxidase- specific</w>
myeloperoxidase- ANCA</w>
myeloperoxid ase-positive</w>
myeloperoxid ase-</w>
myelomeningocoe le</w>
myelomeningocoe le.</w>
myelomening oceles</w>
myelogram ,</w>
myelo-optico- neuropathy</w>
myelo-optico- neuropathy:</w>
myelo-optico- neuropathy,</w>
myelo- suppression</w>
myelo stimulatory</w>
myelo sis</w>
myelo protective</w>
myelo preoxidase</w>
myelo poiesis</w>
myelo poiesis.</w>
myelo peroxidase.</w>
myelo pathy:</w>
myelo pathies</w>
myelo pathies.</w>
myelo ma;</w>
myelo ma)</w>
myelo ma
myeloma -related</w>
myelo id),</w>
myelo fibrotic</w>
myelo fibrosis,</w>
myelo dysplasi
myelodysplasi a:</w>
myelo depression</w>
myelo depression.</w>
myelo ce
myeloce le,</w>
myelo ablation</w>
myelo abl
myeloabl ative.</w>
myelin olytic</w>
myelin olysis:</w>
myelin ogenesis;</w>
myelin ated)</w>
myel on.</w>
myel ino
myelino pathy</w>
myel ine</w>
myel in-like</w>
mye log
myelog eous</w>
mycobacterio sis.</w>
mycobacterio sis,</w>
myco sis,</w>
myco ses</w>
myco phenolate.</w>
myco bacteria</w>
myco bacteria.</w>
myco bacteria,</w>
myco ardi
mycoardi al</w>
myc ,</w>
myalgias/ arthralgias.</w>
myalgia/ ath
myalgia/ath ralgia</w>
myalg ia?</w>
myalg ia:</w>
myalg ia'.</w>
my stic</w>
my stery.</w>
my sositis.</w>
my ringotomy)</w>
my otoxicity:</w>
my otoxicity,</w>
my otomes</w>
my osin-positive</w>
my opic</w>
my ophosphorylase</w>
my ophagocytosis</w>
my opes</w>
my omas.</w>
my olysis</w>
my ography</w>
my ography)</w>
my ofascial</w>
my ocytic</w>
my lo
mylo genous</w>
my colonic</w>
my cin
mycin ),</w>
my cardi
mycardi al</w>
my ?
my? "</w>
mutis m/speech</w>
mutis m)</w>
mutation- positive</w>
mutation- negative</w>
mutagen ic.</w>
mutag ens</w>
mutag ens,</w>
mutag ene
mutagene sis</w>
mut ed,</w>
mut ations;</w>
mut ations)</w>
mut ation:</w>
mut ant
mutant s)</w>
mut MMP
mutMMP 1)</w>
mustar ds.</w>
mustar d-
mustard- dianhydrogalactitol</w>
mush rooms.</w>
musculo -
musculo- skeletal</w>
muscul at
musculat ure,</w>
muscul aris</w>
muscul ar/
muscular/ neurodegenerative</w>
muscul ar)</w>
muscul ar
muscular ized</w>
muscle- type-specific</w>
muscle- invasive</w>
muscle- blocking</w>
muscle- biopsy</w>
muscle ;</w>
muscle :</w>
muscle :
muscle: heart
muscle:heart ]),</w>
muscle /
muscle/ sciatic</w>
muscle .7.</w>
muscle -induced</w>
muscl es;</w>
muscl es-
muscles- obtained</w>
muscl es).</w>
muscl es),</w>
muscim ol).</w>
muscarin ics</w>
muscarin ic.</w>
muscarin ic-induced</w>
muscarin ic-
muscarinic- blocking)</w>
muscar inergic</w>
muscar ine-sensitive</w>
mus sium</w>
mus culos
musculos keletal,</w>
mus cu
muscu loc
musculoc utaneous</w>
muraglitaz ar</w>
muraglitaz ar-treated</w>
muraglitaz ar,</w>
mur dere
murdere r.</w>
mur der</w>
mun oanalysis</w>
mun ici
munici palities</w>
mun i
muni tions</w>
mun d</w>
mumole/ kg</w>
mumole/ kg,</w>
mumole/ kg).</w>
mumole/ brain)</w>
mumol/kg/ h</w>
mumol/ rat)</w>
mumol/ mouse,</w>
mumol/ min,</w>
mumol/ liver;</w>
mumol/ liter,</w>
mumol/ l).</w>
mumol/ kg]).</w>
mumol/ kg/min</w>
mumol/ kg.</w>
mumol/ h),</w>
mumol/ g;</w>
mumol/ g,</w>
mumol s/min</w>
mumol es,</w>
mum ols</w>
mum ol.</w>
mum bl
mumbl ing.</w>
mum ).</w>
multivari ate,</w>
multiv itamin
multivitamin .</w>
multiplic ity.</w>
multiplic ity,</w>
multiplex :</w>
multiplex .</w>
multiple- version,</w>
multiple- unit</w>
multiple- trail</w>
multiple- step</w>
multiple- organ</w>
multiple- dose,</w>
multiple- depth</w>
multiple- component</w>
multim eric</w>
multifactori al:</w>
multif acet
multifacet ed</w>
multidrug- resistance-reversal</w>
multidiscipl ine</w>
multicent ered</w>
multic ystic</w>
multic ycle</w>
multic rystal</w>
multi- unit</w>
multi- target</w>
multi- site</w>
multi- profile</w>
multi- poison</w>
multi- phase</w>
multi- observer</w>
multi- layer</w>
multi- institu
multi-institu tional,</w>
multi- hour</w>
multi- gated</w>
multi- channel</w>
multi- centre,</w>
multi- centered</w>
multi- bacillary</w>
multi- antagonistic</w>
multi- agent</w>
multi trial</w>
multi system,</w>
multi substrate</w>
multi state,</w>
multi spectral</w>
multi specific</w>
multi sensory</w>
multi resistant</w>
multi racial</w>
multi polar</w>
multi plied</w>
multi plication</w>
multi phasic</w>
multi parity,</w>
multi paras.</w>
multi para</w>
multi morphic</w>
multi lineage</w>
multi level</w>
multi lay
multilay ered</w>
multi lamell
multilamell ar-
multilamellar- D
multilamellar-D PPC</w>
multi genic</w>
multi functional</w>
multi form.</w>
multi foc
multifoc al),</w>
multi florum</w>
multi fiber</w>
multi enzyme</w>
multi endocrine</w>
multi drug,</w>
multi dimensional</w>
multi dimensional,</w>
mulat ta)</w>
mulat ta).</w>
mul /
mul/ 100</w>
muk at/
mukat/ L</w>
mug/m L;</w>
mug/m L.</w>
mug/ week</w>
mug/ rat/d</w>
mug/ rat),</w>
mug/ mu
mug/mu L)</w>
mug/ min</w>
mug/ min.</w>
mug/ min,</w>
mug/ kg/min.</w>
mug/ kg/h</w>
mug/ kg.</w>
mug/ kg.
mug/kg. 7.</w>
mug/ heart</w>
mug/ h</w>
mug/ h),</w>
mug/ d.</w>
mug/ d,</w>
mug/ L.</w>
mug/ L),</w>
mug/ 100</w>
mucosi tis;</w>
mucosi tis/stomatitis</w>
mucosi tis)</w>
mucos al-
mucosal- defense</w>
mucos ae.</w>
mucos a:</w>
mucos a.
mucosa. A</w>
much ?</w>
much "</w>
muc us,</w>
muc ous,</w>
muc or.</w>
muc opurulent</w>
muc opolysaccharides.</w>
muc operichondrial</w>
muc omyst).</w>
muc itis).</w>
muc ino
mucino sis.</w>
muc in-secreting</w>
muc ification</w>
muc h,</w>
mu- subtype-selective</w>
mu- receptor-active</w>
mu- opiate-receptor</w>
mu- agonist</w>
mu- OR</w>
mu- O
mu-O R)</w>
mu tilating</w>
mu th-containing</w>
mu st,</w>
mu sic</w>
mu g.</w>
mu g.
mug. h.
mug.h. mL-1</w>
mu g,</w>
mu g),</w>
mu d</w>
mu U/
muU/ min
muU/min .)</w>
mu M.</w>
mu M).</w>
mu L/
muL/ min.</w>
mu /kg</w>
mu -type</w>
mtDNA- content</w>
mt DNA
mtDNA -related</w>
mt 7</w>
mt 7)</w>
ms/ mm)</w>
ms/ mg</w>
ms. kPa-1,</w>
ms. kPa
ms.kPa -1).</w>
ms 1/2)</w>
ms 1/
ms1/ 2),</w>
mpt y</w>
moxon idine.</w>
moxon idine-induced</w>
moxisyly te;</w>
moxisyly te.</w>
moxif loxacin.</w>
moxif loxacin,</w>
moxi role;</w>
movement s;</w>
movement s:</w>
movement s--were</w>
movement s--or</w>
movement s)</w>
movement s).</w>
movement ;</w>
movement ).</w>
mouthwash es,</w>
mouthwash -induced</w>
mouthrin sing.</w>
mouthrin ses:</w>
mouthrin se.</w>
mouth wash</w>
mouth wash,</w>
mouth s,</w>
mouth ."</w>
mouth )</w>
mouth );</w>
mouth ).</w>
mouth "</w>
mouth ":</w>
mouth ".</w>
mouth "),</w>
mouse- to-rat</w>
mouse /day</w>
mouse /
mouse/ human</w>
mouse -1)</w>
mouse ).</w>
moun ts.</w>
moun ting,</w>
mou thing</w>
mott ling</w>
mott led.</w>
motor- score</w>
motor- point</w>
motor- nerve-conduction</w>
motor- incoordin
motor-incoordin ating</w>
motor- impairing</w>
motor peripheral</w>
motor -related</w>
motiv ation,</w>
motiv ate</w>
moti fs,</w>
mother-to- child</w>
mother- offspring</w>
mother s'</w>
mother ;</w>
mother /
mother/ infant</w>
mother )</w>
mot rophs.</w>
mot oneurons.</w>
mot oneuron</w>
most- sensitive</w>
mosmol/kg H(2)O</w>
mosmol/kg H(2)O),</w>
mosmol/kg H(2)O
mosmol/kgH(2)O ).</w>
mosmol/ kg.</w>
mos quitoes</w>
mos quito</w>
mos m/
mosm/ kg),</w>
mos aic</w>
mos .</w>
mortality ?
mortality? :</w>
mortality .We</w>
mortality ."</w>
mortal ity--
mortality-- during</w>
mortal ity)</w>
mortal ity).</w>
mortal ities</w>
mortal ities,</w>
mortal ised</w>
morpholinyl) doxorubicin</w>
morpholinyl) DXR</w>
morpholino- ethyl-
morpholino-ethyl- amino)-4-
morpholino-ethyl-amino)-4- cyano-
morpholino-ethyl-amino)-4-cyano- 6-
morpholino-ethyl-amino)-4-cyano-6- phenyl-pyridazine],</w>
morpholino- eth
morpholino-eth l
morpholino-ethl amino]-
morpholino-ethlamino]- 4-
morpholino-ethlamino]-4- methyl-6-
morpholino-ethlamino]-4-methyl-6- phenyl-pyridazine</w>
morpholin ylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone),</w>
morpholin ylacetyl)</w>
morpho e
morphoe a-like</w>
morphine/ Rg
morphine/Rg 1-treated</w>
morphine- withdrawn</w>
morphine- withdrawal</w>
morphine- pellet.</w>
morphine- neostigmine.</w>
morphine- naloxone-induced</w>
morphine- log</w>
morphine- inhibited</w>
morphine- induced.</w>
morphine- dopamine</w>
morphine- dopamine-
morphine-dopamine- cholinergic</w>
morphine- dominant</w>
morphine- comparable</w>
morphine- catalepsy.</w>
morphine- based</w>
morphine- HC1</w>
morphine- 6-
morphine-6- glucuronide.</w>
morphine- 3-
morphine-3- glucuronide</w>
morphin ans</w>
morphin an-
morphinan- 6
morphinan-6 beta-
morphinan-6beta- yl]-3-(furan-3-yl)-N-methylprop-2-enamide</w>
morphic ept
morphicept in),</w>
morph opathogenesis</w>
morph one's</w>
morph ometry</w>
morph ometry,</w>
morph ometrically.</w>
morph ology;</w>
morph ologically,</w>
morph ologic,</w>
morph ogenesis.</w>
morph ine.HCl</w>
morph ine's</w>
morph ea</w>
morph e
morphe a:</w>
moriciz ine:</w>
moriciz ine)</w>
more ;</w>
more /kg</w>
more ).</w>
more ),</w>
morb id
morbid ity:</w>
mor y</w>
mor tem,</w>
mor ning-dosed</w>
mor ning).</w>
mor h
morh agic</w>
mood- stablizing</w>
mood- elevating</w>
mood- altering</w>
mood iness,</w>
mood ).</w>
months. We</w>
months. ..</w>
months-- four</w>
months-- and</w>
month- old-infant</w>
month- old,</w>
month- old)</w>
month s].</w>
month s/patient),</w>
month s.(ABSTRACT</w>
month s-old</w>
month s-6</w>
month s-1</w>
month s-12</w>
month ly;</w>
month ly,</w>
month -18</w>
month );</w>
month ),</w>
monoter penic</w>
monos accharide</w>
monos acchar
monosacchar ides.</w>
monophosphat ase-
monophosphatase- 1</w>
monophosphat ase)</w>
monophosph ates,</w>
monophosph ate,</w>
monophosph ate).</w>
monophosph ate
monophosphate (
monophosphate( (cG
monophosphate((cG MP),</w>
monophosph atase</w>
monooxygen ases.</w>
monooxygen ases,</w>
mononucle osis.</w>
mononucle osis)</w>
mononucle ated</w>
mononucle ate,</w>
mononit rate.</w>
mononeur itis.</w>
monomorph ic;</w>
monomorph ic,</w>
monomethyl- L-argin
monomethyl-L-argin ine)</w>
monom er.</w>
monoiodo thyronine</w>
monoiodo acetate-induced</w>
monofilam ents</w>
monocyto genes</w>
monocytes/ macrophages</w>
monocytes/ macrophages.</w>
monocytes/ macrophages,</w>
monocyte- macrophages.</w>
monocyte -derived</w>
monoc ular,</w>
monoc hemotherapy,</w>
monoc arboxylic</w>
monoamine- reuptake.</w>
monoamine- related</w>
monoamine- oxidase</w>
monoamine- oxidase-B</w>
monoamine- depletion</w>
monoamine- deple
monoamine-deple ted)</w>
mono- therapy</w>
mono- oxidative</w>
mono- demethylated</w>
mono- O:
mono-O: -
mono-O:- desmethyl
mono-O:-desmethyl tramadol,</w>
mono- N-de
mono-N-de alkyl
mono-N-dealkyl disopyramide.</w>
mono therapy:</w>
mono therapy);</w>
mono therapy),</w>
mono therapies.</w>
mono prophylaxis</w>
mono prophylaxis.</w>
mono paresis</w>
mono infected</w>
mono hydrochloride;</w>
mono hydrochloride),</w>
mono hyd
monohyd rate;</w>
mono exponential</w>
mono ethyl
monoethyl glyc
monoethylglyc ine
monoethylglycine xylidide</w>
mono desethyl
monodesethyl amodiaquine</w>
mono deiodin
monodeiodin ating</w>
mono amine,</w>
mono ,</w>
monkeys/gender )</w>
monkeys/gender ).</w>
monkey s)</w>
monkey s).</w>
monke y).</w>
monke y),</w>
monitore d;</w>
monitor ization</w>
monitor isation</w>
monitor ing;</w>
monitor ing-</w>
monitor ing).</w>
monitor )</w>
monitor ).</w>
money -induced</w>
money )</w>
monet ary-
monetary- based</w>
monet arily</w>
mone y.</w>
mone y-handling</w>
mon ton</w>
mon ozygosity.</w>
mon oxygenase</w>
mon oxide,</w>
mon otonically</w>
mon otonic</w>
mon otonic,</w>
mon osulfate</w>
mon opolar</w>
mon opoiesis</w>
mon ophasic,</w>
mon oneuropathies</w>
mon omethanesulfonate,</w>
mon omers)</w>
mon omeric,</w>
mon olateral</w>
mon ographs.</w>
mon ogenic</w>
mon ocytopenia,</w>
mon ocyclic,</w>
mon oconjugated</w>
mon ocenter</w>
mon obactams</w>
mon o</w>
mon ish</w>
mon il
monil iasis.</w>
mon d</w>
mon amine</w>
mon aive</w>
mon acetylmorphine</w>
momet asone,</w>
mom my?"</w>
mom ents</w>
mom ent.</w>
mom ent,</w>
molind one.</w>
molet s)</w>
moles/ mg</w>
moles/ cc</w>
molecule -1.</w>
molecule 's</w>
molecul e),</w>
molec ularly</w>
molar .</w>
molar -to-
molar-to- molar</w>
mol/ mol</w>
mol/ ml)</w>
mol/ liter),</w>
mol/ l;</w>
mol/ l
mol/l )-induced</w>
mol/ L;</w>
mol/ L).</w>
mol s/L)-(4</w>
mol es)</w>
mol es).</w>
mol e),</w>
mol ds</w>
mol al</w>
mol ).</w>
moi ety.</w>
moi eti
moieti es.</w>
mofetil /
mofetil/ azathioprine</w>
mofetil )</w>
modul us</w>
modul in-related</w>
modul es,</w>
modul ator.</w>
modul ations,</w>
modul ation/
modulation/ imbalance</w>
modul ated,</w>
modul ate,</w>
modifi ers.</w>
modifi ers,</w>
modifi able.</w>
modi olar</w>
modi f
modif y,</w>
moderate/ severe.</w>
moderate/ grade</w>
moderate- to-profound</w>
moderate- risk</w>
moderate- marked</w>
moderate- exercise</w>
moder ately.</w>
moder atel
moderatel y-severe</w>
moder ated</w>
moder ate-</w>
moder ate
moderate ];</w>
modeoxy uridine-positive</w>
modeoxy uridine-(BrdU)</w>
model s.(ABSTRACT</w>
model s)</w>
model s).</w>
model s'</w>
model ?</w>
model ;</w>
model .(ABSTRACT</w>
model -specific</w>
model -induced</w>
model -independent</w>
model ).</w>
mode st-anemia</w>
mode s.</w>
mode oxy-uridine-positive</w>
mode -dependent</w>
mode ).</w>
modal ities;</w>
modafin il-treated</w>
mod reduction</w>
mod ation</w>
moclobemide- venlafaxine</w>
moclobemide- doxepin</w>
mobil ized</w>
mobil ization:</w>
mobil ity-related</w>
mobil ia</w>
mo- dermal</w>
mo yamoya</w>
mo ving;</w>
mo vies.</w>
mo ves</w>
mo tionless,</w>
mo tion:</w>
mo timeter)</w>
mo tility;</w>
mo tile</w>
mo th-eaten</w>
mo sets</w>
mo reactions</w>
mo re-gradual</w>
mo phobes</w>
mo on</w>
mo ist</w>
mo id,</w>
mo graphy</w>
mo graphy.</w>
mo genic.</w>
mo dy
mody ne,</w>
mo d,</w>
mo bit
mobit z</w>
mo bile,</w>
mo aning</w>
mo ;</w>
mo 2),</w>
mo .
mo. -old</w>
mo -</w>
mo -17</w>
mmug. /ml
mmug./ml .,</w>
mmole/ kg)</w>
mmole/ kg).</w>
mmol/kg/ day)</w>
mmol/L }</w>
mmol/L ]),</w>
mmol/ rat).</w>
mmol/ mol</w>
mmol/ min</w>
mmol/ liter;</w>
mmol/ l
mmol/l )]</w>
mmol/ hr</w>
mmol/ hr,</w>
mmol/ h,</w>
mmol/ day)</w>
mmol/ d</w>
mmol/ d).</w>
mmol/ 1.</w>
mmol/ 1)</w>
mmol/ 0.5</w>
mmol. kg-1</w>
mmol. kg-1,</w>
mmol. kg(-1)</w>
mmol. kg(-1))</w>
mmol s/L)+(50xPhenylalanine</w>
mmol -1</w>
mmHg/ s</w>
mmHg/ s).</w>
mmHg/ ml/min/100</w>
mmHg/ ml).</w>
mmHg/ mL</w>
mmHg/ 20</w>
mmHg ].</w>
mmHg =
mmHg= 0.133</w>
mmHg .
mmHg. 1.
mmHg.1. min-1),</w>
mmHg -1</w>
mmHg );</w>
mmHg (2)</w>
mmH g/m
mmHg/m L/min/
mmHg/mL/min/ gr</w>
mmH 20.</w>
mm/ s,</w>
mm/ m2,</w>
mm/ m2)</w>
mm/ hour.</w>
mm. sec-1,</w>
mm. Hg,</w>
mm(- 3);</w>
mm(- 2)</w>
mm c</w>
mm c)</w>
mm ]</w>
mm H2O</w>
mm 3;</w>
mm 3);</w>
mm 2]</w>
mm 2.</w>
mm .,</w>
mm -1,</w>
mm -
mm- Hg</w>
mm (2)),</w>
ml/min/ year</w>
ml/min/ year).</w>
ml/min/ m2,</w>
ml/min/ m2)</w>
ml/min/ kg).</w>
ml/m n</w>
ml/m 2.
ml/m2. (ABSTRACT</w>
ml/kg/ hour.</w>
ml/kg/ hour)</w>
ml/kg/ h</w>
ml/kg/ 24</w>
ml/g/ min;</w>
ml/ session)</w>
ml/ sec)</w>
ml/ sec).</w>
ml/ s,</w>
ml/ s),</w>
ml/ ng).</w>
ml/ minute</w>
ml/ minute.</w>
ml/ minute),</w>
ml/ min/</w>
ml/ m2).</w>
ml/ m(2)),</w>
ml/ lignocaine</w>
ml/ kg.</w>
ml/ hr</w>
ml/ h)</w>
ml/ h),</w>
ml/ g/min</w>
ml/ g,</w>
ml/ day.</w>
ml/ day,</w>
ml/ beat/
ml/beat/ m
ml/beat/m (2),</w>
ml/ beat,</w>
ml/ [
ml/[ min</w>
ml/ 30</w>
ml/ 1.73</w>
ml.min-1. g-1</w>
ml. s-1</w>
ml. s-1).</w>
ml. mmHg-1</w>
ml. min-1
ml.min-1 ).(ABSTRACT</w>
ml. min(-1)</w>
ml. min(-1).</w>
ml. kg-1</w>
ml. kg-1.</w>
ml. kg-1,</w>
ml. kg(-1))</w>
ml s)</w>
ml in</w>
ml a)</w>
ml ])</w>
ml B
mlB G</w>
ml -1);</w>
ml -0.5</w>
ml (-1)).</w>
mixt ures--harmless</w>
mixt ure-hypnotic</w>
mixt ure).</w>
mixed- seizure</w>
mixed- methods</w>
mixed- age,</w>
mix utre</w>
mix ing.</w>
mix ing,</w>
mix ,</w>
mivac urium.</w>
mitoxantr one:</w>
mitoxantr one-treated</w>
mitoxantr one-containing</w>
mitoxantr one)</w>
mitoxantr one).</w>
mitot ane.</w>
mitot ane-associated</w>
mitot ane)</w>
mitogen s,</w>
mitogen icity,</w>
mitogen -stimulated</w>
mitogen -</w>
mitochondrial- targeted</w>
mitochondrial- independent.</w>
mitochondria- dependent</w>
mitochondri um</w>
mitochondri osis,</w>
mitochondri onopathy.</w>
mitochondri as.</w>
mitochondri a-related</w>
mitochondri a-mediated</w>
mitochondri a)</w>
mito tically</w>
mito ses.</w>
mito quinone</w>
miti s).</w>
mith ramycin.</w>
mith Kline</w>
mit tance</w>
mit rytiline</w>
mit rochondrial</w>
mit otoxicity</w>
mit osis,</w>
mit omycin/vinblastine.</w>
mit omycin.</w>
mit omycin-associated</w>
mit omicin</w>
mit ogenicity</w>
mit ogenesis,</w>
mit o-inhibition.</w>
mit ment</w>
mit h</w>
mit es</w>
mit e
mite fur
mitefur ),</w>
mistak es</w>
mish es,</w>
mish ed</w>
miscarri ages</w>
miscarri ages,</w>
misadvent ure</w>
misadvent ure.</w>
misadvent ure,</w>
mis users</w>
mis users.</w>
mis use/abuse</w>
mis understood,</w>
mis understanding</w>
mis sense-treated</w>
mis sed,</w>
mis s.</w>
mis reads'</w>
mis programming</w>
mis perception</w>
mis naming</w>
mis naming,"</w>
mis matches</w>
mis matche
mismatche d-related</w>
mis match
mismatch es,</w>
mis management.</w>
mis labeled</w>
mis interpre
misinterpre ted.</w>
mis hap
mishap s.</w>
mis diagnosed.</w>
mis conception</w>
mis concep
misconcep tions.</w>
mis classified</w>
mis attributed</w>
mis artan</w>
mis )</w>
mis )
mis) use</w>
mirtazap ine:</w>
mirtazap ine-induced</w>
mirtazap ine).</w>
mirro ring</w>
mipafox .</w>
mipafox -induced</w>
mio tic,</w>
mio sis)</w>
minute ]</w>
minute )-atropine</w>
minut es/
minutes/ day(-1),</w>
minut es.2.</w>
minut es);</w>
minut e-
minute- long</w>
minoxidil+ saline</w>
minoxidil+ DEX</w>
minoxidi l:</w>
minoxidi l-
minoxidil- mediated</w>
minoxidi l)</w>
minor ities.</w>
minor ities,</w>
minor :</w>
minor ).</w>
minocycl ine:</w>
minocycl ine/
minocycline/ MPTP-treated</w>
minocycl ine-treated</w>
minocycl ine-associated</w>
minocycl ine
minocycline ."</w>
minipump s,</w>
minipump s).</w>
minipump s),</w>
minipump /
minipump/ intracranial</w>
minipum p.</w>
minimum- maxim
minimum-maxim um)]</w>
minimal- to-slight</w>
minim ized.</w>
minim iz
minimiz e.</w>
minim al/
minimal/ focal</w>
minim al)</w>
minido se)</w>
minido se'</w>
minido se"</w>
mini- review</w>
mini- review.</w>
mini- pumps,</w>
mini- pulse</w>
mini- mental</w>
mini- laparotomy</w>
mini biopsies</w>
mini at
miniat urized</w>
ming s,</w>
ming ham</w>
mineralocortico id-like</w>
mineralocortico id-
mineralocorticoid- NaCl</w>
mineralocortico id)</w>
mineral ization.</w>
mineral iz
mineraliz es)</w>
mineral isation,</w>
min/ rat)</w>
min/ ml</w>
min/ ml.</w>
min/ mg</w>
min/ m2),</w>
min/ h,</w>
min/ g,</w>
min/ dose</w>
min/ day,</w>
min/ day),</w>
min/ after</w>
min/ 60</w>
min/ 10</w>
min-1 kg-1</w>
min-1 ]</w>
min- produced</w>
min- after</w>
min(-1 ):</w>
min(-1 )*
min(-1)* 100</w>
min thic</w>
min t</w>
min s).</w>
min osae)</w>
min or)</w>
min ophyllin)</w>
min ophagen</w>
min omycin</w>
min ology</w>
min ocylcine</w>
min ium</w>
min im</w>
min il
minil aparo
minilaparo tomy.</w>
min iferous</w>
min gh
mingh am.</w>
min g-
ming- up</w>
min ding</w>
min d
mind ful</w>
min ])</w>
min [-1
min[-1 ]).</w>
min .g
min.g .ml
min.g.ml (-1);</w>
min -2</w>
min ).(ABSTRACT</w>
min ).
min). 3.</w>
min )-</w>
min ))</w>
min (-)(1)</w>
mimick ery</w>
mimick ers.</w>
milrinone- vasopressin</w>
milrinone- norephinephrine</w>
milnacipran ,</w>
millisecond s)</w>
millisecond )</w>
milli meters</w>
milli meter.</w>
milli meter
millimeter )</w>
milli grams,</w>
mill iliter
milliliter ),</w>
mill en
millen nia.</w>
milk :</w>
milit ates</w>
milit ated</w>
mile stones.</w>
mild/ moderate</w>
mild/ grade</w>
mild- to-severe</w>
mild- moderately</w>
mild ronate</w>
mild ly,</w>
mild ]</w>
mild ."</w>
mil lim
millim olar</w>
mil ke</w>
mil k)</w>
mil dness</w>
mil der,</w>
mil d:</w>
mil d).</w>
mil d),</w>
mil d'</w>
migran s.</w>
migran s"</w>
migrainos us</w>
migrainos us,</w>
migraine- provoking</w>
migraine- generating</w>
migraine ur</w>
migraine ous</w>
migraine like</w>
migra ine-induced</w>
migr ations</w>
migr ational</w>
migr ation)</w>
migr ation"</w>
mig ratorius)</w>
mifeprist one)</w>
middle- sleep</w>
midd le
middle -</w>
midazolam/ midazolam
midazolam/midazolam )</w>
midazolam/ meperidine.</w>
midazolam- meperidine</w>
midazolam- ketamine</w>
midazolam- fentanyl</w>
midazolam- fentanyl-
midazolam-fentanyl- flu
midazolam-fentanyl-flu anis
midazolam-fentanyl-fluanis one</w>
midazolam :</w>
midazolam -associated</w>
midazolam (n=100)</w>
midagli zole,</w>
mid- ventricular</w>
mid- trimester</w>
mid- trial</w>
mid- rostrocaudal</w>
mid- normal</w>
mid- myocardium</w>
mid- morning</w>
mid- modiolar</w>
mid- luteal</w>
mid- line</w>
mid- leg</w>
mid- left</w>
mid- gut</w>
mid- gastric</w>
mid- frequency</w>
mid- facial</w>
mid- face</w>
mid- epigastric</w>
mid- dia
mid-dia physis.</w>
mid- brain</w>
mid- base</w>
mid- antiarrhythmic</w>
mid- anterior</w>
mid- afternoon</w>
mid- LAD</w>
mid wife</w>
mid western</w>
mid way</w>
mid ventricular,</w>
mid ventricle</w>
mid thoracic</w>
mid thigh</w>
mid thalamic</w>
mid st</w>
mid shaft</w>
mid shaft.</w>
mid segment</w>
mid sagittal</w>
mid position,</w>
mid portion</w>
mid pons,</w>
mid point</w>
mid luteal</w>
mid gestation</w>
mid face,</w>
mid day</w>
mid clav
midclav icular</w>
mid brain;</w>
mid ate,</w>
mid -term</w>
mid -dose</w>
mid -199
mid-199 6</w>
mid -19
mid-19 70
mid-1970 s.</w>
mid -,</w>
micturi tions/24</w>
micturi tions.</w>
micturi tions,</w>
microtubul e-dependent</w>
microtubul e-associated</w>
microstom ia</w>
microstom ia.</w>
microstom ia,</w>
microspher ocytes</w>
microspher ocytes,</w>
microsom ia,</w>
microsom es;</w>
microsom es)</w>
microsom es),</w>
microscop y:</w>
microscop y-confirmed</w>
microscop ists.</w>
microscop es</w>
microphthal mia.</w>
micronutri ent</w>
micronutri ent,</w>
microneuro graphy:</w>
microneuro graphically</w>
microne urography</w>
microne urography.</w>
micron g/kg/
microng/kg/ min)</w>
micron Ci</w>
micromoles/ liter,</w>
micromoles/ L);</w>
micromol/L ]).</w>
micromol/ ml</w>
micromol/ mL</w>
micromol/ mL)</w>
micromol/ liter)</w>
micromol/ liter),</w>
micromol/ kg/min</w>
micromol/ kg/min,</w>
micromol/ kg).</w>
micromol/ hr,</w>
micromol/ g/min,</w>
micromol/ L);</w>
micromicron./ min)</w>
micromicron./ min).</w>
micromicron .).</w>
micromanome ters,</w>
micromanome ter-tipped</w>
microm ol).</w>
microm mol/L),</w>
microm ;</w>
microm 2</w>
microm /
microm/ s)</w>
microm ).</w>
microliters/ min</w>
microliters/ kg)</w>
microliter/ side</w>
microliter/ side,</w>
microliter/ min/g</w>
microliter/ mg</w>
microliter/ h.</w>
microliter/ h)</w>
microliter/ GP)</w>
microliter s.</w>
microliter s,</w>
microliter s),</w>
microliter ).</w>
microl/ side),</w>
microl/ min/</w>
microl/ min/100</w>
microl/ h)</w>
microl/ h).</w>
microgxkg(-1)x min(-1)</w>
microgxkg(-1)x h(-1)</w>
micrograph s.</w>
micrograms/m L),</w>
micrograms/kg/ ml</w>
micrograms/kg/ minute</w>
micrograms/kg/ min;</w>
micrograms/kg/ hr).</w>
micrograms/kg/ day</w>
micrograms/kg );</w>
micrograms/g bw</w>
micrograms/g bw)</w>
micrograms/g bw).</w>
micrograms/g b
micrograms/gb w.</w>
micrograms/d l,</w>
micrograms/d L</w>
micrograms/ site,</w>
micrograms/ site)</w>
micrograms/ side</w>
micrograms/ mouse,</w>
micrograms/ ml);</w>
micrograms/ min),</w>
micrograms/ microL)</w>
micrograms/ kg.
micrograms/kg. min)</w>
micrograms/ injection.</w>
micrograms/ hr</w>
micrograms/ hr)</w>
micrograms/ h.</w>
micrograms/ h
micrograms/h --were</w>
micrograms/ g,</w>
micrograms/ g),</w>
micrograms/ day).</w>
micrograms/ d)</w>
micrograms/ d).</w>
micrograms/ cm2/min</w>
micrograms/ cm2)</w>
micrograms/ body</w>
micrograms/ L.</w>
micrograms/ L).</w>
micrograms/ 1</w>
micrograms.kg-1. min-1;</w>
micrograms.kg-1. min-1.</w>
micrograms.kg-1. hr
micrograms.kg-1.hr -1);</w>
micrograms.kg-1. h-1)</w>
micrograms. ml-1;</w>
micrograms. ml-1.</w>
micrograms. ml-1)</w>
micrograms. ml-1).</w>
micrograms. l-1</w>
micrograms. l-1,</w>
micrograms. kg-1.</w>
micrograms. kg-1,</w>
micrograms. kg-1).</w>
micrograms. h-1,</w>
micrograms. g-1,</w>
micrograms. L-1.</w>
micrograms. /
micrograms./ gm.</w>
microgram/kg/ min;</w>
microgram/kg/ min);</w>
microgram/kg/ min).</w>
microgram/kg/ min),</w>
microgram/ site)</w>
microgram/ side)</w>
microgram/ mouse)</w>
microgram/ ml;</w>
microgram/ ml).</w>
microgram/ min</w>
microgram/ liter),</w>
microgram/ kg).</w>
microgram/ injection,</w>
microgram/ h.</w>
microgram/ h,</w>
microgram/ g</w>
microgram/ g,</w>
microgram/ g),</w>
microgram/ day)</w>
microgram/ d,</w>
microgram/ cm2</w>
microgram/ cm2/min</w>
microgram/ H</w>
microgram/ 50</w>
microgram/ 100</w>
microgram.kg-1. min-1)</w>
microgram.kg-1. min-1).</w>
microgram.kg-1. min-1),</w>
microgram. ml-1;</w>
microgram. -
microgram.- kg-1.
microgram.-kg-1. min-1</w>
microgram s/</w>
microgram s-hr/mL,</w>
microgram s);</w>
microgram s)-induced</w>
microgram -1</w>
micrognath ae.</w>
micrognath ae).</w>
microglobul in/
microglobulin/ creatinine</w>
microglobul in.</w>
microglobul in-positive</w>
microglia/ macrophages</w>
microglia/ macrophage</w>
microglia- derived</w>
microgli osis</w>
microgli al-specific</w>
microgli a,</w>
microgli a).</w>
microg/mL ]).</w>
microg/m 2/day</w>
microg/m 2.</w>
microg/m 2,</w>
microg/kg/ minute,</w>
microg/kg/ minute)</w>
microg/kg/ min),</w>
microg/kg/ infusion;</w>
microg/kg/ hr.</w>
microg/kg/ hr)</w>
microg/kg/ hour</w>
microg/kg/ hour;</w>
microg/kg/ h</w>
microg/kg/ day.</w>
microg/kg/ d</w>
microg/kg )-
microg/kg)- precipitated</w>
microg/d L;</w>
microg/d L)</w>
microg/d L),</w>
microg/ wk</w>
microg/ wk)</w>
microg/ week.</w>
microg/ side).</w>
microg/ rat/d).</w>
microg/ rat.</w>
microg/ rat).</w>
microg/ rat)-induced</w>
microg/ rat),</w>
microg/ paw</w>
microg/ paw.</w>
microg/ mouse/day</w>
microg/ ml).</w>
microg/ ml(-1)</w>
microg/ min.</w>
microg/ min).</w>
microg/ min),</w>
microg/ microl),</w>
microg/ l;</w>
microg/ l.</w>
microg/ l,</w>
microg/ l
microg/l b],</w>
microg/ infusion</w>
microg/ g).</w>
microg/ g),</w>
microg/ day).</w>
microg/ day),</w>
microg/ d)</w>
microg/ d),</w>
microg/ animal,</w>
microg/ animal)-induced</w>
microg/ L),</w>
microg/ Kg</w>
microg/ 7.5</w>
microg/ 2</w>
microg/ 25</w>
microg/ 20</w>
microg/ 10</w>
microg/ 1
microg/1 microL</w>
microg/ 0.5
microg/0.5 microl)</w>
microg/ 0.1</w>
microg/ (kg</w>
microg.kg(-1). h(-1))</w>
microg.kg(-1). h
microg.kg(-1).h (-1).</w>
microg./ kg;</w>
microg./ kg,</w>
microg. kg-1.
microg.kg-1. day-1)</w>
microg. kg-1)</w>
microg. kg(-1),</w>
microg. 10</w>
microg ]</w>
microg -</w>
microg *
microg* hr/
microg*hr/ L,</w>
microg );</w>
microg )-induced</w>
microg %</w>
microg %).</w>
microfilare mia.</w>
microfilare mia,</w>
microfil aria</w>
microelectro de,</w>
microelectro de
microelectrode s)</w>
microcephal us,</w>
microbub bl
microbubbl es.</w>
microbleed s.</w>
microbleed s,</w>
microarra ys.</w>
microarra y.</w>
microarra y,</w>
microV/ ms;</w>
microU/ ml.</w>
microU/ ml)</w>
microM/ L,</w>
microM/ L)</w>
microM)- con-
microM)-con- tracted</w>
microL/ min</w>
microL/ min.</w>
microL/ min)</w>
microL (-1).</w>
microL (-1))</w>
microEq/ min).</w>
microEq/ L)</w>
micro- tubule</w>
micro- receptor</w>
micro- osmotic</w>
micro- organisms</w>
micro- organisms,</w>
micro- organism</w>
micro- hemorrhages</w>
micro- dissected</w>
micro- deposits</w>
micro- crystals,</w>
micro- crystalluria</w>
micro- bios
micro-bios ens
micro-biosens ors</w>
micro- areas.</w>
micro- angiopathic</w>
micro- albuminuria</w>
micro- adenoma</w>
micro viscosity</w>
micro villar</w>
micro vessels.</w>
micro vascular-EB-albumin</w>
micro vacuolization,</w>
micro vacuole</w>
micro vacuolar</w>
micro titer</w>
micro tia/anotia</w>
micro ti.</w>
micro thrombotic</w>
micro syringe.</w>
micro surgical,</w>
micro surgery</w>
micro surgeons,</w>
micro surgeon</w>
micro structure</w>
micro spectrophotometry.</w>
micro spasm</w>
micro simulation</w>
micro satellites</w>
micro retrognathia,</w>
micro recording</w>
micro recording.</w>
micro pustules,</w>
micro proteinuria</w>
micro proteinuria,</w>
micro proteins</w>
micro protein</w>
micro protein).</w>
micro prolactinoma,</w>
micro probe</w>
micro preemies</w>
micro peroxidase</w>
micro perfusion.</w>
micro perfused</w>
micro particles.</w>
micro organisms.</w>
micro ophthalmia</w>
micro meter</w>
micro litres/
microlitres/ kilogram,</w>
micro injections,</w>
micro injection,</w>
micro injection)</w>
micro infusions</w>
micro infusion.</w>
micro infused</w>
micro hemorrhages</w>
micro hemorrhages,</w>
micro hemodynamics,</w>
micro hemodynamic</w>
micro hematuria,</w>
micro haematuria,</w>
micro gravi
microgravi metry.</w>
micro graphic</w>
micro granulo
microgranulo mal
microgranulomal i
microgranulomali ke</w>
micro force</w>
micro fluorimetric</w>
micro filtration</w>
micro filter</w>
micro filament</w>
micro embolization</w>
micro emboli.</w>
micro electrodes,</w>
micro dy
micrody ali
microdyali sis</w>
micro doses</w>
micro dialysis-
microdialysis- electrocorticography</w>
micro deposits</w>
micro cysts.</w>
micro cyst</w>
micro cys
microcys tic,</w>
micro cy
microcy tic,</w>
micro crystals,</w>
micro conductance</w>
micro computer-based</w>
micro computer-
microcomputer- based,</w>
micro clots,</w>
micro circulations.</w>
micro ceph
microceph aly
microcephaly /
microcephaly/ hypoplastic</w>
micro carriers</w>
micro carri
microcarri er
microcarrier s-RPE</w>
micro calcul
microcalcul i;</w>
micro calcifications</w>
micro c
microc oscopically</w>
micro brachy
microbrachy cephaly,</w>
micro blood</w>
micro bleeding</w>
micro bleeding.</w>
micro bleed</w>
micro biologic,</w>
micro bioassay</w>
micro angiitis.</w>
micro aneurysms,</w>
micro analytic</w>
micro analysis</w>
micro albuminuria,</w>
micro adenoma</w>
micro adenoma,</w>
micro abscesses</w>
micro V</w>
micro V),</w>
micro U/ml,</w>
micro L.</w>
micro IU/mL</w>
micro IU/L.</w>
micro IU/
microIU/ mL).</w>
micro A/
microA/ cm2</w>
micro /
micro/ retrognathia.</w>
micro ,</w>
mice/ sex</w>
mice/ sex/dose</w>
mice. We</w>
mice. 6</w>
mice ."</w>
mice ):</w>
micafun g
micafung in,</w>
mic rg/g</w>
mic rangiopathy,</w>
mic org/mL</w>
mic onazole-induced</w>
mic ar).</w>
mic ?</w>
mic )</w>
mibefradi l-treated</w>
mibefradi l,</w>
mianser ine,</w>
mi um.</w>
mi um-exposed</w>
mi se.</w>
mi s.</w>
mi pramine-induced</w>
mi phora</w>
mi pafox</w>
mi osed</w>
mi ocyte</w>
mi )</w>
mgI/ mL)</w>
mg/ml/ min</w>
mg/ml/ hr)</w>
mg/m2/ wk)</w>
mg/m2/ wk).</w>
mg/m2/ week).</w>
mg/m2/ week),</w>
mg/m2/ hr.</w>
mg/m2/ dose.</w>
mg/m2/ dose,</w>
mg/m2/ dose)</w>
mg/m2/ day).</w>
mg/m2/ day),</w>
mg/m2/ d:</w>
mg/m2/ d).</w>
mg/m2/ d),</w>
mg/m2/ cycle.</w>
mg/m2/ 3</w>
mg/m2/ 12</w>
mg/m/ week</w>
mg/m/ d,</w>
mg/m/ course</w>
mg/m(2)/ wk)</w>
mg/m(2)/ dose</w>
mg/m(2)/ dose.</w>
mg/m(2)/ day).</w>
mg/m(2)/ 96</w>
mg/m(2)/ 24</w>
mg/m(2) x3).</w>
mg/m(2) as</w>
mg/m(2) );</w>
mg/m o</w>
mg/m g,</w>
mg/m L);</w>
mg/m 2-1
mg/m2-1 150</w>
mg/m 2+
mg/m2+ either</w>
mg/m .</w>
mg/m )</w>
mg/m (3)
mg/m(3) )-
mg/m(3))- -a</w>
mg/l b]</w>
mg/l b],</w>
mg/kg/day .(ABSTRACT</w>
mg/kg/d ]</w>
mg/kg/d ])</w>
mg/kg/ wk</w>
mg/kg/ wk)</w>
mg/kg/ wk).</w>
mg/kg/ week.</w>
mg/kg/ week,</w>
mg/kg/ week)</w>
mg/kg/ week).</w>
mg/kg/ s.c.),</w>
mg/kg/ per</w>
mg/kg/ patient</w>
mg/kg/ p.o.)</w>
mg/kg/ p.o.),</w>
mg/kg/ p.o).aAnaAV3V</w>
mg/kg/ orally),</w>
mg/kg/ minute).</w>
mg/kg/ min/10</w>
mg/kg/ iv)</w>
mg/kg/ injection),</w>
mg/kg/ inj
mg/kg/inj ).</w>
mg/kg/ infusion</w>
mg/kg/ infusion;</w>
mg/kg/ infusion,</w>
mg/kg/ infusion),</w>
mg/kg/ inf
mg/kg/inf ,</w>
mg/kg/ im)</w>
mg/kg/ i.v.).</w>
mg/kg/ i.p</w>
mg/kg/ i.p.),</w>
mg/kg/ hr.</w>
mg/kg/ hr,</w>
mg/kg/ hr),</w>
mg/kg/ hour</w>
mg/kg/ h;</w>
mg/kg/ h.</w>
mg/kg/ dose.</w>
mg/kg/ dose).</w>
mg/kg/ day);</w>
mg/kg/ daily)</w>
mg/kg/ d.
mg/kg/d. x</w>
mg/kg/ b.w.</w>
mg/kg/ b.w./day</w>
mg/kg/ animal)</w>
mg/kg/ 2</w>
mg/kg/ 24h)</w>
mg/kg/ 10</w>
mg/kg/ 1-1</w>
mg/kg. min-1</w>
mg/kg. min,</w>
mg/kg. min)</w>
mg/kg. ip)</w>
mg/kg. day),</w>
mg/kg- catalepsy</w>
mg/kg- 0.02</w>
mg/kg, sc)</w>
mg/kg, i.p.</w>
mg/kg)/ saline,</w>
mg/kg)/ METH</w>
mg/kg)+ tramadol</w>
mg/kg)+ morphine</w>
mg/kg)+ Sal
mg/kg)+Sal ine.</w>
mg/kg)+ Methamphetamine</w>
mg/kg)+ DOX.</w>
mg/kg)+ 4
mg/kg)+4 MA</w>
mg/kg ];</w>
mg/kg ].</w>
mg/kg .,</w>
mg/kg .)</w>
mg/kg --were</w>
mg/kg --IP</w>
mg/kg )],</w>
mg/kg ).
mg/kg). 6</w>
mg/kg )-treated</w>
mg/kg )-mediated</w>
mg/kg )-</w>
mg/kg )-
mg/kg)- CDZP</w>
mg/kg (-1
mg/kg(-1 )/
mg/kg(-1)/ d
mg/kg(-1)/d (-1);</w>
mg/k p</w>
mg/k gl
mg/kgl day</w>
mg/k d</w>
mg/k d/
mg/kd/ day</w>
mg/k /
mg/k/ d,</w>
mg/eye ;</w>
mg/day ].</w>
mg/day ],</w>
mg/day /
mg/day/ rat</w>
mg/dL ];</w>
mg/dL ].</w>
mg/dL ]).</w>
mg/dL (66.7</w>
mg/d ):</w>
mg/Kg/ wk</w>
mg/Kg/ di
mg/Kg/di e).</w>
mg/K g/min)</w>
mg/K g),</w>
mg/24 h)</w>
mg/100 g,</w>
mg/(kg. min)]</w>
mg/(kg. min)</w>
mg/(kg. d);</w>
mg/(kg. d),</w>
mg/( kg</w>
mg/ wk)</w>
mg/ week.</w>
mg/ week,</w>
mg/ week)</w>
mg/ twi</w>
mg/ trandolapril</w>
mg/ t.i.d.)</w>
mg/ sec.</w>
mg/ rat/day).</w>
mg/ rat)</w>
mg/ rat),</w>
mg/ pyrimethamine</w>
mg/ os/day</w>
mg/ n2</w>
mg/ month</w>
mg/ month)</w>
mg/ minute</w>
mg/ minute.</w>
mg/ minute,</w>
mg/ min/rat)</w>
mg/ min.</w>
mg/ microl,</w>
mg/ litre</w>
mg/ litre
mg/litre ).</w>
mg/ liter;</w>
mg/ liter),</w>
mg/ l.h)</w>
mg/ k</w>
mg/ hydrochlorothiazide</w>
mg/ hr</w>
mg/ hr.</w>
mg/ hr)</w>
mg/ h.</w>
mg/ h)</w>
mg/ h),</w>
mg/ gm</w>
mg/ gm
mg/gm ),
mg/gm), followed</w>
mg/ g.</w>
mg/ g,</w>
mg/ ezetimibe</w>
mg/ drospirenone</w>
mg/ die</w>
mg/ di
mg/di e)</w>
mg/ day-
mg/day- risperidone</w>
mg/ daily</w>
mg/ aspirin</w>
mg/ animal</w>
mg/ alternate-day</w>
mg/ M2,</w>
mg/ M2).</w>
mg/ M
mg/M 2.</w>
mg/ L;</w>
mg/ L/
mg/L/ day,</w>
mg/ 800</w>
mg/ 75</w>
mg/ 4
mg/4 287</w>
mg/ 325</w>
mg/ 30
mg/30 34</w>
mg/ 2</w>
mg/ 2800</w>
mg/ 24h</w>
mg/ 24)</w>
mg/ 21</w>
mg/ 20</w>
mg/ 15</w>
mg/ 10</w>
mg/ 1,</w>
mg/ 0.1</w>
mg.kg-1. hr
mg.kg-1.hr -1.</w>
mg.kg-1. h-1.</w>
mg.kg-1. h-1,</w>
mg.kg-1. day-1)</w>
mg.kg(-1). wk(-1)</w>
mg.kg(-1). s(-1).</w>
mg.kg(-1). min(-1)</w>
mg.kg(-1). day(-1)</w>
mg.kg(-1). day(-1))</w>
mg.kg(-1). d(-1))</w>
mg.kg(-1). d(-1));</w>
mg./kg .)</w>
mg./kg .),</w>
mg./ m.
mg./m. 2</w>
mg./ kg.
mg./kg. ,
mg./kg., i.v.</w>
mg./ 70
mg./70 kg.</w>
mg./ 24</w>
mg. per</w>
mg. m-2;</w>
mg. l-1),</w>
mg. kg-1;</w>
mg. kg(-1)
mg.kg(-1) propofol</w>
mg. hr-1</w>
mg. h-1,</w>
mg. g</w>
mg. day(-1).</w>
mg. ,
mg., /kg.,</w>
mg- kg,</w>
mg- ezetimibe</w>
mg- d
mg-d l)</w>
mg- 400</w>
mg m</w>
mg kg</w>
mg kg-1)</w>
mg ]</w>
mg -1
mg-1 2.5</w>
mg )-induced</w>
mg (-1)</w>
metrorrhag ia</w>
metrorrhag ia;</w>
metronidazole- resistant</w>
metronidazole- -a</w>
metronidazol e:</w>
metronidazol e-associated</w>
metrizo ate.</w>
metriz amide,</w>
metrif onate.</w>
metrif onate,</w>
metric al,</w>
metri tis;</w>
metraz ol-induced</w>
metra zole,</w>
metra zol)</w>
metr ically</w>
metr ical</w>
metr ic,</w>
metr e</w>
metoprolol/ hydrochlorothiazide</w>
metoprolol/ alpha-hydroxymetoprolol</w>
metoprolo l-
metoprolol- glucagon.</w>
metolaz one.</w>
metolaz one-associated</w>
metocur ine.</w>
metocur ine)</w>
metil R)</w>
meti tepine</w>
meti pranolol.</w>
meti pranolol-induced</w>
meti pranolol,</w>
methysergi de:</w>
methysergi de).</w>
methylprednisol one)</w>
methylprednisol one),</w>
methylphenid ate:</w>
methylphenid ate-
methylphenidate- ,</w>
methylox azepam)</w>
methylglutar yl-coenzyme-A</w>
methylglutar yl)</w>
methylethyl) amino]-
methylethyl)amino]- 2-hydroxy
methylethyl)amino]-2-hydroxy propoxy]-1,3-dihydro-2H-benzimidazole-2-one</w>
methylethan -1-amine]</w>
methyleth yl)-4-({1-[6-(trifluoromethyl)-3-pyridinyl]-4-piperidinyl}carbonyl)hexahydro-1H-1,4-diazepine)</w>
methylergonov ine.</w>
methylergometr ine.</w>
methylergometr ine,</w>
methylergometr in</w>
methyleph edrine</w>
methyleph ed
methylephed rine:</w>
methylenedioxymethamphet amine
methylenedioxymethamphetamine /</w>
methylenedioxy- methamphetamine,</w>
methylenedioxy met
methylenedioxymet amphetamine,</w>
methylene ]-
methylene]- amino]-
methylene]-amino]- 3-[4-
methylene]-amino]-3-[4- (4-methyl
methylene]-amino]-3-[4-(4-methyl -1-piperazin
methylene]-amino]-3-[4-(4-methyl-1-piperazin yl)butyl]-2,4-imidazolidi</w>
methyldopa )</w>
methyldopa ).</w>
methylclofenap ate</w>
methylclofenap ate)</w>
methylcell ulose).</w>
methylbenz[c] acridine</w>
methylbenz[c] acri
methylbenz[c]acri dine.</w>
methylamino- pyrimidin-4-yl)</w>
methyl] amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acet
methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acet amide
methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide ],</w>
methyl-8- quinolinyl)</w>
methyl-8- p-sulfophenyl-xanthine</w>
methyl-6-oxo- 4H-
methyl-6-oxo-4H- imidazo-
methyl-6-oxo-4H-imidazo- (1,5-
methyl-6-oxo-4H-imidazo-(1,5- a)</w>
methyl-6-(phenylethyn yl)-pyridine,</w>
methyl-6-( phenyl-ethyl)-pyrimidine</w>
methyl-6- phenylethynyl-pyridine,</w>
methyl-6- Ox
methyl-6-Ox o-4H-imidazo</w>
methyl-5- oxo-thiomorpholinyl]</w>
methyl-5- nitrobenzophenone),</w>
methyl-4-phenyl- isoquinol
methyl-4-phenyl-isoquinol ine)</w>
methyl-4-phenyl- 4H-
methyl-4-phenyl-4H- 3,
methyl-4-phenyl-4H-3, 1-
methyl-4-phenyl-4H-3,1- benz
methyl-4-phenyl-4H-3,1-benz oxazine</w>
methyl-4- phosphonophenylglycine</w>
methyl-4- ethyl-
methyl-4-ethyl- 6,7-di
methyl-4-ethyl-6,7-di methoxy-9H-
methyl-4-ethyl-6,7-dimethoxy-9H- pyrido-(3,4-b)-indol-3-carboxylate)</w>
methyl-4- (3-
methyl-4-(3- nitrophenyl)-3,5-pyridinedicarboxylate,</w>
methyl-4 thiomorpholin</w>
methyl-4 (4-morpholin
methyl-4(4-morpholin ylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one</w>
methyl-2- pyridyl)ethyl]-4-methylsulfonylaminobenzoyl)-piperidine),</w>
methyl-2- oxo-1,2,3,4-tetrahydro-7-quinolyl)-2-[(2-methylpyrrolidin-1-yl)methyl]biphenyl-4-carboxamide</w>
methyl-2- cyclohexen
methyl-2-cyclohexen one</w>
methyl-2- buten
methyl-2-buten ylidene)hydrazino]phthalazine</w>
methyl-2- [4-
methyl-2-[4- (
methyl-2-[4-( naphtylpiperazin-1-yl)butyl]-3-(2H)-pyridazinone),</w>
methyl-2- [(E)-
methyl-2-[(E)- hydroxy
methyl-2-[(E)-hydroxy amino]-
methyl-2-[(E)-hydroxyamino]- 5-nitro-
methyl-2-[(E)-hydroxyamino]-5-nitro- 6-methoxy-
methyl-2-[(E)-hydroxyamino]-5-nitro-6-methoxy- 3-
methyl-2-[(E)-hydroxyamino]-5-nitro-6-methoxy-3- hex
methyl-2-[(E)-hydroxyamino]-5-nitro-6-methoxy-3-hex an
methyl-2-[(E)-hydroxyamino]-5-nitro-6-methoxy-3-hexan amide</w>
methyl-1-phenyl- 2,3,4,5-tetrahydro-1H-3-benz
methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benz azepine]</w>
methyl- tetrahydrofolic</w>
methyl- quinolin-6-yl)-(4-methoxy-cyclohexyl)-methanone</w>
methyl- pyrazolo[1,5-d][1,2,4]-triazine</w>
methyl- prednisolone</w>
methyl- phenyl)-2-(2-oxo-1-pyrrolidinyl)</w>
methyl- man
methyl-man noside</w>
methyl- isoxazole-4-
methyl-isoxazole-4- propionic</w>
methyl- iodophenyl</w>
methyl- ergometrine</w>
methyl- derivatives.</w>
methyl- deacetylthymoxamine</w>
methyl- clozapine</w>
methyl- N-vanillyl-6-nonen
methyl-N-vanillyl-6-nonen amide
methyl-N-vanillyl-6-nonenamide )-induced</w>
methyl- L-cysteine</w>
methyl- L-arginine.</w>
methyl- D-glucose,</w>
methyl- ALA,</w>
methyl- 8-phenyl
methyl-8-phenyl xanthine</w>
methyl- 7-(4-
methyl-7-(4- pyridyl)-5,6,7,8-tetrahydro-3(2H)-isoquinolinone</w>
methyl- 6,</w>
methyl- 6,
methyl-6, 11-
methyl-6,11- dihydro
methyl-6,11-dihydro -11-
methyl-6,11-dihydro-11- [
methyl-6,11-dihydro-11-[ (N,N-
methyl-6,11-dihydro-11-[(N,N- dimethylamino)</w>
methyl- 5-methyl
methyl-5-methyl thio-2,</w>
methyl- 5-FU</w>
methyl- 5,5-
methyl-5,5- diphenylhydantoin,</w>
methyl- 4H
methyl-4H -1,3-
methyl-4H-1,3- thiazine</w>
methyl- 3-(4-
methyl-3-(4- morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone),</w>
methyl- ((S)-4-
methyl-((S)-4- (m-
methyl-((S)-4-(m- nitrophenyl))-1,4-dihydropyridine-3,5-dicarboxyla</w>
methyl)-8- azabicyclo
methyl)-8-azabicyclo (3.
methyl)-8-azabicyclo(3. 2.
methyl)-8-azabicyclo(3.2. 1)
methyl)-8-azabicyclo(3.2.1) octane-3-methanamine</w>
methyl)-1H- imidazol
methyl)-1H-imidazol -2-
methyl)-1H-imidazol-2- yl]-phenoxy]propyl]-amino]ethoxy]-benzamide</w>
methyl)- 4,
methyl)-4, 5alpha-
methyl)-4,5alpha- epoxy-
methyl)-4,5alpha-epoxy- 3,
methyl)-4,5alpha-epoxy-3, 14-
methyl)-4,5alpha-epoxy-3,14- dihydroxy
methyl)-4,5alpha-epoxy-3,14-dihydroxy morphinan-6beta-yl]-3-(furan-3-yl)-N-methylprop-2-enamide</w>
methyl)- 3,4-dihydro-
methyl)-3,4-dihydro- 2,3,7,8-
methyl)-3,4-dihydro-2,3,7,8- tetramethyl-2H-1-benzopyran-6-ol,</w>
methyl) pyrrolidine</w>
methyl) hydroxy
methyl)hydroxy phosphinyl]-2-(S)-</w>
methyl) benz
methyl)benz ylester</w>
methyl(acetoxymethyl) nitrosamine</w>
methyl(acetoxymethyl) nitrosamine,</w>
methyl triazen-1-yl)imidazole-4-caroxamide,</w>
methyl transferase.</w>
methyl transferase,</w>
methyl thiomethyl</w>
methyl tetrahydrofolate</w>
methyl sulphonate</w>
methyl sulfonyl</w>
methyl pyrazolo[1,5-d][1,2,4]</w>
methyl propyl)-2-thiobarbituric</w>
methyl phenobarbitone</w>
methyl phenobarbitone.</w>
methyl ornithine,</w>
methyl nicotinate</w>
methyl nicotinamide.</w>
methyl naloxone</w>
methyl methionine</w>
methyl malon
methylmalon yl-CoA</w>
methyl lysine</w>
methyl indoline</w>
methyl imino]
methylimino] propyl]-2H-3-benzazepin-2-on</w>
methyl histamine</w>
methyl guanidine,</w>
methyl glut
methylglut aril</w>
methyl fluorescein.</w>
methyl enec
methylenec ycloartenol</w>
methyl en-
methylen- di
methylen-di oxy-5H-2,3-</w>
methyl codeine</w>
methyl cobalamin</w>
methyl cobal
methylcobal amine</w>
methyl catechol</w>
methyl ations</w>
methyl ations.</w>
methyl ation-
methylation- de
methylation-de methylation</w>
methyl amphetamine</w>
methyl aminoadamant
methylaminoadamant ane</w>
methyl amine</w>
methyl amide</w>
methyl amide)</w>
methy loxy
methyloxy )
methyloxy) phenyl-1,3-dipropylxant</w>
methy glutaryl-coenzyme</w>
methoxyflur ane;</w>
methoxyflur ane-
methoxyflurane- related</w>
methoxy-9H- fluoren
methoxy-9H-fluoren -9-
methoxy-9H-fluoren-9- one.</w>
methoxy-4-iodo amphetamine,</w>
methoxy-4- morpholinyl)doxorubicin</w>
methoxy-4- bromo
methoxy-4-bromo amphetamine</w>
methoxy-4- [[
methoxy-4-[[ (R)-
methoxy-4-[[(R)- phenylsulphinyl]methyl]-1-piperidinyl]ethyl]-1H-indole</w>
methoxy- phenyl)-piperazin-1-yl]-2-hydroxy-propyl}-3,3-diphenylpyrrolidin-2-one</w>
methoxy- benzyl
methoxy-benzyl ]</w>
methoxy- 4-</w>
methoxy- 3-(2-
methoxy-3-(2- phenylethoxy)phenyl]-ethylamine</w>
methoxy- 3-
methoxy-3- (4-methyl
methoxy-3-(4-methyl -1-piperazinyl)
methoxy-3-(4-methyl-1-piperazinyl) phenyl]-2'-methyl-4'-(5-methyl-1,2</w>
methoxy- 2-propionamid
methoxy-2-propionamid otetralin,</w>
methoxy- 2-
methoxy-2- nitro)phenyl-2-p</w>
methoxy phenylethylene</w>
methoxy phenylethylamino</w>
methoxy phenyl)</w>
methoxy phenoxyethyl)</w>
methoxy methyl)pyrrolidine</w>
methoxy isobut
methoxyisobut yl-isonitrile)</w>
methoxy ethyl</w>
methoxy ethoxy
methoxyethoxy ethyl</w>
methoxy coron
methoxycoron ar
methoxycoronar idine</w>
methoxy carbonyl
methoxycarbonyl phenylcyclopentyl-N,N-dimethyltropinium</w>
methoxy benz
methoxybenz yl)-7-hydroxy-6-methoxy-2-methyl-</w>
methoxy -1-
methoxy-1- naphtyl)</w>
methox yl-4-ethyl-beta-carboline-3-carboxylate</w>
methox amine-
methoxamine- evoked</w>
methox amine)</w>
methotrimepraz ine.</w>
methotrimepraz ine-treated</w>
methotrimepraz ine)</w>
methotrex ate;</w>
methom yl.</w>
methom yl-only</w>
methom yl,</w>
methohexit one;</w>
methohexit one-induced</w>
methohexit one-activated</w>
methohexit al:</w>
methohexit al-induced</w>
methodolog ies.</w>
method s;</w>
method s.A</w>
method s.(ABSTRACT</w>
method s--high</w>
method '.</w>
method "</w>
methoc tramine,</w>
metho thexate</w>
metho k
methok sytryptamine.</w>
methionine- supplemented</w>
methionine- sulfoximine</w>
methionine- enkephalin</w>
methionine- enkephalin.</w>
methion ine)</w>
methiodi de;</w>
methimazol e-</w>
methimazol e).</w>
methim azole-
methimazole- treated</w>
methim azole)</w>
methicill in;</w>
methicill in-treated</w>
methicill in-associated</w>
methicill in-</w>
methicill in)</w>
methi omazole</w>
methi azol
methiazol e:</w>
metherg ine</w>
metherg ine.</w>
metherg ine,</w>
methemoglob inemia;</w>
methemoglob ine
methemoglobine mia:</w>
methemoglob in.</w>
methemoglob in,</w>
methcathin one:</w>
methcathin one.</w>
methcath inone,</w>
methazol amide
methazolamide ).</w>
methan ol.</w>
methamphetamine- unexposed</w>
methamphetamine- responsive</w>
methamphetamine- primed</w>
methamphetamine- pretreated</w>
methamphetamine- mediated</w>
methamphetamine- induced,</w>
methamphetamine- dependent,</w>
methamphetamine- d
methamphetamine-d (14)</w>
methamphetamine- chlordiazepoxide</w>
methamphet amines</w>
methamphet amines.</w>
methamphet amines,</w>
methamphet amine:</w>
methamphet amine)</w>
methamphet amine's</w>
methadone- maintenance:</w>
methadone- dependent</w>
methad onetreated</w>
methad one;</w>
methad one)</w>
methad ol</w>
methach oline-induced</w>
meth ylester,</w>
meth y-glutaryl</w>
meth scopolamine</w>
meth rine</w>
meth oxylation</w>
meth oxamine.</w>
meth orexate</w>
meth ly
methly dopa.</w>
meth io
methio thepin</w>
meth azine</w>
meth apy
methapy rilene.</w>
meth anol,</w>
meth ane:</w>
meth anand
methanand amide.</w>
meth amine-
methamine- sulfadoxine</w>
meth adione</w>
meth acryl
methacryl ate.</w>
metfor min-treated</w>
metfor min)</w>
metest rus.</w>
metergol ine.</w>
mete strus,</w>
mete orologic</w>
metaz idine,</w>
metastasi zes</w>
metastasi ze</w>
metastasi s:</w>
metastasi s-free</w>
metastasi s).</w>
metastas es;</w>
metastas es:</w>
metast atic
metastatic )</w>
metast asis,</w>
metaramin ol-induced</w>
metaramin ol,</w>
metaproteren ol:</w>
metamorph osis</w>
metamiz ole:</w>
metamiz ole-induced</w>
metallothione ins</w>
metallothione in-
metallothionein- i
metallothionein-i ii</w>
metalloproteinase- 9</w>
metalloproteinase- 1</w>
metalloprotein ases.</w>
metalloprotein ase.</w>
metallo protease</w>
metal- rich</w>
metal- chelating</w>
metaiodobenzyl guanidine.</w>
metaclop ramide</w>
metaclop ramide,</w>
metach romatic</w>
metac hloro
metachloro phenylpiperazine</w>
metabonom ics.</w>
metaboliz ers.</w>
metaboliz er.</w>
metabolite (s)</w>
metabolite (s).</w>
metabolite (s),</w>
metabolit es:</w>
metabolit e;</w>
metabolit e:</w>
metabolit e-mediated</w>
metabolit e-induced</w>
metabolit e-
metabolite- protein</w>
metabolism .(ABSTRACT</w>
metabolism -induced</w>
metabolism ),</w>
metabolic/ toxic</w>
metabolic/ neurotransmitter</w>
metabolic- enhancing</w>
metabolic- endocrine</w>
metabol ized,</w>
metabol isms.</w>
metabol iser</w>
metabol ic.</w>
metabol ic"</w>
metab is
metabis ulfite</w>
meta-iodobenzyl guanidine</w>
meta-iodobenzyl guanidine.</w>
meta-iodobenzyl guanidine,</w>
meta- static</w>
meta- chlorphenylpiperaz
meta-chlorphenylpiperaz ine,</w>
meta- analytic</w>
meta- analyses;</w>
meta- analyses,</w>
meta- amphetamines,</w>
meta- ,</w>
meta regression</w>
meta physis</w>
meta phylaxis</w>
meta phases</w>
meta phase</w>
meta hydroxy
metahydroxy benzoylecgonine</w>
meta analysis</w>
met/dex ;</w>
met/dex .</w>
met/dex ).</w>
met- formin</w>
met- enkephalin.</w>
met- enkephal
met-enkephal in).</w>
met yl-4-phenyl-1,2,3,6-tetrahydropyridine</w>
met on</w>
met oclopromide</w>
met ind
metind ene</w>
met astic</w>
met apl
metapl asi
metaplasi a/
metaplasia/ cholangiocellular</w>
met ap
metap lex</w>
met anide</w>
met anephric</w>
met an
metan dien
metandien one,</w>
met als</w>
met als.</w>
met als,</w>
met adine</w>
met .</w>
mesyl ate:</w>
mesyl ate-related</w>
mesyl ate)</w>
mesyl ate),</w>
mesulerg ine,</w>
mestran ol-norethindrone</w>
mestran ol-containing</w>
mestran ol,</w>
messenger "</w>
messeng er-
messenger- RNA</w>
mess ages.</w>
mesop ontine</w>
mesocortic al/
mesocortical/ mesolimbic</w>
meso der
mesoder m,</w>
mesna+ quercetin</w>
mesna+ EGCG</w>
mesn um</w>
mesn um.</w>
mesi otemporal</w>
mesh work.</w>
mesenter ic-
mesenteric- aortic</w>
mesenchyme .</w>
mesench ymoma</w>
mesen chy
mesenchy mal-
mesenchymal- transition</w>
mesangi um,</w>
mesangi olysis,</w>
mesangi al,</w>
mesalaz ine-associated</w>
mesalaz ine)</w>
mes urlergine,</w>
mes ovarium</w>
mes ors</w>
mes oridazine,</w>
mes ocardium</w>
mes o-limbic</w>
mes na)</w>
mes encephalo
mesencephalo striatal</w>
mes cal
mescal ine,</w>
mes angio
mesangio proliferative</w>
meropenem ;</w>
meropenem :</w>
meropenem -related</w>
meropenem -
meropenem- valproic</w>
mere- regulating</w>
mercur y]</w>
mercur y</w>
mercur ial</w>
mercapto- beta,</w>
mercapto- beta,
mercapto-beta, beta-cyclopentamethyl
mercapto-beta,beta-cyclopentamethyl ene</w>
mercapto- 2-methyl
mercapto-2-methyl propranoyl-l-proline)</w>
mercapto acetyl-
mercaptoacetyl- triglycine</w>
mercap turic</w>
mercap tomethyl-3-guanidino-ethylthiopropanoic</w>
merbar one</w>
merbar one.</w>
mer sion</w>
mer s;</w>
mer osin.</w>
mer its.</w>
mer ci
merci ally</w>
mer can</w>
mequiv/ litre.</w>
mequiv/ litre
mequiv/litre .5.</w>
mequiv/ l</w>
mequit azine)</w>
meq/ litre.</w>
meq/ liter</w>
meq/ liter.</w>
meq/ liter)</w>
meq/ liter).</w>
meq/ l</w>
meq/ kg/day)</w>
meq/ kg).</w>
meq/ day.</w>
meq/ day,</w>
meq/ L</w>
meq/ L.</w>
meq/ L)</w>
mepivaca ine;</w>
mepivaca ine:</w>
mepivaca ine).</w>
mephedron e.</w>
meperid ine-induced</w>
meperid ine),</w>
ment- fixation</w>
ment- directed</w>
ment- binding</w>
ment- Geriatric</w>
ment- Directed</w>
ment s-of-learning</w>
ment s)</w>
ment ed,</w>
ment ation.</w>
ment ary,</w>
ment arium</w>
ment alized</w>
ment al,</w>
ment -specific</w>
ment -related</w>
ment -</w>
ment 's</w>
menorrhagia-- suggests</w>
menorrhagia-- diagnosis</w>
menorrhag ia:</w>
menopa use-related</w>
meningo encephalitis,</w>
meningitidi s.</w>
meningitidi s,</w>
meningiti s--all</w>
meningiti s).</w>
meningiti dis
meningitidis :</w>
meningis mus</w>
meningis mus,</w>
meningi omas.</w>
meningi omas,</w>
mening ococcemia,</w>
mening ocele.</w>
mening ocele,</w>
mening es,</w>
men tion.</w>
men tion,</w>
men ses.</w>
men ses,</w>
men onville</w>
men n.</w>
men idine</w>
men arch
menarch e</w>
men arc
menarc he
menarche .</w>
men adi
menadi one/sodium</w>
men ace</w>
men ?</w>
men =1.
men=1. 1%).</w>
men :
men: women</w>
men /
men/ women,vs</w>
memory- saving</w>
memory- impairing</w>
memory- facilitating</w>
memor y-related</w>
memor y),</w>
memor ies.</w>
memor ies,</w>
membrane- related</w>
membrane- permeant</w>
membrane- limited</w>
membrane- enriched</w>
membrane- associated</w>
membran ous,</w>
membran e)</w>
membran aceus</w>
memb ers:</w>
memb ers.</w>
memb er
member ship</w>
memantine ;</w>
memantine ),</w>
memantine 's</w>
memant ine-treated</w>
mem o</w>
mem bered</w>
melphalan-prednis one-thalidomide</w>
melphalan-prednis one+</w>
melphalan- based</w>
melphal an-induced</w>
mellit us-like</w>
melatonin- treated.</w>
melaton in;</w>
melaton in-treated</w>
melanocor tins,</w>
melano tic</w>
melano gast
melanogast er</w>
melan ostatin</w>
melan osis),</w>
melan oma;</w>
melan ocyte,</w>
melan cholic</w>
melaen a.</w>
mel y-low-birth-weight</w>
mel ar
melar somine</w>
megal ocytic</w>
megal oblastosis</w>
megal oblastic,</w>
megakary opoiesis</w>
megakary ocytic</w>
megakary ocytes.</w>
mega ureter.</w>
mega therapy</w>
mega prosthesis.</w>
meg atri
megatri als</w>
meg a-
mega- oxidation</w>
mefloqu ine's</w>
mefen amate</w>
meet ings.</w>
meet ing,</w>
medulloblast oma:</w>
medulloblast oma,</w>
medullo spinal</w>
medullo -
medullo- adrenalectomy,</w>
medulla- projecting</w>
medulla- -6
medulla--6 4%;</w>
medull ectomy,</w>
medull as</w>
medull aris,</w>
medull ae</w>
medull a;</w>
medull a:</w>
medull a/
medulla/ rostral</w>
medull a)</w>
medull a).</w>
medroxy- progesterone</w>
medoxom il/
medoxomil/ HCTZ</w>
medoxom il.</w>
medium- perfused</w>
medium- magnesium</w>
medium- length</w>
medium- infused</w>
medium- -and</w>
medium- ,</w>
medium <
medium< high
medium<high ).</w>
medicine- taking</w>
medication- related,</w>
medical- surgical</w>
medical- record</w>
medic ine:</w>
medic ine)</w>
medic ations:</w>
medic ations--
medications-- even</w>
medic ations).</w>
medic ation?</w>
medic ation:</w>
medic ation/
medication/ counseling</w>
medic ation-associated</w>
medic ation's</w>
medic ated)</w>
medic ament</w>
medic ally;</w>
mediast in
mediastin um,</w>
media- to-lumen</w>
media- -15</w>
medi us,</w>
medi um/high</w>
medi olateral</w>
medi odorsal,</w>
medi atory</w>
medi ator.</w>
medi ator-
mediator- release</w>
medi ation.</w>
medi ated
mediated ?</w>
medi anus</w>
medi alis,</w>
medi a-related</w>
medi a)</w>
medetom indine</w>
medetom id
medetomid ine),</w>
med itine</w>
med iterranean</w>
meclofen amic</w>
mechloreth amine,</w>
mechanomyo graphy;</w>
mechanomyo graphy,</w>
mechanomyo graph
mechanomyograph ic/
mechanomyographic/ electromyographic</w>
mechano- sensitive</w>
mechano- hyperalgesia.</w>
mechano- hyperalgesia,</w>
mechano- allodynia,</w>
mechano receptors,</w>
mechano heat-
mechanoheat- sensitive</w>
mechano and</w>
mechanism s/habituation,</w>
mechanism ?</w>
mechanism .)</w>
mechanis m-
mechanism- substantia</w>
mechanically- insensitive</w>
mechanically- evoked</w>
mechanic ally-induced</w>
mechanic al)</w>
mechan sims</w>
mechan otransduction</w>
mechan onociceptors</w>
mechan omyography</w>
mechan ographical</w>
mechan ographic</w>
mechan o</w>
mechan ics;</w>
mechan ically,</w>
mecamylamine- sensitive</w>
mecamylamine- precipitated</w>
mecamyl amine-induced</w>
mecamyl amine)</w>
measurement s.(ABSTRACT</w>
measurement s),</w>
measurement --a</w>
measure d?</w>
measure d;</w>
measure able</w>
measure )</w>
measur able
measurable ),</w>
meas ures.Mild</w>
meas ures)</w>
mean- Con
mean-Con go</w>
mean+/- S.E.M.)</w>
mean+/- S.</w>
mean while,</w>
mean s,</w>
mean ])</w>
mean -</w>
mean ).</w>
mean ),</w>
mean (SD)</w>
meal time).</w>
meag re.</w>
meag er.</w>
me- pretreated</w>
me tics</w>
me tically</w>
me thergoline,</w>
me tencephalon.</w>
me stat-1</w>
me sional</w>
me re,</w>
me quine</w>
me ptazinol.</w>
me pranol</w>
me pitiostane</w>
me phenytoin.</w>
me phenytoin,</w>
me phentermine</w>
me obentine:</w>
me lon
melon dialdehyde</w>
me last
melast atin</w>
me l</w>
me hy
mehy l-
mehyl- para-tyrosine</w>
me glit
meglit in
meglitin ides</w>
me gl
megl umines</w>
me gen</w>
me gam
megam it
megamit ochondria</w>
me gab
megab ases</w>
me flin
meflin F)</w>
me et,</w>
me ds</w>
me da
meda ).</w>
me bendazole,</w>
me at</w>
me ant</w>
me an.</w>
me als.</w>
me -positive</w>
me -P
me-P 450-
me-P450- system,</w>
me -</w>
mdr1 b)</w>
md m-2,</w>
mcg/ week</w>
mcg/ mouse,</w>
mcg/ ml.</w>
mcg/ ml)</w>
mcg/ l).</w>
mcg/ kg/min.</w>
mcg/ kg/min)</w>
mcg/ kg/day</w>
mcg/ h</w>
mcg/ die</w>
mcg/ Kg</w>
mcg/ K
mcg/K g/
mcg/Kg/ i.m
mcg/Kg/i.m ./
mcg/Kg/i.m./ day).</w>
mcg/ (
mcg/( kg
mcg/(kg day
mcg/(kgday ))</w>
mca ).</w>
mc rog/kg.</w>
mc gm</w>
mc g/m
mcg/m L.</w>
mb ia,</w>
mb al
mbal ance</w>
mazind ol-treated</w>
mazind ol,</w>
mazind ol),</w>
mazep am-induced</w>
mazep am,</w>
maz indol
mazindol -associated</w>
maz e:</w>
maz e)</w>
maz e).</w>
mayonnai se)</w>
maximum- tolerable</w>
maximum- rescaled</w>
maxim um:</w>
maxim ise</w>
maxim al;</w>
maxim al:</w>
maxim al.</w>
maxill ary-
maxillary- ,</w>
maxill a</w>
max/ EC50</w>
max/ A
max/A max</w>
max LV),</w>
max :</w>
matur ation:</w>
matrix- degrading</w>
matric es.</w>
matric es,</w>
matric ellular</w>
matri gel</w>
mathem atic</w>
mathem atic
mathematic s,</w>
mater notoxicity</w>
mater no-fetal</w>
mater nal-neonatal</w>
matching-to- sample</w>
matching-to- position</w>
matched- unrelated</w>
matched- unrelated,</w>
matche d.</w>
matche d)</w>
mat ures</w>
mat ures.</w>
mat ure;</w>
mat tress</w>
mat ters</w>
mat ters,</w>
mat rical</w>
mat ory.</w>
mat ologic</w>
mat ine-
matine- produced</w>
mat es.</w>
mat er.</w>
mat ch.</w>
mat a.</w>
masto pathy.</w>
masto e
mastoe idectomy</w>
mastic ation</w>
mastic ation.</w>
mast urbation)</w>
mast ocytosis:</w>
mast ocytosis.</w>
mast ectomy,</w>
mast ectomies,</w>
mast algia,</w>
massi ve-bilateral</w>
mass- spectroscopic</w>
mass- spectrometry,</w>
mass age),</w>
mass /
mass/ volume</w>
mass ,
mass, an</w>
mass )
mass) -1.h-1)</w>
masquer aded</w>
masquer ade</w>
mask er-
masker- to-signal</w>
mask ;</w>
mascul ine-
masculine- femin
masculine-femin ine</w>
mas titis</w>
mas titis,</w>
mas ses.</w>
mas ome-mediated</w>
marrow- toxic</w>
marrow- stimulating</w>
marrow- laden</w>
marri ed.</w>
marmo sets,</w>
marmo set.</w>
marmo set,</w>
marked "</w>
mark s.</w>
mark s"</w>
mark ing</w>
mark ers)</w>
mark ers).</w>
mark er-
marker- NF
marker-NF 200</w>
mark e
marke ted,</w>
mark de</w>
marijuana -</w>
marijuana )</w>
marg ination</w>
marg inated</w>
marc esc
marcesc ens,</w>
mar tensi</w>
mar ines</w>
mar in</w>
mapp ing.</w>
map s.</w>
map .</w>
manufacturer s.</w>
manufacturer s,</w>
manufacturer s'</w>
manufacture r-recommended</w>
manufacture 's</w>
manufact ure</w>
manu als</w>
manu alized</w>
manu al.</w>
manu al-
manual- guided</w>
mant yl]-1-aminomethyl-3,4-dihydro-5,6-dihydroxy-1H-2-benzo</w>
mant le-cell</w>
manson i-
mansoni- endemic</w>
manson i,</w>
manoeuv re</w>
manoeuv re.</w>
mano al
manoal ide.</w>
mannit ol-treated</w>
mannit ol-nephrosis.</w>
mannit ol)</w>
mannit ol),</w>
manner :</w>
manner .(ABSTRACT</w>
manipul ations,</w>
manipul ated;</w>
manipul ated.</w>
manifest ed.</w>
manifest a
manifesta it
manifestait ons</w>
manic- depression</w>
manic- depressi
manic-depressi ves.</w>
mang osteen</w>
mang ostana</w>
mane b,</w>
mandi bulo
mandibulo facial</w>
mandi bul
mandibul ar,</w>
mandi ble,</w>
manage able.(ABSTRACT</w>
manage ?</w>
manag em
managem ent).</w>
man ometrically</w>
man ometrically.</w>
man ometer</w>
man n,</w>
man idi
manidi pine-treated</w>
man ic'</w>
man ia?</w>
man ia/
mania/ hypomania/
mania/hypomania/ mixed</w>
man ia-inducing</w>
man ia)</w>
man delic</w>
man dated</w>
man ;</w>
man -made</w>
man -K
man-K e
man-Ke uls</w>
man -H
man-H ak
man-Hak im</w>
man -
man- La
man-La Roche</w>
mammar y,</w>
mammar y)</w>
mammal s;</w>
mam motrophs.</w>
mam mography.</w>
mam millary</w>
mam illary</w>
malto philia</w>
malto dextr
maltodextr in)</w>
malondi amide</w>
malondi alde
malondialde h
malondialdeh de</w>
malondi ald
malondiald hy
malondialdhy e</w>
malon ate)</w>
malon aldehyde.</w>
malon aldehyde,</w>
malnutri tion.(ABSTRACT</w>
malnutri tion-induced</w>
malignanc ies;</w>
malignanc ies
malignancies -a</w>
malign ant.</w>
malign ant)</w>
malign ant"</w>
malign ac
malignac ies</w>
malform ation-
malformation- after</w>
malform ation)</w>
male/ female,</w>
male- predominant</w>
male- pigmented</w>
male- female</w>
male imide</w>
male ate;</w>
male ate).</w>
male ate),</w>
male ]</w>
malathi on,</w>
malathi on),</w>
malaria- endemic</w>
malar ia
malaria e</w>
malaox on-(MO)-induced</w>
malai se;</w>
malai se/lassitude,</w>
malac ia</w>
malac ia.</w>
mal- epidermal</w>
mal tol</w>
mal positioning</w>
mal positioned</w>
mal position</w>
mal perfusion</w>
mal onedialdehyde</w>
mal le
malle olar</w>
mal ine,</w>
mal in</w>
mal gi
malgi phian</w>
mal functioning</w>
mal function,</w>
mal es/
males/ 19</w>
mal distribution.</w>
mal development</w>
mal ate.</w>
mal aligned</w>
mal align
malalign ment</w>
mal .</w>
mal -type</w>
mal )</w>
mal '</w>
makal im</w>
mak ing.</w>
mak ing)</w>
mak ers</w>
mak ers.</w>
major '</w>
maj or/serious</w>
maj or-motor</w>
mainten ance),</w>
mainta ins,</w>
mainta ine
maintaine d),</w>
main tanance</w>
main stream</w>
main stays</w>
main ly:</w>
main ing</w>
main )</w>
magnoc ellularis</w>
magnitu des.</w>
magnif y</w>
magnif ies</w>
magneto encephalography</w>
magnesium- depleted</w>
magnesium- alumin
magnesium-alumin um-hydroxide-simethicone</w>
magnesium- activated</w>
magnesi um)</w>
magne tosensitive</w>
magne t.</w>
magn us</w>
magn us.</w>
magn um</w>
magn ification</w>
magn ification,</w>
mag num;</w>
mag nesuria,</w>
mag na)</w>
mafosf amide-induced</w>
mad ,</w>
maculop ap
maculopap ular,</w>
macrophage- like</w>
macrophag es:</w>
macrophag es),</w>
macroph agic</w>
macroph age.</w>
macroph age-specific</w>
macroph age),</w>
macromolec ules:</w>
macromolec ule</w>
macroli des.</w>
macroglobul inemia,</w>
macroglobul in).</w>
macro- adenoma</w>
macro- adenoma.</w>
macro vessels</w>
macro vacuolation</w>
macro vacuolar</w>
macro stomia</w>
macro reticular</w>
macro prolactinomas:</w>
macro prolactinomas,</w>
macro prolactinemia</w>
macro prolactinemia.</w>
macro hematuria,</w>
macro haematuria,</w>
macro globulin</w>
macro dilution</w>
macro cytosis.</w>
macro cytosis,</w>
macro cyclic</w>
macro crystalline</w>
macro circulatory</w>
macro bleeds</w>
macro angiopathy</w>
macro angio
macroangio pathies,</w>
macro aggregates</w>
macro adenomas</w>
macro adenomas.</w>
macro adenoma.</w>
macro /
macro/ micro</w>
macro -</w>
macro )</w>
macaqu es,</w>
macaqu e).</w>
mac ulopathy;</w>
mac ules</w>
mac eration</w>
mac aw
macaw s</w>
mac a
maca ques)</w>
ma- renin</w>
ma z</w>
ma st,</w>
ma res</w>
ma ke
make up</w>
ma in,</w>
ma iled.</w>
ma il:</w>
ma X</w>
ma --comparison</w>
mV/ s</w>
mV/ s.</w>
mU/ ml,</w>
mU/ ml)</w>
mU/ mL).</w>
mU/ l.</w>
mU/ l)</w>
mU/ l).</w>
mU/ kg)</w>
mU/ L)</w>
mT or</w>
mT c)</w>
mT OR.</w>
mT OR,</w>
mRNA- positive</w>
mRNA- labeled</w>
mRNA ).</w>
mOsm/ liter)</w>
mOsm/ kg/
mOsm/kg/ H2O</w>
mOsm/ Kg</w>
mOsm ).</w>
mOsm ),</w>
mO SM
mOSM /kg</w>
mM= -14
mM=-14 +/-1</w>
mM= -1
mM=-1 3+/-
mM=-13+/- 2</w>
mM/ min</w>
mM/ l</w>
mM/ L</w>
mM/ L).</w>
mM/ 10</w>
mM ols/liter</w>
mM ):</w>
mM )-induced</w>
mLg(-1) min(-1)</w>
mLg(-1) min(-1),</w>
mL/minute/ g</w>
mL/minute/ g)</w>
mL/min/ kg.</w>
mL/min/ gr</w>
mL/min/ g;</w>
mL/min/ 1.73
mL/min/1.73 m2,</w>
mL/kg/h ],</w>
mL/kg/h ])</w>
mL/kg/ hr</w>
mL/kg/ hr.</w>
mL/beat/ m2;</w>
mL/beat/ m2)</w>
mL/ s;</w>
mL/ rat</w>
mL/ min])</w>
mL/ min;</w>
mL/ min),</w>
mL/ mL</w>
mL/ kg)</w>
mL/ hour</w>
mL/ h/
mL/h/ kg;</w>
mL/ h.</w>
mL/ h,</w>
mL/ h)</w>
mL/ beat</w>
mL/ beat),</w>
mL.min-1. g-1).</w>
mL.g-1. min-1</w>
mL.g-1. min-1;</w>
mL. 100</w>
mL -1)</w>
mL +
mL+ +/
mL++/ min</w>
mL *
mL* min(-1)*100</w>
mL );</w>
mL (-1)).</w>
mL (-1)),</w>
mL (-1)
mL(-1) (mean+/-
mL(-1)(mean+/- s.e.m.),</w>
mIU/ ml.</w>
mIU/ ml,</w>
mIU/ mL,</w>
mIU/ mL)</w>
mIU/ l</w>
mIU/ l)</w>
mIU/ L,</w>
mGluR1- enhanced</w>
mGluR 8-
mGluR8- mediated</w>
mGluR 5)</w>
mGluR 3)</w>
mGluR 2</w>
mGluR 2/
mGluR2/ 3-
mGluR2/3- stained</w>
mGluR 1alpha</w>
mGluR 1alpha-
mGluR1alpha- related</w>
mGlu R-mediated</w>
mGlu 3)</w>
mGlu 1,
mGlu1, 5</w>
mGlu (5)</w>
mGlu (1)</w>
mEq/kg/ dose,</w>
mEq/ ml</w>
mEq/ ml)</w>
mEq/ ml).</w>
mEq/ liter;</w>
mEq/ liter)</w>
mEq/ l;</w>
mEq/ l/
mEq/l/ h.</w>
mEq/ l.</w>
mEq/ l)</w>
mEq/ kg/min)</w>
mEq/ kg).</w>
mEq/ kg),</w>
mEq/ kg
mEq/kg -60</w>
mEq/ day</w>
mEq/ day.</w>
mEq/ day,</w>
mEq/ day)</w>
mEq/ L])</w>
mEq/ L);</w>
mEq/ L
mEq/L -1.1</w>
mEq/ 24</w>
mEq. l-1</w>
mEq .).</w>
mEq ,</w>
mEq )</w>
mEq ).</w>
m/ sec,</w>
m/ s</w>
m/ s)</w>
m/ min,</w>
m/ m2.</w>
m/ beat/
m/beat/ m2)</w>
m/ antecubital</w>
m/ antagonism.</w>
m/ Am</w>
m/ 20</w>
m. b.
m.b. H.</w>
m-chlorphenylpiperaz ine-induced</w>
m-chlorphenylpiperaz ine,</w>
m-chlorophenyl carbamoyloxy
m-chlorophenylcarbamoyloxy ]-
m-chlorophenylcarbamoyloxy]- 2-
m-chlorophenylcarbamoyloxy]-2- butyn
m-chlorophenylcarbamoyloxy]-2-butyn yltrimethylammonium),</w>
m-chlorophenyl /-
m-chlorophenyl/- piperazine,</w>
m-chloro phenylpiperazine.</w>
m-chloro benzylidenepempidine</w>
m-CPB G</w>
m-CPB G,</w>
m-CP P.</w>
m- xylyl-6-AzUd</w>
m- ventrolateral</w>
m- tyrosine</w>
m- mode</w>
m- methylamphetamine</w>
m- like"</w>
m- fluoro
m-fluoro amphetamine</w>
m- coated</w>
m- TOR</w>
m- CPP</w>
m- AM
m-AM SA</w>
m- 3</w>
m- ,</w>
m(O (2)))</w>
m(2) ).</w>
m(- 2)).</w>
m val</w>
m v</w>
m ute</w>
m uromonab-CD3</w>
m um,</w>
m ths</w>
m ths.</w>
m th</w>
m ter</w>
m t)</w>
m sted</w>
m stadt,</w>
m s);</w>
m rp2-deficient</w>
m q</w>
m q/lt,</w>
m ph,</w>
m pd.</w>
m pared</w>
m oxalactam,</w>
m oplegia</w>
m ocyte</w>
m niscus,</w>
m munoanalysis</w>
m like'</w>
m k</w>
m k/
mk/ kg).</w>
m izoribine</w>
m iz
miz olastine</w>
m ine,</w>
m ia-inducing</w>
m ia--a</w>
m ia--
mia-- two</w>
m ia).</w>
m gr/
mgr/ day.</w>
m free</w>
m ech
mech olyl</w>
m ca.</w>
m bellifer
mbellifer ae)</w>
m ation,</w>
m ated,</w>
m arie-
marie- tooth</w>
m ar</w>
m apped.</w>
m and</w>
m V),</w>
m V
mV )),</w>
m U/L,</w>
m T</w>
m T/
mT/ mm</w>
m R
mR NP</w>
m PFC.</w>
m N-
mN- intensity</w>
m N,</w>
m N)</w>
m IPSCs</w>
m IB
mIB G</w>
m I
mI J/
mIJ/ L
mIJ/L ),
mIJ/L), due</w>
m EPSCs,</w>
m Ci</w>
m Ci
mCi /kg.</w>
m CPP,</w>
m CD.</w>
m Ab-
mAb- treatment</w>
m AIMS</w>
m ACh
mACh R.</w>
m A/
mA/ 0.1</w>
m 2],</w>
m 1</w>
m -related</w>
m -1)</w>
m --is</w>
m (2).</w>
m (2))</w>
m (-1
m(-1 ):</w>
m "</w>
lysozym uria</w>
lysozym uria)</w>
lysosom al-
lysosomal- mediated</w>
lysos ome-associated</w>
lysophosphatidyl choline,</w>
lysophosphatidyl cholin
lysophosphatidylcholin es</w>
lysophosph olipid</w>
lyso zyme.</w>
lyso zyme-conjugated</w>
lyso ),</w>
lysine- vasopressin-induced</w>
lysine- aspirin</w>
lysin opril,</w>
lysergol s</w>
lysergol )</w>
lyser gol</w>
lys o-phosphatidylcholine</w>
lys ate</w>
lynestren ol</w>
lynestren ol.</w>
lymphoplasmacy toid</w>
lymphoplas mocyte</w>
lymphom as:</w>
lymphom as
lymphomas ;</w>
lymphom agenesis</w>
lymphom agenesis.</w>
lymphom a/
lymphoma/ leukemia</w>
lymphoblast s.</w>
lymphoblast oid</w>
lymphoaden opathy,</w>
lymphoaden itis.</w>
lympho kine</w>
lympho histiocytosis</w>
lympho histiocytosis.</w>
lympho histiocytic</w>
lympho adenitis</w>
lymphadenopath y;</w>
lymphadenopath y)</w>
lymphaden ectomy</w>
lymph- fistula</w>
lymph otactin</w>
lymph osarcomas</w>
lymph osarcomas,</w>
lymph oreticular</w>
lymph okine,</w>
lymph oid).</w>
lymph ocytotoxic</w>
lymph ocytosis</w>
lymph ocytoid</w>
lymph ocyte.</w>
lymph ocyte-integrins(+)</w>
lymph ocyte-activating</w>
lymph ocyte,</w>
lymph oceles.</w>
lymph ocele,</w>
lymph atics</w>
lymph angiogram</w>
lym pus</w>
lycopen e</w>
lycopen e.</w>
ly- selective</w>
ly- isolated</w>
ly- injected</w>
ly- folded</w>
ly sis-like</w>
ly sed</w>
ly phenidate</w>
ly ing.</w>
ly ases.</w>
ly ?</w>
ly /day</w>
ly )--
ly)-- L-
ly)--L- histidine</w>
lux ol-fast</w>
lute otrophic</w>
lut )</w>
lusitrop y.</w>
lusitrop ic,</w>
lup uslike</w>
lup us:</w>
lup us-likesyndrome</w>
lup us)</w>
lup ron.</w>
lup ron-induced</w>
lup o</w>
lung '</w>
lun g/body</w>
lun g/
lung/ ovarian</w>
lun g-
lung- converting</w>
lun ch
lunch time),</w>
lun ar</w>
lump ectomy.</w>
lump ectomy)</w>
lumirac oxib.</w>
lumirac oxib,</w>
lumin ol</w>
lumin ance</w>
lumin ae</w>
lumin a,</w>
lumbos ci
lumbosci atic</w>
lumb ocostovertebral</w>
lumb er</w>
lumb ar,</w>
lumb ar),</w>
lumb ar
lumbar >
lumbar> thoracic>cervical</w>
lumb ago</w>
lumb ago,</w>
lum il
lumil ysergol</w>
lum bo
lumbo peritoneal</w>
lucifer ase-positive</w>
luc id.</w>
luc ent</w>
lu theal</w>
lu pron</w>
lu poid'</w>
lu peol,</w>
lu k,</w>
lu ek
luek emia</w>
loxy butyric</w>
loxic am</w>
loxacill in:</w>
loxacill in-associated</w>
loxac in).</w>
lox in,</w>
lox apine.</w>
lox apine-induced</w>
lox ap
loxap ine-
loxapine- overdose</w>
lox an),</w>
lox P</w>
lox P-
loxP- targeted</w>
lox )</w>
lower/ worse</w>
lower/ absent</w>
lower- weight</w>
lower- potency</w>
lower- motor</w>
lower- intensity</w>
lower- dose,</w>
lower- concentration</w>
lower- affinity</w>
lowe st-observable-effect</w>
lowe red;</w>
lowe red,</w>
lowe -
lowe- C
lowe-C rowne</w>
low/ high</w>
low/ Trans
low/Trans port-deficient</w>
low-to- intermediate</w>
low-to- intermediate-risk</w>
low-K(+)- related</w>
low-K(+)- containing</w>
low- weight</w>
low- volume</w>
low- voltage</w>
low- to-moderate</w>
low- thoracic</w>
low- tension</w>
low- susceptible</w>
low- renin,</w>
low- reflow</w>
low- progestogen-dose</w>
low- probability</w>
low- preferring</w>
low- osmolal</w>
low- osmolal,</w>
low- normal.</w>
low- mortality</w>
low- malignant</w>
low- maintenance</w>
low- magnesium</w>
low- lipid</w>
low- knee</w>
low- kindling</w>
low- intensity,</w>
low- hormonal</w>
low- grade,</w>
low- firing-frequency</w>
low- expressing</w>
low- effort</w>
low- dose-
low-dose- ADR
low-dose-ADR -associated</w>
low- dopamine</w>
low- confidence</w>
low- concentration</w>
low- carbohydrate</w>
low- carbohyd
low-carbohyd rate,</w>
low- calcium</w>
low- by</w>
low- birth</w>
low- anxiety,</w>
low- affinity,</w>
low- activ
low-activ ity'</w>
low- Self-Dec
low-Self-Dec eptive</w>
low up</w>
low ering.</w>
low er);</w>
low ?</w>
low <
low< medium<high).</w>
low ).</w>
low ),</w>
lotin ib
lotinib -induced</w>
loth o</w>
loth ane-induced</w>
loss/ seroconversion,</w>
loss/ recovery</w>
loss/ damage</w>
losoxantr one.</w>
losoxantr one,</w>
losartan+ hydrochlorothiazide</w>
losartan+ L-NAME</w>
losart an/
losartan/ hydrochlorothiazide,</w>
losart an-</w>
losart an's</w>
los ses,</w>
los ing"</w>
loro zotocin</w>
lorecle zole,</w>
lorecle zole),</w>
lordo tic</w>
lordo tic)</w>
lorazepam- valproate</w>
lorazepam- fentanyl</w>
lorazepam -treated</w>
lorazepam )</w>
lorazepam ),</w>
lorat ad
loratad ine:</w>
loracarbef .</w>
lor iz
loriz in-induced</w>
lor azep
lorazep ate</w>
lopinavir/ ritonavir.</w>
lopinavir/ ritonavir,</w>
lopinavir- ritonavir</w>
lopinavir- ritonavir-didanosine.</w>
lopin avir.</w>
lopent enyl</w>
lop sia</w>
lop e</w>
lop am
lopam il,</w>
loop s.</w>
loop ing</w>
loop )</w>
loo se.</w>
longev ity</w>
longev ity.</w>
longer- lasting,</w>
longer- acting</w>
long-term -treated</w>
long-term ')</w>
long- tract</w>
long- standing,</w>
long- shafted</w>
long- recognized</w>
long- lived</w>
long- held</w>
long- distance</w>
long- circulating,</w>
long- be
long-be veled</w>
long- TR</w>
long- QT-
long-QT- syndrome</w>
long- /medium-chain</w>
long us;</w>
long us,</w>
long toey,</w>
long term,</w>
long standing,</w>
long est.</w>
long est-
longest- acting</w>
long a)</w>
lonafarni b,</w>
lomust ine:</w>
lomust ine.</w>
lomust ine-containing</w>
lomust ine)</w>
lol- mediated</w>
logis tically</w>
logis tical</w>
logarith ms</w>
log- rank,</w>
log- probit</w>
log yric</w>
log y;</w>
log s,</w>
log rooming,</w>
log ical.</w>
log ia</w>
log copies/ml</w>
log copies/ml.</w>
log copies/ml)</w>
log 10).</w>
log .</w>
log -dose</w>
log (10)
log(10) HBV-DNA</w>
lodip ine,</w>
loder min</w>
locomotor- stimulating</w>
lock out</w>
locally- applied</w>
locally- advanced</w>
local izing</w>
local ized.</w>
local -
local- anesthetics-induced</w>
local ),</w>
loc us?</w>
loc olic</w>
loc isternal</w>
loc ill
locill in.</w>
loc ations)</w>
loc ation-matched</w>
loc ation)</w>
loc ated,</w>
loc ated)</w>
loc ally.</w>
loc adren
locadren ).</w>
lobul es</w>
lobul es.</w>
lobul e,</w>
lobul ated</w>
lobe line-induced</w>
lob otomy</w>
lob a.</w>
load s,</w>
load ing-dose</w>
lo vement.</w>
lo vastatin-treated</w>
lo udness</w>
lo tting</w>
lo ts,</w>
lo teprednol</w>
lo sigamone,</w>
lo se-urethan</w>
lo s.</w>
lo renz</w>
lo re"</w>
lo prost;</w>
lo phenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylam</w>
lo peramide,</w>
lo pathy.</w>
lo pathies:</w>
lo osening</w>
lo metric</w>
lo mere-regulating</w>
lo le</w>
lo l.(ABSTRACT</w>
lo l-treated</w>
lo k
lok ap
lokap ron),</w>
lo id-
loid- beta</w>
lo genesis</w>
lo f
lof ens
lofens ine,</w>
lo dop
lodop ine,</w>
lo d)</w>
lo bo</w>
lo bi
lobi ose</w>
lo bar,</w>
lo acetic</w>
lo P),</w>
lo .</w>
lo -3-
lo-3- 4-quinoline</w>
lo -
lo- vertebral</w>
lm phoproliferate</w>
lli tis</w>
lli "</w>
llect ual</w>
ll y,</w>
ll ong</w>
ll in,</w>
ll i</w>
ll er's</w>
ll ation,</w>
ll ate</w>
ll :
ll: 4.52</w>
ll ).</w>
liz umab.</w>
liz ine-induced</w>
liz arin</w>
liz ard</w>
liximab ,</w>
liver/ bowel</w>
liver- targeting</w>
liver- kidney-
liver-kidney- microsomes),</w>
liver- failure</w>
liver- failure.</w>
liver- disease</w>
liver- disease-related</w>
liver- damage.</w>
liver o</w>
liver :
liver: body</w>
liver -to-body</w>
liver -specific</w>
liver -based</w>
liver --
liver-- proved</w>
liver -,</w>
liver ),</w>
live born</w>
live -related</w>
liv ing
living :
living: cadaveric</w>
lium- potentiated</w>
litter ).</w>
litres /24</w>
litre -1,</w>
litre (-1).</w>
litre (-1),</w>
lithotrip sy,</w>
lithocholate-3-O- glucuronide</w>
lithocholate-3-O- glucuronide-induced</w>
lithocholate-3-O- gluc
lithocholate-3-O-gluc uornide</w>
lithium/ pilocarpine.</w>
lithium/ non-haloperidol</w>
lithium/ neuroleptic</w>
lithium/ haloperidol</w>
lithium/ 100</w>
lithium- withdrawal</w>
lithium- therapy.</w>
lithium- saline</w>
lithium- refractory</w>
lithium- pilocarpine,</w>
lithium- neuroleptic,</w>
lithium- maintained</w>
lithium- like</w>
lithium- induced.</w>
lithium- especially</w>
lithium- dependent</w>
lithium- controlled</w>
lithium- clinic</w>
lithium- chlorothiazide</w>
lithium- and-
lithium-and- carbamazepine</w>
lithium- amitriptyline</w>
lithium- -
lithium-- pilocarpine</w>
lithium "</w>
lith otomies</w>
lith ogenicity</w>
lith ogenesis,</w>
lith ia"</w>
literat ure)</w>
literat ure).</w>
liter s/min/m2)</w>
liter s.1</w>
liter s,</w>
liter s),</w>
liter /
liter/ min,</w>
liter );</w>
lit tle.</w>
lit tle-studied</w>
listen er</w>
list s)</w>
list ings</w>
list ;</w>
list /
list/ 4-1
list/4-1 8</w>
list ).</w>
lisinopri l;</w>
lisinopri l:</w>
lisinopri l-treated</w>
lisinopri l-
lisinopril- hydrochlorothiazide,</w>
lisinopri l)</w>
lisdexamfet amine,</w>
lisdexamfet amine's</w>
lis uride)</w>
lis sencephaly</w>
lis m;</w>
liquid- contrast</w>
liqu orice)</w>
liqu oral</w>
liqu or</w>
liqu id-like</w>
liqu e
lique fac
liquefac tive</w>
lipos omes)</w>
lipos oluble</w>
lipos ar
liposar coma</w>
lipoprotein- deficient</w>
lipoprotein- cholesterol,</w>
lipoprotein- X.</w>
lipoprote inemia</w>
lipopolysacchar ides</w>
lipopolysacchar ide-treated</w>
lipophil icity.</w>
lipophil ic
lipophilic ity;</w>
lipop olysaccaride</w>
lipop eptide</w>
lipofuscin osis.</w>
lipofus cin</w>
lipofus c
lipofusc in,</w>
lipo thymia,</w>
lipo proteinuria</w>
lipo proteins;</w>
lipo protein/HDL</w>
lipo phages</w>
lipo peroxides</w>
lipo peroxidation,</w>
lipo dystrophy</w>
lipo dystrophy.</w>
lipo dermat
lipodermat osclerosis,</w>
lipo der
lipoder moid,</w>
lipo atrophy</w>
lipo atrophy,</w>
lipide mic</w>
lipide mia</w>
lipid- protein</w>
lipid- protein-sugar</w>
lipid- metabolism.</w>
lipid- filled</w>
lipid- altering</w>
lipid s;</w>
lipid aemic</w>
lipid aemia.</w>
lipid /
lipid/ cholesterol</w>
lipid -mediated</w>
lipid -like</w>
lip-DX R-
lip-DXR- injected</w>
lip-DX R)</w>
lip s.</w>
lip s).</w>
lip ped,</w>
lip oma</w>
lip ocytes)</w>
lip idosis.</w>
lip id.</w>
lip emic</w>
lip emia</w>
lip ases</w>
lip asemia,</w>
lip ase;</w>
lip .</w>
lio thyronine</w>
link ing-
linking- blepharospasm</w>
link ages</w>
link ages,</w>
link age.</w>
link age,</w>
lingual- buccal
lingual-buccal -
lingual-buccal- facial</w>
lingu o-masticatory</w>
linezol id-related</w>
linezol id
linezolid .
linezolid. Clinicians</w>
linear .</w>
line- quoted</w>
line- derived</w>
line- crossing</w>
line fel
linefel ter's</w>
line ar-
linear- quadratic</w>
line ages,</w>
line age-specific</w>
line age-
lineage- traceble</w>
line ]</w>
line ?</w>
line ;</w>
lindane- poisoned</w>
lindane- kindled</w>
lind ane/
lindane/ kg).</w>
lind ane-</w>
lin quents</w>
lin ocomycin</w>
lin ks.</w>
lin ked,</w>
lin ings</w>
lin ing;</w>
lin ico</w>
lin es;</w>
lin es:</w>
lin comycin.</w>
lin comycin-induced</w>
limited- stage</w>
limited- access</w>
limit s:</w>
limit s).</w>
limit s),</w>
limit ing;</w>
limit ing:</w>
limit ed;</w>
limit ations,</w>
limit ).</w>
limbic- stimulus</w>
limbic- neuronal</w>
limbic -motor</w>
limbic )</w>
limb- truncal</w>
limb- salvage</w>
limb- axial</w>
limb us,</w>
limb s.Considering</w>
limb s).</w>
lima prost.</w>
lima prost,</w>
lim ta,</w>
lim p,</w>
lim bus.</w>
lim acteric</w>
likre in</w>
likeliho od:</w>
likeliho od,</w>
likeli est</w>
likel y;</w>
likel y:</w>
like wise,</w>
like ."</w>
lik ing
liking ")</w>
lik ened</w>
lik e-1</w>
lik e-
like- immunoreactivity</w>
lignocaine- type</w>
lignocaine- resistant</w>
lignoca ine;</w>
lignoca ine:</w>
lignoca ine-like</w>
lignoca ine).</w>
lignoca ine
lignocaine )/
lignocaine)/ remifentanil</w>
ligible :</w>
lighten ment</w>
lighten ed;</w>
light/ occasional</w>
light/ electron</w>
light- to-mild</w>
light- to-dark</w>
light- sound</w>
light- sound,</w>
light- odor</w>
light- odor,</w>
light- near</w>
light- microscopic,</w>
light- microscope,</w>
light- headache</w>
light- emitting</w>
light- dye-induced</w>
light- coloured</w>
light- adapted</w>
light- B</w>
light+ tone-conditioned</w>
light+ tone).</w>
ligh ts.</w>
ligh ts"),</w>
ligh tly-anesthetized</w>
ligh test</w>
ligh tening</w>
ligh ted</w>
ligh t)</w>
ligand- bound</w>
ligand- activated</w>
ligand ed</w>
ligand -mediated</w>
ligam ents,</w>
lig man</w>
lig ently.</w>
lig atures</w>
lig ature.</w>
lig ation)</w>
lig ation),</w>
lig ating</w>
lig ated.</w>
lig ated,</w>
lig ase</w>
lifesty le,</w>
lifes pan.</w>
lifes pan-based,</w>
lifes pan,</w>
lifes av
lifesav ing.</w>
life-threat ing</w>
life-threat en
life-threaten ing:</w>
life- years,</w>
life- time.</w>
life- style),</w>
life- span</w>
life- span.</w>
life- endangering</w>
life "</w>
life ".</w>
life ",</w>
lif ter.</w>
lif ted</w>
lif ted.</w>
lif ted,</w>
lif t)</w>
lif etime.</w>
lif e),</w>
lidocaine/ propofol</w>
lidocaine/ prilocaine</w>
lidocaine/ placebo</w>
lidocaine/ bupivacaine</w>
lidocaine/ bupivacaine/
lidocaine/bupivacaine/ morphine</w>
lidocaine/ 1:100,000</w>
lidocaine- tocainide</w>
lidocaine- seizure</w>
lidocaine- kindling.</w>
lidocaine- kindled</w>
lidocaine- infusion</w>
lidocaine- fentanyl</w>
lidocaine- etidoca
lidocaine-etidoca ine-
lidocaine-etidocaine- tetracaine</w>
lidocaine- equivalent</w>
lidocaine- alone</w>
lidocaine- allergic</w>
lidocaine- HCl</w>
lidoca ine-containing</w>
lidoca ine).</w>
lidoca ine's</w>
lid onine.</w>
lid okaine</w>
lid ocane</w>
licoric e.</w>
licoric e-induced</w>
licking/lif ting.</w>
licking/lif ting)</w>
licking/ biting</w>
lick s-in-quiet,</w>
lick s,</w>
lick s)</w>
lick ing)</w>
lic orice,</w>
lic ks</w>
lic henoid</w>
lic h
lich en,</w>
lic ens
licens ing</w>
lic ence</w>
lic ations</w>
libido ;</w>
libido ),</w>
libid o-were</w>
liber ation.</w>
liber ating</w>
liber ates</w>
liber ated,</w>
liber ally</w>
liber alized</w>
li zine</w>
li zed</w>
li veless</w>
li ve,</w>
li ve)</w>
li sters</w>
li prolol,</w>
li polytic</w>
li pedemic,</w>
li ott's</w>
li king</w>
li hood</w>
li es.</w>
li es,</w>
li er,</w>
li e,</w>
li des</w>
li brary,</w>
li b,</w>
li ass
liass on</w>
li ane)</w>
li an-
lian- Barre</w>
li adel
liadel )</w>
li ability/
liability/ antiamphetamine</w>
li a.</w>
lexi ble</w>
lex y:</w>
lex ane</w>
lex -
lex- proven</w>
levothyrox ine-treated</w>
levosul piride.</w>
levosul piride-induced</w>
levosul piride,</w>
levofloxac in-</w>
levofloxac in).</w>
levof oxacin</w>
levodopa/ dopa</w>
levodopa/ carbidopa,</w>
levodopa/ benserazide</w>
levodopa- unresponsive,</w>
levodopa- therapy</w>
levodopa- primed,</w>
levodopa- injected</w>
levodopa- induce</w>
levodopa- equivalent</w>
levodopa -free</w>
levodopa -fed</w>
levodopa ).</w>
levoc eti
levoceti rizine.</w>
levoc ar
levocar nitine,</w>
levo-alpha- acetylmethadol</w>
levo-alpha- Acetyl
levo-alpha-Acetyl methadol</w>
levo- floxacin</w>
levo- dopa.</w>
levo simendan.</w>
levo bupivacaine-,</w>
levo bupivacaine)</w>
levit ation.</w>
lever- trained</w>
lever- press</w>
levels-- was</w>
levels-- as</w>
level s/activities</w>
level s.3</w>
level s.(ABSTRACT</w>
level s-namely,</w>
level ing</w>
level /
level/ activity.</w>
level -matched</w>
levamisol e;</w>
levamisol e),</w>
lev ue</w>
lev udine</w>
lev orphanol.</w>
lev orotatory</w>
lev ophed</w>
lev onordefrin</w>
lev itation</w>
lev cromakalim
levcromakalim -
levcromakalim- produced</w>
lev arteren
levarteren ol)</w>
lev acetylmethadol,</w>
lev .</w>
leuproli de/
leuprolide/ bicalutamide</w>
leuproli de-induced</w>
leuproli de,</w>
leupro relin-depot</w>
leukopen ia;</w>
leukopen ia/
leukopenia/ agranulocytosis</w>
leukopen ia-related</w>
leukopen ia-associated</w>
leukopen ia)</w>
leukopen ia),</w>
leukomalac ia;</w>
leukoencephalopath y;</w>
leukoencephalopath y--MR</w>
leukoencephalopath y".</w>
leukocytoc lastic,</w>
leukocytoc l
leukocytocl asis,</w>
leukocyt otoxicity</w>
leuko paenia</w>
leuko enceph
leukoenceph at
leukoencephat lopathy</w>
leuko agglutinins,</w>
leukin -11</w>
leukin -1
leukin-1 3-
leukin-13- PE
leukin-13-PE 38
leukin-13-PE38 Q
leukin-13-PE38Q Q
leukin-13-PE38QQ R)</w>
leukem ia--a</w>
leukem ia).</w>
leukem ia),</w>
leukem i
leukemi as:</w>
leuke mogenic</w>
leuke mogenesis</w>
leukaem ias.</w>
leukaem ia:</w>
leukaem ia)</w>
leukaem ia).</w>
leuk ovorin</w>
leuk otoxins.</w>
leuk ostasis)</w>
leuk ocytotic</w>
leuk ocytopenia.</w>
leuk ocytopenia,</w>
leuk ocytic</w>
leuk ocyte-endothelial</w>
leuk ocyte,</w>
leuk in</w>
leuk encephalopathy</w>
leuk encephalopathy.</w>
leuk encephalopath
leukencephalopath ia</w>
leuk aphere
leukaphere sis,</w>
leuk aemo
leukaemo genicity</w>
leucovor in;</w>
leucovor in:</w>
leucomalac ia.</w>
leucomalac ia,</w>
leuco encephalopathy,</w>
leuco agglutin
leucoagglutin ins</w>
leucine-enkephal in:</w>
leuc opoenia,</w>
leuc ocytopenia,</w>
leuc ocytic</w>
leuc ocytes,</w>
leuc ocyte.</w>
leuc encephalopathy</w>
letro zole.</w>
letro zole,</w>
letharg ic,</w>
lethal ity)</w>
lethal ).</w>
leth symographic</w>
let ting</w>
let ters</w>
let ters,</w>
let ter).</w>
let in.</w>
let es,</w>
lest on</w>
lessen ed.</w>
less-than- synergistic</w>
less-than- complete</w>
less- sulfated</w>
less- painful</w>
less- expressed</w>
less- explored</w>
less ),</w>
lesions/ tumours</w>
lesions/ mm2</w>
lesion- marked</w>
lesion- causing</w>
lesion s.(ABSTRACT</w>
lesion s--chiefly</w>
lesion s)</w>
lesion ed.</w>
lesion ?</w>
lesion -inducing</w>
lesion )</w>
lesion ).</w>
les ser-risk</w>
les se)</w>
ler oxacin</w>
ler osis</w>
leptophyll a</w>
leptophyll a.</w>
leptom ania,</w>
lept inemia</w>
lept azol.</w>
lept azol-induced</w>
lept azol
leptazol ).</w>
lepirud in/
lepirudin/ bivalir
lepirudin/bivalir udin.</w>
lepirud in--
lepirudin-- are</w>
lepirud in,</w>
leph aro
lepharo conjunctivitis,</w>
lep rae</w>
lep ra</w>
length-of- treatment</w>
length-of- stay.</w>
length y.</w>
length wise</w>
length ens</w>
length ening,</w>
length /
length/ cell</w>
length -independent</w>
length )</w>
lenalidomide- bortezomib-dexamethasone</w>
lenalidom ide;</w>
lenalidom ide).</w>
lenalidom ide's</w>
len ticulostriate</w>
len ses</w>
len ses.</w>
len gh
lengh tening</w>
lemon ade
lemonade .</w>
leishman iasis.</w>
leishman ia
leishmania sis?</w>
leiomyosarcom as</w>
leiomyosarcom as:</w>
leiomyosarcom a:</w>
leiomy osarcoma.</w>
leiomy omata</w>
leiomy omas:</w>
leiomy omas.</w>
leiomy omas,</w>
legis lation</w>
legis lation.</w>
legi timate</w>
legi timacy</w>
legi as)</w>
leg ume</w>
leg ia:</w>
leg ant</w>
leg al.</w>
leg al,</w>
leg ).</w>
left- upper-quadrant</w>
left- Purkinje</w>
leflun amide-induced</w>
lef tward,</w>
lef ts,</w>
lect in.</w>
lecith in:</w>
lecith in:
lecithin: cholesterol</w>
lecith in-
lecithin- sphingomyelin</w>
lecith in)</w>
lebrex ,</w>
lebrex ).</w>
lebbec k</w>
leb siella-Enterobacter-Serratia</w>
leav es:</w>
leav es.</w>
leav es,</w>
least ;</w>
least .</w>
least )</w>
learner s."</w>
learner s,"</w>
learn t</w>
learn ing/
learning/ memory</w>
learn ing-related</w>
learn ing-
learning- disabled</w>
learn ing
learning -associated</w>
lear ned:</w>
lean ing</w>
lean '</w>
leak s</w>
leak s.</w>
leak proof</w>
leak age;</w>
leak age-
leakage- controlled</w>
leak age).</w>
leak /
leak/ spills,</w>
leak ,</w>
leaf let.</w>
lead- pipe</w>
lead- in
lead-in "</w>
lead s;</w>
lead s:</w>
lead ing,</w>
lead .</w>
lead -pretreated</w>
lead -associated</w>
lea ved</w>
lea ve.</w>
lea king</w>
lea kin
leakin ess</w>
lea ked</w>
lea der</w>
le/ non-febrile</w>
le/ brachial</w>
le- wise:</w>
le- jerks.</w>
le- cuneate,</w>
le- control</w>
le- aged</w>
le y).</w>
le vers,</w>
le v</w>
le uteotrophic</w>
le uropericardial</w>
le urally</w>
le upeptin</w>
le stat,</w>
le sidren)</w>
le mniscus,</w>
le man</w>
le m</w>
le avage</w>
le a</w>
le 105
le105 Val
le105Val )</w>
le -associated</w>
le -1</w>
le ,
le, central</w>
ld Heart,</w>
lazaro ids</w>
lazaro id
lazaroid s,U-74389G</w>
lay ers:</w>
lay ering</w>
lax ity</w>
lax atives</w>
lax ative</w>
lax ative.</w>
law yer</w>
law .</w>
lav age.</w>
laugh ter</w>
laugh ing</w>
later opulsion,</w>
later als</w>
later ally.</w>
later ally,</w>
later alization.</w>
later alised</w>
later al,</w>
later al
lateral ization,</w>
later .The</w>
later ),</w>
latency ;</w>
latency :</w>
latency -to-
latency-to- onset</w>
latency -
latency- intensity</w>
late- therapy</w>
late- reporting</w>
late- postoperative</w>
late- occurring</w>
late- generation</w>
late- gadolinium</w>
late- conversion</w>
late- arriving</w>
late '</w>
lat ters</w>
lat ter's</w>
lat ory</w>
lat in-
latin- square</w>
lat in)</w>
lat ex-
latex- fixation</w>
lat ex,</w>
lat er-
later- onset</w>
lat ent'</w>
lat enc
latenc ies)</w>
lat -induced</w>
last- resort</w>
last ocysts</w>
last ed,</w>
last ,</w>
last )</w>
lass it
lassit ude</w>
laser- scanning</w>
laser- doppler</w>
laser- acupuncture</w>
las orba,</w>
las er.</w>
las er)</w>
las co</w>
laryngotrache obronchitis</w>
laryngotrache o-bronchitis</w>
laryngospas m.</w>
laryngospas m,</w>
laryng oscopy)</w>
laryng oscopic</w>
laryng omicroscopy.</w>
laryng omicroscope</w>
laryng omalacia</w>
large- scaled</w>
large- magnitude</w>
large- field</w>
large- fibre</w>
large- fiber
large-fiber >
large-fiber> small-fiber</w>
large- dosage</w>
large- diameter</w>
larg est
largest ,
largest, cause</w>
larg er-
larger- scale,</w>
larg ed</w>
lar itin,</w>
laparotom y-induced</w>
laparotom ized,</w>
laparo scopy--influence</w>
laparo scopy,</w>
lant a</w>
lansoprazol e-associated</w>
language- delayed.</w>
langu age,</w>
land s.</w>
land ing.</w>
land .
land. Patients</w>
lan soprozole</w>
lan oteplase.</w>
lan k</w>
lan der,</w>
lamy dia</w>
lamp ,</w>
lamotrig ine:</w>
lamivudine/ interferon</w>
lamivudine/ HBIG</w>
lamivudine- selective</w>
lamivudine- enhanced</w>
lamivud ine).</w>
lamin ectomy,</w>
lamin ation.</w>
lamin ation,</w>
lamellipo dia</w>
lamell ated</w>
lamell ae,</w>
lambda -positive</w>
lambda -
lambda- carrageenan-induced</w>
lam o-trigine</w>
lam ic</w>
lam eness</w>
lam eness.</w>
lagg ing</w>
lagg ing.</w>
lag ophthalmos</w>
lag ,</w>
lag ,"</w>
lados tigil,</w>
lad y.</w>
lad y,</w>
lad ders.</w>
lad dering</w>
lad der-
ladder- test'.</w>
lad der,</w>
lad der
ladder ing
laddering ").</w>
lacunosum-molecul are.</w>
lacunosum-molecul are,</w>
lacunos um/molecular</w>
lacun a</w>
lactotroph s</w>
lactotroph s.</w>
lactotroph s,</w>
lactotroph es,</w>
lactotroph .</w>
lactofer rin</w>
lactofer rin.</w>
lactofer rin,</w>
lacto se,</w>
lacto se)</w>
lacto se),</w>
lacto acidosis,</w>
lacti tol.</w>
lacti flora,</w>
lactacid uria,</w>
lactacid aemia</w>
lact ulose.</w>
lact otrophic</w>
lact osaminated</w>
lact ography.</w>
lact ography,</w>
lact ogen</w>
lact ogen,</w>
lact escence</w>
lact ationally</w>
lact ates</w>
lact ate:</w>
lact ate-induced</w>
lact ate-</w>
lact ate-
lactate- raising</w>
lact ate)</w>
lact acidemia</w>
lacrim ation.</w>
lacrim ation,</w>
lachrym ation.</w>
lachrym ation,</w>
lac idipine,</w>
lac idi
lacidi pine)</w>
lac erations</w>
lac eration,</w>
lac ed</w>
labyr inth</w>
labour ;</w>
labour --a</w>
laborator ies.</w>
laborator ial</w>
labor atories,</w>
labor at
laborat ories:</w>
labetal ol:</w>
labet olol</w>
labell ing)</w>
labell ing
labelling -positive</w>
labele d-positive</w>
labele d).</w>
labele d),</w>
labele d
labeled )-
labeled)- labeled</w>
label s,</w>
label led;</w>
label ing;</w>
label ing),</w>
lab s.</w>
lab orer</w>
lab ored</w>
lab il
labil ized</w>
lab ial,</w>
lab i
labi alis</w>
lab e
labe led,</w>
lab -based</w>
lab )</w>
la unch</w>
lPB N-lesioned</w>
lPB N,</w>
lCo M
lCoM RO
lCoMRO 2</w>
lCo B
lCoB F,</w>
l/min/ m2.</w>
l/min/ m2)</w>
l/ min/m2,</w>
l/ min)</w>
l/ m;</w>
l/ m2/day</w>
l/ l,</w>
l/ kg.</w>
l/ h</w>
l/ h)</w>
l/ day</w>
l/ 10),</w>
l.m.w. p.</w>
l.m.w. p.,</w>
l.m.w. p.)</w>
l. rHu</w>
l. min-1</w>
l. min-1)</w>
l. V.</w>
l. 57</w>
l-NAME ,</w>
l-NAME ).</w>
l-DO PA/
l-DOPA/ MTEP</w>
l-DO PA.</w>
l-DO PA,</w>
l-B unolol</w>
l-- November</w>
l- under/over</w>
l- tryptophan</w>
l- thiocitrulline</w>
l- sensitive</w>
l- norepinephrine</w>
l- naloxone,</w>
l- mlBG</w>
l- methadone</w>
l- methadone,</w>
l- menthol</w>
l- lysine,</w>
l- litter</w>
l- isomer</w>
l- his
l-his tidine.</w>
l- glutamine</w>
l- glutamate</w>
l- ephedrine.</w>
l- dopa.</w>
l- dihydroxyphenylalanine</w>
l- dihydroxy-
l-dihydroxy- phenylalanine</w>
l- deprenyl,</w>
l- carnitine.</w>
l- carnit
l-carnit ine)</w>
l- buthionine-
l-buthionine- (S
l-buthionine-(S ,
l-buthionine-(S, R)-
l-buthionine-(S,R)- sulfoximine</w>
l- bearing</w>
l- amino</w>
l- alpha</w>
l- SMT
l-SMT C</w>
l- S)</w>
l- Nicot
l-Nicot ine).</w>
l- Gln</w>
l- Adenosis</w>
l- 3,4-dihydroxyphenylalanine</w>
l- ,</w>
l' Adul
l'Adul te.</w>
l urching</w>
l ubricating</w>
l sa</w>
l ormadinone</w>
l ness</w>
l n)</w>
l mias.</w>
l logenesis</w>
l ligently.</w>
l is,</w>
l inc
linc osamides.</w>
l in.</w>
l in-
lin- C
lin-C ole</w>
l icul
licul itis</w>
l h),</w>
l gesia</w>
l est</w>
l enti
lenti form
lentiform is,</w>
l ens
lens ectomy</w>
l eno
leno gras
lenogras tin</w>
l ending</w>
l b.</w>
l b)</w>
l ational</w>
l ath
lath osterol</w>
l ately</w>
l ated.</w>
l aring</w>
l apar
lapar atom
laparatom y,</w>
l anto
lanto occipital</w>
l ang
lang en,</w>
l an</w>
l ak
lak es</w>
l agen</w>
l ]-
l]- 3,4-dihydro-
l]-3,4-dihydro- 2,
l]-3,4-dihydro-2, 5,
l]-3,4-dihydro-2,5, 7,8-
l]-3,4-dihydro-2,5,7,8- tetramethyl-2H-1-benzopyran-6-ol,</w>
l ]
l] piperidine</w>
l U/
lU/ month).</w>
l TT
lTT s</w>
l PA
lPA G),</w>
l CE
lCE ).</w>
l 6</w>
l 6)</w>
l 3
l3 C-urea</w>
l 1-adrenoceptor</w>
l -1.</w>
l -1).</w>
l (-1).</w>
l (-1)),</w>
l "</w>
kynuren ines.</w>
ky perkinesia</w>
ky oto,</w>
ky o</w>
kur )</w>
kra in,</w>
kr -mediated</w>
kot t-Aldrich</w>
ko witz</w>
ko ke
koke is
kokeis hi
kokeishi kan
kokeishikan kyoto,</w>
knowledge d.</w>
knowledge ably</w>
knowledge -based</w>
knowledge )</w>
knowledg ment</w>
know n:</w>
knockout s.</w>
knockout s,</w>
knockout )</w>
knock outs</w>
knock in</w>
knock ed-in</w>
knoc ks</w>
knoc k</w>
kne es;</w>
kne es.</w>
kne es,</w>
kne e;</w>
kne e-
knee- replacement</w>
kne e,</w>
kn uckles.(ii)</w>
kleptom anic</w>
kleptom ania</w>
kla o</w>
kit ten.</w>
kininogen s,</w>
kininogen -deficient</w>
kininogen -
kininogen- depleted</w>
kinin ogenic</w>
kinin ase,</w>
kine tics:</w>
kine tically</w>
kine sis,</w>
kine sia.</w>
kine matic</w>
kindling ;</w>
kindling .(ABSTRACT</w>
kindling -like</w>
kindle d"</w>
kind red</w>
kind led,</w>
kind le.</w>
kinase/ extrac
kinase/extrac ellular-
kinase/extracellular- signal</w>
kinase/ Akt/
kinase/Akt/ mTOR</w>
kinase- myocardial</w>
kinase- isoenzymes</w>
kinase- dependent</w>
kinase- coupled</w>
kinase- associated</w>
kinase- MB)</w>
kinase- 3</w>
kin king</w>
kin in-induced</w>
kin in-
kinin- system</w>
kin esthetic</w>
kin es.</w>
kin es
kines ais</w>
kin ases.</w>
kin ases,</w>
kin ase(s)</w>
kin 's</w>
kilogram ),</w>
kilodal tons,</w>
kill ing,</w>
kill ers</w>
kill er/
killer/ T-cell</w>
kill "</w>
kil o</w>
kidney/ drug</w>
kidney ]</w>
kidney ,vs</w>
kidne y)</w>
kidne y),</w>
ki phenylhydantoin.</w>
khell in,</w>
kh z.</w>
kh at)</w>
kh at
khat "</w>
kg/m (2).</w>
kg/m (2),</w>
kg/ m2;</w>
kg/ m2.</w>
kg/ m2,</w>
kg/ m2)</w>
kg/ day,</w>
kg/ 24</w>
kg-1. day-1</w>
kg(-1) morphine</w>
kg(-1) i.p.,</w>
kg(-1) *
kg(-1)* min(-1)</w>
kg(-1) )-induced</w>
kg(-1) )-</w>
kg(-1) )-
kg(-1))- pretreatment</w>
kg(-1 )/
kg(-1)/ day)</w>
kg bw/
kgbw/ min</w>
kg ID/
kgID/ g)</w>
kg .)</w>
kg -1
kg-1 (i.v.)</w>
kg (-)(1)</w>
key presses</w>
ketotifen :</w>
ketorolac ;</w>
ketorolac :</w>
ketorolac -induced</w>
ketol ase</w>
keto- valproic</w>
keto- analogue</w>
keto- PGF1</w>
keto steroids</w>
keto prostaglandin</w>
keto k
ketok onazole</w>
keto glutar
ketoglutar ate,</w>
keto acidosis.</w>
ketamine/ midazolam</w>
ketamine/ flunitrazepam
ketamine/flunitrazepam )</w>
ketamine- treated,</w>
ketamine- pancuronium-narcotic</w>
ketamine- infusion,</w>
ketamine- flunitrazepam</w>
ketamine- flunitrazepam.</w>
ketamine- fentanyl</w>
ketamine- dominant</w>
ketamine- anesthetized</w>
ketamine- anesthetized,</w>
ketamine- ,</w>
ket osis</w>
ket onuria</w>
ket omethoxime</w>
ket amine's</w>
ket amine
ketamine :
ketamine: xylazine-sedated</w>
ket amin</w>
keratouve itis</w>
keratoconjunctivi tis</w>
keratoconjunctivi tis,</w>
kerato tic-type</w>
kerato plasties</w>
kerato plasties.</w>
kerato pathy.</w>
kerat opathy:</w>
kerat omileusis</w>
kerat ome</w>
kerat omas,</w>
kerat ins</w>
kerat ins,</w>
kerat inization</w>
kerat in/
keratin/ S-100</w>
kerat in
keratin ocytes,</w>
ker s:</w>
ker k
kerk and
kerkand l)</w>
ker atitis.</w>
ker ).</w>
kep one</w>
kep one).</w>
ken ),</w>
ke- 50%;</w>
ke ystone</w>
ke o),</w>
ke hol
kehol ders</w>
ke fell
kefell er</w>
ke ep
keep er</w>
ke 0</w>
kdynes/cm 2).</w>
kdyn /
kdyn/ cm
kdyn/cm 2;</w>
kcal )</w>
kcal )/
kcal)/ day</w>
kat/ L</w>
kat/ L,</w>
karyotyp e,</w>
kary orrhexis,</w>
kary omegaly,</w>
kappa- receptors</w>
kappa- receptors.</w>
kappa- opiate-receptor</w>
kappa- chain</w>
kappa- Opioid</w>
kappa- OR</w>
kappa B,</w>
kappa B)</w>
kappa B
kappaB alpha
kappaBalpha Delta
kappaBalphaDelta N</w>
kappa .</w>
kappa -positive</w>
kappa -like</w>
kappa )</w>
kaol in-
kaolin- induced,</w>
kansasi i</w>
kansasi i.</w>
kanamycin- exposed</w>
kanamycin- dextran.</w>
kanam ycin-treated</w>
kanam ycin,</w>
kallikrein- overexpressing</w>
kallikrein- kinin-system</w>
kallikre in/
kallikrein/ kinin</w>
kallikre in-dependent</w>
kallikre in)</w>
kaliure sis.</w>
kali openic</w>
kala-az ar
kala-azar .</w>
kal bi
kalbi i</w>
kal a</w>
kainate/ AMPA</w>
kainate/ (+/-)-
kainate/(+/-)- alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic</w>
kain oids</w>
kain oid,</w>
kain ate-like</w>
kain ate-</w>
kain ate)</w>
kPa -1;</w>
kHz );</w>
kHz ),</w>
kDa- dextran</w>
kDa- TFA</w>
kDa- TF
kDa-TF A)</w>
k/ GCV</w>
k- triggering</w>
k- transduced</w>
k- list</w>
k- control</w>
k- benefit</w>
k- based</w>
k- Erk</w>
k yo,</w>
k ynurinic</w>
k y,</w>
k x2.5-driven</w>
k uda</w>
k tachem</w>
k strom,</w>
k shire</w>
k screw</w>
k s)</w>
k rekic</w>
k r),</w>
k oloff</w>
k o</w>
k mono,</w>
k lotho</w>
k lokapron),</w>
k liniske</w>
k linefelter's</w>
k klao</w>
k it.</w>
k ing"</w>
k ine-
kine- stimulated</w>
k ind,</w>
k in-
kin- El
kin-El mer</w>
k her
kher t</w>
k fur
kfur t</w>
k ers</w>
k er-
ker- For
ker-For mol</w>
k ens</w>
k ene
kene sia.</w>
k elat
kelat orphan</w>
k ei
kei um</w>
k e.</w>
k down</w>
k d.</w>
k d-
kd- plasma</w>
k d
kd A).</w>
k ay
kay ex
kayex al
kayexal ate.</w>
k awa
kawa 's</w>
k W
kW ;</w>
k D).</w>
k ;</w>
k 1</w>
k 1/2</w>
k .
k. C</w>
k -1</w>
k -1/K
k-1/K DR
k-1/KDR ),</w>
k ).</w>
k (e
k(e 0)</w>
k (12)</w>
k (
k( cat
k(cat ).</w>
k "</w>
juxtap yloric</w>
juxtap osed</w>
juxtam embrane</w>
juxtac ellular</w>
justifi able</w>
justi fication.</w>
junctivi tis</w>
junc tions,</w>
junc tion:</w>
junc tion--an</w>
jun ior</w>
jun al</w>
juic e)</w>
juic e),</w>
jug ular,</w>
jug ates</w>
judic ial</w>
judg ments-of-learning</w>
judg ment.</w>
judg ing</w>
jud gem
judgem ent;</w>
ju ice.</w>
journ al.</w>
jour nals,</w>
jour nal</w>
join ts.Evaluation</w>
join t;</w>
jo ins</w>
jo hn
john son-syndrome</w>
jo gg
jogg ing</w>
jo (2))</w>
jitter iness"</w>
jit ter</w>
jer ky,</w>
jer king.</w>
jer k,</w>
jeopardi zing</w>
jeopardi ze</w>
jel ly,</w>
ject ural,</w>
ject )</w>
jec tives</w>
jec tion,</w>
jeal ousy</w>
jaw s.</w>
jaw .</w>
jaundic e--
jaundice-- defective</w>
jaundic e-
jaundice- -a</w>
jasplakin olide.</w>
jack sonian</w>
jack hammer</w>
jacch us)</w>
jac ulation</w>
jac ks</w>
jac ent,</w>
ja1(+/flox )</w>
ja1(+/flox ))</w>
ja1 (+/-)</w>
ja1 (+/-))</w>
j uniors</w>
j umps</w>
j obs</w>
j megen</w>
j is
jis awa</w>
j il</w>
j iang
jiang ,</w>
j et.</w>
j et-
jet- lag</w>
j ei
jei keium</w>
j e</w>
j ab</w>
j ab
jab bing</w>
j :
j: CD-1</w>
j -1,</w>
izot an,</w>
ization- proven</w>
ization- mass</w>
iz ygous</w>
iz u</w>
iz ontal</w>
iz ole,</w>
iz ol</w>
iz ine-and</w>
iz er/
izer/ Sear
izer/Sear le,</w>
iz er-equipped</w>
iz er),</w>
iz ed)</w>
iz ed'</w>
iz ed"</w>
iz e-
ize- selectivity</w>
iz e,</w>
iz ation.(ABSTRACT</w>
iz ation"</w>
iz ation
ization like</w>
iz atidine</w>
iz ance</w>
iz ai</w>
ix ted,</w>
ix ed-dose</w>
ix antrone</w>
ivoc al,</w>
iverm ect
ivermect in's</w>
iv odeship</w>
iv ing
iving ston</w>
iv c</w>
iv aquine</w>
iv ampicillin</w>
iv ably,</w>
iv ;</w>
iv );</w>
ity-- myoclonic</w>
ity-- appears</w>
ity- purified</w>
ity- of-life</w>
ity- hydroxysteroid</w>
ity- achievement</w>
ity- DPOAE</w>
ity );</w>
ity '.</w>
ituit ary-
ituitary- adrenal</w>
itud inal,</w>
itself ;</w>
itself ).</w>
itro glycerin</w>
itro arginine</w>
itri le.</w>
itrat o</w>
itori al.</w>
iti s;</w>
iti s/abscess;</w>
iti es:</w>
iti es/
ities/ year</w>
iti es).</w>
iti de.</w>
ithrom ycin-associated</w>
ith rophagocytic</w>
ith romax),</w>
ith orax),</w>
ith metic</w>
ith iop
ithiop urine</w>
ith ionit</w>
ith ing</w>
ith i
ithi sia,</w>
ith ec
ithec us</w>
ith ),</w>
ith 's</w>
item s),</w>
item .</w>
itch y/prickly</w>
itch ing.</w>
itch ing).</w>
itch ing),</w>
itch iness</w>
itch /
itch/ scratching</w>
itch ,</w>
itch "</w>
itation- Sedation</w>
itari o</w>
itamin -
itamin- A-induced</w>
it zemann</w>
it us,</w>
it uating</w>
it ter</w>
it ser</w>
it self--is</w>
it ruria</w>
it ropium</w>
it reous</w>
it rate,</w>
it ransected</w>
it otriosidase</w>
it osan,</w>
it one-induced</w>
it ological,</w>
it ol,</w>
it o-Lopez</w>
it nitial</w>
it inib</w>
it ine,</w>
it in-like</w>
it es,</w>
it ensi
itensi fied</w>
it ed:</w>
it ed
ited by</w>
it ec,</w>
it e
ite in-1</w>
it azine</w>
it ative,</w>
it ations,</w>
it are
itare x,</w>
it alin)</w>
it aceae)</w>
it ability</w>
it a.</w>
it .(ABSTRACT</w>
it '</w>
isur a.</w>
isthoton us</w>
ister one.</w>
ister '</w>
ist ratified</w>
ist olochic</w>
ist ography</w>
ist ocytic</w>
ist in,</w>
ist er-chromatid</w>
ist atin</w>
ist -mediated</w>
issu ing</w>
issu ed.</w>
issu e?</w>
issu e-type</w>
isradi pine)</w>
isozyme ,</w>
isozyme (s)</w>
isozym es.</w>
isozym es)</w>
isoxazol yl-penicillins</w>
isoxazol o</w>
isoxaz olyl</w>
isoxaz olo-[4,5-c]-pyridin-3-ol</w>
isox as
isoxas olo-(5,4-c)</w>
isotyp es</w>
isotyp es.</w>
isotretino in-related</w>
isotretino in-</w>
isotretino in)</w>
isotop es:</w>
isotop es.</w>
isotop es,</w>
isothiocy anat
isothiocyanat ostilbene-2,2'</w>
isosorbide- mononitrate</w>
isosorb id</w>
isos thenuria.</w>
isos thenuria,</w>
isor is)</w>
isor hythmic</w>
isopuleg ol.</w>
isoproterenol/ kg</w>
isoproterenol- treated,</w>
isoproterenol- injected</w>
isoproterenol- enhanced</w>
isoproterenol- elicited</w>
isoproterenol- HCl</w>
isoproterenol+ SB20655
isoproterenol+SB20655 3.</w>
isoproterenol+ BIIB7
isoproterenol+BIIB7 23-
isoproterenol+BIIB723- treated</w>
isoproterenol .(ABSTRACT</w>
isoproteren ol)</w>
isoproteren ol),</w>
isoprost ol).</w>
isopropyl- p-iodoamphetamine</w>
isopropyl- analog</w>
isopropyl- alpha-methyl-
isopropyl-alpha-methyl- gamma-butyrolactone</w>
isopropyl- 6-</w>
isopropyl- 6-
isopropyl-6- benzyloxy-4-methoxymethyl-
isopropyl-6-benzyloxy-4-methoxymethyl- beta-carb
isopropyl-6-benzyloxy-4-methoxymethyl-beta-carb oxylate)</w>
isopropyl purine),</w>
isopropyl phenol)</w>
isopropyl malathion</w>
isopropyl malathion),</w>
isopropyl arteren
isopropylarteren ol</w>
isopropyl ,</w>
isopro teronol-treated</w>
isopro tenerol.</w>
isoprenaline- mediated</w>
isoprenaline- injected</w>
isoprenaline- altered</w>
isoprenaline- administered</w>
isoprenal ine;</w>
isoprenal ine.
isoprenaline. 3.</w>
isoprenal ine-evoked</w>
isoprenal ine-</w>
isoprenal ine).</w>
isopren oid</w>
isopren alin</w>
isop ter</w>
isop ter.</w>
isop rivan</w>
isop rinaline</w>
isop rene,</w>
isoniazid ?</w>
isoniazid -dependent</w>
isoniaz ids,</w>
isoniaz ide</w>
isoniaz id-related</w>
isoniaz id-</w>
isonar ing
isonaring in.</w>
isonar in
isonarin genin</w>
ison ing</w>
ison icot
isonicot inate</w>
isom ycin,</w>
isom nia</w>
isom es</w>
isom ers:</w>
isom er
isomer .6.</w>
isolectin-B 4.</w>
isolectin-B (4)</w>
isolectin- B4</w>
isol one,</w>
isol euc
isoleuc ine</w>
isol ation-induced</w>
isol ates.</w>
isol ates,</w>
isol ate).</w>
isoform ;</w>
isoform -specific</w>
isoform (s)</w>
isoflurane/ oxygen</w>
isoflurane/ enflurane.</w>
isoflurane- oxygen</w>
isoflurane- oxygen-air</w>
isoflurane- oxygen,</w>
isoflurane- mediated</w>
isoflurane- ,</w>
isoflurane );</w>
isoflurane 's</w>
isoflur ance,</w>
isoflav ones</w>
isoethar ine</w>
isoethar ine,</w>
isochrom osome</w>
isocarboxaz id.</w>
isocarboxaz id,</w>
isoc ratically</w>
isoc itrate,</w>
isobutyl methylxanthine</w>
isobut yrate</w>
isobut yl-3-methoxypyrazine,</w>
isobolograph y.</w>
isobolograph ically.</w>
isobolog ram</w>
iso-PGF(2 alpha
iso-PGF(2alpha ))</w>
iso- ouabain</w>
iso- osmolality</w>
iso- oncotic</w>
iso- density</w>
iso- DI</w>
iso volaemic</w>
iso valeroylurea</w>
iso statin</w>
iso sexual</w>
iso propoxycarbonyl)</w>
iso kinetic</w>
iso intense</w>
iso ind
isoind ol-5-ol).</w>
iso guvac
isoguvac ine,</w>
iso grafts</w>
iso graft</w>
iso genic</w>
iso forms.</w>
iso form.</w>
iso form,</w>
iso flavonoid</w>
iso enzymic</w>
iso enzyme),</w>
iso ara</w>
iso Hex
isoHex )</w>
iso .</w>
iso -</w>
ism- aggravating</w>
ism ?</w>
ism -induced</w>
isle ts,</w>
isi palR).</w>
ishe d).</w>
ish -
ish- American</w>
ish ),</w>
isethion ate,</w>
isethion ate)</w>
ischemic /
ischemic/ reperfusion</w>
ischemic .</w>
ischemic -like</w>
ischemic "</w>
ischemia/ infarction,</w>
ischem ia?</w>
ischem ia-like</w>
ischem ia
ischemia -</w>
ischaem ic-related</w>
ischaem ia;</w>
ischaem ia:</w>
ischaem ia/reperfusion</w>
ischaem ia)</w>
isch iop
ischiop ubic</w>
isch ial</w>
isaxon ine,</w>
is- use</w>
is- extracts</w>
is uprel</w>
is sl</w>
is se</w>
is sance</w>
is sa</w>
is pinal</w>
is pheric</w>
is permaceae)</w>
is otype</w>
is or</w>
is omorphic</w>
is ologous</w>
is ocortical</w>
is ocoria</w>
is ochronal</w>
is ocapnic</w>
is mus</w>
is mic</w>
is m/antagonism.</w>
is ler's</w>
is lation</w>
is lands.</w>
is forms.</w>
is cler
iscler itis,</w>
is chemically</w>
is cence</w>
is can</w>
is can,</w>
is b
isb ren</w>
is ant</w>
is al-induced</w>
is Tur
isTur bu
isTurbu haler)</w>
is /
is/ semitendinosus</w>
is -P
is-P urkinje)</w>
is -M
is-M ent
is-Ment en</w>
is --at</w>
irrit ative,</w>
irrit ations</w>
irrit ations,</w>
irrit ated</w>
irrit ants</w>
irrit ants.</w>
irrit ancy</w>
irrit ability;</w>
irrig ations.</w>
irrig ation:</w>
irrig ants</w>
irrig ant</w>
irrig ant,</w>
irreversib ly;</w>
irreversib ility,</w>
irregular ly.</w>
irregular ities.</w>
irregular ities,</w>
irradi ations,</w>
irradi ation).</w>
irradi ated,</w>
iron/ copper</w>
iron- overload</w>
iron- gentamicin</w>
iron- drug</w>
iron- chelation</w>
iron- catalyzed</w>
iron- binding</w>
iron- bath
iron-bath ophenanthroline</w>
iron- anthracycline</w>
iron cl
ironcl ad</w>
iro day</w>
iri ses,</w>
iri s.</w>
iri form</w>
iri do
irido pathy</w>
iri din
iridin yl-4'-methylsulphonyl-daunorubicin),</w>
iri des</w>
irbes art
irbesart an.</w>
irac -related</w>
irCR F.</w>
ir y,</w>
ir revocable</w>
ir reversibility.</w>
ir respectively</w>
ir resectable</w>
ir relevant.</w>
ir reducible</w>
ir recoverable</w>
ir on's</w>
ir o</w>
ir culating</w>
ir am
iram une)</w>
ir ac-induced</w>
iqu one.</w>
ipsa perone</w>
ipsa perone,</w>
ipran avir</w>
ipr indole-
iprindole- treated</w>
ipr indole,</w>
ipp ines</w>
ipo date.</w>
ipex ole-treated</w>
ip silaeral</w>
ip s</w>
ip postrongylus</w>
ip ino</w>
ip ine,</w>
ip eptidase,</w>
ip amide</w>
ip /
ip/ week),</w>
ip .,</w>
ioxil an</w>
ioxagl ate;</w>
ioxagl ate-treated</w>
iox x</w>
iox aglate)</w>
iothalam ate.</w>
ioprom ide.</w>
iopent ol.</w>
iop s)</w>
iontophore tically</w>
iontophore tical</w>
ion- selective</w>
ion- exchanged</w>
ion- exchange</w>
ion- conductance</w>
ion- ,</w>
ion s;</w>
ion otropic,</w>
ion ophore-</w>
ion ogram</w>
ion ization-mass</w>
ion icity.</w>
ion ic;</w>
ion amide</w>
ion ale</w>
ion -</w>
iome prol.</w>
iohex ol:</w>
iohex ol+electrolytes</w>
iohex ol).</w>
iohex ol),</w>
iodobenzyl guanid
iodobenzylguanid ine:</w>
iodobenzyl )</w>
iodo- antipyrine</w>
iodo- 5-
iodo-5- nitrophenyl)-[1-((1-methyl-piperidin-2-yl)methyl)-1H-indol-3-yl]-methanone]</w>
iodo thyronine</w>
iodo phenyl-pentadecanoic</w>
iodo phenyl)tropane-2beta-carboxylic</w>
iodo phenyl)-3-(R,S)-methylpentadecanoic</w>
iodo acetate-induced</w>
iodixan ol-treated</w>
iodine/ ml,</w>
iodine/ mL).</w>
iodine/ kg.</w>
iodine-125- metaiodobenzylguanidine.</w>
iodine-1 31</w>
iodine -13
iodine-13 1-
iodine-131- metaiodobenzylguanidine</w>
iodin ated-
iodinated- contrast-enhanced</w>
iodi de),</w>
iod onium</w>
iod ocyanopindolol.</w>
iod ine-related</w>
iod ine-induced</w>
iod ine-based</w>
iod ated</w>
io- sinusoidal</w>
io versol)</w>
io therapeutic</w>
io ka</w>
io iminodiacetic</w>
io gen
iogen )</w>
io femoral</w>
io du
iodu -
iodu- DHP</w>
io ds</w>
io dor
iodor ane).</w>
io dis
iodis al
iodisal @
iodisal@ yahoo.it).</w>
io amnion
ioamnion itis</w>
inyl ation,</w>
involvement ;</w>
involvement );</w>
involve ments</w>
involv ment</w>
involv ing:</w>
involunt ary,</w>
involunt arily</w>
invol ves,</w>
investigator- observed</w>
investigator- masked,</w>
investigator- assessed</w>
investigator- administered</w>
investigation al.</w>
investigation ,we</w>
investig ational,</w>
investig ate:</w>
invest ments</w>
invest ment,</w>
inverte d"</w>
inver t</w>
inver sus)</w>
inver sion.</w>
inver sion-recovery)</w>
inventor y,</w>
inventor y),</w>
invent ories,</w>
invasi veness</w>
invari able.</w>
invagin ations</w>
invagin ations,</w>
inv okes</w>
inv oked.</w>
inv lovement.</w>
inv ite</w>
inv ase</w>
inv al
inval idity</w>
inv agination</w>
inv (9)</w>
inul in;</w>
inul in.</w>
inu tion</w>
intub ator</w>
intub ations.</w>
intub ations).</w>
intub ation/
intubation/ face</w>
intub ated;</w>
intub ate</w>
intromis sions</w>
intromis sion</w>
introduc er</w>
introduc er.</w>
introduc er,</w>
intro version</w>
intro version,</w>
intro g
introg ressed</w>
intro -arterial</w>
intrigu ingly,</w>
intrigu ing,</w>
intric ately</w>
intravesi cul
intravesicul arly</w>
intravesi cally.</w>
intravesi cally,</w>
intraventric ularly)</w>
intraventric ular,</w>
intravenously- administered</w>
intravenously- -a</w>
intravenous ly/day</w>
intravenous /
intravenous/ oral).</w>
intravenous -
intravenous- diazepam-induced</w>
intravenous ).</w>
intravenous ),</w>
intravenous (i.v.
intravenous(i.v. )]</w>
intravenous "</w>
intratympan ically</w>
intratympan ically.</w>
intrathecally- injected</w>
intrathecally- infused</w>
intrathec ally)</w>
intrathec ally),</w>
intrathec al)</w>
intrathec al
intrathecal :
intrathecal: epidural</w>
intrat umor</w>
intrat est</w>
intrasub thalamic</w>
intrastriat ally,</w>
intras pinally,</w>
intras inusoidal</w>
intras ellar</w>
intraren ally.</w>
intraren ally,</w>
intrapor tally.</w>
intrapor tal</w>
intrapor tal.</w>
intrapor tal,</w>
intraplant arly,</w>
intraplant ar,</w>
intraplant ar)</w>
intraperitoneally/ daily</w>
intraperitoneally/ 48</w>
intraperitone aly</w>
intraperitone al).</w>
intraperit onially</w>
intraperit eno
intraperiteno eal</w>
intrap sychic</w>
intrap leurally</w>
intrap elvic</w>
intrap art
intrapart um</w>
intrap apillary</w>
intrane uronally</w>
intran uclear</w>
intran odal</w>
intramy ocardially</w>
intramuscular ly)--L-histidine</w>
intramuscular ).</w>
intramuscul ar)</w>
intram olecular</w>
intram embrane</w>
intram as
intramas cular</w>
intralip id,</w>
intraduoden ally</w>
intraduoden ally.</w>
intrad ural</w>
intrad erm
intraderm ally,</w>
intrad er
intrader moreactions</w>
intrad ental</w>
intracut aneously</w>
intracut aneously,</w>
intract able,</w>
intract ability</w>
intracol onic</w>
intracerebroventricular ly-injected</w>
intracerebroventricular ly)</w>
intracerebroventricular )</w>
intracerebr al,</w>
intracell ullar</w>
intracell ularly.</w>
intracell ular:</w>
intrac ranially</w>
intrac onazole</w>
intrac ochlear</w>
intrac ebro
intracebro ventricular</w>
intrac analicular</w>
intrac amer
intracamer ally</w>
intrac am
intracam eral</w>
intra- week</w>
intra- uterine</w>
intra- tumour</w>
intra- tumoral</w>
intra- tegmental</w>
intra- sleep</w>
intra- sinusoidal</w>
intra- route</w>
intra- pyriform</w>
intra- platelet</w>
intra- neuronal</w>
intra- muscular</w>
intra- joint</w>
intra- innom
intra-innom inate</w>
intra- individually</w>
intra- individual</w>
intra- hypothalamic</w>
intra- hippocampal</w>
intra- gastric</w>
intra- epidermal</w>
intra- compartmental</w>
intra- cerebral</w>
intra- cerebellar</w>
intra- artic
intra-artic ulary,</w>
intra- arterial,</w>
intra- amygdaloid</w>
intra- acinar</w>
intra- accumbal</w>
intra- CA1)</w>
intra- ,</w>
intra voxel</w>
intra vescial</w>
intra vascualr</w>
intra urethrally</w>
intra study</w>
intra retinal</w>
intra renal,</w>
intra procedurally.</w>
intra procedural</w>
intra pharyngeal</w>
intra peritonial</w>
intra period</w>
intra pericardial</w>
intra operative,</w>
intra ocular-pressure</w>
intra observer</w>
intra individually</w>
intra hypothalamic</w>
intra hypophyseal</w>
intra hepatocellular</w>
intra hemispheric</w>
intra ey
intraey throcytic</w>
intra erythrocytic</w>
intra erythrocyte</w>
intra epithelial</w>
intra endothelial</w>
intra axonal</w>
intra atrial</w>
intra am
intraam niotically</w>
intra abdominal,</w>
intra NAS</w>
intra /
intra/ extra</w>
intr usions.</w>
intr onic</w>
intr ar
intrar adial</w>
intoxic ations,</w>
intoxic ations),</w>
intoxic ation.
intoxication. Review</w>
intoxic ation--
intoxication-- III.</w>
intoxic ants.</w>
intoler ances</w>
intoler ability.</w>
intimal- type</w>
intimal- medial</w>
inti ma.</w>
intest ines.</w>
intest ines,</w>
interview er-
interviewer- administered,</w>
interview ;</w>
interview ).</w>
interven tion),</w>
interven es</w>
interval- around</w>
interval s-5-14%,</w>
interval ])</w>
interval =1.
interval=1. 62</w>
interval =
interval= 2.1-
interval=2.1- 4
interval=2.1-4 0.8)</w>
interval -specific</w>
interval -matched</w>
interrupt s.</w>
interrup tions.</w>
interru ption,</w>
interrog ation.</w>
interrog ation-
interrogation- proved</w>
interrog ation,</w>
interpret ations.</w>
interpret ations,</w>
interpre tation,</w>
interpol ates</w>
interneuron s--contribute</w>
interneuron s),</w>
internal ize</w>
intern us,</w>
intern ist</w>
intern ally.</w>
intern alized</w>
intern al,</w>
intern a.</w>
intermit tent);</w>
intermediate- care</w>
intermedi us</w>
intermedi ation</w>
intermedi ately</w>
intermedi ate-</w>
intermedi ate)</w>
intermedi ate"</w>
intermedi ate
intermediate -term</w>
intermedi aries</w>
intermedi a,</w>
interleukin-1 alpha</w>
interleukin-1 alpha/beta</w>
interleukin-1 0)</w>
interleukin- 8).</w>
interleukin- 6-related</w>
interleukin- 4</w>
interleukin s</w>
interleukin -13</w>
interleukin -13
interleukin-13 R</w>
interleukin -11</w>
interleukin -10</w>
interleukin -1,</w>
interleukin (IL)-1
interleukin(IL)-1 beta</w>
interferon-alpha-2 b/ribavirin</w>
interferon-alpha-2 b/
interferon-alpha-2b/ ribavirin,</w>
interferon-alpha-2 b-
interferon-alpha-2b- lamivudine</w>
interferon- ribavirin.</w>
interferon- gamma
interferon-gamma ?</w>
interferon- gam
interferon-gam ma.</w>
interferon- alpha2b</w>
interferon- alpha-induced</w>
interferon- alpha,</w>
interferen ce,</w>
interfer on)</w>
interest s</w>
interest ing.</w>
interdigit ation.</w>
interdigit ation,</w>
intercros ses,</w>
interchang eable</w>
interchang e
interchange ably</w>
intercal ator.</w>
intercal ation.</w>
intercal ate</w>
interaction =0.02).</w>
interac tions)</w>
interac tion:</w>
interac tion).</w>
inter- ventricular</w>
inter- rater</w>
inter- patient</w>
inter- model</w>
inter- male</w>
inter- lobular</w>
inter- item</w>
inter- infusion</w>
inter- haem
inter-haem ispheric</w>
inter- group</w>
inter- domain</w>
inter- day</w>
inter- day,</w>
inter villus</w>
inter vall</w>
inter trigo</w>
inter trabecular</w>
inter test</w>
inter spinous</w>
inter sections</w>
inter s</w>
inter relationships</w>
inter relationship,</w>
inter relations</w>
inter posal</w>
inter population</w>
inter phase</w>
inter personal,</w>
inter nodes</w>
inter neurons:</w>
inter neurones</w>
inter myofibrillar</w>
inter muscular</w>
inter mixed</w>
inter mission</w>
inter media</w>
inter male</w>
inter leaving</w>
inter leaved</w>
inter kinetic</w>
inter ior</w>
inter individually</w>
inter im.</w>
inter ictal-like</w>
inter i
interi or).</w>
inter geniculate</w>
inter fibrillar</w>
inter faced</w>
inter face.</w>
inter disciplinary</w>
inter dig
interdig itation</w>
inter dialytic</w>
inter dependent.</w>
inter curren
intercurren tly.</w>
inter course.</w>
inter cour
intercour se;</w>
inter cost
intercost als,</w>
inter copulatory</w>
inter conversion</w>
inter compartmental</w>
inter compar
intercompar timental</w>
inter cerebral</w>
inter ce
interce de</w>
inter beat</w>
inter animal</w>
inter alveolar</w>
inter act,</w>
inter 's</w>
intent -to-
intent-to- treat)</w>
intensivi st,</w>
intensity/ occurrence</w>
intensity/ lower</w>
intensit y;</w>
intensit y'</w>
intensifi ed:</w>
intensi vist</w>
intensi vely--after</w>
intensi fied.</w>
inten se,</w>
inten ding</w>
inten ded.</w>
intelligen ce-
intelligence- matched</w>
intellect ,</w>
integrin- binding</w>
integrin- beta
integrin-beta 1D</w>
integr in-mediated</w>
integr ative-
integrative- nociceptive</w>
integr ations</w>
integr als</w>
integr al,</w>
integr al)</w>
integ umentary</w>
integ rum</w>
integ rator</w>
integ rated,</w>
inte rendothelial</w>
inte relectrode</w>
inte lligently.</w>
inte fer
intefer on</w>
inte .</w>
intak es.</w>
intact- gentamicin</w>
intact- control,</w>
intact -</w>
insur ants</w>
insur ances</w>
insur ance,</w>
insulin/ day</w>
insulin- using</w>
insulin- to-glucose</w>
insulin- secreting</w>
insulin- only</w>
insulin- infused</w>
insulin- independent</w>
insulin- dependent)</w>
insulin- degrading</w>
insul t:</w>
insul t)</w>
insul t).</w>
insul inemia,</w>
insul ating</w>
insul ar)</w>
insul a);</w>
insufficiency ).</w>
insufficiency ),</w>
insuff lation,</w>
insuff lated.</w>
insu rer</w>
insu red</w>
instrument ed,</w>
instrument ation,</w>
instruc tive,</w>
instruc tion,</w>
institut ed;</w>
institu tions)</w>
instill ations,</w>
instant ly.</w>
instant aneous
instantaneous )</w>
instanc es).</w>
install ment</w>
inst ance),</w>
inst ability;</w>
inst ability/
instability/ perniosis)</w>
inst abilities.</w>
inspired .(ABSTRACT</w>
inspired ),</w>
inspi red,</w>
inspi red).</w>
insp ected.</w>
insk i's</w>
insipid us"</w>
insigh ts.</w>
insigh ts,</w>
insidi ously,</w>
insidi ous-onset</w>
insi st</w>
insi c).</w>
inser ts,</w>
inser ts)</w>
inser tions,</w>
inser tion)</w>
inser ted,</w>
inser t.</w>
inser t"</w>
insectic ide.</w>
insectic id
insecticid ally</w>
insec t</w>
ins ects</w>
ins ects,</w>
ins GT)</w>
inqui ries,</w>
inqui res</w>
inqu iry,</w>
input :</w>
input -output</w>
inotrop ic-
inotropic- vasodilator</w>
inotrop ic
inotropic :
inotropic: vasodilator</w>
inotrop es</w>
inotrop es.</w>
inosuccin ate-evoked</w>
inositol- 4-phosphate</w>
inositol -related</w>
inosi s/sclerosis</w>
inos ylcytosine</w>
inos tilbene</w>
inos ine-induced</w>
inos ine,</w>
inocul um</w>
inocul um)</w>
inoc ula,</w>
inoc and
inocand in-class</w>
ino- rats</w>
ino side</w>
ino lol:</w>
ino aminotransferase</w>
ino ;</w>
ino )-9-
ino)-9- isopropylpurine),</w>
innov ations</w>
innom in
innomin ata,</w>
innoc uousness</w>
innoc uous,</w>
innerv ated,</w>
inner /
inner/ outer</w>
inn ing-
inning- of-dose</w>
ink si</w>
injur y?</w>
injur y-related</w>
injur y-evoked</w>
injur y--not</w>
injur y),</w>
injin 'yoeit
injin'yoeit o,</w>
injection- evoked</w>
injection s.(ABSTRACT</w>
injection .3.</w>
injection .
injection. );</w>
injection -treated</w>
injection -related</w>
injection -induced</w>
injection -1,</w>
inject or</w>
inject ables</w>
inject ables.</w>
inject able.</w>
inj ured:</w>
inj ured.</w>
inj ective</w>
initiation- selection</w>
initi o</w>
initi ators.</w>
initi ator.</w>
initi ative.</w>
initi ations</w>
initi ation;</w>
initi ation)</w>
initi ated;</w>
initi ated"</w>
initi ally;</w>
inib ,</w>
inib ).</w>
ini um)</w>
ini s.</w>
ini press;</w>
ini ,</w>
inhomogene ity.</w>
inhomogene ity,</w>
inhibitors ?</w>
inhibitors --
inhibitors-- argatroban</w>
inhibitors ),</w>
inhibitors (PIs),</w>
inhibitor- na</w>
inhibitor- mirtazapine</w>
inhibitor- mediated</w>
inhibitor- free</w>
inhibitor- free,</w>
inhibitor- (CNI)</w>
inhibitor y/anticancer</w>
inhibitor y,</w>
inhibitor y)</w>
inhibitor y'</w>
inhibitor s/angiotensin-receptor</w>
inhibitor ]</w>
inhibitor /
inhibitor/ tricyclic</w>
inhibitor -treated</w>
inhibitor -like</w>
inhibitor -</w>
inhibitor -1),</w>
inhibit s,</w>
inhibi tion?</w>
inhibi tion/ablation</w>
inhibi tion-excitation</w>
inhibi tion)</w>
inhibi tion);</w>
inhibi tion'</w>
inhib tiion</w>
inherit ed.</w>
inherit ance;</w>
inherit ance
inheritance ?</w>
inher itary</w>
inhal er-induced</w>
inhal er,</w>
inhal ed.</w>
inhal ation-
inhalation- based</w>
inhal ants,</w>
inhal ant</w>
inh bit
inhbit or,</w>
ingrow ths</w>
ingrow th</w>
ingrow ing</w>
ingredi ent.</w>
inges tions;</w>
inges tions.</w>
inges tions,</w>
inges tion/inhalation</w>
inges tion-were</w>
inges tion)</w>
inges ."</w>
ing/ postponing</w>
ing/ newly</w>
ing/ irregular</w>
ing/ CNS</w>
ing- time-dependent</w>
ing- thawing</w>
ing- that</w>
ing- series</w>
ing- prone</w>
ing- of-knowing</w>
ing- less</w>
ing- inducing</w>
ing- impaired</w>
ing- heart</w>
ing- guided</w>
ing- agent</w>
ing- ,</w>
ing s),</w>
ing ko</w>
ing iber
ingiber is</w>
ing ful</w>
ing estive</w>
ing er's</w>
ing er
inger nail</w>
ing '.</w>
ing "),</w>
infusion- time</w>
infusion- site</w>
infusion s:</w>
infusion );</w>
infusion (
infusion( diluted</w>
infrequ ently-
infrequently- reported</w>
infran odal)</w>
infra- clinical</w>
infra renal</w>
infra ophthalmic</w>
infra Hisian</w>
inform ing</w>
inform ative.</w>
inform atics</w>
infor cing</w>
influenz ae,</w>
influenz a.</w>
influ xes</w>
influ ential</w>
influ ence;</w>
influ enc</w>
inflexi on</w>
inflammat ory/analgesic</w>
inflammat ory-associated</w>
inflammat ories</w>
inflamm ations</w>
inflamm ation;</w>
inflamm ation/
inflammation/ oxidative</w>
inflamm ation-mediated</w>
inflamm ation).</w>
inflamm ation
inflammation dri
inflammationdri ven,</w>
inflam masome-mediated</w>
infl ic
inflic ts</w>
infinity )]</w>
infinity ))</w>
infin ity;</w>
infin ity.</w>
infin ity-hydroxysteroid</w>
infiltr ative-
infiltrative- looking</w>
infiltr ations.</w>
infiltr ations,</w>
infiltr ation;</w>
infiltr ation:</w>
infiltr ates;</w>
infiltr ate)</w>
infest ing</w>
infest ation</w>
infero septal</w>
infero apical</w>
inferi orly</w>
inferi ority,</w>
inferi or-basal</w>
inferen ces</w>
inferen ce.</w>
infer tility;</w>
infer tility,</w>
infer ring</w>
infer red,</w>
infer olateral</w>
infer obasal</w>
infection s/infestations</w>
infection --case</w>
infec tivity</w>
infec tives</w>
infec tions;</w>
infec tion-associated,</w>
infec tion).</w>
infarction s.(ABSTRACT</w>
infarction ].</w>
infarction .(ABSTRACT</w>
infarction -free</w>
infarction --a</w>
infarction ,"</w>
infarct- type</w>
infarc ts),</w>
infarc tion/necrosis,</w>
infarc ted);</w>
infarc t-induced</w>
infarc t-</w>
infarc t).</w>
infanti lism;</w>
infanti c
infantic ide</w>
infant s;</w>
infant s--a</w>
infant s)</w>
infant s),</w>
infant s'</w>
infant :</w>
inf usin</w>
inf used;</w>
inf ringement.</w>
inf raction</w>
inf oldings</w>
inf liximab.</w>
inf ective,</w>
inf ected.</w>
inexpen sive"</w>
inex perienced</w>
inex cit
inexcit ability.</w>
inevit able.</w>
ineur ial</w>
iness man</w>
iness ;</w>
ineph ritic</w>
ineffective :</w>
ineffective .(ABSTRACT</w>
ineff iciency</w>
ineff ect
ineffect ual</w>
ine/ tacrolimus</w>
ine/ placebo</w>
ine/ placebo.</w>
ine/ oxaliplatin</w>
ine/ methylchloroform</w>
ine/ hepatitis</w>
ine/ cyclophosphamide/
ine/cyclophosphamide/ rituximab</w>
ine/ chlorine</w>
ine/ cGMP</w>
ine/ butorphanol</w>
ine/ Rg1</w>
ine/ Metoprolol</w>
ine/ 019</w>
ine. Conclu
ine.Conclu sions.</w>
ine-to- exit</w>
ine-N- oxide.</w>
ine-N- oxide,</w>
ine-6- carboxylic</w>
ine-3- glucuronide</w>
ine-- were</w>
ine-- nausea,</w>
ine-- especially</w>
ine-- dobutamine</w>
ine-- 0.00
ine--0.00 75</w>
ine- vasopressin</w>
ine- tuning</w>
ine- sulfoximine</w>
ine- sulfate-related</w>
ine- sulbactam</w>
ine- responsive</w>
ine- propafenone</w>
ine- polyurethane</w>
ine- oxotremorine-induced</w>
ine- naive</w>
ine- mannitol</w>
ine- homocysteine</w>
ine- glycol
ine-glycol ato
ine-glycolato platinum</w>
ine- gated</w>
ine- end</w>
ine- dobutamine</w>
ine- diltiazem</w>
ine- derivative</w>
ine- cocaine</w>
ine- carboxylate</w>
ine- arabinoside</w>
ine- arabinoside-induced</w>
ine- angiograms</w>
ine- Tacrolimus</w>
ine- HC1</w>
ine- 5-
ine-5- carboxamide)</w>
ine- 4-
ine-4- yl)propenyl-1-</w>
ine+ yohimbine</w>
ine us</w>
ine t-Ringuet</w>
ine strase</w>
ine se-language</w>
ine quities</w>
ine mias.</w>
ine met</w>
ine ment.</w>
ine ll).</w>
ine ligible;</w>
ine ligible,</w>
ine l</w>
ine d-modality</w>
ine d-
ined- Release</w>
ine d).</w>
ine bri
inebri ation</w>
ine ation</w>
ine al
ineal ectomy</w>
ine a.</w>
ine ].</w>
ine B</w>
ine .(ABSTRACT</w>
ine -18</w>
ine -18-
ine-18- F-
ine-18-F- deoxyglucose</w>
ine ,
ine, propranolol,</w>
ine )-
ine)- -1</w>
ine (CPZ)-induced</w>
ine (AD
ine(AD )-induced</w>
ine (25</w>
industry- sponsored</w>
industry- sponsored,</w>
industri es</w>
industri alized</w>
industr y;</w>
industr y,</w>
inducible -B</w>
inducible -
inducible- NO</w>
induci ble.</w>
induci bility.</w>
induced- urticaria</w>
induced- supraventricular</w>
induced- phlebitis.</w>
induced- parkinsonian</w>
induced- neurotoxicity</w>
induced- local</w>
induced- cardiomyopathy,</w>
induced- behaviour</w>
induced- PE.</w>
induced- ARF</w>
induc tions</w>
induc tion-consolidation</w>
induc tion--are</w>
induc tion),</w>
induc er.</w>
induc er
inducer s")</w>
induc e,</w>
indomethacin- pretreatment</w>
indomethacin- DEHP</w>
indomethacin- -
indomethacin-- lymphocyte</w>
indomethacin was</w>
indomethacin ?</w>
indomethacin +
indomethacin+ arginine</w>
indomethac in;</w>
indomethac in/
indomethacin/ 100</w>
indomethac in-mediated</w>
indomethac in's</w>
indomet acin.</w>
indole- negative</w>
indole- acetic</w>
indole- 3-
indole-3- acetamide]</w>
indole amines</w>
indol es,</w>
indol ent.</w>
indol amines</w>
indol acetic</w>
indobu fen
indobufen .</w>
indo lol,</w>
individual s/BMIMCG)</w>
individu al-specific</w>
individu al-
individual- level</w>
indistinguish able.</w>
indinavir/ ritonavir</w>
indin av
indinav air</w>
indiges tion/epigastric</w>
indic ted</w>
indic ted,</w>
indic es--
indices-- further</w>
indic ators,</w>
indic ators'</w>
indic ation;</w>
indic ation,</w>
indic ating,</w>
indic ates.</w>
indic ated;</w>
indic ated-
indicated- without</w>
indic ate.</w>
indic at
indicat ors-multiple</w>
indic ants</w>
indi visibility</w>
indi um-111-antimyosin</w>
indi genous</w>
indi -c
indi-c ate</w>
index-AI cr
index-AIcr ).</w>
index-AI c)</w>
index- A1
index-A1 r),</w>
index of</w>
index es.</w>
index -matched</w>
index "</w>
indetermin ate).</w>
independ ent).</w>
indefinit ely,</w>
inde ed.</w>
indap amide.</w>
inda zole,</w>
ind ol;</w>
ind ol-2-one,</w>
ind ol).</w>
ind le</w>
ind ine,</w>
ind ented</w>
ind ent
indent ation.</w>
ind an-4-
indan-4- yloxy)-3-isopropylaminobutan-2-ol</w>
ind al
indal pine</w>
ind ).</w>
ind '</w>
incrimin ating</w>
incrimin ated-
incriminated- ceftriaxone,</w>
incrimin ate</w>
increment s/dose),</w>
increment s)</w>
increment ),</w>
increased ".</w>
increas ingly,</w>
increas ing-current</w>
increas es;</w>
increas es:</w>
increas e:</w>
incre ta.</w>
incorrec t.</w>
incorpor ation.</w>
incorpor ated.</w>
incorpor ated,</w>
inconveni ences</w>
incontin ence),</w>
incongru ous</w>
incongru ent.</w>
include d)</w>
includ ing;</w>
inclu sions,</w>
inclu de,</w>
incl ines</w>
incl ine</w>
incl inations</w>
incident al,</w>
incident al
incidental oma.</w>
incid ents,</w>
incid ence).</w>
incid ence
incidence or</w>
inci sion-induced</w>
inci sion-</w>
incarc eration</w>
incarc eration,</w>
incapacit ating,</w>
incapacit ated</w>
incap acity</w>
inc ulpating</w>
inc tion</w>
inc o-ordination</w>
inc kers</w>
inc ke's</w>
inc ites</w>
inc isura.</w>
inc isor</w>
inc ial</w>
inc ess</w>
inc enti
incenti ve.</w>
inc ar</w>
inc ,</w>
inbre d-
inbred- quantitative</w>
inbre d,</w>
inbre d)</w>
inappet ence</w>
inappet ence.</w>
inapar sin,</w>
inadvert ently.</w>
inadvert ence</w>
inadvert ant</w>
inadver tency</w>
in: Hb</w>
in/ sulbactam</w>
in/ polyubiquitin-positive</w>
in/ kg</w>
in/ kg/24</w>
in/ isradipine</w>
in/ gemfibrozil</w>
in/ ferritin</w>
in/ dicloxacillin</w>
in/ defensiveness</w>
in/ cyclosporine</w>
in/ clavulan
in/clavulan ate-induced</w>
in/ catenin</w>
in/ a-syntrophin</w>
in/ LPS</w>
in-7- yl)oxy]-N-methyl-2-pyrazinecarboxamide)</w>
in-4- one)</w>
in-3- like</w>
in-1-yl) methyl)-8-azabicyclo(3.2.1)octane-3-methanamine</w>
in-1- converting</w>
in-1 25)</w>
in- vitro,</w>
in- transit,</w>
in- tolerant</w>
in- thiobarbiturate-halothane</w>
in- test</w>
in- spin</w>
in- skeletal</w>
in- situ</w>
in- selective</w>
in- releasing-hormone</w>
in- protamine</w>
in- pretreated</w>
in- patients,</w>
in- patients).</w>
in- order</w>
in- na</w>
in- mediated,</w>
in- man</w>
in- line</w>
in- laden</w>
in- intoxicated</w>
in- infused</w>
in- hou
in-hou se).</w>
in- horseradish</w>
in- gemcitabine</w>
in- fluoxetine</w>
in- exacerbated</w>
in- dwelling</w>
in- derivates</w>
in- dep
in-dep ent</w>
in- deficiency</w>
in- damaged</w>
in- coordination.</w>
in- conjug
in-conjug ating</w>
in- cefotaxime</w>
in- allergic</w>
in- actin</w>
in- A/
in-A/ FK506-related</w>
in- 5-
in-5- isothiocyanate</w>
in- 4.</w>
in- 2
in-2 yl-amino)-2,1,3-benzothiazole,</w>
in- ---
in---- CM
in----CM F)</w>
in- (1-7)</w>
in+ silymarin</w>
in versus</w>
in vention</w>
in uric</w>
in um)</w>
in toxicity</w>
in toxcation</w>
in ton</w>
in tolerated</w>
in tolerability</w>
in the</w>
in tamitochondrial</w>
in tacerebral</w>
in surmountable</w>
in sure</w>
in structor</w>
in stable</w>
in spect</w>
in son</w>
in sofar</w>
in sistence</w>
in significant;</w>
in significant,</w>
in side/outside</w>
in setting</w>
in sensitivity.</w>
in sensitive)</w>
in scription</w>
in s/fibrates).</w>
in rcease,</w>
in patients;</w>
in patient/outpatient</w>
in one:</w>
in oma.</w>
in of</w>
in odilator,</w>
in ocystic</w>
in most</w>
in mmunoanalysis</w>
in kinase</w>
in k</w>
in itation</w>
in idine</w>
in homogenous</w>
in heren
inheren tly</w>
in gence</w>
in erg
inerg ic-dopaminergic</w>
in er
iner t's</w>
in duration.</w>
in duration,</w>
in distinction</w>
in disput
indisput able.</w>
in discrimin
indiscrimin ately</w>
in direc
indirec t.</w>
in difference</w>
in dependence.</w>
in dependence,</w>
in definite</w>
in convenient</w>
in controver
incontrover tible.</w>
in consistent,</w>
in consistency</w>
in considerably</w>
in consequ
inconsequ enti
inconsequenti al.</w>
in compliance</w>
in competence</w>
in compet
incompet ence,</w>
in compensation</w>
in compati
incompati bility.</w>
in com
incom e,</w>
in ch
inch es.</w>
in blocker</w>
in berg</w>
in aud</w>
in attentiveness</w>
in attentive</w>
in attention.</w>
in appropriately.</w>
in applicable</w>
in ani
inani tion.</w>
in amide-induced</w>
in after</w>
in aemia:</w>
in aemia.</w>
in aem
inaem ia).</w>
in advisable</w>
in active,</w>
in active
inactive .2.</w>
in activators</w>
in activator</w>
in activated.</w>
in activ
inactiv ates,</w>
in actin</w>
in accurate</w>
in accuracy.</w>
in a-like</w>
in ])</w>
in 43</w>
in 10%,</w>
in .6.</w>
in ,
in, Dx
in,Dx Dx
in,DxDx ):</w>
in ):</w>
in )-
in)- loaded</w>
in (14)
in(14) CO(2)
in(14)CO(2) released</w>
imput ability</w>
imput abil
imputabil ity).</w>
impulsi vity,</w>
impulsi veness,</w>
impul se.</w>
improvement/ resolution</w>
improvement/ resolution;</w>
improve d).</w>
impro ving.</w>
impro ving,</w>
impro midine</w>
impres sive.</w>
impres sion,</w>
impregn ated,</w>
impoten ce).</w>
impost ors</w>
impost ers</w>
impost er.</w>
import ation</w>
import .</w>
implic it,</w>
implic ation.</w>
implic ated:</w>
implic ated),</w>
implic ate,</w>
implement ation.</w>
imple menting</w>
imple mentation,</w>
implant- supported</w>
implant- supported)</w>
implant ing</w>
implant ations</w>
implant ations.</w>
implant ations,</w>
implant ation),</w>
implant ,</w>
impl ied.</w>
impl au
implau sible,</w>
impl ante
implante d/
implanted/ nonstimulated,</w>
imped ance)</w>
imped ance
impedance -derived</w>
impe tigo</w>
impe ding</w>
impe des</w>
impe de</w>
impar ted</w>
impar ied</w>
impairment/ death.</w>
impairment/ amnesia,</w>
impairment/ ED50</w>
impairment s;</w>
impairment s).</w>
impairment ]).</w>
impairment ?</w>
impairment .4.</w>
impairment --is</w>
impairment ,
impairment, thus</w>
impairment );</w>
impairment ),</w>
impac ted)</w>
imp inge</w>
imp action</w>
imp acting</w>
immunosuppressi ves</w>
immunosuppressi ves.</w>
immunosuppressi ves,</w>
immunosuppressi ve-induced</w>
immunosuppress or.</w>
immunosuppress or,</w>
immunosuppress ant-induced</w>
immunosuppres sive,</w>
immunosuppres sion-associated</w>
immunosuppres sion--i.e.,</w>
immunosuppres ant</w>
immunosu pressed</w>
immunosu pressant.</w>
immunos timulatory</w>
immunos er
immunoser um</w>
immunore activity;</w>
immunore activities,</w>
immunore active
immunoreactive .
immunoreactive. C-
immunoreactive.C- fos</w>
immunore action</w>
immunore action,</w>
immunoprecipit ation/Western</w>
immunoprecipit ation,</w>
immunoprecipit ates</w>
immunoprecipit ate</w>
immunophil in</w>
immunophil in,</w>
immunopath ologic</w>
immunopath ologic,</w>
immunopath ogenetic</w>
immunoneutr alization</w>
immunoneutr al
immunoneutral ize</w>
immunomodul ators</w>
immunomodul ator,</w>
immunomodul ating</w>
immunolab ell
immunolabell ing.</w>
immunolab el,</w>
immunohistochemistr y;</w>
immunohistochemistr y).</w>
immunohist ology</w>
immunohist ology.</w>
immunohist ologically</w>
immunohist ochemistry),</w>
immunohist ochemically.</w>
immunohist oblot</w>
immunoglobul ins,</w>
immunoglobul ine</w>
immunoglobul ine.</w>
immunoglobul in-related</w>
immunofluoro cytometry</w>
immunofluoro cytometry.</w>
immunofluoresc ence;</w>
immunofluoresc ence-
immunofluorescence- labeling</w>
immunofluoresc ence)</w>
immunocyt oma.</w>
immunocyt ochemically</w>
immunocyt ochemically.</w>
immunocyt ochemical,</w>
immunocompet ent,</w>
immunocompet ence.</w>
immunocom promized</w>
immunocom promising</w>
immunoblo t.</w>
immunoblo t,</w>
immuno- suppression</w>
immuno- regulatory</w>
immuno- reactive</w>
immuno- positive</w>
immuno- modulator,</w>
immuno- haematological</w>
immuno- globulin</w>
immuno- deposition.</w>
immuno therapy.</w>
immuno regulation</w>
immuno regulation.</w>
immuno phenotyping.</w>
immuno phenotypically,</w>
immuno phenotypic</w>
immuno phenotype,</w>
immuno localization</w>
immuno hemat
immunohemat oxicities</w>
immuno globin</w>
immuno fixation</w>
immuno fixation,</w>
immuno expressions</w>
immuno expression.</w>
immuno electrophoresis</w>
immuno ele
immunoele trophoresis</w>
immuno deficiency.</w>
immuno deficiencies</w>
immuno assays</w>
immuno allergy</w>
immuno allergy.</w>
immuno affinity</w>
immuno adsor
immunoadsor ption.</w>
immuno -</w>
immune- suppressed</w>
immune- globulin</w>
immune- deficient</w>
immune- complex-mediated</w>
immune mediated</w>
immune -based</w>
immun positive</w>
immun otoxicity</w>
immun operoxidase,</w>
immun omodulation</w>
immun ometric</w>
immun omediated</w>
immun ology</w>
immun ology,</w>
immun ological,</w>
immun olesion</w>
immun ogenicity</w>
immun ogenicity,</w>
immun ogenetically</w>
immun oflourescence</w>
immun ochemistry.</w>
immun ochemical</w>
immun obolt</w>
immun oblastic</w>
immun obiology</w>
immun ized.</w>
immun izations</w>
immun cytochemistry</w>
immu ocompromised</w>
immobil ization)</w>
immobil ization).</w>
immobil ization),</w>
immobil ity).</w>
immin ent.</w>
immin ent,</w>
immigr ants,</w>
immigr ant</w>
immer sions.</w>
immediate- type</w>
immediate- early-gene</w>
immedi ate-</w>
imipramine- sensitive</w>
imipramine- may</w>
imipramine- desipramine</w>
imipr amine/
imipramine/ desipramine.</w>
imipr amine-associated</w>
imipenem/ cilastatin,</w>
imipenem -treated</w>
iminodi propionitrile:</w>
imino] triphosphate</w>
imino -1,</w>
imin o-4-piperidinopyrimidine)</w>
imidazole- containing</w>
imidazol ine,</w>
imidazol in-2yl-amino)-2,1,3-benzothiazole,</w>
imidazol es</w>
imidazol e-induced</w>
imidazol e
imidazole acetic</w>
imidazol -1-
imidazol-1- yl)-6-nitro-1,2,3,4-tetrahydro-1-quinoxalinyl]-acetic</w>
imidazo- (2,</w>
imidazo quinazoline</w>
imidazo [4,5-
imidazo[4,5- c]
imidazo[4,5-c] pyridine-4-carboxylate</w>
imidazo [1,5-
imidazo[1,5- a]-
imidazo[1,5-a]- pyrrolo-[2,1-c][1,4]benzodiazepine-1-carboxylate)</w>
imidaz otetrazines</w>
imidaz opyridine.</w>
imidaz opyridine),</w>
imidaz odiazepine,</w>
imidaz en
imidazen il)</w>
imi quimod</w>
imi peride</w>
imel dine,</w>
ime tric</w>
ime tics.</w>
ime Light,</w>
imbal ances.</w>
imbal anced</w>
imbal ance
imbalance "</w>
imbal anc
imbalanc es,
imbalances, dose</w>
imatinib -related</w>
imatinib -
imatinib- mesylate-induced</w>
image- processing</w>
image- guided</w>
image- guided,</w>
imag ing:</w>
imag ing-guided</w>
imag ine</w>
imag es)</w>
imag er.</w>
imag ed.</w>
im unohistochemical</w>
im purities,</w>
im prisonment.</w>
im precisely</w>
im precise,</w>
im practicable</w>
im position</w>
im posing</w>
im petus</w>
im persistence,</w>
im permeant</w>
im permeable.</w>
im perfectly</w>
im perceptible</w>
im pediment</w>
im parts</w>
im parting</w>
im one,</w>
im mortalised</w>
im mobile</w>
im mobile,</w>
im mel</w>
im maturity</w>
im mature,</w>
im izu</w>
im itate</w>
im inostilbene</w>
im ino</w>
im ine)</w>
im idine-
imidine- N-1-
imidine-N-1- adamant
imidine-N-1-adamant yl-N'-</w>
im idi
imidi zoline</w>
im icking</w>
im entin,</w>
im ent</w>
im azole,</w>
im amide)</w>
im alleolar</w>
im age)</w>
im TOR)</w>
im -1</w>
im -1)</w>
im ,</w>
im ),</w>
ilo ),</w>
illust rates,</w>
illust rated.</w>
illust rate,</w>
illumin ate</w>
illumin ance</w>
illu stration</w>
illu sions--although</w>
illu sions,</w>
illu c</w>
illo ver</w>
illo t,</w>
illo metry</w>
illo id</w>
illness -
illness- related.</w>
illness ).</w>
illnes ses;</w>
illnes s)</w>
illain- bar
illain-bar re</w>
ill- tempers,</w>
ill- guided</w>
ill- advised</w>
ill side</w>
ill roth</w>
ill ness:</w>
ill in-associated</w>
ill d.</w>
ill ations</w>
iliter ])</w>
ilic ifol
ilicifol ia.</w>
iliac )</w>
ili bration</w>
ili ation,</w>
ili arity</w>
ili aceae)</w>
ileut on</w>
ileut on,</w>
ileu s.</w>
ile y-Liss,</w>
ile us).</w>
ile us),</w>
ile ostomy,</w>
ile ocecocystoplasty.</w>
ile o-psoas</w>
ild -
ild- moderate,</w>
il- statin</w>
il ymph</w>
il worth,</w>
il ting</w>
il taxel</w>
il lopsia</w>
il itis,</w>
il is,</w>
il iofemoral</w>
il ine,</w>
il i</w>
il ec
ilec tically</w>
il co
ilco til</w>
il ation</w>
il ate</w>
il antin
ilantin )</w>
il a</w>
il a,</w>
il -mediated</w>
il -containing</w>
il -M
il-M aking</w>
il -</w>
il --
il-- treatment</w>
il ):</w>
ign s</w>
ign oring</w>
ign ore</w>
ign ition</w>
ign ar
ignar d-
ignard- Bo
ignard-Bo ulange</w>
ign ,</w>
ign ).</w>
ig ne's</w>
ig mented</w>
ig e</w>
ig atus</w>
ig ation,</w>
ig alu
igalu po</w>
ig ,</w>
ig )</w>
ig ),</w>
ifosfamide/ mesna,</w>
ifosfamide/ cisplatin/
ifosfamide/cisplatin/ doxorubicin</w>
ifosfamide/ cisplatin
ifosfamide/cisplatin um-induced</w>
ifosfamide- have</w>
ifosfamide- cycle.</w>
ifosfamide ?</w>
ifosfamide ;</w>
ifosfamide :</w>
ifosfamide /kg</w>
ifosfamide -mediated</w>
ifosfamide -based</w>
ifosfamide )</w>
ifosfamide ).</w>
ifor nia,</w>
ifl uridine)</w>
ific ations/
ifications/ increases:</w>
ific ation:</w>
ifer ols</w>
ifenpro dil
ifenprodil -induced</w>
ifen e,</w>
if y,</w>
if t</w>
if ing</w>
if ies,</w>
if ax</w>
if acial</w>
if a</w>
if :</w>
if .)</w>
if )</w>
ies ."</w>
iel schowsky-stained</w>
iel d-
ield- stimulated</w>
idze in</w>
ido- 3-
ido-3- pyridyl)-N-[N-(2,</w>
ido steronism.</w>
ido pathy</w>
ido iminodiacetic</w>
ido derm</w>
ido acetate</w>
idne y</w>
idiosyncrati c"</w>
idiosyncras y.</w>
idiosyncras y).</w>
idiosyn crac
idiosyncrac y,</w>
idiosyn cra
idiosyncra sic,</w>
idiosyn ch
idiosynch ratic</w>
idiopath ic)</w>
idinedi ones</w>
idine- methylprednisolone</w>
idine- managed</w>
idine- ephedrine</w>
idi otoxicity</w>
idi onodal</w>
idi ol"</w>
identifi es,</w>
identifi ers.</w>
identifi able,</w>
identif y,</w>
identi ty).</w>
identi fication,</w>
iden tial</w>
iden )</w>
ide- resistant</w>
ide- or</w>
ide- maintained</w>
ide- lithium</w>
ide- insensitive</w>
ide- bortezomib-dexamethasone</w>
ide- 5-
ide-5- mononitrate</w>
ide x).</w>
ide omotor</w>
ide mic</w>
ide d.</w>
ide ation
ideation ';</w>
ide as</w>
ide as,</w>
ide al.</w>
ide a.</w>
ide ]</w>
ide ]),</w>
ide .(ABSTRACT</w>
ide -like</w>
ide --
ide-- importance</w>
idazox an:</w>
idazox an-treated</w>
idazol e)</w>
id- rifampicin-induced</w>
id- kindled</w>
id- attenuated</w>
id- MG</w>
id- MG)</w>
id- Induced</w>
id y,</w>
id steroid</w>
id s)</w>
id s'</w>
id ray,</w>
id one.</w>
id one,</w>
id olamines</w>
id itol</w>
id inosuccinate-evoked</w>
id ine:</w>
id ine-evoked</w>
id ening</w>
id ase,</w>
id ap</w>
id aceae).</w>
id Fent</w>
id :</w>
id "
id" ]</w>
icul ar)</w>
icto genesis</w>
icto genesis.</w>
icter ic,</w>
icro fil
icrofil are
icrofilare mic</w>
icot inell).</w>
icon ception</w>
ico thyrotomy.</w>
ico thoracic</w>
iclospor in),</w>
ick son-Glazer</w>
ick s-in-quiet</w>
ick ers</w>
ick er-
icker- Schwar
icker-Schwar zer)</w>
ick ens</w>
ick ening</w>
ick av
ickav ance</w>
ick am
ickam er's</w>
ick ,"</w>
ick ),</w>
icin- injected</w>
icin- B</w>
ici an-
ician- Administered</w>
ichthyo sis.</w>
ichthyo sis-like)</w>
ich terus,</w>
ich mond</w>
ich l.</w>
ice- cold</w>
ically- evoked</w>
ically- enhanced</w>
ically- assessed</w>
ically- administered</w>
icalTri als.</w>
ical- pathological</w>
ical- controlled</w>
ical -</w>
ic/ withdrawal)</w>
ic/ tonic</w>
ic/ pre-optic</w>
ic/ panicogenic</w>
ic/ neuroendocrine</w>
ic/ mixed</w>
ic/ mass</w>
ic/ hypoman
ic/hypoman ic/mixed</w>
ic/ cholinergic</w>
ic/ antioxidant</w>
ic/ 5-HT2</w>
ic- toxic</w>
ic- pyruvic</w>
ic- ouabain</w>
ic- opioid</w>
ic- opiate</w>
ic- noradrenergic</w>
ic- mean</w>
ic- mass</w>
ic- independent</w>
ic- hydrophobic</w>
ic- ester</w>
ic- drug</w>
ic- clear</w>
ic- based</w>
ic- anti
ic-anti catabolic</w>
ic- and</w>
ic- anabolic</w>
ic- acid-sensitive</w>
ic- acid-
ic-acid- exposed</w>
ic- Psychiatric</w>
ic- Associated</w>
ic- 4,4'-
ic-4,4'- 3H]
ic-4,4'-3H] )</w>
ic yazine</w>
ic v,</w>
ic v).</w>
ic tally,</w>
ic tal1,</w>
ic s-induced</w>
ic s--no,</w>
ic s'</w>
ic ous</w>
ic obactericidal</w>
ic o-clinical</w>
ic linico</w>
ic les</w>
ic ity.(ABSTRACT</w>
ic ism</w>
ic ins</w>
ic in;</w>
ic ilin</w>
ic ides</w>
ic ide)</w>
ic henoid</w>
ic ha
icha el</w>
ic eps</w>
ic ene,</w>
ic e)</w>
ic ate</w>
ic arb
icarb azide</w>
ic ally-induced</w>
ic ally)</w>
ic ality</w>
ic --
ic-- cholinergic</w>
ic )-
ic)- a</w>
ibuprofen :</w>
ibuprofen /
ibuprofen/ diclofenac.</w>
ibuprofen -mediated</w>
ibuprofen -
ibuprofen- lysine</w>
ibuprofen )</w>
iboten ate,</w>
iboten ate)</w>
iberiotox in.</w>
iberiotox in-sensitive</w>
iberi otoxin,</w>
ib ial</w>
ib b
ibb 's</w>
ib and
iband ronate)</w>
ib a-
iba- Gei
iba-Gei gy
iba-Geigy 's</w>
ib (7
ib(7 )
ib(7) Arg
ib(7)Arg (14)
ib(7)Arg(14) Lys(15)]
ib(7)Arg(14)Lys(15)] N/OF
ib(7)Arg(14)Lys(15)]N/OF Q-
ib(7)Arg(14)Lys(15)]N/OFQ- NH
ib(7)Arg(14)Lys(15)]N/OFQ-NH (2)</w>
iang -
iang- Tang</w>
ian s,</w>
ian ensis</w>
ian abol,</w>
ian /
ian/ Asi
ian/Asi an/
ian/Asian/ European</w>
ian )</w>
ia/ thrombocytopenia/emesis/rash</w>
ia/ rhabdomyolysis-a</w>
ia/ reperfusion:</w>
ia/ reoxygenation</w>
ia/ other</w>
ia/ myalgia</w>
ia/ lactic</w>
ia/ hyperthermia,</w>
ia/ 7/
ia/7/ 83-
ia/7/83- like</w>
ia-- to</w>
ia-- the</w>
ia-- hypercalciuria</w>
ia- that</w>
ia- provoking</w>
ia- pinprick</w>
ia- dyskinesia</w>
ia- dependent.</w>
ia- chromosome</w>
ia- DSM-IV-
ia-DSM-IV- who</w>
ia okou)</w>
ia ."</w>
ia -positive</w>
ia -free</w>
ia -Pres
ia-Pres by
ia-Presby terian</w>
iK r.</w>
iK r,</w>
i.v. or</w>
i.v. epinephrine.</w>
i.v. c.</w>
i.v. ]</w>
i.v. /
i.v./ sublingual</w>
i.v. ,
i.v., i.p.</w>
i.v. );</w>
i.v. )-
i.v.)- pretreated</w>
i.v ).</w>
i.th .),</w>
i.t. -administered</w>
i.p.)- pretreated</w>
i.p.)- only</w>
i.p.)- -induced</w>
i.p. s.p.,</w>
i.p. ])</w>
i.p. :
i.p.: 600</w>
i.p. /day)</w>
i.p. ):</w>
i.p. )-treated</w>
i.p. )-,</w>
i.p ,
i.p, )</w>
i.d .).</w>
i.d .),</w>
i.c.v.- ouabain</w>
i.c.v .
i.c.v. )-induced</w>
i.c.v ,</w>
i.c.v )</w>
i.c. b
i.c.b .),</w>
i.c. ].</w>
i.c. )-
i.c.)- evoked</w>
i. ve</w>
i. ve.)</w>
i. th)</w>
i. t),</w>
i. n.)</w>
i. g.
i.g. )]</w>
i. g
i.g .)</w>
i. a
i.a .),</w>
i. Ao.)</w>
i. ,</w>
i-butyl phenyl)</w>
i-butyl phenyl)-propionyl]-N4-alkyl/aryl-thiosemicarbazides</w>
i- virus</w>
i- component</w>
i- Z
i-Z hi
i-Zhi -G
i-Zhi-G an-
i-Zhi-Gan- J
i-Zhi-Gan-J iang-Tang</w>
i- Tang</w>
i- Hu
i-Hu -
i-Hu- Gu
i-Hu-Gu i-Zhi-Gan-Jiang-Tang</w>
i- DBS</w>
i ving</w>
i um-,</w>
i um)</w>
i u/kg</w>
i u/kg).</w>
i u,</w>
i sion-analytic</w>
i setron,</w>
i ritis</w>
i raea</w>
i ra,</w>
i phenylacetic</w>
i patory</w>
i paratide</w>
i pafox,</w>
i oxamine</w>
i one</w>
i on.</w>
i on,</w>
i olitis</w>
i ola,</w>
i led,</w>
i le-cuneate,</w>
i le,</w>
i escence</w>
i es.(ABSTRACT</w>
i er's</w>
i er
ier i</w>
i enz
ienz a"</w>
i ences</w>
i emia</w>
i emia),</w>
i ed:</w>
i ed/
ied/ overactive</w>
i ed.
ied. Suggestions</w>
i e.,</w>
i atrogen
iatrogen ic,</w>
i atric
iatric a</w>
i ations</w>
i ants</w>
i al-
ial- resistant</w>
i RP
iRP 1),</w>
i NOS-
iNOS- protein</w>
i NO,</w>
i NO
iNO S.</w>
i Glu
iGlu Rs</w>
i CGRP</w>
i 2</w>
i 2,</w>
i 1,</w>
i /ml)</w>
i /
i/ section;</w>
i (11),</w>
hyth mia,</w>
hyth m</w>
hysterosalping ography:</w>
hysterosalping ogram,</w>
hysterectom ies</w>
hysterectom ies,</w>
hystere sislike</w>
hystere sis.</w>
hystere sis,</w>
hyster otomy</w>
hyster oscopy,</w>
hyster oscopy).</w>
hyster oscopic</w>
hyster ical."</w>
hyster ia,</w>
hypoxia- sensing</w>
hypoxia- lesioned</w>
hypoxia -mediated</w>
hypoxia ,
hypoxia, --the</w>
hypox ia/reoxygenation</w>
hypox emic.</w>
hypovolaem ic;</w>
hypovolaem ic'</w>
hypovol emia.</w>
hypouric emia.</w>
hypouric aemia,</w>
hypoton y.</w>
hypoton ous,</w>
hypothyroidis m;</w>
hypothyroidis m--is</w>
hypothyroidis m--a</w>
hypothyroidis m)</w>
hypothesi zing</w>
hypothesi zes</w>
hypothesi zed.</w>
hypothesi sed.</w>
hypothesi s')</w>
hypothesi s"</w>
hypotherm y,</w>
hypotherm ia/hyperthermia,</w>
hypotherm ia).</w>
hypother mic.</w>
hypothe tical.</w>
hypothe ses:</w>
hypothalamus- pituitary-adrenal</w>
hypothalamo- pituitary-testicular</w>
hypothalamo- pituitary-gonadal</w>
hypothalamo- hypophysial-
hypothalamo-hypophysial- ovarian</w>
hypothalamo- hypophyseal</w>
hypothalamic- releasing</w>
hypothalamic- pituitary-thyroid</w>
hypothalamic- pituitary-testicular</w>
hypothalamic- limbic</w>
hypothalam us)</w>
hypothalam ic/pre-optic</w>
hypotestosteron emia.</w>
hypotestosteron em
hypotestosteronem ia.(ABSTRACT</w>
hypotension/ dizziness,</w>
hypotension/ bradycardia,</w>
hypotension- inducing</w>
hypotension [2]</w>
hypotension ?</w>
hypotension .4.</w>
hypotension .2.</w>
hypotension ).
hypotension). 8.</w>
hypoten tion</w>
hypoten soid</w>
hypoten sives.</w>
hypoten sive/bradycardic</w>
hypoten sive.</w>
hypoten sions,</w>
hypot rophic</w>
hypot el
hypotel orism,</w>
hypospadi as.</w>
hypospadi a</w>
hypos thenuria,</w>
hypos thenia,</w>
hypos mia</w>
hypos mia.</w>
hyporen inemic</w>
hypoprote inemia;</w>
hypopituit rism</w>
hypopituit aris
hypopituitaris m)</w>
hypophys ectomy.</w>
hypophys ectomy,</w>
hypophys ectomized,</w>
hypophy sis,</w>
hypophosphat emia:</w>
hypophosphat aemia</w>
hypoparathyro id</w>
hypop yon</w>
hypop igmented</w>
hyponatra emic</w>
hyponatra emia/
hyponatraemia/ SIADH.</w>
hyponat ruria,</w>
hypomethyl ated,</w>
hypoman ic.</w>
hypoman ia:</w>
hypomagnesem ia--hypercalciuria</w>
hypomagnes aemia.</w>
hypomagne semic-related</w>
hypomagne semic,</w>
hypom obility,</w>
hypom imia,</w>
hypolip emic</w>
hypolip em
hypolipem iants</w>
hypokine sis</w>
hypokine sis.</w>
hypokine sia/rigidity</w>
hypokine sia-rigidity</w>
hypokalem ic-induced</w>
hypokalem ia-dependent.</w>
hypokalem ia-associated</w>
hypokal aem
hypokalaem ia-induced</w>
hypoinsul inemia.</w>
hypogonadis m:</w>
hypoglyce mia;</w>
hypogly caemic</w>
hypoestrogen ism</w>
hypoestrogen ism.</w>
hypoestrogen ism,</w>
hypoesthe sia:</w>
hypoesthe sia,</w>
hypoesthe sia),</w>
hypocontrac tility</w>
hypocontrac tile</w>
hypochond rium</w>
hypochond ria,</w>
hypocholesterol aemic</w>
hypochol inergic</w>
hypocapn ia;</w>
hypocapn ia),</w>
hypocap nic.</w>
hypocalci uria.</w>
hypocalci uria,</w>
hypocalce mia;</w>
hypocalce mia-induced</w>
hypocal caemic</w>
hypocal caemia,</w>
hypoc oagulability.</w>
hypoc itruria</w>
hypoalgesi a)</w>
hypoalgesi a).</w>
hypoaldosteron ism.</w>
hypoaldosteron ism,</w>
hypoalbum inemia)</w>
hypo- pigmented.</w>
hypo- osmolar</w>
hypo- locomotion</w>
hypo- glutamatergic</w>
hypo zincaemia</w>
hypo thyroid,</w>
hypo thyroid)</w>
hypo thetic</w>
hypo thermal</w>
hypo thelia</w>
hypo thalmic-pituitary-adrenal</w>
hypo reflexia,</w>
hypo reactivity</w>
hypo reactivity:</w>
hypo proliferative</w>
hypo prolactinemic</w>
hypo prolactinemia.</w>
hypo prolactinemia)</w>
hypo plastic,</w>
hypo plasia).</w>
hypo pharynx</w>
hypo pharyngeal</w>
hypo osmolality)</w>
hypo locomotor</w>
hypo locomotion,</w>
hypo intense</w>
hypo geu
hypogeu sia.</w>
hypo genesis</w>
hypo fraction
hypofraction ation,</w>
hypo dopaminerg
hypodopaminerg ia.</w>
hypo dipsia</w>
hypo diploid</w>
hypo density,</w>
hypo densities</w>
hypo attenuating</w>
hypo agenesis</w>
hypo aesthesia</w>
hypo adrenal
hypoadrenal ism,</w>
hypo acu
hypoacu sis</w>
hypo a
hypoa idosteronism.</w>
hypo X</w>
hypo /
hypo/ hyper
hypo/hyper tyroidi,</w>
hypno tic:</w>
hypno sis;</w>
hypno sis)</w>
hypno sis),</w>
hyph ema</w>
hyph em
hyphem as.</w>
hypervol emic,</w>
hypervol aemia</w>
hypertrophy .(ABSTRACT</w>
hypertroph y-responsive</w>
hypertroph y-associated</w>
hypertroph ied/overactive</w>
hypertroph ied,</w>
hypertroph ic.</w>
hypertriglycerid aemia</w>
hypertriglycerid aemia.</w>
hypertriglycerid aem
hypertriglyceridaem ia;</w>
hyperton us,</w>
hyperton icity,</w>
hyperthyrox inemia.</w>
hyperthyrox inemia,</w>
hyperthyroidis m;</w>
hyperthyroidis m),</w>
hyperther mic,</w>
hyperther mia;</w>
hyperther mia--two</w>
hyperther mia)</w>
hypertension- thrombocytopenia,</w>
hypertension- prone</w>
hypertension+ normoglycemia.</w>
hypertension+ diabetes</w>
hypertension ."</w>
hypertension --a</w>
hypertension --
hypertension-- either</w>
hypertension ),</w>
hypertension '</w>
hypertension '.</w>
hypertensin ogenicity</w>
hypertensin ogenic'</w>
hypertensi ve;</w>
hypertensi ve-associated</w>
hyperten tion.</w>
hyperten sion-inducing</w>
hypertelor ism</w>
hypertelor ism,</w>
hypersplen ism</w>
hypersplen ism,</w>
hypersomn ulence,</w>
hypersomn ia,</w>
hypersensitivity- like</w>
hypersensitivity ."</w>
hypersensitivity ")</w>
hypersensitiv ity;</w>
hypersensitiv ity'</w>
hypersensi tivities,</w>
hyperren inism,</w>
hyperren inemic</w>
hyperren inemic,</w>
hyperren inemia.</w>
hyperpyrex ic.</w>
hyperpyrex ia.</w>
hyperprolactine mia;</w>
hyperprolactine mia-induced</w>
hyperprolactine mia)</w>
hyperprolactine mia).</w>
hyperprolactin aemia:</w>
hyperprolactin aem
hyperprolactinaem ic.</w>
hyperpolar ization,</w>
hyperplasi as)</w>
hyperplasi a-inducing</w>
hyperphosphat aemia.</w>
hyperparathyroidis m)</w>
hyperp nea</w>
hyperoxal uric</w>
hyperoxal uria,</w>
hypernat remic</w>
hypernat remia.</w>
hypernat raemia.</w>
hypermagnesi uria,</w>
hypermagne semic</w>
hypermagne semia,</w>
hyperlipoprote inemias.</w>
hyperlipide mia:</w>
hyperlip emia</w>
hyperlactat emia</w>
hyperlactat aem
hyperlactataem ia/lactic</w>
hyperkine tic,</w>
hyperkine sia;</w>
hyperkine sia:</w>
hyperkalaem ia/rhabdomyolysis-a</w>
hyperkalaem ia-induced</w>
hyperkalaem ia)</w>
hyperkal uria,</w>
hyperkal iemia),</w>
hyperkal ema</w>
hyperinsul inaemic</w>
hyperinsul inaemia</w>
hyperhomocyste inemia</w>
hyperhomocyste inemia.</w>
hyperhid rosis.</w>
hyperglyce mic,</w>
hyperglyc inemia.</w>
hyperglyc inaemia</w>
hyperglyc inaemia:</w>
hypergly caemia.</w>
hypergly ca
hyperglyca em
hyperglycaem ia-provoking</w>
hypergammaglobul inemia</w>
hypergammaglobul inemia,</w>
hypergammaglobul inaemia).</w>
hyperexcit atory</w>
hyperexcit ation</w>
hyperexcit ation,</w>
hyperexcit able</w>
hyperexcit abil
hyperexcitabil ity--myoclonic</w>
hypereosinophil ic</w>
hypereosinophil ia--to</w>
hyperem ia.(ABSTRACT</w>
hyperech ogenicity</w>
hyperech ogenicity.</w>
hypere mic)</w>
hypere mesis</w>
hypercortisol emic</w>
hypercoagul able,</w>
hyperchrom ic</w>
hyperchrom atic.</w>
hypercholesterol emia)</w>
hypercarb ic.</w>
hypercarb ia</w>
hypercapn ia)</w>
hypercapn ia),</w>
hypercap nic</w>
hypercap nea,</w>
hypercalci uric.</w>
hypercalci uria;</w>
hypercalci uria.Normocalcemic</w>
hypercalce mic.</w>
hypercalce mia-related</w>
hypercalce mia)</w>
hypercal oric</w>
hypercal caemic</w>
hyperbilirub inuria</w>
hyperbilirub inemic</w>
hyperbilirub inaemic</w>
hyperbilirub inaemia</w>
hyperbilirub inaemia.</w>
hyperbilirub inaemia,</w>
hyperandrogen ism</w>
hyperamylas emia</w>
hyperamylas emia)</w>
hyperamylas aemia</w>
hyperamylas aemia,</w>
hyperammon iemia</w>
hyperammon emia:</w>
hyperalim ent
hyperaliment ation,</w>
hyperalgesi c,</w>
hyperalgesi c)</w>
hyperalgesi as</w>
hyperalgesi a/
hyperalgesia/ allodynia</w>
hyperalgesi a.
hyperalgesia. We</w>
hyperalgesi a-related</w>
hyperalgesi a--a</w>
hyperalgesi a'</w>
hyperaldosteron sim</w>
hyperaldosteron emia</w>
hyperal er
hyperaler tness,</w>
hyperactiv ity?</w>
hyperactiv ity.(ABSTRACT</w>
hyperactiv ity).</w>
hyperactiv ity),</w>
hyperactiv ity'</w>
hyper- uricosuria.</w>
hyper- responsivity.</w>
hyper- responsiveness.</w>
hyper- responsive,</w>
hyper- reflexia.</w>
hyper- reactivity)</w>
hyper- prolactinemic</w>
hyper- prolactinaemia,</w>
hyper- osmolar</w>
hyper- locomotor</w>
hyper- locomotion.</w>
hyper- locomotion,</w>
hyper- expressed</w>
hyper- excitatory</w>
hyper- excitability</w>
hyper- estrogen
hyper-estrogen emia</w>
hyper- echogenicity</w>
hyper- dopaminergic</w>
hyper- aggregability</w>
hyper- IgM</w>
hyper vigilance</w>
hyper ventilating</w>
hyper vascular</w>
hyper variable</w>
hyper vagotonia,</w>
hyper tricosis,</w>
hyper transfusion</w>
hyper transaminemia</w>
hyper transaminasemia,</w>
hyper thyroid-related</w>
hyper thyroid,</w>
hyper thymia.</w>
hyper themia</w>
hyper synchrony</w>
hyper synchrony,</w>
hyper stimulation,</w>
hyper sexuality.</w>
hyper sensory</w>
hyper sensitivities</w>
hyper segmented</w>
hyper responsive.</w>
hyper reflexive.</w>
hyper pyretic</w>
hyper pyerexia</w>
hyper prolactin</w>
hyper prolactimemia</w>
hyper proLactinaemia</w>
hyper pro-lactinemic</w>
hyper plesia</w>
hyper plastic/dysplastic</w>
hyper pigmented</w>
hyper phosphotemia,</w>
hyper perfusion</w>
hyper perfusion;</w>
hyper parathormonemia</w>
hyper oxic</w>
hyper ostosis,</w>
hyper osmotic</w>
hyper osmolarity,</w>
hyper osmolar,</w>
hyper osmolality:</w>
hyper opia</w>
hyper nociception.</w>
hyper nephromas</w>
hyper motility;</w>
hyper motility.</w>
hyper methylation,</w>
hyper metabolism.</w>
hyper metabolism,</w>
hyper magnesuria,</w>
hyper macroglobulinemia.</w>
hyper locomotive</w>
hyper locomotion.</w>
hyper lipedemic,</w>
hyper leptinemia</w>
hyper keratotic-type</w>
hyper keratosis</w>
hyper keratosis,</w>
hyper irritability</w>
hyper irritability,</w>
hyper intensive</w>
hyper intensities.</w>
hyper intense.</w>
hyper innervation</w>
hyper inhibition</w>
hyper hydro
hyperhydro sis</w>
hyper hydration.</w>
hyper hydration,</w>
hyper histamine
hyperhistamine mia,</w>
hyper gonad
hypergonad otropic</w>
hyper glycer
hyperglycer idemic</w>
hyper glucagon
hyperglucagon emia.</w>
hyper globul
hyperglobul inemia,</w>
hyper function</w>
hyper function.</w>
hyper fibrinogen
hyperfibrinogen emia,</w>
hyper cortic
hypercortic ism,</w>
hyper contraction</w>
hyper cholest
hypercholest ere
hypercholestere mia.</w>
hyper chlor
hyperchlor aemia,</w>
hyper cellularity.</w>
hyper catecholaminergic</w>
hyper catabolism</w>
hyper bicarbonat
hyperbicarbonat emia.</w>
hyper arousal</w>
hyper aminoaciduria</w>
hyper alo
hyperalo dosteron
hyperalodosteron ism,</w>
hyper allergic</w>
hyper aggression.</w>
hyper aggregation</w>
hyper aemic</w>
hyper adrenergic-induced</w>
hyper activity)</w>
hyper activities</w>
hyper activities.</w>
hyper activation,</w>
hyper acetylation</w>
hyper CK
hyperCK aemia</w>
hype resthesias</w>
hype resthesia.</w>
hype responsiveness</w>
hyp ocortisolaemia</w>
hyp ochondria</w>
hyp ochloridemia</w>
hyp ochloremia,</w>
hyp esthe
hypesthe sia,</w>
hyp ear
hypear lgesia</w>
hyp algesia</w>
hyosc ine)</w>
hygi ene.</w>
hydroxyure a:</w>
hydroxyure a)</w>
hydroxyure a's</w>
hydroxyphenyl)- N-n-propyl
hydroxyphenyl)-N-n-propyl piperidine]</w>
hydroxynaphtho ate</w>
hydroxynaphtho ate.</w>
hydroxylase- reactive</w>
hydroxylase- negative</w>
hydroxylase- immunoreactivity</w>
hydroxylase- immunoreactive</w>
hydroxylase- containing</w>
hydroxyl- containing</w>
hydroxyl- amine</w>
hydroxyl- 2,2,6,6-tetramethylpiperidine-1-oxyl</w>
hydroxyl ators</w>
hydroxyl ation,</w>
hydroxyl ase.</w>
hydroxyl ase-</w>
hydroxyl ase)</w>
hydroxyl ase),</w>
hydroxyl ase
hydroxylase -1;</w>
hydroxyfas udil-</w>
hydroxyfas udil,</w>
hydroxyethyl )</w>
hydroxyeicosa- (5E-9,11,13
hydroxyeicosa-(5E-9,11,13 Z)-tetraenoic</w>
hydroxyeicos atrienoic</w>
hydroxychloroquine-plus- piroxicam.</w>
hydroxyc am
hydroxycam ptothecin</w>
hydroxybut yric</w>
hydroxyapati te.</w>
hydroxy-3-[4- [(2-
hydroxy-3-[4-[(2- hydroxy
hydroxy-3-[4-[(2-hydroxy phenyl)piperazin-1-yl]propyl]pyrrolidin-2-one</w>
hydroxy-3-[4- [
hydroxy-3-[4-[ 1-methyl-4-
hydroxy-3-[4-[1-methyl-4- (trifluoro
hydroxy-3-[4-[1-methyl-4-(trifluoro methyl)-1H-imidazol-2-yl]-phenoxy]propyl]-amino]ethoxy]-benzamide</w>
hydroxy-3-[4- (4-
hydroxy-3-[4-(4- phenyl-1,2,3,6-tetrahydropyridyl(1))-butyl(1)]-indole</w>
hydroxy-3- tert-butylamino)propoxy]2,3-naphthalenediol</w>
hydroxy-3- phenoxypropyl)amino)butyl</w>
hydroxy-3- methylglutaryl)</w>
hydroxy-3- methoxyphenylethylene</w>
hydroxy-3- (1
hydroxy-3-(1 ',
hydroxy-3-(1', 1'-
hydroxy-3-(1',1'- dimethylhept
hydroxy-3-(1',1'-dimethylhept yl)-6H-benzo[c]chromene-6-one),</w>
hydroxy-2- quinoxalinecarboxylic</w>
hydroxy-2- pyrrolidinone)</w>
hydroxy-2- propoxy)methylguanine,</w>
hydroxy-2- phenyl-cyclohexanecarboxylic</w>
hydroxy-2- nonenal</w>
hydroxy-2- imino-4-piperidinopyrimidine)</w>
hydroxy-2- (4-
hydroxy-2-(4- cyano
hydroxy-2-(4-cyano phenyl)ethyl]-</w>
hydroxy- urea</w>
hydroxy- propyl]</w>
hydroxy- propyl]-3,3-diphenylpyrrolidin-2-one</w>
hydroxy- phenylglycol</w>
hydroxy- nomifensine)</w>
hydroxy- carbamazepine</w>
hydroxy- N'-
hydroxy-N'- (4-
hydroxy-N'-(4- butyl-
hydroxy-N'-(4-butyl- 2-methyl
hydroxy-N'-(4-butyl-2-methyl phenyl)</w>
hydroxy- 5-
hydroxy-5- [2-
hydroxy-5-[2- [[2-
hydroxy-5-[2-[[2- hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]-phenoxy]propyl]-amino]ethoxy]-benzamide</w>
hydroxy- 5
hydroxy-5 (4'-chloro
hydroxy-5(4'-chloro phenyl)-2,</w>
hydroxy- 4-
hydroxy-4- (1,
hydroxy-4-(1, 1-
hydroxy-4-(1,1- dimethylhept
hydroxy-4-(1,1-dimethylhept yl)phenyl]-trans-4-(3-hydroxypropyl)-cyclohexanol)</w>
hydroxy- 3-</w>
hydroxy- 24-
hydroxy-24- OXO
hydroxy-24-OXO -16ene-vitamin</w>
hydroxy zine:</w>
hydroxy zine.</w>
hydroxy triamterene</w>
hydroxy triamterene.</w>
hydroxy triamterene,</w>
hydroxy salcofen</w>
hydroxy prostaglandin</w>
hydroxy propylidene-1,1-bisphosphonate</w>
hydroxy propyl]-pyrrolidin-2-one</w>
hydroxy propyl</w>
hydroxy phenylalanine),</w>
hydroxy phenylacetic</w>
hydroxy phenethyleneglycol</w>
hydroxy flutamide</w>
hydroxy flutamide,</w>
hydroxy ethyl]-2-
hydroxyethyl]-2- [(3
hydroxyethyl]-2-[(3 S,
hydroxyethyl]-2-[(3S, 5
hydroxyethyl]-2-[(3S,5 S)-
hydroxyethyl]-2-[(3S,5S)- 5
hydroxyethyl]-2-[(3S,5S)-5 (S-
hydroxyethyl]-2-[(3S,5S)-5(S- methyl-4thiomorpholin</w>
hydroxy cortisone</w>
hydroxy cholecalciferol.</w>
hydroxy chlorpromazine</w>
hydroxy chloroqu
hydroxychloroqu ine).</w>
hydroxy carb
hydroxycarb amide.</w>
hydroxam ates.</w>
hydrox ystearate</w>
hydrox ypyridine</w>
hydrox iphenylacetic</w>
hydrox ide),</w>
hydroureteroneph rosis.</w>
hydroureteroneph rosis,</w>
hydroure tronephrosis.</w>
hydrophil icity,</w>
hydrophil ic-hydrophobic</w>
hydroperoxide s)</w>
hydroperoxide s).</w>
hydroperoxide s),</w>
hydropen ic</w>
hydronephro ses</w>
hydromorph one-treated</w>
hydromorph one-3-glucoronide,</w>
hydromorph one).</w>
hydroly sis)</w>
hydroly sed</w>
hydroly se</w>
hydrolas es,</w>
hydrolas e.</w>
hydrolas e-
hydrolase- expressing</w>
hydrolas e)</w>
hydrogen ated)</w>
hydrogen -
hydrogen- potassium</w>
hydrocortis one-induced</w>
hydrocortis one--a</w>
hydrocod one-related</w>
hydrochlorothiazide- triamterene.</w>
hydrochlorothiazide- spironolactone)</w>
hydrochlorothiazide- enalapril</w>
hydrochlorothiazide- enalapri
hydrochlorothiazide-enalapri l-alpha</w>
hydrochlorothiaz ide;</w>
hydrochlorothiaz ide-</w>
hydrochloride }</w>
hydrochloride ],</w>
hydrochloride --a</w>
hydrochloride ).</w>
hydrochloride )-treated</w>
hydrochloride )-induced</w>
hydrochloride (EPI).</w>
hydrochlor idum</w>
hydrochlor idine</w>
hydrochlor ides</w>
hydrochlor ide:</w>
hydrochlor ide-maintained</w>
hydrochlor ide-associated</w>
hydrocephal y</w>
hydrocephal y.</w>
hydro zide</w>
hydro quinone,</w>
hydro quinidine</w>
hydro phobic)</w>
hydro genated</w>
hydro ethidine</w>
hydro electrolyte</w>
hydro dynamic</w>
hydro chol
hydrochol oride</w>
hydro carbons.</w>
hydro carbon)</w>
hydro bromide)</w>
hydro brom
hydrobrom ide]),</w>
hydro -
hydro- methanolic</w>
hydraz ine-treated</w>
hydraz ide-induced</w>
hydraz ide,</w>
hydration- ketorolac</w>
hydration- alkalisation</w>
hydram ine,</w>
hydr ylethane-1,2-diamine</w>
hydr inate</w>
hydr ation;</w>
hydantoin ),</w>
hydanto ins</w>
hydanto in-induced</w>
hydanto in,</w>
hyd ria.</w>
hyd rating</w>
hyd onoylglycerol</w>
hyd antion</w>
hybridiz ation;</w>
hybridis ation.</w>
hybri dized</w>
hybri d,</w>
hybri d"</w>
hyaluron ate.</w>
hyal inosis/sclerosis</w>
hyal ine.</w>
hyal ine,</w>
hy tm</w>
hy roxyphenylglycol</w>
hy er
hyer bilirubinemia</w>
hy doxy
hydoxy tryptamine</w>
hy ar
hyar as
hyaras ay
hyarasay an
hyarasayan as</w>
hy a</w>
hus band.</w>
hur dle</w>
hungr y</w>
hungr y.</w>
hundred- twenty</w>
hundred- thirty</w>
hundred- eight</w>
hund redth</w>
hun ger</w>
human in</w>
human -specific</w>
human )</w>
hum ps)</w>
hum p-like.</w>
hum ane
humane ly</w>
huPBL- SCI
huPBL-SCI D)</w>
hu an</w>
hu EPO)</w>
hs PDA</w>
hs PDA,</w>
hr/ m2</w>
hr us)</w>
hr s;</w>
hr s);</w>
hr SEM</w>
hr SEM)</w>
hr -P
hr-P MS
hr-PMS F,</w>
hr -M
hr-M ipafox,</w>
hr -1).</w>
hr -
hr- duration.</w>
hr (-1)</w>
hr (-1))</w>
hr (-1)),</w>
howe ver).</w>
hous ing.</w>
hour- obstructed</w>
hour s]),</w>
hour s/day</w>
hour s/day,</w>
hour s--1</w>
hour ly.</w>
hour ly,</w>
hour ly)</w>
hour ]</w>
hour :</w>
hour ).</w>
hou se.</w>
hotpl ate-induced</w>
hotpl ate)</w>
hot line</w>
hot '</w>
host- specific</w>
host- protective</w>
host- defensi
host-defensi ve,</w>
host :</w>
hospitalis ations.</w>
hospital- years).</w>
hospital- affiliated</w>
hospital- acquired</w>
hospital ized;</w>
hospital ization)</w>
hospital ization),</w>
hospital -treated</w>
hospital 's</w>
hospit a
hospita Ls</w>
hos tility.</w>
hos tile</w>
hos tile-suspiciousness,</w>
hos pice.</w>
hormone- secreting,</w>
hormone- retardive</w>
hormone- replacement</w>
hormone- refractory,</w>
hormone- like</w>
hormone- large</w>
hormone- dependent.</w>
hormone- deficient</w>
hormone- cyclic</w>
hormone- associated</w>
hormon otherapy).</w>
hormon omodulator</w>
hormon es:</w>
hormon es)</w>
hormon e-</w>
horizont ally-
horizontally- orientated</w>
horizont al,</w>
hor se--a</w>
hor rea,</w>
hor n;</w>
hor n-CA1,</w>
hor n)</w>
hor ioamnionitis</w>
hor ic</w>
hop ping.</w>
hop ping,</w>
hop ing</w>
hop el
hopel essness</w>
hoo ks</w>
homozygot es)</w>
homozyg ous)</w>
homovan illuc</w>
homota urinate)</w>
homologu e.</w>
homologu e)</w>
homolog ous)</w>
homogene ous.</w>
homogene ous,</w>
homogene ity</w>
homogene ity);</w>
homogen ization</w>
homogen ate)</w>
homogen ate"</w>
homocyste ine:</w>
homocyste ine.</w>
homo sexuality</w>
homic ides,</w>
homic ide.</w>
homeost asia.</w>
homeost asi
homeostasi s;</w>
home- maintenance</w>
home ostat.</w>
hom otransplantation</w>
hom opiperidinyl)eth</w>
hom ophilic</w>
hom onas</w>
hom omeric</w>
hom ology,</w>
hom ocystinuria</w>
hom ocorticosteroid,</w>
hom ing</w>
hom icide</w>
hom icide,</w>
hom es.</w>
hom atropine,</w>
hom a,</w>
holiday )</w>
holiday '
holiday' '.</w>
holid ay,</w>
hol ster</w>
hol est
holest atic</w>
hol e:</w>
hodgkins ine.</w>
hodgkins ine-induced</w>
hodgkins ine's</w>
hoarsen ess,</w>
ho ver)</w>
ho sts</w>
ho p</w>
ho ok</w>
ho kawa's</w>
ho ice</w>
ho g</w>
ho 123)</w>
hn )</w>
hmt 2)</w>
hloro ethylene</w>
hlor inase</w>
hlor hex
hlorhex amed</w>
histor y;</w>
histor y-taking</w>
histor y)</w>
histor y).</w>
histor ical-controlled</w>
histor ical-</w>
histoplasmo sis</w>
histoplasmo sis.</w>
histoplasmo sis,</w>
histopath ology:</w>
histopath ology)</w>
histopath ological,</w>
histopath ologic,</w>
histopath alo
histopathalo g
histopathalog ical</w>
histomorph ometry</w>
histomorph ometry.</w>
histomorph ology.</w>
histoly ticum.</w>
histoly tica,</w>
histolog y;</w>
histolog y-proven</w>
histolog y);</w>
histo grams,</w>
histo fluorescence</w>
histo enzymatic</w>
histo autoradiographic</w>
histi ocytoma,</w>
histi ocytic/lymphocytic</w>
histi dinol</w>
histaminerg ics</w>
histaminerg ics-induced</w>
histaminerg ic-noradrenergic</w>
histamine- release</w>
histamine- challenged</w>
histamine- N-methyl</w>
histamine- 3</w>
histamine- 2</w>
histamine 2-receptor</w>
histamine 2-
histamine2- antagonists;</w>
histamine 1</w>
histamin ic</w>
histamin ergic,</w>
hist otoxic-induced</w>
hist opath</w>
hist ones),</w>
hist omorphological</w>
hist ologies</w>
hist ological;</w>
hist ograms</w>
hist ogram</w>
hist ogenesis,</w>
hist ocytosis,</w>
hist ocytic</w>
hist ocompatible</w>
hist ochemistry)</w>
hist ochemically,</w>
hist o-morphometric</w>
hist ine</w>
hist aminop
histaminop exic</w>
hist amine),</w>
his sing</w>
his cence</w>
hirsu tismus</w>
hir udin;</w>
hippocampus ]</w>
hippocampus .(ABSTRACT</w>
hippocampus );</w>
hippocampi i</w>
hippocamp us-related</w>
hippocamp us).</w>
hippocamp al-induced</w>
hippocamp al,</w>
hippocamp al)</w>
hipp uran</w>
hipp c
hippc amp
hippcamp al</w>
hipp any,</w>
hindquarter ,</w>
hind- paw</w>
hind- leg</w>
hind paw,</w>
hind paw)</w>
hind limbs.</w>
hind limb,</w>
hind leg</w>
hind leg.</w>
hind foot</w>
hin ts</w>
hin d.</w>
him otsuto,</w>
him achal
himachal ol.</w>
him .</w>
hilus= 70.6</w>
hilus= 59.
hilus=59. 08</w>
hilus= 43.8</w>
hilus .
hilus. These</w>
hil us)</w>
hil ips</w>
hik unshito,</w>
highligh ted,</w>
higher- intensity</w>
higher- frequency</w>
highe st-dose</w>
high- yield</w>
high- voltage-activated</w>
high- voltage,</w>
high- titred</w>
high- titered</w>
high- stimulation</w>
high- signal</w>
high- sensitive</w>
high- risk"</w>
high- responder</w>
high- responder.</w>
high- purity</w>
high- progesterone</w>
high- profile</w>
high- preferring</w>
high- pitched</w>
high- normal,</w>
high- molecular</w>
high- lights</w>
high- lighted</w>
high- intensive</w>
high- fructose</w>
high- firing-frequency</w>
high- fidelity</w>
high- fat,</w>
high- dose)</w>
high- dopamine</w>
high- dobutamine</w>
high- diameter</w>
high- confidence</w>
high- calcium</w>
high- attenuation</w>
high- arched</w>
high- arched,</w>
high- affinity,</w>
high ly-selective</w>
high ly,</w>
high er;</w>
high er:</w>
high er/
higher/ ED
higher/ED 50
higher/ED50 lower)</w>
high er)</w>
high er),</w>
high dose</w>
high ',</w>
high ")</w>
hid roepiandrosterone,</w>
hid den
hidden "</w>
hiccup ing,</w>
hic hever</w>
hic cough)</w>
hib er
hiber nating"</w>
hib a</w>
hi ves</w>
hi ve</w>
hi t</w>
hi ps,</w>
hi ponatremia</w>
hi poacusia.</w>
hi jacks</w>
hi fts</w>
hi atus</w>
hi at
hiat us,</w>
hi a:</w>
hi -squ
hi-squ are)</w>
hexyl carbam
hexylcarbam yl-5-fluorouracil),</w>
hexobarbit al.</w>
hexo ses,</w>
hexo semonophosphate</w>
hexo kinase</w>
hexane-2,6- dicarboxylic</w>
hexane-2,6- dicarboxylate</w>
hexane- 4,6-
hexane-4,6- dicarboxyl
hexane-4,6-dicarboxyl ate]</w>
hexane- 2,6,
hexane-2,6, -
hexane-2,6,- dicarboxylic</w>
hexameth yl-propyleneamine</w>
hexameth onium-treated</w>
hexameth onium-induced</w>
hexahydro sila-difenidol</w>
hexahydro cannabinol</w>
hexafluoro diethyl</w>
hexafluor o</w>
hexafluor ide).</w>
hexacos anol)</w>
hexachlorocyclohex ane,</w>
hexachloro benzene</w>
hexachlor ide</w>
hexa relin.</w>
hexa ald
hexaald onic</w>
hexa al
hexaal dose,</w>
hex yl</w>
hex itol</w>
hex eti
hexeti l)</w>
hex estro
hexestro l.</w>
hex aur
hexaur onic</w>
hex anoyl
hexanoyl taxol</w>
hex ane:</w>
hex amet
hexamet onium</w>
hex ak
hexak is</w>
hex agon
hexagon s,</w>
hex adi
hexadi methrine</w>
hex aceton
hexaceton ide,</w>
hex -5-
hex-5- enoic</w>
hev in,</w>
heterozyg ous)</w>
heterozyg otes.</w>
heterotopi as</w>
heterotopi as,</w>
heterodi mer</w>
heterodi mer.</w>
heterochrom ia</w>
heterochrom atin</w>
hetero yohimbine</w>
hetero atom</w>
hetero aggressiveness,</w>
heter ophil</w>
heter onuclear</w>
heter omers)</w>
heter ogenous,</w>
hetastarch /kg</w>
hetastarch -treated</w>
hetastarch ).</w>
heta starch)</w>
hes itation</w>
hes itate</w>
herpetiform is.</w>
herpetiform is,</w>
herpes -based</w>
herp es.</w>
heroin- using</w>
heroin- treatment</w>
heroin- overdose.</w>
hero ine.</w>
hero in:</w>
hero in-induced</w>
hero in)</w>
herni otomy</w>
herni ation
herniation --an</w>
herni ated</w>
herit able,</w>
herit ability</w>
herit ability,</w>
heren tly.</w>
here inafter</w>
here in),</w>
here dofamilial</w>
here :</w>
here )</w>
herb icides</w>
herb icide,</w>
her tz)</w>
her self</w>
her self,</w>
her ardi
herardi ,</w>
heptano ate.</w>
hepta valent</w>
hepta phylum</w>
hepta phyllum</w>
hepta phyllum,</w>
hept ylate</w>
hept amin
heptamin ol,</w>
hepcid in</w>
hepcid in,</w>
hepatotumori genesis</w>
hepatotumori genesis:</w>
hepatotoxic osis.</w>
hepatotoxic ity?</w>
hepatotoxic ity).</w>
hepatotoxic ;</w>
hepatotox ins.</w>
hepatotox in,</w>
hepatosplen omegaly</w>
hepatosplen omegaly.</w>
hepatonephro toxicity</w>
hepatonephro toxicity:</w>
hepatomegal ic</w>
hepatolith iasis.</w>
hepatocyt otoxicity</w>
hepatocyt es
hepatocytes (esp,</w>
hepatocellular- holestatic</w>
hepatocellular- cholestatic.</w>
hepatocell ular-type</w>
hepatocell ular,</w>
hepatocarcin omas.</w>
hepatocarcin oma.</w>
hepatocarcin oma-intestine-pancreas/pancreatic-associated</w>
hepatocarcin ogens</w>
hepatocarcin ogens,</w>
hepatocarcin ogenicity.</w>
hepatocarcin ogenesis:</w>
hepatocarcin ogenesis,</w>
hepatocarcin o-genesis</w>
hepatoblast omas,</w>
hepatoblast oma:</w>
hepatoblast oma.</w>
hepato- toxic</w>
hepato- renal</w>
hepato selectivity,</w>
hepato protectively</w>
hepatitis .(ABSTRACT</w>
hepatitis ."</w>
hepatitis -related</w>
hepatitis -inducing</w>
hepatitis --a</w>
hepatitis ,"</w>
hepatitis );</w>
hepatitis "</w>
hepatitis ")</w>
hepati de</w>
hepati ca</w>
hepati c-
hepatic- vein</w>
hepati c
hepatic us.</w>
hepatectom y;</w>
hepatectom y:</w>
hepat oxicity.</w>
hepat oxicity,</w>
hepat ototoxic</w>
hepat osplenic</w>
hepat oportal</w>
hepat opetal</w>
hepat oma-derived</w>
hepat oma-bearing</w>
hepat ologists</w>
hepat ologist.</w>
hepat olenticular</w>
hepat ocyte-specific</w>
hepat ocyte-derived</w>
hepat ocyte,</w>
hepat acellular</w>
heparin- thrombin</w>
heparin- like</w>
heparin- doxorubicin</w>
heparin- agarose</w>
heparin- PF4</w>
heparin- -induced</w>
heparin oid.</w>
heparin ize</w>
heparin ization.</w>
heparin ):</w>
heparan ase.</w>
hepar ins,</w>
hepar inic</w>
hepar in-treated</w>
hepar in).</w>
hepar in's</w>
hepar i</w>
hepar an-
heparan- sulfate-proteoglycan</w>
hen ylpropanolamine)</w>
hen :</w>
hemosider otic</w>
hemosider osis.</w>
hemosider osis,</w>
hemosider inuria,</w>
hemosider in</w>
hemosider in.</w>
hemosider in-laden</w>
hemorrh aging.</w>
hemorrh aged</w>
hemorrh age).</w>
hemorhe ologic</w>
hemoradi otoxicity-associated</w>
hemopty sis.</w>
hemopty sis,</w>
hemophil ic),</w>
hemop legia,</w>
hemoly zing</w>
hemoly sis;</w>
hemoglob inopathy,</w>
hemoglob in-skeletal</w>
hemodynam ics;</w>
hemodynam ic-inotropic</w>
hemodynam ic-independent</w>
hemodilution- normotension,</w>
hemodilution- hypertension,</w>
hemodilu tin</w>
hemodialy sis?</w>
hemodialy sis-requiring</w>
hemodialy sis-associated</w>
hemodialy ses</w>
hemodialy ses.</w>
hemodialy is</w>
hemoconcentr ation,</w>
hemo thorax</w>
hemo peritoneum.</w>
hemo pericardium</w>
hemo pathic</w>
hemo gram,</w>
hemo dy</w>
hemo diluting</w>
hemo diab
hemodiab sorption</w>
hemo bil
hemobil ia</w>
hemo -
hemo- dynamically,</w>
hemisuccin ate</w>
hemisuccin ate,</w>
hemisphere ).</w>
hemis ulfate,</w>
hemipleg ic,</w>
hemipleg ia)</w>
hemip legias)</w>
hemip legia.</w>
hemip legia,</w>
hemime lia</w>
hemime lia.</w>
hemil igation,</w>
hemil amin
hemilamin ectomy.</w>
hemif umarate</w>
hemif ield</w>
hemicholinium- 3;</w>
hemichol inium,</w>
hemic ranic</w>
hemic olectomy.</w>
hemic entral</w>
hemic -induced</w>
hemiball ismic</w>
hemianop sia</w>
hemianop ia.</w>
hemi- parkinsonism.</w>
hemi paresthesias</w>
hemi paresis:</w>
hemi hydrate.</w>
hemi block</w>
hemi bladders,</w>
hemi anaesthesia</w>
hemi an
hemian opic</w>
heme-L-lysin ate,</w>
heme- globin</w>
heme- bearing</w>
hematopoi ectic</w>
hematopoi e
hematopoie tic/megakaryocytopoietic</w>
hematom a/
hematoma/ patient</w>
hematom a-induced</w>
hematocrit s.</w>
hematoc rits</w>
hematoc rite</w>
hemat oxylin-</w>
hemat otoxicity.</w>
hemat otoxicity,</w>
hemat oporphyrin.</w>
hemat opolietic</w>
hemat omata</w>
hemat ology/clinical</w>
hemat ologist</w>
hemat ologist,</w>
hemat obilia</w>
hemat o-biochemical</w>
hemangioendotheli omas</w>
hem otoxylin</w>
hem otoxicity.</w>
hem otoxicities</w>
hem opoietic,</w>
hem opoetic</w>
hem olytic-uremiclike</w>
hem olysis)</w>
hem ocytometric</w>
hem ocrit,</w>
hem ochromatosis-associated</w>
hem morhagic</w>
hem izygous</w>
hem itransected</w>
hem ithorax),</w>
hem agglutination</w>
hem agglutin
hemagglutin ation,</w>
hem agglut
hemagglut inating</w>
helpless ness,</w>
helpless ness)</w>
helpless ness).</w>
help ing</w>
help fulness</w>
help ful.</w>
help ful
helpful .
helpful. (2)</w>
heloder min</w>
heloder min-produced</w>
heloder min-induced</w>
heloder min,</w>
heli x</w>
heli x,</w>
hel per-inducer</w>
hel p.</w>
hel minthic</w>
hel ley</w>
hel icobactericidal</w>
heim )</w>
heigh ts</w>
heigh t-1)</w>
hei m</w>
heel s</w>
heel -to-
heel-to- toe</w>
hedon ic"</w>
hedon ia,</w>
hed ge
hedge hog</w>
hed ding</w>
heavi er,</w>
heav y"</w>
heav iness;</w>
heav iness,</w>
heav iness)</w>
heav ily.</w>
heav es</w>
heat- selective</w>
heat- pain,</w>
heat- loss</w>
heat- hyperalgesia,</w>
heat- adapted</w>
heat stroke-related</w>
heat ing.</w>
heat -exposed</w>
heart/ kidney,vs</w>
heart- type</w>
heart- to-lung</w>
heart- failure</w>
heart- disease,</w>
heart- derived</w>
heart s.(ABSTRACT</w>
heart lung</w>
heart bur
heartbur n,</w>
heart beat),</w>
heart -</w>
heart )/
heart)/ (dpm/
heart)/(dpm/ ml</w>
heart ),</w>
heart 's</w>
heart ',</w>
hear tworms</w>
hear t).</w>
hear ing-impaired</w>
health- care-associated</w>
health y-control</w>
health y)</w>
health y'</w>
health y"</w>
health :</w>
health ),</w>
heal thier</w>
heal ed;</w>
heal ;</w>
heade dness</w>
headache/ migraine-provoking</w>
headache/ anal</w>
headache ?</w>
headache .The</w>
headache -inducing</w>
headache --
headache-- attributed</w>
headache -
headache- eliciting</w>
headache ).</w>
headache ),</w>
headach es--
headaches-- especially</w>
headach es),</w>
head-to- tail</w>
head- weaving,</w>
head- upright</w>
head- twitching</w>
head- out</w>
head- on</w>
head- lift</w>
head- fold</w>
head- focused</w>
head- co
head-co il).</w>
head- bobbing</w>
head space</w>
head s</w>
head s.</w>
head ings,</w>
head ing</w>
head /
head/ neck</w>
head -</w>
head "</w>
he uristically,</w>
he sive</w>
he re-described</w>
he phroangiography</w>
he on,</w>
he min-treated</w>
he min,</w>
he me-positive</w>
he me,</w>
he lothane-induced</w>
he jiang,</w>
he iro</w>
he i</w>
he el</w>
he el-
heel- toe</w>
he d)</w>
he ath</w>
he ated.</w>
he ar</w>
he al.</w>
he al,</w>
he ach
heach ache</w>
he )-induced</w>
hazard s.</w>
hazard s,</w>
hazar d.</w>
hazar d,</w>
hass les</w>
hass le</w>
hash ish</w>
hash ish),</w>
harvest ;</w>
harve sting</w>
harve st.</w>
harmon ically</w>
harmon ic-mean</w>
harml ess,</w>
harml ess
harmless ly</w>
harmful ?</w>
harmful ;</w>
harmal ine)</w>
harm ine-induced</w>
harm ine,</w>
harm fulness</w>
harm Check
harmCheck )</w>
harm :</w>
harb our</w>
har t</w>
har on.</w>
har nessed</w>
har ming</w>
har med</w>
har man</w>
har man.</w>
har man,</w>
har der
harder ian</w>
har d,</w>
hapten ic</w>
hapten .</w>
hapten -cell</w>
happ y</w>
happ y,</w>
happ en</w>
happ en.</w>
happ en,</w>
haplo types.</w>
haplo block,</w>
hap tens</w>
hap oA-I,</w>
hap ing</w>
hang over</w>
hang over,</w>
handic ap
handicap ,</w>
handgri p.</w>
handgri p)</w>
hand- tapping</w>
hand- injected</w>
hand- held</w>
hand- grip</w>
hand writing,</w>
hand searching</w>
hand searched</w>
hand ra</w>
hand ong</w>
hand les</w>
hand :</w>
hand ,
hand, bupropion</w>
hamster ,</w>
hampe red,</w>
hamar toma)</w>
ham strings,</w>
halothane/ nitrous</w>
halothane/ SNP</w>
halothane- specific</w>
halothane- sensitized</w>
halothane- pretreated</w>
halothane- pretreated,</w>
halothane- oxygen</w>
halothane- nitrous</w>
halothane- free)</w>
halothane- associ
halothane-associ ated-
halothane-associated- hepatitis</w>
halothane- anaesthetized</w>
halothane- O2-
halothane-O2- N2O</w>
halothane- N2O</w>
halothane- N2O-O2</w>
halothane- N2O-O2-
halothane-N2O-O2- curare</w>
halothane- ,</w>
halothane :</w>
halothane .2</w>
halothane ).</w>
halothane ),</w>
halothane 's</w>
halothane "</w>
haloperidol- scopolamine</w>
haloperidol- pretreated</w>
haloperidol- induced)</w>
haloperidol- controlled</w>
haloperidol- (D</w>
haloperidol+ NG-nitro-L-arginine:</w>
haloperidol+ 7-nitroindazole:</w>
haloperidol -dependent</w>
haloperid ol/kg</w>
haloperid o-l-</w>
haloperid al</w>
haloalk anes</w>
halo s</w>
halo periodol</w>
halo genation</w>
halo -
halo- lysergols</w>
hallucinator y-like</w>
hallucinator y).</w>
hallucinator y"</w>
hallucin ogens.</w>
hallucin ogen.</w>
hallucin ogen-characteristic</w>
hallucin ations:</w>
hallucin ations--
hallucinations-- whereas</w>
halluc is</w>
hall marks.</w>
half-li ves).</w>
half- relaxation</w>
half- receptor</w>
half- normal</w>
half- maximally</w>
half- field</w>
half- field,</w>
half- effective</w>
half- cyst
half-cyst ine</w>
half way</w>
hal ts</w>
hal ted;</w>
hal ted.</w>
hal ted,</w>
hal t.</w>
hal os)</w>
hal fl
halfl ife</w>
hal er.</w>
hair s).</w>
hair pin-like</w>
hair less.</w>
hair -induced</w>
haemorrhag es-
haemorrhages- warfarin</w>
haemorrh ages,</w>
haemorrh age:</w>
haemorrh age).</w>
haemoglob inuria.</w>
haemodilu tion;</w>
haemodilu tion).</w>
haemodialy tical</w>
haemodialy sis,</w>
haemoconcentr ation;</w>
haemoconcentr ation.</w>
haemo stasis.</w>
haemo siderosis.</w>
haemo siderosis,</w>
haemo philus),</w>
haemo philia.</w>
haemo perfusion/plasmaperfusion</w>
haemo perfusion.</w>
haemo pathological</w>
haemo filter.</w>
haemo -
haemo- concentration</w>
haematob ium.</w>
haemat uria)</w>
haemat omas,</w>
haemat oma:</w>
haemat ology</w>
haemat ocrit.</w>
haemat ochemical</w>
haemat ocele.</w>
haem orrage,</w>
haem opoietic</w>
haem olysis:</w>
haem olysis)</w>
haem olysing</w>
haem ocyanin</w>
haem e</w>
haem .</w>
habit us.</w>
habit us,</w>
habil itation,</w>
haben ulo-interpeduncular</w>
haben ula).</w>
hab it.</w>
ha v.</w>
ha ustion</w>
ha stening</w>
ha im)</w>
ha iled</w>
ha i-Hu-Gui-Zhi-Gan-Jiang-Tang</w>
ha i,</w>
ha hran</w>
ha el
hael is-Menten</w>
ha e
hae ophyceae)</w>
hPA SM
hPASM C</w>
hPA EC</w>
hG H-
hGH- producing</w>
hERG- trafficking</w>
hERG- blocking</w>
hB SEP</w>
hB NP.</w>
h/ session)</w>
h/ rat)</w>
h/ patient).</w>
h/ mm3</w>
h/ ml.</w>
h/ min;</w>
h/ mL,</w>
h/ lh),</w>
h/ l</w>
h/ l,</w>
h/ day;</w>
h/ day,</w>
h/ d</w>
h.p.f .,</w>
h.p.f .)</w>
h- receptor.</w>
h- prBCM</w>
h- period</w>
h- endorphin</w>
h- SOD1</w>
h x</w>
h x4</w>
h u</w>
h ttp://www.clinicaltrials.gov</w>
h thoff's</w>
h ta</w>
h relin</w>
h oxa2</w>
h ousewife</w>
h ounds</w>
h ounds.</w>
h on</w>
h me</w>
h l-S)</w>
h it,</w>
h it'</w>
h inges</w>
h ine)</w>
h ide</w>
h f</w>
h ering</w>
h er.</w>
h eno
heno yl-1-beta-D-arabinofuranosyl</w>
h ectic</w>
h dad</w>
h as
has a</w>
h arg
harg ava</w>
h and/
hand/ wrist.</w>
h amp
hamp er</w>
h ame
hame olysis</w>
h am,</w>
h TERT</w>
h PF4,</w>
h NTS2.</w>
h NTS1</w>
h NT
hNT S2</w>
h LF</w>
h C
hC G-
hCG- stimulated</w>
h BSEP-
hBSEP- expressing</w>
h AN
hAN a
hANa P)</w>
h 7</w>
h /kg</w>
h .(ABSTRACT</w>
h -1).</w>
h -1),</w>
h );</w>
h )-1
h)-1 ].</w>
h (p<0.01)</w>
h (1)</w>
h (-1));</w>
h (-1)).</w>
gyr us--were</w>
gyr us),</w>
gyr i</w>
gypt i</w>
gynecomasti a/
gynecomastia/ breast</w>
gynec ologist</w>
gynaec omastia.</w>
gynaec ologist</w>
gym nasium.</w>
gym .</w>
gy ri,</w>
gut ta-percha)</w>
gun .</w>
guinea- pigs.5.</w>
guinea- pigs,</w>
guide wires,</w>
guide wire,</w>
guide lines:</w>
guarante es</w>
guar ded.</w>
guar ded,</w>
guar ana
guarana -derived</w>
guanoxabenz .</w>
guanosine-5'- [beta-
guanosine-5'-[beta- thio]</w>
guanosine-5'- [
guanosine-5'-[ gamma-
guanosine-5'-[gamma- thio]triphosphate</w>
guanosine- positive</w>
guanosine- 5'-O-(2-thiodiphosphate),</w>
guanine- nucleotide-binding</w>
guanine- alkylating</w>
guanidinosuccin ate.</w>
guanidinosuccin ate-evoked</w>
guanidinosuccin ate,</w>
guanid ino</w>
guanid ine;</w>
guaneth idine-evoked</w>
guanabenz ,</w>
guan ylyl,</w>
guan inosine</w>
guan idoacetate</w>
guan ide</w>
gu statory-affective</w>
gu minosae)</w>
gu ing</w>
gu illain-barre</w>
gu ides</w>
gu ianensis</w>
gu atox
guatox in:</w>
gu ards</w>
gu arding,</w>
gu an,</w>
gu aifen
guaifen es
guaifenes in-thiobarbiturate-halothane</w>
growth- retarded</w>
growth- inhibiting</w>
growth -</w>
grow ths</w>
grow s</w>
grow n.</w>
grow n,</w>
grow ing.</w>
grow .</w>
groups-- normal</w>
groups-- non-responders</w>
groups-- control</w>
groups-- 7,</w>
groups ];</w>
groups :1)</w>
groups (G
groups(G F</w>
group-- 7</w>
group- randomized</w>
group- level</w>
group- comparative</w>
group- -14</w>
group sipsilateral</w>
group s].</w>
group s.The</w>
group ing.</w>
group ]</w>
group ].</w>
group ],</w>
group .It</w>
group -2</w>
group ,"</w>
group )=
group)= 37.
group)=37. 905,</w>
gross ly,</w>
groom ing.</w>
groom ing-inducing</w>
groo ve.</w>
grommet s.</w>
gro oves"</w>
gro in,</w>
gro cer
grocer y</w>
griseofulv in-fed</w>
griseofulv in-exacerbated</w>
grimac ing</w>
grimac ing,</w>
grimac e</w>
gri seus).</w>
gri seofulvin(GF)</w>
gri pping</w>
gri p-lift</w>
gri p,</w>
gri m</w>
grepa floxacin</w>
gren s</w>
greml in.</w>
grel :</w>
great est.</w>
great er;</w>
great er-than-
greater-than- or-equal</w>
great er)</w>
great .</w>
great ,</w>
gre yness</w>
gre y,</w>
gre y);</w>
gre tol)-induced</w>
gre ately</w>
gray- spinal</w>
gravis -
gravis- polymyositis</w>
gravid arum,</w>
gravid a"</w>
grav ity.</w>
grati f
gratif yingly</w>
gras per</w>
gras p</w>
gras -like</w>
graph ically-defined</w>
graph ically,</w>
graph er</w>
granzyme B</w>
granzyme B
granzymeB +</w>
granulomat a</w>
granulomat a.</w>
granulomat a,</w>
granulocy te,</w>
granulo vascular</w>
granulo sum</w>
granulo sum.</w>
granulo monopoiesis</w>
granulo mas)</w>
granulo ma,</w>
granulo id</w>
granulo cytosis,</w>
granulo cytopen
granulocytopen ia-related</w>
granulo cytes.</w>
granulo cytes,</w>
grandi osity</w>
gran/ dex
gran/dex );</w>
gran ules.</w>
gran ulation</w>
gran ularity</w>
gran d
grand mother,</w>
gran culo
granculo cyte-macrophage</w>
gram- for
gram-for -
gram-for- gram</w>
gram- documented</w>
gram- confirmed</w>
gram s;</w>
gram ineus</w>
graft- versus-host-disease</w>
graft- hepatic</w>
graft- derived</w>
graf ts:</w>
graf tment</w>
graf ting:</w>
graf t;</w>
graf ;</w>
gradi ents,</w>
gradi ent.</w>
gradi ent-echo</w>
grade s;</w>
grade d)</w>
grad uation</w>
grad ing)</w>
grad ations</w>
grac ilis,</w>
grac ile-cuneate,</w>
gra yscale</w>
gra y/white</w>
gra y),</w>
gra vity-dependent</w>
gra ins</w>
gra des.</w>
gr/ m2.</w>
gr/ m2)</w>
gr ylin,</w>
gr inding</w>
gr ation</w>
gr asp
grasp ing</w>
gr ant</w>
gr an</w>
gp 91-
gp91- phox</w>
gp 91
gp91 phox</w>
gp )-mediated</w>
gout )</w>
got amine,</w>
good- to-excellent</w>
good- after</w>
gonadotroph s</w>
gonadotroph s,</w>
gonadotroph oma.</w>
gonadotroph in.</w>
gonadotrop inomas</w>
gonadotrop inoma.</w>
gonadotrop in-induced</w>
gonadotrop in,</w>
gonad ectomy,</w>
gonad ectom
gonadectom ized)</w>
gonad ally-intact</w>
gonad -
gonad- intact</w>
gon um</w>
gon orrhoeae</w>
gon ine</w>
gon algia.</w>
gon ad</w>
gold- responders</w>
gold- contain
gold-contain ing"</w>
gold -treated</w>
gol ese</w>
gol d)</w>
goit re</w>
goit re,</w>
goat s,</w>
goal- oriented</w>
go/ nogo</w>
go/ no-go</w>
go- signals</w>
go- signals.</w>
go v</w>
go v/medwatch),</w>
go s</w>
go gue</w>
go als,</w>
go al
goal ?</w>
gn oring</w>
gm/d l</w>
gm/d l)</w>
gm/ m2/day</w>
gm/ m2.</w>
gm/ m2,</w>
gm/ day</w>
gm/ 24h,</w>
gm/ 24
gm/24 h;</w>
gm /dl.</w>
gm ./
gm./ kg.,</w>
gm .).</w>
gm (-1).</w>
glycyrrhiz in.</w>
glycyrrhiz in,</w>
glycyr rhizin)</w>
glycyr rhetinic</w>
glycyl histamine</w>
glycyl glycine,</w>
glycoside- mediated</w>
glycoside- infused</w>
glycosaminoglyc ans.</w>
glycosaminoglyc an.</w>
glycosamino g
glycosaminog yclan)</w>
glycos ylation,</w>
glycos ylated</w>
glycos ylase</w>
glycos uric</w>
glycopyrron ium.</w>
glycopyrron ium,</w>
glycopyrrol ate-
glycopyrrolate- ritodrine</w>
glycopyrrol ate).</w>
glycopyrrol ate),</w>
glycopepti des.</w>
glycopepti des,</w>
glycol- liposomal</w>
glycol- asparaginase</w>
glycol methacrylate</w>
glycol methacrylate.</w>
glycogen storing</w>
glycogen olysis</w>
glycogen olysis,</w>
glycogen -
glycogen- packed</w>
glycogen ,</w>
glycoferol- alcohol-
glycoferol-alcohol- benzoic</w>
glyco sides,</w>
glyco side.</w>
glyco sidases,</w>
glyco protein,</w>
glyco oxidation</w>
glyco hydrolases</w>
glyco hydrolase</w>
glyco amino
glycoamino glyc
glycoaminoglyc ans</w>
glycine- substituted</w>
glycine- sites</w>
glycine- receptor</w>
glycin ergic,</w>
glyceryl trinitrate-induced</w>
glyceryl phosphorylcholine</w>
glycerophosph orylcholine</w>
glycerophosph olipids</w>
glycerophosph olipid</w>
glycerophosph ocholine).</w>
glyceraldehyde- phosphate</w>
glycer yl-phosphorylcholine</w>
glycer ophosphate</w>
glycer ol>anti-GBM=gentamicin>nephrectomy=uranium</w>
glycer ol-exposed</w>
glycer ol-</w>
glycer ol)</w>
glycer o)phosphate,</w>
glycer ides,</w>
glyce mia.</w>
glyc oxylic</w>
glyc oxidation,</w>
glyc osphingolipids</w>
glyc opeptides</w>
glyc olysis,</w>
glyc olysis),</w>
glyc ols</w>
glyc olipid</w>
glyc olipid,</w>
glyc olic</w>
glyc ol;</w>
glyc ol)</w>
glyc ocholic</w>
glyc ine]</w>
glyc ine).</w>
glyc ate</w>
glyc anation</w>
glybur ide-like</w>
glybur ide-induced</w>
glybur ide-associated</w>
gly oxylic</w>
gly oxylate</w>
gly oxylate.</w>
gly cy
glycy l</w>
gly corrhachia</w>
gly con
glycon e
glycone ogenesis</w>
gly caemia.</w>
gly caemia,</w>
glutethim ide,</w>
glutathione-S- transferase-alpha</w>
glutathione- for</w>
glutathi one:</w>
glutathi one/glutathione</w>
glutar aldehyde,</w>
glutamate-1- decarboxylase</w>
glutamate-1- carboxy-ly
glutamate-1-carboxy-ly ase
glutamate-1-carboxy-lyase ).
glutamate-1-carboxy-lyase). 2.</w>
glutamate- stimulated</w>
glutamate- pyruvate</w>
glutamate- photolysis</w>
glutamate- oxalacetic</w>
glutamate- metabolizing</w>
glutamate- inhibiting</w>
glutamate- gated</w>
glutam ine:</w>
glutam ic-pyruvic</w>
glutam ergic)</w>
glutam ate/
glutamate/ N-methyl-D-aspartate</w>
glut eal</w>
glut aminergic</w>
glucuronid ation.</w>
glucuron ides</w>
glucuron ides,</w>
glucuron ide:</w>
glucose-6- phosphatase.</w>
glucose- specific</w>
glucose- saline</w>
glucose- regulatory</w>
glucose- regulated</w>
glucose- physostigmine</w>
glucose- neutral.</w>
glucose- 6</w>
glucose .4.</w>
glucose -treated</w>
glucose ),</w>
glucosaminid ase),</w>
glucos ylated</w>
glucos yl-galactosyl-hydroxylysine</w>
glucos uria.</w>
glucos oaminidase</w>
glucos amin
glucosamin ad
glucosaminad ase</w>
glucoron osyltransferases</w>
glucoron idase,</w>
glucopri vation</w>
glucocorticoid- treatment</w>
glucocorticoid- sensitivity</w>
glucocorticoid- hypertensive</w>
glucocorticoid- hypertension</w>
glucocorticoid- hypertension.</w>
glucocorticoid- denervation</w>
glucocorticoid -related</w>
glucocorticoid )-induced</w>
glucocortico id.</w>
glucocortico id)</w>
gluco sides.</w>
gluco ses.</w>
gluco se-induced</w>
gluco regulatory</w>
glucar pidase</w>
glucar pidase,</w>
glucagon :</w>
glucagon -stimulated</w>
glucagon -induced</w>
glucagon 's</w>
gluc uro-conjugated</w>
gluc orticoid-treated</w>
gluc openia</w>
gluc ocerebrosides.</w>
glu fosin
glufosin ate</w>
glu e,</w>
glu e)</w>
glu athione</w>
glot titis</w>
glomerulosclero sis:</w>
glomerulosclero sis).</w>
glomerulonephri tis-like</w>
glomerulonephri tides.</w>
glomerulonephri tides,</w>
glomeruloneph ritic</w>
glomerulo constrictor</w>
glomerulo -
glomerulo- tubular</w>
glomerul us)</w>
glomerul i/section;</w>
glomerul ar),</w>
globul inuria</w>
globul ins.</w>
globul in/cyclosporine</w>
globul in-actin</w>
glob otriasylceramide</w>
glob inuria</w>
glob ata</w>
glob ally,</w>
glo ves,</w>
glo -
glo- Scandinavian</w>
glitaz one,</w>
glipiz ide</w>
glipiz ide;</w>
glipiz ide,</w>
glioblast omas,</w>
glioblast oma:</w>
glime piride.</w>
glime piride,</w>
glicl azide.</w>
glibencl amide;</w>
glibencl amide-sensitive</w>
glibencl amide)</w>
glia- derived</w>
gli omas:</w>
gli oma:</w>
gli ogenesis</w>
gli ogenesis,</w>
gli al-
glial- selective</w>
gli adin</w>
gland ;</w>
gland -derived</w>
glab rata</w>
glab rata.</w>
gl ymidodrine,</w>
gl uteraldehyde</w>
gl ue-secured</w>
gl imiperide</w>
gl asses</w>
gl ass
glass -
glass- microelectrode</w>
gl as
glas ses,</w>
gl arg
glarg ine</w>
gl are,</w>
gl aphen
glaphen ine,</w>
gk 1)</w>
given-- one</w>
given-- diluted</w>
given :</w>
given --the</w>
given )</w>
girl s;</w>
girl s.</w>
gir l)</w>
gir l),</w>
gir d
gird ling</w>
ginseno sides,</w>
ginsen g.</w>
gingiv ostomatitis.</w>
gingiv a</w>
gingiv a,</w>
gin ate-
ginate- encapsulated</w>
gigant ocellularis</w>
gigant o-cellularis</w>
giddin ess)</w>
giardi asis.</w>
gi ves:</w>
gi vers</w>
gi onella</w>
gi mestat-1</w>
gi de,</w>
gi bind
gibind )</w>
gi al</w>
gi Bas
giBas e).</w>
ght- lateralised</w>
ght fiel
ghtfiel d-</w>
ghrel in;</w>
gh tly</w>
gh relin,</w>
gh ost</w>
gh orn</w>
gh man-Hakim</w>
gh -Protein</w>
gg y</w>
gg ulsterones</w>
gg es
gges hall</w>
gg ered</w>
gg )</w>
get ween</w>
gestod ene
gestodene /ethinyl</w>
gest ure.</w>
gest ations.</w>
gest ations,</w>
gest ationally</w>
gest ation-
gestation- only</w>
gest ation),</w>
gest a,</w>
geranyl ger
geranylger ani
geranylgerani ol).</w>
ger ian</w>
geot axis</w>
geot axis.</w>
genu inely</w>
gentamicin- renal</w>
gentamicin- iron</w>
gentamicin- impregnated</w>
gentamicin- enhanced</w>
gentamicin- ARF</w>
gentamicin );</w>
gentamic in;</w>
gentamic in:</w>
gentamic in-</w>
gentamic cin</w>
gentam ycin</w>
gentam ycin,</w>
gent leman</w>
gent in),</w>
genotype- wise:</w>
genotype- environment</w>
genotype ;</w>
genotype -specific</w>
genotyp ing,</w>
genotyp ical</w>
genotyp ic-dependent</w>
genom ics</w>
genom e.</w>
genit al-
genital- mutilating</w>
genist ein,</w>
genip in.</w>
genip in,</w>
genetically- linked</w>
genetically- determined</w>
genetic s-based</w>
genetic ists</w>
general ized;</w>
general isation</w>
gener s.</w>
gener ous</w>
gener ically</w>
gener ators</w>
gener ator,</w>
gener ator
generator '.</w>
gener ations,</w>
gener ation;</w>
gener ation/
generation/ recall</w>
gener ation.(ABSTRACT</w>
gener ation),</w>
gener ation"</w>
gener ated,</w>
gener ality</w>
gener al-
general- epidural</w>
gene- silencing</w>
gene- encoded</w>
gene- dependent</w>
gene- deletion</w>
gene tics)</w>
gene tically.</w>
gene tic/developmental</w>
gene tic-epilepsy</w>
gene sis)</w>
gene alo
genealo gy</w>
gene ;</w>
gender- specific,</w>
gender- dependency</w>
gender s.</w>
gender :</w>
gender -specific</w>
gender -dependent</w>
gen value</w>
gen us</w>
gen us.</w>
gen otoxicity</w>
gen otoxicity.</w>
gen otoxic,</w>
gen onutrient.</w>
gen omewide</w>
gen ome-length</w>
gen ographic</w>
gen ine-vasopressin</w>
gen ic"</w>
gen es)</w>
gen enic</w>
gen ders</w>
gen ce,</w>
gen -specific</w>
gen -derived</w>
gemfibroz il;</w>
gemfibroz il-related</w>
gemfibroz il-lovastatin</w>
gemfibroz il-</w>
gemcitab ine-treated</w>
gemcitab ine-related</w>
gemcitab ine-based</w>
gemcitab ine)</w>
gem istocytic</w>
gem ents</w>
gell an)</w>
gelatin ase-</w>
gelat inous</w>
gel s,</w>
gel s)</w>
gel heim)</w>
gel ding</w>
gel dan
geldan am
geldanam ycin,</w>
gel ation</w>
gel -type</w>
gel -like</w>
gefit inib).</w>
ge red</w>
ge phyrin-positive</w>
ge orgetown</w>
ge ons</w>
ge ographically</w>
ge minal</w>
ge .,</w>
ge -
ge- light</w>
gcd- null)</w>
gaz e.</w>
gav ages,</w>
gav age:</w>
gav age,</w>
gav ag
gavag es)</w>
gav aceae).</w>
gaug es</w>
gaug ed</w>
gau ze.</w>
gat tii.</w>
gastrointestin al-related</w>
gastrointestin al)</w>
gastroenter ology</w>
gastroenter ologists</w>
gastroduoden oscopy</w>
gastroduoden itis,</w>
gastrocnemi us.</w>
gastrocnemi us,</w>
gastrocnemi us).</w>
gastro- esophageal</w>
gastro- enter
gastro-enter ostomy.</w>
gastro- duodenal</w>
gastro protection</w>
gastro prokinetic</w>
gastro paresis</w>
gastro enteropathy</w>
gastro enterocolitis,</w>
gastro duodenal</w>
gastro cne
gastrocne mic</w>
gastr one</w>
gastr in.</w>
gastr in-releasing</w>
gastr in,</w>
gastr algia.</w>
gastr algia,</w>
gast ruloid</w>
gast roschisis,</w>
gast ritis'</w>
gast odene,</w>
gas ),</w>
garlic :</w>
garlic -treated</w>
garlic -induced</w>
garen oxacin,</w>
gar ty</w>
gar s</w>
gar ments.</w>
gar lic,</w>
gar land</w>
gar an).</w>
gar ,</w>
gap s.</w>
gap /low</w>
gap -
gap- detection</w>
gap )</w>
gangrenos um</w>
gangrenos um.</w>
ganglion- derived</w>
ganglion- blockers</w>
ganglion opathy</w>
gangli osides,</w>
gangli ons</w>
gangli a:</w>
ganciclovir -treated</w>
ganciclovir -induced</w>
ganciclovir -associated</w>
ganciclovir -
ganciclovir- or</w>
gan zfeld</w>
gan on,</w>
gammaglut amyl</w>
gammaglobul inaemia</w>
gammaR III
gammaRIII b,</w>
gamma-hydroxybut yrolactone;</w>
gamma-hydroxybut yrate.</w>
gamma-glutamyltranspeptid ase,</w>
gamma-glutamyl- transferase.</w>
gamma-glutamyl- aminomethyl
gamma-glutamyl-aminomethyl sulfonic</w>
gamma-carboxyl ation</w>
gamma-carboxyl ated.</w>
gamma-butyro -
gamma-butyro- lactone.</w>
gamma-aminobuty rate-mediated</w>
gamma-aminobuty rate-dependent</w>
gamma-aminobut yric-acidA</w>
gamma-HC H)</w>
gamma-G T,</w>
gamma-D-glutamyl glycine</w>
gamma-D-glutamyl amino-
gamma-D-glutamylamino- methylsulphonate</w>
gamma-D-glutam yl-aminomethyl</w>
gamma- vinyl-GABA,</w>
gamma- sarcoglycan,</w>
gamma- rays</w>
gamma- radiation</w>
gamma- radiated</w>
gamma- nucleoside</w>
gamma- irradiation.</w>
gamma- imino]triphosphate</w>
gamma- enol
gamma-enol ase,</w>
gamma- endorphin,</w>
gamma- cholest
gamma-cholest ery
gamma-cholestery loxybutyric</w>
gamma- carboxy
gamma-carboxy glutamate</w>
gamma- az
gamma-az opigment</w>
gamma- amino</w>
gamma- V
gamma-V inyl</w>
gamma- IMGB
gamma-IMGB L
gamma-IMGBL )]</w>
gamma- Hexachlorocyclohexane</w>
gamma- Glutam
gamma-Glutam yl</w>
gamma- Glut
gamma-Glut amyl
gamma-Glutamyl transpeptidase</w>
gamma- GTP</w>
gamma- GT
gamma-GT +</w>
gamma- ENaC,</w>
gamma- DNA</w>
gamma- Acetyl
gamma-Acetyl enic</w>
gamma- ,</w>
gamma dex</w>
gamma S),</w>
gamma GT</w>
gamma 2S</w>
gamma 2</w>
gamma 2
gamma2 L</w>
gamma -</w>
gamma ),</w>
gamma (2)-
gamma(2)- subunits</w>
gamet ogenic</w>
gamet ocytes</w>
gamet ocytes,</w>
gambl ing:</w>
gam mopathy,</w>
gall- stones.</w>
gall- stone</w>
gall stones:</w>
gall amine-induced</w>
gall amine)</w>
galect in-1</w>
galect in-1,</w>
galan inergic</w>
galan in.</w>
galan in-immunoreactive</w>
galactosyl- terminating</w>
galactosid ase</w>
galactosid ase-
galactosidase- encoded</w>
galactosid ase)</w>
galactos amine.</w>
galactos amine-induced</w>
galact osido-sorbitol)</w>
gal non,</w>
gal lopamil,</w>
gal ae</w>
gain s.</w>
gain ;</w>
gain -related</w>
gain )</w>
gagg ing,</w>
gagg ed</w>
gag/pol ;</w>
gag/pol ).</w>
gadopentet ate,</w>
gadolinium- diethylenetriamine</w>
gadolinium- DTPA.</w>
gadolinium- DTPA-
gadolinium-DTPA- B
gadolinium-DTPA-B MA</w>
gadolinium- DOTA</w>
gadodi amide;</w>
gadodi amide-
gadodiamide- enhanced</w>
gadodi amide),</w>
gad oversetamide</w>
gad ose</w>
gad a</w>
gaba erg
gabaerg ic--cholinergic</w>
gab oxadol,</w>
gab azine</w>
gab azine,</w>
gab az
gabaz ine;</w>
gab a-
gaba- ergic</w>
ga y-oriented</w>
ga onists</w>
ga it)</w>
ga ined,</w>
ga g</w>
ga -dose</w>
g/m2/ day.</w>
g/m2/ day).</w>
g/m2/ d;</w>
g/m2/ d.</w>
g/m2/ course</w>
g/m2/ 24</w>
g/m2/ 12</w>
g/m(2)/ day)</w>
g/m(2)/ cour
g/m(2)/cour se)</w>
g/m 2.7)</w>
g/m 2.7).</w>
g/m 2);</w>
g/m (2),</w>
g/kg/ min,</w>
g/kg/ h.</w>
g/kg/ day)</w>
g/kg/ day).</w>
g/kg/ d</w>
g/day -1.
g/day-1. k-1</w>
g/day )-
g/day)- lovastatin</w>
g/d L;</w>
g/d ).</w>
g/cm 2.</w>
g/cm 2,</w>
g/cm 2)</w>
g/cm (2);</w>
g/cm (2),</w>
g/cm (2)).</w>
g/ wk,</w>
g/ ml.</w>
g/ ml,</w>
g/ minute,</w>
g/ mg</w>
g/ mL</w>
g/ liter,</w>
g/ liter).</w>
g/ liter),</w>
g/ light</w>
g/ l).</w>
g/ l),</w>
g/ kgbw/min</w>
g/ hepatitis</w>
g/ h</w>
g/ h/rat)</w>
g/ g
g/g ].</w>
g/ die</w>
g/ day;</w>
g/ day).</w>
g/ daily).</w>
g/ d,</w>
g/ M2)</w>
g/ 5</w>
g/ 10</w>
g.kg(-1). min(-1)</w>
g.kg(-1). min(-1))</w>
g.kg(-1). min(-1)).</w>
g.kg(-1). d(-1))</w>
g. l-1</w>
g. dl
g.dl -1).</w>
g. L-1</w>
g. KG
g.KG ,</w>
g. 3.</w>
g. /kg.,</w>
g- m/beat/m2)</w>
g- Mania</w>
g- 300
g-300 g)</w>
g- /
g-/ ng-regimen,</w>
g- (1-7))</w>
g yroscopes,</w>
g ylycine.</w>
g ycolysis"),</w>
g wheeling.</w>
g urate</w>
g um:</w>
g um-induced</w>
g t11</w>
g s"</w>
g reasiness</w>
g oserilin</w>
g oblet</w>
g ms)</w>
g ms).</w>
g m;</w>
g m,</w>
g letes</w>
g islation</w>
g iodisal@yahoo.it).</w>
g hosts</w>
g hosts.</w>
g hosts,</w>
g es,</w>
g ers</w>
g ero
gero protector</w>
g ently</w>
g e,</w>
g ato</w>
g ated.</w>
g ate,</w>
g ate
gate keeper</w>
g asp
gasp ing-less</w>
g as)</w>
g an.</w>
g ability.</w>
g TX)</w>
g SD)</w>
g N
gN [
gN[ SOD
gN[SOD 1]
gN[SOD1] 3C
gN[SOD1]3C je</w>
g G)</w>
g 2)</w>
g -1);</w>
g -1),</w>
g *
g* kg(-1)*min(-1)</w>
g ).
g). Control</w>
g (-1);</w>
g (-1)).</w>
fusi form
fusiform -shaped</w>
fus ario
fusario sis,</w>
further )</w>
furosem ide;</w>
furosem ide-resistant</w>
furosem ide-associated</w>
furosem ide--importance</w>
furo senmide</w>
furo semid,</w>
furazolid one.</w>
furazolid one,</w>
furan-2- il)</w>
fura-2/ AM.</w>
fura-2/ AM-
fura-2/AM- loaded</w>
fur yl[1,2,4]-triazolo[2,3-a[1,3,5]triazin-5-yl-aminoethyl)phenol</w>
fur yl-9-ethyladenine</w>
fur nished</w>
fur an:</w>
fungi .</w>
fungi ,</w>
fung us</w>
fung icide,</w>
fung als</w>
funduscop y.</w>
fundoscop ic</w>
fundoscop ic,</w>
fund al</w>
functional- structural</w>
functional- endothelium.</w>
function/ morphology.</w>
function/ inhibition,</w>
function/ activity</w>
function-- results</w>
function-- impairs</w>
function s;</w>
function s/behaviour</w>
function ality</w>
function ality.</w>
function al/
functional/ physiological</w>
function al
functional ,"</w>
function .
function. alpha(1)-Adrenoceptor</w>
function -dependent</w>
function -associated</w>
function ".</w>
fun ny</w>
fun nel-like</w>
fun iculi</w>
fun do
fundo plication</w>
fun ded,</w>
fun dam
fundam entally</w>
fumar ate.</w>
fumar ate,</w>
fumar ate).</w>
fumar ate),</w>
fum igatus</w>
fum bling</w>
fum aric</w>
fulmin ate</w>
fulmin ant"</w>
fully- opened</w>
fully- informed</w>
fully- effective</w>
full- thickness</w>
full- text</w>
full- sibling</w>
full- scan</w>
full- field,</w>
full- dose")</w>
full- criteria</w>
full- analysis</w>
full ness</w>
full ness.</w>
full filling</w>
fulfil s</w>
fulfil ment</w>
ful ness,</w>
ful l.</w>
ful gurate</w>
ful fill
fulfill s</w>
ful ).</w>
fugu e-
fugue- state.</w>
fucosid ase</w>
fucoid an,</w>
fuch sinophilia</w>
fu gues</w>
fu dex
fudex ).</w>
fu /
fu/ mL</w>
fu ,</w>
frutesc ens,</w>
frutesc ens
frutescens --
frutescens-- containing</w>
frust rating</w>
frusem ide.</w>
fructose-1,6-di phosphate.</w>
fructose-1,6-di phosphate,</w>
fructose-1, 6-bisphosphate</w>
fru stration</w>
fru ste"</w>
fru its,</w>
fru it,</w>
frotteur ism</w>
frotteur ism,</w>
frontop olar</w>
fronto- temporal</w>
frontal- lobe</w>
fron ts</w>
fron tostriatal</w>
fron tal"</w>
fron t.</w>
fro vatriptan</w>
fro gs.</w>
fro g,</w>
fric tion.</w>
fric an-American</w>
fri ends</w>
fri ends.</w>
fri able</w>
fresh water</w>
frequency /low</w>
frequency -matched</w>
frequenc ies;</w>
frequenc ies:</w>
frequenc ies.(ABSTRACT</w>
frequ ently-
frequently- occurring</w>
freeze- clamped</w>
freez ing-thawing</w>
freez ing,</w>
freez ing)</w>
freebas e)</w>
freebas e).</w>
free-bas ing</w>
free-bas ing"),</w>
free- text</w>
free- standing</w>
free- running</w>
free- radical-scavenging</w>
free- choice</w>
free- calcium</w>
fre undii</w>
fre on</w>
fre es</w>
fre ed</w>
fran k,</w>
frame ;</w>
fram ycetin-</w>
fram ingham</w>
fram es</w>
fram es/
frames/ s</w>
fram es
frames hifts</w>
fragment s:</w>
fragment ing</w>
fragment ations</w>
fragment :</w>
fragil is</w>
fragil is).</w>
frag rans</w>
frag mentary</w>
frag ility.</w>
frag ile</w>
fractions/ week)</w>
fractions/ 40</w>
fraction [LVE
fraction[LVE F
fraction[LVEF ])</w>
fraction .(ABSTRACT</w>
fraction ).</w>
fraction (EA
fraction(EA F)</w>
fractalkine- immunoreactivity</w>
fractalkine- IR</w>
fract uring</w>
frac tive</w>
fra udulent</w>
fra il,</w>
fr umil</w>
fr uctan)</w>
fr ican</w>
fr .</w>
fr .)</w>
fox ine:</w>
fox ine),</w>
fove a</w>
fourth- level</w>
four- way</w>
four- times-daily</w>
four- tenths</w>
four- period</w>
four- month-old</w>
four- methylcatechol</w>
four- day</w>
four- compartment</w>
four- cohort</w>
four- category</w>
four- bed</w>
four ths</w>
four th:</w>
four teen-weeks</w>
four s</w>
four fold;</w>
four fold.</w>
four fold)</w>
four ),</w>
foun ding</w>
foun der</w>
foun ded</w>
foun d;</w>
foun d
found ation</w>
foti amine,</w>
foti am</w>
fostriec in,</w>
fost ine</w>
fosinopri l,</w>
fosfob ion-</w>
fosfob ion)</w>
fosf amides,</w>
fosel is</w>
foscarne t:</w>
fos sae,</w>
fos sa;</w>
fos poren),</w>
fos phenytoin;</w>
fos phenytoin);</w>
fos /
fos/ jun</w>
forwar d;</w>
forwar d).</w>
forty- two-year</w>
forty- three</w>
forty- one-year</w>
forty- eight-hour</w>
fortuit um</w>
fortuit ously.</w>
forth coming</w>
forth com
forthcom ing.</w>
fort night.</w>
forni x</w>
forni x-hypothalamus-hypophysis</w>
formular y,</w>
formul ations--
formulations-- Valium</w>
formul as</w>
formul as.</w>
formul aries</w>
formul ae,</w>
formul a:</w>
formul a).</w>
formul a),</w>
formed /min</w>
formed )</w>
formaz an</w>
formaz an.</w>
formaz an-
formazan- containing</w>
formaz an,</w>
formalin- injected</w>
formalin- fixed,</w>
formal ine.</w>
formal in:</w>
form yltransferase</w>
form ylaminoantipyrine).</w>
form ulate</w>
form s;</w>
form s)</w>
form er;</w>
form ations.</w>
form ations,</w>
form ations)</w>
form ation;</w>
form ation).</w>
form am
formam idine</w>
form aldehy
formaldehy de-induced</w>
form :</w>
form -manifested</w>
forgotten :</w>
forgotten "</w>
forelimb -
forelimb- reaching</w>
forel imbic</w>
foreign er</w>
foreign -
foreign- body</w>
forebrain- restricted</w>
forebrain- elicited</w>
forear ms;</w>
forear m;</w>
forear m/antecubital</w>
fore warned</w>
fore sts</w>
fore seen.</w>
fore paws.</w>
fore paw.</w>
fore paw-on-dowel</w>
fore paw,</w>
fore most</w>
fore leg</w>
fore head,</w>
fore brains</w>
fore brain:</w>
fore /
fore/ midbrain;</w>
fore -
fore- period</w>
forcep s</w>
forcep s-assisted</w>
forced- titration</w>
forced- choice</w>
force- velocity</w>
force- titrated</w>
force- sensitive</w>
force- rate</w>
force- length</w>
force- frequency</w>
force fully</w>
for ward-masking,</w>
for um</w>
for th</w>
for te</w>
for nices</w>
for ming.</w>
for med,</w>
for go</w>
for getting</w>
for d-Binet</w>
for ci
forci ble</w>
for ces.</w>
for ant</w>
for amin
foramin a</w>
for aging</w>
for aging:</w>
for .</w>
for )</w>
footshock ).</w>
footshock ),</w>
foot- withdrawal</w>
foot- shock)</w>
foot shock.</w>
foot shock,</w>
foot prints</w>
foot print</w>
foot pad,</w>
foot pad)</w>
foot ?</w>
foot )</w>
food- producing</w>
food- frequency</w>
food s.</w>
fondaparinu x.</w>
fomep izole</w>
fomep izole,</w>
follow-up s</w>
follow-up s.</w>
follow-up s,</w>
follow-up ):</w>
follow-up ).</w>
follow ups</w>
follow up.</w>
follow up)</w>
follow s,</w>
follow ingly</w>
follow .</w>
folliculo stellate,</w>
folliculo genesis</w>
follic les.</w>
follic les,</w>
foli ative</w>
fold able</w>
fold ).(ABSTRACT</w>
fol liculitis</w>
fol k</w>
fol d-
fold- increased</w>
fol ates),</w>
fol ate]</w>
fol ate-
folate- Vinca</w>
fol ate)</w>
foet us</w>
focus sing</w>
foci :</w>
foci -in-
foci-in- foci,</w>
foc us;</w>
foc tor</w>
foc ally,</w>
foc alizing</w>
foc al.</w>
fo wl</w>
fo reshortened</w>
fo reshadows</w>
fo refoot</w>
fo il;</w>
fo il,</w>
fo ggy</w>
fo g)</w>
fmol/ mm,</w>
fmol/ ml,</w>
fmol/ mg</w>
fmol s/mg</w>
fmol es
fmoles -10</w>
fmol ).</w>
fluvox amine-treated</w>
fluvox amine's</w>
flut ter;</w>
flut ter)</w>
flut amide-related</w>
flut amide)</w>
flush ing;</w>
flush ing)</w>
flush es.</w>
flush es,</w>
flush :</w>
fluroth yl-</w>
fluroth yl)</w>
fluroth yl),</w>
flurbi profen.</w>
flur ry</w>
flur ries,</w>
flur idine.</w>
flur azepam)</w>
flur ane.</w>
flur ane-associated</w>
flur ane-
flurane- H</w>
flur and
flurand renolide</w>
fluphenazine- sulfoxide.</w>
fluphenazine- sulfoxide,</w>
fluphenazine- clonidine</w>
fluphenazine- challenged</w>
fluphenaz ine-induced</w>
fluphenaz ine-</w>
fluphenaz in,</w>
flupentix ol,</w>
fluparox an,</w>
flup enthix
flupenthix ol.</w>
fluoxyme sterone,</w>
fluoxetine- warfarin</w>
fluoxetine- exposed</w>
fluoxetine- equivalent
fluoxetine-equivalent s)</w>
fluoxet ine;</w>
fluoxet ine-</w>
fluoxet ine's</w>
fluoroscop ies</w>
fluoroscop ically</w>
fluoroquinol ones).</w>
fluoroquinol one.</w>
fluoroquinol one).</w>
fluoropyrimid ines</w>
fluoropyrimid ines.</w>
fluorophenyl) pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one</w>
fluorometh olone,</w>
fluoro- methylornithine,</w>
fluoro- D-glucose</w>
fluoro- 3,6-dimethylpyrazine</w>
fluoro- 2,3-dihydro-
fluoro-2,3-dihydro- 3-methyl
fluoro-2,3-dihydro-3-methyl -10-
fluoro-2,3-dihydro-3-methyl-10- (4-methyl
fluoro-2,3-dihydro-3-methyl-10-(4-methyl -1-</w>
fluoro uracil/folinic</w>
fluoro uracil-induced</w>
fluoro scopy</w>
fluoro photometer</w>
fluoro phenyl-(4-fluoro-4-[[(5-methyl-6-methylamino-pyridin-2-ylmethyl)-amino]-methyl]-piperidin-1-yl-methanone</w>
fluoro metry</w>
fluoro metrically</w>
fluoro gold</w>
fluoro genic</w>
fluoro cytometry</w>
fluoro angiographic</w>
fluori metry</w>
fluori metric,</w>
fluoresce in-conjugated</w>
fluoresce in-5-isothiocyanate</w>
fluoresc ently</w>
fluoresc ence.</w>
fluoresc ence-
fluorescence- microscopic</w>
fluores ence</w>
fluores ence,</w>
fluoren onyl</w>
fluoren one</w>
fluore sein</w>
fluore ne,</w>
fluor quinolone</w>
fluor ine/chlorine</w>
fluor ine-18</w>
fluor ides</w>
fluor ide]</w>
fluor ide,</w>
fluocin onide</w>
flunitrazepam -dependent</w>
flunitrazepam --
flunitrazepam-- legal</w>
flunar izine-induced</w>
flunar izine-and</w>
flun g</w>
flumazen il;</w>
flumazen il:</w>
flumazen il)</w>
fluindi one-induced</w>
fluindi one,</w>
fluid- resuscitated</w>
fluid- pharmacologic</w>
fluid- mechanics</w>
fluid- diluted</w>
fluid ity;</w>
fluid /
fluid/ plasma</w>
fludro cortisone,</w>
fludro cortis
fludrocortis one)</w>
fludarab ine/cyclophosphamide/rituximab</w>
fludarab ine.</w>
fluctu ations)</w>
fluctu ation.</w>
fluctu ation,</w>
fluctu ation)</w>
fluctu ation
fluctuation s);</w>
fluconazol e;</w>
fluconazol e's</w>
flucloxacill in-tolerant</w>
flucloxacill in),</w>
fluc onazole-induced</w>
flu- 2,</w>
flu vastatin.</w>
flu ticasone-17-</w>
flu rescence</w>
flu orthyl-</w>
flu minating</w>
flu methasone</w>
flu idity,</w>
flu idic</w>
flu fen
flufen azine</w>
flu ence</w>
flu e-like</w>
flu -1,</w>
flu "</w>
floxac in-associated</w>
floxac in)</w>
flox uridine-induced</w>
flox uridine,</w>
flow/ metabolism</w>
flow/ increased</w>
flow- meter.</w>
flow- mediated</w>
flow- independently</w>
flow- directed</w>
flow- cytometry</w>
flow ire</w>
flow ers.</w>
flow cytometry,</w>
flow "</w>
flouro uracil-induced</w>
flop py</w>
flop py,</w>
floc tafenine</w>
flo ur</w>
flo ur,</w>
flo sequinan,</w>
flo sequinan),</w>
flo or,</w>
flo at
float ers,</w>
flinch ing/licking</w>
flinch ing)</w>
flinch es.</w>
flin ching,</w>
flin ch)</w>
flick ering</w>
flick )</w>
flic ting</w>
flexible- titration</w>
flexible- dosing,</w>
flexible- dose,</w>
flexi ons</w>
flexi on.</w>
flexi on--extension</w>
flexi ble,</w>
flexi bility.</w>
flexi bil
flexibil ity,</w>
flex ors</w>
flex ors).</w>
flex ing</w>
flex ed</w>
flex ).</w>
fler oxacin.</w>
flecain ide.(ABSTRACT</w>
flecain ide)</w>
fle x,</w>
fle eting</w>
flavox ate</w>
flavox ate.</w>
flavon ol</w>
flavon oid.</w>
flav our,</w>
flav or</w>
flav onols,</w>
flav one:</w>
flatul ence).</w>
flatten s</w>
flatten ing.</w>
flatten ing,</w>
flatten ed/
flattened/ incongruous</w>
flat us</w>
flat ness.</w>
flat .</w>
flash ing</w>
flare- ups</w>
flare- up.</w>
flare metry</w>
flare :</w>
flare /
flare/ increase</w>
flare ).</w>
flap :</w>
flan ks,</w>
flan ker</w>
flan k;</w>
flaccid ity.</w>
fla wed.</w>
fla ure</w>
fl ying</w>
fl usal</w>
fl ulike</w>
fl oribundi</w>
fl on-coated</w>
fl inch</w>
fl aw
flaw ed</w>
fl avi
flavi viral</w>
fl as
flas ks</w>
fl aring</w>
fl ail
flail ing</w>
fl ag
flag "</w>
fl acid</w>
fl ac
flac ain
flacain ide</w>
fl -
fl- [1,
fl-[1, 2,
fl-[1,2, 5]
fl-[1,2,5] thiadiazepine</w>
fl )</w>
fixed- speed</w>
fixed- salt</w>
fix ed"</w>
fix ative.</w>
fix ation;</w>
fix ating</w>
fix ate</w>
five- stage</w>
five- point</w>
five- fold,</w>
five- fold).</w>
five ),</w>
fit ting.</w>
fit ted.</w>
fit s?</w>
fit ness</w>
fit ness'</w>
fit :</w>
fit -free</w>
fistul as:</w>
fissure -related</w>
fissure --
fissure-- healing</w>
fissu res,</w>
fissu re:</w>
fissu re-in-ano.</w>
fish er</w>
fish bone,</w>
first- phase</w>
first- metatarsal</w>
first- in-man</w>
first- in-class</w>
first- hand</w>
first- ever</w>
first- dose"</w>
first- detected,</w>
first ly,</w>
first :</w>
firm ly,</w>
fir stly</w>
fir mer,</w>
finger- to-nose</w>
finger tips</w>
finger tips.</w>
finger s.(iii)</w>
finger nails</w>
fing ers,</w>
fine- wire</w>
finaster ide-treated</w>
fin ishing</w>
fin ished.</w>
fin ished).</w>
fin ish</w>
fin avir/
finavir/ Z
finavir/Z alcit
finavir/Zalcit ab
finavir/Zalcitab ine/</w>
fin anced</w>
fin al
final ized.</w>
filtr ate.</w>
filter ability.</w>
filter )</w>
filo viral</w>
filo podia</w>
fill ing),</w>
fill er</w>
filgrastim ).</w>
filaria e.</w>
filaria e,</w>
filament s)</w>
filament ous.</w>
filament ous)]</w>
filam ent.</w>
filam ent-
filament- 200).</w>
fil ters.</w>
fil ters,</w>
fil ter-topped</w>
fil nine</w>
fil ms.</w>
fil m.</w>
fil m-coated</w>
fil ium,</w>
fil icene</w>
fil icene,</w>
fil es.</w>
fil ed</w>
fil ar
filar iasis.</w>
figh ting,</w>
fig ures:</w>
fig ures--would</w>
fig ures,</w>
fig ures).</w>
fig ure-8</w>
fifty- six-year-old</w>
fifty- seven</w>
fifty- seven-year-old</w>
fifty- four</w>
fifty- four-year-old</w>
fif ties.</w>
fif ties,</w>
fif th-generation</w>
fif th,</w>
field- potential</w>
field- contrast</w>
fiel ds.</w>
fiel d--
field-- suggest</w>
fiel d)</w>
fiel d
field s),</w>
fic ation)</w>
fibrosis/ cirrhosis</w>
fibrosis/ cirrhosis.</w>
fibrosar coma.</w>
fibron ectin.</w>
fibron ect
fibronect in)</w>
fibrom yositis</w>
fibrom uscular</w>
fibrom as,</w>
fibroelast osis,</w>
fibroblast -dependent</w>
fibro sis--were</w>
fibro sis),</w>
fibro plasia,</w>
fibro intimal</w>
fibro id</w>
fibro histiocytoma,</w>
fibro genesis,</w>
fibro fatty</w>
fibro cytes.</w>
fibro cystic</w>
fibro calcification</w>
fibro adenomas.</w>
fibro adenomas,</w>
fibrinoly tics.</w>
fibrinoly tic,</w>
fibrinoly sin</w>
fibrinogen .</w>
fibrinogen ),</w>
fibrin opeptide</w>
fibrin ogens</w>
fibrillation/ flutter</w>
fibrillation/ flutter.</w>
fibrill atory,</w>
fibrill ations.</w>
fibrill ation-associated</w>
fibrill ation--a</w>
fibrill ation-
fibrillation- two</w>
fibri ls.</w>
fibri llogenesis</w>
fibre -type</w>
fibre -induced</w>
fibrate- derived</w>
fibr inated</w>
fiber- released</w>
fiber- granule</w>
fiber- evoked</w>
fiber s)</w>
fiber s).</w>
fiber ;</w>
fiber /
fiber/ mm(2)</w>
fiber -type</w>
fiber -mediated</w>
fiber -like</w>
fib ula.</w>
fib res;</w>
fib res)</w>
fib re-specific)</w>
fib rates.</w>
fib rates,</w>
fib er.</w>
fial uridine</w>
fial uridine-induced</w>
fi refly</w>
fi red</w>
fi re/explosion,</w>
fi prim).</w>
fi er
fier y-red</w>
fi -
fi- Aven
fi-Aven tis,</w>
ffere tiation,</w>
ffe 's</w>
ff- person</w>
ff y</w>
ff ield</w>
ff icient</w>
ff ian</w>
ff =
ff= 38.5</w>
ff .</w>
fex ofenadine?</w>
fever/ sepsis</w>
fever/ infection</w>
fever ;</w>
fever :</w>
fever -like</w>
fever )</w>
fever "</w>
fetu ses/litter,</w>
fetu ses)</w>
fetal/ neonatal</w>
fetal/ maternal</w>
fet us:</w>
fet or</w>
fet oplacental</w>
fet olethality,</w>
fet al-
fetal- growth</w>
fet al
fetal ]</w>
ferro kinetics</w>
feren ce,</w>
fer tile,</w>
fer rin</w>
fer rets</w>
fer oposterior</w>
fer on)</w>
fer ioxamine</w>
fentanyl/ medetomidine</w>
fentanyl-etomidate- vecuronium</w>
fentanyl-etomidate- pancuronium</w>
fentanyl- tolerant</w>
fentanyl- thiopentone-vecuronium</w>
fentanyl- thiopentone-suxamethonium</w>
fentanyl- pentobarbital-anesthetized,</w>
fentanyl- oxygen</w>
fentanyl- experienced</w>
fentanyl- anesthetized</w>
fentanyl+ NG-nitro-L-arginine:</w>
fentanyl+ 7-nitroindazole:</w>
fentanyl -</w>
fentanyl --a</w>
fentan il,</w>
fenoterol- hydrobromide</w>
fenoterol- hydrobromide,</w>
fenoldopam .(ABSTRACT</w>
fenob am,</w>
feno profen:</w>
feno profen-induced</w>
feno fibrate-induced</w>
feno fibrate-associated</w>
fenfluramine/ dexfenfluramine</w>
fenfluramine/ dexfenfluramine,</w>
fenfluramine. These</w>
fenfluramine. There</w>
fenfluramine- phentermine.</w>
fenfluramine- phentermine,</w>
fenfluramine- derivative</w>
fenfluramine ].</w>
fenflur amine-</w>
fenest ral</w>
fenbufen -treated</w>
fen-phen )</w>
fen-phen "
fen-phen" -associated</w>
fen- tanyl,</w>
fen- phen,</w>
fen valerate-induced</w>
fen valerate,</w>
fen ethylline</w>
fen bendazole,</w>
femoro popliteal</w>
femor is/semitendinosus</w>
femor alis)</w>
femin ized"</w>
female- typical"</w>
female- predominant</w>
femal es:</w>
femal e:</w>
femal e-like</w>
femal e),</w>
fem urs</w>
fem tomole</w>
fem oris</w>
fem oral-popliteal</w>
fem oral,</w>
fem oral)</w>
fely pressin</w>
fely pressin.</w>
felodip ine-treated</w>
felodip ine-diltiazem</w>
felbam ate)</w>
feel ings,</w>
feel ing-of-knowing</w>
feed s</w>
feed ings.</w>
feed back
feedback ?</w>
feed ;</w>
fed sson</w>
fec undity,</w>
fec es,</w>
febri le/non-febrile</w>
febri le,</w>
febri le)</w>
feat ures--comprising</w>
feat ures)</w>
feat ure)</w>
feasib ile,</w>
fear- potentiated</w>
fear- motivated</w>
fear- conditioning</w>
fear some</w>
fear s.</w>
fear :</w>
fear .</w>
fear -inducing</w>
fear ).</w>
fe west</w>
fe tishism</w>
fe til,</w>
fe lodopine,</w>
fe izer</w>
fe ed.</w>
fe ed,</w>
fe ather
feather y</w>
fe ase
fease able</w>
fazad inium,</w>
favour ably.</w>
favour ably,</w>
favor ites,</w>
favor ably.</w>
favor ably,</w>
favor able;</w>
favor able,</w>
fatigue/ tiredness</w>
fatigue/ malaise</w>
fatigu e;</w>
fatigu e:</w>
fatigu e--
fatigue-- appear</w>
fatigu e-
fatigue- resistant</w>
fatigu e),</w>
fatigu e
fatigue like</w>
fatigu ability,</w>
fati gability.</w>
father s</w>
father s.</w>
father .</w>
father 's</w>
fatal ities/year</w>
fat tly</w>
fat ally</w>
fat -
fat- soluble</w>
fat )</w>
fat )/
fat)/ fat.</w>
fast- twitch</w>
fast- spiking</w>
fast- sodium-channel</w>
fast- reversible</w>
fast- neutron</w>
fast- flowing</w>
fast est-
fastest- growing</w>
fast er,</w>
fast ed,</w>
fashi oned</w>
fascicul us.</w>
fascicul ations;</w>
fascicul ation;</w>
fascicul ation
fasciculation s?--a</w>
fascicul ata.</w>
fascicul at
fasciculat ing).</w>
fascic ualtion</w>
fascic les</w>
fascic le,</w>
fasci otomies,</w>
fasci itis</w>
fasci itis.</w>
fasci itis,</w>
fas udil</w>
fas tigial</w>
fas tigeal</w>
fas cination</w>
farnes oid</w>
far- reaching</w>
far- advanced</w>
far- advanced,</w>
far sightedness,</w>
far ming</w>
far abine-induced</w>
far .
far. Furthermore,</w>
famoti dine:</w>
famoti dine-associated</w>
famoti dine)</w>
famili ar
familiar ize</w>
famili al)</w>
famil y:</w>
famil y)</w>
famil y's</w>
fam ous</w>
fam ciclo
famciclo vir,</w>
fallop ian)</w>
fall s)</w>
fall ing,</w>
fall ing)</w>
fall en.</w>
fall [6]</w>
falcipar um,</w>
fal se-positive</w>
fal se-positive"</w>
fair -
fair- quality</w>
fair ,</w>
fain tness.</w>
fain tly</w>
fain tings.</w>
fain ting[2]</w>
fain ting.</w>
fain t.</w>
failure-- should</w>
failure-- first</w>
failure /
failure/ relapse</w>
failure -the</w>
failure -related</w>
failure --a</w>
failure -
failure- prone,</w>
failure );</w>
failure '</w>
failure "</w>
fail s,</w>
fai led;</w>
faec ium.</w>
faec es</w>
faec es.</w>
faec es,</w>
faec alis,</w>
fade d.</w>
fade ;</w>
fade ,</w>
factors-- lead</w>
factors-- declines</w>
factor-beta 1.</w>
factor-beta (1)</w>
factor- mediated</w>
factor- binding</w>
factor- b</w>
factor- b
factor-b 1</w>
factor- alpha/beta</w>
factor- alpha)</w>
factor- B</w>
factor- 4</w>
factor- 2</w>
factor- -
factor-- cleaving</w>
factor s).</w>
factor ;</w>
factor 2</w>
factor /
factor/ vascular</w>
factor -</w>
factor )/
factor)/ nitric</w>
factor ).</w>
facti tiously</w>
facti tia</w>
fact s:</w>
fact s,</w>
facilit y-level</w>
facilit es</w>
facilit atory,</w>
facilit ators</w>
facilit ator,</w>
facilit ative</w>
facilit ation)</w>
facilit ated.</w>
facilit ate,</w>
facil ities,</w>
facil ities).</w>
faci ent,</w>
faci e</w>
faci ale,</w>
faci al/
facial/ forelimb</w>
face- name</w>
face- grooming</w>
fac ulty</w>
fac ile</w>
fac ies</w>
fac es</w>
fac e;</w>
fa ults</w>
fa des</w>
fa ")</w>
fEP SP</w>
fEP SP)</w>
fAr M</w>
fAr M)</w>
f. CLO
f.CLO F)</w>
f- Perception</w>
f- DXR</w>
f uzzy</w>
f utile,</w>
f usions</w>
f usions.</w>
f uses</w>
f used,</w>
f use</w>
f unisitis,</w>
f torafur</w>
f ten,</w>
f s</w>
f rowning,</w>
f rightening.</w>
f pr</w>
f oul</w>
f ontanelle</w>
f onate</w>
f odrin</w>
f o</w>
f moles/mg</w>
f mk</w>
f lips).</w>
f its,</w>
f ically</w>
f g</w>
f g.KG,</w>
f ent
fent ay
fentay l</w>
f ecting</w>
f da
fda .
fda. gov/medwatch),</w>
f bc
fbc )
fbc) 3.</w>
f ather,</w>
f an-
fan- shaped</w>
f all-
fall- off</w>
f ading</w>
f acet
facet s</w>
f PD.</w>
f MRI.</w>
f MLT</w>
f M
fM LT
fMLT -induced</w>
f ;</w>
f 9</w>
f 2)</w>
f 1-
f1- f2)</w>
f /
f/ azep
f/azep ine-5-carboxamide)</w>
f -</w>
f ),</w>
f (2)</w>
f (1)</w>
f (1),</w>
ezetimi be-induced</w>
ez rin)</w>
ez ira,</w>
ez e-
eze- fracturing</w>
eyel ash
eyelash es,</w>
eye- tracking</w>
eye- hand</w>
eye- drops</w>
eye- blinking</w>
eye drops.</w>
eye brow
eyebrow s,</w>
eye ).</w>
eye "</w>
ey ronie's</w>
ey nep</w>
ey elas
eyelas h</w>
ey ed</w>
ey ase
eyase el
eyaseel an,</w>
exud ation</w>
exud ation,</w>
exud ates,</w>
extub ation;</w>
extub ated.</w>
extremit es,</w>
extrem es.</w>
extrem es,</w>
extre mis,</w>
extre mely-low-birth-weight</w>
extre me.</w>
extravas atory</w>
extravas ations</w>
extrasystol e
extrasystole (s),</w>
extrastimul ation.</w>
extras ytoles</w>
extras timulation</w>
extrapyramid al,</w>
extrapyramid al)</w>
extrapol ations</w>
extrapol ates</w>
extrap ituitary</w>
extraneuron al.</w>
extraneuron al,</w>
extraneuron al)</w>
extran uclear</w>
extram yeloid</w>
extram embranous</w>
extrac ted,</w>
extrac erebr
extracerebr ally</w>
extrac ell
extracell ularly,</w>
extrac apillary</w>
extrac ap
extracap sular</w>
extra- strength</w>
extra- stimuli</w>
extra- ocular</w>
extra- label</w>
extra- hypothalamic</w>
extra- hematologic</w>
extra- cor
extra-cor poreal</w>
extra vascularly</w>
extra vascular.</w>
extra thoracic</w>
extra prostatic</w>
extra ordinary</w>
extra ordinarily</w>
extra ordinarily,</w>
extra operative</w>
extra intestinal</w>
extra hypothalamic</w>
extra hypothalamic-limbic</w>
extra haematological</w>
extra -</w>
extr uding</w>
extr ude</w>
extr ication</w>
extr at
extrat esticular</w>
extr af
extraf usal</w>
extr act
extract able</w>
extingu ished,</w>
extingu ish</w>
external- internal</w>
exteri orized</w>
exteri orised</w>
exteri or,</w>
exter nal,</w>
exter nal)</w>
exter ior</w>
extens ors);</w>
extens ores</w>
exten uated</w>
exten sions</w>
exten sion;</w>
exten ded-
extended- field</w>
exten ded,</w>
ext ents,</w>
ext ent)</w>
ext ant</w>
exstroph y</w>
exstroph y,</w>
exsangu inated</w>
expul sion.</w>
expul sion,</w>
expres sions,</w>
expres sion;</w>
expres sion,which</w>
expres sion).</w>
expres sed;</w>
exposure ?</w>
exposure >
exposure> single</w>
exposure -based</w>
exposure --in</w>
exposed +
exposed+ melatonin-treated.</w>
expos ures;</w>
expos ures:</w>
expos ures)</w>
expos ures),</w>
expon ential,</w>
expon enti
exponenti ally,</w>
expo sed;</w>
explosi vity,</w>
explosi ves</w>
explo sivity</w>
explo re:</w>
explo ited.</w>
explo itation</w>
explic ating</w>
explic able</w>
explant ation</w>
explant ation.</w>
explan ted;</w>
explan atory</w>
explain able</w>
explain able.</w>
expl ants,</w>
expl ain.</w>
expir ing</w>
expir ation,</w>
expi red:</w>
expi red.</w>
experti se</w>
experti se.</w>
experimenter 's</w>
experiment s:</w>
experiment s).</w>
experiment ations.</w>
experiment ation,</w>
experiment ally.</w>
experiment al-induced</w>
experiment )</w>
experim ented</w>
experience d,</w>
experienc es:</w>
experi ence;</w>
experi ence:</w>
experi ence).</w>
exper ts.</w>
expendit ure,</w>
expen sive,</w>
expen sive"</w>
expen se.</w>
expen se,</w>
expedi tiously</w>
expedi ent</w>
exped iting</w>
expector ate</w>
expector ants</w>
expector ant</w>
expect ed).</w>
expect ations.</w>
expect ant</w>
expect anc
expectanc y,</w>
expan ders,</w>
expan der.</w>
expan d.</w>
exp ound</w>
exp ended</w>
exp 2,</w>
exophthal mia.</w>
exophthal mia,</w>
exo erythrocytic</w>
exo )-
exo)- 8-
exo)-8- benzoyl-
exo)-8-benzoyl- N-(
exo)-8-benzoyl-N-( ((2
exo)-8-benzoyl-N-(((2 S)
exo)-8-benzoyl-N-(((2S) 7-chloro-
exo)-8-benzoyl-N-(((2S)7-chloro- 2,3-
exo)-8-benzoyl-N-(((2S)7-chloro-2,3- dihydro
exo)-8-benzoyl-N-(((2S)7-chloro-2,3-dihydro -1,4-
exo)-8-benzoyl-N-(((2S)7-chloro-2,3-dihydro-1,4- benzodiox
exo)-8-benzoyl-N-(((2S)7-chloro-2,3-dihydro-1,4-benzodiox in-1-yl)methyl)-8-azabicyclo(3.2.1)octane-3-methanamine</w>
exist s;</w>
exist ential</w>
exist ed,</w>
exist ;</w>
exhib ited:</w>
exhib ited.</w>
exhib it:</w>
exhib it.</w>
exhib it,</w>
exhaust ed</w>
exfoli ation.</w>
exfoli ate</w>
exercise- trained</w>
exercise- isoproterenol</w>
exercise- RNV</w>
exercise -mediated</w>
exercise -associated</w>
exercise +
exercise+ ischemia</w>
exencephaly )</w>
exempl ify</w>
exempl ifies,</w>
exec uting</w>
exec ute.</w>
excur sion</w>
excur sion,</w>
excret ory,</w>
excre tions.</w>
excre tion-limited</w>
excre tion).</w>
excre tion),</w>
excre ting</w>
excre ted,</w>
exclude d;</w>
exclude d),</w>
exclu sively.</w>
exclu sions,</w>
exclu sion).</w>
exclu ded)</w>
excitoneuro toxicity</w>
excitoneuro toxicity.</w>
excitatory/ inhibitory</w>
excitatory/ inhibitory)</w>
excitator y.</w>
excit otoxicity,</w>
excit otoxic,</w>
excit ement.</w>
excit ation?</w>
excit ation/
excitation/ inhibition</w>
excit able,</w>
excit ability;</w>
excipi ent-related</w>
exci sional</w>
exci sed.</w>
exchang er,</w>
exchang e),</w>
exces ses</w>
excep tions</w>
excep tions:</w>
excep tional;</w>
excep tion).</w>
excell ent;</w>
excell ent'</w>
excell ent"</w>
excell ent
excellent ',</w>
exceede d,</w>
exce pting</w>
exce pt;</w>
exce lsa</w>
exc rescences</w>
exc ise</w>
exanth em.</w>
examp le,central</w>
examp le).</w>
examine d.(ABSTRACT</w>
examine d,
examined, was</w>
examine d).</w>
examin ining</w>
examin ations;</w>
exam s.</w>
exam ined;</w>
exam ine,</w>
exam ethyl
examethyl melamine</w>
exam .</w>
exacerb ation;</w>
exacerb ated.</w>
exac lone</w>
ex- users</w>
ex- users,</w>
ex- smokers,</w>
ex- smoker</w>
ex- change</w>
ex ultation</w>
ex uberant</w>
ex troversion</w>
ex t-dependent</w>
ex sudation</w>
ex sorption</w>
ex quisitely</w>
ex ports</w>
ex otoxin,</w>
ex ortion</w>
ex orbitantly</w>
ex ophytic</w>
ex ophoria.</w>
ex on.</w>
ex ofenadine</w>
ex ocytotic</w>
ex ocytosis,</w>
ex ocytic</w>
ex it.</w>
ex imone,</w>
ex id)</w>
ex enter
exenter ation</w>
ex end
exend in-4</w>
ex e
exe eding</w>
ex cor
excor iations</w>
ex changes,</w>
ex anec
exanec arboxamide</w>
ex act,</w>
ex ;</w>
ex -opioid</w>
ew s).</w>
ew on</w>
ew is)</w>
evolu tionarily</w>
evol ving.</w>
evol ved.</w>
evol ved,</w>
evol utive</w>
evol ed</w>
evoked- seizure</w>
evoked- hypotension.</w>
eviprostat -treated</w>
eviprostat ,</w>
evidence ;</w>
evid ent;</w>
every- other-day</w>
every- growing</w>
every- 21-day</w>
every- 2-week</w>
every day,</w>
everolim us--microcytosis,</w>
everolim us,</w>
ever -
ever- growing</w>
events/ disease</w>
events/ 100</w>
event s.)</w>
event s--headache/migraine,</w>
event s)</w>
event s'</w>
event s"</w>
event ?</w>
event ;</w>
event --a</w>
event -
event- reporting</w>
event (s)</w>
even ing).</w>
evalu ative</w>
evalu ations)</w>
evalu ation:</w>
evalu ation.(ABSTRACT</w>
evalu ating,</w>
evalu atable</w>
evalu able:</w>
evacu ative</w>
evacu ation:</w>
evacu ation.</w>
evacu ation,</w>
ev ski-Weizman</w>
ev ocate</w>
ev ised</w>
ev ened</w>
ev apor
evapor ative</w>
ev al</w>
ev agination</w>
ev ac</w>
ev ac
evac or)</w>
ev a,</w>
euthanati zed.</w>
euthan ization,</w>
euphori genic</w>
euphori ants</w>
euphori ant</w>
euphor ic,</w>
euphor ia?</w>
eugen olol:</w>
eugen ol.</w>
eucalce mic,</w>
euc ap
eucap nia.</w>
eu thyroidism,</w>
eu thermia</w>
eu ptake</w>
eu glycemia.</w>
etybenz atropine</w>
etybenz atropine,</w>
etri ggered</w>
etretin ate-induced</w>
etretin ate-exposed</w>
etretin ate-
etretinate- hepatitis</w>
etra )</w>
etoposide :</w>
etoposide /ml)</w>
etoposide ).</w>
etomidate- vecuronium</w>
etomidate- alfentanil</w>
etomid ate-associated</w>
etom y</w>
etodol ac-
etodolac- dextran</w>
etodol ac
etodolac :</w>
etiolog y;</w>
etidoca ine;</w>
etidoca ine:</w>
etid ronate</w>
etid ronate)</w>
eti opathology</w>
eti opathological</w>
eti opathogenetic</w>
eti ological,</w>
eti odcaine</w>
eti foxine),</w>
ethynyl- androst
ethynyl-androst ano[
ethynyl-androstano[ 3,2-
ethynyl-androstano[3,2- b]
ethynyl-androstano[3,2-b] pyrimido[1,2-a]benzimidazole;</w>
ethyn yloestradiol</w>
ethyn ylestradiol-treated</w>
ethyn il</w>
ethylketazoc ine.</w>
ethyl]-4-(3-phenylpropyl) piperazine.</w>
ethyl]- benzoic</w>
ethyl-beta-carboline-3- carboxyl
ethyl-beta-carboline-3-carboxyl ate.</w>
ethyl-5- phenylbarbituric</w>
ethyl-2- oxo-pyrrolidine</w>
ethyl-2- methyl-quinolin-6-yl)-(4-methoxy-cyclohexyl)-methanone</w>
ethyl- beta-methyl-
ethyl-beta-methyl- gamma-thiobutyrolactone</w>
ethyl- amine-initiated</w>
ethyl- alpha-p-chlorophenoxyisobut
ethyl-alpha-p-chlorophenoxyisobut yrate</w>
ethyl- [2,
ethyl-[2, 5-dimethyl-
ethyl-[2,5-dimethyl- 7-
ethyl-[2,5-dimethyl-7- (2,4,6-
ethyl-[2,5-dimethyl-7-(2,4,6- trimethylphenyl)-7H-pyrrolo</w>
ethyl- 4-methyl
ethyl-4-methyl pentanoyl</w>
ethyl- 2,4-dioxo-5,5-diphenyl-imidazol
ethyl-2,4-dioxo-5,5-diphenyl-imidazol idine</w>
ethyl)- aminoc
ethyl)-aminoc arboxyl
ethyl)-aminocarboxyl methyloxy)phenyl-1,3-dipropylxant</w>
ethyl)- 4,5-
ethyl)-4,5- dihydroxy
ethyl)-4,5-dihydroxy -1,
ethyl)-4,5-dihydroxy-1, 6-di
ethyl)-4,5-dihydroxy-1,6-di methoxy-9H-fluoren-9-one.</w>
ethyl)- 3-(trans-4-methylcyclohexyl)-1-nitrosourea</w>
ethyl) spiro[2,5]octane-1-carboxamide].</w>
ethyl) phenyl]ethylamino]-5'-N-ethylcarboxamidoadenosine;</w>
ethyl) naphthalenesulfonamide</w>
ethyl) lysine</w>
ethyl) benzyl)
ethyl)benzyl) acetam
ethyl)benzyl)acetam idine</w>
ethyl starch</w>
ethyl morphine</w>
ethyl ene.</w>
ethyl ammonium</w>
ethyl amino)-4-
ethylamino)-4- methyl-4-phenyl-4H-3,1-benzoxazine</w>
ethyl amide)</w>
ethyl /-
ethyl/- N-ethyl-2-bromobenzyl
ethyl/-N-ethyl-2-bromobenzyl amine]</w>
ethyl -10-
ethyl-10- hydroxycamptothecin</w>
ethoxyqu in-treated</w>
ethoxy- 5-(
ethoxy-5-( morpholinylacetyl)</w>
ethoxy zolamide</w>
ethoxy zolamide,</w>
ethoxy methyl-5-FU</w>
ethoxy carbonyl
ethoxycarbonyl -1,4-
ethoxycarbonyl-1,4- dihydro
ethoxycarbonyl-1,4-dihydro coll
ethoxycarbonyl-1,4-dihydrocoll idine</w>
ethoxy carbon
ethoxycarbon yl,</w>
ethoxy acetoxy-
ethoxyacetoxy- daunorubicin</w>
ethoxy -</w>
ethosuxim ide-associated</w>
ethnomedic ine</w>
ethnomedic ine.</w>
ethno pharmacology</w>
ethno graphic</w>
ethnic ity</w>
ethnic ,</w>
ethmo ids,</w>
ethmo idal</w>
ethinylo estradiol)</w>
ethinylo estradiol
ethinyloestradiol ),</w>
ethinylestradi ol/dienogest</w>
ethinylestradi ol,</w>
ethinyl- oestradiol,</w>
ethinyl- estradiol</w>
ether s</w>
ether :</w>
ether -
ether- eluate</w>
ethchlorv ynol,</w>
ethanol/ water</w>
ethanol/ saline</w>
ethanol/ bupropion</w>
ethanol- withdrawal</w>
ethanol- potentiated</w>
ethanol- fed</w>
ethanol- evoked</w>
ethanol- drinking,</w>
ethanol- derived</w>
ethanol and</w>
ethanol amine,</w>
ethanol amin
ethanolamin es:</w>
ethanol :
ethanol: distilled</w>
ethanol ).</w>
ethan oate</w>
ethan esulfonic</w>
ethan amine</w>
ethambut ol-related</w>
ethambut ol-associated</w>
ethambut ol's</w>
eth yleinamine</w>
eth oxy</w>
eth nomedical</w>
eth nically</w>
eth isterone.</w>
eth iops)</w>
eth ically</w>
eth enyl)
ethenyl) -1,3-diethyl-
ethenyl)-1,3-diethyl- 7-methyl-3,7-dihydro-1H-purine-
ethenyl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine- 2,6-
ethenyl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6- dione</w>
eth -
eth- Ay
eth-Ay er
eth-Ayer st,</w>
eth ).</w>
etc. );</w>
etax olol,</w>
etan idazole,</w>
etan idazole)</w>
et- stained</w>
et- ketamine</w>
et terlund,</w>
et te:</w>
et te,</w>
et onogestrel</w>
et ofibrate/clofibrate</w>
et ine-associated</w>
et ine,</w>
et in)</w>
et ens
etens in</w>
et c</w>
et but
etbut al-
etbutal- anaesthetized</w>
et ate</w>
et aphen
etaphen )</w>
et al,</w>
et acin</w>
et abolic</w>
et abine</w>
et ab
etab onate,</w>
et a-
eta- cryst
eta-cryst alin,</w>
et a,</w>
et -to-
et-to- dry</w>
et (CO
et(CO 2)),</w>
esulfon yl-7-(4-methyl-piperazin-1-yl)1H-indole)</w>
esul -
esul- fonate</w>
estrus/ metestrus</w>
estrogen- supplemented</w>
estrogen- related.</w>
estrogen- progesterone-induced</w>
estrogen- plus-progestin</w>
estrogen- initiated</w>
estrogen- implanted</w>
estrogen- content</w>
estrogen- ER</w>
estrogen s).</w>
estrogen isation.</w>
estrogen icity</w>
estrogen -mediated</w>
estrogen ).</w>
estrogen 's</w>
estro usfemales.</w>
estro l)</w>
estramust ine.</w>
estradiol-3- glucuronide</w>
estradiol-3- D-
estradiol-3-D- glucuronide</w>
estradiol-17 beta-D-glucuronide</w>
estradiol-17 beta-
estradiol-17beta- related</w>
estradiol -17-
estradiol-17- beta-glucuronide</w>
estradi ol-supplemented</w>
estr us)</w>
estim ators</w>
estim ator</w>
estim ate.</w>
estim ate,</w>
estic ated</w>
esthe tics.</w>
ester- analogs</w>
ester- (L-NAME)</w>
ester ification</w>
ester ase-
esterase- 4</w>
ester ase),</w>
ester ],</w>
ester )</w>
establ ished;</w>
establ ished:</w>
establ ish,</w>
est- forming</w>
est rone-induced,</w>
est romustine</w>
est ril)</w>
est ration</w>
est or,</w>
est ogens.</w>
est in-immunoreactive</w>
est etized</w>
est azol
estazol am</w>
est abil
estabil ishment</w>
essenti ally,</w>
essenti al-
essential- like</w>
essenti al"</w>
essen ger</w>
essen ce;</w>
ess ay</w>
ess ?</w>
esorub icin.</w>
esorub icin-induced</w>
esorub icin,</w>
esophag us),</w>
esoph oric</w>
esoph oria</w>
esol id).</w>
esmo lol.(ABSTRACT</w>
eser ine-induced</w>
esculent a</w>
esculent a.</w>
esculent a,</w>
escitalopram -treated</w>
escitalopram -induced</w>
esch ,</w>
escap ing</w>
escap e;</w>
escap e-like</w>
escap e).</w>
escap ade
escapade -r
escapade-r hytm</w>
escal ations.</w>
esac aine-
esacaine- CE
esacaine-CE ;</w>
es/ registries</w>
es/ mitoxantrone</w>
es/ min</w>
es/ min,</w>
es/ menstrual</w>
es/ mL.</w>
es/ hour)</w>
es/ Roussel</w>
es. m.b.H.</w>
es. Overall,</w>
es-- visual</w>
es-- relation</w>
es-- precipitation</w>
es-- in</w>
es-- daunorubicin</w>
es-- aldolase</w>
es-- HB-7</w>
es- or</w>
es- noradrenergic</w>
es- corrected</w>
es- clo
es-clo sed"</w>
es- Depression</w>
es- 40</w>
es, with</w>
es ther</w>
es ses</w>
es ponse</w>
es otropia,</w>
es orubicin;</w>
es opathies</w>
es on</w>
es omeprazole.</w>
es na)</w>
es ity</w>
es in),</w>
es h</w>
es cinti
escinti graphy,</w>
es cent
escent -onset</w>
es -induced</w>
es (P</w>
es 's</w>
es '.</w>
es ".</w>
erythropoiet in:Hb</w>
erythropoiet in-dependent</w>
erythropoie tic-stimulating</w>
erythropoie sis:</w>
erythromel algia.</w>
erythromel alg
erythromelalg ia."</w>
erythrom ycin-carbamazepine</w>
erythrodysesthesi a)</w>
erythroder ma;</w>
erythroder ma.</w>
erythrocyte -related</w>
erythrocyte -</w>
erythrocy te,</w>
erythroblast s.</w>
erythroblast openia,</w>
erythroblast -
erythroblast- intrinsic</w>
erythro leukemia),</w>
erythro cytotoxicity</w>
erythro cytotoxicity.</w>
erythro cytosis.</w>
erythro cytosis,</w>
erythro cytopenia</w>
erythro cytopenia,</w>
erythro cyt
erythrocyt es--relation</w>
erythro blastic</w>
erythro -
erythro- (+/-)-1-
erythro-(+/-)-1- (7-methyl
erythro-(+/-)-1-(7-methyl indan-4-yloxy)-3-isopropylaminobutan-2-ol</w>
erythematos us;</w>
erythematos us--3;</w>
erythemat osis</w>
erythemat osis.</w>
erythemat opurpuric</w>
erythemat odes.</w>
erythema /
erythema/ desquamation.</w>
erythema ".</w>
eryth ymic</w>
eryth ron.</w>
eryth ron,</w>
eryth riod</w>
eryth omycin</w>
eryth ma</w>
ery ptosis</w>
ery /
ery/ anesthesi
ery/anesthesi ology,</w>
erv ical,</w>
erv ain
ervain 's</w>
erup tive</w>
erup tion"</w>
ertap enem,</w>
ertap enem
ertapenem ;</w>
error= 46.
error=46. 6,</w>
error= 10.
error=10. 8,</w>
error s).</w>
error :</w>
error -related</w>
error ),</w>
error "</w>
erro r-processing</w>
erro r)</w>
erro kinetic</w>
errati cally.</w>
errati c,</w>
ero sitis</w>
ero sion.</w>
ero infundibular</w>
ero gotamine,</w>
ero ded.</w>
erm cath
ermcath )</w>
ering- Plo
ering-Plo ugh</w>
ergot s,</w>
ergot amine;</w>
ergot -treated</w>
ergot -like</w>
ergonov ine.</w>
ergonov ine-induced</w>
ergol ines</w>
ergol ines:</w>
ergol ine-derivative</w>
ergol ide</w>
erg y.</w>
erg otism.</w>
erg opeptide</w>
erg onomic</w>
erg ometry</w>
erg ometry.</w>
erg mann's</w>
eren oa</w>
erec tions/30</w>
erec tion:</w>
erebr i</w>
ere z</w>
ere vent),</w>
ere sis,</w>
ere d:</w>
erdoste ine-treated</w>
erdoste ine,</w>
erculo us</w>
erb ati
erbati m"</w>
erb al
erbal ife</w>
eral d)</w>
eradic ates</w>
eradic able</w>
er-than- anticipated</w>
er- verapamil</w>
er- susceptible</w>
er- scanning</w>
er- scale</w>
er- reviewed</w>
er- identification</w>
er- extremity</w>
er- drug</w>
er- damaging</w>
er usalem,</w>
er uloplasminaemia.</w>
er twig-Magendie</w>
er thema</w>
er str</w>
er son's</w>
er s);</w>
er ry</w>
er ratic</w>
er r</w>
er obes.</w>
er noff</w>
er nece</w>
er max)</w>
er ization</w>
er ithrophagocytic</w>
er isostatin</w>
er ics.</w>
er ich,</w>
er ia</w>
er gies</w>
er fulness,</w>
er cap
ercap tosuccinic</w>
er ase,</w>
er as,</w>
er T
erT K)</w>
er 344</w>
er /kg</w>
er -type</w>
er -associated</w>
er --a</w>
er "</w>
equivalent s/day.</w>
equivalent s/day,</w>
equivalent s).</w>
equival ent)</w>
equival ent).</w>
equival ency</w>
equival ence.</w>
equisetiform is.</w>
equip ment,</w>
equimyelo suppressive</w>
equilibri um,</w>
equilibri um"</w>
equilibr ation.</w>
equilib rates</w>
equi potential</w>
equi osmotic</w>
equi brady
equibrady cardic.</w>
equi analgesia</w>
equi active</w>
equi -active</w>
equ orin-loaded</w>
equ ivocal,</w>
equ itazine</w>
equ idose</w>
equ ator.</w>
equ ations,</w>
equ ation:</w>
equ ation).</w>
equ ation
equation s'</w>
equ ating</w>
equ ated</w>
equ alling</w>
equ alled</w>
equ alization</w>
equ al-
equal- sized</w>
equ al,</w>
ept ors.</w>
ept omeningeal</w>
ept apir
eptapir one,</w>
ept aminol</w>
ept ,</w>
epsilon- nitro-L-arginine</w>
epsilon- amin
epsilon-amin ocaproic-acid-induced</w>
epsilon- Amin
epsilon-Amin ocaproic</w>
epsilon .</w>
epoxy hexahydrocannabinol</w>
epoprosten ol.</w>
epoprosten ol)</w>
epomedi ol-treated</w>
epomedi ol,</w>
epoi etin</w>
epoch s</w>
epoch s.</w>
epoch s)</w>
epoch ,</w>
epo etin)</w>
epitheli um-derived</w>
epitheli otropic</w>
epitheli al-to-
epithelial-to- mesenchymal</w>
epitheli al,</w>
epitheli a,</w>
epit rochlearis</w>
epit opes.</w>
epist axis</w>
epist atic</w>
episode s:</w>
episode s/patient/month</w>
episode s.(ABSTRACT</w>
episode ;</w>
episode :</w>
episode ).</w>
episo dic,</w>
episo des
episodes );</w>
episiotom y-uterine</w>
episiotom y),</w>
epirubicin/ number</w>
epirubicin/ m2</w>
epirubicin/ duration</w>
epirubicin/ cyclophosphamide</w>
epirubicin/ Lipiodol</w>
epirubic in;</w>
epirubic in:</w>
epirubic in-mediated</w>
epirubic in-gemcitabine</w>
epirubic in)</w>
epirubic in).</w>
epir udin</w>
epir one,</w>
epiphy sis</w>
epineur ium.</w>
epineur ally</w>
epinephrine/ clonidine</w>
epinephrine- sufentanil</w>
epinephrine- propranolol</w>
epinephrine- halothane</w>
epinephrine- free</w>
epinephrine- enflurane</w>
epinephrine- arrhythmia</w>
epinephrine- ,</w>
epinephr ine-dependent</w>
epim erase,</w>
epim er,</w>
epileptic us?</w>
epileptic us-dependent</w>
epileptic us"</w>
epileptic s),</w>
epileptic /brain</w>
epileptic -related</w>
epileptic "</w>
epilepsy- resistant</w>
epilepsy- elicited</w>
epilepsy -like</w>
epilepsy )</w>
epilep sia.</w>
epilep sia,</w>
epiflu orescent</w>
epiflu orescence</w>
epidur als</w>
epidur ally:</w>
epidur ally.</w>
epidur ally,</w>
epidur al/
epidural/ general</w>
epidur al.</w>
epididy mitis.</w>
epididy mitis,</w>
epidermidi s.</w>
epiderm ized</w>
epiderm atiz
epidermatiz ation.</w>
epider mo-dermal</w>
epider mis,</w>
epider mis)</w>
epidemio logy;</w>
epidemio logy.</w>
epidemio logically</w>
epide mics</w>
epide mic?</w>
epide mic.</w>
epid ydimitis.</w>
epid oxorubicin-related</w>
epicardi um,</w>
epicardi ally,</w>
epic at
epicat ech
epicatech in,</w>
epib atidine.</w>
epi- D
epi-D 3;</w>
epi podophyllotoxin</w>
epi phora</w>
epi phenomena</w>
epi phenomena,</w>
epi me-related</w>
epi glottitis</w>
epi genetically</w>
epi gastralgia,</w>
epi gallocatethin-3-O-gallate</w>
epi ep
epiep ticus</w>
epi depri
epidepri de</w>
ephedrine- caffeine</w>
ephedrine- caffeine-treated</w>
ephedr ine:</w>
ephedr ine)</w>
ephedr ine(25</w>
ephed rone.</w>
ephed ra-containing</w>
eph in),</w>
eph ilic</w>
epend ymoma,</w>
epend ymoblastomas,</w>
epal restat,</w>
ep yramine</w>
ep tives</w>
ep tics</w>
ep tember</w>
ep siodes</w>
ep sia,</w>
ep oxygenase(s)</w>
ep oxide:</w>
ep oxide.</w>
ep oxidation</w>
ep oxidation,</w>
ep one)</w>
ep iscleritis,</w>
ep imer</w>
ep ilectically</w>
ep dog</w>
ep )</w>
eosinophil uria,</w>
eosinophil s;</w>
eosinophil s)</w>
eosinophil ic-clear</w>
eosinophil ic)</w>
eosinophil ia;</w>
eosinophil ia:</w>
eosinophil -
eosinophil- rich</w>
eosin- detectable</w>
eoniflor in</w>
eochromocyt omas</w>
enzyme- documented</w>
enzyme- blocking</w>
enzyme -mediated</w>
enzyme -induced</w>
enzyme )</w>
enzym uria:</w>
enzym es--aldolase</w>
enzym es)</w>
enzym atic,</w>
enz ymopathy.</w>
enz a-like</w>
enz a,</w>
environ ments,</w>
environ ment:</w>
environ ment-directed</w>
environ ment-</w>
environ ment)</w>
envelop e,</w>
enucle ations</w>
enucle ation.</w>
entrop y-based</w>
entrop y)</w>
entrain ment,</w>
entra ins</w>
entra in</w>
entr y-blood</w>
entr y)</w>
entor rinal</w>
entof ylline</w>
entiaz em</w>
enti sts</w>
enti rety,</w>
enti meters</w>
enti april</w>
enthusi ast</w>
enthusi as
enthusias m</w>
enth esopathies</w>
entero kinetics</w>
enter tained</w>
enter oscopy</w>
enter oscopy.</w>
enter ology,</w>
enter ocytes.</w>
enter ocol</w>
enter ococcus.</w>
enter ococci.</w>
enter itis.</w>
enter ally</w>
enter al,</w>
enter )</w>
entec avir
entecavir -treated</w>
entan .</w>
entail ing</w>
entail ed</w>
enta il</w>
ent- throughout</w>
ent- t-test</w>
ent- second")</w>
ent- owned</w>
ent- assisted</w>
ent zel</w>
ent s;</w>
ent s:</w>
ent ries.</w>
ent ries)</w>
ent renched.</w>
ent on</w>
ent olinDiskhaler)</w>
ent ing,</w>
ent ina.</w>
ent genographic</w>
ent etate</w>
ent ered:</w>
ent e
ente e
entee ism</w>
ent at),</w>
ent angle</w>
ent ang
entang led</w>
ent ane)</w>
ent al.</w>
ent affin</w>
ensu red</w>
ensu red,</w>
ensu re,</w>
ensu es.</w>
ens oring</w>
ens chop
enschop ,</w>
ens atory</w>
enroll ments</w>
enrol ment,</w>
enqu ire</w>
enoxim one.</w>
enoxim one-induced</w>
enoxim one's</w>
enoxapar ine.</w>
enoxapar in;</w>
enoxapar in-induced</w>
enoxapar in-associated</w>
enoxapar in)</w>
enox olone</w>
enox acin)</w>
enol ase)</w>
eno yl</w>
eno virus</w>
eno s</w>
eno protective</w>
enn a,</w>
enn Care
ennCare ),</w>
enlarg ing,</w>
enlarg ement)</w>
enlarg e,</w>
enkephalin- Th
enkephalin-Th r)</w>
enkephalin ase,</w>
enkephalin ase
enkephalinase ",</w>
enkephal in,</w>
enjo ys</w>
enjo yed</w>
enig mas.</w>
enig ma.</w>
eni ker).</w>
enhance ments.</w>
enhanc es-noradrenergic</w>
enhanc ers</w>
enh ouse-Geisser</w>
engulf ment</w>
engulf ment,</w>
ength ening</w>
engraft ment,</w>
engraf ted.</w>
engraf ted,</w>
engag ement.</w>
engag ement,</w>
eng itide.</w>
eng ines</w>
eng erich,</w>
eng er</w>
eng du
engdu ,</w>
eng al</w>
enflur ane;</w>
enflur ane-associated</w>
enflur ane-
enflurane- nitrous</w>
energy- rich</w>
energy- restricted</w>
energy- disper
energy-disper sive</w>
energ y)</w>
energ ising</w>
enem y</w>
enem id).</w>
enem -induced</w>
enedi one,</w>
enedi onate)</w>
ene- propionyl-o-Met-Tyr-Arg-vasopressin</w>
ene- D3:</w>
ene se)</w>
ene fit:</w>
ene del
enedel a,</w>
ene ;</w>
ene :tamoxifen)</w>
ene ),</w>
endpoint s;</w>
endpoint ),</w>
endotoxin- tolerant</w>
endotox in/LPS</w>
endotox in.</w>
endotox in-related</w>
endotox in-mediated</w>
endotox in-like</w>
endotox in-</w>
endotox emic</w>
endothelium- denuded</w>
endothelin-1 -induced</w>
endothelin-1 -dependent</w>
endothelin- B</w>
endothelin- A/
endothelin-A/ endothelin-B</w>
endothelin- A-</w>
endothelin :</w>
endothelin ,
endothelin, transforming</w>
endothelial- mesenchymal</w>
endothelial- mesenchymal-transition</w>
endothelial- independent</w>
endothelial- dependent</w>
endotheli opathy)</w>
endotheli ally</w>
endotheli alization</w>
endotheli al)</w>
endotheli a</w>
endothel in-A</w>
endot racheally</w>
endoscop y;</w>
endoscop y:</w>
endoscop ies</w>
endoscop ic,</w>
endoscop ed</w>
endos omes.</w>
endos omal/lysosomal</w>
endorph ins</w>
endorph ins.</w>
endorph in(1-31)</w>
endor se</w>
endophthal mitis</w>
endophthal mitis.</w>
endophthal mitis).</w>
endonuclease- generated</w>
endometri um(defined</w>
endometri osis:</w>
endometri osis,</w>
endometri al,</w>
endom an
endoman nosidase</w>
endolym phatic</w>
endolym ph,</w>
endogen ous-ouabain-displacing</w>
endogen ous"</w>
endocrino pathies,</w>
endocrin ology</w>
endocrin ologist</w>
endocrin ologist.</w>
endocrin ologically</w>
endocardi um.</w>
endocardi tis:</w>
endocardi tis-related</w>
endocardi ally</w>
endocardi al/
endocardial/ epicardial</w>
endocardi al)</w>
endocannabin oid-mediated</w>
endoc rine-related</w>
endoc ranial</w>
endoc oids</w>
endoc oids.</w>
endoc ervical</w>
endoc ervical,</w>
endo- extracapillary</w>
endo rotation</w>
endo reticular</w>
endo renal</w>
endo proteinase,</w>
endo plasmic/sarcoplasmic</w>
endo peroxides</w>
endo glycosidases,</w>
endo dermal</w>
endo derm</w>
endo bronchial</w>
endo arteritis,</w>
endo -</w>
endi x).</w>
endeav ors</w>
endeav ored</w>
ende mic.</w>
endarterectom y;</w>
endarterectom y:</w>
endarte rectomy,</w>
endang ered.</w>
end-tid al,</w>
end-tid al
end-tidal )-
end-tidal)- anesthetized</w>
end-of- trial</w>
end-of- therapy</w>
end-of- study</w>
end-of- dose"</w>
end- systole</w>
end- products,</w>
end- product</w>
end- linkage</w>
end- labeled)-labeled</w>
end- expired</w>
end- diastolic,</w>
end- diastole</w>
end u-Osler</w>
end opeptidase/endothelin-converting</w>
end omyofibrillar</w>
end ocytotic</w>
end ocytosis,</w>
end ocytosed</w>
end initis</w>
end ings),</w>
end ing.</w>
end ectomy</w>
end diastolic</w>
end arteritis,</w>
end all</w>
end -dose</w>
end ).</w>
encounte red:</w>
encoun ters</w>
encoun ter.</w>
enco red</w>
enco d
encod ing:</w>
encephaly ),</w>
encephalopath y?</w>
encephalopath y),</w>
encephalopath y").</w>
encephalomyeli tis.</w>
encephalo gram.</w>
encephal omyelopathy</w>
encephal omalacia)</w>
encephal oceles,</w>
encephal ocele,</w>
encephal itis;</w>
ence- assessment</w>
encapsul ation.</w>
encapsul ating</w>
encapsul ates</w>
enc losure</w>
enantiom ers;</w>
enantiom eric</w>
enantiom er,</w>
enantio selectivity.</w>
enantio selectivity,</w>
enantio selective</w>
enanth ate:</w>
enanth ate,</w>
enanth ae,</w>
enalapri l;</w>
enalapri l.(ABSTRACT</w>
enalapri l-associated</w>
enalapri l)</w>
enal /
enal/ electrolyte</w>
enadol ine.</w>
enadol ine-induced</w>
enabl es--in</w>
ena ve</w>
ena issance</w>
ena [c]
ena[c] phenathrene-9-10-diol),</w>
en-VPA ;</w>
en-2- one),</w>
en- valproic</w>
en- VPA.</w>
en- Thr</w>
en- Phen
en-Phen )</w>
en- MG</w>
en- M
en-M G).</w>
en- Irish</w>
en yl-2-acyl-GPE</w>
en visaged.</w>
en venomation</w>
en umerate</w>
en thyl-1,3-dipropylxanthine</w>
en thorinal</w>
en son.</w>
en sis.</w>
en sion</w>
en semble</w>
en quirer</w>
en profylline.</w>
en phenamic</w>
en oxiparine</w>
en osis</w>
en opyridines</w>
en ophthalmitis,</w>
en one</w>
en on-based</w>
en olone,</w>
en nially</w>
en listed</w>
en lightenment</w>
en ker-Formol</w>
en ite</w>
en ispermaceae)</w>
en il;</w>
en il:</w>
en grafting</w>
en g</w>
en forced</w>
en ethylline</w>
en ergies</w>
en eral</w>
en ema</w>
en drum</w>
en der-
ender- Utah</w>
en ber
enber gh</w>
en ario
enario s</w>
en ame
ename l</w>
en ae</w>
en -treated</w>
en -related</w>
en ,"</w>
en ).</w>
emulsi fied</w>
emul sion)</w>
emul en</w>
empye ma.</w>
employ ment</w>
employ ed;</w>
employ ed),</w>
emplo yees</w>
emphyse ma.</w>
emphyse ma,</w>
emphyse ma),</w>
emph asis.</w>
emotion ality.</w>
emotion ality,</w>
emotion -related</w>
emo tions;</w>
emo tions,</w>
emo tion,</w>
emit ter</w>
emis sions:</w>
emis sions.</w>
emis sion,</w>
emis pheric</w>
emfiler min,</w>
emfiler min)</w>
emergency- room</w>
emergency ?</w>
emergency :</w>
emergen ci
emergenci es:</w>
emergen ce.</w>
emergen ce
emergence ])</w>
emerg ent"</w>
emerg ed:</w>
emer tence</w>
emer on;</w>
ement- membrane</w>
eme togenic.</w>
eme tics</w>
eme tacin,</w>
eme sis).</w>
eme sis"</w>
embryos :</w>
embryos .(ABSTRACT</w>
embryoleth ality.</w>
embryo pathic</w>
embry otoxic.</w>
embry onal'</w>
embry ologic</w>
embry ocidal</w>
embolism --case</w>
embol ized</w>
embol ization:</w>
embol isms</w>
embol ism:</w>
embol ic-toxic</w>
embol i),</w>
embol ectomy,</w>
embarr assing</w>
embarr assed</w>
embark ing</w>
embark ed</w>
emb yopathic</w>
emb ers</w>
emat osus</w>
eman n-Pick</w>
em- cilastatin</w>
em- CD</w>
em tricitabine</w>
em sa</w>
em pered,</w>
em pathy</w>
em ory</w>
em ollient</w>
em ias</w>
em ia;</w>
em erol</w>
em erald)</w>
em bark</w>
em aci
emaci ated</w>
em -induced</w>
elym oclavine.</w>
elucid ation.</w>
elucid ates</w>
elucid ated
elucidated .(ABSTRACT</w>
elucid ate.</w>
elu ate,</w>
elsewhere )</w>
elsewhere ),</w>
elong ate</w>
ellular -free</w>
ello ,</w>
ellisi ana</w>
ellisi ana.</w>
ellip tical</w>
elli ,</w>
ell o</w>
ell ingly</w>
ell aril</w>
ell ae</w>
ell a,</w>
ell .</w>
ell ,</w>
elimin ation;</w>
elimin ation:</w>
elimin ation-
elimination- that</w>
elimin ates,</w>
elimin ated-
eliminated- in</w>
elic itedby</w>
elic itable</w>
eli xir</w>
elev atum</w>
elev ated;</w>
elev ated).</w>
electroretino grams,</w>
electroretino gram;</w>
electroretino gram,</w>
electroretin ography,</w>
electroretin ographic</w>
electrophysi ology.</w>
electronystagmo graphy</w>
electronystagmo grams.</w>
electronystagmo gram</w>
electronystagmo gram.</w>
electroneuro graphy</w>
electroneuro graphy,</w>
electron- microscopy</w>
electron- microscopy.</w>
electron- microscopical</w>
electron- lucent</w>
electron- den
electron-den se,</w>
electron microscopic</w>
electromyo graphically.</w>
electromyo graphic,</w>
electromyo graph,</w>
electromyo gram,</w>
electrom yelogram</w>
electrom agne
electromagne tic-flow</w>
electroly tes:</w>
electroly te.</w>
electroencephalo graphs</w>
electroencephalo graphic,</w>
electroencephalo grapher</w>
electroencephalo graph.</w>
electroencephalo grams.</w>
electroencephalo gram;</w>
electroencephalo gram-confirmed</w>
electrocortico graphical</w>
electrocardiogram .3.</w>
electrocardiogram ):</w>
electrocardiogram ).</w>
electrocardio version</w>
electrocardio graphy;</w>
electrocardio graphy)</w>
electro-ocu lography.</w>
electro-ocu lographic</w>
electro- physiologic</w>
electro- oculogram</w>
electro- oculogram)</w>
electro- neurochemical</w>
electro- lesions</w>
electro- encephalography</w>
electro- encephalographic</w>
electro- encephalogram</w>
electro- encephalogram,</w>
electro- cardiographic</w>
electro version</w>
electro version.</w>
electro version,</w>
electro transfer</w>
electro transfer.</w>
electro tonically</w>
electro therapy</w>
electro therapy.</w>
electro stimulation</w>
electro stimulated</w>
electro static</w>
electro shock-treated</w>
electro shock-</w>
electro shock-,</w>
electro phoresed</w>
electro philic</w>
electro philes.</w>
electro phile</w>
electro pheresis</w>
electro pharmacologic</w>
electro oculography</w>
electro oculographic</w>
electro oculogram</w>
electro ocular</w>
electro microscopical</w>
electro immunoassay.</w>
electro graphically.</w>
electro graphically-defined</w>
electro graphical</w>
electro grams.</w>
electro gram.</w>
electro gram,</w>
electro genic</w>
electro genesis</w>
electro diagnostic,</w>
electro de-
electrode- implanted</w>
electro de)</w>
electro de
electrode s;</w>
electro cutaneous</w>
electro chemilumin
electrochemilumin iscence</w>
electro cardiac</w>
electro analgesia</w>
electr o</w>
electr myography)</w>
electr ically-induced</w>
electr ical'</w>
elect rified</w>
elect rification</w>
elect oral</w>
elect oencephalographic</w>
ele ven-month</w>
ele trolyte</w>
ele triptan,</w>
ele t</w>
ele stone</w>
ele metry</w>
ele ments)</w>
ele ment-binding</w>
ele ment,</w>
elder s.</w>
elder s,</w>
elder ly?</w>
elder ly;</w>
elder ly)</w>
elat acept</w>
elast osis</w>
elast omeric</w>
elast olysis</w>
elast in.</w>
elast ase.</w>
elast ance</w>
elas ticity,</w>
elabor ates</w>
elabor ated.</w>
el- doxorubicin</w>
el y),</w>
el y"</w>
el tier-controlled</w>
el per,</w>
el lia</w>
el les</w>
el itser</w>
el ite</w>
el fiprim).</w>
el finavir/Zalcitabine/</w>
el er</w>
el en,</w>
el ective,</w>
el ect</w>
el dr
eldr in,</w>
el ch</w>
el ca
elca de),</w>
el ata</w>
el apse</w>
el -based</w>
ek ati
ekati t</w>
ek as</w>
ejac ulation-most</w>
ej ection.</w>
ej ecting</w>
eighty- two</w>
eighty- three</w>
eighty- seven</w>
eighty- five</w>
eight- year</w>
eight- week,</w>
eight- minute</w>
eight- item</w>
eight- four</w>
eight- center,</w>
eigh t;</w>
eigh t/sex.</w>
eigh t).</w>
eigh bo
eighbo uring</w>
eicosan oids;</w>
eicosan oids.</w>
ei genvalue</w>
ei ,</w>
eh rig's</w>
egg s/g</w>
egg s.</w>
eg ac
egac e)</w>
efonidip ine.</w>
efonidip ine,</w>
effu sion;</w>
effu sion:</w>
effort lessly</w>
effort ful</w>
effor t-induced</w>
efflu ent</w>
efflo resces</w>
efflo rescences.</w>
effici ent,</w>
effici ency.</w>
effici encies</w>
efficaci ousness</w>
efficaci ously</w>
efficac y/failure.</w>
efficac ies.</w>
efferen ts</w>
efferen ts,</w>
efferen s</w>
effects-- specifically,</w>
effects-- on</w>
effects-- more</w>
effects-- drowsiness,</w>
effects-- also</w>
effectiven ess?</w>
effective ?</w>
effective .5</w>
effect- compartment</w>
effect uate</w>
effect s.These</w>
effect s.The</w>
effect s-stupor</w>
effect s,with</w>
effect ors</w>
effect or.</w>
effect --
effect-- falling</w>
effect '</w>
effect '.</w>
effect ',</w>
effect ",</w>
effec tivity</w>
effec tively,</w>
eff usions;</w>
eff usion),</w>
efavirenz .</w>
efavirenz -treated</w>
efavirenz -induced</w>
efavirenz -based</w>
efarox an</w>
ef tizox).</w>
edull ar</w>
educ t.</w>
educ ating</w>
educ ated)</w>
educ ated"</w>
educ ate</w>
edrophonium- hyoscine</w>
edrophonium- atropine</w>
edic s</w>
edic ation</w>
edi ble</w>
edi atricians</w>
edet ate</w>
edet ate,</w>
edemat ous.</w>
edemat ose</w>
edema /
edema/ blisters</w>
edema -related</w>
edema --
edema-- sequential</w>
ede wald</w>
ede s,</w>
ede mas.</w>
ede l</w>
edat rexate,</w>
edarav one-induced</w>
edarav one,</w>
edar s-Sinai</w>
ed/ transplanted</w>
ed. Recently,</w>
ed-- intermittent</w>
ed- function</w>
ed- cell</w>
ed- based</w>
ed- Man's</w>
ed- An
ed-An ce
ed-Ance stry</w>
ed ulis,</w>
ed sQL.</w>
ed orn</w>
ed mont</w>
ed itorial.</w>
ed ing.</w>
ed ing,</w>
ed ging</w>
ed ges,</w>
ed ged</w>
ed ge-light</w>
ed ent</w>
ed da
edda h.</w>
ed Health</w>
ed .5.</w>
ed .,</w>
ed ",</w>
ecyst ohepatolithiasis)</w>
ectropi on</w>
ectropi on,</w>
ectropi on),</w>
ectro zyme</w>
ectop y,</w>
ectop ies.</w>
ectop ically</w>
ectop ically,</w>
ectop ic)</w>
ectop ia</w>
ectop ar
ectopar asi
ectoparasi ticide</w>
ectom y:</w>
ecto- ATPases</w>
ecto plasmic</w>
ecto domain.</w>
ecto der
ectoder m.</w>
ective/ cognitive</w>
ecti lis,</w>
ecti fying</w>
ect or.</w>
ect oplasm.</w>
ect oma</w>
ect ocervix</w>
ect ins</w>
ect in-treated</w>
ect asias</w>
ect asia:</w>
ect asia,</w>
ect ,</w>
ecstasy/ MDMA</w>
ecstasy "),</w>
ecstas y,</w>
ecstas y).</w>
ecstas y"</w>
ecoxi b,</w>
ecopip am),</w>
econom ics</w>
econom ics;</w>
econom ics.</w>
echocardiography- electrophysiologic</w>
echocardiography- calculated</w>
echocardiograph y--two</w>
echocardiograph y),</w>
echocardiograph ies</w>
echocardiograph ically-assessed</w>
echocardiograph ically,</w>
echocardiograph ically)</w>
echocardiograph ers</w>
echocardiograph ers.</w>
echocardiograph ,</w>
echocardio grams,</w>
echocardio gram-documented</w>
echocardi oscan</w>
echo- planar</w>
echo- doppler</w>
echo thiophate.</w>
echo graphy.</w>
echo graphy,</w>
echo encephalography</w>
echo doppler</w>
echo :</w>
echo /
echo/ Doppler</w>
echloreth amine</w>
echloreth amine,</w>
echin ocystic</w>
echin ata</w>
echin ata.</w>
echi al</w>
ech st</w>
ech st-stained</w>
ech sler,</w>
ech opraxia,</w>
ech olamines</w>
ech olalia,</w>
ech ocardlography</w>
ech inocandin-class</w>
ech -
ech- L
ech-L angu
ech-Langu age-
ech-Language- Hearing</w>
ecgon ine,</w>
ecchymo sis,</w>
ecchymo ses</w>
ecchymo ses.</w>
ecchymo ses,</w>
ecarbox ylate</w>
ecarbox imidine-N-1-adamantyl-N'-</w>
ec ystitis</w>
ec urrent</w>
ec tioned</w>
ec tion-evoked,</w>
ec tion).</w>
ec ticus),</w>
ec sys</w>
ec reted</w>
ec othiophate</w>
ec onase</w>
ec ological</w>
ec ognine,</w>
ec id</w>
ec g</w>
ec etabine</w>
ec edent</w>
ec centr
eccentr ic,</w>
ec arboxyl
ecarboxyl ate.</w>
ec .</w>
ec )</w>
ebro tidine.</w>
ebast ine</w>
ebast ine,</w>
eb siella</w>
eb bed.</w>
eat .</w>
easi ly.</w>
easi est</w>
eas y-to-administer</w>
eas ed/transplanted</w>
early- reporting</w>
early- onset,</w>
early- morning</w>
early- malnourished</w>
early- delayed</w>
early- conversion</w>
early- afterdepolar
early-afterdepolar ization</w>
early- acting</w>
early /
early/ late</w>
early -induced</w>
earli est-forming</w>
earli est).</w>
earli er-identification</w>
earli er),</w>
ear- by-
ear-by- year,</w>
ear th</w>
ear son's</w>
ear n</w>
ear ly"</w>
ear drum</w>
ear ;</w>
ear )</w>
ear ),</w>
eNOS- /-</w>
eNO S
eNOS (-/-)</w>
eIF2alpha (P).</w>
eIF2alpha (P),</w>
eIF2 alpha</w>
eIF2 alpha,</w>
eIF 2-
eIF2- GTP</w>
e/ highly</w>
e.c. g.3.</w>
e. v.</w>
e. 6.</w>
e-N yman's</w>
e- walking</w>
e- teratogen</w>
e- specificity</w>
e- refractory</w>
e- pines,</w>
e- opener)</w>
e- max</w>
e- like'</w>
e- inhibitor,</w>
e- escalating</w>
e- dos
e-dos age
e-dosage ".</w>
e- dema</w>
e- by-
e-by- frame</w>
e- based,</w>
e- antigen-positive</w>
e- Women
e-Women s</w>
e- WBH</w>
e- W
e-W BH),</w>
e- Phe-
e-Phe- Gly-
e-Phe-Gly- ol</w>
e- H2O)</w>
e- Dav
e-Dav is)</w>
e- Albumin</w>
e+ APAP</w>
e ye's</w>
e worthy</w>
e w</w>
e ver,</w>
e vealed</w>
e utectic</w>
e uropathy,</w>
e ural</w>
e upalmerin</w>
e uchromatin;</w>
e time</w>
e tical</w>
e tek</w>
e res,</w>
e perisone,</w>
e over</w>
e osin,</w>
e onia</w>
e ligible;</w>
e ligible:</w>
e legant</w>
e ks</w>
e jection,</w>
e gypti</w>
e ger</w>
e g</w>
e ener</w>
e dow
edow -
edow- Graves'</w>
e des</w>
e bruary</w>
e bin
ebin ophilia,</w>
e ase,</w>
e ache</w>
e ]</w>
e GFR.</w>
e GFR,</w>
e GFP</w>
e GFP-
eGFP- microglia</w>
e CB</w>
e :
e: dexmedetomidine</w>
e (AP
e(AP Z</w>
e "
e" ].</w>
dysur ia)</w>
dystrophin- glycoprotein</w>
dystroph y--a</w>
dystroph in/a-syntrophin</w>
dystroph in,</w>
dystroph ies.</w>
dystro phy).</w>
dystonia- parkinsonism)</w>
dystonia- dyskinesia</w>
dystonia- dyskinesia,</w>
dyston ic-like</w>
dyston ia/other</w>
dyston ia-like</w>
dyston ia-free</w>
dyston ia)</w>
dyston ia),</w>
dyston ia'</w>
dyssynerg y.</w>
dyssynerg y,</w>
dyssynerg ia,</w>
dysrhyth mogenic.</w>
dysrhyth mia-inducing</w>
dysraph ism</w>
dysraph ism;</w>
dysraph ism,</w>
dysr rhythmic</w>
dysr rhythmias,</w>
dysplasi as)</w>
dysplasi a;</w>
dysplasi a),</w>
dysphasi a,</w>
dysph oric"</w>
dysph agic</w>
dyspareun ia,</w>
dysp raxia,</w>
dysmorph ogenic</w>
dysmorph ogen.</w>
dysmenorrhe ic</w>
dysmenorrhe a:</w>
dysmen orrhea,</w>
dyslipide mic</w>
dyskinesias --are</w>
dyskinesias "</w>
dyskinesia- susceptible</w>
dyskinesia- dystonia.</w>
dyskinesia ."</w>
dyskinesia -</w>
dyskinesi genic</w>
dyskinesi as:</w>
dyskinesi as)</w>
dyskinesi ae</w>
dyskinesi a/
dyskinesia/ dystonia</w>
dyskinesi a-related</w>
dyskinesi a-like</w>
dyskinesi a--
dyskinesia-- two</w>
dyskinesi a'</w>
dyskine tic/dyskinetic).</w>
dyskine tic),</w>
dysgeusi a:</w>
dysgeusi a),</w>
dysgermin oma.</w>
dysfunction al.</w>
dysfunction :
dysfunction: inability</w>
dysfunction --with</w>
dysfunction -
dysfunction- muscle</w>
dysesthesi a,</w>
dyses thetic</w>
dyses thesia.</w>
dyscrasi as:</w>
dyschromatop sy,</w>
dyschromatop sia</w>
dyschromatop sia.</w>
dysarth ric.</w>
dysarth ia</w>
dys thyroid</w>
dys thymia.</w>
dys synchrony</w>
dys somnia</w>
dys regulation,</w>
dys reflexia.</w>
dys ostosis</w>
dys osmia</w>
dys myelopoiesis</w>
dys motility,</w>
dys morphology</w>
dys morphology,</w>
dys metabolism,</w>
dys lipidaemia.</w>
dys kinesais</w>
dys kenesia.</w>
dys innervation</w>
dys innervation.</w>
dys horic</w>
dys granular</w>
dys glycaemia</w>
dys glycaemia.</w>
dys genic</w>
dys genesis.</w>
dys genesis)</w>
dys fluency.</w>
dys control,</w>
dys chrom
dyschrom ia,</w>
dys arrhythmias,</w>
dynorph in.</w>
dynorph in's</w>
dynes/s/cm- 5).</w>
dynes.s.cm- 5)</w>
dyne /
dyne/ cm2,</w>
dyne .
dyne. sec/cm5.m2).</w>
dynam ometer.</w>
dynam ically.</w>
dynam ically-enhanced</w>
dynam ic-inotropic</w>
dyn ia.</w>
dyn .
dyn. sec.cm-5</w>
dying- back</w>
dying- back"</w>
dye- tracing</w>
dye- dilution</w>
dy sutility</w>
dy simmune</w>
dy sexecutive</w>
dy ing,</w>
dy es.</w>
dy es,</w>
dy e.</w>
dy -We
dy-We inberg</w>
dy -
dy- Walker</w>
dwarf ism</w>
dwar f</w>
dut eplase</w>
dur ind</w>
dur in</w>
dur ations:</w>
dur ations,</w>
dur ation]</w>
dur ation?</w>
dur ation/
duration/ event.</w>
dur ation-related</w>
dur ation-
duration- of-exposure-related.</w>
dur ation),</w>
dur ance</w>
dur ably,</w>
dur able;</w>
dur able.</w>
dur able,</w>
dur a.</w>
duplic ates</w>
duoden itis,</w>
dumm y</w>
duloxet ine-induced</w>
duloxet ine-,</w>
dul y</w>
dul lness</w>
dul ling,</w>
dul es</w>
duct- ligated</w>
duct- duodenum</w>
duct- cannulated</w>
duct us.</w>
duct us,</w>
duct ulogenesis</w>
duct ules.</w>
duct ule</w>
duct openia).</w>
duct ance</w>
duc tors)</w>
duc tion/release</w>
dual- tuned</w>
dual- perfusion</w>
dual- immunofluorescence</w>
dual- immunoelectron</w>
dual- diagnosis</w>
dual- antiplatelet</w>
du e.</w>
du al)</w>
dt max,</w>
dt (-1)</w>
dt (-1)
dt(-1) (max)</w>
ds DNA</w>
ds DNA),</w>
drugs-- theophylline,</w>
drugs-- barbiturates</w>
drug-- etodolac.</w>
drug-- dapsone</w>
drug-- can</w>
drug-- and</w>
drug- withdrawal.</w>
drug- use</w>
drug- unrelated</w>
drug- treatment</w>
drug- toxic</w>
drug- substitution</w>
drug- sensitivity</w>
drug- sensitive</w>
drug- seeking.</w>
drug- related;</w>
drug- related,</w>
drug- refractory,</w>
drug- protein</w>
drug- negative</w>
drug- nai;ve</w>
drug- na</w>
drug- metabolising</w>
drug- lipid</w>
drug- liking</w>
drug- iron</w>
drug- intolerant</w>
drug- interaction</w>
drug- immune</w>
drug- hypersensitivity</w>
drug- free,</w>
drug- dispensing</w>
drug- disease</w>
drug- delivery</w>
drug- craving.</w>
drug- context</w>
drug- class</w>
drug- by-
drug-by- condition</w>
drug- benefit</w>
drug- abuser</w>
drug- -14
drug--14 91</w>
drug- ,</w>
drug- (NSAID)</w>
drug s?</w>
drug s/unstable</w>
drug s."</w>
drug s-related</w>
drug s-associated</w>
drug s'</w>
drug metabolizing</w>
drug ,"</w>
drug (s),</w>
drug '</w>
dru g/light</w>
droxy- 5-
droxy-5- (4'-chloro
droxy-5-(4'-chloro phenyl-2,</w>
droxy chloroqu
droxychloroqu ine)-induced</w>
drowsiness/ sedation</w>
drowsiness/ sedation,</w>
drospiren one.</w>
drospiren one-containing</w>
droptain ers.</w>
droptain er</w>
droptain er,</w>
dropout s.</w>
dropout s).</w>
drople ts).</w>
droperid ol-pentazocine</w>
drop- off"</w>
drop ped.</w>
drop ped,</w>
drop out.</w>
drop out,</w>
droop ing</w>
droop ed</w>
dro p.</w>
dro p)</w>
dro op</w>
dro oling,</w>
dro -1
dro-1 H-</w>
drink s)</w>
drink ing;</w>
drink ing)</w>
drink ers,</w>
drin kers:</w>
driman ial,</w>
dri ving.</w>
dri ving,"</w>
dri ves,</w>
dri ver.</w>
dri ver's</w>
dri ven-astrocyte</w>
dri pped</w>
dri p/day</w>
dri p.</w>
dri lled</w>
dri dg
dridg e</w>
dri asis,</w>
dres sings.</w>
dream s.</w>
dream s)</w>
dream ers</w>
dre amin
dreamin ess</w>
dre ad
dread ful</w>
drawbac ks.</w>
drawbac ks,</w>
draw n:</w>
draw n,</w>
dramatic ally;</w>
dramatic ;</w>
dram atical</w>
dram atic.</w>
drain ages</w>
drain age;</w>
drain age,</w>
dragon "</w>
dragon ".</w>
dra in,</w>
dr y-powder</w>
dr um"</w>
dpp .</w>
dpp ,</w>
dpp ).</w>
dp/dt max),</w>
dp/dt (min),</w>
dp/dt (max
dp/dt(max )
dp/dt(max) <</w>
dp/d t.</w>
dp/d t-changes</w>
dp m/mg</w>
dp f</w>
dp f.</w>
doxycycl ine:</w>
doxycycl ine,</w>
doxycycl ine's</w>
doxy fluridine.</w>
doxorubicin/ vinorelbine</w>
doxorubicin/ taxol</w>
doxorubicin/ kg</w>
doxorubicin/ cyclophosphamide</w>
doxorubicin-treated- venotomized</w>
doxorubicin- treatment.</w>
doxorubicin- treatment,</w>
doxorubicin- stimulated</w>
doxorubicin- sensitized</w>
doxorubicin- reduced</w>
doxorubicin- plus-placebo</w>
doxorubicin- only,</w>
doxorubicin- na</w>
doxorubicin- more</w>
doxorubicin- lysozyme</w>
doxorubicin- loaded</w>
doxorubicin- exposed</w>
doxorubicin- eluting-bead</w>
doxorubicin- dose-related</w>
doxorubicin- damaged</w>
doxorubicin- caused</w>
doxorubicin- administered</w>
doxorubic inol,</w>
doxorubic ine</w>
doxorubic in-</w>
doxorubic in,DxDx):</w>
doxorubic in's</w>
doxorub ucin</w>
doxo- HF)</w>
doxifl uridine.</w>
doxifl uridine,</w>
doxep in-related</w>
dox ylstearic</w>
dox ylamine</w>
dox y-cycline,</w>
dox oubicin</w>
dox orrubicin.</w>
dox il.</w>
dox azos
doxazos in-induced</w>
dox an),</w>
dox ,</w>
down- sloping</w>
down- regulated,</w>
down- loaded</w>
down- growths</w>
down- going</w>
down- fluctuation</w>
down- beating</w>
down wards</w>
down turned</w>
down stream.</w>
down stream,</w>
down stage</w>
down sloping</w>
down regulate</w>
down loaded</w>
down beat</w>
down ;</w>
down ").</w>
doubt ful).</w>
double- vessel</w>
double- valve</w>
double- strength</w>
double- step</w>
double- staining</w>
double- outlet</w>
double- null</w>
double- level</w>
double- labeling),</w>
double- labeled</w>
double- label</w>
double- injured</w>
double- edged</w>
double- crossover</w>
double- color</w>
double- bind
double-bind ed</w>
double- balloon</w>
double t</w>
double t,</w>
double s</w>
double d,</w>
double blind,</w>
double ,</w>
double ),</w>
doub tedly,</w>
doub ted</w>
dot s</w>
dot oxin</w>
dot -labeled</w>
dosing- is</w>
doses ?</w>
doses /
doses/ day).</w>
doses .4.</w>
doses .(ABSTRACT</w>
doses --
doses-- synergistically</w>
doses "</w>
dose= 4.8</w>
dose= 4.1</w>
dose= 29
dose=29 0.0</w>
dose= 15
dose=15 15</w>
dose= 12.4</w>
dose/ week</w>
dose/ unit</w>
dose/ route</w>
dose/ patient</w>
dose/ course</w>
dose-depend ent)</w>
dose-depend ency.</w>
dose-depend ency,</w>
dose- volumes</w>
dose- volume,</w>
dose- titration,</w>
dose- titrated</w>
dose- tapering</w>
dose- sequence</w>
dose- schedules</w>
dose- schedule</w>
dose- responsiveness.</w>
dose- responsively</w>
dose- responsively.</w>
dose- response,</w>
dose- respone</w>
dose- ratios</w>
dose- proportionality</w>
dose- proportionality,</w>
dose- proportional</w>
dose- prior</w>
dose- optimization</w>
dose- minimizing</w>
dose- matched</w>
dose- limiting;</w>
dose- levels:</w>
dose- levels,</w>
dose- level,</w>
dose- intensified</w>
dose- intensification</w>
dose- independent.</w>
dose- independent,</w>
dose- increase</w>
dose- high</w>
dose- finding,</w>
dose- dependence.</w>
dose- cumulative</w>
dose- and-
dose-and- structure-dependent</w>
dose- adjusted</w>
dose- 50</w>
dose d.</w>
dose 25</w>
dose /kg</w>
dose .(ABSTRACT</w>
dose (s).</w>
doscop y</w>
dosage- regimen-dependent</w>
dosage- might</w>
dosage- finding</w>
dosage- -associated</w>
dos ulfan</w>
dos ulepine</w>
dos sier</w>
dos ing)</w>
dos al</w>
dos age?</w>
dos age-related</w>
dos age),</w>
dorsomedi al,</w>
dorsol ater
dorsolater al,</w>
dorsal- medial,</w>
dorsal- lateral,</w>
dorsal is.</w>
dorsal is,</w>
dorsal ,</w>
dorsal ).</w>
dors oflexion</w>
dors o-medial</w>
dors o-lateral</w>
dors a</w>
dorm ant.</w>
dor am
doram ectin,</w>
doppl er,</w>
doppl er),</w>
dopaminergic- serotoninergic</w>
dopaminergic- cholinergic</w>
dopaminergic- agonist</w>
dopaminerg ically</w>
dopaminerg ic/cholinergic</w>
dopaminerg ic-mediated</w>
dopaminerg ic-</w>
dopamine/ neuroleptic</w>
dopamine/ acetylcholine</w>
dopamine-beta- hydroxylase-positive</w>
dopamine-beta- hydroxylase,</w>
dopamine- specific</w>
dopamine- specific:</w>
dopamine- serotonin</w>
dopamine- releasing</w>
dopamine- poor</w>
dopamine- one</w>
dopamine- norephinephrine</w>
dopamine- modulating</w>
dopamine- enhancing</w>
dopamine- dominated</w>
dopamine- depleting</w>
dopamine- antagonist</w>
dopamine- agonistic</w>
dopamine- agonist-induced</w>
dopamine- 2/
dopamine-2/ serotonin-2</w>
dopamine ?</w>
dopamine 2-receptor</w>
dopamine ."</w>
dopamine -1,</w>
dopamine ,"</w>
dopamine (O
dopamine(O HD
dopamine(OHD A)-induced</w>
dopa- dyskinesia</w>
dopa- dopamine</w>
dopa ),</w>
dop ed</w>
dop amine:</w>
dop amine-</w>
dop amine).</w>
dop amine's</w>
dop am
dopam imetic</w>
donor s;</w>
donor s:</w>
donor s).</w>
donor ]</w>
donepez il:</w>
don or/recipient</w>
don ditioned</w>
don ating</w>
don a</w>
don 's</w>
domin o</w>
domin ating</w>
domin ates</w>
domin antly</w>
domin ant.</w>
domin ance/
dominance/ isolation,</w>
dometh as
domethas one)</w>
domain ;</w>
domain -specific</w>
dom s).</w>
dom perione</w>
dom etacin</w>
dom esticated</w>
dom .</w>
dolicho ectasia:</w>
dolicho ectasia.</w>
dolasetr on,</w>
dogs. 4</w>
dogs. 3</w>
dogs. 2.</w>
dog s].</w>
dog s.(ABSTRACT</w>
dog s--a</w>
dog s'</w>
dog ;</w>
dog --comparison</w>
dog --an</w>
dog )</w>
dog ).</w>
dog "</w>
dofetili de.</w>
dodec ylsulfate-polyacrylamide</w>
dodec anedi
dodecanedi oic</w>
document ed)</w>
document ations</w>
document ation,</w>
doctor -bl
doctor-bl ind'</w>
doctor 's</w>
docetaxel/ epirubicin/cyclophosphamide</w>
docetaxel- epirubicin</w>
docetaxel- epirubicin,</w>
docetaxel- cisplatin</w>
docetaxel -induced</w>
docetaxel -</w>
docetaxel )</w>
doc tor-open'</w>
doc tor,</w>
doc a</w>
dobutamine- stress-induced</w>
dobutamine- related</w>
dobutamine- infusions</w>
dobutamine- elicited</w>
dobutamine- -
dobutamine-- atropine</w>
dobut amine;</w>
dobut amine:</w>
dobut amine)</w>
dobut amine),</w>
do- not-resuscitate</w>
do- aminobenzo
do-aminobenzo phenone</w>
do- Ac)</w>
do zen</w>
do ze,</w>
do wel.</w>
do uches</w>
do thiepin.</w>
do steine</w>
do simeter</w>
do planin,</w>
do femoral</w>
do es,</w>
do .</w>
dn/P dn
dn/Pdn )</w>
dn-sec(-1).m(2).cm (5)</w>
dn rb)</w>
dn .</w>
dl- verapamil</w>
dl- sulfoximine</w>
dl- isoproterenol</w>
dl- fenfluramine</w>
dl- ,</w>
dl [-1
dl[-1 ]);</w>
dl ST</w>
dl ST.</w>
dl ST,</w>
dl '
dl' propranolol,</w>
dk 5)</w>
dk 4),</w>
dizziness/ vertigo,</w>
dizziness+ taste</w>
dizziness+ taste.</w>
dizziness ;</w>
dizziness ).</w>
dizziness ),</w>
dizocil pine),</w>
diz zy.</w>
diz ocilipine</w>
divorced/ separated)</w>
divor ce.</w>
divid ing/newly</w>
diverticul um,</w>
diverticul itis</w>
diverticul i,</w>
diverticul a;</w>
divertic ulation</w>
diver ticulosis,</w>
diver sus,</w>
diver sities.</w>
diver sion).</w>
diver se.</w>
diuretic s-induced</w>
diuretic s)</w>
diuretic ).</w>
diuretic 's</w>
diure tic-beta-adrenoceptor</w>
diure sis;</w>
diure sis).</w>
dithiothre itol,</w>
dithiocarb amate.</w>
ditekiren .</w>
ditekiren ,</w>
dit ar
ditar trate</w>
disulph onic</w>
disulph ide,</w>
disulfiram- pyridoxine</w>
disulfiram- pretreated</w>
disulfiram- chloral</w>
disulfiram- alcohol</w>
disulfiram- (Antabuse
disulfiram-(Antabuse -)
disulfiram-(Antabuse-) induced</w>
disulfiram -treated</w>
disulfiram -associated</w>
disulfir m</w>
disulfide- linked</w>
disulfide- isomerase</w>
disulfi de
disulfide -dependent</w>
disturbanc es:</w>
disturbanc es--visual</w>
disturb ingly</w>
disturb ing,</w>
disturb ances)</w>
disturb ance:</w>
disturb ance-
disturbance- were</w>
disturb ance)</w>
disturb ance).</w>
disturb ance
disturbance --
disturbance-- to</w>
distur bed;</w>
distur bed,</w>
distribut or,</w>
distribu tions.</w>
distribu tions,</w>
distribu tion;</w>
distribu tion)</w>
distres sing.</w>
distres s-related</w>
distr acting</w>
distr act
distract or</w>
distor tion-product</w>
distor ted,</w>
distingu ished.</w>
distingu ished,</w>
distinc tively</w>
distinc tion.</w>
distinc t:</w>
distinc t.</w>
disten tion,</w>
disten sible</w>
dist omer</w>
dist empered,</w>
dist ally,</w>
dist alis</w>
dist al/
distal/ dendritic</w>
dist al.</w>
dist al-
distal- proximal</w>
dissol ving</w>
dissol ved.</w>
dissoci ations</w>
dissoci ation:</w>
dissoci ation),</w>
dissoci ate"</w>
dissoci ably</w>
dissip ated;</w>
dissip ated.</w>
dissip ate</w>
dissi pates.</w>
dissemin ation,</w>
dissemin ate</w>
disrupt or,</w>
disrup ters,</w>
disrup ter</w>
disru pters.'</w>
disput es</w>
disput ed.Recently,</w>
disput ed,</w>
disproportion ation</w>
disproportion ately.</w>
disproportion ality,</w>
disposi tion;</w>
disposi tion-phase</w>
disper sions</w>
disper sion)</w>
disper sion);</w>
dispens able,</w>
dispen sing,</w>
dispen ses</w>
dispar ity.</w>
dispar ities.</w>
dispar aging</w>
disp osal</w>
disp ense</w>
disorient ated.</w>
disori ented</w>
disorgan ization.</w>
disorgan ization,</w>
disorgan isation</w>
disorder s?</w>
disorder s.(ABSTRACT</w>
disorder s).</w>
disorder s),</w>
disorder s".</w>
disorder ?</w>
disorder .(ABSTRACT</w>
disorder --a</w>
disorder ).</w>
disorder '</w>
disorder "</w>
disodi um,</w>
dismut ases</w>
dismut ase),</w>
disease/ organ</w>
disease/ minor</w>
disease/ hypertension</w>
disease-- comparison</w>
disease-- case</w>
disease-- as</w>
disease-- New</w>
disease- oriented</w>
disease- monitoring</w>
disease- model</w>
disease- free.</w>
disease- causing</w>
disease- associated</w>
disease- addition</w>
disease ]</w>
disease .(ABSTRACT</w>
disease ."</w>
disease ):</w>
disease (s),</w>
disease (I
disease(I HD),</w>
diseas es)</w>
diseas es),</w>
diseas es'</w>
diseas es'.</w>
diseas e-induced</w>
diseas e-</w>
diseas e's</w>
diseas e'</w>
discus sion;</w>
discus sed.This</w>
discrimin ative-
discriminative- stimulus</w>
discrimin ations</w>
discrimin ation;</w>
discrimin ation).</w>
discrimin ation
discrimination ',</w>
discrimin ated:</w>
discrimin able</w>
discrimin ability</w>
discri bed.</w>
discrep anc
discrepanc ies,</w>
discre te.</w>
discre te,</w>
discover y.</w>
discour aging</w>
discour aging,</w>
discour ages</w>
discour aged,</w>
discontinu es,</w>
discontinu ed).</w>
discontinu ation;</w>
discontinu ation.(ABSTRACT</w>
discontinu ation
discontinuation ).(ABSTRACT</w>
discomfor ts</w>
discomfor ting</w>
discomfor t;</w>
discolor ations</w>
disco idal</w>
disco id)</w>
discipl ined</w>
discharge- evoking</w>
discharge :</w>
discharge ."</w>
discharge )</w>
discharg ing</w>
discer ned,</w>
disc s.</w>
disc rediting</w>
disc iform</w>
disc ectomy,</w>
disappoint ment.</w>
disappear s.</w>
disappear red</w>
disappea red:</w>
disap preared</w>
disadvant aged</w>
disadvant age.</w>
disabil ity)</w>
disabil ity).</w>
disabil ities:</w>
dis suade</w>
dis solve</w>
dis sections,</w>
dis repute.</w>
dis regulation</w>
dis regulated</w>
dis regarded.</w>
dis qualification</w>
dis proved</w>
dis proved,</w>
dis prove</w>
dis proportional</w>
dis proportion</w>
dis proportion,</w>
dis positional</w>
dis played.</w>
dis oumarin</w>
dis locations</w>
dis location.</w>
dis lipidemia</w>
dis kinesia.</w>
dis k.</w>
dis interest</w>
dis integrins.</w>
dis integrations</w>
dis integrate</w>
dis inhibits</w>
dis inhibiting</w>
dis ine,</w>
dis entangle</w>
dis count</w>
dis cordance</w>
dis cord
discord ant.</w>
dis connection</w>
dis colored</w>
dis closure</w>
dis closure,</w>
dis assembly</w>
dis artic
disartic ulations</w>
dis arthria</w>
dis arrayed</w>
dis arrangement</w>
dis arranged</w>
dis approved</w>
dis appearance,</w>
dis aggregation.</w>
dis aggregated</w>
dis acchar
disacchar ide,</w>
diri thromycin-treated</w>
direct- reacting</w>
direc tors</w>
direc tor,</w>
direc tly:</w>
direc tly-acting</w>
direc tly)</w>
direc tionally</w>
direc tionality</w>
direc tion;</w>
direc ting</w>
direc ted,</w>
dipyron e:</w>
dipyron e-mediated</w>
dipyron e-induced</w>
dipyron e-containing</w>
dipyridamole/ thallium-201</w>
dipyridamole/ symptom-limited</w>
dipyridamole/ baseline</w>
dipyridamole/ ASA</w>
dipyridamole- stress</w>
dipyridamole- related</w>
dipyridamole- positive</w>
dipyridamole- negative</w>
dipyridamole- like</w>
dipyridamole- hyperemia.</w>
dipyridamole- handgrip</w>
dipyridamole- containing</w>
dipyridamole- assisted</w>
dipyridamole- aspirin</w>
dipyridamole- acetylsalicylic</w>
dipyridamole- Doppler</w>
dipyridamol e:</w>
dipyridamol e),</w>
dipyri d
dipyrid yl,</w>
dipy rone,</w>
dips ticks.</w>
dips ogenia</w>
dipropyl amino-
dipropylamino- tetralin,</w>
dipropyl amin
dipropylamin otetraline</w>
dipropyl acetate,</w>
dipren orphine>nalorphine=naloxonazine.</w>
dipren orphine.</w>
dipren orphine,</w>
dipper s)</w>
dipper s).</w>
dipivoxil/ lamivudine,</w>
dipivox il;</w>
dipivox il,</w>
diphther ia,</w>
diphosph anil
diphosphanil ate:</w>
diphenylhydantoin ;</w>
diphenylhydantoin (D
diphenylhydantoin(D PH)-induced</w>
diphenylhydanto ine,</w>
diphenylhydanto in-induced</w>
diphenylacetoxy-N-methyl piperidine-methiodide)</w>
diphenylacetoxy- N-(2-chloroethyl)-
diphenylacetoxy-N-(2-chloroethyl)- piperidine</w>
diphenyl hydantion</w>
diphenyl hexatriene</w>
diphenyl ene</w>
diphenyl butyl
diphenylbutyl piperidine</w>
diphenyl -2'-
diphenyl-2'- hydroxy-ethoxy)tropane</w>
diphenyl ,</w>
diphenhydram ine-exposed</w>
diphenhydram ine-containing</w>
diphenhydram ine-</w>
diphenhydram ine)</w>
diphenhydram ine);</w>
dipepti dyl</w>
dipepti do-aminobenzophenone</w>
dip stix.</w>
dip s,</w>
dip ole</w>
dip ocyte-derived</w>
dip ine.</w>
dioxo-benzo[f]quinoxaline-7- sulfonamide)</w>
dioxo- 7-
dioxo-7- (1H-
dioxo-7-(1H- imidazol-1-yl)-6-nitro-1,2,3,4-tetrahydro-1-quinoxalinyl]-acetic</w>
diop tres</w>
diop ters).</w>
dio estrus</w>
dio des.</w>
dio de</w>
dino prostone.</w>
dino prostone,</w>
dino prost</w>
dinitro phenyl-S-glutathione</w>
dinitro phenol-uncoupled</w>
dinitro catechol</w>
ding- out</w>
ding- on</w>
din or-6-keto-PGF(1alpha)</w>
din ia:</w>
din )</w>
dimin utions</w>
dimin ution,</w>
dimin ished;</w>
dimin ished:</w>
dimin ish.</w>
dimethylethan -1-amine]</w>
dimethylbenz idine</w>
dimethylbenz [c]
dimethylbenz[c] acri
dimethylbenz[c]acri dine:</w>
dimethylaminoadamant ane.</w>
dimethylaminoadamant ane,</w>
dimethylamino propyl)</w>
dimethylamino propionyl)forskolin</w>
dimethylamino ethyl)naphthalenesulfonamide</w>
dimethylamino ethanol</w>
dimethylamino )-
dimethylamino)- N-(2-
dimethylamino)-N-(2- dimethylaminoethyl)naphthalenesulfonamide</w>
dimethyl-4-phenylpiperaz ium</w>
dimethyl-4-phenylpiperaz inium</w>
dimethyl-1-propargyl xanthane</w>
dimethyl tryptamine</w>
dimethyl triazeno</w>
dimethyl thiourea.</w>
dimethyl thiourea,</w>
dimethyl sulphoxide</w>
dimethyl sulfoxide.</w>
dimethyl phenylpiperazinium.</w>
dimethyl nitrosamine.</w>
dimethyl cysteine)</w>
dimethyl carb
dimethylcarb azine.</w>
dimethyl ated</w>
dimethyl amino)
dimethylamino) pyridine</w>
dimethyl acetaminophen</w>
dimethyl -1,4-dihydro-2,3-quinoxalinedione)</w>
dimethyl -1,2,3,4,
dimethyl-1,2,3,4, 5,6,7,8-
dimethyl-1,2,3,4,5,6,7,8- octahydro-5-oxo-3-(substitutedphenyl)quinazoline</w>
dimethyl (7-methylcoumaran-3-yl)
dimethyl(7-methylcoumaran-3-yl) ammonium</w>
dimethoxy benz
dimethoxybenz idine</w>
dimethoxy -18-
dimethoxy-18- [
dimethoxy-18-[ (3,
dimethoxy-18-[(3, 4,5-trimethoxy
dimethoxy-18-[(3,4,5-trimethoxy benzo
dimethoxy-18-[(3,4,5-trimethoxybenzo yl)oxy]yohimban-16-carboxylic</w>
dimethoxy -1-phenyl-
dimethoxy-1-phenyl- 4H-2,3-benzodiazep
dimethoxy-1-phenyl-4H-2,3-benzodiazep in-4-one)</w>
dimeth adi
dimethadi one,</w>
dimension s:</w>
dimension s/volumes;</w>
dimension /
dimension/ function</w>
dimenhydrin ate:</w>
dilut ed.</w>
dilu tions.</w>
dilu tions,</w>
dilu tion,</w>
dilu ents;</w>
dilu ents,</w>
dilu ent,</w>
diltiazem /
diltiazem/ beta</w>
diltiazem -related</w>
diltiazem -pretreated</w>
diltiazem -associated</w>
diltiazem -
diltiazem- fentanyl</w>
dilemm as.</w>
dilat ory</w>
dilat ors</w>
dilat ative</w>
dilat ation.(ABSTRACT</w>
dilat ated</w>
dilat able</w>
dilant in.</w>
dilant in,</w>
dil ative</w>
dil ations</w>
dil actone</w>
dil :</w>
dil ).</w>
diisopropylfluoro phosphate.</w>
diisopropylfluoro phosphate-induced</w>
diisopropyl phosphorodiamidofluoridate),</w>
dihydroxyphenyl serine,</w>
dihydroxyphenyl glycol</w>
dihydroxyphenyl glycol,</w>
dihydroxyphenyl glycine</w>
dihydroxyphenyl alanine.</w>
dihydroxy-6-nitro-7-sulfamoyl- benzo[f]
dihydroxy-6-nitro-7-sulfamoyl-benzo[f] quinoxaline),</w>
dihydroxy-6-nitro-7- sulfamoylbenzo(F)-quinoxaline</w>
dihydroxy- phenylacetic</w>
dihydroxy- N-n-propylnorapomorphine</w>
dihydroxy- 4'-
dihydroxy-4'- methyl-5-nitrobenzophenone),</w>
dihydroxy tryptamine,</w>
dihydroxy phenyl</w>
dihydroxy phenacetic</w>
dihydroxy cholecalciferol</w>
dihydroxy cholecalcifer
dihydroxycholecalcifer ol)</w>
dihydroxy benzoic</w>
dihydroxy anthracenedione</w>
dihydroxy analog</w>
dihydrotachy sterol.</w>
dihydropyridine- calcium</w>
dihydroergot oxin</w>
dihydroergot amine:</w>
dihydroergocrist ine.</w>
dihydrobenz oxazine</w>
dihydrobenz oxazine,</w>
dihydro-beta-erythro idine,</w>
dihydro-7,8- dimethoxy-1-phenyl-4H-2,3-benzodiazepin-4-one)</w>
dihydro-6- methyl-4H-1,3-thiazine</w>
dihydro-6- [1-
dihydro-6-[1- [2-
dihydro-6-[1-[2- hydroxy-2-(4-cyanophenyl)ethyl]-</w>
dihydro-6 (6
dihydro-6(6 H)-
dihydro-6(6H)- oxodibenz[b,e]azepin-11-yl]-1-piperazinyl]-2-oxoethyl]cyclopentyl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl]ethyl]argininamide</w>
dihydro-5H-di benzo[a,d]
dihydro-5H-dibenzo[a,d] cyclohepten-5-ylidene)-1-
dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-1- propyl)-3-piperidine</w>
dihydro-5H-di benzo[a,
dihydro-5H-dibenzo[a, b]
dihydro-5H-dibenzo[a,b] cyclohepten-5,10-imine</w>
dihydro-5- methyl-6-oxo-4H-imidazo-(1,5-a)</w>
dihydro-5- methyl-6-Oxo-4H-imidazo</w>
dihydro-5- methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone),</w>
dihydro-2- methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one</w>
dihydro-2,3-quinoxaline dione</w>
dihydro-10- hydroxy-carbamazepine</w>
dihydro-10- (1-methyl-4-
dihydro-10-(1-methyl-4- piperidylidene)-9-anthrol),</w>
dihydro-1- hydroxy-2-imino-4-piperidinopyrimidine)</w>
dihydro- testosterone</w>
dihydro- ouabain</w>
dihydro- fluorescein</w>
dihydro- 2,6-di
dihydro-2,6-di methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate,</w>
dihydro- 2,3</w>
dihydro thienopyridine</w>
dihydro tetrabenazine</w>
dihydro testosterone-induced</w>
dihydro rhodamine</w>
dihydro pyrimidinase-related</w>
dihydro pyridine-induced</w>
dihydro pteridine</w>
dihydro kainate</w>
dihydro isoquinoline</w>
dihydro fluoresein</w>
dihydro ethidium</w>
dihydro ethedium</w>
dihydro erogotamine,</w>
dihydro ergotamine,</w>
dihydro ergocryptine</w>
dihydro chloride;</w>
dihydro bromide</w>
dihydro bromide.</w>
dihydro avermectin</w>
dihydro al
dihydroal prenolol;</w>
dihydro -2'-
dihydro-2'- deoxyguanosine</w>
digoxin/ diuretic</w>
digoxin/ diuretic.</w>
digoxin- treated)</w>
digoxin- toxic</w>
digoxin- serum</w>
digoxin- quinidine</w>
digoxin- metabolizing</w>
digoxin- infused</w>
digoxin- immune</w>
digoxin- amiodarone</w>
digoxin- Fab</w>
digox in;</w>
digox in-like</w>
digitox in-treated</w>
digitox in-intoxicated</w>
digitalis m:</w>
digital ism</w>
digital ism,</w>
digital ise</w>
digit s.</w>
digit s,</w>
digit oxicity</w>
digit alo
digitalo -
digitalo- diuretic</w>
digit alis.</w>
digit al-
digital- type,</w>
dig m</w>
dig ar
digar h.</w>
difluoromethyl ornithine.</w>
difluoromethyl -1-
difluoromethyl-1- chloro
difluoromethyl-1-chloro tetrafluoroethyl</w>
difluoro phenyl)-salicylic</w>
difluoro deoxyuridine.</w>
diflun isal.</w>
diffuse /
diffuse/ generalized</w>
diffuse )</w>
difficult-to- reach</w>
difficult-to- cure</w>
difficul ty)</w>
difficul ties;</w>
difficul t."</w>
difficul t"</w>
diffici le-related</w>
diffici le-associated</w>
differenti ative</w>
differenti ated:</w>
differenti ally,</w>
differenti al,</w>
difference= 0.25).</w>
difference )</w>
differenc es:</w>
differenc es)</w>
differenc es).</w>
differenc es(P</w>
differen tly:</w>
differen tly,</w>
differen ting</w>
diff usivity</w>
diff usional</w>
diff usible</w>
diff uses</w>
diff useness</w>
diff used</w>
diff ernece</w>
diff ering,</w>
diff er;</w>
diff er),</w>
diethylstilbestrol- adenosis</w>
diethylstilbestro l-treated</w>
diethylstilbestro l-related</w>
diethylstilbestro l-associated</w>
diethylstilbestro l-</w>
diethylnor spermine)</w>
diethylnitrosam ine;</w>
diethylnitrosam ine/kg</w>
diethylnitrosam ine-treated</w>
diethylnitros amine-
diethylnitrosamine- sodium</w>
diethylnitros amine,</w>
diethylenetri amin
diethylenetriamin opentoacetic</w>
diethylcarbamo yl</w>
diethylcarbamo yl-4-methyl-4-aza,5alpha-androstan-3-one,</w>
diethyl- stilbestrol</w>
diethyl stilboestrol</w>
diethyl stilbesterol</w>
diethyl glycine-substituted</w>
diethyl dithiocarbamate.</w>
diethyl amine</w>
diethyl amide</w>
diethyl amide,</w>
diet- supplementation</w>
diet- fed/low</w>
diet- aid</w>
diet s);</w>
diet ary,</w>
diet -treated</w>
diet +L-NAME.</w>
diet );</w>
diet )-induced</w>
dien es.</w>
dieldrin /kg</w>
dieldrin )</w>
dideoxyinos ine)</w>
dideoxy nucleosides</w>
dideoxy nucleoside</w>
dideoxy cy
dideoxycy tidine-induced</w>
dideoxy adenosine)</w>
dide oxy</w>
dide aza-
dideaza- 5,6,7,8-tetrahydro
dideaza-5,6,7,8-tetrahydro folate]</w>
didanosine/ tenofovir/nevirapine</w>
didanosine/ stavudine</w>
didanosine/ stavudine/HU</w>
didanos ine-induced</w>
dicyclo hexyl</w>
dicloxacill in,</w>
dicloxacill in)</w>
diclofenac ;</w>
diclofenac :</w>
diclofenac -associated</w>
diclofenac -</w>
diclofenac ).</w>
diclofen ate</w>
dicho lophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylam</w>
dichlorv os-induced</w>
dichlorv os,</w>
dichlorometh ane.</w>
dichlorometh ane-
dichloromethane- exposed</w>
dichlorohexafluorocyclobut ane</w>
dichlorodiphenyl trichloroethane,</w>
dichloro- kynurenic</w>
dichloro vinyl</w>
dichloro quinoxaline-2,3-dione)</w>
dichloro phenyl</w>
dichloro phenoxy)-ethyl]-2-imidazoline</w>
dichloro dihydro-fluorescein</w>
dichloro -4-
dichloro-4- oxo-1(4H)-pyridyl]-acetamido)-3-([(5-methyl-1,3,4-thiadiazol-2-yl)-thio]methyl)-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic</w>
dichloro -1,4-dihydro-2,3-quinoxalinedione)</w>
dichlor phenyl;</w>
dich otomized</w>
dicarb amate</w>
dicarb am
dicarbam ate),</w>
dic tionary.</w>
dic rofenac</w>
dic oumarol</w>
dic oumarol.</w>
dic oumarol,</w>
dic lofensine,</w>
dic itrato</w>
dic am
dicam ent,</w>
dic ally</w>
dic ain)</w>
dibutyryl- cyclic</w>
dibutyryl- cAMP</w>
dibutyl aminopropyl
dibutylaminopropyl amine</w>
dibuc ain</w>
dibenzo[ c
dibenzo[c ,
dibenzo[c, fl-[1,2,5]thiadiazepine</w>
dibenz hydrylethane-1,2-diamine</w>
diazepam-- can</w>
diazepam-- Valium</w>
diazepam- withdrawal</w>
diazepam- tolerant</w>
diazepam- sensitive</w>
diazepam- saline</w>
diazepam- pretreated</w>
diazepam- fluoxetine</w>
diazepam- ephedrine</w>
diazepam- elicited</w>
diazepam- antagonist</w>
diazepam- antagonism</w>
diazepam /kg</w>
diazepam -related</w>
diazepam -</w>
diazepam +
diazepam+ flumazenil</w>
diazepam ).</w>
diazepam ),</w>
diazepam 's</w>
diazabicyclo [
diazabicyclo[ 5,
diazabicyclo[5, 4,0
diazabicyclo[5,4,0 ]-
diazabicyclo[5,4,0]- 7-
diazabicyclo[5,4,0]-7- undecene.</w>
diaz oxide-induced</w>
diaz oxide)</w>
diaz oimidazole-4-carboxamide</w>
diaz iquone.</w>
diatrizo ate-induced</w>
diatrizo ate),</w>
diathe sis.</w>
diastol ic).</w>
diastere omeric</w>
diastematomyeli a,</w>
diastematomyeli a)</w>
diastemat omyelia</w>
diast ole.</w>
diast inal</w>
diast asis</w>
diast ase</w>
diarrhoe a).</w>
diarrhe a;</w>
diarrhe a-inducing</w>
diaphrag ms.</w>
diaphrag m-like"</w>
diaphore tic</w>
diaphor ase;</w>
diaphor ase-positive</w>
diaph eresis,</w>
diant aceae)</w>
diamm ine-glycolatoplatinum</w>
diaminopteridine-6-(N- diethylaminoethyl)</w>
diaminopteridine-6-(N- 2-
diaminopteridine-6-(N-2- hydroxyethyl)</w>
diaminodiphenyl sulfone,</w>
diamin opyridine</w>
diameter/ volume</w>
diameter/ body</w>
diameter- systole,</w>
diameter s.</w>
diameter s,</w>
diameter :</w>
dialysis- transplant</w>
dialysis- disequilibrium</w>
dialys tic</w>
dialys ate,</w>
dialys ance</w>
dialy zing</w>
dialy zer</w>
dialy zer;</w>
dialy sis-induced</w>
dialy ses,</w>
dialy sed</w>
dialy sed,</w>
diagnos tics.</w>
diagnos tically.</w>
diagnos tic"</w>
diagno sis?</w>
diagno sis--a</w>
diagno sis).</w>
diagno sis),</w>
diagno ses;</w>
diagno ses:</w>
diagno sed)</w>
diag ram.</w>
diacetyl morphine.</w>
diabetic- untreated</w>
diabetic- room</w>
diabetes- downregulated</w>
diabetes ?</w>
diabetes -related</w>
diabetes -associated</w>
diabetes -</w>
diabet ogenicity,</w>
diabet es)</w>
diabe tics:</w>
diabe tics,</w>
diabe tic)</w>
di-n-propyl acetic</w>
di- ortho-chlorinated</w>
di- n-hexyl</w>
di- N,N-
di-N,N- propylaminotetralin</w>
di(2-ethylhex yl)phthalate.</w>
di(2- tolyl)guanidine</w>
di xyrazine</w>
di vulged</w>
di vision,</w>
di vinorum</w>
di vided-dose</w>
di valproex,</w>
di utinum.</w>
di thizonate</w>
di thiotreitol-sensitive</w>
di sutility</w>
di stricts</w>
di strict</w>
di propyloaminotetralin</w>
di privan</w>
di pping,</w>
di pped</w>
di povixil</w>
di posity</w>
di phosphatidylglycerol</w>
di pentyl</w>
di palmitoylphosphatidyl</w>
di p-stick</w>
di oxorubicin;</w>
di oxopiperazinyl-1-yl)propane]</w>
di oxide,</w>
di one.</w>
di olol,</w>
di ol]</w>
di oestrous</w>
di odes</w>
di mished</w>
di metindene</w>
di methyl-8-phenylxanthine</w>
di methyl-8-p-sulfophenyl-xanthine</w>
di methoxyl-4-ethyl-beta-carboline-3-carboxylate</w>
di mesylate:</w>
di mercaptoacetyl-triglycine</w>
di mer,</w>
di me,</w>
di lox)</w>
di isothiocyanatostilbene-2,2'</w>
di iodothyronine</w>
di iodated</w>
di hyroxyphenylglycol</w>
di hydroxyeicosatrienoic</w>
di hydroxyeicosatetraenoic</w>
di hydroxy</w>
di hydro</w>
di hydrate</w>
di hydrate.</w>
di hydralazine-induced</w>
di hydralazine,</w>
di glycylhistamine</w>
di glyceride</w>
di gastric</w>
di fumarate</w>
di fumarate.</w>
di fluoro</w>
di fluoro-methylornithine,</w>
di fied</w>
di fferetiation,</w>
di ethoxyacetoxy-daunorubicin</w>
di estrus/metestrus</w>
di ene-VPA</w>
di encephalon.</w>
di ed.5.</w>
di e.</w>
di dox</w>
di dox,</w>
di den
diden osine</w>
di dehydro
didehydro -
didehydro- 3'-deoxy
didehydro-3'-deoxy thymidine)</w>
di bromosul
dibromosul phthalein</w>
di ble</w>
di bility</w>
di benzodiazepine</w>
di benzo[a,d]cyclohepten-5,10-imine</w>
di benzo
dibenzo thiadiazepine</w>
di asis.</w>
di arrhythmia</w>
di aper
diaper s</w>
di aminophen
diaminophen othiazine</w>
di amino</w>
di amino-n-
diamino-n- butyric</w>
di amino
diamino dec
diaminodec ane</w>
di ame
diame trically</w>
di allyl-
diallyl- nor-toxiferine</w>
di alkylation</w>
di alkylated</w>
di alde
dialde ydes</w>
di acyl
diacyl glycerol</w>
di acetate.</w>
di HE
diHE TEs</w>
di -</w>
di (1-
di(1- adamantyl)
di(1-adamantyl) malondiamide</w>
dge water,</w>
dg ing</w>
dg ell,</w>
dextrose- gentamicin)</w>
dextrose- containing</w>
dextromor amide,</w>
dextromethorph an/
dextromethorphan/ mephenytoin</w>
dextromethorph an-treated</w>
dextromethorph an
dextromethorphan -related</w>
dextro- isomer.</w>
dextro- (d-
dextro-(d- )</w>
dextro cardia</w>
dextro cardia.</w>
dextro amphetamine;</w>
dextro amphetamine.</w>
dextro amphetamine)</w>
dextro -</w>
dextran s.</w>
dextran s,</w>
dexter ity</w>
dexter ity,</w>
dexrazox one</w>
dexrazox ane:
dexrazoxane: epirubicin</w>
dexrazox ane-treated</w>
dexrazox ane-
dexrazoxane- mediated</w>
dexrazox ane)</w>
dexmedetom idine-treated</w>
dexmedetom idine-managed</w>
dexmedetom idine-induced</w>
dexaraz oxane</w>
dexaraz oxane-treated</w>
dexamfet amine's</w>
dexamethasone- mediated</w>
dexamethasone- induced,</w>
dexamethasone- cyclophosphamide</w>
dexamethasone- 21-
dexamethasone-21- isonicotinate</w>
dexamethasone /kg</w>
dexamethasone ).(ABSTRACT</w>
dexamethas one-related</w>
dexamethas one-</w>
dexamethas one).</w>
dexamethas one),</w>
dex verapamil/EPOCH</w>
dex verapamil.</w>
dex propranolol,</w>
dex ketoprofen</w>
dex chlorpheniramine</w>
dex chlorpheniramine.</w>
dex amphetamine.</w>
dex amphetamine-induced</w>
dex amphetamine-</w>
dex amphetamine-
dexamphetamine- chlordiazepoxide</w>
dex amphetamine,</w>
dex amphet
dexamphet amine/
dexamphetamine/ chlordiazepoxide</w>
dex amisol
dexamisol e.</w>
dex a-induced</w>
dex a,</w>
dex -only</w>
dex -induced</w>
dex -
dex- caused</w>
devic e;</w>
devic e-related</w>
devi ations,</w>
devi ated</w>
devi ance</w>
devi ance,</w>
development ally-
developmentally- normal</w>
development al,</w>
development :</w>
development /
development/ resolution</w>
development --with</w>
develop s;</w>
develop ments</w>
develop ing,</w>
develop ed--intermittent</w>
develop ?</w>
develop ;</w>
develop :</w>
dev ila,</w>
dev azep
devazep ide</w>
detrus or-sphincter</w>
detri ment</w>
detoxic ation</w>
detoxic ation;</w>
detox ifications</w>
detox ification:</w>
determin istic</w>
determin ing:</w>
determin ations;</w>
determin ation:</w>
determin ate</w>
deterior ation'</w>
deterior ating.</w>
deterior ates,</w>
deterior ates),</w>
deteri otation</w>
deterg ent.</w>
deterg ent,</w>
deter red</w>
detect ors</w>
detect or.</w>
detect ed)</w>
detach ments.</w>
deta iled,</w>
det ection).</w>
destruc tive,</w>
destruc tion/inhibition</w>
destro y</w>
destin ation.</w>
destin ation,</w>
dest ined</w>
desquam ating</w>
desper ation,</w>
despair ,</w>
desoxy steroid.</w>
desoxy cholate</w>
desoxy chol
desoxychol ate.</w>
desor ption</w>
deson ide</w>
desogestrel /ethinyl</w>
desogestrel 's,</w>
desmo plasia.</w>
desmethyl imipramine.</w>
desmethyl fluoxetine)</w>
desmethyl diazepam)</w>
desmethyl clomipramine.</w>
desmethyl clomipramine,</w>
desirab le.</w>
desirab le,</w>
design s.</w>
design s--randomized</w>
design er-drug</w>
design ate</w>
design ;</w>
design :</w>
design --
design-- consisting</w>
desi pramine;</w>
desethyl amiodarone</w>
dese thyl</w>
dese ase.</w>
descript ors,</w>
descript or</w>
descrip tive.</w>
descrip tion:</w>
describe d:</w>
describe d.)</w>
describe .</w>
describ es,</w>
descri ption.</w>
desbutyl bupivacaine.</w>
desbutyl bupivacaine-
desbutylbupivacaine- infused</w>
desatur ation,</w>
desatur ated</w>
desatur ase</w>
desacetyl vinblastine</w>
desArg9Leu8- bradykinin</w>
desArg 10
desArg10 [
desArg10[ Hoe</w>
des-Arg9- bradykinin</w>
des-Arg9- [Leu
des-Arg9-[Leu 8]
des-Arg9-[Leu8] BK</w>
des-Arg9- BK.</w>
des-Arg9- BK-induced</w>
des-Arg 10-
des-Arg10- Hoe</w>
des- angiotensin</w>
des- acetyl</w>
des oximetasone,</w>
des mon,</w>
des leukin</w>
des k</w>
des glymidodrine,</w>
des flurane.</w>
des feroxamine,</w>
des ferioxamine</w>
des amino-8-D-
desamino-8-D- arginine-
desamino-8-D-arginine- vasopressin)</w>
dermato ses.</w>
dermato fibrosarcoma</w>
dermat osis.</w>
dermat one)</w>
dermat omes.</w>
dermat ologists</w>
dermat ologists.</w>
dermat ologist.</w>
dermat o-myopathy</w>
derm is</w>
derm ati
dermati tis)</w>
derivati zation,</w>
deriv ations</w>
deriv ation</w>
deriv ate-
derivate- eluting</w>
deriv ate,</w>
dere alis
derealis ation)</w>
derang ment</w>
derang ement,</w>
derang ed.</w>
der- stratified</w>
der- manic</w>
der termined</w>
der t</w>
der mopathy</w>
der mopathy,</w>
der mis.</w>
der mis,</w>
der mal-epidermal</w>
der ley</w>
der le)</w>
der bil
derbil t</w>
der al)</w>
der a</w>
der -related</w>
depriv ation:</w>
depri ving</w>
depri ved.</w>
depri ve</w>
depression- subscale</w>
depression- inducer</w>
depression ?</w>
depression ).</w>
depression ),</w>
depression ))</w>
depression '</w>
depression ".</w>
depressi ves,</w>
depressi ve/anxiety</w>
depressi ve"</w>
depress or)</w>
depress ant"</w>
depres sive,</w>
depres sion;</w>
depres sion-inducing</w>
depot- steroid</w>
depot- medroxyprogesterone</w>
depot s</w>
depot .</w>
depot )</w>
depolymer ize</w>
depolariz ing,</w>
depolar ized,</w>
depolar ize</w>
depolar isation.</w>
deplo yment.</w>
deplo yed</w>
deplo yed,</w>
depletion/ Ca2+</w>
depletion/ Ca2+-
depletion/Ca2+- ionophore-</w>
deple tors</w>
deple tors,</w>
deple tions.</w>
deple tions,</w>
deple tion-</w>
deple ter.</w>
depic ts</w>
depersonal isation</w>
dependence ?</w>
dependence --a</w>
depend ents.</w>
depend ent;</w>
depend ences:</w>
depend ence)</w>
depend ant</w>
depend ancy</w>
depend able</w>
department s:</w>
department s(EDs)</w>
department -based</w>
depart ure</w>
depart ure,</w>
dep uration.</w>
dep th;</w>
dep th-electrode</w>
dep th)</w>
dep o</w>
deoxyp yridoxne,</w>
deoxyp yridinoline</w>
deoxynucleotid yltransferase-mediated</w>
deoxycorticosterone- acetate-
deoxycorticosterone-acetate- hypertensive</w>
deoxycorticoster one.</w>
deoxycorticoster one-induced</w>
deoxycor tone</w>
deoxycor tone.</w>
deoxychol ate:</w>
deoxy- corticosterone</w>
deoxy- 5-
deoxy-5- (4-
deoxy-5-(4- substituted</w>
deoxy uridine-labeling</w>
deoxy uridine,</w>
deoxy uridine)</w>
deoxy thymidine</w>
deoxy ribose.</w>
deoxy hemoglobin</w>
deoxy guanosine-positive</w>
deoxy glucose-induced</w>
deoxy doxorubicin-induced</w>
deoxy doxorubicin)</w>
deoxy doxorubicin).</w>
deoxy cytidine</w>
deoxy cortisone</w>
deoxy adenosine,</w>
deodar a</w>
deodar a.</w>
denud ation.</w>
denti st</w>
dent ofacial</w>
dent inal</w>
dent ate,</w>
dent ata</w>
dent ata,</w>
dent al,</w>
dent ).</w>
density- voltage</w>
densit y/appearance</w>
densit y),</w>
densit ometry.</w>
densit ometric</w>
dens ity:</w>
dens er</w>
dens a,</w>
denop amine.</w>
denomin ators,</w>
denomin ator,</w>
denerv ation:</w>
denerv ation-induced</w>
denerv ation)</w>
denerv ation).</w>
denerv ating</w>
dendrit es;</w>
dendrit es,</w>
dendrit e,</w>
dend tritic</w>
den y</w>
den sest</w>
den ow)</w>
den otes</w>
den ote</w>
den ied.Suggestions</w>
den ,</w>
demyelin ative.</w>
demyelin ating,</w>
demonstrat ed;</w>
demonstrat ed).</w>
demonstr ation.</w>
demonstr ably</w>
demonstr able.</w>
demonst rate,</w>
demograph y,</w>
demograph ics;</w>
demograph ics.</w>
demeton- methyl,</w>
demethyl clomipramine</w>
demethyl ation.</w>
demethoxy- geldanamycin,</w>
demethoxy- daunorubicin.</w>
demethoxy- 3'-deamino-
demethoxy-3'-deamino- 3'
demethoxy-3'-deamino-3' az
demethoxy-3'-deamino-3'az iridinyl-4'-methylsulphonyl-daunorubicin),</w>
demet yldeacetylthymoxamine.</w>
dementi as</w>
dementi a--
dementia-- increased</w>
dementi a)</w>
dementi a"</w>
demedull ation.</w>
demedull ated,</w>
demarc ation</w>
deman d?</w>
deman d"</w>
dem ia:</w>
delta9-TH C-treated</w>
delta9-TH C,</w>
delta9- Tetrahydrocannabinol</w>
delta9 tetrahydrocannabinol</w>
delta9 tetrahydrocannabinol-induced</w>
delta9 THC.</w>
delta9 TH
delta9TH C).</w>
delta-aminol evulinate</w>
delta-amino valerate.</w>
delta-AV A.</w>
delta-AV A,</w>
delta-AV A)</w>
delta- tetrahydrocannabinol</w>
delta- sarcoglycan-deficient</w>
delta- receptor</w>
delta- focus</w>
delta- fibre-specific)</w>
delta- activity</w>
delta- OR</w>
delta- Amino
delta-Amino valerate</w>
delta- 9-tetrahydrocannabinol</w>
delta SR</w>
delta SR)</w>
delta +</w>
delta )</w>
delta (2)-receptor</w>
delta (2)-
delta(2)- antagonist</w>
deliver ies,</w>
deliri um;</w>
deliri um:</w>
deliri um/confusion,</w>
deliri um'.</w>
deliri ous,</w>
deliri ogenic</w>
deliri a</w>
deline ating</w>
deline ated,</w>
deliber ately</w>
deliber ate,</w>
deli ver,</w>
deleteri ous.</w>
deleteri ous,</w>
delayed- progressive</w>
delayed- onset,</w>
delayed- onset"</w>
delayed- matching-to-sample</w>
delay ed-release</w>
dela ide</w>
delT961 C
delT961C n),</w>
del usions;</w>
del usion.</w>
del uded</w>
del toids</w>
del t9-THC.</w>
del icate</w>
del avir
delavir dine,</w>
del ate</w>
del april,</w>
del AG,</w>
del A</w>
deiodin ase.</w>
dehydrogenase- xanthine</w>
dehydrogenase- 1</w>
dehydrogen se</w>
dehydrogen ation</w>
dehydrogen ases</w>
dehydrogen ase).</w>
dehydrogen ase),</w>
dehydro epiandrosterone,</w>
dehyd rated.</w>
degre es;</w>
degre es-40</w>
degre es)</w>
degre es).</w>
degrad ative</w>
degrad ation:</w>
degrad ation.(ABSTRACT</w>
degeneration- regeneration</w>
degeneration- regeneration.</w>
degener ation/
degeneration/ regeneration.</w>
degener ated.</w>
degener ate.</w>
deg )</w>
deg ),</w>
deform ity.</w>
deform ability,</w>
defl ection.</w>
defl ection-evoked,</w>
defl ated</w>
definiti ve.</w>
definiti ve."</w>
definit e.</w>
defini tions.</w>
defini tion,</w>
defini tion)</w>
defini tion),</w>
deficit s;</w>
deficit s/mental</w>
deficit s-all</w>
deficit ;</w>
deficiency ;</w>
deficiency -induced</w>
defici ent),</w>
defibrill ators,</w>
defibrill ations</w>
defibrill ations.</w>
defibrill ation;</w>
deferox amine-treated</w>
deferox amine's</w>
deferen s)</w>
defensi ve/repressive</w>
defen ses.</w>
defen ses,</w>
defen se,</w>
defect s)</w>
defect ;</w>
defect :</w>
defect )</w>
defec ation.</w>
defascicul ant</w>
def orestation</w>
def ined).</w>
def ences</w>
def ective.</w>
def ected</w>
def ault</w>
def aul
defaul ters</w>
def at)</w>
def asciculation</w>
def a
defa ecation</w>
deep en</w>
decur sinol</w>
decur sin,</w>
decreas ing;</w>
decreas es:</w>
decreas es)</w>
decreas ed",</w>
decreas e]</w>
decreas e;</w>
decreas e:</w>
decreas e);</w>
decre ments,</w>
decor tication</w>
decor ated</w>
decongest ant.</w>
decompens ations</w>
decompens ating</w>
decom pression-</w>
decom press</w>
decom position,</w>
decom poses</w>
decom plementation</w>
deco y</w>
deco de</w>
decline ).</w>
decl aring</w>
decl are</w>
decl amp
declamp ing)</w>
decision- analytic</w>
decilit er</w>
decilit er.</w>
decidu omas</w>
decidu omas.</w>
decibel s.</w>
deci pher</w>
deci les</w>
decerebr ation.</w>
decerebr ation,</w>
decentr alization</w>
decel erated</w>
deced ents,</w>
deced ent,</w>
decarboxyl ase-positive</w>
decarboxyl ase-
decarboxylase- 67,</w>
decarboxyl ase)</w>
decarboxyl ase
decarboxylase (6
decarboxylase(6 7)-
decarboxylase(67)- immunoreactive</w>
decapit ation,</w>
decapit ated.</w>
decano ate-induced</w>
decano ate,</w>
decano ate
decanoate .(ABSTRACT</w>
decameth onium</w>
decameth onium),</w>
decahydro quinoline</w>
decahydro quinoline,</w>
dec rescendo</w>
dec oxib</w>
dec onvolution</w>
dec ongestion.</w>
dec oction</w>
dec lotting</w>
dec lining.</w>
dec iliter])</w>
dec ided.</w>
dec hlorinase</w>
dec eased/transplanted</w>
dec ease</w>
dec ay,</w>
dec ay
decay ed.</w>
dec arbox
decarbox ylated</w>
dec ar
decar bod
decarbod ylase</w>
dec ap
decap itation</w>
dec ann
decann ulated</w>
dec al
decal vans)</w>
debul king,</w>
debride ments</w>
debride ment</w>
debride ment.</w>
debilit ating.</w>
debilit ating,</w>
debilit ated.</w>
debil ity.</w>
debat able;</w>
deb ated,</w>
death- promoting</w>
death- producing</w>
death s.(ABSTRACT</w>
death s."</w>
death s-2</w>
death s).</w>
death ]</w>
death [2
death[2 ]).</w>
death /</w>
death /
death/ regeneration</w>
death -related</w>
death '</w>
death "</w>
deamin ated</w>
deamin ase,</w>
deafferen ted</w>
deafferen tation,</w>
deafferen tated,</w>
deaf ness:</w>
deaf ness.Fenoprofen</w>
deaf ness).</w>
deaf ening</w>
deaf en</w>
deaf .</w>
dead space</w>
dead space.</w>
dead lier</w>
dead /
dead/ transplanted</w>
dead .</w>
deacetyl ation.</w>
deacetyl ase/
deacetylase/ adenosine</w>
deacetyl ase.</w>
deacetyl ase,</w>
de/ clarithromycin</w>
de- escalation</w>
de- escalation.</w>
de- M</w>
de yhdrogenase</w>
de vise</w>
de vascularization</w>
de vascularization.</w>
de v</w>
de uteroporphyrin</w>
de utan</w>
de tubation,</w>
de tox</w>
de synchronication</w>
de sulphated</w>
de sulfated</w>
de stabilize</w>
de stabilization</w>
de smosomes,</w>
de sh.</w>
de serve.</w>
de sensitizing</w>
de sensitization;</w>
de sensitization).</w>
de sensitization")</w>
de realization,</w>
de realisation</w>
de qualinium</w>
de proteinization</w>
de previation</w>
de positions</w>
de phosphorylation.</w>
de phosphorylated</w>
de pakine</w>
de oxygenation</w>
de oxygenation.</w>
de opamine</w>
de mise.</w>
de mineralization</w>
de mineralization.</w>
de methyl-clozapine</w>
de methoxydaunorubicin</w>
de merits.</w>
de ments</w>
de mented,</w>
de matologic</w>
de linquents</w>
de limits</w>
de late,</w>
de iraea</w>
de iodinated</w>
de innervation.</w>
de hydrochloride</w>
de hydration;</w>
de hydration-ketorolac</w>
de hiscence</w>
de hidroepiandrosterone,</w>
de graded.</w>
de graded)</w>
de genic</w>
de formation</w>
de fied</w>
de fibrinated</w>
de es.</w>
de d:</w>
de d).</w>
de bility</w>
de arth</w>
de arterial
dearterial ization,</w>
de alkylation</w>
de alcohol
dealcohol ized</w>
de activations</w>
de activation.</w>
de activates</w>
de activate</w>
de Toni-Debr</w>
de Qu
deQu ervain's</w>
de -related</w>
de -</w>
ddI ]</w>
ddI -related</w>
dd I/
ddI/ ZDV</w>
daz oxiben</w>
daz ac</w>
days/ week.</w>
days/ week,</w>
days/ week(-1),</w>
days/ month</w>
days/ course).</w>
days/ 12</w>
days. 6.</w>
days. 11.</w>
days- upper</w>
days- Mipafox,</w>
days -</w>
days )></w>
days ).(ABSTRACT</w>
day- pretreatment</w>
day- old-rats.</w>
day- old,</w>
day- interval,</w>
day- cases,</w>
day- care.</w>
day- 22</w>
day- 21</w>
day time.</w>
day time),</w>
day s]</w>
day s],</w>
day s:</w>
day s.(ABSTRACT</w>
day s-old</w>
day s);</w>
day s):</w>
day dreaming</w>
day case</w>
day <
day< 10,</w>
day 4,</w>
day -15</w>
day -1,</w>
day -1).</w>
day -1
day-1 )-induced</w>
day )=
day)= 45.
day)=45. 310,</w>
day )-treated</w>
day )-
day)- treatment,</w>
day (-1)).</w>
daunorubic inol.</w>
daunorubic in)</w>
daunomyc in;</w>
daunomyc in.6.</w>
daun omycin-toxic</w>
daugh ter's</w>
datas ets</w>
datas et</w>
databas es:</w>
databas es/registries</w>
databan k</w>
databan k-based</w>
datab ase;</w>
datab ase)</w>
data- signalling</w>
data- linkage</w>
data- collection</w>
dat es,</w>
dat a:</w>
dat a
data indicated</w>
dark- adapted</w>
dark ness.</w>
dark er</w>
dark er.</w>
dark ened.</w>
dark /
dark/ light</w>
dark -cell</w>
darifen acin.</w>
darifen ac
darifenac in-na</w>
darbepoietin- alpha</w>
darbepoietin- alpha.</w>
darbe poetin,</w>
dar apri
darapri m</w>
daptom ycin-induced</w>
daptom ycin,</w>
dantrol ene;</w>
danger ously</w>
danger ous?</w>
danger ous:</w>
dang ling.</w>
dang er.</w>
danazol -
danazol- hereditary</w>
danazol )</w>
danaparo id.</w>
danaparo id)</w>
dam s:</w>
dam s)</w>
dam age?</w>
dam age).</w>
dam )</w>
daily- propranolol</w>
daily- injection</w>
dail y/14</w>
daidze in)</w>
dacty litis.</w>
dactin omycin.</w>
dactin omycin,</w>
dacryocystorhin ostomy.</w>
dacarb azine,</w>
dacarb azine)</w>
dac y,</w>
dac lizumab.</w>
dac 3-
dac3- Tg)</w>
dab etes</w>
da wley</w>
da e.</w>
d] pyrimidin-4-yl]amine</w>
d] naptho++</w>
d] cyclohepten-5-ylidene)-1-
d]cyclohepten-5-ylidene)-1- [(E)-
d]cyclohepten-5-ylidene)-1-[(E)- 3-(3-
d]cyclohepten-5-ylidene)-1-[(E)-3-(3- methoxy-2-nitro)phenyl-2-p</w>
d] [1,2,4]
d][1,2,4] triazine</w>
dV /dtmax</w>
dV /dt</w>
dUT P-</w>
dTc- containing</w>
dSP /dt</w>
dSP /d
dSP/d t.</w>
dPI/ d
dPI/d SP,</w>
dP/dt min)</w>
dP/dt max;</w>
dP/dt 60,</w>
dP/dt (min),</w>
dP/dt (MA
dP/dt(MA X),</w>
dP/d T.</w>
dP/d T,</w>
dF /dtmax</w>
dF /dt</w>
d: 12</w>
d4T- ddI</w>
d4T- containing</w>
d4T ];</w>
d4T -related</w>
d4T -dose</w>
d4T -associated</w>
d4T -</w>
d4 T,</w>
d4 T)</w>
d4 T).</w>
d/ wk;</w>
d/ wk.</w>
d/ week.</w>
d/ mo,</w>
d/ menthol</w>
d/ malignant</w>
d/ liter</w>
d. c.</w>
d. When</w>
d-carnit ine-induced</w>
d-carnit ine)</w>
d-amphetamine- mediated</w>
d-amphetamine- ,</w>
d-amphet amine-treated</w>
d-amphet amine).</w>
d-PG J
d-PGJ 2),</w>
d-- amphetamine</w>
d- water</w>
d- ventricle</w>
d- tubo-curarine</w>
d- treatment</w>
d- transposition</w>
d- standard</w>
d- stained</w>
d- sotalol.</w>
d- sotalol,</w>
d- propranolol.</w>
d- practolol,</w>
d- party</w>
d- naloxone</w>
d- methamphetamine</w>
d- ketamine,</w>
d- galactosidase,</w>
d- galactosidase)</w>
d- enantiomer</w>
d- corrected</w>
d- chlorpheniramine.</w>
d- bucindolol.</w>
d- break</w>
d- back"</w>
d- arginine-methyl</w>
d- amphetamine-evoked</w>
d- aminol
d-aminol aevulinic</w>
d- Tubocurarine</w>
d- Tr</w>
d- Sotalol</w>
d- Propranolol</w>
d- Penicillamine</w>
d- D-32</w>
d- Amphetamine</w>
d- Amphetamine-induced</w>
d- AMPH</w>
d- ,</w>
d,l-sotal ol-</w>
d,l-sotal ol-,</w>
d,l- sotalol</w>
d,l- sotalol,</w>
d,l- methadone</w>
d,l- methadone.</w>
d,l- methadone,</w>
d,l- Propranolol</w>
d, l</w>
d, 1-propranolol</w>
d(LVP)/ dt</w>
d(LVP)/ d
d(LVP)/d t,</w>
d(CH2)5D AVP</w>
d welled</w>
d well</w>
d usky</w>
d uits.</w>
d ubious</w>
d sykinesia</w>
d ritis</w>
d rifting</w>
d ribbling,</w>
d rete</w>
d ress</w>
d oleamine</w>
d ol.</w>
d nicarbate</w>
d man</w>
d luid</w>
d le-aged</w>
d ings,</w>
d inger-Westphal</w>
d entin</w>
d ectoma</w>
d ds</w>
d b
db /d
db/d b</w>
d ate),</w>
d ana
dana proid</w>
d an.</w>
d aloid</w>
d all</w>
d al</w>
d agg
dagg er</w>
d actinomycin-
dactinomycin- -
dactinomycin-- preliminary</w>
d ]</w>
d ]-
d]- pyrimidin-7-one</w>
d TXB
dTXB 2),</w>
d T</w>
d T)</w>
d RT
dRT A,</w>
d MT).</w>
d L,</w>
d G),</w>
d D
dD AVP-stimulated</w>
d CTP</w>
d B
dB nHL</w>
d A,</w>
d A)</w>
d 5,</w>
d 4,</w>
d 2</w>
d 2,</w>
d 2)</w>
d 1,</w>
d 1)</w>
d ."</w>
d -old</w>
d -14
d-14 d</w>
d )].</w>
d ):</w>
d )
d) :YAG</w>
d (left</w>
d '
d' Etude</w>
cytox an,</w>
cytox an)</w>
cytotoxic s</w>
cytotoxic ity)</w>
cytotoxic ities</w>
cytotoxic -
cytotoxic- cholestatic</w>
cytot oxins.</w>
cytoskeleton .</w>
cytoskeleton -
cytoskeleton- linking</w>
cytosegres omes</w>
cytosegres omes.</w>
cytos ine-arabinoside</w>
cytoplasmic- pattern-ANCA.</w>
cytoplasmic- antineutrophil</w>
cytoplasmic- ANCA</w>
cytopen ias,</w>
cytomegalo virus-associated</w>
cytomegalo viral</w>
cytoly sis),</w>
cytokine- induced,</w>
cytokine- expressing</w>
cytokin es.(ABSTRACT</w>
cytok ine-induced</w>
cytok ine-based</w>
cytochrome- C-
cytochrome-C- oxidase</w>
cytochro me-P450-system,</w>
cytoarchitect ural</w>
cytoarchitect onically</w>
cyto static,</w>
cyto protector,</w>
cyto protection,</w>
cyto protection"</w>
cyto pathology</w>
cyto pathologies</w>
cyto pathological</w>
cyto kinesis,</w>
cyto keratin,</w>
cyto genesis</w>
cyto architecture.</w>
cyto -
cyto- histologically</w>
cytarab ine-associated</w>
cytarab ine-</w>
cyt. a,
cyt.a, a3</w>
cyt osines</w>
cyt ons</w>
cyt onecrosis.</w>
cyt ometry)</w>
cyt omegaly</w>
cyt omegalic</w>
cyt olysis</w>
cyt ocrome-c</w>
cyt ocin</w>
cyt ochemically</w>
cyt ochemically,</w>
cyt ochalasin</w>
cyt oblastoma</w>
cyt obiology</w>
cystou rethroscopy</w>
cystou rethrectomy</w>
cystoscop y?</w>
cystoscop e</w>
cysto prostatectomy</w>
cysto pathy</w>
cystin uria:</w>
cysti tis;</w>
cysti s;</w>
cysteinyl glycine</w>
cyste inuria</w>
cyste ine;</w>
cyst otomy</w>
cyst otomy,</w>
cyst ometry.</w>
cyst ometry,</w>
cyst ometrically</w>
cyst olithotomy</w>
cyst ogenesis,</w>
cyst ocentesis</w>
cyst adenomas,</w>
cyst adenoma</w>
cyst adenocarcinomas</w>
cys tically</w>
cys tic)</w>
cyr rhetic</w>
cyprohept ad
cyproheptad ine).</w>
cypro terone.</w>
cypro dime,</w>
cylind ruria</w>
cylind ruria.</w>
cylind ers</w>
cylind er;</w>
cylind er.</w>
cyl co
cylco phosphamide,</w>
cyge us,</w>
cyclosporine- and-
cyclosporine-and- prednisone-treated</w>
cyclosporine- A</w>
cyclosporine- A/
cyclosporine-A/ methotrexate</w>
cyclospor ins</w>
cyclospor ine?</w>
cyclospor ine/tacrolimus</w>
cyclospor ine.Conclusions.</w>
cyclospor ine-associated</w>
cyclospor ine)</w>
cyclospor ine).</w>
cyclospor ine),</w>
cyclospor in-treated</w>
cyclospor in-induced</w>
cyclospor in-A/FK506-related</w>
cyclospor in).</w>
cyclopropyl methyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6beta-yl]-3-(furan-3-yl)-N-methylprop-2-enamide</w>
cyclopropyl -4-
cyclopropyl-4- phosphonophenylglycine.</w>
cyclophosphamide/etoposide /
cyclophosphamide/etoposide/ cisplatin
cyclophosphamide/etoposide/cisplatin ],</w>
cyclophosphamide/ vincristine,</w>
cyclophosphamide/ thiotepa/carboplatin.</w>
cyclophosphamide/ mesna</w>
cyclophosphamide/ m2.</w>
cyclophosphamide/ etoposide</w>
cyclophosphamide/ doxorubicin/dexamethasone],</w>
cyclophosphamide induced</w>
cyclophosphamide -sensitive</w>
cyclophosphamide -
cyclophosphamide- (CYP)</w>
cyclophosphamide ).</w>
cyclophosph amid</w>
cyclopentyl adenosine-
cyclopentyladenosine- elicited</w>
cyclopent olate.</w>
cyclopent olate,</w>
cyclopent enone</w>
cyclop enthyl-1,3-dipropylxanthine</w>
cyclooxygenase- 2.</w>
cyclooxygenase- 2,</w>
cyclooxygen ase/
cyclooxygenase/ lipoxygenase</w>
cyclooxygen ase)</w>
cyclohexyl]benzene ac
cyclohexyl]benzeneac temide)</w>
cyclohexyl) benzen
cyclohexyl)benzen acet
cyclohexyl)benzenacet amide
cyclohexyl)benzenacetamide ++</w>
cyclohexyl methyl)hydroxyphosphinyl]-2-(S)-</w>
cyclohexyl hydrochloride)</w>
cyclohexyl carbam
cyclohexylcarbam ic</w>
cyclohexyl adenosine),</w>
cyclohexyl -1H-
cyclohexyl-1H- tetrazol-5-yl)butoxy]-3,4-dihydro-2</w>
cyclohexim ide.</w>
cyclohexim ide-or</w>
cyclohexim ide,</w>
cyclohexanedi ol</w>
cyclohex yloxy-carbonyloxy-ethyl)</w>
cyclohex yl,</w>
cyclohex anol</w>
cyclohepten- 5,</w>
cyclohepten- 5,10-
cyclohepten-5,10- imine)</w>
cyclo thymia,</w>
cyclo sposphamide</w>
cyclo serine.</w>
cyclo propyl)-carboxamidoadenosine</w>
cyclo propane</w>
cyclo propane-epinephrine-induced</w>
cyclo cryotherapy</w>
cyclo cryotherapy.</w>
cyclo butyl-
cyclobutyl- 2,3,4,5-tetrahydro-1H-3-benz
cyclobutyl-2,3,4,5-tetrahydro-1H-3-benz azep
cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazep in-7-yl)oxy]-N-methyl-2-pyrazinecarboxamide)</w>
cycli zine</w>
cycli zine)</w>
cycli zine's</w>
cycli zed</w>
cycli zation</w>
cycle- length</w>
cycle- control</w>
cycle- check
cycle-check point</w>
cycle .(ABSTRACT</w>
cycle -specific</w>
cycle -controlled</w>
cycle )</w>
cycle ),</w>
cyclan delate</w>
cyclan delate,</w>
cycl ing:</w>
cycl ing)</w>
cycl icity,</w>
cycl ic,</w>
cycl es:</w>
cycl es/min,</w>
cycl azocine</w>
cycl ases.</w>
cycl ase/
cyclase/ cAMP-
cyclase/cAMP- system.</w>
cycl ase).</w>
cycl amate.</w>
cycl amate,</w>
cyanopindo lol.</w>
cyanocobal amine</w>
cyanocobal amin
cyanocobalamin )</w>
cyano-7-nitro quinoxaline-2,3-dione</w>
cyano-7-nitro quinoxaline-2,3-dione)</w>
cyano- N'-
cyano-N'- (2-
cyano-N'-(2- nitroxyethyl)-3-pyridinecarboximidamide</w>
cyano- 7-
cyano-7- nitro-quinoxaline-2,3-dione</w>
cyano- 2,6-di
cyano-2,6-di hydroxypyridine</w>
cyano tic,</w>
cyano -1,
cyano-1, 3
cyano-1,3 a,
cyano-1,3a, 4,
cyano-1,3a,4, 9
cyano-1,3a,4,9 b-
cyano-1,3a,4,9b- tetrahydro-3H-benzopyrano[3,4-c]pyrrole-2-yl)-butyl](4-phenyl)benzamide]</w>
cyan methemoglobin</w>
cyan ide-insensitive</w>
cyan ide,</w>
cyan ide)</w>
cyan amide.</w>
cyan amide,</w>
cy tolethal,</w>
cy tidyl</w>
cy te,</w>
cy pionate</w>
cy klokapron),</w>
cy chlo
cychlo thiazide</w>
cy cad
cycad ,</w>
cy ca
cyca d</w>
cy ).</w>
cy ),</w>
cutoff s.</w>
cutoff ).</w>
cutane us</w>
cutane ous,</w>
cut- points,</w>
cut s,</w>
cut ane</w>
cut ane,</w>
cut an
cutan E
cutanE ous</w>
custom arily</w>
cust om</w>
cust ody</w>
cust ody,</w>
cust odial</w>
cushi oned</w>
cushi on</w>
curv ature</w>
curv ature.</w>
curren ts:</w>
curren ts)</w>
curren t:</w>
cure d;</w>
cure d."</w>
cure ;</w>
curar ization.</w>
curar ization"</w>
curar iform</w>
cur vilinear,</w>
cur ves)</w>
cur ved</w>
cur ve;</w>
cur ve)</w>
cur ve).</w>
cur tails</w>
cur tailing</w>
cur tail</w>
cur sors</w>
cur s</w>
cur ring</w>
cur on,</w>
cur b</w>
cur atively</w>
cur ative-
curative- intent</w>
cur ative,</w>
cur ative"</w>
cur are
curare -like</w>
cur ability</w>
cups/ day.</w>
cups/ day)</w>
cups/ d,</w>
cup ruretic</w>
cup /day,</w>
cup /
cup/ day),</w>
cup -shaped</w>
cune us</w>
cune us,</w>
cune us)</w>
cumul atively.</w>
cumul ativel
cumulativel y)</w>
cumber stome.</w>
cum ar
cumar in-derivates</w>
cultur ation,</w>
cultur able</w>
cult ures)</w>
cult ures).</w>
cult ured.</w>
cult ured,</w>
cult ure-proven</w>
cult ure-negative</w>
culpr its</w>
culo us</w>
culo motor</w>
culo genic</w>
culmin ates</w>
cul tivated</w>
cul t</w>
cul ly,</w>
cul inum)</w>
cul arization</w>
cul ar-
cular- specific</w>
cuff s</w>
cuff s.</w>
cuff s,</w>
cuff ing,</w>
cuff .</w>
cuff -</w>
cuff ,</w>
cue- target</w>
cue- specific</w>
cue- induced,</w>
cubo idal</w>
cubo id</w>
cu min,</w>
cu logyric</w>
cu ing</w>
cu ing),</w>
cu es;</w>
cu e,</w>
ct us</w>
cs f)</w>
crystallo ids,</w>
crystall uria;</w>
crystall uria-dysuria.</w>
crystall urea</w>
crystall ine-induced</w>
crystal lization.</w>
crystal -related</w>
cryst al-
crystal- laden</w>
cryptococ cosis</w>
cryptococ cosis.</w>
cryptococ coma.</w>
crypt o-epileptics</w>
cryp tic,</w>
cryos urgery</w>
cryos ectioned</w>
cryoglobul ins,</w>
cryoglobul inemia,</w>
cryo preservability,</w>
cry otermination</w>
cry omapping.</w>
cruci ating</w>
cruc ial,</w>
crouch ing.</w>
crouch ing).</w>
cross-tal k,</w>
cross-sec tionally,</w>
cross-sec tional,</w>
cross-foster ing.</w>
cross-foster ing)</w>
cross- tapered</w>
cross- sensitisation</w>
cross- section</w>
cross- resistant.</w>
cross- resistance.</w>
cross- regulation</w>
cross- referenced</w>
cross- reactivity.</w>
cross- over.</w>
cross- linkages,</w>
cross- injections</w>
cross- dressing</w>
cross- country</w>
cross- comple
cross-comple mentation</w>
cross- clamp</w>
cross- clamp,</w>
cross- challenge</w>
cross- analysis,</w>
cross matching</w>
cross match.</w>
cross link</w>
cross bridges</w>
cross bridge</w>
cross "</w>
cros stalk</w>
cros sing).</w>
cros sed.</w>
cros sed-over</w>
cros sed,</w>
cros s,</w>
cromoglyc ate.</w>
cromakalim -</w>
cromakal im.</w>
crocin s,</w>
cro ton</w>
cro p</w>
critic ized,</w>
critic ism</w>
critic al-
critical- incident</w>
critic al,</w>
critic al)</w>
critic al'</w>
criter ium,</w>
criter ion)</w>
criter ia),</w>
crist ae)</w>
crist a</w>
cri tically,</w>
cri ses.</w>
cri ses,</w>
cri me</w>
cri me.</w>
crest s</w>
cres yl-eosin.</w>
crepit us</w>
crepit us.</w>
creatinine phosphokinase.</w>
creatinine mia:</w>
creatinine =1.
creatinine=1. 2-1.
creatinine=1.2-1. 4</w>
creatinine =
creatinine= 1.5-
creatinine=1.5- 3.5</w>
creatinin- phosphokinase</w>
creatinin- phosphokinase,</w>
creatine- supplemented</w>
creatine- kinase</w>
creatine- ch
creatine-ch inase</w>
creatin inkinase</w>
creatin ines.</w>
creatin inemia</w>
creatin inemia.</w>
creatin ine--were</w>
creatin ine--a</w>
creatin in</w>
creatin in,</w>
creat ures</w>
creat inemia,</w>
creat ine.</w>
creat ine-treated</w>
creat ine).</w>
cream ).</w>
cre ments</w>
cre dibility</w>
cre ated.</w>
cre ated,</w>
cre akin
creakin ess.</w>
cre a</w>
craw ling</w>
craw l.</w>
craw l-under/over</w>
crav ing-that</w>
crav ing-induced</w>
crav ing),</w>
craniotom y:</w>
craniotom ized.</w>
cranio vertebral</w>
crani um.</w>
crani orachischisis,</w>
crani ectomy</w>
crani alis</w>
cran ifacial</w>
cramp s:</w>
cramp s/myalgias</w>
cramp .</w>
cramp ,</w>
crack- smoking</w>
crack- cocaine.</w>
crack les,</w>
crack -induced</w>
crac ks,</w>
crac king</w>
cra b</w>
cr umbling</w>
cr l</w>
cr j</w>
cr icothyrotomy.</w>
cr as
cras h.</w>
cr 3</w>
cr ,</w>
cr ),</w>
cp m;</w>
cp m.</w>
cp m).</w>
cp inephrine</w>
cox sackievirus</w>
cow bo
cowbo y's</w>
covit ine</w>
covari ates)</w>
covari ate.</w>
cour t.</w>
cour ses).</w>
cour ses),</w>
cour se),</w>
cour iers</w>
couple ts.</w>
couple s</w>
couple d.</w>
countri es;</w>
countr y,</w>
counterpuls ation.</w>
counter- staining</w>
counter- balanced</w>
counter- balance</w>
counter- adaptive</w>
counter transferential</w>
counter shocks</w>
counter shock.</w>
counter measures</w>
counter measures)</w>
counter balances</w>
counter balance</w>
counter balance
counterbalance d.</w>
counter active</w>
counter ac
counterac ted.</w>
counter "</w>
counsel s</w>
counsel ors</w>
coun ty,</w>
coun ts;</w>
coun ts/30</w>
coun ties</w>
coun ties.</w>
coun ties,</w>
coun ted.</w>
coun t;</w>
coun t-versus-time</w>
coun selling,</w>
coumad in.</w>
coumad in,</w>
coumad in)</w>
cough s,</w>
cough ing.</w>
cough /
cough/ cold</w>
cou teractive</w>
cou lometric</w>
cotrimox azole</w>
cotrimox azole,</w>
cotranspor ting</w>
cotranspor ter-1</w>
cotranspor ter)</w>
cotrans mitter</w>
cotrans fecting</w>
cot ton-tipped</w>
cot reatment,</w>
cost- effectiveness.</w>
cost- effectiveness,</w>
cost- consuming</w>
cost s;</w>
cost ly.</w>
cost ly,</w>
cosolvent s.</w>
cosolvent -free</w>
cosol vents</w>
cos timulated</w>
cos metically</w>
cortisol -dependent</w>
cortis ol/cortisone</w>
cortis ol-mediated</w>
cortis ol)</w>
corticotrop in.</w>
corticotrop in-releasing-hormone</w>
corticotrop in-like</w>
corticosteroid- responsive</w>
corticosteroid- receptor?</w>
corticosteroid s;</w>
corticoster onemia</w>
corticoster one)</w>
corticoster iods</w>
corticom edullar</w>
cortico- papillary</w>
cortico- mesolimbic</w>
cortico- cortical</w>
cortico striatalpallidothalamic</w>
cortico reticular</w>
cortico idsteroid</w>
cortico ids</w>
cortico ids.</w>
cortico id-treated</w>
cortico id,</w>
cortico graphy</w>
cortico graphic</w>
cortical- ventral</w>
cortic otrophin</w>
cortic otrophin-releasing</w>
cortic olimbic</w>
cortic les</w>
cortic es;</w>
cortic es),</w>
cortex/ ventromedial</w>
cortex/ outer</w>
cortex- spinal</w>
cortex- periaqueductal</w>
cortex- outer</w>
cortex es,</w>
cortex :</w>
cortex .4.</w>
cortex --
cortex-- 43%;</w>
cortex );</w>
cortex ).</w>
cortex ),</w>
cortag ine-induced</w>
cortag ine,</w>
cort in,</w>
cort actin,</w>
correl ations:</w>
correl ations,</w>
correl ately</w>
correl ate?</w>
correc tion:</w>
correc tion"</w>
correc ted).</w>
correc table,</w>
correc t),</w>
correc t"</w>
corp us.</w>
coronary- stent</w>
coronary- perfused</w>
coronary- oxygen</w>
coronary- ligation-,</w>
coronary- artery</w>
coron opathy.</w>
coron er</w>
coron avir
coronavir us,</w>
coron ary.</w>
corne um</w>
corne al,</w>
corn starch,</w>
corn '</w>
cord- blood</w>
cord- S
cord-S m-ventrolateral</w>
cord ).</w>
cord 's</w>
cor ymbifera</w>
cor ylifolia</w>
cor ydalis),</w>
cor us</w>
cor responding.</w>
cor poral</w>
cor ner</w>
cor n-type'</w>
cor kscrew</w>
cor k</w>
cor ing</w>
cor ds.</w>
cor azol,</w>
cor ,</w>
copropor phyrin</w>
copropor phyria</w>
copies/ ml).</w>
copies/ ml),</w>
copies/ mL).</w>
cop ula</w>
cop per/zinc-superoxide</w>
cop per.</w>
cop per-indomethacin),</w>
cop ithecus</w>
cop ing,</w>
cop ies.</w>
cop ies,</w>
cop ic</w>
cop es/mL.</w>
coordin ators</w>
coordin ation;</w>
coordin ating</w>
coordin ates,</w>
cool ing-induced</w>
cool ed,</w>
convulsion s.)</w>
convulsion s-induced</w>
convulsion s),</w>
convulsant- potentiating</w>
convulsant- anticonvulsant</w>
convulsant s-induced</w>
convulsant ;</w>
convulsant -treated</w>
convuls ant)</w>
convul sive.</w>
convul sion;</w>
convul siogenic</w>
convul sing.</w>
convul sing,</w>
convolu tions</w>
convolu tions.</w>
convolu tion.</w>
convers ations</w>
convers ational</w>
convers ation</w>
convers ant.</w>
conver tors.</w>
conver tin),</w>
conver ted.</w>
conver tase</w>
conver sions</w>
conver sions.</w>
conver sion.9.</w>
conver sion)</w>
conver gence,</w>
conver ge,</w>
conveni ently</w>
conveni ent.</w>
conven tionally</w>
conven tionally.</w>
conve yance</w>
conve y</w>
conve xity.</w>
controversi ally</w>
controversi al:</w>
controls. Participants</w>
controls. By</w>
controlled- trials.com).</w>
controlled- onset</w>
controlled- force</w>
controlle d;</w>
controlle d:</w>
controll er</w>
controll ability.</w>
control---- 5.2%</w>
control---- 5%</w>
control---- 4.
control----4. 21%</w>
control s(P<0.01).</w>
control >
control> glycerol>anti-GBM=gentamicin>nephrectomy=uranium</w>
control /
control/ sham</w>
control -treated</w>
control -fed</w>
contribut or,</w>
contribut ing?</w>
contribut es.</w>
contribut es,</w>
contribut ary.</w>
contribu tions,</w>
contrast- medium-perfused</w>
contrast- medium-induced</w>
contrast- media-induced</w>
contrast- derived</w>
contralater ally,</w>
contralater al,</w>
contralater al),</w>
contraindic ations/
contraindications/ failure</w>
contraindic ation,</w>
contraindic ated;</w>
contradictor y,</w>
contradic tor</w>
contractilit y.8.</w>
contractilit y.(ABSTRACT</w>
contractilit y)</w>
contraceptiv es?</w>
contraceptiv es;</w>
contracepti ve;</w>
contracepti ve-associated</w>
contrac tions;</w>
contrac tion-causing</w>
contrac tion).</w>
contrac ted.</w>
contrac eptors</w>
contra- lateral</w>
contra- indications</w>
contra- indication.</w>
contra- indicated</w>
contra- indicated.</w>
contra- indicate</w>
contra indication.</w>
contra indicating</w>
continuous- treatment</w>
continuous ly)</w>
continuous ly).</w>
continu um"</w>
continu ous.</w>
continu ous)</w>
continu ing.</w>
continu es,</w>
continu e.</w>
continu e,</w>
continu ation.</w>
continu ation,</w>
continu a</w>
continu a.</w>
continu a,</w>
contin ent.</w>
contin ence</w>
contin ence.</w>
contig uous,</w>
contextu ally-
contextually- sensitized</w>
contextu alized</w>
contextu al-
contextual- cuing</w>
context ).</w>
contex ts.</w>
contex t-dependent</w>
contex t)</w>
contempl ated</w>
contamin ation.</w>
contamin ation-induced</w>
contamin ation,</w>
contamin ate</w>
contamin ants.</w>
contamin ants,</w>
contain ment,</w>
contagios um</w>
contagios um.</w>
cont usions.</w>
cont usion.</w>
cont usion,</w>
cont our.</w>
cont ortions</w>
cont ents:</w>
cont ent;</w>
cont ent:</w>
cont ent-throughout</w>
cont ent)</w>
cont ent).</w>
cont end</w>
cont acted,</w>
cont act
contact s);</w>
consump tion:</w>
consump tion-appearance</w>
consump tion),</w>
consum es</w>
consult ations.</w>
consult ations,</w>
consult ation;</w>
consult ant</w>
consul vant</w>
consul ting</w>
consul ting.</w>
consu mers;</w>
consu med,</w>
construc tion:</w>
construc ted.</w>
construc t,</w>
constric ts</w>
constric tors</w>
constric tors).</w>
constric tion/reperfusion</w>
constric t.</w>
constrain ts.</w>
constrain t</w>
constitu tion.</w>
constipati on)</w>
constant- flow</w>
const ants.</w>
const ancy</w>
conspic uously</w>
conspic uous,</w>
conson ants,</w>
conson ant</w>
consolid ations</w>
consolid ation;</w>
consolid ation"</w>
consolid ating</w>
consolid ates</w>
consolid ated</w>
consist ently.</w>
consist ency,</w>
consist antly</w>
consist ant,</w>
consider able:</w>
consider able,</w>
consider ab
considerab ly:</w>
consider --
consider-- under</w>
conside red:</w>
conserv ative,</w>
conserv ation.</w>
conserv ati
conservati ve;</w>
consequ ences:</w>
consensu s.</w>
consensu al</w>
consecuti ve,</w>
consecu tives</w>
conscious ness--are</w>
conscious ness)</w>
conscious ),</w>
consci ously</w>
consci ence.</w>
cons in,</w>
cons enting,</w>
cons ent;</w>
cons anguineous</w>
connexin- 43</w>
connexin- 43-
connexin-43- positive</w>
connex in43</w>
connec tivity,</w>
connec tions,</w>
connec tions)</w>
conn ector.</w>
conjunc tive</w>
conjug ation,</w>
conjug ates,</w>
conjug ate.</w>
conjug ate,</w>
conjug at
conjugat es:</w>
congenit al)</w>
congenit a:</w>
congenit a,</w>
cong ress.</w>
cong regate</w>
confusion/ restlessness</w>
confusion/ disorientation</w>
confusion al.</w>
confu sion).</w>
confron ting</w>
confoun ds</w>
confoun der</w>
confoun der.</w>
conform ity</w>
conform ationally</w>
conform able</w>
conflu ented</w>
conflu ent,</w>
conflic ts</w>
conflic ts,</w>
conflic ting:</w>
conflic t.</w>
confirm ative</w>
confir matory.</w>
confir m,</w>
configur ational</w>
confid ence.</w>
confid ence,</w>
conf usion-appeared</w>
conf using</w>
conf used;</w>
conf use</w>
conf ines</w>
conf inement.</w>
conf abul
confabul ating</w>
condylo mata.</w>
condylo mas</w>
condylo mas.</w>
condy le</w>
condy le.</w>
conduct ances,</w>
conduct ance;</w>
conduct ance.</w>
conduc tions</w>
conduc tion:</w>
conduc t,</w>
conduc ion</w>
condition s.5.</w>
condition s--a</w>
condition s)</w>
condition s")</w>
condition ing."</w>
condition ing)</w>
condition ing),</w>
condition ally</w>
condition .
condition. Any</w>
condens ation,</w>
concurren tly;</w>
concurren t.</w>
concurren ce</w>
concomitant /
concomitant/ adjuvant</w>
concomit ant,</w>
concoc tion</w>
concoc tion.</w>
conclu sions,</w>
conclu sion:</w>
conclu ded:</w>
concer t,</w>
concer ned;</w>
concer ned).</w>
concer n;</w>
concept us.</w>
concept s.</w>
concept .</w>
concentration/ response</w>
concentration/ mg</w>
concentration- versus-time</w>
concentration- relaxation</w>
concentration- related,</w>
concentration- hour</w>
concentration s--which</w>
concentration ),</w>
concentr ically</w>
concentr ic,</w>
concent rating,</w>
concent rates.</w>
concent rate.</w>
conceiv able.</w>
conceiv able,</w>
conc ussive</w>
con- current</w>
con- centr
con-centr ations</w>
con vection</w>
con undrum.</w>
con temporary,</w>
con sumatory</w>
con strains</w>
con strain</w>
con stitute,</w>
con sortium</w>
con sole</w>
con serve</w>
con sensus,</w>
con otruncal</w>
con notations</w>
con jectural,</w>
con ing</w>
con globata</w>
con geners.</w>
con forming</w>
con duits.</w>
con doms).</w>
con dom</w>
con curs</w>
con curred</w>
con crements</w>
con cavity</w>
con a</w>
con 1,</w>
con )</w>
computer- assessed</w>
computer- administered</w>
computer s</w>
comput es</w>
comput ation</w>
comput -
comput- ed</w>
compul sory</w>
compul sive"</w>
compul sions</w>
compression- ischaemia</w>
compression- decompression</w>
compression- decompression.</w>
compres sed,</w>
compres s</w>
comprehen sive,</w>
comprehen sion</w>
compound- against</w>
compound- 52</w>
compound s;</w>
compound s:</w>
compound s--racemate</w>
compound s)</w>
compound -1
compound-1 '</w>
compound (s)</w>
compoun ding</w>
compoun d;</w>
compoun d:</w>
compoun d)</w>
component s--INR,</w>
component s)</w>
component ),</w>
compon ent;</w>
complications-- including</w>
complications-- GABA</w>
complication s.Le</w>
complication s--a</w>
complic taions</w>
complic ations)</w>
complic ation:</w>
complic ation).</w>
compli ance/
compliance/ patient</w>
compli ance)</w>
compli ance
compliance -controlled</w>
complex ity,</w>
complex ities</w>
complex es;</w>
complex es/min</w>
complex -1,</w>
complex "</w>
complete --
complete-- among</w>
complete ),</w>
comple tes</w>
comple ters.</w>
comple ters,</w>
comple teness</w>
comple teness.</w>
complain ts:</w>
complain ts)</w>
complain t.</w>
complain t-free</w>
complain t,</w>
complain t"</w>
complain .</w>
compl iment</w>
compl ied</w>
compl ained.</w>
competi tion:</w>
competi tion.</w>
compet es</w>
compet ence.</w>
compet ed</w>
compens atory,</w>
compens ative</w>
compens ating</w>
compens ated.</w>
compart mentalized</w>
comparison s;</w>
comparison s)</w>
comparison :</w>
compar ing,</w>
compar ators</w>
compar ators.</w>
compar ator.</w>
compar ator,</w>
compar ative.</w>
compar ated</w>
compar ably.</w>
compar able;</w>
compar able:</w>
compac ta,</w>
compa red;</w>
comp ose</w>
comp ilation</w>
comp ellingly</w>
comp action</w>
community- wide</w>
communic ative</w>
communic ation;</w>
communic ation).</w>
communic ate.</w>
communic ant
communicant es</w>
communic ans</w>
commun ity:</w>
commun ities.</w>
commun is,</w>
common ly-isolated</w>
common est,</w>
common ality</w>
common L
commonL y</w>
common ),</w>
common '</w>
committe es.</w>
committe e,</w>
commissure- posterior</w>
commissure- commissure</w>
commissu res</w>
commissu res.</w>
commissu re;</w>
commis suralis,</w>
commis sioned</w>
commerci alized</w>
commerci alization.</w>
commerci al
commercial isation</w>
commence ment,</w>
commence d,</w>
comman ds,</w>
comman d.</w>
comman d,</w>
comman d),</w>
comm it</w>
comm ents</w>
comm ences</w>
comit ogen</w>
combine d-treatment</w>
combine d)</w>
combine d).</w>
combine d"</w>
combination- chemotherapy</w>
combination- agent</w>
combin ation-induced</w>
combin ation-dose</w>
combin ation-associated</w>
comb ustion-derived</w>
comb ativeness</w>
comb ativeness,</w>
comb ative</w>
comb ative,</w>
comat ogenic</w>
com positions.</w>
com positional</w>
com position:</w>
com position)</w>
com posites</w>
com modation</w>
com mitment</w>
com mented</w>
com mentary.</w>
com mentary,</w>
com eal</w>
com a;</w>
com a/
coma/ unresponsiveness</w>
com a-inducing</w>
com a-induced</w>
com a),</w>
colum ns.</w>
colum ns,</w>
colum ns).</w>
colum n.</w>
colum n)</w>
colpos uspension,</w>
colpos copic</w>
colorect al.</w>
color ing.</w>
color ata,</w>
color ant</w>
colony- stimulating-factor</w>
colony- promoting</w>
colony- formation</w>
coloni es,</w>
colon oscopic</w>
colon ization,</w>
colon )</w>
colocysto plasty:</w>
colocysto plasty.</w>
colo ur.</w>
colo stomy,</w>
collo ids,</w>
collo id;</w>
collicul us)</w>
collicul us).</w>
colli sion);</w>
collec tions.</w>
collec tions,</w>
collater alization</w>
collap sing.</w>
collap se;</w>
collap se--for</w>
collap se'</w>
collagen/ epinephrine</w>
collagen- vascular</w>
collagen- specific</w>
collagen- epinephrine-induced</w>
collagen- coated</w>
collagen- binding</w>
collagen- III</w>
collagen- ,</w>
collagen s,</w>
collagen ous</w>
collagen olytic</w>
collagen ).</w>
coll ects</w>
coll ectively,</w>
coll ective</w>
coll ect,</w>
coll ated.</w>
coll ate</w>
coliti s?</w>
coliti des.</w>
coliti des,</w>
cold- restraint</w>
cold- pain.</w>
cold- allodynia,</w>
colchic ine-treated</w>
colchic ine--especially</w>
col umella</w>
col orimetry.</w>
col or-coded</w>
col ons</w>
col on-26</w>
col o</w>
col itis)</w>
col itis).</w>
col istin,</w>
col ics</w>
col ics.</w>
col i.</w>
col ectomy</w>
col ds</w>
col d;</w>
col d/menthol</w>
col ab
colab eled</w>
coit us.</w>
coit um</w>
coincid ent.</w>
cohor t]</w>
cohor t;</w>
cohor t-controlled</w>
cohor t),</w>
cognitive- perceptual</w>
cogniti ve/emotional</w>
cogni tion:</w>
cogn isant</w>
coffe es</w>
coffe es.</w>
coffe e)</w>
coer uleus:</w>
coer ci
coerci on,</w>
coeffici ent:</w>
code s,</w>
code ine--a</w>
code ine)</w>
code ine).</w>
cocult uring</w>
cochle as</w>
cocci ,</w>
cocaine/ placebo</w>
cocaine/ opiate</w>
cocaine- withdrawal</w>
cocaine- unexposed</w>
cocaine- unexposed.</w>
cocaine- specific</w>
cocaine- smoking</w>
cocaine- seeking,</w>
cocaine- priming</w>
cocaine- pretreated</w>
cocaine- poisoned</w>
cocaine- plus-tobacco</w>
cocaine- naive</w>
cocaine- modulating</w>
cocaine- modified</w>
cocaine- kindling).</w>
cocaine- intoxicated</w>
cocaine- free,</w>
cocaine- ethanol.</w>
cocaine- enhanced</w>
cocaine- elicited</w>
cocaine- driven</w>
cocaine- drinking,</w>
cocaine- depressed</w>
cocaine- dependence</w>
cocaine- decreased</w>
cocaine- clozapine</w>
cocaine- blocking</w>
cocaine- beta</w>
cocaine- benzodiazepine</w>
cocaine- association</w>
cocaine- addiction.</w>
cocaine- abused</w>
cocaine- HCl</w>
cocaine- BUP</w>
cocaine- -a</w>
cocaine induced</w>
cocaine associated</w>
cocaine ,"</w>
cocaine ):</w>
cocaine ',</w>
coca ine]</w>
coca ethylene.</w>
coca ,</w>
coc k</w>
coc atropine.</w>
coc atropine-</w>
coc atrop
cocatrop ine-related</w>
cob ay
cobay a)</w>
coast ing)</w>
coast ing'.</w>
coast al</w>
coarsen ed</w>
coar se-muscle</w>
coales ce</w>
coagulopath y;</w>
coagulopath y)</w>
coagulopath ies."</w>
coagulo pathies</w>
coagul um.</w>
coagul ation;</w>
coagul able</w>
co-ordin ates</w>
co-morbidi ties.</w>
co-morbidi ties,</w>
co- vary</w>
co- varied</w>
co- use</w>
co- twin</w>
co- transporter,</w>
co- stimulatory</w>
co- stimulation</w>
co- receptors</w>
co- product</w>
co- perfusion</w>
co- perfused</w>
co- ordinated</w>
co- oncogenic</w>
co- occurs</w>
co- occurrence.</w>
co- occur</w>
co- migrating</w>
co- medications</w>
co- medication.</w>
co- medication,</w>
co- medicated</w>
co- location</w>
co- localizing</w>
co- localize</w>
co- labeled</w>
co- labeled),</w>
co- involvement</w>
co- infusion</w>
co- immunoprecipitate</w>
co- exposed</w>
co- existent</w>
co- existence</w>
co- enzyme</w>
co- entry</w>
co- deleted,</w>
co- cultured</w>
co- culture</w>
co- contraction</w>
co- chaper
co-chaper one,</w>
co- amplified</w>
co- administration,</w>
co- administered.</w>
co- administered,</w>
co- abused</w>
co verage.</w>
co ved-type</w>
co varying</w>
co vary.</w>
co variables</w>
co variables.</w>
co t</w>
co segregates</w>
co segregate</w>
co sediment</w>
co rollaries</w>
co rectopia</w>
co prological</w>
co prescription</w>
co prescribed</w>
co planar</w>
co pers</w>
co perfusions</w>
co perfused</w>
co oximetry</w>
co oximetry.</w>
co operative,</w>
co operate</w>
co ombs'</w>
co oking</w>
co oked</w>
co oked-food-related</w>
co locolic</w>
co localize</w>
co itus</w>
co investigators</w>
co ingestion</w>
co ingested</w>
co infected).</w>
co ined</w>
co induced</w>
co incubated</w>
co in</w>
co iling</w>
co il.</w>
co idosis</w>
co herently.</w>
co herent</w>
co gwheeling.</w>
co gen</w>
co factors.</w>
co factors)</w>
co factor.</w>
co expression</w>
co expressed</w>
co express</w>
co enzyme,</w>
co dine</w>
co dified</w>
co dependent</w>
co dependence</w>
co dependence,</w>
co ded.</w>
co at,</w>
co application</w>
co ap
coap tation.</w>
co administration:</w>
co administration,</w>
co administering</w>
co administered,</w>
co activator</w>
co activation</w>
co abuse</w>
co 2)</w>
co 1</w>
co ,</w>
cm2/ 100</w>
cm/ second</w>
cm/ second)</w>
cm/ sec/mmHg</w>
cm/ s]</w>
cm. s(-1).mmHg(-1),</w>
cm. 5,</w>
cm- 5,</w>
cm- 5)</w>
cm(- 5
cm(-5 )/
cm(-5)/ m2,</w>
cm(- 2)</w>
cm x3cm</w>
cm ];</w>
cm H2O</w>
cm H2O.</w>
cm H(2)O</w>
cm H(2)O),</w>
cm (2).</w>
cm (2),</w>
cm (-1)</w>
cluster s,</w>
cluster ing.</w>
clump s.</w>
clump s,</w>
clum siness,</w>
clum ps</w>
club bing</w>
club ,</w>
clu stered,</w>
clu sion-induced</w>
clu es,</w>
clozapine/ day</w>
clozap ine;</w>
clozap ine-N-oxide.</w>
clozap ine-</w>
cloxacill in;</w>
cloxacill in/dicloxacillin</w>
cloxacill in-related</w>
cloxacill in,</w>
cloud s,</w>
cloud s".</w>
clotrimaz ole-treated</w>
clotrimaz ole-dependent</w>
clotrimaz ole,</w>
cloth ing.</w>
cloth es,</w>
clot- producing</w>
clot- bound</w>
clot ting.</w>
clot ting-time</w>
closu res</w>
closu re),</w>
closel y;</w>
closel y-followed</w>
closed- mouth</w>
closed- arm</w>
clorazep ate-treated</w>
clorazep ate-</w>
clopidogrel ;</w>
clopidogrel -related</w>
clopidogrel -associated</w>
clopidogrel )</w>
clopidogrel ).</w>
clopidogrel ),</w>
clonidine- suppressible</w>
clonidine- saline</w>
clonidine- naloxone</w>
clonidine- ephedrine</w>
clonidine- -induced</w>
clonid ine?</w>
clonid ine-treated</w>
clonid ine-associated</w>
clonid ine-</w>
clonid ine+yohimbine</w>
clonid ine).</w>
clonazepam ;</w>
clonazepam :
clonazepam: busulfan</w>
clonazepam -induced</w>
clonazepam )</w>
clonazepam ).</w>
clon ing,</w>
clon ic/tonic</w>
clon ic,</w>
clon azep
clonazep ame</w>
clomipr amine).</w>
clomipr amine's</w>
clomi pramine)</w>
clometac in-induced</w>
clometac in,</w>
clofil ium-,</w>
clofib rate:</w>
clofib rate/etofibrate</w>
clofib rate-administration</w>
clofazim ine--an</w>
clofazim ine,</w>
clofaz amine</w>
cloc k.</w>
cloc k,</w>
clobut inol.</w>
clobaz am,</w>
clo uding</w>
clo uded</w>
clo ud</w>
clo ts,"</w>
clo thiapine,</w>
clo t,</w>
clo seness</w>
clo sed)</w>
clo se.</w>
clo se-ended</w>
clo rexolone,</w>
clo farabine</w>
clo aca</w>
clo ac
cloac ae.</w>
clit oromegaly</w>
clipp ings</w>
clipp ing;</w>
clipp ing,</w>
clioquinol :</w>
clioquinol -containing</w>
clinicoradi ological</w>
clinico- biological</w>
clinico- biologic</w>
clinici ans'</w>
clinici an-</w>
clinici an-
clinician- assessed</w>
clinici an's</w>
clinically- useful</w>
clinically- effective</w>
clinical/ emergency</w>
clinical/ anatomical</w>
clinical- pharmacologic</w>
clinic oepidemiologic</w>
clinic al"</w>
clinic ;</w>
clinic 's</w>
clindam ycin-induced</w>
clin ostat</w>
clin ic-based</w>
clin ches</w>
clin af
clinaf loxacin).</w>
climb ing;</w>
clim ate.</w>
click s,</w>
click s).</w>
click s"</w>
cli ents</w>
cli ent-owned</w>
cler ogenesis.</w>
clen ching,</w>
clen ched</w>
clemast ine.</w>
clef ts.</w>
clef t-like</w>
cleb opride</w>
cleb opride,</w>
cleav age,</w>
cleare r</w>
cleare d,</w>
clear ing.</w>
clear ances.</w>
clear ances)</w>
clear ance:</w>
clear ance).</w>
clear ;</w>
clea ve</w>
cle aves</w>
cle aning</w>
cle an</w>
claw s</w>
claw s,</w>
claw -
claw- like,</w>
clavulan ate</w>
clav ines</w>
claustroph obia.</w>
claustroph obia)</w>
classific ations,</w>
classific ation),</w>
classifi able</w>
classes ')</w>
class ;</w>
class -I</w>
class -
class- II</w>
clarithrom ycin-pimozide</w>
clarithrom ycin),</w>
clar ity;</w>
clar ifying</w>
clar ifing</w>
clar ifies</w>
clar ified,</w>
clar ification,</w>
clamp ing.</w>
clamp ing,</w>
clamp ing)</w>
clamp ing),</w>
clamp .</w>
clam ped.</w>
clam ped,</w>
claim s-based</w>
claim s,</w>
cl uded</w>
cl sssic</w>
cl nical</w>
cl ings</w>
cl incial</w>
cl enching</w>
cl ay
clay like</w>
cl avian</w>
cl ause</w>
cl areol</w>
citronell al.</w>
citrate- phosphate</w>
citrate- heparin</w>
citrate- anticoagulated</w>
citrat us,</w>
citrat uric</w>
citalopram ;</w>
citalopram -treated</w>
citalopram -
citalopram- fluconazole</w>
cit rulline,</w>
cit rate/day)</w>
cit ral,</w>
cit otoxic</w>
cit ations.</w>
cister ns.</w>
cister n.</w>
cister n,</w>
cisplatin/ etoposide</w>
cisplatin/ ble
cisplatin/ble omycin/vincristine</w>
cisplatin/ 5-FU</w>
cisplatin- vinblastine-bleomycin</w>
cisplatin- then-paclitaxel</w>
cisplatin- paclitaxel.</w>
cisplatin- paclitaxel,</w>
cisplatin- gemcitabine</w>
cisplatin- fluorouracil,</w>
cisplatin- exposed</w>
cisplatin- 5-fluorouracil-resistant</w>
cisplat in).</w>
cisplat in's</w>
cisapride- evoked</w>
cisapride- diltiazem</w>
cisapri de:</w>
cisapri de/clarithromycin</w>
cisapri de-related</w>
cisDDP-then-pct x.</w>
cisDDP-then-pct x,</w>
cisDDP-then-pct x)</w>
cisDD P</w>
cisDD P)</w>
cis-(+)-5-methoxy-1-methyl-2- (di-n-propyl
cis-(+)-5-methoxy-1-methyl-2-(di-n-propyl amino)
cis-(+)-5-methoxy-1-methyl-2-(di-n-propylamino) tetralin,</w>
cis-(+)-5-methoxy-1-methyl-2- (
cis-(+)-5-methoxy-1-methyl-2-( n-propylamino)tetralin,</w>
cis- platinum-induced</w>
cis- nicotine-N'-oxide</w>
cis- mutations</w>
cis- inhibits</w>
cis- flupenthixol</w>
cis- diammine-glycolatoplatinum</w>
cis- aconit
cis-aconit yl</w>
cis- RA.</w>
cis- RA),</w>
cis- R
cis-R A/
cis-RA/ mL</w>
cis- 3-[2-
cis-3-[2- hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)-cyclohexanol)</w>
cis- 2-methyl
cis-2-methyl spiro</w>
cis- 2-
cis-2- hydroxy-2-phenyl-cyclohexanecarboxylic</w>
cis retinoic</w>
cis ed</w>
cis -1,2,3,4-tetrahydro-
cis-1,2,3,4-tetrahydro- 5-
cis-1,2,3,4-tetrahydro-5- [(2-
cis-1,2,3,4-tetrahydro-5-[(2- hydroxy-3-tert-butylamino)propoxy]2,3-naphthalenediol</w>
cis (Z
cis(Z )-
cis(Z)- flupentixol,</w>
cirrho sis-like</w>
cirrho sis--successful</w>
cirrho sis)</w>
cirrho sis),</w>
circumst anc
circumstanc es:</w>
circumference /
circumference/ s,</w>
circumference ),</w>
circumferen tial,</w>
circumci sion:</w>
circum vention.</w>
circum venting</w>
circum flex,</w>
circul flex</w>
circul atory,</w>
circul ator
circulator y-responsive</w>
circul ations,</w>
circul ation:</w>
circul ation/
circulation/ heartbeat</w>
circul ation-induced</w>
circul ation)</w>
circul ate</w>
circul ate.</w>
circul at
circulat ing/CNS</w>
circuit s),</w>
circuit ries</w>
circl ing.</w>
circl ing),</w>
circ a</w>
cirazol ine-mediated</w>
cirazol ine-induced</w>
cirazol ine-</w>
cir cle.</w>
cir ch
circh oral</w>
ciproxif an,</w>
ciprofloxac in-treated</w>
ciprofloxac in-related</w>
ciprofloxac in-allergic</w>
cipro fibrate.</w>
cipro fibrate-induced</w>
cipro fibrate-derived</w>
cipar um</w>
cinti graphic</w>
cine angiography</w>
cine angiocardiography</w>
cinchon ism,</w>
cinchon a</w>
cin tredekin</w>
cin oxacin.</w>
cin oxacin-</w>
cin onide</w>
cin obufagin</w>
cin ching</w>
cin anserin,</w>
cimetid ine;</w>
cimetid ine-treated</w>
cimetid ine--dobutamine</w>
cimetid ine).</w>
cimetid ine)--1</w>
cim um</w>
cilost amide.</w>
cilnidip ine.</w>
cilnidip ine-treated</w>
cilexeti l-bearing</w>
cilexeti l),</w>
cilastat in).</w>
cil ia</w>
cil engitide.</w>
cil azapril</w>
cil az
cilaz april.</w>
cigu atoxin</w>
cigu ater
ciguater a</w>
cigarette )</w>
cigaret tes)</w>
cidofovir -induced</w>
ciclospor in,</w>
ciclo prolol;</w>
cic loxilic</w>
cibenz oline.</w>
ci vilian</w>
ci vilian,</w>
ci vil</w>
ci sion</w>
ci metadine</w>
ci meditine</w>
ci an</w>
chylo microns.</w>
chy matous</w>
chronotrop y)</w>
chronotrop ism</w>
chronic- resistant</w>
chronic- obstructive</w>
chronic- AV</w>
chron tropic</w>
chron otrophy)</w>
chron otoxicologic</w>
chron o</w>
chron ization</w>
chron icles</w>
chron icle</w>
chron icity,</w>
chron ically-administered</w>
chron ically,</w>
chron ic/withdrawal)</w>
chron dritis</w>
chromosome- positive</w>
chromosome- positive,</w>
chromosom es).</w>
chromosom e.</w>
chromosom ally</w>
chromatography- time</w>
chromatography- electron</w>
chromatograph y-</w>
chromatograph ic/mass</w>
chromatograph ic-mass</w>
chromatograph ,</w>
chromat olytic</w>
chromat olysis</w>
chromat olysis,</w>
chromat in.</w>
chrom ycin,</w>
chrom ium</w>
chro mophobes</w>
chro mogenic</w>
chow s,</w>
chow -fed</w>
chow ).</w>
chow ),</w>
chow 's</w>
choro phenoxy)butyrate)</w>
choro idopathy</w>
choriocarcin omic</w>
choriocarcin oma.</w>
chorio retinitis</w>
chorio retinitis,</w>
chorio amnion
chorioamnion itis,</w>
chori ocarcinoma</w>
choreoathe osis</w>
chore o-athetosis</w>
chore o-athetoid</w>
chore ic,</w>
chore atiform</w>
chore a--
chorea-- dynamic</w>
chor diazepoxide</w>
chor dae.</w>
chor age-
chorage- independent</w>
chondro sarcoma;</w>
chondro lysis,</w>
chondro itin-like</w>
chondro dysplasia</w>
cholyl tetraglycylhistamine</w>
cholyl diglycylhistamine</w>
cholinomime tics.</w>
cholinomime tic.</w>
cholinomime tic-induced</w>
cholinomime tic,</w>
cholinoc eptors.</w>
cholinoc eptor</w>
choling erics.</w>
cholinesterase- monoamine</w>
cholinesterase- inhibitor</w>
cholinesterase- free</w>
cholinester ases.</w>
cholinester ase)</w>
cholinester as
cholinesteras e:</w>
cholinergically- activated</w>
cholinergic- transmission</w>
cholinergic- insensitive</w>
cholinergic- adrenergic</w>
cholinerg ic-related</w>
cholinerg ic-mediated</w>
cholinerg ic-like</w>
cholinerg ic-</w>
choline- supplemented,</w>
choline- bound</w>
cholin oreactive</w>
cholin omimetics</w>
cholesterol/ total</w>
cholesterol/ phospholipid</w>
cholesterol/ paraffin</w>
cholesterol/ PL</w>
cholesterol- rich</w>
cholesterol- lowering</w>
cholesterol- lowering,</w>
cholesterol- independent</w>
cholesterol -</w>
cholester ols</w>
cholester ol-mediated</w>
cholestatic -type</w>
cholestatic --
cholestatic-- hepatocellular</w>
cholestatic )</w>
cholestatic "</w>
cholestasi s?</w>
cholestasi s.(ABSTRACT</w>
cholestasi s-induced</w>
cholestasi s--a</w>
cholestasi s)</w>
cholest yramine</w>
cholest atic,</w>
cholere tic.</w>
cholere tic,</w>
cholere sis</w>
choledoch otomy</w>
choledoch olithiasis,</w>
cholecystokinin B</w>
cholecystokinin B-receptor</w>
cholecystokin in-A</w>
cholecysto hepatolithiasis.</w>
cholecyst olithiasis</w>
cholecyst olithiasis,</w>
cholecyst ectomy)</w>
cholecyst ectomized</w>
cholecalcifer ol,</w>
chole lithiasis:</w>
cholangiti s-like</w>
cholangiti s--fever,</w>
cholangiopancreat ogram</w>
cholangio pathy?</w>
cholangio pathies</w>
cholangio grams,</w>
cholangio fibrosis</w>
cholangio fibromas,</w>
cholangi tic</w>
cholangi omas.</w>
cholangi omas,</w>
cholangi oma</w>
cholangi oles</w>
cholangi ocarcinomas</w>
cholangi o</w>
cholang itis:</w>
chol yl-lysylfluorescein</w>
chol inestrase</w>
chol ine.</w>
chol ine-associated</w>
chol escintigraphy,</w>
chol ephilic</w>
chol ate,</w>
chol ar</w>
chol angiography)</w>
chol angiograms</w>
chol amines,</w>
choic es.</w>
choic e).</w>
choic e"</w>
cho w,</w>
cho tics:</w>
cho ana
choana e,</w>
cho a</w>
cho a,</w>
chlorthalid one-induced</w>
chlortal idone.</w>
chlorprothixen i</w>
chlorprop amide-induced</w>
chlorpromaz ine:</w>
chlorpromaz ine-HC1</w>
chlorpromaz ine(CPZ)-induced</w>
chlorpromaz ine's</w>
chlorphenir amine;</w>
chlorozotoc in:</w>
chlorozotoc in,</w>
chloroquine- sensitive</w>
chloroqu ine-treated</w>
chloroqu ine),</w>
chloroform- adrenaline</w>
chloroform- adrenaline,</w>
chloroform -</w>
chloroethyl nitrosoureas</w>
chloroethyl nitrosoureas,</w>
chloroethyl nitrosourea,</w>
chloro-7- trifluoromethyl-1,2,3,4-tetrahydroquinoxaline-2,3-dione</w>
chloro- quine</w>
chloro- AP
chloro-AP B.</w>
chloro- 7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benz
chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benz aze</w>
chloro- 4-hydroxy-
chloro-4-hydroxy- 3
chloro-4-hydroxy-3 (3-
chloro-4-hydroxy-3(3- phenoxy)</w>
chloro- 4-(2-
chloro-4-(2- imidazolin-2yl-amino)-2,1,3-benzothiazole,</w>
chloro- 4-
chloro-4- fluorophenyl-(4-fluoro-4-[[(5-methyl-6-methylamino-pyridin-2-ylmethyl)-amino]-methyl]-piperidin-1-yl-methanone</w>
chloro- 3-methyl
chloro-3-methyl phenyl)-1-(4-methylbenzyl)-N-(1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl)-1H-pyrazole-3-carboxamide],</w>
chloro- 2-methyl
chloro-2-methyl phenylsulfonylaminomethyl)-bicyclo[2.2.2]octan-2-yl]-5Z-hexenoic</w>
chloro- 2-hydroxy-
chloro-2-hydroxy- N-methyl-
chloro-2-hydroxy-N-methyl- 5H-
chloro-2-hydroxy-N-methyl-5H- benzo[
chloro-2-hydroxy-N-methyl-5H-benzo[ d]naptho++</w>
chloro- 2,</w>
chloro- 2,3,4,5-
chloro-2,3,4,5- n-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine</w>
chloro- 2,3,
chloro-2,3, 4,5,
chloro-2,3,4,5, -
chloro-2,3,4,5,- tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin</w>
chloro rbenzoyl-4-chloro-N-methyl-N</w>
chloro promazine</w>
chloro phenyl)-8-(4-chlorophenyl)-2-methylpyrazolo[1,5-a]-[1,3,5]triazin-4-yl]-3-ethylaminoazetidine-3-carboxylic</w>
chloro phenoxyisobutyric</w>
chloro phenolic</w>
chloro lose-urethan</w>
chloro kynurenic</w>
chloro form,</w>
chloro ethane,</w>
chloro deoxyadenosine,</w>
chloro bromofosfamide</w>
chloro benzene</w>
chlormethi azole.</w>
chlormethi azole,</w>
chlorisondam ine.</w>
chlorisondam ine).</w>
chloride- induced,</w>
chloride- containing</w>
chloride- channel</w>
chloride- ,</w>
chlordiazep oxide-induced</w>
chlordec one's</w>
chloramphenic ol:</w>
chloramphenic ol-related</w>
chloramphenic ol-like</w>
chlorambuc il-associated</w>
chlorambuc il,</w>
chloralose- urethane.</w>
chloralose- urethane-anesthetized,</w>
chloralose- urethan</w>
chloralose- anaesthetized</w>
chloralo se;</w>
chloralo se,</w>
chloral osed</w>
chlor propanol,</w>
chlor onitrosourea</w>
chlor ides</w>
chlor ides.</w>
chlor guanide</w>
chlor desmethyldiazepam</w>
chlor desmethyldiazepam)</w>
chlo ropent,</w>
chlo roma</w>
chl ormadinone</w>
chl ormadinone,</w>
chl ecystohepatolithiasis)</w>
chiro practic</w>
chiro -
chiro- inositol</w>
chinchill as</w>
chinchill a.</w>
chinchill a)</w>
chin ensis</w>
chin cona</w>
chimpanze es</w>
chimpanze e</w>
chim ney"</w>
chill s.</w>
chill i</w>
chill ,</w>
children /
children/ adolescents</w>
children .(ABSTRACT</w>
children ."</w>
children --a</w>
children --
children-- two</w>
childhood ?</w>
childhood ;</w>
childho od-onset</w>
child birth</w>
child ?</w>
chil i</w>
chie vement</w>
chie fly,</w>
chick s:</w>
chick s'</w>
chick ens</w>
chick ens,</w>
chick en,</w>
chick ,</w>
chick )</w>
chias mopathy,</w>
chi-squ ared</w>
chi-squ are.</w>
chi el</w>
chi ectomy</w>
chi 2=</w>
chi -
chi- test,</w>
chi ,</w>
chi (2)=
chi(2)= 15.
chi(2)=15. 2,</w>
chest- wall</w>
chest- pain,</w>
chest- arm</w>
chenodeoxychol ate-
chenodeoxycholate- fed</w>
chenodeoxychol ate,</w>
chenodeoxychol ate)</w>
chemotherapy- refractory</w>
chemotherapy- naive.</w>
chemotherapy- complication</w>
chemotherapy- -
chemotherapy-- three</w>
chemotherapeu tically</w>
chemotherap y),</w>
chemotherap eutical</w>
chemosensi tizing</w>
chemopre vention.</w>
chemopre vention,</w>
chemopre ventative</w>
chemon ociceptive"--may</w>
chemon europathy,</w>
chemon ai
chemonai ve.</w>
chemoconvuls ant.</w>
chemoconvul sive</w>
chemoconvul sions,</w>
chemoconvul sion</w>
chemo- somatosensory</w>
chemo- resistant</w>
chemo- radiotherapy</w>
chemo- naive</w>
chemo- hormonal</w>
chemo- convulsants</w>
chemo sis</w>
chemo resistant</w>
chemo resistance.</w>
chemo reflexes</w>
chemo reflex.</w>
chemo reflex,</w>
chemo receptors</w>
chemo receptor-mediated</w>
chemo receptor,</w>
chemo reception</w>
chemo protectors</w>
chemo protector</w>
chemo protection?</w>
chemo protection</w>
chemo prophylaxis;</w>
chemo prophylactic</w>
chemo kines.</w>
chemo kines,</w>
chemo dectoma</w>
chemo ?
chemo? therapy.</w>
chemist ries.</w>
chemical s;</w>
chemical s:</w>
chemic ally-</w>
chemic ally-
chemically- modified</w>
chemic al/
chemical/ inflammatory</w>
chemic al-related</w>
chemic al-induced</w>
chemic al-
chemical- ,</w>
chemic al"</w>
chem otoxicity</w>
chem osuppression</w>
chem ostimulation</w>
chem omodulator</w>
chem ists</w>
chem ist</w>
chem iotherapeutic</w>
cheleryth rine</w>
cheleryth rine,</w>
chelat or)</w>
chelat e.</w>
chel ate)</w>
check- list</w>
check ups</w>
check up.</w>
check list.</w>
check list,</w>
chec ks.</w>
chec k.</w>
cheap est</w>
cheap ,</w>
che wed</w>
che m</w>
che llong</w>
che lidonine.</w>
che lation,</w>
che iralgia</w>
che ilitis,</w>
che erfulness,</w>
che aper</w>
che ap</w>
charybdotox in)</w>
charge- balanced,</w>
charg ing</w>
charg e.</w>
charg e,</w>
charco al/
charcoal/ anion</w>
charco al,</w>
characteris tics;</w>
characteris tics--locomotor</w>
characteris ation</w>
character ize,</w>
character izations.</w>
character ization:</w>
character ization,</w>
character ises</w>
character ised,</w>
char t.</w>
char t,</w>
chaper one-mediated</w>
chap ter</w>
channel- mediated</w>
channel- activation.</w>
channel- 2</w>
channel s;</w>
channel s:</w>
channel s-blocker</w>
channel s).</w>
channel s),</w>
channel 's</w>
channe lopathies:</w>
channe led</w>
channe l)</w>
chang es).</w>
chang e),</w>
chang e'</w>
chamb ers.</w>
chamb ers)</w>
challenge- rechallenge</w>
challenge- proven</w>
challenge d;</w>
challenge d"</w>
challenge ;</w>
challenge /
challenge/ rechallenge</w>
challenge -induced</w>
challenge ).</w>
challenge ),</w>
challeng ing,</w>
chalaz ion.</w>
chalaz ia.</w>
chain --particularly</w>
chain )</w>
ch- jump</w>
ch- clamp</w>
ch- Ros
ch-Ros snagel,</w>
ch ymotrypsin,</w>
ch ure</w>
ch unks</w>
ch ordal</w>
ch onic</w>
ch ocolate</w>
ch ke</w>
ch itotriosidase</w>
ch in</w>
ch in.</w>
ch illing</w>
ch id</w>
ch field</w>
ch es,</w>
ch at
chat ty.</w>
ch ased</w>
ch art
chart s,</w>
ch arcot
charcot -
charcot- marie-tooth</w>
ch airs</w>
ch air
chair )</w>
ch T)</w>
ceti rizine,</w>
cetam olol.</w>
cet yl-GABA</w>
cet alop
cetalop ram).</w>
cesare an.</w>
cesare an,</w>
cervical- sectioned</w>
cervical- cranial</w>
cerv icothoracic</w>
cerv ices</w>
ceruloplas min;</w>
certific ates;</w>
certific ates.</w>
certific ate</w>
certific ate.</w>
certain ment</w>
certain '</w>
certa in;</w>
certa in.</w>
certa in,</w>
ceroid-lipofuscin osis</w>
ceroid-lipofuscin osis.</w>
cerivastat in).</w>
cerivastat in's</w>
cerebroventricle- large</w>
cerebro- ventricular</w>
cerebro- vascular</w>
cerebro- spinal</w>
cerebro ventricularly.</w>
cerebro ventricle</w>
cerebro vasodilation</w>
cerebro vasculature.</w>
cerebro spinal-fluid</w>
cerebro sides,</w>
cerebro protection</w>
cerebro physiologic</w>
cerebro pathologic</w>
cerebro circulatory</w>
cerebri tis.</w>
cerebri ,"</w>
cerebr uspinal</w>
cerebr ums,</w>
cerebr um.</w>
cerebello vestibular</w>
cerebello -
cerebello- myoclonic</w>
cerebell um...</w>
cerebell ar-
cerebellar- activated</w>
cerebell ar,</w>
cerebell ar)</w>
cerebell a</w>
cere beli
cerebeli omedullary</w>
cere be
cerebe llitis</w>
cere al,</w>
cer uleus.</w>
cer ruloplasmin,</w>
cer ous</w>
cer oid</w>
cer nuus</w>
cer cosis</w>
cer bri
cerbri .</w>
cer amide.</w>
cer amide-
ceramide- fluorescein</w>
cer -treated</w>
cephazol in</w>
cephazol in,</w>
cephapir in;</w>
cephapir in.</w>
cephalothin- coated</w>
cephalospor in-resistant</w>
cephalospor anic</w>
cephalor idine-methylprednisolone</w>
cephalor idine,</w>
cephalo -
cephalo- pelvic</w>
cephalex in,</w>
cephal algia.</w>
ceph acet
cephacet rile</w>
centur y,</w>
centrophen oxine.</w>
centro mere,</w>
centro -
centro- portal</w>
centrifug ation.</w>
centrifug ation,</w>
centri lobular,</w>
centrally- evoked</w>
centrally- acting,</w>
central- western</w>
central- stimulant</w>
central- nervous</w>
central- nervous-system</w>
central- field</w>
central- depressant</w>
central- city</w>
central- apneic</w>
centr ation</w>
centr ally-induced</w>
centr ally,</w>
centr ally)</w>
centr alized</w>
centr al.</w>
centr al'</w>
centr al"</w>
center- perimeter</w>
center- based,</w>
centbut indol</w>
centbut indol;</w>
cent ury</w>
cent uation</w>
cent rifuged,</w>
cent res,</w>
cent rencephalic')</w>
cent red</w>
cent rating</w>
cent ers);</w>
cent ers).</w>
cembran oids.</w>
cellul itis/abscess;</w>
cellul itis,</w>
cellul itis).</w>
cells/micro l.</w>
cells/micro l,</w>
cells/micro l),</w>
cells/micro L),</w>
cells/ well)</w>
cells/ mm3);</w>
cells/ mm2</w>
cells/ mm2)</w>
cells/ mm(3)</w>
cells/ mm(3),</w>
cells/ mL</w>
cells/ l,</w>
cells/ L;</w>
cells/ L.</w>
cells/ L)</w>
cells/ L).</w>
cell/ plasma</w>
cell/ mm3</w>
cell/ microL</w>
cell/ T-cell</w>
cell- sap</w>
cell- sap)</w>
cell- proliferating</w>
cell- mediated.</w>
cell- grafted</w>
cell- fate</w>
cell- extracellular</w>
cell- directed</w>
cell- dependent;</w>
cell- cycle-checkpoint</w>
cell- culture</w>
cell- conditioned</w>
cell- bound</w>
cell- beta</w>
cell ulose.</w>
cell ulose,</w>
cell s/</w>
cell s.(ABSTRACT</w>
cell s,but</w>
cell s'</w>
cell h/mm3</w>
cell erated</w>
cell autotransplant
cellautotransplant :</w>
cell -treated</w>
cell -independent</w>
cell -free</w>
cell -dependent</w>
cell -associated</w>
cell -Mei
cell-Mei bo
cell-Meibo om-Gill</w>
cell -,</w>
cell ),</w>
cell 's</w>
celi prolol.</w>
celi prolol,</w>
celi otomy</w>
celi otomy.</w>
celi ac-
celiac- mesenteric</w>
celi ac,</w>
celecoxi b)</w>
cel lobiose</w>
ceftriax one-sensitive</w>
ceftizoxi me-</w>
ceftizoxi me,</w>
ceftazidime -related</w>
ceftazidime -dependent</w>
ceftazidi me-pretreated</w>
cefox itin,</w>
cefotetan- specific</w>
cefotetan -related</w>
cefotetan -dependent</w>
cefotet an;</w>
cefosel is),</w>
cefoperaz one,</w>
cefepi me,</w>
cefepi me's</w>
cefazol in.</w>
cefazol in-induced</w>
cefazed one,</w>
cefamand ole:</w>
cefamand ole-induced</w>
cefalospor ins</w>
cefalospor in</w>
cefadrox il</w>
cefadrox il.</w>
cefaclor ;</w>
cefaclor .</w>
cefaclor -treated</w>
cef obactam</w>
cec um.</w>
cec ostomy</w>
cec ocentral</w>
ce- Ou
ce-Ou est</w>
ce t)</w>
ce sium-induced</w>
ce ptor</w>
ce mic,</w>
ce ment's</w>
ce fotiam</w>
ce "</w>
cd c2,</w>
cc/ hr</w>
cc ;</w>
cc );</w>
cavit y),</w>
cavit ation</w>
cavit ating</w>
cavernos a.</w>
cavernos a
cavernosa ."</w>
caver noma,</w>
caveolin- positivity</w>
caveolin- interacting</w>
caveol ae</w>
caveol ae,</w>
cave olin-1alpha-positive</w>
cave at
caveat s.</w>
cav us</w>
cav o-tricuspid</w>
cav a-
cava- tricuspid</w>
cauti ousness</w>
cauti ously,</w>
cause ?</w>
cause ;</w>
cause )</w>
caus tic</w>
caus ation?</w>
caus ation;</w>
caus ation,</w>
caus ality,</w>
caus algia</w>
caus al,</w>
caudatus- putamen</w>
caudatus- putamen.</w>
caudat us.</w>
caudal- rostral</w>
caudal- dorsal</w>
caud oputamen</w>
caud omedially.</w>
caud atus</w>
caud ates,</w>
caud ally,</w>
cau ses]</w>
cau ses)</w>
cau ses).</w>
cation -dependent</w>
catheter ized,</w>
catheter izations.</w>
catheter ization;</w>
catheter ization:</w>
catheter ization-proven</w>
catheter ization)</w>
catheter :</w>
catheter -
catheter- can
catheter-can opy</w>
catheter ).</w>
catheter ),</w>
cathepsin- D</w>
cathepsin- D,</w>
cathepsin- D).</w>
cathep sin,</w>
cath inone:</w>
cath echolamines</w>
cath ar
cathar tics</w>
caten ins</w>
caten ins,</w>
caten in,</w>
caten ary,</w>
categor y:</w>
categor ize</w>
categ ories;</w>
catecholamine- related</w>
catecholamine- independent</w>
catecholamine- driven</w>
catecholamine- dependent</w>
catechol-O- methyltransferase.</w>
catechol- o-methyl-transferase</w>
catechol s,</w>
catechol estrogens</w>
catechol estrogen</w>
catechol amine/
catecholamine/ cholinergic</w>
catechol amine,</w>
catech ine,</w>
catatonia/ neuroleptic</w>
catatonia/ NMS</w>
cataton ogenic</w>
cataton ic-like</w>
cataton ia)</w>
cataton ia).</w>
cataton ia),</w>
cataton ia"</w>
catastroph es</w>
catarrh alis</w>
catarrh alis.</w>
cataract 's</w>
catapl ecticus),</w>
catap lexy:</w>
catalyst .</w>
catalyst ,</w>
cataly tically</w>
cataly sis</w>
cataly sis,</w>
cataly sed</w>
catalepsy- reversal</w>
catalepsy /
catalepsy/ catatonia:</w>
catalepsy .7</w>
catalepsy -related</w>
catal ase;</w>
catal ase-
catalase- overexpressing</w>
cat s;</w>
cat s.3.</w>
cat mint</w>
cat h</w>
cat cholamines,</w>
cat ch</w>
cat away,</w>
cat amen
catamen ial</w>
cat alo
catalo guing</w>
cat ak
catak epsy</w>
cat a,</w>
cat :</w>
cat 1,</w>
cat --a</w>
casual ty</w>
casual ties</w>
castrat ed;</w>
castrat ed,</w>
cast s:</w>
cast rate,</w>
cass ;</w>
caspase- dependent</w>
caspase- 9,</w>
caspase- 8</w>
caspase- 8,</w>
caspase- 3.</w>
casopit ant.</w>
casiragu as,</w>
casiragu a)</w>
cases/ million</w>
cases/ 10</w>
cases-- to</w>
cases-- most</w>
case-- was</w>
case-- long-lasting</w>
case- study</w>
case- report.</w>
case- population</w>
case- notes.</w>
case- fatality</w>
case- fatality.</w>
case- controlled,</w>
case- comparison</w>
case- -the</w>
case are
caseare an</w>
case /</w>
casca de;</w>
casca de)</w>
casca de).</w>
cas ual.</w>
cas sette,</w>
cas e:</w>
cas .</w>
carvedi lol-treated</w>
carvac rol</w>
carvac rol.</w>
carumon am.</w>
cartograph ies</w>
cartograph ies,</w>
cartil ages</w>
cartil age.</w>
carri ers:</w>
carri er,</w>
carrageenan/ kaolin-induced</w>
carrageen in,</w>
carrageen an-
carrageenan- provoked</w>
carrageen an)</w>
carr yover,</w>
carr y-over</w>
caroti dofemoral</w>
caroti d.</w>
caroten oids,</w>
caro tidartery</w>
carnit ines</w>
carmustine- impregnated</w>
carmustine- [1,
carmustine-[1, 3-bis</w>
carmust ine-treated</w>
carmust ine)</w>
carmofur :</w>
carmin omycin.</w>
carmin ative,</w>
careful ,</w>
care- givers</w>
care- are</w>
care takers.</w>
care taker</w>
care ers,</w>
care --
care-- especially</w>
cardioverter/defibrill ator,</w>
cardioverter/ defibrillator</w>
cardioverter-defibrill ator,</w>
cardiover sions,</w>
cardiovascular /
cardiovascular/ cerebrovascular</w>
cardiovascular -specific</w>
cardiovascular -related</w>
cardiovascular -
cardiovascular- drug-related</w>
cardiotoxic osis</w>
cardiotoxic osis.</w>
cardiotoxic ity?</w>
cardiotoxic ity--appears</w>
cardiotoxic ity,"</w>
cardiotoxic ity)</w>
cardiotoxic )</w>
cardiotoc ography.</w>
cardiotoc ogram.</w>
cardiostimul atory</w>
cardiostimul ator</w>
cardiostimul ant</w>
cardioprotect ants.</w>
cardioprotect ant.</w>
cardiomyopathy-- risk</w>
cardiomyopathy-- comparison</w>
cardiomyopath y/coccidioidomycosis,</w>
cardiomyopath y.(ABSTRACT</w>
cardiomyopath y-echocardiographic</w>
cardiomyopath y-associated</w>
cardiomyopath y--a</w>
cardiomyopath y,"</w>
cardiomyopath y)</w>
cardiomyopath y")</w>
cardiomyopath ies,</w>
cardiomyocyt es;</w>
cardiomyo plasty:</w>
cardiomyo -</w>
cardiomy ocyte.</w>
cardiomy ocyte-toxicity</w>
cardiomy ocyte-restricted</w>
cardiom oderation</w>
cardiom etabolic</w>
cardiolip in.</w>
cardio- vascular</w>
cardio- selective</w>
cardio- protective</w>
cardio- impaired</w>
cardio- cerebrovascular</w>
cardio vasculotoxicity</w>
cardio vasculat</w>
cardio thromboembolism</w>
cardio selective.</w>
cardio selective,</w>
cardio selective),</w>
cardio protective:</w>
cardio protection,</w>
cardio pathology</w>
cardio inhibitory</w>
cardio inhibitory,</w>
cardio embolism</w>
cardio echographic</w>
cardio dynamics</w>
cardio dynamic</w>
cardio depressive</w>
cardio depressive.</w>
cardio depressant"</w>
cardio acceleratory</w>
cardio acceler
cardioacceler ation,</w>
cardic -
cardic- hypotensive</w>
cardiac- restricted</w>
cardiac- depressant</w>
cardiac- denervated</w>
cardiac- arrest</w>
cardiac dysfunction,</w>
cardiac -derived</w>
cardiac )</w>
cardiac ),</w>
cardi tis.</w>
cardi otoxocity</w>
cardi otoxity</w>
cardi otoxin</w>
cardi otonic,</w>
cardi ostimulation</w>
cardi osparing</w>
cardi osclerosis</w>
cardi oneuropathy.</w>
cardi onephromegaly,</w>
cardi ology:</w>
cardi ologist.</w>
cardi olite</w>
cardi oconversion.</w>
cardi ocirculatory</w>
cardi oballistic</w>
cardi ale.</w>
carcinosarcom a;</w>
carcinosarcom a-
carcinosarcoma- cells,</w>
carcinosarcom a)</w>
carcinomas ?</w>
carcinomas ).</w>
carcinomas ),</w>
carcinom as:</w>
carcinom a;</w>
carcinom a);</w>
carcinogen icity.</w>
carcinogen icity.(ABSTRACT</w>
carcinogen icity,</w>
carcinogen ic/antioxidant</w>
carcinogen ic.</w>
carcinogen ic,</w>
carcinogen ;</w>
carcinogen -treated</w>
carcinogen -
carcinogen- initiated</w>
carcin osarcoma</w>
carcin omatous</w>
carcin omatosis,</w>
carcin oid-like,</w>
carcin oid);</w>
carcin ogenesis--VIII.</w>
carboxypiperazin-4- yl]-propyl-1-phosphonate</w>
carboxypiperaz ine-4-yl)propenyl-1-</w>
carboxymethylcell ulose-based</w>
carboxymethylcell ulose,</w>
carboxyl ic-ester</w>
carboxyl ation.</w>
carboxyl ate-
carboxylate- t-butyl</w>
carboxycyclo propyl-1-yl)-3-(xanth-9-yl)</w>
carboxycyclo propyl)-glycine</w>
carboxy-ly ase</w>
carboxy-3-hydroxy phenyl-glycine</w>
carboxy- terminal</w>
carboxy phenylglycine</w>
carboxy methyllysine</w>
carboxy methyl-L-cysteine</w>
carboxy hemoglobin</w>
carboxy fluorescein</w>
carboxy fluorescein,</w>
carboxy ethyl)phenyl]ethylamino]-5'-N-ethylcarboxamidoadenosine;</w>
carboxamido adenosine)</w>
carboxamide adenosine</w>
carboxamide ]</w>
carboxamide ],</w>
carboxamide :</w>
carbox ymuconate-epsilon-semialdehyde</w>
carbox yl-terminal</w>
carbox y</w>
carbox amido-
carboxamido- adenosine</w>
carbox amides</w>
carboplatin/ cyclophosphamide/etoposide</w>
carboplatin- paclitaxel.</w>
carboplatin- evoked</w>
carboplatin- cisplatin</w>
carbonyl ation,</w>
carbon ylation</w>
carbon yl]-L-histidyl-L-</w>
carbon yl-Val-Ala-DL-Asp</w>
carbon ate-treated</w>
carbon ate-</w>
carbon ate-
carbonate- dependent.</w>
carbon -11</w>
carbon -1
carbon-1 4-
carbon-14- amino
carbon-14-amino isobutyric</w>
carbohyd rates</w>
carbocyste ine</w>
carbocyste ine.</w>
carbocyste ine,</w>
carbocrom ene,</w>
carbo prostacyclin</w>
carbo prost.</w>
carbo platinum</w>
carbo furan</w>
carbo furan:</w>
carbim ide</w>
carbim azole)</w>
carbim azol
carbimazol e?</w>
carbidopa /
carbidopa/ levodopa</w>
carbidopa )</w>
carbidopa );</w>
carbidopa ),</w>
carbet ocin.</w>
carbet ap
carbetap entane)</w>
carbenicill in-induced</w>
carbenicill in)</w>
carben icilin</w>
carbap enems</w>
carbap enem-induced</w>
carbamyl ation-mediated</w>
carbamyl ating</w>
carbamoyloxy -1-
carbamoyloxy-1- (4-
carbamoyloxy-1-(4- (4-fluoro
carbamoyloxy-1-(4-(4-fluoro phenyl)-4-oxobutyl)</w>
carbamo ylphosphate.</w>
carbamazepine-10,11- trans-diol</w>
carbamazepine-10,11- epoxide:</w>
carbamazepine-10,11- epoxide,</w>
carbamazep ine-exacerbated</w>
carbamazep ine)</w>
carbamazep ine).</w>
carbam yl</w>
carbam azine</w>
carbam ates,</w>
carbachol- stimulated</w>
carbachol- evoked</w>
carbachol- elicited</w>
carbachol- contracted</w>
carbach ol-mediated</w>
carbach ol-</w>
carbaceph ems,</w>
carb osulfan</w>
carb on.</w>
carb ia</w>
carb enoxolone</w>
carb azine</w>
carb ar
carbar yl,</w>
carb ame
carbame zepine</w>
carami phen</w>
carami phen),</w>
car teolol,</w>
car ra-geenan-induced</w>
car popedal</w>
car pet,</w>
car p,</w>
car neae.</w>
car moxirole</w>
car moxirole;</w>
car ius,</w>
car ini</w>
car ies,</w>
car idiotoxicity</w>
car fully</w>
car ds</w>
car din)</w>
car d.</w>
car d,</w>
car cass;</w>
car but
carbut amide)</w>
car bas
carbas al
carbasal ate</w>
car acemide,</w>
captopril- type</w>
captopril- sensitive</w>
captopril- evoked</w>
captopri l;</w>
captopri l-related</w>
captopri l-like</w>
captopri l's</w>
captop urine</w>
capt uring</w>
capt ure.</w>
capsul itis</w>
capsul es/menstrual</w>
capsul es).</w>
capsul e),</w>
capsazep ine.</w>
capsazep ine-sensitive</w>
capsazep ine)</w>
capsaicin/ vanilloid</w>
capsaicin/ morphine,</w>
capsaicin- treated,</w>
capsaicin- sensitized</w>
capsaicin- only</w>
capsaicin- irritated</w>
capsaicin- insensitive</w>
capsaicin- initiated</w>
capsaicin- infusion,</w>
capsaicin- enhanced</w>
capsaicin- -a</w>
capsaicin- (50</w>
capsaic ine,</w>
capsaic in;</w>
capsaic in.(ABSTRACT</w>
caps ulation</w>
capre omycin),</w>
capno graphy</w>
capno graphy,</w>
capillari es/number</w>
capillari es).</w>
capillar itis,</w>
capill ary.</w>
capill aro
capillaro scopic</w>
capecitab ine/oxaliplatin</w>
capecitab ine-containing</w>
capecitab ine-associated</w>
capac ity;</w>
cap toethane</w>
cap tase</w>
cap sid</w>
cap ric</w>
cap ric,</w>
cap ping</w>
cap itis:</w>
cap ital</w>
cap ita.</w>
cap elin</w>
cap ecetabine</w>
cap ability.</w>
cap -
cap- system</w>
cap )</w>
cannul ated,</w>
cannul as.</w>
cannul a-
cannula- osmotic</w>
cannul a)</w>
cannul a
cannula e;</w>
cannabin oid-independent</w>
cannabin oid,</w>
cannabimi metics</w>
cannabimi metic,</w>
cannab is.</w>
cannab is-extracts</w>
cannab is),</w>
cannab idiol"</w>
cann abil
cannabil actone</w>
candide mia.</w>
candi demia:</w>
candi dal</w>
candi dacy,</w>
candi da</w>
candesart an-treated</w>
candesart an-associated</w>
cancer-- self-rated</w>
cancer-- 9
cancer--9 6-month</w>
cancer ?</w>
cancer --a</w>
cance led,</w>
cance l</w>
canc er-susceptible</w>
canal :</w>
can ula,</w>
can tholysis</w>
can s;</w>
can renoate</w>
can naliculi</w>
can is</w>
can is,</w>
can ines</w>
can ines.</w>
can es,</w>
can dicain)</w>
can :</w>
can 't</w>
camsy late</w>
camsy late.</w>
campt othecin,</w>
campt ocormia,</w>
campa igns</w>
camera- computer</w>
cam p</w>
calretin in-positive</w>
calretin in-immunoreactive</w>
calori metry.</w>
calmodul in-related</w>
calmodul in-mediated</w>
calmodul in-depent</w>
callo sum)</w>
calibr ation.</w>
calib rating"</w>
calib rated.</w>
calib er.</w>
cali pers</w>
cali bration</w>
calcul us:</w>
calcul i).</w>
calcul ation.</w>
calcul ated).</w>
calcul ate
calculate d.When</w>
calcium/ sodium</w>
calcium- specific</w>
calcium- sparing</w>
calcium- regulating</w>
calcium- regulated</w>
calcium- raising</w>
calcium- phosphate</w>
calcium- loading</w>
calcium- like</w>
calcium- independent</w>
calcium- enriched</w>
calcium- dependent,</w>
calcitri ol-refractory</w>
calcitri ol--i.e.,</w>
calcitri ol).</w>
calcitri ol),</w>
calcitonin- producing</w>
calcitonin- gene-related</w>
calcit roic</w>
calcineurin- inhibitors.</w>
calcineurin- inhibitor-related</w>
calcineurin- inhibitor-free,</w>
calcineurin- inhibitor-based</w>
calcineur inblocker</w>
calcineur in-dependent</w>
calcineur in-based</w>
calcineur in-associated</w>
calcineur in,</w>
calcin osis,</w>
calcific ation;</w>
calci uric</w>
calci ums</w>
calci septine</w>
calci otrophic</w>
calc ified,</w>
calc ific</w>
calc iferols</w>
calbindin-D28 k</w>
calbindin-D28 k.</w>
calbindin-D28 k,</w>
calbindin-D28 K,</w>
calbindin-D(28 K).</w>
calbindin- ,</w>
calbind in.</w>
calab ura),</w>
cal reticulin,</w>
cal phostin</w>
cal ories.</w>
cal mer,</w>
cal mative</w>
cal m,</w>
cal desmon,</w>
cal culogenic</w>
cal cerous</w>
cal cemic,</w>
cal cemia</w>
cal cemia.</w>
caffeine- pretreated</w>
caffeine- mediated</w>
caffeine- -
caffeine-- most</w>
caffe inism</w>
caffe inism,</w>
caffe ine:</w>
caffe ine/placebo.</w>
caffe ine-like</w>
caffe ine),</w>
caffe ine'</w>
cadher ins</w>
cadher in/catenin</w>
cadher in.</w>
cad mium.</w>
cachex ia.</w>
cachex ia,</w>
cac odylate</w>
cab ies</w>
ca vities.</w>
ca utery</w>
ca used.</w>
ca re:</w>
ca in)</w>
ca erulein,</w>
ca des</w>
ca -1
ca-1 +</w>
cTn I-
cTnI- positive,</w>
cTn I,</w>
cTn I)</w>
cGMP- mediated</w>
cGMP- hydrolysing</w>
cG y.</w>
cG MP
cGMP /
cGMP/ PKG</w>
cAR T,</w>
cAR T),</w>
cAMP- independent</w>
c/ second</w>
c/ CA4</w>
c/ 2</w>
c.v .,</w>
c.v .).</w>
c. s.f.</w>
c. n.),</w>
c. 366
c.366 C>G,</w>
c. 26
c.26 64
c.2664 C>T,</w>
c. 13
c.13 79
c.1379 C>T,</w>
c. -
c.- 200
c.-200 T>
c.-200T> G,</w>
c. ).</w>
c-fos- regulated</w>
c-fos- immunoreactive.C-fos</w>
c-fos -like</w>
c- troponin</w>
c- preterminal</w>
c- oxidase</w>
c- myc,</w>
c- kit.</w>
c- antipyretic</w>
c- Met
c-Met ,</w>
c- LD
c-LD L),</w>
c- K
c-K it.</w>
c- Jun</w>
c- ANCA/
c-ANCA/ PR3-ANCA</w>
c- AMP.</w>
c- AMP-
c-AMP- stimulated</w>
c- AFL)</w>
c vpO2).</w>
c ushingoid</w>
c ures.</w>
c untional</w>
c ubes</w>
c tytes</w>
c tober</w>
c t,</w>
c rusts</w>
c romolyn</w>
c ribiform</w>
c rest.</w>
c remasteric,</w>
c reases.</w>
c rease</w>
c p.</w>
c osuppression</w>
c osinor</w>
c ocarcinogenic,</w>
c nc4)</w>
c moat)</w>
c lips</w>
c lipped,</w>
c lip,</w>
c levudine</w>
c ities.</w>
c ite</w>
c istography</w>
c isternal</w>
c ine-angiograms</w>
c fu/mL</w>
c esses</w>
c ers</w>
c entimeters</w>
c ensored</w>
c c.</w>
c ations;</w>
c ation-induced</w>
c ated</w>
c anted</w>
c ans</w>
c am,</w>
c alling</w>
c all
call ers</w>
c age,</w>
c age)</w>
c able</w>
c [
c[ DPen
c[DPen (2)
c[DPen(2) ,
c[DPen(2), DPen
c[DPen(2),DPen (5)]enkephalin</w>
c RA)</w>
c PK
cPK C.</w>
c PCO
cPCO 2),</w>
c P</w>
c O
cO )-
cO)- Fe
cO)-Fe (III)</w>
c NOS,</w>
c N0M
cN0M 0,</w>
c M;</w>
c Gy</w>
c Gy,</w>
c Gy).</w>
c ES)</w>
c DNA
cDNA s</w>
c Ag
cAg (+),</w>
c AUC</w>
c ART</w>
c ANCA</w>
c ANCA-
cANCA- titre,</w>
c AMP;</w>
c 3.</w>
c 2</w>
c -associated</w>
c );</w>
c )-induced</w>
bypass ;</w>
by- products</w>
by- products,</w>
by- passing</w>
by- breath</w>
by products</w>
by product</w>
bw/ min)</w>
butyryl cholinestrase</w>
butyrophen ones,</w>
butyrophen one,</w>
butyn in</w>
butyl- ethyl-[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo</w>
butyl- 3-[4-
butyl-3-[4- [3-(di
butyl-3-[4-[3-(di butyl
butyl-3-[4-[3-(dibutyl amino)
butyl-3-[4-[3-(dibutylamino) pro-pyl]benzoyl]-1-benzofuran-5-carboxylate</w>
butyl- 2-
butyl-2- pyrrolidinyl)methyl]-2-methyl-5-sulfamoyl-2,</w>
butyl -1-
butyl-1- nitrosourea]</w>
butyl )</w>
buttoc k</w>
buthionine- S,</w>
buter ol,</w>
buten enedionate)</w>
butaz ones,</w>
butaz one,</w>
butanoyl urea:</w>
butano ylurea</w>
butano yl</w>
butaclam ol,</w>
but yrate),</w>
but tons</w>
but terfly</w>
but ter,</w>
but oxyethoxy)ethoxy]-4,5-methylenedioxy-2-propyltol</w>
but oxide.</w>
but oxamine</w>
but orphanol;</w>
but olol-induced</w>
but anone</w>
but amide-induced</w>
but -
but- relative</w>
busulph an-induced</w>
busulph an-cyclophosphamide</w>
busulph an-
busulphan- thioguanine</w>
busulph an,</w>
busulfan/ cyclophosphamide.</w>
busulf an;</w>
busulf an:</w>
busulf an-cyclophosphamide</w>
busulf an-associated</w>
buspir one-injected</w>
buspir one-induced</w>
buspir one-</w>
buspir one),</w>
buse relin</w>
buse relin,</w>
bus inessman</w>
burst/ min</w>
burst/ min)</w>
burst s/min)</w>
burst ing.</w>
burst ing,</w>
burrow ing</w>
burg 's</w>
burden s,</w>
burden ed</w>
burden .</w>
bur ying</w>
bur sitis</w>
bur r</w>
bur ns.</w>
bur ns,</w>
bur ning.</w>
bur imamide)</w>
bupropri on</w>
bupropri on.</w>
bupropi on/lamotrigine-induced</w>
bupropi on-related</w>
bupropi on)</w>
buprenorph ine/kg</w>
buprenorph ine-cocaine</w>
buprenorph ine-</w>
bupivacaine/epinephrine/ sufentanil</w>
bupivacaine/epinephrine/ sufentanil/clonidine</w>
bupivacaine/ sufentanil,</w>
bupivacaine/ rofecoxib</w>
bupivacaine/ placebo</w>
bupivacaine/ epinephrine</w>
bupivacaine/ diamorphine</w>
bupivacaine/ adrenaline</w>
bupivacaine- morphine.</w>
bupivacaine- induced,</w>
bupivacaine- epinephrine-sufentanil</w>
bupivaca ine:</w>
bupivaca ine/</w>
bupivaca ine-containing</w>
bupivaca ine-associated</w>
bupivaca ine).</w>
bunitro lol.</w>
buni onectomy.</w>
bundle- ventricular</w>
bundle- -
bundle-- hence</w>
bund ling</w>
bun g.</w>
bun azosin.</w>
bun azosin,</w>
bumetan ide-sensitive</w>
bullo us-hemorrhagic</w>
bullo stomy</w>
bull '
bull' s-eye</w>
bulim ia.</w>
bulim ia,</w>
bul l's</w>
bul k,</w>
build s</w>
buil ders.</w>
buil d,</w>
bufur alol.</w>
bufur al
bufural ol).</w>
buff ers.</w>
buff ering.</w>
buff er/kg</w>
buff er).</w>
budral azine.</w>
budral azine)</w>
budg eting</w>
budg etary</w>
budg et.</w>
bud ding-out</w>
bucumo lol,</w>
bucumo lol),</w>
bucindo lol)</w>
bucco- linguo-masticatory</w>
bucco- lingual</w>
buc olome.</w>
bu ying</w>
bu tiric</w>
bu tions</w>
bu profen),</w>
bu pranolol.</w>
bu nex,</w>
bu l</w>
bu gs</w>
bu gs"</w>
bu fen</w>
bu dipine</w>
bu dipine.</w>
bt b)</w>
bt O(2))</w>
brux ism)</w>
brucello sis.</w>
bruc ellae</w>
bru it</w>
bru gada</w>
bru ary,</w>
brow sing</w>
brou ght.</w>
brother s.</w>
brother s,</w>
bronchospas tic</w>
bronchospas ms</w>
bronchospas m-related</w>
bronchospas m--a</w>
bronchopneum onia</w>
bronchodilat ors:</w>
bronchodilat ors.</w>
bronchodilat or-induced</w>
bronchodilat ation,</w>
broncho gram</w>
broncho gram.</w>
broncho gram,</w>
broncho alveolar</w>
bronchi olitis.</w>
bronchi olitis,</w>
bronchi oles</w>
bronchi ale</w>
bronchi ale.</w>
bronch us</w>
bronch us.</w>
bronch oscopy:</w>
bronch itis:</w>
bronch i.</w>
bronch i,</w>
bromosul phalein.</w>
bromocript ine?</w>
bromocript ine;</w>
bromocript ine-associated</w>
bromocript ine--nausea,</w>
bromocript ine's</w>
bromoc resine.</w>
bromoc amph
bromocamph or-pi-sulfonate</w>
bromo- alpha-erg
bromo-alpha-erg ocryptin</w>
bromo- DHP</w>
bromo- 9-ethyladenine</w>
bromo- 8-hydroxy-
bromo-8-hydroxy- 3-</w>
bromo- 4,
bromo-4, 5-di
bromo-4,5-di methoxybenzyl)-7-hydroxy-6-methoxy-2-methyl-</w>
bromo- 2-chloro
bromo-2-chloro -1,
bromo-2-chloro-1, 1,1-
bromo-2-chloro-1,1,1- trifluoro-ethane)</w>
bromo phenyl)-8-fluoro-4H-imidazo-[1,5-a]</w>
bromo ethane,</w>
bromo benzo[b]furan-2-ylsulfonyl)
bromobenzo[b]furan-2-ylsulfonyl) hydantoin)</w>
brom yalgia,</w>
brom peridol,</w>
brom osulfophthalein,</w>
brom osubstituted</w>
brom olisuride</w>
brom ocryptine.</w>
brom ocryptin</w>
brom ide),</w>
broaden ed</w>
broad- spectrum,</w>
broad- spectra</w>
broad- breast
broad-breast ed</w>
broad- based,</w>
broad er,</w>
broad casting</w>
bro ther.</w>
bro th</w>
bro modeoxyuridine-positive</w>
bro modeoxy-uridine-positive</w>
bro mazepam.</w>
bro chure</w>
bro aden</w>
brin olytic</w>
briefl y;</w>
brie f;</w>
bridge-to- transplantation</w>
bridge-to- transplant</w>
bridge "</w>
bridg ing,</w>
bri ghtfield-</w>
brety lium-potentiated</w>
bretaz enil</w>
bretaz enil.</w>
bree ders</w>
bree ders,</w>
bree der,</w>
bree der)</w>
breath- by-breath</w>
breath s/min,</w>
breath s/min).</w>
breath s.min(-1).</w>
breath )</w>
breast/ lung/ovarian</w>
breast/ chest</w>
breast- conserving</w>
breast s,</w>
breast feeding,</w>
breast feed;</w>
breast ;</w>
breast -fed</w>
breast ),</w>
break s.</w>
break s)</w>
break point</w>
break down;</w>
break -
break- point</w>
break ,</w>
bre wed</w>
bre w</w>
bre vity</w>
bre vicornum</w>
bre tastatin</w>
bre eding.</w>
bre ed?</w>
bre a
brea the</w>
brasili ensis.</w>
brasili ensis,</w>
branch ;</w>
branch ,</w>
brainstem- spinal</w>
brainstem -evoked</w>
brainstem -dependent</w>
brain- wide</w>
brain- stem-evoked</w>
brain- specific</w>
brain- region-specific</w>
brain- penetrating</w>
brain- lesioned</w>
brain- injured,</w>
brain- evoked</w>
brain- dead</w>
brain- -
brain-- may</w>
brah mi)</w>
brah mi),</w>
bradyp sychism</w>
bradyp noea,</w>
bradyp nea.</w>
bradyp nea,</w>
bradykine tic,</w>
bradykine sia/akinesia</w>
bradykine sia)</w>
bradykin ins.</w>
bradykin in;</w>
bradykin in-mediated,</w>
bradykin in-</w>
bradykin in)</w>
bradykin in).</w>
bradykin in's</w>
bradycardia/ collapse</w>
bradycardia/ atrioventricular</w>
bradycardia- hypotensive</w>
bradycardia ?</w>
bradycardia .4.</w>
bradycardia .(ABSTRACT</w>
bradycardia -related</w>
bradycardia -inducing</w>
bradycardi as</w>
bradycardi as.</w>
bradycardi ac,</w>
brady- dysrhythmias</w>
brady- cardia</w>
brady tachy</w>
brady dysrrhythmias,</w>
brady dysrhythmias.</w>
brady dysrhythmias,</w>
brady cardic-hypotensive</w>
brady asystole.</w>
brady arrythmias</w>
brady arrhythmia:</w>
bracket s</w>
bracket s):</w>
brachy ury,</w>
brachy therapy.</w>
brachi a,</w>
brac elet</w>
brac e</w>
bra ve</w>
bra king"</w>
bra kes</w>
bra ke</w>
bra in's</w>
bra diarrhythmia</w>
bra d</w>
br ush)</w>
br ass</w>
br an</w>
br am
bram s-Griffiths</w>
bp m/20</w>
bp )</w>
boy s;</w>
boy s).</w>
box ing,"</w>
box )</w>
box '</w>
bowel /
bowel/ gastric</w>
bout ons.</w>
bout on-like</w>
bour g</w>
bound ary</w>
bound ari
boundari es)</w>
boun ding</w>
boun d;</w>
boun d/liter</w>
boun d.</w>
bothersom eness</w>
bothersom eness.</w>
bothersom eness,</w>
both );</w>
bot an
botan ical</w>
bos entan,</w>
bortezomib- thalidomide</w>
bortezomib- resistant</w>
bortezomib- melphalan-prednisone</w>
bortezomib- melphalan-prednisone.</w>
bortezomib- melphalan-prednisone-thalidomide</w>
bortezomib ;</w>
bortezomib :</w>
bortezomib -</w>
border s.</w>
border line;</w>
border )</w>
bor ted</w>
bor neol</w>
bor naprolol,</w>
bor n,</w>
bor der.</w>
booster s.</w>
booster ).</w>
boost ,</w>
book let</w>
book ends</w>
bone- seeking</w>
bone- marrow-toxic</w>
bone- marrow-derived</w>
bone- health</w>
bone- forming</w>
bon krekic</w>
bon es;</w>
bon d.</w>
bon d,</w>
bolus- methylprednisolone</w>
bolus- methylprednisolone.</w>
bolus+ 800</w>
bolus+ 500</w>
bol uses,</w>
bol us/3-h</w>
bol stered</w>
bol one</w>
bol i.</w>
bol a</w>
body- weight/day</w>
body- weaving.</w>
body- surface-area</w>
body- packer</w>
body- mass</w>
body- forming</w>
body- builder.</w>
body weight;</w>
body weight/day,</w>
body weight.</w>
body weight)</w>
body builder</w>
body -mediated</w>
body 's</w>
bodi es'</w>
boar d.</w>
bo y-friend</w>
bo wl</w>
bo wing.</w>
bo ve</w>
bo urs</w>
bo urg.</w>
bo thered</w>
bo rough,</w>
bo red</w>
bo is.</w>
bo iling</w>
bo id</w>
bo gen</w>
bo estrol)</w>
blur ring,</w>
blun ted,</w>
blun t,</w>
blue- green</w>
blue- gray</w>
blue- albumin.</w>
blue- albumin,</w>
blu ish</w>
blu ish,</w>
blu es)</w>
blu e;</w>
blot ted</w>
blood- urea</w>
blood- type-identical</w>
blood- to-brain</w>
blood- red"</w>
blood- pool</w>
blood- injury</w>
blood- gases</w>
blood- derived</w>
blood- contaminated</w>
blood- concentration</w>
blood- cerebrospinal</w>
blood stream;</w>
blood flow</w>
blood :</w>
blood /bone</w>
blood --brain</w>
blood ).</w>
blocker s;</w>
blocker s),</w>
blocker ;</w>
blocker -associated</w>
blocker ),</w>
blockade s,</w>
blockade .
blockade. 8.</w>
blockade )</w>
block s:</w>
block ing-agent</w>
block er-verapamil</w>
block ed),</w>
block .(ABSTRACT</w>
block -type</w>
block ):</w>
block "</w>
blo ods</w>
blo c</w>
blo ating</w>
blinde d).</w>
blinde d'</w>
blinde d';</w>
blinde d"</w>
blind ness?</w>
blind ness)</w>
blind ness),</w>
blind ly.</w>
blind ly,</w>
blind ;</w>
blind -
blind- randomized</w>
bli ster;</w>
bli ster.</w>
blepharo spasm"</w>
blepharo conjunctivitis</w>
blepharo conjunctivitis,</w>
bleed s:</w>
bleed s.</w>
bleed ings,</w>
bleed ing/irregular</w>
bleed ing-prone</w>
bleed ing).</w>
bleed ing"</w>
bleb bing</w>
ble mishes,</w>
blastocy sts</w>
blastocy st,</w>
blast openia</w>
blast ogenic</w>
blast -induced</w>
blan k-control</w>
bladder- protein</w>
bladder -dependent</w>
bladder )</w>
black- outs</w>
black- eyed</w>
black- box'</w>
black- and-
black-and- white</w>
black ened</w>
blac king</w>
bl iterative</w>
bl ings</w>
bl ended</w>
bl ecortin</w>
bl and,</w>
bl and
bland "</w>
bl )</w>
bivalir udin,</w>
bit ter;</w>
bit ter.</w>
bit ter)</w>
bit ocis.</w>
bit ing/licking</w>
bit ing),</w>
bit es/hour)</w>
bit es.</w>
bit al/
bital/ insular</w>
bisulfit e?</w>
bisulfit e;</w>
bisulfit e:</w>
bisulfit e-free</w>
bisulfit e),</w>
bisulf ate</w>
bisphosphonat es.Overall,</w>
bisopro lole</w>
bisopro lol-induced</w>
bismu thate</w>
bis- methylamino-pyrimidin-4-yl)</w>
bis- chloronitrosourea</w>
bis- (4-fluorophenyl)
bis-(4-fluorophenyl) methyl)-4-(3-phenyl-2-propenyl)-piperazine],</w>
bis- (2,
bis-(2, 2,6,
bis-(2,2,6, 6-
bis-(2,2,6,6- tetramethyl-4-piperidinyl)</w>
bis(2-chloroethyl)-1- nitrosurea</w>
bis(1-methylethyl) phosphordiamidic</w>
bis ynchronous</w>
bis phosphonate-related</w>
bis phosphonate,</w>
bis methylamide</w>
bis (trifluoro
bis(trifluoro methyl)benzylester</w>
bis (3.
bis(3. 5-di
bis(3.5-di oxopiperazinyl-l-yl)propane]</w>
bis (2-
bis(2- aminophen
bis(2-aminophen oxy)ethane-N,N,N',N'-tetraacetic</w>
birth- record</w>
birth- 9</w>
birth weights</w>
birth ?</w>
birth )</w>
birth ),</w>
birefr ingence</w>
bir ds.</w>
bir acial</w>
bipolar ity</w>
bipolar ity:</w>
bipolar -type</w>
biphasic ;</w>
biphasic :</w>
biphasi cally.</w>
biphasi cally,</w>
biphasi c.</w>
biphasi c-preterminal</w>
biperid ene</w>
biperid en-treated</w>
biot inylation,</w>
biosynthesi s;</w>
biosynthesi s--at</w>
biosynthe ses,</w>
bios py</w>
biopsy- sized</w>
biopsy :</w>
biopsy /
biopsy/ surgery.</w>
biopsi es;</w>
biop tome</w>
biop tic</w>
biomark ers;</w>
biom odulatory</w>
biom edical</w>
biom echanical</w>
biolog y/biochemical</w>
biolog ists,</w>
biochemist ries.</w>
bioc ontinuous</w>
bioc linical</w>
bioc hemotherapy.</w>
bioc hemotherapy,</w>
bio tic</w>
bio protective</w>
bio prosthesis</w>
bio phase.</w>
bio phase,</w>
bio inversion</w>
bio informatics</w>
bio impedance)</w>
bio humoral,</w>
bio genesis.</w>
bio flavonoid</w>
bio equivalent.</w>
bio energetics.</w>
bio assay-guided</w>
bio assay)</w>
bio activity</w>
bio activities</w>
bio actives</w>
bio activating</w>
bio activated</w>
binucle ation.</w>
binucle arity</w>
binge- pattern</w>
binge- limited</w>
binge- -
binge-- abstinence</w>
binge ing,</w>
bing ing.</w>
bing es.</w>
bing es,</w>
bind ings</w>
bind ing;</w>
bind ing:</w>
bind ing).</w>
bind ing),</w>
bind er.</w>
bin ocular</w>
bin aural</w>
bimod al.</w>
bimod al'</w>
bimato prost.</w>
bimato prost,</w>
billion/ ml)</w>
billi on)</w>
biliver dine</w>
biliver dine,</w>
bilirubin ostasis</w>
bilirubin ostasis,</w>
bilirub inuria</w>
bilirub inate</w>
bilirub in-conjugating</w>
bilirub in)</w>
bilirub in),</w>
bile- to-perfusate</w>
bile- salt-independent</w>
bile- fistula</w>
bile- changes</w>
bile :
bile: liver</w>
bile -like</w>
bilay ers,</w>
bilay er</w>
bilater ally;</w>
bilater ality</w>
bilater ality,</w>
bil io-sinusoidal</w>
bil ify,</w>
biguan ides.</w>
biguan ides,</w>
biguan ide-induced</w>
bigg est</w>
bigg er</w>
big- ET
big-ET -1),</w>
bifur cated</w>
bifid a-
bifida- causing</w>
bifeprun ox,</w>
bif rontal,</w>
bidi mesional</w>
bicyt openia</w>
bicyt openia.</w>
bicyt openia,</w>
bicuculline- provoked</w>
bicuculline- insensitive)</w>
bicucull ine-treated</w>
bicucull ine-,</w>
bicucul ine,</w>
bicarbonate- loaded</w>
bicarbonate- -
bicarbonate-- preferred</w>
bicarbonat uria</w>
bicarbonat uria,</w>
bicarbon ate:</w>
bicalutamide- tamoxifen,</w>
bicalut amide-induced</w>
bic yclic</w>
bic ycle.</w>
bic uspid</w>
bic hat</w>
bic eps)</w>
bic an</w>
bibli ography</w>
bibli ographies.</w>
bi- weekly</w>
bi- exponential</w>
bi- dimensionally</w>
bi- block</w>
bi- axial</w>
bi- annual</w>
bi weekly,</w>
bi weekly)</w>
bi ventricular/body</w>
bi variate,</w>
bi variable</w>
bi vagotomized</w>
bi quinone</w>
bi pyridine,</w>
bi psy.</w>
bi phosphonate,</w>
bi phenyls</w>
bi phenyl]-4-carboxamide</w>
bi phenyl-3-yl</w>
bi phenyl)-2,5-diylbis(oxy)(2,2-dimethylpentanoic</w>
bi phasely</w>
bi parietal</w>
bi ol.</w>
bi ocompatibility?</w>
bi ocompatibility</w>
bi ochemistry.</w>
bi ochemist</w>
bi ochemically,</w>
bi ochemical-specific</w>
bi loba.</w>
bi le;</w>
bi exponentially</w>
bi exponentially,</w>
bi exponential</w>
bi ent</w>
bi ennially</w>
bi directionality</w>
bi asing</w>
bi ases.</w>
bi as
bias ed.</w>
bi annual</w>
bezafib rate-fed</w>
bever age,</w>
bevaciz umab,</w>
between- test</w>
between- subject</w>
between- session</w>
between- groups</w>
between- gender</w>
between- age-groups</w>
between .7
between.7 -1.2</w>
between -</w>
betwe en.</w>
bethanech ol-related</w>
bethan ecol</w>
betax olol)</w>
betan in.</w>
betan in,</w>
betamethas one,</w>
betam imetics.</w>
betam imetic</w>
betal actam</w>
betal act
betalact am
betalactam s,</w>
betacytot oxic-induced</w>
betacytot oxic-icv</w>
betablock ers.</w>
beta=- 0.06
beta=-0.06 5,</w>
beta=- 0.05
beta=-0.05 4,</w>
beta= 9.
beta=9. 19,</w>
beta= 2.7
beta=2.7 6,</w>
beta= 0.49,</w>
beta4- subunit,</w>
beta4- nAChR</w>
beta4- deficient</w>
beta4- /-)</w>
beta3- adrenoceptor.</w>
beta3- adrenergic</w>
beta2-leukocyte-integrins +,</w>
beta2- subunits</w>
beta2- selectivity</w>
beta2- receptors.</w>
beta2- nAChR</w>
beta2- microglobulinuria,</w>
beta2- microglobulin,</w>
beta2- microglobulin)</w>
beta2- lymphocyte-integrins(+)</w>
beta2- containing</w>
beta2- blocking</w>
beta2- antagonist.</w>
beta2- agonists,</w>
beta2- agonist</w>
beta2- adrenoreceptors.</w>
beta2- adrenoceptor;</w>
beta2- adrenoceptor-mediated</w>
beta2- adrenergic-
beta2-adrenergic- stimulators.</w>
beta2- Micro
beta2-Micro globulinuria</w>
beta2- /-)</w>
beta2- ,</w>
beta2 MG)</w>
beta2 GPI</w>
beta2 +/+</w>
beta1- integrin,</w>
beta1- adrenoceptors,</w>
beta1- adrenoceptor;</w>
beta1- AR</w>
beta1- /
beta1-/ beta2-adrenoceptor-mediated</w>
beta/ delta,</w>
beta/ beta-catenin</w>
beta/ alpha</w>
beta-methyl- iodophenyl-pentadecanoic</w>
beta-methyl- branched</w>
beta-methyl digoxin,</w>
beta-methyl ated</w>
beta-lactamase-positive );</w>
beta-lactamase-positive ).</w>
beta-lactamase-positive ),</w>
beta-lactamase- stable,</w>
beta-lactam ase</w>
beta-lactam ase.</w>
beta-lactam ase-positive</w>
beta-lact ams</w>
beta-lact am-induced</w>
beta-hydroxy-17- alpha-
beta-hydroxy-17-alpha- ethynyl-androstano[3,2-b]pyrimido[1,2-a]benzimidazole;</w>
beta-hydroxy -19-nor-
beta-hydroxy-19-nor- andro
beta-hydroxy-19-nor-andro st-4-ene-17</w>
beta-funaltrex amine.</w>
beta-endorph in.</w>
beta-endorph in-like</w>
beta-endorph in(1-31)</w>
beta-cyclopentamethyl ene-propionyl-o-Met-Tyr-Arg-vasopressin</w>
beta-carboline-3- carboxylate-t-butyl</w>
beta-carbol ine-carboxylate</w>
beta-carbol ine-</w>
beta-carbol ine)</w>
beta-carb omethoxy-3-beta-(4-fluorophenyl)tropane</w>
beta-blocker/ vasodilator</w>
beta-blocker/ digitalis</w>
beta-blocker/ calcium</w>
beta-blocker s)</w>
beta-adrenoceptor- blocked</w>
beta-adrenoceptor- binding</w>
beta-adren ostimulating</w>
beta-adren oblocking</w>
beta-OH SD)</w>
beta-HSD 2.</w>
beta-HSD 2),</w>
beta-HSD 1</w>
beta-HSD 1)</w>
beta-End orphin</w>
beta-End orphin(1-31)</w>
beta-D-arabinofuranos ylcytosine)</w>
beta-D- glucuronide:</w>
beta-D- glucosoaminidase</w>
beta-D- glucosaminidase)</w>
beta-D- control</w>
beta-D- N-acetyl-glucosaminidase,</w>
beta-CC t.</w>
beta-CC t-sensitive</w>
beta-2' S</w>
beta-2' R</w>
beta-(4-dimethylaminophenyl) 17</w>
beta-(4-dimethylaminophenyl) -17</w>
beta- vinyllactic</w>
beta- tubulin.</w>
beta- treated</w>
beta- to-beat</w>
beta- thalassemia.</w>
beta- synmpathomimetic</w>
beta- subunits</w>
beta- subunit</w>
beta- stimulation</w>
beta- steroid</w>
beta- sensitive</w>
beta- selective</w>
beta- reductase</w>
beta- receptor-stimulating</w>
beta- prostaglandin</w>
beta- pretreated</w>
beta- positive</w>
beta- position</w>
beta- phenylethylamine,</w>
beta- phenylethyl-6-AzUd</w>
beta- phenethylamine-induced</w>
beta- noradrenergic</w>
beta- naphthoflavone</w>
beta- n-decanoate)</w>
beta- myosin</w>
beta- methylene</w>
beta- mercapto-beta,</w>
beta- luteinizing</w>
beta- insensitive</w>
beta- hydroxylase,</w>
beta- half-time</w>
beta- hCG</w>
beta- glucuronidase,</w>
beta- glucosaminidase</w>
beta- glucosaminidase,</w>
beta- glucosaminidase),</w>
beta- glucoronidase,</w>
beta- ethyl-beta-methyl-gamma-thiobutyrolactone</w>
beta- estradiol-17beta-D-glucuronide</w>
beta- ergoline</w>
beta- epoxyhexahydrocannabinol</w>
beta- epimers</w>
beta- emitter</w>
beta- effects</w>
beta- dystroglycan,</w>
beta- d-galactosidase,</w>
beta- d-N-acetylglucosaminidase,</w>
beta- configurations</w>
beta- chain</w>
beta- cells,</w>
beta- cell</w>
beta- catenin,</w>
beta- carboxymuconate-epsilon-semialdehyde</w>
beta- blocking,</w>
beta- blockers:</w>
beta- blocker)</w>
beta- blocked</w>
beta- blockade;</w>
beta- blockade:</w>
beta- blockade.8.</w>
beta- band</w>
beta- antagonistic</w>
beta- antagonism</w>
beta- alanine</w>
beta- alan
beta-alan yl</w>
beta- agonist)</w>
beta- adrenoceptors:</w>
beta- adrenoceptors,</w>
beta- adrenocept
beta-adrenocept or,</w>
beta- adreno
beta-adreno receptor-stimulating</w>
beta- adrenergic-
beta-adrenergic- blocked</w>
beta- actin</w>
beta- acetyl
beta-acetyl digoxine</w>
beta- [
beta-[ p-(dimethylamino)</w>
beta- T
beta-T ag)</w>
beta- SR)</w>
beta- Receptor</w>
beta- NTP</w>
beta- N-acetylglucosaminidase,</w>
beta- N-acetyl-
beta-N-acetyl- D-glucosaminidase</w>
beta- L-
beta-L- thymidine,</w>
beta- ENaC,</w>
beta- EMTBL
beta-EMTBL -induced</w>
beta- EH
beta-EH HC.</w>
beta- E,</w>
beta- DMCM,</w>
beta- C
beta-C CM.</w>
beta- Blockers</w>
beta- 3H]
beta-3H] 1,25-(OH)2D3</w>
beta- 2-receptor</w>
beta- 2-agonist</w>
beta- 2-adrenergic</w>
beta- 2-
beta-2- fucosidase,</w>
beta, 9</w>
beta, 3</w>
beta, 20
beta,20 alpha
beta,20alpha )-1
beta,20alpha)-1 1,
beta,20alpha)-11, 17-
beta,20alpha)-11,17- dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic</w>
beta, 17,</w>
beta, 17
beta,17 alpha,
beta,17alpha, 18
beta,17alpha,18 beta,20alpha)-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic</w>
beta, 16
beta,16 beta,17alpha,18beta,20alpha)-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic</w>
beta)- knockout</w>
beta)- expressing</w>
beta(2)- selective</w>
beta(2)- adrenoceptors</w>
beta(2)- adrenoceptors,</w>
beta(2)- adrenoceptor-selective</w>
beta(2)- AR)</w>
beta(1)- blockers.</w>
beta(1)- adrenoceptors.</w>
beta(1)- adrenoceptor-mediated</w>
beta ine-homocysteine</w>
beta histine</w>
beta histine,</w>
beta histidine,</w>
beta NGF,</w>
beta M,</w>
beta E,</w>
beta E),</w>
beta =.
beta=. 20).</w>
beta ;</w>
beta 6.1.</w>
beta 3,</w>
beta 25-35</w>
beta 2-</w>
beta 2)</w>
beta 2),</w>
beta -1-
beta-1- blocking</w>
beta -1,2</w>
beta )]</w>
beta )-</w>
beta (</w>
beta (2-
beta(2- 4)</w>
beta (2).</w>
beta (2))</w>
beta (1)</w>
beta (1)/
beta(1)/ beta(2)</w>
bet ocin</w>
bet le.</w>
bet le)</w>
bet ami
betami pron</w>
bet ag
betag al)</w>
best- quality</w>
best os-exposed</w>
best )</w>
best "</w>
bes ylate.</w>
berg hei</w>
ber a
bera prost.</w>
ber 's).</w>
bepridil -treated</w>
bepridil -induced</w>
benzylthio inosine</w>
benzyloxy-4-methoxymethyl- beta-carboline-3-carboxylate</w>
benzyloxy carbonyl-Val-Ala-DL-Asp</w>
benzyl) glutarimide</w>
benzyl piperidin-4-yl)ethyl]-2,3-dihydro-9-methoxy-1H-pyrrolo[3,4-b]quinolin-1-one</w>
benzyl pempidine,</w>
benzyl ene),</w>
benzyl ate;</w>
benzyl ate,</w>
benzyl adriamycin-14-valerate</w>
benzyl -related</w>
benzoyl- 6</w>
benzoyl)- propyl-piperazino-l-yl-isoquinolino</w>
benzoyl)- piperidin-1-yl]-1-phenyl-ethyl</w>
benzoyl hydrazone</w>
benzoyl ecognine,</w>
benzoxaz ine-6-carboxylic</w>
benzothiazol inone</w>
benzothiazol e),</w>
benzopyran opyrimidines</w>
benzopyran opyrimidine</w>
benzol amide)</w>
benzol amide),</w>
benzofuran yl)piperazino]butyl]-4-methyl-2H,4H-1,2,4-triazin-3,5-dione</w>
benzodiox ol-5-ylcarbonyl)piperidine</w>
benzodiazepine/ tricyclic</w>
benzodiazepine/ ionophore</w>
benzodiazepine/ GABA</w>
benzodiazepine-3- carboxamide</w>
benzodiazepine- tricyclic</w>
benzodiazepine- sensitive</w>
benzodiazepine- ketamine</w>
benzodiazepine- gamma-aminobutyric</w>
benzodiazepine- free</w>
benzodiazepine- GABA(A)</w>
benzodiazepin es:</w>
benzodiazepin es'</w>
benzodiazep ine)</w>
benzodi az
benzodiaz e-pines,</w>
benzo[b]furan-2-ylsulfonyl) hydantoin),</w>
benzo[a,d] cyclohepten-5,</w>
benzo[a,d] -</w>
benzo[a, d]</w>
benzo[ a]-
benzo[a]- pyrene</w>
benzo[ a,</w>
benzo(F )
benzo(F) quinoxaline</w>
benzo yl</w>
benzo thiazepine</w>
benzo thiadiazide</w>
benzo ate.</w>
benzo /
benzo/ b,
benzo/b, f/azepine-5-carboxamide)</w>
benzil ic-4,4'-3H])</w>
benzhex ol</w>
benzhex ol.</w>
benzene- derived</w>
benzene- 2,4-
benzene-2,4- disulfonic</w>
benzene acetamide]</w>
benzen esulfonyl-7-(4-methyl-piperazin-1-yl)1H-indole)</w>
benzen esulfonate</w>
benzar one:</w>
benzar one.</w>
benzar one,</w>
benz yl-,</w>
benz omorphan</w>
benz oline</w>
benz olamide</w>
benz ocaine.</w>
benz o-(F)quinoxalline</w>
benz methoxy</w>
benz isoxazole</w>
benz hydramine</w>
benz hydramine,</w>
benz ene,</w>
benz azepine]</w>
benz azepine</w>
benz azepine,</w>
benz amide-induced</w>
benz amide,</w>
benseraz ide).</w>
benign /
benign/ malignant</w>
benign "</w>
benflu orex,</w>
benefit/ toxic</w>
benefit :</w>
benefit -to-
benefit-to- risk</w>
benefit )</w>
benefici al;</w>
bendroflumethiaz ide.</w>
bendroflumethiaz ide),</w>
bendroflu azide-induced</w>
bendroflu azide,</w>
bend am
bendam ustin.</w>
bench marks"</w>
benazepri l.</w>
benazepri l,</w>
ben ozdiazepine</w>
ben onium,</w>
ben fotiamine,</w>
ben ecid</w>
ben dectin</w>
ben dazac</w>
ben ch.</w>
ben azapril</w>
ben a
bena us</w>
bemegri de.</w>
beme setron</w>
beme setron,</w>
belotec an,</w>
belong ed.</w>
bell .</w>
belie ve.</w>
belie fs</w>
belie fs,</w>
belie f,</w>
beli eving</w>
beli eves</w>
belat acept</w>
belat ac
belatac ept,</w>
bel ted</w>
bel cet)</w>
behaviour al/
behavioural/ motor</w>
behaviour :</w>
behaviour ),</w>
behavior s).</w>
behavior ial</w>
behavior ally-</w>
behavior al/
behavioral/ EEG</w>
behavior '</w>
behavior "</w>
behavi ors"</w>
behavi or--tail</w>
beha v.</w>
begin ning.</w>
beg s</w>
beg ins,</w>
beg inning-of-dose</w>
beg in,</w>
befun olol.</w>
befun olol,</w>
before hand.</w>
before hand,</w>
before /
before/ after"</w>
before )-treated</w>
bef ,</w>
beet root</w>
beet root.</w>
beet root),</w>
bedd ing,</w>
bed time;</w>
bed time,</w>
bed time)</w>
bed time).</w>
bed side.</w>
bed rest</w>
bed pan.</w>
bed clothes,</w>
beclometh asone,</w>
beclometh as
beclomethas one.</w>
bec ker</w>
beats/min .,</w>
beats/min .).</w>
beats/min .),</w>
beats/ total</w>
beats/ minute)</w>
beats/ hour]</w>
beats/ 30</w>
beats/ 24</w>
beats. min-1]</w>
beats. min-1.</w>
beat/ min</w>
beat/ min;</w>
beat/ min)</w>
beat. min-1</w>
beat. min-1.</w>
beat s/</w>
beat s)</w>
beat s),</w>
beat ing-heart</w>
beam s,</w>
beagl es;</w>
beag le.</w>
beag le,</w>
bead s.</w>
be zoar</w>
be vel</w>
be tel</w>
be statin.</w>
be poetin</w>
be pithelial</w>
be low?</w>
be ito-Lopez</w>
be it,</w>
be ige</w>
be hind.</w>
be henoyl-1-beta-D-arabinofuranosyl</w>
be es</w>
be ers.</w>
be ers,</w>
be er--a</w>
be er)</w>
be ds,</w>
be ar
bear ing-down</w>
be am-
beam- traversing</w>
be ak</w>
be :</w>
be )</w>
bcl- x(L)</w>
bcl- 2.</w>
bcl 2</w>
bcl -2-
bcl-2- expressing</w>
bc x(L)</w>
bc 1-2</w>
bax/ bcl2</w>
bax/ bcl-2</w>
bax ,</w>
batter y;</w>
batter y.</w>
batter ing.</w>
batter ies</w>
batima stat.</w>
batima stat,</w>
bath mo-</w>
bath house</w>
bath ed</w>
bath .</w>
bath )</w>
batan opride,</w>
bat tle</w>
bat tered</w>
bat talion</w>
bat ches</w>
bat ches,</w>
basi s)</w>
basi s).</w>
basi ocranio</w>
basi occipital</w>
basi lo-vertebral</w>
basi liximab.</w>
basi cranial</w>
basel ine-to-exit</w>
basel ine-end</w>
base/ kg/day</w>
base/ kg.</w>
base/ kg)</w>
base/ day</w>
base- -
base-- none</w>
bas ophilic.</w>
bas ophilia</w>
bas olateral-to-apical</w>
bas es,</w>
bas ement-membrane</w>
bas al.</w>
bas al-
basal- mid</w>
bas al),</w>
barri ers.</w>
barri er-damaging</w>
barri er).</w>
barr age</w>
baroreflex- vagal</w>
baroreflex- cardiac</w>
baroreceptor- cardiac</w>
baro sensitive</w>
baro reflexes.6.</w>
baro receptors)</w>
baro ceptor</w>
baro -
baro- reflex</w>
bark .</w>
bark ,</w>
bari um-induced</w>
barbiturate- mediated</w>
barbiturate- halothane</w>
barbiturate- anesthetized</w>
barbitur ate.</w>
barbitur at
barbiturat es--HB-7</w>
barbit uate;</w>
barbit one</w>
barbit al-anesthetized</w>
barb otage,</w>
barb otage').</w>
barb exaclone</w>
bar ak
barak i,</w>
bar ;</w>
band s)</w>
band pass</w>
band ing.</w>
ban ks</w>
balloon ing.</w>
balloon ing,</w>
balloon ing"</w>
balloon ed</w>
balloon -like</w>
balloon "</w>
ballo ons</w>
ballo on-expandable</w>
ball players</w>
balance ?</w>
balance ;</w>
bal anc
balanc er"</w>
baical ensis,</w>
baical ein.</w>
bag s,</w>
baculo virus</w>
bacteremia/ sepsis</w>
bacter ial,</w>
bacter aemia,</w>
bacte remias.</w>
baclofen ;</w>
baclofen -</w>
baclofen ),</w>
backgroun d-corrected</w>
backcros s,</w>
back- up</w>
back- projection</w>
back- averaging</w>
back ward--associated</w>
back scatter.</w>
back diffusion</w>
back averaging</w>
back averaged</w>
back aches,</w>
back ache.</w>
back ache,</w>
bacill us.</w>
bacill us,</w>
bac osides,</w>
bac ili</w>
bac hia:</w>
bac h,</w>
bac cata,</w>
bac avir-induced</w>
babo ons,</w>
babo on,</w>
bab ygrams</w>
bab ly,</w>
bab ies:</w>
ba x</w>
ba um</w>
ba roslopes</w>
ba il</w>
bS)- N
bS)-N [4-
bS)-N[4- (8-
bS)-N[4-(8- cyano-1,3a,4,9b-tetrahydro-3H-benzopyrano[3,4-c]pyrrole-2-yl)-butyl](4-phenyl)benzamide]</w>
bS)- (-)-enantiomer</w>
b/ ribavirin-induced</w>
b/ min</w>
b/ min,</w>
b/ melphalan/prednisone</w>
b/ c</w>
b/ CD18</w>
b.w./ h</w>
b.w./ h)</w>
b.w./ day).</w>
b.w. -1)</w>
b.w. )]</w>
b.w .),</w>
b.p. m.).</w>
b.p. m.),</w>
b.i. d</w>
b.i. d,</w>
b.i. d)</w>
b.i. d).</w>
b. d.)</w>
b-hexahydro -3-
b-hexahydro-3- chloro-2-hydroxy-N-methyl-5H-benzo[d]naptho++</w>
b-hexahydro -2-
b-hexahydro-2- propyl-3-thia-5-+</w>
b- tubulin,</w>
b- infected</w>
b- downregulation</w>
b- catenin</w>
b- cAMP-induced</w>
b- Williams</w>
b- N,</w>
b- 9</w>
b- 82</w>
b)- (+)-
b)-(+)- N-methyl-N
b)-(+)-N-methyl-N [7-
b)-(+)-N-methyl-N[7- (1-pyrrolidinyl)
b)-(+)-N-methyl-N[7-(1-pyrrolidinyl) -1-
b)-(+)-N-methyl-N[7-(1-pyrrolidinyl)-1- oxaspiro[4.5]dec-8-yl]</w>
b) azepin</w>
b ystander"</w>
b u</w>
b ts/min,</w>
b regma</w>
b or,</w>
b one:</w>
b one-associated</w>
b old</w>
b m)</w>
b low-by</w>
b ite</w>
b istratified</w>
b inges."</w>
b id).</w>
b id),</w>
b iasis.</w>
b dotoxin</w>
b d)</w>
b cr3</w>
b b-Williams</w>
b ation</w>
b ane
bane ?</w>
b an.</w>
b ail
bail -out</w>
b ad
bad ?</w>
b O2),</w>
b DNA
bDNA ]</w>
b =1.
b=1. 179,</w>
b 5.</w>
b 5,</w>
b 1,</w>
b .)</w>
b (5)</w>
b (5).</w>
azoxymeth ane.</w>
azoxymeth ane-treated</w>
azoxymeth ane-induced</w>
azot emia)</w>
azot emia),</w>
azot aemia</w>
azot aem
azotaem ia)</w>
azosin ).</w>
azos pirone</w>
azole- trimethoprim</w>
azol ine.</w>
azol in</w>
azol ides,</w>
azol es</w>
azol es.</w>
azol es,</w>
azobenz ene,</w>
azo ospermia,</w>
azithrom ycin-treated</w>
azithrom ycin-associated</w>
azine- ketamine-induced</w>
azin obis-(3-ethyl-benzothiazoline-6-sulfonic</w>
azido- 5,</w>
azido- 5,6-
azido-5,6- dihydro-5-methyl-6-oxo-4H-imidazo-(1,5-a)</w>
azido- 3'
azido-3' deoxythymidine</w>
azetidin ones</w>
azepex ole</w>
azepex ole)</w>
azepam :</w>
azepam -related</w>
azed one</w>
azathiopr ine)</w>
azathiop rine-prednisone</w>
azathiop rin</w>
azathiop rin.</w>
azaspirodec anediones</w>
azad on)</w>
aza- anthracenedi
aza-anthracenedi one,</w>
az urocidin</w>
az uren-L-glutamine</w>
az oxy-alkanes</w>
az opyridine-induced</w>
az o,</w>
az locillin.</w>
az ione</w>
az ionale</w>
az indol).</w>
az ide),</w>
az ekas</w>
az ar</w>
az acytidine</w>
az acitidine</w>
az ac
azac yclopent-1-</w>
az a
aza hypoxanthine.</w>
az ,</w>
ayna ud's</w>
ay side</w>
ay s)</w>
ay ne</w>
ay ley</w>
ay ette,</w>
ay er</w>
axoplas m,</w>
axon s)</w>
axon s).</w>
axon opathy,</w>
axon olysis</w>
axon ;</w>
axo- spinous</w>
axit inib,</w>
axis --
axis-- A-
axis--A- P)</w>
axill ary.</w>
axill ar
axillar y/interscalene</w>
axill ae.</w>
axill ae,</w>
axill a</w>
axi post),</w>
axi om"</w>
ax otomy</w>
ax otomy.</w>
ax olon).</w>
ax okine-1</w>
ax le.</w>
ax il)</w>
ax etil.</w>
ax es,</w>
awaken ings.</w>
awaken ings,</w>
awaken ing;</w>
awake ;</w>
awake /
awake/ alert</w>
awake '</w>
awa its</w>
aw ay.</w>
aw are.</w>
aw -like</w>
aw )]</w>
aw )</w>
avul sion</w>
avul anic</w>
avoide d;</w>
avoide d).</w>
avoid ant</w>
avoid ances</w>
avoid ance/
avoidance/ escape</w>
avoid ance)</w>
avoid .</w>
avocad o</w>
avocad o)</w>
avocad o'</w>
avo protein</w>
avium-intracellul are</w>
avium-intracellul are.</w>
avitript an</w>
avitript an).</w>
avir/ lamivudine</w>
avir in,</w>
avidin- biotin</w>
avid in,</w>
avid in)</w>
avi st;</w>
avi ruses</w>
avi l</w>
avi aud</w>
averm ectins</w>
averm ectilis,</w>
aver ts</w>
aver siveness</w>
aver sively</w>
aver sions</w>
aver sion,</w>
aver ject)</w>
aver aged,</w>
aver age;</w>
aver age-
average- dose</w>
aver ag
averag ing)</w>
avail able)</w>
av olition-like</w>
av in-adenine-dinucleotide</w>
av id.</w>
av iceps</w>
av an,</w>
av ail</w>
av F.</w>
aux otonic</w>
autum n</w>
autum n.</w>
autotransplant ation,</w>
autos haping</w>
autoradiograph y)</w>
autoradiograph s</w>
autoradiograph ic,</w>
autoradi ogram.</w>
autopsy )</w>
autophag y.</w>
autophag y,</w>
autophag osomes</w>
autophag osomes,</w>
autop sy-confirmed</w>
autonom y</w>
autonom ous,</w>
autonom ic/neuroendocrine</w>
autonom ic-mediated</w>
autonom ic,</w>
automatism s.</w>
automatism s,</w>
automatism .</w>
automatic ity.</w>
automatic "</w>
autom onic</w>
auto- receptor.</w>
auto- injector</w>
auto- injection</w>
auto- inflammatory</w>
auto- antibody-associated</w>
auto- PBSCT</w>
auto- PB
auto-PB SCT)</w>
auto regulation,fenoldopam-induced</w>
auto regressive</w>
auto regressive-integrated</w>
auto receptors)</w>
auto receptors",</w>
auto receptor.</w>
auto receptor-mediated</w>
auto receptor,</w>
auto oxidation.</w>
auto inhibition,</w>
auto inhibited</w>
auto immune-related</w>
auto immune-mediated</w>
auto grafts.</w>
auto grafting</w>
auto grafted</w>
auto fluorescent</w>
auto dearterialization,</w>
auto antibody.</w>
auto antibody-mediated</w>
auto analyzer,</w>
auto aggressive</w>
auto /
auto/ allo
auto/allo immunity</w>
auto -</w>
author ities,</w>
author itative,</w>
author ised</w>
author isation.</w>
author at
authorat ative</w>
auth ors'first</w>
auth or-section</w>
auth optic</w>
autac oids.</w>
autac oid</w>
autac oid.</w>
aut ospectra</w>
aut ophosphorylation</w>
aut ometallography</w>
aut ologous),</w>
aut ogenous</w>
aut ochthonous</w>
aut ocamtide</w>
aut ap
autap se-like</w>
auscult ator
auscultator ily,</w>
auscult ation.</w>
auscult ation,</w>
auscult ated.</w>
auro thiomalate.</w>
auro thioglucose-</w>
aure us),</w>
aure paire</w>
auranof in-treated</w>
aur urus</w>
aur a;</w>
aur a:</w>
aur a--a</w>
aur ),</w>
aun t,</w>
augment er</w>
augment ations</w>
augh n-Williams</w>
aug umented</w>
auditory- verbal</w>
auditory- cued</w>
auditory- cognitive</w>
audit ory-</w>
audiometr y).</w>
audiometr y"</w>
audiometr ic,</w>
audio gram,</w>
audi ology</w>
audi ology,</w>
audi ographic</w>
audi ble</w>
audi a</w>
aud i</w>
au wolscine</w>
au sible</w>
au )</w>
au ).</w>
atyp ically</w>
atyp icality</w>
atyp ical'</w>
atyp ia.</w>
attribut es</w>
attribut es,</w>
attribut e-specificity</w>
attribut able,</w>
attribu tions,</w>
attribu tion,</w>
attrac tive.</w>
attrac tive,</w>
attrac tion:</w>
atter mann,</w>
attenu ations</w>
attenu ations/
attenuations/ decreases:</w>
attenu ation.</w>
attenu ation)</w>
attenu ates,</w>
attenu ated;</w>
attention/ working</w>
attention/ executive</w>
attention- deficit-hyperactivity</w>
attention- deficient</w>
attent uates</w>
attent uated</w>
attend ants.</w>
attend ance,</w>
atten tion:</w>
atten tion)</w>
atten tion',</w>
atten ds</w>
atten dees.</w>
attempts/ suicides</w>
attempts/ suicides,</w>
attempt s.</w>
attempt s)</w>
attempt ,</w>
attemp ters</w>
attemp ters,</w>
attemp ted;</w>
attain able,</w>
attack s;</w>
attack s:</w>
attack :</w>
attack )],</w>
attack )</w>
attack '</w>
attach ment,</w>
attac ked</w>
attac ked,</w>
attac k-triggering</w>
attac hed)</w>
atropine- resistant</w>
atropine- like."</w>
atrophy ?</w>
atrophy ;</w>
atrophy :</w>
atrophy /
atrophy/ degeneration,</w>
atrophy )</w>
atrophy ).</w>
atrophy ),</w>
atroph ogenicity</w>
atroph ogeneity</w>
atroph ies.</w>
atrop inized</w>
atrop inization</w>
atrop inic</w>
atrop ine;</w>
atrop ine-pretreated</w>
atrop ine--0.0075</w>
atrop ine,propranolol,</w>
atrop ine)</w>
atrop ic</w>
atriure tic</w>
atript an-induced</w>
atrio- His</w>
atrio ventrucular</w>
atrio ventricular-nodal</w>
atric -
atric- Neurolog
atric-Neurolog ic-Psychiatric</w>
atrial- ventricular</w>
atrial- paced</w>
atrial- His</w>
atria- H
atria-H is,</w>
atri um;</w>
atri um)</w>
atri otomy.</w>
atri a.
atria. 6.</w>
atresi as.</w>
atresi a:</w>
atre ated</w>
atovaquone/ proguanil.</w>
atovaqu one</w>
atosib an-
atosiban- group</w>
ator- resistant</w>
ator y),</w>
ator vastatin-ezetimibe</w>
ator va)</w>
atop y.</w>
atop y,</w>
atop ics,</w>
atop ic,</w>
atomoxet ine.</w>
atomoxet ine-induced</w>
atomoxet ine's</w>
ato statin-14</w>
ato hepatitis-inducing</w>
atmosph eres,</w>
atipamezol e:dexmedetomidine</w>
ation/ trephine</w>
ation/ degradation</w>
ation- overuse</w>
ation- accelerating</w>
ation- 2</w>
ation al-
ational- commissural</w>
ation al'</w>
ating- sedating</w>
ating- containing</w>
atic um</w>
ati zed</w>
ati ve:</w>
ati ve-like</w>
ati ve-induced</w>
ati mastat</w>
ati 300-
ati300- scop</w>
ati )</w>
athle te</w>
athi sia.</w>
athi one-S-transferase</w>
athi ),</w>
atherospermin ine.</w>
atherosclero sis:</w>
atherosclero sis-inducing</w>
atheros clerogenesis.</w>
athero- arteriosclerosis</w>
athero- arteriosclerosis.</w>
ather ogenic,</w>
ather ogenesis,</w>
athe totic</w>
athe tosis.</w>
athe rectomy)</w>
ath letes,</w>
ath esin),</w>
ath -c
ath-c ensored</w>
atenolo l-treated</w>
atenolo l-associated</w>
atenolo l),</w>
atel y.(ABSTRACT</w>
atel y)</w>
atel ut</w>
ated- measures</w>
ated ."</w>
ate: methanol</w>
ate/ vitamin</w>
ate/ naproxen-associated</w>
ate- valproate-induced</w>
ate- risk</w>
ate- Buffered</w>
ate ur</w>
ate l</w>
ate d/malignant</w>
ate -1
ate-1 -14
ate-1-14 C</w>
ate )-induced</w>
ate ",</w>
atazanavir -based</w>
atax o-myoclonic</w>
atax ic.</w>
atax ic,</w>
atax ias</w>
atax ia)</w>
at/ after</w>
at- school</w>
at urated-15</w>
at ubular.</w>
at torneys</w>
at tle,</w>
at titudes</w>
at tinic</w>
at tibutable</w>
at tests</w>
at testing</w>
at tains</w>
at ta</w>
at rend</w>
at ps2</w>
at pase</w>
at oxic</w>
at ories)</w>
at on-Lambert</w>
at ology-Self</w>
at ological</w>
at ographic</w>
at ogenic</w>
at m</w>
at m),</w>
at lantooccipital</w>
at ing)</w>
at ine</w>
at germ</w>
at es-corrected</w>
at away</w>
at atonic</w>
at ac
atac orp,</w>
at RA-treated</w>
at RA)</w>
at -dose</w>
asystol ic.</w>
asystol ia</w>
asystol ia.</w>
asystol e.6.</w>
asystol e).</w>
asystol e),</w>
asynchron ous</w>
asyn ergy</w>
asyn ergy.</w>
asymptomatic .We</w>
asym metry,</w>
astroglia- specific</w>
astroglia- marker,</w>
astrocyt es:</w>
astrocyt es),</w>
astro zole</w>
astro glia</w>
astro genesis</w>
astro cytosis,</w>
astro cyte,</w>
astro ctytes</w>
astigm atism</w>
astig otes</w>
astig mates</w>
asti gial</w>
asthmatic us,</w>
asthmatic s;</w>
asthmatic )</w>
asthenia/ fatigue,</w>
asthen ia)</w>
asth ma-like</w>
asth ma--comparison</w>
asth ma)</w>
aster y</w>
astemiz ole)</w>
astat in/gemfibrozil</w>
ast ritis</w>
ast ressin,</w>
ast ases</w>
ast an</w>
ast an)</w>
ast .</w>
ast -
ast- year</w>
assur ances</w>
assur ance.</w>
assur ance,</w>
assum ptions,</w>
assum ption,</w>
assu red</w>
assu red.</w>
assu med,</w>
associ ative,</w>
associ ative)</w>
associ ations,</w>
associ ational-commissural</w>
associ ation?</w>
assist s</w>
assist ing</w>
assist ant</w>
assist ant-
assistant- ventilated</w>
assist ance,</w>
assist .</w>
assign ing</w>
assig ned.</w>
assig ned,</w>
assi ve--active</w>
assi ve)</w>
assess ors</w>
assess or-blind</w>
assess ment:</w>
assess able;</w>
assess able)</w>
asses s.</w>
asses s,</w>
assemb lies.</w>
assem bling</w>
assay s:</w>
assay s).</w>
assay ;</w>
assa y-proven</w>
ass uring</w>
ass ortment</w>
ass on's</w>
ass ent,</w>
ass enger</w>
ass ail
assail ant</w>
ass a</w>
aspirodec anediones</w>
aspirin- tolerant.</w>
aspirin- tinnitus,</w>
aspirin- sensitivity</w>
aspirin- provoked</w>
aspirin- hypersensitivity.</w>
aspirin- exacerbated</w>
aspirin- controlled</w>
aspirin- controlled,</w>
aspirin- clopidogrel,</w>
aspir in;</w>
aspir in),</w>
aspir ations.</w>
aspir ation:</w>
aspir ation/trephine</w>
aspi rated,</w>
aspi rate,</w>
asphy xia.</w>
aspect )</w>
aspartate- receptor</w>
aspart ate-</w>
aspart ate)-induced</w>
aspart ase</w>
asp ase</w>
asleep .</w>
asleep ,</w>
asleep )</w>
asiati ca.</w>
asiati ca,</w>
asi ly</w>
asi an</w>
asi alo</w>
asi ,</w>
ash ed</w>
ased- array</w>
ase- regulating</w>
ase- protection</w>
ase- oriented</w>
ase- -a</w>
ase ]</w>
ascrib ing</w>
ascorb yl</w>
ascorb ate;</w>
ascorb ate)</w>
ascit es;</w>
ascer tained.</w>
ascer tain,</w>
ascend ing-series</w>
ascend ing-dose</w>
asc trocytomas</w>
asc itis</w>
as- needed</w>
as- needed,</w>
as ytolic</w>
as ymptotes)</w>
as similating</w>
as sertion</w>
as prin</w>
as plenic,</w>
as phyctic,</w>
as pertin)</w>
as pecific</w>
as part</w>
as min</w>
as mal</w>
as ked:</w>
as ked.</w>
as ked,</w>
as k:</w>
as ini.</w>
as ing"</w>
as ine,</w>
as ey</w>
as ert</w>
as electively</w>
as cularization</w>
as comycin.</w>
as certainment</w>
as cardin)</w>
as bestos-exposed</w>
as al,</w>
as L)</w>
as 6-
as6- R
as6-R s:</w>
as -treated</w>
as -matched</w>
as ),</w>
as ))</w>
as ")</w>
arylpempid ines</w>
arylpempid ines.</w>
arylpempid ines,</w>
aryl- substituted</w>
aryl- heteroatom</w>
aryl- 3-
aryl-3- indoleacetamides</w>
aryl triazenes</w>
aryl propionyl-CoA</w>
aryl piperazinylmethylpyrazolo</w>
aryl piperazine</w>
aryl hydroxylamine</w>
aryl amines,</w>
ary- bladder</w>
ary omegaly</w>
ary bdotoxin</w>
arvan il.</w>
artic ulations.</w>
artic ulation.</w>
artic le:</w>
artic le).</w>
arti brary</w>
arthro scopy,</w>
arthro pods.</w>
arthro plasties.</w>
arthro pathy)</w>
arthri tis;</w>
arthri tis--short-</w>
arthri tis--1).</w>
arthri tides</w>
arthralgias/ myalgias.</w>
arthralgias/ myalgias,</w>
arthralgi as)</w>
arthralg ia/myalgia</w>
arth ran)</w>
arth ,</w>
artesun ate.</w>
artesun ate-mefloquine</w>
artery. 5</w>
artery. 4</w>
arterios us;</w>
arterios us:</w>
arteriol e,</w>
arterio- cerebral</w>
arterio vascular</w>
arterio thromboses,</w>
arterio pathy,</w>
arterio lopathy.</w>
arterio graphy)</w>
arterio graphic</w>
arterio grams,</w>
arterialized- venous,</w>
arterial- venous</w>
arterial- left</w>
arterial- hypertension+normoglycemia.</w>
arteri otomy</w>
arteri ole-constricting</w>
arteri es?</w>
arteri es).</w>
arteri al/
arterial/ venous</w>
arteri al.</w>
arteri al),</w>
arter y:</w>
arter y).</w>
arter y),</w>
arter ia</w>
arter horse</w>
arter al</w>
artemisin ins,</w>
artemis inin</w>
artemether -
artemether- lumefantrine</w>
artemether )</w>
arteme ther,</w>
arte reial</w>
arte facts</w>
art mann's</w>
art an:</w>
arsen ite</w>
arsen ite,</w>
arsen ics</w>
arsen ic,</w>
arsen al</w>
arryth mia</w>
arri ves</w>
arri val;</w>
arrhythmo genicity,</w>
arrhythmo genic.</w>
arrhythmo genesis.</w>
arrhythmo genenic</w>
arrhythmic s</w>
arrhythmic ),</w>
arrhythmias cardiac</w>
arrhythmias ?</w>
arrhythmias .2</w>
arrhythmias .(ABSTRACT</w>
arrhythmias --
arrhythmias-- best</w>
arrhythmia- triggering</w>
arrhythmia- slowing</w>
arrhythmia .6.</w>
arrhythmia 's.</w>
arrhythm olytic</w>
arrhythm ia).</w>
arrhyth niias</w>
arrhyth mic,</w>
arrhyth emias</w>
arrhy tmias,</w>
arrhy lmias.</w>
arrest ed,</w>
arrest ;</w>
arrest .A</w>
arrest --a</w>
arrest "</w>
arra ys.</w>
arra y.</w>
arr nil),</w>
arr age</w>
arous al;</w>
arom atized</w>
arom aticum</w>
aro use</w>
aro und-the-clock</w>
aro tinolol</w>
aro se.</w>
aro se,</w>
aro -1,4-
aro-1,4- 6,
aro-1,4-6, 3-
aro-1,4-6,3- dilactone</w>
arn est</w>
armit alia</w>
armac ogenetic</w>
arm- cuff</w>
arm- chest</w>
arm Check</w>
arke ley</w>
ark s</w>
ark er</w>
aris -
aris- Ile</w>
aripiprazol e:</w>
aripiprazol e),</w>
aripi pra-zole</w>
aripi pirazole</w>
ariju ana,</w>
arib avirin,</w>
ari um-supplemented</w>
ari ses.</w>
ari sen</w>
ari e</w>
ari bavirin</w>
ari am),</w>
ari al).</w>
arginine- nitric</w>
arginine- aspartate-</w>
arginine ]
arginine] vasopressin</w>
arginine ))</w>
argin ine/cGMP</w>
argin ine/</w>
argin ine-induced</w>
argin ine)</w>
arge- transfer</w>
arge- scale</w>
arge ted)</w>
argatrob an:</w>
argatrob an-
argatroban- to-warfarin</w>
arg uing</w>
arg reave's</w>
arg on-washin</w>
arg er,</w>
arg entaffin</w>
arg e</w>
arg am
argam et)</w>
arg a</w>
arg ,</w>
aren aviruses</w>
aren a,</w>
areflex ia.</w>
areflex ia).</w>
areas ed</w>
areas )</w>
areas "</w>
area/ substantia</w>
area/ number</w>
area/ ischemic</w>
area-under- the-curve</w>
area-under- curve</w>
are y</w>
are x</w>
are tic</w>
are t</w>
are generative</w>
are a).</w>
are a),</w>
are =
are= 5.
are=5. 16,</w>
are --in</w>
are ).</w>
ardi ovascular</w>
ardi l</w>
ardi a</w>
arcin ia</w>
archi val</w>
arch ive</w>
arc us</w>
arc uate-periventricular</w>
arc s</w>
arc oumar)-induced</w>
arc an)</w>
arc :</w>
arbor izing</w>
arbor ization</w>
arbor ization.</w>
arbit ar
arbitar ary</w>
arb urg</w>
arb ose</w>
arb orized</w>
arb or</w>
arb ocaine)</w>
arb er.</w>
arap rim)</w>
arachno id.</w>
arachidon ylglycerol</w>
arachidon ic-acid-sensitive</w>
arachidon ic-acid-induced</w>
arachid onate.</w>
arac ytine-C</w>
arac ts</w>
arac ogenetic</w>
arac hydonoylglycerol</w>
arabinoside -associated</w>
arabinoside ).</w>
arabino side)</w>
arab inosylcytosine</w>
arab i</w>
ara- c)</w>
ara- CTP,</w>
ara- AMP.</w>
ar- tip</w>
ar- associated,</w>
ar thel</w>
ar ter</w>
ar ryhythmias</w>
ar rollo</w>
ar ris)</w>
ar one,</w>
ar o</w>
ar nofsky</w>
ar ms;</w>
ar ms).</w>
ar ms),</w>
ar mingly</w>
ar mentarium</w>
ar m;</w>
ar m)</w>
ar m),</w>
ar l</w>
ar izine,</w>
ar ithmetic</w>
ar istolochic</w>
ar hythmias</w>
ar hythmia,</w>
ar genine-vasopressin</w>
ar fonad</w>
ar dised</w>
ar d-Binet</w>
ar caine.</w>
ar bours</w>
ar a,</w>
ar ]</w>
aquaporin- 6</w>
aquaporin- 4</w>
aquaporin- 4,</w>
aquaporin- 3</w>
aquaporin- 3,</w>
aquapor ins,</w>
aquapor in-1</w>
aquapor in-1,</w>
aqu ious</w>
aqu enil;</w>
aqu educt.</w>
aqu aretic</w>
aqu a</w>
aprotin in)</w>
aprot onin.</w>
aprocl ate</w>
apra xia.</w>
approxim ation</w>
approxim ates</w>
approxim ately)</w>
appropri ate;</w>
appro ved.</w>
appro bation</w>
apprehen sion,</w>
appreci able.</w>
appreci able,</w>
appoint ments,</w>
appoint ment.</w>
applic ator</w>
applic ations,</w>
appl ied:</w>
appl anation</w>
appetite- suppressing</w>
appetite- controlling</w>
appeti tively</w>
appeti tive</w>
appeti tes</w>
appendic itis</w>
appendic etomy</w>
appendic ectomy</w>
appendic ectomy.</w>
appendic ectomy,</w>
append ages</w>
appear s.</w>
appear s,</w>
appear ance:</w>
appear ance)</w>
appea red:</w>
appe d"</w>
appe al</w>
app ing,</w>
app ing"</w>
app ended</w>
app ,</w>
app ),</w>
apor pine,</w>
apor izer-equipped</w>
apoptosis- positive</w>
apoptosis- mediated</w>
apopto tic,</w>
apopto sis)</w>
apopto sis).</w>
apopto sis),</w>
apoplex y,</w>
apop morphine</w>
apomorphine- treated,</w>
apomorphine- stimulated</w>
apomorphine- stereotyped</w>
apomorphine- responsive</w>
apomorph ine.(ABSTRACT</w>
apomorph ine-treated</w>
apomorph ine),</w>
apoC- II,</w>
apoA- IV</w>
apoA- IV.</w>
apoA- II,</w>
apoA- I-
apoA-I- transgenic</w>
apoA- I)</w>
apo proteins.</w>
apo proteins)</w>
apo proteins).</w>
apo protein</w>
apo enzyme</w>
apo LDL</w>
apo HD
apoHD L)</w>
apo E.</w>
apo E,</w>
apo C</w>
apo B</w>
apno ic</w>
apno ea.</w>
apnea- prone</w>
apne usis.</w>
apne usis),</w>
apne ic.</w>
apne a;</w>
apne a)</w>
apne a).</w>
apne a
apnea -</w>
aplac ental</w>
aplac e's</w>
apir in</w>
aphasi a).</w>
aphak ic</w>
aphak ia</w>
aph onia.</w>
aph ilias</w>
aper ture</w>
aper ta)</w>
apatri lat,</w>
apati te</w>
apath y/amotivation'</w>
apath ia,</w>
apart ;</w>
apart ).</w>
apam ycin).</w>
ap yrogenic</w>
ap yrase</w>
ap ses</w>
ap res,</w>
ap repitant</w>
ap positions.</w>
ap posing</w>
ap portions)</w>
ap ple</w>
ap orphines.</w>
ap omophine</w>
ap oferritin</w>
ap o-A-I,</w>
ap noea,</w>
ap lexy</w>
ap lerosis</w>
ap latin)</w>
ap lastic,</w>
ap ipuncture)</w>
ap io</w>
ap ine-treated</w>
ap ically</w>
ap ically.</w>
ap gar,</w>
ap f.</w>
ap ex;</w>
ap est,</w>
ap enems</w>
ap ella,</w>
ap azole)</w>
ap amin
apamin ).</w>
ap a
apa thetic</w>
ap :</w>
ap ).</w>
ap ),</w>
aorto- iliac</w>
aorto iliac</w>
aorto gram</w>
aortic- arch</w>
aorta e,</w>
aorta -
aorta- mesenteric</w>
aort as,</w>
aor tico-pulmonary</w>
aor tic)</w>
aor tas;</w>
aor tal</w>
any one.</w>
any '</w>
anxioly tics.</w>
anxioly tics),</w>
anxiogen ics</w>
anxiogen ic/panicogenic</w>
anxiogen ic-</w>
anxiogen ecity</w>
anxio selective</w>
anxio genesis:</w>
anxio genesis.</w>
anxiety/ panic</w>
anxiety/ fear-like</w>
anxiety/ depression</w>
anxiety/ agitation,</w>
anxiety- response</w>
anxiety- like'</w>
anxiety- depression,</w>
anxiet y;</w>
anxiet y,"</w>
anxiet y),</w>
anxiet y',</w>
anxi ousness,</w>
anxi ous-depressed</w>
anxi olitics</w>
antr um,</w>
antr one)</w>
anto thenic</w>
antithyroid medications.</w>
antithyroid "</w>
antithromb olic</w>
antithromb ins</w>
antithromb in-treated</w>
antithromb in,</w>
antisialo gue</w>
antisialo gogue</w>
antisen se.</w>
antisen se-induced</w>
antiretrovir al.</w>
antiretrovir al-associated</w>
antipyre tics.</w>
antipyre tics,</w>
antipy rene;</w>
antipy chotics:</w>
antipsychotic s?</w>
antipsychotic s;</w>
antipsychotic s"</w>
antipsychotic :</w>
antipsychotic -</w>
antioxidant s;</w>
antioxidant s-amifostine</w>
antioxidant s)</w>
antioxidant ;</w>
antioxid ative,</w>
antioxid ant-
antioxidant- rich</w>
antioxid ant)</w>
antinocicep tives</w>
antineoplas tics</w>
antine utrophil-cytoplasmic</w>
antine urotic'</w>
antinause ant</w>
antin ucleus</w>
antin oceiception,</w>
antin atriuresis</w>
antimyco tics</w>
antimyco tics.</w>
antimon ials</w>
antimon ial</w>
antimon ial-resistant</w>
antimicrobi als,</w>
antimicrobi al
antimicrobial s;</w>
antimicro tubular</w>
antimalari als.</w>
antimalari als)</w>
antimalari al-related</w>
antimalari al-induced</w>
antihistamin ic-opiate</w>
antihistamin ic,</w>
antihistamin es:</w>
antihistamin ergic,</w>
antihist aminergic</w>
antihist amine-treated</w>
antihist amine-
antihistamine- barbiturate</w>
antigest agen</w>
antigest ag
antigestag enic</w>
antigen- positive,</w>
antigen- positive)</w>
antigen- carrier</w>
antigen- antibody</w>
antigen s;</w>
antigen s)</w>
antigen icity</w>
antigen emia;</w>
antigen aemic</w>
antigen aemia</w>
antigen -matched</w>
antigen -1</w>
antigen )</w>
antigen (s),</w>
antiepileptogen ics.</w>
antiepileptogen ic.</w>
antieme tic)</w>
antidepressant s;</w>
antidepressant s:</w>
antidepressant s--moclobemide</w>
antidepressant s'</w>
antidepressant -related</w>
antidepressant -
antidepressant- antipsychotic</w>
antidepressant )</w>
antidepressant ),</w>
antidepressant '.</w>
anticonvulsant ),</w>
anticonvulsant '</w>
anticonvuls ant)</w>
anticoagulant s:</w>
anticoagulant s)</w>
anticoagulant -related</w>
anticoagulant '</w>
anticoagul ation;</w>
anticoagul ation:</w>
anticoagul ation)</w>
anticoagul ant-
anticoagulant- unrelated</w>
anticip ating</w>
anticip ated:</w>
antici patory</w>
antici pate,</w>
anticholinerg ics;</w>
anticholinerg ics--no,</w>
anticholinerg icity,</w>
anticholinerg ic;</w>
anticholinerg ic-induced</w>
anticholinerg ic-associated</w>
antibody- neutralization</w>
antibody- digitoxin</w>
antibody- colloidal</w>
antibody- (PR3-ANCA)</w>
antibody ?</w>
antibody ;</w>
antibody :
antibody: iproniazid-induced</w>
antibody -negative</w>
antibody -dependent</w>
antibody ")</w>
antibodi es)</w>
antibodi es).</w>
antibiotic s--aminoglycoside,</w>
antibiotic s).</w>
antibiotic -related</w>
antibiomania ."</w>
antibiomania .
antibiomania. '</w>
antibiomania ):</w>
antibiom ania</w>
antibiom ania.</w>
antibacter ial,</w>
antiarryth mics</w>
antiarrhythmic .</w>
antiarrhythmic )</w>
anti-psycho tics</w>
anti-psycho tics.</w>
anti-oxid ative,</w>
anti-oxid ants,</w>
anti-oxid ant,</w>
anti-eme tics.</w>
anti-eme tic.</w>
anti-aggreg ant</w>
anti-LK M
anti-LKM 2
anti-LKM2 '.</w>
anti-HBs- titers</w>
anti-HBs- titers.</w>
anti-HBs Ab</w>
anti-HBs (+)</w>
anti-HBs (+),</w>
anti-HB e,</w>
anti-HB cAg(+),</w>
anti-HB S</w>
anti-HB E).</w>
anti-Goalpha (2))</w>
anti-Goalpha (1),</w>
anti-Go alpha2</w>
anti-Go alpha1</w>
anti-Go alpha(2)</w>
anti-Go alpha(1)</w>
anti-Gialpha (3),</w>
anti-Gialpha (2),</w>
anti-Gi alpha3</w>
anti-Gi alpha2</w>
anti-Gi alpha1</w>
anti-Gi alpha(3)</w>
anti-Gi alpha(2)</w>
anti-Gi alpha(1)</w>
anti-CD 8</w>
anti-CD 20</w>
anti-CD 18</w>
anti- virus</w>
anti- ulcer</w>
anti- ulcer,</w>
anti- tyrosine</w>
anti- tumoral</w>
anti- trifluoroacetyl</w>
anti- toxoplasmosis</w>
anti- tachycardial</w>
anti- stress/anti-fatigue</w>
anti- serotonin</w>
anti- serotonergic</w>
anti- serine</w>
anti- scMet</w>
anti- rigor</w>
anti- rifampicin</w>
anti- rheumatoid</w>
anti- reticulocyte</w>
anti- pyretics</w>
anti- psoriatic</w>
anti- pruretic</w>
anti- proteinuric</w>
anti- proteinase-3</w>
anti- proliferative,</w>
anti- pica</w>
anti- phospholipid</w>
anti- peroxidative</w>
anti- penicilloyl</w>
anti- pan</w>
anti- oxidants</w>
anti- ouabain</w>
anti- oestrogens</w>
anti- oestrogen</w>
anti- obesity</w>
anti- nociception</w>
anti- nociception.</w>
anti- nicotine</w>
anti- neutrophilic</w>
anti- myeloperoxidase,</w>
anti- myeloma</w>
anti- mycobacterial</w>
anti- monocyte/macrophage</w>
anti- mitotic</w>
anti- mitochondrial</w>
anti- minocycline</w>
anti- mineralocorticoid</w>
anti- migratory</w>
anti- migraine</w>
anti- microtubule</w>
anti- microbial</w>
anti- manic</w>
anti- malaria</w>
anti- lysozyme</w>
anti- lymphocyte</w>
anti- lipoperoxidative</w>
anti- lipid</w>
anti- lipemic</w>
anti- leukemic</w>
anti- leprosy</w>
anti- laminin</w>
anti- lactoferrin,</w>
anti- itch</w>
anti- ischemic,</w>
anti- interleukin-1</w>
anti- inflammatory/analgesic</w>
anti- infective,</w>
anti- infarction,</w>
anti- hypotensive</w>
anti- hypertensives.</w>
anti- hyperlipedemic,</w>
anti- histamine.</w>
anti- heparan</w>
anti- heparan-sulfate-proteoglycan</w>
anti- hemoglobin</w>
anti- heart</w>
anti- haemostatic</w>
anti- glycoprotein</w>
anti- glutamate</w>
anti- ganglioside</w>
anti- gamma</w>
anti- folate</w>
anti- failure</w>
anti- epileptogenic</w>
anti- epileptics),</w>
anti- epilectically</w>
anti- endoplasmic</w>
anti- edema</w>
anti- eIF2alpha(P)</w>
anti- dsDNA</w>
anti- depressants</w>
anti- depressant,</w>
anti- dementia</w>
anti- cytokine-based</w>
anti- craving</w>
anti- convulsants.</w>
anti- convulsant;</w>
anti- convulsant,</w>
anti- converting</w>
anti- complement</w>
anti- coagulant</w>
anti- cimetidine</w>
anti- cholinesterase,</w>
anti- cholestatic</w>
anti- cephalothin</w>
anti- ceftizoxime</w>
anti- cefamandole-induced</w>
anti- cathepsin</w>
anti- cataleptogenic</w>
anti- catalepsy</w>
anti- calcium</w>
anti- calbindin</w>
anti- biotin</w>
anti- bicuculline</w>
anti- beta</w>
anti- beta2GPI</w>
anti- atrophy</w>
anti- atherosclerotic</w>
anti- asialo</w>
anti- arteriosclerotic</w>
anti- arrhythmics</w>
anti- arrhythmic,</w>
anti- apoptosis</w>
anti- anxiety,</w>
anti- anti-idiotypic</w>
anti- anhedonic</w>
anti- angiotensin</w>
anti- aminophylline</w>
anti- allodynia,</w>
anti- albumin</w>
anti- akinetic</w>
anti- aging</w>
anti- aggregation</w>
anti- aggregating</w>
anti- adrenergic,</w>
anti- adhesive</w>
anti- adenovirus</w>
anti- adenoviral</w>
anti- acne</w>
anti- acetylcholinesterase</w>
anti- Thy</w>
anti- TNF-
anti-TNF- alpha-</w>
anti- TGF-beta</w>
anti- TGF-beta1</w>
anti- TFA</w>
anti- TBM</w>
anti- T-lymphocyte</w>
anti- T
anti-T B</w>
anti- Sm</w>
anti- SS
anti-SS G-pretreated</w>
anti- Ro
anti-Ro (S
anti-Ro(S SA)</w>
anti- Parkinsonism</w>
anti- Parkinson's</w>
anti- PTHrP</w>
anti- PR
anti-PR 3</w>
anti- P1</w>
anti- NeuN</w>
anti- NMDA</w>
anti- NH2-terminal</w>
anti- N-methyl-D-aspartate</w>
anti- Mycobacterium</w>
anti- MM
anti-MM S</w>
anti- MHC</w>
anti- MES</w>
anti- LID</w>
anti- LHRH</w>
anti- LC3</w>
anti- IgM.</w>
anti- IgA</w>
anti- IL
anti-IL -</w>
anti- I</w>
anti- HE
anti-HE V</w>
anti- HCV,</w>
anti- HC
anti-HC V).</w>
anti- HBe
anti-HBe (-)</w>
anti- HBV</w>
anti- H.</w>
anti- Gd
anti-Gd 1b.</w>
anti- GAD</w>
anti- F</w>
anti- F
anti-F x1A</w>
anti- EPS</w>
anti- DNA,</w>
anti- CO
anti-CO OH-
anti-COOH- terminal</w>
anti- CD4</w>
anti- CD154</w>
anti- C3,</w>
anti- Brucella</w>
anti- BK</w>
anti- B-CLL</w>
anti- Alzheimer's</w>
anti- AChR</w>
anti- 58</w>
anti vitamin</w>
anti viral-resistant</w>
anti vertigo,</w>
anti ulcer</w>
anti ulcer,</w>
anti tubulin</w>
anti tryptaminergic</w>
anti tremorigenic</w>
anti tremorgenic</w>
anti thrombogenic</w>
anti thrombin-III</w>
anti thermonociceptive</w>
anti tachycardia</w>
anti sympathotonic</w>
anti stress,</w>
anti spasticity</w>
anti sociality</w>
anti serum-reversible</w>
anti serum,</w>
anti serotonin,</w>
anti septic</w>
anti septic.</w>
anti senescent</w>
anti schistosomal</w>
anti rhinitis</w>
anti rejection</w>
anti rat</w>
anti purine</w>
anti psychtic</w>
anti pshycotic</w>
anti promotional</w>
anti polyuric</w>
anti platelets,</w>
anti plasmin</w>
anti parkinsonians.</w>
anti parietal</w>
anti omers</w>
anti myeloperoxidase-positive</w>
anti myeloperoxidase-antineutrophil</w>
anti myeloid</w>
anti mycotic</w>
anti muscarinics</w>
anti muscarinic,</w>
anti mitogenic</w>
anti mitogen</w>
anti mitochondria</w>
anti migrainous</w>
anti metabolites.</w>
anti metabolites,</w>
anti metabolite-induced</w>
anti lymphocyte</w>
anti luminal</w>
anti liver-kidney-microsomes),</w>
anti lipoperoxidative</w>
anti lipidemic</w>
anti lethal</w>
anti ischaemic</w>
anti hypoxic</w>
anti hypertrophic</w>
anti hypertensives.</w>
anti hypertensives,</w>
anti hypertensive-associated</w>
anti hyperglycemic</w>
anti hyperalgesic,</w>
anti hyperactivity</w>
anti hormonal</w>
anti heparin/platelet</w>
anti heparan</w>
anti helminthic</w>
anti hallucinogenic</w>
anti gravity</w>
anti genetically</w>
anti fungals</w>
anti fibrotic,</w>
anti fibrinolytics.</w>
anti fertility,</w>
anti extravasatory</w>
anti ethanol</w>
anti estrogens.</w>
anti erectile</w>
anti epileptic-related</w>
anti epilepsy</w>
anti edema</w>
anti dysrrhythmic</w>
anti dyskinetic,</w>
anti dyskinesia</w>
anti double</w>
anti double-stranded</w>
anti diuretic,</w>
anti diuresis,</w>
anti digoxin-Fab</w>
anti depressives,</w>
anti cubital</w>
anti craving</w>
anti complement</w>
anti complement.</w>
anti chymotrypsin,</w>
anti cholingerics.</w>
anti cholingeric</w>
anti cholinesterase.</w>
anti cholinesterase,</w>
anti centromere,</w>
anti carcinogenic</w>
anti carcinogenic/antioxidant</w>
anti calciuric</w>
anti bradykinetic</w>
anti bitocis.</w>
anti atherosclerotic</w>
anti arteriosclerotic</w>
anti angiogenesis</w>
anti androgen,</w>
anti androgen
antiandrogen )</w>
anti anaphylactic</w>
anti analgesia</w>
anti amnestic</w>
anti aminophylline</w>
anti allergy</w>
anti alcoholism</w>
anti albumin
antialbumin uric</w>
anti aggressive</w>
anti aggregation</w>
anti aggregating</w>
anti adhesive</w>
anti adenovirus</w>
anti addictive</w>
anti acetylcholinesterase</w>
anti CD25</w>
anti CD
antiCD 25;</w>
anthraquin one-containing</w>
anthraquin one)</w>
anthran ilate</w>
anthracyl ine-treated</w>
anthracyl ine-naive</w>
anthracycline/ mitoxantrone</w>
anthracycline/ cytosine</w>
anthracycline- naive</w>
anthracycline- iron</w>
anthracycline- cytarabine</w>
anthracyclin ic</w>
anthracyclin es:</w>
anthracyclin es/mitoxantrone</w>
anthracyclin es--daunorubicin</w>
anthracycl ine-treated</w>
anthracycl ine-sensitive</w>
anthracycl ine's</w>
anthracycl in</w>
anthrac ene-induced</w>
anthra quinone</w>
anthocyanid in</w>
anth us.</w>
anth rene,</w>
anth rapyrazole</w>
anth otomy</w>
anth ine</w>
anth ine-treated</w>
anth a</w>
antero septal,</w>
antero gradely</w>
antero apical</w>
anterior/ ventral</w>
anterior/ inferior</w>
anterior- lateral</w>
anterior- apical</w>
anteri orly</w>
anter ocaudal</w>
anter o-posterior</w>
anten atally</w>
anteced ent,</w>
antec ollis).</w>
ante verted</w>
ante flexion</w>
antazol ine-treated</w>
antazol ine,</w>
antagonist/ partial</w>
antagonist/ mGluR8</w>
antagonist/ group</w>
antagonist/ 5-HT1A</w>
antagonist s/inverse</w>
antagonist s-kynurenic</w>
antagonist s).</w>
antagonist s"</w>
antagonist ]</w>
antagonist -like</w>
antagonist --
antagonist-- or</w>
antagonist )]</w>
antagonist )-induced</w>
antagonis tic?</w>
antagonis tic,</w>
antagonis tic"</w>
antagon ism;</w>
antagon ism:</w>
antagon ism-induced</w>
antagon ism)</w>
antagon ises</w>
ant/ neoadjuvant</w>
ant s'</w>
ant roline</w>
ant or)</w>
ant on</w>
ant olol's</w>
ant ly-folded</w>
ant inflammatories</w>
ant inephritic</w>
ant gaonists</w>
ant an
antan amine</w>
ant amine</w>
ant al</w>
ant acid,</w>
ant ac
antac ;</w>
ant ab
antab uri,</w>
ant a
anta an</w>
ant -related</w>
ant -dependent</w>
ant ).</w>
answ ers,</w>
answ ers)</w>
anser t</w>
anser ina.</w>
ans sen</w>
ans as</w>
anox ia.</w>
anox ia-induced</w>
anoti a,</w>
anos mia,</w>
anorexigen s,</w>
anorexigen .</w>
anorexigen -induced</w>
anorexigen -
anorexigen- exposed,</w>
anorexi ants,</w>
anorexi ant.</w>
anorex ic-drug</w>
anorex ic,</w>
anopthal mia.</w>
anonym ously</w>
anonym ous,</w>
anonym ised</w>
anomaloscop e.</w>
anomaloscop e,</w>
anomal ies:</w>
anom olous</w>
anom aly),</w>
anof in</w>
anof i</w>
anod ine,</w>
anococ cygeus,</w>
ano- genital</w>
ano yl</w>
ano vulation.</w>
ano tic</w>
ano fi-Aventis,</w>
ano derm</w>
ano ,</w>
annulo plasty,</w>
annu ally,</w>
annu alized</w>
anne xing</w>
anne xin-V</w>
anne l</w>
anne ,</w>
ann um</w>
ann um.</w>
ann ulus,</w>
ann ouncements.</w>
ann ina.</w>
ann e</w>
ank yrin</w>
ank yrin-G+</w>
ank ylosis.</w>
ank s'</w>
ank les</w>
ank les.</w>
ank les,</w>
ank le-jerks.</w>
anisomet ropic</w>
anisocor ia;</w>
anisocor ia,</w>
anis onucleosis</w>
animal s/dose/sex/species.</w>
animal ;</w>
animal -1</w>
anim ated</w>
anil ino)-9-isopropylpurine),</w>
ani epileptic</w>
ani ans</w>
anhydro hexitol</w>
anhydro -L-
anhydro-L- iditol</w>
anhydr ase.</w>
angu ana.</w>
angrad o(R))</w>
angiotensin- II.</w>
angiotensin- II,</w>
angiotensin- I</w>
angiotensin- 1</w>
angiotensin ogen)</w>
angiotensin 1-
angiotensin1- 7/
angiotensin1-7/ Mas</w>
angiotensin (1-7)</w>
angiotens ins</w>
angiotens ins.</w>
angioten sion</w>
angiopo itein-1</w>
angioplast y),</w>
angioplast y"),</w>
angiograph y-proven</w>
angiograph ies</w>
angiograph ies)</w>
angiograph ically.</w>
angioedema ?</w>
angioedema -
angioedema- angiotensin-converting</w>
angioedema ),</w>
angiocardi ography,</w>
angio- tensin</w>
angio- oedema,</w>
angio static</w>
angio plasty:</w>
angio pathies</w>
angio keratomas,</w>
angio id</w>
angio gram,</w>
angio genesis:</w>
angio edemas</w>
angio e-dema</w>
angin ous</w>
angin a?</w>
angin a-
angina- free</w>
angiect asia,</w>
angi oscopic</w>
angi osarcomas,</w>
angi osarcoma</w>
angi opoietin-1</w>
angi omatosis</w>
angi omas.</w>
angi oma</w>
angi oma.</w>
angi itis:</w>
ang over</w>
ang or</w>
ang le,</w>
ang le)</w>
ang itis.</w>
ang hai,</w>
ang es</w>
ang er-associated</w>
ang ed</w>
ang an
angan elli,</w>
anex ate</w>
anex ate.</w>
anex ate)</w>
aneurysm s?</w>
aneurysm s:</w>
aneurysm atic</w>
aneurysm ;</w>
aneurys mal.</w>
aneuplo idy</w>
aneuplo idy,</w>
aneuplo id,</w>
aneuplo id)</w>
anesthetiz ed.</w>
anesthetiz ed),</w>
anesthetic- epinephrine</w>
anesthetic s).</w>
anesthetic :</w>
anesthetic -related</w>
anestheti st,</w>
anesthesia .(ABSTRACT</w>
anesthesi zed</w>
anesthesi ology:</w>
anesthesi ologists.</w>
anesthesi ologist,</w>
anesthesi as.</w>
anesthe tised</w>
anesthe tic)</w>
anerg ia,</w>
anerg ia).</w>
anem is,</w>
anem ias,</w>
anem ia/thrombocytopenia/emesis/rash</w>
anem ia-induced</w>
anem ia'</w>
anecdot e.</w>
anecdot al,</w>
ane- altered</w>
ane sian</w>
ane se).</w>
ane acetyl-
aneacetyl- D-Arg-(Hyp
aneacetyl-D-Arg-(Hyp 3,Thi5,
aneacetyl-D-Arg-(Hyp3,Thi5, 8,
aneacetyl-D-Arg-(Hyp3,Thi5,8, D-Phe
aneacetyl-D-Arg-(Hyp3,Thi5,8,D-Phe 7
aneacetyl-D-Arg-(Hyp3,Thi5,8,D-Phe7 ]-
aneacetyl-D-Arg-(Hyp3,Thi5,8,D-Phe7]- brad</w>
androst enedione,</w>
androgen- suppressing</w>
androgen- receptor</w>
androgen- deprivation,</w>
androgen s;</w>
androgen icity</w>
androgen ic-anabolic</w>
androgen ic,</w>
androgen .</w>
androgen -treated</w>
androgen -dependent</w>
androgen -</w>
androgen ),</w>
andro genetic</w>
andos pirone</w>
ando genous</w>
and/ or,</w>
and-- together</w>
and-- most</w>
and- in</w>
and- Amphetamine-
and-Amphetamine- Reg
and-Amphetamine-Reg ulated</w>
and ra</w>
and ra,</w>
and facilitated</w>
and enbergh</w>
and ardised</w>
and ODQ,</w>
and :</w>
and /</w>
and .9%</w>
ancy -related</w>
ancon i's</w>
anciclo vir.</w>
anciclo vir-associated</w>
ancestr y</w>
ance- Adams</w>
ance t</w>
ance -induced</w>
anc rod.</w>
anatom ico-clinical</w>
anatom ically-defined</w>
anatom ical-pathological</w>
anatom ic-histologic</w>
anastro zole.</w>
anastom osed</w>
anast razole.</w>
anas i</w>
anaphylaxis --case</w>
anaphylaxis )</w>
anaphylaxis ),</w>
anaphylaxis ".</w>
anaphylac tic-type</w>
anaphylac tic)</w>
anaphyl act
anaphylact oid)</w>
anap ylactoid</w>
anand amide-induced</w>
anand amide)</w>
anand amide),</w>
anand amide
anandamide -</w>
anamne sis,</w>
analyz er.</w>
analyz able</w>
analysis -12,</w>
analysis ")</w>
analyser ,</w>
analy ses)</w>
analy ses).</w>
analy sed:</w>
analogu es),</w>
analogu e:</w>
analogu e-based</w>
analogu e-based,</w>
analog s:</w>
analog -to-
analog-to- digital</w>
analog -induced</w>
analog 's</w>
analo gies</w>
analgo sedation,</w>
analgo sedated.</w>
analgesic/ antihyperalgesic</w>
analgesic/ anti-inflammatory</w>
analgesic/ anti-hyperalgesic</w>
analgesic-antipyretic /
analgesic-antipyretic/ anti-inflammatory</w>
analgesic-antipyretic -
analgesic-antipyretic- anti-inflammatory</w>
analgesic- consuming</w>
analgesic s:</w>
analgesic s-resistant</w>
analgesic s).</w>
analgesic -related</w>
analgesia -</w>
analgesia ".</w>
analgesia ").</w>
analgesi a/
analgesia/ sedation,</w>
analgesi a--
analgesia-- duration,</w>
analgesi a),</w>
analge tics,</w>
analbum inemia</w>
anal zyed</w>
anal ization</w>
anal icular)</w>
anal eptics</w>
anagreli de.</w>
anagreli de's</w>
anaesthesi ology.</w>
anaesthesi ology,</w>
anaesthesi a;</w>
anaesthe tics).</w>
anaesthe tic/saline</w>
anaesthe tic)</w>
anaesthe tic(s)</w>
anaem ic.</w>
anaem ia?</w>
anaem ia:</w>
anaem ia-that</w>
anaem ia-related</w>
anaem ia--the</w>
anaem ia--a</w>
anaem ia)</w>
anabol ism</w>
anabol ics</w>
anabol ics.</w>
anabol ic-anticatabolic</w>
ana erobes.</w>
an/ Austral
an/Austral asian</w>
an-2- ol,</w>
an- specific</w>
an- referred</w>
an- pretreated</w>
an- diabetic</w>
an- based</w>
an- 2beta-
an-2beta- ol-17-one-hydrochloride)</w>
an xyolitic</w>
an us-like</w>
an uria:</w>
an um)</w>
an ulocytosis,</w>
an ulaceae)</w>
an trazole).</w>
an thelmintic</w>
an sidar</w>
an s?</w>
an other's</w>
an onymous</w>
an olol</w>
an ol-induced</w>
an oids,</w>
an noyance</w>
an notations</w>
an niversary,</w>
an lagen</w>
an itin,</w>
an isomycin,</w>
an ions,</w>
an hydramnios,</w>
an estetized</w>
an ergy</w>
an ergic</w>
an encephaly,</w>
an dom</w>
an digarh.</w>
an dering</w>
an der</w>
an chorage-independent</w>
an aplasia</w>
an amnesic</w>
an ab
anab asine,</w>
an :
an: NMRI</w>
an -dependent</w>
an --a</w>
an --
an-- .</w>
an +/-
an+/- SD).</w>
amyloid- beta-induced</w>
amyloid- b</w>
amylo idosis,</w>
amyl ase;</w>
amyl amine,</w>
amygdalo id-kindled</w>
amygdalo id,</w>
amygdala- lesioned</w>
amygdala- kindling</w>
amygdala- kindling,</w>
amygdala- evoked</w>
amygdal ae.</w>
amygdal a;</w>
amygdal a);</w>
amygd alop
amygdalop iriform</w>
amy triptyline,</w>
amy tal</w>
amy obarbitol.</w>
amsac rine.</w>
amsac rine-related</w>
amrin one-treated</w>
amrin one-induced</w>
amput ation),</w>
amput ated.</w>
ampros ate</w>
ampo ules</w>
ampo ules.</w>
ampo ule</w>
amplitu de;</w>
amplitu de)</w>
amplifi er,</w>
ampl ing</w>
ampl ifying</w>
ampl ifications</w>
ampl ifications/increases:</w>
ampl ification.</w>
ampl ification,</w>
ampicillin- cefotaxime.</w>
ampicill ine-sulbactam</w>
ampicill in/sulbactam</w>
ampicill in-induced</w>
amphoter icins</w>
amphoter icin-treated</w>
amphoter icin-B</w>
amphoter cin</w>
ampho B.</w>
ampho B)</w>
amphetamine- stimulated</w>
amphetamine- like"</w>
amphetamine- induced)</w>
amphetamine- exposed</w>
amphetamine- dosed</w>
amphetamine- based</w>
amphetamin es:</w>
amphetamin es-induced</w>
amphetamin es--precipitation</w>
amphetamin es).</w>
amphet amine-treated</w>
amphet amine).</w>
amphet amine
amphetamine (s)</w>
amperoz ide.</w>
amperoz ide,</w>
amp ylobacter</w>
amp ules</w>
amp ule</w>
amp ere</w>
amp anulaceae)</w>
amoxycill in/clavulanic</w>
amoxycill in/clavulanate-induced</w>
amoxycill in-</w>
amoxicillin/clavulan ate,</w>
amoxicill in-treated</w>
amoxicill in-coated</w>
amox ycillin</w>
amox ipine,</w>
amox apine-treated</w>
amox apine-induced</w>
amoun ts--bupivacaine</w>
amoun ts,</w>
amoun ts)</w>
amoun t/type</w>
amorph ogranular</w>
amoeb iasis</w>
amodiaqu ine-treated</w>
amodiaqu ine-induced</w>
amodiaqu ine)</w>
amodiaqu in</w>
amo haron</w>
amni otomy.</w>
amni ocentesis.</w>
amnesi a;</w>
amnesi a-inducing</w>
amnesi a-
amnesia- model.</w>
amnesi a)</w>
ammoni um-induced</w>
ammoni emia</w>
ammon iac</w>
ammon ia-induced</w>
ammon emia.</w>
amlodipine/ benazepril,</w>
amlodipine/ benazapril</w>
amlodip ine:</w>
amlodip ine).</w>
amlodip ine),</w>
amitriptyt ine</w>
amitriptyt ine.</w>
amitriptyline/ perphenazine</w>
amitriptyline/ nortriptyline</w>
amitriptyline- treatment</w>
amitriptyline- controlled,</w>
amitriptyl ine:</w>
amitriptyl ine-treated</w>
amitriptyl ine-controlled</w>
amitriptyl ine)</w>
amit ryptyline</w>
amit ryptiline</w>
amit osis;</w>
amit os,</w>
amisulpri de-</w>
amisulpri de)</w>
amis fostine</w>
amiodarone- simvastatin</w>
amiodarone- resistant</w>
amiodarone- only</w>
amiodar one;</w>
amiodar one-like</w>
amiodar one--should</w>
amiodar one)</w>
amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acet amide)</w>
aminot rasferase</w>
aminot ranferases</w>
aminopter ine,</w>
aminopropyl phosphonic</w>
aminophylline :</w>
aminophylline )</w>
aminophyll ine-elicited</w>
aminophyll ine-,</w>
aminophen ols,</w>
aminoph osphonovaleric</w>
aminonucleoside- -
aminonucleoside-- (PAN)</w>
aminonucleoside :</w>
aminonucleoside -</w>
aminomethyl -1,4-
aminomethyl-1,4- benzodioxane</w>
aminom ethyl)benzyl)acetamidine</w>
aminol evulinate</w>
aminoindan-1, 5
aminoindan-1,5 (R,S)-
aminoindan-1,5(R,S)- dicarboxylic</w>
aminoglycoside- resistant</w>
aminoglycoside- penicillin</w>
aminoglycoside- membrane</w>
aminoglycoside- impregnated</w>
aminoglyco side.</w>
aminoglyco side),</w>
aminocyclopentane-1,3- dicarboxylic</w>
aminocyclopentane -1,3,4-tricarboxylic</w>
aminoc etaphen)</w>
aminoadamant anes</w>
aminoadamant ane,</w>
amino] ethyl]-benzoic</w>
amino-2-(2- furyl[1,2,4]-triazolo[2,3-a[1,3,5]triazin-5-yl-aminoethyl)phenol</w>
amino-1- methyl</w>
amino-1- hydroxypropylidene-1,1-bisphosphonate</w>
amino-1- hydroxy-2-pyrrolidinone)</w>
amino-1- butanol</w>
amino- transferase,</w>
amino- tetralin</w>
amino- salicylates,</w>
amino- hex-5-enoic</w>
amino- cephalosporanic</w>
amino- acid-
amino-acid- altering</w>
amino- 4-
amino-4- phosphonobutyric</w>
amino- 4,5,
amino-4,5, 6,</w>
amino- 3,5-dimethyl
amino-3,5-dimethyl adamant
amino-3,5-dimethyladamant ane),</w>
amino- 3'-(2-
amino-3'-(2- methoxy-4-morpholinyl)-doxorubicin</w>
amino- 2-oxo
amino-2-oxo ethyl)spiro[2,5]octane-1-carboxamide].</w>
amino- 2-(
amino-2-( methoxymethyl)pyrrolidine</w>
amino)- 6-
amino)-6- (3-chloro
amino)-6-(3-chloro anilino)-9-isopropylpurine),</w>
amino)- 5,6,7,8-tetrahydro
amino)-5,6,7,8-tetrahydro -</w>
amino)- 5,5-di
amino)-5,5-di methyl-2-cyclohexenone</w>
amino) propyl]-N-phenyl-2-indanamine,</w>
amino) ethylamine)</w>
amino valeric</w>
amino steroidal</w>
amino proprionitrile).</w>
amino phenyl)-3,5-dihydro-7,8-dimethoxy-4H-2,3-benzodiazepin</w>
amino oxy</w>
amino ketone</w>
amino imidazole-4-carboxamide</w>
amino guanidine;</w>
amino gram</w>
amino glucosides.</w>
amino fluorene</w>
amino ethyl)-aminocarboxylmethyloxy)phenyl-1,3-dipropylxant</w>
amino ethoxy</w>
amino disulphide</w>
amino butiric</w>
amino aspartate</w>
amino antipyrine,</w>
amino alkyl
aminoalkyl indole</w>
amino alk
aminoalk anolic</w>
amino acid</w>
amino -17-
amino-17- demethoxy-geldanamycin,</w>
amino -1,2,3,4-tetrahydro-2-
amino-1,2,3,4-tetrahydro-2- methyl-4-phenyl-isoquinoline)</w>
amine- sensitive</w>
amine- pancuronium-narcotic</w>
amine- derivative</w>
amine- depleting</w>
amine- -induced</w>
amine R,</w>
amine /kg</w>
amin osalicylates</w>
amin orex.</w>
amin orex,</w>
amin opyrrolidine-2R,4R-dicarboxylate,</w>
amin opyrine-N-demethylase</w>
amin openicillins</w>
amin odarone</w>
amin odarone.</w>
amin obenzamide,</w>
amin ipeptidase,</w>
amin ectomy</w>
amin :</w>
amilor ide-sensitive</w>
amilor ide)</w>
amilor ide),</w>
amik acin)</w>
amifost ine:</w>
amifost ine-related</w>
amifost ine-pretreated</w>
amide/ mesna</w>
amide- phenothiazine</w>
amide- linked</w>
amid ronate)</w>
amid opyrine,</w>
amezin ium.</w>
amezin ium,</w>
amex ane</w>
amethyl melamine</w>
amethas one-induced</w>
amet ropic</w>
ames 's</w>
amer oid</w>
amenorrhea/ oligomenorrhea</w>
amenorrhea/ galactorrhea.</w>
amenorrhe ic.</w>
amenorrhe a-
amenorrhea- galactorrhea</w>
amend ment,</w>
amen orrhoeic</w>
amen orrhoea.</w>
amen orrhoea,</w>
amen horrea,</w>
amen dements</w>
amef alone</w>
amef alone,</w>
ame dic</w>
ame boid</w>
ame biasis.</w>
ambul atory),</w>
ambul ation-accelerating</w>
ambul ate.</w>
ambul ance.</w>
ambigu us,</w>
ambigu ous</w>
ambigu ous.</w>
ambigu ity</w>
ambi que</w>
ambi an</w>
amb urger</w>
amantad ines</w>
amantad ine-trimethoprim</w>
amantad ine)</w>
amantad ine's</w>
amant atine</w>
am- exposed</w>
am- I
am-I PC).</w>
am yopathic</w>
am ycin-induced</w>
am us</w>
am ulet</w>
am s'</w>
am pakine</w>
am ond</w>
am ond-Blackfan</w>
am mation</w>
am iodorane).</w>
am ined</w>
am idic</w>
am icrofilaremic</w>
am i.</w>
am en,</w>
am ely,</w>
am d</w>
am cinonide</w>
am bican</w>
am benonium,</w>
am ateur</w>
am astigotes</w>
am ap</w>
am anitin,</w>
am ae</w>
am B)</w>
am -like</w>
alw ays,</w>
alveol itis,</w>
alve olitis</w>
alumin um-related</w>
alumin um-induced</w>
altitu des</w>
altitu des.</w>
alternati ve/adjuvant</w>
altern atively.</w>
altern ation)</w>
altern ates</w>
altern ate,</w>
alter ing),</w>
alter ations;</w>
alter ation'</w>
alteplas etriggered</w>
alteplas e)</w>
alte red;</w>
alte red'</w>
alt schanoff</w>
alston ine</w>
alston ine:</w>
alston ine,</w>
alprosta dil.</w>
alprosta dil).</w>
alprazolam ;</w>
alprazol am-exposed</w>
alphax alone,</w>
alphax al
alphaxal one-,</w>
alphab etized</w>
alphab etical</w>
alphab eta-crystalin,</w>
alpha7- subunits</w>
alpha7- subunit-containing</w>
alpha7- non-neronal</w>
alpha7- nicotinic</w>
alpha7- antagonist,</w>
alpha7- /-</w>
alpha5- subunit,</w>
alpha5- containing</w>
alpha5- ,</w>
alpha4- mutated</w>
alpha4- ,</w>
alpha4 or</w>
alpha4 beta2-receptor</w>
alpha4 beta2)</w>
alpha4 S248
alpha4S248 F
alpha4S248F beta2</w>
alpha4 *</w>
alpha4 (L9'
alpha4(L9' A)
alpha4(L9'A) beta2</w>
alpha2A- antagonist</w>
alpha2A- adrenoceptors</w>
alpha2A- adrenoceptor</w>
alpha2- resistant</w>
alpha2- receptors</w>
alpha2- noradrenergic</w>
alpha2- macroglobulin</w>
alpha2- inhibitory</w>
alpha2- delta</w>
alpha2- antiplasmin</w>
alpha2- antagonist</w>
alpha2- agonist
alpha2-agonist -mediated</w>
alpha2- Adrenoceptors</w>
alpha2- AR</w>
alpha2 receptors</w>
alpha2 b)</w>
alpha2 a,</w>
alpha1- subunit,</w>
alpha1- selective</w>
alpha1- isoform</w>
alpha1- containing</w>
alpha1- adrenoceptors</w>
alpha1- Adrenergic</w>
alpha1- AR</w>
alpha/ interferon-gamma,</w>
alpha/ beta)]</w>
alpha/ beta),</w>
alpha-tropanyl-2- (4-chloro
alpha-tropanyl-2-(4-chloro phenoxy)butyrate</w>
alpha-tropanyl-2- (4-
alpha-tropanyl-2-(4- chorophenoxy)butyrate)</w>
alpha-tropan yl-2(pCl-phenoxy)butyrate</w>
alpha-tocopher ol/ascorbic</w>
alpha-tocopher ol-deficient</w>
alpha-synucle in/polyubiquitin-positive</w>
alpha-r ANP.</w>
alpha-phenyl-N- t-butyl</w>
alpha-naphthylisothiocyan ate-treated</w>
alpha-naphthylisothiocyan ate-induced</w>
alpha-naphtho flavone</w>
alpha-naphtho flavone:</w>
alpha-methyldopa .
alpha-methyldopa. 10.</w>
alpha-methyldopa -</w>
alpha-methyl-p-tyros ine-pretreated</w>
alpha-methyl-p-tyros ine).</w>
alpha-methyl-p-tyros ine),</w>
alpha-methyl- dopa</w>
alpha-methyl- dopa.</w>
alpha-methyl- P-
alpha-methyl-P- tyrosine</w>
alpha-methyl- L-AP4</w>
alpha-methyl- DL-
alpha-methyl-DL- p-tyrosine</w>
alpha-methyl- Arg
alpha-methyl-Arg 7-
alpha-methyl-Arg7- D-Leu
alpha-methyl-Arg7-D-Leu 8]
alpha-methyl-Arg7-D-Leu8] dynorphin</w>
alpha-methyl- 5-HT.</w>
alpha-methyl- 5-HT)</w>
alpha-methyl tyrosine.</w>
alpha-methyl tyrosine-catalepsy</w>
alpha-methyl para-tyrosine</w>
alpha-methyl noradrenaline</w>
alpha-methyl noradrenaline,</w>
alpha-methyl noradrenaline).</w>
alpha-methyl histamine-induced</w>
alpha-methyl histamine,</w>
alpha-methyl dopamine</w>
alpha-methyl adrenaline</w>
alpha-melan otropin</w>
alpha-melan otropin,</w>
alpha-mangost in.</w>
alpha-man nosidase</w>
alpha-man nosidase,</w>
alpha-hydroxy- metoprolol</w>
alpha-fluoro-beta- alanine.</w>
alpha-ethyl- 2-oxo-1-pyrrolidine</w>
alpha-erg okryptine,</w>
alpha-carbon itrile</w>
alpha-carbon itrile.</w>
alpha-amino-3-hydroxy-5-methylisoxazole-4- propionate</w>
alpha-amino-3-hydroxy-5- methyl-isoxazole-4-propionic</w>
alpha-amino- beta-carboxymuconate-epsilon-semialdehyde</w>
alpha-amino- 5alpha-androst
alpha-amino-5alpha-androst an-2beta-ol-17-one-hydrochloride)</w>
alpha-amino isobutyrate</w>
alpha-amino ergoline,</w>
alpha-actin in.</w>
alpha-actin in-4</w>
alpha-actin in-4.</w>
alpha-actin in,</w>
alpha-OH- DH
alpha-OH-DH P)</w>
alpha-OH- D(2))</w>
alpha-Mp T</w>
alpha-Mp T-induced</w>
alpha-Methyl paratyrosine</w>
alpha-M NE</w>
alpha-EMT B
alpha-EMTB L,</w>
alpha-EH HC-
alpha-EHHC- tolerant</w>
alpha-EH HC,</w>
alpha-D- methyl-mannoside</w>
alpha-D- galactose</w>
alpha-Aman itin.</w>
alpha-Aman itin,</w>
alpha-A sarone</w>
alpha-2 b/ribavirin</w>
alpha-2 b/ribavirin-induced</w>
alpha-2 b.</w>
alpha-2 a,</w>
alpha-2 a)</w>
alpha-2 A-
alpha-2A- adrenoceptor</w>
alpha-1-anti trypsin.</w>
alpha-1-anti proteinase,</w>
alpha-1- microglobulin</w>
alpha-1- microglobulin/creatinine</w>
alpha-1- microglobulin,</w>
alpha-1- micro</w>
alpha-1- micro,</w>
alpha-1- blocker,</w>
alpha-1- adrenoceptor</w>
alpha-1 B</w>
alpha-1 A</w>
alpha-(prop-1- ynyl)estra-4,9-dien-3-one],</w>
alpha-(prop-1- ynyl)-estra-</w>
alpha-( carboxycyclopropyl)glycine</w>
alpha-( (2S,
alpha-((2S, 5
alpha-((2S,5 R)-
alpha-((2S,5R)- 4-
alpha-((2S,5R)-4- allyl-
alpha-((2S,5R)-4-allyl- 2,5-dimethyl
alpha-((2S,5R)-4-allyl-2,5-dimethyl -1-piperazin
alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazin yl)-3-methoxybenzyl]-N,N-diethyl-benzamide</w>
alpha- tubulin,</w>
alpha- subunits</w>
alpha- subunit(s),</w>
alpha- substituted</w>
alpha- stimulation</w>
alpha- sarcomeric</w>
alpha- release</w>
alpha- reductase;</w>
alpha- receptor-blockade</w>
alpha- rat</w>
alpha- position</w>
alpha- phenylethylamine-induced</w>
alpha- phenylethyl-6-AzUd</w>
alpha- napthylisothiocyanate,</w>
alpha- muricholic</w>
alpha- mehyl-para-tyrosine</w>
alpha- linolenic</w>
alpha- keto</w>
alpha- isopropyl</w>
alpha- isopropyl-alpha-methyl-gamma-butyrolactone</w>
alpha- interferon.</w>
alpha- imino</w>
alpha- hydroxylase)</w>
alpha- hexachlorocyclohexane</w>
alpha- hexachlorocyclohexane,</w>
alpha- haemolytic</w>
alpha- glycerophosphate</w>
alpha- glutathione</w>
alpha- glucosidase,</w>
alpha- galactosidase</w>
alpha- galactosidase,</w>
alpha- flupenthixol</w>
alpha- fluorination</w>
alpha- ethynylestradiol,</w>
alpha- ethyl-2-oxo-pyrrolidine</w>
alpha- ethinylestradiol.</w>
alpha- ethinylestradiol-induced</w>
alpha- ergolines</w>
alpha- ergoline</w>
alpha- epithelial</w>
alpha- endorphin,</w>
alpha- endomannosidase</w>
alpha- dystroglycan,</w>
alpha- difluoromethylornithine</w>
alpha- difluoromethylornithine.</w>
alpha- dialkylated</w>
alpha- d-galactosidase)</w>
alpha- d-N-acetylglucosaminidase,</w>
alpha- converting</w>
alpha- configurations</w>
alpha- configuration</w>
alpha- chloralose-urethane-anesthetized,</w>
alpha- chloralose,</w>
alpha- catenin</w>
alpha- calcitonin</w>
alpha- bromocamphor-pi-sulfonate</w>
alpha- blockers,</w>
alpha- blocker,</w>
alpha- antagonists</w>
alpha- antagonist,</w>
alpha- antagonist),</w>
alpha- amino</w>
alpha- amanitin,</w>
alpha- agonists:</w>
alpha- agonists,</w>
alpha- agonist</w>
alpha- agonism</w>
alpha- adrenoceptors,</w>
alpha- actin.</w>
alpha- act
alpha-act in/ferritin</w>
alpha- [2-
alpha-[2- (2-
alpha-[2-(2- butoxyethoxy)ethoxy]-4,5-methylenedioxy-2-propyltol</w>
alpha- [125I]
alpha-[125I] bungarotoxin</w>
alpha- TH
alpha-TH B)</w>
alpha- SM-
alpha-SM- actin,</w>
alpha- S
alpha-S MA,</w>
alpha- MPT</w>
alpha- MD.</w>
alpha- MD
alpha-MD --
alpha-MD-- producing</w>
alpha- L-
alpha-L- fucosidase</w>
alpha- IMGB
alpha-IMGB L</w>
alpha- Hexachlorocyclohexane</w>
alpha- Helical</w>
alpha- HC
alpha-HC H.</w>
alpha- HB
alpha-HB DH</w>
alpha- H)</w>
alpha- GF
alpha-GF C)</w>
alpha- G
alpha-G ST.</w>
alpha- Ethinylestradiol</w>
alpha- CH
alpha-CH 3</w>
alpha- BT
alpha-BT X,</w>
alpha- B
alpha-B ungarotoxin</w>
alpha- Amino
alpha-Amino adi
alpha-Aminoadi pic</w>
alpha- ANP</w>
alpha- 5</w>
alpha- 4/
alpha-4/ beta-2</w>
alpha- 2-adrenoceptors</w>
alpha- 2-adrenergic</w>
alpha- (2
alpha-(2 '
alpha-(2' ,2'-
alpha-(2',2'- diphenyl-2'-hydroxy-ethoxy)tropane</w>
alpha- (125
alpha-(125 I
alpha-(125I )-
alpha-(125I)- bungarotoxin</w>
alpha,betame ATP</w>
alpha,betame ATP-
alpha,betameATP- insensitive</w>
alpha,betame ATP
alpha,betameATP :</w>
alpha,beta-me ATP-sensitive</w>
alpha,beta- amyrin,</w>
alpha,alpha'-diethyl-4,4'-stilbene diol]</w>
alpha,alpha'-diethyl-4,4'-stilbene diol)</w>
alpha,25- Dihydroxy
alpha,25-Dihydroxy cholecalciferol</w>
alpha, 9</w>
alpha, 8
alpha,8 b)-(+)-N-methyl-N[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]</w>
alpha, 7
alpha,7 alpha,8b)-(+)-N-methyl-N[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]</w>
alpha(4) beta(2).</w>
alpha(2)- receptor</w>
alpha(2)- adrenoreceptors,</w>
alpha(2)- adrenoreceptor</w>
alpha(2)- activity</w>
alpha(2)- AR</w>
alpha(2)- AR.</w>
alpha(1D)- adrenoceptors</w>
alpha(1D)- adrenoceptor</w>
alpha(1D)- AR,</w>
alpha(1D )=
alpha(1D)= 7.26.</w>
alpha(1B )=
alpha(1B)= 6.
alpha(1B)=6. 55</w>
alpha(1B )-</w>
alpha(1B )-
alpha(1B)- adrenoceptor</w>
alpha(1)- receptor</w>
alpha(1)- microglobulin</w>
alpha(1)- microglobulin,</w>
alpha(1)- blocker,</w>
alpha(1)- adrenoreceptors,</w>
alpha(1)- AR</w>
alpha(1)- AR.</w>
alpha(1 A)-</w>
alpha prodine</w>
alpha MT).</w>
alpha C</w>
alpha B-crystallin</w>
alpha 9/
alpha9/ alpha
alpha9/alpha 10</w>
alpha 7
alpha7 +/+</w>
alpha 5
alpha5 beta4-deficient</w>
alpha 47</w>
alpha 4.1,</w>
alpha 4-</w>
alpha 3-
alpha3- integrin,</w>
alpha 3),</w>
alpha 1A-
alpha1A- selective</w>
alpha 1.</w>
alpha 1
alpha1 (IV)</w>
alpha ).</w>
alpha )),</w>
alpha (i)</w>
alpha (T
alpha(T 28
alpha(T28 6
alpha(T286 A)</w>
alpha (2A)</w>
alpha (2-
alpha(2- 9)</w>
alpha (2)/
alpha(2)/ imidazoline</w>
alpha (2
alpha(2 B,
alpha(2B, C)</w>
alpha (1),</w>
alph as))</w>
alph adol
alphadol one</w>
aloxif ene:tamoxifen)</w>
alop rim</w>
alop oecia</w>
along with</w>
alone ].</w>
alone ?</w>
alo w's</w>
alo sis).</w>
alo s</w>
alo acetic</w>
alo )</w>
almotript an,</w>
almokal ant</w>
almokal ant-induced</w>
almokal ant,</w>
almo plantar</w>
allyl- substitution)</w>
allyl- clonidine,</w>
allyl- 3,7-
allyl-3,7- dimethyl-8-p-sulfophenyl-xanthine</w>
allyl normetazocine</w>
allyl gylycine.</w>
allyl amino-17-demethoxy-geldanamycin,</w>
allox an-diabetic</w>
allox an--a</w>
allowe d).</w>
allow ance</w>
allow able</w>
allograf ts,</w>
allograf t).</w>
allodynia/ hyperalgesia).</w>
allodyn ia:</w>
allodyn ia-pinprick</w>
allodyn ia).</w>
allo wed,</w>
allo typic</w>
allo types</w>
allo tetrahydrocortisol</w>
allo pregnanolone,</w>
allo pregnalone.</w>
allo immunization.</w>
allo immunization,</w>
allo immune</w>
allo dinia:</w>
allo antigens</w>
allo antigen,</w>
allo antibody.</w>
allo antibodies.</w>
allo -B
allo-B MT)</w>
alli in)</w>
alli ance.</w>
allevi ated;</w>
allergen s,</w>
allergen .</w>
allerg y:</w>
allerg y-like</w>
allerg y--specifically,</w>
allerg ological</w>
allerg ologic</w>
allerg ist</w>
allerg ist.</w>
allerg ic-like</w>
alleng ing</w>
alleng es</w>
alle le-wise:</w>
alle le-specific</w>
alle le)</w>
alle le).</w>
alle dynia.</w>
all-trans- isomer.</w>
all-trans- RA.</w>
all-trans- HPR</w>
all-trans- HE
all-trans-HE R</w>
all-trans- ER.</w>
all-trans retinoic</w>
all-or- nothing'</w>
all-or- none,</w>
all- patients</w>
all- night</w>
all- bladder</w>
all- Delayed</w>
all uria</w>
all ure</w>
all trans-retinoic</w>
all enge,</w>
all ayed</w>
all ay</w>
all ard's</w>
all -treated</w>
all -dose</w>
all )</w>
alkyl- derivatives</w>
alkyl- bis(4'-fluorophenyl)amine</w>
alkyl- 2-</w>
alkyl- ,</w>
alkyl piperazine</w>
alkyl guanine</w>
alkyl azacycloalkan-2-one</w>
alkyl ators,</w>
alkyl ator-resistant</w>
alkyl ating-containing</w>
alkyl acetyl
alkylacetyl glycerol.</w>
alkalo ids'</w>
alkalin izing</w>
alkalin ization.(ABSTRACT</w>
alkalin ization),</w>
alkalin isation</w>
alkal ization.</w>
alkal ine-mannitol</w>
alkal i.</w>
alk yl-2-pyrrolidinyl)methyl]-5-</w>
alk ovits'</w>
alk -1
alk-1 '-
alk-1'- enyl-2-acyl-GPE</w>
aliz arin</w>
aliz ability</w>
alis zed</w>
alis kiren</w>
alis kiren-induced</w>
alis ).</w>
aliqu ots</w>
aliqu ot</w>
alin opsia),</w>
alim entation</w>
align ing</w>
ali ve;</w>
ali uretic</w>
ali ke.</w>
ali ke-50%;</w>
algorith m,</w>
algorith m's</w>
algesi a,</w>
alga e,</w>
alg ometry,</w>
alg ometer,</w>
alg inate</w>
alfuz osin-related</w>
alfentanil- supplemented</w>
alfentanil- isoflurane-nitrous</w>
alfentan il-treated</w>
alfentan il)</w>
alfentan il),</w>
alfa-2 b/melphalan/prednisone</w>
alfa-2 b.</w>
alfa-2 a:</w>
alfa-2 a.</w>
alfa- ribavirin</w>
alfa 2a</w>
alf on)</w>
alf athesin),</w>
alf al</w>
alf adex</w>
alf a)</w>
alf -dose</w>
aler ts</w>
aler tness.</w>
aler ting</w>
aler t:</w>
aldosterone- salt-induced</w>
aldosterone- mediated</w>
aldosterone- acetate</w>
aldosteron ism.</w>
aldoster one;</w>
aldoster one/mg</w>
aldoster one.(ABSTRACT</w>
aldol ase,</w>
aldo V),</w>
ald =
ald= 7.
ald=7. 46
ald=7.46 8,</w>
alcur onium.</w>
alcur onium,</w>
alcohol- treated),</w>
alcohol- naive</w>
alcohol- mediated</w>
alcohol- exposed</w>
alcohol- dependent,</w>
alcohol s,</w>
alcohol ism;</w>
alcohol ;</w>
alcohol -</w>
alcohol ),</w>
alcoh ol/cocaine</w>
alcit ol</w>
alc k,</w>
alc alosis).</w>
albuter ol:</w>
albumin/ total</w>
albumin- filled</w>
albumin- IgG-
albumin-IgG- complexes</w>
albumin aemia</w>
albumin -to-
albumin-to- creatinine</w>
albumin -containing</w>
albifron s</w>
albifron s,</w>
alben dazole-induced</w>
alb ustix</w>
alb ino-rats</w>
alb a</w>
alaz un</w>
alaz opyrin,</w>
alan ylamino-peptidase</w>
alan yl-arginine-7-amido-4-methylcoumarin</w>
alan inoaminotransferase</w>
alan in-IR</w>
al-He FT</w>
al-He F
al-HeF T).</w>
al- verapamil-induced</w>
al- striatal</w>
al- respiratory</w>
al- lobe</w>
al- evoked</w>
al- emergent</w>
al- containing</w>
al- averaged</w>
al- IV</w>
al- Blood</w>
al- 5'-phosphate</w>
al via</w>
al vaceae)</w>
al udring).</w>
al tricial</w>
al titudinal</w>
al titrexed</w>
al t-60</w>
al ropine</w>
al ready.</w>
al prenolol.</w>
al ox)</w>
al oud,</w>
al otransaminase</w>
al ose</w>
al one:</w>
al one--a</w>
al logrooming,</w>
al location,</w>
al lization</w>
al likrein</w>
al ities</w>
al ine:</w>
al ine-treated</w>
al ign</w>
al etra)</w>
al desleukin</w>
al d's</w>
al captase</w>
al ation</w>
al at</w>
al at),</w>
al arms</w>
al arms,</w>
al armingly</w>
al anin</w>
al ae</w>
al ae,</w>
al a</w>
al -1)</w>
akinesia/ catalepsy.</w>
akine tic,</w>
akine sis</w>
akine sis.</w>
akine sis),</w>
akine sia;</w>
akine sia)</w>
akathisi a?</w>
akathisi a")</w>
ak u</w>
ak lin</w>
ak land,</w>
ak ithisia,</w>
ak itabine</w>
ak ai</w>
ak a</w>
ak a
aka thesia,</w>
ajmal ine,</w>
air- warming</w>
air- oxygen</w>
air- jet</w>
air ways,</w>
air way:</w>
air tight</w>
air line</w>
air flow,</w>
air field</w>
air d</w>
air /
air/ oxygen</w>
air "</w>
ain tness</w>
aim s-based</w>
aim ,</w>
ail ylglycine,</w>
ail ments.</w>
ail .</w>
ai thersburg,</w>
ai rian)</w>
ai rei-to</w>
ai red-pulse</w>
ai kokeishikankyoto,</w>
ai guan,</w>
agu as,</w>
agricul ture</w>
agranulocyto sis:</w>
agranulocyto sis)</w>
agoraphob ics</w>
agoraphob ia:</w>
agoraphob ia-DSM-IV-who</w>
agoraph obic</w>
agonist/ D(2)</w>
agonist- naive</w>
agonist- gated</w>
agonist- clonidine.</w>
agonist- antagonist,</w>
agonist s),</w>
agonist /</w>
agonist .
agonist. Our</w>
agonist -treated</w>
agonist -associated</w>
agonist ):</w>
agon ism/antagonism.</w>
agon ism,</w>
agon ally</w>
ago gastroduodenoscopy</w>
agne vist).</w>
agmat ine,</w>
aglu timide</w>
aglu timide,</w>
agl ate-treated</w>
agitation/ hallucinations</w>
agitation/ delirium</w>
agit ations),</w>
agit ation)</w>
agit ation),</w>
agin ally</w>
aggressi veness.</w>
aggressi ve)</w>
aggres sive.</w>
aggregation- prone</w>
aggregation- inhibitory</w>
aggreg ometry</w>
aggreg ation;</w>
aggreg ation:</w>
aggreg ates;</w>
aggreg ates,</w>
aggreg ate.</w>
aggreg ability.</w>
aggrav ation,</w>
agglutin ins.</w>
agglutin in-horseradish</w>
ageu sia,</w>
agents-- taxol,</w>
agents-- prazosin</w>
agents-- aspirin,</w>
agent- specific.</w>
agent- driven</w>
agent s.(ABSTRACT</w>
agent s).</w>
agent .5.</w>
agent -in</w>
agent -evoked</w>
agent --
agent-- cocaine</w>
agent ),</w>
agent (s)</w>
agent (s),</w>
agent ".</w>
agene sis/bilateral</w>
agene sis)</w>
agen ized'</w>
agen ase</w>
aged- rat</w>
age= 38.
age=38. 8,</w>
age= 23.3</w>
age/ weight</w>
age- similar</w>
age- sex</w>
age- response</w>
age- related.</w>
age- range</w>
age- interaction</w>
age- gated</w>
age- expected</w>
age- dependence</w>
age- damaged</w>
age- comparable</w>
age- associated</w>
age ing-</w>
age e-Womens</w>
age bogen</w>
age >or=18</w>
age ></w>
age .)</w>
age );</w>
agamet -induced</w>
agamet ).</w>
agal us,</w>
again st.</w>
again ;</w>
again ).</w>
ag ue</w>
ag rid)</w>
ag ressive</w>
ag outis.</w>
ag o)</w>
ag nostic</w>
ag nex,</w>
ag lomerular</w>
ag ing-induced</w>
ag ing-</w>
ag hdad</w>
ag gered</w>
ag es;</w>
ag ers)</w>
ag ement,</w>
ag anulocytosis,</w>
ag ani</w>
ag alus.</w>
afun gin</w>
afterwar ds)</w>
afterno ons.</w>
afterno on/early</w>
afterno on)</w>
aftereff ects</w>
aftereff ects,</w>
afterdepolar izationlike</w>
after- sensations</w>
after- effects</w>
after taste</w>
after loads.</w>
after load;</w>
after images</w>
after hyperpolarization</w>
after discharge-evoking</w>
after contractions</w>
afosf amide</w>
affor ding</w>
afflu ent</w>
afflu ent,</w>
afflic ts</w>
afflic ting</w>
afflic ted.</w>
afflic t</w>
affir ming</w>
affir mative</w>
affiniti es.</w>
affiniti es,</w>
affin ity-purified</w>
afferen ts)</w>
afferen t/efferent</w>
afferen t--tentatively</w>
afferen s</w>
affect s.</w>
affect ).</w>
aff ordable</w>
aff ixed</w>
aff ective/cognitive</w>
aff ective,</w>
aff ection</w>
aff ection.</w>
aff airs</w>
afebri le.</w>
af ur-uracil</w>
af oveal</w>
af ayette,</w>
aeros ol.</w>
aer omedical</w>
aer ogenes</w>
aer ogenes,</w>
aem ia/reperfusion</w>
advoc ating</w>
advoc ates</w>
advoc ated;</w>
advoc ated,</w>
advis ory</w>
advis ory,</w>
adverse- event</w>
adver tisements</w>
adver sity,</w>
adver sities</w>
adventi tia.</w>
advant age,</w>
advance d.</w>
adv ising</w>
adurabol in</w>
adur in,</w>
adulter ation</w>
adulter ating</w>
adult- type</w>
adult- focused</w>
adul ts)<0.006)</w>
adul ts).</w>
adul ts),</w>
adul ticidal</w>
adul t)</w>
adsor ption)</w>
adsor b</w>
adriamycin- perfused,</w>
adriamycin- normotensive</w>
adriamycin- nephrotic</w>
adriamycin- injured</w>
adriamycin- evoked</w>
adriamycin- containing</w>
adriamycin- cardiomyopathy</w>
adriamycin- DNA</w>
adriamycin- -
adriamycin-- etiology.</w>
adriamycin- ,</w>
adriamyc in/kg</w>
adriamyc in-mediated</w>
adriamyc in+silymarin</w>
adri paresis</w>
adri a-
adria- DNA</w>
adrenocortico steroids</w>
adrenocortico steroids.</w>
adrenocortico id</w>
adrenocortic al,</w>
adrenoceptor- blockers</w>
adrenoceptor- agonists</w>
adrenocept ors-mediated</w>
adrenocept or/imidazoline</w>
adrenergic- nerve</w>
adrenergic- alpha(1)</w>
adrenerg ics.</w>
adrenerg ic/5-HT2</w>
adrenerg ic).</w>
adrenaline. 7.</w>
adrenaline. 5.</w>
adrenaline- synthesizing</w>
adrenaline- hypertension'</w>
adrenal- medullary</w>
adrenal- intact</w>
adrenal- independent,</w>
adrenal- demedullated</w>
adrenal- demedullated,</w>
adrenal ine/methylchloroform</w>
adrenal ine-containing</w>
adrenal ine).</w>
adrenal ine(AD)-induced</w>
adrenal )</w>
adrenal ),</w>
adren omedullin,</w>
adren ectomy</w>
adren als.</w>
adren als,</w>
adren ally</w>
adren alized</w>
adop entetate</w>
adolescent s;</w>
adolescent s)</w>
adolescent s'</w>
adolescent )</w>
adnex a</w>
admit tance</w>
admis sions).</w>
admis sion)</w>
administr ations;</w>
administr ations,</w>
administr ation-related</w>
administr ation--a</w>
administr ation),</w>
administ rator</w>
administ rateion</w>
administ eration</w>
administ er.</w>
administ ed</w>
adjuv ant/neoadjuvant</w>
adjuv ant,</w>
adjuv ant),</w>
adjusted- dose:</w>
adjusted- dose--a</w>
adjust ments.</w>
adjust ment:</w>
adjust able</w>
adjunc tives</w>
adjunc tively</w>
adjunc tion</w>
adis cal'</w>
adipos ity:</w>
adipos ity.</w>
adipon ectin.</w>
adipon ectin,</w>
adip ocytic</w>
adip ocytes.</w>
adip ocyte</w>
adic tory</w>
adi azine-induced</w>
adhe sivity</w>
adhe siolysis</w>
adequ ately.(ABSTRACT</w>
adequ ate"</w>
adenylate- cyclase</w>
adenylate- cyclase/cAMP-system.</w>
adenylate- cyclase,</w>
adenyl yl,</w>
adenotonsill ectomy</w>
adenotonsill ectomy:</w>
adenotonsill ectomy,</w>
adenosine-3'5'-monophospho thioate</w>
adenosine-3'5'-monophospho thioate,</w>
adenosine- stress</w>
adenosine- sensitive</w>
adenosine- dopamine</w>
adenosine- deaminase</w>
adenosine- MIBI</w>
adenosine- 5'-
adenosine-5'- N-methyl
adenosine-5'-N-methyl carboxamide)</w>
adenosine- -
adenosine-- augments</w>
adenosine- ,</w>
adenosine triphosphate</w>
adenosine triphosphatase</w>
adenosin es</w>
adenosin c</w>
adenos ine/placebo</w>
adenos ine-related</w>
adenos ine's</w>
adenos ine"</w>
adenomyo sis:</w>
adenomyo sis,</w>
adenomas/ carcinomas</w>
adenomas/ animal</w>
adenom ectomy,</w>
adenom as),</w>
adenoid ectomy</w>
adenoid ectomy,</w>
adenohypophy sis,</w>
adenofibrom a</w>
adenocarcin oma;</w>
adenocarcin oma).</w>
adeno virus,</w>
adeno virus)-induced.</w>
adeno pathy.</w>
adeno hypophysial</w>
aden osis).</w>
aden opituitary</w>
aden opathy,</w>
aden omatosis</w>
aden oma:</w>
aden ocortical</w>
aden ocard</w>
aden o-,</w>
adefovir .</w>
ade oxycytidine</w>
ade ks</w>
adduct ors,</w>
addiction like</w>
addiction --a</w>
addic tive,</w>
addic tions.</w>
addic tions,</w>
addic tion?</w>
addic tion-intensified</w>
addic tion)</w>
addic t,</w>
addi tivity.</w>
addi tional,</w>
add- on/ADV</w>
add- on,</w>
add- back</w>
add- back"</w>
add a</w>
adap tivity</w>
adap tivity,</w>
adap ter</w>
adap ted.</w>
adap tation,</w>
adap table</w>
adamantyl) ethyl,</w>
adamant aneacetyl-D-Arg-(Hyp3,Thi5,8,D-Phe7]-brad</w>
ad ron</w>
ad riceps</w>
ad reneline-induced</w>
ad or,</w>
ad olol)</w>
ad o,</w>
ad monish</w>
ad mixtures</w>
ad mixture-hypnotic</w>
ad mium-exposed</w>
ad mantyl]-1-aminomethyl-3,4-dihydro-5,6-dihydroxy-1H-2-benzo</w>
ad judged</w>
ad jacent,</w>
ad ina</w>
ad hering</w>
ad ductors)</w>
ad duction</w>
ad duct,</w>
ad ded)</w>
ad ded).</w>
ad axonal</w>
ad an</w>
ad -
ad- spectrum</w>
acyl- protected</w>
acyl ureas</w>
acyl transferase</w>
acyl imidazole</w>
acyl glycero)phosphate,</w>
acyl carnitine</w>
acyclovir :</w>
acyclovir -mediated</w>
acyclovir -,</w>
acyclovir -
acyclovir- toxic</w>
acyclovir )</w>
acyclin -like</w>
acy tidine,</w>
acute/ subacute</w>
acute/ severe</w>
acute/ etiology;</w>
acute/ epidemiology;</w>
acute/ economics.</w>
acute/ drug</w>
acute/ chronic</w>
acute- subacute</w>
acute- onset,</w>
acute- on-therapeutic</w>
acute- care</w>
acut us</w>
acut us.</w>
acut ely),</w>
acut e)</w>
acut e),</w>
acupunct ure;</w>
acupunct ure,</w>
acupunct ure's</w>
acumin ata</w>
acul ine</w>
acuit y;</w>
acuit y-VEPs-color</w>
acu points.</w>
acu points)</w>
acu men</w>
actomy osin--made</w>
activity- stimulating</w>
activity- related</w>
activity- -
activity-- increased</w>
activity .7.</w>
activiti es:</w>
activiti es.2.</w>
activiti es)</w>
active- memory</w>
active- lever</w>
active :
active: salt)],</w>
active ')</w>
activator )</w>
activator ),</w>
activation- recovery</w>
activation- linked</w>
activation- euphoria</w>
activation- cell</w>
activ ity"</w>
activ ators.</w>
activ ational</w>
activ ating-sedating</w>
actinomycin- D.</w>
actin- complex</w>
actin- binding</w>
actin- anesthetized</w>
actin- ABP</w>
actin omycete.</w>
actin ochemotherapy.</w>
acti ve)</w>
acti tious</w>
acti metre</w>
acti graphy</w>
acti graphy.</w>
act ylcysteine</w>
act rim</w>
act ors.</w>
act ometers,</w>
act ing.</w>
act in-associated</w>
act in),</w>
act )-associated</w>
act ),</w>
acryl amide-induced</w>
acryl amide),</w>
acromegal ics,</w>
acromeg aly)</w>
acrolein- dithiouric</w>
acrolein- DTP</w>
acrole in.(ABSTRACT</w>
acro paresthesias</w>
acridin ylamino)</w>
acri vastine,</w>
acqui res</w>
acqui red.</w>
acqui red-immune-deficiency-syndrome</w>
acqui red"</w>
acquain ted</w>
acquain tance</w>
acous ticovestibular</w>
acous tically-evoked</w>
aconit ine.</w>
aconit ine-</w>
aconit ine,</w>
acne :</w>
acne -like</w>
aclam ol</w>
acknowledg ment</w>
ack son-Rees</w>
acitret in,</w>
acit retin).</w>
acin us</w>
acin i</w>
acill in-induced</w>
acidi fying</w>
acidi fication)</w>
acid/ nonsteroidal</w>
acid/ dopamine</w>
acid/ alkali</w>
acid/ AMPA</w>
acid-- whose</w>
acid-- profile</w>
acid-- on</w>
acid- treated,</w>
acid- reacting</w>
acid- reactant</w>
acid- photodynamic</w>
acid- peptic</w>
acid- paclitaxel</w>
acid- mimetic</w>
acid- loading</w>
acid- labile</w>
acid- kainate</w>
acid- insoluble</w>
acid- injected</w>
acid- inhibited</w>
acid- induces</w>
acid- independent</w>
acid- ergic</w>
acid- dipyridamole</w>
acid- derived</w>
acid- damaged</w>
acid- convulsive</w>
acid- containing</w>
acid- benzodiazepine</w>
acid- base,</w>
acid- antagonistic</w>
acid- acetoxy
acid-acetoxy methyl</w>
acid- B</w>
acid- A</w>
acid- (NMDA),</w>
acid+ isoproterenol</w>
acid+ isoproterenol.</w>
acid+ isoproterenol,</w>
acid yl)</w>
acid s;</w>
acid otic.</w>
acid osis:</w>
acid ity,</w>
acid aemia</w>
acid ):</w>
acid )-associated</w>
acid )),</w>
acid (UDCA)</w>
aci tivity</w>
achlor hydria.</w>
ache )</w>
ach t,</w>
ach s</w>
ach oline</w>
ach olic</w>
ach ol-induced</w>
ach ment</w>
ach ing</w>
ach iness,</w>
ach ine,</w>
ach ectic</w>
ach dev</w>
acetylcholine- synthesis</w>
acetylcholine- dopamine</w>
acetylchol ine:</w>
acetylchol ine-dependent</w>
acetylchol ine)</w>
acetylator s;</w>
acetylator s:</w>
acetylamino fluorene,</w>
acetylamino antipyrine</w>
acetyl-L- carnitine.</w>
acetyl- salicylate</w>
acetyl- carnitine,</w>
acetyl- beta-glucosaminidase,</w>
acetyl- D-gluc
acetyl-D-gluc aro-1,4-6,3-dilactone</w>
acetyl- ChE</w>
acetyl transferase),</w>
acetyl sulfisoxazole)</w>
acetyl sulfamethoxazole,</w>
acetyl phenyl)ethynyl-3alpha,21-dihydroxy-5beta++</w>
acetyl morphine,</w>
acetyl morphine).</w>
acetyl hydrolase</w>
acetyl homotaurinate)</w>
acetyl cholinesterase.</w>
acetyl cholinesterase,</w>
acetyl carnitine</w>
acetyl ator,</w>
acetyl ate</w>
acetyl ]
acetyl] dibenzo[c,fl-[1,2,5]thiadiazepine</w>
acetyl -</w>
acetyl -1-
acetyl-1- methyl-7-(4-pyridyl)-5,6,7,8-tetrahydro-3(2H)-isoquinolinone</w>
acety lized</w>
acetoxy- N-methyl
acetoxy-N-methyl piperidine</w>
acetoxy- 3-carbamo
acetoxy-3-carbamo yl-2,2,5,5-tetramethylpyrrolidine</w>
acetoxy -10,11-dihydro-5H-di
acetoxy-10,11-dihydro-5H-di benzo/b,f/azepine-5-carboxamide)</w>
aceton ide:</w>
acetohex amide</w>
acetohex amide.</w>
acetazol amide-related</w>
acetate- sodium</w>
acetate- promoted</w>
acetate- pretreated</w>
acetate- -
acetate-- saline-treat</w>
acetanil ioiminodiacetic</w>
acetanil idoiminodiacetic</w>
acetaminophen- related)</w>
acetaminophen- propoxyphene.</w>
acetaminophen- intoxicated</w>
acetaminophen- injected</w>
acetaminophen- cysteine</w>
acetaminophen -associated</w>
acetaminophen -</w>
acetaminophen -,</w>
acetaminophen ),</w>
acetam ol</w>
acetam ido-3-pyridyl)-N-[N-(2,</w>
acet uria</w>
acet rizoate),</w>
acet onitrile/the</w>
acet one)</w>
acet in-based</w>
acet ate:methanol</w>
acet ate-treated</w>
acet ate-1-14C</w>
acet ate's</w>
acet amide)</w>
acet ab
acetab ular</w>
acet ,</w>
acepromaz ine/butorphanol</w>
acepif ylline-induced</w>
acepif ylline,</w>
acenoc umarol)</w>
acenoc oumarol,</w>
acenaph then-1-yl-1-phenyl-1,3,8-triaza-spiro[4,5]decan-4-one),</w>
aceclofen ac,</w>
acebut olol,</w>
ace prometazine</w>
ace promazine.</w>
ace iform</w>
accurac ies</w>
accur ate.</w>
accumul ation;</w>
accumul ation/degradation</w>
accumul ation)</w>
accumul ation).</w>
accumul ates.</w>
accumul ated.</w>
accumul ate.</w>
accumbens :</w>
accumbens -
accumbens- ventromedial</w>
accumben s)</w>
accru ing</w>
accru al.</w>
accred its</w>
accoun ts.</w>
accoun ts,</w>
accompl ished,</w>
accompan yingrheumatoid</w>
accommod ation:</w>
accid ental.</w>
accid ent-related</w>
acchar in</w>
access -dependent</w>
acces sible.</w>
accept s</w>
accept ors</w>
accept ors.</w>
accept able;</w>
accep ted,</w>
acceler omyography.</w>
acceler ometry,</w>
acceler ation-induced</w>
acceler ated/malignant</w>
acc used</w>
acc oud's</w>
acar icide</w>
acar icide)</w>
acampros ate,</w>
acal culous</w>
acade mic,</w>
ac- source</w>
ac- SP)</w>
ac ylurea</w>
ac yl-coenzyme</w>
ac urium),</w>
ac tions;</w>
ac tions/outcomes</w>
ac tion?</w>
ac tion/intention-tremor</w>
ac tion.)</w>
ac ters</w>
ac ronym</w>
ac onazole-increased</w>
ac ognition</w>
ac obson,</w>
ac o-2</w>
ac lidine</w>
ac le</w>
ac knowledged.</w>
ac ini.</w>
ac ini,</w>
ac ia)</w>
ac i</w>
ac eruloplasminaemia.</w>
ac enza,</w>
ac emetacin,</w>
ac e-inhibitor,</w>
ac cutane,</w>
ac culturation,</w>
ac corded</w>
ac cord.</w>
ac cent</w>
ac cellerated</w>
ac athisia.</w>
ac arbose</w>
ac al</w>
ac acia)</w>
abuse ?</w>
abuse /</w>
abuse --was</w>
abuse --an</w>
abuse "</w>
abund antly</w>
abumet one-associated</w>
abul ia,</w>
abstr acts;</w>
abstr acts,</w>
abstr actors.</w>
abstr action</w>
abstr action,</w>
abstr acters</w>
abstr act,</w>
abstin ent.</w>
abstin ence-related</w>
abstin ence-assessment</w>
abstin ence).</w>
absorpti ometry.</w>
absorp tion;</w>
absor bed,</w>
absolut e;</w>
absolut e,</w>
absen ce.</w>
absen ce,</w>
absces s)</w>
absc issa</w>
abs enteeism</w>
abs ent)</w>
abs ences.</w>
abs .)</w>
abs .).</w>
abrupt y</w>
abrupt ,</w>
abru ption.</w>
abru ption,</w>
abro gated.</w>
abro ad.</w>
above- stated</w>
above- background</w>
aborti facient,</w>
abor tus</w>
abor ts</w>
abor tions</w>
abor tions.</w>
abor ting</w>
abor t.</w>
abor 's</w>
abol ishment</w>
abol ic-androgenic</w>
abo ve.(ABSTRACT</w>
abo ve),</w>
abo os</w>
abo on</w>
abnormaliti es?</w>
abnormaliti es.(ABSTRACT</w>
abnormaliti es-or</w>
abnormaliti es).</w>
abnormal ity)</w>
abnormal ity).</w>
abnormal ,"</w>
able d,</w>
ablact ation</w>
ablact ation,</w>
abl ated.</w>
abil one</w>
abil ity-achievement</w>
abicyclo (2.
abicyclo(2. 2.
abicyclo(2.2. 2.
abicyclo(2.2.2. )
abicyclo(2.2.2.) octan-6,7-endo,endo-diol)</w>
abic yclo</w>
aberr ation,</w>
aberr antly-folded</w>
aber ration</w>
abecarnil .(ABSTRACT</w>
abecarnil ++</w>
abecarn il:</w>
abecarn il-treated</w>
abec ornil</w>
abec arrnil),</w>
abduc tion.</w>
abdomin operineal</w>
abdomin als,</w>
abdomin aL</w>
abdom inis.</w>
abdom en;</w>
abdom en,"</w>
abdom en)</w>
abandon ed.</w>
abandon ed,</w>
aband oning</w>
abac avir/lamivudine</w>
abac avir-induced</w>
abac avir,</w>
ab uses</w>
ab users;</w>
ab users).</w>
ab user:</w>
ab staining</w>
ab stainers</w>
ab solved</w>
ab s)</w>
ab raded</w>
ab out.</w>
ab original</w>
ab ody</w>
ab nomalities,</w>
ab lating</w>
ab ismus</w>
ab igatran</w>
ab i</w>
ab ex,</w>
ab enese)</w>
ab ello</w>
ab cess</w>
ab c/2</w>
ab ates,</w>
ab ate)</w>
ab ana</w>
ab ama</w>
ab ain</w>
ab a,</w>
ab 1-
ab1- HR
ab1-HR P,</w>
ab -based</w>
a] anthracene-induced</w>
aV R,</w>
aV F)</w>
aR, 9
aR,9 bS)-N[4-(8-cyano-1,3a,4,9b-tetrahydro-3H-benzopyrano[3,4-c]pyrrole-2-yl)-butyl](4-phenyl)benzamide]</w>
aR, 11b
aR,11b S]-
aR,11bS]- 4,5,
aR,11bS]-4,5, 5
aR,11bS]-4,5,5 a,
aR,11bS]-4,5,5a, 6,7,
aR,11bS]-4,5,5a,6,7, 11
aR,11bS]-4,5,5a,6,7,11 b-hexahydro-2-propyl-3-thia-5-+</w>
aPTT s,</w>
aPT T,</w>
aF GF-induced</w>
a/ b,</w>
a/ a,</w>
a/ Tran
a/Tran ))</w>
a/ II
a/II a.</w>
a/ Cr)</w>
a. m.),</w>
a- regulated</w>
a- o)</w>
a- ketoglutarate,</w>
a- go-go-related</w>
a- electrocardiogram</w>
a- e,</w>
a- e),</w>
a- containing</w>
a- T1</w>
a- T
a-T 1).</w>
a- K-
a-K- ATPase)</w>
a- Cre</w>
a- Common</w>
a- 3</w>
a- 3
a-3 f)</w>
a,5,6, 10b-
a,5,6,10b- octahydrobenzo(f)quinoline</w>
a) isoindole</w>
a) DO
a)DO 2</w>
a z</w>
a ycol)</w>
a venues</w>
a venue</w>
a therapeutic</w>
a reactive.</w>
a prost).</w>
a prospective,</w>
a pertures</w>
a opomorphine</w>
a is),</w>
a iodobenzylguanidine:</w>
a ids,</w>
a ids)</w>
a id,</w>
a ically</w>
a haler.</w>
a etiopathology</w>
a etiologically</w>
a ethiops)</w>
a equorin-loaded</w>
a egypti</w>
a and</w>
a ]),</w>
a VF</w>
a T,</w>
a SA
aSA H)</w>
a S,
aS, 10
aS,10 bS)-(-)-enantiomer</w>
a RS-
aRS- 6-[
aRS-6-[ phosphonomethyl]decahydr</w>
a M),</w>
a LQTS</w>
a HRP</w>
a HRP)</w>
a GVHD.</w>
a D:</w>
a D)</w>
a D).</w>
a CSF</w>
a CL,</w>
a 8</w>
a 4.</w>
a 2A</w>
a 1</w>
a 199
a199 8
a1998 a]</w>
a .).</w>
a -19
a-19 a</w>
a +</w>
a ):</w>
a )/
a)/ 5-HT(2
a)/5-HT(2 c)</w>
a )-induced</w>
a )),</w>
a (L)</w>
a (1)-
a(1)- blocking</w>
_C_ C_
_C_C_ G)</w>
_C_ A)</w>
_ T
_T _C_A)</w>
_ M)</w>
_ C)</w>
_ <0.05)</w>
_ 2-adrenergic</w>
]= 5.0
]=5.0 2,</w>
]= 3.6
]=3.6 5,</w>
]= 2.0
]=2.0 9,</w>
]= 1.9
]=1.9 35,</w>
]= 0.4</w>
]- positive),</w>
]- hexane-2,6-dicarboxylate</w>
]- fluorodeoxyglucose</w>
]- enkephalin</w>
]- alpha-bungarotoxin</w>
]- [Leu
]-[Leu ]
]-[Leu] enkephalin-Thr)</w>
]- [5
]-[5 aR,11bS]-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-+</w>
]- VIP</w>
]- GnR
]-GnR H;</w>
]- CSF),</w>
]- C</w>
]- ,</w>
])- guided,</w>
])- dipyridamole</w>
] i).</w>
] hexane-2,6-dicarboxylic</w>
] hexane-2,6,-dicarboxylic</w>
] enkephalin</w>
] citalopram</w>
] CaCl(2)</w>
] -mediated</w>
] (
]( o),</w>
[i PTH
[iPTH ]</w>
[i (11
[i(11 )],</w>
[dexamethasone/ thalidomide/cisplatin/doxorubicin/cyclophosphamide/etoposide]</w>
[dexamethasone/ cyclophosphamide/etoposide/cisplatin],</w>
[d.f.= 53
[d.f.=53 ]=3.65,</w>
[d.f.= 4
[d.f.=4 1]
[d.f.=41] =4.
[d.f.=41]=4. 31,</w>
[d.f.= 30
[d.f.=30 ]=2.09,</w>
[bis(4-fluorophenyl)methoxy] ethyl]piperazinyl]-3-phenylpropan-2-ol</w>
[beta- mercapto-beta,beta-cyclopentamethylene</w>
[beta- gamma-imino]triphosphate</w>
[[(5- (4-chlorophenyl)-
[[(5-(4-chlorophenyl)- 2-fur
[[(5-(4-chlorophenyl)-2-fur anyl)</w>
[X u</w>
[X II
[XII ]),</w>
[X 2;</w>
[W inton</w>
[W MD</w>
[V SM
[VSM C
[VSMC ],</w>
[V M
[VM ]</w>
[V H
[VH c]</w>
[V F]</w>
[U-14C] sucrose</w>
[U-14C] lindane/kg).</w>
[T SS
[TSS S]</w>
[T PR
[TPR ])</w>
[T 6-1
[T6-1 2],</w>
[T 5-1
[T5-1 1]</w>
[T (3
[T(3 )]</w>
[Sh imizu</w>
[Sh antha</w>
[Se S
[SeS BP]</w>
[Se DBP
[SeDBP ]</w>
[Sar 1,
[Sar1, Ala
[Sar1,Ala 8]
[Sar1,Ala8] angiotensin</w>
[SI R]</w>
[SEM ])</w>
[SEM ]),</w>
[SBP ]:</w>
[SBP ],</w>
[S3 (30
[S3(30 )].</w>
[S3 (0
[S3(0 )],</w>
[S olomon</w>
[S MR
[SMR ]</w>
[RR ]=5.02,</w>
[R HR
[RHR ]</w>
[R (+)
[R(+) WIN
[R(+)WIN 55,2
[R(+)WIN55,2 12</w>
[PT ],</w>
[PT 1]</w>
[PR s])</w>
[PR ]</w>
[P tio2]</w>
[P illot,</w>
[P ]).</w>
[P ]),</w>
[OR s],</w>
[OR ]=1.935,</w>
[Neuro pharmacology</w>
[Neuro biol.</w>
[NS ]</w>
[NS ],</w>
[NS ])</w>
[NS ]),</w>
[NPhe(1)] nociceptin(1-13)NH(2).</w>
[NPhe(1)] nociceptin(1-13)NH(2),</w>
[N- phenylpropyl-N'-(3,4-dichlorophenethyl)piperazine]</w>
[N- [2-
[N-[2- [4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridin
[N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridin yl)cyclohexanecarboxamide</w>
[N- /
[N-/ 2-chloro
[N-/2-chloro ethyl/-N-ethyl-2-bromobenzylamine]</w>
[N- (7-methylcoumaran-3-yl)
[N-(7-methylcoumaran-3-yl) guanidine</w>
[N- (4-hydroxy
[N-(4-hydroxy phenyl)</w>
[N- (4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)</w>
[N- (1-{[(cyanoimino)(5-quinolinylamino)</w>
[N- (
[N-( piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide];</w>
[N PR
[NPR S]</w>
[N NH
[NNH ],</w>
[N NC</w>
[Mg2+] i.</w>
[MSD BP]</w>
[MSD BP
[MSDBP ],</w>
[ME T
[MET ];</w>
[ME L])</w>
[MD A]</w>
[MD A])</w>
[MAP ],</w>
[MAP ]),</w>
[M ACE
[MACE ])</w>
[LVE DP
[LVEDP ],</w>
[K+ ],</w>
[IV ]</w>
[IV ])</w>
[IQR ]</w>
[IQR ]:</w>
[IP ]</w>
[IP S
[IPS ],</w>
[ID(50)= 9.
[ID(50)=9. 17</w>
[ID(50)= 24.
[ID(50)=24. 0
[ID(50)=24.0 (13.
[ID(50)=24.0(13. 1-
[ID(50)=24.0(13.1- 43.
[ID(50)=24.0(13.1-43. 8)</w>
[ID(50)= 18.8</w>
[ID(50)= 12.
[ID(50)=12. 1
[ID(50)=12.1 (9.
[ID(50)=12.1(9. 40
[ID(50)=12.1(9.40 -15.
[ID(50)=12.1(9.40-15. 6)</w>
[Hyp 3,</w>
[HR ]:</w>
[H(+)] ATPase</w>
[H(+)] ATPase-
[H(+)]ATPase- labeled</w>
[H PA]</w>
[Gly ]</w>
[Gly ],</w>
[GM ]-CSF),</w>
[GM ]),</w>
[G pp(NH)p]</w>
[G ]-</w>
[G GT
[GGT ],</w>
[G .
[G. A.</w>
[F adda</w>
[F A]).</w>
[F -18
[F-18 ]-fluorodeoxyglucose</w>
[E AE
[EAE ].</w>
[E -1,3-diethyl-
[E-1,3-diethyl- 8
[E-1,3-diethyl-8 (3,4-dimethoxy
[E-1,3-diethyl-8(3,4-dimethoxy styryl-7-methyl-3,7-dihydro-1H-purine-2,6-dione]</w>
[DBP ]</w>
[D-Ala 2,</w>
[D-Ala (2),</w>
[D- Ser
[D-Ser 2
[D-Ser2 ]-[Leu]enkephalin-Thr)</w>
[Ca2+] i,</w>
[Ca2+] i)</w>
[CR ]</w>
[CR ]).</w>
[CMF ])</w>
[CI ]=0.4</w>
[CH S]</w>
[CH 2]
[CH2] 1
[CH2]1 (5),</w>
[CFU- S])</w>
[CFU- E]</w>
[CAD ]</w>
[CAD ]),</w>
[C ].</w>
[C 8-
[C8- T2];</w>
[B ])</w>
[B HR
[BHR ],</w>
[B As
[BAs ]</w>
[Amp 4-8
[Amp4-8 ]).</w>
[Amp 1-
[Amp1- 4]</w>
[AZT ])</w>
[AZT ]).</w>
[AUC ]</w>
[AUC ])</w>
[AUC (0-
[AUC(0- infinity)]</w>
[ASA ])-dipyridamole</w>
[ASA ]),</w>
[AM PA]</w>
[AM L])</w>
[AC ])</w>
[AC I-
[ACI- TI
[ACI-TI PI
[ACI-TIPI ]</w>
[95. 7%</w>
[95. 7
[95.7 %]</w>
[95. 6
[95.6 %],</w>
[9 5.4</w>
[9 4.7
[94.7 %]</w>
[9 3.
[93. 5%
[93.5% ],</w>
[9 0.06
[90.06 -1.
[90.06-1. 33
[90.06-1.33 ]</w>
[9 %],</w>
[9 %])</w>
[85% ])</w>
[85% ]),</w>
[8. 9]</w>
[8. 2]</w>
[8 3-1
[83-1 93
[83-193 ]</w>
[8 2-1
[82-1 10
[82-110 ]</w>
[8 1.4
[81.4 %],</w>
[8 %]).</w>
[73 %]</w>
[73 %])</w>
[7. 5]</w>
[7. 5-1
[7.5-1 5]</w>
[7. 4%
[7.4% ]);</w>
[7. 2]</w>
[7. 25</w>
[7-acetyl- 5-
[7-acetyl-5- (4-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-di
[7-acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-di oxolo(4,</w>
[7-acetyl- 3-
[7-acetyl-3- (4-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-di
[7-acetyl-3-(4-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-di oxazolo[4,5-h][2,3]-benzodiazepine],</w>
[7-(2- phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-(4,3-e)-1,2,4-triazolo(1,5-c)</w>
[7-(2- chlorophenyl)-8-(4-chlorophenyl)-2-methylpyrazolo[1,5-a]-[1,3,5]triazin-4-yl]-3-ethylaminoazetidine-3-carboxylic</w>
[7- chloro-4-hydroxy-3(3-phenoxy)</w>
[7- amino-2-(2-furyl[1,2,4]-triazolo[2,3-a[1,3,5]triazin-5-yl-aminoethyl)phenol</w>
[7- (N,N-dipropyl
[7-(N,N-dipropyl amino)-5,6,7,8-tetrahydro-</w>
[7 ];</w>
[7 9.7
[79.7 %]</w>
[7 8.6
[78.6 %]).</w>
[7 4-8
[74-8 5]</w>
[7 30</w>
[7 2%]</w>
[7 1.5
[71.5 %],</w>
[7 1%]</w>
[7 0.7
[70.7 %]</w>
[7 %],</w>
[69 -125
[69-125 ]</w>
[69 %]),</w>
[6.0 %]).</w>
[6.0 %]),</w>
[6 15-1
[615-1 10
[615-110 8]</w>
[6 1.0]</w>
[5.3 %],</w>
[5.3 %])</w>
[5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo[4,3-epsilon]-1,2,4- triazolo[1,5-c]pyrimidine;</w>
[5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo[4,3-epsilon]-1,2,4- triazolo[1,5-c]-pyrimidine</w>
[5- 8
[5-8 ])</w>
[5- (4-fluoro
[5-(4-fluoro phenyl)-3-pyridylmethylaminomethyl]-chromane</w>
[5- (4-chlorophenyl)-1-(2,4-dichloro
[5-(4-chlorophenyl)-1-(2,4-dichloro phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide],</w>
[5- (4-
[5-(4- chloro-3-methylphenyl)-1-(4-methylbenzyl)-N-(1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl)-1H-pyrazole-3-carboxamide],</w>
[5- (2,
[5-(2, 4-
[5-(2,4- difluorophenyl)-salicylic</w>
[5 ],</w>
[5 2.5%</w>
[4. 5-
[4.5- 8.
[4.5-8. 3]</w>
[4. 5,</w>
[4-(4-fluorophenyl) piperazin-1-yl]</w>
[4-(4- pyridylamino)phenyl]-4,</w>
[4-(4- chloro-phenyl)-piperazin-1-yl]-propyl}-pyrrolidin-2-one</w>
[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridin yl)</w>
[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]- N-2-
[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2- pyridinyl-cyclohexanecarboxamide</w>
[4-(2-methoxyphenyl) -1-piperazin
[4-(2-methoxyphenyl)-1-piperazin yl-]ethyl</w>
[4-(2- ter-butyl-quinolyl)]-3-(4-piperidyl)propanol</w>
[4-(2,6-di -1-pyrrolidinyl-4-pyrimidinyl)
[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl) -1-piperazinyl]-
[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl]- pregna-1,4,9</w>
[4-(2,6-di -1-
[4-(2,6-di-1- pyrrlidinyl-4-pyrimidinyl)-1-piperazinyl]methy</w>
[4- quinolinecarboxamide,N-[trans-4-[2-(6-cyano-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]-cyclohexyl]-(9CI)]</w>
[4- methoxy-3-(2-phenylethoxy)phenyl]-ethylamine</w>
[4- m-chlorophenylcarbamoyloxy]-2-butynyltrimethylammonium),</w>
[4- acetyl-1-methyl-7-(4-pyridyl)-5,6,7,8-tetrahydro-3(2H)-isoquinolinone</w>
[4- (1-
[4-(1- cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2</w>
[4,5- c]</w>
[4,3- d]-pyrimidin-7-one</w>
[4'-(2-hydroxy-3- tert-butyl-aminopropoxy)-3'-methoxyphenyl]-</w>
[4'-(2-hydroxy-3- (
[4'-(2-hydroxy-3-( tert-butylamino)propoxy)-3'-methoxyphenyl]</w>
[4 -14C]
[4-14C] cholesterol</w>
[4 %]</w>
[3H][3-Me-His2] TRH</w>
[3H][3-Me-His2] TRH,</w>
[3H]- spiroperidol</w>
[3H]- spiperone</w>
[3H]- spiperone-labelled</w>
[3H]- resiniferatoxin</w>
[3H]- norepinephrine</w>
[3H]- noradrenaline,</w>
[3H]- nimodipine</w>
[3H]- nicotine.</w>
[3H]- naloxone</w>
[3H]- mazindol</w>
[3H]- labeled</w>
[3H]- l-arginine</w>
[3H]- flunitrazepam,</w>
[3H]- dihydroergocryptine</w>
[3H]- SCH</w>
[3H]- 5-az
[3H]-5-az adeoxycytidine</w>
[3H] uridine</w>
[3H] thymidine.</w>
[3H] taurocholate</w>
[3H] taurocholate,</w>
[3H] spierone</w>
[3H] ryanodine-binding</w>
[3H] quinuclinyl</w>
[3H] prazosin</w>
[3H] paroxetine.</w>
[3H] pCCK-8</w>
[3H] norepinephrine.</w>
[3H] noradrenaline</w>
[3H] nitrendipine</w>
[3H] nicotine.</w>
[3H] n-propylnorapomorphine</w>
[3H] muscimol,</w>
[3H] met-enkephalin</w>
[3H] mecamylamine,</w>
[3H] mazindol</w>
[3H] leucine</w>
[3H] kainic</w>
[3H] inulin;</w>
[3H] imipramine</w>
[3H] haloperidol</w>
[3H] glutamate</w>
[3H] gamma-aminobutyric</w>
[3H] flupentixol</w>
[3H] estradiol-17</w>
[3H] epibatidine,</w>
[3H] dihydroalprenolol;</w>
[3H] digoxin</w>
[3H] dehydroepiandrosterone</w>
[3H] cytisine,</w>
[3H] benzylpempidine,</w>
[3H] adrenaline.</w>
[3H] aHRP</w>
[3H] WIN</w>
[3H] Thymidine</w>
[3H] TCA</w>
[3H] T</w>
[3H] T
[3H]T CA.</w>
[3H] Ro15-4513</w>
[3H] Quin
[3H]Quin uclidinyl</w>
[3H] N-methylscopolamine</w>
[3H] Muscimol</w>
[3H] Muscimol,</w>
[3H] EE</w>
[3H] EE-17
[3H]EE-17 beta-glucuronide.</w>
[3H] E217G</w>
[3H] DA</w>
[3H] CP-
[3H]CP- 55,940</w>
[3H] CI-9
[3H]CI-9 77</w>
[3H] CHA</w>
[3H] CGP</w>
[3H] CG
[3H]CG P-1
[3H]CGP-1 217
[3H]CGP-1217 7</w>
[3H] BSA</w>
[3H] ACh</w>
[3H] ACh,</w>
[3H] 24,25-(OH)2D3</w>
[3H] 1,
[3H]1, 24,25-(OH)2D3</w>
[3H] -P
[3H]-P N
[3H]-PN 200-110</w>
[3H] -M
[3H]-M us</w>
[3H1] thymidine</w>
[3H1] Thymidine</w>
[36 %]</w>
[36 %])</w>
[35S] thio)triphosphate</w>
[35S] t-butylbicyclophosphorothionate</w>
[35S] t-butyl-bicyclophosphorothioate</w>
[35S] Methionine</w>
[35S] GTPgamma
[35S]GTPgamma S)</w>
[35 S]-
[35S]- sulfate</w>
[33 12.
[3312. 9
[3312.9 (2
[3312.9(2 17.
[3312.9(217. 4)</w>
[33 %])</w>
[31] P</w>
[3. 62</w>
[3. 5-
[3.5- -19.
[3.5--19. 5]</w>
[3. 5%]</w>
[3. 4-
[3.4- 8.
[3.4-8. 6]</w>
[3. 4
[3.4 %]).</w>
[3. 1.0]</w>
[3. 1-1
[3.1-1 4.
[3.1-14. 4]</w>
[3-(di ethyl</w>
[3- [
[3-[ (1,
[3-[(1, 1-di
[3-[(1,1-di methylethyl)amino]-2-hydroxypropoxy]-1,3-dihydro-2H-benzimidazole-2-one</w>
[3- Amino-
[3-Amino- 2-(2-hydroxyethyl
[3-Amino-2-(2-hydroxyethyl )-
[3-Amino-2-(2-hydroxyethyl)- 2
[3-Amino-2-(2-hydroxyethyl)-2 H-
[3-Amino-2-(2-hydroxyethyl)-2H- pyrazol-1-ium-1-yl]methyl]-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetylamino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate</w>
[3- 3H]
[3-3H] glucose)</w>
[3- -13
[3--13 ]</w>
[3- (3-
[3-(3- hydroxyphenyl)-N-n-propylpiperidine]</w>
[3- (2-chloroethyl
[3-(2-chloroethyl )-3-
[3-(2-chloroethyl)-3- nitrosoureido]-D-glucopyranose)</w>
[3- (2-
[3-(2- morpholino-ethyl-amino)-4-cyano-6-phenyl-pyridazine],</w>
[3 ].</w>
[3 ])</w>
[3 T
[3T C];</w>
[3 9.1</w>
[3 8.6</w>
[3 8.3</w>
[3 8.
[38. 2%]</w>
[3 8-
[38- 91
[38-91 %]</w>
[3 7.4</w>
[3 7.
[37. 1]</w>
[3 60</w>
[3 5.1</w>
[3 5.
[35. 6-
[35.6- 58.
[35.6-58. 5]</w>
[3 4.0-
[34.0- 42.
[34.0-42. 3]</w>
[3 4
[34 %]</w>
[3 3</w>
[3 3.9-
[33.9- 4
[33.9-4 2.0
[33.9-42.0 ]</w>
[3 26</w>
[3 2
[32 %]);</w>
[3 1.7</w>
[3 1.5</w>
[3 0.1</w>
[3 0-
[30- 245</w>
[27 %]</w>
[26- 92</w>
[26- 80]</w>
[22 ].</w>
[22 %]</w>
[2. 89</w>
[2. 50</w>
[2. 35</w>
[2. 3-
[2.3- 5.7
[2.3-5.7 ]</w>
[2. 23</w>
[2. 2-
[2.2- 3.7
[2.2-3.7 ]).</w>
[2. 1%]</w>
[2. 0-
[2.0- 3.6
[2.0-3.6 ]),</w>
[2-[4- methoxy-4-[[(R)-phenylsulphinyl]methyl]-1-piperidinyl]ethyl]-1H-indole</w>
[2-[4- [(R,S)-
[2-[4-[(R,S)- 5,
[2-[4-[(R,S)-5, 11-
[2-[4-[(R,S)-5,11- dihydro-6(6H)-oxodibenz[b,e]azepin-11-yl]-1-piperazinyl]-2-oxoethyl]cyclopentyl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl]ethyl]argininamide</w>
[2-[4- [(2-
[2-[4-[(2- carboxyethyl)phenyl]ethylamino]-5'-N-ethylcarboxamidoadenosine;</w>
[2-(6- methyl-2-pyridyl)ethyl]-4-methylsulfonylaminobenzoyl)-piperidine),</w>
[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2- (di
[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(di amino)ethylamine)</w>
[2-(3,4- dicholophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylam</w>
[2-(1- pyrrolidinyl)</w>
[2-(1- benzylpiperidin-4-yl)ethyl]-2,3-dihydro-9-methoxy-1H-pyrrolo[3,4-b]quinolin-1-one</w>
[2- morpholino-ethlamino]-4-methyl-6-phenyl-pyridazine</w>
[2- ethoxy-5-(morpholinylacetyl)</w>
[2- C]</w>
[2- 3
[2-3 H]</w>
[2- (di
[2-(di propylamino)ethyl]-2-indolinone</w>
[2- (13)
[2-(13) C]
[2-(13)C] uracil</w>
[2,3- dioxo-7-(1H-imidazol-1-yl)-6-nitro-1,2,3,4-tetrahydro-1-quinoxalinyl]-acetic</w>
[2,3- dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone),</w>
[2,3- d]pyrimidin-4-yl]amine</w>
[2,1- a]</w>
[2 ].</w>
[2 ])</w>
[2 S-
[2S- 2-amino-
[2S-2-amino- 2-
[2S-2-amino-2- (1
[2S-2-amino-2-(1 S,2
[2S-2-amino-2-(1S,2 S-2-
[2S-2-amino-2-(1S,2S-2- carboxycyclopropyl-1-yl)-3-(xanth-9-yl)</w>
[2 1%;</w>
[2 0.9
[20.9 ]</w>
[1998 a1998a]</w>
[199 1]</w>
[19 %]</w>
[19 %]),</w>
[18]-FDG- PET,</w>
[18 %]</w>
[18 %]),</w>
[17. 8%])</w>
[17. 7]</w>
[15 1/
[151/ 17
[151/17 4]</w>
[15 1.2</w>
[15 %]</w>
[15 %])</w>
[14C]- taurocholate</w>
[14C]- alpha-aminoisobutyrate</w>
[14C]- 2</w>
[14C] taurocholic</w>
[14C] taurocholate</w>
[14C] p-aminohippuric</w>
[14C] inulin</w>
[14C] glycocholic</w>
[14C] diclofenac</w>
[14C] biliary</w>
[14C] DAVA</w>
[14C] 2DG</w>
[14C] 2-deoxy-D-glucose</w>
[14. 6
[14.6 %]</w>
[14. 3
[14.3 %],</w>
[14 ]</w>
[14 ]-C</w>
[14 9/
[149/ 17
[149/17 6],</w>
[14 8
[148 0.4</w>
[14 %],</w>
[13 ]</w>
[13 ].</w>
[13 3-1
[133-1 81</w>
[125I] pindolol)</w>
[125I] cholyldiglycylhistamine</w>
[125I] RTI-55</w>
[125I] MIBG</w>
[125I] C1q</w>
[125I ]</w>
[125I ]-alpha-bungarotoxin</w>
[12 ]</w>
[12 5/
[125/ 16
[125/16 1])</w>
[12 3
[123 I]
[123I] I
[123I]I BZ
[123I]IBZ M</w>
[11C]-car fentanil,</w>
[11C] diprenorphine</w>
[11C] diprenorphine.</w>
[11C] Raclopride</w>
[11. 5]</w>
[11. 4
[11.4 %])</w>
[11. 3]</w>
[11 beta-[p-(dimethylamino)</w>
[11 ]</w>
[11 7.6</w>
[11 3-
[113- 33
[113-33 2]</w>
[10 ]).</w>
[10 %],</w>
[10 %])</w>
[10 %]);</w>
[10 %]).</w>
[1.5- 4.
[1.5-4. 4],</w>
[1.5- 2.5
[1.5-2.5 ]),</w>
[1.3 5-2.
[1.35-2. 49
[1.35-2.49 ]).</w>
[1.3 1-18.
[1.31-18. 68
[1.31-18.68 ],</w>
[1-14C] arachidonic</w>
[1-14C] acetate</w>
[1-11C] Acetate</w>
[1-(14)C] pyruvate</w>
[1-(14)C] pyruvate,</w>
[1-(14)C] palmitoylcarnitine,</w>
[1-(14)C] palmitoyl-CoA</w>
[1-(14)C] octanoate</w>
[1- [2-[4-[(R,S)-5,11-dihydro-6(6H)-oxodibenz[b,e]azepin-11-yl]-1-piperazinyl]-2-oxoethyl]cyclopentyl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl]ethyl]argininamide</w>
[1- 7]</w>
[1- 4]</w>
[1- 39
[1-39 ]</w>
[1- (R)-
[1-(R)- [(3-
[1-(R)-[(3- cyclohexylmethyl)hydroxyphosphinyl]-2-(S)-</w>
[1- (4-chloro
[1-(4-chloro phenoxy)]ethyl]-1,2,4-triazolo(1,5-alpha)pyrimidine,</w>
[1- (4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-
[1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H- 2,3-benzodiazep
[1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazep ine]</w>
[1- (2,
[1-(2, 6-
[1-(2,6- dichlorophenoxy)-ethyl]-2-imidazoline</w>
[1,5- d][1,2,4]triazine</w>
[1,4] benzoxazine-6-carboxylic</w>
[1,4] benzodiazepine-3-carboxamide</w>
[1,25(OH)2D ],</w>
[1,24-(OH)(2) D(3)],</w>
[1,24-(OH)(2) D(2)],</w>
[1,2,4]- oxadiazolo-:[4,3-a]</w>
[1,2,4] oxadiazolo[4,3-a]quinoxalin-1-one)</w>
[1, 5
[1,5 a]</w>
[1, 4]</w>
[1, 165</w>
[1 ].</w>
[1 ],</w>
[1 0.7
[10.7 %]),</w>
[1 '-
[1'- admantyl]-1-aminomethyl-3,4-dihydro-5,6-dihydroxy-1H-2-benzo</w>
[0.8 4]</w>
[0.8 15</w>
[0.7 57</w>
[0.7 1]).</w>
[0.7 0-1
[0.70-1 .0
[0.70-1.0 7
[0.70-1.07 ]),</w>
[0.6 9]</w>
[0.6 2]</w>
[0.6 25,</w>
[0.6 1]</w>
[0.6 0]</w>
[0.28- 0.7
[0.28-0.7 3]</w>
[0.28- 0.6
[0.28-0.6 2]</w>
[0.2 6-
[0.26- -3.
[0.26--3. 2],</w>
[0. 27
[0.27 ]</w>
[0. 18-
[0.18- 2.4
[0.18-2.4 1]</w>
[0. 17-
[0.17- 0.6
[0.17-0.6 4]</w>
[0. 11-
[0.11- 0.3
[0.11-0.3 3]</w>
[0- 5
[0-5 ])</w>
[0- 4],</w>
[-1 3.3
[-13.3 %])</w>
[- 3]</w>
[- 27.
[-27. 4%
[-27.4% ];</w>
[+ 7</w>
[+ 10</w>
[+ )-4-
[+)-4- propyl-9-hydroxynaphthoxazine)</w>
[(pF)Phe(4)] nociceptin(1-13)NH(2)</w>
[(pF)Phe(4)] nociceptin(1-13)NH(2),</w>
[(pF)Phe (4)
[(pF)Phe(4) A
[(pF)Phe(4)A ib(7)Arg(14)Lys(15)]N/OFQ-NH(2)</w>
[(R,S)-3,4-DCPG ]</w>
[(R,S)-3,4-DCPG ],</w>
[(R,S)- (2-
[(R,S)-(2- iodo-5-nitrophenyl)-[1-((1-methyl-piperidin-2-yl)methyl)-1H-indol-3-yl]-methanone]</w>
[(E)-1- (diphenyl
[(E)-1-(diphenyl methyl)-4-(3-phenyl-2-propenyl)-piperazine],</w>
[(E)-1- (
[(E)-1-( bis-(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)-piperazine],</w>
[(35)S] TBP
[(35)S]TBP S-
[(35)S]TBPS- specific</w>
[(3- pentyloxy)carbonyloxymethyl-5-acetyl-2-n-propyl-3-[2'(1H</w>
[(3- cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-2-pyrazinecarboxamide)</w>
[(3)H]- quinuclidinyl</w>
[(3)H]- pirenzepine,</w>
[(3)H]- citrulline</w>
[(3)H]- arginine</w>
[(3)H]- arginine,</w>
[(3)H]- TdR</w>
[(3)H]- R-
[(3)H]-R- alpha-methylhistamine</w>
[(3)H]- NMS</w>
[(3)H]- AF-DX384</w>
[(3)H] saxitoxin</w>
[(3)H] quinuclidinyl</w>
[(3)H] pirenzepine,</w>
[(3)H] overflow</w>
[(3)H] overflow.</w>
[(3)H] overflow,</w>
[(3)H] nicotine</w>
[(3)H] flunitrazepam</w>
[(3)H] dopamine.</w>
[(3)H] digitoxin</w>
[(3)H] clonidine</w>
[(3)H] apomorphine.</w>
[(3)H] PK
[(3)H]PK -11
[(3)H]PK-11 195</w>
[(3)H] Flunitrazepam</w>
[(3)H] D
[(3)H]D TBZ</w>
[(3)H] AF-DX384</w>
[(3 beta,16beta,17alpha,18beta,20alpha)-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic</w>
[(3 aR,9bS)-N[4-(8-cyano-1,3a,4,9b-tetrahydro-3H-benzopyrano[3,4-c]pyrrole-2-yl)-butyl](4-phenyl)benzamide]</w>
[(3 R,
[(3R, 6
[(3R,6 R)-
[(3R,6R)- 6-
[(3R,6R)-6- methyl-5-oxo-thiomorpholinyl]</w>
[(3 '-
[(3'- oxo-4-butenyl-4-methyl-Thr1)-(Val2)-cyclosporin]</w>
[(2- methyl-8-quinolinyl)</w>
[(15) O]</w>
[(15) O]
[(15)O] H(2)O.</w>
[(14)C] succinate</w>
[(14)C] phenylalanine</w>
[(125)I] epibatidine</w>
[(125)I] RTI-1
[(125)I]RTI-1 21-
[(125)I]RTI-121- labeled</w>
[(125)I] RTI-
[(125)I]RTI- 55-
[(125)I]RTI-55- labeled</w>
[(125)I] CGP</w>
[(125)I] AM
[(125)I]AM 13-
[(125)I]AM13- 52</w>
[(-)-2- oxa-4-aminobicyclo</w>
[(-)-2- beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane</w>
[(-)- trans-6,7,7a,8,</w>
[(-)- 2-(
[(-)-2-( (4-
[(-)-2-((4- (2,
[(-)-2-((4-(2, 6-Di
[(-)-2-((4-(2,6-Di -1-pyrrolidinyl-4-pyrimidinyl)
[(-)-2-((4-(2,6-Di-1-pyrrolidinyl-4-pyrimidinyl) -1-piperazinyl)
[(-)-2-((4-(2,6-Di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl) methyl)-3,4-dihydro-2,3,7,8-tetramethyl-2H-1-benzopyran-6-ol,</w>
[(+/-)- trans-3-(3,4-dichlorophenyl)-N-methyl-l-indanamine,</w>
[(+/-)- [7-(N,N-dipropylamino)-5,6,7,8-tetrahydro-</w>
[(+/-)- 6-chloro-
[(+/-)-6-chloro- 7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benz
[(+/-)-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benz azepine</w>
[(+)- CQ</w>
[(+)- (5
[(+)-(5 alpha,7alpha,8b)-(+)-N-methyl-N[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]</w>
[(+) 1.2-
[(+)1.2- bis(3.5-dioxopiperazinyl-l-yl)propane]</w>
[(+) -1,2-bis(3,5-dioxopiperazinyl-1-yl)prop
[(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)prop ane]</w>
[(+) -1,2-bis(3,5-di
[(+)-1,2-bis(3,5-di oxopiperazinyl-1-yl)]propane</w>
[(+) -1,2-bis(3,
[(+)-1,2-bis(3, 5</w>
[" toxicity"</w>
[" therapeutic</w>
[" fat</w>
[ with</w>
[ weighted</w>
[ visual</w>
[ vincristine/doxorubicin/dexamethasone],</w>
[ two</w>
[ two-tail]</w>
[ trans-(-)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamine],</w>
[ train-of-four</w>
[ threo-8-[1-(4-hydroxyphenyl)-1-hydroxy-propan-2-yl]-1-phenyl-1,3,8-triazaspiro[4,5]decane-4-one]</w>
[ thoracic</w>
[ theophylline-2-ethylenediamine]-induced</w>
[ the</w>
[ temporal</w>
[ t</w>
[ t(3;19)],</w>
[ systolic</w>
[ superoxide</w>
[ stroke,</w>
[ steroid</w>
[ serum</w>
[ seated</w>
[ sc]),</w>
[ saline],</w>
[ ring-14C]APAP.</w>
[ relative</w>
[ recombinant</w>
[ rapid</w>
[ range]:</w>
[ protective</w>
[ progressive</w>
[ progression-free</w>
[ pregnancy</w>
[ posttetanic</w>
[ postnatal</w>
[ polychlorinated</w>
[ phenobarbital</w>
[ pentylenetetrazole</w>
[ pegylated</w>
[ p=0.006,</w>
[ p.o.]),</w>
[ one</w>
[ omega</w>
[ nucleus</w>
[ norZTP;</w>
[ no</w>
[ nine</w>
[ near</w>
[ nNOS(-/-)]</w>
[ myocardial</w>
[ muscle:heart]),</w>
[ morning</w>
[ moderate];</w>
[ minimum</w>
[ mild]</w>
[ methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'-(5-methyl-1,2</w>
[ medical</w>
[ maximum</w>
[ macrophages,</w>
[ m-fluoroamphetamine</w>
[ log-rank</w>
[ less</w>
[ left</w>
[ interferon-gamma</w>
[ intact,</w>
[ inspired</w>
[ inositol</w>
[ induced</w>
[ incremental</w>
[ imidazoline</w>
[ ie,</w>
[ i.v.]</w>
[ i.p.])</w>
[ i.e.,</w>
[ hypoglycemic</w>
[ high</w>
[ gradient</w>
[ glutathione</w>
[ glomerular</w>
[ former</w>
[ forced</w>
[ fluorouracil,</w>
[ fluorescein</w>
[ fixed</w>
[ first</w>
[ fasciculation</w>
[ excess</w>
[ etiology</w>
[ electrophysiologic</w>
[ eight</w>
[ e.g.</w>
[ e.g.,</w>
[ dose</w>
[ dimethyl</w>
[ diltiazem</w>
[ difference</w>
[ diabetes</w>
[ delta-aminolevulinic</w>
[ delayed</w>
[ delayed-matching-to-sample</w>
[ ddI]</w>
[ d4T];</w>
[ cytolysis</w>
[ cyclophosphamide/doxorubicin/dexamethasone],</w>
[ cumulative</w>
[ crude</w>
[ correction</w>
[ convulsions,</w>
[ conditioned</w>
[ chronic</w>
[ characteristic</w>
[ central</w>
[ causes</w>
[ catalase</w>
[ cardiac</w>
[ c]</w>
[ benzilic-4,4'-3H])</w>
[ beats</w>
[ b]</w>
[ bDNA]</w>
[ at</w>
[ applied</w>
[ an</w>
[ also</w>
[ alpha-methylnorepinephrine</w>
[ adriamycin</w>
[ a]anthracene-induced</w>
[ a]),</w>
[ [3-Amino-2-(2-hydroxyethyl)-2H-pyrazol-1-ium-1-yl]methyl]-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetylamino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate</w>
[ ZTP;</w>
[ ZD
[ZD V]</w>
[ Vcf
[Vcf ]:</w>
[ VCM
[VCM s]),</w>
[ VAC
[VAC V</w>
[ Urograf
[Urograf in])</w>
[ Unified</w>
[ Toxicol.</w>
[ TI
[TI Q
[TIQ ],</w>
[ T1-
[T1- T2];</w>
[ T.</w>
[ Sty
[Sty les</w>
[ STAT
[STAT ]-induced</w>
[ SM
[SM M
[SMM ])</w>
[ SH(-)</w>
[ SF
[SF -12
[SF-12 ]),</w>
[ SERCA2
[SERCA2 ]),</w>
[ SC
[SC r]</w>
[ S.
[S. E.</w>
[ S(+)-ketoprofen</w>
[ RyR
[RyR s]),</w>
[ Ropivacaine</w>
[ R-(+)-
[R-(+)- 7-
[R-(+)-7- bromo-8-hydroxy-3-</w>
[ QTc
[QTc ]</w>
[ Q-AM
[Q-AM I
[Q-AMI ])</w>
[ Published</w>
[ Psychopharmac
[Psychopharmac ol.</w>
[ PRO
[PRO M
[PROM ],</w>
[ PPARalpha-
[PPARalpha- /-
[PPARalpha-/- ]</w>
[ PO
[PO ]</w>
[ PM
[PM L])</w>
[ PG
[PG WB
[PGWB ]</w>
[ PEGS
[PEGS OD
[PEGSOD ],</w>
[ PEAR
[PEAR L
[PEARL S]</w>
[ PAS
[PAS +
[PAS+ ]</w>
[ PAN
[PAN ]</w>
[ P=0.001,</w>
[ P.</w>
[ Odds</w>
[ OR</w>
[ OI
[OI H]
[OIH] ).</w>
[ OD
[OD ])</w>
[ O/
[O/ E]</w>
[ O'Bri
[O'Bri en,</w>
[ O
[O H]
[OH] (2)
[OH](2) D(3))</w>
[ Nat
[Nat .</w>
[ NY
[NY HA
[NYHA ]</w>
[ NTG
[NTG ];</w>
[ NOS
[NOS 3
[NOS3 ]),</w>
[ NMDA
[NMDA ]</w>
[ NI
[NI HS
[NIHS S]</w>
[ NBQ
[NBQ X
[NBQX ]).</w>
[ NA,</w>
[ NA
[NA G
[NAG ],</w>
[ N.</w>
[ N-methyl-
[N-methyl- 3
[N-methyl-3 (
[N-methyl-3( thyomethylphenyl)cyanamide]</w>
[ N-acetyl-
[N-acetyl- l-tryptophan</w>
[ N,N'-
[N,N'- bis(1-methylethyl)phosphordiamidic</w>
[ N,</w>
[ Myocet</w>
[ Moy</w>
[ Mor
[Mor an</w>
[ Mo(t
[Mo(t )]</w>
[ Mean
[Mean +/-
[Mean+/- Standard</w>
[ Me
[Me hta</w>
[ MR
[MR T
[MRT ]</w>
[ MP,</w>
[ MB
[MB s])</w>
[ MAP</w>
[ Lys
[Lys 1,</w>
[ Long</w>
[ Lactate</w>
[ LRS
[LRS ])</w>
[ LDH
[LDH ],</w>
[ L.</w>
[ L-Dopa
[L-Dopa ],</w>
[ K(+)
[K(+) ](o),</w>
[ K
[K well])</w>
[ J</w>
[ J.</w>
[ Influence</w>
[ Id
[Id ],</w>
[ IR
[IR R]</w>
[ INR
[INR ]),</w>
[ ICI
[ICI ],</w>
[ ICD-10
[ICD-10 :</w>
[ HUS
[HUS ]).</w>
[ HU
[HU ])</w>
[ HSP
[HSP ]).</w>
[ HR,</w>
[ HITT
[HITT ]</w>
[ HCV
[HCV ]-positive),</w>
[ HB
[HB V]</w>
[ HAAR
[HAAR T
[HAART ]).</w>
[ HA</w>
[ H+</w>
[ Group</w>
[ Glasgow</w>
[ GTN
[GTN ;</w>
[ GSSG/GSH</w>
[ GR
[GR ])</w>
[ GP
[GP x]</w>
[ G-
[G- (3)H]
[G-(3)H] heparin</w>
[ Fischer</w>
[ Experiments</w>
[ Es
[Es ]citalopram</w>
[ Eastern</w>
[ EP
[EP S])</w>
[ ELIS
[ELIS A])</w>
[ EF
[EF ]:</w>
[ ED
[ED (
[ED( min)]</w>
[ ECG
[ECG ])</w>
[ EB
[EB GM
[EBGM ]</w>
[ E-
[E- 8-
[E-8- (3,4-dimethoxy
[E-8-(3,4-dimethoxy styryl)-1,3-dipropyl-7-methylxanthine]</w>
[ Diagnostic</w>
[ DTR
[DTR ])</w>
[ DO
[DO PA]</w>
[ DES
[DES ])</w>
[ Cros
[Cros sman</w>
[ Cr
[Cr l:</w>
[ Confidence</w>
[ Co
[Co oper</w>
[ Cl-]
[Cl-] in</w>
[ Cl
[Cl ],</w>
[ CaCl
[CaCl (2)
[CaCl(2) ]-,</w>
[ Ca2+
[Ca2+ ]</w>
[ Ca(2+
[Ca(2+ )]</w>
[ CT
[CT ])-guided,</w>
[ CL
[CL ],</w>
[ CD25
[CD25 ])</w>
[ CC
[CC ]</w>
[ CA
[CA (F
[CA(F )]</w>
[ Brown</w>
[ Bi
[Bi ochem</w>
[ BFU-
[BFU- E
[BFU-E ]),</w>
[ B(t
[B(t )]</w>
[ Arn
[Arn dt</w>
[ Ang-(1-7
[Ang-(1-7 )]</w>
[ Anderson</w>
[ Am
[Am ado,</w>
[ Addiction</w>
[ Ac-RY(3-Cl)YRWR-NH
[Ac-RY(3-Cl)YRWR-NH 2]</w>
[ Abbott,</w>
[ AV
[AV ]</w>
[ AST
[AST ]</w>
[ AS
[AS AT
[ASAT ])</w>
[ ANF
[ANF ]</w>
[ AN
[AN C]</w>
[ ALT
[ALT ],</w>
[ ALN+D2800
[ALN+D2800 ]),</w>
[ ALN+
[ALN+ D56
[ALN+D56 00
[ALN+D5600 ]</w>
[ AL
[AL AT
[ALAT ]</w>
[ AH
[AH I
[AHI ],</w>
[ A/J,</w>
[ >30</w>
[ <</w>
[ 96.
[96. 1
[96.1 %]).</w>
[ 96
[96 %]</w>
[ 95</w>
[ 9/
[9/ 16
[9/16 3]</w>
[ 9.7</w>
[ 9.4</w>
[ 9.2</w>
[ 9.1</w>
[ 9-1
[9-1 1]</w>
[ 9-
[9- (1,3-di
[9-(1,3-di hydroxy-2-propoxy)methylguanine,</w>
[ 9,
[9, 10
[9,10 (n
[9,10(n )-
[9,10(n)- 3H]
[9,10(n)-3H] palmitate</w>
[ 9%</w>
[ 8</w>
[ 88
[88 %])</w>
[ 87
[87 %])</w>
[ 86
[86 %];</w>
[ 83</w>
[ 80%])</w>
[ 8.3%</w>
[ 8-1
[8-1 9]</w>
[ 8-(p-
[8-(p- (O
[8-(p-(O H)-
[8-(p-(OH)- phenylpropionyl)]-</w>
[ 8-
[8- arginine]vasopressin</w>
[ 78
[78 %]).</w>
[ 76.
[76. 3
[76.3 %]</w>
[ 70</w>
[ 7.7
[7.7 ]</w>
[ 7.5</w>
[ 7.3</w>
[ 7.08</w>
[ 67-1
[67-1 80]</w>
[ 64</w>
[ 64
[64 %]</w>
[ 63.
[63. 0%</w>
[ 60
[60 %]);</w>
[ 6.9</w>
[ 6.
[6. 9]</w>
[ 6-1
[6-1 4C]
[6-14C] glucose</w>
[ 6,7-
[6,7- 3H]
[6,7-3H] ethynylestradiol</w>
[ 59</w>
[ 59
[59 /
[59/ 154
[59/154 ])</w>
[ 58.
[58. 2%]</w>
[ 58
[58 %]).</w>
[ 57</w>
[ 56
[56 %];</w>
[ 55.
[55. 5%]</w>
[ 54%-
[54%- 94
[54%-94 %]</w>
[ 53
[53 %]).</w>
[ 52%-
[52%- 87
[52%-87 %]),</w>
[ 50
[50 %]</w>
[ 5.5-
[5.5- 23]</w>
[ 5-fluoro
[5-fluoro -3-
[5-fluoro-3- [2-[4-methoxy-4-[[(R)-phenylsulphinyl]methyl]-1-piperidinyl]ethyl]-1H-indole</w>
[ 5-Fluorouracil</w>
[ 5-1
[5-1 4C]
[5-14C] mevalonate</w>
[ 5%
[5% ]).</w>
[ 49.
[49. 8</w>
[ 49
[49 %]</w>
[ 48
[48 %])</w>
[ 46.2%</w>
[ 45</w>
[ 45
[45 Ca
[45Ca ]CaCl(2)</w>
[ 43</w>
[ 40</w>
[ 40-
[40- 240</w>
[ 40
[40 %]</w>
[ 3.6
[3.6 %],</w>
[ 3.2</w>
[ 3.09</w>
[ 3,5-
[3,5- dichloro-4-oxo-1(4H)-pyridyl]-acetamido)-3-([(5-methyl-1,3,4-thiadiazol-2-yl)-thio]methyl)-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic</w>
[ 3,
[3, 96
[3,96 ]</w>
[ 29</w>
[ 29.4</w>
[ 28
[28 3.0</w>
[ 25(OH)D
[25(OH)D ]</w>
[ 25%</w>
[ 24.
[24. 1%]</w>
[ 24-h</w>
[ 24,25-(OH)2D
[24,25-(OH)2D 3]</w>
[ 24
[24 -14C]
[24-14C] sodium</w>
[ 23</w>
[ 230</w>
[ 212</w>
[ 20mg/kg,</w>
[ 20.0
[20.0 %],</w>
[ 2/
[2/ 15
[2/15 6]</w>
[ 2.3</w>
[ 2-1
[2-1 2])</w>
[ 2,3,4-
[2,3,4- Tri
[2,3,4-Tri methoxy-benzyl]</w>
[ 19</w>
[ 197</w>
[ 19.5</w>
[ 19-nor-
[19-nor- pregn-4-ene-3,20-dione</w>
[ 18-
[18- 54
[18-54 ]</w>
[ 17beta-
[17beta- E
[17beta-E (2)
[17beta-E(2) ])</w>
[ 17</w>
[ 17/
[17/ 10
[17/10 6
[17/106 ];</w>
[ 17-
[17- 44]</w>
[ 16/
[16/ 104
[16/104 ]).</w>
[ 16-
[16- 44]</w>
[ 16
[16 7.1</w>
[ 15.
[15. 2%;</w>
[ 14</w>
[ 14.0
[14.0 ]</w>
[ 131
[131 I]
[131I] cholyltetraglycylhistamine</w>
[ 13-
[13- 38
[13-38 ]</w>
[ 125</w>
[ 12.
[12. 3]</w>
[ 10.0
[10.0 ]</w>
[ 10-
[10- 32]</w>
[ 1.8-
[1.8- 3.5
[1.8-3.5 ]),</w>
[ 1.7</w>
[ 1.7
[1.7 ]</w>
[ 1.4-
[1.4- 39.
[1.4-39. 3]</w>
[ 1.3-
[1.3- -18.
[1.3--18. 6]</w>
[ 1.25</w>
[ 1.20,</w>
[ 1.1</w>
[ 1.04-1.
[1.04-1. 74
[1.04-1.74 ],</w>
[ 1.00
[1.00 ],</w>
[ 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrid
[1-methyl-4-phenyl-1,2,3,6-tetrahydropyrid ine].</w>
[ 1,25-(OH)2D
[1,25-(OH)2D 3]</w>
[ 1,25(OH)(2)
[1,25(OH)(2) D(3)
[1,25(OH)(2)D(3) ]-induced</w>
[ 1+</w>
[ 1%</w>
[ 0]</w>
[ 0.90
[0.90 ]</w>
[ 0.56-1.
[0.56-1. 26
[0.56-1.26 ]),</w>
[ 0.5
[0.5 3--
[0.53-- 7.
[0.53--7. 9]</w>
[ 0.45</w>
[ 0.42-
[0.42- 0.7
[0.42-0.7 9
[0.42-0.79 ];</w>
[ 0.4
[0.4 2]</w>
[ 0.3
[0.3 4-3.
[0.34-3. 2]</w>
[ 0.16</w>
[ 0.018</w>
[ -3</w>
[ -3
[-3 3.3</w>
[ -2
[-2 0.1
[-20.1 %];</w>
[ -16.
[-16. 6
[-16.6 %])</w>
[ -1.0</w>
[ -0.7
[-0.7 9</w>
[ -0.4</w>
[ +/-1
[+/-1 5.8
[+/-15.8 ]</w>
[ +/-
[+/- SD]</w>
[ (alpha</w>
[ (TP)</w>
[ (SR
[(SR C)</w>
[ (S)-(-)-
[(S)-(-)- 3-bromo-
[(S)-(-)-3-bromo- N-[(1-ethyl-2-
[(S)-(-)-3-bromo-N-[(1-ethyl-2- pyrrolidinyl)methyl]-2,6-dimethoxybenz</w>
[ (R)-1-
[(R)-1- hydroxyethyl]-2-[(3S,5S)-5(S-methyl-4thiomorpholin</w>
[ (R)-
[(R)- N-
[(R)-N- (2</w>
[ (PB)</w>
[ (NBU)</w>
[ (FANFT)</w>
[ (DZR),</w>
[ (DES)</w>
[ (CK-MB</w>
[ (BA)</w>
[ (B
[(B B)</w>
[ (AB
[(AB )</w>
[ (8R,15S)-di
[(8R,15S)-di HETE
[(8R,15S)-diHETE ]</w>
[ (71%)</w>
[ (6
[(6 R)-
[(6R)- 5,10-
[(6R)-5,10- dideaza-5,6,7,8-tetrahydrofolate]</w>
[ (3)
[(3) H]</w>
[ (2R,4R)-
[(2R,4R)- APD
[(2R,4R)-APD C]</w>
[ (29%)</w>
[ (1</w>
[ (18)
[(18) F]
[(18)F] fluoro-D-glucose</w>
[ (147</w>
[ (14)
[(14) C]</w>
[ (-)</w>
[ (+/-)-2-carboxypiperazin-4-
[(+/-)-2-carboxypiperazin-4- yl]</w>
[ (+)</w>
[ (+)-CP
[(+)-CP CA
[(+)-CPCA ].</w>
Zuc kerkandl)</w>
Zopiclon e-induced</w>
Zopiclon e,</w>
Zomep irac-related</w>
Zomep irac-induced</w>
Zn t3/Mt3</w>
Zn SOD</w>
Zn SOD)-
ZnSOD)- overexpressed</w>
Zn 2+</w>
Zn -</w>
Zn )</w>
Zn (2+
Zn(2+ ),</w>
Ziprasid one</w>
Ziprasid one-</w>
Zinec ard</w>
Zinec ard,</w>
Zidovud ine-associated</w>
Zicon otide</w>
Zicon otide:</w>
Zer o</w>
Zer o-inflated</w>
Zeal and,</w>
Ze iss</w>
Zangrad o,</w>
Zafirlukast -induced</w>
Zafirlukast ,</w>
ZT P,</w>
ZI- LH,</w>
ZD V-induced</w>
ZD V-containing</w>
ZD V
ZDV -mediated</w>
Z- plasty,</w>
Z- amplitude</w>
Z- V
Z-V D-
Z-VD- fmk</w>
Z- Phenyl
Z-Phenyl alanyl-arginine-7-amido-4-methylcoumarin</w>
Z- E),</w>
Z)- refractory,</w>
Z)- monotherapy</w>
Z yprexa,</w>
Z usanli</w>
Z urich</w>
Z u</w>
Z tm</w>
Z ones</w>
Z onal</w>
Z ona</w>
Z ofenopril</w>
Z ingiberis</w>
Z inc,</w>
Z imeldine,</w>
Z ileuton</w>
Z i-Tang</w>
Z hejiang,</w>
Z eynep</w>
Z etterlund,</w>
Z enker-Formol</w>
Z elandopam</w>
Z c).</w>
Z arisch</w>
Z akitabine</w>
Z airian)</w>
Z Z),</w>
Z Rs,</w>
Z Rs)</w>
Z Rs).</w>
Z P.</w>
Z MI)</w>
Z M</w>
Z M2413
ZM2413 85</w>
Z IO
ZIO -
ZIO- reactive</w>
Z I.</w>
Z ET</w>
Z AS</w>
Z :</w>
Z /E</w>
Z /
Z/ CL
Z/CL Z-treated</w>
Z )+
Z)+ Flut</w>
Youn g-Mania</w>
Yor kshire</w>
Yor k)</w>
Yel low/Transport-deficient</w>
Yang ,</w>
YZ-0 69</w>
YZ-0 69,</w>
YOH ;</w>
YOH -induced</w>
YMSM .</w>
YMSM ).</w>
YM-1615 1-1
YM-16151-1 .</w>
YM-1615 1
YM-16151 -1,</w>
YM-080 50,</w>
YM 264</w>
YKP14 47,</w>
Y719 F)</w>
Y719 F),</w>
Y-0 46</w>
Y-0 46,</w>
Y- null)</w>
Y- mutant</w>
Y- maze.</w>
Y- LI).</w>
Y- BO
Y-BO CS,</w>
Y- 5Y</w>
Y- 25
Y-25 801)</w>
Y udis</w>
Y s)</w>
Y ield</w>
Y ekatit</w>
Y ears</w>
Y early)</w>
Y ear-by-year,</w>
Y ates</w>
Y ates-corrected</w>
Y asmin</w>
Y ale</w>
Y Y</w>
Y VD
YVD D,</w>
Y S-
YS- MTX)</w>
Y N</w>
Y N)</w>
Y L
YL ATED</w>
Y ID
YID D,</w>
Y CI
YCI N,</w>
Y 903/
Y903/ 1087</w>
Y 705</w>
Y 5445</w>
Y (V
Y(V /
Y(V/ I)
Y(V/I) DD
Y(V/I)DD ),</w>
Y "</w>
Xyl azine</w>
Xyl azine-ketamine-induced</w>
Ximel agatran,</w>
XX X
XXX VII.</w>
XI a.</w>
XI X.</w>
XE )],</w>
XD- XO</w>
XD- XO.</w>
X/X- bp</w>
X/X- bp)</w>
X/ coagulation</w>
X/ LAD</w>
X/ Doxil)</w>
X-ra y).</w>
X-100 5,</w>
X- radiation</w>
X- chromosome</w>
X- binding</w>
X- alone</w>
X- VNB</w>
X- O,</w>
X- M)</w>
X- HT)</w>
X- Chromosome</w>
X- CM)</w>
X- C,</w>
X- 4,</w>
X- 4),</w>
X- -in</w>
X ylocaine</w>
X ipamide</w>
X enon-based</w>
X anthine</w>
X agrid)</w>
X YY</w>
X X</w>
X VI.</w>
X T)</w>
X O)</w>
X LI.</w>
X LH.</w>
X LH,</w>
X Ia</w>
X IV)</w>
X IM</w>
X III</w>
X II</w>
X II)</w>
X II),</w>
X I)</w>
X D</w>
X D2</w>
X C)</w>
X A
XA 41),</w>
X 82
X82 100
X82100 2),</w>
X 8
X8 110
X8110 59
X811059 A</w>
X 2-
X2- test).</w>
X 1</w>
X -associated</w>
X );</w>
X ):</w>
X )-
X)- kindling</w>
X (L))</w>
Wy eth</w>
Wy eth-Ayerst,</w>
Wy -14,
Wy-14, 643.</w>
Wy -1
Wy-1 46
Wy-146 43,</w>
Wright- stained</w>
Wright- Gi
Wright-Gi emsa</w>
Wortmann in</w>
Wortmann in)</w>
World wide</w>
World wide,</w>
Work shop</w>
Work place.</w>
Work ers</w>
Wor th</w>
Wor risome,</w>
Wor k</w>
Wor d</w>
Wom en.</w>
Wol ffian</w>
Wol bachia:</w>
Wo olf</w>
Wo odgett,</w>
Within- session</w>
Within- cell</w>
Withdraw ing</w>
Withdraw al-emergent</w>
Withdraw al"</w>
With in-</w>
Wit te,</w>
Wistar/ ST</w>
Wistar- rats.</w>
Wistar- derived</w>
Wistar- M</w>
Wistar- Furth</w>
Wist eria</w>
Wist er</w>
Wist ar]</w>
Wist ar)</w>
Wist ar).</w>
Wiscon sin).</w>
Wis kott-Aldrich</w>
Wis consin,</w>
Wilm 's</w>
Willi ams'</w>
Will is)</w>
Will denow)</w>
Wild ing</w>
Wilcox on.</w>
Wilcox on-Mann-Whitney</w>
Wil ford</w>
Wi reless</w>
Whole- kidney</w>
Whole- brain</w>
Whit worth</w>
Whit es,</w>
Whit e)</w>
Whe rever</w>
Whe ezing</w>
Whe eler</w>
Whe atgerm</w>
Whe al</w>
Wh o</w>
West borough,</w>
Wernicke-Korsak off-like</w>
Wellbutr in,</w>
Well- recognized</w>
Well- known</w>
Well- described</w>
Weigh ted</w>
Week ly,</w>
Week end</w>
Wech sler,</w>
Web ster's</w>
Wean ing</w>
Weak ening</w>
We iss,</w>
We isler's</w>
We ak</w>
Water- replete</w>
Wash -out</w>
Warfar in-treated</w>
Warfar in-related</w>
Warfar in-fluoxetine</w>
War ming</w>
War med,</w>
Wall ace</w>
Wak sman's</w>
Wak ayama</w>
Wag nerian</w>
Wag ner</w>
Wa velet</w>
Wa ve</w>
Wa ve-break</w>
Wa isbren</w>
WY-14, 64
WY-14,64 3,</w>
WTM .</w>
WTM ,</w>
WT- KvLQT1</w>
WT- Epo
WT-Epo R,</w>
WT S-
WTS- 4</w>
WT 1,</w>
WT -like</w>
WR-27 21.</w>
WR-27 21)</w>
WR-10 65,</w>
WR s)</w>
WOR K
WORK :</w>
WM H).</w>
WKY- STZ</w>
WKY- STZ.</w>
WK .</w>
WIPTI DE</w>
WIPTI DE,</w>
WIN-35,065- 2.</w>
WIN-35,065- 2,</w>
WIN- 55,212-2</w>
WIN- 55,212-2,</w>
WIN ),</w>
WIL L
WILL DE
WILLDE NO
WILLDENO W,</w>
WI AT</w>
WH O)</w>
WH IMS</w>
WH IM
WHIM S.</w>
WH ;</w>
WEB20 86</w>
WEB20 86,</w>
WBC/ mm3</w>
WBC/ microliter</w>
WB4 101,</w>
WB RT,</w>
WB Cs</w>
WB Cs,</w>
WB C;</w>
WB C.</w>
WB C,</w>
WB C)</w>
WAY-100 13
WAY-10013 5.</w>
WAY 100</w>
WAR s)</w>
WAI S</w>
WAI S,</w>
WAI CH,</w>
WA HD</w>
W/ W
W/W v</w>
W/ BW</w>
W/ BW),</w>
W. I.
W.I. N.
W.I.N. G
W.I.N.G .-
W.I.N.G.- 99,</w>
W- nitro-L-arginine</w>
W- L-N
W-L-N itroarginine</w>
W- 7,</w>
W- 600
W-600 2;</w>
W v)</w>
W u-Tang</w>
W rithing</w>
W right's</w>
W ords:</w>
W nt-signaling,</w>
W m.</w>
W inter's</w>
W ill</w>
W iley-Liss,</w>
W idening</w>
W hippany,</w>
W hichever</w>
W et-to-dry</w>
W est.</w>
W ender</w>
W ender-Utah</w>
W eight.</w>
W ei,</w>
W edging</w>
W ayne</w>
W arburg</w>
W andering</w>
W alter</w>
W aking</w>
W aiguan,</w>
W ada</w>
W ]</w>
W UR
WUR S</w>
W TT),</w>
W TS
WTS )-1,</w>
W T:</w>
W T1</w>
W T-1</w>
W T,</w>
W SP
WSP /
WSP/ WSR</w>
W S.</w>
W S,</w>
W Q</w>
W Q)</w>
W P-
WP- 4
WP-4 101,</w>
W O,</w>
W N</w>
W MM
WMM HC,</w>
W MH
WMH ;</w>
W M.</w>
W M,</w>
W M)</w>
W M).</w>
W L</w>
W ISH</w>
W IS
WIS C-
WISC- R</w>
W I,</w>
W I),</w>
W G,</w>
W G)</w>
W F
WF )-
WF)- cleaving</w>
W ER)</w>
W E
WE ST)</w>
W DS</w>
W CST,</w>
W CS</w>
W CS
WCS "</w>
W BH
WBH -treated</w>
W B-
WB- 4
WB-4 101</w>
W B,</w>
W AT
WAT CH</w>
W AG</w>
W A-
WA- 33
WA-33 5,</w>
W A)</w>
W )F1</w>
W ):</w>
W ).</w>
Vyvan se</w>
Vyvan se,</w>
Vp 35)</w>
Vp -1
Vp-1 6,</w>
Voric onazole-induced</w>
Voric onazole-associated</w>
Volume -
Volume- loaded</w>
Volt age-gated</w>
Vol untary</w>
Vo ivodeship</w>
Vo gel-type</w>
Vo g.</w>
Vmean /
Vmean/ baseline</w>
Vmean )/
Vmean)/ delta</w>
Viusid )].</w>
Viusid );</w>
Viusi d.</w>
Visc ous)</w>
Visc osity</w>
Vis ualization</w>
Vis ual,</w>
Vis entin</w>
Virgin ia</w>
Vir gin</w>
Vir dex</w>
Vir chow's</w>
Vir amidine,</w>
Vir al,</w>
Viol et-stained</w>
Vinorelb ine-based</w>
Vindes ine:</w>
Vindes ine.</w>
Vincrist ine:</w>
Vincrist ine-sulfate-related</w>
Vincrist ine-associated</w>
Vin nik's</w>
Vigil ant</w>
Vigi B
VigiB ase</w>
Vide otapes</w>
Victor ino</w>
Victor ian</w>
Victor ia/7/83-like</w>
Victor ia,</w>
Victim ization</w>
Vi vid</w>
Vi rilization</w>
Vi ridal.</w>
Vi enna,</w>
Vi als</w>
Vi able</w>
Vi ability</w>
Vglut 3)</w>
Vglut 3
Vglut3 (-/-)</w>
Vesi cular</w>
Vesi coureteral</w>
Vesi cles</w>
Vesi cle</w>
Vesi cal</w>
Ves tibulotoxicity</w>
Vertex- EEG</w>
Vertex- EEG.</w>
Verapam il-mediated</w>
Ver y-high-dose</w>
Ver tebrobasilar</w>
Ver tebral</w>
Ver mont</w>
Ver fied</w>
Ventricu lography,</w>
Ventricu locisternal</w>
Ventric ulography</w>
Ventric ulo-peritoneal</w>
Ventric les</w>
Ventr al</w>
Venti latory</w>
Venlafax ine-propafenone</w>
Venlafax ine-induced</w>
Venlafax ine-associated</w>
Ven ous,</w>
Ven omous</w>
Ven odilator</w>
Ven odilation</w>
Veloc ity-DPOAE</w>
Ved as")</w>
Ved aclidine</w>
Ved a</w>
Vecur onium-induced</w>
Ve h.</w>
Vcf :</w>
Vc f</w>
Vc f,</w>
Vasospas tic</w>
Vasodilat or-Heart</w>
Vasodilat ing</w>
Vascul itic</w>
Vas ovagal</w>
Vas ospasm</w>
Vas omotor</w>
Vas oconstrictions</w>
Varic ocele</w>
Varic ella</w>
Var idase</w>
Var anasi</w>
Vanidi lol:</w>
Vanidi lol,</w>
Vancou ver,</w>
Vancom ycin-related</w>
Vancom ycin-associated</w>
Van inolol:</w>
Van illoid</w>
Van derbilt</w>
Vals artan-induced</w>
Vals artan,</w>
Valpro ic-acid-exposed</w>
Valpro ate,</w>
Valg anciclovir.</w>
Val158 Met</w>
Val158 Met
Val158Met ),</w>
Val noctamide</w>
Val ium)</w>
Val evski-Weizman</w>
Val ette:</w>
Val et</w>
Val decoxib</w>
Val 601</w>
Val /
Val/ Val</w>
Vag us</w>
Vag ue</w>
Vag ally</w>
Vacuol ization</w>
Vacuol ated</w>
Vacu ous</w>
Vacu oles</w>
Vac ous</w>
VT/ VF</w>
VT/ PE).</w>
VT was</w>
VT s.</w>
VT :</w>
VT .(ABSTRACT</w>
VSM C</w>
VR1- transfected</w>
VR- curves</w>
VR- curve</w>
VR s)</w>
VR L-
VRL- based</w>
VR E</w>
VR CZ
VRCZ -associated</w>
VR C</w>
VR )-1</w>
VPA/ ml</w>
VPA/ NH(4+)-treated</w>
VPA- sensitive</w>
VPA- modulated</w>
VPA- hydroxamic</w>
VPA- encephalopathy</w>
VPA- LZP</w>
VPA /g</w>
VPA -containing</w>
VPA -</w>
VP-16-LV- UFT</w>
VP-16-LV- UFT.</w>
VP-1 6.</w>
VP- associated</w>
VP- HNP.</w>
VP- H
VP-H NP,</w>
VP X)</w>
VP F)</w>
VP CARBO</w>
VP ;</w>
VP 16.</w>
VP 16-2
VP16-2 13,</w>
VP -related</w>
VP -16
VP-16 -induced</w>
VP )-related</w>
VP )-
VP)- sensitive</w>
VO2 max)</w>
VO S</w>
VO (2)
VO(2) max</w>
VO (2
VO(2 peak)</w>
VN B-
VNB- containing</w>
VMR T,</w>
VM- 26.</w>
VM H.</w>
VL S.</w>
VL F</w>
VL BW,</w>
VL AC)</w>
VIP 's</w>
VIII c</w>
VIII ,
VIII, IX,</w>
VII a.</w>
VII ,
VII, VIII,IX,</w>
VI th</w>
VI P.</w>
VI P-
VIP- ,</w>
VI ;</w>
VGLUT 3.</w>
VGLUT 3,</w>
VG SC.</w>
VG AT,</w>
VF C.</w>
VF C,</w>
VEN ,</w>
VEN ),</w>
VELOCIT Y,</w>
VEGF/ VEGF</w>
VEGF R-2</w>
VEGF -induced</w>
VEC- MRI,</w>
VE xP,</w>
VE X)</w>
VE V)</w>
VE Ps.</w>
VE P,</w>
VE NT:</w>
VE L-</w>
VE L)</w>
VE H.</w>
VE H,</w>
VE GF-
VEGF- targeted</w>
VE GF,</w>
VE F</w>
VE F),</w>
VE EG</w>
VE D.</w>
VE B</w>
VE .</w>
VDB T.</w>
VDB T,</w>
VD S-
VDS- DDP</w>
VD R)</w>
VD CC
VDCC s.</w>
VCR -treated</w>
VCM s,</w>
VCM s)</w>
VCM .</w>
VCM ,</w>
VCM 's</w>
VCM 's,</w>
VBD S</w>
VAS- score</w>
VAS- Anxiety</w>
VAN ,</w>
VAC V.</w>
VAC UR
VACUR G).</w>
V232 I,</w>
V173 L</w>
V1-V 6,</w>
V1-V 3,</w>
V1- V3</w>
V1- 6.</w>
V1- 3,</w>
V1 V2</w>
V1 M.</w>
V1 M,</w>
V/T V</w>
V/T V)</w>
V/Fn n</w>
V/Fn n)</w>
V/Delta F</w>
V/ sec)</w>
V/ s</w>
V/ s,</w>
V/ SVR</w>
V/ RTV</w>
V/ RT
V/RT V)</w>
V/ Bk</w>
V/ BP</w>
V. N
V.N ull)</w>
V-t k)</w>
V-- ACT</w>
V-- 4,000,000</w>
V- strengthened</w>
V- shaped</w>
V- nodal</w>
V- filled</w>
V- apipuncture</w>
V- STZ)</w>
V- P</w>
V- He
V-He FT</w>
V- DNA)</w>
V- B)</w>
V- ),</w>
V)- seronegative</w>
V)- adefovir</w>
V)- DNA</w>
V(s s)</w>
V(s s),</w>
V v</w>
V ulnerability</w>
V s)</w>
V p35</w>
V oris</w>
V omiting,</w>
V oided</w>
V ocalization</w>
V mca.</w>
V max,</w>
V m.</w>
V itreous</w>
V itis</w>
V itamin-A-induced</w>
V ioxx</w>
V imentin,</w>
V i</w>
V etbutal-anaesthetized</w>
V et,</w>
V erbatim"</w>
V elcade),</w>
V e.</w>
V e,</w>
V b.</w>
V aughn-Williams</w>
V aporizer-equipped</w>
V an</w>
V alley</w>
V al-HeFT</w>
V aginally</w>
V aD</w>
V aD:</w>
V ZI.</w>
V X,</w>
V VI</w>
V SDs</w>
V S/
VS/ LV</w>
V S)</w>
V RBC</w>
V RBC.</w>
V R)</w>
V R),</w>
V PD,</w>
V PB
VPB s</w>
V PAC
VPAC (2)</w>
V P,</w>
V OR</w>
V OD
VOD --was</w>
V MT-
VMT- lesioned</w>
V MR</w>
V MF</w>
V MA,</w>
V M),</w>
V L)</w>
V IQ</w>
V IO
VIO XX</w>
V IN</w>
V IC
VIC TOR</w>
V I:</w>
V I/
VI/ E
VI/E SV
VI/ESV I:</w>
V I).</w>
V HD)</w>
V H.</w>
V H)</w>
V Glu
VGlu T1</w>
V FD
VFD S.</w>
V EC)</w>
V D)</w>
V CP</w>
V CG
VCG s</w>
V CFC</w>
V CB</w>
V C</w>
V B)</w>
V AS)</w>
V AS
VAS -A</w>
V AR
VAR I
VARI AB
VARIAB LE
VARIABLE S:</w>
V ACh
VACh T,</w>
V AB
VAB EC</w>
V A.</w>
V A-treated</w>
V A)</w>
V A),</w>
V A
VA S:</w>
V 6,</w>
V 3-
V3- V6</w>
V 3,</w>
V 1.</w>
V .,</w>
V .)</w>
V -to-
V-to- Y</w>
V )-resistant</w>
V )-positive</w>
V (Le
V(Le iden)</w>
V (1-
V(1- 4)</w>
V (1),</w>
Use ful</w>
Ursodeoxychol ate-3-O-glucuronide</w>
Urograf in,</w>
Uro toxic</w>
Uro logy</w>
Uro kinase</w>
Uro epithelial</w>
Uro dynamically,</w>
Uro dynamic</w>
Uro cortin,</w>
Urinaly sis,</w>
Urinaly ses</w>
Urin ary-bladder</w>
Uri dine-induced</w>
Ureth ritis/Cervicitis</w>
Ureth ane</w>
Ure ters</w>
Ure teritis</w>
Ure ter-ligated</w>
Ur ine,</w>
Ur gency</w>
Ur d.</w>
Ur d-related</w>
Ur d).</w>
Upreg ulated</w>
Upr V</w>
Uppsal a.</w>
Upjohn ;</w>
Upjohn ),</w>
Up- to-date</w>
Up ward</w>
Up swings</w>
Up date</w>
University- based</w>
University- affiliated,</w>
Univers ity.</w>
Univer sity).</w>
Univer sidad</w>
Units/ mL</w>
Units/ mL).</w>
Unit s.</w>
Unit edHealth</w>
Uniqu ely,</w>
Unineph rectomy</w>
Unineph rectomized,</w>
Uni parous,</w>
Uni -</w>
Unex plained</w>
Une ven</w>
Une sterified</w>
Une qual</w>
Under standably</w>
Under sized</w>
Under scoring</w>
Under reporting</w>
Under recognized</w>
Under going</w>
Un usually</w>
Un usually,</w>
Un treated,</w>
Un toward</w>
Un terach,</w>
Un successful</w>
Un selective</w>
Un reported</w>
Un recognised</w>
Un predictable</w>
Un pleasant</w>
Un modified</w>
Un manipulated</w>
Un its</w>
Un ipolar</w>
Un interrupted</w>
Un ilateral,</w>
Un favorable</w>
Un enhanced</w>
Un doubtedly,</w>
Un differentiated</w>
Un diagnosed,</w>
Un detectable</w>
Un consciousness</w>
Un complicated</w>
Un competitive</w>
Un commonly,</w>
Un certainty</w>
Un anesthetized,</w>
Umbil ical</w>
Ultras onic</w>
Ultra- low</w>
Ultra- early</w>
Ultra violet-</w>
Ultra structural,</w>
Ultra m</w>
Ultim ately</w>
Ulcer ation,</w>
Ul udag</w>
Ul tralente</w>
Ul trafiltered</w>
Ul m,</w>
Ul cers</w>
Ul cer</w>
Ugand a</w>
Ud R)</w>
UV- spectrophotometric</w>
UV- B</w>
UT P</w>
UT P,</w>
UT P),</w>
UT E</w>
UT ;</w>
UST O)</w>
USPST F</w>
USPST F)</w>
USPIO .</w>
USPIO )-
USPIO)- enhanced</w>
USPI O)</w>
US- derived</w>
US- based</w>
US- NIH</w>
US DA</w>
US ADE</w>
URO -
URO- E.
URO-E. W.I.N.G.-99,</w>
URE S,</w>
URB59 7;</w>
UR SI
URSI NG
URSING :</w>
UR S)</w>
UR R,</w>
UR ON
URON E</w>
UR G)</w>
UR E</w>
UR ,</w>
UQ 5,</w>
UQ 20</w>
UPL IF
UPLIF T</w>
UPL C/TOF-
UPLC/TOF- MS-
UPLC/TOF-MS- based</w>
UPDRS- IV</w>
UPDRS- IV,</w>
UPDRS- III,</w>
UN X,</w>
UN T</w>
UN DS.</w>
UN DING:</w>
UN DER</w>
UN /
UN/ Ccr)</w>
UN -4
UN-4 6).</w>
UN );</w>
UMD M</w>
UMD M
UMDM )-treated</w>
UK-61,26 0.</w>
UK-61,26 0),</w>
UK-61, 260</w>
UK-38,48 5</w>
UK-38,48 5,</w>
UK SR
UKSR -2
UKSR-2 22)</w>
UK PD
UKPD S</w>
UK ?</w>
UI/ kg</w>
UI/ L.</w>
UG R)</w>
UFP-1 12.</w>
UFP-1 12
UFP-112 -induced</w>
UF H.</w>
UF H-bridged</w>
UF H
UFH -related</w>
UDP-glucuron osyltransferase</w>
UDP- glucuronic</w>
UD PG-
UDPG- transferase</w>
UD EC
UDEC O),</w>
UD CA-treated</w>
UD CA)</w>
UD CA),</w>
UD 1,</w>
UD .</w>
UD ).</w>
UCL AF</w>
UCL A</w>
UCD CL</w>
UCD CL)</w>
UC R</w>
UC ).</w>
UA- induced-neurotoxicity</w>
UA- ,</w>
U69 593,</w>
U5048 8H</w>
U50,48 8.</w>
U50,48 8,</w>
U46 619</w>
U46 6
U466 19
U46619 -induced</w>
U37883A -treated</w>
U37883A 's</w>
U3788 3
U37883 A,</w>
U/ ml.</w>
U/ ml).</w>
U/ ml),</w>
U/ min,</w>
U/ mg</w>
U/ mL.</w>
U/ m2/day</w>
U/ liter.</w>
U/ liter);</w>
U/ kg;</w>
U/ kg).</w>
U/ kg),</w>
U/ g</w>
U/ day</w>
U/ day.</w>
U/ day,</w>
U/ day).</w>
U/ d)</w>
U/ d).</w>
U/ S).</w>
U/ MCU</w>
U/ L
U/L ];</w>
U/ I</w>
U/ I)</w>
U/ I);</w>
U/ GFAP</w>
U/ FA)</w>
U/ 100</w>
U.S. A.,</w>
U.S. A.)</w>
U.S. -
U.S.- born</w>
U. kg-1.day-1</w>
U. K.</w>
U-900 42,</w>
U- wave.</w>
U- test.</w>
U- test,</w>
U- neg).</w>
U- exposed+melatonin-treated.</w>
U- adriamycin</w>
U- TTP
U-TTP )-
U-TTP)- conditioning</w>
U- LI)</w>
U- 5048
U-5048 8</w>
U- 48
U-48 6).</w>
U- 2
U-2 10)</w>
U tvalg</w>
U shiku</w>
U s.</w>
U rotensin-II</w>
U remia</w>
U rea</w>
U raemic</w>
U osm-Posm</w>
U nopposed</w>
U nopened</w>
U niformity</w>
U max.</w>
U max,</w>
U hthoff's</w>
U e)</w>
U biquinone</w>
U ]</w>
U VA</w>
U V,</w>
U UI</w>
U TRs</w>
U TIs</w>
U TI
UTI s)</w>
U T)</w>
U SED</w>
U SE
USE D:</w>
U R)</w>
U Q10</w>
U Pro
UPro t,</w>
U PA</w>
U PA.</w>
U P:</w>
U P-
UP- 454-
UP-454- 21,</w>
U P
UP r,</w>
U MA
UMA RA
UMARA N</w>
U M.</w>
U L/
UL/ L.</w>
U Iso
UIso V</w>
U IS)</w>
U GT</w>
U GT1
UGT1 A1</w>
U F-
UF- heparin</w>
U F)</w>
U E</w>
U C.</w>
U C)</w>
U BMT</w>
U BMT.</w>
U B.</w>
U B).</w>
U AE</w>
U AE.</w>
U A.</w>
U A).</w>
U =
U= 48
U=48 37,</w>
U 50,488H</w>
U 133</w>
U -</w>
U ):</w>
U )-positive</w>
U 's</w>
Tyro de</w>
Tyro 3</w>
Tyro 3,</w>
Tyro -3,</w>
Tyr-D- Arg</w>
Tyr-D- Ala-Gly-
Tyr-D-Ala-Gly- NM
Tyr-D-Ala-Gly-NM e-Phe-Gly-ol</w>
Tyr 6
Tyr6 ]-VIP</w>
Tyr 3-
Tyr3- octreotide</w>
Tyr 1,</w>
Typ es</w>
Tx nip,</w>
Tx B2,</w>
Tx B
TxB 2/
TxB2/ 6-keto-PGF1</w>
Tx A2,</w>
Tx A-induced</w>
Tx A,</w>
Two- month-old</w>
Two- hundred-eight</w>
Two- dimensional,</w>
Two- D</w>
Twice- weekly</w>
Twenty- two-,</w>
Twenty- seven-,</w>
Twenty- lone</w>
Twenty- four-bed</w>
Twelve- year</w>
Twel ve,</w>
Tw ofold</w>
Tw o-</w>
Tw in</w>
Tum ors).</w>
Tum origenicity</w>
Tum ori</w>
Tum oral</w>
Tubulo reticular</w>
Tubulo pathy</w>
Tub eroinfundibular</w>
Tub erculous</w>
Tu key</w>
Tu j-1,</w>
Tu en</w>
Trypt ophan</w>
Trypt ophan-niacin</w>
Trx R-specific</w>
Trx 1</w>
Trp- Arg-
Trp-Arg- Thr
Trp-Arg-Thr -P
Trp-Arg-Thr-P en-Thr</w>
Trp 64
Trp64 Arg</w>
Trp 11
Trp11 )-
Trp11)- NT</w>
Troponin- I</w>
Trop onine</w>
Tro vafloxacin-induced</w>
Tro lox</w>
TrkA (+)/
TrkA(+)/ IB4
TrkA(+)/IB4 (-),</w>
TrkA (+
TrkA(+ ).</w>
Tris mus,</w>
Trin itroglycerin</w>
Trimolet s.</w>
Trimolet s')</w>
Trimethoprim-sulfamethox azole-associated</w>
Trimethoprim-sulfamethox asole</w>
Trimethop rim-Sulfomethoxazole</w>
Trimethaph an-induced</w>
Trimeth adione</w>
Trigg ering</w>
Trigg ered</w>
Tric yclic-antidepressant-induced</w>
Tric homonas</w>
Tric hloroethylene</w>
Triamte rene-induced</w>
Triamcin olone</w>
Tri vial</w>
Tri tium</w>
Tri tiated</w>
Tri s.</w>
Tri ple-binge</w>
Tri phenyl</w>
Tri mipramine</w>
Tri mipramine-induced</w>
Tri meton</w>
Tri metazidine,</w>
Tri mepranol</w>
Tri glycerides,</w>
Tri glyceride</w>
Tri geminal</w>
Tri flusal</w>
Tri azole</w>
Tri angular</w>
Tri als.</w>
Tri al:</w>
Tri al-Blood</w>
Tri al,</w>
Tri al)</w>
Tri al).</w>
Tri ad.</w>
Trendelen burg's</w>
Tremor s.</w>
Tremor ine-oxotremorine-induced</w>
Trem ulous</w>
Treatment -dose</w>
Trazod one-related</w>
Trazod one,</w>
Traum atological</w>
Transplant ations)</w>
Transplant ation-associated</w>
Transplant ation)</w>
Transplant -free</w>
Transit ory,</w>
Transi tions</w>
Transf usions</w>
Transf usion-requiring</w>
Transf ection</w>
Transcript ase</w>
Transcript ,</w>
Transcri pt</w>
Transamin ases</w>
Transamin ases,</w>
Trans venous</w>
Trans sphenoidal</w>
Trans plants</w>
Trans planted</w>
Trans placentally</w>
Trans mitter</w>
Trans mitral</w>
Trans membrane</w>
Trans lational</w>
Trans ketolase</w>
Trans jugular</w>
Trans generational</w>
Trans formed</w>
Trans ferrin</w>
Trans fer</w>
Tran stympanic</w>
Tran slesional</w>
Tran quilizers</w>
Tran date),</w>
Tramad ol/APAP</w>
Tramad ol-induced</w>
Tradi tionally</w>
Tradi tionally,</w>
Trac king</w>
Trac er</w>
Tra veler's</w>
Tra its</w>
Tra ined</w>
Tra ils</w>
Tra il</w>
Tra il-Making</w>
Tr ying</w>
Tr p.</w>
Tr apped</w>
Toxic ological</w>
Toxic ologic</w>
Toxic okinetic</w>
Toxic odynamics</w>
Toxic "</w>
Tourniqu ets</w>
Torsa degenic</w>
Toron to.</w>
Toron to-Sunnybrook</w>
Toron jil</w>
Torem ifene,</w>
Tor ulopsis</w>
Tor r]</w>
Tor r),</w>
Topiram ate-valproate-induced</w>
Topiram ate-induced</w>
Topiram ate's</w>
Top ographical</w>
Ton sillectomy</w>
Ton otopic</w>
Ton o-pen</w>
Ton gue</w>
Tomat o</w>
Tomat o-based</w>
Tolu ene-induced</w>
Toler ated</w>
Toler ance,</w>
Tolaz amide-induced</w>
Tol vaptan,</w>
Tol l-like</w>
Tol butamide-induced</w>
Tol azoline.</w>
Tocain ide.</w>
Tocain ide-induced</w>
Toc olysis</w>
Tob ramycin-impregnated</w>
Tob anum)</w>
To wards</w>
To ward</w>
To uch</w>
To pliss</w>
To o</w>
To kyo</w>
To kyo,</w>
To ilet</w>
Tn T,</w>
Tit les</w>
Tit ers</w>
Tin ted</w>
Tin s/Tins</w>
Tin idazole</w>
Timed- mated</w>
Timed- exposure</w>
Time-of- flight</w>
Time-of- day</w>
Time- weighted</w>
Time- series</w>
Time- evolving</w>
Time- effect</w>
Time- dated</w>
Time- Line</w>
Time d-pregnant</w>
Time .</w>
Time -to-
Time-to- Onset</w>
Time -</w>
Time )</w>
Tim olol/pilocarpine</w>
Tim olol-induced</w>
Tim isoara</w>
Tig an</w>
Tig an.</w>
Tie2-Cre; R
Tie2-Cre;R 26
Tie2-Cre;R26 R-
Tie2-Cre;R26R- stop-EYFP</w>
Tie 2</w>
Ticlop idine:</w>
Ticlop idine-associated</w>
Ticarc illin-induced</w>
Tiaz ofurin,</w>
Tiag abine</w>
Ti redness</w>
Ti ght</w>
Ti bolone</w>
Thyro tropin-releasing</w>
Thyro toxic</w>
Thym oxamine</w>
Thym oxamine,</w>
Thym ectomy</w>
Thrombo stat</w>
Thrombo prophylaxis</w>
Thrombo genicity</w>
Thrombo genesis</w>
Thrombo emboli</w>
Thromb otest.</w>
Thromb olytics,</w>
Thromb ocythaemia</w>
Thromb ocyte</w>
Thromb i</w>
Thromb ectomies</w>
Thrice- weekly</w>
Thrice- daily</w>
Thresh olds</w>
Three- h</w>
Three- drug</w>
Three- dose</w>
Three- dimensional</w>
Three- days</w>
Three- day</w>
Thr 8</w>
Thr 4
Thr4 15
Thr415 As
Thr415As n)</w>
Thr 34</w>
Thr 3
Thr3 4.</w>
Thr (SO3H)7-Ac-CCK-2-8-SE</w>
Thor azine</w>
Thor azine.</w>
Thor acal</w>
Thirty- four,</w>
Thir y-Vella</w>
Thir ty-</w>
Thir teen-cis</w>
Thir st</w>
Thir d-party</w>
Thioridaz ine-tricyclic</w>
Thioridaz ine-induced</w>
Thioridaz ine,</w>
Thiopent one)</w>
Thiopent al-anesthetized</w>
Thiopent al,</w>
ThioTE PA-treated</w>
ThioTE PA,</w>
Thio- TEPA</w>
Thio- TE
Thio-TE PA
Thio-TEPA 's</w>
Thio peramide,</w>
Thio l</w>
Thio TEPA</w>
Thiazol idinediones</w>
Thiazol idinedione</w>
Thiaz ide-lithium</w>
Thi5, 8,</w>
Thi otepa-associated</w>
Thi ol-containing</w>
Thi obarbituric</w>
Thi enopyridines</w>
Thi 5,</w>
There by</w>
There by,</w>
There ,</w>
Therapeu tically</w>
Therapeu tic"</w>
Therap y-related</w>
Therap y-na</w>
Ther mography</w>
Theore tically,</w>
Theophyll ine-derived</w>
The sis.</w>
The ses</w>
The ory</w>
The ories</w>
The orectical</w>
Thalidom ide.</w>
Thalidom ide-related</w>
Thalidom ide-associated</w>
Thalam us</w>
Thal es</w>
Th ymoquinone</w>
Th y1</w>
Th y-1.2</w>
Th us:</w>
Th roat</w>
Th re</w>
Th ionamide</w>
Th ies,</w>
Th ickening</w>
Th elper,</w>
Th an</w>
Th 2</w>
Th 12</w>
Th 1/
Th1/ Th2</w>
Th .</w>
Tez o</w>
Tez o,</w>
Tex ier's</w>
Tex as,</w>
Tetrahydro isoquinolines</w>
Tetra ethylammonium</w>
Tet/ Dox-treated</w>
Tet rodotoxin</w>
Tet anus</w>
Tet anus-like</w>
Tet ).</w>
Testoster one-treated</w>
Testoster one-indued</w>
Testoster one-induced</w>
Test s,</w>
Test ;</w>
Test -
Test- retest</w>
Tes la</w>
Terbut aline-treated</w>
Terbut aline-induced</w>
Terbin afine-induced</w>
Ter rier</w>
Ter natin,</w>
Ter ms</w>
Ter minology</w>
Ter med</w>
Ter m</w>
Ter iparatide</w>
Ter aklin</w>
Ten- year</w>
Ten- week-old</w>
Ten- micron</w>
Ten silon</w>
Ten oxicam</w>
Ten oxicam.</w>
Ten on's</w>
Ten nessee</w>
Ten idap</w>
Tempor ally,</w>
Tempor al-lobe</w>
Temper atures</w>
Temozolom ide.</w>
Temozolom ide,</w>
Temoc april,</w>
Tem sirolimus-induced</w>
Tem pol,</w>
Teli thromycin-induced</w>
Teli thromycin,</w>
Tel sa</w>
Tel misartan</w>
Tel angiectasia,</w>
Teicoplan in-induced</w>
Teg retol</w>
Teg afur-uracil</w>
Technetium- cardiolite</w>
Technetium- MDP</w>
Technetium- 99m-
Technetium-99m- HMPAO</w>
Techne tium</w>
Tech nology,</w>
Tech nical</w>
Teach ers</w>
Te zo).</w>
Te trandrine,</w>
Te mazepam,</w>
Te lomere-regulating</w>
Te hran</w>
Te flon-coated</w>
Te ased-fiber</w>
TdP- susceptible</w>
Td T-mediated</w>
Td R,</w>
Td R)</w>
Td Ps.</w>
Td P-like</w>
Td P)</w>
Tc-99m- sestamibi</w>
Tc-99m- pertechnetate</w>
Tc-99m- Sestamibi</w>
Tc- HMPAO</w>
Tc- E
Tc-E HI
Tc-EHI DA</w>
Tc ES,</w>
Tax otere</w>
Tax ol:</w>
Tax ol-induced</w>
Tax oids</w>
Tax ane-based</w>
Taus sig</w>
Tauro ursodeoxycholate</w>
Tauro cholate</w>
Taur ine-treated</w>
Taur ine's</w>
Tar trazine,</w>
Tar iff</w>
Tar atogenic</w>
Tar "</w>
Taq man</w>
Taq M
TaqM an-based</w>
Taq 1A,</w>
Tanz anian</w>
Tanz ania.</w>
Tanz ania,</w>
Tamsulos in,</w>
Tamoxif en-related</w>
Tamoxif en-associated</w>
Tam il</w>
Tam an,</w>
Tam a</w>
Tak otsubo-shaped</w>
Taiw anese).</w>
Taipe i.</w>
Tai wan's</w>
Tacrolim us-treated</w>
Tachy dysrhythmia</w>
Tachy cardic</w>
Tachy arrhythmias</w>
Tac rine-induced</w>
Tac alcitol</w>
Tac ,</w>
Ta u</w>
Ta p</w>
Ta it</w>
TXB (2),</w>
TXA 2:</w>
TXA 2/
TXA2/ PGI2</w>
TXA 2-</w>
TX A2)</w>
TWEA K.</w>
TWEA K-induced</w>
TW A.</w>
TV3 27
TV327 9,</w>
TV F)</w>
TV BT</w>
TV 506</w>
TUNEL- based</w>
TUNE L/
TUNEL/ NeuN</w>
TUNE L)</w>
TUD C/
TUDC/ min,</w>
TUD C,</w>
TTP/HUS ."</w>
TTP/HUS "</w>
TTP- associated</w>
TTP- HUS
TTP-HUS -associated</w>
TTP- HU
TTP-HU S:</w>
TTP :</w>
TT X-induced</w>
TT X)</w>
TT F</w>
TT -associated</w>
TT );</w>
TT )-associated</w>
TSH -
TSH- releasing</w>
TSC ;</w>
TS- ISTR
TS-ISTR ).</w>
TS ST-1</w>
TS Q</w>
TS PA</w>
TS F</w>
TS F,</w>
TS CA
TSCA N,</w>
TS AT</w>
TRPV1- receptors,</w>
TRPV1- expressing</w>
TRPV1- /
TRPV1-/ Na(v)1.8
TRPV1-/Na(v)1.8 -</w>
TRPV1 b-downregulation</w>
TRPV1 b,</w>
TRPV1 +/
TRPV1+/ Na(v)1.8
TRPV1+/Na(v)1.8 +</w>
TRPV 6</w>
TRPV 1:</w>
TRPV 1/
TRPV1/ TRPV1b</w>
TRPV 1)</w>
TRPM 6,</w>
TRO196 22,</w>
TRK- 8
TRK-8 20,</w>
TRI ALS</w>
TRH- dependent</w>
TR s,</w>
TR IM</w>
TR I,</w>
TR H:</w>
TR H.</w>
TR H-induced</w>
TR H
TRH .(ABSTRACT</w>
TR F2</w>
TR F.</w>
TR B</w>
TR AP
TRAP /
TRAP/ TA
TRAP/TA R</w>
TR A),</w>
TR -
TR- )</w>
TPMT* 3A</w>
TPMT* 2,</w>
TP s.</w>
TP ase)</w>
TP Q</w>
TP N</w>
TP N.</w>
TP MPA</w>
TP M.</w>
TP M
TPM 's</w>
TP L)</w>
TOR S</w>
TOR 1A</w>
TOR -treated</w>
TOF- MS.</w>
TO CP,</w>
TO COL
TOCOL :</w>
TO 1</w>
TNS s</w>
TNS s,</w>
TNS r.</w>
TNS r,</w>
TNS ;</w>
TNS ,</w>
TNP- ATP.</w>
TNP- ATP-sensitive</w>
TNP- ATP-</w>
TNP- ATP)</w>
TNF-alpha/ IL-6</w>
TNF-alpha/ IL
TNF-alpha/IL 6/
TNF-alpha/IL6/ STAT3</w>
TNF- beta</w>
TNF alpha/interferon-gamma,</w>
TNF SF
TNFSF 12)</w>
TNF B</w>
TNF --
TNF-- involving</w>
TN K-
TNK- TPA</w>
TN Fs</w>
TN D),</w>
TN C.</w>
TN BE</w>
TN )+
TN)+ DOX.</w>
TMTX/ 5-FU/
TMTX/5-FU/ L
TMTX/5-FU/L CV
TMTX/5-FU/LCV .</w>
TMP/SM X.</w>
TMP/SM X-induced</w>
TMP/SM X,</w>
TMP-SM Z;</w>
TMP-SM Z),</w>
TMP-SM X,</w>
TMP SM
TMPSM X</w>
TMP S)</w>
TMP H</w>
TMP G</w>
TMB- 8.</w>
TM Z.</w>
TM Z,</w>
TM S-
TMS- based</w>
TM O.</w>
TM O,</w>
TM O)</w>
TM CD,</w>
TM CD)</w>
TM ),</w>
TL W)</w>
TL S.</w>
TL S,</w>
TL R-2</w>
TL PR.</w>
TL CA.</w>
TJM s.</w>
TIVE -
TIVE- W</w>
TIMP -1.</w>
TI- 336)</w>
TI s;</w>
TI s).</w>
TI s),</w>
TI VITY</w>
TI T.</w>
TI S</w>
TI S)</w>
TI R)</w>
TI R
TIR ON:</w>
TI PS.</w>
TI MP)</w>
TI ME</w>
TI ME-
TIME- II,</w>
TI M
TIM I-II</w>
TI I)</w>
TI D).</w>
TI CH.</w>
TI C),</w>
TI AA</w>
TI A;</w>
TI )/
TI)/ Kunitz-type</w>
THE O),</w>
THCCO OH</w>
THCCO OH,</w>
TH e</w>
TH T</w>
TH R</w>
TH R.</w>
TH PO
THPO .</w>
TH OR
THOR S
THORS '</w>
TH OC</w>
TH L-induced</w>
TH L-
THL- related</w>
TH FR</w>
TH F,</w>
TH DOC,</w>
TH C-</w>
TH B
THB )/
THB)/ THA</w>
TH A)</w>
TH <300</w>
TH 5</w>
TH .</w>
TH -labeled</w>
TH +</w>
TGR(A1-7)3 29
TGR(A1-7)329 2.</w>
TGFbeta1- driven</w>
TGFbeta1- dependent</w>
TGF- b</w>
TGF- b1,</w>
TGF- alpha-positive</w>
TGF- alpha,</w>
TGF beta1,</w>
TGF beta-mediated</w>
TG N)</w>
TG C</w>
TG :</w>
TG +H
TG+H F).</w>
TG +
TG+ AL</w>
TFMP P,</w>
TFA- proteins</w>
TFA- lysine.</w>
TFA- labelled</w>
TFA- chloride.</w>
TF V,</w>
TF L</w>
TF C),</w>
TER T,</w>
TER L)</w>
TER ,</w>
TEO AE
TEOAE s'</w>
TEE- diagnostic</w>
TEE- confirmed</w>
TE- averaged</w>
TE- OAE</w>
TE s;</w>
TE WL</w>
TE PH).</w>
TE P),</w>
TE N.</w>
TE MPO</w>
TE D).</w>
TE AR
TEAR E</w>
TE AEs</w>
TE ).</w>
TE ),</w>
TDH L,</w>
TDF ;</w>
TD(50)/ anticonvulsive</w>
TD(50)/ ED(50)</w>
TD s).</w>
TD R,</w>
TD M;</w>
TD M.</w>
TD I-
TDI- derived</w>
TD F,</w>
TD ;</w>
TD 50,</w>
TD )-induced</w>
TD ),</w>
TCV-1 16,</w>
TCPOB OP
TCPOBOP -treated</w>
TCPOB O
TCPOBO P.</w>
TCDD /kg.</w>
TCD D-
TCDD- contaminated</w>
TCA s,</w>
TCA 's</w>
TC s).</w>
TC s),</w>
TC S)</w>
TC C,</w>
TC -</w>
TC )-resistant</w>
TBX A2
TBXA2 R</w>
TBX 21,</w>
TBP S</w>
TBP S)</w>
TBM ,</w>
TBAR s</w>
TBAR Ss</w>
TB Z)</w>
TB S)</w>
TB P)</w>
TB OB)</w>
TB I-associated</w>
TB I)</w>
TB C</w>
TB A</w>
TB ).</w>
TAT OC),</w>
TAT -P
TAT-P NA</w>
TAT -
TAT- peptide</w>
TAS S</w>
TAS S,</w>
TAM 's</w>
TAC -associated</w>
TA- Standard</w>
TA- D-Phe
TA-D-Phe 1-
TA-D-Phe1- Tyr3-octreotide</w>
TA- 60
TA-60 6,</w>
TA P)</w>
TA K-
TAK- 0
TAK-0 44</w>
TA H.</w>
TA -treated</w>
TA -1
TA-1 )]</w>
T> G),</w>
T9-T 10).</w>
T9-T 10),</w>
T9- T10</w>
T4/ day</w>
T3 ];</w>
T3 N0M
T3N0M 0</w>
T2- weighted,</w>
T2- T4)</w>
T2- T3];</w>
T2- L3</w>
T2* :</w>
T2* -
T2*- weighted</w>
T1- weighted,</w>
T1- 201</w>
T1 cN0M0,</w>
T1 )=
T1)= 0.5
T1)=0.5 ].</w>
T/ ml/h.</w>
T/ initial</w>
T/ G</w>
T/ DAT</w>
T/ B
T/B C)</w>
T--> CMF:</w>
T--> A-->
T-->A--> CMF:</w>
T- wave,</w>
T- wave),</w>
T- turnover</w>
T- tubule</w>
T- treatment.</w>
T- stimulation</w>
T- stimulation,</w>
T- receptor</w>
T- promoted</w>
T- obtained</w>
T- maze,</w>
T- lymphocytes.</w>
T- injected</w>
T- helper</w>
T- experienced</w>
T- evoked</w>
T- currents</w>
T- channel</w>
T- cells</w>
T- cells,</w>
T- cell-mediated</w>
T- cell-directed</w>
T- alpha),</w>
T- VT)</w>
T- T-
T-T- A:</w>
T- III)</w>
T- H
T-H NP).</w>
T- F)</w>
T- CS,</w>
T- B</w>
T- AL
T-AL F)</w>
T- A1)</w>
T- 82,</w>
T- 5</w>
T- 2,</w>
T- 2)</w>
T- 2).</w>
T- /-)</w>
T+ CM</w>
T+ CM),</w>
T)- specific</w>
T)- initiated</w>
T)- didanosine</w>
T)- analyzed</w>
T( peak-end)</w>
T zanck's</w>
T ylenol</w>
T x,</w>
T witch</w>
T ween-20,</w>
T unisian</w>
T turn</w>
T suppressor,</w>
T ruly</w>
T rue</w>
T roxidone</w>
T romso</w>
T rofosfamide</w>
T riton-100</w>
T richrome</w>
T retment-emergence</w>
T remorolytic</w>
T ramadol-associated</w>
T pTe/QTc,</w>
T ox,</w>
T own,</w>
T ong</w>
T one</w>
T ome</w>
T na</w>
T max</w>
T issue-type</w>
T ipranavir</w>
T ip</w>
T inel</w>
T ilting</w>
T ibial</w>
T gd</w>
T gN[SOD1]3Cje</w>
T endinitis</w>
T en,</w>
T elemetry</w>
T ea</w>
T ayside</w>
T ask:</w>
T aribavirin</w>
T aribavirin,</w>
T andospirone</w>
T ampere</w>
T aglutimide</w>
T agamet-induced</w>
T aft</w>
T a-T1</w>
T X.</w>
T X,</w>
T V</w>
T V,</w>
T UA</w>
T ST</w>
T SE
TSE -based</w>
T SC</w>
T SC,</w>
T SA
TSA 201</w>
T S).</w>
T Q
TQ );</w>
T PA.</w>
T PA).</w>
T P.</w>
T P)</w>
T OB
TOB I.</w>
T NG
TNG -induced</w>
T MT,</w>
T MA
TMA ?</w>
T M-
TM- use</w>
T LR</w>
T LE).</w>
T LA</w>
T L.</w>
T L-
TL- 99</w>
T K
TK I
TKI s).</w>
T GH</w>
T GF,</w>
T G).</w>
T G),</w>
T FL
TFL :</w>
T F</w>
T EE.</w>
T DX,</w>
T D-
TD- analogue</w>
T Cs</w>
T Cs)</w>
T CRs</w>
T CRV</w>
T CP.</w>
T CO
TCO G</w>
T CM.</w>
T CM,</w>
T CI,</w>
T CH)</w>
T CE,</w>
T CD</w>
T CC
TCC ;</w>
T CA3</w>
T CA3,</w>
T CA-induced</w>
T C;</w>
T C),</w>
T AR
TAR GE
TARGE T</w>
T AD</w>
T AD/
TAD/ HAM
TAD/HAM ).</w>
T AC.</w>
T AB
TAB LE</w>
T 8.</w>
T 8,</w>
T 72,</w>
T 7-
T7- 8:</w>
T 7)</w>
T 6</w>
T 60)</w>
T 6,</w>
T 5-
T5- T7)</w>
T 4;</w>
T 40</w>
T 4.</w>
T 4-induced</w>
T 4-6</w>
T 30)</w>
T 22,</w>
T 21</w>
T 2.</w>
T 2,</w>
T 1=
T1= 0.5),</w>
T 13
T13 91
T1391 C</w>
T 12</w>
T 12-
T12- L1</w>
T 12)</w>
T 11</w>
T 11-
T11- T12</w>
T 1-</w>
T 0.</w>
T .O.V.
T.O.V. A.
T.O.V.A. -
T.O.V.A.- A
T.O.V.A.-A .),</w>
T -related</w>
T -1).</w>
T +</w>
T +/+)</w>
T )]</w>
T );</w>
T )-deficient</w>
T (4)</w>
T (12
T(12 )-
T(12)- L
T(12)-L (1)</w>
T (1).</w>
T (0)</w>
System s,</w>
System atically</w>
Synap topodin,</w>
Syn tocinon</w>
Syn tex</w>
Syn tex)</w>
Syn ergy</w>
Syn denham</w>
Syn chrotron</w>
Syn chronization</w>
Syn acthen</w>
Symptom atology-Self</w>
Symptom -limited</w>
Sympatho adrenomedullary</w>
Sympatho adrenal</w>
Sympath omimetic-related</w>
Sympath olytic</w>
Sym metrical</w>
Sym metrical,</w>
Syd ney.</w>
Sy zygium</w>
Sy philis</w>
Sy novitis</w>
Sy denham</w>
Switzerland ),</w>
Swis sAir</w>
Swis s)</w>
Sweden /
Sweden/ UK),</w>
Swe des</w>
Swe at</w>
Sw ine</w>
Sw ift</w>
Sw ana</w>
Sw allowing</w>
Sv/ E
Sv/E v</w>
Sv/ 129</w>
Sv xC57B1/6</w>
Sv O2</w>
Sv J</w>
Suxameth onium,</w>
Susta ined-Release</w>
Sus ceptible</w>
Surviv als</w>
Survi val;</w>
Survi val.</w>
Surve ys,</w>
Surve y,</w>
Surve y)</w>
Surger y.</w>
Surger y-related</w>
Surger y,</w>
Surg ery/anesthesiology,</w>
Surg e</w>
Sur rounding</w>
Sur rey</w>
Sur reptitious</w>
Sur geons</w>
Supra threshold</w>
Supra therapeutic</w>
Supra physiological</w>
Supple mentary</w>
Super sensitive</w>
Super precipitation</w>
Super infections</w>
Sup pressibility</w>
Sup pl</w>
Sun day</w>
Sumatript an,</w>
Sum ming</w>
Sum ming-up</w>
Sum med</w>
Sum mation</w>
Sulphasalaz ine-related</w>
Sulphasalaz ine,</w>
Sulph oxidation</w>
Sulph one</w>
Sulph ate-pretreatment</w>
Sulph adiazine-induced</w>
Sulind ac.</w>
Sulfon amide-induced</w>
Sulfasalaz ine-associated</w>
Sulfamethox azole-trimethoprim</w>
Sulfamethox azole-induced</w>
Sulfadiaz ine-related</w>
Sulf one</w>
Sulf obromophthalein</w>
Sulf ated</w>
Sulf a</w>
Sul prostone,</w>
Sud den,</w>
Sud anese</w>
Sud an</w>
Succinyl choline-associated</w>
Success fully</w>
Substanti ally</w>
Substanti al,</w>
Subst ances</w>
Subst ance-induced</w>
Subject s.</w>
Subject -dependent</w>
Subject -
Subject- rated,</w>
Subj ectively,</w>
Sub- groups</w>
Sub- group</w>
Sub- effective</w>
Sub- continent</w>
Sub- acute</w>
Sub- Tenon's</w>
Sub unit-containing</w>
Sub typing</w>
Sub tract</w>
Sub thalamic</w>
Sub study</w>
Sub stituting</w>
Sub stituted</w>
Sub plantar</w>
Sub hypnotic</w>
Sub fulminant</w>
Sub endocardial</w>
Sub dermal</w>
Sub convulsive</w>
Sub clavian</w>
Sub classification</w>
Sub cellular</w>
Sub capsular</w>
Suanzaoren tang,</w>
Su profen-related</w>
Su profen-induced</w>
Su perimposed</w>
Su perfusion</w>
Su gar</w>
Su gammadex</w>
Su fficient</w>
Su bepithelial</w>
Su an</w>
Sty rene</w>
Studi o</w>
Studi es-Depression</w>
Studi es,</w>
Stud ying</w>
Stud y--involving</w>
Stud ent-t-test</w>
Strych nine-insensitive</w>
Strych nine-dependent</w>
Struct ures</w>
Struc ture</w>
Strok es,</w>
Strok es)</w>
Stro king</w>
Stro kes</w>
Stric ture</w>
Stri ps</w>
Stress like</w>
Stres sors).</w>
Streptozotocin- treated,</w>
Streptozotocin- nicotinamide-induced</w>
Streptozotocin- cyclophosphamide</w>
Streptozotoc in-diabetic</w>
Streptococc us,</w>
Streptococc us),</w>
Strept okinase</w>
Strept ococcal</w>
Strept .</w>
Stre et-ketamine</w>
Strati fied</w>
Stras bourg</w>
Stras bourg.</w>
Stra in-dependent</w>
Str ingent</w>
Str atus</w>
Str atum</w>
Str abismus</w>
Stop ).</w>
Stom atitis,</w>
Stom achs</w>
Sto red</w>
Sto icism</w>
Sto dgell,</w>
Stimul i</w>
Stimul ators</w>
Stimul ating</w>
Stimul ated),</w>
Stimul ant-induced</w>
Stimul ant-dependent</w>
Stimul ant"</w>
Stim ulated</w>
Still ,</w>
Stilbe strol</w>
Stilbe stro</w>
Sti ff-person</w>
Steroid ally</w>
Steroid -related</w>
Stern bach,</w>
Stereotyp y</w>
Stereotyp ed</w>
Stere otaxically</w>
Stere otaxic</w>
Stere otactic</w>
Stere ologic</w>
Sten otrophomonas</w>
Sten otic-zone</w>
Ste phania</w>
Ste p-wise</w>
Ste metilR)</w>
Ste llate</w>
Ste ep</w>
Ste atohepatitis-inducing</w>
Stavud ine/019</w>
Stavud ine-</w>
Statis tics</w>
State- Tait</w>
Stat us-related</w>
Stat us,</w>
Stat ins,</w>
Stat es,with</w>
Stat es),</w>
Stat 5-
Stat5- binding</w>
Star t</w>
Stand ards</w>
Stand ard-Binet</w>
Stan ford-Binet</w>
Sta phylococci.</w>
Sta phyloccocus</w>
Sta phlococcus</w>
Sta keholders</w>
St unning</w>
St ory</w>
St ones</w>
St one</w>
St one-forming</w>
St ockholm</w>
St esolid).</w>
St ent-assisted</w>
St ate.</w>
St apf.</w>
St anton</w>
St aggered</w>
St abilization</w>
St AR
StAR -related</w>
Squ irrel</w>
Squ ibb's</w>
Squ are</w>
Spre ading</w>
Sprague-Daw ley).</w>
Sprague- dawley</w>
Spironolact one:</w>
Spiro peridol,</w>
Spiro metry</w>
Spiro metric</w>
Spiro grams</w>
Spiro cercosis</w>
Spiradol ine-induced</w>
Spiradol ine-</w>
Spir ulina,</w>
Spin y</w>
Spin al-induced</w>
Spike- wave</w>
Spike- and-wave</w>
Spi king</w>
Sphygmo- Recording</w>
Sphygmo- Record
Sphygmo-Record ing"</w>
Spectr a</w>
Spect aline</w>
Spect acle</w>
Special ities</w>
Special ist.</w>
Special ist's</w>
Spec ies.</w>
Spear man</w>
Spear man's</w>
Spe ech-Language-Hearing</w>
Spati ally</w>
Spas ticity,</w>
Spas m,</w>
Spar se</w>
Span ish.</w>
Span ish-American</w>
Sp ray</w>
Sp ongiform</w>
Sp indle</w>
Sp in-spin</w>
Sp illover</w>
Sp an</w>
Sp O2,</w>
Sp O(2)</w>
Sp F</w>
South western</w>
Soun d.</w>
Soun d-induced</w>
Sotal ol-Digoxin-Quinidine</w>
Sotal ol's</w>
Sot alol,</w>
Sor ting</w>
Son ography</w>
Somnambul ism,</w>
Some what</w>
Some times</w>
Somat ostatin</w>
Somat omotor</w>
Somat odendritic</w>
Som atostatin-14</w>
Sol uspan).</w>
Sol uble</w>
Sol t</w>
Sol itary</w>
Sol ifenacin</w>
Sof tware</w>
Sof t-tissue</w>
Sodium- valproate-induced</w>
Sodium- pump</w>
Sodium- depletion</w>
Sodi um,</w>
Soci o-Mental</w>
Soci ety.</w>
Soci ability</w>
So-1 100.</w>
So y</w>
So x</w>
So koloff</w>
So kal</w>
Smok ers</w>
Smo ked</w>
Smo 2</w>
Smith Kline</w>
Smith .</w>
Smit 1</w>
Smit 1-
Smit1- knockout</w>
Smad 2/
Smad2/ Smad3</w>
Smac/ Diab
Smac/Diab lo.</w>
Sm all-dose</w>
Sm all-</w>
Sm -mediated</w>
Slit 2,</w>
Sleep y"</w>
Sleep -related</w>
Sleep -
Sleep- deprived</w>
Slc :
Slc: ddY</w>
Slc 17
Slc17 a8</w>
Skin :</w>
Sk ye</w>
Sk in-test</w>
Sk in,</w>
Sk ene</w>
Sjo grens</w>
Sjo (2),</w>
Six- month-old</w>
Six- day-old</w>
Sive lestat,</w>
Situ ational</w>
Sirolim us:</w>
Sirolim us-tacrolimus</w>
Sirolim us-related</w>
Siri us</w>
Siri us-red</w>
Single- unit</w>
Single- twitch</w>
Single- nephron</w>
Single- day</w>
Single -blind,</w>
Sing le,</w>
Sinemet .</w>
Sinemet '</w>
Sinemet ").</w>
Simvastatin- ezetimibe-induced</w>
Simvastatin- amiodarone</w>
Simult aneously</w>
Sim vastatinezetimibe</w>
Sim ulated</w>
Sim ply</w>
Sim ple-blind</w>
Sim onian</w>
Sim on</w>
Sil ver</w>
Sil ent'</w>
Sign alling</w>
Sign aling</w>
Sign al-averaged</w>
Sigma -1</w>
Sig mund</w>
Side- Effect</w>
Sic ilian</w>
Sic huan</w>
Si- Wu-Tang</w>
Si- Jun
Si-Jun -
Si-Jun- Zi-Tang</w>
Si yami</w>
Si m</w>
Si blings</w>
Short- time</w>
Short- term/recent</w>
Short- term,</w>
Short- lasting</w>
Short- course</w>
Short- circuit</w>
Short- Term</w>
Shor tness</w>
Shor thaired</w>
Shor ter</w>
Shor tening</w>
Shi raz</w>
Shi fts</w>
Shi ft</w>
Shengmai-y in</w>
Shengmai-y in:</w>
Shen fu,</w>
Sheeh an</w>
Sheeh an's</w>
She tland</w>
She ffield</w>
She epdog</w>
She ep</w>
Shar p</w>
Shar ing.</w>
Sham- lesioned</w>
Sham s</w>
Sham s,</w>
Sham Veh.</w>
Sham -treated</w>
Sham )</w>
Sham ).</w>
Sham ),</w>
Shakuyaku-Kanzo- to,</w>
Shakuyaku-Kanzo- to)</w>
Shakuyaku-Kanzo- to).</w>
Sha h,</w>
Sh rinker</w>
Sh ock</w>
Sh ock.</w>
Sh h</w>
Sh eng-mai-san</w>
Sh anghai,</w>
Sh am.</w>
Sh am,</w>
Sgk 1</w>
Sgk 1,</w>
Sex ualit</w>
Sex -related</w>
Sever ity,</w>
Sever ing</w>
Sevent h</w>
Seven- year</w>
Sev ille,</w>
Set ting</w>
Set ting,</w>
Set ter</w>
Set operone,</w>
Servic e,</w>
Sertr aline,</w>
Serotonin 2C</w>
Serotonin (2
Serotonin(2 C)</w>
Seroton in-selective</w>
Seroton in-4</w>
Ser311 Cys</w>
Ser311 Cys,</w>
Ser- contained</w>
Ser um/urine</w>
Ser um-fibrin</w>
Ser otype</w>
Ser osal</w>
Ser oprevalence</w>
Ser ologically,</w>
Ser ies</w>
Ser ially</w>
Ser a,</w>
Ser 15.</w>
Ser (SO3H)7-Ac-CCK-2-8-SE</w>
Sequ estration</w>
Sequ ences</w>
Sequ ence</w>
Seph arose</w>
Seph adex</w>
Sep t</w>
Sep sis-induced</w>
Sensor y-sympathetic</w>
Sensi tizing</w>
Sensi tized</w>
Sensi tivity-specificity</w>
Sensi tivities,</w>
Sens or,</w>
Sens ation</w>
Sene gal</w>
Senda i</w>
Senda i-virus</w>
Sen escent</w>
Sen escence</w>
Semi- quantitative</w>
Sem icarbazide</w>
Self-Dec eption</w>
Self- tuning</w>
Self- reported,</w>
Self- report</w>
Self- rated</w>
Self- injurious</w>
Self- administration</w>
Self- adhesive</w>
Self- Rating</w>
Seleg iline,</w>
Sel man</w>
Sel f-</w>
Sel enite</w>
Seizure -like</w>
Seiz ure-Resistant</w>
Seg mented</w>
Seg ment-specific</w>
Sed entary</w>
Sed ative-induced</w>
Sed ation,</w>
Sed ated</w>
Second- look</w>
Second- degree</w>
Second- cycle</w>
Sec retion.</w>
Sear ching</w>
Se- deficient,</w>
Se- adequate</w>
Se rendipitous</w>
Se phacel</w>
Se oul,</w>
Se miniferous</w>
Se e</w>
Se bum</w>
Se aweed</w>
Se attle,</w>
Se ated</w>
Se V/DeltaF</w>
Se V/DeltaF)</w>
Se ),</w>
Scre ener</w>
Scre en</w>
Scre en.</w>
Scot land</w>
Scop ulariopsis</w>
Sco tian</w>
Sco tia</w>
Sco tia,</w>
Sco res.</w>
Sco re.</w>
Sco re,</w>
Sco p</w>
Sco 2</w>
Sco 2.</w>
Scleroder moid</w>
Sclero tic</w>
Scler osant</w>
Scienti fically</w>
Scienti fic</w>
Scienc es/Roussel</w>
Scienc es)</w>
Sci ence,</w>
Sci ence).</w>
Sci .</w>
Schwar tz,</w>
Schuknech t's</w>
Schu ur</w>
Scho ol.</w>
Scho ol-Age</w>
Schle mm.</w>
Schizophren ia-like</w>
Schiz otypal</w>
Schiz oid</w>
Schistos omiasis</w>
Schering- Plough
Schering-Plough ,</w>
Schedul e.</w>
Schedul e-dependent</w>
Schedul e,</w>
Sche uer</w>
Sche ffe's</w>
Sch umacher</w>
Sch nauzer</w>
Sch acht,</w>
Sch 's</w>
Scan d.</w>
Scan )</w>
Scale- Revised,</w>
Scale- Observer</w>
Scale- III</w>
Scale- Cognitive</w>
Scale- -Re
Scale--Re vised.</w>
Scal es.</w>
Scal es,</w>
Scal e;</w>
Sc vpO2,</w>
Sc ene</w>
Sc enarios</w>
Sc ans</w>
Sc ).</w>
Sat uration</w>
Sat urating</w>
Sarc olemmal</w>
Sar pogrelate-Aspirin</w>
Sar izotan,</w>
Sar coidosis</w>
Sar 1
Sar1 Thr8</w>
Sap poro</w>
Sap ienza"</w>
Sando z,</w>
Sando statin,</w>
Salv ador,</w>
Salmeter ol:</w>
Salmeter ol-induced</w>
Saliv ation</w>
Saliv ary</w>
Saliv a</w>
Saline+ Sal
Saline+Sal ine;</w>
Saline+ Methamphetamine</w>
Salicyl ate-induced</w>
Salicyl ate-</w>
Salbutam ol-induced</w>
Sal salate</w>
Sal p</w>
Sal ine-injected</w>
Sal es</w>
Sal ary</w>
Saiko-ka-ryukotsu-borei- to</w>
Saiko-ka-ryukotsu-borei- to,</w>
Sac rifice</w>
Sac cades</w>
Saba h</w>
Saba h.</w>
Sa ve</w>
Sa O2,</w>
Sa O2)</w>
Sa O(2)</w>
Sa O(2).</w>
Sa (O2),</w>
SZ- treatment,</w>
SZ- injection.</w>
SY S).</w>
SY M</w>
SWR/ J,</w>
SWR/ J).</w>
SW V/Fnn</w>
SW V/Bk</w>
SW V)</w>
SW S</w>
SW R)</w>
SW I:</w>
SW I,</w>
SW Ds</w>
SW Ds.</w>
SW D)</w>
SW C</w>
SW C.</w>
SW =
SW= -6
SW=-6 1+/-5</w>
SW ,</w>
SV Z</w>
SV T.</w>
SV T,</w>
SV R,</w>
SV P.</w>
SV P-induced</w>
SV P,</w>
SV M
SVM TH)</w>
SV C</w>
SUN-1334 H.</w>
SULT1 )-
SULT1)- catalyzed</w>
SULT 1A
SULT1A 1)</w>
SUBJECT :</w>
SUBJEC T</w>
SU RE</w>
SU R</w>
SU D)</w>
SU )-induced</w>
STZ- treatment.</w>
STZ- model</w>
STZ- intracerebroventricularly</w>
STZ- infused</w>
STZ- SHRs.</w>
STZ ).</w>
STR 1</w>
STN- DBS.</w>
STN- DBS,</w>
STI s)</w>
STI -
STI- 57
STI-57 1.</w>
STI ,</w>
STAT A</w>
STAT 3/
STAT3/ IL-6</w>
STAT 3.</w>
STAT -3</w>
STAR S,</w>
STAR (*)
STAR(*) D</w>
ST/ b</w>
ST/ b)</w>
ST/ SW,</w>
ST- segments</w>
ST- segment,</w>
ST- depressions</w>
ST- depression)</w>
ST- change</w>
ST s)</w>
ST max</w>
ST S.</w>
ST RES</w>
ST N,</w>
ST M-
STM- impairment</w>
ST L.</w>
ST FA)</w>
ST EP,</w>
ST C-
STC- VM</w>
ST C,</w>
ST BP</w>
ST BP
STBP S-
STBPS- ,</w>
ST AT)</w>
ST AR</w>
ST AI</w>
ST AI,</w>
ST >or=2</w>
ST :</w>
ST 6
ST6 GAL
ST6GAL 1</w>
ST 38</w>
ST /P
ST/P W</w>
ST -treated</w>
ST -14</w>
ST -1,</w>
ST );</w>
ST 's).</w>
SSSI s</w>
SSSI s;</w>
SSSI s,</w>
SSRI -treated</w>
SSRI -associated</w>
SSR149744 C:</w>
SSR149744 C,</w>
SSR T,</w>
SSH L,</w>
SSE H.</w>
SS- B</w>
SS- A.</w>
SS c</w>
SS c,</w>
SS TIs;</w>
SS TIs.</w>
SS S).</w>
SS M</w>
SS A),</w>
SS ):</w>
SRL-CsA- ST>or=2</w>
SRL-CsA- ST,</w>
SRL- related</w>
SRL- cyclosporine</w>
SRL- ST.</w>
SRL- ST,</w>
SRIF -14</w>
SRIF -1
SRIF-1 4.</w>
SR250 8.</w>
SR1445 28</w>
SR1445 28.</w>
SR141716 A-sensitive</w>
SR141716 A,</w>
SR-141716 A,</w>
SR- LA
SR-LA B</w>
SR- 48968</w>
SR T)</w>
SR S)</w>
SR L;</w>
SR L-induced</w>
SR Is</w>
SR Is.</w>
SR II</w>
SR I.</w>
SR B
SRB T.</w>
SR A</w>
SR 9
SR9 55
SR955 31</w>
SR 142
SR142 801,</w>
SR /
SR/ trandolapril</w>
SR -treated</w>
SR ,8
SR,8 aRS-6-[phosphonomethyl]decahydr</w>
SR ,
SR, 4a
SR,4a RS
SR,4aRS ,6
SR,4aRS,6 SR,8aRS-6-[phosphonomethyl]decahydr</w>
SQ 14
SQ14 225</w>
SPA D-treated</w>
SPA D-
SPAD- treated,</w>
SP- immunoreactivity</w>
SP- LI</w>
SP- 40,
SP-40, 40</w>
SP- 4)</w>
SP- 27)</w>
SP+ AS</w>
SP+ AS.</w>
SP X</w>
SP X;</w>
SP PI).</w>
SP ON
SPON SE</w>
SP N.</w>
SP MT)</w>
SP MS</w>
SP Ls)</w>
SP L,</w>
SP ID
SPID 48</w>
SP H)</w>
SP G</w>
SP F</w>
SP C</w>
SP B,</w>
SP ;</w>
SP -</w>
SOUR CE</w>
SOPH IA</w>
SOPH IA,</w>
SOD2- O
SOD2-O X,</w>
SOD)- overexpressing</w>
SOD 1-
SOD1- injected</w>
SOCS 3</w>
SOCS 3.</w>
SO T</w>
SO S),</w>
SO R</w>
SO P</w>
SO P)</w>
SO ME</w>
SO M</w>
SO LVD</w>
SO L)</w>
SO CS</w>
SO CI
SOCI ATED</w>
SO :</w>
SO 4</w>
SO 4-</w>
SO -induced</w>
SO )],</w>
SNZ c.</w>
SNP stream</w>
SNP (single</w>
SNH L,</w>
SNC V)</w>
SNA Ps</w>
SNA ;</w>
SNA .</w>
SNA ),</w>
SN- stimulated</w>
SN- 38</w>
SN- 38,</w>
SN r,</w>
SN RIs,</w>
SN P-</w>
SN P)</w>
SN I</w>
SN F1-
SNF1- kinase,</w>
SN D.</w>
SN A-
SNA- III</w>
SN -induced</w>
SN )</w>
SN ).</w>
SN ),</w>
SMT C),</w>
SMIL E</w>
SMIL E-
SMILE- 2</w>
SM-58 87,</w>
SM- actin),</w>
SM- 21</w>
SM- 21.</w>
SM ase)</w>
SM Z</w>
SM Z,</w>
SM S.</w>
SM S,</w>
SM P.</w>
SM P)</w>
SM O
SMO L/
SMOL/ KG).</w>
SM N</w>
SM M</w>
SM LN)</w>
SM IT-
SMIT- expressing</w>
SM Cs).</w>
SM 3)</w>
SM 2,</w>
SM /
SM/ J,</w>
SM ,</w>
SM ),</w>
SLV P,</w>
SLI s</w>
SLI -related</w>
SLE -induced</w>
SLCO 1B1,</w>
SLCO 1
SLCO1 B1</w>
SLC6 A
SLC6A 4.</w>
SL s)</w>
SL S-induced</w>
SL P,</w>
SL N</w>
SL I,</w>
SL G</w>
SL G)</w>
SL E)</w>
SL 88.
SL88. 0
SL88.0 338</w>
SL 3
SL3 27
SL327 -treated</w>
SL )-induced</w>
SKF 81297</w>
SKF 81297-induced</w>
SKF 38393,</w>
SKF 105
SKF105 111</w>
SKF -10,0
SKF-10,0 47</w>
SK-N- MC</w>
SK- 3;</w>
SK T</w>
SK T)</w>
SK P
SKP ],</w>
SK KT</w>
SK K
SKK T),</w>
SK F-induced</w>
SK Ca)</w>
SK .</w>
SK -1,</w>
SK )</w>
SK ).</w>
SJ L).</w>
SIB 17
SIB17 65
SIB1765 F</w>
SIAD H-
SIADH- syndrome</w>
SI- MS</w>
SI- 27</w>
SI s),</w>
SI X</w>
SI TS</w>
SI TIVITY</w>
SI TION:</w>
SI TA-Standard</w>
SI S.</w>
SI P.</w>
SI OP-
SIOP- MMT</w>
SI MD,</w>
SI LENT
SILENT .</w>
SI I</w>
SI I)</w>
SI E-
SIE- 30</w>
SI A</w>
SHR SR,</w>
SHR SP;</w>
SHR L</w>
SHR H</w>
SHR H),</w>
SHR .(ABSTRACT</w>
SHR ).</w>
SHB G.</w>
SHAM- saline</w>
SHAM- MA</w>
SH x-induced</w>
SH x,</w>
SH S
SHS Y-5Y</w>
SH R)</w>
SH PGE2</w>
SH P,</w>
SH LA,</w>
SH L)</w>
SH I,</w>
SH F</w>
SH F.</w>
SH E,</w>
SH AM,</w>
SH A)</w>
SH 2</w>
SH 2/
SH2/ 21,</w>
SH 1/
SH1/ 57),</w>
SH /
SH/ acetyl-CoA</w>
SH .</w>
SH )-releasing</w>
SH (12
SH(12 ))</w>
SG aw</w>
SG Z,</w>
SG Ks</w>
SG K</w>
SG C)</w>
SG ):</w>
SF- 36.</w>
SF- 36,</w>
SF Q),</w>
SF P.</w>
SF O.</w>
SF MD),</w>
SF B</w>
SF 36</w>
SF -12</w>
SETTING S</w>
SETTING S:</w>
SETTING /
SETTING/ PATIENT</w>
SETTING "</w>
SERCA2 a,</w>
SERCA 2,</w>
SERCA -2</w>
SER UM.</w>
SER T.</w>
SER T,</w>
SER M-treated</w>
SER CA</w>
SENT -2</w>
SENSU S).</w>
SEM ]:</w>
SEM ):</w>
SED+ DOX</w>
SE=0.0 33;</w>
SE=0.0 23;</w>
SE s.</w>
SE ])</w>
SE VO,</w>
SE S:</w>
SE RI
SERI ES:</w>
SE Ps.</w>
SE Ps,</w>
SE Ps)</w>
SE P)</w>
SE N
SEN SITIVITY</w>
SE M.</w>
SE I</w>
SE H)</w>
SE ER</w>
SE E</w>
SE D.</w>
SE CON
SECON DAR
SECONDAR Y</w>
SE 25</w>
SE 12</w>
SE /
SE/ OBJECTIVES:</w>
SE -associated</w>
SE -
SE- CASE</w>
SE );</w>
SE )-induced</w>
SDS-PA GE,</w>
SDS- polyacrylamide</w>
SDI- sensitive</w>
SDI- resistant</w>
SD/ mean),</w>
SD/ dysphoria</w>
SD- specific</w>
SD- like'</w>
SD- fed</w>
SD- STZ</w>
SD ],</w>
SD S),</w>
SD PB</w>
SD MAP</w>
SD MAP.</w>
SD MA</w>
SD M,</w>
SD I,</w>
SD F.</w>
SD F),</w>
SD F
SDF -1/
SDF-1/ CXCL
SDF-1/CXCL 12</w>
SD DR
SDDR R,</w>
SD C</w>
SD BP)</w>
SD AT.</w>
SD +/-
SD+/- 9.3</w>
SCO P-
SCOP- shortened</w>
SCO ,</w>
SCN5 A-associated</w>
SCN 8
SCN8 A
SCN8A +/
SCN8A+/ ankyrin-G+</w>
SCL-90- R;</w>
SCL-90- R
SCL-90-R --and</w>
SCL- 90</w>
SCL- 56)</w>
SCL C).</w>
SCI S,</w>
SCI E
SCIE NCE</w>
SCI D-
SCID- hu</w>
SCH000 13,</w>
SCH 58261,</w>
SCH 5826
SCH5826 1]</w>
SCH 44
SCH44 24
SCH4424 16,</w>
SCH 23390.</w>
SCH 23390-</w>
SCD/ enoxaparin</w>
SCD/ enoxaparin-treated</w>
SCD L</w>
SCD ),</w>
SCCH N</w>
SCCH N.</w>
SC19 220</w>
SC19 220,</w>
SC-3660 2.</w>
SC-3660 2,</w>
SC s.</w>
SC r,</w>
SC b</w>
SC a</w>
SC UE</w>
SC R</w>
SC R)</w>
SC N</w>
SC M)</w>
SC G</w>
SC FA</w>
SC F-
SCF- hemin</w>
SC E,</w>
SC C</w>
SC 5
SC5 10
SC510 89,</w>
SC 1,</w>
SB3667 91.</w>
SB-PS+ FO</w>
SB-PS+ FO,</w>
SB-334867- A</w>
SB-334867- A,</w>
SB-277011 A,</w>
SB-2770 11-A</w>
SB-228 357</w>
SB-228 3
SB-2283 57.</w>
SB-224 289</w>
SB-224 28
SB-22428 9.</w>
SB-2 15505</w>
SB- PS,</w>
SB- 39
SB-39 98
SB-3998 85</w>
SB s)</w>
SB V,</w>
SB P/
SBP/ MSDBP</w>
SB P),</w>
SB F,</w>
SB 242084</w>
SB 2
SB2 15505</w>
SAS P,</w>
SAS P),</w>
SAR T).</w>
SAR S-related</w>
SAR S-
SARS- coronavirus,</w>
SAPS- CIP,</w>
SAP S.</w>
SAP ).</w>
SAM e-induced</w>
SAM e+APAP</w>
SAM e)</w>
SAM e).</w>
SAM -dependent</w>
SAM ,</w>
SAL IN
SALIN E,</w>
SAL .</w>
SAH- hydrolase.</w>
SAFIRE -D</w>
SAFIRE -
SAFIRE- D,</w>
SAB- 378</w>
SAB- 37
SAB-37 8,</w>
SA Y</w>
SA P.</w>
SA HA,</w>
SA H),</w>
SA FE
SAFE ,</w>
SA F
SAF ET
SAFET Y:</w>
SA ECG</w>
SA ECG.</w>
SA E)</w>
SA A,</w>
SA ;</w>
SA -induced</w>
S978 8;</w>
S9 80
S980 6,</w>
S727 A</w>
S727 A.</w>
S3A- 410</w>
S3A- 409</w>
S3 25)</w>
S3 (
S3( 0).</w>
S2/ S3</w>
S2/ S1</w>
S140 80.</w>
S14 A-
S14A- HN,</w>
S100 beta-positive</w>
S1 P</w>
S1 P.</w>
S1 (-/-))</w>
S/ g</w>
S/ dt</w>
S/ SS</w>
S/ S;</w>
S/ S,</w>
S/ R-citalopram</w>
S/ PC)</w>
S/ NRH</w>
S/ NO</w>
S/ NO
S/NO ),</w>
S/ MA;</w>
S/ MA,</w>
S/ LV),</w>
S/ Ib
S/Ib g)</w>
S/ E.</w>
S/ DOB</w>
S/ DOB
S/DOB ).</w>
S/ CONCLUSIONS:</w>
S/ CCK-
S/CCK- immunopositive</w>
S/ C;</w>
S/ C,</w>
S/ BACKGROUND:</w>
S/ AM
S/AM I).</w>
S.E.=0.0 27;</w>
S.E.=0.0 26;</w>
S.E. M),</w>
S.E .,</w>
S.D. M.,</w>
S.D. =1.
S.D.=1. 2)</w>
S.D. =
S.D.= 55.
S.D.=55. 2)</w>
S.D .;</w>
S. c.</w>
S. We</w>
S. R.</w>
S. C.</w>
S. C.,</w>
S. C.)</w>
S. A.</w>
S. -H.,</w>
S-nitroso-N-acetyl- penicillamine</w>
S-nitroso-N-acetyl- D,
S-nitroso-N-acetyl-D, L-penicillamine</w>
S-nitroso- N-acetylpenicillamine</w>
S-methyliso thiourea</w>
S-methyl- l-thiocitrulline</w>
S-methyl- L-
S-methyl-L- thiocitrulline</w>
S-methyl thiourea</w>
S-methyl thiocitrulline</w>
S-adenosyl-L- homocysteine</w>
S-adenosyl methionine)</w>
S-adenosyl homocysteine:</w>
S-312- l,</w>
S-312- d.</w>
S-312- d,</w>
S-3 39</w>
S-3 12,</w>
S-2068 2:</w>
S-2068 2,</w>
S-2068 2)</w>
S-2-(3-aminopropyl amino)-ethylphosphorothioic</w>
S-2-(3- Amino
S-2-(3-Amino propylamino)-ethylphosphorothioic</w>
S-(-)- isomer,</w>
S-(-)- YM-16151-1</w>
S-(-)- 4-en-VPA</w>
S-(-) enantiomer</w>
S-(-) -10-
S-(-)-10- acetoxy-10,11-dihydro-5H-dibenzo/b,f/azepine-5-carboxamide)</w>
S-(+)- mecamylamine</w>
S- zinc</w>
S- warfarin</w>
S- transferases</w>
S- transferase-positive</w>
S- specific.</w>
S- sires</w>
S- sire</w>
S- sarcoma</w>
S- positive</w>
S- phase-specific,</w>
S- pattern,</w>
S- nitrosocysteine,</w>
S- labeled</w>
S- isomer</w>
S- isomer,</w>
S- isomer),</w>
S- interval</w>
S- exposure</w>
S- derived</w>
S- defining</w>
S- dam</w>
S- citalopram</w>
S- carvedilol</w>
S- carboxymethyl</w>
S- carboxymethyl-L-cysteine</w>
S- TTP:</w>
S- TS</w>
S- T/T</w>
S- PIA</w>
S- PIA)</w>
S- PG)</w>
S- M</w>
S- III-
S-III- R</w>
S- ED(50)of</w>
S- E),</w>
S- DA),</w>
S- D3-
S-D3- cells</w>
S- D),</w>
S- Citalopram</w>
S- Ca</w>
S- CAs)</w>
S- Allyl
S-Allyl cysteine</w>
S- 92/
S-92/ E
S-92/E URO-E.W.I.N.G.-99,</w>
S- 7</w>
S- 4-
S-4- carboxy-3-hydroxyphenylglycine</w>
S- 3,4-DCPG
S-3,4-DCPG -mediated</w>
S- 2</w>
S- -
S-- METHODS:</w>
S- )</w>
S- (2,
S-(2, 4-dinitro
S-(2,4-dinitro phenyl)glutathione</w>
S- (1-
S-(1- ethoxycarbonyl,</w>
S- (+/-
S-(+/- )-</w>
S, 6
S,6 S)-
S,6S)- 6
S,6S)-6 [(R)-1-hydroxyethyl]-2-[(3S,5S)-5(S-methyl-4thiomorpholin</w>
S, 4
S,4 S)
S,4S) alpha-(carboxycyclopropyl)glycine</w>
S, 2</w>
S)-1- aminocyclopentane-1,3-dicarboxylate</w>
S)- induced,</w>
S)- 3-(4-
S)-3-(4- chloro-2-methylphenylsulfonylaminomethyl)-bicyclo[2.2.2]octan-2-yl]-5Z-hexenoic</w>
S)- -
S)-- which</w>
S)- (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine</w>
S) 3,5-dihydroxyphenyl
S)3,5-dihydroxyphenyl -
S)3,5-dihydroxyphenyl- glycine</w>
S) ".</w>
S(-)- isomer.</w>
S(-)- Bay</w>
S(-)- BAC
S(-)-BAC .</w>
S(+)- ibuprofen</w>
S(+)- fluoxetine)</w>
S"> changes</w>
S"> University-based</w>
S zczecin</w>
S yo-Saiko-To</w>
S welling</w>
S weet</w>
S vedberg</w>
S um</w>
S ultan</w>
S top</w>
S tembach's</w>
S tem</w>
S tained</w>
S tacy</w>
S t,</w>
S s.</w>
S riraj</w>
S r</w>
S qualene</w>
S purious</w>
S prouting</w>
S plit-brain</w>
S phincter</w>
S pherical</w>
S phenoidal</w>
S phenoid</w>
S permidine</w>
S pain</w>
S pacer-induced</w>
S ox.</w>
S ound</w>
S onomicrometry</w>
S omalia</w>
S olution</w>
S olus</w>
S o-called</w>
S o,</w>
S niffing</w>
S low-kindling</w>
S low,</w>
S lopes</w>
S lope</w>
S light-to-mild</w>
S light,</w>
S ize</w>
S ize-selectivity</w>
S ituating</w>
S ister-chromatid</w>
S ise</w>
S idney</w>
S ick,"</w>
S helley</w>
S hedding</w>
S heaves</w>
S handong</w>
S h.</w>
S h).</w>
S f9</w>
S erositis</w>
S d</w>
S d)</w>
S cully,</w>
S cr,</w>
S coring</w>
S clareol</w>
S cintigraphic</w>
S cholar</w>
S can,</w>
S cabies</w>
S ca-1+</w>
S b</w>
S b,</w>
S aururus</w>
S audia</w>
S audi</w>
S app,</w>
S ansert</w>
S anofi-Aventis,</w>
S andler</w>
S ampling</w>
S ame</w>
S airei-to</w>
S achdev</w>
S accharin</w>
S Z-treated</w>
S Z).</w>
S Z),</w>
S Y</w>
S W)</w>
S VO,</w>
S VO(2)</w>
S VF</w>
S V)</w>
S TH,</w>
S ST-14</w>
S SEPs</w>
S SA</w>
S S/Ibg</w>
S S/CCK-immunopositive</w>
S RO)</w>
S PT
SPT -pretreated</w>
S PO
SPO RTI
SPORTI F</w>
S PA-induced</w>
S MT.</w>
S MT-
SMT- deficits.</w>
S MT,</w>
S MA.</w>
S Li</w>
S K-3
SK-3 b),</w>
S FK</w>
S F.</w>
S F,</w>
S F).</w>
S Ch;</w>
S Ch.</w>
S Ch,</w>
S CS.</w>
S CS,</w>
S CBC</w>
S CBC)</w>
S CARB
SCARB 1),</w>
S BPs</w>
S BP
SBP /</w>
S B)</w>
S AT</w>
S AS).</w>
S AN.</w>
S AN,</w>
S AN
SAN S</w>
S AMP).</w>
S AEs.</w>
S AE,</w>
S AE
SAE s;</w>
S AD
SAD S-E),</w>
S AC.</w>
S 9%</w>
S 80%</w>
S 73.</w>
S 7-2
S7-2 A-->
S7-2A--> G,</w>
S 7
S7 27.</w>
S 6</w>
S 67-
S67- S73.</w>
S 486
S486 T),</w>
S 4+
S4+ L1308F</w>
S 4)</w>
S 3)</w>
S 2-receptors</w>
S 18
S18 ].</w>
S 100</w>
S 1-
S1- S2</w>
S 1,</w>
S 1);</w>
S -17G),</w>
S -15-
S-15- methyl</w>
S -1-
S-1- based</w>
S -1).</w>
S -1
S-1 00-
S-100- beta</w>
S )]</w>
S )],</w>
S )/
S)/ nitrogen</w>
S (a)
S(a) O
S(a)O (2
S(a)O(2 p)</w>
S (D)</w>
S (2)</w>
S 's</w>
RyR s,</w>
RyR 2/
RyR2/ GAPDH</w>
RyR 2.</w>
RyR 2,</w>
Ry anodine,</w>
Ry Rs.</w>
Rut gers</w>
Rus sia.</w>
Rupt ure</w>
Run way</w>
Run down</w>
Rub ral</w>
Ru tin</w>
Rox ithromycin</w>
Rox indole</w>
Rox indole,</w>
Rous sy.</w>
Rous sy,</w>
Rous sel-Uclaf</w>
Roten one-treated</w>
Roten one,</w>
Rotaro d,</w>
Rot tweilers</w>
Rot orod</w>
Rot ahaler.</w>
Rosu vastatin-associated</w>
Rosi glitazone-induced</w>
Rosi glitazone,</w>
Rosen thal's</w>
Rosen 's</w>
Ros well</w>
Ros covitine</w>
Ros aceiform</w>
Ropi vacaine-induced</w>
Rom e.</w>
Rom e,</w>
Rom berg</w>
Rom ano,</w>
Rom ania.</w>
Rom ania,</w>
Rol p.</w>
Rof ecoxib,</w>
Roenig k)</w>
Rod nan</w>
Roche )</w>
Roche ).</w>
Roc kefeller</w>
Rob inson</w>
Rob ert</w>
Ro15-45 13.</w>
Ro15-45 13-
Ro15-4513- sensitive</w>
Ro om</w>
Ro entgenographic</w>
Ro R),</w>
Ro 4-4602.</w>
Rk 1,</w>
Riz zoli</w>
Riz zetto,</w>
Rivas tigmine-induced</w>
Rituxim ab</w>
Rituxim ab-based</w>
Riton avir,</w>
Ritod rine-induced</w>
Ritod rine-</w>
Rit tler</w>
Rit tenberg</w>
Rit anserin,</w>
Risperid one-</w>
Ris ser</w>
Ris k-benefit</w>
Ris ing</w>
Ring ers'</w>
Rim onabant</w>
Rim cazole,</w>
Ril menidine</w>
Rig iscan,</w>
Rig idity,</w>
Rig as</w>
Rifampic in/kg/24</w>
Rifampic in-related</w>
Rifampic in-dependent</w>
Rifamp in-induced</w>
Rifabut in-related</w>
Rif t</w>
Rif abutin</w>
Rib onucleotide</w>
Rib )</w>
Ri yadh,</w>
Ri ver</w>
Ri ver,</w>
Ri gorous</w>
Ri ght-lateralised</w>
Ri edel</w>
Rho A</w>
Rho 123</w>
Rho -kinase</w>
Rho -
Rho- GTP
Rho-GTP ase,</w>
Rhn ull-typed</w>
Rhn ull,</w>
Rhi zomes.</w>
Rhi zoma</w>
Rheum atic</w>
Rhe omacrodex</w>
Rhe i</w>
Rhabdomyoly sis-induced</w>
Rhabdomyoly sis--which</w>
Rhabdomy olysis:</w>
Rhabdomy olysis,</w>
Rh one-Poulenc</w>
Rh initis</w>
Rh initis,</w>
Rh (n
Rh(n ull)</w>
Rg5/Rk 1.</w>
Rg5/Rk 1-treated</w>
Rg5/Rk 1,</w>
Rg3(R ).</w>
Rg 5</w>
Rg 1,</w>
Rey es's</w>
Rey e.</w>
Rey e-like'</w>
Review s,</w>
Review ers</w>
Review ,</w>
Rever sible,</w>
Rev ascularization</w>
Rev .</w>
Retro vir</w>
Retro bulbar</w>
Retri ever</w>
Retri eval</w>
Retin ol-Binding</w>
Retin oid</w>
Reticulo endothelial</w>
Reticulo cytopenic,</w>
Retard ation</w>
Retard ation,</w>
Ret rosplenial</w>
Result s-Medicare</w>
Result ant</w>
Resul t.</w>
Rest on,</w>
Rest enosis</w>
Rest aging</w>
Respond ing,</w>
Respond ents</w>
Respon sive</w>
Respon der</w>
Reser pine:</w>
Reser pine-treated</w>
Reser pine-</w>
Reser pine,</w>
Res piration</w>
Res pective</w>
Res onance,</w>
Res ected</w>
Repub lic,</w>
Reproduc tive</w>
Replic ative</w>
Repeti tion</w>
Repe ated-measures</w>
Repe ated,</w>
Repe at-dose</w>
Rep olarization</w>
Rep ellent</w>
Renografin- 76.</w>
Renografin- 76,</w>
Renografin- 60</w>
Renografin- 60,</w>
Renograf in,</w>
Renograf in)</w>
Renin- sodium</w>
Ren ovascular</w>
Ren ally</w>
Ren al,</w>
Remoxi pride,</w>
Remifentan il-related</w>
Relax ations</w>
Rel apses</w>
Regist ered</w>
Regist er.</w>
Regist er-based</w>
Regi on.</w>
Regi men</w>
Reg2/ Reg
Reg2/Reg III
Reg2/RegIII beta</w>
Reg2/ HIP/PAP</w>
Reg urgitant</w>
Reg ulations</w>
Reg ulation,</w>
Reg ularly</w>
Reg itine,</w>
Reg ister'</w>
Reg 2,</w>
Refract oriness</w>
Refer ral-based</w>
Reduc ed-function</w>
Red ox-metal</w>
Red ness</w>
Recre ational'</w>
Recor ded</w>
Reconsider ations</w>
Recommend ation</w>
Recogn ized</w>
Recogn izable</w>
Recogn ising</w>
Reci pient</w>
Rech allenging</w>
Rech allenge,</w>
Recei ving</w>
Recei ver-operator</w>
Recei ved</w>
Rec ycling</w>
Rec umbent</w>
Rec ruitment</w>
Rec irculating</w>
Rec analization</w>
Rec all-Delayed</w>
Reb oxetine-treated</w>
Real- Time</w>
Read iness</w>
Read ers</w>
Read ,</w>
Read 's</w>
ReN18 69-
ReN1869- -
ReN1869-- primarily</w>
Re- uptake</w>
Re- treatment</w>
Re- takeover</w>
Re- challenging</w>
Re- challenge</w>
Re- bleeding</w>
Re y-like</w>
Re y-Osterrieth</w>
Re wiring</w>
Re ward-Seeking</w>
Re vision,</w>
Re vision).</w>
Re vised.</w>
Re vised)</w>
Re viewed</w>
Re version</w>
Re tired</w>
Re silience</w>
Re sequencing</w>
Re search.</w>
Re search'</w>
Re quirement</w>
Re pressive/defensive</w>
Re port.</w>
Re plenishment</w>
Re pair</w>
Re organization</w>
Re moving</w>
Re minding</w>
Re meflinF)</w>
Re maining</w>
Re liability</w>
Re jection</w>
Re initiating</w>
Re initiated</w>
Re inforcing</w>
Re implantation</w>
Re habilitation,</w>
Re gesta,</w>
Re generative</w>
Re generation</w>
Re fractive</w>
Re fraction</w>
Re fosporen),</w>
Re formulated</w>
Re ference,</w>
Re examination</w>
Re entry</w>
Re entrant</w>
Re elin</w>
Re ed</w>
Re distribution</w>
Re al</w>
Re activity</w>
Re absorption</w>
Rb 2</w>
Rati os</w>
Rati o]</w>
Rati o,</w>
Rat 's</w>
Rash es,</w>
Rasay an</w>
Rasay an.</w>
Rasay an,</w>
Ras- Raf
Ras-Raf -1-
Ras-Raf-1- Me
Ras-Raf-1-Me k-Erk</w>
Rapid- sequence</w>
Rapid- cycling</w>
Rapam ycin-associated</w>
Rapam unE)</w>
Rap -1,</w>
Rap ,</w>
Ranol azine,</w>
Random ization</w>
Random -
Random- digit</w>
Randall-Selit to)</w>
Ran vier</w>
Ran king</w>
Ran k</w>
Ramipri lat,</w>
Ram sey</w>
Ram say</w>
Raloxif ene-induced</w>
Raloxif ene's</w>
Raf 1</w>
Radio immunoassay</w>
Radi x,</w>
Radi ologists</w>
Radi oligand</w>
Radi olabeled</w>
Radi ography</w>
Radi ocontrast</w>
Radi ation-induced</w>
Raclopri de,</w>
Racem ic-and</w>
Rac ine</w>
Rac 1.</w>
Rac 1,</w>
Rabep razole-induced</w>
Rab 5</w>
Ra uscher</w>
Ra ther</w>
Ra izer</w>
Ra ising</w>
RW M.</w>
RW AT</w>
RW AT,</w>
RV R,</w>
RV L)</w>
RV CF</w>
RV CF,</w>
RV /
RV/ LV
RV/LV +
RV/LV+ septum</w>
RV ,</w>
RV ),</w>
RU38 486,</w>
RU-430 44,</w>
RU BE
RUBE X)</w>
RU 486,</w>
RU 28
RU28 318</w>
RTI-1 21)</w>
RTI s)</w>
RTI -specific</w>
RTI -17
RTI-17 7.</w>
RT- -
RT-- PCR</w>
RT s</w>
RT PL</w>
RT A</w>
RT A.</w>
RT A)</w>
RT 42-
RT42- 89</w>
RT 2</w>
RSD S,</w>
RS- sulfoximine</w>
RS- IV</w>
RS- IV)</w>
RS V-strengthened</w>
RS NA,</w>
RS B)</w>
RS A.</w>
RS A),</w>
RS 10
RS10 22
RS1022 21</w>
RS -1-
RS-1- aminoindan-1,5-dicarboxylic</w>
RS -1
RS-1 538
RS-1538 5-1
RS-15385-1 97</w>
RR MS</w>
RR I.</w>
RR F</w>
RR =
RR= 2.51,</w>
RR ;</w>
RR :</w>
RR ).</w>
RPL S.</w>
RP- HPLC,</w>
RP- 67
RP-67 58
RP-6758 0,</w>
RP s)</w>
RP S</w>
RP MI
RPMI -16
RPMI-16 40.</w>
RP M)</w>
RP F,</w>
RP D)</w>
RP 78.</w>
RP 78
RP78 /B
RP78/B IP)</w>
RP 1</w>
RP -1/
RP-1/ ml</w>
ROS- capturing</w>
ROM-1 26,</w>
ROD ),</w>
RO UP:</w>
RO S/NO</w>
RO S.</w>
RO S,</w>
RO R</w>
RO P)</w>
RO M</w>
RO M
ROM -mediated</w>
RO L,</w>
RO Is.</w>
RO Is)</w>
RO I</w>
RO D</w>
RO CO-
ROCO- CO
ROCO-CO PIL
ROCO-COPIL OT
ROCO-COPILOT E</w>
RO BIO
ROBIO LO
ROBIOLO GICAL</w>
RO 15-1788</w>
RO -positive</w>
RO -1
RO-1 5-1
RO-15-1 788</w>
RO -,</w>
RNF LT,</w>
RNF L.</w>
RNA- to-DNA</w>
RNA- positive)</w>
RNA s,</w>
RNA -</w>
RN ase-protection</w>
RN P),</w>
RN E
RNE s;</w>
RN -induced</w>
RN ).</w>
RL S).</w>
RL MA)</w>
RK P,</w>
RK 3)</w>
RK 2)</w>
RIS/ RIS</w>
RIS/ RIS)</w>
RIS K</w>
RI s.</w>
RI s)</w>
RI beta,</w>
RI alpha</w>
RI TED</w>
RI TED).</w>
RI ST.</w>
RI M),</w>
RI HA,</w>
RI H</w>
RI H,</w>
RI EF</w>
RI EF).</w>
RI E,</w>
RI A;</w>
RI A)</w>
RI :</w>
RG M,</w>
RF+ 1.2%</w>
RF s),</w>
RF TIR)</w>
RF P,</w>
RF B</w>
RF B)</w>
RF ).</w>
RF )+0.6%</w>
RESULT S/CONCLUSIONS:</w>
RESULT S">changes</w>
REG I
REGI ME
REGIME N</w>
READ Y</w>
RE s)</w>
RE SPONSE</w>
RE SCUE</w>
RE QU
REQU ENT</w>
RE PO
REPO RT</w>
RE NER
RENER G
RENERG IC
RENERGIC -
RENERGIC- NE
RENERGIC-NE URONE</w>
RE Md</w>
RE CI
RECI ST</w>
RE CE
RECE NT</w>
RE C,</w>
RE ACTION</w>
RE 3</w>
RE 3)</w>
RE 2</w>
RE 2,</w>
RE 1</w>
RE 1,</w>
RE -M
RE-M OD
RE-MOD EL</w>
RE -50</w>
RE -2
RE-2 6,</w>
RCT s,</w>
RBV ;</w>
RBV -treated</w>
RBV -associated</w>
RBCs/ high</w>
RBCs/ H
RBCs/H PF
RBCs/HPF ;</w>
RB s</w>
RB V-related</w>
RB V)</w>
RB T)</w>
RB D</w>
RB D.</w>
RB D,</w>
RB Cs;</w>
RB Cs/HP
RBCs/HP F.</w>
RB C/
RBC/ HP
RBC/HP F)</w>
RB C-related</w>
RB C-reactive</w>
RB C-
RBC- folate</w>
RB C,</w>
RB BB</w>
RASSF 1A.</w>
RASSF 1A(-)(/)
RASSF1A(-)(/) (-)</w>
RAS .</w>
RAR S)</w>
RANTE S</w>
RANTE S,</w>
RANK /
RANK/ RANKL</w>
RAN GE,</w>
RAL ),</w>
RAEB- T).</w>
RAE s)</w>
RAD00 1,</w>
RA s,</w>
RA s)</w>
RA W</w>
RA U</w>
RA ST.</w>
RA PA.</w>
RA PA,</w>
RA P</w>
RA P,</w>
RA G)</w>
RA F</w>
RA )].</w>
R56 86
R5686 5,</w>
R0 4-4602</w>
R0 4-4602,</w>
R/ SVR</w>
R/ S</w>
R/ Jcl
R/Jcl )</w>
R/ Gy</w>
R/ Delta
R/Delta MAP,</w>
R. W.</w>
R. S.</w>
R. J.</w>
R. A.</w>
R. A.
R.A. /kg</w>
R-T B)</w>
R-1 -induced</w>
R-(-)- mecamylamine</w>
R-(-)- mecamylamine,</w>
R-(+)-8-OHDPA T-induced</w>
R-(+)-8-OHDPA T)</w>
R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl- 2,3,4,5-
R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5- tetrahydro-1H-3-</w>
R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl- 2,3,
R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3, 4,</w>
R-(+)- isomer</w>
R-(+)- isomer,</w>
R-(+)- chloro-2,3,4,5,-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin</w>
R-(+)- YM-16151-1.</w>
R-(+)- 8-hydroxy-2-(di
R-(+)-8-hydroxy-2-(di -</w>
R-(+)- 4-
R-(+)-4- en-VPA.</w>
R- triggered</w>
R- trans]-4,4a,5,6,7,8,8a,9-o-dihydro-5n-propyl-2H-pyrazo</w>
R- sulfoximine</w>
R- measured</w>
R- exposed</w>
R- enantiomer.</w>
R- citalopram:</w>
R- carvedilol</w>
R- carvedilol,</w>
R- analogues</w>
R- alpha-methylhistamine-induced</w>
R- TB).</w>
R- STZ).</w>
R- R:</w>
R- R1</w>
R- MuMTV.</w>
R- J
R-J P,</w>
R- HM</w>
R- Ex,</w>
R- CM</w>
R- CG)</w>
R- ARF</w>
R- AA
R-AA P)</w>
R- 6-
R-6- Br-
R-6-Br- APB</w>
R- 6)</w>
R- 486)</w>
R- 3,</w>
R- 21.8</w>
R- /
R-/ S-isomer</w>
R,4R- APD
R,4R-APD C;</w>
R, 10
R,10 S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine</w>
R)- sensitive</w>
R)- extrasystoles</w>
R)- evoked</w>
R)- curve</w>
R)- alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethyl-benzamide</w>
R)- AAP</w>
R(2)= 0.6
R(2)=0.6 0)</w>
R(2)= 0.54).</w>
R(-)- ketoprofen</w>
R(-)- ketamine</w>
R(-)- ibuprofen.</w>
R(-)- ibuprofen,</w>
R(-)- fluoxetine,</w>
R(-)- ,</w>
R(- ),</w>
R(+)- isomer</w>
R(+)- HA-966</w>
R(+)- HA-
R(+)-HA- 96
R(+)-HA-96 6),</w>
R z</w>
R yswyh,</w>
R x</w>
R ush</w>
R s;</w>
R ound</w>
R ound"</w>
R oughly</w>
R ostock,</w>
R ose</w>
R omberg's</w>
R olipram</w>
R olipram,</w>
R olandic</w>
R odier</w>
R ocaltrol</w>
R oberts,</w>
R n.</w>
R n,</w>
R ise</w>
R idray,</w>
R ichmond</w>
R ich</w>
R ica.</w>
R hythm</w>
R euptake</w>
R es</w>
R entiapril</w>
R enoprotective</w>
R endu-Osler</w>
R enal/electrolyte</w>
R en</w>
R ed.</w>
R ed-cell</w>
R ectus</w>
R earing</w>
R dl</w>
R auwolscine</w>
R ated.</w>
R ate-dependent</w>
R as.</w>
R as,</w>
R anges</w>
R and</w>
R altitrexed</w>
R a),</w>
R XR)</w>
R X811059A</w>
R VR).</w>
R VEF</w>
R V.</w>
R U/mL</w>
R U/mL.</w>
R TEC</w>
R ST.</w>
R SR;</w>
R SR.</w>
R SI,</w>
R SD.</w>
R SA)</w>
R S).</w>
R RT</w>
R RP</w>
R R-analogues</w>
R Q</w>
R PTD</w>
R PD
RPD /
RPD/ ,</w>
R P)</w>
R NS.</w>
R MT</w>
R MS,</w>
R M,</w>
R M)</w>
R L,</w>
R ISP</w>
R IP</w>
R IIa</w>
R III</w>
R ICH,</w>
R I,</w>
R I).</w>
R HD</w>
R HD,</w>
R H)</w>
R H
RH 77
RH77 77</w>
R GE
RGE PTA</w>
R GD</w>
R G.</w>
R G,</w>
R F-
RF- positive</w>
R F,</w>
R DS</w>
R CT.</w>
R CT,</w>
R CR</w>
R CR,</w>
R CM.</w>
R CGP</w>
R CD.</w>
R CC,</w>
R CC)</w>
R C
RC MD)</w>
R AV
RAV LT</w>
R AS,</w>
R AD.</w>
R A-exposed</w>
R =
R= 0.6
R=0.6 55,</w>
R 9%,</w>
R 76</w>
R 76.</w>
R 70%</w>
R 6/
R6/ 2</w>
R 6.</w>
R 43</w>
R 43%</w>
R 33
R33 27)</w>
R 32
R32 30</w>
R 3,</w>
R 296
R296 C)</w>
R 2.</w>
R 2);</w>
R 17%</w>
R 17
R17 6
R176 W),</w>
R 15</w>
R 15).</w>
R .)</w>
R -associated</w>
R +/-)</w>
R )]</w>
R )-1-
R)-1- aminocyclopentane-1,3-dicarboxylate</w>
R (2)
R(2) C</w>
R (-)
R(-) -10,</w>
R (+)
R(+) BAC</w>
Quinpi role-induced</w>
Quin oxalin-1-One</w>
Quin olone</w>
Quin ke</w>
Quin april</w>
Quin april,</w>
Queti apine-associated</w>
Question able</w>
Quercet in-fed</w>
Quebec .</w>
Quebec ,</w>
Quanti ty</w>
Quanti tive</w>
Quanti tative,</w>
Quanti met</w>
Quanti fied</w>
Qual ity-of-life</w>
Qual ities</w>
Qual ification</w>
QuaDS-Q P2</w>
QuaDS-Q P2-
QuaDS-QP2- eluting</w>
Qua DS)</w>
Qu otient</w>
Qu incke's</w>
Qu ignard-Boulange</w>
Qu iescence</w>
Qu ick),</w>
Qu ens</w>
Qu arterhorse</w>
Qu arter</w>
Qu antal</w>
Qu adriparesis</w>
Qu adriceps</w>
Qu abain</w>
Qs/Q t</w>
Qs/Q t,</w>
Qo L.</w>
Q_ Irb</w>
Q_ Irb),</w>
Q_ Irb
Q_Irb -treated</w>
QU c</w>
QU I
QUI SITION:</w>
QU ES
QUES TIONS</w>
QTc- time</w>
QTc- prolongation</w>
QTc :</w>
QTc ),</w>
QTL s,</w>
QT/ RR</w>
QT- intervals</w>
QT- interval;</w>
QT- interval.</w>
QT- interval,</w>
QT(Fri d)</w>
QT( u).</w>
QT( U)</w>
QT peak/QT</w>
QT ii</w>
QT f</w>
QT d,</w>
QT c).</w>
QT S</w>
QT S)</w>
QT Ls)</w>
QT L)</w>
QT 3</w>
QT -dependent</w>
QS2 c.</w>
QS/ QT</w>
QS CAN</w>
QS ART</w>
QS 2,</w>
QR S.</w>
QR S-interval</w>
QR S),</w>
QO L.</w>
QO L,</w>
QO 1;</w>
QN B)</w>
QM CM),</w>
Q-NO H)</w>
Q-AM I)</w>
Q- waves</w>
Q- interval.</w>
Q- generated</w>
Q- U</w>
Q- TU</w>
Q- R),</w>
Q- F
Q-F max</w>
Q- D-
Q-D- M
Q-D-M IN</w>
Q- 39).</w>
Q- 28),</w>
Q- ,</w>
Q tc</w>
Q s)</w>
Q iu,</w>
Q aboos</w>
Q aT,</w>
Q ]</w>
Q S</w>
Q OD
QOD ;</w>
Q L
QL Q</w>
Q I).</w>
Q D;</w>
Q D,</w>
Q D)</w>
Q D).</w>
Q D
QD ]</w>
Q CA</w>
Q ALY
QALY s</w>
Q =
Q= 9.
Q=9. 5).</w>
Q :</w>
Q 9</w>
Q 3</w>
Q 2</w>
Q 2-3</w>
Q 1</w>
Q 123)</w>
Q 10.</w>
Q 1)</w>
Q .
Q. R.S.</w>
Q +
Q+ Irb</w>
Pyro phosphate</w>
Pyro gastrone</w>
Pyridox ine-responsive</w>
Pyridox al-5'-phosphate</w>
Pyridox al,</w>
Pyri methamine</w>
Pyri methamine-sulfadoxine</w>
Pyraz inamide-induced</w>
Pyr -
Pyr- His-P
Pyr-His-P ro</w>
Py scho-stimulants</w>
Py rexia,</w>
Py razolones-intolerant</w>
Py k2,</w>
Pv f</w>
Pv f.</w>
Pv O2</w>
Pv O2,</w>
Pv CO2,</w>
Pv ;</w>
Pv ,
Pv, O2</w>
Purpur a.</w>
Puro m-2,</w>
Puro m-2)</w>
Puro m-1)</w>
Pur suant</w>
Pur pose.</w>
Pur cell-Meiboom-Gill</w>
Pup s</w>
Pup illopharmacological</w>
Pup illometric</w>
Pup il-sparing</w>
Pul sed</w>
Pul satility</w>
Pul pal</w>
Puer peral</w>
Puer aria</w>
PubM ed-based</w>
Pub lications</w>
Pub Med
PubMed /
PubMed/ MEDLINE</w>
Pu get</w>
Pu b</w>
Pu '
Pu' uwai</w>
Ptio 2,</w>
Psychostimul ants</w>
Psychostimul ant</w>
Psychosis- resistant</w>
Psychosis- resistant"</w>
Psychosis- prone</w>
Psychosis- prone"</w>
Psychopharmac ology;</w>
Psychopharmac ologic</w>
Psychiatr y;</w>
Psychiatr y,</w>
Psychi atrists</w>
Psych osomatic</w>
Psych osis.</w>
Psych oneuroendocrine</w>
Psych omotor,</w>
Psych ological</w>
Psych ologic</w>
Psych ogenic</w>
Psych ic</w>
Psych L
PsychL it</w>
Psi ,</w>
Pseudo- epileptiform</w>
Pseudo- Bartter</w>
Pseudo- Bartter's</w>
Pseudo thyrotoxic</w>
Pseudo ephedrine,</w>
Pseudo atrophy</w>
Pseudo aneurysms</w>
Pseud otetanus</w>
Pseud osclerodermatous</w>
Pseud oscleroderma</w>
Pseud omembranous</w>
Pseud ococaine</w>
Ps oriatic</w>
Ps om</w>
Prur itus,</w>
Prun g</w>
Prun e</w>
Provoc ative</w>
Prover a;</w>
Protoc ol.</w>
Protoc ol"</w>
Prote osynthesis</w>
Prote omic</w>
Prote ome</w>
Prote oglycans</w>
Prote ins</w>
Prote in,</w>
Prote ases</w>
Prote ase</w>
Prot ects</w>
Prot ected</w>
Prost ate-specific</w>
Prost anoids,</w>
Prost acyclin-like</w>
Pros tigmine-morphine</w>
Propylthiourac il-treated</w>
Propylthio- uracil-induced</w>
Propylthio- uracil,</w>
Propylthio uracil,</w>
Propri etary</w>
Propran olol-exacerbated</w>
Propor tionate</w>
Propofol-Lipuro ,</w>
Propofol- thiopentone</w>
Propofol- ketamine</w>
Propofol -</w>
Propion yl-L-carnitine</w>
Propion yl-</w>
Prophyl axis.</w>
Prophyl atic</w>
Propafen one-related</w>
Propafen one's</w>
Prop ronolol</w>
Prop entofylline</w>
Prop ensity</w>
Prop anolol</w>
Prop acetamol</w>
Prolact inomas</w>
Prolact inoma</w>
Prolact in-secreting</w>
Prolact in,</w>
Prol yl</w>
Prol ab</w>
Project :</w>
Project ,</w>
Project ).</w>
Progres sively,</w>
Program ming</w>
Program med</w>
Program me's</w>
Program matic</w>
Program 's</w>
Progester one-filled</w>
Progester one,</w>
Progest ogenic</w>
Progest ogen</w>
Progest asert</w>
Prog estin</w>
Proechim ys.</w>
Prochlorper azine,</w>
Proce dural</w>
Procain amide,</w>
Probuc ol-associated</w>
Prob it</w>
Prob ation</w>
Prob ation,</w>
Prob ably</w>
Pro-Pro- Pro-
Pro-Pro-Pro- Gly-
Pro-Pro-Pro-Gly- Ly
Pro-Pro-Pro-Gly-Ly s-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val,</w>
Pro- epileptic</w>
Pro- collagen</w>
Pro- Leu-Gly-NH2)</w>
Pro xymetacaine</w>
Pro x-1,</w>
Pro voking</w>
Pro vision</w>
Pro triptyline</w>
Pro toporphyria</w>
Pro t)</w>
Pro spects</w>
Pro scar</w>
Pro posing</w>
Pro portion</w>
Pro paracaine</w>
Pro of</w>
Pro motional</w>
Pro methazine</w>
Pro gram,</w>
Pro graf;</w>
Pro gestational</w>
Pro found,</w>
Pro filnine</w>
Pro files</w>
Pro estrus/estrus</w>
Pro ducts,</w>
Pro duction/release</w>
Pro cysteine</w>
Pro cysteine)</w>
Pro cyclidine</w>
Pro convulsant-treated</w>
Pro cesses</w>
Pro cess</w>
Pro carbazine</w>
Pro c.</w>
Pro biotic</w>
Pro benecid</w>
Pro bably,</w>
Pro arrhythmia,</w>
Pro anthocyanidin</w>
Pro 2,
Pro2, 5,</w>
Primid one/phenobarbital-induced</w>
Primid one-induced</w>
Primi tive</w>
Primi parous</w>
Primar y'</w>
Primar ily,</w>
Prim arily</w>
Pri oritizing</w>
Preven tion,</w>
Preval ences</w>
Preval ence,</w>
Presyn copal</w>
Preser vative-free</w>
Prescri ptions</w>
Prescri ption/event</w>
Presc ribed</w>
Pres ystolic</w>
Pres urgical</w>
Pres surized</w>
Pres sure-volume</w>
Pres s.</w>
Pren ylamine</w>
Pregn enolone,</w>
Pregn ant,</w>
Pregn ancies</w>
Predn isolone,</w>
Predic tor</w>
Precipit ous</w>
Precipit ating</w>
Precipit ated</w>
Prec hemotherapy</w>
Pre- test</w>
Pre- suction</w>
Pre- operative</w>
Pre- loading</w>
Pre- lidocaine</w>
Pre- incubation</w>
Pre- curarization</w>
Pre- cotreatment</w>
Pre- clinical</w>
Pre- chemotherapy</w>
Pre- anesthetic</w>
Pre- administration</w>
Pre vot</w>
Pre vention.</w>
Pre trained</w>
Pre stroke</w>
Pre sident</w>
Pre septal</w>
Pre pulse</w>
Pre pubertal</w>
Pre prodynorphin</w>
Pre parative</w>
Pre neoplastic</w>
Pre mixing</w>
Pre marin</w>
Pre ischemic</w>
Pre ischemia,</w>
Pre ischaemic</w>
Pre injury</w>
Pre ferences</w>
Pre ference</w>
Pre existed</w>
Pre dose</w>
Pre dominantly</w>
Pre dnicarbate</w>
Pre disposition</w>
Pre discharge</w>
Pre defined</w>
Pre cursors</w>
Pre curarization"</w>
Pre contraceptive</w>
Pre conditioning</w>
Pre anaesthetic</w>
Pre admission</w>
Pre administration</w>
Pre S2</w>
Praz osin:</w>
Praz iquantel</w>
Prasu grel</w>
Prasu grel:</w>
Prasu grel,</w>
Pram ipexole-treated</w>
Practition ers.</w>
Practi ce.</w>
Prac t</w>
Pra vastatin-associated</w>
Pra desh.</w>
Pr mt7</w>
Pr incess</w>
Pr Ca</w>
Pr Ca.</w>
Pr Ca,</w>
Pr Ca)</w>
Pr BCM</w>
Pr ),</w>
Pp a</w>
Pp IX,</w>
Pow dered</w>
Potenti ated</w>
Potenti als,</w>
Potassi um-supplemented</w>
Potassi um-magnesium</w>
Potassi um-induced</w>
Pot ent,</w>
Pot ency</w>
Pot encies</w>
Postres t</w>
Post- voiding</w>
Post- vaccination</w>
Post- trial</w>
Post- transplant</w>
Post- transplant,</w>
Post- translational</w>
Post- testing,</w>
Post- synaptic</w>
Post- suxamethonium</w>
Post- status</w>
Post- rifampicin</w>
Post- renal</w>
Post- rapamycin</w>
Post- prandial</w>
Post- partum</w>
Post- operatively</w>
Post- natal</w>
Post- micturition</w>
Post- ischemia,</w>
Post- incubation</w>
Post- heparin</w>
Post- exposure</w>
Post- exercise</w>
Post- cocaine</w>
Post- baseline</w>
Post- RAPA</w>
Post- OLT,</w>
Post- Exposure</w>
Post venographic</w>
Post traumatic</w>
Post trauma</w>
Post transplantation</w>
Post synapticdopamine</w>
Post surgical</w>
Post steroid</w>
Post stenotic</w>
Post prandial</w>
Post partum,</w>
Post occlusion</w>
Post natally</w>
Post ma</w>
Post intervention</w>
Post ganglionic</w>
Post fibrillatory</w>
Post experiment</w>
Post ers</w>
Post endarterectomy</w>
Post delivery</w>
Post contrast</w>
Post cesarean</w>
Post anesthetic</w>
Post al</w>
Post administration</w>
Post --
Post-- paracervical</w>
Pos timplantation</w>
Pos m,</w>
Pos aconazole-increased</w>
Port mann's</w>
Port land.Patients</w>
Porsol t's</w>
Por tugal</w>
Por tions</w>
Por tapres</w>
Por table</w>
Polyradicul oneuropathy</w>
Polygodi al</w>
Polygalasap onins</w>
Polygalasap onin</w>
Poly uria,</w>
Poly saccharide</w>
Poly pharmacy</w>
Poly oxyethylene</w>
Poly myositis/dermatomyositis</w>
Poly myoclonus</w>
Poly morphism</w>
Poly medication</w>
Poly gonum</w>
Poly galae</w>
Poly gala</w>
Poly ethyleneimine</w>
Poly ethylene</w>
Poly ethyleinamine</w>
Poly estradiol</w>
Poly drug</w>
Poly dipsia</w>
Poly arteritis</w>
Pol yps</w>
Pol iclinico</w>
Pol fa")</w>
Pol and</w>
Pol acrilex</w>
Pois -
Pois- son</w>
Poin tes:</w>
Poin tes),</w>
Poin t</w>
Poin t,</w>
Pod ocytes</w>
Pod ocyte-associated</w>
Po sterior-anterior</w>
Po orer</w>
Po oling</w>
Po kklao</w>
Po isoning</w>
Po inters</w>
Po inte.</w>
Po incar</w>
Po doplanin,</w>
Po 2</w>
Pneum omediastinum:</w>
PmO (2).</w>
Pm(O (2)),</w>
Pm(O (2)
Pm(O(2) ):</w>
Plo idy</w>
Platelet- rich-plasma</w>
Platelet- fibrin</w>
Platelet- derived</w>
Platelet- count</w>
Platelet- associated</w>
Platelet- activating</w>
Plasma pheresis,</w>
Plas matic</w>
Plas ma-renin</w>
Plaqu enil.</w>
Plan ned</w>
Plan imetric</w>
Placebo -treated</w>
Placebo -
Placebo- level</w>
Placebo ,</w>
Plac enta</w>
Pl us,</w>
Pl ausible</w>
Pl atin</w>
Pl an,</w>
Pl ain</w>
Pitts burgh,</w>
Pit i</w>
Pis cataway,</w>
Piroxic am</w>
Piroxic am-induced</w>
Pirox antrone,</w>
Piribe dil:</w>
Pirenzep ine-induced</w>
Pir profen-induced</w>
Pir menol</w>
Pir arubicin,</w>
Pir :</w>
Piper onyl</w>
Piper acillin-induced</w>
Pindo lol-induced</w>
Pindo lol,</w>
Pinacidi l,</w>
Pin prick</w>
Pimoz ide-induced</w>
Pilo -treated</w>
Pilo ).</w>
Pig s</w>
Pig mented</w>
Pig ment</w>
Picrotox in,</w>
Pic ture</w>
Pic colo</w>
Pic a</w>
Pi- 2</w>
Pi- 2),</w>
Pi rezepine,</w>
Pi renperone,</w>
Pi peroxan,</w>
Pi edmont</w>
Pi acenza,</w>
Physos tigmine-induced</w>
Physici ans'</w>
Physici an-referred</w>
Physici an,</w>
Physi otherapy</w>
Physi opathologically,</w>
Physi ological,</w>
Physi ol</w>
Physi cally</w>
Phyll anthus.</w>
Phy toconstituents</w>
Phy tochemical</w>
Phot ostimulation</w>
Phot ofrin-mediated</w>
Phot ofrin,</w>
Phot odistributed</w>
Phosphodi esterase-4</w>
Phosphatidyl serine-exposing</w>
Phosphatidyl serine,</w>
Phosphatidyl inositol</w>
Phosph otungstic</w>
Phosph oinositide</w>
Phosph o-Thr-34</w>
Phosph atidyl</w>
Phosph ate</w>
Phosph ate-Buffered</w>
Phob ic</w>
Phleb otomy</w>
Phleb itis,</w>
Philippin es,</w>
Philadelph ia-positive</w>
Philadelph ia-chromosome</w>
Philadelph ia,</w>
Philadelph ia)</w>
Phil ippines</w>
Phenyto in/isradipine</w>
Phenylpropanol amine:</w>
Phenylpropanol amine)</w>
Phenylpropan olamine-induced</w>
Phenyleth ylamine</w>
Phenyleth ylamine-induced</w>
Phenyleth yl</w>
Phenyleph rine,</w>
Phenyleph erine,</w>
Phenylbutaz one,</w>
Phenyl methylsulfonyl</w>
Phenyl hydrazine</w>
Phenter mine</w>
Phenter mine,</w>
Phent olamine-induced</w>
Phenothiaz ine-induced</w>
Phenothiaz ine-associated</w>
Phenobarbit one-induced</w>
Phenobarbit one,</w>
Phenobarbit al-associated</w>
Phen yl-3(2H)-pyridazinon-2-yl-[4-(4-fluorophenyl)piperazinyl]</w>
Phen otypically</w>
Phen otype</w>
Phen omena</w>
Phen olization</w>
Phen ol-evoked</w>
Phen cyclidine</w>
Phen azopyridine-induced</w>
Phen acetin-based</w>
Phe- Met</w>
Phe- Met
Phe-Met (O
Phe-Met(O )-
Phe-Met(O)- ol),</w>
Phe -induced</w>
Phase- II</w>
Phase- I</w>
Pharmacokine tics:</w>
Pharmacokine tic-dynamic</w>
Pharmacokine tic,</w>
Pharmaco vigilance.</w>
Pharmaco therapeutic</w>
Pharmaceutic als)</w>
Pharmaceutic als),</w>
Pharmaceutic al.</w>
Pharmac y</w>
Pharmac ology.</w>
Phar ma</w>
Phar ma,</w>
Pha sic</w>
Pha eochromocytomas</w>
Ph ototoxicity</w>
Ph otobeam</w>
Ph olidotin</w>
Ph lorizin-induced</w>
Ph ased-array</w>
Ph ase,</w>
Ph armCheck</w>
Ph aracogenetic</w>
Ph ,</w>
Ph ),</w>
Pg I
PgI 2.</w>
Pg (CO)</w>
Pf rimmer,</w>
Pf izer</w>
Pf izer),</w>
Pet ursson</w>
Pet echial</w>
Pestic ides</w>
Pestic ide</w>
Pert wee</w>
Persist ently</w>
Persist ence,</w>
Perox isomes</w>
Perme abilization</w>
Perit onsillar</w>
Peripher al,</w>
Period ical</w>
Perio steal</w>
Perio peratively,</w>
Perio ds</w>
Perio dically</w>
Pericardi um-lined</w>
Pericardi tis:</w>
Pericardi tis,</w>
Pericardi ocentesis</w>
Peri- event</w>
Peri- Per
Peri-Per i</w>
Peri vesical</w>
Peri procedural,</w>
Peri ocular</w>
Peri metry</w>
Pergol ide.</w>
Pergol ide-associated</w>
Pergol ide,</w>
Perflutre n.</w>
Per u</w>
Per th,</w>
Per son-years</w>
Per secutory</w>
Per phenazine</w>
Per phenazine-induced</w>
Per petration</w>
Per oxynitrite</w>
Per oxidative</w>
Per oxidase</w>
Per oral</w>
Per niosis</w>
Per mission</w>
Per kins</w>
Per kin-Elmer</w>
Per ispinal</w>
Per ineurial</w>
Per imalleolar</w>
Per ilymph</w>
Per icyazine</w>
Per iconception</w>
Per forant</w>
Per cent</w>
Pepti de,</w>
Pentylenetetra zole</w>
Pentylenetetra zol</w>
Pentobarbit al-induced</w>
Pentobarbit al-anesthetized</w>
Pentazocine- myopathy</w>
Pentazocine- blocked</w>
Pentazoc ine/tripelennamine</w>
Pentazoc ine-treated</w>
Pentam idine-associated</w>
Pentam idine,</w>
Pentagastr in-induced</w>
Pent ylsparteine</w>
Pent olinium</w>
Pent amethylmelamine</w>
Penicill ins</w>
Penicill in-induced</w>
Penicill amine.</w>
Penicill amine,</w>
Pen ny</w>
Pen k2</w>
Pen icous</w>
Pen butolol</w>
Pen az</w>
Pen 2.5
Pen2.5 ]-enkephalin</w>
Pemphig us,</w>
Peme trexed</w>
Peme trexed-associated</w>
Pem oline-associated</w>
Pem oline,</w>
Peg- IFN-alpha2b</w>
Peg IFN</w>
Pedi atrics</w>
Pedi atric-Neurologic-Psychiatric</w>
Peak s</w>
Pe ter</w>
Pe liosis-like</w>
Pe g</w>
Pe floxacin:</w>
Pe floxacin,</w>
Pe er-reviewed</w>
Pe abody</w>
Pdn/P dn.</w>
Pco (2)</w>
Patient -R
Patient-R ated</w>
Pati ents.</w>
Pathophysi ologically</w>
Path ology.</w>
Path ol</w>
Path ol.,</w>
Path ogenicity</w>
Path ogenic</w>
Pat ellar</w>
Pat ch</w>
Pat ch-clamp</w>
Pas pertin)</w>
Particip ating</w>
Partic ulate</w>
Parti tioning</w>
Parti cles,</w>
Parox ysms</w>
Parox etine,</w>
Parom omycin,</w>
Parkinson s</w>
Parkinson ism?</w>
Parkinson ism:</w>
Parkinson ism-aggravating</w>
Parkinson -like</w>
Park er</w>
Park e-Davis)</w>
Park .</w>
Parg yline-induced</w>
Parenter ally</w>
Parenter al-verapamil-induced</w>
Paren ts,</w>
Paren ts'</w>
Paren tal</w>
Paren t-Teacher</w>
Paren chymatous</w>
Paren chymal</w>
Paras itological,</w>
Parap legia:</w>
Parano ia,</w>
Parameter s,</w>
Paralle ls</w>
Paralle lly,</w>
Paralle ling</w>
Paralle l,</w>
Paradoxic ally</w>
Paracetam ol:</w>
Para phenylenediamine</w>
Para hippocampal</w>
Para digm</w>
Par zosin,</w>
Par vovirus</w>
Par ty</w>
Par ts</w>
Par tially</w>
Par inaud</w>
Par icalcitol-treated</w>
Par atrend</w>
Par athion</w>
Par aphilias</w>
Par anoid</w>
Par amedic</w>
Par afoveal</w>
Par affin</w>
Par adiscal'</w>
Papillo ma</w>
Papillo edema</w>
Papaver ine,</w>
Pantop razole-induced</w>
Pancre atic</w>
Panam anian</w>
Pan ventricular</w>
Pan niculitis,</w>
Pan ickers</w>
Pan ic-Associated</w>
Pan handle</w>
Pan eth</w>
Pamid ronate-induced</w>
Palli ator</w>
Palli ative</w>
Pal pebral</w>
Pal o</w>
Pal mar</w>
Pakist ani</w>
Pakist an</w>
Pair -matched</w>
Pain less</w>
Pain --
Pain-- Ninth</w>
Pad ua).</w>
Paclitaxel/ carboplatin</w>
Paclitaxel :</w>
Pac o2,</w>
Pac ked</w>
Pac kage</w>
Pac ing</w>
Pac iltaxel</w>
Pac e</w>
Pab2- HRP)</w>
PaCO 2=
PaCO2= 26</w>
PaCO 2).</w>
PaCO (2).</w>
Pa ul</w>
Pa ul,</w>
Pa recoxib</w>
Pa ir</w>
Pa eoniflorin</w>
Pa eonia</w>
Pa ediatricians</w>
Pa O2.</w>
Pa O(2)</w>
Pa (O
Pa(O (2))</w>
Pa (CO2),</w>
Pa (CO)</w>
PY s</w>
PY 719</w>
PY 343-Stat5</w>
PY 343-
PY343- mediated</w>
PW V/BP</w>
PW TT.</w>
PW Rs</w>
PW P</w>
PW L.</w>
PVT s.</w>
PVT )-associated</w>
PVC 's.</w>
PVB s</w>
PVB EC
PVBEC DN
PVBECDN X,</w>
PVAB EC</w>
PVAB EC
PVABEC -like</w>
PV/ SS/CCK-immunopositive</w>
PV- immunpositive</w>
PV U</w>
PV S,</w>
PV RI:</w>
PV RI.</w>
PV R/SVR</w>
PV N-induced</w>
PV M
PVM -related</w>
PV L)</w>
PV F</w>
PV F.</w>
PV Cs.</w>
PV Cs,</w>
PV Cs)</w>
PV C.</w>
PV C,</w>
PV B</w>
PV B.</w>
PV B-therapy</w>
PV A-
PVA- drops.</w>
PV ;</w>
PV .</w>
PV -,</w>
PV )
PV) -16</w>
PURPO SE/OBJECTIVES:</w>
PUF A-treated</w>
PU VA</w>
PU T.</w>
PU I.</w>
PU B
PUB MED,</w>
PTZ- seizure,</w>
PTZ ;</w>
PTZ --and</w>
PTZ ),</w>
PTU -related</w>
PTP beta)</w>
PTH -r
PTH-r P.</w>
PTH -induced</w>
PTH -independent</w>
PTH (1-
PTH(1- 34
PTH(1-34 )]</w>
PTA- AM,</w>
PTA- AM
PTA-AM ;</w>
PT/ INR</w>
PT s.</w>
PT s)</w>
PT X-mediated</w>
PT X,</w>
PT X)</w>
PT U)</w>
PT T.</w>
PT SD-specific</w>
PT RA</w>
PT RA.</w>
PT N,</w>
PT LD</w>
PT L.</w>
PT EN,</w>
PT E.</w>
PT E,</w>
PT C,</w>
PT ;</w>
PT :</w>
PT 1</w>
PT ).</w>
PSP s)</w>
PSP MT,</w>
PSA- decline</w>
PSA- NCAM</w>
PS/ PC-
PS/PC- injected</w>
PS ST</w>
PS P.</w>
PS P,</w>
PS AD,</w>
PS A.</w>
PS A,</w>
PS >or=
PS>or= 60%</w>
PS ;</w>
PRO scar</w>
PRO TOCOL:</w>
PRO SPECT</w>
PRO M</w>
PRO L</w>
PRO L.</w>
PRO G</w>
PRO B
PROB AB
PROBAB LE.</w>
PRO ACT</w>
PRO ,</w>
PRO )</w>
PRL- lowering</w>
PRL- AB
PRL-AB -induced</w>
PRIS -associated</w>
PRIN CI
PRINCI PL
PRINCIPL ES:</w>
PRE SS</w>
PRE S</w>
PRE S.</w>
PRE NAT
PRENAT AL</w>
PRE -</w>
PRACTI CAL</w>
PR3- ANCA,</w>
PR3- ANCA),</w>
PR- II</w>
PR s,</w>
PR oFESS</w>
PR V/SVR</w>
PR P.</w>
PR OD,</w>
PR M.</w>
PR LE</w>
PR L-induced</w>
PR IT,</w>
PR IT)</w>
PR IE)</w>
PR I),</w>
PR F</w>
PR C,</w>
PR BC.</w>
PR B</w>
PR B,</w>
PR B
PRB Cs</w>
PR ALL</w>
PR A;</w>
PR ;</w>
PR /
PR/ QT</w>
PR .(ABSTRACT</w>
PR -3,</w>
PR -,</w>
PR ).</w>
PR 's,</w>
PPO H,</w>
PPARalpha- null</w>
PPARalpha- /-</w>
PPAR- I
PPAR-I +/-</w>
PPAR gamma</w>
PPAR alpha/gamma</w>
PPA DS.</w>
PPA DS-
PPADS- sensitive,</w>
PPA DS
PPADS -</w>
PPA -related</w>
PPA -mediated</w>
PPA -associated</w>
PP i</w>
PP i)</w>
PP T</w>
PP SI)</w>
PP S</w>
PP S.</w>
PP S)</w>
PP R</w>
PP N</w>
PP N.</w>
PP I-induced</w>
PP H-
PPH- scavenging</w>
PP F.</w>
PP F,</w>
PP C.</w>
PP C,</w>
PP 2B</w>
PP 2)</w>
PP 2
PP2 A,</w>
PP +).</w>
PP )],</w>
POST- atropine</w>
POST- atropine,</w>
POR C.</w>
POPUL ATION</w>
PON V,</w>
POD 6,</w>
POD 30</w>
POD 1</w>
POD 0</w>
POD ,</w>
PO4 (3-
PO4(3- )</w>
PO4 (-
PO4(- 3),</w>
PO- na</w>
PO x).</w>
PO pulation</w>
PO UNDS.</w>
PO TS</w>
PO TS.</w>
PO MC-
POMC- derived</w>
PO MC),</w>
PO LD
POLD IP
POLDIP 3)</w>
PO INT
POINT ):</w>
PO H,</w>
PO CD.</w>
PO A.</w>
PO A,</w>
PO 2.</w>
PO 2)</w>
PO );</w>
PO (4),</w>
PO (4)
PO(4) (3-
PO(4)(3- ),</w>
PO (2)</w>
PN T</w>
PN PO)</w>
PN MT-
PNMT- negative.</w>
PN G</w>
PN A-injected</w>
PN ;</w>
PN 9</w>
PN -induced</w>
PMSF/ GF</w>
PMSF/ 1.5</w>
PMS F-treated</w>
PMS F-
PMSF- 4</w>
PMS F
PMSF -14</w>
PMN L</w>
PMN L,</w>
PMN /
PMN/ 50</w>
PM/ DM,</w>
PM/ ACEi</w>
PM/ ACEi.</w>
PM s,</w>
PM s).</w>
PM P)</w>
PM OH.</w>
PM /kg</w>
PM -treated</w>
PM --at</w>
PLT s</w>
PLK ;</w>
PLK /P
PLK/P NPO</w>
PLA/ RIS</w>
PLA/ RIS)</w>
PL3 25).</w>
PL3 19-
PL319- PL325).</w>
PL- DOX.</w>
PL s</w>
PL s)</w>
PL V.</w>
PL T</w>
PL SN.</w>
PL N</w>
PL M,</w>
PL G.</w>
PL E</w>
PL E;</w>
PL E.</w>
PL C/TOF-
PLC/TOF- MS
PLC/TOF-MS )-based</w>
PL C.</w>
PL C,</w>
PL A2G
PLA2G 6</w>
PL )-induced</w>
PL ),</w>
PKC zeta</w>
PKC gamma,</w>
PKC gamma)</w>
PKC eta,</w>
PKC delta</w>
PKC delta,</w>
PKC alpha,</w>
PK- PD</w>
PK s)</w>
PK R</w>
PK R2.</w>
PK R1:</w>
PK C)</w>
PK ,</w>
PK ),</w>
PJ 34,</w>
PIP s</w>
PIP s.</w>
PIP S</w>
PILO- plus-WAR</w>
PILO- injected</w>
PIL O)</w>
PIIIN P.</w>
PIC RO-,</w>
PIC .</w>
PIC ,</w>
PI3K /
PI3K/ Akt/
PI3K/Akt/ GSK3beta</w>
PI3 K</w>
PI3 K-
PI3K- Akt</w>
PI RO)</w>
PI Q</w>
PI P,</w>
PI L,</w>
PI HF</w>
PI HF.</w>
PI H</w>
PI H
PIH F,</w>
PI AS).</w>
PI A,</w>
PI >
PI> 29.</w>
PI ;</w>
PI 3</w>
PHEN -treated</w>
PHARM O-
PHARMO- database,</w>
PHA-L- labelled</w>
PHA-L- immunopositive</w>
PHA- L</w>
PH d),</w>
PH T;</w>
PH S)</w>
PH PA.</w>
PH OS)</w>
PH EN,</w>
PH E,</w>
PH E
PHE N/
PHEN/ FEN</w>
PH ;</w>
PH 1).</w>
PH )--in</w>
PGP 9.5,</w>
PGI- M.</w>
PGI- I</w>
PGI 2)</w>
PGF(2 a)</w>
PGF 2a</w>
PGF (2</w>
PGE 2-,</w>
PGE 2-
PGE2- evoked</w>
PGE 2)</w>
PGE 1-</w>
PGE 1)</w>
PGE .</w>
PGE (1)-H</w>
PG/ RANK/RANKL</w>
PG/ ML</w>
PG- group</w>
PG- group.</w>
PG- catabolizing</w>
PG ].</w>
PG WB,</w>
PG T),</w>
PG S;</w>
PG P,</w>
PG N).</w>
PG K
PGK PA
PGKPA DD
PGKPADD AG
PGKPADDAG LV,</w>
PG J2</w>
PG H),</w>
PG D2-induced</w>
PG D(2),</w>
PG C
PGC -1a</w>
PG AR</w>
PG AD
PGAD S</w>
PG A),</w>
PG :</w>
PG 2)</w>
PFT- alpha.</w>
PF4/ heparin-reactive</w>
PF X)-induced</w>
PF T)</w>
PF S.</w>
PF S,</w>
PF R</w>
PF R:</w>
PF C);</w>
PF C),</w>
PF 4.</w>
PF 4),</w>
PF ).</w>
PES B,</w>
PER IC
PERIC O</w>
PER 2</w>
PER 2)</w>
PEP line]</w>
PEP I
PEPI :
PEPI: LVE
PEPI:LVE TI</w>
PEG-IFN- based</w>
PEG-IFN- associated</w>
PEG-IFN- alpha2a</w>
PEG-IFN- alpha2a,</w>
PEG- asparaginase</w>
PEG- IFN/ribavirin</w>
PEG- IFN/
PEG-IFN/ RBV-induced</w>
PEG- IFN.</w>
PEG- IFN-alpha</w>
PEG US,</w>
PEG SOD</w>
PEF R),</w>
PED F.</w>
PECAM -1</w>
PECAM -1-
PECAM-1- reactive</w>
PEAR LS</w>
PE T-obtained</w>
PE T-based</w>
PE SPL</w>
PE SB</w>
PE S,</w>
PE P-
PEP- ratio</w>
PE P,</w>
PE M</w>
PE M).</w>
PE G</w>
PE G.</w>
PE F.</w>
PE B-therapy</w>
PE A-induced</w>
PE -induced</w>
PE -C)</w>
PE +
PE+ O2)</w>
PDQ- 39</w>
PDQ- 39,</w>
PDGF- B.</w>
PDE 5A</w>
PDE 4,</w>
PDE 3
PDE3 B,</w>
PD980 59</w>
PD980 59,</w>
PD9 8.</w>
PD117, 503</w>
PD117, 302</w>
PD-1233 19</w>
PD s,</w>
PD s)</w>
PD YN</w>
PD Ts)</w>
PD T.</w>
PD T-related</w>
PD T-induced</w>
PD SLG,</w>
PD SLG)</w>
PD SK</w>
PD SK.</w>
PD S);</w>
PD R</w>
PD R)</w>
PD PE),</w>
PD P.</w>
PD I),</w>
PD H.</w>
PD GFR-
PDGFR- beta,</w>
PD GF
PDGF -dependent</w>
PD G)</w>
PD G),</w>
PD C,</w>
PD ;</w>
PD 40</w>
PD 40,</w>
PD 35</w>
PD 35,</w>
PD 30</w>
PD 21.</w>
PD 14
PD14 50
PD1450 65,</w>
PD )-deficient</w>
PD ),
PD), but,</w>
PD (90
PD(90 S)</w>
PCa ),</w>
PCW P,</w>
PCV ;</w>
PCV 7</w>
PCO 2.</w>
PCO -induced</w>
PCNA- positive</w>
PCB -treated</w>
PCB -
PCB- contaminated</w>
PCA Ps</w>
PCA -</w>
PC x)</w>
PC s).</w>
PC _C)</w>
PC Z)</w>
PC WP</w>
PC T)</w>
PC S</w>
PC S)</w>
PC PA,</w>
PC P-like</w>
PC NA.</w>
PC NA,</w>
PC EA.</w>
PC C-treated</w>
PC :LPC</w>
PC 2</w>
PC 2,</w>
PC -</w>
PC -12</w>
PC )-
PC)- and</w>
PB- treatment</w>
PB- promotion</w>
PB- administered</w>
PB S;</w>
PB S,</w>
PB R.</w>
PB O.</w>
PB O-induced</w>
PB O
PBO :</w>
PB N.</w>
PB N,</w>
PB N)</w>
PB N).</w>
PB N),</w>
PB M</w>
PB L</w>
PB F)</w>
PB CA</w>
PB C.</w>
PB C),</w>
PB -pretreated</w>
PB -containing</w>
PB -</w>
PAl do</w>
PAl do,</w>
PAX- 2</w>
PAX- 2/
PAX-2/ CK8</w>
PATIENT S--METHODS:</w>
PAS +</w>
PARTICIPANT :</w>
PAR S)</w>
PAR P-1</w>
PAR K
PARK 2;</w>
PAR G</w>
PAR DL
PARDL AR
PARDLAR S.</w>
PANS S-derived</w>
PAN/ 100
PAN/100 g</w>
PAN- rats,</w>
PAN- MCNS,</w>
PAN- FSGS,</w>
PAN /</w>
PAN -</w>
PAN +
PAN+ CsA).</w>
PAN 's</w>
PACP P,</w>
PACE 4</w>
PACE 4.</w>
PACAP- /-</w>
PACAP- /-)</w>
PACAP 6-
PACAP6- 38,</w>
PACAP 27</w>
PACAP +/-
PACAP+/- .</w>
PAC(1) null,</w>
PAC(1) HOP
PAC(1)HOP 1,</w>
PAC TG</w>
PAC AP,</w>
PAC ,</w>
PA/ kainate)</w>
PA/ XI</w>
PA- pretreated</w>
PA- injection,</w>
PA- injection).</w>
PA- elicited</w>
PA- KA)</w>
PA Z</w>
PA X2</w>
PA T)</w>
PA SS</w>
PA SS,</w>
PA SI</w>
PA SI).</w>
PA S-positive</w>
PA RS</w>
PA P.</w>
PA P),</w>
PA O)</w>
PA MN</w>
PA M,</w>
PA M
PAM N,</w>
PA LA,</w>
PA K.</w>
PA IgG</w>
PA GE</w>
PA F-induced</w>
PA F-
PAF- acetylhydrolase</w>
PA Ds</w>
PA 9</w>
PA 1-/-)</w>
PA -type</w>
P=1.00 0)</w>
P=1.00 0),</w>
P=0.000 9)</w>
P=0.000 6,</w>
P=0.00 9).</w>
P=0.00 8).</w>
P=0.00 7</w>
P=0.00 76</w>
P=0.00 7).</w>
P=0.00 7),</w>
P=0.00 65
P=0.0065 ],</w>
P=0.00 6)</w>
P=0.00 6),</w>
P=0.00 5)</w>
P=0.00 5),</w>
P=0.00 4</w>
P=0.00 42).</w>
P=0.00 4)</w>
P=0.00 4),</w>
P=0.00 32),</w>
P=0.00 3).</w>
P=0.00 2,</w>
P=0.00 1</w>
P=0.0 99)</w>
P=0.0 9)</w>
P=0.0 7).</w>
P=0.0 62)</w>
P=0.0 6
P=0.06 6.</w>
P=0.0 499)</w>
P=0.0 45),</w>
P=0.0 44),</w>
P=0.0 43)</w>
P=0.0 4,</w>
P=0.0 4),</w>
P=0.0 3</w>
P=0.0 3;</w>
P=0.0 36)</w>
P=0.0 36).</w>
P=0.0 33).</w>
P=0.0 310,</w>
P=0.0 30),</w>
P=0.0 3).</w>
P=0.0 3),</w>
P=0.0 2</w>
P=0.0 29).</w>
P=0.0 28;</w>
P=0.0 27)</w>
P=0.0 25).</w>
P=0.0 24).</w>
P=0.0 23);</w>
P=0.0 1;</w>
P=0.0 18)</w>
P=0.0 17).</w>
P=0.0 16).</w>
P=0.0 16),</w>
P=0.0 14).</w>
P=0.0 12)</w>
P=0.0 12).</w>
P=0.0 11)</w>
P=0.0 10).</w>
P=0.0 1,</w>
P=0. 385)</w>
P=0. 35
P=0.35 1),</w>
P=0. 292)</w>
P=0. 27
P=0.27 6).</w>
P=0. 20);</w>
P=0. 192)</w>
P=0. 19).</w>
P=0. 18).</w>
P=0. 17)</w>
P=.0 55)</w>
P=.0 49).</w>
P=.0 44)</w>
P=.0 3).</w>
P=.0 2].</w>
P=.0 23).</w>
P=.0 2).</w>
P=.0 2),</w>
P=.0 1</w>
P=.0 17).</w>
P=.0 1)</w>
P=.0 1).</w>
P=. 68).</w>
P=. 22).</w>
P= NS.</w>
P= NS,</w>
P= NS),</w>
P= 0.</w>
P= 0.78).</w>
P= 0.71,</w>
P= 0.66,</w>
P= 0.65).</w>
P= 0.41).</w>
P= 0.4
P=0.4 9)</w>
P= 0.3
P=0.3 3;</w>
P= 0.21).</w>
P= 0.0003).</w>
P= 0.000)</w>
P= .008),</w>
P= .004).</w>
P= .003)</w>
P= .002</w>
P= .001)</w>
P= .0000
P=.0000 6).</w>
P<0.001 ].</w>
P<0.00 5]</w>
P<0.00 5],</w>
P<0.00 4)</w>
P<0.00 3
P<0.003 125)</w>
P<.000 6)</w>
P<.000 2)</w>
P< 0.05.</w>
P< 0.03
P<0.03 5)</w>
P< 0.02;</w>
P< 0.02).</w>
P< 0.02),</w>
P< 0.01;</w>
P< 0.01,</w>
P< 0.005)</w>
P< 0.005).</w>
P< 0.003).</w>
P< 0.001</w>
P< 0.001,</w>
P< 0.0005,</w>
P< 0.0005).</w>
P< 0.0001;</w>
P< 0.0001),</w>
P< .05).</w>
P< .05),</w>
P< .015)</w>
P< .002).</w>
P< .001</w>
P< .0001)</w>
P< .0001).</w>
P: PA</w>
P: =0.02</w>
P: =
P:= NS).</w>
P: <0.05).</w>
P6 s</w>
P6 s,</w>
P450sc c.</w>
P450 cc</w>
P450 IIB-
P450IIB- selective</w>
P450 2C</w>
P450 1A2</w>
P450 1A1/1A2,</w>
P450 /
P450/ CCl4</w>
P450 .</w>
P450 -1
P450-1 A2,</w>
P400 +
P400+ VIT</w>
P4 A)</w>
P4 50-
P450- derived</w>
P4 5.</w>
P2X 4</w>
P2X 3/
P2X3/ P2X2/3</w>
P2X 2+
P2X2+ 3</w>
P2X 1,</w>
P2X (2/3)</w>
P2R- extrasystole</w>
P2- wave</w>
P2- component,</w>
P2- SeV/DeltaF)</w>
P2- P4</w>
P2 Y)</w>
P2 A)</w>
P2 2.</w>
P2 2,</w>
P2 -</w>
P2 )-
P2)- eluting</w>
P1- enhancement</w>
P1- P2</w>
P1- N1</w>
P/d t(max)</w>
P/Q -</w>
P/ taxanes-containing</w>
P/ kg</w>
P/ UTP),</w>
P/ SP</w>
P/ S)</w>
P/ Q</w>
P/ O,</w>
P/ J).</w>
P/ DeltaMAP</w>
P/ D,</w>
P/ ATP)</w>
P/ 3/4,</w>
P/ +
P/+ cyclic</w>
P.I. B.</w>
P.I. B
P.I.B .),</w>
P. R.</w>
P. O.)</w>
P. Furthermore,</w>
P-glyco proteine</w>
P-glyco protein;</w>
P-glyco protein),</w>
P-g p.</w>
P-g Ly
P-gLy coprotein</w>
P-SM Z)</w>
P-S G.</w>
P-BM C)</w>
P-450 .</w>
P-10 3),</w>
P-1 5
P-15 34</w>
P-1 12),</w>
P- waves,</w>
P- to-ATP</w>
P- sensitive</w>
P- selectin,</w>
P- responses</w>
P- overexpressing</w>
P- loop,</w>
P- labeled</w>
P- groups</w>
P- exposed</w>
P- domains</w>
P- derivatives</w>
P- deficient</w>
P- chlorophenylalanine</w>
P- changes.</w>
P- VABEC</w>
P- SH</w>
P- P450)</w>
P- OAE</w>
P- LI</w>
P- LI)</w>
P- H
P-H NP)</w>
P- GA)</w>
P- D),</w>
P- ATP
P-ATP ),</w>
P- ANCA</w>
P- ADR</w>
P- 60</w>
P- 3H</w>
P- 3.0,</w>
P- 3)</w>
P- 2)</w>
P- -
P-- K</w>
P+ CTR.</w>
P+ 4MA,</w>
P+ ).</w>
P)- type</w>
P)- expressing</w>
P)- a</w>
P)- PCR</w>
P(2y 4),</w>
P(2y 2),</w>
P ustuloderma.</w>
P ush-pull</w>
P urkinge</w>
P urine</w>
P unding</w>
P unding"</w>
P unctate</w>
P unch</w>
P tychopetalum</w>
P ty</w>
P ts</w>
P sycLIT</w>
P soralea</w>
P soas</w>
P seudemys</w>
P ricing</w>
P reveious</w>
P respecified</w>
P recision</w>
P ratt,</w>
P ra</w>
P r-5,6-ADTN</w>
P pa-Pla</w>
P orges'</w>
P ontine</w>
P nd</w>
P lots</w>
P leuropericardial</w>
P lethsymographic</w>
P ixantrone</w>
P ivampicillin</w>
P ituitary-adrenal</w>
P ithing</w>
P ir</w>
P inealectomy</w>
P im-1</w>
P ifithrin-alpha</w>
P ickavance</w>
P ic)</w>
P i.</w>
P i,</w>
P h</w>
P feizer</w>
P eyronie's</w>
P ers.</w>
P erez</w>
P er</w>
P eptide</w>
P en,</w>
P eltier-controlled</w>
P edsQL.</w>
P edal</w>
P e</w>
P dn</w>
P atel</w>
P ast-year</w>
P assive--active</w>
P ase,</w>
P ase)</w>
P article</w>
P armacogenetic</w>
P aresis</w>
P antothenic</w>
P an-American</w>
P all</w>
P alkovits'</w>
P ale</w>
P aired-pulse</w>
P agani</w>
P a</w>
P ]</w>
P ];</w>
P Zn</w>
P Z-dependent</w>
P Z,</w>
P Y-mutant</w>
P Y,</w>
P XR</w>
P UFA)</w>
P SR),</w>
P SP</w>
P SNS</w>
P SLG</w>
P SLG,</w>
P SE</w>
P SD</w>
P SD.</w>
P SC.</w>
P SC,</w>
P SA)</w>
P S-exposure</w>
P S).</w>
P QTS</w>
P Q-interval.</w>
P Q,</w>
P PH).</w>
P PGKPADDAGLV,</w>
P PG.</w>
P PG,</w>
P PD.</w>
P PA-pretreated</w>
P P,</w>
P NT-
PNT- potentiated</w>
P NT
PNT .</w>
P NG,</w>
P ND
PND s</w>
P N-
PN- reducing</w>
P MDD,</w>
P M).</w>
P KG
PKG -K+</w>
P IR</w>
P IN</w>
P I-3
PI-3 K</w>
P I-
PI- signalling</w>
P HD).</w>
P F.</w>
P ECs</w>
P CT.</w>
P CT-treated</w>
P CO2,</w>
P CO2)</w>
P CI:</w>
P CD.</w>
P CAP</w>
P CAP.</w>
P CA.</w>
P CA-treated</w>
P BPC.</w>
P BP
PBP CT.</w>
P BMC</w>
P ACE</w>
P >
P> 0.6</w>
P 9</w>
P 9.</w>
P 9)</w>
P 80</w>
P 80.</w>
P 75.</w>
P 75
P75 :</w>
P 600.</w>
P 6)</w>
P 56,</w>
P 50:</w>
P 50)</w>
P 49</w>
P 45</w>
P 42,</w>
P 41</w>
P 4).</w>
P 3;</w>
P 39</w>
P 39).</w>
P 388</w>
P 388)</w>
P 35</w>
P 35.</w>
P 35,</w>
P 32
P32 T)</w>
P 30s</w>
P 30,</w>
P 30).</w>
P 30
P30 s,</w>
P 3)</w>
P 3),</w>
P 29</w>
P 29.</w>
P 25.</w>
P 200
P200 )</w>
P 20)</w>
P 2)</w>
P 16</w>
P 16.</w>
P 120</w>
P 12.</w>
P 11</w>
P 11,</w>
P 104.</w>
P 100</w>
P 100
P100 :</w>
P 10.</w>
P 1.</w>
P 0.5,</w>
P .,</w>
P .)</w>
P -related</w>
P )]</w>
P )-positive</w>
P (ic
P(ic a)</w>
P (i)</w>
P (O2)</w>
P (FK506</w>
P (CO2)</w>
P (CO)</w>
P (-1)</w>
P (-1),</w>
P (+))</w>
P (+)
P(+) cells</w>
P "</w>
P ").</w>
Oxytoc in-related</w>
Oxytoc in-induced</w>
Oxytoc in,</w>
Oxy tetracycline-induced</w>
Oxy morphone's</w>
Oxy metazoline</w>
Oxy genated</w>
Oxy gen-derived</w>
Oxy demeton-methyl,</w>
Oxy butynin</w>
Oxid ant-induced</w>
Oxcarbazep ine-induced</w>
Oxcarbazep ine-associated</w>
Oxaproz in</w>
Oxand rin</w>
Oxand rin,</w>
Oxamniqu ine,</w>
Oxali platin-related</w>
Oxali platin-induced</w>
Oxali platin,</w>
Oxacill in-associated</w>
Oxacill in,</w>
Ox-ph os,</w>
Ox prenolol,</w>
Ox otremorine-induced</w>
Ox itropium</w>
Ox idation</w>
Ox alotransaminase</w>
Ox aloacetic</w>
Over- the-Counter</w>
Over whelming</w>
Over view</w>
Over stimulation</w>
Over production</w>
Over lay</w>
Over ingestion</w>
Over flow</w>
Ov ulation</w>
Out break</w>
Ouabain -</w>
Ouabain 's</w>
Otot oxicity,</w>
Otorhinolaryng ology</w>
Otorhinolaryng ologic</w>
Otolaryng ologists</w>
Ot t,</w>
Ot suka</w>
Ot ologico,</w>
Ot ological</w>
Ot %),</w>
Oster g</w>
Oste opathic</w>
Oste onecrosis</w>
Oste omalacia</w>
Osmo receptor</w>
Osc illopsia</w>
Osc illometry</w>
Osc illometric</w>
Osc illations</w>
Os seous</w>
Os s,</w>
Orthopa edics</w>
Orthopa edic</w>
Orth opedic</w>
Orth onovum777</w>
Orth ocarboxybenzeno-seleninic</w>
Orig inally</w>
Orig inal</w>
Orig in</w>
Ori entation</w>
Ori ental</w>
Orgas mic</w>
Organophosph orus-induced</w>
Organ ochlorine</w>
Organ ized</w>
Organ ization;</w>
Organ ization.</w>
Organ ization,</w>
Organ isation)</w>
Organ elles</w>
Org an-specific</w>
Org 27
Org27 66,</w>
Oreg on)</w>
Oral- ibuprofen-induced</w>
Oral- contraceptive</w>
Orac on,</w>
OraVer se,</w>
Or tiz,</w>
Or thodromic</w>
Or phanin</w>
Or dinal</w>
Or chiectomy</w>
Or bital/insular</w>
Or al,</w>
Optim ized</w>
Optim ising</w>
Optim ally,</w>
Opioid- insensitive</w>
Opioid- exposed</w>
Opio id-related</w>
Opio id-</w>
Ophthalmo logy,</w>
Ophthal moplegia</w>
Oper ations</w>
Oper ational</w>
Open- chest</w>
Open- chest,</w>
Opan a</w>
Opan a,</w>
Op tison.</w>
Op positely</w>
Op posing</w>
Op isthotonus</w>
One-hundred-and- twenty</w>
One-hundred-and- sixty-nine</w>
One-hundred-and- forty-three</w>
One-hundred-and- fifty</w>
One-hundred- fifty</w>
One- year,</w>
One- week</w>
One- sided</w>
One- percent</w>
One- ml</w>
One- methyl</w>
One- hour</w>
One- dimensional</w>
Onco logia</w>
Onco l</w>
Onco genesis</w>
On- medication</w>
On- line,</w>
On- demand</w>
On- Line</w>
On- L-dopa</w>
On togeny</w>
On togenic</w>
On sets</w>
On cor,</w>
On "</w>
Omniscan -treated</w>
Omniscan )</w>
Omeprazol e;</w>
Omeprazol e.</w>
Omeprazol e-related</w>
Om phalocele-exstrophy-imperforate-anus-spina</w>
Om apatrilat,</w>
Oligo hydramnios,</w>
Oligo ethylene</w>
Oligo anuric</w>
Olig uria,</w>
Ole amide,</w>
Olanzap ine-induced</w>
Olanzap ine-associated</w>
Olanzap ine-</w>
Olanzap ine,</w>
Olan zipine</w>
Ol sen,</w>
Ol msted</w>
Ol der,</w>
Oklah oma</w>
Oklah oma.</w>
Okla homa,</w>
Oic 8]-
Oic8]- bradykinin)</w>
Ohi o.</w>
Ohi o)</w>
Oh ta's</w>
Oh meda).</w>
Off- medication</w>
Off- line</w>
Off "</w>
Oddi :</w>
Oct yl-4H-1,3,2-benzodioxaphosphorin</w>
Oct amethylcyclotetrasiloxane</w>
Occasion ally</w>
Oc tober,</w>
Oc curring</w>
Oc cult</w>
Oc clusion</w>
Oc clusion-induced</w>
Oc cluded</w>
Obj ectively,</w>
Obj ectifying</w>
Ob vious</w>
Ob tundation,</w>
Ob tained</w>
Ob jectives</w>
Ob esity</w>
Ob ese</w>
Oatp 4</w>
Oatp 1</w>
Oatp 1.</w>
Oatp 1,</w>
Oat 3</w>
Oat 1/3</w>
Oat 1,</w>
OXY- NC,</w>
OXY- CS,</w>
OXO- metabolite</w>
OXO- D3,</w>
OX O-induced</w>
OX CBZ</w>
OX CBZ,</w>
OX C-induced</w>
OX :
OX: P)</w>
OX 8</w>
OX 6</w>
OX 5</w>
OX 42</w>
OX 19
OX19 +</w>
OX 1
OX1 +,</w>
OVCA R-3</w>
OVCA R-3,</w>
OV X,</w>
OV ID</w>
OV I
OVI D-based</w>
OV 100</w>
OT Z.</w>
OT O
OTO X)</w>
OT /
OT/ GPT)</w>
OT -associated</w>
OS ".</w>
OR- coated</w>
OR- 25%),</w>
OR R),</w>
OR O</w>
OR N</w>
OR N).</w>
OR L
ORL 1),</w>
OR DER</w>
OR AC(-ROO
ORAC(-ROO o)</w>
OR ;</w>
OR 6</w>
OR -1)</w>
OR ),</w>
OPN- positive</w>
OPN- negative</w>
OPID P</w>
OPID N-
OPIDN- causing</w>
OPC-145 97.</w>
OPC-145 97-induced</w>
OPC-145 97,</w>
OPC -1
OPC-1 30
OPC-130 13)</w>
OP r)</w>
OP P.</w>
OP N,</w>
OP F)</w>
OP C-312
OPC-312 60,</w>
OP (90
OP(90 ):</w>
OP (30
OP(30 ):</w>
ONO-87 11),</w>
ONO- AE-
ONO-AE- 24
ONO-AE-24 8,</w>
ONME M.</w>
ONME M).</w>
ON S)</w>
ON ES:</w>
ON CO
ONCO PAZ</w>
ON -like</w>
ON -drug</w>
ON -</w>
ON '</w>
ON "</w>
OLT s,</w>
OLT X,</w>
OLT X).</w>
OL Z</w>
OL Z/CLZ-treated</w>
OL P.</w>
OL AN</w>
OK Y-046</w>
OK HA
OKHA WA</w>
OI s/1,000</w>
OI L</w>
OI L.</w>
OI ;</w>
OHD PAT,</w>
OHD ),</w>
OHC s.</w>
OH-H Q)</w>
OH- 5alpha-pregnan-20-
OH-5alpha-pregnan-20- one</w>
OH P.</w>
OH EM).</w>
OH E)</w>
OH C</w>
OH ),</w>
OH ))</w>
OG N-
OGN- ,</w>
OG C/
OGC/ torticollis</w>
OFQ/ N</w>
OFQ/ N.</w>
OFQ/ N,</w>
OFF- drug</w>
OFF '</w>
OFF ".</w>
OF S,</w>
OF S).</w>
OF Q)</w>
OF P</w>
OF P.</w>
OF H.</w>
OF F.</w>
OF ;
OF; 462</w>
OEF s</w>
OE IS</w>
OE A,</w>
ODN s.</w>
ODN s-treated</w>
OD T,</w>
OD S.</w>
OD Q).</w>
OD O
ODO X-M)</w>
OD E)</w>
OD ></w>
OD ),</w>
OBSERV ATION</w>
OBSERV ATION:</w>
OBJECTIVE S.</w>
OBJECTIVE (S):</w>
OBJECTIVE ">
OBJECTIVE"> To</w>
OBJECTIVE "</w>
OB PM</w>
OB PM.</w>
OB I),</w>
OB DPO</w>
OB DPO
OBDPO -induced</w>
OB )-induced</w>
OB ),</w>
OAT 3,</w>
OAT 1.</w>
OAT ,</w>
OAT ),</w>
OA Y).</w>
OA E)</w>
O: O2.</w>
O2/ min.</w>
O2/ balance</w>
O2- enriched</w>
O2- concentrations</w>
O2- carrying</w>
O2- anesthesia.</w>
O/ min/mg</w>
O/ (CH2O</w>
O. D.,</w>
O-de methylation</w>
O-de alkylation</w>
O-1 602</w>
O-1 101),</w>
O- tetradecanoylphorbol-13-acetate</w>
O- stained</w>
O- sensitive</w>
O- methyldopa</w>
O- infused</w>
O- glycosylation</w>
O- exposed</w>
O- alk-1'-enyl-2-acyl-GPE</w>
O- acetyltransferase</w>
O- acetyl-D-glucaro-1,4-6,3-dilactone</w>
O- NO
O-NO GO</w>
O- NAF</w>
O- 02)</w>
O- (2,4,6-
O-(2,4,6- trinitrophenyl)adenosine</w>
O(6)- guanine-alkylating</w>
O(6)- alkylguanine</w>
O'Bri en</w>
O' D
O'D wyer</w>
O z</w>
O xidized</w>
O vary</w>
O varies</w>
O valbumin</w>
O valbumin-sensitized</w>
O tilonium</w>
O strobothnia,</w>
O slo</w>
O sicka,</w>
O saka</w>
O s</w>
O rexin</w>
O range,</w>
O pto-Varimex</w>
O pacification</w>
O olong</w>
O mega-oxidation</w>
O lympus</w>
O ily</w>
O il</w>
O hokawa's</w>
O gilvie's</w>
O ften,</w>
O d</w>
O culomotor</w>
O culogyric</w>
O cular-specific</w>
O cimum</w>
O choa</w>
O c</w>
O bliterative</w>
O akland,</w>
O ZRs,</w>
O ZR</w>
O W</w>
O UT</w>
O UA-,</w>
O UA).</w>
O U.</w>
O TMN-induced</w>
O T.</w>
O SMOL/KG).</w>
O S:</w>
O RO.</w>
O RO)</w>
O PG/RANK/RANKL</w>
O PG,</w>
O PD.</w>
O PD,</w>
O PBM</w>
O O
OO (-))</w>
O MPA).</w>
O MI
OMI M</w>
O MD)</w>
O MD).</w>
O MAC)</w>
O MA
OMA TIC</w>
O M.</w>
O Ls</w>
O Ls)</w>
O LV.</w>
O LR</w>
O LD
OLD A.</w>
O L)</w>
O K)</w>
O IM</w>
O IA</w>
O HR.</w>
O G),</w>
O EP</w>
O CT.</w>
O CT,</w>
O CT)</w>
O C
OC s'</w>
O Ac
OAc ).</w>
O AT1</w>
O ASS</w>
O AS-
OAS- M.</w>
O AD,</w>
O AD).</w>
O AC,</w>
O AB,</w>
O AB
OAB ;</w>
O 8.</w>
O 2:
O2: 0.21),</w>
O 2*
O2* -,</w>
O -15</w>
O -15-labeled</w>
O )].</w>
O );</w>
O )-related</w>
O (2)-
O(2)- inhalation</w>
Nur r1</w>
Nucle otide</w>
Nucle otidase,</w>
Nucle oli</w>
Nucle i</w>
Nrf2 (+/+)</w>
Nrf 2-mediated</w>
Novar tis,</w>
Novar tis),</w>
Nov astan</w>
Nov a2</w>
Nov a1</w>
Nov a-regulated</w>
Not withstanding,</w>
Not eworthy</w>
Norway ]).</w>
Norway )</w>
Norway ),</w>
Norvaline2- thyrotropin-releasing</w>
Norvaline2- TRH:</w>
Nortriptyl ine-treated</w>
Norpr amin:</w>
Norpr amin,</w>
Norplant -6</w>
Norplant (
Norplant( (R))</w>
Normoten sion</w>
Norm oxic</w>
Norm ocapnia,</w>
Norm ocalciuria</w>
Norm alizing</w>
Norm :</w>
Norepinephr ine,</w>
Nor-Prog )]</w>
Nor- adrenaline).</w>
Nor- Prog</w>
Nor- BNI</w>
Nor- BNI.</w>
Nor zotepine</w>
Nor zotepine,</w>
Nor wegian</w>
Nor way-Katholiek</w>
Nor way,</w>
Nor thern-blot</w>
Nor pethidine</w>
Nor pace</w>
Nor meperidine</w>
Nor floxacin:</w>
Nor floxacin-induced</w>
Nor fenfluramine,</w>
Nor d-Tr</w>
Nor cpinephrine</w>
Nor adrenaline-evoked</w>
Nor BNI</w>
Nor 1</w>
Non- vascular</w>
Non- users</w>
Non- treatment</w>
Non- thromboembolic</w>
Non- sustained</w>
Non- steatohepatitis,</w>
Non- specific</w>
Non- smokers</w>
Non- small</w>
Non- significant</w>
Non- shadowing</w>
Non- response</w>
Non- responders</w>
Non- residue</w>
Non- randomized,</w>
Non- randomised</w>
Non- painful</w>
Non- nucleoside</w>
Non- neoplastic</w>
Non- necrotic</w>
Non- ketotic</w>
Non- hematological</w>
Non- haematologic</w>
Non- fatal</w>
Non- ergot</w>
Non- controlled</w>
Non- contrast</w>
Non- auditory</w>
Non- Small</w>
Non- Q-wave</w>
Non- NMDA</w>
Non- N-methyl-D-aspartate</w>
Non- Index
Non-Index ed</w>
Non- Domin
Non-Domin ant,</w>
Non- AA</w>
Non steroidal,</w>
Non significant</w>
Non sedating</w>
Non sclerotic</w>
Non responders</w>
Non respiratory</w>
Non redundant</w>
Non parametric</w>
Non oliguric</w>
Non metastatic</w>
Non menstrual</w>
Non inflammatory</w>
Non inferiority</w>
Non immune</w>
Non imaging</w>
Non human</w>
Non haematological</w>
Non exploratory</w>
Non exencephalic</w>
Non dyskinetic</w>
Non controlled</w>
Non compliance</w>
Non compartmental</w>
Non caseating</w>
Non arrhythmogenicity</w>
Non aphasic</w>
Non H
NonH al)</w>
Non -treated</w>
Nomifens ine,</w>
Nocicept ors</w>
Nocicept or</w>
Noc istatin</w>
Noc ifensive</w>
No velty-</w>
No vacor</w>
No onan,</w>
No dules</w>
NlmCategory=" RESULTS">changes</w>
NlmCategory=" OBJECTIVE">To</w>
NlmCategory=" METHOD
NlmCategory="METHOD S">University-based</w>
Nitroprus side-hypotension:</w>
Nitroglycer in-</w>
Nitro- L-Arginine</w>
Nitro sonornicotine</w>
Nitro indazole</w>
Nitro gen</w>
Nitro flurbiprofen,</w>
Nitro bid.</w>
Nitra disc</w>
Nitra disc,</w>
Nit rosamine--a</w>
Nit rite</w>
Nit rite,</w>
Nit razepam</w>
Nit razepam-induced</w>
Nit rates</w>
Nit rates,</w>
Nit rate-induced</w>
Nit ecapone</w>
Nisoldip ine.</w>
Nisoldip ine,</w>
Nis sl's</w>
Nis sen</w>
Nis onger</w>
Ninjin 'yoeit
Ninjin'yoeit o'</w>
Ninety- seven</w>
Nimodi pine-treated</w>
Nimodi pine-reduction</w>
Night mares</w>
Night cap</w>
Nigeri an,</w>
Nifedip ine/Metoprolol</w>
Nifedip ine's</w>
Nifedi pine.</w>
Nifedi pine--a</w>
Nicot ine;</w>
Nicot ine-sensitive</w>
Nicot ine-exposed</w>
Nicot ine-containing</w>
Nicot ine's</w>
Nicot inamide</w>
Nicardi pine-,</w>
Nicardi pine,</w>
Nic orette</w>
Ni jmegen</w>
Ni hon</w>
Ni ghtly</w>
Ni emann-Pick</w>
Ni acin-induced</w>
New ton,</w>
New man-Keuls</w>
Nevir apine.</w>
Nevir apine,</w>
Neutr alizing</w>
Neuroten sin</w>
Neuroten sin,</w>
Neuroten sin's</w>
Neurosc i.,</w>
Neuropath ologically,</w>
Neurolog ically,</w>
Neurolep tic-associated</w>
Neuro- ophthalmology</w>
Neuro- Intensive</w>
Neuro tron,</w>
Neuro transmitters/neuromodulators</w>
Neuro transmission</w>
Neuro toxicology</w>
Neuro toxicity)</w>
Neuro ticism</w>
Neuro surgical</w>
Neuro surgery</w>
Neuro surg</w>
Neuro stimulation</w>
Neuro spychiatric</w>
Neuro sensory:</w>
Neuro sci,</w>
Neuro report</w>
Neuro radiological</w>
Neuro radiologic</w>
Neuro psychopharmacological</w>
Neuro physiologically,</w>
Neuro physiol.</w>
Neuro pharmacology</w>
Neuro peptides</w>
Neuro pathy,</w>
Neuro pahrmacology</w>
Neuro ophthalmologic</w>
Neuro oncol.</w>
Neuro myelitis</w>
Neuro muscular/neurodegenerative</w>
Neuro muscular,</w>
Neuro kinin-1</w>
Neuro image</w>
Neuro hormones</w>
Neuro grams</w>
Neuro ethological</w>
Neuro endocrine</w>
Neuro endocrine-related</w>
Neuro embyopathic</w>
Neuro embryotoxic</w>
Neuro circulatory</w>
Neuro chemistry</w>
Neuro chem</w>
Neuro biology</w>
Neuro biological</w>
Neuro behavioural</w>
Neuro apoptosis</w>
Neuro aminidase</w>
Neur axial</w>
Neur alation</w>
Neu/Erb B2.</w>
Neu tral</w>
Neu N-
NeuN- positive</w>
Netherland s:</w>
Net work)</w>
Nesacaine- CE,</w>
Nesacaine- CE
Nesacaine-CE --an</w>
Nerv ousness,</w>
Ner ves</w>
Ner ve-conduction</w>
Ner amexane</w>
Nephro tic-range</w>
Nephro stomy</w>
Nephro sis-induced</w>
Nephro pathy,</w>
Nephro logists</w>
Neph ew</w>
Neos ynephrine</w>
Neodolpas se</w>
Neo- minophagen</w>
Neo- Min
Neo-Min ophagen</w>
Nelfin avir</w>
Nel son</w>
Nefir acetam,</w>
Nefazod one-induced</w>
Needle- free</w>
Nedd4- 2,</w>
Necrop sies,</w>
Necro sis,</w>
Necro ses</w>
Near- infrared</w>
Near- fatal</w>
Ne urally</w>
Ne orologic</w>
Ne oral)</w>
Ne oplasms</w>
Ne onatally</w>
Ne omycin-induced</w>
Ne omycin,</w>
Ne ocortical</w>
Ne obladder</w>
Ne ar</w>
Ndi 1</w>
Ndi 1.</w>
Nd1- L.</w>
Nd1- L,</w>
Nd 1,</w>
Nav y,</w>
Nav oban</w>
Nation ale</w>
Nat ure,</w>
Nat uralistic</w>
Nas oseptal</w>
Nas opharyngitis,</w>
Nas opharyngeal,</w>
Naranj o's</w>
Nar ingin</w>
Nar atriptan-induced</w>
Naltrex one,</w>
Nalox one-precipitated</w>
Nalox one-induced</w>
Nalox one--for</w>
Nalmefen e</w>
Nalmefen e:</w>
Nal triben</w>
Nairobi .</w>
Nafc illin-associated</w>
Naf amostat</w>
Nad u,</w>
Nad ler</w>
NaHCO 3.</w>
NaHCO (3)</w>
NaCl- sensitive</w>
NaCl- Ringer's</w>
NaCl- 5%</w>
NaCl +
NaCl+ KCl</w>
NaCl );</w>
Na/ K-ATPase</w>
Na/ Ccr</w>
Na/ Ccr)</w>
Na/ Ca</w>
Na-K- Cl-
Na-K-Cl- cotransporter</w>
Na- pentobarbital</w>
Na- adamantaneacetyl-D-Arg-(Hyp3,Thi5,8,D-Phe7]-brad</w>
Na- K</w>
Na- Ca</w>
Na,K- ATPase.</w>
Na,K- ATPase,</w>
Na+/K+- atpase</w>
Na+/K+- adenosinetriphosphatase</w>
Na+/K+- ATPase,</w>
Na+/ glycine</w>
Na+/ K+
Na+/K+ ATPase</w>
Na+/ K(+)-ATPase</w>
Na+/ K(+)-
Na+/K(+)- ATPase,</w>
Na+/ HCO
Na+/HCO 3-
Na+/HCO3- symport</w>
Na+- taurocholate</w>
Na+- Cl(-)</w>
Na+- Ca2+</w>
Na+,K+- adenosine</w>
Na+,K+- ATPase,</w>
Na+,K+- ATP
Na+,K+-ATP ase]</w>
Na+, K+
Na+,K+ ,
Na+,K+, -ATPase</w>
Na+ K+-2
Na+K+-2 Cl(-)</w>
Na+ :</w>
Na(v)1.8- expressing</w>
Na(v)1.8- dependent</w>
Na(v) 1.6</w>
Na(+)/K(+)- ATPase.</w>
Na(+)/K(+)- ATPase,</w>
Na(+)/ bile</w>
Na(+)/ K(+)</w>
Na(+)/ H
Na(+)/H (+)</w>
Na(+)/ Ca(2+)</w>
Na(+)- coupled</w>
Na(+)- K(+)-
Na(+)-K(+)- 2
Na(+)-K(+)-2 Cl(-)</w>
Na(+)- Cl(-)</w>
Na(+), K(+)-
Na(+),K(+)- ATPase-
Na(+),K(+)-ATPase- inhibiting</w>
Na(+) K(+)-ATPase</w>
Na(+) K(+)
Na(+)K(+) ATPase,</w>
Na(+ ).</w>
Na phazoline</w>
Na VP</w>
Na VP.</w>
Na S,</w>
Na RIs.</w>
Na RIs,</w>
Na Pi-2</w>
Na OH).</w>
Na H2
NaH2 PO4</w>
Na F</w>
Na F.</w>
Na F,</w>
Na CI</w>
Na CHO
NaCHO (3)</w>
Na -P
Na-P i</w>
Na )</w>
NZ W)F1</w>
NZ B/
NZB/ NZW</w>
NY T.</w>
NY T),</w>
NY ).</w>
NTS 1/
NTS1/ DA</w>
NTS 1-selective</w>
NTS 1-
NTS1- deficient</w>
NTG- tolerant</w>
NTG- only</w>
NTG- infusion.</w>
NTG -</w>
NT- ANP.</w>
NT g</w>
NT X</w>
NT X,</w>
NT S:</w>
NT P,</w>
NT P),</w>
NT N</w>
NT G)</w>
NT F)</w>
NT E's</w>
NT D)</w>
NT Cs.</w>
NT C</w>
NT 79
NT79 :</w>
NT 1,</w>
NT -M
NT-M I)</w>
NT )-
NT)- limited</w>
NSCL C;</w>
NSAID- associated</w>
NSAID s:</w>
NSAID s-related</w>
NSAID s-intolerance.</w>
NSAID s-induced</w>
NSAID s-associated</w>
NSAID S.</w>
NSAID S,</w>
NSAI D)</w>
NSAI As</w>
NSAI ,</w>
NS SD</w>
NS S.</w>
NS R.</w>
NS PM),</w>
NS I</w>
NS G.</w>
NS G-pretreated</w>
NS G).</w>
NS F,</w>
NS C-
NSC- 27
NSC-27 98
NSC-2798 36</w>
NS A
NSA ids.</w>
NS +
NS+ Garlic</w>
NS );</w>
NRV L.</w>
NRTI ;</w>
NRTI -mediated</w>
NR2 ab</w>
NR2 a,</w>
NR2 B.</w>
NR2 B-
NR2B- selective</w>
NR-AN X-C,</w>
NR TIs.</w>
NR T)</w>
NR PD</w>
NR P104.</w>
NR I</w>
NR I)</w>
NR H/
NRH/ VOD</w>
NR G)</w>
NR F</w>
NR AN
NRAN X-</w>
NR 2a</w>
NR 2A</w>
NR 1,</w>
NR 1)</w>
NR ).</w>
NPY- immunoreactive</w>
NPY- LI.</w>
NPY -</w>
NPY (Ab)</w>
NPY 's</w>
NPH S1.</w>
NP s.</w>
NP Y,</w>
NP T</w>
NP N</w>
NP ;</w>
NP 250
NP250 A</w>
NP )-stimulated</w>
NOS3- deficient</w>
NOS- inhibition-induced</w>
NOS- immunoreactive</w>
NOS- Tg)</w>
NOS- NO</w>
NOS- IR
NOS-IR :</w>
NOS )]</w>
NOS (-/-)</w>
NOC-1 8.</w>
NOC-1 8,</w>
NOAR G</w>
NOAR G,</w>
NOAR G),</w>
NO/ cGMP/PKG</w>
NO-cGMP- ATP-sensitive</w>
NO-cGMP- ATP-
NO-cGMP-ATP- sensitive-K(+)</w>
NO- releasing</w>
NO- producing</w>
NO- hypothesis</w>
NO- compromised</w>
NO- activity,</w>
NO- activated</w>
NO- INH</w>
NO- ERK</w>
NO( x).</w>
NO( x),</w>
NO X-mediated</w>
NO X-4</w>
NO X-4)</w>
NO WN</w>
NO VEL-</w>
NO T.</w>
NO SIE-30</w>
NO S).</w>
NO R</w>
NO R-1-induced</w>
NO P).</w>
NO ED</w>
NO 3-,</w>
NO 2-</w>
NO 2-,</w>
NO /</w>
NO -</w>
NO )</w>
NO ).</w>
NO (4))</w>
NO (3)</w>
NO (2)</w>
NN s</w>
NN M</w>
NN M.</w>
NN LA</w>
NN LA-induced</w>
NN H</w>
NN A)</w>
NMU- SS,</w>
NMU- PB-treated</w>
NMU- PB,</w>
NMRI- mice</w>
NMDA/ non-NMDA</w>
NMDA- type</w>
NMDA- receptors</w>
NMDA- receptors,</w>
NMDA- receptor.</w>
NMDA- independent</w>
NMDA- blocking</w>
NMDA- associated</w>
NMDA- antagonists.</w>
NMDA- antagonist,</w>
NMDA- R</w>
NMDA- Ca</w>
NMD AR
NMDAR 2A</w>
NMD A-induced</w>
NM R)</w>
NM P,</w>
NM P)</w>
NM O.</w>
NM C</w>
NM :</w>
NK3- R</w>
NK H,</w>
NK CC</w>
NK CC)</w>
NK 3,</w>
NK 2,</w>
NK (1)-
NK(1)- tachykinin</w>
NJ ;</w>
NJ )/
NJ)/ cisplatin</w>
NJ )-containing</w>
NIN -induced</w>
NIK- 24
NIK-24 7,</w>
NIH- sponsored</w>
NIH- 31</w>
NIH- 07</w>
NIDA- funded,</w>
NIDA- 4
NIDA-4 1020</w>
NIC Us.</w>
NIC U)</w>
NIC ,</w>
NI RS</w>
NI NA</w>
NI NA),</w>
NI H.</w>
NI H
NIH SS</w>
NI E)</w>
NI AM
NIAM DD</w>
NI AD.</w>
NI AD,</w>
NI ).</w>
NHS ST.</w>
NHS DA</w>
NHB Ds</w>
NHB D.</w>
NH4 Cl</w>
NH4 Cl;</w>
NH4 Cl-
NH4Cl- acidified</w>
NH X,</w>
NH L.</w>
NH (4)
NH(4) Cl</w>
NGF- induction</w>
NGF- based</w>
NG- methyl-L-arginine</w>
NG- Nitro</w>
NG ;</w>
NG 108-1
NG108-1 5</w>
NG ),</w>
NF-kappa B;</w>
NF-kappa B.</w>
NF- MI).</w>
NF s)</w>
NF AT</w>
NF AT
NFAT c3.</w>
NF A.</w>
NF A,</w>
NF 1,</w>
NF 1),</w>
NER AL</w>
NE- protein</w>
NE- antagonistic</w>
NE- alone</w>
NE- ARF,</w>
NE s)</w>
NE W)</w>
NE T,</w>
NE T)</w>
NE S)</w>
NE F.</w>
NE F,</w>
NE A)</w>
NE ;</w>
NE /
NE/ DA</w>
NE -</w>
NE -100</w>
NE )-
NE)- protein</w>
NDE A.</w>
NDE A.
NDEA. PB</w>
NDE A-
NDEA- initiated,</w>
NDE .</w>
ND ST-1,</w>
ND ST,</w>
ND S</w>
ND P),</w>
ND MA-
NDMA- d</w>
ND I)</w>
ND I),</w>
ND I
NDI -like</w>
ND 7-
ND7- 23</w>
ND 5</w>
ND 30</w>
ND 10</w>
ND ),</w>
NCr 1
NCr1 BR</w>
NCT0023 40
NCT002340 65.</w>
NCT0023 114
NCT0023114 0.</w>
NCT0014 4
NCT00144 17
NCT0014417 0.</w>
NCT0014 28
NCT001428 57.</w>
NCT000 95
NCT00095 251.</w>
NCT000 77
NCT00077 79
NCT0007779 2.
NCT00077792. ).</w>
NCT00 66
NCT0066 66
NCT006666 53.</w>
NCT00 6
NCT006 170
NCT006170 19.</w>
NCT00 54
NCT0054 15
NCT005415 54.</w>
NCT00 500
NCT00500 07
NCT0050007 1.</w>
NCT00 49
NCT0049 27
NCT004927 52.</w>
NCT00 42
NCT0042 80
NCT004280 64).</w>
NCT00 38
NCT0038 5
NCT00385 80
NCT0038580 1.</w>
NCT00 378
NCT00378 10
NCT0037810 5.</w>
NCT00 37
NCT0037 46
NCT003746 21.</w>
NCT00 366
NCT00366 44
NCT0036644 4.</w>
NCT00 312
NCT00312 27
NCT0031227 3.</w>
NCT00 27
NCT0027 1219
NCT00271219 .).</w>
NCT00 243
NCT00243 17
NCT0024317 8.</w>
NCT00 216
NCT00216 34
NCT0021634 6
NCT00216346 .)</w>
NCT00 20
NCT0020 26
NCT002026 57.</w>
NCT00 1753
NCT001753 57
NCT00175357 .)</w>
NCT00 17
NCT0017 478
NCT0017478 5.
NCT00174785. )</w>
NCT00 11
NCT0011 1020).</w>
NCT00 10
NCT0010 37
NCT001037 53.</w>
NCT00 000
NCT00000 6
NCT000006 11.
NCT00000611. ).</w>
NCT00 00
NCT0000 27
NCT000027 44.</w>
NCT 0
NCT0 10
NCT010 63
NCT01063 17
NCT0106317 9.</w>
NCS LC</w>
NCS -1
NCS-1 96
NCS-196 473</w>
NCQ 34
NCQ34 4,</w>
NCQ (1)-
NCQ(1)- gene</w>
NCL CC).</w>
NCL 118,</w>
NCA M/
NCAM/ D3-
NCAM/D3- ratio.</w>
NCA M)</w>
NC X1</w>
NC SE;</w>
NC SE,</w>
NC 80),</w>
NBU .</w>
NBU -treated</w>
NBQ X)</w>
NBQ X),</w>
NBI A:</w>
NB T</w>
NB T-positive</w>
NB L/
NBL/ Cr</w>
NB F.</w>
NB F,</w>
NB E)</w>
NB 97,</w>
NB 90</w>
NAc Sh</w>
NAc Sh.</w>
NAc C,</w>
NAT O</w>
NAME ,</w>
NAME )</w>
NAI ON.</w>
NAF LD</w>
NAF LD.</w>
NAF LD,</w>
NAF LD
NAFLD ;</w>
NAF -treated</w>
NADPH- dependent</w>
NADPH- d-positive</w>
NADPH d-stained</w>
NADH- quinone</w>
NADH- dehydrogenase</w>
NAD(P) H:</w>
NAD(P) H
NAD(P)H :
NAD(P)H: quinone</w>
NAD P</w>
NAD H),</w>
NAD ,</w>
NAC- DFX</w>
NAC+ APAP</w>
NAC+ APAP.</w>
NAC ;</w>
NAA/ tCr</w>
NAA/ tCr.</w>
NA- uptake</w>
NA- lesioned</w>
NA ]</w>
NA UC</w>
NA SCIS,</w>
NA POR</w>
NA PAP,</w>
NA Gi</w>
NA G/
NAG/ creatinine</w>
NA G.</w>
NA F.</w>
NA E
NAE )).</w>
NA D</w>
NA ALF</w>
NA /kg</w>
NA /
NA/ 5-HT</w>
NA -induced</w>
NA -</w>
NA );</w>
N= 15).</w>
N= 14,</w>
N6-(2-phenylisopropyl )</w>
N6-(2-phenylisopropyl )
N6-(2-phenylisopropyl) adenosine)</w>
N6- phenylisopropyladenosine</w>
N40 57)</w>
N40 57),</w>
N363 S,</w>
N3- position</w>
N3- p-xylyl-6-AzUd</w>
N3- o-xylyl-6-AzUd</w>
N3- m-xylyl-6-AzUd</w>
N3- beta-phenylethyl-6-AzUd</w>
N3- alpha-phenylethyl-6-AzUd</w>
N3- alkylated</w>
N2O/ isoflurane/enflurane.</w>
N2O/ O2</w>
N2O/ O2-anesthesia.</w>
N2O-O2- sevoflurane</w>
N2O-O2- halothane</w>
N2O- 30%</w>
N20/ BR
N20/BR L,</w>
N2 O;</w>
N2 O:O2.</w>
N2 O),</w>
N1/ P2</w>
N1/ P1</w>
N1- wave</w>
N1- components</w>
N1- component</w>
N1- component,</w>
N1- acetyltransferase</w>
N/ V.</w>
N/ V-),</w>
N/ V,</w>
N/ S.</w>
N/ S-treated</w>
N/ PHEN</w>
N/ C</w>
N. Ac
N.Ac c</w>
N. A.</w>
N-vanillyl-6-nonen amide</w>
N-tert-butyl- 3-
N-tert-butyl-3- (4-(2-methoxyphenyl)
N-tert-butyl-3-(4-(2-methoxyphenyl) piperazine-1-yl)-2-phenylpropanamide</w>
N-propylnorap orphine</w>
N-propylnorap orphine,</w>
N-propylnor aporpine,</w>
N-propyl piperidine)</w>
N-propargyl-1- aminoindan</w>
N-phosphonacetyl-L- aspartate</w>
N-phosphonacetyl-L- aspartate,</w>
N-nitrosoure a-containing</w>
N-nitrosou rea,</w>
N-nitrosomorph oline</w>
N-nitrosomorph oline-induced</w>
N-nitrosomethyl urea</w>
N-nitrosomethyl urea.</w>
N-nitrosodiethyl amine/kg</w>
N-nitrosodiethyl amine-induced</w>
N-nitrosodi methylamine</w>
N-nitrosodi ethyl-amine-initiated</w>
N-nitrosobutyl-4-hydroxybutyl amine</w>
N-nitrosobutyl-4-hydroxybutyl amine.</w>
N-nitrosobut ylurea.</w>
N-nitroso-n-butyl-(4-hydroxybutyl) amine</w>
N-nitroso-n-butyl-(4-hydroxybutyl) amine.</w>
N-nitroso- N-
N-nitroso-N- diethylamine</w>
N-methylox azepam,</w>
N-methyl-N- trimethylsilyltrifluoroacetamide</w>
N-methyl-N- nitosourea</w>
N-methyl-N'-nitro-N-nitroso guanidine.</w>
N-methyl-N [2-(1-pyrrolidinyl)</w>
N-methyl-DL- aspartate</w>
N-methyl-DL- aspartate.</w>
N-methyl-D- aspartate-receptor</w>
N-methyl- beta-carboline-3-carboxamide</w>
N-methyl- Tyr1,</w>
N-methyl- N-nitrosourea-containing</w>
N-methyl- N-nitrosourea,</w>
N-methyl- D-</w>
N-methyl- D,
N-methyl-D, L-
N-methyl-D,L- aspartate</w>
N-methyl- 4-
N-methyl-4- phenyl-1,2,3,6-tetrahydropyridine</w>
N-methyl urea</w>
N-methyl transferase</w>
N-methyl sulfonyl-6-(2-proparglyoxyphenyl)hexanoic</w>
N-methyl nicotinamide</w>
N-methyl amino-1-butanol</w>
N-methyl adrenaline.</w>
N-methyl -1-
N-methyl-1- aspartate</w>
N-methyl -1,2-diphenyl</w>
N-methyl ,</w>
N-form ylmethionylleucyl-phenylalanine</w>
N-form yl-Met-Leu-Phe</w>
N-ethyl-2-bromobenzyl amine</w>
N-ethyl- carboxamidoadenosine</w>
N-ethyl- carboxamide</w>
N-ethyl- N-nitrosourea</w>
N-ethyl maleimide</w>
N-ethyl carboxamidoadenosine)</w>
N-desmethyl zotepine,</w>
N-desmethyl topotecan,</w>
N-desmethyl sildenafil</w>
N-de methylation</w>
N-de methyl</w>
N-de methyl-deacetylthymoxamine</w>
N-butyl-N- (4-hydroxy
N-butyl-N-(4-hydroxy butyl)</w>
N-butyl- N-nitrosourea</w>
N-acetyl-beta-D-glucosaminid ase--a</w>
N-acetyl-beta- glucosaminidase,</w>
N-acetyl-beta- glucosaminidase)</w>
N-acetyl-beta- D</w>
N-acetyl- para-benzoquinone-imine</w>
N-acetyl- cysteine.</w>
N-acetyl- beta</w>
N-acetyl- D-penicillamine</w>
N-acetyl- B-
N-acetyl-B- D-glucosaminidase</w>
N-acetyl sphingosine</w>
N-acetyl procainamide.</w>
N-acetyl glucosamine</w>
N-acetyl ation,</w>
N-acetyl -1-
N-acetyl-1- beta-D-glucosoaminidase</w>
N-[8-amino-1(S)-carboxyoctyl]-L-alan yl-L-proline</w>
N-[8-amino-1(S)-carboxyoctyl]-L-alan yl-L-proline.</w>
N-[4-(5-nitro-2-furyl)-2-thiazolyl]form amide.</w>
N-[4-(5-nitro-2-furyl)-2-thiazolyl]form amide-induced</w>
N-[4-(5-nitro-2-furyl)-2-thiazolyl]-form amide</w>
N-[4,7-dimethoxy-6-(2- pyrrolidinoethoxy)-5-benzofuranyl]-N'-methylurea</w>
N-[4,7-dimethoxy-6-(2- piperidinoethoxy)-5-benzofuranyl]-N'-methylurea</w>
N-[2- [4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl-cyclohexanecarboxamide</w>
N-[2- [4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)</w>
N-[(1-ethyl-2-pyrrolidinyl)methyl]-2- methyl-5-methylthio-2,</w>
N-[(1-ethyl-2-pyrrolidinyl)methyl]-2- 6-di
N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-6-di methoxybenz</w>
N-[(1- butyl-2-pyrrolidinyl)methyl]-2-methyl-5-sulfamoyl-2,</w>
N-[(1- alkyl-2-pyrrolidinyl)methyl]-5-</w>
N-[(1- alkyl-2-</w>
N-[ [(3R,6R)-6-methyl-5-oxo-thiomorpholinyl]</w>
N-[ 17-
N-[17- (
N-[17-( cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6beta-yl]-3-(furan-3-yl)-N-methylprop-2-enamide</w>
N-[ (2-
N-[(2- pyrrolidinyl)methyl]-2,3-dihydrobenzofuran-7-carboxamide</w>
N-S SEPs)</w>
N-S MT,</w>
N-Methyl-D- Aspartate</w>
N-Me- Phe4,</w>
N-76 A),</w>
N-2-fluorenyl acetamide-induced</w>
N-10 55)</w>
N-1- methylnicotinamide.</w>
N-(2-pyridin yl)cycloh</w>
N-(2-chloroethyl)- N-ethyl-2-bromobenzylamine</w>
N-(2- piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzam</w>
N-(2- (1-pyrrolidinyl)
N-(2-(1-pyrrolidinyl) cyclohexyl)benzenacetamide++</w>
N-(2, 4</w>
N-(1- methyl-2-oxo-1,2,3,4-tetrahydro-7-quinolyl)-2-[(2-methylpyrrolidin-1-yl)methyl]biphenyl-4-carboxamide</w>
N-( trans-3-hydroxy-1,2,3,4-tetrahydro-2-naphthyl)-N-(3-oxo-3-phenyl-2-methylpropyl)-piperazine</w>
N-( pyridin-4-ylmethyl)benzamide)</w>
N-( piperidin-1-yl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamidehydrochloride</w>
N- x)</w>
N- x),</w>
N- w-fluoropropyl-2[beta]-carbomethoxy-3[beta]-(4-iodophenyl)nortropane</w>
N- type,</w>
N- tert-butylnitrone,</w>
N- sulfotransferase</w>
N- sulfamoyl-hexahydroazepine</w>
N- substituted</w>
N- stimulated</w>
N- propyl-N-nitrosourea.</w>
N- pretreated</w>
N- position</w>
N- omega-nitro-L-arginine</w>
N- omega-L-arginine</w>
N- nitrosamines,</w>
N- nitro</w>
N- nitro-L-arginine-methyl</w>
N- nACHR).</w>
N- myc</w>
N- methylethan-1-amine]</w>
N- labeled</w>
N- isopropyl-p-iodoamphetamine</w>
N- hydroxylation</w>
N- hydroxy</w>
N- hydroxy-N'-(4-butyl-2-methylphenyl)</w>
N- highly</w>
N- formyl</w>
N- diethylnitrosamine</w>
N- diethylcarbamoyl-4-methyl-4-aza,5alpha-androstan-3-one,</w>
N- di-n-hexyl</w>
N- demetyldeacetylthymoxamine.</w>
N- deacetylase/adenosine</w>
N- cyano-N'-(2-nitroxyethyl)-3-pyridinecarboximidamide</w>
N- butyl</w>
N- benzyladriamycin-14-valerate</w>
N- arylpiperazinylmethylpyrazolo</w>
N- alpha-methyl-Arg7-D-Leu8]dynorphin</w>
N- allylnormetazocine</w>
N- allyl-clonidine,</w>
N- acylimidazole</w>
N- actylcysteine</w>
N- [3-(diethyl</w>
N- W-L-Nitroarginine</w>
N- Tezo</w>
N- R)</w>
N- Open-label,</w>
N- OAc).</w>
N- Nitro</w>
N- L-
N-L- nitro-arginine</w>
N- ESR
N-ESR D).</w>
N- DB
N-DB S).</w>
N- D-
N-D- nitro-arginine</w>
N- CE</w>
N- CE.</w>
N- CE)</w>
N- Benzyl
N-Benzyl adriamycin-14-valerate</w>
N- 93
N-93 G</w>
N- 69
N-69 6,</w>
N- 50
N-50 7
N-507 30-
N-50730- (P
N-50730-(P AF</w>
N- 38),</w>
N- 20.</w>
N- (4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)</w>
N- (3-
N-(3- (
N-(3-( aminomethyl)benzyl)acetamidine</w>
N- (2,6-di
N-(2,6-di methyl-phenyl)-2-(2-oxo-1-pyrrolidinyl)</w>
N,N- dimethylethan-1-amine]</w>
N,N- dimethyl</w>
N,N,N',N'-tetramethyl-p- phenylenediamine</w>
N,N,N',N'-tetramethyl-p- phenyldiamine-ascorbate,</w>
N,N'- dicyclohexyl</w>
N,N'- dibenzhydrylethane-1,2-diamine</w>
N,N'- di(1-adamantyl)malondiamide</w>
N+ phenobarbital</w>
N+ DOX</w>
N)- propyl</w>
N)- lesioned</w>
N)- initiated</w>
N)- immunolabeling</w>
N(omega)- nitro-l-arginine</w>
N(omega)- nitro-l-arginine-methyl</w>
N(omega)- Nitro-L-arginine</w>
N(epsilon)-(carboxymethyl) lysine</w>
N(epsilon)-(carboxymethyl) lysine,</w>
N(M HC
N(MHC ))</w>
N(G)-nitro- l-arginine-methyl</w>
N(G)-nitro- d-arginine-methyl</w>
N(G)-nitro- L-arginine-methyl</w>
N(G)-nitro- L-Arginine</w>
N(G)- monomethyl-L-arginine</w>
N(G)- methyl</w>
N(G)- methyl-L-arginine.</w>
N(G)- Nitro-L-arginine</w>
N(G)- Nitro-L-Arginine</w>
N(6)- cyclopentyladenosine-elicited</w>
N(2)O/ naloxone.</w>
N(2)O/ Naloxone,</w>
N(2)- 5%</w>
N( w)-nitro-L-arginine,</w>
N'- nitrosonornicotine</w>
N'- diisopropylphosphorodiamidofluoridate),</w>
N'- Nitrosonornicotine</w>
N yquil;</w>
N ylor.</w>
N yegaard</w>
N va2]TRH)</w>
N utri</w>
N ull</w>
N tox)</w>
N ote</w>
N orthryn,</w>
N omoto</w>
N olan,</w>
N ocardia</w>
N oble</w>
N kx2.5-driven</w>
N izatidine</w>
N ivaquine</w>
N iroday</w>
N ippostrongylus</w>
N ile</w>
N i-component</w>
N fg.KG,</w>
N estin</w>
N estin-immunoreactive</w>
N eighbouring</w>
N crj</w>
N co1</w>
N cam,</w>
N azionale</w>
N avy</w>
N atriuretic</w>
N ations</w>
N ardil</w>
N ap:</w>
N akai</w>
N abumetone-associated</w>
N abilone</w>
N a.</w>
N Y.</w>
N Y,</w>
N WTS-4</w>
N W-nitro-L-arginine</w>
N VP.</w>
N VP-related</w>
N VP,</w>
N VA</w>
N V.</w>
N URSING:</w>
N SE)</w>
N S:</w>
N RS</w>
N RF+0.6%</w>
N R)</w>
N PE,</w>
N PDG)</w>
N P-SH</w>
N ONMEM.</w>
N NC</w>
N N)</w>
N Me
NMe Phe-Met(O)-ol),</w>
N MT</w>
N MT.</w>
N MT
NMT T-containing</w>
N MPs</w>
N LA)</w>
N L.</w>
N L
NL 's</w>
N J,</w>
N IC).</w>
N I.</w>
N G)</w>
N EP
NEP H
NEPH 2),</w>
N ECA,</w>
N D,</w>
N CV,</w>
N CR
NCR 18
NCR18 1,</w>
N CM
NCM 001,</w>
N C)</w>
N Alpha2
NAlpha2 b)</w>
N AR.</w>
N AN-1
NAN-1 90</w>
N AN
NAN B</w>
N AME</w>
N ADR
NADR PS,</w>
N AC)</w>
N AC).</w>
N 93,</w>
N 3</w>
N 3-benz
N3-benz yl-6-AzUd</w>
N 2a</w>
N 2</w>
N 20.</w>
N 20-
N20- O2.</w>
N 20,</w>
N 2-[
N2-[ [1-[2-[4-[(R,S)-5,11-dihydro-6(6H)-oxodibenz[b,e]azepin-11-yl]-1-piperazinyl]-2-oxoethyl]cyclopentyl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl]ethyl]argininamide</w>
N 2-
N2- cooled</w>
N 2,</w>
N 1:
N1: 1-dependent</w>
N 13</w>
N 11-
N11- diethylnorspermine)</w>
N 1-[2-
N1-[2- (4-
N1-[2-(4- i-butylphenyl)-propionyl]-N4-alkyl/aryl-thiosemicarbazides</w>
N 1)</w>
N 08
N08 2),</w>
N .,</w>
N -1</w>
N -113
N-113 5),</w>
N )/kg</w>
N (1)-
N(1)- (DL-
N(1)-(DL- seryl)-N(2)-(2,3,4-trihydroxybenzyl)</w>
Myoglob inuric</w>
Myoglob inemia</w>
Myoclon us,</w>
Myoclon ic-astatic</w>
Myoclon ic,</w>
Myocardi otoxicity</w>
Myocardi a</w>
Myo- inositol-1-phosphate</w>
Myo- inositol,</w>
Myo graph</w>
Myo fibrils,</w>
Myo fibrillar</w>
Mylotarg -based</w>
Mylotarg ,</w>
Myeloperoxidase- antineutrophil</w>
Myeloperoxidase- anti-neutrophil</w>
Myelo- suppression</w>
Myelo- optico-neuropathy</w>
Myelo dysplasia</w>
My ristica</w>
My otubes,</w>
My opia</w>
My ocytolysis,</w>
My ocyte-specific</w>
My ocilin</w>
My driasis,</w>
My algia:</w>
My HC.</w>
Mw A</w>
Mw A.</w>
Mut lib</w>
Mus carius,</w>
Muraglitaz ar-associated,</w>
Muraglitaz ar,</w>
Mur ray)</w>
Mun ich</w>
Mun ich,</w>
Multivari ate-adjusted</w>
Multiv itamin</w>
Multiplic ative</w>
Multi- organ</w>
Multi- item</w>
Multi- generational</w>
Multi- agent</w>
Multi- Health</w>
Multi- Drug</w>
Multi unit</w>
Multi systemic</w>
Multi plying</w>
Multi ple-drug</w>
Multi dimensional</w>
Multi -drug</w>
Mul tinational</w>
Mul tiform</w>
Mul ticentre</w>
Muc in-secreting</w>
Mu tism/speech</w>
Mu stard</w>
Mu n</w>
Mu ell.</w>
Mu LV)</w>
Mu 2)</w>
Mt v7a/Ty</w>
Mrp 2,</w>
Moz ambique</w>
Moz ambican</w>
Move ment-related</w>
Motiv ation:</w>
Motiv ation,</w>
Mot tled</w>
Mot oric</w>
Mot or-evoked</w>
Mot or,</w>
Mos s</w>
Mos quitoes</w>
Mos enii</w>
Morphine- tolerant</w>
Morphine- sensitized</w>
Morphine- DEX
Morphine-DEX CO
Morphine-DEXCO M</w>
Morphine- Benz
Morphine-Benz edrine</w>
Morph ophysiological</w>
Morph ology,</w>
Morph odynamics</w>
Morph o-physiologic</w>
Morph ine/Rg1</w>
Morph ine-3-glucuronide</w>
Morph ea</w>
Morph ea,</w>
Morph :</w>
Moric izine-induced</w>
More los.</w>
Mor rel,</w>
Mor ning-dosed</w>
Mor ioka</w>
Montre al.</w>
Montre al,</w>
Monte ",</w>
Mono graph</w>
Mono exponential</w>
Mono arthritis</w>
Mono amine-depleting</w>
Monitor ing:</w>
Monitor ing.</w>
Monitor ing,</w>
Monitor ing)</w>
Monitor ;</w>
Monit ors.</w>
Mon ths</w>
Mon thly</w>
Mon sodium</w>
Mon osialic</w>
Mon onucleosis</w>
Mon oclonal</w>
Mon o-methylarginine</w>
Mon key</w>
Mon day</w>
Molec ules</w>
Molec ularly,</w>
Modul e</w>
Modul ators</w>
Moder ately</w>
Moder ate-risk</w>
Moder ate-</w>
Model ing</w>
Modafin il-treated</w>
Mod alities</w>
Mo(t)/ B(t
Mo(t)/B(t )
Mo(t)/B(t) =</w>
Mo yamoya-like</w>
Mo v</w>
Mo tion</w>
Mo ore's</w>
Mo od-stabilizing</w>
Mo fetil,</w>
Mo de-M</w>
Mo )</w>
MnDPD P</w>
MnDPD P.</w>
Mn SOD.</w>
Mn (2+
Mn(2+ )-dependent</w>
Mm p-3</w>
Mm p-2</w>
Mix ing</w>
Mix ed-Ancestry</w>
Mito- Q.</w>
Mito- Q,</w>
Mito Sox</w>
Mito Sox.</w>
Mito Q.</w>
Mito Q,</w>
Miti gation</w>
Miti gating</w>
Mit otane</w>
Mit omycin/vinblastine</w>
Mit omycin-associated</w>
Mit 285</w>
Mit -C</w>
Missour i;</w>
Missour i.</w>
Misoprost ol-induced</w>
Mis sissippi</w>
Mis siouri</w>
Mis sed</w>
Mis match</w>
Mis localization</w>
Mis diagnosis</w>
Mis cellaneous</w>
Mirtazap ine.</w>
Mirtazap ine-Tacrolimus</w>
Mirtazap ine,</w>
Mipafox .</w>
Mipafox -4</w>
Minoxidi l.</w>
Minoxidi l-treated</w>
Minoxidi l-related</w>
Minoxidi l-induced</w>
Minocycl ine-related</w>
Minocycl ine-associated</w>
Minnesot a.</w>
Minneap olis-St.</w>
Minim ising</w>
Minim al,</w>
Mini- mental</w>
Mineralocortico id</w>
Mineralocortico id-induced</w>
Min ute</w>
Min ulet</w>
Min n.</w>
Min idose</w>
Min eral</w>
Min K
MinK -related</w>
Mill ar-tip</w>
Mil rinone,</w>
Mil nacipran</w>
Mil itary</w>
Mil an</w>
Midazol an</w>
Midagli zole</w>
Midagli zole,</w>
Mid ventricular</w>
Mid rin--a</w>
Mid odrine:</w>
Mid line</w>
Mid lands</w>
Mid facial</w>
Mid dle-aged</w>
Mid Fent</w>
Mid -</w>
Microscop ically</w>
Micros porum</w>
Micros phere</w>
Micros phere-determined</w>
Microgynon- 30,</w>
Micro vesicular</w>
Micro tubules</w>
Micro surgeons</w>
Micro infusion</w>
Micro graphic</w>
Micro filaments</w>
Micro filament</w>
Micro emulsion</w>
Micro electrode</w>
Micro dialysates</w>
Micro dialysate</w>
Micro cephaly,</w>
Micro cephalic</w>
Micro biological</w>
Micro angiopathies</w>
Micro -
Micro- injection</w>
Michi gan.</w>
Mic ronodular</w>
Mic onazole-induced</w>
Mic haelis-Menten</w>
Mic e,</w>
Mic afungin</w>
Mibefradi l.</w>
Mibefradi l,</w>
Mi les</w>
Mi gration</w>
Mi glustat</w>
Mi anserin,</w>
Mi ami.</w>
Mi RP1</w>
MgSO 4.</w>
MgSO (4).</w>
MgSO (4),</w>
MgCl 2.</w>
MgCl 2)</w>
MgCl (2);</w>
MgCl (2).</w>
MgC it)</w>
Mg2+ ]i).</w>
Mg2+ .</w>
Mg2+ -induced</w>
Mg2+ -ATPase</w>
Mg2+ -ATPase,</w>
Mg2+ ,</w>
Mg+ +).</w>
Mg(2+)- ATPases</w>
Mg(2+ )-</w>
Mg(2+ )
Mg(2+) ATPase).</w>
Mg (2</w>
Mexilet ine-induced</w>
Mexilet ine-associated</w>
Mexilet ine's</w>
Metyrap one.</w>
Metyrap one-treated</w>
Metyrap one-treated,</w>
Metronidazol e:</w>
Metronidazol e-induced</w>
Metriz amide-phenothiazine</w>
Metoclopram ide:</w>
Metoclopram ide-</w>
Meto prolol,</w>
Meto /
Meto/ HCTZ.</w>
Meti pranolol</w>
Methyser gide,</w>
Methyl- atropine</w>
Methyl- N-vanillyl-6-nonenamide</w>
Methyl xanthine</w>
Methyl scopolamine</w>
Methyl naloxonium</w>
Methyl ergonovine</w>
Methyl ergonovine-induced</w>
Methyl ergometrine</w>
Methyl dopa,</w>
Methyl atropine</w>
Methyl -1-
Methyl-1- triazeno)imidazole-4-carboxamide</w>
Methotrex ate/naproxen-associated</w>
Methotrex ate-associated</w>
Methohex itone-induced</w>
Methion ine-sulfoximine</w>
Methemoglob inemia</w>
Methemoglob inemia-induced</w>
Methazol amide-induced</w>
Methan esul-fonate</w>
Methadone- exposed</w>
Methad one-treated</w>
Methad one's</w>
Meth ylephedrine,</w>
Meth oxy-2-propionamidotetralin</w>
Meth odological</w>
Meth od)</w>
Meth octramine,</w>
Meth lyphenidate</w>
Meth imazole,</w>
Meth cathinone:</w>
Meth cathinone,</w>
Meth amphetamine:</w>
Meth amphetamine-related</w>
Meth amphetamine-exposed</w>
Meth amphetamine-associated</w>
Meth acholine</w>
Meth .</w>
Metam izol</w>
Metam emory</w>
Metabol ites</w>
Metabol ite</w>
Meta- analyses</w>
Met- enkephalin</w>
Met- enkephalin.</w>
Met- F-
Met-F- AEA,</w>
Met ropolitan</w>
Met olazone-induced</w>
Met astatic</w>
Met astases</w>
Met aplasia</w>
Met alcaptase</w>
Met aiodobenzylguanidine:</w>
Met acognition</w>
Met (0
Met(0 )
Met(0) 5-ol
Met(0)5-ol )-
Met(0)5-ol)- enkephalin,</w>
Mes num</w>
Mes encephalon</w>
Meropenem :</w>
Meropenem -related</w>
Meropenem )</w>
Merc k,</w>
Merb arone</w>
Merb arone,</w>
Mer z</w>
Mer tk</w>
Mer its</w>
Mer ck's</w>
Mer captopurine</w>
Mer captoethane</w>
Mepi vacaine,</w>
Meperid ine-related</w>
Meperid ine's</w>
Mening itis,</w>
Men opause</w>
Men opausal</w>
Men ingeal</w>
Men i</w>
Membrane- stabilizing</w>
Membrane- bound</w>
Memant ine-induced</w>
Mem ory-strengthening</w>
Melphal an,</w>
Mel sungen,</w>
Mel anesian</w>
Mei er</w>
Meflo quine-induced</w>
Meflo quine-artesunate</w>
Meflo quine,</w>
Medro l).</w>
Medicam entous</w>
Medicam ental</w>
Medicam ent,</w>
Medic us)</w>
Medic us).</w>
Medic ine.</w>
Medic ine's</w>
Medic ation-related</w>
Medic ation-overuse</w>
Medic al-respiratory</w>
Medic -
Medic- Al
Medic-Al ert</w>
Medi ans</w>
Med line-quoted</w>
Med itec,</w>
Med hyarasayanas</w>
Med L
MedL ine,</w>
Mechan ographic</w>
Mechan o-allodynia</w>
Mechan ically-evoked</w>
Mec onium-stained</w>
Mec 3)-
Mec3)- kinase</w>
Meas uring</w>
Meas urable</w>
Mean while</w>
Mean ingful</w>
Me ynert</w>
Me trics</w>
Me trazol,</w>
Me thergoline</w>
Me tergoline</w>
Me ter</w>
Me sigyna</w>
Me phenytoin</w>
Me phedrone</w>
Me pha,</w>
Me obentine</w>
Me loxicam</w>
Me gadose</w>
Me ga-dose</w>
Me g),</w>
Me dic</w>
Me diastinal</w>
Me dia</w>
Me ans</w>
Me ad</w>
Me V</w>
Me Phe4,</w>
Me CCN
MeCCN U.</w>
McNemar s,</w>
McNem ar</w>
McN-A-34 3.</w>
McN-A-34 3,</w>
McN-56 52:</w>
McLe od</w>
McLe an</w>
Mc SPI</w>
Mc M
McM aster</w>
Mc Don
McDon ald's</w>
Mc Clure</w>
Maz e.</w>
Matric es</w>
Matri gel,</w>
Mater nal-fetal</w>
Mater ials</w>
Mat ching</w>
Mat B
MatB III</w>
Masson- trichrome</w>
Masson- Trichrome</w>
Mass .).</w>
Mas uyama</w>
Mas ugi</w>
Mas s.</w>
Mas lin-Cole</w>
Mas ker</w>
Mas k</w>
Maryl and;</w>
Marsh all</w>
Marsh all's</w>
Market scan</w>
Mark eting</w>
Mark er</w>
Mark e-Nyman's</w>
Mark -
Mark- Ho
Mark-Ho wink-Sakurada</w>
Mariju ana</w>
Marg aret</w>
Mar velon</w>
Mar mosets</w>
Mar lowe-Crowne</w>
Mar ine.</w>
Mar ia</w>
Mar .</w>
Mapro tiline,</w>
Manufacture rs</w>
Manufacture r-provided</w>
Manu al-IV</w>
Mantel-Ha entzel</w>
Mannit ol,</w>
Mann ich</w>
Mann heim</w>
Mann 's</w>
Manip ulation</w>
Mang anese</w>
Mane uvers</w>
Mane b,</w>
Man y,</w>
Man sari</w>
Man nion</w>
Man n-Whitney).</w>
Man n-U-Withney</w>
Man ic-like</w>
Man dibular</w>
Man agement,</w>
Malon aldehyde</w>
Mall ory's</w>
Malign ancy-related</w>
Malay sia)</w>
Malay an</w>
Mal tolyl</w>
Mal tese</w>
Mal nourished</w>
Mal formed</w>
Mal formations,</w>
Mal formation</w>
Mal ate</w>
Mal ama</w>
Mal absorption</w>
Main taining</w>
Main tained</w>
Magnus son</w>
Magnesium- aluminum</w>
Magnesium- Sulphate-pretreatment</w>
Magnesi um-deficient</w>
Mag nitude</w>
Mag nified</w>
Mag napen</w>
Madop ar-treated</w>
Madop ar,</w>
Mad hya</w>
Macrophage- derived</w>
Macroph ages,</w>
Macro scopically,</w>
Macro scopical</w>
Macro prolactinemia</w>
Macro lides</w>
Macro cytes</w>
Mac ula</w>
Mac ro</w>
Mac 1+</w>
Mac -3
Mac-3 +</w>
Mac -1</w>
Mac -1
Mac-1 +,</w>
Ma retto,</w>
M_ M,</w>
MXC- pre</w>
MXC- post</w>
MX C)</w>
MX 1</w>
MW S)</w>
MW F/
MWF/ Ztm</w>
MVO (2),</w>
MVL AC</w>
MVL AC,</w>
MV Rs</w>
MV R</w>
MV C.</w>
MV C,</w>
MUGA- variables</w>
MUGA- scans</w>
MU/ day</w>
MU- AcNeu</w>
MU- Ac
MU-Ac Neu)</w>
MTX/ 5-FU</w>
MTX- limb</w>
MTX- limb.</w>
MTX- leucovorin</w>
MTX- group,</w>
MTX- CF</w>
MTX- CF)</w>
MTX- C
MTX-C F.</w>
MT/ MAO</w>
MT/ HSCT</w>
MT- III</w>
MT- III,</w>
MT- I/II</w>
MT s,</w>
MT s)</w>
MT T,</w>
MT T)</w>
MT S.</w>
MT LE,</w>
MT EP,</w>
MT C;</w>
MT 4</w>
MT 42.</w>
MT 1A)</w>
MT -derived</w>
MT -</w>
MT -,</w>
MT )-
MT)- IR</w>
MSX- 3.</w>
MS/ MS</w>
MS/ MS).</w>
MS-8 57.</w>
MS-8 57,</w>
MS- 2</w>
MS V)</w>
MS SD)].</w>
MS SBP/MSDBP</w>
MS SBP.</w>
MS NA]</w>
MS NA.</w>
MS LT</w>
MS L,</w>
MS I</w>
MS G-treated</w>
MS D)</w>
MS A,</w>
MS A)</w>
MS 325</w>
MS );</w>
MS )
MS) "</w>
MRI/MR A.</w>
MR s</w>
MR Z.</w>
MR T</w>
MR T)</w>
MR S)</w>
MR P</w>
MR P.</w>
MR M),</w>
MR I;</w>
MR I:</w>
MR I)</w>
MR F</w>
MR F
MRF s.</w>
MR BC.</w>
MR 226
MR226 6.</w>
MR -</w>
MR );</w>
MR )-based</w>
MPTP- lesioned,</w>
MPTP- injected</w>
MPT ;</w>
MPO- and</w>
MPO- ANCA-positive</w>
MPO- ANCA-associated</w>
MPE P)</w>
MPE +BZ.</w>
MPA SS).</w>
MPA );</w>
MP- injected</w>
MP- associated</w>
MP- PDIE</w>
MP- 3)</w>
MP ase)</w>
MP a</w>
MP PA,</w>
MP P,</w>
MP H:</w>
MP H-induced</w>
MP H,</w>
MP G</w>
MP D</w>
MP 15-</w>
MP -induced</w>
MP )-mediated</w>
MO TIC</w>
MO P.</w>
MO P),</w>
MO M</w>
MO H.</w>
MO FS</w>
MNU- initiated</w>
MN PA-treated</w>
MN NG.</w>
MN NG,</w>
MN E),</w>
MN A)</w>
MN ).</w>
MMR M</w>
MMR M;</w>
MMR M.</w>
MMP s,</w>
MMP Is</w>
MMP I-
MMPI- 2</w>
MMP -1.</w>
MMF- group</w>
MMF- based</w>
MMC- resistant</w>
MMC- dependent</w>
MMA .</w>
MM S-pattern,</w>
MM Q</w>
MM P.</w>
MM NC)</w>
MM MTs,</w>
MM I-induced</w>
MM I-exposed</w>
MM I)</w>
MM HC)</w>
MM ;</w>
MM 500).</w>
MM ):</w>
MM ).</w>
MM ),</w>
MLM-1 60.</w>
MLM-1 60,</w>
MK80 1-</w>
MK-80 1:</w>
MK-80 1-treated</w>
MK-14 2)</w>
MK- 90
MK-90 6,</w>
MK- 0
MK-0 59
MK-059 1,</w>
MK II
MKII alpha)</w>
MK 2B)</w>
MK 212</w>
MK 2
MK2 12.</w>
MIT U.</w>
MIT U,</w>
MIP-1 alpha</w>
MIP-1 alpha,</w>
MIN O</w>
MIN ISTR
MINISTR ATION:</w>
MIL ES</w>
MIL :</w>
MIC s</w>
MIC ROBIOLOGICAL</w>
MIB I)</w>
MIB G-
MIBG- SPECT</w>
MI- AR
MI-AR I.</w>
MI T)</w>
MI MI
MIMI C</w>
MI AMI</w>
MI :</w>
MI -induced</w>
MI )-
MI)- matched</w>
MH- susceptible</w>
MH- susceptible.</w>
MH- susceptible,</w>
MH T.</w>
MH N,</w>
MH E,</w>
MF Q</w>
MF Q,</w>
MF A,</w>
MF -induced</w>
METH- treatment</w>
METH- treatment,</w>
METH- abusers,</w>
METH- abuse</w>
METH YLATED</w>
METH -treated</w>
METH -exposed</w>
METH )</w>
METH ),</w>
MENT S:</w>
MEMA N.</w>
MEK 1/2-
MEK1/2- ERK1/2</w>
MEK 1-
MEK1- specific</w>
MEK -1,
MEK-1, 2/
MEK-1,2/ ERK
MEK-1,2/ERK -1,2</w>
MED WATCH</w>
MED STAT</w>
MED SAFE,</w>
MED AL</w>
MEASURE MENT</w>
MEA SURE</w>
ME- AmB</w>
ME s</w>
ME q/mL</w>
ME Ts)</w>
ME T-CS,</w>
ME T,</w>
ME T+</w>
ME STBPS-,</w>
ME SNA,</w>
ME S.</w>
ME S-ED(50)of</w>
ME S-</w>
ME S)</w>
ME P,</w>
ME NDS</w>
ME L.</w>
ME L
MEL AS.</w>
ME K-
MEK- pretreated</w>
ME K)</w>
ME G.</w>
ME F
MEF 2C</w>
ME DA</w>
ME D)</w>
ME C</w>
ME C;</w>
ME C)</w>
ME C).</w>
ME ),</w>
MDS/ AML)</w>
MDS- CAs)</w>
MDS- CA</w>
MDS- CA
MDS-CA s,</w>
MDR-T B,</w>
MDR 1/
MDR1/ ABCB1</w>
MDR 1,</w>
MDMA/ MDA</w>
MDMA ;</w>
MDMA -free</w>
MDMA -associated</w>
MDMA -</w>
MDMA 's</w>
MDL 100907</w>
MDL -100
MDL-100 907</w>
MDL -1
MDL-1 7,
MDL-17, 0
MDL-17,0 43)</w>
MD2 F,</w>
MD2 F)</w>
MD s,</w>
MD T</w>
MD T)</w>
MD S-associated</w>
MD RD</w>
MD R1</w>
MD R),</w>
MD PIT</w>
MD M2</w>
MD M2,</w>
MD M)</w>
MD L),</w>
MD I</w>
MD D:</w>
MD D).</w>
MD .(ABSTRACT</w>
MCT D,</w>
MCT 1</w>
MCL .</w>
MCL ).(ABSTRACT</w>
MCF 7</w>
MCF 7.</w>
MCAv(mean ).</w>
MCA O,</w>
MCA ))</w>
MC)- derived</w>
MC)- a</w>
MC V</w>
MC J
MCJ s</w>
MC F-
MCF- 7</w>
MC ;</w>
MC -1)</w>
MB- 45,</w>
MB q</w>
MB q.</w>
MB q),</w>
MB P.</w>
MB P,</w>
MB IN
MBIN ED</w>
MB Hs</w>
MB H,</w>
MB )-induced</w>
MATERIAL :</w>
MAT ).</w>
MAPK s</w>
MAPK s.</w>
MAPD s,</w>
MAP/ Vmca.</w>
MAP/ CO.</w>
MAP s.</w>
MAP K-
MAPK- positive</w>
MAP )]</w>
MAOI s;</w>
MAOI s,</w>
MAOI -associated</w>
MAOI -</w>
MAOI 's.</w>
MAO- inhibiting</w>
MAO- A-mediated</w>
MAO -mediated</w>
MAO 's.</w>
MAMP -</w>
MAG 3),</w>
MAFb x.</w>
MAFb x,</w>
MAC- fraction</w>
MA/ S;</w>
MA/ S,</w>
MA/ C;</w>
MA/ C,</w>
MA- vinyl-GABA</w>
MA- d)</w>
MA s).</w>
MA XIM</w>
MA X)</w>
MA T-2)</w>
MA Q),</w>
MA Ps</w>
MA PD.</w>
MA P),</w>
MA N</w>
MA N,</w>
MA LT</w>
MA LD
MALD I</w>
MA L,</w>
MA J
MAJ OR</w>
MA H</w>
MA F-activated</w>
MA E</w>
MA BP.</w>
MA BP,</w>
MA BP)</w>
MA BP
MABP 's</w>
MA +</w>
MA +
MA+ vehicle</w>
M= 47+/-
M=47+/- 6</w>
M= 18+/-4</w>
M50 76</w>
M50 76,</w>
M40 40
M4040 3,</w>
M3 G.</w>
M2413 85)</w>
M204 V)</w>
M2- specific</w>
M2- muscarinic</w>
M1628 7.</w>
M1628 7,</w>
M1/M 3/M5</w>
M1/M 2-antagonist</w>
M1/ M2</w>
M1- specific</w>
M1- mediated</w>
M1- blockade</w>
M1- antagonist</w>
M1- antagonist,</w>
M1- M5</w>
M/ min</w>
M/ mg</w>
M/ l).</w>
M/ l),</w>
M/ P/3/4,</w>
M/ F</w>
M/ CIO
M/CIO MS)</w>
M. J.,</w>
M-1 26,</w>
M-1 -</w>
M- phase</w>
M- mode,</w>
M- kinase</w>
M- current</w>
M- component</w>
M- cholinoreactive</w>
M- TMCD,</w>
M- NEO</w>
M- Mode</w>
M- M204V)</w>
M- IV,</w>
M- DAT
M-DAT )</w>
M- 3)</w>
M(3)- muscarinic</w>
M(3)- mAChR.</w>
M yricetin</w>
M yelography</w>
M usical</w>
M uddy</w>
M u</w>
M sc</w>
M sc,</w>
M s),</w>
M rs</w>
M r</w>
M r.</w>
M pT)-induced</w>
M oxifloxacin-induced</w>
M oxalactam,</w>
M outh</w>
M otherisk</w>
M ostly,</w>
M organ</w>
M organ,</w>
M oney</w>
M ofid</w>
M obility</w>
M o</w>
M n-superoxide</w>
M n-SOD,</w>
M l</w>
M inet-Ringuet</w>
M imicking</w>
M ild-moderate,</w>
M id</w>
M g)</w>
M essenger</w>
M er.</w>
M er)</w>
M equitazine</w>
M epyramine</w>
M embers</w>
M ellaril</w>
M ed.</w>
M echlorethamine,</w>
M b</w>
M axillary</w>
M ax</w>
M astery</w>
M asked</w>
M ary</w>
M arey</w>
M apping,</w>
M anguana.</w>
M amoharon</w>
M aloprim</w>
M aking</w>
M aine</w>
M aier</w>
M ai</w>
M agee-Womens</w>
M afosfamide</w>
M achine,</w>
M Y</w>
M Y5445</w>
M X.</w>
M WF</w>
M VP</w>
M UP</w>
M UCR</w>
M TIC</w>
M THFR</w>
M SH.</w>
M SE</w>
M SE,</w>
M SE)</w>
M SDPB</w>
M SCs,</w>
M RO2)</w>
M R)</w>
M PR,</w>
M PO)</w>
M PA;</w>
M OR.</w>
M OPP.</w>
M ONES:</w>
M OFS,</w>
M OAT,</w>
M O-exposed</w>
M NS,</w>
M NPN</w>
M NG,</w>
M N)</w>
M MR.</w>
M LT,</w>
M LT)</w>
M LA</w>
M LA.</w>
M L
ML AERs</w>
M ID.</w>
M ICU</w>
M HD.</w>
M H.</w>
M H)</w>
M GP
MGP S</w>
M Fs</w>
M FF
MFF -</w>
M F.</w>
M F-
MF- pretreated</w>
M DE:</w>
M Cs</w>
M CTD</w>
M CS.</w>
M CRs</w>
M CL)</w>
M CA-
MCA- RH7777</w>
M C,</w>
M C).</w>
M ACE,</w>
M AC).</w>
M AC),</w>
M 99)</w>
M 8</w>
M 7</w>
M 75</w>
M 6</w>
M 60+C600</w>
M 5,</w>
M 4,</w>
M 4
M4 E
M4E o</w>
M 3/M5</w>
M 3-
M3- specific</w>
M 2;</w>
M 25,</w>
M 2-mediated</w>
M 2-antagonist</w>
M 15</w>
M 100907</w>
M 1.</w>
M 1-</w>
M 0)</w>
M .)</w>
M -</w>
M )]</w>
M )/
M)/ integrin</w>
Lys(15)] Nociceptin</w>
Lys ine</w>
Lymph oproliferative</w>
Lymph omes</w>
Lymph omatous</w>
Lymph omas</w>
Lymph oblastic</w>
Lymph atic</w>
Ly sosomes</w>
Ly solecithin-treated</w>
Ly on</w>
Ly on.</w>
Ly ell</w>
Lup us-like</w>
Lup ron.</w>
Lup ron-induced</w>
Lu peol</w>
Lu minal</w>
Lu men</w>
Lt d.,</w>
Lt d.).</w>
Lt d,</w>
Lt d).</w>
Lp [a]),</w>
Lp -induced</w>
Low- osmolality</w>
Low- intensity</w>
Low- frequency,</w>
Low- density</w>
Low- defensive</w>
Low- Dose</w>
Low n</w>
Low er-extremity</w>
Low er-dose</w>
Love ")</w>
Love ").</w>
Lov astatin/gemfibrozil</w>
Lov astatin,</w>
Lou d:</w>
Los ses</w>
Los artan:</w>
Loracar bef,</w>
Lor azepam:</w>
Lor azepam.</w>
Long- established</w>
Long- access</w>
Long- QT</w>
Long- /medium-chain</w>
Long term</w>
Long itudinal,</w>
Long -</w>
Log dose</w>
Lofex idine,</w>
Lof etensin</w>
Loest rin,</w>
Lock hart</w>
Lock ed-in</w>
Loc us</w>
Loc ally</w>
Loc ally-induced</w>
Lob und</w>
Lo yola</w>
Lo u</w>
Lo reclezole</w>
Lo iasis</w>
Lo ghman-Hakim</w>
Lo be</w>
Liver pool</w>
Liver :</w>
Liver -to-body</w>
Liver -specific</w>
Liver -cell</w>
Lithium- pilocarpine</w>
Lithium- neuroleptic</w>
Lithium- methomyl</w>
Lithium- alone</w>
Lithi um/pilocarpine-induced</w>
Lithi um-treated</w>
Lithi um-related</w>
Lithi um-</w>
Lithi um's</w>
Lith ionit</w>
Lith iasis</w>
Lit chfield</w>
Lit arex</w>
List -90</w>
Lissau er</w>
Lissau er).</w>
Lis dexamfetamine's</w>
Lipos omal-encapsulated</w>
Lipo protein</w>
Lipid- lowering</w>
Lip inski's</w>
Linezol id-Induced</w>
Lind ane-altered</w>
Lin king</w>
Lin kage</w>
Lin comycin-induced</w>
Limit ed)</w>
Lim onexic</w>
Lim a,</w>
Like lihood</w>
Lign ocaine-induced</w>
Light- microscopically,</w>
Light- headedness</w>
Ligh tCycler-based</w>
Lig ands</w>
Life- threatening,</w>
Life- long</w>
Life- link</w>
Lif etime</w>
Lif etime.</w>
Lidoca ine-polyurethane</w>
Lid ocame</w>
LiCl/ pilocarpine-</w>
LiCl- pretreated</w>
LiCl- pre-treated</w>
LiCl- containing</w>
Li/ pilocarine</w>
Li/ Li,</w>
Li/ Li
Li/Li ).</w>
Li/ C)</w>
Li-PC -induced</w>
Li- withdrawn</w>
Li- sensitive</w>
Li- pilocarpine-treated</w>
Li- exposure</w>
Li- added</w>
Li- NDI</w>
Li- NDI.</w>
Li- NDI,</w>
Li ving</w>
Li ve</w>
Li ve-born</w>
Li khert</w>
Li Hal</w>
Li Cl)</w>
Li ;</w>
Li -P
Li-P C.</w>
Li +)</w>
Li ),</w>
Li (+),</w>
Li 's</w>
Lg A)</w>
Lew is).</w>
Levosul piride-induced</w>
Levo thyroxine-induced</w>
Levo simendan,</w>
Levo dopa-dyskinesia</w>
Levo bupivacaine-induced</w>
Levamisol e:</w>
Levamisol e-dependent</w>
Levamisol e,</w>
Lev enson.</w>
Lev acetylmethadol</w>
Lev acetylmethadol,</w>
Leukotri enes</w>
Leuk ocyturia</w>
Leuk ocytosis</w>
Leuk ocytopenia</w>
Leuk ocytoclastic</w>
Leuk ocyte</w>
Leuk emic</w>
Leuk emia.</w>
Leuc ovorin.</w>
Leuc openia</w>
Leuc ocytopenia</w>
Leuc ocytoclastic</w>
Leu- enkephalin</w>
Leu- enkephalin.</w>
Leu prorelin</w>
Leu prolide-alone</w>
Leu 593</w>
Leu 250-
Leu250- to-Thr</w>
Leu -1
Leu-1 9;</w>
Leu ),</w>
Let ter:</w>
Let ter,</w>
Less ons</w>
Less er</w>
Less .)</w>
Lenalidom ide:</w>
Lenalidom ide-related</w>
Lenalidom ide-bortezomib-dexamethasone</w>
Len nox</w>
Leiomy osarcomas</w>
Leiomy osarcoma</w>
Lef t-ventricular</w>
Lef t-</w>
Lear k,</w>
Leak y</w>
Le yodopa-induced</w>
Le vetiracetam:</w>
Le ver-pressing</w>
Le sioning</w>
Le sion)</w>
Le guminosae)</w>
Le gislation</w>
Le gionella</w>
Le ghorn</w>
Le gal</w>
Le eds</w>
Le derle)</w>
Le ague</w>
Le adeks</w>
Ld T-treated</w>
Ld T,</w>
Laus anne</w>
Laus anne,</w>
Latin- square</w>
Late- life</w>
Late- developing</w>
Late- Phase</w>
Latano prost-related</w>
Latano prost,</w>
Lat ino</w>
Lat ino;</w>
Lat est</w>
Lat ent</w>
Lat ency,</w>
Lat encies,</w>
Las er-scanning</w>
Larg er-scale</w>
Larg er,</w>
Lare do</w>
Langerhan s-cell</w>
Langerhan s'</w>
Langendorff- heart</w>
Langendor ff.</w>
Langendor f</w>
Land ry,</w>
Land race</w>
Lan diolol</w>
Lan diolol,</w>
Lamivudine- refractory</w>
Lamivudine- adefovir</w>
Lamivud ine/hepatitis</w>
Lam oxactam</w>
Lam ellar</w>
Lact ography</w>
Lact ation</w>
Lact ate-</w>
Lacidi pine</w>
Lacidi pine,</w>
Lac Z</w>
Laborator y,</w>
Laborator ies.</w>
Labor atories)</w>
Label=" SETTING"</w>
Label=" PRIMARY</w>
Label=" EFF
Label="EFF IC
Label="EFFIC AC
Label="EFFICAC Y"</w>
Lab roy</w>
Lab eled</w>
Lab az,</w>
La six</w>
LY379 26
LY37926 8,</w>
LY367 385</w>
LY367 38
LY36738 5-
LY367385- mediated</w>
LY3414 95-
LY341495- reversible</w>
LY2746 14.</w>
LY1753 26
LY175326 :</w>
LY1418 65.</w>
LY-17 1555,</w>
LY-17 15
LY-1715 55.</w>
LY X</w>
LY X/Doxil)</w>
LY 35
LY35 4,
LY354, 740</w>
LY .</w>
LY )</w>
LX -1</w>
LX -1)</w>
LVF X-</w>
LVF W</w>
LVEFr n.</w>
LVE SDs</w>
LVE SD</w>
LVE F;</w>
LVE F-
LVEF- reduction</w>
LVE F
LVEF 's</w>
LVE DP</w>
LVE DP).</w>
LVE DP
LVEDP ]</w>
LVE DD</w>
LVE DD.</w>
LVD d</w>
LVD .(ABSTRACT</w>
LV- I).</w>
LV- EF</w>
LV dP/dt,</w>
LV T).</w>
LV SWI,</w>
LV SP</w>
LV SF.</w>
LV PW</w>
LV P-</w>
LV P)</w>
LV P),</w>
LV M.</w>
LV F.</w>
LV F,</w>
LV Ds</w>
LV DP.</w>
LV DP,</w>
LV D;</w>
LV Ad</w>
LV /5-FU</w>
LUT S,</w>
LTBM Cs.</w>
LTBM C.</w>
LT oma),</w>
LT X.</w>
LT S</w>
LT P-like</w>
LT M</w>
LT G-induced</w>
LT G,</w>
LT Es</w>
LT E.</w>
LT D</w>
LT D4.</w>
LT CPP,</w>
LT C4/
LTC4/ D4.</w>
LT BMC</w>
LT B
LTB 4,</w>
LT A
LTA (4)</w>
LT 3-
LT3- IT
LT3-IT D</w>
LT -1,</w>
LSM LN.</w>
LSE P.</w>
LSE P,</w>
LRTI s,</w>
LRS -</w>
LR S/kg</w>
LR R.</w>
LR D
LRD 70
LRD70 %:</w>
LR 172,</w>
LQT Ss</w>
LQT Ss.</w>
LQT S,</w>
LQT S)</w>
LQT 3</w>
LQT 3)</w>
LQT 1.</w>
LPS- pretreated</w>
LP S.</w>
LP S,</w>
LP Ms</w>
LP Ms.</w>
LP M</w>
LP H</w>
LP C.</w>
LP ;</w>
LP 0
LP0 20,</w>
LP ).</w>
LO X,</w>
LO X)</w>
LO S,</w>
LO CK
LOCK IN
LOCKIN G</w>
LO CF);</w>
LO .</w>
LND-6 23;</w>
LN NA.</w>
LN ).</w>
LMW- heparin,</w>
LMW H-bridged</w>
LM s,</w>
LM WH;</w>
LM V.</w>
LM V-resistant</w>
LM S)</w>
LM 2,</w>
LM /
LM/ GEE</w>
LLC-PK 1</w>
LLC-PK 1-
LLC-PK1- cells,</w>
LL L.</w>
LK 1)</w>
LIS ),</w>
LIMIT ATION:</w>
LIL AC</w>
LID I</w>
LI s)</w>
LI S)</w>
LI PFC.</w>
LI P.</w>
LI P,</w>
LI MA</w>
LI M.</w>
LI M-kinase</w>
LI H</w>
LI G.</w>
LI D-
LID- related</w>
LI D)</w>
LI C</w>
LI 6</w>
LI 3-
LI3- LI6</w>
LHR HG
LHRHG )-</w>
LHR H-
LHRH- based</w>
LH-Z I.</w>
LH- releasing</w>
LH ON-like</w>
LH L.</w>
LG MD2F,</w>
LG D)</w>
LF basal</w>
LF U</w>
LF U.</w>
LF Ts</w>
LF T.</w>
LF P).</w>
LF B;</w>
LF );</w>
LF (nu)</w>
LEP s,</w>
LEP s)).</w>
LEG/ ml,</w>
LEF- group,</w>
LE V-induced</w>
LE V-filled</w>
LE SS)</w>
LE R</w>
LE P</w>
LE D</w>
LE -like</w>
LE );</w>
LDL- c.</w>
LDL- c,</w>
LDL- C.</w>
LDL- C,</w>
LDH- 2)</w>
LDH -1</w>
LDH -1,</w>
LD- related</w>
LD- associated</w>
LD- MRI</w>
LD- HD,</w>
LD(con v).</w>
LD s</w>
LD S</w>
LD LT.</w>
LD L.</w>
LD I)</w>
LD H)</w>
LD H),</w>
LD D</w>
LD D.</w>
LD D,</w>
LD AE
LDAE P</w>
LD A),</w>
LD A
LDA EP.</w>
LD 97</w>
LD 95),</w>
LD 90,</w>
LD 90).</w>
LD 86</w>
LD 85</w>
LD 85),</w>
LD 50.</w>
LD 10</w>
LD 100.</w>
LD /
LD/ benserazide</w>
LD -treated</w>
LD +BZ.</w>
LD )]</w>
LD )-
LD)- MRI</w>
LD ),</w>
LD (pl)</w>
LD (50)=
LD(50)= 2
LD(50)=2 154
LD(50)=2154 mg/kg.</w>
LD (50))</w>
LD (50
LD(50 );</w>
LD (10)</w>
LCT/ MCT.</w>
LCR s,</w>
LCR >
LCR> HC
LCR>HC R),</w>
LCCG 1</w>
LCCG 1,</w>
LCB Fs</w>
LCA )-induced</w>
LC3- II</w>
LC3- II,</w>
LC- MS/MS</w>
LC s,</w>
LC X/LAD</w>
LC 2</w>
LC 1</w>
LAM- refractory</w>
LA- pretreated</w>
LA- pre-treated</w>
LA s.</w>
LA ST),</w>
LA SIX</w>
LA R)</w>
LA P,</w>
LA FA</w>
LA AM,</w>
LA AM
LAAM :
LAAM: methadone</w>
LA 4</w>
L78 10,</w>
L6- S1);</w>
L5- S2</w>
L4- S1).</w>
L3- L5</w>
L3- 4)</w>
L20/F 25).</w>
L180 M-M204V)</w>
L12 10,</w>
L12 10),</w>
L/min/ m2</w>
L/ s</w>
L/ min/m2,</w>
L/ min,</w>
L/ min);</w>
L/ min),</w>
L/ m2</w>
L/ kg;</w>
L/ kg/day,</w>
L/ kg)</w>
L/ kg),</w>
L/ hr/m2</w>
L/ hr,</w>
L/ ethanol/saline</w>
L/ dtmax,</w>
L/ day)</w>
L/ P</w>
L/ P,</w>
L/ LDL</w>
L/ KIT</w>
L.min-1.%SaO2(-1 ]</w>
L.min-1.%SaO2(-1 ],</w>
L.min-1.%SaO2 (-1)</w>
L.min-1. m-2;</w>
L. N.,</w>
L. B
L.B .)</w>
L. :</w>
L. (kg</w>
L-methionine- dl-sulfoximine</w>
L-methionine- RS-sulfoximine</w>
L-lysin ate</w>
L-dopa- related.</w>
L-dopa :</w>
L-dopa -</w>
L-dopa )</w>
L-arginine- derived</w>
L-argin ine-induced</w>
L-alpha- glycerylphosphorylcholine</w>
L-alpha- glyceryl-phosphorylcholine</w>
L-alpha- GF
L-alpha-GF C</w>
L-OH P.</w>
L-NOAR G-treated</w>
L-NOAR G-induced</w>
L-NO Arg,</w>
L-NI L,</w>
L-NG- Mono-methylarginine</w>
L-NAME ;</w>
L-NAME -treated</w>
L-NAME -sensitive</w>
L-NAME -pretreated</w>
L-NAME -
L-NAME- posttreated</w>
L-NAME )</w>
L-N MMA.</w>
L-N 6-
L-N6- (1-imino
L-N6-(1-imino ethyl)</w>
L-N (6)-
L-N(6)- (1-imino
L-N(6)-(1-imino ethyl)lysine</w>
L-His tidinol</w>
L-His tidine,</w>
L-HO P</w>
L-HO P.</w>
L-Dopa )</w>
L-DOPA- therapy</w>
L-DOPA- psychosis</w>
L-DOPA- primed</w>
L-DOPA .7.</w>
L-DOPA -derived</w>
L-DOPA +
L-DOPA+ CGP</w>
L-DOPA ).</w>
L-DOPA 's</w>
L-DO X)</w>
L-AP 4,</w>
L-AP 4)</w>
L-701,3 24.</w>
L-701,3 24,</w>
L-659,0 66</w>
L-659,0 66).</w>
L-657 ,7
L-657,7 43</w>
L-657 ,
L-657, 74
L-657,74 3;</w>
L-655,70 8.</w>
L-5-HT P.</w>
L-5-HT P-induced</w>
L- tyrosine</w>
L- tryptophan.</w>
L- tryptophan-induced</w>
L- tryptophan,</w>
L- thyroxine.</w>
L- thyroxine,</w>
L- threo-DOPS.</w>
L- threo-3,4-dihydroxyphenylserine</w>
L- tert-Leu,</w>
L- serine-O-phosphate</w>
L- selectin</w>
L- related.</w>
L- pyroglutamyl-L-histidyl-L-prolinamide,</w>
L- propranolol.</w>
L- prolyl-L-leucyl-glycinamide</w>
L- phenylalanine,</w>
L- ornithine</w>
L- nucleoside</w>
L- neo-Trp,</w>
L- multilamellar-DPPC</w>
L- morphine)</w>
L- methionine,</w>
L- leucine</w>
L- kynurenine</w>
L- isoproterenol.</w>
L- histidinol</w>
L- histidine,</w>
L- glutamate-1-decarboxylase</w>
L- gamma-glutamyltransferase</w>
L- folinic</w>
L- deprenyl</w>
L- carnitine;</w>
L- carnitine.</w>
L- buthionine-S,</w>
L- asparaginase,</w>
L- ascorbate,</w>
L- amino-4-phosphonobutyric</w>
L- allylglycine</w>
L- [benzilic-4,4'-3H])</w>
L- [3H]quinuclidinyl</w>
L- [3H]nicotine</w>
L- Tyr-D-Arg</w>
L- Tryptophan</w>
L- ST).</w>
L- SOP</w>
L- Pro,</w>
L- PS)</w>
L- PIA</w>
L- PIA,</w>
L- Leu),</w>
L- L
L-L ys,</w>
L- HCl</w>
L- Glutamate</w>
L- Dop
L-Dop atreated</w>
L- Dihydroxyphenylalanine</w>
L- DOX;</w>
L- Carnit
L-Carnit ine,</w>
L- CCG
L-CCG I.</w>
L- Baclofen,</w>
L- BF
L-BF M</w>
L- AMB</w>
L- AM
L-AM B.</w>
L- 73
L-73 3,0
L-733,0 60</w>
L- 7
L-7 32
L-732 138</w>
L- 69
L-69 5,
L-695, 256</w>
L- 5-hydroxytryptophan</w>
L- 5-hydroxytryptophan.</w>
L- 5-hydroxytryptophan-induced</w>
L- 4</w>
L- 485</w>
L- 48
L-48 5,</w>
L- 4-
L-4- amino-hex-5-enoic</w>
L- 3,4-dihydroxyphenylalan
L-3,4-dihydroxyphenylalan ine-induced</w>
L- 3,4-
L-3,4- Dihydroxyphenylalanine</w>
L- 2-oxothiazolidine-
L-2-oxothiazolidine- 4</w>
L- 2-amino-4-phosphonobutyrate</w>
L- 2-amino-3-phosphono
L-2-amino-3-phosphono propanoic</w>
L- (+)-
L-(+)- 2-amino-4-phosphonobutyric</w>
L)- triglyceride</w>
L)- labelled</w>
L)- bovine</w>
L)- based,</w>
L(L act),</w>
L(+)- INPEA</w>
L(+)- 2-amino-4-phosphonobutyric</w>
L(+)- 2-amino-4-phosphonobutyrate</w>
L ycopene,</w>
L utte</w>
L uteinizing</w>
L uschka,</w>
L undbeck</w>
L umpur</w>
L umpur,</w>
L ucigenin</w>
L s),</w>
L p/Lp</w>
L p/+</w>
L oxacor),</w>
L operamide</w>
L omustine</w>
L ivingston</w>
L is</w>
L ingual</w>
L iliaceae)</w>
L ign</w>
L idoderm</w>
L icks-in-quiet</w>
L ichenoid</w>
L hasa</w>
L ethality,</w>
L ergotrile</w>
L eptomeningeal</w>
L epirudin</w>
L ens</w>
L engthening</w>
L ayer</w>
L ately,</w>
L assa</w>
L arge-scale</w>
L aplace's</w>
L anthanum</w>
L and</w>
L ancet</w>
L aminectomy</w>
L aka</w>
L aird</w>
L afayette,</w>
L add</w>
L abs.).</w>
L ZP.</w>
L URE</w>
L UF</w>
L UF)</w>
L UCDCL</w>
L U)</w>
L SVP</w>
L SVP,</w>
L STR1</w>
L ST</w>
L SP,</w>
L SN.</w>
L SD/dysphoria</w>
L SD-like'</w>
L SD,</w>
L SAS</w>
L SA</w>
L S/SS</w>
L S/Ibg</w>
L S-treated</w>
L S-induced</w>
L S,</w>
L S),</w>
L RE.</w>
L PO,</w>
L PDG),</w>
L PC-</w>
L PBN.</w>
L OD></w>
L NP250A</w>
L N-pretreated</w>
L MT,</w>
L MA;</w>
L LT)</w>
L LD.</w>
L IN
LIN onHal</w>
L H).</w>
L CVR</w>
L CRs</w>
L CR</w>
L CP</w>
L CH.</w>
L CH,</w>
L CE.</w>
L CBF.</w>
L CBF)</w>
L CA</w>
L CA-
LCA- assigned</w>
L BW</w>
L BW)</w>
L BUP</w>
L BNP,</w>
L BH),</w>
L BB
LBB BM</w>
L AR).</w>
L AMP-
LAMP- 2A</w>
L AM,</w>
L AEs,</w>
L AE</w>
L AD,</w>
L ABC</w>
L A-treated</w>
L 97.</w>
L 7)</w>
L 552
L552 S,</w>
L 5418</w>
L 50</w>
L 50)</w>
L 5-6</w>
L 5)</w>
L 5
L5 28
L528 M</w>
L 4.</w>
L 3-4</w>
L 2-3</w>
L 2-3)</w>
L 0
L0 57;</w>
L .g-1.
L.g-1. min-1)</w>
L .)</w>
L .).</w>
L -10
L-10 20)</w>
L -1),</w>
L +BIC,</w>
L +</w>
L )/
L)/ myelodysplastic</w>
L )-treated</w>
L (G),</w>
L (A
L(A ))</w>
L (2)</w>
L (1),</w>
L (-1).</w>
L (-1))</w>
L (-1)),</w>
L (+/-)-
L(+/-)- INPEA</w>
Kynuren ine</w>
Kv LQT1.</w>
Kv 7</w>
Kv ,</w>
Krus kal</w>
Krox- 24</w>
Krox- 24.</w>
Krebs- Hen
Krebs-Hen seleit</w>
Kos sa's</w>
Kos nik</w>
Korean- born</w>
Korean- Americans</w>
Kore t</w>
Kore ans</w>
Kore ans.</w>
Kore ans,</w>
Kore an-American</w>
Kore a).</w>
Know ing</w>
Knoc kdown</w>
Kloth o.</w>
Kloth o,</w>
Kit(Y567F/Y567 F:Y569F/Y569F)</w>
Kit -</w>
Kit +</w>
Kit (pos
Kit(pos )CD71(high)</w>
Kit (
Kit( neg)CD71(high)</w>
Kir6.2- knockout</w>
Kir6.2- encoded</w>
Kir schner</w>
Kir 2.3
Kir2.3 's</w>
Kir 2.
Kir2. 3.</w>
Kir 2,</w>
King sland</w>
Kine matical</w>
Kine matic</w>
Kind schi,</w>
Kind ling</w>
Kinase- isoenzyme</w>
Kinase- -M
Kinase--M B</w>
Kidne y:</w>
Ki= 45.9</w>
Ki= 4
Ki=4 2.1</w>
Ki= 20.7</w>
Ki= 0.61</w>
Ki- 67.</w>
Ki- 67-
Ki-67- ,</w>
Ki :</w>
Ki 67</w>
Ki 67-
Ki67- positive</w>
Khe t</w>
Khe llin,</w>
Ketocon azole.</w>
Ketocon azole-associated</w>
Ketocon azole,</w>
Ket anserin:</w>
Ket anserin,</w>
Ket amine.</w>
Ket amine-treated</w>
Ket amine-pancuronium-narcotic</w>
Ket amine-induced</w>
Ket :</w>
Kerat ins</w>
Ker nohan</w>
Ker atin</w>
Ker ala</w>
Keny atta</w>
Keny an</w>
Ken ya</w>
Ken ilworth,</w>
Kell er,</w>
Kawasak i-like</w>
Kawasak i's</w>
Kau fmann</w>
Karnov sky-Roots</w>
Karnov sky's</w>
Kar sch),</w>
Kar ara,</w>
Kappa- agonists</w>
Kappa- agonist</w>
Kappa- agonist,</w>
Kaplan-Mei er-type</w>
Kaplan-Mei er,</w>
Kanz o</w>
Kanz o,</w>
Kamp ala,</w>
Kain ate</w>
Kain ate-treated</w>
Ka umann</w>
Ka olin</w>
Ka ohsiung</w>
KW- 6002,</w>
KV (s)</w>
KV (r)</w>
KT58 23</w>
KT58 23,</w>
KT- enhanced</w>
KR B</w>
KR /
KR/ crl</w>
KP14 47)</w>
KP -1</w>
KOPr -1.</w>
KOP r</w>
KO s,</w>
KO /
KO/ heparin-treated</w>
KIT-PY567- directed</w>
KIT-PY567- dependent</w>
KIT- PY719</w>
KIT- PY567</w>
KIT(Y719 F/
KIT(Y719F/ Y719F)</w>
KIT(Y719 F
KIT(Y719F ,
KIT(Y719F, Y719F),</w>
KIT(Y567F/Y567 F:Y569F/Y569F)</w>
KIT(Y567F/Y567 F),</w>
KIT L/KIT</w>
KIT (Y56
KIT(Y56 9F/Y569
KIT(Y569F/Y569 F),</w>
KG F-treated</w>
KF178 37
KF17837 :</w>
KE T</w>
KCl -treated</w>
KCl -induced</w>
KCl );</w>
KCl ),</w>
KCl 's</w>
KCN Q2-3</w>
KCN J
KCNJ 11-
KCNJ11- encoded</w>
KCN -induced</w>
KCN ,</w>
KCD- 232,</w>
KCC 2,</w>
KCA L)</w>
KCA F-activated</w>
K1 C)</w>
K1 20).</w>
K-49 F)</w>
K-35 C)</w>
K- values</w>
K- strophanthin.</w>
K- producing</w>
K- kappa</w>
K- hole:</w>
K- channel</w>
K- TPA)</w>
K- FLU
K-FLU OR-25%),</w>
K- Cl</w>
K- C)</w>
K- 293</w>
K- 2004)</w>
K+- losses</w>
K+- channels.</w>
K+- ATPase,</w>
K+ ]</w>
K+ -</w>
K+ -1</w>
K(v)7. 5/
K(v)7.5/ 3</w>
K(v)7. 4-
K(v)7.4- K(v)
K(v)7.4-K(v) 7.5</w>
K(v)7. 2/3</w>
K(i ))</w>
K(+)- stimulated</w>
K(+)- deficient</w>
K(+)- currents</w>
K(+)- channel</w>
K(+)- HCTZ</w>
K(+)- ATPase.</w>
K(+)- ATPase)</w>
K(+) ATPase)</w>
K(+) ATP</w>
K yoto-Wistar</w>
K urashiki,</w>
K ung</w>
K unMing</w>
K ugler</w>
K rames</w>
K owa</w>
K okka,</w>
K odak</w>
K noll</w>
K nodell</w>
K night,</w>
K nee</w>
K max)</w>
K luk,</w>
K longtoey,</w>
K leptomania,</w>
K lein</w>
K lebsiella-Enterobacter-Serratia</w>
K ing,</w>
K g-1)</w>
K g).</w>
K f.</w>
K elch</w>
K eener</w>
K edes,</w>
K ebsiella</w>
K cnc4)</w>
K aryomegaly</w>
K arger,</w>
K aplan</w>
K ane</w>
K amil</w>
K alow's</w>
K allikrein</w>
K aliuretic</w>
K abi</w>
K a,</w>
K a)</w>
K Y-046,</w>
K Y),</w>
K W/BW</w>
K UB</w>
K S.</w>
K S,</w>
K S),</w>
K PS>or=60%</w>
K PN</w>
K P),</w>
K O.</w>
K NOWN</w>
K NCQ(1)-gene</w>
K N93,</w>
K LS.</w>
K LK1)</w>
K L,</w>
K KS</w>
K KO</w>
K KO/heparin-treated</w>
K KO,</w>
K J865)</w>
K IU/day</w>
K I),</w>
K HCO3</w>
K HCO3.</w>
K H,</w>
K D-treated</w>
K D-
KD- fed</w>
K D,</w>
K D).</w>
K Cl-
KCl- evoked</w>
K Ca)</w>
K CN-
KCN- insensitive</w>
K C)</w>
K B)</w>
K ATP</w>
K A/
KA/ EA</w>
K ;</w>
K :
K: liver-/-</w>
K 562</w>
K 2-
K2- loxP-targeted</w>
K 2)</w>
K 2),</w>
K 1:</w>
K 18)</w>
K 173</w>
K 15),</w>
K 120</w>
K 1/2)</w>
K 1,</w>
K 1)</w>
K .)</w>
K -treated</w>
K ,
K, 1
K,1 C-
K,1C- renal</w>
K +/
K+/ Cl-</w>
K )--
K)-- each</w>
K (Ca)</w>
K (C
K(C a),</w>
K (ATP),</w>
K (ACh)</w>
K (1)</w>
K (+),</w>
Juzen-taiho- to</w>
Juzen-taiho- to,</w>
Jun g</w>
Jun ).</w>
Judg ments</w>
Jud gements</w>
Jour nal.</w>
Joules/ min,</w>
Joules/ min)</w>
Join tly,</w>
John ston</w>
Joh ns</w>
Joh n</w>
Jo- mediated</w>
Jo- 2</w>
Jo witt</w>
Jo ve,</w>
Jia xing</w>
Jia xing,</w>
Jerse y,</w>
Jerse y)</w>
Jer usalem</w>
Je junal</w>
Jcl :</w>
Japane se.</w>
Japane se-Canadian</w>
Jap an--.</w>
Jap an)</w>
Jank ovic</w>
Jank ovic,</w>
Jan us</w>
Jamaic an.</w>
Jamaic a,</w>
Jama ica</w>
JOl a</w>
JOl a,</w>
JNK 2/
JNK2/ p54</w>
JNK .</w>
JNK ),</w>
JAK- binding</w>
JAK 2</w>
J/ m(2)</w>
J. M.,</w>
J. C.</w>
J. -H.,</w>
J-113 397</w>
J-113 39
J-11339 7.</w>
J- stent</w>
J- resolved</w>
J- evolution</w>
J- C)</w>
J ustice,</w>
J umping,</w>
J ones</w>
J onckheere-Terpstra</w>
J eyaseelan,</w>
J ews).</w>
J et</w>
J eddah.</w>
J aw</w>
J ava</w>
J an.</w>
J ames's</w>
J ail.</w>
J aff</w>
J acobson,</w>
J accoud's</w>
J TV506</w>
J T)</w>
J RA</w>
J RA.</w>
J OLs</w>
J NK2</w>
J NK1</w>
J ME</w>
J ME,</w>
J M</w>
J M,</w>
J L,</w>
J K),</w>
J J,</w>
J IA.</w>
J IA,</w>
J H,</w>
J G,</w>
J DO
JDO H)</w>
J C</w>
J C,</w>
J AB
JAB /
JAB/ SOCS-1/SSI-1</w>
J 2,</w>
J 129
J129 Sv/Ev</w>
J 0-2</w>
Italian a</w>
It ching</w>
It ch</w>
It aly:</w>
It aly),</w>
Istan bul</w>
Isradi pine,</w>
Isra el,</w>
Isra el).</w>
Isovue- 370.</w>
Isotretino in-associated</w>
Isotretino in,</w>
Isosorb ide-5-mononitrate</w>
Isoproteren ol-headup</w>
Isopren aline-induced</w>
Isop ulegol</w>
Isoniaz id-rifampin</w>
Isoniaz id-rifampicin-induced</w>
Isom erization</w>
Isol ectin</w>
Isol ation</w>
Isob aric</w>
Iso volumetric</w>
Iso eugenolol:</w>
Iso V)</w>
Isl es.</w>
Isl and,</w>
Isl -1/
Isl-1/ Mec3)-kinase</w>
Ishihar a,</w>
Ischemia- injured</w>
Ischemia- Time</w>
Ischem ia/reperfusion:</w>
Ischem ia)</w>
Isch aemia/reperfusion</w>
Is- Mn</w>
Is- 5-Mn)</w>
Is sue</w>
Is s</w>
Is real:</w>
Is ostenuria</w>
Is ocarboxazid</w>
Is o-osmolar</w>
Is les</w>
Is lander,</w>
Is land.</w>
Is lamic</w>
Is an</w>
Irrit ative</w>
Irrit able</w>
Irrit ability,</w>
Irin otecan,</w>
Irb ;</w>
Ira q</w>
Ira q.</w>
Ira q,</w>
Ir-CP I,</w>
Ir sa</w>
Ir reversibility</w>
Ir radiation-induced</w>
Ir an</w>
Ipsapir one,</w>
Iox aglate-treated</w>
Iox aglate,</w>
Iopent ol</w>
Iopent ol,</w>
Iohex ol-treated</w>
Iohex ol,</w>
Iohex al</w>
Io annina.</w>
Investig ations,</w>
Inver ted</w>
Inver sely</w>
Inver sely,</w>
Inventory- State</w>
Inventory- 2</w>
Intraven ously,</w>
Intrathec al,</w>
Intras plenic</w>
Intrapl atelet</w>
Intran eural</w>
Intran asal,</w>
Intram ucosal</w>
Intram edullary</w>
Intralip id.</w>
Intralip id)</w>
Intralip id"]</w>
Intral ymphatic</w>
Intral umbar</w>
Intracor tical</w>
Intracerebro ventricularly</w>
Intracerebro ventricular-streptozotocin</w>
Intrac utaneous</w>
Intrac orporeal</w>
Intrac ellular-free</w>
Intra- striatal</w>
Intra- renal</w>
Intra- operative</w>
Intra- articular</w>
Intra- amygdaloid</w>
Intra- AId</w>
Intra urethral</w>
Intra thoracic</w>
Intra renally</w>
Intra pericardial</w>
Intra hisian</w>
Intra epidermal</w>
Intra dialytic</w>
Intra accumbal</w>
Intr atubular</w>
Intr atracheal</w>
Intr aglomerular</w>
Interview -Pl
Interview-Pl us,</w>
Interval ],</w>
Interval :</w>
Interpre ting</w>
Interpre tation</w>
Interleukin- 3,</w>
Interferon- ribavirin-associated</w>
Interferon- gamma</w>
Interferon- alpha-2b/ribavirin-induced</w>
Interfer on-induced</w>
Inter- species</w>
Inter- individual</w>
Inter vention.</w>
Inter val</w>
Inter university</w>
Inter subject</w>
Inter stimulus</w>
Inter patient</w>
Inter observer</w>
Inter nventions</w>
Inter net</w>
Inter national,</w>
Inter nally</w>
Inter mediate</w>
Inter lobular</w>
Inter leukin-11</w>
Inter ictally,</w>
Inter current</w>
Inter continental</w>
Inter cellular</w>
Intensi ties</w>
Intensi fied,</w>
Inten tional</w>
Inten tion-to-treat</w>
Integr ity</w>
Integr in</w>
Inte resting</w>
Inte llectual</w>
Inte grating</w>
Insul inoma</w>
Insul in-infused</w>
Instrum ents</w>
Instrum ented</w>
Instrum ental</w>
Institu tionalized</w>
Insp ired</w>
Insp ection</w>
Ins1P- levels.</w>
Ins1 P.</w>
Ins 4P)</w>
Inj ured</w>
Inj ectors</w>
Inj ection.</w>
Initi ative:</w>
Initi ating</w>
Inhib ition,</w>
Inhib ited</w>
Inher itance</w>
Inhal ational</w>
Ing enta</w>
Influ x</w>
Influ enza-like</w>
Inflam mation,</w>
Inf usion-dosed</w>
Inf used</w>
Inf ants'</w>
Induc ing</w>
Induc ibility</w>
Induc es</w>
Indomethac ine</w>
Indometh acin.</w>
IndoPro Caf
IndoProCaf )</w>
IndoPro Ca
IndoProCa f</w>
Indo bufen</w>
Indo -1</w>
Individu alizing</w>
Indin avir.</w>
Indic ator.</w>
Indic ation,</w>
Indic a,</w>
Indi um</w>
Indi a:</w>
Index ing</w>
Index /
Index/ Psychomotor</w>
Index ).</w>
Index ),</w>
Inde ed</w>
Indap amide-induced</w>
Indap amide,</w>
Incub ated</w>
Increas ingly</w>
Increas ing-current</w>
Incre ments</w>
Incl ude</w>
Incid ent</w>
Inc rusted</w>
Inc heon,</w>
Inc as</w>
Inc .</w>
In- vitro</w>
In- utero</w>
In- depth</w>
In- Process</w>
In ward</w>
In vest.62:</w>
In verted"</w>
In tricate</w>
In timal</w>
In tended</w>
In strument</w>
In stitution</w>
In stantaneous</w>
In stant</w>
In st.</w>
In spectorate</w>
In somnia,</w>
In significant</w>
In sight</w>
In sertion</w>
In sensitivity</w>
In sensitive</w>
In s/Del</w>
In put-output</w>
In patient.</w>
In osine</w>
In organic</w>
In nsbruck</w>
In novar,</w>
In nocuous</w>
In ner-city,</w>
In homogeneous</w>
In herent</w>
In gelheim)</w>
In frequently</w>
In frequent</w>
In formation,</w>
In feroposterior</w>
In f-DXR</w>
In dometacin</w>
In doleamine</w>
In do</w>
In discriminate</w>
In dependence</w>
In compatibility</w>
In comitant</w>
In cas.</w>
In apparent</w>
In active</w>
In activated</w>
In actin-anesthetized</w>
In TIME-II,</w>
In ,</w>
Impul siveness</w>
Improve ment.</w>
Impro ving</w>
Impressions- Bipolar</w>
Impression- Improvement.</w>
Impres sions.</w>
Impres sions,</w>
Implan on:</w>
Implan on.</w>
Immunosup pressants</w>
Immunoprecipit ation</w>
Immunoprecipit ation/Western</w>
Immunohist ochemistical</w>
Immunohist ochemically</w>
Immunoglobul ins</w>
Immunoglobul ine</w>
Immunoblo t</w>
Immuno- histochemical</w>
Immuno- electron</w>
Immuno histological</w>
Immuno hematotoxicity</w>
Immuno hematologic</w>
Immuno gold</w>
Immuno globulin</w>
Immuno flurescence</w>
Immuno assay</w>
Immuno allergological</w>
Immuno allergic</w>
Immuno /
Immuno/ histochemistry</w>
Immun oreactivity</w>
Immun opathology</w>
Immun ology</w>
Immun ologically</w>
Immun ogenicity</w>
Immun ogenetic</w>
Immun ocompromised</w>
Immun ized</w>
Immedi ate-type</w>
Imipramine- serotonin</w>
Imipramine- provoked</w>
Imipen em-induced</w>
Imipen em-cilastatin</w>
Imidaz enil:</w>
Imid aprilat</w>
Imi pramine,</w>
Imi ,</w>
Imat inib-induced</w>
Im plementing</w>
Im planted</w>
Im plantation</w>
Im plantable</w>
Im pending</w>
Im pa1</w>
Im pa1-knockout</w>
Im mulite</w>
Im mersion</w>
Ilo prost,</w>
Illino is)</w>
Ill .</w>
Ill ,</w>
Ile/ Val</w>
Ile 4,
Ile4, Arg
Ile4,Arg 8,
Ile4,Arg8, Ala
Ile4,Arg8,Ala 9
Ile4,Arg8,Ala9 )-
Ile4,Arg8,Ala9)- VP</w>
Ile 105</w>
IgM- titer</w>
IgM- producing</w>
IgG- secreting</w>
IgG- positive</w>
IgG- mediated</w>
IgG- immune</w>
IgG- coated</w>
IgG- IC</w>
IgG- AECA</w>
IgG IR,</w>
IgG 4</w>
IgG 2-mediated.</w>
IgG 1</w>
IgG -like</w>
IgE -related</w>
IgA- nephropathy</w>
IgA- mediated</w>
Ig M)</w>
Ig M),</w>
Ig G2</w>
Ig G/
IgG/ clearance</w>
Ig E-
IgE- bearing</w>
Ig AN.</w>
Ig AN,</w>
Ig ),</w>
Ifosfamide :</w>
Ifosfamide -treated</w>
Ifosf amide/mesna</w>
Ifosf amide-related</w>
Ifenpro dil,</w>
Idiosyncr asy</w>
Identi fy</w>
Identi fier</w>
Iden tically</w>
Idarub icin</w>
Id raparinux,</w>
Ic- IV),</w>
Ic- AFL</w>
Ic v</w>
Ic teric</w>
Ic atibant</w>
Ibuprofen- incurred</w>
Ibuprofen- associated,</w>
Ibuprofen :</w>
Ibu tilide-induced</w>
Ib/ IX,</w>
Ib adan</w>
I] RTI-55</w>
IV-TR :</w>
IV-TR )]</w>
IV-- ACT</w>
IV-- 2,
IV--2, 000
IV--2,000 ,000,</w>
IV- large</w>
IV- criteria,</w>
IV- V</w>
IV- TR</w>
IV- S</w>
IV- MTX</w>
IV- MTX.</w>
IV- MTX,</w>
IV- A</w>
IV a</w>
IV a-3</w>
IV US</w>
IV S7-2A-->G,</w>
IV S)</w>
IV RT</w>
IV RA,</w>
IV P</w>
IV MP;</w>
IV M,</w>
IV F</w>
IV CD.</w>
IV CD,</w>
IV B)</w>
IV B
IVB )]</w>
IV .
IV. C.
IV.C. 2)</w>
IV -P
IV-P 21.</w>
IUD s</w>
IUD s;</w>
IUD R-exposed</w>
IUD ),</w>
IU/kg/ i.v.)</w>
IU/kg/ h)</w>
IU/ week</w>
IU/ week,</w>
IU/ ml.</w>
IU/ ml,</w>
IU/ ml)</w>
IU/ m2</w>
IU/ m2.</w>
IU/ m2),</w>
IU/ liter.</w>
IU/ l</w>
IU/ l).</w>
IU/ kg/day</w>
IU/ kg).</w>
IU/ day;</w>
IU/ d</w>
IU/ d.</w>
IU/ animal)</w>
IU/ animal).</w>
IU/ L);</w>
IU/ I).</w>
IU/ 2-4</w>
IU ).</w>
IT- methotrexate,</w>
IT- cytosine</w>
IT- BUP.</w>
IT U</w>
IT SG)</w>
IT S,</w>
IT P,</w>
IT P)</w>
IT M</w>
IT M.</w>
IT C)</w>
IT B.</w>
IT B,</w>
IT A)</w>
IT .</w>
ISRCTN 68
ISRCTN68 13
ISRCTN6813 34
ISRCTN681334 35</w>
ISRCTN 45
ISRCTN45 1219
ISRCTN451219 50.</w>
ISRCTN 375
ISRCTN375 17
ISRCTN37517 54
ISRCTN3751754 9.</w>
ISO- rats.</w>
ISO- intoxicated</w>
ISO- injected</w>
ISO- infused</w>
ISO- induction</w>
ISO- administered</w>
ISO- accelerated</w>
ISO P,</w>
ISO ;</w>
ISO /
ISO/ ml</w>
ISO -mediated</w>
ISO -associated</w>
ISO +
ISO+ CAPE.</w>
ISM N.</w>
ISM N,</w>
ISM N)</w>
ISC EV</w>
IS/ TIA;</w>
IS/ TIA,</w>
IS-5-M N-20.</w>
IS PH</w>
IS P.</w>
IS P-3H</w>
IS P)</w>
IS P),</w>
IS ORDER</w>
IS N).</w>
IS MN).</w>
IS M-IV,</w>
IS L).</w>
IS H.</w>
IS F).</w>
IS DN.</w>
IS B,</w>
IS A</w>
IS A,</w>
IS -free</w>
IS ):</w>
IRREGULARIT Y.</w>
IRREGULARIT Y,</w>
IRA OS".</w>
IRA E</w>
IR N</w>
IR HC.</w>
IR F.</w>
IR F,</w>
IR Cs)</w>
IR C.</w>
IR ACE
IRACE PT),</w>
IR -treated</w>
IQ R)</w>
IPR K</w>
IPR ;</w>
IP- /-)</w>
IP V</w>
IP SP</w>
IP S-339</w>
IP P)</w>
IP N)</w>
IP I</w>
IP H-
IPH- administered</w>
IP F
IPF C).</w>
IP C)</w>
IP );</w>
IOR/OS- 2</w>
IOR/OS- 2,</w>
ION S.</w>
IO TA)</w>
IO Ss</w>
IO S</w>
IO P]</w>
IO P;</w>
IO MS)</w>
IO Ger
IOGer ).</w>
IO 2</w>
IO ),</w>
INVESTIGA TION:</w>
INTERVENTION S</w>
INTERPRETATION/ SUMMARY:</w>
INTERPRETATION/ DISCUSSION:</w>
INT -
INT- 00
INT-00 91.</w>
INT )</w>
INR value</w>
INH -treated</w>
IND I).</w>
IN VOS</w>
IN Rs.</w>
IN R).</w>
IN NIE)</w>
IN I
INI TION:</w>
IN H:</w>
IN H-I</w>
IN H)</w>
IN EC
INEC O)</w>
IN E</w>
IN CLU
INCLU DE:</w>
IN 3
IN3 A)</w>
IN 2B</w>
IN 1.</w>
IMPLICA TIONS</w>
IMPA 1,</w>
IMPA -1</w>
IMP ase)</w>
IMID -</w>
IMID 's</w>
IM/ once</w>
IM X</w>
IM S),</w>
IM P,</w>
IM O)</w>
IM C</w>
IM B</w>
IM 9</w>
IM );</w>
IL-6/ STAT-3</w>
IL-6/ Glycoprotein</w>
IL-1- receptor-1</w>
IL-1- could</w>
IL-1 ra</w>
IL-1 beta)-expressing</w>
IL-1 7.</w>
IL-1 7,</w>
IL-1 7)</w>
IL-1 3</w>
IL-1 -</w>
IL- 8.</w>
IL- 6-related</w>
IL- 3,</w>
IL ])</w>
IL P,</w>
IL K:liver-/-</w>
IL I)</w>
IL E</w>
IL E-
ILE- 2)</w>
IL E)</w>
IL AE</w>
IL A.</w>
IL A,</w>
IL 6,</w>
IL 10</w>
IL 10
IL10 -dependent</w>
IK v1.5</w>
IK ur</w>
IK s</w>
IK s,</w>
IK r-blocking</w>
IK Na.</w>
IK ACh</w>
IK 2),</w>
IK 1</w>
IK ).</w>
IK (ACh)</w>
IIb/III a,</w>
IIb/ III</w>
IIIR Ag</w>
IIIR Ag)</w>
III/ IV)</w>
III-- comparative</w>
III-- ACT</w>
III- V,</w>
III- S4)</w>
III- P17</w>
III rd</w>
III c</w>
III R</w>
III E</w>
III C</w>
III B;</w>
III B/
IIIB/ IV</w>
III B)</w>
III B).</w>
III B),</w>
III );</w>
IIE024 6.</w>
IIE0 246</w>
IIE F,</w>
IIB- IVA</w>
IIB- IV);</w>
II/ IV</w>
II-- dactinomycin</w>
II-- 7</w>
II-- 300,000</w>
II- receptor</w>
II- XIV)</w>
II- VIII)</w>
II- VI</w>
II- IV:</w>
II- III;</w>
II- A)</w>
II- (BPS)3</w>
II b:</w>
II a-Cre</w>
II HA)</w>
II E</w>
II B.</w>
II B,</w>
II A)</w>
II -treated</w>
II -independent</w>
II -P
II-P 7,</w>
II ,
II, VII,VIII,IX,</w>
II );</w>
II ):</w>
II (BPS)3</w>
IHG- 2,</w>
IH N</w>
IGFBP s,</w>
IGFBP -1,</w>
IGF-I- treatment</w>
IGF-I- containing</w>
IGF- IR,</w>
IGF- I/
IGF-I/ IGFBP</w>
IGF- I.</w>
IGF -1)</w>
IG OR),</w>
IG O)</w>
IG L</w>
IFO -treated</w>
IFN/ placebo</w>
IFN/ PEG-IFN</w>
IFN/ PEG-IFN-associated</w>
IFN-alpha -treated</w>
IFN-alpha )/
IFN-alpha)/ RBV</w>
IFN- ribavirin</w>
IFN- related</w>
IFN- beta</w>
IFN- alpha-induced</w>
IFN- RBV-related</w>
IFN- RBV-associated</w>
IFN alpha2b)</w>
IFN Alpha
IFNAlpha 2b</w>
IF X-induced</w>
IF X-VNB</w>
IF IR),</w>
IF G.</w>
IF C,</w>
IF 2
IF2 alpha)</w>
IF -14)</w>
IF -1)</w>
IF ).</w>
IF ),</w>
IE G.</w>
ID/ heart)</w>
ID s)</w>
ID X</w>
ID V/RTV</w>
ID V.</w>
ID V-containing</w>
ID V)</w>
ID S),</w>
ID PN-induced</w>
ID N-stimulated</w>
ID IS</w>
ID DS</w>
ID DM</w>
ID AS).</w>
ID AC</w>
ID A-based</w>
ID A,</w>
ID A)</w>
ID 50's</w>
ID 48),</w>
ID (50)</w>
ICV- STZ-infused</w>
ICRF-18 7)</w>
ICRF-18 7).</w>
ICRF-1 87
ICRF-187 ]</w>
ICR: 75%</w>
ICR: 50%</w>
ICR: 25%</w>
ICI 18
ICI18 2780</w>
ICI 118
ICI118 55
ICI11855 1.</w>
ICD-10 .</w>
ICD -10</w>
ICAM -1.</w>
ICAM -1,</w>
ICA-27 243,</w>
ICA M-1-</w>
IC a(L)</w>
IC V),</w>
IC U/MCU</w>
IC T</w>
IC S.</w>
IC RO),</w>
IC RF.</w>
IC R)</w>
IC P;</w>
IC P-responses</w>
IC OS,</w>
IC MP</w>
IC MP;</w>
IC Hs</w>
IC Hs,</w>
IC H]
ICH] ),</w>
IC HD-
ICHD- 2</w>
IC H;</w>
IC H).</w>
IC F</w>
IC ES</w>
IC ES
ICES S-92/EURO-E.W.I.N.G.-99,</w>
IC ER.</w>
IC E-
ICE- regimen</w>
IC D,</w>
IC C.</w>
IC C)</w>
IC C).</w>
IC -induced</w>
IC -</w>
IC )-</w>
IC (50)=
IC(50)= 9.
IC(50)=9. 20+/-
IC(50)=9.20+/- 0.36</w>
IC (50)
IC(50) s</w>
IBP B</w>
IBP B,</w>
IBM X</w>
IBM X.</w>
IBM X,</w>
IB4-sapor in.</w>
IB4-sapor in-pretreated</w>
IB4- saporin</w>
IB4- binding</w>
IB4 (+)-
IB4(+)- nociceptors,</w>
IB-ME CA,</w>
IB S)</w>
IB O-sensitive</w>
IB M</w>
IB D.</w>
IB D,</w>
IB C,</w>
IB ).</w>
IB ),</w>
IB (4)
IB(4) +/
IB(4)+/ TRPV1+/Na(v)1.8+</w>
IB (4
IB(4 )-
IB(4)- /
IB(4)-/ TRPV1-/Na(v)1.8-</w>
I1- receptors</w>
I1- receptors,</w>
I/ saline</w>
I/ pharmacokinetic/biochemical</w>
I/ mL</w>
I/ mL)</w>
I/ blindness),</w>
I/ 6J</w>
I/ 3</w>
I.U. /kg</w>
I.U. /
I.U./ kg,</w>
I.P .,</w>
I.P .)</w>
I. m.</w>
I. V.,</w>
I. )].</w>
I-ex t)</w>
I-3 e,</w>
I-2 e</w>
I-2 e,</w>
I-- may</w>
I-- 0.9%</w>
I- treatment</w>
I- positive</w>
I- mediated</w>
I- matched</w>
I- iodophenyl)tropane-2beta-carboxylic</w>
I- doxorubicin</w>
I- angiotensinogen,</w>
I- Vb.</w>
I- VI</w>
I- SFMD),</w>
I- S4+L1308F</w>
I- QTL)</w>
I- PILO)</w>
I- P9,</w>
I- II.</w>
I- H
I-H SA).</w>
I- DX</w>
I- DX,</w>
I- B).</w>
I- AR
I-AR I)</w>
I- 4
I-4 e</w>
I- 3000</w>
I- ->
I--> Lewis).</w>
I- -6</w>
I- -100
I--100 ,000</w>
I) N-w-fluoropropyl-2[beta]-carbomethoxy-3[beta]-(4-iodophenyl)nortropane</w>
I) BTX</w>
I(K s)</w>
I(K r).</w>
I(K r),</w>
I wata</w>
I vory</w>
I vermectin,</w>
I v</w>
I to.</w>
I to,</w>
I til).</w>
I tabashi</w>
I stituto</w>
I slet</w>
I shikawa,</w>
I shak</w>
I scove</w>
I schemic:normal</w>
I s),</w>
I ron-</w>
I ron,</w>
I proniazid,</w>
I podate</w>
I oversol.</w>
I opamidol,</w>
I onic</w>
I on</w>
I omeprol</w>
I mbalance</w>
I ll</w>
I le.</w>
I le)</w>
I kr-mediated</w>
I kappaBalphaDeltaN</w>
I gnoring</w>
I g</w>
I dent).</w>
I d</w>
I d.</w>
I ctus</w>
I ce"</w>
I c.</w>
I baraki,</w>
I b,</w>
I b),</w>
I asi,</w>
I a/IIa.</w>
I a+</w>
I X/coagulation</w>
I X/X-bp</w>
I WG</w>
I TI.</w>
I ST)</w>
I S:</w>
I RT</w>
I RN-induced</w>
I RLS</w>
I RBs</w>
I RA</w>
I PV,</w>
I PP).</w>
I PH-induced</w>
I PG.</w>
I PD.</w>
I PD,</w>
I NSS</w>
I NS.</w>
I NS,</w>
I MP</w>
I MMP.</w>
I MB.</w>
I MA)</w>
I M-NEO</w>
I M-NC</w>
I L</w>
I K,</w>
I HC,</w>
I H),</w>
I GE
IGE .</w>
I G),</w>
I EDs</w>
I E,</w>
I DS)</w>
I DO
IDO .</w>
I AT,</w>
I AT
IAT ;</w>
I ARC</w>
I AP)</w>
I AN,</w>
I AM
IAM YCIN,</w>
I AE</w>
I AD
IAD H
IADH S),</w>
I A-
IA- FUDR-induced</w>
I A).</w>
I 2),</w>
I 1/
I1/ alpha2</w>
I 1,</w>
I /</w>
I .(ABSTRACT</w>
I -related</w>
I -1a</w>
I -13</w>
I ,
I, II,VII,VIII,IX,</w>
I ):</w>
I )-induced</w>
I (GABA)</w>
I (2),</w>
I (1)</w>
I (1)
I(1) R</w>
I (
I( h),</w>
Hz /
Hz/ s.</w>
Hz .,</w>
Hypox anthine-treated</w>
Hypoten sion-sensitive</w>
Hypot onous</w>
Hyponat remic</w>
Hyponat remia-induced</w>
Hyponat raemic</w>
Hyponat raemia-induced</w>
Hypomagne semia</w>
Hypokal emic,</w>
Hypokal emia,</w>
Hypokal aemic</w>
Hypokal aemia,</w>
Hypoalbum inemia</w>
Hypoalbum inemia,</w>
Hypo volaemia</w>
Hypo thesizing</w>
Hypo thermia-induced</w>
Hypo thalamo-pituitary</w>
Hypo responsiveness</w>
Hypo reninemic</w>
Hypo proteinemia</w>
Hypo proteinemia,</w>
Hypo prolactinemia</w>
Hypo plasia</w>
Hypo physitis</w>
Hypo physectomy,</w>
Hypo phosphatemia</w>
Hypo phosphataemic</w>
Hypo perfusion</w>
Hypo glycorrhachia</w>
Hypo glycaemic</w>
Hypo gammaglobulinaemia</w>
Hypo PP</w>
Hypo ARC</w>
Hypo AR
HypoAR C.</w>
Hyperuric emia</w>
Hyperuric emia,</w>
Hyperparathyroidis m,</w>
Hyperlipide mic</w>
Hyperlipide mia,</w>
Hyperkal aemic</w>
Hyperinsul inemic</w>
Hypercholesterol emia</w>
Hypercholesterol aemia</w>
Hypercalce mia:</w>
Hypercalce mia-induced</w>
Hypercal cemic</w>
Hypercal caemia</w>
Hyper tropia,</w>
Hyper trophy</w>
Hyper tonia/rigidity</w>
Hyper thermic</w>
Hyper tensives</w>
Hyper tension:</w>
Hyper tension.</w>
Hyper tension-related</w>
Hyper susceptibility</w>
Hyper somnolence</w>
Hyper sexual</w>
Hyper sensitivity,</w>
Hyper reninemia</w>
Hyper reflexia</w>
Hyper pyrexia</w>
Hyper prolactinemia,</w>
Hyper prolactinaemia,</w>
Hyper plasia</w>
Hyper physiological</w>
Hyper phosphatemia</w>
Hyper permeable</w>
Hyper osmolar</w>
Hyper osmolality</w>
Hyper natraemia</w>
Hyper motility</w>
Hyper lipoproteinemia</w>
Hyper lactacidemia</w>
Hyper kinetic</w>
Hyper hydration</w>
Hyper dynamic</w>
Hyper coagulopathy</w>
Hyper coagulable</w>
Hyper coagulability</w>
Hyper carbia</w>
Hyper ammoniemia</w>
Hyper alimentation</w>
Hyper algesia,</w>
Hyper active</w>
Hyper GEN</w>
Hyper -
Hyper- responsivity</w>
Hype rexcitability</w>
Hype rechoic</w>
Hypaque- 76</w>
Hypaque- 76,</w>
Hypaque- 76)</w>
Hyp opnoea</w>
Hyp olipidemic</w>
Hyp ochloremic</w>
Hyp ocalcemia,</w>
Hyp norm</w>
Hyp nagogic</w>
Hyp (SO3
Hyp(SO3 H)-
Hyp(SO3H)- Ac-CCK-2-8-SE</w>
Hyoscy mus</w>
Hyoscy amus</w>
Hydroxyure a-associated</w>
Hydroxy zine-induced</w>
Hydroxy proline</w>
Hydroxy fasudil</w>
Hydroxy ethylstarch</w>
Hydroxy estradiol</w>
Hydroxy dopamine</w>
Hydroxy chloroquine,</w>
Hydrox ylation</w>
Hydroneph rosis,</w>
Hydrocortis one-induced</w>
Hydrocortis one's</w>
Hydro xylator</w>
Hydro morphone</w>
Hydro gen</w>
Hydro chlorothiazide.</w>
Hydro chlorothiazide,</w>
Hydro cephaly</w>
Hydralaz ine,</w>
Hydr ation,</w>
Hy pospadias,</w>
Hy paque.</w>
Hy oscyamine</w>
Hy opkalemia</w>
Hy )</w>
Hunting ton-like</w>
Hunting don's</w>
Hun tsville,</w>
Hun ter</w>
Hun t-Hess</w>
Humph rey-Zeiss,</w>
Hum ans</w>
Hum anin</w>
Hu xley's</w>
Hu h7</w>
Hu H-
HuH- 7</w>
Hsp 90,</w>
Hsp 70.</w>
Hsp 70,</w>
Hsp 40,</w>
Hsp 110,</w>
Hoxa 3.</w>
Hoxa -1</w>
Hospit als,</w>
Hospit al-based</w>
Hormon e-refractory</w>
Hor ses</w>
Hor izontal</w>
Hope fully</w>
Hope fully,</w>
Homozyg otes</w>
Homer1b/ c</w>
Homer1b/ c,</w>
Homer 2
Homer2 a/b,</w>
Hom ologous</w>
Hom ocystine</w>
Hom ocysteine</w>
Hom e,</w>
Hol land.</w>
Hol land,</w>
Hol dings,</w>
Hoff man-LaRoche</w>
Hoe-1 40;</w>
Hodgkin sine</w>
Ho wever:</w>
Ho urs</w>
Ho urly</w>
Ho st-specific</w>
Ho ok</w>
Ho loxan),</w>
Ho igne's</w>
Ho elen,</w>
Ho echst</w>
Histamine- releasing</w>
Histamine- N-methyl,</w>
Histamine- 1</w>
Hist ories</w>
Hist orically,</w>
Hist orical</w>
Hist oric</w>
Hist one</w>
Hist omorphological</w>
Hist ologic,</w>
Hist ochemical,</w>
Hispan iola,</w>
Hispan ics</w>
His- ventricle,</w>
His tidine</w>
His panics)</w>
His panic.</w>
Hir schberg,</w>
Hippocamp al-striatal</w>
Hind u</w>
High- signal</w>
High- resolution</w>
High- rate</w>
High- dose"</w>
High- calcium</w>
High- altitude</w>
High- affinity</w>
High- affinity,</w>
High- Risk</w>
High er-than-anticipated</w>
High -</w>
High "</w>
Hic cup</w>
Hi DAC.</w>
Hg/ week.</w>
Hg/ week,</w>
Hg/ week).</w>
Hg/ sec,</w>
Hg/ s,15.4</w>
Hg/ 98
Hg/98 +/-16</w>
Hg/ 115+/-
Hg/115+/- 32</w>
Hg.mL-1.min-1. g-1);</w>
Hg.mL-1.min-1. g-1).</w>
Hg. s-1]</w>
Hg. min.g.ml(-1);</w>
Hg b.</w>
Hg b,</w>
Hg ],</w>
Hg --a</w>
Hg )-induced</w>
Hexachloro phene</w>
Hexachloro phene-induced</w>
Hexabri x.</w>
Heter ozygotes</w>
Heter otopia</w>
Hero in-dependent</w>
Here with</w>
Here with,</w>
Here tofore,</w>
Here ditary</w>
Here by,</w>
Her zog,</w>
Her z).</w>
Her twig-Magendie</w>
Her on,</w>
Her nia</w>
Her lev</w>
Her lev.</w>
Her itability</w>
Hepatocellular- cholestatic</w>
Hepatocellular- altered</w>
Hepato renal</w>
Hepato protective</w>
Hepato pathy</w>
Hepati tis.</w>
Hepati tis,</w>
Hepat otumorigenicity</w>
Hepat otoxity</w>
Hepat otoxic</w>
Hepat osplenomegaly</w>
Hepat oportal</w>
Hepat onecrosis</w>
Hepat oma</w>
Hepat ology.</w>
Hepat ocarcinogenesis</w>
Hepar inized</w>
Hepar inization</w>
Hepar inase</w>
Hepar in-protamine</w>
Hepar in-dependent</w>
Hep es</w>
Hen ry-Stephens</w>
Hen kin's</w>
Hemorrh ages,</w>
Hemo static</w>
Hemo siderosis</w>
Hemo philia</w>
Hemo perfusion</w>
Hemo gram</w>
Hemo globinuria</w>
Hemo dynamic-inotropic</w>
Hemo dynamic,</w>
Hemi vertebrae,</w>
Hemi parkinsonism</w>
Hemi parkinsonian</w>
Hemi paresis</w>
Heme- L-lysinate</w>
Heme- L-arginate</w>
Hemat oxylin</w>
Hemat oxylin-eosin</w>
Hemat ology.</w>
Hemat ology-oncology</w>
Hemat ologic,</w>
Hemat ol.</w>
Hemat odeanol,</w>
Hemat est</w>
Hem otoxicity</w>
Hem orheological</w>
Hem in</w>
Hel singborg,</w>
Heart- to-body</w>
Heart- rate</w>
Hear tworm</w>
Hear t-type</w>
Hear .</w>
Health care,</w>
Health Watch</w>
Health -related</w>
Heal th-care</w>
Head -H
Head-H UNT</w>
Head ,</w>
He mobilia</w>
He lodermin</w>
He dera</w>
He bb-Williams</w>
He La</w>
He FT)</w>
Hdac3- transgenic</w>
Hdac3- Tg</w>
Hdac 3,</w>
Hdac 2-
Hdac2- Tg</w>
Hdac 2,</w>
Hdac 1</w>
HbA1 c</w>
HbA1 c,</w>
HbA1 C</w>
Hb sAg</w>
Hb A1</w>
Hb A(1)
HbA(1) c</w>
Haz ard</w>
Haz ard's</w>
Hawai ian/Asian/European</w>
Hawai i</w>
Hass les</w>
Hass all's</w>
Has haron.</w>
Har vard</w>
Har per,</w>
Har mon,</w>
Har lem</w>
Har lan</w>
Har dy-Weinberg</w>
Haplo types</w>
Haplo type-based</w>
Hap toglobin</w>
Hap tenic</w>
Han sen's</w>
Han over,</w>
Hampshi re</w>
Hampshi re.</w>
Ham sters</w>
Ham dan.</w>
Halothane- nitrous</w>
Halothane- epinephrine-induced</w>
Haloth ane-associated</w>
Haloth ane,</w>
Haloperid ol-treated</w>
Haloperid ol's</w>
Halo genated</w>
Hallucin osis</w>
Hallucin ation</w>
Hall marks</w>
Half- relaxation</w>
Half- life</w>
Hal stead-Reitan</w>
Hal ifax</w>
Hal ford</w>
Hal dol.</w>
Hal ),</w>
Hag edorn</w>
Hag a</w>
Haemo globin</w>
Haemo dynamic,</w>
Haemat oxylin</w>
Haemat oxylin-eosin</w>
Haemat otoxicity,</w>
Haemat omata</w>
Haemat ological,</w>
Haemacce l"</w>
Haem orrhages</w>
Haem olytic-uraemic</w>
Haem olysis</w>
Ha ith's</w>
Ha ifa</w>
Ha ),</w>
H_ E,</w>
H] ;</w>
HY D</w>
HW/ BW</w>
HW/ BW,</w>
HW -16
HW-16 5,</w>
HV P)</w>
HV OD,</w>
HV LT</w>
HV LT,</w>
HV B-
HVB- DNA</w>
HV A)</w>
HUVEC .</w>
HUVEC ,</w>
HUS /
HUS/ TTP</w>
HU2 10.</w>
HU2 10,</w>
HU-2 10;</w>
HU-2 10.</w>
HU-2 10-induced</w>
HU-2 10,</w>
HU ]</w>
HU VEC</w>
HU TT.</w>
HU T,</w>
HU S-TTP:</w>
HU P-pretreated</w>
HU MAN</w>
HU E)</w>
HU .</w>
HU -induced</w>
HU ).</w>
HTN- related</w>
HTN- ESRD,</w>
HTLV- I.</w>
HT X.</w>
HT S</w>
HT G.</w>
HT B-
HTB- 7
HTB-7 7,</w>
HT 1080</w>
HT )-elicited</w>
HSV-t k/GCV</w>
HSV-t k.</w>
HSV-t k-transduced</w>
HSP- 70</w>
HSP- 60</w>
HSP 90.</w>
HSP 73.</w>
HSP 70,</w>
HSP 60</w>
HSP 47-
HSP47- producing</w>
HSP 25</w>
HS ST).</w>
HS R)</w>
HS M)</w>
HS I</w>
HS G.</w>
HRCB P,</w>
HR/ delta</w>
HR/ LR</w>
HR- disease</w>
HR V.</w>
HR R).</w>
HR PC</w>
HR ON)</w>
HR =4.
HR=4. 8).</w>
HR =1.
HR=1. 12).</w>
HR =0.9
HR=0.9 4;</w>
HR =
HR= 2.0
HR=2.0 6)</w>
HR :</w>
HR ),</w>
HPV 16</w>
HPLC- electrochemical</w>
HPLC- ECD</w>
HPLC- E
HPLC-E SI-MS</w>
HPL C/
HPLC/ ECD</w>
HPL C)</w>
HPL ),</w>
HPD G)</w>
HP+ Delta9-THC</w>
HP+ Delta9-THC-induced</w>
HP+ Delta9-TH
HP+Delta9-TH C;</w>
HP max</w>
HP max,</w>
HP S/NRH</w>
HP F</w>
HP C)</w>
HP ;</w>
HP -treated</w>
HOsmR x</w>
HOsmR x.</w>
HORIZ ON</w>
HORIZ ON:</w>
HOR MONES:</w>
HOP )-based</w>
HO S,</w>
HO PE</w>
HO P</w>
HO /
HO/ MDT)</w>
HO ).</w>
HLA-DR 5.</w>
HLA-DR 2</w>
HLA-B*57 0
HLA-B*570 1.</w>
HLA-B 8/
HLA-B8/ DR3</w>
HLA-B 35</w>
HLA-B 18,</w>
HLA- mismatched</w>
HLA- A1</w>
HLA- A,</w>
HLA- A
HLA-A ,
HLA-A, B,
HLA-A,B, C</w>
HL- 60.</w>
HL GD,</w>
HL B,</w>
HIVMPT .</w>
HIVMPT ,</w>
HIV/ HBV</w>
HIV-1- specific</w>
HIV-1- seropositive</w>
HIV- seropositive,</w>
HIV- seronegative</w>
HIV- seroconversions</w>
HIV- risk</w>
HIV- positive.</w>
HIV- non-infected</w>
HIV- negative,</w>
HIV- monoinfected</w>
HIV- infection</w>
HIV- infection.</w>
HIV- infected).</w>
HIV- individuals</w>
HIV- antibody</w>
HIV- NAT</w>
HIV- ITP</w>
HIV- HBV</w>
HIV ;</w>
HIV :</w>
HIV (+)</w>
HITT -related</w>
HITT -associated</w>
HIT/ T,</w>
HIT/ HITT</w>
HIT T,</w>
HIT -associated</w>
HIP/PA P.</w>
HI-E+HI- P,</w>
HI-E+HI- N).</w>
HI- E,</w>
HI AA)</w>
HG P,</w>
HF basal</w>
HF SR</w>
HF S.</w>
HF S)</w>
HF RS</w>
HF O.</w>
HF DE
HFDE -induced</w>
HF D</w>
HF (nu)</w>
HETE ,</w>
HETE ),</w>
HET -induced</w>
HER2- positive,</w>
HER2- overexpressing</w>
HER 2/
HER2/ neu)</w>
HER -2</w>
HER -
HER- 2/
HER-2/ neu</w>
HE6E7 T-1).</w>
HE s)</w>
HE alth</w>
HE X</w>
HE X-alone</w>
HE T</w>
HE S/DOB</w>
HE PTOX</w>
HE N).</w>
HE K</w>
HE K-293</w>
HE ART</w>
HDM 220,</w>
HDM 2
HDM2 20.</w>
HDL- cholesterol/total</w>
HDL- cholesterol,</w>
HDL- c,</w>
HDL- accessible</w>
HDL- C.</w>
HDL- C,</w>
HDL 3
HDL3 c.</w>
HDL 2b</w>
HDC-9 12,</w>
HD-CT X-induced</w>
HD-CT X-associated</w>
HD- MT</w>
HD- CD
HD-CD DP)</w>
HD s).</w>
HD ara-C.</w>
HD ara-C,</w>
HD V</w>
HD T;</w>
HD T.</w>
HD T,</w>
HD S:</w>
HD RS,</w>
HD MTX.</w>
HD MTX-CF</w>
HD M</w>
HD M,</w>
HD L/LDL</w>
HD I.</w>
HD I-3000</w>
HD Ds</w>
HD CA,</w>
HD C/
HDC/ PBSCT.</w>
HD ACs</w>
HD AC,</w>
HD AC
HDAC s,</w>
HD );</w>
HCl ],</w>
HCl 3,</w>
HCh -
HCh- 3)</w>
HCV- negative),</w>
HCV- genotype</w>
HCV- coinfected).</w>
HCV- RNA-positive</w>
HCV -positive</w>
HCT Z;</w>
HCT Z-induced</w>
HCO 3-/
HCO3-/ SO4-</w>
HCO 3-,</w>
HCO 3).</w>
HCB D,</w>
HCB .</w>
HCB -induced</w>
HC- I)</w>
HC l;</w>
HC l-sensitive</w>
HC l-associated</w>
HC l),</w>
HC ]</w>
HC W</w>
HC V-related</w>
HC Rs</w>
HC Rs;</w>
HC Rs,</w>
HC Q;</w>
HC H)</w>
HC G).</w>
HC F</w>
HC F.</w>
HC F,</w>
HC DL</w>
HC Cs.</w>
HC +
HC+ VPA</w>
HC )-
HC)- tolerant</w>
HBsAg- seronegative</w>
HBsAg- positive;</w>
HBsAg- positive.</w>
HBsAg- carrier</w>
HBsAg ;</w>
HBsAg -associated</w>
HBsAg (-)</w>
HBsAg (-),</w>
HBs Ab</w>
HBeAg- positive;</w>
HBeAg- positive)</w>
HBeAg -</w>
HBeAg (-
HBeAg(- )/
HBeAg(-)/ anti-HBe(-)</w>
HBeAg (+)</w>
HBeAg (+),</w>
HBe A
HBeA g/hepatitis</w>
HBe ),</w>
HBcAb ,</w>
HBc Ag</w>
HBc Ab</w>
HBV-DNA- positivity</w>
HBV-DNA- negative.</w>
HBV- infected</w>
HBV- OLT</w>
HBV -positive</w>
HBV -associated</w>
HBV -</w>
HBD H.</w>
HBD H)</w>
HB s.</w>
HB r</w>
HB e-antigen</w>
HB R),</w>
HB O.</w>
HB O(2)</w>
HB MEC</w>
HB F,</w>
HB E.</w>
HB D,</w>
HB D)</w>
HB A)</w>
HB ),</w>
HAT T)</w>
HAT ),</w>
HAM-D 28</w>
HAL- treatment.</w>
HAL- catalepsy</w>
HAL O.</w>
HAL -</w>
HAC- 9
HAC-9 11,</w>
HAAR T-induced</w>
HAAR T-experienced</w>
HAAR T,</w>
HAAR T)</w>
HA MA,</w>
HA E</w>
HA ;</w>
HA )-
HA)- paclitaxel</w>
H9 c2</w>
H9 c2,</w>
H3K 9</w>
H3K 4</w>
H3- receptors</w>
H3- histamine</w>
H3- agonist,</w>
H2O/ g</w>
H2O/ L/s</w>
H2O t%.</w>
H2O 2.</w>
H2O 2-induced</w>
H2O 2-</w>
H2- receptor-antagonists</w>
H2- receptor,</w>
H2- blocking</w>
H2- blocker.</w>
H2- blocker,</w>
H2- antihistaminic,</w>
H2- agonist</w>
H2 RAs,</w>
H2 A.
H2A. X,</w>
H2 15
H215 O.</w>
H2 (15)
H2(15) O.</w>
H1- blocking</w>
H1- blocker,</w>
H1- antihistaminics</w>
H1- antihistamines,</w>
H1- antihistamine</w>
H1- antagonists,</w>
H/ PO)</w>
H/ P-3.0,</w>
H. O.)</w>
H-benz otriazole.</w>
H-F AB
H-FAB P-overexpressing</w>
H- wave-related</w>
H- wave)</w>
H- regulated</w>
H- reflex.</w>
H- reflex,</w>
H- ras</w>
H- only</w>
H- independent</w>
H- grafts</w>
H- a)</w>
H- PILO.</w>
H- P)</w>
H- II</w>
H- E</w>
H- Di
H-Di benzo[a,</w>
H- C)</w>
H- 8,</w>
H- 220
H-220 2)</w>
H)- releasing</w>
H)- 2,3-benzodiazep
H)-2,3-benzodiazep ine],</w>
H) one-1,</w>
H) ].</w>
H) /</w>
H) +
H)+ chlordiazepoxide</w>
H) *)</w>
H(2)O(2)- scavenger</w>
H(2)O (2</w>
H(2)O (2)-induced</w>
H(2)O (2)
H(2)O(2) -</w>
H(2)- receptors</w>
H(2)- receptors.</w>
H(2)- histaminergic,</w>
H(1)- receptor</w>
H uttenlocher</w>
H urlingham</w>
H umps,</w>
H ue</w>
H tr1b.</w>
H sc70</w>
H ouston</w>
H our</w>
H otline</w>
H ost</w>
H ope</w>
H omonymous</w>
H omeostatic</w>
H lTTs</w>
H illside</w>
H examethylmelamine</w>
H ester,</w>
H erbalife</w>
H eptaminol</w>
H emispheric</w>
H eight</w>
H e,</w>
H dT</w>
H cy.</w>
H cy),</w>
H ct,</w>
H b)</w>
H ass</w>
H artmann's</w>
H argreave's</w>
H ardy</w>
H antaan</w>
H anssen</w>
H anks'</w>
H angover</w>
H an</w>
H amburger</w>
H all</w>
H alf-dose</w>
H alazun</w>
H ad</w>
H Z-amplitude</w>
H SRs</w>
H SNCV</w>
H SD</w>
H SA)</w>
H S/Ibg</w>
H PR.(ABSTRACT</w>
H PO(4),</w>
H PHPA.</w>
H PDT</w>
H PC</w>
H PC.(ABSTRACT</w>
H P-induced</w>
H O,</w>
H NPs</w>
H NF1,</w>
H NE)</w>
H NE)-protein</w>
H MM.</w>
H MB-45,</w>
H M,</w>
H M),</w>
H L).</w>
H J.</w>
H IS</w>
H IC-</w>
H HS</w>
H HH</w>
H H,</w>
H GG
HGG W</w>
H GF</w>
H GF)</w>
H GE
HGE H</w>
H FD
HFD -induced</w>
H FA</w>
H E,</w>
H CI],</w>
H AT)</w>
H APS</w>
H AP</w>
H AM</w>
H AE;</w>
H AE,</w>
H AD</w>
H AC</w>
H 76.</w>
H 63
H63 D</w>
H 50</w>
H 4</w>
H 4,</w>
H 4
H4 IIE</w>
H 2.</w>
H 2)</w>
H 18
H18 O8.</w>
H 1
H1 N1</w>
H +/
H+/ HCO-3</w>
H +
H+ P)</w>
H (4))</w>
H (2)</w>
H (2
H(2 1)
H(21) NO(4))</w>
H (+)]
H(+)] ATPase-
H(+)]ATPase- positive)</w>
Gynec ology</w>
Gynec ology,</w>
Gynec ologists</w>
Gynaec ology</w>
Gynaec ological</w>
Gynaec ologic</w>
Gy/ d</w>
Gy/ d)</w>
Gy/ 30</w>
Gusta ve-Roussy</w>
Guil ty,</w>
Guil lian-Barre</w>
Guide line.</w>
Guid ice,</w>
Guid ance</w>
Guanfac ine,</w>
Guaneth idine,</w>
Guan idinosuccinate-evoked</w>
Gu t</w>
Gu statory</w>
Gu inea.</w>
Gu ild</w>
Gu ggulsterones</w>
Gu engerich,</w>
Gu anosine</w>
Gu anine</w>
Gu a),</w>
Gu Cl</w>
Gs-- decreased</w>
Gs-- both</w>
Gs- mediated.</w>
Group- affiliated</w>
Group- IV</w>
Group- III</w>
Group- 6</w>
Group- 5</w>
Group- 4</w>
Group- 3</w>
Group- 2</w>
Grou pxPeriod</w>
Grou p/Scandinavian</w>
Grou p-1</w>
Gro oved</w>
Gro ote</w>
Gro oming</w>
Gri seofulvin</w>
Gri seofulvin(GF)</w>
Gri p</w>
Gri a4.</w>
Green berg,</w>
Greec e</w>
Gre mlin</w>
Gre enhouse-Geisser</w>
Gre ek</w>
Granulo cytopenia,</w>
Granulo cyte-macrophage</w>
Gran ulosa</w>
Gran isetron,</w>
Gram- stain</w>
Gram ont</w>
Graf ts</w>
Graf ting</w>
Graf t-versus-host</w>
Grad ing</w>
Gra y.</w>
Gra y,</w>
Gra ves</w>
Gra de,</w>
Gr nwd.</w>
Gr inding</w>
Gr ant</w>
Gr and</w>
Goog le</w>
Goog le.</w>
Good win</w>
Gonad otropins</w>
Gonad otropin-releasing</w>
Gonad ectomy</w>
Gonad ally-intact</w>
Gomori -stained</w>
Gomori 's</w>
Gom ory's</w>
Gom ori</w>
Golgi/ endoplasmic</w>
Golgi/ ER</w>
Golgi- impregnated</w>
Golgi- granule</w>
Gol den</w>
Gol d-standard</w>
Go ods</w>
Go averts</w>
Go al</w>
Go 2</w>
Go 2,</w>
Go 1</w>
Go 1,</w>
Go /
Go/ i</w>
GnRH- immunoreactive</w>
GnRH- containing</w>
GnRH- antagonist)</w>
GnRH- agonists.</w>
GnR h</w>
Glycopyr rolate,</w>
Glycer yltrinitrate</w>
Glyc osuria</w>
Glyc opeptide-induced</w>
Glyc olytic</w>
Glyc olysis</w>
Glyc olipid</w>
Glyc ineB</w>
Glyc ine,</w>
Glyc idol</w>
Glyc erol</w>
Gly- Phe-Met</w>
Gly- Gly-Phe-Met</w>
Gly- Glu
Gly-Glu -
Gly-Glu- Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val,</w>
Gly- Asp</w>
Gly cyrrhetic</w>
Gly cogen</w>
Gly cemic</w>
Gly cemia,</w>
Gly 5-ol
Gly5-ol ]enkephalin</w>
Gly 16
Gly16 Arg</w>
Gly 14
Gly14 5-
Gly145- to-Arg145</w>
Glutamate- dopamine</w>
Glutamate- aspartate</w>
Glut eal</w>
Glut athione-S-transferase</w>
Glucocorticoid s:</w>
Glucocorticoid -dependent</w>
Glucocortico id-like</w>
Gluco se-6-phosphate</w>
Gluco se,</w>
Gluc uronide</w>
Gluc onate</w>
GluR2/ 3,</w>
GluR- 3).</w>
GluR- 2,</w>
GluR 4</w>
GluR 2,</w>
GluR 1-</w>
Glu T1)</w>
Glu R-2</w>
Glu .</w>
Glu -18
Glu-18 FDG)</w>
Glu )</w>
Glomer ulopathy</w>
Gln- supplemented</w>
Gln- enriched</w>
Glicl azide,</w>
Glibencl amide</w>
Glibencl amide-sensitive</w>
Gli vec;</w>
Glax oSmithKline,</w>
Glax o</w>
Glauc omatous</w>
Glauc oma--a</w>
Glauc ine</w>
Ginsen osides,</w>
Ginsen oside</w>
Gingi vitis</w>
Gi/ Go</w>
Gi- proteins</w>
Gi- coupled</w>
Gi eson</w>
Gi ardia</w>
Gi alpha(1),</w>
Gi 2</w>
Gi 2,</w>
Gi ).</w>
Gi (2)-
Gi(2)- protein</w>
Gi (1)-</w>
Gest odene's,</w>
Ger shenfeld</w>
Ger ome</w>
Ger mfree</w>
Ger m</w>
Ger iatrica</w>
Ger ais),</w>
Georg ia,</w>
Georg e</w>
Gentam icin.</w>
Gentam icin-injected</w>
Gentam icin,</w>
Gentac oll.</w>
Genotyp ic</w>
Genotyp es</w>
Genit ourinary</w>
Genit o-urinary</w>
Gener ation</w>
Gener alized,</w>
Gener alizability</w>
Gener aliszed</w>
Gene tics</w>
Gene tically</w>
Gene Chi
GeneChi ps.</w>
Gen ome</w>
Gen ome-wide</w>
Gen oa,</w>
Gen ioglossus</w>
Gen eva</w>
Gen eva,</w>
Gen et.</w>
Gen es</w>
Gen e-teratogen</w>
Gen der-stratified</w>
Gen der-related</w>
Gemfibroz il-statin</w>
Gemfibroz il-lovastatin</w>
Geme prost</w>
Geme lli</w>
Geme lli"</w>
Gemcit abine,</w>
Gelsemi um</w>
Gelsemi um,</w>
Gei gy</w>
Gefit inib-induced</w>
Ge orgi.,</w>
Ge ometric</w>
Ge ographically</w>
Ge odon,</w>
Gd-DTPA- administration.</w>
Gd-DTPA- B
Gd-DTPA-B MA),</w>
Gd- labeled</w>
Gd- ethylenediamine</w>
Gd- deposition</w>
Gd- DT
Gd-DT PA),</w>
Gd /kg</w>
Gc- globulin:</w>
Gati floxacin</w>
Gati floxacin-associated</w>
Gati floxacin,</w>
Gastro protective</w>
Gastro intestinal,</w>
Gastro enterology,</w>
Gastro enteritis</w>
Gastro dia</w>
Gastro -
Gastro- intestinal</w>
Gas6- mediated</w>
Gas 6,</w>
Gar avan,</w>
Gangli oside</w>
Gang rene</w>
Gamma- hydroxybutyrate</w>
Gam bling</w>
Gall stone</w>
Gall ic</w>
Gall amine-induced</w>
Galact ose</w>
Galact osamine</w>
Galact orrhea</w>
Gal en,</w>
Gal antamine</w>
Gal anin</w>
Gaert n</w>
Gaert n.</w>
Gaert n.):</w>
Gaert n.),</w>
Gadolinium- DTPA-
Gadolinium-DTPA- enhanced</w>
Gabap entin,</w>
Gab aculine</w>
G_C_G_ G-
G_C_G_G- high</w>
GW A</w>
GV G)</w>
GV 6,</w>
GV 2-
GV2- GV6,</w>
GV -1
GV-1 500
GV-1500 13</w>
GV ),</w>
GUSTO- IIa</w>
GUSTO- I</w>
GUST O</w>
GTP-gamma- S.</w>
GTP- binding</w>
GTP ase-regulating</w>
GTN- triggered</w>
GTN- responsive</w>
GTN /capsaicin</w>
GT1 b)</w>
GT T</w>
GT T.</w>
GT T)</w>
GT G).</w>
GT D-
GTD- containing</w>
GT Cs</w>
GT Cs.</w>
GT CS
GTCS s.</w>
GT C</w>
GT A)</w>
GT -treated</w>
GSK334 4
GSK3344 29,</w>
GSK3 beta.</w>
GSK-3 beta/beta-catenin</w>
GSK-3 beta,</w>
GSI F)</w>
GSH-P x)</w>
GSH -dependent</w>
GS SG).</w>
GS R)</w>
GS P.</w>
GS I</w>
GS 216
GS216 80
GS21680 )-</w>
GR205 171</w>
GR205 17
GR20517 1,</w>
GR113 808</w>
GR P</w>
GR P),</w>
GR Ks</w>
GR K</w>
GR K2-loxP-targeted</w>
GR IN2B</w>
GR IK2),</w>
GR ADE</w>
GR -113
GR-113 808</w>
GR (max)</w>
GPR(5 5)</w>
GPR(5 5))</w>
GPR D,</w>
GPI AS</w>
GPI AS
GPIAS ;</w>
GP x)</w>
GP i-DBS</w>
GP e</w>
GP X</w>
GP S)</w>
GP N,</w>
GP Ib/IX</w>
GP Ib/IX,</w>
GP C</w>
GP C,</w>
GP >
GP> striatum>SNr.</w>
GP +)</w>
GOAL S:</w>
GOAL :</w>
GO R)</w>
GMP- dependent</w>
GMP- PKG-K+</w>
GM1- sensitized</w>
GM1- pretreated</w>
GM- CSF)</w>
GM+ vehicle</w>
GM+ saline</w>
GM+ rrALR</w>
GM P,</w>
GM -treated</w>
GLUT 1),</w>
GL- PS.</w>
GJ K.</w>
GJ K-treated</w>
GIF- P</w>
GIF- D2</w>
GH r</w>
GH Q</w>
GG 1)</w>
GFR- beta)</w>
GFR- CG,</w>
GFAP- staining</w>
GFAP- immunolabeled</w>
GFAP- expressing</w>
GFAP- TNF</w>
GF- fed</w>
GF- 2)</w>
GF R;</w>
GF R).</w>
GF P(+)cells</w>
GF AP,</w>
GF AP
GFAP -</w>
GF 2.0,</w>
GF 120
GF120 9
GF1209 18,</w>
GF -dose</w>
GF );</w>
GF ).</w>
GEPR- 9</w>
GEPR- 9,</w>
GEC .</w>
GEC ,</w>
GE PR-3,</w>
GE NERAL</w>
GE -
GE- II).</w>
GDE E</w>
GDE E,</w>
GD 1a,</w>
GD 14)</w>
GD 1
GD1 b</w>
GD ):</w>
GCT s</w>
GCT s.</w>
GCB .</w>
GCB -related</w>
GCB -induced</w>
GC/ MS</w>
GC/ ECD</w>
GC- 0501</w>
GBM ,</w>
GB S,</w>
GB H,</w>
GB CA,</w>
GB 34,</w>
GB 30-
GB30- GB34,</w>
GB ).</w>
GATA- 4,</w>
GAP-43- immunoreactivity</w>
GAP-43- IR.</w>
GAP- 43.</w>
GAP ).</w>
GAM S</w>
GAM S)</w>
GAM MA-vinyl-GABA</w>
GAL- immunoreactive</w>
GAL Fs</w>
GAL F
GALF s'</w>
GAERTN .):</w>
GAERTN .),</w>
GAER S,</w>
GAD ;</w>
GAD 65,</w>
GAD ).</w>
GAD (6
GAD(6 7)</w>
GABAn ergic</w>
GABAn ergic,</w>
GABAerg ic-related</w>
GABAA/ benzodiazepine/ionophore</w>
GABA/ benzodiazepine</w>
GABA/ Benzodiazepine</w>
GABA/ BZ
GABA/BZ -and</w>
GABA- transaminase</w>
GABA- transaminase.</w>
GABA- synthesizing</w>
GABA- sensitive</w>
GABA- reducing</w>
GABA- positive</w>
GABA- peptides.</w>
GABA- peptides,</w>
GABA- neurons</w>
GABA- negative</w>
GABA- negative.</w>
GABA- like</w>
GABA- insensitive</w>
GABA- inhibitory</w>
GABA- independent</w>
GABA- immunoreactivity.</w>
GABA- immunoreactive</w>
GABA- immunocytochemistry</w>
GABA- evoked</w>
GABA- coupled</w>
GABA- blocking</w>
GABA- benzodiazepine</w>
GABA- benozdiazepine</w>
GABA- antagonistic</w>
GABA- T,</w>
GABA- -independent</w>
GABA(A )/
GABA(A)/ B
GABA(A)/B zR</w>
GABA(A ).</w>
GABA(A )-mediated</w>
GABA A-mediated</w>
GABA A,</w>
GABA A)</w>
GABA -treated</w>
GABA -related</w>
GABA ).</w>
GABA (C)</w>
GAB AB,</w>
GAB AB
GABAB 1</w>
GA s)</w>
GA Gs</w>
GA G)</w>
GA EE,</w>
GA 2;</w>
G> A</w>
G> A.</w>
G6 PDH.</w>
G6 P-deficient</w>
G434 S.</w>
G/ EMG)</w>
G-CSF :</w>
G-CSF .(ABSTRACT</w>
G-6 PD</w>
G-5 128</w>
G-5 128)</w>
G- nitro-arginine</w>
G- group)</w>
G- actin</w>
G- VEGF</w>
G- II),</w>
G- IC)</w>
G- I:</w>
G- CSF-
G-CSF- stimulated</w>
G- C-
G-C- G-
G-C-G- A</w>
G- Asp
G-Asp -in</w>
G- 25</w>
G)- positron</w>
G)- like</w>
G)- gated</w>
G(i )),</w>
G vHD</w>
G ung</w>
G sk3b</w>
G s).</w>
G roningen</w>
G ram</w>
G radient-echo</w>
G q</w>
G px</w>
G p53</w>
G ovaerts</w>
G out</w>
G oudie</w>
G ore-Tex</w>
G one</w>
G ja1(+/flox)</w>
G ja1(+/-)</w>
G ingko</w>
G hrelin</w>
G gg)</w>
G gamma(2)-subunits</w>
G ezira,</w>
G es.m.b.H.</w>
G epirone,</w>
G el</w>
G ehrig's</w>
G d,</w>
G beta</w>
G aze</w>
G ay</w>
G aussian</w>
G ault</w>
G ated</w>
G astritis</w>
G arcinia</w>
G aps</w>
G anciclovir</w>
G anciclovir-associated</w>
G ambian</w>
G all-bladder</w>
G alanin-IR</w>
G al-containing</w>
G aithersburg,</w>
G adopentetate</w>
G a.)</w>
G X)</w>
G T-mediated</w>
G ST)</w>
G SDF</w>
G SDF.</w>
G S)</w>
G S),</w>
G RP78.</w>
G ROUP:</w>
G R.</w>
G R-mediated</w>
G R-MuMTV.</w>
G PV.</w>
G PT),</w>
G PE.</w>
G PD),</w>
G PA9</w>
G P.</w>
G OC</w>
G O-NOGO</w>
G O)</w>
G NC</w>
G N,</w>
G N)</w>
G MT)</w>
G MD2F)</w>
G M.</w>
G M,</w>
G M),</w>
G LY.</w>
G LT-1,</w>
G LM/GEE</w>
G L</w>
G L)</w>
G IV,</w>
G ITS,</w>
G IST</w>
G IR)</w>
G III</w>
G III.</w>
G III,</w>
G II,</w>
G HRP</w>
G HRP)</w>
G H.</w>
G H-regulated</w>
G GTP</w>
G G,</w>
G DN
GDN F.</w>
G D2)</w>
G D.</w>
G Cs
GCs ".</w>
G CSF-
GCSF- mobilized</w>
G CS,</w>
G CL</w>
G CC1)</w>
G CA</w>
G BP;</w>
G BH),</w>
G ASY
GASY S,</w>
G AR
GAR FT</w>
G A-
GA- matched</w>
G :</w>
G 58
G58 9
G589 D</w>
G 4.1</w>
G 3/4</w>
G 3/
G3/ G4</w>
G 3-
G3- G4</w>
G 29.</w>
G 2/
G2/ M.</w>
G 1:</w>
G 15
G15 22
G1522 1A</w>
G 1-
G1- G2,</w>
G 0/
G0/ G1</w>
G .
G. B
G.B .).</w>
G (16)</w>
G 's.</w>
Furosem ide.</w>
Furosem ide,</w>
Furazol idone,</w>
Fun doscopy</w>
Fun dic</w>
Ful ly</w>
Ful l-litter</w>
Fu thermore,</w>
Fu kuda</w>
Fu jisawa</w>
Fructo se-pretreated</w>
Fructo se-induced</w>
Fructo se-1,6-bisphosphate</w>
Fru semide-induced</w>
Fru semide,</w>
Fru it</w>
Fro thy,</w>
Frideric ia's</w>
Fri edewald</w>
Frequency -dependent</w>
Frequ ently,</w>
Frequ encies</w>
Free- water</w>
Free- choice</w>
Free dom.</w>
Fre ud</w>
Fre qudncy</w>
Fre ezing</w>
Fre eze-fracturing</w>
Fre ely</w>
Francis co,</w>
France ;</w>
France ).</w>
Fran kfurt</w>
Fran ce-Ouest</w>
Fram e-by-frame</w>
Frag min</w>
Frag ility</w>
Fract ures</w>
Frac tions</w>
Frac tionated</w>
Fra xiparine</w>
Fra xiparin</w>
Fr n)</w>
Fr ame</w>
Fr agebogen</w>
Fr action</w>
Fr 2,</w>
Fr 1,</w>
Fourty- one</w>
Four- week,</w>
Four- extremity</w>
Four th,</w>
Four teen-day</w>
Four nier's</w>
Four -drug</w>
Found ation,</w>
Fosin opril</w>
Fosin opril-induced</w>
Fosf omycin</w>
Fosf obion</w>
Foscarne t-Ganciclovir</w>
FosB/Delta Fos
FosB/DeltaFos B-related</w>
Fos- like-immunoreactivity</w>
Fos- li</w>
Fos- immunoreactivity</w>
Fos /
Fos/ Jun</w>
Fos .</w>
Forty- two,</w>
Forsk olin</w>
Forsk olin,</w>
Formal in.</w>
Form ulation</w>
Form ulary</w>
Form .</w>
Form -3
Form-3 6,</w>
Fore stomach:</w>
Fore ign</w>
Fore brain</w>
For tuitously,</w>
For tification</w>
For te,</w>
For ker</w>
For d</w>
For ces</w>
For ceful</w>
For DeltaHb</w>
Foot- shock</w>
Foot- dystonia,</w>
Follow- Back</w>
Fol lowup</w>
Foc used</w>
Fo x</w>
Fo ods</w>
Fo od-maintained</w>
Fo garty</w>
Flut -
Flut- receiving</w>
Flurbi profen-treated</w>
Flurbi profen-associated</w>
Flurbi profen,</w>
Flur azepam-induced</w>
Fluoxet ine:</w>
FluoroJade B</w>
FluoroJade -stained</w>
FluoroJade -positive</w>
Fluoro-Jade -labeled</w>
Fluoro-Jade ,</w>
Fluoro uracil-induced</w>
Fluoro uracil,</w>
Fluoro -G
Fluoro-G old</w>
Fluoro -11
Fluoro-11 beta,17,</w>
Fluoro -
Fluoro- VPA-hydroxamic</w>
Fluor ine-18-F-deoxyglucose</w>
Fluor inated</w>
Fluo 3-dependent</w>
Flunit razepam.</w>
Flun arizine,</w>
Flumazen il-treated</w>
Flumazen il-induced</w>
Flumazen il--treatment</w>
Flud rocortisone,</w>
Fluc ytosine</w>
Fluc onazole.</w>
Fluc onazole-induced</w>
Fluc onazole-</w>
Fluc loxacillin-associated</w>
Flu x</w>
Flu voxamine-induced</w>
Flu v-treated</w>
Flu v).</w>
Flu o-3</w>
Flu mequine</w>
Flu ids</w>
Flu id-attenuated</w>
Flu ffy</w>
Flox uridine</w>
Flox uridine-induced</w>
Flox uridine-associated</w>
Flow- function</w>
Flow- dependent</w>
Florid a,</w>
Flo sequinan,</w>
Flo rence.</w>
Flo or</w>
Flk -1</w>
Flk -1/K
Flk-1/K DR)</w>
Flk -1.</w>
Flin t</w>
Flin ch-jump</w>
Flest olol:</w>
Flest olol,</w>
Fl uspirilene</w>
Fl inch</w>
Fl avoprotein</w>
Fl avin-adenine-dinucleotide</w>
Fl ap</w>
Fl ;</w>
Fl ).</w>
Five- minute</w>
Five- day</w>
Fissu res</w>
Fissu re-in-ano</w>
Fish er344</w>
First- pass</w>
First- degree</w>
Finn prostate</w>
Finger- to-Nose</w>
Finger- Nose</w>
Finaster ide,</w>
Fin nell</w>
Fin negan.</w>
Fin ley,</w>
Fin land</w>
Fil terability</w>
Fil ter</w>
Fil ipino</w>
Fig ures</w>
Fig ure</w>
Fifty- day-old</w>
Fifteen- fold</w>
Fifteen- day-old</w>
Ficoll- Hypaque.</w>
Ficol ls</w>
Fibro sis,</w>
Fibro scan</=7.1</w>
Fibri llation,</w>
Fib rosing</w>
Fib ronectin</w>
Fib ric</w>
Fib rates</w>
Fib ers</w>
Fib ),</w>
Fi ve-</w>
Fi le,</w>
Fi brinolytic</w>
Fer ulic</w>
Fer ubinac</w>
Fer ring</w>
Fer ric</w>
Fer nando</w>
Fentan yl-associated</w>
Feno profen,</w>
Fenflur amine-like</w>
Fenflur amine-induced</w>
Fenflur amine-derivative</w>
Fenflur amine-associated</w>
Fen-Phen /
Fen-Phen/ LFP).</w>
Femoden e,</w>
Femal es,</w>
Femal e,</w>
Fel ty's</w>
Fel ine</w>
Fel dman</w>
FeNa %</w>
Fe vers</w>
Fe gato</w>
Fe bruary,</w>
Fe b</w>
Fe LV</w>
Fe II-(BPS)3</w>
Fe II(BPS)3</w>
Fe /kg</w>
Fdd I-treated</w>
Fdd A-treated</w>
FcgammaRII A.</w>
FcgammaRII A,</w>
Fazad inium</w>
Fazad inium)</w>
Fav ourable</w>
Fat 1.</w>
Fast- kindling</w>
Fast est</w>
Fast blue</w>
Fascicul ations,</w>
Fas- L.</w>
Fas- L,</w>
Fas- Fas</w>
Fas udil,</w>
Fas L,</w>
Fas L+</w>
Fas /
Fas/ FasL</w>
Farnsworth 's</w>
Famoti dine-induced</w>
Fam iliarity</w>
Fallo t:</w>
Fal sely</w>
Fal se-photosensitivity</w>
Fal k,</w>
Fal ciparum</w>
Fail ures</w>
Fag erstr</w>
Fag an</w>
Fact ors',</w>
Fact orial</w>
Fact or,</w>
Fac ulty</w>
Fab .</w>
Fab -
Fab- bound</w>
Fab ,</w>
F] fluorodeoxyglucose</w>
FZ-2 HCl</w>
FZ- sulfoxide</w>
FZ- metabolites</w>
FZ- enanthae,</w>
FZ- decanoate.</w>
FXII- null</w>
FX Ia,</w>
FX II-induced</w>
FX )-</w>
FVII a,</w>
FVB/ N</w>
FV R</w>
FV IIIRAg</w>
FV C)</w>
FUDEC O's</w>
FUD R-treated</w>
FUD R-associated</w>
FUD R)</w>
FU/ FA/
FU/FA/ DP</w>
FTI R</w>
FTI I</w>
FTI I.</w>
FTI I,</w>
FS <
FS< 25%)</w>
FS -like</w>
FS %</w>
FR1736 57
FR173657 :</w>
FR S)</w>
FR LMA</w>
FR LMA;</w>
FR G).</w>
FR :</w>
FR 5
FR5 TO1</w>
FR 4</w>
FR 2</w>
FR 10.</w>
FR -1
FR-1 39
FR-139 3
FR-1393 17),</w>
FR ).</w>
FP-CI T,</w>
FP- VS)</w>
FP Z;</w>
FP Z-treated</w>
FOLFO X-4,</w>
FOLFO X-4)</w>
FOLFO X)</w>
FOLF OX6</w>
FO LIC</w>
FO K</w>
FO ).</w>
FN Z)</w>
FM Z</w>
FM L.</w>
FM F,</w>
FM 100</w>
FLA- 63.</w>
FLA 87
FLA87 3,</w>
FLA 8
FLA8 38,</w>
FLA 79
FLA79 7,</w>
FL X)</w>
FL U</w>
FL D)</w>
FL ):</w>
FKBP 51,</w>
FKBP -12,</w>
FK97 3.</w>
FK50 6-</w>
FK50 6)</w>
FK50 6
FK506 ?</w>
FK3 3,8
FK33,8 24</w>
FK3 17,</w>
FK3 17
FK317 :</w>
FK- 506-treated</w>
FK ,</w>
FJ+/PV -</w>
FJ+/PV +</w>
FJ C</w>
FJ -positive</w>
FJ -C</w>
FITC- labeled).</w>
FITC- albumin;</w>
FITC- albumin.</w>
FITC- albumin)</w>
FITC- albumin).</w>
FIO 2
FIO2 '</w>
FI B</w>
FH G</w>
FH G,</w>
FG- 7142.</w>
FG H.</w>
FG 7142</w>
FF P,</w>
FEV 1.</w>
FEV %</w>
FEF25- 75)</w>
FEAT URES,</w>
FE V</w>
FE NT</w>
FE N/PHEN</w>
FE N.</w>
FE N-induced</w>
FE (NA)</w>
FDG- PET</w>
FDE IA</w>
FDA- cleared</w>
FD s)</w>
FD P,</w>
FD G;</w>
FD A/
FDA/ MEDWATCH</w>
FD A.</w>
FCH L.</w>
FC -1000</w>
FBM/ ESM</w>
FBM/ CZP</w>
FB I</w>
FB ;</w>
FANFT----4. 44%</w>
FANFT----4. 21%</w>
FANFT----1. 34%</w>
FANFT----1. 15%</w>
FANFT---- control</w>
FANFT---- control;</w>
FANFT---- 3.
FANFT----3. 12%</w>
FANFT---- 3%</w>
FANFT---- 2.5
FANFT----2.5 3%</w>
FANFT- pretreated</w>
FANF T-treated</w>
FAMP/ Ara-C</w>
FAMP/ Ara-C.</w>
FAM TX,</w>
FAC TORS</w>
FAC -treated</w>
FAB Ps,</w>
FAB P3)</w>
FA A-induced</w>
FA +/-
FA+/- interferon</w>
F= 8.
F=8. 46,</w>
F= 29.
F=29. 280</w>
F= 24.
F=24. 255</w>
F= 16.
F=16. 53
F=16.53 7,</w>
F= 0/
F=0/ 35,</w>
F344/ Du
F344/Du Cr
F344/DuCr j</w>
F32. 11</w>
F32. 10</w>
F2- isoprostanes,</w>
F100 +
F100+ N</w>
F1- sires</w>
F1- ATPase</w>
F1,6 BP.</w>
F/ death</w>
F/ blood</w>
F/ LFbasal</w>
F/ HFbasal</w>
F/ Adriamyc
F/Adriamyc in).</w>
F/ AFL)</w>
F/ 8</w>
F-actin- depolymerizing</w>
F-actin- ,</w>
F-97013- GD,</w>
F- wave</w>
F- type</w>
F- reducing</w>
F- heparin).</w>
F- free</w>
F- actin.</w>
F- NS</w>
F- NS,</w>
F- HD</w>
F- FDG)</w>
F- AM)</w>
F- 36
F-36 v2).</w>
F- 334</w>
F- -induced</w>
F( o)F(1)</w>
F( group)=37.905,</w>
F( day)=45.310,</w>
F z.</w>
F z-fed</w>
F yn</w>
F uzzy</w>
F usarium</w>
F uro/Cap</w>
F ur.</w>
F undacion</w>
F udan</w>
F ucoidan-treated</w>
F u)</w>
F torafur</w>
F torafur,</w>
F s)/tetrahydrocortisone</w>
F s),</w>
F rontotemporal</w>
F resh</w>
F rench-American-British</w>
F ratta</w>
F r</w>
F r,</w>
F ondparinux</w>
F lying</w>
F lexible</w>
F leroxacin</w>
F leming</w>
F lank</w>
F ixed-dose</w>
F its</w>
F issure</w>
F ingernail</w>
F ine-tuning</w>
F iltration</w>
F illing</w>
F ield-stimulated</w>
F ick's</w>
F exofenadine</w>
F etal,</w>
F errokinetic</w>
F erol</w>
F enton</w>
F enethylline</w>
F e-mediated</w>
F azekas</w>
F ate</w>
F at</w>
F astigial</w>
F arum,</w>
F arber</w>
F arber.</w>
F arabi</w>
F ansidar</w>
F am</w>
F alling</w>
F alck,</w>
F airfield</w>
F aintness</w>
F actitious</w>
F Z-induced</w>
F UR,</w>
F UNDING:</w>
F U),</w>
F TD.</w>
F T),</w>
F S-myosin</w>
F REQUENT</w>
F Q.</w>
F Q,</w>
F PW</w>
F PI</w>
F PD</w>
F OR</w>
F O.</w>
F NG.</w>
F MD.</w>
F MD,</w>
F M.</w>
F LT3-ITD</w>
F L</w>
F ITC</w>
F ISH</w>
F INITION:</w>
F HS</w>
F HR,</w>
F H,</w>
F GF</w>
F FS</w>
F F)</w>
F F),</w>
F DP
FDP s</w>
F D)</w>
F CS</w>
F CS.</w>
F CQ</w>
F CH</w>
F CCC</w>
F C.</w>
F C,</w>
F BA
FBA L-HCl</w>
F B</w>
F B.</w>
F B-induced</w>
F AST</w>
F AMP.</w>
F AM</w>
F AI
FAI LURE</w>
F AD.</w>
F ACS</w>
F AC.</w>
F AA,</w>
F A-mediated</w>
F A-
FA- Na</w>
F A)-
FA)- labeled</w>
F =1.
F=1. 232,</w>
F 9</w>
F 8
F8 35
F835 66
F83566 ))</w>
F 33.2</w>
F 32.2</w>
F 3-
F3- positive</w>
F 1alpha</w>
F 1alpha,</w>
F 150
F150 63</w>
F 1/
F1/ Cr
F1/Cr l</w>
F 1+2</w>
F 1)</w>
F -11</w>
F );</w>
F )-positive</w>
F )-induced</w>
F (3,
F(3, 76
F(3,76 2)</w>
Ey es</w>
Ey es-closed"</w>
Ey e-opener)</w>
Extrac ardiovascular</w>
Extrac apillary</w>
Extra vascular</w>
Extra renal</w>
Extra hippocampal</w>
Exten sivity</w>
Ext inction</w>
Ext ents</w>
Expos ures</w>
Expos ure-disease</w>
Explo sive</w>
Explo itation</w>
Expl oring</w>
Experim entation</w>
Exper t</w>
Exerci se-stress</w>
Exer tional</w>
Exer iences</w>
Excit otoxicity</w>
Excell ent</w>
Excell ence</w>
Exce pting</w>
Exce l</w>
Examin ers;</w>
Examin er's</w>
Exacerb ations</w>
Ex udative</w>
Ex tubation</w>
Ex trastimulus</w>
Ex traneous</w>
Ex tramedullary</w>
Ex traction</w>
Ex tent</w>
Ex tension</w>
Ex pressive</w>
Ex pression.</w>
Ex pectancy</w>
Ex pansion</w>
Ex ovascular</w>
Ex ogenously</w>
Ex ocytotic</w>
Ex isting</w>
Ex haustion</w>
Ex haled</w>
Ex foliative</w>
Ex encephalic</w>
Ex cruciating</w>
Ex cision</w>
Ex cised</w>
Ex amined</w>
Ex )</w>
Ew ing-,</w>
Ew ing,</w>
Evid ences</w>
Everolim us,</w>
Event ually</w>
Event s,</w>
Event s)</w>
Event -related</w>
Evan s-Blue</w>
Evan s,</w>
Evan s),</w>
Evan s'</w>
Evalu ative</w>
Evalu ation-2</w>
Evalu ated</w>
Ev ra</w>
Ev acet,</w>
Europe an/Australasian</w>
Europe ;</w>
Europe )</w>
Euro -
Euro- Ewing</w>
Euphor ia,</w>
Eu thanasias</w>
Eu (h
Eu(h fbc)3.</w>
Etoric oxib:</w>
Etoric oxib,</w>
Etopo side-induced</w>
Etopo side-</w>
Etomid ate:</w>
Eti opathogenesis</w>
Eti ologies</w>
Eti ological</w>
Eti foxine:</w>
Ethyl sulfonylnaphthalene-1-sulfonamide,</w>
Ethyl enediamine</w>
Ethyl dimethyl(7-methylcoumaran-3-yl)ammonium</w>
Ethosuxim ide-induced</w>
Ethin ylestradiol/drospirenone</w>
Ethin ylestradiol,</w>
Ethambut ol-associated</w>
Eth yol)</w>
Eth ynylestradiol-induced</w>
Eth ynodiol</w>
Eth yl-alpha-p-chlorophenoxyisobutyrate),</w>
Eth oxyestradiol</w>
Eth odolac</w>
Eth ics'</w>
Eth anol-induced</w>
Et CO2</w>
Estrogen- replacement</w>
Estrogen- progestin</w>
Estrogen /
Estrogen/ progestin</w>
Estrogen -treated</w>
Estrogen -mediated</w>
Estro genic</w>
Estradi ol-3-sulfate-17</w>
Estradi ol,</w>
Estim ations</w>
Establ ishment</w>
Establ ishing</w>
Establ ished</w>
Est rous</w>
Est ado</w>
Essen er</w>
Esoph agogastroduodenoscopy</w>
Esoph ageal,</w>
Esmo lol-induced</w>
Escitalop ram,</w>
Esc uletine</w>
Esc ape</w>
Es sex</w>
Es sT</w>
Es orubicin</w>
Erythromel algia</w>
Erythro leukemia</w>
Erythro blastopenia</w>
Eryth matous</w>
Eryth ematosus</w>
Ery thromycin-induced</w>
Ery thermalgia</w>
Ergot amine</w>
Ergot amine-induced</w>
Ergot amine,</w>
Ergot -derived</w>
Erg ometrine</w>
Erg ometric</w>
Erec tions</w>
Er yptosis</w>
Er tapenem</w>
Er sek</w>
Er ror-processing</w>
Er menonville</w>
Er lotinib-induced</w>
Er langen,</w>
Er k1/2</w>
Er k.</w>
Er dosteine</w>
Equi sedative</w>
Equ ilibration</w>
Equ ations</w>
Equ ally</w>
Epste in</w>
EpoR- PY343</w>
EpoR- PY343-Stat5</w>
EpoR- HM,</w>
Epo -dependent</w>
Epo -
Epo- production</w>
Epo ,</w>
Epit opes</w>
Epit ope</w>
Episo de</w>
Epirub icin;</w>
Epirub icin-induced</w>
Epinephrine- Induced</w>
Epinephr ine,</w>
Epileptic us.</w>
Epileptic us,</w>
Epilep ticus</w>
Epilep sy:</w>
Epilep sy,</w>
Epid x</w>
Epid oxorubicin</w>
Epid endrum</w>
Epi rus</w>
Epi medium</w>
Epi medium,</w>
Epi genetic</w>
Epi gallocatethin-3-O-gallate</w>
Epi .</w>
Ephed rine-induced</w>
Epac 1.</w>
Epac -R
Epac-R ap</w>
Ep tifibatide-induced</w>
Ep on</w>
Eosinophil s,</w>
Enzym uria,</w>
Environ ment-Directed</w>
Enter ocolitis</w>
Enter obacteria,</w>
Entec avir,</w>
Enoxim one</w>
Enoxim one:</w>
Enoxapar in-related</w>
Enoxapar in-induced</w>
Enoxapar in,</w>
Enox acin,</w>
Engl and:</w>
Engl .</w>
Endotox in-induced</w>
Endotox emia</w>
Endotheli um-independent</w>
Endotheli um-derived</w>
Endotheli opathy:</w>
Endothel in-3</w>
Endothel in-3-like</w>
Endothel in,</w>
Endot racheally</w>
Endot oxin</w>
Endocrin ology</w>
Endocrin ological</w>
Endo thelins</w>
Endo MT,</w>
End- treatment</w>
End- proximal</w>
End- of-study</w>
End points</w>
End ocytic</w>
End ocarditis</w>
End MT-derived</w>
End -</w>
Encephalo pathy,</w>
Encephalo pathic</w>
Encephal omyelopathy</w>
Encephal ocele</w>
Enalapri lat-induced</w>
Enalapri l-related</w>
En thesopathy</w>
En teral</w>
En tamoeba</w>
En tacapone</w>
En rolled</w>
En riched</w>
En larged</w>
En graftment</w>
En forcement</w>
En flurane-associated</w>
En during</w>
En durance</w>
En dosulfan</w>
En ding</w>
En coding</w>
En capsulation</w>
En cainide</w>
En antiomers</w>
En abling</w>
En abled,</w>
En )</w>
Empir ically</w>
Embry otoxic</w>
Embry ology,</w>
Embry ological</w>
Embry o</w>
Em ploying</w>
Em piric</w>
Em physema</w>
Em phasizes</w>
Em phasis</w>
Em boli</w>
Em /
Em/ Am</w>
Ell man</w>
Eleven- week-old</w>
Eleven- bed</w>
Elev ating</w>
Electrophore tic</w>
Electrophore sis</w>
Electron ystagmography</w>
Electron microscopy</w>
Electromyo gram</w>
Electroencephalo graphically</w>
Electroencephalo gram,</w>
Electrocardio graphically</w>
Electro version</w>
Electro retinography</w>
Electro physiologically,</w>
Electro lytic</w>
Electro grams</w>
Electro corticographic</w>
Electro acupuncture</w>
Electro -
Electro- physiological</w>
Electr onic</w>
Electr oneuromyographic</w>
Electr ically</w>
Electr ic,</w>
Elect ric</w>
El ucidation</w>
El liott's</w>
El avil</w>
El an</w>
Eight- year</w>
Egypt .</w>
Egypt ,</w>
Efficac ies</w>
Effect s.</w>
Effect s,</w>
Effect s)</w>
Eff ectively</w>
Eff ective,</w>
Efavirenz -induced</w>
Efavirenz -associated</w>
Educ ational</w>
Educ ating</w>
Edroph onium</w>
Edroph onium-induced</w>
Edroph onium-hyoscine</w>
Edin burgh,</w>
Ed wards,</w>
Ed monton</w>
Ed inger-Westphal</w>
Ed 50</w>
Ecstas y-specific</w>
Ecstas y-induced</w>
Ecstas y),</w>
Ecstas y')</w>
Eco-Dobutamin a,</w>
Eco-Dobutamin a):</w>
Echocardi ography,</w>
Echo- dobutamine</w>
Echo- Dobutamine</w>
Ech osens,</w>
Ech inocystic</w>
Ec gonine</w>
Ec g</w>
Ec centric</w>
Ebste in</w>
Eb selen</w>
Eb n</w>
Early- onset</w>
Early- life</w>
Ear lier,</w>
Ear le's</w>
EaHy 926</w>
EaHy 9
EaHy9 26.</w>
Ea M</w>
EXPOSURE s</w>
EXP 3
EXP3 174</w>
EX AC
EXAC ER
EXACER BA
EXACERBA TIONS:</w>
EX ).</w>
EX ),</w>
EW P).</w>
EW E</w>
EV TAC</w>
EV L)</w>
ETH OMATIC</w>
ET= 30/
ET=30/ -1</w>
ET= 22
ET=22 +/-1</w>
ET/ PEP-ratio</w>
ET/ DAT</w>
ET(B )R</w>
ET(B )-selective</w>
ET(B )-receptors</w>
ET(B )
ET(B) R),</w>
ET(A )/
ET(A)/ ET(B)</w>
ET(A )-selective</w>
ET(A )-</w>
ET V).</w>
ET T</w>
ET T.</w>
ET PPS)</w>
ET E</w>
ET C</w>
ET C),</w>
ET B</w>
ET A-
ETA- blocker-induced</w>
ET 00
ET00 16),</w>
ET -1.</w>
ET -1-mediated</w>
ET -1)</w>
ET +L-NAME.</w>
ET ),</w>
ESR S.</w>
ESR F-HD</w>
ESR ,</w>
ES S).</w>
ES PRIT,</w>
ES PDR</w>
ES AE
ESAE -induced</w>
ES 25</w>
ES 25,</w>
ES 100</w>
ES 100;</w>
ES );</w>
ERK 1/2.</w>
ERK /
ERK/ mitogen-activated</w>
ER22/23E K,</w>
ER- beta.</w>
ER- beta)</w>
ER- DP),</w>
ER T</w>
ER T)-deficient</w>
ER R/Gy</w>
ER PF.</w>
ER P,</w>
ER N</w>
ER K.</w>
ER K,</w>
ER K)</w>
ER Gs,</w>
ER CP,</w>
ER CC
ERCC 1,</w>
ER A)</w>
ER -positive</w>
ER -negative</w>
ER )-induced</w>
ER )-
ER)- Medicare</w>
EPSP s,</w>
EPSP s)</w>
EPO R-HM</w>
EPO CH.</w>
EPO CH,</w>
EPO -treated</w>
EPO -mediated</w>
EPO ).</w>
EPI-ex t.</w>
EP3 (-/-))</w>
EP s;</w>
EP s),</w>
EP Ss</w>
EP SP,</w>
EP SEs.</w>
EP SE</w>
EP SCs.</w>
EP SC,</w>
EP S).</w>
EP Q-R),</w>
EP PPGKPADDAGLV,</w>
EP P</w>
EP M,</w>
EP I/3</w>
EP I.</w>
EP I-induced</w>
EP I-doxorubicin</w>
EP H1</w>
EP H,</w>
EP DS</w>
EP Cs</w>
EP 4-
EP4- targeted</w>
EP 3,</w>
EP 2,</w>
EP 1-receptor</w>
EP 1
EP1 (+/+),</w>
EP -</w>
EP ).</w>
EP (2),</w>
EP (1),</w>
EOP F</w>
EO G,</w>
EO 0
EO0 122</w>
EO -treated</w>
EO -12
EO-12 2.</w>
EO -1
EO-1 22,</w>
ENa C-
ENaC- blocking</w>
ENa C)</w>
ENT RAL),</w>
ENT -limited</w>
ENT )</w>
EN U]</w>
EN U,</w>
EN G</w>
EN D</w>
EN ),</w>
EMTBL )]</w>
EMT BL)</w>
EMT B
EMTB L),</w>
EMG- proven</w>
EMG- findings</w>
EMG- findings,</w>
EME A</w>
EMB ,</w>
EM s.</w>
EM s)</w>
EM SA.</w>
EM S)</w>
EM LA-treated</w>
EM LA-pre-treated</w>
EM LA,</w>
EM Gs</w>
EM G.</w>
EM G).</w>
EM 12</w>
EM /
EM/ WS</w>
EM .</w>
EM -
EM- N-demethylase</w>
EL F,</w>
EK 293)</w>
EI AEDs</w>
EI AEDs.</w>
EI A,</w>
EHX O</w>
EHX O,</w>
EHX A-exposed</w>
EHE N.</w>
EGT A.</w>
EGT A-
EGTA- am</w>
EG F)</w>
EG Cs.</w>
EG Cs,</w>
EG Cs).</w>
EG A</w>
EF V-induced</w>
EF As)</w>
EF AD.</w>
EF :</w>
EF %</w>
EEG- video</w>
EEG- detectable</w>
EEG- changes.</w>
EEG- changes,</w>
EEG- /
EEG-/ video-monitoring</w>
EE/ D
EE/D NG.</w>
EE-17 beta-glucuronide</w>
EE- treatment</w>
EE- pre</w>
EE- cholestatic</w>
EE- cholestasis;</w>
EE- cholestasis,</w>
EE- EPO</w>
EE- EPO-treated</w>
EE SC</w>
EE LV.</w>
EE LV,</w>
EE Gs,</w>
EE G)</w>
EE G's.</w>
EE D
EED 's.</w>
EE ;</w>
EE 2/
EE2/ kg</w>
EE 2.</w>
EE /day</w>
EE -mediated</w>
EE )].</w>
EE )-
EE)- guided</w>
EE ),</w>
EDT A),</w>
ED-1- ,</w>
ED(9 5).</w>
ED(50)= 31</w>
ED(50)= 22</w>
ED(50)= 0.42</w>
ED(50)= 0.19</w>
ED(50) =</w>
ED s)</w>
ED VI</w>
ED V/sec)</w>
ED SS</w>
ED S),</w>
ED RF</w>
ED RF.</w>
ED RF,</w>
ED P.</w>
ED P,</w>
ED LVP,</w>
ED L)</w>
ED I,</w>
ED HF.</w>
ED D
EDD 's</w>
ED 99</w>
ED 97</w>
ED 95.</w>
ED 95)</w>
ED 7-
ED7- positive</w>
ED 50's</w>
ED 30</w>
ED 1/
ED1/ CD
ED1/CD 68
ED1/CD68 (+)</w>
ED 1-ED
ED1-ED 4</w>
ED 1,</w>
ED /
ED/ LD97</w>
ED +
ED+ DOX)</w>
ED (95)</w>
ED (50</w>
ED (50),</w>
ED 's)</w>
ECo Gs</w>
ECG- gated</w>
ECG- confirmed</w>
ECG s;</w>
ECG /
ECG/ Echo</w>
ECE -1.</w>
EC- MRI).</w>
EC- 66
EC-66 5,</w>
EC s).</w>
EC TS.</w>
EC TS)</w>
EC T,</w>
EC T)</w>
EC S-</w>
EC R</w>
EC Ps,</w>
EC P)</w>
EC P),</w>
EC MO</w>
EC M,</w>
EC HO)</w>
EC F-AM)</w>
EC E</w>
EC D).</w>
EC ASS</w>
EC 50s</w>
EC 50.</w>
EC 145,</w>
EC -induced</w>
EC )].</w>
EC ),</w>
EC (50))</w>
EC (50
EC(50 )).</w>
EB+ P.</w>
EB+ P,</w>
EB V</w>
EB RT).</w>
EB E</w>
EAC A.</w>
EAC A,</w>
EA K,</w>
EA AT
EAAT 2/
EAAT2/ GLT-1,</w>
EA ;</w>
EA 1)</w>
EA -treated</w>
E: carbamazepine</w>
E: A</w>
E609 X.</w>
E2/ T</w>
E2/ P-induced</w>
E2-17 G-induced</w>
E10- E
E10-E 20)</w>
E10- 20),</w>
E1 a)</w>
E1 E
E1E 3
E1E3 E
E1E3E 4-deleted</w>
E/ LDL-cholesterol</w>
E/ LDL-c.</w>
E. M.)</w>
E. C.
E.C. G.</w>
E. A.,</w>
E-9, 13
E-9,13 Z)-tetraenoic</w>
E-9, 11
E-9,11 Z)-tetraenoic</w>
E-40 31.</w>
E-40 31,</w>
E-20 20</w>
E-20 20.</w>
E-20 20,</w>
E-17 G-treated</w>
E-17 G-induced</w>
E- wave</w>
E- type,</w>
E- supplemented</w>
E- selectin.</w>
E- rosette-forming</w>
E- knockout</w>
E- cadherin.</w>
E- binding</w>
E- TOC</w>
E- KO)</w>
E- Is)</w>
E- Ferol</w>
E- ARF)</w>
E- 45),</w>
E- )</w>
E zetimibe</w>
E vista</w>
E tidocaine,</w>
E thiopia</w>
E ther</w>
E ther-a-go-go</w>
E t-A</w>
E strone-induced,</w>
E stramustine</w>
E specially,</w>
E slicarbazepine</w>
E rosion</w>
E ristostatin</w>
E riksen</w>
E radication</w>
E qualizing</w>
E osinophil</w>
E oM</w>
E novid</w>
E mpty</w>
E motional</w>
E mory</w>
E metic</w>
E max/Amax</w>
E max,</w>
E ll</w>
E liasson</w>
E l</w>
E ktachem</w>
E izai</w>
E ichl.</w>
E gletes</w>
E fferent</w>
E do</w>
E dam)</w>
E bola</w>
E aton-Lambert</w>
E ast.</w>
E ast,</w>
E asily</w>
E arnest</w>
E arly,</w>
E X)</w>
E VENT:</w>
E U.</w>
E U),</w>
E T.</w>
E T-receptor</w>
E T,</w>
E SWS</w>
E SVI</w>
E SO-induced</w>
E SM,</w>
E S.</w>
E S-induced</w>
E S-D3-cells</w>
E ROD</w>
E PRs.</w>
E PRs,</w>
E PA.</w>
E P-containing</w>
E O,</w>
E N.</w>
E MP).</w>
E MA,</w>
E LYX</w>
E LT</w>
E LOX)</w>
E L/ethanol/saline</w>
E L-4</w>
E L,</w>
E L)</w>
E L),</w>
E IIa-Cre</w>
E IDV</w>
E IDV.</w>
E ICESS-92/EURO-E.W.I.N.G.-99,</w>
E HDP,</w>
E GF.</w>
E G-VEGF</w>
E F-reducing</w>
E F)</w>
E D-
ED- SCLC</w>
E D)</w>
E CLS</w>
E BP</w>
E BP
EBP alpha)</w>
E B.</w>
E B,</w>
E AF</w>
E AE.</w>
E AD</w>
E AB,</w>
E A,</w>
E A),</w>
E 9</w>
E 9.5,</w>
E 8.5,</w>
E 70,</w>
E 7,</w>
E 30</w>
E 30,</w>
E 30).</w>
E 23-
E23- glucuronide</w>
E 20.</w>
E 20
E20 78</w>
E 2-3
E2-3 G.</w>
E 2-
E2- containing</w>
E 2).</w>
E 2
E2 (PGE2)</w>
E 1a
E1a E1a)</w>
E 19,</w>
E 17,</w>
E 150</w>
E 150,</w>
E 15)</w>
E 15),</w>
E 13.</w>
E 110</w>
E 110,</w>
E 11.5.</w>
E 10</w>
E 1-treated</w>
E 0).</w>
E /kg</w>
E .),</w>
E -like</w>
E -1-
E-1- [[(5-(4-chlorophenyl)-2-furanyl)</w>
E +/-</w>
E )-
E)- derived</w>
E (m)</w>
E (GABA),</w>
E (2)-induced</w>
E (1).</w>
Dystroph in</w>
Dystroph in-deficiency</w>
Dyston ia-dyskinesia</w>
Dyston ia'-like</w>
Dyst onias,</w>
Dysph onia</w>
Dysph asia</w>
Dysp noea</w>
Dysp eptic</w>
Dysp epsia,</w>
Dyskine sia-an</w>
Dyskine sia,</w>
Dys rhythmias</w>
Dys rhythmia</w>
Dys port.</w>
Dys plasia</w>
Dys phoria,</w>
Dys phagia,</w>
Dys morphologic</w>
Dys morphic</w>
Dys functional</w>
Dy sosmia</w>
Dy sk,</w>
Dy sexecutive</w>
Dy sautonomia</w>
Dy azide-induced</w>
Dx D
DxD x)</w>
Duret tes.</w>
Duret tes,</w>
Dur ham,</w>
Dur ability</w>
Dup uy,</w>
Dup lex-proven</w>
Dulox etine-associated</w>
Duct ular</w>
Dub utamine</w>
Dual- parameter</w>
Dual- isotope</w>
Du plication</w>
Du ke's</w>
Du bois.</w>
Du P</w>
Drug- seeking</w>
Drug- Taking</w>
Drug s.</w>
Drug s,</w>
Drug -dependent</w>
Drospiren one</w>
Drospiren one,</w>
Dro pped</w>
Dre ams</w>
Drd 2</w>
Drd 2.</w>
Dra wn</w>
Dr ummond,</w>
Dr ickamer's</w>
Doxy fluridine</w>
Doxy cycline</w>
Doxorubicin- eluting-bead</w>
Doxorubicin- aconityl-lysozyme</w>
Doxorubic in-related</w>
Doxorubic in's</w>
Dox urubicin</w>
Dox il,</w>
Dox azosin,</w>
Dox CM</w>
Dox ).</w>
Down stream</w>
Double- labelling</w>
Double- electrode</w>
Double- balloon</w>
Dou blecortin</w>
Dose- responses</w>
Dose- reponse</w>
Dose- proportionality</w>
Dose- independent</w>
Dose- escalation</w>
Dose- escalated</w>
Dose- doubling</w>
Dose -</w>
Dos pan,</w>
Dos ing-time-dependent</w>
Dorme x</w>
Dorme x.</w>
Dorme x,</w>
Doppler- measured</w>
Doppler- flow</w>
Doppler- echocardiographic</w>
Doppl er,</w>
Doppl er).</w>
Doppl er),</w>
Dop maine</w>
Dop amine-sensitive</w>
Dop amine-like</w>
Donepez il-related</w>
Donepez il-induced</w>
Donepez il-associated</w>
Donepez il,</w>
Don ors</w>
Don or,</w>
Domperid one-induced</w>
Domperid one,</w>
Domin ican</w>
Domin ant</w>
Dom oprednate</w>
Dol lar</w>
Dol asetron</w>
Dofetili de:</w>
Dofetili de-induced</w>
Docetax el-doxorubicin</w>
Docetax el-based</w>
Doc tors</w>
Do w</w>
Do ses,</w>
Do se,</w>
Do om</w>
Do hme</w>
Diz zy"</w>
Diver gent</w>
Diver gence</w>
Diure tics,</w>
Diure sis,</w>
Disulfir am-like</w>
Disulfir am,</w>
Disturb ed</w>
Disturb ances</w>
Disturb ance</w>
Dist ributions</w>
Dist ressing</w>
Dist ension</w>
Dist ance</w>
Dist al,</w>
Dissoci ative</w>
Dissemin ation</w>
Disor ders.</w>
Disor dered</w>
Disor der.</w>
Disor der-manic</w>
Disor d</w>
Disopyram ide.</w>
Disopyram ide-associated</w>
Dise ases.</w>
Dise ase-oriented</w>
Discus sions</w>
Discus sion</w>
Discus sed</w>
Discri mination</w>
Discri minating</w>
Dis similar</w>
Dis rupting</w>
Dis rupted</w>
Dis proportionate</w>
Dis organized</w>
Dis oprivan.</w>
Dis cordance</w>
Dis continuity</w>
Dis connecting</w>
Dis charges</w>
Dis accharide</w>
Dis .,</w>
Dipyridamole- atropine-induced</w>
Dipyridamole- associated</w>
Diprivan --
Diprivan-- median</w>
Diplop ia</w>
Diplop ia,</w>
Diphenyl thiohydantoin</w>
Diphenyl acetoxy-N-methylpiperidine</w>
Diphenhydram ine,</w>
Dip olar</w>
Din ley's</w>
Din amap</w>
Dimin ishment</w>
Dimin ished</w>
Dimethylethan olamine</w>
Dimethylethan olamine,</w>
Dimer- X,</w>
Dimen hydrinate</w>
Dim inution</w>
Dim ers</w>
Dim ercaptosuccinic</w>
Diltiaz em-CD</w>
Dilat ations</w>
Dilant in.</w>
Dil ution</w>
Dil ute</w>
Dihydroxy tryptamine</w>
Dihydroxy benzoate</w>
Dihydroxy anthracenedione</w>
Dihydroxy -16-ene-23-yne-vitamin</w>
Dihydro- 8-oxo-
Dihydro-8-oxo- guanine</w>
Dihydro- 5-azacytidine</w>
Dihydro testosterone</w>
Dihydro pyridine</w>
Dihydro ethedium</w>
Dihydro codeine--a</w>
Digox in-specific</w>
Digox in-induced</w>
Dig iscan</w>
Diflun isal</w>
Diflun isal-induced</w>
Differenti aton</w>
Differen tly,</w>
Differen tiated</w>
Differen ces,</w>
Differen ce</w>
Diff ering</w>
Diethylstilbestro l-associated</w>
Diethylstilbestro l-Adenosis</w>
Diethyl nitrosamine</w>
Diethyl nitrosamine-initiated</w>
Diethyl dithiocarbamate</w>
Diethyl carbamazine</w>
Dideoxy nucleosides</w>
Dideoxy nucleoside-induced</w>
Dideoxy inosine-induced</w>
Dideoxy cytidine</w>
Diclofenac -dependent</w>
Diclofenac -associated</w>
Diclofenac -</w>
Diclofen ac,</w>
Dichloro methane</w>
Dic umarol</w>
Dic tionary</w>
Dic loxacillin</w>
Dic loxacillin:</w>
Dic :</w>
Diazepam -associated</w>
Diazepam -
Diazepam- atenolol</w>
Diazemul s.</w>
Diazemul s--in</w>
Diaz oxide,</w>
Diarrho ea,</w>
Diaphrag mlike'</w>
Dialys ates</w>
Dialy sis.</w>
Dialy sis,</w>
Diagnos ing</w>
Diagno sis,</w>
Di vision,</w>
Di viding</w>
Di s.</w>
Di propylxanthine,</w>
Di privan,</w>
Di prifusor</w>
Di phenidol</w>
Di methylaminoadamantane</w>
Di methadione</w>
Di isopropyl</w>
Di hydroxyeicosa-(5E-9,11,13Z)-tetraenoic</w>
Di gene</w>
Di ets</w>
Di eldrin,</w>
Di aplacental</w>
Di amond-Blackfan</w>
Di Pr-5,6-ADTN</w>
Di HETE</w>
Di George</w>
Di -n-propyl
Di-n-propyl acetic</w>
Dextromethorph an-pretreated</w>
Dextromethorph an-</w>
Dextro se</w>
Dextro amphetamine</w>
Dextro -</w>
Dextran -induced</w>
Dextran -
Dextran- etodolac</w>
Dexrazox ane:</w>
Dexrazox ane.</w>
Dexmedetom idine-treated</w>
Dexmedetom idine-associated</w>
Dexamethas one-treated</w>
Dexamethas one,</w>
Dex- hypertension,</w>
Dex fenfluramine-related</w>
Dex etimide</w>
Dex amphetamine</w>
Dex Pla</w>
Dex /
Dex/ saline</w>
Dex .</w>
Dex ),</w>
Devic es)</w>
Devic 's</w>
Develop mental,</w>
Deteri orating</w>
Det oxification</w>
Det ected</w>
Det achment</w>
Desmethyl astemizole</w>
Desmethyl astemizole,</w>
Desi rable</w>
Desi rability</w>
Desi pramine-associated</w>
Desi pramine,</w>
Desensi tisation</w>
Desc ending</w>
Desbutyl bupivacaine</w>
Desbutyl bupivacaine,</w>
Des-Arg9- bradykinin</w>
Des-Arg9- BK</w>
Des ogestrel</w>
Des ogestrel,</w>
Des loratadine</w>
Des k</w>
Des flurane</w>
Des flurane-induced</w>
Des aturated-15</w>
Des arrollo</w>
Dermat ology</w>
Dermat ological</w>
Dermat ologic</w>
Deriv atives</w>
Deriv ative</w>
Der mo-epidermal</w>
Der anged</w>
Depres sion.</w>
Depres sion-inducing</w>
Depo- Provera,</w>
Depend ency</w>
Dep t</w>
Dep ot,</w>
Dep olarizing</w>
Dep olarization</w>
Dep o</w>
Dep o-</w>
Deoxy glucose</w>
Deoxy corticosterone</w>
Deoxy cholic</w>
Deoxy adenosines</w>
Denmark .</w>
Denmark ).</w>
Den/ morph:</w>
Den/ morph,</w>
Den+ morph:</w>
Den+ morph,</w>
Den se,</w>
Den :</w>
Demon strating</w>
Demon strates</w>
Demo s</w>
Dem yelinating</w>
Dem erol</w>
Dem ands</w>
Delta9-THCA- A</w>
Delta9-THCA- A,</w>
Delta9-TH C+
Delta9-THC+ CLOZ</w>
Delta9- tetrahydrocannabinol,</w>
Delta9- Tetrahydrocannabinol</w>
Delta9- THC.</w>
Delta- tetrahydrocannabinol</w>
Delta- tetrahydrocannabinol-standardized</w>
Delta- aminovaleric</w>
Delta(9)- tetrahydrocannabinol's</w>
Delta SR</w>
Delta SR.</w>
Delta CVR</w>
Delta CV
DeltaCV R/DeltaMAP,</w>
Delta AV
DeltaAV P/DeltaMAP</w>
Delta ALB</w>
Delta AL
DeltaAL B)</w>
Deliri ous</w>
Dele tions</w>
Dele strogen,</w>
Delay ing</w>
Del toid</w>
Del ineation</w>
Dehydro cholate,</w>
Defin ition</w>
Defen sive</w>
Defen se</w>
Def icient</w>
Def ects,</w>
Def ecation</w>
Def NS,</w>
Def C</w>
Deep- brain</w>
Decur sin</w>
Decur sin,</w>
Decom plementation</w>
Declar ative-like</w>
Declar ation.</w>
Dec rements</w>
Dec ongestants</w>
Dec line</w>
Dec laring</w>
Dec ision-analytic</w>
Dec adurabolin</w>
Dec adron</w>
Debriso quine,</w>
De viation</w>
De v</w>
De signated</w>
De regulation</w>
De pressant</w>
De pakote,</w>
De pakene,</w>
De oxy-D-glucose</w>
De methoxydaunorubicin</w>
De hydration,</w>
De hydrated</w>
De glutition</w>
De fibrillation</w>
De feroxamine,</w>
De ath-censored</w>
De amino-3'-(2-methoxy-4-morpholinyl)-doxorubicin</w>
De ad</w>
Day ton,</w>
Daw ley,</w>
Dav ila</w>
Daun orubicinol,</w>
Daun omycin,</w>
Datab ases</w>
Dar von</w>
Dar mstadt,</w>
Dar inaparsin,</w>
Dar bepoetin</w>
Daptom ycin-induced</w>
Dapson e-related</w>
Dapson e,</w>
Dap sone-</w>
Dan dy-Walker</w>
Dam s.</w>
Dakot a</w>
Dak o,</w>
Da y-case</w>
Da idzein</w>
Da TSCAN,</w>
DZ s,</w>
DZ X</w>
DZ X),</w>
DZ P.</w>
DZ P-induced</w>
DZ P),</w>
DZ ),</w>
DYRK 3-
DYRK3- deficiency</w>
DX Rz</w>
DX R;</w>
DX R-CM</w>
DX NP,</w>
DX MN</w>
DX /C)</w>
DX -induced</w>
DX -116</w>
DVT/ PE.</w>
DVP X</w>
DVP X.</w>
DU B.</w>
DU 145</w>
DU 145,</w>
DTR ,</w>
DTI C),</w>
DTI .</w>
DTI ,</w>
DTI 's</w>
DT- diaphorase;</w>
DT- diaphorase,</w>
DT- PACE</w>
DT rp3,</w>
DT T</w>
DT S),</w>
DT PA,</w>
DT P.</w>
DT P,</w>
DT G-induced</w>
DT G,</w>
DT D)</w>
DT C.</w>
DT C,</w>
DT ).</w>
DSM-III- defined</w>
DSM-III- R)</w>
DSM- IV.</w>
DSM- IV)</w>
DSM- IIIR</w>
DSM- III,</w>
DS s</w>
DS ST</w>
DS S),</w>
DS Q.</w>
DS ;</w>
DRO P.</w>
DRO MEDA</w>
DRB1 *0
DRB1*0 3,</w>
DRB1 *
DRB1* 13
DRB1*13 02</w>
DR/ RXR)</w>
DR-33 55</w>
DR- 335
DR-335 5,</w>
DR w4</w>
DR w3</w>
DR UGS</w>
DR S)</w>
DR S),</w>
DR R-mediated</w>
DR R-induced</w>
DR P.</w>
DR P,</w>
DR D2.</w>
DR A)</w>
DR 9).</w>
DR 5</w>
DR 4;</w>
DR 4.</w>
DR 4-
DR4- positive,</w>
DR 3-</w>
DR 2</w>
DR 1:
DR1: peptide</w>
DR 1.</w>
DR 1+</w>
DR ).</w>
DQ B1</w>
DQ B1*0
DQB1*0 609</w>
DQ A1
DQA1 *</w>
DPO Es</w>
DPH- intoxicated</w>
DPH- TBM</w>
DPCP X.</w>
DPA T-evoked</w>
DPA .</w>
DP en-MG</w>
DP T</w>
DP M/mg</w>
DP IT)</w>
DP I;</w>
DP I.</w>
DP I.(ABSTRACT</w>
DP B1*0
DPB1*0 301</w>
DP -treated</w>
DOXY +
DOXY+ IVM</w>
DOX/ sedentary</w>
DOX/ exercise</w>
DOX/ SED.</w>
DOX/ EX;</w>
DOX/ DZX</w>
DOX- triggered</w>
DOX- treatment</w>
DOX- injured</w>
DOX- LPS</w>
DOX- CM</w>
DOX Y.</w>
DOX NPH</w>
DOX 3.</w>
DOX 3,</w>
DOX 2,</w>
DOX 1</w>
DOX -</w>
DOX 's</w>
DOPAC/ dopamine</w>
DOPAC .</w>
DOPAC .(ABSTRACT</w>
DOPAC ),</w>
DOCA- salt)</w>
DOB -
DOB- infusion.</w>
DOB ,</w>
DO TA-D-Phe1-Tyr3-octreotide</w>
DO TA)</w>
DO Ps.</w>
DO PA)</w>
DO I.</w>
DO CA-induced</w>
DO CA)</w>
DO CA
DOCA ;</w>
DO C.</w>
DO C-treated</w>
DO C),</w>
DO A).</w>
DO -
DO- elicited</w>
DO ,</w>
DO ),</w>
DO ))</w>
DNP- MSH.</w>
DNP- HES</w>
DNA- negative</w>
DNA- methyltransferase</w>
DNA- directed</w>
DNA- depleting</w>
DNA- bound</w>
DNA P</w>
DNA E</w>
DNA <</w>
DNA /
DNA/ unit</w>
DNA +,</w>
DN X)</w>
DN QX,</w>
DN P.</w>
DN P-SG.</w>
DN G)</w>
DN F).</w>
DN B,</w>
DMTU :</w>
DMT U;</w>
DMT U,</w>
DMT S</w>
DMSO ,</w>
DMP X.</w>
DMP X,</w>
DMP P</w>
DMCM -</w>
DMCM -,</w>
DMBA-prolactin- estradiol</w>
DMBA-prolactin- estradiol-induced</w>
DM-9 38
DM-938 4,</w>
DM-1K- SHR</w>
DM- sensitive</w>
DM- resistant</w>
DM- nephropathy</w>
DM UA)</w>
DM SO;</w>
DM S-III-R</w>
DM S)</w>
DM P.</w>
DM P,</w>
DM O-induced</w>
DM O),</w>
DM N</w>
DM I.</w>
DM H.</w>
DM H)</w>
DM F).</w>
DM CM.</w>
DM B</w>
DM 23
DM23 5,</w>
DLT .</w>
DL-tetrahydropal matine</w>
DL-tetrahydropal matine-produced</w>
DL- threo-3,4-dihydroxyphenylserine</w>
DL- thiorphan</w>
DL- p-chlorophenylalanine</w>
DL- naloxone</w>
DL- amphetamine</w>
DL- C-
DL-C- All
DL-C-All yglycine,</w>
DL- 2-
DL-2- mercaptomethyl-3-guanidino-ethylthiopropanoic</w>
DL- (E)-2-amino-4-methyl-5-phosphono-3-
DL-(E)-2-amino-4-methyl-5-phosphono-3- pentoic</w>
DL ST</w>
DL PF</w>
DL M</w>
DL F,</w>
DL B,</w>
DL 50,</w>
DL -</w>
DK-35 C,</w>
DK-35 20</w>
DISCUSSION/ CONCLUSIONS:</w>
DISCUSSION/ CONCLUSION:</w>
DIL I,</w>
DII HA,</w>
DIC C</w>
DI P,</w>
DI L.</w>
DI AM</w>
DI A,</w>
DI -13).</w>
DI +
DI+ GI</w>
DI )-containing</w>
DHSM ;</w>
DHSM :</w>
DH betaE,</w>
DH T-treated</w>
DH T)</w>
DH SM</w>
DH S.</w>
DH S-associated</w>
DH PG].</w>
DH PG),</w>
DH P-derivatives</w>
DH P,</w>
DH O-infused</w>
DH O,</w>
DH L),</w>
DH I</w>
DH I).</w>
DH HS</w>
DH F).</w>
DH EA-treated</w>
DH AD,</w>
DH AC,</w>
DH A,</w>
DG Cs;</w>
DG Cs,</w>
DG 2.</w>
DG -</w>
DFP/ 60</w>
DFO- P</w>
DFO- P,</w>
DFO- M</w>
DFO- M.</w>
DFO- M,</w>
DF X.</w>
DF T1,</w>
DF S</w>
DF P-</w>
DF P).</w>
DF O;</w>
DF MO,</w>
DF MO),</w>
DF GL</w>
DF G-Asp-in</w>
DF C</w>
DF 1</w>
DEX- HT</w>
DEX- HT.</w>
DESIGN S:</w>
DESIGN /METHODS:</w>
DESIGN /
DESIGN/ SETTING/PATIENT</w>
DESIG N-Open-label,</w>
DES- exposed,</w>
DES- based</w>
DES ;</w>
DENS PM;</w>
DENS PM/kg</w>
DENA- phenobarbital</w>
DEN/ PB-treated</w>
DEN/ PB,</w>
DEN- initiated,</w>
DEN- ,</w>
DEH P-exposed</w>
DE TC</w>
DE T</w>
DE SPM</w>
DE SAD</w>
DE S/kg</w>
DE S/g</w>
DE RS</w>
DE P,</w>
DE NA/kg</w>
DE NA,</w>
DE N.</w>
DE N-</w>
DE N+phenobarbital</w>
DE L</w>
DE L,</w>
DE K.</w>
DE K),</w>
DE IA)</w>
DE I,</w>
DE HP-treated</w>
DE FINITION:</w>
DE E),</w>
DE AE-
DEAE- Sephacel</w>
DE -based</w>
DE ),</w>
DDP+ P-induced</w>
DDP M,</w>
DD s)</w>
DD T-promoted</w>
DD S-treated</w>
DD S-induced</w>
DD S-associated</w>
DD R</w>
DD R)</w>
DD P.</w>
DD P-ADR</w>
DD NOS)</w>
DD M)</w>
DD L</w>
DD D.</w>
DD CI</w>
DD CI
DDCI -like</w>
DD AVP.</w>
DCX- positive</w>
DCE- T</w>
DCE P</w>
DCA- saline-treated</w>
DC- specific</w>
DC- MD</w>
DC F.</w>
DC F,</w>
DC C,</w>
DBP :</w>
DBP -induced</w>
DBA/2 )F1</w>
DBA/ 2,</w>
DBA/ 1</w>
DBA/ 1
DBA/1 J</w>
DBA- 2,</w>
DB cAMP</w>
DB V-apipuncture</w>
DB U,</w>
DB U's</w>
DB T),</w>
DB P)</w>
DB N-induced</w>
DB I</w>
DB H.</w>
DB H-independent</w>
DB E</w>
DB Ds</w>
DB A.</w>
DAV G(16)</w>
DAT was</w>
DAT .</w>
DAT -negative</w>
DAT -
DAT- binding</w>
DAT ,</w>
DAT ).</w>
DAB K-induced</w>
DAB -treated</w>
DAB ,</w>
DAB +
DAB+ TMX</w>
DA-8 15
DA-815 9,</w>
DA- transporter</w>
DA- stimulated</w>
DA- selective</w>
DA- receptor</w>
DA- ergic</w>
DA- GABA</w>
DA- D1/D2</w>
DA- 2</w>
DA- 2)</w>
DA s.</w>
DA THF)</w>
DA P.</w>
DA H.</w>
DA GO</w>
DA G</w>
DA -</w>
DA )-related</w>
D56 00)</w>
D5 W,</w>
D5 NS</w>
D5 NS),</w>
D5 600</w>
D3- protein.</w>
D3- hypercalcemic</w>
D3- based</w>
D3- administered</w>
D28 k</w>
D28 00)</w>
D2/ 5-HT2A</w>
D2- receptors</w>
D2- receptors.</w>
D2- fed</w>
D2- autoreceptor</w>
D2- Mtv7a/Ty</w>
D2 Rs</w>
D2 R-mediated</w>
D2 R)</w>
D2 )
D2) F2</w>
D1/ D2/D3</w>
D1/ D2-like</w>
D. H.</w>
D. E.</w>
D. C.</w>
D. C.,</w>
D-penicill amine--induced</w>
D-penicill amine).</w>
D-pen -treated</w>
D-pen -
D-pen- pulsed</w>
D-pen ,</w>
D-glutam ylaminomethyl</w>
D-glucar ates</w>
D-glucar ates,</w>
D-Trp6- luteinizing</w>
D-Trp6- LHRH,</w>
D-Trp-6- luteinizing</w>
D-Trp-6- LHRH,</w>
D-Trp 3,
D-Trp3, D-Arg
D-Trp3,D-Arg 6,
D-Trp3,D-Arg6, D-
D-Trp3,D-Arg6,D- Ala
D-Trp3,D-Arg6,D-Ala 10)</w>
D-Tic 7,</w>
D-Phe 7)
D-Phe7) BK</w>
D-Phe 2,</w>
D-Phe ),</w>
D-Leu (5)]enkephalin</w>
D-Glucar ates.</w>
D-Arg-(Hyp 2,</w>
D-Arg 0-
D-Arg0- [Hyp3,</w>
D-AP 7),</w>
D-AP 5,</w>
D-1 alpha-hydroxylase</w>
D-1 5,</w>
D-1 0)</w>
D- type</w>
D- tubocurarine</w>
D- tubocurarine-induced</w>
D- ring</w>
D- ribose</w>
D- regulated</w>
D- phenylalanine</w>
D- p-Cl-Phe1,2,</w>
D- myo-inositol-1-phosphate</w>
D- methamphetamine</w>
D- methamphetamine:</w>
D- isomers</w>
D- isomers,</w>
D- isomer.</w>
D- isomer,</w>
D- homocorticosteroid,</w>
D- glucose),</w>
D- glucarate</w>
D- gal).</w>
D- fucosidase,</w>
D- disopyramide,</w>
D- dipalmitoylphosphatidyl</w>
D- cysteine.</w>
D- cycloserine.</w>
D- carnitine</w>
D- associated</w>
D- aspartate</w>
D- amphetamine-induced)</w>
D- amino</w>
D- amino-8-D-arginine</w>
D- XO)</w>
D- STZ)</w>
D- SCLC).</w>
D- Penicillamine.</w>
D- Penicillamine-associated</w>
D- Pen2.5]-enkephalin</w>
D- Pen,</w>
D- PA.</w>
D- P),</w>
D- NATO</w>
D- NAME</w>
D- I),</w>
D- HD)</w>
D- GAMS)</w>
D- Dimers</w>
D- CS.</w>
D- CPPene,</w>
D- Asp
D-Asp )</w>
D- Amphetamine-induced</w>
D- Ala-Gly-
D-Ala-Gly- NMePhe-Met(O)-ol),</w>
D- AP-5</w>
D- AP-
D-AP- 5,</w>
D- AMP
D-AMP H.</w>
D- 99,</w>
D- 32,</w>
D- 25).</w>
D- 24-hydroxylase</w>
D- -,</w>
D, L(+/-)-INPEA</w>
D+ P</w>
D(3)- linked</w>
D(3)- expressing</w>
D(3) (-/-)</w>
D(3) (+/-)</w>
D(3) (+/+),</w>
D(3 )-</w>
D(2)/ D(1)</w>
D(2)- treated</w>
D(2)- like,</w>
D(2)- dosed</w>
D(2)- blocking</w>
D(2)- antagonist</w>
D(2) (+/+),</w>
D(1 )/
D(1)/ D(2)</w>
D(-)- INPEA</w>
D ysmenorrhoea</w>
D utta,</w>
D urie-Salmon</w>
D unnet</w>
D umex</w>
D sat-15</w>
D s).</w>
D rops</w>
D ress</w>
D r.</w>
D par</w>
D oxifluridine</w>
D ousa.</w>
D ormicum</w>
D oniach</w>
D one</w>
D ollars</w>
D ithiopurine</w>
D ickson-Glazer</w>
D hahran</w>
D er</w>
D entists</w>
D eniker).</w>
D en,</w>
D emulen</w>
D e-escalating</w>
D b-cAMP-induced</w>
D avid</w>
D aviaud</w>
D antroline</w>
D anger</w>
D actinomycin</w>
D abigatran</w>
D a)</w>
D [25(OH)D]</w>
D [1,25(OH)2D],</w>
D X)</w>
D UB</w>
D U</w>
D TBZ)</w>
D T</w>
D SI,</w>
D SE-associated</w>
D SA</w>
D PT)</w>
D PPH</w>
D PPH-scavenging</w>
D PO)</w>
D PH-treated</w>
D PH-induced</w>
D PH),</w>
D PA)</w>
D P/taxanes-containing</w>
D P-OAE</w>
D N)</w>
D MSA)</w>
D MR</w>
D MD.(ABSTRACT</w>
D MD,</w>
D LT,</w>
D L.</w>
D L)</w>
D KA.</w>
D KA,</w>
D Is</w>
D ITP</w>
D ISORDER</w>
D IP).</w>
D III-S4)</w>
D ID),</w>
D ICP</w>
D I-S4+L1308F</w>
D I,</w>
D GF,</w>
D G-5128</w>
D EC,</w>
D DS)</w>
D DE.</w>
D D)</w>
D CT
DCT 2,</w>
D CPP</w>
D CMP.</w>
D CM-
DCM- model</w>
D CF
DCF DA)</w>
D Ala
DAla 10
DAla10 ]-GnRH;</w>
D AN</w>
D AM
DAM GO</w>
D ADs</w>
D AD</w>
D AD
DAD -dependent</w>
D AC),</w>
D AB.</w>
D A2</w>
D ?</w>
D =
D= 2/
D=2/ 34;</w>
D :
D: 16.7%;</w>
D 8:</w>
D 7
D7 Mit285</w>
D 60,</w>
D 4-induced</w>
D 4).</w>
D 30
D30 %:</w>
D 3/
D3/ D2</w>
D 3'</w>
D 2/3</w>
D 2.5)</w>
D 19,</w>
D 17,</w>
D 16,</w>
D 12</w>
D 11,</w>
D 10.
D10. G4.1</w>
D 1-
D1- dopamine</w>
D 1)</w>
D 0,</w>
D 0)</w>
D .)</w>
D )],</w>
D (s)</w>
D (7)</w>
D (2).</w>
D (1),</w>
D (0)</w>
Cytox an</w>
Cytox an,</w>
Cytot oxic-induced</w>
Cytos pins</w>
Cytos olic</w>
Cytos keletal</w>
Cytos ine-arabinoside-induced</w>
Cytoarchitecton ics</w>
Cytoarchitecton ically,</w>
Cyto protective</w>
Cyto protection</w>
Cyto pathological</w>
Cyto kines</w>
Cyto kine-stimulated</w>
Cyto genetically</w>
Cyt openias</w>
Cyt olysis</w>
Cyt Flu</w>
Cystometro grams</w>
Cystometro gram</w>
Cysti tic</w>
Cyst otomy,</w>
Cyst oscopically,</w>
Cyst oscopic</w>
Cyst ometry</w>
Cys tic</w>
Cys A</w>
Cys A.</w>
Cypro hepatide</w>
Cyclospor ine-pancuronium</w>
Cyclophosphamide -treated</w>
Cyclophosphamide -evoked</w>
Cyclophosphamide -</w>
Cyclophosph amide-related</w>
Cyclo thymic</w>
Cyclo cytidine</w>
Cyclo benzaprine</w>
Cycl icity</w>
Cycl ical</w>
Cyc lopentenyl</w>
Cyc lizine</w>
Cyc lizine-induced</w>
Cyc le-control</w>
Cyc le-1</w>
CyA/ methylprednisolone</w>
CyA/ MTX,</w>
Cy tocochleograms</w>
Cy tidine</w>
Cy te)</w>
Cy steine)</w>
Cy s-Tyr-D:</w>
Cy perus</w>
Cy anotic</w>
Cy A:</w>
Cy A-treated</w>
Cy A).</w>
Cx AD</w>
Cx AD,</w>
Curren ts</w>
Cur ve;</w>
Cur ran</w>
Cur cumin,</w>
Cur ative</w>
Cumul atively,</w>
Cum mings,</w>
Cul ture</w>
Cul tivated</w>
Cul len</w>
Cub a,</w>
Cu/ Zn-superoxide</w>
Cu- loading</w>
Cu- deficient,</w>
Cu- Se)</w>
Cu, Zn-superoxide</w>
Cu, Zn-</w>
Cu ff</w>
Cu e-induced</w>
Cu ZnSOD</w>
Cu Zn</w>
Cu Zn-SOD</w>
Cu SO(4)</w>
Cu B.</w>
Cu ;</w>
Cu +
Cu+ Se),</w>
Cu ),</w>
Ctrl CE</w>
Ctrl CE,</w>
Ctr l,</w>
Ctr .</w>
CsA/ carboplatin</w>
CsA/ FK506-related</w>
CsA- prednisone</w>
CsA- pharmacokinetics</w>
CsA- associated</w>
CsA- PK.</w>
Cs Cl.</w>
Cs A-related</w>
Cs A
CsA 's</w>
Cs )/
Cs)/ HPF.</w>
Cs )--
Cs)-- can</w>
Cryst als</w>
Cryst alluria</w>
Cryst allization</w>
Crypt ogenic</w>
Crypt ococcal</w>
Cross- validation</w>
Cross- reaction</w>
Cro makalim</w>
Crl:CD (SD)</w>
Crl:CD (BR)</w>
Crl: CD</w>
Criter ia.</w>
Criter ia'.</w>
Cri xivan</w>
Cri tically,</w>
Cri mean-Congo</w>
Cres cent</w>
Cremoph or.</w>
Creat ine,</w>
Creat .</w>
Creat )</w>
Cre/ loxP</w>
Cre/ lox</w>
Cre dible</w>
Crack- cocaine</w>
Crack- cocaine,</w>
Crac k"</w>
Cra vings</w>
Cr ude</w>
Cr n,</w>
Cr j:CD-1</w>
Cr P-to-ATP</w>
Cr (ED
Cr(ED TA).</w>
Cp G</w>
Cp 50s</w>
Cox- proportional</w>
Cox- model</w>
Cox on,</w>
Coupl ing</w>
Counter clockwise</w>
Counter active</w>
Counter action</w>
Coun ty.</w>
Coun ting</w>
Coun t</w>
Coun seling</w>
Coumad in.</w>
Coumad in,</w>
Cot watch</w>
Cot rimoxazole,</w>
Cot inine,</w>
Cost ello,</w>
Cost all</w>
Cost a</w>
Cortis ol-induced</w>
Cortis ol,</w>
Cortico sterone</w>
Cortico steroids,</w>
Cortico steroid-</w>
Cortic otrophin</w>
Cortic al-evoked</w>
Corpor ation,</w>
Corpor ation)</w>
Corpor ation),</w>
Cordar one,</w>
Cor ynebacterium</w>
Cor ynanthe</w>
Cor ti,</w>
Cor tagine,</w>
Cor sodyl</w>
Cor related</w>
Cor rect</w>
Cor p)</w>
Cor onial</w>
Cor nu</w>
Cor nea</w>
Cor ding</w>
Copenhag en.</w>
Copenhag en-Irish</w>
Copenhag en,</w>
Cop tis</w>
Cop tidis</w>
Cop per-indomethacin</w>
Convul sivity</w>
Conver ted</w>
Conver gent</w>
Conven tional-dose</w>
Conven ience</w>
Control- withdrawal</w>
Control- recommended</w>
Control- Nicotine</w>
Control- ---
Control---- control;</w>
Control led-release</w>
Control led,</w>
Contro lling</w>
Contro l;</w>
Contribut ory</w>
Contribut ing</w>
Contri butions</w>
Contrast- medium-induced</w>
Contrast- media-induced</w>
Contrac tions</w>
Contrac tile</w>
Contrac eptives</w>
Contra indications</w>
Contr e</w>
Contr arily,</w>
Contr adictory</w>
Continuous- infusion</w>
Continu ously</w>
Cont ext-dependent</w>
Consul tation</w>
Consul tation-liaison</w>
Consul t,</w>
Constric tor</w>
Constric ting</w>
Consist ently,</w>
Consist ency</w>
Consec utively,</w>
Conner s,</w>
Connecticut ;</w>
Connecticut .</w>
Confir ming</w>
Condi tionally</w>
Condi tion,</w>
Conclu sively,</w>
Conclu sions</w>
Conclu sions:</w>
Conce ptuses</w>
Conce iving</w>
Conce ivably,</w>
Conce aled</w>
Con vection-enhanced</w>
Con us</w>
Con traction</w>
Con taining</w>
Con tact</w>
Con sumer</w>
Con stitutive</w>
Con sortium</w>
Con solidation</w>
Con scoius,</w>
Con ray</w>
Con ray,</w>
Con ners</w>
Con n</w>
Con junctivitis</w>
Con jugates</w>
Con golese</w>
Con flicting</w>
Con ducted</w>
Con ductance</w>
Con cordance</w>
Con centric</w>
Con centrating</w>
Computer ised</w>
Computer -
Computer- aided</w>
Compon ent</w>
Complic ations,</w>
Complic ating</w>
Comple xity</w>
Comple tion</w>
Comple mentary</w>
Comple ment-fixation</w>
Complain t</w>
Compan y;</w>
Compan y's</w>
Comp iling</w>
Comp ensatory</w>
Comp elling</w>
Comp any</w>
Commun itario</w>
Commun ication</w>
Common wealth</w>
Common ly,</w>
Committe e;</w>
Comb ined-modality</w>
Comb ined,</w>
Com promising</w>
Com posite,</w>
Com per.</w>
Com miphora</w>
Com mercially</w>
Com mand</w>
Com edication</w>
Com bretastatin</w>
Com a,</w>
Com Sim</w>
Columb us,</w>
Columb ia-Presbyterian</w>
Colon y-promoting</w>
Colo ur</w>
Colo stomy</w>
Colo mbia,</w>
Coll es'</w>
Coll ectively</w>
Coll agenase</w>
Col umnar</w>
Col loid</w>
Col laterals</w>
Col lateral</w>
Col itis</w>
Col d-water</w>
Col IV,</w>
Cogn izance</w>
Coffe y.</w>
Coffe e:</w>
Coffe e,</w>
Code ine-containing</w>
Code ine,</w>
Cock roft-Gault</w>
Cochran e,</w>
Cochran -Mantel-Haenszel</w>
Coch lea</w>
Cocaine/ heroin</w>
Cocaine/ crack</w>
Cocaine- specific</w>
Cocaine- seeking</w>
Cocaine- mediated</w>
Cocaine- kindled</w>
Cocaine- elicited</w>
Cocaine- decreased</w>
Cocaine- convulsed</w>
Cocaine- and-Amphetamine-Regulated</w>
Cocaine- alcohol</w>
Cocaine- addicted</w>
Coca ine.HCl</w>
Coca ine-treated</w>
Coca ethylene,</w>
Coc ulture</w>
Coc atropine</w>
Cob alt-60</w>
CoA- SH/acetyl-CoA</w>
Co-trimox azole,</w>
Co- therapy</w>
Co- morbidity,</w>
Co- morbid</w>
Co- injection</w>
Co- infusion</w>
Co- incubation</w>
Co- exposure</w>
Co- dosage</w>
Co- application</w>
Co wan</w>
Co w's</w>
Co variates</w>
Co variate</w>
Co ulter</w>
Co omb</w>
Co oley's</w>
Co ok</w>
Co ital</w>
Co ingestions</w>
Co incidentally</w>
Co incidentally,</w>
Co incidental</w>
Co incident</w>
Co incidence</w>
Co immunoprecipitation</w>
Co gwheel</w>
Co ggeshall</w>
Co exposure</w>
Co eliac</w>
Co de)</w>
Co at-Core</w>
Co ast</w>
Co ast,</w>
Co a</w>
Co Q</w>
Co P</w>
Co P,</w>
Co MFA</w>
Co F-treated</w>
Co A.</w>
Clozap ine:</w>
Cloti azepam</w>
Cloti azepam-induced</w>
Clostri dia</w>
Clopidogrel -induced</w>
Clopidogrel -associated</w>
Clop ine</w>
Clon ogenic</w>
Clon inger's</w>
Clon ing</w>
Clon idine-treated</w>
Clon idine-ephedrine</w>
Clon azepam-related</w>
Clon azepam,</w>
Clomi pramine,</w>
Clomi phene-induced</w>
Clobaz am,</w>
Clo zaril</w>
Clo tting</w>
Clo thiapine</w>
Clo sely</w>
Clo filium,</w>
Clo farabine</w>
Clo farabine-induced</w>
Clio quinol-treated</w>
Clinici ans'</w>
Clinici an's</w>
Clind amycin-induced</w>
Clin ics</w>
Clin icalTrials.</w>
Clin ic.</w>
Classi fying</w>
Classi fication.</w>
Classi fication,</w>
Classi c</w>
Clar ithromycin-associated</w>
Clar ithromycin,</w>
Clar ification</w>
Clar a</w>
ClBr s</w>
Cl-] in)</w>
Cl-BZ T),</w>
Cl- influx</w>
Cl- .</w>
Cl(-)- repleted</w>
Cl(-)- permeable</w>
Cl(-)- ATPase</w>
Cl in.</w>
Cl entiazem</w>
Cl cr</w>
Cl aw-like</w>
Cl avulanic</w>
Cl aviceps</w>
Cl ark-type</w>
Cl aims</w>
Cl aims-based</w>
Cl adina</w>
Cl )-
Cl)- proline</w>
Citalopram -associated</w>
Citalopram ,</w>
Cisplatin /5-FU</w>
Cisplatin -</w>
Cisplat in.</w>
Cisplat in-related</w>
Cisplat in)</w>
Cis- retinoic</w>
Cis- platinum</w>
Cis- platin</w>
Cirrho tic</w>
Circumst ances,</w>
Ciprofloxac in-related</w>
Ciprofloxac in-</w>
Ciprof loxacin.</w>
Cinacalce t-induced</w>
Cin tredekin</w>
Cimetid ine:</w>
Cimetid ine-treated</w>
Cimetid ine-dobutamine</w>
Cilost azol,</w>
Cil astatin</w>
Ci ticoline</w>
Ci proxifan,</w>
Ci guatoxin:</w>
Ci benzoline</w>
Ci ;</w>
Chronopharmac ology</w>
Chronopharmac ological</w>
Chron o",</w>
Chron ic-ouabain</w>
Chron ic,</w>
Chrom atographic</w>
Chrom atin</w>
Chore o-athetosis</w>
Chore a,</w>
Cholester yl</w>
Chol inergic-dopaminergic</w>
Chol ecystitis</w>
Chol angiopathy</w>
Cho king</w>
Cho ices</w>
Cho ice)</w>
Cho ay.</w>
Cho ),</w>
Chlorprop amide</w>
Chlorprop amide,</w>
Chlorpromaz ine:</w>
Chlorpromaz ine-N-oxide,</w>
Chloro zotocin:</w>
Chloro quine-treated</w>
Chloro phenyl)-2beta-(3-(4'-methylphenyl)-isoxazol-5-yl)tropane</w>
Chloro ethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea</w>
Chloro benzoyl-4-chloro-N-methyl-N</w>
Chloramphenic ol-induced</w>
Chloramphenic ol,</w>
Chlor promazine,</w>
Chlor phentermine</w>
Chlor pheniramine</w>
Chlor methiazole:</w>
Chlor inated</w>
Chlor alose</w>
Chlor -
Chlor- Trimeton</w>
Chinchill as</w>
Chinchill a</w>
Chin a).</w>
Children -Re
Children-Re vised)</w>
Children -R
Children-R evised</w>
Children -Pres
Children-Pres ent</w>
Children -
Children- Third</w>
Children )</w>
Children ).</w>
Child-P ugh-Turcotte</w>
Child -
Child- Global</w>
Chi r</w>
Chi asmal</w>
Chi ang</w>
Chi -squ
Chi-squ ared</w>
Chemotherapy- treated</w>
Chemotherapy- experienced</w>
Chemo therapy-related</w>
Chemo receptors</w>
Chemo kines</w>
Chemo kines,</w>
Chemo kine</w>
Chemo hormonal</w>
Chemo -
Chemo- naive</w>
Chemic als</w>
Chemic ally</w>
Chemic ally,</w>
Chemic al-associated</w>
Chem osensory</w>
Chem oconvulsants</w>
Chem o</w>
Chem .</w>
Chel ly</w>
Checklist-90- Revised</w>
Checklist-90- R,</w>
Checklist- 90</w>
Checklist- -
Checklist-- Community</w>
Check list/4-18</w>
Chec k-list</w>
Che yne-Stokes</w>
Che st-related</w>
Che monaive</w>
Che lidonine</w>
Charcot-M arie</w>
Characteris tically</w>
Char leston</w>
Char cot</w>
Chang es.</w>
Chang eover</w>
Chang e.</w>
ChE- Is.</w>
Ch ulalongkorn</w>
Ch ondrotoxicity</w>
Ch lormadinone</w>
Ch lamydia</w>
Ch k2,</w>
Ch itosan,</w>
Ch inese-language</w>
Ch ills,</w>
Ch ickens</w>
Ch i</w>
Ch ernoff</w>
Ch eng</w>
Ch atelut</w>
Ch ataway</w>
Ch at</w>
Ch asing</w>
Ch ase</w>
Ch arybdotoxin</w>
Ch arge</w>
Ch arge-transfer</w>
Ch aracter</w>
Ch antaburi,</w>
Ch annel</w>
Ch ang</w>
Ch andigarh.</w>
Ch ance</w>
Ch allenges</w>
Ch Cl.</w>
Ch 14.
Ch14. 18</w>
Ch )-stimulated</w>
Ch )-induced</w>
Ch ),</w>
Ceti rizine-induced</w>
Cetam olol:</w>
Cetam olol,</w>
Cervic ogenic</w>
Cerebro ventricular</w>
Cer tainly,</w>
Cer amide</w>
Cephalo thin</w>
Cephalo thin-induced</w>
Cephalex in-related</w>
Cephalex in-induced</w>
Ceph radine-induced</w>
Ceph otaxime-associated</w>
Ceph apirin</w>
Central- nervous-system</w>
Centr ally,</w>
Cent rocecal</w>
Cell ular,</w>
Cell C
CellC ept)</w>
Cell .</w>
Cell -mediated</w>
Cell -associated</w>
Ceftriax one.</w>
Ceftazidi me-related</w>
Ceftazidi me-induced</w>
Ceftazidi me,</w>
Cefotet an-dependent</w>
Cef uroxime</w>
Cef oxitin</w>
Cef oxitin-associated</w>
Cef otaxime</w>
Cef otaxime-induced</w>
Cef operazone</w>
Cef epime-related</w>
Cef azolin</w>
Cef azedone</w>
Ce sium</w>
Ce renkov</w>
Ce liprolol,</w>
Ce lebrex,</w>
Ce foselis</w>
Ce A.</w>
Ce (50)</w>
Cdkn2 c.</w>
Cdkn2 b,</w>
Cdkn1 c,</w>
Cdkn1 b,</w>
Cdkn 1a,</w>
Cc O.</w>
Caz enave</w>
Caz enae</w>
Cave olin-1alpha</w>
Cave olin-1,</w>
Cavalhei ro,</w>
Cavalhei ro's</w>
Caval ieri</w>
Caval heiro</w>
Cau tiously</w>
Catheter -related</w>
Cath olic</w>
Cath a</w>
Categor ical</w>
Catech olaminergic</w>
Catech olamine-</w>
Catech ol-O-methyl</w>
Cataton ia-like</w>
Cataton ia'</w>
Catalep sy--a</w>
Catal ase.</w>
Cat ovsky</w>
Cat nip</w>
Cat aracts</w>
Cat aplexy</w>
Cat ania</w>
Caspase- 3,</w>
Case- report</w>
Case- based</w>
Case- Control</w>
Cas pofungin</w>
Cas opitant</w>
Carvedi lol-mediated</w>
Carvedi lol,</w>
Carolin a;</w>
Carmofur ,</w>
Carmo fur</w>
Caref ully</w>
Care /
Care/ National</w>
Cardiomyo plasty</w>
Cardiomyo plasty,</w>
Cardiomyo pathic</w>
Cardiomy ocyte-specific</w>
Cardiomy ocyte-restricted</w>
Cardio vascular-related</w>
Cardio vascular,</w>
Cardi otoxicity,</w>
Cardi osympathetic</w>
Cardi omotor</w>
Cardi o-respiratory</w>
Cardi ff</w>
Cardi ac-source</w>
Carcin osarcoma</w>
Carcin omas</w>
Carcin ogenic</w>
Carcin ogenesis.</w>
Carbo prost</w>
Carbo platin-related</w>
Carbo hydrate</w>
Carbamazep ine-exacerbated</w>
Carbamazep ine-associated</w>
Carbamazep ine-</w>
Carbam yl</w>
Carbam ic</w>
Carb imazole-induced</w>
Carb idopa</w>
Carb apenems</w>
Carb achol-induced</w>
Car teolol,</w>
Car stairs</w>
Car rying</w>
Car rion</w>
Car rageenan</w>
Car r</w>
Car pinteria,</w>
Car pene</w>
Car pal</w>
Car minomycin</w>
Car dona</w>
Car betocin</w>
Captopri l.</w>
Captop ril-related</w>
Capsaicin- injected</w>
Capsaic in-related</w>
Capsaic in-</w>
Capecit abine.</w>
Capecit abine,</w>
Cap ture</w>
Cap sules</w>
Cap reomycin,</w>
Cap nocytophaga</w>
Cap gras-like</w>
Cap e</w>
Cap acity</w>
Cap ability</w>
Cannabin oids,</w>
Cannabin oid-mediated</w>
Cannab is-use</w>
Cann ulated</w>
Cann ulae</w>
Candi diasis.</w>
Candi dates</w>
Candi date</w>
CancerL it</w>
CancerL it,</w>
Canad a-Common</w>
Canad a)</w>
Campt ocormia,</w>
Cambodi a</w>
Cam perdown,</w>
Cam ellia</w>
Cam bridge,</w>
Califor nian</w>
Calcium- containing</w>
Calcium- binding</w>
Calcium- alkali</w>
Calcit riol-mediated</w>
Calcit onin,</w>
Calcineurin- inhibitor-based</w>
Calci uria</w>
Calci um,</w>
Calc ification</w>
Calbind in</w>
Calbind in,</w>
Cal retinin</w>
Cal orie</w>
Cal oric</w>
Cal modulin-related</w>
Cal if.)</w>
Cal andra,</w>
Caffe ine-related</w>
Caffe ine-</w>
Cab ergoline-induced</w>
Cab ergoline-associated</w>
Cab ergoline,</w>
CaMKII alpha(T286A)</w>
CaCl 2-</w>
CaCl 2-,</w>
CaCO 3)</w>
Ca2+/ ryanodine</w>
Ca2+/ parathyroid/bone</w>
Ca2+/ calmodulin-dependent</w>
Ca2+- sensitivity</w>
Ca2+- reducing</w>
Ca2+- permeable</w>
Ca2+- dependent,</w>
Ca2+- antagonists"</w>
Ca2+ Mg(2+)-ATPase</w>
Ca2+ -dependent</w>
Ca2+ -ATPase</w>
Ca2+ -</w>
Ca2 +)</w>
Ca2 (+)-
Ca2(+)- binding</w>
Ca/ g</w>
Ca/ Cr)</w>
Ca- dependent,</w>
Ca- blocker</w>
Ca- Mg-activated</w>
Ca- DTPA</w>
Ca- DTPA.</w>
Ca+ -ATPase</w>
Ca(2+)- uptake</w>
Ca(2+)- transport</w>
Ca(2+)- sensitizing</w>
Ca(2+)- sensitive</w>
Ca(2+)- handling</w>
Ca(2+)- free</w>
Ca(2+)- dependent,</w>
Ca(2+)- channel.</w>
Ca(2+)- binding</w>
Ca(2+)- ATPases</w>
Ca(2+)- ATPase-
Ca(2+)-ATPase- 1</w>
Ca(2+) ATPase</w>
Ca(2+) ATPase,</w>
Ca(2+ )/
Ca(2+)/ calmodulin-depent</w>
Ca(2+ ).</w>
Ca(2+ )-</w>
Ca(2+ ),</w>
Ca used</w>
Ca usal</w>
Ca ulophyllum</w>
Ca stration,</w>
Ca re,</w>
Ca proic</w>
Ca erulein</w>
Ca erulein,</w>
Ca HPO(4),</w>
Ca EDTA.</w>
Ca B
CaB P-immunoreactive</w>
Ca ATPase</w>
Ca 1</w>
Ca -activated</w>
Ca ),</w>
Ca (2</w>
Ca (2)</w>
Ca (+
Ca(+ +
Ca(++ )-dependent</w>
CZ P,</w>
CYSLT R2</w>
CYSLT R1</w>
CYP4 A3,</w>
CYP4 A,</w>
CYP3 A1</w>
CYP3 A.</w>
CYP3 A,</w>
CYP2J2* 7</w>
CYP2J2* 7,</w>
CYP2D6* 4,</w>
CYP2D6 B,</w>
CYP2C9* 2</w>
CYP2C8* 4</w>
CYP2C8* 3,</w>
CYP2C19* 2,</w>
CYP2C 9.</w>
CYP2C 9,</w>
CYP2C 11</w>
CYP2 E1</w>
CYP2 E1,</w>
CYP2 CMP.</w>
CYP2 C</w>
CYP2 C)</w>
CYP2 B.</w>
CYP1A2*1 F,</w>
CYP1A 2.</w>
CYP1A 2-
CYP1A2- independent</w>
CYP1A 2).</w>
CYP1A 1/2</w>
CYP- treatment,</w>
CYP ;</w>
CYP 1B1,</w>
CY LSTR1</w>
CY C</w>
CY C-induced</w>
CY A.</w>
CY A,</w>
CY -
CY- induced.</w>
CY ),</w>
CXCR 4+</w>
CXCL 1</w>
CXCL 1.</w>
CX7 17.</w>
CX7 17,</w>
CX- 39
CX-39 7,</w>
CX C</w>
CX 516</w>
CX 1</w>
CX 1),</w>
CX )).</w>
CV- S</w>
CV- ADRs,</w>
CV- ADR</w>
CV VH.</w>
CV ST</w>
CV S</w>
CV R)</w>
CV O.</w>
CV IB</w>
CV D?</w>
CV D,</w>
CV C</w>
CV C,</w>
CV B.</w>
CV B
CVB 3-</w>
CV A</w>
CV A.</w>
CV ;</w>
CV 7)</w>
CU P,</w>
CU +</w>
CTR-0 5:</w>
CTR-0 5,</w>
CTR L.</w>
CTR L,</w>
CTE PH</w>
CT- scans</w>
CT- scan.</w>
CT- guided,</w>
CT- defined</w>
CT- assessed</w>
CT s</w>
CT s).</w>
CT X.</w>
CT X)</w>
CT X).</w>
CT T.</w>
CT S,</w>
CT R)</w>
CT P:PA</w>
CT N</w>
CT LA4</w>
CT GF,</w>
CT D,</w>
CT CAE</w>
CT AP,</w>
CT 2),</w>
CT 00
CT00 60
CT0060 40
CT006040 19).</w>
CT -1.</w>
CT -1-mediated</w>
CT -1,</w>
CT -1
CT-1 -induced</w>
CT ),</w>
CSF s,</w>
CSF L.</w>
CSF );</w>
CS- heparan</w>
CS- US</w>
CS s:</w>
CS s,</w>
CS s).</w>
CS SEPs</w>
CS SEP</w>
CS SEP)</w>
CS Ps</w>
CS PH.</w>
CS P)</w>
CS P);</w>
CS G</w>
CS F/blood</w>
CS CA),</w>
CS A-based</w>
CS 2</w>
CS 2;</w>
CS 2-mediated</w>
CS 2,</w>
CS /
CS/ Ao</w>
CRL -1
CRL-1 572</w>
CRF9- 41</w>
CRF9- 41,</w>
CRF 2.</w>
CRF 2-mediated</w>
CRF (9
CRF(9 -4
CRF(9-4 1)</w>
CRF (2),</w>
CRE B,</w>
CRE -2
CRE-2 23</w>
CR- tablets.</w>
CR- tablets,</w>
CR- VPA.</w>
CR- P</w>
CR- AB
CR-AB L</w>
CR s.</w>
CR s,</w>
CR s),</w>
CR p</w>
CR ].</w>
CR USADE</w>
CR T-induced</w>
CR RT</w>
CR PC.</w>
CR P.</w>
CR P,</w>
CR H.</w>
CR H,</w>
CR F-41</w>
CR E</w>
CR D,</w>
CR 4)</w>
CR /
CR/ CRp</w>
CR -</w>
CR -,</w>
CR );</w>
CR )-induced</w>
CR )-containing</w>
CPZ MI</w>
CPZ MI-induced</w>
CPU2 28.</w>
CPT-P -1)</w>
CPT-11/ FU/LV</w>
CPT .</w>
CPOB OP)</w>
CPG :</w>
CPG 2</w>
CPG 2,</w>
CPF X.</w>
CPF X-induced</w>
CPE- C
CPE-C .(ABSTRACT</w>
CP94 25
CP9425 3,</w>
CP/ saline</w>
CP-101,60 6)</w>
CP- mediated</w>
CP- lesioned,</w>
CP- injected,</w>
CP- 99
CP-99 ,
CP-99, 994</w>
CP- 448
CP-448 ,
CP-448, 187</w>
CP u.</w>
CP u,</w>
CP ss(50)</w>
CP Z)</w>
CP VT,</w>
CP R,</w>
CP PN</w>
CP P.Furthermore,</w>
CP P.</w>
CP NN)</w>
CP N.</w>
CP M,</w>
CP K.</w>
CP H-only</w>
CP EC-induced</w>
CP DG2.</w>
CP CS</w>
CP CS,</w>
CP ;</w>
CP 55,9
CP55,9 40,</w>
CP -related</w>
CP +BIC,</w>
CP +
CP+ SKEO</w>
CP ).</w>
CP )-induced</w>
COX-2- immunoreactivity</w>
COX-2- derived</w>
COX- selective</w>
COX- activity,</w>
COX- I.</w>
COX- 2.</w>
COX IV</w>
COX III,</w>
COX II</w>
COX II,</w>
COX I,</w>
COX 2</w>
COX -associated</w>
COX -1,</w>
COSS- 96,</w>
COSS- 80</w>
CORM- 3.</w>
CORM- 3,</w>
CORM- 3)</w>
CONTROL-CA P,</w>
CONTROL-CA P);</w>
CONTEX T</w>
CONTE NT:</w>
CONCLU SION</w>
CONCLU DING:</w>
CON+ NS,</w>
CON+ HS</w>
CON .</w>
CON +H
CON+H S,</w>
COM POUNDS.</w>
COM MENTS:</w>
COL- 3.</w>
COL- 3,</w>
COL O</w>
COL 4A1</w>
COL -induced</w>
CO2- stimulation</w>
CO- depleted</w>
CO- curves</w>
CO- curve</w>
CO sm,</w>
CO mpared</w>
CO X,</w>
CO VA).</w>
CO UMARAN</w>
CO S-7</w>
CO R</w>
CO R),</w>
CO PRALL</w>
CO PA.</w>
CO OP</w>
CO MT/MAO</w>
CO MBINED</w>
CO Hb,</w>
CO G)</w>
CO FFI</w>
CO C,</w>
CO 8</w>
CO 4.</w>
CO 3)</w>
CO 2;</w>
CO 2:</w>
CO 2-induced</w>
CO 2-</w>
CO 2),</w>
CO 1B
CO1B 1)</w>
CO -</w>
CO )</w>
CO (2)-
CO(2)- LEPs</w>
CO (2))</w>
CNa ;</w>
CNa )/
CNa)/ Ccr</w>
CNa ).</w>
CNSB00 2.</w>
CNS- toxicity.</w>
CNS- symptoms</w>
CNS- symptoms.</w>
CNS- side</w>
CNS- depressant</w>
CNS- DA</w>
CNS ;</w>
CNS -related</w>
CNS -derived</w>
CNS ).</w>
CNI- induced,</w>
CNI- based</w>
CN- B12)</w>
CN V</w>
CN U,</w>
CN S:</w>
CN RG.</w>
CN Pase,</w>
CN Is,</w>
CN I-treated</w>
CN I-related</w>
CN I,</w>
CN ES.</w>
CN 5
CN5 A).</w>
CMV- seronegative</w>
CMT ;</w>
CMT 1A</w>
CMT 1,</w>
CMT 1
CMT1 X.</w>
CMR glc</w>
CMR Glu-18FDG)</w>
CMR G</w>
CMM L)</w>
CML- chronic</w>
CML- BSA</w>
CMF/ Adriamycin.</w>
CM V.Null)</w>
CM V.</w>
CM V-induced</w>
CM V)</w>
CM V).</w>
CM S</w>
CM L),</w>
CM G.</w>
CM B</w>
CM -related</w>
CM -mediated</w>
CLO F-type</w>
CLIN )</w>
CL218 ,
CL218, 872,</w>
CL r</w>
CL r,</w>
CL Z:</w>
CL V</w>
CL SI</w>
CL OF</w>
CL L.</w>
CL L,</w>
CL IP,</w>
CL IP),</w>
CL D=2/34;</w>
CL AD</w>
CL A),</w>
CL 1),</w>
CL .</w>
CL -6
CL-6 B</w>
CL ).</w>
CL (R)</w>
CK- MB,</w>
CK- ISO</w>
CK ]</w>
CK DH)</w>
CK D:</w>
CK D,</w>
CK A),</w>
CK ;</w>
CK 8-
CK8- containing</w>
CK 8,</w>
CIS3/SOCS-3/SSI -3</w>
CIS3/SOCS-3/SSI -3,</w>
CIS s,</w>
CIS 3,</w>
CIP- endorsing</w>
CIP- denying</w>
CIO MS</w>
CINC -1</w>
CIMD L</w>
CIMD L.</w>
CIC F</w>
CIC ,</w>
CI=22. 8-25.
CI=22.8-25. 7)</w>
CI=22. 5-
CI=22.5- 25.
CI=22.5-25. 3)</w>
CI=1. 24-
CI=1.24- 2.04,</w>
CI=1. 2-1.
CI=1.2-1. 6)</w>
CI= 8.4
CI=8.4 %-1
CI=8.4%-1 4.3%)</w>
CI= 7</w>
CI= 40</w>
CI= 39.
CI=39. 9%-
CI=39.9%- 68.
CI=39.9%-68. 7%).</w>
CI= 3.6-
CI=3.6- -1.
CI=3.6--1. 6).</w>
CI= 2</w>
CI= 28.
CI=28. 8%-
CI=28.8%- 58.6%)</w>
CI= 26.
CI=26. 7-
CI=26.7- 29.
CI=26.7-29. 7)</w>
CI= 25</w>
CI= 25.
CI=25. 2-
CI=25.2- 28.
CI=25.2-28. 2)</w>
CI= 18.
CI=18. 3--
CI=18.3-- 8.7).</w>
CI= 16.
CI=16. 8%-
CI=16.8%- 65.
CI=16.8%-65. 0%)</w>
CI= 14.
CI=14. 2%-
CI=14.2%- 2
CI=14.2%-2 0.5%)</w>
CI= 1.5-
CI=1.5- 2.9).</w>
CI= 1.0-1.
CI=1.0-1. 4)</w>
CI= 0.9
CI=0.9 6-1.
CI=0.96-1. 83%).</w>
CI= 0%-
CI=0%- 39.
CI=0%-39. 2%)</w>
CI: 1.06-1.
CI:1.06-1. 96).</w>
CI: 0.5-
CI:0.5- 8.5)</w>
CI-1 2.2%,</w>
CI- AmB</w>
CI- AmB.</w>
CI s,</w>
CI s)</w>
CI s).</w>
CI [1.20,</w>
CI V</w>
CI T</w>
CI ST)</w>
CI S),</w>
CI PS</w>
CI PN,</w>
CI Na)</w>
CI NV</w>
CI M).</w>
CI HA</w>
CI HA,</w>
CI E</w>
CI DP</w>
CI DI</w>
CI DI.</w>
CI B
CIB A)</w>
CI ACS</w>
CI ACS.</w>
CI ACS,</w>
CI =0.0
CI=0.0 4,</w>
CI 50</w>
CI -mediated</w>
CI ):</w>
CI )-
CI)- ALL</w>
CHX+ Pilo,</w>
CHO-K1/ human</w>
CHO-K1/ hERG</w>
CHO- THF</w>
CHO- THF)</w>
CHO R)</w>
CHO P.</w>
CHF3 38
CHF338 1,</w>
CHF s)</w>
CHF -related</w>
CH3- THF)</w>
CH3- B12)</w>
CH X.</w>
CH T,</w>
CH T)</w>
CH S</w>
CH R</w>
CH PA)</w>
CH P-pretreated</w>
CH OR</w>
CH OAY).</w>
CH O</w>
CH N).</w>
CH L</w>
CH L)</w>
CH H)</w>
CH F-free</w>
CH F).</w>
CH D.</w>
CH D).</w>
CH AD
CHAD S(2)</w>
CH 50,</w>
CH 3)</w>
CH 3
CH3 O)</w>
CH 2
CH2 O/(CH2O</w>
CH -
CH- ANH</w>
CH );</w>
CH )/
CH)/ wk</w>
CGS216 80</w>
CGS216 80.</w>
CGS216 80)</w>
CGS216 80
CGS21680 ]-mediated</w>
CGS -197
CGS-197 55</w>
CGS -19
CGS-19 75
CGS-1975 5,</w>
CGRP(8- 37),</w>
CGR P/SP</w>
CGR P-like</w>
CGR P-containing</w>
CGR P-LI</w>
CGR P)</w>
CGR P),</w>
CGP20712 A</w>
CGP20712 A,</w>
CGI- Severity</w>
CGI- S,</w>
CGI- I.</w>
CGI- I,</w>
CGI- C</w>
CGI- BP</w>
CG4 H</w>
CG4 H.</w>
CG VHD.</w>
CG I).</w>
CG D</w>
CG D,</w>
CG 370
CG370 3)</w>
CG -195
CG-195 2)</w>
CFU- S</w>
CFU- C</w>
CFM- 2-induced</w>
CFA- inflammation</w>
CFA- inflammation,</w>
CF SL.</w>
CF F</w>
CF C).</w>
CF B/
CFB/ kg</w>
CF A</w>
CF A.</w>
CF A)</w>
CF -induced</w>
CF )/kg</w>
CER s;</w>
CE SS):</w>
CE R</w>
CE Q,</w>
CE Q)</w>
CE I.</w>
CE I,</w>
CE E</w>
CE As</w>
CE A.</w>
CE ),</w>
CDP- alone,</w>
CDP- alone)</w>
CD8 +
CD8+ T</w>
CD7 1
CD71 posTer119pos</w>
CD45 RO</w>
CD45 RO-positive</w>
CD45 RA</w>
CD40- expressing</w>
CD40- CD40</w>
CD4+CD25 -</w>
CD4+CD25 +</w>
CD4+ T</w>
CD4 +/
CD4+/ CD8+</w>
CD4 +,</w>
CD4 (+),</w>
CD34 +/
CD34+/ CD
CD34+/CD 19-</w>
CD34 +
CD34+ cell</w>
CD15 4.</w>
CD15 4-
CD154- dependent.</w>
CD11b +)</w>
CD11b (+)),</w>
CD11a +,</w>
CD11a (+),</w>
CD11 b/CD18</w>
CD11 b,</w>
CD-8 32.</w>
CD-8 32,</w>
CD- elicited</w>
CD T</w>
CD T)</w>
CD RS</w>
CD R</w>
CD L)</w>
CD H.</w>
CD F</w>
CD F-1</w>
CD DP/taxanes-containing</w>
CD DP-induced</w>
CD DP-containing</w>
CD C
CDC 's</w>
CD 8</w>
CD 8)</w>
CD 68</w>
CD 5</w>
CD 54)</w>
CD 50s</w>
CD 50.</w>
CD 50,</w>
CD 50's</w>
CD 41</w>
CD 39</w>
CD 33-
CD33- positive</w>
CD 31)</w>
CD 31),</w>
CD 31
CD31 +</w>
CD 3-</w>
CD 3+</w>
CD 2</w>
CD 20-
CD20- positive</w>
CD 2
CD2 F1/Crl</w>
CD 19
CD19 +,</w>
CD 18)</w>
CD 18).</w>
CD 16
CD16 b)</w>
CD 15</w>
CD 14.</w>
CD 10</w>
CD 10
CD10 +,</w>
CD 00
CD00 12</w>
CD -</w>
CCl 4-
CCl4- post-treatment</w>
CCl 4,</w>
CCl (4)</w>
CCl (4).</w>
CCl (4),</w>
CCl (4
CCl(4 )-induced</w>
CCR2- labeling</w>
CCR2- labeled</w>
CCR 8.</w>
CCR 7-10,</w>
CCR 2.</w>
CCR 2+</w>
CCO OH))</w>
CCNU -associated</w>
CCN U-adriamycin</w>
CCK-8- NS.</w>
CCK-8- NS,</w>
CCK- elicited</w>
CCK- antagonists</w>
CCK- 5</w>
CCK- 5-
CCK-5- 8,</w>
CCK- 2-8</w>
CCK- ,</w>
CCK B</w>
CCK B-receptor</w>
CCK (B
CCK(B )-receptors</w>
CCG I)</w>
CCG 1)</w>
CCG -195
CCG-195 2.</w>
CCB s,</w>
CCB s)</w>
CCB s),</w>
CCB -induced</w>
CC s)</w>
CC V)</w>
CC U,</w>
CC PA.</w>
CC PA-elicited</w>
CC MA.</w>
CC MA,</w>
CC KA</w>
CC K,</w>
CC GRP</w>
CC GRP)</w>
CC G-I:</w>
CC F-induced</w>
CC E</w>
CC E),</w>
CC D)</w>
CC /
CC/ CNS</w>
CBZ-10,11- epoxide</w>
CBZ-10,11- epoxide,</w>
CBZ- treatment,</w>
CBZ- E:carbamazepine</w>
CBZ -10,</w>
CBZ 's</w>
CBFrest)/ CBFrest
CBFrest)/CBFrest /
CBFrest)/CBFrest/ mm</w>
CBFrest)/ CBF
CBFrest)/CBF rest</w>
CBF hypotension)</w>
CBF hypercapnia)</w>
CBF V</w>
CBF (mca))</w>
CBD L</w>
CBD CA.</w>
CBD CA
CBDCA -</w>
CBD ;</w>
CBA/ J,</w>
CB1- receptor-positive</w>
CB1- receptor-expressing</w>
CB1- immunostained</w>
CB(1)- selective</w>
CB(1)- knock-out</w>
CB s</w>
CB s),</w>
CB Z;</w>
CB Z).</w>
CB V.</w>
CB T+CM</w>
CB P)</w>
CB IR.</w>
CB IR-treated</w>
CB F).</w>
CB C,</w>
CB 2-selective</w>
CB 2,</w>
CB 11),</w>
CB 1/
CB1/ CB2</w>
CB 1).</w>
CB -</w>
CB -,</w>
CB ,</w>
CB ),</w>
CB (2).</w>
CB (2),</w>
CB (1/2)</w>
CB (1)/
CB(1)/ CB(2)</w>
CB (1),</w>
CAV B.</w>
CAV B,</w>
CART- positive</w>
CART- containing</w>
CARE T.</w>
CAR +
CAR+ DOX,</w>
CAM )-1,</w>
CAH- unaffected</w>
CAH- affected</w>
CAF F,</w>
CADASI L</w>
CADASI L,</w>
CAD SS</w>
CA3= 70.1</w>
CA3= 63.5</w>
CA3= 38.1</w>
CA3- septum</w>
CA1= 74.3</w>
CA1= 53.2</w>
CA1- subiculum-CA1</w>
CA1- CA3</w>
CA1- 3.</w>
CA(3 b).</w>
CA(3 a)</w>
CA V</w>
CA USE</w>
CA U</w>
CA U.</w>
CA U,</w>
CA TS,</w>
CA TRs,</w>
CA T)</w>
CA T).</w>
CA SES:</w>
CA RT42-89</w>
CA RAF</w>
CA R;</w>
CA R-3)</w>
CA PIT</w>
CA PE,</w>
CA P;</w>
CA P-</w>
CA P,</w>
CA P)</w>
CA P).</w>
CA Ms</w>
CA MP-PDIE</w>
CA MK2B)</w>
CA LM2,</w>
CA Is</w>
CA GE</w>
CA GE,</w>
CA GA</w>
CA G</w>
CA F.</w>
CA F),</w>
CA ELYX</w>
CA E.</w>
CA DSS),</w>
CA DO-elicited</w>
CA DO)</w>
CA D;</w>
CA B.</w>
CA B-
CAB- related,</w>
CA B,</w>
CA AT</w>
CA ACS.</w>
CA A.</w>
CA A-induced</w>
CA A-associated</w>
CA 3;</w>
CA 3)</w>
CA 3
CA3 c/CA4</w>
CA 2/3</w>
CA 2.</w>
CA 2,</w>
CA 2+</w>
CA 1/
CA1/ CA3</w>
CA -1)</w>
CA (3)</w>
C> Tins</w>
C> T</w>
C57Bl/10 -associated</w>
C57Bl/ 6J,</w>
C57BL/6J Bk</w>
C57BL/6J :
C57BL/6J: DBA/2J</w>
C57BL/6J ),</w>
C57BL/6 NCr1BR</w>
C57BL/6 )F1</w>
C57BL/6 (J
C57BL/6(J A
C57BL/6(JA X)</w>
C57BL/10 J</w>
C57BL/10 B
C57BL/10B g</w>
C57BL/ 6-
C57BL/6- TgN[SOD1]3Cje</w>
C57B1/ 6J</w>
C57B I/6J</w>
C57B 1</w>
C57/B l6</w>
C57 /
C57/ 6</w>
C4/ D4</w>
C4/ D4).</w>
C4 A</w>
C4 3
C43 2A</w>
C3H/He J,</w>
C3H/ J,</w>
C3H/ He,</w>
C3H PG),</w>
C3 c</w>
C3 a</w>
C3 +/+</w>
C3 )-
C3)- I</w>
C2- epimer,</w>
C2- ceramide</w>
C2- cer</w>
C2- cer-treated</w>
C/ T</w>
C/ T),</w>
C/ SH</w>
C/ S;</w>
C/ S,</w>
C/ MS/MS).</w>
C/ MS).</w>
C/ MA;</w>
C/ MA,</w>
C/ I,</w>
C/ EC)</w>
C/ EBP</w>
C/ C;</w>
C/ C677T</w>
C/ C,</w>
C/ 2B</w>
C.I. =1.
C.I.=1. 16-
C.I.=1.16- 5.4
C.I.=1.16-5.4 7.</w>
C.I. :</w>
C.I .)</w>
C.I .),</w>
C. P.I.B.</w>
C. F.</w>
C. C.F.</w>
C-312 60)</w>
C- units.</w>
C- sires,</w>
C- section</w>
C- peptide</w>
C- nucleoside</w>
C- nociceptors.</w>
C- nemonapride</w>
C- mediated</w>
C- l</w>
C- jun</w>
C- infected</w>
C- hydroxylation,</w>
C- groups.</w>
C- group</w>
C- folate)</w>
C- fibres,</w>
C- fibres)</w>
C- fibre-induced</w>
C- fibers,</w>
C- cells.</w>
C- alpha</w>
C- alpha,</w>
C- X-C</w>
C- VM),</w>
C- SOD)</w>
C- Quens</w>
C- PUFA)</w>
C- NCI</w>
C- LEP</w>
C- Irish</w>
C- IMPPA</w>
C- HUS.</w>
C- B)</w>
C- ANCA</w>
C- AI
C-AI B)</w>
C- A-
C-A- C:</w>
C- 90
C-90 89)</w>
C- 7</w>
C- 5</w>
C- 53)</w>
C- 4</w>
C- 480</w>
C- 30</w>
C- 3)</w>
C- 26).</w>
C- 239</w>
C- 2
C-2 )/
C-2)/ vesicular</w>
C- 001).</w>
C(s s)(max)</w>
C' 4</w>
C z</w>
C yp1a2-null</w>
C ynomolgus</w>
C w4</w>
C w4,</w>
C utting</w>
C ustomary</w>
C ushingoid</w>
C ue</w>
C ubic</w>
C rofton</w>
C ricetulus</w>
C res,</w>
C rataeva</w>
C pss</w>
C ovic</w>
C osopt</w>
C osinor</w>
C orman,</w>
C operative</w>
C ologne,</w>
C ocarcinogenic</w>
C max/EC50</w>
C max)</w>
C losure</w>
C loser</w>
C lorozotocin</w>
C lorazepate</w>
C limacteric</w>
C lexane</w>
C lefts,</w>
C left</w>
C leavage</w>
C lamp</w>
C itrulline</w>
C itations,</w>
C itation</w>
C isternal</w>
C ine-gated</w>
C in</w>
C iclosporin</w>
C iba-Geigy's</w>
C how</w>
C horioamnionitis</w>
C hiba</w>
C hen</w>
C hemoradiotoxicity-associated</w>
C hai-Hu-Gui-Zhi-Gan-Jiang-Tang</w>
C gamma</w>
C fibers</w>
C erebri</w>
C epsilon</w>
C enter)</w>
C ensoring</w>
C enedela,</w>
C el)</w>
C edars-Sinai</w>
C e)</w>
C d</w>
C b)</w>
C ayama</w>
C aspase</w>
C antor)</w>
C anthotomy</w>
C analicular</w>
C ampylobacter</w>
C aguas,</w>
C admium-exposed</w>
C aco-2</w>
C achectic</w>
C X</w>
C WM</w>
C UD.</w>
C U</w>
C U.</w>
C ST),</w>
C SRT.</w>
C SE.</w>
C SE,</w>
C Q]</w>
C Q-induced</w>
C Q,</w>
C PO2)</w>
C PAP.</w>
C PAP)</w>
C PAH</w>
C PA)</w>
C Na/Ccr</w>
C MA,</w>
C In</w>
C In,</w>
C HCl3,</w>
C ER.</w>
C ER,</w>
C EEG.</w>
C ECF-AM)</w>
C CSs,</w>
C CIP</w>
C CA,</w>
C 9
C9 57
C957 T</w>
C 8).</w>
C 7-
C7- T1</w>
C 7).</w>
C 6</w>
C 6;</w>
C 6-
C6- type</w>
C 5V</w>
C 5</w>
C 52</w>
C 5
C5 b-9</w>
C 48/
C48/ 80-
C48/80- cimetidine.</w>
C 4-7</w>
C 3-/-</w>
C 2C12</w>
C 20).</w>
C 2.</w>
C 19
C19 H18O8.</w>
C 18</w>
C 14,</w>
C 10),</w>
C 1-
C1- AD
C1-AD O)</w>
C 02</w>
C 0,</w>
C -1</w>
C ):</w>
C )-</w>
C )-
C)- Pentazocine-treated</w>
C (max).</w>
C (max),</w>
C (P).</w>
C (6
C(6 0)</w>
C (-)
C(-) P(+)</w>
Bv 8.</w>
Bv 8-
Bv8- responsive</w>
Bv 8,</w>
But ts</w>
But aclamol</w>
Busulf an-cyclophosphamide</w>
Bus ulphan</w>
Bus s-Durkee</w>
Bus pirone-treated</w>
Bus chke</w>
Bus ch-Rossnagel,</w>
Burkit t</w>
Burkit t-type</w>
Bur ning</w>
Bur den</w>
Bur chiel</w>
Bur ch</w>
Bupropi on-treated</w>
Buprenorph ine-soaked</w>
Buprenorph ine's</w>
Bup ranolol</w>
Bul letin.</w>
Bul imia,</w>
Bul bar</w>
Buff ering</w>
Buerg er's</w>
Bud apest,</w>
Buc olome</w>
Buc olome,</w>
Bu thionine</w>
Bu n</w>
Bu metanide</w>
Bu enos</w>
Bu desonide</w>
Bu 4Cy
Bu4Cy 2</w>
Bu )</w>
Bt x)</w>
Brown- S</w>
Brown- Norway-Katholiek</w>
Brown- Goodwin</w>
Bronch odilator</w>
Bronch odilation</w>
Bronch odilatation</w>
Bronch iolitis</w>
Bromocript ine-associated</w>
Bromo fosfamides,</w>
Brom ocryptin</w>
Brom ocryptin.</w>
Brom age.</w>
Bro modeoxyuridine-(BrdU)</w>
Bro mazepam</w>
Bro mazepam.</w>
Bro mazepam-induced</w>
Bro ken</w>
Bro ck</w>
Bro ca.</w>
Bro ad-spectrum</w>
Brn-3 a.</w>
Brit ain,</w>
Brisb ane.</w>
Brisb ane-based</w>
Brisb ane,</w>
Bri xton</w>
Bri dging</w>
Bri dgewater,</w>
Breath ing</w>
Breath -
Breath- holding</w>
Break down</w>
Bre vifolia,</w>
Bre vibacterium</w>
Bre eding</w>
BrdU- pulsed</w>
BrdU- immunoexpressions</w>
Brd U/GFAP</w>
Brd U-</w>
Braz il</w>
Brady kinin-induced</w>
Brady cardiac</w>
Brady arrhythmias</w>
Brady arrhythmias,</w>
Bra in.</w>
Bra in-specific</w>
Bra in-derived</w>
Bra in-damaged</w>
Bra in,</w>
Br- cGMP,</w>
Br- LIS)</w>
Br s)--selected</w>
Br c</w>
Br Ca.</w>
Br Ca,</w>
Br .</w>
Br ,</w>
Bow man</w>
Botul ism</w>
Botul ism,</w>
Bos entan.</w>
Bos entan,</w>
Bos ch)</w>
Bortezomib -associated</w>
Bortezomib 's</w>
Bor naprolol</w>
Bor ing'</w>
Bor amae</w>
Bonferron i's</w>
Bonfer oni</w>
Bomb ay</w>
Body builders</w>
BoNT/ A.</w>
BoNT/ A-treated</w>
BoNT/ A-injected</w>
BoNT/ A,</w>
BoNT -
BoNT- A,</w>
Bo yden</w>
Bo ucherville,</w>
Bo s</w>
Bo oster</w>
Bo NT</w>
Blu es</w>
Blu es)</w>
Blu es"</w>
Blu es".</w>
Blu e-Albumin</w>
Blu e)</w>
Blood- pressure</w>
Blo ts</w>
Blo tchy</w>
Blo t)</w>
Blo ods</w>
Blo od,</w>
Blo m,</w>
Blo ating,</w>
Blind ness</w>
Blind ed</w>
Ble eding,</w>
Bl urred</w>
Bis phosphonate-exposed</w>
Bis ome)</w>
Bis muth-containing</w>
Bis hop</w>
Bis (mono
Bis(mono acylglycero)phosphate,</w>
Bir mingham</w>
Bir mingham.</w>
Biperid en-induced</w>
Biperid en,</w>
Biop sy-proved</w>
Biochem ,</w>
Bio tin</w>
Bio physical</w>
Bio phys.</w>
Bio identical</w>
Bio distribution</w>
Bio degradable</w>
Bio behav.</w>
Bio assay-guided</w>
Bio -G
Bio-G el</w>
Bin aural</w>
Bimoclo mol.</w>
Bilirub in.</w>
Bilirub in),</w>
Bifid a</w>
Bifid a,</w>
Bifen thrin</w>
Bicucul line-induced</w>
Bic yclo(2,2,1)heptane-2-endo-3-endo-dicarboximido]-glutarimide</w>
Bibli ographical</w>
Bibli ographic</w>
Bi weekly</w>
Bi ventricular</w>
Bi valirudin,</w>
Bi parietal</w>
Bi osystems,</w>
Bi omicroscopy</w>
Bi ometer,</w>
Bi omedical</w>
Bi oluminescence</w>
Bi ochim.</w>
Bi er's</w>
Bi asing</w>
Bi ases</w>
Bi as,</w>
Bi PN-reducing</w>
Bi PN,</w>
Bi -
Bi- weekly</w>
Bezold- Zarisch</w>
Bezol d)</w>
Bezafib rate</w>
Bezafib rate-induced</w>
Bev antolol's</w>
Between- subject</w>
Bethan echol</w>
Beta-endorph in/defensiveness</w>
Beta-endorph in-immunoreactive</w>
Beta- methyl-iodophenyl</w>
Beta- endorphin</w>
Beta- antagonists</w>
Beta- agonists</w>
Beta- adrenoreceptor</w>
Beta- adrenoceptor-blockers</w>
Beta- Carotene</w>
Beta- Adrenoceptor</w>
Beta- 2</w>
Beta- 2-adrenoceptor-mediated</w>
Bet amethasone-induced</w>
Beren son</w>
Beren s</w>
Ber tazzoli</w>
Ber ne</w>
Ber lin.</w>
Ber kowitz</w>
Bepri dil,</w>
Benzyl acyclouridine</w>
Benzodiazep ine-induced</w>
Benzodiazep ine-</w>
Benzer azide</w>
Benzer azide.</w>
Benz yl</w>
Benz oylecgonine</w>
Benz hydramine</w>
Benflu orex:</w>
Benefit :
Benefit: Risk</w>
Benefit -
Benefit- Risk</w>
Bene ath</w>
Bend s,</w>
Bend ectin.</w>
Bend ectin-treated</w>
Ben in</w>
Ben ign,</w>
Ben fotiamine</w>
Belgi um,</w>
Bel levue</w>
Bel grade.</w>
Beij ing's</w>
Behavi ours</w>
Behavi oural,</w>
Behavi our</w>
Behavi orally</w>
Behavi or,</w>
Beh enoyl</w>
Bech -6</w>
Bec k's</w>
Bec ause,</w>
Be utler's</w>
Be low-knee</w>
Be hav.</w>
Be aurepaire</w>
Be ComSim</w>
Be Ch</w>
Bcr p.</w>
Bcr p,</w>
Bcl-x L,</w>
Bcl-x (L
Bcl-x(L )/
Bcl-x(L)/ kanamycin</w>
Bcl- X(L))</w>
Bcl- 2/
Bcl-2/ Bax</w>
Bcl- 2).</w>
Bcl 2-
Bcl2- like</w>
Bc 1-2</w>
Bc 1-
Bc1- 2.</w>
Bazet t</w>
BayK- 8644
BayK-8644 :</w>
Bay lor</w>
Bay er</w>
Bay er),</w>
Bax .</w>
Bax -to-
Bax-to- Bcl-2</w>
Bax )</w>
Basi liximab,</w>
Basi c,</w>
Basel ines</w>
Basel ine,</w>
Basel ]</w>
Bas edow-Graves'</w>
Bas e),</w>
Bartter 's-like</w>
Bart ter-syndrome-like</w>
Baro reflex-sympathoneural</w>
Baro reflex-mediated</w>
Baro reflex-linked</w>
Baro reflex,</w>
Baro receptors</w>
Baro receptor-heart</w>
Bark ley</w>
Bark ley's</w>
Barbit urate-mediated</w>
Barb otage'</w>
Barb aro</w>
Bar ring</w>
Bar rett's</w>
Bar rel</w>
Bar ratt</w>
Bar rat</w>
Bar beito-Lopez</w>
Bangko k.</w>
Bangk ok</w>
Bangk ok)</w>
Ban ks</w>
Ban deiraea</w>
Bam buterol,</w>
Ballo oned</w>
Balb/ c-associated</w>
Balb/ C</w>
Balb C</w>
Balb -
Balb- c</w>
Bal salazide-induced</w>
Bal b</w>
Bal ancing</w>
Bal ance</w>
Bad )</w>
Bad "</w>
Baclofen -</w>
Backgro und.</w>
Backgro und-subtracted</w>
Bac opa.</w>
Bac kstrom,</w>
Bac igalupo</w>
Babinsk i's</w>
Bab inksi</w>
Bab ies</w>
Bab cock</w>
BaCl (2).</w>
BZ s.</w>
BZ s,</w>
BZ D-receptor</w>
BZ D)</w>
BZ ),</w>
BXL 74
BXL74 6.</w>
BW373U 86,</w>
BW 7
BW7 55
BW755 C</w>
BW /day,</w>
BW /
BW/ 3</w>
BUd R.</w>
BUd R-induced</w>
BUd R,</w>
BUP- intoxicated</w>
BUP- attenuated</w>
BUN /creatinine</w>
BUN .</w>
BU P-related</w>
BU P-induced</w>
BU B</w>
BU B,</w>
BU .</w>
BT4 AN</w>
BT X)</w>
BT P.</w>
BT C-001).</w>
BT B</w>
BT 2</w>
BT ).</w>
BSI F.</w>
BSI .</w>
BSEP- mediated</w>
BSE Q.</w>
BSC -1</w>
BS Q,</w>
BS O)</w>
BS A.</w>
BS A,</w>
BRL35 135,</w>
BRL 44
BRL44 40
BRL4440 8,</w>
BRAC- remeasured</w>
BRAC- detected</w>
BR- 93
BR-93 1)</w>
BR- 350)</w>
BR ]</w>
BR M-induced</w>
BR M,</w>
BR CA-1</w>
BR AC.</w>
BQ78 8.</w>
BQ78 8,</w>
BQ O)</w>
BQ 788</w>
BQ 12
BQ12 3,</w>
BPR Sd</w>
BPR S,</w>
BPA A.</w>
BP/ hypertension."</w>
BP/ hypertension,"</w>
BP/ diastolic</w>
BP s.</w>
BP V</w>
BP N.</w>
BP N,</w>
BP C,</w>
BP B).</w>
BP 89
BP89 7.</w>
BP 12/
BP12/ 12.
BP12/12. 6)</w>
BP -1)</w>
BOF- A2</w>
BOF- A2,</w>
BO T</w>
BO T-2,</w>
BO OH,</w>
BO O.</w>
BO LD-MRI</w>
BO CS)</w>
BO CS),</w>
BN520 21.</w>
BMY-4048 1-induced</w>
BMY-4048 1,</w>
BMS-181 174.</w>
BMIP P,</w>
BMIP P),</w>
BMA H.</w>
BM+ peripheral</w>
BM Y</w>
BM SC</w>
BM PR-II</w>
BM P)</w>
BM I:</w>
BM I-matched</w>
BM C.</w>
BM C,</w>
BM :</w>
BLA- CeA</w>
BLA- CeA.</w>
BL-MaTU/ s6,</w>
BL-MaTU/ A1</w>
BL-10 20,</w>
BL 60,</w>
BL 6)</w>
BL 40-
BL40- BL60,</w>
BK- elicited</w>
BK- antagonist</w>
BK- ,</w>
BK -like</w>
BIP N,</w>
BIO SIS</w>
BIIB7 23.</w>
BIIB7 23)</w>
BID ]</w>
BID ).</w>
BHT/ kg/day)</w>
BHT/ kg),</w>
BHT- 920</w>
BHT- 920-induced</w>
BH- AC,</w>
BH s)</w>
BH A-</w>
BH ;</w>
BF I,</w>
BF C).</w>
BF :</w>
BEAC OPP,</w>
BE SC</w>
BE R)</w>
BE P)</w>
BE A),</w>
BD100 8,</w>
BD10 47.</w>
BD10 47)</w>
BD s)</w>
BD S).</w>
BD L),</w>
BD I-13</w>
BD F</w>
BD -1
BD-1 407</w>
BCh E.</w>
BCPT-P -1,</w>
BCNU +
BCNU+ TMZ</w>
BCN U-exposed+melatonin-treated.</w>
BCN U)</w>
BB- 94.</w>
BB+ ARB</w>
BB+ ARB.</w>
BB S,</w>
BB N;</w>
BB N.</w>
BB BD</w>
BB B
BBB M)</w>
BB ),</w>
BALB/c J,</w>
BALB/c An
BALB/cAn Ncrj</w>
BALB/ c,</w>
BAL B,</w>
BAE R</w>
BACKGROUND/ OBJECTIVE:</w>
BAC ),</w>
BA SE-CASE</w>
BA PTA-AM,</w>
BA EPs</w>
BA EPs;</w>
BA 9</w>
BA 24</w>
BA 24.</w>
BA );</w>
B6NH sd</w>
B6NH sd,</w>
B6NCr l,</w>
B6NCr l)</w>
B6C3 F1)</w>
B6 XD2</w>
B6 JOla</w>
B6 D2</w>
B6 C3</w>
B6 :</w>
B6 63)</w>
B56 30</w>
B56 30.</w>
B2 R</w>
B2 R)</w>
B2 KO,</w>
B12- vitamin</w>
B12- malabsorption</w>
B12- deficiency</w>
B12- associated</w>
B10D2/ old</w>
B10D2/ o</w>
B1 b</w>
B1 a</w>
B1 R(-/-)</w>
B1 )-mediated</w>
B/ W</w>
B/ L</w>
B/ C</w>
B/ C,</w>
B/ AP-1</w>
B/ 1D-
B/1D- agonist)</w>
B. W.)</w>
B. I.D.</w>
B. D.H.</w>
B-24 13)</w>
B- subunit</w>
B- pretreated</w>
B- mode</w>
B- lactam</w>
B- labeled</w>
B- infected</w>
B- T)</w>
B- PS)</w>
B- LDL</w>
B- E</w>
B- 94),</w>
B) induced</w>
B) R).</w>
B(t)dt/B(t ).</w>
B(t)dt/B(t ),</w>
B(t )dt/
B(t)dt/ B(t)</w>
B z</w>
B w35</w>
B ureau.</w>
B ultmann</w>
B ull</w>
B ucindolol</w>
B s</w>
B ronchoalveolar</w>
B rof,</w>
B rodmann</w>
B righton</w>
B righam</w>
B regma</w>
B ox-Jenkins</w>
B outs</w>
B oundaries</w>
B ound</w>
B otox-treated</w>
B ony</w>
B onadonna</w>
B odily</w>
B listers</w>
B linking-blepharospasm</w>
B link</w>
B lepharoconjunctivitis,</w>
B lastocysts</w>
B ladder,</w>
B lacks</w>
B lack,</w>
B l.</w>
B itter</w>
B itemporal</w>
B illroth</w>
B ielschowsky-stained</w>
B id</w>
B id.</w>
B ic</w>
B hargava</w>
B ge.,</w>
B fArM</w>
B f,</w>
B etaxolol,</w>
B enschop,</w>
B engal</w>
B elatacept</w>
B earing</w>
B atimastat</w>
B arkeley</w>
B arium-supplemented</w>
B allistic</w>
B allard's</w>
B all's</w>
B aghdad</w>
B ad.</w>
B actrim</w>
B abor's</w>
B aboon</w>
B abol,</w>
B ]).</w>
B Y.</w>
B VR.</w>
B VAS,</w>
B V/TV</w>
B SA),</w>
B S:</w>
B RIEF</w>
B REM)</w>
B RE-26,</w>
B PT:</w>
B PH;</w>
B PD.</w>
B PC.(ABSTRACT</w>
B P-lowering</w>
B ORG</w>
B OR</w>
B OR.</w>
B O,</w>
B NP).</w>
B NK</w>
B NA</w>
B N-50730-(PAF</w>
B MTs</w>
B MT/HSCT</w>
B MPs</w>
B LOCKING</w>
B IS:</w>
B IIE0246</w>
B IIE0246.</w>
B IIE0246)</w>
B IC</w>
B IC-induced</w>
B IC,</w>
B F).</w>
B F),</w>
B ETA-blocker-induced</w>
B ES</w>
B ERA</w>
B ECTS.</w>
B DS)</w>
B DHI</w>
B DF1</w>
B D)</w>
B CTX.</w>
B CS.</w>
B CR-ABL</w>
B CP)</w>
B CL).</w>
B CDT</w>
B CA</w>
B B,</w>
B B)</w>
B AU
BAU ,</w>
B AS</w>
B ARS</w>
B AN.</w>
B AN
BAN s.</w>
B 8.</w>
B 7-
B7- H4,</w>
B 6.
B6. D2-Mtv7a/Ty</w>
B 5</w>
B 35</w>
B 35.</w>
B 35-
B35- Cw4,</w>
B 3)</w>
B 16,</w>
B 12
B12 D,</w>
B 10.
B10. M</w>
B 1,</w>
B /</w>
B -positive</w>
B -</w>
B -1
B-1 00,</w>
B --are</w>
B +
B+ 5alpha-
B+5alpha- THB)/THA</w>
B )-treated</w>
B (6)</w>
B 's</w>
B '</w>
Azot emia,</w>
Azot aemia</w>
Azimil ide</w>
Azimil ide,</w>
Azimil ide's</w>
Azathiop rine,</w>
AzU d)</w>
Az ulfidline,</w>
Az treonam</w>
Az oxymethane-induced</w>
Az locillin</w>
Az elastine</w>
Az aspirodecanediones</w>
Az arga</w>
Az an</w>
Az a-treated</w>
Az a,</w>
Az C)</w>
Ay ur</w>
Ax ons</w>
Ax o-shaft</w>
Ax l</w>
Ax l,</w>
Ax itinib</w>
Ax illary</w>
Ax ial</w>
Ax SYM</w>
Ax C-Irish</w>
Ax 1)</w>
Avy/ a,</w>
Avoid ing/postponing</w>
Aven tis-Pharma),</w>
Av oid</w>
Av ance</w>
Autoradi ography</w>
Autoradi ograms</w>
Autom atic</w>
Auto grafts</w>
Auto antibody</w>
Auto anti-e</w>
Auth entic</w>
Aut osomal</w>
Aut o-immune</w>
Austri a.</w>
Austri a,</w>
Austri a)</w>
Austral ians,</w>
Austral ia:</w>
Austral ia),</w>
Austral ia's</w>
Austral asia,</w>
Aur icular</w>
Aur anofin</w>
Augment in.</w>
Augment er</w>
Audi t</w>
Audi ovestibular</w>
Audi ometrically</w>
Audi ological</w>
Audi ogram</w>
Au tistic</w>
Au thier</w>
Au t</w>
Au stria</w>
Au ,</w>
Attention- deficit</w>
Attention- deficit/hyperactivity</w>
Attention- Deficit</w>
Atten uating</w>
Attempt ing</w>
Atri a</w>
Atrac urium,</w>
Atomoxet ine-induced</w>
Atomoxet ine,</w>
Ather othrombosis</w>
Ather osclearosis</w>
Ath letes</w>
Ath ens</w>
Aten olol.</w>
Aten olol-associated</w>
Atazana vir:</w>
Atax ia,</w>
At titude</w>
At tainment</w>
At taining</w>
At tachment</w>
At romid-S')</w>
At las</w>
At lanta</w>
At lanta,</w>
At i</w>
Astro cytic</w>
Astro cytes</w>
Astr agalus.</w>
Astr agalus,</w>
Astr a</w>
Astemiz ole-induced</w>
Astemiz ole,</w>
Ast elin</w>
Associ azione</w>
Associ ation.</w>
Associ ation,</w>
Associ ation's</w>
Assess ment-Geriatric</w>
Asses s</w>
Aspir in-associated</w>
Asp ects</w>
Asp AT,</w>
Asi ans?</w>
Ash erson's</w>
Ascer tainment</w>
Ascer taining</w>
As surance</w>
As suming</w>
As says</w>
As pergillosis</w>
As n,</w>
As king</w>
Arthrot ec.</w>
Arthrot ec,</w>
Arthralgi as</w>
Arthralgi as,</w>
Arth ritis</w>
Artesun ate</w>
Artesun ate-mefloquine</w>
Arterio- venous</w>
Arterio- coronary-oxygen</w>
Arterio venous</w>
Arterio pathy</w>
Arterio lopathy</w>
Arterio graphically,</w>
Arterio gram</w>
Arter y</w>
Arter ies</w>
Artepar on.</w>
Arrhyth mogenicity</w>
Arom atic</w>
Aroclor -1254</w>
Aroclor -125
Aroclor-125 4,</w>
Aro ylhydrazone</w>
Aro und-the-clock</w>
Aripiprazol e-</w>
Aripiprazol e,</w>
Ari thmetic,</w>
Argatroban- 915</w>
Argatroban- 911</w>
Argatrob an-treated</w>
Argatrob an,</w>
Arg- Gly-Asp</w>
Arg- 2000</w>
Arg uments</w>
Arg entina.</w>
Arg 389
Arg389 Gly</w>
Arg 3,
Arg3, 4,</w>
Arg 27
Arg27 5
Arg275 Trp</w>
Arg 25
Arg25 6
Arg256 Cys,</w>
Arg .,</w>
Arab inoside</w>
Arab ia.</w>
Arab ia,</w>
Ara- c</w>
Ara- c,</w>
Ara- C:</w>
Ara U.</w>
Ara CTP,</w>
Ar yl-3-indoleacetamides</w>
Ar thralgia:</w>
Ar senic</w>
Ar s)</w>
Ar rang,</w>
Ar my</w>
Ar fedsson</w>
Ar ch</w>
Ar bor,</w>
Aque ous.</w>
Aquapor in-2</w>
Aquaf ol,</w>
Apri l.</w>
Apri l--November</w>
Apr indine,</w>
Apr .</w>
Appetite- suppressing</w>
Appetite- suppressant</w>
App endix).</w>
App endectomy</w>
Apop toses</w>
Apomorph ine:</w>
Apo zepam,</w>
Apo E</w>
Apo A-IV</w>
Apo ,</w>
ApcMin mouse</w>
ApcMin condition</w>
Ap so</w>
Ap proximate</w>
Ap pointment</w>
Ap pl.</w>
Ap ocynin+Dex,</w>
Ap neic</w>
Ap gars</w>
Ao P</w>
Ao P,</w>
Anxio genesis</w>
Anxiet y;</w>
Anxiet y-like</w>
Anxi olytic</w>
Anxi olytic-like</w>
Antiretro viral-induced</w>
Antiretro viral-associated</w>
Antipsycho tic-induced</w>
Antineoplast ons</w>
Antineoplast on</w>
Antineoplast on-related</w>
Antin ociceptive,</w>
Antin oceptive</w>
Antimicrobi als</w>
Antimicrobi al-induced</w>
Antim anic</w>
Antihistamin ics</w>
Antihistamin ic-opioid</w>
Anticoagul ation.</w>
Anticoagul ation-related</w>
Anticoagul ant-related</w>
Antic ipatory</w>
Antic ipation</w>
Antic atatonic</w>
Antibio tic-induced</w>
Anti- tumour</w>
Anti- tumor</w>
Anti- thrombotic</w>
Anti- single-</w>
Anti- nociceptive</w>
Anti- nicotinic</w>
Anti- neutrophil</w>
Anti- myoclonic</w>
Anti- migraine</w>
Anti- infectives</w>
Anti- histone</w>
Anti- heparin-platelet</w>
Anti- haemostatic</w>
Anti- emetic</w>
Anti- denatured</w>
Anti- cholinergic</w>
Anti- angiogenic</w>
Anti- alphaB-crystallin</w>
Anti- acetyl</w>
Anti- TNF</w>
Anti- TFA-albumin</w>
Anti- TCA</w>
Anti- Proliferating</w>
Anti- PreS2</w>
Anti- Narcotic</w>
Anti- LSP</w>
Anti- Jo-1</w>
Anti- HIV</w>
Anti- H/PF4</w>
Anti- ChAT</w>
Anti- CD18</w>
Anti ulcer</w>
Anti tuberculous</w>
Anti tricyclic</w>
Anti thrypsin</w>
Anti sialagogic</w>
Anti sense-infused</w>
Anti seizure</w>
Anti rifampicin</w>
Anti porter</w>
Anti platelets</w>
Anti pentylenetetrazol</w>
Anti parkinsonian-like</w>
Anti oxidant-associated</w>
Anti organelle</w>
Anti microbial</w>
Anti lipoperoxidative</w>
Anti inflammatory</w>
Anti hyperalgesic</w>
Anti glaucoma</w>
Anti gen-specific</w>
Anti fungal</w>
Anti fibrotic</w>
Anti fibrinolytic</w>
Anti fibrillatory,</w>
Anti epileptics</w>
Anti emetics</w>
Anti dyskinetic</w>
Anti dotal</w>
Anti convulsants-induced</w>
Anti cholinergic-induced</w>
Anti bradykinetic</w>
Anti body-mediated</w>
Anti body-forming</w>
Anti asthmatic</w>
Anti apoptotic</w>
Anti anginal</w>
Anti androgenic</w>
Anthracycl ine-pretreated</w>
Anthracycl ine-containing</w>
Anthrac yclin-based</w>
Anth ropometric</w>
Antero ventral</w>
Antagon izing</w>
Ant ecedent</w>
Ant arth</w>
Ant arth,</w>
Ant agonistic</w>
Ant agonist</w>
Ant agonist,</w>
Anorexigen -related</w>
Anorexigen -exposed</w>
Anorexi gen</w>
Ano va</w>
Ano rectic</w>
Ann uals</w>
Ank yrin-G</w>
Ank le/brachial</w>
Anim als,</w>
Anim al,</w>
Angptl 4.</w>
Angiotens inogen</w>
Angiotens in-1-converting</w>
Angiotens in-(1-7)</w>
Angio- oedema</w>
Angio- oedema'.</w>
Angio plasty</w>
Angio graphically</w>
Angio gram</w>
Angio edema:</w>
Angio dema</w>
Angio Jet</w>
Angi otoxicity</w>
Angi otension</w>
Angi omatoid</w>
Angel es).</w>
Ang-(1-7 )-treated</w>
Ang- II</w>
Ang ina-like</w>
Aneur ysms</w>
Anesthesi a-induced</w>
Anesthe tized,</w>
Ane mic</w>
Ane mias.</w>
Ane mia.</w>
Ane mia-related</w>
Ane mia--a</w>
Ane mia,</w>
Andro stenedione</w>
Andro gens</w>
Ander sen-Gill's</w>
Ancro d:</w>
Ancro d,</w>
Anc illary</w>
Anatom opathological</w>
Anatom ically</w>
Analy zed</w>
Analy tical</w>
Analy tic</w>
Analo gs</w>
Analgesic s</w>
Analgesic s,</w>
Analgesi c-antipyretic</w>
Analgesi a,</w>
Anagreli de:</w>
Anagreli de-induced</w>
Anagreli de-associated</w>
Anagreli de,</w>
Anaestheti sts'</w>
Anaesthesi ol</w>
Anaesthe tised</w>
Anaesthe sia.</w>
An uric</w>
An uria</w>
An uria,</w>
An tivomiting</w>
An tegrade</w>
An tazoline</w>
An swer:</w>
An noyed,</w>
An kle</w>
An isocoria</w>
An ionic</w>
An iline-induced</w>
An hedonia,</w>
An glo-Scandinavian</w>
An d,</w>
An choring</w>
An astrozole</w>
An aplerosis</w>
An aplastic</w>
An andamide</w>
An al</w>
An aerobic</w>
An abolic-androgenic</w>
An a</w>
Amygdala- lesioned</w>
Amygdala- kindled</w>
Amygdal a</w>
Amyg daloid</w>
Amy loid</w>
Amy loid-beta</w>
Amplitu des</w>
Amplitu de,</w>
Amplit ude</w>
Ampicill in-related</w>
Ampicill in-induced</w>
Ampicill in-cefotaxime</w>
Ampicill in-associated</w>
Ampicill in,</w>
Amphetamine- sensitized</w>
Amphetamine- related</w>
Amph ocil)</w>
Amp B.</w>
Amp B-treated</w>
Amp B-induced</w>
Amp B,</w>
Amp 4-
Amp4- 8).</w>
Amoxicill in/clavulanic</w>
Amox ycillin/clavulanic</w>
Amox apine</w>
Amox apine-induced</w>
Amox apine-associated</w>
Amon t</w>
Amodi aquine</w>
Ammon is</w>
Amitript yline,</w>
Amiodar oneinduced</w>
Amiodar one-related</w>
Amiodar one--avoid</w>
Amio- Aqueous.</w>
Aminoglyco sides,</w>
Aminoglyco side-impregnated</w>
Aminoglyco side-associated</w>
Amino- N-(2,4</w>
Amino- 5-phosphonovaleric</w>
Amino guanidine,</w>
Amino glutethimide</w>
Amin oxyacete</w>
Amin otriazole,</w>
Amin otransferase</w>
Amin oterminal</w>
Amin osalicylic</w>
Amin orex</w>
Amin orex,</w>
Amin ergic</w>
Amil oride,</w>
Amik acin.</w>
Amik acin-induced</w>
Amifost ine.</w>
Amifost ine,</w>
Ami paque</w>
Ami o</w>
Ami gos</w>
Ami dic</w>
Americ ans,</w>
Americ an.</w>
Americ an)</w>
Americ a;</w>
Americ a),</w>
Amen orrhea,</w>
Ameli orating</w>
Ame bic</w>
Amb esh</w>
Amaz onian</w>
Amaz on</w>
Am sacrine</w>
Am plified</w>
Am perozide</w>
Am pakine</w>
Am ounts</w>
Am nestic</w>
Am lodipine,</w>
Am fepramone</w>
Am bient</w>
Am ado</w>
Am BiLoad</w>
Am B-pretreated</w>
Am B)</w>
Alzheim ers'</w>
Altern ate-day</w>
Alter ative</w>
Alprazol am-induced</w>
Alpha- methyldopa-induced</w>
Alpha- chloralose</w>
Alpha- blockers</w>
Alpha- adrenoceptor</w>
Alpha- HCH</w>
Alpha B-crystallin</w>
Alpha 2-adrenergic</w>
Alpha (2)</w>
Alpha (2)-
Alpha(2)- adrenoceptors,</w>
Allyl glycine</w>
Allyl glycine-induced</w>
Allo P,</w>
Alle lic</w>
Alle le-specific</w>
All- trans-RA</w>
All- cause</w>
All- causality</w>
All an</w>
All -</w>
Alkalo tic</w>
Alkalo sis</w>
Alkal inization</w>
Alkal ine</w>
Alis kiren</w>
Alis kiren-induced</w>
Alfuz osin-induced</w>
Alfentan il,</w>
Alf red</w>
Alf 20</w>
Alf 15</w>
Alf 10,</w>
Alex andra</w>
Alex ander</w>
Alendron ate/vitamin</w>
Alendron ate-induced</w>
Alend ronate</w>
Aldo- salt</w>
Aldo- Ac</w>
Aldo- Ac
Aldo-Ac -treated</w>
Aldo sterone,</w>
Aldo )</w>
Alcohol ism.</w>
Albino- Wistar-rats.</w>
Albino- Swiss</w>
Alber to</w>
Alber ta,</w>
Alb anians</w>
Alb ania.</w>
Alb ania,</w>
Ala 2,</w>
Al veolitis,</w>
Al uminium</w>
Al um</w>
Al to,</w>
Al thesin.</w>
Al t</w>
Al ready</w>
Al port</w>
Al pidem</w>
Al pers'</w>
Al lowing</w>
Al inidine</w>
Al ginate-encapsulated</w>
Al gerian</w>
Al dridge</w>
Al drete</w>
Al dose</w>
Al derley</w>
Al con)</w>
Al cian</w>
Al bolabrin</w>
Al beit,</w>
Al arming</w>
Al aproclate</w>
Al amitos,</w>
Al abama</w>
Al Ph</w>
Al Ph,</w>
Al AT,</w>
Al )</w>
Akt/ GSK-3beta/beta-catenin</w>
Aj maline-induced</w>
Aj maline,</w>
Air ways</w>
Air ways,</w>
Ai wa</w>
Ai res,</w>
Ai redale</w>
Ah ti</w>
Ah mad,</w>
Agoraph obia</w>
Agoraph obia.</w>
Agon ist-mediated</w>
Aggres siveness</w>
Aggres sive,</w>
Aggres ome</w>
Aggra vated</w>
Agg regated</w>
Agen cy.</w>
Agen cies</w>
Age -</w>
Age -
Age- incidence</w>
Ag- positive/HBe</w>
Ag- positive,</w>
Ag- negative/HBe</w>
Ag way</w>
Ag itation-Sedation</w>
Ag ent.</w>
Ag arose</w>
Ag ain</w>
Ag T/ml/h.</w>
Ag SD.</w>
Ag M,</w>
After wards</w>
After ward</w>
After depolarizations</w>
African- Americans,</w>
Afric a;</w>
Afric a:</w>
Affair s,</w>
Affair 's</w>
Aff ymetrix</w>
Aff ordable</w>
Aff iliation,</w>
Aeros olized</w>
Aeros ol</w>
Adul terant</w>
Adul t.</w>
Adriamycin- exposed</w>
Adriamycin- Injured</w>
Adriamyc in;</w>
Adriamyc in-related</w>
Adriamyc in-</w>
Adrenerg ically</w>
Adrenerg aically</w>
Adrenal ine-treated</w>
Adrenal ine-evoked</w>
Adren ocortical</w>
Adren ic</w>
Adren als</w>
Adren alized</w>
Adol escent-onset</w>
Adjust ed-dose</w>
Adequ ately</w>
Aden omatous</w>
Aden omas</w>
Aden o-associated</w>
Adelta- meningeal</w>
Adelta- mechanonociceptors</w>
Adelta- fibre</w>
Addic ts</w>
Addic tive</w>
Addic tion.</w>
Addic tion-related</w>
Addic t</w>
Addi s</w>
Adap tation</w>
Adam antanamine</w>
Ad.N ull,</w>
Ad.N ull).</w>
Ad. hapoA-I,</w>
Ad- betagal</w>
Ad- SOD1</w>
Ad- SOD1-injected</w>
Ad x</w>
Ad x.</w>
Ad ventitial</w>
Ad sorbent</w>
Ad mittance</w>
Ad jacent</w>
Ad hesive</w>
Ad enovirus</w>
Ad dressing</w>
Ad ding-on</w>
Ad d</w>
Ad d-back"</w>
Ad alat</w>
Ad P/O,</w>
Ad ;</w>
Ad 2/CM
Ad2/CM Vp35</w>
Ad 2/
Ad2/ CMV</w>
Acyclovir ,</w>
Acute- phase</w>
Acute- onset</w>
Acute- on-chronic</w>
Actom yosin</w>
Actom ycin-D,</w>
Activ ator</w>
Activ ating</w>
Actin omycin-D</w>
Actin omyces-like</w>
Act- D.</w>
Acromegal ic</w>
Acrole in</w>
Acrole in,</w>
Acous tically</w>
Acous tic</w>
Acit retin-associated</w>
Acid- Like</w>
Acetyl strophanthidin</w>
Acetyl codeine,</w>
Acetyl choline,</w>
Acetazol amide-associated</w>
Acetazol amide,</w>
Acetaminophen -treated</w>
Acetaminophen -related</w>
Acet yl-carnitine</w>
Acet one,</w>
Acet ate.</w>
Ace butolol-induced</w>
Accid ent</w>
Accept ors'</w>
Accept ability</w>
Acceler ometric</w>
Ac-RY(3-Cl)YRWR-NH 2</w>
Ac- pClPhe1,</w>
Ac- D-p-Cl-Phe1,2,</w>
Ac upoint</w>
Ac tivities,</w>
Ac tin</w>
Ac timetrics).</w>
Ac ti-Track,</w>
Ac t</w>
Ac t,</w>
Ac t),</w>
Ac rodermatitis</w>
Ac quisition</w>
Ac neform</w>
Ac knowledgment</w>
Ac idemia</w>
Ac id:</w>
Ac id.</w>
Ac id-induced</w>
Ac cutane</w>
Ac cumulated</w>
Ac commodation</w>
Ac centuation</w>
Ac c)</w>
Ac c).</w>
Ac b.</w>
Ac amprosate</w>
Ac ad.</w>
Ac S,</w>
Ac C,</w>
Abu se;</w>
Abu se,</w>
Abstract /
Abstract/ Visual</w>
Abstr acts</w>
Abstin ence-related</w>
Abs orbed</w>
Abn-cb d,</w>
Abeta- fiber</w>
Abeta- fiber-mediated</w>
Abeta- amnesic</w>
Abecarn il,</w>
Abcc 2)</w>
Abcc 11)</w>
Abbot )</w>
Ab- negative.</w>
Ab undant</w>
Ab sidia</w>
Ab ruptly</w>
Ab ana,</w>
Ab aba,</w>
Ab 3s</w>
Ab 1</w>
Ab ),</w>
AZT- untreated</w>
AZT- dose-related,</w>
AZT- 3TC</w>
AZT+ ddl</w>
AZT :</w>
AZT -associated</w>
AZT )-induced</w>
AX UD1,</w>
AX OL)</w>
AX IN1.</w>
AVP- sensitive</w>
AVP- resistant</w>
AVP- receptor</w>
AV3 V)</w>
AV- node</w>
AV- dissociation</w>
AV- conduction</w>
AV- conduction.</w>
AV- blocks</w>
AV- blocks)</w>
AV T,</w>
AV R</w>
AV P;</w>
AV P-induced</w>
AV P-P</w>
AV P).</w>
AV Ms</w>
AV Ms.</w>
AV IOTA)</w>
AV F</w>
AV B).</w>
AV A.</w>
AV 370</w>
AV 370.</w>
AV 2)</w>
AUC-1/ 2)</w>
AUC(0-12h) S.</w>
AUC(0- t),</w>
AUC(0- infinity)</w>
AUC iv</w>
AUC =
AUC= 5).</w>
AUC :</w>
AUC (0-</w>
AUC (
AUC( last)</w>
AU THORS'</w>
AU ECs</w>
AU CCGRP</w>
AU C-l</w>
ATT- ALF.</w>
ATRA--> CT.</w>
ATRA--> CT,</w>
ATRA ;</w>
ATRA -related</w>
ATR A-associated</w>
ATP- producing</w>
ATP- positive</w>
ATP- metabolizing</w>
ATP- mediated</w>
ATP- depletion/Ca2+-ionophore-</w>
ATP- depletion-</w>
ATP- MgCl2.</w>
ATP' ase</w>
ATP' ase,</w>
ATP ase),</w>
ATP /P
ATP/P i</w>
ATP -induced</w>
ATP ).</w>
ATI N,</w>
AT/ RT</w>
AT/ ALAT</w>
AT- III</w>
AT- ICH)</w>
AT RA-treated</w>
AT R;</w>
AT R.</w>
AT N.</w>
AT N+DOX</w>
AT LAS</w>
AT L.</w>
AT L-related.</w>
AT L,</w>
AT G,</w>
AT F3-positive</w>
AT D;</w>
AT D-induced</w>
AT D,</w>
AT AC</w>
AT A</w>
AT 87
AT87 7.</w>
AT 2)</w>
AT 1,</w>
AT 1).</w>
AT -treated</w>
AT -1
AT-1 R,</w>
AT )].</w>
AST: 274</w>
AST: 111</w>
AST -1
AST-1 20.</w>
ASP S,</w>
ASP S)</w>
ASP 1928370</w>
ASL-812 3.</w>
ASI- psychological</w>
ASI- alcohol</w>
ASI L)</w>
ASI K)</w>
ASI C</w>
ASI -drug</w>
ASA/ NSAIDs-intolerance.</w>
ASA- intolerant</w>
ASA- NSAIDs</w>
AS1892 80
AS189280 2,</w>
AS-co g</w>
AS-co g)</w>
AS- SR),</w>
AS- M),</w>
AS- Anxiety;</w>
AS+ AQ
AS+AQ .</w>
AS SOCIATED</w>
AS SENT-2</w>
AS SAY</w>
AS FQ.</w>
AS Ds</w>
AS CO,</w>
AS AT</w>
AS AT/ALAT</w>
AS AI</w>
AS A1</w>
AS A).</w>
AS A),</w>
AS 2
AS2 -1.</w>
AS );</w>
ARN- x,</w>
ARE MI</w>
ARB s,</w>
ARB O)</w>
ARB -associated</w>
ARA- C.</w>
AR V</w>
AR T,</w>
AR S).</w>
AR R</w>
AR I,</w>
AR I),</w>
AR G</w>
AR G)</w>
AR FT),</w>
AR F).</w>
AR DS,</w>
AR D-NATO</w>
AR CH.</w>
AR C-239</w>
AR B-induced</w>
AR B,</w>
AR B)</w>
AR AC)</w>
AR A</w>
AR -J
AR-J P</w>
AR -3,</w>
AR ),</w>
AQP 9.</w>
AQP 4-deleted</w>
AQP 3</w>
AQP 1.</w>
AQP 1-</w>
AQP 1
AQP1 (+/+)</w>
AQ ,</w>
AQ ),</w>
APPRO Ve.</w>
APO LT</w>
APO LT,</w>
APO L2,</w>
APO -induced</w>
API SE.</w>
APD s).</w>
APD C,</w>
APD C)</w>
APD =
APD= LV</w>
APD 90</w>
APD 90,</w>
APD 90)</w>
APD 50,</w>
APD 20,</w>
APD ),</w>
APAP- nephrotoxicity</w>
APAP- elicited</w>
APAP- derived</w>
APAP- concentrations</w>
APAP- bioactivating</w>
APAP- administration</w>
APAP- administration)</w>
APAP- administration).</w>
APA RS</w>
APA P;</w>
APA P/kg</w>
APA P),</w>
APA ).</w>
AP- dependent,</w>
AP- 7</w>
AP- 7,</w>
AP- 5.</w>
AP s)</w>
AP Z</w>
AP Z.</w>
AP S)</w>
AP S).</w>
AP ROCO-COPILOTE</w>
AP QI).</w>
AP P</w>
AP P,</w>
AP LAFA</w>
AP ISE</w>
AP H.</w>
AP H)</w>
AP H),</w>
AP E1</w>
AP CA.</w>
AP Bs</w>
AP 7,</w>
AP 5.</w>
AP 43-
AP43- ir)</w>
AP 4),</w>
AP 3)</w>
AP -treated</w>
AP );</w>
AP (50)</w>
AP (-/-))</w>
AOA A-induced</w>
AO E</w>
ANIMA LS</w>
ANCA- vasculitis.</w>
ANCA- positive,</w>
ANCA :</w>
ANCA -related</w>
ANCA -negative</w>
ANCA -mediated</w>
ANALY SIS</w>
AN P;</w>
AN IT</w>
AN H,</w>
AN H).</w>
AN Gs</w>
AN F.</w>
AN F,</w>
AN DROMEDA</w>
AN D,</w>
AN COVA).</w>
AN CHOR</w>
AN A,</w>
AN .(ABSTRACT</w>
AN -13
AN-13 2,</w>
AN )]</w>
AN ).</w>
AMPH- sensitized-state</w>
AMPH- naive</w>
AMPH- na</w>
AMPH -</w>
AMPH ,</w>
AMPA- receptor</w>
AMP- system,</w>
AMP- phosphodiesterase</w>
AMP- alpha2</w>
AMP- PDE</w>
AMP- 2A).</w>
AMP T</w>
AMP )-stimulated</w>
AMLE t.</w>
AMLE t-pretreated</w>
AML/MD S.</w>
AML/MD S,</w>
AML/ MDS</w>
AMD3 100</w>
AMD3 100.</w>
AM4 24,</w>
AM4 24)</w>
AM17 14.</w>
AM/ CL.</w>
AM/ CGRP</w>
AM/ AM</w>
AM- stimulated</w>
AM- ICU).</w>
AM- 251</w>
AM T)</w>
AM R</w>
AM PT,</w>
AM PA-type</w>
AM P/+cyclic</w>
AM N)</w>
AM Ls,</w>
AM L-BFM</w>
AM Is,</w>
AM IS</w>
AM I/</w>
AM I)</w>
AM I),</w>
AM Hs</w>
AM Hs,</w>
AM GO)</w>
AM G</w>
AM G.</w>
AM G,</w>
AM D)</w>
AM BC</w>
AM BC,</w>
AM B-associated</w>
AM B)</w>
AM 404</w>
AM 281</w>
AM 281)</w>
AM 28
AM28 1.</w>
AM 251.</w>
AM 2)</w>
AM 149</w>
AM 1-
AM1- 50,</w>
AM -like</w>
AM -induced</w>
AM );</w>
ALT: 122</w>
ALT s</w>
ALT H)</w>
ALT /
ALT/ AST</w>
ALN+D2800 .</w>
ALN+ D5600</w>
ALLH AT</w>
ALLH AT,</w>
ALL- risk</w>
ALL- immunophenotype,</w>
ALL- associated</w>
ALA- S</w>
ALA- S.</w>
ALA- PDT-related</w>
ALA- ,</w>
AL ZET</w>
AL Y)</w>
AL S.We</w>
AL S-specific.</w>
AL RT1057)</w>
AL READY</w>
AL OX5</w>
AL N</w>
AL LO.</w>
AL L97.</w>
AL I)</w>
AL F=0/35,</w>
AL F/death</w>
AL F).</w>
AL D.</w>
AL D,</w>
AL C.</w>
AL B.</w>
AL AT)</w>
AL A-treated</w>
AKAP 150-
AKAP150- enzyme</w>
AK-FLU OR-coated</w>
AK- 0
AK-0 44)</w>
AK T.</w>
AK T)</w>
AK I)</w>
AK ).</w>
AK )-
AK)- STAT</w>
AIM s</w>
AIM S/BACKGROUND:</w>
AIM S,</w>
AIM S)</w>
AIM S).</w>
AIM .</w>
AID S:</w>
AID S-defining</w>
AID S).</w>
AID A)</w>
AIC U</w>
AIC U.</w>
AIC U)</w>
AI s)</w>
AI cr</w>
AI Z</w>
AI U),</w>
AI T.</w>
AI R.</w>
AI PC,</w>
AI P</w>
AI P,</w>
AI N-93G</w>
AI MAH</w>
AI HL</w>
AI H</w>
AI H.</w>
AI D)</w>
AI CH)</w>
AI B;</w>
AI AI,</w>
AI AI
AIAI .</w>
AI .ml
AI.ml -1.
AI.ml-1. h-1</w>
AI -labeled</w>
AHR-12 234,</w>
AH6 809</w>
AH6 80
AH680 9,</w>
AH SCT</w>
AH S)</w>
AH D)</w>
AH A,</w>
AH )-
AH)- hydrolase</w>
AGE s,</w>
AG- MPA</w>
AG s)</w>
AG P.</w>
AG C.</w>
AG C,</w>
AG ARD-NATO</w>
AG -treated</w>
AG )-positive</w>
AFB1- PB</w>
AFB1- PB.</w>
AFB1- NAF</w>
AFB1- NAF-treated</w>
AF M</w>
AF LD),</w>
AF L,</w>
AF L),</w>
AF DX-116</w>
AF ASAK</w>
AF .(ABSTRACT</w>
AF );</w>
AER s.</w>
AER S.</w>
AER S)</w>
AED s).</w>
AE s).</w>
AE S</w>
AE S's</w>
AE R)</w>
AE LYX/Doxil)</w>
AE D-associated</w>
AE D)</w>
AE B-T)</w>
AE A/
AEA/ HU210</w>
AE /
AE/ AA</w>
ADX- rats</w>
ADX- SAL</w>
ADX- MA</w>
ADR/ m2).</w>
ADR-E NA,</w>
ADR-5 29;</w>
ADR-5 29,</w>
ADR-5 29),</w>
ADR- stimulated</w>
ADR- reports</w>
ADR- register.</w>
ADR- nephrotic</w>
ADR- injured</w>
ADR- containing</w>
ADR- CSA</w>
ADR- CM.</w>
ADR- CC</w>
ADR- C</w>
ADR- 9
ADR-9 25,</w>
ADR+ V:</w>
ADR+ Phosphate-Buffered</w>
ADR+ PBS</w>
ADR+ PBS,</w>
ADR+ MEL,</w>
ADR+ FasL</w>
ADR s)</w>
ADR s).</w>
ADR PS)</w>
ADR AC)</w>
ADR AC
ADRAC 's</w>
ADR /kg</w>
ADR -related</w>
ADR ),</w>
ADR (6),</w>
ADR (12),</w>
ADR 's</w>
ADP/ adrenaline</w>
ADP/ O.</w>
ADP- ,</w>
ADNF LE,</w>
ADHD- RS-IV</w>
ADH- stimulated</w>
ADH- stimulated,</w>
ADH- secretion</w>
ADH- mediated</w>
ADD S:</w>
ADAMTS 13,</w>
AD/ TAD</w>
AD V-resistant</w>
AD V,</w>
AD T.</w>
AD SPX</w>
AD S)</w>
AD RS</w>
AD RENERGIC-NEURONE</w>
AD P.</w>
AD N-induced</w>
AD MINISTRATION:</w>
AD MA</w>
AD M;</w>
AD M).</w>
AD L,</w>
AD L)</w>
AD HS)</w>
AD HD;</w>
AD E.</w>
AD DH,</w>
AD D:</w>
AD Cs</w>
AD CA)</w>
AD C)</w>
AD AS-cog</w>
AD -related</w>
AD -induced</w>
AD );</w>
ACh T)</w>
ACh E+/-</w>
ACh -sensitive</w>
ACTI VITY</w>
ACTH1- 39</w>
ACTH1- 39,</w>
ACTH-(4-10 ),</w>
ACTH-(4-10 )
ACTH-(4-10) (7
ACTH-(4-10)(7 D-Phe),</w>
ACTH-(1-1 8),</w>
ACTH-(1-1 6)</w>
ACTH-(1- 39),</w>
ACTH-(1- 24),</w>
ACTH- stimulated</w>
ACTH- depo</w>
ACTH- (4-
ACTH-(4- 9),</w>
ACTH- (18-
ACTH-(18- 39)</w>
ACTH :</w>
ACTH /
ACTH/ steroid-induced</w>
ACTH -like</w>
ACTH -dependent</w>
ACS/ MI,</w>
ACS/ AMI</w>
ACS/ AMI,</w>
ACPT -1,</w>
ACEi )</w>
ACEi 's</w>
ACEi "</w>
ACEA-13 28</w>
ACEA-10 21</w>
ACEA -1
ACEA-1 32
ACEA-132 8)</w>
ACE- inhibitors</w>
ACE- inhibitors,</w>
ACE- inhibitor.</w>
ACE- inhibition</w>
ACE- inhibition.</w>
ACE- I</w>
ACE- I-induced</w>
ACE- 2,</w>
ACE Is.</w>
ACE I.</w>
ACE I-treatment</w>
ACE I-associated</w>
ACE I)</w>
ACE /ARB</w>
ACE -induced</w>
ACC-96 53,</w>
AC- P)</w>
AC- ORN</w>
AC- ICH)</w>
AC- DXMN</w>
AC- DFMO</w>
AC- C)</w>
AC(-ROO )
AC(-ROO) *)</w>
AC(-OHo ))</w>
AC(-O H)*)</w>
AC m</w>
AC h)</w>
AC Z.</w>
AC Z-treated</w>
AC Z-induced</w>
AC Z,</w>
AC UTE</w>
AC TIVE-W</w>
AC TG</w>
AC T/initial</w>
AC T,</w>
AC T).</w>
AC SF,</w>
AC S;</w>
AC Rs.</w>
AC QUISITION:</w>
AC M.</w>
AC M)</w>
AC IS.</w>
AC ID</w>
AC ID)</w>
AC I;</w>
AC I.</w>
AC I,</w>
AC H50</w>
AC E2</w>
AC D</w>
AC CESS):</w>
AC C)</w>
AC C),</w>
AC AT</w>
AC A.</w>
AC A-induced</w>
AC 9
AC9 27,</w>
AC );</w>
AC )-positive</w>
ABT-7 69
ABT-769 :</w>
ABT-59 4).</w>
ABT- 4
ABT-4 31,</w>
ABT- 239</w>
ABO- matched</w>
ABO- identical</w>
ABI-00 7.</w>
ABI-00 7,</w>
AB V</w>
AB S</w>
AB S.</w>
AB Rs,</w>
AB R.</w>
AB R-measured</w>
AB R,</w>
AB P.</w>
AB P)</w>
AB OUT</w>
AB MT</w>
AB F,</w>
AB CC)</w>
AB CB11),</w>
AB B</w>
AB )/
AB)/ SOCS-1/SSI-1</w>
AAV2- enhanced</w>
AAV2- Bcl-x(L)</w>
AAV2- Bcl-x(L)/kanamycin</w>
AAV 2/6)</w>
AAV 2-mediated</w>
AAV .</w>
AAV ,</w>
AAPD -induced</w>
AAL F;</w>
AAL F-S,</w>
AAL F-NS</w>
AA/ S)</w>
AA/ DHA.</w>
AA- supplemented</w>
AA- rats)</w>
AA s)</w>
AA G,</w>
AA F),</w>
AA :</w>
AA ))</w>
A: cholesterol</w>
A5 MB,</w>
A5 49</w>
A2G 6-
A2G6- associated</w>
A23 187,</w>
A2 a,</w>
A2 a)</w>
A2 AR</w>
A2 A/
A2A/ A1</w>
A2 A-
A2A- dependent</w>
A2 80/
A280/ h</w>
A1/ A2</w>
A1- receptor.</w>
A1- group.</w>
A1- adenosine</w>
A1- B1</w>
A1 c</w>
A/ Victoria/7/83-like</w>
A/ S,</w>
A/ G</w>
A/ DZR</w>
A/ D</w>
A/ 5-HT)</w>
A. S.A.</w>
A. G.</w>
A. C.)</w>
A-869 29
A-86929 :</w>
A-77 9,</w>
A--> T-->CMF:</w>
A--> CT</w>
A-(1-1 7).</w>
A-(1-1 7),</w>
A- waves</w>
A- waves,</w>
A- wave</w>
A- silica</w>
A- ring</w>
A- mediated)</w>
A- immunoadsorption</w>
A- fibers</w>
A- fibers.</w>
A- fibers,</w>
A- case</w>
A- beta;</w>
A- agonist</w>
A- S)</w>
A- R)</w>
A- P"</w>
A- NCAM)</w>
A- N)</w>
A- MT),</w>
A- Kinase</w>
A- IV,</w>
A- G-C-G-A</w>
A- FUDR)</w>
A- CHF,</w>
A- 9</w>
A- 4</w>
A- 48
A-48 66</w>
A- 43
A-43 140
A-43140 4,</w>
A- 2</w>
A- 2000</w>
A- 2
A-2 )]</w>
A- -induced</w>
A- ,</w>
A- (2-1
A-(2-1 7)</w>
A- (2
A-(2 -13)</w>
A- (1-
A-(1- 8)</w>
A)/ lead</w>
A)/ glycine</w>
A)/ benzodiazepine</w>
A)/ FK506-related</w>
A)- sponsored</w>
A)- resistant,</w>
A)- nephrotic</w>
A)- mediated</w>
A)- matched</w>
A)- enriched</w>
A)- associated</w>
A) -1,</w>
A(2A) R-specific</w>
A(2 B)</w>
A(2 A),</w>
A(2 )/
A(2)/ prostaglandin</w>
A zole</w>
A xial,</w>
A vidinated</w>
A ventyl</w>
A ve.,</w>
A ura</w>
A u</w>
A tubular</w>
A trophy</w>
A trophogenicity,</w>
A trophic</w>
A tresia,</w>
A traumatic</w>
A topic</w>
A though</w>
A therectomy</w>
A ter</w>
A systolic</w>
A symptomatic,</w>
A stronauts</w>
A straZeneca,</w>
A spect</w>
A sia</w>
A senapine</w>
A s;</w>
A s),</w>
A recoline</w>
A recaceae</w>
A reca-specific</w>
A quina,</w>
A plasia</w>
A pheresis</w>
A periodicity</w>
A periodic</w>
A percutaneous</w>
A pathy</w>
A orta</w>
A nonymous</w>
A mussium</w>
A mitrytiline</w>
A methamphetamine-treated</w>
A mercan</w>
A mal</w>
A m.</w>
A m,</w>
A lizarin</w>
A kinesia,</w>
A in</w>
A im.</w>
A h</w>
A h-receptor.</w>
A fferent</w>
A febrile</w>
A f</w>
A esch,</w>
A edes</w>
A dynamic</w>
A diposity</w>
A dipocyte-derived</w>
A delta-</w>
A delaide</w>
A corus</w>
A chievement</w>
A ches</w>
A chT)</w>
A ce</w>
A cat1,</w>
A case</w>
A brams-Griffiths</w>
A bove</w>
A borted</w>
A bility</w>
A bilify,</w>
A beta25-35</w>
A belcet)</w>
A bacavir-induced</w>
A aldoV),</w>
A WS</w>
A WQ</w>
A WD</w>
A PTT.</w>
A PTT,</w>
A PO-na</w>
A PGAR</w>
A O.</w>
A MED</w>
A ME.</w>
A ME-AmB</w>
A ME,</w>
A K)</w>
A II-mediated</w>
A H.</w>
A H,</w>
A Gs</w>
A Fl;</w>
A F)</w>
A F).</w>
A F),</w>
A EP;</w>
A ECA,</w>
A AR,</w>
A AP-induced</w>
A AN.</w>
A AM)</w>
A ALF,</w>
A AIR.</w>
A ADR:</w>
A ADC</w>
A AD</w>
A ABB</w>
A A).</w>
A 75</w>
A 60+C600</w>
A 4)</w>
A 33
A33 3A</w>
A 2.</w>
A 2-
A2- adenosine</w>
A 140
A140 62
A14062 G</w>
A 14-year-old</w>
A 12
A12 98
A1298 C/C677T</w>
A 1-selective</w>
A 1),</w>
A .(ABSTRACT</w>
A -1.</w>
A -1,</w>
A ):</w>
A )).</w>
A )),</w>
A (3,
A(3, )</w>
A (2)=
A(2)= 9.
A(2)=9. 26
A(2)=9.26 +/-0.04</w>
A (2)-
A(2)- production</w>
A (1)/A(2A)</w>
A (1)/
A(1)/ A(2)</w>
A (1),</w>
A "</w>
? SD</w>
? Hypersensitivity</w>
>or= grade</w>
>or= III:</w>
>or= 8</w>
>or= 80</w>
>or= 80)</w>
>or= 75</w>
>or= 6</w>
>or= 66</w>
>or= 60</w>
>or= 600</w>
>or= 5</w>
>or= 50%.</w>
>or= 50%).</w>
>or= 5%</w>
>or= 30%</w>
>or= 25%</w>
>or= 20</w>
>or= 1</w>
>or= 13</w>
>or= 12</w>
>or= 10</w>
>or= 1.2</w>
>or= 0.5</w>
>or= 0.05).</w>
>/= p-F-HHSiD</w>
>/= F2,</w>
>/= 7.5</w>
>/= 6</w>
>/= 65</w>
>/= 50%).</w>
>/= 415</w>
>/= 4-DAMP</w>
>/= 18</w>
>/= 100</w>
>/= 1000</w>
>/= 1.9</w>
> II,</w>
> 97%</w>
> 94%</w>
> 92%</w>
> 83</w>
> 80%</w>
> 80%.</w>
> 8.7</w>
> 8
>8 mm</w>
> 7</w>
> 75</w>
> 750</w>
> 75%.</w>
> 74</w>
> 72-96</w>
> 70%).</w>
> 7.0</w>
> 6-fold</w>
> 53</w>
> 500/
>500/ microl.</w>
> 50%;</w>
> 5.5</w>
> 5,</w>
> 40).</w>
> 40%</w>
> 40%)</w>
> 4.5</w>
> 38</w>
> 36</w>
> 350</w>
> 300-
>300- 3500</w>
> 30%.</w>
> 3.0.</w>
> 3.0,</w>
> 3
>3 50).</w>
> 26</w>
> 256</w>
> 24</w>
> 240</w>
> 20,000</w>
> 20%</w>
> 2.4</w>
> 2.0</w>
> 2-fold</w>
> 160</w>
> 152).</w>
> 14</w>
> 140/90</w>
> 14-fold</w>
> 13</w>
> 11</w>
> 1000</w>
> 1000-fold</w>
> 10-fold</w>
> 10-
>10- fold.</w>
> 10,</w>
> 10%;</w>
> 1.5,</w>
> 1.32</w>
> 1.07</w>
> 1,</w>
> 0.99).</w>
> 0.5).</w>
> 0.4
>0.4 40</w>
> 0.31).</w>
> 0.15</w>
> 0.05)</w>
=4. 5)</w>
=4. 3)</w>
=1. 6)</w>
=1. 4,</w>
=0.9 2)</w>
=0.00 1;</w>
=0.0 33).</w>
=0.0 19
=0.019 0).</w>
=0.0 18).</w>
=.000 4)</w>
=.000 4).</w>
=.000 3)</w>
=.000 2).</w>
=.000 1</w>
=.00 8)</w>
=.00 74).</w>
=.00 6;</w>
=.00 6)</w>
=.00 5,</w>
=.00 4)</w>
=.00 4).</w>
=.00 37),</w>
=.00 3)</w>
=.00 3),</w>
=.00 2)</w>
=.00 18)</w>
=.0 9).</w>
=.0 8)</w>
=.0 7</w>
=.0 71)</w>
=.0 57).</w>
=.0 48).</w>
=.0 48),</w>
=.0 41)</w>
=.0 4)</w>
=.0 4).</w>
=.0 39).</w>
=.0 38),</w>
=.0 37),</w>
=.0 33),</w>
=.0 31.</w>
=.0 3,</w>
=.0 3);</w>
=.0 2</w>
=.0 28).</w>
=.0 27).</w>
=.0 26)</w>
=.0 26),</w>
=.0 23
=.023 2)</w>
=.0 2)</w>
=.0 18)</w>
=.0 14).</w>
=.0 13),</w>
=.0 12),</w>
=.0 11)</w>
=.0 1.</w>
=.0 1),</w>
=. 99)</w>
=. 90</w>
=. 83).</w>
=. 74).</w>
=. 72).</w>
=. 67)</w>
=. 60).</w>
=. 54,</w>
=. 52,</w>
=. 50</w>
=. 43).</w>
=. 4
=.4 32,</w>
=. 38).</w>
=. 38),</w>
=. 34).</w>
=. 32)</w>
=. 21).</w>
=. 15).</w>
=. 14,</w>
=. 14),</w>
=. 1).</w>
=- 6.7%;</w>
= second-degree</w>
= living:cadaveric</w>
= diprenorphine>nalorphine=naloxonazine.</w>
= cigarettes</w>
= cell-sap)</w>
= FS<25%)</w>
= 95</w>
= 95%</w>
= 90</w>
= 90%).</w>
= 9),</w>
= 9
=9 7.2</w>
= 80</w>
= 80%</w>
= 75</w>
= 75-
=75- 80%</w>
= 7)</w>
= 7%</w>
= 680</w>
= 66</w>
= 65%)</w>
= 63</w>
= 55%</w>
= 500</w>
= 50%.</w>
= 50%)</w>
= 5-fold</w>
= 46</w>
= 45</w>
= 40</w>
= 400</w>
= 4000</w>
= 40%</w>
= 39%</w>
= 38</w>
= 36%</w>
= 35</w>
= 350</w>
= 30-fold</w>
= 3.</w>
= 3.7
=3.7 7,</w>
= 3.0</w>
= 28%</w>
= 22,</w>
= 200</w>
= 20),</w>
= 20%),</w>
= 2.7
=2.7 2,</w>
= 2.5</w>
= 2.3</w>
= 1x</w>
= 18</w>
= 18)</w>
= 17</w>
= 15)</w>
= 14</w>
= 140/90</w>
= 14)</w>
= 14
=14 5/90</w>
= 138</w>
= 132.6</w>
= 12),</w>
= 11</w>
= 11,
=11, 224),</w>
= 100,000/
=100,000/ microl.</w>
= 10%</w>
= 10%)</w>
= 1.5</w>
= 1.2</w>
= 1.0</w>
= 1-
=1- plug</w>
= 1).</w>
= 0.60,</w>
= 0.5</w>
= 0.5%</w>
= 0.45,</w>
= 0.2</w>
= 0.2
=0.2 1;</w>
= 0.001)</w>
= 0.001).</w>
= 0.0001).</w>
= .</w>
= .0001).</w>
= -4
=-4 3+/-3</w>
<or= 75</w>
<or= 45%,</w>
<or= 300</w>
<or= 19.
<or=19. 3%).</w>
<or= 15%</w>
<or= 140/90</w>
<10 th%</w>
<0.0 24,</w>
<0.0 17,</w>
<0.0 15)</w>
<0.0 122)</w>
</= 4</w>
</= 40</w>
</= 3.5</w>
</= 1.1</w>
</= 0.7,</w>
</= .05).</w>
</ =.05)</w>
<.000 5).</w>
<.000 2);</w>
<.000 1,</w>
<.00 7;</w>
<.0 5.</w>
<.0 5);</w>
<.0 2.</w>
<.0 14).</w>
<.0 1.</w>
< or=.05)</w>
< group</w>
< F2,</w>
< =</w>
< =20</w>
< 93%,</w>
< 90%)</w>
< 90
<90 mmHg)</w>
< 8</w>
< 8.5</w>
< 7</w>
< 75</w>
< 72</w>
< 70-year</w>
< 70,</w>
< 70%,</w>
< 7%,</w>
< 65</w>
< 600</w>
< 60)</w>
< 6-
<6- years-old</w>
< 56</w>
< 55</w>
< 53</w>
< 50%).</w>
< 5.6</w>
< 48</w>
< 45,</w>
< 45%)</w>
< 420</w>
< 40%,</w>
< 36</w>
< 35</w>
< 32</w>
< 30</w>
< 30)</w>
< 30%)</w>
< 3.2</w>
< 25%</w>
< 20%.</w>
< 20%)</w>
< 2.</w>
< 2.0</w>
< 2-fold</w>
< 2%</w>
< 2%.</w>
< 18</w>
< 16</w>
< 150</w>
< 15.
<15. 1).</w>
< 15%</w>
< 140/90</w>
< 13</w>
< 130/
<130/ <80</w>
< 13,</w>
< 120/80</w>
< 120
<120 g/L.</w>
< 12/
<12/ min),</w>
< 11.5</w>
< 100%.</w>
< 100
<100 mmol/L.</w>
< 10.</w>
< 10%</w>
< 10%,</w>
< 1.5).</w>
< 1.2).</w>
< 1.0</w>
< 1.0.</w>
< 1%.</w>
< 1%,</w>
< 0.</w>
< 0.9,</w>
< 0.7</w>
< 0.7.</w>
< 0.5</w>
< 0.45,</w>
< 0.4
<0.4 4);</w>
< 0.1,</w>
< 0.02)</w>
< 0.02).</w>
< 0.01]</w>
< 0.01].</w>
< 0.01</w>
< 0.01),</w>
< 0.002;</w>
< 0.001</w>
< 0.000
<0.000 9)
<0.0009) (
<0.0009)( adults),</w>
< 0.00
<0.00 6)
<0.006) (
<0.006)( pediatric)</w>
< 0.
<0. 20%.</w>
< .</w>
< .05,</w>
< .04).</w>
< .02)</w>
< .005)</w>
< .003).</w>
< .0001</w>
< .0001).</w>
; supine'</w>
; q12)].</w>
; Urticaria</w>
; Paranoid</w>
; 7:
;7: 53-
;7:53- 57).</w>
; 45
;45 3)</w>
; 38
;38 :
;38: 97
;38:97 6-
;38:976- 98
;38:976-98 1]</w>
; 24
;24 6-
;246- 9.].</w>
; 23.9)</w>
; 17
;17 )
;17) (q
;17)(q 22
;17)(q22 ;q12)].</w>
; 15:
;15: 23
;15:23 78.</w>
; 00:
;00: 1-1
;00:1-1 4).</w>
; ,</w>
:18 5-9
:185-9 1),</w>
:18 5-1
:185-1 94,</w>
:12 h.</w>
:00 -19
:00-19 :00</w>
:00 -18
:00-18 :00</w>
:00 -16
:00-16 :00</w>
:00 -12
:00-12 :00</w>
:00 -10
:00-10 :30</w>
: unconsciousness</w>
: [1,2,4]-oxadiazolo-:[4,3-a]</w>
: PRBC</w>
: DOX)</w>
: 99.5%</w>
: 8
:8 34-
:834- 43)</w>
: 64
:64 7-
:647- 65
:647-65 1;</w>
: 63,</w>
: 51-
:51- 53,</w>
: 50),</w>
: 39
:39 95-
:3995- 39
:3995-39 96)</w>
: 31;</w>
: 3
:3 23-
:323- 3
:323-3 30,</w>
: 29
:29 7-30
:297-30 4;</w>
: 26</w>
: 26
:26 40-
:2640- 2].</w>
: 233-
:233- 24
:233-24 2;</w>
: 194
:194 2-1
:1942-1 94
:1942-194 6)</w>
: 18,</w>
: 14
:14 6
:146 1-1
:1461-1 463</w>
: 117
:117 0-
:1170- 9].</w>
: 114
:114 2,</w>
: 1),</w>
9p 21-
9p21- qter,</w>
9p 11-1
9p11-1 3.</w>
99mTc-MAG 3.</w>
99mTc-MAG 3,</w>
99mTc- tetrofosmin,</w>
99mTc- pyrrolidino</w>
99mTc- p-isopropyl-iminodiacetic</w>
99mTc- labeled</w>
99mTc- hexamethyl-propyleneamine</w>
99mTc- hexakis</w>
99mTc- dimercaptosuccinic</w>
99mTc- dimercaptoacetyl-triglycine</w>
99mTc- SestaMIBI</w>
99mTc- PPi</w>
99mTc- PM</w>
99mTc- MIBI</w>
99mTc- MDP</w>
99mTc- DTPA,</w>
99mTc DTPA</w>
99mTc (S
99mTc(S n)-PyP,</w>
99m- technetium</w>
99m- Tc-HMPAO</w>
99m technetium</w>
99m Technetium</w>
99m Technetium-MDP</w>
999/ mm3),</w>
99. ].</w>
99. 9)</w>
99. 7,</w>
99. 7%</w>
99. 5%.</w>
99. 3+/-1
99.3+/-1 4.1</w>
99. 3)</w>
99 th</w>
99 m)</w>
99 Tc-EHIDA</w>
99 9).</w>
99 9),</w>
99 8)</w>
99 76-
9976- A,</w>
99 7,</w>
99 7),</w>
99 6;</w>
99 5.6</w>
99 5)</w>
99 3</w>
99 29;</w>
99 1</w>
99 1).</w>
99 0).</w>
99 -18
99-18 8).</w>
99 -1
99-1 68</w>
99 +/-17</w>
99 +/-1.
99+/-1. 33</w>
99 %.</w>
98. 8%;</w>
98. 7
98.7 %/min,</w>
98. 3
98.3 +/-1.8</w>
98+/- 6</w>
98 th</w>
98 ],</w>
98 6-
986- 85-
986-85- 4)</w>
98 5)</w>
98 1;</w>
98 0,</w>
98 -10
98-10 3)</w>
98 +/-1.5</w>
98 );</w>
97.0+/- 69.0</w>
97.0+/- 26.
97.0+/-26. 1microg/g,</w>
97. 9%,</w>
97. 8%)</w>
97. 7%,</w>
97. 7%)</w>
97. 6%</w>
97. 5%,</w>
97. 5%)</w>
97. 4%</w>
97. 22</w>
97. 1%.</w>
97. 0%</w>
97. 0%)</w>
97 ];</w>
97 :1942-1946)</w>
97 9,</w>
97 76</w>
97 7)</w>
97 5,</w>
97 4,</w>
97 201.</w>
97 2.1</w>
97 2),</w>
97 +/-1.
97+/-1. 65</w>
97 )>/=
97)>/= methoctramine</w>
97 %;</w>
96. 9%,</w>
96. 9%).</w>
96. 8%</w>
96. 5%.</w>
96. 4%</w>
96. 345</w>
96. 3%</w>
96 A)</w>
96 :3995-3996)</w>
96 9,</w>
96 85</w>
96 8,</w>
96 7,</w>
96 50).</w>
96 5-
965- 968)</w>
96 4),</w>
96 2).</w>
96 -10
96-10 5%,</w>
96 +/-1
96+/-1 3</w>
95. 8%).</w>
95. 7%</w>
95. 6%</w>
95. 5+/-
95.5+/- 0.9%</w>
95. 5%</w>
95. 4-
95.4- kDa</w>
95. 4%</w>
95-1 20</w>
95-1 15</w>
95-1 14</w>
95- 680</w>
95- 50</w>
95+/- 7.1</w>
95+/- 43</w>
95+/- 39</w>
95+/- 0.2</w>
95% ]</w>
95% CI:0.5-8.5)</w>
95 :unconsciousness</w>
95 :</w>
95 8)</w>
95 5,</w>
95 1).</w>
95 -105</w>
94. 8%.</w>
94. 6%;</w>
94. 5)</w>
94. 3).</w>
94. 19</w>
94 A)</w>
94 1)</w>
93. 6,</w>
93. 5%),</w>
93. 4%),</w>
93-0 24.</w>
93-0 24).</w>
93- 5)</w>
93- 2%</w>
93 7)</w>
93 6,</w>
93 3/
933/ kg</w>
93 3)</w>
93 29</w>
93 129),</w>
93 );</w>
920 3
9203 X.</w>
92/ 63</w>
92 ])</w>
92 18</w>
91- yr-old</w>
91- 67
91-67 98],</w>
91- 4
91-4 400</w>
91- 01</w>
91 C)</w>
91 +),</w>
90Y-DOTAT OC.</w>
90Y-DOTAT OC,</w>
903/ 108
903/108 7),</w>
900- 2400</w>
900- 2
900-2 100)</w>
900 5.</w>
900 5,</w>
900 0)</w>
900 .</w>
900 -1200</w>
900 ).</w>
900 %</w>
90/NO RM</w>
90/NO RM,</w>
90/ HTN</w>
90/ HTN,</w>
90/ 58</w>
90/ 54</w>
90/ 50</w>
90/ 49</w>
90/ 163</w>
90.0 +/-12</w>
90.0 %.</w>
90-1 320</w>
90-1 00,</w>
90- year-old</w>
90- minute</w>
90- mg</w>
90- g</w>
90- 87
90-87 0)</w>
90- 39
90-39 90)</w>
90,23 8.</w>
90,23 8)</w>
90, 238</w>
90, 109)</w>
90+/- 4.7</w>
90+/- 0.55</w>
90 s.</w>
90 s,</w>
90 min.</w>
90 db</w>
90 87</w>
90 8
908 (-)</w>
90 62</w>
90 5</w>
90 5).</w>
90 5
905 20-
90520- 42-
90520-42- 6)</w>
90 4+/-
904+/- 434</w>
90 24),</w>
90 21</w>
90 1</w>
90 13.</w>
90 13,</w>
90 -13
90-13 10)</w>
90 -120</w>
90 -1.210</w>
90 "</w>
9/8 9.8</w>
9/8 8),</w>
9/8 5.3</w>
9/32 6)</w>
9/- 9.0,</w>
9/- 0.2
9/-0.2 12);</w>
9/ mm3</w>
9/ microL</w>
9/ 90</w>
9/ 9.5</w>
9/ 9.
9/9. 7,</w>
9/ 75)</w>
9/ 7.0</w>
9/ 36</w>
9/ 35,</w>
9/ 28
9/28 1,</w>
9/ 27</w>
9/ 26,</w>
9/ 23</w>
9/ 22</w>
9/ 21</w>
9/ 20</w>
9/ 20)</w>
9/ 18</w>
9/ 150;</w>
9/ 15.6</w>
9/ 13</w>
9/ 107</w>
9/ 103</w>
9/ 102)</w>
9/ 10)</w>
9/ 10(6)</w>
9/ 1.0
9/1.0 3).</w>
9/ 1,000</w>
9/ 1,000,000</w>
9/ 06</w>
9/ 0
9/0 8,</w>
9.9 microg/ml</w>
9.9 7),</w>
9.9 %-1
9.9%-1 3.5%)</w>
9.8 9).</w>
9.8 4;</w>
9.7 7;</w>
9.1/ 6.1,</w>
9.0 ]).</w>
9.0 9%</w>
9.0 8+/-
9.08+/- 0.16</w>
9.0 6;</w>
9.0 5%)</w>
9.0 2;</w>
9.0 1,</w>
9.0 +/-1.8</w>
9.0 );</w>
9. 99%</w>
9. 98</w>
9. 97</w>
9. 9+/-2.0</w>
9. 9%)</w>
9. 89%,</w>
9. 83</w>
9. 80</w>
9. 80).</w>
9. 8.</w>
9. 8-
9.8- 46.
9.8-46. 7%)</w>
9. 8+/-
9.8+/- 47.8</w>
9. 8).</w>
9. 8),</w>
9. 8%;</w>
9. 77</w>
9. 76</w>
9. 75.</w>
9. 74</w>
9. 72</w>
9. 71</w>
9. 7-fold</w>
9. 7+/-
9.7+/- 7.2%</w>
9. 7).</w>
9. 7%.</w>
9. 7%)</w>
9. 7%).</w>
9. 69]</w>
9. 69,</w>
9. 68,</w>
9. 67+/-
9.67+/- 0.06</w>
9. 67).</w>
9. 66</w>
9. 61-
9.61- fold</w>
9. 6-1
9.6-1 2.5)</w>
9. 6%)</w>
9. 6
9.6 3;</w>
9. 55,</w>
9. 54).</w>
9. 53</w>
9. 53,</w>
9. 51)</w>
9. 5-point</w>
9. 5-fold</w>
9. 5),</w>
9. 5%);</w>
9. 5%),</w>
9. 4];</w>
9. 49+/-
9.49+/- 0.09,</w>
9. 48%).</w>
9. 47</w>
9. 47)</w>
9. 44;</w>
9. 43</w>
9. 41,</w>
9. 4-
9.4- T</w>
9. 4+/-
9.4+/- 34
9.4+/-34 9.3</w>
9. 4).</w>
9. 4),</w>
9. 4%),</w>
9. 4%
9.4% versus</w>
9. 3]</w>
9. 37,</w>
9. 37+/-
9.37+/- 6.0
9.37+/-6.0 7</w>
9. 36).</w>
9. 3-
9.3- 35.7)</w>
9. 3,</w>
9. 3)</w>
9. 3);</w>
9. 3%,</w>
9. 3
9.3 ],</w>
9. 2;</w>
9. 27
9.27 4,</w>
9. 26</w>
9. 24</w>
9. 2-1
9.2-1 6.3),</w>
9. 2+/-
9.2+/- 2.4</w>
9. 2).</w>
9. 2%</w>
9. 2%,</w>
9. 2
9.2 %/min</w>
9. 18</w>
9. 18,</w>
9. 18%</w>
9. 17;</w>
9. 14</w>
9. 12+/-
9.12+/- 0.14,</w>
9. 11</w>
9. 10</w>
9. 10,</w>
9. 1,</w>
9. 1)</w>
9. 1%.</w>
9. 1%).</w>
9. 09</w>
9. 03</w>
9. 02</w>
9. 0%).</w>
9-di hydroxy-3-(1',1'-dimethylheptyl)-6H-benzo[c]chromene-6-one),</w>
9-7. 98;</w>
9-7. 2)</w>
9-5 3%)</w>
9-5 23),</w>
9-5 0.1)</w>
9-4. 35,</w>
9-4. 22;</w>
9-4. 2
9-4.2 x10(9)/l</w>
9-3. 42,</w>
9-3. 25)</w>
9-3. 23)</w>
9-3. 15)</w>
9-2. 80)</w>
9-2. 37).</w>
9-2. 17,</w>
9-1.6 6).</w>
9-1.6 2]</w>
9-1.6 1
9-1.61 ))</w>
9-1.0 9).</w>
9-1.0 7;</w>
9-1. 74
9-1.74 9).</w>
9-1. 23</w>
9-1 9</w>
9-1 990</w>
9-1 985)</w>
9-1 9).</w>
9-1 88
9-188 9),</w>
9-1 84</w>
9-1 6.</w>
9-1 6%</w>
9-1 5</w>
9-1 5)</w>
9-1 4.5</w>
9-1 33).</w>
9-1 3.33</w>
9-1 3,</w>
9-1 3%);</w>
9-1 21.
9-121. 3),</w>
9-1 15
9-115 2],</w>
9-1 1.9)</w>
9-1 1.1%).</w>
9-1 00)</w>
9-1 0,</w>
9- week,</w>
9- minute</w>
9- mg/kg</w>
9- methyl-6-oxo-7,13-dihydro-6H-benzofuro[2,3-e]pyrido[1,2-a][1,3]diazepin-12-ium</w>
9- mN-intensity</w>
9- fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-</w>
9- dimethylbenz[c]acridine:</w>
9- delta-tetrahydrocannabinol</w>
9- day</w>
9- day-old</w>
9- cm</w>
9- cis-RA/mL</w>
9- beat/min</w>
9- Mb</w>
9- 99.].</w>
9- 9.97),</w>
9- 9
9-9 9-
9-99- 2)</w>
9- 81.
9-81. 1%,</w>
9- 8
9-8 7.0
9-87.0 1;</w>
9- 79%</w>
9- 70</w>
9- 64</w>
9- 56.
9-56. 9
9-56.9 ]),</w>
9- 5.04).</w>
9- 5.
9-5. 32</w>
9- 47)</w>
9- 46
9-46 4).</w>
9- 4.6,</w>
9- 33</w>
9- 3.8
9-3.8 9).</w>
9- 28).</w>
9- 26</w>
9- 24%</w>
9- 23.
9-23. 3)</w>
9- 22</w>
9- 2000.</w>
9- 20.
9-20. 3)</w>
9- 2.9</w>
9- 2.6
9-2.6 1),</w>
9- 0.28</w>
9- 0
9-0 1-2;</w>
9- -14</w>
9- -
9-- 301</w>
9, 438</w>
9, 304</w>
9, 2.30</w>
9, 13
9,13 b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H-benzo[d]naptho++</w>
9, 11,
9,11, 14),</w>
9+/-2. 95</w>
9+/-2. 6,
9+/-2.6, *</w>
9+/-1 8.9,</w>
9+/-1 5.5%,</w>
9+/-1 5%)</w>
9+/-1 4.0</w>
9+/-1 33.1</w>
9+/-1 28.9</w>
9+/-1 2.1</w>
9+/- 7.0</w>
9+/- 5</w>
9+/- 4.6</w>
9+/- 4.4</w>
9+/- 3</w>
9+/- 32.7</w>
9+/- 30.2</w>
9+/- 3.9</w>
9+/- 3.3</w>
9+/- 3.1</w>
9+/- 27</w>
9+/- 2.8</w>
9+/- 2.7).</w>
9+/- 2.5</w>
9+/- 2.4
9+/-2.4 *</w>
9+/- 2.1</w>
9+/- 2,</w>
9+/- 0.8</w>
9+/- 0.8)</w>
9+/- 0.6,</w>
9+/- 0.5</w>
9+/- 0.4</w>
9+/- 0.27</w>
9+/- 0.25</w>
9+/- 0.19</w>
9+/- 0.12</w>
9+/- 0.02</w>
9+/- 0.
9+/-0. 107</w>
9) moles).</w>
9) -10(-
9)-10(- 2)
9)-10(-2) M)</w>
9) %.</w>
9%/ y)</w>
9%- 57.
9%-57. 9%)</w>
9 x400</w>
9 p.</w>
9 mm)</w>
9 mg/dl,</w>
9 h</w>
9 gm).</w>
9 THC</w>
9 THC.</w>
9 B:</w>
9 A</w>
9 :1</w>
9 :00,</w>
9 9.8%</w>
9 9.5</w>
9 9.3</w>
9 9.1</w>
9 9-year-old</w>
9 89
989 7),</w>
9 88</w>
9 87</w>
9 86</w>
9 81</w>
9 80</w>
9 800</w>
9 8.</w>
9 8.8</w>
9 8.7</w>
9 8.5+/-
98.5+/- 6.3</w>
9 8.5%</w>
9 8.3</w>
9 8.2</w>
9 72</w>
9 7.7</w>
9 7.5</w>
9 7-
97- kg</w>
9 7,
97, 392</w>
9 7%)</w>
9 7%),</w>
9 69</w>
9 64</w>
9 63</w>
9 60,</w>
9 6.6</w>
9 6,
96, 6
96,6 39</w>
9 6%).</w>
9 58
958 ,7
958,7 29)</w>
9 57</w>
9 55</w>
9 52</w>
9 51</w>
9 500</w>
9 50-
950- 2,4
950-2,4 75</w>
9 50,000</w>
9 5/80</w>
9 5.6</w>
9 5.5</w>
9 5.4</w>
9 5-year-old</w>
9 5-day</w>
9 5%.</w>
9 5%),</w>
9 41</w>
9 40</w>
9 40-6
940-6 100</w>
9 4.6%</w>
9 4.4</w>
9 4.2%</w>
9 4.1%</w>
9 3;</w>
9 39</w>
9 39).</w>
9 37</w>
9 37),</w>
9 36</w>
9 35</w>
9 32.
932. 2).</w>
9 30</w>
9 3/
93/ 53</w>
9 3.9%</w>
9 3.8%</w>
9 3.7</w>
9 3.7,</w>
9 3.4%</w>
9 3.3</w>
9 3.2%</w>
9 3.1</w>
9 3.0</w>
9 3,4
93,4 33</w>
9 3,000/
93,000/ cu</w>
9 3,
93, 29.
93,29. 13
93,29.13 )).</w>
9 3+/-8.
93+/-8. 36</w>
9 3+/-3</w>
9 3%).</w>
9 29</w>
9 29
929 2),</w>
9 281</w>
9 24</w>
9 22</w>
9 2.9
92.9 9%</w>
9 2.8%</w>
9 2.7</w>
9 2.7,</w>
9 2.6</w>
9 2.6%.</w>
9 2.6%,</w>
9 2.5).</w>
9 2.5%</w>
9 2.5%)</w>
9 2.4</w>
9 2.2</w>
9 2.2)</w>
9 2.2%,</w>
9 2.0%</w>
9 2,5
92,5 66</w>
9 2),</w>
9 2%;</w>
9 2%).</w>
9 2%),</w>
9 17</w>
9 17
917 ]</w>
9 160</w>
9 15),</w>
9 145</w>
9 13),</w>
9 12</w>
9 10+/-
910+/- 770</w>
9 1.9</w>
9 1.9%</w>
9 1.8%</w>
9 1.8%,</w>
9 1.70</w>
9 1.7%</w>
9 1.7%,</w>
9 1.6</w>
9 1.6%</w>
9 1.5%</w>
9 1.1</w>
9 1-1
91-1 ),</w>
9 1%)</w>
9 1%).</w>
9 1%),</w>
9 00,</w>
9 0.9%,</w>
9 0.6%</w>
9 0.5%</w>
9 0.4%</w>
9 0.3;</w>
9 0.3%;</w>
9 0.3%,</w>
9 0.2%</w>
9 0.1%</w>
9 0.1%,</w>
9 0.1%).</w>
9 0.00</w>
9 0.0%,</w>
9 .)</w>
9 -17
9-17 8)</w>
9 -12</w>
9 ,8
9,8 32</w>
9 ,6
9,6 20</w>
9 ,000</w>
9 ,000).</w>
9 ,0
9,0 37</w>
9 +/-1</w>
9 +/-10</w>
9 +/-1.2</w>
9 +/-1.0</w>
9 +/-1.
9+/-1. 3,</w>
9 *
9* 6)</w>
9 )]</w>
9 ):</w>
9 ).(ABSTRACT</w>
9 (7)</w>
9 %:</w>
9 %+/-
9%+/- 8.
9%+/-8. 5%;</w>
8d, 18
8d,18 h</w>
8d, 12h,</w>
89. ].</w>
89. 9,</w>
89. 9%</w>
89. 9%,</w>
89. 8+/-
89.8+/- 7.0</w>
89. 8%</w>
89. 6+/-
89.6+/- 2.2</w>
89. 6%</w>
89. 40</w>
89. 3%</w>
89. 25-
89.25- 36
89.25-36 9.5)</w>
89. 13%,</w>
89- 93;</w>
89- 4.7
89-4.7 6)</w>
89 :834-43)</w>
89 7).</w>
89 -199
89-199 3).</w>
89 -16
89-16 95</w>
89 );</w>
89 )),</w>
89 %-
89%- 99%).</w>
8800 6),</w>
8800 1</w>
88. 95+/-7.1</w>
88. 9%.</w>
88. 9%,</w>
88. 5%;</w>
88. 5%)</w>
88. 4-
88.4- 87
88.4-87 5.
88.4-875. 2)</w>
88. 4%</w>
88. 3)</w>
88. 3%,</w>
88. 2%</w>
88 81</w>
88 8-4
888-4 48-
888-448- 49
888-448-49 11)</w>
88 78</w>
88 7,</w>
88 4.</w>
88 4),</w>
88 2.5</w>
88 -1.6
88-1.6 2)</w>
88 -1)</w>
88 ,000</w>
88 +/-17</w>
88 );</w>
88 %.</w>
87. 9%</w>
87. 8%</w>
87. 8%,</w>
87. 5%).</w>
87. 4,</w>
87. 3%</w>
87- lead</w>
87- 2)</w>
87 percent</w>
87 :</w>
87 :323-330,</w>
87 9/microL</w>
87 9).</w>
87 8)</w>
87 614
87614 8).</w>
87 5)</w>
87 1)</w>
87 -1.
87-1. 29)</w>
87 );</w>
86. 90</w>
86. 9%;</w>
86. 80%</w>
86. 8%,</w>
86. 7)</w>
86. 7%</w>
86. 4,</w>
86. 4%</w>
86. 3)</w>
86. 1%</w>
86- 98).</w>
86- 4
86-4 21/
86-421/ min)</w>
86 ]).</w>
86 Rb</w>
86 Rb+</w>
86 9-01-2;</w>
86 8)</w>
86 6,
866, 399</w>
86 44.
8644. (ABSTRACT</w>
86 44,</w>
86 4+/-1
864+/-1 441</w>
86 3)</w>
86 3).</w>
86 20-
8620- 9650).</w>
86 1/
861/ patient)</w>
86 0,</w>
86 0)</w>
86 0%)</w>
86 -1).</w>
86 +/-1.
86+/-1. 26</w>
86 (3)</w>
86 %;</w>
86 %/y)</w>
85/ 108</w>
85. 9%,</w>
85. 7%</w>
85. 6,</w>
85. 6%</w>
85. 6%,</w>
85. 5%</w>
85. 1%</w>
85-1 10</w>
85-1 00);</w>
85- yr-old</w>
85- kDa</w>
85- Kd</w>
85- 99;</w>
85- 97;</w>
85- 87%.</w>
85- 2],</w>
84. 9%</w>
84. 8).</w>
84. 8%</w>
84. 79%</w>
84. 61%</w>
84. 57</w>
84. 5+/-
84.5+/- 3.1%</w>
84. 4.</w>
84. 0%,</w>
84+/- 41</w>
84+/- 3</w>
84+/- 0.04,</w>
84 8)</w>
84 60</w>
84 6)</w>
84 15</w>
84 12</w>
84 1+/-1
841+/-1 45</w>
84 +/-18</w>
838 7</w>
838 +/-
838+/- 209</w>
83. 9+/-6.8</w>
83. 12).</w>
83- 0)</w>
83 %])</w>
83 %-
83%- 8
83%-8 7%)</w>
83 %
83% and</w>
823 34),</w>
82.07 5.</w>
82- 97%</w>
82- 36-
82-36- 4)</w>
82 %:</w>
818 40
81840 -15-
81840-15- 5)</w>
81. 4%,</w>
81. 25%</w>
800/ mm3.</w>
800/ group)</w>
800/ 20</w>
800/ 200</w>
800- micrograms</w>
80/ min.</w>
80/ 45</w>
80/ 115</w>
80- mg</w>
80- mg/m2/d</w>
80- mg/day</w>
80- kHz</w>
80- fold</w>
80- coated</w>
80- V</w>
80- 89.].</w>
80- 7.
80-7. 92),</w>
80- 390)</w>
80- 350%</w>
80+/- 293</w>
80+/- 224</w>
80+/- 2.7</w>
80 mg</w>
80 mg/kg</w>
80 ])</w>
80 :</w>
80 :99.5%</w>
80 98</w>
80 9),</w>
80 8.</w>
80 8
808 30-
80830- 42-
80830-42- 8),</w>
80 7)</w>
80 3,</w>
80 3+/-0.
803+/-0. 108</w>
80 1:</w>
80 1),</w>
80 -120</w>
80 -1000</w>
80 -1,
80-1, 000).</w>
80 ,000</w>
80 ,
80, 5.4
80,5.4 2)),</w>
80 +/-17</w>
80 +/-1.
80+/-1. 77</w>
80 +/-0.06)</w>
80 %-
80%- occluded</w>
80 %);</w>
8/ year</w>
8/ s)</w>
8/ min),</w>
8/ greater</w>
8/ condition)</w>
8/ K18)</w>
8/ 99.3</w>
8/ 8</w>
8/ 86.7</w>
8/ 85</w>
8/ 81)</w>
8/ 72</w>
8/ 69</w>
8/ 57</w>
8/ 38</w>
8/ 33</w>
8/ 30,</w>
8/ 3/
8/3/ 0,</w>
8/ 28).</w>
8/ 23;</w>
8/ 21</w>
8/ 219</w>
8/ 20</w>
8/ 16.6</w>
8/ 159</w>
8/ 12,</w>
8/ 105</w>
8/ 101</w>
8/ 100,000).</w>
8/ 10,</w>
8/ 1/2/0,</w>
8/ 0.29
8/0.29 -1.
8/0.29-1. 27/
8/0.29-1.27/ 0.4
8/0.29-1.27/0.4 2).</w>
8/ -1
8/-1 3.6</w>
8.7+/- 7.8</w>
8.7+/- 3.7</w>
8.6 2;</w>
8.5+/- 7.7
8.5+/-7.7 s</w>
8.5+/- 55.
8.5+/-55. 31</w>
8.5+/- 3.
8.5+/-3. 5%).</w>
8.5+/- 24.3</w>
8.5+/- 20.4%,</w>
8.5 +/-1.7</w>
8.5 +/-1.0</w>
8.4 s.</w>
8.4 9;</w>
8.4 6;</w>
8.4 6),</w>
8.4 2),</w>
8.0/ 11.5</w>
8.0/ -5.
8.0/-5. 5,</w>
8.0+/- 8.6</w>
8.0+/- 8.5</w>
8.0 1,</w>
8.0 +/-1.6</w>
8. 9.</w>
8. 9)</w>
8. 9%</w>
8. 9%;</w>
8. 8;</w>
8. 89,</w>
8. 88</w>
8. 88)</w>
8. 85</w>
8. 84,</w>
8. 84+/-0.04,</w>
8. 8-1
8.8-1 1.7),</w>
8. 8-
8.8- 32.
8.8-32. 0)</w>
8. 8,</w>
8. 8+/-
8.8+/- 6.4</w>
8. 8%),</w>
8. 8
8.8 7;</w>
8. 79).</w>
8. 75</w>
8. 73</w>
8. 72</w>
8. 7/
8.7/ 1,000,000</w>
8. 7-fold</w>
8. 7-day-old</w>
8. 7-1
8.7-1 1.6
8.7-11.6 ],</w>
8. 7%,</w>
8. 7%)</w>
8. 67</w>
8. 65</w>
8. 64</w>
8. 63)</w>
8. 62,</w>
8. 60</w>
8. 60,</w>
8. 6+/-
8.6+/- 3.3</w>
8. 6),</w>
8. 6%)</w>
8. 59+/-
8.59+/- 0.04</w>
8. 551</w>
8. 53)</w>
8. 52</w>
8. 51</w>
8. 50</w>
8. 50,</w>
8. 5-10</w>
8. 5-1
8.5-1 8.7)</w>
8. 4;</w>
8. 48</w>
8. 47</w>
8. 4%.</w>
8. 4%,</w>
8. 3+/-
8.3+/- 47.6</w>
8. 3);</w>
8. 3).</w>
8. 3%,</w>
8. 3%).</w>
8. 3%),</w>
8. 2])</w>
8. 25-mg</w>
8. 23</w>
8. 23,</w>
8. 22</w>
8. 21),</w>
8. 2-fold</w>
8. 2+/-1.2</w>
8. 2).</w>
8. 2)
8.2) mg/kg.</w>
8. 2%,</w>
8. 2%).</w>
8. 2%),</w>
8. 2
8.2 mm</w>
8. 19%</w>
8. 16</w>
8. 16;</w>
8. 12</w>
8. 1),</w>
8. 1%;</w>
8. 1%,</w>
8. 1%).</w>
8. 09</w>
8. 07</w>
8. 06</w>
8. 0-fold</w>
8. 0,</w>
8. 0);</w>
8. 0%,</w>
8. 0%),</w>
8-phenyl theophylline,</w>
8-oxo- 7,8-
8-oxo-7,8- dihydro-2'-deoxyguanosine</w>
8-oxo guanine</w>
8-oxo deoxyguanosine</w>
8-hydroxy-2-di-n-propyl aminotetralin</w>
8-hydroxy-2-di-n-propyl amino</w>
8-hydroxy-2-di-n-propyl amino-tetralin</w>
8-hydroxy-2-(di-n-propyl amino)-tetralin</w>
8-hydroxy-2-(di-n-propyl -
8-hydroxy-2-(di-n-propyl- amino)-tetralin</w>
8-hydroxy-2-(di propylamino)tetralin</w>
8-hydroxy- dipropylamino-tetralin,</w>
8-hydroxy- di-N,N-propylaminotetralin</w>
8-hydroxy- deoxyguanosine-positive</w>
8-hydroxy- 2
8-hydroxy-2 (di-n-propyl
8-hydroxy-2(di-n-propyl amino)tetralin</w>
8-hydroxy guanosine</w>
8-hydroxy dipropylaminotetraline</w>
8-hydroxy deoxyguanosine</w>
8-cyclopentyl-1,3-dipropyl xantine</w>
8-cyclopentyl-1,3-dipropyl xanthine,</w>
8-cyclopentyl -1,3-di
8-cyclopentyl-1,3-di propulxanthine</w>
8-bromo guanosine</w>
8-OHGu a,</w>
8-OHDPA T-induced</w>
8-OH-DPA T-injected</w>
8-OH-DPA T-</w>
8-OH-DPA T)</w>
8-OH- dG)</w>
8-Hydroxy- 2-
8-Hydroxy-2- (di-n-propyl
8-Hydroxy-2-(di-n-propyl amino)</w>
8-Hydroxy- 2'-deoxyguanosine</w>
8-9. 95,</w>
8-9. 23;</w>
8-4 0.5%,</w>
8-25. 3).</w>
8-17 5.</w>
8-17 1)</w>
8-1. 60
8-1.60 ],</w>
8-1. 56)</w>
8-1. 48</w>
8-1. 29)</w>
8-1 9</w>
8-1 990).</w>
8-1 9).</w>
8-1 8</w>
8-1 8)</w>
8-1 8
8-18 y)</w>
8-1 7.
8-17. 9).</w>
8-1 68</w>
8-1 6.
8-16. 77)</w>
8-1 6%</w>
8-1 6%)</w>
8-1 5.</w>
8-1 5.9</w>
8-1 5-
8-15- 22,</w>
8-1 4,</w>
8-1 25)</w>
8-1 1.66).</w>
8-- with</w>
8-- portal</w>
8-(p-sulfophenyl) theophylline</w>
8-(p-sulfophenyl) theophylline,</w>
8-(3-chlorostyr yl)caffeine</w>
8-(3-chlorostyr yl)-caffeine</w>
8-( (E)-2-
8-((E)-2- (3,4-dimethoxyphenyl)
8-((E)-2-(3,4-dimethoxyphenyl) ethenyl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione</w>
8- yr-old</w>
8- wk-old</w>
8- weeks-old</w>
8- somite</w>
8- second</w>
8- p-sulfophenyltheophylline</w>
8- oxodG</w>
8- min</w>
8- methylbenz[c]acridine.</w>
8- methoxy-2-propionamidotetralin,</w>
8- isoprostanes</w>
8- isoprostane</w>
8- hydroxy</w>
8- furyl-9-ethyladenine</w>
8- ethoxy-</w>
8- dichloro-1,</w>
8- day,</w>
8- cyclopenthyl-1,3-dipropylxanthine</w>
8- chloro-2,3,4,5-n-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine</w>
8- bromo</w>
8- bromo-9-ethyladenine</w>
8- azido-5,6-dihydro-5-methyl-6-oxo-4H-imidazo-(1,5-a)</w>
8- Tetrahydrocannabinol</w>
8- THC</w>
8- SPT-pretreated</w>
8- Methyl-N-vanillyl-6-nonenamide</w>
8- Methoxy-2-propionamidotetralin</w>
8- MOP.</w>
8- 9%</w>
8- 88-1)</w>
8- 8.63)</w>
8- 78.
8-78. 0%</w>
8- 76.
8-76. 0)</w>
8- 73</w>
8- 73,</w>
8- 72;</w>
8- 67).</w>
8- 63.
8-63. 5,</w>
8- 58).</w>
8- 538
8-538 7</w>
8- 53-
8-53- 9),</w>
8- 50
8-50 ];</w>
8- 5.0
8-5.0 9),</w>
8- 467)</w>
8- 45)</w>
8- 42</w>
8- 423</w>
8- 37.9</w>
8- 37.
8-37. 1]),</w>
8- 37-
8-37- 7),</w>
8- 35.
8-35. 6]</w>
8- 3.8).</w>
8- 3.0
8-3.0 9/1.03).</w>
8- 3
8-3 1.88).</w>
8- 28
8-28 3)</w>
8- 26-
8-26- 4)</w>
8- 24</w>
8- 234</w>
8- 23
8-23 %];</w>
8- 22.
8-22. 2)</w>
8- 22),</w>
8- 215)</w>
8- 2001,</w>
8- 2.9
8-2.9 5,</w>
8- 2.5).</w>
8- 2.4</w>
8- 2.08).</w>
8- -12</w>
8- -10</w>
8- (4-(2-
8-(4-(2- aminoethyl)-aminocarboxylmethyloxy)phenyl-1,3-dipropylxant</w>
8,5 66</w>
8,5 12</w>
8, 809</w>
8, 800</w>
8, 770</w>
8, 245</w>
8, 165</w>
8, 15;</w>
8, 151)</w>
8, 140</w>
8, 0</w>
8+/-1 40</w>
8+/-1 2.9%</w>
8+/-1 0%</w>
8+/- 9.36).</w>
8+/- 9%,</w>
8+/- 8</w>
8+/- 7.5</w>
8+/- 6.
8+/-6. 90</w>
8+/- 5.4</w>
8+/- 4</w>
8+/- 4.6%</w>
8+/- 3.1</w>
8+/- 3.0</w>
8+/- 3%</w>
8+/- 21.0</w>
8+/- 20</w>
8+/- 2.0</w>
8+/- 2.0%</w>
8+/- 0.7</w>
8+/- 0.6</w>
8+/- 0.4</w>
8+/- 0.3</w>
8+/- 0.20</w>
8+/- 0.03),</w>
8%- 95%)</w>
8%- 32%).</w>
8%- 23%).</w>
8%- 20%</w>
8 p11.1-21,</w>
8 nmol/mg</w>
8 months</w>
8 mm.</w>
8 mg</w>
8 gm/24h,</w>
8 e</w>
8 beta-ergoline</w>
8 alpha-ergoline</w>
8 a,</w>
8 ];</w>
8 ]).</w>
8 P</w>
8 H),</w>
8 :18,</w>
8 9;</w>
8 9976-A,</w>
8 93</w>
8 90</w>
8 9.4</w>
8 9).</w>
8 9%).</w>
8 8;</w>
8 88</w>
8 85</w>
8 82</w>
8 800</w>
8 80+/-293</w>
8 8.9</w>
8 8.4</w>
8 8.3</w>
8 8.0</w>
8 8+/-6.90</w>
8 8+/-2</w>
8 8%).</w>
8 78
878 /
878/ patient</w>
8 75%</w>
8 73</w>
8 71</w>
8 7/
87/ %</w>
8 7.8</w>
8 7.7</w>
8 7.5</w>
8 7.5%</w>
8 7),</w>
8 7%).</w>
8 7%),</w>
8 6;</w>
8 64</w>
8 6.9</w>
8 6.6</w>
8 6.5</w>
8 6.3</w>
8 6.2</w>
8 58</w>
8 58-
858- 860,</w>
8 56
856 +/-
856+/- 259</w>
8 55
855 2.</w>
8 54</w>
8 53).</w>
8 51</w>
8 51%</w>
8 506)</w>
8 50
850 1/
8501/ GOG</w>
8 5.9</w>
8 5.4</w>
8 5.1</w>
8 5+/-16</w>
8 5+/-
85+/- 3%</w>
8 5);</w>
8 5%-
85%- 90%</w>
8 5
85 Sr</w>
8 49</w>
8 47</w>
8 45</w>
8 44
844 C)</w>
8 43</w>
8 42)</w>
8 40/
840/ microL,</w>
8 40)</w>
8 4.7</w>
8 4.6%</w>
8 4.6
84.6 -10
84.6-10 0.0%)</w>
8 4.2</w>
8 4.1</w>
8 4.0</w>
8 4-1
84-1 6-
84-16- 2).</w>
8 4%;</w>
8 4%.</w>
8 395</w>
8 39.5</w>
8 38</w>
8 36</w>
8 34).</w>
8 33,</w>
8 33)</w>
8 33),</w>
8 32</w>
8 31</w>
8 305</w>
8 3/
83/ min</w>
8 3.8</w>
8 3.7</w>
8 3.7%</w>
8 3.7
83.7 +/-1
83.7+/-1 0.1</w>
8 3.6</w>
8 3.6%</w>
8 3.5</w>
8 3.3,</w>
8 3.2</w>
8 3.1%</w>
8 3.0).</w>
8 3.0%</w>
8 3,7
83,7 70</w>
8 3,
83, 156).</w>
8 3+/-
83+/- 34</w>
8 3),</w>
8 3%.</w>
8 28</w>
8 263</w>
8 26
826 266)</w>
8 24%,</w>
8 23</w>
8 22</w>
8 22.</w>
8 216</w>
8 2/
82/ 44</w>
8 2.8,</w>
8 2.7</w>
8 2.7)</w>
8 2.7
82.7 1%,</w>
8 2.4</w>
8 2.2</w>
8 2.2%</w>
8 2.1</w>
8 2.1;</w>
8 2.0</w>
8 2.
82. 7%),</w>
8 2-year</w>
8 2,8
82,8 54</w>
8 2+</w>
8 2)
82) >/=p-F-HHSiD</w>
8 2%)</w>
8 2%).</w>
8 19</w>
8 18</w>
8 16</w>
8 16),</w>
8 143</w>
8 14),</w>
8 138</w>
8 12</w>
8 12.5+/-
812.5+/- 839.5</w>
8 10</w>
8 102).</w>
8 1/2</w>
8 1.8</w>
8 1.8%,</w>
8 1.4%</w>
8 1.4
81.4 8%</w>
8 1.3</w>
8 1.3%.</w>
8 1.2%</w>
8 1.0%</w>
8 1.0%.</w>
8 1-month</w>
8 1-4
81-4 457</w>
8 1-1
81-1 20</w>
8 1-
81- 97%</w>
8 1,6
81,6 20</w>
8 1,000</w>
8 1,
81, 373</w>
8 1+/-
81+/- 0.69</w>
8 1);</w>
8 00-mg</w>
8 00
800 -1
800-1 600</w>
8 0.9</w>
8 0.9%.</w>
8 0.7%</w>
8 0.6,</w>
8 0.6%</w>
8 0.5</w>
8 0.5
80.5 -10
80.5-10 9.3);</w>
8 0.4%</w>
8 0.4%;</w>
8 0.35%</w>
8 0.29;</w>
8 0.2%,</w>
8 0.2%).</w>
8 0.1</w>
8 0.1%</w>
8 0.0).</w>
8 0.0%</w>
8 -14
8-14 2.9)</w>
8 -1,020</w>
8 ,0
8,0 11</w>
8 +/-1.8</w>
8 +).</w>
8 +
8+ 5.6</w>
8 )M</w>
8 ):</w>
8 ))</w>
8 )%</w>
8 (18.
8(18. 3)
8(18.3) %.</w>
7th- day.</w>
7alpha- hydroxylase.</w>
7: 217
7:217 20-
7:21720- 217
7:21720-217 26).</w>
797 (-
797(- ).</w>
79/ 88)</w>
79/ 10,000</w>
79. 8%,</w>
79. 6,</w>
79. 6%</w>
79. 4%</w>
79. 3%.</w>
79. 0%</w>
79 ],</w>
79 8-26-4)</w>
79 8),</w>
79 7.
797. 6
797.6 +/-10
797.6+/-10 3.3</w>
79 5)</w>
79 31</w>
79 +/-1</w>
79 %.</w>
7810 94)</w>
7810 94),</w>
78. 9%</w>
78. 8)</w>
78. 56</w>
78. 5%,</w>
78. 30mg/kg</w>
78. 3%.</w>
78. 1+/-
78.1+/- 2.9</w>
78. 1%.</w>
78- 89%</w>
78- 3.95</w>
78+/- 0.28</w>
78+/- 0.02)</w>
78 ])</w>
78 9,</w>
78 8.5</w>
78 70</w>
78 7-
787- 4,7
787-4,7 66</w>
78 7%</w>
78 5</w>
78 5,</w>
78 5)</w>
78 21,</w>
78 15</w>
78 +/-1
78+/-1 0.60</w>
78 %.</w>
78 %
78% )).</w>
77. 8),</w>
77. 8%</w>
77. 7).</w>
77. 5)</w>
77. 4+/-1
77.4+/-1 4.6</w>
77. 4%</w>
77- 954</w>
77- 91%)</w>
77%- 98%</w>
77%- 93%</w>
77 9,</w>
77 7,</w>
77 5.8</w>
77 28;</w>
77 20</w>
77 -induced</w>
77 +/-1.
77+/-1. 43,</w>
76. 7)</w>
76. 7%</w>
76. 6),</w>
76. 6%</w>
76. 6%,</w>
76. 5%</w>
76. 4%</w>
76. 3).</w>
76. 2;</w>
76. 2%</w>
76. 1%,</w>
76. 0).</w>
76. 0%</w>
76- yr-old</w>
76- kD</w>
76- 94)</w>
76- 2000).</w>
76 8;</w>
76 6),</w>
76 3,</w>
76 2.</w>
76 )>
76)> methoctramine</w>
750 mg.</w>
750 -1500</w>
75/ 829</w>
75/ 292)</w>
75. 996;</w>
75. 9%)</w>
75. 8).</w>
75. 6%</w>
75. 4%,</w>
75. 38</w>
75. 35
75.35 +/-15.
75.35+/-15. 77</w>
75. 3+/-1
75.3+/-1 9.9microg/ml</w>
75. 2%</w>
75. 15+/-
75.15+/- 24.
75.15+/-24. 23</w>
75. 0%,</w>
75- micrograms</w>
75- microg</w>
75- kDa</w>
75- 85</w>
75- 80</w>
75- 0.1</w>
75+/- 3.7</w>
75+/- 2.31;</w>
75 s,</w>
75 8.60</w>
75 7.6</w>
75 5.3</w>
75 42</w>
75 25</w>
75 1).</w>
75 000).</w>
75 -</w>
75 ,000</w>
75 +</w>
75 ):</w>
75 %).(ABSTRACT</w>
74. 8%</w>
74. 6,</w>
74. 4-
74.4- mN</w>
74. 36%,</w>
74. 2%.</w>
74. 1%),</w>
74. 0-
74.0- 94.8%.</w>
74- 76</w>
74- 2001)</w>
74 min;</w>
74 6).</w>
74 4.</w>
74 4-
744- anesthetized</w>
74 3,</w>
74 1)</w>
74 (14)</w>
73:259-26 5;</w>
73:259-26 5).</w>
73. 7%,</w>
73. 5-1
73.5-1 00%).</w>
73. 4%,</w>
73. 3%,</w>
73. 1)],</w>
73. 1%,</w>
73- kilodalton</w>
73- 91),</w>
73- 3,</w>
73 6)</w>
73 49</w>
73 2,
732, 13
732,13 8),</w>
73 0.5</w>
727 ]</w>
727 2-80
7272-80 ].</w>
726 64-
72664- -</w>
726 64,</w>
720 63),</w>
72/ day.</w>
72/ 48</w>
72- 98);</w>
72- 78)</w>
72+/- 30</w>
72+/- 0.15
72+/-0.15 nmol/ml</w>
72 h.</w>
72 ])</w>
72 +/-1</w>
714 2,</w>
714 2).</w>
711389- S,</w>
71+/- 0</w>
71+/- 0.97</w>
71+/- 0.69</w>
71+/- 0.019</w>
700/ mm3.</w>
700/ mm3)</w>
700- 7
700-7 25</w>
700- 2,800</w>
70/ min</w>
70/ min.</w>
70/ 55</w>
70/ 45</w>
70/ 40</w>
70/ 0).</w>
70- year-old)</w>
70- kg</w>
70- kDa</w>
70- day-old</w>
70- August</w>
70- 90%</w>
70- 85%).</w>
70- 80%).</w>
70- 8),</w>
70- 75</w>
70- 448
70-448 5),</w>
70- 400%</w>
70- 4),</w>
70 s</w>
70 mug/ml,</w>
70 dB</w>
70 b)</w>
70 9;</w>
70 8</w>
70 8),</w>
70 33</w>
70 2</w>
70 -125</w>
70 -100</w>
70 -100
70-100 %).</w>
70 ,9
70,9 71</w>
70 ,000</w>
70 (SEM</w>
70 (3)</w>
70 (2
70(2 6)</w>
70 %);</w>
7/27 9)</w>
7/27 4)</w>
7/ s)</w>
7/ min,</w>
7/ min)</w>
7/ group)</w>
7/ 9</w>
7/ 99</w>
7/ 99.1</w>
7/ 90</w>
7/ 7/
7/7/ 7)</w>
7/ 52</w>
7/ 50
7/50 5)</w>
7/ 48</w>
7/ 46</w>
7/ 3
7/3 10)</w>
7/ 25</w>
7/ 24</w>
7/ 22</w>
7/ 22).</w>
7/ 20</w>
7/ 16</w>
7/ 161)</w>
7/ 16.6</w>
7/ 15</w>
7/ 1513</w>
7/ 150</w>
7/ 150;</w>
7/ 134)</w>
7/ 123</w>
7/ 11</w>
7/ 118)</w>
7/ 100,000</w>
7/ 10,</w>
7/ 1,000</w>
7.8 mm</w>
7.8 ]</w>
7.8 9+/-0.12</w>
7.8 2)</w>
7.8 1,</w>
7.8 +/-1.6</w>
7.8 %
7.8% versus</w>
7.7 6).</w>
7.7 47</w>
7.7 3;</w>
7.7 2,</w>
7.7 1/
7.71/ dl</w>
7.7 +/-19.
7.7+/-19. 2,</w>
7.5-1 29</w>
7.5-1 0.0
7.5-10.0 mg/day,</w>
7.5- cm)</w>
7.5- 8.3</w>
7.5- 750</w>
7.4 28
7.428 +/-0.0
7.428+/-0.0 32</w>
7.4 +/-1.3</w>
7.3- 8.0</w>
7.3- 32.
7.3-32. 8%,</w>
7.2+/- 3.6</w>
7.2+/- 3.4,</w>
7.2+/- 3.3</w>
7.2+/- 0.1,</w>
7.1+/- 2.4)</w>
7.1+/- 0.08%</w>
7.0 7</w>
7.0 5)</w>
7.0 4</w>
7.0 4),</w>
7.0 3)</w>
7.0 2;</w>
7.0 1</w>
7. Patient</w>
7. 92</w>
7. 91</w>
7. 9-56.9]),</w>
7. 9)</w>
7. 9%;</w>
7. 9%.</w>
7. 9%,</w>
7. 89</w>
7. 85</w>
7. 8-fold,</w>
7. 8%</w>
7. 8%.</w>
7. 8%,</w>
7. 78</w>
7. 70,</w>
7. 7-fold</w>
7. 7-2
7.7-2 0.9%,</w>
7. 7).</w>
7. 7),</w>
7. 7%;</w>
7. 7%.</w>
7. 7%),</w>
7. 6;</w>
7. 67;</w>
7. 64,</w>
7. 63</w>
7. 63+/-
7.63+/- 0.03,</w>
7. 62</w>
7. 61,</w>
7. 6-1
7.6-1 8%</w>
7. 6)</w>
7. 6%.</w>
7. 6%),</w>
7. 5;</w>
7. 59</w>
7. 57,</w>
7. 563)</w>
7. 56)</w>
7. 56%).</w>
7. 55),</w>
7. 54</w>
7. 54,</w>
7. 53</w>
7. 50,</w>
7. 5/10.</w>
7. 5-10</w>
7. 5%).</w>
7. 5%),</w>
7. 5
7.5 11,</w>
7. 46;</w>
7. 45</w>
7. 45%</w>
7. 420</w>
7. 42,</w>
7. 40</w>
7. 4%.</w>
7. 3;</w>
7. 39</w>
7. 39,</w>
7. 38</w>
7. 37
7.37 2+/-0.0
7.372+/-0.0 15.</w>
7. 35,</w>
7. 35)</w>
7. 339</w>
7. 33)</w>
7. 30</w>
7. 30:</w>
7. 30,</w>
7. 3.</w>
7. 3+/-1
7.3+/-1 6.2%;</w>
7. 3+/-0.
7.3+/-0. 1.</w>
7. 3),</w>
7. 3%;</w>
7. 3%.</w>
7. 3%,</w>
7. 29</w>
7. 29.</w>
7. 29,</w>
7. 28),</w>
7. 27</w>
7. 25</w>
7. 25%),</w>
7. 23;</w>
7. 20</w>
7. 2+/-1.
7.2+/-1. 9</w>
7. 2)</w>
7. 2);</w>
7. 2%,</w>
7. 2
7.2 g</w>
7. 19</w>
7. 19;</w>
7. 18).</w>
7. 15,</w>
7. 13</w>
7. 13.</w>
7. 13,</w>
7. 1/
7.1/ 1,000,000</w>
7. 1.</w>
7. 1.3
7.1.3 5)</w>
7. 1-fold</w>
7. 1-1
7.1-1 5.4
7.1-15.4 );</w>
7. 1,</w>
7. 1%),</w>
7. 1
7.1 x10(9)/l</w>
7. 00,</w>
7. 00
7.00 )].</w>
7. 0-18.7</w>
7. 0)</w>
7. 0%</w>
7. 0%).</w>
7-oxo- PgI2.</w>
7-nitroinda zole.</w>
7-hydroxy- methotrexate</w>
7-hydroxy- dipropyloaminotetralin</w>
7-hydroxy- FZ</w>
7-hydroxy chlorpromazine</w>
7-hydroxy chlorpromazine,</w>
7-hydroxy aminofluorene</w>
7-hydroxy -1,2,3,4,
7-hydroxy-1,2,3,4, 4
7-hydroxy-1,2,3,4,4 a,5,6,10b-octahydrobenzo(f)quinoline</w>
7-chloro- 2-methyl
7-chloro-2-methyl xanthone</w>
7-chloro kynurinic</w>
7-OH- MTX.</w>
7-OH- AF</w>
7-N I/saline</w>
7-N I.</w>
7-F r</w>
7-Cl-Kyn A</w>
7-CK A.</w>
7-CK A,</w>
7-CK A)</w>
7-CK A),</w>
7-8 4.6</w>
7-8 3);</w>
7-75. 7)</w>
7-75. 4%),</w>
7-70 0.0</w>
7-70 +/-
7-70+/- 9</w>
7-5. 44</w>
7-5. 21).</w>
7-30 2]</w>
7-3. 54)</w>
7-3. 5%).</w>
7-2.5 6,</w>
7-2.5 2).</w>
7-2. 57
7-2.57 );</w>
7-2. 34</w>
7-2. 27).</w>
7-2 0.75</w>
7-2 0.7);</w>
7-1.7 5%).</w>
7-1.7 0)</w>
7-1. 85;</w>
7-1. 85)</w>
7-1. 38;</w>
7-1 998</w>
7-1 995)</w>
7-1 8</w>
7-1 83)</w>
7-1 80</w>
7-1 8.5)</w>
7-1 70</w>
7-1 6-year-old</w>
7-1 6,</w>
7-1 50</w>
7-1 5.8).</w>
7-1 360</w>
7-1 3/
7-13/ group)</w>
7-1 3)</w>
7-1 2.
7-12. 3),</w>
7-1 2,</w>
7-1 2).</w>
7-1 1h</w>
7-1 10</w>
7-1 0-
7-10- day-old</w>
7-1 0%</w>
7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)- 3,4-dihydro-2</w>
7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)- 3,4-di
7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-di hydro</w>
7-(2- [3,5-dichloro-4-oxo-1(4H)-pyridyl]-acetamido)-3-([(5-methyl-1,3,4-thiadiazol-2-yl)-thio]methyl)-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic</w>
7- year)</w>
7- type</w>
7- triamino-6-phenylpteridine)</w>
7- transmembrane</w>
7- tetrahydro-6-propyl-amino-benzthiazole-dihydrochloride),</w>
7- subunit.</w>
7- null</w>
7- month</w>
7- item</w>
7- hour</w>
7- hexanoyltaxol</w>
7- fold.</w>
7- ethyl-10-hydroxycamptothecin</w>
7- dimethoxyl-4-ethyl-beta-carboline-3-carboxylate</w>
7- dichloroquinoxaline-2,3-dione)</w>
7- diaminopteridine-6-(N-2-hydroxyethyl)</w>
7- d-old</w>
7- county</w>
7- containing</w>
7- amino</w>
7- amino-cephalosporanic</w>
7- [1-(4-chlorophenoxy)]ethyl]-1,2,4-triazolo(1,5-alpha)pyrimidine,</w>
7- P9)</w>
7- October</w>
7- Nitroindazole</w>
7- NINA</w>
7- DHT</w>
7- D-glutamylaminomethyl</w>
7- C8).</w>
7- 9mm)</w>
7- 92)</w>
7- 9.6</w>
7- 9-week-old</w>
7- 9)</w>
7- 82</w>
7- 81)</w>
7- 80</w>
7- 79.3%.</w>
7- 76</w>
7- 70-8),</w>
7- 7.11).</w>
7- 68
7-68 ):</w>
7- 6.5</w>
7- 6
7-6 1.4)</w>
7- 5</w>
7- 4.
7-4. 21)</w>
7- 36</w>
7- 36)</w>
7- 31</w>
7- 300
7-300 )</w>
7- 3.1</w>
7- 23)</w>
7- 22.
7-22. 6)</w>
7- 21</w>
7- 20-fold</w>
7- 2.5</w>
7- 2)</w>
7- 0.75</w>
7- 0.6
7-0.6 6]).</w>
7- 0.4
7-0.4 6),</w>
7- 0.37)</w>
7- 0),</w>
7- -4
7--4 4%).</w>
7,8- Dihydro-8-oxo-guanine</w>
7,7- triphenylheptyl-UDP.</w>
7,7- dimethyl-1,2,3,4,5,6,7,8-octahydro-5-oxo-3-(substitutedphenyl)quinazoline</w>
7,12-dimethylbenz [a]anthracene-induced</w>
7,12-dimethylbenz (a)
7,12-dimethylbenz(a) anthracene</w>
7, 9-dimethylbenz[c]acridine:</w>
7, 7,7-triphenylheptyl-UDP.</w>
7, 668</w>
7, 644</w>
7, 600</w>
7, 60
7,60 7</w>
7, 400/
7,400/ cu.mm</w>
7, 348</w>
7, 313</w>
7, 177</w>
7, 171</w>
7, -
7,- dimethyl-1-propargylxanthine</w>
7+/-1 4.6</w>
7+/-1 2.3</w>
7+/-1 0.62</w>
7+/- 9</w>
7+/- 8</w>
7+/- 8.7</w>
7+/- 6.5%</w>
7+/- 4.3</w>
7+/- 4,*</w>
7+/- 3</w>
7+/- 3.7</w>
7+/- 3.4</w>
7+/- 3.3,</w>
7+/- 3.1</w>
7+/- 27.
7+/-27. 7%;</w>
7+/- 2.2</w>
7+/- 0.7</w>
7+/- 0.75</w>
7+/- 0.4
7+/-0.4 3
7+/-0.43 nmol/ml</w>
7+/- 0.3</w>
7+/- 0.10).</w>
7+/- 0.05</w>
7+/- 0.01</w>
7)- 2.58</w>
7) %,</w>
7 patients</w>
7 ol</w>
7 mg%),</w>
7 e</w>
7 e,</w>
7 d-14d</w>
7 a-19a</w>
7 ]).</w>
7 LiCl-treated</w>
7 LiCl)</w>
7 Li.</w>
7 A1,</w>
7 ;15:2378.</w>
7 :30</w>
7 :1.</w>
7 :00</w>
7 :00-19:00</w>
7 9;</w>
7 97</w>
7 96</w>
7 94</w>
7 90</w>
7 9.9</w>
7 9.8</w>
7 9.8%</w>
7 9.7</w>
7 9.5</w>
7 9.4</w>
7 9.0</w>
7 9-year</w>
7 9-month</w>
7 9-1985)</w>
7 9),</w>
7 9%)</w>
7 9%).</w>
7 80.</w>
7 8.9</w>
7 8.5</w>
7 8.5%</w>
7 8.3%</w>
7 75</w>
7 7.</w>
7 7.9</w>
7 7.4</w>
7 7.2</w>
7 7.0</w>
7 7+/-9</w>
7 6;</w>
7 65</w>
7 6002</w>
7 6.6</w>
7 6.4</w>
7 6-1
76-1 33%,</w>
7 6%),</w>
7 58
758 47-
75847- 73-3,</w>
7 55</w>
7 51</w>
7 50/
750/ 1000</w>
7 50-mg</w>
7 50-1000</w>
7 50-
750- bed</w>
7 5.6</w>
7 5.5</w>
7 5.0</w>
7 5-150</w>
7 5,
75, 761</w>
7 49</w>
7 49
749 +).</w>
7 46.
746. 5
746.5 nM).</w>
7 45</w>
7 450</w>
7 44
744 -</w>
7 42)</w>
7 4/
74/ 48</w>
7 4.4</w>
7 4.3%</w>
7 4.2%</w>
7 4.1%</w>
7 4-year</w>
7 4-fold</w>
7 4),</w>
7 4%),</w>
7 39).</w>
7 378</w>
7 36+/-
736+/- 277</w>
7 36),</w>
7 3.9</w>
7 3.8</w>
7 3.7</w>
7 3.6%</w>
7 3.5</w>
7 3.4</w>
7 3.3</w>
7 3.2%</w>
7 3.0</w>
7 3+/-26</w>
7 3%.</w>
7 3%)</w>
7 3%),</w>
7 29,
729, 294</w>
7 28).</w>
7 22.</w>
7 21).</w>
7 2.</w>
7 2.8%</w>
7 2.7</w>
7 2.7%</w>
7 2.6</w>
7 2.6+/-1
72.6+/-1 8.6;</w>
7 2.5</w>
7 2.5%</w>
7 2.2</w>
7 2.1%</w>
7 2.0%,</w>
7 2.0
72.0 +/-
72.0+/- 6.3</w>
7 2.
72. 4/mm3</w>
7 2-year</w>
7 2-</w>
7 2-1.
72-1. 96)</w>
7 2%;</w>
7 2%)</w>
7 2%),</w>
7 1A)</w>
7 18
718 5,</w>
7 17-
717- 722.</w>
7 152</w>
7 145</w>
7 11;</w>
7 111</w>
7 1038
71038 ),</w>
7 10,</w>
7 10),</w>
7 1/75</w>
7 1.9%</w>
7 1.9%,</w>
7 1.8%</w>
7 1.6-
71.6- 95.3</w>
7 1.5%</w>
7 1.4;</w>
7 1.4%,</w>
7 1.3%</w>
7 1.2).</w>
7 1.1</w>
7 1.1%</w>
7 1.0</w>
7 1.0%</w>
7 1.0%,</w>
7 1.
71. 3),</w>
7 1-1
71-1 5-
71-15- 4)</w>
7 1,100</w>
7 1%;</w>
7 1%).</w>
7 1%),</w>
7 0.9</w>
7 0.6%.</w>
7 0.4%</w>
7 0.3</w>
7 0.1-
70.1- 91.3%).</w>
7 0.0%,</w>
7 0.
70. ].</w>
7 ,000/mm3.</w>
7 +/-101</w>
7 +/-1.6</w>
7 +/-1.3</w>
7 +/-1.
7+/-1. 8%,</w>
7 )]</w>
7 )],</w>
7 ).(ABSTRACT</w>
7 ))</w>
7 )).</w>
7 %])</w>
7 %-
7%- 4
7%-4 6%)</w>
7 %)].</w>
7 %).(ABSTRACT</w>
6B 9;</w>
6B 9:</w>
6B 9)</w>
6; 7.4)</w>
69. 75</w>
69. 74%),</w>
69. 72</w>
69. 7%,</w>
69. 3%</w>
69. 17</w>
69. 1),</w>
69- yr-old</w>
69- 89%,</w>
69- 66-
69-66- 5)</w>
69 :647-651;</w>
69 9</w>
69 88)</w>
69 76.</w>
69 61)</w>
69 5/
695/ mm(3).</w>
69 5.0
695.0 5+/-
695.05+/- 9.69,</w>
69 22</w>
69 2).</w>
69 2),</w>
69 1),</w>
69 00</w>
69 /
69/ 19
69/19 43)</w>
69 -199
69-199 0,</w>
69 -1.6
69-1.6 3;</w>
69 +/-
69+/- 868</w>
69 );</w>
69 %.</w>
69 %):</w>
68/ 176</w>
68/ 100).</w>
68. 8,</w>
68. 4%;</w>
68. 35</w>
68. 3%,</w>
68. 1%</w>
68. 0%</w>
68- year-old-man</w>
68- 95</w>
68- 92</w>
68- 88)</w>
68- 0.9
68-0.9 42)</w>
68, 798),</w>
68, 779</w>
68 dB</w>
68 98</w>
68 97</w>
68 9),</w>
68 53</w>
68 4-
684- 93-5)</w>
68 4,
684, 706</w>
68 4+/-
684+/- 215</w>
68 2,2,
682,2, 803,</w>
68 10</w>
68 0.7</w>
68 -</w>
68 );</w>
68 %;</w>
67/ 78</w>
67/ 52
67/52 mmHg</w>
67/ 1513</w>
67. 9%).</w>
67. 7%</w>
67. 7%,</w>
67. 6</w>
67. 66</w>
67. 6-
67.6- 90,</w>
67. 6%</w>
67. 5,</w>
67. 5+/-
67.5+/- 5.7</w>
67. 5%</w>
67. 5%,</w>
67. 48),</w>
67. 40
67.40 +/-1
67.40+/-1 0.25</w>
67. 4+/-
67.4+/- 88.1</w>
67. 4%)</w>
67. 2</w>
67. 2%</w>
67. 17)</w>
67. 0%</w>
67. 0%;</w>
67. 0%,</w>
67-1 483</w>
67-1 27
67-127 3].</w>
67- 89</w>
67- 87).</w>
67- 84%</w>
67- 73%</w>
67- 5
67-5 2-
67-52- 7],</w>
67+/- 0.49,</w>
67 phox)</w>
67 Gallium</w>
67 :51-53,</w>
67 97</w>
67 91-6798],</w>
67 9)</w>
67 8).</w>
67 7),</w>
67 64</w>
67 2,</w>
67 +</w>
67 +/-10</w>
67 )].</w>
67 )>
67)> carbachol</w>
67 );</w>
67 %;</w>
66. 9+/-14.0</w>
66. 8%</w>
66. 78+/-10.60</w>
66. 7%.</w>
66. 7%),</w>
66. 6%;</w>
66. 6%,</w>
66. 5%</w>
66. 4-10
66.4-10 8.6%).</w>
66. 4%.</w>
66. 3)</w>
66. 2%,</w>
66-year-old- resident</w>
66-year-old- male</w>
66- year-old-female</w>
66- fold,</w>
66- d-break</w>
66- 99</w>
66- 2.
66-2. 17)</w>
66 8.3+/-47.6</w>
66 8).</w>
66 7;</w>
66 75</w>
66 49</w>
66 4.
664. 81</w>
66 2,</w>
66 -1.7
66-1.7 2)</w>
66 +/-1
66+/-1 1%</w>
66 );</w>
66 %].</w>
655 1</w>
65/ 88),</w>
65/ 35</w>
65/ 188</w>
65. 8%</w>
65. 7-79.3%.</w>
65. 7%).</w>
65. 6%</w>
65. 6%,</w>
65. 5+/-
65.5+/- 27.0</w>
65. 5),</w>
65. 3%</w>
65. 2+/-1
65.2+/-1 0.8</w>
65. 2+/-
65.2+/- 9.8</w>
65. 2%;</w>
65- year-old,</w>
65- present).</w>
65- 95),</w>
65- 85)</w>
65- 85%</w>
65- 83</w>
65- 80</w>
65- 8.12</w>
65- 77);</w>
65- 73</w>
65- 0.25</w>
65+/-1 1</w>
65+/-1 0.27</w>
65+/- 4</w>
65+/- 0.98</w>
65 8)</w>
65 66</w>
65 32</w>
65 1,6
651,6 67</w>
65 +</w>
65 )
65) ];</w>
64. 92,</w>
64. 9-81.1%,</w>
64. 9+/-12.1</w>
64. 7%</w>
64. 5%,</w>
64. 0-
64.0- 95.8%).</w>
64- yr-old</w>
64- slice</w>
64- 93).</w>
64- 324</w>
64, 740</w>
64, 311</w>
64 y.)</w>
64 Cu-loading</w>
64 7,</w>
64 35</w>
64 213</w>
64 13
6413 9,</w>
64 10),</w>
637- 643.</w>
637- 0
637-0 7-0),</w>
63. 63%</w>
63. 6%)</w>
63. 46%</w>
63. 4)</w>
63. 2%</w>
63. 2%)</w>
63. 1,</w>
63. 1%</w>
63. 1%,</w>
63- 85</w>
63- 6)</w>
63- 3.58)</w>
63- 2.5</w>
63+/- 9.98</w>
63+/- 0.75</w>
63 7,</w>
63 6,</w>
63 5)</w>
63 5).</w>
63 39</w>
63 1)</w>
63 +</w>
63 +/-12</w>
62026 1)</w>
62026 1).</w>
620 5+/-
6205+/- 3
6205+/-3 184</w>
62/ 92</w>
62/ 88).</w>
62.9 3%,</w>
62.9 (2
62.9(2 26.
62.9(226. 3)</w>
62. 9%</w>
62. 8%</w>
62. 8%,</w>
62. 5+/-
62.5+/- 33.0</w>
62. 5%:</w>
62. 4%)</w>
62. 2%,</w>
62+/- 6</w>
62+/- 3.
62+/-3. 12;</w>
62 ].</w>
62 E),</w>
615 ].</w>
61-80 48.</w>
61-80 48,</w>
61- 85</w>
61, 26
61,26 0);</w>
61+/- 34</w>
61+/- 3,</w>
61+/- 0.08</w>
606 A</w>
606 A,</w>
606 37.</w>
600/ mm3</w>
600/ microL</w>
600/ 300</w>
600- s</w>
600- mg/m2</w>
600- mg/kg</w>
600- fold),</w>
600- 900</w>
600- 9000)</w>
600- 800</w>
600- 750</w>
600- 54</w>
600- 4
600-4 900</w>
600 2)</w>
600 1,</w>
600 00,</w>
600 0,</w>
600 0
6000 U/ml.</w>
600 -</w>
600 -1,
600-1, 900</w>
600 -1
600-1 200mg</w>
600 ,000</w>
600 ).</w>
600 ),</w>
60/ 30</w>
60/ 225</w>
60/ 2
60/2 25.</w>
60-0 175,</w>
60-- 70</w>
60-- 69</w>
60- trial</w>
60- mg/kg</w>
60- fold</w>
60- day</w>
60- day-old</w>
60- Kd</w>
60- 76</w>
60- 64</w>
60- 62,</w>
60- 360</w>
60- 224),</w>
60- ,</w>
60+/- 9%,</w>
60+/- 22.
60+/-22. 91</w>
60 s</w>
60 min</w>
60 i</w>
60 dBnHL</w>
60 d</w>
60 ].</w>
60 Co</w>
60 :1)</w>
60 8,</w>
60 79</w>
60 7)</w>
60 6.6+/-
606.6+/- 23.00</w>
60 5)</w>
60 5
605 1-8
6051-8 7-2)</w>
60 4.2+/-
604.2+/- 26
604.2+/-26 1.9</w>
60 28</w>
60 25
6025 44),</w>
60 0.0</w>
60 -16
60-16 62].</w>
60 -100%</w>
60 -1.7
60-1.7 6)</w>
60 -1,000</w>
60 ,000/
60,000/ HR)</w>
60 ,
60, 600</w>
60 +/-0.0
60+/-0.0 24;</w>
60 )-
60)- seizuring</w>
60 's.</w>
60 %-
60%- 70%</w>
60 %):</w>
60 "</w>
6/ sec,</w>
6/ million</w>
6/ l)</w>
6/ group).</w>
6/ day)</w>
6/ 9</w>
6/ 99</w>
6/ 8</w>
6/ 82</w>
6/ 7.0,</w>
6/ 691)</w>
6/ 60</w>
6/ 5</w>
6/ 52</w>
6/ 5,</w>
6/ 4</w>
6/ 44).</w>
6/ 38,</w>
6/ 38)</w>
6/ 35</w>
6/ 354;</w>
6/ 32</w>
6/ 27</w>
6/ 263</w>
6/ 24</w>
6/ 18,</w>
6/ 16</w>
6/ 15</w>
6/ 1513</w>
6/ 14</w>
6/ 146)</w>
6/ 129</w>
6/ 100</w>
6/ 1000</w>
6/ 10.</w>
6/ 10)</w>
6/ 1/
6/1/ 06</w>
6.8+/- 92.4</w>
6.8+/- 0.2</w>
6.8 s)</w>
6.8 microg/ml</w>
6.8 9;</w>
6.8 3,</w>
6.7 mm(3)</w>
6.7 7,</w>
6.7 4;</w>
6.7 -16
6.7-16 6.3),</w>
6.6+/- 2.6</w>
6.6 7-fold</w>
6.6 6+/-4.
6.66+/-4. 42</w>
6.4 6)</w>
6.4 4).</w>
6.4 1;</w>
6.4 +/-1.7</w>
6.4 +/-1.3</w>
6.4 );</w>
6.4 (14.7)</w>
6.4 %-
6.4%- 9.4%),</w>
6.2- 6.4</w>
6.0 g</w>
6.0 ],</w>
6.0 9</w>
6.0 7;</w>
6.0 4)</w>
6.0 2,</w>
6.0 2);</w>
6.0 +/-
6.0+/- 6.8microg/ml</w>
6.0 %;</w>
6.0 %.</w>
6. 99</w>
6. 98</w>
6. 93</w>
6. 90).</w>
6. 9-50.1)</w>
6. 9,</w>
6. 9),</w>
6. 9%;</w>
6. 9%.</w>
6. 9%),</w>
6. 8;</w>
6. 88,</w>
6. 87</w>
6. 86</w>
6. 85)</w>
6. 84</w>
6. 83</w>
6. 80</w>
6. 8-25.3).</w>
6. 8-22.2)</w>
6. 8,</w>
6. 8%,</w>
6. 77</w>
6. 75</w>
6. 71</w>
6. 7.</w>
6. 7-8</w>
6. 7);</w>
6. 7),</w>
6. 7%).</w>
6. 67</w>
6. 67,</w>
6. 66-fold,</w>
6. 65)</w>
6. 64</w>
6. 63)</w>
6. 6-1
6.6-1 1.1).</w>
6. 6)</w>
6. 6%)</w>
6. 59</w>
6. 59;</w>
6. 59,</w>
6. 57</w>
6. 54</w>
6. 54;</w>
6. 53,</w>
6. 52</w>
6. 50</w>
6. 50).</w>
6. 5-year</w>
6. 5-fold</w>
6. 5-
6.5- 7.5.</w>
6. 5).</w>
6. 5%-
6.5%- 9.7%).</w>
6. 5%).</w>
6. 5%),</w>
6. 49</w>
6. 48</w>
6. 47</w>
6. 45</w>
6. 458</w>
6. 45+/-
6.45+/- 4.0</w>
6. 43</w>
6. 4+/-
6.4+/- 7.0</w>
6. 4).</w>
6. 4%;</w>
6. 4%.</w>
6. 39-
6.39- 6.44).</w>
6. 37)</w>
6. 36</w>
6. 336</w>
6. 33),</w>
6. 31;</w>
6. 3-10
6.3-10 0.7</w>
6. 3-1
6.3-1 4.1).</w>
6. 3)</w>
6. 3).</w>
6. 3%;</w>
6. 3%.</w>
6. 2;</w>
6. 28</w>
6. 26</w>
6. 25),</w>
6. 25%</w>
6. 25
6.25 mg/kg</w>
6. 24</w>
6. 24,</w>
6. 24),</w>
6. 23,</w>
6. 21</w>
6. 21+/-1
6.21+/-1 9.55,</w>
6. 20</w>
6. 2.</w>
6. 2,</w>
6. 2)</w>
6. 2).</w>
6. 2%,</w>
6. 19</w>
6. 17</w>
6. 15,</w>
6. 12+/-
6.12+/- 0.05,</w>
6. 12%,</w>
6. 11</w>
6. 11,</w>
6. 10</w>
6. 1/
6.1/ 3.0,</w>
6. 1-,</w>
6. 1+/-1.2</w>
6. 1+/-
6.1+/- 0.11%</w>
6. 1);</w>
6. 1).</w>
6. 1%;</w>
6. 1%).</w>
6. 1
6.1 %:</w>
6. 02</w>
6. 00,</w>
6. 0-fold</w>
6. 0-
6.0- 72])</w>
6. 0).</w>
6. 0%,</w>
6-thioguan ine-related</w>
6-thioguan ine,</w>
6-thioguan ine).</w>
6-thio uric</w>
6-thio guanosine</w>
6-tetramethyl piperidin-4-yl</w>
6-tetrahydro pyridine-induced</w>
6-oxo- PGF1</w>
6-oxo- 7,13-dihydro-6H-benzofuro[2,3-e]pyrido[1,2-a][1,3]diazepin-12-ium</w>
6-nitro benzylthioinosine</w>
6-n-propyl- transdi-hydrolisuride</w>
6-n-propyl- lisuride</w>
6-n-propyl- LIS,</w>
6-methoxy-8-hydroxylamino quinoline</w>
6-methoxy-8-hydroxylamino quinoline.</w>
6-methoxy- 8-aminoquinoline</w>
6-mercaptop urine.</w>
6-mercaptop urine),</w>
6-keto-PGF 1alpha</w>
6-keto- prostaglandin1</w>
6-hydroxydopamine- lesion</w>
6-hydroxydop amine-treated</w>
6-hydroxydop amine)</w>
6-hydroxydop amine).</w>
6-hydroxy-DA- circling</w>
6-hydroxy dopamine(OHDA)-induced</w>
6-hydroxy dopa.</w>
6-dimethylbenzimidazol yly-Co-cyanocobamide,</w>
6-dimethylbenzimidazol yl-Co-methylcobamide,</w>
6-dimethyl anilide</w>
6-chloro- 2-(1-
6-chloro-2-(1- piperazinyl)pyrazine</w>
6-chloro- 2-(
6-chloro-2-( ethylamino)-4-methyl-4-phenyl-4H-3,1-benzoxazine</w>
6-[ (2S,3
6-[(2S,3 S)-3-(4-chloro-2-methylphenylsulfonylaminomethyl)-bicyclo[2.2.2]octan-2-yl]-5Z-hexenoic</w>
6-OHD A-treated</w>
6-OHD A-</w>
6-Di anhydrohexitol</w>
6-5. 1,</w>
6-5. 0/
6-5.0/ 100,000).</w>
6-3. 54;</w>
6-3. 00)</w>
6-27 8.2)mg/kg.</w>
6-27 4],</w>
6-1.0 99,</w>
6-1.0 63</w>
6-1. 88]</w>
6-1. 19)</w>
6-1. 18;</w>
6-1 997),</w>
6-1 987,</w>
6-1 967,</w>
6-1 8.7</w>
6-1 8)</w>
6-1 6%,</w>
6-1 58</w>
6-1 5/
6-15/ group).</w>
6-1 44</w>
6-1 3</w>
6-1 3.
6-13. 145,</w>
6-1 2).</w>
6-1 1</w>
6-1 1.
6-11. 21).</w>
6-1 1).</w>
6-1 00
6-100 %)</w>
6-1 0-
6-10- fold.</w>
6-1 0)</w>
6-1 0%</w>
6-0.8 3;</w>
6-0.8 1)</w>
6-- CP</w>
6-- 241</w>
6-(N- dimethylaminopropyl)</w>
6-(N- diethylaminoethyl)</w>
6-(3- iodobenzyl)</w>
6-(3- dimethylaminopropionyl)forskolin</w>
6-(2- bromophenyl)-8-fluoro-4H-imidazo-[1,5-a]</w>
6- weed</w>
6- to-8-month</w>
6- tertahydropyridine</w>
6- subunit-deficient</w>
6- s</w>
6- recognized</w>
6- phosphatase</w>
6- nephrectomy</w>
6- nephrectomy,</w>
6- month,</w>
6- monoacetylmorphine.</w>
6- mo</w>
6- mm</w>
6- methylprednisolone</w>
6- methyl-6,11-dihydro-11-[(N,N-dimethylamino)</w>
6- ketoprostaglandin</w>
6- hydroxy</w>
6- g/d</w>
6- fold,</w>
6- dihydro-5-methyl-6-Oxo-4H-imidazo</w>
6- degree</w>
6- cyclohexyladenosine),</w>
6- cyano-7-nitroquinoxaline-2,3-dione</w>
6- cyano-7-nitro-quinoxaline-2,3-dione</w>
6- cm</w>
6- amino-acid</w>
6- acetylmorphine,</w>
6- [4-(4-pyridylamino)phenyl]-4,</w>
6- TG,</w>
6- Phenyl-3(2H)-pyridazinon-2-yl-[4-(4-fluorophenyl)piperazinyl]</w>
6- Nov.</w>
6- Mercaptopurine</w>
6- MP</w>
6- MP,</w>
6- MHz</w>
6- June</w>
6- Hz</w>
6- Hydroxydopamine</w>
6- G),</w>
6- DHT)</w>
6- 94.0</w>
6- 9-months</w>
6- 85</w>
6- 84</w>
6- 8.</w>
6- 8-somite</w>
6- 8)</w>
6- 79)</w>
6- 78%),</w>
6- 750</w>
6- 72</w>
6- 7.11).</w>
6- 7,</w>
6- 65</w>
6- 60%)</w>
6- 6.45</w>
6- 6%)</w>
6- 6
6-6 39
6-639 7).</w>
6- 58</w>
6- 58%.</w>
6- 55</w>
6- 54</w>
6- 5.1%</w>
6- 5
6-5 13.0</w>
6- 48</w>
6- 47.
6-47. 8%)</w>
6- 47)</w>
6- 45).</w>
6- 45%</w>
6- 44</w>
6- 417</w>
6- 400
6-400 0)</w>
6- 40%,</w>
6- 4.1).</w>
6- 4.
6-4. 22).</w>
6- 38</w>
6- 38.5</w>
6- 38.
6-38. 4).</w>
6- 36</w>
6- 36).</w>
6- 3.0)</w>
6- 3
6-3 26),</w>
6- 26</w>
6- 25%</w>
6- 21</w>
6- 21.
6-21. 4),</w>
6- 20</w>
6- 2.6</w>
6- 2.2</w>
6- 2-2</w>
6- 2
6-2 0.8)</w>
6- 0</w>
6- 0.85</w>
6- 0.7
6-0.7 89,</w>
6- 0.5
6-0.5 7).</w>
6- 0.48,</w>
6- 0.037,</w>
6- /-)</w>
6- -7</w>
6- -10</w>
6- -10
6--10 8</w>
6,7-dimethoxy-4-ethyl- beta-carboline-carboxylate</w>
6,7- dichloro-1,</w>
6,2 25)</w>
6,2 20</w>
6,0 16</w>
6,0 15</w>
6, 951</w>
6, 800</w>
6, 591</w>
6, 4</w>
6, 400</w>
6, 397</w>
6, 342</w>
6, 333</w>
6, 293)</w>
6, 121</w>
6+/-4. 1%,</w>
6+/-1. 4%,</w>
6+/-1. 3,</w>
6+/-1 9.5</w>
6+/-1 5</w>
6+/-1 21.3</w>
6+/-1 2.
6+/-12. 12,</w>
6+/-1 .03</w>
6+/- 9</w>
6+/- 9.3</w>
6+/- 7</w>
6+/- 7.6%,</w>
6+/- 6</w>
6+/- 6.2%</w>
6+/- 6.1%;</w>
6+/- 5</w>
6+/- 43%.</w>
6+/- 31</w>
6+/- 3.6</w>
6+/- 3.6%,</w>
6+/- 29,</w>
6+/- 25</w>
6+/- 0.58</w>
6+/- 0.4,</w>
6+/- 0.4
6+/-0.4 3%).</w>
6+/- 0.34)</w>
6+/- 0.27,</w>
6+/- 0.23)</w>
6+/- 0.17</w>
6+/- 0.11%</w>
6+/- 0.03</w>
6+/- 0.02;</w>
6+/- 0.
6+/-0. 195</w>
6) xDBA/2J</w>
6) );</w>
6'-iodo- DHP</w>
6'-iodo- DHP,</w>
6'- iodu-DHP</w>
6'- bromo-DHP</w>
6%- 98%),</w>
6%- 93%)</w>
6%- 57.
6%-57. 0%)</w>
6%- 36%)</w>
6% --
6%-- 70.5%</w>
6% (-)-
6%(-)- 33%</w>
6 x9</w>
6 th,</w>
6 s</w>
6 h,</w>
6 d</w>
6 ].</w>
6 R)</w>
6 PD)</w>
6 M)</w>
6 96</w>
6 92</w>
6 90;</w>
6 9.6</w>
6 9.4</w>
6 9.3</w>
6 9.2</w>
6 8;</w>
6 89-1695</w>
6 88</w>
6 82</w>
6 809),</w>
6 80)</w>
6 8.6</w>
6 8.5</w>
6 8.4%</w>
6 8.1</w>
6 8-fold</w>
6 8+/-9%,</w>
6 78),</w>
6 77</w>
6 76</w>
6 73</w>
6 72</w>
6 71</w>
6 70(26)</w>
6 7.8</w>
6 7.7</w>
6 7.0</w>
6 7,668</w>
6 6;</w>
6 69+/-868</w>
6 67</w>
6 67-1483</w>
6 66</w>
6 62</w>
6 600</w>
6 60),</w>
6 6.9</w>
6 6.5</w>
6 6.4</w>
6 6-100%)</w>
6 6+/-9</w>
6 6%;</w>
6 6%)</w>
6 6%).</w>
6 6%),</w>
6 5;</w>
6 57
657 (10
657(10 5)</w>
6 53</w>
6 51</w>
6 50-mg</w>
6 50),</w>
6 50
650 ,000).</w>
6 5.8</w>
6 5.7</w>
6 5.6</w>
6 5.5</w>
6 5.4</w>
6 5-fold</w>
6 5,8
65,8 60</w>
6 5).</w>
6 5%;</w>
6 5%),</w>
6 4;</w>
6 41</w>
6 4.</w>
6 4.7</w>
6 4.3</w>
6 4.2%</w>
6 4.0</w>
6 4-h</w>
6 4-1
64-1 00;</w>
6 4),</w>
6 4%;</w>
6 4%.</w>
6 38.
638. 65+/-10.27</w>
6 38
638 6-6397).</w>
6 37</w>
6 36),</w>
6 35;</w>
6 32</w>
6 3/
63/ 88)</w>
6 3.9</w>
6 3.8
63.8 )],</w>
6 3.5%</w>
6 3.2</w>
6 3.1</w>
6 3,000</w>
6 3,
63, 575</w>
6 3%)</w>
6 3%).</w>
6 297</w>
6 29)</w>
6 26,</w>
6 26%.</w>
6 25-
625- 0.5</w>
6 23</w>
6 23,</w>
6 219</w>
6 205</w>
6 20-
620- 37
620-37 00</w>
6 20)</w>
6 20),</w>
6 2.9</w>
6 2.5-
62.5- 92.5).</w>
6 2.4</w>
6 2.3
62.3 mg/day,</w>
6 2.0</w>
6 2.0%,</w>
6 2-
62- y-old</w>
6 2,500</w>
6 1st</w>
6 1A</w>
6 1;</w>
6 19;</w>
6 19)</w>
6 18</w>
6 171</w>
6 17.
617. 3+/-1
617.3+/-1 4.38</w>
6 16</w>
6 16-
616- 91-1),</w>
6 14</w>
6 13)</w>
6 11).</w>
6 10-
610- 615].</w>
6 1/
61/ 230</w>
6 1.</w>
6 1.9</w>
6 1.9%,</w>
6 1.8%,</w>
6 1.7</w>
6 1.7%</w>
6 1.7%,</w>
6 1.6</w>
6 1.5%,</w>
6 1.3%</w>
6 1.2</w>
6 1.2),</w>
6 1.2%</w>
6 1.1</w>
6 1.1%</w>
6 1.0%</w>
6 1.0
61.0 6+/-12.12,</w>
6 1-year</w>
6 1+/-1
61+/-1 3</w>
6 1),</w>
6 1%/
61%/ y)</w>
6 1%).</w>
6 1
61 +/-10</w>
6 0.93)</w>
6 0.9%</w>
6 0.8+/-
60.8+/- 2.4%</w>
6 0.7</w>
6 0.7,</w>
6 0.7%</w>
6 0.7%,</w>
6 0.6</w>
6 0.6,</w>
6 0.5%</w>
6 0.5%).</w>
6 0.5%),</w>
6 0.5
60.5 +/-1
60.5+/-1 0.2%</w>
6 0.4</w>
6 0.44</w>
6 0.4)</w>
6 0.3%</w>
6 0.2%</w>
6 0.2%,</w>
6 0.0,</w>
6 0.0%</w>
6 0.0%,</w>
6 -16</w>
6 ,000,</w>
6 +</w>
6 +/-1.6</w>
6 +/-1.2</w>
6 )-related</w>
6 ))</w>
6 )).</w>
6 '</w>
6 ')</w>
6 "</w>
5x 4
5x4 x4</w>
5x 106</w>
5x 10(9)/l,</w>
5q 15-
5q15- qter.</w>
5q -</w>
5beta-pregnan-20- one</w>
5alpha-pregnan-20- one,</w>
5alpha-pregnan- 3,20-
5alpha-pregnan-3,20- dione.</w>
5alpha- tetrahydrocorticosterone</w>
5alpha- reductase.</w>
5alpha- dihydroprogesterone</w>
5alpha- THP)</w>
5HT 2A</w>
5HT 2
5HT2 c</w>
5HT -</w>
5H- dibenzo[a,d]cyclohepten-5,10-imine</w>
5H T-turnover</w>
5H (2A)</w>
5: S)</w>
5: 48
5:48 1-
5:481- 49
5:481-49 2)</w>
5: 16
5:16 2-1
5:162-1 63,</w>
5: 1).</w>
599 ]</w>
59. 8;</w>
59. 8-142.9)</w>
59. 8%</w>
59. 8%)</w>
59. 7%</w>
59. 7%,</w>
59. 6%</w>
59. 6%,</w>
59. 5,</w>
59. 5%</w>
59. 5%)</w>
59. 4%).</w>
59-1 97</w>
59-1 964),</w>
59-1 2.47;</w>
59- year-old,</w>
59- y-old</w>
59- kDa</w>
59- kDa-TFA</w>
59- 78%</w>
59+/-1. 28</w>
59+/-1. 10</w>
59+/- 80.29;</w>
59+/- 36%</w>
59+/- 2
59+/-2 122</w>
59+/- 0.7
59+/-0.7 1),</w>
59+/- 0.68).</w>
59+/- 0.62</w>
59 x10(9)/L,</w>
59 8</w>
59 6</w>
59 63</w>
59 625</w>
59 6,</w>
59 4/
594/ 2107</w>
59 4)</w>
59 3]</w>
59 2.</w>
59 2).</w>
59 1.40</w>
59 0,</w>
59 0).</w>
59 0
590 G>A.</w>
59 .</w>
59 %.</w>
59 %,</w>
59 %),</w>
5826 1)</w>
5826 1);</w>
58. 9%</w>
58. 9%).</w>
58. 7%</w>
58. 7%).</w>
58. 63</w>
58. 6%--70.5%</w>
58. 50%,</w>
58. 5-
58.5- 83.0).</w>
58. 4%,</w>
58. 3%;</w>
58. 2-80
58.2-80 0.0).</w>
58. 2%</w>
58. 16+/-
58.16+/- 2.31;</w>
58. 11</w>
58. 1+/-1.
58.1+/-1. 4%</w>
58. 00</w>
58. 0
58.0 2
58.02 mN,</w>
58- years-old</w>
58- y-old</w>
58- 79</w>
58- 658)</w>
58 ;</w>
58 94</w>
58 87)</w>
58 69</w>
58 52</w>
58 5-bed</w>
58 5,</w>
58 41</w>
58 4,</w>
58 1,</w>
58 /8
58/8 8).</w>
58 %:</w>
58 %).</w>
57. 9%</w>
57. 9%.</w>
57. 9%,</w>
57. 70</w>
57. 7,</w>
57. 7)]</w>
57. 7),</w>
57. 5).</w>
57. 5%)</w>
57. 4%</w>
57. 4%.</w>
57. 3+/-
57.3+/- 5.4</w>
57. 1%</w>
57. 1%,</w>
57. 0%,</w>
57- 96;</w>
57- 85-2],</w>
57- 83-0)</w>
57- 70.].</w>
57- 65%</w>
57- 63-6)</w>
57- 43-
57-43- 2],</w>
57+/- 8%,</w>
57+/- 5.9%,</w>
57+/- 2%</w>
57+/- 0.19</w>
57 :1461-1463</w>
57 9.7</w>
57 9-</w>
57 9,</w>
57 445</w>
57 43),</w>
57 3,</w>
57 24
5724 8-88-1)</w>
57 1.
571. ].</w>
57 00</w>
57 000</w>
57 /
57/ 72</w>
57 -1.
57-1. 56)</w>
57 -1
57-1 63</w>
57 ,000</w>
57 ,00
57,00 0)</w>
57 +/-1.0</w>
57 +/-1
57+/-1 54</w>
57 %).</w>
57 %),</w>
56999 A.</w>
56999 A,</w>
56/ 72</w>
56/ 265)</w>
56. 8-78.0%</w>
56. 8%,</w>
56. 8%).</w>
56. 7+/-12.3</w>
56. 7%</w>
56. 6;</w>
56. 5%,</w>
56. 47%,</w>
56. 4
56.4 +/-10
56.4+/-10 2.3</w>
56. 3%,</w>
56. 29+/-
56.29+/- 5.0%</w>
56. 1)</w>
56. 1%</w>
56. 0+/-1
56.0+/-1 0.4</w>
56. 0%).</w>
56- year-old-man</w>
56- residue-long</w>
56- item</w>
56- 84</w>
56- 7.56)</w>
56- 53-1)</w>
56- 388</w>
56 7.0</w>
56 7)</w>
56 4-
564- 0</w>
56 30)</w>
56 3).</w>
56 2-
562- 571.].</w>
56 2)</w>
56 1)</w>
56 -18
56-18 57).</w>
56 -10
56-10 2</w>
56 ,
56, 200</w>
56 +</w>
56 +/-5</w>
56 +/-3</w>
56 +/-10</w>
56 +/-1.5%</w>
56 %);</w>
559 40-
55940- mediated</w>
559 40,</w>
557 12</w>
557 12,</w>
55212- 2.</w>
551- 600</w>
551- -a</w>
550- 700</w>
550- 600</w>
55. 8);</w>
55. 8%,</w>
55. 8%).</w>
55. 76</w>
55. 6%.</w>
55. 6%).</w>
55. 5%</w>
55. 5%,</w>
55. 4+/-1.
55.4+/-1. 3%,</w>
55. 4%</w>
55. 25</w>
55. 2%</w>
55. 2%).</w>
55. 1%</w>
55- yr-old</w>
55- min</w>
55- 81);</w>
55- 75</w>
55- 65%</w>
55- 60%.</w>
55- 59</w>
55- 57</w>
55- 3.
55-3. 36),</w>
55- 270</w>
55,212- 2.</w>
55 th</w>
55 :185-194,</w>
55 8.7</w>
55 562)</w>
55 5.
555. 10</w>
55 5-1
555-1 490</w>
55 3.77</w>
55 /
55/ 26
55/26 7)</w>
55 -</w>
55 -160</w>
55 ,000</w>
55 +/-10</w>
55 +/-0.0
55+/-0.0 4,</w>
55 +/-
55+/- 29</w>
55 )
55) when</w>
54. 8%);</w>
54. 79%,</w>
54. 75+/-3.7</w>
54. 7%)</w>
54. 6%).</w>
54. 4%</w>
54. 3%,</w>
54. 1;</w>
54. 1+/-1
54.1+/-1 1.3</w>
54. 1%</w>
54. 1%.</w>
54- year-old,</w>
54- week,</w>
54+/-1. 59</w>
54+/-1. 17</w>
54%- 82%</w>
54 ];</w>
54 99</w>
54 9,</w>
54 9)</w>
54 6-4000)</w>
54 6,</w>
54 6).</w>
54 41</w>
54 18).</w>
54 16</w>
54 10-
5410- 4A</w>
54 0.21</w>
54 +/-16</w>
54 );</w>
54 (3)</w>
54 %]</w>
53. 9/mm3</w>
53. 4%</w>
53. 30</w>
53. 3)</w>
53. 3%),</w>
53. 2+/-1
53.2+/-1 1.8</w>
53. 2%</w>
53. 18%)</w>
53. 11</w>
53. 1%,</w>
53- 86-1).</w>
53- 83</w>
53- 76%),</w>
53- 613)</w>
53- 60%</w>
53+/- 7</w>
53+/- 20-
53+/-20- 34
53+/-20-34 +/-1
53+/-20-34+/-1 5</w>
53 8)</w>
53 5)</w>
53 37</w>
53 33</w>
53 3,</w>
53 23</w>
53 2.4</w>
53 0.9</w>
53 -10
53-10 2).</w>
53 +/-10</w>
525- A,</w>
525- 0.1</w>
5246 6;</w>
5246 6)</w>
5246 6).</w>
520 T/G</w>
520 7</w>
52%- 90%.</w>
52%- 59%)</w>
52 ]),</w>
52 E</w>
52 E).</w>
52 :233-242;</w>
52 3.5</w>
52 +/-19</w>
52 +/-18</w>
52 %]</w>
51Cr EDTA</w>
51Cr -labeled</w>
518 32-
51832- 87-2)</w>
515 8),</w>
51.8 ).(ABSTRACT</w>
51.8 %.</w>
51.5 +/-1.2</w>
51.5 +/-1
51.5+/-1 2.1</w>
51. 71</w>
51. 4%,</w>
51. 3%,</w>
51. 1+/-7.1</w>
51- 60.93)</w>
51 Cr</w>
51 +/-1</w>
5048 8H),</w>
501- 550</w>
501- 36-
501-36- 0),</w>
500/ mmc)</w>
500/ mm3),</w>
500/ microL)</w>
500/ cu</w>
500/ 750/1000</w>
500/ 200</w>
500- patient</w>
500- mg/d</w>
500- 550</w>
500- 4000</w>
500- 4,
500-4, 300/
500-4,300/ microL),</w>
500- 3,500</w>
500- 2070</w>
500- ,</w>
500 mg/kg</w>
500 g,</w>
500 4</w>
500 0;</w>
500 0-ppm</w>
500 0-</w>
500 0-10
5000-10 ,000</w>
500 0-
5000- 7000</w>
500 0,</w>
500 /dl.</w>
500 -</w>
500 -1500</w>
500 )</w>
50/ mm3</w>
50/ high-power</w>
50/ ED50</w>
50/ 500</w>
50/ 50%</w>
50/ 367</w>
50/ 225,</w>
50/ 200</w>
50/ 200,</w>
50/ 17</w>
50/ 175</w>
50/ 175,</w>
50/ 135,</w>
50/ 100/
50/100/ 150</w>
50.0 %;</w>
50.0 %);</w>
50-200 6),</w>
50-200 %</w>
50-06- 6],</w>
50-06- 6),</w>
50- year</w>
50- percent</w>
50- millisecond)</w>
50- microgram</w>
50- microg</w>
50- mg/m2</w>
50- g</w>
50- day</w>
50- 90).</w>
50- 90%</w>
50- 84</w>
50- 800</w>
50- 80%</w>
50- 780</w>
50- 75%</w>
50- 65%</w>
50- 54</w>
50- 5
50-5 80%)</w>
50- 48
50-48 2.5</w>
50- 300</w>
50- 3,500</w>
50- -100</w>
50,48 3</w>
50,000/micro L.</w>
50,000/micro L),</w>
50+/- 7)</w>
50+/- 23</w>
50+/- 2.45</w>
50+/- 2.
50+/-2. 70%,</w>
50+/- 0.08</w>
50 th</w>
50 s.</w>
50 s,</w>
50 microg/kg</w>
50 mg/m(2)).</w>
50 mg/kg/infusion)</w>
50 mg/kg/day</w>
50 mg/kg.</w>
50 mL</w>
50 g)</w>
50 C>T,</w>
50 =</w>
50 :1</w>
50 9.4+/-349.3</w>
50 85</w>
50 8-1,020</w>
50 6:</w>
50 6),</w>
50 5).</w>
50 3)</w>
50 26</w>
50 2,</w>
50 10</w>
50 -100%</w>
50 -1.0
50-1.0 90</w>
50 -1
50-1 24
50-124 4).</w>
50 ,000/
50,000/ mmc</w>
50 ,
50, 255</w>
50 +</w>
50 +/-1</w>
50 +/-14</w>
50 +/-1.
50+/-1. 42</w>
50 );</w>
50 (0-1
50(0-1 00),</w>
50 %-
50%- 81%)</w>
5/ condition)</w>
5/ 97.</w>
5/ 9)</w>
5/ 7</w>
5/ 6-nephrectomy,</w>
5/ 6,</w>
5/ 6)</w>
5/ 59</w>
5/ 594</w>
5/ 5,</w>
5/ 39</w>
5/ 27
5/27 15,</w>
5/ 24</w>
5/ 20</w>
5/ 2
5/2 12),</w>
5/ 19</w>
5/ 18.
5/18. 2/
5/18.2/ 6.1,</w>
5/ 16,</w>
5/ 156)</w>
5/ 150-
5/150- kDa</w>
5/ 126</w>
5/ 10</w>
5/ 104</w>
5/ 100</w>
5/ 1000</w>
5/ 100,000</w>
5/ 1/
5/1/ 1/
5/1/1/ 0.</w>
5.8 74</w>
5.8 6;</w>
5.8 6)</w>
5.8 6).</w>
5.8 26</w>
5.8 2+/-
5.82+/- 0.09,</w>
5.8 1;</w>
5.8 +/-1.3</w>
5.7 9,</w>
5.7 8).</w>
5.7 7),</w>
5.7 6-fold</w>
5.7 3,</w>
5.7 2,</w>
5.7 19,</w>
5.6+/-1 6.9,</w>
5.5- mg,</w>
5.5- 6.5)</w>
5.4 ])</w>
5.4 6)</w>
5.4 4,</w>
5.4 2-1
5.42-1 1.
5.42-11. 18).</w>
5.4 2).</w>
5.4 +/-1.3</w>
5.4 %-
5.4%- 8.0%),</w>
5.3+/- 71.3</w>
5.3+/- 0.4
5.3+/-0.4 4%</w>
5.3 +/-1.
5.3+/-1. 6,</w>
5.3 (SEM</w>
5.2+/- 5.
5.2+/-5. 1microg/g,</w>
5.2+/- 0.2</w>
5.1- 7.2);</w>
5.1- 5.8</w>
5.0 microg/rat,</w>
5.0 mg/kg</w>
5.0 h,</w>
5.0 8.</w>
5.0 8,</w>
5.0 7).</w>
5.0 6</w>
5.0 5</w>
5.0 5).</w>
5.0 2</w>
5.0 2;</w>
5.0 1;</w>
5.0 +/-1
5.0+/-1 2.7</w>
5.0 +/-
5.0+/- 2.0</w>
5.0 %;</w>
5. ].</w>
5. CMV.Null)</w>
5. 99,</w>
5. 97;</w>
5. 96</w>
5. 96,</w>
5. 95</w>
5. 94</w>
5. 93),</w>
5. 911</w>
5. 90</w>
5. 9/7.0</w>
5. 9-fold</w>
5. 9-Mb</w>
5. 9-11.1%).</w>
5. 9,</w>
5. 9+</w>
5. 9+/-2.7).</w>
5. 9).</w>
5. 9),</w>
5. 9%;</w>
5. 9%.</w>
5. 9%)</w>
5. 9%).</w>
5. 88</w>
5. 81)</w>
5. 80</w>
5. 8-73,</w>
5. 8-23</w>
5. 8+/-0.4</w>
5. 8)</w>
5. 8%).</w>
5. 8%),</w>
5. 79</w>
5. 75</w>
5. 75,</w>
5. 72</w>
5. 7-fold</w>
5. 7-</w>
5. 7-75.7)</w>
5. 7-6.5</w>
5. 7-12.3),</w>
5. 7,</w>
5. 7+/-27.7%;</w>
5. 7+/-0.4</w>
5. 7).</w>
5. 7%)</w>
5. 6;</w>
5. 68)</w>
5. 67).</w>
5. 65</w>
5. 65)</w>
5. 65%)</w>
5. 64</w>
5. 63</w>
5. 625</w>
5. 60</w>
5. 60%;</w>
5. 6-fold</w>
5. 6+/-1.6</w>
5. 6+/-0.4,</w>
5. 6)</w>
5. 6),</w>
5. 6%.</w>
5. 5x10(9)/l,</w>
5. 57</w>
5. 57;</w>
5. 56-7.56)</w>
5. 55</w>
5. 54</w>
5. 53</w>
5. 53;</w>
5. 52</w>
5. 50</w>
5. 50,</w>
5. 5-13</w>
5. 5),</w>
5. 5%)</w>
5. 4;</w>
5. 49</w>
5. 47</w>
5. 458</w>
5. 45,</w>
5. 44</w>
5. 41</w>
5. 40,</w>
5. 4-fold</w>
5. 4-
5.4- 92.2)</w>
5. 4+/-
5.4+/- 2.0,</w>
5. 4).</w>
5. 4),</w>
5. 4%,</w>
5. 4%).</w>
5. 39</w>
5. 39;</w>
5. 39,</w>
5. 38</w>
5. 36),</w>
5. 31;</w>
5. 3.
5.3. 1.1).</w>
5. 3-fold</w>
5. 3-</w>
5. 3-
5.3- 27)</w>
5. 3);</w>
5. 3).</w>
5. 3),</w>
5. 2;</w>
5. 29</w>
5. 29,</w>
5. 28),</w>
5. 27</w>
5. 26</w>
5. 238</w>
5. 23,</w>
5. 22</w>
5. 22%)</w>
5. 21).</w>
5. 20),</w>
5. 2-fold</w>
5. 2-
5.2- 8.7)</w>
5. 2),</w>
5. 2%;</w>
5. 2%,</w>
5. 2%),</w>
5. 1])</w>
5. 17</w>
5. 17,</w>
5. 17)</w>
5. 16-
5.16- 67.17)</w>
5. 16),</w>
5. 15</w>
5. 13</w>
5. 13).</w>
5. 11;</w>
5. 109),</w>
5. 10,</w>
5. 10).</w>
5. 1/
5.1/ s)</w>
5. 1+/-
5.1+/- 62.3mg/day,</w>
5. 1)</w>
5. 1%;</w>
5. 1%,</w>
5. 1%).</w>
5. 00)</w>
5. 0-fold,</w>
5. 0-
5.0- mg</w>
5. 0)</w>
5. 0),</w>
5-nitro- 6,7-dichloro-1,</w>
5-methyl-10,11-dihydro-5H-di benzo[a,d]cyclohepten-5,</w>
5-methyl-10,11-dihydro-5H-di benzo[a,d]cyclohepten-5,10-imine</w>
5-methyl urapidil</w>
5-methyl tetrahydrofolate</w>
5-methyl -10
5-methyl-10 ,
5-methyl-10, 11,
5-methyl-10,11, -
5-methyl-10,11,- dihydro-5H-dibenzo[a,b]cyclohepten-5,10-imine</w>
5-methoxy- N-acetyl</w>
5-methoxy- N,N-dimethyl</w>
5-methoxy tryptoline,</w>
5-methoxy tryptamine</w>
5-methoxy dimethyltryptamine</w>
5-hydroxytryptamine- (5-HT)</w>
5-hydroxytryptamine 1a</w>
5-hydroxytryptamine 1A</w>
5-hydroxytryptamine 1,</w>
5-hydroxytryptamine -1)</w>
5-hydroxytrypt amine.</w>
5-hydroxytrypt amine-induced</w>
5-hydroxyindo loacetic</w>
5-hydroxyindo acetic</w>
5-hydroxy trytamine</w>
5-hydroxy triptamine,</w>
5-hydroxy primaquine</w>
5-hydroxy primaquine.</w>
5-hydroxy phenylglycine</w>
5-hydroxy indole-acetic</w>
5-hydroxy indolacetic</w>
5-fluorourac il-related</w>
5-fluorourac il-containing</w>
5-fluoro cytosine.</w>
5-fluoro cytocin</w>
5-fluoro -2'-
5-fluoro-2'- deoxyuridine.</w>
5-flouro uracil,</w>
5-ethyl-5- (1-
5-ethyl-5-(1- methylpropyl)-2-thiobarbituric</w>
5-dimethyl- N-(pyridin-4-ylmethyl)benzamide)</w>
5-dimethyl- 2,4-oxazolidinedione,</w>
5-dihydro- 3-(2H)-
5-dihydro-3-(2H)- pyridazinone</w>
5-di ethoxycarbonyl-1,4-dihydrocollidine</w>
5-bromo-2'- deoxyuridine,</w>
5-azacy tidine,</w>
5-amin obenzofuran</w>
5-[5-amino-3- (4-fluorophenyl)</w>
5-[5-amino-3- (4-fluorophenyl)
5-[5-amino-3-(4-fluorophenyl) pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one</w>
5-[5-amino-3- (4
5-[5-amino-3-(4 fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one</w>
5-M n</w>
5-M N)</w>
5-Hydroxy tryptamine</w>
5-Hydroxy tryptamine,</w>
5-Hy droxy-5-(4'-chlorophenyl-2,</w>
5-Ht 6</w>
5-Ht 4</w>
5-HT2/ D2</w>
5-HT2/ 5-HT3</w>
5-HT2 C/2B</w>
5-HT2 A,</w>
5-HT1B/ 1D-
5-HT1B/1D- agonists,</w>
5-HT1B/ 1C</w>
5-HT1A/ 5-HT-
5-HT1A/5-HT- 2A</w>
5-HT1 A-agonist</w>
5-HT-1 B</w>
5-HT- uptake</w>
5-HT- receptor</w>
5-HT- potentiated</w>
5-HT- induced:</w>
5-HT- dopamine</w>
5-HT(2B) R</w>
5-HT(2A/ 2
5-HT(2A/2 B/2C)</w>
5-HT(2 a)/5-HT(2c)</w>
5-HT(2 C),</w>
5-HT(2 B/2C)</w>
5-HT(2 B),</w>
5-HT(2 A),</w>
5-HT(1B) Rs)</w>
5-HT(1B) R</w>
5-HT(1A/ 7)</w>
5-HT(1A/ 7),</w>
5-HT(1A)- partial</w>
5-HT(1A)- mediated</w>
5-HT(1 A),</w>
5-HT(1 /2)</w>
5-HT(1 )/
5-HT(1)/ 5-HT(2)</w>
5-HT(1 ),</w>
5-HT ergic</w>
5-HT TLPR.</w>
5-HT T,</w>
5-HT P.</w>
5-HT P-induced</w>
5-HT ;</w>
5-HT 4,</w>
5-HT 2a</w>
5-HT 2A/2C</w>
5-HT 2,</w>
5-HT 1-
5-HT1- like,</w>
5-HT 1,</w>
5-HT -containing</w>
5-HT -3</w>
5-HT -1</w>
5-HT )-releasing</w>
5-HT )-like</w>
5-HT ),</w>
5-HT (6),</w>
5-HT (3
5-HT(3 )-dependent</w>
5-HT (2)-receptor</w>
5-HT (2))</w>
5-HP Q.</w>
5-HP Q-generated</w>
5-HP Q,</w>
5-HP Q),</w>
5-HI AA,</w>
5-HI AA)</w>
5-H IIA</w>
5-H ETE</w>
5-H A.</w>
5-Fu orouracil</w>
5-Fu -treated</w>
5-Fu -induced</w>
5-Fluoro uracil,</w>
5-FU/FA/ MMC</w>
5-FU/FA/ DP</w>
5-FU/FA/ DP;</w>
5-FU- resistant</w>
5-FU- containing</w>
5-FU 48h</w>
5-FU +/-
5-FU+/- FA+/-interferon</w>
5-FU ),</w>
5-F(2t)-Iso P).</w>
5-F(2t)- isoprostane</w>
5-F ebruary</w>
5-CHO- THF.</w>
5-CHO- THF,</w>
5-Az acytidine,</w>
5-9 5%)</w>
5-5. 70),</w>
5-5. 50</w>
5-4 709;</w>
5-4 27
5-427 9).</w>
5-2. 30)</w>
5-199 5),</w>
5-199 0,</w>
5-1. 41),</w>
5-1- 6-recognized</w>
5-1- 6-induced</w>
5-1 9</w>
5-1 996</w>
5-1 98.</w>
5-1 979,</w>
5-1 9.8)</w>
5-1 72</w>
5-1 70</w>
5-1 5.78).</w>
5-1 5)</w>
5-1 47</w>
5-1 4.</w>
5-1 4,</w>
5-1 30</w>
5-1 2%</w>
5-1 1.4
5-11.4 9)</w>
5-1 000</w>
5-1 .0
5-1.0 35)</w>
5-- RF</w>
5-- CP</w>
5-- 70</w>
5-(3- methyltriazen-1-yl)imidazole-4-caroxamide,</w>
5-(3- Methyl-1-triazeno)imidazole-4-carboxamide</w>
5-(3,3-dimethyl-1- triazeno)imidazole-4-carboxamide</w>
5-(3,3-dimethyl-1- triazeno)-imidazole-4-carboxamide,</w>
5-( dimethylamino)-N-(2-dimethylaminoethyl)naphthalenesulfonamide</w>
5- {2-[4-(1,2-dihydro-2-acenaphthylenyl)piperazinyl]ethyl}-2,3-dihy</w>
5- year-old,</w>
5- week,</w>
5- thio-D-glucose</w>
5- tetrahydro-3-methyl-5-phenyl-1-H-3-benzazepine;</w>
5- tetrahydro-1H-3-benzazepine</w>
5- step</w>
5- site</w>
5- phenyl</w>
5- patient,</w>
5- month-old-infant</w>
5- mm</w>
5- micromol/g</w>
5- mg/ml</w>
5- mg/m2</w>
5- mg/day</w>
5- methyl</w>
5- methyl-tetrahydrofolic</w>
5- methoxy</w>
5- methoksytryptamine.</w>
5- membered</w>
5- mM</w>
5- isosorbide-mononitrate</w>
5- hydroxylated</w>
5- hydroxyeicosatetraenoic</w>
5- hydroxy</w>
5- hydroxy-5(4'-chlorophenyl)-2,</w>
5- hydroxy-3-[4-(4-phenyl-1,2,3,6-tetrahydropyridyl(1))-butyl(1)]-indole</w>
5- hydoxytryptamine</w>
5- graded</w>
5- fold.</w>
5- doxylstearic</w>
5- diphenylhydantoin;</w>
5- dihydroxyphenylglycine</w>
5- diazoimidazole-4-carboxamide</w>
5- deoxy-5-(4-substituted</w>
5- day-old</w>
5- cm</w>
5- chloro-7-trifluoromethyl-1,2,3,4-tetrahydroquinoxaline-2,3-dione</w>
5- chloro-4-(2-imidazolin-2yl-amino)-2,1,3-benzothiazole,</w>
5- bromodeoxyuridine</w>
5- bromo</w>
5- antigen</w>
5- aminoimidazole-4-carboxamide</w>
5- amino-salicylates,</w>
5- alpha-reductase;</w>
5- LO,</w>
5- H</w>
5- Aminosalicylic</w>
5- ASA).</w>
5- 9;</w>
5- 900</w>
5- 80</w>
5- 8.</w>
5- 8)</w>
5- 77).</w>
5- 7.2</w>
5- 7.23;</w>
5- 7-DHT</w>
5- 7).</w>
5- 7%</w>
5- 67</w>
5- 611</w>
5- 60</w>
5- 60.</w>
5- 500</w>
5- 5
5-5 0.5).</w>
5- 47)</w>
5- 47
5-47 2).</w>
5- 400</w>
5- 40.5</w>
5- 4.0
5-4.0 3;</w>
5- 3</w>
5- 374)</w>
5- 36</w>
5- 359).</w>
5- 34
5-34 );</w>
5- 320</w>
5- 31</w>
5- 30)</w>
5- 30).</w>
5- 3.9
5-3.9 8;</w>
5- 29.
5-29. 6),</w>
5- 28).</w>
5- 27)</w>
5- 26</w>
5- 26
5-26 h</w>
5- 22</w>
5- 22.
5-22. 4).</w>
5- 21</w>
5- 215</w>
5- 21)</w>
5- 20mg/kg/day</w>
5- 2005).</w>
5- 20.</w>
5- 20+</w>
5- 0:
5-0: 9),</w>
5- 0.001)</w>
5- -7</w>
5- -19
5--19 78.</w>
5- -10</w>
5- (p-chloro
5-(p-chloro phenyl)-2,5-dihydro-3H-imidazo</w>
5,9 20/
5,920/ microl</w>
5,9 13.</w>
5,8 96</w>
5,7-DCK A</w>
5,7-DCK A.</w>
5,7-DCK A,</w>
5,7- dihydroxytryptamine,</w>
5,7- Dihydroxytryptamine</w>
5,7- DHT.</w>
5,6- dihydro-6-methyl-4H-1,3-thiazine</w>
5,6- dihydro-5-azacytidine</w>
5,6- ,</w>
5,6, -
5,6,- tetrahydropyrido-4-yl]pyridazin-3(2H)-one</w>
5,6 74</w>
5,5-diethyl hydantoin</w>
5,5-diethyl hydantoin,</w>
5,5-di oxide,</w>
5,5- trimethyl-2,4-oxazolidinedione,</w>
5, 877</w>
5, 871)</w>
5, 8)</w>
5, 732</w>
5, 712</w>
5, 7-</w>
5, 613</w>
5, 595</w>
5, 575</w>
5, 503</w>
5, 414</w>
5, 251</w>
5, 24
5,24 0;</w>
5, 220</w>
5, 142</w>
5, 0
5,0 36)</w>
5, -7-
5,-7- dihydroxytryptamine</w>
5, -
5,- DHT</w>
5+/-1 9.1</w>
5+/-1 6.2%,</w>
5+/-1 49</w>
5+/-1 15</w>
5+/-1 %</w>
5+/- 92</w>
5+/- 8.9</w>
5+/- 8.9%,</w>
5+/- 8.4s.</w>
5+/- 8.0</w>
5+/- 7-70+/-9</w>
5+/- 66.7</w>
5+/- 6.2</w>
5+/- 5.3</w>
5+/- 3</w>
5+/- 37</w>
5+/- 34</w>
5+/- 32</w>
5+/- 3.8%</w>
5+/- 3.5</w>
5+/- 3.1</w>
5+/- 2</w>
5+/- 25</w>
5+/- 24.
5+/-24. 62</w>
5+/- 20</w>
5+/- 2021</w>
5+/- 2.96</w>
5+/- 2.06</w>
5+/- 2%</w>
5+/- 0.09</w>
5+/- 0.055)</w>
5+/- 0.025</w>
5)S] TBPS)</w>
5) S-labeled</w>
5) >/=4-DAMP</w>
5) -10(-
5)-10(- 3)
5)-10(-3) M)</w>
5) %</w>
5) %;</w>
5) %,</w>
5'-phosph osulfate:</w>
5'-bromo -2-deoxyuridine</w>
5'-bromo -2'-
5'-bromo-2'- deoxyuridine-labeling</w>
5'-O-(2-thiodiphosph ate).</w>
5'-O- (gamma-
5'-O-(gamma- [35S]thio)triphosphate</w>
5'-O- (3-
5'-O-(3- thiotriphosphate)</w>
5'-N-ethyl carboxamidoadenosine</w>
5'-N-ethyl carboxamido-adenosine</w>
5'-N-ethyl carboxamideadenosine</w>
5'- triphosphate-biotin</w>
5'- region</w>
5'- phosphate,</w>
5'- nucleotidase</w>
5'- guanosine</w>
5'- cyclic</w>
5'- adenosine</w>
5'- [beta-gamma-imino]triphosphate</w>
5'- T2)</w>
5'- Nucleotidase,</w>
5'- NTD</w>
5'- N-ethyl-carboxamidoadenosine</w>
5'- Bromodeoxyuridine</w>
5'- (N-
5'-(N- cyclopropyl)-carboxamidoadenosine</w>
5'- (1,
5'-(1, 1'-
5'-(1,1'- biphenyl)-2,5-diylbis(oxy)(2,2-dimethylpentanoic</w>
5%- confidence</w>
5%- 89%).</w>
5%- 62.4%)</w>
5%- 61%)</w>
5%- 32.
5%-32. 9%).</w>
5%- 30%.</w>
5%- 3%</w>
5%- 24%)</w>
5%- 24%),</w>
5% :P</w>
5% /24</w>
5% -10
5%-10 %.</w>
5% )-induced</w>
5% )-
5%)- isocaloric</w>
5 x/day;</w>
5 mg/kg</w>
5 mg/kg/h</w>
5 mg/kg).</w>
5 mg/gm),followed</w>
5 mg,</w>
5 mM</w>
5 h.</w>
5 delA</w>
5 d</w>
5 c.</w>
5 ];</w>
5 V)</w>
5 S,6S)-6[(R)-1-hydroxyethyl]-2-[(3S,5S)-5(S-methyl-4thiomorpholin</w>
5 MB)</w>
5 H)-2,3-benzodiazepine],</w>
5 GABAA)</w>
5 F</w>
5 A),</w>
5 90</w>
5 9.8</w>
5 9.6</w>
5 9.3</w>
5 9.0</w>
5 9-year</w>
5 80+/-224</w>
5 8.</w>
5 8.7</w>
5 8.2</w>
5 8),</w>
5 7.6</w>
5 7.5%</w>
5 7.4</w>
5 7.1</w>
5 69</w>
5 65</w>
5 64</w>
5 63</w>
5 60),</w>
5 6.6</w>
5 6.1</w>
5 6.0</w>
5 501</w>
5 500</w>
5 50-1244).</w>
5 50).</w>
5 50%),</w>
5 5.8</w>
5 5.7</w>
5 5.5</w>
5 5.4</w>
5 5.2</w>
5 5.1</w>
5 5.0</w>
5 5-year</w>
5 5-fold</w>
5 49</w>
5 451</w>
5 44</w>
5 42</w>
5 40,000</w>
5 4.9</w>
5 4.3</w>
5 4-year</w>
5 4-week</w>
5 4-mg</w>
5 4,
54, 571</w>
5 4%)</w>
5 38</w>
5 31%</w>
5 300</w>
5 3.6</w>
5 3.6
53.6 +/-1.5%</w>
5 3.5</w>
5 3.5%</w>
5 3.3</w>
5 3.3%</w>
5 3.3%)</w>
5 3.1</w>
5 3%;</w>
5 3%),</w>
5 2;</w>
5 29,</w>
5 27</w>
5 250</w>
5 25,</w>
5 22</w>
5 225</w>
5 22,</w>
5 20,</w>
5 2.9%.</w>
5 2.9%).</w>
5 2.8</w>
5 2.8%.</w>
5 2.7</w>
5 2.7%</w>
5 2.7
52.7 4);</w>
5 2.6+/-1
52.6+/-1 1.4</w>
5 2.6%</w>
5 2.6%,</w>
5 2.5%</w>
5 2.5%.</w>
5 2.5
52.5 +/-1.9</w>
5 2.3%,</w>
5 2.1</w>
5 2.1%)</w>
5 2.0-
52.0- 97.0%)</w>
5 2.0%</w>
5 2-yr-old</w>
5 2-year</w>
5 2-week,</w>
5 2-1
52-1 00;</w>
5 2,0
52,0 23.</w>
5 2);</w>
5 1st</w>
5 19</w>
5 18</w>
5 182</w>
5 18.4</w>
5 17</w>
5 171</w>
5 16),</w>
5 146</w>
5 14,</w>
5 14
514 1-
5141- 29-
5141-29- 0),</w>
5 130
5130 12</w>
5 129)</w>
5 12.
512. 2+/-1
512.2+/-1 33.5</w>
5 12)</w>
5 11</w>
5 11).</w>
5 106</w>
5 100</w>
5 10)</w>
5 10).</w>
5 1/
51/ 1380</w>
5 1.9</w>
5 1.86</w>
5 1.5%</w>
5 1.4</w>
5 1.4%</w>
5 1.3%</w>
5 1-year</w>
5 1,5
51,5 39</w>
5 1,
51, 708</w>
5 1%)</w>
5 1%),</w>
5 0.9).</w>
5 0.8%)</w>
5 0.7</w>
5 0.7%</w>
5 0.7
50.7 %.</w>
5 0.3+/-1.
50.3+/-1. 1%</w>
5 0.3%,</w>
5 0.2
50.2 %;</w>
5 0.1-
50.1- 270
50.1-270 0.3).</w>
5 0.0%,</w>
5 +</w>
5 +/-1.3</w>
5 )-2</w>
5 (13)</w>
5 (10)</w>
5 (1/2)</w>
5 (1)-
5(1)- nucleotidase</w>
4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha- carboxylic</w>
4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha- carboxylate,</w>
4a R-trans]-4,4a,5,6,7,8,8a,9-o-dihydro-5n-propyl-2H-pyrazo</w>
4H NE-protein</w>
4Cy 2).</w>
4: 30</w>
4: 3,
4:3, 6-Dianhydrohexitol</w>
4: 15-
4:15- 24,</w>
4: 00,</w>
499 9</w>
499 80,</w>
49. 91</w>
49. 9%,</w>
49. 8%</w>
49. 7+/-1.8%,</w>
49. 52%,</w>
49. 50%,</w>
49. 5+/-19.1</w>
49. 5),</w>
49. 4-10
49.4-10 8.0</w>
49. 3</w>
49. 3%.</w>
49. 3
49.3 +/-1.
49.3+/-1. 7%</w>
49. 2</w>
49. 29</w>
49. 28</w>
49. 2%,</w>
49. 1+/-
49.1+/- 2.2%</w>
49. 1%</w>
49. 05</w>
49. 0%</w>
49+/- 8]</w>
49+/- 68</w>
49+/- 29</w>
49+/- 22</w>
49%- 85%)</w>
49%- 78%).</w>
49 th</w>
49 86</w>
49 85</w>
49 842)</w>
49 5)</w>
49 465</w>
49 365</w>
49 3+)</w>
49 0,</w>
49 %;</w>
480- 536</w>
48/ min</w>
48/ 80.</w>
48. 9+/-3.9</w>
48. 8%.</w>
48. 7).</w>
48. 6/100</w>
48. 6%,</w>
48. 5;</w>
48. 57+/-5.9%,</w>
48. 5%</w>
48. 49</w>
48. 4%.</w>
48. 3%.</w>
48. 3%,</w>
48. 24
48.24 2,</w>
48. 2+/-
48.2+/- 27.8</w>
48. 2%;</w>
48. 17</w>
48- year</w>
48- week),</w>
48- kg</w>
48- hour-obstructed</w>
48- fold</w>
48- day</w>
48- 96</w>
48- 878)</w>
48- 80).</w>
48- 77)</w>
48,6 78</w>
48,6 74</w>
48,6 12</w>
48+/- 4%</w>
48+/- 3%</w>
48 h.</w>
48 h)</w>
48 ;453)</w>
48 968,</w>
48 968)</w>
48 94</w>
48 9,</w>
48 86).</w>
48 72</w>
48 692),</w>
48 6.</w>
48 59+/-2122</w>
48 5-bed</w>
48 5).</w>
48 4</w>
48 4),</w>
48 34</w>
48 2),</w>
48 1
481 C>T,</w>
48 00-6
4800-6 400</w>
48 0,</w>
48 -15.
48-15. 20)</w>
48 ,000</w>
48 ,000/cu</w>
48 +/-12</w>
48 );</w>
48 %;</w>
478 2</w>
47. 9</w>
47. 9%</w>
47. 8%</w>
47. 8%.</w>
47. 8%),</w>
47. 5)</w>
47. 5%,</w>
47. 49</w>
47. 47;</w>
47. 2-
47.2- 77.8),</w>
47. 2)</w>
47. 2).</w>
47. 2%</w>
47. 17</w>
47. 1%.</w>
47. 0,</w>
47. 0
47.0 +/-1.6</w>
47- yr-old,</w>
47- February</w>
47- 79)</w>
47- 78</w>
47- 71%</w>
47+/- 7</w>
47+/- 22</w>
47+/- 2.3</w>
47 ]</w>
47 :1170-9].</w>
47 9.3</w>
47 63</w>
47 4,</w>
47 20
4720 3)</w>
47 0.4</w>
47 0)</w>
47 ,000/cu</w>
47 +/-1.35</w>
47 +/-1
47+/-1 %</w>
47 )>himbacine</w>
46. 92</w>
46. 9+/-32.7</w>
46. 82%)</w>
46. 8%</w>
46. 8%).</w>
46. 7%</w>
46. 7%;</w>
46. 7%,</w>
46. 6-94.0</w>
46. 6%,</w>
46. 4%</w>
46. 3).</w>
46. 3%</w>
46. 18+/-
46.18+/- 4
46.18+/-4 3.0
46.18+/-43.0 6;</w>
46. 1+/-
46.1+/- 9.1</w>
46. 0;</w>
46. 0
46.0 +/-1.5</w>
46- year-old,</w>
46- fold)</w>
46- day-old</w>
46- 85)</w>
46- 82</w>
46- 77).</w>
46- 58)</w>
46- 52</w>
46- 3.
46-3. 30),</w>
46, 300</w>
46+/- 7.5%,</w>
46+/- 6</w>
46+/- 681</w>
46 82-36-4)</w>
46 619</w>
46 6.3</w>
46 50</w>
46 5),</w>
46 42</w>
46 40</w>
46 3)</w>
46 28</w>
46 2,</w>
46 ,000</w>
46 %].</w>
46 %;</w>
454- 505</w>
450- 900</w>
450- 550</w>
450 scc)</w>
450 b)</w>
450 8).</w>
450 3,</w>
450 +/-
450+/- 5.1%;</w>
45/ 367</w>
45/ 27
45/27 9)</w>
45. 9%;</w>
45. 9%,</w>
45. 7)</w>
45. 6+/-19.5</w>
45. 6%</w>
45. 5;</w>
45. 5/18.2/6.1,</w>
45. 5%).</w>
45. 44%,</w>
45. 3].</w>
45. 2%</w>
45. 2%)</w>
45-1 95</w>
45-1 951).</w>
45- yr-old</w>
45- y-old</w>
45- s</w>
45- minute</w>
45- 913),</w>
45- 90</w>
45- 82</w>
45- 80</w>
45- 80%.</w>
45- 67.5,</w>
45- 60%</w>
45- 52</w>
45- 50</w>
45- 50%</w>
45- 49</w>
45- 48).</w>
45- 30</w>
45- 250</w>
45- 0088-
45-0088- S</w>
45+/- 6</w>
45+/- 299</w>
45 ml),</w>
45 calcium</w>
45 ].</w>
45 ])</w>
45 X-O,</w>
45 U)</w>
45 84</w>
45 82</w>
45 8-37-7),</w>
45 8,</w>
45 68</w>
45 5,</w>
45 4.0</w>
45 36</w>
45 32</w>
45 3
453 Stop).</w>
45 1-
451- 500</w>
45 00-6
4500-6 200</w>
45 00,</w>
45 -</w>
45 -14
45-14 5).</w>
45 -120</w>
45 -100
45-100 )</w>
45 +</w>
45 +/-1
45+/-1 2.72</w>
45 %),</w>
44/ 594</w>
44/ 150</w>
44. 8)</w>
44. 7+/-14.6</w>
44. 65</w>
44. 6)</w>
44. 5%</w>
44. 4),</w>
44. 4%;</w>
44. 18</w>
44. 1+/-
44.1+/- 41.2</w>
44- years-old</w>
44- bed</w>
44- 85)</w>
44- 73%</w>
44- 70);</w>
44- 65%.</w>
44+/- 8</w>
44+/- 2.
44+/-2. 91</w>
44+/- 0.11</w>
44+/- 0.01).</w>
44 :1142,</w>
44 97</w>
44 7].</w>
44 76</w>
44 74)</w>
44 72/day.</w>
44 70-4485),</w>
44 3,0
443,0 47</w>
44 1.2</w>
44 1-
441- 447].</w>
44 1,</w>
44 1
441 102</w>
44 -1.
44-1. 78);</w>
44 +</w>
44 +/-1</w>
44 +/-12</w>
44 )),</w>
44 %;</w>
436 94A)</w>
43. 9)</w>
43. 9%</w>
43. 8+/-4.6%</w>
43. 7-700.0</w>
43. 7%.</w>
43. 6);</w>
43. 6%</w>
43. 5%</w>
43. 46%).</w>
43. 4-
43.4- 75.9%)</w>
43. 4,</w>
43. 4).</w>
43. 4%;</w>
43. 4%,</w>
43. 3),</w>
43. 3%</w>
43. 2+
43.2+ 8</w>
43. 10%</w>
43. 1%</w>
43- yr-old</w>
43- years-old</w>
43- fold)</w>
43- 78</w>
43- 76);</w>
43- 71</w>
43+/- 6</w>
43+/- 4</w>
43 5.1</w>
43 (3)</w>
429. 72</w>
429. 04</w>
427. 32).</w>
427. 31</w>
42/ 59</w>
42/ 56</w>
42. 92;</w>
42. 9%</w>
42. 9%;</w>
42. 9%,</w>
42. 77</w>
42. 71</w>
42. 7%</w>
42. 6%;</w>
42. 5;</w>
42. 5%,</w>
42. 4-
42.4- 69.74%),</w>
42. 4+/-
42.4+/- 8.5</w>
42. 4%</w>
42. 3%</w>
42. 3%.</w>
42. 3%,</w>
42. 2,</w>
42. 2%;</w>
42. 1%</w>
42. 00</w>
42. 0,</w>
42- year-old,</w>
42- 90</w>
42- 83</w>
42- 65%)</w>
42 d</w>
42 ]).</w>
42 GPA9</w>
412 34
41234 8,</w>
41. 8+/-2.0%</w>
41. 66</w>
41. 50%</w>
41. 5%),</w>
41. 3)</w>
41. 2+/-
41.2+/- 2.1)</w>
41- yr-old</w>
41- y-o</w>
41- amino-acid</w>
41- 69</w>
41- 2272</w>
41+/- 799</w>
41+/- 2</w>
41+/- 0.8
41+/-0.8 3cm</w>
401 16.</w>
401 16)</w>
400/ mm3</w>
400/ mm3,</w>
400/ 100</w>
400- vs</w>
400- ms,</w>
400- mg/m(2)</w>
400- 800</w>
400- 730</w>
400- 600</w>
400 mg/kg</w>
400 mg.</w>
400 mg,</w>
400 g).Control</w>
400 2</w>
400 0,</w>
400 )</w>
400 ),</w>
40/ min</w>
40/ h).</w>
40/ 8</w>
40/ 44</w>
40/ 367</w>
40/ 163</w>
40.9 %);</w>
40.9 %),</w>
40-7 592.</w>
40-7 4),</w>
40-7 20</w>
40-6 18)</w>
40-59 67,</w>
40-59 5</w>
40-1 50);</w>
40-1 15</w>
40- year</w>
40- y-o</w>
40- month</w>
40- mg/kg</w>
40- kHz</w>
40- kDa</w>
40- item</w>
40- day</w>
40- amino-acid</w>
40- 90%</w>
40- 860%)</w>
40- 83</w>
40- 72%</w>
40- 70%</w>
40- 691),</w>
40- 65%</w>
40- 60</w>
40- 60%</w>
40- 55</w>
40- 48</w>
40- 4800</w>
40- 45%</w>
40- 44</w>
40- 41</w>
40- 300</w>
40- 2</w>
40- 250</w>
40- 210</w>
40- 0.9
40-0.9 34).</w>
40- -
40-- 59</w>
40%- 90%</w>
40%- 50%</w>
40 microg/mouse/day</w>
40 mg</w>
40 mg/day</w>
40 ];</w>
40 ])</w>
40 :1</w>
40 96</w>
40 86</w>
40 8).</w>
40 74</w>
40 72</w>
40 7+/-6.5%</w>
40 5),</w>
40 46</w>
40 33;</w>
40 3.</w>
40 21</w>
40 18</w>
40 16</w>
40 14</w>
40 1)</w>
40 0.5</w>
40 0.2
400.2 +/-1
400.2+/-1 1.8</w>
40 -induced</w>
40 -14
40-14 76),</w>
40 -120</w>
40 -100</w>
40 -100
40-100 /
40-100/ 0-
40-100/0- 40</w>
40 -1.6
40-1.6 1)</w>
40 ,9
40,9 60,</w>
40 +/-6</w>
40 +/-
40+/- 29-
40+/-29- 200
40+/-29-200 +/-
40+/-29-200+/- 22</w>
40 );</w>
40 %:</w>
4/ second),</w>
4/ heparin</w>
4/ heparin-reactive</w>
4/ group)</w>
4/ 9</w>
4/ 97</w>
4/ 92</w>
4/ 91</w>
4/ 9,</w>
4/ 8</w>
4/ 8,</w>
4/ 77)</w>
4/ 6</w>
4/ 66</w>
4/ 6.1/3.0,</w>
4/ 6).</w>
4/ 2</w>
4/ 29</w>
4/ 29;</w>
4/ 27</w>
4/ 20</w>
4/ 17).</w>
4/ 16</w>
4/ 15;</w>
4/ 150;</w>
4/ 15)</w>
4/ 12</w>
4/ 11/
4/11/ 1/2,</w>
4/ 108</w>
4/ 104</w>
4/ 100,000</w>
4/ 10,</w>
4/ 1
4/1 18;</w>
4/ 0</w>
4/ -</w>
4/ -11.3</w>
4.9 ],</w>
4.9 7;</w>
4.9 5;</w>
4.9 4,</w>
4.9 2),</w>
4.9 1%),</w>
4.8 ],</w>
4.8 ]),</w>
4.8 7%)</w>
4.8 6;</w>
4.8 5).</w>
4.8 35</w>
4.8 2),</w>
4.78 x</w>
4.78 )].</w>
4.7 ];</w>
4.7 9-5.32</w>
4.7 9,</w>
4.7 9)</w>
4.7 5;</w>
4.7 4+/-
4.74+/- 0.05</w>
4.7 3+/-
4.73+/- 0.12,</w>
4.7 2
4.72 )].</w>
4.7 1).</w>
4.7 +/-1.7</w>
4.7 +/-1
4.7+/-1 2.5</w>
4.7 );</w>
4.7 %-
4.7%- 29.
4.7%-29. 5%)</w>
4.6+/- 7.7</w>
4.6 mg/kg/daily)</w>
4.6 8;</w>
4.6 6;</w>
4.6 6,</w>
4.6 5;</w>
4.6 2)</w>
4.6 1,</w>
4.6 +/-1.5</w>
4.5+/- 0.6</w>
4.5+/- 0.04%</w>
4.4 mm</w>
4.4 7/100</w>
4.4 39,</w>
4.3 F</w>
4.3 2%)</w>
4.3 +/-1.9</w>
4.2+/-1. 2</w>
4.2+/- 0.4</w>
4.1.1. 15)</w>
4.1.1. 15
4.1.1.15 :</w>
4.1+/- 0.3</w>
4.0- kHz</w>
4.0- 85);</w>
4.0- 8.6,</w>
4.0- 6.5;</w>
4.0- 585,</w>
4.0 mg/kg</w>
4.0 mg/kg,</w>
4.0 9+/-2.95</w>
4.0 5,</w>
4.0 5+/-24.62</w>
4.0 3);</w>
4.0 1%)</w>
4.0 +/-1.
4.0+/-1. 1</w>
4.0 +/-
4.0+/- 0.3
4.0+/-0.3 fold</w>
4.0 );</w>
4. g/day-1.k-1</w>
4. 99</w>
4. 99+/-1.33</w>
4. 96</w>
4. 95</w>
4. 95)</w>
4. 94</w>
4. 9-11.9)</w>
4. 9+/-15.5%,</w>
4. 9)</w>
4. 9%;</w>
4. 9%).</w>
4. 89</w>
4. 88</w>
4. 884,</w>
4. 87</w>
4. 86]).</w>
4. 80,</w>
4. 80+/-1.77</w>
4. 8.</w>
4. 8-76.0)</w>
4. 8)</w>
4. 8),</w>
4. 8%.</w>
4. 8%).</w>
4. 79</w>
4. 74</w>
4. 73</w>
4. 7.</w>
4. 7-18.5)</w>
4. 7,</w>
4. 7+/-4.8</w>
4. 7%.</w>
4. 7%,</w>
4. 67</w>
4. 65,</w>
4. 60,</w>
4. 6-fold</w>
4. 6-5.1%</w>
4. 6%,</w>
4. 6%)</w>
4. 6%).</w>
4. 6%),</w>
4. 59</w>
4. 59)</w>
4. 58</w>
4. 56;</w>
4. 54</w>
4. 54+/-1.17</w>
4. 514,</w>
4. 50).</w>
4. 5.</w>
4. 5-mM</w>
4. 5-6</w>
4. 5),</w>
4. 5%)</w>
4. 49</w>
4. 49).</w>
4. 47</w>
4. 46,</w>
4. 45;</w>
4. 45%</w>
4. 44+/-2.91</w>
4. 41</w>
4. 41,</w>
4. 40,</w>
4. 40%)</w>
4. 4-1
4.4-1 0.9).</w>
4. 4+/-
4.4+/- 73.4</w>
4. 4)</w>
4. 4).</w>
4. 4%,</w>
4. 3;</w>
4. 37</w>
4. 36</w>
4. 36+/-
4.36+/- 2.90</w>
4. 35</w>
4. 336,</w>
4. 33,</w>
4. 31</w>
4. 30</w>
4. 3.</w>
4. 3.6)</w>
4. 3-fold</w>
4. 3-
4.3- 27
4.3-27 7);</w>
4. 3+/-
4.3+/- 0.4</w>
4. 3);</w>
4. 3%;</w>
4. 3%,</w>
4. 3%).</w>
4. 29</w>
4. 29)</w>
4. 28</w>
4. 27</w>
4. 26-
4.26- fold</w>
4. 23</w>
4. 23;</w>
4. 23.5),</w>
4. 21).</w>
4. 20</w>
4. 2/
4.2/ 100</w>
4. 2.</w>
4. 2.30)</w>
4. 2-1
4.2-1 3.
4.2-13. 6%)</w>
4. 2-
4.2- 43)</w>
4. 2).</w>
4. 2),</w>
4. 2%;</w>
4. 18</w>
4. 18;</w>
4. 17;</w>
4. 17)</w>
4. 16</w>
4. 16;</w>
4. 16)</w>
4. 15</w>
4. 15).</w>
4. 15%</w>
4. 14)</w>
4. 14
4.14 +/-1.
4.14+/-1. 39</w>
4. 13</w>
4. 13;</w>
4. 13)</w>
4. 12%</w>
4. 11,</w>
4. 1/
4.1/ 110.8</w>
4. 1.</w>
4. 1-8
4.1-8 2.5)</w>
4. 1-
4.1- 31.2</w>
4. 1%;</w>
4. 1%.</w>
4. 00;</w>
4. 00,</w>
4. 0-fold</w>
4. 0-1
4.0-1 36.
4.0-136. 6],</w>
4. 0%,</w>
4. 0%)</w>
4-methyl- alpha-phenylethylamine-induced</w>
4-methyl catechol</w>
4-methyl catechol,</w>
4-methyl aminorex,</w>
4-hydroxycoumar in.</w>
4-hydroxycoumar in,</w>
4-hydroxy-2,2,6,6-tetramethyl piperidine</w>
4-hydroxy-2,2,6,6-tetramethyl piperidine-1</w>
4-hydroxy- metabolites.</w>
4-hydroxy- cyclophosphamide</w>
4-hydroxy- cyclophosphamide.</w>
4-hydroxy- 2,3,3',4',5-pentachlorobiphenyl</w>
4-hydroxy tryptamine,</w>
4-hydroxy trofosfamide,</w>
4-hydroxy proline,</w>
4-hydroxy nonenal</w>
4-hydroxy mephenytoin</w>
4-hydroxy ifosfamide.</w>
4-hydroxy glutethimide,</w>
4-hydroxy debrisoquine</w>
4-hydroperoxy cyclophosphamide</w>
4-hydroperoxy cyclophosphamide:</w>
4-hydroperoxy cyclophosphamide.</w>
4-dinitro phenyl)-ethylenediamine</w>
4-dichloro phenyl)-n-methyl-n-[(1S)-1-(3-isothiocynatophenyl)-2-(1-</w>
4-dichloro -3-
4-dichloro-3- [(2-methyl-8-quinolinyl)</w>
4-OH-CB 107,</w>
4-OH- 2,3,3',4',5-pentachlorobiphenyl</w>
4-DMD R.</w>
4-DMD R,</w>
4-D AMP)</w>
4-8 6),</w>
4-7. 38).</w>
4-7. 21)</w>
4-4. 58;</w>
4-4 1%)</w>
4-4 1%).</w>
4-3. 37;</w>
4-3. 11)</w>
4-198 7.</w>
4-198 7).</w>
4-10 ).</w>
4-1. 82;</w>
4-1 998</w>
4-1 988</w>
4-1 962).</w>
4-1 84</w>
4-1 80</w>
4-1 6.90).</w>
4-1 5).</w>
4-1 4</w>
4-1 2)</w>
4-1 16</w>
4-1 1),</w>
4-1 0)</w>
4-1 0%)</w>
4-1 .0
4-1.0 29;</w>
4-- cimetidine</w>
4-- adriamycin+silymarin</w>
4-- RF</w>
4-- CP</w>
4-- 8</w>
4-- 6/sec,</w>
4-(2- [7-amino-2-(2-furyl[1,2,4]-triazolo[2,3-a[1,3,5]triazin-5-yl-aminoethyl)phenol</w>
4-( thiofen-2-il)-2-metilbut-3-yn-2-ol</w>
4-( dimethylamino)pyridine</w>
4- yr</w>
4- yr-old</w>
4- year,</w>
4- y-old</w>
4- weeks</w>
4- weekly</w>
4- vessel</w>
4- tetrahydroisoquinoline),</w>
4- tetrahydroanaphthalene.</w>
4- tetrahydro-6-nitro-2,3-dioxo-benzo(f)quinoxaline-7-sulphonamide</w>
4- specific</w>
4- somite-stage</w>
4- session</w>
4- related</w>
4- quinolone,</w>
4- position</w>
4- phosphonophenylglycine</w>
4- period,</w>
4- pentenoic</w>
4- oxadiazol-3-yl)</w>
4- min</w>
4- methyl-2-[(E)-hydroxyamino]-5-nitro-6-methoxy-3-hexanamide</w>
4- mEq/L</w>
4- m-chlorobenzylidenepempidine</w>
4- kHz</w>
4- item</w>
4- hydroxylated</w>
4- hydroxyl-2,2,6,6-tetramethylpiperidine-1-oxyl</w>
4- hydroxy-3-methoxyphenylethylene</w>
4- hydroxy-2-nonenal</w>
4- hourly,</w>
4- h)</w>
4- g</w>
4- formylaminoantipyrine).</w>
4- fold.</w>
4- fold,</w>
4- fold).</w>
4- ene-VPA</w>
4- drug</w>
4- diphenylacetoxy-N-(2-chloroethyl)-piperidine</w>
4- dihydroxyphenylacetic</w>
4- dihydro-2,3-quinoxalinedione</w>
4- diaminopyridine</w>
4- deoxypyridoxne,</w>
4- demethoxydaunorubicin</w>
4- demethoxy-daunorubicin.</w>
4- day-old,</w>
4- cm</w>
4- benzylidenepempidine</w>
4- behenoyl-1-beta-D-arabinofuranosyl</w>
4- antibody</w>
4- acetylaminoantipyrine</w>
4- [4'-(2-hydroxy-3-tert-butyl-aminopropoxy)-3'-methoxyphenyl]-</w>
4- [3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,3-dihydro-2H-benzimidazole-2-one</w>
4- [(alpha</w>
4- MC.</w>
4- HC.</w>
4- HC,</w>
4- Ethylsulfonylnaphthalene-1-sulfonamide,</w>
4- Diphenylacetoxy-N-methylpiperidine</w>
4- Demethoxydaunorubicin</w>
4- Cl,</w>
4- Amino-N-(2,4</w>
4- 9.0</w>
4- 9,</w>
4- 9%)</w>
4- 8,</w>
4- 79</w>
4- 75)</w>
4- 7).</w>
4- 6:</w>
4- 68)</w>
4- 68),</w>
4- 664</w>
4- 62</w>
4- 6.5</w>
4- 6,</w>
4- 6).</w>
4- 6%</w>
4- 5h.</w>
4- 540</w>
4- 53-1)</w>
4- 52)</w>
4- 5.97;</w>
4- 5-week-old</w>
4- 5-fold</w>
4- 5,</w>
4- 5).</w>
4- 5),</w>
4- 47</w>
4- 467)</w>
4- 44</w>
4- 39</w>
4- 38.
4-38. 4);</w>
4- 38%).</w>
4- 36).</w>
4- 35</w>
4- 35,</w>
4- 35),</w>
4- 307</w>
4- 3.0
4-3.0 6).</w>
4- 28</w>
4- 26-
4-26- 5]</w>
4- 25)</w>
4- 25%</w>
4- 24</w>
4- 23.6</w>
4- 2005).</w>
4- 2004.</w>
4- 2002</w>
4- 2.9
4-2.9 2).</w>
4- 2.7
4-2.7 5).</w>
4- 2.15</w>
4- 0.12</w>
4- 0.10</w>
4- 0.0011).</w>
4- 0
4-0 2-
4-02- 5],</w>
4- ->
4--> 59</w>
4- -15.
4--15. 0%)</w>
4- (5
4-(5 H-Dibenzo[a,</w>
4,9-dien-3- one</w>
4,7 93</w>
4,5-trimethoxy propenylbenzene)</w>
4,5- tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl]</w>
4,5- dihydro-6-[1-[2-hydroxy-2-(4-cyanophenyl)ethyl]-</w>
4,5- dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one</w>
4,5,6,7-tetrahydro isoxazolo</w>
4,5,6,7-tetrahydro isoxazolo-[4,5-c]-pyridin-3-ol</w>
4,5,6,7-tetrahydro isoxasolo-(5,4-c)</w>
4,5 24</w>
4,4a,5,6,7,8,8a,9-octahydro-5- n-propyl-2H-pyrazolo-3,4-g-quinoline</w>
4,4'-diethylaminoethoxy hexestrol</w>
4,4'-diethylaminoethoxy hexestrol.</w>
4,4'-diaminodiphenyl methane</w>
4,4'-diaminodiphenyl methane:</w>
4,4'- diisothiocyanatostilbene-2,2'</w>
4,4 46</w>
4,000/ mm3</w>
4,000/ microL)</w>
4,0 96</w>
4,0 52;</w>
4,0 48</w>
4,0 30</w>
4, 977</w>
4, 905).</w>
4, 858</w>
4, 846</w>
4, 846)</w>
4, 800</w>
4, 78</w>
4, 593</w>
4, 591</w>
4, 500</w>
4, 500/microL</w>
4, 400/mm3,</w>
4, 35
4,35 8,</w>
4, 314</w>
4, 3',4'-
4,3',4'- tetrachlorobiphenyl)</w>
4, 248</w>
4, 236</w>
4, 210</w>
4, 2
4,2 23).</w>
4, 187</w>
4, 169</w>
4, 15
4,15 7)</w>
4, 132</w>
4+/-1. 90</w>
4+/-1. 61</w>
4+/-1 13</w>
4+/- 77</w>
4+/- 7.0%</w>
4+/- 6.6,</w>
4+/- 6.1</w>
4+/- 5.0</w>
4+/- 4.9</w>
4+/- 4,*</w>
4+/- 3</w>
4+/- 30</w>
4+/- 3.7%</w>
4+/- 3.4,</w>
4+/- 3.3</w>
4+/- 23</w>
4+/- 2.67</w>
4+/- 0.64</w>
4+/- 0.61</w>
4+/- 0.06,</w>
4+ ])</w>
4+ )-induced</w>
4)- benzodiazepine-3-carboxylate)</w>
4'-iodo-4'- deoxydoxorubicin-induced</w>
4'-deoxy-4'-iodo- doxorubicin</w>
4'-deoxy-4'-iodo- doxorubicin.</w>
4'-deoxy- doxorubicin.</w>
4'-deoxy- doxorubicin,</w>
4'- disulphonic</w>
4'- diaminodiphenylsulfone,</w>
4'- Epidoxorubicin</w>
4'- EPI-doxorubicin</w>
4'- (9-
4'-(9- acridinylamino)</w>
4' deoxydoxorubicin</w>
4' deoxydoxorubicin)</w>
4%- 6%</w>
4%- 46%</w>
4%- 37.
4%-37. 3%).</w>
4%- 22%),</w>
4% +/-
4%+/- 3.4%</w>
4% )--and</w>
4 x10(9)/l</w>
4 x/wk</w>
4 th,</w>
4 p15.3-16</w>
4 microg/rat)</w>
4 mg/m2</w>
4 mg/m(2)</w>
4 mg/kg/d</w>
4 mg/kg)</w>
4 hour</w>
4 h)</w>
4 a</w>
4 S</w>
4 MU-AcNeu</w>
4 MA+vehicle</w>
4 H).</w>
4 Gy</w>
4 F;</w>
4 E-binding</w>
4 C/T),</w>
4 C-IMPPA</w>
4 BQO)</w>
4 Ac)</w>
4 AP-induced</w>
4 A1),</w>
4 =living:cadaveric</w>
4 :1</w>
4 99</w>
4 96</w>
4 93</w>
4 90-1320</w>
4 90,000</w>
4 90),</w>
4 9/10(6)</w>
4 9-year</w>
4 9-week</w>
4 9-79%</w>
4 9-523),</w>
4 9%)</w>
4 80).</w>
4 78</w>
4 751).</w>
4 72</w>
4 679)</w>
4 66</w>
4 60i</w>
4 60,</w>
4 6.9</w>
4 6.7</w>
4 6.3</w>
4 6.2</w>
4 6.1</w>
4 6.0</w>
4 6-158</w>
4 558</w>
4 50-mg</w>
4 50%</w>
4 5.7</w>
4 5.3</w>
4 5.1</w>
4 5.08</w>
4 5-day</w>
4 457</w>
4 453</w>
4 40-691),</w>
4 4.4</w>
4 4.3</w>
4 4,858</w>
4 396</w>
4 390</w>
4 39.9</w>
4 39.5</w>
4 39.1</w>
4 39
439 ,7
439,7 17</w>
4 389</w>
4 380</w>
4 38.9</w>
4 38
438 +/-102</w>
4 350</w>
4 34)</w>
4 300</w>
4 30-
430- 600</w>
4 30%</w>
4 3/47</w>
4 3.7</w>
4 3.6</w>
4 3-week</w>
4 3-1
43-1 391)</w>
4 3%),</w>
4 2nd</w>
4 289</w>
4 27</w>
4 27
427 5-4279).</w>
4 22)</w>
4 213</w>
4 21.</w>
4 21.9</w>
4 202</w>
4 200</w>
4 20,
420, 600</w>
4 20),</w>
4 20
420 814),</w>
4 2.9</w>
4 2.6</w>
4 2.5%;</w>
4 2.0</w>
4 2.0%,</w>
4 2-week</w>
4 2-hour</w>
4 2,6
42,6 71</w>
4 2,418</w>
4 2,
42, 124</w>
4 2);</w>
4 2%).</w>
4 1Cins>del,</w>
4 19</w>
4 199</w>
4 18,</w>
4 18),</w>
4 18
418 ):</w>
4 17)</w>
4 15;</w>
4 158</w>
4 155</w>
4 15.
415. 1,</w>
4 15,</w>
4 143</w>
4 13.9</w>
4 124</w>
4 12.9</w>
4 107</w>
4 100</w>
4 1/
41/ min</w>
4 1.9</w>
4 1.6</w>
4 1.5-
41.5- 41.8</w>
4 1.5%</w>
4 1.3%</w>
4 1.1%</w>
4 1.02</w>
4 1.0%</w>
4 1-month</w>
4 1-1
41-1 78),</w>
4 1%);</w>
4 1%),</w>
4 0.9%,</w>
4 0.8
40.8 4+/-2.67</w>
4 0.7%</w>
4 0.7%,</w>
4 0.6+/-
40.6+/- 3.5%</w>
4 0.6%</w>
4 0.50</w>
4 0.5%</w>
4 0.5%,</w>
4 0.4</w>
4 0.34</w>
4 0.31</w>
4 0.3%,</w>
4 0.2
40.2 C,</w>
4 0.0).</w>
4 0.0%,</w>
4 /</w>
4 -17</w>
4 -1700</w>
4 +/-</w>
4 *</w>
4 )]</w>
4 )],</w>
4 )M</w>
4 )-induced</w>
4 )).</w>
4 )),</w>
4 (SEM)</w>
4 (1/
4(1/ 2)-
4(1/2)- year-old</w>
4 (-/-))</w>
4 (+))</w>
4 %:</w>
3x 400</w>
3x 30</w>
3x 25</w>
3x 20</w>
3x 10(-5)</w>
3x 10
3x10 (12)</w>
3r d-ventricle</w>
3r d)</w>
3p 97</w>
3p 12.
3p12. 3-1
3p12.3-1 3,</w>
3beta-methyl-5alpha-pregnan-20- one),</w>
3beta-(4- Chlorophenyl)-2beta-(3-(4'-methylphenyl)-isoxazol-5-yl)tropane</w>
3beta-(4- (125)
3beta-(4-(125) I-iodophenyl)tropane-2beta-carboxylic</w>
3alpha-hydroxy- 5beta-pregnan-20-one</w>
3alpha-hydroxy- 5alpha-pregnan-20-one,</w>
3alpha- hydroxysteroid</w>
3alpha- OH-5alpha-pregnan-20-one</w>
3alpha,5alpha- tetrahydroprogesterone</w>
3alpha,5alpha- tetrahydroprogesterone),</w>
3a- e</w>
3K gamma),</w>
3H] T)</w>
3H- serotonin</w>
3H- norepinephrine</w>
3H- muscimol</w>
3H- leucine</w>
3H- dexamethasone</w>
3H- acetate</w>
3H- TdR</w>
3H- PrBCM</w>
3H- GABA</w>
3H- Flunitrazepam.</w>
3H- E-17G</w>
3H- DHPG,</w>
3H- DEX</w>
3C 1).</w>
3A 5)</w>
3A 4;</w>
3A 4.</w>
3A 4)</w>
3A 1,</w>
3= severe</w>
3= severe);</w>
3: >3.5</w>
3: 4=living:cadaveric</w>
3: 33
3:33 1:
3:331: 11
3:331:11 1-1
3:331:111-1 21).</w>
3: 3,</w>
3: 2</w>
3: 28
3:28 7-302]</w>
3: 19
3:19 59-1964),</w>
3: 13;</w>
3: 1),</w>
3: 00-
3:00- 9:00</w>
39. 9,</w>
39. 9)</w>
39. 7</w>
39. 7;</w>
39. 7).</w>
39. 7%</w>
39. 7%;</w>
39. 6%</w>
39. 5+/-8.4s.</w>
39. 5%,</w>
39. 4%</w>
39. 36%,</w>
39. 31
39.31 )),</w>
39. 3%</w>
39. 3%),</w>
39. 21%</w>
39. 20+/-
39.20+/- 86.90</w>
39. 11</w>
39. 1%;</w>
39. 1%)</w>
39. 0%,</w>
39-1. 94),</w>
39-1. 63)</w>
39- yr-old</w>
39- year</w>
39- y-o</w>
39- kDa</w>
39- 81</w>
39- 69)</w>
39- 629)</w>
39- 51</w>
39- 50%</w>
39- 45,</w>
39- 40</w>
39+/- 3.78</w>
39+/- 0.18</w>
39+/- 0.03)</w>
39 G>A</w>
39 :</w>
39 92</w>
39 9,</w>
39 9)</w>
39 8+/-6</w>
39 8)</w>
39 72</w>
39 7.2</w>
39 653</w>
39 6)</w>
39 5:481-492)</w>
39 551)</w>
39 4,000</w>
39 37</w>
39 24</w>
39 2),</w>
39 1),</w>
39 00</w>
39 00-
3900- 4200</w>
39 0),</w>
39 -16
39-16 2)</w>
39 -1.6
39-1.6 6),</w>
39 ,
39, 579-</w>
39 +/-1
39+/-1 64</w>
39 )
39) <or=75</w>
39 %.</w>
39 %+/-
39%+/- 64%</w>
389 3).</w>
389 2),</w>
3839 3.</w>
3839 3-
38393- A</w>
380 mmH2O</w>
380 32
38032 F,</w>
38/ 45</w>
38/ 150;</w>
38/ 129</w>
38. 93+/-8.36</w>
38. 8;</w>
38. 8+/-9.36).</w>
38. 8%,</w>
38. 77%</w>
38. 6%)</w>
38. 5%,</w>
38. 5%).</w>
38. 4</w>
38. 46%</w>
38. 4+/-3.4,</w>
38. 4%</w>
38. 4%;</w>
38. 4%,</w>
38. 3+/-
38.3+/- 2.6%,</w>
38. 3%).</w>
38. 3
38.3 %+/-1
38.3%+/-1 0.7%</w>
38. 2</w>
38. 2
38.2 degrees</w>
38. 1,</w>
38. 1%</w>
38. 1%,</w>
38. 1%)</w>
38- kHz</w>
38- 75%)</w>
38- 70</w>
38- 60%):</w>
38- 56</w>
38- 39</w>
38- 3.8</w>
38,0 74</w>
38,0 48</w>
38+/- 4%</w>
38+/- 3%</w>
38+/- 209</w>
38 th</w>
38 CM;</w>
38 893</w>
38 8).</w>
38 70</w>
38 5).</w>
38 3).</w>
38 24</w>
38 2
382 27.</w>
38 17</w>
38 1.33</w>
38 1).</w>
38 00-
3800- 7000</w>
38 00
3800 -10,000</w>
38 0-
380- 400</w>
38 0,</w>
38 .</w>
38 +/-19</w>
38 +/-1.
38+/-1. 10</w>
38 );</w>
38 )-responsive</w>
38 %);</w>
38 %),</w>
3784 9;</w>
3784 9)</w>
3784 9).</w>
375- 3.0</w>
375- 0.60</w>
375 mg/kg</w>
375 -1.5</w>
370 3),</w>
37. 9+/-7.0</w>
37. 9)</w>
37. 9%)</w>
37. 8)</w>
37. 8(18.3)%.</w>
37. 7),</w>
37. 65%</w>
37. 6+/-1.4%,</w>
37. 6%</w>
37. 50</w>
37. 5-150</w>
37. 5%:P</w>
37. 5%-62.4%)</w>
37. 4+/-4</w>
37. 4%,</w>
37. 38</w>
37. 3%</w>
37. 2</w>
37. 2%,</w>
37. 1-fold</w>
37. 1%</w>
37. 1%,</w>
37. 1%);</w>
37. 1%),</w>
37. 0%).</w>
37- years-old</w>
37- 84</w>
37- 714</w>
37- 5.109),</w>
37- 47).</w>
37- 44</w>
37- 300</w>
37, 495</w>
37, 233</w>
37, 232</w>
37+/- 75.38</w>
37+/- 24.
37+/-24. 43</w>
37%- 78%)).</w>
37%- 70%)</w>
37 :63,</w>
37 :1).</w>
37 9</w>
37 9.3]</w>
37 82</w>
37 8.9</w>
37 8)</w>
37 70)</w>
37 7-70-8),</w>
37 7)</w>
37 52</w>
37 51</w>
37 50</w>
37 5),</w>
37 4+/-113</w>
37 32</w>
37 3.8)</w>
37 22</w>
37 20</w>
37 18</w>
37 1.5</w>
37 1,</w>
37 1),</w>
37 0-
370- 770</w>
37 0%</w>
37 /
37/ 98</w>
37 -</w>
37 -14.
37-14. 17</w>
37 ,000/micro
37,000/micro L.</w>
37 +/-15.
37+/-15. 53,</w>
37 +/-12</w>
36/ 80</w>
36/ 61,</w>
36/ 177)</w>
36/ 16,</w>
36. 9)</w>
36. 9%</w>
36. 8-37.9</w>
36. 8%,</w>
36. 8%).</w>
36. 77</w>
36. 7),</w>
36. 7%</w>
36. 7%,</w>
36. 6%</w>
36. 53%</w>
36. 5),</w>
36. 5%),</w>
36. 4/6.1/3.0,</w>
36. 4%,</w>
36. 4%)</w>
36. 39+/-3.78</w>
36. 3%</w>
36. 2</w>
36. 22</w>
36. 20</w>
36. 2%-
36.2%- 59.5%)</w>
36. 2%,</w>
36. 1%-
36.1%- 41.9%</w>
36- week,</w>
36- minute</w>
36- 81</w>
36- 78),</w>
36- 55</w>
36- 5.44</w>
36- 42</w>
36- 202</w>
36- -48</w>
36, 568</w>
36, 282</w>
36+/- 0.12).</w>
36 h</w>
36 ],</w>
36 Cl</w>
36 Cl-influx</w>
36 9mg/dl,</w>
36 98</w>
36 9.7</w>
36 8</w>
36 8.8</w>
36 7.5</w>
36 6.1</w>
36 6.0</w>
36 5-fold</w>
36 5)</w>
36 5),</w>
36 5%)</w>
36 4.4).</w>
36 4+/-7.0%</w>
36 4)</w>
36 28</w>
36 1+/-22</w>
36 00)</w>
36 0.5</w>
36 0-
360- degree</w>
36 0,000</w>
36 0,
360, 333</w>
36 -</w>
36 -100</w>
36 -10
36-10 1</w>
36 -1.
36-1. 2)</w>
36 +</w>
36 +/-10
36+/-10 %,</w>
36 +/-1.2</w>
36 )-
36)- amide</w>
36 %).</w>
35S- sulfate.</w>
35S- labelled</w>
3500- 4500</w>
3500- 4000</w>
35/ 98</w>
35/ 66</w>
35/ 650</w>
35/ 35</w>
35/ 354;</w>
35/ 35/35</w>
35/ 30/
35/30/ 30</w>
35/ 15-25</w>
35. 82</w>
35. 8%,</w>
35. 7).</w>
35. 62,</w>
35. 6)</w>
35. 5+/-8.9</w>
35. 5),</w>
35. 5%</w>
35. 5%).</w>
35. 4+/-6.6,</w>
35. 3%</w>
35. 3%,</w>
35. 22</w>
35. 2+/-1
35.2+/-1 7.0</w>
35. 2%</w>
35. 2%,</w>
35. 00
35.00 +/-
35.00+/- 23.
35.00+/-23. 95</w>
35. 0%</w>
35-1. 55)</w>
35-1. 40</w>
35- years-old</w>
35- year-old,</w>
35- wk</w>
35- week</w>
35- kg</w>
35- fold.</w>
35- day-old</w>
35- amino</w>
35- 75).</w>
35- 59</w>
35- 55</w>
35- 52</w>
35- 44</w>
35- 42,</w>
35- 40%</w>
35- 39</w>
35- 37)</w>
35- ,</w>
35+/- 92</w>
35+/- 6</w>
35+/- 41</w>
35+/- 2%;</w>
35+/- 0.10</w>
35+/- 0.005</w>
35 ],</w>
35 93)</w>
35 8.7).</w>
35 8)</w>
35 75</w>
35 7.5</w>
35 7,</w>
35 66</w>
35 6.2</w>
35 6.25</w>
35 50</w>
35 5-359).</w>
35 5).</w>
35 41</w>
35 3:1959-1964),</w>
35 3),</w>
35 2
352 (25
352(25 )
352(25) :2640-2].</w>
35 1A)</w>
35 18).</w>
35 1.8</w>
35 00/
3500/ microliters)</w>
35 0.8</w>
35 -19.
35-19. 61)</w>
35 -1
35-1 0.78</w>
35 +/-18</w>
35 +/-12</w>
35 )]</w>
35 %+/-1
35%+/-1 3%</w>
35 %);</w>
35 %).</w>
344/ Lis</w>
341 (2
341(2 4)</w>
34. 9,</w>
34. 9%,</w>
34. 8+/-5.4</w>
34. 75+/-2.31;</w>
34. 7),</w>
34. 7%</w>
34. 6%</w>
34. 6%.</w>
34. 5).</w>
34. 4%.</w>
34. 3;</w>
34. 33</w>
34. 3)</w>
34. 3%</w>
34. 2+/-1
34.2+/-1 8.1</w>
34. 2%</w>
34. ),</w>
34- yr-old</w>
34- year-old,</w>
34- month-old</w>
34- 78);</w>
34- 76</w>
34- 75).</w>
34- 74</w>
34- 59%).</w>
34- 2.0
34-2.0 4)</w>
34+/- 9</w>
34+/- 8%</w>
34+/- 5%</w>
34 97</w>
34 95</w>
34 915),</w>
34 9-464).</w>
34 9).</w>
34 65</w>
34 6,</w>
34 6%,</w>
34 5,</w>
34 30</w>
34 3,
343, 132</w>
34 3+/-26</w>
34 25),</w>
34 2-</w>
34 1.5</w>
34 0,</w>
34 /
34/ min),</w>
34 -18
34-18 7)</w>
34 +/-5</w>
34 +/-4</w>
34 (55%)</w>
33:1258-126 4;</w>
33:1258-126 4).</w>
335 677),</w>
335 (SD</w>
330 84,</w>
330 5</w>
33/ 347</w>
33/ 217</w>
33/ 134)</w>
33/ 131</w>
33. 97;</w>
33. 9+/-3.1</w>
33. 9%;</w>
33. 8-63.5,</w>
33. 8+/-21.0</w>
33. 8%</w>
33. 7%])</w>
33. 7%</w>
33. 7%,</w>
33. 6),</w>
33. 6%.</w>
33. 6%).</w>
33. 54</w>
33. 5).</w>
33. 42</w>
33. 41%,</w>
33. 4%</w>
33. 3/
33.3/ 9.1/6.1,</w>
33. 3%.</w>
33. 3%)</w>
33. 3
33.3 +/-1.5</w>
33. 25</w>
33. 24+/-
33.24+/- 4.95</w>
33. 2%</w>
33. 10)</w>
33. 1)</w>
33. 1%;</w>
33. 1%.</w>
33. 0%-
33.0%- 37.7%</w>
33. 0%)</w>
33- yr-old</w>
33- weeks'</w>
33- ms</w>
33- bed</w>
33- 85</w>
33- 73)</w>
33- 67</w>
33- 67%</w>
33- 62.5%</w>
33- 50%</w>
33- 44</w>
33- 370</w>
33+/- 6%</w>
33+/- 2.9
33+/-2.9 4)</w>
33+/- 0.007</w>
33 80</w>
33 8%</w>
33 6.2</w>
33 5-patient,</w>
33 41</w>
33 4.</w>
33 4.6</w>
33 3:</w>
33 342-</w>
33 3),</w>
33 3%.</w>
33 26)</w>
33 2).</w>
33 12</w>
33 1.5</w>
33 1.0</w>
33 1-
331- 334.</w>
33 -</w>
33 -16.0</w>
33 -1
33-1 12%</w>
33 ))</w>
33 (0-1
33(0-1 00).</w>
32P-post labelling</w>
32P-post labelling,</w>
32P-post labeling,</w>
32P- post-labeling</w>
320/ 12.5</w>
320/ 12.5,</w>
320 DM,</w>
320 3,</w>
320 2,</w>
32/ 46</w>
32/ 33</w>
32. 9)</w>
32. 80</w>
32. 8-37.1]),</w>
32. 8%</w>
32. 8%).</w>
32. 78%</w>
32. 70),</w>
32. 7,</w>
32. 7%.</w>
32. 6%,</w>
32. 45,</w>
32. 4%).</w>
32. 3%,</w>
32. 2%</w>
32. 2%),</w>
32. 1,</w>
32. 1).</w>
32. 1),</w>
32. 1%</w>
32. 1%;</w>
32. 0-
32.0- 71.3),</w>
32- positive</w>
32- g</w>
32- 84</w>
32- 766),</w>
32- 72</w>
32- 67),</w>
32- 62)</w>
32- 53)</w>
32- 48</w>
32- 36</w>
32- 35</w>
32- 3.9
32-3.9 1)</w>
32- ,</w>
32, 546</w>
32, 280</w>
32+/- 21%)</w>
32+/- 2
32+/-2 0.7
32+/-20.7 3
32+/-20.73 min).</w>
32 percent</w>
32 ];</w>
32 P</w>
32 :297-304;</w>
32 4.5</w>
32 2
322 insGT)</w>
32 +/-12</w>
32 +/-1
32+/-1 3%,</w>
32 %/
32%/ 3%</w>
315 40-induced</w>
31/ 45</w>
31/ 39</w>
31/ 33</w>
31/ 32</w>
31/ 07</w>
31.6 7,</w>
31.6 %-
31.6%- 35.6%</w>
31. 97</w>
31. 96</w>
31. 91</w>
31. 9%).</w>
31. 85</w>
31. 8%,</w>
31. 8%).</w>
31. 70%).</w>
31. 7%),</w>
31. 6).</w>
31. 6%</w>
31. 6%,</w>
31. 6%).</w>
31. 4;</w>
31. 4.</w>
31. 3+/-
31.3+/- 8.2</w>
31. 1+/-1
31.1+/-1 1.6</w>
31. 00</w>
31- 82</w>
31- 73</w>
31- 66%].</w>
31- 35</w>
31- 2.8
31-2.8 6),</w>
31, 748</w>
31 ])</w>
31 +/-12</w>
31 +/-1.
31+/-1. 34%</w>
3036 6:</w>
3036 6.</w>
300/ min,</w>
300/ cu.mm</w>
300/ 100;</w>
300- mg/m(2)</w>
300- mg/d</w>
300- fold</w>
300- fold)</w>
300- 900</w>
300- 600</w>
300- 599</w>
300- 450</w>
300- 400%</w>
300- 4,000/microL)</w>
300- 310</w>
300 ms</w>
300 mg</w>
300 mg/kg</w>
300 6</w>
300 5</w>
300 38CM;</w>
300 1)</w>
300 -induced</w>
300 -100
300-100 0-fold</w>
300 -1/
300-1/ 10.</w>
300 -1,200</w>
300 ,000,</w>
30/ min.</w>
30/ Norm</w>
30/ Norm,</w>
30/ HTN:</w>
30/ HTN,</w>
30/ 54</w>
30/ 3.
30/3. 364</w>
30/ 117</w>
30.0 %).</w>
30- yr-old</w>
30- year-old,</w>
30- subject</w>
30- second-intervals</w>
30- mg/m(2)</w>
30- mg/</w>
30- day,</w>
30- bp</w>
30- MHz</w>
30- Hz</w>
30- 95%</w>
30- 90</w>
30- 90)</w>
30- 875)</w>
30- 73)</w>
30- 70</w>
30- 67)</w>
30- 62</w>
30- 55</w>
30- 540</w>
30- 490),</w>
30- 45%</w>
30- 44%),</w>
30- 40/min</w>
30- 40%.</w>
30- 39.9</w>
30- 365%)</w>
30- 34</w>
30- 32%</w>
30- 31</w>
30- 2</w>
30- 2.8
30-2.8 7;</w>
30, 800</w>
30, 453</w>
30, 400/mm3</w>
30+/-1. 55</w>
30+/-1. 40</w>
30+/- 38</w>
30+/- 30%).</w>
30 s.</w>
30 s).</w>
30 minutes/day(-1),</w>
30 mg/kg)</w>
30 g)</w>
30 ])</w>
30 90</w>
30 9,</w>
30 9+/-27</w>
30 85</w>
30 8%</w>
30 78</w>
30 762.</w>
30 761)</w>
30 7).</w>
30 7%</w>
30 69</w>
30 62</w>
30 61</w>
30 6,</w>
30 6)</w>
30 53)</w>
30 40</w>
30 4),</w>
30 3</w>
30 38</w>
30 3.62</w>
30 3)</w>
30 3).</w>
30 27
3027 6)</w>
30 22</w>
30 2+/-
302+/- 205</w>
30 2
302 +/-102</w>
30 16</w>
30 1)</w>
30 -150</w>
30 -123</w>
30 -100</w>
30 -1
30-1 70</w>
30 ,000/mm3.</w>
30 ,000,</w>
30 +;</w>
30 +/-2</w>
30 +/-17</w>
30 (+
30(+ 2)</w>
30 %;</w>
30 %
30% *),</w>
3/ month;</w>
3/ less</w>
3/ day)</w>
3/ beta</w>
3/ 99)</w>
3/ 89</w>
3/ 85</w>
3/ 81</w>
3/ 63</w>
3/ 594</w>
3/ 50</w>
3/ 45</w>
3/ 425</w>
3/ 40</w>
3/ 4)</w>
3/ 3/
3/3/ 1/
3/3/1/ 0,</w>
3/ 29</w>
3/ 29
3/29 6)</w>
3/ 27</w>
3/ 24,</w>
3/ 19</w>
3/ 18</w>
3/ 16,
3/16, 1
3/16,1 17),</w>
3/ 15</w>
3/ 15.</w>
3/ 144</w>
3/ 13/
3/13/ 4/0</w>
3/ 12</w>
3/ 126</w>
3/ 125</w>
3/ 11</w>
3/ 10</w>
3/ 105</w>
3/ 10,</w>
3/ 10)</w>
3/ 10(6)</w>
3/ 0.18-
3/0.18- 0.7
3/0.18-0.7 3/
3/0.18-0.73/ 0.
3/0.18-0.73/0. 24).</w>
3/ 0.12)</w>
3/ 0.005).</w>
3.9- 7</w>
3.9- 45+).</w>
3.9- 26
3.9-26 4.4.</w>
3.9 9%</w>
3.9 8-16.77)</w>
3.9 7;</w>
3.9 7,</w>
3.9 7)</w>
3.9 6;</w>
3.9 6,</w>
3.9 6%</w>
3.9 5,</w>
3.9 5)</w>
3.9 5).</w>
3.9 3)</w>
3.9 3%)</w>
3.9 2;</w>
3.9 1,</w>
3.9 +/-1.3</w>
3.9 +/-1
3.9+/-1 5.5%,</w>
3.9 )/
3.9)/ 114.7</w>
3.9 %.</w>
3.8- micromol/g</w>
3.8- 9.8</w>
3.8- 48.4</w>
3.8- 26.2)</w>
3.8+/- 9.8%,</w>
3.8+/- 5.5</w>
3.8 9-9.97),</w>
3.8 7),</w>
3.8 6,</w>
3.8 4,</w>
3.8 3]</w>
3.8 3,</w>
3.8 2,</w>
3.8 2).</w>
3.8 2),</w>
3.8 13,</w>
3.8 +/-1.5</w>
3.7- fold,</w>
3.7- cm</w>
3.7- 6.4)</w>
3.7+/- 6.6</w>
3.7+/- 0.3,</w>
3.7 8)</w>
3.7 7)</w>
3.7 5%,</w>
3.7 3;</w>
3.7 3,</w>
3.7 3+/-
3.73+/- 0.51</w>
3.7 3).</w>
3.7 2)</w>
3.7 1;</w>
3.7 1/
3.71/ ul</w>
3.6-1 5.5</w>
3.6-1 0.7%)</w>
3.6- fold,</w>
3.6- 7.1x10(9)/l</w>
3.6- 20.0
3.6-20.0 ).</w>
3.6+/- 2.0
3.6+/-2.0 2
3.6+/-2.02 gm/24h;</w>
3.6+/- 0.8</w>
3.6 6)</w>
3.6 5),</w>
3.6 4;</w>
3.6 4%)</w>
3.6 3,</w>
3.6 1,</w>
3.6 00,</w>
3.6 )/100,000</w>
3.6 %/s</w>
3.6 %.</w>
3.6 %);</w>
3.5-1 7.8)</w>
3.5-1 1.9)</w>
3.5- 6.7</w>
3.5- 4Gy</w>
3.5- 21.
3.5-21. 8)</w>
3.5+/- 0.9</w>
3.5+/- 0.9.</w>
3.5 3/100,000</w>
3.4-Methylene-di oxymethamphetamine</w>
3.4-Methylene-di oxymethamphetamine.</w>
3.4- kg</w>
3.4- 9.7)</w>
3.4- 42.5;</w>
3.4- 4.6,</w>
3.4 mm</w>
3.4 9-mg/kg</w>
3.4 7;</w>
3.4 7%).</w>
3.4 +/-1.4</w>
3.4 +/-1
3.4+/-1 0.7</w>
3.3-1 3.2).</w>
3.3-1 1.8),</w>
3.3 %-5.
3.3%-5. 0%)</w>
3.2- 8.7)</w>
3.2- 5.6</w>
3.2- 364.4).</w>
3.2+/- 0.9</w>
3.2+/- 0.9.</w>
3.2+/- 0.1</w>
3.1- fold,</w>
3.1- 6.2</w>
3.1- 4.9).</w>
3.1+/- 81</w>
3.1+/- 2.3</w>
3.1+/- 0.1,</w>
3.0- ml</w>
3.0- fold.</w>
3.0- 8.0</w>
3.0- 6.6%)</w>
3.0- 39.7).</w>
3.0- 3.5</w>
3.0- 3.4)</w>
3.0- 3.2</w>
3.0+/- 4.2</w>
3.0+/- 0.1fold</w>
3.0+/- 0.1%</w>
3.0 ],</w>
3.0 8</w>
3.0 8,</w>
3.0 6),</w>
3.0 4</w>
3.0 3,</w>
3.0 3)</w>
3.0 2;</w>
3.0 23</w>
3.0 2).</w>
3.0 1]).</w>
3.0 1,</w>
3.0 1%</w>
3.0 +/-1.9</w>
3.0 ):</w>
3. Pretreatment</w>
3. 99,</w>
3. 98</w>
3. 90;</w>
3. 9+/-2.5</w>
3. 9)</w>
3. 8;</w>
3. 88);</w>
3. 87)</w>
3. 86</w>
3. 85</w>
3. 83</w>
3. 81</w>
3. 81)</w>
3. 80])</w>
3. 8-fold</w>
3. 8-15.9</w>
3. 8),</w>
3. 78;</w>
3. 77+/-1.43,</w>
3. 74</w>
3. 72</w>
3. 70</w>
3. 69</w>
3. 68</w>
3. 65</w>
3. 63);</w>
3. 61</w>
3. 6-fold</w>
3. 6,</w>
3. 6).</w>
3. 59-12.47;</w>
3. 59+/-1.28</w>
3. 59+/-0.68).</w>
3. 58,</w>
3. 57</w>
3. 56</w>
3. 56;</w>
3. 56,</w>
3. 55</w>
3. 54</w>
3. 54;</w>
3. 54,</w>
3. 54).</w>
3. 51,</w>
3. 50+/-2.45</w>
3. 5.</w>
3. 5-</w>
3. 5-14</w>
3. 5).</w>
3. 5%;</w>
3. 48</w>
3. 48,</w>
3. 47</w>
3. 47,</w>
3. 46-fold)</w>
3. 45</w>
3. 44,</w>
3. 43</w>
3. 40%</w>
3. 4.</w>
3. 4.23.5),</w>
3. 4+/-3.3</w>
3. 4),</w>
3. 4%.</w>
3. 4%).</w>
3. 4%),</w>
3. 39),</w>
3. 38;</w>
3. 38),</w>
3. 37</w>
3. 37;</w>
3. 35+/-0.10</w>
3. 34</w>
3. 34,</w>
3. 32];</w>
3. 31</w>
3. 31).</w>
3. 30</w>
3. 3/100</w>
3. 3-</w>
3. 3-
3.3- 47.2)</w>
3. 3)</w>
3. 3%.</w>
3. 3%,</w>
3. 29</w>
3. 29;</w>
3. 29),</w>
3. 28</w>
3. 27,</w>
3. 25-
3.25- hr</w>
3. 25,</w>
3. 24</w>
3. 24-
3.24- 7.55),</w>
3. 24),</w>
3. 24%)</w>
3. 22,</w>
3. 22)</w>
3. 21,</w>
3. 20
3.20 +/-1.
3.20+/-1. 38</w>
3. 2/
3.2/ 100,000</w>
3. 2.
3.2. 1.5
3.2.1.5 1),</w>
3. 2%).</w>
3. 2%),</w>
3. 18</w>
3. 18,</w>
3. 18)</w>
3. 17%)</w>
3. 16;</w>
3. 15;</w>
3. 14</w>
3. 14,</w>
3. 134</w>
3. 12</w>
3. 12-
3.12- 8.79).</w>
3. 12)</w>
3. 11</w>
3. 10</w>
3. 10).</w>
3. 1.</w>
3. 1.1.
3.1.1. 1).</w>
3. 1.
3.1. 3.4)</w>
3. 1+/-1.2</w>
3. 1),</w>
3. 1%]</w>
3. 1%;</w>
3. 1%.</w>
3. 1%,</w>
3. 1%).</w>
3. 0-fold</w>
3. 0),</w>
3. 0%,</w>
3. 0%)</w>
3. 0%).</w>
3. 0%),</w>
3-phenyl tropanes</w>
3-phenyl -2
3-phenyl-2 (E)-
3-phenyl-2(E)- propenyl</w>
3-methylchol anthrene,</w>
3-methoxy-4-hydroxy phenylglycol,</w>
3-methoxy-4-hydroxy phenethyleneglycol</w>
3-methoxy-4-hydroxy phenethylene</w>
3-methoxy-4- hydroxy-phenylglycol</w>
3-methoxy- phenylacetic</w>
3-methoxy- O-demethyl</w>
3-methoxy- 9-methyl-6-oxo-7,13-dihydro-6H-benzofuro[2,3-e]pyrido[1,2-a][1,3]diazepin-12-ium</w>
3-methoxy- 6-oxo-7,13-dihydro-6H-benzofuro[2,3-e]pyrido[1,2-a][1,3]diazepin-12-ium</w>
3-methoxy tyramine</w>
3-methoxy -11-
3-methoxy-11- methyl-6-oxo-7,13-dihydro-6H-benzofuro[2,3-e]pyrido[1,2-a][1,3]diazepin-12-ium</w>
3-mercapto propionate</w>
3-mercapto propionate-induced</w>
3-isobut yl-xanthine</w>
3-hydroxy-3- methylglutaryl-coenzyme-A</w>
3-hydroxy-3- methyglutaryl-coenzyme</w>
3-hydroxy-3- methy-glutaryl</w>
3-hydroxy- hydroquinidine</w>
3-hydroxy- L-kynurenine</w>
3-hydroxy- 4-methyl-alpha-phenylethylamine-induced</w>
3-hydroxy- 3</w>
3-hydroxy methyl-5,5-diphenylhydantoin,</w>
3-hydroxy anthranilic</w>
3-hydroxy acyl-CoA</w>
3-dioxo-benzo[f]quinoxaline-7- sulphonamide</w>
3-dioxo-benzo[f]quinoxaline-7- sulfonamide</w>
3-dihydro-5H- imidazo</w>
3-dihydro-5H- imidazo-(2,</w>
3-desacetyl vecuronium</w>
3-desacetyl vecuronium.</w>
3-desacetyl vecuronium,</w>
3-carbamo yl</w>
3-but en-2-one),</w>
3-bromo- N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-6-dimethoxybenz</w>
3-bromo- 7-nitroindazole</w>
3-[2- carboxypiperazin-4-yl]-propyl-1-phosphonate</w>
3-PP P.</w>
3-PP P)</w>
3-OH-H Q:</w>
3-OH-H Q).</w>
3-OH AA</w>
3-O- methyl-D-glucose,</w>
3-O- glucuronide</w>
3-M X.</w>
3-3. 14),</w>
3-3. 13).</w>
3-2.9 7).</w>
3-2.9 6;</w>
3-2. 27)</w>
3-2. 20,</w>
3-10 4</w>
3-10 2</w>
3-10 ),</w>
3-1. 56).</w>
3-1 985,</w>
3-1 8</w>
3-1 8)</w>
3-1 8%).</w>
3-1 6.24,</w>
3-1 4.1</w>
3-1 4)</w>
3-1 35.5),</w>
3-1 35)</w>
3-1 32.1),</w>
3-1 30+/-38</w>
3-1 3).</w>
3-1 3
3-13 +).</w>
3-1 2-day-old</w>
3-1 0)</w>
3-- renal</w>
3-- is</w>
3-- diclofenac,</w>
3-- chlorpheniramine,</w>
3-- adriamycin</w>
3-- above</w>
3-- CP</w>
3-(methylnitrosamino) propionitrile</w>
3-(4- (3
3-(4-(3 (4-fluoro
3-(4-(3(4-fluoro benzoyl)-propyl-piperazino-l-yl-isoquinolino</w>
3-(3-hydroxyphenyl)- N-propylpiperidine)</w>
3-(2- carboxypiperazine-4-yl)propenyl-1-</w>
3-(2- carboxypiperazin-4-yl)-propyl-1-phosphonic</w>
3-(2- (dimethylamino)</w>
3-((+/-)-2-carboxypiperazin-4- yl)propyl-1-phosphonic</w>
3-((+/-)-2-carboxypiperazin-4- yl)propenyl-1-phosphonic</w>
3-((+/-)-2-carboxypiperazin-4- yl)-propyl-1-phosphonic</w>
3-( furan-2-il)</w>
3-( (RS)-
3-((RS)- 2-
3-((RS)-2- carboxypiperazin-4-yl)-propyl-1-phosphonic</w>
3- y-old</w>
3- weekly,</w>
3- week-long</w>
3- week-</w>
3- vessel</w>
3- treated</w>
3- to-1</w>
3- those</w>
3- receptors</w>
3- receptors.</w>
3- position</w>
3- point</w>
3- pentanone</w>
3- night,</w>
3- months-old</w>
3- mm</w>
3- ml</w>
3- mg/</w>
3- mercapto-2-methylpropranoyl-l-proline)</w>
3- kinase/Akt/mTOR</w>
3- kinase-dependent</w>
3- kg</w>
3- keto-valproic</w>
3- integrin</w>
3- hydroxy-2-quinoxalinecarboxylic</w>
3- hr)</w>
3- hr).</w>
3- head</w>
3- gallate</w>
3- fold.</w>
3- ethyl-2,4-dioxo-5,5-diphenyl-imidazolidine</w>
3- desacetyl</w>
3- day-interval,</w>
3- d</w>
3- cyano-2,6-dihydroxypyridine</w>
3- cm</w>
3- cm;</w>
3- choice,</w>
3- chloro-4-fluorophenyl-(4-fluoro-4-[[(5-methyl-6-methylamino-pyridin-2-ylmethyl)-amino]-methyl]-piperidin-1-yl-methanone</w>
3- centre</w>
3- bromo</w>
3- bis(2-chloroethyl)-1-nitrosurea</w>
3- benzodiazepine</w>
3- arm,</w>
3- aminopropylphosphonic</w>
3- amino-1-hydroxypropylidene-1,1-bisphosphonate</w>
3- alpha-tropanyl-2(pCl-phenoxy)butyrate</w>
3- [[3-Amino-2-(2-hydroxyethyl)-2H-pyrazol-1-ium-1-yl]methyl]-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetylamino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate</w>
3- [1-(R)-[(3-cyclohexylmethyl)hydroxyphosphinyl]-2-(S)-</w>
3- [1'-admantyl]-1-aminomethyl-3,4-dihydro-5,6-dihydroxy-1H-2-benzo</w>
3- Rs)</w>
3- OMD</w>
3- OMD.</w>
3- MT</w>
3- MT,</w>
3- MPA,</w>
3- Hz</w>
3- Factor</w>
3- FR5)</w>
3- CCNU)</w>
3- 91</w>
3- 90-day-old</w>
3- 9.7)</w>
3- 9-day-old</w>
3- 9+</w>
3- 9).</w>
3- 9%;</w>
3- 9%,</w>
3- 85.6,</w>
3- 8.42),</w>
3- 8-day-old</w>
3- 75</w>
3- 73</w>
3- 710),</w>
3- 70</w>
3- 70-4),</w>
3- 7.73;</w>
3- 7-day</w>
3- 7)</w>
3- 6d</w>
3- 6988)</w>
3- 6.</w>
3- 6.07;</w>
3- 50)</w>
3- 5.</w>
3- 5.1</w>
3- 4;</w>
3- 44),</w>
3- 4/100,000</w>
3- 4.</w>
3- 4).</w>
3- 390</w>
3- 38+</w>
3- 37</w>
3- 358.7).</w>
3- 31</w>
3- 30-day-old</w>
3- 30)</w>
3- 29.
3-29. 8);</w>
3- 27.
3-27. 28),</w>
3- 26</w>
3- 24%).</w>
3- 23</w>
3- 23.5,</w>
3- 2003.</w>
3- 200
3-200 6)</w>
3- 2.7
3-2.7 4)</w>
3- 2.6
3-2.6 5];</w>
3- 2.0
3-2.0 6;</w>
3- 0.94)</w>
3- 0.9
3-0.9 6),</w>
3- 0.87</w>
3- -4-
3--4- fold.</w>
3- (6-
3-(6- acetamido-3-pyridyl)-N-[N-(2,</w>
3- (4-chlorophenyl
3-(4-chlorophenyl amino)-5,5-dimethyl-2-cyclohexenone</w>
3- (+/-)-2-carboxypiperazin-4-
3-(+/-)-2-carboxypiperazin-4- yl)propyl-l-phosphonic</w>
3,8 74</w>
3,8 32</w>
3,7-disulf ate.</w>
3,7- trimethyl-8-(3-chlorostyryl)xanthine</w>
3,7- dimethyl-1-propargylxanthine</w>
3,7- dimethyl-1-propargylxanthane</w>
3,7 90-g</w>
3,6-dimethyl pyrazine-2-thiol</w>
3,6-di butanoylmorphine</w>
3,6-di anhydro-L-iditol</w>
3,5-dimethyl acetaminophen,</w>
3,5-dihydroxyphenyl glycine]</w>
3,5- triphenyltetrazoium</w>
3,5- dinitrocatechol</w>
3,5- bis(trifluoromethyl)benzylester</w>
3,5- DHPG,</w>
3,4-dihydroxyphenylalan ine)</w>
3,4-dihydroxyphenyl -
3,4-dihydroxyphenyl- acetic</w>
3,4-dihydro papaverine</w>
3,4-dicarboxy phenylglycines</w>
3,4-di methoxyphenylethylamino</w>
3,4-di hydroxiphenylacetic</w>
3,4-di amino-1-methyl</w>
3,4- methylenedioxymethamphetamine/</w>
3,4- methylenedioxymethamphetamine,</w>
3,4- methylenedioxy-methamphetamine,</w>
3,4- dihydroxyphenacetic</w>
3,4- dichlorophenyl</w>
3,4- Methylenedioxymethamphetamine</w>
3,4 75</w>
3,4 24</w>
3,4 18
3,418 ])</w>
3,3-dimethyl butanoylurea</w>
3,3-dimethyl butanoylurea:</w>
3,3'- iminodipropionitrile:</w>
3,3'- dimethylbenzidine</w>
3,3'- dimethoxybenzidine</w>
3,000/ microL.</w>
3,00 1,</w>
3,00 0.</w>
3,00 0-
3,000- 4,000/mm3</w>
3,00 0,</w>
3,0 94).</w>
3,0 92;</w>
3,0 80</w>
3,0 77</w>
3,0 16</w>
3, dihydroxybenzoic</w>
3, 999/mm3)</w>
3, 987,</w>
3, 985,</w>
3, 954</w>
3, 911</w>
3, 700</w>
3, 7,-dimethyl-1-propargylxanthine</w>
3, 625</w>
3, 611</w>
3, 600)</w>
3, 530</w>
3, 5-diethoxycarbonyl-1,4-dihydrocollidine</w>
3, 4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl]</w>
3, 322</w>
3, 270</w>
3, 257</w>
3, 200</w>
3, 200/
3,200/ cu.mm</w>
3, 2.
3,2. 16;</w>
3, 195</w>
3, 164</w>
3, 152</w>
3, 14
3,14 8,165</w>
3, 129</w>
3, 108</w>
3+/-8. 74min;</w>
3+/-1 6.56</w>
3+/-1 1.9</w>
3+/-1 1.2</w>
3+/-1 0.0</w>
3+/-0. 118</w>
3+/- 9</w>
3+/- 8.3,</w>
3+/- 8.2%</w>
3+/- 7</w>
3+/- 7.5</w>
3+/- 6.8s)</w>
3+/- 6.2</w>
3+/- 5.2</w>
3+/- 4</w>
3+/- 40.2</w>
3+/- 4.1</w>
3+/- 32</w>
3+/- 3.1%]</w>
3+/- 3%</w>
3+/- 22%</w>
3+/- 2.6</w>
3+/- 2.34</w>
3+/- 0.91</w>
3+/- 0.27</w>
3+/- 0.04;</w>
3)- 50</w>
3) >AF-DX</w>
3) %,</w>
3'UTR s.</w>
3'UTR .</w>
3'UTR ,</w>
3'-deamino-3'-(2- methoxy-4-morpholinyl)doxorubicin</w>
3'-deamino-3'-(2- methoxy-4-morpholinyl)-doxorubicin</w>
3'-deamino-3'-(2- methoxy-4-</w>
3'- untranslated</w>
3'- thiacytidine)-induced</w>
3'- region</w>
3'- region.</w>
3'- phosphorothioated</w>
3'- phosphohydrolase</w>
3'- phosphodiesterase,</w>
3'- phosphate</w>
3'- monoiodothyronine</w>
3'- UTRs</w>
3'- Deamino-3'-(2-methoxy-4-morpholinyl)-doxorubicin</w>
3',5'- monophosphate).</w>
3',5'- diiodothyronine</w>
3',5'- cyclic</w>
3',4'- TCB:</w>
3', dideoxycytidine</w>
3', 5'</w>
3' azido-3'deoxythymidine</w>
3 x</w>
3 mm</w>
3 microg/kg).</w>
3 mg</w>
3 mg/kg,</w>
3 mg/kg)</w>
3 meq/lt,</w>
3 infinity-hydroxysteroid</w>
3 h-prBCM</w>
3 g</w>
3 delAG,</w>
3 cmx3cm</w>
3 c</w>
3 beta</w>
3 beta-methylated</w>
3 beta)</w>
3 beta)-knockout</w>
3 b)</w>
3 ];</w>
3 ]).</w>
3 TC,</w>
3 S]</w>
3 SR,4aRS,6SR,8aRS-6-[phosphonomethyl]decahydr</w>
3 R)</w>
3 P3),</w>
3 OMD.</w>
3 NT</w>
3 N,</w>
3 MU/day</w>
3 K)</w>
3 HdT</w>
3 H2O</w>
3 G),</w>
3 FF)</w>
3 F</w>
3 D8</w>
3 D8:</w>
3 CL1),</w>
3 A1</w>
3 A.</w>
3 6.7</w>
3 6-week</w>
3 579</w>
3 578</w>
3 573</w>
3 57+/-154</w>
3 57).</w>
3 57),</w>
3 551</w>
3 505</w>
3 50-450</w>
3 50-1000</w>
3 50,</w>
3 50,000</w>
3 5.8</w>
3 5.3</w>
3 5.0</w>
3 5-fold</w>
3 483</w>
3 400</w>
3 40)</w>
3 4.2</w>
3 4.01%)</w>
3 4-week</w>
3 4-day</w>
3 4,793</w>
3 4,400/mm3,</w>
3 4,048</w>
3 398</w>
3 390</w>
3 390)</w>
3 39+/-164</w>
3 39)</w>
3 387</w>
3 369</w>
3 36).</w>
3 35+/-92</w>
3 30-fold</w>
3 3.9</w>
3 3.6</w>
3 3-fold</w>
3 3,832</w>
3 2nd</w>
3 2;</w>
3 298</w>
3 29+/-
329+/- 7.3%,</w>
3 28).</w>
3 26;</w>
3 269</w>
3 26%,</w>
3 26
326 mg/dl,</w>
3 25-mg</w>
3 243</w>
3 232,</w>
3 21-
321- 322insGT)</w>
3 206</w>
3 20.</w>
3 2.9</w>
3 2.5%</w>
3 2.5
32.5 +/-1
32.5+/-1 0.3</w>
3 2.0</w>
3 2.08</w>
3 2.02</w>
3 2-fold</w>
3 2-1
32-1 90</w>
3 2,000</w>
3 19,</w>
3 180</w>
3 18.7</w>
3 17.</w>
3 17.
317. 6,</w>
3 17
317 :185-91),</w>
3 165</w>
3 164)</w>
3 154</w>
3 151</w>
3 15.7</w>
3 14),</w>
3 130</w>
3 13,</w>
3 13).</w>
3 13),</w>
3 12)</w>
3 12).</w>
3 112</w>
3 111</w>
3 11.
311. 3-358.7).</w>
3 11-
311- 315;</w>
3 100</w>
3 100,</w>
3 100
3100 R,</w>
3 1/2</w>
3 1.9</w>
3 1.5</w>
3 1.5%.</w>
3 1.4</w>
3 1.0</w>
3 1-week</w>
3 1%;</w>
3 1%)</w>
3 1%),</w>
3 0.91</w>
3 0.9%</w>
3 0.9%;</w>
3 0.9%.</w>
3 0.8
30.8 8%</w>
3 0.7%</w>
3 0.7%,</w>
3 0.6)</w>
3 0.6
30.6 5%)</w>
3 0.49</w>
3 0.4%).</w>
3 0.4%),</w>
3 0.3;</w>
3 0.24
30.24 7,</w>
3 0.14</w>
3 0.1%</w>
3 0.07</w>
3 0.0%</w>
3 0.0%,</w>
3 0.0%)</w>
3 -1.7
3-1.7 0)</w>
3 -1.0</w>
3 +/-1</w>
3 +/-1.9</w>
3 )].</w>
3 )],</w>
3 ).(ABSTRACT</w>
3 ).
3). These</w>
3 )-</w>
3 (17)</w>
3 %/min,</w>
3 %-
3%- 5%</w>
3 %
3% )--
3%)-- was</w>
3 "</w>
2n d-degree</w>
2beta-carb omethoxy-3beta-phenyltropane.</w>
2beta- propanoyl-3beta-(4-tolyl)-tropane</w>
2a- e</w>
2a- 2b).</w>
2R,4R- 4-aminopyrrolidine-2,4-dicarboxylate</w>
2K1C- eNOS</w>
2D 6,</w>
2C- B</w>
2C 8,</w>
2C 19.</w>
2C 19,</w>
2C 19*
2C19* 2</w>
2C 12,</w>
2C 11,</w>
2B1/ 2B
2B1/2B 2,</w>
2B 9,</w>
2B 6.</w>
2B 1,</w>
2A/ 2C,</w>
2= moderate</w>
2= moderate,</w>
2: >300-3500</w>
2: 1:
2:1: 1).</w>
2: 1.</w>
2: 00-0
2:00-0 4:00</w>
29. 9,</w>
29. 9).</w>
29. 9%</w>
29. 9%)</w>
29. 8+/-12.9%</w>
29. 8),</w>
29. 8%,</w>
29. 8%).</w>
29. 7;</w>
29. 76%</w>
29. 7%</w>
29. 7%,</w>
29. 6%</w>
29. 5%,</w>
29. 5%).</w>
29. 45%</w>
29. 3)</w>
29. 29</w>
29. 21</w>
29. 2-
29.2- 373.8)</w>
29. 2).</w>
29. 2%)</w>
29. 1;</w>
29. 1%).</w>
29. 0+/-1
29.0+/-1 8.0</w>
29. 0+/-
29.0+/- 2.1</w>
29- year</w>
29- kg,</w>
29- 86</w>
29- 865)</w>
29- 78).</w>
29- 71%),</w>
29- 51%.</w>
29- 37</w>
29- 22.
29-22. 99</w>
29- 0.31</w>
29, 999/mm3)</w>
29, 410</w>
29, 357</w>
29+/- 264</w>
29+/- 22</w>
29+/- 0.07</w>
29 9)</w>
29 7),</w>
29 6961)</w>
29 6-0</w>
29 6%</w>
29 59</w>
29 58</w>
29 5-fold,</w>
29 5,</w>
29 5%)</w>
29 4002</w>
29 21</w>
29 2.0</w>
29 2+/-
292+/- 24</w>
29 18</w>
29 16)</w>
29 1.7</w>
29 1).</w>
29 08</w>
29 07</w>
29 06</w>
29 0.3</w>
29 0),</w>
29 /
29/ 65</w>
29 -</w>
29 -16
29-16 80).</w>
29 -100%</w>
29 -1.
29-1. 349).</w>
29 ,8
29,8 23.</w>
29 ,000/cu</w>
29 (th)</w>
29 (7)</w>
29 %-
29%- 34%)</w>
280- 360</w>
280- 340</w>
280- 300</w>
280 g)</w>
280 4)</w>
280 1-
2801- 28
2801-28 10,</w>
280 +/-17</w>
28/ min,</w>
28/ 221</w>
28. 9%</w>
28. 87</w>
28. 8)</w>
28. 7%).</w>
28. 67</w>
28. 62+/-3.12;</w>
28. 6/million</w>
28. 6-513.0</w>
28. 6,</w>
28. 6%.</w>
28. 6%,</w>
28. 6%)</w>
28. 55%</w>
28. 5%</w>
28. 5%,</w>
28. 4;</w>
28. 4%,</w>
28. 36,</w>
28. 21</w>
28. 2%]</w>
28. 2%</w>
28. 2%),</w>
28. 1)</w>
28. 0%,</w>
28- yr-old</w>
28- week,</w>
28- period</w>
28- night</w>
28- month-old</w>
28- gauge</w>
28- fold</w>
28- 90%</w>
28- 86).</w>
28- 72),</w>
28- 56</w>
28- 48%,</w>
28- 463)</w>
28- 43%</w>
28- 42;</w>
28- 40</w>
28- 36</w>
28- 36%</w>
28- 33</w>
28- 33.</w>
28- 32</w>
28- 0.38</w>
28- ,</w>
28+/- 4.13)</w>
28+/- 3%</w>
28+/- 2</w>
28+/- 0.2</w>
28+/- 0.25</w>
28%- 90%</w>
28%- 47%),</w>
28 mg/kg</w>
28 T>G),</w>
28 9;</w>
28 9--301</w>
28 9,</w>
28 9,000).</w>
28 9)</w>
28 80</w>
28 8.5+/-7.7s</w>
28 8+/-8</w>
28 8)</w>
28 8),</w>
28 79</w>
28 71</w>
28 7),</w>
28 69</w>
28 6.</w>
28 6+/-0.195</w>
28 6)</w>
28 6),</w>
28 54</w>
28 5.7</w>
28 5-4709;</w>
28 5+/-149</w>
28 5(10)</w>
28 4.9</w>
28 4,846)</w>
28 4+/-23</w>
28 4).</w>
28 4%</w>
28 3.2-364.4).</w>
28 3);</w>
28 00/
2800/ microliter</w>
28 0.5</w>
28 -13
28-13 39).</w>
28 +/-101</w>
28 +/-1
28+/-1 %;</w>
28 (th)</w>
28 %.</w>
28 %-1
28%-1 4.32%)</w>
28 %),</w>
2770 11</w>
27/ 67;</w>
27/ 47</w>
27. 905,</w>
27. 9%.</w>
27. 8,</w>
27. 8%</w>
27. 8%.</w>
27. 7],</w>
27. 6;</w>
27. 65</w>
27. 5)</w>
27. 5%.</w>
27. 4,</w>
27. 4%</w>
27. 37</w>
27. 35,</w>
27. 3%).</w>
27. 2</w>
27. 29,</w>
27. 2+/-1
27.2+/-1 0.6</w>
27. 2).</w>
27. 2%</w>
27. 2%,</w>
27. 15</w>
27. 1)</w>
27. 1%).</w>
27. 02,</w>
27-1 3.18)</w>
27-1 2)</w>
27-1 0.11,</w>
27-- 70</w>
27-- 45%</w>
27- kDa</w>
27- g</w>
27- fold</w>
27- 90</w>
27- 75</w>
27- 73),</w>
27- 7.76).</w>
27- 61</w>
27- 59)</w>
27- 46)</w>
27- 40</w>
27- 32%).</w>
27- 29</w>
27- 26.
27-26. 88</w>
27- 23
27-23 0%)</w>
27, 257</w>
27, 0.8
27,0.8 4)),</w>
27 G</w>
27 9%),</w>
27 80,</w>
27 78)</w>
27 78),</w>
27 72</w>
27 722</w>
27 7.2g</w>
27 7),</w>
27 6.4</w>
27 6),</w>
27 5:</w>
27 57</w>
27 50-g</w>
27 5.7</w>
27 5+/-25</w>
27 5%</w>
27 4).</w>
27 4),</w>
27 37</w>
27 3.9</w>
27 3+/-32</w>
27 3)</w>
27 3),</w>
27 3%),</w>
27 25)</w>
27 20-
2720- gram</w>
27 2.94</w>
27 2),</w>
27 2%</w>
27 0.6</w>
27 0,000</w>
27 0),</w>
27 0%</w>
27 +/-2</w>
27 (SEM</w>
27 %]</w>
27 %/y</w>
27 %/
27%/ 2%</w>
2630 3</w>
2630 3-treated</w>
260- 330</w>
260- 290</w>
260- 280g)</w>
26/ 31</w>
26/ 30</w>
26/ 20</w>
26/ 135)</w>
26/ 134)</w>
26.7+/- 9.4</w>
26.7+/- 5.4.</w>
26.7+/- 3</w>
26. 9+/-133.1</w>
26. 9%</w>
26. 9%;</w>
26. 9%,</w>
26. 79</w>
26. 74).</w>
26. 66</w>
26. 6%,</w>
26. 5)</w>
26. 5%.</w>
26. 4%),</w>
26. 3;</w>
26. 38</w>
26. 37+/-15.53,</w>
26. 34</w>
26. 3+/-6.2</w>
26. 3+/-3.6</w>
26. 3),</w>
26. 2</w>
26. 2%).</w>
26. 1,</w>
26. 1),</w>
26. 1%</w>
26. 0/
26.0/ 10.7</w>
26. 0,</w>
26. 0)</w>
26. 0%;</w>
26. 0%)</w>
26- weeks'</w>
26- month-old</w>
26- hour</w>
26- fold.</w>
26- day</w>
26- 8.3).</w>
26- 78).</w>
26- 65</w>
26- 60</w>
26- 603</w>
26- 6.63)</w>
26- 50</w>
26- 50/high-power</w>
26- 48</w>
26- 44%</w>
26- 3.82),</w>
26 ]).</w>
26 9.80</w>
26 9).</w>
26 7:21720-21726).</w>
26 78</w>
26 77</w>
26 763,</w>
26 7,000/mm3.</w>
26 6.5</w>
26 6-274],</w>
26 6,951</w>
26 6+/-25</w>
26 5%)</w>
26 438</w>
26 4.7</w>
26 3.9</w>
26 3.7</w>
26 3.5</w>
26 23</w>
26 21),</w>
26 2,
262, 14
262,14 4;</w>
26 14</w>
26 10</w>
26 09</w>
26 06</w>
26 0/
260/ 160,</w>
26 0.4
260.4 3+/-8.74min;</w>
26 0,</w>
26 0,000</w>
26 0%)</w>
26 -1.
26-1. 63,</w>
26 ,9
26,9 00/
26,900/ mm3,</w>
26 ,7
26,7 33</w>
26 ,
26, 294</w>
26 +/-2</w>
26 +/-16</w>
26 +/-0.07</w>
26 )].</w>
26 )],</w>
26 )>/=
26)>/= pirenzepine</w>
26 (1/2)</w>
26 %/
26%/ cm</w>
25: 50)</w>
25: 11;</w>
2592 Tins/Tins</w>
2592 C>Tins</w>
2500- 3000</w>
250- mu</w>
250- msec</w>
250- Hz</w>
250- 750</w>
250- 400g).Control</w>
250- 350</w>
250- 300</w>
250- 265</w>
250 mg/kg</w>
250 T)</w>
250 9</w>
250 66)</w>
250 5)</w>
250 4</w>
250 /
250/ minute.</w>
250 -1700</w>
250 ,000</w>
25/ min</w>
25/ 9</w>
25/ 79</w>
25/ 72</w>
25/ 35</w>
25/ 33)</w>
25/ 32,</w>
25/ 26,</w>
25/ 100,000</w>
25. 9;</w>
25. 92</w>
25. 9%,</w>
25. 9%),</w>
25. 8,</w>
25. 7%</w>
25. 7%,</w>
25. 6.</w>
25. 6),</w>
25. 5;</w>
25. 5-26h</w>
25. 5).</w>
25. 4%,</w>
25. 3</w>
25. 35</w>
25. 2;</w>
25. 2+/-
25.2+/- 2.3</w>
25. 2%;</w>
25. 2%,</w>
25. 17</w>
25. 1,</w>
25. 0;</w>
25. 05</w>
25. 00</w>
25. 0%</w>
25. 0%,</w>
25-OHD 3</w>
25-OHD .</w>
25-1 2.5</w>
25-1 14</w>
25-(OH)(2) D(3)</w>
25-(OH)(2) D(3),</w>
25- years</w>
25- week</w>
25- week,</w>
25- mu</w>
25- mmHg</w>
25- kg</w>
25- h)</w>
25- gauge,</w>
25- g,</w>
25- dihydroxycholecalciferol)</w>
25- OH</w>
25- G</w>
25- 75%</w>
25- 74</w>
25- 71)</w>
25- 54</w>
25- 500</w>
25- 450</w>
25- 43</w>
25- 30),</w>
25- 28%</w>
25- 2.75</w>
25- 0.7
25-0.7 75</w>
25- 0.01</w>
25- .5</w>
25- -120</w>
25- ,</w>
25, 750</w>
25, 302</w>
25, 1.04-1.
25,1.04-1. 50),</w>
25+/- 5</w>
25+/- 4%,</w>
25+/- 3</w>
25+/- 0.91</w>
25+/- 0.06</w>
25(OH) D</w>
25(OH) D3</w>
25(OH) D3-treated</w>
25(OH) D.</w>
25 th;</w>
25 mug</w>
25 mug/ml</w>
25 mg/kg/day)</w>
25 h</w>
25 h.</w>
25 :</w>
25 9/107</w>
25 9.0]).</w>
25 8.0</w>
25 76;</w>
25 7,</w>
25 7).</w>
25 64</w>
25 600.</w>
25 60)</w>
25 6.21+/-19.55,</w>
25 6-0.037,</w>
25 6,000</w>
25 6)</w>
25 5delA</w>
25 5days</w>
25 584,</w>
25 50.0</w>
25 5.6+/-16.7</w>
25 5.3</w>
25 5+/-115</w>
25 49</w>
25 4.3</w>
25 4)</w>
25 3.77</w>
25 3.4</w>
25 3%</w>
25 24</w>
25 2)</w>
25 2
252 -1,020</w>
25 15</w>
25 1-
251- insensitive</w>
25 00
2500 -</w>
25 0.35</w>
25 -150</w>
25 -14.
25-14. 64</w>
25 -120</w>
25 -1.0
25-1.0 50</w>
25 ,9
25,9 81</w>
25 ,7
25,7 68</w>
25 ,000/
25,000/ microl</w>
25 (OH)</w>
25 %/
25%/ year</w>
25 %-
25%- 33%</w>
25 %);</w>
24a,26a,27a-tri-homo-22,24-di ene-D3:</w>
2455 9).</w>
2455 4-26-5]</w>
2413 95</w>
240- 390</w>
240- 280</w>
240- 24
240-24 8;</w>
240 3,</w>
240 -1,
240-1, 305</w>
24/ group)</w>
24/ 88</w>
24/ 6</w>
24/ 59),</w>
24/ 57</w>
24/ 54</w>
24/ 45,</w>
24/ 33</w>
24/ 16/
24/16/ 12;</w>
24. 97;</w>
24. 90</w>
24. 9.</w>
24. 9,</w>
24. 8).</w>
24. 8%</w>
24. 768;</w>
24. 72</w>
24. 7/16.6</w>
24. 7-75.4%),</w>
24. 7)</w>
24. 7%;</w>
24. 63</w>
24. 6)</w>
24. 6).</w>
24. 55,</w>
24. 5%.</w>
24. 4%.</w>
24. 32+/-20.73min).</w>
24. 3%.</w>
24. 29).</w>
24. 23;</w>
24. 2/9.1/0,</w>
24. 2-49</w>
24. 2%</w>
24. 1;</w>
24. 1-</w>
24. 1,</w>
24. 0</w>
24. 08</w>
24-(OH)(2) D(3)],</w>
24-(OH)(2) D(3)-</w>
24-(OH)(2) D(2)],</w>
24-(OH)(2) D(2)-treated</w>
24-(OH)(2) D(2),</w>
24- year-old-female</w>
24- week,</w>
24- methylenecycloartenol</w>
24- hour,</w>
24- day-old</w>
24- amino</w>
24- OXO-D3,</w>
24- Hour</w>
24- 76</w>
24- 60</w>
24- 46),</w>
24- 40</w>
24- 4.02,</w>
24- 36</w>
24- 35</w>
24- 34%.</w>
24- 313),</w>
24- 26</w>
24- 2.50;</w>
24- 0.9
24-0.9 7].</w>
24- ,</w>
24,25-(OH)2D 2/25-OHD2</w>
24, 523</w>
24, 242</w>
24+/- 3.87</w>
24 x</w>
24 hr</w>
24 hours</w>
24 h.</w>
24 ].</w>
24 :</w>
24 :00,</w>
24 97</w>
24 969</w>
24 95</w>
24 9/-0.212);</w>
24 9%,</w>
24 8.7</w>
24 78</w>
24 77</w>
24 72</w>
24 71</w>
24 7/150</w>
24 62</w>
24 61</w>
24 6.4</w>
24 6)</w>
24 5,</w>
24 5,595</w>
24 46</w>
24 41</w>
24 3.71/ul</w>
24 3.4</w>
24 3)</w>
24 22</w>
24 213,</w>
24 2,0
242,0 84</w>
24 2,
242, 08
242,08 4.</w>
24 15</w>
24 13</w>
24 1%,</w>
24 06</w>
24 00,</w>
24 00
2400 mg/day)</w>
24 0.3</w>
24 0,000</w>
24 -120</w>
24 +/-2</w>
24 );</w>
24 ):</w>
24 )-based</w>
24 (OH)2D3)</w>
24 %:</w>
24 %);</w>
24 %
24% *
24%* ).</w>
2376 2):</w>
2376 2).</w>
236 4),</w>
23390 :</w>
2339 0;</w>
2339 0-
23390- labelled</w>
2339 0)</w>
23339 A,</w>
23339 0
233390 -induced</w>
233- 408</w>
233- 267</w>
232 I</w>
230 g-300g)</w>
230 3).</w>
230 20
23020 29</w>
23/ min</w>
23/ 57</w>
23/ 32</w>
23/ 30</w>
23/ 150;</w>
23/ -16</w>
23. 9/9.7,</w>
23. 9%)</w>
23. 8/16.6</w>
23. 8)</w>
23. 7+/-3.1</w>
23. 7)</w>
23. 6;</w>
23. 65</w>
23. 59,</w>
23. 5)</w>
23. 5%.</w>
23. 5%-61%)</w>
23. 5%)</w>
23. 4;</w>
23. 49;</w>
23. 42,</w>
23. 4,</w>
23. 3%;</w>
23. 2),</w>
23. 2%</w>
23. 17%</w>
23. 17
23.17 4,</w>
23. 1,</w>
23. 1+/-
23.1+/- 3.5</w>
23. 1%-
23.1%- 58.9%).</w>
23. 1%,</w>
23. 0/
23.0/ 9.0</w>
23. 0%</w>
23- year-old-woman</w>
23- y-old</w>
23- gauge</w>
23- fold,</w>
23- dihydroavermectin</w>
23- 76)</w>
23- 69);</w>
23- 65)</w>
23- 56</w>
23- 54];</w>
23- 54.8%);</w>
23- 52</w>
23- 51</w>
23- 5.16),</w>
23- 48)</w>
23- 48%).</w>
23- 41)</w>
23- 4.32)</w>
23- 39</w>
23- 36%</w>
23- 32</w>
23- 30</w>
23- 27;</w>
23- 26</w>
23- -
23-- 75</w>
23, 977)</w>
23, 289,</w>
23, 100,</w>
23, 0.7
23,0.7 6)),</w>
23+/- 43</w>
23+/- 4).</w>
23+/- 38.5</w>
23+/- 21</w>
23+/- 0.03</w>
23 th</w>
23 rd</w>
23 ];</w>
23 G)</w>
23 :</w>
23 9),</w>
23 9%,</w>
23 884</w>
23 87</w>
23 848)</w>
23 8.7</w>
23 71</w>
23 7.0</w>
23 6.9</w>
23 58</w>
23 50</w>
23 5.9</w>
23 5.8</w>
23 5(13)</w>
23 45</w>
23 40</w>
23 3;</w>
23 36</w>
23 2:</w>
23 29).</w>
23 27</w>
23 26.9+/-133.1</w>
23 2-
232- bp</w>
23 2,
232, 390</w>
23 2%</w>
23 127)</w>
23 11</w>
23 1),</w>
23 1
231 (17),</w>
23 01</w>
23 00,</w>
23 0%</w>
23 +/-</w>
23 +/-4</w>
23 +/-1
23+/-1 22</w>
23 +/-0.0
23+/-0.0 4%</w>
23 (CsA)</w>
23 %/y</w>
23 %);</w>
23 %
23% (-)-
23%(-)- 26%</w>
22: 14</w>
22: 00-
22:00- 00
22:00-00 :00</w>
229 8-5387</w>
229 +/-10
229+/-10 8</w>
226 6,</w>
226 546).</w>
225- 550</w>
225- 550).</w>
225- 500</w>
225- 375</w>
225- 300</w>
225- 248</w>
224 4],</w>
224 1),</w>
220 71-15-4)</w>
220 3-70-4),</w>
220 23)</w>
22/ 523</w>
22/ 40</w>
22/ 31</w>
22/ 11</w>
22.7+/- 7.8</w>
22.7+/- 0.9</w>
22. 9+/-6.8</w>
22. 9)</w>
22. 9%:</w>
22. 9%-57.9%)</w>
22. 87)</w>
22. 82%</w>
22. 8-35.6]</w>
22. 8+/-1.5</w>
22. 8),</w>
22. 8%,</w>
22. 8%),</w>
22. 7;</w>
22. 77</w>
22. 75%</w>
22. 71</w>
22. 7,</w>
22. 7%.</w>
22. 7%,</w>
22. 62</w>
22. 6,</w>
22. 5+/-8.0</w>
22. 5).</w>
22. 5%.</w>
22. 5%,</w>
22. 4)</w>
22. 4%</w>
22. 4%).</w>
22. 3-132.1),</w>
22. 3+/-3.6</w>
22. 3%</w>
22. 24,</w>
22. 1;</w>
22. 18</w>
22. 1,</w>
22. 1+/-7.1</w>
22. 0-
22.0- not</w>
22. 0%</w>
22- year-old,</w>
22- oxa-1,25-(OH)2D3</w>
22- hour</w>
22- g</w>
22- fold</w>
22- day</w>
22- bed</w>
22- 68</w>
22- 56</w>
22- 51%).</w>
22- 38);</w>
22- 35</w>
22- 34</w>
22- 27</w>
22- 26</w>
22- 25,</w>
22- 00
22-00 31</w>
22, 875</w>
22, 843</w>
22, 781</w>
22, 23-dihydroavermectin</w>
22 days</w>
22 ].</w>
22 :00</w>
22 29),</w>
22 20
2220 4-53-1)</w>
22 2.3</w>
22 2),</w>
22 19</w>
22 1.6</w>
22 0.5;</w>
22 -1.
22-1. 20)</w>
22 %-
22%- 31%</w>
21C--> T)</w>
21: 45-48).</w>
21: 11.0</w>
21: 00</w>
21: 00
21:00 h,</w>
218 ]</w>
218 ,872</w>
217 G)</w>
217 %,</w>
217 %)</w>
216-2 24].</w>
216-2 24).</w>
216 80),</w>
214 32</w>
210/ 150</w>
210/ 140</w>
210 1.8+/-
2101.8+/- 882.5</w>
210 -1,
210-1, 140</w>
21/ 83</w>
21/ 82</w>
21/ 70</w>
21/ 63</w>
21/ 59</w>
21/ 38</w>
21/ 28</w>
21/ 27</w>
21/ 14
21/14 mmHg</w>
21. 97)</w>
21. 9/9.5</w>
21. 9+/-128.9</w>
21. 9%</w>
21. 8+/-7.5</w>
21. 8%</w>
21. 8%,</w>
21. 7;</w>
21. 7+/-4.3</w>
21. 7%.</w>
21. 7%,</w>
21. 54</w>
21. 50+/-1.42</w>
21. 5,</w>
21. 5+/-0.8</w>
21. 5%</w>
21. 5%,</w>
21. 4,</w>
21. 4)</w>
21. 4%,</w>
21. 37,</w>
21. 30</w>
21. 3)</w>
21. 3%</w>
21. 28)</w>
21. 2+/-
21.2+/- 6.7mm(3)</w>
21. 2).</w>
21. 2%</w>
21. 2%;</w>
21. 1%;</w>
21. 1%,</w>
21. 1%),</w>
21. 0%</w>
21-amino steroids.</w>
21-amino steroids,</w>
21-1 236</w>
21-1 0.12)</w>
21- trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione),</w>
21- subject</w>
21- month-old</w>
21- days-old</w>
21- acetate.</w>
21- 73%).</w>
21- 72)</w>
21- 59</w>
21- 51</w>
21- 50</w>
21- 40</w>
21- 28</w>
21- 27</w>
21- 27)</w>
21- /+
21-/+ 35</w>
21+/-1 9</w>
21+/-1 9%,</w>
21 mg/gm),</w>
21 ]</w>
21 14.</w>
21 )/
21)/ without</w>
21 (CsA)</w>
21 %-
21%- 38%).</w>
20712 A;</w>
207 42</w>
20655 3</w>
20655 3,</w>
205-9 30</w>
205-9 30)</w>
201-99 5.</w>
201-10 6</w>
201-10 6,</w>
201 thallium</w>
201 Thallium</w>
201 TI</w>
201 *</w>
2006; 21:45-48).</w>
2006; 120
2006;120 :</w>
2005; 352(25):2640-2].</w>
2005; 23:</w>
2005- June</w>
2005- 2006.</w>
2004; 89:834-43)</w>
2004; 47:1170-9].</w>
2004; 3:287-302]</w>
2004; 110
2004;110 ;246-9.].</w>
2003- 2005.</w>
2002- Dec.</w>
2002- 2006.</w>
2002- 2006,</w>
2002- 2005.</w>
2002- 0
2002-0 3.</w>
2000; 96:3995-3996)</w>
2000; 57:1461-1463</w>
2000- Hz</w>
2000- August</w>
2000- 2008.</w>
2000- 2006</w>
2000- 2003,</w>
2000- 2002</w>
2000- 2002.</w>
2000- 2001</w>
2000- 2001.</w>
2000 g</w>
200/ 160</w>
200-1 6,800</w>
200-1 10-induced</w>
200- micron</w>
200- microg</w>
200- mg/m2</w>
200- fold</w>
200- 900</w>
200- 750</w>
200- 600</w>
200- 450</w>
200- 400mg</w>
200- 340</w>
200- 250</w>
200- 233</w>
200 microg/hour</w>
200 mg:</w>
200 mg/m(2))</w>
200 mg/kg.</w>
200 mg/kg)</w>
200 mg,</w>
200 U)</w>
200 9),</w>
200 8).</w>
200 8),</w>
200 7.Patient</w>
200 7):</w>
200 7),</w>
200 6:</w>
200 6).</w>
200 5;</w>
200 5)</w>
200 4;</w>
200 4-g</w>
200 3)</w>
200 3);</w>
200 3).</w>
200 3),</w>
200 1;
2001; 97:1942-1946)</w>
200 1);</w>
200 0;</w>
200 000).</w>
200 0/
2000/ cu</w>
200 0%</w>
200 -2
200-2 50g)</w>
200 -100</w>
200 -1000).</w>
200 -10,000</w>
200 --
200-- 300</w>
200 ,000/
200,000/ microl,</w>
200 ,
200, 500</w>
200 ),</w>
200 %)</w>
200 %),</w>
20/ sec,</w>
20/ s)</w>
20/ min.</w>
20/ group)</w>
20/ 72</w>
20/ 64.</w>
20/ 60</w>
20/ 40.</w>
20/ 33</w>
20/ 31</w>
20/ 30</w>
20/ 30(+2)</w>
20/ 13;</w>
20/ 10</w>
20/ 102</w>
20/ 100.</w>
20.0 -5
20.0-5 9.5</w>
20.0 -4
20.0-4 0.2</w>
20.0 ,</w>
20.0 +/-1
20.0+/-1 7.0</w>
20.0 )</w>
20.0 ),</w>
20. 15).</w>
20-tetrak is</w>
20- week-old</w>
20- week,</w>
20- s</w>
20- pole</w>
20- one-21-hemisuccinate),</w>
20- ml</w>
20- minute-long</w>
20- microm</w>
20- microg</w>
20- mg/m2</w>
20- mg/d</w>
20- kDa</w>
20- hour</w>
20- epi-D3;</w>
20- cm</w>
20- center</w>
20- HETE,</w>
20- 99+/-17</w>
20- 92%)</w>
20- 90).</w>
20- 83).</w>
20- 80%;</w>
20- 79</w>
20- 797</w>
20- 79)</w>
20- 78%).</w>
20- 68</w>
20- 67</w>
20- 66%</w>
20- 65</w>
20- 64</w>
20- 63)</w>
20- 60%</w>
20- 49</w>
20- 482),</w>
20- 45%)</w>
20- 40%;</w>
20- 35</w>
20- 350</w>
20- 35/15-25</w>
20- 35%;</w>
20- 34</w>
20- 30-minute</w>
20- 28</w>
20- 25).</w>
20- 25%.</w>
20- 240</w>
20- 24)</w>
20- 230</w>
20- 22</w>
20- 200</w>
20- 2.15).</w>
20- 0.69</w>
20- 0.0
20-0.0 35%</w>
20- ,</w>
20, 520</w>
20, 506</w>
20, 40,</w>
20, 310</w>
20, 306</w>
20+/- 8</w>
20+/- 5</w>
20+/- 0.05</w>
20+/- 0.001</w>
20%- 81</w>
20%- 54%).</w>
20 th,</w>
20 p13</w>
20 min</w>
20 mg/kg)</w>
20 mg/day</w>
20 mg.</w>
20 S</w>
20 :00,</w>
20 9-mN-intensity</w>
20 9,</w>
20 9)</w>
20 86)</w>
20 81</w>
20 8.8</w>
20 8.7+/-7.8</w>
20 8,</w>
20 8%</w>
20 76</w>
20 74</w>
20 7/123</w>
20 7.7+/-19.2,</w>
20 7.6</w>
20 7,</w>
20 7)</w>
20 67.4+/-88.1</w>
20 61</w>
20 6/129</w>
20 6)</w>
20 54).</w>
20 53</w>
20 52</w>
20 50</w>
20 5.6+/-16.7</w>
20 5-215</w>
20 5%</w>
20 48</w>
20 48;</w>
20 41</w>
20 4)</w>
20 3delAG,</w>
20 32)</w>
20 32),</w>
20 3).</w>
20 3),</w>
20 3%)</w>
20 2916)</w>
20 27</w>
20 25-g,</w>
20 2.9</w>
20 2.58</w>
20 2+/-
202+/- 82</w>
20 2)</w>
20 15</w>
20 14)</w>
20 11</w>
20 11
2011 16.</w>
20 10,</w>
20 10
2010 ;00:1-14).</w>
20 1+/-
201+/- 81</w>
20 0.000).</w>
20 -1
20-1 15)</w>
20 --
20-- 240</w>
20 ,8
20,8 78</w>
20 ,000/
20,000/ cu.mm.</w>
20 ,000-fold</w>
20 +/-14</w>
20 (2
20(2 8.6</w>
2/57 9.</w>
2/57 6</w>
2/57 1</w>
2/57 0,</w>
2/ day)</w>
2/ cmoat)</w>
2/ Flk-1/KDR)</w>
2/ D2</w>
2/ 9</w>
2/ 94</w>
2/ 90</w>
2/ 9,</w>
2/ 84</w>
2/ 78.5</w>
2/ 65</w>
2/ 60</w>
2/ 6),</w>
2/ 579</w>
2/ 5,</w>
2/ 47</w>
2/ 46)</w>
2/ 40,</w>
2/ 3,</w>
2/ 3)</w>
2/ 3).</w>
2/ 2</w>
2/ 2505)</w>
2/ 20;</w>
2/ 18</w>
2/ 14</w>
2/ 130</w>
2/ 13,</w>
2/ 110;</w>
2/ 10</w>
2/ 100,000)</w>
2/ 1/
2/1/ 12/
2/1/12/ 5</w>
2/ 0/
2/0/ 0,</w>
2.9- point</w>
2.9- 9.3,</w>
2.9- 57.7),</w>
2.9- 5.5x10(9)/l,</w>
2.9- 4.1)</w>
2.9 x10(9)/L,</w>
2.9 9-87.01;</w>
2.9 8-9.95,</w>
2.9 7),</w>
2.9 4;</w>
2.9 4%.</w>
2.9 4%,</w>
2.9 3.</w>
2.9 3).</w>
2.9 3),</w>
2.9 1;</w>
2.9 1,</w>
2.9 1)</w>
2.9 0,</w>
2.9 0%)</w>
2.9 -</w>
2.9 +/-1.0</w>
2.8- 8</w>
2.8- 84.4.</w>
2.8- 3.7</w>
2.8- 29.2).</w>
2.8- 28</w>
2.8+/- 0.4</w>
2.8+/- 0.2</w>
2.8+/- 0.2,</w>
2.8 Delta</w>
2.8 9;</w>
2.8 9,</w>
2.8 9).</w>
2.8 8)</w>
2.8 7,</w>
2.8 6;</w>
2.8 5-fold</w>
2.8 5-5.70),</w>
2.8 5),</w>
2.8 3;</w>
2.8 2-
2.82- 333),</w>
2.8 2+/-
2.82+/- 0.62</w>
2.8 -</w>
2.7-1 7.7</w>
2.7-1 1.8</w>
2.7- fold.</w>
2.7- 8.7%)</w>
2.7- 7.7)</w>
2.7- 63);</w>
2.7- 5.9</w>
2.7- 5.1</w>
2.7- 3.6%.</w>
2.7+/- 4.9</w>
2.7+/- 2.0</w>
2.7 ]);</w>
2.7 9;</w>
2.7 9)</w>
2.7 9),</w>
2.7 8-31.88).</w>
2.7 8,</w>
2.7 7,</w>
2.7 6;</w>
2.7 6-3.0)</w>
2.7 5;</w>
2.7 5-mg,</w>
2.7 4-3.06).</w>
2.7 4,</w>
2.7 4).</w>
2.7 4%,</w>
2.7 3)</w>
2.7 2;</w>
2.7 0,</w>
2.7 %.</w>
2.7 %-
2.7%- 8.5%)</w>
2.6-1 8.6;</w>
2.6-1 7).</w>
2.6-1 1.0;</w>
2.6- fold)</w>
2.6- dimethylacetaminophen</w>
2.6- 8.9</w>
2.6- 64</w>
2.6- 32.4%).</w>
2.6- 25.2%;</w>
2.6- 21.4)</w>
2.6- ,</w>
2.6 8-9.23;</w>
2.6 7;</w>
2.6 7,</w>
2.6 6)</w>
2.6 56</w>
2.6 5-4.03;</w>
2.6 4];</w>
2.6 4;</w>
2.6 4,</w>
2.6 3;</w>
2.6 2;</w>
2.6 2)</w>
2.6 2).</w>
2.6 1)</w>
2.6 +/-1.
2.6+/-1. 9,</w>
2.6 )
2.6) mg/kg.</w>
2.6 %/s</w>
2.6 %-
2.6%- 21.2%;</w>
2.5- to-1</w>
2.5- minute</w>
2.5- micromol/g</w>
2.5- hr</w>
2.5- fold.</w>
2.5- cm</w>
2.5- MHz</w>
2.5- 7.4).</w>
2.5- 5.0mg/kg</w>
2.5- 5.0</w>
2.5- 3</w>
2.5- 3.5%.</w>
2.5- 3.0-fold.</w>
2.5- 3.0%</w>
2.5- 25</w>
2.5- 22.5</w>
2.5- 2.9</w>
2.5- 0.5</w>
2.5- -12</w>
2.5 x10(12)/L,</w>
2.5 s</w>
2.5 mg</w>
2.5 mg/kg)</w>
2.5 h</w>
2.5 ]).</w>
2.5 U)</w>
2.5 :1.</w>
2.5 9,</w>
2.5 9)</w>
2.5 8,</w>
2.5 8)</w>
2.5 6,</w>
2.5 5)</w>
2.5 37-5.109),</w>
2.5 3+/-2.34</w>
2.5 3).</w>
2.5 3),</w>
2.5 2;</w>
2.5 1).</w>
2.5 1),</w>
2.5 -</w>
2.5 +/-1.
2.5+/-1. 1).</w>
2.5 );</w>
2.4- 50)</w>
2.4- 5.0</w>
2.4- 4.0);</w>
2.4- 37.7),</w>
2.4+/- 71.3</w>
2.4 9;</w>
2.4 9).</w>
2.4 9),</w>
2.4 6+/-0.23)</w>
2.4 6)</w>
2.4 4-7.21)</w>
2.4 4-4.58;</w>
2.4 4)</w>
2.4 38,</w>
2.4 3-fold</w>
2.4 2)</w>
2.4 1.</w>
2.4 1-1
2.41-1 3.8,</w>
2.4 1)</w>
2.4 1),</w>
2.4 -</w>
2.4 -17
2.4-17 8).</w>
2.38 :1;</w>
2.38 -</w>
2.3- 94)</w>
2.3- 76.3).</w>
2.3- 3.5)</w>
2.3 7,</w>
2.3 5).</w>
2.3 4,</w>
2.3 3;</w>
2.3 3,</w>
2.3 2,</w>
2.3 2+/-
2.32+/- 0.64,</w>
2.3 2),</w>
2.3 1+/-
2.31+/- 0.12</w>
2.3 1).</w>
2.3 +/-1.
2.3+/-1. 2,</w>
2.3 )/100,000</w>
2.25+/- 5.1</w>
2.25+/- 33.3</w>
2.24- 75.8).</w>
2.24- 4.85).</w>
2.2- fold.</w>
2.2- fold)</w>
2.2- 20.0),</w>
2.2- 2.5</w>
2.2- 2.4</w>
2.2+/- 0.6</w>
2.13 ]).</w>
2.13 -14.
2.13-14. 40])</w>
2.1- fold,</w>
2.1- 68.8,</w>
2.1- 6.0).</w>
2.1- 3.0</w>
2.1- 3.0,</w>
2.1- 24.6).</w>
2.1+/-1. 7</w>
2.1+/-1. 2;</w>
2.08- 44.65</w>
2.08- 3.54;</w>
2.0- point</w>
2.0- 5.0</w>
2.0- 3.0</w>
2.0- 3.0;</w>
2.0- 3.0).</w>
2.0 mg/day.</w>
2.0 ])</w>
2.0 ]).</w>
2.0 9;</w>
2.0 9-7.98;</w>
2.0 9).</w>
2.0 8]).</w>
2.0 8)</w>
2.0 7</w>
2.0 7-2.52).</w>
2.0 7,</w>
2.0 6-5.0/100,000).</w>
2.0 54</w>
2.0 5,</w>
2.0 5).</w>
2.0 4;</w>
2.0 4+/-1.61</w>
2.0 4%;</w>
2.0 3;</w>
2.0 3-27.28),</w>
2.0 3).</w>
2.0 2;</w>
2.0 2%</w>
2.0 1;</w>
2.0 1-2
2.01-2 27.29,</w>
2.0 -18.
2.0-18. 3),</w>
2.0 -1
2.0-1 6.4</w>
2.0 ),</w>
2.0 %.</w>
2.0 %).</w>
2.0 %),</w>
2. ],</w>
2. 99</w>
2. 99),</w>
2. 975,</w>
2. 95</w>
2. 90;</w>
2. 9+/-2.1</w>
2. 9%),</w>
2. 85%</w>
2. 82</w>
2. 80;</w>
2. 80%</w>
2. 8.</w>
2. 8-year-old</w>
2. 8-17.9).</w>
2. 79</w>
2. 78</w>
2. 78),</w>
2. 77</w>
2. 76</w>
2. 75%</w>
2. 73</w>
2. 7.1.35)</w>
2. 7-fold</w>
2. 7%).</w>
2. 68%</w>
2. 66</w>
2. 63</w>
2. 6+/-3.6%,</w>
2. 56</w>
2. 56%).</w>
2. 55)when</w>
2. 50,</w>
2. 5/100</w>
2. 5+/-8.9%,</w>
2. 5%).</w>
2. 49);</w>
2. 49%</w>
2. 48,</w>
2. 48),</w>
2. 47,</w>
2. 44+/-0.11</w>
2. 40</w>
2. 400</w>
2. 4.2.30)</w>
2. 4%.</w>
2. 4%),</w>
2. 38).</w>
2. 37+/-75.38</w>
2. 36</w>
2. 36;</w>
2. 35),</w>
2. 35%</w>
2. 3-fold)</w>
2. 3-14.1</w>
2. 3).</w>
2. 3%;</w>
2. 3%.</w>
2. 29),</w>
2. 286+/-0.195</w>
2. 28,</w>
2. 28)</w>
2. 28),</w>
2. 27,</w>
2. 27%/y</w>
2. 26-8.3).</w>
2. 26).</w>
2. 25-2.75</w>
2. 25,</w>
2. 24</w>
2. 242</w>
2. 23];</w>
2. 23;</w>
2. 22,</w>
2. 21),</w>
2. 205,</w>
2. 20,</w>
2. 2.2</w>
2. 2-fold</w>
2. 2,
2.2, *</w>
2. 2);</w>
2. 2%.</w>
2. 2%-
2.2%- 3.7%).</w>
2. 2
2.2 ]).</w>
2. 1]).</w>
2. 19,</w>
2. 19).</w>
2. 19),</w>
2. 18;</w>
2. 18-
2.18- 33.97;</w>
2. 18,</w>
2. 18%,</w>
2. 17,</w>
2. 17).</w>
2. 16</w>
2. 15+/-
2.15+/- 0.72</w>
2. 14,</w>
2. 14+/-
2.14+/- 0.15
2.14+/-0.15 nmol/mg</w>
2. 13,</w>
2. 12</w>
2. 12;</w>
2. 12-1
2.12-1 0.87;</w>
2. 12-
2.12- 2.59)</w>
2. 10),</w>
2. 1-1
2.1-1 6.2</w>
2. 1);</w>
2. 1).</w>
2. 1%;</w>
2. 00;</w>
2. 00
2.00 %</w>
2. 0-fold</w>
2-propyl -2-
2-propyl-2- pentenoic</w>
2-propion ate).</w>
2-phenylamino adenosine.</w>
2-phenylamino adenosine,</w>
2-phenyl-3,3a-dihydro-4-oxo-5- [4-(4-fluorophenyl)piperazin-1-yl]</w>
2-phenyl-3,3a-dihydro-4-oxo-5- (4-
2-phenyl-3,3a-dihydro-4-oxo-5-(4- phenylpiperazin-1-yl)</w>
2-oxo glutarate</w>
2-o- chlororbenzoyl-4-chloro-N-methyl-N</w>
2-o- Chlorobenzoyl-4-chloro-N-methyl-N</w>
2-methyl-N,N-dimethyl-4-amino azobenzene</w>
2-methyl-N,N-dimethyl-4-amino azobenzene,</w>
2-methyl naphtoquinone</w>
2-methyl butanoyl</w>
2-methoxy-4- (2-
2-methoxy-4-(2- propenyl)</w>
2-methoxy phenylpiperazine</w>
2-methoxy idazoxan.</w>
2-methoxy estradiol,</w>
2-mercaptoethan esulfonic</w>
2-mercaptoethan esulfonate</w>
2-mercapto ethanol.</w>
2-mercapto ethanol,</w>
2-hydroxy- propyl]-</w>
2-hydroxy benzoate</w>
2-ethylhex anoyl</w>
2-deoxy- [14C]</w>
2-deoxy- D-glucose),</w>
2-deoxy- 2
2-deoxy-2 [(18)F]fluoro-D-glucose</w>
2-chlorodeoxy adenosine.</w>
2-chlorodeoxy adenosine-related</w>
2-chlorodeoxy adenosine),</w>
2-chloro- N6-cyclopentyladenosine</w>
2-chloro- N6-cyclopentyladenosine,</w>
2-chloro- N(6)-cyclopentyladenosine</w>
2-chloro- N(6)-cyclopentyladenosine-elicited</w>
2-chloro- 5-hydroxyphenylglycine</w>
2-chloro- 3,6-dimethylpyrazine</w>
2-chloro procaine.</w>
2-chloro -1,</w>
2-bromo ethanamine</w>
2-bromo ergocryptine</w>
2-benzylglutarim ides</w>
2-benzylglutarim ides.</w>
2-amino-7- phosphonic</w>
2-amino-5-phosphono valerate,</w>
2-amino-4-phosphonobut yrate,</w>
2-amino-4- propyl-5-phosphono-3-pentenoic</w>
2-amino- 5,6-dihydro-6-methyl-4H-1,3-thiazine</w>
2-[4-[4-(7- methoxy-1-naphtyl)</w>
2-[4-[4-(7- benzofuranyl)piperazino]butyl]-4-methyl-2H,4H-1,2,4-triazin-3,5-dione</w>
2-[4- (4-fluoro
2-[4-(4-fluoro -
2-[4-(4-fluoro- benzoyl)-piperidin-1-yl]-1-phenyl-ethyl</w>
2-[(8-chlorodibenzo[b,f]thiepin-10-yl)oxy]- N-methylethan-1-amine]</w>
2-[(8-chlorodibenzo[b,f]thiepin-10-yl)oxy]- N,N-dimethylethan-1-amine]</w>
2-[ p-(2-carboxyethyl)</w>
2-[ [4-(2,6-di-1-pyrrlidinyl-4-pyrimidinyl)-1-piperazinyl]methy</w>
2-[ Bicyclo(2,2,1)heptane-2-endo-3-endo-dicarboximido]-glutarimide</w>
2-OH E,</w>
2-Chloro adenosine,</w>
2-Cd A-induced</w>
2-Cd A),</w>
2-Br- alpha-ergokryptine,</w>
2-B EA;</w>
2-3 G)</w>
2-3 5.0</w>
2-2.6 7)</w>
2-2.6 2).</w>
2-2.6 1),</w>
2-199 0.</w>
2-17 G)</w>
2-1.0 8,</w>
2-1.0 8).</w>
2-1.0 7</w>
2-1.0 6</w>
2-1.0 6,</w>
2-1. 82);</w>
2-1. 7;</w>
2-1. 56,</w>
2-1. 55;</w>
2-1 8</w>
2-1 85</w>
2-1 8+).</w>
2-1 7.511,</w>
2-1 608,</w>
2-1 6%)</w>
2-1 4.</w>
2-1 4%;</w>
2-1 3.</w>
2-1 3).</w>
2-1 200</w>
2-1 2.7)</w>
2-1 2-hour</w>
2-1 1.5
2-11.5 9)</w>
2-1 0,</w>
2-1 /2</w>
2-0 93,</w>
2-0 93)</w>
2-0 7).</w>
2-- silymarin</w>
2-- cimetidine,</w>
2-- OTZ</w>
2-- NRF</w>
2-- Aminergic</w>
2-- 48</w>
2-- 30-39.9</w>
2-- 3-months-old</w>
2-- 0.08</w>
2-(4- i-butylphenyl)</w>
2-(4- (4-(2-
2-(4-(4-(2- pyrimidinyl)-1-piperazinyl)butyl)-1,2-benzisothiazol-3-</w>
2-(2-hydroxyethyl amino)-6-(3-chloroanilino)-9-isopropylpurine),</w>
2-(1- adamantyl)ethyl,</w>
2-( phenylamino)adenosine</w>
2- years</w>
2- weeks-delayed</w>
2- weeks)</w>
2- week-interval</w>
2- w</w>
2- type</w>
2- to-1</w>
2- those</w>
2- thiobarbituric</w>
2- thiobarbituric-acid-reactive</w>
2- test,</w>
2- test);</w>
2- tailed,</w>
2- sympathomimetic</w>
2- subunits.</w>
2- step</w>
2- sites</w>
2- sequence,</w>
2- selectivity</w>
2- selectivity.</w>
2- second</w>
2- sec-butylthiazoline,</w>
2- s</w>
2- receptors.</w>
2- receptors,</w>
2- propionate</w>
2- position</w>
2- point</w>
2- piperidino</w>
2- phenylethylamine</w>
2- phenylethylamine.</w>
2- phenyl-1,3-propane-diol</w>
2- period</w>
2- p-(2-carboxyethyl)</w>
2- oxide</w>
2- overexpressing</w>
2- nitrates</w>
2- night,</w>
2- msec</w>
2- morpholino</w>
2- mo</w>
2- min,</w>
2- methyl-6-phenylethynyl-pyridine,</w>
2- methyl-6-(phenyl-ethyl)-pyrimidine</w>
2- macroglobulin).</w>
2- lead</w>
2- isopropoxycarbonyl)</w>
2- isobutyl-3-methoxypyrazine,</w>
2- hydroxylated</w>
2- hydroxy</w>
2- halo-lysergols</w>
2- g</w>
2- fold:</w>
2- fold,</w>
2- fold)</w>
2- fluoro-3,6-dimethylpyrazine</w>
2- fluorenonyl</w>
2- ethyl-4-methylpentanoyl</w>
2- ethyl-3-methylpentanoyl</w>
2- en-valproic</w>
2- dihydro-1-hydroxy-2-imino-4-piperidinopyrimidine)</w>
2- dichlorohexafluorocyclobutane</w>
2- deoxyguanosine</w>
2- deoxyglucose-induced</w>
2- component</w>
2- choice,</w>
2- center</w>
2- butyl-3-[4-[3-(dibutylamino)pro-pyl]benzoyl]-1-benzofuran-5-carboxylate</w>
2- butenenedionate)</w>
2- butanone</w>
2- bromolisuride</w>
2- blocking</w>
2- blocker</w>
2- azahypoxanthine.</w>
2- arylpropionyl-CoA</w>
2- aryl</w>
2- arachydonoylglycerol</w>
2- arachidonylglycerol</w>
2- arachidonyl</w>
2- antagonist,</w>
2- antagonist),</w>
2- amino</w>
2- agonists.</w>
2- agonistic</w>
2- agonist,</w>
2- adrenoceptor-blocking</w>
2- acetylaminofluorene,</w>
2- [5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane</w>
2- [4-(2-methoxyphenyl)-1-piperazinyl-]ethyl</w>
2- [3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose)</w>
2- [2-(1-benzylpiperidin-4-yl)ethyl]-2,3-dihydro-9-methoxy-1H-pyrrolo[3,4-b]quinolin-1-one</w>
2- [14C]deoxyglucose</w>
2- SNP</w>
2- Receptor</w>
2- Octyl-4H-1,3,2-benzodioxaphosphorin</w>
2- N-methylamino-1-butanol</w>
2- Mg,</w>
2- Mercaptoethane</w>
2- In</w>
2- Hydroxyestradiol</w>
2- HE</w>
2- Fluoro-VPA-hydroxamic</w>
2- Ethoxyestradiol</w>
2- Electrophysiologically,</w>
2- Deoxyglucose</w>
2- Deoxy-D-glucose</w>
2- DG.</w>
2- DG-</w>
2- DG,</w>
2- DE-based</w>
2- D</w>
2- CH3O)</w>
2- CDA</w>
2- CADO-elicited</w>
2- BFI,</w>
2- Aryl-3-indoleacetamides</w>
2- Amino-5-phosphonovaleric</w>
2- Agonists</w>
2- Adrenoceptor</w>
2- AR)</w>
2- 96</w>
2- 941)</w>
2- 93</w>
2- 92).</w>
2- 9.89).</w>
2- 9.44)</w>
2- 9).</w>
2- 9),</w>
2- 71</w>
2- 7.</w>
2- 69</w>
2- 66</w>
2- 64</w>
2- 6,</w>
2- 6)</w>
2- 5;</w>
2- 58.7%).</w>
2- 5410-4A</w>
2- 52</w>
2- 50)</w>
2- 5.</w>
2- 5.42).</w>
2- 5).</w>
2- 5%</w>
